id|nct_id|mesh_term|downcase_mesh_term|mesh_type
13986897|NCT02984657|Anesthetics|anesthetics|mesh-list
13986898|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986899|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261095|NCT00359801|Insulin|insulin|mesh-list
14261096|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14261097|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14261098|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261099|NCT00360126|Lamotrigine|lamotrigine|mesh-list
14261100|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
14261101|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14261102|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261103|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261104|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14261105|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261106|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14261107|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14261108|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14261109|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14261110|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14261111|NCT00360230|Vaccines|vaccines|mesh-list
14261112|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
14261113|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261114|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14261115|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14261116|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261117|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261118|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261119|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
14261120|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261121|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261122|NCT00360282|Rizatriptan|rizatriptan|mesh-list
14261123|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14261124|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
14261125|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261126|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261127|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261128|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
14261129|NCT00360334|Exenatide|exenatide|mesh-list
14261130|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14261131|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261132|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14261133|NCT00360334|Incretins|incretins|mesh-ancestor
14261134|NCT00360334|Hormones|hormones|mesh-ancestor
14261135|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261136|NCT00360360|Paclitaxel|paclitaxel|mesh-list
14261137|NCT00360360|Bevacizumab|bevacizumab|mesh-list
14261138|NCT00360360|Carboplatin|carboplatin|mesh-list
14261139|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14261140|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14261141|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261142|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
14261143|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
14261144|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
14261145|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261146|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261147|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261148|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261149|NCT00360360|Growth Substances|growth substances|mesh-ancestor
14261150|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261151|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261152|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14261153|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261154|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14261155|NCT00360399|Citalopram|citalopram|mesh-list
14261156|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14261157|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261158|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261159|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261160|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261161|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
14261162|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261163|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13986900|NCT02984345|Caseins|caseins|mesh-list
13986901|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
13986902|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
13986903|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986904|NCT02984475|Metformin|metformin|mesh-list
13986905|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13986906|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986907|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
13986908|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
13986909|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986910|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
13986911|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986912|NCT02984397|Ketotifen|ketotifen|mesh-list
13986913|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
13986914|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986915|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13986916|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
13986917|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
13986918|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986919|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986920|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986921|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13986922|NCT02984293|Atorvastatin|atorvastatin|mesh-list
13986923|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13986924|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13986925|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
13986926|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986927|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13986928|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13986929|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986930|NCT02984176|Simethicone|simethicone|mesh-list
13986931|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
13986932|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986933|NCT02984176|Emollients|emollients|mesh-ancestor
13986934|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986935|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
13986936|NCT02984111|Hematinics|hematinics|mesh-ancestor
14535611|NCT01189071|Darifenacin|darifenacin|mesh-list
14535612|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14535613|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14535614|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
14535615|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535616|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535617|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535618|NCT01189071|Urological Agents|urological agents|mesh-ancestor
14535619|NCT01183416|Tretinoin|tretinoin|mesh-list
14535620|NCT01183416|Isotretinoin|isotretinoin|mesh-list
14535621|NCT01183416|Antibodies|antibodies|mesh-list
14535622|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14535623|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
14535624|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261164|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
14261165|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14261166|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261167|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14261168|NCT00360399|Analgesics|analgesics|mesh-ancestor
14261169|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
14261170|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
14261171|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14261172|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
14261173|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
14261174|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14261175|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
14261176|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14261177|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261178|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14261179|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14261180|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14261181|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14261182|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14261183|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14261184|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261185|NCT00360568|Levodopa|levodopa|mesh-list
14261186|NCT00360568|Carbidopa|carbidopa|mesh-list
14535625|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535626|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
14022702|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14535627|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535628|NCT01183221|Oxytocin|oxytocin|mesh-list
14535629|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
14535630|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14535631|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535632|NCT01190306|Riboflavin|riboflavin|mesh-list
13986959|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
13986960|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13986961|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
13986962|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986963|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
13986964|NCT02984228|Protective Agents|protective agents|mesh-ancestor
13986965|NCT02984072|Menthol|menthol|mesh-list
13986966|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
13986967|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986968|NCT02983747|Loxoprofen|loxoprofen|mesh-list
13986969|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986970|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986971|NCT02983747|Analgesics|analgesics|mesh-ancestor
13986972|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
13986973|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986974|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261187|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14261188|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14261189|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14261190|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
14261191|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261192|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261193|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261194|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14261195|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261196|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14261197|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
14261198|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
14261199|NCT00360672|Lenalidomide|lenalidomide|mesh-list
14261200|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
14261201|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261202|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261203|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261204|NCT00360672|Growth Substances|growth substances|mesh-ancestor
14261205|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261206|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261207|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
14261208|NCT00360685|Methotrexate|methotrexate|mesh-list
14261209|NCT00360685|Tacrolimus|tacrolimus|mesh-list
14261210|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14261211|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
14261212|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14261213|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261214|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14261215|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
14261216|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261217|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261218|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
14261219|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261220|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14261221|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261222|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
14261223|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081314|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
15081315|NCT04736706|Lenvatinib|lenvatinib|mesh-list
15081316|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261224|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14261225|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14261226|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14261227|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14261228|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
14261229|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14261230|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261231|NCT00360698|Insulin|insulin|mesh-list
14261232|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14261233|NCT00360698|Metformin|metformin|mesh-list
14261234|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
13986975|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986976|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261235|NCT00360698|Glimepiride|glimepiride|mesh-list
14535633|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
13986977|NCT02983591|Misoprostol|misoprostol|mesh-list
13986978|NCT02983591|Oxytocin|oxytocin|mesh-list
13986979|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
13986980|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13986981|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986982|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13986983|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
13986984|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986985|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986986|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13986987|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
13986988|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986989|NCT02983682|Lidocaine|lidocaine|mesh-list
13986990|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
13986991|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
13986992|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986993|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986994|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
13986995|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986996|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14261236|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
14261237|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14261238|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261239|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14261240|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261241|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
14261242|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14261243|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14261244|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261245|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261246|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261247|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261248|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081317|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081318|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081319|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261249|NCT00360724|Analgesics|analgesics|mesh-ancestor
14261250|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
14261251|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261252|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
14261253|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14261254|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
14261255|NCT00360828|Irinotecan|irinotecan|mesh-list
14261256|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14261257|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14261258|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261259|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261260|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261261|NCT00360971|Cisplatin|cisplatin|mesh-list
14261262|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261263|NCT00361140|Vidarabine|vidarabine|mesh-list
14261264|NCT00361140|Fludarabine|fludarabine|mesh-list
14261265|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
14261266|NCT00361140|Busulfan|busulfan|mesh-list
14261267|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261268|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14261269|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
14261270|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261271|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261272|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
14261273|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261274|NCT00361140|Antiviral Agents|antiviral agents|mesh-ancestor
14261275|NCT00361140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261276|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
14261277|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14261278|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14261279|NCT00361218|Citalopram|citalopram|mesh-list
14261280|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14261281|NCT00361218|Serotonin|serotonin|mesh-list
14261282|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261283|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14022703|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261284|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261285|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986997|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13986998|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13986999|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13987000|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987001|NCT02983773|Dronabinol|dronabinol|mesh-list
13987002|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
13987003|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987004|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13987005|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13987006|NCT02983773|Analgesics|analgesics|mesh-ancestor
13987007|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
13987008|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987009|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13987010|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13987011|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987012|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987013|NCT02983773|Hormones|hormones|mesh-ancestor
13987014|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987015|NCT02983734|Cycloserine|cycloserine|mesh-list
13987016|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13987017|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987018|NCT02983734|Renal Agents|renal agents|mesh-ancestor
13987019|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13987020|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
13987021|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13987022|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
13987023|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987024|NCT02983630|Penicillins|penicillins|mesh-list
13987025|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13987026|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022704|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
14022705|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14022706|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14022707|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
14261286|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
14261287|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261288|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14261289|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
14261290|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14261291|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14261292|NCT00361231|Gemcitabine|gemcitabine|mesh-list
14261293|NCT00361231|Bevacizumab|bevacizumab|mesh-list
14261294|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
14261295|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261296|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261297|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261298|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261299|NCT00361231|Growth Substances|growth substances|mesh-ancestor
14261300|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261301|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261302|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14261303|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
14261304|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261305|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
14261306|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261307|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261308|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261309|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
14261310|NCT00361257|Minocycline|minocycline|mesh-list
14535634|NCT01190306|Vitamins|vitamins|mesh-ancestor
14535635|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
14535636|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535637|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14535638|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642768|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14642769|NCT00187070|Renal Agents|renal agents|mesh-ancestor
14642770|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14642771|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
14642772|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14642773|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14642774|NCT00187083|Dexamethasone|dexamethasone|mesh-list
14642775|NCT00187083|Methotrexate|methotrexate|mesh-list
14642776|NCT00187083|Fludarabine|fludarabine|mesh-list
14261311|NCT00361257|Tetracycline|tetracycline|mesh-list
14642777|NCT00187083|Etoposide|etoposide|mesh-list
14642778|NCT00187083|Vincristine|vincristine|mesh-list
14642779|NCT00187083|Topotecan|topotecan|mesh-list
13987027|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
13987028|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
13987029|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13987030|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13987031|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987032|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987033|NCT02983461|Urological Agents|urological agents|mesh-ancestor
13987034|NCT02983214|Cilostazol|cilostazol|mesh-list
13987035|NCT02983214|Clopidogrel|clopidogrel|mesh-list
13987036|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13987037|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13987038|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13987039|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13987040|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
13987041|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987042|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987043|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987044|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13987045|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
14261312|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14261313|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261314|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14261315|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261316|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292040|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15081320|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081321|NCT04710030|Valacyclovir|valacyclovir|mesh-list
15081322|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
14535639|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14535640|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
14535641|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13987046|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292041|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292042|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292043|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14292044|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292045|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
14292046|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14292047|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14292048|NCT00558103|Lapatinib|lapatinib|mesh-list
14292049|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292050|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14292051|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292052|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292053|NCT00558259|Dabigatran|dabigatran|mesh-list
14292054|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
14292055|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14292056|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
14292057|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292058|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292059|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
14292060|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
14292061|NCT00558272|Saracatinib|saracatinib|mesh-list
14292062|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14292063|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292064|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292065|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292066|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292067|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
14292068|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14292069|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14292070|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14292071|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
14292072|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292073|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292074|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292075|NCT00558363|Dutasteride|dutasteride|mesh-list
14292076|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14292077|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14292078|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535642|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14535643|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
13987047|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13987048|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
13987049|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13987050|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13987051|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
13987052|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13987053|NCT02983214|Protective Agents|protective agents|mesh-ancestor
13987054|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13987055|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13987056|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987057|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
13987058|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13987059|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987060|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987061|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13987062|NCT02983344|Fentanyl|fentanyl|mesh-list
13987063|NCT02983344|Ropivacaine|ropivacaine|mesh-list
13987064|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
13987065|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
13987066|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987067|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987068|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
13987069|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987070|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13987071|NCT02983344|Narcotics|narcotics|mesh-ancestor
13987072|NCT02983344|Analgesics|analgesics|mesh-ancestor
13987073|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13987074|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13987075|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
13987076|NCT02983084|Copper|copper|mesh-list
13987077|NCT02983084|Nickel|nickel|mesh-list
13987078|NCT02983084|Trace Elements|trace elements|mesh-ancestor
13987079|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
13987080|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987081|NCT02983422|Aminophylline|aminophylline|mesh-list
13987082|NCT02983422|Furosemide|furosemide|mesh-list
13987083|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13987084|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
13987085|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987086|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987087|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13987088|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
13987089|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13987090|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13987091|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987092|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987093|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13987094|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13987095|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
15081323|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081324|NCT04704050|Dronedarone|dronedarone|mesh-list
15081325|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15081326|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
15081327|NCT04700072|Lenvatinib|lenvatinib|mesh-list
15081328|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987096|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987097|NCT02983422|Protective Agents|protective agents|mesh-ancestor
13987098|NCT02983422|Diuretics|diuretics|mesh-ancestor
13987099|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
13987100|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13987101|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13987102|NCT02983097|Cytarabine|cytarabine|mesh-list
13987103|NCT02983097|Dexamethasone|dexamethasone|mesh-list
13987104|NCT02983097|Rituximab|rituximab|mesh-list
13987105|NCT02983097|Carboplatin|carboplatin|mesh-list
13987106|NCT02983097|Lenalidomide|lenalidomide|mesh-list
13987107|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987108|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987109|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
13987110|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
13987111|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261317|NCT00361270|Complement Factor H|complement factor h|mesh-list
14261318|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15081329|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987112|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987113|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987114|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
13987115|NCT02983097|Hormones|hormones|mesh-ancestor
13987116|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987117|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987118|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987119|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
13987120|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13987121|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13987122|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
13987123|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987124|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
13987125|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987126|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987127|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13987128|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13987129|NCT02983097|Growth Substances|growth substances|mesh-ancestor
13987130|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
13987131|NCT02983383|Anesthetics|anesthetics|mesh-list
13987132|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987133|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987134|NCT02982798|Metformin|metformin|mesh-list
13987135|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13987136|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987137|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987138|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13987139|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13987140|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
13987141|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987142|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13987143|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13987144|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022708|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14022709|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14261319|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261320|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
14261321|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261322|NCT00361283|Atorvastatin|atorvastatin|mesh-list
14261323|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14261324|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14261325|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
14261326|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261327|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14261328|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14261329|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261330|NCT00361335|Golimumab|golimumab|mesh-list
14261331|NCT00361335|Methotrexate|methotrexate|mesh-list
14261332|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14261333|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
14261334|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14261335|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261336|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14261337|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
14261338|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261339|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261340|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535644|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535645|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022710|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14261341|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261342|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14261343|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261344|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
14261345|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261346|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14261347|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14261348|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022711|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14022712|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14022713|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
14022714|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022715|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14022716|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13987145|NCT02982889|Bupivacaine|bupivacaine|mesh-list
13987146|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
13987147|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
13987148|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
13987149|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987150|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987151|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
13987152|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987153|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13987154|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
13987155|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
13987156|NCT02982889|Protective Agents|protective agents|mesh-ancestor
13987157|NCT02982694|Bevacizumab|bevacizumab|mesh-list
13987158|NCT02982694|Atezolizumab|atezolizumab|mesh-list
13987159|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987160|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987161|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13987162|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13987163|NCT02982694|Growth Substances|growth substances|mesh-ancestor
13987164|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987165|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
13987166|NCT02982850|Aspirin|aspirin|mesh-list
14261349|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
14261350|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14261351|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14261352|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14261353|NCT00361504|Oxycodone|oxycodone|mesh-list
14261354|NCT00361504|Tapentadol|tapentadol|mesh-list
14261355|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14261356|NCT00361504|Narcotics|narcotics|mesh-ancestor
14261357|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14261358|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261359|NCT00361504|Analgesics|analgesics|mesh-ancestor
14261360|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
14261361|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261362|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14261363|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261364|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261365|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261366|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
14261367|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261368|NCT00361569|Estrogens|estrogens|mesh-list
14261369|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14261370|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
14261371|NCT00361569|Hormones|hormones|mesh-ancestor
14261372|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261373|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261374|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
14261375|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14261376|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261377|NCT00361634|Etanercept|etanercept|mesh-list
14261378|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14261379|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14261380|NCT00361634|Analgesics|analgesics|mesh-ancestor
14261381|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
14261382|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261383|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261384|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14261385|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261386|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14261387|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261388|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
14261389|NCT00361842|Irinotecan|irinotecan|mesh-list
14261390|NCT00361842|Floxuridine|floxuridine|mesh-list
14261391|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14261392|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14261393|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261394|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261395|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261396|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14261397|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
14261398|NCT00361972|Lansoprazole|lansoprazole|mesh-list
14261399|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
14261400|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14535646|NCT01181921|Galantamine|galantamine|mesh-list
13987167|NCT02982850|Warfarin|warfarin|mesh-list
13987168|NCT02982850|Dabigatran|dabigatran|mesh-list
13987169|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13987170|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13987171|NCT02982850|Analgesics|analgesics|mesh-ancestor
13987172|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
13987173|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987174|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987175|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987176|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13987177|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13987178|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13987179|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987180|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13987181|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13987182|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987183|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
13987184|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
13987185|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
13987186|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13987187|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
13987188|NCT02982551|Insulin|insulin|mesh-list
13987189|NCT02982551|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13987190|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987191|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987192|NCT02982486|Nivolumab|nivolumab|mesh-list
13987193|NCT02982486|Ipilimumab|ipilimumab|mesh-list
13987194|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987195|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987196|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13987197|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987198|NCT02982577|Pilocarpine|pilocarpine|mesh-list
13987199|NCT02982577|Miotics|miotics|mesh-ancestor
13987200|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
13987201|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987202|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987203|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13987204|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13987205|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
13987206|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987207|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987208|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
13987209|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13987210|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987211|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987212|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13987213|NCT02982512|Analgesics|analgesics|mesh-ancestor
13987214|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
13987215|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987216|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13987217|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13987218|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13987219|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
14261401|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14261402|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14261403|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261404|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261405|NCT00362115|Olmesartan|olmesartan|mesh-list
14261406|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14261407|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14261408|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14261409|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14261410|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261411|NCT00362180|Mipomersen|mipomersen|mesh-list
14261412|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14261413|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14261414|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
14261415|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261416|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14261417|NCT00362232|Enoxaparin|enoxaparin|mesh-list
14261418|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
14261419|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
14261420|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14261421|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
14261422|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13987220|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022717|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
13987221|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987222|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
13987223|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13987224|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14022718|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
14261423|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
14261424|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261425|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261426|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
14261427|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14261428|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14261429|NCT00362297|Valacyclovir|valacyclovir|mesh-list
14261430|NCT00362297|Acyclovir|acyclovir|mesh-list
14261431|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
14261432|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261433|NCT00362414|Mitogens|mitogens|mesh-list
14261434|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
14261435|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261436|NCT00362440|Metformin|metformin|mesh-list
14261437|NCT00362440|Pioglitazone|pioglitazone|mesh-list
14261438|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14261439|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261440|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
14261441|NCT00362466|Dasatinib|dasatinib|mesh-list
14261442|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261443|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14261444|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261445|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261446|NCT00362609|Pantoprazole|pantoprazole|mesh-list
14261447|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14261448|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14261449|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14261450|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261451|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261452|NCT00362817|Carboplatin|carboplatin|mesh-list
14261453|NCT00362817|Temozolomide|temozolomide|mesh-list
14261454|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261455|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14261456|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
14261457|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261458|NCT00362882|Docetaxel|docetaxel|mesh-list
14261459|NCT00362882|Bortezomib|bortezomib|mesh-list
15081330|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081331|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081332|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081333|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
15081334|NCT04697576|Nivolumab|nivolumab|mesh-list
15081335|NCT04697576|Ipilimumab|ipilimumab|mesh-list
15081336|NCT04697576|Vaccines|vaccines|mesh-list
14261460|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261461|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
14261462|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
14261463|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
14261464|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261465|NCT00363051|Everolimus|everolimus|mesh-list
14261466|NCT00363051|Octreotide|octreotide|mesh-list
14261467|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261468|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261469|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
14261470|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261471|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14261472|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14261473|NCT00363077|Vaccines|vaccines|mesh-list
14261474|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
14261475|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261476|NCT00363129|Vitamin E|vitamin e|mesh-list
14261477|NCT00363129|Vitamins|vitamins|mesh-ancestor
14261478|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
14261479|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261480|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
14261481|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081337|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
14261482|NCT00363129|Protective Agents|protective agents|mesh-ancestor
14535647|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14261483|NCT00363142|Ritonavir|ritonavir|mesh-list
14261484|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
14261485|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15081338|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987225|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987226|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
13987227|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987228|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987229|NCT02982161|Celecoxib|celecoxib|mesh-list
13987230|NCT02982161|Tramadol|tramadol|mesh-list
13987231|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13987232|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13987233|NCT02982161|Analgesics|analgesics|mesh-ancestor
13987234|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
13987235|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987236|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987237|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987238|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13987239|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13987240|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13987241|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987242|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261486|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14261487|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
14261488|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261489|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261490|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14261491|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14261492|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
14261493|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261494|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14261495|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14261496|NCT00363168|Ranibizumab|ranibizumab|mesh-list
14261497|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261498|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261499|NCT00363168|Growth Substances|growth substances|mesh-ancestor
14261500|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261501|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261502|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261503|NCT00363298|Caffeine|caffeine|mesh-list
14261504|NCT00363298|Amphetamine|amphetamine|mesh-list
14261505|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
14261506|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14261507|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261508|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14261509|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261510|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261511|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14261512|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14261513|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
14261514|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261515|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
14261516|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
14261517|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261518|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
14261519|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14261520|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14261521|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261522|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261523|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14261524|NCT00363311|Dutasteride|dutasteride|mesh-list
14261525|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14261526|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14261527|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261528|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261529|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
14261530|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261531|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261532|NCT00363415|Carboplatin|carboplatin|mesh-list
14261533|NCT00363415|Etoposide|etoposide|mesh-list
14261534|NCT00363415|Pemetrexed|pemetrexed|mesh-list
14261535|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261536|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14261537|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14261538|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14261539|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535648|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987243|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13987244|NCT02982161|Narcotics|narcotics|mesh-ancestor
13987245|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987246|NCT02982395|Ethanol|ethanol|mesh-list
13987247|NCT02982395|Docetaxel|docetaxel|mesh-list
13987248|NCT02982395|Mitomycins|mitomycins|mesh-list
13987249|NCT02982395|Mitomycin|mitomycin|mesh-list
13987250|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987251|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
13987252|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
13987253|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
13987254|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987255|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13987256|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
13987257|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13987258|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987259|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13987260|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987261|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987262|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987263|NCT02982005|Brodalumab|brodalumab|mesh-list
13987264|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
13987265|NCT02982148|Methylene Blue|methylene blue|mesh-list
13987266|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987267|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987268|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
13987269|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
13987270|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13987271|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987272|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987273|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987274|NCT02981979|Prednisone|prednisone|mesh-list
13987275|NCT02981979|Leflunomide|leflunomide|mesh-list
13987276|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987277|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
13987278|NCT02981979|Hormones|hormones|mesh-ancestor
13987279|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987280|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987281|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987282|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987283|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987284|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987285|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987286|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
13987287|NCT02981836|Vaccines|vaccines|mesh-list
13987288|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
13987289|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987290|NCT02981784|Ponatinib|ponatinib|mesh-list
13987291|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987292|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13987293|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987294|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987295|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
13987296|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987297|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987298|NCT02981719|Gemcitabine|gemcitabine|mesh-list
13987299|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13987300|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
13987301|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987302|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987303|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
13987304|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987305|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987306|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987307|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
13987308|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642780|NCT00187083|Asparaginase|asparaginase|mesh-list
13987309|NCT02981615|Levofloxacin|levofloxacin|mesh-list
14261540|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261541|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14261542|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14261543|NCT00363467|Busulfan|busulfan|mesh-list
14261544|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
14261545|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261546|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261547|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
14261548|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261549|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14261550|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261551|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14261552|NCT00363480|Fluticasone|fluticasone|mesh-list
14535649|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535650|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
14535651|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261553|NCT00363480|Albuterol|albuterol|mesh-list
14261554|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14261555|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14261556|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14261557|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
14261558|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261559|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261560|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14261561|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
14261562|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
14261563|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14261564|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14261565|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14261566|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14261567|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
14261568|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261569|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261570|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
14261571|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14261572|NCT00363545|Vaccines|vaccines|mesh-list
14261573|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
14261574|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261575|NCT00363649|Interferons|interferons|mesh-list
14261576|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
14261577|NCT00363649|Sargramostim|sargramostim|mesh-list
14261578|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261579|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
14261580|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261581|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
14261582|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261583|NCT00363779|Cyclosporine|cyclosporine|mesh-list
14261584|NCT00363779|Cyclosporins|cyclosporins|mesh-list
14261585|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261586|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261587|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261588|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
14261589|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261590|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
14261591|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261592|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
14261593|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261594|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14261595|NCT00363883|Vorinostat|vorinostat|mesh-list
14261596|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261597|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14261598|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261599|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261600|NCT00363896|Bromides|bromides|mesh-list
14261601|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
14261602|NCT00364013|Panitumumab|panitumumab|mesh-list
14261603|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261604|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261605|NCT00364156|Nicotine|nicotine|mesh-list
14261606|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14261607|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
14261608|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261609|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261610|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13987310|NCT02981615|Ofloxacin|ofloxacin|mesh-list
13987311|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13987312|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987313|NCT02981615|Renal Agents|renal agents|mesh-ancestor
13987314|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13987315|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13987316|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13987317|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987318|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987319|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987320|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13987321|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13987322|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13987323|NCT02981446|Latanoprost|latanoprost|mesh-list
13987324|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14261611|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14261612|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
14261613|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261614|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261615|NCT00364286|Dasatinib|dasatinib|mesh-list
14261616|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261617|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14261618|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535652|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535653|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14535654|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
14535655|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535656|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
14535657|NCT01188798|Methotrexate|methotrexate|mesh-list
14535658|NCT01188798|Pentostatin|pentostatin|mesh-list
14535659|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14535660|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
14535661|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14535662|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535663|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535664|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
14535665|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535666|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535667|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535668|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535669|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14535670|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535671|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
14535672|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535673|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14535674|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14261619|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261620|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14261621|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261622|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14261623|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261624|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261625|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14261626|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14261627|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261628|NCT00364377|Incretins|incretins|mesh-ancestor
14261629|NCT00364377|Hormones|hormones|mesh-ancestor
14261630|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261631|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14261632|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
14261633|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261634|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261635|NCT00364533|Oxycodone|oxycodone|mesh-list
14261636|NCT00364533|Tapentadol|tapentadol|mesh-list
13987325|NCT02981329|Metformin|metformin|mesh-list
13987326|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987327|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261637|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14261638|NCT00364533|Narcotics|narcotics|mesh-ancestor
14261639|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14261640|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261641|NCT00364533|Analgesics|analgesics|mesh-ancestor
14261642|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
14261643|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261644|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14261645|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261646|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261647|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261648|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
14261649|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261650|NCT00364611|Bevacizumab|bevacizumab|mesh-list
14261651|NCT00364611|Trastuzumab|trastuzumab|mesh-list
14261652|NCT00364611|Docetaxel|docetaxel|mesh-list
14261653|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261654|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261655|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261656|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261657|NCT00364611|Growth Substances|growth substances|mesh-ancestor
14261658|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261659|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261660|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
14261661|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
14261662|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
14261663|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261664|NCT00364793|Emtricitabine|emtricitabine|mesh-list
14261665|NCT00364793|Efavirenz|efavirenz|mesh-list
14261666|NCT00364793|Didanosine|didanosine|mesh-list
14261667|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
14261668|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261669|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14261670|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14261671|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261672|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261673|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14261674|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14261675|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14261676|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14261677|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14261678|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14261679|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14261680|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14261681|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
14261682|NCT00364819|Rituximab|rituximab|mesh-list
14261683|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261684|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261685|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
14261686|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261687|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261688|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
14261689|NCT00364832|Hematinics|hematinics|mesh-ancestor
14261690|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
14261691|NCT00364845|Hematinics|hematinics|mesh-ancestor
14292079|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292080|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
14292081|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292082|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292083|NCT00558428|Amlodipine|amlodipine|mesh-list
14292084|NCT00558428|Telmisartan|telmisartan|mesh-list
14292085|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14292086|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14292087|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14292088|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292089|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292090|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14292091|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292092|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
14022719|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13987328|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
13987329|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13987330|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987331|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13987332|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
13987333|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13987334|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987335|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987336|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987337|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
13987338|NCT02981212|Prednisolone|prednisolone|mesh-list
13987339|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13987340|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13987341|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987342|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13987343|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
13987344|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13987345|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987346|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987347|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987348|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987349|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
13987350|NCT02981212|Hormones|hormones|mesh-ancestor
13987351|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987352|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987353|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987354|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
13987355|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
13987356|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987357|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987358|NCT02981264|Lidocaine|lidocaine|mesh-list
13987359|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
13987360|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
13987361|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987362|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987363|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
13987364|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987365|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13987366|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13987367|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15081339|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081340|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081341|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081342|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081343|NCT04683627|Diclofenac|diclofenac|mesh-list
15081344|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15081345|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15081346|NCT04683627|Analgesics|analgesics|mesh-ancestor
15081347|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
15081348|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081349|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081350|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987368|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13987369|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987370|NCT02981459|Mirabegron|mirabegron|mesh-list
13987371|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14261692|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14261693|NCT00364923|Aminopterin|aminopterin|mesh-list
14261694|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14261695|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261696|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261697|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261698|NCT00365053|Belinostat|belinostat|mesh-list
14261699|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261700|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14261701|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261702|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261703|NCT00365105|Vitamin D|vitamin d|mesh-list
14261704|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
14261705|NCT00365105|Calcium|calcium|mesh-list
14261706|NCT00365105|Vitamins|vitamins|mesh-ancestor
14261707|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
14261708|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987372|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13987373|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13987374|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
13987375|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987376|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987377|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987378|NCT02981459|Urological Agents|urological agents|mesh-ancestor
13987379|NCT02981173|Psilocybin|psilocybin|mesh-list
13987380|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
13987381|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987382|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13987383|NCT02981121|Metformin|metformin|mesh-list
13987384|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987385|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987386|NCT02981095|Bupivacaine|bupivacaine|mesh-list
13987387|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
13987388|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
13987389|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987390|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987391|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
13987392|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987393|NCT02980991|Pemetrexed|pemetrexed|mesh-list
13987394|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987395|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987396|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987397|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13987398|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13987399|NCT02981030|Misoprostol|misoprostol|mesh-list
13987400|NCT02981030|Mifepristone|mifepristone|mesh-list
13987401|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13987402|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
13987403|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13987404|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081351|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13987405|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13987406|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987407|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
13987408|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13987409|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13987410|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13987411|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13987412|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
13987413|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13987414|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13987415|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
13987416|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987417|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
13987418|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13987419|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13987420|NCT02980809|Apatinib|apatinib|mesh-list
13987421|NCT02980809|Topotecan|topotecan|mesh-list
13987422|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987423|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13987424|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987425|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987426|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13987427|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13987428|NCT02980926|Bupivacaine|bupivacaine|mesh-list
13987429|NCT02980926|Mepivacaine|mepivacaine|mesh-list
13987430|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
14261709|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14261710|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14261711|NCT00365144|Bevacizumab|bevacizumab|mesh-list
14261712|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14261713|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261714|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261715|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261716|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261717|NCT00365144|Growth Substances|growth substances|mesh-ancestor
14261718|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261719|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261720|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14535675|NCT01183884|Tretinoin|tretinoin|mesh-list
14535676|NCT01183884|Isotretinoin|isotretinoin|mesh-list
13987431|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
13987432|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987433|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987434|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
13987435|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987436|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14261721|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261722|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261723|NCT00365209|Curcumin|curcumin|mesh-list
14261724|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14261725|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14261726|NCT00365209|Analgesics|analgesics|mesh-ancestor
14261727|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
14261728|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261729|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261730|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14261731|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261732|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261733|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261734|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261735|NCT00365261|Eszopiclone|eszopiclone|mesh-list
14261736|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14261737|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14261738|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261739|NCT00365274|Prednisone|prednisone|mesh-list
14261740|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
14261741|NCT00365274|Doxorubicin|doxorubicin|mesh-list
14261742|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14261743|NCT00365274|Vincristine|vincristine|mesh-list
14261744|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14261745|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261746|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
14261747|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261748|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261749|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14261750|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
14261751|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261752|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261753|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14261754|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14261755|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14261756|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14261757|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261758|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14261759|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
14261760|NCT00365274|Hormones|hormones|mesh-ancestor
14261761|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261762|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14261763|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14261764|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
14261765|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
14261766|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
14261767|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261768|NCT00365300|Pantoprazole|pantoprazole|mesh-list
14261769|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14261770|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14261771|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14261772|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261773|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261774|NCT00365352|Gabapentin|gabapentin|mesh-list
14261775|NCT00365352|Analgesics|analgesics|mesh-ancestor
14261776|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
14261777|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261778|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261779|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
14261780|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13987437|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13987438|NCT02980835|Dexamethasone|dexamethasone|mesh-list
13987439|NCT02980835|Epinephrine|epinephrine|mesh-list
13987440|NCT02980835|Ropivacaine|ropivacaine|mesh-list
13987441|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987442|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
13987443|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
14261781|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13987444|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987445|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987446|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987447|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
13987448|NCT02980835|Hormones|hormones|mesh-ancestor
13987449|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987450|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987451|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987452|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
13987453|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
13987454|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987455|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
13987456|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13987457|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13987458|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
13987459|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987460|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987461|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13987462|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13987463|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13987464|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
13987465|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
13987466|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
13987467|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13987468|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
13987469|NCT02980965|Docetaxel|docetaxel|mesh-list
13987470|NCT02980965|Fluorouracil|fluorouracil|mesh-list
13987471|NCT02980965|Letrozole|letrozole|mesh-list
13987472|NCT02980965|Epirubicin|epirubicin|mesh-list
13987473|NCT02980965|Leuprolide|leuprolide|mesh-list
13987474|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987475|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
13987476|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987477|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13987478|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13987479|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
13987480|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987481|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987482|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13987483|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
13987484|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
13987485|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
13987486|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
13987487|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13987488|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13987489|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13987490|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987491|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13987492|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
13987493|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987494|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13987495|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13987496|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13987497|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13987498|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
13987499|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13987500|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987501|NCT02980757|Gliclazide|gliclazide|mesh-list
13987502|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987503|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987504|NCT02980653|Megestrol|megestrol|mesh-list
13987505|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
13987506|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14261782|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14261783|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14261784|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14261785|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14261786|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261787|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261788|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
14261789|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
14261790|NCT00365365|Bevacizumab|bevacizumab|mesh-list
14261791|NCT00365365|Carboplatin|carboplatin|mesh-list
14261792|NCT00365365|Docetaxel|docetaxel|mesh-list
14261793|NCT00365365|Doxorubicin|doxorubicin|mesh-list
13987507|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14261794|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13987508|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13987509|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
13987510|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13987511|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987512|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14535677|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535678|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
14535679|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535680|NCT01183429|Tretinoin|tretinoin|mesh-list
14535681|NCT01183429|Isotretinoin|isotretinoin|mesh-list
14535682|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535683|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
14535684|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535685|NCT01166178|Vitamin D|vitamin d|mesh-list
13987513|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13987514|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987515|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987516|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
13987517|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13987518|NCT02980562|Bisacodyl|bisacodyl|mesh-list
13987519|NCT02980562|Cathartics|cathartics|mesh-ancestor
13987520|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987521|NCT02980562|Laxatives|laxatives|mesh-ancestor
13987522|NCT02980497|Ethanol|ethanol|mesh-list
13987523|NCT02980497|Listerine|listerine|mesh-list
13987524|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
13987525|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
13987526|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987527|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987528|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535686|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
14535687|NCT01166178|Calcium|calcium|mesh-list
14535688|NCT01166178|Vitamins|vitamins|mesh-ancestor
14535689|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
14535690|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535691|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13987529|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
13987530|NCT02980497|Protective Agents|protective agents|mesh-ancestor
13987531|NCT02980510|Leucovorin|leucovorin|mesh-list
13987532|NCT02980510|Folic Acid|folic acid|mesh-list
13987533|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
13987534|NCT02980510|Irinotecan|irinotecan|mesh-list
13987535|NCT02980510|Panitumumab|panitumumab|mesh-list
13987536|NCT02980510|Fluorouracil|fluorouracil|mesh-list
13987537|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
13987538|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987539|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13987540|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13987541|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987542|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987543|NCT02980510|Antidotes|antidotes|mesh-ancestor
13987544|NCT02980510|Protective Agents|protective agents|mesh-ancestor
13987545|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261795|NCT00365365|Trastuzumab|trastuzumab|mesh-list
14261796|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261797|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
14261798|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261799|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261800|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14261801|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
14261802|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261803|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261804|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14261805|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261806|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261807|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261808|NCT00365365|Growth Substances|growth substances|mesh-ancestor
14261809|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261810|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
14261811|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
14261812|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
14261813|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14261814|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13987546|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
14261815|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14535692|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13987547|NCT02980510|Vitamins|vitamins|mesh-ancestor
14535693|NCT01169753|Modafinil|modafinil|mesh-list
14642781|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
13987548|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
13987549|NCT02980510|Hematinics|hematinics|mesh-ancestor
13987550|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987551|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
13987552|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13987553|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987554|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
13987555|NCT02980458|Deferiprone|deferiprone|mesh-list
13987556|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13987557|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
13987558|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
13987559|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987560|NCT02980250|Domperidone|domperidone|mesh-list
13987561|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
13987562|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
13987563|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987564|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987565|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987566|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13987567|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
13987568|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987569|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987570|NCT02980094|Vitamins|vitamins|mesh-list
13987571|NCT02980094|Vitamin E|vitamin e|mesh-list
13987572|NCT02980094|Tocopherols|tocopherols|mesh-list
13987573|NCT02980094|Tocotrienols|tocotrienols|mesh-list
13987574|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
13987575|NCT02980094|Selenium|selenium|mesh-list
13987576|NCT02980094|Antioxidants|antioxidants|mesh-list
13987577|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
13987578|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987579|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261816|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261817|NCT00365391|Bevacizumab|bevacizumab|mesh-list
14261818|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14261819|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14261820|NCT00365391|Antibodies|antibodies|mesh-list
14261821|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
14261822|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14261823|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261824|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261825|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261826|NCT00365391|Growth Substances|growth substances|mesh-ancestor
14261827|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261828|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261829|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
14261830|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14261831|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261832|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261833|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
14261834|NCT00365417|Bevacizumab|bevacizumab|mesh-list
14261835|NCT00365417|Docetaxel|docetaxel|mesh-list
14261836|NCT00365417|Doxorubicin|doxorubicin|mesh-list
14261837|NCT00365417|Capecitabine|capecitabine|mesh-list
14261838|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261839|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
14261840|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261841|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261842|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14261843|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
14261844|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261845|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261846|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14261847|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261848|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261849|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261850|NCT00365417|Growth Substances|growth substances|mesh-ancestor
14261851|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261852|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14535694|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14261853|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14261854|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
13987580|NCT02980094|Protective Agents|protective agents|mesh-ancestor
14261855|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13987581|NCT02980094|Trace Elements|trace elements|mesh-ancestor
13987582|NCT02980276|Metformin|metformin|mesh-list
13987583|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987584|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987585|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13987586|NCT02979886|Menotropins|menotropins|mesh-list
13987587|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
13987588|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13987589|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
13987590|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13987591|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987592|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13987593|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987594|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987595|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13987596|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
13987597|NCT02980016|Isoniazid|isoniazid|mesh-list
13987598|NCT02980016|Rifapentine|rifapentine|mesh-list
13987599|NCT02980016|Rifampin|rifampin|mesh-list
13987600|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
13987601|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13987602|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987603|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13987604|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13987605|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
13987606|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987607|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13987608|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13987609|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
13987610|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13987611|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261856|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14261857|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14535695|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535696|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14535697|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14535698|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14535699|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535700|NCT01169610|Varenicline|varenicline|mesh-list
14535701|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14535702|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14535703|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
14535704|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535705|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535706|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081352|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15081353|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081354|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081355|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15081356|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15081357|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081358|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
14535715|NCT01163084|Leuprolide|leuprolide|mesh-list
14535716|NCT01163084|Goserelin|goserelin|mesh-list
14535717|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14535718|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
14535719|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14535720|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535721|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535722|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535723|NCT01166724|Sirolimus|sirolimus|mesh-list
14535724|NCT01166724|Tacrolimus|tacrolimus|mesh-list
13987612|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13987613|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13987614|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13987615|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13987616|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13987617|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13987618|NCT02979665|Ranibizumab|ranibizumab|mesh-list
13987619|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13987620|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13987621|NCT02979665|Growth Substances|growth substances|mesh-ancestor
13987622|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535725|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987623|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
13987624|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987625|NCT02979704|Atorvastatin|atorvastatin|mesh-list
13987626|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13987627|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13987628|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13987629|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
13987630|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987631|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13987632|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13987633|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022720|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14022721|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14022722|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022723|NCT02767154|Mannitol|mannitol|mesh-list
14022724|NCT02767154|Dextrans|dextrans|mesh-list
14022725|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14022726|NCT02767154|Diuretics|diuretics|mesh-ancestor
14022727|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
14022728|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022729|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
14022730|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
14022731|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
14022732|NCT02767102|Melatonin|melatonin|mesh-list
14022733|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
14022734|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022735|NCT02767102|Protective Agents|protective agents|mesh-ancestor
14022736|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022737|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022738|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14022739|NCT02767232|Plasminogen|plasminogen|mesh-list
14022740|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14022741|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14022742|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022743|NCT02767479|Esomeprazole|esomeprazole|mesh-list
14022744|NCT02767479|Rabeprazole|rabeprazole|mesh-list
14022745|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14022746|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022747|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14022748|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022749|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022750|NCT02767089|Prednisone|prednisone|mesh-list
14022751|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022752|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
14022753|NCT02767089|Hormones|hormones|mesh-ancestor
14022754|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022755|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022756|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14022757|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022758|NCT02767219|Dexamethasone|dexamethasone|mesh-list
14022759|NCT02767219|Bevacizumab|bevacizumab|mesh-list
14022760|NCT02767219|Fluorouracil|fluorouracil|mesh-list
14022761|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14022762|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022763|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14022764|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14022765|NCT02767219|Growth Substances|growth substances|mesh-ancestor
14022766|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022767|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
14022768|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022769|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
14022770|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
14022771|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022772|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022773|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
14022774|NCT02767219|Hormones|hormones|mesh-ancestor
14022775|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022776|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987634|NCT02979548|Ondansetron|ondansetron|mesh-list
13987635|NCT02979548|Aprepitant|aprepitant|mesh-list
13987636|NCT02979548|Metoclopramide|metoclopramide|mesh-list
13987637|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
13987638|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
13987639|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987640|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987641|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987642|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
13987643|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
13987644|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13987645|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
13987646|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987647|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987648|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13987649|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13987650|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987651|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13987652|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13987653|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13987654|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13987655|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13987656|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
13987657|NCT02979561|Warfarin|warfarin|mesh-list
13987658|NCT02979561|Dabigatran|dabigatran|mesh-list
13987659|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
13987660|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
13987661|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13987662|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
13987663|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987664|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987665|NCT02979405|Phenylephrine|phenylephrine|mesh-list
13987666|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
13987667|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13987668|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
13987669|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
13987670|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987671|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987672|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
13987673|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13987674|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
13987675|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
14261858|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261859|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14261860|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
14261861|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
14261862|NCT00365456|Hormones|hormones|mesh-list
14261863|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
14261864|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261865|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261866|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14261867|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14261868|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261869|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14261870|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14261871|NCT00365508|Nicotine|nicotine|mesh-list
14261872|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14261873|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
14261874|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261875|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261876|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14261877|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14261878|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14261879|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261880|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261881|NCT00365547|Bevacizumab|bevacizumab|mesh-list
14261882|NCT00365547|Topotecan|topotecan|mesh-list
14261883|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261884|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261885|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261886|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261887|NCT00365547|Growth Substances|growth substances|mesh-ancestor
14261888|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987676|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14261889|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
14022777|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
13987677|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13987678|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13987679|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
13987680|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987681|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987682|NCT02979405|Protective Agents|protective agents|mesh-ancestor
13987683|NCT02979392|Paclitaxel|paclitaxel|mesh-list
13987684|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13987685|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987686|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
13987687|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
13987688|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
13987689|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987690|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
13987691|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
13987692|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
13987693|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987694|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
13987695|NCT02979223|Protective Agents|protective agents|mesh-ancestor
13987696|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987697|NCT02979223|Vitamins|vitamins|mesh-ancestor
13987698|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
13987699|NCT02979223|Cathartics|cathartics|mesh-ancestor
13987700|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987701|NCT02979093|Oxytocin|oxytocin|mesh-list
13987702|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
13987703|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13987704|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987705|NCT02978976|Betamethasone|betamethasone|mesh-list
13987706|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987707|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
13987708|NCT02978976|Hormones|hormones|mesh-ancestor
13987709|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987710|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987711|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13987712|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
13987713|NCT02979132|Iron|iron|mesh-list
13987714|NCT02979132|Trace Elements|trace elements|mesh-ancestor
13987715|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
13987716|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987717|NCT02978482|Durvalumab|durvalumab|mesh-list
13987718|NCT02978482|Tremelimumab|tremelimumab|mesh-list
13987719|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13987720|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987721|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987722|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
13987723|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987724|NCT02978313|Cetuximab|cetuximab|mesh-list
13987725|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987726|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987727|NCT02978404|Nivolumab|nivolumab|mesh-list
13987728|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987729|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987730|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13987731|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987732|NCT02978495|Paclitaxel|paclitaxel|mesh-list
14261890|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14261891|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14261892|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261893|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261894|NCT00365599|Tamoxifen|tamoxifen|mesh-list
14261895|NCT00365599|Vorinostat|vorinostat|mesh-list
14261896|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261897|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14261898|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
14261899|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261900|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261901|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987733|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
13987734|NCT02978495|Carboplatin|carboplatin|mesh-list
13987735|NCT02978495|Doxorubicin|doxorubicin|mesh-list
13987736|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13987737|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987738|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
13987739|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
13987740|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
13987741|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987742|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987743|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
13987744|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987745|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13987746|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13987747|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
13987748|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13987749|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15081359|NCT04666038|Rituximab|rituximab|mesh-list
15081360|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15081361|NCT04666038|Idelalisib|idelalisib|mesh-list
13987750|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13987751|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13987752|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987753|NCT02978547|Metformin|metformin|mesh-list
13987754|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13987755|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987756|NCT02978222|Molgramostim|molgramostim|mesh-list
13987757|NCT02978222|Sargramostim|sargramostim|mesh-list
13987758|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
13987759|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987760|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987761|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14261902|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261903|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14261904|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14261905|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14261906|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14261907|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261908|NCT00365716|Vaccines|vaccines|mesh-list
14261909|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
14261910|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261911|NCT00365794|Testosterone|testosterone|mesh-list
14261912|NCT00365794|Androgens|androgens|mesh-ancestor
14261913|NCT00365794|Hormones|hormones|mesh-ancestor
14261914|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261915|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261916|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
14261917|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261918|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261919|NCT00365859|Aripiprazole|aripiprazole|mesh-list
14261920|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
14261921|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14261922|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14261923|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14261924|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14261925|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261926|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
14261927|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
14261928|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261929|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261930|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14261931|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14261932|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
14261933|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14261934|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14261935|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14261936|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14261937|NCT00365976|Eszopiclone|eszopiclone|mesh-list
14261938|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14261939|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14261940|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261941|NCT00366106|Dexamethasone|dexamethasone|mesh-list
14261942|NCT00366106|Doxorubicin|doxorubicin|mesh-list
14261943|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13987762|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
14261944|NCT00366106|Bortezomib|bortezomib|mesh-list
13987763|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13987764|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13987765|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13987766|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987767|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987768|NCT02978443|Nivolumab|nivolumab|mesh-list
13987769|NCT02978443|Ipilimumab|ipilimumab|mesh-list
13987770|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987771|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987772|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13987773|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987774|NCT02977897|Octreotide|octreotide|mesh-list
13987775|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987776|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987777|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987778|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13987779|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13987780|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
13987781|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987782|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987783|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13987784|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13987785|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13987786|NCT02978040|Tirofiban|tirofiban|mesh-list
13987787|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13987788|NCT02978040|Cangrelor|cangrelor|mesh-list
13987789|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13987790|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13987791|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13987792|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987793|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13987794|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13987795|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13987796|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
13987797|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987798|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022778|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022779|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022780|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022781|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
14022782|NCT02767076|Anesthetics|anesthetics|mesh-list
14022783|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022784|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022785|NCT02767063|Pioglitazone|pioglitazone|mesh-list
14261945|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14261946|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
14261947|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
14261948|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261949|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261950|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14261951|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
14261952|NCT00366106|Hormones|hormones|mesh-ancestor
14261953|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261954|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14261955|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261956|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14261957|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14261958|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14261959|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261960|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261961|NCT00366249|Ertapenem|ertapenem|mesh-list
14022786|NCT02767063|Avelumab|avelumab|mesh-list
14022787|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14022788|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022789|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14022790|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022791|NCT02766764|Hormones|hormones|mesh-list
14022792|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022793|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022794|NCT02766855|Cysteamine|cysteamine|mesh-list
14022795|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14261962|NCT00366249|Tigecycline|tigecycline|mesh-list
13987799|NCT02977832|Alfuzosin|alfuzosin|mesh-list
13987800|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13987801|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13987802|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13987803|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
13987804|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987805|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987806|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987807|NCT02977832|Urological Agents|urological agents|mesh-ancestor
13987808|NCT02978066|Anesthetics|anesthetics|mesh-list
13987809|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987810|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987811|NCT02978001|Glycerol|glycerol|mesh-list
13987812|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13987813|NCT02978001|Protective Agents|protective agents|mesh-ancestor
13987814|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987815|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
13987816|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13987817|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987818|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13987819|NCT02977637|Hematinics|hematinics|mesh-ancestor
13987820|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13987821|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13987822|NCT02977741|Olanzapine|olanzapine|mesh-list
13987823|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
13987824|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
13987825|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987826|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987827|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987828|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13987829|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13987830|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987831|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13987832|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13987833|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14261963|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14261964|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261965|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14261966|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261967|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261968|NCT00366301|Metformin|metformin|mesh-list
14261969|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
14261970|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14261971|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261972|NCT00366340|Vaccines|vaccines|mesh-list
14261973|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14261974|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
14261975|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261976|NCT00366444|Diclofenac|diclofenac|mesh-list
14261977|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14261978|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14261979|NCT00366444|Analgesics|analgesics|mesh-ancestor
14261980|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
14261981|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261982|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261983|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14261984|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14261985|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14261986|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261987|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261988|NCT00366457|Gemcitabine|gemcitabine|mesh-list
14261989|NCT00366457|Bevacizumab|bevacizumab|mesh-list
14261990|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14261991|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14261992|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14261993|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14261994|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14261995|NCT00366457|Growth Substances|growth substances|mesh-ancestor
14261996|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261997|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
14261998|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14261999|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
15081362|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262000|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987834|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13987835|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987836|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987837|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
13987838|NCT02977533|Acyclovir|acyclovir|mesh-list
13987839|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
13987840|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987841|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13987842|NCT02977611|Hematinics|hematinics|mesh-ancestor
13987843|NCT02977494|Dexamethasone|dexamethasone|mesh-list
13987844|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
13987845|NCT02977494|Bortezomib|bortezomib|mesh-list
13987846|NCT02977494|Daratumumab|daratumumab|mesh-list
13987847|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13987848|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
13987849|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
13987850|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987851|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987852|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987853|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
13987854|NCT02977494|Hormones|hormones|mesh-ancestor
13987855|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13987856|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13987857|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987858|NCT02977208|Gabapentin|gabapentin|mesh-list
13987859|NCT02977208|Analgesics|analgesics|mesh-ancestor
13987860|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
13987861|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262001|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
14262002|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262003|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262004|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262005|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
14262006|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262007|NCT00366535|Neurotropin|neurotropin|mesh-list
14262008|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14262009|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
14262010|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262011|NCT00366535|Analgesics|analgesics|mesh-ancestor
14262012|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
14262013|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262014|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
14262015|NCT00366548|Vaccines|vaccines|mesh-list
15081363|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081364|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
15081365|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081366|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081367|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081368|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
14262016|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14262017|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
14262018|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262019|NCT00366626|Naltrexone|naltrexone|mesh-list
14262020|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14262021|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14262022|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262023|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
14262024|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262025|NCT00366678|Vaccines|vaccines|mesh-list
14262026|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14262027|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
14262028|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262029|NCT00366899|Vaccines|vaccines|mesh-list
14262030|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14262031|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
14262032|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292093|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14292094|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14292095|NCT00558467|Pramipexole|pramipexole|mesh-list
14292096|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
15172937|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14292097|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292098|NCT00558467|Protective Agents|protective agents|mesh-ancestor
14292099|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292100|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13987862|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987863|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
13987864|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13987865|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13987866|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987867|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13987868|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13987869|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13987870|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987871|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987872|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
13987873|NCT02977169|Cisplatin|cisplatin|mesh-list
13987874|NCT02977169|Carboplatin|carboplatin|mesh-list
13987875|NCT02977169|Pemetrexed|pemetrexed|mesh-list
13987876|NCT02977169|Vinorelbine|vinorelbine|mesh-list
13987877|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987878|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987879|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987880|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13987881|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13987882|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13987883|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
13987884|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
13987885|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
13987886|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
13987887|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13987888|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
13987889|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987890|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13987891|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987892|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535726|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
14535727|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535728|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14535729|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535730|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535731|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14535732|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535733|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14535734|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535735|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
14535736|NCT01157533|Vancomycin|vancomycin|mesh-list
14535737|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14535738|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535739|NCT01162304|Oxycodone|oxycodone|mesh-list
14535740|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14535741|NCT01162304|Narcotics|narcotics|mesh-ancestor
14535742|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14535743|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535744|NCT01162304|Analgesics|analgesics|mesh-ancestor
14535745|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
14535746|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535747|NCT01151904|Timolol|timolol|mesh-list
14535748|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13987916|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
13987917|NCT02977286|Naloxegol|naloxegol|mesh-list
13987918|NCT02977286|Bisacodyl|bisacodyl|mesh-list
13987919|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
13987920|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
13987921|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13987922|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987923|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
13987924|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987925|NCT02977286|Cathartics|cathartics|mesh-ancestor
13987926|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987927|NCT02977286|Laxatives|laxatives|mesh-ancestor
13987928|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
13987929|NCT02977065|Atorvastatin|atorvastatin|mesh-list
13987930|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13987931|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13987932|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13987933|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
13987934|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262033|NCT00367016|Omalizumab|omalizumab|mesh-list
14262034|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14535749|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14535750|NCT01151904|Latanoprost|latanoprost|mesh-list
14535751|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14642782|NCT00187083|Idarubicin|idarubicin|mesh-list
13987935|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13987936|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13987937|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987938|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13987939|NCT02977013|Dalteparin|dalteparin|mesh-list
13987940|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
13987941|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13987942|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13987943|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987944|NCT02977000|Propranolol|propranolol|mesh-list
13987945|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13987946|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13987947|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
13987948|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13987949|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987950|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987951|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13987952|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13987953|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
13987954|NCT02976987|Cidofovir|cidofovir|mesh-list
13987955|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
13987956|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13987957|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13987958|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987959|NCT02976805|Bisacodyl|bisacodyl|mesh-list
13987960|NCT02976805|Cathartics|cathartics|mesh-ancestor
13987961|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13987962|NCT02976805|Laxatives|laxatives|mesh-ancestor
13987963|NCT02976909|Paclitaxel|paclitaxel|mesh-list
13987964|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13987965|NCT02976909|Cisplatin|cisplatin|mesh-list
13987966|NCT02976909|Fluorouracil|fluorouracil|mesh-list
13987967|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13987968|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987969|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
13987970|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
13987971|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
13987972|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987973|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
13987974|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13987975|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13987976|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
14262035|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14262036|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14262037|NCT00367055|Metformin|metformin|mesh-list
14262038|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
14262039|NCT00367055|Gliclazide|gliclazide|mesh-list
14262040|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14262041|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262042|NCT00367133|Triamcinolone|triamcinolone|mesh-list
14262043|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14262044|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14262045|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14262046|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262047|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
14262048|NCT00367133|Hormones|hormones|mesh-ancestor
14262049|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262050|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262051|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262052|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
14262053|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262054|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262055|NCT00367237|Methotrexate|methotrexate|mesh-list
14262056|NCT00367237|Infliximab|infliximab|mesh-list
14262057|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14262058|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
14262059|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14262060|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262061|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13987977|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262062|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
14262063|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262064|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13987978|NCT02976727|Vitamin D|vitamin d|mesh-list
13987979|NCT02976727|Lidocaine|lidocaine|mesh-list
13987980|NCT02976727|Prilocaine|prilocaine|mesh-list
13987981|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13987982|NCT02976727|Calcipotriene|calcipotriene|mesh-list
13987983|NCT02976727|Vitamins|vitamins|mesh-ancestor
13987984|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
13987985|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13987986|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
13987987|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
13987988|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13987989|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
13987990|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13987991|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13987992|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13987993|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13987994|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13987995|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13987996|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13987997|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
13987998|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13987999|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
13988000|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988001|NCT02976571|Bupivacaine|bupivacaine|mesh-list
13988002|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
14262065|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
14262066|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262067|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14262068|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262069|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
14262070|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14262071|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262072|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262073|NCT00367341|Citalopram|citalopram|mesh-list
14262074|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14262075|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14262076|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262077|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262078|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262079|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
14262080|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262081|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14262082|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
14262083|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262084|NCT00367432|Levetiracetam|levetiracetam|mesh-list
14262085|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
14262086|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
14262087|NCT00367458|Atorvastatin|atorvastatin|mesh-list
14262088|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14262089|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14535752|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14535753|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14535754|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
14535755|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535756|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535757|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535758|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14535759|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14535760|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14535761|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15081369|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081370|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081371|NCT04659369|Nivolumab|nivolumab|mesh-list
15081372|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081373|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081374|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081375|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081376|NCT04644237|Trastuzumab|trastuzumab|mesh-list
15081377|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13988003|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
13988004|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262090|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
14262091|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262092|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14262093|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13988005|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988006|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
13988007|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988008|NCT02976935|Xenon|xenon|mesh-list
13988009|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14262094|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262095|NCT00367484|Interferons|interferons|mesh-list
14262096|NCT00367484|Interferon-beta|interferon-beta|mesh-list
14262097|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
14262098|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262099|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
14262100|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262101|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
14262102|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262103|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14262104|NCT00367601|Bevacizumab|bevacizumab|mesh-list
15081378|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081379|NCT04636034|Anesthetics|anesthetics|mesh-list
13988010|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
14262105|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14262106|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262107|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262108|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14262109|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14262110|NCT00367601|Growth Substances|growth substances|mesh-ancestor
14262111|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262112|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
14262113|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262114|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262115|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262116|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
14262117|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262118|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
14262119|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14262120|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262121|NCT00367770|Bosentan|bosentan|mesh-list
14262122|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14262123|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15081380|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
13988011|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
13988012|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988013|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988014|NCT02976623|Metronidazole|metronidazole|mesh-list
13988015|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988016|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988017|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13988018|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13988019|NCT02976896|Apatinib|apatinib|mesh-list
13988020|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988021|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262124|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262125|NCT00367835|Guanfacine|guanfacine|mesh-list
14262126|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14262127|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14262128|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14262129|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14262130|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
14262131|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262132|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262133|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262134|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
14262135|NCT00367991|Hematinics|hematinics|mesh-ancestor
14262136|NCT00368069|Levetiracetam|levetiracetam|mesh-list
14262137|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
14262138|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
14262139|NCT00368251|Brivaracetam|brivaracetam|mesh-list
14262140|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
14262141|NCT00368277|Amlodipine|amlodipine|mesh-list
14262142|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14262143|NCT00368277|Ramipril|ramipril|mesh-list
14262144|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14262145|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14262146|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262147|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262148|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13988022|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988023|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988024|NCT02976272|Bortezomib|bortezomib|mesh-list
13988025|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988026|NCT02976259|Dolutegravir|dolutegravir|mesh-list
13988027|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13988028|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13988029|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988030|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988031|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13988032|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13988033|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
13988034|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262149|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262150|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
14262151|NCT00368277|Diuretics|diuretics|mesh-ancestor
14262152|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
14262153|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14262154|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14262155|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
14262156|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262157|NCT00368290|Modafinil|modafinil|mesh-list
14262158|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14262159|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262160|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14262161|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14262162|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14262163|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262164|NCT00368355|Cytarabine|cytarabine|mesh-list
14262165|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
14262166|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
14262167|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262168|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
14262169|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262170|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14262171|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14262172|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
14262173|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262174|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262175|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14262176|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14262177|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
14262178|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
14262179|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262180|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262181|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14262182|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14262183|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
14262184|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262185|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262186|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14262187|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14262188|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14262189|NCT00368537|Ampicillin|ampicillin|mesh-list
14262190|NCT00368537|Tigecycline|tigecycline|mesh-list
14262191|NCT00368537|Sulbactam|sulbactam|mesh-list
14262192|NCT00368537|Sultamicillin|sultamicillin|mesh-list
14262193|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14262194|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262195|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14262196|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262197|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262198|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14262199|NCT00368550|Sertraline|sertraline|mesh-list
14262200|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
14262201|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262202|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14262203|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14262204|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262205|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262206|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262207|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
13988035|NCT02976597|Morphine|morphine|mesh-list
13988036|NCT02976597|Bupivacaine|bupivacaine|mesh-list
13988037|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
13988038|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
13988039|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988040|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988041|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
13988042|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988043|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13988044|NCT02976597|Narcotics|narcotics|mesh-ancestor
13988045|NCT02976597|Analgesics|analgesics|mesh-ancestor
14022796|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022797|NCT02767024|Nitroprusside|nitroprusside|mesh-list
14022798|NCT02767024|Dobutamine|dobutamine|mesh-list
14022799|NCT02767024|Furosemide|furosemide|mesh-list
14022800|NCT02767024|Diuretics|diuretics|mesh-ancestor
14022801|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
14022802|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022803|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14022804|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14022805|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022806|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14022807|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
14022808|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
14022809|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022810|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14022811|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14022812|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14022813|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022814|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022815|NCT02767024|Protective Agents|protective agents|mesh-ancestor
14022816|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14022817|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
14022818|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14022819|NCT02766803|Resveratrol|resveratrol|mesh-list
14022820|NCT02766803|Simvastatin|simvastatin|mesh-list
14262208|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262209|NCT00368641|Icodextrin|icodextrin|mesh-list
14262210|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
14262211|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14262212|NCT00368745|Pregabalin|pregabalin|mesh-list
14262213|NCT00368745|Analgesics|analgesics|mesh-ancestor
14262214|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
14262215|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262216|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262217|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
14262218|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14262219|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262220|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262221|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14262222|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14262223|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14262224|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262225|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262226|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14262227|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14262228|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14262229|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262230|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535762|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14535763|NCT01155518|Clomiphene|clomiphene|mesh-list
14535764|NCT01155518|Testosterone|testosterone|mesh-list
14535765|NCT01155518|Androgens|androgens|mesh-ancestor
14535766|NCT01155518|Hormones|hormones|mesh-ancestor
14535767|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535768|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535769|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14535770|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
14535771|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14535772|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
14535773|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14262231|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
14535774|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14535775|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14022821|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14022822|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13988046|NCT02976194|Ranibizumab|ranibizumab|mesh-list
13988047|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13988048|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13988049|NCT02976194|Growth Substances|growth substances|mesh-ancestor
13988050|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988051|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
13988052|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988053|NCT02976467|Fulacimstat|fulacimstat|mesh-list
13988054|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988055|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988056|NCT02976441|Temozolomide|temozolomide|mesh-list
13988057|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13988058|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
13988059|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988060|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988061|NCT02976246|Vitamin K|vitamin k|mesh-list
13988062|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
13988063|NCT02976246|Vitamins|vitamins|mesh-ancestor
13988064|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
13988065|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988066|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13988067|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13988068|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988069|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
13988070|NCT02976246|Coagulants|coagulants|mesh-ancestor
13988071|NCT02976116|Gefitinib|gefitinib|mesh-list
13988072|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988073|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13988074|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988075|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988076|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
13988077|NCT02975921|Povidone|povidone|mesh-list
13988078|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
13988079|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
13988080|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13988081|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988082|NCT02975843|Beclomethasone|beclomethasone|mesh-list
13988083|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
13988084|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
13988085|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13988086|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
13988087|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988088|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988089|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13988090|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
13988091|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13988092|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13988093|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13988094|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
13988095|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988096|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988097|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13988098|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13988099|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13988100|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
13988101|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988102|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
13988103|NCT02975843|Hormones|hormones|mesh-ancestor
14262232|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262233|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262234|NCT00368875|Paclitaxel|paclitaxel|mesh-list
14262235|NCT00368875|Bevacizumab|bevacizumab|mesh-list
13988104|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988105|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
13988106|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13988107|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988108|NCT02975999|Vasopressins|vasopressins|mesh-list
13988109|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
13988110|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
13988111|NCT02975999|Coagulants|coagulants|mesh-ancestor
13988112|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13988113|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13988114|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
13988115|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988116|NCT02976012|Aflibercept|aflibercept|mesh-list
14262236|NCT00368875|Vorinostat|vorinostat|mesh-list
13988117|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13988118|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13988119|NCT02976012|Growth Substances|growth substances|mesh-ancestor
13988120|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988121|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
13988122|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988123|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
13988124|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13988125|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
13988126|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13988127|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
13988128|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988129|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988130|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
13988131|NCT02975440|Rifampin|rifampin|mesh-list
13988132|NCT02975440|Midazolam|midazolam|mesh-list
13988133|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13988134|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13988135|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988136|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988137|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13988138|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13988139|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13988140|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13988141|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
13988142|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
13988143|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
13988144|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
13988145|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988146|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988147|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13988148|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
13988149|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988150|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988151|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
13988152|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262237|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14262238|NCT00368875|Antibodies|antibodies|mesh-list
14262239|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
14262240|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14262241|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14262242|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262243|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
14262244|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14262245|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14262246|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262247|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14262248|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14262249|NCT00368875|Growth Substances|growth substances|mesh-ancestor
14262250|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262251|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
14262252|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
14262253|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14262254|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262255|NCT00368927|Sulindac|sulindac|mesh-list
14262256|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14262257|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14262258|NCT00368927|Analgesics|analgesics|mesh-ancestor
14262259|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
14262260|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262261|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262262|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262263|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535776|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
13988153|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988154|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13988155|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13988156|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13988157|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13988158|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13988159|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13988160|NCT02975583|Vorapaxar|vorapaxar|mesh-list
13988161|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14535777|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988162|NCT02975570|Levofloxacin|levofloxacin|mesh-list
13988163|NCT02975570|Ofloxacin|ofloxacin|mesh-list
13988164|NCT02975570|Linezolid|linezolid|mesh-list
13988165|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
13988166|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13988167|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988168|NCT02975570|Renal Agents|renal agents|mesh-ancestor
13988169|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988170|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13988171|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13988172|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988173|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988174|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988175|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13988176|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13988177|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13988178|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
13988179|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
13988180|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
13988181|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13988182|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
13988183|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988184|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988185|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13988186|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
13988187|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13988188|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
13988189|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988190|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988191|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13988192|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
13988193|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
13988194|NCT02975258|Protective Agents|protective agents|mesh-ancestor
13988195|NCT02975258|Miotics|miotics|mesh-ancestor
13988196|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13988197|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
13988198|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13988199|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13988200|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
13988201|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13988202|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13988203|NCT02975076|Aspirin|aspirin|mesh-list
13988204|NCT02975076|Clopidogrel|clopidogrel|mesh-list
13988205|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988206|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988207|NCT02975076|Analgesics|analgesics|mesh-ancestor
14262264|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262265|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14262266|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262267|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262268|NCT00368966|Vaccines|vaccines|mesh-list
14262269|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14262270|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
14262271|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262272|NCT00368979|Dutasteride|dutasteride|mesh-list
14262273|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14262274|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14262275|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262276|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262277|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
14262278|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262279|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262280|NCT00368992|Paclitaxel|paclitaxel|mesh-list
14262281|NCT00368992|Bevacizumab|bevacizumab|mesh-list
14262282|NCT00368992|Cetuximab|cetuximab|mesh-list
14262283|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14262284|NCT00368992|Antibodies|antibodies|mesh-list
14262285|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
14262286|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14262287|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14262288|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262289|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14262290|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
13988208|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
13988209|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988210|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988211|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988212|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988213|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13988214|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13988215|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988216|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13988217|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13988218|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988219|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
13988220|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13988221|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13988222|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14262291|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14262292|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262293|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14262294|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14262295|NCT00368992|Growth Substances|growth substances|mesh-ancestor
14262296|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262297|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
14262298|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
14262299|NCT00369122|Bevacizumab|bevacizumab|mesh-list
14262300|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14262301|NCT00369122|Cisplatin|cisplatin|mesh-list
14262302|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
14262303|NCT00369122|Antibodies|antibodies|mesh-list
14262304|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
14262305|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14262306|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
14262307|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262308|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14262309|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14262310|NCT00369122|Growth Substances|growth substances|mesh-ancestor
14262311|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262312|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
14262313|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
14262314|NCT00369161|Everolimus|everolimus|mesh-list
14262315|NCT00369161|Tacrolimus|tacrolimus|mesh-list
14262316|NCT00369161|Basiliximab|basiliximab|mesh-list
14262317|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262318|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
14262319|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262320|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14262321|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262322|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262323|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262324|NCT00369226|Methotrexate|methotrexate|mesh-list
14262325|NCT00369226|Bortezomib|bortezomib|mesh-list
14262326|NCT00369226|Tacrolimus|tacrolimus|mesh-list
14262327|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14262328|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
14262329|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14262330|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262331|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14262332|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
14262333|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262334|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262335|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
14262336|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262337|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14262338|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262339|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
14262340|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14262341|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262342|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14262343|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
14262344|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14262345|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262346|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14262347|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
14262348|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14262349|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988223|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
14262350|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262351|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262352|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
13988224|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988225|NCT02975037|Itraconazole|itraconazole|mesh-list
13988226|NCT02975037|Erythromycin|erythromycin|mesh-list
13988227|NCT02975037|Erythromycin Estolate|erythromycin estolate|mesh-list
13988228|NCT02975037|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
13988229|NCT02975037|Erythromycin stearate|erythromycin stearate|mesh-list
13988230|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
13988231|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
14262353|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14262354|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14262355|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262356|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262357|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262358|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262359|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
14262360|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262361|NCT00369382|Cyclosporine|cyclosporine|mesh-list
14262362|NCT00369382|Sirolimus|sirolimus|mesh-list
14262363|NCT00369382|Tacrolimus|tacrolimus|mesh-list
14262364|NCT00369382|Cyclosporins|cyclosporins|mesh-list
14262365|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262366|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
14262367|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262368|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14262369|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262370|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262371|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
14262372|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262373|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14262374|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14262375|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14262376|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14262377|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262378|NCT00369486|Triamcinolone|triamcinolone|mesh-list
14262379|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14262380|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14262381|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14262382|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262383|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
14262384|NCT00369486|Hormones|hormones|mesh-ancestor
14262385|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262386|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262387|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262388|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
14262389|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262390|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262391|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14262392|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262393|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262394|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262395|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262396|NCT00369577|Loxapine|loxapine|mesh-list
14262397|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14262398|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14262399|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262400|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262401|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262402|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14262403|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
14262404|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262405|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262406|NCT00369590|Aflibercept|aflibercept|mesh-list
14262407|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
14262408|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14262409|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14262410|NCT00369590|Growth Substances|growth substances|mesh-ancestor
14262411|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262412|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
14262413|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262414|NCT00369629|Gemcitabine|gemcitabine|mesh-list
14262415|NCT00369629|Pemetrexed|pemetrexed|mesh-list
14535778|NCT01147393|Epratuzumab|epratuzumab|mesh-list
15081381|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988232|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15081382|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988233|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13988234|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988235|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988236|NCT02975037|Urological Agents|urological agents|mesh-ancestor
14262416|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14262417|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
14262418|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262419|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262420|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
14262421|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262422|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262423|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262424|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
14262425|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262426|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14262427|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262428|NCT00369655|Aflibercept|aflibercept|mesh-list
14262429|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
14262430|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14262431|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14262432|NCT00369655|Growth Substances|growth substances|mesh-ancestor
14262433|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262434|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
14262435|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262436|NCT00369681|Rituximab|rituximab|mesh-list
14262437|NCT00369681|Doxorubicin|doxorubicin|mesh-list
14262438|NCT00369681|Dacarbazine|dacarbazine|mesh-list
14262439|NCT00369681|Bleomycin|bleomycin|mesh-list
14262440|NCT00369681|Vinblastine|vinblastine|mesh-list
14262441|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262442|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262443|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
14262444|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262445|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14262446|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14262447|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14262448|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14262449|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262450|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262451|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14262452|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
14262453|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14262454|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
14262455|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
14262456|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14262457|NCT00369707|Rituximab|rituximab|mesh-list
14262458|NCT00369707|Bortezomib|bortezomib|mesh-list
14262459|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262460|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262461|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
14262462|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262463|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14262464|NCT00369746|Citalopram|citalopram|mesh-list
13988237|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
13988238|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988239|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13988240|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13988241|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13988242|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
13988243|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988244|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988245|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13988246|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988247|NCT02975037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13988248|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13988249|NCT02975219|Bevacizumab|bevacizumab|mesh-list
13988250|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13988251|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988252|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13988253|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13988254|NCT02975219|Growth Substances|growth substances|mesh-ancestor
13988255|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988256|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
13988257|NCT02975323|Carvedilol|carvedilol|mesh-list
13988258|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13988259|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13988260|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
13988261|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988262|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988263|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988264|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13988265|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
13988266|NCT02975323|Protective Agents|protective agents|mesh-ancestor
13988267|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13988268|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13988269|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13988270|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
13988271|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13988272|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13988273|NCT02975141|Gemcitabine|gemcitabine|mesh-list
13988274|NCT02975141|Paclitaxel|paclitaxel|mesh-list
13988275|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13988276|NCT02975141|Afatinib|afatinib|mesh-list
13988277|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13988278|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988279|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
13988280|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
13988281|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
13988282|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988283|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13988284|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
13988285|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
14262465|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14262466|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14262467|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262468|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262469|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262470|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
14262471|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262472|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14262473|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
14262474|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262475|NCT00369785|Donepezil|donepezil|mesh-list
14262476|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14262477|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262478|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262479|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
14262480|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262481|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081383|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
15081384|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081385|NCT04634604|Bevacizumab|bevacizumab|mesh-list
15081386|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081387|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081388|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15081389|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15081390|NCT04634604|Growth Substances|growth substances|mesh-ancestor
14262482|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
14262483|NCT00369915|Scopolamine|scopolamine|mesh-list
14262484|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14262485|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14262486|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
14262487|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
14262488|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262489|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262490|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262491|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
14262492|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14262493|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
13988286|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262494|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081391|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988287|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988288|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13988289|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
13988290|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988291|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13988292|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
13988293|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13988294|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
13988295|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988296|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
14262495|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262496|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14262497|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
14262498|NCT00369941|Tenofovir|tenofovir|mesh-list
14262499|NCT00369941|Emtricitabine|emtricitabine|mesh-list
14262500|NCT00369941|Efavirenz|efavirenz|mesh-list
14262501|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
14262502|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14262503|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
14262504|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262505|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14262506|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262507|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262508|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262509|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14262510|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14262511|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14262512|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14262513|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14262514|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14262515|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14262516|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14262517|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14262518|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14262519|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
14262520|NCT00369967|NuvaRing|nuvaring|mesh-list
14262521|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14262522|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262523|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14262524|NCT00370032|Alosetron|alosetron|mesh-list
14262525|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262526|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14262527|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
14262528|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262529|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262530|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262531|NCT00370071|Interferons|interferons|mesh-list
14262532|NCT00370071|Interferon-beta|interferon-beta|mesh-list
14262533|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
14262534|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262535|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
14262536|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262537|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
14262538|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262539|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14262540|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14262541|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262542|NCT00370292|Pemetrexed|pemetrexed|mesh-list
14262543|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262544|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262545|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262546|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14262547|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262548|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
14262549|NCT05288075|Charcoal|charcoal|mesh-list
14262550|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14262551|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14262552|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14262553|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
14262554|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262555|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988297|NCT02974985|Protective Agents|protective agents|mesh-ancestor
14262556|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262557|NCT05288075|Antidotes|antidotes|mesh-ancestor
13988298|NCT02974920|Aspirin|aspirin|mesh-list
13988299|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
13988300|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988301|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988302|NCT02974920|Analgesics|analgesics|mesh-ancestor
13988303|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
13988304|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988305|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988306|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988307|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988308|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13988309|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13988310|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988311|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13988312|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13988313|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988314|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
13988315|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13988316|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
13988317|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13988318|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
13988319|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
13988320|NCT02974933|Pemetrexed|pemetrexed|mesh-list
13988321|NCT02974933|Apatinib|apatinib|mesh-list
13988322|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988323|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988324|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988325|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13988326|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13988327|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14022823|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
14022824|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262558|NCT05288075|Protective Agents|protective agents|mesh-ancestor
14262559|NCT05287633|Esomeprazole|esomeprazole|mesh-list
14262560|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14262561|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262562|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14262563|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262564|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262565|NCT05287607|Bilirubin|bilirubin|mesh-list
14262566|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
14262567|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262568|NCT05287607|Protective Agents|protective agents|mesh-ancestor
14262569|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262570|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14262571|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262572|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292101|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14292102|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
14292103|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
14292104|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292105|NCT00558519|Cytarabine|cytarabine|mesh-list
14292106|NCT00558519|Dexamethasone|dexamethasone|mesh-list
14292107|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
14292108|NCT00558519|Doxorubicin|doxorubicin|mesh-list
14292109|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14292110|NCT00558519|Methotrexate|methotrexate|mesh-list
14292111|NCT00558519|Vincristine|vincristine|mesh-list
14292112|NCT00558519|Daunorubicin|daunorubicin|mesh-list
14292113|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
14292114|NCT00558519|Pegaspargase|pegaspargase|mesh-list
14292115|NCT00558519|Thioguanine|thioguanine|mesh-list
14292116|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292117|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
14292118|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292119|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292120|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14292121|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
14292122|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292123|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292124|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14292125|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022825|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14026092|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292126|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
14292127|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
14292128|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988328|NCT02974712|Fentanyl|fentanyl|mesh-list
13988329|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13988330|NCT02974712|Narcotics|narcotics|mesh-ancestor
13988331|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988332|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988333|NCT02974712|Analgesics|analgesics|mesh-ancestor
13988334|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
13988335|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988336|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13988337|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13988338|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
13988339|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
13988340|NCT02974556|Capecitabine|capecitabine|mesh-list
13988341|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
13988342|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13988343|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
13988344|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988345|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988346|NCT02974660|Protamines|protamines|mesh-list
13988347|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
13988348|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988349|NCT02974660|Coagulants|coagulants|mesh-ancestor
13988350|NCT02974439|Amlodipine|amlodipine|mesh-list
13988351|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13988352|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13988353|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13988354|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988355|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13988356|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988357|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
13988358|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
13988359|NCT02974387|Fluorometholone|fluorometholone|mesh-list
13988360|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14262573|NCT05287503|Ambroxol|ambroxol|mesh-list
14262574|NCT05287503|Expectorants|expectorants|mesh-ancestor
14262575|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
14262576|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
14262577|NCT05287464|Nivolumab|nivolumab|mesh-list
14262578|NCT05287464|Ipilimumab|ipilimumab|mesh-list
14262579|NCT05287464|Avelumab|avelumab|mesh-list
14262580|NCT05287464|Atezolizumab|atezolizumab|mesh-list
14262581|NCT05287464|Lenvatinib|lenvatinib|mesh-list
14262582|NCT05287464|Axitinib|axitinib|mesh-list
14262583|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262584|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262585|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14262586|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262587|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262588|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262589|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
14262590|NCT05287425|Gentamicins|gentamicins|mesh-list
14262591|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14262592|NCT05287425|Povidone|povidone|mesh-list
14262593|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14262594|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262595|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14262596|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14262597|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262598|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262599|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262600|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14262601|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14262602|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14262603|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
14262604|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
14262605|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14262606|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
14262607|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
15081392|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
13988361|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262608|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15081393|NCT04631029|Carboplatin|carboplatin|mesh-list
13988362|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
13988363|NCT02974387|Hormones|hormones|mesh-ancestor
14262609|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14262610|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988364|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988365|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988366|NCT02974504|Linagliptin|linagliptin|mesh-list
13988367|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13988368|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988369|NCT02974504|Incretins|incretins|mesh-ancestor
13988370|NCT02974504|Hormones|hormones|mesh-ancestor
13988371|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988372|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13988373|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
13988374|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988375|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988376|NCT02974426|Cisplatin|cisplatin|mesh-list
13988377|NCT02974426|Carboplatin|carboplatin|mesh-list
13988378|NCT02974426|Pemetrexed|pemetrexed|mesh-list
13988379|NCT02974426|Vinorelbine|vinorelbine|mesh-list
13988380|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988381|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988382|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988383|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13988384|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13988385|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13988386|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
13988387|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
13988388|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
13988389|NCT02974244|Exenatide|exenatide|mesh-list
13988390|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13988391|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988392|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13988393|NCT02974244|Incretins|incretins|mesh-ancestor
13988394|NCT02974244|Hormones|hormones|mesh-ancestor
13988395|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988396|NCT02974361|Ibuprofen|ibuprofen|mesh-list
13988397|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988398|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988399|NCT02974361|Analgesics|analgesics|mesh-ancestor
13988400|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
13988401|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988402|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988403|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988404|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988405|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13988406|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081394|NCT04631029|Etoposide|etoposide|mesh-list
15081395|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
15081396|NCT04631029|Atezolizumab|atezolizumab|mesh-list
15081397|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
15081398|NCT04631029|Entinostat|entinostat|mesh-list
15081399|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15081400|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15081401|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988407|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988408|NCT02974348|Acetaminophen|acetaminophen|mesh-list
13988409|NCT02974348|Amoxicillin|amoxicillin|mesh-list
13988410|NCT02974348|Artesunate|artesunate|mesh-list
13988411|NCT02974348|Lumefantrine|lumefantrine|mesh-list
13988412|NCT02974348|Piperaquine|piperaquine|mesh-list
13988413|NCT02974348|Artenimol|artenimol|mesh-list
13988414|NCT02974348|Mefloquine|mefloquine|mesh-list
13988415|NCT02974348|Quinine|quinine|mesh-list
13988416|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988417|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988418|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988419|NCT02974348|Analgesics|analgesics|mesh-ancestor
13988420|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
13988421|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988422|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988423|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
13988424|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
13988425|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13988426|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13988427|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988428|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
13988429|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
13988430|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13988431|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
13988432|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15081402|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13988433|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13988434|NCT02974166|Ibuprofen|ibuprofen|mesh-list
13988435|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13988436|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
13988437|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988438|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988439|NCT02974166|Analgesics|analgesics|mesh-ancestor
13988440|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
13988441|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988442|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988443|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988444|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13988445|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988446|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988447|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13988448|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
13988449|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13988450|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13988451|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13988452|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13988453|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988454|NCT02974270|Leuprolide|leuprolide|mesh-list
13988455|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13988456|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
13988457|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13988458|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988459|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13988460|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988461|NCT02974257|Thiamine|thiamine|mesh-list
13988462|NCT02974257|Vitamins|vitamins|mesh-ancestor
13988463|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
13988464|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988465|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
13988466|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13988467|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13988468|NCT02973958|Acetaminophen|acetaminophen|mesh-list
13988469|NCT02973958|Ibuprofen|ibuprofen|mesh-list
13988470|NCT02973958|Ketorolac|ketorolac|mesh-list
13988471|NCT02973958|Bupivacaine|bupivacaine|mesh-list
13988472|NCT02973958|Sevoflurane|sevoflurane|mesh-list
13988473|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
13988474|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
13988475|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262611|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262612|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262613|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14262614|NCT05287256|Dronabinol|dronabinol|mesh-list
14262615|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
14262616|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262617|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262618|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14262619|NCT05287256|Analgesics|analgesics|mesh-ancestor
14262620|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
14262621|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262622|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14262623|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14262624|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262625|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262626|NCT05287256|Hormones|hormones|mesh-ancestor
14262627|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262628|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
14262629|NCT05287191|Digoxin|digoxin|mesh-list
14262630|NCT05287191|Amiodarone|amiodarone|mesh-list
15081403|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14262631|NCT05287191|Analgesics|analgesics|mesh-ancestor
13988476|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988477|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
13988478|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988479|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988480|NCT02973958|Analgesics|analgesics|mesh-ancestor
13988481|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
13988482|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988483|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988484|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988485|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13988486|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988487|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988488|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13988489|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13988490|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
13988491|NCT02973737|Capecitabine|capecitabine|mesh-list
13988492|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13988493|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
13988494|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988495|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988496|NCT02973763|Aflutinib|aflutinib|mesh-list
13988497|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13988498|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988499|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988500|NCT02973724|Remifentanil|remifentanil|mesh-list
13988501|NCT02973724|Propofol|propofol|mesh-list
13988502|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
13988503|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988504|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988505|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13988506|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13988507|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
13988508|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13988509|NCT02973724|Narcotics|narcotics|mesh-ancestor
13988510|NCT02973724|Analgesics|analgesics|mesh-ancestor
13988511|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
13988512|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988513|NCT02973776|Clobetasol|clobetasol|mesh-list
13988514|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13988515|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988516|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
13988517|NCT02973776|Hormones|hormones|mesh-ancestor
13988518|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988519|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988520|NCT02973646|Tenofovir|tenofovir|mesh-list
13988521|NCT02973646|Entecavir|entecavir|mesh-list
13988522|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
13988523|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
13988524|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988525|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13988526|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14535779|NCT01147393|Veltuzumab|veltuzumab|mesh-list
14535780|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14642783|NCT00187083|Pegaspargase|pegaspargase|mesh-list
13988527|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988528|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988529|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13988530|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13988531|NCT02973659|Oxybutynin|oxybutynin|mesh-list
13988532|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
13988533|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
13988534|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988535|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988536|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13988537|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13988538|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
13988539|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988540|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988541|NCT02973659|Urological Agents|urological agents|mesh-ancestor
13988542|NCT02973620|Simendan|simendan|mesh-list
13988543|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13988544|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
13988545|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13988546|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13988547|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262632|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
13988548|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988549|NCT02973620|Protective Agents|protective agents|mesh-ancestor
13988550|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988551|NCT02973451|Bupivacaine|bupivacaine|mesh-list
13988552|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
13988553|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
13988554|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988555|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988556|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
13988557|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988558|NCT02973464|Valganciclovir|valganciclovir|mesh-list
13988559|NCT02973464|Ganciclovir|ganciclovir|mesh-list
13988560|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13988561|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
13988562|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988563|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13988564|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988565|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988566|NCT02973295|Silymarin|silymarin|mesh-list
13988567|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
13988568|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988569|NCT02973295|Protective Agents|protective agents|mesh-ancestor
13988570|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988571|NCT02973581|Acetaminophen|acetaminophen|mesh-list
13988572|NCT02973581|Dipyrone|dipyrone|mesh-list
13988573|NCT02973581|Lidocaine|lidocaine|mesh-list
13988574|NCT02973581|Bupivacaine|bupivacaine|mesh-list
13988575|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
13988576|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
14535781|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14807785|NCT00823550|Lamivudine|lamivudine|mesh-list
14807786|NCT00823550|Entecavir|entecavir|mesh-list
15081404|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13988577|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
13988578|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988579|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988580|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
13988581|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988582|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13988583|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13988584|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13988585|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13988586|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988587|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988588|NCT02973581|Analgesics|analgesics|mesh-ancestor
13988589|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
13988590|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988591|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988592|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988593|NCT02973113|Nivolumab|nivolumab|mesh-list
13988594|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13988595|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988596|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13988597|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988598|NCT02973204|Everolimus|everolimus|mesh-list
13988599|NCT02973204|Sorafenib|sorafenib|mesh-list
13988600|NCT02973204|Octreotide|octreotide|mesh-list
13988601|NCT02973204|Lanreotide|lanreotide|mesh-list
13988602|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081405|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081406|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081407|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
15081408|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988603|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13988604|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
13988605|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988606|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13988607|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988608|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988609|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13988610|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14262633|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262634|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262635|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
14262636|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262637|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807787|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13988611|NCT02973035|Amlodipine|amlodipine|mesh-list
13988612|NCT02973035|Valsartan|valsartan|mesh-list
13988613|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13988614|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13988615|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13988616|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988617|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13988618|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988619|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
13988620|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13988621|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13988622|NCT02972918|Simendan|simendan|mesh-list
13988623|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13988624|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
13988625|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13988626|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13988627|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988628|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988629|NCT02972918|Protective Agents|protective agents|mesh-ancestor
13988630|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988631|NCT02972957|Azithromycin|azithromycin|mesh-list
13988632|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988633|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022826|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14022827|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022828|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
14262638|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
14262639|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14262640|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262641|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262642|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14262643|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
14262644|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14262645|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14262646|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262647|NCT05287191|Protective Agents|protective agents|mesh-ancestor
14262648|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
14262649|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14262650|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14262651|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14262652|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14262653|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14262654|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14262655|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14262656|NCT05287100|Midodrine|midodrine|mesh-list
14262657|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
14262658|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
14262659|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262660|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262661|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14262662|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14262663|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14262664|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14262665|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
14262666|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262667|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262668|NCT05287035|Dexamethasone|dexamethasone|mesh-list
14262669|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
14262670|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262671|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
14262672|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
14262673|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262674|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262675|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262676|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
14262677|NCT05287035|Hormones|hormones|mesh-ancestor
14262678|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262679|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14262680|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262681|NCT05286996|Anesthetics|anesthetics|mesh-list
14262682|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
14642784|NCT00187083|Teniposide|teniposide|mesh-list
14022829|NCT02766803|Protective Agents|protective agents|mesh-ancestor
13988634|NCT02972983|Daptomycin|daptomycin|mesh-list
13988635|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988636|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988637|NCT02972905|Nemiralisib|nemiralisib|mesh-list
13988638|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13988639|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988640|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988641|NCT02972866|Budesonide|budesonide|mesh-list
13988642|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988643|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13988644|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
13988645|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988646|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988647|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13988648|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
13988649|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
13988650|NCT02972866|Hormones|hormones|mesh-ancestor
13988651|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988652|NCT02972723|Metformin|metformin|mesh-list
13988653|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13988654|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988655|NCT02972762|Propofol|propofol|mesh-list
13988656|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13988657|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988658|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988659|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13988660|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
13988661|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
13988662|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
13988663|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13988664|NCT02972463|Antibodies|antibodies|mesh-list
13988665|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
13988666|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988667|NCT02972450|Vedolizumab|vedolizumab|mesh-list
13988668|NCT02972450|Vaccines|vaccines|mesh-list
13988669|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
13988670|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988671|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13988672|NCT02972476|Fluticasone|fluticasone|mesh-list
13988673|NCT02972476|Xhance|xhance|mesh-list
13988674|NCT02972476|Budesonide|budesonide|mesh-list
13988675|NCT02972476|Bromides|bromides|mesh-list
13988676|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
13988677|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13988678|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13988679|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988680|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13988681|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
13988682|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988683|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988684|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15081409|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
15081410|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
15081411|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081412|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081413|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
13988685|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
13988686|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
13988687|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13988688|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
14262683|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262684|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262685|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
14262686|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262687|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
14262688|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14262689|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262690|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14262691|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14262692|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262693|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262694|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081414|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
13988689|NCT02972476|Hormones|hormones|mesh-ancestor
13988690|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988691|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14026093|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13988692|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13988693|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13988694|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
13988695|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988696|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988697|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
13988698|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
13988699|NCT02972320|Temozolomide|temozolomide|mesh-list
13988700|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13988701|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
13988702|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988703|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988704|NCT02972333|Osimertinib|osimertinib|mesh-list
13988705|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988706|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13988707|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988708|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988709|NCT02972294|Iron|iron|mesh-list
13988710|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
13988711|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13988712|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
13988713|NCT02972294|Trace Elements|trace elements|mesh-ancestor
13988714|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
13988715|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988716|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13988717|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13988718|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988719|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
13988720|NCT02972294|Coagulants|coagulants|mesh-ancestor
13988721|NCT02972294|Hematinics|hematinics|mesh-ancestor
13988722|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13988723|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
13988724|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
13988725|NCT02972346|Hormones|hormones|mesh-ancestor
13988726|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988727|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988728|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988729|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988730|NCT02972411|Acetazolamide|acetazolamide|mesh-list
13988731|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
13988732|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13988733|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988734|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988735|NCT02972411|Diuretics|diuretics|mesh-ancestor
13988736|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
13988737|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988738|NCT02972424|Teriparatide|teriparatide|mesh-list
13988739|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13988740|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988741|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13988742|NCT02972268|Tamsulosin|tamsulosin|mesh-list
13988743|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
13988744|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14262695|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14262696|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14262697|NCT05286801|Atezolizumab|atezolizumab|mesh-list
14262698|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14262699|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262700|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
14262701|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262702|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14262703|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14262704|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262705|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14262706|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14262707|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14262708|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262709|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
14262710|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988745|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13988746|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13988747|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
13988748|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988749|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988750|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988751|NCT02972268|Urological Agents|urological agents|mesh-ancestor
13988752|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13988753|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13988754|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
13988755|NCT02972216|Docetaxel|docetaxel|mesh-list
13988756|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988757|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
13988758|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
13988759|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
13988760|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988761|NCT02972255|Meropenem|meropenem|mesh-list
13988762|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988763|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988764|NCT02971930|Factor VIII|factor viii|mesh-list
13988765|NCT02971930|Coagulants|coagulants|mesh-ancestor
13988766|NCT02971982|Dexamethasone|dexamethasone|mesh-list
13988767|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
13988768|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
13988769|NCT02971982|Rituximab|rituximab|mesh-list
13988770|NCT02971982|Bortezomib|bortezomib|mesh-list
13988771|NCT02971982|BB 1101|bb 1101|mesh-list
13988772|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13988773|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
13988774|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988775|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988776|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13988777|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
13988778|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988779|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988780|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13988781|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988782|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
13988783|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
13988784|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988785|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13988786|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
13988787|NCT02971982|Hormones|hormones|mesh-ancestor
13988788|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13988789|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13988790|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
13988791|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988792|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13988793|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
13988794|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13988795|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988796|NCT02972125|Lacosamide|lacosamide|mesh-list
13988797|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
13988798|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13988799|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14262711|NCT05286619|Gemcitabine|gemcitabine|mesh-list
14262712|NCT05286619|Carboplatin|carboplatin|mesh-list
14262713|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
14262714|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262715|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14262716|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
14262717|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262718|NCT05286619|Antiviral Agents|antiviral agents|mesh-ancestor
14262719|NCT05286619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262720|NCT05286619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262721|NCT05286619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262722|NCT05286619|Immunologic Factors|immunologic factors|mesh-ancestor
14262723|NCT05286619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262724|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262725|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
14262726|NCT05286528|Dasatinib|dasatinib|mesh-list
14262727|NCT05286528|Ponatinib|ponatinib|mesh-list
14262728|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262729|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262730|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262731|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081415|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081416|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
13988800|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13988801|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988802|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
13988803|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13988804|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988805|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
13988806|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
13988807|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
13988808|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13988809|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
13988810|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988811|NCT02971878|Protective Agents|protective agents|mesh-ancestor
13988812|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988813|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
13988814|NCT02971878|Vitamins|vitamins|mesh-ancestor
13988815|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
13988816|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
13988817|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
13988818|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988819|NCT02971878|Expectorants|expectorants|mesh-ancestor
13988820|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
13988821|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13988822|NCT02971878|Antidotes|antidotes|mesh-ancestor
13988823|NCT02971644|Cobalt|cobalt|mesh-list
13988824|NCT02971644|Trace Elements|trace elements|mesh-ancestor
13988825|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
13988826|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988827|NCT02971475|Analgesics|analgesics|mesh-list
13988828|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
13988829|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988830|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988831|NCT02971696|Sorafenib|sorafenib|mesh-list
13988832|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988833|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13988834|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988835|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988836|NCT02971423|Imipenem|imipenem|mesh-list
13988837|NCT02971423|Sulbactam|sulbactam|mesh-list
13988838|NCT02971423|Cilastatin|cilastatin|mesh-list
13988839|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13988840|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988841|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
13988842|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988843|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988844|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14262732|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
14262733|NCT05286437|Letrozole|letrozole|mesh-list
14262734|NCT05286437|Lenvatinib|lenvatinib|mesh-list
14262735|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262736|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262737|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14262738|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14262739|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262740|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262741|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14262742|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
14262743|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262744|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262745|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262746|NCT05286346|Tenofovir|tenofovir|mesh-list
14262747|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
14262748|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262749|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14262750|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262751|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262752|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262753|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14262754|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14262755|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
14262756|NCT05286320|Lenvatinib|lenvatinib|mesh-list
14262757|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262758|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262759|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14262760|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262761|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988845|NCT02971410|Simvastatin|simvastatin|mesh-list
13988846|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13988847|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13988848|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
13988849|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988850|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13988851|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13988852|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988853|NCT02971540|Dipyrone|dipyrone|mesh-list
13988854|NCT02971540|Tramadol|tramadol|mesh-list
13988855|NCT02971540|Bupivacaine|bupivacaine|mesh-list
13988856|NCT02971540|Ropivacaine|ropivacaine|mesh-list
13988857|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
13988858|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
14262762|NCT05286268|Plasminogen|plasminogen|mesh-list
14262763|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14262764|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14262765|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262766|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
14262767|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262768|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262769|NCT05286008|Dexamethasone|dexamethasone|mesh-list
14262770|NCT05286008|Ropivacaine|ropivacaine|mesh-list
14262771|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262772|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
14262773|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
14262774|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262775|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262776|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262777|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
14262778|NCT05286008|Hormones|hormones|mesh-ancestor
14262779|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262780|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14262781|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262782|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
14262783|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
14262784|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262785|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
14262786|NCT05285943|Betamethasone|betamethasone|mesh-list
14262787|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
14262788|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14262789|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
14262790|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14262791|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262792|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
14262793|NCT05285943|Hormones|hormones|mesh-ancestor
14262794|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262795|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262796|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14262797|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
14262798|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
14262799|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262800|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
14262801|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262802|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262803|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14262804|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
14262805|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
14262806|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081417|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15081418|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081419|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081420|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
15081421|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081422|NCT04586231|Lenvatinib|lenvatinib|mesh-list
15081423|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081424|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081425|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081426|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081427|NCT04586023|Teriflunomide|teriflunomide|mesh-list
15081428|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15081429|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15081430|NCT04586023|Analgesics|analgesics|mesh-ancestor
15081431|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
15081432|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081433|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988859|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988860|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988861|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
13988862|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988863|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13988864|NCT02971540|Narcotics|narcotics|mesh-ancestor
13988865|NCT02971540|Analgesics|analgesics|mesh-ancestor
13988866|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988867|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988868|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988869|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988870|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
13988871|NCT02971397|Cytarabine|cytarabine|mesh-list
13988872|NCT02971397|Daunorubicin|daunorubicin|mesh-list
13988873|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13988874|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
13988875|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988876|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988877|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
13988878|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988879|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13988880|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
13988881|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988882|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13988883|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13988884|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13988885|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022830|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022831|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14026094|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14026095|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
14026096|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14026097|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14026098|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14026099|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14026100|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
14026101|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14026102|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14026103|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
14262807|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14262808|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14262809|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262810|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262811|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
14262812|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292129|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292130|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
14535782|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535783|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
14535784|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
14535785|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535786|NCT01147042|Interferons|interferons|mesh-list
14535787|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
14535788|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535789|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
14535790|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535791|NCT01139996|Clonidine|clonidine|mesh-list
14535792|NCT01139996|Analgesics|analgesics|mesh-ancestor
14535793|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
14535794|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535795|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535796|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14535797|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
14535798|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
14535799|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14535800|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14535801|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14535802|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14535803|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535804|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535805|NCT01142128|Esomeprazole|esomeprazole|mesh-list
14535806|NCT01142128|Pancrelipase|pancrelipase|mesh-list
14535807|NCT01142128|Pancreatin|pancreatin|mesh-list
14535808|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14535809|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14535810|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14292131|NCT00558519|Hormones|hormones|mesh-ancestor
14535811|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988886|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
13988887|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13988888|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
13988889|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988890|NCT02971306|Expectorants|expectorants|mesh-ancestor
13988891|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
13988892|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13988893|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
13988894|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988895|NCT02971306|Protective Agents|protective agents|mesh-ancestor
13988896|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988897|NCT02971306|Antidotes|antidotes|mesh-ancestor
13988898|NCT02971254|Sevoflurane|sevoflurane|mesh-list
13988899|NCT02971254|Desflurane|desflurane|mesh-list
13988900|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13988901|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13988902|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
13988903|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
13988904|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988905|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988906|NCT02971345|Iodine|iodine|mesh-list
13988907|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
13988908|NCT02971345|Epirubicin|epirubicin|mesh-list
13988909|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
13988910|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13988911|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13988912|NCT02971345|Trace Elements|trace elements|mesh-ancestor
13988913|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
13988914|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988915|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13988916|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988917|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13988918|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13988919|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262813|NCT05285813|Acetaminophen|acetaminophen|mesh-list
14262814|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
14262815|NCT05285813|Promethazine|promethazine|mesh-list
14262816|NCT05285813|Dexamethasone|dexamethasone|mesh-list
14262817|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14262818|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
14262819|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
14262820|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262821|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262822|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262823|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
14262824|NCT05285813|Hormones|hormones|mesh-ancestor
14262825|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14262826|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14262827|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262828|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14262829|NCT05285813|Analgesics|analgesics|mesh-ancestor
14262830|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
14262831|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
14262832|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14262833|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14262834|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262835|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
14262836|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
14642785|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988920|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262837|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14262838|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
14262839|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
14262840|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262841|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988921|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
13988922|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13988923|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988924|NCT02971033|Ezetimibe|ezetimibe|mesh-list
13988925|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13988926|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13988927|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
13988928|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988929|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13988930|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
13988931|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13988932|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
13988933|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13988934|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
13988935|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988936|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988937|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
13988938|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
13988939|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
13988940|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13988941|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13988942|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988943|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988944|NCT02970916|Aflibercept|aflibercept|mesh-list
13988945|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13988946|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13988947|NCT02970916|Growth Substances|growth substances|mesh-ancestor
13988948|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988949|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
13988950|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988951|NCT02970630|Everolimus|everolimus|mesh-list
13988952|NCT02970630|Tacrolimus|tacrolimus|mesh-list
13988953|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13988954|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
13988955|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988956|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13988957|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13988958|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988959|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988960|NCT02970643|Olanzapine|olanzapine|mesh-list
13988961|NCT02970643|Palonosetron|palonosetron|mesh-list
13988962|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
13988963|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
13988964|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988965|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988966|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13988967|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13988968|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13988969|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13988970|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13988971|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13988972|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13988973|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13988974|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988975|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13988976|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
13988977|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13988978|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13988979|NCT02970539|Paclitaxel|paclitaxel|mesh-list
13988980|NCT02970539|Ramucirumab|ramucirumab|mesh-list
13988981|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13988982|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13988983|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
14262842|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14262843|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
14262844|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14262845|NCT05285787|Vitamin MK 7|vitamin mk 7|mesh-list
14262846|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
14262847|NCT05285787|Coagulants|coagulants|mesh-ancestor
14262848|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14262849|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14262850|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262851|NCT05260593|Vitamins|vitamins|mesh-list
14262852|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
14262853|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
14262854|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
14262855|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
14262856|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262857|NCT05260593|Hematinics|hematinics|mesh-ancestor
14262858|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
14262859|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262860|NCT05250050|Amoxicillin|amoxicillin|mesh-list
14262861|NCT05250050|Metronidazole|metronidazole|mesh-list
14642786|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
13988984|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
13988985|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
14262862|NCT05250050|Clarithromycin|clarithromycin|mesh-list
14262863|NCT05250050|Levofloxacin|levofloxacin|mesh-list
14262864|NCT05250050|Tetracycline|tetracycline|mesh-list
13988986|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988987|NCT02970604|Aspirin|aspirin|mesh-list
13988988|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13988989|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13988990|NCT02970604|Analgesics|analgesics|mesh-ancestor
13988991|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
13988992|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13988993|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13988994|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13988995|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13988996|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13988997|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13988998|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13988999|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13989000|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13989001|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989002|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
13989003|NCT02970682|Tamoxifen|tamoxifen|mesh-list
13989004|NCT02970682|Fulvestrant|fulvestrant|mesh-list
13989005|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13989006|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13989007|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
13989008|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989009|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989010|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13989011|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989012|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13989013|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13989014|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13989015|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13989016|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13989017|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989018|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989019|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
13989020|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989021|NCT02970409|Heparin|heparin|mesh-list
13989022|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
13989023|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13989024|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13989025|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989026|NCT02970383|Narcotics|narcotics|mesh-list
13989027|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989028|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989029|NCT02970383|Analgesics|analgesics|mesh-ancestor
13989030|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
13989031|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989032|NCT02970175|Terlipressin|terlipressin|mesh-list
13989033|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13989034|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13989035|NCT02970097|Fentanyl|fentanyl|mesh-list
13989036|NCT02970097|Midazolam|midazolam|mesh-list
13989037|NCT02970097|Ropivacaine|ropivacaine|mesh-list
13989038|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13989039|NCT02970097|Narcotics|narcotics|mesh-ancestor
13989040|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262865|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
14262866|NCT05250050|Esomeprazole|esomeprazole|mesh-list
14262867|NCT05250050|Bismuth|bismuth|mesh-list
14262868|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262869|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989041|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989042|NCT02970097|Analgesics|analgesics|mesh-ancestor
13989043|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
13989044|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989045|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13989046|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13989047|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
13989048|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
13989049|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13989050|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13989051|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13989052|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13989053|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
13989054|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
13989055|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989056|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989057|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
13989058|NCT02970084|Vitamin K|vitamin k|mesh-list
13989059|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
13989060|NCT02970084|Vitamins|vitamins|mesh-ancestor
13989061|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
13989062|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989063|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13989064|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13989065|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989066|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
13989067|NCT02970084|Coagulants|coagulants|mesh-ancestor
13989068|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
13989069|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989070|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
13989071|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989072|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989073|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13989074|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
13989075|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989076|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989077|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13989078|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
13989079|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
14262870|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262871|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14262872|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14262873|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14262874|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262875|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14262876|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262877|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14262878|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14262879|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14262880|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14262881|NCT05250050|Renal Agents|renal agents|mesh-ancestor
14262882|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14262883|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14262884|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262885|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14262886|NCT05250050|Antacids|antacids|mesh-ancestor
14262887|NCT05250050|Diuretics|diuretics|mesh-ancestor
14262888|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
14262889|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262890|NCT05250050|Expectorants|expectorants|mesh-ancestor
14262891|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14262892|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
14262893|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14262894|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14262895|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262896|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
14262897|NCT05248321|Coagulants|coagulants|mesh-ancestor
14262898|NCT05225805|Lefamulin|lefamulin|mesh-list
13989080|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13989081|NCT02969720|Protective Agents|protective agents|mesh-ancestor
14262899|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14262900|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262901|NCT05220462|Midazolam|midazolam|mesh-list
14262902|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14262903|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14262904|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14262905|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989082|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989083|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
13989084|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13989085|NCT02969746|Charcoal|charcoal|mesh-list
13989086|NCT02969746|Antidotes|antidotes|mesh-ancestor
13989087|NCT02969746|Protective Agents|protective agents|mesh-ancestor
13989088|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989089|NCT02969733|Lidocaine|lidocaine|mesh-list
13989090|NCT02969733|Ketamine|ketamine|mesh-list
13989091|NCT02969733|Analgesics|analgesics|mesh-ancestor
13989092|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
13989093|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989094|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989095|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13989096|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13989097|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
13989098|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
13989099|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989100|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13989101|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13989102|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989103|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989104|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
13989105|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13989106|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13989107|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13989108|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13989109|NCT02969798|Metformin|metformin|mesh-list
13989110|NCT02969798|Pioglitazone|pioglitazone|mesh-list
13989111|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
13989112|NCT02969798|Saxagliptin|saxagliptin|mesh-list
13989113|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989114|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989115|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13989116|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989117|NCT02969798|Incretins|incretins|mesh-ancestor
13989118|NCT02969798|Hormones|hormones|mesh-ancestor
13989119|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989120|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13989121|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
13989122|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989123|NCT02969629|Apomorphine|apomorphine|mesh-list
13989124|NCT02969629|Emetics|emetics|mesh-ancestor
13989125|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989126|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
13989127|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081434|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081435|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081436|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262906|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14262907|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14262908|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14262909|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14262910|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
14262911|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
14262912|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
14262913|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
14262914|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262915|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262916|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
14262917|NCT05219604|Promethazine|promethazine|mesh-list
14262918|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14262919|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14262920|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081437|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
15081438|NCT04586010|Teriflunomide|teriflunomide|mesh-list
15081439|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13989128|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989129|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
13989130|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
13989131|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989132|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262921|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022832|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
14262922|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
15081440|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13989133|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
13989134|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989135|NCT02969681|Vitamins|vitamins|mesh-ancestor
13989136|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
13989137|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
13989138|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989139|NCT02969681|Protective Agents|protective agents|mesh-ancestor
13989140|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
13989141|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13989142|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989143|NCT02969447|Oxytocin|oxytocin|mesh-list
13989144|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
13989145|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13989146|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989147|NCT02969473|Cisplatin|cisplatin|mesh-list
13989148|NCT02969473|Docetaxel|docetaxel|mesh-list
13989149|NCT02969473|Fluorouracil|fluorouracil|mesh-list
13989150|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989151|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
13989152|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
13989153|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
13989154|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989155|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
13989156|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13989157|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989158|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
13989159|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989160|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13989161|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
13989162|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989163|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
13989164|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262923|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
14262924|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
14262925|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262926|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
14262927|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
14262928|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081441|NCT04586010|Analgesics|analgesics|mesh-ancestor
15081442|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
15081443|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081444|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081445|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081446|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081447|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081448|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
15081449|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
15081450|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
15081451|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081452|NCT04576117|Vinblastine|vinblastine|mesh-list
15081453|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081454|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081455|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081456|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081457|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081458|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262929|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14262930|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
14262931|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
14262932|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262933|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262934|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14262935|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
14262936|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14262937|NCT05206955|Tadalafil|tadalafil|mesh-list
14262938|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
14262939|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14262940|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14262941|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262942|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262943|NCT05206955|Urological Agents|urological agents|mesh-ancestor
14262944|NCT05189756|Aprepitant|aprepitant|mesh-list
14262945|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
13989165|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14262946|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
13989166|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14022833|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
13989167|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989168|NCT02969265|Amlodipine|amlodipine|mesh-list
13989169|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
13989170|NCT02969265|Candesartan|candesartan|mesh-list
13989171|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13989172|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13989173|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13989174|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989175|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13989176|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989177|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
13989178|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13989179|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13989180|NCT02969252|Rifamycins|rifamycins|mesh-list
13989181|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
13989182|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989183|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989184|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989185|NCT02969239|Phenylephrine|phenylephrine|mesh-list
13989186|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
13989187|NCT02969239|Norepinephrine|norepinephrine|mesh-list
13989188|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
13989189|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13989190|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
13989191|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
13989192|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989193|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989194|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
13989195|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
13989196|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
13989197|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13989198|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13989199|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13989200|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989201|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989202|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989203|NCT02969239|Protective Agents|protective agents|mesh-ancestor
13989204|NCT02968901|Tadalafil|tadalafil|mesh-list
13989205|NCT02968901|Macitentan|macitentan|mesh-list
13989206|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
13989207|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13989208|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13989209|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989210|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989211|NCT02968901|Urological Agents|urological agents|mesh-ancestor
13989212|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13989213|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13989214|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
13989215|NCT02968927|Vitamin D|vitamin d|mesh-list
14262947|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
14262948|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14262949|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262950|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14262951|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14262952|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14262953|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262954|NCT05187286|Apixaban|apixaban|mesh-list
14262955|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14262956|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
14262957|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14262958|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
13989216|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
13989217|NCT02968927|Rifabutin|rifabutin|mesh-list
14262959|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262960|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262961|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
14262962|NCT05183035|Cytarabine|cytarabine|mesh-list
14262963|NCT05183035|Fludarabine|fludarabine|mesh-list
14262964|NCT05183035|Azacitidine|azacitidine|mesh-list
14262965|NCT05183035|Venetoclax|venetoclax|mesh-list
14262966|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
14262967|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262968|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14262969|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
14262970|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989218|NCT02968927|Everolimus|everolimus|mesh-list
13989219|NCT02968927|Auranofin|auranofin|mesh-list
13989220|NCT02968927|Vitamins|vitamins|mesh-ancestor
13989221|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
13989222|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989223|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13989224|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989225|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989226|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
13989227|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13989228|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989229|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989230|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13989231|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
13989232|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989233|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13989234|NCT02968693|Vancomycin|vancomycin|mesh-list
13989235|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13989236|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
13989237|NCT02968693|Calcium|calcium|mesh-list
13989238|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13989239|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989240|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989241|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
13989242|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
13989243|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13989244|NCT02968693|Protective Agents|protective agents|mesh-ancestor
13989245|NCT02968719|Donepezil|donepezil|mesh-list
13989246|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13989247|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989248|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989249|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
13989250|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989251|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989252|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
13989253|NCT02968641|Ritonavir|ritonavir|mesh-list
13989254|NCT02968641|Lonafarnib|lonafarnib|mesh-list
13989255|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13989256|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13989257|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
13989258|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262971|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14262972|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
14262973|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14262974|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
14262975|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14262976|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262977|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262978|NCT05171049|Apixaban|apixaban|mesh-list
14262979|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14262980|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
14262981|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14262982|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
14262983|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14262984|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262985|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
14262986|NCT05169957|Nivolumab|nivolumab|mesh-list
14262987|NCT05169957|Ipilimumab|ipilimumab|mesh-list
14262988|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262989|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262990|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14262991|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14262992|NCT05165966|Vaccines|vaccines|mesh-list
15081459|NCT04574713|Candesartan|candesartan|mesh-list
15081460|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
15081461|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15081462|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15081463|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15081464|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081465|NCT04560686|Atezolizumab|atezolizumab|mesh-list
14262993|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
14262994|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535812|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989259|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989260|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13989261|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13989262|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
13989263|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989264|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13989265|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13989266|NCT02968498|Methamphetamine|methamphetamine|mesh-list
14262995|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
14262996|NCT05156268|Olaparib|olaparib|mesh-list
14262997|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14262998|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14262999|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14263000|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263001|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263002|NCT05146739|Vidarabine|vidarabine|mesh-list
14263003|NCT05146739|Cytarabine|cytarabine|mesh-list
14263004|NCT05146739|Fludarabine|fludarabine|mesh-list
14263005|NCT05146739|Fludarabine phosphate|fludarabine phosphate|mesh-list
14263006|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263007|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263008|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
14263009|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263010|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263011|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
14263012|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263013|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
14263014|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263015|NCT05143502|Fluticasone|fluticasone|mesh-list
14263016|NCT05143502|Xhance|xhance|mesh-list
14263017|NCT05143502|Prednisolone|prednisolone|mesh-list
14263018|NCT05143502|Montelukast|montelukast|mesh-list
14263019|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263020|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14263021|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
14263022|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263023|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263024|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14263025|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
14263026|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
14263027|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14263028|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
14263029|NCT05143502|Hormones|hormones|mesh-ancestor
14263030|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263031|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263032|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263033|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14263034|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
14263035|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14263036|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14263037|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263038|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
14263039|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
14263040|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14263041|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263042|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263043|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
14263044|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14263045|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263046|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263047|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
14263048|NCT05109429|Narcotics|narcotics|mesh-ancestor
14263049|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263050|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263051|NCT05109429|Analgesics|analgesics|mesh-ancestor
14535813|NCT01131884|Alendronate|alendronate|mesh-list
14535814|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13989267|NCT02968498|Lactulose|lactulose|mesh-list
13989268|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989269|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14263052|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
14263053|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263054|NCT05081492|Antibodies|antibodies|mesh-list
14263055|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
14263056|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
14263057|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263058|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
14263059|NCT05075330|Narcotics|narcotics|mesh-ancestor
13989270|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989271|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
13989272|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
13989273|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989274|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
13989275|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989276|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989277|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989278|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13989279|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13989280|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13989281|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13989282|NCT02968394|Omalizumab|omalizumab|mesh-list
13989283|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13989284|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13989285|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
13989286|NCT02968342|Progesterone|progesterone|mesh-list
13989287|NCT02968342|Progestins|progestins|mesh-ancestor
13989288|NCT02968342|Hormones|hormones|mesh-ancestor
13989289|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989290|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989291|NCT02968303|Vemurafenib|vemurafenib|mesh-list
13989292|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989293|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13989294|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989295|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989296|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
13989297|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
13989298|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263060|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263061|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263062|NCT05075330|Analgesics|analgesics|mesh-ancestor
14263063|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
14263064|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263065|NCT05069038|Palbociclib|palbociclib|mesh-list
14263066|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263067|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14263068|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263069|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263070|NCT05059600|Pregnanolone|pregnanolone|mesh-list
14263071|NCT05059600|Brexanolone|brexanolone|mesh-list
14263072|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
14263073|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263074|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263075|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
14263076|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263077|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535815|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535816|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14535817|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
14535818|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14535819|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14535820|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14535821|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14535822|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535823|NCT01126879|Genistein|genistein|mesh-list
14535824|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14535825|NCT01126879|Protective Agents|protective agents|mesh-ancestor
14535826|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535827|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081466|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081467|NCT04557956|Trametinib|trametinib|mesh-list
15081468|NCT04557956|Dabrafenib|dabrafenib|mesh-list
15081469|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15081470|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081471|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081472|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081473|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081474|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15081475|NCT04557956|Protective Agents|protective agents|mesh-ancestor
15081476|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081477|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14535828|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081478|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
15081479|NCT04553770|Trastuzumab|trastuzumab|mesh-list
13989299|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989300|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989301|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
13989302|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
13989303|NCT02968160|Telmisartan|telmisartan|mesh-list
13989304|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13989305|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13989306|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13989307|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
13989308|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989309|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13989310|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13989311|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989312|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13989313|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13989314|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13989315|NCT02968082|Scopolamine|scopolamine|mesh-list
13989316|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13989317|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13989318|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
13989319|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
13989320|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989321|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081480|NCT04553770|Anastrozole|anastrozole|mesh-list
15081481|NCT04553770|Camptothecin|camptothecin|mesh-list
15081482|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
15081483|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081484|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081485|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081486|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15081487|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15081488|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081489|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081490|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15081491|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
15081492|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081493|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989322|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14263078|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
14263079|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
14292132|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292133|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292134|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14292135|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14292136|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14292137|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292138|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14292139|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
14292140|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14292141|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14292142|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
14292143|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
14292144|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14292145|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14292146|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
14292147|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292148|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292149|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
14292150|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
14292151|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292152|NCT00558571|Empagliflozin|empagliflozin|mesh-list
14292153|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14292154|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292155|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14292156|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292157|NCT00558636|Paclitaxel|paclitaxel|mesh-list
14292158|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14292159|NCT00558636|Carboplatin|carboplatin|mesh-list
14292160|NCT00558636|Sorafenib|sorafenib|mesh-list
14292161|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292162|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292163|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
13989323|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
13989324|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13989325|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
13989326|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989327|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989328|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13989329|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
13989330|NCT02967939|Tenofovir|tenofovir|mesh-list
13989331|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
13989332|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989333|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13989334|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13989335|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989336|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989337|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13989338|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13989339|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
13989340|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13989341|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
13989342|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989343|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
13989344|NCT02967874|Protective Agents|protective agents|mesh-ancestor
13989345|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
13989346|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13989347|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989348|NCT02967757|Liraglutide|liraglutide|mesh-list
13989349|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989350|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989351|NCT02967757|Incretins|incretins|mesh-ancestor
13989352|NCT02967757|Hormones|hormones|mesh-ancestor
13989353|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022834|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14022835|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14022836|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022837|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022838|NCT02766725|Urological Agents|urological agents|mesh-ancestor
14022839|NCT02766647|Lenograstim|lenograstim|mesh-list
14022840|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14022841|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
14022842|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022843|NCT02766634|Lenograstim|lenograstim|mesh-list
14022844|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14022845|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
14022846|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022847|NCT02766439|Etanercept|etanercept|mesh-list
14022848|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14022849|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022850|NCT02766439|Analgesics|analgesics|mesh-ancestor
14263080|NCT05025787|Celecoxib|celecoxib|mesh-list
14263081|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14263082|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14263083|NCT05025787|Analgesics|analgesics|mesh-ancestor
14263084|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
14022851|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
14022852|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263085|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989354|NCT02967887|Fluorouracil|fluorouracil|mesh-list
13989355|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989356|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
13989357|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989358|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13989359|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989360|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
13989361|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989362|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
13989363|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989364|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
13989365|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13989366|NCT02967302|Triamcinolone|triamcinolone|mesh-list
13989367|NCT02967302|Morphine|morphine|mesh-list
13989368|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13989369|NCT02967302|Narcotics|narcotics|mesh-ancestor
13989370|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989371|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989372|NCT02967302|Analgesics|analgesics|mesh-ancestor
13989373|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
13989374|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989375|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989376|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
13989377|NCT02967302|Hormones|hormones|mesh-ancestor
13989378|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989379|NCT02967653|Atorvastatin|atorvastatin|mesh-list
13989380|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13989381|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13989382|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
13989383|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989384|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13989385|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13989386|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989387|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
13989388|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989389|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989390|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13989391|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13989392|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989393|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989394|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989395|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13989396|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13989397|NCT02967614|Timolol|timolol|mesh-list
13989398|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13989399|NCT02967614|Dorzolamide|dorzolamide|mesh-list
13989400|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13989401|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13989402|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989403|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989404|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989405|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989406|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15081494|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081495|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15081496|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15081497|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
15081498|NCT04553666|Vitamins|vitamins|mesh-list
15081499|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
15081500|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
13989407|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13989408|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13989409|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13989410|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13989411|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13989412|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989413|NCT02967289|Irinotecan|irinotecan|mesh-list
13989414|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13989415|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13989416|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989417|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989418|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989419|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
13989420|NCT02967380|Antidotes|antidotes|mesh-ancestor
15081501|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
13989421|NCT02967380|Protective Agents|protective agents|mesh-ancestor
13989422|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989423|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
13989424|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
13989425|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989426|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13989427|NCT02967276|Metformin|metformin|mesh-list
13989428|NCT02967276|Dexamethasone|dexamethasone|mesh-list
13989429|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989430|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
13989431|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
13989432|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989433|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989434|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989435|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
13989436|NCT02967276|Hormones|hormones|mesh-ancestor
13989437|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989438|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13989439|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989440|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989441|NCT02967432|Mupirocin|mupirocin|mesh-list
13989442|NCT02967432|Petrolatum|petrolatum|mesh-list
13989443|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989444|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989445|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13989446|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989447|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989448|NCT02967432|Emollients|emollients|mesh-ancestor
13989449|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
13989450|NCT02967172|Epinephrine|epinephrine|mesh-list
13989451|NCT02967172|Morphine|morphine|mesh-list
13989452|NCT02967172|Ropivacaine|ropivacaine|mesh-list
13989453|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13989454|NCT02967172|Narcotics|narcotics|mesh-ancestor
13989455|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989456|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989457|NCT02967172|Analgesics|analgesics|mesh-ancestor
13989458|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
13989459|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989460|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
13989461|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
14263086|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263087|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263088|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263089|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14263090|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14263091|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263092|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263093|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
14263094|NCT05005299|Fludarabine|fludarabine|mesh-list
14263095|NCT05005299|Venetoclax|venetoclax|mesh-list
14263096|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263097|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
14263098|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263099|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263100|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14263101|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
14263102|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263103|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263104|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14263105|NCT04991025|Gemcitabine|gemcitabine|mesh-list
14263106|NCT04991025|Carboplatin|carboplatin|mesh-list
14263107|NCT04991025|Pemetrexed|pemetrexed|mesh-list
14263108|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
14263109|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263110|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263111|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
14263112|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263113|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
14263114|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263115|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263116|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263117|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
13989462|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13989463|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13989464|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989465|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989466|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989467|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13989468|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13989469|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
13989470|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13989471|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
13989472|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
13989473|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
13989474|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13989475|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
13989476|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989477|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989478|NCT02967211|Insulin|insulin|mesh-list
13989479|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13989480|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
13989481|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
13989482|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
13989483|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
13989484|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
13989485|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989486|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989487|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
13989488|NCT02966912|Antacids|antacids|mesh-ancestor
13989489|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989490|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989491|NCT02967029|Remifentanil|remifentanil|mesh-list
13989492|NCT02967029|Esmolol|esmolol|mesh-list
13989493|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14263118|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263119|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14263120|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14263121|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263122|NCT04976283|Pioglitazone|pioglitazone|mesh-list
14263123|NCT04976283|Empagliflozin|empagliflozin|mesh-list
14263124|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14263125|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263126|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14263127|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263128|NCT04971187|Cisplatin|cisplatin|mesh-list
14263129|NCT04971187|Carboplatin|carboplatin|mesh-list
14263130|NCT04971187|Pemetrexed|pemetrexed|mesh-list
14263131|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263132|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263133|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263134|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14263135|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14263136|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
14263137|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
14263138|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14263139|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263140|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14263141|NCT04930783|Nivolumab|nivolumab|mesh-list
14263142|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263143|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263144|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14263145|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263146|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
14263147|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
14263148|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14263149|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
14263150|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263151|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263152|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
14263153|NCT04901975|Spironolactone|spironolactone|mesh-list
14263154|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14263155|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
14263156|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263157|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263158|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14263159|NCT04901975|Diuretics|diuretics|mesh-ancestor
14263160|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
14263161|NCT04899388|Fentanyl|fentanyl|mesh-list
13989494|NCT02967029|Narcotics|narcotics|mesh-ancestor
13989495|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989496|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989497|NCT02967029|Analgesics|analgesics|mesh-ancestor
13989498|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
13989499|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989500|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13989501|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13989502|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13989503|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989504|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989505|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989506|NCT02967094|Expectorants|expectorants|mesh-list
13989507|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
13989508|NCT02967133|Paclitaxel|paclitaxel|mesh-list
13989509|NCT02967133|Nivolumab|nivolumab|mesh-list
13989510|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13989511|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989512|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
14263162|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14263163|NCT04899388|Narcotics|narcotics|mesh-ancestor
14263164|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263165|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263166|NCT04899388|Analgesics|analgesics|mesh-ancestor
14263167|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
14263168|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263169|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14263170|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14263171|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
14263172|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
14263173|NCT04892186|Inositol|inositol|mesh-list
14263174|NCT04892186|Metformin|metformin|mesh-list
14263175|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14263176|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263177|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
13989513|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
13989514|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
13989515|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989516|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13989517|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13989518|NCT02967224|Insulin|insulin|mesh-list
13989519|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13989520|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
13989521|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
13989522|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
13989523|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
13989524|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
13989525|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989526|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989527|NCT02966847|Anesthetics|anesthetics|mesh-list
13989528|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989529|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989530|NCT02966717|Rituximab|rituximab|mesh-list
13989531|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13989532|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989533|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
13989534|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989535|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989536|NCT02966522|Thalidomide|thalidomide|mesh-list
13989537|NCT02966522|Dexamethasone|dexamethasone|mesh-list
13989538|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989539|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
13989540|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
13989541|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989542|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989543|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989544|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
13989545|NCT02966522|Hormones|hormones|mesh-ancestor
13989546|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989547|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13989548|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989549|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989550|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
13989551|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
13989552|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989553|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263178|NCT04892186|Vitamins|vitamins|mesh-ancestor
14807788|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14263179|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
14263180|NCT04884763|Erenumab|erenumab|mesh-list
13989554|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13989555|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13989556|NCT02966522|Growth Substances|growth substances|mesh-ancestor
13989557|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
13989558|NCT02966587|Durvalumab|durvalumab|mesh-list
13989559|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
13989560|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13989561|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
13989562|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13989563|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989564|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
13989565|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989566|NCT02966457|Colistin|colistin|mesh-list
13989567|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989568|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989569|NCT02966665|Vitamins|vitamins|mesh-list
13989570|NCT02966665|Vitamin E|vitamin e|mesh-list
13989571|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
13989572|NCT02966665|Fexofenadine|fexofenadine|mesh-list
13989573|NCT02966665|Valsartan|valsartan|mesh-list
13989574|NCT02966665|Nitroprusside|nitroprusside|mesh-list
13989575|NCT02966665|Phentolamine|phentolamine|mesh-list
13989576|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
13989577|NCT02966665|Norepinephrine|norepinephrine|mesh-list
13989578|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
13989579|NCT02966665|Giapreza|giapreza|mesh-list
13989580|NCT02966665|Acetylcholine|acetylcholine|mesh-list
13989581|NCT02966665|Ranitidine|ranitidine|mesh-list
13989582|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
13989583|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
13989584|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989585|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13989586|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13989587|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13989588|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989589|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
13989590|NCT02966665|Protective Agents|protective agents|mesh-ancestor
13989591|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13989592|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13989593|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989594|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989595|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
13989596|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
13989597|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989598|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13989599|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
13989600|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13989601|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13989602|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13989603|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
13989604|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
13989605|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13989606|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989607|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13989608|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
13989609|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13989610|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13989611|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
13989612|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989613|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14263181|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14263182|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263183|NCT04884763|Analgesics|analgesics|mesh-ancestor
14263184|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
14263185|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263186|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263187|NCT04847453|Dexamethasone|dexamethasone|mesh-list
14263188|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
14263189|NCT04847453|Venetoclax|venetoclax|mesh-list
14263190|NCT04847453|Ixazomib|ixazomib|mesh-list
14263191|NCT04847453|Ichthammol|ichthammol|mesh-list
14263192|NCT04847453|BB 1101|bb 1101|mesh-list
14263193|NCT04847453|Glycine|glycine|mesh-list
14263194|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989614|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
13989615|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13989616|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13989617|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13989618|NCT02966743|Midazolam|midazolam|mesh-list
14263195|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
13989619|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
13989620|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13989621|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989622|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989623|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13989624|NCT02966743|Analgesics|analgesics|mesh-ancestor
13989625|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
13989626|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989627|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13989628|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13989629|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13989630|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989631|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989632|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989633|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13989634|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13989635|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13989636|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13989637|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13989638|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
13989639|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
15081502|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081503|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
13989640|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
13989641|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
13989642|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
13989643|NCT02966652|Testosterone|testosterone|mesh-list
14263196|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
14263197|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263198|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263199|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14263200|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
14263201|NCT04847453|Hormones|hormones|mesh-ancestor
14263202|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263203|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263204|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263205|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
14263206|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263207|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263208|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
14263209|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
14263210|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263211|NCT04820673|Sarecycline|sarecycline|mesh-list
14263212|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14263213|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263214|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
14263215|NCT04802590|Venetoclax|venetoclax|mesh-list
14263216|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263217|NCT04781855|Nivolumab|nivolumab|mesh-list
14263218|NCT04781855|Ipilimumab|ipilimumab|mesh-list
14263219|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263220|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263221|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14263222|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263223|NCT04684238|Midazolam|midazolam|mesh-list
14263224|NCT04684238|Isoflurane|isoflurane|mesh-list
14263225|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14263226|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14263227|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263228|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263229|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14263230|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14263231|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14263232|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14263233|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
14263234|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
14263235|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
14263236|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
14263237|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263238|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263239|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14535829|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263240|NCT04681443|Phenol|phenol|mesh-list
14263241|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14263242|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263243|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
13989644|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
13989645|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
13989646|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13989647|NCT02966652|Androgens|androgens|mesh-ancestor
13989648|NCT02966652|Hormones|hormones|mesh-ancestor
13989649|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989650|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989651|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13989652|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989653|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
13989654|NCT02966288|Ibuprofen|ibuprofen|mesh-list
13989655|NCT02966288|Ketorolac|ketorolac|mesh-list
13989656|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13989657|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13989658|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13989659|NCT02966288|Analgesics|analgesics|mesh-ancestor
13989660|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
13989661|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989662|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989663|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989664|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989665|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13989666|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989667|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989668|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
13989669|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989670|NCT02966704|Caseins|caseins|mesh-list
13989671|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
13989672|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
13989673|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989674|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
13989675|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13989676|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13989677|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989678|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
13989679|NCT02966236|Coagulants|coagulants|mesh-ancestor
13989680|NCT02966119|Aspirin|aspirin|mesh-list
13989681|NCT02966119|Clopidogrel|clopidogrel|mesh-list
13989682|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13989683|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13989684|NCT02966119|Analgesics|analgesics|mesh-ancestor
13989685|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
13989686|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989687|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989688|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989689|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989690|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13989691|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13989692|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989693|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13989694|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13989695|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989696|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
15081504|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081505|NCT04553666|Protective Agents|protective agents|mesh-ancestor
15081506|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15081507|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15081508|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989697|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13989698|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13989699|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13989700|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
13989701|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989702|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
13989703|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989704|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
13989705|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989706|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989707|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13989708|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
13989709|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263244|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14263245|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13989710|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989711|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14022853|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022854|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022855|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022856|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022857|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022858|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
14022859|NCT02766192|Ketamine|ketamine|mesh-list
14022860|NCT02766192|Analgesics|analgesics|mesh-ancestor
14022861|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
14022862|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022863|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022864|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14022865|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14022866|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
14022867|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
14022868|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022869|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14022870|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14022871|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022872|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022873|NCT02766270|Temozolomide|temozolomide|mesh-list
14022874|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14022875|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
14022876|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022877|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022878|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
14022879|NCT02766556|Ropivacaine|ropivacaine|mesh-list
14022880|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14022881|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022882|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022883|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022884|NCT02766556|Analgesics|analgesics|mesh-ancestor
14022885|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
14022886|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022887|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14022888|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14022889|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14022890|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022891|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022892|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022893|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
14022894|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
14022895|NCT02766348|Gemcitabine|gemcitabine|mesh-list
14022896|NCT02766348|Cisplatin|cisplatin|mesh-list
14022897|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022898|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
14022899|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022900|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022901|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
14022902|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022903|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022904|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022905|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
14022906|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022907|NCT02766322|Ethanol|ethanol|mesh-list
14022908|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14022909|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022910|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022911|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022912|NCT02766257|Anesthetics|anesthetics|mesh-list
14022913|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022914|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263246|NCT04666272|Trametinib|trametinib|mesh-list
14263247|NCT04666272|Dabrafenib|dabrafenib|mesh-list
14263248|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263249|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14263250|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263251|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263252|NCT04600141|Heparin|heparin|mesh-list
14263253|NCT04600141|Calcium heparin|calcium heparin|mesh-list
14263254|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
14022915|NCT02766140|Docetaxel|docetaxel|mesh-list
14263255|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14263256|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13989712|NCT02966067|Anesthetics|anesthetics|mesh-list
13989713|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13989714|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989715|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989716|NCT02966041|Ondansetron|ondansetron|mesh-list
13989717|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
13989718|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
13989719|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989720|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989721|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989722|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
13989723|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
13989724|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13989725|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
13989726|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263257|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263258|NCT04584255|Niraparib|niraparib|mesh-list
14263259|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14263260|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263261|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263262|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292164|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
14292165|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292166|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292167|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14292168|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292169|NCT00558753|Pregabalin|pregabalin|mesh-list
14292170|NCT00558753|Analgesics|analgesics|mesh-ancestor
14292171|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
14292172|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292173|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292174|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
14292175|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14292176|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292177|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292178|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14292179|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14292180|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14292181|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292182|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292183|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14292184|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
14292185|NCT00558896|Dexamethasone|dexamethasone|mesh-list
14292186|NCT00558896|Pomalidomide|pomalidomide|mesh-list
14292187|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14292188|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
14292189|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
14292190|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292191|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292192|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292193|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
14292194|NCT00558896|Hormones|hormones|mesh-ancestor
14292195|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292196|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292197|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989727|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989728|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13989729|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13989730|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989731|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13989732|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13989733|NCT02965911|Fenofibrate|fenofibrate|mesh-list
13989734|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13989735|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
13989736|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989737|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13989738|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
13989739|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
13989740|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
13989741|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13989742|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989743|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
13989744|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989745|NCT02966080|Heparin|heparin|mesh-list
13989746|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
13989747|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13989748|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13989749|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989750|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
13989751|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13989752|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13989753|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
13989754|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13989755|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13989756|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989757|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
14535830|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535831|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
14535832|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14535833|NCT01126879|Estrogens|estrogens|mesh-ancestor
14535834|NCT01126879|Hormones|hormones|mesh-ancestor
14535835|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535836|NCT01139125|Cysteamine|cysteamine|mesh-list
13989758|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989759|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263263|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
14263264|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
14263265|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263266|NCT04555096|Protective Agents|protective agents|mesh-ancestor
14263267|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263268|NCT04551352|Adalimumab|adalimumab|mesh-list
14263269|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
14263270|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263271|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263272|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263273|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263274|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
14263275|NCT04541017|Magrolimab|magrolimab|mesh-list
14263276|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
14263277|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
14535837|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14535838|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263278|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
14263279|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263280|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535839|NCT01133639|Ketorolac|ketorolac|mesh-list
14535840|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14535841|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14535842|NCT01133639|Analgesics|analgesics|mesh-ancestor
14535843|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
14535844|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535845|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535846|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535847|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535848|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14535849|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535850|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535851|NCT01126801|Estradiol|estradiol|mesh-list
14535852|NCT01126801|Estrogens|estrogens|mesh-ancestor
14535853|NCT01126801|Hormones|hormones|mesh-ancestor
14263281|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263282|NCT04526288|Cytarabine|cytarabine|mesh-list
13989760|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13989761|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989762|NCT02965859|Adefovir|adefovir|mesh-list
13989763|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
13989764|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
13989765|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989766|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13989767|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13989768|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989769|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989770|NCT02965404|Vaccines|vaccines|mesh-list
13989771|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
13989772|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989773|NCT02965677|Paclitaxel|paclitaxel|mesh-list
13989774|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13989775|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989776|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
13989777|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
13989778|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
13989779|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989780|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
13989781|NCT02965443|Saxagliptin|saxagliptin|mesh-list
13989782|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13989783|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989784|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989785|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263283|NCT04526288|Daunorubicin|daunorubicin|mesh-list
14263284|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263285|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
14263286|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263287|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263288|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
14263289|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263290|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263291|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
14263292|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263293|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14263294|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14263295|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14263296|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263297|NCT04522739|Spironolactone|spironolactone|mesh-list
14263298|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14263299|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
14263300|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263301|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263302|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14263303|NCT04522739|Diuretics|diuretics|mesh-ancestor
14263304|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
14263305|NCT04517799|Cannabidiol|cannabidiol|mesh-list
14263306|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
14263307|NCT04517396|Fenofibrate|fenofibrate|mesh-list
14263308|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
14263309|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14263310|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
14263311|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263312|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14263313|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14263314|NCT04504318|Enoxaparin|enoxaparin|mesh-list
14263315|NCT04504318|Apixaban|apixaban|mesh-list
14263316|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
14263317|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14263318|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14263319|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263320|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14263321|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
14263322|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14263323|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
14263324|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263325|NCT04492553|Testosterone|testosterone|mesh-list
14263326|NCT04492553|Androgens|androgens|mesh-ancestor
14263327|NCT04492553|Hormones|hormones|mesh-ancestor
14263328|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263329|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263330|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14263331|NCT04422431|Choline|choline|mesh-list
13989786|NCT02965443|Incretins|incretins|mesh-ancestor
13989787|NCT02965443|Hormones|hormones|mesh-ancestor
13989788|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989789|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13989790|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
13989791|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989792|NCT02965768|Naltrexone|naltrexone|mesh-list
13989793|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13989794|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13989795|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989796|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
13989797|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989798|NCT02965053|Sevelamer|sevelamer|mesh-list
13989799|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
13989800|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
13989801|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989802|NCT02965196|Dexamethasone|dexamethasone|mesh-list
14263332|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
14263333|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14263334|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
14263335|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263336|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14263337|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14263338|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
14263339|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
14263340|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
14263341|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263342|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14263343|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14263344|NCT04422431|Growth Substances|growth substances|mesh-ancestor
14263345|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263346|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
14263347|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263348|NCT04417179|Bupivacaine|bupivacaine|mesh-list
14263349|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
14263350|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
14263351|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263352|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263353|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
14263354|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263355|NCT04415151|Tofacitinib|tofacitinib|mesh-list
14263356|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14263357|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263358|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263359|NCT04395196|Choline|choline|mesh-list
14263360|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
14263361|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14263362|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
14263363|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263364|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14263365|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14263366|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
14263367|NCT04375813|Sirolimus|sirolimus|mesh-list
14263368|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14263369|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263370|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14263371|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263372|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
14263373|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263374|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
14263375|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263376|NCT04339036|Capecitabine|capecitabine|mesh-list
14263377|NCT04339036|Temozolomide|temozolomide|mesh-list
14263378|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263379|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
14263380|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263381|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263382|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14263383|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
14263384|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
14263385|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14263386|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989803|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263387|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14263388|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14263389|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
13989804|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
13989805|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
13989806|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989807|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989808|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989809|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
13989810|NCT02965196|Hormones|hormones|mesh-ancestor
13989811|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989812|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13989813|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989814|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
13989815|NCT02965248|Leucovorin|leucovorin|mesh-list
13989816|NCT02965248|Capecitabine|capecitabine|mesh-list
13989817|NCT02965248|Raltitrexed|raltitrexed|mesh-list
13989818|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
13989819|NCT02965248|Calcium|calcium|mesh-list
13989820|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
13989821|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13989822|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989823|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13989824|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13989825|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
13989826|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989827|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989828|NCT02965248|Antidotes|antidotes|mesh-ancestor
13989829|NCT02965248|Protective Agents|protective agents|mesh-ancestor
13989830|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
13989831|NCT02965248|Vitamins|vitamins|mesh-ancestor
14263390|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263391|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
14263392|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
14263393|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14263394|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14263395|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263396|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263397|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263398|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263399|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
14263400|NCT04314843|Fludarabine|fludarabine|mesh-list
14263401|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263402|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
14263403|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263404|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263405|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14263406|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
14263407|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263408|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263409|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14263410|NCT04299113|Vinorelbine|vinorelbine|mesh-list
14263411|NCT04299113|Mocetinostat|mocetinostat|mesh-list
14263412|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14263413|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263414|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
14263415|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
14263416|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
14263417|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263418|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14263419|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263420|NCT04294264|Trifluridine|trifluridine|mesh-list
14263421|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
14263422|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263423|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
14263424|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263425|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
14263426|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263427|NCT04288895|Vortioxetine|vortioxetine|mesh-list
14263428|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
14263429|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14263430|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14263431|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14263432|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263433|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535854|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13989832|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
13989833|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13989834|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989835|NCT02965274|Fluoxetine|fluoxetine|mesh-list
13989836|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13989837|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13989838|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13989839|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989840|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989841|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
13989842|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989843|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13989844|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
13989845|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13989846|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13989847|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13989848|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989849|NCT02965261|Fluoxetine|fluoxetine|mesh-list
13989850|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13989851|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14263434|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14263435|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14263436|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14263437|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263438|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263439|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
14263440|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14263441|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14263442|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14263443|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14263444|NCT04271202|Erenumab|erenumab|mesh-list
14263445|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14263446|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263447|NCT04271202|Analgesics|analgesics|mesh-ancestor
14263448|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
14263449|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263450|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263451|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
14263452|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
14263453|NCT04259060|Hematinics|hematinics|mesh-ancestor
14263454|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
14263455|NCT04259060|Vitamins|vitamins|mesh-ancestor
14263456|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
14263457|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263458|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
14263459|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14263460|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263461|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14263462|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263463|NCT04247126|Gemcitabine|gemcitabine|mesh-list
14263464|NCT04247126|Paclitaxel|paclitaxel|mesh-list
14263465|NCT04247126|Fulvestrant|fulvestrant|mesh-list
14263466|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14263467|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263468|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14263469|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14263470|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14263471|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263472|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263473|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
14263474|NCT04247126|Antiviral Agents|antiviral agents|mesh-ancestor
14263475|NCT04247126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263476|NCT04247126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263477|NCT04247126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263478|NCT04247126|Immunologic Factors|immunologic factors|mesh-ancestor
14263479|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263480|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263481|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14263482|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14263483|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
14263484|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263485|NCT04230499|Sirolimus|sirolimus|mesh-list
14263486|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14263487|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263488|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13989852|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13989853|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989854|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989855|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
13989856|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989857|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14263489|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263490|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
14263491|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263492|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
14263493|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535855|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535856|NCT01126957|Fentanyl|fentanyl|mesh-list
14535857|NCT01126957|Ketamine|ketamine|mesh-list
14535858|NCT01126957|Propofol|propofol|mesh-list
14535859|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14263499|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
14263500|NCT04163107|Dexamethasone|dexamethasone|mesh-list
14263501|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263502|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
14263503|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
14263504|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263505|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263506|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14263507|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
14263508|NCT04163107|Hormones|hormones|mesh-ancestor
14263509|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263510|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263511|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263512|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
14263513|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14263514|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14263515|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263516|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263517|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263518|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535860|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14535861|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535862|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14535863|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
14535864|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
14535865|NCT01126957|Analgesics|analgesics|mesh-ancestor
14535866|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
14535867|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535868|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14535869|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14535870|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14535871|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535872|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535873|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14535874|NCT01126957|Narcotics|narcotics|mesh-ancestor
14535875|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14535876|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
14535877|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535878|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535879|NCT01122511|Dexamethasone|dexamethasone|mesh-list
13989858|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
13989859|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13989860|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13989861|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13989862|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989863|NCT02965027|Prazosin|prazosin|mesh-list
13989864|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13989865|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13989866|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13989867|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13989868|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989869|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989870|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989871|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989872|NCT02964715|Empagliflozin|empagliflozin|mesh-list
13989873|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13989874|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989875|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989876|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989877|NCT02964949|Edoxaban|edoxaban|mesh-list
13989878|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13989879|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
13989880|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13989881|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
13989882|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989883|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989884|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
13989885|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
13989886|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13989887|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13989888|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13989889|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13989890|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989891|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
13989892|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989893|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989894|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14263538|NCT04080284|Niraparib|niraparib|mesh-list
14263539|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14263540|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263541|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263542|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263543|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14263544|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14263545|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
14263546|NCT04072107|Capecitabine|capecitabine|mesh-list
14263547|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263548|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
14263549|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263550|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292198|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
14292199|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14292200|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14292201|NCT00558896|Growth Substances|growth substances|mesh-ancestor
14292202|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14292203|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
14292204|NCT00559104|Carmustine|carmustine|mesh-list
14292205|NCT00559104|Etoposide|etoposide|mesh-list
14292206|NCT00559104|Sargramostim|sargramostim|mesh-list
14292207|NCT00559104|Lenograstim|lenograstim|mesh-list
14292208|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292209|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
14292210|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292211|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292212|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14292213|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
14292214|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989895|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989896|NCT02964689|Pemetrexed|pemetrexed|mesh-list
13989897|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989898|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989899|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989900|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13989901|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13989902|NCT02964455|Docetaxel|docetaxel|mesh-list
13989903|NCT02964455|Nedaplatin|nedaplatin|mesh-list
13989904|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989905|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
13989906|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
13989907|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
13989908|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989909|NCT02964572|Empagliflozin|empagliflozin|mesh-list
13989910|NCT02964572|Glimepiride|glimepiride|mesh-list
13989911|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13989912|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989913|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989914|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989915|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13989916|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13989917|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
14022916|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022917|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14022918|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14022919|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14022920|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022921|NCT02766036|Propolis|propolis|mesh-list
14263551|NCT03997123|Paclitaxel|paclitaxel|mesh-list
14263552|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14263553|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263554|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
14263555|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
14263556|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
14263557|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263558|NCT03984240|Midazolam|midazolam|mesh-list
14263559|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
14263560|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14263561|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263562|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263563|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14263564|NCT03984240|Analgesics|analgesics|mesh-ancestor
14263565|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
14263566|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263567|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14263568|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14263569|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14263570|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14263571|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263572|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263573|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14263574|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14263575|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14263576|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14263577|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14263578|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
14263579|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
14263580|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
14263581|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
14263582|NCT03983226|Gemcitabine|gemcitabine|mesh-list
14263583|NCT03983226|Carboplatin|carboplatin|mesh-list
14263584|NCT03983226|Doxorubicin|doxorubicin|mesh-list
14263585|NCT03983226|Niraparib|niraparib|mesh-list
14022922|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022923|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
14022924|NCT02765971|Cathartics|cathartics|mesh-ancestor
14022925|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022926|NCT02765815|Ketorolac|ketorolac|mesh-list
14022927|NCT02765815|Epinephrine|epinephrine|mesh-list
14022928|NCT02765815|Racepinephrine|racepinephrine|mesh-list
14022929|NCT02765815|Morphine|morphine|mesh-list
14022930|NCT02765815|Bupivacaine|bupivacaine|mesh-list
14022931|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
14022932|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
14022933|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
14263586|NCT03983226|Taxane|taxane|mesh-list
14263587|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13989918|NCT02964195|Rifaximin|rifaximin|mesh-list
13989919|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989920|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989921|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13989922|NCT02964104|Insulin|insulin|mesh-list
13989923|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13989924|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13989925|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989926|NCT02964403|Indomethacin|indomethacin|mesh-list
13989927|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13989928|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13989929|NCT02964403|Analgesics|analgesics|mesh-ancestor
13989930|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
13989931|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989932|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989933|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989934|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989935|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
13989936|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
13989937|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13989938|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13989939|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989940|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989941|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
13989942|NCT02964091|Ledipasvir|ledipasvir|mesh-list
13989943|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
13989944|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989945|NCT02963779|Apremilast|apremilast|mesh-list
13989946|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13989947|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13989948|NCT02963779|Analgesics|analgesics|mesh-ancestor
13989949|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
13989950|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13989951|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989952|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989953|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989954|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13989955|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15081509|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15081510|NCT04553003|Prednisone|prednisone|mesh-list
15081511|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
13989956|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989957|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989958|NCT02963896|Gentamicins|gentamicins|mesh-list
13989959|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13989960|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13989961|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13989962|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989963|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989964|NCT02963402|Adalimumab|adalimumab|mesh-list
13989965|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13989966|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13989967|NCT02963454|Simendan|simendan|mesh-list
13989968|NCT02963454|Dobutamine|dobutamine|mesh-list
13989969|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13989970|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
13989971|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13989972|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13989973|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989974|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989975|NCT02963454|Protective Agents|protective agents|mesh-ancestor
13989976|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989977|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
13989978|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
13989979|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263588|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263589|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
14263590|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263591|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
14263592|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263593|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263594|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081512|NCT04553003|Choline|choline|mesh-list
15081513|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
13989980|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13989981|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13989982|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13989983|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
13989984|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13989985|NCT02963051|Copper|copper|mesh-list
13989986|NCT02963051|Disulfiram|disulfiram|mesh-list
13989987|NCT02963051|Trace Elements|trace elements|mesh-ancestor
13989988|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
13989989|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989990|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13989991|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
13989992|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13989993|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13989994|NCT02963194|Oxytocin|oxytocin|mesh-list
13989995|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
13989996|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13989997|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13989998|NCT02963129|Mupirocin|mupirocin|mesh-list
13989999|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13990000|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990001|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13990002|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990003|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990004|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
15081514|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
15081515|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081516|NCT04553003|Hormones|hormones|mesh-ancestor
14263595|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
14263596|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263597|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14263598|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14263599|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14263600|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14263601|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14263602|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263603|NCT03948347|Liraglutide|liraglutide|mesh-list
14263604|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14263605|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263606|NCT03948347|Incretins|incretins|mesh-ancestor
14263607|NCT03948347|Hormones|hormones|mesh-ancestor
14263608|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263609|NCT03944434|Leuprolide|leuprolide|mesh-list
14263610|NCT03944434|Goserelin|goserelin|mesh-list
14263611|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14263612|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14263613|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14263614|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
14263615|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14263616|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263617|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263618|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263619|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14263620|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263621|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263622|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14263623|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
14263624|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263625|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
14263626|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14263627|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
14263628|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14263629|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
14263630|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263631|NCT03924635|Budesonide|budesonide|mesh-list
15081517|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081518|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081519|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081520|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081521|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
15081522|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
15081523|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081524|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990005|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13990006|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14263632|NCT03924635|Albuterol|albuterol|mesh-list
14263633|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
13990007|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
13990008|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990009|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13990010|NCT02963168|Docetaxel|docetaxel|mesh-list
13990011|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990012|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
13990013|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
13990014|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
13990015|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990016|NCT02963181|Melatonin|melatonin|mesh-list
13990017|NCT02963181|Yohimbine|yohimbine|mesh-list
13990018|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
13990019|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990020|NCT02963181|Protective Agents|protective agents|mesh-ancestor
13990021|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990022|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990023|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
13990024|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
13990025|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990026|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13990027|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13990028|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13990029|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990030|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990031|NCT02963181|Urological Agents|urological agents|mesh-ancestor
13990032|NCT02963337|Remifentanil|remifentanil|mesh-list
13990033|NCT02963337|Bupivacaine|bupivacaine|mesh-list
13990034|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990035|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
13990036|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990037|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990038|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
13990039|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990040|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13990041|NCT02963337|Narcotics|narcotics|mesh-ancestor
13990042|NCT02963337|Analgesics|analgesics|mesh-ancestor
13990043|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
14263634|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14263635|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263636|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14263637|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
14263638|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263639|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263640|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14263641|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
14263642|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
14263643|NCT03924635|Hormones|hormones|mesh-ancestor
14263644|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263645|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14263646|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14263647|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14263648|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
14263649|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263650|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263651|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
14263652|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14263653|NCT03924401|Abatacept|abatacept|mesh-list
14263654|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14263655|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263656|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263657|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263658|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
14263659|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263660|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263661|NCT03907475|Gemcitabine|gemcitabine|mesh-list
14263662|NCT03907475|Paclitaxel|paclitaxel|mesh-list
14263663|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14263664|NCT03907475|Carboplatin|carboplatin|mesh-list
14263665|NCT03907475|Doxorubicin|doxorubicin|mesh-list
14263666|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14263667|NCT03907475|Capecitabine|capecitabine|mesh-list
14263668|NCT03907475|Durvalumab|durvalumab|mesh-list
14263669|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
14263670|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13990044|NCT02963090|Topotecan|topotecan|mesh-list
14263671|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
13990045|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990046|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990047|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13990048|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13990049|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990050|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990051|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13990052|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13990053|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13990054|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
13990055|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990056|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13990057|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13990058|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990059|NCT02963103|Tacrolimus|tacrolimus|mesh-list
13990060|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990061|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
13990062|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990063|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13990064|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990065|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990066|NCT02962999|Ketamine|ketamine|mesh-list
13990067|NCT02962999|Analgesics|analgesics|mesh-ancestor
13990068|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
13990069|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263672|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14263673|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263674|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
14263675|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
14263676|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
14263677|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263678|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263679|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
14263680|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
14263681|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263682|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263683|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263684|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
14263685|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263686|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14263687|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14263688|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14263689|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263690|NCT03873805|Vidarabine|vidarabine|mesh-list
14263691|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
14263692|NCT03873805|Fludarabine|fludarabine|mesh-list
14263693|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
14263694|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263695|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
14263696|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263697|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263698|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14263699|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
14263700|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263701|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263702|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14263703|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263704|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
14263705|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
14263706|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263707|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
14263708|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263709|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263710|NCT03859024|Acetaminophen|acetaminophen|mesh-list
14263711|NCT03859024|Dexamethasone|dexamethasone|mesh-list
14263712|NCT03859024|Ibuprofen|ibuprofen|mesh-list
14263713|NCT03859024|Celecoxib|celecoxib|mesh-list
14263714|NCT03859024|Oxycodone|oxycodone|mesh-list
14263715|NCT03859024|Gabapentin|gabapentin|mesh-list
14263716|NCT03859024|Bupivacaine|bupivacaine|mesh-list
14263717|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263718|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
14263719|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
14263720|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263721|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263722|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081525|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13990070|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990071|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13990072|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14263723|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
14263724|NCT03859024|Hormones|hormones|mesh-ancestor
14263725|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263726|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263727|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263728|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
14263729|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
14263730|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263731|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
14263732|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14263733|NCT03859024|Analgesics|analgesics|mesh-ancestor
14263734|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
14263735|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14263736|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263737|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14263738|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263739|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263740|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14263741|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14263742|NCT03859024|Narcotics|narcotics|mesh-ancestor
14263743|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
14263744|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14263745|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14263746|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14263747|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14263748|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14263749|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263750|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
14263751|NCT03845517|PF-06700841|pf-06700841|mesh-list
14263752|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14263753|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263754|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263755|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14263756|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
14263757|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263758|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
14263759|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263760|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
14263761|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263762|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263763|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14263764|NCT03818607|Eculizumab|eculizumab|mesh-list
14263765|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14263766|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263767|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
14263768|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263769|NCT03809000|Leuprolide|leuprolide|mesh-list
14263770|NCT03809000|Goserelin|goserelin|mesh-list
14263771|NCT03809000|Bicalutamide|bicalutamide|mesh-list
14263772|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263773|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263774|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14263775|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
14263776|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14263777|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263778|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263779|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
14263780|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
14535880|NCT01122511|Ranibizumab|ranibizumab|mesh-list
13990073|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
13990074|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
13990075|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990076|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13990077|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13990078|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990079|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990080|NCT02962986|Phenylephrine|phenylephrine|mesh-list
13990081|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
13990082|NCT02962986|Norepinephrine|norepinephrine|mesh-list
13990083|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13990084|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
13990085|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
13990086|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990087|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990088|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
13990089|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13990090|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
13990091|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
13990092|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13990093|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13990094|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13990095|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990096|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990097|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990098|NCT02962986|Protective Agents|protective agents|mesh-ancestor
13990099|NCT02963324|Ivermectin|ivermectin|mesh-list
13990100|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13990101|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990102|NCT02962947|Propranolol|propranolol|mesh-list
13990103|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13990104|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13990105|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990106|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990107|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990108|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990109|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13990110|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13990111|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
13990112|NCT02962804|Nivolumab|nivolumab|mesh-list
13990113|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990114|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990115|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13990116|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990117|NCT02962830|Sufentanil|sufentanil|mesh-list
14263781|NCT03796195|Bupivacaine|bupivacaine|mesh-list
14263782|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
14263783|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
14263784|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14263785|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263786|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
14263787|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263788|NCT03794583|Treprostinil|treprostinil|mesh-list
14263789|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14263790|NCT03770689|Capecitabine|capecitabine|mesh-list
14263791|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14263792|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
14263793|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263794|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263795|NCT03751631|Phenylephrine|phenylephrine|mesh-list
14263796|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
14263797|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14263798|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14263799|NCT03751631|Tropicamide|tropicamide|mesh-list
14263800|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14263801|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
14263802|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
14263803|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263804|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263805|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
14263806|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14263807|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
13990118|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13990119|NCT02962830|Narcotics|narcotics|mesh-ancestor
13990120|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990121|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990122|NCT02962830|Analgesics|analgesics|mesh-ancestor
13990123|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
13990124|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990125|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13990126|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13990127|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
13990128|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
13990129|NCT02962921|Insulin|insulin|mesh-list
13990130|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13990131|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
13990132|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13990133|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263808|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
13990134|NCT02962232|Paclitaxel|paclitaxel|mesh-list
13990135|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081526|NCT04553003|Protective Agents|protective agents|mesh-ancestor
15081527|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
15081528|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13990136|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990137|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
13990138|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
13990139|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
13990140|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990141|NCT02962388|Anagrelide|anagrelide|mesh-list
13990142|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13990143|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13990144|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990145|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13990146|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
13990147|NCT02962401|Idelalisib|idelalisib|mesh-list
13990148|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990149|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990150|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990151|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990152|NCT02962258|Amlodipine|amlodipine|mesh-list
13990153|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13990154|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13990155|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13990156|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990157|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990158|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13990159|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990160|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
13990161|NCT02962258|Diuretics|diuretics|mesh-ancestor
13990162|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
13990163|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14022934|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022935|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022936|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
14022937|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022938|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14022939|NCT02765815|Narcotics|narcotics|mesh-ancestor
14022940|NCT02765815|Analgesics|analgesics|mesh-ancestor
14022941|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14022942|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14022943|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022944|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022945|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022946|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14022947|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14022948|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
14022949|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14022950|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
14022951|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
14022952|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
14022953|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14022954|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14022955|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022956|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022957|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022958|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14022959|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022960|NCT02765633|Cangrelor|cangrelor|mesh-list
14022961|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14022962|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14022963|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14022964|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14022965|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
14022966|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022967|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022968|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022969|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
14022970|NCT02765594|Valsartan|valsartan|mesh-list
14022971|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14263809|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14263810|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15081529|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
13990164|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
13990165|NCT02962492|Exenatide|exenatide|mesh-list
14263811|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14263812|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
14263813|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263814|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263815|NCT03751631|Protective Agents|protective agents|mesh-ancestor
14535881|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535882|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
14535883|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
14535884|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263816|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14263817|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14263818|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
14263819|NCT03751098|Phenylephrine|phenylephrine|mesh-list
14263820|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
14263821|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14263822|NCT03751098|Tropicamide|tropicamide|mesh-list
14263823|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14263824|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14263825|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
14263826|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
14263827|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263828|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263829|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
14263830|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14263831|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
14263832|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
14263833|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14263834|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14263835|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14263836|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14263837|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263838|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263839|NCT03751098|Protective Agents|protective agents|mesh-ancestor
14263840|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14263841|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14263842|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
14263843|NCT03729869|Progesterone|progesterone|mesh-list
14263844|NCT03729869|Progestins|progestins|mesh-ancestor
14263845|NCT03729869|Hormones|hormones|mesh-ancestor
14263846|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263847|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263848|NCT03677141|Prednisone|prednisone|mesh-list
14263849|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
14263850|NCT03677141|Doxorubicin|doxorubicin|mesh-list
14263851|NCT03677141|Vincristine|vincristine|mesh-list
14263852|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263853|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
14263854|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263855|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263856|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14263857|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
14263858|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263859|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263860|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14263861|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14263862|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14263863|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14263864|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263865|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263866|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
14263867|NCT03677141|Hormones|hormones|mesh-ancestor
14263868|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263869|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14263870|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14263871|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
14263872|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
14263873|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
13990166|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13990167|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990168|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13990169|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990170|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13990171|NCT02962492|Incretins|incretins|mesh-ancestor
13990172|NCT02962492|Hormones|hormones|mesh-ancestor
14535885|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535886|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14535887|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
14535888|NCT01122511|Hormones|hormones|mesh-ancestor
14535889|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13990173|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13990174|NCT02962518|Triamcinolone|triamcinolone|mesh-list
13990175|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990176|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
13990177|NCT02962518|Hormones|hormones|mesh-ancestor
13990178|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13990179|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990180|NCT02962336|Amlodipine|amlodipine|mesh-list
13990181|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13990182|NCT02962336|Olmesartan|olmesartan|mesh-list
13990183|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13990184|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13990185|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13990186|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990187|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990188|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13990189|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990190|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
13990191|NCT02962336|Diuretics|diuretics|mesh-ancestor
13990192|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
13990193|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13990194|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13990195|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13990196|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13990197|NCT02962310|Calcium|calcium|mesh-list
13990198|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13990199|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990200|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13990201|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13990202|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
13990203|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990204|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13990205|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14263874|NCT03675412|Caffeine|caffeine|mesh-list
14263875|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14263876|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263877|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14263878|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263879|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263880|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14263881|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14263882|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
14263883|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263884|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
14263885|NCT03644485|Tacrolimus|tacrolimus|mesh-list
14263886|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14263887|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
14263888|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263889|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14263890|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263891|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263892|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14263893|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263894|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14263895|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
14263896|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14263897|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14263898|NCT03636503|Rituximab|rituximab|mesh-list
14263899|NCT03636503|Avelumab|avelumab|mesh-list
14263900|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263901|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263902|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
14263903|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263904|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263905|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
14263906|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081530|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990206|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990207|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13990208|NCT02962323|Calcium|calcium|mesh-list
13990209|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13990210|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990211|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13990212|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13990213|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
13990214|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990215|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13990216|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13990217|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990218|NCT02962050|Capsaicin|capsaicin|mesh-list
13990219|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
13990220|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
13990221|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
13990222|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990223|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990224|NCT02962141|Paclitaxel|paclitaxel|mesh-list
13990225|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13990226|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990227|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
13990228|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
13990229|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
13990230|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990231|NCT02961855|Diclofenac|diclofenac|mesh-list
13990232|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13990233|NCT02961855|Lidocaine|lidocaine|mesh-list
13990234|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990235|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
13990236|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990237|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990238|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
13990239|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263907|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14263908|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14263909|NCT03561584|Analgesics|analgesics|mesh-ancestor
14263910|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
14263911|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14263912|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263913|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14263914|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263915|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14263916|NCT03554083|Atezolizumab|atezolizumab|mesh-list
14263917|NCT03554083|Vemurafenib|vemurafenib|mesh-list
14263918|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14263919|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263920|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
14263921|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263922|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14263923|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263924|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263925|NCT03496623|Treprostinil|treprostinil|mesh-list
14263926|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14263927|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14263928|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14263929|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263930|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263931|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
14263932|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14263933|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263934|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
14263935|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
14263936|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263937|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263938|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263939|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
14263940|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
14263941|NCT03344965|Olaparib|olaparib|mesh-list
14263942|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14263943|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263944|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263945|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535890|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13990240|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13990241|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13990242|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13990243|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990244|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990245|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990246|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990247|NCT02961855|Analgesics|analgesics|mesh-ancestor
13990248|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990249|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13990250|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990251|NCT02961998|Celecoxib|celecoxib|mesh-list
13990252|NCT02961998|Sorafenib|sorafenib|mesh-list
13990253|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990254|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13990255|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990256|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990257|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990258|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990259|NCT02961998|Analgesics|analgesics|mesh-ancestor
13990260|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
13990261|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990262|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990263|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990264|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14263946|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14263947|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14263948|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263949|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
14263950|NCT03302234|Ipilimumab|ipilimumab|mesh-list
14535891|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535892|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14535893|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14535894|NCT01122511|Growth Substances|growth substances|mesh-ancestor
14535895|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
14535896|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
14535897|NCT01118013|Methotrexate|methotrexate|mesh-list
14535898|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
14535899|NCT01118013|Fludarabine|fludarabine|mesh-list
14535900|NCT01118013|Busulfan|busulfan|mesh-list
14535901|NCT01118013|Tacrolimus|tacrolimus|mesh-list
14535902|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14535903|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14535904|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
14535905|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14535906|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535907|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535908|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
14535909|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535910|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535911|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535912|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535913|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14535914|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535915|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
14535916|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535917|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14535918|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14535919|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14535920|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14535921|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
14535922|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14535923|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535924|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
14535925|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14535926|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14535927|NCT01122381|Ethosuximide|ethosuximide|mesh-list
14535928|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
14535929|NCT01116232|Sirolimus|sirolimus|mesh-list
14535930|NCT01116232|Rituximab|rituximab|mesh-list
14535931|NCT01116232|Tacrolimus|tacrolimus|mesh-list
14263951|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14535932|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14535933|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14642787|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
13990265|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13990266|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13990267|NCT02961829|Niacinamide|niacinamide|mesh-list
13990268|NCT02961829|Maraviroc|maraviroc|mesh-list
13990269|NCT02961829|Dolutegravir|dolutegravir|mesh-list
13990270|NCT02961829|Auranofin|auranofin|mesh-list
13990271|NCT02961829|Vaccines|vaccines|mesh-list
13990272|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
13990273|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
13990274|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263952|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263953|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14263954|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263955|NCT03284723|Letrozole|letrozole|mesh-list
14263956|NCT03284723|Palbociclib|palbociclib|mesh-list
14263957|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263958|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14263959|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14263960|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263961|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263962|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14263963|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
14263964|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14263965|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263966|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14263967|NCT03282981|Timolol|timolol|mesh-list
14263968|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14263969|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14263970|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
14263971|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14263972|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263973|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263974|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14263975|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14263976|NCT03278717|Olaparib|olaparib|mesh-list
14263977|NCT03278717|Cediranib|cediranib|mesh-list
14263978|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14263979|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14263980|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535934|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535935|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
14535936|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535937|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535938|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535939|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14535940|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535941|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535942|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14535943|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535944|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14535945|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
14535946|NCT01108666|Nelfinavir|nelfinavir|mesh-list
14535947|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14535948|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14535949|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
14535950|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535951|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535952|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14535953|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14535954|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
14535955|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535956|NCT01115244|Dapsone|dapsone|mesh-list
14535957|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535958|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
14535959|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14535960|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14535961|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14535962|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535963|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535964|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
13990275|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13990276|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14263981|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535965|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13990277|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990278|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13990279|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13990280|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
14263982|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14535966|NCT01106534|Aspirin|aspirin|mesh-list
14292215|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292216|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14292217|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292218|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14292219|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14292220|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292221|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14292222|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
14292223|NCT00559273|Hematinics|hematinics|mesh-ancestor
14292224|NCT00559364|Omeprazole|omeprazole|mesh-list
14292225|NCT00559364|Pancrelipase|pancrelipase|mesh-list
14292226|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14292227|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14292228|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292229|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292230|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292231|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14292232|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14292233|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292234|NCT00559468|Bromides|bromides|mesh-list
14292235|NCT00559468|Propofol|propofol|mesh-list
14292236|NCT00559468|Sevoflurane|sevoflurane|mesh-list
14292237|NCT00559468|Rocuronium|rocuronium|mesh-list
14292238|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14292239|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292240|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292241|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14292242|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
14292243|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
14292244|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14292245|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14292246|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
14292247|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14292248|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14292249|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14292250|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292251|NCT00559507|Saracatinib|saracatinib|mesh-list
14292252|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292253|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292254|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292255|NCT00559585|Abatacept|abatacept|mesh-list
14292256|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14292257|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292258|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292259|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292260|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
14292261|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292262|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292263|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
14292264|NCT00559637|Hematinics|hematinics|mesh-ancestor
14292265|NCT00559754|Bevacizumab|bevacizumab|mesh-list
14292266|NCT00559754|Docetaxel|docetaxel|mesh-list
14292267|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14292268|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292269|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14292270|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14292271|NCT00559754|Growth Substances|growth substances|mesh-ancestor
14535967|NCT01106534|Everolimus|everolimus|mesh-list
14535968|NCT01106534|Clopidogrel|clopidogrel|mesh-list
14535969|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13990281|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990282|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14292272|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292273|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
14292274|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
14292275|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
14292276|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292277|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292278|NCT00559845|Paclitaxel|paclitaxel|mesh-list
14292279|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
14807789|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990283|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13990284|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13990285|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990286|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
13990287|NCT02961829|Vitamins|vitamins|mesh-ancestor
13990288|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
13990289|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990290|NCT02961842|Ephedrine|ephedrine|mesh-list
13990291|NCT02961842|Fentanyl|fentanyl|mesh-list
13990292|NCT02961842|Bupivacaine|bupivacaine|mesh-list
13990293|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990294|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
13990295|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990296|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990297|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
13990298|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990299|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14263983|NCT03165955|Paclitaxel|paclitaxel|mesh-list
14263984|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14263985|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14263986|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
14263987|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
14263988|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
14263989|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14263990|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
14263991|NCT03133793|Vitamins|vitamins|mesh-ancestor
14263992|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
14263993|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14263994|NCT03130127|Terlipressin|terlipressin|mesh-list
14263995|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14263996|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14263997|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
14263998|NCT03127774|Antidotes|antidotes|mesh-ancestor
14263999|NCT03127774|Protective Agents|protective agents|mesh-ancestor
14264000|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264001|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
14264002|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264003|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
14264004|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14264005|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264006|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
14264007|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
14264008|NCT03127267|Riluzole|riluzole|mesh-list
14264009|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
14264010|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14264011|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14264012|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14264013|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264014|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264015|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14264016|NCT03127267|Protective Agents|protective agents|mesh-ancestor
14264017|NCT03108131|Atezolizumab|atezolizumab|mesh-list
14264018|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14264019|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264020|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
14264021|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264022|NCT03063203|Decitabine|decitabine|mesh-list
14264023|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264024|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
14264025|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264026|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264027|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264028|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14264029|NCT03057795|Nivolumab|nivolumab|mesh-list
14264030|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14264031|NCT03057795|Antibodies|antibodies|mesh-list
14264032|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
14264033|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14264034|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
14264035|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
14264036|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264037|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264038|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14535970|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990300|NCT02961842|Narcotics|narcotics|mesh-ancestor
13990301|NCT02961842|Analgesics|analgesics|mesh-ancestor
14264039|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264040|NCT02947685|Trastuzumab|trastuzumab|mesh-list
13990302|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13990303|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14264041|NCT02947685|Pertuzumab|pertuzumab|mesh-list
14264042|NCT02947685|Letrozole|letrozole|mesh-list
14264043|NCT02947685|Fulvestrant|fulvestrant|mesh-list
14264044|NCT02947685|Palbociclib|palbociclib|mesh-list
14264045|NCT02947685|Anastrozole|anastrozole|mesh-list
14264046|NCT02947685|Exemestane|exemestane|mesh-list
14264047|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264048|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264049|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14264050|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14264051|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264052|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264053|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14264054|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
14264055|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264056|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264057|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264058|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14264059|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264060|NCT02927769|Nivolumab|nivolumab|mesh-list
14264061|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14264062|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14264063|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264064|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264065|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14264066|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264067|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264068|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
14264069|NCT02845882|Cytarabine|cytarabine|mesh-list
14264070|NCT02845882|Dexamethasone|dexamethasone|mesh-list
14264071|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
14264072|NCT02845882|Prednisone|prednisone|mesh-list
14264073|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
14264074|NCT02845882|Ifosfamide|ifosfamide|mesh-list
14264075|NCT02845882|Doxorubicin|doxorubicin|mesh-list
14264076|NCT02845882|Methotrexate|methotrexate|mesh-list
14264077|NCT02845882|Etoposide|etoposide|mesh-list
14264078|NCT02845882|Vincristine|vincristine|mesh-list
14264079|NCT02845882|Daunorubicin|daunorubicin|mesh-list
14264080|NCT02845882|Asparaginase|asparaginase|mesh-list
14264081|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
14264082|NCT02845882|Vindesine|vindesine|mesh-list
14264083|NCT02845882|Pegaspargase|pegaspargase|mesh-list
14264084|NCT02845882|BB 1101|bb 1101|mesh-list
14264085|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264086|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
14264087|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264088|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264089|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264090|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
14264091|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264092|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264093|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264094|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264095|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
14264096|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
14264097|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264098|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14264099|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
14264100|NCT02845882|Hormones|hormones|mesh-ancestor
14264101|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264102|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264103|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
14264104|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264105|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264106|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264107|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264108|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14264109|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
14264110|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14264111|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264112|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
14264113|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
13990304|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
14264114|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14292280|NCT00559845|Bevacizumab|bevacizumab|mesh-list
13990305|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13990306|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
13990307|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
13990308|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13990309|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990310|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990311|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990312|NCT02962024|Morphine|morphine|mesh-list
13990313|NCT02962024|Bupivacaine|bupivacaine|mesh-list
13990314|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990315|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
13990316|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990317|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990318|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
13990319|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990320|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13990321|NCT02962024|Narcotics|narcotics|mesh-ancestor
13990322|NCT02962024|Analgesics|analgesics|mesh-ancestor
15081531|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15081532|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
15081533|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
13990323|NCT02962037|Melatonin|melatonin|mesh-list
13990324|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
13990325|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990326|NCT02962037|Protective Agents|protective agents|mesh-ancestor
13990327|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990328|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990329|NCT02961816|Pyridoxine|pyridoxine|mesh-list
13990330|NCT02961816|Gemcitabine|gemcitabine|mesh-list
13990331|NCT02961816|Dexamethasone|dexamethasone|mesh-list
13990332|NCT02961816|Rituximab|rituximab|mesh-list
13990333|NCT02961816|Melphalan|melphalan|mesh-list
13990334|NCT02961816|Busulfan|busulfan|mesh-list
13990335|NCT02961816|Panobinostat|panobinostat|mesh-list
13990336|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990337|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
13990338|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
13990339|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990340|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990341|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990342|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
13990343|NCT02961816|Hormones|hormones|mesh-ancestor
13990344|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13990345|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13990346|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990347|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990348|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
13990349|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990350|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13990351|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
13990352|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990353|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
13990354|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990355|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990356|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990357|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13990358|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
13990359|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13990360|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13990361|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
13990362|NCT02961816|Vitamins|vitamins|mesh-ancestor
13990363|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
13990364|NCT02961803|Biotin|biotin|mesh-list
13990365|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
13990366|NCT02961803|Vitamins|vitamins|mesh-ancestor
13990367|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
13990368|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990369|NCT02961660|Odalasvir|odalasvir|mesh-list
13990370|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
13990371|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990372|NCT02961608|Tacrolimus|tacrolimus|mesh-list
13990373|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990374|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
13990375|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990376|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13990377|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990378|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990379|NCT02961634|Ciclopirox|ciclopirox|mesh-list
15081534|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
13990380|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
13990381|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990382|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
13990383|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990384|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990385|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990386|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13990387|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
13990388|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13990389|NCT02961166|Antibodies|antibodies|mesh-list
13990390|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
13990391|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990392|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
13990393|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
13990394|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990395|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
13990396|NCT02961361|Ropivacaine|ropivacaine|mesh-list
13990397|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13990398|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990399|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990400|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990401|NCT02961361|Analgesics|analgesics|mesh-ancestor
13990402|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
13990403|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990404|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13990405|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13990406|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13990407|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990408|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990409|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990410|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990411|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
13990412|NCT02961257|Prednisone|prednisone|mesh-list
13990413|NCT02961257|Sargramostim|sargramostim|mesh-list
13990414|NCT02961257|Lenograstim|lenograstim|mesh-list
13990415|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990416|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
14264115|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14264116|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264117|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
14264118|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264119|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264120|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264121|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264122|NCT02843451|Silymarin|silymarin|mesh-list
14264123|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
14264124|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264125|NCT02843451|Protective Agents|protective agents|mesh-ancestor
14264126|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264127|NCT02795156|Afatinib|afatinib|mesh-list
14264128|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264129|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264130|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264131|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264132|NCT02782949|Curcumin|curcumin|mesh-list
14264133|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14264134|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14264135|NCT02782949|Analgesics|analgesics|mesh-ancestor
14264136|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
14264137|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264138|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264139|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264140|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264141|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264142|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264143|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264144|NCT02772003|Interleukin-12|interleukin-12|mesh-list
14264145|NCT02772003|Vaccines|vaccines|mesh-list
14264146|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
14264147|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264148|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13990417|NCT02961257|Hormones|hormones|mesh-ancestor
13990418|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13990419|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264149|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13990420|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13990421|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990422|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
13990423|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13990424|NCT02961101|Decitabine|decitabine|mesh-list
13990425|NCT02961101|Antibodies|antibodies|mesh-list
13990426|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
13990427|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990428|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13990429|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
13990430|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990431|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990432|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990433|NCT02961075|Anesthetics|anesthetics|mesh-list
13990434|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990435|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990436|NCT02960763|Aripiprazole|aripiprazole|mesh-list
13990437|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
13990438|NCT02960763|Bupropion|bupropion|mesh-list
13990439|NCT02960763|Nortriptyline|nortriptyline|mesh-list
13990440|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13990441|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
13990442|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13990443|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13990444|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13990445|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990446|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990447|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
13990448|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990449|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990450|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13990451|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13990452|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990453|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13990454|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13990455|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990456|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
13990457|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13990458|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13990459|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
13990460|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13990461|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13990462|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13990463|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13990464|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
13990465|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13990466|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13990467|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990468|NCT02960828|Bevacizumab|bevacizumab|mesh-list
13990469|NCT02960828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990470|NCT02960828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990471|NCT02960828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13990472|NCT02960828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13990473|NCT02960828|Growth Substances|growth substances|mesh-ancestor
13990474|NCT02960828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990475|NCT02960828|Growth Inhibitors|growth inhibitors|mesh-ancestor
13990476|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
13990477|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
13990478|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13990479|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
13990480|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14264150|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14264151|NCT02772003|Growth Substances|growth substances|mesh-ancestor
14264152|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
14264153|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264154|NCT02662634|Paclitaxel|paclitaxel|mesh-list
14264155|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14264156|NCT02662634|Cisplatin|cisplatin|mesh-list
14264157|NCT02662634|Carboplatin|carboplatin|mesh-list
14264158|NCT02662634|Pemetrexed|pemetrexed|mesh-list
14264159|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264160|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264161|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264162|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264163|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292281|NCT00559845|Fluorouracil|fluorouracil|mesh-list
13990481|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
13990482|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990483|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990484|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
14022972|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14022973|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14022974|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022975|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
14022976|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14022977|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14022978|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022979|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022980|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022981|NCT02765347|Metformin|metformin|mesh-list
14022982|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14022983|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022984|NCT02765399|Liraglutide|liraglutide|mesh-list
14022985|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14022986|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022987|NCT02765399|Incretins|incretins|mesh-ancestor
14022988|NCT02765399|Hormones|hormones|mesh-ancestor
14022989|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022990|NCT02765373|Letrozole|letrozole|mesh-list
14022991|NCT02765373|Anastrozole|anastrozole|mesh-list
14022992|NCT02765373|Exemestane|exemestane|mesh-list
14022993|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022994|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14022995|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14022996|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022997|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022998|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14022999|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
14023000|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023001|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023002|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023003|NCT02765217|Amoxicillin|amoxicillin|mesh-list
14023004|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
14023005|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
14023006|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14023007|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14023008|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023009|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023010|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023011|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14023012|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
14023013|NCT02765204|Saxagliptin|saxagliptin|mesh-list
14023014|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14023015|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023016|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14023017|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023018|NCT02765204|Incretins|incretins|mesh-ancestor
14023019|NCT02765204|Hormones|hormones|mesh-ancestor
14023020|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023021|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14023022|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
14023023|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023024|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14023025|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14264164|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264165|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264166|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14264167|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14264168|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
14264169|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264170|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264171|NCT02599714|Fulvestrant|fulvestrant|mesh-list
14264172|NCT02599714|Palbociclib|palbociclib|mesh-list
14264173|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264174|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264175|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14264176|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14023026|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
14023027|NCT02765022|Hormones|hormones|mesh-ancestor
14264177|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
13990485|NCT02960906|Nivolumab|nivolumab|mesh-list
13990486|NCT02960906|Ipilimumab|ipilimumab|mesh-list
13990487|NCT02960906|Sunitinib|sunitinib|mesh-list
13990488|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990489|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990490|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13990491|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990492|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13990493|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13990494|NCT02960906|Growth Substances|growth substances|mesh-ancestor
13990495|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990496|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
13990497|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13990498|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990499|NCT02960919|Amoxicillin|amoxicillin|mesh-list
13990500|NCT02960919|Gentamicins|gentamicins|mesh-list
13990501|NCT02960919|Penicillins|penicillins|mesh-list
13990502|NCT02960919|Ampicillin|ampicillin|mesh-list
13990503|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13990504|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990505|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13990506|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990507|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990508|NCT02960815|Imiquimod|imiquimod|mesh-list
13990509|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13990510|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
13990511|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990512|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990513|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
13990514|NCT02960503|Azithromycin|azithromycin|mesh-list
13990515|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13990516|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990517|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
13990518|NCT02960646|Melphalan|melphalan|mesh-list
13990519|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
13990520|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13990521|NCT02960646|Rituximab|rituximab|mesh-list
13990522|NCT02960646|Fludarabine|fludarabine|mesh-list
13990523|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
13990524|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13990525|NCT02960646|Tacrolimus|tacrolimus|mesh-list
13990526|NCT02960646|Antibodies|antibodies|mesh-list
13990527|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
13990528|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13990529|NCT02960646|Lenograstim|lenograstim|mesh-list
13990530|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990531|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
13990532|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990533|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990534|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13990535|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
13990536|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990537|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990538|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13990539|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13990540|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
13990541|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13990542|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13990543|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990544|NCT02960412|Furosemide|furosemide|mesh-list
13990545|NCT02960412|Diuretics|diuretics|mesh-ancestor
13990546|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
13990547|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990548|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13990549|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990550|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990551|NCT02960711|Metformin|metformin|mesh-list
13990552|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13990553|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990554|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
13990555|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990556|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
13990557|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
13990558|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
13990559|NCT02960126|Aspirin|aspirin|mesh-list
13990560|NCT02960126|Clopidogrel|clopidogrel|mesh-list
13990561|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990562|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990563|NCT02960126|Analgesics|analgesics|mesh-ancestor
13990564|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
13990565|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990566|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990567|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990568|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990569|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13990570|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13990571|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990572|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13990573|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13990574|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990575|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
13990576|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13990577|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13990578|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13990579|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
13990580|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990581|NCT02960113|Scopolamine|scopolamine|mesh-list
13990582|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13990583|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14264178|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264179|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264180|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264181|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264182|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264195|NCT02503722|Osimertinib|osimertinib|mesh-list
14264196|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264197|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264198|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264199|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264200|NCT02491632|Dexamethasone|dexamethasone|mesh-list
14264201|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
14264202|NCT02491632|Ichthammol|ichthammol|mesh-list
14264203|NCT02491632|BB 1101|bb 1101|mesh-list
14264204|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264205|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
14264206|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
14264207|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264208|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264209|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14264210|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
14264211|NCT02491632|Hormones|hormones|mesh-ancestor
14264212|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264213|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264214|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264215|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
14264216|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264217|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264218|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
14264219|NCT02448420|Trastuzumab|trastuzumab|mesh-list
14264220|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14264221|NCT02448420|Palbociclib|palbociclib|mesh-list
14264222|NCT02448420|Antibodies|antibodies|mesh-list
14264223|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
14264224|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
14264225|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264226|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264227|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264228|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13990584|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
13990585|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
13990586|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990587|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990588|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990589|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
13990590|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13990591|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
13990592|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990593|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990594|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13990595|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
13990596|NCT02959957|Cefotaxime|cefotaxime|mesh-list
13990597|NCT02959957|Cefoxitin|cefoxitin|mesh-list
13990598|NCT02959957|Temocillin|temocillin|mesh-list
13990599|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13990600|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990601|NCT02960035|Etanercept|etanercept|mesh-list
13990602|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990603|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990604|NCT02960035|Analgesics|analgesics|mesh-ancestor
13990605|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
13990606|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990607|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990608|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990609|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990610|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990611|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990612|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
13990613|NCT02959879|Folfirinox|folfirinox|mesh-list
13990614|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990615|NCT02959905|Vidarabine|vidarabine|mesh-list
13990616|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
13990617|NCT02959905|Fludarabine|fludarabine|mesh-list
13990618|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
13990619|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990620|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
13990621|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990622|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990623|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13990624|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
13990625|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990626|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990627|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13990628|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13990629|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
13990630|NCT02959905|Antiviral Agents|antiviral agents|mesh-ancestor
13990631|NCT02959905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990632|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
13990633|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
13990634|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990635|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
13990636|NCT02959762|Vitamins|vitamins|mesh-list
13990637|NCT02959762|Vitamin K|vitamin k|mesh-list
13990638|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
13990639|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
13990640|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
13990641|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990642|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13990643|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13990644|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990645|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
13990646|NCT02959762|Coagulants|coagulants|mesh-ancestor
13990647|NCT02959749|Bevacizumab|bevacizumab|mesh-list
14264229|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081535|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081536|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15081537|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15081538|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
15081539|NCT04539366|Fludarabine|fludarabine|mesh-list
15081540|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
15081541|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
15081542|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264230|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264231|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264232|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
13990648|NCT02959749|Docetaxel|docetaxel|mesh-list
13990649|NCT02959749|Osimertinib|osimertinib|mesh-list
13990650|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081543|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990651|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990652|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13990653|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13990654|NCT02959749|Growth Substances|growth substances|mesh-ancestor
13990655|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990656|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
13990657|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
13990658|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
13990659|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
13990660|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990661|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13990662|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990663|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13990664|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
13990665|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990666|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
13990667|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990668|NCT02959697|Lidocaine|lidocaine|mesh-list
13990669|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990670|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
13990671|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990672|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990673|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
13990674|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081544|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081545|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081546|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
15081547|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081548|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081549|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15081550|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15081551|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
15081552|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
15081553|NCT04535401|Leucovorin|leucovorin|mesh-list
15081554|NCT04535401|Folic Acid|folic acid|mesh-list
13990675|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13990676|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13990677|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13990678|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990679|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990680|NCT02959554|Nivolumab|nivolumab|mesh-list
13990681|NCT02959554|Sunitinib|sunitinib|mesh-list
13990682|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990683|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990684|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13990685|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990686|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13990687|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13990688|NCT02959554|Growth Substances|growth substances|mesh-ancestor
13990689|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990690|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
13990691|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13990692|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990693|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
13990694|NCT02959606|Clopidogrel|clopidogrel|mesh-list
13990695|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13990696|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13990697|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13990698|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13990699|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
13990700|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081555|NCT04535401|Fluorouracil|fluorouracil|mesh-list
15081556|NCT04535401|Irinotecan|irinotecan|mesh-list
13990701|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990702|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990703|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13990704|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13990705|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13990706|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
13990707|NCT02959541|Leucovorin|leucovorin|mesh-list
13990708|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
13990709|NCT02959541|Antidotes|antidotes|mesh-ancestor
13990710|NCT02959541|Protective Agents|protective agents|mesh-ancestor
13990711|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990712|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
13990713|NCT02959541|Vitamins|vitamins|mesh-ancestor
13990714|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
13990715|NCT02959476|Ropivacaine|ropivacaine|mesh-list
13990716|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990717|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
13990718|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990719|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990720|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
13990721|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990722|NCT02959255|Esomeprazole|esomeprazole|mesh-list
13990723|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13990724|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990725|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13990726|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990727|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990728|NCT02959229|Lactoferrin|lactoferrin|mesh-list
13990729|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990730|NCT02959359|Ribavirin|ribavirin|mesh-list
13990731|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
13990732|NCT02959359|Ledipasvir|ledipasvir|mesh-list
13990733|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
13990734|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990735|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
13990736|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990737|NCT02959411|Tolvaptan|tolvaptan|mesh-list
13990738|NCT02959411|Diuretics|diuretics|mesh-list
13990739|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
13990740|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990741|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13990742|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990743|NCT02959125|Micronutrients|micronutrients|mesh-list
14264233|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081557|NCT04535401|Camptothecin|camptothecin|mesh-list
15081558|NCT04535401|Calcium|calcium|mesh-list
15081559|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
15081560|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15081561|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081562|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15081563|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
15081564|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081565|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15081566|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081567|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081568|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
15081569|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15081570|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15081571|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081572|NCT04535401|Antidotes|antidotes|mesh-ancestor
15081573|NCT04535401|Protective Agents|protective agents|mesh-ancestor
15081574|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
15081575|NCT04535401|Vitamins|vitamins|mesh-ancestor
15081576|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
15081577|NCT04535401|Hematinics|hematinics|mesh-ancestor
15081578|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081579|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
15081580|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081581|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264243|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
14264244|NCT02432963|Vaccines|vaccines|mesh-list
14264245|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
15081582|NCT04509336|Orphenadrine|orphenadrine|mesh-list
13990744|NCT02959125|Trace Elements|trace elements|mesh-list
13990745|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990746|NCT02959112|Indomethacin|indomethacin|mesh-list
14264246|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264247|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13990747|NCT02959112|Epinephrine|epinephrine|mesh-list
13990748|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13990749|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13990750|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990751|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990752|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264248|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264249|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14264250|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14264251|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14264252|NCT02405676|Cytarabine|cytarabine|mesh-list
14264253|NCT02405676|Prednisone|prednisone|mesh-list
14264254|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
14264255|NCT02405676|Ifosfamide|ifosfamide|mesh-list
14264256|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
14264257|NCT02405676|Rituximab|rituximab|mesh-list
14264258|NCT02405676|Methotrexate|methotrexate|mesh-list
14264259|NCT02405676|Etoposide|etoposide|mesh-list
14264260|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
14264261|NCT02405676|Vincristine|vincristine|mesh-list
14264262|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264263|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
14264264|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264265|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081583|NCT04509336|Baclofen|baclofen|mesh-list
15081584|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15081585|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081586|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15081587|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264266|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264267|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
14264268|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264269|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264270|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264271|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264272|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264273|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
14264274|NCT02405676|Hormones|hormones|mesh-ancestor
14264275|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264276|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264277|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14264278|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
14264279|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14264280|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264281|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
14264282|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
14264283|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264284|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14264285|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14264286|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264287|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264288|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264289|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
14264290|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264291|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264292|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264293|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264294|NCT02362451|Vaccines|vaccines|mesh-list
14264295|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
14264296|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264297|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
14264298|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264299|NCT02342782|Cytarabine|cytarabine|mesh-list
14264300|NCT02342782|Etoposide|etoposide|mesh-list
14264301|NCT02342782|Melphalan|melphalan|mesh-list
14264302|NCT02342782|Carmustine|carmustine|mesh-list
14264303|NCT02342782|Basiliximab|basiliximab|mesh-list
14264304|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264305|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264306|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264307|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264308|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264309|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264310|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13990753|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990754|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13990755|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13990756|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
13990757|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990758|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13990759|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
13990760|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
13990761|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
13990762|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13990763|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990764|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990765|NCT02959112|Analgesics|analgesics|mesh-ancestor
13990766|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
13990767|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990768|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990769|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
13990770|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
13990771|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13990772|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13990773|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990774|NCT02959060|Rifampin|rifampin|mesh-list
13990775|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13990776|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
13990777|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13990778|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990779|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
13990780|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13990781|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990782|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990783|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13990784|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13990785|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13990786|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13990787|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13990788|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14535971|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14535972|NCT01106534|Analgesics|analgesics|mesh-ancestor
14535973|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
14535974|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535975|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535976|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535977|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535978|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14535979|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14535980|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535981|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14535982|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14535983|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535984|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
14535985|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535986|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535987|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
14535988|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14535989|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14535990|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14535991|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
13990789|NCT02958917|Pirfenidone|pirfenidone|mesh-list
13990790|NCT02958917|Analgesics|analgesics|mesh-ancestor
13990791|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
13990792|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990793|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990794|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990795|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990796|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990797|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990798|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990799|NCT02958852|Letrozole|letrozole|mesh-list
13990800|NCT02958852|Fulvestrant|fulvestrant|mesh-list
13990801|NCT02958852|Atorvastatin|atorvastatin|mesh-list
13990802|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13990803|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13990804|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
13990805|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990806|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13990807|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13990808|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990809|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990810|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13990811|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13990812|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13990813|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
13990814|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13990815|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990816|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13990817|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13990818|NCT02958878|Tamsulosin|tamsulosin|mesh-list
13990819|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13990820|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13990821|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13990822|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
13990823|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990824|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990825|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990826|NCT02958878|Urological Agents|urological agents|mesh-ancestor
14023028|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023029|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023030|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023031|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026104|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026105|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
14026106|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14026107|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14026108|NCT02744690|Mitomycins|mitomycins|mesh-list
14026109|NCT02744690|Mitomycin|mitomycin|mesh-list
14264311|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
15081588|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14264312|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
14264313|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264314|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264315|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
14264316|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264317|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264318|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
14264319|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264320|NCT02337634|Silymarin|silymarin|mesh-list
14264321|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
14264322|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264323|NCT02337634|Protective Agents|protective agents|mesh-ancestor
14264324|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264325|NCT02336087|Metformin|metformin|mesh-list
14264326|NCT02336087|Gemcitabine|gemcitabine|mesh-list
14264327|NCT02336087|Paclitaxel|paclitaxel|mesh-list
14264328|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14264329|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264330|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264331|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264332|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264333|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264334|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264335|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264336|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
14264337|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
14264338|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264339|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264340|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13990827|NCT02958800|Olanzapine|olanzapine|mesh-list
13990828|NCT02958800|Risperidone|risperidone|mesh-list
13990829|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13990830|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
13990831|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13990832|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
13990833|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990834|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990835|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990836|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13990837|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990838|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13990839|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13990840|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
13990841|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
13990842|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
13990843|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990844|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990845|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13990846|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13990847|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990848|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
13990849|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
13990850|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13990851|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
13990852|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990853|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
13990854|NCT02958761|Protective Agents|protective agents|mesh-ancestor
13990855|NCT02958566|Acetaminophen|acetaminophen|mesh-list
13990856|NCT02958566|Ketorolac|ketorolac|mesh-list
13990857|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
13990858|NCT02958566|Lidocaine|lidocaine|mesh-list
13990859|NCT02958566|Fentanyl|fentanyl|mesh-list
13990860|NCT02958566|Ketamine|ketamine|mesh-list
13990861|NCT02958566|Morphine|morphine|mesh-list
14264341|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
14264342|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264343|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14264344|NCT02335580|Somatostatin|somatostatin|mesh-list
14264345|NCT02335580|Hormones|hormones|mesh-ancestor
14264346|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264347|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264348|NCT02282020|Olaparib|olaparib|mesh-list
14264349|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14264350|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264351|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264352|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264353|NCT02277782|Fentanyl|fentanyl|mesh-list
14264354|NCT02277782|Hydromorphone|hydromorphone|mesh-list
14264355|NCT02277782|Bupivacaine|bupivacaine|mesh-list
14264356|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
14264357|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
14264358|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14264359|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264360|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
14264361|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264362|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14264363|NCT02277782|Narcotics|narcotics|mesh-ancestor
14264364|NCT02277782|Analgesics|analgesics|mesh-ancestor
14264365|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14264366|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14264367|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
14264368|NCT02271230|Vitamin D|vitamin d|mesh-list
14264369|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
14264370|NCT02271230|Vitamins|vitamins|mesh-list
14264371|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
14264372|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264373|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14264374|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14264375|NCT02268448|Clonidine|clonidine|mesh-list
14264376|NCT02268448|Naltrexone|naltrexone|mesh-list
14264377|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14264378|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13990862|NCT02958566|Gabapentin|gabapentin|mesh-list
13990863|NCT02958566|Tramadol|tramadol|mesh-list
13990864|NCT02958566|Methadone|methadone|mesh-list
13990865|NCT02958566|Hydrocodone|hydrocodone|mesh-list
13990866|NCT02958566|Hydromorphone|hydromorphone|mesh-list
14264379|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264380|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
13990867|NCT02958566|Orphenadrine|orphenadrine|mesh-list
13990868|NCT02958566|Bupivacaine|bupivacaine|mesh-list
13990869|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
13990870|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
13990871|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13990872|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990873|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
13990874|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990875|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13990876|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13990877|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13990878|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13990879|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990880|NCT02958566|Analgesics|analgesics|mesh-ancestor
13990881|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13990882|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13990883|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
13990884|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13990885|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13990886|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990887|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13990888|NCT02958566|Narcotics|narcotics|mesh-ancestor
13990889|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13990890|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13990891|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
13990892|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
13990893|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13990894|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13990895|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13990896|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
13990897|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13990898|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13990899|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13990900|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13990901|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990902|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
13990903|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
13990904|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13990905|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13990906|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13990907|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13990908|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
13990909|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
13990910|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13990911|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13990912|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
13990913|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
13990914|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13990915|NCT02958514|Tobramycin|tobramycin|mesh-list
13990916|NCT02958514|Dexamethasone|dexamethasone|mesh-list
13990917|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264381|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264382|NCT02268448|Analgesics|analgesics|mesh-ancestor
14264383|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14264384|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
14264385|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
14264386|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14264387|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14264388|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14264389|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
14264390|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14264391|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264392|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
14264393|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264394|NCT02048150|Antibodies|antibodies|mesh-list
14264395|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13990918|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
13990919|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
13990920|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990921|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990922|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990923|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
13990924|NCT02958514|Hormones|hormones|mesh-ancestor
13990925|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13990926|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264396|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
13990927|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990928|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14264397|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264398|NCT02038777|Cytarabine|cytarabine|mesh-list
14264399|NCT02038777|Azacitidine|azacitidine|mesh-list
14264400|NCT02038777|Daunorubicin|daunorubicin|mesh-list
14264401|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264402|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
14264403|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264404|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264405|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
14264406|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264407|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264408|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
14264409|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264410|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264411|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264412|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264413|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264414|NCT01996449|Amlodipine|amlodipine|mesh-list
14264415|NCT01996449|Eplerenone|eplerenone|mesh-list
14264416|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14264417|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14264418|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14264419|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264420|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14264421|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264422|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
14264423|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14264424|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
14264425|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535992|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535993|NCT01100658|Methylphenidate|methylphenidate|mesh-list
14535994|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14535995|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535996|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14535997|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14535998|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14535999|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536000|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
14536001|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536002|NCT01103180|Citalopram|citalopram|mesh-list
14536003|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14536004|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14536005|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536006|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081589|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
15081590|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
15081591|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990929|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990930|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
13990931|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13990932|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990933|NCT02958501|Vitamins|vitamins|mesh-ancestor
13990934|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
13990935|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13990936|NCT02958631|Losartan|losartan|mesh-list
13990937|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13990938|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13990939|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13990940|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13990941|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990942|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
13990943|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13990944|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
13990945|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990946|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990947|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990948|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13990949|NCT02958059|Cefoxitin|cefoxitin|mesh-list
13990950|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13990951|NCT02958046|Domperidone|domperidone|mesh-list
13990952|NCT02958046|Lansoprazole|lansoprazole|mesh-list
13990953|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
13990954|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13990955|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13990956|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13990957|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990958|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990959|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
13990960|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
13990961|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990962|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990963|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13990964|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
13990965|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13990966|NCT02957994|Tenofovir|tenofovir|mesh-list
13990967|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
14264426|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14264427|NCT01996449|Diuretics|diuretics|mesh-ancestor
14264428|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
14264429|NCT01958190|Sirolimus|sirolimus|mesh-list
14264430|NCT01958190|Tacrolimus|tacrolimus|mesh-list
14264431|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264432|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
14264433|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264434|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14264435|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264436|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264437|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14264438|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264439|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264440|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264441|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
14264442|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
14264443|NCT01936831|Pyridoxal|pyridoxal|mesh-list
14264444|NCT01936831|Pyridoxine|pyridoxine|mesh-list
14264445|NCT01936831|Isoniazid|isoniazid|mesh-list
13990968|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264446|NCT01936831|Vitamins|vitamins|mesh-ancestor
14264447|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
14264448|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264449|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
14264450|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
14264451|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14264452|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264453|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14264454|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14264455|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
14264456|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264457|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14264458|NCT01927419|Nivolumab|nivolumab|mesh-list
14264459|NCT01927419|Ipilimumab|ipilimumab|mesh-list
14264460|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264461|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264462|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14264463|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264464|NCT01924533|Paclitaxel|paclitaxel|mesh-list
14264465|NCT01924533|Olaparib|olaparib|mesh-list
14264466|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264467|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264468|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264469|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264470|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264471|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264472|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14264473|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990969|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13990970|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13990971|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990972|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990973|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13990974|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13990975|NCT02958111|Capecitabine|capecitabine|mesh-list
13990976|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13990977|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
13990978|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990979|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990980|NCT02958163|Doxorubicin|doxorubicin|mesh-list
13990981|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13990982|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13990983|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13990984|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13990985|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13990986|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13990987|NCT02958215|Phenylephrine|phenylephrine|mesh-list
13990988|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
13990989|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14264474|NCT01773395|Methotrexate|methotrexate|mesh-list
14264475|NCT01773395|Fludarabine|fludarabine|mesh-list
14264476|NCT01773395|Busulfan|busulfan|mesh-list
14264477|NCT01773395|Tacrolimus|tacrolimus|mesh-list
14264478|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14264479|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
14264480|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14264481|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264482|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264483|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
14264484|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264485|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264486|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
14264487|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264488|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14264489|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264490|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
14264491|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264492|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14264493|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14264494|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
14264495|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264496|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264497|NCT01750073|Paclitaxel|paclitaxel|mesh-list
14264498|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
14264499|NCT01750073|Doxorubicin|doxorubicin|mesh-list
14264500|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14264501|NCT01750073|Trastuzumab|trastuzumab|mesh-list
14264502|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14264503|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14264504|NCT01750073|Antibodies|antibodies|mesh-list
14264505|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
14264506|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14264507|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264508|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264509|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264510|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264511|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264512|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264513|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264514|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
14264515|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264516|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264517|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264518|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
14264519|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264520|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264521|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264522|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264523|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081592|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264524|NCT01730833|Paclitaxel|paclitaxel|mesh-list
14264525|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14264526|NCT01730833|Trastuzumab|trastuzumab|mesh-list
14264527|NCT01730833|Pertuzumab|pertuzumab|mesh-list
13990990|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
13990991|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
13990992|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13990993|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13990994|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
13990995|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13990996|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
13990997|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
13990998|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13990999|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13991000|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13991001|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
13991002|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991003|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991004|NCT02958215|Protective Agents|protective agents|mesh-ancestor
13991005|NCT02957903|Ropivacaine|ropivacaine|mesh-list
13991006|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
13991007|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
13991008|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991009|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991010|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
13991011|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991012|NCT02957864|Tenofovir|tenofovir|mesh-list
13991013|NCT02957864|Abacavir|abacavir|mesh-list
13991014|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
13991015|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991016|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13991017|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13991018|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991019|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991020|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13991021|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13991022|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
13991023|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991024|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
13991025|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991026|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991027|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13991028|NCT02957786|Varenicline|varenicline|mesh-list
13991029|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13991030|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13991031|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
13991032|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991033|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991034|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991035|NCT02957877|Heparin|heparin|mesh-list
13991036|NCT02957877|Calcium heparin|calcium heparin|mesh-list
13991037|NCT02957877|Nadroparin|nadroparin|mesh-list
13991038|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
13991039|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13991040|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13991041|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991042|NCT02957890|Vaccines|vaccines|mesh-list
13991043|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
13991044|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991045|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
13991046|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13991047|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
13991048|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
13991049|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991050|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991051|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13991052|NCT02957851|Analgesics|analgesics|mesh-ancestor
14264528|NCT01730833|Antibodies|antibodies|mesh-list
14264529|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
14264530|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264531|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264532|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264533|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264534|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264535|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264536|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
13991053|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
14023032|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13991054|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991055|NCT02957643|Iron|iron|mesh-list
13991056|NCT02957643|Trace Elements|trace elements|mesh-ancestor
13991057|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
13991058|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991059|NCT02957604|Evolocumab|evolocumab|mesh-list
13991060|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13991061|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991062|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
13991063|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991064|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13991065|NCT02957435|Eplerenone|eplerenone|mesh-list
13991066|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13991067|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
13991068|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991069|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991070|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13991071|NCT02957435|Diuretics|diuretics|mesh-ancestor
13991072|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
13991073|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13991074|NCT02957448|Rifampin|rifampin|mesh-list
13991075|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13991076|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
13991077|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13991078|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991079|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
13991080|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13991081|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991082|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991083|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13991084|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13991085|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13991086|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13991087|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15081593|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15081594|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15081595|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
15081596|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
15081597|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15081598|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15081599|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
15081600|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
15081601|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15081602|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081603|NCT04500548|Nivolumab|nivolumab|mesh-list
15081604|NCT04500548|Ipilimumab|ipilimumab|mesh-list
15081605|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081606|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081607|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081608|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081609|NCT04496453|Vaccines|vaccines|mesh-list
15081610|NCT04496453|Immunologic Factors|immunologic factors|mesh-ancestor
15081611|NCT04496453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081612|NCT04491942|Gemcitabine|gemcitabine|mesh-list
15081613|NCT04491942|Cisplatin|cisplatin|mesh-list
13991088|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13991089|NCT02957656|Vaccines|vaccines|mesh-list
13991090|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
13991091|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991092|NCT02957630|Drospirenone|drospirenone|mesh-list
13991093|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
13991094|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13991095|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13991096|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
13991097|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13991098|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991099|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13991100|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13991101|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13991102|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13991103|NCT02957630|Estrogens|estrogens|mesh-ancestor
15081614|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081615|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13991104|NCT02957630|Hormones|hormones|mesh-ancestor
14023033|NCT02765009|Furosemide|furosemide|mesh-list
13991105|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991106|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13991107|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
13991108|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13991109|NCT02957630|Diuretics|diuretics|mesh-ancestor
13991110|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
13991111|NCT02957474|Omeprazole|omeprazole|mesh-list
13991112|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13991113|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991114|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13991115|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991116|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991117|NCT02957266|Gemcitabine|gemcitabine|mesh-list
13991118|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991119|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13991120|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
13991121|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991122|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
13991123|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991124|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991125|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991126|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
13991127|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991128|NCT02957162|Atorvastatin|atorvastatin|mesh-list
13991129|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13991130|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991131|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
13991132|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991133|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13991134|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13991135|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023034|NCT02765009|Bumetanide|bumetanide|mesh-list
14023035|NCT02765009|Diuretics|diuretics|mesh-list
14023036|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14023037|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
14023038|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023039|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14023040|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14023041|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023042|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14023043|NCT02765126|Vaccines|vaccines|mesh-list
14023044|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
14023045|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023046|NCT02764619|Spironolactone|spironolactone|mesh-list
14023047|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14023048|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
14023049|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023050|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023051|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14023052|NCT02764619|Diuretics|diuretics|mesh-ancestor
14023053|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
14023054|NCT02764515|Methotrexate|methotrexate|mesh-list
14023055|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14023056|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
14023057|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14023058|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023059|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14023060|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
14023061|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023062|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023063|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023064|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023065|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14023066|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14023067|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
14023068|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023069|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14023070|NCT02764736|Atorvastatin|atorvastatin|mesh-list
14023071|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14023072|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14023073|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
14023074|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991136|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13991137|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991138|NCT02957097|Gabapentin|gabapentin|mesh-list
13991139|NCT02957097|Analgesics|analgesics|mesh-ancestor
13991140|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
13991141|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991142|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991143|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
13991144|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13991145|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13991146|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991147|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13991148|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13991149|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13991150|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991151|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991152|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
14264537|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264538|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264539|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
14264540|NCT01723839|Rituximab|rituximab|mesh-list
14264541|NCT01723839|Fludarabine|fludarabine|mesh-list
14264542|NCT01723839|Lenalidomide|lenalidomide|mesh-list
14264543|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264544|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
14264545|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264546|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264547|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13991164|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
13991165|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991166|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
13991167|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13991168|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991169|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13991170|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991171|NCT02956655|Insulin|insulin|mesh-list
13991172|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13991173|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14264548|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
14264549|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264550|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264551|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264552|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264553|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14264554|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14264555|NCT01723839|Growth Substances|growth substances|mesh-ancestor
14264556|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
14264557|NCT01711879|Aflibercept|aflibercept|mesh-list
14264558|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14264559|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14264560|NCT01711879|Growth Substances|growth substances|mesh-ancestor
14264561|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264562|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
14264563|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264564|NCT01697267|Rituximab|rituximab|mesh-list
14264565|NCT01697267|Azathioprine|azathioprine|mesh-list
14264566|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264567|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264568|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
14264569|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264570|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264571|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
14264572|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264573|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264574|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264575|NCT01653223|Simvastatin|simvastatin|mesh-list
14264576|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14264577|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14264578|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
14264579|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264580|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14264581|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14264582|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991174|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536007|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536008|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
14536009|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991175|NCT02956538|Thalidomide|thalidomide|mesh-list
13991176|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991177|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
13991178|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991179|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
13991180|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13991181|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991182|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13991183|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13991184|NCT02956538|Growth Substances|growth substances|mesh-ancestor
13991185|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
13991186|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991187|NCT02956785|Dinoprostone|dinoprostone|mesh-list
13991188|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
13991189|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13991190|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991191|NCT02957409|Valsartan|valsartan|mesh-list
13991192|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13991193|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13991194|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13991195|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991196|NCT02956590|Pitavastatin|pitavastatin|mesh-list
13991197|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13991198|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13991199|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991200|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
13991201|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991202|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991203|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13991204|NCT02956447|Hormones|hormones|mesh-list
13991205|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991206|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991207|NCT02956252|Anesthetics|anesthetics|mesh-list
13991208|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991209|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991210|NCT02956408|Vitamin D|vitamin d|mesh-list
13991211|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
13991212|NCT02956408|Vitamins|vitamins|mesh-ancestor
13991213|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
13991214|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991215|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13991216|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13991217|NCT02956421|Vaccines|vaccines|mesh-list
13991218|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
13991219|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991220|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
13991221|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13991222|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991223|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264583|NCT01527149|Cytarabine|cytarabine|mesh-list
14264584|NCT01527149|Dexamethasone|dexamethasone|mesh-list
14264585|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
14264586|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
14264587|NCT01527149|Doxorubicin|doxorubicin|mesh-list
14264588|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14264589|NCT01527149|Methotrexate|methotrexate|mesh-list
14264590|NCT01527149|Vincristine|vincristine|mesh-list
14264591|NCT01527149|Ofatumumab|ofatumumab|mesh-list
14264592|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14264593|NCT01527149|BB 1101|bb 1101|mesh-list
14264594|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264595|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
14264596|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264597|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264598|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264599|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
14264600|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264601|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264602|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13991224|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
13991225|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991226|NCT02955810|Dexamethasone|dexamethasone|mesh-list
13991227|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
13991228|NCT02955810|Bortezomib|bortezomib|mesh-list
13991229|NCT02955810|Daratumumab|daratumumab|mesh-list
13991230|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991231|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
13991232|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991233|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991234|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13991235|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
13991236|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991237|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991238|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13991239|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991240|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
13991241|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
13991242|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991243|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991244|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
13991245|NCT02955810|Hormones|hormones|mesh-ancestor
13991246|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991247|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536010|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14536011|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
14536012|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14536013|NCT01090141|Micafungin|micafungin|mesh-list
14536014|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
14536015|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536016|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14536017|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
14536018|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536019|NCT01094561|Secretin|secretin|mesh-list
14536020|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14536021|NCT01094561|Hormones|hormones|mesh-ancestor
13991248|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13991249|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13991250|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
13991251|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13991252|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991253|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991254|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13991255|NCT02955732|Analgesics|analgesics|mesh-ancestor
13991256|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
13991257|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991258|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13991259|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13991260|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13991261|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
13991262|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991263|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991264|NCT02955719|Sertraline|sertraline|mesh-list
13991265|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13991266|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
13991267|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13991268|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13991269|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13991270|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991271|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991272|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991273|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
13991274|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991275|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13991276|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13991277|NCT02955524|Lidocaine|lidocaine|mesh-list
13991278|NCT02955524|Tetracaine|tetracaine|mesh-list
13991279|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
13991280|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
13991281|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991282|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991283|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
13991284|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536022|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991285|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13991286|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13991287|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13991288|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991289|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991290|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13991291|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991292|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991293|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
13991294|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991295|NCT02955602|Seladelpar|seladelpar|mesh-list
13991296|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991297|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
13991298|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991299|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13991300|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
13991301|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
13991302|NCT02955706|Vitamins|vitamins|mesh-ancestor
13991303|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
13991304|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991305|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
13991306|NCT02955641|Dexamethasone|dexamethasone|mesh-list
13991307|NCT02955641|Nepafenac|nepafenac|mesh-list
13991308|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13991309|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991310|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
13991311|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
13991312|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991313|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991314|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081616|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
13991315|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
14264603|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264604|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
14264605|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
14264606|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264607|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14264608|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
14264609|NCT01527149|Hormones|hormones|mesh-ancestor
14264610|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264611|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264612|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264613|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264614|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264615|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264616|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14264617|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
14264618|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14264619|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264620|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
14264621|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
14264622|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14264623|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13991316|NCT02955641|Hormones|hormones|mesh-ancestor
13991317|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991318|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13991319|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991320|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13991321|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13991322|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13991323|NCT02955641|Analgesics|analgesics|mesh-ancestor
13991324|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
13991325|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991326|NCT02955927|Atropine|atropine|mesh-list
13991327|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13991328|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13991329|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13991330|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13991331|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13991332|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
13991333|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991334|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991335|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13991336|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
13991337|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
13991338|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
13991339|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13991340|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13991341|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
13991342|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991343|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023075|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14023076|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14023077|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023078|NCT02764723|Bupivacaine|bupivacaine|mesh-list
14023079|NCT02764723|Ropivacaine|ropivacaine|mesh-list
14023080|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
14023081|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
14023082|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023083|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023084|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
14023085|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023086|NCT02764710|Amoxicillin|amoxicillin|mesh-list
14023087|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
14023088|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
14023089|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14023090|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14023091|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264624|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
14264625|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264626|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264627|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264628|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264629|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264630|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
14264631|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
14264632|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264633|NCT01494662|Capecitabine|capecitabine|mesh-list
14264634|NCT01494662|Trastuzumab|trastuzumab|mesh-list
14264635|NCT01494662|Maytansine|maytansine|mesh-list
15081617|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081618|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
15081619|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081620|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023092|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14023093|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023094|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023095|NCT02764749|Phenol|phenol|mesh-list
14023096|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14023097|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023098|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
14023099|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14023100|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14023101|NCT02764593|Nivolumab|nivolumab|mesh-list
14023102|NCT02764593|Cetuximab|cetuximab|mesh-list
14023103|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023104|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14023105|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14023106|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023107|NCT02764359|Vancomycin|vancomycin|mesh-list
14023108|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14023109|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023110|NCT02764125|Levodopa|levodopa|mesh-list
14292282|NCT00559845|Epirubicin|epirubicin|mesh-list
15081621|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081622|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
13991344|NCT02955654|Aripiprazole|aripiprazole|mesh-list
13991345|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
13991346|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13991347|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13991348|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13991349|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991350|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991351|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
13991352|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
13991353|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991354|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991355|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13991356|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13991357|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
13991358|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13991359|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13991360|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13991361|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14264636|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14264637|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264638|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
14264639|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264640|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264641|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264642|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264643|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264644|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264645|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264646|NCT01476839|Cytarabine|cytarabine|mesh-list
14264647|NCT01476839|Etoposide|etoposide|mesh-list
14264648|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
14264649|NCT01476839|Melphalan|melphalan|mesh-list
14264650|NCT01476839|Carmustine|carmustine|mesh-list
14264651|NCT01476839|Basiliximab|basiliximab|mesh-list
14264652|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264653|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264654|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264655|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264656|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264657|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264658|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264659|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
14264660|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
14264661|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264662|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264663|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
14264664|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264665|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264666|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
14264667|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14292283|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292284|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292285|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14292286|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14292287|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292288|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292289|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292290|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
14292291|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292292|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292293|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14292294|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
14292295|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14292296|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14292297|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14292298|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14292299|NCT00559845|Growth Substances|growth substances|mesh-ancestor
14292300|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
14292301|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
14292302|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14292303|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14292304|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14292305|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13991362|NCT02955056|Teriparatide|teriparatide|mesh-list
13991363|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991364|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13991365|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13991366|NCT02954939|Prednisone|prednisone|mesh-list
13991367|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264668|NCT01388920|Tesamorelin|tesamorelin|mesh-list
14264669|NCT01388920|Growth Substances|growth substances|mesh-ancestor
14264670|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264671|NCT01164202|Sunitinib|sunitinib|mesh-list
14264672|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264673|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14264674|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14264675|NCT01164202|Growth Substances|growth substances|mesh-ancestor
14264676|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264677|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
14264678|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264679|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264680|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264681|NCT01163357|Sirolimus|sirolimus|mesh-list
14264682|NCT01163357|Fludarabine|fludarabine|mesh-list
14264683|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
14264684|NCT01163357|Bortezomib|bortezomib|mesh-list
14264685|NCT01163357|Melphalan|melphalan|mesh-list
14264686|NCT01163357|Tacrolimus|tacrolimus|mesh-list
14264687|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264688|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14264689|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
14264690|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264691|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264692|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
14264693|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264694|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14264695|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264696|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14264697|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264698|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264699|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
14264700|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264701|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
14264702|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264703|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
14264704|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264705|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
14264706|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264707|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264708|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264709|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
14264710|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264711|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264712|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264713|NCT00638898|Melphalan|melphalan|mesh-list
14264714|NCT00638898|Busulfan|busulfan|mesh-list
14264715|NCT00638898|Topotecan|topotecan|mesh-list
14264716|NCT00638898|Lenograstim|lenograstim|mesh-list
14264717|NCT00638898|Sargramostim|sargramostim|mesh-list
14264718|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14264719|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
14264720|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264721|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264722|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
14264723|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264724|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264725|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264726|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264727|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14264728|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264729|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264730|NCT00609791|Paclitaxel|paclitaxel|mesh-list
14264731|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14264732|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264733|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264734|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264735|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264736|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264737|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991368|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
13991369|NCT02954939|Hormones|hormones|mesh-ancestor
13991370|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991371|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991372|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13991373|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991374|NCT02955251|Nivolumab|nivolumab|mesh-list
13991375|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13991376|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991377|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13991378|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991379|NCT02954913|Liver Extracts|liver extracts|mesh-list
13991380|NCT02954913|Hematinics|hematinics|mesh-ancestor
13991381|NCT02954692|Metformin|metformin|mesh-list
13991382|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
13991383|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
13991384|NCT02954692|Meglitinide|meglitinide|mesh-list
13991385|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
13991386|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13991387|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991388|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991389|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991390|NCT02954822|Glimepiride|glimepiride|mesh-list
13991391|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13991392|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13991393|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991394|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991395|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
13991396|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
13991397|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
13991398|NCT02954588|Vitamins|vitamins|mesh-ancestor
13991399|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
13991400|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991401|NCT02954549|Vitamin D|vitamin d|mesh-list
13991402|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
13991403|NCT02954549|Vitamins|vitamins|mesh-ancestor
13991404|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
13991405|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991406|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13991407|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13991408|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
14264738|NCT00577278|Sirolimus|sirolimus|mesh-list
14264739|NCT00577278|Rituximab|rituximab|mesh-list
14264740|NCT00577278|Fludarabine|fludarabine|mesh-list
14264741|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
14264742|NCT00577278|Melphalan|melphalan|mesh-list
14264743|NCT00577278|Tacrolimus|tacrolimus|mesh-list
14264744|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14264745|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264746|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264747|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
14264748|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536023|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536024|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14536025|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
14536026|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536027|NCT01078844|Memantine|memantine|mesh-list
14536028|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14536029|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14536030|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
14536031|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536032|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536033|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536034|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14536035|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14536036|NCT01085643|Lubiprostone|lubiprostone|mesh-list
14536037|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14536038|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536039|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536040|NCT01080768|Amlodipine|amlodipine|mesh-list
14536041|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14536042|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13991409|NCT02954536|Fluorouracil|fluorouracil|mesh-list
13991410|NCT02954536|Capecitabine|capecitabine|mesh-list
13991411|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
14264749|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264750|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13991412|NCT02954536|Trastuzumab|trastuzumab|mesh-list
13991413|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991414|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13991415|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
13991416|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991417|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13991418|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264751|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
14264752|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264753|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264754|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14264755|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264756|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14264757|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264758|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264759|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
14264760|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264761|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
14264762|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264763|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
14264764|NCT00576979|Etoposide|etoposide|mesh-list
14264765|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
14264766|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264767|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
14264768|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264769|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264770|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264771|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
14264772|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264773|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264774|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264775|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264776|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14264777|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14264778|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264779|NCT00554840|Varenicline|varenicline|mesh-list
14264780|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14264781|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14264782|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
14264783|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14264784|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264785|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264786|NCT00538031|Celecoxib|celecoxib|mesh-list
14264787|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
14264788|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14264789|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
14264790|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264791|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264792|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14264793|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
14264794|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264795|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264796|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14264797|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14264798|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14264799|NCT00538031|Analgesics|analgesics|mesh-ancestor
14264800|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
14264801|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264802|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264803|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14264804|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14264805|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264806|NCT00003656|Interferons|interferons|mesh-list
14264807|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
14264808|NCT00003656|Tretinoin|tretinoin|mesh-list
14264809|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264810|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
14264811|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264812|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
14264813|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264814|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
14264815|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
14264816|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14264817|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
13991419|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
13991420|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991421|NCT02954393|Amoxicillin|amoxicillin|mesh-list
13991422|NCT02954393|Metronidazole|metronidazole|mesh-list
13991423|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13991424|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264818|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264819|NCT00370552|Paclitaxel|paclitaxel|mesh-list
14264820|NCT00370552|Epothilones|epothilones|mesh-list
14264821|NCT00370552|Bevacizumab|bevacizumab|mesh-list
14264822|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14264823|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264824|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264825|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264826|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264827|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264828|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264829|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14264830|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14264831|NCT00370552|Growth Substances|growth substances|mesh-ancestor
14264832|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264833|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
14264834|NCT00370682|Vaccines|vaccines|mesh-list
14264835|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
14264836|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264837|NCT00370838|Clonidine|clonidine|mesh-list
14264838|NCT00370838|Levetiracetam|levetiracetam|mesh-list
14264839|NCT00370838|Analgesics|analgesics|mesh-ancestor
14264840|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
14264841|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264842|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264843|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14264844|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
14264845|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
14264846|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14264847|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14264848|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14264849|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
14264850|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14264851|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264852|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
14264853|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
14264854|NCT00371150|Entecavir|entecavir|mesh-list
14264855|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
14264856|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264857|NCT00371176|Cycloserine|cycloserine|mesh-list
14264858|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14264859|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264860|NCT00371176|Renal Agents|renal agents|mesh-ancestor
14264861|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14264862|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
14264863|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14264864|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
14264865|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264866|NCT00371254|Dasatinib|dasatinib|mesh-list
14264867|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264868|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264869|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264870|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264871|NCT00371345|Dasatinib|dasatinib|mesh-list
14264872|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264873|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264874|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264875|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264876|NCT00371566|Lapatinib|lapatinib|mesh-list
14264877|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264878|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264879|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264880|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264881|NCT00371683|Enoxaparin|enoxaparin|mesh-list
14264882|NCT00371683|Apixaban|apixaban|mesh-list
14264883|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
14264884|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14264885|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14264886|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264887|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13991425|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13991426|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13991427|NCT02954276|Sumatriptan|sumatriptan|mesh-list
13991428|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13991429|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13991430|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13991431|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
13991432|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991433|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991434|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991435|NCT02954484|Acetaminophen|acetaminophen|mesh-list
13991436|NCT02954484|Etoricoxib|etoricoxib|mesh-list
13991437|NCT02954484|Pregabalin|pregabalin|mesh-list
13991438|NCT02954484|Morphine|morphine|mesh-list
13991439|NCT02954484|Ropivacaine|ropivacaine|mesh-list
13991440|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13991441|NCT02954484|Narcotics|narcotics|mesh-ancestor
13991442|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991443|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991444|NCT02954484|Analgesics|analgesics|mesh-ancestor
13991445|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
13991446|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991447|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
13991448|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
13991449|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13991450|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
13991451|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
13991452|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13991453|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991454|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991455|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13991456|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13991457|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13991458|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13991459|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13991460|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991461|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991462|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13991463|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13991464|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264888|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
14264889|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14264890|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
14264891|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264892|NCT00371761|Interferons|interferons|mesh-list
14264893|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
14264894|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
14264895|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14264896|NCT00371761|Adefovir|adefovir|mesh-list
14264897|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14264898|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264899|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
14264900|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264901|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
14264902|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264903|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14264904|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14264905|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264906|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264907|NCT00371826|Cyclosporine|cyclosporine|mesh-list
14264908|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
14264909|NCT00371826|Prednisone|prednisone|mesh-list
14264910|NCT00371826|Everolimus|everolimus|mesh-list
14264911|NCT00371826|Cyclosporins|cyclosporins|mesh-list
14264912|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14264913|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14264914|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
14264915|NCT00371826|Hormones|hormones|mesh-ancestor
14264916|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264917|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264918|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14264919|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264920|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991465|NCT02954068|Oxytocin|oxytocin|mesh-list
14264921|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991466|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
14264922|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991467|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13991468|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991469|NCT02954029|Hemostatics|hemostatics|mesh-list
13991470|NCT02954029|Coagulants|coagulants|mesh-ancestor
13991471|NCT02954055|Paclitaxel|paclitaxel|mesh-list
13991472|NCT02954055|Vinorelbine|vinorelbine|mesh-list
13991473|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13991474|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
13991475|NCT02954055|Capecitabine|capecitabine|mesh-list
13991476|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13991477|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991478|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
13991479|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
13991480|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
13991481|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991482|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991483|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
13991484|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991485|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991486|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13991487|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
13991488|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13991489|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13991490|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
13991491|NCT02953834|Insulin|insulin|mesh-list
13991492|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13991493|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991494|NCT02953847|Rifampin|rifampin|mesh-list
13991495|NCT02953847|Isoniazid|isoniazid|mesh-list
14264923|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
14264924|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
14264925|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264926|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
14264927|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14264928|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14264929|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14264930|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
14536043|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536044|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536045|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536046|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536047|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
14536048|NCT01074502|Apremilast|apremilast|mesh-list
14536049|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14536050|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14536051|NCT01074502|Analgesics|analgesics|mesh-ancestor
14536052|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
14536053|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536054|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536055|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536056|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536057|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14536058|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14536059|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536060|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536061|NCT01074437|Prednisolone|prednisolone|mesh-list
14536062|NCT01074437|Propranolol|propranolol|mesh-list
14536063|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536064|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
14536065|NCT01074437|Hormones|hormones|mesh-ancestor
14536066|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536067|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536068|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536069|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536070|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14536071|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14536072|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
14536073|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536074|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536075|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14536076|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13991496|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14264931|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13991497|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
14264932|NCT00372060|Pioglitazone|pioglitazone|mesh-list
13991498|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13991499|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991500|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
13991501|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13991502|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991503|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991504|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13991505|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13991506|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13991507|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13991508|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13991509|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13991510|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13991511|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991512|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
13991513|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13991514|NCT02953743|Lenvatinib|lenvatinib|mesh-list
13991515|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991516|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13991517|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991518|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023111|NCT02764125|Carbidopa|carbidopa|mesh-list
14023112|NCT02764125|Entacapone|entacapone|mesh-list
14023113|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14023114|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14023115|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
14023116|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023117|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023118|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023119|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14023120|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264933|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14264934|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14264935|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264936|NCT00372060|Incretins|incretins|mesh-ancestor
14264937|NCT00372060|Hormones|hormones|mesh-ancestor
14264938|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14264939|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14264940|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
14264941|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264942|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264943|NCT00372385|Interferons|interferons|mesh-list
14264944|NCT00372385|Ribavirin|ribavirin|mesh-list
14264945|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
14264946|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
14264947|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14264948|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264949|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
14264950|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14264951|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
14264952|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264953|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
14264954|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264955|NCT00372424|Docetaxel|docetaxel|mesh-list
14264956|NCT00372424|Trastuzumab|trastuzumab|mesh-list
14264957|NCT00372424|Sunitinib|sunitinib|mesh-list
14264958|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264959|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
14264960|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
14264961|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
14264962|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264963|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14264964|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14264965|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14264966|NCT00372424|Growth Substances|growth substances|mesh-ancestor
14264967|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023121|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14023122|NCT02764281|Dexamethasone|dexamethasone|mesh-list
14023123|NCT02764281|Methotrexate|methotrexate|mesh-list
14023124|NCT02764281|Etoposide|etoposide|mesh-list
14023125|NCT02764281|Pegaspargase|pegaspargase|mesh-list
14023126|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023127|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
14023128|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
13991519|NCT02953522|Folic Acid|folic acid|mesh-list
13991520|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
13991521|NCT02953522|Hematinics|hematinics|mesh-ancestor
13991522|NCT02953522|Vitamins|vitamins|mesh-ancestor
13991523|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
13991524|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991525|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
13991526|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
13991527|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991528|NCT02953457|Durvalumab|durvalumab|mesh-list
13991529|NCT02953457|Ipilimumab|ipilimumab|mesh-list
13991530|NCT02953457|Olaparib|olaparib|mesh-list
13991531|NCT02953457|Tremelimumab|tremelimumab|mesh-list
13991532|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13991533|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
13991534|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13991535|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
13991536|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13991537|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991538|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
13991539|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991540|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991541|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991542|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13991543|NCT02953405|Clopidogrel|clopidogrel|mesh-list
13991544|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13991545|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13991546|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13991547|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13991548|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
13991549|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991550|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991551|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264968|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
14264969|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264970|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264971|NCT00372528|Pregabalin|pregabalin|mesh-list
14264972|NCT00372528|Analgesics|analgesics|mesh-ancestor
14264973|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
14264974|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14264975|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264976|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
15081623|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081624|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
15081625|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081626|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15081627|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081628|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081629|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
15081630|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081631|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14264977|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14264978|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14264979|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264980|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14264981|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14264982|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14264983|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14264984|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14264985|NCT00372567|Sunitinib|sunitinib|mesh-list
14264986|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
14264987|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14264988|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14264989|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14264990|NCT00372567|Growth Substances|growth substances|mesh-ancestor
15081632|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15081633|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
15081634|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15081635|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081636|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292306|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991552|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
13991553|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991554|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991555|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13991556|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
13991557|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991558|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991559|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13991560|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
13991561|NCT02953275|Vedolizumab|vedolizumab|mesh-list
13991562|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13991563|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991564|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991565|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13991566|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13991567|NCT02953275|Protective Agents|protective agents|mesh-ancestor
13991568|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991569|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
13991570|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15081637|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15081638|NCT04454515|Analgesics|analgesics|mesh-ancestor
15081639|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
15081640|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081641|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15081642|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15081643|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15081644|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
15081645|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081646|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081647|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15081648|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
15081649|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081650|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15081651|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
15081652|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081653|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081654|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15081655|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15081656|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15081657|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
15081658|NCT04435795|Ciclesonide|ciclesonide|mesh-list
15081659|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
15081660|NCT04435795|Hormones|hormones|mesh-ancestor
15081661|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081662|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081663|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15081664|NCT04429555|Ibudilast|ibudilast|mesh-list
15081665|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15081666|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
15081667|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081668|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081669|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15081670|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
15081671|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15081672|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081673|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081674|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15081675|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
15081676|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
15081677|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
15081678|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
15081679|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081680|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081681|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
15081682|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081683|NCT04396860|Nivolumab|nivolumab|mesh-list
15081684|NCT04396860|Ipilimumab|ipilimumab|mesh-list
15081685|NCT04396860|Temozolomide|temozolomide|mesh-list
15081686|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081687|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991571|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
15081688|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081689|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991572|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081690|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081691|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
15081692|NCT04368533|Fluorides|fluorides|mesh-list
15081693|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
15081694|NCT04368533|Protective Agents|protective agents|mesh-ancestor
15081695|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081696|NCT04339738|Paclitaxel|paclitaxel|mesh-list
15081697|NCT04339738|Nivolumab|nivolumab|mesh-list
15081698|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15081699|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081700|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081701|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081702|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081703|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081704|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081705|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081706|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081707|NCT04334941|Atezolizumab|atezolizumab|mesh-list
15081708|NCT04334941|Talazoparib|talazoparib|mesh-list
15081709|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13991573|NCT02953210|Dexamethasone|dexamethasone|mesh-list
13991574|NCT02953210|Ketorolac|ketorolac|mesh-list
13991575|NCT02953210|Lidocaine|lidocaine|mesh-list
13991576|NCT02953210|Clonidine|clonidine|mesh-list
13991577|NCT02953210|Fentanyl|fentanyl|mesh-list
13991578|NCT02953210|Midazolam|midazolam|mesh-list
13991579|NCT02953210|Ketamine|ketamine|mesh-list
13991580|NCT02953210|Ondansetron|ondansetron|mesh-list
13991581|NCT02953210|Bupivacaine|bupivacaine|mesh-list
13991582|NCT02953210|Propofol|propofol|mesh-list
13991583|NCT02953210|Isoflurane|isoflurane|mesh-list
13991584|NCT02953210|Ranitidine|ranitidine|mesh-list
13991585|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14264991|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081710|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081711|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
15081712|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081713|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15081714|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081715|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264992|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
14264993|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14264994|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14264995|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14264996|NCT00372593|Cytarabine|cytarabine|mesh-list
14264997|NCT00372593|Etoposide|etoposide|mesh-list
14264998|NCT00372593|Daunorubicin|daunorubicin|mesh-list
14264999|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
14265000|NCT00372593|Asparaginase|asparaginase|mesh-list
14265001|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
14265002|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14265003|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265004|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14265005|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14265006|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265007|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265008|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265009|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
14265010|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
14265011|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265012|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265013|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
14265014|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265015|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265016|NCT00372593|Analgesics|analgesics|mesh-ancestor
14265017|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
14265018|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265019|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14265020|NCT00372619|Cytarabine|cytarabine|mesh-list
14265021|NCT00372619|Methotrexate|methotrexate|mesh-list
14265022|NCT00372619|Clofarabine|clofarabine|mesh-list
15081716|NCT04284774|Tipifarnib|tipifarnib|mesh-list
13991586|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13991587|NCT02953210|Rocuronium|rocuronium|mesh-list
13991588|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991589|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
13991590|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
14265023|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14265024|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
15081717|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991591|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991592|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991593|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991594|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
13991595|NCT02953210|Hormones|hormones|mesh-ancestor
13991596|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265025|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14265026|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265027|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265028|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
14265029|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265030|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265031|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
14265032|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265033|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14265034|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265035|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
14265036|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265037|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14265038|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
14265039|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265040|NCT00372697|Octreotide|octreotide|mesh-list
14265041|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14265042|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14265043|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265044|NCT00372775|Sunitinib|sunitinib|mesh-list
14265045|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265046|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265047|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265048|NCT00372775|Growth Substances|growth substances|mesh-ancestor
14265049|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265050|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265051|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265052|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265053|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265054|NCT00372905|Rituximab|rituximab|mesh-list
14265055|NCT00372905|Bortezomib|bortezomib|mesh-list
14265056|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14265057|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14265058|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265059|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
14265060|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265061|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265062|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
14265063|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14265064|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14265065|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14265066|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14265067|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265068|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
14265069|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265070|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265071|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14265072|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265073|NCT00372996|Fulvestrant|fulvestrant|mesh-list
14265074|NCT00372996|Exemestane|exemestane|mesh-list
14265075|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14265076|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265077|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14265078|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14265079|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
14265080|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265081|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265082|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14265083|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14265084|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265085|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265086|NCT00373113|Capecitabine|capecitabine|mesh-list
13991597|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13991598|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991599|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
13991600|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
13991601|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991602|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
13991603|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13991604|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13991605|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13991606|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991607|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991608|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13991609|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13991610|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
13991611|NCT02953210|Analgesics|analgesics|mesh-ancestor
13991612|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13991613|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13991614|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14536077|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
14536078|NCT01072526|Cyclosporine|cyclosporine|mesh-list
14536079|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
14536080|NCT01072526|Cyclosporins|cyclosporins|mesh-list
15081718|NCT04280562|Acetaminophen|acetaminophen|mesh-list
13991615|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991616|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13991617|NCT02953210|Narcotics|narcotics|mesh-ancestor
13991618|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13991619|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13991620|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13991621|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13991622|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
13991623|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
13991624|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
13991625|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991626|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13991627|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
13991628|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13991629|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13991630|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13991631|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991632|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13991633|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991634|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13991635|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13991636|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13991637|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13991638|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
13991639|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13991640|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13991641|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13991642|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
13991643|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13991644|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13991645|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13991646|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
13991647|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
13991648|NCT02953106|Fluticasone|fluticasone|mesh-list
13991649|NCT02953106|Azelastine|azelastine|mesh-list
13991650|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991651|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13991652|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
13991653|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991654|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991655|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13991656|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
13991657|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991658|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13991659|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
13991660|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991661|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991662|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13991663|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13991664|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
14265087|NCT00373113|Sunitinib|sunitinib|mesh-list
14265088|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265089|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
14265090|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265091|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265092|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14536081|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081719|NCT04280562|Analgesics|analgesics|mesh-list
13991665|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
13991666|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991667|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
13991668|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13991669|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991670|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
13991671|NCT02953041|Bromides|bromides|mesh-list
13991672|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
13991673|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13991674|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13991675|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13991676|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
13991677|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991678|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991679|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991680|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13991681|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13991682|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13991683|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991684|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991685|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13991686|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991687|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991688|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
13991689|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991690|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13991691|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
13991692|NCT02953145|Coagulants|coagulants|mesh-ancestor
13991693|NCT02953184|Vitamins|vitamins|mesh-list
13991694|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
13991695|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
13991696|NCT02953184|Docetaxel|docetaxel|mesh-list
13991697|NCT02953184|Doxorubicin|doxorubicin|mesh-list
14265093|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265094|NCT00373113|Growth Substances|growth substances|mesh-ancestor
14265095|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265096|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265097|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265098|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265099|NCT00373256|Paclitaxel|paclitaxel|mesh-list
14265100|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14265101|NCT00373256|Bevacizumab|bevacizumab|mesh-list
14265102|NCT00373256|Sunitinib|sunitinib|mesh-list
14265103|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14265104|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265105|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14265106|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14265107|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14265108|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265109|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14265110|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265111|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265112|NCT00373256|Growth Substances|growth substances|mesh-ancestor
14265113|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265114|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265115|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265116|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265117|NCT00373295|Baclofen|baclofen|mesh-list
14265118|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14265119|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265120|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14265121|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265122|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14265123|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
14265124|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
14265125|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265126|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265127|NCT00373334|Nizatidine|nizatidine|mesh-list
14265128|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14265129|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14265130|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14265131|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
13991698|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13991699|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
13991700|NCT02953184|Razoxane|razoxane|mesh-list
13991701|NCT02953184|Pirarubicin|pirarubicin|mesh-list
13991702|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991703|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
13991704|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991705|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991706|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13991707|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
13991708|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991709|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991710|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13991711|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
13991712|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
13991713|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
13991714|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
13991715|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13991716|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13991717|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13991718|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991719|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13991720|NCT02953184|Protective Agents|protective agents|mesh-ancestor
13991721|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
13991722|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
13991723|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13991724|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991725|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
14265132|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
14642788|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265133|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265134|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265135|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265136|NCT00373360|Treprostinil|treprostinil|mesh-list
14265137|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14265138|NCT00373386|Hormones|hormones|mesh-list
14265139|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265140|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265141|NCT00373399|Dronabinol|dronabinol|mesh-list
14265142|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
14265143|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265144|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14265145|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265146|NCT00373399|Analgesics|analgesics|mesh-ancestor
14265147|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
14265148|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265149|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14265150|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14265151|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265152|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265153|NCT00373399|Hormones|hormones|mesh-ancestor
14265154|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265155|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14265156|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265157|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265158|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265159|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265160|NCT00373490|Vorinostat|vorinostat|mesh-list
14265161|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265162|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14265163|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265164|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265165|NCT00373529|Clofarabine|clofarabine|mesh-list
14265166|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265167|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
14265168|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265169|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265170|NCT00373685|Celecoxib|celecoxib|mesh-list
14265171|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14265172|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265173|NCT00373685|Analgesics|analgesics|mesh-ancestor
14265174|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
14265175|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265176|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265177|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991726|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991727|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13991728|NCT02952963|Cathartics|cathartics|mesh-ancestor
13991729|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991730|NCT02952573|Dexamethasone|dexamethasone|mesh-list
13991731|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
13991732|NCT02952573|BB 1101|bb 1101|mesh-list
13991733|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991734|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
13991735|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
13991736|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991737|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991738|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991739|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
13991740|NCT02952573|Hormones|hormones|mesh-ancestor
13991741|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991742|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13991743|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991744|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
13991745|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991746|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991747|NCT02952599|Edoxaban|edoxaban|mesh-list
13991748|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13991749|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
13991750|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13991751|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
13991752|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991753|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991754|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
13991755|NCT02952807|Misoprostol|misoprostol|mesh-list
13991756|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13991757|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
13991758|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13991759|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991760|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13991761|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991762|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
13991763|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
13991764|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14265178|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265179|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14265180|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14265181|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265182|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265183|NCT00373880|Cocaine|cocaine|mesh-list
14265184|NCT00373880|Aripiprazole|aripiprazole|mesh-list
14265185|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
14265186|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14265187|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14265188|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14265189|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14265190|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265191|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
14265192|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
14265193|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265194|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265195|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14265196|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15081720|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265197|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
14265198|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14265199|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14265200|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14265201|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14265202|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
14265203|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
14265204|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
14265205|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265206|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14265207|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14265208|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14265209|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14265210|NCT00373958|Vaccines|vaccines|mesh-list
14265211|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14265212|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
13991765|NCT02952235|Protective Agents|protective agents|mesh-ancestor
13991766|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991767|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991768|NCT02952469|Edetic Acid|edetic acid|mesh-list
13991769|NCT02952469|Chelating Agents|chelating agents|mesh-ancestor
13991770|NCT02952469|Sequestering Agents|sequestering agents|mesh-ancestor
13991771|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265213|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265214|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
14265215|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14265216|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
14265217|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265218|NCT00374088|Expectorants|expectorants|mesh-ancestor
14265219|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
14265220|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14265221|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
14265222|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265223|NCT00374088|Protective Agents|protective agents|mesh-ancestor
14265224|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265225|NCT00374088|Antidotes|antidotes|mesh-ancestor
14265226|NCT00374140|Everolimus|everolimus|mesh-list
14265227|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265228|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265229|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
14265230|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265231|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
14265232|NCT00374231|Prednisone|prednisone|mesh-list
14265233|NCT00374231|Tacrolimus|tacrolimus|mesh-list
14265234|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14265235|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
14265236|NCT00374231|Hormones|hormones|mesh-ancestor
14265237|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265238|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265239|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081721|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
15081722|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081723|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081724|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
15081725|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
15081726|NCT04270682|Cathartics|cathartics|mesh-ancestor
14265240|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265241|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265242|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
14265243|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14265244|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265245|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265246|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265247|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14265248|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
14265249|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265250|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265251|NCT00374244|Pimozide|pimozide|mesh-list
14265252|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14265253|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14265254|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14265255|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265256|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14265257|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14265258|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
14265259|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991772|NCT02952469|Anticoagulants|anticoagulants|mesh-ancestor
13991773|NCT02952469|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13991774|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
13991775|NCT02952092|Hematinics|hematinics|mesh-ancestor
13991776|NCT02952157|Lidocaine|lidocaine|mesh-list
13991777|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
13991778|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
13991779|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991780|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991781|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
13991782|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991783|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13991784|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13991785|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13991786|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991787|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023129|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023130|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023131|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023132|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
14023133|NCT02764281|Hormones|hormones|mesh-ancestor
14023134|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023135|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023136|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023137|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023138|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265260|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265261|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14265262|NCT00374322|Lapatinib|lapatinib|mesh-list
14265263|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265264|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265265|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265266|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265267|NCT00374556|Eszopiclone|eszopiclone|mesh-list
14265268|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14265269|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14265270|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265271|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
14265272|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265273|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265274|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14265275|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
14265276|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265277|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265278|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265279|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265280|NCT00374868|Pemetrexed|pemetrexed|mesh-list
14265281|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265282|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265283|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265284|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14265285|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14265286|NCT00374907|Metformin|metformin|mesh-list
14265287|NCT00374907|Saxagliptin|saxagliptin|mesh-list
14265288|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14265289|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265290|NCT00374907|Incretins|incretins|mesh-ancestor
14265291|NCT00374907|Hormones|hormones|mesh-ancestor
14265292|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265293|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14265294|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14265295|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265296|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265297|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
14265298|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14265299|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265300|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14265301|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265302|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265303|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
14265304|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14265305|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265306|NCT00375492|Exenatide|exenatide|mesh-list
14265307|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14265308|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265309|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14265310|NCT00375492|Incretins|incretins|mesh-ancestor
14265311|NCT00375492|Hormones|hormones|mesh-ancestor
14265312|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265313|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
14265314|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14265315|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265316|NCT00375518|Atorvastatin|atorvastatin|mesh-list
14265317|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14265318|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14265319|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
13991788|NCT02951754|Methylphenidate|methylphenidate|mesh-list
13991789|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13991790|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991791|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13991792|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13991793|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991794|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991795|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
13991796|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13991797|NCT02951728|Prednisone|prednisone|mesh-list
13991798|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
13991799|NCT02951728|Rituximab|rituximab|mesh-list
13991800|NCT02951728|Doxorubicin|doxorubicin|mesh-list
13991801|NCT02951728|Vincristine|vincristine|mesh-list
13991802|NCT02951728|Decitabine|decitabine|mesh-list
13991803|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13991804|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
13991805|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991806|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991807|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13991808|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
13991809|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991810|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265320|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265321|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14265322|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14265323|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265324|NCT00375609|Enoxaparin|enoxaparin|mesh-list
14265325|NCT00375609|Betrixaban|betrixaban|mesh-list
14265326|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
14265327|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14265328|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14265329|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265330|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14265331|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
14265332|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14265333|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
14265334|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265335|NCT00375674|Sunitinib|sunitinib|mesh-list
14265336|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265337|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265338|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265339|NCT00375674|Growth Substances|growth substances|mesh-ancestor
14265340|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265341|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265342|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265343|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265344|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265345|NCT00375713|Cetirizine|cetirizine|mesh-list
14265346|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
14265347|NCT00375713|Levocetirizine|levocetirizine|mesh-list
14265348|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14265349|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14265350|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14265351|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14265352|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
14265353|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
14265354|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265355|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265356|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265357|NCT00375752|Letrozole|letrozole|mesh-list
14265358|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265359|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14265360|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14265361|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265362|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265363|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14265364|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
14265365|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265366|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265367|NCT00375830|Diphosphonates|diphosphonates|mesh-list
14265368|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
14265369|NCT00375830|Listerine|listerine|mesh-list
14265370|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
14265371|NCT00375830|Fluorides|fluorides|mesh-list
13991811|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13991812|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13991813|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13991814|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13991815|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13991816|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991817|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991818|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
13991819|NCT02951728|Hormones|hormones|mesh-ancestor
13991820|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265372|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
14265373|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14265374|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
14265375|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
14265376|NCT00375830|Protective Agents|protective agents|mesh-ancestor
14265377|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265378|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14265379|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265380|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14265381|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265382|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
14265383|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
14265384|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14265385|NCT00375934|Diclofenac|diclofenac|mesh-list
14265386|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14265387|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265388|NCT00375934|Analgesics|analgesics|mesh-ancestor
14265389|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
14265390|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265391|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265392|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14265393|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265394|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14265395|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265396|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292315|NCT00559962|Atorvastatin|atorvastatin|mesh-list
14292316|NCT00559962|Ezetimibe|ezetimibe|mesh-list
14292317|NCT00559962|Fenofibrate|fenofibrate|mesh-list
14292318|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14292319|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14292320|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
14292321|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292322|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14292323|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14292324|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292325|NCT00560066|Vaccines|vaccines|mesh-list
14292326|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
14292327|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292328|NCT00560352|Dexamethasone|dexamethasone|mesh-list
13991821|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13991822|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13991823|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
13991824|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
13991825|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
13991826|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13991827|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
13991828|NCT02951975|Dexamethasone|dexamethasone|mesh-list
13991829|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991830|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
13991831|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
13991832|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991833|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991834|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991835|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
13991836|NCT02951975|Hormones|hormones|mesh-ancestor
13991837|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991838|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13991839|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991840|NCT02951806|Fentanyl|fentanyl|mesh-list
13991841|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13991842|NCT02951806|Narcotics|narcotics|mesh-ancestor
13991843|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13991844|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991845|NCT02951806|Analgesics|analgesics|mesh-ancestor
13991846|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
13991847|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991848|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13991849|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13991850|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
13991851|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
13991852|NCT02951962|Amlodipine|amlodipine|mesh-list
13991853|NCT02951962|Telmisartan|telmisartan|mesh-list
13991854|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
13991855|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13991856|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13991857|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13991858|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13991859|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991860|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13991861|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991862|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
13991863|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13991864|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991865|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
13991866|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13991867|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13991868|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991869|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13991870|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13991871|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
13991872|NCT02951897|Pemetrexed|pemetrexed|mesh-list
13991873|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991874|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991875|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991876|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13991877|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13991878|NCT02951637|Carboplatin|carboplatin|mesh-list
13991879|NCT02951637|Pemetrexed|pemetrexed|mesh-list
13991880|NCT02951637|Gefitinib|gefitinib|mesh-list
13991881|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991882|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991883|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991884|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14265397|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14265398|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14265399|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14265400|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14265401|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265402|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265403|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265404|NCT00375973|Analgesics|analgesics|mesh-ancestor
14265405|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
14265406|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265407|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
14265408|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14265409|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
14265410|NCT00375999|Docetaxel|docetaxel|mesh-list
14265411|NCT00375999|Epirubicin|epirubicin|mesh-list
14265412|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265413|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
14265414|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
14265415|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
14265416|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265417|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265418|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14265419|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14265420|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265421|NCT00376220|Riluzole|riluzole|mesh-list
14265422|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
13991885|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13991886|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13991887|NCT02951234|Aspirin|aspirin|mesh-list
13991888|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13991889|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
13991890|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13991891|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13991892|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13991893|NCT02951234|Analgesics|analgesics|mesh-ancestor
13991894|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
13991895|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991896|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991897|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991898|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991899|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13991900|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13991901|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991902|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13991903|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13991904|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991905|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
13991906|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
13991907|NCT02951260|Metformin|metformin|mesh-list
13991908|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13991909|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991910|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
13991911|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13991912|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991913|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991914|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13991915|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13991916|NCT02951299|Protective Agents|protective agents|mesh-ancestor
13991917|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991918|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
13991919|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13991920|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
13991921|NCT02950948|Progesterone|progesterone|mesh-list
13991922|NCT02950948|Progestins|progestins|mesh-ancestor
13991923|NCT02950948|Hormones|hormones|mesh-ancestor
13991924|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991925|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991926|NCT02951039|Edoxaban|edoxaban|mesh-list
15081727|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991927|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13991928|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
13991929|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13991930|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
13991931|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991932|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991933|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
13991934|NCT02951117|Dexamethasone|dexamethasone|mesh-list
13991935|NCT02951117|Venetoclax|venetoclax|mesh-list
13991936|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13991937|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
13991938|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
13991939|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13991940|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991941|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13991942|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
13991943|NCT02951117|Hormones|hormones|mesh-ancestor
13991944|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991945|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13991946|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13991947|NCT02950935|Progesterone|progesterone|mesh-list
14265423|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14265424|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14265425|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265426|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265427|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265428|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14265429|NCT00376220|Protective Agents|protective agents|mesh-ancestor
14265430|NCT00376246|Ezetimibe|ezetimibe|mesh-list
14265431|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14265432|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14265433|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
14265434|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991948|NCT02950935|Progestins|progestins|mesh-ancestor
13991949|NCT02950935|Hormones|hormones|mesh-ancestor
13991950|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13991951|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991952|NCT02950870|Ritonavir|ritonavir|mesh-list
13991953|NCT02950870|Ribavirin|ribavirin|mesh-list
13991954|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13991955|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13991956|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
13991957|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13991958|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991959|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13991960|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13991961|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
13991962|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991963|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13991964|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13991965|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
13991966|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
13991967|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
13991968|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13991969|NCT02950623|Protective Agents|protective agents|mesh-ancestor
13991970|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991971|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991972|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13991973|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
13991974|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
13991975|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13991976|NCT02950584|Protective Agents|protective agents|mesh-ancestor
13991977|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991978|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
13991979|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13991980|NCT02950441|Niacinamide|niacinamide|mesh-list
13991981|NCT02950441|Niacin|niacin|mesh-list
13991982|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
13991983|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
13991984|NCT02950441|Vitamins|vitamins|mesh-ancestor
13991985|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
13991986|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991987|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13991988|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
14265435|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14265436|NCT00376259|Adefovir|adefovir|mesh-list
14265437|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14265438|NCT00376259|Telbivudine|telbivudine|mesh-list
14265439|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
14265440|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265441|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14265442|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14265443|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265444|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265445|NCT00376675|Methylphenidate|methylphenidate|mesh-list
14265446|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14265447|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265448|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14265449|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14265450|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14265451|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265452|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
14265453|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265454|NCT00376688|Sirolimus|sirolimus|mesh-list
14265455|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265456|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265457|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265458|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265459|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
14265460|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265461|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
14265462|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265463|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
14265464|NCT00376805|Fludarabine|fludarabine|mesh-list
14265465|NCT00376805|Interleukin-2|interleukin-2|mesh-list
14265466|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265467|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
14265468|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13991989|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13991990|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14265469|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991991|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
13991992|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
13991993|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13991994|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13991995|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
13991996|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
13991997|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13991998|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023139|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14023140|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
14023141|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14023142|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14023143|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
14023144|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023145|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14023146|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14023147|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
14265470|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14265471|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
14265472|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265473|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265474|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14265475|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265476|NCT00376805|Analgesics|analgesics|mesh-ancestor
14265477|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
14265478|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265479|NCT00376948|Gemcitabine|gemcitabine|mesh-list
14265480|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14265481|NCT00376948|Genistein|genistein|mesh-list
14265482|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265483|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
14265484|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265485|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265486|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
14265487|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265488|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265489|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265490|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
14265491|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265492|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265493|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14265494|NCT00376948|Protective Agents|protective agents|mesh-ancestor
14265495|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
14265496|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14265497|NCT00376948|Estrogens|estrogens|mesh-ancestor
14265498|NCT00376948|Hormones|hormones|mesh-ancestor
14265499|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265500|NCT00376961|Prednisone|prednisone|mesh-list
14265501|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
14265502|NCT00376961|Rituximab|rituximab|mesh-list
14265503|NCT00376961|Doxorubicin|doxorubicin|mesh-list
14265504|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14265505|NCT00376961|Vincristine|vincristine|mesh-list
14265506|NCT00376961|Bortezomib|bortezomib|mesh-list
14265507|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265508|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
14265509|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265510|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265511|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14265512|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
14536082|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536083|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536084|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
14536085|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536086|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
14536087|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536088|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
14536089|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536090|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14536091|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14536092|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14265513|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536093|NCT01071993|Atorvastatin|atorvastatin|mesh-list
14265514|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265515|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14023148|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13991999|NCT02950168|Edoxaban|edoxaban|mesh-list
13992000|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13992001|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
13992002|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13992003|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992004|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992005|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992006|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
13992007|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
13992008|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
13992009|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13992010|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992011|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992012|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992013|NCT02950155|Rituximab|rituximab|mesh-list
13992014|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992015|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992016|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
13992017|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992018|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992019|NCT02950038|Nivolumab|nivolumab|mesh-list
13992020|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992021|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992022|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13992023|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992024|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
13992025|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13992026|NCT02950051|Rituximab|rituximab|mesh-list
13992027|NCT02950051|Fludarabine|fludarabine|mesh-list
13992028|NCT02950051|Venetoclax|venetoclax|mesh-list
13992029|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
13992030|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13992031|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
14265516|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14265517|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265518|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14265519|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14265520|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265521|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081728|NCT04267848|Gemcitabine|gemcitabine|mesh-list
15081729|NCT04267848|Paclitaxel|paclitaxel|mesh-list
15081730|NCT04267848|Cisplatin|cisplatin|mesh-list
14265522|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
14265523|NCT00376961|Hormones|hormones|mesh-ancestor
14265524|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265525|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14265526|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14265527|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
14265528|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
14265529|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
14265530|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
14265531|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
14265532|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14265533|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14265534|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265535|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14265536|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265537|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14265538|NCT00377260|Amoxicillin|amoxicillin|mesh-list
14265539|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
14265540|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
14265541|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14265542|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265543|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265544|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14265545|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265546|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265547|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14265548|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
14265549|NCT00377312|Hormones|hormones|mesh-list
14265550|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
14292329|NCT00560352|Bortezomib|bortezomib|mesh-list
14292330|NCT00560352|Dasatinib|dasatinib|mesh-list
13992032|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992033|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081731|NCT04267848|Carboplatin|carboplatin|mesh-list
13992034|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13992035|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
13992036|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265551|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265552|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265553|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14265554|NCT00377364|Acetaminophen|acetaminophen|mesh-list
14265555|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265556|NCT00377364|Analgesics|analgesics|mesh-ancestor
14265557|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
14265558|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265559|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265560|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
14265561|NCT00377403|Acetaminophen|acetaminophen|mesh-list
14265562|NCT00377403|Amoxicillin|amoxicillin|mesh-list
14265563|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
14265564|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
14265565|NCT00377403|Ephedrine|ephedrine|mesh-list
14265566|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
14265567|NCT00377403|Guaifenesin|guaifenesin|mesh-list
14265568|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14265569|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265570|NCT00377403|Analgesics|analgesics|mesh-ancestor
14265571|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
14265572|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265573|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265574|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
14265575|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265576|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265577|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
14265578|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
14265579|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14265580|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14265581|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265582|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265583|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14265584|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
14265585|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14265586|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
14265587|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14265588|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14265589|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
14265590|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
14265591|NCT00377403|Expectorants|expectorants|mesh-ancestor
14265592|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14265593|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14265594|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
14265595|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14265596|NCT00377429|Catumaxomab|catumaxomab|mesh-list
14265597|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14265598|NCT00377520|Pemetrexed|pemetrexed|mesh-list
14265599|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265600|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265601|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265602|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14265603|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14265604|NCT00377572|Omalizumab|omalizumab|mesh-list
14265605|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14265606|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14265607|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14265608|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
14265609|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
13992037|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992038|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13992039|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992040|NCT02949752|Aripiprazole|aripiprazole|mesh-list
13992041|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
13992042|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13992043|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13992044|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13992045|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992046|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992047|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
13992048|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
13992049|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992050|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992051|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13992052|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13992053|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
13992054|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13992055|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13992056|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13992057|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14265610|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265611|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
14265612|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
14265613|NCT00377637|Azathioprine|azathioprine|mesh-list
14265614|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265615|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
14265616|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265617|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265618|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14265619|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
14265620|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265621|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265622|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14265623|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265624|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14265625|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
14265626|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265627|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265628|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265629|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
14265630|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265631|NCT00377676|Bromocriptine|bromocriptine|mesh-list
14265632|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14265633|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14265634|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
14265635|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081732|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
15081733|NCT04267848|Pemetrexed|pemetrexed|mesh-list
15081734|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15081735|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081736|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081737|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081738|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081739|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081740|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265636|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265637|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
14265638|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
14265639|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265640|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265641|NCT00377741|Valganciclovir|valganciclovir|mesh-list
14265642|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
14265643|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265644|NCT00377819|Denosumab|denosumab|mesh-list
14265645|NCT00377819|Alendronate|alendronate|mesh-list
14265646|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14265647|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265648|NCT00377832|Acetaminophen|acetaminophen|mesh-list
14265649|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14265650|NCT00377832|Analgesics|analgesics|mesh-ancestor
14265651|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
14265652|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265653|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265654|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
14265655|NCT00377858|Insulin|insulin|mesh-list
14265656|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14265657|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
14265658|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
14265659|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14265660|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265661|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
14265662|NCT00377962|Everolimus|everolimus|mesh-list
14265663|NCT00377962|Azathioprine|azathioprine|mesh-list
14265664|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14265665|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265666|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13992058|NCT02949895|Etoposide|etoposide|mesh-list
14265667|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
13992059|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992060|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992061|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13992062|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13992063|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992064|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992065|NCT02949648|Nicotine|nicotine|mesh-list
13992066|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13992067|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
13992068|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265668|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265669|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265670|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265671|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
14265672|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265673|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265674|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265675|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14265676|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
14265677|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265678|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265679|NCT00378014|Everolimus|everolimus|mesh-list
14265680|NCT00378014|Basiliximab|basiliximab|mesh-list
14265681|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265682|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265683|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
14265684|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265685|NCT00378079|Methadone|methadone|mesh-list
14265686|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14265687|NCT00378079|Narcotics|narcotics|mesh-ancestor
14265688|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14265689|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265690|NCT00378079|Analgesics|analgesics|mesh-ancestor
14265691|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
14265692|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265693|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
14265694|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
14265695|NCT00378105|Dexamethasone|dexamethasone|mesh-list
14265696|NCT00378105|Lenalidomide|lenalidomide|mesh-list
14265697|NCT00378105|Bortezomib|bortezomib|mesh-list
14265698|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14265699|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
14265700|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
15081741|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15081742|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
15081743|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
15081744|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081745|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081746|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081747|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
15081748|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081749|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081750|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14265701|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265702|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265703|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14265704|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
14265705|NCT00378105|Hormones|hormones|mesh-ancestor
14265706|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265707|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14265708|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265709|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
14265710|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265711|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265712|NCT00378105|Growth Substances|growth substances|mesh-ancestor
14265713|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265714|NCT00378209|Dexamethasone|dexamethasone|mesh-list
14265715|NCT00378209|Lenalidomide|lenalidomide|mesh-list
14265716|NCT00378209|Bortezomib|bortezomib|mesh-list
14265717|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14265718|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
14265719|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
14265720|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265721|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265722|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13992069|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992070|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13992071|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13992072|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
13992073|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992074|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992075|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
13992076|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13992077|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992078|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
13992079|NCT02949765|Iron|iron|mesh-list
13992080|NCT02949765|Trace Elements|trace elements|mesh-ancestor
13992081|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
13992082|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992083|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
13992084|NCT02949843|Nivolumab|nivolumab|mesh-list
13992085|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992086|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992087|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13992088|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992089|NCT02949778|Ropivacaine|ropivacaine|mesh-list
13992090|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
13992091|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
13992092|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992093|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992094|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
13992095|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992096|NCT02949492|Interleukin-2|interleukin-2|mesh-list
13992097|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992098|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13992099|NCT02949492|Analgesics|analgesics|mesh-ancestor
13992100|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
13992101|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992102|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992103|NCT02949232|Prednisolone|prednisolone|mesh-list
13992104|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992105|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
13992106|NCT02949232|Hormones|hormones|mesh-ancestor
13992107|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992108|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992109|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13992110|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081751|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15081752|NCT04260464|PF-06700841|pf-06700841|mesh-list
15081753|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081754|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081755|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081756|NCT04252742|Erenumab|erenumab|mesh-list
15081757|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
13992111|NCT02949466|Triamcinolone|triamcinolone|mesh-list
13992112|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
13992113|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992114|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
13992115|NCT02949466|Hormones|hormones|mesh-ancestor
13992116|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992117|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992118|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
13992119|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13992120|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
13992121|NCT02949466|Protective Agents|protective agents|mesh-ancestor
13992122|NCT02949310|Nefopam|nefopam|mesh-list
13992123|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13992124|NCT02949310|Analgesics|analgesics|mesh-ancestor
13992125|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
13992126|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992127|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992128|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
15081758|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081759|NCT04252742|Analgesics|analgesics|mesh-ancestor
15081760|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
15081761|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081762|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992129|NCT02949349|Prednisolone|prednisolone|mesh-list
13992130|NCT02949349|Azathioprine|azathioprine|mesh-list
13992131|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13992132|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992133|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13992134|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
13992135|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13992136|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992137|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992138|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992139|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992140|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
13992141|NCT02949349|Hormones|hormones|mesh-ancestor
13992142|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992143|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992144|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13992145|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
13992146|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13992147|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13992148|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
13992149|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992150|NCT02949206|Thrombin|thrombin|mesh-list
15081763|NCT04214262|Atezolizumab|atezolizumab|mesh-list
14265723|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
14265724|NCT00378209|Hormones|hormones|mesh-ancestor
14265725|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265726|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14265727|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265728|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
14265729|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265730|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265731|NCT00378209|Growth Substances|growth substances|mesh-ancestor
14265732|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265733|NCT00378326|Tacrolimus|tacrolimus|mesh-list
14265734|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265735|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
15081764|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15081765|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081766|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
15081767|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081768|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
15081769|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081770|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081771|NCT04199728|Liraglutide|liraglutide|mesh-list
14265736|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265737|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14265738|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265739|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265740|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
14265741|NCT00378352|Hematinics|hematinics|mesh-ancestor
14265742|NCT00378534|Cyclosporine|cyclosporine|mesh-list
14265743|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
14265744|NCT00378534|Fludarabine|fludarabine|mesh-list
15081772|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15081773|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081774|NCT04199728|Incretins|incretins|mesh-ancestor
15081775|NCT04199728|Hormones|hormones|mesh-ancestor
15081776|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081777|NCT04195555|Ivosidenib|ivosidenib|mesh-list
15081778|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265745|NCT00378534|Cyclosporins|cyclosporins|mesh-list
14265746|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265747|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
14265748|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265749|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265750|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14265751|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
14265752|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265753|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265754|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14265755|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265756|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
14265757|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265758|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
14265759|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15081779|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081780|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265760|NCT00378573|Gemcitabine|gemcitabine|mesh-list
14265761|NCT00378573|Bevacizumab|bevacizumab|mesh-list
13992151|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
13992152|NCT02949206|Coagulants|coagulants|mesh-ancestor
13992153|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
13992154|NCT02949258|Etoposide|etoposide|mesh-list
13992155|NCT02949258|Epirubicin|epirubicin|mesh-list
13992156|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992157|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992158|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13992159|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13992160|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992161|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992162|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13992163|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13992164|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13992165|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992166|NCT02949193|Incretins|incretins|mesh-ancestor
13992167|NCT02949193|Hormones|hormones|mesh-ancestor
13992168|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992169|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13992170|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992171|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992172|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992173|NCT02948985|Cetuximab|cetuximab|mesh-list
13992174|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992175|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992176|NCT02948998|Spironolactone|spironolactone|mesh-list
13992177|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13992178|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
13992179|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992180|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081781|NCT04185883|Bevacizumab|bevacizumab|mesh-list
15081782|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
15081783|NCT04185883|Panitumumab|panitumumab|mesh-list
15081784|NCT04185883|Carboplatin|carboplatin|mesh-list
15081785|NCT04185883|Docetaxel|docetaxel|mesh-list
15081786|NCT04185883|Pemetrexed|pemetrexed|mesh-list
15081787|NCT04185883|Everolimus|everolimus|mesh-list
13992181|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13992182|NCT02948998|Diuretics|diuretics|mesh-ancestor
13992183|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
13992184|NCT02949284|Prednisone|prednisone|mesh-list
13992185|NCT02949284|Cortisone|cortisone|mesh-list
13992186|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
13992187|NCT02949284|Hormones|hormones|mesh-list
13992188|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
13992189|NCT02949284|Androgens|androgens|mesh-list
13992190|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
13992191|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992192|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
13992193|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992194|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992195|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13992196|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992197|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13992198|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992199|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992200|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
13992201|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13992202|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
14265762|NCT00378573|Docetaxel|docetaxel|mesh-list
14265763|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14265764|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265765|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265766|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265767|NCT00378573|Growth Substances|growth substances|mesh-ancestor
14265768|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265769|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265770|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265771|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
14265772|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265773|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
14536094|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15081788|NCT04185883|Atezolizumab|atezolizumab|mesh-list
15081789|NCT04185883|Palbociclib|palbociclib|mesh-list
15081790|NCT04185883|Trametinib|trametinib|mesh-list
15081791|NCT04185883|Afatinib|afatinib|mesh-list
15081792|NCT04185883|Loperamide|loperamide|mesh-list
13992203|NCT02948920|Ephedrine|ephedrine|mesh-list
13992204|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13992205|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992206|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
13992207|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
13992208|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992209|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13992210|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
13992211|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992212|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992213|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
13992214|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13992215|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265774|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265775|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265776|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265777|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
14265778|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
14265779|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
14265780|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
14265781|NCT00378599|Interferons|interferons|mesh-list
14265782|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
14265783|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
14265784|NCT00378599|Ribavirin|ribavirin|mesh-list
14265785|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14265786|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992229|NCT02948543|Mitomycins|mitomycins|mesh-list
13992230|NCT02948543|Mitomycin|mitomycin|mesh-list
13992231|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13992232|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992233|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
13992234|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992235|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13992236|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023149|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14023150|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14023151|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14023152|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14023153|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14023154|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14023155|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14023156|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14023157|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14023158|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
14023159|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023160|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023161|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023162|NCT02763969|Interferons|interferons|mesh-list
14023163|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
14023164|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
14023165|NCT02763969|Ustekinumab|ustekinumab|mesh-list
14023166|NCT02763969|Famotidine|famotidine|mesh-list
14023167|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023168|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
14023169|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023170|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
14023171|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023172|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023173|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14023174|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023175|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14023176|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
14265787|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
14265788|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265789|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
14265790|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265791|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
14265792|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265793|NCT00378703|Sirolimus|sirolimus|mesh-list
14265794|NCT00378703|Bevacizumab|bevacizumab|mesh-list
14265795|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14265796|NCT00378703|Sorafenib|sorafenib|mesh-list
14265797|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
14265798|NCT00378703|Antibodies|antibodies|mesh-list
14023177|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
14265799|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
14265800|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13992237|NCT02948348|Capecitabine|capecitabine|mesh-list
13992238|NCT02948348|Nivolumab|nivolumab|mesh-list
13992239|NCT02948348|Ipilimumab|ipilimumab|mesh-list
13992240|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13992241|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
13992242|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992243|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992244|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992245|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13992246|NCT02948283|Metformin|metformin|mesh-list
13992247|NCT02948283|Ritonavir|ritonavir|mesh-list
13992248|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13992249|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992250|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13992251|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13992252|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992253|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992254|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992255|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13992256|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13992257|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
13992258|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265801|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
14265802|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265803|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265804|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265805|NCT00378703|Growth Substances|growth substances|mesh-ancestor
14265806|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265807|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265808|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
14265809|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265810|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265811|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265812|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265813|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265814|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265815|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
14265816|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265817|NCT00379145|Trabectedin|trabectedin|mesh-list
14265818|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14265819|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
14265820|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265821|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265822|NCT00379197|Naltrexone|naltrexone|mesh-list
14265823|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14265824|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14265825|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265826|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
14265827|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14265828|NCT00379353|Thalidomide|thalidomide|mesh-list
14265829|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265830|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
14265831|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265832|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
14265833|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265834|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265835|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265836|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265837|NCT00379353|Growth Substances|growth substances|mesh-ancestor
14265838|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265839|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265840|NCT00379574|Prednisolone|prednisolone|mesh-list
14265841|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
14265842|NCT00379574|Doxorubicin|doxorubicin|mesh-list
14265843|NCT00379574|Vincristine|vincristine|mesh-list
14265844|NCT00379574|Bortezomib|bortezomib|mesh-list
14265845|NCT00379574|Lenograstim|lenograstim|mesh-list
14265846|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265847|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
15081793|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081794|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081795|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15081796|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265848|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265849|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265850|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081797|NCT04185883|Growth Substances|growth substances|mesh-ancestor
15081798|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081799|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
15081800|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081801|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081802|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081803|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081804|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081805|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13992259|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13992260|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13992261|NCT02947945|Reslizumab|reslizumab|mesh-list
13992262|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13992263|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
13992264|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
13992265|NCT02948101|Antibodies|antibodies|mesh-list
13992266|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13992267|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13992268|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
13992269|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992270|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992271|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13992272|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
13992273|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992274|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992275|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13992276|NCT02948075|Paclitaxel|paclitaxel|mesh-list
13992277|NCT02948075|Carboplatin|carboplatin|mesh-list
13992278|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992279|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992280|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
13992281|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
13992282|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
13992283|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992284|NCT02947932|Indomethacin|indomethacin|mesh-list
13992285|NCT02947932|Resveratrol|resveratrol|mesh-list
13992286|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
13992287|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992288|NCT02947932|Protective Agents|protective agents|mesh-ancestor
13992289|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992290|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992291|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13992292|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13992293|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13992294|NCT02947932|Analgesics|analgesics|mesh-ancestor
13992295|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
13992296|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992297|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992298|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992299|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
13992300|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
13992301|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13992302|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13992303|NCT02947880|Bumetanide|bumetanide|mesh-list
13992304|NCT02947880|Diuretics|diuretics|mesh-ancestor
13992305|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
13992306|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992307|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13992308|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13992309|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992310|NCT02947711|Diltiazem|diltiazem|mesh-list
13992311|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13992312|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13992313|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13992314|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992315|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13992316|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992317|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
13992318|NCT02947620|Metformin|metformin|mesh-list
13992319|NCT02947620|Atorvastatin|atorvastatin|mesh-list
13992320|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13992321|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081806|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15081807|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13992322|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13992323|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13992324|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
13992325|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992326|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13992327|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13992328|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992329|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
13992330|NCT02947854|Poly ICLC|poly iclc|mesh-list
13992331|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
13992332|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
13992333|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
13992334|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992335|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13992336|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
13992337|NCT02947763|Metronidazole|metronidazole|mesh-list
13992338|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
13992339|NCT02947763|Minocycline|minocycline|mesh-list
13992340|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992341|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13992342|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13992343|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13992344|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13992345|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13992346|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992347|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992348|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992349|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13992350|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13992351|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
13992352|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13992353|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13992354|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13992355|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13992356|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992357|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
13992358|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992359|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265851|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
14265852|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265853|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265854|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14265855|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265856|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14265857|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14265858|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265859|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992360|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14265860|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
14265861|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
14265862|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
14265863|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14265864|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
14265865|NCT00379574|Hormones|hormones|mesh-ancestor
14265866|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536095|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536096|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
14536097|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536098|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536099|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14536100|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536101|NCT01065051|Riociguat|riociguat|mesh-list
14536102|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
14536103|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536104|NCT01058642|Pregabalin|pregabalin|mesh-list
14536105|NCT01058642|Analgesics|analgesics|mesh-ancestor
14536106|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
15081808|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
13992361|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992362|NCT02947737|Gentamicins|gentamicins|mesh-list
13992363|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13992364|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992365|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13992366|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992367|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992368|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
13992369|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13992370|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13992371|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992372|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
14265867|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14265868|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14265869|NCT00379587|Rituximab|rituximab|mesh-list
14265870|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14265871|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265872|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
14265873|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265874|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265875|NCT00379639|Gemcitabine|gemcitabine|mesh-list
14265876|NCT00379639|Romidepsin|romidepsin|mesh-list
14265877|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265878|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
14265879|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265880|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265881|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
14265882|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265883|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265884|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265885|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
14265886|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265887|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14265888|NCT00379769|Metformin|metformin|mesh-list
14265889|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
14265890|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14265891|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265892|NCT00379795|Ranibizumab|ranibizumab|mesh-list
14265893|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14265894|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14265895|NCT00379795|Growth Substances|growth substances|mesh-ancestor
14265896|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265897|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14265898|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265899|NCT00379808|Montelukast|montelukast|mesh-list
14265900|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14265901|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
14265902|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14265903|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
14265904|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265905|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265906|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14265907|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14265908|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265909|NCT00379821|Azithromycin|azithromycin|mesh-list
14265910|NCT00379821|Artesunate|artesunate|mesh-list
14265911|NCT00379821|Chloroquine|chloroquine|mesh-list
14265912|NCT00379821|Atovaquone|atovaquone|mesh-list
14265913|NCT00379821|Proguanil|proguanil|mesh-list
14265914|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14265915|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14265916|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992373|NCT02947529|Coagulants|coagulants|mesh-ancestor
13992374|NCT02947672|Dexamethasone|dexamethasone|mesh-list
13992375|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992376|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
13992377|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
13992378|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992379|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992380|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13992381|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
13992382|NCT02947672|Hormones|hormones|mesh-ancestor
13992383|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265917|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
13992384|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13992385|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992386|NCT02947178|Bupivacaine|bupivacaine|mesh-list
13992387|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
13992388|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
13992389|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992390|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992391|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
13992392|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992393|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
13992394|NCT02947438|Hematinics|hematinics|mesh-ancestor
13992395|NCT02947347|Rituximab|rituximab|mesh-list
13992396|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992397|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992398|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
13992399|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992400|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992401|NCT02947113|Etoposide|etoposide|mesh-list
13992402|NCT02947113|Pemetrexed|pemetrexed|mesh-list
13992403|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992404|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992405|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13992406|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13992407|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992408|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265918|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14536107|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536108|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536109|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
14536110|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14265919|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14265920|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265921|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
14265922|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
14265923|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14265924|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
14265925|NCT00379821|Amebicides|amebicides|mesh-ancestor
14265926|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14265927|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265928|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265929|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
14265930|NCT00379834|Timolol|timolol|mesh-list
14265931|NCT00379834|Dorzolamide|dorzolamide|mesh-list
14265932|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14265933|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14265934|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14265935|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536111|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536112|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081809|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14536113|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536114|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14536115|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14536116|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536117|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14536118|NCT01065818|Telbivudine|telbivudine|mesh-list
14536119|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
14536120|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536121|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14536122|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536123|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536124|NCT01051921|Interferons|interferons|mesh-list
14536125|NCT01051921|Ribavirin|ribavirin|mesh-list
14536126|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536127|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
14536128|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536129|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
14536130|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536131|NCT01048125|Nitroprusside|nitroprusside|mesh-list
14536132|NCT01048125|Phenylephrine|phenylephrine|mesh-list
14536133|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
14536134|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14536135|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
13992409|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14265936|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536136|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
13992410|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13992411|NCT02947334|Bococizumab|bococizumab|mesh-list
13992412|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13992413|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13992414|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
13992415|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992416|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13992417|NCT02947269|Prucalopride|prucalopride|mesh-list
13992418|NCT02947269|Laxatives|laxatives|mesh-ancestor
13992419|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13992420|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
13992421|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13992422|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
13992423|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992424|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992425|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992426|NCT02947243|Morphine|morphine|mesh-list
13992427|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13992428|NCT02947243|Narcotics|narcotics|mesh-ancestor
13992429|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992430|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992431|NCT02947243|Analgesics|analgesics|mesh-ancestor
13992432|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
13992433|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992434|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
13992435|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
13992436|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13992437|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992438|NCT02947126|Antidotes|antidotes|mesh-ancestor
13992439|NCT02947126|Protective Agents|protective agents|mesh-ancestor
13992440|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992441|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
13992442|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
13992443|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13992444|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
13992445|NCT02946944|Apixaban|apixaban|mesh-list
13992446|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
13992447|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13992448|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13992449|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992450|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992451|NCT02946944|Urological Agents|urological agents|mesh-ancestor
13992452|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15081810|NCT04185883|Antidiarrheals|antidiarrheals|mesh-ancestor
15081811|NCT04185883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081812|NCT04175912|Paclitaxel|paclitaxel|mesh-list
15081813|NCT04175912|Carboplatin|carboplatin|mesh-list
15081814|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15081815|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15081816|NCT04175912|Pevonedistat|pevonedistat|mesh-list
15081817|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992453|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
14265937|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265938|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14265939|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14265940|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14265941|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265942|NCT00379899|Vitamin D|vitamin d|mesh-list
14265943|NCT00379899|Cinacalcet|cinacalcet|mesh-list
14265944|NCT00379899|Vitamins|vitamins|mesh-ancestor
14265945|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
14265946|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265947|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14265948|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14265949|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14265950|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
14265951|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14265952|NCT00379912|Azacitidine|azacitidine|mesh-list
14265953|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
14265954|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265955|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
14265956|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265957|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265958|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265959|NCT00379912|Hematinics|hematinics|mesh-ancestor
15081818|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992454|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13992455|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992456|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
13992457|NCT02946970|Quinine|quinine|mesh-list
13992458|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
13992459|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13992460|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14536137|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536138|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536139|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
14536140|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14536141|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
14536142|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
14536143|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14536144|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14536145|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14536146|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14536147|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536148|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536149|NCT01048125|Protective Agents|protective agents|mesh-ancestor
13992461|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992462|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13992463|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992464|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13992465|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992466|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13992467|NCT02946970|Analgesics|analgesics|mesh-ancestor
13992468|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
13992469|NCT02947061|Docetaxel|docetaxel|mesh-list
13992470|NCT02947061|Capecitabine|capecitabine|mesh-list
15081819|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081820|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081821|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081822|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081823|NCT04167813|Ondansetron|ondansetron|mesh-list
13992471|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992472|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
13992473|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
13992474|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
13992475|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992476|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13992477|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
13992478|NCT02946671|Nivolumab|nivolumab|mesh-list
13992479|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
13992480|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992481|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992482|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13992483|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992484|NCT02946684|Letrozole|letrozole|mesh-list
13992485|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13992486|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992487|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13992488|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992489|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992490|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13992491|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
13992492|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992493|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023178|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023179|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023180|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
14023181|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023182|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265960|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14265961|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265962|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14265963|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265964|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265965|NCT00380068|Ambrisentan|ambrisentan|mesh-list
14265966|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14265967|NCT00380081|Zolpidem|zolpidem|mesh-list
15081824|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
14023183|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
14265968|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13992494|NCT02946801|Listerine|listerine|mesh-list
13992495|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
13992496|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13992497|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992498|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
14265969|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14265970|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14265971|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265972|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14265973|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
14265974|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
14265975|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14265976|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265977|NCT00380250|Lubiprostone|lubiprostone|mesh-list
14265978|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14265979|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14265980|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265981|NCT00380393|Vaccines|vaccines|mesh-list
14265982|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
14265983|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265984|NCT00380588|Gemcitabine|gemcitabine|mesh-list
14265985|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14265986|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14265987|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
14265988|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14265989|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
14265990|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14265991|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14265992|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14265993|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
14265994|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14265995|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14265996|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14265997|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14265998|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14265999|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266000|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
14266001|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266002|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266003|NCT00380718|Pemetrexed|pemetrexed|mesh-list
14266004|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266005|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266006|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266007|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14266008|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14266009|NCT00380874|Pregabalin|pregabalin|mesh-list
14266010|NCT00380874|Analgesics|analgesics|mesh-ancestor
14266011|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
14266012|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266013|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266014|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
14266015|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14266016|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266017|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266018|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14266019|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14266020|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14266021|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266022|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266023|NCT00380978|Narcotics|narcotics|mesh-list
14266024|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266025|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266026|NCT00380978|Analgesics|analgesics|mesh-ancestor
14266027|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
14266028|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266029|NCT00381004|Vidarabine|vidarabine|mesh-list
13992499|NCT02946801|Protective Agents|protective agents|mesh-ancestor
13992500|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992501|NCT02946359|Bevacizumab|bevacizumab|mesh-list
13992502|NCT02946359|Crizotinib|crizotinib|mesh-list
13992503|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992504|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992505|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13992506|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13992507|NCT02946359|Growth Substances|growth substances|mesh-ancestor
13992508|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992509|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
13992510|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13992511|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992512|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992513|NCT02946437|Midazolam|midazolam|mesh-list
13992514|NCT02946437|Propofol|propofol|mesh-list
13992515|NCT02946437|Sevoflurane|sevoflurane|mesh-list
13992516|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13992517|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992518|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992519|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13992520|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
13992521|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
13992522|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13992523|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13992524|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13992525|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13992526|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
13992527|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
13992528|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992529|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992530|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13992531|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13992532|NCT02946814|Listerine|listerine|mesh-list
13992533|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
13992534|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13992535|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992536|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
13992537|NCT02946814|Protective Agents|protective agents|mesh-ancestor
13992538|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992539|NCT02946632|Metformin|metformin|mesh-list
13992540|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13992541|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
13992542|NCT02946632|Glimepiride|glimepiride|mesh-list
13992543|NCT02946632|Saxagliptin|saxagliptin|mesh-list
13992544|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13992545|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992546|NCT02946632|Incretins|incretins|mesh-ancestor
13992547|NCT02946632|Hormones|hormones|mesh-ancestor
13992548|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992549|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13992550|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992551|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992552|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992553|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13992554|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13992555|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13992556|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
13992557|NCT02946788|Minocycline|minocycline|mesh-list
13992558|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13992559|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992560|NCT02946294|Epinephrine|epinephrine|mesh-list
13992561|NCT02946294|Racepinephrine|racepinephrine|mesh-list
13992562|NCT02946294|Bupivacaine|bupivacaine|mesh-list
13992563|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
13992564|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
13992565|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
13992566|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992567|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992568|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
13992569|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992570|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14266030|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
14266031|NCT00381004|Rituximab|rituximab|mesh-list
14266032|NCT00381004|Fludarabine|fludarabine|mesh-list
14266033|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
14266034|NCT00381004|Sargramostim|sargramostim|mesh-list
14266035|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266036|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
13992571|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13992572|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
13992573|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992574|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266037|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992575|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13992576|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13992577|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
13992578|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13992579|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
13992580|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
13992581|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
13992582|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13992583|NCT02946268|Ropivacaine|ropivacaine|mesh-list
13992584|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
13992585|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
13992586|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992587|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992588|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
13992589|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992590|NCT02946060|TEMPO|tempo|mesh-list
13992591|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
13992592|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992593|NCT02946060|Protective Agents|protective agents|mesh-ancestor
13992594|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992595|NCT02945982|Entecavir|entecavir|mesh-list
13992596|NCT02945982|Carvedilol|carvedilol|mesh-list
13992597|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
13992598|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992599|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13992600|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13992601|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
13992602|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992603|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992604|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992605|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13992606|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
13992607|NCT02945982|Protective Agents|protective agents|mesh-ancestor
13992608|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13992609|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13992610|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13992611|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
13992612|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13992613|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13992614|NCT02945956|Entecavir|entecavir|mesh-list
13992615|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
13992616|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992617|NCT02945696|Ropivacaine|ropivacaine|mesh-list
13992618|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
13992619|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
13992620|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992621|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992622|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
13992623|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992624|NCT02945839|Topiramate|topiramate|mesh-list
13992625|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
13992626|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13992627|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992628|NCT02945852|Apatinib|apatinib|mesh-list
13992629|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992630|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13992631|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992632|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992633|NCT02945644|Trazodone|trazodone|mesh-list
13992634|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13992635|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13992636|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992637|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992638|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13992639|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13992640|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13992641|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13992642|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992643|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992644|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
13992645|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13992646|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
13992647|NCT02945527|Dexamethasone|dexamethasone|mesh-list
13992648|NCT02945527|Acetazolamide|acetazolamide|mesh-list
13992649|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992650|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
13992651|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
13992652|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992653|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992654|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14266038|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266039|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14266040|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
14266041|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266042|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266043|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14266044|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14266045|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266046|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
14266047|NCT00381004|Antiviral Agents|antiviral agents|mesh-ancestor
14266048|NCT00381004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266049|NCT00381043|Acamprosate|acamprosate|mesh-list
14266050|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14266051|NCT00381095|Pregabalin|pregabalin|mesh-list
14266052|NCT00381095|Analgesics|analgesics|mesh-ancestor
14266053|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
14266054|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266055|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266056|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
14266057|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14266058|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266059|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266060|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14266061|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14266062|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14266063|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266064|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266065|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
14266066|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14266067|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266068|NCT00381303|Ritonavir|ritonavir|mesh-list
14266069|NCT00381303|Darunavir|darunavir|mesh-list
14266070|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14266071|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14266072|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
14266073|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266074|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266075|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14266076|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14266077|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
14266078|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266079|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14266080|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14266081|NCT00381550|Fludarabine|fludarabine|mesh-list
14266082|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
14266083|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266084|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266085|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
14266086|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266087|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266088|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
14266089|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266090|NCT00381615|Vaccines|vaccines|mesh-list
14266091|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
14266092|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266093|NCT00381680|Leucovorin|leucovorin|mesh-list
14266094|NCT00381680|Cytarabine|cytarabine|mesh-list
14266095|NCT00381680|Dexamethasone|dexamethasone|mesh-list
14266096|NCT00381680|Prednisone|prednisone|mesh-list
14266097|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
14266098|NCT00381680|Doxorubicin|doxorubicin|mesh-list
14266099|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14266100|NCT00381680|Methotrexate|methotrexate|mesh-list
14266101|NCT00381680|Etoposide|etoposide|mesh-list
14266102|NCT00381680|Vincristine|vincristine|mesh-list
14266103|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
14266104|NCT00381680|Asparaginase|asparaginase|mesh-list
14266105|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
14266106|NCT00381680|Pegaspargase|pegaspargase|mesh-list
14266107|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
14266108|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266109|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
15081825|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
14266110|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992655|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
13992656|NCT02945527|Hormones|hormones|mesh-ancestor
14266111|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266112|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14266113|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
14266114|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081826|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081827|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081828|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081829|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
15081830|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14266115|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266116|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14266117|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266118|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
14266119|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
14266120|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266121|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14266122|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
14266123|NCT00381680|Hormones|hormones|mesh-ancestor
14266124|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266125|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14266126|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14266127|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14266128|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14266129|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266130|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14266131|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
14266132|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14266133|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266134|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
14266135|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14266136|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14266137|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14266138|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14266139|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
14266140|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266141|NCT00381680|Antidotes|antidotes|mesh-ancestor
14266142|NCT00381680|Protective Agents|protective agents|mesh-ancestor
14266143|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
14266144|NCT00381680|Vitamins|vitamins|mesh-ancestor
14266145|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
14266146|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
14266147|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
14266148|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
14266149|NCT00381693|Azacitidine|azacitidine|mesh-list
14266150|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266151|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
14266152|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266153|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266154|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266155|NCT00381706|Leucovorin|leucovorin|mesh-list
14266156|NCT00381706|Cisplatin|cisplatin|mesh-list
14266157|NCT00381706|Fluorouracil|fluorouracil|mesh-list
14266158|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
14266159|NCT00381706|Irinotecan|irinotecan|mesh-list
14266160|NCT00381706|Cetuximab|cetuximab|mesh-list
14266161|NCT00381706|Epirubicin|epirubicin|mesh-list
14266162|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266163|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
14266164|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266165|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266166|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081831|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13992657|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992658|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13992659|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992660|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
13992661|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13992662|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992663|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992664|NCT02945527|Diuretics|diuretics|mesh-ancestor
13992665|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
13992666|NCT02945293|Oxycodone|oxycodone|mesh-list
14536150|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13992667|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13992668|NCT02945293|Narcotics|narcotics|mesh-ancestor
13992669|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992670|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992671|NCT02945293|Analgesics|analgesics|mesh-ancestor
13992672|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
13992673|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992674|NCT02945280|Apixaban|apixaban|mesh-list
13992675|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15081832|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
14266167|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
14266168|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266169|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14266170|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14266171|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266172|NCT00381706|Antidotes|antidotes|mesh-ancestor
14266173|NCT00381706|Protective Agents|protective agents|mesh-ancestor
14266174|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
14266175|NCT00381706|Vitamins|vitamins|mesh-ancestor
14266176|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
14266177|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14266178|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14266179|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14266180|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
14266181|NCT00381797|Bevacizumab|bevacizumab|mesh-list
14266182|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14266183|NCT00381797|Irinotecan|irinotecan|mesh-list
14266184|NCT00381797|Camptothecin|camptothecin|mesh-list
14266185|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
14266186|NCT00381797|Antibodies|antibodies|mesh-list
14266187|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
14266188|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14266189|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
14266190|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14266191|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266192|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14266193|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14266194|NCT00381797|Growth Substances|growth substances|mesh-ancestor
14266195|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266196|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
14266197|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
14266198|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14266199|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14266200|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266201|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266202|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14266203|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14266204|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
14266205|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
14266206|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266207|NCT00381810|Acetaminophen|acetaminophen|mesh-list
15081833|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266208|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
14266209|NCT00381810|Promethazine|promethazine|mesh-list
14266210|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
14266211|NCT00381810|Rituximab|rituximab|mesh-list
14266212|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14266213|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266214|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
14266215|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266216|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266217|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14266218|NCT00381810|Analgesics|analgesics|mesh-ancestor
14266219|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
14266220|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266221|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
14266222|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266223|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
14266224|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
14266225|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14266226|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
13992676|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
14266227|NCT00381810|Hormones|hormones|mesh-ancestor
14266228|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266229|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14266230|NCT00381810|Protective Agents|protective agents|mesh-ancestor
14266231|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14536151|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
13992677|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13992678|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992679|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992680|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992681|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
13992682|NCT02945267|Tegafur|tegafur|mesh-list
13992683|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
13992684|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13992685|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
13992686|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992687|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992688|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992689|NCT02945241|Vancomycin|vancomycin|mesh-list
13992690|NCT02945241|Cystatins|cystatins|mesh-list
13992691|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13992692|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992693|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13992694|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992695|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992696|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992697|NCT02945163|Tenofovir|tenofovir|mesh-list
13992698|NCT02945163|Lamivudine|lamivudine|mesh-list
13992699|NCT02945163|Efavirenz|efavirenz|mesh-list
13992700|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
13992701|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992702|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13992703|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13992704|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992705|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992706|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13992707|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13992708|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13992709|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13992710|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13992711|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13992712|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13992713|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14023184|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266232|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14266233|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266234|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
14266235|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
14266236|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14266237|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
14266238|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
14266239|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266240|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266241|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14266242|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
14266243|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
14266244|NCT00381862|Leucovorin|leucovorin|mesh-list
14266245|NCT00381862|Dexamethasone|dexamethasone|mesh-list
14266246|NCT00381862|Fluorouracil|fluorouracil|mesh-list
14266247|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
14266248|NCT00381862|Irinotecan|irinotecan|mesh-list
14266249|NCT00381862|Camptothecin|camptothecin|mesh-list
14266250|NCT00381862|Aprepitant|aprepitant|mesh-list
14266251|NCT00381862|Palonosetron|palonosetron|mesh-list
14266252|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
14266253|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266254|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
14266255|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
14266256|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266257|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266258|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14266259|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
14266260|NCT00381862|Hormones|hormones|mesh-ancestor
14266261|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266262|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14266263|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266264|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
14266265|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266266|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266267|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266268|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
14266269|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13992714|NCT02945215|Rituximab|rituximab|mesh-list
13992715|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992716|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992717|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
13992718|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992719|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992720|NCT02945072|Sevoflurane|sevoflurane|mesh-list
13992721|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13992722|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13992723|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
13992724|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
13992725|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992726|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992727|NCT02944942|Anesthetics|anesthetics|mesh-list
13992728|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992729|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992730|NCT02945020|Simeprevir|simeprevir|mesh-list
13992731|NCT02945020|Odalasvir|odalasvir|mesh-list
13992732|NCT02945020|Dabigatran|dabigatran|mesh-list
13992733|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
13992734|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13992735|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992736|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992737|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992738|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
13992739|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
13992740|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266270|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14266271|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266272|NCT00381862|Antidotes|antidotes|mesh-ancestor
14266273|NCT00381862|Protective Agents|protective agents|mesh-ancestor
14266274|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
14266275|NCT00381862|Vitamins|vitamins|mesh-ancestor
14266276|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
14266277|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14266278|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266279|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14266280|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14266281|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
14266282|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14266283|NCT00381888|PENTA|penta|mesh-list
14266284|NCT00381888|Fondaparinux|fondaparinux|mesh-list
14266285|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14266286|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
14266287|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14266288|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14266289|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266290|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266291|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
14266292|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14266293|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14266294|NCT00381940|Bortezomib|bortezomib|mesh-list
14266295|NCT00381940|Vinorelbine|vinorelbine|mesh-list
14266296|NCT00381940|Ifosfamide|ifosfamide|mesh-list
14266297|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266298|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14266299|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
14266300|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
14266301|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
14266302|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266303|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14266304|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
14266305|NCT00382031|Zalutumumab|zalutumumab|mesh-list
14266306|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14266307|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14266308|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266309|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
14266310|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266311|NCT00382070|Letrozole|letrozole|mesh-list
14266312|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266313|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14266314|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14266315|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266316|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992741|NCT02944981|Gabapentin|gabapentin|mesh-list
13992742|NCT02944981|Analgesics|analgesics|mesh-ancestor
14266317|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14266318|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
13992743|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
13992744|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992745|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992746|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
13992747|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13992748|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13992749|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992750|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13992751|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13992752|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13992753|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992754|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266319|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266320|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266321|NCT00382109|Sirolimus|sirolimus|mesh-list
14266322|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
14266323|NCT00382109|Thiotepa|thiotepa|mesh-list
14266324|NCT00382109|Methotrexate|methotrexate|mesh-list
14266325|NCT00382109|Tacrolimus|tacrolimus|mesh-list
14266326|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266327|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
14266328|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266329|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266330|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14266331|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
14266332|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266333|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266334|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14536152|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14536153|NCT01058369|Deferasirox|deferasirox|mesh-list
14536154|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14536155|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
14536156|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
14536157|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536158|NCT01048723|Everolimus|everolimus|mesh-list
14536159|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536160|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536161|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
14536162|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536163|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
14536164|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14536165|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536166|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14536167|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
14536168|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14536169|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536170|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536171|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536172|NCT01038752|Suramin|suramin|mesh-list
14536173|NCT01038752|Carboplatin|carboplatin|mesh-list
14536174|NCT01038752|Docetaxel|docetaxel|mesh-list
14536175|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536176|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
14536177|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
14536178|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
14536179|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536180|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
14536181|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
14536182|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14536183|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536184|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14536185|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14536186|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14536187|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14536188|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14536189|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536190|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536191|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536192|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536193|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
14536194|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266335|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14536195|NCT01045694|Triamcinolone|triamcinolone|mesh-list
14536196|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13992755|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
13992756|NCT02945033|Aspirin|aspirin|mesh-list
13992757|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13992758|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13992759|NCT02945033|Analgesics|analgesics|mesh-ancestor
13992760|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
13992761|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992762|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992763|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992764|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992765|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13992766|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15081834|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081835|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15081836|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15081837|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081838|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15081839|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15081840|NCT04166409|Carboplatin|carboplatin|mesh-list
15081841|NCT04166409|Vincristine|vincristine|mesh-list
15081842|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081843|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081844|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081845|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081846|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081847|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081848|NCT04165096|Acetaminophen|acetaminophen|mesh-list
15081849|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
15081850|NCT04165096|Promethazine|promethazine|mesh-list
15081851|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
15081852|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081853|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081854|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15081855|NCT04165096|Analgesics|analgesics|mesh-ancestor
15081856|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
15081857|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081858|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081859|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
15081860|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15081861|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13992767|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992768|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13992769|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13992770|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992771|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
13992772|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
13992773|NCT02944825|Trimethoprim|trimethoprim|mesh-list
13992774|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
13992775|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13992776|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992777|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13992778|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14536197|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14536198|NCT01045694|Lidocaine|lidocaine|mesh-list
14536199|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
14536200|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14536201|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14536202|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14536203|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
14536204|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
14536205|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992779|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266336|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
14266337|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14266338|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266339|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
14266340|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
14266341|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266342|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14266343|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14266344|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14266345|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14266346|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266347|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14266348|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
14536206|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992780|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992781|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992782|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13992783|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13992784|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13992785|NCT02944825|Renal Agents|renal agents|mesh-ancestor
13992786|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
13992787|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13992788|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13992789|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13992790|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13992791|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13992792|NCT02944734|Amlodipine|amlodipine|mesh-list
13992793|NCT02944734|Candesartan|candesartan|mesh-list
13992794|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
13992795|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13992796|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14266349|NCT00382148|Omalizumab|omalizumab|mesh-list
14266350|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14266351|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14266352|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
14266353|NCT00382265|Tamsulosin|tamsulosin|mesh-list
14266354|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14536207|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
14536208|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536209|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14536210|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14536211|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14536212|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536213|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536214|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14536215|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14536216|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536217|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14536218|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536219|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
14536220|NCT01045694|Hormones|hormones|mesh-ancestor
14536221|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536222|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536223|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
14536224|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536225|NCT01035944|Chitosan|chitosan|mesh-list
14536226|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14536227|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536228|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
14536229|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536230|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536231|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
14536232|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
14536233|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
14536234|NCT01035944|Coagulants|coagulants|mesh-ancestor
14536235|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
14536236|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536237|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14536238|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536239|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081862|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081863|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
14536240|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14536241|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14536242|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15081864|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
15081865|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
15081866|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
15081867|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081868|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15081869|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
15081870|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
15081871|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081872|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081873|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15081874|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
13992797|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266355|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13992798|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992799|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13992800|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992801|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
14266356|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14266357|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
14266358|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266359|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266360|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266361|NCT00382265|Urological Agents|urological agents|mesh-ancestor
14266362|NCT00382590|Cytarabine|cytarabine|mesh-list
14266363|NCT00382590|Azacitidine|azacitidine|mesh-list
15081875|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
15081876|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
15081877|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081878|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081879|NCT04165070|Paclitaxel|paclitaxel|mesh-list
15081880|NCT04165070|Carboplatin|carboplatin|mesh-list
15081881|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
15081882|NCT04165070|Pemetrexed|pemetrexed|mesh-list
15081883|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081884|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081885|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081886|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081887|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081888|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081889|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081890|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081891|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15081892|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15081893|NCT04123067|Pioglitazone|pioglitazone|mesh-list
14266364|NCT00382590|Valproic Acid|valproic acid|mesh-list
14266365|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266366|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
14266367|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266368|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266369|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
14266370|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266371|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266372|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
14266373|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266374|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266375|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
14266376|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
14266377|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266378|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
14266379|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14266380|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266381|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266382|NCT00382720|Docetaxel|docetaxel|mesh-list
14266383|NCT00382720|Capecitabine|capecitabine|mesh-list
14266384|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
14266385|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266386|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14266387|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
14266388|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14266389|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266390|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266391|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
14266392|NCT00382733|Topotecan|topotecan|mesh-list
14266393|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14266394|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14266395|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266396|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266397|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266398|NCT00382824|Ubiquinone|ubiquinone|mesh-list
14266399|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
14536243|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15081894|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13992802|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13992803|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13992804|NCT02944227|Ranibizumab|ranibizumab|mesh-list
13992805|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13992806|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13992807|NCT02944227|Growth Substances|growth substances|mesh-ancestor
13992808|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992809|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
13992810|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992811|NCT02944292|Propofol|propofol|mesh-list
13992812|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13992813|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992814|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992815|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13992816|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
13992817|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
13992818|NCT02944357|Gemcitabine|gemcitabine|mesh-list
13992819|NCT02944357|Cisplatin|cisplatin|mesh-list
13992820|NCT02944357|Vaccines|vaccines|mesh-list
13992821|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992822|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13992823|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
13992824|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992825|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
13992826|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992827|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992828|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13992829|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
13992830|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266400|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
14266401|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266402|NCT00382824|Vitamins|vitamins|mesh-ancestor
14266403|NCT00382993|Naproxen|naproxen|mesh-list
14266404|NCT00382993|Sumatriptan|sumatriptan|mesh-list
14266405|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14266406|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14536244|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536245|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992831|NCT02944214|Febuxostat|febuxostat|mesh-list
13992832|NCT02944214|Benzbromarone|benzbromarone|mesh-list
13992833|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
13992834|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992835|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
13992836|NCT02944214|Renal Agents|renal agents|mesh-ancestor
13992837|NCT02944396|Paclitaxel|paclitaxel|mesh-list
14536246|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536247|NCT01035073|Analgesics|analgesics|mesh-ancestor
14536248|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
14536249|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536250|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
14536251|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14536252|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
14536253|NCT01031550|Propofol|propofol|mesh-list
14536254|NCT01031550|Isoflurane|isoflurane|mesh-list
14536255|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14536256|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536257|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536258|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13992838|NCT02944396|Carboplatin|carboplatin|mesh-list
13992839|NCT02944396|Nivolumab|nivolumab|mesh-list
13992840|NCT02944396|Pemetrexed|pemetrexed|mesh-list
13992841|NCT02944396|Veliparib|veliparib|mesh-list
14266407|NCT00382993|Analgesics|analgesics|mesh-ancestor
14266408|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
14266409|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266410|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266411|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266412|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266413|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
14266414|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14266415|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266416|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266417|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14266418|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14266419|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14266420|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
14266421|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266422|NCT00383019|Latanoprost|latanoprost|mesh-list
14266423|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14266424|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14266425|NCT00383149|Cetuximab|cetuximab|mesh-list
13992842|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992843|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536259|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
13992844|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
13992845|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
13992846|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
13992847|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992848|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992849|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13992850|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992851|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13992852|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14536260|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
14536261|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14536262|NCT01025271|Daptomycin|daptomycin|mesh-list
14536263|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14536264|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536265|NCT01022398|Vitamin D|vitamin d|mesh-list
14536266|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
14536267|NCT01022398|Vitamins|vitamins|mesh-ancestor
14536268|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
14536269|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536270|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14536271|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536272|NCT01019980|Acetaminophen|acetaminophen|mesh-list
14536273|NCT01019980|Diclofenac|diclofenac|mesh-list
14536274|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14536275|NCT01019980|Analgesics|analgesics|mesh-ancestor
14536276|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
14536277|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536278|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536279|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
14536280|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14536281|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536282|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536283|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14536284|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536285|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536286|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
14536287|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14536288|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536289|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
14536290|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536291|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536292|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14536293|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
14536294|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14536295|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536296|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14536297|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14536298|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536299|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536300|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
14536301|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642789|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642790|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14642791|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
14642792|NCT00187083|Hormones|hormones|mesh-ancestor
14642793|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642794|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14642795|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642796|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14642797|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
14642798|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642799|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642800|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
14642801|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642802|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642803|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642804|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642805|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642806|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
14642807|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642808|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642809|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642810|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13992853|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13992854|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
13992855|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13992856|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
13992857|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992858|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13992859|NCT02944526|Ropivacaine|ropivacaine|mesh-list
14536302|NCT01020903|Aprepitant|aprepitant|mesh-list
14536303|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
14536304|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
14536305|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536306|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536307|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14536308|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14536309|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536310|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992860|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
13992861|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
13992862|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13992863|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992864|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
13992865|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992866|NCT02944500|Liraglutide|liraglutide|mesh-list
13992867|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13992868|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992869|NCT02944500|Incretins|incretins|mesh-ancestor
13992870|NCT02944500|Hormones|hormones|mesh-ancestor
13992871|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992872|NCT02944201|Carvedilol|carvedilol|mesh-list
13992873|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13992874|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13992875|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
13992876|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992877|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992878|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992879|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13992880|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
13992881|NCT02944201|Protective Agents|protective agents|mesh-ancestor
13992882|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13992883|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13992884|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13992885|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
13992886|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13992887|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13992888|NCT02944123|Clopidogrel|clopidogrel|mesh-list
13992889|NCT02944123|Ticagrelor|ticagrelor|mesh-list
13992890|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13992891|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13992892|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13992893|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13992894|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13992895|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
13992896|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992897|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992898|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992899|NCT02944019|Edoxaban|edoxaban|mesh-list
13992900|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13992901|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
13992902|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14266426|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14536311|NCT01023620|Pioglitazone|pioglitazone|mesh-list
14536312|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14536313|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536314|NCT01018810|Interleukin-23|interleukin-23|mesh-list
14536315|NCT01018810|Antibodies|antibodies|mesh-list
14536316|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
14536317|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
14536318|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536319|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14536320|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14536321|NCT01018810|Growth Substances|growth substances|mesh-ancestor
14536322|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
14807790|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992903|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
13992904|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992905|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266427|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266428|NCT00383162|Naproxen|naproxen|mesh-list
14266429|NCT00383162|Sumatriptan|sumatriptan|mesh-list
14266430|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14266431|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14266432|NCT00383162|Analgesics|analgesics|mesh-ancestor
14266433|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
14266434|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266435|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266436|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266437|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266438|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
14266439|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14266440|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266441|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266442|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14266443|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14266444|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14266445|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
14266446|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266447|NCT00383266|Carboplatin|carboplatin|mesh-list
14266448|NCT00383266|Pemetrexed|pemetrexed|mesh-list
14266449|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266450|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266451|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266452|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14266453|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14266454|NCT00383331|Gemcitabine|gemcitabine|mesh-list
14266455|NCT00383331|Pemetrexed|pemetrexed|mesh-list
14266456|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266457|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
14266458|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266459|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266460|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
14266461|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266462|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266463|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266464|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
14266465|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266466|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14266467|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14266468|NCT00383448|Cyclosporine|cyclosporine|mesh-list
14266469|NCT00383448|Melphalan|melphalan|mesh-list
14266470|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
14266471|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
14266472|NCT00383448|Clofarabine|clofarabine|mesh-list
14266473|NCT00383448|Cyclosporins|cyclosporins|mesh-list
14266474|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266475|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266476|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266477|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
14266478|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266479|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
14266480|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266481|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
14266482|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266483|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14266484|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14266485|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
14536323|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536324|NCT01016561|Cisplatin|cisplatin|mesh-list
14536325|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536326|NCT01016847|Montelukast|montelukast|mesh-list
14536327|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14536328|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
14536329|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14536330|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
14536331|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266486|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266487|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14536332|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266488|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13992906|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
13992907|NCT02944175|Neostigmine|neostigmine|mesh-list
13992908|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14266489|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
14266490|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14266491|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266492|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
14266493|NCT00383565|Romidepsin|romidepsin|mesh-list
14266494|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14266495|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266496|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
14266497|NCT00383643|Zolpidem|zolpidem|mesh-list
14266498|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14266499|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14266500|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266501|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266502|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14266503|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
14266504|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
14266505|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266506|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266507|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14266508|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14266509|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
14266510|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
14266511|NCT00383747|Nicotine|nicotine|mesh-list
14266512|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14266513|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
14266514|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266515|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266516|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14266517|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14266518|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
14266519|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266520|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266521|NCT00383786|Vofopitant|vofopitant|mesh-list
14266522|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
14266523|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
14266524|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266525|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266526|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14266527|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14266528|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266529|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266530|NCT00383942|Misoprostol|misoprostol|mesh-list
14266531|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14536333|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14536334|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14536335|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536336|NCT01014767|Leucovorin|leucovorin|mesh-list
14536337|NCT01014767|Dactinomycin|dactinomycin|mesh-list
14536338|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
14536339|NCT01014767|Temozolomide|temozolomide|mesh-list
14536340|NCT01014767|Cisplatin|cisplatin|mesh-list
14536341|NCT01014767|Carboplatin|carboplatin|mesh-list
14807791|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
14807792|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807793|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14807794|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14807795|NCT00823563|Adenosine|adenosine|mesh-list
13992909|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992910|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992911|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
13992912|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13992913|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992914|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13992915|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
13992916|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992917|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
13992918|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13992919|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13992920|NCT02944045|Prednisolone|prednisolone|mesh-list
13992921|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
14807796|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
14266532|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
14536342|NCT01014767|Doxorubicin|doxorubicin|mesh-list
14807797|NCT00823563|Analgesics|analgesics|mesh-ancestor
13992922|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13992923|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
13992924|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992925|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
13992926|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
13992927|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992928|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992929|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13992930|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
13992931|NCT02944045|Hormones|hormones|mesh-ancestor
13992932|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992933|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13992934|NCT02944045|Protective Agents|protective agents|mesh-ancestor
13992935|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13992936|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992937|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
13992938|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13992939|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13992940|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13992941|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
13992942|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
13992943|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13992944|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13992945|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13992946|NCT02944110|Glucagon|glucagon|mesh-list
13992947|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13992948|NCT02944110|Hormones|hormones|mesh-ancestor
13992949|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13992950|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992951|NCT02943993|Edoxaban|edoxaban|mesh-list
13992952|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13992953|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
13992954|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14266533|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14266534|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081895|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081896|NCT04120246|Acetic Acid|acetic acid|mesh-list
15081897|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15081898|NCT04120246|Trastuzumab|trastuzumab|mesh-list
15081899|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14266535|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14266536|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14266537|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
14266538|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14266539|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14266540|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14266541|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14266542|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266543|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266544|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266545|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266546|NCT00384033|Analgesics|analgesics|mesh-ancestor
14266547|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
14266548|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266549|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
14266550|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266551|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
14536343|NCT01014767|Methotrexate|methotrexate|mesh-list
15081900|NCT04120246|Antibodies|antibodies|mesh-list
15081901|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
14536344|NCT01014767|Irinotecan|irinotecan|mesh-list
14536345|NCT01014767|Etoposide|etoposide|mesh-list
14536346|NCT01014767|Vincristine|vincristine|mesh-list
14536347|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536348|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
14536349|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536350|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536351|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14536352|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
14536353|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536354|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536355|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15081902|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15081903|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
15081904|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992955|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
15081905|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081906|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15081907|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081908|NCT04110080|Anesthetics|anesthetics|mesh-list
15081909|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081910|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081911|NCT04101357|Carboplatin|carboplatin|mesh-list
15081912|NCT04101357|Etoposide|etoposide|mesh-list
15081913|NCT04101357|Atezolizumab|atezolizumab|mesh-list
15081914|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081915|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081916|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15081917|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15081918|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081919|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081920|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15081921|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081922|NCT04092283|Paclitaxel|paclitaxel|mesh-list
15081923|NCT04092283|Etoposide|etoposide|mesh-list
15081924|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
15081925|NCT04092283|Cisplatin|cisplatin|mesh-list
13992956|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992957|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992958|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
13992959|NCT02943798|Paclitaxel|paclitaxel|mesh-list
13992960|NCT02943798|Etoposide|etoposide|mesh-list
13992961|NCT02943798|Carboplatin|carboplatin|mesh-list
13992962|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13992963|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992964|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
13992965|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
13992966|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
13992967|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13992968|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13992969|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13992970|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992971|NCT02943902|Vaccines|vaccines|mesh-list
13992972|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13992973|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
13992974|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992975|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
13992976|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13992977|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
13992978|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
13992979|NCT02943655|Progesterone|progesterone|mesh-list
13992980|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13992981|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13992982|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13992983|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13992984|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13992985|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13992986|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13992987|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13992988|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13992989|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13992990|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13992991|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13992992|NCT02943655|Analgesics|analgesics|mesh-ancestor
13992993|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
13992994|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13992995|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13992996|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13992997|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13992998|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13992999|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993000|NCT02943655|Progestins|progestins|mesh-ancestor
13993001|NCT02943655|Hormones|hormones|mesh-ancestor
13993002|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023185|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023186|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14023187|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023188|NCT02763722|Emollients|emollients|mesh-list
14023189|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023190|NCT02763592|Lidocaine|lidocaine|mesh-list
15081926|NCT04092283|Carboplatin|carboplatin|mesh-list
15081927|NCT04092283|Pemetrexed|pemetrexed|mesh-list
13993003|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
13993004|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993005|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993006|NCT02943369|Ticagrelor|ticagrelor|mesh-list
13993007|NCT02943369|Cangrelor|cangrelor|mesh-list
13993008|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13993009|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14536356|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14536357|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14536358|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14536359|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536360|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14536361|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
14536362|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14536363|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14536364|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
14536365|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14536366|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14536367|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14536368|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14536369|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14536370|NCT01014767|Antidotes|antidotes|mesh-ancestor
14536371|NCT01014767|Protective Agents|protective agents|mesh-ancestor
14536372|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
14536373|NCT01014767|Vitamins|vitamins|mesh-ancestor
14536374|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
14536375|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
14536376|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
14536377|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
14536378|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14536379|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536380|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14536381|NCT01013701|Fluticasone|fluticasone|mesh-list
14536382|NCT01013701|Xhance|xhance|mesh-list
14536383|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536384|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14536385|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
14536386|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536387|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536388|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14536389|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
14536390|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14536391|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14536392|NCT01009931|Dexamethasone|dexamethasone|mesh-list
14536393|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
14536394|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
14536395|NCT01009931|Choline|choline|mesh-list
14536396|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14536397|NCT01009931|BB 1101|bb 1101|mesh-list
14536398|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536399|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
14536400|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
14536401|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536402|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536403|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14536404|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
14536405|NCT01009931|Hormones|hormones|mesh-ancestor
14536406|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536407|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536408|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536409|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
14536410|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536411|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536412|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
14536413|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536414|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
14536415|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536416|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
14536417|NCT01009931|Analgesics|analgesics|mesh-ancestor
14536418|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
14536419|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14536420|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14536421|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266552|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13993010|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14536422|NCT01006018|Pioglitazone|pioglitazone|mesh-list
14536423|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13993011|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13993012|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
15081928|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15081929|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
15081930|NCT04092283|Durvalumab|durvalumab|mesh-list
15081931|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
15081932|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15081933|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
15081934|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081935|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081936|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081937|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081938|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081939|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081940|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15081941|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15081942|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081943|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15081944|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15081945|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081946|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
15081947|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993013|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993014|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993015|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993016|NCT02943317|Avelumab|avelumab|mesh-list
13993017|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993018|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993019|NCT02943642|Vorinostat|vorinostat|mesh-list
13993020|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993021|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13993022|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993023|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993024|NCT02943356|Tadalafil|tadalafil|mesh-list
13993025|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
13993026|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13993027|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13993028|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536424|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14536425|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993029|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993030|NCT02943356|Urological Agents|urological agents|mesh-ancestor
13993031|NCT02943252|Apatinib|apatinib|mesh-list
13993032|NCT02943252|Tegafur|tegafur|mesh-list
13993033|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266553|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
14266554|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266555|NCT00384085|Insulin|insulin|mesh-list
14266556|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14266557|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
14266558|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
14266559|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14266560|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266561|NCT00384176|Leucovorin|leucovorin|mesh-list
14266562|NCT00384176|Bevacizumab|bevacizumab|mesh-list
14266563|NCT00384176|Fluorouracil|fluorouracil|mesh-list
14266564|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
15081948|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
15081949|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
13993034|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13993035|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993036|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993037|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993038|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
13993039|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
13993040|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13993041|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993042|NCT02943135|Lidocaine|lidocaine|mesh-list
13993043|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
13993044|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
13993045|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993046|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993047|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
13993048|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993049|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13993050|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14536426|NCT01006018|Incretins|incretins|mesh-ancestor
14536427|NCT01006018|Hormones|hormones|mesh-ancestor
14536428|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536429|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14536430|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
14536431|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536432|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536433|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
14536434|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14536435|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536436|NCT01005914|Cytarabine|cytarabine|mesh-list
14536437|NCT01005914|Dexamethasone|dexamethasone|mesh-list
15081950|NCT04092270|Doxorubicin|doxorubicin|mesh-list
15081951|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15081952|NCT04092270|Peposertib|peposertib|mesh-list
15081953|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15081954|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536438|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
14536439|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14536440|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14536441|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
14536442|NCT01005914|Doxorubicin|doxorubicin|mesh-list
14536443|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15081955|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15081956|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15081957|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081958|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081959|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081960|NCT04091126|Dexamethasone|dexamethasone|mesh-list
15081961|NCT04091126|Lenalidomide|lenalidomide|mesh-list
15081962|NCT04091126|Bortezomib|bortezomib|mesh-list
15081963|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081964|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
15081965|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
15081966|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266565|NCT00384176|Cediranib|cediranib|mesh-list
14266566|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14266567|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266568|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14266569|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14266570|NCT00384176|Growth Substances|growth substances|mesh-ancestor
14266571|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266572|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
15081967|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081968|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081969|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
15081970|NCT04091126|Hormones|hormones|mesh-ancestor
15081971|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081972|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081973|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081974|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
15081975|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15081976|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15081977|NCT04091126|Growth Substances|growth substances|mesh-ancestor
15081978|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
14266573|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
14292331|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081979|NCT04079621|Primaquine|primaquine|mesh-list
13993051|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13993052|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13993053|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993054|NCT02943057|Ganciclovir|ganciclovir|mesh-list
13993055|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13993056|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
13993057|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993058|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13993059|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993060|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993061|NCT02942888|Niacinamide|niacinamide|mesh-list
13993062|NCT02942888|Niacin|niacin|mesh-list
13993063|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
13993064|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
13993065|NCT02942888|Vitamins|vitamins|mesh-ancestor
13993066|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
13993067|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993068|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13993069|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
13993070|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993071|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13993072|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
13993073|NCT02942810|Cefepime|cefepime|mesh-list
13993074|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13993075|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993076|NCT02942680|Aspirin|aspirin|mesh-list
13993077|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13993078|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13993079|NCT02942680|Analgesics|analgesics|mesh-ancestor
13993080|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
13993081|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993082|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993083|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993084|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993085|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14292332|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
14536444|NCT01005914|Methotrexate|methotrexate|mesh-list
14536445|NCT01005914|Vincristine|vincristine|mesh-list
14536446|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
14536447|NCT01005914|Asparaginase|asparaginase|mesh-list
14536448|NCT01005914|Pegaspargase|pegaspargase|mesh-list
14536449|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536450|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
14536451|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536452|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536453|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14536454|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
14536455|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536456|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536457|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14536458|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536459|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
14536460|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
14536461|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081980|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
15081981|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15081982|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15081983|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081984|NCT04072042|Apatinib|apatinib|mesh-list
15081985|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536462|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14536463|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
13993086|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14023191|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
14536464|NCT01005914|Hormones|hormones|mesh-ancestor
15081986|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081987|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081988|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081989|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
15081990|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15081991|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081992|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081993|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15081994|NCT04042727|Analgesics|analgesics|mesh-ancestor
15081995|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
15081996|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081997|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15081998|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15081999|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15082000|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
15082001|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082002|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082003|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
15082004|NCT04042155|Apixaban|apixaban|mesh-list
15082005|NCT04042155|Edoxaban|edoxaban|mesh-list
15082006|NCT04042155|Dabigatran|dabigatran|mesh-list
15082007|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15082008|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
13993087|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993088|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13993089|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13993090|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993091|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
13993092|NCT02942693|Apatinib|apatinib|mesh-list
13993093|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993094|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13993095|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993096|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993097|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
13993098|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13993099|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993100|NCT02942732|Vitamins|vitamins|mesh-ancestor
13993101|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
13993102|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14266574|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266575|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14536465|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536466|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536467|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14536468|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14536469|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14536470|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536471|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14536472|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
14536473|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14536474|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14536475|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
14536476|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
14536477|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14536478|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14536479|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
14536480|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536481|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082009|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15082010|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
15082011|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082012|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082013|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
15082014|NCT04029480|Metformin|metformin|mesh-list
15082015|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
15082016|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15082017|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082018|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14266576|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266577|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
14266578|NCT00384176|Antidotes|antidotes|mesh-ancestor
14266579|NCT00384176|Protective Agents|protective agents|mesh-ancestor
14266580|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
14266581|NCT00384176|Vitamins|vitamins|mesh-ancestor
13993103|NCT02942758|Pioglitazone|pioglitazone|mesh-list
13993104|NCT02942758|Azacitidine|azacitidine|mesh-list
13993105|NCT02942758|Tretinoin|tretinoin|mesh-list
13993106|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993107|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
13993108|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993109|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993110|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993111|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13993112|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993113|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
13993114|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
13993115|NCT02942563|Capecitabine|capecitabine|mesh-list
13993116|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
13993117|NCT02942563|Irinotecan|irinotecan|mesh-list
13993118|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993119|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
13993120|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993121|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993122|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13993123|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13993124|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993125|NCT02942420|Bucillamine|bucillamine|mesh-list
14536482|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14536483|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14536484|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14536485|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14536486|NCT01005914|Protective Agents|protective agents|mesh-ancestor
14536487|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14536488|NCT00996333|Gemcitabine|gemcitabine|mesh-list
14536489|NCT00996333|Capecitabine|capecitabine|mesh-list
14536490|NCT00996333|Docetaxel|docetaxel|mesh-list
14536491|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14536492|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
14536493|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536494|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536495|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
14536496|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536497|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536498|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536499|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
14536500|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536501|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
13993126|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13993127|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13993128|NCT02942420|Analgesics|analgesics|mesh-ancestor
13993129|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
13993130|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536502|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14536503|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14536504|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
14536505|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
14536506|NCT00998738|Calcium|calcium|mesh-list
14536507|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536508|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536509|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14536510|NCT00998738|Analgesics|analgesics|mesh-ancestor
14536511|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
14536512|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536513|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
14536514|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536515|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14536516|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
14536517|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14536518|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536519|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536520|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
14536521|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14536522|NCT00996502|Prednisone|prednisone|mesh-list
14536523|NCT00996502|Bevacizumab|bevacizumab|mesh-list
14536524|NCT00996502|Docetaxel|docetaxel|mesh-list
15172938|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13993131|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993132|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993133|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536525|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14536526|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993134|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
13993135|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993136|NCT02942420|Protective Agents|protective agents|mesh-ancestor
13993137|NCT02942706|Cetuximab|cetuximab|mesh-list
13993138|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993139|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993140|NCT02942498|Vitamins|vitamins|mesh-list
13993141|NCT02942498|Ascorbic Acid|ascorbic acid|mesh-list
13993142|NCT02942498|Vitamin E|vitamin e|mesh-list
13993143|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
13993144|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993145|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
13993146|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993147|NCT02942498|Protective Agents|protective agents|mesh-ancestor
13993148|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
13993149|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
13993150|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13993151|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14536527|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536528|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14536529|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14536530|NCT00996502|Growth Substances|growth substances|mesh-ancestor
14536531|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536532|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
14536533|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
14536534|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
14536535|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
14536536|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536537|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536538|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
14536539|NCT00996502|Hormones|hormones|mesh-ancestor
14536540|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536541|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536542|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14536543|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536544|NCT00997386|Melphalan|melphalan|mesh-list
14536545|NCT00997386|Busulfan|busulfan|mesh-list
14536546|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
14536547|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14536548|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
14536549|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536550|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536551|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14536552|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536553|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
14536554|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536555|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14536556|NCT00985738|Dutasteride|dutasteride|mesh-list
14536557|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14536558|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14536559|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536560|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536561|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
14536562|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536563|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536564|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14536565|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14536566|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536567|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
14536568|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536569|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536570|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14536571|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536572|NCT00989937|Oxytocin|oxytocin|mesh-list
14536573|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
14536574|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14536575|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536576|NCT00986947|Rituximab|rituximab|mesh-list
14536577|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14536578|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536579|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
13993152|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993153|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993154|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993155|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993156|NCT02942550|Bromides|bromides|mesh-list
13993157|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
13993158|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
14266582|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
14266583|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14266584|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266585|NCT00384189|Ciclesonide|ciclesonide|mesh-list
14266586|NCT00384189|Albuterol|albuterol|mesh-list
14266587|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14266588|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
14266589|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266590|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266591|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14266592|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
14266593|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
14266594|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14266595|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14266596|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14266597|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14266598|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
14266599|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266600|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536580|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536581|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15082019|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082020|NCT04014387|Zolpidem|zolpidem|mesh-list
15082021|NCT04014387|Suvorexant|suvorexant|mesh-list
14536582|NCT00982995|Palonosetron|palonosetron|mesh-list
14536583|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
14536584|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
14536585|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536586|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536587|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14536588|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14536589|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14536590|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
14536591|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536592|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536593|NCT00984490|Metformin|metformin|mesh-list
14536594|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14536595|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536596|NCT00986310|Fluoxetine|fluoxetine|mesh-list
14536597|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14536598|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14536599|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536600|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536601|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536602|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
14536603|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536604|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14536605|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
15082022|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13993159|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13993160|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993161|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
13993162|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993163|NCT02942602|Atorvastatin|atorvastatin|mesh-list
13993164|NCT02942602|Ezetimibe|ezetimibe|mesh-list
13993165|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
13993166|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13993167|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13993168|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
13993169|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993170|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13993171|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13993172|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993173|NCT02942329|Apatinib|apatinib|mesh-list
13993174|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993175|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13993176|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993177|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993178|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13993179|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13993180|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13993181|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993182|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
13993183|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993184|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993185|NCT02942212|Nicotine|nicotine|mesh-list
13993186|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13993187|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
13993188|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993189|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993190|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13993191|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13993192|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
13993193|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993194|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993195|NCT02942043|Bevacizumab|bevacizumab|mesh-list
13993196|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993197|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993198|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13993199|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13993200|NCT02942043|Growth Substances|growth substances|mesh-ancestor
13993201|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993202|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
13993203|NCT02941913|Palonosetron|palonosetron|mesh-list
13993204|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
13993205|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
13993206|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993207|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993208|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13993209|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13993210|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13993211|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
13993212|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536606|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14536607|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14536608|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14536609|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536610|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14536611|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14536612|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536613|NCT00983645|Cyclosporine|cyclosporine|mesh-list
14536614|NCT00983645|Tacrolimus|tacrolimus|mesh-list
14536615|NCT00983645|Cyclosporins|cyclosporins|mesh-list
14536616|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536617|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
14536618|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536619|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14536620|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536621|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536622|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
14536623|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536624|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
14536625|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536626|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14536627|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14536628|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536629|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
14536630|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536631|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536632|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14536633|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536634|NCT00979550|Imiquimod|imiquimod|mesh-list
14536635|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14536636|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
14536637|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536638|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536639|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
14536640|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
14536641|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14536642|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536643|NCT00981370|Deferasirox|deferasirox|mesh-list
14536644|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14536645|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
14536646|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
13993213|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023192|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
14023193|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023194|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023195|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
14023196|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023197|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14023198|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14023199|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14023200|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14023201|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023202|NCT02763761|Prednisone|prednisone|mesh-list
14023203|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
14266601|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
14266602|NCT00384189|Hormones|hormones|mesh-ancestor
14266603|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266604|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14266605|NCT00384332|Olanzapine|olanzapine|mesh-list
14266606|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
14266607|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
14266608|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266609|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266610|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14266611|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14266612|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14266613|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266614|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266615|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14266616|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14266617|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266618|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266619|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266620|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
14266621|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14536647|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536648|NCT00975611|Amantadine|amantadine|mesh-list
14536649|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14536650|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14536651|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
14536652|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536653|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
14536654|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536655|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536656|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536657|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14536658|NCT00975611|Analgesics|analgesics|mesh-ancestor
14536659|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
14536660|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536661|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15082023|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15082024|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15082025|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082026|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15082027|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
15082028|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
15082029|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082030|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082031|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15082032|NCT03993912|Dexamethasone|dexamethasone|mesh-list
15082033|NCT03993912|Lenalidomide|lenalidomide|mesh-list
15082034|NCT03993912|Daratumumab|daratumumab|mesh-list
15082035|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082036|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
15082037|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
15082038|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082039|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082040|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15082041|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
15082042|NCT03993912|Hormones|hormones|mesh-ancestor
15082043|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082044|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082045|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082046|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
13993214|NCT02941575|Methamphetamine|methamphetamine|mesh-list
13993215|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13993216|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993217|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
13993218|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
13993219|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993220|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
13993221|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993222|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993223|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
13993224|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13993225|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13993226|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13993227|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13993228|NCT02941562|Leucovorin|leucovorin|mesh-list
13993229|NCT02941562|Fluorouracil|fluorouracil|mesh-list
13993230|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
13993231|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
13993232|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993233|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993234|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993235|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993236|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
13993237|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993238|NCT02941562|Antidotes|antidotes|mesh-ancestor
13993239|NCT02941562|Protective Agents|protective agents|mesh-ancestor
13993240|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
13993241|NCT02941562|Vitamins|vitamins|mesh-ancestor
13993242|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
13993243|NCT02941731|Oseltamivir|oseltamivir|mesh-list
13993244|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
13993245|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536662|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14536663|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536664|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
14536665|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536666|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536667|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14536668|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536669|NCT00979810|Alovudine|alovudine|mesh-list
14536670|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
14536671|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536672|NCT00974922|Vitamin D|vitamin d|mesh-list
14536673|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
14536674|NCT00974922|Vitamins|vitamins|mesh-ancestor
14536675|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
14536676|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536677|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14536678|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536679|NCT00976339|Vitamin D|vitamin d|mesh-list
14536680|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
14536681|NCT00976339|Vitamins|vitamins|mesh-ancestor
14536682|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
14536683|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536684|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14536685|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536686|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14536687|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14536688|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
14536689|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536690|NCT00957827|Cephalexin|cephalexin|mesh-list
14536691|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14266622|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
14266623|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266624|NCT00384449|Ranibizumab|ranibizumab|mesh-list
14266625|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14266626|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14266627|NCT00384449|Growth Substances|growth substances|mesh-ancestor
14266628|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266629|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
14266630|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266631|NCT00384670|Vaccines|vaccines|mesh-list
14536692|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266632|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
14536693|NCT00953329|Alefacept|alefacept|mesh-list
14536694|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
14536695|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
13993246|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993247|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993248|NCT02941744|Nivolumab|nivolumab|mesh-list
13993249|NCT02941744|Ipilimumab|ipilimumab|mesh-list
13993250|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993251|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993252|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13993253|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993254|NCT02941822|Ambroxol|ambroxol|mesh-list
13993255|NCT02941822|Expectorants|expectorants|mesh-ancestor
13993256|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
13993257|NCT02941445|Metformin|metformin|mesh-list
13993258|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13993259|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13993260|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993261|NCT02941445|Incretins|incretins|mesh-ancestor
13993262|NCT02941445|Hormones|hormones|mesh-ancestor
13993263|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993264|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13993265|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
13993266|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993267|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993268|NCT02941510|Budesonide|budesonide|mesh-list
13993269|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993270|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13993271|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
13993272|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993273|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993274|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13993275|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
14266633|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266634|NCT00384774|Lasmiditan|lasmiditan|mesh-list
14536696|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536697|NCT00965055|Atorvastatin|atorvastatin|mesh-list
14536698|NCT00965055|Ezetimibe|ezetimibe|mesh-list
14536699|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14536700|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14536701|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
14536702|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536703|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14536704|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14536705|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536706|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
14536707|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
14536708|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536709|NCT00962429|Protective Agents|protective agents|mesh-ancestor
14536710|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536711|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
14536712|NCT00962429|Vitamins|vitamins|mesh-ancestor
14536713|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
14536714|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14536715|NCT00966654|Incretins|incretins|mesh-ancestor
14536716|NCT00966654|Hormones|hormones|mesh-ancestor
14536717|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536718|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536719|NCT00954187|Pregabalin|pregabalin|mesh-list
14536720|NCT00954187|Gabapentin|gabapentin|mesh-list
14536721|NCT00954187|Analgesics|analgesics|mesh-ancestor
14536722|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
14536723|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536724|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536725|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
14536726|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14536727|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14536728|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536729|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536730|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14536731|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14536732|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536733|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14536734|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14536735|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14536736|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536737|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
14536738|NCT00953615|Thalidomide|thalidomide|mesh-list
13993276|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
13993277|NCT02941510|Hormones|hormones|mesh-ancestor
13993278|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993279|NCT02941601|Gemcitabine|gemcitabine|mesh-list
13993280|NCT02941601|Carboplatin|carboplatin|mesh-list
13993281|NCT02941601|Necitumumab|necitumumab|mesh-list
13993282|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993283|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993284|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
13993285|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993286|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
13993287|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993288|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993289|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993290|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
13993291|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993292|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993293|NCT02941367|Metformin|metformin|mesh-list
13993294|NCT02941367|Lixisenatide|lixisenatide|mesh-list
13993295|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13993296|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993297|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
13993298|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13993299|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993300|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993301|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
13993302|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993303|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536739|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536740|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
14536741|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536742|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
14536743|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14536744|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536745|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14536746|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14536747|NCT00953615|Growth Substances|growth substances|mesh-ancestor
14536748|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
14536749|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536750|NCT00947284|Nalbuphine|nalbuphine|mesh-list
14536751|NCT00947284|Naloxone|naloxone|mesh-list
14536752|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14536753|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536754|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
14536755|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993304|NCT02941315|Captopril|captopril|mesh-list
13993305|NCT02941315|Spironolactone|spironolactone|mesh-list
14536756|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14536757|NCT00947284|Narcotics|narcotics|mesh-ancestor
14536758|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536759|NCT00947284|Analgesics|analgesics|mesh-ancestor
14536760|NCT00957034|Testosterone|testosterone|mesh-list
14536761|NCT00957034|Androgens|androgens|mesh-ancestor
14536762|NCT00957034|Hormones|hormones|mesh-ancestor
14536763|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536764|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536765|NCT00949988|Rituximab|rituximab|mesh-list
14536766|NCT00949988|Dasatinib|dasatinib|mesh-list
14536767|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14536768|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536769|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
14536770|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536771|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536772|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14536773|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536774|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536775|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
14536776|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14536777|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
14536778|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536779|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536780|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14536781|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
14536782|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14536783|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
13993306|NCT02941315|Furosemide|furosemide|mesh-list
13993307|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13993308|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13993309|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
13993310|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993311|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993312|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13993313|NCT02941315|Diuretics|diuretics|mesh-ancestor
13993314|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
13993315|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13993316|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
13993317|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993318|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993319|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13993320|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
13993321|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993322|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13993323|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13993324|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13993325|NCT02941224|Sirolimus|sirolimus|mesh-list
13993326|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13993327|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993328|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13993329|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993330|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
13993331|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993332|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
13993333|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993334|NCT02941198|Copper|copper|mesh-list
13993335|NCT02941198|Trace Elements|trace elements|mesh-ancestor
13993336|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
13993337|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993338|NCT02940990|Gemcitabine|gemcitabine|mesh-list
13993339|NCT02940990|Paclitaxel|paclitaxel|mesh-list
13993340|NCT02940990|Etoposide|etoposide|mesh-list
13993341|NCT02940990|Vinorelbine|vinorelbine|mesh-list
14266635|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14536784|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536785|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536786|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15082047|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15082048|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082049|NCT03993912|Growth Substances|growth substances|mesh-ancestor
14536787|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
14536788|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
14536789|NCT00948194|Protective Agents|protective agents|mesh-ancestor
14536790|NCT00946985|Risperidone|risperidone|mesh-list
14807798|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
14807799|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807800|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807801|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807802|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
14807803|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14807804|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
14807805|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
14807806|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807807|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807808|NCT00823576|Ropivacaine|ropivacaine|mesh-list
14807809|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
14807810|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
14807811|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807812|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807813|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
14807814|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807815|NCT00823602|Buserelin|buserelin|mesh-list
14807816|NCT00823602|Ganirelix|ganirelix|mesh-list
14807817|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
14807818|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14807819|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807820|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14807821|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
15082050|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
13993342|NCT02940990|Docetaxel|docetaxel|mesh-list
13993343|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13993344|NCT02940990|Carboplatin|carboplatin|mesh-list
13993345|NCT02940990|Pemetrexed|pemetrexed|mesh-list
13993346|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13993347|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993348|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
13993349|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
13993350|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
13993351|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993352|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993353|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
13993354|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
13993355|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993356|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993357|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993358|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
13993359|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993360|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13993361|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13993362|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13993363|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13993364|NCT02940925|Cisplatin|cisplatin|mesh-list
13993365|NCT02940925|Fluorouracil|fluorouracil|mesh-list
13993366|NCT02940925|Capecitabine|capecitabine|mesh-list
13993367|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993368|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
13993369|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993370|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993371|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993372|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
13993373|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993374|NCT02941016|Evolocumab|evolocumab|mesh-list
13993375|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13993376|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13993377|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
13993378|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993379|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13993380|NCT02940912|Apomorphine|apomorphine|mesh-list
13993381|NCT02940912|Emetics|emetics|mesh-ancestor
13993382|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993383|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
13993384|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993385|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13993386|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
13993387|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
13993388|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993389|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993390|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13993391|NCT02940821|Fluorides|fluorides|mesh-list
14266636|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
14266637|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266638|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266639|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266640|NCT00384839|Azacitidine|azacitidine|mesh-list
14266641|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14536791|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14536792|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14536793|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
14536794|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536795|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536796|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536797|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14266642|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
14266643|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266644|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266645|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266646|NCT00384865|Aspirin|aspirin|mesh-list
14266647|NCT00384865|Simvastatin|simvastatin|mesh-list
14266648|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14266649|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14266650|NCT00384865|Analgesics|analgesics|mesh-ancestor
14266651|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
14266652|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266653|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266654|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536798|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14266655|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266656|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14266657|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13993392|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
13993393|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
13993394|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
13993395|NCT02940821|Protective Agents|protective agents|mesh-ancestor
13993396|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993397|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13993398|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993399|NCT02940808|Caffeine|caffeine|mesh-list
13993400|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13993401|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993402|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13993403|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993404|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536799|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536800|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14536801|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14536802|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
14536803|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14536804|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14642811|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642812|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642813|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642814|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642815|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14642816|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14642817|NCT00187122|Cytarabine|cytarabine|mesh-list
14642818|NCT00187122|Dexamethasone|dexamethasone|mesh-list
14642819|NCT00187122|Prednisone|prednisone|mesh-list
14642820|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
14642821|NCT00187122|Methotrexate|methotrexate|mesh-list
14642822|NCT00187122|Etoposide|etoposide|mesh-list
14642823|NCT00187122|Vincristine|vincristine|mesh-list
14642824|NCT00187122|Asparaginase|asparaginase|mesh-list
14642825|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
14642826|NCT00187122|Daunorubicin|daunorubicin|mesh-list
14642827|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642828|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
14642829|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642830|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642831|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642832|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
14642833|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642834|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642835|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642836|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642837|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
14642838|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
14642839|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642840|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14642841|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
14642842|NCT00187122|Hormones|hormones|mesh-ancestor
14642843|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642844|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14642845|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14642846|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
14642847|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642848|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642849|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
14642850|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642851|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642852|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642853|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642854|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642855|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14642856|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642857|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
14642858|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642859|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
13993405|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14642860|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642861|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
13993406|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14642862|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13993407|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
13993408|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993409|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
13993410|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
14266658|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266659|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14266660|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14266661|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266662|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
14266663|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14266664|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14266665|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
14266666|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14266667|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14266668|NCT00384930|Tadalafil|tadalafil|mesh-list
14266669|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
14266670|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14266671|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14266672|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266673|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266674|NCT00384930|Urological Agents|urological agents|mesh-ancestor
14266675|NCT00384956|Azacitidine|azacitidine|mesh-list
14266676|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266677|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
14266678|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266679|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266680|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266681|NCT00385008|Naproxen|naproxen|mesh-list
14266682|NCT00385008|Sumatriptan|sumatriptan|mesh-list
14266683|NCT00385008|Eletriptan|eletriptan|mesh-list
14266684|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14266685|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14266686|NCT00385008|Analgesics|analgesics|mesh-ancestor
14266687|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
14266688|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266689|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266690|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266691|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266692|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
14266693|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14266694|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266695|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266696|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14266697|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14266698|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14266699|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
14536805|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14536806|NCT00950690|Latanoprost|latanoprost|mesh-list
14536807|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14536808|NCT00941928|Vidarabine|vidarabine|mesh-list
14536809|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
14536810|NCT00941928|Fludarabine|fludarabine|mesh-list
14536811|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
14536812|NCT00941928|Interleukin-2|interleukin-2|mesh-list
15082051|NCT03970096|Cyclosporine|cyclosporine|mesh-list
15082052|NCT03970096|Sirolimus|sirolimus|mesh-list
15082053|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
15082054|NCT03970096|Busulfan|busulfan|mesh-list
15082055|NCT03970096|Thiotepa|thiotepa|mesh-list
15082056|NCT03970096|Methotrexate|methotrexate|mesh-list
15082057|NCT03970096|Fludarabine|fludarabine|mesh-list
15082058|NCT03970096|Tacrolimus|tacrolimus|mesh-list
15082059|NCT03970096|Cyclosporins|cyclosporins|mesh-list
15082060|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082061|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
15082062|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082063|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15082064|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082065|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
15082066|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082067|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082068|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13993411|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266700|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536813|NCT00941928|Epratuzumab|epratuzumab|mesh-list
14536814|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082069|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13993412|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993413|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993414|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
13993415|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13993416|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993417|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993418|NCT02940756|Artesunate|artesunate|mesh-list
13993419|NCT02940756|Lumefantrine|lumefantrine|mesh-list
13993420|NCT02940756|Artemether|artemether|mesh-list
13993421|NCT02940756|Piperaquine|piperaquine|mesh-list
13993422|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
13993423|NCT02940756|Amodiaquine|amodiaquine|mesh-list
14536815|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
14536816|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536817|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536818|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14536819|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
14536820|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536821|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536822|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14536823|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14536824|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
14536825|NCT00941928|Antiviral Agents|antiviral agents|mesh-ancestor
14536826|NCT00941928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536827|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14536828|NCT00941928|Analgesics|analgesics|mesh-ancestor
14536829|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
14536830|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536831|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14536832|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14536833|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536834|NCT00947791|Midazolam|midazolam|mesh-list
14536835|NCT00947791|Ketamine|ketamine|mesh-list
14536836|NCT00947791|Analgesics|analgesics|mesh-ancestor
14536837|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
14536838|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536839|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536840|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14536841|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14536842|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
14536843|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
14536844|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536845|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14536846|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14536847|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536848|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536849|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14536850|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14536851|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14536852|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14536853|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14536854|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
14536855|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
14536856|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14536857|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14536858|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536859|NCT00947011|Incretins|incretins|mesh-ancestor
14536860|NCT00947011|Hormones|hormones|mesh-ancestor
14536861|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536862|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14536863|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
14536864|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536865|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536866|NCT00936598|Zolpidem|zolpidem|mesh-list
14536867|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14536868|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14536869|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536870|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536871|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14536872|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
14536873|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
14536874|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642863|NCT00187161|Cytarabine|cytarabine|mesh-list
13993424|NCT02940756|Artenimol|artenimol|mesh-list
13993425|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
13993426|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13993427|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13993428|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993429|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993430|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
13993431|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
13993432|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13993433|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
13993434|NCT02941068|Fluconazole|fluconazole|mesh-list
13993435|NCT02941068|Caspofungin|caspofungin|mesh-list
13993436|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
13993437|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993438|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13993439|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13993440|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993441|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993442|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13993443|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
13993444|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266701|NCT00385138|Clopidogrel|clopidogrel|mesh-list
14266702|NCT00385138|Cangrelor|cangrelor|mesh-list
14266703|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14266704|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14266705|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14266706|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14266707|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
14266708|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266709|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266710|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266711|NCT00385203|Cediranib|cediranib|mesh-list
14266712|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266713|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14266714|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266715|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266716|NCT00385216|Nicotine|nicotine|mesh-list
14266717|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14266718|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
14266719|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266720|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266721|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14266722|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14266723|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
14266724|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266725|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266726|NCT00385268|Acamprosate|acamprosate|mesh-list
14266727|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14266728|NCT00385541|Morphine|morphine|mesh-list
14266729|NCT00385541|Hydromorphone|hydromorphone|mesh-list
14266730|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14266731|NCT00385541|Narcotics|narcotics|mesh-ancestor
14266732|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266733|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266734|NCT00385541|Analgesics|analgesics|mesh-ancestor
14266735|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
14266736|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266737|NCT00385580|Dasatinib|dasatinib|mesh-list
14266738|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266739|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14266740|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292333|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
13993445|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993446|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13993447|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14536875|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536876|NCT00920309|Sirolimus|sirolimus|mesh-list
14536877|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14536878|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536879|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14536880|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536881|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
14536882|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536883|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
14536884|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536885|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
14536886|NCT00934791|Sirolimus|sirolimus|mesh-list
14536887|NCT00934791|Prednisone|prednisone|mesh-list
14536888|NCT00934791|Tacrolimus|tacrolimus|mesh-list
14536889|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536890|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
14536891|NCT00934791|Hormones|hormones|mesh-ancestor
14536892|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536893|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536894|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536895|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536896|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536897|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
14536898|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14536899|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536900|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536901|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14536902|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14536903|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
14536904|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14536905|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536906|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
14536907|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14536908|NCT00932152|Bevacizumab|bevacizumab|mesh-list
14536909|NCT00932152|Fulvestrant|fulvestrant|mesh-list
14536910|NCT00932152|Anastrozole|anastrozole|mesh-list
14536911|NCT00932152|Analgesics|analgesics|mesh-list
14536912|NCT00932152|Antiemetics|antiemetics|mesh-list
14536913|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14536914|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536915|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14536916|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14536917|NCT00932152|Growth Substances|growth substances|mesh-ancestor
14536918|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536919|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
14536920|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14536921|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536922|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14536923|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14536924|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
14536925|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536926|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14536927|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14536928|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536929|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536930|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
14536931|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14536932|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
14536933|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14536934|NCT00924807|Sorafenib|sorafenib|mesh-list
14536935|NCT00924807|Leuprolide|leuprolide|mesh-list
14536936|NCT00924807|Bicalutamide|bicalutamide|mesh-list
14536937|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082070|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
14536938|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14536939|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536940|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993459|NCT02940301|Nivolumab|nivolumab|mesh-list
13993460|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993461|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993462|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13993463|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993464|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13993465|NCT02940379|Metoprolol|metoprolol|mesh-list
13993466|NCT02940379|Midazolam|midazolam|mesh-list
13993467|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13993468|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13993469|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993470|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993471|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13993472|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13993473|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13993474|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13993475|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
13993476|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
13993477|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
13993478|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
13993479|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993480|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993481|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13993482|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13993483|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
13993484|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
13993485|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993486|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13993487|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13993488|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13993489|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
13993490|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13993491|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13993492|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13993493|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13993494|NCT02940535|Menotropins|menotropins|mesh-list
14536941|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14536942|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
14536943|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14536944|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536945|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14536946|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
14536947|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
14536948|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536949|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
14536950|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14536951|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
14536952|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536953|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14536954|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14536955|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
14536956|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536957|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536958|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14536959|NCT00926575|Beclomethasone|beclomethasone|mesh-list
14536960|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14536961|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
14536962|NCT00926575|Hormones|hormones|mesh-ancestor
14536963|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14536964|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536965|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14536966|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14536967|NCT00911053|Melatonin|melatonin|mesh-list
14536968|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
14536969|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536970|NCT00911053|Protective Agents|protective agents|mesh-ancestor
13993495|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
13993496|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13993497|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
13993498|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13993499|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993500|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13993501|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13993502|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993503|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13993504|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
13993505|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
13993506|NCT02940509|Ketamine|ketamine|mesh-list
13993507|NCT02940509|Analgesics|analgesics|mesh-ancestor
13993508|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
13993509|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993510|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993511|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14536971|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536972|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14536973|NCT00918463|Dasatinib|dasatinib|mesh-list
14536974|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14536975|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14536976|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14536977|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536978|NCT00913692|Glycine|glycine|mesh-list
14536979|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
14536980|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536981|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536982|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536983|NCT00918645|Calcium|calcium|mesh-list
14536984|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14536985|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536986|NCT00907218|Varenicline|varenicline|mesh-list
14536987|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14536988|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14536989|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
14536990|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14536991|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14536992|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14536993|NCT00906035|Aspirin|aspirin|mesh-list
14536994|NCT00906035|Dipyridamole|dipyridamole|mesh-list
14536995|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14536996|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14536997|NCT00906035|Analgesics|analgesics|mesh-ancestor
14536998|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
15082071|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15082072|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15082073|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
15082074|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
15082075|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082076|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15082077|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15082078|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15082079|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
15082080|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082081|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15082082|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082083|NCT03965689|Paclitaxel|paclitaxel|mesh-list
15082084|NCT03965689|Carboplatin|carboplatin|mesh-list
15082085|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15082086|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15082087|NCT03965689|Pevonedistat|pevonedistat|mesh-list
15082088|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082089|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082090|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082091|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
14536999|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537000|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537001|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537002|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537003|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14537004|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15082092|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
13993512|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15082093|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993513|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
13993514|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
13993515|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993516|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13993517|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13993518|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993519|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993520|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13993521|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
13993522|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13993523|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13993524|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13993525|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
13993526|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14266741|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266742|NCT00385593|Budesonide|budesonide|mesh-list
14266743|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
14266744|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14266745|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266746|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14266747|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
14266748|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266749|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266750|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14266751|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
14266752|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
14266753|NCT00385593|Hormones|hormones|mesh-ancestor
14266754|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266755|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14266756|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14266757|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14266758|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
14266759|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266760|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266761|NCT00385671|Pregabalin|pregabalin|mesh-list
14266762|NCT00385671|Gabapentin|gabapentin|mesh-list
14266763|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14266764|NCT00385671|Analgesics|analgesics|mesh-ancestor
14266765|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
14266766|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266767|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266768|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
14266769|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14266770|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266771|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266772|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14266773|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14266774|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14266775|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266776|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266777|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14266778|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14266779|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266780|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
14266781|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14266782|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14266783|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
14266784|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
14266785|NCT00385684|Acetaminophen|acetaminophen|mesh-list
14537005|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537006|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14537007|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14537008|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537009|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
14537010|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14537011|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
14537012|NCT00904423|Vitamin D|vitamin d|mesh-list
14537013|NCT00904423|Vitamins|vitamins|mesh-ancestor
14537014|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
14537015|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537016|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14537017|NCT00903396|Palonosetron|palonosetron|mesh-list
13993527|NCT02940561|Methotrexate|methotrexate|mesh-list
13993528|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13993529|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
13993530|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13993531|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993532|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993533|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
13993534|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993535|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993536|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
13993537|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993538|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13993539|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993540|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
13993541|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993542|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13993543|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
13993544|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13993545|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13993546|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
13993547|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993548|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993549|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993550|NCT02940314|Urological Agents|urological agents|mesh-ancestor
13993551|NCT02940366|Atorvastatin|atorvastatin|mesh-list
13993552|NCT02940366|Pitavastatin|pitavastatin|mesh-list
13993553|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13993554|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13993555|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
13993556|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993557|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13993558|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13993559|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993560|NCT02940405|Ketorolac|ketorolac|mesh-list
13993561|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13993562|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13993563|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13993564|NCT02940405|Analgesics|analgesics|mesh-ancestor
13993565|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
13993566|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993567|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993568|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993569|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993570|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13993571|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993572|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993573|NCT02940444|Heparin|heparin|mesh-list
13993574|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
14537018|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
14537019|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
14537020|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537021|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537022|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537023|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14537024|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14537025|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
14537026|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537027|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537028|NCT00894790|Celecoxib|celecoxib|mesh-list
14537029|NCT00894790|Diclofenac|diclofenac|mesh-list
14537030|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14537031|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14537032|NCT00894790|Analgesics|analgesics|mesh-ancestor
14537033|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
14537034|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537035|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537036|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537037|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537038|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14537039|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14537040|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993575|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13993576|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14537041|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993577|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993578|NCT02940483|Azacitidine|azacitidine|mesh-list
13993579|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993580|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
13993581|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993582|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993583|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993584|NCT02940262|Edetic Acid|edetic acid|mesh-list
13993585|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13993586|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
14537042|NCT00902668|Lovastatin|lovastatin|mesh-list
14537043|NCT00902668|L 647318|l 647318|mesh-list
14537044|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
14537045|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14537046|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14537047|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
14537048|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537049|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14537050|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14537051|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537052|NCT00881205|Rivastigmine|rivastigmine|mesh-list
14537053|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14537054|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537055|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537056|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
14537057|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537058|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537059|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14537060|NCT00881205|Protective Agents|protective agents|mesh-ancestor
14537061|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
14537062|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14537063|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
14537064|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537065|NCT00896025|Expectorants|expectorants|mesh-ancestor
14537066|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
14537067|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14537068|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
14537069|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537070|NCT00896025|Protective Agents|protective agents|mesh-ancestor
14537071|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537072|NCT00896025|Antidotes|antidotes|mesh-ancestor
14537073|NCT00903006|Dasatinib|dasatinib|mesh-list
14537074|NCT00903006|Fulvestrant|fulvestrant|mesh-list
14537075|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537076|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537077|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537078|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537079|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14537080|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14537081|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14537082|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
14537083|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537084|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537085|NCT00887315|Cisplatin|cisplatin|mesh-list
14537086|NCT00887315|Docetaxel|docetaxel|mesh-list
14537087|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537088|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14537089|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537090|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537091|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537092|NCT00891904|Cetuximab|cetuximab|mesh-list
14537093|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14537094|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537095|NCT00889421|Apremilast|apremilast|mesh-list
14537096|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14537097|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14537098|NCT00889421|Analgesics|analgesics|mesh-ancestor
14537099|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
14537100|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537101|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537102|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537103|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537104|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14537105|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13993587|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
13993588|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993589|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
13993590|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13993591|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14023204|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14023205|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14023206|NCT02763761|Prednisolone|prednisolone|mesh-list
14023207|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
14023208|NCT02763761|Infliximab|infliximab|mesh-list
14023209|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14537106|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537107|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642864|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
14642865|NCT00187161|Doxorubicin|doxorubicin|mesh-list
14642866|NCT00187161|Methotrexate|methotrexate|mesh-list
14642867|NCT00187161|Etoposide|etoposide|mesh-list
14642868|NCT00187161|Vincristine|vincristine|mesh-list
14642869|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642870|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
14642871|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642872|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642873|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642874|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
14642875|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642876|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642877|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642878|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14642879|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14642880|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642881|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642882|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14642883|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
14642884|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642885|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642886|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
14642887|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642888|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642889|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642890|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642891|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
14642892|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642893|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642894|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642895|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642896|NCT00187174|Everolimus|everolimus|mesh-list
14642897|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642898|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642899|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
14642900|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642901|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
14642902|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14642903|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
14642904|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642905|NCT00187330|Expectorants|expectorants|mesh-ancestor
14642906|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
14642907|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14642908|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
14642909|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642910|NCT00187330|Protective Agents|protective agents|mesh-ancestor
14642911|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642912|NCT00187330|Antidotes|antidotes|mesh-ancestor
14642913|NCT00187408|Heparin|heparin|mesh-list
14642914|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14642915|NCT00187408|Tinzaparin|tinzaparin|mesh-list
14642916|NCT00187408|Dalteparin|dalteparin|mesh-list
14642917|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
14642918|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14642919|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14642920|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642921|NCT00187447|Indomethacin|indomethacin|mesh-list
14642922|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14023210|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
14023211|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642923|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14642924|NCT00187447|Analgesics|analgesics|mesh-ancestor
14642925|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
14642926|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993592|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13993593|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13993594|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993595|NCT02940184|Incretins|incretins|mesh-ancestor
13993596|NCT02940184|Hormones|hormones|mesh-ancestor
13993597|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993598|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13993599|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
13993600|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993601|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993602|NCT02940002|Betamethasone|betamethasone|mesh-list
13993603|NCT02940002|Clobetasol|clobetasol|mesh-list
13993604|NCT02940002|Calcipotriene|calcipotriene|mesh-list
13993605|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993606|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
13993607|NCT02940002|Hormones|hormones|mesh-ancestor
13993608|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993609|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993610|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13993611|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
13993612|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
13993613|NCT02939833|Ropivacaine|ropivacaine|mesh-list
13993614|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
13993615|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
13993616|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993617|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993618|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
13993619|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993620|NCT02939872|Aspirin|aspirin|mesh-list
14266786|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14266787|NCT00385684|Hydrocodone|hydrocodone|mesh-list
14266788|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14266789|NCT00385684|Narcotics|narcotics|mesh-ancestor
14266790|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266791|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266792|NCT00385684|Analgesics|analgesics|mesh-ancestor
14266793|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
14266794|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266795|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
14266796|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
14266797|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14266798|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
14266799|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14266800|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266801|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266802|NCT00385736|Adalimumab|adalimumab|mesh-list
14266803|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266804|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266805|NCT00385762|Paroxetine|paroxetine|mesh-list
14266806|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14266807|NCT00385762|Serotonin|serotonin|mesh-list
14266808|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14266809|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537108|NCT00875394|Metformin|metformin|mesh-list
14537109|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14537110|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14537111|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537112|NCT00875394|Incretins|incretins|mesh-ancestor
14537113|NCT00875394|Hormones|hormones|mesh-ancestor
14537114|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537115|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14537116|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
14537117|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807822|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14807823|NCT00823641|Infliximab|infliximab|mesh-list
14807824|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14807825|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14807826|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807827|NCT00823849|Cilostazol|cilostazol|mesh-list
14807828|NCT00823849|Probucol|probucol|mesh-list
14807829|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14807830|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
14807831|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993621|NCT02939872|Clopidogrel|clopidogrel|mesh-list
14266810|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807832|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993622|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13993623|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13993624|NCT02939872|Analgesics|analgesics|mesh-ancestor
13993625|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
13993626|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993627|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993628|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993629|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993630|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13993631|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13993632|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993633|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13993634|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13993635|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993636|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
13993637|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13993638|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13993639|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13993640|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
13993641|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993642|NCT02939898|Letrozole|letrozole|mesh-list
13993643|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13993644|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993645|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13993646|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993647|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993648|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13993649|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
13993650|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993651|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993652|NCT02939846|Trametinib|trametinib|mesh-list
13993653|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993654|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13993655|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993656|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993657|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
13993658|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
13993659|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13993660|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13993661|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993662|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993663|NCT02939495|Urological Agents|urological agents|mesh-ancestor
13993664|NCT02939482|Triamcinolone|triamcinolone|mesh-list
13993665|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13993666|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13993667|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13993668|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993669|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
13993670|NCT02939482|Hormones|hormones|mesh-ancestor
13993671|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993672|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993673|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993674|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
13993675|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993676|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993677|NCT02939430|Atropine|atropine|mesh-list
13993678|NCT02939430|Neostigmine|neostigmine|mesh-list
13993679|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13993680|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13993681|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13993682|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
13993683|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537118|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537119|NCT00882310|Gemcitabine|gemcitabine|mesh-list
14537120|NCT00882310|Capecitabine|capecitabine|mesh-list
14537121|NCT00882310|Docetaxel|docetaxel|mesh-list
14537122|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537123|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
14537124|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537125|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537126|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
14537127|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537128|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993684|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993685|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13993686|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
13993687|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
13993688|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
13993689|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13993690|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13993691|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
13993692|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993693|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993694|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13993695|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993696|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13993697|NCT02939365|Abatacept|abatacept|mesh-list
13993698|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13993699|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993700|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993701|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993702|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
13993703|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993704|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993705|NCT02939547|Betadex|betadex|mesh-list
13993706|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
13993707|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993708|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
13993709|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13993710|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993711|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
13993712|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993713|NCT02939417|Protective Agents|protective agents|mesh-ancestor
13993714|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993715|NCT02939274|Verteporfin|verteporfin|mesh-list
13993716|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13993717|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
13993718|NCT02939287|Olanzapine|olanzapine|mesh-list
13993719|NCT02939287|Aprepitant|aprepitant|mesh-list
13993720|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
13993721|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
13993722|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
13993723|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993724|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993725|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13993726|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13993727|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13993728|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993729|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537129|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537130|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
14537131|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537132|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14537133|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14266811|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266812|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
14266813|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266814|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14266815|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
14266816|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537134|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537135|NCT00880542|Sorafenib|sorafenib|mesh-list
14537136|NCT00880542|Ifosfamide|ifosfamide|mesh-list
14537137|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537138|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537139|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537140|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537141|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14537142|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
14537143|NCT00879619|Prednisone|prednisone|mesh-list
14537144|NCT00879619|Cortisone|cortisone|mesh-list
14537145|NCT00879619|Docetaxel|docetaxel|mesh-list
14537146|NCT00879619|Sunitinib|sunitinib|mesh-list
14537147|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537148|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
13993730|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14537149|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
14023212|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
14537150|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642927|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993731|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13993732|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13993733|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993734|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993735|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
13993736|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13993737|NCT02939300|Nivolumab|nivolumab|mesh-list
13993738|NCT02939300|Ipilimumab|ipilimumab|mesh-list
13993739|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993740|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993741|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13993742|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993743|NCT02939248|Morphine|morphine|mesh-list
13993744|NCT02939248|Naloxone|naloxone|mesh-list
13993745|NCT02939248|Ticagrelor|ticagrelor|mesh-list
13993746|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13993747|NCT02939248|Narcotics|narcotics|mesh-ancestor
13993748|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993749|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993750|NCT02939248|Analgesics|analgesics|mesh-ancestor
13993751|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
13993752|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993753|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13993754|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13993755|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13993756|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13993757|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
13993758|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993759|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537151|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537152|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537153|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
14537154|NCT00879619|Hormones|hormones|mesh-ancestor
14537155|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537156|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537157|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14537158|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14537159|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14537160|NCT00879619|Growth Substances|growth substances|mesh-ancestor
14537161|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
14537162|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537163|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537164|NCT00874939|Donepezil|donepezil|mesh-list
14537165|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14537166|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537167|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537168|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
14537169|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537170|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537171|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
14537172|NCT00877071|Doxorubicin|doxorubicin|mesh-list
14537173|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14537174|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082094|NCT03954379|Dexamethasone|dexamethasone|mesh-list
15082095|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
15082096|NCT03954379|Analgesics|analgesics|mesh-list
15082097|NCT03954379|Anesthetics|anesthetics|mesh-list
15082098|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
15082099|NCT03954379|BB 1101|bb 1101|mesh-list
15082100|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082101|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
15082102|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
15082103|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082104|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082105|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15082106|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
15082107|NCT03954379|Hormones|hormones|mesh-ancestor
15082108|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082109|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082110|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082111|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
15082112|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082113|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082114|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993760|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13993761|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
13993762|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13993763|NCT02938988|Methylene Blue|methylene blue|mesh-list
13993764|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993765|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993766|NCT02939235|Morphine|morphine|mesh-list
13993767|NCT02939235|Metoclopramide|metoclopramide|mesh-list
13993768|NCT02939235|Ticagrelor|ticagrelor|mesh-list
13993769|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13993770|NCT02939235|Narcotics|narcotics|mesh-ancestor
13993771|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993772|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993773|NCT02939235|Analgesics|analgesics|mesh-ancestor
13993774|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
13993775|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993776|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13993777|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13993778|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13993779|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13993780|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
13993781|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993782|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993783|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
13993784|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
13993785|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13993786|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13993787|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13993788|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
13993789|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
13993790|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13993791|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13993792|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993793|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
13993794|NCT02938962|Coagulants|coagulants|mesh-ancestor
13993795|NCT02938975|Permethrin|permethrin|mesh-list
13993796|NCT02938975|Insect Repellents|insect repellents|mesh-list
13993797|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993798|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993799|NCT02938975|Protective Agents|protective agents|mesh-ancestor
14537175|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14537176|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537177|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537178|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537179|NCT00878969|Valsartan|valsartan|mesh-list
14537180|NCT00878969|Ramipril|ramipril|mesh-list
14537181|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14537182|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14537183|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14537184|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14537185|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537186|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
14537187|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537188|NCT00869414|Insulin|insulin|mesh-list
14537189|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14537190|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
14537191|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14537192|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537193|NCT00863512|Gemcitabine|gemcitabine|mesh-list
14537194|NCT00863512|Docetaxel|docetaxel|mesh-list
14537195|NCT00863512|Pemetrexed|pemetrexed|mesh-list
14537196|NCT00863512|Vinorelbine|vinorelbine|mesh-list
14537197|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537198|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537199|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
14537200|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537201|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
14537202|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537203|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537204|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537205|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
14537206|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537207|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
13993800|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993801|NCT02939209|Hydromorphone|hydromorphone|mesh-list
13993802|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13993803|NCT02939209|Narcotics|narcotics|mesh-ancestor
13993804|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993805|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537208|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537209|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537210|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14537211|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14537212|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14537213|NCT00868998|Gemcitabine|gemcitabine|mesh-list
14537214|NCT00868998|Capecitabine|capecitabine|mesh-list
14537215|NCT00868998|Docetaxel|docetaxel|mesh-list
14537216|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537217|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
14537218|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537219|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537220|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
14537221|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537222|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537223|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537224|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
14537225|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537226|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
14537227|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537228|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537229|NCT00869258|Gemcitabine|gemcitabine|mesh-list
14537230|NCT00869258|Capecitabine|capecitabine|mesh-list
14537231|NCT00869258|Docetaxel|docetaxel|mesh-list
14537232|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537233|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
14537234|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537235|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537236|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
14537237|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537238|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537239|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537240|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
14537241|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537242|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
14537243|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537244|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537245|NCT00853229|Pregabalin|pregabalin|mesh-list
14537246|NCT00853229|Analgesics|analgesics|mesh-ancestor
14537247|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
14537248|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537249|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537250|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
14537251|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14537252|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537253|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537254|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14537255|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14537256|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14537257|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537258|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537259|NCT00860158|Dasatinib|dasatinib|mesh-list
14537260|NCT00860158|Leuprolide|leuprolide|mesh-list
14537261|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537262|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537263|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537264|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537265|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14537266|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
14537267|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14266817|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14266818|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14266819|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266820|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14266821|NCT00385788|Gemcitabine|gemcitabine|mesh-list
14266822|NCT00385788|Vidarabine|vidarabine|mesh-list
14266823|NCT00385788|Methotrexate|methotrexate|mesh-list
14266824|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
13993806|NCT02939209|Analgesics|analgesics|mesh-ancestor
14266825|NCT00385788|Fludarabine|fludarabine|mesh-list
14266826|NCT00385788|Melphalan|melphalan|mesh-list
14537268|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537269|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13993807|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
13993808|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993809|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
13993810|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13993811|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993812|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
13993813|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
13993814|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
13993815|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993816|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993817|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13993818|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13993819|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993820|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
13993821|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13993822|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993823|NCT02938468|Dexamethasone|dexamethasone|mesh-list
13993824|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993825|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
14537270|NCT00843986|Conivaptan|conivaptan|mesh-list
14537271|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14537272|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537273|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
14537274|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537275|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
14537276|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14537277|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14537278|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14537279|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537280|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537281|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
14537282|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537283|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537284|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14537285|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537286|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
14537287|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14537288|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537289|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
14537290|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14537291|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
14537292|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537293|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
14537294|NCT00852241|Protective Agents|protective agents|mesh-ancestor
14537295|NCT00851552|Rituximab|rituximab|mesh-list
14537296|NCT00851552|Doxorubicin|doxorubicin|mesh-list
14537297|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14537298|NCT00851552|Bortezomib|bortezomib|mesh-list
14537299|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14537300|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537301|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
14537302|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537303|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537304|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14537305|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14537306|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537307|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537308|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537309|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
14537310|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14537311|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14537312|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14537313|NCT00850720|Vasopressins|vasopressins|mesh-list
14537314|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537315|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
14537316|NCT00850720|Coagulants|coagulants|mesh-ancestor
14537317|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14537318|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14537319|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
14537320|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537321|NCT00851591|Psyllium|psyllium|mesh-list
14537322|NCT00851591|Cathartics|cathartics|mesh-ancestor
14537323|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537324|NCT00843310|Dexamethasone|dexamethasone|mesh-list
14537325|NCT00843310|Lenalidomide|lenalidomide|mesh-list
13993826|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
14537326|NCT00843310|Melphalan|melphalan|mesh-list
13993827|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993828|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993829|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13993830|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
13993831|NCT02938468|Hormones|hormones|mesh-ancestor
13993832|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13993833|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13993834|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023213|NCT02763761|Hormones|hormones|mesh-ancestor
14023214|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023215|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023216|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023217|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023218|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
14023219|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
14023220|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023221|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023222|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14023223|NCT02763761|Protective Agents|protective agents|mesh-ancestor
14023224|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023225|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023226|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14023227|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14023228|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
14266827|NCT00385788|Tacrolimus|tacrolimus|mesh-list
14266828|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
14537327|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537328|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
14537329|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
14537330|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537331|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537332|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537333|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
14537334|NCT00843310|Hormones|hormones|mesh-ancestor
14537335|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537336|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14537337|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537338|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
14537339|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14537340|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14537341|NCT00843310|Growth Substances|growth substances|mesh-ancestor
14537342|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
14537343|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14537344|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
14537345|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537346|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14537347|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537348|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14537349|NCT00847002|Laxatives|laxatives|mesh-ancestor
14537350|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537351|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14537352|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
14537353|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
14537354|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537355|NCT00843830|Vaccines|vaccines|mesh-list
14537356|NCT00843830|Immunologic Factors|immunologic factors|mesh-ancestor
14537357|NCT00843830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537358|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14537359|NCT00835679|Cetuximab|cetuximab|mesh-list
14537360|NCT00835679|Dasatinib|dasatinib|mesh-list
14537361|NCT00835679|Antibodies|antibodies|mesh-list
14537362|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
14537363|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14537364|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
14537365|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537366|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537367|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537368|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537369|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537370|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14537371|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537372|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537373|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993835|NCT02938507|Solabegron|solabegron|mesh-list
13993836|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13993837|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13993838|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13993839|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
13993840|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993841|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993842|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266829|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14266830|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14266831|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
14266832|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993847|NCT02938260|Metoprolol|metoprolol|mesh-list
13993848|NCT02938260|Diltiazem|diltiazem|mesh-list
13993849|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13993850|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13993851|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
13993852|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
13993853|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993854|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993855|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13993856|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13993857|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13993858|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
13993859|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993860|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993861|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13993862|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13993863|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13993864|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
13993865|NCT02938273|Cetuximab|cetuximab|mesh-list
13993866|NCT02938273|Avelumab|avelumab|mesh-list
13993867|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13993868|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993869|NCT02938286|Epinephrine|epinephrine|mesh-list
13993870|NCT02938286|Carticaine|carticaine|mesh-list
13993871|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13993872|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14266833|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266834|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
14266835|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266836|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266837|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14266838|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
14266839|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266840|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14266841|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
14266842|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14266843|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
14537374|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537375|NCT00832520|Mirtazapine|mirtazapine|mesh-list
14537376|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
14537377|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537378|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14537379|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
14537380|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
14537381|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082115|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
15082116|NCT03952585|Cisplatin|cisplatin|mesh-list
15082117|NCT03952585|Nivolumab|nivolumab|mesh-list
15082118|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082119|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082120|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082121|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082122|NCT03919071|Trametinib|trametinib|mesh-list
15082123|NCT03919071|Dabrafenib|dabrafenib|mesh-list
15082124|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15082125|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082126|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13993873|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
13993874|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266844|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13993875|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993876|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993877|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13993878|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13993879|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
13993880|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993881|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13993882|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
13993883|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
13993884|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
13993885|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13993886|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
13993887|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
13993888|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993889|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
13993890|NCT02938182|Clopidogrel|clopidogrel|mesh-list
13993891|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13993892|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13993893|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13993894|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13993895|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
13993896|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993897|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993898|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993899|NCT02937662|Cytarabine|cytarabine|mesh-list
13993900|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
13993901|NCT02937662|Idarubicin|idarubicin|mesh-list
13993902|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993903|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
13993904|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266845|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266846|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14266847|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14266848|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14266849|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
14266850|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14266851|NCT00385801|Risperidone|risperidone|mesh-list
14266852|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14537382|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537383|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537384|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14537385|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14537386|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537387|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14537388|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14537389|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14537390|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
14537391|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14537392|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14537393|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
14537394|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14537395|NCT00833859|Gemcitabine|gemcitabine|mesh-list
14537396|NCT00833859|Capecitabine|capecitabine|mesh-list
14537397|NCT00833859|Docetaxel|docetaxel|mesh-list
14537398|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537399|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
14537400|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537401|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537402|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
14537403|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537404|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537405|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537406|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
14537407|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537408|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
14537409|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537410|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537411|NCT00840827|Cyclosporine|cyclosporine|mesh-list
14537412|NCT00840827|Lenalidomide|lenalidomide|mesh-list
14537413|NCT00840827|Cyclosporins|cyclosporins|mesh-list
14537414|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537415|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537416|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537417|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
14266853|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
14266854|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993905|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993906|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13993907|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
13993908|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993909|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993910|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13993911|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13993912|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
13993913|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
13993914|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993915|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13993916|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13993917|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13993918|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993919|NCT02937857|Antipyretics|antipyretics|mesh-list
13993920|NCT02937857|Expectorants|expectorants|mesh-list
13993921|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
13993922|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993923|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
13993924|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
13993925|NCT02937844|Fludarabine|fludarabine|mesh-list
13993926|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13993927|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
13993928|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993929|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993930|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13993931|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
13993932|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993933|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993934|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13993935|NCT02937896|Ketorolac|ketorolac|mesh-list
13993936|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13993937|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13993938|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13993939|NCT02937896|Analgesics|analgesics|mesh-ancestor
13993940|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
13993941|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993942|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993943|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13993944|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13993945|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14266855|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266856|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266857|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14266858|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14537418|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537419|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
14537420|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537421|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14537422|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537423|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14537424|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14537425|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14537426|NCT00840827|Growth Substances|growth substances|mesh-ancestor
14537427|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
14537428|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537429|NCT00832572|Ranolazine|ranolazine|mesh-list
14537430|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14537431|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537432|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537433|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14807833|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14266859|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266860|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14266861|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14266862|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
14266863|NCT00385827|Prednisone|prednisone|mesh-list
14266864|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
14266865|NCT00385827|Siltuximab|siltuximab|mesh-list
14266866|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266867|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
14266868|NCT00385827|Hormones|hormones|mesh-ancestor
13993946|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993947|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082127|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993948|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
13993949|NCT02937896|Coagulants|coagulants|mesh-ancestor
13993950|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13993951|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
13993952|NCT02937792|Bupivacaine|bupivacaine|mesh-list
13993953|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
13993954|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
13993955|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13993956|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993957|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
13993958|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993959|NCT02937779|Tenofovir|tenofovir|mesh-list
13993960|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
13993961|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993962|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13993963|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14537434|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14537435|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537436|NCT00832624|Incretins|incretins|mesh-ancestor
14537437|NCT00832624|Hormones|hormones|mesh-ancestor
14537438|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537439|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14537440|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
14537441|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537442|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537443|NCT00832299|Leucovorin|leucovorin|mesh-list
14537444|NCT00832299|Fluorouracil|fluorouracil|mesh-list
14537445|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
14537446|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
14537447|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537448|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537449|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537450|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537451|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
14537452|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537453|NCT00832299|Antidotes|antidotes|mesh-ancestor
14537454|NCT00832299|Protective Agents|protective agents|mesh-ancestor
14537455|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
14807834|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
14807835|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14807836|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14807837|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807838|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14807839|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
14807840|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14807841|NCT00823849|Protective Agents|protective agents|mesh-ancestor
14807842|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14807843|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14807844|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807845|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14807846|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14807847|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
14807848|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14807849|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
14807850|NCT00823862|Ribavirin|ribavirin|mesh-list
14807851|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
14807852|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807853|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
14807854|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807855|NCT00823875|Cilostazol|cilostazol|mesh-list
14807856|NCT00823875|Probucol|probucol|mesh-list
14807857|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14807858|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
14807859|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807860|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807861|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14807862|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
14807863|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14807864|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14807865|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807866|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14807867|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
14807868|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14537456|NCT00832299|Vitamins|vitamins|mesh-ancestor
14537457|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
14537458|NCT00836355|Minocycline|minocycline|mesh-list
13993964|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13993965|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993966|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13993967|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13993968|NCT02937519|Cisplatin|cisplatin|mesh-list
13993969|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993970|NCT02937415|Antioxidants|antioxidants|mesh-list
13993971|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
13993972|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537459|NCT00836355|Enoxaparin|enoxaparin|mesh-list
14537460|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
14537461|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14537462|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14537463|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537464|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14537465|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537466|NCT00816777|Irinotecan|irinotecan|mesh-list
14537467|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14537468|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537469|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537470|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537471|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537472|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
14537473|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14537474|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
14537475|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537476|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537477|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14537478|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
14537479|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14537480|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
14537481|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537482|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537483|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14537484|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
14537485|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
14537486|NCT00823095|Protective Agents|protective agents|mesh-ancestor
14537487|NCT00827567|Everolimus|everolimus|mesh-list
14537488|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537489|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537490|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
14537491|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537492|NCT00815633|Alefacept|alefacept|mesh-list
14537493|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
14537494|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
14537495|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537496|NCT00825227|Modafinil|modafinil|mesh-list
14537497|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14537498|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537499|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14537500|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14537501|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14537502|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537503|NCT00822679|Eszopiclone|eszopiclone|mesh-list
14537504|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14537505|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537506|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537507|NCT00809458|Vitamin E|vitamin e|mesh-list
14537508|NCT00809458|Tocopherols|tocopherols|mesh-list
14537509|NCT00809458|Tocotrienols|tocotrienols|mesh-list
14537510|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
14537511|NCT00809458|Vitamins|vitamins|mesh-ancestor
14537512|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
14537513|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537514|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
14537515|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537516|NCT00809458|Protective Agents|protective agents|mesh-ancestor
14537517|NCT00807365|Hormones|hormones|mesh-list
14537518|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14537519|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537520|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537521|NCT00814333|Thrombin|thrombin|mesh-list
14537522|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
14537523|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
14807869|NCT00823875|Protective Agents|protective agents|mesh-ancestor
13993973|NCT02937415|Protective Agents|protective agents|mesh-ancestor
13993974|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993975|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
13993976|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
13993977|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13993978|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
13993979|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
13993980|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13993981|NCT02937363|Protective Agents|protective agents|mesh-ancestor
13993982|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993983|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
13993984|NCT02937363|Vitamins|vitamins|mesh-ancestor
13993985|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
13993986|NCT02937285|Interferons|interferons|mesh-list
13993987|NCT02937285|Interferon-beta|interferon-beta|mesh-list
13993988|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
13993989|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
13993990|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13993991|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
13993992|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13993993|NCT02937285|Analgesics|analgesics|mesh-ancestor
13993994|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
13993995|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13993996|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13993997|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13993998|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13993999|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994000|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994001|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
13994002|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13994003|NCT02937272|Gemcitabine|gemcitabine|mesh-list
13994004|NCT02937272|Paclitaxel|paclitaxel|mesh-list
13994005|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13994006|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994007|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
13994008|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537524|NCT00814333|Coagulants|coagulants|mesh-ancestor
14537525|NCT00809341|Prednisone|prednisone|mesh-list
14537526|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
14537527|NCT00809341|Ifosfamide|ifosfamide|mesh-list
14537528|NCT00809341|Rituximab|rituximab|mesh-list
14537529|NCT00809341|Carboplatin|carboplatin|mesh-list
14537530|NCT00809341|Doxorubicin|doxorubicin|mesh-list
14537531|NCT00809341|Etoposide|etoposide|mesh-list
14537532|NCT00809341|Vincristine|vincristine|mesh-list
14537533|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537534|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
14537535|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537536|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537537|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14537538|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
14537539|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537540|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537541|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15082128|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082129|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15082130|NCT03919071|Protective Agents|protective agents|mesh-ancestor
15082131|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082132|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15082133|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
15082134|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
15082135|NCT03914625|Leucovorin|leucovorin|mesh-list
15082136|NCT03914625|Folic Acid|folic acid|mesh-list
15082137|NCT03914625|Cytarabine|cytarabine|mesh-list
15082138|NCT03914625|Dexamethasone|dexamethasone|mesh-list
15082139|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
15082140|NCT03914625|Prednisone|prednisone|mesh-list
15082141|NCT03914625|Prednisolone|prednisolone|mesh-list
15082142|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15082143|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
15082144|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15082145|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
13994009|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
13994010|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994011|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537542|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082146|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
15082147|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15082148|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13994012|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
13994013|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
13994014|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994015|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994016|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13994017|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
13994018|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994019|NCT02936934|Morphine|morphine|mesh-list
13994020|NCT02936934|Oxycodone|oxycodone|mesh-list
13994021|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13994022|NCT02936934|Narcotics|narcotics|mesh-ancestor
13994023|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994024|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994025|NCT02936934|Analgesics|analgesics|mesh-ancestor
15082149|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15082150|NCT03914625|Cortisone|cortisone|mesh-list
15082151|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
15082152|NCT03914625|Doxorubicin|doxorubicin|mesh-list
15082153|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15082154|NCT03914625|Methotrexate|methotrexate|mesh-list
15082155|NCT03914625|Vincristine|vincristine|mesh-list
15082156|NCT03914625|Asparaginase|asparaginase|mesh-list
15082157|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
15082158|NCT03914625|Pegaspargase|pegaspargase|mesh-list
15082159|NCT03914625|Thioguanine|thioguanine|mesh-list
15082160|NCT03914625|Blinatumomab|blinatumomab|mesh-list
15082161|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15082162|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
15082163|NCT03914625|Antibodies|antibodies|mesh-list
15082164|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
14537543|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082165|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082166|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15082167|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15082168|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
15082169|NCT03914625|BB 1101|bb 1101|mesh-list
15082170|NCT03914625|Calcium|calcium|mesh-list
15082171|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
14537544|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14537545|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537546|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537547|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537548|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
14537549|NCT00809341|Hormones|hormones|mesh-ancestor
14537550|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537551|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14537552|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14537553|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
14537554|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537555|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537556|NCT00803283|Morphine|morphine|mesh-list
14537557|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14537558|NCT00803283|Narcotics|narcotics|mesh-ancestor
14537559|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537560|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537561|NCT00803283|Analgesics|analgesics|mesh-ancestor
14537562|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
14537563|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537564|NCT00811590|Everolimus|everolimus|mesh-list
14537565|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537566|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537567|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
14537568|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537569|NCT00808899|Sirolimus|sirolimus|mesh-list
14537570|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
14537571|NCT00808899|Doxorubicin|doxorubicin|mesh-list
14537572|NCT00808899|Irinotecan|irinotecan|mesh-list
14537573|NCT00808899|Etoposide|etoposide|mesh-list
14537574|NCT00808899|Topotecan|topotecan|mesh-list
14537575|NCT00808899|Tretinoin|tretinoin|mesh-list
14537576|NCT00808899|Isotretinoin|isotretinoin|mesh-list
14537577|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537578|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
15082172|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
15082173|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082174|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
15082175|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994026|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
13994027|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994028|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
13994029|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994030|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994031|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13994032|NCT02937012|Bezafibrate|bezafibrate|mesh-list
13994033|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13994034|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994035|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13994036|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
13994037|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994038|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13994039|NCT02936895|Vitamin D|vitamin d|mesh-list
13994040|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
13994041|NCT02936895|Vitamins|vitamins|mesh-ancestor
13994042|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
13994043|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994044|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14537579|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537580|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537581|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14537582|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
14537583|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537584|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537585|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14537586|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14537587|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14537588|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537589|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537590|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14537591|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14537592|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14537593|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537594|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
14537595|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
14537596|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
14537597|NCT00808769|Omeprazole|omeprazole|mesh-list
14537598|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
14537599|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14537600|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537601|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14537602|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537603|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537604|NCT00803179|Hormones|hormones|mesh-list
14537605|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537606|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537607|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
14537608|NCT00801931|Melphalan|melphalan|mesh-list
14537609|NCT00801931|Busulfan|busulfan|mesh-list
15082176|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15082177|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082178|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
15082179|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082180|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082181|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15082182|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082183|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
15082184|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
15082185|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082186|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15082187|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
15082188|NCT03914625|Hormones|hormones|mesh-ancestor
15082189|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082190|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082191|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
15082192|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082193|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082194|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15082195|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15082196|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13994045|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14537610|NCT00801931|Thiotepa|thiotepa|mesh-list
13994046|NCT02936830|Listerine|listerine|mesh-list
13994047|NCT02936830|Fluorides|fluorides|mesh-list
13994048|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
13994049|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
13994050|NCT02936830|Glycerol|glycerol|mesh-list
13994051|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
13994052|NCT02936830|Protective Agents|protective agents|mesh-ancestor
13994053|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994054|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13994055|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994056|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13994057|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
13994058|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13994059|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13994060|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994061|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
13994062|NCT02936661|Coagulants|coagulants|mesh-ancestor
13994063|NCT02936622|Paclitaxel|paclitaxel|mesh-list
13994064|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13994065|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13994066|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994067|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
13994068|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
13994069|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
13994070|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994071|NCT02936492|Clobetasol|clobetasol|mesh-list
13994072|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994073|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
13994074|NCT02936492|Hormones|hormones|mesh-ancestor
13994075|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994076|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994077|NCT02936505|Cyclosporine|cyclosporine|mesh-list
13994078|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
13994079|NCT02936505|Tacrolimus|tacrolimus|mesh-list
13994080|NCT02936505|Cyclosporins|cyclosporins|mesh-list
13994081|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
13994082|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13994083|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13994084|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
13994085|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994086|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13994087|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994088|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994089|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
13994090|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994091|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
13994092|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994093|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13994094|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994095|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13994096|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
13994097|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994098|NCT02936427|Dexamethasone|dexamethasone|mesh-list
13994099|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
13994100|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13994101|NCT02936427|BB 1101|bb 1101|mesh-list
13994102|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994103|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
13994104|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
13994105|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994106|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994107|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994108|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
13994109|NCT02936427|Hormones|hormones|mesh-ancestor
13994110|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994111|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13994112|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994113|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
13994114|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994115|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537611|NCT00801931|Fludarabine|fludarabine|mesh-list
14537612|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
14537613|NCT00801931|Phenytoin|phenytoin|mesh-list
14537614|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
14537615|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
14537616|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14537617|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537618|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
14537619|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537620|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537621|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14537622|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
14537623|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537624|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537625|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14537626|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14537627|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
14537628|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14537629|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14537630|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537631|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14537632|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14537633|NCT00793520|Milnacipran|milnacipran|mesh-list
14537634|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
14537635|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14537636|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14537637|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537638|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537639|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537640|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537641|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14537642|NCT00793520|Analgesics|analgesics|mesh-ancestor
14537643|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
14537644|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537645|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
14537646|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537647|NCT00795236|Melatonin|melatonin|mesh-list
14537648|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
14537649|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537650|NCT00795236|Protective Agents|protective agents|mesh-ancestor
14537651|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537652|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537653|NCT00799773|Rituximab|rituximab|mesh-list
14537654|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14537655|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537656|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
14537657|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537658|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537659|NCT00790452|Aspirin|aspirin|mesh-list
14537660|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14537661|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14537662|NCT00790452|Analgesics|analgesics|mesh-ancestor
14537663|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
14537664|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537665|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537666|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14537667|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994116|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
13994117|NCT02936375|Azathioprine|azathioprine|mesh-list
14537668|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13994118|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13994119|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
13994120|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994121|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994122|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13994123|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
13994124|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994125|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994126|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13994127|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
13994128|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13994129|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
13994130|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13994131|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13994132|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
13994133|NCT02935933|Morphine|morphine|mesh-list
13994134|NCT02935933|Bupivacaine|bupivacaine|mesh-list
13994135|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
13994136|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
13994137|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994138|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994139|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
13994140|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537669|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14537670|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537671|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14537672|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14537673|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537674|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
14537675|NCT00795665|Bevacizumab|bevacizumab|mesh-list
14537676|NCT00795665|Carmustine|carmustine|mesh-list
14537677|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14537678|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537679|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14537680|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14537681|NCT00795665|Growth Substances|growth substances|mesh-ancestor
14537682|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537683|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
14537684|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14537685|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
14537686|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537687|NCT00787917|Omalizumab|omalizumab|mesh-list
14537688|NCT00787917|Itraconazole|itraconazole|mesh-list
14537689|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
14537690|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537691|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14537692|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14537693|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537694|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537695|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14537696|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
14537697|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537698|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537699|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14537700|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14537701|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14537702|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
14537703|NCT00798590|Glucagon|glucagon|mesh-list
14537704|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14537705|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537706|NCT00798590|Hormones|hormones|mesh-ancestor
14537707|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537708|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537709|NCT00798590|Incretins|incretins|mesh-ancestor
14537710|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
14537711|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
14537712|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
14537713|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14537714|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14537715|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082197|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13994141|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994142|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13994143|NCT02935933|Analgesics|analgesics|mesh-ancestor
13994144|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13994145|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13994146|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13994147|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
13994148|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994149|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994150|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13994151|NCT02935933|Narcotics|narcotics|mesh-ancestor
13994152|NCT02935725|Ketamine|ketamine|mesh-list
13994153|NCT02935725|Analgesics|analgesics|mesh-ancestor
13994154|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
13994155|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994156|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994157|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13994158|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13994159|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
13994160|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
13994161|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994162|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13994163|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13994164|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994165|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994166|NCT02935764|Leucovorin|leucovorin|mesh-list
13994167|NCT02935764|Fluorouracil|fluorouracil|mesh-list
13994168|NCT02935764|Irinotecan|irinotecan|mesh-list
13994169|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
13994170|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994171|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13994172|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994173|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13994174|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
13994175|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994176|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13994177|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537716|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537717|NCT00796510|Urological Agents|urological agents|mesh-ancestor
14537718|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14537719|NCT00796861|Sunitinib|sunitinib|mesh-list
14537720|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537721|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14537722|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14537723|NCT00796861|Growth Substances|growth substances|mesh-ancestor
14537724|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537725|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
14537726|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537727|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537728|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537729|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
14537730|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537731|NCT00791076|Hormones|hormones|mesh-ancestor
14537732|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537733|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537734|NCT00790478|Melatonin|melatonin|mesh-list
14537735|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
14537736|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537737|NCT00790478|Protective Agents|protective agents|mesh-ancestor
14537738|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537739|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537740|NCT00796107|Letrozole|letrozole|mesh-list
14537741|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537742|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14537743|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14537744|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537745|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537746|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14537747|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
14537748|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537749|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537750|NCT00791336|Nelfinavir|nelfinavir|mesh-list
14537751|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14537752|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14537753|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
13994178|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994179|NCT02935764|Antidotes|antidotes|mesh-ancestor
13994180|NCT02935764|Protective Agents|protective agents|mesh-ancestor
13994181|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
13994182|NCT02935764|Vitamins|vitamins|mesh-ancestor
13994183|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
13994184|NCT02935751|Apixaban|apixaban|mesh-list
13994185|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13994186|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
13994187|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13994188|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
13994189|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994190|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994191|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
13994192|NCT02935998|Ziprasidone|ziprasidone|mesh-list
13994193|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13994194|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
13994195|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994196|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994197|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994198|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13994199|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13994200|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994201|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13994202|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14266869|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266870|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266871|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14266872|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537754|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537755|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537756|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14537757|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14537758|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
14537759|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537760|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
14537761|NCT00786682|Docetaxel|docetaxel|mesh-list
14537762|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537763|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14537764|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14537765|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14537766|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537767|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
14537768|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14537769|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14537770|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537771|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537772|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537773|NCT00791843|Hormones|hormones|mesh-list
14537774|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14537775|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14537776|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537777|NCT00774306|Phenytoin|phenytoin|mesh-list
14537778|NCT00774306|Levetiracetam|levetiracetam|mesh-list
14537779|NCT00774306|Valproic Acid|valproic acid|mesh-list
14537780|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
14537781|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
14537782|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537783|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537784|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
14537785|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537786|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537787|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
14537788|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14537789|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537790|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537791|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14537792|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14537793|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537794|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14537795|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14537796|NCT00771602|Rituximab|rituximab|mesh-list
13994203|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
14266873|NCT00385827|Analgesics|analgesics|mesh-ancestor
14537797|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
14537798|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13994204|NCT02935790|Nivolumab|nivolumab|mesh-list
13994205|NCT02935790|Ipilimumab|ipilimumab|mesh-list
13994206|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13994207|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994208|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13994209|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994210|NCT02935829|Locust bean gum|locust bean gum|mesh-list
13994211|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
13994212|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994213|NCT02935959|Midazolam|midazolam|mesh-list
13994214|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
13994215|NCT02935959|Ketamine|ketamine|mesh-list
13994216|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994217|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994218|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994219|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13994220|NCT02935959|Analgesics|analgesics|mesh-ancestor
13994221|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
13994222|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994223|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13994224|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13994225|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13994226|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
13994227|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994228|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994229|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13994230|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13994231|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
13994232|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
13994233|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13994234|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13994235|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13994236|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13994237|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13994238|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13994239|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
13994240|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
13994241|NCT02935972|Lidocaine|lidocaine|mesh-list
13994242|NCT02935972|Diazepam|diazepam|mesh-list
13994243|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
13994244|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
13994245|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537799|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537800|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
14537801|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537802|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537803|NCT00779038|Fentanyl|fentanyl|mesh-list
14537804|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14537805|NCT00779038|Narcotics|narcotics|mesh-ancestor
14537806|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537807|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537808|NCT00779038|Analgesics|analgesics|mesh-ancestor
14537809|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
14537810|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537811|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14537812|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14537813|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
14537814|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
14537815|NCT00780455|Interferons|interferons|mesh-list
14537816|NCT00780455|Interferon-beta|interferon-beta|mesh-list
14537817|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
14537818|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537819|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
14537820|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537821|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
14537822|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537823|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14537824|NCT00771316|Meropenem|meropenem|mesh-list
14537825|NCT00771316|Ertapenem|ertapenem|mesh-list
14537826|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14537827|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537828|NCT00780481|Bradykinin|bradykinin|mesh-list
14537829|NCT00780481|Kininogens|kininogens|mesh-list
15082198|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14537830|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
14537831|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13994246|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994247|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
13994248|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994249|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13994250|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13994251|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13994252|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13994253|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994254|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13994255|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
13994256|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
13994257|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
13994258|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994259|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994260|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13994261|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13994262|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13994263|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13994264|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13994265|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13994266|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
13994267|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
13994268|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
13994269|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994270|NCT02935855|Warfarin|warfarin|mesh-list
13994271|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
13994272|NCT02935855|Dabigatran|dabigatran|mesh-list
13994273|NCT02935855|Apixaban|apixaban|mesh-list
13994274|NCT02935855|Edoxaban|edoxaban|mesh-list
13994275|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
13994276|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13994277|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
13994278|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13994279|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
13994280|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994281|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537832|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
14537833|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537834|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537835|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14537836|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
14537837|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14537838|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537839|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14537840|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14537841|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537842|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537843|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
14537844|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537845|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
14537846|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14537847|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14537848|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
14537849|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14537850|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537851|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14537852|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14537853|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14537854|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14537855|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537856|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14537857|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537858|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537859|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537860|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642928|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642929|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642930|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
14642931|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
14642932|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642933|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14642934|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642935|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642936|NCT00187499|Fluticasone|fluticasone|mesh-list
13994282|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
13994283|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13994284|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13994285|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994286|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
13994287|NCT02935985|Coagulants|coagulants|mesh-ancestor
13994288|NCT02935647|Propofol|propofol|mesh-list
13994289|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994290|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266874|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
14266875|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266876|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14266877|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14266878|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266879|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266880|NCT00385944|Clopidogrel|clopidogrel|mesh-list
15082199|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
15082200|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15082201|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15082202|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
15082203|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
15082204|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15082205|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15082206|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
14266881|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14266882|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14266883|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14537861|NCT00755261|Bevacizumab|bevacizumab|mesh-list
14537862|NCT00755261|Doxorubicin|doxorubicin|mesh-list
14537863|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14537864|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537865|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14537866|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14537867|NCT00755261|Growth Substances|growth substances|mesh-ancestor
14537868|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537869|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14537870|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14537871|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14537872|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14537873|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537874|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537875|NCT00766636|Gemcitabine|gemcitabine|mesh-list
14537876|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14537877|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14537878|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
14537879|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537880|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537881|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
14537882|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537883|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537884|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14537885|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
14537886|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537887|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537888|NCT00768248|Ropivacaine|ropivacaine|mesh-list
14537889|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
14537890|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
14537891|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14537892|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537893|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
14537894|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537895|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
14537896|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
14537897|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14537898|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14537899|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14537900|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994291|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994292|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13994293|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
13994294|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
13994295|NCT02935582|Betamethasone|betamethasone|mesh-list
13994296|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
15082207|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082208|NCT03914625|Antidotes|antidotes|mesh-ancestor
15082209|NCT03914625|Protective Agents|protective agents|mesh-ancestor
13994297|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13994298|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
13994299|NCT02935582|Calcipotriene|calcipotriene|mesh-list
13994300|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13994301|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994302|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
13994303|NCT02935582|Hormones|hormones|mesh-ancestor
13994304|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994305|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994306|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13994307|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
13994308|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
13994309|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14537901|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537902|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14537903|NCT00764699|Mecasermin|mecasermin|mesh-list
14537904|NCT00764699|Growth Substances|growth substances|mesh-ancestor
14537905|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537906|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
14537907|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14537908|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15082210|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
15082211|NCT03914625|Vitamins|vitamins|mesh-ancestor
15082212|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
15082213|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082214|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082215|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082216|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082217|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15082218|NCT03914625|Hematinics|hematinics|mesh-ancestor
15082219|NCT03914612|Paclitaxel|paclitaxel|mesh-list
15082220|NCT03914612|Carboplatin|carboplatin|mesh-list
15082221|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
15082222|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15082223|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082224|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082225|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082226|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082227|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082228|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082229|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082230|NCT03910387|Gemcitabine|gemcitabine|mesh-list
15082231|NCT03910387|Paclitaxel|paclitaxel|mesh-list
15082232|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15082233|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082234|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082235|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082236|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082237|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082238|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082239|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15082240|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
15082241|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
15082242|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082243|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082244|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082245|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
15082246|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082247|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15082248|NCT03907488|Nivolumab|nivolumab|mesh-list
15082249|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15082250|NCT03907488|Doxorubicin|doxorubicin|mesh-list
15082251|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15082252|NCT03907488|Dacarbazine|dacarbazine|mesh-list
15082253|NCT03907488|Vinblastine|vinblastine|mesh-list
15082254|NCT03907488|Antibodies|antibodies|mesh-list
15082255|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
13994310|NCT02935530|Tinzaparin|tinzaparin|mesh-list
15082256|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13994311|NCT02935530|Dalteparin|dalteparin|mesh-list
13994312|NCT02935530|Argatroban|argatroban|mesh-list
13994313|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
13994314|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13994315|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13994316|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994317|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
13994318|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13994319|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
13994320|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994321|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13994322|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13994323|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
13994324|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13994325|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994326|NCT02935231|Nicotine|nicotine|mesh-list
13994327|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13994328|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
13994329|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994330|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994331|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13994332|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13994333|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
13994334|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994335|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994336|NCT02935374|Amoxicillin|amoxicillin|mesh-list
13994337|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
13994338|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
14537909|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
14537910|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537911|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537912|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537913|NCT00759577|Urological Agents|urological agents|mesh-ancestor
14537914|NCT00763009|Dipyridamole|dipyridamole|mesh-list
14537915|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14537916|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537917|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537918|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14537919|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
14537920|NCT00760461|Domperidone|domperidone|mesh-list
14537921|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
14537922|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
14537923|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537924|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537925|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14537926|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14537927|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
14537928|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537929|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537930|NCT00749658|Bupropion|bupropion|mesh-list
14537931|NCT00749658|Varenicline|varenicline|mesh-list
14537932|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14537933|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
14537934|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537935|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14537936|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14537937|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537938|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537939|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
14537940|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537941|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537942|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14537943|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14537944|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537945|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14537946|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14537947|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
14537948|NCT00754793|Dexetimide|dexetimide|mesh-list
14537949|NCT00754793|Citalopram|citalopram|mesh-list
14537950|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14537951|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14807870|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15082257|NCT03907488|Lenograstim|lenograstim|mesh-list
13994339|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994340|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994341|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13994342|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994343|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994344|NCT02935361|Atezolizumab|atezolizumab|mesh-list
13994345|NCT02935361|Guadecitabine|guadecitabine|mesh-list
13994346|NCT02935361|Azacitidine|azacitidine|mesh-list
13994347|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13994348|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994349|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
13994350|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994351|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13994352|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
13994353|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994354|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994355|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
13994356|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13994357|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13994358|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994359|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
13994360|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
13994361|NCT02935335|Menotropins|menotropins|mesh-list
13994362|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13994363|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
13994364|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13994365|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994366|NCT02935075|Tenofovir|tenofovir|mesh-list
14537952|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537953|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537954|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537955|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
14537956|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537957|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13994367|NCT02935075|Lamivudine|lamivudine|mesh-list
13994368|NCT02935075|Efavirenz|efavirenz|mesh-list
13994369|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
13994370|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994371|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13994372|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13994373|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994374|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994375|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13994376|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13994377|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13994378|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13994379|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13994380|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13994381|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13994382|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13994383|NCT02935101|Prednisolone|prednisolone|mesh-list
13994384|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13994385|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
13994386|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13994387|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
13994388|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13994389|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
13994390|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994391|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
13994392|NCT02935101|Hormones|hormones|mesh-ancestor
13994393|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994394|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994395|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14537958|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
14537959|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14537960|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14537961|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14537962|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
14537963|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
14537964|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14537965|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14537966|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14537967|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
14537968|NCT00754052|Donepezil|donepezil|mesh-list
13994396|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994397|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
15082258|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
13994398|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
13994399|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994400|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994401|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13994402|NCT02935101|Protective Agents|protective agents|mesh-ancestor
13994403|NCT02934945|Budesonide|budesonide|mesh-list
13994404|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
13994405|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994406|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13994407|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
13994408|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994409|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994410|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13994411|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
13994412|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
13994413|NCT02934945|Hormones|hormones|mesh-ancestor
13994414|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994415|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13994416|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13994417|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13994418|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
13994419|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994420|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994421|NCT02934919|Nalmefene|nalmefene|mesh-list
13994422|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13994423|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994424|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
13994425|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023229|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023230|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14023231|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14023232|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
14023233|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
14023234|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023235|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023236|NCT02764008|Bupivacaine|bupivacaine|mesh-list
14023237|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
14023238|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
14537969|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14537970|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537971|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537972|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
14537973|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537974|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537975|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
14537976|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14537977|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537978|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14537979|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14537980|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537981|NCT00752986|Fulvestrant|fulvestrant|mesh-list
14537982|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14537983|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14537984|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14537985|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14537986|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
14537987|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023239|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023240|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023241|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
14266884|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14266885|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14266886|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
14266887|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266888|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266889|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266890|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14266891|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266892|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14266893|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266894|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082259|NCT03907488|Imidazole|imidazole|mesh-list
13994426|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
13994427|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
13994428|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13994429|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13994430|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994431|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13994432|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
13994433|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13994434|NCT02934906|Antibodies|antibodies|mesh-list
13994435|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
13994436|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13994437|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
13994438|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994439|NCT02935010|Amoxicillin|amoxicillin|mesh-list
13994440|NCT02935010|Metronidazole|metronidazole|mesh-list
13994441|NCT02935010|Clarithromycin|clarithromycin|mesh-list
13994442|NCT02935010|Levofloxacin|levofloxacin|mesh-list
13994443|NCT02935010|Ofloxacin|ofloxacin|mesh-list
13994444|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
13994445|NCT02935010|Esomeprazole|esomeprazole|mesh-list
13994446|NCT02935010|Bismuth|bismuth|mesh-list
13994447|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994448|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994449|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994450|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13994451|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13994452|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13994453|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994454|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13994455|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994456|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13994457|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13994458|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13994459|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13994460|NCT02935010|Renal Agents|renal agents|mesh-ancestor
13994461|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13994462|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13994463|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994464|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14537988|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537989|NCT00746239|Dexetimide|dexetimide|mesh-list
14537990|NCT00746239|Citalopram|citalopram|mesh-list
14537991|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14537992|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14537993|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14537994|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14537995|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14537996|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
14537997|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14537998|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14537999|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
14538000|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538001|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14538002|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14538003|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
14538004|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
14538005|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538006|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14538007|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14538008|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
14538009|NCT00754013|Donepezil|donepezil|mesh-list
14538010|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14538011|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538012|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538013|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
14538014|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538015|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538016|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
14538017|NCT00751933|Vaccines|vaccines|mesh-list
14538018|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
14538019|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538020|NCT00746603|Simvastatin|simvastatin|mesh-list
14538021|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14538022|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13994465|NCT02935010|Antacids|antacids|mesh-ancestor
13994466|NCT02935010|Diuretics|diuretics|mesh-ancestor
14538023|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
13994467|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
13994468|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994469|NCT02935010|Expectorants|expectorants|mesh-ancestor
13994470|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
13994471|NCT02934763|Propranolol|propranolol|mesh-list
13994472|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13994473|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13994474|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
13994475|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994476|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994477|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994478|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13994479|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13994480|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
13994481|NCT02934464|Leucovorin|leucovorin|mesh-list
13994482|NCT02934464|Paclitaxel|paclitaxel|mesh-list
13994483|NCT02934464|Ramucirumab|ramucirumab|mesh-list
13994484|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
13994485|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
13994486|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13994487|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994488|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
13994489|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
13994490|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
13994491|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994492|NCT02934464|Antidotes|antidotes|mesh-ancestor
13994493|NCT02934464|Protective Agents|protective agents|mesh-ancestor
13994494|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994495|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
13994496|NCT02934464|Vitamins|vitamins|mesh-ancestor
13994497|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
13994498|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
13994499|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13994500|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
13994501|NCT02934321|Erythritol|erythritol|mesh-list
13994502|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
13994503|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13994504|NCT02934035|Citalopram|citalopram|mesh-list
13994505|NCT02934035|Fluoxetine|fluoxetine|mesh-list
13994506|NCT02934035|Paroxetine|paroxetine|mesh-list
13994507|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13994508|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
13994509|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13994510|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13994511|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13994512|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266895|NCT00386009|Tadalafil|tadalafil|mesh-list
14266896|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
14266897|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14266898|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14266899|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266900|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266901|NCT00386009|Urological Agents|urological agents|mesh-ancestor
14266902|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14266903|NCT00386022|Estrogens|estrogens|mesh-list
14266904|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
14266905|NCT00386022|Hormones|hormones|mesh-ancestor
14266906|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14266907|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266908|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
14266909|NCT00386100|Metformin|metformin|mesh-list
14266910|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14266911|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266912|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
14266913|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
14266914|NCT00386152|Hematinics|hematinics|mesh-ancestor
14538024|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538025|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14538026|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14538027|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538028|NCT00736385|Metformin|metformin|mesh-list
14538029|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14538030|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266915|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
14538031|NCT00738972|Valsartan|valsartan|mesh-list
14538032|NCT00738972|Simvastatin|simvastatin|mesh-list
13994513|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994514|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
13994515|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994516|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13994517|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13994518|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994519|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13994520|NCT02934035|Analgesics|analgesics|mesh-ancestor
13994521|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
13994522|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
13994523|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13994524|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13994525|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994526|NCT02934152|Amoxicillin|amoxicillin|mesh-list
13994527|NCT02934152|Clarithromycin|clarithromycin|mesh-list
13994528|NCT02934152|Rabeprazole|rabeprazole|mesh-list
13994529|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994530|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266916|NCT00386243|Analgesics|analgesics|mesh-list
14266917|NCT00386243|Narcotics|narcotics|mesh-ancestor
14266918|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266919|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266920|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
14266921|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266922|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
14266923|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14266924|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14266925|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266926|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
14266927|NCT00386308|Coagulants|coagulants|mesh-ancestor
14266928|NCT00386334|Eszopiclone|eszopiclone|mesh-list
14266929|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14266930|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266931|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266932|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
14266933|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14266934|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266935|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266936|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14266937|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266938|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14266939|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14266940|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266941|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
14266942|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14266943|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266944|NCT00386607|Valsartan|valsartan|mesh-list
14266945|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14266946|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14538033|NCT00738972|Ezetimibe|ezetimibe|mesh-list
14538034|NCT00738972|Pravastatin|pravastatin|mesh-list
14538035|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14538036|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14538037|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
14538038|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538039|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14538040|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14538041|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538042|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14538043|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14538044|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14538045|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14538046|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538047|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14538048|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538049|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538050|NCT00739882|Antibodies|antibodies|mesh-list
14538051|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14538052|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
14807871|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14807872|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807873|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15082260|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
13994531|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13994532|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994533|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994534|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13994535|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13994536|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13994537|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994538|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13994539|NCT02934295|Antibodies|antibodies|mesh-list
13994540|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
13994541|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994542|NCT02934022|Maraviroc|maraviroc|mesh-list
13994543|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13994544|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14538053|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538054|NCT00731770|Fluticasone|fluticasone|mesh-list
14538055|NCT00731770|Xhance|xhance|mesh-list
14538056|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14538057|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14538058|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538059|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14538060|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
14538061|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538062|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538063|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14538064|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
14538065|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
14538066|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14538067|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14538068|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14538069|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14538070|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
14538071|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538072|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538073|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
14538074|NCT00731770|Hormones|hormones|mesh-ancestor
14538075|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538076|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
14538077|NCT00729365|Ramipril|ramipril|mesh-list
14538078|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14538079|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
14538080|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538081|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538082|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14538083|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
14538084|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14538085|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14538086|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14538087|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538088|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538089|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
14538090|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538091|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538092|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14538093|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538094|NCT00726180|Trastuzumab|trastuzumab|mesh-list
14538095|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14538096|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538097|NCT00724282|Eszopiclone|eszopiclone|mesh-list
14538098|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14538099|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538100|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538101|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
14538102|NCT00728845|Paclitaxel|paclitaxel|mesh-list
14538103|NCT00728845|Bevacizumab|bevacizumab|mesh-list
14538104|NCT00728845|Carboplatin|carboplatin|mesh-list
14538105|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14538106|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538107|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14538108|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14538109|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14538110|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082261|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538111|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13994545|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994546|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13994547|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13994548|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
13994549|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994550|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13994551|NCT02934204|Methotrexate|methotrexate|mesh-list
13994552|NCT02934204|Temozolomide|temozolomide|mesh-list
13994553|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13994554|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
13994555|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13994556|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994557|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13994558|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
13994559|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994560|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994561|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
13994562|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538112|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14538113|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14538114|NCT00728845|Growth Substances|growth substances|mesh-ancestor
14538115|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538116|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
14538117|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
14538118|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14538119|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14538120|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538121|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538122|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14538123|NCT00726830|Morphine|morphine|mesh-list
14538124|NCT00726830|Oxycodone|oxycodone|mesh-list
14538125|NCT00726830|Methadone|methadone|mesh-list
14538126|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14538127|NCT00726830|Narcotics|narcotics|mesh-ancestor
14538128|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538129|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538130|NCT00726830|Analgesics|analgesics|mesh-ancestor
14538131|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
14538132|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538133|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
14538134|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
14538135|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
14538136|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538137|NCT00729560|Flutamide|flutamide|mesh-list
14538138|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
14538139|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
14538140|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538141|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538142|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14538143|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538144|NCT00716807|Nalbuphine|nalbuphine|mesh-list
14538145|NCT00716807|Naloxone|naloxone|mesh-list
14538146|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14538147|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538148|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
14538149|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538150|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14538151|NCT00716807|Narcotics|narcotics|mesh-ancestor
14538152|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538153|NCT00716807|Analgesics|analgesics|mesh-ancestor
14538154|NCT00714948|Gemcitabine|gemcitabine|mesh-list
14538155|NCT00714948|Sorafenib|sorafenib|mesh-list
14538156|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538157|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14538158|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
14538159|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538160|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
14538161|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14266947|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14266948|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14266949|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266950|NCT00386607|Diuretics|diuretics|mesh-ancestor
14266951|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
14538162|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538163|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538164|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
13994563|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13994564|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13994565|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
13994566|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994567|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13994568|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13994569|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
13994570|NCT02934061|Tizanidine|tizanidine|mesh-list
13994571|NCT02934061|Analgesics|analgesics|mesh-ancestor
13994572|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
13994573|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994574|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994575|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
13994576|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13994577|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13994578|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
13994579|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
13994580|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13994581|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13994582|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13994583|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
13994584|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994585|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538165|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538166|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14538167|NCT00720343|Choline|choline|mesh-list
14538168|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
14538169|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14538170|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
14538171|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538172|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14538173|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14538174|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
14538175|NCT00719914|Eptifibatide|eptifibatide|mesh-list
14538176|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14538177|NCT00718640|Dexamethasone|dexamethasone|mesh-list
14538178|NCT00718640|Bortezomib|bortezomib|mesh-list
14538179|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538180|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
14538181|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
14538182|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538183|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538184|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14538185|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
14538186|NCT00718640|Hormones|hormones|mesh-ancestor
14538187|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538188|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14538189|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538190|NCT00720083|Cisplatin|cisplatin|mesh-list
14538191|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538192|NCT00717275|Temozolomide|temozolomide|mesh-list
14538193|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14538194|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
14538195|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538196|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538197|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
14538198|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14538199|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14538200|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14538201|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538202|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538203|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
14538204|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538205|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538206|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14538207|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538208|NCT00706797|Etanercept|etanercept|mesh-list
14538209|NCT00706797|Methotrexate|methotrexate|mesh-list
14538210|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14538211|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
14538212|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14538213|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266952|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538214|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13994586|NCT02934217|Cyclosporine|cyclosporine|mesh-list
13994587|NCT02934217|Cyclosporins|cyclosporins|mesh-list
13994588|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994589|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994590|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13994591|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
13994592|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994593|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
13994594|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994595|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
13994596|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994597|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13994598|NCT02933905|Ranibizumab|ranibizumab|mesh-list
13994599|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13994600|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13994601|NCT02933905|Growth Substances|growth substances|mesh-ancestor
13994602|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994603|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
13994604|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994605|NCT02933697|Apixaban|apixaban|mesh-list
14266953|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14266954|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14266955|NCT00387010|Fentanyl|fentanyl|mesh-list
14266956|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14266957|NCT00387010|Narcotics|narcotics|mesh-ancestor
14266958|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14266959|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266960|NCT00387010|Analgesics|analgesics|mesh-ancestor
14266961|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
14266962|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266963|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14266964|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14538215|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
14538216|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538217|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538218|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
14538219|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538220|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14538221|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538222|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
14538223|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14538224|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14538225|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14538226|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14538227|NCT00706797|Analgesics|analgesics|mesh-ancestor
14538228|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
14538229|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538230|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538231|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14538232|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14538233|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
14538234|NCT00713596|Coagulants|coagulants|mesh-ancestor
14538235|NCT00703885|Alprazolam|alprazolam|mesh-list
14538236|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14538237|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538238|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538239|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14538240|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14538241|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538242|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
14538243|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
14538244|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538245|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538246|NCT00713258|Alendronate|alendronate|mesh-list
14538247|NCT00713258|Hormones|hormones|mesh-list
14538248|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
14538249|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538250|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538251|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14538252|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14538253|NCT00707161|Cisplatin|cisplatin|mesh-list
14538254|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538255|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
14538256|NCT00704496|Ephedrine|ephedrine|mesh-list
13994606|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
14266965|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
13994607|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13994608|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
13994609|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13994610|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
13994611|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994612|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994613|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
13994614|NCT02933814|Bupivacaine|bupivacaine|mesh-list
13994615|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
13994616|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
13994617|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994618|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994619|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
13994620|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994621|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
13994622|NCT02933775|Fludarabine|fludarabine|mesh-list
13994623|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13994624|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
13994625|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994626|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994627|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13994628|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
14538257|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14538258|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
14538259|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538260|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538261|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14538262|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
14538263|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
14538264|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14538265|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14538266|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
14538267|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
14538268|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538269|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538270|NCT00708916|Apremilast|apremilast|mesh-list
14538271|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14538272|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14538273|NCT00708916|Analgesics|analgesics|mesh-ancestor
14538274|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
14538275|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538276|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082262|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082263|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082264|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15082265|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15082266|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082267|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082268|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082269|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15082270|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082271|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
15082272|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082273|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082274|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082275|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082276|NCT03878095|Olaparib|olaparib|mesh-list
15082277|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15082278|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082279|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082280|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082281|NCT03871257|Carboplatin|carboplatin|mesh-list
15082282|NCT03871257|Vincristine|vincristine|mesh-list
15082283|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082284|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082285|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082286|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082287|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082288|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082289|NCT03866382|Nivolumab|nivolumab|mesh-list
15082290|NCT03866382|Ipilimumab|ipilimumab|mesh-list
15082291|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082292|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082293|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13994629|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994630|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994631|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13994632|NCT02933788|Aspirin|aspirin|mesh-list
13994633|NCT02933788|Cilostazol|cilostazol|mesh-list
13994634|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13994635|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13994636|NCT02933788|Analgesics|analgesics|mesh-ancestor
13994637|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
13994638|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994639|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994640|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994641|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994642|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13994643|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13994644|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994645|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13994646|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13994647|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994648|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
13994649|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13994650|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
13994651|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13994652|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
13994653|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
13994654|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13994655|NCT02933788|Protective Agents|protective agents|mesh-ancestor
13994656|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13994657|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13994658|NCT02933658|Amlodipine|amlodipine|mesh-list
13994659|NCT02933658|Telmisartan|telmisartan|mesh-list
13994660|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13994661|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13994662|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13994663|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13994664|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994665|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13994666|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994667|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
13994668|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13994669|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13994670|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
13994671|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13994672|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13994673|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994674|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13994675|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13994676|NCT02933593|Hydralazine|hydralazine|mesh-list
13994677|NCT02933593|Labetalol|labetalol|mesh-list
13994678|NCT02933593|Nifedipine|nifedipine|mesh-list
13994679|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13994680|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13994681|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994682|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13994683|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994684|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
13994685|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
13994686|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13994687|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13994688|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14538277|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538278|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14538279|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14538280|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14538281|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538282|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538283|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14538284|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14538285|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538286|NCT00699842|Lenalidomide|lenalidomide|mesh-list
14538287|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
14538288|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538289|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13994689|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13994690|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
13994691|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994692|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
13994693|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
13994694|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994695|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13994696|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13994697|NCT02933853|Insulin|insulin|mesh-list
13994698|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13994699|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
13994700|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
13994701|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
13994702|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13994703|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994704|NCT02933645|Insulin|insulin|mesh-list
13994705|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13994706|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13994707|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994708|NCT02933684|Cycloserine|cycloserine|mesh-list
13994709|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13994710|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994711|NCT02933684|Renal Agents|renal agents|mesh-ancestor
13994712|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13994713|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
13994714|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994715|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
13994716|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023242|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026110|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14026111|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026112|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
14026113|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026114|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14026115|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026116|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
14026117|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14026118|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026119|NCT02744716|Aspirin|aspirin|mesh-list
14026120|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14026121|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14026122|NCT02744716|Analgesics|analgesics|mesh-ancestor
14026123|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
14026124|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026125|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026126|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14026127|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026128|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14026129|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14026130|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026131|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14026132|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14026133|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026134|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
14026135|NCT02744768|Dasatinib|dasatinib|mesh-list
14026136|NCT02744768|Blinatumomab|blinatumomab|mesh-list
14026137|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026138|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14026139|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026140|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026141|NCT02744872|Felodipine|felodipine|mesh-list
14026142|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14026143|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14026144|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14026145|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026146|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026147|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14026148|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026149|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
14026150|NCT02744703|Capecitabine|capecitabine|mesh-list
14026151|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14026152|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14807874|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14026153|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
13994717|NCT02933333|Molgramostim|molgramostim|mesh-list
13994718|NCT02933333|Lenograstim|lenograstim|mesh-list
13994719|NCT02933333|Sargramostim|sargramostim|mesh-list
13994720|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13994721|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
13994722|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994723|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994724|NCT02933437|Ajmaline|ajmaline|mesh-list
13994725|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13994726|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13994727|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13994728|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13994729|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994730|NCT02932930|Ropivacaine|ropivacaine|mesh-list
13994731|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
13994732|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
13994733|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994734|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266966|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
14538290|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14538291|NCT00699842|Growth Substances|growth substances|mesh-ancestor
14538292|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
14538293|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538294|NCT00702962|Carboplatin|carboplatin|mesh-list
14538295|NCT00702962|Etoposide|etoposide|mesh-list
14538296|NCT00702962|Vorinostat|vorinostat|mesh-list
14538297|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538298|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14538299|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14538300|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14538301|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538302|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538303|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14538304|NCT00703534|Lesogaberan|lesogaberan|mesh-list
14538305|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14538306|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14538307|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
14538308|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
14538309|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538310|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538311|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538312|NCT00698009|Vidarabine|vidarabine|mesh-list
14538313|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
14538314|NCT00698009|Fludarabine|fludarabine|mesh-list
14538315|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
14538316|NCT00698009|Interleukin-2|interleukin-2|mesh-list
14538317|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538318|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
14538319|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538320|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14538321|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14538322|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
14538323|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538324|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538325|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14538326|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14538327|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
14538328|NCT00698009|Antiviral Agents|antiviral agents|mesh-ancestor
14538329|NCT00698009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538330|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14538331|NCT00698009|Analgesics|analgesics|mesh-ancestor
14538332|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
14538333|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538334|NCT00703339|Treprostinil|treprostinil|mesh-list
14538335|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14538336|NCT00691444|Melatonin|melatonin|mesh-list
14538337|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
14538338|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538339|NCT00691444|Protective Agents|protective agents|mesh-ancestor
14538340|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538341|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538342|NCT00691652|Rituximab|rituximab|mesh-list
15082294|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082295|NCT03865212|Interferons|interferons|mesh-list
13994735|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
14266967|NCT00387023|Rituximab|rituximab|mesh-list
14538343|NCT00691652|Clofarabine|clofarabine|mesh-list
13994736|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994737|NCT02932826|Insulin|insulin|mesh-list
13994738|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13994739|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994740|NCT02933099|Dexamethasone|dexamethasone|mesh-list
13994741|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
13994742|NCT02933099|Aprepitant|aprepitant|mesh-list
13994743|NCT02933099|Palonosetron|palonosetron|mesh-list
13994744|NCT02933099|BB 1101|bb 1101|mesh-list
13994745|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994746|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
13994747|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
13994748|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994749|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994750|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994751|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
13994752|NCT02933099|Hormones|hormones|mesh-ancestor
13994753|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994754|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13994755|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994756|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
13994757|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994758|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994759|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13994760|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994761|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13994762|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13994763|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
14266968|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14266969|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266970|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
14266971|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266972|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14266973|NCT00387036|Fluticasone|fluticasone|mesh-list
14266974|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14266975|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14266976|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
14266977|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266978|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266979|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14266980|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
14266981|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
14266982|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14266983|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
14266984|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14266985|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
14266986|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14266987|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14266988|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14266989|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
14266990|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
14266991|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14266992|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
14266993|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14266994|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14266995|NCT00387127|Lapatinib|lapatinib|mesh-list
14266996|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14266997|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14538344|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14538345|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538346|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
14266998|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14266999|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267000|NCT00387335|Sunitinib|sunitinib|mesh-list
14267001|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267002|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267003|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267004|NCT00387335|Growth Substances|growth substances|mesh-ancestor
14267005|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267006|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267007|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267008|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082296|NCT03865212|Interferon-beta|interferon-beta|mesh-list
13994764|NCT02932722|Anesthetics|anesthetics|mesh-list
13994765|NCT02932722|Propofol|propofol|mesh-list
13994766|NCT02932722|Sevoflurane|sevoflurane|mesh-list
13994767|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994768|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994769|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994770|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13994771|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
13994772|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13994773|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13994774|NCT02932761|Goserelin|goserelin|mesh-list
13994775|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13994776|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994777|NCT02932774|Cetirizine|cetirizine|mesh-list
13994778|NCT02932774|Loratadine|loratadine|mesh-list
13994779|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13994780|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13994781|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13994782|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
13994783|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
13994784|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994785|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994786|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994787|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
13994788|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
13994789|NCT02932605|Cannabidiol|cannabidiol|mesh-list
13994790|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
13994791|NCT02932488|Sumatriptan|sumatriptan|mesh-list
13994792|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13994793|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13994794|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13994795|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
13994796|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994797|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994798|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994799|NCT02932397|Propofol|propofol|mesh-list
13994800|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994801|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994802|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994803|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13994804|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
13994805|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
13994806|NCT02932566|Pirfenidone|pirfenidone|mesh-list
13994807|NCT02932566|Analgesics|analgesics|mesh-ancestor
13994808|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
13994809|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994810|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994811|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14538347|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538348|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14538349|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14538350|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
14538351|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538352|NCT00686972|Glucagon|glucagon|mesh-list
14538353|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14538354|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14538355|NCT00686972|Hormones|hormones|mesh-ancestor
14538356|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538357|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538358|NCT00686972|Incretins|incretins|mesh-ancestor
14538359|NCT00693017|Zonisamide|zonisamide|mesh-list
14538360|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
14538361|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14538362|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538363|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538364|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14538365|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538366|NCT00691574|Melatonin|melatonin|mesh-list
14538367|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
14538368|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538369|NCT00691574|Protective Agents|protective agents|mesh-ancestor
14538370|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807875|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
15082297|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082298|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
15082299|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082300|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
13994812|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13994813|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994814|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994815|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994816|NCT02932644|Vitamin D|vitamin d|mesh-list
15082301|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082302|NCT03843463|Dexetimide|dexetimide|mesh-list
15082303|NCT03843463|Citalopram|citalopram|mesh-list
15082304|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15082305|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15082306|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15082307|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082308|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082309|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
13994817|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
13994818|NCT02932644|Vitamins|vitamins|mesh-list
13994819|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
13994820|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994821|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13994822|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13994823|NCT02932436|Empagliflozin|empagliflozin|mesh-list
13994824|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13994825|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994826|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13994827|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994828|NCT02932007|Chloroquine|chloroquine|mesh-list
13994829|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
13994830|NCT02932007|Amebicides|amebicides|mesh-ancestor
14538371|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538372|NCT00692094|Melatonin|melatonin|mesh-list
14538373|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
14538374|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538375|NCT00692094|Protective Agents|protective agents|mesh-ancestor
14538376|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538377|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538378|NCT00692003|Zonisamide|zonisamide|mesh-list
14538379|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
14538380|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14538381|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538382|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538383|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14538384|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538385|NCT00678288|Interferons|interferons|mesh-list
14538386|NCT00678288|Sorafenib|sorafenib|mesh-list
14538387|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538388|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
14538389|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538390|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14538391|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538392|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538393|NCT00676026|Zolpidem|zolpidem|mesh-list
14538394|NCT00676026|Fluoxetine|fluoxetine|mesh-list
14538395|NCT00676026|Progesterone|progesterone|mesh-list
14538396|NCT00676026|Progestins|progestins|mesh-ancestor
14538397|NCT00676026|Hormones|hormones|mesh-ancestor
14538398|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538399|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538400|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14538401|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14538402|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538403|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538404|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538405|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
14538406|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14538407|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
14538408|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538409|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14538410|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14538411|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538412|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13994831|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13994832|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13994833|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994834|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
13994835|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13994836|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13994837|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13994838|NCT02932007|Analgesics|analgesics|mesh-ancestor
13994839|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
13994840|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994841|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994842|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994843|NCT02932007|Filaricides|filaricides|mesh-ancestor
13994844|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
13994845|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
13994846|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13994847|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
13994848|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13994849|NCT02932020|Prednisolone|prednisolone|mesh-list
13994850|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
13994851|NCT02932020|Bupivacaine|bupivacaine|mesh-list
13994852|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13994853|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
13994854|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
13994855|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
13994856|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994857|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994858|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
13994859|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994860|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13994861|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
13994862|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
13994863|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994864|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
13994865|NCT02932020|Hormones|hormones|mesh-ancestor
13994866|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994867|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13994868|NCT02932020|Protective Agents|protective agents|mesh-ancestor
13994869|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13994870|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994871|NCT02932137|Interleukin-2|interleukin-2|mesh-list
13994872|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13994873|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13994874|NCT02932137|Analgesics|analgesics|mesh-ancestor
13994875|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
13994876|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994877|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994878|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
13994879|NCT02932254|Analgesics|analgesics|mesh-ancestor
13994880|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
13994881|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994882|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994883|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
13994884|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994885|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13994886|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
13994887|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13994888|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13994889|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994890|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14538413|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14538414|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538415|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14538416|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
14538417|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
14538418|NCT00689052|Pramipexole|pramipexole|mesh-list
14538419|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
14538420|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538421|NCT00689052|Protective Agents|protective agents|mesh-ancestor
14538422|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538423|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14538424|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14538425|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
15082310|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538426|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
13994891|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
13994892|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13994893|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
13994894|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
13994895|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13994896|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994897|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267009|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267010|NCT00387348|Dexetimide|dexetimide|mesh-list
14267011|NCT00387348|Citalopram|citalopram|mesh-list
14267012|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14267013|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14267014|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14267015|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267016|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538427|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538428|NCT00678574|Fluoxetine|fluoxetine|mesh-list
14538429|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14538430|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14538431|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538432|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538433|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538434|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
14267017|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
14267018|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538435|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538436|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14538437|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
14538438|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538439|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14538440|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14538441|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538442|NCT00683917|Leuprolide|leuprolide|mesh-list
14538443|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14538444|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
14538445|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14538446|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538447|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14538448|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538449|NCT00688935|Melatonin|melatonin|mesh-list
14538450|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
14538451|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538452|NCT00688935|Protective Agents|protective agents|mesh-ancestor
14538453|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538454|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538455|NCT00685880|Betamethasone|betamethasone|mesh-list
14538456|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
14538457|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538458|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
14538459|NCT00685880|Hormones|hormones|mesh-ancestor
14538460|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538461|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538462|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14538463|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
14538464|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14538465|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
14807876|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14807877|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
14807878|NCT00823940|Glucagon|glucagon|mesh-list
13994898|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
13994899|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13994900|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994901|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994902|NCT02931786|Ketamine|ketamine|mesh-list
13994903|NCT02931786|Propofol|propofol|mesh-list
13994904|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994905|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994906|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994907|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14267019|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14267020|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14267021|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14267022|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14267023|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14267024|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
14267025|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
13994908|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
13994909|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
13994910|NCT02931786|Analgesics|analgesics|mesh-ancestor
13994911|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
13994912|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994913|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13994914|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13994915|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13994916|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994917|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994918|NCT02931877|Propofol|propofol|mesh-list
13994919|NCT02931877|Sevoflurane|sevoflurane|mesh-list
13994920|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13994921|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994922|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994923|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13994924|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
13994925|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
13994926|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13994927|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14023243|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
14023244|NCT02763475|Fludarabine|fludarabine|mesh-list
14023245|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14023246|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
14023247|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023248|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023249|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14023250|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
14023251|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023252|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023253|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14023254|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14023255|NCT02763137|Carbidopa|carbidopa|mesh-list
14023256|NCT02763137|Levodopa|levodopa|mesh-list
14023257|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14023258|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
14023259|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023260|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14023261|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14023262|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
14023263|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
14023264|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023265|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023266|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14023267|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023268|NCT02762955|Adalimumab|adalimumab|mesh-list
14023269|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023270|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023271|NCT02763098|Remifentanil|remifentanil|mesh-list
14023272|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14023273|NCT02763098|Narcotics|narcotics|mesh-ancestor
14023274|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023275|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538466|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538467|NCT00681044|Melphalan|melphalan|mesh-list
14538468|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
14538469|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538470|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14538471|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
14538472|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538473|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538474|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14538475|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538476|NCT00684255|Fludarabine|fludarabine|mesh-list
14538477|NCT00684255|Busulfan|busulfan|mesh-list
14538478|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
14538479|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538480|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538481|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538482|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
14538483|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538484|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
14538485|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14023276|NCT02763098|Analgesics|analgesics|mesh-ancestor
14023277|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
13994928|NCT02931591|Metformin|metformin|mesh-list
13994929|NCT02931591|Hormones|hormones|mesh-list
13994930|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13994931|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994932|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994933|NCT02931383|Liraglutide|liraglutide|mesh-list
13994934|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13994935|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994936|NCT02931383|Incretins|incretins|mesh-ancestor
13994937|NCT02931383|Hormones|hormones|mesh-ancestor
13994938|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994939|NCT02931474|Tesamorelin|tesamorelin|mesh-list
13994940|NCT02931474|Growth Substances|growth substances|mesh-ancestor
13994941|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994942|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
13994943|NCT02931357|Lidocaine|lidocaine|mesh-list
13994944|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
13994945|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
13994946|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
13994947|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13994948|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994949|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
13994950|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13994951|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13994952|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13994953|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13994954|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13994955|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994956|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13994957|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
13994958|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
13994959|NCT02931357|Protective Agents|protective agents|mesh-ancestor
13994960|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13994961|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994962|NCT02931526|Tigecycline|tigecycline|mesh-list
13994963|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994964|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994965|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13994966|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994967|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994968|NCT02931123|Rifaximin|rifaximin|mesh-list
13994969|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13994970|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994971|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13994972|NCT02931136|Huperzine A|huperzine a|mesh-list
13994973|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13994974|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13994975|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994976|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
13994977|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13994978|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994979|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13994980|NCT02931136|Protective Agents|protective agents|mesh-ancestor
13994981|NCT02931188|Anacetrapib|anacetrapib|mesh-list
13994982|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13994983|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13994984|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
13994985|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13994986|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13994987|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14538486|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14538487|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14538488|NCT00683787|Docetaxel|docetaxel|mesh-list
14538489|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538490|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
14538491|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
14538492|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
14538493|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642937|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642938|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14642939|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
14642940|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642941|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13994988|NCT02931175|Hormones|hormones|mesh-ancestor
14642942|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13994989|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13994990|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267026|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267027|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14267028|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14538494|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
14267029|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
14267030|NCT00387426|Sunitinib|sunitinib|mesh-list
14267031|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267032|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267033|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267034|NCT00387426|Growth Substances|growth substances|mesh-ancestor
14267035|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267036|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267037|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267038|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267039|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267040|NCT00387465|Azacitidine|azacitidine|mesh-list
14267041|NCT00387465|Entinostat|entinostat|mesh-list
14267042|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14267043|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267044|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
14267045|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267046|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267047|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267048|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14267049|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
14267050|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267051|NCT00387647|Azacitidine|azacitidine|mesh-list
14267052|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267053|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
14267054|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267055|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267056|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267057|NCT00387660|Carboplatin|carboplatin|mesh-list
14267058|NCT00387660|Irinotecan|irinotecan|mesh-list
14267059|NCT00387660|Camptothecin|camptothecin|mesh-list
14267060|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267061|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14267062|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14267063|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267064|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267065|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292334|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292335|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292336|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292337|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
14292338|NCT00560352|Hormones|hormones|mesh-ancestor
14292339|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292340|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292341|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292342|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14292343|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292344|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292345|NCT00560391|Dexamethasone|dexamethasone|mesh-list
14292346|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
14292347|NCT00560391|Lenalidomide|lenalidomide|mesh-list
14538495|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14538496|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538497|NCT00678041|Renal Agents|renal agents|mesh-ancestor
14538498|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14538499|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14538500|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
13994991|NCT02931071|Plerixafor|plerixafor|mesh-list
13994992|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13994993|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13994994|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
13994995|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13994996|NCT02930733|Bupivacaine|bupivacaine|mesh-list
13994997|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
13994998|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
13994999|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995000|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995001|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
13995002|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995003|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
13995004|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
13995005|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13995006|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13995007|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995008|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995009|NCT02930811|Urological Agents|urological agents|mesh-ancestor
13995010|NCT02930954|Gemcitabine|gemcitabine|mesh-list
13995011|NCT02930954|Bevacizumab|bevacizumab|mesh-list
13995012|NCT02930954|Carboplatin|carboplatin|mesh-list
13995013|NCT02930954|Pemetrexed|pemetrexed|mesh-list
13995014|NCT02930954|Gefitinib|gefitinib|mesh-list
13995015|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13995016|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995017|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13995018|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13995019|NCT02930954|Growth Substances|growth substances|mesh-ancestor
13995020|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995021|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
13995022|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995023|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
13995024|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995025|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
13995026|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995027|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995028|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995029|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
13995030|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13995031|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14267066|NCT00387751|Bevacizumab|bevacizumab|mesh-list
14267067|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14538501|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538502|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14538503|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14538504|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538505|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538506|NCT00669461|Lubiprostone|lubiprostone|mesh-list
14538507|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14538508|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538509|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538510|NCT00673309|Insulin|insulin|mesh-list
14538511|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14538512|NCT00673309|Itraconazole|itraconazole|mesh-list
14538513|NCT00673309|Propranolol|propranolol|mesh-list
14538514|NCT00673309|Hormones|hormones|mesh-list
14538515|NCT00673309|Oxandrolone|oxandrolone|mesh-list
14538516|NCT00673309|Nandrolone|nandrolone|mesh-list
14538517|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14538518|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538519|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538520|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538521|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14538522|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14538523|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
14538524|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538525|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14538526|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14538527|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
15082311|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15082312|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
15082313|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15082314|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14267068|NCT00387751|Sorafenib|sorafenib|mesh-list
14267069|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
14267070|NCT00387751|Antibodies|antibodies|mesh-list
14267071|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
14267072|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14267073|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
14267074|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267075|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267076|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13995032|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267077|NCT00387751|Growth Substances|growth substances|mesh-ancestor
14292348|NCT00560391|Dasatinib|dasatinib|mesh-list
14538528|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
13995033|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13995034|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13995035|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995036|NCT02930551|Lidocaine|lidocaine|mesh-list
13995037|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
13995038|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
13995039|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995040|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995041|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
13995042|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995043|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995044|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13995045|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13995046|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995047|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995048|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
13995049|NCT02930707|Bupivacaine|bupivacaine|mesh-list
13995050|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
13995051|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
13995052|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995053|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995054|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
13995055|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995056|NCT02930707|Analgesics|analgesics|mesh-ancestor
13995057|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995058|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
13995059|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13995060|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995061|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995062|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995063|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
13995064|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13995065|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
13995066|NCT02930434|Vitamin D|vitamin d|mesh-list
13995067|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
14538529|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538530|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14538531|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14538532|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538533|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14538534|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
14538535|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14538536|NCT00673309|Androgens|androgens|mesh-ancestor
14538537|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
14538538|NCT00673595|Varenicline|varenicline|mesh-list
14538539|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14538540|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14538541|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
14538542|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538543|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538544|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538545|NCT00673361|Temozolomide|temozolomide|mesh-list
14538546|NCT00673361|Sorafenib|sorafenib|mesh-list
14538547|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14538548|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
14538549|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538550|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538551|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14538552|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538553|NCT00668785|Ranibizumab|ranibizumab|mesh-list
14538554|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14538555|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14538556|NCT00668785|Growth Substances|growth substances|mesh-ancestor
14538557|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538558|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
14538559|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538560|NCT00673179|Leucovorin|leucovorin|mesh-list
14538561|NCT00673179|Gemcitabine|gemcitabine|mesh-list
14538562|NCT00673179|Doxorubicin|doxorubicin|mesh-list
14538563|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14538564|NCT00673179|Methotrexate|methotrexate|mesh-list
14538565|NCT00673179|Ifosfamide|ifosfamide|mesh-list
14538566|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
13995068|NCT02930434|Vitamins|vitamins|mesh-ancestor
14538567|NCT00673179|Razoxane|razoxane|mesh-list
14807879|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13995069|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
13995070|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995071|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13995072|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995073|NCT02930317|Factor VIII|factor viii|mesh-list
13995074|NCT02930317|Coagulants|coagulants|mesh-ancestor
13995075|NCT02930057|Betamethasone|betamethasone|mesh-list
13995076|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995077|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
13995078|NCT02930057|Hormones|hormones|mesh-ancestor
13995079|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13995080|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995081|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13995082|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
13995083|NCT02930109|Cytarabine|cytarabine|mesh-list
13995084|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995085|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
13995086|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995087|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995088|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
13995089|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995090|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995091|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
13995092|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995093|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
13995094|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13995095|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
13995096|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995097|NCT02930031|Expectorants|expectorants|mesh-ancestor
13995098|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
13995099|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13995100|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
13995101|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995102|NCT02930031|Protective Agents|protective agents|mesh-ancestor
13995103|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995104|NCT02930031|Antidotes|antidotes|mesh-ancestor
14023278|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023279|NCT02763059|Acetaminophen|acetaminophen|mesh-list
14267078|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267079|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267080|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
14267081|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267082|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267083|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267084|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
14267085|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267086|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14267087|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14267088|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14267089|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14267090|NCT00387829|Estradiol|estradiol|mesh-list
14267091|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14267092|NCT00387829|Estrogens|estrogens|mesh-ancestor
14267093|NCT00387829|Hormones|hormones|mesh-ancestor
14267094|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267095|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267096|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14267097|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
14267098|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14267099|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14267100|NCT00387881|Naproxen|naproxen|mesh-list
14267101|NCT00387881|Sumatriptan|sumatriptan|mesh-list
14023280|NCT02763059|Dexamethasone|dexamethasone|mesh-list
14267102|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14267103|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14267104|NCT00387881|Analgesics|analgesics|mesh-ancestor
14267105|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
14267106|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267107|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267108|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14267109|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14267110|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
14267111|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14267112|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267113|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995105|NCT02930265|Liraglutide|liraglutide|mesh-list
13995106|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13995107|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995108|NCT02930265|Incretins|incretins|mesh-ancestor
13995109|NCT02930265|Hormones|hormones|mesh-ancestor
13995110|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13995111|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
13995112|NCT02929927|Eusol|eusol|mesh-list
13995113|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
13995114|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995115|NCT02929797|Gemcitabine|gemcitabine|mesh-list
14267114|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14267115|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14267116|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14267117|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
14267118|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267119|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14267120|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267121|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267122|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267123|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267124|NCT00387959|Cyclosporine|cyclosporine|mesh-list
14267125|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
14267126|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
14267127|NCT00387959|Rituximab|rituximab|mesh-list
14267128|NCT00387959|Fludarabine|fludarabine|mesh-list
14267129|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
14267130|NCT00387959|Cyclosporins|cyclosporins|mesh-list
14267131|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267132|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
14267133|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267134|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14267135|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14267136|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
14267137|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267138|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267139|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14267140|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267141|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267142|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
14267143|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267144|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
14267145|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267146|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
14267147|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14267148|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14267149|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14267150|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
14267151|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14267152|NCT00388037|Sunitinib|sunitinib|mesh-list
14267153|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267154|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267155|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267156|NCT00388037|Growth Substances|growth substances|mesh-ancestor
14267157|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267158|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267159|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267160|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267161|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267162|NCT00388154|Gemcitabine|gemcitabine|mesh-list
14267163|NCT00388154|Cisplatin|cisplatin|mesh-list
14267164|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267165|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267166|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
14267167|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267168|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
14267169|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267170|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267171|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267172|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
14267173|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267174|NCT00388349|Gemcitabine|gemcitabine|mesh-list
13995116|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995117|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
14267175|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
14267176|NCT00388349|Carmustine|carmustine|mesh-list
14267177|NCT00388349|Etoposide|etoposide|mesh-list
13995118|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995119|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995120|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
13995121|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995122|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995123|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995124|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
13995125|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995126|NCT02929901|Caffeine|caffeine|mesh-list
13995127|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13995128|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995129|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13995130|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995131|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995132|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13995133|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13995134|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
13995135|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995136|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
13995137|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13995138|NCT02929706|Azathioprine|azathioprine|mesh-list
13995139|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
13995140|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995141|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995142|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995143|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995144|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
13995145|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995146|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995147|NCT02929693|Gefitinib|gefitinib|mesh-list
13995148|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995149|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13995150|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995151|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995152|NCT02929719|Dapsone|dapsone|mesh-list
13995153|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995154|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
13995155|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13995156|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13995157|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13995158|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995159|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995160|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
13995161|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995162|NCT02929524|Ketamine|ketamine|mesh-list
13995163|NCT02929524|Analgesics|analgesics|mesh-ancestor
13995164|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
13995165|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995166|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995167|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13995168|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13995169|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
13995170|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
13995171|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995172|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13995173|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13995174|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995175|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995176|NCT02929888|Aspirin|aspirin|mesh-list
13995177|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13995178|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995179|NCT02929888|Analgesics|analgesics|mesh-ancestor
13995180|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
13995181|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267178|NCT00388349|Vinorelbine|vinorelbine|mesh-list
14267179|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267180|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
14267181|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267182|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14267183|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14267184|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
14538568|NCT00673179|Sargramostim|sargramostim|mesh-list
14538569|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538570|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995182|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995183|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995184|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995185|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13995186|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13995187|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995188|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13995189|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13995190|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995191|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
13995192|NCT02929563|Pantoprazole|pantoprazole|mesh-list
13995193|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13995194|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13995195|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13995196|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995197|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995198|NCT02929459|Vitamins|vitamins|mesh-list
13995199|NCT02929459|Riboflavin|riboflavin|mesh-list
13995200|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
13995201|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
13995202|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995203|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13995204|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
13995205|NCT02929576|Paclitaxel|paclitaxel|mesh-list
13995206|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13995207|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995208|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
13995209|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
13995210|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
13995211|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995212|NCT02929121|Doxycycline|doxycycline|mesh-list
13995213|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995214|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995215|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
13995216|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13995217|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13995218|NCT02929134|Doxycycline|doxycycline|mesh-list
13995219|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995220|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538571|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
14538572|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538573|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
14538574|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538575|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538576|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538577|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
14538578|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538579|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14538580|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14538581|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14538582|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14538583|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
14538584|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14538585|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
14538586|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14538587|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14538588|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14538589|NCT00673179|Antidotes|antidotes|mesh-ancestor
14538590|NCT00673179|Protective Agents|protective agents|mesh-ancestor
14538591|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
14538592|NCT00673179|Vitamins|vitamins|mesh-ancestor
14538593|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
14538594|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14538595|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
14538596|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14538597|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
14538598|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
14538599|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14538600|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
14538601|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538602|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14538603|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14538604|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995221|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
13995222|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13995223|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14538605|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995224|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13995225|NCT02929147|Morphine|morphine|mesh-list
13995226|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13995227|NCT02929147|Narcotics|narcotics|mesh-ancestor
13995228|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995229|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995230|NCT02929147|Analgesics|analgesics|mesh-ancestor
13995231|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
13995232|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995233|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13995234|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995235|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995236|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995237|NCT02929212|Acetaminophen|acetaminophen|mesh-list
13995238|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995239|NCT02929212|Analgesics|analgesics|mesh-ancestor
13995240|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
13995241|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995242|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995243|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
13995244|NCT02929251|Adalimumab|adalimumab|mesh-list
13995245|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13995246|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995247|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995248|NCT02929394|Trabectedin|trabectedin|mesh-list
13995249|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13995250|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
13995251|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995252|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538606|NCT00660348|Morphine|morphine|mesh-list
14538607|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14538608|NCT00660348|Narcotics|narcotics|mesh-ancestor
14538609|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538610|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538611|NCT00660348|Analgesics|analgesics|mesh-ancestor
14538612|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
14538613|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538614|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
14538615|NCT00664066|Hematinics|hematinics|mesh-ancestor
14538616|NCT00667017|Immunotoxins|immunotoxins|mesh-list
14538617|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
14538618|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538619|NCT00665444|Aripiprazole|aripiprazole|mesh-list
14538620|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
14538621|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538622|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14538623|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14538624|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538625|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538626|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
14538627|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
14538628|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538629|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538630|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14538631|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14538632|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
14538633|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14538634|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14538635|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14538636|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14538637|NCT00656916|Fluticasone|fluticasone|mesh-list
14538638|NCT00656916|Xhance|xhance|mesh-list
14538639|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538640|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14538641|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
14538642|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538643|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538644|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14538645|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
14538646|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
14538647|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14538648|NCT00660595|Risperidone|risperidone|mesh-list
14538649|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14538650|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14538651|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
13995253|NCT02929316|Vedolizumab|vedolizumab|mesh-list
14538652|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538653|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538654|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538655|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13995254|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13995255|NCT02929095|Midazolam|midazolam|mesh-list
13995256|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
14538656|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14538657|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538658|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538659|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14538660|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
14538661|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
14538662|NCT00661466|Bupivacaine|bupivacaine|mesh-list
14538663|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
14538664|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
15082315|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15082316|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
15082317|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
15082318|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082319|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15082320|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15082321|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
15082322|NCT03842709|Pramipexole|pramipexole|mesh-list
15082323|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
15082324|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082325|NCT03842709|Protective Agents|protective agents|mesh-ancestor
15082326|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082327|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15082328|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15082329|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
15082330|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
15082331|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082332|NCT03838484|Nicotine|nicotine|mesh-list
15082333|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15082334|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
15082335|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082336|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082337|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15082338|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15082339|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
15082340|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082341|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082342|NCT03813147|Cytarabine|cytarabine|mesh-list
15082343|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
15082344|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15082345|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15082346|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13995257|NCT02929095|Remifentanil|remifentanil|mesh-list
13995258|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13995259|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995260|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995261|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995262|NCT02929095|Analgesics|analgesics|mesh-ancestor
13995263|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
13995264|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995265|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13995266|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13995267|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13995268|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
13995269|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995270|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995271|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13995272|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13995273|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13995274|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13995275|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13995276|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
13995277|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
13995278|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
13995279|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
13995280|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15082347|NCT03813147|Methotrexate|methotrexate|mesh-list
15082348|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
13995281|NCT02929095|Narcotics|narcotics|mesh-ancestor
14292349|NCT00560391|BB 1101|bb 1101|mesh-list
13995282|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15082349|NCT03813147|Azacitidine|azacitidine|mesh-list
15082350|NCT03813147|Fludarabine|fludarabine|mesh-list
13995283|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13995284|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995285|NCT02928965|Minocycline|minocycline|mesh-list
13995286|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995287|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995288|NCT02928692|Minocycline|minocycline|mesh-list
13995289|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995290|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995291|NCT02928991|Vidarabine|vidarabine|mesh-list
13995292|NCT02928991|Fludarabine|fludarabine|mesh-list
13995293|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
13995294|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995295|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995296|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
13995297|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995298|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995299|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
13995300|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995301|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
13995302|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995303|NCT02928679|Liraglutide|liraglutide|mesh-list
13995304|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13995305|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995306|NCT02928679|Incretins|incretins|mesh-ancestor
13995307|NCT02928679|Hormones|hormones|mesh-ancestor
13995308|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13995309|NCT02928510|Idelalisib|idelalisib|mesh-list
13995310|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995311|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995312|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995313|NCT02928419|Lenalidomide|lenalidomide|mesh-list
13995314|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
13995315|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995316|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13995317|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13995318|NCT02928419|Growth Substances|growth substances|mesh-ancestor
13995319|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
13995320|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995321|NCT02928614|Liraglutide|liraglutide|mesh-list
13995322|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13995323|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995324|NCT02928614|Incretins|incretins|mesh-ancestor
13995325|NCT02928614|Hormones|hormones|mesh-ancestor
13995326|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023281|NCT02763059|Ibuprofen|ibuprofen|mesh-list
14023282|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023283|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
14023284|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
14023285|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023286|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023287|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023288|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
14023289|NCT02763059|Hormones|hormones|mesh-ancestor
14023290|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023291|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023292|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023293|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14023294|NCT02763059|Analgesics|analgesics|mesh-ancestor
14023295|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
14023296|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
14023297|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14023298|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023299|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14023300|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023301|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023302|NCT02763007|Pioglitazone|pioglitazone|mesh-list
14023303|NCT02763007|Alogliptin|alogliptin|mesh-list
14023304|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14023305|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023306|NCT02763007|Incretins|incretins|mesh-ancestor
14023307|NCT02763007|Hormones|hormones|mesh-ancestor
14023308|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023309|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14023310|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14023311|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082351|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
13995327|NCT02928601|Ondansetron|ondansetron|mesh-list
13995328|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
13995329|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
13995330|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995331|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995332|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13995333|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
15082352|NCT03813147|Pevonedistat|pevonedistat|mesh-list
15082353|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15082354|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
15082355|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15082356|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082357|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15082358|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
15082359|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082360|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082361|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
15082362|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13995334|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
13995335|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13995336|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
13995337|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995338|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995339|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13995340|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13995341|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995342|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13995343|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14538665|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538666|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538667|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
14538668|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538669|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14538670|NCT00646282|Vitamins|vitamins|mesh-ancestor
14538671|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
14538672|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538673|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14538674|NCT00657553|Bortezomib|bortezomib|mesh-list
14538675|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538676|NCT00655057|Citalopram|citalopram|mesh-list
14538677|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14538678|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14538679|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538680|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538681|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538682|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
14538683|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538684|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14538685|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
14538686|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538687|NCT00648895|Metoprolol|metoprolol|mesh-list
14538688|NCT00648895|Nebivolol|nebivolol|mesh-list
14538689|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14538690|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14538691|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
14538692|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
14538693|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538694|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538695|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14538696|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14538697|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14538698|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
14538699|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538700|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538701|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
14538702|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14538703|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14538704|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14538705|NCT00647426|Carboplatin|carboplatin|mesh-list
14538706|NCT00647426|Docetaxel|docetaxel|mesh-list
14538707|NCT00647426|Sorafenib|sorafenib|mesh-list
14538708|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538709|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
14538710|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082363|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995344|NCT02928575|Temozolomide|temozolomide|mesh-list
13995345|NCT02928575|Sunitinib|sunitinib|mesh-list
13995346|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14267185|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267186|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267187|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14267188|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267189|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
14267190|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
14267191|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267192|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267193|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14267194|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14267195|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14267196|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267197|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267198|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267199|NCT00388362|Sirolimus|sirolimus|mesh-list
14267200|NCT00388362|Prednisone|prednisone|mesh-list
14267201|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14267202|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
14267203|NCT00388362|Hormones|hormones|mesh-ancestor
14267204|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267205|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267206|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14267207|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267208|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14267209|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267210|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14267211|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
14267212|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267213|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
14267214|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14267215|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14538711|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
14538712|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538713|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14538714|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538715|NCT00637806|Megestrol|megestrol|mesh-list
14538716|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
14538717|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14538718|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14538719|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14538720|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
14538721|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14538722|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538723|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14538724|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14538725|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14538726|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538727|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
15082364|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
15082365|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995347|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
14538728|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14538729|NCT00652457|Memantine|memantine|mesh-list
14538730|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14538731|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14538732|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
14538733|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538734|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082366|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15082367|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
15082368|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082369|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082370|NCT03811002|Cisplatin|cisplatin|mesh-list
15082371|NCT03811002|Carboplatin|carboplatin|mesh-list
15082372|NCT03811002|Etoposide|etoposide|mesh-list
15082373|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
15082374|NCT03811002|Atezolizumab|atezolizumab|mesh-list
15082375|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
13995348|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995349|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082376|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082377|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995350|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13995351|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13995352|NCT02928575|Growth Substances|growth substances|mesh-ancestor
13995353|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995354|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
13995355|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13995356|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995357|NCT02928328|Lidocaine|lidocaine|mesh-list
13995358|NCT02928328|Lorazepam|lorazepam|mesh-list
13995359|NCT02928328|Capsaicin|capsaicin|mesh-list
13995360|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
13995361|NCT02928328|Butyric Acid|butyric acid|mesh-list
13995362|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
13995363|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
13995364|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995365|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995366|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
13995367|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995368|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995369|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13995370|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13995371|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995372|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995373|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
13995374|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
13995375|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
15082378|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13995376|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
13995377|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
13995378|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13995379|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13995380|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13995381|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13995382|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13995383|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
13995384|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
13995385|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995386|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
13995387|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
13995388|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
13995389|NCT02928315|Analgesics|analgesics|mesh-ancestor
13995390|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
13995391|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995392|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995393|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
13995394|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995395|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995396|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
14538735|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538736|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14538737|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14538738|NCT00642603|Bevacizumab|bevacizumab|mesh-list
14538739|NCT00642603|Capecitabine|capecitabine|mesh-list
14538740|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
14538741|NCT00642603|Irinotecan|irinotecan|mesh-list
14538742|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14538743|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538744|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14538745|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14538746|NCT00642603|Growth Substances|growth substances|mesh-ancestor
14538747|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538748|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
14538749|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14538750|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
14538751|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538752|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14538753|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14538754|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538755|NCT00629798|Fludarabine|fludarabine|mesh-list
14538756|NCT00629798|Melphalan|melphalan|mesh-list
14538757|NCT00629798|Busulfan|busulfan|mesh-list
14538758|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14538759|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995397|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14267216|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14538760|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995398|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995399|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995400|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995401|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
13995402|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13995403|NCT02927951|Pregabalin|pregabalin|mesh-list
13995404|NCT02927951|Analgesics|analgesics|mesh-ancestor
13995405|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
13995406|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995407|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995408|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
13995409|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13995410|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995411|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995412|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995413|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14267217|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14267218|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267219|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267220|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267221|NCT00388414|Analgesics|analgesics|mesh-ancestor
14267222|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
14267223|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267224|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
14267225|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14267226|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
14267227|NCT00388505|Tobramycin|tobramycin|mesh-list
14267228|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14267229|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267230|NCT00388583|Vaccines|vaccines|mesh-list
14267231|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
14267232|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267233|NCT00388674|Entecavir|entecavir|mesh-list
14267234|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
14267235|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267236|NCT00388804|Leuprolide|leuprolide|mesh-list
14267237|NCT00388804|Goserelin|goserelin|mesh-list
14267238|NCT00388804|Flutamide|flutamide|mesh-list
14267239|NCT00388804|Bicalutamide|bicalutamide|mesh-list
14267240|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14267241|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
14267242|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14267243|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267244|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14267245|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267246|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
14267247|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
15082379|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15082380|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15082381|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082382|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082383|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
15082384|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082385|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
15082386|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
15082387|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082388|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082389|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082390|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15082391|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
15082392|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082393|NCT03796650|Vancomycin|vancomycin|mesh-list
15082394|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15082395|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082396|NCT03793179|Carboplatin|carboplatin|mesh-list
15082397|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
15082398|NCT03793179|Pemetrexed|pemetrexed|mesh-list
15082399|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082400|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082401|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082402|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082403|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14267248|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267249|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14267250|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
13995414|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13995415|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995416|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13995417|NCT02927847|Nicotine|nicotine|mesh-list
13995418|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13995419|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
14267251|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14267252|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14267253|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14267254|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267255|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267256|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14267257|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
14267258|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14538761|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538762|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
14538763|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538764|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14538765|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
14538766|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14538767|NCT00637728|Megestrol|megestrol|mesh-list
14538768|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
14538769|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14538770|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14538771|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14538772|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
14538773|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14538774|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538775|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14538776|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14538777|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14538778|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538779|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
14538780|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14538781|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
14538782|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14538783|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538784|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
14538785|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14538786|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
14538787|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538788|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
14538789|NCT00642382|Protective Agents|protective agents|mesh-ancestor
14538790|NCT00637416|Lansoprazole|lansoprazole|mesh-list
14538791|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
14538792|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14538793|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14538794|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15082404|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15082405|NCT03793166|Nivolumab|nivolumab|mesh-list
13995420|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995421|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995422|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14267259|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14267260|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14267261|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267262|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267263|NCT00389168|Atenolol|atenolol|mesh-list
14267264|NCT00389168|Irbesartan|irbesartan|mesh-list
14267265|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14267266|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14267267|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14267268|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267269|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14267270|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
14267271|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
14267272|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267273|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267274|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14267275|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14267276|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14267277|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
14267278|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538795|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995423|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13995424|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
13995425|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995426|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995427|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
13995428|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13995429|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995430|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995431|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
13995432|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995433|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995434|NCT02927587|Propofol|propofol|mesh-list
13995435|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13995436|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995437|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995438|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13995439|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
13995440|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
13995441|NCT02927392|Leuprolide|leuprolide|mesh-list
13995442|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13995443|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
13995444|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13995445|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995446|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13995447|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995448|NCT02927405|Gabapentin|gabapentin|mesh-list
13995449|NCT02927405|Analgesics|analgesics|mesh-ancestor
13995450|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
13995451|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995452|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995453|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
13995454|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13995455|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13995456|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995457|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13995458|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13995459|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13995460|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995461|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995462|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
13995463|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
13995464|NCT02927379|Ketamine|ketamine|mesh-list
13995465|NCT02927379|Bupivacaine|bupivacaine|mesh-list
15082406|NCT03793166|Ipilimumab|ipilimumab|mesh-list
15082407|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082408|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995466|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
13995467|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
13995468|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995469|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995470|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
13995471|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995472|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13995473|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995474|NCT02927379|Analgesics|analgesics|mesh-ancestor
13995475|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13995476|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13995477|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13995478|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
13995479|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995480|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267279|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14267280|NCT00389207|Nevirapine|nevirapine|mesh-list
14538796|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538797|NCT00638222|Carvedilol|carvedilol|mesh-list
14538798|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14538799|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14538800|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14538801|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538802|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538803|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538804|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13995481|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15082409|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13995482|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13995483|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
13995484|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13995485|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13995486|NCT02927496|Doxycycline|doxycycline|mesh-list
13995487|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995488|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995489|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
13995490|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13995491|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13995492|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
13995493|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995494|NCT02927353|Adalimumab|adalimumab|mesh-list
13995495|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995496|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995497|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13995498|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
13995499|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995500|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
13995501|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13995502|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
13995503|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995504|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995505|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995506|NCT02927522|Donepezil|donepezil|mesh-list
13995507|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13995508|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995509|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995510|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
13995511|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995512|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995513|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
13995514|NCT02926976|Valproic Acid|valproic acid|mesh-list
13995515|NCT02926976|Risperidone|risperidone|mesh-list
13995516|NCT02926976|Aripiprazole|aripiprazole|mesh-list
13995517|NCT02926976|Clozapine|clozapine|mesh-list
13995518|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13995519|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
13995520|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538805|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
14538806|NCT00638222|Protective Agents|protective agents|mesh-ancestor
14538807|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14538808|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538809|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14538810|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
14538811|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14538812|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14538813|NCT00634322|Leucovorin|leucovorin|mesh-list
14538814|NCT00634322|Antidotes|antidotes|mesh-ancestor
14538815|NCT00634322|Protective Agents|protective agents|mesh-ancestor
14538816|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538817|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
14538818|NCT00634322|Vitamins|vitamins|mesh-ancestor
14538819|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
14538820|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
14538821|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
14538822|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538823|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
14538824|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538825|NCT00631137|Testosterone|testosterone|mesh-list
14538826|NCT00631137|Androgens|androgens|mesh-ancestor
14538827|NCT00631137|Hormones|hormones|mesh-ancestor
14538828|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14538829|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538830|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14538831|NCT00634972|Ketorolac|ketorolac|mesh-list
14538832|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14538833|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14538834|NCT00634972|Analgesics|analgesics|mesh-ancestor
14538835|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
14538836|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538837|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538838|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538839|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995521|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538840|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14538841|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538842|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538843|NCT00633061|Enoxaparin|enoxaparin|mesh-list
14538844|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
14538845|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13995522|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995523|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13995524|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13995525|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995526|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13995527|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13995528|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
13995529|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
13995530|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
13995531|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13995532|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13995533|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13995534|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13995535|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
13995536|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267281|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14267282|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14267283|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
14267284|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267285|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538846|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14538847|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538848|NCT00626444|Ascorbic Acid|ascorbic acid|mesh-list
14538849|NCT00626444|Vitamins|vitamins|mesh-ancestor
14538850|NCT00626444|Micronutrients|micronutrients|mesh-ancestor
14538851|NCT00626444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538852|NCT00626444|Antioxidants|antioxidants|mesh-ancestor
14538853|NCT00626444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538854|NCT00626444|Protective Agents|protective agents|mesh-ancestor
14538855|NCT00634010|Morphine|morphine|mesh-list
14538856|NCT00634010|Methadone|methadone|mesh-list
14538857|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14538858|NCT00634010|Narcotics|narcotics|mesh-ancestor
14538859|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538860|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538861|NCT00634010|Analgesics|analgesics|mesh-ancestor
14538862|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
14538863|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538864|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
14538865|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
14538866|NCT00623974|Teriparatide|teriparatide|mesh-list
14538867|NCT00623974|Calcitriol|calcitriol|mesh-list
14538868|NCT00623974|Calcium|calcium|mesh-list
14538869|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
14538870|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14538871|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538872|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14538873|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14538874|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538875|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538876|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14538877|NCT00623974|Vitamins|vitamins|mesh-ancestor
14538878|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
14538879|NCT00624650|Phenylephrine|phenylephrine|mesh-list
13995537|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
14267286|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14267287|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14267288|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
14267289|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538880|NCT00624650|Dobutamine|dobutamine|mesh-list
14538881|NCT00624650|Furosemide|furosemide|mesh-list
14538882|NCT00624650|Vasopressins|vasopressins|mesh-list
14538883|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
14538884|NCT00624650|Epinephrine|epinephrine|mesh-list
14538885|NCT00624650|Racepinephrine|racepinephrine|mesh-list
14538886|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
14538887|NCT00624650|Norepinephrine|norepinephrine|mesh-list
14538888|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14538889|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
14538890|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14538891|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14538892|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
14538893|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995538|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
13995539|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
13995540|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
13995541|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13995542|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13995543|NCT02926885|Liver Extracts|liver extracts|mesh-list
13995544|NCT02926885|Hematinics|hematinics|mesh-ancestor
13995545|NCT02926859|Cannabidiol|cannabidiol|mesh-list
13995546|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
13995547|NCT02927015|Iproplatin|iproplatin|mesh-list
13995548|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995549|NCT02926846|Vancomycin|vancomycin|mesh-list
13995550|NCT02926846|Gentamicins|gentamicins|mesh-list
13995551|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995552|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995553|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13995554|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995555|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995556|NCT02926690|OTS167|ots167|mesh-list
13995557|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13995558|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995559|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023312|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023313|NCT02762838|Folic Acid|folic acid|mesh-list
14023314|NCT02762838|Methotrexate|methotrexate|mesh-list
14023315|NCT02762838|Infliximab|infliximab|mesh-list
14023316|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14023317|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
14023318|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14023319|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023320|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14023321|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
14023322|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023323|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023324|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023325|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538894|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082410|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082411|NCT03787602|Avelumab|avelumab|mesh-list
15082412|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082413|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082414|NCT03775265|Gemcitabine|gemcitabine|mesh-list
15082415|NCT03775265|Cisplatin|cisplatin|mesh-list
15082416|NCT03775265|Fluorouracil|fluorouracil|mesh-list
15082417|NCT03775265|Atezolizumab|atezolizumab|mesh-list
15082418|NCT03775265|Mitomycins|mitomycins|mesh-list
15082419|NCT03775265|Mitomycin|mitomycin|mesh-list
15082420|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082421|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082422|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15082423|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
15082424|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082425|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
15082426|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082427|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082428|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082429|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
15082430|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082431|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082432|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
15082433|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15082434|NCT03749460|Nivolumab|nivolumab|mesh-list
15082435|NCT03749460|Ipilimumab|ipilimumab|mesh-list
14023326|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14023327|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538895|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538896|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14538897|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14538898|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
14538899|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538900|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14538901|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
14538902|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
14538903|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
15082436|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082437|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082438|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13995560|NCT02926586|Cytarabine|cytarabine|mesh-list
13995561|NCT02926586|Fludarabine|fludarabine|mesh-list
13995562|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995563|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995564|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
13995565|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995566|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995567|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
14267290|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14267291|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14267292|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14267293|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14538904|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14538905|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
14538906|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14538907|NCT00624650|Protective Agents|protective agents|mesh-ancestor
14538908|NCT00624650|Diuretics|diuretics|mesh-ancestor
14538909|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
14538910|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14538911|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14538912|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
14538913|NCT00624650|Coagulants|coagulants|mesh-ancestor
14538914|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14538915|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14538916|NCT00626561|Paclitaxel|paclitaxel|mesh-list
14538917|NCT00626561|Bevacizumab|bevacizumab|mesh-list
14538918|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14807880|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14807881|NCT00823940|Hormones|hormones|mesh-ancestor
14807882|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14807883|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807884|NCT00823940|Incretins|incretins|mesh-ancestor
14807885|NCT00824057|Midazolam|midazolam|mesh-list
14807886|NCT00824057|Caffeine|caffeine|mesh-list
14807887|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14807888|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14807889|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807890|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807891|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14807892|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807893|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14807894|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14807895|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
14807896|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
14807897|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
14807898|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
14807899|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807900|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807901|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14807902|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15082439|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082440|NCT03743662|Bevacizumab|bevacizumab|mesh-list
15082441|NCT03743662|Nivolumab|nivolumab|mesh-list
15082442|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082443|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082444|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15082445|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082446|NCT03743662|Growth Substances|growth substances|mesh-ancestor
13995568|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995569|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
14267294|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
14267295|NCT00389324|Antibodies|antibodies|mesh-list
14267296|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
14267297|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14267298|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14267299|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
14267300|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
14267301|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267302|NCT00389441|Axitinib|axitinib|mesh-list
14267303|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267304|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267305|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538919|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538920|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807903|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995570|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995571|NCT02926248|Colchicine|colchicine|mesh-list
13995572|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
13995573|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995574|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
13995575|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
13995576|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082447|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082448|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
15082449|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13995577|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538921|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
14538922|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
14538923|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538924|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14538925|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14538926|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14538927|NCT00626561|Growth Substances|growth substances|mesh-ancestor
14538928|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538929|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
14538930|NCT00613730|Gemcitabine|gemcitabine|mesh-list
14538931|NCT00613730|Panitumumab|panitumumab|mesh-list
14538932|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14538933|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
14538934|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538935|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538936|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
14538937|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538938|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538939|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538940|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
14538941|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538942|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14538943|NCT00625586|Gemcitabine|gemcitabine|mesh-list
14538944|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14538945|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
14538946|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538947|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538948|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
14538949|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538950|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538951|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14538952|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
14538953|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538954|NCT00625703|Linezolid|linezolid|mesh-list
14538955|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14538956|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14538957|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14538958|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538959|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538960|NCT00625742|Ibuprofen|ibuprofen|mesh-list
14538961|NCT00625742|Atenolol|atenolol|mesh-list
14538962|NCT00625742|Melatonin|melatonin|mesh-list
14538963|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14538964|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14538965|NCT00625742|Analgesics|analgesics|mesh-ancestor
14538966|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
14538967|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538968|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538969|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14538970|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14538971|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14538972|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538973|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538974|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
14538975|NCT00625742|Protective Agents|protective agents|mesh-ancestor
14538976|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538977|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14538978|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14538979|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
14538980|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
14538981|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13995578|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995579|NCT02926326|Azithromycin|azithromycin|mesh-list
13995580|NCT02926326|Acumapimod|acumapimod|mesh-list
13995581|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995582|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995583|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13995584|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995585|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995586|NCT02926183|Gemcitabine|gemcitabine|mesh-list
13995587|NCT02926183|Paclitaxel|paclitaxel|mesh-list
13995588|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13995589|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995590|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
13995591|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
13995592|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
13995593|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082450|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082451|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15082452|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
15082453|NCT03739814|Blinatumomab|blinatumomab|mesh-list
15082454|NCT03739814|Antibodies|antibodies|mesh-list
15082455|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
15082456|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082457|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
15082458|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15082459|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
15082460|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082461|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082462|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082463|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082464|NCT03737981|Venetoclax|venetoclax|mesh-list
15082465|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
15082466|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082467|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082468|NCT03729102|Vaccines|vaccines|mesh-list
15082469|NCT03729102|Immunologic Factors|immunologic factors|mesh-ancestor
15082470|NCT03729102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082471|NCT03728361|Nivolumab|nivolumab|mesh-list
15082472|NCT03728361|Temozolomide|temozolomide|mesh-list
15082473|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082474|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082475|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082476|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082477|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082478|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
15082479|NCT03715127|Psilocybin|psilocybin|mesh-list
15082480|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
13995594|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995595|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
13995596|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
13995597|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267306|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538982|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14538983|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14538984|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
14538985|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14538986|NCT00619242|Sorafenib|sorafenib|mesh-list
14538987|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14538988|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14538989|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14538990|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14538991|NCT00616577|Ropivacaine|ropivacaine|mesh-list
14538992|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
14538993|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
14538994|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14538995|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14538996|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
14538997|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14538998|NCT00616759|Propofol|propofol|mesh-list
14538999|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14539000|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15082481|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267307|NCT00389493|Risperidone|risperidone|mesh-list
15082482|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15082483|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
13995598|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995599|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995600|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
13995601|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995602|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
13995603|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13995604|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
13995605|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13995606|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
15082484|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082485|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082486|NCT03701282|Venetoclax|venetoclax|mesh-list
15082487|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
15082488|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082489|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082490|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
15082491|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082492|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082493|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15082494|NCT03682289|Olaparib|olaparib|mesh-list
15082495|NCT03682289|Adenosine|adenosine|mesh-list
15082496|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13995607|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995608|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995609|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
13995610|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
13995611|NCT02926053|Fludarabine|fludarabine|mesh-list
13995612|NCT02926053|Interleukin-2|interleukin-2|mesh-list
13995613|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995614|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
13995615|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995616|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995617|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14539001|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539002|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14539003|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
14539004|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
14539005|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
14539006|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14539007|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539008|NCT00616343|Zonisamide|zonisamide|mesh-list
14539009|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
14539010|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14539011|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14539012|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539013|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14539014|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539015|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
14539016|NCT00612677|Pemetrexed|pemetrexed|mesh-list
14539017|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267308|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14267309|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
14267310|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539018|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539019|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539020|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14539021|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14539022|NCT00616603|Dexamethasone|dexamethasone|mesh-list
14539023|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
14539024|NCT00616603|Ropivacaine|ropivacaine|mesh-list
14539025|NCT00616603|BB 1101|bb 1101|mesh-list
14539026|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539027|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
14539028|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
14539029|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539030|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539031|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539032|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
14539033|NCT00616603|Hormones|hormones|mesh-ancestor
14539034|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539035|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13995618|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
14539036|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539037|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
14539038|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539039|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995619|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995620|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995621|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13995622|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995623|NCT02926053|Analgesics|analgesics|mesh-ancestor
13995624|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
13995625|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995626|NCT02925832|Bupivacaine|bupivacaine|mesh-list
13995627|NCT02925832|Ropivacaine|ropivacaine|mesh-list
13995628|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
13995629|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
13995630|NCT02925832|Anesthetics|anesthetics|mesh-list
13995631|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995632|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995633|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
13995634|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995635|NCT02925975|Carvedilol|carvedilol|mesh-list
13995636|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13995637|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13995638|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
13995639|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995640|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995641|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995642|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13995643|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
13995644|NCT02925975|Protective Agents|protective agents|mesh-ancestor
13995645|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13995646|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995647|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995648|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
13995649|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13995650|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13995651|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13995652|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995653|NCT02925351|Clofarabine|clofarabine|mesh-list
13995654|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13995655|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
13995656|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995657|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995658|NCT02925299|Insulin|insulin|mesh-list
13995659|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13995660|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995661|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
13995662|NCT02925559|Gliclazide|gliclazide|mesh-list
14023328|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
14539040|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
14539041|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
14539042|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14539043|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
14539044|NCT00610532|Probenecid|probenecid|mesh-list
14539045|NCT00610532|Phenytoin|phenytoin|mesh-list
14539046|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
14539047|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14539048|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14539049|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14539050|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539051|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14539052|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14539053|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
14539054|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
14539055|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539056|NCT00610532|Renal Agents|renal agents|mesh-ancestor
14539057|NCT00609765|Dexamethasone|dexamethasone|mesh-list
14539058|NCT00609765|Bevacizumab|bevacizumab|mesh-list
14539059|NCT00609765|Doxorubicin|doxorubicin|mesh-list
14539060|NCT00609765|Fluorouracil|fluorouracil|mesh-list
14539061|NCT00609765|Streptozocin|streptozocin|mesh-list
14539062|NCT00609765|Ondansetron|ondansetron|mesh-list
14539063|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539064|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539065|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14539066|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14539067|NCT00609765|Growth Substances|growth substances|mesh-ancestor
15082497|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539068|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539069|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
13995663|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13995664|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995665|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13995666|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995667|NCT02925247|Anticoagulants|anticoagulants|mesh-list
13995668|NCT02925416|Oritavancin|oritavancin|mesh-list
13995669|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995670|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995671|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
14539070|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539071|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
14539072|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
14539073|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995672|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13995673|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995674|NCT02925195|Vitamin D|vitamin d|mesh-list
13995675|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
13995676|NCT02925195|Vitamins|vitamins|mesh-ancestor
13995677|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
13995678|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995679|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14267311|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267312|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267313|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14267314|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14267315|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267316|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14539074|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539075|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
14539076|NCT00609765|Hormones|hormones|mesh-ancestor
14539077|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539078|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539079|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14539080|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14539081|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14539082|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539083|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539084|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
14539085|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539086|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539087|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
14539088|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
14539089|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539090|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14539091|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
14539092|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539093|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14539094|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14539095|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14539096|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14539097|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14539098|NCT00608465|Ramipril|ramipril|mesh-list
14539099|NCT00608465|Eplerenone|eplerenone|mesh-list
14539100|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14539101|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
14539102|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539103|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539104|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14539105|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14539106|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
14539107|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539108|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539109|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14539110|NCT00608465|Diuretics|diuretics|mesh-ancestor
14539111|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
14539112|NCT00608777|Betamethasone|betamethasone|mesh-list
14539113|NCT00608777|Calcipotriene|calcipotriene|mesh-list
14539114|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539115|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
14539116|NCT00608777|Hormones|hormones|mesh-ancestor
14539117|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539118|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267317|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14023329|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995680|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995681|NCT02924922|Mannitol|mannitol|mesh-list
13995682|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13995683|NCT02924922|Diuretics|diuretics|mesh-ancestor
13995684|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
13995685|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995686|NCT02925026|Lactoferrin|lactoferrin|mesh-list
13995687|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995688|NCT02925130|Albuterol|albuterol|mesh-list
13995689|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13995690|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
13995691|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995692|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995693|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13995694|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
13995695|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
13995696|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13995697|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13995698|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13995699|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13995700|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
13995701|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995702|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995703|NCT02925000|Vinorelbine|vinorelbine|mesh-list
13995704|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13995705|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995706|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
13995707|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
13995708|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
13995709|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995710|NCT02924987|Aflibercept|aflibercept|mesh-list
13995711|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13995712|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13995713|NCT02924987|Growth Substances|growth substances|mesh-ancestor
13995714|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995715|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
13995716|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995717|NCT02924974|Lidocaine|lidocaine|mesh-list
13995718|NCT02924974|Morphine|morphine|mesh-list
13995719|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
13995720|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
13995721|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995722|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995723|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
13995724|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995725|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995726|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13995727|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13995728|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995729|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995730|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13995731|NCT02924974|Narcotics|narcotics|mesh-ancestor
13995732|NCT02924974|Analgesics|analgesics|mesh-ancestor
14023330|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14023331|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023332|NCT02762838|Hematinics|hematinics|mesh-ancestor
14023333|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
14023334|NCT02762838|Vitamins|vitamins|mesh-ancestor
14023335|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
14023336|NCT02762851|Vaccines|vaccines|mesh-list
14023337|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
14023338|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267318|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
14267319|NCT00389519|Ramipril|ramipril|mesh-list
14267320|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14267321|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
14267322|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267323|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267324|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14267325|NCT00389532|Vaccines|vaccines|mesh-list
14267326|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
14267327|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267328|NCT00389805|Pemetrexed|pemetrexed|mesh-list
14539119|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14023339|NCT02762981|Paclitaxel|paclitaxel|mesh-list
14023340|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14267329|NCT00389805|Bortezomib|bortezomib|mesh-list
13995733|NCT02924909|Paclitaxel|paclitaxel|mesh-list
13995734|NCT02924909|Carboplatin|carboplatin|mesh-list
13995735|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13995736|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995737|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
13995738|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
13995739|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
13995740|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995741|NCT02924857|Paclitaxel|paclitaxel|mesh-list
13995742|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13995743|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995744|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
13995745|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
13995746|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
13995747|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539120|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
14539121|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539122|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14539123|NCT00601848|Trioxsalen|trioxsalen|mesh-list
14539124|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539125|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539126|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14539127|NCT00607477|Minoxidil|minoxidil|mesh-list
14539128|NCT00607477|Hydralazine|hydralazine|mesh-list
14539129|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14539130|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
15082498|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082499|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082500|NCT03682289|Analgesics|analgesics|mesh-ancestor
15082501|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
15082502|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082503|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082504|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15082505|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
15082506|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15082507|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
15082508|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
15082509|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082510|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
15082511|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
15082512|NCT03670966|Fludarabine|fludarabine|mesh-list
15082513|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
15082514|NCT03670966|Tacrolimus|tacrolimus|mesh-list
15082515|NCT03670966|Antibodies|antibodies|mesh-list
15082516|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082517|NCT03670966|Sargramostim|sargramostim|mesh-list
15082518|NCT03670966|Lenograstim|lenograstim|mesh-list
15082519|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082520|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
15082521|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082522|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15082523|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082524|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
15082525|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082526|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082527|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15082528|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15082529|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
15082530|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082531|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15082532|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082533|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082534|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15082535|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
15082536|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15082537|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15082538|NCT03660826|Durvalumab|durvalumab|mesh-list
15082539|NCT03660826|Olaparib|olaparib|mesh-list
15082540|NCT03660826|Cediranib|cediranib|mesh-list
15082541|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15082542|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
15082543|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13995748|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
14539131|NCT00595920|Vaccines|vaccines|mesh-list
15082544|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
15082545|NCT03660826|Maleic acid|maleic acid|mesh-list
14539132|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
15082546|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13995749|NCT02924753|Fludarabine|fludarabine|mesh-list
13995750|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995751|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
13995752|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995753|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995754|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13995755|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
13995756|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995757|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995758|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13995759|NCT02924766|Prednisone|prednisone|mesh-list
13995760|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
13995761|NCT02924766|Niraparib|niraparib|mesh-list
13995762|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995763|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
13995764|NCT02924766|Hormones|hormones|mesh-ancestor
13995765|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539133|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539134|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
14539135|NCT00596947|Prednisone|prednisone|mesh-list
14539136|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
14539137|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14539138|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14539139|NCT00596947|Prednisolone|prednisolone|mesh-list
14539140|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
14539141|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13995766|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995767|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13995768|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995769|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13995770|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995771|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995772|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
13995773|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13995774|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13995775|NCT02924675|Pregabalin|pregabalin|mesh-list
13995776|NCT02924675|Analgesics|analgesics|mesh-ancestor
13995777|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
13995778|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995779|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995780|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
13995781|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13995782|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995783|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082547|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995784|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995785|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13995786|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13995787|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995788|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13995789|NCT02924532|Hormones|hormones|mesh-list
13995790|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
14539142|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
14539143|NCT00596947|Tacrolimus|tacrolimus|mesh-list
14539144|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
14539145|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14539146|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539147|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
14539148|NCT00596947|Hormones|hormones|mesh-ancestor
14539149|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539150|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539151|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539152|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539153|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539154|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
14539155|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14539156|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539157|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539158|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14539159|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14539160|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
14539161|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14539162|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082548|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
13995791|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13995792|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995793|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13995794|NCT02924506|Meloxicam|meloxicam|mesh-list
13995795|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13995796|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995797|NCT02924506|Analgesics|analgesics|mesh-ancestor
13995798|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
13995799|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995800|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995801|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995802|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995803|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13995804|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13995805|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995806|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995807|NCT02924727|Valsartan|valsartan|mesh-list
13995808|NCT02924727|Ramipril|ramipril|mesh-list
13995809|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
13995810|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13995811|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13995812|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13995813|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995814|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13995815|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
13995816|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267330|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267331|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539163|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
14539164|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
14539165|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539166|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539167|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14539168|NCT00596947|Protective Agents|protective agents|mesh-ancestor
14539169|NCT00584012|Docetaxel|docetaxel|mesh-list
14539170|NCT00584012|Lovastatin|lovastatin|mesh-list
14539171|NCT00584012|L 647318|l 647318|mesh-list
14539172|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
14539173|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539174|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14539175|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539176|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14539177|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539178|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14539179|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14539180|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
14539181|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14539182|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14539183|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539184|NCT00599131|Docetaxel|docetaxel|mesh-list
14539185|NCT00599131|Fluorouracil|fluorouracil|mesh-list
14539186|NCT00599131|Cetuximab|cetuximab|mesh-list
14539187|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539188|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
14539189|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539190|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
14539191|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539192|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
14539193|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539194|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539195|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
14539196|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539197|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539198|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
14539199|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
14539200|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539201|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
14539202|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539203|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539204|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
14539205|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539206|NCT00589550|Interferons|interferons|mesh-list
14539207|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
14807904|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14267332|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267333|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14267334|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14267335|NCT00389818|Prednisone|prednisone|mesh-list
14267336|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
14267337|NCT00389818|Rituximab|rituximab|mesh-list
14267338|NCT00389818|Doxorubicin|doxorubicin|mesh-list
14267339|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13995828|NCT02924311|Aflibercept|aflibercept|mesh-list
13995829|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13995830|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13995831|NCT02924311|Growth Substances|growth substances|mesh-ancestor
14539208|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
14539209|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14539210|NCT00589550|Sorafenib|sorafenib|mesh-list
14539211|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539212|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
14539213|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539214|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539215|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539216|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539217|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
14539218|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539219|NCT00577772|Rifaximin|rifaximin|mesh-list
14539220|NCT00577772|Lactulose|lactulose|mesh-list
14539221|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14539222|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539223|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539224|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14539225|NCT00592007|Fulvestrant|fulvestrant|mesh-list
14539226|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539227|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539228|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539229|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539230|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539231|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14539232|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14539233|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
14539234|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539235|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539236|NCT00595582|Curcumin|curcumin|mesh-list
14539237|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14539238|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14539239|NCT00595582|Analgesics|analgesics|mesh-ancestor
14539240|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
14539241|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539242|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539243|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539244|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539245|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539246|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539247|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539248|NCT00588146|Interferons|interferons|mesh-list
14539249|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
14539250|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
14539251|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14539252|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539253|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
14539254|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539255|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
14539256|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539257|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14539258|NCT00590538|Genistein|genistein|mesh-list
14539259|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539260|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14539261|NCT00590538|Protective Agents|protective agents|mesh-ancestor
14539262|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539263|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539264|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539265|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539266|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
15082549|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082550|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082551|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267340|NCT00389818|Vincristine|vincristine|mesh-list
13995832|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995833|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
13995834|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995835|NCT02924285|Amiodarone|amiodarone|mesh-list
13995836|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995837|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
13995838|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13995839|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13995840|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995841|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13995842|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13995843|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13995844|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995845|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13995846|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13995847|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13995848|NCT02924454|Metoprolol|metoprolol|mesh-list
13995849|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13995850|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13995851|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
13995852|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995853|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13995854|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
13995855|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
13995856|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995857|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995858|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13995859|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13995860|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13995861|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
13995862|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995863|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995864|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13995865|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
13995866|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995867|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267341|NCT00389818|Sargramostim|sargramostim|mesh-list
14267342|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267343|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
14267344|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267345|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14267346|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14267347|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
14267348|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267349|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267350|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14539267|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14539268|NCT00590538|Estrogens|estrogens|mesh-ancestor
15082552|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15082553|NCT03641313|Irinotecan|irinotecan|mesh-list
15082554|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15082555|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15082556|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082557|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082558|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082559|NCT03637972|Nicotine|nicotine|mesh-list
15082560|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15082561|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
15082562|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082563|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082564|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15082565|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14267351|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267352|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14267353|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14539269|NCT00590538|Hormones|hormones|mesh-ancestor
14539270|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267354|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14267355|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267356|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14267357|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
14267358|NCT00389818|Hormones|hormones|mesh-ancestor
15082566|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
13995868|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13995869|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13995870|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995871|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995872|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995873|NCT02924246|Vaccines|vaccines|mesh-list
13995874|NCT02924246|Immunologic Factors|immunologic factors|mesh-ancestor
13995875|NCT02924246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995876|NCT02924233|Nivolumab|nivolumab|mesh-list
13995877|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13995878|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995879|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13995880|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995881|NCT02923986|Dasatinib|dasatinib|mesh-list
13995882|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995883|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13995884|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995885|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995886|NCT02923934|Nivolumab|nivolumab|mesh-list
13995887|NCT02923934|Ipilimumab|ipilimumab|mesh-list
13995888|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13995889|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995890|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13995891|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995892|NCT02924038|Poly ICLC|poly iclc|mesh-list
13995893|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
13995894|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
13995895|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995896|NCT02924090|Ketamine|ketamine|mesh-list
13995897|NCT02924090|Etomidate|etomidate|mesh-list
13995898|NCT02924090|Analgesics|analgesics|mesh-ancestor
13995899|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
13995900|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995901|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995902|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13995903|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13995904|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
13995905|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
13995906|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995907|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13995908|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13995909|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995910|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995911|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13995912|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13995913|NCT02923999|Antibodies|antibodies|mesh-list
13995914|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
13995915|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13995916|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
13995917|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995918|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995919|NCT02923856|Clarithromycin|clarithromycin|mesh-list
13995920|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13995921|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13995922|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13995923|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023341|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14267359|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539271|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
14539272|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539273|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539274|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539275|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539276|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
14539277|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
14539278|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14539279|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539280|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539281|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
14539282|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14539283|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14539284|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539285|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
14539286|NCT00586716|Antibodies|antibodies|mesh-list
13995924|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995925|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13995926|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13995927|NCT02923869|Bupivacaine|bupivacaine|mesh-list
13995928|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
13995929|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
13995930|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
13995931|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995932|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995933|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
13995934|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995935|NCT02923791|Lenograstim|lenograstim|mesh-list
13995936|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13995937|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
13995938|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995939|NCT02923687|Ketorolac|ketorolac|mesh-list
13995940|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13995941|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13995942|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13995943|NCT02923687|Analgesics|analgesics|mesh-ancestor
13995944|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
13995945|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13995946|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995947|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13995948|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13995949|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13995950|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13995951|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995952|NCT02923557|Pirarubicin|pirarubicin|mesh-list
13995953|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13995954|NCT02923583|Abatacept|abatacept|mesh-list
13995955|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13995956|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539287|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
14539288|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14539289|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14539290|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
14539291|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539292|NCT00588471|Simvastatin|simvastatin|mesh-list
14539293|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14539294|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14539295|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
14539296|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539297|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14539298|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14539299|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539300|NCT00590135|Atorvastatin|atorvastatin|mesh-list
14539301|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14539302|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14539303|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
14539304|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539305|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14539306|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14539307|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539308|NCT00582036|Insulin|insulin|mesh-list
14539309|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14539310|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14539311|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539312|NCT00585585|Betahistine|betahistine|mesh-list
14539313|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
14539314|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
14539315|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
14539316|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539317|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539318|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539319|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14539320|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
14539321|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539322|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539323|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539324|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539325|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
14539326|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539327|NCT00579254|Amlodipine|amlodipine|mesh-list
14539328|NCT00579254|Atorvastatin|atorvastatin|mesh-list
14539329|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14539330|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14539331|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
14539332|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539333|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14539334|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14539335|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539336|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14539337|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14539338|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14539339|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14539340|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539341|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
14539342|NCT00585611|Atorvastatin|atorvastatin|mesh-list
14539343|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14539344|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14539345|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
14539346|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539347|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14539348|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14807905|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14807906|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
14814131|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14814132|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
14814133|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
14814134|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814135|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14814136|NCT00861627|Paclitaxel|paclitaxel|mesh-list
14814137|NCT00861627|Carboplatin|carboplatin|mesh-list
14814138|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14814139|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814140|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
14814141|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
14814142|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
14814143|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814548|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814549|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814550|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
14814551|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14814552|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
14814553|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814554|NCT00863785|Expectorants|expectorants|mesh-ancestor
14814555|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
14814556|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14814557|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
14814558|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814559|NCT00863785|Protective Agents|protective agents|mesh-ancestor
14814560|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814561|NCT00863785|Antidotes|antidotes|mesh-ancestor
14814562|NCT00863837|Terlipressin|terlipressin|mesh-list
14814563|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14814564|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14814565|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814566|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814567|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814568|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14814569|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14814570|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
14814571|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814572|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814573|NCT00863863|Griseofulvin|griseofulvin|mesh-list
14814574|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
14814575|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814576|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14814577|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
14814578|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14814579|NCT00863889|Prednisolone|prednisolone|mesh-list
14814580|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
14814581|NCT00863889|Lidocaine|lidocaine|mesh-list
14814582|NCT00863889|Bupivacaine|bupivacaine|mesh-list
14814583|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14814584|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
14814585|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
14814586|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
14539349|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539350|NCT00572260|Daptomycin|daptomycin|mesh-list
14539351|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14539352|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539353|NCT00571194|Pravastatin|pravastatin|mesh-list
14539354|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14539355|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14539356|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
14539357|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539358|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14539359|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14539360|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539361|NCT00584935|Rituximab|rituximab|mesh-list
14539362|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539363|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539364|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
14539365|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539366|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539367|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
14539368|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14539369|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14539370|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539371|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14539372|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539373|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14539374|NCT00573391|Thalidomide|thalidomide|mesh-list
14539375|NCT00573391|Dexamethasone|dexamethasone|mesh-list
14539376|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
14539377|NCT00573391|Melphalan|melphalan|mesh-list
14539378|NCT00573391|Bortezomib|bortezomib|mesh-list
14539379|NCT00573391|BB 1101|bb 1101|mesh-list
14539380|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539381|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
14539382|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
14539383|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539384|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539385|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539386|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
14539387|NCT00573391|Hormones|hormones|mesh-ancestor
14539388|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539389|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539390|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539391|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
14539392|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539393|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539394|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14539395|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
14539396|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14539397|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539398|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
14539399|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
14539400|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15082567|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082568|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267360|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082569|NCT03623854|Nivolumab|nivolumab|mesh-list
15082570|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
15082571|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
15082572|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082573|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082574|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082575|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082576|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
15082577|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539401|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539402|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14539403|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14539404|NCT00573391|Growth Substances|growth substances|mesh-ancestor
14539405|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
14539406|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15082578|NCT03617328|Poly ICLC|poly iclc|mesh-list
15082579|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
14539407|NCT00570258|Fulvestrant|fulvestrant|mesh-list
14539408|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082580|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539409|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539410|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539411|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539412|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539413|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14539414|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14539415|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
14539416|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539417|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539418|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
14539419|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539420|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
14539421|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539422|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539423|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14539424|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
14539425|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539426|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
14539427|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539428|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539429|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14539430|NCT00574080|Cytarabine|cytarabine|mesh-list
14539431|NCT00574080|Thalidomide|thalidomide|mesh-list
14539432|NCT00574080|Dexamethasone|dexamethasone|mesh-list
14539433|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
14539434|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
14539435|NCT00574080|Melphalan|melphalan|mesh-list
14539436|NCT00574080|Carmustine|carmustine|mesh-list
14539437|NCT00574080|Cisplatin|cisplatin|mesh-list
14539438|NCT00574080|Etoposide|etoposide|mesh-list
14539439|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
14539440|NCT00574080|Doxorubicin|doxorubicin|mesh-list
14539441|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14539442|NCT00574080|Bortezomib|bortezomib|mesh-list
14539443|NCT00574080|BB 1101|bb 1101|mesh-list
14539444|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539445|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
14539446|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539447|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539448|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14539449|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
14539450|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539451|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539452|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14539453|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539454|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
14539455|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
14539456|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539457|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539458|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
14539459|NCT00574080|Hormones|hormones|mesh-ancestor
14539460|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539461|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539462|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
14539463|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539464|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14539465|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14539466|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14539467|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539468|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
14539469|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
14539470|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539471|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14539472|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
14539473|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14539474|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14539475|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14539476|NCT00574080|Growth Substances|growth substances|mesh-ancestor
14539477|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
14539478|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
14539479|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539480|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
14539481|NCT00558558|Hormones|hormones|mesh-ancestor
14539482|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539483|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539484|NCT00577356|Docetaxel|docetaxel|mesh-list
14539485|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539486|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082581|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
15082582|NCT03604991|Paclitaxel|paclitaxel|mesh-list
15082583|NCT03604991|Carboplatin|carboplatin|mesh-list
15082584|NCT03604991|Nivolumab|nivolumab|mesh-list
15082585|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15082586|NCT03604991|Ipilimumab|ipilimumab|mesh-list
15082587|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082588|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539487|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539488|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
14539489|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539490|NCT00573937|Morphine|morphine|mesh-list
14539491|NCT00573937|Methadone|methadone|mesh-list
14539492|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14539493|NCT00573937|Narcotics|narcotics|mesh-ancestor
14539494|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14539495|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539496|NCT00573937|Analgesics|analgesics|mesh-ancestor
14539497|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
14539498|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539499|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
14539500|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14539501|NCT00571922|Acamprosate|acamprosate|mesh-list
14539502|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14539503|NCT00569868|Bortezomib|bortezomib|mesh-list
14539504|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539505|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
14539506|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14539507|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539508|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14539509|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
14539510|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14539511|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539512|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539513|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539514|NCT00570531|Paclitaxel|paclitaxel|mesh-list
14539515|NCT00570531|Bevacizumab|bevacizumab|mesh-list
14539516|NCT00570531|Fluorouracil|fluorouracil|mesh-list
14539517|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14539518|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539519|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
14539520|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539521|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
14539522|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539523|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539524|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14539525|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14539526|NCT00570531|Growth Substances|growth substances|mesh-ancestor
14539527|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539528|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
14539529|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
14539530|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539531|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539532|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
14539533|NCT00561912|Interferons|interferons|mesh-list
14539534|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
14539535|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
14539536|NCT00561912|Decitabine|decitabine|mesh-list
14539537|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539538|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
14539539|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539540|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
14539541|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539542|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539543|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
14539544|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539545|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539546|NCT00561795|Paclitaxel|paclitaxel|mesh-list
14539547|NCT00561795|Carboplatin|carboplatin|mesh-list
14539548|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082589|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14539549|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539550|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
14539551|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539552|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082590|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539553|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539554|NCT00564876|Dasatinib|dasatinib|mesh-list
14539555|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539556|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539557|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539558|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539559|NCT00558870|Morphine|morphine|mesh-list
14539560|NCT00558870|Methadone|methadone|mesh-list
14539561|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14539562|NCT00558870|Narcotics|narcotics|mesh-ancestor
14539563|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14539564|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539565|NCT00558870|Analgesics|analgesics|mesh-ancestor
14539566|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
14539567|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539568|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
14539569|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
14539570|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
14539571|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
14539572|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14539573|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14539574|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539575|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14539576|NCT00521924|Cyclosporine|cyclosporine|mesh-list
14539577|NCT00521924|Chloroquine|chloroquine|mesh-list
14539578|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
14539579|NCT00521924|Methotrexate|methotrexate|mesh-list
14539580|NCT00521924|Infliximab|infliximab|mesh-list
14539581|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
14539582|NCT00521924|Cyclosporins|cyclosporins|mesh-list
14539583|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14539584|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
14539585|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14539586|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539587|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539588|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
14539589|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539590|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539591|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539592|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539593|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14539594|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539595|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
14539596|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14539597|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
14539598|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539599|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14539600|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539601|NCT00521924|Amebicides|amebicides|mesh-ancestor
14539602|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14539603|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14539604|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
14539605|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14539606|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14539607|NCT00521924|Analgesics|analgesics|mesh-ancestor
14539608|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
14539609|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539610|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539611|NCT00548886|Epinephrine|epinephrine|mesh-list
14539612|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14539613|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14539614|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14539615|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539616|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539617|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539618|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14539619|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14539620|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
14539621|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539622|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14539623|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
14539624|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
14539625|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
14539626|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14539627|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
14539628|NCT00539838|Prednisone|prednisone|mesh-list
14539629|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
14539630|NCT00539838|Methotrexate|methotrexate|mesh-list
14539631|NCT00539838|Azathioprine|azathioprine|mesh-list
14539632|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14539633|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
14539634|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539635|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
14539636|NCT00539838|Hormones|hormones|mesh-ancestor
14539637|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539638|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539639|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539640|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539641|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14539642|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
14539643|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14539644|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14807907|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
14807908|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14807909|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
14807910|NCT00824135|Rituximab|rituximab|mesh-list
14807911|NCT00824135|Melphalan|melphalan|mesh-list
14807912|NCT00824135|Thiotepa|thiotepa|mesh-list
14807913|NCT00824135|Clofarabine|clofarabine|mesh-list
14807914|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
14807915|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14807916|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082591|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082592|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082593|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082594|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082595|NCT03595124|Nivolumab|nivolumab|mesh-list
15082596|NCT03595124|Axitinib|axitinib|mesh-list
15082597|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082598|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082599|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082600|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082601|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15082602|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082603|NCT03587311|Paclitaxel|paclitaxel|mesh-list
15082604|NCT03587311|Maytansine|maytansine|mesh-list
15082605|NCT03587311|Bevacizumab|bevacizumab|mesh-list
15082606|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15082607|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15082608|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
15082609|NCT03587311|Antibodies|antibodies|mesh-list
15082610|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
15082611|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082612|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
15082613|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082614|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082615|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082616|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082617|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082618|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082619|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15082620|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082621|NCT03587311|Growth Substances|growth substances|mesh-ancestor
15082622|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082623|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
15082624|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
15082625|NCT03581292|Temozolomide|temozolomide|mesh-list
15082626|NCT03581292|Veliparib|veliparib|mesh-list
15082627|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082628|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
15082629|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082630|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082631|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15082632|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082633|NCT03573947|Paclitaxel|paclitaxel|mesh-list
15082634|NCT03573947|Nivolumab|nivolumab|mesh-list
15082635|NCT03573947|Ipilimumab|ipilimumab|mesh-list
15082636|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082637|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082638|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807917|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
14807918|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082639|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539645|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
14539646|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539647|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539648|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539649|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14539650|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
14539651|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539652|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14539653|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14539654|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14539655|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
14539656|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14539657|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539658|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
14539659|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
14539660|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539661|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539662|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14539663|NCT00539838|Protective Agents|protective agents|mesh-ancestor
14539664|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14539665|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14539666|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14539667|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14539668|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539669|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
14539670|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539671|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539672|NCT00542542|Fentanyl|fentanyl|mesh-list
14539673|NCT00542542|Midazolam|midazolam|mesh-list
14539674|NCT00542542|Propofol|propofol|mesh-list
14539675|NCT00542542|Ropivacaine|ropivacaine|mesh-list
14539676|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14539677|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14539678|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539679|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14539680|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
14539681|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
14539682|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14539683|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
14539684|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539685|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14539686|NCT00542542|Narcotics|narcotics|mesh-ancestor
14539687|NCT00542542|Analgesics|analgesics|mesh-ancestor
14539688|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14539689|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14539690|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14539691|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14539692|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
14539693|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
14539694|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539695|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539696|NCT00547300|Metoprolol|metoprolol|mesh-list
14539697|NCT00547300|Nebivolol|nebivolol|mesh-list
14539698|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14539699|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15082640|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
14539700|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
14539701|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
14539702|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539703|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539704|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14539705|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14539706|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14539707|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
14539708|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539709|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539710|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
14539711|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14539712|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14539713|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14539714|NCT00539617|Leucovorin|leucovorin|mesh-list
14539715|NCT00539617|Fluorouracil|fluorouracil|mesh-list
14539716|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
14539717|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14539718|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
14642943|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14539719|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539720|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539721|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539722|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539723|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
14539724|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539725|NCT00539617|Antidotes|antidotes|mesh-ancestor
14539726|NCT00539617|Protective Agents|protective agents|mesh-ancestor
14539727|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
14539728|NCT00539617|Vitamins|vitamins|mesh-ancestor
14539729|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
14539730|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539731|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539732|NCT00546455|Fenretinide|fenretinide|mesh-list
14539733|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539734|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14539735|NCT00546455|Protective Agents|protective agents|mesh-ancestor
14539736|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539737|NCT00538980|Dasatinib|dasatinib|mesh-list
14539738|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539739|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539740|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539741|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539742|NCT00535262|Selegiline|selegiline|mesh-list
14539743|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
14539744|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14539745|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14539746|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14539747|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14539748|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539749|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539750|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14539751|NCT00535262|Protective Agents|protective agents|mesh-ancestor
14539752|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539753|NCT00536978|Cytarabine|cytarabine|mesh-list
14539754|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
14539755|NCT00536978|Melphalan|melphalan|mesh-list
14539756|NCT00536978|Carmustine|carmustine|mesh-list
14539757|NCT00536978|Rituximab|rituximab|mesh-list
14539758|NCT00536978|Methotrexate|methotrexate|mesh-list
14539759|NCT00536978|Fludarabine|fludarabine|mesh-list
14539760|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
14539761|NCT00536978|Etoposide|etoposide|mesh-list
14539762|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
14539763|NCT00536978|Tacrolimus|tacrolimus|mesh-list
14539764|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539765|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
14539766|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539767|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539768|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14539769|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
14539770|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539771|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539772|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14539773|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539774|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14539775|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
14539776|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14539777|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539778|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
14539779|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539780|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539781|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14539782|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14539783|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
14539784|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539785|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14539786|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14539787|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14539788|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14539789|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14539790|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14539791|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539792|NCT00529282|Vancomycin|vancomycin|mesh-list
14539793|NCT00529282|Cefepime|cefepime|mesh-list
14539794|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
14539795|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14539796|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14539797|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539798|NCT00524134|Carvedilol|carvedilol|mesh-list
14539799|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14539800|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14539801|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
14539802|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14539803|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539804|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539805|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14539806|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
14539807|NCT00524134|Protective Agents|protective agents|mesh-ancestor
14539808|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14539809|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14539810|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14539811|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
14539812|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14539813|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14539814|NCT00517699|Cytarabine|cytarabine|mesh-list
14539815|NCT00517699|Rituximab|rituximab|mesh-list
14539816|NCT00517699|Methotrexate|methotrexate|mesh-list
14539817|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539818|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539819|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
14539820|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539821|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539822|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14539823|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
14539824|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14539825|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539826|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
14539827|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539828|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539829|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539830|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14539831|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539832|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14539833|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
14539834|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539835|NCT00528437|Carboplatin|carboplatin|mesh-list
14539836|NCT00528437|Temozolomide|temozolomide|mesh-list
14539837|NCT00528437|Thiotepa|thiotepa|mesh-list
14539838|NCT00528437|Tretinoin|tretinoin|mesh-list
14539839|NCT00528437|Isotretinoin|isotretinoin|mesh-list
14539840|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539841|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14539842|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
14539843|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539844|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14539845|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539846|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
14539847|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539848|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
14539849|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539850|NCT00527982|Celecoxib|celecoxib|mesh-list
14539851|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14539852|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14539853|NCT00527982|Analgesics|analgesics|mesh-ancestor
14539854|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
14539855|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539856|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539857|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539858|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539859|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14539860|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14539861|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539862|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539863|NCT00524459|Docetaxel|docetaxel|mesh-list
14539864|NCT00524459|Doxorubicin|doxorubicin|mesh-list
14539865|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14539866|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539867|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
14539868|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
14539869|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
14539870|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807919|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539871|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14539872|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14539873|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14539874|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539875|NCT00517361|Bevacizumab|bevacizumab|mesh-list
14539876|NCT00517361|Carboplatin|carboplatin|mesh-list
14539877|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539878|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082641|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082642|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082643|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082644|NCT03561870|Olaparib|olaparib|mesh-list
15082645|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15082646|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082647|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082648|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082649|NCT03530267|Aflibercept|aflibercept|mesh-list
15082650|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15082651|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082652|NCT03530267|Growth Substances|growth substances|mesh-ancestor
15082653|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539879|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14539880|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14539881|NCT00517361|Growth Substances|growth substances|mesh-ancestor
14539882|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539883|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
14539884|NCT00523939|Cytarabine|cytarabine|mesh-list
15082654|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
15082655|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082656|NCT03529110|Trastuzumab|trastuzumab|mesh-list
15082657|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15082658|NCT03529110|Maytansine|maytansine|mesh-list
15082659|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082660|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082661|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082662|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082663|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082664|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082665|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082666|NCT03526250|Palbociclib|palbociclib|mesh-list
15082667|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082668|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15082669|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082670|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082671|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
15082672|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15082673|NCT03524417|Antibodies|antibodies|mesh-list
15082674|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
15082675|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082676|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
15082677|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15082678|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082679|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15082680|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15082681|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
15082682|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082683|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15082684|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15082685|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082686|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15082687|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15082688|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15082689|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082690|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
15082691|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082692|NCT03497156|Lercanidipine|lercanidipine|mesh-list
15082693|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15082694|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15082695|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15082696|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082697|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14642944|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14539885|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539886|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
14539887|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539888|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539889|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
14539890|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539891|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539892|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
14539893|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539894|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
14539895|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539896|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539897|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539898|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539899|NCT00523809|Vidarabine|vidarabine|mesh-list
14539900|NCT00523809|Bevacizumab|bevacizumab|mesh-list
14539901|NCT00523809|Fludarabine|fludarabine|mesh-list
14539902|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
14539903|NCT00523809|Melphalan|melphalan|mesh-list
14539904|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
14539905|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14539906|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539907|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539908|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14539909|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14539910|NCT00523809|Growth Substances|growth substances|mesh-ancestor
14539911|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539912|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
14539913|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539914|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
14539915|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539916|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539917|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
14539918|NCT00523809|Antiviral Agents|antiviral agents|mesh-ancestor
14539919|NCT00523809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539920|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14539921|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
14539922|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14539923|NCT00522301|Sorafenib|sorafenib|mesh-list
14539924|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539925|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14539926|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539927|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539928|NCT00517192|Ritonavir|ritonavir|mesh-list
14539929|NCT00517192|Darunavir|darunavir|mesh-list
14539930|NCT00517192|Tipranavir|tipranavir|mesh-list
14539931|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14539932|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14539933|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
14539934|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14539935|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539936|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14539937|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14539938|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
14539939|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14539940|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14539941|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14539942|NCT00503581|Megestrol|megestrol|mesh-list
14539943|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
14539944|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14539945|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14539946|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14539947|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
14539948|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14539949|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539950|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14539951|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14539952|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14539953|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539954|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
14539955|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14539956|NCT00509600|Etanercept|etanercept|mesh-list
14539957|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14539958|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14539959|NCT00509600|Analgesics|analgesics|mesh-ancestor
14539960|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
14539961|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14539962|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539963|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14539964|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14539965|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14539966|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539967|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
14539968|NCT00515112|Testosterone|testosterone|mesh-list
14539969|NCT00515112|Androgens|androgens|mesh-ancestor
14539970|NCT00515112|Hormones|hormones|mesh-ancestor
14539971|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14539972|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539973|NCT00508872|Leucovorin|leucovorin|mesh-list
14539974|NCT00508872|Bevacizumab|bevacizumab|mesh-list
14539975|NCT00508872|Fluorouracil|fluorouracil|mesh-list
14539976|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
14539977|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14539978|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14539979|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14539980|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14539981|NCT00508872|Growth Substances|growth substances|mesh-ancestor
14539982|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539983|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
14539984|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
14539985|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539986|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14539987|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14539988|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
14539989|NCT00508872|Antidotes|antidotes|mesh-ancestor
14539990|NCT00508872|Protective Agents|protective agents|mesh-ancestor
14539991|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
14539992|NCT00508872|Vitamins|vitamins|mesh-ancestor
14539993|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
14539994|NCT00506064|Melatonin|melatonin|mesh-list
14539995|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
14539996|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14539997|NCT00506064|Protective Agents|protective agents|mesh-ancestor
14539998|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14539999|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540000|NCT00503880|Cytarabine|cytarabine|mesh-list
14540001|NCT00503880|Clofarabine|clofarabine|mesh-list
14540002|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540003|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
14540004|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540005|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540006|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
14540007|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540008|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540009|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
14540010|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540011|NCT00501228|Lenograstim|lenograstim|mesh-list
14540012|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14540013|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
14540014|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540015|NCT00496782|Maraviroc|maraviroc|mesh-list
14540016|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14540017|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14540018|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540019|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14540020|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14540021|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
14540022|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540023|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14540024|NCT00506909|Oxytocin|oxytocin|mesh-list
14540025|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
14540026|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14540027|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540028|NCT00487578|Naratriptan|naratriptan|mesh-list
14807920|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14807921|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14807922|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
14807923|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540029|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14807924|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540030|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14540031|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14540032|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
14540033|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540034|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540035|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995957|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082698|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082699|NCT03497143|Lamotrigine|lamotrigine|mesh-list
15082700|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
15082701|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15082702|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15082703|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082704|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14540036|NCT00503009|Fluticasone|fluticasone|mesh-list
14540037|NCT00503009|Xhance|xhance|mesh-list
14540038|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14540039|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540040|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14540041|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
14540042|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540043|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540044|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14540045|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14540046|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14540047|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14540048|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14540049|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14540050|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14540051|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
14540052|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540053|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540054|NCT00500045|Niacin|niacin|mesh-list
14540055|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
14540056|NCT00500045|Niacinamide|niacinamide|mesh-list
14540057|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14540058|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
14540059|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540060|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14540061|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14540062|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
14540063|NCT00500045|Vitamins|vitamins|mesh-ancestor
14540064|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
14540065|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540066|NCT00499590|Ranibizumab|ranibizumab|mesh-list
14540067|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14540068|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14540069|NCT00499590|Growth Substances|growth substances|mesh-ancestor
14540070|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540071|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
14540072|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540073|NCT00501345|Aspirin|aspirin|mesh-list
14540074|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14540075|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14540076|NCT00501345|Analgesics|analgesics|mesh-ancestor
14540077|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
14540078|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540079|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540080|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540081|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540082|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14540083|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14540084|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540085|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14540086|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14540087|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540088|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
14540089|NCT00496756|Sorafenib|sorafenib|mesh-list
14540090|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540091|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14540092|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540093|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807925|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267361|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540094|NCT00495716|Acyclovir|acyclovir|mesh-list
14540095|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
14540096|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540097|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
14540098|NCT00500890|Carboplatin|carboplatin|mesh-list
14540099|NCT00500890|Etoposide|etoposide|mesh-list
15082705|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082706|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15082707|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15082708|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15082709|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15082710|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15082711|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
15082712|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082713|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082714|NCT03479684|Warfarin|warfarin|mesh-list
15082715|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
15082716|NCT03466151|Sirolimus|sirolimus|mesh-list
15082717|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15082718|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082719|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082720|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082721|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
15082722|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082723|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
15082724|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082725|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
15082726|NCT03463460|Sunitinib|sunitinib|mesh-list
15082727|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082728|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082729|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15082730|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082731|NCT03463460|Growth Substances|growth substances|mesh-ancestor
15082732|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082733|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
15082734|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15082735|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082736|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082737|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
15082738|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15082739|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082740|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082741|NCT03440190|Methylphenidate|methylphenidate|mesh-list
15082742|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15082743|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082744|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15082745|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15082746|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15082747|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082748|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
15082749|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082750|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082751|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
15082752|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082753|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
15082754|NCT03393845|Fulvestrant|fulvestrant|mesh-list
15082755|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082756|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082757|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082758|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15082759|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15082760|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
15082761|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082762|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082763|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
15082764|NCT03391466|Fludarabine|fludarabine|mesh-list
15082765|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082766|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
15082767|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082768|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15082769|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082770|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
15082771|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540100|NCT00500890|Vincristine|vincristine|mesh-list
14540101|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540102|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
14540103|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540104|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540105|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14540106|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
14540107|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540108|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540109|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14540110|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540111|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14540112|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14540113|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540114|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540115|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540116|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540117|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14540118|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540119|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14540120|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540121|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540122|NCT00493025|Paclitaxel|paclitaxel|mesh-list
14540123|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14540124|NCT00493025|Cisplatin|cisplatin|mesh-list
14540125|NCT00493025|Gefitinib|gefitinib|mesh-list
14540126|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540127|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540128|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540129|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540130|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540131|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540132|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14540133|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540134|NCT00491400|Atorvastatin|atorvastatin|mesh-list
14540135|NCT00491400|Fenofibrate|fenofibrate|mesh-list
14540136|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14540137|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14540138|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
14540139|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540140|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14540141|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14540142|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540143|NCT00490776|Panobinostat|panobinostat|mesh-list
14540144|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540145|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14540146|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540147|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540148|NCT00487162|Insulin|insulin|mesh-list
14540149|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14540150|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540151|NCT00491387|Metoprolol|metoprolol|mesh-list
14540152|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14540153|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14540154|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
14540155|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
14540156|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540157|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540158|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14540159|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14540160|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14540161|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
14540162|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540163|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540164|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
14540165|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540166|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
14540167|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
14540168|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14540169|NCT00483119|Antibodies|antibodies|mesh-list
14540170|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
14540171|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14540172|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540173|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
14540174|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540175|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642945|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14540176|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14540177|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
14540178|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540179|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540180|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14540181|NCT00487461|Simvastatin|simvastatin|mesh-list
14540182|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14540183|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14540184|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
14540185|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540186|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14540187|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14540188|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540189|NCT00484718|Celecoxib|celecoxib|mesh-list
14540190|NCT00484718|Oxycodone|oxycodone|mesh-list
14540191|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14540192|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14540193|NCT00484718|Analgesics|analgesics|mesh-ancestor
14540194|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
14540195|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540196|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540197|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540198|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540199|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14540200|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14540201|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540202|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540203|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14540204|NCT00484718|Narcotics|narcotics|mesh-ancestor
14540205|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14642946|NCT00187525|Memantine|memantine|mesh-list
14642947|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14642948|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14642949|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
14642950|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642951|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642952|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642953|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14642954|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14642955|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
14642956|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14642957|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14642958|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642959|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14642960|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14642961|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
14642962|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642963|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
14642964|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
14642965|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642966|NCT00187564|Protective Agents|protective agents|mesh-ancestor
14642967|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642968|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
14642969|NCT00187564|Vitamins|vitamins|mesh-ancestor
14642970|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
14642971|NCT00187577|Bimatoprost|bimatoprost|mesh-list
14642972|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14642973|NCT00187577|Latanoprost|latanoprost|mesh-list
14642974|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14642975|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642976|NCT00187707|Gabapentin|gabapentin|mesh-list
14642977|NCT00187707|Analgesics|analgesics|mesh-ancestor
14642978|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
14642979|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642980|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642981|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
14642982|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14642983|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14642984|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14642985|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14642986|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14642987|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15082772|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642988|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540206|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14540207|NCT00470067|Carboplatin|carboplatin|mesh-list
14540208|NCT00470067|Doxorubicin|doxorubicin|mesh-list
14540209|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14540210|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540211|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14540212|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14540213|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14540214|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540215|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540216|NCT00476827|Gemcitabine|gemcitabine|mesh-list
14540217|NCT00476827|Paclitaxel|paclitaxel|mesh-list
14540218|NCT00476827|Vinorelbine|vinorelbine|mesh-list
14540219|NCT00476827|Docetaxel|docetaxel|mesh-list
14540220|NCT00476827|Bevacizumab|bevacizumab|mesh-list
14540221|NCT00476827|Irinotecan|irinotecan|mesh-list
14540222|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540223|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540224|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540225|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540226|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540227|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540228|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540229|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14540230|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082773|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15082774|NCT03382561|Cisplatin|cisplatin|mesh-list
15082775|NCT03382561|Carboplatin|carboplatin|mesh-list
15082776|NCT03382561|Nivolumab|nivolumab|mesh-list
15082777|NCT03382561|Etoposide|etoposide|mesh-list
15082778|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
15082779|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
15082780|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082781|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082782|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082783|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082784|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540231|NCT00476827|Growth Substances|growth substances|mesh-ancestor
14540232|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540233|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
14540234|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540235|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
14540236|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
14540237|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540238|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540239|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540240|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
14540241|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14540242|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14540243|NCT00475657|Pemetrexed|pemetrexed|mesh-list
14540244|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540245|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540246|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540247|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14540248|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540249|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14540250|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14540251|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
14540252|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540253|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
14540254|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
14540255|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14540256|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14540257|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14540258|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540259|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14540260|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14540261|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
14540262|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082785|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14540263|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
14540264|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14540265|NCT00459121|Paclitaxel|paclitaxel|mesh-list
14540266|NCT00459121|Carboplatin|carboplatin|mesh-list
14540267|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540268|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540269|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540270|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540271|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540272|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540273|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
14540274|NCT00450333|Hematinics|hematinics|mesh-ancestor
14540275|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
14540276|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14540277|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540278|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540279|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14540280|NCT00455143|Analgesics|analgesics|mesh-ancestor
14540281|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
14540282|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540283|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14540284|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14540285|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14540286|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
14540287|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540288|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082786|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15082787|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082788|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
15082789|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
15082790|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082791|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082792|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
15082793|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
15082794|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082795|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082796|NCT03367741|Nivolumab|nivolumab|mesh-list
15082797|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540289|NCT00456989|Docetaxel|docetaxel|mesh-list
14540290|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540291|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082798|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082799|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082800|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082801|NCT03360721|Prednisone|prednisone|mesh-list
15082802|NCT03360721|Cortisone|cortisone|mesh-list
15082803|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
15082804|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082805|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
15082806|NCT03360721|Hormones|hormones|mesh-ancestor
15082807|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082808|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082809|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082810|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082811|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15082812|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082813|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082814|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
15082815|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15082816|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082817|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
15082818|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082819|NCT03347331|Befiradol|befiradol|mesh-list
15082820|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15082821|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15082822|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
15082823|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082824|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082825|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082826|NCT03339128|Eluxadoline|eluxadoline|mesh-list
15082827|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15082828|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
15082829|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082830|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082831|NCT03317392|Olaparib|olaparib|mesh-list
15082832|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14540292|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540293|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540294|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540295|NCT00448682|Leucovorin|leucovorin|mesh-list
14540296|NCT00448682|Docetaxel|docetaxel|mesh-list
14540297|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
14540298|NCT00448682|Floxuridine|floxuridine|mesh-list
14540299|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
14540300|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540301|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540302|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540303|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540304|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540305|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540306|NCT00448682|Antidotes|antidotes|mesh-ancestor
14540307|NCT00448682|Protective Agents|protective agents|mesh-ancestor
14540308|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
14540309|NCT00448682|Vitamins|vitamins|mesh-ancestor
14540310|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
14540311|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540312|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
14540313|NCT00454571|Leuprolide|leuprolide|mesh-list
14540314|NCT00454571|Goserelin|goserelin|mesh-list
14540315|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14540316|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
14540317|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14540318|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540319|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14540320|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540321|NCT00452361|Cyclosporine|cyclosporine|mesh-list
14540322|NCT00452361|Sirolimus|sirolimus|mesh-list
14540323|NCT00452361|Tacrolimus|tacrolimus|mesh-list
14540324|NCT00452361|Cyclosporins|cyclosporins|mesh-list
14540325|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14540326|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540327|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
14540328|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540329|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540330|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540331|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
14540332|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540333|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
14540334|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540335|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540336|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14540337|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540338|NCT00447421|Pemetrexed|pemetrexed|mesh-list
14540339|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540340|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540341|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540342|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14540343|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540344|NCT00441272|Pioglitazone|pioglitazone|mesh-list
14540345|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14540346|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540347|NCT00440271|Ritonavir|ritonavir|mesh-list
14540348|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
14540349|NCT00440271|Maraviroc|maraviroc|mesh-list
14540350|NCT00440271|Tipranavir|tipranavir|mesh-list
14540351|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
14540352|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14540353|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14540354|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14540355|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
14540356|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540357|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540358|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14540359|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14540360|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
14540361|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540362|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14540363|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14540364|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14540365|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14540366|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14540367|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14540368|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14540369|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540370|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14540371|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540372|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
14540373|NCT00429026|Melphalan|melphalan|mesh-list
14540374|NCT00429026|Fludarabine|fludarabine|mesh-list
14540375|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540376|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
14540377|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540378|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540379|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14540380|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
14540381|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540382|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540383|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14540384|NCT00428207|Insulin|insulin|mesh-list
14540385|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14540386|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
14540387|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
14540388|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14540389|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
14540390|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14540391|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540392|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14540393|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540394|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
14540395|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14540396|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540397|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14540398|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
14540399|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540400|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540401|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540402|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540403|NCT00430027|Capecitabine|capecitabine|mesh-list
14540404|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
14540405|NCT00430027|Cetuximab|cetuximab|mesh-list
14540406|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540407|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
14540408|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540409|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540410|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540411|NCT00429858|Gemcitabine|gemcitabine|mesh-list
14540412|NCT00429858|Tegafur|tegafur|mesh-list
14540413|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540414|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
14540415|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540416|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540417|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
14540418|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540419|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540420|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540421|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
14540422|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540423|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
14540424|NCT00425438|Prednisolone|prednisolone|mesh-list
14540425|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
14540426|NCT00425438|Azathioprine|azathioprine|mesh-list
14540427|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540428|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
14540429|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540430|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15082833|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15082834|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082835|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082836|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082837|NCT03301415|Valganciclovir|valganciclovir|mesh-list
15082838|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
15082839|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082840|NCT03300557|Exemestane|exemestane|mesh-list
15082841|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082842|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15082843|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15082844|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540431|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14540432|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
15082845|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814144|NCT00861640|Omeprazole|omeprazole|mesh-list
14540433|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540434|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540435|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14540436|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14540437|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14540438|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
14540439|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540440|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540441|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540442|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540443|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
14540444|NCT00425438|Hormones|hormones|mesh-ancestor
14540445|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14540446|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14540447|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
14540448|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540449|NCT00421954|Ziprasidone|ziprasidone|mesh-list
14540450|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14540451|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
14540452|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540453|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540454|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540455|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14540456|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14540457|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540458|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14540459|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14540460|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
14807926|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807927|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14807928|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
14807929|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14807930|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807931|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14807932|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
14807933|NCT00824200|Tamsulosin|tamsulosin|mesh-list
14807934|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
14807935|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14807936|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14807937|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14807938|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807939|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807940|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807941|NCT00824200|Urological Agents|urological agents|mesh-ancestor
14807942|NCT00824239|Fentanyl|fentanyl|mesh-list
14807943|NCT00824239|Midazolam|midazolam|mesh-list
14807944|NCT00824239|Propofol|propofol|mesh-list
14807945|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14807946|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807947|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807948|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14807949|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
14807950|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
14807951|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14807952|NCT00824239|Narcotics|narcotics|mesh-ancestor
14807953|NCT00824239|Analgesics|analgesics|mesh-ancestor
14807954|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
14807955|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807956|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14807957|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14807958|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807959|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14807960|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
14807961|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
15082846|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15082847|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
15082848|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082849|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082850|NCT03298893|Nivolumab|nivolumab|mesh-list
15082851|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082852|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082853|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14540461|NCT00422942|Rituximab|rituximab|mesh-list
14540462|NCT00422942|Methotrexate|methotrexate|mesh-list
14540463|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540464|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540465|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
14540466|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540467|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540468|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14540469|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
14540470|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14540471|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540472|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
14540473|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540474|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14540475|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540476|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14540477|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540478|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540479|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
14540480|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14540481|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540482|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540483|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14540484|NCT00409344|Analgesics|analgesics|mesh-ancestor
14540485|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
14540486|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540487|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14540488|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14540489|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14540490|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
14540491|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540492|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540493|NCT00414453|Lidocaine|lidocaine|mesh-list
14540494|NCT00414453|Oxycodone|oxycodone|mesh-list
14540495|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
14540496|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
14540497|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540498|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540499|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
14540500|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540501|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14540502|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14540503|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15082854|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082855|NCT03298451|Sorafenib|sorafenib|mesh-list
14540504|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14540505|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540506|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14540507|NCT00414453|Narcotics|narcotics|mesh-ancestor
14540508|NCT00414453|Analgesics|analgesics|mesh-ancestor
14540509|NCT00417248|Etoposide|etoposide|mesh-list
14540510|NCT00417248|Sorafenib|sorafenib|mesh-list
14540511|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540512|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540513|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14540514|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14540515|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540516|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540517|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14540518|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
14540519|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14540520|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14540521|NCT00418145|Prednisolone|prednisolone|mesh-list
14540522|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
14540523|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14540524|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
14540525|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540526|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
14540527|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
14540528|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540529|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540530|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14540531|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
14540532|NCT00418145|Hormones|hormones|mesh-ancestor
14647408|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082856|NCT03298451|Durvalumab|durvalumab|mesh-list
15082857|NCT03298451|Tremelimumab|tremelimumab|mesh-list
15082858|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14540533|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14540534|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14540535|NCT00418145|Protective Agents|protective agents|mesh-ancestor
14540536|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14540537|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540538|NCT00409331|Amifostine|amifostine|mesh-list
14540539|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14540540|NCT00409331|Protective Agents|protective agents|mesh-ancestor
14540541|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540542|NCT00391430|Sertraline|sertraline|mesh-list
14540543|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
14540544|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14540545|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14540546|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14540547|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14540548|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540549|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540550|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
14540551|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540552|NCT00384293|Niacin|niacin|mesh-list
14540553|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14540554|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
14540555|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540556|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14540557|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
14540558|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
14540559|NCT00384293|Vitamins|vitamins|mesh-ancestor
14540560|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
14540561|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540562|NCT00374543|Ziprasidone|ziprasidone|mesh-list
14540563|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14540564|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
14540565|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540566|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540567|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540568|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14540569|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14540570|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540571|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14540572|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14540573|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
14540574|NCT00377455|Bosentan|bosentan|mesh-list
14540575|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14540576|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14540577|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540578|NCT00369265|Lansoprazole|lansoprazole|mesh-list
14540579|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
14540580|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14540581|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14540582|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14540583|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540584|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540585|NCT00364689|Rifaximin|rifaximin|mesh-list
14540586|NCT00364689|Lactulose|lactulose|mesh-list
14540587|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540588|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540589|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14540590|NCT00352118|Docetaxel|docetaxel|mesh-list
14540591|NCT00352118|Fluorouracil|fluorouracil|mesh-list
14540592|NCT00352118|Lenograstim|lenograstim|mesh-list
14540593|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540594|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540595|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540596|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540597|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540598|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
14540599|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540600|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540601|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
14540602|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540603|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14540604|NCT00368654|Methotrexate|methotrexate|mesh-list
14540605|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14540606|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
14540607|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14814145|NCT00861640|Rabeprazole|rabeprazole|mesh-list
14540608|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540609|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540610|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
14540611|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540612|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540613|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
14540614|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540615|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14540616|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540617|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
14540618|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540619|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540620|NCT00356421|Insulin|insulin|mesh-list
14540621|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14540622|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
14540623|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14540624|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540625|NCT00356187|Propranolol|propranolol|mesh-list
14540626|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14540627|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14540628|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
14540629|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540630|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540631|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540632|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14540633|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14540634|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
14540635|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
14540636|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540637|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
14540638|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540639|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540640|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540641|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14540642|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
14540643|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540644|NCT00319839|Paclitaxel|paclitaxel|mesh-list
14540645|NCT00319839|Cetuximab|cetuximab|mesh-list
14540646|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14540647|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540648|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540649|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540650|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540651|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540652|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540653|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540654|NCT00344019|Atorvastatin|atorvastatin|mesh-list
14540655|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14540656|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14540657|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
14540658|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540659|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14540660|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14540661|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540662|NCT00338455|Dobutamine|dobutamine|mesh-list
14540663|NCT00338455|Milrinone|milrinone|mesh-list
14540664|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14540665|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14540666|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
14540667|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
14540668|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540669|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540670|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14540671|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14540672|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14540673|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
14540674|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540675|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540676|NCT00338455|Protective Agents|protective agents|mesh-ancestor
14540677|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
14540678|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14540679|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
14540680|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14540681|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14540682|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540683|NCT00329108|Olanzapine|olanzapine|mesh-list
14540684|NCT00329108|Ziprasidone|ziprasidone|mesh-list
14540685|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
14540686|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
14540687|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540688|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540689|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14540690|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14540691|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14540692|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540693|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14540694|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14540695|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14540696|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14540697|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540698|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540699|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
14540700|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14540701|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14540702|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
14540703|NCT00325572|Ascorbic Acid|ascorbic acid|mesh-list
14540704|NCT00325572|Vitamins|vitamins|mesh-ancestor
14540705|NCT00325572|Micronutrients|micronutrients|mesh-ancestor
14540706|NCT00325572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540707|NCT00325572|Antioxidants|antioxidants|mesh-ancestor
14540708|NCT00325572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540709|NCT00325572|Protective Agents|protective agents|mesh-ancestor
14540710|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
14540711|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14540712|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540713|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14540714|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14540715|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14540716|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
14540717|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540718|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540719|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082859|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082860|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15082861|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082862|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082863|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082864|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
15082865|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082866|NCT03289351|Tazobactam|tazobactam|mesh-list
15082867|NCT03289351|Piperacillin|piperacillin|mesh-list
15082868|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14540720|NCT00323635|Urological Agents|urological agents|mesh-ancestor
14540721|NCT00329732|Lidocaine|lidocaine|mesh-list
14540722|NCT00329732|Bupivacaine|bupivacaine|mesh-list
14540723|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
14540724|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
14540725|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540726|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540727|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
14540728|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540729|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14540730|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14540731|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14540732|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14540733|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540734|NCT00314353|Bevacizumab|bevacizumab|mesh-list
15082869|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540735|NCT00314353|Capecitabine|capecitabine|mesh-list
14540736|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
14540737|NCT00314353|Irinotecan|irinotecan|mesh-list
14540738|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540739|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540740|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14540741|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14540742|NCT00314353|Growth Substances|growth substances|mesh-ancestor
14540743|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540744|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
14540745|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540746|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
14540747|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082870|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15082871|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15082872|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082873|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082874|NCT03287908|Dexamethasone|dexamethasone|mesh-list
15082875|NCT03287908|Pomalidomide|pomalidomide|mesh-list
15082876|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082877|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
15082878|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
15082879|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15082880|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082881|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15082882|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
15082883|NCT03287908|Hormones|hormones|mesh-ancestor
15082884|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082885|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082886|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082887|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
15082888|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15082889|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082890|NCT03287908|Growth Substances|growth substances|mesh-ancestor
14267362|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267363|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267364|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267365|NCT00389831|Rotigotine|rotigotine|mesh-list
14267366|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
14267367|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
14267368|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267369|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267370|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267371|NCT00389857|Vaccines|vaccines|mesh-list
15082891|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
15082892|NCT03283488|Megestrol|megestrol|mesh-list
15082893|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
15082894|NCT03283488|Mirtazapine|mirtazapine|mesh-list
15082895|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
15082896|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15082897|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15082898|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
15082899|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
15082900|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082901|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082902|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082903|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15082904|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15082905|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15082906|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15082907|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15082908|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15082909|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
15082910|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15082911|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15082912|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
15082913|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15082914|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15082915|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15082916|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15082917|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
15082918|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15082919|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15082920|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15082921|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082922|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082923|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
15082924|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15082925|NCT03282916|Valacyclovir|valacyclovir|mesh-list
15082926|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
15082927|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540748|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14540749|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14540750|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540751|NCT00314327|Risperidone|risperidone|mesh-list
14540752|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14540753|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
14540754|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540755|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540756|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540757|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14540758|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14540759|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540760|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14540761|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14540762|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
14540763|NCT00308113|Ubiquinone|ubiquinone|mesh-list
14540764|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
14540765|NCT00308113|Prednisone|prednisone|mesh-list
14540766|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540767|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
14540768|NCT00308113|Hormones|hormones|mesh-ancestor
14540769|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14540770|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540771|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14540772|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540773|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
14540774|NCT00308113|Vitamins|vitamins|mesh-ancestor
14540775|NCT00305643|Celecoxib|celecoxib|mesh-list
14540776|NCT00305643|Capecitabine|capecitabine|mesh-list
14540777|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540778|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
14540779|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540780|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540781|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14540782|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14540783|NCT00305643|Analgesics|analgesics|mesh-ancestor
14540784|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
14540785|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540786|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540787|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540788|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540789|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14540790|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14540791|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540792|NCT00298740|Insulin|insulin|mesh-list
14540793|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14540794|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540795|NCT00301080|Cycloserine|cycloserine|mesh-list
14540796|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14540797|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540798|NCT00301080|Renal Agents|renal agents|mesh-ancestor
14540799|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14540800|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
14540801|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540802|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
14540803|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540804|NCT00299195|Sulindac|sulindac|mesh-list
14540805|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14540806|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14540807|NCT00299195|Analgesics|analgesics|mesh-ancestor
14540808|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
14540809|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540810|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540811|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540812|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540813|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540814|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14540815|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540816|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540817|NCT00290407|Rituximab|rituximab|mesh-list
14540818|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540819|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540820|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
14540821|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540822|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540823|NCT00268463|Capecitabine|capecitabine|mesh-list
14540824|NCT00268463|Floxuridine|floxuridine|mesh-list
14540825|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
14540826|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540827|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
14540828|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540829|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540830|NCT00276419|Diclofenac|diclofenac|mesh-list
14540831|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14540832|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14540833|NCT00276419|Analgesics|analgesics|mesh-ancestor
14540834|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
14540835|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540836|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540837|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540838|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540839|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14540840|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540841|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540842|NCT00279409|Aripiprazole|aripiprazole|mesh-list
14540843|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
14540844|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14540845|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14540846|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14540847|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14540848|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540849|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
14540850|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
14540851|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540852|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540853|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14540854|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14540855|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
14540856|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14540857|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14540858|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14540859|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14540860|NCT00281879|Cytarabine|cytarabine|mesh-list
14540861|NCT00281879|Cyclosporine|cyclosporine|mesh-list
14540862|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
14540863|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
14540864|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
14540865|NCT00281879|Melphalan|melphalan|mesh-list
14540866|NCT00281879|Busulfan|busulfan|mesh-list
14540867|NCT00281879|Carmustine|carmustine|mesh-list
14540868|NCT00281879|Methotrexate|methotrexate|mesh-list
14540869|NCT00281879|Fludarabine|fludarabine|mesh-list
14540870|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
14540871|NCT00281879|Etoposide|etoposide|mesh-list
14540872|NCT00281879|Tacrolimus|tacrolimus|mesh-list
14540873|NCT00281879|Cyclosporins|cyclosporins|mesh-list
14540874|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14540875|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540876|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
14540877|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540878|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540879|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14540880|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
14540881|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540882|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540883|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14540884|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14540885|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
14540886|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14540887|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540888|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
15082928|NCT03269669|Prednisone|prednisone|mesh-list
15082929|NCT03269669|Cortisone|cortisone|mesh-list
15082930|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
15082931|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15082932|NCT03269669|Doxorubicin|doxorubicin|mesh-list
13995958|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13995959|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
14540889|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
14540890|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540891|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14814146|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15082933|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15082934|NCT03269669|Vincristine|vincristine|mesh-list
14540892|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540893|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540894|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14540895|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14540896|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
14540897|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540898|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14540899|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
14540900|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14540901|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14540902|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
14540903|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14540904|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540905|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
14540906|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
14540907|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540908|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14540909|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
14540910|NCT00281879|Hormones|hormones|mesh-ancestor
14540911|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14540912|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14540913|NCT00281879|Protective Agents|protective agents|mesh-ancestor
14540914|NCT00271011|Irinotecan|irinotecan|mesh-list
14540915|NCT00271011|Cetuximab|cetuximab|mesh-list
14540916|NCT00271011|Mitomycins|mitomycins|mesh-list
14540917|NCT00271011|Mitomycin|mitomycin|mesh-list
14540918|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14540919|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14540920|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540921|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540922|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540923|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540924|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14540925|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
14540926|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14540927|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14540928|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
14540929|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807962|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807963|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807964|NCT00824317|Methylphenidate|methylphenidate|mesh-list
14807965|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14807966|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807967|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14807968|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14807969|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807970|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807971|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
14807972|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15082935|NCT03269669|Lenalidomide|lenalidomide|mesh-list
15082936|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
15082937|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15082938|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
15082939|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082940|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15082941|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15082942|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
15082943|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082944|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082945|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15082946|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15082947|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15082948|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15082949|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15082950|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15082951|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
15082952|NCT03269669|Hormones|hormones|mesh-ancestor
15082953|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15082954|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15082955|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15082956|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
15082957|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
15082958|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540930|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14540931|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
14540932|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14540933|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540934|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14540935|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14540936|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14540937|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
14540938|NCT00256295|Gemcitabine|gemcitabine|mesh-list
14540939|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
14540940|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540941|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
14540942|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540943|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540944|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
14540945|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540946|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540947|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540948|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
14540949|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540950|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
14540951|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540952|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14540953|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540954|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540955|NCT00268450|Gemcitabine|gemcitabine|mesh-list
13995960|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995961|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14540956|NCT00268450|Paclitaxel|paclitaxel|mesh-list
14540957|NCT00268450|Bevacizumab|bevacizumab|mesh-list
14540958|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14540959|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540960|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
14540961|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
14540962|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
14540963|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14540964|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540965|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14540966|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14540967|NCT00268450|Growth Substances|growth substances|mesh-ancestor
14540968|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540969|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14540970|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14540971|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
14540972|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
14540973|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14540974|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14540975|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540976|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
14540977|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
14540978|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
14540979|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540980|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14540981|NCT00250718|Levofloxacin|levofloxacin|mesh-list
14540982|NCT00250718|Ofloxacin|ofloxacin|mesh-list
14540983|NCT00250718|Dexamethasone|dexamethasone|mesh-list
14540984|NCT00250718|Rituximab|rituximab|mesh-list
14540985|NCT00250718|Etoposide|etoposide|mesh-list
14540986|NCT00250718|Vincristine|vincristine|mesh-list
14540987|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14540988|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
14540989|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
14540990|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14540991|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14540992|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14540993|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
14540994|NCT00250718|Hormones|hormones|mesh-ancestor
14540995|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14540996|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14540997|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14540998|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14540999|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
14541000|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541001|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541002|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541003|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541004|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541005|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541006|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541007|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541008|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541009|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14541010|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541011|NCT00250718|Renal Agents|renal agents|mesh-ancestor
14541012|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541013|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14541014|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14642989|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642990|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
14642991|NCT00187746|Adefovir|adefovir|mesh-list
14642992|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14642993|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
14642994|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642995|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14642996|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642997|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642998|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642999|NCT00187759|Cephalexin|cephalexin|mesh-list
14643000|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643001|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643002|NCT00187798|Metformin|metformin|mesh-list
14643003|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14643004|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643005|NCT00187915|Cyclosporine|cyclosporine|mesh-list
14643006|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
14643007|NCT00187915|Tacrolimus|tacrolimus|mesh-list
14643008|NCT00187915|Cyclosporins|cyclosporins|mesh-list
14643009|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643010|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
14643011|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643012|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14643013|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643014|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643015|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
14643016|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643017|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
14643018|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643019|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14643020|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643021|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14643022|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
14643023|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643024|NCT00187928|Topiramate|topiramate|mesh-list
14643025|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
14643026|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14643027|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643028|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
14643029|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14643030|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643031|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14643032|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
14643033|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643034|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643035|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643036|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643037|NCT00187993|Hormones|hormones|mesh-list
14643038|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643039|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643040|NCT00188006|Heparin|heparin|mesh-list
14643041|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
14643042|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14643043|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14643044|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643045|NCT00188045|Propranolol|propranolol|mesh-list
14643046|NCT00188045|Spironolactone|spironolactone|mesh-list
14643047|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14643048|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14541015|NCT00218036|Dexetimide|dexetimide|mesh-list
14541016|NCT00218036|Modafinil|modafinil|mesh-list
14541017|NCT00218036|Citalopram|citalopram|mesh-list
14541018|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14541019|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14541020|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14541021|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541022|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541023|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
14541024|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541025|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14541026|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
14541027|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14541028|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14541029|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14541030|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
14541031|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
14541032|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541033|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14541034|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14541035|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
14541036|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14541037|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14541038|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14541039|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14541040|NCT00240227|Prazosin|prazosin|mesh-list
14541041|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14541042|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14541043|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14541044|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14541045|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
14541046|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541047|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541048|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541049|NCT00206375|Hormones|hormones|mesh-list
14541050|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541051|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541052|NCT00229931|Triamcinolone|triamcinolone|mesh-list
14541053|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14541054|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14541055|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14541056|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541057|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
14541058|NCT00229931|Hormones|hormones|mesh-ancestor
14541059|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541060|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541061|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541062|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
14541063|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541064|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541065|NCT00209131|Tamsulosin|tamsulosin|mesh-list
14541066|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14541067|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14541068|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14267372|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
14267373|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267374|NCT00389974|Sunitinib|sunitinib|mesh-list
14267375|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267376|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267377|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267378|NCT00389974|Growth Substances|growth substances|mesh-ancestor
14267379|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267380|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267381|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267382|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267383|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267384|NCT00390013|Gabapentin|gabapentin|mesh-list
14267385|NCT00390013|Analgesics|analgesics|mesh-ancestor
14267386|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
14267387|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267388|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267389|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
14541069|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
14541070|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541071|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541072|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541073|NCT00209131|Urological Agents|urological agents|mesh-ancestor
14541074|NCT00233090|Modafinil|modafinil|mesh-list
14541075|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14541076|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541077|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14541078|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14541079|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14541080|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541081|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
14541082|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14541083|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541084|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541085|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15082959|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15082960|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15082961|NCT03269669|Growth Substances|growth substances|mesh-ancestor
15082962|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
15082963|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082964|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15082965|NCT03258554|Cetuximab|cetuximab|mesh-list
15082966|NCT03258554|Durvalumab|durvalumab|mesh-list
15082967|NCT03258554|Antibodies|antibodies|mesh-list
15082968|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
15082969|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082970|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
15082971|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
15082972|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082973|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082974|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
15082975|NCT03257163|Capecitabine|capecitabine|mesh-list
15082976|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082977|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082978|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15082979|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
15082980|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082981|NCT03250377|Brivaracetam|brivaracetam|mesh-list
15082982|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
15082983|NCT03249714|Ofatumumab|ofatumumab|mesh-list
15082984|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15082985|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082986|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
15082987|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082988|NCT03233711|Nivolumab|nivolumab|mesh-list
15082989|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15082990|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082991|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15082992|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15082993|NCT03228069|Vaccines|vaccines|mesh-list
15082994|NCT03228069|Immunologic Factors|immunologic factors|mesh-ancestor
15082995|NCT03228069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15082996|NCT03213652|Ensartinib|ensartinib|mesh-list
15082997|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15082998|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15082999|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083000|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083001|NCT03212274|Olaparib|olaparib|mesh-list
15083002|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15083003|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083004|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083005|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083006|NCT03199885|Paclitaxel|paclitaxel|mesh-list
15083007|NCT03199885|Docetaxel|docetaxel|mesh-list
15083008|NCT03199885|Trastuzumab|trastuzumab|mesh-list
15083009|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15083010|NCT03199885|Atezolizumab|atezolizumab|mesh-list
15083011|NCT03199885|Pertuzumab|pertuzumab|mesh-list
15083012|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15083013|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15083014|NCT03199885|Antibodies|antibodies|mesh-list
15083015|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
15083016|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14541086|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14541087|NCT00205049|Protective Agents|protective agents|mesh-ancestor
14541088|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541089|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14541090|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14541091|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
14541092|NCT00209027|Aripiprazole|aripiprazole|mesh-list
14541093|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
14541094|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14541095|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14541096|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14541097|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14541098|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541099|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
14541100|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
14541101|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541102|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541103|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14541104|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14541105|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
14541106|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14541107|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14541108|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14541109|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14541110|NCT00182637|Bortezomib|bortezomib|mesh-list
14541111|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541112|NCT00176488|Vinorelbine|vinorelbine|mesh-list
14541113|NCT00176488|Epirubicin|epirubicin|mesh-list
14541114|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541115|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541116|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541117|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541118|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541119|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541120|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14541121|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541122|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541123|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541124|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
14541125|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14541126|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541127|NCT00183963|Tamoxifen|tamoxifen|mesh-list
14541128|NCT00183963|Fulvestrant|fulvestrant|mesh-list
14541129|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14541130|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
14541131|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541132|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541133|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14541134|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541135|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14541136|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14541137|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14541138|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14541139|NCT00162773|Omalizumab|omalizumab|mesh-list
14541140|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14541141|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14541142|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14541143|NCT00176631|Docetaxel|docetaxel|mesh-list
14541144|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541145|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541146|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541147|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541148|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541149|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
14541150|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14541151|NCT00177970|Antibodies|antibodies|mesh-list
14541152|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
14541153|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
14541154|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14541155|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
14541156|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541157|NCT00177866|Celecoxib|celecoxib|mesh-list
14541158|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14541159|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14541160|NCT00177866|Analgesics|analgesics|mesh-ancestor
14541161|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
14541162|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541163|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541164|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541165|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541166|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14541167|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14541168|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541169|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541170|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
14541171|NCT00165503|Pemetrexed|pemetrexed|mesh-list
14541172|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541173|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541174|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541175|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14541176|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14541177|NCT00165503|Antidotes|antidotes|mesh-ancestor
14541178|NCT00165503|Protective Agents|protective agents|mesh-ancestor
14541179|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541180|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
14541181|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
14541182|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541183|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541184|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
14541185|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
15083017|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083018|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083019|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083020|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083021|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083022|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083023|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
15083024|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083025|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
14541186|NCT00160563|Levocetirizine|levocetirizine|mesh-list
14541187|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14541188|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14541189|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
14541190|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
14541191|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541192|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541193|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541194|NCT00142519|Morphine|morphine|mesh-list
14541195|NCT00142519|Methadone|methadone|mesh-list
14541196|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14541197|NCT00142519|Narcotics|narcotics|mesh-ancestor
14541198|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15083026|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
15083027|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083028|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083029|NCT03178149|Tacrolimus|tacrolimus|mesh-list
15083030|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083031|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
14541199|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541200|NCT00142519|Analgesics|analgesics|mesh-ancestor
14541201|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
14541202|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541203|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
14541204|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
14541205|NCT00145704|Vitamin D|vitamin d|mesh-list
14541206|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
14541207|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
14541208|NCT00145704|Diphosphonates|diphosphonates|mesh-list
14541209|NCT00145704|Vitamins|vitamins|mesh-list
14541210|NCT00145704|Calcium|calcium|mesh-list
14541211|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
14541212|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541213|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14541214|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14541215|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14541216|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14541217|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083032|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541218|NCT00113386|Docetaxel|docetaxel|mesh-list
14541219|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541220|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541221|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541222|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541223|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083033|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15083034|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083035|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083036|NCT03176953|Topiramate|topiramate|mesh-list
15083037|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
15083038|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15083039|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083040|NCT03174197|Temozolomide|temozolomide|mesh-list
15083041|NCT03174197|Atezolizumab|atezolizumab|mesh-list
14541224|NCT00138151|Interferons|interferons|mesh-list
14541225|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
14541226|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
14541227|NCT00138151|Paclitaxel|paclitaxel|mesh-list
14541228|NCT00138151|Isotretinoin|isotretinoin|mesh-list
14541229|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541230|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541231|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541232|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541233|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541234|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083042|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083043|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083044|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
15083045|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083046|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083047|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
14541235|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
14541236|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541237|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
14541238|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541239|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14541240|NCT00129974|Gemcitabine|gemcitabine|mesh-list
14541241|NCT00129974|Pemetrexed|pemetrexed|mesh-list
14541242|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14541243|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
14541244|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541245|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541246|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
14541247|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541248|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541249|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541250|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
14541251|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541252|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14541253|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14541254|NCT00126659|Sorafenib|sorafenib|mesh-list
14541255|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541256|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14541257|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541258|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541259|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
14541260|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
14541261|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14541262|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14541263|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541264|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541265|NCT00133679|Urological Agents|urological agents|mesh-ancestor
14541266|NCT00113399|Paclitaxel|paclitaxel|mesh-list
14541267|NCT00113399|Docetaxel|docetaxel|mesh-list
14541268|NCT00113399|Fluorouracil|fluorouracil|mesh-list
14541269|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541270|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541271|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541272|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541273|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541274|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541275|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
14267390|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14541276|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14541277|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083048|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083049|NCT03170882|Dexamethasone|dexamethasone|mesh-list
14541278|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
14541279|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541280|NCT00118053|Carboplatin|carboplatin|mesh-list
14541281|NCT00118053|Docetaxel|docetaxel|mesh-list
14541282|NCT00118053|Trastuzumab|trastuzumab|mesh-list
14541283|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541284|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541285|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541286|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541287|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541288|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14541289|NCT00107614|Rituximab|rituximab|mesh-list
14541290|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14541291|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541292|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
14541293|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541294|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541295|NCT00107315|Bevacizumab|bevacizumab|mesh-list
14541296|NCT00107315|Capecitabine|capecitabine|mesh-list
14541297|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14541298|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083050|NCT03170882|Pomalidomide|pomalidomide|mesh-list
15083051|NCT03170882|Ixazomib|ixazomib|mesh-list
15083052|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15083053|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
15083054|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
15083055|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15083056|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083057|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15083058|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
15083059|NCT03170882|Hormones|hormones|mesh-ancestor
15083060|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15083061|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15083062|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083063|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
15083064|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15083065|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15083066|NCT03170882|Growth Substances|growth substances|mesh-ancestor
15083067|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
15083068|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
15083069|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083070|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083071|NCT03165994|Paclitaxel|paclitaxel|mesh-list
15083072|NCT03165994|Carboplatin|carboplatin|mesh-list
15083073|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083074|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083075|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083076|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083077|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083078|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083079|NCT03155620|Olaparib|olaparib|mesh-list
15083080|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15083081|NCT03155620|Palbociclib|palbociclib|mesh-list
15083082|NCT03155620|Vemurafenib|vemurafenib|mesh-list
15083083|NCT03155620|Tipifarnib|tipifarnib|mesh-list
15083084|NCT03155620|Ensartinib|ensartinib|mesh-list
15083085|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083086|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083087|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083088|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083089|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
15083090|NCT03148457|Apixaban|apixaban|mesh-list
15083091|NCT03148457|Edoxaban|edoxaban|mesh-list
15083092|NCT03148457|Dabigatran|dabigatran|mesh-list
15083093|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15083094|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
15083095|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15083096|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
15083097|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083098|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541299|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14541300|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14541301|NCT00107315|Growth Substances|growth substances|mesh-ancestor
14541302|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083099|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
15083100|NCT03126435|Gemcitabine|gemcitabine|mesh-list
15083101|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083102|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
14541303|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
14541304|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14541305|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
14541306|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541307|NCT00108433|Vancomycin|vancomycin|mesh-list
14541308|NCT00108433|Cefazolin|cefazolin|mesh-list
14541309|NCT00108433|Linezolid|linezolid|mesh-list
14541310|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541311|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541312|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14807973|NCT00824668|Insulin|insulin|mesh-list
14807974|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14807975|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
14807976|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
14807977|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
14807978|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14807979|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
14807980|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14807981|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807982|NCT00824707|Entecavir|entecavir|mesh-list
14807983|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
14807984|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807985|NCT00824785|Capecitabine|capecitabine|mesh-list
14807986|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
14807987|NCT00824785|Epirubicin|epirubicin|mesh-list
14807988|NCT00824785|Panitumumab|panitumumab|mesh-list
14807989|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14807990|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
14807991|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807992|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807993|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14807994|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14807995|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14807996|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807997|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14807998|NCT00824811|Fluorometholone|fluorometholone|mesh-list
14807999|NCT00824811|Cyclosporine|cyclosporine|mesh-list
14808000|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14808001|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
14808002|NCT00824811|Cyclosporins|cyclosporins|mesh-list
14808003|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808004|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808005|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14808006|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
14808007|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808008|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
14808009|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808010|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14808011|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808012|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14808013|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14808014|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808015|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
14808016|NCT00824811|Hormones|hormones|mesh-ancestor
14808017|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808018|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14808019|NCT00824863|Ketoconazole|ketoconazole|mesh-list
14808020|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
14808021|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808022|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14808023|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14808024|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808025|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808026|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14808027|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
14808028|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808029|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808030|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14808031|NCT00825019|Paroxetine|paroxetine|mesh-list
14808032|NCT00825019|Amibegron|amibegron|mesh-list
14808033|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14808034|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14808035|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808036|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541313|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541314|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541315|NCT00113919|Busulfan|busulfan|mesh-list
14541316|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
14541317|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541318|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541319|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
14541320|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541321|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14541322|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541323|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14541324|NCT00108342|Nicotine|nicotine|mesh-list
14541325|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14541326|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
14541327|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541328|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541329|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14541330|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14541331|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
14541332|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541333|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541334|NCT00100828|Irinotecan|irinotecan|mesh-list
14541335|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14541336|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541337|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541338|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541339|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541340|NCT00104728|Gefitinib|gefitinib|mesh-list
14541341|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541342|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14541343|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541344|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541345|NCT00089414|Drospirenone|drospirenone|mesh-list
14541346|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14541347|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14541348|NCT00089414|Estradiol|estradiol|mesh-list
14541349|NCT00089414|Progesterone|progesterone|mesh-list
14541350|NCT00089414|Estrogens|estrogens|mesh-ancestor
14541351|NCT00089414|Hormones|hormones|mesh-ancestor
14541352|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541353|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541354|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14541355|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
14541356|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14541357|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14541358|NCT00089414|Progestins|progestins|mesh-ancestor
14541359|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14541360|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14541361|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14541362|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
14541363|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14541364|NCT00089414|Diuretics|diuretics|mesh-ancestor
14541365|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
14541366|NCT00083915|Thalidomide|thalidomide|mesh-list
14541367|NCT00083915|Dexamethasone|dexamethasone|mesh-list
14541368|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
14541369|NCT00083915|Melphalan|melphalan|mesh-list
14541370|NCT00083915|Cisplatin|cisplatin|mesh-list
14541371|NCT00083915|Doxorubicin|doxorubicin|mesh-list
14541372|NCT00083915|Etoposide|etoposide|mesh-list
14541373|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14541374|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541375|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
14541376|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541377|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541378|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14541379|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
14541380|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541381|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541382|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14541383|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541384|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
14541385|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
14541386|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541387|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14541388|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
14541389|NCT00083915|Hormones|hormones|mesh-ancestor
14541390|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541391|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14541392|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14541393|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541394|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541395|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541396|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541397|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
14541398|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541399|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541400|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14541401|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14541402|NCT00083915|Growth Substances|growth substances|mesh-ancestor
14541403|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
14541404|NCT00090870|Interferons|interferons|mesh-list
14541405|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
14541406|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
14541407|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14541408|NCT00090870|Thalidomide|thalidomide|mesh-list
14541409|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541410|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
14541411|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541412|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
14541413|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541414|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541415|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
14541416|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541417|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14541418|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14541419|NCT00090870|Growth Substances|growth substances|mesh-ancestor
14541420|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
14541421|NCT00088972|Celecoxib|celecoxib|mesh-list
14541422|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14541423|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14541424|NCT00088972|Analgesics|analgesics|mesh-ancestor
14541425|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
14541426|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541427|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541428|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541429|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541430|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14541431|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14541432|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541433|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541434|NCT00088829|Paclitaxel|paclitaxel|mesh-list
14541435|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14541436|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541437|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541438|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541439|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541440|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541441|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541442|NCT00089128|Gemcitabine|gemcitabine|mesh-list
14541443|NCT00089128|Irinotecan|irinotecan|mesh-list
14541444|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14541445|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
14541446|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541447|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541448|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
14541449|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541450|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541451|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541452|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
14541453|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541454|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14541455|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541456|NCT00075608|Melphalan|melphalan|mesh-list
14541457|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
14541458|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541459|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14541460|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
14541461|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541462|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541463|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14541464|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541465|NCT00074724|Dobutamine|dobutamine|mesh-list
14541466|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14541467|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
14541468|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
14541469|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541470|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541471|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14541472|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14541473|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14541474|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
14541475|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541476|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541477|NCT00074724|Protective Agents|protective agents|mesh-ancestor
14541478|NCT00085631|Cisplatin|cisplatin|mesh-list
14541479|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541480|NCT00062751|Sirolimus|sirolimus|mesh-list
14541481|NCT00062751|Letrozole|letrozole|mesh-list
14541482|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541483|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14541484|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14541485|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541486|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541487|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14541488|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
14541489|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541490|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541491|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541492|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541493|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14541494|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
14541495|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541496|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
14541497|NCT00066807|Tamoxifen|tamoxifen|mesh-list
14541498|NCT00066807|Epirubicin|epirubicin|mesh-list
14541499|NCT00066807|Exemestane|exemestane|mesh-list
14541500|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14541501|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14541502|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541503|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541504|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541505|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541506|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541507|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14541508|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
14541509|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541510|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541511|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14541512|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14541513|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14541514|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14541515|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14541516|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14541517|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
14541518|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14541519|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
14541520|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14541521|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14541522|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
14541523|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
14541524|NCT00058188|Calcium|calcium|mesh-list
14541525|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14541526|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541527|NCT00058188|Vitamins|vitamins|mesh-ancestor
14541528|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
14541529|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14541530|NCT00014560|Antibodies|antibodies|mesh-list
14541531|NCT00014560|Sargramostim|sargramostim|mesh-list
14541532|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14541533|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
14541534|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541535|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
14541536|NCT00038142|Doxorubicin|doxorubicin|mesh-list
14541537|NCT00038142|Vincristine|vincristine|mesh-list
14541538|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
14541539|NCT00038142|Razoxane|razoxane|mesh-list
14541540|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541541|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
14541542|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541543|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541544|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14541545|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
14541546|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541547|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541548|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14541549|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14541550|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541551|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541552|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541553|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541554|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541555|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541556|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541557|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14541558|NCT00038142|Protective Agents|protective agents|mesh-ancestor
14541559|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
14541560|NCT00020722|Ifosfamide|ifosfamide|mesh-list
14541561|NCT00020722|Thiotepa|thiotepa|mesh-list
14541562|NCT00020722|Carboplatin|carboplatin|mesh-list
14541563|NCT00020722|Etoposide|etoposide|mesh-list
14541564|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
14541565|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541566|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
14541567|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541568|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541569|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14541570|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
14541571|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541572|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541573|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14541574|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083103|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083104|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083105|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
15083106|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083107|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083108|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083109|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
15083110|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083111|NCT03092674|Cytarabine|cytarabine|mesh-list
15083112|NCT03092674|Nivolumab|nivolumab|mesh-list
15083113|NCT03092674|Azacitidine|azacitidine|mesh-list
15083114|NCT03092674|Decitabine|decitabine|mesh-list
15083115|NCT03092674|Midostaurin|midostaurin|mesh-list
15083116|NCT03092674|Staurosporine|staurosporine|mesh-list
15083117|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083118|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083119|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083120|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083121|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083122|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
15083123|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
15083124|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083125|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083126|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
15083127|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083128|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083129|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083130|NCT03083665|Brivaracetam|brivaracetam|mesh-list
15083131|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
15083132|NCT03074318|Avelumab|avelumab|mesh-list
15083133|NCT03074318|Trabectedin|trabectedin|mesh-list
15083134|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083135|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083136|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083137|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083138|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
15083139|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541575|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15083140|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
15083141|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083142|NCT03055013|Nivolumab|nivolumab|mesh-list
14541576|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541577|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541578|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14541579|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14541580|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
14541581|NCT00006478|Sargramostim|sargramostim|mesh-list
14541582|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14541583|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
14541584|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541585|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14541586|NCT00019747|Thalidomide|thalidomide|mesh-list
14541587|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541588|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
14541589|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541590|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
14541591|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541592|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541593|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14541594|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14541595|NCT00019747|Growth Substances|growth substances|mesh-ancestor
14541596|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
14541597|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541598|NCT00006916|Bleomycin|bleomycin|mesh-list
14541599|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14541600|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541601|NCT00003726|Lepirudin|lepirudin|mesh-list
14541602|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
14541603|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14541604|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
14541605|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541606|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541607|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
14541608|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14541609|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14541610|NCT04051996|Decitabine|decitabine|mesh-list
14541611|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14541612|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
14541613|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541614|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541615|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541616|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14541617|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541618|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
14541619|NCT02126878|Hormones|hormones|mesh-ancestor
14541620|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541621|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541622|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541623|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
14541624|NCT02595996|Propranolol|propranolol|mesh-list
14541625|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14541626|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14541627|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14541628|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541629|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541630|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541631|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14267391|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14267392|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267393|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14267394|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14267395|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14267396|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267397|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267398|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
14267399|NCT00390182|Gemcitabine|gemcitabine|mesh-list
14267400|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267401|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
14267402|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267403|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267404|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
14267405|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267406|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541632|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14541633|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
14541634|NCT02009384|Ipilimumab|ipilimumab|mesh-list
14267407|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267408|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
14267409|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267410|NCT00390221|Daclizumab|daclizumab|mesh-list
14267411|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267412|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
14267413|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267414|NCT00390234|Aflibercept|aflibercept|mesh-list
14267415|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
14267416|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267417|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267418|NCT00390234|Growth Substances|growth substances|mesh-ancestor
14267419|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267420|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
15083143|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083144|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083145|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083146|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267421|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267422|NCT00390325|Sorafenib|sorafenib|mesh-list
14267423|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267424|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267425|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267426|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267427|NCT00390364|Everolimus|everolimus|mesh-list
14267428|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267429|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267430|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
15083147|NCT03052608|Crizotinib|crizotinib|mesh-list
15083148|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083149|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083150|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083151|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083152|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
15083153|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15083154|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15083155|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
15083156|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15083157|NCT03043924|Estradiol|estradiol|mesh-list
15083158|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15083159|NCT03043924|Cyproterone|cyproterone|mesh-list
15083160|NCT03043924|Estrogens|estrogens|mesh-ancestor
15083161|NCT03043924|Hormones|hormones|mesh-ancestor
15083162|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267431|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267432|NCT00390416|Leucovorin|leucovorin|mesh-list
14267433|NCT00390416|Bevacizumab|bevacizumab|mesh-list
14267434|NCT00390416|Docetaxel|docetaxel|mesh-list
14267435|NCT00390416|Fluorouracil|fluorouracil|mesh-list
14267436|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267437|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267438|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267439|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267440|NCT00390416|Growth Substances|growth substances|mesh-ancestor
14267441|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267442|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267443|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541635|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14541636|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541637|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14541638|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541639|NCT04558125|Heparin|heparin|mesh-list
14541640|NCT04558125|Calcium heparin|calcium heparin|mesh-list
14541641|NCT04558125|Enoxaparin|enoxaparin|mesh-list
14541642|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14541643|NCT04558125|Tinzaparin|tinzaparin|mesh-list
14541644|NCT04558125|Dalteparin|dalteparin|mesh-list
14541645|NCT04558125|Tenecteplase|tenecteplase|mesh-list
14541646|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
14541647|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
14541648|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14267444|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267445|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541649|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15083163|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541650|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541651|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
14541652|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
14541653|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14541654|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14541655|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541656|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541657|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541658|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541659|NCT00521885|Enoxaparin|enoxaparin|mesh-list
14541660|NCT00521885|Fondaparinux|fondaparinux|mesh-list
14541661|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
14541662|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14541663|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14541664|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541665|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14541666|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
14541667|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14541668|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
14541669|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541670|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
14541671|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14541672|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14541673|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541674|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14541675|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541676|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541677|NCT00479167|Bortezomib|bortezomib|mesh-list
14541678|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
14541679|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541680|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
14541681|NCT02212574|Lomustine|lomustine|mesh-list
14541682|NCT02212574|Vincristine|vincristine|mesh-list
14541683|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541684|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
14541685|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541686|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541687|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14541688|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
14541689|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541690|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541691|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14541692|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541693|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541694|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541695|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541696|NCT04422210|Carboplatin|carboplatin|mesh-list
14541697|NCT04422210|Etoposide|etoposide|mesh-list
14541698|NCT04422210|Atezolizumab|atezolizumab|mesh-list
14541699|NCT04422210|Venetoclax|venetoclax|mesh-list
14541700|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541701|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541702|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541703|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541704|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541705|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541706|NCT04298918|Trastuzumab|trastuzumab|mesh-list
14541707|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14541708|NCT04298918|Venetoclax|venetoclax|mesh-list
14541709|NCT04298918|Maytansine|maytansine|mesh-list
14541710|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14541711|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541712|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541713|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
14541714|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14541715|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14541716|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541717|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
14541718|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14541719|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541720|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
14541721|NCT00955929|Alprostadil|alprostadil|mesh-list
14541722|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
14541723|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14541724|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14541725|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541726|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541727|NCT00955929|Urological Agents|urological agents|mesh-ancestor
14541728|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14541729|NCT00402883|Folic Acid|folic acid|mesh-list
14541730|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
14541731|NCT00402883|Hydroxocobalamin|hydroxocobalamin|mesh-list
14541732|NCT00402883|Bevacizumab|bevacizumab|mesh-list
14541733|NCT00402883|Carboplatin|carboplatin|mesh-list
14541734|NCT00402883|Pemetrexed|pemetrexed|mesh-list
14541735|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14541736|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541737|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14541738|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14541739|NCT00402883|Growth Substances|growth substances|mesh-ancestor
14541740|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541741|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
14541742|NCT00402883|Vitamins|vitamins|mesh-ancestor
14541743|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
14541744|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541745|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541746|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14541747|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14541748|NCT00402883|Hematinics|hematinics|mesh-ancestor
15083164|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15083165|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
15083166|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15083167|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15083168|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15083169|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15083170|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15083171|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
15083172|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
15083173|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541749|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
14541750|NCT02934503|Carboplatin|carboplatin|mesh-list
14541751|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
14541752|NCT02934503|Etoposide|etoposide|mesh-list
14541753|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541754|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14541755|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541756|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541757|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14541758|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541759|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541760|NCT02137252|Naltrexone|naltrexone|mesh-list
14541761|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14541762|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14541763|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541764|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
14541765|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541766|NCT01294670|Etoposide|etoposide|mesh-list
14541767|NCT01294670|Vorinostat|vorinostat|mesh-list
14541768|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14541769|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541770|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14541771|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14808037|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808038|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
14808039|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808040|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14808041|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
14808042|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808043|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14808044|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14808045|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808046|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14808047|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14808048|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
15083174|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15083175|NCT03041740|Perflubron|perflubron|mesh-list
15083176|NCT03041740|Bromides|bromides|mesh-list
15083177|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
15083178|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14541772|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808049|NCT00825045|Risperidone|risperidone|mesh-list
15083179|NCT03033576|Nivolumab|nivolumab|mesh-list
14541773|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541774|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14541775|NCT03095287|Factor VIII|factor viii|mesh-list
14541776|NCT03095287|Coagulants|coagulants|mesh-ancestor
14541777|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14541778|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643049|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
14643050|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643051|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643052|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643053|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14643054|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14643055|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14643056|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14643057|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
14643058|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643059|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14643060|NCT00188045|Diuretics|diuretics|mesh-ancestor
14643061|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
14643062|NCT00188071|Acetaminophen|acetaminophen|mesh-list
14643063|NCT00188071|Ketoprofen|ketoprofen|mesh-list
14643064|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14643065|NCT00188071|Analgesics|analgesics|mesh-ancestor
14643066|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
14643067|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643068|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643069|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
14643070|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14643071|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14643072|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643073|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14643074|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643075|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643076|NCT00188136|Fludarabine|fludarabine|mesh-list
14643077|NCT00188136|Melphalan|melphalan|mesh-list
14643078|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643079|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643080|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643081|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
14643082|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643083|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14643084|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
14643085|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14643086|NCT00188227|Midazolam|midazolam|mesh-list
14643087|NCT00188227|Pirinitramide|pirinitramide|mesh-list
14643088|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14643089|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14643090|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14643091|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643092|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14643093|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14643094|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643095|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14643096|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
14643097|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
14643098|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
14643099|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
14643100|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643101|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643102|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14643103|NCT00188227|Narcotics|narcotics|mesh-ancestor
14643104|NCT00188227|Analgesics|analgesics|mesh-ancestor
14643105|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
14643106|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643107|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14643108|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
14643109|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643110|NCT00188266|Fluorouracil|fluorouracil|mesh-list
14643111|NCT00188266|Cisplatin|cisplatin|mesh-list
14643112|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
14643113|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643114|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643115|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643116|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643117|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
14541779|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
14541780|NCT00000105|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14541781|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14541782|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
14541783|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541784|NCT00000114|Vitamins|vitamins|mesh-list
14541785|NCT00000114|Vitamin E|vitamin e|mesh-list
14541786|NCT00000114|Vitamin A|vitamin a|mesh-list
14541787|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
14541788|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541789|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
14541790|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541791|NCT00000114|Protective Agents|protective agents|mesh-ancestor
14541792|NCT00000115|Acetazolamide|acetazolamide|mesh-list
14541793|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
14541794|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14541795|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541796|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541797|NCT00000115|Diuretics|diuretics|mesh-ancestor
14541798|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
14541799|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541800|NCT00000116|Vitamin A|vitamin a|mesh-list
14541801|NCT00000116|Vitamins|vitamins|mesh-ancestor
14541802|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
14541803|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541804|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
14541805|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14541806|NCT00000117|Antibodies|antibodies|mesh-list
14541807|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
14541808|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541809|NCT00000119|Heparin|heparin|mesh-list
14541810|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
14541811|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14541812|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14541813|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541814|NCT00000120|Erythromycin|erythromycin|mesh-list
14541815|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
14541816|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14541817|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
14541818|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
14541819|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14541820|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541821|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14541822|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14541823|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541824|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541825|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14541826|NCT00000122|Fluorouracil|fluorouracil|mesh-list
14541827|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
14541828|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541829|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14541830|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541831|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14541832|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
14541833|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541834|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14541835|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
14541836|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14541837|NCT00000123|Protective Agents|protective agents|mesh-ancestor
14541838|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541839|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14541840|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541841|NCT00000132|Betaxolol|betaxolol|mesh-list
14541842|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14541843|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
14541844|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
14541845|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541846|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541847|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14541848|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14541849|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14541850|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
14541851|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15083180|NCT03033576|Ipilimumab|ipilimumab|mesh-list
14808050|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14541852|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541853|NCT00000138|Acyclovir|acyclovir|mesh-list
14541854|NCT00000138|Prednisolone|prednisolone|mesh-list
14541855|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14541856|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
14541857|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14541858|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
14541859|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14541860|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
14541861|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541862|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
14541863|NCT00000138|Hormones|hormones|mesh-ancestor
14541864|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541865|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541866|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14541867|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541868|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
14541869|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
14541870|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541871|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14541872|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14541873|NCT00000138|Protective Agents|protective agents|mesh-ancestor
14541874|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
14541875|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541876|NCT00000139|Acyclovir|acyclovir|mesh-list
14541877|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
14541878|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14541879|NCT00000145|Zinc|zinc|mesh-list
14541880|NCT00000145|Antioxidants|antioxidants|mesh-list
14541881|NCT00000145|Trace Elements|trace elements|mesh-ancestor
14541882|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
14541883|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541884|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541885|NCT00000145|Protective Agents|protective agents|mesh-ancestor
14541886|NCT00000146|Prednisone|prednisone|mesh-list
14541887|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
14541888|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14541889|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14541890|NCT00000146|Prednisolone|prednisolone|mesh-list
14541891|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
14541892|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14541893|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
14541894|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541895|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
14541896|NCT00000146|Hormones|hormones|mesh-ancestor
14541897|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541898|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541899|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14541900|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541901|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
14541902|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
14541903|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541904|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14541905|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14541906|NCT00000146|Protective Agents|protective agents|mesh-ancestor
14541907|NCT00000147|Prednisone|prednisone|mesh-list
14541908|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
14541909|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14541910|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14541911|NCT00000147|Prednisolone|prednisolone|mesh-list
14541912|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
14541913|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14541914|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
14541915|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541916|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
14541917|NCT00000147|Hormones|hormones|mesh-ancestor
14541918|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14541919|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541920|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14541921|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14541922|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
14541923|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
14541924|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541925|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14541926|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14541927|NCT00000147|Protective Agents|protective agents|mesh-ancestor
14541928|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14541929|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14541930|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14541931|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14541932|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541933|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541934|NCT00000151|Aspirin|aspirin|mesh-list
14541935|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14541936|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14541937|NCT00000151|Analgesics|analgesics|mesh-ancestor
14541938|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
14541939|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541940|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541941|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541942|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541943|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14541944|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14541945|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541946|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14541947|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14541948|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541949|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
14541950|NCT00000152|Aspirin|aspirin|mesh-list
14541951|NCT00000152|Beta Carotene|beta carotene|mesh-list
14541952|NCT00000152|Carotenoids|carotenoids|mesh-list
14541953|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14541954|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14541955|NCT00000152|Analgesics|analgesics|mesh-ancestor
14541956|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
14541957|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541958|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541959|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541960|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541961|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14541962|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14541963|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541964|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14541965|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14541966|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541967|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
14541968|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
14541969|NCT00000152|Protective Agents|protective agents|mesh-ancestor
14541970|NCT00000152|Provitamins|provitamins|mesh-ancestor
14541971|NCT00000152|Vitamins|vitamins|mesh-ancestor
15083181|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083182|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083183|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083184|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083185|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
15083186|NCT03030378|Interleukin-12|interleukin-12|mesh-list
15083187|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083188|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083189|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15083190|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
15083191|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083192|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15083193|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15083194|NCT03030378|Growth Substances|growth substances|mesh-ancestor
15083195|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
15083196|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15083197|NCT03008278|Olaparib|olaparib|mesh-list
15083198|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15083199|NCT03008278|Ramucirumab|ramucirumab|mesh-list
15083200|NCT03008278|Antibodies|antibodies|mesh-list
15083201|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
15083202|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083203|NCT03008278|Lexatumumab|lexatumumab|mesh-list
15083204|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
15083205|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083206|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083207|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083208|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541972|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
15083209|NCT02997228|Leucovorin|leucovorin|mesh-list
15083210|NCT02997228|Bevacizumab|bevacizumab|mesh-list
14541973|NCT00000157|Aspirin|aspirin|mesh-list
14808051|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
14541974|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14541975|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14541976|NCT00000157|Analgesics|analgesics|mesh-ancestor
14541977|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
14541978|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14541979|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541980|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14541981|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14541982|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14541983|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14541984|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14541985|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14541986|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14541987|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14541988|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
14541989|NCT00000160|Xenon|xenon|mesh-list
14541990|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14541991|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
14541992|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
14541993|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14541994|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14541995|NCT00000161|Aspirin|aspirin|mesh-list
14541996|NCT00000161|Vitamins|vitamins|mesh-list
14541997|NCT00000161|Ascorbic Acid|ascorbic acid|mesh-list
14541998|NCT00000161|Vitamin E|vitamin e|mesh-list
14541999|NCT00000161|Beta Carotene|beta carotene|mesh-list
14542000|NCT00000161|Carotenoids|carotenoids|mesh-list
14542001|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
14542002|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542003|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14542004|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542005|NCT00000161|Analgesics|analgesics|mesh-ancestor
14542006|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
14542007|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542008|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14542009|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14542010|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14542011|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14542012|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542013|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14542014|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14808052|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808053|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808054|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808055|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14808056|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15083211|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15083212|NCT02997228|Fluorouracil|fluorouracil|mesh-list
15083213|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
15083214|NCT02997228|Atezolizumab|atezolizumab|mesh-list
15083215|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
15083216|NCT02997228|Antibodies|antibodies|mesh-list
15083217|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
15083218|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083219|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
15083220|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083221|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15083222|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15083223|NCT02997228|Growth Substances|growth substances|mesh-ancestor
15083224|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083225|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
15083226|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
15083227|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
15083228|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542015|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542016|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
14542017|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
14542018|NCT00000161|Protective Agents|protective agents|mesh-ancestor
14542019|NCT00000161|Provitamins|provitamins|mesh-ancestor
14542020|NCT00000170|Atropine|atropine|mesh-list
14542021|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14542022|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14542023|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14542024|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
14542025|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542026|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542027|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14542028|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
14542029|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
14542030|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
14542031|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14542032|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14542033|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
14542034|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542035|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542036|NCT00000171|Melatonin|melatonin|mesh-list
14542037|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
14542038|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542039|NCT00000171|Protective Agents|protective agents|mesh-ancestor
14542040|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542041|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542042|NCT00000172|Galantamine|galantamine|mesh-list
14542043|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14542044|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542045|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542046|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
14542047|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542048|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542049|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14542050|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
14542051|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542052|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
14542053|NCT00000173|Vitamin E|vitamin e|mesh-list
14542054|NCT00000173|Donepezil|donepezil|mesh-list
14542055|NCT00000173|Vitamins|vitamins|mesh-ancestor
14542056|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
14542057|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542058|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14542059|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083229|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083230|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083231|NCT02997228|Antidotes|antidotes|mesh-ancestor
15083232|NCT02997228|Protective Agents|protective agents|mesh-ancestor
15083233|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
14542060|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542061|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
14542062|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542063|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
14542064|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
14542065|NCT00000173|Protective Agents|protective agents|mesh-ancestor
14542066|NCT00000174|Rivastigmine|rivastigmine|mesh-list
14542067|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14542068|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542069|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542070|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
14542071|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542072|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542073|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14542074|NCT00000174|Protective Agents|protective agents|mesh-ancestor
14542075|NCT00000175|Testosterone|testosterone|mesh-list
14542076|NCT00000175|Estrogens|estrogens|mesh-list
15083234|NCT02997228|Vitamins|vitamins|mesh-ancestor
15083235|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
15083236|NCT02991456|Ondansetron|ondansetron|mesh-list
15083237|NCT02991456|Rolapitant|rolapitant|mesh-list
15083238|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
15083239|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
14542077|NCT00000175|Androgens|androgens|mesh-ancestor
15083240|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542078|NCT00000175|Hormones|hormones|mesh-ancestor
14542079|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15083241|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542080|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083242|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14542081|NCT00000176|Progesterone|progesterone|mesh-list
14542082|NCT00000176|Estrogens|estrogens|mesh-list
14542083|NCT00000176|Progestins|progestins|mesh-ancestor
14542084|NCT00000176|Hormones|hormones|mesh-ancestor
14542085|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14542086|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542087|NCT00000177|Estrogens|estrogens|mesh-list
14542088|NCT00000177|Hormones|hormones|mesh-ancestor
14542089|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14542090|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542091|NCT00000178|Prednisone|prednisone|mesh-list
14542092|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14542093|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
14542094|NCT00000178|Hormones|hormones|mesh-ancestor
14542095|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14542096|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542097|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14542098|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14542099|NCT00000179|Haloperidol|haloperidol|mesh-list
14542100|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
14542101|NCT00000179|Trazodone|trazodone|mesh-list
14542102|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
14542103|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
14542104|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542105|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083243|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
15083244|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
15083245|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15083246|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
15083247|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15083248|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083249|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15083250|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15083251|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15083252|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15083253|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15083254|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15083255|NCT02983578|Durvalumab|durvalumab|mesh-list
15083256|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
15083257|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083258|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
15083259|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083260|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083261|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
15083262|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083263|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
15083264|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083265|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083266|NCT02940548|Amlodipine|amlodipine|mesh-list
15083267|NCT02940548|Nifedipine|nifedipine|mesh-list
15083268|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15083269|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15083270|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15083271|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083272|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15083273|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083274|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
15083275|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
15083276|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15083277|NCT02921256|Leucovorin|leucovorin|mesh-list
15083278|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
15083279|NCT02921256|Fluorouracil|fluorouracil|mesh-list
15083280|NCT02921256|Capecitabine|capecitabine|mesh-list
15083281|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
15083282|NCT02921256|Veliparib|veliparib|mesh-list
15083283|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14542106|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15083284|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083285|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
14542107|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14542108|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542109|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542110|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542111|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14542112|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
14542113|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542114|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542115|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14542116|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14542117|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14542118|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542119|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542120|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
14542121|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14542122|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542123|NCT00000187|Ritanserin|ritanserin|mesh-list
14542124|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14542125|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
14542126|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542127|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542128|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542129|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14542130|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542131|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13995970|NCT02923388|Vitamins|vitamins|mesh-list
13995971|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
13995972|NCT02923388|Pyridoxine|pyridoxine|mesh-list
13995973|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
13995974|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
13995975|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
13995976|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995977|NCT02923258|Docetaxel|docetaxel|mesh-list
13995978|NCT02923258|Cisplatin|cisplatin|mesh-list
13995979|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14542132|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542133|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14542134|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14542135|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542136|NCT00000188|Selegiline|selegiline|mesh-list
14542137|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542138|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542139|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14542140|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14542141|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14542142|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542143|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542144|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14542145|NCT00000188|Protective Agents|protective agents|mesh-ancestor
14542146|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542147|NCT00000189|Gepirone|gepirone|mesh-list
14542148|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542149|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542150|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14542151|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542152|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542153|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542154|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15083286|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083287|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083288|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083289|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
13995980|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
14542155|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
14542156|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15083290|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083291|NCT02921256|Antidotes|antidotes|mesh-ancestor
15083292|NCT02921256|Protective Agents|protective agents|mesh-ancestor
15083293|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
15083294|NCT02921256|Vitamins|vitamins|mesh-ancestor
15083295|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
15083296|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15083297|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542157|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542158|NCT00000191|Carbamazepine|carbamazepine|mesh-list
14542159|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
14542160|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
14542161|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542162|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542163|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542164|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542165|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542166|NCT00000191|Analgesics|analgesics|mesh-ancestor
14542167|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
14542168|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542169|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14542170|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542171|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542172|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14542173|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14542174|NCT00000192|Lamotrigine|lamotrigine|mesh-list
14542175|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
14542176|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14542177|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15083298|NCT02915016|Vaccines|vaccines|mesh-list
15083299|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
15083300|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
13995981|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
13995982|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
13995983|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995984|NCT02923336|Propranolol|propranolol|mesh-list
13995985|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13995986|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13995987|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
13995988|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13995989|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13995990|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13995991|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13995992|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13995993|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
13995994|NCT02923128|Sufentanil|sufentanil|mesh-list
13995995|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
13995996|NCT02923128|Dsuvia|dsuvia|mesh-list
13995997|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13995998|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542178|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542179|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14542180|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542181|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14542182|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542183|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542184|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542185|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14542186|NCT00000194|Cycloserine|cycloserine|mesh-list
14542187|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14542188|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14542189|NCT00000194|Renal Agents|renal agents|mesh-ancestor
14542190|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14542191|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
14542192|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14542193|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
14542194|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542195|NCT00000195|Naltrexone|naltrexone|mesh-list
14542196|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14542197|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542198|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542199|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
14542200|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542201|NCT00000196|Naltrexone|naltrexone|mesh-list
14542202|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14542203|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542204|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542205|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
14542206|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542207|NCT00000197|Propranolol|propranolol|mesh-list
14542208|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14542209|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14542210|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
14542211|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542212|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542213|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542214|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14542215|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14542216|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
14542217|NCT00000198|Piracetam|piracetam|mesh-list
14542218|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14542219|NCT00000198|Protective Agents|protective agents|mesh-ancestor
14542220|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542221|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
14542222|NCT00000199|Piracetam|piracetam|mesh-list
14542223|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14542224|NCT00000199|Protective Agents|protective agents|mesh-ancestor
14542225|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542226|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
14542227|NCT00000200|Methadone|methadone|mesh-list
14542228|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542229|NCT00000200|Narcotics|narcotics|mesh-ancestor
14542230|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542231|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542232|NCT00000200|Analgesics|analgesics|mesh-ancestor
14542233|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
14542234|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542235|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
14542236|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
14542237|NCT00000201|Selegiline|selegiline|mesh-list
14542238|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542239|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542240|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14542241|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14542242|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14542243|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542244|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542245|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14542246|NCT00000201|Protective Agents|protective agents|mesh-ancestor
14542247|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542248|NCT00000202|Buprenorphine|buprenorphine|mesh-list
14542249|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542250|NCT00000202|Narcotics|narcotics|mesh-ancestor
14542251|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542252|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542253|NCT00000202|Analgesics|analgesics|mesh-ancestor
14542254|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
14542255|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542256|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542257|NCT00000203|Buprenorphine|buprenorphine|mesh-list
14542258|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542259|NCT00000203|Narcotics|narcotics|mesh-ancestor
14542260|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542261|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542262|NCT00000203|Analgesics|analgesics|mesh-ancestor
14542263|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
14542264|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542265|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542266|NCT00000204|Buprenorphine|buprenorphine|mesh-list
14542267|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542268|NCT00000204|Narcotics|narcotics|mesh-ancestor
14542269|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542270|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542271|NCT00000204|Analgesics|analgesics|mesh-ancestor
14542272|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
14542273|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542274|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542275|NCT00000205|Buprenorphine|buprenorphine|mesh-list
14542276|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542277|NCT00000205|Narcotics|narcotics|mesh-ancestor
14542278|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542279|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542280|NCT00000205|Analgesics|analgesics|mesh-ancestor
14542281|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
14542282|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542283|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542284|NCT00000206|Buprenorphine|buprenorphine|mesh-list
14542285|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542286|NCT00000206|Narcotics|narcotics|mesh-ancestor
14542287|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542288|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542289|NCT00000206|Analgesics|analgesics|mesh-ancestor
15083301|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083302|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15083303|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
15083304|NCT02912559|Leucovorin|leucovorin|mesh-list
15083305|NCT02912559|Folic Acid|folic acid|mesh-list
15083306|NCT02912559|Fluorouracil|fluorouracil|mesh-list
15083307|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
15083308|NCT02912559|Atezolizumab|atezolizumab|mesh-list
15083309|NCT02912559|Calcium|calcium|mesh-list
15083310|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083311|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
15083312|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15083313|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083314|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15083315|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
15083316|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083317|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083318|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083319|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083320|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
15083321|NCT02912559|Antidotes|antidotes|mesh-ancestor
15083322|NCT02912559|Protective Agents|protective agents|mesh-ancestor
13995999|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996000|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15083323|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
15083324|NCT02912559|Vitamins|vitamins|mesh-ancestor
15083325|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
15083326|NCT02912559|Hematinics|hematinics|mesh-ancestor
13996001|NCT02923128|Analgesics|analgesics|mesh-ancestor
13996002|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
13996003|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996004|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13996005|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13996006|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13996007|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
14542290|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
14542291|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15083327|NCT02888743|Durvalumab|durvalumab|mesh-list
14542292|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15083328|NCT02888743|Ipilimumab|ipilimumab|mesh-list
15083329|NCT02888743|Tremelimumab|tremelimumab|mesh-list
15083330|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
14542293|NCT00000207|Buprenorphine|buprenorphine|mesh-list
14542294|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542295|NCT00000207|Narcotics|narcotics|mesh-ancestor
14542296|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542297|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542298|NCT00000207|Analgesics|analgesics|mesh-ancestor
14542299|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
14542300|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542301|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542302|NCT00000208|Buprenorphine|buprenorphine|mesh-list
14542303|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542304|NCT00000208|Narcotics|narcotics|mesh-ancestor
14542305|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542306|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542307|NCT00000208|Analgesics|analgesics|mesh-ancestor
14542308|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
14542309|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542310|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542311|NCT00000209|Buprenorphine|buprenorphine|mesh-list
14542312|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542313|NCT00000209|Narcotics|narcotics|mesh-ancestor
14542314|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542315|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542316|NCT00000209|Analgesics|analgesics|mesh-ancestor
14542317|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
14542318|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15083331|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083332|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
15083333|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083334|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083335|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
14542319|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542320|NCT00000210|Buprenorphine|buprenorphine|mesh-list
14542321|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542322|NCT00000210|Narcotics|narcotics|mesh-ancestor
14542323|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542324|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542325|NCT00000210|Analgesics|analgesics|mesh-ancestor
14542326|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
14542327|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542328|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542329|NCT00000211|Buprenorphine|buprenorphine|mesh-list
14542330|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542331|NCT00000211|Narcotics|narcotics|mesh-ancestor
14542332|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542333|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542334|NCT00000211|Analgesics|analgesics|mesh-ancestor
14542335|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
14542336|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542337|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14643118|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647409|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647410|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
14647411|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647412|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
14808057|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808058|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808059|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14808060|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
14808061|NCT00825058|Paroxetine|paroxetine|mesh-list
14808062|NCT00825058|Amibegron|amibegron|mesh-list
14808063|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14808064|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14808065|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808066|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808067|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808068|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
14808069|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808070|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14808071|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
14808072|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808073|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14808074|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14647413|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647414|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542338|NCT00000212|Desipramine|desipramine|mesh-list
14542339|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14542340|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542341|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542342|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542343|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542344|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14267446|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267447|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
14267448|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14542345|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542346|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542347|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
14542348|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542349|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542350|NCT00000213|Fluoxetine|fluoxetine|mesh-list
14542351|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14542352|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542353|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996008|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996009|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267449|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267450|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
14267451|NCT00390416|Antidotes|antidotes|mesh-ancestor
14267452|NCT00390416|Protective Agents|protective agents|mesh-ancestor
14267453|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
14267454|NCT00390416|Vitamins|vitamins|mesh-ancestor
14267455|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
14267456|NCT00390429|Docetaxel|docetaxel|mesh-list
14267457|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14267458|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267459|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267460|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267461|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267462|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267463|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267464|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267465|NCT00390455|Fulvestrant|fulvestrant|mesh-list
14267466|NCT00390455|Lapatinib|lapatinib|mesh-list
14267467|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14267468|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267469|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14267470|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14267471|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
14267472|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267473|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267474|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267475|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267476|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267477|NCT00390546|Propranolol|propranolol|mesh-list
14267478|NCT00390546|Digoxin|digoxin|mesh-list
14267479|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14267480|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14267481|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
14267482|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267483|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267484|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267485|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14542354|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643119|NCT00188383|Amantadine|amantadine|mesh-list
13996010|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13996011|NCT02923128|Narcotics|narcotics|mesh-ancestor
13996012|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13996013|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13996014|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
13996015|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
14023342|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023343|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
14023344|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
14023345|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
14023346|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267486|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14542355|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542356|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
14542357|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542358|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14542359|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542360|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542361|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14542362|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14542363|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542364|NCT00000214|Buprenorphine|buprenorphine|mesh-list
14542365|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542366|NCT00000214|Narcotics|narcotics|mesh-ancestor
14542367|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542368|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542369|NCT00000214|Analgesics|analgesics|mesh-ancestor
14542370|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
14542371|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542372|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542373|NCT00000215|Pergolide|pergolide|mesh-list
14542374|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
14542375|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
14542376|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542377|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542378|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542379|NCT00000216|Buprenorphine|buprenorphine|mesh-list
14542380|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542381|NCT00000216|Narcotics|narcotics|mesh-ancestor
14542382|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542383|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542384|NCT00000216|Analgesics|analgesics|mesh-ancestor
14542385|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
14542386|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542387|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542388|NCT00000217|Carbamazepine|carbamazepine|mesh-list
14542389|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
14542390|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
14542391|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542392|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542393|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542394|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542395|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542396|NCT00000217|Analgesics|analgesics|mesh-ancestor
14542397|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
14542398|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542399|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14542400|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542401|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542402|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14542403|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14542404|NCT00000218|Carbamazepine|carbamazepine|mesh-list
14542405|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
14542406|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
14542407|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542408|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542409|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542410|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542411|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542412|NCT00000218|Analgesics|analgesics|mesh-ancestor
14542413|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
14542414|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542415|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14542416|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542417|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542418|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14542419|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14542420|NCT00000219|Buprenorphine|buprenorphine|mesh-list
14542421|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542422|NCT00000219|Narcotics|narcotics|mesh-ancestor
14542423|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542424|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542425|NCT00000219|Analgesics|analgesics|mesh-ancestor
14542426|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
14542427|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542428|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542429|NCT00000220|Buprenorphine|buprenorphine|mesh-list
14542430|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542431|NCT00000220|Narcotics|narcotics|mesh-ancestor
14542432|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542433|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542434|NCT00000220|Analgesics|analgesics|mesh-ancestor
14542435|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
14542436|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542437|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542438|NCT00000221|Buprenorphine|buprenorphine|mesh-list
14542439|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542440|NCT00000221|Narcotics|narcotics|mesh-ancestor
14542441|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542442|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542443|NCT00000221|Analgesics|analgesics|mesh-ancestor
14542444|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
14542445|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542446|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542447|NCT00000222|Buprenorphine|buprenorphine|mesh-list
14542448|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542449|NCT00000222|Narcotics|narcotics|mesh-ancestor
14542450|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542451|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542452|NCT00000222|Analgesics|analgesics|mesh-ancestor
14542453|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
14542454|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542455|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542456|NCT00000223|Buprenorphine|buprenorphine|mesh-list
14542457|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542458|NCT00000223|Narcotics|narcotics|mesh-ancestor
14542459|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542460|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542461|NCT00000223|Analgesics|analgesics|mesh-ancestor
14542462|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
14542463|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542464|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542465|NCT00000224|Buprenorphine|buprenorphine|mesh-list
14542466|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542467|NCT00000224|Narcotics|narcotics|mesh-ancestor
14542468|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542469|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542470|NCT00000224|Analgesics|analgesics|mesh-ancestor
14542471|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
14542472|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542473|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542474|NCT00000225|Buprenorphine|buprenorphine|mesh-list
14542475|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542476|NCT00000225|Narcotics|narcotics|mesh-ancestor
14542477|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542478|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542479|NCT00000225|Analgesics|analgesics|mesh-ancestor
14542480|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
14542481|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542482|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542483|NCT00000226|Buprenorphine|buprenorphine|mesh-list
14542484|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542485|NCT00000226|Narcotics|narcotics|mesh-ancestor
14542486|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542487|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542488|NCT00000226|Analgesics|analgesics|mesh-ancestor
14542489|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
14542490|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542491|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542492|NCT00000227|Buprenorphine|buprenorphine|mesh-list
14542493|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542494|NCT00000227|Narcotics|narcotics|mesh-ancestor
14542495|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542496|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542497|NCT00000227|Analgesics|analgesics|mesh-ancestor
14542498|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
14542499|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542500|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542501|NCT00000228|Buprenorphine|buprenorphine|mesh-list
14542502|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13996016|NCT02922894|Trazodone|trazodone|mesh-list
14542503|NCT00000228|Narcotics|narcotics|mesh-ancestor
14542504|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542505|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542506|NCT00000228|Analgesics|analgesics|mesh-ancestor
14542507|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
14542508|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542509|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542510|NCT00000229|Buprenorphine|buprenorphine|mesh-list
14542511|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542512|NCT00000229|Narcotics|narcotics|mesh-ancestor
15083336|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083337|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083338|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083339|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
15083340|NCT02883049|Leucovorin|leucovorin|mesh-list
15083341|NCT02883049|Folic Acid|folic acid|mesh-list
15083342|NCT02883049|Cytarabine|cytarabine|mesh-list
15083343|NCT02883049|Dexamethasone|dexamethasone|mesh-list
15083344|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
15083345|NCT02883049|Prednisone|prednisone|mesh-list
15083346|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
15083347|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15083348|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15083349|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15083350|NCT02883049|Cortisone|cortisone|mesh-list
15083351|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
15083352|NCT02883049|Doxorubicin|doxorubicin|mesh-list
15083353|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15083354|NCT02883049|Methotrexate|methotrexate|mesh-list
15083355|NCT02883049|Etoposide|etoposide|mesh-list
15083356|NCT02883049|Vincristine|vincristine|mesh-list
15083357|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
15083358|NCT02883049|Daunorubicin|daunorubicin|mesh-list
15083359|NCT02883049|Asparaginase|asparaginase|mesh-list
15083360|NCT02883049|Dasatinib|dasatinib|mesh-list
15083361|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
15083362|NCT02883049|Clofarabine|clofarabine|mesh-list
15083363|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
15083364|NCT02883049|Pegaspargase|pegaspargase|mesh-list
15083365|NCT02883049|Thioguanine|thioguanine|mesh-list
15083366|NCT02883049|BB 1101|bb 1101|mesh-list
15083367|NCT02883049|Calcium|calcium|mesh-list
15083368|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
15083369|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
15083370|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083371|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
15083372|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083373|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15083374|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083375|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
15083376|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083377|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083378|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15083379|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15083380|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
15083381|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
15083382|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15083383|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15083384|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
15083385|NCT02883049|Hormones|hormones|mesh-ancestor
15083386|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15083387|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15083388|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
15083389|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083390|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083391|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15083392|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083393|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15083394|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15083395|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15083396|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
15083397|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15083398|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083399|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
15083400|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
15083401|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15083402|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15083403|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13996017|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15083404|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
15083405|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083406|NCT02883049|Antidotes|antidotes|mesh-ancestor
15083407|NCT02883049|Protective Agents|protective agents|mesh-ancestor
14542513|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542514|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542515|NCT00000229|Analgesics|analgesics|mesh-ancestor
14542516|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
14542517|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542518|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542519|NCT00000230|Buprenorphine|buprenorphine|mesh-list
14542520|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542521|NCT00000230|Narcotics|narcotics|mesh-ancestor
14542522|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542523|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542524|NCT00000230|Analgesics|analgesics|mesh-ancestor
14542525|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
14542526|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542527|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542528|NCT00000231|Buprenorphine|buprenorphine|mesh-list
14542529|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542530|NCT00000231|Narcotics|narcotics|mesh-ancestor
14542531|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542532|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542533|NCT00000231|Analgesics|analgesics|mesh-ancestor
14542534|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
14542535|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542536|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542537|NCT00000232|Buprenorphine|buprenorphine|mesh-list
14542538|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542539|NCT00000232|Narcotics|narcotics|mesh-ancestor
14542540|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542541|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542542|NCT00000232|Analgesics|analgesics|mesh-ancestor
14542543|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
14542544|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542545|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542546|NCT00000233|Buprenorphine|buprenorphine|mesh-list
14542547|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542548|NCT00000233|Narcotics|narcotics|mesh-ancestor
14542549|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542550|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542551|NCT00000233|Analgesics|analgesics|mesh-ancestor
14542552|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
14542553|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542554|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542555|NCT00000234|Buprenorphine|buprenorphine|mesh-list
14542556|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542557|NCT00000234|Narcotics|narcotics|mesh-ancestor
14542558|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542559|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542560|NCT00000234|Analgesics|analgesics|mesh-ancestor
14542561|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
14542562|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542563|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542564|NCT00000235|Buprenorphine|buprenorphine|mesh-list
14542565|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542566|NCT00000235|Narcotics|narcotics|mesh-ancestor
14542567|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542568|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542569|NCT00000235|Analgesics|analgesics|mesh-ancestor
14542570|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
14542571|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542572|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542573|NCT00000236|Buprenorphine|buprenorphine|mesh-list
14542574|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14542575|NCT00000236|Naloxone|naloxone|mesh-list
14542576|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542577|NCT00000236|Narcotics|narcotics|mesh-ancestor
14542578|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542579|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542580|NCT00000236|Analgesics|analgesics|mesh-ancestor
14542581|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
14542582|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542583|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542584|NCT00000237|Buprenorphine|buprenorphine|mesh-list
14542585|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542586|NCT00000237|Narcotics|narcotics|mesh-ancestor
14542587|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542588|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542589|NCT00000237|Analgesics|analgesics|mesh-ancestor
14542590|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
14542591|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542592|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542593|NCT00000238|Buprenorphine|buprenorphine|mesh-list
14542594|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542595|NCT00000238|Narcotics|narcotics|mesh-ancestor
14542596|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542597|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542598|NCT00000238|Analgesics|analgesics|mesh-ancestor
14542599|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
14542600|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542601|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542602|NCT00000239|Buprenorphine|buprenorphine|mesh-list
14542603|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542604|NCT00000239|Narcotics|narcotics|mesh-ancestor
14542605|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542606|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542607|NCT00000239|Analgesics|analgesics|mesh-ancestor
14542608|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
14542609|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542610|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542611|NCT00000240|Buprenorphine|buprenorphine|mesh-list
14542612|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542613|NCT00000240|Narcotics|narcotics|mesh-ancestor
14542614|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542615|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542616|NCT00000240|Analgesics|analgesics|mesh-ancestor
14542617|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
14542618|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542619|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15083408|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
15083409|NCT02883049|Vitamins|vitamins|mesh-ancestor
15083410|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
15083411|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083412|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083413|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083414|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083415|NCT02883049|Hematinics|hematinics|mesh-ancestor
15083416|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
15083417|NCT02871401|Valganciclovir|valganciclovir|mesh-list
15083418|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
15083419|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083420|NCT02839707|Bevacizumab|bevacizumab|mesh-list
15083421|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15083422|NCT02839707|Doxorubicin|doxorubicin|mesh-list
15083423|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15083424|NCT02839707|Atezolizumab|atezolizumab|mesh-list
15083425|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
15083426|NCT02839707|Antibodies|antibodies|mesh-list
15083427|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
14808075|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808076|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14808077|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14808078|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
14808079|NCT00825071|Dexamethasone|dexamethasone|mesh-list
14808080|NCT00825071|Ondansetron|ondansetron|mesh-list
14808081|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808082|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
14808083|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
14808084|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808085|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808086|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14808087|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
14808088|NCT00825071|Hormones|hormones|mesh-ancestor
14808089|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808090|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14808091|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808092|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
14808093|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
14808094|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14808095|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
14808096|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808097|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083428|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14542620|NCT00000241|Flupenthixol|flupenthixol|mesh-list
14542621|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14542622|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15083429|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
15083430|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14542623|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14267487|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
14267488|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14267489|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267490|NCT00390546|Protective Agents|protective agents|mesh-ancestor
14267491|NCT00390559|Nicotine|nicotine|mesh-list
14267492|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14542624|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542625|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542626|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542627|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14542628|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
14542629|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542630|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542631|NCT00000242|Carbamazepine|carbamazepine|mesh-list
14542632|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
14542633|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
14542634|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542635|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542636|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542637|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542638|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542639|NCT00000242|Analgesics|analgesics|mesh-ancestor
14542640|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
14542641|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542642|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14542643|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542644|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542645|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14542646|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14542647|NCT00000243|Buprenorphine|buprenorphine|mesh-list
14542648|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542649|NCT00000243|Narcotics|narcotics|mesh-ancestor
14542650|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542651|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542652|NCT00000243|Analgesics|analgesics|mesh-ancestor
14542653|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
14542654|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542655|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542656|NCT00000244|Dynorphins|dynorphins|mesh-list
14542657|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542658|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542659|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542660|NCT00000245|Desipramine|desipramine|mesh-list
14542661|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14542662|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542663|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542664|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542665|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542666|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14542667|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542668|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542669|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
14542670|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542671|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542672|NCT00000246|Flumazenil|flumazenil|mesh-list
14542673|NCT00000246|Antidotes|antidotes|mesh-ancestor
14542674|NCT00000246|Protective Agents|protective agents|mesh-ancestor
14542675|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542676|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
14542677|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
14542678|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542679|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542680|NCT00000248|Pergolide|pergolide|mesh-list
14542681|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
14542682|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
14542683|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542684|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542685|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542686|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
14542687|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542688|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
14267493|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
14267494|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542689|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
14542690|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542691|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542692|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542693|NCT00000249|Analgesics|analgesics|mesh-ancestor
14542694|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
14542695|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542696|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
14542697|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542698|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
14542699|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
14542700|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542701|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542702|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542703|NCT00000250|Analgesics|analgesics|mesh-ancestor
14542704|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
14542705|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542706|NCT00000251|Isoflurane|isoflurane|mesh-list
14542707|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15083431|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15083432|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15083433|NCT02839707|Growth Substances|growth substances|mesh-ancestor
15083434|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083435|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
15083436|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
15083437|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083438|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15083439|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083440|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083441|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083442|NCT02834013|Nivolumab|nivolumab|mesh-list
15083443|NCT02834013|Ipilimumab|ipilimumab|mesh-list
15083444|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083445|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083446|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083447|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083448|NCT02801656|Vancomycin|vancomycin|mesh-list
15083449|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15083450|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083451|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
15083452|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083453|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083454|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
15083455|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
15083456|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15083457|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
15083458|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083459|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
15083460|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15083461|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083462|NCT02684162|Guadecitabine|guadecitabine|mesh-list
15083463|NCT02684162|Azacitidine|azacitidine|mesh-list
15083464|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083465|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083466|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
15083467|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083468|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083469|NCT02661971|Leucovorin|leucovorin|mesh-list
15083470|NCT02661971|Docetaxel|docetaxel|mesh-list
15083471|NCT02661971|Fluorouracil|fluorouracil|mesh-list
15083472|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
15083473|NCT02661971|Ramucirumab|ramucirumab|mesh-list
15083474|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083475|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083476|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083477|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083478|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083479|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
15083480|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083481|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083482|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
15083483|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083484|NCT02661971|Antidotes|antidotes|mesh-ancestor
15083485|NCT02661971|Protective Agents|protective agents|mesh-ancestor
15083486|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
15083487|NCT02661971|Vitamins|vitamins|mesh-ancestor
14542708|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
14542709|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
14542710|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542711|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542712|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
14542713|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542714|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
14542715|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
14542716|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542717|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542718|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542719|NCT00000252|Analgesics|analgesics|mesh-ancestor
14542720|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
14267495|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267496|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14267497|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14267498|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
14267499|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267500|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267501|NCT00390611|Paclitaxel|paclitaxel|mesh-list
14267502|NCT00390611|Carboplatin|carboplatin|mesh-list
14267503|NCT00390611|Sorafenib|sorafenib|mesh-list
14267504|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14267505|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267506|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267507|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267508|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267509|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267510|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267511|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267512|NCT00390689|Pramipexole|pramipexole|mesh-list
14267513|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
14267514|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267515|NCT00390689|Protective Agents|protective agents|mesh-ancestor
14267516|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267517|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14267518|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14267519|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
14267520|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
14267521|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267522|NCT00390780|Clotrimazole|clotrimazole|mesh-list
14267523|NCT00390780|Miconazole|miconazole|mesh-list
14267524|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14267525|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267526|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
14267527|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14267528|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14267529|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267530|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267531|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14267532|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
14267533|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267534|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267535|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14267536|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14267537|NCT00390806|Topotecan|topotecan|mesh-list
14267538|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14267539|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14267540|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267541|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267542|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267543|NCT00390858|Deferasirox|deferasirox|mesh-list
14267544|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14267545|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
14267546|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
14542721|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542722|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
14542723|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542724|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
14542725|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
14542726|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542727|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542728|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542729|NCT00000253|Analgesics|analgesics|mesh-ancestor
14542730|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
14267547|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542731|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542732|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
14542733|NCT00000254|Isoflurane|isoflurane|mesh-list
14542734|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542735|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
14542736|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
14542737|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542738|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542739|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542740|NCT00000254|Analgesics|analgesics|mesh-ancestor
14542741|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
14542742|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542743|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
14542744|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542745|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
14542746|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
14542747|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542748|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542749|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542750|NCT00000255|Analgesics|analgesics|mesh-ancestor
14542751|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
14542752|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542753|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
14542754|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542755|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
14542756|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
14542757|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542758|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542759|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542760|NCT00000256|Analgesics|analgesics|mesh-ancestor
14542761|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
14542762|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542763|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
14542764|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542765|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
14542766|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
14542767|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542768|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542769|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542770|NCT00000257|Analgesics|analgesics|mesh-ancestor
14542771|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
14542772|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542773|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
14542774|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542775|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
14542776|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
14542777|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542778|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542779|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542780|NCT00000258|Analgesics|analgesics|mesh-ancestor
14542781|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
14542782|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542783|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
14542784|NCT00000259|Sevoflurane|sevoflurane|mesh-list
14542785|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14542786|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542787|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
14542788|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
14542789|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542790|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542791|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542792|NCT00000259|Analgesics|analgesics|mesh-ancestor
14542793|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
14542794|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542795|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
14542796|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542797|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
14542798|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
14542799|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542800|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542801|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542802|NCT00000260|Analgesics|analgesics|mesh-ancestor
14542803|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
14542804|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542805|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
14542806|NCT00000261|Sevoflurane|sevoflurane|mesh-list
14542807|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14542808|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542809|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
14542810|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
14542811|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542812|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542813|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542814|NCT00000261|Analgesics|analgesics|mesh-ancestor
14542815|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
14542816|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542817|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
14542818|NCT00000262|Sevoflurane|sevoflurane|mesh-list
14542819|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14542820|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542821|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
14542822|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
14542823|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542824|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542825|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542826|NCT00000262|Analgesics|analgesics|mesh-ancestor
14542827|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
14542828|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542829|NCT00000263|Ethanol|ethanol|mesh-list
14542830|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
14542831|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14542832|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14542833|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542834|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542835|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542836|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
14542837|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
14542838|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542839|NCT00000263|Analgesics|analgesics|mesh-ancestor
14542840|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
14542841|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542842|NCT00000264|Ethanol|ethanol|mesh-list
14542843|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
14542844|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14542845|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14542846|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542847|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542848|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14542849|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
14542850|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
14542851|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14542852|NCT00000264|Analgesics|analgesics|mesh-ancestor
14542853|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
14542854|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542855|NCT00000266|Flupenthixol|flupenthixol|mesh-list
14542856|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14542857|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14542858|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542859|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542860|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542861|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542862|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14542863|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
14542864|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542865|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542866|NCT00000267|Risperidone|risperidone|mesh-list
14542867|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14542868|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
14542869|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542870|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542871|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542872|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14542873|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542874|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542875|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542876|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14542877|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
14542878|NCT00000268|Bupropion|bupropion|mesh-list
14542879|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14542880|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542881|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542882|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13996018|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542883|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542884|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542885|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542886|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
14542887|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542888|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542889|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14542890|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14542891|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542892|NCT00000269|Pergolide|pergolide|mesh-list
14542893|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
14542894|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
14542895|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542896|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542897|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542898|NCT00000270|Cocaine|cocaine|mesh-list
14542899|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
14542900|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
14542901|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542902|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542903|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
14542904|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542905|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14542906|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14542907|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542908|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542909|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542910|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
14542911|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542912|NCT00000271|Desipramine|desipramine|mesh-list
14542913|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14542914|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542915|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542916|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542917|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542918|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14542919|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542920|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542921|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14542922|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542923|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542924|NCT00000273|Fentanyl|fentanyl|mesh-list
14542925|NCT00000273|Morphine|morphine|mesh-list
14542926|NCT00000273|Oxycodone|oxycodone|mesh-list
14542927|NCT00000273|Buprenorphine|buprenorphine|mesh-list
14542928|NCT00000273|Methadone|methadone|mesh-list
14542929|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14542930|NCT00000273|Narcotics|narcotics|mesh-ancestor
14542931|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542932|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542933|NCT00000273|Analgesics|analgesics|mesh-ancestor
14542934|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
14542935|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542936|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14542937|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14542938|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
14542939|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
14542940|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14542941|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
14542942|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
14542943|NCT00000274|Flupenthixol|flupenthixol|mesh-list
15083488|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
15083489|NCT02621398|Paclitaxel|paclitaxel|mesh-list
15083490|NCT02621398|Carboplatin|carboplatin|mesh-list
15083491|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
15083492|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15083493|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083494|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083495|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083496|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083497|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083498|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083499|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083500|NCT02616055|XL647|xl647|mesh-list
15083501|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14542944|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14542945|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14542946|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542947|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542948|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996019|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996020|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542949|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542950|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14542951|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
14542952|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542953|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542954|NCT00000275|Flupenthixol|flupenthixol|mesh-list
14542955|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14542956|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14542957|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14542958|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14542959|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542960|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542961|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14542962|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
14542963|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542964|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542965|NCT00000276|Bupropion|bupropion|mesh-list
14542966|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14542967|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
14542968|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14542969|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14542970|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542971|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14542972|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542973|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
14542974|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542975|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542976|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14542977|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14542978|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542979|NCT00000277|Mazindol|mazindol|mesh-list
15083502|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083503|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083504|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083505|NCT02595944|Nivolumab|nivolumab|mesh-list
15083506|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083507|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083508|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083509|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083510|NCT02590393|Nicotine|nicotine|mesh-list
15083511|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15083512|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
15083513|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15083514|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996021|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15083515|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15083516|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13996022|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13996023|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13996024|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996025|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996026|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996027|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
13996028|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15083517|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
15083518|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15083519|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083520|NCT02588105|Leucovorin|leucovorin|mesh-list
14267548|NCT00390884|Vaccines|vaccines|mesh-list
14542980|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14542981|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14542982|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14542983|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14542984|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808098|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14808099|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14808100|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808101|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808102|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14808103|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
14808104|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14808105|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808106|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808107|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
14808108|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808109|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808110|NCT00825123|Metoprolol|metoprolol|mesh-list
14808111|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14808112|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14808113|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
14808114|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
14808115|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808116|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808117|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14808118|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14808119|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14808120|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
14808121|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808122|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808123|NCT00825149|Prednisone|prednisone|mesh-list
14808124|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
14808125|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14808126|NCT00825149|Doxorubicin|doxorubicin|mesh-list
14808127|NCT00825149|Fludarabine|fludarabine|mesh-list
14808128|NCT00825149|Vincristine|vincristine|mesh-list
14808129|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
14808130|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14808131|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
14808132|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808133|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808134|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14808135|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
14808136|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808137|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808138|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14808139|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14808140|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14808141|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14808142|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808143|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808144|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
14808145|NCT00825149|Hormones|hormones|mesh-ancestor
14808146|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808147|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14808148|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14808149|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
14808150|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
14808151|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
14808152|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14808153|NCT00825188|Amlodipine|amlodipine|mesh-list
14808154|NCT00825188|Eplerenone|eplerenone|mesh-list
14808155|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15083521|NCT02588105|Folic Acid|folic acid|mesh-list
14267549|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
14542985|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542986|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
14542987|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14542988|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14542989|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
14542990|NCT00000278|Disulfiram|disulfiram|mesh-list
14542991|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14542992|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14542993|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14542994|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14542995|NCT00000279|Clonidine|clonidine|mesh-list
14542996|NCT00000279|Analgesics|analgesics|mesh-ancestor
14542997|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
14542998|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14542999|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543000|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543001|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
14543002|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
14543003|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14543004|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14543005|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14543006|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543007|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543008|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543009|NCT00000280|Nimodipine|nimodipine|mesh-list
14543010|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543011|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14543012|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543013|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543014|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543015|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543016|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
14543017|NCT00000281|Amantadine|amantadine|mesh-list
14543018|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14543019|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14543020|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
14543021|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14543022|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
14543023|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543024|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543025|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543026|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14543027|NCT00000281|Analgesics|analgesics|mesh-ancestor
14543028|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
14543029|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543030|NCT00000282|Pemoline|pemoline|mesh-list
14543031|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14543032|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543033|NCT00000285|Phenytoin|phenytoin|mesh-list
14543034|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
14543035|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14543036|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14543037|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996029|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
13996030|NCT02922933|Entinostat|entinostat|mesh-list
13996031|NCT02922933|Omeprazole|omeprazole|mesh-list
13996032|NCT02922933|Famotidine|famotidine|mesh-list
13996033|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14543038|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543039|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14543040|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14543041|NCT00000286|Nefazodone|nefazodone|mesh-list
14543042|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14543043|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543044|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543045|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543046|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543047|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543048|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543049|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
13996034|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14543050|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543051|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14543052|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543053|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
14543054|NCT00000289|Ondansetron|ondansetron|mesh-list
14543055|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
14543056|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
14543057|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543058|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543059|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14543060|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
14543061|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
14543062|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543063|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
14543064|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543065|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543066|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543067|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543068|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543069|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543070|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14543071|NCT00000290|Cocaine|cocaine|mesh-list
14543072|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
14543073|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
14543074|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543075|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543076|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
14543077|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543078|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14543079|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543080|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543081|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543082|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543083|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
14543084|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543085|NCT00000291|Labetalol|labetalol|mesh-list
14543086|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14543087|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14543088|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543089|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543090|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543091|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543092|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543093|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
14543094|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
14543095|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543096|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14543097|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14543098|NCT00000292|Cocaine|cocaine|mesh-list
14543099|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
14543100|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
14543101|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15083522|NCT02588105|Fluorouracil|fluorouracil|mesh-list
15083523|NCT02588105|Irinotecan|irinotecan|mesh-list
15083524|NCT02588105|Olaparib|olaparib|mesh-list
15083525|NCT02588105|AZD0156|azd0156|mesh-list
15083526|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
15083527|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
15083528|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543102|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543103|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
14543104|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543105|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14543106|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543107|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543108|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543109|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083529|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083530|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083531|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083532|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
15083533|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083534|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15083535|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14543110|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
14543111|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543112|NCT00000293|Nefazodone|nefazodone|mesh-list
14543113|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14543114|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543115|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543116|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543117|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543118|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543119|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543120|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543121|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543122|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14543123|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543124|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
14543125|NCT00000294|Carvedilol|carvedilol|mesh-list
14543126|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14543127|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14543128|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543129|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543130|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543131|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543132|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543133|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
14543134|NCT00000294|Protective Agents|protective agents|mesh-ancestor
14543135|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14543136|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543137|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543138|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
14543139|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14543140|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14543141|NCT00000295|Progesterone|progesterone|mesh-list
14543142|NCT00000295|Progestins|progestins|mesh-ancestor
14543143|NCT00000295|Hormones|hormones|mesh-ancestor
14543144|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14543145|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543146|NCT00000297|Labetalol|labetalol|mesh-list
14543147|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14543148|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14543149|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543150|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543151|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543152|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543153|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543154|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
14543155|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
14543156|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543157|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14543158|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14543159|NCT00000298|Buprenorphine|buprenorphine|mesh-list
14543160|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14543161|NCT00000298|Naloxone|naloxone|mesh-list
14543162|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543163|NCT00000298|Narcotics|narcotics|mesh-ancestor
14543164|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543165|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543166|NCT00000298|Analgesics|analgesics|mesh-ancestor
14543167|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
14543168|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543169|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543170|NCT00000299|Buprenorphine|buprenorphine|mesh-list
14543171|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543172|NCT00000299|Narcotics|narcotics|mesh-ancestor
14543173|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543174|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543175|NCT00000299|Analgesics|analgesics|mesh-ancestor
14543176|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
14543177|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543178|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543179|NCT00000301|Amantadine|amantadine|mesh-list
14543180|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14543181|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14543182|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
14543183|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14543184|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
14543185|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543186|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543187|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543188|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14543189|NCT00000301|Analgesics|analgesics|mesh-ancestor
14543190|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
14543191|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543192|NCT00000302|Buprenorphine|buprenorphine|mesh-list
14543193|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543194|NCT00000302|Narcotics|narcotics|mesh-ancestor
14543195|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543196|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543197|NCT00000302|Analgesics|analgesics|mesh-ancestor
14543198|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
14543199|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543200|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543201|NCT00000303|Baclofen|baclofen|mesh-list
14543202|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14543203|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543204|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14543205|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543206|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14543207|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
14543208|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
14543209|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543210|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543211|NCT00000304|Amphetamine|amphetamine|mesh-list
14543212|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
14543213|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14543214|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543215|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
14543216|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
14543217|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543218|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
14543219|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543220|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543221|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543222|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543223|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543224|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543225|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543226|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
14543227|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14543228|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543229|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543230|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543231|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543232|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543233|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
14543234|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543235|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
14543236|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14543237|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543238|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543239|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543240|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543241|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543242|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
14543243|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543244|NCT00000307|Naltrexone|naltrexone|mesh-list
14543245|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14543246|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543247|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543248|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
14543249|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543250|NCT00000308|Amphetamine|amphetamine|mesh-list
14543251|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
14543252|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14543253|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543254|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
14543255|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
14543256|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543257|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
14543258|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543259|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543260|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543261|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543262|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543263|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543264|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543265|NCT00000309|Risperidone|risperidone|mesh-list
14543266|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543267|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
14543268|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543269|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543270|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543271|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543272|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543273|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543274|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543275|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543276|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
14543277|NCT00000310|Risperidone|risperidone|mesh-list
14543278|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543279|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
14543280|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543281|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543282|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808156|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14808157|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808158|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808159|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14808160|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808161|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
14808162|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14808163|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
14808164|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808165|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14808166|NCT00825188|Diuretics|diuretics|mesh-ancestor
14808167|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
14808168|NCT00825201|Paclitaxel|paclitaxel|mesh-list
14808169|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14808170|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14808171|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808172|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
14808173|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
14808174|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
14808175|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808176|NCT00825253|Insulin|insulin|mesh-list
14808177|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14808178|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
14808179|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
14808180|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14808181|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14808182|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808183|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14808184|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14808185|NCT00825422|Ropivacaine|ropivacaine|mesh-list
14808186|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
14808187|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
14808188|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808189|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808190|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
14808191|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808192|NCT00825552|Risperidone|risperidone|mesh-list
14808193|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14808194|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
14808195|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15083536|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083537|NCT02588105|Antidotes|antidotes|mesh-ancestor
15083538|NCT02588105|Protective Agents|protective agents|mesh-ancestor
15083539|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
15083540|NCT02588105|Vitamins|vitamins|mesh-ancestor
15083541|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
15083542|NCT02588105|Hematinics|hematinics|mesh-ancestor
14543283|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543284|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543285|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543286|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543287|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543288|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
14543289|NCT00000311|Buprenorphine|buprenorphine|mesh-list
14543290|NCT00000311|Methadone|methadone|mesh-list
14543291|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543292|NCT00000311|Narcotics|narcotics|mesh-ancestor
14543293|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543294|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543295|NCT00000311|Analgesics|analgesics|mesh-ancestor
14543296|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
14543297|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543298|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543299|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
14543300|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
14543301|NCT00000313|Fenfluramine|fenfluramine|mesh-list
14543302|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14543303|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543304|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543305|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543306|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543307|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
14543308|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643120|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14643121|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14643122|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
14643123|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643124|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
14643125|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643126|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643127|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643128|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14643129|NCT00188383|Analgesics|analgesics|mesh-ancestor
14643130|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
14643131|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643132|NCT00188396|Citalopram|citalopram|mesh-list
14643133|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14643134|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643135|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643136|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643137|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643138|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
14643139|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643140|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14643141|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643142|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643143|NCT00188552|Tocopherols|tocopherols|mesh-list
14643144|NCT00188552|Vitamin E|vitamin e|mesh-list
14643145|NCT00188552|Tocotrienols|tocotrienols|mesh-list
14643146|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
14643147|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
14643148|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14643149|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643150|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643151|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14643152|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14643153|NCT00188552|Protective Agents|protective agents|mesh-ancestor
14643154|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643155|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
14643156|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14643157|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
14643158|NCT00188552|Vitamins|vitamins|mesh-ancestor
14643159|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
14643160|NCT00188565|Celecoxib|celecoxib|mesh-list
14643161|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14643162|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14643163|NCT00188565|Analgesics|analgesics|mesh-ancestor
14643164|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
14643165|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643166|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083543|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14643167|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14543309|NCT00000315|Cocaine|cocaine|mesh-list
14543310|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
14543311|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
14543312|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543313|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543314|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
14543315|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543316|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14543317|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543318|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543319|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543320|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543321|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
14543322|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543323|NCT00000316|Cocaine|cocaine|mesh-list
14543324|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
14543325|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
14543326|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543327|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543328|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
14543329|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543330|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14543331|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543332|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543333|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543334|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543335|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
14543336|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543337|NCT00000317|Risperidone|risperidone|mesh-list
14543338|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15083544|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083545|NCT02567435|Sirolimus|sirolimus|mesh-list
15083546|NCT02567435|Dactinomycin|dactinomycin|mesh-list
15083547|NCT02567435|Cactinomycin|cactinomycin|mesh-list
14543339|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
14543340|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543341|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543342|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543343|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543344|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543345|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543346|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543347|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543348|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
14543349|NCT00000318|Buprenorphine|buprenorphine|mesh-list
14543350|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543351|NCT00000318|Narcotics|narcotics|mesh-ancestor
14543352|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543353|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543354|NCT00000318|Analgesics|analgesics|mesh-ancestor
14543355|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
14543356|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543357|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543358|NCT00000319|Buprenorphine|buprenorphine|mesh-list
14543359|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543360|NCT00000319|Narcotics|narcotics|mesh-ancestor
14543361|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543362|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543363|NCT00000319|Analgesics|analgesics|mesh-ancestor
14543364|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
14543365|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543366|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543367|NCT00000320|Buprenorphine|buprenorphine|mesh-list
14543368|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543369|NCT00000320|Narcotics|narcotics|mesh-ancestor
14543370|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543371|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543372|NCT00000320|Analgesics|analgesics|mesh-ancestor
14543373|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
14543374|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543375|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543376|NCT00000321|Desipramine|desipramine|mesh-list
14543377|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15083548|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
15083549|NCT02567435|Irinotecan|irinotecan|mesh-list
15083550|NCT02567435|Vincristine|vincristine|mesh-list
14543378|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543379|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543380|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543381|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543382|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543383|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543384|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543385|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543386|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543387|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083551|NCT02567435|Vinorelbine|vinorelbine|mesh-list
15083552|NCT02567435|Camptothecin|camptothecin|mesh-list
14543388|NCT00000324|Tryptophan|tryptophan|mesh-list
14543389|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543390|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543391|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543392|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14543393|NCT00000325|Hormones|hormones|mesh-ancestor
14543394|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14543395|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543396|NCT00000326|Heroin|heroin|mesh-list
14543397|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543398|NCT00000326|Narcotics|narcotics|mesh-ancestor
14543399|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543400|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543401|NCT00000326|Analgesics|analgesics|mesh-ancestor
14543402|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
14543403|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543404|NCT00000327|Heroin|heroin|mesh-list
14543405|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543406|NCT00000327|Narcotics|narcotics|mesh-ancestor
14543407|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543408|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543409|NCT00000327|Analgesics|analgesics|mesh-ancestor
14808196|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808197|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808198|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15083553|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083554|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
15083555|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083556|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15083557|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083558|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
15083559|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083560|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083561|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15083562|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15083563|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083564|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083565|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083566|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083567|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083568|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083569|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15083570|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083571|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083572|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
15083573|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15083574|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15083575|NCT02567422|Cisplatin|cisplatin|mesh-list
15083576|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643168|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808199|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14808200|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808201|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808202|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14808203|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
14808204|NCT00825591|Melatonin|melatonin|mesh-list
14808205|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
14808206|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808207|NCT00825591|Protective Agents|protective agents|mesh-ancestor
14808208|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083577|NCT02567409|Gemcitabine|gemcitabine|mesh-list
14543410|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
14543411|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543412|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
14543413|NCT00000328|Narcotics|narcotics|mesh-ancestor
14543414|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543415|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543416|NCT00000328|Analgesics|analgesics|mesh-ancestor
14543417|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
14543418|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543419|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
14543420|NCT00000329|Narcotics|narcotics|mesh-ancestor
14543421|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543422|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543423|NCT00000329|Analgesics|analgesics|mesh-ancestor
14543424|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
14543425|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543426|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
14543427|NCT00000330|Narcotics|narcotics|mesh-ancestor
14543428|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543429|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543430|NCT00000330|Analgesics|analgesics|mesh-ancestor
14543431|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
14543432|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543433|NCT00000332|Nimodipine|nimodipine|mesh-list
14543434|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543435|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14543436|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543437|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543438|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543439|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543440|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
14543441|NCT00000333|Benztropine|benztropine|mesh-list
14543442|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14543443|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14543444|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
14543445|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
14543446|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543447|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543448|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14543449|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14543450|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
14543451|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543452|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543453|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14543454|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543455|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543456|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
14543457|NCT00000334|Buprenorphine|buprenorphine|mesh-list
14543458|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543459|NCT00000334|Narcotics|narcotics|mesh-ancestor
14543460|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543461|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543462|NCT00000334|Analgesics|analgesics|mesh-ancestor
14543463|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
14543464|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543465|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543466|NCT00000335|Morphine|morphine|mesh-list
14543467|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543468|NCT00000335|Narcotics|narcotics|mesh-ancestor
14543469|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543470|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543471|NCT00000335|Analgesics|analgesics|mesh-ancestor
14543472|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
14543473|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543474|NCT00000336|Selegiline|selegiline|mesh-list
14543475|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543476|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543477|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14543478|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14543479|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14543480|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543481|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543482|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15083578|NCT02567409|Cisplatin|cisplatin|mesh-list
15083579|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14543483|NCT00000336|Protective Agents|protective agents|mesh-ancestor
14543484|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543485|NCT00000337|Selegiline|selegiline|mesh-list
14543486|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543487|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543488|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14543489|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14543490|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14543491|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543492|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543493|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14543494|NCT00000337|Protective Agents|protective agents|mesh-ancestor
14543495|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543496|NCT00000338|Lisuride|lisuride|mesh-list
14543497|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14543498|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14543499|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14543500|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
14543501|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543502|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543503|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543504|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
15083580|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083581|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
15083582|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083583|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
15083584|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083585|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083586|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083587|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
15083588|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083589|NCT02535312|Cisplatin|cisplatin|mesh-list
15083590|NCT02535312|Pemetrexed|pemetrexed|mesh-list
15083591|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083592|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083593|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543505|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
14543506|NCT00000339|Risperidone|risperidone|mesh-list
14543507|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543508|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
14543509|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543510|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543511|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543512|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543513|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543514|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543515|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543516|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543517|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
14543518|NCT00000340|Pemoline|pemoline|mesh-list
14543519|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14543520|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543521|NCT00000341|Buprenorphine|buprenorphine|mesh-list
14543522|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543523|NCT00000341|Narcotics|narcotics|mesh-ancestor
14543524|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543525|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543526|NCT00000341|Analgesics|analgesics|mesh-ancestor
14543527|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
14543528|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543529|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543530|NCT00000342|Risperidone|risperidone|mesh-list
14543531|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543532|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
14543533|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543534|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543535|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083594|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15083595|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15083596|NCT02533232|Minocycline|minocycline|mesh-list
15083597|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15083598|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083599|NCT02506959|Gemcitabine|gemcitabine|mesh-list
14543536|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15083600|NCT02506959|Melphalan|melphalan|mesh-list
15083601|NCT02506959|Busulfan|busulfan|mesh-list
15083602|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
15083603|NCT02506959|Panobinostat|panobinostat|mesh-list
14543537|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543538|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543539|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543540|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543541|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
14543542|NCT00000344|Buprenorphine|buprenorphine|mesh-list
14543543|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14543544|NCT00000344|Naloxone|naloxone|mesh-list
14543545|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543546|NCT00000344|Narcotics|narcotics|mesh-ancestor
14543547|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543548|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543549|NCT00000344|Analgesics|analgesics|mesh-ancestor
14543550|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
14808209|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808210|NCT00825617|Hormones|hormones|mesh-list
14808211|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808212|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808213|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
15083604|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15083605|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083606|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
15083607|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083608|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083609|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
15083610|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083611|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083612|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083613|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
15083614|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083615|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083616|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
15083617|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15083618|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15083619|NCT02506153|Interferons|interferons|mesh-list
15083620|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
15083621|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
15083622|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
15083623|NCT02506153|Ipilimumab|ipilimumab|mesh-list
15083624|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083625|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083626|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
15083627|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083628|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083629|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083630|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
15083631|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083632|NCT02502266|Paclitaxel|paclitaxel|mesh-list
15083633|NCT02502266|Doxorubicin|doxorubicin|mesh-list
15083634|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15083635|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15083636|NCT02502266|Topotecan|topotecan|mesh-list
15083637|NCT02502266|Olaparib|olaparib|mesh-list
15083638|NCT02502266|Cediranib|cediranib|mesh-list
15083639|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15083640|NCT02502266|Maleic acid|maleic acid|mesh-list
15083641|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083642|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083643|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083644|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083645|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083646|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083647|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083648|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15083649|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083650|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808214|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14808215|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808216|NCT00825656|Capsaicin|capsaicin|mesh-list
14808217|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
14808218|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
14808219|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
14808220|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543551|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543552|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543553|NCT00000345|Lofexidine|lofexidine|mesh-list
14543554|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543555|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543556|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543557|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
14543558|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543559|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14543560|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14543561|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14543562|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543563|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543564|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543565|NCT00000347|Risperidone|risperidone|mesh-list
14543566|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543567|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
14543568|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543569|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543570|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543571|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543572|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543573|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543574|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15083651|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15083652|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083653|NCT02466971|Cisplatin|cisplatin|mesh-list
15083654|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14543575|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543576|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
14543577|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
14543578|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
14543579|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
14543580|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543581|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543582|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543583|NCT00000349|Flupenthixol|flupenthixol|mesh-list
14543584|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14543585|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543586|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543587|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543588|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543589|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543590|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543591|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
14543592|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543593|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543594|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
14543595|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
14543596|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
14543597|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14543598|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14543599|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543600|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543601|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543602|NCT00000353|Buprenorphine|buprenorphine|mesh-list
14543603|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14543604|NCT00000353|Naloxone|naloxone|mesh-list
14543605|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543606|NCT00000353|Narcotics|narcotics|mesh-ancestor
14543607|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543608|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543609|NCT00000353|Analgesics|analgesics|mesh-ancestor
14543610|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
14543611|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543612|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543613|NCT00000354|Lofexidine|lofexidine|mesh-list
14543614|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543615|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543616|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543617|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
15083655|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14543618|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543619|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14543620|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14543621|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14543622|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543623|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543624|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543625|NCT00000355|Buprenorphine|buprenorphine|mesh-list
14543626|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543627|NCT00000355|Narcotics|narcotics|mesh-ancestor
14543628|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543629|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543630|NCT00000355|Analgesics|analgesics|mesh-ancestor
14543631|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
14543632|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543633|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543634|NCT00000357|Buprenorphine|buprenorphine|mesh-list
14543635|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14543636|NCT00000357|Narcotics|narcotics|mesh-ancestor
14543637|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543638|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543639|NCT00000357|Analgesics|analgesics|mesh-ancestor
14543640|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
14543641|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543642|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543643|NCT00000358|Lofexidine|lofexidine|mesh-list
14543644|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14543645|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14543646|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543647|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
14543648|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543649|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14543650|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14543651|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14543652|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543653|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543654|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543655|NCT00000361|Methotrexate|methotrexate|mesh-list
14543656|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14543657|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
14543658|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15083656|NCT02465060|Nivolumab|nivolumab|mesh-list
15083657|NCT02465060|Trastuzumab|trastuzumab|mesh-list
15083658|NCT02465060|Pertuzumab|pertuzumab|mesh-list
15083659|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15083660|NCT02465060|Sunitinib|sunitinib|mesh-list
15083661|NCT02465060|Dasatinib|dasatinib|mesh-list
15083662|NCT02465060|Palbociclib|palbociclib|mesh-list
15083663|NCT02465060|Trametinib|trametinib|mesh-list
15083664|NCT02465060|Afatinib|afatinib|mesh-list
15083665|NCT02465060|Osimertinib|osimertinib|mesh-list
15083666|NCT02465060|Dabrafenib|dabrafenib|mesh-list
15083667|NCT02465060|Crizotinib|crizotinib|mesh-list
15083668|NCT02465060|Maytansine|maytansine|mesh-list
15083669|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15083670|NCT02465060|GSK2636771|gsk2636771|mesh-list
15083671|NCT02465060|Antibodies|antibodies|mesh-list
15083672|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
14543659|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543660|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14543661|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
14543662|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543663|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14543664|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
14543665|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543666|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14543667|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14543668|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
14543669|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14543670|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14543671|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
14543672|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14543673|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
15083673|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083674|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
15083675|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
15083676|NCT02465060|Adavosertib|adavosertib|mesh-list
15083677|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
15083678|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543674|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543675|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543676|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543677|NCT00000368|Paroxetine|paroxetine|mesh-list
14543678|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14543679|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543680|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543681|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543682|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543683|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
14543684|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543685|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543686|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543687|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543688|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14543689|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14543690|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543691|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
14543692|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543693|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543694|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543695|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543696|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
14543697|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543698|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543699|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543700|NCT00000372|Cycloserine|cycloserine|mesh-list
14543701|NCT00000372|Clozapine|clozapine|mesh-list
14543702|NCT00000372|Glycine|glycine|mesh-list
14543703|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14543704|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14543705|NCT00000372|Renal Agents|renal agents|mesh-ancestor
14543706|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14543707|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
14543708|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14543709|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
14543710|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543711|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543712|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
14543713|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543714|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543715|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543716|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543717|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543718|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543719|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
14543720|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
14543721|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
14543722|NCT00000373|Olanzapine|olanzapine|mesh-list
14543723|NCT00000373|Fluoxetine|fluoxetine|mesh-list
14543724|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
14543725|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
14543726|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543727|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543728|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15083679|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083680|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083681|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083682|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15083683|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15083684|NCT02465060|Growth Substances|growth substances|mesh-ancestor
15083685|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
15083686|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083687|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083688|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083689|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083690|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083691|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083692|NCT02446600|Gemcitabine|gemcitabine|mesh-list
15083693|NCT02446600|Paclitaxel|paclitaxel|mesh-list
15083694|NCT02446600|Carboplatin|carboplatin|mesh-list
15083695|NCT02446600|Doxorubicin|doxorubicin|mesh-list
15083696|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15083697|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15083698|NCT02446600|Olaparib|olaparib|mesh-list
14543729|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543730|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543731|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543732|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543733|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14543734|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543735|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543736|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543737|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543738|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
14543739|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543740|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543741|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14543742|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14543743|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543744|NCT00000374|Olanzapine|olanzapine|mesh-list
14543745|NCT00000374|Risperidone|risperidone|mesh-list
14543746|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14543747|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
14543748|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543749|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543750|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543751|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14543752|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543753|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543754|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543755|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14543756|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
14543757|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
14543758|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
14543759|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543760|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14543761|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14543762|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543763|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543764|NCT00000375|Nortriptyline|nortriptyline|mesh-list
14543765|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543766|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543767|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543768|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543769|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14543770|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543771|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543772|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543773|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543774|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543775|NCT00000376|Desipramine|desipramine|mesh-list
14543776|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14543777|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543778|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543779|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543780|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543781|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543782|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543783|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543784|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543785|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543786|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083699|NCT02446600|Cediranib|cediranib|mesh-list
15083700|NCT02446600|Maleic acid|maleic acid|mesh-list
14543787|NCT00000377|Nortriptyline|nortriptyline|mesh-list
14543788|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14543789|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543790|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543791|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543792|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543793|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543794|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543795|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543796|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543797|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543798|NCT00000379|Fluoxetine|fluoxetine|mesh-list
14543799|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14543800|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543801|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543802|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543803|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543804|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
14543805|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543806|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543807|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543808|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543809|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14543810|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14543811|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543812|NCT00000381|Fluoxetine|fluoxetine|mesh-list
14543813|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14543814|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543815|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543816|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543817|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543818|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
14543819|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543820|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543821|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543822|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543823|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14543824|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14543825|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543826|NCT00000384|Sertraline|sertraline|mesh-list
14543827|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543828|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543829|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14543830|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543831|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543832|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543833|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543834|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
14543835|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543836|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
14543837|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543838|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543839|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543840|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543841|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
14543842|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543843|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543844|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543845|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
14543846|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14543847|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14543848|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14543849|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543850|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543851|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15083701|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083702|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083703|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083704|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083705|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
15172939|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14543852|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543853|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543854|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543855|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543856|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
14543857|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14543858|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543859|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14543860|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14543861|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543862|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14543863|NCT00000390|Imipramine|imipramine|mesh-list
14543864|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14543865|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543866|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543867|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543868|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543869|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543870|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543871|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
14543872|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14543873|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543874|NCT00000395|Folic Acid|folic acid|mesh-list
14543875|NCT00000395|Leucovorin|leucovorin|mesh-list
14543876|NCT00000395|Methotrexate|methotrexate|mesh-list
14543877|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
14543878|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14543879|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
14543880|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14543881|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543882|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14543883|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
14543884|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543885|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14543886|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
14543887|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14543888|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14543889|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14543890|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
14543891|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14543892|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14543893|NCT00000395|Hematinics|hematinics|mesh-ancestor
14543894|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
14543895|NCT00000395|Vitamins|vitamins|mesh-ancestor
14543896|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
14543897|NCT00000395|Antidotes|antidotes|mesh-ancestor
14543898|NCT00000395|Protective Agents|protective agents|mesh-ancestor
14543899|NCT00000399|Hormones|hormones|mesh-list
14543900|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14543901|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543902|NCT00000400|Alendronate|alendronate|mesh-list
14543903|NCT00000400|Teriparatide|teriparatide|mesh-list
14543904|NCT00000400|Hormones|hormones|mesh-list
14543905|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
14543906|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14543907|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543908|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14543909|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543910|NCT00000402|Calcium|calcium|mesh-list
14543911|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543912|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543913|NCT00000403|Doxycycline|doxycycline|mesh-list
14543914|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14543915|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14543916|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
14543917|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14543918|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14543919|NCT00000412|Alendronate|alendronate|mesh-list
14543920|NCT00000412|Calcitriol|calcitriol|mesh-list
14543921|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14543922|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543923|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15083706|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543924|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14543925|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543926|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14543927|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14543928|NCT00000412|Vitamins|vitamins|mesh-ancestor
14543929|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
14543930|NCT00000415|Calcium|calcium|mesh-list
14543931|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543932|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543933|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14543934|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14543935|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14543936|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
14543937|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14543938|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808221|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808222|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14808223|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14808224|NCT00825851|Nicotine|nicotine|mesh-list
14808225|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15083707|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083708|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
15083709|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
15083710|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083711|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083712|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083713|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
15083714|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083715|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083716|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15083717|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083718|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15083719|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083720|NCT02443077|Cytarabine|cytarabine|mesh-list
15083721|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
15083722|NCT02443077|Melphalan|melphalan|mesh-list
15083723|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
15083724|NCT02443077|Carmustine|carmustine|mesh-list
15083725|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15083726|NCT02443077|Etoposide|etoposide|mesh-list
15083727|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
15083728|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
15083729|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083730|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
15083731|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083732|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15083733|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083734|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
15083735|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083736|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083737|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15083738|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083739|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15083740|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083741|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083742|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083743|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
15083744|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
15083745|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083746|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
15083747|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
15083748|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
14808226|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
14808227|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808228|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808229|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14808230|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14808231|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
14808232|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808233|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808234|NCT00825864|Dexamethasone|dexamethasone|mesh-list
14808235|NCT00825864|Diclofenac|diclofenac|mesh-list
14808236|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
14808237|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14808238|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14543939|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14543940|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14543941|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14543942|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14543943|NCT00000419|Estrogens|estrogens|mesh-ancestor
14543944|NCT00000419|Hormones|hormones|mesh-ancestor
14543945|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14543946|NCT00000420|Norinyl|norinyl|mesh-list
14543947|NCT00000420|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14543948|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14543949|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14543950|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14543951|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
14543952|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14543953|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543954|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14543955|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14543956|NCT00000420|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14543957|NCT00000420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14543958|NCT00000421|Prednisone|prednisone|mesh-list
14543959|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14543960|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
14543961|NCT00000421|Hormones|hormones|mesh-ancestor
14543962|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14543963|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543964|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14543965|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643169|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14643170|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14643171|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643172|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643173|NCT00188604|Selenious Acid|selenious acid|mesh-list
14643174|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
14643175|NCT00188604|Trace Elements|trace elements|mesh-ancestor
14643176|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
14643177|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643178|NCT00188617|Gefitinib|gefitinib|mesh-list
14643179|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643180|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14643181|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643182|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643183|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
14643184|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14643185|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
14643186|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643187|NCT00188630|Expectorants|expectorants|mesh-ancestor
14643188|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14643189|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14643190|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
14643191|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643192|NCT00188630|Protective Agents|protective agents|mesh-ancestor
14643193|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643194|NCT00188630|Antidotes|antidotes|mesh-ancestor
14643195|NCT00188643|Lamotrigine|lamotrigine|mesh-list
14643196|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14643197|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643198|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643199|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643200|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643201|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643202|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643203|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14643204|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643205|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643206|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
14643207|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14643208|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14643209|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14643210|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14643211|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15083749|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083750|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
14543966|NCT00000425|Acetaminophen|acetaminophen|mesh-list
14543967|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14543968|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14543969|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14543970|NCT00000425|Analgesics|analgesics|mesh-ancestor
14543971|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
14543972|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543973|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543974|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
14543975|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14543976|NCT00000426|Calcium|calcium|mesh-list
14543977|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543978|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543979|NCT00000427|Alendronate|alendronate|mesh-list
14543980|NCT00000427|Hormones|hormones|mesh-list
14543981|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
14543982|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14543983|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543984|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14543985|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14543986|NCT00000428|Amitriptyline|amitriptyline|mesh-list
14543987|NCT00000428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14543988|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14543989|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
14543990|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14543991|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14543992|NCT00000428|Analgesics|analgesics|mesh-ancestor
14543993|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
14543994|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14543995|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14543996|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14543997|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14543998|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14543999|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544000|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544001|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544002|NCT00000428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14544003|NCT00000428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14544004|NCT00000428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14544005|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
14544006|NCT00000429|Calcium|calcium|mesh-list
14544007|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14544008|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544009|NCT00000429|Antacids|antacids|mesh-ancestor
14544010|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544011|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14544012|NCT00000430|Alendronate|alendronate|mesh-list
14544013|NCT00000430|Estrogens|estrogens|mesh-list
14544014|NCT00000430|Progestins|progestins|mesh-list
14544015|NCT00000430|Hormones|hormones|mesh-ancestor
14544016|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14544017|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544018|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14544019|NCT00000437|Naltrexone|naltrexone|mesh-list
14544020|NCT00000437|Nicotine|nicotine|mesh-list
14544021|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14544022|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
14544023|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544024|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544025|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14544026|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14544027|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
14544028|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544029|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544030|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544031|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544032|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
14544033|NCT00000438|Naltrexone|naltrexone|mesh-list
14544034|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544035|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544036|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544037|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
14544038|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544039|NCT00000439|Valproic Acid|valproic acid|mesh-list
14544040|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
14544041|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544042|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544043|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
14544044|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544045|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544046|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
14544047|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14544048|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14544049|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544050|NCT00000440|Naltrexone|naltrexone|mesh-list
14544051|NCT00000440|Sertraline|sertraline|mesh-list
14544052|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544053|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544054|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544055|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
14544056|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544057|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544058|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544059|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14544060|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544061|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544062|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544063|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544064|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
14544065|NCT00000441|Carbamazepine|carbamazepine|mesh-list
14544066|NCT00000441|Lorazepam|lorazepam|mesh-list
14544067|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
14544068|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
14544069|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
14544070|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544071|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544072|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14544073|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14544074|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14544075|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14544076|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14544077|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544078|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
14544079|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
14544080|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544081|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544082|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
14544083|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544084|NCT00000441|Analgesics|analgesics|mesh-ancestor
14544085|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
14544086|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14544087|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544088|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14544089|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14544090|NCT00000442|Naltrexone|naltrexone|mesh-list
14544091|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544092|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544093|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544094|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
14544095|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544096|NCT00000443|Ondansetron|ondansetron|mesh-list
14544097|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
14544098|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
14544099|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544100|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544101|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14544102|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
14544103|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
14544104|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14544105|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
14544106|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544107|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544108|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14544109|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15083751|NCT02398773|Estradiol|estradiol|mesh-list
14544110|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14544111|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544112|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14544113|NCT00000444|Nicotine|nicotine|mesh-list
14544114|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15083752|NCT02398773|Estrogens|estrogens|mesh-ancestor
14544115|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
14544116|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544117|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544118|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14544119|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14544120|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
14544121|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544122|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544123|NCT00000445|Naltrexone|naltrexone|mesh-list
14544124|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544125|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544126|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544127|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
14544128|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544129|NCT00000446|Sertraline|sertraline|mesh-list
14544130|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544131|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544132|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14544133|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544134|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544135|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544136|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544137|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
14544138|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544139|NCT00000447|Naltrexone|naltrexone|mesh-list
14544140|NCT00000447|Nicotine|nicotine|mesh-list
14544141|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14544142|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
14544143|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544144|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544145|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14544146|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14544147|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
14544148|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544149|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544150|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544151|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544152|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
14544153|NCT00000448|Naltrexone|naltrexone|mesh-list
14544154|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544155|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544156|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544157|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
14544158|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544159|NCT00000449|Naltrexone|naltrexone|mesh-list
14544160|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544161|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544162|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544163|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
14544164|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544165|NCT00000450|Naltrexone|naltrexone|mesh-list
14544166|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544167|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544168|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544169|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
14544170|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544171|NCT00000451|Naltrexone|naltrexone|mesh-list
14544172|NCT00000451|Sertraline|sertraline|mesh-list
14544173|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544174|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544175|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544176|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
14544177|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544178|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544179|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544180|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14544181|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544182|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15083753|NCT02398773|Hormones|hormones|mesh-ancestor
15083754|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15083755|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083756|NCT02392429|Cytarabine|cytarabine|mesh-list
15083757|NCT02392429|Alovudine|alovudine|mesh-list
14023347|NCT02762812|Infliximab|infliximab|mesh-list
14544183|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544184|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544185|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
14544186|NCT00000452|Naltrexone|naltrexone|mesh-list
14544187|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544188|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544189|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544190|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
14544191|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544192|NCT00000454|Nicotine|nicotine|mesh-list
14544193|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14544194|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
14544195|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544196|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544197|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14544198|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14544199|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
14544200|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544201|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544202|NCT00000455|Naltrexone|naltrexone|mesh-list
14544203|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544204|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544205|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544206|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
14544207|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544208|NCT00000456|Naltrexone|naltrexone|mesh-list
14544209|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14544210|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14544211|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544212|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
14544213|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544214|NCT00000457|Bupropion|bupropion|mesh-list
14544215|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14544216|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544217|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544218|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14544219|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544220|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544221|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544222|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
14544223|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544224|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544225|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14544226|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14544227|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544228|NCT00000458|Sertraline|sertraline|mesh-list
14808239|NCT00825864|BB 1101|bb 1101|mesh-list
14808240|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808241|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
14808242|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
14808243|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808244|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808245|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14808246|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
14808247|NCT00825864|Hormones|hormones|mesh-ancestor
14808248|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808249|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14808250|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808251|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14808252|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14808253|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14808254|NCT00825864|Analgesics|analgesics|mesh-ancestor
14808255|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
14808256|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808257|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14808258|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808259|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808260|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
14808261|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14808262|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14814147|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14814148|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14814149|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083758|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14814150|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544229|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544230|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544231|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14544232|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544233|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544234|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544235|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544236|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
14544237|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544238|NCT00000461|Niacin|niacin|mesh-list
14544239|NCT00000461|Pravastatin|pravastatin|mesh-list
14544240|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
14544241|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
14544242|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544243|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
14544244|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544245|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544246|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544247|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
14544248|NCT00000461|Vitamins|vitamins|mesh-ancestor
14544249|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
14544250|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544251|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544252|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544253|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544254|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14544255|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14544256|NCT00000463|Warfarin|warfarin|mesh-list
14544257|NCT00000463|Lovastatin|lovastatin|mesh-list
14544258|NCT00000463|L 647318|l 647318|mesh-list
14544259|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
14544260|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
14544261|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
14544262|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544263|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544264|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
14544265|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544266|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544267|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544268|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544269|NCT00000464|Quinidine|quinidine|mesh-list
14544270|NCT00000464|Amiodarone|amiodarone|mesh-list
14544271|NCT00000464|Sotalol|sotalol|mesh-list
14544272|NCT00000464|Propafenone|propafenone|mesh-list
14544273|NCT00000464|Mexiletine|mexiletine|mesh-list
14544274|NCT00000464|Procainamide|procainamide|mesh-list
14544275|NCT00000464|Imipramine|imipramine|mesh-list
14544276|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544277|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544278|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14544279|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544280|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544281|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14544282|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14544283|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14544284|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544285|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14544286|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14544287|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14544288|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544289|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544290|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544291|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544292|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544293|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
14544294|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
14544295|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544296|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14544297|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544298|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544299|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14544300|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544301|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14544302|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
14544303|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14544304|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14544305|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14544306|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14544307|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14544308|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
14544309|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14544310|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14544311|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
14544312|NCT00000466|Progesterone|progesterone|mesh-list
14544313|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14544314|NCT00000466|Estrogens|estrogens|mesh-list
14544315|NCT00000466|Progestins|progestins|mesh-ancestor
14544316|NCT00000466|Hormones|hormones|mesh-ancestor
14544317|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14544318|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544319|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14544320|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14544321|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14544322|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
14544323|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14544324|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14544325|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14544326|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14544327|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14544328|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14544329|NCT00000468|Plasminogen|plasminogen|mesh-list
14544330|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14544331|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544332|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544333|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544334|NCT00000469|Aspirin|aspirin|mesh-list
14544335|NCT00000469|Lovastatin|lovastatin|mesh-list
14544336|NCT00000469|L 647318|l 647318|mesh-list
14544337|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
14544338|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14544339|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544340|NCT00000469|Analgesics|analgesics|mesh-ancestor
14544341|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
14544342|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544343|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544344|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544345|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544346|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544347|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544348|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544349|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14544350|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544351|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544352|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
14544353|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544354|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544355|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
14544356|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544357|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544358|NCT00000472|Heparin|heparin|mesh-list
14544359|NCT00000472|Plasminogen|plasminogen|mesh-list
14544360|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14544361|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
14544362|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544363|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544364|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544365|NCT00000477|Lovastatin|lovastatin|mesh-list
14544366|NCT00000477|L 647318|l 647318|mesh-list
14544367|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
14544368|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544369|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544370|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
14544371|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544372|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544373|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544374|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544375|NCT00000478|Atenolol|atenolol|mesh-list
14544376|NCT00000478|Diltiazem|diltiazem|mesh-list
14544377|NCT00000478|Nifedipine|nifedipine|mesh-list
14544378|NCT00000478|Isosorbide|isosorbide|mesh-list
14808263|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
14544379|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14544380|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14544381|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14544382|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544383|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544384|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14544385|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544386|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544387|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
14544388|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14544389|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544390|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544391|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
14544392|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
14544393|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544394|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14544395|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544396|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544397|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544398|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544399|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14544400|NCT00000478|Diuretics|diuretics|mesh-ancestor
14544401|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544402|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14544403|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14544404|NCT00000482|Niacin|niacin|mesh-list
14544405|NCT00000482|Clofibrate|clofibrate|mesh-list
14544406|NCT00000482|Estrogens|estrogens|mesh-list
14544407|NCT00000482|Hormones|hormones|mesh-ancestor
14544408|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14544409|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544410|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544411|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
14544412|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544413|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544414|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544415|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
14544416|NCT00000482|Vitamins|vitamins|mesh-ancestor
14544417|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
14544418|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544419|NCT00000483|Niacin|niacin|mesh-list
14544420|NCT00000483|Clofibrate|clofibrate|mesh-list
14544421|NCT00000483|Estrogens|estrogens|mesh-list
14544422|NCT00000483|Hormones|hormones|mesh-ancestor
14544423|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14544424|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544425|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544426|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
14544427|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544428|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544429|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544430|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
14544431|NCT00000483|Vitamins|vitamins|mesh-ancestor
14544432|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
14544433|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544434|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
14544435|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544436|NCT00000484|Diuretics|diuretics|mesh-ancestor
14544437|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544438|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544439|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14544440|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15083759|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
15083760|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083761|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083762|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
15083763|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083764|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083765|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
15083766|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083767|NCT02389946|Sirolimus|sirolimus|mesh-list
15083768|NCT02389946|Everolimus|everolimus|mesh-list
14544441|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544442|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
14544443|NCT00000485|Diuretics|diuretics|mesh-list
14544444|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
15083769|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14544445|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544446|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
14544447|NCT00000487|Diuretics|diuretics|mesh-list
14544448|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544449|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544450|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
14544451|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544452|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544453|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
14544454|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544455|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544456|NCT00000491|Aspirin|aspirin|mesh-list
14544457|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14544458|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544459|NCT00000491|Analgesics|analgesics|mesh-ancestor
14544460|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
14544461|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544462|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544463|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544464|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544465|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544466|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544467|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544468|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14544469|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544470|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544471|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
14544472|NCT00000492|Propranolol|propranolol|mesh-list
14544473|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544474|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544475|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544476|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544477|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544478|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544479|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544480|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544481|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544482|NCT00000493|Propranolol|propranolol|mesh-list
14544483|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544484|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544485|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544486|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544487|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544488|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544489|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544490|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544491|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544492|NCT00000494|Indomethacin|indomethacin|mesh-list
14544493|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14544494|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544495|NCT00000494|Analgesics|analgesics|mesh-ancestor
14544496|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
14544497|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544498|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544499|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544500|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544501|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
14544502|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
14544503|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14544504|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544505|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544506|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544507|NCT00000496|Aspirin|aspirin|mesh-list
14544508|NCT00000496|Dipyridamole|dipyridamole|mesh-list
14544509|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15083770|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083771|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
15083772|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083773|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14544510|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544511|NCT00000496|Analgesics|analgesics|mesh-ancestor
14544512|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
15083774|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14544513|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544514|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544515|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544516|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544517|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544518|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544519|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544520|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14544521|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544522|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544523|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
14544524|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14544525|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544526|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
14544527|NCT00000499|Metoprolol|metoprolol|mesh-list
14544528|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
14544529|NCT00000499|Hydralazine|hydralazine|mesh-list
14544530|NCT00000499|Reserpine|reserpine|mesh-list
14544531|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544532|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544533|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
14544534|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
14544535|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544536|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544537|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14544538|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544539|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544540|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544541|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544542|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544543|NCT00000499|Diuretics|diuretics|mesh-ancestor
14544544|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544545|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14544546|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544547|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544548|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14544549|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14544550|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14544551|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544552|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14544553|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544554|NCT00000500|Aspirin|aspirin|mesh-list
14544555|NCT00000500|Carotenoids|carotenoids|mesh-list
14544556|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14544557|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544558|NCT00000500|Analgesics|analgesics|mesh-ancestor
14544559|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
14544560|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544561|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544562|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544563|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544564|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544565|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544566|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544567|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14544568|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544569|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544570|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
14544571|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
14544572|NCT00000500|Protective Agents|protective agents|mesh-ancestor
14544573|NCT00000503|Streptokinase|streptokinase|mesh-list
14544574|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
14544575|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544576|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544577|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544578|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544579|NCT00000504|Flecainide|flecainide|mesh-list
14544580|NCT00000504|Moricizine|moricizine|mesh-list
14544581|NCT00000504|Encainide|encainide|mesh-list
14544582|NCT00000504|Imipramine|imipramine|mesh-list
14544583|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544584|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14544585|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14544586|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544587|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544588|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14544589|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544590|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544591|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14544592|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544593|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544594|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544595|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544596|NCT00000505|Plasminogen|plasminogen|mesh-list
14544597|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14544598|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15083775|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083776|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
15083777|NCT02339571|Nivolumab|nivolumab|mesh-list
15083778|NCT02339571|Ipilimumab|ipilimumab|mesh-list
15083779|NCT02339571|Sargramostim|sargramostim|mesh-list
15083780|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083781|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083782|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083783|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083784|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
15083785|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083786|NCT02317874|Paclitaxel|paclitaxel|mesh-list
15083787|NCT02317874|Carboplatin|carboplatin|mesh-list
15083788|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15083789|NCT02317874|Talazoparib|talazoparib|mesh-list
15083790|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083791|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083792|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083793|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083794|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083795|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544599|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544600|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544601|NCT00000506|Phentermine|phentermine|mesh-list
14544602|NCT00000506|Fenfluramine|fenfluramine|mesh-list
14544603|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14544604|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544605|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
14544606|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14544607|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
14544608|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
14544609|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544610|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544611|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544612|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544613|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14544614|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544615|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544616|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
14544617|NCT00000507|Streptokinase|streptokinase|mesh-list
14544618|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544619|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544620|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544621|NCT00000510|Aspirin|aspirin|mesh-list
14544622|NCT00000510|Dipyridamole|dipyridamole|mesh-list
14544623|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14544624|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544625|NCT00000510|Analgesics|analgesics|mesh-ancestor
14544626|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
14544627|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544628|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544629|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544630|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544631|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544632|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544633|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544634|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14544635|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544636|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544637|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
14544638|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14544639|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814151|NCT00861731|Simvastatin|simvastatin|mesh-list
14544640|NCT00000512|Niacin|niacin|mesh-list
15172940|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
14544641|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
14544642|NCT00000512|Lovastatin|lovastatin|mesh-list
14544643|NCT00000512|L 647318|l 647318|mesh-list
14544644|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
14544645|NCT00000512|Colestipol|colestipol|mesh-list
14544646|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544647|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
14544648|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544649|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544650|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544651|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
14544652|NCT00000512|Vitamins|vitamins|mesh-ancestor
14544653|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
14544654|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544655|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544656|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544657|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544658|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
14544659|NCT00000513|Atenolol|atenolol|mesh-list
14544660|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
14544661|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544662|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544663|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
14544664|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
14544665|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544666|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544667|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14544668|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544669|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544670|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544671|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544672|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544673|NCT00000513|Diuretics|diuretics|mesh-ancestor
14544674|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544675|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14544676|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544677|NCT00000514|Atenolol|atenolol|mesh-list
14544678|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
14544679|NCT00000514|Reserpine|reserpine|mesh-list
14544680|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544681|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544682|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
14544683|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
14544684|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544685|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544686|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14544687|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544688|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544689|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
14808264|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808265|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
14808266|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808267|NCT00826163|Budesonide|budesonide|mesh-list
14808268|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808269|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14808270|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
14808271|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808272|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808273|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14808274|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
15083796|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15083797|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083798|NCT02314169|Nivolumab|nivolumab|mesh-list
15083799|NCT02314169|Ipilimumab|ipilimumab|mesh-list
15083800|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083801|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083802|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083803|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083804|NCT02296229|Androgens|androgens|mesh-list
15083805|NCT02296229|Hormones|hormones|mesh-ancestor
15083806|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15083807|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083808|NCT02275533|Nivolumab|nivolumab|mesh-list
15083809|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083810|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14544690|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544691|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544692|NCT00000514|Diuretics|diuretics|mesh-ancestor
14544693|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544694|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14544695|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544696|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14544697|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14544698|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14544699|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544700|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14544701|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544702|NCT00000516|Enalapril|enalapril|mesh-list
14544703|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14544704|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
14544705|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544706|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544707|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544708|NCT00000517|Warfarin|warfarin|mesh-list
14544709|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
14544710|NCT00000518|Quinidine|quinidine|mesh-list
14544711|NCT00000518|Sotalol|sotalol|mesh-list
14544712|NCT00000518|Mexiletine|mexiletine|mesh-list
14544713|NCT00000518|Procainamide|procainamide|mesh-list
14544714|NCT00000518|Imipramine|imipramine|mesh-list
14544715|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544716|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544717|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544718|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544719|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544720|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544721|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544722|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
14544723|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
14544724|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544725|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14544726|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
14544727|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14544728|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14544729|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14544730|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544731|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14544732|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
14544733|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14544734|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14544735|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14544736|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544737|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14544738|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14544739|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
14544740|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14544741|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14544742|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14544743|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14544744|NCT00000520|Aspirin|aspirin|mesh-list
14544745|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
14544746|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14544747|NCT00000520|Antibodies|antibodies|mesh-list
14544748|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
14544749|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14544750|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14544751|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544752|NCT00000520|Analgesics|analgesics|mesh-ancestor
14544753|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
14544754|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544755|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544756|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544757|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544758|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544759|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544760|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083811|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083812|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544761|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14544762|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544763|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544764|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
14544765|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
14544766|NCT00000522|Acebutolol|acebutolol|mesh-list
14544767|NCT00000522|Amlodipine|amlodipine|mesh-list
14544768|NCT00000522|Enalapril|enalapril|mesh-list
14544769|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
14544770|NCT00000522|Doxazosin|doxazosin|mesh-list
14544771|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544772|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14544773|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544774|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544775|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14544776|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544777|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544778|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14544779|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
14544780|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544781|NCT00000522|Diuretics|diuretics|mesh-ancestor
14544782|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544783|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14544784|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14544785|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14544786|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544787|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544788|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544789|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544790|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
14544791|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
14544792|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544793|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14544794|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14643212|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14643213|NCT00188669|Tocopherols|tocopherols|mesh-list
14643214|NCT00188669|Vitamin E|vitamin e|mesh-list
14643215|NCT00188669|Tocotrienols|tocotrienols|mesh-list
14643216|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
14643217|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
14643218|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14643219|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267550|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267551|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14267552|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
14267553|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267554|NCT00391027|Insulin|insulin|mesh-list
14643220|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643221|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14643222|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14643223|NCT00188669|Protective Agents|protective agents|mesh-ancestor
14643224|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643225|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
14643226|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14643227|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
14643228|NCT00188669|Vitamins|vitamins|mesh-ancestor
14643229|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
14643230|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
14643231|NCT00188773|Heparin|heparin|mesh-list
14643232|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14643233|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14643234|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
14643235|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14643236|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14808275|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
15083813|NCT02224781|Nivolumab|nivolumab|mesh-list
15083814|NCT02224781|Ipilimumab|ipilimumab|mesh-list
15083815|NCT02224781|Trametinib|trametinib|mesh-list
15083816|NCT02224781|Dabrafenib|dabrafenib|mesh-list
15083817|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15083818|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083819|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083820|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083821|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083822|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14023348|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
15083823|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643237|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808276|NCT00826163|Hormones|hormones|mesh-ancestor
15172941|NCT04008784|Hormones|hormones|mesh-ancestor
15083824|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15083825|NCT02224781|Protective Agents|protective agents|mesh-ancestor
14544795|NCT00000524|Cyclosporine|cyclosporine|mesh-list
14544796|NCT00000524|Prednisone|prednisone|mesh-list
14544797|NCT00000524|Cyclosporins|cyclosporins|mesh-list
14544798|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544799|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
14544800|NCT00000524|Hormones|hormones|mesh-ancestor
14544801|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14544802|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544803|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14544804|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14544805|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544806|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544807|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14544808|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
15083826|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083827|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15083828|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
15083829|NCT02194738|Gemcitabine|gemcitabine|mesh-list
15083830|NCT02194738|Paclitaxel|paclitaxel|mesh-list
15083831|NCT02194738|Cisplatin|cisplatin|mesh-list
15083832|NCT02194738|Carboplatin|carboplatin|mesh-list
15083833|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
15083834|NCT02194738|Nivolumab|nivolumab|mesh-list
15083835|NCT02194738|Pemetrexed|pemetrexed|mesh-list
15083836|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15083837|NCT02194738|Crizotinib|crizotinib|mesh-list
15083838|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083839|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083840|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083841|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083842|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083843|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544809|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
14544810|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14544811|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14544812|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544813|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14544814|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14544815|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
15083844|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083845|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
15083846|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
15083847|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083848|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083849|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083850|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
15083851|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083852|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15083853|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15083854|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15083855|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15083856|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083857|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15083858|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083859|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15083860|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083861|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083862|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15083863|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
15083864|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15083865|NCT02185417|Diuretics|diuretics|mesh-ancestor
15083866|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
15083867|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083868|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15083869|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15083870|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083871|NCT02180867|Doxorubicin|doxorubicin|mesh-list
15083872|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15083873|NCT02180867|Daunorubicin|daunorubicin|mesh-list
15083874|NCT02180867|Ifosfamide|ifosfamide|mesh-list
14544816|NCT00000525|Triamterene|triamterene|mesh-list
14267555|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15083875|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
14544817|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544818|NCT00000525|Diuretics|diuretics|mesh-ancestor
14544819|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544820|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544821|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14544822|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544823|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544824|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14544825|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14544826|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14544827|NCT00000526|Flecainide|flecainide|mesh-list
14544828|NCT00000526|Moricizine|moricizine|mesh-list
14544829|NCT00000526|Encainide|encainide|mesh-list
14544830|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544831|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14544832|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14544833|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544834|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544835|NCT00000527|Aspirin|aspirin|mesh-list
14544836|NCT00000527|Dipyridamole|dipyridamole|mesh-list
14544837|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14544838|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14544839|NCT00000527|Analgesics|analgesics|mesh-ancestor
14544840|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
14544841|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544842|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544843|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14544844|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14544845|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14544846|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544847|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544848|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14544849|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14544850|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544851|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
14544852|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14544853|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544854|NCT00000529|Tamoxifen|tamoxifen|mesh-list
14544855|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14544856|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
14544857|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14544858|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544859|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14544860|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14544861|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14544862|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14544863|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14544864|NCT00000530|Nifedipine|nifedipine|mesh-list
14544865|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14544866|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544867|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544868|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14544869|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544870|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544871|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
14544872|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14544873|NCT00000531|Amiodarone|amiodarone|mesh-list
14544874|NCT00000531|Sotalol|sotalol|mesh-list
14544875|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14544876|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544877|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14544878|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544879|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544880|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14544881|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14544882|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14544883|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544884|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14544885|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14544886|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14544887|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14544888|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544889|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544890|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544891|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544892|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
14544893|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
14544894|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14544895|NCT00000534|Calcium|calcium|mesh-list
14544896|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14544897|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544898|NCT00000539|Vitamins|vitamins|mesh-list
14544899|NCT00000539|Vitamin E|vitamin e|mesh-list
14544900|NCT00000539|Beta Carotene|beta carotene|mesh-list
14544901|NCT00000539|Warfarin|warfarin|mesh-list
14544902|NCT00000539|Pravastatin|pravastatin|mesh-list
14544903|NCT00000539|Carotenoids|carotenoids|mesh-list
14544904|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
14544905|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544906|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
14544907|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
14544908|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544909|NCT00000539|Protective Agents|protective agents|mesh-ancestor
14544910|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544911|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
14544912|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544913|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544914|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544915|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544916|NCT00000539|Provitamins|provitamins|mesh-ancestor
14544917|NCT00000541|Vitamins|vitamins|mesh-list
14544918|NCT00000541|Folic Acid|folic acid|mesh-list
14544919|NCT00000541|Vitamin E|vitamin e|mesh-list
14544920|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
14544921|NCT00000541|Hydroxocobalamin|hydroxocobalamin|mesh-list
14544922|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
14544923|NCT00000541|Pyridoxal|pyridoxal|mesh-list
14544924|NCT00000541|Pyridoxine|pyridoxine|mesh-list
14544925|NCT00000541|Beta Carotene|beta carotene|mesh-list
14544926|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
14544927|NCT00000541|Carotenoids|carotenoids|mesh-list
14544928|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
14544929|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544930|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
14544931|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544932|NCT00000541|Protective Agents|protective agents|mesh-ancestor
14544933|NCT00000541|Hematinics|hematinics|mesh-ancestor
14544934|NCT00000541|Provitamins|provitamins|mesh-ancestor
14544935|NCT00000542|Amlodipine|amlodipine|mesh-list
14544936|NCT00000542|Lisinopril|lisinopril|mesh-list
14544937|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
14544938|NCT00000542|Doxazosin|doxazosin|mesh-list
14544939|NCT00000542|Pravastatin|pravastatin|mesh-list
14544940|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14544941|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544942|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14544943|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14544944|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544945|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14544946|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544947|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544948|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14267556|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
14544949|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544950|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
14544951|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544952|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544953|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544954|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
14544955|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14544956|NCT00000542|Protective Agents|protective agents|mesh-ancestor
14544957|NCT00000542|Diuretics|diuretics|mesh-ancestor
14544958|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
14544959|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14544960|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14544961|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14544962|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14544963|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
14544964|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14544965|NCT00000543|Calcium|calcium|mesh-list
14544966|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14544967|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544968|NCT00000547|Enalapril|enalapril|mesh-list
14544969|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14544970|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
14544971|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544972|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544973|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14544974|NCT00000549|Hormones|hormones|mesh-list
14808277|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808278|NCT00826254|Vitamins|vitamins|mesh-list
14808279|NCT00826254|Vitamin K|vitamin k|mesh-list
14808280|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
14808281|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808282|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14808283|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14808284|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808285|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
14808286|NCT00826254|Coagulants|coagulants|mesh-ancestor
14808287|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
14808288|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14808289|NCT00826306|Protective Agents|protective agents|mesh-ancestor
14808290|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808291|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14808292|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14808293|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14808294|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14808295|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
14808296|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808297|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14808298|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14808299|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808300|NCT00826371|Ranibizumab|ranibizumab|mesh-list
14808301|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14808302|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14808303|NCT00826371|Growth Substances|growth substances|mesh-ancestor
14808304|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808305|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
14808306|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808307|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
14808308|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14808309|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14808310|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
14808311|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808312|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808313|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808314|NCT00826527|Urological Agents|urological agents|mesh-ancestor
14808315|NCT00826553|Midazolam|midazolam|mesh-list
14544975|NCT00000549|Estrogens|estrogens|mesh-list
14544976|NCT00000549|Progestins|progestins|mesh-list
14544977|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14544978|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544979|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14544980|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14544981|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544982|NCT00000553|Niacin|niacin|mesh-list
14544983|NCT00000553|Simvastatin|simvastatin|mesh-list
14544984|NCT00000553|Antioxidants|antioxidants|mesh-list
14544985|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14544986|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14544987|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
14544988|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14544989|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14544990|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14544991|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14544992|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
14544993|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
14544994|NCT00000553|Vitamins|vitamins|mesh-ancestor
14544995|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
14544996|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14544997|NCT00000553|Protective Agents|protective agents|mesh-ancestor
14544998|NCT00000554|Dobutamine|dobutamine|mesh-list
14544999|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14545000|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
14545001|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
14545002|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545003|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545004|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14545005|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14545006|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14545007|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
14545008|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545009|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545010|NCT00000554|Protective Agents|protective agents|mesh-ancestor
14545011|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
14545012|NCT00000555|Vitamin E|vitamin e|mesh-list
14545013|NCT00000555|Hormones|hormones|mesh-list
14545014|NCT00000555|Progesterone|progesterone|mesh-list
14545015|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14545016|NCT00000555|Estrogens|estrogens|mesh-list
14545017|NCT00000555|Vitamins|vitamins|mesh-ancestor
14545018|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
15083876|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083877|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083878|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15083879|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083880|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083881|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083882|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083883|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
15083884|NCT02176148|Fluocinonide|fluocinonide|mesh-list
15083885|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15083886|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
15083887|NCT02176148|Hormones|hormones|mesh-ancestor
15083888|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15083889|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083890|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15083891|NCT02166463|Prednisone|prednisone|mesh-list
15083892|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
15083893|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15083894|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15083895|NCT02166463|Prednisolone|prednisolone|mesh-list
15083896|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
15083897|NCT02166463|Cortisone|cortisone|mesh-list
15083898|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
15083899|NCT02166463|Doxorubicin|doxorubicin|mesh-list
15083900|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15083901|NCT02166463|Etoposide|etoposide|mesh-list
15083902|NCT02166463|Vincristine|vincristine|mesh-list
15083903|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
15083904|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15083905|NCT02166463|Bleomycin|bleomycin|mesh-list
15083906|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
15083907|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14545019|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643238|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
15083908|NCT02166463|Antibodies|antibodies|mesh-list
15083909|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
14545020|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545021|NCT00000555|Progestins|progestins|mesh-ancestor
14545022|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
14545023|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545024|NCT00000555|Protective Agents|protective agents|mesh-ancestor
14545025|NCT00000556|Quinidine|quinidine|mesh-list
14545026|NCT00000556|Digoxin|digoxin|mesh-list
14545027|NCT00000556|Amiodarone|amiodarone|mesh-list
14545028|NCT00000556|Verapamil|verapamil|mesh-list
14545029|NCT00000556|Sotalol|sotalol|mesh-list
14545030|NCT00000556|Flecainide|flecainide|mesh-list
14545031|NCT00000556|Propafenone|propafenone|mesh-list
14545032|NCT00000556|Procainamide|procainamide|mesh-list
14545033|NCT00000556|Moricizine|moricizine|mesh-list
14545034|NCT00000556|Disopyramide|disopyramide|mesh-list
14545035|NCT00000556|Diltiazem|diltiazem|mesh-list
14545036|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14545037|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
14545038|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15083910|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15083911|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
15083912|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15083913|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
15083914|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14545039|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14545040|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545041|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545042|NCT00000556|Protective Agents|protective agents|mesh-ancestor
14545043|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545044|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
14545045|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14545046|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14545047|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14545048|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14545049|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545050|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14545051|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14545052|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14545053|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14545054|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14545055|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14545056|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14545057|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545058|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
14545059|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
14545060|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545061|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14545062|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14545063|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
14545064|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14545065|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14545066|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545067|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14545068|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14545069|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
14545070|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14545071|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14545072|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545073|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
14545074|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14545075|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
14545076|NCT00000559|Hormones|hormones|mesh-list
14545077|NCT00000559|Estradiol|estradiol|mesh-list
14545078|NCT00000559|Estrogens|estrogens|mesh-list
14545079|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545080|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545081|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14545082|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
14545083|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14545084|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14545085|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14545086|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14545087|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14545088|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14545089|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14545090|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545091|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
14545092|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14545093|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545094|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545095|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545096|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14545097|NCT00000563|Dexamethasone|dexamethasone|mesh-list
14545098|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545099|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
14545100|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
14545101|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545102|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545103|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14545104|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
14545105|NCT00000563|Hormones|hormones|mesh-ancestor
14545106|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545107|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14545108|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545109|NCT00000568|Ipratropium|ipratropium|mesh-list
14545110|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14545111|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
14545112|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545113|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083915|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
15083916|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083917|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15083918|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083919|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
15083920|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083921|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545114|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14545115|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
14545116|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14545117|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
14545118|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545119|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545120|NCT00000569|Triamcinolone|triamcinolone|mesh-list
14545121|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545122|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
14545123|NCT00000569|Hormones|hormones|mesh-ancestor
14545124|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545125|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545126|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14545127|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
14545128|NCT00000574|Ibuprofen|ibuprofen|mesh-list
14545129|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14545130|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14545131|NCT00000574|Analgesics|analgesics|mesh-ancestor
14545132|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
14545133|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545134|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545135|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545136|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15083922|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15083923|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15083924|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14545137|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14545138|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545139|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545140|NCT00000576|Beclomethasone|beclomethasone|mesh-list
14545141|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545142|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
14545143|NCT00000576|Hormones|hormones|mesh-ancestor
14545144|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545145|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545146|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14545147|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
14545148|NCT00000577|Colchicine|colchicine|mesh-list
14545149|NCT00000577|Albuterol|albuterol|mesh-list
15083925|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15083926|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083927|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15083928|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
15083929|NCT02166463|Hormones|hormones|mesh-ancestor
15083930|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15083931|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15083932|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083933|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083934|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083935|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083936|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
15083937|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
15083938|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15083939|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14545150|NCT00000577|Hormones|hormones|mesh-list
14545151|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
14545152|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
14545153|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545154|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545155|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14545156|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
14545157|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545158|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14545159|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
14545160|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
14545161|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14545162|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15083940|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15083941|NCT02166463|Protective Agents|protective agents|mesh-ancestor
15083942|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
15083943|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
15083944|NCT02152982|Temozolomide|temozolomide|mesh-list
15083945|NCT02152982|Veliparib|veliparib|mesh-list
15083946|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15083947|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
15083948|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083949|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083950|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15083951|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083952|NCT02135042|Gemcitabine|gemcitabine|mesh-list
15083953|NCT02135042|Paclitaxel|paclitaxel|mesh-list
15083954|NCT02135042|Cisplatin|cisplatin|mesh-list
15083955|NCT02135042|Fluorouracil|fluorouracil|mesh-list
15083956|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15083957|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15083958|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083959|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
15083960|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
15083961|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
15083962|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083963|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083964|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
15083965|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
15083966|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083967|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545163|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14545164|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545165|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545166|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
14545167|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14545168|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
14545169|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
14545170|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
14545171|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545172|NCT00000578|Beclomethasone|beclomethasone|mesh-list
14545173|NCT00000578|Theophylline|theophylline|mesh-list
14545174|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545175|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
14545176|NCT00000578|Hormones|hormones|mesh-ancestor
14545177|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545178|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545179|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14545180|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
14545181|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14545182|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
14545183|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545184|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14545185|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545186|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545187|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
14545188|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14545189|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14545190|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
14545191|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545192|NCT00000579|Ketoconazole|ketoconazole|mesh-list
14545193|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
14545194|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14545195|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14545196|NCT00000579|Prednisolone|prednisolone|mesh-list
14545197|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
14545198|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14545199|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
14545200|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545201|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
14545202|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
14545203|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545204|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545205|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14545206|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
14545207|NCT00000579|Hormones|hormones|mesh-ancestor
15083968|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083969|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
15083970|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083971|NCT02101775|Gemcitabine|gemcitabine|mesh-list
15083972|NCT02101775|Adavosertib|adavosertib|mesh-list
15083973|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15083974|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
15083975|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15083976|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15083977|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
15083978|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15083979|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15083980|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15083981|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
15083982|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15083983|NCT02003222|Cytarabine|cytarabine|mesh-list
15083984|NCT02003222|Dexamethasone|dexamethasone|mesh-list
15083985|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
15083986|NCT02003222|Prednisone|prednisone|mesh-list
15083987|NCT02003222|Cortisone|cortisone|mesh-list
15083988|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
15083989|NCT02003222|Rituximab|rituximab|mesh-list
15083990|NCT02003222|Methotrexate|methotrexate|mesh-list
15083991|NCT02003222|Etoposide|etoposide|mesh-list
15083992|NCT02003222|Vincristine|vincristine|mesh-list
15083993|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
15083994|NCT02003222|Daunorubicin|daunorubicin|mesh-list
15083995|NCT02003222|Asparaginase|asparaginase|mesh-list
15083996|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
15083997|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
15083998|NCT02003222|Pegaspargase|pegaspargase|mesh-list
15083999|NCT02003222|Blinatumomab|blinatumomab|mesh-list
15084000|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15084001|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
15084002|NCT02003222|Antibodies|antibodies|mesh-list
15084003|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
15084004|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084005|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15084006|NCT02003222|BB 1101|bb 1101|mesh-list
15084007|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084008|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
15084009|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084010|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084011|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084012|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
14545208|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084013|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084014|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084015|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15084016|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545209|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14545210|NCT00000579|Protective Agents|protective agents|mesh-ancestor
14545211|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14545212|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545213|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
14545214|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545215|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14545216|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545217|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545218|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545219|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14545220|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
14545221|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14545222|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
14545223|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14545224|NCT00000580|Antibodies|antibodies|mesh-list
14545225|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
14545226|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14545227|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
14545228|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545229|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
14545230|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14545231|NCT00000584|Antibodies|antibodies|mesh-list
14545232|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
14545233|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545234|NCT00000585|Penicillins|penicillins|mesh-list
14545235|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545236|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545237|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
14545238|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545239|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
14545240|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545241|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545242|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545243|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
14545244|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14545245|NCT00000590|Antibodies|antibodies|mesh-list
14545246|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
14545247|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545248|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
14545249|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14545250|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14545251|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
14545252|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545253|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14545254|NCT00000595|Deferoxamine|deferoxamine|mesh-list
14545255|NCT00000595|Siderophores|siderophores|mesh-ancestor
14545256|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14545257|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
14545258|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
14545259|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545260|NCT00000596|Dapsone|dapsone|mesh-list
14545261|NCT00000596|Prednisone|prednisone|mesh-list
14545262|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
14545263|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14545264|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
14545265|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545266|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14545267|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14545268|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
14545269|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545270|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267557|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14267558|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545271|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14545272|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545273|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
14545274|NCT00000596|Hormones|hormones|mesh-ancestor
14545275|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545276|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14545277|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545278|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
14545279|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14545280|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14808316|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
14808317|NCT00826553|Lorazepam|lorazepam|mesh-list
14545281|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14545282|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545283|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
14545284|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545285|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
14545286|NCT00000597|Nandrolone|nandrolone|mesh-list
14545287|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
14545288|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14545289|NCT00000597|Androgens|androgens|mesh-ancestor
14545290|NCT00000597|Hormones|hormones|mesh-ancestor
14545291|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545292|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545293|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
15084017|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
15084018|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
15084019|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084020|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15084021|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
15084022|NCT02003222|Hormones|hormones|mesh-ancestor
15084023|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084024|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084025|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084026|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084027|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15084028|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
15084029|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15084030|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15084031|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
15084032|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
15084033|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15084034|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084035|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084036|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084037|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084038|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
15084039|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084040|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084041|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084042|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084043|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084044|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
15084045|NCT01947023|Lapatinib|lapatinib|mesh-list
15084046|NCT01947023|Dabrafenib|dabrafenib|mesh-list
15084047|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084048|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084049|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084050|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084051|NCT01912625|Paclitaxel|paclitaxel|mesh-list
15084052|NCT01912625|Carboplatin|carboplatin|mesh-list
15084053|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084054|NCT01912625|Trametinib|trametinib|mesh-list
15084055|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084056|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084057|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084058|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084059|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
14545294|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14545295|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
14545296|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14545297|NCT00000599|Niacin|niacin|mesh-list
14545298|NCT00000599|Colestipol|colestipol|mesh-list
14545299|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14545300|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
14545301|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545302|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14545303|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
14545304|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
14545305|NCT00000599|Vitamins|vitamins|mesh-ancestor
14545306|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
14545307|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545308|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
14545309|NCT00000600|Vitamins|vitamins|mesh-list
14545310|NCT00000600|Ascorbic Acid|ascorbic acid|mesh-list
14545311|NCT00000600|Vitamin E|vitamin e|mesh-list
14545312|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
14545313|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545314|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
15084060|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545315|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545316|NCT00000600|Protective Agents|protective agents|mesh-ancestor
14545317|NCT00000601|Hormones|hormones|mesh-list
15084061|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084062|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084063|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15084064|NCT01896999|Nivolumab|nivolumab|mesh-list
15084065|NCT01896999|Ipilimumab|ipilimumab|mesh-list
15084066|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15084067|NCT01896999|Antibodies|antibodies|mesh-list
15084068|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
15084069|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084070|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
15084071|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
15084072|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084073|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084074|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15084075|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084076|NCT01866111|Cenobamate|cenobamate|mesh-list
15084077|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
15084078|NCT01810913|Cisplatin|cisplatin|mesh-list
15084079|NCT01810913|Docetaxel|docetaxel|mesh-list
15084080|NCT01810913|Cetuximab|cetuximab|mesh-list
15084081|NCT01810913|Atezolizumab|atezolizumab|mesh-list
15084082|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15084083|NCT01810913|Antibodies|antibodies|mesh-list
15084084|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
15084085|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084086|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
15084087|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084088|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084089|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084090|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084091|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084092|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084093|NCT01767194|Sirolimus|sirolimus|mesh-list
15084094|NCT01767194|Irinotecan|irinotecan|mesh-list
15084095|NCT01767194|Camptothecin|camptothecin|mesh-list
15084096|NCT01767194|Temozolomide|temozolomide|mesh-list
15084097|NCT01767194|Dinutuximab|dinutuximab|mesh-list
15084098|NCT01767194|Sargramostim|sargramostim|mesh-list
15084099|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15084100|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084101|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084102|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084103|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084104|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084105|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
15084106|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15084107|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084108|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084109|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
15084110|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084111|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
15084112|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084113|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084114|NCT01767129|Quinidine|quinidine|mesh-list
15084115|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
15084116|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
15084117|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
15084118|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15084119|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15084120|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15084121|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084122|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084123|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15084124|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15084125|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
15084126|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15084127|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
15084128|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15084129|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15084130|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084131|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084132|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15084133|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15084134|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
15182262|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14545318|NCT00000601|Progesterone|progesterone|mesh-list
14545319|NCT00000601|Estrogens|estrogens|mesh-list
14545320|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545321|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545322|NCT00000601|Progestins|progestins|mesh-ancestor
14545323|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
14545324|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545325|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
14545326|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545327|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545328|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545329|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14545330|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
14545331|NCT00000605|Hormones|hormones|mesh-list
14545332|NCT00000605|Estrogens|estrogens|mesh-list
14545333|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545334|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545335|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14545336|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14545337|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14545338|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
14545339|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14545340|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14545341|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14545342|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14545343|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14545344|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545345|NCT00000609|Amiodarone|amiodarone|mesh-list
14545346|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14545347|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
14545348|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14545349|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14545350|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545351|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14545352|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14545353|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545354|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545355|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14545356|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14545357|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14545358|NCT00000611|Vitamin D|vitamin d|mesh-list
14545359|NCT00000611|Calcium|calcium|mesh-list
14545360|NCT00000611|Hormones|hormones|mesh-list
14545361|NCT00000611|Estrogens|estrogens|mesh-list
14545362|NCT00000611|Progestins|progestins|mesh-list
14545363|NCT00000611|Vitamins|vitamins|mesh-ancestor
15084135|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15084136|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15084137|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15084138|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15084139|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15084140|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15084141|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084142|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084143|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084144|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084145|NCT01708941|Interferons|interferons|mesh-list
15084146|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
15084147|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
15084148|NCT01708941|Ipilimumab|ipilimumab|mesh-list
15084149|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084150|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
15084151|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084152|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15084153|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15084154|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084155|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
15084156|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084157|NCT01659606|Cyclosporine|cyclosporine|mesh-list
15084158|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
15084159|NCT01659606|Fludarabine|fludarabine|mesh-list
15084160|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
15084161|NCT01659606|Tacrolimus|tacrolimus|mesh-list
15084162|NCT01659606|Cyclosporins|cyclosporins|mesh-list
15084163|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084164|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084165|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084166|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
15084167|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084168|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15084169|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084170|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
15084171|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084172|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
15084173|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084174|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084175|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15084176|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
15084177|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15084178|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15084179|NCT01622868|Lapatinib|lapatinib|mesh-list
15084180|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084181|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084182|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084183|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084184|NCT01609790|Bevacizumab|bevacizumab|mesh-list
15084185|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15084186|NCT01609790|Trebananib|trebananib|mesh-list
15084187|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
14545364|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
14545365|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545366|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14545367|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14545368|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545369|NCT00000612|Estrogens|estrogens|mesh-list
14545370|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14545371|NCT00000612|Hormones|hormones|mesh-ancestor
14545372|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545373|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545374|NCT00000613|Genistein|genistein|mesh-list
14545375|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14545376|NCT00000613|Protective Agents|protective agents|mesh-ancestor
14545377|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545378|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545379|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13996035|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13996036|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996037|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996038|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13996039|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
13996040|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
14545380|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545381|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545382|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
14545383|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14545384|NCT00000613|Estrogens|estrogens|mesh-ancestor
14545385|NCT00000613|Hormones|hormones|mesh-ancestor
14545386|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545387|NCT00000614|Warfarin|warfarin|mesh-list
14545388|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
14545389|NCT00000617|Azithromycin|azithromycin|mesh-list
14545390|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14808318|NCT00826553|Propofol|propofol|mesh-list
14808319|NCT00826553|GABA Agonists|gaba agonists|mesh-list
14808320|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14808321|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808322|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808323|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14808324|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
13996041|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996042|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996043|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996044|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13996045|NCT02922946|Entinostat|entinostat|mesh-list
13996046|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996047|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13996048|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996049|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084188|NCT01609790|Antibodies|antibodies|mesh-list
14545391|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545392|NCT00000621|Tretinoin|tretinoin|mesh-list
14545393|NCT00000621|Isotretinoin|isotretinoin|mesh-list
14545394|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545395|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
14545396|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
14545397|NCT00000623|Decitabine|decitabine|mesh-list
14545398|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
14545399|NCT00000623|Deferiprone|deferiprone|mesh-list
14545400|NCT00000623|Deferoxamine|deferoxamine|mesh-list
14545401|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14545402|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
14545403|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545404|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545405|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996050|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
13996051|NCT02922803|Vitamin D|vitamin d|mesh-list
13996052|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
13996053|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
13996054|NCT02922803|Vitamins|vitamins|mesh-list
13996055|NCT02922803|Calcium|calcium|mesh-list
14545406|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
14545407|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14545408|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14545409|NCT00000623|Urological Agents|urological agents|mesh-ancestor
14267559|NCT00391053|Vaccines|vaccines|mesh-list
14267560|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
14267561|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267562|NCT00391079|Nabiximols|nabiximols|mesh-list
14267563|NCT00391079|Analgesics|analgesics|mesh-ancestor
14267564|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
14267565|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267566|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267567|NCT00391092|Bevacizumab|bevacizumab|mesh-list
14267568|NCT00391092|Trastuzumab|trastuzumab|mesh-list
14267569|NCT00391092|Docetaxel|docetaxel|mesh-list
14267570|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267571|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267572|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267573|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267574|NCT00391092|Growth Substances|growth substances|mesh-ancestor
14267575|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545410|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14545411|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
14267576|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267577|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267578|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267579|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267580|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267581|NCT00391118|Paclitaxel|paclitaxel|mesh-list
14545412|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
14545413|NCT00000623|Siderophores|siderophores|mesh-ancestor
14545414|NCT00000625|Zidovudine|zidovudine|mesh-list
14545415|NCT00000625|Didanosine|didanosine|mesh-list
14545416|NCT00000625|Zalcitabine|zalcitabine|mesh-list
14545417|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
14545418|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545419|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545420|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545421|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545422|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
14545423|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545424|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545425|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545426|NCT00000626|Doxorubicin|doxorubicin|mesh-list
14545427|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14545428|NCT00000626|Bleomycin|bleomycin|mesh-list
14545429|NCT00000626|Dacarbazine|dacarbazine|mesh-list
14545430|NCT00000626|Vinblastine|vinblastine|mesh-list
14545431|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14545432|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545433|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14545434|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13996056|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
13996057|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267582|NCT00391118|Carboplatin|carboplatin|mesh-list
14545435|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545436|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545437|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14545438|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
14545439|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14545440|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14545441|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14545442|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14545443|NCT00000627|Fluconazole|fluconazole|mesh-list
14545444|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
14545445|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545446|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14545447|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545448|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545449|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545450|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14545451|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
14545452|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545453|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545454|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14545455|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14545456|NCT00000628|Zidovudine|zidovudine|mesh-list
14545457|NCT00000628|L-697661|l-697661|mesh-list
14545458|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
14545459|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545460|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545461|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545462|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545463|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
14545464|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545465|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545466|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545467|NCT00000629|Zidovudine|zidovudine|mesh-list
14545468|NCT00000629|Valproic Acid|valproic acid|mesh-list
14545469|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
14545470|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545471|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545472|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545473|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545474|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
14545475|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545476|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545477|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545478|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
14545479|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
14545480|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545481|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545482|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
14545483|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14545484|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14545485|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643239|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643240|NCT00188773|Expectorants|expectorants|mesh-ancestor
14643241|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14643242|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14643243|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
14643244|NCT00188773|Protective Agents|protective agents|mesh-ancestor
14643245|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643246|NCT00188773|Antidotes|antidotes|mesh-ancestor
14643247|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14643248|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14643249|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14643250|NCT00188812|Donepezil|donepezil|mesh-list
14643251|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14643252|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643253|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643254|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
14643255|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643256|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643257|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
14643258|NCT00188825|Basiliximab|basiliximab|mesh-list
14643259|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643260|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
14643261|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643262|NCT00188864|Dexamethasone|dexamethasone|mesh-list
14643263|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14643264|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
14643265|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
14643266|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545486|NCT00000633|Vaccines|vaccines|mesh-list
14545487|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
14545488|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545489|NCT00000634|Nevirapine|nevirapine|mesh-list
14545490|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545491|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545492|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545493|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545494|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
14545495|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545496|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545497|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545498|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14545499|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15084189|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
15084190|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084191|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
15084192|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084193|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084194|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084195|NCT01609790|Growth Substances|growth substances|mesh-ancestor
15084196|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084197|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084198|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
15084199|NCT01553149|Lenalidomide|lenalidomide|mesh-list
15084200|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
15084201|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084202|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084203|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084204|NCT01553149|Growth Substances|growth substances|mesh-ancestor
15084205|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084206|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084207|NCT01371981|Cytarabine|cytarabine|mesh-list
15084208|NCT01371981|Etoposide|etoposide|mesh-list
15084209|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
15084210|NCT01371981|Daunorubicin|daunorubicin|mesh-list
15084211|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
15084212|NCT01371981|Bortezomib|bortezomib|mesh-list
15084213|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
15084214|NCT01371981|Sorafenib|sorafenib|mesh-list
15084215|NCT01371981|Asparaginase|asparaginase|mesh-list
15084216|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084217|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084218|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084219|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084220|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084221|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084222|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15084223|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
15084224|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
15084225|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084226|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084227|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
15084228|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084229|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084230|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084231|NCT01371981|Analgesics|analgesics|mesh-ancestor
15084232|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
15084233|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084234|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
14545500|NCT00000635|Trifluridine|trifluridine|mesh-list
14545501|NCT00000635|Polymyxins|polymyxins|mesh-list
14545502|NCT00000635|Bacitracin|bacitracin|mesh-list
14545503|NCT00000635|Polymyxin B|polymyxin b|mesh-list
14545504|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
14545505|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545506|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
14545507|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545508|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545509|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14545510|NCT00000636|Pyridoxine|pyridoxine|mesh-list
14545511|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
14545512|NCT00000636|Rifampin|rifampin|mesh-list
14545513|NCT00000636|Isoniazid|isoniazid|mesh-list
14545514|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
14545515|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14545516|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
15084235|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
15084236|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267583|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14267584|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545517|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545518|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545519|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
14545520|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545521|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545522|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545523|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14545524|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14545525|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14545526|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14545527|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14545528|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14545529|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14545530|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14545531|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
14545532|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14545533|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
14545534|NCT00000636|Vitamins|vitamins|mesh-ancestor
14545535|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
14545536|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545537|NCT00000637|Zidovudine|zidovudine|mesh-list
14545538|NCT00000637|Didanosine|didanosine|mesh-list
14545539|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
14545540|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545541|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545542|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545543|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084237|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084238|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084239|NCT01366144|Paclitaxel|paclitaxel|mesh-list
15084240|NCT01366144|Carboplatin|carboplatin|mesh-list
15084241|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084242|NCT01366144|Veliparib|veliparib|mesh-list
15084243|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084244|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084245|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084246|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084247|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084248|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084249|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15084250|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084251|NCT01309191|Minoxidil|minoxidil|mesh-list
15084252|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15084253|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
15084254|NCT01236560|Bevacizumab|bevacizumab|mesh-list
15084255|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15084256|NCT01236560|Temozolomide|temozolomide|mesh-list
15084257|NCT01236560|Vorinostat|vorinostat|mesh-list
15084258|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
15084259|NCT01236560|Antibodies|antibodies|mesh-list
15084260|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
15084261|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14267585|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267586|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267587|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267588|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267589|NCT00391222|Olanzapine|olanzapine|mesh-list
14267590|NCT00391222|Risperidone|risperidone|mesh-list
14267591|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15084262|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
15084263|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084264|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267592|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
14545544|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
14545545|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545546|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545547|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545548|NCT00000638|Pyridoxine|pyridoxine|mesh-list
14545549|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
14545550|NCT00000638|Rifampin|rifampin|mesh-list
15084265|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084266|NCT01236560|Growth Substances|growth substances|mesh-ancestor
15084267|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545551|NCT00000638|Isoniazid|isoniazid|mesh-list
14545552|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
14545553|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14545554|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
14545555|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545556|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545557|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
14545558|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545559|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545560|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545561|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14545562|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14545563|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14545564|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14545565|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14545566|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14545567|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14545568|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14545569|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
14545570|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14545571|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
14545572|NCT00000638|Vitamins|vitamins|mesh-ancestor
14545573|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
14545574|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545575|NCT00000639|Itraconazole|itraconazole|mesh-list
14545576|NCT00000639|Fluconazole|fluconazole|mesh-list
14545577|NCT00000639|Amphotericin B|amphotericin b|mesh-list
14545578|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14545579|NCT00000639|Flucytosine|flucytosine|mesh-list
14545580|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
15084268|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084269|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
14545581|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545582|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14545583|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545584|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545585|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545586|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14545587|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
14545588|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545589|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545590|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14545591|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14545592|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14545593|NCT00000639|Amebicides|amebicides|mesh-ancestor
14545594|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14545595|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14545596|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545597|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
14545598|NCT00000640|Clindamycin|clindamycin|mesh-list
14545599|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
14545600|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
14545601|NCT00000640|Dapsone|dapsone|mesh-list
14545602|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14545603|NCT00000640|Primaquine|primaquine|mesh-list
14545604|NCT00000640|Trimethoprim|trimethoprim|mesh-list
15084270|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084271|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
15084272|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084273|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15084274|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084275|NCT01236547|Paclitaxel|paclitaxel|mesh-list
15182263|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545605|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
14545606|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545607|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545608|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14545609|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545610|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545611|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
14545612|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14545613|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14545614|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14545615|NCT00000640|Renal Agents|renal agents|mesh-ancestor
14545616|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14545617|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14545618|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14545619|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545620|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
14545621|NCT00000641|Azithromycin|azithromycin|mesh-list
14545622|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
14545623|NCT00000641|Rifampin|rifampin|mesh-list
14545624|NCT00000641|Amikacin|amikacin|mesh-list
14545625|NCT00000641|Ethambutol|ethambutol|mesh-list
14545626|NCT00000641|Clofazimine|clofazimine|mesh-list
14545627|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545628|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545629|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14545630|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14545631|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545632|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545633|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545634|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14545635|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545636|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14545637|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
14545638|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
14545639|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545640|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14545641|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14545642|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14545643|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14545644|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14545645|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14545646|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545647|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14545648|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
14545649|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545650|NCT00000643|Leucovorin|leucovorin|mesh-list
14545651|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
14545652|NCT00000643|Calcium|calcium|mesh-list
14545653|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
14545654|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14545655|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545656|NCT00000643|Antidotes|antidotes|mesh-ancestor
14545657|NCT00000643|Protective Agents|protective agents|mesh-ancestor
14545658|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
14545659|NCT00000643|Vitamins|vitamins|mesh-ancestor
14545660|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
14545661|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
14545662|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14545663|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14545664|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545665|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14545666|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545667|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545668|NCT00000644|Clarithromycin|clarithromycin|mesh-list
14545669|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545670|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545671|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14545672|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545673|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545674|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14545675|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545676|NCT00000645|Hypericin|hypericin|mesh-list
14545677|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
14545678|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14545679|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545680|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
14545681|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545682|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545683|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545684|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14545685|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
14545686|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545687|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
14545688|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14545689|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545690|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545691|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14545692|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14545693|NCT00000646|Protective Agents|protective agents|mesh-ancestor
14545694|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545695|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
14545696|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14545697|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
14545698|NCT00000647|Interferons|interferons|mesh-list
14545699|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
14545700|NCT00000647|Zidovudine|zidovudine|mesh-list
14545701|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14545702|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545703|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
14545704|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545705|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
14545706|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545707|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
14545708|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545709|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545710|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545711|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545712|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545713|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545714|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
14545715|NCT00000648|Penicillins|penicillins|mesh-list
14545716|NCT00000648|Penicillin G|penicillin g|mesh-list
14545717|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14545718|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
14545719|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545720|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545721|NCT00000649|Zidovudine|zidovudine|mesh-list
14545722|NCT00000649|Nevirapine|nevirapine|mesh-list
14545723|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
14545724|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545725|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545726|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545727|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545728|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
14545729|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084276|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084277|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084278|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084279|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267593|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545730|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545731|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545732|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14267594|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267595|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267596|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14545733|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14545734|NCT00000650|Ditiocarb|ditiocarb|mesh-list
14545735|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14545736|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
14545737|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545738|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
14545739|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545740|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
14545741|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
14545742|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545743|NCT00000651|Zidovudine|zidovudine|mesh-list
14545744|NCT00000651|Zalcitabine|zalcitabine|mesh-list
14808325|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
14808326|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14808327|NCT00826553|Analgesics|analgesics|mesh-ancestor
14808328|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
14808329|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545745|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
14545746|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545747|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545748|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545749|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545750|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
14545751|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545752|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545753|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545754|NCT00000652|Zidovudine|zidovudine|mesh-list
14545755|NCT00000652|Didanosine|didanosine|mesh-list
14545756|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
14545757|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545758|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545759|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545760|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545761|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
14545762|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545763|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545764|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545765|NCT00000653|Zalcitabine|zalcitabine|mesh-list
15084280|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084281|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084282|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084283|NCT01142388|Paclitaxel|paclitaxel|mesh-list
15084284|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084285|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084286|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084287|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084288|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084289|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084290|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084291|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084292|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
15084293|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084294|NCT01134614|Ipilimumab|ipilimumab|mesh-list
15084295|NCT01134614|Sargramostim|sargramostim|mesh-list
15084296|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15084297|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084298|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15084299|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084300|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
15084301|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084302|NCT01062425|Temozolomide|temozolomide|mesh-list
15084303|NCT01062425|Cediranib|cediranib|mesh-list
15084304|NCT01062425|Maleic acid|maleic acid|mesh-list
15084305|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084306|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
15084307|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084308|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084309|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084310|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084311|NCT01042379|Metformin|metformin|mesh-list
15084312|NCT01042379|Paclitaxel|paclitaxel|mesh-list
15084313|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15084314|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084315|NCT01042379|Carboplatin|carboplatin|mesh-list
15084316|NCT01042379|Doxorubicin|doxorubicin|mesh-list
15084317|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
15084318|NCT01042379|Trastuzumab|trastuzumab|mesh-list
15084319|NCT01042379|Irinotecan|irinotecan|mesh-list
15084320|NCT01042379|Letrozole|letrozole|mesh-list
15084321|NCT01042379|Durvalumab|durvalumab|mesh-list
15084322|NCT01042379|Olaparib|olaparib|mesh-list
15084323|NCT01042379|Pertuzumab|pertuzumab|mesh-list
15084324|NCT01042379|Veliparib|veliparib|mesh-list
15084325|NCT01042379|Talazoparib|talazoparib|mesh-list
15084326|NCT01042379|Cemiplimab|cemiplimab|mesh-list
15084327|NCT01042379|Trebananib|trebananib|mesh-list
15084328|NCT01042379|Tucatinib|tucatinib|mesh-list
15084329|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084330|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545766|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
14545767|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084331|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084332|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084333|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084334|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545768|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545769|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545770|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545771|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
14545772|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545773|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545774|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545775|NCT00000654|Fialuridine|fialuridine|mesh-list
14545776|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
14545777|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545778|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545779|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545780|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545781|NCT00000655|Trimethoprim|trimethoprim|mesh-list
14545782|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14545783|NCT00000655|Atovaquone|atovaquone|mesh-list
14545784|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
14545785|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14545786|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545787|NCT00000655|Renal Agents|renal agents|mesh-ancestor
14545788|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
14545789|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14545790|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14545791|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14545792|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545793|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545794|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14545795|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14545796|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14545797|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545798|NCT00000656|Zidovudine|zidovudine|mesh-list
14545799|NCT00000656|Didanosine|didanosine|mesh-list
14545800|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
14545801|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545802|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545803|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545804|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545805|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
14545806|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545807|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545808|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545809|NCT00000657|Zidovudine|zidovudine|mesh-list
14545810|NCT00000657|Didanosine|didanosine|mesh-list
14545811|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
14545812|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545813|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545814|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084335|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15084336|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084337|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084338|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084339|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14545815|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545816|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
14545817|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545818|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545819|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545820|NCT00000658|Leucovorin|leucovorin|mesh-list
14545821|NCT00000658|Cytarabine|cytarabine|mesh-list
14545822|NCT00000658|Dexamethasone|dexamethasone|mesh-list
14545823|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
14545824|NCT00000658|Doxorubicin|doxorubicin|mesh-list
14545825|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14545826|NCT00000658|Methotrexate|methotrexate|mesh-list
14545827|NCT00000658|Vincristine|vincristine|mesh-list
14545828|NCT00000658|Bleomycin|bleomycin|mesh-list
14545829|NCT00000658|Allopurinol|allopurinol|mesh-list
14545830|NCT00000658|Sargramostim|sargramostim|mesh-list
14545831|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
14545832|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14545833|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
14545834|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545835|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084340|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545836|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14545837|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
14545838|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545839|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545840|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14545841|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14545842|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
14545843|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
14545844|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545845|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14545846|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
14545847|NCT00000658|Hormones|hormones|mesh-ancestor
14545848|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14545849|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14545850|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14545851|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14545852|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14545853|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545854|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14545855|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
14545856|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14545857|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14545858|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
14545859|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
14545860|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14545861|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545862|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
14545863|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545864|NCT00000658|Antidotes|antidotes|mesh-ancestor
14545865|NCT00000658|Protective Agents|protective agents|mesh-ancestor
14545866|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
14545867|NCT00000658|Vitamins|vitamins|mesh-ancestor
14545868|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
14545869|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14545870|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
14545871|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
14545872|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
14545873|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
14545874|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14545875|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
14545876|NCT00000659|Zidovudine|zidovudine|mesh-list
14545877|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
14545878|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545879|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545880|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545881|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084341|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15084342|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15084343|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15084344|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15084345|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15084346|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
14267597|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14267598|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267599|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14267600|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14267601|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
14267602|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
14545882|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
14545883|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545884|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545885|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545886|NCT00000660|Etoposide|etoposide|mesh-list
14545887|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14545888|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545889|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14545890|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14545891|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545892|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545893|NCT00000661|Zidovudine|zidovudine|mesh-list
14545894|NCT00000661|Oxazepam|oxazepam|mesh-list
14545895|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
14545896|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996058|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14267603|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
14545897|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545898|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545899|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545900|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
14545901|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545902|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545903|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545904|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14545905|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14545906|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545907|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14545908|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14545909|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14545910|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
14545911|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
14545912|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14545913|NCT00000662|Zidovudine|zidovudine|mesh-list
14545914|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
14545915|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545916|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545917|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545918|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545919|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
14545920|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545921|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545922|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545923|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14545924|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
14545925|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545926|NCT00000664|Zidovudine|zidovudine|mesh-list
14545927|NCT00000664|Interleukin-2|interleukin-2|mesh-list
14545928|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14545929|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14545930|NCT00000664|Analgesics|analgesics|mesh-ancestor
14545931|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
14545932|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14545933|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14545934|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
14545935|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545936|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545937|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545938|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545939|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
14545940|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545941|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545942|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545943|NCT00000665|Ganciclovir|ganciclovir|mesh-list
14545944|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14545945|NCT00000665|Foscarnet|foscarnet|mesh-list
14545946|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14545947|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
14545948|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545949|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545950|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545951|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545952|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545953|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
14545954|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
14545955|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14545956|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14545957|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545958|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14545959|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545960|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545961|NCT00000668|Ganciclovir|ganciclovir|mesh-list
14545962|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14545963|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
14545964|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545965|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545966|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545967|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545968|NCT00000669|Didanosine|didanosine|mesh-list
14545969|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
14545970|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545971|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545972|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545973|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14545974|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
14545975|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14545976|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545977|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545978|NCT00000670|Zidovudine|zidovudine|mesh-list
14545979|NCT00000670|Probenecid|probenecid|mesh-list
14545980|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
14545981|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545982|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545983|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545984|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084347|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084348|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15084349|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084350|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084351|NCT01042379|Growth Substances|growth substances|mesh-ancestor
14545985|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
14545986|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084352|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084353|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084354|NCT01004978|Cisplatin|cisplatin|mesh-list
15084355|NCT01004978|Doxorubicin|doxorubicin|mesh-list
15084356|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15084357|NCT01004978|Sorafenib|sorafenib|mesh-list
15084358|NCT01004978|Mitomycins|mitomycins|mesh-list
15084359|NCT01004978|Mitomycin|mitomycin|mesh-list
15084360|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084361|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084362|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084363|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084364|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084365|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084366|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084367|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
15084368|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084369|NCT00980460|Sirolimus|sirolimus|mesh-list
15084370|NCT00980460|Cisplatin|cisplatin|mesh-list
15084371|NCT00980460|Doxorubicin|doxorubicin|mesh-list
15084372|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15084373|NCT00980460|Fluorouracil|fluorouracil|mesh-list
15084374|NCT00980460|Irinotecan|irinotecan|mesh-list
15084375|NCT00980460|Vincristine|vincristine|mesh-list
15084376|NCT00980460|Camptothecin|camptothecin|mesh-list
15084377|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
15084378|NCT00980460|Razoxane|razoxane|mesh-list
15084379|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
15084380|NCT00980460|Liver Extracts|liver extracts|mesh-list
15084381|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084382|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084383|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084384|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084385|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084386|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084387|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
15084388|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15084389|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084390|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
15084391|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084392|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15084393|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084394|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084395|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084396|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084397|NCT00980460|Hematinics|hematinics|mesh-ancestor
15084398|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15084399|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084400|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
15084401|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15084402|NCT00980460|Protective Agents|protective agents|mesh-ancestor
15084403|NCT00977574|Sirolimus|sirolimus|mesh-list
14545987|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14545988|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14545989|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
14545990|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
14545991|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14545992|NCT00000670|Renal Agents|renal agents|mesh-ancestor
14545993|NCT00000671|Zidovudine|zidovudine|mesh-list
15084404|NCT00977574|Paclitaxel|paclitaxel|mesh-list
15084405|NCT00977574|Epothilones|epothilones|mesh-list
15084406|NCT00977574|Epothilone B|epothilone b|mesh-list
15084407|NCT00977574|Bevacizumab|bevacizumab|mesh-list
15084408|NCT00977574|Carboplatin|carboplatin|mesh-list
14267604|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267605|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14267606|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14267607|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14267608|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14267609|NCT00391274|Docetaxel|docetaxel|mesh-list
14267610|NCT00391274|Pemetrexed|pemetrexed|mesh-list
14267611|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267612|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267613|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267614|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267615|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267616|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267617|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14267618|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14267619|NCT00391391|Vaccines|vaccines|mesh-list
14267620|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
14267621|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267622|NCT00391443|Bosentan|bosentan|mesh-list
14267623|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14267624|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14267625|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267626|NCT00391586|Gemcitabine|gemcitabine|mesh-list
14267627|NCT00391586|Paclitaxel|paclitaxel|mesh-list
14267628|NCT00391586|Etoposide|etoposide|mesh-list
14267629|NCT00391586|Vinorelbine|vinorelbine|mesh-list
14267630|NCT00391586|Docetaxel|docetaxel|mesh-list
14267631|NCT00391586|Irinotecan|irinotecan|mesh-list
14267632|NCT00391586|Pemetrexed|pemetrexed|mesh-list
14545994|NCT00000671|Didanosine|didanosine|mesh-list
15084409|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084410|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13996059|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13996060|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
13996061|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13996062|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
13996063|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13996064|NCT02922686|Floxacillin|floxacillin|mesh-list
13996065|NCT02922686|Penicillin V|penicillin v|mesh-list
13996066|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13996067|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996068|NCT02922712|Nimesulide|nimesulide|mesh-list
15084411|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
15084412|NCT00977574|Antibodies|antibodies|mesh-list
15084413|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
15084414|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084415|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
15084416|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084417|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996069|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13996070|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15084418|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084419|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084420|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084421|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084422|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084423|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084424|NCT00977574|Growth Substances|growth substances|mesh-ancestor
15084425|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996071|NCT02922712|Analgesics|analgesics|mesh-ancestor
13996072|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
14267633|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14267634|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14545995|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
14643267|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084426|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267635|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267636|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267637|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267638|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267639|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084427|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
15084428|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15084429|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084430|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084431|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
15084432|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084433|NCT00843882|Lenalidomide|lenalidomide|mesh-list
15084434|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
15084435|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
15084436|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084437|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084438|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084439|NCT00843882|Growth Substances|growth substances|mesh-ancestor
15084440|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084441|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084442|NCT00843882|Hematinics|hematinics|mesh-ancestor
15084443|NCT00652574|Dasatinib|dasatinib|mesh-list
15084444|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084445|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084446|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084447|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084448|NCT00644228|Dexamethasone|dexamethasone|mesh-list
15084449|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
15084450|NCT00644228|Lenalidomide|lenalidomide|mesh-list
15084451|NCT00644228|Bortezomib|bortezomib|mesh-list
15084452|NCT00644228|Ichthammol|ichthammol|mesh-list
15084453|NCT00644228|BB 1101|bb 1101|mesh-list
15084454|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15084455|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
15084456|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
15084457|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084458|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084459|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15084460|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
15084461|NCT00644228|Hormones|hormones|mesh-ancestor
15084462|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084463|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084464|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084465|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084466|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084467|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084468|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
15084469|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084470|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084471|NCT00644228|Growth Substances|growth substances|mesh-ancestor
14267640|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267641|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
14267642|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
14267643|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267644|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267645|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267646|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
14267647|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267648|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14267649|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14267650|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14267651|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14267652|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14267653|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267654|NCT00391716|Gabapentin|gabapentin|mesh-list
14267655|NCT00391716|Analgesics|analgesics|mesh-ancestor
14267656|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
14267657|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267658|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267659|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
14267660|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14267661|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15084472|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084473|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
15084474|NCT00602641|Thalidomide|thalidomide|mesh-list
15084475|NCT00602641|Prednisone|prednisone|mesh-list
15084476|NCT00602641|Cortisone|cortisone|mesh-list
15084477|NCT00602641|Lenalidomide|lenalidomide|mesh-list
15084478|NCT00602641|Melphalan|melphalan|mesh-list
15084479|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
15084480|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15084481|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15084482|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
15084483|NCT00602641|Hormones|hormones|mesh-ancestor
15084484|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084485|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084486|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084487|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084488|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
15084489|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084490|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084491|NCT00602641|Growth Substances|growth substances|mesh-ancestor
15084492|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084493|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084494|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
15084495|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084496|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15084497|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084498|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
15084499|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14545996|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14545997|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14545998|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14545999|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546000|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
14546001|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546002|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546003|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546004|NCT00000672|Didanosine|didanosine|mesh-list
14546005|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
14546006|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546007|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546008|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546009|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546010|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
14546011|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267662|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267663|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14267664|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14267665|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14267666|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267667|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267668|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
14267669|NCT00391768|Oseltamivir|oseltamivir|mesh-list
14267670|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
15084500|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084501|NCT00559936|Bevacizumab|bevacizumab|mesh-list
15084502|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15084503|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546012|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546013|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546014|NCT00000673|Ganciclovir|ganciclovir|mesh-list
14546015|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14546016|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
14546017|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546018|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546019|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546020|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546021|NCT00000674|Leucovorin|leucovorin|mesh-list
14546022|NCT00000674|Clindamycin|clindamycin|mesh-list
14546023|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
14546024|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
14546025|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
14546026|NCT00000674|Calcium|calcium|mesh-list
14546027|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
14546028|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14546029|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546030|NCT00000674|Antidotes|antidotes|mesh-ancestor
14546031|NCT00000674|Protective Agents|protective agents|mesh-ancestor
14546032|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
14546033|NCT00000674|Vitamins|vitamins|mesh-ancestor
14546034|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
15084504|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14546035|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546036|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546037|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14808330|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14808331|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14808332|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14808333|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
14808334|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808335|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808336|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14808337|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14808338|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14808339|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808340|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
14808341|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
14808342|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
14808343|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
14808344|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
14808345|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14808346|NCT00826566|Caffeine|caffeine|mesh-list
14808347|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14808348|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808349|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14808350|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808351|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808352|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14808353|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14808354|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
14808355|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808356|NCT00826644|Etoposide|etoposide|mesh-list
14808357|NCT00826644|Belotecan|belotecan|mesh-list
14808358|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808359|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14808360|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14808361|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14808362|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808363|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808364|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14808365|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
14808366|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
14808367|NCT00826657|Vitamins|vitamins|mesh-ancestor
14808368|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
14808369|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808370|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
14808371|NCT00826657|Hematinics|hematinics|mesh-ancestor
14808372|NCT00826722|Levetiracetam|levetiracetam|mesh-list
14808373|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
14808374|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
15084505|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084506|NCT00559936|Growth Substances|growth substances|mesh-ancestor
15084507|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084508|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084509|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15084510|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
15084511|NCT00504582|Coagulants|coagulants|mesh-ancestor
15084512|NCT00494182|Paclitaxel|paclitaxel|mesh-list
14267671|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808375|NCT00826787|Levetiracetam|levetiracetam|mesh-list
14808376|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
14808377|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
15084513|NCT00494182|Carboplatin|carboplatin|mesh-list
14267672|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267673|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267674|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14267675|NCT00391807|Norethindrone|norethindrone|mesh-list
14267676|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
14267677|NCT00391807|Estradiol|estradiol|mesh-list
14267678|NCT00391807|Estrogens|estrogens|mesh-ancestor
14267679|NCT00391807|Hormones|hormones|mesh-ancestor
14546038|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546039|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546040|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
14546041|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546042|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546043|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546044|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14546045|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
14546046|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546047|NCT00000676|Fluconazole|fluconazole|mesh-list
14546048|NCT00000676|Clotrimazole|clotrimazole|mesh-list
14546049|NCT00000676|Miconazole|miconazole|mesh-list
14546050|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
14546051|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546052|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14546053|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14546054|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546055|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546056|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14546057|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
14546058|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546059|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546060|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14546061|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14546062|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14546063|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14546064|NCT00000677|Sch 39304|sch 39304|mesh-list
14546065|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
14546066|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546067|NCT00000678|Zidovudine|zidovudine|mesh-list
14546068|NCT00000678|Zalcitabine|zalcitabine|mesh-list
14546069|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
14546070|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546071|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546072|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546073|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546074|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
14546075|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546076|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546077|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546078|NCT00000679|Zidovudine|zidovudine|mesh-list
14546079|NCT00000679|Zalcitabine|zalcitabine|mesh-list
14546080|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
14546081|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546082|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546083|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546084|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546085|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
14546086|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546087|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546088|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546089|NCT00000680|Zidovudine|zidovudine|mesh-list
14546090|NCT00000680|Aldesleukin|aldesleukin|mesh-list
14546091|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
14546092|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546093|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546094|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546095|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546096|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
14546097|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546098|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546099|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546100|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546101|NCT00000681|Zidovudine|zidovudine|mesh-list
14546102|NCT00000681|Doxorubicin|doxorubicin|mesh-list
14546103|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14546104|NCT00000681|Bleomycin|bleomycin|mesh-list
14546105|NCT00000681|Vincristine|vincristine|mesh-list
14546106|NCT00000681|Sargramostim|sargramostim|mesh-list
14546107|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14546108|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546109|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14546110|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14546111|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546112|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546113|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14546114|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
14546115|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
14546116|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14546117|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
14546118|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546119|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546120|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
14546121|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546122|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546123|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546124|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
14546125|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546126|NCT00000682|Zidovudine|zidovudine|mesh-list
14546127|NCT00000682|Zalcitabine|zalcitabine|mesh-list
14546128|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
14546129|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546130|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546131|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546132|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546133|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
14546134|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546135|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546136|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546137|NCT00000684|Dextrans|dextrans|mesh-list
14546138|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
14546139|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
14546140|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
14546141|NCT00000685|Zidovudine|zidovudine|mesh-list
14546142|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
14546143|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546144|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546145|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084514|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084515|NCT00494182|Sorafenib|sorafenib|mesh-list
14546146|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546147|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
14546148|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546149|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546150|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546151|NCT00000686|Stavudine|stavudine|mesh-list
14546152|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
14546153|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546154|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546155|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546156|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546157|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
14546158|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546159|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546160|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546161|NCT00000687|Interferons|interferons|mesh-list
14546162|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
14546163|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
14546164|NCT00000687|Zidovudine|zidovudine|mesh-list
14546165|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546166|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
14546167|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546168|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
14546169|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546170|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
14546171|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546172|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546173|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546174|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546175|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546176|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546177|NCT00000688|Ganciclovir|ganciclovir|mesh-list
14546178|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14546179|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
14546180|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546181|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546182|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546183|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546184|NCT00000689|Leucovorin|leucovorin|mesh-list
14546185|NCT00000689|Cytarabine|cytarabine|mesh-list
14546186|NCT00000689|Dexamethasone|dexamethasone|mesh-list
14546187|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
14546188|NCT00000689|Doxorubicin|doxorubicin|mesh-list
14546189|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14546190|NCT00000689|Methotrexate|methotrexate|mesh-list
14546191|NCT00000689|Vincristine|vincristine|mesh-list
14546192|NCT00000689|Bleomycin|bleomycin|mesh-list
15084516|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14546193|NCT00000689|Sargramostim|sargramostim|mesh-list
14546194|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
14546195|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14546196|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
14546197|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546198|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14546199|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14546200|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
14546201|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546202|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546203|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14546204|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14546205|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
14546206|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
14546207|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546208|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14546209|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
14546210|NCT00000689|Hormones|hormones|mesh-ancestor
14546211|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546212|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14546213|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14546214|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14546215|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14546216|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546217|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14546218|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
14546219|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14546220|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14546221|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
14546222|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
14546223|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546224|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546225|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
14546226|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546227|NCT00000689|Antidotes|antidotes|mesh-ancestor
14546228|NCT00000689|Protective Agents|protective agents|mesh-ancestor
14546229|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
14546230|NCT00000689|Vitamins|vitamins|mesh-ancestor
14546231|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
14546232|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14546233|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
14546234|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
14546235|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
14546236|NCT00000690|Dextrans|dextrans|mesh-list
15084517|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084518|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084519|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084520|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084521|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084522|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084523|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084524|NCT00454753|Dasatinib|dasatinib|mesh-list
15084525|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084526|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15084527|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084528|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084529|NCT00436254|Molgramostim|molgramostim|mesh-list
15084530|NCT00436254|Sargramostim|sargramostim|mesh-list
15084531|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
15084532|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084533|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084534|NCT00433511|Paclitaxel|paclitaxel|mesh-list
15084535|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
15084536|NCT00433511|Bevacizumab|bevacizumab|mesh-list
15084537|NCT00433511|Doxorubicin|doxorubicin|mesh-list
15084538|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15084539|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14546237|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
14808378|NCT00826826|Amiodarone|amiodarone|mesh-list
14808379|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14808380|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
14808381|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14808382|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808383|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808384|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14808385|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14808386|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14808387|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808388|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14546238|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
14546239|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
14546240|NCT00000691|Foscarnet|foscarnet|mesh-list
14546241|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14546242|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
14546243|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546244|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546245|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546246|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546247|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546248|NCT00000692|Miglustat|miglustat|mesh-list
14546249|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546250|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546251|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546252|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546253|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
14546254|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546255|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14546256|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14546257|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546258|NCT00000693|Zidovudine|zidovudine|mesh-list
14546259|NCT00000693|Acyclovir|acyclovir|mesh-list
14546260|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
14546261|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546262|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546263|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546264|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084540|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15084541|NCT00433511|Antibodies|antibodies|mesh-list
15084542|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
15084543|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084544|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
15084545|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
15084546|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084547|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084548|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084549|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084550|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084551|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084552|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084553|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
15084554|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084555|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084556|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084557|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
15084558|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15084559|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084560|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084561|NCT00433511|Growth Substances|growth substances|mesh-ancestor
15084562|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084563|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084564|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084565|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084566|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084567|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
15084568|NCT00408005|Leucovorin|leucovorin|mesh-list
15084569|NCT00408005|Folic Acid|folic acid|mesh-list
15084570|NCT00408005|Cytarabine|cytarabine|mesh-list
15084571|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
15084572|NCT00408005|Dexamethasone|dexamethasone|mesh-list
14546265|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
14546266|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546267|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546268|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546269|NCT00000694|Interferons|interferons|mesh-list
14546270|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
14546271|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
14546272|NCT00000694|Zidovudine|zidovudine|mesh-list
14546273|NCT00000694|Sargramostim|sargramostim|mesh-list
14546274|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084573|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
15084574|NCT00408005|Prednisone|prednisone|mesh-list
15084575|NCT00408005|Cortisone|cortisone|mesh-list
14546275|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
15084576|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
13996073|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546276|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546277|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
14546278|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546279|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
14546280|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546281|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546282|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546283|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546284|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546285|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546286|NCT00000695|Interferons|interferons|mesh-list
14546287|NCT00000695|Zidovudine|zidovudine|mesh-list
14546288|NCT00000695|Interferon-beta|interferon-beta|mesh-list
14546289|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
14546290|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546291|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
14546292|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546293|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
14546294|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546295|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546296|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546297|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546298|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546299|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546300|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
14546301|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546302|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14546303|NCT00000696|Interferons|interferons|mesh-list
14546304|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
14546305|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
14546306|NCT00000696|Zidovudine|zidovudine|mesh-list
14546307|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546308|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
14546309|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546310|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
14546311|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546312|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
14546313|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084577|NCT00408005|Doxorubicin|doxorubicin|mesh-list
14292350|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14546314|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546315|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546316|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546317|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546318|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546319|NCT00000697|Foscarnet|foscarnet|mesh-list
14546320|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14546321|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
14546322|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546323|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546324|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546325|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546326|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546327|NCT00000698|Ganciclovir|ganciclovir|mesh-list
14546328|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14546329|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
14546330|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546331|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546332|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546333|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808389|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14546334|NCT00000699|Ribavirin|ribavirin|mesh-list
14546335|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
14546336|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
14546337|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546338|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
14546339|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546340|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14546341|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
14546342|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546343|NCT00000700|Zidovudine|zidovudine|mesh-list
14546344|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
14546345|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546346|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546347|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546348|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546349|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
14546350|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546351|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546352|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546353|NCT00000701|Zidovudine|zidovudine|mesh-list
14546354|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
14546355|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546356|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546357|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546358|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546359|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
14546360|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546361|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546362|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546363|NCT00000702|Zidovudine|zidovudine|mesh-list
14546364|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
14546365|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546366|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546367|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546368|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546369|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
14546370|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546371|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546372|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546373|NCT00000703|Leucovorin|leucovorin|mesh-list
14546374|NCT00000703|Cytarabine|cytarabine|mesh-list
14546375|NCT00000703|Zidovudine|zidovudine|mesh-list
14546376|NCT00000703|Dexamethasone|dexamethasone|mesh-list
14546377|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
14546378|NCT00000703|Doxorubicin|doxorubicin|mesh-list
14546379|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14546380|NCT00000703|Methotrexate|methotrexate|mesh-list
14546381|NCT00000703|Vincristine|vincristine|mesh-list
14546382|NCT00000703|Bleomycin|bleomycin|mesh-list
14546383|NCT00000703|Allopurinol|allopurinol|mesh-list
14546384|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
14546385|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14546386|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
14546387|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546388|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14546389|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14808390|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14808391|NCT00826839|Leuprolide|leuprolide|mesh-list
14808392|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
14808393|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
14808394|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14808395|NCT00826839|Ganirelix|ganirelix|mesh-list
14808396|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14808397|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808398|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14808399|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
14808400|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14808401|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808402|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14808403|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
14808404|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808405|NCT00826852|Carboplatin|carboplatin|mesh-list
14808406|NCT00826852|Docetaxel|docetaxel|mesh-list
14808407|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808408|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14808409|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14546390|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
14546391|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546392|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546393|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14267680|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084578|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15084579|NCT00408005|Methotrexate|methotrexate|mesh-list
14267681|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546394|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14546395|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
14546396|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
14546397|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546398|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14546399|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
14546400|NCT00000703|Hormones|hormones|mesh-ancestor
14546401|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546402|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14546403|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14546404|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14546405|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14546406|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546407|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14546408|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
14546409|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14546410|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14546411|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
14546412|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
14546413|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546414|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546415|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
14546416|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546417|NCT00000703|Antidotes|antidotes|mesh-ancestor
14546418|NCT00000703|Protective Agents|protective agents|mesh-ancestor
14546419|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
14546420|NCT00000703|Vitamins|vitamins|mesh-ancestor
14546421|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
14546422|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14546423|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
14546424|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
14546425|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
14546426|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546427|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546428|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546429|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
14546430|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14546431|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
14546432|NCT00000704|Zalcitabine|zalcitabine|mesh-list
14546433|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
14546434|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546435|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546436|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546437|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546438|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
14546439|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546440|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546441|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546442|NCT00000705|Zidovudine|zidovudine|mesh-list
14546443|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
14546444|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546445|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546446|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546447|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546448|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
14546449|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546450|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14267682|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14267683|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
14267684|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14267685|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14267686|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14267687|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14267688|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14267689|NCT00391846|Metoprolol|metoprolol|mesh-list
14267690|NCT00391846|Valsartan|valsartan|mesh-list
14267691|NCT00391846|Carvedilol|carvedilol|mesh-list
14267692|NCT00391846|Candesartan|candesartan|mesh-list
14267693|NCT00391846|Ramipril|ramipril|mesh-list
14267694|NCT00391846|Enalapril|enalapril|mesh-list
14546451|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546452|NCT00000706|Zidovudine|zidovudine|mesh-list
14546453|NCT00000706|Quinine|quinine|mesh-list
14546454|NCT00000706|Probenecid|probenecid|mesh-list
14546455|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
14546456|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546457|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546458|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546459|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546460|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
14546461|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546462|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546463|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546464|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
14546465|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546466|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546467|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14546468|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546469|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14546470|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546471|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14546472|NCT00000706|Analgesics|analgesics|mesh-ancestor
14546473|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
14546474|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
14546475|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
14546476|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14546477|NCT00000706|Renal Agents|renal agents|mesh-ancestor
14546478|NCT00000707|Pentamidine|pentamidine|mesh-list
14546479|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
14546480|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546481|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546482|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546483|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14546484|NCT00000708|Fluconazole|fluconazole|mesh-list
14546485|NCT00000708|Amphotericin B|amphotericin b|mesh-list
14546486|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14546487|NCT00000708|Flucytosine|flucytosine|mesh-list
14546488|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
14546489|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546490|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14546491|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14546492|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546493|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546494|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14546495|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
14546496|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546497|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546498|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14546499|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14546500|NCT00000708|Amebicides|amebicides|mesh-ancestor
14546501|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546502|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546503|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546504|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
14546505|NCT00000709|Zidovudine|zidovudine|mesh-list
14546506|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
14546507|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084580|NCT00408005|Vincristine|vincristine|mesh-list
15084581|NCT00408005|Daunorubicin|daunorubicin|mesh-list
15084582|NCT00408005|Asparaginase|asparaginase|mesh-list
15084583|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
15084584|NCT00408005|Pegaspargase|pegaspargase|mesh-list
15084585|NCT00408005|Thioguanine|thioguanine|mesh-list
15084586|NCT00408005|BB 1101|bb 1101|mesh-list
15084587|NCT00408005|Calcium|calcium|mesh-list
15084588|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
15084589|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
15084590|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084591|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
15084592|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084593|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084594|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14546508|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15084595|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
14546509|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084596|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084597|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084598|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14546510|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546511|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
14546512|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546513|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546514|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546515|NCT00000710|Didanosine|didanosine|mesh-list
14546516|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
14546517|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084599|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14267695|NCT00391846|Lisinopril|lisinopril|mesh-list
14267696|NCT00391846|Eplerenone|eplerenone|mesh-list
14267697|NCT00391846|Bisoprolol|bisoprolol|mesh-list
14267698|NCT00391846|Captopril|captopril|mesh-list
14267699|NCT00391846|Trandolapril|trandolapril|mesh-list
14267700|NCT00391846|Spironolactone|spironolactone|mesh-list
14267701|NCT00391846|Diuretics|diuretics|mesh-list
14267702|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14267703|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14267704|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14267705|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546518|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546519|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546520|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546521|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
14546522|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546523|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546524|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546525|NCT00000711|Zidovudine|zidovudine|mesh-list
14546526|NCT00000711|Sargramostim|sargramostim|mesh-list
14546527|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
14546528|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546529|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546530|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546531|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546532|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
14546533|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546534|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546535|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546536|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
14546537|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546538|NCT00000712|Zidovudine|zidovudine|mesh-list
14546539|NCT00000712|Acyclovir|acyclovir|mesh-list
14546540|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
14546541|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546542|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546543|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546544|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546545|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
14546546|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546547|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546548|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546549|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14546550|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
14546551|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546552|NCT00000714|Leucovorin|leucovorin|mesh-list
14546553|NCT00000714|Trimetrexate|trimetrexate|mesh-list
14546554|NCT00000714|Calcium|calcium|mesh-list
14546555|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
14546556|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14546557|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546558|NCT00000714|Antidotes|antidotes|mesh-ancestor
14546559|NCT00000714|Protective Agents|protective agents|mesh-ancestor
14546560|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
14546561|NCT00000714|Vitamins|vitamins|mesh-ancestor
14546562|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
14546563|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
14546564|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546565|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14546566|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
14546567|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546568|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546569|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546570|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267706|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15084600|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
14546571|NCT00000715|Trimethoprim|trimethoprim|mesh-list
14546572|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14546573|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
14546574|NCT00000715|Pentamidine|pentamidine|mesh-list
14546575|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14546576|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546577|NCT00000715|Renal Agents|renal agents|mesh-ancestor
14546578|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
14546579|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546580|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546581|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546582|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546583|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546584|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14546585|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14546586|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14546587|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
14546588|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14546589|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546590|NCT00000716|Zidovudine|zidovudine|mesh-list
14546591|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
14546592|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546593|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546594|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546595|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546596|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
14546597|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546598|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546599|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546600|NCT00000717|Clindamycin|clindamycin|mesh-list
14546601|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
14546602|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
14546603|NCT00000717|Primaquine|primaquine|mesh-list
14546604|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546605|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546606|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14546607|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084601|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
15084602|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084603|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15084604|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
15084605|NCT00408005|Hormones|hormones|mesh-ancestor
15084606|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084607|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084608|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084609|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084610|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084611|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084612|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084613|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15084614|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15084615|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15084616|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
15084617|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15084618|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15084619|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
15084620|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
15084621|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15084622|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084623|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
15084624|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084625|NCT00408005|Antidotes|antidotes|mesh-ancestor
15084626|NCT00408005|Protective Agents|protective agents|mesh-ancestor
15084627|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
15084628|NCT00408005|Vitamins|vitamins|mesh-ancestor
15084629|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
15084630|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084631|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084632|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084633|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084634|NCT00408005|Hematinics|hematinics|mesh-ancestor
15084635|NCT00358163|Paclitaxel|paclitaxel|mesh-list
15084636|NCT00358163|Vatalanib|vatalanib|mesh-list
15084637|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084638|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084639|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084640|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084641|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084642|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084643|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14546608|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546609|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
14546610|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546611|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546612|NCT00000718|Zidovudine|zidovudine|mesh-list
14546613|NCT00000718|Zalcitabine|zalcitabine|mesh-list
14267707|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
14267708|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
14267709|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267710|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267711|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14267712|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14267713|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14267714|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
14267715|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267716|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14267717|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
14267718|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546614|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
14546615|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546616|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546617|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546618|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546619|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
14546620|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546621|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546622|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546623|NCT00000719|Zidovudine|zidovudine|mesh-list
14546624|NCT00000719|Zalcitabine|zalcitabine|mesh-list
14546625|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
14267719|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14267720|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
14267721|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
14267722|NCT00391846|Protective Agents|protective agents|mesh-ancestor
14267723|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14267724|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14546626|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546627|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546628|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546629|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546630|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
14546631|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546632|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546633|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546634|NCT00000720|Zidovudine|zidovudine|mesh-list
14546635|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
14546636|NCT00000720|Antibodies|antibodies|mesh-list
14546637|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
14546638|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546639|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546640|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546641|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546642|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
14546643|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546644|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546645|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546646|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
14546647|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546648|NCT00000722|Pentamidine|pentamidine|mesh-list
14546649|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
14546650|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546651|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546652|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546653|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14546654|NCT00000723|Leucovorin|leucovorin|mesh-list
14546655|NCT00000723|Zidovudine|zidovudine|mesh-list
14546656|NCT00000723|Dexamethasone|dexamethasone|mesh-list
14546657|NCT00000723|Methotrexate|methotrexate|mesh-list
14546658|NCT00000723|Calcium|calcium|mesh-list
14546659|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
14808410|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084644|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546660|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14546661|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
14546662|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
14546663|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546664|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546665|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14546666|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
14546667|NCT00000723|Hormones|hormones|mesh-ancestor
14546668|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546669|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14546670|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546671|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14546672|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14546673|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
14546674|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14546675|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14546676|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
14546677|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546678|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
14546679|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546680|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546681|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14546682|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
14546683|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14546684|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546685|NCT00000723|Antidotes|antidotes|mesh-ancestor
14546686|NCT00000723|Protective Agents|protective agents|mesh-ancestor
14546687|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
14546688|NCT00000723|Vitamins|vitamins|mesh-ancestor
14546689|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
14546690|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546691|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
15084645|NCT00268385|Temozolomide|temozolomide|mesh-list
15084646|NCT00268385|Vorinostat|vorinostat|mesh-list
15084647|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084648|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
15084649|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084650|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084651|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15084652|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084653|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
15084654|NCT00217737|Leucovorin|leucovorin|mesh-list
15084655|NCT00217737|Folic Acid|folic acid|mesh-list
15084656|NCT00217737|Bevacizumab|bevacizumab|mesh-list
15084657|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15084658|NCT00217737|Fluorouracil|fluorouracil|mesh-list
15084659|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
15084660|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
15084661|NCT00217737|Antibodies|antibodies|mesh-list
15084662|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
15084663|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15084664|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
14546692|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546693|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546694|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546695|NCT00000724|Leucovorin|leucovorin|mesh-list
14546696|NCT00000724|Trimetrexate|trimetrexate|mesh-list
14546697|NCT00000724|Calcium|calcium|mesh-list
14546698|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
14546699|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14546700|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546701|NCT00000724|Antidotes|antidotes|mesh-ancestor
14546702|NCT00000724|Protective Agents|protective agents|mesh-ancestor
14546703|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
14546704|NCT00000724|Vitamins|vitamins|mesh-ancestor
14546705|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
14546706|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
14546707|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546708|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14546709|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
14546710|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546711|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546712|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546713|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546714|NCT00000725|Interferons|interferons|mesh-list
14546715|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
14546716|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
15084665|NCT00217737|Calcium|calcium|mesh-list
15084666|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
15084667|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546717|NCT00000725|Zidovudine|zidovudine|mesh-list
14546718|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084668|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084669|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14546719|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
14546720|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546721|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
14546722|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546723|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
14546724|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546725|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546726|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546727|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546728|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546729|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546730|NCT00000726|Foscarnet|foscarnet|mesh-list
14546731|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14546732|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
14546733|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546734|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546735|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546736|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546737|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546738|NCT00000727|Zidovudine|zidovudine|mesh-list
14546739|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
14546740|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
14546741|NCT00000727|Trimethoprim|trimethoprim|mesh-list
14546742|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
14546743|NCT00000727|Pentamidine|pentamidine|mesh-list
14546744|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14546745|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
14546746|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546747|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546748|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546749|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546750|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
14546751|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546752|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546753|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546754|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
14546755|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546756|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546757|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546758|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14546759|NCT00000727|Renal Agents|renal agents|mesh-ancestor
14546760|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14546761|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14546762|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14546763|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
14546764|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14546765|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546766|NCT00000728|Zidovudine|zidovudine|mesh-list
14546767|NCT00000728|Aldesleukin|aldesleukin|mesh-list
14546768|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
14546769|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546770|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546771|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546772|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546773|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
14546774|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546775|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546776|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546777|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546778|NCT00000729|Foscarnet|foscarnet|mesh-list
14546779|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14546780|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
14546781|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546782|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546783|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546784|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546785|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643268|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14643269|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
14643270|NCT00188864|Hormones|hormones|mesh-ancestor
14643271|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643272|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084670|NCT00217737|Growth Substances|growth substances|mesh-ancestor
14643273|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643274|NCT00188877|Fluorouracil|fluorouracil|mesh-list
14546786|NCT00000730|Leucovorin|leucovorin|mesh-list
14546787|NCT00000730|Trimethoprim|trimethoprim|mesh-list
14546788|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14546789|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
14546790|NCT00000730|Pentamidine|pentamidine|mesh-list
15084671|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084672|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084673|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
15084674|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15084675|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15084676|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
15084677|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084678|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15084679|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084680|NCT00217737|Antidotes|antidotes|mesh-ancestor
15084681|NCT00217737|Protective Agents|protective agents|mesh-ancestor
15084682|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
15084683|NCT00217737|Vitamins|vitamins|mesh-ancestor
15084684|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
15084685|NCT00217737|Hematinics|hematinics|mesh-ancestor
15084686|NCT00098475|Thalidomide|thalidomide|mesh-list
15084687|NCT00098475|Dexamethasone|dexamethasone|mesh-list
15084688|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
15084689|NCT00098475|Lenalidomide|lenalidomide|mesh-list
15084690|NCT00098475|Ichthammol|ichthammol|mesh-list
15084691|NCT00098475|BB 1101|bb 1101|mesh-list
15084692|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15084693|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
15084694|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
15084695|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084696|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084697|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15084698|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
14267725|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14267726|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
14267727|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14267728|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14292351|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
15084699|NCT00098475|Hormones|hormones|mesh-ancestor
15084700|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084701|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084702|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084703|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084704|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084705|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084706|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
15084707|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084708|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084709|NCT00098475|Growth Substances|growth substances|mesh-ancestor
15084710|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
15084711|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084712|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
15084713|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15084714|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546791|NCT00000730|Trimetrexate|trimetrexate|mesh-list
14546792|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
14546793|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
14546794|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546795|NCT00000730|Antidotes|antidotes|mesh-ancestor
14546796|NCT00000730|Protective Agents|protective agents|mesh-ancestor
14546797|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
14546798|NCT00000730|Vitamins|vitamins|mesh-ancestor
14546799|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
14546800|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14546801|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
14546802|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
14546803|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546804|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14546805|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
14546806|NCT00000730|Hormones|hormones|mesh-ancestor
14546807|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546808|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14546809|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546810|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14546811|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084715|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
15084716|NCT00026312|Vitamin A|vitamin a|mesh-list
14546812|NCT00000730|Renal Agents|renal agents|mesh-ancestor
14546813|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
14546814|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546815|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546816|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546817|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546818|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546819|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14546820|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14546821|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14546822|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
14546823|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14546824|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546825|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14546826|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
14546827|NCT00000731|Acetaminophen|acetaminophen|mesh-list
14546828|NCT00000731|Zidovudine|zidovudine|mesh-list
14546829|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14808411|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808412|NCT00826865|Levetiracetam|levetiracetam|mesh-list
14808413|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
14808414|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
14808415|NCT00826891|Topotecan|topotecan|mesh-list
14808416|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808417|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14808418|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14808419|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808420|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808421|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14808422|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
14808423|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808424|NCT00826930|Protective Agents|protective agents|mesh-ancestor
14808425|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808426|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14808427|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808428|NCT00826969|Ciclesonide|ciclesonide|mesh-list
14808429|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
14808430|NCT00826969|Hormones|hormones|mesh-ancestor
14808431|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808432|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808433|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14808434|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
14808435|NCT00827021|Hematinics|hematinics|mesh-list
14808436|NCT00827034|Warfarin|warfarin|mesh-list
14808437|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
14808438|NCT00827138|Rebastinib|rebastinib|mesh-list
14808439|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808440|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14808441|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808442|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808443|NCT00827151|Estrogens|estrogens|mesh-list
14808444|NCT00827151|Hormones|hormones|mesh-ancestor
14808445|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808446|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808447|NCT00827177|Sorafenib|sorafenib|mesh-list
14808448|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808449|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14808450|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808451|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808452|NCT00827216|Erythromycin|erythromycin|mesh-list
14808453|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
14808454|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14808455|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
14808456|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14808457|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808458|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14808459|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14808460|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808461|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808462|NCT00827281|Cycloserine|cycloserine|mesh-list
14808463|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14808464|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808465|NCT00827281|Renal Agents|renal agents|mesh-ancestor
14808466|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15084717|NCT00026312|Aldesleukin|aldesleukin|mesh-list
14808467|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
14546830|NCT00000731|Analgesics|analgesics|mesh-ancestor
14546831|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
14546832|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546833|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546834|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
14546835|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
14546836|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546837|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546838|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546839|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546840|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
14546841|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546842|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15084718|NCT00026312|Interleukin-2|interleukin-2|mesh-list
15084719|NCT00026312|Tretinoin|tretinoin|mesh-list
15084720|NCT00026312|Dinutuximab|dinutuximab|mesh-list
15084721|NCT00026312|Isotretinoin|isotretinoin|mesh-list
15084722|NCT00026312|Sargramostim|sargramostim|mesh-list
15084723|NCT00026312|Vitamins|vitamins|mesh-ancestor
15084724|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
15084725|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084726|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084727|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15084728|NCT00026312|Analgesics|analgesics|mesh-ancestor
15084729|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
15084730|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084731|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
15084732|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15084733|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15084734|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
15084735|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084736|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
15084737|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
15172942|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172943|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172944|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15172945|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
15172946|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172947|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172948|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15172949|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15172950|NCT04008966|Cetrorelix|cetrorelix|mesh-list
14546843|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546844|NCT00000732|Zidovudine|zidovudine|mesh-list
14546845|NCT00000732|Trimethoprim|trimethoprim|mesh-list
14546846|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
14546847|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14546848|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
14546849|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546850|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546851|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546852|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546853|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
14546854|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546855|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546856|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546857|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14546858|NCT00000732|Renal Agents|renal agents|mesh-ancestor
14546859|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
14546860|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546861|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546862|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546863|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14546864|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14546865|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14546866|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546867|NCT00000733|Ribavirin|ribavirin|mesh-list
14546868|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
14546869|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546870|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
14546871|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546872|NCT00000734|Zidovudine|zidovudine|mesh-list
14546873|NCT00000734|Trimethoprim|trimethoprim|mesh-list
14546874|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
15172951|NCT04008966|Progesterone|progesterone|mesh-list
15172952|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15172953|NCT04008966|Progestins|progestins|mesh-ancestor
15172954|NCT04008966|Hormones|hormones|mesh-ancestor
14546875|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14546876|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
14546877|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546878|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546879|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546880|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546881|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
14546882|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546883|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546884|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546885|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14546886|NCT00000734|Renal Agents|renal agents|mesh-ancestor
14546887|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
14546888|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546889|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546890|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546891|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14546892|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14546893|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14546894|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546895|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14546896|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
15084738|NCT02248571|Bevacizumab|bevacizumab|mesh-list
15084739|NCT02248571|Capecitabine|capecitabine|mesh-list
15084740|NCT02248571|Everolimus|everolimus|mesh-list
15084741|NCT02248571|Exemestane|exemestane|mesh-list
15084742|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14546897|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546898|NCT00000736|Zidovudine|zidovudine|mesh-list
14546899|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
14546900|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546901|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546902|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546903|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546904|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
14546905|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546906|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546907|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546908|NCT00000737|Megestrol|megestrol|mesh-list
14546909|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
14546910|NCT00000737|Dronabinol|dronabinol|mesh-list
14546911|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
14546912|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546913|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14546914|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14546915|NCT00000737|Analgesics|analgesics|mesh-ancestor
14546916|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
14546917|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546918|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14546919|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14546920|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14546921|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546922|NCT00000737|Hormones|hormones|mesh-ancestor
14546923|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084743|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084744|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15084745|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15084746|NCT02248571|Growth Substances|growth substances|mesh-ancestor
15084747|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084748|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
14546924|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14546925|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14546926|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14546927|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
14546928|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14546929|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14546930|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14546931|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14546932|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546933|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
14546934|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14546935|NCT00000738|Zidovudine|zidovudine|mesh-list
14546936|NCT00000738|Nimodipine|nimodipine|mesh-list
14546937|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
15084749|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14546938|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546939|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546940|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546941|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546942|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
14546943|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546944|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546945|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546946|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14546947|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14546948|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14546949|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14546950|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546951|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
14546952|NCT00000739|Dapsone|dapsone|mesh-list
14546953|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546954|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
14546955|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14546956|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14546957|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14546958|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546959|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546960|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
14546961|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14546962|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
14546963|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14546964|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14546965|NCT00000741|Prednisolone|prednisolone|mesh-list
14546966|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
14546967|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14546968|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
14546969|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14546970|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
14546971|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
14546972|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14546973|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14546974|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14546975|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
14546976|NCT00000741|Hormones|hormones|mesh-ancestor
14546977|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14546978|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14546979|NCT00000741|Protective Agents|protective agents|mesh-ancestor
14546980|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14546981|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14546982|NCT00000742|Zidovudine|zidovudine|mesh-list
14546983|NCT00000742|Didanosine|didanosine|mesh-list
14546984|NCT00000742|Atevirdine|atevirdine|mesh-list
14546985|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
14546986|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546987|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546988|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546989|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14546990|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
14546991|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14546992|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14546993|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14546994|NCT00000743|Zidovudine|zidovudine|mesh-list
14546995|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
14546996|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14546997|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14546998|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14546999|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547000|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
14547001|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547002|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547003|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547004|NCT00000744|Fluconazole|fluconazole|mesh-list
14547005|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
15084750|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
15084751|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084752|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084753|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
15084754|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14547006|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547007|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14547008|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547009|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547010|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547011|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14547012|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
14547013|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14547014|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547015|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14547016|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14547017|NCT00000745|Vaccines|vaccines|mesh-list
14547018|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
15084755|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15084756|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084757|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15084758|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
15084759|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084760|NCT02248584|Ascorbic Acid|ascorbic acid|mesh-list
15084761|NCT02248584|Vitamins|vitamins|mesh-ancestor
15084762|NCT02248584|Micronutrients|micronutrients|mesh-ancestor
15084763|NCT02248584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084764|NCT02248584|Antioxidants|antioxidants|mesh-ancestor
15084765|NCT02248584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084766|NCT02248584|Protective Agents|protective agents|mesh-ancestor
15084767|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
15084768|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
15084769|NCT02248597|Busulfan|busulfan|mesh-list
15084770|NCT02248597|Fludarabine|fludarabine|mesh-list
15084771|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
15084772|NCT02248597|Tacrolimus|tacrolimus|mesh-list
14547019|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547020|NCT00000747|Nevirapine|nevirapine|mesh-list
14547021|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547022|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547023|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547024|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547025|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
14547026|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547027|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547028|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547029|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14547030|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14547031|NCT00000748|Trimethoprim|trimethoprim|mesh-list
14547032|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14547033|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
14547034|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14547035|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547036|NCT00000748|Renal Agents|renal agents|mesh-ancestor
14547037|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
14547038|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547039|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547040|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14547041|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547042|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547043|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14547044|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14547045|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547046|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547047|NCT00000750|Zidovudine|zidovudine|mesh-list
14547048|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
14547049|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547050|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547051|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547052|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547053|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
14547054|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547055|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547056|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547057|NCT00000751|Zidovudine|zidovudine|mesh-list
14547058|NCT00000751|Immune Sera|immune sera|mesh-list
14547059|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
14547060|NCT00000751|Antibodies|antibodies|mesh-list
15084773|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084774|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
14547061|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
14547062|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547063|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547064|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547065|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547066|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
14547067|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547068|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547069|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547070|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
14547071|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547072|NCT00000752|Cefuroxime|cefuroxime|mesh-list
14547073|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
14547074|NCT00000752|Beclomethasone|beclomethasone|mesh-list
14547075|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
14547076|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
14547077|NCT00000752|Ephedrine|ephedrine|mesh-list
14547078|NCT00000752|Guaifenesin|guaifenesin|mesh-list
14547079|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14547080|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14547081|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
14547082|NCT00000752|Hormones|hormones|mesh-ancestor
14547083|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14547084|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547085|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14547086|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
14547087|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14547088|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
14547089|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547090|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
14547091|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14547092|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14547093|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
14547094|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
14547095|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14547096|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547097|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547098|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547099|NCT00000752|Expectorants|expectorants|mesh-ancestor
14547100|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14547101|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14547102|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
15084775|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084776|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084777|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15084778|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
14547103|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14547104|NCT00000753|Zidovudine|zidovudine|mesh-list
14547105|NCT00000753|Didanosine|didanosine|mesh-list
14547106|NCT00000753|Zalcitabine|zalcitabine|mesh-list
14547107|NCT00000753|Atevirdine|atevirdine|mesh-list
14547108|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
14547109|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547110|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547111|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547112|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547113|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
14547114|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547115|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547116|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547117|NCT00000754|Interferons|interferons|mesh-list
14547118|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
14547119|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
14547120|NCT00000754|Zidovudine|zidovudine|mesh-list
14547121|NCT00000754|Zalcitabine|zalcitabine|mesh-list
14547122|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547123|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
14547124|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547125|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
14547126|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084779|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084780|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084781|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15084782|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15084783|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
14547127|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
14643275|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
14547128|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547129|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547130|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547131|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547132|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547133|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547134|NCT00000755|Zidovudine|zidovudine|mesh-list
14547135|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
14547136|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547137|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547138|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547139|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547140|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
14547141|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547142|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547143|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15084784|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15084785|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084786|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15084787|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15084788|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
15084789|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547144|NCT00000758|Fluorouracil|fluorouracil|mesh-list
14547145|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
14547146|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547147|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14547148|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547149|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14547150|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
14547151|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547152|NCT00000760|Zidovudine|zidovudine|mesh-list
14547153|NCT00000760|Didanosine|didanosine|mesh-list
14547154|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
14547155|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547156|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547157|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547158|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547159|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
14547160|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547161|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547162|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547163|NCT00000761|Interferons|interferons|mesh-list
14547164|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
14547165|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547166|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
14547167|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547168|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
14547169|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14547170|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547171|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14547172|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14547173|NCT00000763|Growth Substances|growth substances|mesh-ancestor
14547174|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547175|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
14547176|NCT00000764|Interferons|interferons|mesh-list
14547177|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
14547178|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
14547179|NCT00000764|Isotretinoin|isotretinoin|mesh-list
14547180|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547181|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
14547182|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808468|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14808469|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
14808470|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808471|NCT00827307|Tamoxifen|tamoxifen|mesh-list
14808472|NCT00827307|Goserelin|goserelin|mesh-list
14808473|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14808474|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
14808475|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808476|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808477|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084790|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084791|NCT02248753|Metoprolol|metoprolol|mesh-list
14547183|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
14547184|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547185|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
14547186|NCT00000765|Zidovudine|zidovudine|mesh-list
14547187|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
14547188|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547189|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547190|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547191|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547192|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
14547193|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547194|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547195|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547196|NCT00000766|Ganciclovir|ganciclovir|mesh-list
15084792|NCT02248753|Digoxin|digoxin|mesh-list
15084793|NCT02248753|Amiodarone|amiodarone|mesh-list
15084794|NCT02248753|Verapamil|verapamil|mesh-list
15084795|NCT02248753|Flecainide|flecainide|mesh-list
15084796|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15084797|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15084798|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
15084799|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
15084800|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084801|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084802|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15084803|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15084804|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15084805|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
15084806|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15084807|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547197|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14547198|NCT00000766|Foscarnet|foscarnet|mesh-list
14547199|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14547200|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
15084808|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15084809|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084810|NCT02248753|Protective Agents|protective agents|mesh-ancestor
15084811|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
15084812|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15084813|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15084814|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15084815|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15084816|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15084817|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15084818|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15084819|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15084820|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15084821|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15084822|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15084823|NCT02248792|Methotrexate|methotrexate|mesh-list
15084824|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15084825|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
15084826|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15084827|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084828|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15084829|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
15084830|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084831|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084832|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
15084833|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084834|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15084835|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084836|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
15084837|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084838|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084839|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
15084840|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15084841|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15084842|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15084843|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15084844|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084845|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
15084846|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15084847|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084848|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14547201|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547202|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547203|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547204|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547205|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547206|NCT00000767|Vaccines|vaccines|mesh-list
14547207|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
14547208|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547209|NCT00000768|Ganciclovir|ganciclovir|mesh-list
14547210|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14547211|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
14547212|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547213|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547214|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547215|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547216|NCT00000769|Interleukin-4|interleukin-4|mesh-list
14547217|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14547218|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
14547219|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547220|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547221|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14547222|NCT00000770|Zidovudine|zidovudine|mesh-list
14547223|NCT00000770|Nevirapine|nevirapine|mesh-list
14547224|NCT00000770|Didanosine|didanosine|mesh-list
14547225|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
14547226|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547227|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547228|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547229|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547230|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
14547231|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547232|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547233|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547234|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14547235|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14547236|NCT00000771|Paromomycin|paromomycin|mesh-list
14547237|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547238|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547239|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547240|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547241|NCT00000772|Ribavirin|ribavirin|mesh-list
14547242|NCT00000772|Didanosine|didanosine|mesh-list
14547243|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
14547244|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547245|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
14547246|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547247|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547248|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547249|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547250|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547251|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547252|NCT00000773|Atovaquone|atovaquone|mesh-list
14547253|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547254|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
14547255|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547256|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547257|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547258|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547259|NCT00000776|Fluconazole|fluconazole|mesh-list
14547260|NCT00000776|Amphotericin B|amphotericin b|mesh-list
14547261|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14547262|NCT00000776|Flucytosine|flucytosine|mesh-list
14547263|NCT00000776|Dexamethasone|dexamethasone|mesh-list
14547264|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14547265|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
14547266|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
14547267|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547268|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547269|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14547270|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
14547271|NCT00000776|Hormones|hormones|mesh-ancestor
14547272|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14547273|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14547274|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547275|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
14547276|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547277|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14547278|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547279|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547280|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547281|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14547282|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
14547283|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14547284|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14547285|NCT00000776|Amebicides|amebicides|mesh-ancestor
14547286|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547287|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547288|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547289|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
14547290|NCT00000778|Pyridoxine|pyridoxine|mesh-list
14547291|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
14547292|NCT00000778|Levofloxacin|levofloxacin|mesh-list
14547293|NCT00000778|Ofloxacin|ofloxacin|mesh-list
14547294|NCT00000778|Isoniazid|isoniazid|mesh-list
14547295|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14547296|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547297|NCT00000778|Renal Agents|renal agents|mesh-ancestor
14547298|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547299|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14547300|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14547301|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547302|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547303|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547304|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14547305|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547306|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
14547307|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14547308|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14547309|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
14547310|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14547311|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
14547312|NCT00000778|Vitamins|vitamins|mesh-ancestor
14547313|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
14547314|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547315|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14547316|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14547317|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
14547318|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547319|NCT00000779|Antacids|antacids|mesh-ancestor
14547320|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547321|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14547322|NCT00000781|Zidovudine|zidovudine|mesh-list
14547323|NCT00000781|Nevirapine|nevirapine|mesh-list
14547324|NCT00000781|Didanosine|didanosine|mesh-list
14547325|NCT00000781|Zalcitabine|zalcitabine|mesh-list
14547326|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
14547327|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547328|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547329|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547330|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547331|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
14547332|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547333|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547334|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547335|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14547336|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14547337|NCT00000782|Vaccines|vaccines|mesh-list
14547338|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
14547339|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547340|NCT00000788|Fluconazole|fluconazole|mesh-list
14547341|NCT00000788|Methadone|methadone|mesh-list
14547342|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14547343|NCT00000788|Narcotics|narcotics|mesh-ancestor
14547344|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14547345|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547346|NCT00000788|Analgesics|analgesics|mesh-ancestor
14547347|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
14547348|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547349|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
14547350|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
14547351|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
14547352|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547353|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14547354|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547355|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547356|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547357|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14267729|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14267730|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
14267731|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267732|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14267733|NCT00391872|Clopidogrel|clopidogrel|mesh-list
14267734|NCT00391872|Ticagrelor|ticagrelor|mesh-list
14547358|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
14547359|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14547360|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14547361|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14547362|NCT00000789|Zidovudine|zidovudine|mesh-list
14547363|NCT00000789|Stavudine|stavudine|mesh-list
14547364|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
14547365|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547366|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547367|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547368|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547369|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
14547370|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547371|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547372|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547373|NCT00000790|Thalidomide|thalidomide|mesh-list
14547374|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15084849|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084850|NCT02248870|Dexamethasone|dexamethasone|mesh-list
14547375|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
14547376|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547377|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
14547378|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547379|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547380|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14547381|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14547382|NCT00000790|Growth Substances|growth substances|mesh-ancestor
14547383|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
14547384|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547385|NCT00000791|Zidovudine|zidovudine|mesh-list
14547386|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
14547387|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547388|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547389|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547390|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547391|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
14547392|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547393|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547394|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547395|NCT00000792|Hypericin|hypericin|mesh-list
14547396|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
14547397|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14547398|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547399|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
14547400|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547401|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547402|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547403|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14547404|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
14547405|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547406|NCT00000793|Mexiletine|mexiletine|mesh-list
14547407|NCT00000793|Amitriptyline|amitriptyline|mesh-list
14547408|NCT00000793|Benztropine|benztropine|mesh-list
14547409|NCT00000793|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14547410|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14547411|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
14547412|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14547413|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14547414|NCT00000793|Analgesics|analgesics|mesh-ancestor
14547415|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
14547416|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547417|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267735|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14292352|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
14547418|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14547419|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14547420|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14547421|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547422|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
14547423|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14547424|NCT00000793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14547425|NCT00000793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14547426|NCT00000793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14547427|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14547428|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14547429|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14547430|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14547431|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14547432|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
14547433|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
14547434|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15084851|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15084852|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
15084853|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
15084854|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084855|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084856|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15084857|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
15084858|NCT02248870|Hormones|hormones|mesh-ancestor
15084859|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15084860|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15084861|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084862|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
15084863|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15084864|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084865|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15084866|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15084867|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084868|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084869|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084870|NCT02248896|Telmisartan|telmisartan|mesh-list
15084871|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
15084872|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15084873|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15084874|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15084875|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15084876|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084877|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084878|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
15084879|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15084880|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15084881|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084882|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15084883|NCT02249013|Paclitaxel|paclitaxel|mesh-list
15084884|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15084885|NCT02249013|Carboplatin|carboplatin|mesh-list
15084886|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15084887|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15084888|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
15084889|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
15084890|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
15084891|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084892|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15084893|NCT02249026|Buprenorphine|buprenorphine|mesh-list
15084894|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
15084895|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15084896|NCT02249026|Narcotics|narcotics|mesh-ancestor
15084897|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15084898|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084899|NCT02249026|Analgesics|analgesics|mesh-ancestor
15084900|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
15084901|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084902|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15084903|NCT02249039|Clonidine|clonidine|mesh-list
15084904|NCT02249039|Analgesics|analgesics|mesh-ancestor
15084905|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
15084906|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547435|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14547436|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
14547437|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14547438|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
14547439|NCT00000794|Leucovorin|leucovorin|mesh-list
14547440|NCT00000794|Clarithromycin|clarithromycin|mesh-list
14547441|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
14547442|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
14547443|NCT00000794|Atovaquone|atovaquone|mesh-list
14547444|NCT00000794|Calcium|calcium|mesh-list
14547445|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
14547446|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14547447|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547448|NCT00000794|Antidotes|antidotes|mesh-ancestor
14547449|NCT00000794|Protective Agents|protective agents|mesh-ancestor
14547450|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
14547451|NCT00000794|Vitamins|vitamins|mesh-ancestor
14547452|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
14547453|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547454|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547455|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14547456|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547457|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547458|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14547459|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547460|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
14547461|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547462|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547463|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14547464|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
14547465|NCT00000796|Pyridoxine|pyridoxine|mesh-list
14547466|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
14547467|NCT00000796|Levofloxacin|levofloxacin|mesh-list
14547468|NCT00000796|Cycloserine|cycloserine|mesh-list
14547469|NCT00000796|Rifampin|rifampin|mesh-list
14547470|NCT00000796|Isoniazid|isoniazid|mesh-list
14547471|NCT00000796|Amikacin|amikacin|mesh-list
14547472|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
14547473|NCT00000796|Ethambutol|ethambutol|mesh-list
14547474|NCT00000796|Clofazimine|clofazimine|mesh-list
14547475|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14547476|NCT00000796|Streptomycin|streptomycin|mesh-list
14547477|NCT00000796|Ethionamide|ethionamide|mesh-list
14547478|NCT00000796|Capreomycin|capreomycin|mesh-list
14547479|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14547480|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547481|NCT00000796|Renal Agents|renal agents|mesh-ancestor
14547482|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547483|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14547484|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14547485|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547486|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547487|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547488|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14547489|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547490|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14547491|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
14547492|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
14547493|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547494|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14547495|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14547496|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14547497|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14547498|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14547499|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14547500|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14547501|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14547502|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
14547503|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14547504|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
14547505|NCT00000796|Vitamins|vitamins|mesh-ancestor
14547506|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
14547507|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547508|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14547509|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14547510|NCT00000799|Cidofovir|cidofovir|mesh-list
14547511|NCT00000799|Probenecid|probenecid|mesh-list
14547512|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
14547513|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
14547514|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14547515|NCT00000799|Renal Agents|renal agents|mesh-ancestor
14547516|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
14547517|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547518|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547519|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547520|NCT00000800|Zidovudine|zidovudine|mesh-list
14547521|NCT00000800|Methadone|methadone|mesh-list
14547522|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
14547523|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547524|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547525|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547526|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547527|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
14547528|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547529|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547530|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547531|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14547532|NCT00000800|Narcotics|narcotics|mesh-ancestor
14547533|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14547534|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547535|NCT00000800|Analgesics|analgesics|mesh-ancestor
14547536|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
14547537|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547538|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
14547539|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
14547540|NCT00000801|Cytarabine|cytarabine|mesh-list
14547541|NCT00000801|Dexamethasone|dexamethasone|mesh-list
14547542|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
14547543|NCT00000801|Doxorubicin|doxorubicin|mesh-list
14547544|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14547545|NCT00000801|Vincristine|vincristine|mesh-list
14547546|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14547547|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
14547548|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547549|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14547550|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14547551|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
14547552|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547553|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547554|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14547555|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14547556|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
14547557|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
14547558|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547559|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14547560|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
14547561|NCT00000801|Hormones|hormones|mesh-ancestor
14547562|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14547563|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14547564|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14547565|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14547566|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14547567|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547568|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14547569|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
14547570|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
14547571|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547572|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14547573|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
14547574|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267736|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14267737|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14267738|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14267739|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
14547575|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
14547576|NCT00000802|Dapsone|dapsone|mesh-list
14547577|NCT00000802|Atovaquone|atovaquone|mesh-list
14547578|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547579|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
14547580|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547581|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547582|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14547583|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547584|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084907|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547585|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
14547586|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547587|NCT00000803|Zidovudine|zidovudine|mesh-list
14547588|NCT00000803|Didanosine|didanosine|mesh-list
14547589|NCT00000803|Delavirdine|delavirdine|mesh-list
14547590|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
14547591|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547592|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547593|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547594|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547595|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
14547596|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547597|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547598|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547599|NCT00000804|Indinavir|indinavir|mesh-list
15084908|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15084909|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
15084910|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
15084911|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15084912|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15084913|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15084914|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
15084915|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15084916|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084917|NCT02249078|Quetmolimab|quetmolimab|mesh-list
15084918|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15084919|NCT02249130|Ritonavir|ritonavir|mesh-list
15084920|NCT02249130|Lamivudine|lamivudine|mesh-list
15084921|NCT02249130|Zidovudine|zidovudine|mesh-list
15084922|NCT02249130|Stavudine|stavudine|mesh-list
15084923|NCT02249130|Tipranavir|tipranavir|mesh-list
15084924|NCT02249130|Delavirdine|delavirdine|mesh-list
15084925|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15084926|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15084927|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084928|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084929|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084930|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15084931|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15084932|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
15084933|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084934|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15084935|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15084936|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15084937|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084938|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
15084939|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15084940|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15084941|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084942|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084943|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15084944|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15084945|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084946|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
15084947|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15084948|NCT02249299|Nabiximols|nabiximols|mesh-list
15084949|NCT02249299|Analgesics|analgesics|mesh-ancestor
15084950|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
15084951|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084952|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084953|NCT02249364|Propofol|propofol|mesh-list
15084954|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15084955|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15084956|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084957|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15084958|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
15084959|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
15084960|NCT02249416|Ritonavir|ritonavir|mesh-list
15084961|NCT02249416|Zidovudine|zidovudine|mesh-list
15084962|NCT02249416|Tipranavir|tipranavir|mesh-list
15084963|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14547600|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14547601|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15084964|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15084965|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084966|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547602|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
14547603|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547604|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547605|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547606|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547607|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
14547608|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547609|NCT00000805|Ganciclovir|ganciclovir|mesh-list
14547610|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14547611|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
14547612|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547613|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547614|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547615|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547616|NCT00000807|Etoposide|etoposide|mesh-list
14547617|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14547618|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547619|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14547620|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14547621|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547622|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547623|NCT00000808|Nevirapine|nevirapine|mesh-list
14547624|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547625|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547626|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547627|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547628|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
14547629|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547630|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547631|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547632|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14547633|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14547634|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14547635|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14547636|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
14547637|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547638|NCT00000809|Antacids|antacids|mesh-ancestor
14547639|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547640|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14547641|NCT00000810|Zidovudine|zidovudine|mesh-list
14547642|NCT00000810|Didanosine|didanosine|mesh-list
14547643|NCT00000810|Delavirdine|delavirdine|mesh-list
14547644|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
14547645|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547646|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547647|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547648|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547649|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
14547650|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547651|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547652|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547653|NCT00000811|Azithromycin|azithromycin|mesh-list
14547654|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14547655|NCT00000811|Trimethoprim|trimethoprim|mesh-list
14547656|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
14547657|NCT00000811|Atovaquone|atovaquone|mesh-list
14547658|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547659|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547660|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14547661|NCT00000811|Renal Agents|renal agents|mesh-ancestor
14547662|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
14547663|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547664|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14808478|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808479|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14808480|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14808481|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14808482|NCT00827320|Levetiracetam|levetiracetam|mesh-list
14808483|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
14808484|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
14808485|NCT00827346|Clopidogrel|clopidogrel|mesh-list
14808486|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14808487|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14808488|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14808489|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14808490|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
14808491|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808492|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808493|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808494|NCT00827411|Aspirin|aspirin|mesh-list
14808495|NCT00827411|Clopidogrel|clopidogrel|mesh-list
14808496|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14808497|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14808498|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14808499|NCT00827411|Analgesics|analgesics|mesh-ancestor
14808500|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
14808501|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808502|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808503|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808504|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808505|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14808506|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14808507|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808508|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14808509|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14808510|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808511|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
14808512|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14808513|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14808514|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14808515|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
14808516|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808517|NCT00827450|Caffeine|caffeine|mesh-list
14808518|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14808519|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808520|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14808521|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808522|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808523|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14808524|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14808525|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
14808526|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808527|NCT00827554|Nadroparin|nadroparin|mesh-list
14808528|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
14808529|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14808530|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14808531|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808532|NCT00827580|Eniluracil|eniluracil|mesh-list
14808533|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808534|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808535|NCT00827671|Cetuximab|cetuximab|mesh-list
14808536|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14808537|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808538|NCT00827684|Sirolimus|sirolimus|mesh-list
14808539|NCT00827684|Irinotecan|irinotecan|mesh-list
14547665|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14808540|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14547666|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547667|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547668|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14547669|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14547670|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547671|NCT00000812|Thalidomide|thalidomide|mesh-list
14547672|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14547673|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
14547674|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547675|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
14547676|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547677|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547678|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14547679|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14547680|NCT00000812|Growth Substances|growth substances|mesh-ancestor
14547681|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
14547682|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547683|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
14547684|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14547685|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
14547686|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547687|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14547688|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547689|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
14547690|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547691|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
14547692|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14547693|NCT00000813|Protective Agents|protective agents|mesh-ancestor
14547694|NCT00000814|Zidovudine|zidovudine|mesh-list
14547695|NCT00000814|Nevirapine|nevirapine|mesh-list
14547696|NCT00000814|Didanosine|didanosine|mesh-list
14547697|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
14547698|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547699|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547700|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547701|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547702|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
14547703|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547704|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547705|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547706|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14547707|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14547708|NCT00000816|Trimethoprim|trimethoprim|mesh-list
14547709|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14547710|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
14547711|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14547712|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547713|NCT00000816|Renal Agents|renal agents|mesh-ancestor
14547714|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
14547715|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547716|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547717|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14547718|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547719|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547720|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14547721|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14547722|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547723|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547724|NCT00000817|Amitriptyline|amitriptyline|mesh-list
14547725|NCT00000817|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14547726|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14547727|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
14547728|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14547729|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14547730|NCT00000817|Analgesics|analgesics|mesh-ancestor
14547731|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
14547732|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14547733|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547734|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14547735|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14547736|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14547737|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547738|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
14547739|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14547740|NCT00000817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14547741|NCT00000817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14547742|NCT00000817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14547743|NCT00000818|Zidovudine|zidovudine|mesh-list
14547744|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
14547745|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547746|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547747|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547748|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547749|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
14547750|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547751|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547752|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547753|NCT00000819|Prednisone|prednisone|mesh-list
14547754|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14547755|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
14547756|NCT00000819|Hormones|hormones|mesh-ancestor
14547757|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14547758|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084967|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084968|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547759|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14547760|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547761|NCT00000820|Aldesleukin|aldesleukin|mesh-list
14547762|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547763|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547764|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547765|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
14547766|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547767|NCT00000821|Aldesleukin|aldesleukin|mesh-list
14547768|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547769|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547770|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547771|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
14547772|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547773|NCT00000822|Ritonavir|ritonavir|mesh-list
14547774|NCT00000822|Stavudine|stavudine|mesh-list
14547775|NCT00000822|Didanosine|didanosine|mesh-list
14547776|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14547777|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14547778|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14547779|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547780|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547781|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547782|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547783|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
14547784|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547785|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14547786|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547787|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
14547788|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547789|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084969|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15084970|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
15084971|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15084972|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15084973|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15084974|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
15084975|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15084976|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15084977|NCT02249442|Ritonavir|ritonavir|mesh-list
15084978|NCT02249442|Tipranavir|tipranavir|mesh-list
15084979|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15084980|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15084981|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
15084982|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15084983|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084984|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15084985|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15084986|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
15084987|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547790|NCT00000823|Zidovudine|zidovudine|mesh-list
14547791|NCT00000823|Didanosine|didanosine|mesh-list
14547792|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
14647415|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14547793|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547794|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547795|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547796|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547797|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
14547798|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547799|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547800|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547801|NCT00000825|Aldesleukin|aldesleukin|mesh-list
14547802|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547803|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547804|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547805|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
14547806|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547807|NCT00000826|Clarithromycin|clarithromycin|mesh-list
14547808|NCT00000826|Dapsone|dapsone|mesh-list
14547809|NCT00000826|Rifabutin|rifabutin|mesh-list
14547810|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14547811|NCT00000826|Fluconazole|fluconazole|mesh-list
14547812|NCT00000826|Trimethoprim|trimethoprim|mesh-list
14547813|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
14547814|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14547815|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547816|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14547817|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547818|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547819|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14547820|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547821|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
14547822|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14547823|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14547824|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
14547825|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14547826|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547827|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14547828|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14547829|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14547830|NCT00000826|Renal Agents|renal agents|mesh-ancestor
14547831|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
14547832|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14547833|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14547834|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14547835|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14547836|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14547837|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
14547838|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14547839|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
14547840|NCT00000827|Immune Sera|immune sera|mesh-list
14547841|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
14547842|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547843|NCT00000829|Vaccines|vaccines|mesh-list
14547844|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14547845|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
14547846|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643276|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643277|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643278|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643279|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643280|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
14643281|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643282|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
14643283|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
14643284|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084988|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15084989|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15084990|NCT02249481|Bupivacaine|bupivacaine|mesh-list
15084991|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
15084992|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
13996074|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643285|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
14643286|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643287|NCT00188942|Olanzapine|olanzapine|mesh-list
15084993|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14547847|NCT00000831|Lamivudine|lamivudine|mesh-list
14547848|NCT00000831|Zidovudine|zidovudine|mesh-list
14547849|NCT00000831|Stavudine|stavudine|mesh-list
14547850|NCT00000831|Didanosine|didanosine|mesh-list
14547851|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547852|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547853|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547854|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547855|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
14547856|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547857|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547858|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547859|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
14547860|NCT00000833|Ribavirin|ribavirin|mesh-list
14547861|NCT00000833|Didanosine|didanosine|mesh-list
14547862|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
14547863|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547864|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
14547865|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547866|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547867|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547868|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547869|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547870|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547871|NCT00000834|Lamivudine|lamivudine|mesh-list
14547872|NCT00000834|Zidovudine|zidovudine|mesh-list
14547873|NCT00000834|Methotrexate|methotrexate|mesh-list
14547874|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14547875|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
14547876|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14547877|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547878|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14547879|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
14547880|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547881|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547882|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14547883|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547884|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14547885|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14547886|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
14547887|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14547888|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547889|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547890|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
14547891|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547892|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547893|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547894|NCT00000838|Lamivudine|lamivudine|mesh-list
14547895|NCT00000838|Zidovudine|zidovudine|mesh-list
14547896|NCT00000838|Stavudine|stavudine|mesh-list
14547897|NCT00000838|Didanosine|didanosine|mesh-list
14547898|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547899|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547900|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547901|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547902|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
14547903|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547904|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547905|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547906|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
14547907|NCT00000839|Didanosine|didanosine|mesh-list
14547908|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
14547909|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547910|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547911|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547912|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547913|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
14547914|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547915|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547916|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547917|NCT00000841|Lamivudine|lamivudine|mesh-list
14547918|NCT00000841|Zidovudine|zidovudine|mesh-list
14547919|NCT00000841|Stavudine|stavudine|mesh-list
14547920|NCT00000841|Indinavir|indinavir|mesh-list
14547921|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547922|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547923|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547924|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547925|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
14547926|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547927|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547928|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547929|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
14547930|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14547931|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14547932|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
14547933|NCT00000842|Mitogens|mitogens|mesh-list
14547934|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
14547935|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547936|NCT00000843|Adefovir|adefovir|mesh-list
14547937|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14547938|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
14547939|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547940|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547941|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14547942|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547943|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547944|NCT00000844|Interferons|interferons|mesh-list
14547945|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
14547946|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547947|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
14547948|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547949|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
14547950|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547951|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
14267740|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14547952|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14547953|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
14547954|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547955|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14267741|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267742|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267743|NCT00391898|Levodopa|levodopa|mesh-list
14267744|NCT00391898|Carbidopa|carbidopa|mesh-list
14267745|NCT00391898|Entacapone|entacapone|mesh-list
14267746|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14267747|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14267748|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
14267749|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267750|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267751|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267752|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14267753|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267754|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14267755|NCT00391976|Tobramycin|tobramycin|mesh-list
14267756|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14267757|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267758|NCT00391989|Dasatinib|dasatinib|mesh-list
14267759|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267760|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267761|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267762|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267763|NCT00392041|Eszopiclone|eszopiclone|mesh-list
14267764|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14267765|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267766|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267767|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14267768|NCT00392171|Temozolomide|temozolomide|mesh-list
14547956|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547957|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
14547958|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547959|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
14547960|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14547961|NCT00000847|Protective Agents|protective agents|mesh-ancestor
14547962|NCT00000848|Indinavir|indinavir|mesh-list
14547963|NCT00000848|Saquinavir|saquinavir|mesh-list
14547964|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14547965|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14547966|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
14808541|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14808542|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808543|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808544|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808545|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14808546|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808547|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14808548|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
14808549|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14808550|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
14808551|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814152|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14814153|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14814154|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
14814155|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814156|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14814157|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14814158|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814159|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
14814160|NCT00861783|Irinotecan|irinotecan|mesh-list
14814161|NCT00861783|Camptothecin|camptothecin|mesh-list
14814162|NCT00861783|ON 01910|on 01910|mesh-list
14814163|NCT00861783|Glycine|glycine|mesh-list
14814164|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814165|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14814166|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14814167|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814168|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15084994|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15084995|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
15084996|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15084997|NCT02249546|Amoxicillin|amoxicillin|mesh-list
14814169|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14814170|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14814171|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
14814172|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814173|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814174|NCT00861861|Atorvastatin|atorvastatin|mesh-list
14814175|NCT00861861|Pitavastatin|pitavastatin|mesh-list
14814176|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14814177|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14814178|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
14814179|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814180|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14814181|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14814182|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814183|NCT00861874|Sirolimus|sirolimus|mesh-list
15084998|NCT02249546|Clarithromycin|clarithromycin|mesh-list
15084999|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
15085000|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15085001|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15085002|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085003|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15085004|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814184|NCT00861874|Decitabine|decitabine|mesh-list
14814185|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14814186|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814187|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14814188|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814189|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
14814190|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14814191|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
14814192|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085005|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085006|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085007|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085008|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
14267769|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14267770|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
14267771|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267772|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267773|NCT00392197|Aripiprazole|aripiprazole|mesh-list
14267774|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
14267775|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14267776|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14267777|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14267778|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14267779|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267780|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
14267781|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
14267782|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267783|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547967|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547968|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547969|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547970|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547971|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
14547972|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547973|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14547974|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14547975|NCT00000849|Aldesleukin|aldesleukin|mesh-list
14547976|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14547977|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547978|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547979|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
14547980|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547981|NCT00000850|Indinavir|indinavir|mesh-list
14547982|NCT00000850|Sargramostim|sargramostim|mesh-list
14547983|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
15085009|NCT02249546|Expectorants|expectorants|mesh-ancestor
15085010|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085011|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15085012|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
15085013|NCT02249546|Protective Agents|protective agents|mesh-ancestor
15085014|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085015|NCT02249546|Antidotes|antidotes|mesh-ancestor
15085016|NCT02249663|Fluticasone|fluticasone|mesh-list
15085017|NCT02249663|Xhance|xhance|mesh-list
15085018|NCT02249663|Azelastine|azelastine|mesh-list
15085019|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085020|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15085021|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
15085022|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085023|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085024|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15085025|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085026|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
14547984|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14547985|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14547986|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14547987|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
14547988|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14547989|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547990|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14547991|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14547992|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
14547993|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14547994|NCT00000851|Stavudine|stavudine|mesh-list
14547995|NCT00000851|Didanosine|didanosine|mesh-list
14547996|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
14547997|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14547998|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14547999|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548000|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548001|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
14548002|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548003|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548004|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548005|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
14548006|NCT00000854|Nandrolone|nandrolone|mesh-list
15085027|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14548007|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
15085028|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15085029|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548008|NCT00000854|Androgens|androgens|mesh-ancestor
14548009|NCT00000854|Hormones|hormones|mesh-ancestor
14548010|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14548011|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548012|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
14548013|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14548014|NCT00000855|Zidovudine|zidovudine|mesh-list
14548015|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
14548016|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548017|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14267784|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14267785|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14267786|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
14267787|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14548018|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548019|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548020|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
14548021|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548022|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548023|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548024|NCT00000856|Ganciclovir|ganciclovir|mesh-list
14548025|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14548026|NCT00000856|Foscarnet|foscarnet|mesh-list
14548027|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14548028|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
14548029|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548030|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548031|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548032|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548033|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548034|NCT00000857|Interleukin-12|interleukin-12|mesh-list
14548035|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14548036|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
14548037|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548038|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14548039|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14548040|NCT00000857|Growth Substances|growth substances|mesh-ancestor
14548041|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
14548042|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548043|NCT00000859|Ritonavir|ritonavir|mesh-list
14548044|NCT00000859|Nelfinavir|nelfinavir|mesh-list
14548045|NCT00000859|Indinavir|indinavir|mesh-list
14548046|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548047|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548048|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548049|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548050|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548051|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548052|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548053|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
14548054|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548055|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548056|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548057|NCT00000861|Indinavir|indinavir|mesh-list
14548058|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548059|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548060|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548061|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548062|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548063|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548064|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548065|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
14548066|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548067|NCT00000862|Zidovudine|zidovudine|mesh-list
14548068|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
14548069|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548070|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548071|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548072|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548073|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
14548074|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548075|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548076|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548077|NCT00000864|Zidovudine|zidovudine|mesh-list
14548078|NCT00000864|Abacavir|abacavir|mesh-list
14548079|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
14548080|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548081|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548082|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548083|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548084|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
14548085|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548086|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548087|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548088|NCT00000865|Lamivudine|lamivudine|mesh-list
14548089|NCT00000865|Zidovudine|zidovudine|mesh-list
14548090|NCT00000865|Abacavir|abacavir|mesh-list
14548091|NCT00000865|Stavudine|stavudine|mesh-list
14267788|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14267789|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14267790|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14548092|NCT00000865|Didanosine|didanosine|mesh-list
14548093|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548094|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548095|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548096|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548097|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
14548098|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548099|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548100|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548101|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
14548102|NCT00000867|Memantine|memantine|mesh-list
14548103|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14548104|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14548105|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
14548106|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14548107|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548108|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548109|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14548110|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14548111|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14548112|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14548113|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
14548114|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548115|NCT00000868|Antacids|antacids|mesh-ancestor
14548116|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548117|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14548118|NCT00000869|Nevirapine|nevirapine|mesh-list
14548119|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548120|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548121|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548122|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548123|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
14548124|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548125|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548126|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548127|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548128|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548129|NCT00000870|Lamivudine|lamivudine|mesh-list
14548130|NCT00000870|Zidovudine|zidovudine|mesh-list
14548131|NCT00000870|Stavudine|stavudine|mesh-list
14548132|NCT00000870|Didanosine|didanosine|mesh-list
14548133|NCT00000870|Aldesleukin|aldesleukin|mesh-list
14548134|NCT00000870|Indinavir|indinavir|mesh-list
14548135|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548136|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548137|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548138|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548139|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
14548140|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548141|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548142|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14267791|NCT00392223|Azithromycin|azithromycin|mesh-list
14267792|NCT00392223|Minocycline|minocycline|mesh-list
14267793|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548143|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
14548144|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548145|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548146|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548147|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548148|NCT00000872|Lamivudine|lamivudine|mesh-list
14548149|NCT00000872|Zidovudine|zidovudine|mesh-list
14548150|NCT00000872|Nevirapine|nevirapine|mesh-list
14267794|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548151|NCT00000872|Abacavir|abacavir|mesh-list
14548152|NCT00000872|Stavudine|stavudine|mesh-list
14548153|NCT00000872|Nelfinavir|nelfinavir|mesh-list
14548154|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548155|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548156|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548157|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548158|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
14548159|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548160|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548161|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548162|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
14548163|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548164|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548165|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548166|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548167|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548168|NCT00000875|Acetaminophen|acetaminophen|mesh-list
14267795|NCT00392288|Ciclesonide|ciclesonide|mesh-list
14267796|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
14267797|NCT00392288|Hormones|hormones|mesh-ancestor
14267798|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14267799|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267800|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14267801|NCT00392379|Nicotine|nicotine|mesh-list
14267802|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14267803|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
14267804|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267805|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267806|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14267807|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14267808|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
14267809|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14548169|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
14548170|NCT00000875|Promethazine|promethazine|mesh-list
14548171|NCT00000875|Lamivudine|lamivudine|mesh-list
14548172|NCT00000875|Zidovudine|zidovudine|mesh-list
14548173|NCT00000875|Aldesleukin|aldesleukin|mesh-list
14548174|NCT00000875|Indinavir|indinavir|mesh-list
14548175|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14548176|NCT00000875|Analgesics|analgesics|mesh-ancestor
14548177|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
14548178|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14548179|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548180|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
14548181|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548182|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548183|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548184|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548185|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
14548186|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548187|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548188|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548189|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
14548190|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548191|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14808552|NCT00827814|Dutasteride|dutasteride|mesh-list
14808553|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14808554|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14808555|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808556|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267810|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267811|NCT00392392|Paclitaxel|paclitaxel|mesh-list
14267812|NCT00392392|Bevacizumab|bevacizumab|mesh-list
14267813|NCT00392392|Trastuzumab|trastuzumab|mesh-list
14267814|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14267815|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267816|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267817|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267818|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267819|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267820|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267821|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14548192|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14548193|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808557|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
14548194|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
14548195|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
14548196|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
14548197|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
14548198|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14548199|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14548200|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
14548201|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
14548202|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085030|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085031|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15085032|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15085033|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
15085034|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
15085035|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085036|NCT02249702|Gemcitabine|gemcitabine|mesh-list
15085037|NCT02249702|Docetaxel|docetaxel|mesh-list
15085038|NCT02249702|Trabectedin|trabectedin|mesh-list
15085039|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15085040|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
15085041|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085042|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085043|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
15085044|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085045|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085046|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15085047|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
14267822|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15085048|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085049|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
15085050|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
15085051|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
15085052|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15085053|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
15085054|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
15085055|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15085056|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085057|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
15085058|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15085059|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085060|NCT02249871|Omeprazole|omeprazole|mesh-list
15085061|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15085062|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085063|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15085064|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085065|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085066|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
15085067|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15085068|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085069|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
15085070|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15085071|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15085072|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
15085073|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085074|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15085075|NCT02249910|Metformin|metformin|mesh-list
14548203|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14548204|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
14548205|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
15085076|NCT02249910|Digoxin|digoxin|mesh-list
14548206|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548207|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548208|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548209|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14548210|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
14548211|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548212|NCT00000877|Indinavir|indinavir|mesh-list
14548213|NCT00000877|Rifabutin|rifabutin|mesh-list
14548214|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548215|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548216|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548217|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548218|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548219|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548220|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548221|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
14548222|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548223|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548224|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14548225|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
14548226|NCT00000878|Lamivudine|lamivudine|mesh-list
14548227|NCT00000878|Zidovudine|zidovudine|mesh-list
14548228|NCT00000878|Stavudine|stavudine|mesh-list
14548229|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548230|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548231|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548232|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548233|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
14548234|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548235|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548236|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548237|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
14267823|NCT00392392|Growth Substances|growth substances|mesh-ancestor
14267824|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267825|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267826|NCT00392444|Sunitinib|sunitinib|mesh-list
14267827|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267828|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14548238|NCT00000880|Cyclosporine|cyclosporine|mesh-list
14548239|NCT00000880|Cyclosporins|cyclosporins|mesh-list
14548240|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548241|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548242|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14548243|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
14548244|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548245|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
14548246|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548247|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
14548248|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14548249|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14548250|NCT00000881|Cidofovir|cidofovir|mesh-list
14548251|NCT00000881|Probenecid|probenecid|mesh-list
14548252|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
14548253|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
14548254|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14548255|NCT00000881|Renal Agents|renal agents|mesh-ancestor
14548256|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
14548257|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548258|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548259|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548260|NCT00000882|Lamivudine|lamivudine|mesh-list
14548261|NCT00000882|Zidovudine|zidovudine|mesh-list
14548262|NCT00000882|Stavudine|stavudine|mesh-list
14548263|NCT00000882|Delavirdine|delavirdine|mesh-list
14548264|NCT00000882|Indinavir|indinavir|mesh-list
14548265|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548266|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548267|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548268|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548269|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
14548270|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548271|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548272|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548273|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
13996075|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14548274|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548275|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548276|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548277|NCT00000883|Azithromycin|azithromycin|mesh-list
14548278|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548279|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548280|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
14548281|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14548282|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
14548283|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548284|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14548285|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548286|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
14548287|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548288|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
14548289|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14548290|NCT00000884|Protective Agents|protective agents|mesh-ancestor
14548291|NCT00000885|Lamivudine|lamivudine|mesh-list
14548292|NCT00000885|Zidovudine|zidovudine|mesh-list
14548293|NCT00000885|Efavirenz|efavirenz|mesh-list
14548294|NCT00000885|Abacavir|abacavir|mesh-list
14548295|NCT00000885|Stavudine|stavudine|mesh-list
14548296|NCT00000885|Didanosine|didanosine|mesh-list
14548297|NCT00000885|Adefovir|adefovir|mesh-list
14548298|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14548299|NCT00000885|Nelfinavir|nelfinavir|mesh-list
14548300|NCT00000885|Indinavir|indinavir|mesh-list
14548301|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548302|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548303|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548304|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548305|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
14548306|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548307|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548308|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548309|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
14548310|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548311|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548312|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548313|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548314|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548315|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548316|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548317|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548318|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548319|NCT00000887|Lamivudine|lamivudine|mesh-list
14548320|NCT00000887|Zidovudine|zidovudine|mesh-list
14548321|NCT00000887|Nelfinavir|nelfinavir|mesh-list
14548322|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548323|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548324|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548325|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548326|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
14548327|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548328|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548329|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548330|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
14548331|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548332|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548333|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548334|NCT00000888|Ritonavir|ritonavir|mesh-list
14548335|NCT00000888|Lamivudine|lamivudine|mesh-list
14548336|NCT00000888|Zidovudine|zidovudine|mesh-list
14548337|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548338|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548339|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548340|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548341|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548342|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548343|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548344|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
14548345|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548346|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548347|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548348|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548349|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548350|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
14548351|NCT00000889|Aldesleukin|aldesleukin|mesh-list
14548352|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548353|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548354|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548355|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
14548356|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548357|NCT00000891|Ritonavir|ritonavir|mesh-list
14548358|NCT00000891|Saquinavir|saquinavir|mesh-list
14548359|NCT00000891|Lamivudine|lamivudine|mesh-list
14548360|NCT00000891|Zidovudine|zidovudine|mesh-list
14548361|NCT00000891|Stavudine|stavudine|mesh-list
14548362|NCT00000891|Didanosine|didanosine|mesh-list
14548363|NCT00000891|Delavirdine|delavirdine|mesh-list
14548364|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548365|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548366|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548367|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548368|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548369|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548370|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548371|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
14548372|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548373|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548374|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548375|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548376|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548377|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
14548378|NCT00000892|Ritonavir|ritonavir|mesh-list
14548379|NCT00000892|Nelfinavir|nelfinavir|mesh-list
14548380|NCT00000892|Saquinavir|saquinavir|mesh-list
14548381|NCT00000892|Delavirdine|delavirdine|mesh-list
14548382|NCT00000892|Adefovir|adefovir|mesh-list
14548383|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14548384|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548385|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548386|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548387|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548388|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548389|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548390|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548391|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
14548392|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548393|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548394|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548395|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548396|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548397|NCT00000893|Efavirenz|efavirenz|mesh-list
14548398|NCT00000893|Nelfinavir|nelfinavir|mesh-list
14548399|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548400|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548401|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548402|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548403|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
14548404|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548405|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548406|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548407|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548408|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548409|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548410|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548411|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548412|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548413|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548414|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548415|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548416|NCT00000894|Ganciclovir|ganciclovir|mesh-list
14548417|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14548418|NCT00000894|Cidofovir|cidofovir|mesh-list
14548419|NCT00000894|Probenecid|probenecid|mesh-list
14548420|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
14548421|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548422|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548423|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548424|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548425|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
14548426|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
14548427|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14548428|NCT00000894|Renal Agents|renal agents|mesh-ancestor
14548429|NCT00000895|Azithromycin|azithromycin|mesh-list
14548430|NCT00000895|Nevirapine|nevirapine|mesh-list
14548431|NCT00000895|Nelfinavir|nelfinavir|mesh-list
14548432|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548433|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548434|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14267829|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267830|NCT00392444|Growth Substances|growth substances|mesh-ancestor
14267831|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267832|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267833|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14548435|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548436|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548437|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548438|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
14548439|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548440|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548441|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548442|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548443|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548444|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548445|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548446|NCT00000896|Lamivudine|lamivudine|mesh-list
14548447|NCT00000896|Zidovudine|zidovudine|mesh-list
14548448|NCT00000896|Nevirapine|nevirapine|mesh-list
14548449|NCT00000896|Stavudine|stavudine|mesh-list
14548450|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14548451|NCT00000896|Indinavir|indinavir|mesh-list
14548452|NCT00000896|Interleukin-12|interleukin-12|mesh-list
14548453|NCT00000896|Sargramostim|sargramostim|mesh-list
14548454|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548455|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548456|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548457|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548458|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
14548459|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267834|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267835|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548460|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548461|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548462|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
14548463|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
14548464|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548465|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548466|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548467|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548468|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548469|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548470|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548471|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14548472|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14548473|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14548474|NCT00000896|Growth Substances|growth substances|mesh-ancestor
14548475|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14548476|NCT00000897|Zidovudine|zidovudine|mesh-list
14548477|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
14548478|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548479|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548480|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548481|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548482|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
14548483|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548484|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085077|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15085078|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085079|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15085080|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15085081|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085082|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085083|NCT02249910|Protective Agents|protective agents|mesh-ancestor
14548485|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548486|NCT00000898|Ritonavir|ritonavir|mesh-list
14548487|NCT00000898|Nelfinavir|nelfinavir|mesh-list
14548488|NCT00000898|Saquinavir|saquinavir|mesh-list
14548489|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548490|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548491|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085084|NCT02249936|Omeprazole|omeprazole|mesh-list
15085085|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14548492|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548493|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548494|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548495|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548496|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
14548497|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548498|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548499|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548500|NCT00000899|Lamivudine|lamivudine|mesh-list
14548501|NCT00000899|Stavudine|stavudine|mesh-list
14548502|NCT00000899|Nelfinavir|nelfinavir|mesh-list
14548503|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
14548504|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14548505|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
14548506|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548507|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14548508|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15085086|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085087|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15085088|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085089|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085090|NCT02250118|Bevacizumab|bevacizumab|mesh-list
15085091|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15085092|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085093|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15085094|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15085095|NCT02250118|Growth Substances|growth substances|mesh-ancestor
15085096|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085097|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
15085098|NCT02250209|Capecitabine|capecitabine|mesh-list
15085099|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
15085100|NCT02250209|Trastuzumab|trastuzumab|mesh-list
15085101|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15085102|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
15085103|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085104|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085105|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15085106|NCT02250300|Ixazomib|ixazomib|mesh-list
15085107|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085108|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085109|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085110|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172955|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172956|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172957|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
15172958|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15172959|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
15172960|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15172961|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15172962|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15172963|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172964|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15172965|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
15172966|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
15172967|NCT04008888|Dexamethasone|dexamethasone|mesh-list
15172968|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
15172969|NCT04008888|Fludarabine|fludarabine|mesh-list
15172970|NCT04008888|Melphalan|melphalan|mesh-list
15172971|NCT04008888|BB 1101|bb 1101|mesh-list
15172972|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172973|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
15172974|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
15172975|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172976|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172977|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15172978|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
15172979|NCT04008888|Hormones|hormones|mesh-ancestor
15172980|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172981|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15172982|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172983|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
15172984|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548509|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
14643288|NCT00188942|Fluoxetine|fluoxetine|mesh-list
15172985|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548510|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548511|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548512|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14548513|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548514|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548515|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548516|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
14548517|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548518|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548519|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548520|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
14548521|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548522|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548523|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548524|NCT00000901|Lamivudine|lamivudine|mesh-list
14548525|NCT00000901|Stavudine|stavudine|mesh-list
14548526|NCT00000901|Indinavir|indinavir|mesh-list
14548527|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548528|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548529|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548530|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548531|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
14548532|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548533|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548534|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548535|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
14548536|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548537|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548538|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548539|NCT00000902|Ritonavir|ritonavir|mesh-list
14548540|NCT00000902|Nelfinavir|nelfinavir|mesh-list
14548541|NCT00000902|Lamivudine|lamivudine|mesh-list
14548542|NCT00000902|Zidovudine|zidovudine|mesh-list
14548543|NCT00000902|Nevirapine|nevirapine|mesh-list
14548544|NCT00000902|Stavudine|stavudine|mesh-list
14548545|NCT00000902|Didanosine|didanosine|mesh-list
14548546|NCT00000902|Zalcitabine|zalcitabine|mesh-list
14548547|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548548|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548549|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548550|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085111|NCT02250482|Factor VIII|factor viii|mesh-list
15085112|NCT02250482|Coagulants|coagulants|mesh-ancestor
15085113|NCT02250508|Factor VIII|factor viii|mesh-list
14548551|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548552|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548553|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548554|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
14548555|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548556|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548557|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548558|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548559|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548560|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
14548561|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548562|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548563|NCT00000903|Lamivudine|lamivudine|mesh-list
14548564|NCT00000903|Zidovudine|zidovudine|mesh-list
14548565|NCT00000903|Efavirenz|efavirenz|mesh-list
14548566|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14548567|NCT00000903|Nelfinavir|nelfinavir|mesh-list
14548568|NCT00000903|Indinavir|indinavir|mesh-list
14548569|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548570|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548571|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548572|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548573|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
14548574|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548575|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548576|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548577|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
14548578|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14808558|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808559|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808560|NCT00827840|Risperidone|risperidone|mesh-list
15085114|NCT02250508|Coagulants|coagulants|mesh-ancestor
14548579|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14643289|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
14548580|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548581|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548582|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548583|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548584|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548585|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548586|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548587|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
14548588|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14548589|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
14548590|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548591|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14548592|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548593|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
14548594|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548595|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
14548596|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14548597|NCT00000904|Protective Agents|protective agents|mesh-ancestor
14548598|NCT00000906|Ritonavir|ritonavir|mesh-list
14548599|NCT00000906|Saquinavir|saquinavir|mesh-list
14548600|NCT00000906|Methadone|methadone|mesh-list
14548601|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548602|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548603|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548604|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548605|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548606|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548607|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548608|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
14548609|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548610|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548611|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548612|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14548613|NCT00000906|Narcotics|narcotics|mesh-ancestor
14548614|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14548615|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548616|NCT00000906|Analgesics|analgesics|mesh-ancestor
14548617|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
14548618|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14548619|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
14548620|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
14548621|NCT00000909|Aldesleukin|aldesleukin|mesh-list
14548622|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548623|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548624|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548625|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
14548626|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548627|NCT00000912|Efavirenz|efavirenz|mesh-list
14548628|NCT00000912|Abacavir|abacavir|mesh-list
14548629|NCT00000912|Adefovir|adefovir|mesh-list
14548630|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14548631|NCT00000912|Nelfinavir|nelfinavir|mesh-list
14548632|NCT00000912|Indinavir|indinavir|mesh-list
14548633|NCT00000912|Saquinavir|saquinavir|mesh-list
14548634|NCT00000912|Amprenavir|amprenavir|mesh-list
14548635|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548636|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548637|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548638|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548639|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
14548640|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548641|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548642|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548643|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548644|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548645|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548646|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548647|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548648|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548649|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548650|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548651|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548652|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548653|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14808561|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15085115|NCT02250534|Nicotine|nicotine|mesh-list
15085116|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15085117|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
15085118|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085119|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085120|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15085121|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15085122|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
15085123|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085124|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085125|NCT02250599|Paclitaxel|paclitaxel|mesh-list
15085126|NCT02250599|Bevacizumab|bevacizumab|mesh-list
15085127|NCT02250599|Carboplatin|carboplatin|mesh-list
15085128|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15085129|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085130|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
15085131|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
15085132|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
15085133|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085134|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15085135|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15085136|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15085137|NCT02250599|Growth Substances|growth substances|mesh-ancestor
15085138|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085139|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
15085140|NCT02250664|Nicotine|nicotine|mesh-list
15085141|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15085142|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
15085143|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085144|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085145|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15085146|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15085147|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
15085148|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085149|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085150|NCT02250729|Pholcodine|pholcodine|mesh-list
15085151|NCT02250729|Analgesics|analgesics|mesh-ancestor
15085152|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
15085153|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085154|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085155|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
15085156|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085157|NCT02250781|TIC10 compound|tic10 compound|mesh-list
15085158|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085159|NCT02250794|Insulin|insulin|mesh-list
15085160|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14267836|NCT00392496|Sunitinib|sunitinib|mesh-list
15085161|NCT02250794|Metformin|metformin|mesh-list
15085162|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
15085163|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15085164|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
15085165|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15085166|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085167|NCT02250794|Incretins|incretins|mesh-ancestor
15085168|NCT02250794|Hormones|hormones|mesh-ancestor
15085169|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15085170|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15085171|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085172|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085173|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085174|NCT02250820|Pentobarbital|pentobarbital|mesh-list
15085175|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
15085176|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15085177|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085178|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085179|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085180|NCT02250820|Analgesics|analgesics|mesh-ancestor
15085181|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
15085182|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085183|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15085184|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15085185|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15085186|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
15085187|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14267837|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085188|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548654|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
14548655|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548656|NCT00000913|Ritonavir|ritonavir|mesh-list
14548657|NCT00000913|Nelfinavir|nelfinavir|mesh-list
14548658|NCT00000913|Saquinavir|saquinavir|mesh-list
14548659|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548660|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548661|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548662|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548663|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548664|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548665|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548666|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
14548667|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548668|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548669|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548670|NCT00000914|Ritonavir|ritonavir|mesh-list
14548671|NCT00000914|Nelfinavir|nelfinavir|mesh-list
14548672|NCT00000914|Indinavir|indinavir|mesh-list
14548673|NCT00000914|Efavirenz|efavirenz|mesh-list
14548674|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548675|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548676|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548677|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548678|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548679|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548680|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548681|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
14548682|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548683|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548684|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548685|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548686|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548687|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548688|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548689|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548690|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548691|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548692|NCT00000916|Lamivudine|lamivudine|mesh-list
14548693|NCT00000916|Zidovudine|zidovudine|mesh-list
14548694|NCT00000916|Stavudine|stavudine|mesh-list
14548695|NCT00000916|Didanosine|didanosine|mesh-list
14548696|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14548697|NCT00000916|Indinavir|indinavir|mesh-list
14548698|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
14548699|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548700|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548701|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548702|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548703|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
14548704|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548705|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548706|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548707|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
14548708|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548709|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
14548710|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548711|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548712|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548713|NCT00000918|Ritonavir|ritonavir|mesh-list
14548714|NCT00000918|Indinavir|indinavir|mesh-list
14548715|NCT00000918|Saquinavir|saquinavir|mesh-list
14548716|NCT00000918|Amprenavir|amprenavir|mesh-list
14548717|NCT00000918|Lamivudine|lamivudine|mesh-list
14548718|NCT00000918|Zidovudine|zidovudine|mesh-list
14548719|NCT00000918|Stavudine|stavudine|mesh-list
14548720|NCT00000918|Didanosine|didanosine|mesh-list
14548721|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14548722|NCT00000918|Efavirenz|efavirenz|mesh-list
14548723|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548724|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548725|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548726|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548727|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996076|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14548728|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548729|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548730|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
14548731|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548732|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548733|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548734|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548735|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548736|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
14548737|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548738|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548739|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548740|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548741|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15085189|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15085190|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
15085191|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
15085192|NCT02250833|Amlodipine|amlodipine|mesh-list
15085193|NCT02250833|Telmisartan|telmisartan|mesh-list
15085194|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15085195|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15085196|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15085197|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085198|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15085199|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548742|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14548743|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
14548744|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548745|NCT00000919|Ritonavir|ritonavir|mesh-list
14548746|NCT00000919|Nelfinavir|nelfinavir|mesh-list
14548747|NCT00000919|Indinavir|indinavir|mesh-list
14548748|NCT00000919|Amprenavir|amprenavir|mesh-list
14548749|NCT00000919|Lamivudine|lamivudine|mesh-list
14548750|NCT00000919|Zidovudine|zidovudine|mesh-list
14548751|NCT00000919|Abacavir|abacavir|mesh-list
14548752|NCT00000919|Stavudine|stavudine|mesh-list
14548753|NCT00000919|Didanosine|didanosine|mesh-list
14548754|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14548755|NCT00000919|Efavirenz|efavirenz|mesh-list
14548756|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
14548757|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548758|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548759|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548760|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548761|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548762|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548763|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085200|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
15085201|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15085202|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15085203|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15085204|NCT02250859|Minocycline|minocycline|mesh-list
15085205|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085206|NCT02250872|Cisplatin|cisplatin|mesh-list
15085207|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548764|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
14548765|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548766|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548767|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548768|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548769|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548770|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
14548771|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548772|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548773|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548774|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548775|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548776|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548777|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
14548778|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14548779|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
14548780|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548781|NCT00000920|Ritonavir|ritonavir|mesh-list
14548782|NCT00000920|Saquinavir|saquinavir|mesh-list
14548783|NCT00000920|Lamivudine|lamivudine|mesh-list
14548784|NCT00000920|Zidovudine|zidovudine|mesh-list
15085208|NCT02250924|Caffeine|caffeine|mesh-list
14548785|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548786|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548787|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548788|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548789|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548790|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548791|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548792|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
14548793|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548794|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548795|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548796|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548797|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548798|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
14548799|NCT00000921|Prednisone|prednisone|mesh-list
14548800|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14548801|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
14548802|NCT00000921|Hormones|hormones|mesh-ancestor
14548803|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14548804|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548805|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14548806|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548807|NCT00000922|Lamivudine|lamivudine|mesh-list
14548808|NCT00000922|Efavirenz|efavirenz|mesh-list
14548809|NCT00000922|Nevirapine|nevirapine|mesh-list
14548810|NCT00000922|Abacavir|abacavir|mesh-list
14548811|NCT00000922|Stavudine|stavudine|mesh-list
14548812|NCT00000922|Didanosine|didanosine|mesh-list
14548813|NCT00000922|Nelfinavir|nelfinavir|mesh-list
14548814|NCT00000922|Indinavir|indinavir|mesh-list
14548815|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548816|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548817|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548818|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548819|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
14548820|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548821|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548822|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548823|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548824|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548825|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548826|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548827|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548828|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548829|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
14548830|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548831|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548832|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548833|NCT00000923|Lamivudine|lamivudine|mesh-list
14548834|NCT00000923|Zidovudine|zidovudine|mesh-list
14548835|NCT00000923|Stavudine|stavudine|mesh-list
14548836|NCT00000923|Didanosine|didanosine|mesh-list
14548837|NCT00000923|Aldesleukin|aldesleukin|mesh-list
14548838|NCT00000923|Indinavir|indinavir|mesh-list
14267838|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267839|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267840|NCT00392496|Growth Substances|growth substances|mesh-ancestor
14267841|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267842|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267843|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267844|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267845|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267846|NCT00392665|Sulindac|sulindac|mesh-list
14267847|NCT00392665|Bevacizumab|bevacizumab|mesh-list
14267848|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14267849|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267850|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267851|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267852|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267853|NCT00392665|Growth Substances|growth substances|mesh-ancestor
14267854|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267855|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
14267856|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267857|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548839|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548840|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548841|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548842|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548843|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
14548844|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548845|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548846|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548847|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
14548848|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548849|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548850|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548851|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548852|NCT00000924|Ritonavir|ritonavir|mesh-list
14548853|NCT00000924|Nelfinavir|nelfinavir|mesh-list
14548854|NCT00000924|Nevirapine|nevirapine|mesh-list
14548855|NCT00000924|Stavudine|stavudine|mesh-list
14548856|NCT00000924|Didanosine|didanosine|mesh-list
14548857|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548858|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548859|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548860|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548861|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548862|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548863|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548864|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
14548865|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548866|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548867|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548868|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548869|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548870|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548871|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548872|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
14548873|NCT00000926|Nonoxynol|nonoxynol|mesh-list
14548874|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14548875|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14548876|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548877|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14548878|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
14548879|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14548880|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14548881|NCT00000929|Nonoxynol|nonoxynol|mesh-list
14548882|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14548883|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14548884|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548885|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15085209|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15085210|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085211|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15085212|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085213|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085214|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15085215|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15085216|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
15085217|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085218|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
15085219|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085220|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
15085221|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
15085222|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
15085223|NCT02251041|Tocopherols|tocopherols|mesh-list
15085224|NCT02251041|Vitamin E|vitamin e|mesh-list
15085225|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
15085226|NCT02251041|Infliximab|infliximab|mesh-list
15085227|NCT02251041|Epoprostenol|epoprostenol|mesh-list
15085228|NCT02251041|Tezosentan|tezosentan|mesh-list
15085229|NCT02251041|Melatonin|melatonin|mesh-list
15085230|NCT02251041|Antithrombins|antithrombins|mesh-list
15085231|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
14548886|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
14548887|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15085232|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
14548888|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14643290|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
14643291|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643292|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643293|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14643294|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14808562|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14808563|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
14808564|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808565|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808566|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808567|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14808568|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14808569|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808570|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808571|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14808572|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
14808573|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14808574|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14808575|NCT00827892|Pioglitazone|pioglitazone|mesh-list
14808576|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14808577|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808578|NCT00827996|Adalimumab|adalimumab|mesh-list
14808579|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808580|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808581|NCT00828087|Cobalt|cobalt|mesh-list
14808582|NCT00828087|Chromium|chromium|mesh-list
14808583|NCT00828087|Everolimus|everolimus|mesh-list
14808584|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808585|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14808586|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
14808587|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808588|NCT00828087|Trace Elements|trace elements|mesh-ancestor
14808589|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
14808590|NCT00828230|Budesonide|budesonide|mesh-list
14808591|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808592|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14808593|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
14808594|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808595|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808596|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14808597|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
14808598|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
14808599|NCT00828230|Hormones|hormones|mesh-ancestor
14808600|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808601|NCT00828282|Simvastatin|simvastatin|mesh-list
14808602|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14808603|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14808604|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
14808605|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808606|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14808607|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14808608|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808609|NCT00828373|Lidocaine|lidocaine|mesh-list
14808610|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
14808611|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
14808612|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808613|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808614|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
14808615|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808616|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14808617|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14808618|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14808619|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808620|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643295|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14643296|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14643297|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643298|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14643299|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643300|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643301|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643302|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14548889|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
14548890|NCT00000935|Antibodies|antibodies|mesh-list
14548891|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
14548892|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14548893|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14548894|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
14548895|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548896|NCT00000936|Cyclosporine|cyclosporine|mesh-list
14548897|NCT00000936|Cyclosporins|cyclosporins|mesh-list
14548898|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548899|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548900|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14548901|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
14548902|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548903|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
14548904|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548905|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
14548906|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14548907|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14548908|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14548909|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548910|NCT00000938|Doxycycline|doxycycline|mesh-list
14548911|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
14548912|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548913|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548914|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
14548915|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14548916|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14548917|NCT00000939|Efavirenz|efavirenz|mesh-list
14548918|NCT00000939|Stavudine|stavudine|mesh-list
14548919|NCT00000939|Didanosine|didanosine|mesh-list
14548920|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
14548921|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548922|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548923|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548924|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548925|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
14548926|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548927|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14548928|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548929|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14548930|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14548931|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548932|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548933|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14548934|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
14548935|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
14548936|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548937|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548938|NCT00000940|Ritonavir|ritonavir|mesh-list
14548939|NCT00000940|Amprenavir|amprenavir|mesh-list
14267858|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267859|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14267860|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14267861|NCT00392665|Analgesics|analgesics|mesh-ancestor
14267862|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
14267863|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267864|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14267865|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14267866|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14548940|NCT00000940|Lamivudine|lamivudine|mesh-list
14548941|NCT00000940|Abacavir|abacavir|mesh-list
14548942|NCT00000940|Stavudine|stavudine|mesh-list
14548943|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548944|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548945|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548946|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548947|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548948|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548949|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548950|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
14548951|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548952|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548953|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548954|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548955|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548956|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
14548957|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14548958|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
14548959|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14548960|NCT00000941|Ritonavir|ritonavir|mesh-list
14548961|NCT00000941|Nelfinavir|nelfinavir|mesh-list
14548962|NCT00000941|Saquinavir|saquinavir|mesh-list
14548963|NCT00000941|Atorvastatin|atorvastatin|mesh-list
14548964|NCT00000941|Simvastatin|simvastatin|mesh-list
14548965|NCT00000941|Pravastatin|pravastatin|mesh-list
14548966|NCT00000941|Calcium|calcium|mesh-list
14548967|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14548968|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548969|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14548970|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14548971|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
14548972|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548973|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14548974|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14548975|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548976|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14548977|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14548978|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
14548979|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548980|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548981|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
14548982|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548983|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14548984|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14548985|NCT00000942|Nevirapine|nevirapine|mesh-list
14548986|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14548987|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14548988|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14548989|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14548990|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
14548991|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14548992|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14548993|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14548994|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14548995|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14548996|NCT00000943|Vaccines|vaccines|mesh-list
14548997|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
14548998|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14548999|NCT00000944|Lamivudine|lamivudine|mesh-list
14549000|NCT00000944|Zidovudine|zidovudine|mesh-list
14549001|NCT00000944|Indinavir|indinavir|mesh-list
14549002|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549003|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549004|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549005|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549006|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
14549007|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549008|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549009|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549010|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
14549011|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14549012|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14549013|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14549014|NCT00000945|Cidofovir|cidofovir|mesh-list
14549015|NCT00000945|Probenecid|probenecid|mesh-list
14549016|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
14549017|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
14549018|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14549019|NCT00000945|Renal Agents|renal agents|mesh-ancestor
14549020|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
14549021|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549022|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549023|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549024|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
14549025|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14549026|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
14549027|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549028|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14549029|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549030|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
14549031|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549032|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
14549033|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14549034|NCT00000946|Protective Agents|protective agents|mesh-ancestor
14549035|NCT00000947|Azithromycin|azithromycin|mesh-list
14549036|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549037|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549038|NCT00000948|Aldesleukin|aldesleukin|mesh-list
14549039|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549040|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549041|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549042|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
14549043|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549044|NCT00000949|Aldesleukin|aldesleukin|mesh-list
14549045|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549046|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549047|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549048|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
14549049|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549050|NCT00000950|Pyridoxine|pyridoxine|mesh-list
14549051|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
14549052|NCT00000950|Rifampin|rifampin|mesh-list
14549053|NCT00000950|Isoniazid|isoniazid|mesh-list
14549054|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
14549055|NCT00000950|Ethambutol|ethambutol|mesh-list
14549056|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14549057|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
14549058|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549059|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549060|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
14549061|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549062|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549063|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549064|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14549065|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14549066|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14549067|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14549068|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14549069|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14549070|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14549071|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14549072|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
14549073|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14549074|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549075|NCT00000950|Vitamins|vitamins|mesh-ancestor
14549076|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
14549077|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549078|NCT00000951|Fluconazole|fluconazole|mesh-list
14549079|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
14549080|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549081|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14549082|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549083|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549084|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549085|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14549086|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
14549087|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14549088|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549089|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14549090|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14549091|NCT00000952|Ritonavir|ritonavir|mesh-list
14549092|NCT00000952|Lamivudine|lamivudine|mesh-list
14549093|NCT00000952|Zidovudine|zidovudine|mesh-list
14549094|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14549095|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14549096|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
14549097|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549098|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549099|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549100|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549101|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
14549102|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549103|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14643303|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
14549104|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549105|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549106|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549107|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
14549108|NCT00000953|Acyclovir|acyclovir|mesh-list
14549109|NCT00000953|Sorivudine|sorivudine|mesh-list
14549110|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
14549111|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549112|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549113|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549114|NCT00000954|Didanosine|didanosine|mesh-list
14549115|NCT00000954|Zalcitabine|zalcitabine|mesh-list
14549116|NCT00000954|Doxorubicin|doxorubicin|mesh-list
14267867|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14549117|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14549118|NCT00000954|Bleomycin|bleomycin|mesh-list
14549119|NCT00000954|Vincristine|vincristine|mesh-list
14549120|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14549121|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549122|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14549123|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14549124|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549125|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549126|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14549127|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
14549128|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14549129|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14549130|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
14549131|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15085233|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
15085234|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085235|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085236|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
15085237|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085238|NCT02251041|Protective Agents|protective agents|mesh-ancestor
15085239|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085240|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085241|NCT02251041|Hematinics|hematinics|mesh-ancestor
15085242|NCT02251041|Vitamins|vitamins|mesh-ancestor
15085243|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
15085244|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15085245|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085246|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549132|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549133|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
14549134|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549135|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549136|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549137|NCT00000959|Pyridoxine|pyridoxine|mesh-list
14549138|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
14549139|NCT00000959|Isoniazid|isoniazid|mesh-list
14549140|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
14549141|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549142|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549143|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14549144|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14549145|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
14549146|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549147|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14549148|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549149|NCT00000959|Vitamins|vitamins|mesh-ancestor
14549150|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
14549151|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549152|NCT00000960|Zidovudine|zidovudine|mesh-list
14549153|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
14549154|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549155|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549156|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549157|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549158|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
14549159|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549160|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549161|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549162|NCT00000961|Zidovudine|zidovudine|mesh-list
14549163|NCT00000961|Immune Sera|immune sera|mesh-list
14549164|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
14549165|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549166|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549167|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549168|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549169|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
14549170|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549171|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549172|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549173|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
14549174|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549175|NCT00000962|Nevirapine|nevirapine|mesh-list
14549176|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14267868|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
14267869|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14549177|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549178|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549179|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549180|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
14549181|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549182|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549183|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549184|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14549185|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14549186|NCT00000963|Didanosine|didanosine|mesh-list
14549187|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
14549188|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549189|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549190|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549191|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549192|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
14549193|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549194|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549195|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549196|NCT00000964|Foscarnet|foscarnet|mesh-list
14549197|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14549198|NCT00000964|Ranitidine|ranitidine|mesh-list
14549199|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14549200|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14549201|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14549202|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14549203|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
14549204|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
14549205|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14549206|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549207|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549208|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
14549209|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549210|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549211|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549212|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549213|NCT00000965|Zidovudine|zidovudine|mesh-list
14549214|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
14549215|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549216|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549217|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549218|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549219|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
14549220|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549221|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549222|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549223|NCT00000966|Leucovorin|leucovorin|mesh-list
14549224|NCT00000966|Azithromycin|azithromycin|mesh-list
14549225|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
14549226|NCT00000966|Calcium|calcium|mesh-list
14549227|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
14549228|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14549229|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549230|NCT00000966|Antidotes|antidotes|mesh-ancestor
14549231|NCT00000966|Protective Agents|protective agents|mesh-ancestor
14549232|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549233|NCT00000966|Vitamins|vitamins|mesh-ancestor
14549234|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
14549235|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549236|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549237|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
14549238|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549239|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549240|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14549241|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549242|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549243|NCT00000967|Interferons|interferons|mesh-list
14549244|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
14549245|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
14549246|NCT00000967|Zidovudine|zidovudine|mesh-list
14549247|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549248|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
14549249|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549250|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
14549251|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549252|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
14549253|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549254|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549255|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549256|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549257|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549258|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549259|NCT00000969|Didanosine|didanosine|mesh-list
14549260|NCT00000969|Zalcitabine|zalcitabine|mesh-list
14549261|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
14549262|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549263|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549264|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549265|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549266|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
14549267|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549268|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549269|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549270|NCT00000970|Ganciclovir|ganciclovir|mesh-list
14549271|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14549272|NCT00000970|Foscarnet|foscarnet|mesh-list
14549273|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14549274|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
14549275|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549276|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549277|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549278|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549279|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549280|NCT00000971|Zidovudine|zidovudine|mesh-list
14549281|NCT00000971|Didanosine|didanosine|mesh-list
14549282|NCT00000971|Clarithromycin|clarithromycin|mesh-list
14549283|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
14549284|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549285|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549286|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549287|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549288|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
14549289|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549290|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549291|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549292|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549293|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14549294|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14549295|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549296|NCT00000973|Leucovorin|leucovorin|mesh-list
14549297|NCT00000973|Zidovudine|zidovudine|mesh-list
14549298|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
14549299|NCT00000973|Calcium|calcium|mesh-list
14549300|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
14549301|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14549302|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549303|NCT00000973|Antidotes|antidotes|mesh-ancestor
14549304|NCT00000973|Protective Agents|protective agents|mesh-ancestor
14549305|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549306|NCT00000973|Vitamins|vitamins|mesh-ancestor
14549307|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
14549308|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
15085247|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
14549309|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549310|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549311|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549312|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549313|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
14549314|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549315|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549316|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549317|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
14549318|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549319|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15085248|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15085249|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15085250|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
15085251|NCT02251119|Ritonavir|ritonavir|mesh-list
15085252|NCT02251119|Tipranavir|tipranavir|mesh-list
15085253|NCT02251119|Loperamide|loperamide|mesh-list
15085254|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
15085255|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085256|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085257|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085258|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085259|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085260|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085261|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085262|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
15085263|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085264|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085265|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085266|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085267|NCT02251132|Ritonavir|ritonavir|mesh-list
15085268|NCT02251132|Erythromycin|erythromycin|mesh-list
15085269|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
15085270|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15085271|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
15085272|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085273|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085274|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085275|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085276|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085277|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085278|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085279|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
15085280|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085281|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085282|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085283|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15085284|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085285|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15085286|NCT02251145|Ritonavir|ritonavir|mesh-list
15085287|NCT02251145|Tenofovir|tenofovir|mesh-list
15085288|NCT02251145|Tipranavir|tipranavir|mesh-list
15085289|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085290|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085291|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085292|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085293|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085294|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085295|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085296|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
15085297|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085298|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085299|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085300|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15085301|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15085302|NCT02251158|Ritonavir|ritonavir|mesh-list
15085303|NCT02251158|Tipranavir|tipranavir|mesh-list
15085304|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15085305|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085306|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085307|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085308|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085309|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085310|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085311|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085312|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
15085313|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085314|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085315|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549320|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15085316|NCT02251171|Ritonavir|ritonavir|mesh-list
15085317|NCT02251171|Tipranavir|tipranavir|mesh-list
15085318|NCT02251171|Rifabutin|rifabutin|mesh-list
15085319|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085320|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085321|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085322|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085323|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085324|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549321|NCT00000974|Pentamidine|pentamidine|mesh-list
14549322|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
14549323|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549324|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549325|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549326|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14549327|NCT00000975|Itraconazole|itraconazole|mesh-list
14549328|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
14549329|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549330|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14549331|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549332|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549333|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549334|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14549335|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
14549336|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14549337|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549338|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14549339|NCT00000976|Zidovudine|zidovudine|mesh-list
14549340|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14549341|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
14549342|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549343|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549344|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549345|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549346|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
14549347|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549348|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549349|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549350|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
14549351|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549352|NCT00000978|Zidovudine|zidovudine|mesh-list
14549353|NCT00000978|Zalcitabine|zalcitabine|mesh-list
14549354|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
14549355|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549356|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549357|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549358|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549359|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
14549360|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549361|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14808621|NCT00828477|Nepafenac|nepafenac|mesh-list
14808622|NCT00828477|Bromfenac|bromfenac|mesh-list
14808623|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14808624|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14808625|NCT00828477|Analgesics|analgesics|mesh-ancestor
14808626|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
14808627|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808628|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808629|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808630|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808631|NCT00828503|Valganciclovir|valganciclovir|mesh-list
14808632|NCT00828503|Everolimus|everolimus|mesh-list
14808633|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808634|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14808635|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
14808636|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808637|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
14808638|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808639|NCT00828529|Bedaquiline|bedaquiline|mesh-list
14808640|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
14808641|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14808642|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085325|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085326|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
15085327|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549362|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14808643|NCT00828555|Vaccines|vaccines|mesh-list
15085328|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14549363|NCT00000979|Zidovudine|zidovudine|mesh-list
14549364|NCT00000979|Didanosine|didanosine|mesh-list
14549365|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
14549366|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549367|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549368|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549369|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267870|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14267871|NCT00392678|Analgesics|analgesics|mesh-ancestor
14267872|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
14267873|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267874|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267875|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14267876|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14267877|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14267878|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549370|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
14549371|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549372|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549373|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549374|NCT00000980|Spiramycin|spiramycin|mesh-list
14549375|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549376|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549377|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
14549378|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549379|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549380|NCT00000981|Fiacitabine|fiacitabine|mesh-list
14549381|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549382|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
14549383|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549384|NCT00000982|Zidovudine|zidovudine|mesh-list
14549385|NCT00000982|Didanosine|didanosine|mesh-list
14549386|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
14549387|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549388|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549389|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549390|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549391|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
14549392|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549393|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549394|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549395|NCT00000983|Zidovudine|zidovudine|mesh-list
14549396|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
14549397|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549398|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549399|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549400|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549401|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
14549402|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549403|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549404|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549405|NCT00000985|Acyclovir|acyclovir|mesh-list
14549406|NCT00000985|Foscarnet|foscarnet|mesh-list
14549407|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14549408|NCT00000985|Vidarabine|vidarabine|mesh-list
14549409|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
14549410|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549411|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549412|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549413|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549414|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549415|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
14549416|NCT00000986|Zidovudine|zidovudine|mesh-list
14549417|NCT00000986|Aldesleukin|aldesleukin|mesh-list
14549418|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
14549419|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549420|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549421|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549422|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549423|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
14549424|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549425|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549426|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085329|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549427|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549428|NCT00000987|Zidovudine|zidovudine|mesh-list
14549429|NCT00000987|Doxorubicin|doxorubicin|mesh-list
14549430|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14549431|NCT00000987|Bleomycin|bleomycin|mesh-list
14549432|NCT00000987|Vincristine|vincristine|mesh-list
14549433|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14549434|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549435|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14549436|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14549437|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549438|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549439|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14549440|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
14549441|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
14549442|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
14549443|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
14549444|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549445|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549446|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
14549447|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549448|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549449|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549450|NCT00000988|Stavudine|stavudine|mesh-list
14549451|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
14549452|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549453|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549454|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549455|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549456|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
14549457|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549458|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549459|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549460|NCT00000989|Zidovudine|zidovudine|mesh-list
14549461|NCT00000989|Ganciclovir|ganciclovir|mesh-list
14549462|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14549463|NCT00000989|Sargramostim|sargramostim|mesh-list
14549464|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
14549465|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549466|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549467|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549468|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549469|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
14549470|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549471|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549472|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549473|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
14549474|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549475|NCT00000990|Zidovudine|zidovudine|mesh-list
14549476|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
14549477|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549478|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549479|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549480|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549481|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
14549482|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549483|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14267879|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267880|NCT00392704|Paclitaxel|paclitaxel|mesh-list
14267881|NCT00392704|Bevacizumab|bevacizumab|mesh-list
14267882|NCT00392704|Fluorouracil|fluorouracil|mesh-list
14267883|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14267884|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14267885|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267886|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267887|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267888|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267889|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267890|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267891|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14267892|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14267893|NCT00392704|Growth Substances|growth substances|mesh-ancestor
14267894|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549484|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549485|NCT00000991|Zidovudine|zidovudine|mesh-list
14267895|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14549486|NCT00000991|Trimethoprim|trimethoprim|mesh-list
14549487|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
14549488|NCT00000991|Dapsone|dapsone|mesh-list
14549489|NCT00000991|Pentamidine|pentamidine|mesh-list
14549490|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14549491|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
14549492|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549493|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549494|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549495|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549496|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
14549497|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549498|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549499|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549500|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14549501|NCT00000991|Renal Agents|renal agents|mesh-ancestor
14549502|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
14549503|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549504|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549505|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14549506|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14549507|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14549508|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549509|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
14549510|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549511|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
14549512|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14549513|NCT00000992|Itraconazole|itraconazole|mesh-list
14549514|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
14549515|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549516|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14549517|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549518|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549519|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549520|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14549521|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
14549522|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14549523|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549524|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14549525|NCT00000993|Zidovudine|zidovudine|mesh-list
14549526|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
14549527|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549528|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549529|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549530|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549531|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
14549532|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549533|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549534|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549535|NCT00000994|Zidovudine|zidovudine|mesh-list
14549536|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
14549537|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549538|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549539|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549540|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549541|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
14549542|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549543|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549544|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549545|NCT00000995|Zidovudine|zidovudine|mesh-list
14549546|NCT00000995|Ganciclovir|ganciclovir|mesh-list
14549547|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14549548|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
14549549|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549550|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549551|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549552|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549553|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
14549554|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549555|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549556|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549557|NCT00000996|Doxorubicin|doxorubicin|mesh-list
14549558|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14549559|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15085330|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549560|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549561|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14549562|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14549563|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549564|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549565|NCT00000997|Zalcitabine|zalcitabine|mesh-list
14549566|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
14549567|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549568|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549569|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549570|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549571|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
14549572|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549573|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549574|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549575|NCT00000998|Leucovorin|leucovorin|mesh-list
14549576|NCT00000998|Trimetrexate|trimetrexate|mesh-list
14549577|NCT00000998|Calcium|calcium|mesh-list
14549578|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
14549579|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14549580|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549581|NCT00000998|Antidotes|antidotes|mesh-ancestor
14549582|NCT00000998|Protective Agents|protective agents|mesh-ancestor
14549583|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549584|NCT00000998|Vitamins|vitamins|mesh-ancestor
14549585|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
14549586|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
14549587|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549588|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14549589|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
14549590|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549591|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549592|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14549593|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549594|NCT00000999|Zidovudine|zidovudine|mesh-list
14549595|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
14549596|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549597|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549598|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549599|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549600|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
14549601|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549602|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549603|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549604|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14549605|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
14549606|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549607|NCT00001001|Zidovudine|zidovudine|mesh-list
14549608|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
14549609|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549610|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549611|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549612|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549613|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
14549614|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549615|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549616|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549617|NCT00001002|Zidovudine|zidovudine|mesh-list
14549618|NCT00001002|Foscarnet|foscarnet|mesh-list
14549619|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14549620|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
14549621|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549622|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15085331|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15085332|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
15085333|NCT02251184|Aspirin|aspirin|mesh-list
15085334|NCT02251184|Dipyridamole|dipyridamole|mesh-list
15085335|NCT02251184|Lansoprazole|lansoprazole|mesh-list
15085336|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
15085337|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15085338|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15085339|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085340|NCT02251184|Analgesics|analgesics|mesh-ancestor
15085341|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
14549623|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549624|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549625|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
14549626|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549627|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549628|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549629|NCT00001003|Zidovudine|zidovudine|mesh-list
14549630|NCT00001003|Pentamidine|pentamidine|mesh-list
14549631|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
14549632|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549633|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549634|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549635|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549636|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
14549637|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549638|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549639|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549640|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
14549641|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549642|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549643|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14549644|NCT00001004|Interferons|interferons|mesh-list
14549645|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
14549646|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549647|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
14549648|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549649|NCT00001005|Zidovudine|zidovudine|mesh-list
14549650|NCT00001005|Aldesleukin|aldesleukin|mesh-list
14549651|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
14549652|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549653|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549654|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549655|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549656|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
14549657|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549658|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549659|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549660|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549661|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14549662|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14549663|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
14549664|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549665|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549666|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14549667|NCT00001006|Protective Agents|protective agents|mesh-ancestor
14549668|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549669|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549670|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549671|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549672|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
14549673|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549674|NCT00001007|Zidovudine|zidovudine|mesh-list
14549675|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
14267896|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
14549676|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549677|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549678|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549679|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549680|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
14549681|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549682|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549683|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549684|NCT00001008|Zidovudine|zidovudine|mesh-list
14549685|NCT00001008|Methadone|methadone|mesh-list
14549686|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
14549687|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549688|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549689|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549690|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549691|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
14549692|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549693|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549694|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549695|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14549696|NCT00001008|Narcotics|narcotics|mesh-ancestor
14549697|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14549698|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549699|NCT00001008|Analgesics|analgesics|mesh-ancestor
14549700|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
14808644|NCT00828555|Immunologic Factors|immunologic factors|mesh-ancestor
14808645|NCT00828555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808646|NCT00828594|Sorafenib|sorafenib|mesh-list
14808647|NCT00828594|Everolimus|everolimus|mesh-list
14808648|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808649|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14808650|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808651|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808652|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14808653|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
14808654|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808655|NCT00828763|Dolutegravir|dolutegravir|mesh-list
14808656|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14808657|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14808658|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808659|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808660|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14808661|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14808662|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
14808663|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808664|NCT00828776|Heparin|heparin|mesh-list
14808665|NCT00828776|Calcium heparin|calcium heparin|mesh-list
14808666|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
14808667|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14808668|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14808669|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808670|NCT00828789|Tenofovir|tenofovir|mesh-list
14808671|NCT00828789|Efavirenz|efavirenz|mesh-list
14808672|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
14808673|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808674|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14808675|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14808676|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808677|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808678|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14808679|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14808680|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14808681|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14808682|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14808683|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14808684|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14808685|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14808686|NCT00828802|Lenalidomide|lenalidomide|mesh-list
14808687|NCT00828802|Decitabine|decitabine|mesh-list
14808688|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
14808689|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808690|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14808691|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14808692|NCT00828802|Growth Substances|growth substances|mesh-ancestor
14808693|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
14808694|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808695|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14808696|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
14808697|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808698|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808699|NCT00828815|Etravirine|etravirine|mesh-list
14808700|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14808701|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14808702|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549701|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14549702|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
14549703|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
14549704|NCT00001009|Dextrans|dextrans|mesh-list
14549705|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
14549706|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
14549707|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
14549708|NCT00001010|Zidovudine|zidovudine|mesh-list
14549709|NCT00001010|Acyclovir|acyclovir|mesh-list
14549710|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
14549711|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549712|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549713|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549714|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549715|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
14549716|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549717|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549718|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549719|NCT00001011|Zidovudine|zidovudine|mesh-list
14549720|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
14549721|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549722|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549723|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549724|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549725|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
14549726|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549727|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549728|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549729|NCT00001013|Leucovorin|leucovorin|mesh-list
14549730|NCT00001013|Trimethoprim|trimethoprim|mesh-list
14549731|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14549732|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
14549733|NCT00001013|Pentamidine|pentamidine|mesh-list
14549734|NCT00001013|Trimetrexate|trimetrexate|mesh-list
14549735|NCT00001013|Calcium|calcium|mesh-list
14549736|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
14549737|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14549738|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549739|NCT00001013|Antidotes|antidotes|mesh-ancestor
14549740|NCT00001013|Protective Agents|protective agents|mesh-ancestor
14549741|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549742|NCT00001013|Vitamins|vitamins|mesh-ancestor
14549743|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
14549744|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14549745|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549746|NCT00001013|Renal Agents|renal agents|mesh-ancestor
14549747|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
14549748|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549749|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549750|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14549751|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549752|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549753|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14549754|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14549755|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549756|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
14549757|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14549758|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549759|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14549760|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
14549761|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549762|NCT00001014|Leucovorin|leucovorin|mesh-list
14549763|NCT00001014|Trimethoprim|trimethoprim|mesh-list
14549764|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14549765|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
14549766|NCT00001014|Trimetrexate|trimetrexate|mesh-list
14549767|NCT00001014|Calcium|calcium|mesh-list
14549768|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
14549769|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14549770|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549771|NCT00001014|Antidotes|antidotes|mesh-ancestor
14549772|NCT00001014|Protective Agents|protective agents|mesh-ancestor
14549773|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549774|NCT00001014|Vitamins|vitamins|mesh-ancestor
14549775|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
14549776|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14549777|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549778|NCT00001014|Renal Agents|renal agents|mesh-ancestor
14549779|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
14549780|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549781|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549782|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14549783|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549784|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549785|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14549786|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14549787|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549788|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549789|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
14549790|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14549791|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
14549792|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549793|NCT00001015|Ribavirin|ribavirin|mesh-list
14549794|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
14549795|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549796|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
14549797|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549798|NCT00001016|Leucovorin|leucovorin|mesh-list
14549799|NCT00001016|Trimetrexate|trimetrexate|mesh-list
14549800|NCT00001016|Calcium|calcium|mesh-list
14549801|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
14549802|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14549803|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549804|NCT00001016|Antidotes|antidotes|mesh-ancestor
14549805|NCT00001016|Protective Agents|protective agents|mesh-ancestor
14549806|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549807|NCT00001016|Vitamins|vitamins|mesh-ancestor
14549808|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
14549809|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
14549810|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549811|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14549812|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
14549813|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549814|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549815|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14549816|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549817|NCT00001017|Fluconazole|fluconazole|mesh-list
14549818|NCT00001017|Amphotericin B|amphotericin b|mesh-list
14549819|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14549820|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
14549821|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549822|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14549823|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549824|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549825|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549826|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14549827|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
14549828|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14549829|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549830|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14549831|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14549832|NCT00001017|Amebicides|amebicides|mesh-ancestor
14549833|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549834|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549835|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549836|NCT00001022|Zidovudine|zidovudine|mesh-list
14549837|NCT00001022|Didanosine|didanosine|mesh-list
14549838|NCT00001022|Zalcitabine|zalcitabine|mesh-list
14549839|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
14549840|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549841|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549842|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549843|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549844|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
14549845|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549846|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549847|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549848|NCT00001023|Azithromycin|azithromycin|mesh-list
14549849|NCT00001023|Clarithromycin|clarithromycin|mesh-list
14549850|NCT00001023|Rifabutin|rifabutin|mesh-list
14549851|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549852|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549853|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14549854|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549855|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549856|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14549857|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549858|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14549859|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
14549860|NCT00001024|Zidovudine|zidovudine|mesh-list
14549861|NCT00001024|Didanosine|didanosine|mesh-list
14549862|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
14549863|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549864|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549865|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549866|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549867|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
14549868|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549869|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549870|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549871|NCT00001025|Zidovudine|zidovudine|mesh-list
14549872|NCT00001025|Didanosine|didanosine|mesh-list
14549873|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
14549874|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549875|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549876|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549877|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549878|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
14549879|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549880|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549881|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549882|NCT00001027|Pentamidine|pentamidine|mesh-list
14549883|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
14549884|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549885|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14549886|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549887|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14549888|NCT00001028|Dapsone|dapsone|mesh-list
14549889|NCT00001028|Pentamidine|pentamidine|mesh-list
14549890|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549891|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
14549892|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15085342|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085343|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085344|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085345|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085346|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14549893|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14549894|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14549895|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549896|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549897|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
14549898|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549899|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
14549900|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14549901|NCT00001029|Zidovudine|zidovudine|mesh-list
14549902|NCT00001029|Didanosine|didanosine|mesh-list
14549903|NCT00001029|Zalcitabine|zalcitabine|mesh-list
14549904|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
14549905|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549906|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549907|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549908|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549909|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
14549910|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549911|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549912|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549913|NCT00001030|Clarithromycin|clarithromycin|mesh-list
14549914|NCT00001030|Rifabutin|rifabutin|mesh-list
14549915|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549916|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085347|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15085348|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085349|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15085350|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15085351|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085352|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
15085353|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15085354|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085355|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15085356|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15085357|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
15085358|NCT02251223|Ritonavir|ritonavir|mesh-list
14549917|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14549918|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647416|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
14549919|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549920|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14549921|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549922|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15085359|NCT02251223|Tipranavir|tipranavir|mesh-list
15085360|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14549923|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
14643304|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14643305|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643306|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14643307|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14643308|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643309|NCT00188955|Sirolimus|sirolimus|mesh-list
14643310|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643311|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643312|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14643313|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643314|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
14643315|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643316|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
14643317|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643318|NCT00188994|Insulin|insulin|mesh-list
14643319|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14643320|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643321|NCT00189007|Allopurinol|allopurinol|mesh-list
14643322|NCT00189007|Mannitol|mannitol|mesh-list
14643323|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
14643324|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643325|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643326|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
14643327|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643328|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14643329|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
14643330|NCT00189007|Protective Agents|protective agents|mesh-ancestor
14643331|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643332|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14643333|NCT00189007|Diuretics|diuretics|mesh-ancestor
14643334|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
14643335|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14643336|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
14643337|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643338|NCT00189033|Psyllium|psyllium|mesh-list
14643339|NCT00189033|Cathartics|cathartics|mesh-ancestor
14643340|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14643341|NCT00189059|Amitriptyline|amitriptyline|mesh-list
14643342|NCT00189059|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14643343|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14643344|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643345|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643346|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14643347|NCT00189059|Analgesics|analgesics|mesh-ancestor
14643348|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
14643349|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643350|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643351|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14643352|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643353|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643354|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643355|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14643356|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643357|NCT00189059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14643358|NCT00189059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14643359|NCT00189059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14643360|NCT00189072|Gabapentin|gabapentin|mesh-list
14643361|NCT00189072|Analgesics|analgesics|mesh-ancestor
14643362|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
14643363|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643364|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643365|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
14643366|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14643367|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14643368|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085361|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085362|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
14549924|NCT00001032|Zidovudine|zidovudine|mesh-list
14549925|NCT00001032|Zalcitabine|zalcitabine|mesh-list
14549926|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
14549927|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549928|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549929|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549930|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549931|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
14549932|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549933|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549934|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549935|NCT00001033|Pyridoxine|pyridoxine|mesh-list
14549936|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
14549937|NCT00001033|Levofloxacin|levofloxacin|mesh-list
14549938|NCT00001033|Rifampin|rifampin|mesh-list
14549939|NCT00001033|Isoniazid|isoniazid|mesh-list
14549940|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
14549941|NCT00001033|Ethambutol|ethambutol|mesh-list
14549942|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14549943|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549944|NCT00001033|Renal Agents|renal agents|mesh-ancestor
14549945|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14549946|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14549947|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14549948|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549949|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549950|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14549951|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14549952|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549953|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14267897|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267898|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267899|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
14267900|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14267901|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267902|NCT00392769|Cetuximab|cetuximab|mesh-list
14267903|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267904|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267905|NCT00392782|Fludarabine|fludarabine|mesh-list
14267906|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
15085363|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085364|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085365|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085366|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085367|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
15085368|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549954|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
14549955|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
14549956|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549957|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14549958|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14549959|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14549960|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14549961|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14549962|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14549963|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14549964|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14549965|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
14549966|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14549967|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
14549968|NCT00001033|Vitamins|vitamins|mesh-ancestor
14549969|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
14549970|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549971|NCT00001034|Ganciclovir|ganciclovir|mesh-list
14549972|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14549973|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
14549974|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549975|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549976|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549977|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549978|NCT00001035|Interferons|interferons|mesh-list
14549979|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
14549980|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
14549981|NCT00001035|Zidovudine|zidovudine|mesh-list
14549982|NCT00001035|Didanosine|didanosine|mesh-list
14549983|NCT00001035|Zalcitabine|zalcitabine|mesh-list
14549984|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085369|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085370|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14549985|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
14549986|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14549987|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
14549988|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14549989|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
14549990|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14549991|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14549992|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14549993|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14549994|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14549995|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14549996|NCT00001036|Zidovudine|zidovudine|mesh-list
14549997|NCT00001036|Interleukin-2|interleukin-2|mesh-list
14549998|NCT00001036|Thymalfasin|thymalfasin|mesh-list
14549999|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550000|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14550001|NCT00001036|Analgesics|analgesics|mesh-ancestor
14550002|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
14550003|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14550004|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550005|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
14550006|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550007|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550008|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550009|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550010|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
14550011|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550012|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550013|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550014|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550015|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
14550016|NCT00001038|Valacyclovir|valacyclovir|mesh-list
14550017|NCT00001038|Acyclovir|acyclovir|mesh-list
14550018|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
14550019|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550020|NCT00001039|Clarithromycin|clarithromycin|mesh-list
14550021|NCT00001039|Ethambutol|ethambutol|mesh-list
14550022|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550023|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550024|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14550025|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550026|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550027|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550028|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550029|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
14550030|NCT00001040|Zidovudine|zidovudine|mesh-list
14550031|NCT00001040|Zalcitabine|zalcitabine|mesh-list
14550032|NCT00001040|Saquinavir|saquinavir|mesh-list
14550033|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
14550034|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550035|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550036|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550037|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550038|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
14550039|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550040|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550041|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550042|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550043|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550044|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550045|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14808703|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808704|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
14808705|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808706|NCT00828828|Vaccines|vaccines|mesh-list
14808707|NCT00828828|Immunologic Factors|immunologic factors|mesh-ancestor
14808708|NCT00828828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808709|NCT00828854|Entinostat|entinostat|mesh-list
14808710|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085371|NCT02251249|Acetaminophen|acetaminophen|mesh-list
14550046|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550047|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14550048|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14550049|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
14550050|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550051|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
14550052|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550053|NCT00001042|Antacids|antacids|mesh-ancestor
14550054|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550055|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14550056|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14550057|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550058|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
14550059|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550060|NCT00001044|Antacids|antacids|mesh-ancestor
14550061|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550062|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14550063|NCT00001045|Zidovudine|zidovudine|mesh-list
14550064|NCT00001045|Nevirapine|nevirapine|mesh-list
14550065|NCT00001045|Didanosine|didanosine|mesh-list
15085372|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085373|NCT02251249|Analgesics|analgesics|mesh-ancestor
15085374|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
14267907|NCT00392782|Thiotepa|thiotepa|mesh-list
14267908|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14267909|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085375|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996077|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13996078|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996079|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996080|NCT02922699|Omeprazole|omeprazole|mesh-list
13996081|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13996082|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996083|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13996084|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996085|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996086|NCT02922673|Aspirin|aspirin|mesh-list
13996087|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15085376|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085377|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
15085378|NCT02251288|Vaccines|vaccines|mesh-list
15085379|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
15085380|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085381|NCT02251431|Exenatide|exenatide|mesh-list
13996088|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13996089|NCT02922673|Analgesics|analgesics|mesh-ancestor
13996090|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
13996091|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996092|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996093|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996094|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996095|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13996096|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14267910|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267911|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
14267912|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267913|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267914|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
14267915|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267916|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14267917|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
14267918|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15085382|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15085383|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550066|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
14550067|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550068|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550069|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550070|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550071|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
14550072|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550073|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550074|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550075|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550076|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550077|NCT00001047|Clarithromycin|clarithromycin|mesh-list
14550078|NCT00001047|Ethambutol|ethambutol|mesh-list
14550079|NCT00001047|Rifabutin|rifabutin|mesh-list
14550080|NCT00001047|Clofazimine|clofazimine|mesh-list
14550081|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550082|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550083|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14550084|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550085|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550086|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550087|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550088|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
14550089|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14550090|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14550091|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
14550092|NCT00001048|Cytarabine|cytarabine|mesh-list
14550093|NCT00001048|Zidovudine|zidovudine|mesh-list
14550094|NCT00001048|Didanosine|didanosine|mesh-list
14550095|NCT00001048|Zalcitabine|zalcitabine|mesh-list
14550096|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14550097|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
14550098|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550099|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550100|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
14550101|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550102|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550103|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
14550104|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550105|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550106|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550107|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550108|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550109|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550110|NCT00001049|Zidovudine|zidovudine|mesh-list
14550111|NCT00001049|Didanosine|didanosine|mesh-list
14550112|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
14550113|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550114|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550115|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550116|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550117|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
14550118|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550119|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550120|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550121|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14550122|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550123|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
14550124|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550125|NCT00001052|Antacids|antacids|mesh-ancestor
14550126|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550127|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14550128|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14550129|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550130|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
14550131|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550132|NCT00001053|Antacids|antacids|mesh-ancestor
14550133|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550134|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14550135|NCT00001054|Valacyclovir|valacyclovir|mesh-list
14550136|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
14550137|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550138|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
14550139|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550140|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
14550141|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550142|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14550143|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550144|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
14550145|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550146|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
14550147|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14550148|NCT00001055|Protective Agents|protective agents|mesh-ancestor
14550149|NCT00001057|Zidovudine|zidovudine|mesh-list
14550150|NCT00001057|Didanosine|didanosine|mesh-list
14550151|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
14550152|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550153|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550154|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550155|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550156|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
14550157|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550158|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550159|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550160|NCT00001058|Ritonavir|ritonavir|mesh-list
14550161|NCT00001058|Indinavir|indinavir|mesh-list
14550162|NCT00001058|Clarithromycin|clarithromycin|mesh-list
14550163|NCT00001058|Ethambutol|ethambutol|mesh-list
14550164|NCT00001058|Rifabutin|rifabutin|mesh-list
14550165|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550166|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550167|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550168|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550169|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550170|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550171|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550172|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
14550173|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550174|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550175|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550176|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550177|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14550178|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
14550179|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14550180|NCT00001059|Doxorubicin|doxorubicin|mesh-list
14550181|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14550182|NCT00001059|Bleomycin|bleomycin|mesh-list
14550183|NCT00001059|Vincristine|vincristine|mesh-list
14550184|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14550185|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550186|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14550187|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14550188|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550189|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550190|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14550191|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14550192|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14550193|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14550194|NCT00001061|Ganciclovir|ganciclovir|mesh-list
14550195|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14550196|NCT00001061|Foscarnet|foscarnet|mesh-list
14550197|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14550198|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
14550199|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550200|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550201|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550202|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550203|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550204|NCT00001062|Ganciclovir|ganciclovir|mesh-list
14550205|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14550206|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
14550207|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550208|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550209|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550210|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550211|NCT00001063|Zidovudine|zidovudine|mesh-list
14550212|NCT00001063|Stavudine|stavudine|mesh-list
14550213|NCT00001063|Didanosine|didanosine|mesh-list
15085384|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14550214|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
14550215|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550216|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550217|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15085385|NCT02251431|Incretins|incretins|mesh-ancestor
14550218|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550219|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
14550220|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550221|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550222|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550223|NCT00001065|Amphotericin B|amphotericin b|mesh-list
14550224|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14550225|NCT00001065|Amebicides|amebicides|mesh-ancestor
14550226|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14550227|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14550228|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550229|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550230|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
14550231|NCT00001066|Lamivudine|lamivudine|mesh-list
14550232|NCT00001066|Zidovudine|zidovudine|mesh-list
14550233|NCT00001066|Didanosine|didanosine|mesh-list
14550234|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550235|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550236|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550237|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550238|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
14550239|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550240|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550241|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550242|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
14550243|NCT00001067|Lamivudine|lamivudine|mesh-list
14550244|NCT00001067|Zidovudine|zidovudine|mesh-list
14550245|NCT00001067|Stavudine|stavudine|mesh-list
14550246|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550247|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550248|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550249|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550250|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
14550251|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550252|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550253|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550254|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
14550255|NCT00001068|Lamivudine|lamivudine|mesh-list
14550256|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550257|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550258|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550259|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550260|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
14550261|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550262|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550263|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550264|NCT00001070|Ascorbic Acid|ascorbic acid|mesh-list
14550265|NCT00001070|Vitamins|vitamins|mesh-ancestor
14550266|NCT00001070|Micronutrients|micronutrients|mesh-ancestor
14550267|NCT00001070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550268|NCT00001070|Antioxidants|antioxidants|mesh-ancestor
14550269|NCT00001070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550270|NCT00001070|Protective Agents|protective agents|mesh-ancestor
14550271|NCT00001071|Lenograstim|lenograstim|mesh-list
14550272|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550273|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
15085386|NCT02251431|Hormones|hormones|mesh-ancestor
15085387|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15085388|NCT02251457|Ranolazine|ranolazine|mesh-list
15085389|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15085390|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15085391|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085392|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
14292353|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14550274|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085393|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14550275|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
14550276|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550277|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
14550278|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550279|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14550280|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550281|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
14550282|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550283|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
14550284|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14550285|NCT00001072|Protective Agents|protective agents|mesh-ancestor
14550286|NCT00001073|Isotretinoin|isotretinoin|mesh-list
14550287|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14550288|NCT00001074|Didanosine|didanosine|mesh-list
14550289|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
14550290|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550291|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
14550292|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550293|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550294|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550295|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
14550296|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550297|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
14550298|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550299|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550300|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550301|NCT00001075|Ritonavir|ritonavir|mesh-list
14550302|NCT00001075|Lamivudine|lamivudine|mesh-list
14550303|NCT00001075|Zidovudine|zidovudine|mesh-list
14550304|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550305|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550306|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550307|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550308|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550309|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550310|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550311|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
14550312|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550313|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550314|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550315|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550316|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550317|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
14550318|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
14550319|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550320|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
14550321|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550322|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14550323|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550324|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
14550325|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550326|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
14550327|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14550328|NCT00001076|Protective Agents|protective agents|mesh-ancestor
14550329|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
14550330|NCT00001079|Megestrol|megestrol|mesh-list
14550331|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
14550332|NCT00001079|Testosterone|testosterone|mesh-list
14550333|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
14550334|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
14550335|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14550336|NCT00001079|Androgens|androgens|mesh-ancestor
14550337|NCT00001079|Hormones|hormones|mesh-ancestor
14550338|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550339|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550340|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14550341|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550342|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
14550343|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14550344|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14550345|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15085394|NCT02251483|Antibodies|antibodies|mesh-list
15085395|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
15085396|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085397|NCT02251509|Metoprolol|metoprolol|mesh-list
15085398|NCT02251509|Carvedilol|carvedilol|mesh-list
14550346|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
14550347|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14643369|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15085399|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15085400|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14550348|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14550349|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14550350|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
14550351|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14550352|NCT00001080|Lamivudine|lamivudine|mesh-list
14550353|NCT00001080|Vaccines|vaccines|mesh-list
14550354|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14267928|NCT00392834|Leucovorin|leucovorin|mesh-list
15085401|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
14550355|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
14550356|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550357|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550358|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550359|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808711|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14808712|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808713|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808714|NCT00828919|Axitinib|axitinib|mesh-list
14808715|NCT00828919|Crizotinib|crizotinib|mesh-list
14808716|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808717|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14808718|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808719|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808720|NCT00828958|Risperidone|risperidone|mesh-list
14808721|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14808722|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
14808723|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808724|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808725|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808726|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14808727|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14808728|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808729|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808730|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14808731|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
14808732|NCT00828971|Amoxicillin|amoxicillin|mesh-list
14808733|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
14808734|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14808735|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14808736|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808737|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14808738|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14808739|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808740|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808741|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808742|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14808743|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
14808744|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14808745|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808746|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14808747|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14808748|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14808749|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14808750|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
14808751|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808752|NCT00829023|Ethanol|ethanol|mesh-list
14808753|NCT00829023|Chlorhexidine|chlorhexidine|mesh-list
14808754|NCT00829023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14808755|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
14808756|NCT00829023|Povidone|povidone|mesh-list
14267929|NCT00392834|Cytarabine|cytarabine|mesh-list
14267930|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
14267931|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14267932|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14267933|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14267934|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
14808757|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14808758|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808759|NCT00829023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808760|NCT00829023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808761|NCT00829023|Disinfectants|disinfectants|mesh-ancestor
14808762|NCT00829023|Dermatologic Agents|dermatologic agents|mesh-ancestor
14808763|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
14267935|NCT00392834|Ifosfamide|ifosfamide|mesh-list
14267936|NCT00392834|Rituximab|rituximab|mesh-list
14550360|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550361|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
14550362|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550363|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550364|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550365|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
14550366|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14550367|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550368|NCT00001082|Adefovir|adefovir|mesh-list
14550369|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14550370|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
14550371|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550372|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550373|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550374|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550375|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550376|NCT00001083|Ritonavir|ritonavir|mesh-list
14550377|NCT00001083|Indinavir|indinavir|mesh-list
14550378|NCT00001083|Lamivudine|lamivudine|mesh-list
14550379|NCT00001083|Zidovudine|zidovudine|mesh-list
14550380|NCT00001083|Nevirapine|nevirapine|mesh-list
14550381|NCT00001083|Stavudine|stavudine|mesh-list
14550382|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550383|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550384|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550385|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550386|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550387|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550388|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550389|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
14550390|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550391|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550392|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550393|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550394|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550395|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
14550396|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550397|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550398|NCT00001084|Lamivudine|lamivudine|mesh-list
14550399|NCT00001084|Zidovudine|zidovudine|mesh-list
14550400|NCT00001084|Stavudine|stavudine|mesh-list
14550401|NCT00001084|Indinavir|indinavir|mesh-list
14550402|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550403|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550404|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550405|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550406|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
14550407|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550408|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550409|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550410|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
14550411|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550412|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550413|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550414|NCT00001085|Lamivudine|lamivudine|mesh-list
14550415|NCT00001085|Zidovudine|zidovudine|mesh-list
14550416|NCT00001085|Amprenavir|amprenavir|mesh-list
14550417|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550418|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550419|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550420|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550421|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
14550422|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550423|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550424|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550425|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
14550426|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14550427|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
14550428|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550429|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550430|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550431|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550432|NCT00001086|Efavirenz|efavirenz|mesh-list
14550433|NCT00001086|Abacavir|abacavir|mesh-list
14550434|NCT00001086|Indinavir|indinavir|mesh-list
14550435|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550436|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550437|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550438|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550439|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
14550440|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550441|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14550442|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550443|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14550444|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14550445|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550446|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550447|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550448|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550449|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550450|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550451|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550452|NCT00001087|Ritonavir|ritonavir|mesh-list
14550453|NCT00001087|Nelfinavir|nelfinavir|mesh-list
14550454|NCT00001087|Saquinavir|saquinavir|mesh-list
14550455|NCT00001087|Lamivudine|lamivudine|mesh-list
14550456|NCT00001087|Zidovudine|zidovudine|mesh-list
14550457|NCT00001087|Stavudine|stavudine|mesh-list
14550458|NCT00001087|Didanosine|didanosine|mesh-list
14550459|NCT00001087|Zalcitabine|zalcitabine|mesh-list
14550460|NCT00001087|Efavirenz|efavirenz|mesh-list
14550461|NCT00001087|Adefovir|adefovir|mesh-list
14550462|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14550463|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550464|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550465|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550466|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550467|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550468|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550469|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550470|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
14550471|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550472|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550473|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550474|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550475|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550476|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
14550477|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14550478|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14550479|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14550480|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550481|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550482|NCT00001088|Bupivacaine|bupivacaine|mesh-list
14550483|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
14550484|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
14550485|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14550486|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550487|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
14550488|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14550489|NCT00001090|Sargramostim|sargramostim|mesh-list
14550490|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
14550491|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550492|NCT00001091|Ritonavir|ritonavir|mesh-list
14550493|NCT00001091|Nelfinavir|nelfinavir|mesh-list
14550494|NCT00001091|Lamivudine|lamivudine|mesh-list
14550495|NCT00001091|Nevirapine|nevirapine|mesh-list
14550496|NCT00001091|Stavudine|stavudine|mesh-list
14550497|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550498|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550499|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550500|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550501|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550502|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550503|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550504|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
14550505|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550506|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550507|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550508|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550509|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550510|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550511|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550512|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
14550513|NCT00001094|Lamivudine|lamivudine|mesh-list
14550514|NCT00001094|Zidovudine|zidovudine|mesh-list
14550515|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14550516|NCT00001094|Delavirdine|delavirdine|mesh-list
14550517|NCT00001094|Nelfinavir|nelfinavir|mesh-list
14550518|NCT00001094|Saquinavir|saquinavir|mesh-list
14550519|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550520|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550521|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550522|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550523|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
14550524|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550525|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550526|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550527|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
14550528|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550529|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550530|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550531|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550532|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550533|NCT00001095|Lamivudine|lamivudine|mesh-list
14550534|NCT00001095|Zidovudine|zidovudine|mesh-list
14550535|NCT00001095|Nevirapine|nevirapine|mesh-list
14550536|NCT00001095|Stavudine|stavudine|mesh-list
14550537|NCT00001095|Indinavir|indinavir|mesh-list
14550538|NCT00001095|Amprenavir|amprenavir|mesh-list
14550539|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550540|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550541|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550542|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550543|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
14550544|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550545|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550546|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550547|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
14550548|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550549|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550550|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550551|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550552|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550553|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14550554|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
14550555|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550556|NCT00001100|Ganciclovir|ganciclovir|mesh-list
14550557|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14550558|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
14550559|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550560|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550561|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550562|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085402|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
15085403|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085404|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085405|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15085406|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15085407|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15085408|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
15085409|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085410|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085411|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
15085412|NCT02251509|Protective Agents|protective agents|mesh-ancestor
15085413|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15085414|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15085415|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15085416|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
15085417|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15085418|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15085419|NCT02251600|Deflazacort|deflazacort|mesh-list
15085420|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085421|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15085422|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
14550563|NCT00001101|Doxycycline|doxycycline|mesh-list
14550564|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
14550565|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550566|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550567|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
14550568|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14550569|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14550570|NCT00001104|Zidovudine|zidovudine|mesh-list
14550571|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
14550572|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550573|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550574|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550575|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550576|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
14550577|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550578|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550579|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550580|NCT00001105|Antibodies|antibodies|mesh-list
14550581|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14550582|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
14550583|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550584|NCT00001106|Zidovudine|zidovudine|mesh-list
14550585|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
14550586|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550587|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550588|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550589|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550590|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
14550591|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550592|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550593|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550594|NCT00001107|Fluconazole|fluconazole|mesh-list
14550595|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14550596|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
14550597|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550598|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14550599|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550600|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550601|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550602|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14550603|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
14550604|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550605|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550606|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14550607|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14550608|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14550609|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14550610|NCT00001108|Ritonavir|ritonavir|mesh-list
14550611|NCT00001108|Nelfinavir|nelfinavir|mesh-list
14550612|NCT00001108|Saquinavir|saquinavir|mesh-list
14267937|NCT00392834|Doxorubicin|doxorubicin|mesh-list
14267938|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14267939|NCT00392834|Methotrexate|methotrexate|mesh-list
14267940|NCT00392834|Etoposide|etoposide|mesh-list
14267941|NCT00392834|Vincristine|vincristine|mesh-list
14267942|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
14267943|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267944|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
14550613|NCT00001108|Lamivudine|lamivudine|mesh-list
14550614|NCT00001108|Nevirapine|nevirapine|mesh-list
14550615|NCT00001108|Stavudine|stavudine|mesh-list
14550616|NCT00001108|Didanosine|didanosine|mesh-list
14550617|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550618|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550619|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550620|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550621|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550622|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550623|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550624|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
14550625|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550626|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550627|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550628|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550629|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550630|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550631|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550632|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
14550633|NCT00001111|Zidovudine|zidovudine|mesh-list
14550634|NCT00001111|Nevirapine|nevirapine|mesh-list
14550635|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
14550636|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550637|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550638|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550639|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550640|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
14550641|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550642|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550643|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550644|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550645|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550646|NCT00001112|Interferons|interferons|mesh-list
14550647|NCT00001112|Zidovudine|zidovudine|mesh-list
14550648|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
14550649|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550650|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
14550651|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550652|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
14550653|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550654|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550655|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550656|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550657|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550658|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550659|NCT00001113|Interferons|interferons|mesh-list
14550660|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
14550661|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
14550662|NCT00001113|Zidovudine|zidovudine|mesh-list
14550663|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550664|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
14550665|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550666|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
14550667|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550668|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
14550669|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550670|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550671|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550672|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550673|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550674|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550675|NCT00001114|Interferons|interferons|mesh-list
14550676|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
14550677|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
14550678|NCT00001114|Didanosine|didanosine|mesh-list
14550679|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550680|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
14550681|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550682|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
14550683|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550684|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
14550685|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550686|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550687|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550688|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550689|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14808764|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
14808765|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14550690|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550691|NCT00001115|Acyclovir|acyclovir|mesh-list
14550692|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
14550693|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550694|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
14550695|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14550696|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14550697|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550698|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550699|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550700|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
14550701|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550702|NCT00001119|Ritonavir|ritonavir|mesh-list
14550703|NCT00001119|Indinavir|indinavir|mesh-list
14550704|NCT00001119|Amprenavir|amprenavir|mesh-list
14550705|NCT00001119|Lamivudine|lamivudine|mesh-list
14550706|NCT00001119|Zidovudine|zidovudine|mesh-list
14550707|NCT00001119|Abacavir|abacavir|mesh-list
14550708|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14550709|NCT00001119|Efavirenz|efavirenz|mesh-list
14550710|NCT00001119|Vaccines|vaccines|mesh-list
14550711|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
14550712|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550713|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550714|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550715|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550716|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550717|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550718|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550719|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550720|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
14550721|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550722|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550723|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550724|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550725|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550726|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
14550727|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14550728|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14550729|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14550730|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550731|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550732|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14550733|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
14550734|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550735|NCT00001122|Efavirenz|efavirenz|mesh-list
14550736|NCT00001122|Stavudine|stavudine|mesh-list
14550737|NCT00001122|Didanosine|didanosine|mesh-list
14550738|NCT00001122|Nelfinavir|nelfinavir|mesh-list
14550739|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550740|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550741|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550742|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550743|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
14550744|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550745|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14550746|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550747|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14550748|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15085423|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085424|NCT02251626|Ubiquinone|ubiquinone|mesh-list
15085425|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
15085426|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
15085427|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085428|NCT02251626|Vitamins|vitamins|mesh-ancestor
15085429|NCT02251691|Tacrolimus|tacrolimus|mesh-list
15085430|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15085431|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
15085432|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085433|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15085434|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085435|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085436|NCT02251769|Ritonavir|ritonavir|mesh-list
14550749|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14550750|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15085437|NCT02251769|Tipranavir|tipranavir|mesh-list
15085438|NCT02251769|Clarithromycin|clarithromycin|mesh-list
15085439|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085440|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085441|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085442|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085443|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085444|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085445|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085446|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
15085447|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085448|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085449|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085450|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15085451|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15085452|NCT02251795|Aspirin|aspirin|mesh-list
15085453|NCT02251795|Ritonavir|ritonavir|mesh-list
15085454|NCT02251795|Darunavir|darunavir|mesh-list
15085455|NCT02251795|Tipranavir|tipranavir|mesh-list
15085456|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15085457|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085458|NCT02251795|Analgesics|analgesics|mesh-ancestor
15085459|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
15085460|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085461|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085462|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085463|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085464|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15085465|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15085466|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085467|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15085468|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15085469|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085470|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
15085471|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550751|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
14550752|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550753|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550754|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550755|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550756|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550757|NCT00001123|Ribavirin|ribavirin|mesh-list
14550758|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
14550759|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550760|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
14550761|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550762|NCT00001126|Cidofovir|cidofovir|mesh-list
14550763|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
14550764|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550765|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550766|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550767|NCT00001128|Azithromycin|azithromycin|mesh-list
14550768|NCT00001128|Paromomycin|paromomycin|mesh-list
14550769|NCT00001128|Interleukin-12|interleukin-12|mesh-list
14550770|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14550771|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550772|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550773|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
14550774|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550775|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14550776|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14550777|NCT00001128|Growth Substances|growth substances|mesh-ancestor
14550778|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
14550779|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550780|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14550781|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14550782|NCT00001131|Aldesleukin|aldesleukin|mesh-list
14550783|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550784|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550785|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550786|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
14550787|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550788|NCT00001132|Abacavir|abacavir|mesh-list
14550789|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550790|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550791|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550792|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550793|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
14550794|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550795|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550796|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550797|NCT00001133|Ritonavir|ritonavir|mesh-list
14550798|NCT00001133|Indinavir|indinavir|mesh-list
14550799|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14550800|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14550801|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
14550802|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550803|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550804|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550805|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550806|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
14550807|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550808|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14550809|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14550810|NCT00001135|Nevirapine|nevirapine|mesh-list
14550811|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14550812|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550813|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550814|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550815|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
14550816|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550817|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14550818|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14550819|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14550820|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14643370|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14643371|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14643372|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643373|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643374|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
14643375|NCT00189085|Simvastatin|simvastatin|mesh-list
14643376|NCT00189085|Ezetimibe|ezetimibe|mesh-list
14643377|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14643378|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14643379|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14643380|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
14643381|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643382|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14643383|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14643384|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643385|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14643386|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14643387|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
14643388|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643389|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
14643390|NCT00189150|Valganciclovir|valganciclovir|mesh-list
14643391|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14643392|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643393|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14643394|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
14643395|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643396|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643397|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643398|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643399|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
14643400|NCT00189163|Pioglitazone|pioglitazone|mesh-list
14643401|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14643402|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643403|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14643404|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
14643405|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
14643406|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643407|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643408|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14643409|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14643410|NCT00189176|Growth Substances|growth substances|mesh-ancestor
14643411|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643412|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
14643413|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643414|NCT00189345|Catumaxomab|catumaxomab|mesh-list
14643415|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
14643416|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
14643417|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550821|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14550822|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14550823|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14550824|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
14550825|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550826|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
14550827|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550828|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14550829|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14550830|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
14550831|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550832|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550833|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14550834|NCT00001165|Doxorubicin|doxorubicin|mesh-list
14550835|NCT00001165|Streptozocin|streptozocin|mesh-list
14550836|NCT00001165|Fluorouracil|fluorouracil|mesh-list
14550837|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14550838|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550839|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14550840|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14550841|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550842|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550843|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
15085472|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085473|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085474|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085475|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085476|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
15085477|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085478|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085479|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085480|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15085481|NCT02251847|Ezetimibe|ezetimibe|mesh-list
15085482|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15085483|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15085484|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
14550844|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14550845|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550846|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
14550847|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550848|NCT00001180|Hormones|hormones|mesh-list
14550849|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14550850|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14550851|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550852|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550853|NCT00001181|Testolactone|testolactone|mesh-list
14550854|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14550855|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550856|NCT00001190|Deslorelin|deslorelin|mesh-list
14550857|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550858|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550859|NCT00001191|Omeprazole|omeprazole|mesh-list
14550860|NCT00001191|Pantoprazole|pantoprazole|mesh-list
14550861|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14550862|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14550863|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14550864|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550865|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550866|NCT00001193|Melphalan|melphalan|mesh-list
14550867|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14550868|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
14550869|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550870|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550871|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14550872|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550873|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
14550874|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550875|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
14550876|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550877|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
14267945|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267946|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085485|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085486|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14550878|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550879|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550880|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550881|NCT00001202|Testolactone|testolactone|mesh-list
14550882|NCT00001202|Spironolactone|spironolactone|mesh-list
14550883|NCT00001202|Deslorelin|deslorelin|mesh-list
14550884|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14550885|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
14550886|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550887|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550888|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14550889|NCT00001202|Diuretics|diuretics|mesh-ancestor
14550890|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
14550891|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14550892|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550893|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550894|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550895|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
14550896|NCT00001209|Ifosfamide|ifosfamide|mesh-list
14550897|NCT00001209|Vincristine|vincristine|mesh-list
14550898|NCT00001209|Doxorubicin|doxorubicin|mesh-list
14550899|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14550900|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550901|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
14550902|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550903|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14550904|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14550905|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
14550906|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550907|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550908|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14550909|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14550910|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
14550911|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14550912|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14550913|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14550914|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14550915|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14550916|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550917|NCT00001212|Cyclosporine|cyclosporine|mesh-list
14550918|NCT00001212|Prednisone|prednisone|mesh-list
14550919|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
14550920|NCT00001212|Cyclosporins|cyclosporins|mesh-list
14550921|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550922|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
14550923|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550924|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14550925|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14550926|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
14550927|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550928|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550929|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14550930|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14550931|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
14550932|NCT00001212|Hormones|hormones|mesh-ancestor
14550933|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550934|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14550935|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550936|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
14550937|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550938|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
14550939|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14550940|NCT00001221|Hormones|hormones|mesh-list
14550941|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550942|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550943|NCT00001228|Interferons|interferons|mesh-list
14550944|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550945|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
14550946|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14550947|NCT00001237|Molgramostim|molgramostim|mesh-list
15172986|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550948|NCT00001237|Sargramostim|sargramostim|mesh-list
14550949|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
14550950|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550951|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550952|NCT00001249|Antibodies|antibodies|mesh-list
14550953|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
14550954|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550955|NCT00001251|Mafosfamide|mafosfamide|mesh-list
14550956|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14550957|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
14550958|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550959|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550960|NCT00001256|Prednisone|prednisone|mesh-list
14550961|NCT00001256|Methotrexate|methotrexate|mesh-list
14550962|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085487|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15085488|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085489|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15085490|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15085491|NCT02251925|Estradiol|estradiol|mesh-list
15085492|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15085493|NCT02251925|Estrogens|estrogens|mesh-ancestor
15085494|NCT02251925|Hormones|hormones|mesh-ancestor
15085495|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15085496|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085497|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15085498|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
15085499|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15085500|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15085501|NCT02251951|Paclitaxel|paclitaxel|mesh-list
15085502|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15085503|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085504|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
15085505|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
15085506|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
15085507|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085508|NCT02251964|Rituximab|rituximab|mesh-list
15085509|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15085510|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085511|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
15085512|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085513|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085514|NCT02251977|Leucovorin|leucovorin|mesh-list
15085515|NCT02251977|Fluorouracil|fluorouracil|mesh-list
15085516|NCT02251977|Capecitabine|capecitabine|mesh-list
15085517|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085518|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
15085519|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085520|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15085521|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085522|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15085523|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
15085524|NCT02251977|Antidotes|antidotes|mesh-ancestor
15085525|NCT02251977|Protective Agents|protective agents|mesh-ancestor
15085526|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
15085527|NCT02251977|Vitamins|vitamins|mesh-ancestor
15085528|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
15172987|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
15172988|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15172989|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
15172990|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15172991|NCT04008511|Capecitabine|capecitabine|mesh-list
15172992|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
15172993|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15172994|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
15172995|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172996|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172997|NCT04008290|Liraglutide|liraglutide|mesh-list
15172998|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15172999|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173000|NCT04008290|Incretins|incretins|mesh-ancestor
15173001|NCT04008290|Hormones|hormones|mesh-ancestor
15173002|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173003|NCT04008264|Scopolamine|scopolamine|mesh-list
15173004|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15173005|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14550963|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
14550964|NCT00001256|Hormones|hormones|mesh-ancestor
14643418|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15173006|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
14550965|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550966|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550967|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14550968|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550969|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14550970|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
14550971|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14550972|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14550973|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
14550974|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14550975|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
14550976|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14550977|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14550978|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14550979|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
14550980|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14550981|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14550982|NCT00001259|Leuprolide|leuprolide|mesh-list
14550983|NCT00001259|Estradiol|estradiol|mesh-list
14550984|NCT00001259|Progesterone|progesterone|mesh-list
14550985|NCT00001259|Estrogens|estrogens|mesh-ancestor
14550986|NCT00001259|Hormones|hormones|mesh-ancestor
14550987|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14550988|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14550989|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14550990|NCT00001259|Progestins|progestins|mesh-ancestor
14550991|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14550992|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
14550993|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14550994|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14550995|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
14550996|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14550997|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14550998|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
14550999|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551000|NCT00001266|Suramin|suramin|mesh-list
14551001|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
14551002|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
14551003|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14551004|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551005|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551006|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14551007|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14551008|NCT00001267|Zidovudine|zidovudine|mesh-list
14551009|NCT00001267|Didanosine|didanosine|mesh-list
14551010|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
14551011|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551012|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14551013|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551014|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551015|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
14551016|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551017|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551018|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551019|NCT00001280|Itraconazole|itraconazole|mesh-list
14551020|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
14551021|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551022|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14551023|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14551024|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551025|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551026|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14551027|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
14551028|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551029|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551030|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14551031|NCT00001282|Zidovudine|zidovudine|mesh-list
14551032|NCT00001282|Interleukin-2|interleukin-2|mesh-list
14551033|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551034|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551035|NCT00001282|Analgesics|analgesics|mesh-ancestor
14551036|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
14551037|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551038|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551039|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
14551040|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551041|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14551042|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551043|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551044|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
14551045|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551046|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551047|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551048|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
14551049|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14551050|NCT00001287|Antibodies|antibodies|mesh-list
14551051|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
14551052|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14551053|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
14551054|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643419|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14808766|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14808767|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14808768|NCT00829114|Estradiol|estradiol|mesh-list
14808769|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14808770|NCT00829114|Estrogens|estrogens|mesh-ancestor
14808771|NCT00829114|Hormones|hormones|mesh-ancestor
14808772|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14808773|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808774|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14808775|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
14808776|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14808777|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14808778|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14808779|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14808780|NCT00829192|Afamelanotide|afamelanotide|mesh-list
14808781|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
15085529|NCT02252107|Decitabine|decitabine|mesh-list
15085530|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15085531|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
15085532|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085533|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085534|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085535|NCT02252263|Elotuzumab|elotuzumab|mesh-list
15085536|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808782|NCT00829205|Rituximab|rituximab|mesh-list
14808783|NCT00829205|Carboplatin|carboplatin|mesh-list
14808784|NCT00829205|Etoposide|etoposide|mesh-list
14808785|NCT00829205|Ifosfamide|ifosfamide|mesh-list
14808786|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
14808787|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14808788|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808789|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
14808790|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808791|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808792|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14808793|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14808794|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14808795|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808796|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808797|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14808798|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
14808799|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14808800|NCT00829205|Protective Agents|protective agents|mesh-ancestor
14808801|NCT00829231|Sorafenib|sorafenib|mesh-list
14808802|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808803|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14808804|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808805|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808806|NCT00829257|Fluticasone|fluticasone|mesh-list
14808807|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14808808|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808809|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14808810|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
14808811|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808812|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808813|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14808814|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
14808815|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14808816|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15085537|NCT02252302|Albuterol|albuterol|mesh-list
14551055|NCT00001296|Interferons|interferons|mesh-list
14551056|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
14267947|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14267948|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
14267949|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267950|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085538|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15085539|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
14267951|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14267952|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14267953|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14551057|NCT00001296|Melphalan|melphalan|mesh-list
14551058|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551059|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
14551060|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551061|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551062|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
14551063|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551064|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551065|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551066|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
14551067|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551068|NCT00001300|Doxorubicin|doxorubicin|mesh-list
14551069|NCT00001300|Ifosfamide|ifosfamide|mesh-list
14551070|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14551071|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551072|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14551073|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14551074|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551075|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551076|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551077|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
14551078|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
14551079|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14551080|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
14551081|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551082|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551083|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14551084|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
14551085|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14551086|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
14551087|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551088|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551089|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14551090|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
14551091|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
14551092|NCT00001303|Protective Agents|protective agents|mesh-ancestor
14551093|NCT00001307|Capsaicin|capsaicin|mesh-list
14551094|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
14551095|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551096|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
14551097|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551098|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551099|NCT00001311|Heparin|heparin|mesh-list
14551100|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
14551101|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14551102|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14551103|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551104|NCT00001317|Interferons|interferons|mesh-list
14551105|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
14551106|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551107|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
14551108|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551109|NCT00001318|Interferons|interferons|mesh-list
14551110|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
14551111|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551112|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
14551113|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551114|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14551115|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14551116|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551117|NCT00001328|Ganciclovir|ganciclovir|mesh-list
14551118|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14551119|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
14551120|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551121|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551122|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551123|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551124|NCT00001332|Cisplatin|cisplatin|mesh-list
14551125|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551126|NCT00001333|Topotecan|topotecan|mesh-list
14551127|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14551128|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14551129|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551130|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551131|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551132|NCT00001335|Topotecan|topotecan|mesh-list
14551133|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14551134|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14551135|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551136|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551137|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551138|NCT00001339|Doxorubicin|doxorubicin|mesh-list
14551139|NCT00001339|Etoposide|etoposide|mesh-list
14551140|NCT00001339|Vincristine|vincristine|mesh-list
14551141|NCT00001339|Mitotane|mitotane|mesh-list
14551142|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14551143|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551144|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14551145|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14551146|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551147|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551148|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551149|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551150|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551151|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551152|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14551153|NCT00001341|Raltitrexed|raltitrexed|mesh-list
14551154|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14551155|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
14551156|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551157|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551158|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14551159|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551160|NCT00001343|Oxandrolone|oxandrolone|mesh-list
14551161|NCT00001343|Androgens|androgens|mesh-ancestor
14551162|NCT00001343|Hormones|hormones|mesh-ancestor
14551163|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551164|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551165|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
14551166|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
14551167|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
14551168|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
14551169|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14551170|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14551171|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551172|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551173|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551174|NCT00001354|Zidovudine|zidovudine|mesh-list
14551175|NCT00001354|Interleukin-2|interleukin-2|mesh-list
14551176|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551177|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551178|NCT00001354|Analgesics|analgesics|mesh-ancestor
14551179|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
14551180|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085540|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085541|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085542|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15085543|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085544|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
15085545|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15085546|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15085547|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14551181|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551182|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
14551183|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551184|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14551185|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551186|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551187|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
14551188|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551189|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551190|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551191|NCT00001357|Interleukin-2|interleukin-2|mesh-list
14551192|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551193|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551194|NCT00001357|Analgesics|analgesics|mesh-ancestor
14551195|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
14551196|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551197|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551198|NCT00001359|Penicillins|penicillins|mesh-list
14551199|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551200|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551201|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
14551202|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
14551203|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
14551204|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14551205|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14551206|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551207|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551208|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551209|NCT00001378|Fenretinide|fenretinide|mesh-list
14551210|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551211|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14551212|NCT00001378|Protective Agents|protective agents|mesh-ancestor
14551213|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551214|NCT00001381|Suramin|suramin|mesh-list
14551215|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
14551216|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
14551217|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14551218|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551219|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551220|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14551221|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14551222|NCT00001383|Paclitaxel|paclitaxel|mesh-list
14551223|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551224|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551225|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551226|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551227|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551228|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551229|NCT00001384|Paclitaxel|paclitaxel|mesh-list
14551230|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
14551231|NCT00001384|Doxorubicin|doxorubicin|mesh-list
14551232|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14551233|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551234|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551235|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551236|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551237|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
15085548|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15085549|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
15085550|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085551|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085552|NCT02252328|Simvastatin|simvastatin|mesh-list
15085553|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15085554|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15085555|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
15085556|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085557|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15085558|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15085559|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085560|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
15085561|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15085562|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
15085563|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085564|NCT02252341|Expectorants|expectorants|mesh-ancestor
15085565|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085566|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15085567|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
15085568|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551238|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551239|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551240|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
14551241|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551242|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551243|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551244|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
14551245|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551246|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14551247|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15085569|NCT02252341|Protective Agents|protective agents|mesh-ancestor
15085570|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085571|NCT02252341|Antidotes|antidotes|mesh-ancestor
15085572|NCT02252367|Tadalafil|tadalafil|mesh-list
15085573|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
15085574|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14267954|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14267955|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14267956|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14267957|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14551248|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14551249|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551250|NCT00001387|Paclitaxel|paclitaxel|mesh-list
14551251|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15085575|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15085576|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085577|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085578|NCT02252367|Urological Agents|urological agents|mesh-ancestor
15085579|NCT02252419|Acetaminophen|acetaminophen|mesh-list
15085580|NCT02252419|Dexamethasone|dexamethasone|mesh-list
15085581|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085582|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
13996097|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551252|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551253|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551254|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551255|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551256|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551257|NCT00001407|Interferons|interferons|mesh-list
14551258|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
13996098|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14267958|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
14267959|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14267960|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14267961|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
14267962|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14267963|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14267964|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14267965|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14267966|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
13996099|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13996100|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996101|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
13996102|NCT02922660|Remifentanil|remifentanil|mesh-list
13996103|NCT02922660|Anesthetics|anesthetics|mesh-list
13996104|NCT02922660|Propofol|propofol|mesh-list
13996105|NCT02922660|Desflurane|desflurane|mesh-list
13996106|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996107|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996108|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13996109|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13996110|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
13996111|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13996112|NCT02922660|Narcotics|narcotics|mesh-ancestor
13996113|NCT02922660|Analgesics|analgesics|mesh-ancestor
13996114|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
13996115|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996116|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13996117|NCT02922465|Clopidogrel|clopidogrel|mesh-list
13996118|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13996119|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13996120|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14267967|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267968|NCT00392834|Antidotes|antidotes|mesh-ancestor
14551259|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085583|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
15085584|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267969|NCT00392834|Protective Agents|protective agents|mesh-ancestor
14551260|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
14551261|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551262|NCT00001409|Interleukin-2|interleukin-2|mesh-list
14551263|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551264|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551265|NCT00001409|Analgesics|analgesics|mesh-ancestor
14551266|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
14551267|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551268|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551269|NCT00001421|Methimazole|methimazole|mesh-list
14551270|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
14551271|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
14551272|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551273|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551274|NCT00001422|Fludarabine|fludarabine|mesh-list
14551275|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551276|NCT00001426|Paclitaxel|paclitaxel|mesh-list
14551277|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
14551278|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551279|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551280|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551281|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551282|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551283|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551284|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551285|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
14551286|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551287|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551288|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551289|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
14551290|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551291|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
14551292|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551293|NCT00001428|Fluorouracil|fluorouracil|mesh-list
14551294|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
14551295|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551296|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14551297|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551298|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551299|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
14551300|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551301|NCT00001431|Gemcitabine|gemcitabine|mesh-list
14551302|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14551303|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
14551304|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551305|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551306|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
14551307|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551308|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551309|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551310|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
14551311|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551312|NCT00001436|Tamoxifen|tamoxifen|mesh-list
14551313|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14551314|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
14551315|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551316|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551317|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14551318|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551319|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14551320|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14551321|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14551322|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
14551323|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14551324|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551325|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551326|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14551327|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14551328|NCT00001437|Protective Agents|protective agents|mesh-ancestor
14551329|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551330|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
14551331|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14551332|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
14551333|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
14551334|NCT00001438|Tretinoin|tretinoin|mesh-list
14551335|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551336|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
15085585|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085586|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085587|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
15085588|NCT02252419|Hormones|hormones|mesh-ancestor
15085589|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15085590|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15085591|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085592|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085593|NCT02252419|Analgesics|analgesics|mesh-ancestor
15085594|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
15085595|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
15085596|NCT02252458|Fentanyl|fentanyl|mesh-list
15085597|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15085598|NCT02252458|Narcotics|narcotics|mesh-ancestor
15085599|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085600|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085601|NCT02252458|Analgesics|analgesics|mesh-ancestor
15085602|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
15085603|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085604|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14551337|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551338|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
14551339|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643420|NCT00189358|Tamoxifen|tamoxifen|mesh-list
14643421|NCT00189358|Gefitinib|gefitinib|mesh-list
14643422|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14643423|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
14643424|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643425|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643426|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14643427|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643428|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14643429|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14643430|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14643431|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14643432|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643433|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643434|NCT00189371|Paclitaxel|paclitaxel|mesh-list
14643435|NCT00189371|Carboplatin|carboplatin|mesh-list
14643436|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
14643437|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14643438|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643439|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
14643440|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
14643441|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
14643442|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643443|NCT00189371|Hematinics|hematinics|mesh-ancestor
14643444|NCT00189384|Gentamicins|gentamicins|mesh-list
14643445|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
14643446|NCT00189384|Penicillins|penicillins|mesh-list
14643447|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14643448|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
14643449|NCT00189384|Penicillin G|penicillin g|mesh-list
14808817|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
14808818|NCT00829257|Hormones|hormones|mesh-ancestor
14808819|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15085605|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15085606|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
15085607|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
15085608|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
15085609|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15085610|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15085611|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808820|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
14808821|NCT00829322|Modafinil|modafinil|mesh-list
14808822|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14808823|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808824|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15085612|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
15085613|NCT02252497|Coagulants|coagulants|mesh-ancestor
13996121|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14643450|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
15085614|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
14551340|NCT00001440|Interleukin-2|interleukin-2|mesh-list
14551341|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551342|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551343|NCT00001440|Analgesics|analgesics|mesh-ancestor
14551344|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
14551345|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551346|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551347|NCT00001442|Paclitaxel|paclitaxel|mesh-list
14551348|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551349|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551350|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551351|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551352|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551353|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551354|NCT00001443|Indinavir|indinavir|mesh-list
14551355|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085615|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15085616|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085617|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551356|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14551357|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
14551358|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551359|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551360|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551361|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551362|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
14551363|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551364|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14551365|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551366|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14551367|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551368|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551369|NCT00001446|Thalidomide|thalidomide|mesh-list
15085618|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085619|NCT02252523|Analgesics|analgesics|mesh-ancestor
15085620|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
13996122|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
13996123|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085621|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085622|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15085623|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15085624|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15085625|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
15085626|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085627|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085628|NCT02252614|Acetaminophen|acetaminophen|mesh-list
15085629|NCT02252614|Naproxen|naproxen|mesh-list
15085630|NCT02252614|Codeine|codeine|mesh-list
15085631|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085632|NCT02252614|Analgesics|analgesics|mesh-ancestor
15085633|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
15085634|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085635|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085636|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
13996124|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267970|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
14267971|NCT00392834|Vitamins|vitamins|mesh-ancestor
14267972|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
14267973|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
14267974|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
14267975|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
14267976|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14267977|NCT00392925|Pramlintide|pramlintide|mesh-list
14267978|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14267979|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15173007|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
14267980|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173008|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551370|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551371|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
14551372|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551373|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
14551374|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551375|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551376|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15085637|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15085638|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085639|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551377|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14551378|NCT00001446|Growth Substances|growth substances|mesh-ancestor
14551379|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
14551380|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551381|NCT00001449|Leucovorin|leucovorin|mesh-list
15085640|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
15085641|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15085642|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085643|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085644|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15085645|NCT02252614|Narcotics|narcotics|mesh-ancestor
15085646|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085647|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
15085648|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085649|NCT02252627|Phenylephrine|phenylephrine|mesh-list
15085650|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
15085651|NCT02252627|Ephedrine|ephedrine|mesh-list
15085652|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15085653|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
15085654|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
15085655|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14267981|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
14267982|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14267983|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
13996125|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996126|NCT02922426|Olanzapine|olanzapine|mesh-list
15085656|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085657|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
15085658|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15085659|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
14551382|NCT00001449|Gemcitabine|gemcitabine|mesh-list
14551383|NCT00001449|Floxuridine|floxuridine|mesh-list
14551384|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14551385|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
14551386|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551387|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551388|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
14551389|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551390|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551391|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551392|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
14551393|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551394|NCT00001449|Antidotes|antidotes|mesh-ancestor
14551395|NCT00001449|Protective Agents|protective agents|mesh-ancestor
14551396|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
14551397|NCT00001449|Vitamins|vitamins|mesh-ancestor
14551398|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
14551399|NCT00001450|Paclitaxel|paclitaxel|mesh-list
14551400|NCT00001450|Cisplatin|cisplatin|mesh-list
14551401|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551402|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996127|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
13996128|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
13996129|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996130|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996131|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085660|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085661|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15085662|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14551403|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551404|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
15085663|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14551405|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551406|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551407|NCT00001457|Lamivudine|lamivudine|mesh-list
14551408|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14551409|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551410|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551411|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551412|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
14551413|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551414|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551415|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551416|NCT00001474|Interleukin-2|interleukin-2|mesh-list
15085664|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
15085665|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085666|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085667|NCT02252627|Protective Agents|protective agents|mesh-ancestor
15085668|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15085669|NCT02252692|Enalapril|enalapril|mesh-list
15085670|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15085671|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085672|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085673|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551417|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551418|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551419|NCT00001474|Analgesics|analgesics|mesh-ancestor
14551420|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
14551421|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551422|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551423|NCT00001475|Thalidomide|thalidomide|mesh-list
14551424|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551425|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
14551426|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551427|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
14551428|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551429|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085674|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15085675|NCT02252731|Warfarin|warfarin|mesh-list
15085676|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
15085677|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
15085678|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15085679|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
15085680|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085681|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085682|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15085683|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085684|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15085685|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
15085686|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085687|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085688|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15085689|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
15085690|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
15085691|NCT02252770|Protective Agents|protective agents|mesh-ancestor
15085692|NCT02252796|Paclitaxel|paclitaxel|mesh-list
15085693|NCT02252796|Carboplatin|carboplatin|mesh-list
15085694|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15085695|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085696|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
15085697|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
15085698|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
15085699|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085700|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
15085701|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15085702|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15085703|NCT02252809|Prednisolone|prednisolone|mesh-list
15085704|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
15085705|NCT02252809|Adalimumab|adalimumab|mesh-list
15085706|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15085707|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
15085708|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085709|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
15085710|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
15085711|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085712|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085713|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14551430|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14551431|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14551432|NCT00001475|Growth Substances|growth substances|mesh-ancestor
14551433|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
14551434|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085714|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
15085715|NCT02252809|Hormones|hormones|mesh-ancestor
15085716|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551435|NCT00001482|Lamotrigine|lamotrigine|mesh-list
14551436|NCT00001482|Gabapentin|gabapentin|mesh-list
14551437|NCT00001482|Analgesics|analgesics|mesh-ancestor
14551438|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
15085717|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15085718|NCT02252809|Protective Agents|protective agents|mesh-ancestor
15085719|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15085720|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085721|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085722|NCT02252887|Gemcitabine|gemcitabine|mesh-list
15085723|NCT02252887|Trastuzumab|trastuzumab|mesh-list
15085724|NCT02252887|Pertuzumab|pertuzumab|mesh-list
15085725|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15085726|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
15085727|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085728|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085729|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
15085730|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085731|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085732|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15085733|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
15085734|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085735|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15085736|NCT02252913|Docetaxel|docetaxel|mesh-list
15085737|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085738|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
15085739|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
15085740|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
15085741|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085742|NCT02252926|Acetaminophen|acetaminophen|mesh-list
15085743|NCT02252926|Lidocaine|lidocaine|mesh-list
15085744|NCT02252926|Morphine|morphine|mesh-list
15085745|NCT02252926|Gabapentin|gabapentin|mesh-list
15085746|NCT02252926|Bupivacaine|bupivacaine|mesh-list
15085747|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
15085748|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
15085749|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085750|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085751|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
15085752|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085753|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15085754|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14267984|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14267985|NCT00392951|Sirolimus|sirolimus|mesh-list
14267986|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14267987|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14267988|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15085755|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15085756|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15085757|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085758|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15085759|NCT02252926|Narcotics|narcotics|mesh-ancestor
15085760|NCT02252926|Analgesics|analgesics|mesh-ancestor
15085761|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085762|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
14267989|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14267990|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
14267991|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14267992|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
14267993|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14267994|NCT00392990|Cytarabine|cytarabine|mesh-list
14267995|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
14267996|NCT00392990|Ifosfamide|ifosfamide|mesh-list
14267997|NCT00392990|Rituximab|rituximab|mesh-list
14267998|NCT00392990|Doxorubicin|doxorubicin|mesh-list
14267999|NCT00392990|Methotrexate|methotrexate|mesh-list
15085763|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
15085764|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14268000|NCT00392990|Etoposide|etoposide|mesh-list
14268001|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
14268002|NCT00392990|Vincristine|vincristine|mesh-list
14551439|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268003|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14268004|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
14268005|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268006|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
14268007|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268008|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268009|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14268010|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
14268011|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268012|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268013|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551440|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551441|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
14551442|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14551443|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14551444|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14551445|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14551446|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14551447|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14551448|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551449|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551450|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
14551451|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14551452|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14551453|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14551454|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14551455|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14551456|NCT00001483|Sertraline|sertraline|mesh-list
14551457|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14551458|NCT00001483|Bupropion|bupropion|mesh-list
14551459|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
14551460|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14551461|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14551462|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14551463|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14551464|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551465|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551466|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
14551467|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551468|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14551469|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14551470|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14551471|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
14551472|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14551473|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14551474|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551475|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14551476|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14551477|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
14551478|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551479|NCT00001495|Irinotecan|irinotecan|mesh-list
14551480|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14268014|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268015|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14268016|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14268017|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14268018|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268019|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14268020|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
14268021|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14268022|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268023|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
14268024|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
14268025|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14551481|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14551482|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551483|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551484|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085765|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15085766|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15085767|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15085768|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14551485|NCT00001498|Leucovorin|leucovorin|mesh-list
14551486|NCT00001498|Paclitaxel|paclitaxel|mesh-list
14551487|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
14551488|NCT00001498|Doxorubicin|doxorubicin|mesh-list
14551489|NCT00001498|Fluorouracil|fluorouracil|mesh-list
14551490|NCT00001498|Methotrexate|methotrexate|mesh-list
14551491|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551492|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551493|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551494|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551495|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551496|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551497|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551498|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
14551499|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551500|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551501|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551502|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
14551503|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551504|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14551505|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14551506|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14551507|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551508|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
15085769|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085770|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
15085771|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
15085772|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15085773|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085774|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15085775|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15085776|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085777|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085778|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085779|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15085780|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085781|NCT02253004|Cilostazol|cilostazol|mesh-list
15085782|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15085783|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
15085784|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085785|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085786|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15085787|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
15085788|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15085789|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15085790|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085791|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15085792|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
15085793|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15085794|NCT02253004|Protective Agents|protective agents|mesh-ancestor
15085795|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15085796|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15085797|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085798|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
15085799|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085800|NCT02253095|Micronutrients|micronutrients|mesh-list
15085801|NCT02253095|Trace Elements|trace elements|mesh-list
15085802|NCT02253095|Albendazole|albendazole|mesh-list
15085803|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
15085804|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15085805|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085806|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
15085807|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15085808|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15085809|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
15085810|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
15085811|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
15085812|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085813|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085814|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085815|NCT02253108|Everolimus|everolimus|mesh-list
14551509|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15085816|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643451|NCT00189384|Procaine|procaine|mesh-list
14551510|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14551511|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
14551512|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14551513|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551514|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14551515|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551516|NCT00001498|Antidotes|antidotes|mesh-ancestor
14551517|NCT00001498|Protective Agents|protective agents|mesh-ancestor
14551518|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
14551519|NCT00001498|Vitamins|vitamins|mesh-ancestor
14551520|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
14551521|NCT00001499|Paclitaxel|paclitaxel|mesh-list
14551522|NCT00001499|Cisplatin|cisplatin|mesh-list
14551523|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551524|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551525|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551526|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551527|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551528|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551529|NCT00001502|Carboplatin|carboplatin|mesh-list
14551530|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551531|NCT00001504|Tretinoin|tretinoin|mesh-list
14551532|NCT00001504|Alitretinoin|alitretinoin|mesh-list
14551533|NCT00001504|Isotretinoin|isotretinoin|mesh-list
14551534|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551535|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
14551536|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
15085817|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15085818|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
15085819|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085820|NCT02253121|Insulin|insulin|mesh-list
15085821|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14551537|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14551538|NCT00001507|Antibodies|antibodies|mesh-list
14551539|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
14268026|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14268027|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14268028|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
14268029|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268030|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268031|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
14268032|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
14268033|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
14268034|NCT00393029|Aldesleukin|aldesleukin|mesh-list
14268035|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
14268036|NCT00393029|Fludarabine|fludarabine|mesh-list
14268037|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
14268038|NCT00393029|Interleukin-2|interleukin-2|mesh-list
14268039|NCT00393029|Lenograstim|lenograstim|mesh-list
14268040|NCT00393029|Sargramostim|sargramostim|mesh-list
14268041|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268042|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
14551540|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14551541|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
15085822|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
15085823|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15085824|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085825|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15085826|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085827|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
15085828|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15085829|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085830|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085831|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551542|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551543|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551544|NCT00001509|Tretinoin|tretinoin|mesh-list
14551545|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551546|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
14551547|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551548|NCT00001520|Neostigmine|neostigmine|mesh-list
15085832|NCT02253199|Analgesics|analgesics|mesh-ancestor
14268043|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268044|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551549|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14551550|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551551|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551552|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
14551553|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551554|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551555|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14551556|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
14551557|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551558|NCT00001524|Thalidomide|thalidomide|mesh-list
14551559|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551560|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
14551561|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551562|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
14551563|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551564|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551565|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14551566|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14551567|NCT00001524|Growth Substances|growth substances|mesh-ancestor
14551568|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
14551569|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551570|NCT00001526|Daclizumab|daclizumab|mesh-list
14551571|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551572|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
14551573|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551574|NCT00001533|Cyclosporine|cyclosporine|mesh-list
14551575|NCT00001533|Cyclosporins|cyclosporins|mesh-list
14551576|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551577|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551578|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551579|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
14551580|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551581|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
14551582|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551583|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551584|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085833|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
14551585|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14551586|NCT00001534|Losartan|losartan|mesh-list
14551587|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14551588|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14551589|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14551590|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14551591|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551592|NCT00001535|Interleukin-2|interleukin-2|mesh-list
14551593|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551594|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551595|NCT00001535|Analgesics|analgesics|mesh-ancestor
14551596|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
14551597|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551598|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551599|NCT00001542|Fluconazole|fluconazole|mesh-list
14551600|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
14551601|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551602|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14551603|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14551604|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551605|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551606|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14551607|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
14551608|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551609|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551610|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14551611|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15085834|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085835|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15085836|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15085837|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15085838|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
15085839|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085840|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085841|NCT02253212|Carboplatin|carboplatin|mesh-list
15085842|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085843|NCT02253264|Rituximab|rituximab|mesh-list
15085844|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15085845|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085846|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
14551612|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
14551613|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14551614|NCT00001561|Antibodies|antibodies|mesh-list
14551615|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14551616|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
14551617|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085847|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085848|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085849|NCT02253420|Itraconazole|itraconazole|mesh-list
15085850|NCT02253420|Rifampin|rifampin|mesh-list
15085851|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
15085852|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085853|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15085854|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085855|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085856|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551618|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14551619|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551620|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
14551621|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551622|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
14551623|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551624|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
14268045|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14268046|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
14268047|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551625|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14551626|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
14551627|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551628|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
14551629|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551630|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14551631|NCT00001569|Paclitaxel|paclitaxel|mesh-list
14551632|NCT00001569|Cisplatin|cisplatin|mesh-list
14808825|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14808826|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14808827|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808828|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14808829|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
14808830|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808831|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14808832|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14808833|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14808834|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14808835|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14808836|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
14808837|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808838|NCT00829608|Vaccines|vaccines|mesh-list
14808839|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
14808840|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808841|NCT00829634|Methamphetamine|methamphetamine|mesh-list
14808842|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14808843|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808844|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
14808845|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
14808846|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808847|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
14808848|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808849|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808850|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14268048|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268049|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14268050|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268051|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
14551633|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14808851|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14808852|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15085857|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15085858|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
15085859|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15085860|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551634|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551635|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
15085861|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085862|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14268052|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14268053|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14268054|NCT00393029|Analgesics|analgesics|mesh-ancestor
14268055|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
14268056|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551636|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551637|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551638|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551639|NCT00001570|Vinblastine|vinblastine|mesh-list
14551640|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551641|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551642|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551643|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551644|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551645|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551646|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
14551647|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14551648|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
14551649|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551650|NCT00001576|Leucovorin|leucovorin|mesh-list
14551651|NCT00001576|Melphalan|melphalan|mesh-list
14551652|NCT00001576|Floxuridine|floxuridine|mesh-list
14551653|NCT00001576|Antidotes|antidotes|mesh-ancestor
14551654|NCT00001576|Protective Agents|protective agents|mesh-ancestor
14551655|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085863|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
15085864|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15085865|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
15085866|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15085867|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15085868|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15085869|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15085870|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15085871|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15085872|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15085873|NCT02253446|Diclofenac|diclofenac|mesh-list
15085874|NCT02253446|Piroxicam|piroxicam|mesh-list
15085875|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15085876|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15085877|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15085878|NCT02253446|Analgesics|analgesics|mesh-ancestor
15085879|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
15085880|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268057|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551656|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
14551657|NCT00001576|Vitamins|vitamins|mesh-ancestor
15085881|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085882|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085883|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15085884|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15085885|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085886|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085887|NCT02253459|Capecitabine|capecitabine|mesh-list
15085888|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15085889|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
14551658|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
14551659|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15085890|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085891|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085892|NCT02253485|Telbivudine|telbivudine|mesh-list
15085893|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
15085894|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085895|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15085896|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085897|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085898|NCT02253524|Metoclopramide|metoclopramide|mesh-list
15085899|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
15085900|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
15085901|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
15085902|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085903|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085904|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085905|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15085906|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15085907|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
15085908|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15085909|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085910|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15085911|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
15085912|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
15085913|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
15085914|NCT02253550|Simeprevir|simeprevir|mesh-list
15085915|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
15085916|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085917|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085918|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085919|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085920|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15085921|NCT02253602|Hematinics|hematinics|mesh-ancestor
15085922|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15085923|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15173009|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996132|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14268058|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14268059|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
14268060|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268061|NCT00393042|Amphetamine|amphetamine|mesh-list
14268062|NCT00393042|Adderall|adderall|mesh-list
14268063|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14268064|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14268065|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268066|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
14268067|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
14268068|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268069|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
14551660|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
14551661|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551662|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551663|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551664|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551665|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
14551666|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14551667|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
14551668|NCT00001577|Melphalan|melphalan|mesh-list
14551669|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551670|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
14551671|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551672|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551673|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551674|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551675|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
14551676|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551677|NCT00001579|Leucovorin|leucovorin|mesh-list
14551678|NCT00001579|Fluorouracil|fluorouracil|mesh-list
14551679|NCT00001579|Eniluracil|eniluracil|mesh-list
14551680|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
14551681|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551682|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14551683|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551684|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551685|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
14551686|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268070|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268071|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268072|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
14268073|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14268074|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14268075|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14551687|NCT00001579|Antidotes|antidotes|mesh-ancestor
14551688|NCT00001579|Protective Agents|protective agents|mesh-ancestor
14551689|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
14551690|NCT00001579|Vitamins|vitamins|mesh-ancestor
14551691|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
14551692|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551693|NCT00001587|Melphalan|melphalan|mesh-list
14551694|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551695|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
14551696|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268076|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14268077|NCT00393094|Bevacizumab|bevacizumab|mesh-list
14268078|NCT00393094|Irinotecan|irinotecan|mesh-list
14268079|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268080|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268081|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268082|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268083|NCT00393094|Growth Substances|growth substances|mesh-ancestor
14268084|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268085|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268086|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14268087|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14268088|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268089|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268090|NCT00393367|Prednisone|prednisone|mesh-list
14268091|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
14268092|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14551697|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551698|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15085924|NCT02253758|Propofol|propofol|mesh-list
15085925|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15085926|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085927|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085928|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15085929|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
14551699|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551700|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
14551701|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643452|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643453|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643454|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14643455|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643456|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643457|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14643458|NCT00189384|Renal Agents|renal agents|mesh-ancestor
14643459|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
14643460|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14643461|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15085930|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
14643462|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
14643463|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
15085931|NCT02253784|Dexamethasone|dexamethasone|mesh-list
14551702|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14551703|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14551704|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
14551705|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551706|NCT00001599|Thalidomide|thalidomide|mesh-list
14551707|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551708|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
14551709|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551710|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
14551711|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551712|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551713|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14551714|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14551715|NCT00001599|Growth Substances|growth substances|mesh-ancestor
14551716|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
14551717|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551718|NCT00001624|Insulin|insulin|mesh-list
14551719|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14551720|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551721|NCT00001626|Cyclosporine|cyclosporine|mesh-list
14551722|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
14551723|NCT00001626|Cyclosporins|cyclosporins|mesh-list
14551724|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14551725|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551726|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
14551727|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551728|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551729|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14551730|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
14551731|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551732|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551733|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14551734|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551735|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
14551736|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551737|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551738|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14551739|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
14551740|NCT00001628|Giapreza|giapreza|mesh-list
14551741|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
14551742|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
14551743|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14551744|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14551745|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
14551746|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551747|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551748|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14551749|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
14551750|NCT00001629|Giapreza|giapreza|mesh-list
14551751|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
14551752|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
14551753|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14551754|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14551755|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
14551756|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551757|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551758|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14551759|NCT00001644|Lamivudine|lamivudine|mesh-list
14551760|NCT00001644|Zidovudine|zidovudine|mesh-list
14551761|NCT00001644|Nevirapine|nevirapine|mesh-list
14551762|NCT00001644|Indinavir|indinavir|mesh-list
14551763|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14551764|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551765|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551766|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551767|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
14551768|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551769|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551770|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551771|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
14551772|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14551773|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14551774|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13996133|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14551775|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14551776|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
14551777|NCT00001646|Voriconazole|voriconazole|mesh-list
14551778|NCT00001646|Amphotericin B|amphotericin b|mesh-list
14551779|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14551780|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
14551781|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551782|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14551783|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14551784|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551785|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551786|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14551787|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14551788|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551789|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551790|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14551791|NCT00001646|Amebicides|amebicides|mesh-ancestor
14551792|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14551793|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14551794|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551795|NCT00001649|Valacyclovir|valacyclovir|mesh-list
14551796|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
15085932|NCT02253784|Bupivacaine|bupivacaine|mesh-list
15085933|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15085934|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
15085935|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
15085936|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15085937|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15085938|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15085939|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
15085940|NCT02253784|Hormones|hormones|mesh-ancestor
14551797|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551798|NCT00001658|Amoxicillin|amoxicillin|mesh-list
14551799|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551800|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551801|NCT00001666|Methamphetamine|methamphetamine|mesh-list
14551802|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15085941|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15085942|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15085943|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15085944|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
15085945|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
15085946|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085947|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
15085948|NCT02253797|Ritonavir|ritonavir|mesh-list
15085949|NCT02253797|Tipranavir|tipranavir|mesh-list
15085950|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085951|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085952|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085953|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085954|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551803|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551804|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
14551805|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
14551806|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551807|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
14551808|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551809|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551810|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
14551811|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14551812|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14551813|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14551814|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15085955|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085956|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085957|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
15085958|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085959|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085960|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085961|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
15085962|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15085963|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15085964|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085965|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
15085966|NCT02253810|Coagulants|coagulants|mesh-ancestor
15085967|NCT02253836|Ritonavir|ritonavir|mesh-list
15085968|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14551815|NCT00001669|Mecasermin|mecasermin|mesh-list
14551816|NCT00001669|Growth Substances|growth substances|mesh-ancestor
14551817|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551818|NCT00001676|Fludarabine|fludarabine|mesh-list
14551819|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551820|NCT00001677|Methotrexate|methotrexate|mesh-list
14551821|NCT00001677|Fludarabine|fludarabine|mesh-list
14551822|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14551823|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
14551824|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14551825|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551826|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14551827|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
14551828|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551829|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551830|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551831|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551832|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14551833|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551834|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
14551835|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551836|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551837|NCT00001680|Thalidomide|thalidomide|mesh-list
14551838|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551839|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
14551840|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551841|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
14551842|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14551843|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551844|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14551845|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14551846|NCT00001680|Growth Substances|growth substances|mesh-ancestor
14551847|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
14551848|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551849|NCT00001688|Ritonavir|ritonavir|mesh-list
14551850|NCT00001688|Nevirapine|nevirapine|mesh-list
14551851|NCT00001688|Stavudine|stavudine|mesh-list
14551852|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14551853|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14551854|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
14551855|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551856|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551857|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551858|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551859|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
14551860|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551861|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14551862|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14551863|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14551864|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14551865|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14551866|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14551867|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
14551868|NCT00001689|Vincristine|vincristine|mesh-list
14551869|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14551870|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551871|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
14551872|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
14551873|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
14551874|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268093|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14268094|NCT00393367|Prednisolone|prednisolone|mesh-list
14268095|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
14268096|NCT00393367|Budesonide|budesonide|mesh-list
14268097|NCT00393367|Bromides|bromides|mesh-list
14268098|NCT00393367|Albuterol|albuterol|mesh-list
14268099|NCT00393367|Ipratropium|ipratropium|mesh-list
14268100|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14268101|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
14268102|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14268103|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
14268104|NCT00393367|Hormones|hormones|mesh-ancestor
14268105|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268106|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551875|NCT00001693|Celecoxib|celecoxib|mesh-list
14551876|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14551877|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551878|NCT00001693|Analgesics|analgesics|mesh-ancestor
14551879|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
14551880|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551881|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551882|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14551883|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551884|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14551885|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14551886|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551887|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551888|NCT00001696|Genistein|genistein|mesh-list
14268107|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14268108|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268109|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
14268110|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
14268111|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268112|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14268113|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14268114|NCT00393367|Protective Agents|protective agents|mesh-ancestor
14268115|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13996134|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268116|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14268117|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
14268118|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
14268119|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
14268120|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14268121|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14268122|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14268123|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14268124|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
14268125|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268126|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268127|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14268128|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
14268129|NCT00393380|Teriparatide|teriparatide|mesh-list
14268130|NCT00393380|Hormones|hormones|mesh-list
14268131|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
14268132|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268133|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268134|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268135|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14268136|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
14268137|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14268138|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
14268139|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268140|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551889|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14551890|NCT00001696|Protective Agents|protective agents|mesh-ancestor
14551891|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268141|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14268142|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
14268143|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14268144|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15085969|NCT02253836|Tipranavir|tipranavir|mesh-list
15085970|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085971|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085972|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085973|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268145|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14268146|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
14268147|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268148|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268149|NCT00393484|Lamivudine|lamivudine|mesh-list
14268150|NCT00393484|Entecavir|entecavir|mesh-list
14268151|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14268152|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14268153|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268154|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268155|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
14268156|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268157|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14551892|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14551893|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14551894|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551895|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551896|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
14551897|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14551898|NCT00001696|Estrogens|estrogens|mesh-ancestor
14551899|NCT00001696|Hormones|hormones|mesh-ancestor
14551900|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14551901|NCT00001698|Ketorolac|ketorolac|mesh-list
14551902|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14551903|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14551904|NCT00001698|Analgesics|analgesics|mesh-ancestor
14551905|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
15085974|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085975|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085976|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085977|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
15085978|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085979|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085980|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085981|NCT02253849|Ritonavir|ritonavir|mesh-list
15085982|NCT02253849|Tipranavir|tipranavir|mesh-list
15085983|NCT02253849|Carbamazepine|carbamazepine|mesh-list
15085984|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15085985|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15085986|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
15085987|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15085988|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15085989|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15085990|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15085991|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
15085992|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15085993|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15085994|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15085995|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
15085996|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
15085997|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15085998|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15085999|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086000|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086001|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086002|NCT02253849|Analgesics|analgesics|mesh-ancestor
14551906|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551907|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551908|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14551909|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551910|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14551911|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551912|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551913|NCT00001713|Heparin|heparin|mesh-list
14551914|NCT00001713|Plasminogen|plasminogen|mesh-list
14551915|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14551916|NCT00001713|Warfarin|warfarin|mesh-list
14551917|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
14551918|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14551919|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14551920|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551921|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
14551922|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
14551923|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14551924|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
14551925|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551926|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551927|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14551928|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
14551929|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14551930|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
14551931|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551932|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551933|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14551934|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
14551935|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
14551936|NCT00001716|Protective Agents|protective agents|mesh-ancestor
15086003|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
15086004|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086005|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15086006|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086007|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14551937|NCT00001720|Alendronate|alendronate|mesh-list
15086008|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13996135|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086009|NCT02253862|Ritonavir|ritonavir|mesh-list
14268158|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14551938|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14551939|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551940|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
14551941|NCT00001724|Analgesics|analgesics|mesh-ancestor
14551942|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
14551943|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14551944|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551945|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14551946|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086010|NCT02253862|Tipranavir|tipranavir|mesh-list
15086011|NCT02253862|Tadalafil|tadalafil|mesh-list
15086012|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14551947|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14551948|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551949|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14551950|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551951|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551952|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
14551953|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
14551954|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
14551955|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14551956|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14551957|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14551958|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551959|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551960|NCT00001728|Alendronate|alendronate|mesh-list
14551961|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14551962|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808853|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14808854|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14814193|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14814194|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
14814195|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814196|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814197|NCT00861887|Vancomycin|vancomycin|mesh-list
14814198|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14814199|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814200|NCT00861926|Beclomethasone|beclomethasone|mesh-list
14814201|NCT00861926|Albuterol|albuterol|mesh-list
14814202|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
14814203|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14268159|NCT00393705|Insulin|insulin|mesh-list
14268160|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14268161|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
14268162|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268163|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268164|NCT00393718|Liraglutide|liraglutide|mesh-list
14814204|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
14814205|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814206|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814207|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14814208|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
14814209|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14814210|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14814211|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14814212|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814213|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814214|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814215|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
14814216|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15086013|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086014|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086015|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086016|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086017|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086018|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086019|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
15086020|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086021|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14268165|NCT00393718|Glyburide|glyburide|mesh-list
14551963|NCT00001729|Ribavirin|ribavirin|mesh-list
14551964|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
14551965|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551966|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
14551967|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643464|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14643465|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643466|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
14643467|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643468|NCT00189397|Azathioprine|azathioprine|mesh-list
14643469|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
14643470|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643471|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643472|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643473|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643474|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
14643475|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643476|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643477|NCT00189410|Carboplatin|carboplatin|mesh-list
14643478|NCT00189410|Doxorubicin|doxorubicin|mesh-list
14643479|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14643480|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643481|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14643482|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14643483|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14643484|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643485|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643486|NCT00189501|Cinacalcet|cinacalcet|mesh-list
14643487|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268166|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268167|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268168|NCT00393718|Incretins|incretins|mesh-ancestor
14268169|NCT00393718|Hormones|hormones|mesh-ancestor
14268170|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268171|NCT00393796|Sunitinib|sunitinib|mesh-list
14268172|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268173|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268174|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268175|NCT00393796|Growth Substances|growth substances|mesh-ancestor
14268176|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643488|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643489|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15086022|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086023|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
15086024|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15086025|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15086026|NCT02253862|Urological Agents|urological agents|mesh-ancestor
15086027|NCT02253875|Ritonavir|ritonavir|mesh-list
15086028|NCT02253875|Tipranavir|tipranavir|mesh-list
15086029|NCT02253875|Omeprazole|omeprazole|mesh-list
15086030|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086031|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086032|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
14643490|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
14643491|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643492|NCT00189514|Pramlintide|pramlintide|mesh-list
14643493|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14643494|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643495|NCT00189553|Paclitaxel|paclitaxel|mesh-list
14643496|NCT00189553|Carboplatin|carboplatin|mesh-list
14643497|NCT00189553|Doxorubicin|doxorubicin|mesh-list
14643498|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14643499|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14643500|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643501|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
14643502|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
14643503|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
14643504|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808855|NCT00829647|Lenalidomide|lenalidomide|mesh-list
15086033|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086034|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086035|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086036|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14268177|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268178|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15086037|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
15086038|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086039|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086040|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086041|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15086042|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15086043|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15086044|NCT02253888|Ritonavir|ritonavir|mesh-list
15086045|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086046|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086047|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086048|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086049|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086050|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086051|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086052|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
15086053|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086054|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086055|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086056|NCT02253901|Ritonavir|ritonavir|mesh-list
15086057|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14551968|NCT00001731|Cyclosporine|cyclosporine|mesh-list
14551969|NCT00001731|Cyclosporins|cyclosporins|mesh-list
14551970|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551971|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551972|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551973|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
14551974|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551975|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
14551976|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551977|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551978|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551979|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14551980|NCT00001736|Cysteamine|cysteamine|mesh-list
14551981|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14551982|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551983|NCT00001737|Cyclosporine|cyclosporine|mesh-list
14551984|NCT00001737|Cyclosporins|cyclosporins|mesh-list
14551985|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14551986|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14551987|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14551988|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
14551989|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14551990|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
14551991|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14551992|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
14551993|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14551994|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14551995|NCT00001741|Losartan|losartan|mesh-list
14551996|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14551997|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14551998|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14551999|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14552000|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552001|NCT00001749|Cyclosporine|cyclosporine|mesh-list
14552002|NCT00001749|Cyclosporins|cyclosporins|mesh-list
14552003|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14552004|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268179|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268180|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268181|NCT00393848|Ketoconazole|ketoconazole|mesh-list
14268182|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
14268183|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268184|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14268185|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552005|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086058|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086059|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14552006|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552007|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
14552008|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552009|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
14552010|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552011|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14552012|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552013|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14552014|NCT00001752|Estrogens|estrogens|mesh-list
14552015|NCT00001752|Hormones|hormones|mesh-ancestor
14552016|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552017|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552018|NCT00001757|Voriconazole|voriconazole|mesh-list
14552019|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
14552020|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552021|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14552022|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552023|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552024|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268186|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268187|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268188|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552025|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552026|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
14552027|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552028|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552029|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14552030|NCT00001758|Efavirenz|efavirenz|mesh-list
14552031|NCT00001758|Abacavir|abacavir|mesh-list
14552032|NCT00001758|Amprenavir|amprenavir|mesh-list
14552033|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552034|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552035|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552036|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552037|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
14552038|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552039|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14552040|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552041|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14552042|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14552043|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14552044|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15086060|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086061|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086062|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086063|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086064|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086065|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
15086066|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086067|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086068|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086069|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15086070|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15086071|NCT02253914|Ritonavir|ritonavir|mesh-list
15086072|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086073|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086074|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086075|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086076|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552045|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552046|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552047|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14552048|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
14552049|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552050|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14552051|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086077|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268189|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
14268190|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268191|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268192|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14552052|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
14552053|NCT00001763|Interleukin-12|interleukin-12|mesh-list
14552054|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14552055|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
14552056|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552057|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14552058|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14552059|NCT00001763|Growth Substances|growth substances|mesh-ancestor
14552060|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
14552061|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552062|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
14552063|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14552064|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552065|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14552066|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
14552067|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552068|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552069|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552070|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552071|NCT00001766|Ritonavir|ritonavir|mesh-list
14552072|NCT00001766|Nelfinavir|nelfinavir|mesh-list
14552073|NCT00001766|Amprenavir|amprenavir|mesh-list
14552074|NCT00001766|Abacavir|abacavir|mesh-list
14552075|NCT00001766|Efavirenz|efavirenz|mesh-list
14552076|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14552077|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14552078|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
14552079|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268193|NCT00393861|Bevacizumab|bevacizumab|mesh-list
14268194|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
14552080|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552081|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552082|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14808856|NCT00829647|Dasatinib|dasatinib|mesh-list
15086078|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086079|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
15086080|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086081|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086082|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086083|NCT02253927|Ritonavir|ritonavir|mesh-list
15086084|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086085|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086086|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086087|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086088|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086089|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086090|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086091|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
15086092|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086093|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086094|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086095|NCT02253940|Ritonavir|ritonavir|mesh-list
15086096|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086097|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086098|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086099|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086100|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086101|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086102|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086103|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
15086104|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086105|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086106|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552083|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
14552084|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552085|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14552086|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552087|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552088|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552089|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14552090|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14552091|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14552092|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14552093|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14552094|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14552095|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
14552096|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552097|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
14552098|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14552099|NCT00001768|Antibodies|antibodies|mesh-list
14552100|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
14552101|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14552102|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
14552103|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552104|NCT00001777|Sertraline|sertraline|mesh-list
14552105|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
14552106|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14552107|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14552108|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14552109|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14552110|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552111|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552112|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
14552113|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552114|NCT00001784|Mexiletine|mexiletine|mesh-list
14552115|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14552116|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14552117|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14552118|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14552119|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552120|NCT00001785|Interferons|interferons|mesh-list
14552121|NCT00001785|Interferon-beta|interferon-beta|mesh-list
14552122|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
14552123|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086107|NCT02253953|Ritonavir|ritonavir|mesh-list
15086108|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086109|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086110|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
14552124|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
15086111|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086112|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086113|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086114|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086115|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
15086116|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086117|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086118|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14268195|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268196|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268197|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268198|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268199|NCT00393861|Growth Substances|growth substances|mesh-ancestor
14268200|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268201|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268202|NCT00393874|Prazosin|prazosin|mesh-list
14268203|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14268204|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14268205|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14268206|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14268207|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14268208|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268209|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268210|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268211|NCT00393939|Docetaxel|docetaxel|mesh-list
14268212|NCT00393939|Sunitinib|sunitinib|mesh-list
14268213|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268214|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268215|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14552125|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268216|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14268217|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552126|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
14552127|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552128|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14552129|NCT00001790|Micafungin|micafungin|mesh-list
14552130|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
14552131|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552132|NCT00001805|Rituximab|rituximab|mesh-list
14552133|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14552134|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552135|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
14552136|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552137|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552138|NCT00001810|Voriconazole|voriconazole|mesh-list
14552139|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
14268218|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268219|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14552140|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552141|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14552142|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552143|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552144|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552145|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552146|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
14552147|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552148|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552149|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14552150|NCT00001812|Nystatin|nystatin|mesh-list
14552151|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552152|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552153|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
14552154|NCT00001812|Ionophores|ionophores|mesh-ancestor
14552155|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14552156|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552157|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
14552158|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552159|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
14552160|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552161|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552162|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552163|NCT00001827|Aldesleukin|aldesleukin|mesh-list
14552164|NCT00001827|Sargramostim|sargramostim|mesh-list
14552165|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
14552166|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
14552167|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552168|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552169|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552170|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552171|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
14552172|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552173|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14552174|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
14552175|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552176|NCT00001839|Cyclosporine|cyclosporine|mesh-list
14552177|NCT00001839|Cyclosporins|cyclosporins|mesh-list
14552178|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14552179|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552180|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552181|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552182|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
14552183|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552184|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
14552185|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552186|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14552187|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552188|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14552189|NCT00001842|Dexamethasone|dexamethasone|mesh-list
14552190|NCT00001842|Sargramostim|sargramostim|mesh-list
14552191|NCT00001842|Lenograstim|lenograstim|mesh-list
14552192|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14552193|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
14552194|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
14552195|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552196|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552197|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552198|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
14552199|NCT00001842|Hormones|hormones|mesh-ancestor
14552200|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552201|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14552202|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552203|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
14552204|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14552205|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14552206|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14808857|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
14808858|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808859|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14808860|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14808861|NCT00829647|Growth Substances|growth substances|mesh-ancestor
14808862|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
14808863|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808864|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14808865|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808866|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808867|NCT00829660|Acarbose|acarbose|mesh-list
14808868|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14808869|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808870|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808871|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14808872|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808873|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14808874|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14808875|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14808876|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14808877|NCT00829777|Naloxone|naloxone|mesh-list
14808878|NCT00829777|Lactulose|lactulose|mesh-list
14808879|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14808880|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808881|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
14808882|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808883|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14808884|NCT00829881|Betahistine|betahistine|mesh-list
14808885|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
14808886|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
14808887|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
14808888|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808889|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808890|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808891|NCT00829894|Risperidone|risperidone|mesh-list
14808892|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15086119|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15086120|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
15086121|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14808893|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
14808894|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808895|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808896|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808897|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14808898|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14808899|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808900|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808901|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14808902|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
14808903|NCT00830050|Naproxen|naproxen|mesh-list
14808904|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14808905|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14808906|NCT00830050|Analgesics|analgesics|mesh-ancestor
14808907|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
15086122|NCT02253966|Prednisolone|prednisolone|mesh-list
15086123|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
15086124|NCT02253966|Lidocaine|lidocaine|mesh-list
15086125|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15086126|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
15086127|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
15086128|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
15086129|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808908|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086130|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086131|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
15086132|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086133|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15086134|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14552207|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
14552208|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552209|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552210|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14552211|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14552212|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14552213|NCT00001854|Ribavirin|ribavirin|mesh-list
14552214|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
14552215|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552216|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
14552217|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552218|NCT00001860|Octreotide|octreotide|mesh-list
14552219|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552220|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14552221|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552222|NCT00001862|Etanercept|etanercept|mesh-list
14552223|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14552224|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552225|NCT00001862|Analgesics|analgesics|mesh-ancestor
14552226|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
14552227|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086135|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15086136|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086137|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086138|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086139|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
15086140|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
15086141|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15086142|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
15086143|NCT02253966|Hormones|hormones|mesh-ancestor
15086144|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15086145|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15086146|NCT02253966|Protective Agents|protective agents|mesh-ancestor
15086147|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15086148|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086149|NCT02254005|Maytansine|maytansine|mesh-list
15086150|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
15086151|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15086152|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086153|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
15086154|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
15086155|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
15086156|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086157|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15086158|NCT02254018|Maytansine|maytansine|mesh-list
15086159|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
15086160|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15086161|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086162|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
15086163|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
15086164|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
15086165|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086166|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15086167|NCT02254031|Maytansine|maytansine|mesh-list
15086168|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
15086169|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15086170|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086171|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
15086172|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
15086173|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
15086174|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086175|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15086176|NCT02254044|Maytansine|maytansine|mesh-list
15086177|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
15086178|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15086179|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086180|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
15086181|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
15086182|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
14552228|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552229|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14552230|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552231|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552232|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552233|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
14552234|NCT00001863|Leflunomide|leflunomide|mesh-list
14552235|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552236|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552237|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552238|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
14552239|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552240|NCT00001864|Atropine|atropine|mesh-list
14552241|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14552242|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14552243|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14552244|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
14552245|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552246|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552247|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14552248|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
14552249|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
14552250|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
14552251|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14552252|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14552253|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
14552254|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552255|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552256|NCT00001865|Daclizumab|daclizumab|mesh-list
14552257|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552258|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
14552259|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552260|NCT00001870|Acetylcholine|acetylcholine|mesh-list
14552261|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
14552262|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14552263|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
14552264|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552265|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552266|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552267|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
14552268|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14552269|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552270|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552271|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14552272|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14552273|NCT00001877|Protective Agents|protective agents|mesh-ancestor
14552274|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552275|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
14552276|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14552277|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
14552278|NCT00001889|Dobutamine|dobutamine|mesh-list
14552279|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14552280|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
14552281|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
14552282|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552283|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552284|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14552285|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14552286|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14552287|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
14552288|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552289|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552290|NCT00001889|Protective Agents|protective agents|mesh-ancestor
14643505|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14643506|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15086183|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086184|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15086185|NCT02254148|Metoprolol|metoprolol|mesh-list
15086186|NCT02254148|Digoxin|digoxin|mesh-list
15086187|NCT02254148|Midazolam|midazolam|mesh-list
15086188|NCT02254148|Caffeine|caffeine|mesh-list
15086189|NCT02254148|Omeprazole|omeprazole|mesh-list
15086190|NCT02254148|Warfarin|warfarin|mesh-list
15086191|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15086192|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15086193|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086194|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552291|NCT00001890|Estrogens|estrogens|mesh-list
14552292|NCT00001890|Hormones|hormones|mesh-ancestor
14552293|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552294|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552295|NCT00001891|Dobutamine|dobutamine|mesh-list
14552296|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14552297|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
14552298|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
14552299|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552300|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552301|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14552302|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14552303|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14268220|NCT00393939|Growth Substances|growth substances|mesh-ancestor
15086195|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15086196|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086197|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086198|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15086199|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
15086200|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
15086201|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
15086202|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
15086203|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086204|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086205|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
15086206|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14268221|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268222|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268223|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14268224|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268225|NCT00393978|Topiramate|topiramate|mesh-list
14268226|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14268227|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
14552304|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14552305|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552306|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552307|NCT00001891|Protective Agents|protective agents|mesh-ancestor
14552308|NCT00001893|Etanercept|etanercept|mesh-list
14552309|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14552310|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552311|NCT00001893|Analgesics|analgesics|mesh-ancestor
14552312|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
14552313|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552314|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552315|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14552316|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552317|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552318|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552319|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
14552320|NCT00001901|Etanercept|etanercept|mesh-list
14552321|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14552322|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552323|NCT00001901|Analgesics|analgesics|mesh-ancestor
14552324|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
15086207|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14268228|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268229|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14268230|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14268231|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268232|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268233|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
14268234|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268235|NCT00394082|Paclitaxel|paclitaxel|mesh-list
15086208|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15086209|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086210|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15086211|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14552325|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268236|NCT00394082|Bevacizumab|bevacizumab|mesh-list
15086212|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15086213|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15086214|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
15086215|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15086216|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15086217|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
15086218|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
14552326|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552327|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14552328|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552329|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552330|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552331|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
14552332|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
14552333|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14552334|NCT00001903|Antibodies|antibodies|mesh-list
14552335|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
14552336|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086219|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086220|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15086221|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15086222|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15086223|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086224|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15086225|NCT02254148|Protective Agents|protective agents|mesh-ancestor
15086226|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
15086227|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14552337|NCT00001905|Interferons|interferons|mesh-list
14552338|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
14552339|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552340|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
14552341|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552342|NCT00001906|Interleukin-12|interleukin-12|mesh-list
14552343|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15086228|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15086229|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
15086230|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086231|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552344|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14552345|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
14552346|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552347|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14552348|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15086232|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15086233|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086234|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
15086235|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15086236|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
15086237|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086238|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086239|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15086240|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15086241|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15086242|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086243|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15086244|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15086245|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
15086246|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086247|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086248|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15086249|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086250|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15086251|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15086252|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15086253|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086254|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552349|NCT00001906|Growth Substances|growth substances|mesh-ancestor
14552350|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
14552351|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552352|NCT00001906|Antacids|antacids|mesh-ancestor
14552353|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552354|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552355|NCT00001911|Interleukin-12|interleukin-12|mesh-list
14552356|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14552357|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
14552358|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552359|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14552360|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14552361|NCT00001911|Growth Substances|growth substances|mesh-ancestor
15086255|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086256|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15086257|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15086258|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
15086259|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086260|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086261|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15086262|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086263|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15086264|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15086265|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15086266|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086267|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086268|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086269|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15086270|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15086271|NCT02254239|Everolimus|everolimus|mesh-list
15086272|NCT02254239|Antibodies|antibodies|mesh-list
15086273|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
15086274|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15086275|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
15086276|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
15086277|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086278|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086279|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15086280|NCT02254447|Candesartan|candesartan|mesh-list
14552362|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14552363|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552364|NCT00001929|Eliprodil|eliprodil|mesh-list
14552365|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14552366|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14552367|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552368|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552369|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552370|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14552371|NCT00001929|Protective Agents|protective agents|mesh-ancestor
14552372|NCT00001930|Amantadine|amantadine|mesh-list
14552373|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14552374|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14552375|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
14552376|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552377|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
14552378|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552379|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552380|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552381|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552382|NCT00001930|Analgesics|analgesics|mesh-ancestor
14552383|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
14552384|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552385|NCT00001933|Nefiracetam|nefiracetam|mesh-list
14552386|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14552387|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14552388|NCT00001933|Protective Agents|protective agents|mesh-ancestor
14552389|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552390|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
14552391|NCT00001934|Daclizumab|daclizumab|mesh-list
14552392|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552393|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
14552394|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552395|NCT00001937|Fluconazole|fluconazole|mesh-list
14552396|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
14552397|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552398|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14552399|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552400|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552401|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552402|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552403|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
15086281|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
15086282|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14552404|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552405|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552406|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14552407|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14552408|NCT00001940|Voriconazole|voriconazole|mesh-list
14552409|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
14552410|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552411|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14552412|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552413|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552414|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552415|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552416|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
14552417|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552418|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552419|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14552420|NCT00001944|Vinorelbine|vinorelbine|mesh-list
14552421|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14552422|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552423|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
14552424|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
14552425|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
14552426|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552427|NCT00001954|Etanercept|etanercept|mesh-list
14552428|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14552429|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552430|NCT00001954|Analgesics|analgesics|mesh-ancestor
14552431|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
14268237|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14268238|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14268239|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268240|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268241|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
15086283|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14552432|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552433|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552434|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14552435|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552436|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552437|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552438|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
14552439|NCT00001955|Celecoxib|celecoxib|mesh-list
14552440|NCT00001955|Etanercept|etanercept|mesh-list
15086284|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15086285|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086286|NCT02254525|Ibuprofen|ibuprofen|mesh-list
15086287|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15086288|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086289|NCT02254525|Analgesics|analgesics|mesh-ancestor
15086290|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
15086291|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086292|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086293|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086294|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15086295|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15086296|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086297|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086298|NCT02254577|Progesterone|progesterone|mesh-list
15086299|NCT02254577|Progestins|progestins|mesh-ancestor
15086300|NCT02254577|Hormones|hormones|mesh-ancestor
15086301|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15086302|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086303|NCT02254629|Laxatives|laxatives|mesh-list
15086304|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15086305|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
15086306|NCT02254655|Puerarin|puerarin|mesh-list
15086307|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
15086308|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
15086309|NCT02254668|Everolimus|everolimus|mesh-list
15086310|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086311|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15086312|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
15086313|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086314|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15086315|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15086316|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
15086317|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15086318|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086319|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086320|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086321|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15086322|NCT02254759|Midazolam|midazolam|mesh-list
15086323|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15086324|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15086325|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086326|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552441|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14552442|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552443|NCT00001955|Analgesics|analgesics|mesh-ancestor
14552444|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
14552445|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552446|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552447|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14552448|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552449|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14552450|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14552451|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552452|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552453|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14552454|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552455|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
14552456|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
14552457|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552458|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
14552459|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552460|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552461|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552462|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
14552463|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14552464|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
14552465|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552466|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552467|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14552468|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
14552469|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14552470|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
14552471|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552472|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14552473|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14552474|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
14552475|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
15086327|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15086328|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086329|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086330|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15086331|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
15086332|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
15086333|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
15086334|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
15086335|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086336|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086337|NCT02254824|Atorvastatin|atorvastatin|mesh-list
15086338|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15086339|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15086340|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
15086341|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086342|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15086343|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15086344|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086345|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15086346|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086347|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086348|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
15086349|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15086350|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
15086351|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086352|NCT02254954|Temozolomide|temozolomide|mesh-list
15086353|NCT02254954|Macitentan|macitentan|mesh-list
15086354|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15086355|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
15086356|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086357|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086358|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15086359|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15086360|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15086361|NCT02254967|Vancomycin|vancomycin|mesh-list
15086362|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
15086363|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552476|NCT00001963|Protective Agents|protective agents|mesh-ancestor
14552477|NCT00001964|Cyclosporine|cyclosporine|mesh-list
14552478|NCT00001964|Cyclosporins|cyclosporins|mesh-list
15086364|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086365|NCT02254980|Vitamin E|vitamin e|mesh-list
15086366|NCT02254980|Vitamins|vitamins|mesh-ancestor
15086367|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
15086368|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086369|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
15086370|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086371|NCT02254980|Protective Agents|protective agents|mesh-ancestor
15086372|NCT02255006|Glyburide|glyburide|mesh-list
15086373|NCT02255006|Celecoxib|celecoxib|mesh-list
15086374|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15086375|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086376|NCT02255006|Analgesics|analgesics|mesh-ancestor
15086377|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
15086378|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086379|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086380|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086381|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15086382|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15086383|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15086384|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086385|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086386|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15086387|NCT02255045|Diclofenac|diclofenac|mesh-list
15086388|NCT02255045|Meloxicam|meloxicam|mesh-list
15086389|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15086390|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086391|NCT02255045|Analgesics|analgesics|mesh-ancestor
15086392|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
15086393|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086394|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086395|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086396|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15086397|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15086398|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086399|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086400|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15086401|NCT02255084|Menthol|menthol|mesh-list
15086402|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
15086403|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
15086404|NCT02255162|Cytarabine|cytarabine|mesh-list
15086405|NCT02255162|Lenalidomide|lenalidomide|mesh-list
15086406|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15086407|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
15086408|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086409|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086410|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
15086411|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086412|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15086413|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
15086414|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086415|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14552479|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552480|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552481|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552482|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
14552483|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552484|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
14808909|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552485|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552486|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
14552487|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552488|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14552489|NCT00001965|Cyclosporine|cyclosporine|mesh-list
14552490|NCT00001965|Cyclosporins|cyclosporins|mesh-list
14552491|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086416|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15086417|NCT02255162|Growth Substances|growth substances|mesh-ancestor
15086418|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
15086419|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15086420|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
15086421|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086422|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15086423|NCT02255253|Telmisartan|telmisartan|mesh-list
15086424|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15086425|NCT02255253|Diuretics|diuretics|mesh-ancestor
15086426|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
15086427|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086428|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15086429|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086430|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086431|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15086432|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15086433|NCT02255266|Liraglutide|liraglutide|mesh-list
15086434|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15086435|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086436|NCT02255266|Incretins|incretins|mesh-ancestor
14552492|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552493|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14552494|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
14552495|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552496|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
14552497|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552498|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
14552499|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14552500|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14552501|NCT00001968|Ritonavir|ritonavir|mesh-list
14552502|NCT00001968|Amprenavir|amprenavir|mesh-list
14552503|NCT00001968|Lamivudine|lamivudine|mesh-list
14552504|NCT00001968|Abacavir|abacavir|mesh-list
14552505|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086437|NCT02255266|Hormones|hormones|mesh-ancestor
15086438|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15086439|NCT02255292|Cannabidiol|cannabidiol|mesh-list
15086440|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
15086441|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
15086442|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15173010|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173011|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
15173012|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15173013|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
15173014|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173015|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173016|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15173017|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
15173018|NCT04008186|Metformin|metformin|mesh-list
15173019|NCT04008186|Repaglinide|repaglinide|mesh-list
15173020|NCT04008186|Itraconazole|itraconazole|mesh-list
15173021|NCT04008186|Digoxin|digoxin|mesh-list
15173022|NCT04008186|Verapamil|verapamil|mesh-list
15173023|NCT04008186|Midazolam|midazolam|mesh-list
15173024|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15173025|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
15173026|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15173027|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173028|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15173029|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15173030|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173031|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15173032|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15173033|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15173034|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15173035|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
15173036|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
15173037|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
15173038|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
14552506|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14552507|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
14552508|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552509|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552510|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552511|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552512|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
14552513|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552514|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14552515|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552516|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552517|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552518|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14552519|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
14552520|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552521|NCT00001989|Zidovudine|zidovudine|mesh-list
14552522|NCT00001989|Trichosanthin|trichosanthin|mesh-list
14552523|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
14552524|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552525|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552526|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552527|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552528|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
14552529|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552530|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552531|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552532|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14552533|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
14552534|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14552535|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552536|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14552537|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086443|NCT02255370|Curcumin|curcumin|mesh-list
15086444|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15086445|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086446|NCT02255370|Analgesics|analgesics|mesh-ancestor
15086447|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
15086448|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086449|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086450|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086451|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15086452|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086453|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086454|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086455|NCT02255396|Estradiol|estradiol|mesh-list
15086456|NCT02255396|Estrogens|estrogens|mesh-ancestor
14552538|NCT00001990|Atovaquone|atovaquone|mesh-list
14552539|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552540|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
14552541|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552542|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552543|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552544|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552545|NCT00001991|Atovaquone|atovaquone|mesh-list
14552546|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552547|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
14552548|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552549|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552550|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552551|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552552|NCT00001993|Miglustat|miglustat|mesh-list
14552553|NCT00001993|Zidovudine|zidovudine|mesh-list
14552554|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
14552555|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552556|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14808910|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14808911|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14808912|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
14808913|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14808914|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808915|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808916|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
14808917|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
14808918|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
14808919|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808920|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552557|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552558|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552559|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
14552560|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552561|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552562|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552563|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14552564|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14552565|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552566|NCT00001994|Atovaquone|atovaquone|mesh-list
14552567|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552568|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
14552569|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552570|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552571|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552572|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552573|NCT00001995|Rifabutin|rifabutin|mesh-list
14552574|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552575|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552576|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14552577|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
14552578|NCT00001996|Atovaquone|atovaquone|mesh-list
14552579|NCT00001996|Pentamidine|pentamidine|mesh-list
14268242|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
14268243|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268244|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14552580|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552581|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
15086457|NCT02255396|Hormones|hormones|mesh-ancestor
15086458|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15086459|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086460|NCT02255578|Clomiphene|clomiphene|mesh-list
15086461|NCT02255578|Enclomiphene|enclomiphene|mesh-list
15086462|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
15086463|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15086464|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
15086465|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15086466|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086467|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15086468|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
15086469|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15086470|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15086471|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15086472|NCT02255591|Lidocaine|lidocaine|mesh-list
15086473|NCT02255591|Epinephrine|epinephrine|mesh-list
15086474|NCT02255591|Racepinephrine|racepinephrine|mesh-list
15086475|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
15086476|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
15086477|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
15086478|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086479|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086480|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
15086481|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552582|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552583|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552584|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552585|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552586|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
14552587|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14552588|NCT00001997|Zidovudine|zidovudine|mesh-list
14552589|NCT00001997|Didanosine|didanosine|mesh-list
14552590|NCT00001997|Interleukin-2|interleukin-2|mesh-list
14552591|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552592|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552593|NCT00001997|Analgesics|analgesics|mesh-ancestor
14552594|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
14552595|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552596|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552597|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
14552598|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552599|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552600|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15086482|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14552601|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552602|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
14552603|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086483|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15086484|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15086485|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086486|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086487|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14552604|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552605|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552606|NCT00001998|Nystatin|nystatin|mesh-list
14552607|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552608|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552609|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
14552610|NCT00001998|Ionophores|ionophores|mesh-ancestor
14552611|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14552612|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552613|NCT00001999|Ganciclovir|ganciclovir|mesh-list
14552614|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14552615|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
14552616|NCT00001999|Antibodies|antibodies|mesh-list
14552617|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
14552618|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552619|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552620|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552621|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552622|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
14552623|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552624|NCT00002000|Valacyclovir|valacyclovir|mesh-list
14552625|NCT00002000|Acyclovir|acyclovir|mesh-list
14552626|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
14552627|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552628|NCT00002001|Zidovudine|zidovudine|mesh-list
14552629|NCT00002001|Didanosine|didanosine|mesh-list
14552630|NCT00002001|Zalcitabine|zalcitabine|mesh-list
14552631|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
14552632|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552633|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552634|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552635|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552636|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
14552637|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552638|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552639|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552640|NCT00002002|Leucovorin|leucovorin|mesh-list
15086488|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15086489|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086490|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086491|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14552641|NCT00002002|Trimethoprim|trimethoprim|mesh-list
14552642|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
14552643|NCT00002002|Calcium|calcium|mesh-list
14552644|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
14552645|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14552646|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552647|NCT00002002|Antidotes|antidotes|mesh-ancestor
14552648|NCT00002002|Protective Agents|protective agents|mesh-ancestor
14552649|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
14552650|NCT00002002|Vitamins|vitamins|mesh-ancestor
14552651|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
14552652|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15086492|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15086493|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
15086494|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15086495|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086496|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
15086497|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
15086498|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15086499|NCT02255682|Simvastatin|simvastatin|mesh-list
15086500|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15086501|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15086502|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
15086503|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086504|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15086505|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15086506|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552653|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552654|NCT00002002|Renal Agents|renal agents|mesh-ancestor
14552655|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
14552656|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552657|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552658|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14552659|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552660|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552661|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14552662|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14552663|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552664|NCT00002003|Etoposide|etoposide|mesh-list
14552665|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
14552666|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14552667|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552668|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14552669|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14552670|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552671|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552672|NCT00002003|Analgesics|analgesics|mesh-ancestor
14552673|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
14552674|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552675|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552676|NCT00002006|Zidovudine|zidovudine|mesh-list
14552677|NCT00002006|Sargramostim|sargramostim|mesh-list
14552678|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
14552679|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552680|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552681|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552682|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552683|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
14552684|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552685|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552686|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552687|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
14552688|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552689|NCT00002007|Zidovudine|zidovudine|mesh-list
14552690|NCT00002007|Sargramostim|sargramostim|mesh-list
14552691|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
14552692|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552693|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552694|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552695|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552696|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
14552697|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552698|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552699|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552700|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
14552701|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552702|NCT00002008|Sargramostim|sargramostim|mesh-list
14552703|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
14552704|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552705|NCT00002009|Sargramostim|sargramostim|mesh-list
14552706|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
14552707|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552708|NCT00002010|Fluconazole|fluconazole|mesh-list
14552709|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
14552710|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552711|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14552712|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552713|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552714|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552715|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552716|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
14552717|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552718|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552719|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14552720|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14552721|NCT00002011|Methoxsalen|methoxsalen|mesh-list
14552722|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14552723|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
14552724|NCT00002012|Interferons|interferons|mesh-list
14552725|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
14552726|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552727|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
14552728|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552729|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
15086507|NCT02255734|Acyclovir|acyclovir|mesh-list
14552730|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552731|NCT00002013|Zidovudine|zidovudine|mesh-list
14552732|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
14552733|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552734|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552735|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552736|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552737|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
15086508|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
15086509|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086510|NCT02255747|Lactulose|lactulose|mesh-list
15086511|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15086512|NCT02255812|Quinine|quinine|mesh-list
14552738|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552739|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552740|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552741|NCT00002014|Zidovudine|zidovudine|mesh-list
14552742|NCT00002014|Didanosine|didanosine|mesh-list
14552743|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
14552744|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552745|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552746|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552747|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552748|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
14552749|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552750|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552751|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552752|NCT00002015|Ganciclovir|ganciclovir|mesh-list
14552753|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14552754|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
14552755|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552756|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552757|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552758|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643507|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14643508|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643509|NCT00189566|Paclitaxel|paclitaxel|mesh-list
14643510|NCT00189566|Carboplatin|carboplatin|mesh-list
14643511|NCT00189566|Topotecan|topotecan|mesh-list
14643512|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14643513|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643514|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
14643515|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
14643516|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
14643517|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643518|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14643519|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14643520|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643521|NCT00189579|Trastuzumab|trastuzumab|mesh-list
14643522|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14643523|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643524|NCT00189618|Aspirin|aspirin|mesh-list
14643525|NCT00189618|Clopidogrel|clopidogrel|mesh-list
14643526|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14643527|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14643528|NCT00189618|Analgesics|analgesics|mesh-ancestor
14643529|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
14643530|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643531|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643532|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14643533|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643534|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14643535|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14643536|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643537|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14643538|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14643539|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643540|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
14643541|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14643542|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14643543|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14643544|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
14268245|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268246|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268247|NCT00394082|Growth Substances|growth substances|mesh-ancestor
15086513|NCT02255812|Citric Acid|citric acid|mesh-list
15086514|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
14268248|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552759|NCT00002017|Interleukin-2|interleukin-2|mesh-list
14552760|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552761|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14552762|NCT00002017|Analgesics|analgesics|mesh-ancestor
14552763|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
14552764|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14552765|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552766|NCT00002018|Interferons|interferons|mesh-list
14552767|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
14552768|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14552769|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
14552770|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552771|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
14552772|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552773|NCT00002019|Amphotericin B|amphotericin b|mesh-list
14552774|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14552775|NCT00002019|Amebicides|amebicides|mesh-ancestor
14552776|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552777|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552778|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552779|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552780|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
14552781|NCT00002020|Zidovudine|zidovudine|mesh-list
14552782|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
14552783|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552784|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552785|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552786|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552787|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
14552788|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552789|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552790|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552791|NCT00002021|Foscarnet|foscarnet|mesh-list
14552792|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14552793|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
14552794|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552795|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552796|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552797|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552798|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552799|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
14552800|NCT00002022|Hematinics|hematinics|mesh-ancestor
14552801|NCT00002023|Zidovudine|zidovudine|mesh-list
14552802|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
14552803|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552804|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552805|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552806|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552807|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
14552808|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552809|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552810|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552811|NCT00002024|Ganciclovir|ganciclovir|mesh-list
14552812|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14552813|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
14552814|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552815|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552816|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552817|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552818|NCT00002025|Ganciclovir|ganciclovir|mesh-list
14552819|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14552820|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
14552821|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552822|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552823|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552824|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552825|NCT00002026|Acyclovir|acyclovir|mesh-list
14552826|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
14552827|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552828|NCT00002027|Diclazuril|diclazuril|mesh-list
14552829|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
14552830|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15086515|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
14552831|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552832|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552833|NCT00002028|Didanosine|didanosine|mesh-list
14552834|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
14552835|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552836|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552837|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552838|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552839|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
14552840|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552841|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552842|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552843|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14552844|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14552845|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14552846|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14552847|NCT00002030|Pentamidine|pentamidine|mesh-list
14552848|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
14552849|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552850|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552851|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552852|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14552853|NCT00002032|Rifabutin|rifabutin|mesh-list
14552854|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552855|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552856|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14552857|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
14552858|NCT00002033|Zidovudine|zidovudine|mesh-list
14552859|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
14552860|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552861|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552862|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552863|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552864|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
14552865|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552866|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552867|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552868|NCT00002034|Zidovudine|zidovudine|mesh-list
15086516|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15086517|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15086518|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086519|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15086520|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086521|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15086522|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086523|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086524|NCT02255812|Analgesics|analgesics|mesh-ancestor
15086525|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
15086526|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
15086527|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15086528|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
14268249|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
15086529|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
15086530|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173039|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173040|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173041|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15173042|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15173043|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
14552869|NCT00002034|Ganciclovir|ganciclovir|mesh-list
15173044|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15173045|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15173046|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173047|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
15173048|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173049|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15173050|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15173051|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15173052|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
15173053|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173054|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15173055|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15173056|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15173057|NCT04008186|Protective Agents|protective agents|mesh-ancestor
14552870|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14552871|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
14552872|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552873|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552874|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552875|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552876|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
14552877|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552878|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552879|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552880|NCT00002035|Zidovudine|zidovudine|mesh-list
14552881|NCT00002035|Didanosine|didanosine|mesh-list
14552882|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
14552883|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552884|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552885|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552886|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552887|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
14552888|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552889|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552890|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552891|NCT00002036|Immune Sera|immune sera|mesh-list
14552892|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
14808921|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
14808922|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808923|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
14808924|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14808925|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
14808926|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808927|NCT00830193|Expectorants|expectorants|mesh-ancestor
14808928|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
14808929|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14808930|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
14808931|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808932|NCT00830193|Protective Agents|protective agents|mesh-ancestor
14808933|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808934|NCT00830193|Antidotes|antidotes|mesh-ancestor
14808935|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14808936|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808937|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14808938|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808939|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808940|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
14808941|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
14808942|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
14808943|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
14808944|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14808945|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808946|NCT00830323|Oseltamivir|oseltamivir|mesh-list
14808947|NCT00830323|Amantadine|amantadine|mesh-list
14808948|NCT00830323|Zanamivir|zanamivir|mesh-list
14808949|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
14808950|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808951|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14808952|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808953|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14808954|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14808955|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
14808956|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808957|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808958|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14808959|NCT00830323|Analgesics|analgesics|mesh-ancestor
14808960|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
14808961|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14808962|NCT00830349|Risperidone|risperidone|mesh-list
14808963|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14808964|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
14808965|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14808966|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14808967|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808968|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14808969|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14808970|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14808971|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14808972|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14808973|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
14808974|NCT00830401|Doxycycline|doxycycline|mesh-list
15086531|NCT02255942|Zinc|zinc|mesh-list
15086532|NCT02255942|Iron|iron|mesh-list
15086533|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
15086534|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
15086535|NCT02255942|Trace Elements|trace elements|mesh-ancestor
15086536|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
15086537|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086538|NCT02255942|Astringents|astringents|mesh-ancestor
15086539|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
15086540|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
15086541|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15086542|NCT02255942|Protective Agents|protective agents|mesh-ancestor
14552893|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552894|NCT00002037|Trifluridine|trifluridine|mesh-list
14552895|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
14552896|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552897|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
14552898|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552899|NCT00002038|Fluconazole|fluconazole|mesh-list
14552900|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
14552901|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552902|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14552903|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552904|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552905|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552906|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552907|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
14552908|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552909|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552910|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14552911|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14552912|NCT00002039|Foscarnet|foscarnet|mesh-list
14552913|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14552914|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
14552915|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552916|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552917|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552918|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552919|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552920|NCT00002040|Fluconazole|fluconazole|mesh-list
14552921|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
14552922|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552923|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14552924|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14552925|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552926|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552927|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14552928|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
14552929|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14552930|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14552931|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14552932|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14552933|NCT00002041|Amphotericin B|amphotericin b|mesh-list
14552934|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14552935|NCT00002041|Amebicides|amebicides|mesh-ancestor
14552936|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552937|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552938|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552939|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552940|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
14552941|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
14552942|NCT00002042|Hematinics|hematinics|mesh-ancestor
14552943|NCT00002043|Dapsone|dapsone|mesh-list
14552944|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552945|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
14552946|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14552947|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14552948|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14552949|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552950|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552951|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
15086543|NCT02255955|Acetaminophen|acetaminophen|mesh-list
15086544|NCT02255955|Naproxen|naproxen|mesh-list
15086545|NCT02255955|Codeine|codeine|mesh-list
15086546|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086547|NCT02255955|Analgesics|analgesics|mesh-ancestor
14552952|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14552953|NCT00002044|Zidovudine|zidovudine|mesh-list
14552954|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
14552955|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552956|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552957|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552958|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268250|NCT00394095|Topiramate|topiramate|mesh-list
14268251|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
14268252|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268253|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268254|NCT00394251|Paclitaxel|paclitaxel|mesh-list
14268255|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
14268256|NCT00394251|Bevacizumab|bevacizumab|mesh-list
14268257|NCT00394251|Doxorubicin|doxorubicin|mesh-list
14268258|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14268259|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14268260|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14268261|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268262|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268263|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14268264|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14552959|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
14552960|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552961|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552962|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552963|NCT00002045|Zidovudine|zidovudine|mesh-list
14552964|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
14552965|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552966|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552967|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552968|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552969|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
14552970|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552971|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552972|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552973|NCT00002046|Zidovudine|zidovudine|mesh-list
14552974|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
14552975|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552976|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552977|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552978|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552979|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
14552980|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552981|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552982|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552983|NCT00002047|Zidovudine|zidovudine|mesh-list
14552984|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
14552985|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552986|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552987|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552988|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552989|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
14552990|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14552991|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14552992|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14552993|NCT00002048|Zidovudine|zidovudine|mesh-list
14552994|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
14552995|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14552996|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14552997|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14552998|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14552999|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
14553000|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553001|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553002|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553003|NCT00002049|Thymopentin|thymopentin|mesh-list
14553004|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553005|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
14553006|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553007|NCT00002050|Thymopentin|thymopentin|mesh-list
14553008|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553009|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
14553010|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268265|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553011|NCT00002051|Thymopentin|thymopentin|mesh-list
14553012|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553013|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
14553014|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553015|NCT00002052|Amoxicillin|amoxicillin|mesh-list
15086548|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
15086549|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086550|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086551|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
15086552|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15086553|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086554|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15086555|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
15086556|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15086557|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086558|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086559|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15086560|NCT02255955|Narcotics|narcotics|mesh-ancestor
15086561|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086562|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
15086563|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086564|NCT02256033|Istradefylline|istradefylline|mesh-list
15086565|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
15086566|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15086567|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15086568|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
15086569|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086570|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086571|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086572|NCT02256124|Lamotrigine|lamotrigine|mesh-list
15086573|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
15086574|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15086575|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086576|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086577|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15086578|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086579|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15086580|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086581|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086582|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086583|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15086584|NCT02256150|Mizoribine|mizoribine|mesh-list
15086585|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
15086586|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15086587|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
15086588|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086589|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15086590|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15086591|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
15086592|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086593|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086594|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15086595|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15086596|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086597|NCT02256150|Analgesics|analgesics|mesh-ancestor
15086598|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
15086599|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086600|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086601|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15086602|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086603|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15086604|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
15086605|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15086606|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15086607|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086608|NCT02256215|Vitamin D|vitamin d|mesh-list
15086609|NCT02256215|Vitamins|vitamins|mesh-ancestor
15086610|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
15086611|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553016|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
14553017|NCT00002052|Ampicillin|ampicillin|mesh-list
14553018|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553019|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553020|NCT00002053|Pentamidine|pentamidine|mesh-list
14553021|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
14553022|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553023|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553024|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553025|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14553026|NCT00002054|Pentamidine|pentamidine|mesh-list
14553027|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
14553028|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553029|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553030|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553031|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14553032|NCT00002055|Pentamidine|pentamidine|mesh-list
14553033|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
14553034|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553035|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553036|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553037|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14553038|NCT00002056|Pentamidine|pentamidine|mesh-list
14553039|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
14553040|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553041|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553042|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553043|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14553044|NCT00002057|Nystatin|nystatin|mesh-list
14553045|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553046|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553047|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
14553048|NCT00002057|Ionophores|ionophores|mesh-ancestor
14553049|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14553050|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553051|NCT00002058|Clofazimine|clofazimine|mesh-list
14553052|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14553053|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
14553054|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553055|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553056|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
14553057|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553058|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
14553059|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553060|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
14553061|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553062|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
14553063|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553064|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
14553065|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553066|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
14553067|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553068|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
14553069|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553070|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
14553071|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553072|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
14553073|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553074|NCT00002062|Spiramycin|spiramycin|mesh-list
14553075|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553076|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553077|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
14553078|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553079|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553080|NCT00002063|Zidovudine|zidovudine|mesh-list
14553081|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
14553082|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553083|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15086612|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15086613|NCT02256228|Ropivacaine|ropivacaine|mesh-list
15086614|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
14268266|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268267|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
14553084|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553085|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553086|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
14553087|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553088|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553089|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553090|NCT00002064|Clindamycin|clindamycin|mesh-list
14553091|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
14808975|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14268268|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553092|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
14553093|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
14553094|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553095|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553096|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14553097|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553098|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553099|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
14553100|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553101|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553102|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14553103|NCT00002065|Disulfiram|disulfiram|mesh-list
14553104|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14553105|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14553106|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553107|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553108|NCT00002066|Thymopentin|thymopentin|mesh-list
14553109|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553110|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
14553111|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553112|NCT00002067|Megestrol|megestrol|mesh-list
14553113|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
14553114|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14553115|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14553116|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14553117|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
14553118|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14553119|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553120|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14553121|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14553122|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14553123|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553124|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
14553125|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14553126|NCT00002068|Fluconazole|fluconazole|mesh-list
14553127|NCT00002068|Amphotericin B|amphotericin b|mesh-list
14553128|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14553129|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
14553130|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553131|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553132|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553133|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553134|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553135|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553136|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553137|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553138|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553139|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553140|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553141|NCT00002068|Amebicides|amebicides|mesh-ancestor
14553142|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553143|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553144|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553145|NCT00002069|Ditiocarb|ditiocarb|mesh-list
14553146|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553147|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
14553148|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553149|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
14553150|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553151|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
14553152|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
14553153|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553154|NCT00002070|Ganciclovir|ganciclovir|mesh-list
14553155|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14553156|NCT00002070|Sargramostim|sargramostim|mesh-list
14553157|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
14553158|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553159|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
14553160|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553161|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553162|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553163|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553164|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
14553165|NCT00002071|Hematinics|hematinics|mesh-ancestor
14553166|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
14553167|NCT00002072|Hematinics|hematinics|mesh-ancestor
14268269|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14553168|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
14553169|NCT00002073|Hematinics|hematinics|mesh-ancestor
14553170|NCT00002074|Fluconazole|fluconazole|mesh-list
14553171|NCT00002074|Amphotericin B|amphotericin b|mesh-list
14553172|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14553173|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
14553174|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553175|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553176|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553177|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553178|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553179|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553180|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553181|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553182|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553183|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553184|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553185|NCT00002074|Amebicides|amebicides|mesh-ancestor
14553186|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553187|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553188|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553189|NCT00002075|Fluconazole|fluconazole|mesh-list
14553190|NCT00002075|Amphotericin B|amphotericin b|mesh-list
14553191|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14553192|NCT00002075|Flucytosine|flucytosine|mesh-list
14553193|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
14553194|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553195|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553196|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553197|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553198|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553199|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553200|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553201|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553202|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553203|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553204|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553205|NCT00002075|Amebicides|amebicides|mesh-ancestor
14553206|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553207|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553208|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553209|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
14553210|NCT00002076|Fluconazole|fluconazole|mesh-list
14553211|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
14553212|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086615|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
15086616|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086617|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086618|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
15086619|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086620|NCT02256254|Simvastatin|simvastatin|mesh-list
15086621|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15086622|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14553213|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553214|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553215|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553216|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553217|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553218|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553219|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553220|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553221|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553222|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553223|NCT00002077|Fluconazole|fluconazole|mesh-list
14553224|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
14553225|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553226|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553227|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553228|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553229|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553230|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15086623|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
14553231|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553232|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553233|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553234|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553235|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553236|NCT00002078|Interferons|interferons|mesh-list
14553237|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
14553238|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553239|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
14553240|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553241|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
14553242|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553243|NCT00002079|Miglustat|miglustat|mesh-list
14553244|NCT00002079|Zidovudine|zidovudine|mesh-list
15086624|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086625|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15086626|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15086627|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086628|NCT02256280|Neostigmine|neostigmine|mesh-list
15086629|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15086630|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086631|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086632|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
15086633|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086634|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086635|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15086636|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
15086637|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086638|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
15086639|NCT02256319|Propofol|propofol|mesh-list
15086640|NCT02256319|Imidazole|imidazole|mesh-list
15086641|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15086642|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086643|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086644|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15086645|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
14268270|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15086646|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
15086647|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086648|NCT02256319|Analgesics|analgesics|mesh-ancestor
15086649|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
15086650|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086651|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15086652|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15086653|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15086654|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086655|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086656|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086657|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086658|NCT02256423|Ibuprofen|ibuprofen|mesh-list
15086659|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15086660|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086661|NCT02256423|Analgesics|analgesics|mesh-ancestor
15086662|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
15086663|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268271|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
14268272|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14268273|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268274|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268275|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268276|NCT00394251|Growth Substances|growth substances|mesh-ancestor
14268277|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268278|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14268279|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14268280|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14268281|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268282|NCT00394277|Ribavirin|ribavirin|mesh-list
14268283|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14268284|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
14268285|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
14268286|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268287|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
14553245|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
14553246|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553247|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553248|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553249|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553250|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
14553251|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553252|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553253|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553254|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14553255|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14553256|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553257|NCT00002080|Rifabutin|rifabutin|mesh-list
14553258|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553259|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553260|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14553261|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
14553262|NCT00002081|Zidovudine|zidovudine|mesh-list
14553263|NCT00002081|Zalcitabine|zalcitabine|mesh-list
14553264|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
14553265|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553266|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553267|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553268|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553269|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
14553270|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553271|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553272|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553273|NCT00002082|Azithromycin|azithromycin|mesh-list
14553274|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14268288|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268289|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
14268290|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268291|NCT00394329|Beclomethasone|beclomethasone|mesh-list
14553275|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553276|NCT00002084|Valacyclovir|valacyclovir|mesh-list
14553277|NCT00002084|Acyclovir|acyclovir|mesh-list
14553278|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
14553279|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553280|NCT00002085|Azithromycin|azithromycin|mesh-list
14553281|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553282|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553283|NCT00002086|Interferons|interferons|mesh-list
14553284|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
14553285|NCT00002086|Zidovudine|zidovudine|mesh-list
14553286|NCT00002086|Zalcitabine|zalcitabine|mesh-list
14553287|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553288|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
14553289|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808976|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808977|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
14808978|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14808979|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14808980|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14808981|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
14808982|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14808983|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14808984|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14808985|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
14808986|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14808987|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14808988|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14808989|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14808990|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14808991|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14808992|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808993|NCT00830466|Sirolimus|sirolimus|mesh-list
14808994|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14808995|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14808996|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14808997|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14808998|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
14808999|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809000|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
14268292|NCT00394329|Albuterol|albuterol|mesh-list
14553290|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
14553291|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553292|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
14553293|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553294|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553295|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553296|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553297|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553298|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553299|NCT00002089|Azithromycin|azithromycin|mesh-list
14553300|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553301|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553302|NCT00002090|Azithromycin|azithromycin|mesh-list
14553303|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553304|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553305|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
14553306|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14553307|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553308|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553309|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14553310|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14553311|NCT00002091|Protective Agents|protective agents|mesh-ancestor
14268293|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14268294|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
14268295|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268296|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553312|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553313|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
14553314|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14553315|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
14553316|NCT00002092|Cimetidine|cimetidine|mesh-list
14553317|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14553318|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14553319|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14553320|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
14553321|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
14553322|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14553323|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553324|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553325|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14553326|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553327|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553328|NCT00002093|Doxorubicin|doxorubicin|mesh-list
14553329|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14553330|NCT00002093|Daunorubicin|daunorubicin|mesh-list
14553331|NCT00002093|Bleomycin|bleomycin|mesh-list
14553332|NCT00002093|Vincristine|vincristine|mesh-list
14553333|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14553334|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553335|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14553336|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14553337|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553338|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553339|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14553340|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
14553341|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
14553342|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
14553343|NCT00002094|Atevirdine|atevirdine|mesh-list
14553344|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553345|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553346|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553347|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553348|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
14553349|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553350|NCT00002095|Ganciclovir|ganciclovir|mesh-list
14553351|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14553352|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
15086664|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086665|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14553353|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553354|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553355|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553356|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553357|NCT00002096|Zidovudine|zidovudine|mesh-list
14553358|NCT00002096|Didanosine|didanosine|mesh-list
14553359|NCT00002096|Ganciclovir|ganciclovir|mesh-list
14553360|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14553361|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
14553362|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553363|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553364|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553365|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553366|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
14553367|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553368|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086666|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15086667|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15086668|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086669|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086670|NCT02256462|Adalimumab|adalimumab|mesh-list
15086671|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086672|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14553369|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553370|NCT00002097|Nystatin|nystatin|mesh-list
14553371|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553372|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553373|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
14553374|NCT00002097|Ionophores|ionophores|mesh-ancestor
14553375|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086673|NCT02256605|Vitamin D|vitamin d|mesh-list
15086674|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
15086675|NCT02256605|Vitamins|vitamins|mesh-ancestor
14553376|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553377|NCT00002098|Didanosine|didanosine|mesh-list
14553378|NCT00002098|Lentinan|lentinan|mesh-list
14553379|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
14553380|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553381|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553382|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553383|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553384|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
14553385|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553386|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553387|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553388|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553389|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
14553390|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553391|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553392|NCT00002099|Didanosine|didanosine|mesh-list
14553393|NCT00002099|Lentinan|lentinan|mesh-list
14553394|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
14553395|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553396|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553397|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15086676|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
15086677|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086678|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15086679|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15086680|NCT02256683|Dabigatran|dabigatran|mesh-list
15086681|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
15086682|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
15086683|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15086684|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086685|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086686|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086687|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
15086688|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15086689|NCT02256722|Propranolol|propranolol|mesh-list
15086690|NCT02256722|Bisoprolol|bisoprolol|mesh-list
15086691|NCT02256722|Acipimox|acipimox|mesh-list
15086692|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15086693|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15086694|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
15086695|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086696|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086697|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14553398|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553399|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
14553400|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553401|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553402|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553403|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553404|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
14553405|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553406|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553407|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
14553408|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
14553409|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553410|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553411|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553412|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
14553413|NCT00002101|Clarithromycin|clarithromycin|mesh-list
14553414|NCT00002101|Ethambutol|ethambutol|mesh-list
14553415|NCT00002101|Rifabutin|rifabutin|mesh-list
14553416|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553417|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553418|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14553419|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553420|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553421|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14553422|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553423|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
14553424|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14553425|NCT00002102|Leucovorin|leucovorin|mesh-list
14553426|NCT00002102|Trimetrexate|trimetrexate|mesh-list
14553427|NCT00002102|Calcium|calcium|mesh-list
14553428|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
14553429|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14553430|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553431|NCT00002102|Antidotes|antidotes|mesh-ancestor
14553432|NCT00002102|Protective Agents|protective agents|mesh-ancestor
14553433|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
14553434|NCT00002102|Vitamins|vitamins|mesh-ancestor
14553435|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
14553436|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
14553437|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553438|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14553439|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
14553440|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553441|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553442|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14553443|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553444|NCT00002103|Leucovorin|leucovorin|mesh-list
14553445|NCT00002103|Trimetrexate|trimetrexate|mesh-list
14553446|NCT00002103|Calcium|calcium|mesh-list
14553447|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
14553448|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14553449|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553450|NCT00002103|Antidotes|antidotes|mesh-ancestor
14553451|NCT00002103|Protective Agents|protective agents|mesh-ancestor
14553452|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
14553453|NCT00002103|Vitamins|vitamins|mesh-ancestor
14553454|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
14553455|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
14553456|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553457|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14553458|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
14553459|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553460|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553461|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14553462|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553463|NCT00002104|Thalidomide|thalidomide|mesh-list
14553464|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14553465|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
14553466|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553467|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
14553468|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553469|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553470|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14553471|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14553472|NCT00002104|Growth Substances|growth substances|mesh-ancestor
14553473|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
14553474|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553475|NCT00002105|Doxorubicin|doxorubicin|mesh-list
14553476|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14553477|NCT00002105|Bleomycin|bleomycin|mesh-list
14553478|NCT00002105|Vincristine|vincristine|mesh-list
14553479|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14553480|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553481|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14553482|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14553483|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553484|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553485|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14553486|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
14553487|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
14553488|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
14553489|NCT00002106|Ranitidine|ranitidine|mesh-list
14553490|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14553491|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14553492|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14553493|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14553494|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
14553495|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
14553496|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14553497|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268297|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14268298|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
14268299|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
14553498|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553499|NCT00002107|Aldesleukin|aldesleukin|mesh-list
14553500|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268300|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14268301|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14268302|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14268303|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14268304|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
14553501|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553502|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553503|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
14553504|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553505|NCT00002108|Lamivudine|lamivudine|mesh-list
14553506|NCT00002108|Zidovudine|zidovudine|mesh-list
14553507|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553508|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553509|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553510|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553511|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
14553512|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553513|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553514|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553515|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
14553516|NCT00002109|Zidovudine|zidovudine|mesh-list
14553517|NCT00002109|Stavudine|stavudine|mesh-list
14553518|NCT00002109|Didanosine|didanosine|mesh-list
15086698|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086699|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15086700|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15086701|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14553519|NCT00002109|Zalcitabine|zalcitabine|mesh-list
14553520|NCT00002109|Thymopentin|thymopentin|mesh-list
14553521|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
14553522|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553523|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553524|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553525|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553526|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
14553527|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553528|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553529|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553530|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553531|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
14553532|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553533|NCT00002110|Zidovudine|zidovudine|mesh-list
14553534|NCT00002110|Cysteamine|cysteamine|mesh-list
14553535|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
14553536|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553537|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553538|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553539|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553540|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
14553541|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553542|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553543|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553544|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14553545|NCT00002111|Saquinavir|saquinavir|mesh-list
14553546|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14553547|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14553548|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
14553549|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553550|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553551|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553552|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553553|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
14553554|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553555|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14553556|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553557|NCT00002112|Fluconazole|fluconazole|mesh-list
14553558|NCT00002112|Nystatin|nystatin|mesh-list
14809001|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809002|NCT00830492|Clomiphene|clomiphene|mesh-list
14809003|NCT00830492|Enclomiphene|enclomiphene|mesh-list
14809004|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
14809005|NCT00830492|Buserelin|buserelin|mesh-list
14809006|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14809007|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
14809008|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809009|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809010|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14809011|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
14809012|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14809013|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14809014|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14809015|NCT00830505|Fluticasone|fluticasone|mesh-list
14809016|NCT00830505|Xhance|xhance|mesh-list
14809017|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14809018|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14809019|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14809020|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14809021|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
14809022|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809023|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809024|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15086702|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086703|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086704|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809025|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
14809026|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
14809027|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14809028|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14809029|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14809030|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14809031|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
14809032|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809033|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809034|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
14809035|NCT00830505|Hormones|hormones|mesh-ancestor
14809036|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809037|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
14809038|NCT00830531|Bumetanide|bumetanide|mesh-list
14809039|NCT00830531|Diuretics|diuretics|mesh-ancestor
14809040|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
15086705|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15086706|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15086707|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15086708|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15086709|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
15086710|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
15086711|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15086712|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15086713|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
15086714|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15086715|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
15086716|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
14809041|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809042|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15086717|NCT02256735|Ritobegron|ritobegron|mesh-list
14553559|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
14553560|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553561|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553562|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553563|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553564|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553565|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553566|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553567|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553568|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553569|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553570|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553571|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553572|NCT00002112|Ionophores|ionophores|mesh-ancestor
14553573|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14553574|NCT00002113|Fluconazole|fluconazole|mesh-list
14553575|NCT00002113|Flucytosine|flucytosine|mesh-list
14553576|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
14553577|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553578|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553579|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086718|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15086719|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086720|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15086721|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15086722|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553580|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553581|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553582|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553583|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553584|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553585|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553586|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553587|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553588|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
14553589|NCT00002115|Adefovir|adefovir|mesh-list
14553590|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
14553591|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553592|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553593|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553594|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553595|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553596|NCT00002116|Cidofovir|cidofovir|mesh-list
14553597|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
14553598|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553599|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553600|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643545|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643546|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
14643547|NCT00189644|Fluorouracil|fluorouracil|mesh-list
14643548|NCT00189644|Epirubicin|epirubicin|mesh-list
14643549|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643550|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
14643551|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643552|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643553|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14643554|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
14643555|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643556|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643557|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14643558|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
14643559|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643560|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14643561|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14643562|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14643563|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643564|NCT00189657|Irinotecan|irinotecan|mesh-list
14643565|NCT00189657|Fluorouracil|fluorouracil|mesh-list
14643566|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14643567|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14643568|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086723|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553601|NCT00002117|Zidovudine|zidovudine|mesh-list
14553602|NCT00002117|Zalcitabine|zalcitabine|mesh-list
14553603|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
14553604|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553605|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553606|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553607|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553608|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
14553609|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553610|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553611|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553612|NCT00002118|Zalcitabine|zalcitabine|mesh-list
14553613|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
14553614|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553615|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553616|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553617|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553618|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
14553619|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553620|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553621|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553622|NCT00002120|Leucovorin|leucovorin|mesh-list
14553623|NCT00002120|Trimethoprim|trimethoprim|mesh-list
14553624|NCT00002120|Dapsone|dapsone|mesh-list
14553625|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
14553626|NCT00002120|Trimetrexate|trimetrexate|mesh-list
14553627|NCT00002120|Calcium|calcium|mesh-list
14553628|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
14553629|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14553630|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553631|NCT00002120|Antidotes|antidotes|mesh-ancestor
14553632|NCT00002120|Protective Agents|protective agents|mesh-ancestor
14553633|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
14553634|NCT00002120|Vitamins|vitamins|mesh-ancestor
14553635|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
14553636|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14553637|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553638|NCT00002120|Renal Agents|renal agents|mesh-ancestor
14553639|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
14553640|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553641|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553642|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14553643|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553644|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553645|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14553646|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14553647|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553648|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
14553649|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553650|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
14553651|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14553652|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
14553653|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553654|NCT00002122|Azithromycin|azithromycin|mesh-list
14553655|NCT00002122|Rifabutin|rifabutin|mesh-list
14553656|NCT00002122|Fluconazole|fluconazole|mesh-list
14553657|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553658|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553659|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
14553660|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553661|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553662|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553663|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553664|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553665|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553666|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553667|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553668|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553669|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553670|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14553671|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
14553672|NCT00002123|Didanosine|didanosine|mesh-list
15086724|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086725|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553673|NCT00002123|Delavirdine|delavirdine|mesh-list
14553674|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
15086726|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
14553675|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553676|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553677|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553678|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553679|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
14553680|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553681|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553682|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553683|NCT00002124|Lamivudine|lamivudine|mesh-list
14553684|NCT00002124|Zidovudine|zidovudine|mesh-list
14553685|NCT00002124|Delavirdine|delavirdine|mesh-list
14553686|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553687|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553688|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553689|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553690|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
14553691|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553692|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553693|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553694|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
14553695|NCT00002125|Foscarnet|foscarnet|mesh-list
14553696|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14553697|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
14553698|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553699|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553700|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553701|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553702|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553703|NCT00002126|Lenograstim|lenograstim|mesh-list
14553704|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553705|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
14553706|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553707|NCT00002127|Thalidomide|thalidomide|mesh-list
14553708|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14553709|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
14553710|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553711|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
14553712|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553713|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553714|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14553715|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14553716|NCT00002127|Growth Substances|growth substances|mesh-ancestor
14553717|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
14553718|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553719|NCT00002128|Adefovir|adefovir|mesh-list
14553720|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14553721|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
15086727|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
15086728|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086729|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
15086730|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15086731|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15086732|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15086733|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086734|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086735|NCT02256748|Midazolam|midazolam|mesh-list
15086736|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15086737|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15086738|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086739|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086740|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15086741|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086742|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086743|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15086744|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
15086745|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
15086746|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
15086747|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
15086748|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086749|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086750|NCT02256774|Ritonavir|ritonavir|mesh-list
15086751|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
15086752|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14553722|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553723|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15086753|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14553724|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553725|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553726|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553727|NCT00002129|Vesnarinone|vesnarinone|mesh-list
14553728|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553729|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
14553730|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553731|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553732|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
14553733|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553734|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14553735|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14553736|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553737|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553738|NCT00002129|Protective Agents|protective agents|mesh-ancestor
14553739|NCT00002130|Vesnarinone|vesnarinone|mesh-list
15086754|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086755|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086756|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086757|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086758|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086759|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
15086760|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086761|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086762|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086763|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15086764|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15086765|NCT02256813|Vitamin K|vitamin k|mesh-list
15086766|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
15086767|NCT02256813|Midazolam|midazolam|mesh-list
15086768|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
14553740|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553741|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
14553742|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553743|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553744|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
14553745|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553746|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14553747|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14553748|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553749|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553750|NCT00002130|Protective Agents|protective agents|mesh-ancestor
14553751|NCT00002131|Vesnarinone|vesnarinone|mesh-list
14553752|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14553753|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
14553754|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553755|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086769|NCT02256813|Caffeine|caffeine|mesh-list
15086770|NCT02256813|Omeprazole|omeprazole|mesh-list
15086771|NCT02256813|Warfarin|warfarin|mesh-list
15086772|NCT02256813|Vitamins|vitamins|mesh-ancestor
15086773|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
15086774|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553756|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
14553757|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553758|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14553759|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14553760|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553761|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553762|NCT00002131|Protective Agents|protective agents|mesh-ancestor
14553763|NCT00002132|Itraconazole|itraconazole|mesh-list
14553764|NCT00002132|Fluconazole|fluconazole|mesh-list
14553765|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
14553766|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553767|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553768|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553769|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553770|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553771|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553772|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553773|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553774|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553775|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086775|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14553776|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14553777|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14553778|NCT00002133|Itraconazole|itraconazole|mesh-list
14553779|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
14553780|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553781|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553782|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553783|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553784|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553785|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553786|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553787|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553788|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553789|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14553790|NCT00002134|Ganciclovir|ganciclovir|mesh-list
14553791|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14553792|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
14553793|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553794|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553795|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553796|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553797|NCT00002135|Ganciclovir|ganciclovir|mesh-list
14553798|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14553799|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
14553800|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553801|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553802|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553803|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553804|NCT00002139|Azithromycin|azithromycin|mesh-list
14553805|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553806|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553807|NCT00002140|Azithromycin|azithromycin|mesh-list
14553808|NCT00002140|Clarithromycin|clarithromycin|mesh-list
14553809|NCT00002140|Ethambutol|ethambutol|mesh-list
14553810|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553811|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553812|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14553813|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553814|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553815|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14553816|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553817|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
14553818|NCT00002141|Abacavir|abacavir|mesh-list
14553819|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553820|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553821|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553822|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553823|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
14553824|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553825|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553826|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14553827|NCT00002142|Cidofovir|cidofovir|mesh-list
14553828|NCT00002142|Probenecid|probenecid|mesh-list
14553829|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
14553830|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
14553831|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14553832|NCT00002142|Renal Agents|renal agents|mesh-ancestor
14553833|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
14553834|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553835|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553836|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553837|NCT00002143|Acitretin|acitretin|mesh-list
14553838|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
14553839|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14553840|NCT00002144|Foscarnet|foscarnet|mesh-list
14553841|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14553842|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
14553843|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553844|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553845|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553846|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553847|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553848|NCT00002145|Foscarnet|foscarnet|mesh-list
13996136|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13996137|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14268305|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14553849|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14553850|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
14553851|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553852|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553853|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553854|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553855|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553856|NCT00002146|Foscarnet|foscarnet|mesh-list
14553857|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14553858|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
14553859|NCT00002146|Analgesics|analgesics|mesh-ancestor
14553860|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
14553861|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14553862|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553863|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
14553864|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14553865|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14553866|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
14553867|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14553868|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14553869|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553870|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14553871|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
14553872|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14553873|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
14553874|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553875|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553876|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553877|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268306|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553878|NCT00002147|Doxorubicin|doxorubicin|mesh-list
14553879|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14553880|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14553881|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553882|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15086776|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15086777|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086778|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15086779|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086780|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086781|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15086782|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
15086783|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
15086784|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
14553883|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14553884|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553885|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553886|NCT00002148|OPC 14117|opc 14117|mesh-list
14553887|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14553888|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
14647417|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086785|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
15086786|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086787|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086788|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
15086789|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15086790|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15086791|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15086792|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086793|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15086794|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15086795|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15086796|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15086797|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
15086798|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15086799|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15086800|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
15086801|NCT02256813|Coagulants|coagulants|mesh-ancestor
15086802|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
15086803|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086804|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15086805|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15086806|NCT02256826|Ritonavir|ritonavir|mesh-list
15086807|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086808|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086809|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086810|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086811|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268307|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14268308|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
14553889|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553890|NCT00002148|Protective Agents|protective agents|mesh-ancestor
14553891|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553892|NCT00002149|Amoxicillin|amoxicillin|mesh-list
14553893|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
14553894|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
14553895|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
14553896|NCT00002149|Ephedrine|ephedrine|mesh-list
14553897|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553898|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553899|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14553900|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553901|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553902|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14553903|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
14553904|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14553905|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553906|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14553907|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14553908|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
14553909|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14647418|NCT00199771|Dextrans|dextrans|mesh-list
14809043|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809044|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809045|NCT00830570|Warfarin|warfarin|mesh-list
14809046|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
14809047|NCT00830609|Ribavirin|ribavirin|mesh-list
14809048|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14809049|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
14809050|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
14809051|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809052|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
14809053|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809054|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
14809055|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809056|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
14809057|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14809058|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
14809059|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809060|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
14809061|NCT00830830|Protective Agents|protective agents|mesh-ancestor
14809062|NCT00830843|Propofol|propofol|mesh-list
14809063|NCT00830843|Isoflurane|isoflurane|mesh-list
14809064|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14809065|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809066|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809067|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14809068|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
14809069|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
14809070|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14809071|NCT00830856|Lamivudine|lamivudine|mesh-list
14809072|NCT00830856|Nevirapine|nevirapine|mesh-list
14809073|NCT00830856|Stavudine|stavudine|mesh-list
14809074|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
14809075|NCT00830856|Fluconazole|fluconazole|mesh-list
14809076|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14809077|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14809078|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086812|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268309|NCT00394329|Hormones|hormones|mesh-ancestor
14553910|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14553911|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
14553912|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14553913|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14553914|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
14553915|NCT00002154|Selegiline|selegiline|mesh-list
14553916|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
15086813|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086814|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
15086815|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086816|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086817|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086818|NCT02256878|Amitriptyline|amitriptyline|mesh-list
15086819|NCT02256878|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15086820|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15086821|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
14553917|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14553918|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14553919|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14553920|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14553921|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553922|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553923|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14553924|NCT00002154|Protective Agents|protective agents|mesh-ancestor
14553925|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553926|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
14553927|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
14553928|NCT00002154|Vitamins|vitamins|mesh-ancestor
14553929|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
14553930|NCT00002155|Lamivudine|lamivudine|mesh-list
14553931|NCT00002155|Zidovudine|zidovudine|mesh-list
14553932|NCT00002155|Indinavir|indinavir|mesh-list
14553933|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14553934|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553935|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553936|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553937|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
14553938|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553939|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14553940|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086822|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086823|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086824|NCT02256878|Analgesics|analgesics|mesh-ancestor
15086825|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
15086826|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086827|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086828|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14553941|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
14553942|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14553943|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14553944|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
14553945|NCT00002156|Ganciclovir|ganciclovir|mesh-list
14553946|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14553947|NCT00002156|Fomivirsen|fomivirsen|mesh-list
14553948|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
14553949|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553950|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14553951|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553952|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553953|NCT00002157|Thalidomide|thalidomide|mesh-list
14553954|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14553955|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
14553956|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553957|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
14553958|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15086829|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15086830|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14553959|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553960|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14553961|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14553962|NCT00002157|Growth Substances|growth substances|mesh-ancestor
14553963|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
14553964|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14553965|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
14809079|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553966|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553967|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553968|NCT00002159|Itraconazole|itraconazole|mesh-list
14553969|NCT00002159|Amphotericin B|amphotericin b|mesh-list
14553970|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14553971|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
14553972|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14553973|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14553974|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14553975|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14553976|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553977|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14553978|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
14553979|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14553980|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553981|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14553982|NCT00002159|Amebicides|amebicides|mesh-ancestor
14553983|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14553984|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14553985|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14553986|NCT00002160|Ziconotide|ziconotide|mesh-list
14553987|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15086831|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086832|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
14553988|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14553989|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14553990|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14553991|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14553992|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14553993|NCT00002160|Protective Agents|protective agents|mesh-ancestor
14553994|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14553995|NCT00002160|Analgesics|analgesics|mesh-ancestor
14553996|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
14553997|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14553998|NCT00002161|Adefovir|adefovir|mesh-list
14553999|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14554000|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
14554001|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554002|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554003|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554004|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554005|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554006|NCT00002162|Lamivudine|lamivudine|mesh-list
14554007|NCT00002162|Zidovudine|zidovudine|mesh-list
14554008|NCT00002162|Stavudine|stavudine|mesh-list
14554009|NCT00002162|Didanosine|didanosine|mesh-list
14554010|NCT00002162|Zalcitabine|zalcitabine|mesh-list
14554011|NCT00002162|Saquinavir|saquinavir|mesh-list
14554012|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554013|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554014|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554015|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554016|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
14554017|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554018|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268310|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268311|NCT00394433|Bevacizumab|bevacizumab|mesh-list
14268312|NCT00394433|Cisplatin|cisplatin|mesh-list
14268313|NCT00394433|Docetaxel|docetaxel|mesh-list
14268314|NCT00394433|Irinotecan|irinotecan|mesh-list
14268315|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268316|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268317|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268318|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268319|NCT00394433|Growth Substances|growth substances|mesh-ancestor
14268320|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268321|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268322|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268323|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
14554019|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554020|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
14554021|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554022|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086833|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268324|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
14554023|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554024|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554025|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554026|NCT00002163|Abacavir|abacavir|mesh-list
14554027|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554028|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554029|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554030|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554031|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
14554032|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554033|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554034|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554035|NCT00002164|Nelfinavir|nelfinavir|mesh-list
14554036|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554037|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554038|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554039|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554040|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554041|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554042|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554043|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
14554044|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554045|NCT00002165|Nelfinavir|nelfinavir|mesh-list
14554046|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554047|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554048|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554049|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554050|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554051|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554052|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554053|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
14554054|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554055|NCT00002166|Nevirapine|nevirapine|mesh-list
14554056|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554057|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554058|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554059|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554060|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
14554061|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554062|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554063|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554064|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554065|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554066|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
14554067|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14554068|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
14554069|NCT00002168|Lamivudine|lamivudine|mesh-list
14554070|NCT00002168|Zidovudine|zidovudine|mesh-list
14554071|NCT00002168|Stavudine|stavudine|mesh-list
14554072|NCT00002168|Didanosine|didanosine|mesh-list
14554073|NCT00002168|Indinavir|indinavir|mesh-list
14554074|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554075|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554076|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554077|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554078|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
14554079|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554080|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554081|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554082|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
14554083|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554084|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554085|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554086|NCT00002169|Nelfinavir|nelfinavir|mesh-list
14554087|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554088|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554089|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554090|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554091|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554092|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554093|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554094|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
14554095|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554096|NCT00002170|Nelfinavir|nelfinavir|mesh-list
14554097|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554098|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554099|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554100|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554101|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554102|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554103|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554104|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
14554105|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554106|NCT00002171|Nelfinavir|nelfinavir|mesh-list
14554107|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554108|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554109|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554110|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554111|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554112|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554113|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554114|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
14554115|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554116|NCT00002174|Thalidomide|thalidomide|mesh-list
14554117|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14554118|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
14554119|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554120|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
14554121|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554122|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554123|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14554124|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14554125|NCT00002174|Growth Substances|growth substances|mesh-ancestor
14554126|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
14554127|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554128|NCT00002176|Stavudine|stavudine|mesh-list
14554129|NCT00002176|Didanosine|didanosine|mesh-list
14554130|NCT00002176|Nelfinavir|nelfinavir|mesh-list
14554131|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
14554132|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086834|NCT02256878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15086835|NCT02256878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086836|NCT02256878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086837|NCT02256943|Amitriptyline|amitriptyline|mesh-list
15086838|NCT02256943|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15086839|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14554133|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
15086840|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15086841|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15086842|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
15086843|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086844|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086845|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086846|NCT02256943|Urological Agents|urological agents|mesh-ancestor
15086847|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15086848|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
15086849|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086850|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15086851|NCT02256943|Analgesics|analgesics|mesh-ancestor
15086852|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
15086853|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086854|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15086855|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15086856|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086857|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086858|NCT02256943|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15086859|NCT02256943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086860|NCT02256943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086861|NCT02256956|Amitriptyline|amitriptyline|mesh-list
15086862|NCT02256956|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15086863|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
15086864|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15086865|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15086866|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
15086867|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086868|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086869|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086870|NCT02256956|Urological Agents|urological agents|mesh-ancestor
15086871|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14554134|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554135|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647419|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
14554136|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554137|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
14554138|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554139|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
14554140|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554141|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554142|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554143|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086872|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
15086873|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15086874|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14268325|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268326|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14554144|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554145|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554146|NCT00002177|Stavudine|stavudine|mesh-list
14554147|NCT00002177|Didanosine|didanosine|mesh-list
14268327|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14268328|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268329|NCT00394472|Lesogaberan|lesogaberan|mesh-list
14268330|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14268331|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14268332|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
14268333|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
14268334|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268335|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268336|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268337|NCT00394524|Insulin|insulin|mesh-list
14268338|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268339|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268340|NCT00394589|Infliximab|infliximab|mesh-list
14268341|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14268342|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14268343|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268344|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14268345|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14268346|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
14268347|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14554148|NCT00002177|Nelfinavir|nelfinavir|mesh-list
14554149|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
14554150|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554151|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
14554152|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554153|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554154|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554155|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
14554156|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554157|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
14554158|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554159|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554160|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554161|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554162|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554163|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554164|NCT00002178|Ritonavir|ritonavir|mesh-list
14554165|NCT00002178|Nelfinavir|nelfinavir|mesh-list
14554166|NCT00002178|Saquinavir|saquinavir|mesh-list
14554167|NCT00002178|Delavirdine|delavirdine|mesh-list
14554168|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554169|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554170|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554171|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554172|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268348|NCT00394771|Estradiol|estradiol|mesh-list
14268349|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14268350|NCT00394771|Estrogens|estrogens|mesh-ancestor
14268351|NCT00394771|Hormones|hormones|mesh-ancestor
14268352|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268353|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268354|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14268355|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
14554173|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554174|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554175|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
15086875|NCT02256956|Analgesics|analgesics|mesh-ancestor
14268356|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14554176|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647420|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
14554177|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554178|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554179|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15086876|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
15086877|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086878|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15086879|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15086880|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086881|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
15086882|NCT02256956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15086883|NCT02256956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15086884|NCT02256956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14554180|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554181|NCT00002179|Lamivudine|lamivudine|mesh-list
14554182|NCT00002179|Zidovudine|zidovudine|mesh-list
14554183|NCT00002179|Indinavir|indinavir|mesh-list
14554184|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554185|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554186|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554187|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554188|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
14554189|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554190|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554191|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554192|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
14554193|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554194|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554195|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554196|NCT00002180|Tenofovir|tenofovir|mesh-list
14554197|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
14554198|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554199|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554200|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554201|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554202|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554203|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554204|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554205|NCT00002181|Cidofovir|cidofovir|mesh-list
14554206|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
14554207|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554208|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554209|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554210|NCT00002182|Megestrol|megestrol|mesh-list
14554211|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
14554212|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14268357|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14268358|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14268359|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14268360|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14268361|NCT00394836|Ofatumumab|ofatumumab|mesh-list
14268362|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14268363|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268364|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
15086885|NCT02257008|Ritonavir|ritonavir|mesh-list
15086886|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15086887|NCT02257008|Nelfinavir|nelfinavir|mesh-list
13996138|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268365|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268366|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
14268367|NCT00394901|Pregabalin|pregabalin|mesh-list
14268368|NCT00394901|Analgesics|analgesics|mesh-ancestor
14554213|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14554214|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14554215|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
14554216|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14023349|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14554217|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554218|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14554219|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14554220|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14554221|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554222|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
14554223|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14554224|NCT00002183|Lamivudine|lamivudine|mesh-list
14554225|NCT00002183|Zidovudine|zidovudine|mesh-list
14554226|NCT00002183|Abacavir|abacavir|mesh-list
14554227|NCT00002183|Amprenavir|amprenavir|mesh-list
14554228|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554229|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554230|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554231|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554232|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
14554233|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554234|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554235|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554236|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
14554237|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554238|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554239|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554240|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554241|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554242|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554243|NCT00002184|Lamivudine|lamivudine|mesh-list
14554244|NCT00002184|Zidovudine|zidovudine|mesh-list
14554245|NCT00002184|Stavudine|stavudine|mesh-list
14554246|NCT00002184|Adefovir|adefovir|mesh-list
14554247|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14554248|NCT00002184|Nelfinavir|nelfinavir|mesh-list
14554249|NCT00002184|Saquinavir|saquinavir|mesh-list
14554250|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15086888|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086889|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086890|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086891|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086892|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554251|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554252|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554253|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554254|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
14554255|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554256|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554257|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14809080|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
14809081|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809082|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14809083|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14809084|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
14809085|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14809086|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14809087|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14809088|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
14809089|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809090|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086893|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086894|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086895|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
14809091|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14809092|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14809093|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14809094|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14809095|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
14809096|NCT00830882|Albuterol|albuterol|mesh-list
14809097|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14809098|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
14809099|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809100|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809101|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14809102|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086896|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554258|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
14554259|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554260|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554261|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554262|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554263|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554264|NCT00002185|Nelfinavir|nelfinavir|mesh-list
14554265|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14268369|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
14268370|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268371|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554266|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554267|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554268|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554269|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554270|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554271|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554272|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
14554273|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554274|NCT00002186|Acyclovir|acyclovir|mesh-list
14554275|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
14554276|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554277|NCT00002187|Fomivirsen|fomivirsen|mesh-list
14554278|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
14554279|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554280|NCT00002188|Alitretinoin|alitretinoin|mesh-list
14554281|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554282|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
14554283|NCT00002189|Paclitaxel|paclitaxel|mesh-list
14554284|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14554285|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554286|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
14554287|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
14554288|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
14554289|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554290|NCT00002190|Lamivudine|lamivudine|mesh-list
14554291|NCT00002190|Zidovudine|zidovudine|mesh-list
14554292|NCT00002190|Saquinavir|saquinavir|mesh-list
14554293|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554294|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554295|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554296|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554297|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
14554298|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554299|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554300|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554301|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
14554302|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554303|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554304|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554305|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554306|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086897|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086898|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086899|NCT02257021|Ritonavir|ritonavir|mesh-list
15086900|NCT02257021|Tipranavir|tipranavir|mesh-list
15086901|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15086902|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15086903|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
15086904|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086905|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086906|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15086907|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086908|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
15086909|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086910|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15086911|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15086912|NCT02257138|Decitabine|decitabine|mesh-list
15086913|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15086914|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
15086915|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086916|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086917|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173058|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15173059|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14554307|NCT00002191|Albendazole|albendazole|mesh-list
14554308|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
14554309|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14554310|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554311|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
14554312|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14554313|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14554314|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
14554315|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
14554316|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
14554317|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554318|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554319|NCT00002192|Azithromycin|azithromycin|mesh-list
14554320|NCT00002192|Clarithromycin|clarithromycin|mesh-list
14554321|NCT00002192|Ethambutol|ethambutol|mesh-list
14554322|NCT00002192|Rifapentine|rifapentine|mesh-list
14554323|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554324|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554325|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14554326|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554327|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554328|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554329|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554330|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554331|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554332|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
14554333|NCT00002193|Amprenavir|amprenavir|mesh-list
14554334|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554335|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554336|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554337|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554338|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554339|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554340|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
14268372|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
14268373|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14554341|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554342|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554343|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554344|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554345|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
14554346|NCT00002194|Clarithromycin|clarithromycin|mesh-list
14554347|NCT00002194|Erythromycin|erythromycin|mesh-list
14554348|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
13996139|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996140|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996141|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
13996142|NCT02922491|Vitamin E|vitamin e|mesh-list
13996143|NCT02922491|Vitamins|vitamins|mesh-ancestor
13996144|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
13996145|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554349|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14554350|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
14554351|NCT00002194|Nevirapine|nevirapine|mesh-list
14554352|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554353|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554354|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14554355|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554356|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554357|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554358|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554359|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554360|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554361|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
14554362|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554363|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554364|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554365|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554366|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14554367|NCT00002195|Lamivudine|lamivudine|mesh-list
14554368|NCT00002195|Zidovudine|zidovudine|mesh-list
14554369|NCT00002195|Amprenavir|amprenavir|mesh-list
14554370|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554371|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554372|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554373|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554374|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
15086918|NCT02257242|Rituximab|rituximab|mesh-list
13996146|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
14554375|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554376|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554377|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554378|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
14554379|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554380|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554381|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554382|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554383|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554384|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554385|NCT00002197|Abacavir|abacavir|mesh-list
14554386|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554387|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554388|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554389|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554390|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
14554391|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554392|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554393|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554394|NCT00002198|Abacavir|abacavir|mesh-list
14554395|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554396|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554397|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554398|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554399|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
14554400|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554401|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554402|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554403|NCT00002199|Lamivudine|lamivudine|mesh-list
14554404|NCT00002199|Zidovudine|zidovudine|mesh-list
14554405|NCT00002199|Abacavir|abacavir|mesh-list
14554406|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14554407|NCT00002199|Indinavir|indinavir|mesh-list
14554408|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15086919|NCT02257242|Vincristine|vincristine|mesh-list
15086920|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15086921|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15086922|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086923|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
15086924|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554409|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554410|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996147|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996148|NCT02922491|Protective Agents|protective agents|mesh-ancestor
13996149|NCT02922179|Insulin|insulin|mesh-list
13996150|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
13996151|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14554411|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554412|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
14554413|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554414|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554415|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554416|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
14554417|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554418|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554419|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554420|NCT00002200|Abacavir|abacavir|mesh-list
14554421|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554422|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554423|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554424|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554425|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
14554426|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554427|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554428|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15086925|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268374|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268375|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268376|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268377|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14268378|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14554429|NCT00002201|Ritonavir|ritonavir|mesh-list
14554430|NCT00002201|Nelfinavir|nelfinavir|mesh-list
14554431|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554432|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554433|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554434|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554435|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554436|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554437|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554438|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
14554439|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554440|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554441|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554442|NCT00002202|Indinavir|indinavir|mesh-list
14554443|NCT00002202|Amprenavir|amprenavir|mesh-list
14554444|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554445|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554446|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554447|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554448|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554449|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554450|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554451|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
14554452|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554453|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554454|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554455|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554456|NCT00002203|Lamivudine|lamivudine|mesh-list
14554457|NCT00002203|Zidovudine|zidovudine|mesh-list
14554458|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14554459|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554460|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554461|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554462|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554463|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
14554464|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554465|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554466|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554467|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
14554468|NCT00002205|Abacavir|abacavir|mesh-list
14554469|NCT00002205|Amprenavir|amprenavir|mesh-list
14554470|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554471|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554472|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554473|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554474|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
14554475|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554476|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554477|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554478|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554479|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554480|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554481|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554482|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554483|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554484|NCT00002206|Adefovir|adefovir|mesh-list
14554485|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14554486|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
14554487|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554488|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554489|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554490|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554491|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554492|NCT00002208|Lamivudine|lamivudine|mesh-list
14554493|NCT00002208|Zidovudine|zidovudine|mesh-list
14554494|NCT00002208|Stavudine|stavudine|mesh-list
14554495|NCT00002208|Indinavir|indinavir|mesh-list
15086926|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15086927|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
15086928|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
15086929|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
15086930|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086931|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15086932|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
15086933|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15086934|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15086935|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14554496|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554497|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554498|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554499|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554500|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
14554501|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554502|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554503|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554504|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
14554505|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554506|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554507|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554508|NCT00002210|Delavirdine|delavirdine|mesh-list
14554509|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554510|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554511|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554512|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554513|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
14554514|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554515|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554516|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554517|NCT00002211|Stavudine|stavudine|mesh-list
14554518|NCT00002211|Didanosine|didanosine|mesh-list
14554519|NCT00002211|Delavirdine|delavirdine|mesh-list
14554520|NCT00002211|Nelfinavir|nelfinavir|mesh-list
14554521|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
14554522|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554523|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554524|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554525|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554526|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
14554527|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554528|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554529|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554530|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554531|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554532|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554533|NCT00002212|Bexarotene|bexarotene|mesh-list
14554534|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554535|NCT00002213|Efavirenz|efavirenz|mesh-list
14554536|NCT00002213|Abacavir|abacavir|mesh-list
14554537|NCT00002213|Amprenavir|amprenavir|mesh-list
14554538|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554539|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554540|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554541|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554542|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
14554543|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554544|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554545|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554546|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554547|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554548|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14809103|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
14809104|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14809105|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14809106|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14809107|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14809108|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14809109|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809110|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809111|NCT00830895|Everolimus|everolimus|mesh-list
14809112|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809113|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809114|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
14809115|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809116|NCT00831103|Valacyclovir|valacyclovir|mesh-list
14809117|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
14809118|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809119|NCT00831155|Nicotine|nicotine|mesh-list
14809120|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14809121|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
14809122|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809123|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809124|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14554549|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554550|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554551|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554552|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554553|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554554|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554555|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554556|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554557|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554558|NCT00002214|Capravirine|capravirine|mesh-list
14554559|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554560|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554561|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554562|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554563|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
14554564|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554565|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554566|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554567|NCT00002215|Nelfinavir|nelfinavir|mesh-list
14554568|NCT00002215|Emivirine|emivirine|mesh-list
14554569|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554570|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554571|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554572|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554573|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554574|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554575|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554576|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
14554577|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554578|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554579|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554580|NCT00002216|Lamivudine|lamivudine|mesh-list
14554581|NCT00002216|Zidovudine|zidovudine|mesh-list
14554582|NCT00002216|Abacavir|abacavir|mesh-list
14554583|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14554584|NCT00002216|Nelfinavir|nelfinavir|mesh-list
14554585|NCT00002216|Amprenavir|amprenavir|mesh-list
14554586|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554587|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554588|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554589|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554590|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
14554591|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554592|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554593|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554594|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
14554595|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554596|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554597|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554598|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554599|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554600|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554601|NCT00002217|Lamivudine|lamivudine|mesh-list
14554602|NCT00002217|Zidovudine|zidovudine|mesh-list
14554603|NCT00002217|Abacavir|abacavir|mesh-list
14554604|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14554605|NCT00002217|Amprenavir|amprenavir|mesh-list
14554606|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554607|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554608|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554609|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554610|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
14554611|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554612|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554613|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554614|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
14554615|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554616|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554617|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554618|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554619|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554620|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
14643569|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643570|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643571|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
14643572|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14554621|NCT00002219|Nelfinavir|nelfinavir|mesh-list
14554622|NCT00002219|Adefovir|adefovir|mesh-list
14554623|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14554624|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554625|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554626|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554627|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554628|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554629|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554630|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554631|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
14554632|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554633|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554634|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554635|NCT00002220|Efavirenz|efavirenz|mesh-list
14554636|NCT00002220|Adefovir|adefovir|mesh-list
14554637|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14554638|NCT00002220|Indinavir|indinavir|mesh-list
14554639|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554640|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554641|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554642|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554643|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
14554644|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554645|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554646|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554647|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554648|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554649|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554650|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554651|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554652|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554653|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554654|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554655|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554656|NCT00002222|Valganciclovir|valganciclovir|mesh-list
14554657|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
14554658|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554659|NCT00002223|Ritonavir|ritonavir|mesh-list
14554660|NCT00002223|Indinavir|indinavir|mesh-list
14554661|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554662|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554663|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554664|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554665|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554666|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554667|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554668|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
14554669|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554670|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554671|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554672|NCT00002225|Efavirenz|efavirenz|mesh-list
15086936|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086937|NCT02257346|Lidocaine|lidocaine|mesh-list
15086938|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
15086939|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
15086940|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15086941|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086942|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
15086943|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086944|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15086945|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15086946|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15086947|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15086948|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086949|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
15086950|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15086951|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15086952|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086953|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15086954|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15086955|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554673|NCT00002225|Stavudine|stavudine|mesh-list
14554674|NCT00002225|Didanosine|didanosine|mesh-list
14554675|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554676|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554677|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554678|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554679|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
14554680|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554681|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554682|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554683|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554684|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554685|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554686|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554687|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
14554688|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554689|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554690|NCT00002226|Semaxinib|semaxinib|mesh-list
14554691|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14554692|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14554693|NCT00002226|Growth Substances|growth substances|mesh-ancestor
14554694|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554695|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
14554696|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554697|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14554698|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554699|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554700|NCT00002227|Lamivudine|lamivudine|mesh-list
14554701|NCT00002227|Efavirenz|efavirenz|mesh-list
14554702|NCT00002227|Stavudine|stavudine|mesh-list
14554703|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554704|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554705|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554706|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554707|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
14554708|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554709|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554710|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554711|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554712|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554713|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554714|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554715|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554716|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554717|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
14554718|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
14554719|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14554720|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14554721|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554722|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554723|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554724|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
14554725|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554726|NCT00002229|Saquinavir|saquinavir|mesh-list
14554727|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554728|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554729|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554730|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554731|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554732|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554733|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554734|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
14554735|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554736|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554737|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554738|NCT00002230|Efavirenz|efavirenz|mesh-list
14554739|NCT00002230|Stavudine|stavudine|mesh-list
14554740|NCT00002230|Didanosine|didanosine|mesh-list
14554741|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
14554742|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554743|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554744|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554745|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554746|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
14554747|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554748|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554749|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554750|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554751|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554752|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554753|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554754|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554755|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
14554756|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
14554757|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554758|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554759|NCT00002233|Lamivudine|lamivudine|mesh-list
14554760|NCT00002233|Abacavir|abacavir|mesh-list
14554761|NCT00002233|Indinavir|indinavir|mesh-list
14554762|NCT00002233|Amprenavir|amprenavir|mesh-list
14554763|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554764|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554765|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554766|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554767|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
14554768|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554769|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554770|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554771|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554772|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554773|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554774|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554775|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554776|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554777|NCT00002234|Lamivudine|lamivudine|mesh-list
14554778|NCT00002234|Efavirenz|efavirenz|mesh-list
14554779|NCT00002234|Didanosine|didanosine|mesh-list
14554780|NCT00002234|Adefovir|adefovir|mesh-list
14554781|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14554782|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554783|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554784|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554785|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554786|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
14554787|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554788|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554789|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554790|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554791|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554792|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554793|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554794|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554795|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554796|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
14554797|NCT00002235|Efavirenz|efavirenz|mesh-list
14554798|NCT00002235|Nelfinavir|nelfinavir|mesh-list
14554799|NCT00002235|Indinavir|indinavir|mesh-list
14554800|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554801|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554802|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554803|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086956|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086957|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086958|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15086959|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
15086960|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15086961|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554804|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
14554805|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554806|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554807|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554808|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554809|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554810|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554811|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554812|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554813|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554814|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554815|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554816|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554817|NCT00002236|Zidovudine|zidovudine|mesh-list
14809125|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14809126|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14809127|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809128|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809129|NCT00831350|Ranibizumab|ranibizumab|mesh-list
14809130|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14809131|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14809132|NCT00831350|Growth Substances|growth substances|mesh-ancestor
14809133|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809134|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
14809135|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809136|NCT00831376|Albuterol|albuterol|mesh-list
14809137|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14809138|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
14809139|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809140|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809141|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14809142|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
14809143|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
14809144|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14809145|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14809146|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14809147|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14809148|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
14809149|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809150|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809151|NCT00831506|Digoxin|digoxin|mesh-list
14809152|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14809153|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14809154|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809155|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809156|NCT00831506|Protective Agents|protective agents|mesh-ancestor
14809157|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809158|NCT00831545|Temozolomide|temozolomide|mesh-list
14809159|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14809160|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
14809161|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809162|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809163|NCT00831597|Rituximab|rituximab|mesh-list
14809164|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14809165|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14809166|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809167|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
14809168|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809169|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809170|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14809171|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
14809172|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809173|NCT00831636|Cytarabine|cytarabine|mesh-list
14809174|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14809175|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
14809176|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086962|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15086963|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15086964|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15086965|NCT02257463|Theophylline|theophylline|mesh-list
15086966|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
15086967|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
14554818|NCT00002236|Delavirdine|delavirdine|mesh-list
14554819|NCT00002236|Indinavir|indinavir|mesh-list
14554820|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
14554821|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554822|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554823|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554824|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554825|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
14554826|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554827|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554828|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554829|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554830|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554831|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554832|NCT00002238|Interferons|interferons|mesh-list
14554833|NCT00002238|Zidovudine|zidovudine|mesh-list
14554834|NCT00002238|Interferon-beta|interferon-beta|mesh-list
14554835|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
14554836|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554837|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
14554838|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554839|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
14554840|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554841|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554842|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554843|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554844|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554845|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554846|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
14554847|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554848|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14554849|NCT00002239|Ritonavir|ritonavir|mesh-list
14554850|NCT00002239|Amprenavir|amprenavir|mesh-list
14554851|NCT00002239|Abacavir|abacavir|mesh-list
14554852|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
14554853|NCT00002239|Efavirenz|efavirenz|mesh-list
14554854|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554855|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554856|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554857|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554858|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554859|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554860|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554861|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
14554862|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554863|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554864|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554865|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554866|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554867|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14554868|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14554869|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14554870|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14554871|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14554872|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14554873|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14554874|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554875|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554876|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554877|NCT00002241|Ritonavir|ritonavir|mesh-list
14554878|NCT00002241|Indinavir|indinavir|mesh-list
14554879|NCT00002241|Lamivudine|lamivudine|mesh-list
14554880|NCT00002241|Stavudine|stavudine|mesh-list
14554881|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554882|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554883|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554884|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554885|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554886|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554887|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554888|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
14554889|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554890|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14554891|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554892|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554893|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554894|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
14554895|NCT00002243|Calanolide A|calanolide a|mesh-list
14554896|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554897|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554898|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
14554899|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554900|NCT00002245|Lamivudine|lamivudine|mesh-list
14554901|NCT00002245|Abacavir|abacavir|mesh-list
14554902|NCT00002245|Amprenavir|amprenavir|mesh-list
14554903|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554904|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554905|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554906|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554907|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
14554908|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554909|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554910|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554911|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14554912|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
14554913|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554914|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14554915|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14554916|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
14554917|NCT00002247|Ganciclovir|ganciclovir|mesh-list
14554918|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14554919|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
14554920|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554921|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554922|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554923|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554924|NCT00002249|Levofloxacin|levofloxacin|mesh-list
14554925|NCT00002249|Ofloxacin|ofloxacin|mesh-list
14554926|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14554927|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554928|NCT00002249|Renal Agents|renal agents|mesh-ancestor
14554929|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14554930|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14554931|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14554932|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554933|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554934|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554935|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14554936|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14554937|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14554938|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
14554939|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554940|NCT00002251|Ganciclovir|ganciclovir|mesh-list
14554941|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14554942|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
14554943|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554944|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554945|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554946|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554947|NCT00002252|Octreotide|octreotide|mesh-list
14554948|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14554949|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14554950|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554951|NCT00002253|Octreotide|octreotide|mesh-list
14554952|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14554953|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14554954|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554955|NCT00002254|Alovudine|alovudine|mesh-list
14554956|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
14554957|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554958|NCT00002255|Zidovudine|zidovudine|mesh-list
15086968|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086969|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086970|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15086971|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
15086972|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15086973|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086974|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15086975|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15086976|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
15086977|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15086978|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15086979|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
15086980|NCT02257476|Dexamethasone|dexamethasone|mesh-list
15086981|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15086982|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
15086983|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
14554959|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
14554960|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
14554961|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554962|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14647421|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
15086984|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15086985|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554963|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554964|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554965|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
14554966|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554967|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554968|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554969|NCT00002255|Hematinics|hematinics|mesh-ancestor
14554970|NCT00002256|Zalcitabine|zalcitabine|mesh-list
14554971|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
14554972|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554973|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14554974|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554975|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554976|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
14554977|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554978|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14554979|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14554980|NCT00002257|Ganciclovir|ganciclovir|mesh-list
14554981|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14554982|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
14554983|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14554984|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14554985|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554986|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554987|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
14554988|NCT00002259|Analgesics|analgesics|mesh-ancestor
14554989|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
14554990|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14554991|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14554992|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14554993|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14554994|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14554995|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14554996|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14554997|NCT00002260|Alovudine|alovudine|mesh-list
14554998|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
14554999|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555000|NCT00002261|Vaccines|vaccines|mesh-list
14555001|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
14555002|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555003|NCT00002263|Zidovudine|zidovudine|mesh-list
14555004|NCT00002263|Sargramostim|sargramostim|mesh-list
14555005|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
14555006|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555007|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555008|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555009|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555010|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
14555011|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555012|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555013|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555014|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
14555015|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555016|NCT00002265|Zalcitabine|zalcitabine|mesh-list
14555017|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
14555018|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15086986|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15086987|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
15086988|NCT02257476|Hormones|hormones|mesh-ancestor
14268379|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268380|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268381|NCT00394914|Pleconaril|pleconaril|mesh-list
14268382|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
14268383|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268384|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
14268385|NCT00394953|Hematinics|hematinics|mesh-ancestor
14268386|NCT00395018|Entecavir|entecavir|mesh-list
14268387|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
15086989|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15086990|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15086991|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086992|NCT02257502|Aflibercept|aflibercept|mesh-list
15086993|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15086994|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14023350|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268388|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086995|NCT02257502|Growth Substances|growth substances|mesh-ancestor
14268389|NCT00395044|Gabapentin|gabapentin|mesh-list
14268390|NCT00395044|Analgesics|analgesics|mesh-ancestor
14268391|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
14268392|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268393|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268394|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
14268395|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14555019|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555020|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555021|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555022|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
14555023|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555024|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555025|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555026|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14555027|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555028|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
14555029|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555030|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555031|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14555032|NCT00002266|Protective Agents|protective agents|mesh-ancestor
14555033|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555034|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555035|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555036|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555037|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
14555038|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555039|NCT00002267|Rifabutin|rifabutin|mesh-list
14555040|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555041|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15086996|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15086997|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
15086998|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15086999|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
15087000|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
15087001|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14555042|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14555043|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
14555044|NCT00002269|Zidovudine|zidovudine|mesh-list
14555045|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14555046|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
14555047|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555048|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555049|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555050|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555051|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
14555052|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555053|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555054|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555055|NCT00002270|Interferons|interferons|mesh-list
14555056|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
14555057|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
14555058|NCT00002270|Zidovudine|zidovudine|mesh-list
14555059|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555060|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
14555061|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555062|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
14555063|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555064|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
14555065|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647422|NCT00199784|Phenylephrine|phenylephrine|mesh-list
15087002|NCT02257671|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14555066|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555067|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555068|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555069|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555070|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555071|NCT00002271|Alovudine|alovudine|mesh-list
14555072|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
15087003|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
15087004|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15087005|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087006|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15087007|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15087008|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15087009|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15087010|NCT02257671|Estrogens|estrogens|mesh-ancestor
15087011|NCT02257671|Hormones|hormones|mesh-ancestor
15087012|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15087013|NCT02257671|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15087014|NCT02257697|Mizoribine|mizoribine|mesh-list
15087015|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
15087016|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15087017|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
15087018|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087019|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087020|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15087021|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
15087022|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087023|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087024|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15087025|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15087026|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14555073|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555074|NCT00002272|Foscarnet|foscarnet|mesh-list
14555075|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14555076|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
14555077|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555078|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555079|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555080|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555081|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555082|NCT00002273|Ganciclovir|ganciclovir|mesh-list
14555083|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14555084|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
14555085|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555086|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555087|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555088|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555089|NCT00002274|Didanosine|didanosine|mesh-list
14555090|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
14555091|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555092|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555093|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555094|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555095|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
14555096|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555097|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555098|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555099|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14555100|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14555101|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14555102|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14555103|NCT00002276|Zidovudine|zidovudine|mesh-list
14555104|NCT00002276|Ibuprofen|ibuprofen|mesh-list
14555105|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14555106|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14555107|NCT00002276|Analgesics|analgesics|mesh-ancestor
14555108|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
14555109|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14555110|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555111|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14555112|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14555113|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14555114|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555115|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555116|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
14555117|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555118|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14268396|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14268397|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268398|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268399|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14268400|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14268401|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268402|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268403|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
14268404|NCT00395057|Ranibizumab|ranibizumab|mesh-list
14268405|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268406|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268407|NCT00395057|Growth Substances|growth substances|mesh-ancestor
14268408|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268409|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268410|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268411|NCT00395161|Selenium|selenium|mesh-list
14268412|NCT00395161|Metoclopramide|metoclopramide|mesh-list
14268413|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
14268414|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268415|NCT00395161|Protective Agents|protective agents|mesh-ancestor
14268416|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268417|NCT00395161|Trace Elements|trace elements|mesh-ancestor
14268418|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
14268419|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
14268420|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
14268421|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268422|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14268423|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14268424|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14268425|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
14268426|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268427|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
14268428|NCT00395226|Astringents|astringents|mesh-ancestor
14268429|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555119|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
14555120|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555121|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555122|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555123|NCT00002277|Fluconazole|fluconazole|mesh-list
14555124|NCT00002277|Amphotericin B|amphotericin b|mesh-list
14555125|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14555126|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
14555127|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555128|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555129|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555130|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555131|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555132|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555133|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555134|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555135|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647423|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
14809177|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809178|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
14809179|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809180|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809181|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
14809182|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809183|NCT00831649|Natalizumab|natalizumab|mesh-list
14809184|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
15087027|NCT02257697|Analgesics|analgesics|mesh-ancestor
14268430|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
14268431|NCT00395304|Fluticasone|fluticasone|mesh-list
14268432|NCT00395304|Xhance|xhance|mesh-list
14555136|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555137|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555138|NCT00002277|Amebicides|amebicides|mesh-ancestor
14555139|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555140|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555141|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555142|NCT00002278|Diclazuril|diclazuril|mesh-list
14555143|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
14555144|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555145|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555146|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555147|NCT00002279|Zalcitabine|zalcitabine|mesh-list
14555148|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
14555149|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555150|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555151|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555152|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555153|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
14555154|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555155|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555156|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555157|NCT00002280|Didanosine|didanosine|mesh-list
14555158|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
14555159|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555160|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555161|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555162|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555163|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
14555164|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555165|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555166|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555167|NCT00002281|Zidovudine|zidovudine|mesh-list
14555168|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
14555169|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
14555170|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555171|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555172|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555173|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555174|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
14555175|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555176|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555177|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555178|NCT00002281|Hematinics|hematinics|mesh-ancestor
14555179|NCT00002282|Fluconazole|fluconazole|mesh-list
14555180|NCT00002282|Clotrimazole|clotrimazole|mesh-list
14555181|NCT00002282|Miconazole|miconazole|mesh-list
14555182|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
14555183|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555184|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555185|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555186|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555187|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555188|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555189|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555190|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555191|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555192|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555193|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555194|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14555195|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555196|NCT00002283|Trimethoprim|trimethoprim|mesh-list
14555197|NCT00002283|Dapsone|dapsone|mesh-list
14555198|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
14555199|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14555200|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555201|NCT00002283|Renal Agents|renal agents|mesh-ancestor
14555202|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
14555203|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555204|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555205|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14555206|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555207|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555208|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14555209|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14647424|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14555210|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555211|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
14555212|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555213|NCT00002284|Zidovudine|zidovudine|mesh-list
14555214|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
14555215|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555216|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555217|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555218|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555219|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
14555220|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555221|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555222|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555223|NCT00002285|Zidovudine|zidovudine|mesh-list
14555224|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
14555225|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555226|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555227|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555228|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555229|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
14555230|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555231|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555232|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555233|NCT00002286|Zidovudine|zidovudine|mesh-list
14555234|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
15087028|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
15087029|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087030|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087031|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087032|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087033|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15087034|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
15087035|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15087036|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15087037|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087038|NCT02257788|Leronlimab|leronlimab|mesh-list
15087039|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15087040|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15087041|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087042|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15087043|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15087044|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
15087045|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087046|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
15087047|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087048|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087049|NCT02258009|Ranibizumab|ranibizumab|mesh-list
15087050|NCT02258009|Aflibercept|aflibercept|mesh-list
15087051|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15087052|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15087053|NCT02258009|Growth Substances|growth substances|mesh-ancestor
15087054|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087055|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
15087056|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087057|NCT02258204|Ketamine|ketamine|mesh-list
15087058|NCT02258204|Analgesics|analgesics|mesh-ancestor
15087059|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
15087060|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087061|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087062|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15087063|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15087064|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
15087065|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
15087066|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087067|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15087068|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15087069|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087070|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087071|NCT02258282|Etanercept|etanercept|mesh-list
15087072|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15087073|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15087074|NCT02258282|Analgesics|analgesics|mesh-ancestor
14268433|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15087075|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
15087076|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14555235|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555236|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555237|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555238|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555239|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
14555240|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555241|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555242|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555243|NCT00002287|Zidovudine|zidovudine|mesh-list
14555244|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
14555245|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555246|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555247|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555248|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555249|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
14555250|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555251|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555252|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555253|NCT00002288|Zidovudine|zidovudine|mesh-list
14555254|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
14555255|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555256|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555257|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555258|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555259|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
14555260|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555261|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555262|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555263|NCT00002289|Thymopentin|thymopentin|mesh-list
14555264|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555265|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
14555266|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555267|NCT00002290|Zidovudine|zidovudine|mesh-list
14555268|NCT00002290|Acyclovir|acyclovir|mesh-list
14555269|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
14555270|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555271|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555272|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555273|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555274|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
14555275|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555276|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555277|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555278|NCT00002291|Pentamidine|pentamidine|mesh-list
14555279|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
14555280|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555281|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555282|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555283|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14555284|NCT00002292|Pentamidine|pentamidine|mesh-list
14555285|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
14555286|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555287|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555288|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555289|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14555290|NCT00002293|Nystatin|nystatin|mesh-list
14555291|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555292|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555293|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
14555294|NCT00002293|Ionophores|ionophores|mesh-ancestor
14555295|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14555296|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555297|NCT00002294|Fluconazole|fluconazole|mesh-list
14555298|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
14555299|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555300|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555301|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555302|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555303|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555304|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555305|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555306|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555307|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555308|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555309|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555310|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
14555311|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555312|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
14555313|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555314|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
14555315|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555316|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
14555317|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555318|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
14555319|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555320|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
14555321|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555322|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
14555323|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555324|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
14555325|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555326|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
14555327|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555328|NCT00002298|Ribavirin|ribavirin|mesh-list
14555329|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
14555330|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555331|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
14555332|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555333|NCT00002299|Interferons|interferons|mesh-list
14555334|NCT00002299|Interferon-beta|interferon-beta|mesh-list
14555335|NCT00002299|Ganciclovir|ganciclovir|mesh-list
14555336|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14555337|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
14555338|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555339|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
14555340|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555341|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
14555342|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555343|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555344|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555345|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555346|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555347|NCT00002300|Megestrol|megestrol|mesh-list
14555348|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
14555349|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14555350|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14555351|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14555352|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
14555353|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14555354|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555355|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14555356|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14555357|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14555358|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555359|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
14555360|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14555361|NCT00002301|Foscarnet|foscarnet|mesh-list
14555362|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14555363|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
14555364|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555365|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555366|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555367|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555368|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555369|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
14555370|NCT00002302|Hematinics|hematinics|mesh-ancestor
14555371|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
14555372|NCT00002303|Hematinics|hematinics|mesh-ancestor
14555373|NCT00002304|Fluconazole|fluconazole|mesh-list
14555374|NCT00002304|Ketoconazole|ketoconazole|mesh-list
14555375|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
14555376|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087077|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087078|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087079|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087080|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14555377|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555378|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15087081|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14555379|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647425|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
14555380|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555381|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555382|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555383|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555384|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555385|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555386|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555387|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555388|NCT00002305|Fluconazole|fluconazole|mesh-list
14555389|NCT00002305|Amphotericin B|amphotericin b|mesh-list
14555390|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14555391|NCT00002305|Flucytosine|flucytosine|mesh-list
14555392|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
14555393|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555394|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555395|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555396|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555397|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555398|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555399|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555400|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555401|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555402|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555403|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555404|NCT00002305|Amebicides|amebicides|mesh-ancestor
14555405|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555406|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555407|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555408|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
14555409|NCT00002306|Fluconazole|fluconazole|mesh-list
14555410|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
14555411|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555412|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555413|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555414|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555415|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555416|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555417|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555418|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555419|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555420|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555421|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555422|NCT00002307|Zidovudine|zidovudine|mesh-list
14555423|NCT00002307|Stavudine|stavudine|mesh-list
14555424|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
14555425|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555426|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555427|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555428|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555429|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
14555430|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555431|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555432|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555433|NCT00002308|Stavudine|stavudine|mesh-list
14555434|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
14555435|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555436|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14268434|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14268435|NCT00395304|Montelukast|montelukast|mesh-list
14268436|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14268437|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14268438|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
14268439|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268440|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268441|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14268442|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14268443|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
14555437|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555438|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555439|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
14268444|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14555440|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555441|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555442|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555443|NCT00002309|Azithromycin|azithromycin|mesh-list
14555444|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555445|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555446|NCT00002311|Wobenzym|wobenzym|mesh-list
14555447|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555448|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
14555449|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555450|NCT00002312|Zidovudine|zidovudine|mesh-list
14555451|NCT00002312|Delavirdine|delavirdine|mesh-list
14555452|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
14555453|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555454|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555455|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555456|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555457|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
14555458|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555459|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555460|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555461|NCT00002313|Didanosine|didanosine|mesh-list
14555462|NCT00002313|Nystatin|nystatin|mesh-list
14555463|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
14555464|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555465|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555466|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555467|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555468|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
14555469|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555470|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555471|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555472|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555473|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
14555474|NCT00002313|Ionophores|ionophores|mesh-ancestor
14555475|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14555476|NCT00002315|Acyclovir|acyclovir|mesh-list
14555477|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
14809185|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809186|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
14809187|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14809188|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
14809189|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14809190|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
14809191|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809192|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809193|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
14814217|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814218|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
14814219|NCT00861926|Hormones|hormones|mesh-ancestor
14814220|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814221|NCT00861939|Bupropion|bupropion|mesh-list
14814222|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14814223|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
14814224|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814225|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14814226|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814227|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814228|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814229|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
14814230|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814231|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814232|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14814233|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14814234|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814235|NCT00861952|Mineral Oil|mineral oil|mesh-list
14814236|NCT00861952|Emollients|emollients|mesh-ancestor
14814237|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
14814238|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
14814239|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087082|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
14555478|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
14555479|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555480|NCT00002316|Amphotericin B|amphotericin b|mesh-list
14555481|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14814240|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
14555482|NCT00002316|Amebicides|amebicides|mesh-ancestor
14555483|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555484|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555485|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555486|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555487|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
14555488|NCT00002317|Leucovorin|leucovorin|mesh-list
14555489|NCT00002317|Trimetrexate|trimetrexate|mesh-list
14555490|NCT00002317|Calcium|calcium|mesh-list
14555491|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
14555492|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14555493|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555494|NCT00002317|Antidotes|antidotes|mesh-ancestor
14555495|NCT00002317|Protective Agents|protective agents|mesh-ancestor
14555496|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
14555497|NCT00002317|Vitamins|vitamins|mesh-ancestor
14555498|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
14555499|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
14555500|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555501|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14555502|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
14555503|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555504|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809194|NCT00831857|Bevacizumab|bevacizumab|mesh-list
15087083|NCT02258542|Benralizumab|benralizumab|mesh-list
15087084|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15087085|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
15087086|NCT02258581|Tenofovir|tenofovir|mesh-list
15087087|NCT02258581|Vesatolimod|vesatolimod|mesh-list
15087088|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
15087089|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087090|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15087091|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15087092|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087093|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087094|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15087095|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15087096|NCT02258607|Trametinib|trametinib|mesh-list
15087097|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
15087098|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087099|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15087100|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087101|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087102|NCT02258620|Isosorbide|isosorbide|mesh-list
15087103|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15087104|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15087105|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
15087106|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087107|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15087108|NCT02258620|Diuretics|diuretics|mesh-ancestor
15087109|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087110|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087111|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15087112|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087113|NCT02258763|Amoxicillin|amoxicillin|mesh-list
15087114|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
15087115|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
15087116|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15087117|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087118|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087119|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15087120|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087121|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087122|NCT02258815|Dinutuximab|dinutuximab|mesh-list
15087123|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087124|NCT02258828|Memantine|memantine|mesh-list
15087125|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15087126|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15087127|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
15087128|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087129|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087130|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555505|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14555506|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555507|NCT00002318|Doxorubicin|doxorubicin|mesh-list
14555508|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14555509|NCT00002318|Bleomycin|bleomycin|mesh-list
14555510|NCT00002318|Vincristine|vincristine|mesh-list
14555511|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14555512|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555513|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14555514|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14555515|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555516|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555517|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14555518|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14555519|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
14555520|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14555521|NCT00002319|Doxorubicin|doxorubicin|mesh-list
14555522|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14555523|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14555524|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555525|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14555526|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14555527|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555528|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555529|NCT00002320|Lamivudine|lamivudine|mesh-list
14555530|NCT00002320|Zidovudine|zidovudine|mesh-list
14555531|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555532|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555533|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555534|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555535|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
14555536|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555537|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555538|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555539|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
14555540|NCT00002321|Aldesleukin|aldesleukin|mesh-list
14555541|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555542|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555543|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555544|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
14555545|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643573|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643574|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
14643575|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643576|NCT00189683|Capecitabine|capecitabine|mesh-list
14643577|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643578|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
14643579|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643580|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643581|NCT00189709|Fluconazole|fluconazole|mesh-list
14643582|NCT00189709|Micafungin|micafungin|mesh-list
14643583|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
14643584|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643585|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14643586|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14643587|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643588|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643589|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14643590|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
14643591|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643592|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643593|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14643594|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14643595|NCT00189722|Tacrolimus|tacrolimus|mesh-list
14643596|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643597|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
14643598|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643599|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14643600|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643601|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643602|NCT00189748|Tacrolimus|tacrolimus|mesh-list
14643603|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643604|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
14643605|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643606|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14643607|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643608|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643609|NCT00189761|Tacrolimus|tacrolimus|mesh-list
14555546|NCT00002322|Zidovudine|zidovudine|mesh-list
14555547|NCT00002322|Atevirdine|atevirdine|mesh-list
14555548|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
14555549|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555550|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555551|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555552|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555553|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
14555554|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555555|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555556|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555557|NCT00002323|Zidovudine|zidovudine|mesh-list
14555558|NCT00002323|Nevirapine|nevirapine|mesh-list
14555559|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
14555560|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555561|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555562|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555563|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555564|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
14555565|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555566|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555567|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555568|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14555569|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14555570|NCT00002324|Zidovudine|zidovudine|mesh-list
14555571|NCT00002324|Nevirapine|nevirapine|mesh-list
14555572|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
14555573|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555574|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555575|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555576|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555577|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
14555578|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555579|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555580|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555581|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14555582|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14555583|NCT00002325|Fluconazole|fluconazole|mesh-list
14555584|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
14555585|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555586|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555587|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555588|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555589|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555590|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555591|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555592|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555593|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555594|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555595|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555596|NCT00002326|Zidovudine|zidovudine|mesh-list
14555597|NCT00002326|Adefovir|adefovir|mesh-list
14555598|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
14555599|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555600|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555601|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555602|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555603|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
14555604|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555605|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555606|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555607|NCT00002327|Cidofovir|cidofovir|mesh-list
14555608|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
14555609|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555610|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555611|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555612|NCT00002328|Azithromycin|azithromycin|mesh-list
14555613|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555614|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555615|NCT00002330|Ganciclovir|ganciclovir|mesh-list
14555616|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14555617|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
14555618|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555619|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555620|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555621|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555622|NCT00002331|Clarithromycin|clarithromycin|mesh-list
14555623|NCT00002331|Ethambutol|ethambutol|mesh-list
14555624|NCT00002331|Clofazimine|clofazimine|mesh-list
14555625|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555626|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555627|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14555628|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555629|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555630|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555631|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555632|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
14555633|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14555634|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
14555635|NCT00002332|Thymopentin|thymopentin|mesh-list
14555636|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555637|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
14555638|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555639|NCT00002333|Saquinavir|saquinavir|mesh-list
14555640|NCT00002333|Zalcitabine|zalcitabine|mesh-list
14555641|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555642|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555643|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555644|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555645|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555646|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555647|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555648|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
14555649|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555650|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555651|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555652|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
14555653|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555654|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555655|NCT00002334|Zidovudine|zidovudine|mesh-list
14555656|NCT00002334|Zalcitabine|zalcitabine|mesh-list
14555657|NCT00002334|Saquinavir|saquinavir|mesh-list
14555658|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
14555659|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555660|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555661|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555662|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555663|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
14555664|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555665|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555666|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555667|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555668|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555669|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555670|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555671|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555672|NCT00002335|Emtricitabine|emtricitabine|mesh-list
14555673|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
14555674|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555675|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555676|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555677|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555678|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555679|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555680|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555681|NCT00002336|Clarithromycin|clarithromycin|mesh-list
14555682|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555683|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555684|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14555685|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555686|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555687|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555688|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15087131|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15087132|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15087133|NCT02258906|Urinastatin|urinastatin|mesh-list
14555689|NCT00002337|Vesnarinone|vesnarinone|mesh-list
15087134|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14555690|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14555691|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
14555692|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555693|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555694|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
14555695|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555696|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14555697|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14555698|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555699|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555700|NCT00002337|Protective Agents|protective agents|mesh-ancestor
14555701|NCT00002339|Fluconazole|fluconazole|mesh-list
14555702|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
14555703|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555704|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555705|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555706|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555707|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555708|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555709|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555710|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555711|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555712|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555713|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555714|NCT00002340|Atovaquone|atovaquone|mesh-list
14555715|NCT00002340|Pentamidine|pentamidine|mesh-list
14555716|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555717|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
14555718|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14555719|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14555720|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555721|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555722|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
14555723|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14555724|NCT00002341|Itraconazole|itraconazole|mesh-list
14555725|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
14555726|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555727|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555728|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555729|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555730|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555731|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555732|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555733|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555734|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555735|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555736|NCT00002343|Ethambutol|ethambutol|mesh-list
14555737|NCT00002343|Rifabutin|rifabutin|mesh-list
14555738|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
14555739|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555740|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555741|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14555742|NCT00002344|Azithromycin|azithromycin|mesh-list
14555743|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555744|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555745|NCT00002345|Megestrol|megestrol|mesh-list
14555746|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
14555747|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14555748|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14555749|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14555750|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
14555751|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14555752|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555753|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14555754|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14555755|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14555756|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555757|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
14555758|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14555759|NCT00002346|Adefovir|adefovir|mesh-list
14555760|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14555761|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
15087135|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14555762|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555763|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555764|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555765|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555766|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555767|NCT00002347|Zidovudine|zidovudine|mesh-list
14555768|NCT00002347|Nevirapine|nevirapine|mesh-list
14555769|NCT00002347|Zalcitabine|zalcitabine|mesh-list
14555770|NCT00002347|Saquinavir|saquinavir|mesh-list
14555771|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
14555772|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555773|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555774|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555775|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809195|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
14809196|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14809197|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809198|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14809199|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14809200|NCT00831857|Growth Substances|growth substances|mesh-ancestor
14809201|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809202|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
14809203|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14809204|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809205|NCT00832013|Propofol|propofol|mesh-list
14809206|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14809207|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809208|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809209|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14809210|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
14809211|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
14809212|NCT00832039|Selenious Acid|selenious acid|mesh-list
14809213|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
14809214|NCT00832039|Trace Elements|trace elements|mesh-ancestor
14809215|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
14809216|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809217|NCT00832182|Insulin|insulin|mesh-list
14809218|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14809219|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
14809220|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
14809221|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
14809222|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
14809223|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14809224|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809225|NCT00832208|Amphotericin B|amphotericin b|mesh-list
14809226|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14809227|NCT00832208|Amebicides|amebicides|mesh-ancestor
14809228|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14809229|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14809230|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809231|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14809232|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
14809233|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14809234|NCT00832221|Raclopride|raclopride|mesh-list
14809235|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
14809236|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809237|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14809238|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14809239|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809240|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809241|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14809242|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
14809243|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809244|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809245|NCT00832234|Dexamethasone|dexamethasone|mesh-list
14809246|NCT00832234|Rituximab|rituximab|mesh-list
14809247|NCT00832234|Bortezomib|bortezomib|mesh-list
14809248|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14809249|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
14809250|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
14809251|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809252|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809253|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809254|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
14809255|NCT00832234|Hormones|hormones|mesh-ancestor
14809256|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809257|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15087136|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
15087137|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087138|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173060|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15173061|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
15173062|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15173063|NCT04008433|Lidocaine|lidocaine|mesh-list
15173064|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
15173065|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
15173066|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173067|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173068|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
15173069|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173070|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15173071|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15173072|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15173073|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15173074|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173075|NCT04008316|Colchicine|colchicine|mesh-list
15173076|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
15173077|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173078|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
14555776|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
14555777|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555778|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555779|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555780|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14555781|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14555782|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555783|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555784|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555785|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555786|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555787|NCT00002348|Mitoguazone|mitoguazone|mesh-list
14555788|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14555789|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555790|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555791|NCT00002349|Stavudine|stavudine|mesh-list
14555792|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
14555793|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555794|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555795|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555796|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555797|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
14555798|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555799|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555800|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555801|NCT00002351|Indinavir|indinavir|mesh-list
14555802|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555803|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555804|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555805|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173079|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
15173080|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
15173081|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173082|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173083|NCT04008043|Acetaminophen|acetaminophen|mesh-list
15173084|NCT04008043|Dexamethasone|dexamethasone|mesh-list
15173085|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15173086|NCT04008043|Hydrocodone|hydrocodone|mesh-list
15173087|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173088|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
15173089|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
15173090|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173091|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173092|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173093|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
15173094|NCT04008043|Hormones|hormones|mesh-ancestor
15173095|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173096|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15173097|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173098|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15173099|NCT04008043|Analgesics|analgesics|mesh-ancestor
15173100|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
14555806|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555807|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555808|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555809|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
14555810|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555811|NCT00002352|Lobucavir|lobucavir|mesh-list
14555812|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555813|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555814|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555815|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555816|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
14555817|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555818|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555819|NCT00002354|Stavudine|stavudine|mesh-list
14555820|NCT00002354|Indinavir|indinavir|mesh-list
14555821|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
14555822|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555823|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555824|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555825|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555826|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
14555827|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555828|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555829|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555830|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555831|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555832|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555833|NCT00002355|Fomivirsen|fomivirsen|mesh-list
14555834|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
14555835|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555836|NCT00002356|Fomivirsen|fomivirsen|mesh-list
14555837|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
14555838|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555839|NCT00002357|Zidovudine|zidovudine|mesh-list
14555840|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
14555841|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555842|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555843|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555844|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555845|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
14555846|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555847|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555848|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555849|NCT00002358|Sorivudine|sorivudine|mesh-list
14555850|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
14555851|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555852|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555853|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555854|NCT00002360|Didanosine|didanosine|mesh-list
14555855|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
14555856|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555857|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555858|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555859|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555860|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
14555861|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555862|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555863|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555864|NCT00002361|Ritonavir|ritonavir|mesh-list
14555865|NCT00002361|Indinavir|indinavir|mesh-list
14555866|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555867|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555868|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555869|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555870|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555871|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555872|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555873|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
14555874|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555875|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555876|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555877|NCT00002362|Emtricitabine|emtricitabine|mesh-list
14555878|NCT00002362|Efavirenz|efavirenz|mesh-list
14555879|NCT00002362|Abacavir|abacavir|mesh-list
14555880|NCT00002362|Stavudine|stavudine|mesh-list
14555881|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
14555882|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647426|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
14555883|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555884|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555885|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555886|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555887|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555888|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555889|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14555890|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555891|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14555892|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14555893|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14555894|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14555895|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
14555896|NCT00002364|Abacavir|abacavir|mesh-list
14555897|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555898|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555899|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555900|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555901|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
14555902|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555903|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555904|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555905|NCT00002366|Ritonavir|ritonavir|mesh-list
14555906|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555907|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555908|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555909|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555910|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555911|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555912|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555913|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
14555914|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555915|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555916|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555917|NCT00002367|Lamivudine|lamivudine|mesh-list
14555918|NCT00002367|Zidovudine|zidovudine|mesh-list
14555919|NCT00002367|Saquinavir|saquinavir|mesh-list
14555920|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555921|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555922|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555923|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555924|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
14555925|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555926|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555927|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555928|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
14555929|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555930|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555931|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555932|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555933|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555934|NCT00002368|Lamivudine|lamivudine|mesh-list
14555935|NCT00002368|Nevirapine|nevirapine|mesh-list
14555936|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555937|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555938|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555939|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555940|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
14555941|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555942|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555943|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555944|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14555945|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14555946|NCT00002369|Lamivudine|lamivudine|mesh-list
14555947|NCT00002369|Zidovudine|zidovudine|mesh-list
14555948|NCT00002369|Stavudine|stavudine|mesh-list
14555949|NCT00002369|Indinavir|indinavir|mesh-list
14555950|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14555951|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14555952|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555953|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555954|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
14555955|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555956|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555957|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555958|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
14555959|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555960|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555961|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555962|NCT00002370|Itraconazole|itraconazole|mesh-list
14555963|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
14555964|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555965|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14555966|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555967|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555968|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555969|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14555970|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
14555971|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14555972|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14555973|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555974|NCT00002372|Nelfinavir|nelfinavir|mesh-list
14555975|NCT00002372|Indinavir|indinavir|mesh-list
14555976|NCT00002372|Saquinavir|saquinavir|mesh-list
14555977|NCT00002372|Amprenavir|amprenavir|mesh-list
14555978|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14555979|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14555980|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
14555981|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14555982|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14555983|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14555984|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14555985|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
14555986|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555987|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14555988|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14555989|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14555990|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
14555991|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14555992|NCT00002373|Maribavir|maribavir|mesh-list
14555993|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
14555994|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14555995|NCT00002374|Ritonavir|ritonavir|mesh-list
14555996|NCT00002374|Nelfinavir|nelfinavir|mesh-list
14555997|NCT00002374|Saquinavir|saquinavir|mesh-list
14555998|NCT00002374|Stavudine|stavudine|mesh-list
14555999|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556000|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556001|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556002|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556003|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556004|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556005|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556006|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
14556007|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556008|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556009|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556010|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
14556011|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556012|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556013|NCT00002375|Nelfinavir|nelfinavir|mesh-list
14556014|NCT00002375|Indinavir|indinavir|mesh-list
14556015|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556016|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556017|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556018|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556019|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556020|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556021|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556022|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
14556023|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556024|NCT00002376|Lamivudine|lamivudine|mesh-list
14556025|NCT00002376|Zidovudine|zidovudine|mesh-list
14556026|NCT00002376|Stavudine|stavudine|mesh-list
14556027|NCT00002376|Didanosine|didanosine|mesh-list
14556028|NCT00002376|Indinavir|indinavir|mesh-list
14556029|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556030|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556031|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556032|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556033|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
14556034|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556035|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556036|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556037|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
14556038|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15087139|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
15087140|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15087141|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15087142|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15087143|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087144|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087145|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
15087146|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087147|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087148|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15087149|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087150|NCT02259179|Naltrexone|naltrexone|mesh-list
15087151|NCT02259179|Bupropion|bupropion|mesh-list
15087152|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15087153|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15087154|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087155|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
15087156|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087157|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15087158|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
15087159|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15087160|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15087161|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15087162|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087163|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087164|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
15087165|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087166|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15087167|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15087168|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087169|NCT02259309|Misoprostol|misoprostol|mesh-list
15087170|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15087171|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
15087172|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15087173|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087174|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15087175|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15087176|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
15087177|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
15087178|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15087179|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087180|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087181|NCT02259374|Ropivacaine|ropivacaine|mesh-list
15087182|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
15087183|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
15087184|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087185|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087186|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
15087187|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087188|NCT02259426|Piperaquine|piperaquine|mesh-list
15087189|NCT02259426|Primaquine|primaquine|mesh-list
15087190|NCT02259426|Artenimol|artenimol|mesh-list
15087191|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
15087192|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15087193|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15087194|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087195|NCT02259491|Calcium|calcium|mesh-list
15087196|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087197|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087198|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
15087199|NCT02259543|Tetracycline|tetracycline|mesh-list
15087200|NCT02259543|Citric Acid|citric acid|mesh-list
15087201|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
15087202|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087203|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556039|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556040|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556041|NCT00002377|Valganciclovir|valganciclovir|mesh-list
14556042|NCT00002377|Ganciclovir|ganciclovir|mesh-list
15087204|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15087205|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556043|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14556044|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
14556045|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556046|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556047|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556048|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556049|NCT00002378|Ritonavir|ritonavir|mesh-list
14556050|NCT00002378|Nelfinavir|nelfinavir|mesh-list
14556051|NCT00002378|Saquinavir|saquinavir|mesh-list
14809258|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809259|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14809260|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
14809261|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809262|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
14809263|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14809264|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809265|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14809266|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14809267|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809268|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809269|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809270|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14809271|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14809272|NCT00832364|Etanercept|etanercept|mesh-list
14809273|NCT00832364|Acitretin|acitretin|mesh-list
14809274|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14809275|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14809276|NCT00832364|Analgesics|analgesics|mesh-ancestor
14809277|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
14809278|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809279|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809280|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14809281|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809282|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809283|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809284|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
14809285|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
14809286|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
14809287|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14809288|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14809289|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809290|NCT00832442|Metoprolol|metoprolol|mesh-list
14809291|NCT00832442|Carvedilol|carvedilol|mesh-list
14809292|NCT00832442|Nebivolol|nebivolol|mesh-list
14809293|NCT00832442|Bisoprolol|bisoprolol|mesh-list
14809294|NCT00832442|Bucindolol|bucindolol|mesh-list
14809295|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14809296|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14809297|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14809298|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
14809299|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
14809300|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809301|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809302|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14809303|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14809304|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14809305|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809306|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809307|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
14809308|NCT00832442|Protective Agents|protective agents|mesh-ancestor
14809309|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14809310|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809311|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14809312|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
14809313|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14809314|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14809315|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14809316|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14809317|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14809318|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
14809319|NCT00832481|Metformin|metformin|mesh-list
14809320|NCT00832481|Repaglinide|repaglinide|mesh-list
14809321|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14809322|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173101|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
14556052|NCT00002378|Lamivudine|lamivudine|mesh-list
14556053|NCT00002378|Zidovudine|zidovudine|mesh-list
14556054|NCT00002378|Stavudine|stavudine|mesh-list
14556055|NCT00002378|Delavirdine|delavirdine|mesh-list
14556056|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556057|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556058|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556059|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556060|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556061|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556062|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556063|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
14556064|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556065|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556066|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556067|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556068|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556069|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
14556070|NCT00002379|Lamivudine|lamivudine|mesh-list
14556071|NCT00002379|Zidovudine|zidovudine|mesh-list
14556072|NCT00002379|Stavudine|stavudine|mesh-list
14556073|NCT00002379|Adefovir|adefovir|mesh-list
14556074|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14556075|NCT00002379|Indinavir|indinavir|mesh-list
14556076|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556077|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556078|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556079|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556080|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
14556081|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556082|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556083|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556084|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
14556085|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556086|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556087|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556088|NCT00002380|Nelfinavir|nelfinavir|mesh-list
14556089|NCT00002380|Saquinavir|saquinavir|mesh-list
14556090|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556091|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556092|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556093|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556094|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556095|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556096|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556097|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
14556098|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556099|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556100|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556101|NCT00002381|Nevirapine|nevirapine|mesh-list
14556102|NCT00002381|Stavudine|stavudine|mesh-list
14556103|NCT00002381|Nelfinavir|nelfinavir|mesh-list
14556104|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556105|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556106|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556107|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556108|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
14556109|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556110|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556111|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556112|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556113|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556114|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
14556115|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556116|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556117|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556118|NCT00002382|Saquinavir|saquinavir|mesh-list
14556119|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556120|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556121|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
15087206|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087207|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
15087208|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15087209|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
15087210|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
14556122|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556123|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556124|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15087211|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
15087212|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15087213|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
15087214|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
15087215|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087216|NCT02259595|Expectorants|expectorants|mesh-ancestor
15087217|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
15087218|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15087219|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
15087220|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087221|NCT02259595|Protective Agents|protective agents|mesh-ancestor
15087222|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087223|NCT02259595|Antidotes|antidotes|mesh-ancestor
15087224|NCT02259621|Paclitaxel|paclitaxel|mesh-list
15087225|NCT02259621|Carboplatin|carboplatin|mesh-list
15087226|NCT02259621|Nivolumab|nivolumab|mesh-list
15087227|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15087228|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556125|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556126|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
14556127|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556128|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556129|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556130|NCT00002383|Saquinavir|saquinavir|mesh-list
14556131|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556132|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556133|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556134|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556135|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556136|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556137|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556138|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
14556139|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556140|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556141|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556142|NCT00002384|Cidofovir|cidofovir|mesh-list
14556143|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
14556144|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556145|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556146|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556147|NCT00002386|Lamivudine|lamivudine|mesh-list
14556148|NCT00002386|Zidovudine|zidovudine|mesh-list
14556149|NCT00002386|Stavudine|stavudine|mesh-list
14556150|NCT00002386|Didanosine|didanosine|mesh-list
14556151|NCT00002386|Zalcitabine|zalcitabine|mesh-list
14556152|NCT00002386|Indinavir|indinavir|mesh-list
14556153|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556154|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556155|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556156|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556157|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
14556158|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556159|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556160|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556161|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
14556162|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556163|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556164|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556165|NCT00002387|Efavirenz|efavirenz|mesh-list
14556166|NCT00002387|Indinavir|indinavir|mesh-list
14556167|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556168|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556169|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556170|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556171|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
14556172|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556173|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14556174|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556175|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14556176|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14556177|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556178|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556179|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15087229|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
15087230|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
15087231|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
14556180|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556181|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556182|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556183|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556184|NCT00002388|Abacavir|abacavir|mesh-list
14268445|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14268446|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14268447|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14268448|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
14556185|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556186|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556187|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556188|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556189|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
14556190|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556191|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556192|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556193|NCT00002389|Lamivudine|lamivudine|mesh-list
14556194|NCT00002389|Zidovudine|zidovudine|mesh-list
14556195|NCT00002389|Abacavir|abacavir|mesh-list
14556196|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556197|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556198|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556199|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556200|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
14556201|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556202|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556203|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556204|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
14556205|NCT00002390|Abacavir|abacavir|mesh-list
14556206|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556207|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556208|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556209|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556210|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
14556211|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556212|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556213|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556214|NCT00002391|Lamivudine|lamivudine|mesh-list
14556215|NCT00002391|Zidovudine|zidovudine|mesh-list
14556216|NCT00002391|Abacavir|abacavir|mesh-list
14556217|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556218|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556219|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556220|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556221|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
14556222|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556223|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556224|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556225|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
14556226|NCT00002392|Thalidomide|thalidomide|mesh-list
14556227|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14556228|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
14556229|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556230|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
14556231|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14556232|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556233|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14556234|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14556235|NCT00002392|Growth Substances|growth substances|mesh-ancestor
14556236|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
14556237|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556238|NCT00002393|Efavirenz|efavirenz|mesh-list
14556239|NCT00002393|Indinavir|indinavir|mesh-list
14556240|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556241|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556242|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556243|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556244|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
14556245|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556246|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14556247|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556248|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14268449|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292354|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556249|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14556250|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556251|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556252|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556253|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556254|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556255|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15087232|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087233|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15087234|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15087235|NCT02259647|Sorafenib|sorafenib|mesh-list
15087236|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087237|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15087238|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087239|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087240|NCT02259738|Kallikreins|kallikreins|mesh-list
15087241|NCT02259738|Coagulants|coagulants|mesh-ancestor
15087242|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
15087243|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
15087244|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15087245|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087246|NCT02259777|Amlodipine|amlodipine|mesh-list
15087247|NCT02259777|Telmisartan|telmisartan|mesh-list
15087248|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
15087249|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087250|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15087251|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087252|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087253|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087254|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087255|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087256|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087257|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087258|NCT02259790|Amlodipine|amlodipine|mesh-list
15087259|NCT02259790|Telmisartan|telmisartan|mesh-list
15087260|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
15087261|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087262|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15087263|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087264|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087265|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087266|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087267|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087268|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087269|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087270|NCT02259803|Amlodipine|amlodipine|mesh-list
15087271|NCT02259803|Telmisartan|telmisartan|mesh-list
15087272|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
15087273|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087274|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15087275|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087276|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087277|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087278|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087279|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087280|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087281|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087282|NCT02259816|Amlodipine|amlodipine|mesh-list
15087283|NCT02259816|Telmisartan|telmisartan|mesh-list
15087284|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087285|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15087286|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087287|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087288|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087289|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087290|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087291|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087292|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087293|NCT02259829|Amlodipine|amlodipine|mesh-list
15087294|NCT02259829|Telmisartan|telmisartan|mesh-list
14556256|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15087295|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14556257|NCT00002394|Terbinafine|terbinafine|mesh-list
14556258|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
14556259|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556260|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556261|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556262|NCT00002395|Topotecan|topotecan|mesh-list
14556263|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14556264|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14556265|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556266|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556267|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556268|NCT00002396|Tenofovir|tenofovir|mesh-list
14556269|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
14556270|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556271|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556272|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556273|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556274|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556275|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556276|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556277|NCT00002397|Lamivudine|lamivudine|mesh-list
14556278|NCT00002397|Stavudine|stavudine|mesh-list
14556279|NCT00002397|Nelfinavir|nelfinavir|mesh-list
14556280|NCT00002397|Saquinavir|saquinavir|mesh-list
14556281|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556282|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556283|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556284|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556285|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
14556286|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556287|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556288|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556289|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
14556290|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556291|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556292|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556293|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556294|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556295|NCT00002398|Adefovir|adefovir|mesh-list
14556296|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14556297|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
14556298|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556299|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556300|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556301|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556302|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556303|NCT00002399|Fluconazole|fluconazole|mesh-list
14556304|NCT00002399|Posaconazole|posaconazole|mesh-list
14556305|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
14556306|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556307|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14556308|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556309|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556310|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556311|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14556312|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
14556313|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14556314|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556315|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14556316|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14556317|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14556318|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14556319|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14556320|NCT00002400|Lamivudine|lamivudine|mesh-list
14556321|NCT00002400|Zidovudine|zidovudine|mesh-list
14556322|NCT00002400|Delavirdine|delavirdine|mesh-list
14556323|NCT00002400|Indinavir|indinavir|mesh-list
14556324|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556325|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556326|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556327|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087296|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087297|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14556328|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
14556329|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556330|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556331|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556332|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
14556333|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556334|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556335|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556336|NCT00002401|Lamivudine|lamivudine|mesh-list
14556337|NCT00002401|Zidovudine|zidovudine|mesh-list
14556338|NCT00002401|Delavirdine|delavirdine|mesh-list
14556339|NCT00002401|Indinavir|indinavir|mesh-list
14556340|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556341|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556342|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556343|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556344|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
14556345|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556346|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556347|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556348|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
14556349|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556350|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556351|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556352|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14556353|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14556354|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
14556355|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556356|NCT00002402|Antacids|antacids|mesh-ancestor
14556357|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556358|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14556359|NCT00002404|Valacyclovir|valacyclovir|mesh-list
14556360|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
14556361|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556362|NCT00002405|Amprenavir|amprenavir|mesh-list
14556363|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14556364|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
14556365|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14556366|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556367|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15087298|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087299|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087300|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087301|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087302|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087303|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087304|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087305|NCT02259855|Interferons|interferons|mesh-list
15087306|NCT02259855|Ritonavir|ritonavir|mesh-list
15087307|NCT02259855|Ribavirin|ribavirin|mesh-list
15087308|NCT02259855|Tipranavir|tipranavir|mesh-list
14556368|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556369|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556370|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556371|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556372|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556373|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556374|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
14556375|NCT00002406|Indinavir|indinavir|mesh-list
14556376|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556377|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556378|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556379|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556380|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556381|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556382|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556383|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
14556384|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556385|NCT00002407|Lamivudine|lamivudine|mesh-list
14556386|NCT00002407|Nevirapine|nevirapine|mesh-list
14556387|NCT00002407|Stavudine|stavudine|mesh-list
14556388|NCT00002407|Didanosine|didanosine|mesh-list
14556389|NCT00002407|Indinavir|indinavir|mesh-list
14556390|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14809323|NCT00832494|Paclitaxel|paclitaxel|mesh-list
14556391|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556392|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643610|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14556393|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556394|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
14556395|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556396|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556397|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556398|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556399|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556400|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
14556401|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556402|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556403|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556404|NCT00002409|Lamivudine|lamivudine|mesh-list
14556405|NCT00002409|Zidovudine|zidovudine|mesh-list
14556406|NCT00002409|Abacavir|abacavir|mesh-list
14556407|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14556408|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556409|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556410|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556411|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556412|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
14556413|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556414|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556415|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556416|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
14556417|NCT00002410|Lamivudine|lamivudine|mesh-list
14556418|NCT00002410|Zidovudine|zidovudine|mesh-list
14556419|NCT00002410|Indinavir|indinavir|mesh-list
14556420|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556421|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556422|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556423|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556424|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
14556425|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556426|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556427|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556428|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
14556429|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556430|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556431|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556432|NCT00002412|Stavudine|stavudine|mesh-list
14556433|NCT00002412|Didanosine|didanosine|mesh-list
14556434|NCT00002412|Emivirine|emivirine|mesh-list
14556435|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
14556436|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556437|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
14556438|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556439|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556440|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556441|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
14556442|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556443|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
14556444|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556445|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556446|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556447|NCT00002413|Emivirine|emivirine|mesh-list
14556448|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556449|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556450|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556451|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556452|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
14556453|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556454|NCT00002415|Tenofovir|tenofovir|mesh-list
14556455|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
14556456|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556457|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556458|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556459|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556460|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556461|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556462|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556463|NCT00002416|Lamivudine|lamivudine|mesh-list
14556464|NCT00002416|Emtricitabine|emtricitabine|mesh-list
14556465|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556466|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556467|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556468|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556469|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
14556470|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556471|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556472|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556473|NCT00002417|Amprenavir|amprenavir|mesh-list
14556474|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14556475|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
14556476|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14556477|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556478|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556479|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556480|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556481|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556482|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556483|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556484|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556485|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
14556486|NCT00002418|Nevirapine|nevirapine|mesh-list
14556487|NCT00002418|Stavudine|stavudine|mesh-list
14556488|NCT00002418|Didanosine|didanosine|mesh-list
14556489|NCT00002418|Emivirine|emivirine|mesh-list
14556490|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
14556491|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556492|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556493|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556494|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556495|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
14556496|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556497|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556498|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556499|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556500|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556501|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556502|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
14556503|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
14556504|NCT00002419|Efavirenz|efavirenz|mesh-list
14556505|NCT00002419|Abacavir|abacavir|mesh-list
14556506|NCT00002419|Adefovir|adefovir|mesh-list
14556507|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14556508|NCT00002419|Amprenavir|amprenavir|mesh-list
14556509|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556510|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556511|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556512|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556513|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
14556514|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556515|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14556516|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556517|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14556518|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14556519|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556520|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556521|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556522|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556523|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14556524|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
14556525|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087309|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087310|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
15087311|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087312|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15087313|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15087314|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
15087315|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087316|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087317|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15087318|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15087319|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15087320|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15087321|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
15087322|NCT02259868|Ritonavir|ritonavir|mesh-list
15087323|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15087324|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15087325|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556526|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556527|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556528|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556529|NCT00002420|Stavudine|stavudine|mesh-list
14556530|NCT00002420|Didanosine|didanosine|mesh-list
14556531|NCT00002420|Delavirdine|delavirdine|mesh-list
14556532|NCT00002420|Emivirine|emivirine|mesh-list
14556533|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
14556534|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556535|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
14556536|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556537|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556538|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556539|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
14268450|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268451|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14268452|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
14268453|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14556540|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556541|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
14556542|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556543|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556544|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556545|NCT00002423|Lamivudine|lamivudine|mesh-list
14556546|NCT00002423|Abacavir|abacavir|mesh-list
14556547|NCT00002423|Nelfinavir|nelfinavir|mesh-list
14556548|NCT00002423|Indinavir|indinavir|mesh-list
14556549|NCT00002423|Amprenavir|amprenavir|mesh-list
14556550|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556551|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556552|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556553|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556554|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
14556555|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556556|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556557|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556558|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556559|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556560|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556561|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14556562|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
14556563|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14556564|NCT00002424|Lamivudine|lamivudine|mesh-list
14556565|NCT00002424|Stavudine|stavudine|mesh-list
14556566|NCT00002424|Indinavir|indinavir|mesh-list
14556567|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556568|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556569|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556570|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556571|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
14556572|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556573|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556574|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556575|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
14556576|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556577|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556578|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
14643611|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
14643612|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643613|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14643614|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643615|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643616|NCT00189774|Nateglinide|nateglinide|mesh-list
14643617|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14643618|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643619|NCT00189787|Tacrolimus|tacrolimus|mesh-list
14643620|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643621|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
14643622|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556579|NCT00002425|Saquinavir|saquinavir|mesh-list
14556580|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556581|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556582|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556583|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556584|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556585|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556586|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556587|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
14556588|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556589|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556590|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556591|NCT00002426|Adefovir|adefovir|mesh-list
14556592|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14556593|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
14556594|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556595|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556596|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556597|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556598|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556599|NCT00002427|Stavudine|stavudine|mesh-list
14556600|NCT00002427|Didanosine|didanosine|mesh-list
14556601|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
14556602|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556603|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
14556604|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556605|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556606|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556607|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
14556608|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556609|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
14556610|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556611|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556612|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556613|NCT00002428|Vaccines|vaccines|mesh-list
14556614|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
14556615|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556616|NCT00002430|Lamivudine|lamivudine|mesh-list
14556617|NCT00002430|Stavudine|stavudine|mesh-list
14556618|NCT00002430|Nelfinavir|nelfinavir|mesh-list
14556619|NCT00002430|Indinavir|indinavir|mesh-list
14556620|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556621|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556622|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556623|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556624|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
14556625|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556626|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556627|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556628|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
14556629|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556630|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556631|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556632|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
14556633|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14556634|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14556635|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556636|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
14556637|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
14556638|NCT00002432|Foscarnet|foscarnet|mesh-list
14556639|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14556640|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
14556641|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556642|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556643|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556644|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556645|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556646|NCT00002433|Interferons|interferons|mesh-list
14556647|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
14556648|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556649|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
14556650|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556651|NCT00002434|Leucovorin|leucovorin|mesh-list
14556652|NCT00002434|Trimetrexate|trimetrexate|mesh-list
14556653|NCT00002434|Calcium|calcium|mesh-list
14556654|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
14556655|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14556656|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556657|NCT00002434|Antidotes|antidotes|mesh-ancestor
14556658|NCT00002434|Protective Agents|protective agents|mesh-ancestor
14556659|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
14556660|NCT00002434|Vitamins|vitamins|mesh-ancestor
14556661|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
14556662|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
14556663|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556664|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14556665|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
14556666|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556667|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556668|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14556669|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556670|NCT00002435|Zidovudine|zidovudine|mesh-list
14556671|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
14556672|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556673|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556674|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556675|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556676|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
14556677|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556678|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556679|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556680|NCT00002436|Lamivudine|lamivudine|mesh-list
14556681|NCT00002436|Zidovudine|zidovudine|mesh-list
14556682|NCT00002436|Zalcitabine|zalcitabine|mesh-list
14556683|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556684|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556685|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556686|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556687|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
14556688|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556689|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556690|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556691|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
14556692|NCT00002437|Cidofovir|cidofovir|mesh-list
14556693|NCT00002437|Probenecid|probenecid|mesh-list
14556694|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
14556695|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
14556696|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14556697|NCT00002437|Renal Agents|renal agents|mesh-ancestor
14556698|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
14556699|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556700|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556701|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556702|NCT00002438|Itraconazole|itraconazole|mesh-list
14556703|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
14556704|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556705|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14556706|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556707|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556708|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556709|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14556710|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
14556711|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14556712|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556713|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556714|NCT00002439|Alitretinoin|alitretinoin|mesh-list
14556715|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556716|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14556717|NCT00002440|Ritonavir|ritonavir|mesh-list
14556718|NCT00002440|Nelfinavir|nelfinavir|mesh-list
14556719|NCT00002440|Indinavir|indinavir|mesh-list
14556720|NCT00002440|Saquinavir|saquinavir|mesh-list
14556721|NCT00002440|Amprenavir|amprenavir|mesh-list
14556722|NCT00002440|Abacavir|abacavir|mesh-list
14556723|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556724|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556725|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556726|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556727|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556728|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556729|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556730|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
14556731|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556732|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556733|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556734|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556735|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556736|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14556737|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
14556738|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14556739|NCT00002442|Lamivudine|lamivudine|mesh-list
14556740|NCT00002442|Stavudine|stavudine|mesh-list
14556741|NCT00002442|Nelfinavir|nelfinavir|mesh-list
14556742|NCT00002442|Indinavir|indinavir|mesh-list
14556743|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556744|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556745|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556746|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556747|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
14556748|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556749|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556750|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556751|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
14556752|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556753|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556754|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556755|NCT00002443|Zidovudine|zidovudine|mesh-list
14556756|NCT00002443|Indinavir|indinavir|mesh-list
14556757|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
14556758|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556759|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556760|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556761|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556762|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
15087326|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087327|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087328|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15087329|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15087330|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
15087331|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087332|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15087333|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15087334|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
15087335|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
15087336|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
15087337|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087338|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087339|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
15087340|NCT02259946|Bromides|bromides|mesh-list
15087341|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
15087342|NCT02259946|Olodaterol|olodaterol|mesh-list
15087343|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15087344|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
15087345|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087346|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087347|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15087348|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
15087349|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
15087350|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15087351|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
15087352|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087353|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087354|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
15087355|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15087356|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
15087357|NCT02259959|Olodaterol|olodaterol|mesh-list
15087358|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15087359|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
15087360|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087361|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087362|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15087363|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
15087364|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
15087365|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15087366|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
15087367|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087368|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556763|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556764|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556765|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15087369|NCT02259985|Itasetron|itasetron|mesh-list
14556766|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556767|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556768|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556769|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
14268454|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14268455|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14268456|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
14268457|NCT00395304|Hormones|hormones|mesh-ancestor
14268458|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
14268459|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14268460|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268461|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268462|NCT00395343|Incretins|incretins|mesh-ancestor
14268463|NCT00395343|Hormones|hormones|mesh-ancestor
14268464|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268465|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14268466|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
14268467|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268468|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268469|NCT00395486|Atorvastatin|atorvastatin|mesh-list
14268470|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14268471|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14268472|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14268473|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
14268474|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556770|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14556771|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556772|NCT00002446|Fluconazole|fluconazole|mesh-list
14556773|NCT00002446|Posaconazole|posaconazole|mesh-list
14556774|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
14556775|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556776|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14556777|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556778|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556779|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556780|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14556781|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
14556782|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14556783|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556784|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14809324|NCT00832494|Carboplatin|carboplatin|mesh-list
14809325|NCT00832494|Vadimezan|vadimezan|mesh-list
14809326|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14809327|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809328|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
14809329|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
14809330|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
14809331|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809332|NCT00832689|Gemcitabine|gemcitabine|mesh-list
14809333|NCT00832689|Irinotecan|irinotecan|mesh-list
14809334|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14809335|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
14809336|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809337|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809338|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
14809339|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809340|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809341|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809342|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
14809343|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809344|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14809345|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14809346|NCT00832806|Varenicline|varenicline|mesh-list
14809347|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14809348|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14809349|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
14809350|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809351|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809352|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809353|NCT00832884|Lacosamide|lacosamide|mesh-list
14556785|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14556786|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14556787|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14556788|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14556789|NCT00002447|Ritonavir|ritonavir|mesh-list
14556790|NCT00002447|Saquinavir|saquinavir|mesh-list
14556791|NCT00002447|Efavirenz|efavirenz|mesh-list
14556792|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556793|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556794|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556795|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556796|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556797|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556798|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556799|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
14556800|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556801|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556802|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556803|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556804|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556805|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14556806|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14556807|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14556808|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556809|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556810|NCT00002448|Ritonavir|ritonavir|mesh-list
14556811|NCT00002448|Saquinavir|saquinavir|mesh-list
14556812|NCT00002448|Efavirenz|efavirenz|mesh-list
14556813|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556814|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556815|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556816|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556817|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556818|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556819|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556820|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
14556821|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556822|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556823|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556824|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556825|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556826|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14556827|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14556828|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14556829|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14556830|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14556831|NCT00002449|Aldesleukin|aldesleukin|mesh-list
14556832|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556833|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556834|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556835|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
14556836|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556837|NCT00002450|Tenofovir|tenofovir|mesh-list
14556838|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
14556839|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556840|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556841|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556842|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556843|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556844|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556845|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556846|NCT00002451|Ritonavir|ritonavir|mesh-list
14556847|NCT00002451|Indinavir|indinavir|mesh-list
14556848|NCT00002451|Lamivudine|lamivudine|mesh-list
14556849|NCT00002451|Stavudine|stavudine|mesh-list
14556850|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556851|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556852|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556853|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556854|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556855|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556856|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556857|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
14556858|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809354|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
14556859|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14556860|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14556861|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556862|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556863|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
14556864|NCT00002452|Indinavir|indinavir|mesh-list
14556865|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14556866|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14556867|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
14556868|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556869|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556870|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556871|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556872|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
14556873|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556874|NCT00002453|Tenofovir|tenofovir|mesh-list
14556875|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
14556876|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556877|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14556878|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556879|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556880|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556881|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14556882|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14556883|NCT00002456|Cyclosporine|cyclosporine|mesh-list
14556884|NCT00002456|Methotrexate|methotrexate|mesh-list
14556885|NCT00002456|Cyclosporins|cyclosporins|mesh-list
14556886|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14556887|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
14556888|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14556889|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556890|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14556891|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
14556892|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996152|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996153|NCT02922283|Interleukin-2|interleukin-2|mesh-list
14556893|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556894|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
14556895|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556896|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14556897|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14556898|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
14556899|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14556900|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556901|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
14556902|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14556903|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14556904|NCT00002458|Antibodies|antibodies|mesh-list
14556905|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14556906|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
14556907|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556908|NCT00002460|Tamoxifen|tamoxifen|mesh-list
14556909|NCT00002460|Goserelin|goserelin|mesh-list
14556910|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14556911|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
14556912|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14556913|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556914|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14556915|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556916|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14556917|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14556918|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14556919|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
14556920|NCT00002461|Carmustine|carmustine|mesh-list
14556921|NCT00002461|Etoposide|etoposide|mesh-list
14556922|NCT00002461|Sargramostim|sargramostim|mesh-list
14556923|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14556924|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
15087370|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
14556925|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556926|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14556927|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14556928|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
14556929|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556930|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556931|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14556932|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14556933|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14556934|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14556935|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556936|NCT00002462|Cobalt|cobalt|mesh-list
14556937|NCT00002462|Prednisone|prednisone|mesh-list
14556938|NCT00002462|Doxorubicin|doxorubicin|mesh-list
14556939|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14556940|NCT00002462|Bleomycin|bleomycin|mesh-list
14556941|NCT00002462|Vincristine|vincristine|mesh-list
14556942|NCT00002462|Vinblastine|vinblastine|mesh-list
14556943|NCT00002462|Procarbazine|procarbazine|mesh-list
14556944|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
14556945|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14556946|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556947|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14556948|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14556949|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556950|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556951|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14556952|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
14556953|NCT00002462|Hormones|hormones|mesh-ancestor
14556954|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14556955|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556956|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14556957|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14556958|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14556959|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14556960|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14556961|NCT00002462|Trace Elements|trace elements|mesh-ancestor
14556962|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
14556963|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
14556964|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14556965|NCT00002463|Leucovorin|leucovorin|mesh-list
14556966|NCT00002463|Prednisone|prednisone|mesh-list
14556967|NCT00002463|Methotrexate|methotrexate|mesh-list
14556968|NCT00002463|Vincristine|vincristine|mesh-list
14556969|NCT00002463|Procarbazine|procarbazine|mesh-list
14556970|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
14268475|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14268476|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14268477|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268478|NCT00395512|Pioglitazone|pioglitazone|mesh-list
14268479|NCT00395512|Alogliptin|alogliptin|mesh-list
14268480|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268481|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268482|NCT00395512|Incretins|incretins|mesh-ancestor
14556971|NCT00002463|Calcium|calcium|mesh-list
14556972|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
14556973|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14556974|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14556975|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14556976|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
15087371|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
15087372|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087373|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087374|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14556977|NCT00002463|Hormones|hormones|mesh-ancestor
14556978|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14556979|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14556980|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14556981|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14556982|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
14556983|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14556984|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15173102|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14268483|NCT00395512|Hormones|hormones|mesh-ancestor
14556985|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
14556986|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14556987|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
14556988|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14556989|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14556990|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14556991|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
14556992|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14556993|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14556994|NCT00002463|Antidotes|antidotes|mesh-ancestor
14556995|NCT00002463|Protective Agents|protective agents|mesh-ancestor
14556996|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
14556997|NCT00002463|Vitamins|vitamins|mesh-ancestor
14556998|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
14556999|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557000|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557001|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557002|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557003|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
14557004|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557005|NCT00002465|Megestrol|megestrol|mesh-list
14557006|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
14557007|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14557008|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14557009|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14557010|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
14557011|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557012|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557013|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14557014|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14557015|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557016|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557017|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
14557018|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14557019|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
14557020|NCT00002466|Ifosfamide|ifosfamide|mesh-list
14557021|NCT00002466|Doxorubicin|doxorubicin|mesh-list
14557022|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557023|NCT00002466|Etoposide|etoposide|mesh-list
14557024|NCT00002466|Vincristine|vincristine|mesh-list
14557025|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557026|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
14557027|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557028|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557029|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557030|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
14557031|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557032|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557033|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557034|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557035|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557036|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557037|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557038|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557039|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557040|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557041|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
15087375|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15087376|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15087377|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
15087378|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087379|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087380|NCT02259998|Dipyridamole|dipyridamole|mesh-list
15087381|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15087382|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087383|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087384|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15087385|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087386|NCT02260011|Bromides|bromides|mesh-list
15087387|NCT02260011|Norflurane|norflurane|mesh-list
15087388|NCT02260011|Ipratropium|ipratropium|mesh-list
15087389|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
15087390|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15087391|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
15087392|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087393|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087394|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14557042|NCT00002470|Interferons|interferons|mesh-list
14814241|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14557043|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
14557044|NCT00002470|Fluorouracil|fluorouracil|mesh-list
14557045|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
14557046|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557047|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557048|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557049|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557050|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
14557051|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557052|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
14557053|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557054|NCT00002471|Leucovorin|leucovorin|mesh-list
14557055|NCT00002471|Cytarabine|cytarabine|mesh-list
14557056|NCT00002471|Dexamethasone|dexamethasone|mesh-list
14557057|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
14557058|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
14557059|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14557060|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14557061|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14557062|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
14557063|NCT00002471|Thiotepa|thiotepa|mesh-list
14557064|NCT00002471|Methotrexate|methotrexate|mesh-list
14557065|NCT00002471|Etoposide|etoposide|mesh-list
14557066|NCT00002471|Vincristine|vincristine|mesh-list
14557067|NCT00002471|Daunorubicin|daunorubicin|mesh-list
14557068|NCT00002471|Asparaginase|asparaginase|mesh-list
14557069|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
15087395|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
15087396|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15087397|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
15087398|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173103|NCT04008043|Narcotics|narcotics|mesh-ancestor
14268484|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557070|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557071|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
14557072|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557073|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557074|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557075|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
14557076|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557077|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557078|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14268485|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14268486|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
14268487|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268488|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268489|NCT00395629|Deferasirox|deferasirox|mesh-list
14268490|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14268491|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
14268492|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
14268493|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268494|NCT00395694|Lamotrigine|lamotrigine|mesh-list
14557079|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557080|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
14557081|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
14557082|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557083|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557084|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
14557085|NCT00002471|Hormones|hormones|mesh-ancestor
14557086|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557087|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557088|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557089|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557090|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557091|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557092|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
14557093|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557094|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557095|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557096|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557097|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14268495|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
14557098|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557099|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557100|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
14557101|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557102|NCT00002471|Antidotes|antidotes|mesh-ancestor
14557103|NCT00002471|Protective Agents|protective agents|mesh-ancestor
14557104|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
14557105|NCT00002471|Vitamins|vitamins|mesh-ancestor
14557106|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
14557107|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557108|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557109|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557110|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14557111|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557112|NCT00002472|Etoposide|etoposide|mesh-list
14557113|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557114|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557115|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557116|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557117|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557118|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557119|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
14557120|NCT00002474|Carboplatin|carboplatin|mesh-list
14557121|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
14557122|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557123|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
14268496|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14268497|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268498|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268499|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268500|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268501|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14268502|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14268503|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268504|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268505|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14268506|NCT00395746|Liraglutide|liraglutide|mesh-list
14268507|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14557124|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557125|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557126|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557127|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
14557128|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557129|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557130|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557131|NCT00002474|Analgesics|analgesics|mesh-ancestor
14557132|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
14557133|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557134|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557135|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557136|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557137|NCT00002475|Interferons|interferons|mesh-list
14557138|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
14557139|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
14557140|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
14557141|NCT00002475|Vaccines|vaccines|mesh-list
14557142|NCT00002475|Sargramostim|sargramostim|mesh-list
14557143|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
14557144|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557145|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557146|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557147|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557148|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
14557149|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557150|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557151|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557152|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
14557153|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557154|NCT00002476|Leucovorin|leucovorin|mesh-list
14557155|NCT00002476|Cobalt|cobalt|mesh-list
14557156|NCT00002476|Fluorouracil|fluorouracil|mesh-list
14557157|NCT00002476|Methotrexate|methotrexate|mesh-list
14557158|NCT00002476|Vincristine|vincristine|mesh-list
14557159|NCT00002476|Bleomycin|bleomycin|mesh-list
14557160|NCT00002476|Calcium|calcium|mesh-list
14557161|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
14557162|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268508|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557163|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557164|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
14557165|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557166|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557167|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557168|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557169|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
14557170|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557171|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557172|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557173|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557174|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557175|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557176|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557177|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557178|NCT00002476|Antidotes|antidotes|mesh-ancestor
14557179|NCT00002476|Protective Agents|protective agents|mesh-ancestor
14557180|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
14557181|NCT00002476|Vitamins|vitamins|mesh-ancestor
14557182|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
14557183|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557184|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268509|NCT00395746|Incretins|incretins|mesh-ancestor
14268510|NCT00395746|Hormones|hormones|mesh-ancestor
14557185|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557186|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557187|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557188|NCT00002476|Trace Elements|trace elements|mesh-ancestor
14557189|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
14557190|NCT00002477|Carboplatin|carboplatin|mesh-list
14557191|NCT00002477|Doxorubicin|doxorubicin|mesh-list
14557192|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557193|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557194|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
14557195|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557196|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557197|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557198|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
14557199|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557200|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557201|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557202|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557203|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557204|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557205|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557206|NCT00002478|Etoposide|etoposide|mesh-list
14557207|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557208|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557209|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557210|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557211|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557212|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557213|NCT00002481|Cytarabine|cytarabine|mesh-list
14557214|NCT00002481|Dexamethasone|dexamethasone|mesh-list
14557215|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
14557216|NCT00002481|Etoposide|etoposide|mesh-list
14557217|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557218|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
14557219|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557220|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557221|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557222|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
14557223|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557224|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557225|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557226|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557227|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
14557228|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
14557229|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557230|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557231|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
14557232|NCT00002481|Hormones|hormones|mesh-ancestor
14557233|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557234|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557235|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557236|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557237|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557238|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557239|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557240|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
14557241|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
14557242|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557243|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
14557244|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
14557245|NCT00002482|Antibodies|antibodies|mesh-list
14557246|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557247|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
14557248|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557249|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557250|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557251|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
14557252|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557253|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557254|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557255|NCT00002487|Methotrexate|methotrexate|mesh-list
14557256|NCT00002487|Dipyridamole|dipyridamole|mesh-list
14557257|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557258|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557259|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557260|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557261|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557262|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
14557263|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557264|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557265|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557266|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557267|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557268|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557269|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
14557270|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557271|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557272|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14557273|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15087399|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087400|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
15087401|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087402|NCT02260024|Pramipexole|pramipexole|mesh-list
15087403|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
14268511|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268512|NCT00395850|Disulfiram|disulfiram|mesh-list
14557274|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
14557275|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
14557276|NCT00002488|Etoposide|etoposide|mesh-list
14557277|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557278|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
14557279|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557280|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557281|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557282|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
14557283|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557284|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557285|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557286|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557287|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557288|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557289|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557290|NCT00002489|Leucovorin|leucovorin|mesh-list
14557291|NCT00002489|Dactinomycin|dactinomycin|mesh-list
14557292|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
14557293|NCT00002489|Carboplatin|carboplatin|mesh-list
14557294|NCT00002489|Doxorubicin|doxorubicin|mesh-list
14557295|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557296|NCT00002489|Methotrexate|methotrexate|mesh-list
14557297|NCT00002489|Etoposide|etoposide|mesh-list
14557298|NCT00002489|Vincristine|vincristine|mesh-list
14557299|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
14557300|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557301|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
14557302|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557303|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557304|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15087404|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557305|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
14557306|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557307|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557308|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557309|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557310|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557311|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557312|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557313|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557314|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557315|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557316|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557317|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
14557318|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557319|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557320|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557321|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557322|NCT00002489|Antidotes|antidotes|mesh-ancestor
14557323|NCT00002489|Protective Agents|protective agents|mesh-ancestor
14557324|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
14557325|NCT00002489|Vitamins|vitamins|mesh-ancestor
14557326|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
14557327|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557328|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557329|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557330|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14557331|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557332|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14557333|NCT00002490|Mitomycins|mitomycins|mesh-list
14557334|NCT00002490|Mitomycin|mitomycin|mesh-list
14557335|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
14557336|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557337|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557338|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
14557339|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557340|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557341|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557342|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14557343|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
14557344|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557345|NCT00002492|Doxorubicin|doxorubicin|mesh-list
14557346|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557347|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557348|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557349|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557350|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557351|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557352|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557353|NCT00002493|Doxorubicin|doxorubicin|mesh-list
14557354|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557355|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557356|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557357|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557358|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557359|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557360|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557361|NCT00002494|Leucovorin|leucovorin|mesh-list
14557362|NCT00002494|Cobalt|cobalt|mesh-list
14557363|NCT00002494|Cytarabine|cytarabine|mesh-list
14557364|NCT00002494|Dexamethasone|dexamethasone|mesh-list
14557365|NCT00002494|Prednisone|prednisone|mesh-list
14557366|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
14557367|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14557368|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14557369|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14557370|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
14557371|NCT00002494|Ifosfamide|ifosfamide|mesh-list
14557372|NCT00002494|Doxorubicin|doxorubicin|mesh-list
14557373|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557374|NCT00002494|Methotrexate|methotrexate|mesh-list
14557375|NCT00002494|Etoposide|etoposide|mesh-list
14557376|NCT00002494|Vincristine|vincristine|mesh-list
14557377|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
14557378|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557379|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
14557380|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557381|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557382|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557383|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
14557384|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557385|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557386|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557387|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557388|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
14557389|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
14557390|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557391|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557392|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
14557393|NCT00002494|Hormones|hormones|mesh-ancestor
14557394|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557395|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557396|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557397|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557398|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557399|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557400|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557401|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557402|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557403|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557404|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
14557405|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557406|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557407|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557408|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557409|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
14557410|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557411|NCT00002494|Antidotes|antidotes|mesh-ancestor
14557412|NCT00002494|Protective Agents|protective agents|mesh-ancestor
14557413|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
14557414|NCT00002494|Vitamins|vitamins|mesh-ancestor
14557415|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
14557416|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557417|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557418|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557419|NCT00002494|Trace Elements|trace elements|mesh-ancestor
14557420|NCT00002495|Doxorubicin|doxorubicin|mesh-list
14557421|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557422|NCT00002495|Vinblastine|vinblastine|mesh-list
14557423|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557424|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557425|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557426|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557427|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557428|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557429|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15087405|NCT02260024|Protective Agents|protective agents|mesh-ancestor
15087406|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087407|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15087408|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15087409|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
15087410|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
15087411|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087412|NCT02260037|Epinastine|epinastine|mesh-list
15087413|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15087414|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
15087415|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
15087416|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087417|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087418|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087419|NCT02260050|Epinastine|epinastine|mesh-list
15087420|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15087421|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
15087422|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
15087423|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087424|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087425|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087426|NCT02260063|Epinastine|epinastine|mesh-list
15087427|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15087428|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
15087429|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
15087430|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087431|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087432|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087433|NCT02260089|Telmisartan|telmisartan|mesh-list
14557430|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
15087434|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14557431|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557432|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557433|NCT00002496|Cobalt|cobalt|mesh-list
14557434|NCT00002496|Fluorouracil|fluorouracil|mesh-list
14557435|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557436|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
14557437|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557438|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557439|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557440|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
14557441|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557442|NCT00002496|Trace Elements|trace elements|mesh-ancestor
14557443|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
14557444|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
14557445|NCT00002498|Fluorouracil|fluorouracil|mesh-list
14557446|NCT00002498|Methotrexate|methotrexate|mesh-list
14557447|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
14557448|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557449|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
14557450|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557451|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557452|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557453|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
14557454|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557455|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087435|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087436|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087437|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557456|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557457|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
14557458|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557459|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15087438|NCT02260102|Temocillin|temocillin|mesh-list
14557460|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557461|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557462|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557463|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557464|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557465|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557466|NCT00002498|Analgesics|analgesics|mesh-ancestor
14557467|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
14557468|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557469|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557470|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557471|NCT00002499|Cytarabine|cytarabine|mesh-list
14557472|NCT00002499|Dexamethasone|dexamethasone|mesh-list
14557473|NCT00002499|Prednisone|prednisone|mesh-list
14557474|NCT00002499|Methotrexate|methotrexate|mesh-list
14557475|NCT00002499|Vincristine|vincristine|mesh-list
14557476|NCT00002499|Daunorubicin|daunorubicin|mesh-list
14557477|NCT00002499|Asparaginase|asparaginase|mesh-list
14557478|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557479|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
14557480|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
14557481|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557482|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557483|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557484|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
14557485|NCT00002499|Hormones|hormones|mesh-ancestor
14557486|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557487|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557488|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557489|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557490|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557491|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557492|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557493|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
14557494|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557495|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557496|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557497|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557498|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557499|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
14557500|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557501|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557502|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
14557503|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557504|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557505|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557506|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557507|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557508|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557509|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557510|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557511|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
14557512|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557513|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
14557514|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557515|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557516|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557517|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
14557518|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557519|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557520|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557521|NCT00002502|Cytarabine|cytarabine|mesh-list
14557522|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
15087439|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087440|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087441|NCT02260206|Colchicine|colchicine|mesh-list
15087442|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
15087443|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087444|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
15087445|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
15087446|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
15087447|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087448|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087449|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
15087450|NCT02260336|Celecoxib|celecoxib|mesh-list
15087451|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15087452|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15087453|NCT02260336|Analgesics|analgesics|mesh-ancestor
15087454|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
15087455|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087456|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557523|NCT00002502|Busulfan|busulfan|mesh-list
14557524|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557525|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
14557526|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557527|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557528|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557529|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
14557530|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557531|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557532|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557533|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557534|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
14557535|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
14557536|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557537|NCT00002504|Interferons|interferons|mesh-list
15087457|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087458|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087459|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15087460|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15087461|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557538|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
14557539|NCT00002504|Aldesleukin|aldesleukin|mesh-list
14557540|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557541|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
14557542|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557543|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
14557544|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557545|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14557546|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14557547|NCT00002505|Interferons|interferons|mesh-list
14557548|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
14557549|NCT00002505|Vaccines|vaccines|mesh-list
14557550|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557551|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
14557552|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557553|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
14557554|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557555|NCT00002506|Interferons|interferons|mesh-list
14557556|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
14557557|NCT00002506|Isotretinoin|isotretinoin|mesh-list
14557558|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557559|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
14557560|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557561|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
14557562|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557563|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557564|NCT00002507|Mitomycins|mitomycins|mesh-list
14557565|NCT00002507|Mitomycin|mitomycin|mesh-list
14557566|NCT00002507|Porfiromycin|porfiromycin|mesh-list
14557567|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557568|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557569|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
14557570|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557571|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557572|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557573|NCT00002508|Carboplatin|carboplatin|mesh-list
14557574|NCT00002508|Etoposide|etoposide|mesh-list
14557575|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557576|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557577|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557578|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557579|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557580|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557581|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
14557582|NCT00002509|Carboplatin|carboplatin|mesh-list
14557583|NCT00002509|Etoposide|etoposide|mesh-list
14557584|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557585|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
14557586|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557587|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557588|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557589|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
14557590|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557591|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557592|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557593|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557594|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557595|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557596|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557597|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
14557598|NCT00002510|Etoposide|etoposide|mesh-list
14557599|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557600|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
14557601|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557602|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557603|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557604|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
14557605|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557606|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557607|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557608|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14809355|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14809356|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14809357|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809358|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809359|NCT00833079|Tacrolimus|tacrolimus|mesh-list
14809360|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809361|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
14809362|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809363|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14809364|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809365|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809366|NCT00833157|Ibuprofen|ibuprofen|mesh-list
14809367|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14809368|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14809369|NCT00833157|Analgesics|analgesics|mesh-ancestor
14809370|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
14809371|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809372|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557609|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557610|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557611|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557612|NCT00002514|Leucovorin|leucovorin|mesh-list
14557613|NCT00002514|Cytarabine|cytarabine|mesh-list
14557614|NCT00002514|Dexamethasone|dexamethasone|mesh-list
14557615|NCT00002514|Prednisone|prednisone|mesh-list
14557616|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
14557617|NCT00002514|Methotrexate|methotrexate|mesh-list
14557618|NCT00002514|Etoposide|etoposide|mesh-list
14557619|NCT00002514|Vincristine|vincristine|mesh-list
14557620|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
14557621|NCT00002514|Daunorubicin|daunorubicin|mesh-list
14557622|NCT00002514|Asparaginase|asparaginase|mesh-list
14557623|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
14557624|NCT00002514|Thioguanine|thioguanine|mesh-list
14557625|NCT00002514|Sargramostim|sargramostim|mesh-list
14557626|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
14557627|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557628|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
14557629|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557630|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557631|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557632|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
14557633|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557634|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557635|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557636|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557637|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
14557638|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
14557639|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557640|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557641|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
14557642|NCT00002514|Hormones|hormones|mesh-ancestor
14557643|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557644|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557645|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557646|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557647|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557648|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557649|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
14557650|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557651|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557652|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557653|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557654|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557655|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557656|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557657|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
14557658|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557659|NCT00002514|Antidotes|antidotes|mesh-ancestor
14557660|NCT00002514|Protective Agents|protective agents|mesh-ancestor
14557661|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
14557662|NCT00002514|Vitamins|vitamins|mesh-ancestor
14557663|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
14557664|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557665|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557666|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557667|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14557668|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557669|NCT00002515|Carboplatin|carboplatin|mesh-list
14557670|NCT00002515|Topotecan|topotecan|mesh-list
14557671|NCT00002515|Thiotepa|thiotepa|mesh-list
14557672|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557673|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
14557674|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557675|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14557676|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557677|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557678|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557679|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557680|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
14557681|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557682|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557683|NCT00002516|Cobalt|cobalt|mesh-list
14557684|NCT00002516|Dactinomycin|dactinomycin|mesh-list
14557685|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
14557686|NCT00002516|Ifosfamide|ifosfamide|mesh-list
14557687|NCT00002516|Doxorubicin|doxorubicin|mesh-list
14557688|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557689|NCT00002516|Etoposide|etoposide|mesh-list
14557690|NCT00002516|Vincristine|vincristine|mesh-list
14557691|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557692|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
14557693|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557694|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557695|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557696|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
14557697|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557698|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557699|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557700|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15087462|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087463|NCT02260414|Tinzaparin|tinzaparin|mesh-list
15087464|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14557701|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557702|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557703|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557704|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557705|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557706|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557707|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557708|NCT00002516|Trace Elements|trace elements|mesh-ancestor
15087465|NCT02260414|Dalteparin|dalteparin|mesh-list
15087466|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
15087467|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14557709|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
14557710|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14557711|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557712|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14557713|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557714|NCT00002517|Cytarabine|cytarabine|mesh-list
14557715|NCT00002517|Dexamethasone|dexamethasone|mesh-list
14557716|NCT00002517|Etoposide|etoposide|mesh-list
14557717|NCT00002517|Daunorubicin|daunorubicin|mesh-list
14557718|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
14557719|NCT00002517|Idarubicin|idarubicin|mesh-list
14557720|NCT00002517|Thioguanine|thioguanine|mesh-list
14557721|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557722|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
14557723|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
14557724|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557725|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557726|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557727|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
14557728|NCT00002517|Hormones|hormones|mesh-ancestor
14557729|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557730|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15087468|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15087469|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087470|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
15087471|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087472|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15087473|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087474|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087475|NCT02260544|Doxorubicin|doxorubicin|mesh-list
15087476|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15087477|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15087478|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557731|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557732|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557733|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557734|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557735|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557736|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557737|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557738|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
14557739|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
14557740|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557741|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557742|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
14557743|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557744|NCT00002517|Analgesics|analgesics|mesh-ancestor
15087479|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557745|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
14557746|NCT00002519|Paclitaxel|paclitaxel|mesh-list
14557747|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557748|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557749|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557750|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557751|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
14557752|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557753|NCT00002520|Nicotine|nicotine|mesh-list
14557754|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14557755|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
14557756|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557757|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557758|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14557759|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14557760|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
14557761|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14557762|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557763|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
14557764|NCT00002521|Etoposide|etoposide|mesh-list
14557765|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557766|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
14557767|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557768|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557769|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557770|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
14557771|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557772|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557773|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557774|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557775|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557776|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557777|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557778|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
14557779|NCT00002522|Etoposide|etoposide|mesh-list
14557780|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557781|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
14557782|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557783|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557784|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557785|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
15087480|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15087481|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087482|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557786|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557787|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557788|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557789|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557790|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557791|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557792|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557793|NCT00002523|Leucovorin|leucovorin|mesh-list
14557794|NCT00002523|Fluorouracil|fluorouracil|mesh-list
14557795|NCT00002523|Calcium|calcium|mesh-list
14557796|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
14557797|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087483|NCT02260557|Selexipag|selexipag|mesh-list
15087484|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15173104|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173105|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
15173106|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
15173107|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15173108|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173109|NCT04007809|Glucagon|glucagon|mesh-list
15173110|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173111|NCT04007809|Hormones|hormones|mesh-ancestor
15173112|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173113|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173114|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
15173115|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173116|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173117|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15173118|NCT04007835|Gefitinib|gefitinib|mesh-list
15173119|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173120|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15173121|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557798|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557799|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
14557800|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557801|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557802|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557803|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557804|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
14557805|NCT00002523|Antidotes|antidotes|mesh-ancestor
14557806|NCT00002523|Protective Agents|protective agents|mesh-ancestor
14557807|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
14557808|NCT00002523|Vitamins|vitamins|mesh-ancestor
14557809|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
14557810|NCT00002524|Leucovorin|leucovorin|mesh-list
14557811|NCT00002524|Cytarabine|cytarabine|mesh-list
14557812|NCT00002524|Zidovudine|zidovudine|mesh-list
14557813|NCT00002524|Trimethoprim|trimethoprim|mesh-list
14557814|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
14557815|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14557816|NCT00002524|Pentamidine|pentamidine|mesh-list
14557817|NCT00002524|Prednisone|prednisone|mesh-list
14557818|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
14557819|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14557820|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14557821|NCT00002524|Prednisolone|prednisolone|mesh-list
14557822|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
14557823|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
14557824|NCT00002524|Ifosfamide|ifosfamide|mesh-list
14557825|NCT00002524|Doxorubicin|doxorubicin|mesh-list
14557826|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557827|NCT00002524|Fluorouracil|fluorouracil|mesh-list
14557828|NCT00002524|Methotrexate|methotrexate|mesh-list
14557829|NCT00002524|Etoposide|etoposide|mesh-list
14557830|NCT00002524|Vincristine|vincristine|mesh-list
14557831|NCT00002524|Bleomycin|bleomycin|mesh-list
14557832|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14557833|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
14557834|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
14557835|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557836|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
14557837|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557838|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557839|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557840|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
14557841|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557842|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557843|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557844|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557845|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557846|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557847|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557848|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557849|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
14557850|NCT00002524|Hormones|hormones|mesh-ancestor
14557851|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557852|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557853|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
14557854|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557855|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557856|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557857|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557858|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14557859|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14557860|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14557861|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14557862|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
14557863|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557864|NCT00002524|Antidotes|antidotes|mesh-ancestor
14557865|NCT00002524|Protective Agents|protective agents|mesh-ancestor
14557866|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
14557867|NCT00002524|Vitamins|vitamins|mesh-ancestor
14557868|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
14557869|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
14557870|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
14557871|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
14268513|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14557872|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
14557873|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
14557874|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557875|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557876|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14557877|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14557878|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14557879|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14557880|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14557881|NCT00002524|Renal Agents|renal agents|mesh-ancestor
14557882|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
14557883|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14557884|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14557885|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14557886|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14557887|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14557888|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14557889|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
14557890|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14557891|NCT00002526|Doxorubicin|doxorubicin|mesh-list
14557892|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557893|NCT00002526|Ifosfamide|ifosfamide|mesh-list
14557894|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15087485|NCT02260570|Tolcapone|tolcapone|mesh-list
15087486|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15087487|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15087488|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15087489|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087490|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557895|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557896|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557897|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557898|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557899|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557900|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557901|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
14557902|NCT00002527|Aspirin|aspirin|mesh-list
14557903|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14557904|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14557905|NCT00002527|Analgesics|analgesics|mesh-ancestor
14557906|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
14557907|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557908|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557909|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557910|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557911|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14557912|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14557913|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557914|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14557915|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14557916|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557917|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
14557918|NCT00002528|Tamoxifen|tamoxifen|mesh-list
14557919|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14557920|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
14557921|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557922|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557923|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557924|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557925|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14557926|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14557927|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14557928|NCT00002529|Tamoxifen|tamoxifen|mesh-list
14557929|NCT00002529|Toremifene|toremifene|mesh-list
14557930|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
14557931|NCT00002529|Doxorubicin|doxorubicin|mesh-list
14557932|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557933|NCT00002529|Epirubicin|epirubicin|mesh-list
14557934|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557935|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
14557936|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268514|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14268515|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268516|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268517|NCT00395876|Tenecteplase|tenecteplase|mesh-list
14268518|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14557937|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557938|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14268519|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14268520|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268521|NCT00395967|Plerixafor|plerixafor|mesh-list
14268522|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268523|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14268524|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
14268525|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268526|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
14268527|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14268528|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268529|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268530|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14268531|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14268532|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14268533|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
14557939|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
14557940|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557941|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14557942|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557943|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557944|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557945|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557946|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557947|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14557948|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
14557949|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557950|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557951|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14557952|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14557953|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14557954|NCT00002531|Leucovorin|leucovorin|mesh-list
14557955|NCT00002531|Cytarabine|cytarabine|mesh-list
14557956|NCT00002531|Dexamethasone|dexamethasone|mesh-list
14557957|NCT00002531|Prednisolone|prednisolone|mesh-list
14557958|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
14557959|NCT00002531|Ifosfamide|ifosfamide|mesh-list
14557960|NCT00002531|Doxorubicin|doxorubicin|mesh-list
14557961|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14557962|NCT00002531|Methotrexate|methotrexate|mesh-list
14557963|NCT00002531|Etoposide|etoposide|mesh-list
14557964|NCT00002531|Vincristine|vincristine|mesh-list
14557965|NCT00002531|Daunorubicin|daunorubicin|mesh-list
14557966|NCT00002531|Asparaginase|asparaginase|mesh-list
14557967|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
14557968|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
14557969|NCT00002531|Thioguanine|thioguanine|mesh-list
14557970|NCT00002531|Vindesine|vindesine|mesh-list
14557971|NCT00002531|Teniposide|teniposide|mesh-list
14557972|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
14557973|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14557974|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
14557975|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14557976|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14557977|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14557978|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
15087491|NCT02260661|Fulvestrant|fulvestrant|mesh-list
15087492|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15087493|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087494|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15087495|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15087496|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
15087497|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15087498|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087499|NCT02260687|Aflibercept|aflibercept|mesh-list
15087500|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15087501|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15087502|NCT02260687|Growth Substances|growth substances|mesh-ancestor
15087503|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087504|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
15087505|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087506|NCT02260908|Enoxaparin|enoxaparin|mesh-list
15087507|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
15087508|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14268534|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14557979|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14557980|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268535|NCT00396032|Tenecteplase|tenecteplase|mesh-list
14557981|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14557982|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14557983|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
14557984|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
14557985|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14557986|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14557987|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
14557988|NCT00002531|Hormones|hormones|mesh-ancestor
14557989|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14557990|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14557991|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14557992|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14557993|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14557994|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14557995|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14557996|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
14557997|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14557998|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14557999|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
14558000|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558001|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558002|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558003|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558004|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
14558005|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558006|NCT00002531|Antidotes|antidotes|mesh-ancestor
14558007|NCT00002531|Protective Agents|protective agents|mesh-ancestor
14558008|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558009|NCT00002531|Vitamins|vitamins|mesh-ancestor
14558010|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
14558011|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558012|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558013|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558014|NCT00002531|Analgesics|analgesics|mesh-ancestor
14558015|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
14558016|NCT00002532|Leucovorin|leucovorin|mesh-list
14558017|NCT00002532|Cytarabine|cytarabine|mesh-list
14558018|NCT00002532|Dexamethasone|dexamethasone|mesh-list
14558019|NCT00002532|Prednisolone|prednisolone|mesh-list
14558020|NCT00002532|Methotrexate|methotrexate|mesh-list
14558021|NCT00002532|Etoposide|etoposide|mesh-list
14558022|NCT00002532|Daunorubicin|daunorubicin|mesh-list
14558023|NCT00002532|Asparaginase|asparaginase|mesh-list
14558024|NCT00002532|Ifosfamide|ifosfamide|mesh-list
14558025|NCT00002532|Idarubicin|idarubicin|mesh-list
14558026|NCT00002532|Vindesine|vindesine|mesh-list
14558027|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
14558028|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558029|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
14558030|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
14558031|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558032|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558033|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14558034|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
14558035|NCT00002532|Hormones|hormones|mesh-ancestor
14558036|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558037|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558038|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558039|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558040|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558041|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558042|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558043|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
14558044|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558045|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558046|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558047|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558048|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558049|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
14558050|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558051|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558052|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558053|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558054|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558055|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
14809373|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558056|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558057|NCT00002532|Antidotes|antidotes|mesh-ancestor
14558058|NCT00002532|Protective Agents|protective agents|mesh-ancestor
14558059|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558060|NCT00002532|Vitamins|vitamins|mesh-ancestor
14558061|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
14558062|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558063|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558064|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
14558065|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558066|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558067|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558068|NCT00002533|Fluconazole|fluconazole|mesh-list
14558069|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
14558070|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558071|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14558072|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14558073|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558074|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558075|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14558076|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
14558077|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558078|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558079|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14558080|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14558081|NCT00002534|Cytarabine|cytarabine|mesh-list
14558082|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
14558083|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
14558084|NCT00002534|Thiotepa|thiotepa|mesh-list
14558085|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14558086|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558087|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
14558088|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558089|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558090|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558091|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
14558092|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558093|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558094|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558095|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15087509|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15087510|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087511|NCT02260947|Ibuprofen|ibuprofen|mesh-list
15087512|NCT02260947|Pregabalin|pregabalin|mesh-list
15087513|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15087514|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15087515|NCT02260947|Analgesics|analgesics|mesh-ancestor
15087516|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
15087517|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558096|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
14558097|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
14809374|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809375|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14809376|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809377|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809378|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
14809379|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14809380|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14809381|NCT00833300|Haloperidol|haloperidol|mesh-list
14809382|NCT00833300|Olanzapine|olanzapine|mesh-list
14809383|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
14809384|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
14809385|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
14809386|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809387|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809388|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809389|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14809390|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14809391|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809392|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809393|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14809394|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14809395|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809396|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809397|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809398|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
15087518|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558098|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558099|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087519|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087520|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087521|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15087522|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087523|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087524|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
15087525|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15087526|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087527|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087528|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15087529|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15087530|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087531|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14558100|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
14558101|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
14558102|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558103|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14558104|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
14558105|NCT00002534|Hormones|hormones|mesh-ancestor
14558106|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558107|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14558108|NCT00002534|Protective Agents|protective agents|mesh-ancestor
14558109|NCT00002535|Aldesleukin|aldesleukin|mesh-list
14558110|NCT00002535|Indomethacin|indomethacin|mesh-list
14558111|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
14558112|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558113|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
14558114|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558115|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558116|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558117|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
14558118|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558119|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558120|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558121|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14558122|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14558123|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
14558124|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558125|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14558126|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14558127|NCT00002535|Analgesics|analgesics|mesh-ancestor
14558128|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
14558129|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558130|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558131|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
14558132|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
14558133|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558134|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14558135|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087532|NCT02261025|Aspirin|aspirin|mesh-list
15087533|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15087534|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15087535|NCT02261025|Analgesics|analgesics|mesh-ancestor
15087536|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
15087537|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268536|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14558136|NCT00002536|Vincristine|vincristine|mesh-list
14558137|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558138|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558139|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268537|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14268538|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268539|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
14268540|NCT00396084|Levofloxacin|levofloxacin|mesh-list
14268541|NCT00396084|Ofloxacin|ofloxacin|mesh-list
14268542|NCT00396084|Isoniazid|isoniazid|mesh-list
14268543|NCT00396084|Linezolid|linezolid|mesh-list
14268544|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
14268545|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14268546|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558140|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
15087538|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268547|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14268548|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558141|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558142|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558143|NCT00002537|Topotecan|topotecan|mesh-list
14558144|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14558145|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558146|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558147|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558148|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558149|NCT00002539|Doxorubicin|doxorubicin|mesh-list
14558150|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558151|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558152|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558153|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558154|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558155|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558156|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558157|NCT00002542|Tamoxifen|tamoxifen|mesh-list
14558158|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
14558159|NCT00002542|Doxorubicin|doxorubicin|mesh-list
14558160|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558161|NCT00002542|Fluorouracil|fluorouracil|mesh-list
14558162|NCT00002542|Methotrexate|methotrexate|mesh-list
14558163|NCT00002542|Epirubicin|epirubicin|mesh-list
14558164|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558165|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
14558166|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558167|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558168|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558169|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
14558170|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558171|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558172|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558173|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558174|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558175|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558176|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558177|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
14558178|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558179|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558180|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558181|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558182|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558183|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558184|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558185|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14558186|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
14558187|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558188|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558189|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14558190|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14558191|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14558192|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
14558193|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14558194|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558195|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643623|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14643624|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643625|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643626|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
14643627|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14643628|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14643629|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
14643630|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643631|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643632|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643633|NCT00189800|Urological Agents|urological agents|mesh-ancestor
14643634|NCT00189826|Tacrolimus|tacrolimus|mesh-list
14643635|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643636|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
14643637|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643638|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14643639|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087539|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558196|NCT00002544|Docetaxel|docetaxel|mesh-list
14558197|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
14558198|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558199|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558200|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558201|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558202|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558203|NCT00002544|Analgesics|analgesics|mesh-ancestor
14558204|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
14558205|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558206|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558207|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558208|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558209|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558210|NCT00002545|Carmustine|carmustine|mesh-list
14558211|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558212|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
14558213|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558214|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558215|NCT00002546|Ifosfamide|ifosfamide|mesh-list
14558216|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558217|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558218|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
14558219|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558220|NCT00002547|Cytarabine|cytarabine|mesh-list
14558221|NCT00002547|Cyclosporine|cyclosporine|mesh-list
14558222|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
14558223|NCT00002547|Busulfan|busulfan|mesh-list
14558224|NCT00002547|Methotrexate|methotrexate|mesh-list
14558225|NCT00002547|Cyclosporins|cyclosporins|mesh-list
14558226|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558227|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
14558228|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558229|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558230|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558231|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
14558232|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558233|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558234|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15087540|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087541|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15087542|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15087543|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087544|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15087545|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15087546|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087547|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
15087548|NCT02261064|Amlodipine|amlodipine|mesh-list
15087549|NCT02261064|Telmisartan|telmisartan|mesh-list
15087550|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
15087551|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087552|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15087553|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087554|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087555|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15087556|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087557|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
15087558|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087559|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087560|NCT02261077|Scopolamine|scopolamine|mesh-list
15087561|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15087562|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15087563|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
15087564|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
15087565|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087566|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087567|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15087568|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
15087569|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15087570|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
15087571|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087572|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558235|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558236|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558237|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558238|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558239|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
14558240|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558241|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558242|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558243|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558244|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
14558245|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558246|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
14558247|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14558248|NCT00002548|Interferons|interferons|mesh-list
14558249|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
14558250|NCT00002548|Dexamethasone|dexamethasone|mesh-list
14558251|NCT00002548|Prednisone|prednisone|mesh-list
14558252|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
14558253|NCT00002548|Melphalan|melphalan|mesh-list
14558254|NCT00002548|Carmustine|carmustine|mesh-list
14558255|NCT00002548|Doxorubicin|doxorubicin|mesh-list
14558256|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558257|NCT00002548|Vincristine|vincristine|mesh-list
14558258|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558259|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
14558260|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558261|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558262|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558263|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
14558264|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558265|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558266|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558267|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558268|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
14558269|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
14558270|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558271|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14558272|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
14558273|NCT00002548|Hormones|hormones|mesh-ancestor
14558274|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558275|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558276|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558277|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558278|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558279|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558280|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
14558281|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558282|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558283|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558284|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558285|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558286|NCT00002549|Cytarabine|cytarabine|mesh-list
14558287|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
14558288|NCT00002549|Busulfan|busulfan|mesh-list
14558289|NCT00002549|Etoposide|etoposide|mesh-list
14558290|NCT00002549|Daunorubicin|daunorubicin|mesh-list
14558291|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
14558292|NCT00002549|Idarubicin|idarubicin|mesh-list
14558293|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558294|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
14558295|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558296|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558297|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558298|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
14558299|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558300|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558301|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558302|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558303|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558304|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558305|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558306|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558307|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
14558308|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
14268549|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268550|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558309|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558310|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558311|NCT00002549|Analgesics|analgesics|mesh-ancestor
14268551|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268552|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14268553|NCT00396084|Renal Agents|renal agents|mesh-ancestor
14268554|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14268555|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14268556|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
14268557|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14268558|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14268559|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
14268560|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14268561|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14268562|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14558312|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
14558313|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558314|NCT00002550|Etoposide|etoposide|mesh-list
14558315|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558316|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558317|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558318|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558319|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558320|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558321|NCT00002551|Leucovorin|leucovorin|mesh-list
14558322|NCT00002551|Levamisole|levamisole|mesh-list
14558323|NCT00002551|Fluorouracil|fluorouracil|mesh-list
14558324|NCT00002551|Calcium|calcium|mesh-list
14558325|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
14558326|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14558327|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558328|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
14558329|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558330|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558331|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558332|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558333|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
14558334|NCT00002551|Antidotes|antidotes|mesh-ancestor
14558335|NCT00002551|Protective Agents|protective agents|mesh-ancestor
14558336|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558337|NCT00002551|Vitamins|vitamins|mesh-ancestor
14558338|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
14558339|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14558340|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
14558341|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
14558342|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14558343|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558344|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558345|NCT00002552|Leucovorin|leucovorin|mesh-list
14558346|NCT00002552|Cytarabine|cytarabine|mesh-list
14558347|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
14558348|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14558349|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14558350|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14558351|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
14558352|NCT00002552|Carmustine|carmustine|mesh-list
14558353|NCT00002552|Methotrexate|methotrexate|mesh-list
14558354|NCT00002552|Etoposide|etoposide|mesh-list
14558355|NCT00002552|Sargramostim|sargramostim|mesh-list
14558356|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
14558357|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558358|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
14558359|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558360|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558361|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558362|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
14558363|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558364|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558365|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558366|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558367|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558368|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558369|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558370|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
14558371|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558372|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558373|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558374|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558375|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15087573|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14558376|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558377|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558378|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
14558379|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558380|NCT00002552|Antidotes|antidotes|mesh-ancestor
14558381|NCT00002552|Protective Agents|protective agents|mesh-ancestor
14558382|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558383|NCT00002552|Vitamins|vitamins|mesh-ancestor
14558384|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
14558385|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558386|NCT00002553|Cobalt|cobalt|mesh-list
14558387|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
14558388|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558389|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
14558390|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558391|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558392|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558393|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
14268563|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14268564|NCT00396201|Plerixafor|plerixafor|mesh-list
14268565|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268566|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14268567|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
14268568|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268569|NCT00396253|Tenecteplase|tenecteplase|mesh-list
14268570|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14268571|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14268572|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268573|NCT00396266|Plerixafor|plerixafor|mesh-list
14268574|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268575|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14268576|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
14268577|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268578|NCT00396279|Vitamin D|vitamin d|mesh-list
14268579|NCT00396279|Denosumab|denosumab|mesh-list
14268580|NCT00396279|Calcium|calcium|mesh-list
14268581|NCT00396279|Vitamins|vitamins|mesh-ancestor
14268582|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
14268583|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268584|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268585|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14268586|NCT00396318|Tenecteplase|tenecteplase|mesh-list
14268587|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14268588|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14268589|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268590|NCT00396331|Plerixafor|plerixafor|mesh-list
14268591|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268592|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14268593|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
14268594|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268595|NCT00396383|Plerixafor|plerixafor|mesh-list
14268596|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268597|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14558394|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558395|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558396|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558397|NCT00002553|Trace Elements|trace elements|mesh-ancestor
14558398|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
14558399|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
14558400|NCT00002554|Busulfan|busulfan|mesh-list
14558401|NCT00002554|Methotrexate|methotrexate|mesh-list
14558402|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558403|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
14558404|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558405|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558406|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558407|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
14558408|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558409|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558410|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558411|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558412|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558413|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558414|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268598|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
14268599|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268600|NCT00396409|Omalizumab|omalizumab|mesh-list
14558415|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
14558416|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558417|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558418|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558419|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558420|NCT00002555|Cobalt|cobalt|mesh-list
14558421|NCT00002555|Trace Elements|trace elements|mesh-ancestor
14558422|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
14558423|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558424|NCT00002556|Interferons|interferons|mesh-list
14558425|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
14558426|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
14558427|NCT00002556|Prednisone|prednisone|mesh-list
14558428|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
14558429|NCT00002556|Melphalan|melphalan|mesh-list
14558430|NCT00002556|Carmustine|carmustine|mesh-list
14558431|NCT00002556|Vincristine|vincristine|mesh-list
14558432|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558433|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
14558434|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558435|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558436|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558437|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
14558438|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558439|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558440|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558441|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558442|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
14558443|NCT00002556|Hormones|hormones|mesh-ancestor
14558444|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558445|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558446|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
14558447|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558448|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558449|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558450|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558451|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558452|NCT00002557|Leucovorin|leucovorin|mesh-list
14558453|NCT00002557|Doxorubicin|doxorubicin|mesh-list
14558454|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558455|NCT00002557|Etoposide|etoposide|mesh-list
14558456|NCT00002557|Methotrexate|methotrexate|mesh-list
14558457|NCT00002557|Calcium|calcium|mesh-list
14558458|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
14558459|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558460|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558461|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558462|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558463|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558464|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558465|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14558466|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558467|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558468|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558469|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558470|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558471|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
14558472|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558473|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558474|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558475|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
14558476|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558477|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558478|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558479|NCT00002557|Antidotes|antidotes|mesh-ancestor
14558480|NCT00002557|Protective Agents|protective agents|mesh-ancestor
14558481|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558482|NCT00002557|Vitamins|vitamins|mesh-ancestor
14558483|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
14558484|NCT00002559|Paclitaxel|paclitaxel|mesh-list
14558485|NCT00002559|Ifosfamide|ifosfamide|mesh-list
14558486|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14268601|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14268602|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14268603|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
14558487|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023351|NCT02762864|Aspirin|aspirin|mesh-list
14268604|NCT00396565|Olanzapine|olanzapine|mesh-list
14558488|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558489|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558490|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558491|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558492|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558493|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
15087574|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
15087575|NCT02261090|Pramipexole|pramipexole|mesh-list
15087576|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
15087577|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087578|NCT02261090|Protective Agents|protective agents|mesh-ancestor
15087579|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087580|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15087581|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15087582|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
15087583|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
15087584|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087585|NCT02261103|Pramipexole|pramipexole|mesh-list
15087586|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
15087587|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087588|NCT02261103|Protective Agents|protective agents|mesh-ancestor
15087589|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087590|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15087591|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15087592|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
15087593|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
15087594|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087595|NCT02261116|Telmisartan|telmisartan|mesh-list
15087596|NCT02261116|Candesartan|candesartan|mesh-list
15087597|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087598|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087599|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087600|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087601|NCT02261129|Telmisartan|telmisartan|mesh-list
15087602|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087603|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087604|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087605|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087606|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15087607|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087608|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087609|NCT02261207|Axitinib|axitinib|mesh-list
15087610|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087611|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15087612|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087613|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087614|NCT02261220|Durvalumab|durvalumab|mesh-list
15087615|NCT02261220|Tremelimumab|tremelimumab|mesh-list
15087616|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15087617|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087618|NCT02261298|Nivolumab|nivolumab|mesh-list
15087619|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15087620|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087621|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15087622|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087623|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15087624|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15087625|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087626|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
15087627|NCT02261636|Mesalamine|mesalamine|mesh-list
15087628|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15087629|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14558494|NCT00002560|Antibodies|antibodies|mesh-list
14558495|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14558496|NCT00002560|Sargramostim|sargramostim|mesh-list
14558497|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
14558498|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558499|NCT00002561|Doxorubicin|doxorubicin|mesh-list
14558500|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558501|NCT00002561|Bleomycin|bleomycin|mesh-list
14558502|NCT00002561|Dacarbazine|dacarbazine|mesh-list
14558503|NCT00002561|Vinblastine|vinblastine|mesh-list
14558504|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558505|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558506|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558507|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558508|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558509|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558510|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558511|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
14558512|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558513|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558514|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558515|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558516|NCT00002562|Paclitaxel|paclitaxel|mesh-list
14558517|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558518|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558519|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558520|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558521|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558522|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558523|NCT00002565|Cytarabine|cytarabine|mesh-list
14558524|NCT00002565|Prednisone|prednisone|mesh-list
14558525|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
14558526|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
14558527|NCT00002565|Ifosfamide|ifosfamide|mesh-list
14558528|NCT00002565|Doxorubicin|doxorubicin|mesh-list
14558529|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558530|NCT00002565|Etoposide|etoposide|mesh-list
14558531|NCT00002565|Vincristine|vincristine|mesh-list
14558532|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
14558533|NCT00002565|Idarubicin|idarubicin|mesh-list
14558534|NCT00002565|Bleomycin|bleomycin|mesh-list
14558535|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558536|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
14558537|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558538|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558539|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558540|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
14558541|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558542|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558543|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558544|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558545|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558546|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558547|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558548|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558549|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
14558550|NCT00002565|Hormones|hormones|mesh-ancestor
14558551|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558552|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558553|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558554|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558555|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
14558556|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
14558557|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558558|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558559|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558560|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558561|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
14558562|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
14558563|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558564|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14558565|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14558566|NCT00002565|Protective Agents|protective agents|mesh-ancestor
14558567|NCT00002565|Analgesics|analgesics|mesh-ancestor
14558568|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
14558569|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
14558570|NCT00002566|Ifosfamide|ifosfamide|mesh-list
14558571|NCT00002566|Carboplatin|carboplatin|mesh-list
14558572|NCT00002566|Etoposide|etoposide|mesh-list
14558573|NCT00002566|Vinblastine|vinblastine|mesh-list
14558574|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558575|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
14558576|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558577|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558578|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558579|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
14558580|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558581|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558582|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558583|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558584|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558585|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558586|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558587|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558588|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558589|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558590|NCT00002567|Etoposide|etoposide|mesh-list
14558591|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558592|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558593|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558594|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558595|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558596|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558597|NCT00002568|Paclitaxel|paclitaxel|mesh-list
14558598|NCT00002568|Cisplatin|cisplatin|mesh-list
14558599|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558600|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558601|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558602|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558603|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558604|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558605|NCT00002569|Vincristine|vincristine|mesh-list
14558606|NCT00002569|Lomustine|lomustine|mesh-list
14558607|NCT00002569|Procarbazine|procarbazine|mesh-list
14558608|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558609|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558610|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558611|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558612|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558613|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558614|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558615|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
14558616|NCT00002570|Leucovorin|leucovorin|mesh-list
14558617|NCT00002570|Fluorouracil|fluorouracil|mesh-list
14558618|NCT00002570|Calcium|calcium|mesh-list
14558619|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
14558620|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14558621|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558622|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
14558623|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558624|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558625|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558626|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558627|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
14558628|NCT00002570|Antidotes|antidotes|mesh-ancestor
14558629|NCT00002570|Protective Agents|protective agents|mesh-ancestor
14558630|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558631|NCT00002570|Vitamins|vitamins|mesh-ancestor
14558632|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
14558633|NCT00002571|Leucovorin|leucovorin|mesh-list
14558634|NCT00002571|Cytarabine|cytarabine|mesh-list
14558635|NCT00002571|Trimethoprim|trimethoprim|mesh-list
14558636|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
14558637|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14558638|NCT00002571|Prednisone|prednisone|mesh-list
14558639|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
14558640|NCT00002571|Doxorubicin|doxorubicin|mesh-list
14558641|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558642|NCT00002571|Methotrexate|methotrexate|mesh-list
14558643|NCT00002571|Etoposide|etoposide|mesh-list
14558644|NCT00002571|Vincristine|vincristine|mesh-list
14558645|NCT00002571|Bleomycin|bleomycin|mesh-list
14558646|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
14558647|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558648|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
14558649|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558650|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558651|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558652|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
14558653|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558654|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558655|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558656|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558657|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558658|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558659|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558660|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558661|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
14558662|NCT00002571|Hormones|hormones|mesh-ancestor
14558663|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15087630|NCT02261636|Analgesics|analgesics|mesh-ancestor
15087631|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
15087632|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087633|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087634|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087635|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087636|NCT02261662|Ribavirin|ribavirin|mesh-list
15087637|NCT02261662|Betamethasone|betamethasone|mesh-list
15087638|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
15087639|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087640|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
15087641|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558664|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558665|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558666|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558667|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558668|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558669|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
14558670|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558671|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558672|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558673|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558674|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
14558675|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558676|NCT00002571|Antidotes|antidotes|mesh-ancestor
14558677|NCT00002571|Protective Agents|protective agents|mesh-ancestor
14558678|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558679|NCT00002571|Vitamins|vitamins|mesh-ancestor
14558680|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
14558681|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558682|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558683|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558684|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14558685|NCT00002571|Renal Agents|renal agents|mesh-ancestor
14558686|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
14558687|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14558688|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14558689|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14558690|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14558691|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14558692|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14558693|NCT00002572|Aldesleukin|aldesleukin|mesh-list
14558694|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
14558695|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558696|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14558697|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14558698|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
14558699|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558700|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
14558701|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558702|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558703|NCT00002574|Interferons|interferons|mesh-list
14558704|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
14558705|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
14558706|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558707|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
14558708|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558709|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
14558710|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558711|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558712|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14558713|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558714|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558715|NCT00002576|Prednisolone|prednisolone|mesh-list
14558716|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
14558717|NCT00002576|Doxorubicin|doxorubicin|mesh-list
14558718|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558719|NCT00002576|Vincristine|vincristine|mesh-list
14558720|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
14558721|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558722|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
14558723|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558724|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087642|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087643|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
14558725|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558726|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
14809399|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14558727|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558728|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558729|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558730|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558731|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558732|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14809400|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
14809401|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14809402|NCT00833326|Docetaxel|docetaxel|mesh-list
14809403|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
14809404|NCT00833326|Mitogens|mitogens|mesh-list
14809405|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809406|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
14809407|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14809408|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809409|NCT00833339|Mifepristone|mifepristone|mesh-list
14809410|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15087644|NCT02261662|Hormones|hormones|mesh-ancestor
15087645|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15087646|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087647|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15087648|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
15087649|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
15087650|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15087651|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087652|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087653|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15087654|NCT02261675|Analgesics|analgesics|mesh-ancestor
15087655|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
15087656|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087657|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15087658|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15087659|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15087660|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
15087661|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087662|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087663|NCT02261779|Tretinoin|tretinoin|mesh-list
15087664|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
15087665|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087666|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
15087667|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
15087668|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
15087669|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15087670|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15087671|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087672|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087673|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15087674|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15087675|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087676|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087677|NCT02261844|Resveratrol|resveratrol|mesh-list
15087678|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
15087679|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087680|NCT02261844|Protective Agents|protective agents|mesh-ancestor
15087681|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087682|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087683|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15087684|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
15087685|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087686|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087687|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15087688|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15087689|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087690|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087691|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087692|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15087693|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14558733|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558734|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558735|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558736|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558737|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558738|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558739|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
14558740|NCT00002576|Hormones|hormones|mesh-ancestor
14558741|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558742|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558743|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558744|NCT00002576|Analgesics|analgesics|mesh-ancestor
14558745|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
14558746|NCT00002578|Leucovorin|leucovorin|mesh-list
14558747|NCT00002578|Cytarabine|cytarabine|mesh-list
14558748|NCT00002578|Methotrexate|methotrexate|mesh-list
14558749|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
14558750|NCT00002578|Calcium|calcium|mesh-list
14558751|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
14558752|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14558753|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558754|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558755|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558756|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558757|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558758|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
14558759|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558760|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558761|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558762|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558763|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558764|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558765|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
14558766|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558767|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558768|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
14558769|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558770|NCT00002578|Antidotes|antidotes|mesh-ancestor
14558771|NCT00002578|Protective Agents|protective agents|mesh-ancestor
14558772|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
14558773|NCT00002578|Vitamins|vitamins|mesh-ancestor
14558774|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
14558775|NCT00002579|Tamoxifen|tamoxifen|mesh-list
14558776|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
14558777|NCT00002579|Fluorouracil|fluorouracil|mesh-list
14558778|NCT00002579|Methotrexate|methotrexate|mesh-list
14558779|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558780|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
14558781|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558782|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558783|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558784|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
14558785|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558786|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558787|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558788|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
14558789|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558790|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558791|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558792|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558793|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558794|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558795|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558796|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558797|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14558798|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
14558799|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558800|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558801|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14558802|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14558803|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14558804|NCT00002580|Tamoxifen|tamoxifen|mesh-list
14558805|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
14558806|NCT00002580|Fluorouracil|fluorouracil|mesh-list
14558807|NCT00002580|Methotrexate|methotrexate|mesh-list
14558808|NCT00002580|Leuprolide|leuprolide|mesh-list
14558809|NCT00002580|Goserelin|goserelin|mesh-list
14558810|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558811|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
14558812|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558813|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558814|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558815|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
14558816|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558817|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558818|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558819|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
14558820|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558821|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558822|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558823|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558824|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558825|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558826|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558827|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558828|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14558829|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
14558830|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558831|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558832|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14558833|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14558834|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14558835|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14558836|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
14558837|NCT00002581|Tamoxifen|tamoxifen|mesh-list
14558838|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
14558839|NCT00002581|Fluorouracil|fluorouracil|mesh-list
14558840|NCT00002581|Methotrexate|methotrexate|mesh-list
14558841|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558842|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
14558843|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558844|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558845|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558846|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
14558847|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558848|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558849|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558850|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
14558851|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558852|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558853|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558854|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558855|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558856|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558857|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558858|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558859|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14558860|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
14558861|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558862|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558863|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14558864|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14558865|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14558866|NCT00002582|Tamoxifen|tamoxifen|mesh-list
14558867|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
14558868|NCT00002582|Doxorubicin|doxorubicin|mesh-list
15087694|NCT02261922|Ticagrelor|ticagrelor|mesh-list
15087695|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14558869|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558870|NCT00002582|Fluorouracil|fluorouracil|mesh-list
14558871|NCT00002582|Methotrexate|methotrexate|mesh-list
14558872|NCT00002582|Leuprolide|leuprolide|mesh-list
14558873|NCT00002582|Goserelin|goserelin|mesh-list
14558874|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558875|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
14558876|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558877|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558878|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558879|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
14558880|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558881|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558882|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558883|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14558884|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558885|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558886|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558887|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
14558888|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558889|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558890|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558891|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558892|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558893|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558894|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558895|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14558896|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
14558897|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558898|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558899|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14558900|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14558901|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14558902|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14558903|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
14558904|NCT00002583|Vinorelbine|vinorelbine|mesh-list
14558905|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558906|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558907|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558908|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558909|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558910|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558911|NCT00002585|NSC 366140|nsc 366140|mesh-list
14558912|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558913|NCT00002586|Vitamin E|vitamin e|mesh-list
14558914|NCT00002586|Tocopherols|tocopherols|mesh-list
14558915|NCT00002586|Tocotrienols|tocotrienols|mesh-list
14558916|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
15087696|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15087697|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15087698|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15087699|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15087700|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
15087701|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087702|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087703|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087704|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15087705|NCT02262143|Fenofibrate|fenofibrate|mesh-list
15087706|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15087707|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15087708|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
15087709|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087710|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14558917|NCT00002586|Tretinoin|tretinoin|mesh-list
14558918|NCT00002586|Isotretinoin|isotretinoin|mesh-list
14558919|NCT00002586|Vitamins|vitamins|mesh-ancestor
14558920|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
14268605|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14268606|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
14268607|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
14268608|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14558921|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558922|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
14558923|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558924|NCT00002586|Protective Agents|protective agents|mesh-ancestor
14558925|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558926|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
14558927|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558928|NCT00002587|Paclitaxel|paclitaxel|mesh-list
14558929|NCT00002587|Topotecan|topotecan|mesh-list
14558930|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558931|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558932|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14558933|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14558934|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14558935|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558936|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14558937|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558938|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558939|NCT00002588|Etoposide|etoposide|mesh-list
14558940|NCT00002588|Topotecan|topotecan|mesh-list
14558941|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15087711|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15087712|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558942|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558943|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558944|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558945|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558946|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558947|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14558948|NCT00002589|Aldesleukin|aldesleukin|mesh-list
14558949|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
14558950|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558951|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15087713|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
15087714|NCT02262156|Serotonin|serotonin|mesh-list
15087715|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15087716|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15087717|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15087718|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
15087719|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087720|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087721|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087722|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15087723|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087724|NCT02262169|Omeprazole|omeprazole|mesh-list
15087725|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15087726|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15087727|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15087728|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087729|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087730|NCT02262299|Pirfenidone|pirfenidone|mesh-list
15087731|NCT02262299|Analgesics|analgesics|mesh-ancestor
15087732|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
15087733|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087734|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087735|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15087736|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15087737|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15087738|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15087739|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173122|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173123|NCT04008030|Leucovorin|leucovorin|mesh-list
15173124|NCT04008030|Bevacizumab|bevacizumab|mesh-list
15173125|NCT04008030|Nivolumab|nivolumab|mesh-list
15173126|NCT04008030|Cetuximab|cetuximab|mesh-list
15173127|NCT04008030|Ipilimumab|ipilimumab|mesh-list
15173128|NCT04008030|Fluorouracil|fluorouracil|mesh-list
15173129|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
15173130|NCT04008030|Irinotecan|irinotecan|mesh-list
15173131|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173132|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173133|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15173134|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15173135|NCT04008030|Growth Substances|growth substances|mesh-ancestor
15173136|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173137|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
15173138|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
15173139|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173140|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15173141|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15173142|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
15173143|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15173144|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15173145|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15173146|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173147|NCT04008030|Antidotes|antidotes|mesh-ancestor
15173148|NCT04008030|Protective Agents|protective agents|mesh-ancestor
15173149|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
15173150|NCT04008030|Vitamins|vitamins|mesh-ancestor
15173151|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
15173152|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
15173153|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
15173154|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181328|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15181329|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181330|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
14558952|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14558953|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
14558954|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14558955|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
14558956|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558957|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558958|NCT00002590|Leucovorin|leucovorin|mesh-list
14558959|NCT00002590|Cytarabine|cytarabine|mesh-list
14558960|NCT00002590|Prednisone|prednisone|mesh-list
14268609|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268610|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14268611|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14268612|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14268613|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268614|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268615|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14268616|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14268617|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268618|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268619|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268620|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
14268621|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14268622|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14268623|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14268624|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14268625|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
14268626|NCT00396591|Aflibercept|aflibercept|mesh-list
14558961|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
14558962|NCT00002590|Doxorubicin|doxorubicin|mesh-list
14558963|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14558964|NCT00002590|Methotrexate|methotrexate|mesh-list
14558965|NCT00002590|Etoposide|etoposide|mesh-list
14558966|NCT00002590|Vincristine|vincristine|mesh-list
15087740|NCT02262325|Etoposide|etoposide|mesh-list
15087741|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
15087742|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087743|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15087744|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15087745|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15087746|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087747|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087748|NCT02262416|Leuprolide|leuprolide|mesh-list
15087749|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15087750|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
15087751|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15087752|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087753|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15087754|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087755|NCT02262455|Doxorubicin|doxorubicin|mesh-list
15087756|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15087757|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15087758|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087759|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15087760|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15087761|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087762|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558967|NCT00002590|Daunorubicin|daunorubicin|mesh-list
14558968|NCT00002590|Asparaginase|asparaginase|mesh-list
14558969|NCT00002590|Pegaspargase|pegaspargase|mesh-list
14558970|NCT00002590|Thioguanine|thioguanine|mesh-list
14558971|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
14558972|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14558973|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
14558974|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14558975|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14558976|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14558977|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
14558978|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14558979|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14558980|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14558981|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15087763|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
15087764|NCT02262481|Progestins|progestins|mesh-ancestor
14558982|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14558983|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14558984|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14558985|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14558986|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
14558987|NCT00002590|Hormones|hormones|mesh-ancestor
14558988|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14558989|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14558990|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14558991|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
14558992|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14558993|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14558994|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
14558995|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
14558996|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14558997|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14558998|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14558999|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
14559000|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559001|NCT00002590|Antidotes|antidotes|mesh-ancestor
14559002|NCT00002590|Protective Agents|protective agents|mesh-ancestor
14559003|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
14559004|NCT00002590|Vitamins|vitamins|mesh-ancestor
14559005|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
14559006|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559007|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559008|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559009|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
14559010|NCT00002592|Busulfan|busulfan|mesh-list
14559011|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15087765|NCT02262481|Hormones|hormones|mesh-ancestor
15087766|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15087767|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087768|NCT02262520|Digoxin|digoxin|mesh-list
15087769|NCT02262520|Apixaban|apixaban|mesh-list
15087770|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15087771|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
15087772|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15087773|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
15087774|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559012|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
14559013|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559014|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559015|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559016|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
14559017|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559018|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559019|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559020|NCT00002593|Leucovorin|leucovorin|mesh-list
14559021|NCT00002593|Levamisole|levamisole|mesh-list
14559022|NCT00002593|Fluorouracil|fluorouracil|mesh-list
14559023|NCT00002593|Calcium|calcium|mesh-list
14559024|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
14559025|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14559026|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559027|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
14559028|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559029|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559030|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559031|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559032|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
14559033|NCT00002593|Antidotes|antidotes|mesh-ancestor
14559034|NCT00002593|Protective Agents|protective agents|mesh-ancestor
14559035|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
14559036|NCT00002593|Vitamins|vitamins|mesh-ancestor
14559037|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
14559038|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14559039|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
14559040|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
14559041|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14559042|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559043|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559044|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
14559045|NCT00002594|Melphalan|melphalan|mesh-list
14559046|NCT00002594|Molgramostim|molgramostim|mesh-list
14559047|NCT00002594|Sargramostim|sargramostim|mesh-list
14559048|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559049|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
15087775|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087776|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
14559050|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559051|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559052|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559053|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
14559054|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559055|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559056|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559057|NCT00002595|Toremifene|toremifene|mesh-list
14559058|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15087777|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15087778|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15087779|NCT02262520|Protective Agents|protective agents|mesh-ancestor
15087780|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087781|NCT02262533|Atenolol|atenolol|mesh-list
15087782|NCT02262533|Apixaban|apixaban|mesh-list
15087783|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15087784|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
15087785|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15087786|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
15087787|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087788|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559059|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559060|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14559061|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14559062|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
14559063|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559064|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559065|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14559066|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
14559067|NCT00002596|Carboplatin|carboplatin|mesh-list
14559068|NCT00002596|Etoposide|etoposide|mesh-list
14559069|NCT00002596|Bleomycin|bleomycin|mesh-list
14559070|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559071|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
14559072|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559073|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559074|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559075|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
14559076|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559077|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559078|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559079|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559080|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559081|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559082|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559083|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559084|NCT00002598|Interferons|interferons|mesh-list
14559085|NCT00002598|Cytarabine|cytarabine|mesh-list
14559086|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
14559087|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
14559088|NCT00002598|Methotrexate|methotrexate|mesh-list
14559089|NCT00002598|Etoposide|etoposide|mesh-list
14559090|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
14559091|NCT00002598|Sargramostim|sargramostim|mesh-list
14559092|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559093|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
14559094|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559095|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559096|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559097|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
14559098|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559099|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559100|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559101|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14559102|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
14559103|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14559104|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559105|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
14559106|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14559107|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559108|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14559109|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14559110|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559111|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559112|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15087789|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
15087790|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14559113|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
14559114|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559115|NCT00002598|Analgesics|analgesics|mesh-ancestor
14559116|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
15087791|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087792|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
15087793|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
15087794|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087795|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087796|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15087797|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15087798|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15087799|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
15087800|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087801|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
15087802|NCT02262546|Pramipexole|pramipexole|mesh-list
15087803|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15087804|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15087805|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087806|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15087807|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15087808|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087809|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087810|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087811|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15087812|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
15087813|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15087814|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087815|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15087816|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15087817|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15087818|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
15087819|NCT02262546|Protective Agents|protective agents|mesh-ancestor
15087820|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15087821|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15087822|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
15087823|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
15087824|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087825|NCT02262559|Telmisartan|telmisartan|mesh-list
15087826|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087827|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087828|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087829|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087830|NCT02262572|Telmisartan|telmisartan|mesh-list
15087831|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15087832|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087833|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087834|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087835|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087836|NCT02262572|Diuretics|diuretics|mesh-ancestor
15087837|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087838|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087839|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15087840|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087841|NCT02262585|Telmisartan|telmisartan|mesh-list
15087842|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087843|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087844|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087845|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087846|NCT02262598|Telmisartan|telmisartan|mesh-list
15087847|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15087848|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087849|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087850|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15173155|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
15173156|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
14559117|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559118|NCT00002599|Cobalt|cobalt|mesh-list
14559119|NCT00002599|Interferons|interferons|mesh-list
14559120|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
14559121|NCT00002599|Prednisone|prednisone|mesh-list
14559122|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
15173157|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14559123|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
14559124|NCT00002599|Melphalan|melphalan|mesh-list
14559125|NCT00002599|Carmustine|carmustine|mesh-list
14559126|NCT00002599|Doxorubicin|doxorubicin|mesh-list
14559127|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559128|NCT00002599|Vincristine|vincristine|mesh-list
14268627|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268628|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268629|NCT00396591|Growth Substances|growth substances|mesh-ancestor
14268630|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268631|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268632|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559129|NCT00002599|Sargramostim|sargramostim|mesh-list
14559130|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559131|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
15087851|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087852|NCT02262598|Diuretics|diuretics|mesh-ancestor
15087853|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087854|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087855|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15087856|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087857|NCT02262611|Telmisartan|telmisartan|mesh-list
14559132|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559133|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559134|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559135|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
14559136|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559137|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559138|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559139|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559140|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559141|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559142|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559143|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14559144|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
14559145|NCT00002599|Hormones|hormones|mesh-ancestor
14559146|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559147|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559148|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
14559149|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559150|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559151|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559152|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559153|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559154|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
14559155|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
14559156|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559157|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14559158|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14559159|NCT00002599|Protective Agents|protective agents|mesh-ancestor
14559160|NCT00002599|Trace Elements|trace elements|mesh-ancestor
14559161|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
14559162|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
14559163|NCT00002600|Carboplatin|carboplatin|mesh-list
14559164|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559165|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
14559166|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559167|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559168|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559169|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
14559170|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559171|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559172|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559173|NCT00002604|Carmustine|carmustine|mesh-list
14559174|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14559175|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559176|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
14559177|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559178|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559179|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559180|NCT00002608|Tamoxifen|tamoxifen|mesh-list
14559181|NCT00002608|Doxorubicin|doxorubicin|mesh-list
14559182|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559183|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268633|NCT00396656|Atenolol|atenolol|mesh-list
14559184|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14268634|NCT00396656|Valsartan|valsartan|mesh-list
14559185|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559186|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559187|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559188|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559189|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14559190|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
14559191|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559192|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559193|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559194|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14559195|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14559196|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14559197|NCT00002609|Cytarabine|cytarabine|mesh-list
14559198|NCT00002609|Idarubicin|idarubicin|mesh-list
14559199|NCT00002609|Lintuzumab|lintuzumab|mesh-list
14559200|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559201|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
14559202|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559203|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559204|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
14559205|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559206|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559207|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
14559208|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559209|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559210|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559211|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559212|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559213|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14559214|NCT00002610|Dactinomycin|dactinomycin|mesh-list
14559215|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
14559216|NCT00002610|Carboplatin|carboplatin|mesh-list
14559217|NCT00002610|Doxorubicin|doxorubicin|mesh-list
14559218|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559219|NCT00002610|Etoposide|etoposide|mesh-list
14559220|NCT00002610|Vincristine|vincristine|mesh-list
14559221|NCT00002610|Lenograstim|lenograstim|mesh-list
14559222|NCT00002610|Sargramostim|sargramostim|mesh-list
14559223|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559224|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
14559225|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559226|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559227|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559228|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
14559229|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559230|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559231|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559232|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559233|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559234|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559235|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559236|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559237|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14559238|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559239|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559240|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559241|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14559242|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559243|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14559244|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14559245|NCT00002611|Dactinomycin|dactinomycin|mesh-list
14559246|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
14559247|NCT00002611|Doxorubicin|doxorubicin|mesh-list
14559248|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559249|NCT00002611|Etoposide|etoposide|mesh-list
14559250|NCT00002611|Vincristine|vincristine|mesh-list
15087858|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15087859|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14559251|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559252|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
14559253|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559254|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559255|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15087860|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14559256|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
14559257|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559258|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559259|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559260|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559261|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559262|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559263|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559264|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559265|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559266|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559267|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559268|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14559269|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559270|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14559271|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14559272|NCT00002615|Fluorouracil|fluorouracil|mesh-list
14559273|NCT00002615|Epirubicin|epirubicin|mesh-list
14559274|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559275|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
14559276|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559277|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559278|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559279|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
14559280|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559281|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559282|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559283|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559284|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559285|NCT00002616|Aldesleukin|aldesleukin|mesh-list
14559286|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
14559287|NCT00002616|Thiotepa|thiotepa|mesh-list
14559288|NCT00002616|Carboplatin|carboplatin|mesh-list
14559289|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559290|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
14559291|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559292|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559293|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559294|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
14559295|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559296|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087861|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087862|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087863|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15087864|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087865|NCT02262611|Diuretics|diuretics|mesh-ancestor
15087866|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087867|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087868|NCT02262624|Telmisartan|telmisartan|mesh-list
15087869|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15087870|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087871|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087872|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087873|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087874|NCT02262624|Diuretics|diuretics|mesh-ancestor
15087875|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087876|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087877|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15087878|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087879|NCT02262637|Telmisartan|telmisartan|mesh-list
15087880|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15087881|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087882|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087883|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087884|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087885|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15087886|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087887|NCT02262637|Diuretics|diuretics|mesh-ancestor
15087888|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087889|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087890|NCT02262650|Telmisartan|telmisartan|mesh-list
15087891|NCT02262650|Clopidogrel|clopidogrel|mesh-list
14559297|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559298|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14559299|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14559300|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
14559301|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559302|NCT00002618|Leucovorin|leucovorin|mesh-list
14559303|NCT00002618|Cobalt|cobalt|mesh-list
14559304|NCT00002618|Cytarabine|cytarabine|mesh-list
14559305|NCT00002618|Prednisone|prednisone|mesh-list
14559306|NCT00002618|Doxorubicin|doxorubicin|mesh-list
14559307|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559308|NCT00002618|Methotrexate|methotrexate|mesh-list
14559309|NCT00002618|Vincristine|vincristine|mesh-list
14559310|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
14559311|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
14559312|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559313|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559314|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559315|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559316|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559317|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559318|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559319|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14559320|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
14559321|NCT00002618|Hormones|hormones|mesh-ancestor
14559322|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559323|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559324|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14559325|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
14559326|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14559327|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559328|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
14559329|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
14559330|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14559331|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559332|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
14559333|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559334|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14559335|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
14559336|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559337|NCT00002618|Antidotes|antidotes|mesh-ancestor
14559338|NCT00002618|Protective Agents|protective agents|mesh-ancestor
14559339|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
14559340|NCT00002618|Vitamins|vitamins|mesh-ancestor
14559341|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
14559342|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559343|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559344|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559345|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559346|NCT00002618|Trace Elements|trace elements|mesh-ancestor
14559347|NCT00002619|Carboplatin|carboplatin|mesh-list
14559348|NCT00002619|Thiotepa|thiotepa|mesh-list
14559349|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559350|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
14559351|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559352|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559353|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
14559354|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559355|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559356|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559357|NCT00002620|Cobalt|cobalt|mesh-list
14559358|NCT00002620|Carmustine|carmustine|mesh-list
14559359|NCT00002620|Mitolactol|mitolactol|mesh-list
14559360|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559361|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
14559362|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559363|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559364|NCT00002620|Trace Elements|trace elements|mesh-ancestor
14559365|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
14559366|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559367|NCT00002621|Interferons|interferons|mesh-list
14559368|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
14559369|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
15087892|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14559370|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559371|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
14559372|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559373|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
14559374|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559375|NCT00002623|Carboplatin|carboplatin|mesh-list
14559376|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559377|NCT00002625|Topotecan|topotecan|mesh-list
14559378|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14559379|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559380|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559381|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559382|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559383|NCT00002627|Paclitaxel|paclitaxel|mesh-list
14559384|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
14559385|NCT00002627|Carboplatin|carboplatin|mesh-list
14559386|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559387|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559388|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559389|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559390|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559391|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559392|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559393|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
14559394|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559395|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559396|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559397|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
14559398|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559399|NCT00002628|Paclitaxel|paclitaxel|mesh-list
14559400|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
14559401|NCT00002628|Carboplatin|carboplatin|mesh-list
14559402|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559403|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559404|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559405|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559406|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559407|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559408|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559409|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
14559410|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559411|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559412|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559413|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
14559414|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559415|NCT00002630|Cobalt|cobalt|mesh-list
14559416|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
14559417|NCT00002630|Melphalan|melphalan|mesh-list
14559418|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559419|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
14559420|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559421|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559422|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559423|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
14559424|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559425|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559426|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559427|NCT00002630|Trace Elements|trace elements|mesh-ancestor
14559428|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
14559429|NCT00002631|Fluorouracil|fluorouracil|mesh-list
14559430|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559431|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
14559432|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559433|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559434|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559435|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
14559436|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559437|NCT00002632|Paclitaxel|paclitaxel|mesh-list
14559438|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559439|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559440|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559441|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559442|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559443|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559444|NCT00002633|Leuprolide|leuprolide|mesh-list
14559445|NCT00002633|Goserelin|goserelin|mesh-list
14559446|NCT00002633|Flutamide|flutamide|mesh-list
14559447|NCT00002633|Bicalutamide|bicalutamide|mesh-list
14559448|NCT00002633|Nilutamide|nilutamide|mesh-list
14559449|NCT00002633|Buserelin|buserelin|mesh-list
14559450|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14559451|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
14559452|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14559453|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559454|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559455|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559456|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
14559457|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
14559458|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559459|NCT00002634|Cobalt|cobalt|mesh-list
14559460|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
14559461|NCT00002634|Doxorubicin|doxorubicin|mesh-list
14559462|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559463|NCT00002634|Etoposide|etoposide|mesh-list
14559464|NCT00002634|Vincristine|vincristine|mesh-list
14559465|NCT00002634|Antibodies|antibodies|mesh-list
14559466|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14559467|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559468|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
14559469|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559470|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559471|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559472|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
14559473|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559474|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559475|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559476|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559477|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559478|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559479|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559480|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559481|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559482|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559483|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559484|NCT00002634|Trace Elements|trace elements|mesh-ancestor
14559485|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
15087893|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15087894|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15087895|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15087896|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
15087897|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087898|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087899|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087900|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087901|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087902|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087903|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
15087904|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15087905|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
15087906|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15087907|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
15087908|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087909|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087910|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
15087911|NCT02262702|Acetaminophen|acetaminophen|mesh-list
15087912|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15087913|NCT02262702|Analgesics|analgesics|mesh-ancestor
15087914|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
15087915|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087916|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087917|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
15087918|NCT02262715|Oseltamivir|oseltamivir|mesh-list
15087919|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
15087920|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15087921|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15087922|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087923|NCT02262741|Durvalumab|durvalumab|mesh-list
15087924|NCT02262741|Tremelimumab|tremelimumab|mesh-list
15087925|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15087926|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087927|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
15087928|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
15087929|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
15087930|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15087931|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087932|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15087933|NCT02262780|Telmisartan|telmisartan|mesh-list
15173158|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14559486|NCT00002635|Lenograstim|lenograstim|mesh-list
14559487|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14559488|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
14559489|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559490|NCT00002637|Interferons|interferons|mesh-list
14559491|NCT00002637|Aldesleukin|aldesleukin|mesh-list
14559492|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
14559493|NCT00002637|Vaccines|vaccines|mesh-list
14559494|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559495|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
14559496|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559497|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14559498|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14559499|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
14559500|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559501|NCT00002638|Cytarabine|cytarabine|mesh-list
14559502|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
14559503|NCT00002638|Carmustine|carmustine|mesh-list
14559504|NCT00002638|Etoposide|etoposide|mesh-list
14809411|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
14809412|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14809413|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809414|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14809415|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14809416|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14809417|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
14809418|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14809419|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14809420|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
14809421|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809422|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
14809423|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14809424|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14809425|NCT00833378|Ritonavir|ritonavir|mesh-list
14809426|NCT00833378|Lopinavir|lopinavir|mesh-list
14809427|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14809428|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14809429|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
14809430|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809431|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809432|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14809433|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14809434|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
14809435|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809436|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14809437|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14809438|NCT00833404|Nicotine|nicotine|mesh-list
14809439|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14809440|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
14809441|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809442|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809443|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14809444|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14809445|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14809446|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809447|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809448|NCT00833534|Rituximab|rituximab|mesh-list
14809449|NCT00833534|Lenalidomide|lenalidomide|mesh-list
14809450|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14809451|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809452|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
14809453|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809454|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809455|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14809456|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14809457|NCT00833534|Growth Substances|growth substances|mesh-ancestor
14809458|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
14809459|NCT00833729|Etanercept|etanercept|mesh-list
14809460|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14809461|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14809462|NCT00833729|Analgesics|analgesics|mesh-ancestor
14809463|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
15087934|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087935|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14559505|NCT00002638|Sargramostim|sargramostim|mesh-list
14559506|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559507|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
14559508|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559509|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559510|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559511|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
14559512|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559513|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559514|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559515|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559516|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559517|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559518|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559519|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559520|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
14559521|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
14559522|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559523|NCT00002639|Suramin|suramin|mesh-list
14559524|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
14559525|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
14559526|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14559527|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559528|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559529|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14559530|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14559531|NCT00002641|Doxorubicin|doxorubicin|mesh-list
14559532|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559533|NCT00002641|Ifosfamide|ifosfamide|mesh-list
14559534|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559535|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559536|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559537|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559538|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559539|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559540|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559541|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
14559542|NCT00002642|Cobalt|cobalt|mesh-list
14559543|NCT00002642|Etoposide|etoposide|mesh-list
14559544|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559545|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559546|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559547|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559548|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559549|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559550|NCT00002642|Trace Elements|trace elements|mesh-ancestor
14559551|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
14559552|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559553|NCT00002643|Cobalt|cobalt|mesh-list
14559554|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
14559555|NCT00002643|Ifosfamide|ifosfamide|mesh-list
14559556|NCT00002643|Doxorubicin|doxorubicin|mesh-list
14559557|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559558|NCT00002643|Etoposide|etoposide|mesh-list
14559559|NCT00002643|Vincristine|vincristine|mesh-list
14559560|NCT00002643|Topotecan|topotecan|mesh-list
14559561|NCT00002643|Amifostine|amifostine|mesh-list
14559562|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559563|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
14559564|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559565|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559566|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559567|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
14559568|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559569|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559570|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559571|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559572|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559573|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559574|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559575|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559576|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559577|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559578|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559579|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14559580|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14559581|NCT00002643|Protective Agents|protective agents|mesh-ancestor
14559582|NCT00002643|Trace Elements|trace elements|mesh-ancestor
14559583|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
14559584|NCT00002644|Tamoxifen|tamoxifen|mesh-list
14559585|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14559586|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
14559587|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559588|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559589|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559590|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559591|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14559592|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14559593|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14559594|NCT00002646|Tamoxifen|tamoxifen|mesh-list
14559595|NCT00002646|Fenretinide|fenretinide|mesh-list
14559596|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14559597|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14559598|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559599|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559600|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559601|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559602|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14559603|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14559604|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14559605|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14559606|NCT00002646|Protective Agents|protective agents|mesh-ancestor
14559607|NCT00002647|Verteporfin|verteporfin|mesh-list
14559608|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14559609|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
14559610|NCT00002649|Aldesleukin|aldesleukin|mesh-list
14559611|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
14559612|NCT00002649|Etoposide|etoposide|mesh-list
14559613|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
14559614|NCT00002649|Interleukin-2|interleukin-2|mesh-list
14559615|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559616|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
14559617|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559618|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559619|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559620|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
14559621|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559622|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559623|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559624|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559625|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559626|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559627|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559628|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14559629|NCT00002649|Analgesics|analgesics|mesh-ancestor
14559630|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
14559631|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559632|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14559633|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14559634|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
14559635|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559636|NCT00002650|Folic Acid|folic acid|mesh-list
14559637|NCT00002650|Hematinics|hematinics|mesh-ancestor
14559638|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
14559639|NCT00002650|Vitamins|vitamins|mesh-ancestor
14559640|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
14559641|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559642|NCT00002652|Suramin|suramin|mesh-list
14559643|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
14559644|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
14559645|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14559646|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559647|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559648|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14559649|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14559650|NCT00002653|Prednisone|prednisone|mesh-list
14559651|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
14559652|NCT00002653|Melphalan|melphalan|mesh-list
14559653|NCT00002653|Carmustine|carmustine|mesh-list
14559654|NCT00002653|Doxorubicin|doxorubicin|mesh-list
14559655|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559656|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559657|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
14559658|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559659|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559660|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559661|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
14559662|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559663|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559664|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559665|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559666|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559667|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559668|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559669|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14559670|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
14559671|NCT00002653|Hormones|hormones|mesh-ancestor
14559672|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559673|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559674|NCT00002654|Cobalt|cobalt|mesh-list
14559675|NCT00002654|Trace Elements|trace elements|mesh-ancestor
14559676|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
14559677|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559678|NCT00002656|NSC 366140|nsc 366140|mesh-list
14559679|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559680|NCT00002657|Interferons|interferons|mesh-list
14559681|NCT00002657|Cytarabine|cytarabine|mesh-list
14559682|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
14559683|NCT00002657|Prednisone|prednisone|mesh-list
14559684|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
14559685|NCT00002657|Doxorubicin|doxorubicin|mesh-list
14559686|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559687|NCT00002657|Methotrexate|methotrexate|mesh-list
14559688|NCT00002657|Etoposide|etoposide|mesh-list
14559689|NCT00002657|Vincristine|vincristine|mesh-list
14559690|NCT00002657|Bleomycin|bleomycin|mesh-list
14559691|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559692|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
14559693|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559694|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559695|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559696|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
14559697|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559698|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559699|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559700|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559701|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559702|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559703|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559704|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14559705|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
14559706|NCT00002657|Hormones|hormones|mesh-ancestor
14559707|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559708|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559709|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14559710|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
14559711|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14559712|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559713|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
14559714|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
14559715|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14559716|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14559717|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559718|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
14559719|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559720|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559721|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559722|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559723|NCT00002658|Cytarabine|cytarabine|mesh-list
14559724|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
14559725|NCT00002658|Etoposide|etoposide|mesh-list
14559726|NCT00002658|Daunorubicin|daunorubicin|mesh-list
14559727|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
14559728|NCT00002658|Idarubicin|idarubicin|mesh-list
14559729|NCT00002658|Thioguanine|thioguanine|mesh-list
14559730|NCT00002658|Tretinoin|tretinoin|mesh-list
14559731|NCT00002658|Amsacrine|amsacrine|mesh-list
14559732|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559733|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
14559734|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559735|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559736|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559737|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
14559738|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559739|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559740|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559741|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559742|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15087936|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087937|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087938|NCT02262793|Telmisartan|telmisartan|mesh-list
15087939|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087940|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14559743|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559744|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559745|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559746|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
14559747|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
14559748|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559749|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559750|NCT00002658|Analgesics|analgesics|mesh-ancestor
14559751|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
14559752|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559753|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
14559754|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
14559755|NCT00002659|Cisplatin|cisplatin|mesh-list
14559756|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559757|NCT00002662|Paclitaxel|paclitaxel|mesh-list
14559758|NCT00002662|Docetaxel|docetaxel|mesh-list
14559759|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559760|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559761|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
15087941|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087942|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087943|NCT02262858|Telmisartan|telmisartan|mesh-list
15087944|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15087945|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15087946|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15087947|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15087948|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087949|NCT02262858|Diuretics|diuretics|mesh-ancestor
15087950|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087951|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087952|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15087953|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15087954|NCT02262897|Paclitaxel|paclitaxel|mesh-list
15087955|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15087956|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15087957|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15087958|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
15087959|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
15087960|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
15087961|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087962|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15087963|NCT02262936|Fesoterodine|fesoterodine|mesh-list
15087964|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15087965|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15087966|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
15087967|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087968|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087969|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087970|NCT02262936|Urological Agents|urological agents|mesh-ancestor
15087971|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
14559762|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
15087972|NCT02262936|Coagulants|coagulants|mesh-ancestor
15087973|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15087974|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
15087975|NCT02263027|Vaccines|vaccines|mesh-list
15087976|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
15087977|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087978|NCT02263066|Factor VIII|factor viii|mesh-list
15087979|NCT02263066|Coagulants|coagulants|mesh-ancestor
15087980|NCT02263105|Temozolomide|temozolomide|mesh-list
15087981|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15087982|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
15087983|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087984|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559763|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559764|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559765|NCT00002664|Sargramostim|sargramostim|mesh-list
14559766|NCT00002664|Edrecolomab|edrecolomab|mesh-list
14559767|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
14559768|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559769|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14559770|NCT00002665|Leucovorin|leucovorin|mesh-list
14559771|NCT00002665|Cytarabine|cytarabine|mesh-list
14559772|NCT00002665|Dexamethasone|dexamethasone|mesh-list
14559773|NCT00002665|Prednisone|prednisone|mesh-list
14559774|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
14559775|NCT00002665|Doxorubicin|doxorubicin|mesh-list
14559776|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559777|NCT00002665|Methotrexate|methotrexate|mesh-list
14559778|NCT00002665|Etoposide|etoposide|mesh-list
14559779|NCT00002665|Vincristine|vincristine|mesh-list
14559780|NCT00002665|Daunorubicin|daunorubicin|mesh-list
14559781|NCT00002665|Asparaginase|asparaginase|mesh-list
14559782|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
14559783|NCT00002665|Thioguanine|thioguanine|mesh-list
14559784|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
14559785|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559786|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
14559787|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559788|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559789|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559790|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
14559791|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559792|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559793|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559794|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14559795|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
14559796|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
14559797|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559798|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14559799|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
14559800|NCT00002665|Hormones|hormones|mesh-ancestor
14559801|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559802|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559803|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559804|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559805|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559806|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559807|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14559808|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
14559809|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14559810|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559811|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
14559812|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
14559813|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14559814|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14559815|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559816|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
14559817|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559818|NCT00002665|Antidotes|antidotes|mesh-ancestor
14559819|NCT00002665|Protective Agents|protective agents|mesh-ancestor
14559820|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
14559821|NCT00002665|Vitamins|vitamins|mesh-ancestor
14559822|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
14559823|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559824|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559825|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14643640|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643641|NCT00189839|Tacrolimus|tacrolimus|mesh-list
14643642|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643643|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
14643644|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643645|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14643646|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643647|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647427|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647428|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647429|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
14647430|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14647431|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
14647432|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
14647433|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15087985|NCT02263170|Phenobarbital|phenobarbital|mesh-list
15087986|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
15087987|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15087988|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15087989|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15087990|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15087991|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15087992|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15087993|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15087994|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
15087995|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
15087996|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15087997|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15087998|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15087999|NCT02263196|Ethanol|ethanol|mesh-list
15088000|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
15088001|NCT02263196|Povidone|povidone|mesh-list
15088002|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15088003|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088004|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088005|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088006|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
15088007|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
15088008|NCT02263248|Buprenorphine|buprenorphine|mesh-list
15088009|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15088010|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15088011|NCT02263248|Narcotics|narcotics|mesh-ancestor
15088012|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088013|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088014|NCT02263248|Analgesics|analgesics|mesh-ancestor
15088015|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
15088016|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559826|NCT00002669|Interferons|interferons|mesh-list
14559827|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
14559828|NCT00002669|Aldesleukin|aldesleukin|mesh-list
14559829|NCT00002669|Dacarbazine|dacarbazine|mesh-list
14559830|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559831|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
14559832|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559833|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
14559834|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559835|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14559836|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14559837|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559838|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
14559839|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559840|NCT00002670|Cobalt|cobalt|mesh-list
14559841|NCT00002670|Trace Elements|trace elements|mesh-ancestor
14559842|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
14559843|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559844|NCT00002674|Cytarabine|cytarabine|mesh-list
14559845|NCT00002674|Etoposide|etoposide|mesh-list
14559846|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
14559847|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
14559848|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559849|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559850|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559851|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559852|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559853|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559854|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559855|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
14559856|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
14559857|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559858|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559859|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
14559860|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559861|NCT00002674|Analgesics|analgesics|mesh-ancestor
14559862|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
15088017|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15088018|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14559863|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559864|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
14559865|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15088019|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14559866|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
14559867|NCT00002675|Carboplatin|carboplatin|mesh-list
14559868|NCT00002675|Etoposide|etoposide|mesh-list
14559869|NCT00002675|Vincristine|vincristine|mesh-list
14559870|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559871|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
14559872|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559873|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559874|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559875|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
14559876|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559877|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559878|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559879|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559880|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559881|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559882|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559883|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559884|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559885|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559886|NCT00002676|Cobalt|cobalt|mesh-list
14559887|NCT00002676|Cytarabine|cytarabine|mesh-list
14559888|NCT00002676|Dexamethasone|dexamethasone|mesh-list
14559889|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
14559890|NCT00002676|Carmustine|carmustine|mesh-list
14559891|NCT00002676|Doxorubicin|doxorubicin|mesh-list
14559892|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559893|NCT00002676|Methotrexate|methotrexate|mesh-list
14559894|NCT00002676|Vincristine|vincristine|mesh-list
14559895|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559896|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
14559897|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559898|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559899|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559900|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
14559901|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559902|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559903|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559904|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14559905|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
14559906|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
14559907|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14559908|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14559909|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
14559910|NCT00002676|Hormones|hormones|mesh-ancestor
14559911|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559912|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559913|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559914|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559915|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559916|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559917|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14559918|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
14559919|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14559920|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14559921|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
14559922|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
14559923|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14559924|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14559925|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
14559926|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14559927|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559928|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559929|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559930|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559931|NCT00002676|Trace Elements|trace elements|mesh-ancestor
14559932|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
14559933|NCT00002678|Dexamethasone|dexamethasone|mesh-list
14559934|NCT00002678|Prednisone|prednisone|mesh-list
14559935|NCT00002678|Melphalan|melphalan|mesh-list
14559936|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14559937|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
14559938|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
14559939|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268635|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14559940|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559941|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14559942|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
14559943|NCT00002678|Hormones|hormones|mesh-ancestor
14559944|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088020|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088021|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088022|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088023|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15088024|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
15088025|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268636|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14559945|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559946|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559947|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559948|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
14559949|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559950|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559951|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559952|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
14559953|NCT00002679|Tamoxifen|tamoxifen|mesh-list
14559954|NCT00002679|Paclitaxel|paclitaxel|mesh-list
14559955|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
14268637|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14559956|NCT00002679|Doxorubicin|doxorubicin|mesh-list
14559957|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14559958|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14559959|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559960|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
14559961|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
14559962|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
14559963|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559964|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559965|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
14559966|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559967|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559968|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559969|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
14559970|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559971|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14559972|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14559973|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14559974|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14559975|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14559976|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
14559977|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14559978|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14559979|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14559980|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14559981|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14559982|NCT00002680|Tamoxifen|tamoxifen|mesh-list
14559983|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
14559984|NCT00002680|Melphalan|melphalan|mesh-list
14559985|NCT00002680|Thiotepa|thiotepa|mesh-list
14559986|NCT00002680|Megestrol|megestrol|mesh-list
14559987|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
14559988|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14559989|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
14559990|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14559991|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14559992|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14559993|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
14559994|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14559995|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14559996|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14559997|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14559998|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
14559999|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560000|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560001|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14560002|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14560003|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14560004|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14560005|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14560006|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15088026|NCT02263352|Carotenoids|carotenoids|mesh-list
14560007|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
14560008|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560009|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14560010|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14560011|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
14560012|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14560013|NCT00002681|Aldesleukin|aldesleukin|mesh-list
14560014|NCT00002681|Daclizumab|daclizumab|mesh-list
14560015|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560016|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14560017|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14560018|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
14560019|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560020|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15088027|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
15088028|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088029|NCT02263352|Protective Agents|protective agents|mesh-ancestor
15088030|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088031|NCT02263495|Gemcitabine|gemcitabine|mesh-list
15088032|NCT02263495|Paclitaxel|paclitaxel|mesh-list
15088033|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15088034|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088035|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
15088036|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
15088037|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
15088038|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088039|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15088040|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
15088041|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
14560021|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
14560022|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560023|NCT00002682|Amoxicillin|amoxicillin|mesh-list
14560024|NCT00002682|Metronidazole|metronidazole|mesh-list
14560025|NCT00002682|Clarithromycin|clarithromycin|mesh-list
14560026|NCT00002682|Tetracycline|tetracycline|mesh-list
14560027|NCT00002682|Omeprazole|omeprazole|mesh-list
14560028|NCT00002682|Bismuth|bismuth|mesh-list
14809464|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809465|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809466|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14809467|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809468|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809469|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809470|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
14809471|NCT00833768|Sevelamer|sevelamer|mesh-list
14809472|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
14809473|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
14809474|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814242|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14814243|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814244|NCT00862043|Urological Agents|urological agents|mesh-ancestor
14814245|NCT00862095|Topiramate|topiramate|mesh-list
14814246|NCT00862095|Propranolol|propranolol|mesh-list
14814247|NCT00862095|Amitriptyline|amitriptyline|mesh-list
14814248|NCT00862095|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14814249|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14814250|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14814251|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814252|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814253|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814254|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814255|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14814256|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814257|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814258|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
14814259|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14814260|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14814261|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
14814262|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814263|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14814264|NCT00862095|Analgesics|analgesics|mesh-ancestor
14814265|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
14814266|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560029|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14560030|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643648|NCT00189878|Methotrexate|methotrexate|mesh-list
14560031|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560032|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14560033|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14560034|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14560035|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560036|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14560037|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560038|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560039|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14560040|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14560041|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14560042|NCT00002682|Antacids|antacids|mesh-ancestor
14560043|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
14560044|NCT00002684|Paclitaxel|paclitaxel|mesh-list
14560045|NCT00002684|Ifosfamide|ifosfamide|mesh-list
14560046|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560047|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560048|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560049|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560050|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
15088042|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088043|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088044|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15088045|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
15088046|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088047|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15088048|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15088049|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15088050|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15088051|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088052|NCT02263677|Incretins|incretins|mesh-ancestor
15088053|NCT02263677|Hormones|hormones|mesh-ancestor
15088054|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088055|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15088056|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
15088057|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088058|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268638|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15088059|NCT02263690|Lidocaine|lidocaine|mesh-list
15088060|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
15088061|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
15088062|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088063|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088064|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
15088065|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088066|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15088067|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15088068|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15088069|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088070|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088071|NCT02263872|Minocycline|minocycline|mesh-list
15088072|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15088073|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173159|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173160|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173161|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173162|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173163|NCT04007588|Nivolumab|nivolumab|mesh-list
15173164|NCT04007588|Ipilimumab|ipilimumab|mesh-list
15173165|NCT04007588|Linrodostat|linrodostat|mesh-list
15173166|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173167|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173168|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15173169|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173170|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173171|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
14268639|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268640|NCT00396656|Diuretics|diuretics|mesh-ancestor
14268641|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
14268642|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173172|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14268643|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14268644|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268645|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14268646|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
14268647|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
14268648|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268649|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14268650|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14268651|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14268652|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
14560051|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560052|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560053|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
14560054|NCT00002687|Aldesleukin|aldesleukin|mesh-list
14560055|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560056|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14560057|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14560058|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
14560059|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560060|NCT00002688|Cyclosporine|cyclosporine|mesh-list
14560061|NCT00002688|Etoposide|etoposide|mesh-list
14560062|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
14560063|NCT00002688|Cyclosporins|cyclosporins|mesh-list
14560064|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560065|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560066|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560067|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560068|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560069|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560070|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560071|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
14560072|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560073|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
14560074|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560075|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560076|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560077|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14560078|NCT00002688|Analgesics|analgesics|mesh-ancestor
14560079|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
14560080|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560081|NCT00002689|Dexamethasone|dexamethasone|mesh-list
14560082|NCT00002689|Fluorouracil|fluorouracil|mesh-list
14560083|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560084|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
14560085|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
14560086|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560087|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560088|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560089|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
14560090|NCT00002689|Hormones|hormones|mesh-ancestor
14560091|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560092|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560093|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560094|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
14560095|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560096|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560097|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560098|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
14560099|NCT00002691|Leucovorin|leucovorin|mesh-list
14560100|NCT00002691|Cytarabine|cytarabine|mesh-list
14560101|NCT00002691|Dexamethasone|dexamethasone|mesh-list
14560102|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
14560103|NCT00002691|Methotrexate|methotrexate|mesh-list
14560104|NCT00002691|Etoposide|etoposide|mesh-list
14560105|NCT00002691|Vincristine|vincristine|mesh-list
14560106|NCT00002691|Daunorubicin|daunorubicin|mesh-list
14560107|NCT00002691|Asparaginase|asparaginase|mesh-list
14560108|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
14560109|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560110|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
14560111|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268653|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14560112|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268654|NCT00396812|Rituximab|rituximab|mesh-list
14560113|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560114|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
14560115|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560116|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560117|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560118|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560119|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
14560120|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
14560121|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560122|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560123|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
14560124|NCT00002691|Hormones|hormones|mesh-ancestor
14560125|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560126|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560127|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560128|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560129|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560130|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560131|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
14560132|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560133|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560134|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560135|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560136|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560137|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560138|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560139|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
14560140|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560141|NCT00002691|Antidotes|antidotes|mesh-ancestor
14560142|NCT00002691|Protective Agents|protective agents|mesh-ancestor
14560143|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560144|NCT00002691|Vitamins|vitamins|mesh-ancestor
14560145|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
14560146|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560147|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560148|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560149|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560150|NCT00002692|Leucovorin|leucovorin|mesh-list
14560151|NCT00002692|Fluorouracil|fluorouracil|mesh-list
14560152|NCT00002692|Calcium|calcium|mesh-list
14560153|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
14560154|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14560155|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560156|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
14560157|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560158|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560159|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560160|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560161|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
14560162|NCT00002692|Antidotes|antidotes|mesh-ancestor
14560163|NCT00002692|Protective Agents|protective agents|mesh-ancestor
14560164|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560165|NCT00002692|Vitamins|vitamins|mesh-ancestor
14560166|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
14560167|NCT00002693|Carboplatin|carboplatin|mesh-list
14560168|NCT00002693|Topotecan|topotecan|mesh-list
14560169|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560170|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14560171|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560172|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560173|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560174|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
14560175|NCT00002696|Doxorubicin|doxorubicin|mesh-list
14560176|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560177|NCT00002696|Fluorouracil|fluorouracil|mesh-list
14560178|NCT00002696|Methotrexate|methotrexate|mesh-list
14560179|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560180|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
14560181|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560182|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560183|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560184|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
14560185|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560186|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560187|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15088074|NCT02263924|Tocotrienols|tocotrienols|mesh-list
14560188|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560189|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560190|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560191|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560192|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
14560193|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560194|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560195|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560196|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560197|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560198|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560199|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560200|NCT00002697|Carboplatin|carboplatin|mesh-list
14560201|NCT00002697|Etoposide|etoposide|mesh-list
14560202|NCT00002697|Ifosfamide|ifosfamide|mesh-list
14560203|NCT00002697|Sargramostim|sargramostim|mesh-list
14560204|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560205|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560206|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560207|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560208|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560209|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560210|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
14268655|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268656|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268657|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
14268658|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268659|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268660|NCT00396877|Clopidogrel|clopidogrel|mesh-list
14268661|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14560211|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560212|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560213|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
14560214|NCT00002700|Leucovorin|leucovorin|mesh-list
14560215|NCT00002700|Cytarabine|cytarabine|mesh-list
14560216|NCT00002700|Dexamethasone|dexamethasone|mesh-list
14560217|NCT00002700|Prednisone|prednisone|mesh-list
14560218|NCT00002700|Prednisolone|prednisolone|mesh-list
14560219|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
14560220|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14560221|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14560222|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14560223|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
14560224|NCT00002700|Doxorubicin|doxorubicin|mesh-list
14560225|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560226|NCT00002700|Methotrexate|methotrexate|mesh-list
14560227|NCT00002700|Vincristine|vincristine|mesh-list
14560228|NCT00002700|Daunorubicin|daunorubicin|mesh-list
14560229|NCT00002700|Asparaginase|asparaginase|mesh-list
14560230|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
14560231|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
14560232|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
14560233|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560234|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
14560235|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560236|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560237|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560238|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
14560239|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560240|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560241|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560242|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088075|NCT02263924|Vitamin E|vitamin e|mesh-list
15088076|NCT02263924|Tocopherols|tocopherols|mesh-list
15088077|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
15088078|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560243|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
14560244|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
14560245|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560246|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560247|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
14560248|NCT00002700|Hormones|hormones|mesh-ancestor
14560249|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560250|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560251|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14268662|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14560252|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560253|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560254|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560255|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15088079|NCT02263924|Protective Agents|protective agents|mesh-ancestor
14560256|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560257|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560258|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560259|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
14560260|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560261|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560262|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560263|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
14560264|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560265|NCT00002700|Antidotes|antidotes|mesh-ancestor
14560266|NCT00002700|Protective Agents|protective agents|mesh-ancestor
14560267|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560268|NCT00002700|Vitamins|vitamins|mesh-ancestor
14560269|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
14560270|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560271|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560272|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560273|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560274|NCT00002700|Analgesics|analgesics|mesh-ancestor
14560275|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
14560276|NCT00002701|Cytarabine|cytarabine|mesh-list
14560277|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
14560278|NCT00002701|Busulfan|busulfan|mesh-list
14560279|NCT00002701|Methotrexate|methotrexate|mesh-list
14560280|NCT00002701|Etoposide|etoposide|mesh-list
14560281|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
14560282|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
14560283|NCT00002701|Idarubicin|idarubicin|mesh-list
14560284|NCT00002701|Tretinoin|tretinoin|mesh-list
14560285|NCT00002701|Thioguanine|thioguanine|mesh-list
14560286|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560287|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
14560288|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560289|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560290|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560291|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
14560292|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560293|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560294|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560295|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560296|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560297|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560298|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560299|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
14560300|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560301|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560302|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560303|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560304|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560305|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560306|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560307|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
14560308|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560309|NCT00002701|Analgesics|analgesics|mesh-ancestor
14560310|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
14560311|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560312|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560313|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
14560314|NCT00002702|Aldesleukin|aldesleukin|mesh-list
14560315|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560316|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14560317|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14560318|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
14560319|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560320|NCT00002704|Leucovorin|leucovorin|mesh-list
14560321|NCT00002704|Cytarabine|cytarabine|mesh-list
14560322|NCT00002704|Dexamethasone|dexamethasone|mesh-list
14560323|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
14560324|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14560325|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14560326|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14560327|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
14560328|NCT00002704|Thiotepa|thiotepa|mesh-list
14560329|NCT00002704|Methotrexate|methotrexate|mesh-list
14560330|NCT00002704|Etoposide|etoposide|mesh-list
14560331|NCT00002704|Vincristine|vincristine|mesh-list
14560332|NCT00002704|Daunorubicin|daunorubicin|mesh-list
14560333|NCT00002704|Asparaginase|asparaginase|mesh-list
14560334|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
14560335|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
14560336|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560337|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
14560338|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560339|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560340|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560341|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
14560342|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560343|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560344|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560345|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560346|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
14560347|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
14560348|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560349|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560350|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
14560351|NCT00002704|Hormones|hormones|mesh-ancestor
14560352|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088080|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088081|NCT02263924|Vitamins|vitamins|mesh-ancestor
15088082|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
15088083|NCT02263950|Artemether|artemether|mesh-list
15088084|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
15088085|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15088086|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15088087|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088088|NCT02263976|Bromides|bromides|mesh-list
15088089|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
15088090|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
15088091|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15088092|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
15088093|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088094|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088095|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15088096|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
15088097|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
15088098|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15088099|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
15088100|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088101|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088102|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
15088103|NCT02263976|Miotics|miotics|mesh-ancestor
15088104|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15088105|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15088106|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15088107|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15088108|NCT02263989|Telmisartan|telmisartan|mesh-list
15088109|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088110|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15088111|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15088112|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088113|NCT02264002|Metoprolol|metoprolol|mesh-list
15088114|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15088115|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088116|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
15088117|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
15088118|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088119|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088120|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15088121|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15088122|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088123|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088124|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088125|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088126|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
15088127|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15088128|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088129|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15088130|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15088131|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088132|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088133|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088134|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15088135|NCT02264041|Itraconazole|itraconazole|mesh-list
15088136|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
15088137|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088138|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14560353|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560354|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560355|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560356|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560357|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560358|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
14560359|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560360|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560361|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560362|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560363|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560364|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15088139|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15088140|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088141|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088142|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15088143|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
15088144|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088145|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560365|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560366|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
14560367|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560368|NCT00002704|Antidotes|antidotes|mesh-ancestor
14560369|NCT00002704|Protective Agents|protective agents|mesh-ancestor
14560370|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560371|NCT00002704|Vitamins|vitamins|mesh-ancestor
14560372|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
14560373|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560374|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560375|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560376|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560377|NCT00002705|Topotecan|topotecan|mesh-list
14560378|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14560379|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560380|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560381|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560382|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560383|NCT00002707|Tamoxifen|tamoxifen|mesh-list
14560384|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
15088146|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15088147|NCT02264093|Propranolol|propranolol|mesh-list
15088148|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14560385|NCT00002707|Docetaxel|docetaxel|mesh-list
14560386|NCT00002707|Doxorubicin|doxorubicin|mesh-list
14560387|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560388|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
14560389|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560390|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560391|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560392|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
14560393|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560394|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560395|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560396|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560397|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560398|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560399|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560400|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560401|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560402|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560403|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14560404|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
14560405|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560406|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560407|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14560408|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14560409|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14560410|NCT00002711|Paclitaxel|paclitaxel|mesh-list
14560411|NCT00002711|Cisplatin|cisplatin|mesh-list
14560412|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560413|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560414|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560415|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560416|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560417|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560418|NCT00002714|Prednisone|prednisone|mesh-list
14560419|NCT00002714|Doxorubicin|doxorubicin|mesh-list
14560420|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560421|NCT00002714|Bleomycin|bleomycin|mesh-list
14560422|NCT00002714|Etoposide|etoposide|mesh-list
14560423|NCT00002714|Vincristine|vincristine|mesh-list
14560424|NCT00002714|Vinblastine|vinblastine|mesh-list
14560425|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
14560426|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560427|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560428|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560429|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560430|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560431|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560432|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560433|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
14560434|NCT00002714|Hormones|hormones|mesh-ancestor
14560435|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560436|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560437|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560438|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560439|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560440|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560441|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560442|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
14560443|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560444|NCT00002715|Prednisone|prednisone|mesh-list
14560445|NCT00002715|Doxorubicin|doxorubicin|mesh-list
14560446|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560447|NCT00002715|Bleomycin|bleomycin|mesh-list
14560448|NCT00002715|Etoposide|etoposide|mesh-list
14560449|NCT00002715|Vincristine|vincristine|mesh-list
14560450|NCT00002715|Vinblastine|vinblastine|mesh-list
14560451|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
14560452|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560453|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560454|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560455|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560456|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560457|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560458|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560459|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
14560460|NCT00002715|Hormones|hormones|mesh-ancestor
14560461|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560462|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560463|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560464|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560465|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560466|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560467|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560468|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
14560469|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560470|NCT00002716|Leucovorin|leucovorin|mesh-list
14560471|NCT00002716|Dexamethasone|dexamethasone|mesh-list
14560472|NCT00002716|Fluorouracil|fluorouracil|mesh-list
14560473|NCT00002716|Floxuridine|floxuridine|mesh-list
14560474|NCT00002716|Calcium|calcium|mesh-list
14560475|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
14560476|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560477|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
14560478|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
14560479|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560480|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560481|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560482|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
14560483|NCT00002716|Hormones|hormones|mesh-ancestor
14560484|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560485|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560486|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560487|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14560488|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
14560489|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560490|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560491|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560492|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
14560493|NCT00002716|Antidotes|antidotes|mesh-ancestor
15088149|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088150|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088151|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088152|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560494|NCT00002716|Protective Agents|protective agents|mesh-ancestor
14560495|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560496|NCT00002716|Vitamins|vitamins|mesh-ancestor
14560497|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
14560498|NCT00002717|Paclitaxel|paclitaxel|mesh-list
14560499|NCT00002717|Cisplatin|cisplatin|mesh-list
14560500|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560501|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560502|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560503|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560504|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560505|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560506|NCT00002718|Cytarabine|cytarabine|mesh-list
14560507|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
14560508|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
14560509|NCT00002718|Thiotepa|thiotepa|mesh-list
14560510|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14560511|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560512|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
14560513|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560514|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560515|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560516|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
14560517|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560518|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560519|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560520|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560521|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
14560522|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
14560523|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560524|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560525|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
14560526|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
14560527|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560528|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560529|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
14560530|NCT00002718|Hormones|hormones|mesh-ancestor
14560531|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560532|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14560533|NCT00002718|Protective Agents|protective agents|mesh-ancestor
14560534|NCT00002719|Cytarabine|cytarabine|mesh-list
14560535|NCT00002719|Etoposide|etoposide|mesh-list
14560536|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
14560537|NCT00002719|Idarubicin|idarubicin|mesh-list
14560538|NCT00002719|Carmustine|carmustine|mesh-list
14560539|NCT00002719|Amsacrine|amsacrine|mesh-list
14560540|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560541|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560542|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560543|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560544|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560545|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560546|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560547|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
14560548|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
14560549|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560550|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560551|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
14560552|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560553|NCT00002719|Analgesics|analgesics|mesh-ancestor
15088153|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088154|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15088155|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088156|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
15088157|NCT02264106|Pantoprazole|pantoprazole|mesh-list
15088158|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15088159|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15088160|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15088161|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088162|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560554|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
14560555|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560556|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560557|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560558|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
14560559|NCT00002720|Tamoxifen|tamoxifen|mesh-list
14560560|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14560561|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
14560562|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560563|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560564|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560565|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560566|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14560567|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14560568|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14560569|NCT00002721|Doxorubicin|doxorubicin|mesh-list
14560570|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560571|NCT00002721|Estramustine|estramustine|mesh-list
14560572|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560573|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560574|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560575|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560576|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560577|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560578|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560579|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
14560580|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560581|NCT00002722|Leucovorin|leucovorin|mesh-list
14560582|NCT00002722|Fluorouracil|fluorouracil|mesh-list
14560583|NCT00002722|Calcium|calcium|mesh-list
14560584|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
14560585|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560586|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14560587|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560588|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
14560589|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560590|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560591|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560592|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
14560593|NCT00002722|Antidotes|antidotes|mesh-ancestor
14560594|NCT00002722|Protective Agents|protective agents|mesh-ancestor
14560595|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560596|NCT00002722|Vitamins|vitamins|mesh-ancestor
14560597|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
14560598|NCT00002723|Suramin|suramin|mesh-list
14560599|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
14560600|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
14560601|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14560602|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560603|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560604|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15088163|NCT02264119|Pantoprazole|pantoprazole|mesh-list
15088164|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15088165|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15088166|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15088167|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088168|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088169|NCT02264132|Pramipexole|pramipexole|mesh-list
15088170|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
15088171|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560605|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14560606|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
14560607|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14560608|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
14560609|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560610|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560611|NCT00002730|Melphalan|melphalan|mesh-list
14560612|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
14560613|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560614|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
14560615|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560616|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088172|NCT02264132|Protective Agents|protective agents|mesh-ancestor
14560617|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560618|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560619|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
14560620|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560621|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
14560622|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560623|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560624|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14560625|NCT00002730|Protective Agents|protective agents|mesh-ancestor
14560626|NCT00002733|Interferons|interferons|mesh-list
14560627|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
14560628|NCT00002733|Aldesleukin|aldesleukin|mesh-list
14560629|NCT00002733|Cimetidine|cimetidine|mesh-list
14560630|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560631|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
14560632|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560633|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
14560634|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809475|NCT00833807|Paclitaxel|paclitaxel|mesh-list
14809476|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14809477|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14809478|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809479|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14809480|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14809481|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14809482|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809483|NCT00833963|Trastuzumab|trastuzumab|mesh-list
14809484|NCT00833963|Pertuzumab|pertuzumab|mesh-list
14809485|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14809486|NCT00833963|Maytansine|maytansine|mesh-list
14809487|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14809488|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809489|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14809490|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
14809491|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
14809492|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
14809493|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809494|NCT00834093|Vaccines|vaccines|mesh-list
14809495|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
14809496|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809497|NCT00834184|Nikkomycin|nikkomycin|mesh-list
14809498|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
14809499|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809500|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809501|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809502|NCT00834262|Insulin|insulin|mesh-list
14809503|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14809504|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
14809505|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
14809506|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14809507|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
14809508|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14809509|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14809510|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809511|NCT00834379|Pravastatin|pravastatin|mesh-list
14809512|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14809513|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14809514|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
14809515|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809516|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14809517|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14809518|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809519|NCT00834457|Ritonavir|ritonavir|mesh-list
14809520|NCT00834457|Lopinavir|lopinavir|mesh-list
14809521|NCT00834457|Zidovudine|zidovudine|mesh-list
14809522|NCT00834457|Lamivudine|lamivudine|mesh-list
14809523|NCT00834457|Abacavir|abacavir|mesh-list
14809524|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
14809525|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14809526|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14809527|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
14560635|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14560636|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14809528|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809529|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560637|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14560638|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560639|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14560640|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
14560641|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
14560642|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14560643|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560644|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14560645|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14560646|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560647|NCT00002734|Interferons|interferons|mesh-list
14560648|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
14560649|NCT00002734|Paclitaxel|paclitaxel|mesh-list
14560650|NCT00002734|Topotecan|topotecan|mesh-list
14560651|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14560652|NCT00002734|Antibodies|antibodies|mesh-list
14560653|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
14560654|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14560655|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560656|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560657|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560658|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560659|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560660|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560661|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
14560662|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560663|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
14560664|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560665|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14560666|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560667|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560668|NCT00002735|Cobalt|cobalt|mesh-list
14560669|NCT00002735|Cisplatin|cisplatin|mesh-list
14560670|NCT00002735|Fluorouracil|fluorouracil|mesh-list
14560671|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560672|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
14560673|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560674|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560675|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560676|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
14560677|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560678|NCT00002735|Trace Elements|trace elements|mesh-ancestor
14560679|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
14560680|NCT00002737|Interferons|interferons|mesh-list
14560681|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
14560682|NCT00002737|Isotretinoin|isotretinoin|mesh-list
14560683|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560684|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
14560685|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560686|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
14560687|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560688|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560689|NCT00002738|Leucovorin|leucovorin|mesh-list
14560690|NCT00002738|Trimetrexate|trimetrexate|mesh-list
14560691|NCT00002738|Calcium|calcium|mesh-list
14560692|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
14560693|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14560694|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560695|NCT00002738|Antidotes|antidotes|mesh-ancestor
14560696|NCT00002738|Protective Agents|protective agents|mesh-ancestor
14560697|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560698|NCT00002738|Vitamins|vitamins|mesh-ancestor
14560699|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
14560700|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
14560701|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560702|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560703|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
14560704|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560705|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560706|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560707|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560708|NCT00002740|Cobalt|cobalt|mesh-list
14560709|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
14560710|NCT00002740|Carboplatin|carboplatin|mesh-list
14560711|NCT00002740|Doxorubicin|doxorubicin|mesh-list
14560712|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560713|NCT00002740|Etoposide|etoposide|mesh-list
14560714|NCT00002740|Vincristine|vincristine|mesh-list
14560715|NCT00002740|Lenograstim|lenograstim|mesh-list
14560716|NCT00002740|Mesna|mesna|mesh-list
14560717|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560718|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
14560719|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560720|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560721|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560722|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
14560723|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560724|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560725|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560726|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560727|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560728|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560729|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560730|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560731|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14560732|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560733|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560734|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560735|NCT00002740|Protective Agents|protective agents|mesh-ancestor
14560736|NCT00002740|Trace Elements|trace elements|mesh-ancestor
14560737|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
14560738|NCT00002742|Amphotericin B|amphotericin b|mesh-list
14560739|NCT00002742|Nystatin|nystatin|mesh-list
14560740|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14560741|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14560742|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
14560743|NCT00002742|Amebicides|amebicides|mesh-ancestor
14560744|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14560745|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14560746|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560747|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14560748|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
14560749|NCT00002742|Ionophores|ionophores|mesh-ancestor
14560750|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14560751|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560752|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14560753|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560754|NCT00002744|Cobalt|cobalt|mesh-list
14560755|NCT00002744|Cytarabine|cytarabine|mesh-list
14560756|NCT00002744|Dexamethasone|dexamethasone|mesh-list
14560757|NCT00002744|Prednisone|prednisone|mesh-list
14560758|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
14560759|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14560760|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14560761|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14560762|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
14560763|NCT00002744|Doxorubicin|doxorubicin|mesh-list
14560764|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560765|NCT00002744|Methotrexate|methotrexate|mesh-list
14560766|NCT00002744|Vincristine|vincristine|mesh-list
14560767|NCT00002744|Daunorubicin|daunorubicin|mesh-list
15088173|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088174|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15088175|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15088176|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
15088177|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
15088178|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088179|NCT02264145|Norflurane|norflurane|mesh-list
15088180|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15088181|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
15088182|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088183|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088184|NCT02264158|Telmisartan|telmisartan|mesh-list
15088185|NCT02264158|Lacidipine|lacidipine|mesh-list
15088186|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088187|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15088188|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15088189|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088190|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15088191|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088192|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15088193|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560768|NCT00002744|Asparaginase|asparaginase|mesh-list
14560769|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
14560770|NCT00002744|Pegaspargase|pegaspargase|mesh-list
14560771|NCT00002744|Thioguanine|thioguanine|mesh-list
14560772|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560773|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
14560774|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560775|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560776|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560777|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
14560778|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560779|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560780|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560781|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560782|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
14560783|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
14560784|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560785|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14560786|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
14560787|NCT00002744|Hormones|hormones|mesh-ancestor
14560788|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560789|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560790|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560791|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560792|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560793|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560794|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560795|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560796|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560797|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560798|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
14560799|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560800|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560801|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560802|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
14560803|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560804|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560805|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560806|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560807|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560808|NCT00002744|Trace Elements|trace elements|mesh-ancestor
14560809|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
14560810|NCT00002746|Aldesleukin|aldesleukin|mesh-list
14560811|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560812|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14560813|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14560814|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
14560815|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560816|NCT00002747|Cobalt|cobalt|mesh-list
14560817|NCT00002747|Fluorouracil|fluorouracil|mesh-list
14560818|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560819|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
14560820|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560821|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560822|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560823|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
14560824|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560825|NCT00002747|Trace Elements|trace elements|mesh-ancestor
14560826|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
14560827|NCT00002748|Interleukin-2|interleukin-2|mesh-list
14560828|NCT00002748|Vaccines|vaccines|mesh-list
14560829|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560830|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14560831|NCT00002748|Analgesics|analgesics|mesh-ancestor
14560832|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
14560833|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14560834|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560835|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
14560836|NCT00002749|Carboplatin|carboplatin|mesh-list
14560837|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560838|NCT00002750|Melphalan|melphalan|mesh-list
14560839|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560840|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
14560841|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560842|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560843|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560844|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560845|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
15088194|NCT02264171|Ketoconazole|ketoconazole|mesh-list
14560846|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560847|NCT00002751|Antibodies|antibodies|mesh-list
14560848|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14560849|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
14560850|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560851|NCT00002752|Antibodies|antibodies|mesh-list
14560852|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14560853|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
14560854|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560855|NCT00002753|Antibodies|antibodies|mesh-list
14560856|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14560857|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
14560858|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560859|NCT00002754|Antibodies|antibodies|mesh-list
14560860|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14560861|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
14560862|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560863|NCT00002755|Tamoxifen|tamoxifen|mesh-list
14560864|NCT00002755|Cobalt|cobalt|mesh-list
14560865|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
14560866|NCT00002755|Thiotepa|thiotepa|mesh-list
14560867|NCT00002755|Doxorubicin|doxorubicin|mesh-list
14560868|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560869|NCT00002755|Fluorouracil|fluorouracil|mesh-list
14560870|NCT00002755|Methotrexate|methotrexate|mesh-list
14560871|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560872|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
14560873|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560874|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560875|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560876|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
14560877|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560878|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560879|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560880|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560881|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560882|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560883|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560884|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
14560885|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560886|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560887|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560888|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560889|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560890|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560891|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560892|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14560893|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14560894|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560895|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560896|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14560897|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14560898|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14560899|NCT00002755|Trace Elements|trace elements|mesh-ancestor
14560900|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
14560901|NCT00002756|Leucovorin|leucovorin|mesh-list
14560902|NCT00002756|Cytarabine|cytarabine|mesh-list
14560903|NCT00002756|Prednisone|prednisone|mesh-list
14560904|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
14560905|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14560906|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14560907|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14560908|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
14560909|NCT00002756|Methotrexate|methotrexate|mesh-list
14560910|NCT00002756|Etoposide|etoposide|mesh-list
14560911|NCT00002756|Vincristine|vincristine|mesh-list
14560912|NCT00002756|Daunorubicin|daunorubicin|mesh-list
14560913|NCT00002756|Asparaginase|asparaginase|mesh-list
14560914|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
14560915|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
14560916|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560917|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
14560918|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560919|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560920|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15088195|NCT02264171|Tamsulosin|tamsulosin|mesh-list
14560921|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
14560922|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560923|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560924|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560925|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560926|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
14560927|NCT00002756|Hormones|hormones|mesh-ancestor
14560928|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560929|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560930|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560931|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560932|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560933|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560934|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
14560935|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560936|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560937|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560938|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560939|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560940|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560941|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560942|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
14560943|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560944|NCT00002756|Antidotes|antidotes|mesh-ancestor
14560945|NCT00002756|Protective Agents|protective agents|mesh-ancestor
14560946|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
14560947|NCT00002756|Vitamins|vitamins|mesh-ancestor
14560948|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
14560949|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560950|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560951|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560952|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560953|NCT00002757|Cytarabine|cytarabine|mesh-list
14560954|NCT00002757|Prednisone|prednisone|mesh-list
14560955|NCT00002757|Prednisolone|prednisolone|mesh-list
14560956|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
14560957|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14560958|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14560959|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14560960|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
14560961|NCT00002757|Doxorubicin|doxorubicin|mesh-list
14560962|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14560963|NCT00002757|Methotrexate|methotrexate|mesh-list
14560964|NCT00002757|Etoposide|etoposide|mesh-list
14560965|NCT00002757|Vincristine|vincristine|mesh-list
14560966|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14560967|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
14560968|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14560969|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14560970|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14560971|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
14560972|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14560973|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14560974|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14560975|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14560976|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14560977|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14560978|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14560979|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14560980|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
14560981|NCT00002757|Hormones|hormones|mesh-ancestor
14560982|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14560983|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14560984|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14560985|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
14560986|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14560987|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14560988|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
14560989|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
14560990|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14560991|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14560992|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14560993|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
14560994|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14560995|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
14560996|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
14560997|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
14560998|NCT00002759|Cyclosporine|cyclosporine|mesh-list
14809530|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14560999|NCT00002759|Irinotecan|irinotecan|mesh-list
14561000|NCT00002759|Phenobarbital|phenobarbital|mesh-list
14561001|NCT00002759|Cyclosporins|cyclosporins|mesh-list
14561002|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14561003|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561004|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561005|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561006|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561007|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561008|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
14561009|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561010|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
14561011|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561012|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561013|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561014|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14561015|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
14561016|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14561017|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14561018|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14561019|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14561020|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14561021|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
14561022|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
14561023|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14561024|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14561025|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14561026|NCT00002760|Ketoconazole|ketoconazole|mesh-list
14561027|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
14561028|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14561029|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14561030|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14561031|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
14561032|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561033|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
14561034|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561035|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14561036|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14561037|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561038|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561039|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14561040|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
14561041|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561042|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561043|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14561044|NCT00002761|Interferons|interferons|mesh-list
14561045|NCT00002761|Cytarabine|cytarabine|mesh-list
14561046|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
14561047|NCT00002761|Cyclosporine|cyclosporine|mesh-list
14561048|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
14561049|NCT00002761|Busulfan|busulfan|mesh-list
14561050|NCT00002761|Idarubicin|idarubicin|mesh-list
14561051|NCT00002761|Cyclosporins|cyclosporins|mesh-list
14561052|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561053|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
14561054|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561055|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561056|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561057|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
14561058|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561059|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561060|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561061|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
14561062|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088196|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15088197|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15088198|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088199|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088200|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088201|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088202|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088203|NCT02264171|Urological Agents|urological agents|mesh-ancestor
15088204|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
15088205|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561063|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561064|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
14561065|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561066|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
14561067|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561068|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14561069|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561070|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561071|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561072|NCT00002763|Interferons|interferons|mesh-list
14561073|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
14561074|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561075|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
14561076|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561077|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
14561078|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561079|NCT00002764|Doxorubicin|doxorubicin|mesh-list
14561080|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561081|NCT00002764|Ifosfamide|ifosfamide|mesh-list
14561082|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561083|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561084|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561085|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15088206|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15088207|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15088208|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088209|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15088210|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
15088211|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088212|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14561086|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561087|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561088|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561089|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
14561090|NCT00002765|Immunotoxins|immunotoxins|mesh-list
14561091|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
14561092|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561093|NCT00002767|Interferons|interferons|mesh-list
14561094|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
14561095|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
14561096|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561097|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
14561098|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561099|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
14561100|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561101|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14561102|NCT00002768|Cytarabine|cytarabine|mesh-list
14561103|NCT00002768|Methotrexate|methotrexate|mesh-list
14561104|NCT00002768|Etoposide|etoposide|mesh-list
14561105|NCT00002768|Busulfan|busulfan|mesh-list
14561106|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561107|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561108|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561109|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561110|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561111|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
14561112|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561113|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561114|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561115|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561116|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561117|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561118|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
14561119|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561120|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561121|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561122|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561123|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561124|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
14561125|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561126|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
14561127|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561128|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561129|NCT00002771|Interferons|interferons|mesh-list
14561130|NCT00002771|Cytarabine|cytarabine|mesh-list
14561131|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
14561132|NCT00002771|Busulfan|busulfan|mesh-list
14561133|NCT00002771|Idarubicin|idarubicin|mesh-list
14561134|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
14561135|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561136|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
14561137|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561138|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561139|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
14561140|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561141|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561142|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
14561143|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561144|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
14561145|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561146|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561147|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561148|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561149|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561150|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561151|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
14561152|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561153|NCT00002772|Tamoxifen|tamoxifen|mesh-list
14561154|NCT00002772|Paclitaxel|paclitaxel|mesh-list
14561155|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
14561156|NCT00002772|Carboplatin|carboplatin|mesh-list
14561157|NCT00002772|Doxorubicin|doxorubicin|mesh-list
14561158|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561159|NCT00002772|Thiotepa|thiotepa|mesh-list
14561160|NCT00002772|Carmustine|carmustine|mesh-list
14561161|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561162|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561163|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561164|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561165|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561166|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561167|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561168|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
14561169|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561170|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561171|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561172|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
14561173|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561174|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561175|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561176|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561177|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561178|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14561179|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
14561180|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561181|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561182|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14561183|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14561184|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14561185|NCT00002773|Interferons|interferons|mesh-list
14561186|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
14561187|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
14561188|NCT00002773|Sargramostim|sargramostim|mesh-list
14561189|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561190|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
14561191|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561192|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561193|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561194|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
14561195|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561196|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561197|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561198|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
15088213|NCT02264184|Paroxetine|paroxetine|mesh-list
15088214|NCT02264184|Tamsulosin|tamsulosin|mesh-list
14561199|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561200|NCT00002774|Cisplatin|cisplatin|mesh-list
14561201|NCT00002774|Fluorouracil|fluorouracil|mesh-list
14561202|NCT00002774|Tirapazamine|tirapazamine|mesh-list
14561203|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561204|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
14561205|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561206|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561207|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561208|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
14561209|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561210|NCT00002775|Docetaxel|docetaxel|mesh-list
14561211|NCT00002775|Estramustine|estramustine|mesh-list
14561212|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561213|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561214|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561215|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561216|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561217|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561218|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
14561219|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561220|NCT00002777|Tamoxifen|tamoxifen|mesh-list
14561221|NCT00002777|Exemestane|exemestane|mesh-list
14561222|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561223|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14561224|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
14561225|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561226|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561227|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561228|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561229|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14561230|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14561231|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15088215|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15088216|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15088217|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088218|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088219|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088220|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
15088221|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088222|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15088223|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
15088224|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15088225|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15088226|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15088227|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088228|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15088229|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15088230|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088231|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088232|NCT02264184|Urological Agents|urological agents|mesh-ancestor
15088233|NCT02264236|Vaccines|vaccines|mesh-list
15088234|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
15088235|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088236|NCT02264301|Puerarin|puerarin|mesh-list
15088237|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
15088238|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
15088239|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15088240|NCT02264561|Caffeine|caffeine|mesh-list
15088241|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15088242|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088243|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15088244|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088245|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088246|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15088247|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15088248|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
15088249|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088250|NCT02264587|Domperidone|domperidone|mesh-list
15088251|NCT02264587|Mosapride|mosapride|mesh-list
15088252|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
15088253|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
15088254|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561232|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14561233|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14561234|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561235|NCT00002778|Sargramostim|sargramostim|mesh-list
14561236|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
14561237|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561238|NCT00002779|Fludarabine|fludarabine|mesh-list
14561239|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
14561240|NCT00002779|Octreotide|octreotide|mesh-list
14561241|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561242|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561243|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
14561244|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561245|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561246|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
14561247|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561248|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14561249|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561250|NCT00002780|Aldesleukin|aldesleukin|mesh-list
14561251|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
14561252|NCT00002780|Thiotepa|thiotepa|mesh-list
14561253|NCT00002780|Carboplatin|carboplatin|mesh-list
14561254|NCT00002780|Sargramostim|sargramostim|mesh-list
14561255|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561256|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
14561257|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561258|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561259|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561260|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
14561261|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561262|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561263|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561264|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14561265|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14561266|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
14561267|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561268|NCT00002783|Leucovorin|leucovorin|mesh-list
14561269|NCT00002783|Fluorouracil|fluorouracil|mesh-list
14561270|NCT00002783|Floxuridine|floxuridine|mesh-list
14561271|NCT00002783|Calcium|calcium|mesh-list
14561272|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
14561273|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561274|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14561275|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561276|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
14561277|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561278|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561279|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561280|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
14561281|NCT00002783|Antidotes|antidotes|mesh-ancestor
14561282|NCT00002783|Protective Agents|protective agents|mesh-ancestor
14561283|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
14561284|NCT00002783|Vitamins|vitamins|mesh-ancestor
14561285|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
14561286|NCT00002784|Tamoxifen|tamoxifen|mesh-list
14561287|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
14561288|NCT00002784|Doxorubicin|doxorubicin|mesh-list
14561289|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561290|NCT00002784|Fluorouracil|fluorouracil|mesh-list
14561291|NCT00002784|Methotrexate|methotrexate|mesh-list
14561292|NCT00002784|Epirubicin|epirubicin|mesh-list
14561293|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561294|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
14561295|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561296|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561297|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561298|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
14561299|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561300|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561301|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561302|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561303|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561304|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561305|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561306|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
14561307|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561308|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561309|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561310|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561311|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561312|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561313|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561314|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14561315|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
14561316|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561317|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561318|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14561319|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14561320|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14561321|NCT00002785|Leucovorin|leucovorin|mesh-list
14561322|NCT00002785|Cobalt|cobalt|mesh-list
14561323|NCT00002785|Cytarabine|cytarabine|mesh-list
14561324|NCT00002785|Cyclosporine|cyclosporine|mesh-list
14561325|NCT00002785|Dexamethasone|dexamethasone|mesh-list
14561326|NCT00002785|Prednisone|prednisone|mesh-list
14561327|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
14561328|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
14561329|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14561330|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14561331|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14561332|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
14561333|NCT00002785|Methotrexate|methotrexate|mesh-list
14561334|NCT00002785|Etoposide|etoposide|mesh-list
14561335|NCT00002785|Vincristine|vincristine|mesh-list
14561336|NCT00002785|Daunorubicin|daunorubicin|mesh-list
14561337|NCT00002785|Asparaginase|asparaginase|mesh-list
14561338|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
14561339|NCT00002785|Pegaspargase|pegaspargase|mesh-list
14561340|NCT00002785|Cyclosporins|cyclosporins|mesh-list
14561341|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
14561342|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561343|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
14561344|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561345|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561346|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561347|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
14561348|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561349|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561350|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561351|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561352|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
14561353|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
14561354|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561355|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14561356|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
14561357|NCT00002785|Hormones|hormones|mesh-ancestor
14561358|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561359|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561360|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561361|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561362|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561363|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268663|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14268664|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14268665|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
14268666|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268667|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561364|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
14561365|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561366|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561367|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561368|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561369|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14809531|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14809532|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
14809533|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561370|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561371|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561372|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
14561373|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561374|NCT00002785|Antidotes|antidotes|mesh-ancestor
14561375|NCT00002785|Protective Agents|protective agents|mesh-ancestor
14561376|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
14561377|NCT00002785|Vitamins|vitamins|mesh-ancestor
14561378|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
14561379|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561380|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561381|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561382|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
14561383|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14561384|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14561385|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561386|NCT00002785|Trace Elements|trace elements|mesh-ancestor
14561387|NCT00002786|Aldesleukin|aldesleukin|mesh-list
14561388|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561389|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14561390|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14561391|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
14561392|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561393|NCT00002787|Aldesleukin|aldesleukin|mesh-list
14561394|NCT00002787|Interleukin-2|interleukin-2|mesh-list
14561395|NCT00002787|Vaccines|vaccines|mesh-list
14561396|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
14561397|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14561398|NCT00002787|Antibodies|antibodies|mesh-list
14561399|NCT00002787|Sargramostim|sargramostim|mesh-list
14561400|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14561401|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14561402|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
14561403|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561404|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561405|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14561406|NCT00002787|Analgesics|analgesics|mesh-ancestor
14561407|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
14561408|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561409|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14561410|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14561411|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
14561412|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561413|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14561414|NCT00002788|Dexamethasone|dexamethasone|mesh-list
14561415|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
14561416|NCT00002788|Etoposide|etoposide|mesh-list
14268668|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268669|NCT00397020|Valproic Acid|valproic acid|mesh-list
14561417|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561418|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
14561419|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561420|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561421|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561422|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
14561423|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561424|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561425|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561426|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561427|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
14561428|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
14561429|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561430|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14561431|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
14561432|NCT00002788|Hormones|hormones|mesh-ancestor
14561433|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561434|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561435|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561436|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561437|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561438|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561439|NCT00002789|Cyclosporine|cyclosporine|mesh-list
14561440|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
14561441|NCT00002789|Busulfan|busulfan|mesh-list
14561442|NCT00002789|Methotrexate|methotrexate|mesh-list
14561443|NCT00002789|Cyclosporins|cyclosporins|mesh-list
14561444|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561445|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
14561446|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561447|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561448|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561449|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
14561450|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561451|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561452|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561453|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561454|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561455|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561456|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561457|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
14561458|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561459|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561460|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561461|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561462|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
14561463|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561464|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14561465|NCT00002790|Cyclosporine|cyclosporine|mesh-list
14561466|NCT00002790|Sirolimus|sirolimus|mesh-list
14561467|NCT00002790|Methotrexate|methotrexate|mesh-list
14561468|NCT00002790|Cyclosporins|cyclosporins|mesh-list
14561469|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561470|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561471|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561472|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561473|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561474|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
14561475|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561476|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561477|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561478|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561479|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561480|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561481|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
14561482|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561483|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561484|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
14561485|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561486|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14561487|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14561488|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561489|NCT00002791|Doxorubicin|doxorubicin|mesh-list
14561490|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561491|NCT00002791|Ifosfamide|ifosfamide|mesh-list
14561492|NCT00002791|Dacarbazine|dacarbazine|mesh-list
14561493|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561494|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561495|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15088255|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088256|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15088257|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15088258|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
15088259|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088260|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088261|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15088262|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
15088263|NCT02264626|Remifentanil|remifentanil|mesh-list
15088264|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15088265|NCT02264626|Narcotics|narcotics|mesh-ancestor
15088266|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088267|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088268|NCT02264626|Analgesics|analgesics|mesh-ancestor
15088269|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
15088270|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088271|NCT02264665|Everolimus|everolimus|mesh-list
15088272|NCT02264665|Sunitinib|sunitinib|mesh-list
15088273|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088274|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15088275|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
15088276|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088277|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15088278|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15088279|NCT02264665|Growth Substances|growth substances|mesh-ancestor
15088280|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
14561496|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561497|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561498|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561499|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561500|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
14561501|NCT00002792|Cyclosporine|cyclosporine|mesh-list
14561502|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
14561503|NCT00002792|Busulfan|busulfan|mesh-list
14561504|NCT00002792|Methotrexate|methotrexate|mesh-list
14561505|NCT00002792|Tacrolimus|tacrolimus|mesh-list
14561506|NCT00002792|Cyclosporins|cyclosporins|mesh-list
14561507|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561508|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
14561509|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561510|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561511|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561512|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
14561513|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561514|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561515|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561516|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561517|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561518|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561519|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561520|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
14561521|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561522|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561523|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561524|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561525|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14561526|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
14561527|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561528|NCT00002793|Leucovorin|leucovorin|mesh-list
14561529|NCT00002793|Fluorouracil|fluorouracil|mesh-list
14561530|NCT00002793|Calcium|calcium|mesh-list
14561531|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
14561532|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14561533|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561534|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
14561535|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561536|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561537|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561538|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561539|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
14561540|NCT00002793|Antidotes|antidotes|mesh-ancestor
14561541|NCT00002793|Protective Agents|protective agents|mesh-ancestor
14561542|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
14561543|NCT00002793|Vitamins|vitamins|mesh-ancestor
14561544|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
14561545|NCT00002794|Carboplatin|carboplatin|mesh-list
14561546|NCT00002794|Vincristine|vincristine|mesh-list
14561547|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561548|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561549|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561550|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561551|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561552|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561553|NCT00002796|Interferons|interferons|mesh-list
14561554|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
14561555|NCT00002796|Indomethacin|indomethacin|mesh-list
14561556|NCT00002796|Fluorouracil|fluorouracil|mesh-list
14561557|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14561558|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
14561559|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561560|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561561|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561562|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561563|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
14561564|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561565|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
14561566|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561567|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14561568|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14561569|NCT00002796|Analgesics|analgesics|mesh-ancestor
14561570|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
13996154|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561571|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561572|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561573|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561574|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
14561575|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
14561576|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561577|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14561578|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561579|NCT00002798|Cytarabine|cytarabine|mesh-list
14561580|NCT00002798|Aldesleukin|aldesleukin|mesh-list
14561581|NCT00002798|Dexamethasone|dexamethasone|mesh-list
14561582|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
14561583|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14561584|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14561585|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14561586|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
14561587|NCT00002798|Busulfan|busulfan|mesh-list
14561588|NCT00002798|Methotrexate|methotrexate|mesh-list
14561589|NCT00002798|Fludarabine|fludarabine|mesh-list
14561590|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
14561591|NCT00002798|Etoposide|etoposide|mesh-list
15088281|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15088282|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088283|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088284|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15088285|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15088286|NCT02264743|Estradiol|estradiol|mesh-list
15088287|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14268670|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14561592|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
14561593|NCT00002798|Daunorubicin|daunorubicin|mesh-list
14561594|NCT00002798|Interleukin-2|interleukin-2|mesh-list
14561595|NCT00002798|Asparaginase|asparaginase|mesh-list
14561596|NCT00002798|Idarubicin|idarubicin|mesh-list
14561597|NCT00002798|Thioguanine|thioguanine|mesh-list
14561598|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561599|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
14561600|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561601|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561602|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561603|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
14561604|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561605|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561606|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561607|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561608|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
14561609|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
14561610|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561611|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14561612|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
14561613|NCT00002798|Hormones|hormones|mesh-ancestor
14561614|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561615|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561616|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561617|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561618|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561619|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561620|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
14561621|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561622|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561623|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561624|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561625|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561626|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561627|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561628|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
14561629|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561630|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561631|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14561632|NCT00002798|Analgesics|analgesics|mesh-ancestor
14561633|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
14561634|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14561635|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14809534|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14809535|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14809536|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
14809537|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14809538|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14643649|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14643650|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561636|NCT00002800|Cytarabine|cytarabine|mesh-list
14561637|NCT00002800|Etoposide|etoposide|mesh-list
14561638|NCT00002800|Idarubicin|idarubicin|mesh-list
14561639|NCT00002800|Lintuzumab|lintuzumab|mesh-list
14561640|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561641|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561642|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561643|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561644|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561645|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561646|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561647|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
14561648|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
14561649|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561650|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561651|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
14809539|NCT00834470|Atropine|atropine|mesh-list
14809540|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14809541|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14809542|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14809543|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
14809544|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809545|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809546|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14809547|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
14809548|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
14809549|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
14809550|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14809551|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14809552|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
14809553|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809554|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809555|NCT00834600|Amlodipine|amlodipine|mesh-list
14809556|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14809557|NCT00834600|Olmesartan|olmesartan|mesh-list
14809558|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14809559|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14809560|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14809561|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809562|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809563|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14809564|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809565|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
14809566|NCT00834600|Diuretics|diuretics|mesh-ancestor
14809567|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
14809568|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14809569|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14809570|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14809571|NCT00834665|Molgramostim|molgramostim|mesh-list
14809572|NCT00834665|Sargramostim|sargramostim|mesh-list
14809573|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
14809574|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809575|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809576|NCT00834730|Ketamine|ketamine|mesh-list
14809577|NCT00834730|Analgesics|analgesics|mesh-ancestor
14809578|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
14809579|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809580|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809581|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14809582|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14809583|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
14809584|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
14809585|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809586|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14809587|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14809588|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809589|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088288|NCT02264743|Estrogens|estrogens|mesh-ancestor
15088289|NCT02264743|Hormones|hormones|mesh-ancestor
15088290|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088291|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088292|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15088293|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
14561652|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561653|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15088294|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15088295|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15088296|NCT02264769|Carbetocin|carbetocin|mesh-list
15088297|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
15088298|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15088299|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088300|NCT02264795|Lidocaine|lidocaine|mesh-list
15088301|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
14809590|NCT00834847|Pravastatin|pravastatin|mesh-list
14809591|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14809592|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14809593|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
14809594|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809595|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14809596|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14809597|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809598|NCT00834860|Ribavirin|ribavirin|mesh-list
14809599|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14809600|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
14809601|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088302|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
15088303|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088304|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088305|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
15088306|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088307|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15088308|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14809602|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
14809603|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809604|NCT00834925|Diltiazem|diltiazem|mesh-list
14809605|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14809606|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14809607|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809608|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809609|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14809610|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809611|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
14809612|NCT00835029|Clotrimazole|clotrimazole|mesh-list
14809613|NCT00835029|Miconazole|miconazole|mesh-list
14809614|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14809615|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809616|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
15088309|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15088310|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088311|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088312|NCT02264834|Sufentanil|sufentanil|mesh-list
15088313|NCT02264834|Dsuvia|dsuvia|mesh-list
15088314|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
15088315|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
15088316|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
15088317|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088318|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088319|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
15088320|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088321|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15088322|NCT02264834|Narcotics|narcotics|mesh-ancestor
15088323|NCT02264834|Analgesics|analgesics|mesh-ancestor
15088324|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15088325|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15088326|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
15088327|NCT02264847|Clomiphene|clomiphene|mesh-list
15088328|NCT02264847|Enclomiphene|enclomiphene|mesh-list
15088329|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
15088330|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15088331|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15088332|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
15088333|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088334|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088335|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15088336|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
15088337|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15088338|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15088339|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15088340|NCT02264873|Decitabine|decitabine|mesh-list
15088341|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15088342|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
15088343|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088344|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088345|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088346|NCT02264912|Clopidogrel|clopidogrel|mesh-list
15088347|NCT02264912|Ticagrelor|ticagrelor|mesh-list
15088348|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15088349|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14809617|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14809618|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14809619|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809620|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809621|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14809622|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
14809623|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809624|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809625|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15088350|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15088351|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15088352|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15088353|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
15088354|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088355|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088356|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809626|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14809627|NCT00835107|Ziprasidone|ziprasidone|mesh-list
14809628|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14809629|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
14809630|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809631|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809632|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809633|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14809634|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14809635|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809636|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809637|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14809638|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
14809639|NCT00835393|Pantoprazole|pantoprazole|mesh-list
14809640|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14809641|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809642|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14809643|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809644|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809645|NCT00835471|Docetaxel|docetaxel|mesh-list
14809646|NCT00835471|Pemetrexed|pemetrexed|mesh-list
14809647|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14809648|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809649|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14809650|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14809651|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14809652|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809653|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809654|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14809655|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14809656|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14809657|NCT00835627|Sertraline|sertraline|mesh-list
14809658|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
14809659|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809660|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14809661|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14809662|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809663|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809664|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809665|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
14809666|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809667|NCT00835744|Clomiphene|clomiphene|mesh-list
14809668|NCT00835744|Enclomiphene|enclomiphene|mesh-list
14809669|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
14809670|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14809671|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
14809672|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809673|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809674|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14809675|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
14809676|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14809677|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14809678|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14809679|NCT00835848|Exenatide|exenatide|mesh-list
14809680|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14809681|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809682|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14809683|NCT00835848|Incretins|incretins|mesh-ancestor
14809684|NCT00835848|Hormones|hormones|mesh-ancestor
14809685|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809686|NCT00835939|Lidocaine|lidocaine|mesh-list
14809687|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
15088357|NCT02264938|Antioxidants|antioxidants|mesh-list
15088358|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088359|NCT02264938|Protective Agents|protective agents|mesh-ancestor
15088360|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088361|NCT02265068|Ticagrelor|ticagrelor|mesh-list
15088362|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088363|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15088364|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15088365|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15088366|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
15088367|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088368|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809688|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
14809689|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809690|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809691|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
14809692|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268671|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
14268672|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268673|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14268674|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14268675|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268676|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268677|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
14809693|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14809694|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14809695|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14809696|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809697|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809698|NCT00835965|Dexamethasone|dexamethasone|mesh-list
14809699|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
14809700|NCT00835965|Aprepitant|aprepitant|mesh-list
14809701|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
14809702|NCT00835965|BB 1101|bb 1101|mesh-list
14809703|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14809704|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
14809705|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
14809706|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809707|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809708|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809709|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
14809710|NCT00835965|Hormones|hormones|mesh-ancestor
14809711|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14809712|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14809713|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809714|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
14809715|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809716|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809717|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14809718|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809719|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
14809720|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14809721|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809722|NCT00836134|Bupivacaine|bupivacaine|mesh-list
14809723|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
14809724|NCT00836134|Anesthetics|anesthetics|mesh-list
14809725|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809726|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809727|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
14268678|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809728|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809729|NCT00836199|Vaccines|vaccines|mesh-list
14809730|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
14809731|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809732|NCT00836212|Efavirenz|efavirenz|mesh-list
14809733|NCT00836212|Lopinavir|lopinavir|mesh-list
14809734|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14809735|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14809736|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809737|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809738|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
14809739|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809740|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14809741|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14809742|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14809743|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14809744|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14809745|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14809746|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14809747|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14809748|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
14268679|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268680|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
14809749|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14809750|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14809751|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14809752|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
14809753|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
14809754|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
14809755|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809756|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809757|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
14809758|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809759|NCT00836368|Vitamin E|vitamin e|mesh-list
14809760|NCT00836368|Tocopherols|tocopherols|mesh-list
14809761|NCT00836368|Tocotrienols|tocotrienols|mesh-list
14809762|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
14809763|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
14809764|NCT00836368|Vitamins|vitamins|mesh-ancestor
14809765|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
14809766|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809767|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
14809768|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809769|NCT00836368|Protective Agents|protective agents|mesh-ancestor
14809770|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14809771|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14809772|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14809773|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
14809774|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809775|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809776|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809777|NCT00836381|Urological Agents|urological agents|mesh-ancestor
14809778|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14809779|NCT00836485|Ketotifen|ketotifen|mesh-list
14809780|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
14809781|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14809782|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14809783|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14809784|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14809785|NCT00836485|Analgesics|analgesics|mesh-ancestor
14809786|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
14809787|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809788|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809789|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14809790|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809791|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14809792|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14809793|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14809794|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
14809795|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
14809796|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809797|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809798|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
14809799|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
14814267|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14814268|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814269|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814270|NCT00862095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14814271|NCT00862095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14814272|NCT00862095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814273|NCT00862108|Methylphenidate|methylphenidate|mesh-list
14814274|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14814275|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814276|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14814277|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814278|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088369|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088370|NCT02265276|Pioglitazone|pioglitazone|mesh-list
15088371|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15088372|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088373|NCT02265289|Clopidogrel|clopidogrel|mesh-list
15088374|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088375|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15088376|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15088377|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15088378|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
15088379|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088380|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088381|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088382|NCT02265328|Prednisolone|prednisolone|mesh-list
15088383|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088384|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
15088385|NCT02265328|Hormones|hormones|mesh-ancestor
15088386|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088387|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088388|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15088389|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088390|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
15173173|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15173174|NCT04007328|Prednisolone|prednisolone|mesh-list
13996155|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13996156|NCT02922283|Analgesics|analgesics|mesh-ancestor
13996157|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
13996158|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996159|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996160|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
13996161|NCT02922075|Amoxicillin|amoxicillin|mesh-list
15173175|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
15173176|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15173177|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
15173178|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173179|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
15173180|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
15173181|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173182|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173183|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996162|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
14809800|NCT00836537|Benazepril|benazepril|mesh-list
14809801|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14809802|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
14809803|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809804|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809805|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14809806|NCT00836576|Benazepril|benazepril|mesh-list
14809807|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14809808|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
14809809|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809810|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809811|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14809812|NCT00836628|Busulfan|busulfan|mesh-list
14809813|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
14809814|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809815|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809816|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
14809817|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809818|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14809819|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809820|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14809821|NCT00836654|Catumaxomab|catumaxomab|mesh-list
14809822|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809823|NCT00836667|Sertraline|sertraline|mesh-list
14809824|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
14809825|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809826|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14809827|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14809828|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809829|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809830|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809831|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
14809832|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809833|NCT00836823|Alfuzosin|alfuzosin|mesh-list
14809834|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14809835|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14809836|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14809837|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
14809838|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809839|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809840|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809841|NCT00836823|Urological Agents|urological agents|mesh-ancestor
14809842|NCT00836849|Sertraline|sertraline|mesh-list
14809843|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
14809844|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809845|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14809846|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14809847|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809848|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809849|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809850|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
14809851|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809852|NCT00836914|Idelalisib|idelalisib|mesh-list
14809853|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809854|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809855|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809856|NCT00837044|Naproxen|naproxen|mesh-list
14809857|NCT00837044|Sumatriptan|sumatriptan|mesh-list
14809858|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14809859|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14809860|NCT00837044|Analgesics|analgesics|mesh-ancestor
14809861|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
14809862|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809863|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809864|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14809865|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14809866|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
14809867|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14809868|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809869|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809870|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15088391|NCT02265445|beta-Lactams|beta-lactams|mesh-list
15088392|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14809871|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14809872|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14809873|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
14809874|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809875|NCT00837135|Vaccines|vaccines|mesh-list
14809876|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
14809877|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809878|NCT00837174|Bortezomib|bortezomib|mesh-list
14809879|NCT00837174|Vorinostat|vorinostat|mesh-list
14809880|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809881|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14809882|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809883|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809884|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
15088393|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088394|NCT02265484|Rifaximin|rifaximin|mesh-list
15088395|NCT02265484|Bromocriptine|bromocriptine|mesh-list
15088396|NCT02265484|Lactulose|lactulose|mesh-list
15088397|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15088398|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088399|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15088400|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15088401|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15088402|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
15088403|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088404|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088405|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
15088406|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
15088407|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809885|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14809886|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809887|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809888|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14809889|NCT00837187|Analgesics|analgesics|mesh-ancestor
14809890|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
14809891|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14809892|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14809893|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14809894|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14809895|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
14809896|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809897|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809898|NCT00837239|Gemcitabine|gemcitabine|mesh-list
14809899|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14809900|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
14809901|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809902|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14809903|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
14809904|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809905|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14809906|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809907|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
14809908|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809909|NCT00837317|Phenol|phenol|mesh-list
14809910|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14809911|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14809912|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
14809913|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14809914|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14809915|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14809916|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
14809917|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809918|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14809919|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14809920|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809921|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809922|NCT00837369|Regadenoson|regadenoson|mesh-list
14809923|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14809924|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14809925|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
14809926|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
14809927|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088408|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088409|NCT02265562|Alprostadil|alprostadil|mesh-list
14809928|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809929|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809930|NCT00837564|Citalopram|citalopram|mesh-list
14809931|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14809932|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14809933|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809934|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809935|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809936|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
14809937|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809938|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14809939|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
14809940|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809941|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
14809942|NCT00837655|Calcium|calcium|mesh-list
14809943|NCT00837655|Sevelamer|sevelamer|mesh-list
14809944|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14809945|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809946|NCT00837655|Antacids|antacids|mesh-ancestor
14809947|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809948|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14809949|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
14809950|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
14809951|NCT00837707|Aripiprazole|aripiprazole|mesh-list
14809952|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
14809953|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809954|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14809955|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14809956|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14809957|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809958|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
14809959|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
14809960|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14809961|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809962|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14809963|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14809964|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
15088410|NCT02265562|Misoprostol|misoprostol|mesh-list
15088411|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15088412|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
15088413|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15088414|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088415|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15088416|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15088417|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
15088418|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088419|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
15088420|NCT02265562|Urological Agents|urological agents|mesh-ancestor
15088421|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
15088422|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15088423|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
15088424|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088425|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
15088426|NCT02265575|Protective Agents|protective agents|mesh-ancestor
15088427|NCT02265718|Methylphenidate|methylphenidate|mesh-list
15088428|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15088429|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088430|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15088431|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15088432|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088433|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088434|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
15088435|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088436|NCT02265731|Rituximab|rituximab|mesh-list
15088437|NCT02265731|Venetoclax|venetoclax|mesh-list
15088438|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15088439|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088440|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
15088441|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088442|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15088443|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
15088444|NCT02265770|Cisplatin|cisplatin|mesh-list
15088445|NCT02265770|Carboplatin|carboplatin|mesh-list
15088446|NCT02265770|Methotrexate|methotrexate|mesh-list
15088447|NCT02265770|Etoposide|etoposide|mesh-list
14809965|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14268681|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268682|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
14268683|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14809966|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14809967|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14809968|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14809969|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
14809970|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14809971|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14809972|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809973|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14809974|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809975|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14809976|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14809977|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14809978|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14809979|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
14809980|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809981|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
14809982|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
14809983|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
14809984|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14809985|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
14809986|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
14809987|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268684|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14268685|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14268686|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268687|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268688|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14809988|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14809989|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809990|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14809991|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14809992|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
14809993|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14809994|NCT00837850|Protective Agents|protective agents|mesh-ancestor
14809995|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809996|NCT00837889|Diuretics|diuretics|mesh-list
14809997|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
14809998|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14809999|NCT00837915|Loratadine|loratadine|mesh-list
14810000|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
14810001|NCT00837915|Ephedrine|ephedrine|mesh-list
14810002|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
14810003|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810004|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14810005|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14810006|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14810007|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
14810008|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
14810009|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810010|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810011|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810012|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14810013|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
14810014|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810015|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14810016|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
14810017|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
14810018|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14810019|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14810020|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
14810021|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
14810022|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14810023|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14810024|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
14810025|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810026|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810027|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
14810028|NCT00837941|Promethazine|promethazine|mesh-list
14268689|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14810029|NCT00837941|Pregabalin|pregabalin|mesh-list
14810030|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14810031|NCT00837941|Analgesics|analgesics|mesh-ancestor
14268690|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14268691|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
14268692|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268693|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268694|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14268695|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14268696|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
14268697|NCT00397189|Melatonin|melatonin|mesh-list
14268698|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
14268699|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268700|NCT00397189|Protective Agents|protective agents|mesh-ancestor
14810032|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
14810033|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810034|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810035|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
14810036|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14810037|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14810038|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810039|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14810040|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14810041|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14810042|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810043|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14810044|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14810045|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14810046|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810047|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
14810048|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
14810049|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14810050|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14810051|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14810052|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
14810053|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
14810054|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
14810055|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14810056|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14810057|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
14810058|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
14810059|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14810060|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
14810061|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810062|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
14810063|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
14810064|NCT00837954|Coagulants|coagulants|mesh-ancestor
14810065|NCT00838032|Haloperidol|haloperidol|mesh-list
14810066|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14810067|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
14810068|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
14810069|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14810070|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14810071|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14810072|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810073|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810074|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
14810075|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
14810076|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810077|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14810078|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14810079|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
15088448|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
15088449|NCT02265770|Vincristine|vincristine|mesh-list
15088450|NCT02265770|Valproic Acid|valproic acid|mesh-list
15088451|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15088452|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
15088453|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088454|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15088455|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15088456|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
15088457|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268701|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810080|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810081|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088458|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088459|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15088460|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15088461|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
15088462|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15088463|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15088464|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
15088465|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
15088466|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088467|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15088468|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15088469|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15088470|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15088471|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15088472|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
15088473|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
15088474|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
15088475|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
15088476|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
15088477|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088478|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
14810082|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14810083|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
14810084|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14810085|NCT00838071|Antibodies|antibodies|mesh-list
14810086|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
14810087|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088479|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15088480|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14268702|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810088|NCT00838214|Prednisone|prednisone|mesh-list
14810089|NCT00838214|Budesonide|budesonide|mesh-list
14810090|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810091|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
14810092|NCT00838214|Hormones|hormones|mesh-ancestor
14810093|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810094|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810095|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810096|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810097|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14810098|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
14810099|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810100|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14810101|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
14810102|NCT00838227|Modafinil|modafinil|mesh-list
14268703|NCT00397488|Sunitinib|sunitinib|mesh-list
14268704|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268705|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14810103|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14810104|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810105|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14810106|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14810107|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14810108|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810109|NCT00838240|Cytarabine|cytarabine|mesh-list
14810110|NCT00838240|Clofarabine|clofarabine|mesh-list
14810111|NCT00838240|Idarubicin|idarubicin|mesh-list
14810112|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810113|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
14810114|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810115|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810116|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
14810117|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810118|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810119|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
14810120|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810121|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14810122|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14810123|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14810124|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810125|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
14810126|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14810127|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810128|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
14810129|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810130|NCT00838266|Protective Agents|protective agents|mesh-ancestor
14810131|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810132|NCT00838305|Citalopram|citalopram|mesh-list
14810133|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14810134|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14810135|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14810136|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810137|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810138|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
14810139|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810140|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14810141|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
14810142|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14810143|NCT00838357|Plerixafor|plerixafor|mesh-list
14810144|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14268706|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268707|NCT00397488|Growth Substances|growth substances|mesh-ancestor
14268708|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268709|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268710|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14268711|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268712|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292355|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292356|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
14292357|NCT00560391|Hormones|hormones|mesh-ancestor
14292358|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292359|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292360|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292361|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
14292362|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292363|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292364|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
14292365|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14292366|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14292367|NCT00560391|Growth Substances|growth substances|mesh-ancestor
14292368|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
14810145|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14810146|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
15088481|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15088482|NCT02265809|Aldesleukin|aldesleukin|mesh-list
15088483|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088484|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15088485|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15088486|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
15088487|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088488|NCT02265822|Midazolam|midazolam|mesh-list
15088489|NCT02265822|Melatonin|melatonin|mesh-list
15088490|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15088491|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15088492|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088493|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088494|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15088495|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15088496|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15088497|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15088498|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
15088499|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
15088500|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
15088501|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
15088502|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088503|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088504|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
15088505|NCT02265822|Protective Agents|protective agents|mesh-ancestor
15088506|NCT02265874|Nicotine|nicotine|mesh-list
15088507|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15088508|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
14810147|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810148|NCT00838370|Fluorouracil|fluorouracil|mesh-list
14810149|NCT00838370|Capecitabine|capecitabine|mesh-list
14810150|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
14810151|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810152|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810153|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810154|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810155|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
14810156|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810157|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
14810158|NCT00838396|Baclofen|baclofen|mesh-list
14810159|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14810160|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810161|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14810162|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810163|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14810164|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
14810165|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
14810166|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810167|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814279|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814280|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
14814281|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814282|NCT00862264|Beclomethasone|beclomethasone|mesh-list
14814283|NCT00862264|Norflurane|norflurane|mesh-list
14814284|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
14814285|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14814286|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
14814287|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814288|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814289|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14814290|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
14814291|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14814292|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14814293|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14814294|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814295|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814296|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814297|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814298|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
14814299|NCT00862264|Hormones|hormones|mesh-ancestor
14814300|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814301|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
14814302|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814303|NCT00862329|Caseins|caseins|mesh-list
14814304|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
14814305|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
14814306|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814307|NCT00862342|Bevacizumab|bevacizumab|mesh-list
14814308|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14814309|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814310|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14814311|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14814312|NCT00862342|Growth Substances|growth substances|mesh-ancestor
14814313|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814314|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
14814315|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
14814316|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814317|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
14268713|NCT00397631|Pioglitazone|pioglitazone|mesh-list
14268714|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14268715|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14268716|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268717|NCT00397631|Incretins|incretins|mesh-ancestor
14268718|NCT00397631|Hormones|hormones|mesh-ancestor
14268719|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268720|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14814318|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14814319|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
14814320|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810168|NCT00838656|Gemcitabine|gemcitabine|mesh-list
14810169|NCT00838656|Paclitaxel|paclitaxel|mesh-list
14810170|NCT00838656|Carboplatin|carboplatin|mesh-list
14810171|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14810172|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810173|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
14810174|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
14810175|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
14810176|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810177|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810178|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
14810179|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
14810180|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810181|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810182|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810183|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
14810184|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810185|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14810186|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14810187|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14810188|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810189|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810190|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14810191|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14810192|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14810193|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
14810194|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810195|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810196|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14810197|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14810198|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
14810199|NCT00838760|Darunavir|darunavir|mesh-list
14810200|NCT00838760|TMC-310911|tmc-310911|mesh-list
14810201|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14810202|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14810203|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
14810204|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810205|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810206|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14810207|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14810208|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
14810209|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810210|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
14810211|NCT00838838|Testosterone|testosterone|mesh-list
14810212|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
14810213|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
14810214|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14810215|NCT00838838|Androgens|androgens|mesh-ancestor
14810216|NCT00838838|Hormones|hormones|mesh-ancestor
14810217|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810218|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810219|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810220|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810221|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
14810222|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
14810223|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14810224|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810225|NCT00838955|Sirolimus|sirolimus|mesh-list
14810226|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14810227|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810228|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14810229|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810230|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
14810231|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810232|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
14810233|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810234|NCT00838968|Interferons|interferons|mesh-list
14810235|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
14810236|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810237|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
14810238|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810239|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
14810240|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810241|NCT00839059|Lenalidomide|lenalidomide|mesh-list
14810242|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
14810243|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810244|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14810245|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14810246|NCT00839059|Growth Substances|growth substances|mesh-ancestor
14810247|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
14810248|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810249|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
14810250|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
14810251|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
14810252|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810253|NCT00839085|Protective Agents|protective agents|mesh-ancestor
14810254|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810255|NCT00839085|Vitamins|vitamins|mesh-ancestor
14810256|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
14810257|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14810258|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810259|NCT00839111|Irinotecan|irinotecan|mesh-list
14810260|NCT00839111|Sorafenib|sorafenib|mesh-list
14810261|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14810262|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14810263|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810264|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810265|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810266|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14810267|NCT00839163|Vitamin K|vitamin k|mesh-list
14810268|NCT00839163|Enoxaparin|enoxaparin|mesh-list
14810269|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
14810270|NCT00839163|Vitamins|vitamins|mesh-ancestor
14810271|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
14810272|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810273|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14810274|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
14810275|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14810276|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
14810277|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810278|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810279|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
14810280|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14810281|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14810282|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14810283|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
14810284|NCT00839163|Coagulants|coagulants|mesh-ancestor
14810285|NCT00839228|Perhexiline|perhexiline|mesh-list
14810286|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14810287|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14810288|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810289|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14810290|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810291|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
14810292|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
14810293|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
14810294|NCT00839280|Vitamins|vitamins|mesh-ancestor
14810295|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
14810296|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810297|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
14810298|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14810299|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14810300|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
14810301|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810302|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14810303|NCT00839345|Clopidogrel|clopidogrel|mesh-list
14810304|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14810305|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14810306|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14810307|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14810308|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
14810309|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810310|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810311|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810312|NCT00839358|Midodrine|midodrine|mesh-list
14810313|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
14810314|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
15173184|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
14810315|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810316|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810317|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14810318|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14810319|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14268721|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
14268722|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268723|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268724|NCT00397813|Cyclosporine|cyclosporine|mesh-list
14268725|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
14268726|NCT00397813|Fludarabine|fludarabine|mesh-list
14268727|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
14268728|NCT00397813|Cyclosporins|cyclosporins|mesh-list
14268729|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268730|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268731|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
14268732|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268733|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268734|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
14268735|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268736|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268737|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
14268738|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268739|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810320|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14810321|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
14810322|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810323|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810324|NCT00839371|Midazolam|midazolam|mesh-list
14810325|NCT00839371|Propofol|propofol|mesh-list
14810326|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14810327|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810328|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810329|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14810330|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
14810331|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
14810332|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14810333|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14810334|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14810335|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14810336|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
14810337|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
14810338|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810339|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810340|NCT00839397|Paroxetine|paroxetine|mesh-list
14810341|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14810342|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14810343|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14810344|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810345|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810346|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
14810347|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810348|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14810349|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
14810350|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14810351|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14810352|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14810353|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810354|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14810355|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14810356|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14810357|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
14810358|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
14810359|NCT00839462|Vitamins|vitamins|mesh-ancestor
14810360|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
14810361|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810362|NCT00839488|Pantoprazole|pantoprazole|mesh-list
14810363|NCT00839488|Famotidine|famotidine|mesh-list
14810364|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14810365|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14810366|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14810367|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268740|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268741|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14814321|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810368|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810369|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14810370|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
14810371|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
14268742|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14268743|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14268744|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
14268745|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14268746|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
14268747|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14810372|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810373|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810374|NCT00839501|Acetazolamide|acetazolamide|mesh-list
14810375|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
14810376|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14810377|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810378|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088509|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088510|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088511|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15088512|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15088513|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
15088514|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088515|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088516|NCT02266030|Aspirin|aspirin|mesh-list
15088517|NCT02266030|Cilostazol|cilostazol|mesh-list
15088518|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15088519|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15088520|NCT02266030|Analgesics|analgesics|mesh-ancestor
15088521|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
14810379|NCT00839501|Diuretics|diuretics|mesh-ancestor
14810380|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
14810381|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088522|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088523|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088524|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088525|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15088526|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15088527|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15088528|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088529|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088530|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15088531|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088532|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
15088533|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15088534|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
15088535|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15088536|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
15088537|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
15088538|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15088539|NCT02266030|Protective Agents|protective agents|mesh-ancestor
15088540|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15088541|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15088542|NCT02266056|Rocuronium|rocuronium|mesh-list
15088543|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14268748|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088544|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15088545|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15088546|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088547|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088548|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15088549|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
15088550|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
15088551|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088552|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088553|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
15088554|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088555|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15088556|NCT02266173|Pertuzumab|pertuzumab|mesh-list
15088557|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15088558|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088559|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
15088560|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14810382|NCT00839553|Minocycline|minocycline|mesh-list
14810383|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14810384|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810385|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
14810386|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14810387|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810388|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810389|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14810390|NCT00839605|Analgesics|analgesics|mesh-ancestor
14810391|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
14810392|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810393|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14810394|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14810395|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14810396|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14810397|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810398|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810399|NCT00839657|Warfarin|warfarin|mesh-list
14810400|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
14810401|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
14810402|NCT00839683|Valsartan|valsartan|mesh-list
14810403|NCT00839683|Simvastatin|simvastatin|mesh-list
14810404|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14810405|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14810406|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
14810407|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810408|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14810409|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14810410|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810411|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14810412|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14810413|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14810414|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14810415|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14810416|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810417|NCT00839761|Iron|iron|mesh-list
14810418|NCT00839761|Trace Elements|trace elements|mesh-ancestor
14810419|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
14810420|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810421|NCT00839787|Morphine|morphine|mesh-list
14810422|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14810423|NCT00839787|Narcotics|narcotics|mesh-ancestor
14810424|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810425|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810426|NCT00839787|Analgesics|analgesics|mesh-ancestor
14810427|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
14810428|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810429|NCT00839826|Enoxaparin|enoxaparin|mesh-list
14810430|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
14810431|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14810432|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
14810433|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14810434|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
14810435|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810436|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810437|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
14810438|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15088561|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088562|NCT02266303|Insulin|insulin|mesh-list
15088563|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14810439|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14810440|NCT00840112|Vitamin E|vitamin e|mesh-list
14810441|NCT00840112|Tocopherols|tocopherols|mesh-list
14810442|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
14810443|NCT00840112|Vitamins|vitamins|mesh-ancestor
14810444|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
14810445|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810446|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
14810447|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810448|NCT00840112|Protective Agents|protective agents|mesh-ancestor
14810449|NCT00840125|Docetaxel|docetaxel|mesh-list
14810450|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14810451|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810452|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14810453|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
15088564|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810454|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
15088565|NCT02266329|Prazosin|prazosin|mesh-list
14810455|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810456|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14810457|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810458|NCT00840229|Triamcinolone|triamcinolone|mesh-list
14810459|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14810460|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14810461|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14810462|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810463|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
14810464|NCT00840229|Hormones|hormones|mesh-ancestor
14810465|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810466|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810467|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810468|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
14810469|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810470|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810471|NCT00840242|Nicotine|nicotine|mesh-list
14268749|NCT00397878|Saracatinib|saracatinib|mesh-list
14268750|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268751|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268752|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268753|NCT00397904|Irinotecan|irinotecan|mesh-list
14268754|NCT00397904|Cetuximab|cetuximab|mesh-list
14268755|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268756|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14268757|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14268758|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268759|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810472|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14810473|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
14810474|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810475|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810476|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14810477|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14810478|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
14810479|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810480|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810481|NCT00840333|Levofloxacin|levofloxacin|mesh-list
14810482|NCT00840333|Ofloxacin|ofloxacin|mesh-list
14810483|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14810484|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810485|NCT00840333|Renal Agents|renal agents|mesh-ancestor
14810486|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14810487|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14810488|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14810489|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810490|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810491|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810492|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14810493|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14810494|NCT00840346|Panobinostat|panobinostat|mesh-list
14810495|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810496|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14810497|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810498|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810499|NCT00840385|Vidarabine|vidarabine|mesh-list
14810500|NCT00840385|Fludarabine|fludarabine|mesh-list
14810501|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
14810502|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810503|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810504|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
14810505|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810506|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810507|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
14810508|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810509|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
14810510|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810511|NCT00840398|Buspirone|buspirone|mesh-list
14810512|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14810513|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14810514|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810515|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023352|NCT02762864|Clopidogrel|clopidogrel|mesh-list
14810516|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14810517|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14810518|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
14810519|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810520|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814322|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14814323|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
14814324|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14814325|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14814326|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14814327|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814328|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814329|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814330|NCT00862420|Ticlopidine|ticlopidine|mesh-list
14814331|NCT00862420|Clopidogrel|clopidogrel|mesh-list
14814332|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14814333|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14814334|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15088566|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088567|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15088568|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14814335|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14814336|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
14814337|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814338|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814339|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814340|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14814341|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14814342|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14814343|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14814344|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814345|NCT00862472|Timolol|timolol|mesh-list
14814346|NCT00862472|Cloprostenol|cloprostenol|mesh-list
14814347|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
14814348|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14814349|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
14814350|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14814351|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814352|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14814353|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14814354|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14814355|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814356|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814357|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814358|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14814359|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814360|NCT00862628|Rebamipide|rebamipide|mesh-list
14814361|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14814362|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14814363|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
14814364|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814365|NCT00862628|Protective Agents|protective agents|mesh-ancestor
14814366|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814367|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814368|NCT00862693|Calcitriol|calcitriol|mesh-list
14814369|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14814370|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814371|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14814372|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814373|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814374|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14814375|NCT00862693|Vitamins|vitamins|mesh-ancestor
14814376|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
14814377|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14814378|NCT00862706|Telbivudine|telbivudine|mesh-list
14814379|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
14814380|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814381|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14814382|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814383|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814384|NCT00862875|Insulin|insulin|mesh-list
14814385|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15088569|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14810521|NCT00840489|Ribavirin|ribavirin|mesh-list
14810522|NCT00840489|Colchicine|colchicine|mesh-list
14810523|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
14810524|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810525|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
14810526|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810527|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
14810528|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810529|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14810530|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14810531|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14810532|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810533|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
14810534|NCT00840580|Levofloxacin|levofloxacin|mesh-list
14810535|NCT00840580|Ofloxacin|ofloxacin|mesh-list
14810536|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14810537|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14810538|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14810539|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14810540|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810541|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14810542|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14810543|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810544|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810545|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810546|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14810547|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
14810548|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14810549|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810550|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14810551|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14810552|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14810553|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14810554|NCT00840580|Renal Agents|renal agents|mesh-ancestor
14810555|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14810556|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14810557|NCT00840606|Buspirone|buspirone|mesh-list
14810558|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14810559|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14810560|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810561|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810562|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15088570|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088571|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088572|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088573|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088574|NCT02266355|Omalizumab|omalizumab|mesh-list
15088575|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15088576|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15088577|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
15088578|NCT02266485|Pravastatin|pravastatin|mesh-list
15088579|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15088580|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15088581|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
15088582|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088583|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15088584|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15088585|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088586|NCT02266511|Tamsulosin|tamsulosin|mesh-list
15088587|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15088588|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15088589|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088590|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088591|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088592|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088593|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088594|NCT02266511|Urological Agents|urological agents|mesh-ancestor
15088595|NCT02266524|Tamsulosin|tamsulosin|mesh-list
15088596|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15088597|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15088598|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088599|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088600|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810563|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14810564|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
14810565|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810566|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810567|NCT00840645|Mirabegron|mirabegron|mesh-list
14810568|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14810569|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14810570|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14810571|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
14810572|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810573|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810574|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810575|NCT00840645|Urological Agents|urological agents|mesh-ancestor
14810576|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
14810577|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14810578|NCT00840671|Protective Agents|protective agents|mesh-ancestor
14810579|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810580|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
14810581|NCT00840684|Cytarabine|cytarabine|mesh-list
14810582|NCT00840684|Melphalan|melphalan|mesh-list
14810583|NCT00840684|Busulfan|busulfan|mesh-list
14810584|NCT00840684|Daunorubicin|daunorubicin|mesh-list
14810585|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
14810586|NCT00840684|Amsacrine|amsacrine|mesh-list
14810587|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810588|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
14810589|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810590|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810591|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
14810592|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810593|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810594|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
14810595|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810596|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14810597|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
14810598|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14810599|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14810600|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14810601|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14268760|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268761|NCT00397943|Vaccines|vaccines|mesh-list
14268762|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
14268763|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810602|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088601|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088602|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088603|NCT02266524|Urological Agents|urological agents|mesh-ancestor
15088604|NCT02266537|Doxazosin|doxazosin|mesh-list
15088605|NCT02266537|Tamsulosin|tamsulosin|mesh-list
15088606|NCT02266537|Alfuzosin|alfuzosin|mesh-list
15088607|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15088608|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15088609|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088610|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088611|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088612|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088613|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088614|NCT02266537|Urological Agents|urological agents|mesh-ancestor
15088615|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088616|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
15088617|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088618|NCT02266784|Nicotine|nicotine|mesh-list
15088619|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15088620|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
15088621|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088622|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088623|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15088624|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14810603|NCT00840684|Analgesics|analgesics|mesh-ancestor
14810604|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
14810605|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810606|NCT00840801|Vaccines|vaccines|mesh-list
14810607|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
14810608|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810609|NCT00840853|Acetaminophen|acetaminophen|mesh-list
14268764|NCT00397982|Sirolimus|sirolimus|mesh-list
15088625|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
15088626|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810610|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
14810611|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14810612|NCT00840853|Analgesics|analgesics|mesh-ancestor
14810613|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
14810614|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810615|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810616|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
14810617|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14810618|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14810619|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810620|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
14810621|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
14810622|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
14810623|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
14810624|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14810625|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14810626|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
14810627|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
14810628|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810629|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810630|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14810631|NCT00840918|Lidocaine|lidocaine|mesh-list
14810632|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
14810633|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
14810634|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14810635|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810636|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
14810637|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810638|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14810639|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14810640|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14810641|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14810642|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810643|NCT00840931|Lenalidomide|lenalidomide|mesh-list
14810644|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
14810645|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810646|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14810647|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14810648|NCT00840931|Growth Substances|growth substances|mesh-ancestor
14810649|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
14810650|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810651|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14810652|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810653|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
14810654|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14810655|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
14810656|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14810657|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14810658|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810659|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810660|NCT00840957|Infliximab|infliximab|mesh-list
14810661|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810662|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14810663|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810664|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
14810665|NCT00841061|Trace Elements|trace elements|mesh-ancestor
14810666|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
14810667|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810668|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
14810669|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14810670|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14810671|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810672|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
14810673|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810674|NCT00841113|Goserelin|goserelin|mesh-list
14810675|NCT00841113|Bicalutamide|bicalutamide|mesh-list
14810676|NCT00841113|Abarelix|abarelix|mesh-list
14810677|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810678|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810679|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
14810680|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
14810681|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810682|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810683|NCT00841126|Iron|iron|mesh-list
15088627|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088628|NCT02266849|Loperamide|loperamide|mesh-list
15088629|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
15088630|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15088631|NCT02266927|Fluticasone|fluticasone|mesh-list
15088632|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088633|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15088634|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
15088635|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810684|NCT00841126|Trace Elements|trace elements|mesh-ancestor
14810685|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
14810686|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810687|NCT00841139|Perhexiline|perhexiline|mesh-list
14810688|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14810689|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14810690|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810691|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14810692|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810693|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
14810694|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14810695|NCT00841191|Siltuximab|siltuximab|mesh-list
14810696|NCT00841191|Antibodies|antibodies|mesh-list
14810697|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
14810698|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14810699|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
14810700|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810701|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810702|NCT00841256|Glycerol|glycerol|mesh-list
14810703|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14810704|NCT00841256|Protective Agents|protective agents|mesh-ancestor
14810705|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810706|NCT00841373|Ranibizumab|ranibizumab|mesh-list
14810707|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14810708|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14810709|NCT00841373|Growth Substances|growth substances|mesh-ancestor
14810710|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810711|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
14810712|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810713|NCT00841386|Riboflavin|riboflavin|mesh-list
14810714|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
14810715|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
14810716|NCT00841386|Vitamins|vitamins|mesh-ancestor
14810717|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
14810718|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810719|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15088636|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088637|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15088638|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
14810720|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810721|NCT00841438|Abciximab|abciximab|mesh-list
14810722|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
14810723|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14810724|NCT00841477|Vaccines|vaccines|mesh-list
14810725|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
14810726|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810727|NCT00841581|Ranibizumab|ranibizumab|mesh-list
14810728|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14810729|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14810730|NCT00841581|Growth Substances|growth substances|mesh-ancestor
14810731|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088639|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810732|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
14810733|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810734|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
14810735|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
14810736|NCT00841633|Norepinephrine|norepinephrine|mesh-list
14814386|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
14810737|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14810738|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14810739|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
14810740|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810741|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810742|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810743|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
14810744|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
14810745|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810746|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14810747|NCT00841724|Fludarabine|fludarabine|mesh-list
14810748|NCT00841724|Busulfan|busulfan|mesh-list
14810749|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
14810750|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810751|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810752|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810753|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
14810754|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810755|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
14810756|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14810757|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14810758|NCT00841789|Etanercept|etanercept|mesh-list
14810759|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14810760|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14810761|NCT00841789|Analgesics|analgesics|mesh-ancestor
14810762|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
14810763|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810764|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810765|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810766|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810767|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14810768|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810769|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
14810770|NCT00841802|Prednisone|prednisone|mesh-list
14810771|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
14810772|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810773|NCT00841802|Hormones|hormones|mesh-ancestor
14810774|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810775|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810776|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810777|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810778|NCT00841841|Acetaminophen|acetaminophen|mesh-list
14810779|NCT00841841|Dipyrone|dipyrone|mesh-list
14810780|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14810781|NCT00841841|Analgesics|analgesics|mesh-ancestor
14810782|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
14810783|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810784|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810785|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
14810786|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14810787|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810788|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810789|NCT00841854|Metronidazole|metronidazole|mesh-list
14810790|NCT00841854|Tetracycline|tetracycline|mesh-list
14810791|NCT00841854|Pantoprazole|pantoprazole|mesh-list
14810792|NCT00841854|Bismuth|bismuth|mesh-list
14810793|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810794|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14810795|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15088640|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15088641|NCT02267044|Ropivacaine|ropivacaine|mesh-list
15088642|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
15088643|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
15088644|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088645|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088646|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
15088647|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088648|NCT02267057|Acetaminophen|acetaminophen|mesh-list
15088649|NCT02267057|Buprenorphine|buprenorphine|mesh-list
15088650|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15088651|NCT02267057|Analgesics|analgesics|mesh-ancestor
15088652|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
14810796|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14810797|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15088653|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810798|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14810799|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14810800|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810801|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810802|NCT00841854|Antacids|antacids|mesh-ancestor
14810803|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14810804|NCT00841880|Felodipine|felodipine|mesh-list
14810805|NCT00841880|Ramipril|ramipril|mesh-list
14810806|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14810807|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
14810808|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810809|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810810|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14810811|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14810812|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14810813|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088654|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088655|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
15088656|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15088657|NCT02267057|Narcotics|narcotics|mesh-ancestor
15088658|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088659|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15088660|NCT02267122|Mupirocin|mupirocin|mesh-list
15088661|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15088662|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088663|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15088664|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088665|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173185|NCT04007328|Hormones|hormones|mesh-ancestor
15173186|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173187|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15173188|NCT04007328|Protective Agents|protective agents|mesh-ancestor
15173189|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15173190|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810814|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14810815|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810816|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
14810817|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
14810818|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
14810819|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810820|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14810821|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810822|NCT00841919|Insulin|insulin|mesh-list
14810823|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14810824|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
14810825|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
14810826|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
14810827|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
14810828|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
14810829|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14810830|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810831|NCT00841945|Prednisone|prednisone|mesh-list
14810832|NCT00841945|Rituximab|rituximab|mesh-list
14810833|NCT00841945|Doxorubicin|doxorubicin|mesh-list
14810834|NCT00841945|Vincristine|vincristine|mesh-list
14810835|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14810836|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810837|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
14810838|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810839|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810840|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14810841|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14810842|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14810843|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810844|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810845|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810846|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
14810847|NCT00841945|Hormones|hormones|mesh-ancestor
14810848|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810849|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810850|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14810851|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14810852|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14810853|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14810854|NCT00842114|Interferons|interferons|mesh-list
14810855|NCT00842114|Prednisone|prednisone|mesh-list
14810856|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
14810857|NCT00842114|Vincristine|vincristine|mesh-list
14810858|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810859|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
14810860|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810861|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810862|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14810863|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
14810864|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810865|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810866|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14810867|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810868|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
14810869|NCT00842114|Hormones|hormones|mesh-ancestor
14810870|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810871|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810872|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
14810873|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810874|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14810875|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
14810876|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
14810877|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
14810878|NCT00842127|Methylphenidate|methylphenidate|mesh-list
14810879|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14810880|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810881|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14810882|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14810883|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14810884|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810885|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
14810886|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14810887|NCT00842140|Metformin|metformin|mesh-list
14810888|NCT00842140|Spironolactone|spironolactone|mesh-list
14810889|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
14810890|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
14810891|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14810892|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810893|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14810894|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14810895|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
14810896|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810897|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14810898|NCT00842140|Diuretics|diuretics|mesh-ancestor
14810899|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
14810900|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14810901|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
14810902|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14810903|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810904|NCT00842205|Interferons|interferons|mesh-list
14810905|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810906|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
14810907|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814387|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
14814388|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14814389|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814390|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
14814391|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814392|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14814393|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14814394|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814395|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814396|NCT00862888|Urological Agents|urological agents|mesh-ancestor
14814397|NCT00862966|Heparin|heparin|mesh-list
14814398|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
14814399|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814400|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14814401|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14814402|NCT00863096|Vaccines|vaccines|mesh-list
14814403|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
14814404|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814405|NCT00863148|Busulfan|busulfan|mesh-list
14814406|NCT00863148|Clofarabine|clofarabine|mesh-list
14814407|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
14814408|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814409|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810908|NCT00842400|Metformin|metformin|mesh-list
14810909|NCT00842400|Probenecid|probenecid|mesh-list
14810910|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14810911|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810912|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
14810913|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
14810914|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810915|NCT00842400|Renal Agents|renal agents|mesh-ancestor
14810916|NCT00842452|Topotecan|topotecan|mesh-list
14810917|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14810918|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14810919|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810920|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810921|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810922|NCT00842491|Cisplatin|cisplatin|mesh-list
14810923|NCT00842491|Capecitabine|capecitabine|mesh-list
14810924|NCT00842491|Endostar protein|endostar protein|mesh-list
14810925|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810926|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810927|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
14810928|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810929|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14810930|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14810931|NCT00842491|Growth Substances|growth substances|mesh-ancestor
14810932|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810933|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
14810934|NCT00842504|Micafungin|micafungin|mesh-list
14810935|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
14810936|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810937|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14810938|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
14810939|NCT00842556|Glimepiride|glimepiride|mesh-list
15088666|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
15088667|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15088668|NCT02267239|Listerine|listerine|mesh-list
15088669|NCT02267239|Hexetidine|hexetidine|mesh-list
15088670|NCT02267239|Menthol|menthol|mesh-list
15088671|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
15088672|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15088673|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268765|NCT00397982|Bevacizumab|bevacizumab|mesh-list
14810940|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14810941|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810942|NCT00842556|Incretins|incretins|mesh-ancestor
14810943|NCT00842556|Hormones|hormones|mesh-ancestor
14810944|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810945|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14810946|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
14810947|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810948|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810949|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14810950|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14810951|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810952|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
14810953|NCT00842582|Azacitidine|azacitidine|mesh-list
14810954|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810955|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
14810956|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810957|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810958|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810959|NCT00842595|Prednisone|prednisone|mesh-list
14810960|NCT00842595|Rituximab|rituximab|mesh-list
14810961|NCT00842595|Vinorelbine|vinorelbine|mesh-list
14810962|NCT00842595|Ifosfamide|ifosfamide|mesh-list
14810963|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
14810964|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14810965|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088674|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
14810966|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
15088675|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14810967|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810968|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14810969|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14810970|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
14810971|NCT00842595|Hormones|hormones|mesh-ancestor
14810972|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14810973|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14810974|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14810975|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
14810976|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
14810977|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
14810978|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810979|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14810980|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
14810981|NCT00842595|Analgesics|analgesics|mesh-ancestor
14810982|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
14810983|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14810984|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14810985|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14810986|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810987|NCT00842660|Gemcitabine|gemcitabine|mesh-list
14810988|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14810989|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
14810990|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14810991|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14810992|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
14810993|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14810994|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14810995|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14810996|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
14810997|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14810998|NCT00842686|Bevacizumab|bevacizumab|mesh-list
14810999|NCT00842686|Capecitabine|capecitabine|mesh-list
14811000|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14811001|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811002|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811003|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14811004|NCT00842686|Growth Substances|growth substances|mesh-ancestor
14811005|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811006|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811007|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14811008|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
14811009|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811010|NCT00842894|Insulin|insulin|mesh-list
14811011|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14811012|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
14811013|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
14811014|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
14811015|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14811016|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14811017|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811018|NCT00842907|Tretinoin|tretinoin|mesh-list
14811019|NCT00842907|Isotretinoin|isotretinoin|mesh-list
14811020|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088676|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
15088677|NCT02267239|Protective Agents|protective agents|mesh-ancestor
15088678|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088679|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
15088680|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
15088681|NCT02267252|Antibodies|antibodies|mesh-list
15088682|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
15088683|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088684|NCT02267304|Morphine|morphine|mesh-list
15088685|NCT02267304|Naloxone|naloxone|mesh-list
15088686|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15088687|NCT02267304|Narcotics|narcotics|mesh-ancestor
15088688|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088689|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088690|NCT02267304|Analgesics|analgesics|mesh-ancestor
15088691|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
15088692|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088693|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15088694|NCT02267408|Warfarin|warfarin|mesh-list
15088695|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
15088696|NCT02267616|Etonogestrel|etonogestrel|mesh-list
14023353|NCT02762864|Ticagrelor|ticagrelor|mesh-list
14811021|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
14811022|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
14811023|NCT00842920|Simvastatin|simvastatin|mesh-list
14811024|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14811025|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14811026|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
14811027|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811028|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15088697|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15088698|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
15088699|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15088700|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088701|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15088702|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
15088703|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15088704|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
15088705|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088706|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088707|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15088708|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
15088709|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15088710|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
15088711|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088712|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088713|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15088714|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
15088715|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
15088716|NCT02267655|Protective Agents|protective agents|mesh-ancestor
15088717|NCT02267681|Fentanyl|fentanyl|mesh-list
15088718|NCT02267681|Alfentanil|alfentanil|mesh-list
15088719|NCT02267681|Propofol|propofol|mesh-list
15088720|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15088721|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088722|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088723|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15088724|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
15088725|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
15088726|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15088727|NCT02267681|Narcotics|narcotics|mesh-ancestor
15088728|NCT02267681|Analgesics|analgesics|mesh-ancestor
15088729|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
15088730|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088731|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15088732|NCT02267707|Gemcitabine|gemcitabine|mesh-list
15088733|NCT02267707|Paclitaxel|paclitaxel|mesh-list
15088734|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15088735|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088736|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
15088737|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
15088738|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
15088739|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088740|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15088741|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
15088742|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
15088743|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088744|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088745|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15088746|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
15088747|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088748|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
15088749|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088750|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
15088751|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
15088752|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
15088753|NCT02267915|Rituximab|rituximab|mesh-list
15088754|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15088755|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088756|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
15088757|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088758|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15088759|NCT02267980|Ketamine|ketamine|mesh-list
15088760|NCT02267980|Sevoflurane|sevoflurane|mesh-list
15088761|NCT02267980|Analgesics|analgesics|mesh-ancestor
15088762|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
14811029|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15088763|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173191|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
15088764|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088765|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15088766|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15088767|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
15088768|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
15088769|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088770|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15088771|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15088772|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088773|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088774|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088775|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15088776|NCT02268006|Capecitabine|capecitabine|mesh-list
15088777|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15088778|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
15088779|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088780|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088781|NCT02268019|Epinephrine|epinephrine|mesh-list
15088782|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15088783|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15088784|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088785|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088786|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088787|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088788|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15088789|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15088790|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
15088791|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088792|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15088793|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
15088794|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
15088795|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
15088796|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15088797|NCT02268032|Androgens|androgens|mesh-list
15088798|NCT02268032|Hormones|hormones|mesh-ancestor
15088799|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088800|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088801|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
15088802|NCT02268149|Prednisone|prednisone|mesh-list
15088803|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088804|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
15088805|NCT02268149|Hormones|hormones|mesh-ancestor
15088806|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088807|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088808|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15088809|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088810|NCT02268201|Tacrolimus|tacrolimus|mesh-list
15088811|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15088812|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
15088813|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088814|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15088815|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088816|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088817|NCT02268279|Solithromycin|solithromycin|mesh-list
15088818|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15088819|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15088820|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
15088821|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088822|NCT02268357|Propranolol|propranolol|mesh-list
15088823|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15088824|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15088825|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
15088826|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088827|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088828|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088829|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15088830|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088831|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
15088832|NCT02268370|Dasatinib|dasatinib|mesh-list
15088833|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088834|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15088835|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088836|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088837|NCT02268383|Luspatercept|luspatercept|mesh-list
15088838|NCT02268383|Hematinics|hematinics|mesh-ancestor
15088839|NCT02268409|Luspatercept|luspatercept|mesh-list
15088840|NCT02268409|Hematinics|hematinics|mesh-ancestor
15088841|NCT02268422|Buprenorphine|buprenorphine|mesh-list
15088842|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15088843|NCT02268422|Narcotics|narcotics|mesh-ancestor
15088844|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088845|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088846|NCT02268422|Analgesics|analgesics|mesh-ancestor
15088847|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
15088848|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088849|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15088850|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
15088851|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088852|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15088853|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088854|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088855|NCT02268487|Sertraline|sertraline|mesh-list
15088856|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
15088857|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15088858|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15088859|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15088860|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088861|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088862|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088863|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
15088864|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088865|NCT02268565|Aspirin|aspirin|mesh-list
15088866|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15088867|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15088868|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15088869|NCT02268565|Analgesics|analgesics|mesh-ancestor
15088870|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
15088871|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088872|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088873|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15088874|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15088875|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15088876|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088877|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088878|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15088879|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088880|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
15088881|NCT02268656|Propofol|propofol|mesh-list
15088882|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15088883|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088884|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088885|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15088886|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
15088887|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
15088888|NCT02268695|Docetaxel|docetaxel|mesh-list
15088889|NCT02268695|Cetuximab|cetuximab|mesh-list
15088890|NCT02268695|Sargramostim|sargramostim|mesh-list
15088891|NCT02268695|Lenograstim|lenograstim|mesh-list
15088892|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088893|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
15088894|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
15088895|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
15088896|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088897|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15088898|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
15088899|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088900|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15088901|NCT02268773|Aspirin|aspirin|mesh-list
15088902|NCT02268773|Dipyridamole|dipyridamole|mesh-list
15088903|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15088904|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15088905|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15088906|NCT02268773|Analgesics|analgesics|mesh-ancestor
15088907|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
15088908|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088909|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088910|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15088911|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15088912|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15088913|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15088914|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088915|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088916|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15088917|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088918|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
15088919|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15088920|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
15088921|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
15088922|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15088923|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088924|NCT02268890|Bortezomib|bortezomib|mesh-list
15088925|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088926|NCT02268903|Furosemide|furosemide|mesh-list
15088927|NCT02268903|Diuretics|diuretics|mesh-list
15088928|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
15088929|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088930|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15088931|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088932|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088933|NCT02268968|Lidocaine|lidocaine|mesh-list
15088934|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
15088935|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
15088936|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088937|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088938|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
15088939|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15088940|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15088941|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15088942|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15088943|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15088944|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173192|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15173193|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173194|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173195|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15173196|NCT04007341|Analgesics|analgesics|mesh-ancestor
15173197|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
15173198|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173199|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15173200|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15173201|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15173202|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
15173203|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173204|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173205|NCT04007393|Topiramate|topiramate|mesh-list
15173206|NCT04007393|Phentermine|phentermine|mesh-list
15173207|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
15173208|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15173209|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173210|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15173211|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
15173212|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14268766|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14268767|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
14268768|NCT00397982|Antibodies|antibodies|mesh-list
15173213|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
15173214|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
15173215|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173216|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
15173217|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173218|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173219|NCT04007003|Insulin|insulin|mesh-list
15173220|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15173221|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173222|NCT04007055|Ticagrelor|ticagrelor|mesh-list
15173223|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15173224|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15173225|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15173226|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15173227|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
15173228|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088945|NCT02269046|Simvastatin|simvastatin|mesh-list
15088946|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15088947|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15088948|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
15088949|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088950|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15088951|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15088952|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088953|NCT02269072|Anastrozole|anastrozole|mesh-list
15088954|NCT02269072|Leuprolide|leuprolide|mesh-list
15088955|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15088956|NCT02269072|Testosterone|testosterone|mesh-list
15088957|NCT02269072|Androgens|androgens|mesh-ancestor
15088958|NCT02269072|Hormones|hormones|mesh-ancestor
15088959|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15088960|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088961|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15088962|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15088963|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15088964|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15088965|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15088966|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088967|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15088968|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
15088969|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15088970|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
15088971|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15088972|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
15088973|NCT02269176|Losartan|losartan|mesh-list
15088974|NCT02269176|Telmisartan|telmisartan|mesh-list
15088975|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15088976|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15088977|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15088978|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15088979|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088980|NCT02269202|Midazolam|midazolam|mesh-list
15088981|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15088982|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15088983|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15088984|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15088985|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15088986|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15088987|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15088988|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15088989|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
15088990|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
15088991|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
15088992|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
15088993|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15088994|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15088995|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15088996|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15088997|NCT02269280|Azacitidine|azacitidine|mesh-list
15088998|NCT02269280|Decitabine|decitabine|mesh-list
15088999|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089000|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
15089001|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089002|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089003|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089004|NCT02269293|Paclitaxel|paclitaxel|mesh-list
15089005|NCT02269293|Carboplatin|carboplatin|mesh-list
15089006|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15089007|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089008|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
15089009|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
15089010|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
15089011|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089012|NCT02269319|Linezolid|linezolid|mesh-list
15089013|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15089014|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089015|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15089016|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089017|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089018|NCT02269358|Methotrexate|methotrexate|mesh-list
14268769|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
15089019|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15089020|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
15089021|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15089022|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089023|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089024|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
15089025|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089026|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089027|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
15089028|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089029|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15089030|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089031|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
15089032|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089033|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15089034|NCT02269449|Hemostatics|hemostatics|mesh-list
15089035|NCT02269449|Coagulants|coagulants|mesh-ancestor
15089036|NCT02269462|Efavirenz|efavirenz|mesh-list
15089037|NCT02269462|Nevirapine|nevirapine|mesh-list
15089038|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15089039|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15089040|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089041|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089042|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
15089043|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089044|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15089045|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15089046|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15089047|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15089048|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15089049|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15089050|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15089051|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15089052|NCT02269514|Nicotine|nicotine|mesh-list
15089053|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15089054|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
15089055|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089056|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089057|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15089058|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15089059|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
15089060|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089061|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089062|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
15089063|NCT02269540|Sertraline|sertraline|mesh-list
15089064|NCT02269540|Citalopram|citalopram|mesh-list
15089065|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15089066|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
15089067|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089068|NCT02269540|Expectorants|expectorants|mesh-ancestor
15089069|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
15089070|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15089071|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
15089072|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089073|NCT02269540|Protective Agents|protective agents|mesh-ancestor
15089074|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089075|NCT02269540|Antidotes|antidotes|mesh-ancestor
15089076|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
15089077|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15089078|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15089079|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15089080|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15089081|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089082|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
15089083|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15089084|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
15089085|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15089086|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
15089087|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089088|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089089|NCT02269644|Azithromycin|azithromycin|mesh-list
15089090|NCT02269644|Linezolid|linezolid|mesh-list
15089091|NCT02269644|Dalbavancin|dalbavancin|mesh-list
15089092|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15089093|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089094|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15089095|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089096|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089097|NCT02269696|Metoprolol|metoprolol|mesh-list
15089098|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15089099|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15089100|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
15089101|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
15089102|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089103|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089104|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15089105|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15089106|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15089107|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
15089108|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089109|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089110|NCT02269735|Insulin|insulin|mesh-list
15089111|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15089112|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
15089113|NCT02269735|MK-2640|mk-2640|mesh-list
15089114|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15089115|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089116|NCT02269748|Analgesics|analgesics|mesh-list
15089117|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
15089118|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089119|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089120|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
15089121|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15089122|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089123|NCT02269904|Fluorouracil|fluorouracil|mesh-list
15089124|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
15089125|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089126|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089127|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089128|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089129|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
15089130|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089131|NCT02269969|Tobramycin|tobramycin|mesh-list
15089132|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15089133|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089134|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
15089135|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15089136|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089137|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089138|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15089139|NCT02270281|Analgesics|analgesics|mesh-ancestor
15089140|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
15089141|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089142|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15089143|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15089144|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15089145|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
15089146|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089147|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089148|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
15089149|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089150|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
15089151|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089152|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089153|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15089154|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
15089155|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089156|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089157|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15089158|NCT02270424|Fluticasone|fluticasone|mesh-list
15089159|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15089160|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15089161|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15089162|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15089163|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
15089164|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089165|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089166|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15089167|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
15089168|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
15089169|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15089170|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15089171|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15089172|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15089173|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
15089174|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089175|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089176|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
15089177|NCT02270424|Hormones|hormones|mesh-ancestor
15089178|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15089179|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
15089180|NCT02270437|Epinephrine|epinephrine|mesh-list
15089181|NCT02270437|Racepinephrine|racepinephrine|mesh-list
15089182|NCT02270437|Fentanyl|fentanyl|mesh-list
15089183|NCT02270437|Ropivacaine|ropivacaine|mesh-list
15089184|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
15089185|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
15089186|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
15089187|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089188|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089189|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
15089190|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089191|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15089192|NCT02270437|Narcotics|narcotics|mesh-ancestor
15089193|NCT02270437|Analgesics|analgesics|mesh-ancestor
15089194|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15089195|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15089196|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
15089197|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15089198|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15089199|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
15089200|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089201|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089202|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15089203|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15089204|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
15089205|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15089206|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
15089207|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
15089208|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
15089209|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15089210|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
15089211|NCT02270606|Leucovorin|leucovorin|mesh-list
15089212|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
15089213|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
15089214|NCT02270606|Fluorouracil|fluorouracil|mesh-list
15089215|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
15089216|NCT02270606|Calcium|calcium|mesh-list
15089217|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
15089218|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089219|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089220|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089221|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
15089222|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089223|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089224|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089225|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089226|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
15089227|NCT02270606|Antidotes|antidotes|mesh-ancestor
15089228|NCT02270606|Protective Agents|protective agents|mesh-ancestor
15089229|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
15089230|NCT02270606|Vitamins|vitamins|mesh-ancestor
15089231|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
15173229|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173230|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173231|NCT04006873|Ivacaftor|ivacaftor|mesh-list
15173232|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15173233|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15173234|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173235|NCT04006847|Dasatinib|dasatinib|mesh-list
15173236|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173237|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15173238|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173239|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173240|NCT04006821|Apatinib|apatinib|mesh-list
15173241|NCT04006821|Antibodies|antibodies|mesh-list
15089232|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
15089233|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
15089234|NCT02270749|Vitamins|vitamins|mesh-ancestor
15089235|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
15089236|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089237|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
15089238|NCT02270749|Hematinics|hematinics|mesh-ancestor
15089239|NCT02270788|Leucovorin|leucovorin|mesh-list
15089240|NCT02270788|Cytarabine|cytarabine|mesh-list
15089241|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
15089242|NCT02270788|Methotrexate|methotrexate|mesh-list
15089243|NCT02270788|Sorafenib|sorafenib|mesh-list
14268770|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14268771|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
14268772|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268773|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268774|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268775|NCT00397982|Growth Substances|growth substances|mesh-ancestor
14268776|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268777|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268778|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
14268779|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14268780|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268781|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14268782|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
14268783|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089244|NCT02270788|Crenolanib|crenolanib|mesh-list
15089245|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15089246|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
15089247|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15089248|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089249|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089250|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
15089251|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089252|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089253|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
15089254|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089255|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15089256|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089257|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
15089258|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089259|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15089260|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
15089261|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089262|NCT02270788|Antidotes|antidotes|mesh-ancestor
14268784|NCT00398047|Mitogens|mitogens|mesh-list
14268785|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14268786|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268787|NCT00398086|Gemcitabine|gemcitabine|mesh-list
14268788|NCT00398086|Paclitaxel|paclitaxel|mesh-list
14268789|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14268790|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14268791|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268792|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268793|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
14268794|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14268795|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268796|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268797|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
14268798|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
14268799|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268800|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268801|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268802|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
14268803|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268804|NCT00398112|Sunitinib|sunitinib|mesh-list
14268805|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268806|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268807|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268808|NCT00398112|Growth Substances|growth substances|mesh-ancestor
14268809|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089263|NCT02270788|Protective Agents|protective agents|mesh-ancestor
15089264|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
15089265|NCT02270788|Vitamins|vitamins|mesh-ancestor
14268810|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
15089266|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
15089267|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15089268|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15089269|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
15089270|NCT02270827|Aminophylline|aminophylline|mesh-list
15089271|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15089272|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15089273|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
15089274|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089275|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089276|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15089277|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
15089278|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15089279|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15089280|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089281|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089282|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15089283|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15089284|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
15089285|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089286|NCT02270827|Protective Agents|protective agents|mesh-ancestor
15089287|NCT02270918|Apixaban|apixaban|mesh-list
15089288|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15089289|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
15089290|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15089291|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
15089292|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089293|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089294|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
15089295|NCT02270970|Belimumab|belimumab|mesh-list
15089296|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089297|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
15089298|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089299|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
15089300|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15089301|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
15089302|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15089303|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
15089304|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089305|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
15089306|NCT02271035|Protective Agents|protective agents|mesh-ancestor
15089307|NCT02271113|Enoxaparin|enoxaparin|mesh-list
15089308|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
15089309|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
15089310|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15089311|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15089312|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089313|NCT02271126|Heparin|heparin|mesh-list
15089314|NCT02271126|Thromboplastin|thromboplastin|mesh-list
15089315|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
15089316|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15089317|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15089318|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089319|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
15089320|NCT02271126|Coagulants|coagulants|mesh-ancestor
15089321|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
15089322|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15089323|NCT02271165|Antibodies|antibodies|mesh-list
15089324|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
15089325|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089326|NCT02271191|Nicardipine|nicardipine|mesh-list
14268811|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14268812|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268813|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268814|NCT00398138|Sargramostim|sargramostim|mesh-list
14268815|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
14268816|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
14268817|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268818|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14268819|NCT00398216|Edoxaban|edoxaban|mesh-list
14268820|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
14268821|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
14268822|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14268823|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
14268824|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268825|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268826|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
14268827|NCT00398320|Bevacizumab|bevacizumab|mesh-list
14268828|NCT00398320|Capecitabine|capecitabine|mesh-list
15089327|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15089328|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15089329|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268829|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
14268830|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268831|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268832|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14268833|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14268834|NCT00398320|Growth Substances|growth substances|mesh-ancestor
15089330|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089331|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089332|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089333|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
15089334|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
15089335|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089336|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089337|NCT02271282|Toremifene|toremifene|mesh-list
15089338|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15089339|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089340|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15089341|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15089342|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
15089343|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15089344|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089345|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089346|NCT02271295|Enoxaparin|enoxaparin|mesh-list
15089347|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
15089348|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15089349|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15089350|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089351|NCT02271347|Brincidofovir|brincidofovir|mesh-list
15089352|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
15089353|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089354|NCT02271360|Cabergoline|cabergoline|mesh-list
15089355|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
15089356|NCT02271360|Calcium|calcium|mesh-list
15089357|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089358|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089359|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15089360|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15089361|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
15089362|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
15089363|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089364|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089365|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
15089366|NCT02271360|Coagulants|coagulants|mesh-ancestor
15089367|NCT02271399|Aspirin|aspirin|mesh-list
15089368|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
15089369|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15089370|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15089371|NCT02271399|Analgesics|analgesics|mesh-ancestor
15089372|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
15089373|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089374|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089375|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15089376|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089377|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15089378|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15089379|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089380|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089381|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15089382|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089383|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
15089384|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15089385|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
15089386|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15089387|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
15089388|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
15089389|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15089390|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15089391|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15089392|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15089393|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089394|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089395|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089396|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
15089397|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15089398|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
15089399|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15089400|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15089401|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089402|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15089403|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15089404|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089405|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089406|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089407|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15089408|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
15089409|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15089410|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089411|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15089412|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15089413|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15089414|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
15089415|NCT02271464|Bevacizumab|bevacizumab|mesh-list
15089416|NCT02271464|Capecitabine|capecitabine|mesh-list
15089417|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089418|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
15089419|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089420|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089421|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15089422|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
15089423|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089424|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089425|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15089426|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15089427|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15089428|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15089429|NCT02271464|Growth Substances|growth substances|mesh-ancestor
15089430|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
15089431|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089432|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
15089433|NCT02271542|Propofol|propofol|mesh-list
15089434|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15089435|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089436|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089437|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15089438|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
15089439|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
15089440|NCT02271555|Remifentanil|remifentanil|mesh-list
15089441|NCT02271555|Sevoflurane|sevoflurane|mesh-list
15089442|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15089443|NCT02271555|Narcotics|narcotics|mesh-ancestor
15089444|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089445|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089446|NCT02271555|Analgesics|analgesics|mesh-ancestor
15089447|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
15089448|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089449|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089450|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15089451|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
15089452|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
15089453|NCT02271646|Bupivacaine|bupivacaine|mesh-list
15089454|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
15089455|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
15089456|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089457|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089458|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
15089459|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089460|NCT02271802|Butyric Acid|butyric acid|mesh-list
15089461|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
15089462|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
15089463|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089464|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089465|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089466|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
15089467|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
15089468|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
15089469|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15089470|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15089471|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089472|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089473|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089474|NCT02271958|Mifepristone|mifepristone|mesh-list
15089475|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15089476|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
15089477|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15089478|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089479|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15089480|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15089481|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15089482|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
15089483|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15089484|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15089485|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
15089486|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15089487|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
15089488|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15089489|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15089490|NCT02271971|Vitamin D|vitamin d|mesh-list
15089491|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
15089492|NCT02271971|Vitamins|vitamins|mesh-ancestor
15089493|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
15089494|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089495|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089496|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089497|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
15089498|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
15089499|NCT02271997|Trace Elements|trace elements|mesh-ancestor
15089500|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
15089501|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089502|NCT02271997|Hematinics|hematinics|mesh-ancestor
15089503|NCT02272049|Xenon|xenon|mesh-list
15089504|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15089505|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
15089506|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
15089507|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089508|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089509|NCT02272101|Vitamin D|vitamin d|mesh-list
15089510|NCT02272101|Vitamins|vitamins|mesh-ancestor
15089511|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
15089512|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089513|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089514|NCT02272166|Propofol|propofol|mesh-list
15089515|NCT02272166|Sevoflurane|sevoflurane|mesh-list
15089516|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15089517|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089518|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089519|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15089520|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
15089521|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
15089522|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089523|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15089524|NCT02272270|Minocycline|minocycline|mesh-list
15089525|NCT02272270|Temozolomide|temozolomide|mesh-list
15089526|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15089527|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
15089528|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089529|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089530|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15089531|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173242|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
15173243|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173244|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173245|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15173246|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173247|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173248|NCT04006470|Fluorides|fluorides|mesh-list
15173249|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
15173250|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
15173251|NCT04006470|Protective Agents|protective agents|mesh-ancestor
15173252|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173253|NCT04006639|Analgesics|analgesics|mesh-list
15173254|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
15173255|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089532|NCT02272387|Vitamin D|vitamin d|mesh-list
15089533|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
15089534|NCT02272387|Vitamins|vitamins|mesh-ancestor
15089535|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
15089536|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089537|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089538|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089539|NCT02272478|Decitabine|decitabine|mesh-list
15089540|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
15089541|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089542|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
15089543|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089544|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089545|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089546|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15089547|NCT02272517|Vortioxetine|vortioxetine|mesh-list
15089548|NCT02272517|Citalopram|citalopram|mesh-list
15089549|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15089550|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15089551|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15089552|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089553|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089554|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
15089555|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089556|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15089557|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
15089558|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15089559|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15089560|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15089561|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089562|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15089563|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15089564|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15089565|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15089566|NCT02272582|Heparin|heparin|mesh-list
15089567|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
15089568|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15089569|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15089570|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089571|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15089572|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15089573|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15089574|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
15089575|NCT02272647|Estradiol|estradiol|mesh-list
15089576|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15089577|NCT02272647|Progesterone|progesterone|mesh-list
15089578|NCT02272647|Estrogens|estrogens|mesh-ancestor
15089579|NCT02272647|Hormones|hormones|mesh-ancestor
15089580|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15089581|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089582|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15089583|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
15089584|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15089585|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15089586|NCT02272647|Progestins|progestins|mesh-ancestor
15089587|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15089588|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15089589|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15089590|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15089591|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15089592|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089593|NCT02272660|Parecoxib|parecoxib|mesh-list
15089594|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15089595|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15089596|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089597|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089598|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15089599|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15089600|NCT02272660|Analgesics|analgesics|mesh-ancestor
15089601|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
15089602|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089603|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089604|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15089605|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089606|NCT02272699|Paclitaxel|paclitaxel|mesh-list
15089607|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
15089608|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15089609|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089610|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
15089611|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
15089612|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
15089613|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089614|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15089615|NCT02272738|Gemcitabine|gemcitabine|mesh-list
15089616|NCT02272738|Paclitaxel|paclitaxel|mesh-list
15089617|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15089618|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15089619|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089620|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
15089621|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
15089622|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
15089623|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089624|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089625|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
15089626|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
15089627|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089628|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089629|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089630|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
15089631|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089632|NCT02272764|Itraconazole|itraconazole|mesh-list
15089633|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15089634|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
15089635|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089636|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15089637|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15089638|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089639|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089640|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15089641|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
15089642|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15089643|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089644|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15089645|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
15089646|NCT02272829|Narcotics|narcotics|mesh-ancestor
15089647|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089648|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089649|NCT02272829|Analgesics|analgesics|mesh-ancestor
15089650|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
15089651|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089652|NCT02272855|Ipilimumab|ipilimumab|mesh-list
15089653|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15089654|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089655|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15089656|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089657|NCT02272868|Rifaximin|rifaximin|mesh-list
15089658|NCT02272868|Omeprazole|omeprazole|mesh-list
15089659|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15089660|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15089661|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15089662|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15089663|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089664|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089665|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15089666|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089667|NCT02272868|Laxatives|laxatives|mesh-ancestor
15089668|NCT02272998|Ponatinib|ponatinib|mesh-list
15089669|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089670|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15089671|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089672|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089673|NCT02273102|Tretinoin|tretinoin|mesh-list
15089674|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
15089675|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089676|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
15089677|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
15089678|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
15089679|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15089680|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15089681|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089682|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089683|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15089684|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15089685|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089686|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089687|NCT02273128|Calcitonin|calcitonin|mesh-list
15089688|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089689|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089690|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089691|NCT02273154|Buspirone|buspirone|mesh-list
15089692|NCT02273154|Paroxetine|paroxetine|mesh-list
15089693|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15089694|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15089695|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15089696|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089697|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089698|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
15089699|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089700|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15089701|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
15089702|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15089703|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15089704|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15089705|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089706|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15089707|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15089708|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089709|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15089710|NCT02273258|Insulin|insulin|mesh-list
15089711|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15089712|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
15089713|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15089714|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089715|NCT02273271|Alovudine|alovudine|mesh-list
15089716|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
15089717|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089718|NCT02273440|Theophylline|theophylline|mesh-list
15089719|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15089720|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
15089721|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089722|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089723|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15089724|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
15089725|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15089726|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089727|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089728|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
15089729|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15089730|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15089731|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
15089732|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089733|NCT02273453|Oxazepam|oxazepam|mesh-list
15089734|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15089735|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089736|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089737|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15089738|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15089739|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15089740|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
15089741|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
15089742|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089743|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089744|NCT02273466|Desipramine|desipramine|mesh-list
15089745|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15089746|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
15089747|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15089748|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089749|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089750|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15089751|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15089752|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15089753|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
15089754|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089755|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089756|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15089757|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089758|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15089759|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089760|NCT02273505|Aspirin|aspirin|mesh-list
15089761|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
15089762|NCT02273505|Salicylates|salicylates|mesh-list
15089763|NCT02273505|Dipyridamole|dipyridamole|mesh-list
15089764|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15089765|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089766|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
15089767|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
15089768|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
15089769|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15089770|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15089771|NCT02273505|Analgesics|analgesics|mesh-ancestor
15089772|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
15089773|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089774|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089775|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15089776|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089777|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15089778|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089779|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089780|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089781|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15089782|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15089783|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
15089784|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15089785|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
15089786|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15089787|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089788|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15089789|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089790|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15089791|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089792|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15089793|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089794|NCT02273570|Vitamin D|vitamin d|mesh-list
15089795|NCT02273570|Calcium|calcium|mesh-list
15089796|NCT02273570|Vitamins|vitamins|mesh-ancestor
15089797|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
15089798|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089799|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089800|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089801|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
15089802|NCT02273583|Methotrexate|methotrexate|mesh-list
15089803|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15089804|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
15089805|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089806|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089807|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15089808|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
15089809|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089810|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089811|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15089812|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15089813|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
15089814|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15089815|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15089816|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
15089817|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
15089818|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089819|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15089820|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15089821|NCT02273609|Vitamin K|vitamin k|mesh-list
15089822|NCT02273609|Warfarin|warfarin|mesh-list
15089823|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
15089824|NCT02273609|Vitamins|vitamins|mesh-ancestor
15089825|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
15089826|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089827|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
15089828|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15089829|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15089830|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089831|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
15089832|NCT02273609|Coagulants|coagulants|mesh-ancestor
15089833|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
15089834|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089835|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
15089836|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089837|NCT02273622|Protective Agents|protective agents|mesh-ancestor
15089838|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089839|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089840|NCT02273635|Andrographolide|andrographolide|mesh-list
15089841|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15089842|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15089843|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15089844|NCT02273635|Analgesics|analgesics|mesh-ancestor
15089845|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
15089846|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089847|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089848|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15089849|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15089850|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15089851|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089852|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
15089853|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15089854|NCT02273661|Amphotericin B|amphotericin b|mesh-list
15089855|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15089856|NCT02273661|Amebicides|amebicides|mesh-ancestor
15089857|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15089858|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15089859|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089860|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15089861|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
15089862|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
15089863|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15089864|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
15089865|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15089866|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
15089867|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089868|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089869|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
15089870|NCT02273713|Paclitaxel|paclitaxel|mesh-list
15089871|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15089872|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089873|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
15089874|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
15089875|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
15089876|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089877|NCT02273765|Tenofovir|tenofovir|mesh-list
15089878|NCT02273765|Lamivudine|lamivudine|mesh-list
15089879|NCT02273765|Efavirenz|efavirenz|mesh-list
15089880|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
15089881|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
15089882|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089883|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15089884|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15089885|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089886|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089887|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15089888|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15089889|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15089890|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15089891|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15089892|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15089893|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15089894|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15089895|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15089896|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15089897|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15089898|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15089899|NCT02273791|Clomiphene|clomiphene|mesh-list
15089900|NCT02273791|Enclomiphene|enclomiphene|mesh-list
15089901|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
15089902|NCT02273791|Estradiol|estradiol|mesh-list
15089903|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15089904|NCT02273791|Estrogens|estrogens|mesh-ancestor
15089905|NCT02273791|Hormones|hormones|mesh-ancestor
15089906|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15089907|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089908|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15089909|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
15089910|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15089911|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15089912|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15089913|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
15089914|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15089915|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
15089916|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15089917|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15089918|NCT02273804|Topiramate|topiramate|mesh-list
15089919|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
15089920|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15089921|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089922|NCT02273817|Ciclesonide|ciclesonide|mesh-list
15089923|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
15089924|NCT02273817|Hormones|hormones|mesh-ancestor
15089925|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15089926|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089927|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15089928|NCT02273843|Vitamin D|vitamin d|mesh-list
15089929|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
15089930|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
15089931|NCT02273843|Vitamins|vitamins|mesh-list
15089932|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
15089933|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089934|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15089935|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15089936|NCT02273895|Scopolamine|scopolamine|mesh-list
15089937|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15089938|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15089939|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
15089940|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
15089941|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089942|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089943|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15089944|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
15089945|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15089946|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
15089947|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089948|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089949|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15089950|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
15089951|NCT02273947|BMS-955176|bms-955176|mesh-list
15089952|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15089953|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15089954|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
15089955|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15089956|NCT02273986|Digoxin|digoxin|mesh-list
15089957|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15089958|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15089959|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089960|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089961|NCT02273986|Protective Agents|protective agents|mesh-ancestor
15089962|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089963|NCT02274012|Paclitaxel|paclitaxel|mesh-list
15089964|NCT02274012|Afatinib|afatinib|mesh-list
15089965|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15089966|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15089967|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
15089968|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
15089969|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
15089970|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089971|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15089972|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089973|NCT02274051|Kinetin|kinetin|mesh-list
15089974|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
15089975|NCT02274051|Growth Substances|growth substances|mesh-ancestor
15089976|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089977|NCT02274077|Bupivacaine|bupivacaine|mesh-list
15089978|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
15089979|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
15089980|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15089981|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089982|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
15089983|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173256|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173257|NCT04006483|Fluorides|fluorides|mesh-list
15173258|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
15173259|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
15173260|NCT04006483|Protective Agents|protective agents|mesh-ancestor
15173261|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173262|NCT04006262|Nivolumab|nivolumab|mesh-list
15173263|NCT04006262|Ipilimumab|ipilimumab|mesh-list
15173264|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173265|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173266|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15173267|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173268|NCT04006691|Mitomycins|mitomycins|mesh-list
15173269|NCT04006691|Mitomycin|mitomycin|mesh-list
15173270|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15173271|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173272|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
15173273|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173274|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15173275|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173276|NCT04006080|Vedolizumab|vedolizumab|mesh-list
15173277|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173278|NCT04006093|Apixaban|apixaban|mesh-list
15173279|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15173280|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
15173281|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15173282|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
15173283|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173284|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173285|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
15173286|NCT04006041|Paclitaxel|paclitaxel|mesh-list
15173287|NCT04006041|Cisplatin|cisplatin|mesh-list
15173288|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15173289|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173290|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
15173291|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
15173292|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
15173293|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173294|NCT04006353|Rifampin|rifampin|mesh-list
15173295|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15173296|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
15173297|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15173298|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173299|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
15173300|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15173301|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15089984|NCT02274090|Metformin|metformin|mesh-list
15089985|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15089986|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089987|NCT02274142|Methamphetamine|methamphetamine|mesh-list
15089988|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15089989|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15089990|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
15089991|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
15089992|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15089993|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
15089994|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15089995|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15089996|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
15089997|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15089998|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15089999|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15090000|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15090001|NCT02274181|Enclomiphene|enclomiphene|mesh-list
15090002|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15090003|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
15090004|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15090005|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090006|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15090007|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
15090008|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15090009|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15090010|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15090011|NCT02274259|Ranibizumab|ranibizumab|mesh-list
15090012|NCT02274259|Aflibercept|aflibercept|mesh-list
15090013|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15090014|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15090015|NCT02274259|Growth Substances|growth substances|mesh-ancestor
15090016|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090017|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
15090018|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090019|NCT02274337|Abivertinib|abivertinib|mesh-list
15090020|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15090021|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090022|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090023|NCT02274415|Vaccines|vaccines|mesh-list
15090024|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15090025|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
15090026|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090027|NCT02274454|Oxytocin|oxytocin|mesh-list
15090028|NCT02274454|Calcium|calcium|mesh-list
15090029|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15090030|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090031|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
15090032|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15090033|NCT02274506|Vidarabine|vidarabine|mesh-list
15090034|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
15090035|NCT02274506|Fludarabine|fludarabine|mesh-list
15090036|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
15090037|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090038|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
15090039|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090040|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090041|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15090042|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
15090043|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090044|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090045|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15090046|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090047|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
15090048|NCT02274506|Antiviral Agents|antiviral agents|mesh-ancestor
15090049|NCT02274506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090050|NCT02274545|Vaccines|vaccines|mesh-list
15090051|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
15090052|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090053|NCT02274610|Docetaxel|docetaxel|mesh-list
15090054|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268835|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268836|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
14268837|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090055|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268838|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
14268839|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268840|NCT00398398|Capecitabine|capecitabine|mesh-list
14268841|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
14268842|NCT00398398|Cetuximab|cetuximab|mesh-list
14268843|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268844|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
14268845|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268846|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268847|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268848|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
14268849|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14268850|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14268851|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14268852|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14268853|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268854|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268855|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268856|NCT00398476|Fluticasone|fluticasone|mesh-list
14268857|NCT00398476|Xhance|xhance|mesh-list
14268858|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14268859|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14268860|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
14268861|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268862|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268863|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14268864|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
14268865|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
14268866|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15090056|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
15090057|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
15090058|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090059|NCT02274623|Calcifediol|calcifediol|mesh-list
15090060|NCT02274623|Vitamins|vitamins|mesh-ancestor
15090061|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
15090062|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090063|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15090064|NCT02274740|Metformin|metformin|mesh-list
15090065|NCT02274740|Lixisenatide|lixisenatide|mesh-list
15090066|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090067|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090068|NCT02274961|Pantoprazole|pantoprazole|mesh-list
15090069|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15090070|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090071|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15090072|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090073|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090074|NCT02274974|Lidocaine|lidocaine|mesh-list
15090075|NCT02274974|Epinephrine|epinephrine|mesh-list
15090076|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
15090077|NCT02274974|Anesthetics|anesthetics|mesh-list
15090078|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090079|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090080|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
15090081|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090082|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15090083|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15090084|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15090085|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15090086|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090087|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15090088|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15090089|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
15090090|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090091|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15090092|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15090093|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
15090094|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15090095|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
15090096|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
15090097|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
15090098|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15090099|NCT02275013|Simendan|simendan|mesh-list
14268867|NCT00398567|Trastuzumab|trastuzumab|mesh-list
15090100|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15090101|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
15090102|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15090103|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15090104|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090105|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090106|NCT02275013|Protective Agents|protective agents|mesh-ancestor
15090107|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090108|NCT02275039|Gemcitabine|gemcitabine|mesh-list
15090109|NCT02275039|Vaccines|vaccines|mesh-list
15090110|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
15090111|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090112|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090113|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
15090114|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090115|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090116|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
15090117|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090118|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090119|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090120|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
15090121|NCT02275130|Calcium|calcium|mesh-list
15090122|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15090123|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090124|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15090125|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
15090126|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15090127|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090128|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090129|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15090130|NCT02275182|Analgesics|analgesics|mesh-ancestor
15090131|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
15090132|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090133|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15090134|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15090135|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15090136|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
15090137|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090138|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090139|NCT02275247|Ropivacaine|ropivacaine|mesh-list
15090140|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
15090141|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090142|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090143|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
15090144|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
15090145|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090146|NCT02275286|Trabectedin|trabectedin|mesh-list
15090147|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15090148|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
15090149|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090150|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090151|NCT02275299|Methotrexate|methotrexate|mesh-list
15090152|NCT02275299|Leflunomide|leflunomide|mesh-list
15090153|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15090154|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
15090155|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15090156|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090157|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090158|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
15090159|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090160|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090161|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
15090162|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090163|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15090164|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090165|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
14811030|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811031|NCT00842933|Prednisone|prednisone|mesh-list
14811032|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
14811033|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
14811034|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14811035|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14811036|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14811037|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811038|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
14811039|NCT00842933|Hormones|hormones|mesh-ancestor
15090166|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090167|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15090168|NCT02275416|Ipilimumab|ipilimumab|mesh-list
15090169|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15090170|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090171|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15090172|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090173|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15090174|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15090175|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090176|NCT02275663|Cytarabine|cytarabine|mesh-list
15090177|NCT02275663|Fludarabine|fludarabine|mesh-list
15090178|NCT02275663|Azacitidine|azacitidine|mesh-list
15090179|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090180|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090181|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
15090182|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090183|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090184|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
15090185|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090186|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
15090187|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090188|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090189|NCT02275702|Dexamethasone|dexamethasone|mesh-list
15090190|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090191|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
15090192|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
15090193|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090194|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090195|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090196|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
15090197|NCT02275702|Hormones|hormones|mesh-ancestor
15090198|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15090199|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15090200|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090201|NCT02275806|Irinotecan|irinotecan|mesh-list
15090202|NCT02275806|Camptothecin|camptothecin|mesh-list
15090203|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090204|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15090205|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15090206|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090207|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090208|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15090209|NCT02275832|Minoxidil|minoxidil|mesh-list
15090210|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15090211|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
15090212|NCT02275845|Metformin|metformin|mesh-list
15090213|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090214|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173302|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173303|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15173304|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15173305|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15173306|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15173307|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15173308|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15173309|NCT04006054|Midazolam|midazolam|mesh-list
15173310|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
15173311|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15173312|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173313|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173314|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15173315|NCT04006054|Analgesics|analgesics|mesh-ancestor
15173316|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
15173317|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173318|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15173319|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15173320|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15173321|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
15173322|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173323|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173324|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15173325|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15090215|NCT02275897|Methamphetamine|methamphetamine|mesh-list
15090216|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15090217|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090218|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
15090219|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
15090220|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090221|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
15090222|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090223|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090224|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
15090225|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15090226|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15090227|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15090228|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15090229|NCT02275962|Rifampin|rifampin|mesh-list
15090230|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15090231|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
15090232|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15090233|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090234|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
15090235|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15090236|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090237|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090238|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15090239|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15090240|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15090241|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15090242|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15090243|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15090244|NCT02275975|Fluconazole|fluconazole|mesh-list
15090245|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
15090246|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090247|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15090248|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15090249|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090250|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090251|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15090252|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
15090253|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15090254|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090255|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15090256|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15090257|NCT02275988|Clarithromycin|clarithromycin|mesh-list
15090258|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15090259|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090260|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15090261|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090262|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090263|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15090264|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15090265|NCT02276001|Cyclosporine|cyclosporine|mesh-list
15090266|NCT02276001|Cyclosporins|cyclosporins|mesh-list
15090267|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090268|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090269|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090270|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
15090271|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090272|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
15090273|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090274|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
15090275|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090276|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15090277|NCT02276014|Beta Carotene|beta carotene|mesh-list
15090278|NCT02276014|Carotenoids|carotenoids|mesh-list
15090279|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
15090280|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090281|NCT02276014|Protective Agents|protective agents|mesh-ancestor
15090282|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090283|NCT02276014|Provitamins|provitamins|mesh-ancestor
15090284|NCT02276014|Vitamins|vitamins|mesh-ancestor
15090285|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
15090286|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
15090287|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15090288|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
15090289|NCT02276196|Lixisenatide|lixisenatide|mesh-list
15090290|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090291|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090292|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
15090293|NCT02276300|Imiquimod|imiquimod|mesh-list
15090294|NCT02276300|Sargramostim|sargramostim|mesh-list
15090295|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090296|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
15090297|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090298|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090299|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15090300|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
15090301|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090302|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090303|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15090304|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15090305|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
15090306|NCT02276365|Pioglitazone|pioglitazone|mesh-list
15090307|NCT02276365|Empagliflozin|empagliflozin|mesh-list
15090308|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090309|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090310|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15090311|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090312|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15090313|NCT02276378|Telmisartan|telmisartan|mesh-list
15090314|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15090315|NCT02276378|Diuretics|diuretics|mesh-ancestor
15090316|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
15090317|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090318|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15090319|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15090320|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090321|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15090322|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15090323|NCT02276391|Telmisartan|telmisartan|mesh-list
15090324|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15090325|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15090326|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15090327|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090328|NCT02276495|Ketorolac|ketorolac|mesh-list
15090329|NCT02276495|Clonidine|clonidine|mesh-list
15090330|NCT02276495|Epinephrine|epinephrine|mesh-list
15090331|NCT02276495|Ropivacaine|ropivacaine|mesh-list
15090332|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
15090333|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
15090334|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090335|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090336|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
15090337|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090338|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15090339|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15090340|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
15090341|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090342|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090343|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15090344|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15090345|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
15090346|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15090347|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
15090348|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
15090349|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
15090350|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15090351|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15090352|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15090353|NCT02276495|Analgesics|analgesics|mesh-ancestor
15090354|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090355|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090356|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15090357|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090358|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15090359|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
15090360|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15090361|NCT02276677|Oxytocin|oxytocin|mesh-list
15090362|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
15090363|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15090364|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090365|NCT02276690|Hepcidins|hepcidins|mesh-list
15090366|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090367|NCT02276755|Vitamin D|vitamin d|mesh-list
15090368|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
15090369|NCT02276755|Vitamins|vitamins|mesh-ancestor
15090370|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
15090371|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090372|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15090373|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15090374|NCT02276768|Trimebutine|trimebutine|mesh-list
15090375|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090376|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
15090377|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
15090378|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090379|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090380|NCT02276846|Paclitaxel|paclitaxel|mesh-list
15090381|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15090382|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090383|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
15090384|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
15090385|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
15090386|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090387|NCT02276859|Insulin|insulin|mesh-list
15090388|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15090389|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
15090390|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
15090391|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
15090392|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090393|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090394|NCT02276911|Ibuprofen|ibuprofen|mesh-list
15090395|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15090396|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15090397|NCT02276911|Analgesics|analgesics|mesh-ancestor
15090398|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
15090399|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090400|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090401|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090402|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090403|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15090404|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090405|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090406|NCT02276989|Riboflavin|riboflavin|mesh-list
15090407|NCT02276989|Quinine|quinine|mesh-list
15090408|NCT02276989|Acetazolamide|acetazolamide|mesh-list
15090409|NCT02276989|Vitamins|vitamins|mesh-ancestor
15090410|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
15090411|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090412|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
15090413|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15090414|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
15090415|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
15090416|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15090417|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090418|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090419|NCT02276989|Diuretics|diuretics|mesh-ancestor
15090420|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
15090421|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
15090422|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15090423|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15090424|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090425|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15090426|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15090427|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090428|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15090429|NCT02276989|Analgesics|analgesics|mesh-ancestor
15090430|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
15090431|NCT02277041|Misoprostol|misoprostol|mesh-list
15090432|NCT02277041|Carbetocin|carbetocin|mesh-list
15090433|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15090434|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
15090435|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15090436|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090437|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15090438|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090439|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
15090440|NCT02277067|Misoprostol|misoprostol|mesh-list
15090441|NCT02277067|Carbetocin|carbetocin|mesh-list
15090442|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15090443|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
15090444|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15090445|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090446|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15090447|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090448|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
15090449|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
15090450|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
15090451|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15090452|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15090453|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090454|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090455|NCT02277132|Urological Agents|urological agents|mesh-ancestor
15090456|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
15090457|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15090458|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
15090459|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090460|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090461|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15090462|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
15090463|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15090464|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
15090465|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090466|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090467|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15090468|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
15090469|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
15090470|NCT02277171|Protective Agents|protective agents|mesh-ancestor
15090471|NCT02277184|Cisplatin|cisplatin|mesh-list
15090472|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090473|NCT02277197|Cetuximab|cetuximab|mesh-list
15090474|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15090475|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090476|NCT02277223|Curcumin|curcumin|mesh-list
15090477|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15090478|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15090479|NCT02277223|Analgesics|analgesics|mesh-ancestor
15090480|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
15090481|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090482|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090483|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090484|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090485|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090486|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090487|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090488|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15090489|NCT02277457|Crizotinib|crizotinib|mesh-list
15090490|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090491|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15090492|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814410|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
15090493|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173326|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15173327|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15173328|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15173329|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
15173330|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
15173331|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
15173332|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
15173333|NCT04005872|Calcium|calcium|mesh-list
15173334|NCT04005872|Fluorides|fluorides|mesh-list
15173335|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15173336|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173337|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
15173338|NCT04005872|Protective Agents|protective agents|mesh-ancestor
15173339|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
15173340|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
15173341|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15173342|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15173343|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173344|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173345|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090494|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
15090495|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15090496|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15090497|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15090498|NCT02277587|Cortisone|cortisone|mesh-list
15090499|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
15090500|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090501|NCT02277587|Hormones|hormones|mesh-ancestor
15090502|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15090503|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090504|NCT02277600|Darunavir|darunavir|mesh-list
15090505|NCT02277600|Cobicistat|cobicistat|mesh-list
15090506|NCT02277600|Fostemsavir|fostemsavir|mesh-list
15090507|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15090508|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15090509|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
15090510|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090511|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090512|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15090513|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15090514|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
15090515|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090516|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15090517|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15090518|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15090519|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15090520|NCT02277678|Morphine|morphine|mesh-list
15090521|NCT02277678|Oxycodone|oxycodone|mesh-list
15090522|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
15090523|NCT02277678|Narcotics|narcotics|mesh-ancestor
15090524|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090525|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090526|NCT02277678|Analgesics|analgesics|mesh-ancestor
15090527|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
15090528|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090529|NCT02277717|Trastuzumab|trastuzumab|mesh-list
15090530|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15090531|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090532|NCT02277730|Phenylephrine|phenylephrine|mesh-list
15090533|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
15090534|NCT02277730|Ephedrine|ephedrine|mesh-list
15090535|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15090536|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15090537|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
15090538|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
15090539|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090540|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090541|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
15090542|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
15090543|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
15090544|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15090545|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15090546|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15090547|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
15090548|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090549|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090550|NCT02277730|Protective Agents|protective agents|mesh-ancestor
15090551|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15090552|NCT02277808|Amikacin|amikacin|mesh-list
15090553|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15090554|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090555|NCT02277847|Cytarabine|cytarabine|mesh-list
15090556|NCT02277847|Idarubicin|idarubicin|mesh-list
15090557|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090558|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
15090559|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090560|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090561|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
15090562|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090563|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090564|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
15090565|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090566|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15090567|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15090568|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15090569|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090570|NCT02277886|Esomeprazole|esomeprazole|mesh-list
15090571|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15090572|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090573|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15090574|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090575|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090576|NCT02277938|Amantadine|amantadine|mesh-list
15090577|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15090578|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15090579|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
15090580|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090581|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
15090582|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090583|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090584|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090585|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15090586|NCT02277938|Analgesics|analgesics|mesh-ancestor
15090587|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
15090588|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090589|NCT02278081|Lansoprazole|lansoprazole|mesh-list
15090590|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
15090591|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15090592|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090593|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15090594|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090595|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090596|NCT02278172|Vitamin D|vitamin d|mesh-list
15090597|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
15090598|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
15090599|NCT02278172|Vitamins|vitamins|mesh-list
15090600|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
15090601|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090602|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15090603|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15090604|NCT02278250|Carboplatin|carboplatin|mesh-list
15090605|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090606|NCT02278302|Ethanol|ethanol|mesh-list
15090607|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15090608|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15090609|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090610|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090611|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090612|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15090613|NCT02278315|Dexamethasone|dexamethasone|mesh-list
15090614|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090615|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
15090616|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
15090617|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090618|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090619|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090620|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
15090621|NCT02278315|Hormones|hormones|mesh-ancestor
15090622|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15090623|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15090624|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090625|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
15090626|NCT02278419|Simeprevir|simeprevir|mesh-list
15090627|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
15090628|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090629|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
15090630|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090631|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090632|NCT02278458|Gemcitabine|gemcitabine|mesh-list
15090633|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090634|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
15090635|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090636|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090637|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
15090638|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090639|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090640|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090641|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
15090642|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090643|NCT02278510|Topotecan|topotecan|mesh-list
15090644|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15090645|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15090646|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090647|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090648|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090649|NCT02278575|Antithrombins|antithrombins|mesh-list
15090650|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
15090651|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15090652|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
15090653|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090654|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090655|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
15090656|NCT02278588|Rasagiline|rasagiline|mesh-list
15090657|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15090658|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090659|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090660|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15090661|NCT02278588|Protective Agents|protective agents|mesh-ancestor
15090662|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090663|NCT02278601|Fentanyl|fentanyl|mesh-list
15090664|NCT02278601|Ropivacaine|ropivacaine|mesh-list
15090665|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
15090666|NCT02278601|Anesthetics|anesthetics|mesh-list
15090667|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090668|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090669|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
15090670|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090671|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15090672|NCT02278601|Narcotics|narcotics|mesh-ancestor
15090673|NCT02278601|Analgesics|analgesics|mesh-ancestor
15090674|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15090675|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15090676|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
15090677|NCT02278692|Vitamin K|vitamin k|mesh-list
15090678|NCT02278692|Vitamins|vitamins|mesh-ancestor
15090679|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
15090680|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090681|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15090682|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15090683|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090684|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
15090685|NCT02278692|Coagulants|coagulants|mesh-ancestor
15090686|NCT02278861|Tretinoin|tretinoin|mesh-list
15090687|NCT02278861|Isotretinoin|isotretinoin|mesh-list
15090688|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
15090689|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
15090690|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090691|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
15090692|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15090693|NCT02278861|Protective Agents|protective agents|mesh-ancestor
15090694|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090695|NCT02278913|Insulin|insulin|mesh-list
15090696|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
15090697|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15090698|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090699|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090700|NCT02278926|Insulin|insulin|mesh-list
15090701|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090702|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090703|NCT02278965|Metformin|metformin|mesh-list
15090704|NCT02278965|Biguanides|biguanides|mesh-list
15090705|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090706|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090707|NCT02278978|Nintedanib|nintedanib|mesh-list
15090708|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090709|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15090710|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090711|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090712|NCT02279121|Taurolidine|taurolidine|mesh-list
15090713|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15090714|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090715|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15090716|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090717|NCT02279134|Paclitaxel|paclitaxel|mesh-list
15090718|NCT02279134|Nedaplatin|nedaplatin|mesh-list
15090719|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15090720|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090721|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
15090722|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
15090723|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
15090724|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090725|NCT02279147|Neostigmine|neostigmine|mesh-list
15090726|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15090727|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090728|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090729|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
15090730|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090731|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090732|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15090733|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
15090734|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090735|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
15090736|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14268868|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268869|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090737|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15090738|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090739|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
15090740|NCT02279186|Coagulants|coagulants|mesh-ancestor
15090741|NCT02279316|Vitamin D|vitamin d|mesh-list
15090742|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
15090743|NCT02279316|Vitamins|vitamins|mesh-ancestor
15090744|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
15090745|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090746|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15090747|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15173346|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173347|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
15173348|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
15173349|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15173350|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15173351|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173352|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173353|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173354|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268870|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14268871|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14268872|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14268873|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268874|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268875|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173355|NCT04005612|Vitamin D|vitamin d|mesh-list
15173356|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
15173357|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
15173358|NCT04005612|Vitamins|vitamins|mesh-list
15173359|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
15173360|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173361|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15173362|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15173363|NCT04005716|Cisplatin|cisplatin|mesh-list
15173364|NCT04005716|Carboplatin|carboplatin|mesh-list
15173365|NCT04005716|Etoposide|etoposide|mesh-list
15173366|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
15173367|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173368|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15173369|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15173370|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15173371|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173372|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173373|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
15173374|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173375|NCT04005664|Phenylephrine|phenylephrine|mesh-list
15173376|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
15173377|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15173378|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
15173379|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
15173380|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173381|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173382|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
15173383|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15173384|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
15173385|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
15173386|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15173387|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15173388|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15173389|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
15090748|NCT02279342|Febuxostat|febuxostat|mesh-list
15090749|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
15090750|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090751|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
15090752|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15090753|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090754|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
15090755|NCT02279394|Dexamethasone|dexamethasone|mesh-list
15090756|NCT02279394|Lenalidomide|lenalidomide|mesh-list
15090757|NCT02279394|Elotuzumab|elotuzumab|mesh-list
15090758|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090759|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
15090760|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
15090761|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090762|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090763|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090764|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
15090765|NCT02279394|Hormones|hormones|mesh-ancestor
15090766|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15090767|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15090768|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090769|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
15090770|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15090771|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15090772|NCT02279394|Growth Substances|growth substances|mesh-ancestor
15090773|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
15090774|NCT02279511|Adenosine|adenosine|mesh-list
15090775|NCT02279511|Analgesics|analgesics|mesh-ancestor
15090776|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
15090777|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090778|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090779|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15090780|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
15090781|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15090782|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
15090783|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
15090784|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090785|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090786|NCT02279537|Aflibercept|aflibercept|mesh-list
15090787|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15090788|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15090789|NCT02279537|Growth Substances|growth substances|mesh-ancestor
15090790|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090791|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
15090792|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090793|NCT02279563|Fluticasone|fluticasone|mesh-list
14811040|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811041|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090794|NCT02279563|Xhance|xhance|mesh-list
15090795|NCT02279563|Azelastine|azelastine|mesh-list
15090796|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090797|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15090798|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
14811042|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14811043|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811044|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
14811045|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
14811046|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811047|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811048|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14811049|NCT00842933|Protective Agents|protective agents|mesh-ancestor
14811050|NCT00842998|Trastuzumab|trastuzumab|mesh-list
14811051|NCT00842998|Lapatinib|lapatinib|mesh-list
14811052|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14811053|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811054|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14811055|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811056|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814411|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814412|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14814413|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814414|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15090799|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090800|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090801|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15090802|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
15090803|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
15090804|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15090805|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15090806|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090807|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090808|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15090809|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15090810|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
15090811|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
15090812|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090813|NCT02279576|Paclitaxel|paclitaxel|mesh-list
15090814|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15090815|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15090816|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090817|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
15090818|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
15090819|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
15090820|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090821|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15090822|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
15090823|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090824|NCT02279615|Tamsulosin|tamsulosin|mesh-list
15090825|NCT02279615|Mirabegron|mirabegron|mesh-list
15090826|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15090827|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15090828|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15090829|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
15090830|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090831|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090832|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090833|NCT02279615|Urological Agents|urological agents|mesh-ancestor
15090834|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15090835|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15090836|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15090837|NCT02279628|Morphine|morphine|mesh-list
15090838|NCT02279628|Ropivacaine|ropivacaine|mesh-list
15090839|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15090840|NCT02279628|Narcotics|narcotics|mesh-ancestor
15090841|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090842|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090843|NCT02279628|Analgesics|analgesics|mesh-ancestor
15090844|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
15090845|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090846|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
15090847|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
15090848|NCT02279654|Lenalidomide|lenalidomide|mesh-list
15090849|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
14268876|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268877|NCT00398632|Analgesics|analgesics|mesh-ancestor
14268878|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
14268879|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268880|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
14268881|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14268882|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
14268883|NCT00398866|Triamcinolone|triamcinolone|mesh-list
14268884|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14268885|NCT00398866|Bupivacaine|bupivacaine|mesh-list
14268886|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
15090850|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090851|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15090852|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15090853|NCT02279654|Growth Substances|growth substances|mesh-ancestor
15090854|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
15090855|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090856|NCT02279758|Metformin|metformin|mesh-list
15090857|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090858|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090859|NCT02279875|Rifampin|rifampin|mesh-list
15090860|NCT02279875|Isoniazid|isoniazid|mesh-list
15090861|NCT02279875|Linezolid|linezolid|mesh-list
15090862|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
15090863|NCT02279875|Ethambutol|ethambutol|mesh-list
15090864|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14268887|NCT00398866|Hylan|hylan|mesh-list
15090865|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
14268888|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
15090866|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15090867|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090868|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
15090869|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15090870|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090871|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090872|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15090873|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15090874|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15090875|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15090876|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15090877|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15090878|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15090879|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15090880|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
15090881|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15090882|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15090883|NCT02279914|Misoprostol|misoprostol|mesh-list
15090884|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15090885|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
15090886|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15090887|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090888|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15090889|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15090890|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
15090891|NCT02279953|Vortioxetine|vortioxetine|mesh-list
15090892|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
15090893|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15090894|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15090895|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15090896|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090897|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090898|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15090899|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15090900|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15090901|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090902|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090903|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
15090904|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15090905|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15090906|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15090907|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15090908|NCT02279966|Vortioxetine|vortioxetine|mesh-list
15090909|NCT02279966|Paroxetine|paroxetine|mesh-list
15090910|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15090911|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15090912|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15090913|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090914|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090915|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
15090916|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090917|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15090918|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
15090919|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15090920|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15090921|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15090922|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090923|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15090924|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15090925|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15090926|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15090927|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15090928|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15090929|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15090930|NCT02279992|Carboplatin|carboplatin|mesh-list
15090931|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
15090932|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090933|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
15090934|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15090935|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15090936|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090937|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090938|NCT02279992|Urological Agents|urological agents|mesh-ancestor
15090939|NCT02280031|Aspirin|aspirin|mesh-list
15090940|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15090941|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15090942|NCT02280031|Analgesics|analgesics|mesh-ancestor
15090943|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
15090944|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090945|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090946|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15090947|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15090948|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15090949|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15090950|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090951|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15090952|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15090953|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090954|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
15090955|NCT02280057|Metformin|metformin|mesh-list
15090956|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15090957|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090958|NCT02280070|Leucovorin|leucovorin|mesh-list
15090959|NCT02280070|Fluorouracil|fluorouracil|mesh-list
15090960|NCT02280070|Tegafur|tegafur|mesh-list
15090961|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
15090962|NCT02280070|Antibodies|antibodies|mesh-list
15090963|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
15090964|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
15090965|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
15090966|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090967|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
15090968|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090969|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15090970|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15090971|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15090972|NCT02280070|Antidotes|antidotes|mesh-ancestor
15090973|NCT02280070|Protective Agents|protective agents|mesh-ancestor
15090974|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
15090975|NCT02280070|Vitamins|vitamins|mesh-ancestor
15090976|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
15090977|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
15090978|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15090979|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15090980|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15090981|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15090982|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090983|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
15090984|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15090985|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15090986|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15090987|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15090988|NCT02280109|Tenofovir|tenofovir|mesh-list
15090989|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
15090990|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15090991|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15090992|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15090993|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15090994|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15090995|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15090996|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15090997|NCT02280148|Propofol|propofol|mesh-list
15090998|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
15090999|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091000|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091001|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15091002|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15091003|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
15091004|NCT02280174|Linagliptin|linagliptin|mesh-list
15091005|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15091006|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091007|NCT02280174|Incretins|incretins|mesh-ancestor
15091008|NCT02280174|Hormones|hormones|mesh-ancestor
15091009|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091010|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15091011|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
15091012|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091013|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091014|NCT02280239|Acetaminophen|acetaminophen|mesh-list
15091015|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091016|NCT02280239|Analgesics|analgesics|mesh-ancestor
15091017|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
15091018|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091019|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091020|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
15091021|NCT02280265|Factor VIII|factor viii|mesh-list
15091022|NCT02280265|Coagulants|coagulants|mesh-ancestor
15091023|NCT02280447|Vaccines|vaccines|mesh-list
15091024|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
15091025|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091026|NCT02280486|Glimepiride|glimepiride|mesh-list
15091027|NCT02280486|Saxagliptin|saxagliptin|mesh-list
15091028|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15091029|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15091030|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091031|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091032|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
15091033|NCT02280486|Incretins|incretins|mesh-ancestor
15091034|NCT02280486|Hormones|hormones|mesh-ancestor
15091035|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091036|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15091037|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
15091038|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091039|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091040|NCT02280525|Vidarabine|vidarabine|mesh-list
15091041|NCT02280525|Cytarabine|cytarabine|mesh-list
15091042|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
15091043|NCT02280525|Rituximab|rituximab|mesh-list
15091044|NCT02280525|Fludarabine|fludarabine|mesh-list
15091045|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
15091046|NCT02280525|Lenalidomide|lenalidomide|mesh-list
15091047|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091048|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
15091049|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091050|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091051|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15091052|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
15091053|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091054|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091055|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15091056|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15091057|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091058|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
15091059|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
15091060|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091061|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15091062|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15091063|NCT02280525|Growth Substances|growth substances|mesh-ancestor
15091064|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
15091065|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
15091066|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15091067|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
15091068|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091069|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
15091070|NCT02280538|Protective Agents|protective agents|mesh-ancestor
15091071|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15091072|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15091073|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15091074|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
15091075|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091076|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15091077|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15091078|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091079|NCT02280603|Minoxidil|minoxidil|mesh-list
15091080|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15091081|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
15091082|NCT02280616|Budesonide|budesonide|mesh-list
15091083|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091084|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15091085|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
15091086|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091087|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091088|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15091089|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
15091090|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
15091091|NCT02280616|Hormones|hormones|mesh-ancestor
15091092|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091093|NCT02280629|Mesalamine|mesalamine|mesh-list
15091094|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15091095|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091096|NCT02280629|Analgesics|analgesics|mesh-ancestor
15091097|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
15091098|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091099|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091100|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091101|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091102|NCT02280694|Celecoxib|celecoxib|mesh-list
15091103|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
15091104|NCT02280694|Capecitabine|capecitabine|mesh-list
15091105|NCT02280694|Methotrexate|methotrexate|mesh-list
15091106|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091107|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
15091108|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091109|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091110|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15091111|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
15091112|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091113|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091114|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15091115|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091116|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
15091117|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15091118|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
15091119|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15091120|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
15091121|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091122|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15091123|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15091124|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15091125|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091126|NCT02280694|Analgesics|analgesics|mesh-ancestor
15091127|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
15091128|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091129|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091130|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15091131|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15091132|NCT02280720|Tryptophan|tryptophan|mesh-list
15091133|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15091134|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
15091135|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15091136|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
15091137|NCT02280772|Cathartics|cathartics|mesh-ancestor
15091138|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091139|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15091140|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15091141|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091142|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
15091143|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
15091144|NCT02280876|Andrographolide|andrographolide|mesh-list
15091145|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091146|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15091147|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091148|NCT02280876|Analgesics|analgesics|mesh-ancestor
15091149|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
15091150|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091151|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091152|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091153|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15091154|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15091155|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091156|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
15091157|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15091158|NCT02280993|Dexamethasone|dexamethasone|mesh-list
15091159|NCT02280993|Cisplatin|cisplatin|mesh-list
15091160|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14268889|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
15091161|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091162|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091163|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
15091164|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
15091165|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091166|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091167|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091168|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
15091169|NCT02280993|Hormones|hormones|mesh-ancestor
15091170|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091171|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15091172|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15091173|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
15091174|NCT02281006|Antidotes|antidotes|mesh-ancestor
14268890|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091175|NCT02281006|Protective Agents|protective agents|mesh-ancestor
15091176|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091177|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
15091178|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091179|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
15091180|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15091181|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091182|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
15091183|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
15173390|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173391|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173392|NCT04005664|Protective Agents|protective agents|mesh-ancestor
15173393|NCT04005469|Treprostinil|treprostinil|mesh-list
15173394|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15173395|NCT04005430|Dexamethasone|dexamethasone|mesh-list
15173396|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
15173397|NCT04005430|BB 1101|bb 1101|mesh-list
15173398|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173399|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
15173400|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
15173401|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173402|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173403|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173404|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
15173405|NCT04005430|Hormones|hormones|mesh-ancestor
15173406|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173407|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15173408|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173409|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
15173410|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173411|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181331|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181332|NCT03930875|Aspirin|aspirin|mesh-list
15181333|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15181334|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181335|NCT03930875|Analgesics|analgesics|mesh-ancestor
15181336|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
15181337|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181338|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181339|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181340|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181341|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15181342|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15181343|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181344|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15181345|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15181346|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181347|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
15182264|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268891|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268892|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
14268893|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268894|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14268895|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
14268896|NCT00398866|Hormones|hormones|mesh-ancestor
14268897|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14268898|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268899|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
14268900|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14268901|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
14268902|NCT00398866|Protective Agents|protective agents|mesh-ancestor
14268903|NCT00398918|Zonisamide|zonisamide|mesh-list
14268904|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
14268905|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14268906|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268907|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268908|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268909|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268910|NCT00398983|Decitabine|decitabine|mesh-list
15091184|NCT02281045|Citric Acid|citric acid|mesh-list
15091185|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
15091186|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
15091187|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15091188|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
15091189|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
15091190|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091191|NCT02281058|Abatacept|abatacept|mesh-list
15091192|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15091193|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091194|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091195|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091196|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
15091197|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091198|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091199|NCT02281201|Thrombin|thrombin|mesh-list
15091200|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
14268911|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268912|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
14268913|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268914|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268915|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14268916|NCT00399035|Leucovorin|leucovorin|mesh-list
14268917|NCT00399035|Fluorouracil|fluorouracil|mesh-list
14268918|NCT00399035|Capecitabine|capecitabine|mesh-list
14268919|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
14268920|NCT00399035|Cediranib|cediranib|mesh-list
14268921|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
14268922|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
14268923|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268924|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14268925|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268926|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268927|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
14268928|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268929|NCT00399035|Antidotes|antidotes|mesh-ancestor
14268930|NCT00399035|Protective Agents|protective agents|mesh-ancestor
14268931|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
14811057|NCT00843063|Pantoprazole|pantoprazole|mesh-list
14811058|NCT00843063|Famotidine|famotidine|mesh-list
14811059|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14811060|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811061|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14811062|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811063|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811064|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14811065|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
14811066|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
14811067|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811068|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811069|NCT00843154|Candesartan|candesartan|mesh-list
14811070|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14811071|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14811072|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14811073|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811074|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14811075|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14811076|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14811077|NCT00843362|Dinoprostone|dinoprostone|mesh-list
14811078|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
14811079|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15091201|NCT02281201|Coagulants|coagulants|mesh-ancestor
14268932|NCT00399035|Vitamins|vitamins|mesh-ancestor
15091202|NCT02281240|Oprelvekin|oprelvekin|mesh-list
15091203|NCT02281240|Heparin|heparin|mesh-list
15091204|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
14268933|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
14268934|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14268935|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091205|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15091206|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15091207|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091208|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091209|NCT02281266|Entecavir|entecavir|mesh-list
15091210|NCT02281266|Thymalfasin|thymalfasin|mesh-list
15091211|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
15091212|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091213|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15091214|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
15091215|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091216|NCT02281279|Rituximab|rituximab|mesh-list
15091217|NCT02281279|Lenalidomide|lenalidomide|mesh-list
15091218|NCT02281279|Romidepsin|romidepsin|mesh-list
15091219|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15091220|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091221|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
15091222|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091223|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091224|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15091225|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15091226|NCT02281279|Growth Substances|growth substances|mesh-ancestor
15091227|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
15091228|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15091229|NCT02281292|Ranibizumab|ranibizumab|mesh-list
15091230|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15091231|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15091232|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15091233|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15091234|NCT02281292|Growth Substances|growth substances|mesh-ancestor
15091235|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091236|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
15091237|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091238|NCT02281305|Colchicine|colchicine|mesh-list
15091239|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
15091240|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091241|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
15091242|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
15091243|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
15091244|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091245|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091246|NCT02281370|Cyclosporine|cyclosporine|mesh-list
15091247|NCT02281370|Cyclosporins|cyclosporins|mesh-list
15091248|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091249|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091250|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091251|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
15091252|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091253|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
15091254|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091255|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
15091256|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091257|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15091258|NCT02281396|Vaccines|vaccines|mesh-list
15091259|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
15091260|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091261|NCT02281643|Doxycycline|doxycycline|mesh-list
15091262|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15091263|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091264|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
15091265|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15091266|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15091267|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
15091268|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15091269|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15091270|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091271|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
15091272|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15091273|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
15091274|NCT02281682|Fluorouracil|fluorouracil|mesh-list
15091275|NCT02281682|Imiquimod|imiquimod|mesh-list
14268936|NCT00399360|Metformin|metformin|mesh-list
15091276|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
15091277|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
15091278|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091279|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091280|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091281|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091282|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
15091283|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091284|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15091285|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
15091286|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15091287|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
15091288|NCT02281708|Cisplatin|cisplatin|mesh-list
15091289|NCT02281708|Vinorelbine|vinorelbine|mesh-list
15091290|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091291|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15091292|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
15091293|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
15091294|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
15091295|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091296|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
15091297|NCT02281721|Antacids|antacids|mesh-ancestor
15091298|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091299|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091300|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
15091301|NCT02281799|Azathioprine|azathioprine|mesh-list
15091302|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
15091303|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091304|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091305|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091306|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091307|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
15091308|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091309|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15091310|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091311|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091312|NCT02281929|Amoxicillin|amoxicillin|mesh-list
15091313|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
15091314|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
15091315|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15091316|NCT02281929|Prednisolone|prednisolone|mesh-list
15091317|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15091318|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091319|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091320|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
15091321|NCT02281929|Hormones|hormones|mesh-ancestor
15091322|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091323|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091324|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15091325|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091326|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091327|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091328|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15091329|NCT02281968|Naproxen|naproxen|mesh-list
15091330|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15091331|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091332|NCT02281968|Analgesics|analgesics|mesh-ancestor
15091333|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
15091334|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091335|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091336|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091337|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091338|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
15091339|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15091340|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091341|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091342|NCT02281981|Curcumin|curcumin|mesh-list
15091343|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15091344|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091345|NCT02281981|Analgesics|analgesics|mesh-ancestor
15091346|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
15091347|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091348|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091349|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091350|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091351|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091352|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091353|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091354|NCT02282059|Sunitinib|sunitinib|mesh-list
15091355|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091356|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15091357|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15091358|NCT02282059|Growth Substances|growth substances|mesh-ancestor
15091359|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091360|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
15091361|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15091362|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091363|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091364|NCT02282085|Olanzapine|olanzapine|mesh-list
15091365|NCT02282085|Risperidone|risperidone|mesh-list
15091366|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15091367|NCT02282085|Aripiprazole|aripiprazole|mesh-list
15091368|NCT02282085|Ziprasidone|ziprasidone|mesh-list
15091369|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
15091370|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15091371|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15091372|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
15091373|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091374|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091375|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091376|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15091377|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091378|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15091379|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15091380|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
15091381|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
15091382|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
15091383|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091384|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091385|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15091386|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15091387|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15091388|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
15091389|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
15091390|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15091391|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15091392|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15091393|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15091394|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15091395|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15091396|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15091397|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
15091398|NCT02282098|Colchicine|colchicine|mesh-list
15091399|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
15091400|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091401|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
15091402|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
15091403|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
15091404|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091405|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091406|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15091407|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15091408|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091409|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
15091410|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15091411|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15091412|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15091413|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091414|NCT02282176|Azithromycin|azithromycin|mesh-list
15091415|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15091416|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091417|NCT02282241|Melatonin|melatonin|mesh-list
15091418|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
15091419|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091420|NCT02282241|Protective Agents|protective agents|mesh-ancestor
15091421|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091422|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091423|NCT02282267|Gefitinib|gefitinib|mesh-list
15091424|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091425|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15091426|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091427|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091428|NCT02282280|Prilocaine|prilocaine|mesh-list
15091429|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
15091430|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
15091431|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091432|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091433|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
15091434|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091435|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
15091436|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
15091437|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15091438|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091439|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091440|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091441|NCT02282319|Analgesics|analgesics|mesh-ancestor
15091442|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
15091443|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091444|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15091445|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15091446|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15091447|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
15091448|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091449|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091450|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
15091451|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
15091452|NCT02282358|Mocetinostat|mocetinostat|mesh-list
15091453|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15091454|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091455|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091456|NCT02282371|Cetuximab|cetuximab|mesh-list
15091457|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15091458|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091459|NCT02282384|Oseltamivir|oseltamivir|mesh-list
15091460|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
15091461|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
15091462|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091463|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091464|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091465|NCT02282384|Antacids|antacids|mesh-ancestor
15091466|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091467|NCT02282410|Factor VIII|factor viii|mesh-list
15091468|NCT02282410|Coagulants|coagulants|mesh-ancestor
15091469|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15091470|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15091471|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091472|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091473|NCT02282683|Prednisone|prednisone|mesh-list
15091474|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091475|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
15091476|NCT02282683|Hormones|hormones|mesh-ancestor
15091477|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091478|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091479|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15091480|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091481|NCT02282709|Asunaprevir|asunaprevir|mesh-list
15091482|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
15091483|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091484|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091485|NCT02282774|Lidocaine|lidocaine|mesh-list
15091486|NCT02282774|Bupivacaine|bupivacaine|mesh-list
15091487|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
15091488|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
15091489|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091490|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091491|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
15091492|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268937|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15091493|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15091494|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15091495|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15091496|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15091497|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091498|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
15091499|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15091500|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091501|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091502|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091503|NCT02282787|Analgesics|analgesics|mesh-ancestor
15091504|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
15091505|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091506|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15091507|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14268938|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268939|NCT00399490|Tanezumab|tanezumab|mesh-list
14268940|NCT00399490|Analgesics|analgesics|mesh-ancestor
14268941|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
14268942|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14268943|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268944|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
14268945|NCT00399529|Trastuzumab|trastuzumab|mesh-list
14268946|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14268947|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
14268948|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091508|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15091509|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
15091510|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091511|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091512|NCT02282800|Vitamin D|vitamin d|mesh-list
15091513|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
15091514|NCT02282800|Vitamins|vitamins|mesh-ancestor
15091515|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
15091516|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091517|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15091518|NCT02282826|Acyclovir|acyclovir|mesh-list
15091519|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
15091520|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173412|NCT04005365|Propranolol|propranolol|mesh-list
15173413|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15173414|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15173415|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
15173416|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173417|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173418|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173419|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15173420|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15173421|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
15173422|NCT04005326|Anesthetics|anesthetics|mesh-list
15173423|NCT04005326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173424|NCT04005326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173425|NCT04005222|Selenium|selenium|mesh-list
15173426|NCT04005222|Melatonin|melatonin|mesh-list
15173427|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
15173428|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173429|NCT04005222|Protective Agents|protective agents|mesh-ancestor
15173430|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173431|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173432|NCT04005222|Trace Elements|trace elements|mesh-ancestor
15173433|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
15173434|NCT04005417|Fluorides|fluorides|mesh-list
15173435|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
13996163|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13996164|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173436|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
15173437|NCT04005417|Protective Agents|protective agents|mesh-ancestor
15173438|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173439|NCT04004754|Miltefosine|miltefosine|mesh-list
15173440|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
15173441|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173442|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173443|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15173444|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15173445|NCT04005170|Paclitaxel|paclitaxel|mesh-list
15173446|NCT04005170|Cisplatin|cisplatin|mesh-list
15173447|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15173448|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091521|NCT02282891|Ketamine|ketamine|mesh-list
15091522|NCT02282891|Propofol|propofol|mesh-list
15091523|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15091524|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091525|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091526|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15091527|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
15091528|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
15091529|NCT02282891|Analgesics|analgesics|mesh-ancestor
15091530|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
15091531|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091532|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15091533|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15091534|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15091535|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091536|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091537|NCT02282956|Droperidol|droperidol|mesh-list
15091538|NCT02282956|Morphine|morphine|mesh-list
15091539|NCT02282956|Ropivacaine|ropivacaine|mesh-list
15091540|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15091541|NCT02282956|Narcotics|narcotics|mesh-ancestor
15091542|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091543|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091544|NCT02282956|Analgesics|analgesics|mesh-ancestor
15091545|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
15091546|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091547|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
15091548|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
15091549|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15091550|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
15091551|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
15091552|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091553|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15091554|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15091555|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15091556|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15091557|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15091558|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
15091559|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091560|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091561|NCT02283060|Tenofovir|tenofovir|mesh-list
15091562|NCT02283060|Emtricitabine|emtricitabine|mesh-list
15091563|NCT02283060|Efavirenz|efavirenz|mesh-list
15091564|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15091565|NCT02283060|Cobicistat|cobicistat|mesh-list
15091566|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15091567|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15091568|NCT02283060|Elvitegravir|elvitegravir|mesh-list
15091569|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
15091570|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091571|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15091572|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15091573|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091574|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091575|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15091576|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15091577|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15091578|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15091579|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15091580|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15091581|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15091582|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15091583|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15091584|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15091585|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
15091586|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15091587|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
15091588|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
15091589|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
15091590|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15091591|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091592|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15091593|NCT02283177|Cytarabine|cytarabine|mesh-list
15091594|NCT02283177|Daunorubicin|daunorubicin|mesh-list
15091595|NCT02283177|Idarubicin|idarubicin|mesh-list
15091596|NCT02283177|Crenolanib|crenolanib|mesh-list
15091597|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091598|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
15091599|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091600|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091601|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
15091602|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091603|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091604|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
15091605|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091606|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15091607|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15091608|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15091609|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091610|NCT02283190|Asparaginase|asparaginase|mesh-list
15091611|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091612|NCT02283203|Acetaminophen|acetaminophen|mesh-list
15091613|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091614|NCT02283203|Analgesics|analgesics|mesh-ancestor
15091615|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
15091616|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091617|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091618|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
15091619|NCT02283242|Galantamine|galantamine|mesh-list
15091620|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15091621|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091622|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091623|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
15091624|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091625|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091626|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15091627|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
15091628|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091629|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
15091630|NCT02283320|Docetaxel|docetaxel|mesh-list
15091631|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091632|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
15091633|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
15091634|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
15091635|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091636|NCT02283359|Irinotecan|irinotecan|mesh-list
15091637|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15091638|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15091639|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091640|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091641|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091642|NCT02283372|Gemcitabine|gemcitabine|mesh-list
15091643|NCT02283372|Paclitaxel|paclitaxel|mesh-list
15091644|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15091645|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15091646|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091647|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
15091648|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
15091649|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
15091650|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091651|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091652|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
15091653|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
15091654|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091655|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091656|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091657|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
15091658|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091659|NCT02283424|Carboplatin|carboplatin|mesh-list
15091660|NCT02283424|Docetaxel|docetaxel|mesh-list
15091661|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091662|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
15091663|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
15091664|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
15091665|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091666|NCT02283476|Gemcitabine|gemcitabine|mesh-list
15091667|NCT02283476|Endostar protein|endostar protein|mesh-list
15091668|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091669|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091670|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
15091671|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091672|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
15091673|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091674|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091675|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091676|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
15091677|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091678|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15091679|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15091680|NCT02283476|Growth Substances|growth substances|mesh-ancestor
15091681|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
15091682|NCT02283489|Paclitaxel|paclitaxel|mesh-list
15091683|NCT02283489|Endostatins|endostatins|mesh-list
15091684|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15091685|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091686|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
15091687|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
15091688|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
15091689|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091690|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15091691|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15091692|NCT02283489|Growth Substances|growth substances|mesh-ancestor
15091693|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091694|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
15091695|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15091696|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15091697|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15091698|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
15091699|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091700|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15091701|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15091702|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091703|NCT02283554|Metformin|metformin|mesh-list
15091704|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15091705|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091706|NCT02283645|Minoxidil|minoxidil|mesh-list
15091707|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15091708|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
15091709|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
15091710|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15091711|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091712|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091713|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15091714|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15091715|NCT02283710|Protective Agents|protective agents|mesh-ancestor
15091716|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091717|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
15091718|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15091719|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
15091720|NCT02283775|Dexamethasone|dexamethasone|mesh-list
15091721|NCT02283775|Pomalidomide|pomalidomide|mesh-list
15091722|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091723|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
15091724|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
15091725|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091726|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091727|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091728|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
15091729|NCT02283775|Hormones|hormones|mesh-ancestor
15091730|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091731|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15091732|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091733|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
15091734|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15091735|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15091736|NCT02283775|Growth Substances|growth substances|mesh-ancestor
15091737|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
15091738|NCT02283801|Lamotrigine|lamotrigine|mesh-list
15091739|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
15091740|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
15091741|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15091742|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15091743|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091744|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15091745|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091746|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15091747|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15091748|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091749|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15091750|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15091751|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15091752|NCT02283866|Desflurane|desflurane|mesh-list
15091753|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15091754|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
15091755|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
15091756|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091757|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091758|NCT02283905|Voriconazole|voriconazole|mesh-list
15091759|NCT02283905|Amphotericin B|amphotericin b|mesh-list
15091760|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15091761|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
15091762|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091763|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15091764|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15091765|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091766|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091767|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15091768|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
15091769|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091770|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091771|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15091772|NCT02283905|Amebicides|amebicides|mesh-ancestor
15091773|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15091774|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15091775|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15091776|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
15091777|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15091778|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15091779|NCT02283996|Prednisolone|prednisolone|mesh-list
15091780|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
15091781|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15091782|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
15091783|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15091784|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
15091785|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
15091786|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091787|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091788|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15091789|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
15091790|NCT02283996|Hormones|hormones|mesh-ancestor
15091791|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091792|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15091793|NCT02283996|Protective Agents|protective agents|mesh-ancestor
15091794|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14268949|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14268950|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14268951|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
14268952|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091795|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091796|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
15091797|NCT02284035|Lamivudine|lamivudine|mesh-list
15091798|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15091799|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15091800|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
15091801|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091802|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15091803|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15091804|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091805|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091806|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15091807|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15091808|NCT02284048|Ticagrelor|ticagrelor|mesh-list
15091809|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15091810|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15091811|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15091812|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15091813|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
15091814|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091815|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091816|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091817|NCT02284204|Midazolam|midazolam|mesh-list
15091818|NCT02284204|Ketamine|ketamine|mesh-list
15091819|NCT02284204|Sevoflurane|sevoflurane|mesh-list
15091820|NCT02284204|Analgesics|analgesics|mesh-ancestor
15091821|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
15091822|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091823|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091824|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15091825|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15091826|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
15091827|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
15091828|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091829|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15091830|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15091831|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091832|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091833|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15091834|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15091835|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15091836|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15091837|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15091838|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
15091839|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
15091840|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15091841|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15091842|NCT02284230|Liraglutide|liraglutide|mesh-list
15091843|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15091844|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091845|NCT02284230|Incretins|incretins|mesh-ancestor
15091846|NCT02284230|Hormones|hormones|mesh-ancestor
15091847|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15091848|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15091849|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091850|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15091851|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091852|NCT02284282|Lidocaine|lidocaine|mesh-list
15091853|NCT02284282|Morphine|morphine|mesh-list
15091854|NCT02284282|Bupivacaine|bupivacaine|mesh-list
15091855|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
15091856|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
15091857|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091858|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091859|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
15091860|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091861|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15091862|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15091863|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15091864|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15091865|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091866|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15091867|NCT02284282|Narcotics|narcotics|mesh-ancestor
15091868|NCT02284282|Analgesics|analgesics|mesh-ancestor
15091869|NCT02284412|Neostigmine|neostigmine|mesh-list
15091870|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15091871|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091872|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091873|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
15091874|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091875|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091876|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15091877|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
15091878|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173449|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
15173450|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
15173451|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
15173452|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173453|NCT04004871|Paclitaxel|paclitaxel|mesh-list
15173454|NCT04004871|Cisplatin|cisplatin|mesh-list
15173455|NCT04004871|Fluorouracil|fluorouracil|mesh-list
15173456|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15173457|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173458|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
15173459|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
15173460|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
15173461|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173462|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
14268953|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268954|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14268955|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14268956|NCT00399542|Lubiprostone|lubiprostone|mesh-list
14268957|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14268958|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15173463|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15173464|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15173465|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
15173466|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173467|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
15173468|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15173469|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
14268959|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268960|NCT00399568|Acetaminophen|acetaminophen|mesh-list
14268961|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14268962|NCT00399568|Analgesics|analgesics|mesh-ancestor
15173470|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15173471|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173472|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15173473|NCT04004988|Tirzepatide|tirzepatide|mesh-list
15173474|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15173475|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173476|NCT04004988|Incretins|incretins|mesh-ancestor
15173477|NCT04004988|Hormones|hormones|mesh-ancestor
15173478|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173479|NCT04004702|Levetiracetam|levetiracetam|mesh-list
15173480|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
15173481|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
15173482|NCT04004507|Phentolamine|phentolamine|mesh-list
15173483|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15173484|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15173485|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15173486|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15173487|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
15173488|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173489|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173490|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173491|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15173492|NCT04004572|Pegaspargase|pegaspargase|mesh-list
15173493|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173494|NCT04004234|Manganese|manganese|mesh-list
14268963|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
15173495|NCT04004234|Gemcitabine|gemcitabine|mesh-list
15091879|NCT02284490|Pemetrexed|pemetrexed|mesh-list
15091880|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091881|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091882|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091883|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15091884|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15091885|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15091886|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15091887|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15091888|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
15091889|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091890|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15091891|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15091892|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091893|NCT02284529|Leucovorin|leucovorin|mesh-list
15091894|NCT02284529|Fluorouracil|fluorouracil|mesh-list
15091895|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
15091896|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091897|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15091898|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091899|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091900|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
15091901|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091902|NCT02284529|Antidotes|antidotes|mesh-ancestor
15091903|NCT02284529|Protective Agents|protective agents|mesh-ancestor
15091904|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
15091905|NCT02284529|Vitamins|vitamins|mesh-ancestor
15091906|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
15091907|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
15091908|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15091909|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091910|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091911|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15091912|NCT02284672|Analgesics|analgesics|mesh-ancestor
15091913|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
15091914|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091915|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15091916|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15091917|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15091918|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
15091919|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091920|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091921|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
15091922|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
15091923|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15091924|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15091925|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091926|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091927|NCT02284737|Urological Agents|urological agents|mesh-ancestor
15091928|NCT02284984|Rituximab|rituximab|mesh-list
15091929|NCT02284984|Belimumab|belimumab|mesh-list
15091930|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15091931|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091932|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
15091933|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091934|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15091935|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15091936|NCT02285036|Vaccines|vaccines|mesh-list
15091937|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15091938|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
15091939|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091940|NCT02285075|Temocillin|temocillin|mesh-list
15091941|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15091942|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091943|NCT02285101|BCT-100|bct-100|mesh-list
15091944|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091945|NCT02285309|Enoximone|enoximone|mesh-list
15091946|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15091947|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
15091948|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15091949|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15091950|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091951|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091952|NCT02285309|Protective Agents|protective agents|mesh-ancestor
15091953|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091954|NCT02285374|Tenofovir|tenofovir|mesh-list
15091955|NCT02285374|Emtricitabine|emtricitabine|mesh-list
15091956|NCT02285374|Efavirenz|efavirenz|mesh-list
15091957|NCT02285374|Dolutegravir|dolutegravir|mesh-list
15091958|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15091959|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
15091960|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15091961|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15091962|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15091963|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15091964|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091965|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15091966|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15091967|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15091968|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15091969|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15091970|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15091971|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15091972|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15091973|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15091974|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15091975|NCT02285413|Cisplatin|cisplatin|mesh-list
15091976|NCT02285413|Vaccines|vaccines|mesh-list
15091977|NCT02285413|Immunologic Factors|immunologic factors|mesh-ancestor
15091978|NCT02285413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091979|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15091980|NCT02285491|Bupivacaine|bupivacaine|mesh-list
15091981|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
15091982|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
15091983|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15091984|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091985|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
15091986|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15091987|NCT02285647|Rolapitant|rolapitant|mesh-list
15091988|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15091989|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15091990|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15091991|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15091992|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
15091993|NCT02285699|Citalopram|citalopram|mesh-list
15091994|NCT02285699|Fluoxetine|fluoxetine|mesh-list
15091995|NCT02285699|Paroxetine|paroxetine|mesh-list
15091996|NCT02285699|Sertraline|sertraline|mesh-list
15091997|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15091998|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15091999|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092000|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092001|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092002|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
15092003|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092004|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15092005|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
15092006|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092007|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15092008|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15092009|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092010|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15092011|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15092012|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092013|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15092014|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15092015|NCT02285738|Aspirin|aspirin|mesh-list
15092016|NCT02285738|Simvastatin|simvastatin|mesh-list
15092017|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15092018|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092019|NCT02285738|Analgesics|analgesics|mesh-ancestor
15092020|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
15092021|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092022|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092023|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092024|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092025|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15092026|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15092027|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092028|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15092029|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15092030|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092031|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
15092032|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15092033|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15092034|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
15092035|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15092036|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15092037|NCT02285751|Aspirin|aspirin|mesh-list
15092038|NCT02285751|Clopidogrel|clopidogrel|mesh-list
15092039|NCT02285751|Ticagrelor|ticagrelor|mesh-list
15092040|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15092041|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15092042|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092043|NCT02285751|Analgesics|analgesics|mesh-ancestor
15092044|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
15092045|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092046|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092047|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092048|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092049|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15092050|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15092051|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092052|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15092053|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15092054|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092055|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
15092056|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15092057|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15092058|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15092059|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
15092060|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092061|NCT02285829|Bromides|bromides|mesh-list
15092062|NCT02285829|Rocuronium|rocuronium|mesh-list
15092063|NCT02285829|Cisatracurium|cisatracurium|mesh-list
15092064|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
15092065|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15092066|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15092067|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15092068|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092069|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092070|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15092071|NCT02285972|Tenoxicam|tenoxicam|mesh-list
15092072|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15092073|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092074|NCT02285972|Analgesics|analgesics|mesh-ancestor
15092075|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
15092076|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092077|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092078|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092079|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092080|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15092081|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092082|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092083|NCT02285985|Saxagliptin|saxagliptin|mesh-list
15092084|NCT02285985|Incretins|incretins|mesh-ancestor
15092085|NCT02285985|Hormones|hormones|mesh-ancestor
15092086|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092087|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092088|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15092089|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
15092090|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092091|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092092|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15092093|NCT02286206|Clozapine|clozapine|mesh-list
15092094|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15092095|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
15092096|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092097|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092098|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092099|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15092100|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15092101|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092102|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092103|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
15092104|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
15092105|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
15092106|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
15092107|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
15092108|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092109|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
15092110|NCT02286258|Edetic Acid|edetic acid|mesh-list
15092111|NCT02286258|Calcium|calcium|mesh-list
15092112|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14268964|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092113|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092114|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15092115|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
15092116|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
15092117|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092118|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
15092119|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15173496|NCT04004234|Paclitaxel|paclitaxel|mesh-list
15173497|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15173498|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15173499|NCT04004234|Antibodies|antibodies|mesh-list
15173500|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
15173501|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15173502|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268965|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268966|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
14268967|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14268968|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14268969|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14268970|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14268971|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173503|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
15173504|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
15173505|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
15173506|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173507|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
15173508|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173509|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15173510|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
15173511|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
15173512|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173513|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173514|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15173515|NCT04004234|Trace Elements|trace elements|mesh-ancestor
15173516|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
15173517|NCT04004208|Aflibercept|aflibercept|mesh-list
15173518|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15173519|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15173520|NCT04004208|Growth Substances|growth substances|mesh-ancestor
15173521|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173522|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
15173523|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173524|NCT04003987|Bupivacaine|bupivacaine|mesh-list
15173525|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
15173526|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
15173527|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173528|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173529|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
15173530|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173531|NCT04004117|Fentanyl|fentanyl|mesh-list
15173532|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15173533|NCT04004117|Narcotics|narcotics|mesh-ancestor
15173534|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173535|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173536|NCT04004117|Analgesics|analgesics|mesh-ancestor
15173537|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
15173538|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173539|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15173540|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15173541|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
15173542|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
15173543|NCT04003948|Ibogaine|ibogaine|mesh-list
15173544|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
15092120|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15092121|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092122|NCT02286453|Diclofenac|diclofenac|mesh-list
15092123|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15092124|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092125|NCT02286453|Analgesics|analgesics|mesh-ancestor
15092126|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
15092127|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092128|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092129|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092130|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092131|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15092132|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092133|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092134|NCT02286544|Atorvastatin|atorvastatin|mesh-list
15092135|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15092136|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15092137|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
15092138|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092139|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15092140|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15092141|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092142|NCT02286596|Heparin|heparin|mesh-list
15092143|NCT02286596|Dextrans|dextrans|mesh-list
15092144|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
15092145|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15092146|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15092147|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092148|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
15092149|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
15092150|NCT02286609|Deflazacort|deflazacort|mesh-list
15092151|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092152|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15092153|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
15092154|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092155|NCT02286622|Deflazacort|deflazacort|mesh-list
15092156|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092157|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15092158|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
15092159|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092160|NCT02286635|Clarithromycin|clarithromycin|mesh-list
15092161|NCT02286635|Rifampin|rifampin|mesh-list
15092162|NCT02286635|Deflazacort|deflazacort|mesh-list
15092163|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15092164|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092165|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15092166|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092167|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092168|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15092169|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15092170|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15092171|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
15092172|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
15092173|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15092174|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15092175|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15092176|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15092177|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15092178|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15092179|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15092180|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092181|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15092182|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
15092183|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092184|NCT02286687|Talazoparib|talazoparib|mesh-list
15092185|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15092186|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092187|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092188|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092189|NCT02286700|Desonide|desonide|mesh-list
15092190|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092191|NCT02286752|Neostigmine|neostigmine|mesh-list
15092192|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15092193|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092194|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092195|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
15092196|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092197|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092198|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15092199|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
15092200|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092201|NCT02286934|Carvedilol|carvedilol|mesh-list
15092202|NCT02286934|Isoproterenol|isoproterenol|mesh-list
15092203|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15092204|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15092205|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
15092206|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092207|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092208|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092209|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15092210|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
15092211|NCT02286934|Protective Agents|protective agents|mesh-ancestor
15092212|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15092213|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092214|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15092215|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
15092216|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15092217|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15092218|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15092219|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15092220|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15092221|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
15092222|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092223|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15092224|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
15092225|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15092226|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
15092227|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
15092228|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15092229|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15092230|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092231|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
15092232|NCT02286973|Coagulants|coagulants|mesh-ancestor
15092233|NCT02286986|Cannabidiol|cannabidiol|mesh-list
15092234|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
15092235|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
15092236|NCT02287064|Antibodies|antibodies|mesh-list
15092237|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
15092238|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15092239|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15092240|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
15092241|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092242|NCT02287129|Paclitaxel|paclitaxel|mesh-list
15092243|NCT02287129|Carboplatin|carboplatin|mesh-list
15092244|NCT02287129|Capecitabine|capecitabine|mesh-list
15092245|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
15092246|NCT02287129|Epirubicin|epirubicin|mesh-list
15092247|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15092248|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092249|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
15092250|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
15092251|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
15092252|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092253|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15092254|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
15092255|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15092256|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15092257|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15092258|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092259|NCT02287181|Remifentanil|remifentanil|mesh-list
15092260|NCT02287181|Propofol|propofol|mesh-list
15092261|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15092262|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092263|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092264|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15092265|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
15092266|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
15092267|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15092268|NCT02287181|Narcotics|narcotics|mesh-ancestor
15092269|NCT02287181|Analgesics|analgesics|mesh-ancestor
15092270|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
15092271|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092272|NCT02287233|Cytarabine|cytarabine|mesh-list
15092273|NCT02287233|Venetoclax|venetoclax|mesh-list
15092274|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15092275|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
15092276|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092277|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092278|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
15092279|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092280|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15092281|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
15092282|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092283|NCT02287246|Bupivacaine|bupivacaine|mesh-list
15092284|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
15092285|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
15092286|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092287|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092288|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
15092289|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092290|NCT02287259|Olanzapine|olanzapine|mesh-list
15092291|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
15092292|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
15092293|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092294|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092295|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092296|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15092297|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15092298|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092299|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092300|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15092301|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15092302|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092303|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092304|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092305|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
15092306|NCT02287272|Cimetidine|cimetidine|mesh-list
15092307|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15092308|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092309|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15092310|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
15092311|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
15092312|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092313|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092314|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092315|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15092316|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15092317|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092318|NCT02287389|Mitomycins|mitomycins|mesh-list
15092319|NCT02287389|Mitomycin|mitomycin|mesh-list
15092320|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15092321|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092322|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
15092323|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092324|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15092325|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092326|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
15092327|NCT02287428|Temozolomide|temozolomide|mesh-list
15092328|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15092329|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092330|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15092331|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
15092332|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092333|NCT02287558|Pomalidomide|pomalidomide|mesh-list
15092334|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
15092335|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092336|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15092337|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15092338|NCT02287558|Growth Substances|growth substances|mesh-ancestor
15092339|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
15092340|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092341|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15092342|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15092343|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092344|NCT02287857|Tenofovir|tenofovir|mesh-list
15092345|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
15092346|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092347|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15092348|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15092349|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092350|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092351|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15092352|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15092353|NCT02287870|Lidocaine|lidocaine|mesh-list
15092354|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
15092355|NCT02287870|Procaine|procaine|mesh-list
15092356|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
15092357|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
15092358|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092359|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092360|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
15092361|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092362|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15092363|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15092364|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15092365|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092366|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092367|NCT02288000|Memantine|memantine|mesh-list
15092368|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15092369|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15092370|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
15092371|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092372|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092373|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092374|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15092375|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15173545|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173546|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15173547|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15173548|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15173549|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173550|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173551|NCT04003844|Aspirin|aspirin|mesh-list
15173552|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
15173553|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15173554|NCT04003844|Antibodies|antibodies|mesh-list
15173555|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
15173556|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
15173557|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173558|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15173559|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15173560|NCT04003844|Analgesics|analgesics|mesh-ancestor
15173561|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
15173562|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173563|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173564|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173565|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15173566|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15173567|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173568|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15173569|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15173570|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173571|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
15173572|NCT04003922|Adalimumab|adalimumab|mesh-list
15173573|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173574|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173575|NCT04003792|Bevacizumab|bevacizumab|mesh-list
15173576|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
15173577|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173578|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173579|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15173580|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15173581|NCT04003792|Growth Substances|growth substances|mesh-ancestor
15173582|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173583|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
15173584|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
15173585|NCT04003688|Analgesics|analgesics|mesh-ancestor
15173586|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
15173587|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092376|NCT02288078|Dexamethasone|dexamethasone|mesh-list
15092377|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15092378|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092379|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
15092380|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
15092381|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092382|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092383|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092384|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
15092385|NCT02288078|Hormones|hormones|mesh-ancestor
15092386|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092387|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15092388|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092389|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092390|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092391|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
15092392|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15092393|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
15092394|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15092395|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092396|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15092397|NCT02288195|Capecitabine|capecitabine|mesh-list
15092398|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
15092399|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15092400|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
15092401|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092402|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092403|NCT02288208|Tenofovir|tenofovir|mesh-list
15092404|NCT02288208|Entecavir|entecavir|mesh-list
15092405|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
15092406|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092407|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15092408|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15092409|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092410|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092411|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15092412|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15092413|NCT02288234|Telavancin|telavancin|mesh-list
15092414|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15092415|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092416|NCT02288286|Vaccines|vaccines|mesh-list
15092417|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
15092418|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092419|NCT02288338|Atorvastatin|atorvastatin|mesh-list
15092420|NCT02288338|Ezetimibe|ezetimibe|mesh-list
15092421|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15092422|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15092423|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
15092424|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092425|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15092426|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15092427|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092428|NCT02288429|Colistin|colistin|mesh-list
15092429|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15092430|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092431|NCT02288507|Sorafenib|sorafenib|mesh-list
15092432|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092433|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15092434|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092435|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092436|NCT02288741|Dexamethasone|dexamethasone|mesh-list
15092437|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
15092438|NCT02288741|Melphalan|melphalan|mesh-list
15092439|NCT02288741|BB 1101|bb 1101|mesh-list
15092440|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092441|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
15092442|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
15092443|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092444|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092445|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092446|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
15092447|NCT02288741|Hormones|hormones|mesh-ancestor
15092448|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092449|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15092450|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092451|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
15092452|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092453|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092454|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15092455|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
15092456|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15092457|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15092458|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
15092459|NCT02288832|Azithromycin|azithromycin|mesh-list
15092460|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15092461|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092462|NCT02288923|Acetaminophen|acetaminophen|mesh-list
15092463|NCT02288923|Ibuprofen|ibuprofen|mesh-list
15092464|NCT02288923|Morphine|morphine|mesh-list
15092465|NCT02288923|Antiemetics|antiemetics|mesh-list
15092466|NCT02288923|Anesthetics|anesthetics|mesh-list
15092467|NCT02288923|Emetics|emetics|mesh-list
15092468|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092469|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092470|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15092471|NCT02288923|Narcotics|narcotics|mesh-ancestor
15092472|NCT02288923|Analgesics|analgesics|mesh-ancestor
15092473|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
15092474|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092475|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15092476|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092477|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092478|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092479|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15092480|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092481|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092482|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
15092483|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
15092484|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092485|NCT02288962|Cabergoline|cabergoline|mesh-list
15092486|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15092487|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15092488|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
15092489|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
15092490|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092491|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092492|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092493|NCT02289027|Vaccines|vaccines|mesh-list
15092494|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
15092495|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092496|NCT02289144|Ceritinib|ceritinib|mesh-list
15092497|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092498|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15092499|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092500|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092501|NCT02289248|Ketamine|ketamine|mesh-list
15092502|NCT02289248|Analgesics|analgesics|mesh-ancestor
15092503|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
15092504|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092505|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092506|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15092507|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15092508|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
15092509|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
15092510|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092511|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15092512|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15092513|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092514|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092515|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
15092516|NCT02289261|Morphine|morphine|mesh-list
15092517|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15092518|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092519|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092520|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092521|NCT02289261|Analgesics|analgesics|mesh-ancestor
15092522|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
15092523|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092524|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15092525|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15092526|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15092527|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
15092528|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092529|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092530|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15092531|NCT02289261|Narcotics|narcotics|mesh-ancestor
15092532|NCT02289274|Aceclofenac|aceclofenac|mesh-list
15092533|NCT02289274|Eperisone|eperisone|mesh-list
15092534|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15092535|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092536|NCT02289274|Analgesics|analgesics|mesh-ancestor
15092537|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
15092538|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092539|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092540|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092541|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092542|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
15092543|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15092544|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092545|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092546|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15092547|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15092548|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15092549|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
15092550|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
15092551|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
15092552|NCT02289378|Docetaxel|docetaxel|mesh-list
15092553|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
15092554|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092555|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
15092556|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
15092557|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
15092558|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092559|NCT02289391|Anesthetics|anesthetics|mesh-list
15092560|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092561|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092562|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15092563|NCT02289430|Ezetimibe|ezetimibe|mesh-list
15092564|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15092565|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15092566|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
15092567|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092568|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15092569|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15092570|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092571|NCT02289482|Ritonavir|ritonavir|mesh-list
15092572|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
15092573|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15092574|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15092575|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
15092576|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092577|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092578|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15092579|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15092580|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
15092581|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092582|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15092583|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15092584|NCT02289495|Ritonavir|ritonavir|mesh-list
15092585|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
15092586|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15092587|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15092588|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
15092589|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092590|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092591|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15092592|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15092593|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
15092594|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092595|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15092596|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15092597|NCT02289547|Capecitabine|capecitabine|mesh-list
15092598|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15092599|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
15092600|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092601|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092602|NCT02289586|Fentanyl|fentanyl|mesh-list
15092603|NCT02289586|Midazolam|midazolam|mesh-list
15092604|NCT02289586|Remifentanil|remifentanil|mesh-list
15092605|NCT02289586|Dezocine|dezocine|mesh-list
15092606|NCT02289586|Propofol|propofol|mesh-list
15092607|NCT02289586|Rocuronium|rocuronium|mesh-list
15092608|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
15092609|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092610|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092611|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15092612|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15092613|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
15092614|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15092615|NCT02289586|Narcotics|narcotics|mesh-ancestor
15092616|NCT02289586|Analgesics|analgesics|mesh-ancestor
15092617|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
15092618|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092619|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15092620|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15092621|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15092622|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092623|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
15092624|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
15092625|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092626|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092627|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15092628|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15092629|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15173588|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173589|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
15173590|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173591|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15173592|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
15173593|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15173594|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15173595|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173596|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15173597|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
15173598|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15173599|NCT04003376|Vitamin D|vitamin d|mesh-list
15173600|NCT04003376|Triamcinolone|triamcinolone|mesh-list
15173601|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15173602|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15173603|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15173604|NCT04003376|Vitamins|vitamins|mesh-ancestor
15173605|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
15173606|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173607|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15173608|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173609|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
15173610|NCT04003376|Hormones|hormones|mesh-ancestor
15173611|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173612|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15173613|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
15173614|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173615|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181348|NCT03931161|Evolocumab|evolocumab|mesh-list
15181349|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15181350|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15181351|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
15181352|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181353|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15181354|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15181355|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15181356|NCT03930706|Estradiol|estradiol|mesh-list
15181357|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15181358|NCT03930706|Estrogens|estrogens|mesh-ancestor
15181359|NCT03930706|Hormones|hormones|mesh-ancestor
15181360|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181361|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181362|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15181363|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
15181364|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15181365|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15181366|NCT03930433|Nebivolol|nebivolol|mesh-list
15181367|NCT03930433|Diltiazem|diltiazem|mesh-list
15181368|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15181369|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
15092630|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
15092631|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15092632|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
15092633|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15092634|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
15092635|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092636|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092637|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
15092638|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
15092639|NCT02289768|Salicylates|salicylates|mesh-list
15092640|NCT02289768|Fluorouracil|fluorouracil|mesh-list
15092641|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
15092642|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092643|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15092644|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092645|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15092646|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
15092647|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092648|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15092649|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
15092650|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
15092651|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
15092652|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15092653|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092654|NCT02289768|Analgesics|analgesics|mesh-ancestor
15092655|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
15092656|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092657|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092658|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092659|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15092660|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092661|NCT02289807|Cisplatin|cisplatin|mesh-list
15092662|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092663|NCT02289924|Aflibercept|aflibercept|mesh-list
15092664|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15092665|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15092666|NCT02289924|Growth Substances|growth substances|mesh-ancestor
15092667|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092668|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
15092669|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092670|NCT02289937|Ropivacaine|ropivacaine|mesh-list
15092671|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
15092672|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
15092673|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092674|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092675|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
15092676|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092677|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
15092678|NCT02290002|Calcium|calcium|mesh-list
15092679|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15092680|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092681|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
15092682|NCT02290002|Coagulants|coagulants|mesh-ancestor
15092683|NCT02290054|Anesthetics|anesthetics|mesh-list
15092684|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092685|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092686|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
15092687|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
15092688|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092689|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15092690|NCT02290327|Pantoprazole|pantoprazole|mesh-list
15092691|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15092692|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092693|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15092694|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092695|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092696|NCT02290431|Dexamethasone|dexamethasone|mesh-list
15092697|NCT02290431|Bortezomib|bortezomib|mesh-list
15092698|NCT02290431|Panobinostat|panobinostat|mesh-list
15092699|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092700|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
15092701|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
15092702|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092703|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092704|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092705|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
15092706|NCT02290431|Hormones|hormones|mesh-ancestor
15173616|NCT04003467|Teriparatide|teriparatide|mesh-list
15092707|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092708|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15092709|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092710|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15092711|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092712|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092713|NCT02290470|Dexamethasone|dexamethasone|mesh-list
15092714|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
15092715|NCT02290470|Paclitaxel|paclitaxel|mesh-list
15092716|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15092717|NCT02290470|Carboplatin|carboplatin|mesh-list
15092718|NCT02290470|Olanzapine|olanzapine|mesh-list
15092719|NCT02290470|Palonosetron|palonosetron|mesh-list
15092720|NCT02290470|BB 1101|bb 1101|mesh-list
15092721|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15092722|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092723|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
15092724|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
15092725|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
15092726|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092727|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092728|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
15092729|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
15092730|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092731|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092732|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092733|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
15092734|NCT02290470|Hormones|hormones|mesh-ancestor
15092735|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092736|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15092737|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
15092738|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092739|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15092740|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15092741|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092742|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092743|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15092744|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15092745|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092746|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092747|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
15092748|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15092749|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15092750|NCT02290717|Fluticasone|fluticasone|mesh-list
15092751|NCT02290717|Xhance|xhance|mesh-list
15092752|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15092753|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15092754|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
15092755|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092756|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092757|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15092758|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
15092759|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
15092760|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15092761|NCT02291055|Durvalumab|durvalumab|mesh-list
15092762|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15092763|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092764|NCT02291094|Lidocaine|lidocaine|mesh-list
15092765|NCT02291094|Remifentanil|remifentanil|mesh-list
15092766|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
15092767|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
15092768|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092769|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092770|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
15092771|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092772|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15092773|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15092774|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15092775|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092776|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092777|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15092778|NCT02291094|Narcotics|narcotics|mesh-ancestor
15092779|NCT02291094|Analgesics|analgesics|mesh-ancestor
15092780|NCT02291211|Cisplatin|cisplatin|mesh-list
15092781|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092782|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15092783|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15092784|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15092785|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092786|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092787|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092788|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092789|NCT02291341|Analgesics|analgesics|mesh-ancestor
15092790|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
15092791|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092792|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
15092793|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092794|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
15092795|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15092796|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15092797|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15092798|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092799|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092800|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092801|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092802|NCT02291367|Analgesics|analgesics|mesh-ancestor
15092803|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
15092804|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092805|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
15092806|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092807|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
15092808|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
15092809|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15092810|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15092811|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15092812|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092813|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092814|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
15092815|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092816|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092817|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15092818|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092819|NCT02291471|T0001|t0001|mesh-list
15092820|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15092821|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15092822|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
15092823|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173617|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15173618|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173619|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15173620|NCT04003402|Ethanol|ethanol|mesh-list
15173621|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15173622|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173623|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173624|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173625|NCT04003610|Gemcitabine|gemcitabine|mesh-list
15173626|NCT04003610|Carboplatin|carboplatin|mesh-list
15173627|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
15173628|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173629|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15173630|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
15173631|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173632|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
15173633|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173634|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173635|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15173636|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
15173637|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173638|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173639|NCT04003350|Acetaminophen|acetaminophen|mesh-list
15173640|NCT04003350|Meloxicam|meloxicam|mesh-list
15173641|NCT04003350|Oxycodone|oxycodone|mesh-list
15173642|NCT04003350|Tramadol|tramadol|mesh-list
15173643|NCT04003350|Gabapentin|gabapentin|mesh-list
15173644|NCT04003350|Esomeprazole|esomeprazole|mesh-list
15173645|NCT04003350|Metaxalone|metaxalone|mesh-list
15173646|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15173647|NCT04003350|Narcotics|narcotics|mesh-ancestor
15173648|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092824|NCT02291536|Dronabinol|dronabinol|mesh-list
15092825|NCT02291536|Cannabidiol|cannabidiol|mesh-list
15092826|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
15092827|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
15092828|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092829|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092830|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092831|NCT02291536|Analgesics|analgesics|mesh-ancestor
15092832|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
15092833|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092834|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15092835|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15092836|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092837|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092838|NCT02291536|Hormones|hormones|mesh-ancestor
15092839|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092840|NCT02291562|Dronabinol|dronabinol|mesh-list
15092841|NCT02291562|Cannabidiol|cannabidiol|mesh-list
15092842|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
15092843|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
15092844|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092845|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092846|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15092847|NCT02291562|Analgesics|analgesics|mesh-ancestor
15092848|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
15092849|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092850|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15092851|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15092852|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092853|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092854|NCT02291562|Hormones|hormones|mesh-ancestor
15092855|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092856|NCT02291666|Tolbutamide|tolbutamide|mesh-list
15092857|NCT02291666|Midazolam|midazolam|mesh-list
15092858|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
15092859|NCT02291666|Caffeine|caffeine|mesh-list
15092860|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
15092861|NCT02291666|Bupropion|bupropion|mesh-list
15092862|NCT02291666|Omeprazole|omeprazole|mesh-list
15092863|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15092864|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15092865|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092866|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092867|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15092868|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15092869|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15092870|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15092871|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
15092872|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
15092873|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
15092874|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
15092875|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092876|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092877|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15092878|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092879|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15092880|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092881|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15092882|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15092883|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15092884|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15092885|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
15092886|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15092887|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
15092888|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15092889|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15092890|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092891|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
15092892|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15092893|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15092894|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
15092895|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
15092896|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15092897|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15092898|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15092899|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15092900|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15092901|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092902|NCT02291705|Tramadol|tramadol|mesh-list
15092903|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15092904|NCT02291705|Narcotics|narcotics|mesh-ancestor
15092905|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15092906|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092907|NCT02291705|Analgesics|analgesics|mesh-ancestor
15092908|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
15092909|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15092910|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15092911|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15092912|NCT02291796|Bezafibrate|bezafibrate|mesh-list
15092913|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15092914|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
15092915|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092916|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15092917|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
15092918|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15092919|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092920|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15092921|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092922|NCT02291887|Ranibizumab|ranibizumab|mesh-list
15092923|NCT02291887|Aflibercept|aflibercept|mesh-list
15092924|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15092925|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15092926|NCT02291887|Growth Substances|growth substances|mesh-ancestor
15092927|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092928|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
15092929|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092930|NCT02292069|Amlodipine|amlodipine|mesh-list
15092931|NCT02292069|Atorvastatin|atorvastatin|mesh-list
15092932|NCT02292069|Calcium|calcium|mesh-list
15092933|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15092934|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092935|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15092936|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15092937|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
15092938|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092939|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15092940|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15092941|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092942|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15092943|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15092944|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15092945|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
15092946|NCT02292121|Mannitol|mannitol|mesh-list
15092947|NCT02292121|Lactitol|lactitol|mesh-list
15092948|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15092949|NCT02292121|Diuretics|diuretics|mesh-ancestor
15092950|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
15092951|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092952|NCT02292121|Cathartics|cathartics|mesh-ancestor
15092953|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092954|NCT02292173|Sorafenib|sorafenib|mesh-list
15092955|NCT02292173|Trametinib|trametinib|mesh-list
15092956|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092957|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15092958|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15092959|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092960|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
15092961|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15092962|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15092963|NCT02292238|Benphothiamine|benphothiamine|mesh-list
15092964|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15092965|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
15092966|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092967|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
15092968|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
15092969|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092970|NCT02292277|Ticagrelor|ticagrelor|mesh-list
15092971|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15092972|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15092973|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15182265|NCT03923010|Itraconazole|itraconazole|mesh-list
15092974|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15092975|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
15092976|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15092977|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15092978|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092979|NCT02292290|Pioglitazone|pioglitazone|mesh-list
15092980|NCT02292290|Liraglutide|liraglutide|mesh-list
15092981|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15092982|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092983|NCT02292290|Incretins|incretins|mesh-ancestor
15092984|NCT02292290|Hormones|hormones|mesh-ancestor
15092985|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15092986|NCT02292303|Zinc|zinc|mesh-list
15092987|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
15092988|NCT02292303|Trace Elements|trace elements|mesh-ancestor
15092989|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
15092990|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15092991|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
15092992|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
15092993|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15092994|NCT02292303|Protective Agents|protective agents|mesh-ancestor
15092995|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15092996|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15092997|NCT02292459|Laxatives|laxatives|mesh-ancestor
15092998|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15092999|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
15093000|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15093001|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15093002|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15093003|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093004|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093005|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
15093006|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093007|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093008|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15093009|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093010|NCT02292550|Ceritinib|ceritinib|mesh-list
15093011|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093012|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15093013|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093014|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093015|NCT02292667|Acetaminophen|acetaminophen|mesh-list
15093016|NCT02292667|Morphine|morphine|mesh-list
15093017|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15093018|NCT02292667|Narcotics|narcotics|mesh-ancestor
15093019|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093020|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093021|NCT02292667|Analgesics|analgesics|mesh-ancestor
15093022|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
15093023|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093024|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093025|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
15093026|NCT02292732|Trametinib|trametinib|mesh-list
15093027|NCT02292732|Norinyl|norinyl|mesh-list
15093028|NCT02292732|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
15093029|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093030|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15093031|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093032|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093033|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15093034|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15093035|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15093036|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
15093037|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15093038|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093039|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15093040|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15093041|NCT02292732|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
15093042|NCT02292732|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15093043|NCT02292966|Asunaprevir|asunaprevir|mesh-list
15093044|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
15093045|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093046|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093047|NCT02292979|Doxorubicin|doxorubicin|mesh-list
15093048|NCT02292979|Bleomycin|bleomycin|mesh-list
15093049|NCT02292979|Dacarbazine|dacarbazine|mesh-list
15093050|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15093051|NCT02292979|Vinblastine|vinblastine|mesh-list
15093052|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15093053|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093054|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15093055|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15093056|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093057|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093058|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15093059|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
15093060|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15093061|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15093062|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
15093063|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
15093064|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
15093065|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
15093066|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15093067|NCT02293148|Glycine|glycine|mesh-list
15093068|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15093069|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093070|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15093071|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15093072|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093073|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093074|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093075|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15093076|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
15093077|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15093078|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093079|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15093080|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15093081|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15093082|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
15093083|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093084|NCT02293187|Vitamin D|vitamin d|mesh-list
15093085|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
14811080|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811081|NCT00843440|Bevacizumab|bevacizumab|mesh-list
14811082|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14811083|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811084|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811085|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14811086|NCT00843440|Growth Substances|growth substances|mesh-ancestor
14811087|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811088|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811089|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
14811090|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
14811091|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
14811092|NCT00843453|Vitamins|vitamins|mesh-ancestor
15093086|NCT02293187|Vitamins|vitamins|mesh-ancestor
15093087|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
15093088|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093089|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15093090|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15173649|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173650|NCT04003350|Analgesics|analgesics|mesh-ancestor
15173651|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
15173652|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173653|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
15173654|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15173655|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15173656|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15173657|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15173658|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15173659|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173660|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173661|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
15173662|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15173663|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173664|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15173665|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173666|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15173667|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
15173668|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093091|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
15093092|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
15093093|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15093094|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093095|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093096|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
15093097|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15093098|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093099|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093100|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
15093101|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
15093102|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
15093103|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093104|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093105|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
15093106|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093107|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
15093108|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15093109|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093110|NCT02293447|Lidocaine|lidocaine|mesh-list
15093111|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
15093112|NCT02293447|Anesthetics|anesthetics|mesh-list
15093113|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093114|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093115|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
15093116|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093117|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15093118|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15093119|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15093120|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093121|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093122|NCT02293525|Morphine|morphine|mesh-list
15093123|NCT02293525|Oxycodone|oxycodone|mesh-list
15093124|NCT02293525|Ropivacaine|ropivacaine|mesh-list
15093125|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15093126|NCT02293525|Narcotics|narcotics|mesh-ancestor
15093127|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093128|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093129|NCT02293525|Analgesics|analgesics|mesh-ancestor
15093130|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
15093131|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093132|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
15093133|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
15093134|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
15093135|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15093136|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093137|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
15093138|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
15093139|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093140|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
15093141|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093142|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093143|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093144|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093145|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093146|NCT02293590|Analgesics|analgesics|mesh-ancestor
15093147|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
15093148|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093149|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093150|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093151|NCT02293668|Letrozole|letrozole|mesh-list
15093152|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093153|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15093154|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15093155|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093156|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093157|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15093158|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
15093159|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093160|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093161|NCT02293681|Infliximab|infliximab|mesh-list
15093162|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
15093163|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093164|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093165|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14811093|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
14811094|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093166|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
15093167|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15093168|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15093169|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15093170|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
15093171|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15093172|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093173|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15093174|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15093175|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14811095|NCT00843453|Hematinics|hematinics|mesh-ancestor
14811096|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14811097|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14811098|NCT00843570|Nafarelin|nafarelin|mesh-list
14811099|NCT00843570|Estradiol|estradiol|mesh-list
15093176|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15093177|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093178|NCT02293785|Oxycodone|oxycodone|mesh-list
15093179|NCT02293785|Naloxone|naloxone|mesh-list
15093180|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15093181|NCT02293785|Narcotics|narcotics|mesh-ancestor
15093182|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093183|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093184|NCT02293785|Analgesics|analgesics|mesh-ancestor
15093185|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
15093186|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093187|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15093188|NCT02293824|Caffeine|caffeine|mesh-list
15093189|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
15093190|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093191|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15093192|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093193|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15093194|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093195|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14811100|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14811101|NCT00843570|Progesterone|progesterone|mesh-list
14811102|NCT00843570|Estrogens|estrogens|mesh-ancestor
14811103|NCT00843570|Hormones|hormones|mesh-ancestor
15093196|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15093197|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
15093198|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093199|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15093200|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15093201|NCT02293889|Vitamin D|vitamin d|mesh-list
15093202|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
15093203|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
15093204|NCT02293889|Vitamins|vitamins|mesh-list
15093205|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
15093206|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093207|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15093208|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15093209|NCT02293954|Antibodies|antibodies|mesh-list
15093210|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15093211|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
15093212|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093213|NCT02293980|Nivolumab|nivolumab|mesh-list
15093214|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15093215|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093216|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15093217|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093218|NCT02294006|Metformin|metformin|mesh-list
15093219|NCT02294006|Everolimus|everolimus|mesh-list
15093220|NCT02294006|Octreotide|octreotide|mesh-list
15093221|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15093222|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093223|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093224|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093225|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
15093226|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093227|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15093228|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14811104|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811105|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093229|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
15093230|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093231|NCT02294071|Acetaminophen|acetaminophen|mesh-list
15093232|NCT02294071|Ibuprofen|ibuprofen|mesh-list
15093233|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093234|NCT02294071|Analgesics|analgesics|mesh-ancestor
15093235|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
15093236|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093237|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093238|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
15093239|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093240|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093241|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093242|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15093243|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093244|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093245|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15093246|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15093247|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093248|NCT02294084|Incretins|incretins|mesh-ancestor
15093249|NCT02294084|Hormones|hormones|mesh-ancestor
15093250|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093251|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15093252|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
15093253|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093254|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093255|NCT02294110|Anesthetics|anesthetics|mesh-list
15093256|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093257|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093258|NCT02294162|Ketamine|ketamine|mesh-list
15093259|NCT02294162|Analgesics|analgesics|mesh-ancestor
15093260|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
15093261|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093262|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811106|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14811107|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
14811108|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14811109|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14811110|NCT00843570|Progestins|progestins|mesh-ancestor
14811111|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14811112|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
14811113|NCT00843661|Ezetimibe|ezetimibe|mesh-list
14811114|NCT00843661|Pravastatin|pravastatin|mesh-list
14811115|NCT00843661|Fenofibrate|fenofibrate|mesh-list
14811116|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14811117|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14811118|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
15093263|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15093264|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15093265|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
15093266|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
15093267|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093268|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15093269|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15093270|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093271|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093272|NCT02294240|Folic Acid|folic acid|mesh-list
14811119|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811120|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14811121|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15093273|NCT02294240|Hematinics|hematinics|mesh-ancestor
15093274|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
15093275|NCT02294240|Vitamins|vitamins|mesh-ancestor
15093276|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
15093277|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093278|NCT02294266|Ethanol|ethanol|mesh-list
15093279|NCT02294266|Methamphetamine|methamphetamine|mesh-list
15093280|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15093281|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093282|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093283|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093284|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15093285|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
14268972|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
14811122|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093286|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
15093287|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093288|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
15093289|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093290|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093291|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
15093292|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15093293|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15093294|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093295|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15093296|NCT02294279|Beclomethasone|beclomethasone|mesh-list
15093297|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093298|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
15093299|NCT02294279|Hormones|hormones|mesh-ancestor
15093300|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093301|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093302|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15093303|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
15093304|NCT02294292|Carvedilol|carvedilol|mesh-list
15093305|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15093306|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15093307|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
15093308|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093309|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093310|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093311|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15093312|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
15093313|NCT02294292|Protective Agents|protective agents|mesh-ancestor
15093314|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15093315|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093316|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15093317|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
15093318|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15093319|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15093320|NCT02294305|Vortioxetine|vortioxetine|mesh-list
15093321|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
15093322|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15093323|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15093324|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15093325|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093326|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093327|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15093328|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15093329|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093330|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093331|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093332|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
15093333|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15093334|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15093335|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15093336|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15093337|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
15093338|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093339|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
15093340|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093341|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093342|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15093343|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
15093344|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093345|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093346|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15093347|NCT02294357|Dexamethasone|dexamethasone|mesh-list
15093348|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
15093349|NCT02294357|Prednisone|prednisone|mesh-list
15093350|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
15093351|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15093352|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15093353|NCT02294357|Prednisolone|prednisolone|mesh-list
15093354|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
15093355|NCT02294357|Lenalidomide|lenalidomide|mesh-list
15093356|NCT02294357|Pomalidomide|pomalidomide|mesh-list
15093357|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15093358|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
15093359|NCT02294357|BB 1101|bb 1101|mesh-list
15093360|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093361|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
15093362|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
15093363|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093364|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093365|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093366|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
15093367|NCT02294357|Hormones|hormones|mesh-ancestor
15093368|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093369|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15093370|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093371|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
15093372|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093373|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093374|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
15093375|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15093376|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15093377|NCT02294357|Growth Substances|growth substances|mesh-ancestor
15093378|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
15093379|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15093380|NCT02294357|Protective Agents|protective agents|mesh-ancestor
15093381|NCT02294539|Losartan|losartan|mesh-list
15093382|NCT02294539|Amlodipine|amlodipine|mesh-list
15093383|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15093384|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15093385|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15093386|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093387|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093388|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15093389|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093390|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
15093391|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15093392|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15093393|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15093394|NCT02294539|Diuretics|diuretics|mesh-ancestor
15093395|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
15093396|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15093397|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
15093398|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
15093399|NCT02294552|Busulfan|busulfan|mesh-list
15093400|NCT02294552|Fludarabine|fludarabine|mesh-list
15093401|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
15093402|NCT02294552|Tacrolimus|tacrolimus|mesh-list
15093403|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093404|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
15093405|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093406|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093407|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15093408|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
15093409|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093410|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093411|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15093412|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15093413|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
15093414|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15093415|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093416|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15093417|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15093418|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
15093419|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15093420|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093421|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
15093422|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15093423|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
15093424|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093425|NCT02294591|Expectorants|expectorants|mesh-ancestor
15093426|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
15093427|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15093428|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
14268973|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14268974|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093429|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093430|NCT02294591|Protective Agents|protective agents|mesh-ancestor
15093431|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268975|NCT00399893|Octreotide|octreotide|mesh-list
14268976|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14268977|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14268978|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268979|NCT00400153|Ipratropium|ipratropium|mesh-list
14268980|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14268981|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
15093432|NCT02294591|Antidotes|antidotes|mesh-ancestor
15093433|NCT02294617|Nicotine|nicotine|mesh-list
15093434|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15093435|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
15093436|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093437|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093438|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15093439|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15093440|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
15093441|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093442|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093443|NCT02294643|Aspirin|aspirin|mesh-list
15093444|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
15093445|NCT02294643|Clopidogrel|clopidogrel|mesh-list
15093446|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093447|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093448|NCT02294643|Analgesics|analgesics|mesh-ancestor
15093449|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
15093450|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093451|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093452|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093453|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093454|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15093455|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15093456|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093457|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15093458|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15093459|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093460|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
15093461|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15093462|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15093463|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15093464|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
15093465|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093466|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15093467|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
15093468|NCT02294656|Triamcinolone|triamcinolone|mesh-list
15093469|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15093470|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15093471|NCT02294656|Ranibizumab|ranibizumab|mesh-list
15093472|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15093473|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15093474|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15093475|NCT02294656|Growth Substances|growth substances|mesh-ancestor
15093476|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093477|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
15093478|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093479|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093480|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
15093481|NCT02294656|Hormones|hormones|mesh-ancestor
15093482|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093483|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093484|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
15093485|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093486|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093487|NCT02294838|Citric Acid|citric acid|mesh-list
15093488|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
15093489|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
15093490|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14811123|NCT00843791|Pioglitazone|pioglitazone|mesh-list
14811124|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14811125|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14811126|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811127|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14811128|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
14811129|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811130|NCT00843908|Imidacloprid|imidacloprid|mesh-list
15093491|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
15093492|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
15093493|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173669|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173670|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173671|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15173672|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15173673|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15173674|NCT04003246|Durvalumab|durvalumab|mesh-list
15173675|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15173676|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173677|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173678|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
15173679|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173680|NCT04003207|Hormones|hormones|mesh-list
15173681|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173682|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173683|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15173684|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
15173685|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173686|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173687|NCT04003012|Lidocaine|lidocaine|mesh-list
15173688|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
15173689|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
15173690|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173691|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173692|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
15173693|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173694|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15173695|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15173696|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15173697|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15173698|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173699|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15173700|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
15173701|NCT04002635|Letrozole|letrozole|mesh-list
15173702|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15173703|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15173704|NCT04002635|Estradiol|estradiol|mesh-list
15173705|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15173706|NCT04002635|Progesterone|progesterone|mesh-list
15173707|NCT04002635|Estrogens|estrogens|mesh-ancestor
15173708|NCT04002635|Hormones|hormones|mesh-ancestor
15173709|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173710|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811131|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
14811132|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811133|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811134|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811135|NCT00843934|Epirubicin|epirubicin|mesh-list
14811136|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811137|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14811138|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15173711|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15173712|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
15173713|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15173714|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15173715|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173716|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15173717|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15173718|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173719|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173720|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15173721|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
15173722|NCT04002635|Progestins|progestins|mesh-ancestor
15173723|NCT04002323|Lamivudine|lamivudine|mesh-list
15173724|NCT04002323|Dolutegravir|dolutegravir|mesh-list
15173725|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15173726|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15173727|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173728|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173729|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
15173730|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173731|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14811139|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15173732|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15093494|NCT02294955|Amiodarone|amiodarone|mesh-list
15093495|NCT02294955|Sotalol|sotalol|mesh-list
15093496|NCT02294955|Flecainide|flecainide|mesh-list
15093497|NCT02294955|Dronedarone|dronedarone|mesh-list
15093498|NCT02294955|Propafenone|propafenone|mesh-list
15093499|NCT02294955|Disopyramide|disopyramide|mesh-list
15093500|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15093501|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
15093502|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15093503|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093504|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093505|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15093506|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15093507|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15093508|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093509|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15093510|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15093511|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15093512|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15093513|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15093514|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
15093515|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093516|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093517|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
15093518|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
15093519|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093520|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15093521|NCT02294994|Tirofiban|tirofiban|mesh-list
15093522|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15093523|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15093524|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093525|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15093526|NCT02295046|Amlodipine|amlodipine|mesh-list
15093527|NCT02295046|Atorvastatin|atorvastatin|mesh-list
15093528|NCT02295046|Calcium|calcium|mesh-list
15093529|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15093530|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093531|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15093532|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15093533|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
14811140|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811141|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811142|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14811143|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14811144|NCT00844012|Estradiol|estradiol|mesh-list
14811145|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14811146|NCT00844012|Estrogens|estrogens|mesh-ancestor
14811147|NCT00844012|Hormones|hormones|mesh-ancestor
14811148|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811149|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811150|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14811151|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
15093534|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093535|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15093536|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15093537|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093538|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15093539|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15093540|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15093541|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
15093542|NCT02295124|Oxycodone|oxycodone|mesh-list
15093543|NCT02295124|Hydromorphone|hydromorphone|mesh-list
15093544|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15093545|NCT02295124|Narcotics|narcotics|mesh-ancestor
15093546|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093547|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093548|NCT02295124|Analgesics|analgesics|mesh-ancestor
15093549|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
15093550|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093551|NCT02295150|Nadroparin|nadroparin|mesh-list
15093552|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
15093553|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14268982|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811152|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15093554|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15093555|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093556|NCT02295189|Triamcinolone|triamcinolone|mesh-list
15093557|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15093558|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15093559|NCT02295189|Ketorolac|ketorolac|mesh-list
15093560|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15093561|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15093562|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093563|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
15093564|NCT02295189|Hormones|hormones|mesh-ancestor
15093565|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093566|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093567|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093568|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
15093569|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093570|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093571|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093572|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14268983|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14268984|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14268985|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
14268986|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15093573|NCT02295189|Analgesics|analgesics|mesh-ancestor
15093574|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
15093575|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093576|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093577|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15093578|NCT02295475|Warfarin|warfarin|mesh-list
15093579|NCT02295475|Apixaban|apixaban|mesh-list
15093580|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
15093581|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15093582|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
15093583|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15093584|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
15093585|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093586|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093587|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
15093588|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15093589|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
15093590|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093591|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093592|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15093593|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
15093594|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15093595|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
15093596|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093597|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093598|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15093599|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
15093600|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
15093601|NCT02295566|Protective Agents|protective agents|mesh-ancestor
15093602|NCT02295709|Dexamethasone|dexamethasone|mesh-list
15093603|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
15093604|NCT02295709|BB 1101|bb 1101|mesh-list
15093605|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093606|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
15093607|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
15093608|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093609|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093610|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093611|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
15093612|NCT02295709|Hormones|hormones|mesh-ancestor
15093613|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093614|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15093615|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093616|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
15093617|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093618|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093619|NCT02295722|Gemcitabine|gemcitabine|mesh-list
15093620|NCT02295722|Melphalan|melphalan|mesh-list
15093621|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15093622|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
15093623|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093624|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093625|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
15093626|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093627|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093628|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093629|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
15093630|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093631|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15093632|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
15093633|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15093634|NCT02295748|Deflazacort|deflazacort|mesh-list
15093635|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093636|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093637|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
15093638|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093639|NCT02295787|Ketamine|ketamine|mesh-list
15093640|NCT02295787|Analgesics|analgesics|mesh-ancestor
15093641|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
15093642|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093643|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093644|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14811153|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14811154|NCT00844064|Trabedersen|trabedersen|mesh-list
14811155|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811156|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
14811157|NCT00844142|Etanercept|etanercept|mesh-list
14811158|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14811159|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14811160|NCT00844142|Analgesics|analgesics|mesh-ancestor
15093645|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15093646|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
15093647|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
15093648|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093649|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15093650|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15093651|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093652|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093653|NCT02295826|Aspirin|aspirin|mesh-list
15093654|NCT02295826|Dabigatran|dabigatran|mesh-list
15093655|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093656|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093657|NCT02295826|Analgesics|analgesics|mesh-ancestor
15093658|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
15093659|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093660|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093661|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093662|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093663|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15093664|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15093665|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093666|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15093667|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15093668|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093669|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
15093670|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
15093671|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15093672|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
15093673|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
15093674|NCT02295852|Calcium|calcium|mesh-list
15093675|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15093676|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093677|NCT02295930|Bevacizumab|bevacizumab|mesh-list
15093678|NCT02295930|Cetuximab|cetuximab|mesh-list
15093679|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15093680|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093681|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15093682|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15093683|NCT02295930|Growth Substances|growth substances|mesh-ancestor
15093684|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093685|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
15093686|NCT02296021|Amoxicillin|amoxicillin|mesh-list
15093687|NCT02296021|Clarithromycin|clarithromycin|mesh-list
15093688|NCT02296021|Esomeprazole|esomeprazole|mesh-list
14811161|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
15093689|NCT02296021|Bismuth|bismuth|mesh-list
15093690|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15093691|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093692|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15093693|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093694|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15093695|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093696|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093697|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15093698|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15093699|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15093700|NCT02296021|Antacids|antacids|mesh-ancestor
14268987|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
14268988|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093701|NCT02296047|Bromides|bromides|mesh-list
15093702|NCT02296047|Albuterol|albuterol|mesh-list
15093703|NCT02296047|Ipratropium|ipratropium|mesh-list
15093704|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
15093705|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15093706|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
15093707|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093708|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093709|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15093710|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
15093711|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
15093712|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15093713|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15093714|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15093715|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15093716|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
15093717|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093718|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093719|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15093720|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
15093721|NCT02296073|Fentanyl|fentanyl|mesh-list
15093722|NCT02296073|Midazolam|midazolam|mesh-list
15093723|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
15093724|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15093725|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093726|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093727|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093728|NCT02296073|Analgesics|analgesics|mesh-ancestor
15093729|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
15093730|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093731|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15093732|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15093733|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15093734|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
15093735|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093736|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093737|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15093738|NCT02296073|Narcotics|narcotics|mesh-ancestor
15093739|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15093740|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15093741|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
15093742|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
15093743|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15093744|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15093745|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15093746|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
15093747|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
15093748|NCT02296203|Irinotecan|irinotecan|mesh-list
15093749|NCT02296203|Cetuximab|cetuximab|mesh-list
15093750|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15093751|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15093752|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093753|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093754|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093755|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15093756|NCT02296281|Pirfenidone|pirfenidone|mesh-list
15093757|NCT02296281|Analgesics|analgesics|mesh-ancestor
15093758|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
15093759|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093760|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093761|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093762|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093763|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093764|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093765|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268989|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093766|NCT02296333|Ondansetron|ondansetron|mesh-list
15093767|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
15093768|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
15093769|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093770|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093771|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093772|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
15093773|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
15093774|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15093775|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
15093776|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093777|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093778|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15093779|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15093780|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093781|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15093782|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15093783|NCT02296359|Vaccines|vaccines|mesh-list
15093784|NCT02296359|Immunologic Factors|immunologic factors|mesh-ancestor
15093785|NCT02296359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093786|NCT02296398|Romidepsin|romidepsin|mesh-list
15093787|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15093788|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093789|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
15093790|NCT02296411|Bromides|bromides|mesh-list
15093791|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
15093792|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15093793|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15093794|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15093795|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
15093796|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093797|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093798|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093799|NCT02296463|Vaccines|vaccines|mesh-list
15093800|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
15093801|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173733|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15173734|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15173735|NCT04002271|Propofol|propofol|mesh-list
15173736|NCT04002271|Sevoflurane|sevoflurane|mesh-list
15173737|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
15173738|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173739|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173740|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15173741|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15173742|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
15173743|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15173744|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15173745|NCT04002700|Haloperidol|haloperidol|mesh-list
15173746|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
15173747|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
15173748|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
15173749|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
15173750|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173751|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173752|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173753|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15173754|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173755|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15173756|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15173757|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
15173758|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173759|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173760|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15173761|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15173762|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173763|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
15173764|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15173765|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15173766|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15173767|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173768|NCT04002349|Budesonide|budesonide|mesh-list
15173769|NCT04002349|Levocabastine|levocabastine|mesh-list
15173770|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14268990|NCT00400179|Cisplatin|cisplatin|mesh-list
15173771|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15173772|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
15093802|NCT02296567|Bevacizumab|bevacizumab|mesh-list
15093803|NCT02296567|Ranibizumab|ranibizumab|mesh-list
15093804|NCT02296567|Aflibercept|aflibercept|mesh-list
15093805|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15093806|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093807|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15093808|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15093809|NCT02296567|Growth Substances|growth substances|mesh-ancestor
15093810|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093811|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
15093812|NCT02296671|Leucovorin|leucovorin|mesh-list
15093813|NCT02296671|Fluorouracil|fluorouracil|mesh-list
15093814|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
15093815|NCT02296671|Pemetrexed|pemetrexed|mesh-list
15093816|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
15093817|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093818|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15093819|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093820|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093821|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
15093822|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093823|NCT02296671|Antidotes|antidotes|mesh-ancestor
15093824|NCT02296671|Protective Agents|protective agents|mesh-ancestor
15093825|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
15093826|NCT02296671|Vitamins|vitamins|mesh-ancestor
15093827|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
15093828|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093829|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15093830|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15093831|NCT02296723|Valganciclovir|valganciclovir|mesh-list
15093832|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
15093833|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093834|NCT02296749|Sirolimus|sirolimus|mesh-list
15093835|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15093836|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093837|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15093838|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093839|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
15093840|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093841|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
15093842|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093843|NCT02296762|Sirolimus|sirolimus|mesh-list
15093844|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15093845|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093846|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14268991|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14268992|NCT00400205|Docetaxel|docetaxel|mesh-list
15093847|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093848|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
15093849|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093850|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
15093851|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093852|NCT02296996|Trametinib|trametinib|mesh-list
15093853|NCT02296996|Dabrafenib|dabrafenib|mesh-list
15093854|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093855|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15093856|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093857|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093858|NCT02297204|Aflibercept|aflibercept|mesh-list
15093859|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15093860|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15093861|NCT02297204|Growth Substances|growth substances|mesh-ancestor
15093862|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093863|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
15093864|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093865|NCT02297217|Paclitaxel|paclitaxel|mesh-list
15093866|NCT02297217|Carboplatin|carboplatin|mesh-list
15093867|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15093868|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093869|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
15093870|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
15093871|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
15093872|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268993|NCT00400205|Fluorouracil|fluorouracil|mesh-list
15093873|NCT02297386|Testosterone|testosterone|mesh-list
15093874|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
15093875|NCT02297386|Androgens|androgens|mesh-ancestor
15093876|NCT02297386|Hormones|hormones|mesh-ancestor
15173773|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093877|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093878|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093879|NCT02297477|Artesunate|artesunate|mesh-list
15093880|NCT02297477|Atovaquone|atovaquone|mesh-list
15093881|NCT02297477|Proguanil|proguanil|mesh-list
15093882|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
15093883|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
15093884|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15093885|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15093886|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093887|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093888|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
15093889|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
15093890|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15093891|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
15093892|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093893|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093894|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
15093895|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15093896|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15093897|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093898|NCT02297568|Vitamin D|vitamin d|mesh-list
15093899|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
15093900|NCT02297568|Vitamins|vitamins|mesh-ancestor
15093901|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
15093902|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093903|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15093904|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15093905|NCT02297594|Ziresovir|ziresovir|mesh-list
15093906|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
15093907|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093908|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
15093909|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15093910|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093911|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15093912|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093913|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15093914|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
15093915|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15093916|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15093917|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15093918|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15093919|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093920|NCT02297854|Valganciclovir|valganciclovir|mesh-list
15093921|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
15093922|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093923|NCT02297906|Ketorolac|ketorolac|mesh-list
15093924|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15093925|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15093926|NCT02297906|Analgesics|analgesics|mesh-ancestor
15093927|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
15093928|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093929|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093930|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093931|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093932|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15093933|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093934|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093935|NCT02297945|Metyrapone|metyrapone|mesh-list
15093936|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
15093937|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093938|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093939|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
15093940|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15093941|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093942|NCT02298010|Capecitabine|capecitabine|mesh-list
15093943|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
15093944|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15093945|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
15093946|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093947|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093948|NCT02298062|Infliximab|infliximab|mesh-list
15093949|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
15093950|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093951|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15093952|NCT02298088|Clopidogrel|clopidogrel|mesh-list
15093953|NCT02298088|Ticagrelor|ticagrelor|mesh-list
15093954|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15093955|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15093956|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15093957|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15093958|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
15093959|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15093960|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093961|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093962|NCT02298101|Edetic Acid|edetic acid|mesh-list
15093963|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
15093964|NCT02298101|Antidotes|antidotes|mesh-ancestor
15093965|NCT02298101|Protective Agents|protective agents|mesh-ancestor
15093966|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093967|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
15093968|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
15093969|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093970|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15093971|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
15093972|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15173774|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173775|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15173776|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
15173777|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
15173778|NCT04002349|Hormones|hormones|mesh-ancestor
15173779|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173780|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15173781|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15173782|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
15173783|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
15173784|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173785|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173786|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
15173787|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
15173788|NCT04002115|Busulfan|busulfan|mesh-list
15173789|NCT04002115|Fludarabine|fludarabine|mesh-list
15173790|NCT04002115|Clofarabine|clofarabine|mesh-list
15173791|NCT04002115|Tacrolimus|tacrolimus|mesh-list
15173792|NCT04002115|Sargramostim|sargramostim|mesh-list
15173793|NCT04002115|Lenograstim|lenograstim|mesh-list
15173794|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15173795|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
15173796|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173797|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173798|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15173799|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
15173800|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173801|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173802|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15173803|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15173804|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
15173805|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15173806|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173807|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15173808|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15173809|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
15173810|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15173811|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173812|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15173813|NCT04002141|Letrozole|letrozole|mesh-list
15173814|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173815|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15173816|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15173817|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173818|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173819|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15173820|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
15173821|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173822|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173823|NCT04001959|Fluorides|fluorides|mesh-list
15173824|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
13996165|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15173825|NCT04001959|Protective Agents|protective agents|mesh-ancestor
15173826|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173827|NCT04002089|Bupivacaine|bupivacaine|mesh-list
15093973|NCT02298153|Atezolizumab|atezolizumab|mesh-list
15093974|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093975|NCT02298166|Cytarabine|cytarabine|mesh-list
15093976|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
14811162|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811163|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811164|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811165|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811166|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15093977|NCT02298166|Crenolanib|crenolanib|mesh-list
15093978|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15093979|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
15093980|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15093981|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15093982|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
15093983|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15093984|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15093985|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
15093986|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093987|NCT02298166|Analgesics|analgesics|mesh-ancestor
15093988|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
15093989|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15093990|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15093991|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15093992|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15093993|NCT02298205|Beclomethasone|beclomethasone|mesh-list
15093994|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15093995|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
15093996|NCT02298205|Hormones|hormones|mesh-ancestor
15093997|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15093998|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15093999|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15094000|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
15094001|NCT02298218|Meloxicam|meloxicam|mesh-list
15094002|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15094003|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094004|NCT02298218|Analgesics|analgesics|mesh-ancestor
15094005|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
15094006|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094007|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094008|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094009|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094010|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15094011|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15094012|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094013|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094014|NCT02298283|Prednisone|prednisone|mesh-list
15094015|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
15094016|NCT02298283|Doxorubicin|doxorubicin|mesh-list
15094017|NCT02298283|Etoposide|etoposide|mesh-list
15094018|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15094019|NCT02298283|Vincristine|vincristine|mesh-list
15094020|NCT02298283|Bleomycin|bleomycin|mesh-list
15094021|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15094022|NCT02298283|Procarbazine|procarbazine|mesh-list
15094023|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094024|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
15094025|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094026|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094027|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15094028|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
15094029|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094030|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094031|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15094032|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15094033|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15094034|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15094035|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094036|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094037|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
14811167|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14811168|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
14811169|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811170|NCT00844155|Oseltamivir|oseltamivir|mesh-list
14811171|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
15094038|NCT02298283|Hormones|hormones|mesh-ancestor
15173828|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
15094039|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094040|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15094041|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15094042|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
15094043|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
15094044|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
15094045|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15094046|NCT02298335|Prednisone|prednisone|mesh-list
15094047|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094048|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
15094049|NCT02298335|Hormones|hormones|mesh-ancestor
15094050|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094051|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094052|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15094053|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094054|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
15094055|NCT02298348|Sorafenib|sorafenib|mesh-list
15094056|NCT02298348|Topotecan|topotecan|mesh-list
15094057|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094058|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
15094059|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094060|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094061|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15094062|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
15094063|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094064|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094065|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15094066|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15094067|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094068|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15094069|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15094070|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15094071|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
15094072|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094073|NCT02298530|Caffeine|caffeine|mesh-list
15094074|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15094075|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094076|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14811172|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811173|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811174|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811175|NCT00844168|Sorafenib|sorafenib|mesh-list
14811176|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094077|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094078|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094079|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15094080|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15094081|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
15094082|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094083|NCT02298582|Fentanyl|fentanyl|mesh-list
15094084|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15094085|NCT02298582|Narcotics|narcotics|mesh-ancestor
15094086|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094087|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094088|NCT02298582|Analgesics|analgesics|mesh-ancestor
15094089|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
15094090|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094091|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15094092|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15094093|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
15094094|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
15094095|NCT02298595|Cetuximab|cetuximab|mesh-list
15094096|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094097|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15094098|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
15094099|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15094100|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14811177|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14811178|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811179|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814415|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14814416|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
14814417|NCT00863161|Lesogaberan|lesogaberan|mesh-list
14814418|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811180|NCT00844207|Azithromycin|azithromycin|mesh-list
14811181|NCT00844207|Chloroquine|chloroquine|mesh-list
14811182|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14811183|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15094101|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15094102|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15094103|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094104|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
15094105|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094106|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094107|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15094108|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094109|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
15094110|NCT02298985|Curcumin|curcumin|mesh-list
15094111|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
15094112|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15094113|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094114|NCT02298985|Analgesics|analgesics|mesh-ancestor
15094115|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
15094116|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094117|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094118|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094119|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094120|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094121|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094122|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094123|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15094124|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094125|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15094126|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
15094127|NCT02299024|Narcotics|narcotics|mesh-ancestor
15094128|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094129|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094130|NCT02299024|Analgesics|analgesics|mesh-ancestor
15094131|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
15094132|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094133|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
15094134|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15094135|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094136|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094137|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094138|NCT02299063|Analgesics|analgesics|mesh-ancestor
15094139|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
15094140|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094141|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15094142|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15094143|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15094144|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
15094145|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094146|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094147|NCT02299115|Prednisolone|prednisolone|mesh-list
15094148|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15094149|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
15094150|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14811184|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811185|NCT00844207|Amebicides|amebicides|mesh-ancestor
14811186|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14811187|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14811188|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
14811189|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811190|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14811191|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14811192|NCT00844207|Analgesics|analgesics|mesh-ancestor
14811193|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
14811194|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811195|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811196|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811197|NCT00844207|Filaricides|filaricides|mesh-ancestor
14811198|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
14811199|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
14811200|NCT00844233|Irinotecan|irinotecan|mesh-list
14811201|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14811202|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14811203|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094151|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
15094152|NCT02299115|Vigabatrin|vigabatrin|mesh-list
15094153|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15094154|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
15094155|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094156|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
15094157|NCT02299115|Hormones|hormones|mesh-ancestor
15094158|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094159|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094160|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15094161|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094162|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
15094163|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
15094164|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094165|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15094166|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15094167|NCT02299115|Protective Agents|protective agents|mesh-ancestor
15094168|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
15094169|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094170|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094171|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
15094172|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094173|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
15094174|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15094175|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094176|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094177|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094178|NCT02299232|Analgesics|analgesics|mesh-ancestor
15094179|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
15094180|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094181|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15094182|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15094183|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15094184|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
15094185|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094186|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094187|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15094188|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15094189|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15094190|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
15094191|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094192|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15094193|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15094194|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094195|NCT02299271|Ropivacaine|ropivacaine|mesh-list
15094196|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
15094197|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
15094198|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094199|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094200|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
15094201|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094202|NCT02299310|Valsartan|valsartan|mesh-list
15094203|NCT02299310|Perindopril|perindopril|mesh-list
15094204|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15094205|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15094206|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15094207|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094208|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15094209|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
15094210|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094211|NCT02299401|Misoprostol|misoprostol|mesh-list
15094212|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15094213|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
15094214|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094215|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094216|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15094217|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15094218|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
15094219|NCT02299440|Ketamine|ketamine|mesh-list
15094220|NCT02299440|Analgesics|analgesics|mesh-ancestor
15094221|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
15094222|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094223|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094224|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15094225|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15094226|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
15094227|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
15094228|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094229|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15094230|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15094231|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094232|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094233|NCT02299518|Cytarabine|cytarabine|mesh-list
15094234|NCT02299518|Etoposide|etoposide|mesh-list
15094235|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
15094236|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
15094237|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15094238|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094239|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15094240|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15094241|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094242|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094243|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15094244|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
15094245|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
15094246|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094247|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094248|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
15094249|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094250|NCT02299518|Analgesics|analgesics|mesh-ancestor
14268994|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094251|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
15094252|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094253|NCT02299557|Phenylephrine|phenylephrine|mesh-list
15094254|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
15094255|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15094256|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15094257|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
15094258|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094259|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094260|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094261|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
15094262|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
15094263|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094264|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
15094265|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15094266|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
15094267|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15094268|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
14268995|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
14268996|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
14268997|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
14268998|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14268999|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
14269000|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14269001|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269002|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
14269003|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269004|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
14269005|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14269006|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269007|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14811204|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094269|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15094270|NCT02299557|Protective Agents|protective agents|mesh-ancestor
15094271|NCT02299687|Omeprazole|omeprazole|mesh-list
15094272|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15094273|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15094274|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14269008|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
14811205|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811206|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
14811207|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14811208|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
14811209|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811210|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811211|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14811212|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094275|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094276|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094277|NCT02299726|Spironolactone|spironolactone|mesh-list
15094278|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15094279|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
15094280|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094281|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094282|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15094283|NCT02299726|Diuretics|diuretics|mesh-ancestor
15094284|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
15094285|NCT02299765|Gemcitabine|gemcitabine|mesh-list
15094286|NCT02299765|Carboplatin|carboplatin|mesh-list
15094287|NCT02299765|Gefitinib|gefitinib|mesh-list
15094288|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094289|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15094290|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
15094291|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094292|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
15094293|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094294|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094295|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094296|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
15094297|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094298|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15094299|NCT02299817|Denosumab|denosumab|mesh-list
15094300|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15094301|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094302|NCT02299882|Vancomycin|vancomycin|mesh-list
15094303|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15094304|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173829|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
15173830|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173831|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173832|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
15173833|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173834|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
15173835|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173836|NCT04002011|Warfarin|warfarin|mesh-list
15173837|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
15173838|NCT04002011|Dabigatran|dabigatran|mesh-list
15173839|NCT04002011|Apixaban|apixaban|mesh-list
15173840|NCT04002011|Edoxaban|edoxaban|mesh-list
15173841|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
15173842|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15173843|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
15173844|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15173845|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
15173846|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173847|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173848|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
15173849|NCT04002024|Salicylates|salicylates|mesh-list
15173850|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173851|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
15173852|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
15173853|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
15173854|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15173855|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15173856|NCT04002024|Analgesics|analgesics|mesh-ancestor
15173857|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
15173858|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173859|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173860|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173861|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15173862|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15173863|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173864|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173865|NCT04001712|Caffeine|caffeine|mesh-list
15173866|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
15173867|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173868|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15173869|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173870|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13996166|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
13996167|NCT02922166|SRX246|srx246|mesh-list
15173871|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173872|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15173873|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15094305|NCT02299908|Bupivacaine|bupivacaine|mesh-list
15094306|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
15094307|NCT02299908|Anesthetics|anesthetics|mesh-list
15094308|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15094309|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094310|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094311|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
15094312|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094313|NCT02300038|Lidocaine|lidocaine|mesh-list
15094314|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
15094315|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
15094316|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094317|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094318|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
15094319|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094320|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15094321|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15094322|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15094323|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15094324|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094325|NCT02300064|Antioxidants|antioxidants|mesh-list
15094326|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094327|NCT02300064|Protective Agents|protective agents|mesh-ancestor
15094328|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094329|NCT02300194|Morphine|morphine|mesh-list
15094330|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15094331|NCT02300194|Narcotics|narcotics|mesh-ancestor
15094332|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094333|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094334|NCT02300194|Analgesics|analgesics|mesh-ancestor
15094335|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
15094336|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094337|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
15094338|NCT02300350|Digoxin|digoxin|mesh-list
15094339|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15094340|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15094341|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094342|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094343|NCT02300350|Protective Agents|protective agents|mesh-ancestor
15094344|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094345|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15094346|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15094347|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
15094348|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15094349|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15094350|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15094351|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
15094352|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094353|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15094354|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15094355|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094356|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15094357|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15094358|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094359|NCT02300376|Edetic Acid|edetic acid|mesh-list
15094360|NCT02300376|Calcium|calcium|mesh-list
15094361|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
15094362|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15094363|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094364|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
15094365|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15094366|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
15094367|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
15094368|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094369|NCT02300376|Antidotes|antidotes|mesh-ancestor
15094370|NCT02300376|Protective Agents|protective agents|mesh-ancestor
15094371|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15094372|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
15094373|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
15094374|NCT02300428|Trace Elements|trace elements|mesh-ancestor
15094375|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
15094376|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094377|NCT02300428|Hematinics|hematinics|mesh-ancestor
15094378|NCT02300623|Lamivudine|lamivudine|mesh-list
15094379|NCT02300623|Stavudine|stavudine|mesh-list
15094380|NCT02300623|Indinavir|indinavir|mesh-list
15094381|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15094382|NCT02300623|Interleukin-2|interleukin-2|mesh-list
15094383|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15094384|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15094385|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094386|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094387|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
15094388|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094389|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15094390|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094391|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094392|NCT02300623|Analgesics|analgesics|mesh-ancestor
14269009|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269010|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269011|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269012|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094393|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
15094394|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094395|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094396|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
15094397|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15094398|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15094399|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
15094400|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
15094401|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15094402|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094403|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094404|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094405|NCT02300649|Analgesics|analgesics|mesh-ancestor
15094406|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
15094407|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094408|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15094409|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15094410|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15094411|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
15094412|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094413|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094414|NCT02300688|Maleic acid|maleic acid|mesh-list
15094415|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094416|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094417|NCT02300701|Omalizumab|omalizumab|mesh-list
15094418|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15094419|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15094420|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
15094421|NCT02300740|Niacinamide|niacinamide|mesh-list
15094422|NCT02300740|Niacin|niacin|mesh-list
15094423|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
15094424|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
15094425|NCT02300740|Vitamins|vitamins|mesh-ancestor
15094426|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
15094427|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094428|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15094429|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
15094430|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094431|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15094432|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
15094433|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15094434|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15094435|NCT02300922|Antibodies|antibodies|mesh-list
15094436|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
15094437|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094438|NCT02300935|Paclitaxel|paclitaxel|mesh-list
15094439|NCT02300935|Trametinib|trametinib|mesh-list
15094440|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15094441|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094442|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
15094443|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
15094444|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
15094445|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094446|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15094447|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094448|NCT02300948|Folic Acid|folic acid|mesh-list
15094449|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
15094450|NCT02300948|Hematinics|hematinics|mesh-ancestor
15094451|NCT02300948|Vitamins|vitamins|mesh-ancestor
15094452|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
15094453|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094454|NCT02301000|Metronidazole|metronidazole|mesh-list
15094455|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094456|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15094457|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15094458|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15094459|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15094460|NCT02301026|Hematinics|hematinics|mesh-ancestor
15094461|NCT02301091|Mitomycins|mitomycins|mesh-list
15094462|NCT02301091|Mitomycin|mitomycin|mesh-list
15094463|NCT02301091|Pirarubicin|pirarubicin|mesh-list
15094464|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15094465|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094466|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
15094467|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094468|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15094469|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094470|NCT02301130|Durvalumab|durvalumab|mesh-list
15094471|NCT02301130|Tremelimumab|tremelimumab|mesh-list
15094472|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
15094473|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15094474|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15094475|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094476|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
15094477|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094478|NCT02301208|Nedaplatin|nedaplatin|mesh-list
15094479|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094480|NCT02301221|Vancomycin|vancomycin|mesh-list
15094481|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15094482|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094483|NCT02301286|Aspirin|aspirin|mesh-list
15094484|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15094485|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094486|NCT02301286|Analgesics|analgesics|mesh-ancestor
15094487|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
15094488|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094489|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094490|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094491|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094492|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15094493|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15094494|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094495|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15094496|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15094497|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094498|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
15094499|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
15094500|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094501|NCT02301494|Fluocinonide|fluocinonide|mesh-list
15094502|NCT02301494|Imiquimod|imiquimod|mesh-list
15094503|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15094504|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
15094505|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094506|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094507|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
15094508|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094509|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
15094510|NCT02301494|Hormones|hormones|mesh-ancestor
15094511|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094512|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15094513|NCT02301650|Tenofovir|tenofovir|mesh-list
15094514|NCT02301650|Lamivudine|lamivudine|mesh-list
15094515|NCT02301650|Telbivudine|telbivudine|mesh-list
15094516|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
15094517|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094518|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15094519|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15094520|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094521|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094522|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15094523|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15173874|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
15173875|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173876|NCT04001855|Acetic Acid|acetic acid|mesh-list
15173877|NCT04001855|Retinol acetate|retinol acetate|mesh-list
15094524|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
15094525|NCT02301676|Propofol|propofol|mesh-list
15094526|NCT02301676|Sevoflurane|sevoflurane|mesh-list
15094527|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15094528|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094529|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094530|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15094531|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
15094532|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
15094533|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094534|NCT02301676|Analgesics|analgesics|mesh-ancestor
15094535|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
15094536|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094537|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15094538|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15094539|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15094540|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
15094541|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094542|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094543|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15094544|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15094545|NCT02301715|Oxytocin|oxytocin|mesh-list
15094546|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
15094547|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094548|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094549|NCT02301780|Aspirin|aspirin|mesh-list
15094550|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15094551|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15094552|NCT02301780|Analgesics|analgesics|mesh-ancestor
15094553|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
15094554|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094555|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094556|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094557|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094558|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15094559|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15094560|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094561|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15094562|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15094563|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094564|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
15094565|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15094566|NCT02301806|Glimepiride|glimepiride|mesh-list
15094567|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15094568|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094569|NCT02301806|Incretins|incretins|mesh-ancestor
15094570|NCT02301806|Hormones|hormones|mesh-ancestor
15094571|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094572|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15094573|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
15094574|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094575|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094576|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15094577|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094578|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
15094579|NCT02301910|Tenecteplase|tenecteplase|mesh-list
15094580|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15094581|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15094582|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094583|NCT02301949|Thalidomide|thalidomide|mesh-list
15094584|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094585|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
15094586|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094587|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
15094588|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15094589|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094590|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15094591|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15094592|NCT02301949|Growth Substances|growth substances|mesh-ancestor
15094593|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
15094594|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094595|NCT02301962|Panitumumab|panitumumab|mesh-list
15094596|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15094597|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094598|NCT02302170|Vaccines|vaccines|mesh-list
15094599|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
15094600|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094601|NCT02302209|Oxytocin|oxytocin|mesh-list
15094602|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
15094603|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094604|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094605|NCT02302274|Flecainide|flecainide|mesh-list
15094606|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15094607|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15094608|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15094609|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15094610|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094611|NCT02302326|Folic Acid|folic acid|mesh-list
15094612|NCT02302326|Inositol|inositol|mesh-list
15094613|NCT02302326|Metformin|metformin|mesh-list
15094614|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15094615|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094616|NCT02302326|Hematinics|hematinics|mesh-ancestor
15094617|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
15094618|NCT02302326|Vitamins|vitamins|mesh-ancestor
15094619|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
15094620|NCT02302378|Bupivacaine|bupivacaine|mesh-list
15094621|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
15094622|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
15094623|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094624|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094625|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
15094626|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094627|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15094628|NCT02302430|Oxytocin|oxytocin|mesh-list
15094629|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
15094630|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094631|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094632|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
15094633|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15094634|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15094635|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094636|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
15094637|NCT02302456|Coagulants|coagulants|mesh-ancestor
15094638|NCT02302469|Lenalidomide|lenalidomide|mesh-list
15094639|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
15094640|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094641|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15094642|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15094643|NCT02302469|Growth Substances|growth substances|mesh-ancestor
15094644|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
15094645|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094646|NCT02302495|Prednisone|prednisone|mesh-list
15094647|NCT02302495|Melphalan|melphalan|mesh-list
15094648|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094649|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
15094650|NCT02302495|Hormones|hormones|mesh-ancestor
15094651|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094652|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094653|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15094654|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094655|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15094656|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
15094657|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094658|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15094659|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094660|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
15094661|NCT02302508|Clopidogrel|clopidogrel|mesh-list
15094662|NCT02302508|Ticagrelor|ticagrelor|mesh-list
15094663|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15094664|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15094665|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15094666|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15094667|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15094668|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
15094669|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094670|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094671|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094672|NCT02302547|Ritonavir|ritonavir|mesh-list
15094673|NCT02302547|Lopinavir|lopinavir|mesh-list
15094674|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15094675|NCT02302547|Darunavir|darunavir|mesh-list
15094676|NCT02302547|Indinavir|indinavir|mesh-list
15094677|NCT02302547|Saquinavir|saquinavir|mesh-list
15094678|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
15094679|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
15094680|NCT02302547|Tenofovir|tenofovir|mesh-list
15094681|NCT02302547|Emtricitabine|emtricitabine|mesh-list
15094682|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
15094683|NCT02302547|Nevirapine|nevirapine|mesh-list
15094684|NCT02302547|Maraviroc|maraviroc|mesh-list
15094685|NCT02302547|Dolutegravir|dolutegravir|mesh-list
15094686|NCT02302547|Cobicistat|cobicistat|mesh-list
15094687|NCT02302547|Rilpivirine|rilpivirine|mesh-list
15094688|NCT02302547|Tipranavir|tipranavir|mesh-list
15094689|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
15094690|NCT02302547|Elvitegravir|elvitegravir|mesh-list
15094691|NCT02302547|Efavirenz|efavirenz|mesh-list
15094692|NCT02302547|Etravirine|etravirine|mesh-list
15094693|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
15094694|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
15094695|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
15094696|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15094697|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094698|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094699|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15094700|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15094701|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
15094702|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094703|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15094704|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15094705|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15094706|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15094707|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15094708|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15094709|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15094710|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15094711|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15094712|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15094713|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15094714|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15094715|NCT02302586|Morphine|morphine|mesh-list
15094716|NCT02302586|Bupivacaine|bupivacaine|mesh-list
15094717|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
15094718|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
15094719|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094720|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094721|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
15094722|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094723|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15094724|NCT02302586|Narcotics|narcotics|mesh-ancestor
15094725|NCT02302586|Analgesics|analgesics|mesh-ancestor
15094726|NCT02302729|Micronutrients|micronutrients|mesh-list
15094727|NCT02302729|Trace Elements|trace elements|mesh-list
15094728|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094729|NCT02302768|Selenium|selenium|mesh-list
15094730|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
15094731|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094732|NCT02302768|Protective Agents|protective agents|mesh-ancestor
15094733|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094734|NCT02302768|Trace Elements|trace elements|mesh-ancestor
15094735|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
15094736|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
15094737|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15094738|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15094739|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
15094740|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094741|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15094742|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15094743|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094744|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094745|NCT02302976|Exenatide|exenatide|mesh-list
15094746|NCT02302976|Cocaine|cocaine|mesh-list
15094747|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15094748|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094749|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15094750|NCT02302976|Incretins|incretins|mesh-ancestor
14269013|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
15094751|NCT02302976|Hormones|hormones|mesh-ancestor
15094752|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094753|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
15094754|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
15094755|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094756|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
15094757|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094758|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15094759|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15094760|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15094761|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15094762|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094763|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
15094764|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094765|NCT02302989|Ranibizumab|ranibizumab|mesh-list
15094766|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15094767|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15094768|NCT02302989|Growth Substances|growth substances|mesh-ancestor
15094769|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094770|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
15094771|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094772|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
15094773|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15094774|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15094775|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15094776|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15094777|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094778|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
15094779|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094780|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094781|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15094782|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094783|NCT02303028|Topotecan|topotecan|mesh-list
15094784|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15094785|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15094786|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094787|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094788|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094789|NCT02303106|Lamotrigine|lamotrigine|mesh-list
15094790|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
15094791|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15094792|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15094793|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094794|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15094795|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094796|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15094797|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15094798|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094799|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15094800|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15094801|NCT02303119|Rituximab|rituximab|mesh-list
15094802|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15094803|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094804|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
15094805|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094806|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094807|NCT02303171|Enoxaparin|enoxaparin|mesh-list
15094808|NCT02303171|Warfarin|warfarin|mesh-list
15094809|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
15094810|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15094811|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15094812|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094813|NCT02303223|Propofol|propofol|mesh-list
15094814|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15094815|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094816|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094817|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15094818|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
15094819|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
15173878|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15173879|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173880|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15173881|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
15173882|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173883|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15173884|NCT04001855|Protective Agents|protective agents|mesh-ancestor
15173885|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094820|NCT02303327|Androgens|androgens|mesh-list
15094821|NCT02303327|Hormones|hormones|mesh-ancestor
15094822|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094823|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094824|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
15094825|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15094826|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094827|NCT02303405|Pioglitazone|pioglitazone|mesh-list
15094828|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
15094829|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15094830|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094831|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
15094832|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15094833|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15094834|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094835|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094836|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094837|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15094838|NCT02303418|Oxytocin|oxytocin|mesh-list
15094839|NCT02303418|Carbetocin|carbetocin|mesh-list
15094840|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
15094841|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094842|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094843|NCT02303444|Sorafenib|sorafenib|mesh-list
15094844|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094845|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15094846|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094847|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094848|NCT02303483|Niacinamide|niacinamide|mesh-list
15094849|NCT02303483|Niacin|niacin|mesh-list
15094850|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
15094851|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
15094852|NCT02303483|Vitamins|vitamins|mesh-ancestor
15094853|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
15094854|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094855|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15094856|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
15094857|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094858|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15094859|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
15094860|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
15094861|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15094862|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15094863|NCT02303587|Prednisolone|prednisolone|mesh-list
15094864|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
15094865|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15094866|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
15094867|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15094868|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
15094869|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
15094870|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094871|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094872|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15094873|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
15094874|NCT02303587|Hormones|hormones|mesh-ancestor
15094875|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094876|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15094877|NCT02303587|Protective Agents|protective agents|mesh-ancestor
15094878|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15094879|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094880|NCT02303600|Montelukast|montelukast|mesh-list
15094881|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15094882|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
15094883|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15094884|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
15094885|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094886|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094887|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15094888|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15094889|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094890|NCT02303639|Amiodarone|amiodarone|mesh-list
15094891|NCT02303639|Sotalol|sotalol|mesh-list
15094892|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
15094893|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
15094894|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15094895|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15094896|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094897|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15094898|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15094899|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15094900|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094901|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15094902|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15094903|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15094904|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15094905|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15094906|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
15094907|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094908|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094909|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
15094910|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
15094911|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094912|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
15094913|NCT02303730|Exenatide|exenatide|mesh-list
15094914|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15094915|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094916|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15094917|NCT02303730|Incretins|incretins|mesh-ancestor
15094918|NCT02303730|Hormones|hormones|mesh-ancestor
15094919|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094920|NCT02303769|Tamsulosin|tamsulosin|mesh-list
15094921|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15094922|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15094923|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15094924|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
15094925|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094926|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094927|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094928|NCT02303769|Urological Agents|urological agents|mesh-ancestor
15094929|NCT02303782|Azacitidine|azacitidine|mesh-list
15094930|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15094931|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
15094932|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094933|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094934|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094935|NCT02303847|Ketamine|ketamine|mesh-list
15094936|NCT02303847|Analgesics|analgesics|mesh-ancestor
15094937|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
15094938|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15094939|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094940|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15094941|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15094942|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
15094943|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
15094944|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15094945|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15094946|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15094947|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15094948|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811213|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811214|NCT00844324|Candesartan|candesartan|mesh-list
14811215|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
14811216|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14811217|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14811218|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14811219|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811220|NCT00844337|Amoxicillin|amoxicillin|mesh-list
14811221|NCT00844337|Gentamicins|gentamicins|mesh-list
14811222|NCT00844337|Penicillins|penicillins|mesh-list
14811223|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14811224|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811225|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14811226|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811227|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094949|NCT02303873|Alendronate|alendronate|mesh-list
15094950|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15094951|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094952|NCT02303886|Methylene Blue|methylene blue|mesh-list
15094953|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094954|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094955|NCT02303899|Gemcitabine|gemcitabine|mesh-list
15094956|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
15094957|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15094958|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
15094959|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094960|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094961|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
15094962|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15094963|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094964|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15094965|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
15094966|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094967|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15094968|NCT02303912|Carboplatin|carboplatin|mesh-list
15094969|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094970|NCT02303951|Atezolizumab|atezolizumab|mesh-list
15094971|NCT02303951|Vemurafenib|vemurafenib|mesh-list
15094972|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15094973|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15094974|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094975|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094976|NCT02304042|Oxytocin|oxytocin|mesh-list
15094977|NCT02304042|Carbetocin|carbetocin|mesh-list
15094978|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
15094979|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094980|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094981|NCT02304055|Oxytocin|oxytocin|mesh-list
15094982|NCT02304055|Carbetocin|carbetocin|mesh-list
15094983|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
15094984|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15094985|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094986|NCT02304081|Saxagliptin|saxagliptin|mesh-list
15094987|NCT02304081|Incretins|incretins|mesh-ancestor
15094988|NCT02304081|Hormones|hormones|mesh-ancestor
15094989|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15094990|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15094991|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15094992|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
15094993|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15094994|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094995|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14811228|NCT00844350|Letrozole|letrozole|mesh-list
14811229|NCT00844350|Oxytocin|oxytocin|mesh-list
14811230|NCT00844350|Clomiphene|clomiphene|mesh-list
14811231|NCT00844350|Enclomiphene|enclomiphene|mesh-list
14811232|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
14811233|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811234|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
14811235|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14811236|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811237|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811238|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14811239|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14811240|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811241|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14811242|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
14811243|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811244|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14811245|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
14811246|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14811247|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14811248|NCT00844402|Atorvastatin|atorvastatin|mesh-list
14811249|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14811250|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14811251|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
14811252|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15094996|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
15094997|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15094998|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15094999|NCT02304094|Prednisolone|prednisolone|mesh-list
15095000|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
15095001|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15095002|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
15095003|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095004|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
15095005|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
15095006|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095007|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095008|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095009|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
15095010|NCT02304094|Hormones|hormones|mesh-ancestor
15095011|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095012|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15095013|NCT02304094|Protective Agents|protective agents|mesh-ancestor
15095014|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15095015|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095016|NCT02304107|Letrozole|letrozole|mesh-list
15095017|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095018|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15095019|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15095020|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095021|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095022|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15095023|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
15095024|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095025|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095026|NCT02304198|Udenafil|udenafil|mesh-list
15095027|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15095028|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15095029|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095030|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269014|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14269015|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14269016|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
15095031|NCT02304211|Insulin|insulin|mesh-list
15095032|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095033|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095034|NCT02304237|Progesterone|progesterone|mesh-list
15095035|NCT02304237|Progestins|progestins|mesh-ancestor
15095036|NCT02304237|Hormones|hormones|mesh-ancestor
15095037|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095038|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095039|NCT02304250|Dexamethasone|dexamethasone|mesh-list
15095040|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095041|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
15095042|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
15095043|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095044|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095045|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095046|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
15095047|NCT02304250|Hormones|hormones|mesh-ancestor
15095048|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095049|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15095050|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095051|NCT02304276|Calcium|calcium|mesh-list
15095052|NCT02304276|Fluorides|fluorides|mesh-list
15095053|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15095054|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095055|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
15095056|NCT02304276|Protective Agents|protective agents|mesh-ancestor
15095057|NCT02304289|Artesunate|artesunate|mesh-list
15095058|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
15095059|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15095060|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15095061|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095062|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095063|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
15095064|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
15095065|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15095066|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
15095067|NCT02304354|Rituximab|rituximab|mesh-list
15095068|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095069|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095070|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
15095071|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095072|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095073|NCT02304393|Atezolizumab|atezolizumab|mesh-list
15095074|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095075|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
15095076|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15095077|NCT02304445|Estrogens|estrogens|mesh-ancestor
15095078|NCT02304445|Hormones|hormones|mesh-ancestor
15095079|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095080|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095081|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15095082|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095083|NCT02304627|Insulin|insulin|mesh-list
15095084|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095085|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095086|NCT02304783|Acetaminophen|acetaminophen|mesh-list
15095087|NCT02304783|Piroxicam|piroxicam|mesh-list
15095088|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095089|NCT02304783|Analgesics|analgesics|mesh-ancestor
15095090|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
15095091|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095092|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095093|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
15095094|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15095095|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095096|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095097|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15095098|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095099|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095100|NCT02304809|Vemurafenib|vemurafenib|mesh-list
15095101|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095102|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15095103|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095104|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095105|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
15095106|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15095107|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095108|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15095109|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15095110|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095111|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095112|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095113|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15095114|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15173886|NCT04001725|Metformin|metformin|mesh-list
15173887|NCT04001725|Dexamethasone|dexamethasone|mesh-list
15173888|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15173889|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
15173890|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
15173891|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173892|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173893|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173894|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
15173895|NCT04001725|Hormones|hormones|mesh-ancestor
15173896|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15173897|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15173898|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173899|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15173900|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
15173901|NCT04001647|Nitroprusside|nitroprusside|mesh-list
15173902|NCT04001647|Acetylcholine|acetylcholine|mesh-list
15173903|NCT04001647|Vitamins|vitamins|mesh-ancestor
15173904|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
15173905|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173906|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
15173907|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173908|NCT04001647|Protective Agents|protective agents|mesh-ancestor
15173909|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15173910|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
15173911|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15173912|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15173913|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
15173914|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173915|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
15173916|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
15095115|NCT02304887|Denosumab|denosumab|mesh-list
15095116|NCT02304887|Teriparatide|teriparatide|mesh-list
15095117|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15095118|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095119|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15095120|NCT02305030|Opicapone|opicapone|mesh-list
15095121|NCT02305030|Warfarin|warfarin|mesh-list
15095122|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
15095123|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15095124|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095125|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095126|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15095127|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15095128|NCT02305069|Pioglitazone|pioglitazone|mesh-list
15095129|NCT02305069|Octreotide|octreotide|mesh-list
15095130|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095131|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095132|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095133|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15095134|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095135|NCT02305160|Poractant alfa|poractant alfa|mesh-list
15095136|NCT02305160|Beractant|beractant|mesh-list
15095137|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15095138|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
15095139|NCT02305173|Dexamethasone|dexamethasone|mesh-list
15095140|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095141|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
15095142|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
15095143|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095144|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095145|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095146|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
15095147|NCT02305173|Hormones|hormones|mesh-ancestor
15095148|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095149|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15095150|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095151|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
15095152|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095153|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095154|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15095155|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15095156|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15095157|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095158|NCT02305355|Atorvastatin|atorvastatin|mesh-list
15095159|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15095160|NCT02305355|Simvastatin|simvastatin|mesh-list
15095161|NCT02305355|Pravastatin|pravastatin|mesh-list
15095162|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15095163|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15095164|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
15095165|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095166|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15095167|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15095168|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095169|NCT02305394|Ketamine|ketamine|mesh-list
15095170|NCT02305394|Propofol|propofol|mesh-list
15095171|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15095172|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095173|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095174|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15095175|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
15095176|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
15095177|NCT02305394|Analgesics|analgesics|mesh-ancestor
15095178|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
15095179|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095180|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15095181|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15095182|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15095183|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095184|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095185|NCT02305485|Everolimus|everolimus|mesh-list
15095186|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095187|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15095188|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
15095189|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095190|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
15095191|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15095192|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
15095193|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095194|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095195|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15095196|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
15095197|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15095198|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
15095199|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095200|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095201|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15095202|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
15095203|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
15095204|NCT02305550|Protective Agents|protective agents|mesh-ancestor
15095205|NCT02305615|Bevacizumab|bevacizumab|mesh-list
15095206|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095207|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095208|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15095209|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15095210|NCT02305615|Growth Substances|growth substances|mesh-ancestor
15095211|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095212|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
15095213|NCT02305654|Paclitaxel|paclitaxel|mesh-list
15095214|NCT02305654|Ifosfamide|ifosfamide|mesh-list
15095215|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15095216|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095217|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
15095218|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
15095219|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
15095220|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095221|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15095222|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
15095223|NCT02305693|Letrozole|letrozole|mesh-list
15095224|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095225|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15095226|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15095227|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095228|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095229|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15095230|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
15095231|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095232|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095233|NCT02305810|Everolimus|everolimus|mesh-list
15095234|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095235|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15095236|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
15095237|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095238|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15095239|NCT02305823|Aripiprazole|aripiprazole|mesh-list
15095240|NCT02305823|Ziprasidone|ziprasidone|mesh-list
15095241|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
15095242|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15095243|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15095244|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15095245|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095246|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095247|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
15095248|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
15095249|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095250|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095251|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15095252|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15095253|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
15095254|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15095255|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15095256|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15095257|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15095258|NCT02305836|Donepezil|donepezil|mesh-list
15095259|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15095260|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095261|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095262|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
15095263|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182266|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
15095264|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095265|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
15095266|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15095267|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15095268|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15095269|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
15095270|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095271|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15095272|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15095273|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095274|NCT02305901|Repaglinide|repaglinide|mesh-list
15095275|NCT02305901|Bupropion|bupropion|mesh-list
15095276|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15095277|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
15095278|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15095279|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15095280|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15095281|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15095282|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095283|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
15095284|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095285|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095286|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15095287|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15095288|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095289|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095290|NCT02305927|Vitamin D|vitamin d|mesh-list
15095291|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
15095292|NCT02305927|Vitamins|vitamins|mesh-ancestor
15095293|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
15095294|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095295|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15095296|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15095297|NCT02305940|Doxycycline|doxycycline|mesh-list
15095298|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15095299|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095300|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
15095301|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15095302|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15095303|NCT02305979|Loratadine|loratadine|mesh-list
15095304|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
15095305|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
15095306|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15095307|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15095308|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15095309|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
15095310|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
15095311|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095312|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095313|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095314|NCT02305992|Bupivacaine|bupivacaine|mesh-list
15095315|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
15095316|NCT02305992|Anesthetics|anesthetics|mesh-list
15095317|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095318|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095319|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
15095320|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095321|NCT02306031|Diclofenac|diclofenac|mesh-list
15095322|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
15095323|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15095324|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095325|NCT02306031|Analgesics|analgesics|mesh-ancestor
15095326|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
15095327|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095328|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095329|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095330|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095331|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15095332|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095333|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095334|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15095335|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15095336|NCT02306070|Metformin|metformin|mesh-list
15095337|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095338|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095339|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
15095340|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15095341|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095342|NCT02306239|Terlipressin|terlipressin|mesh-list
15095343|NCT02306239|Norepinephrine|norepinephrine|mesh-list
15095344|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15095345|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15095346|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
15095347|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095348|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095349|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095350|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
15095351|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
15095352|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095353|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15095354|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15095355|NCT02306278|Gabapentin|gabapentin|mesh-list
15095356|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095357|NCT02306278|Analgesics|analgesics|mesh-ancestor
15095358|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
15095359|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095360|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
15095361|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15095362|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15095363|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095364|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15095365|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15095366|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15095367|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095368|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095369|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
15173917|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15173918|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
15173919|NCT04001465|Miotics|miotics|mesh-ancestor
15173920|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
15173921|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173922|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173923|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15173924|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15173925|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
15173926|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15173927|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15173928|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
15173929|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173930|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173931|NCT04001231|Exenatide|exenatide|mesh-list
15173932|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15173933|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173934|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15173935|NCT04001231|Incretins|incretins|mesh-ancestor
15173936|NCT04001231|Hormones|hormones|mesh-ancestor
15173937|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181370|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15181371|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15181372|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15181373|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
15181374|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181375|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181376|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181377|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15181378|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15181379|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15181380|NCT03930069|Vasopressins|vasopressins|mesh-list
15181381|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
15181382|NCT03930069|Misoprostol|misoprostol|mesh-list
15181383|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15181384|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
15181385|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15181386|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181387|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15181388|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15181389|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
15181390|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
15181391|NCT03930069|Coagulants|coagulants|mesh-ancestor
15095370|NCT02306473|Mannitol|mannitol|mesh-list
15095371|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15095372|NCT02306473|Diuretics|diuretics|mesh-ancestor
15095373|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
15095374|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095375|NCT02306564|Cabergoline|cabergoline|mesh-list
15095376|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15095377|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15095378|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
15095379|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
15095380|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095381|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095382|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095383|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15095384|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15095385|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15095386|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
15095387|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095388|NCT02306629|Epratuzumab|epratuzumab|mesh-list
15095389|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095390|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095391|NCT02306733|Oxytocin|oxytocin|mesh-list
15095392|NCT02306733|Ergonovine|ergonovine|mesh-list
15095393|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
15095394|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15095395|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095396|NCT02306772|Mesalamine|mesalamine|mesh-list
15095397|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15095398|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095399|NCT02306772|Analgesics|analgesics|mesh-ancestor
15095400|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
15095401|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095402|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095403|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095404|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095405|NCT02306785|Mesalamine|mesalamine|mesh-list
15095406|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15095407|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095408|NCT02306785|Analgesics|analgesics|mesh-ancestor
15095409|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
15095410|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095411|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095412|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095413|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095414|NCT02306798|Mesalamine|mesalamine|mesh-list
15095415|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15095416|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095417|NCT02306798|Analgesics|analgesics|mesh-ancestor
15095418|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
15095419|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095420|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095421|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095422|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095423|NCT02306889|Fenofibrate|fenofibrate|mesh-list
15095424|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15095425|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
15095426|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095427|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15095428|NCT02306902|Fenofibrate|fenofibrate|mesh-list
15095429|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15095430|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
15095431|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095432|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15095433|NCT02306954|Aldesleukin|aldesleukin|mesh-list
15095434|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095435|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15095436|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15095437|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
15095438|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095439|NCT02307006|Vancomycin|vancomycin|mesh-list
15095440|NCT02307006|Cefazolin|cefazolin|mesh-list
15095441|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
15095442|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15095443|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095444|NCT02307045|Nicotine|nicotine|mesh-list
15095445|NCT02307045|Varenicline|varenicline|mesh-list
15095446|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15095447|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
15095448|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095449|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095450|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15095451|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15095452|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
15095453|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095454|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095455|NCT02307149|Ipilimumab|ipilimumab|mesh-list
15095456|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095457|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095458|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15095459|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095460|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
15095461|NCT02307201|Analgesics|analgesics|mesh-ancestor
15095462|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
15095463|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095464|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095465|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
15095466|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095467|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15095468|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
15095469|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15095470|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15095471|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095472|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15095473|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
15095474|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15095475|NCT02307227|Paclitaxel|paclitaxel|mesh-list
15095476|NCT02307227|Docetaxel|docetaxel|mesh-list
15095477|NCT02307227|Trastuzumab|trastuzumab|mesh-list
15095478|NCT02307227|Epirubicin|epirubicin|mesh-list
15095479|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15095480|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095481|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
15095482|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
15095483|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
15095484|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095485|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269017|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811253|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15095486|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15095487|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15095488|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15095489|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095490|NCT02307305|Acetaminophen|acetaminophen|mesh-list
15095491|NCT02307305|Celecoxib|celecoxib|mesh-list
15095492|NCT02307305|Naproxen|naproxen|mesh-list
15095493|NCT02307305|Oxycodone|oxycodone|mesh-list
15095494|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15095495|NCT02307305|Tramadol|tramadol|mesh-list
15095496|NCT02307305|Naloxone|naloxone|mesh-list
15095497|NCT02307305|Esomeprazole|esomeprazole|mesh-list
15095498|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095499|NCT02307305|Analgesics|analgesics|mesh-ancestor
15095500|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
15095501|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095502|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095503|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
15095504|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15095505|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095506|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095507|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15095508|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15095509|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095510|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095511|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15095512|NCT02307305|Narcotics|narcotics|mesh-ancestor
15095513|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095514|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15095515|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095516|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15095517|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15095518|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15095519|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15095520|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095521|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
15095522|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15095523|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
15095524|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
15095525|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15095526|NCT02307383|Lactitol|lactitol|mesh-list
15095527|NCT02307383|Cathartics|cathartics|mesh-ancestor
15095528|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095529|NCT02307396|Haloperidol|haloperidol|mesh-list
15095530|NCT02307396|Pimozide|pimozide|mesh-list
15095531|NCT02307396|Olanzapine|olanzapine|mesh-list
15095532|NCT02307396|Risperidone|risperidone|mesh-list
15095533|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15095534|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15095535|NCT02307396|Ziprasidone|ziprasidone|mesh-list
15095536|NCT02307396|Amisulpride|amisulpride|mesh-list
15095537|NCT02307396|Perphenazine|perphenazine|mesh-list
15095538|NCT02307396|Sertindole|sertindole|mesh-list
15095539|NCT02307396|Fluphenazine|fluphenazine|mesh-list
15095540|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
15095541|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
15095542|NCT02307396|Sulpiride|sulpiride|mesh-list
15095543|NCT02307396|Thioridazine|thioridazine|mesh-list
15095544|NCT02307396|Clopenthixol|clopenthixol|mesh-list
15095545|NCT02307396|Fluspirilene|fluspirilene|mesh-list
15095546|NCT02307396|Perazine|perazine|mesh-list
15095547|NCT02307396|Bromperidol|bromperidol|mesh-list
15095548|NCT02307396|Benperidol|benperidol|mesh-list
15095549|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15095550|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
15095551|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095552|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095553|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095554|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15095555|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15095556|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095557|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15095558|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15095559|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
15095560|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
15095561|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
15095562|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095563|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095564|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15095565|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15095566|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15095567|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
15095568|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15095569|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15095570|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15095571|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15095572|NCT02307487|Mitomycins|mitomycins|mesh-list
15095573|NCT02307487|Mitomycin|mitomycin|mesh-list
15095574|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15095575|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095576|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
15095577|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095578|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15095579|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095580|NCT02307565|Midodrine|midodrine|mesh-list
15095581|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
15095582|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
15095583|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095584|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095585|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15095586|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15095587|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15095588|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15095589|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
15095590|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095591|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095592|NCT02307591|Amiodarone|amiodarone|mesh-list
15095593|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15095594|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
15095595|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15095596|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15095597|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095598|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15095599|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15095600|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15095601|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095602|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15095603|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15095604|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15095605|NCT02307695|Saxagliptin|saxagliptin|mesh-list
15095606|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15095607|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095608|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095609|NCT02307695|Incretins|incretins|mesh-ancestor
15095610|NCT02307695|Hormones|hormones|mesh-ancestor
15095611|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996168|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15095612|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
15095613|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095614|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095615|NCT02307721|Remifentanil|remifentanil|mesh-list
15095616|NCT02307721|Naloxone|naloxone|mesh-list
15095617|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15095618|NCT02307721|Narcotics|narcotics|mesh-ancestor
15095619|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095620|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095621|NCT02307721|Analgesics|analgesics|mesh-ancestor
15095622|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
15095623|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095624|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15095625|NCT02307825|Azithromycin|azithromycin|mesh-list
15095626|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15095627|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095628|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
15095629|NCT02307864|Tramadol|tramadol|mesh-list
15095630|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15095631|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15095632|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095633|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15095634|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15095635|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095636|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095637|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095638|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15095639|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
15095640|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15095641|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095642|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15095643|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15095644|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15095645|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15095646|NCT02307864|Narcotics|narcotics|mesh-ancestor
15095647|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095648|NCT02307864|Analgesics|analgesics|mesh-ancestor
15095649|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
15095650|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095651|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
15095652|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
15095653|NCT02307955|Protective Agents|protective agents|mesh-ancestor
15095654|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095655|NCT02307968|Insulin|insulin|mesh-list
15095656|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095657|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095658|NCT02308072|Olaparib|olaparib|mesh-list
15095659|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095660|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15095661|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095662|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095663|NCT02308098|Budesonide|budesonide|mesh-list
15095664|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
15095665|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15095666|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095667|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15095668|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
15095669|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095670|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095671|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15095672|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
15095673|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
15095674|NCT02308098|Hormones|hormones|mesh-ancestor
15095675|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095676|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15095677|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15095678|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15095679|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
15095680|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095681|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095682|NCT02308137|Domperidone|domperidone|mesh-list
15095683|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095684|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
15095685|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
15095686|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095687|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095688|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095689|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15095690|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
15095691|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173938|NCT04001400|Rabeprazole|rabeprazole|mesh-list
15173939|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15173940|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173941|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15173942|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15173943|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173944|NCT04001387|Anesthetics|anesthetics|mesh-list
15173945|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173946|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173947|NCT04001413|Durvalumab|durvalumab|mesh-list
15173948|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15173949|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173950|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15173951|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
15173952|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15173953|NCT04001374|Ticagrelor|ticagrelor|mesh-list
15173954|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15173955|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15173956|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15173957|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15173958|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
15173959|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173960|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173961|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173962|NCT04001322|Vaccines|vaccines|mesh-list
15173963|NCT04001322|Immunologic Factors|immunologic factors|mesh-ancestor
15173964|NCT04001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173965|NCT04001569|Paclitaxel|paclitaxel|mesh-list
15173966|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15173967|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15173968|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
15173969|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
15173970|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
15173971|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173972|NCT04001348|Diazepam|diazepam|mesh-list
15173973|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15173974|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
15173975|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
15173976|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
15173977|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15173978|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15173979|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15173980|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15173981|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15173982|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15173983|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15173984|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15173985|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15173986|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15173987|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15173988|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
15095692|NCT02308254|Lixisenatide|lixisenatide|mesh-list
15095693|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15095694|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095695|NCT02308280|Bortezomib|bortezomib|mesh-list
15095696|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095697|NCT02308319|Tenofovir|tenofovir|mesh-list
15095698|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
15095699|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095700|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15095701|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15095702|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095703|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095704|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15095705|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15095706|NCT02308332|Tenofovir|tenofovir|mesh-list
15095707|NCT02308332|Emtricitabine|emtricitabine|mesh-list
15095708|NCT02308332|Rilpivirine|rilpivirine|mesh-list
15095709|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
15095710|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095711|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15095712|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15095713|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095714|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095715|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15095716|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15095717|NCT02308553|Paclitaxel|paclitaxel|mesh-list
15095718|NCT02308553|Nintedanib|nintedanib|mesh-list
15095719|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15095720|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095721|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
15095722|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
15095723|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
15095724|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095725|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15095726|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095727|NCT02308644|Bevacizumab|bevacizumab|mesh-list
15095728|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095729|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095730|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15095731|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15095732|NCT02308644|Growth Substances|growth substances|mesh-ancestor
15095733|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095734|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
15095735|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15095736|NCT02308930|Vitamin D|vitamin d|mesh-list
15095737|NCT02308930|Vitamins|vitamins|mesh-list
15095738|NCT02308930|Vitamin A|vitamin a|mesh-list
15095739|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
15095740|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
15095741|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095742|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
15095743|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095744|NCT02308930|Protective Agents|protective agents|mesh-ancestor
15095745|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15095746|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095747|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15095748|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15095749|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
15095750|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095751|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15095752|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15095753|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
15095754|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095755|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095756|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15095757|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
15095758|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15095759|NCT02308982|Antibodies|antibodies|mesh-list
15095760|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
15095761|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15095762|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
15095763|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095764|NCT02309177|Gemcitabine|gemcitabine|mesh-list
15095765|NCT02309177|Paclitaxel|paclitaxel|mesh-list
15095766|NCT02309177|Carboplatin|carboplatin|mesh-list
15095767|NCT02309177|Nivolumab|nivolumab|mesh-list
15095768|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15095769|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095770|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
15095771|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
15095772|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
15095773|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095774|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15095775|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
15095776|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
15095777|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095778|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095779|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15095780|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
15095781|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095782|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095783|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15095784|NCT02309281|Aflibercept|aflibercept|mesh-list
15095785|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15095786|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15095787|NCT02309281|Growth Substances|growth substances|mesh-ancestor
15095788|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095789|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
15095790|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095791|NCT02309320|Gontivimab|gontivimab|mesh-list
15095792|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
15095793|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095794|NCT02309346|Clindamycin|clindamycin|mesh-list
15095795|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
15095796|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
15095797|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15095798|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095799|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15095800|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095801|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095802|NCT02309385|Dexamethasone|dexamethasone|mesh-list
15095803|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
15095804|NCT02309385|Prednisolone|prednisolone|mesh-list
15095805|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15095806|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
15095807|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15095808|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
15095809|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15095810|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
15095811|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15095812|NCT02309385|BB 1101|bb 1101|mesh-list
15095813|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095814|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
15095815|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
15095816|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095817|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095818|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095819|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
15095820|NCT02309385|Hormones|hormones|mesh-ancestor
15095821|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269018|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14269019|NCT00400517|Thalidomide|thalidomide|mesh-list
14269020|NCT00400517|Sargramostim|sargramostim|mesh-list
14269021|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269022|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
14269023|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269024|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
14269025|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269026|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269027|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14269028|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14269029|NCT00400517|Growth Substances|growth substances|mesh-ancestor
14269030|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269031|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269032|NCT00400569|Sunitinib|sunitinib|mesh-list
15095822|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15095823|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095824|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
15095825|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095826|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095827|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15095828|NCT02309385|Protective Agents|protective agents|mesh-ancestor
15095829|NCT02309424|Acetic Acid|acetic acid|mesh-list
15095830|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15095831|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15095832|NCT02309437|Oxycodone|oxycodone|mesh-list
15095833|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15095834|NCT02309437|Narcotics|narcotics|mesh-ancestor
15095835|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095836|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095837|NCT02309437|Analgesics|analgesics|mesh-ancestor
15095838|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
15095839|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095840|NCT02309450|Asunaprevir|asunaprevir|mesh-list
15095841|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
15095842|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095843|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095844|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
15095845|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095846|NCT02309554|Nonoxynol|nonoxynol|mesh-list
15095847|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
15095848|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15095849|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095850|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15095851|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
15095852|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15095853|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15095854|NCT02309658|Gemcitabine|gemcitabine|mesh-list
15095855|NCT02309658|Cisplatin|cisplatin|mesh-list
15095856|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095857|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15095858|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
15095859|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095860|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
15095861|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269033|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095862|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095863|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15095864|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
15095865|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095866|NCT02309801|Daidzin|daidzin|mesh-list
15095867|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15095868|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095869|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173989|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
15173990|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
15173991|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
15173992|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173993|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15173994|NCT04000919|Carbidopa|carbidopa|mesh-list
15173995|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15173996|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15173997|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
15173998|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15173999|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174000|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174001|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15174002|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174003|NCT04000789|Vitamins|vitamins|mesh-list
15174004|NCT04000789|Vitamin E|vitamin e|mesh-list
15174005|NCT04000789|Vitamin A|vitamin a|mesh-list
15174006|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
15174007|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
15174008|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174009|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
15174010|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174011|NCT04000789|Protective Agents|protective agents|mesh-ancestor
15174012|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15174013|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
15174014|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
15174015|NCT04000906|Paclitaxel|paclitaxel|mesh-list
15174016|NCT04000906|Cisplatin|cisplatin|mesh-list
15174017|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15174018|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174019|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
15174020|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
15174021|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
15174022|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174023|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
15174024|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174025|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
15174026|NCT04000932|Hormones|hormones|mesh-ancestor
15174027|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174028|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174029|NCT04000633|Lidocaine|lidocaine|mesh-list
15174030|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
15174031|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
15174032|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174033|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174034|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
15174035|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174036|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15174037|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15174038|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15174039|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174040|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174041|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
15174042|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
15174043|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
15174044|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15174045|NCT04000386|Protective Agents|protective agents|mesh-ancestor
15174046|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174047|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15174048|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
15174049|NCT04000295|Paclitaxel|paclitaxel|mesh-list
15174050|NCT04000295|Etoposide|etoposide|mesh-list
15174051|NCT04000295|Apatinib|apatinib|mesh-list
15174052|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15174053|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174054|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
15174055|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
15174056|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
15095870|NCT02309879|Lidocaine|lidocaine|mesh-list
15095871|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
15095872|NCT02309879|Remifentanil|remifentanil|mesh-list
15095873|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
15095874|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
15095875|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15095876|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095877|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
15095878|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095879|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15095880|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15095881|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15095882|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15095883|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095884|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15095885|NCT02309879|Narcotics|narcotics|mesh-ancestor
15095886|NCT02309879|Analgesics|analgesics|mesh-ancestor
15095887|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
15095888|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15095889|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15095890|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
15095891|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15095892|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
15095893|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15095894|NCT02309970|Aspirin|aspirin|mesh-list
15095895|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15095896|NCT02309970|Warfarin|warfarin|mesh-list
15095897|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
15095898|NCT02309970|Dabigatran|dabigatran|mesh-list
15095899|NCT02309970|Apixaban|apixaban|mesh-list
15095900|NCT02309970|Clopidogrel|clopidogrel|mesh-list
15095901|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15095902|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095903|NCT02309970|Analgesics|analgesics|mesh-ancestor
15095904|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
15095905|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095906|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095907|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095908|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095909|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15095910|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15095911|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095912|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15095913|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15095914|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095915|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
15095916|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15095917|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15095918|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15095919|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
15095920|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095921|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
15095922|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15095923|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
15095924|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15095925|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
15095926|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15095927|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15095928|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15095929|NCT02310074|Hormones|hormones|mesh-list
15095930|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15095931|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095932|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095933|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15095934|NCT02310087|Vitamin E|vitamin e|mesh-list
15095935|NCT02310087|Vitamins|vitamins|mesh-ancestor
15095936|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
15095937|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095938|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
15095939|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095940|NCT02310087|Protective Agents|protective agents|mesh-ancestor
15095941|NCT02310243|Palbociclib|palbociclib|mesh-list
15095942|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095943|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15095944|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095945|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095946|NCT02310269|Pasireotide|pasireotide|mesh-list
15095947|NCT02310269|Hormones|hormones|mesh-ancestor
15095948|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095949|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095950|NCT02310295|Triamcinolone|triamcinolone|mesh-list
15095951|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15095952|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15095953|NCT02310295|Bevacizumab|bevacizumab|mesh-list
15095954|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15095955|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15095956|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15095957|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15095958|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15095959|NCT02310295|Growth Substances|growth substances|mesh-ancestor
15095960|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095961|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
15095962|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15095963|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
15095964|NCT02310295|Hormones|hormones|mesh-ancestor
15095965|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095966|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15095967|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
15095968|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15095969|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095970|NCT02310347|Dronabinol|dronabinol|mesh-list
15095971|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
15095972|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095973|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15095974|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15095975|NCT02310347|Analgesics|analgesics|mesh-ancestor
15095976|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
15095977|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095978|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15095979|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15095980|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095981|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095982|NCT02310347|Hormones|hormones|mesh-ancestor
15095983|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15095984|NCT02310360|Fallypride|fallypride|mesh-list
15095985|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15095986|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15095987|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
15095988|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15095989|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15095990|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095991|NCT02310373|Nicotine|nicotine|mesh-list
15095992|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15095993|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
15095994|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15095995|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15095996|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15095997|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15095998|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
15095999|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096000|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096001|NCT02310490|Mannitol|mannitol|mesh-list
15096002|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15096003|NCT02310490|Diuretics|diuretics|mesh-ancestor
15096004|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
15096005|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096006|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
15096007|NCT02310997|Melphalan|melphalan|mesh-list
15096008|NCT02310997|Busulfan|busulfan|mesh-list
15096009|NCT02310997|Fludarabine|fludarabine|mesh-list
15096010|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096011|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
15096012|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096013|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15096014|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15096015|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
15096016|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096017|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096018|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15096019|NCT02311010|Tacrolimus|tacrolimus|mesh-list
15096020|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096021|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
15096022|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096023|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15096024|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096025|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096026|NCT02311088|Caffeine|caffeine|mesh-list
15096027|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15096028|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096029|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15096030|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096031|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096032|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15096033|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15096034|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
15096035|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096036|NCT02311101|Mitomycins|mitomycins|mesh-list
15096037|NCT02311101|Mitomycin|mitomycin|mesh-list
15096038|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15096039|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096040|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
15096041|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096042|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15096043|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096044|NCT02311179|Cimetidine|cimetidine|mesh-list
15096045|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15096046|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096047|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15096048|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
15096049|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
15096050|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096051|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096052|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096053|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15096054|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15096055|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096056|NCT02311205|Sorafenib|sorafenib|mesh-list
15096057|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096058|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15096059|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096060|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096061|NCT02311231|Heparin|heparin|mesh-list
15096062|NCT02311231|Calcium heparin|calcium heparin|mesh-list
15096063|NCT02311231|Bivalirudin|bivalirudin|mesh-list
15096064|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
15096065|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15096066|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15096067|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096068|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
15096069|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15096070|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
15096071|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096072|NCT02311439|Folfirinox|folfirinox|mesh-list
15096073|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096074|NCT02311517|Ropivacaine|ropivacaine|mesh-list
15096075|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
15096076|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
15096077|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096078|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096079|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
15096080|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096081|NCT02311530|Felodipine|felodipine|mesh-list
15096082|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15096083|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15096084|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15096085|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096086|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096087|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15096088|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096089|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
15174057|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174058|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15096090|NCT02311569|Mirabegron|mirabegron|mesh-list
15096091|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15096092|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15096093|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15096094|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
15096095|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096096|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096097|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096098|NCT02311569|Urological Agents|urological agents|mesh-ancestor
15096099|NCT02311608|Octreotide|octreotide|mesh-list
15096100|NCT02311608|Terlipressin|terlipressin|mesh-list
15096101|NCT02311608|Somatostatin|somatostatin|mesh-list
15096102|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096103|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15096104|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096105|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15096106|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15096107|NCT02311608|Hormones|hormones|mesh-ancestor
15096108|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096109|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096110|NCT02311686|Ethanol|ethanol|mesh-list
15096111|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15096112|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096113|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096114|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096115|NCT02311764|Carboplatin|carboplatin|mesh-list
15096116|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096117|NCT02311777|Pregabalin|pregabalin|mesh-list
15096118|NCT02311777|Ketamine|ketamine|mesh-list
15096119|NCT02311777|Analgesics|analgesics|mesh-ancestor
15096120|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
15096121|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096122|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096123|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15096124|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15096125|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
15096126|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
15096127|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096128|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15096129|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15096130|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096131|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096132|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
15096133|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15096134|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096135|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15096136|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15096137|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15096138|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15096139|NCT02311946|Palbociclib|palbociclib|mesh-list
15096140|NCT02311946|Rabeprazole|rabeprazole|mesh-list
15096141|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15096142|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096143|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15096144|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096145|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096146|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15096147|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096148|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
15096149|NCT02312037|Antibodies|antibodies|mesh-list
15096150|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
15096151|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
15096152|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096153|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096154|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096155|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15096156|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
15096157|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15096158|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
15096159|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15096160|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096161|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15096162|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15096163|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096164|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15096165|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
15096166|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15096167|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
15096168|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15096169|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096170|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15096171|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15096172|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096173|NCT02312102|Lenalidomide|lenalidomide|mesh-list
15096174|NCT02312102|Bortezomib|bortezomib|mesh-list
15096175|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
15096176|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096177|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15096178|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15096179|NCT02312102|Growth Substances|growth substances|mesh-ancestor
15096180|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
15096181|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096182|NCT02312115|Furosemide|furosemide|mesh-list
15096183|NCT02312115|Diuretics|diuretics|mesh-ancestor
15096184|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
15096185|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096186|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15096187|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096188|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096189|NCT02312180|Plasminogen|plasminogen|mesh-list
15096190|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15096191|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15096192|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096193|NCT02312232|Levodopa|levodopa|mesh-list
15096194|NCT02312232|Carbidopa|carbidopa|mesh-list
15096195|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15096196|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15096197|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
15096198|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096199|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096200|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096201|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15096202|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096203|NCT02312297|Minocycline|minocycline|mesh-list
15096204|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15096205|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096206|NCT02312375|Amlodipine|amlodipine|mesh-list
15096207|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15096208|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15096209|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096210|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096211|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15096212|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096213|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
15096214|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15096215|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
15096216|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096217|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096218|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096219|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096220|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
15096221|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15096222|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15096223|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096224|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
15096225|NCT02312440|Coagulants|coagulants|mesh-ancestor
15096226|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
15096227|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096228|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096229|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
15096230|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15096231|NCT02312531|Antibodies|antibodies|mesh-list
15096232|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
15096233|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096234|NCT02312544|Timolol|timolol|mesh-list
15096235|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15096236|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15096237|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
15096238|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096239|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096240|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096241|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15096242|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15096243|NCT02312609|Minocycline|minocycline|mesh-list
15096244|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15096245|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096246|NCT02312635|Cycloserine|cycloserine|mesh-list
15096247|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15096248|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096249|NCT02312635|Renal Agents|renal agents|mesh-ancestor
15096250|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15096251|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
15096252|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15096253|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
15096254|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096255|NCT02312661|Metformin|metformin|mesh-list
15096256|NCT02312661|Paclitaxel|paclitaxel|mesh-list
15096257|NCT02312661|Carboplatin|carboplatin|mesh-list
15096258|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15096259|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096260|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
15096261|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
15096262|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
15096263|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096264|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096265|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096266|NCT02312804|Paclitaxel|paclitaxel|mesh-list
15096267|NCT02312804|Carboplatin|carboplatin|mesh-list
15096268|NCT02312804|Infigratinib|infigratinib|mesh-list
15096269|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15096270|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096271|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
15096272|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
15096273|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
15096274|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096275|NCT02312908|Clonazepam|clonazepam|mesh-list
15096276|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
15096277|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
15096278|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
15096279|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096280|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096281|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096282|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
15096283|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15096284|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15096285|NCT02313051|Everolimus|everolimus|mesh-list
15096286|NCT02313051|Letrozole|letrozole|mesh-list
15096287|NCT02313051|Goserelin|goserelin|mesh-list
15096288|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096289|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096290|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
15096291|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096292|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15096293|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15096294|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096295|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096296|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15096297|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
15096298|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096299|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15096300|NCT02313064|CXA-10|cxa-10|mesh-list
15096301|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15096302|NCT02313103|Lofexidine|lofexidine|mesh-list
15096303|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15096304|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15096305|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096306|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
15096307|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096308|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15096309|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15096310|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15096311|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
15096312|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096313|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096314|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
15096315|NCT02313220|Exenatide|exenatide|mesh-list
15096316|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15096317|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096318|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096319|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096320|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15096321|NCT02313220|Incretins|incretins|mesh-ancestor
15096322|NCT02313220|Hormones|hormones|mesh-ancestor
15096323|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096324|NCT02313272|Bevacizumab|bevacizumab|mesh-list
15096325|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
15096326|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096327|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096328|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15096329|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15096330|NCT02313272|Growth Substances|growth substances|mesh-ancestor
15096331|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096332|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
15174059|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15174060|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174061|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15174062|NCT04000126|Lidocaine|lidocaine|mesh-list
15174063|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
15174064|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
15174065|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174066|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174067|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
15174068|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174069|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15174070|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15174071|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15174072|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174073|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174074|NCT03999580|Vitamin D|vitamin d|mesh-list
15174075|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
15174076|NCT03999580|Vitamins|vitamins|mesh-ancestor
15174077|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
15174078|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174079|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15174080|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15174081|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
15174082|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
15174083|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
15174084|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
15174085|NCT03999775|Vitamin D|vitamin d|mesh-list
15174086|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
15174087|NCT03999775|Vitamins|vitamins|mesh-list
15174088|NCT03999775|Calcium|calcium|mesh-list
15174089|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
15174090|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174091|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15174092|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15174093|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
15174094|NCT03999723|Vitamins|vitamins|mesh-ancestor
15174095|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
15174096|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174097|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
15174098|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174099|NCT03999723|Protective Agents|protective agents|mesh-ancestor
15181392|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15181393|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15181394|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
15181395|NCT03930212|Progesterone|progesterone|mesh-list
15181396|NCT03930212|Progestins|progestins|mesh-ancestor
15181397|NCT03930212|Hormones|hormones|mesh-ancestor
15181398|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181399|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181400|NCT03929861|Fluconazole|fluconazole|mesh-list
15181401|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
15181402|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096333|NCT02313337|Fentanyl|fentanyl|mesh-list
15096334|NCT02313337|Midazolam|midazolam|mesh-list
15096335|NCT02313337|Anesthetics|anesthetics|mesh-list
15096336|NCT02313337|Propofol|propofol|mesh-list
15096337|NCT02313337|Atracurium|atracurium|mesh-list
15096338|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096339|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096340|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15096341|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15096342|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
15096343|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15096344|NCT02313337|Narcotics|narcotics|mesh-ancestor
15096345|NCT02313337|Analgesics|analgesics|mesh-ancestor
15096346|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
15096347|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096348|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15096349|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15096350|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15096351|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15096352|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
15096353|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
15096354|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096355|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096356|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15096357|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15096358|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15096359|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15096360|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15096361|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
15096362|NCT02313584|Dabigatran|dabigatran|mesh-list
15096363|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
15096364|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15096365|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
15096366|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096367|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096368|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
15096369|NCT02313727|Pamidronate|pamidronate|mesh-list
15096370|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15096371|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096372|NCT02313805|Insulin|insulin|mesh-list
15096373|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096374|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096375|NCT02313883|Taurolidine|taurolidine|mesh-list
15096376|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096377|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15096378|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096379|NCT02313922|Etanercept|etanercept|mesh-list
15096380|NCT02313922|Methotrexate|methotrexate|mesh-list
15096381|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15096382|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
15096383|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15096384|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096385|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096386|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
15096387|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096388|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096389|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
15096390|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096391|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15096392|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096393|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
15096394|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15096395|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15096396|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15096397|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15096398|NCT02313922|Analgesics|analgesics|mesh-ancestor
15096399|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
15096400|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096401|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15096402|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096403|NCT02314013|Metronidazole|metronidazole|mesh-list
15096404|NCT02314013|Cephalosporins|cephalosporins|mesh-list
15096405|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096406|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15096407|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15096408|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15096409|NCT02314182|Bevacizumab|bevacizumab|mesh-list
15096410|NCT02314182|Capecitabine|capecitabine|mesh-list
15096411|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
15096412|NCT02314182|Irinotecan|irinotecan|mesh-list
15096413|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096414|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096415|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15096416|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15096417|NCT02314182|Growth Substances|growth substances|mesh-ancestor
15096418|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096419|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
15096420|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096421|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
15096422|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096423|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15096424|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15096425|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096426|NCT02314195|Serotonin|serotonin|mesh-list
15096427|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15096428|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15096429|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
15096430|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096431|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096432|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096433|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15096434|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096435|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
15096436|NCT02314208|Resveratrol|resveratrol|mesh-list
15096437|NCT02314208|Atorvastatin|atorvastatin|mesh-list
15096438|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15096439|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15096440|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
15096441|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096442|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15096443|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15096444|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096445|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
15096446|NCT02314208|Protective Agents|protective agents|mesh-ancestor
15096447|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096448|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15096449|NCT02314208|Cathartics|cathartics|mesh-ancestor
15096450|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096451|NCT02314273|Oprelvekin|oprelvekin|mesh-list
15096452|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096453|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15096454|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15096455|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15096456|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
15096457|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096458|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15096459|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15096460|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096461|NCT02314312|Cyclosporine|cyclosporine|mesh-list
15096462|NCT02314312|Prednisolone|prednisolone|mesh-list
15096463|NCT02314312|Everolimus|everolimus|mesh-list
15096464|NCT02314312|Cyclosporins|cyclosporins|mesh-list
15096465|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096466|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096467|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096468|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
15096469|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096470|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
15096471|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096472|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
15096473|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15096474|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15096475|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096476|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15096477|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
15096478|NCT02314312|Hormones|hormones|mesh-ancestor
15174100|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
15174101|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15174102|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
15174103|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174104|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
15096479|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096480|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15096481|NCT02314325|Factor VIII|factor viii|mesh-list
15096482|NCT02314325|Coagulants|coagulants|mesh-ancestor
15096483|NCT02314351|Fentanyl|fentanyl|mesh-list
15096484|NCT02314351|Metoclopramide|metoclopramide|mesh-list
15096485|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15096486|NCT02314351|Narcotics|narcotics|mesh-ancestor
15096487|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096488|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096489|NCT02314351|Analgesics|analgesics|mesh-ancestor
15096490|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
15096491|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096492|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15096493|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15096494|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
15096495|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
15096496|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
15096497|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
15096498|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096499|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15096500|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15096501|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
15096502|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096503|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096504|NCT02314377|Bevacizumab|bevacizumab|mesh-list
15096505|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096506|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096507|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15096508|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15096509|NCT02314377|Growth Substances|growth substances|mesh-ancestor
15096510|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096511|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
15096512|NCT02314468|Glycerol|glycerol|mesh-list
15096513|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15096514|NCT02314468|Protective Agents|protective agents|mesh-ancestor
15096515|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096516|NCT02314481|Trastuzumab|trastuzumab|mesh-list
15096517|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15096518|NCT02314481|Atezolizumab|atezolizumab|mesh-list
15096519|NCT02314481|Vemurafenib|vemurafenib|mesh-list
15096520|NCT02314481|Maytansine|maytansine|mesh-list
15096521|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096522|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096523|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15096524|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096525|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096526|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15096527|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
15096528|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
15096529|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
15096530|NCT02314533|Fenofibrate|fenofibrate|mesh-list
15096531|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15096532|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
15096533|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096534|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15096535|NCT02314559|Propofol|propofol|mesh-list
15096536|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15096537|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096538|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096539|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15096540|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
15096541|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
15096542|NCT02314754|Misoprostol|misoprostol|mesh-list
15096543|NCT02314754|Mifepristone|mifepristone|mesh-list
15096544|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15096545|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
15096546|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15096547|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096548|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15096549|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096550|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
15096551|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15096552|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15096553|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15096554|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15096555|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
15096556|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15096557|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15096558|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
15096559|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096560|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
15096561|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15096562|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15096563|NCT02314806|Clindamycin|clindamycin|mesh-list
15096564|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
15096565|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
15096566|NCT02314806|Gentamicins|gentamicins|mesh-list
15096567|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15096568|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15096569|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096570|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15096571|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096572|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096573|NCT02314871|Morphine|morphine|mesh-list
15096574|NCT02314871|Pirinitramide|pirinitramide|mesh-list
15096575|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15096576|NCT02314871|Narcotics|narcotics|mesh-ancestor
15096577|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096578|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096579|NCT02314871|Analgesics|analgesics|mesh-ancestor
15096580|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
15096581|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096582|NCT02315001|Liraglutide|liraglutide|mesh-list
15096583|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096584|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096585|NCT02315001|Incretins|incretins|mesh-ancestor
15096586|NCT02315001|Hormones|hormones|mesh-ancestor
15096587|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174105|NCT03999372|Protective Agents|protective agents|mesh-ancestor
15174106|NCT03999437|Terbinafine|terbinafine|mesh-list
14269034|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14269035|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14269036|NCT00400569|Growth Substances|growth substances|mesh-ancestor
14269037|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269038|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269039|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14269040|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269041|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269042|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
14269043|NCT00400686|Hematinics|hematinics|mesh-ancestor
14269044|NCT00400764|Rituximab|rituximab|mesh-list
14269045|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269046|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269047|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
14269048|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269049|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269050|NCT00400803|Gemcitabine|gemcitabine|mesh-list
14269051|NCT00400803|Bevacizumab|bevacizumab|mesh-list
14269052|NCT00400803|Carboplatin|carboplatin|mesh-list
14269053|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269054|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269055|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15174107|NCT03999437|Butenafine|butenafine|mesh-list
15174108|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
15174109|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174110|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174111|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174112|NCT03999099|Suvorexant|suvorexant|mesh-list
15174113|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15174114|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15174115|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174116|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174117|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15174118|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174119|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174120|NCT03999216|Diuretics|diuretics|mesh-list
15174121|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
15174122|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14269056|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15096588|NCT02315118|Rituximab|rituximab|mesh-list
15096589|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096590|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096591|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
15096592|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096593|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15096594|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15096595|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15096596|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
15096597|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096598|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096599|NCT02315196|Paclitaxel|paclitaxel|mesh-list
15096600|NCT02315196|Carboplatin|carboplatin|mesh-list
15096601|NCT02315196|Doxorubicin|doxorubicin|mesh-list
15096602|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15096603|NCT02315196|Epirubicin|epirubicin|mesh-list
15096604|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15096605|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096606|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
15096607|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
15096608|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
15096609|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096610|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15096611|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15096612|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15096613|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096614|NCT02315287|Pioglitazone|pioglitazone|mesh-list
15096615|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096616|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096617|NCT02315326|Rituximab|rituximab|mesh-list
15096618|NCT02315326|Methotrexate|methotrexate|mesh-list
15096619|NCT02315326|Procarbazine|procarbazine|mesh-list
15096620|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096621|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096622|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
15096623|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096624|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15096625|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15096626|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
15096627|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15096628|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096629|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
15096630|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096631|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
15096632|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096633|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15096634|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096635|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15096636|NCT02315391|Glycine|glycine|mesh-list
15096637|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
15096638|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096639|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096640|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096641|NCT02315495|Saxagliptin|saxagliptin|mesh-list
15096642|NCT02315495|Acarbose|acarbose|mesh-list
15096643|NCT02315495|Incretins|incretins|mesh-ancestor
15096644|NCT02315495|Hormones|hormones|mesh-ancestor
15096645|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096646|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096647|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15096648|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
15096649|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096650|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096651|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096652|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15096653|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15096654|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096655|NCT02315573|Lidocaine|lidocaine|mesh-list
15096656|NCT02315573|Epinephrine|epinephrine|mesh-list
15096657|NCT02315573|Racepinephrine|racepinephrine|mesh-list
15096658|NCT02315573|Bupivacaine|bupivacaine|mesh-list
15096659|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
14269057|NCT00400803|Growth Substances|growth substances|mesh-ancestor
15096660|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
15096661|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
15096662|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096663|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096664|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
15096665|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096666|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15096667|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15096668|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15096669|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096670|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096671|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15096672|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15096673|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
15096674|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096675|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15096676|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15096677|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
15096678|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15096679|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
15096680|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
15096681|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
15096682|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15096683|NCT02315651|Ubiquinone|ubiquinone|mesh-list
15096684|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
15096685|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
15096686|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096687|NCT02315651|Vitamins|vitamins|mesh-ancestor
15096688|NCT02315690|Piperaquine|piperaquine|mesh-list
15096689|NCT02315690|Artenimol|artenimol|mesh-list
15096690|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
15096691|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15096692|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15096693|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096694|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
15096695|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096696|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096697|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15096698|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15096699|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15096700|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096701|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
15096702|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15096703|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096704|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096705|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
15096706|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096707|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096708|NCT02316028|Decitabine|decitabine|mesh-list
15096709|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096710|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
15096711|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096712|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096713|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096714|NCT02316197|Peposertib|peposertib|mesh-list
15096715|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15096716|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096717|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096718|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
15096719|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15096720|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096721|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096722|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15096723|NCT02316236|Analgesics|analgesics|mesh-ancestor
15096724|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
15096725|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096726|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15096727|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15096728|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15096729|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
15096730|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096731|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096732|NCT02316249|Estradiol|estradiol|mesh-list
15096733|NCT02316249|Hormones|hormones|mesh-ancestor
15096734|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096735|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096736|NCT02316249|Estrogens|estrogens|mesh-ancestor
15096737|NCT02316301|Misoprostol|misoprostol|mesh-list
15096738|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15096739|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
15096740|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15096741|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096742|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15096743|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096744|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
15096745|NCT02316327|Gemcitabine|gemcitabine|mesh-list
15096746|NCT02316327|Bevacizumab|bevacizumab|mesh-list
15096747|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096748|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096749|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15096750|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15096751|NCT02316327|Growth Substances|growth substances|mesh-ancestor
15096752|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096753|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
15096754|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096755|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
15096756|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096757|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
15096758|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096759|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096760|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096761|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
15096762|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
15096763|NCT02316340|Vorinostat|vorinostat|mesh-list
15096764|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
15096765|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15096766|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15096767|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096768|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096769|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096770|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15096771|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096772|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15096773|NCT02316379|Xenon|xenon|mesh-list
15096774|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15096775|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
15096776|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
15096777|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096778|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096779|NCT02316496|Irinotecan|irinotecan|mesh-list
15096780|NCT02316496|Cetuximab|cetuximab|mesh-list
15096781|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15096782|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15096783|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096784|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096785|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096786|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15096787|NCT02316535|Capecitabine|capecitabine|mesh-list
15096788|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096789|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
15096790|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096791|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096792|NCT02316626|Progesterone|progesterone|mesh-list
15096793|NCT02316626|Progestins|progestins|mesh-ancestor
15096794|NCT02316626|Hormones|hormones|mesh-ancestor
15096795|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096796|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096797|NCT02316704|Tacrine|tacrine|mesh-list
15096798|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15096799|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096800|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096801|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
15096802|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096803|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096804|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15096805|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
15096806|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096807|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
15174123|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
15174124|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174125|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174126|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096808|NCT02316899|Linaclotide|linaclotide|mesh-list
15096809|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15096810|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
15096811|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096812|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096813|NCT02316964|Aldesleukin|aldesleukin|mesh-list
15096814|NCT02316964|Decitabine|decitabine|mesh-list
15096815|NCT02316964|Azacitidine|azacitidine|mesh-list
15096816|NCT02316964|Interleukin-2|interleukin-2|mesh-list
15096817|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096818|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
15096819|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096820|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096821|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096822|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15096823|NCT02316964|Analgesics|analgesics|mesh-ancestor
15096824|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
15096825|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096826|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096827|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15096828|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15096829|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
15096830|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096831|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
15096832|NCT02317146|Analgesics|analgesics|mesh-ancestor
15096833|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
15096834|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096835|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096836|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
15096837|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096838|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15096839|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
15096840|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15096841|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096842|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096843|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15096844|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
15096845|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15096846|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
15096847|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096848|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15096849|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096850|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096851|NCT02317198|Clopidogrel|clopidogrel|mesh-list
15096852|NCT02317198|Ticagrelor|ticagrelor|mesh-list
15096853|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15096854|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15096855|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15096856|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15096857|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15096858|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
15096859|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096860|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096861|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096862|NCT02317237|Anesthetics|anesthetics|mesh-list
15096863|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096864|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096865|NCT02317263|Testosterone|testosterone|mesh-list
15096866|NCT02317263|Androgens|androgens|mesh-ancestor
15096867|NCT02317263|Hormones|hormones|mesh-ancestor
15096868|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096869|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096870|NCT02317341|Midazolam|midazolam|mesh-list
15096871|NCT02317341|Ketamine|ketamine|mesh-list
15096872|NCT02317341|Analgesics|analgesics|mesh-ancestor
15096873|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
15096874|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096875|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096876|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15096877|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15096878|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
15096879|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
15096880|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096881|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15096882|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15096883|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096884|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096885|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15096886|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15096887|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15096888|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15096889|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15096890|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
15096891|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
15096892|NCT02317419|Gemcitabine|gemcitabine|mesh-list
15096893|NCT02317419|Paclitaxel|paclitaxel|mesh-list
15096894|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15096895|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096896|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
15096897|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
15096898|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
15096899|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096900|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15096901|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
15096902|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
15096903|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15096904|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15096905|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15096906|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
15096907|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096908|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
15096909|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096910|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15096911|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
15096912|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096913|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15096914|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096915|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15096916|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
15096917|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15096918|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15096919|NCT02317601|Prednisolone|prednisolone|mesh-list
15096920|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
15096921|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15096922|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
15096923|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15096924|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
15096925|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
15096926|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096927|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096928|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15096929|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
15096930|NCT02317601|Hormones|hormones|mesh-ancestor
15096931|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096932|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15096933|NCT02317601|Protective Agents|protective agents|mesh-ancestor
15096934|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15096935|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096936|NCT02317640|Testosterone|testosterone|mesh-list
15096937|NCT02317640|Androgens|androgens|mesh-ancestor
15096938|NCT02317640|Hormones|hormones|mesh-ancestor
15096939|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096940|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096941|NCT02317679|Bosentan|bosentan|mesh-list
15096942|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15096943|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15096944|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096945|NCT02317770|Lidocaine|lidocaine|mesh-list
15096946|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
15096947|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
15096948|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15096949|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096950|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
15096951|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096952|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15096953|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15096954|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15096955|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174127|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
15096956|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096957|NCT02317861|Febuxostat|febuxostat|mesh-list
15096958|NCT02317861|Verinurad|verinurad|mesh-list
15096959|NCT02317861|Benzbromarone|benzbromarone|mesh-list
15096960|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
15096961|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15096962|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
15096963|NCT02317861|Renal Agents|renal agents|mesh-ancestor
15096964|NCT02317991|Paclitaxel|paclitaxel|mesh-list
15096965|NCT02317991|Ramucirumab|ramucirumab|mesh-list
15096966|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15096967|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15096968|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
15096969|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
15096970|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
15096971|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096972|NCT02318017|Methylphenidate|methylphenidate|mesh-list
15096973|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15096974|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096975|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15096976|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15096977|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15096978|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15096979|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
15096980|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15096981|NCT02318043|Fluticasone|fluticasone|mesh-list
15096982|NCT02318043|Budesonide|budesonide|mesh-list
15096983|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15096984|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15096985|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15096986|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15096987|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
15096988|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15096989|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15096990|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15096991|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
15096992|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
15096993|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15096994|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
15096995|NCT02318043|Hormones|hormones|mesh-ancestor
15096996|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15096997|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15096998|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15096999|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15097000|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
15097001|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097002|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097003|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
15097004|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15097005|NCT02318056|Bacitracin|bacitracin|mesh-list
15097006|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15097007|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097008|NCT02318056|Laxatives|laxatives|mesh-ancestor
15097009|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097010|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15097011|NCT02318082|Aldesleukin|aldesleukin|mesh-list
15097012|NCT02318082|Interleukin-2|interleukin-2|mesh-list
15097013|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097014|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15097015|NCT02318082|Analgesics|analgesics|mesh-ancestor
15097016|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
15097017|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097018|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097019|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15097020|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15097021|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
15097022|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097023|NCT02318121|Oxytocin|oxytocin|mesh-list
15097024|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
15097025|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15097026|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097027|NCT02318199|Anesthetics|anesthetics|mesh-list
15097028|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097029|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097030|NCT02318225|Misoprostol|misoprostol|mesh-list
15097031|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15097032|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
15097033|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15097034|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097035|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15097036|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097037|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
15097038|NCT02318290|Analgesics|analgesics|mesh-list
15097039|NCT02318290|Narcotics|narcotics|mesh-list
15097040|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
15097041|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097042|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097043|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097044|NCT02318433|Dexamethasone|dexamethasone|mesh-list
15097045|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097046|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
15097047|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
15097048|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097049|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097050|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097051|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
15097052|NCT02318433|Hormones|hormones|mesh-ancestor
15097053|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097054|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15097055|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097056|NCT02318446|Folic Acid|folic acid|mesh-list
15097057|NCT02318446|Hematinics|hematinics|mesh-ancestor
15097058|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
15097059|NCT02318446|Vitamins|vitamins|mesh-ancestor
15097060|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
15097061|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174128|NCT03999203|Citric Acid|citric acid|mesh-list
15174129|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
15174130|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15174131|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
15174132|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174133|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174134|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15174135|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
15174136|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15174137|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
15174138|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174139|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174140|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15174141|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
15174142|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
15174143|NCT03999203|Protective Agents|protective agents|mesh-ancestor
15174144|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
15174145|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15174146|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
15174147|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
15174148|NCT03999190|Raclopride|raclopride|mesh-list
15174149|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
15174150|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15174151|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174152|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15174153|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15174154|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174155|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174156|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
15174157|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174158|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15174159|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15174160|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174161|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15174162|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15174163|NCT03999008|Budesonide|budesonide|mesh-list
15174164|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174165|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15174166|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
15174167|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174168|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174169|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15174170|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
15174171|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
15174172|NCT03999008|Hormones|hormones|mesh-ancestor
15174173|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097062|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
15097063|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15097064|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
15097065|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097066|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
15097067|NCT02318511|Protective Agents|protective agents|mesh-ancestor
15097068|NCT02318537|Cannabidiol|cannabidiol|mesh-list
15097069|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15097070|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
15097071|NCT02318563|Cannabidiol|cannabidiol|mesh-list
15097072|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15097073|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
15097074|NCT02318758|Ethanol|ethanol|mesh-list
15097075|NCT02318758|Treprostinil|treprostinil|mesh-list
15097076|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15097077|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097078|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097079|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097080|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15097081|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
15097082|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15097083|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097084|NCT02318810|Rocuronium|rocuronium|mesh-list
15097085|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15097086|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15097087|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15097088|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097089|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097090|NCT02318836|Lofexidine|lofexidine|mesh-list
15097091|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15097092|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15097093|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097094|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
15097095|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097096|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15097097|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15097098|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15097099|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
15097100|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097101|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097102|NCT02318888|Icodextrin|icodextrin|mesh-list
15097103|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
15097104|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15097105|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
15097106|NCT02319018|Leucovorin|leucovorin|mesh-list
15097107|NCT02319018|Folic Acid|folic acid|mesh-list
15097108|NCT02319018|Fluorouracil|fluorouracil|mesh-list
15097109|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
15097110|NCT02319018|Calcium|calcium|mesh-list
15097111|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
15097112|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15097113|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097114|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15097115|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
15097116|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097117|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15097118|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097119|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097120|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
15097121|NCT02319018|Antidotes|antidotes|mesh-ancestor
15097122|NCT02319018|Protective Agents|protective agents|mesh-ancestor
15097123|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
15097124|NCT02319018|Vitamins|vitamins|mesh-ancestor
15097125|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
15097126|NCT02319018|Hematinics|hematinics|mesh-ancestor
15097127|NCT02319135|Cytarabine|cytarabine|mesh-list
15097128|NCT02319135|Fludarabine|fludarabine|mesh-list
15097129|NCT02319135|Lenograstim|lenograstim|mesh-list
15097130|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097131|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15097132|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
15097133|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097134|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097135|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
15097136|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097137|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
15097138|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097139|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15097140|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
15097141|NCT02319161|Calcium|calcium|mesh-list
15097142|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15097143|NCT02319161|Esmolol|esmolol|mesh-list
15097144|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15097145|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097146|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15097147|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
15097148|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097149|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097150|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15097151|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15097152|NCT02319187|Irinotecan|irinotecan|mesh-list
15097153|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15097154|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15097155|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097156|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097157|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097158|NCT02319200|Metformin|metformin|mesh-list
15097159|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15097160|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097161|NCT02319265|Melatonin|melatonin|mesh-list
15097162|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
15097163|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097164|NCT02319265|Protective Agents|protective agents|mesh-ancestor
15097165|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097166|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097167|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15097168|NCT02319278|Hematinics|hematinics|mesh-ancestor
15097169|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15097170|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15097171|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
15097172|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15097173|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15097174|NCT02319343|Prednisolone|prednisolone|mesh-list
15097175|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
15097176|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15097177|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
15097178|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097179|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
15097180|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
15097181|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097182|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097183|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097184|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
15097185|NCT02319343|Hormones|hormones|mesh-ancestor
15097186|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097187|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15097188|NCT02319343|Protective Agents|protective agents|mesh-ancestor
15097189|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15097190|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097191|NCT02319460|Thrombin|thrombin|mesh-list
15097192|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
15097193|NCT02319460|Coagulants|coagulants|mesh-ancestor
15097194|NCT02319499|Vitamin A|vitamin a|mesh-list
15097195|NCT02319499|Iron|iron|mesh-list
15097196|NCT02319499|Zinc|zinc|mesh-list
15097197|NCT02319499|Vitamins|vitamins|mesh-ancestor
15097198|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
15097199|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097200|NCT02319499|Trace Elements|trace elements|mesh-ancestor
15097201|NCT02319564|Beclomethasone|beclomethasone|mesh-list
15097202|NCT02319564|Albuterol|albuterol|mesh-list
15097203|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15097204|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
15097205|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097206|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097207|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15097208|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
15097209|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
15097210|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15097211|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15097212|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14269058|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097213|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15097214|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
15097215|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097216|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097217|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097218|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
15097219|NCT02319564|Hormones|hormones|mesh-ancestor
15097220|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097221|NCT02319577|Vinorelbine|vinorelbine|mesh-list
15097222|NCT02319577|Gefitinib|gefitinib|mesh-list
15097223|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15097224|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097225|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
15097226|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
15097227|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
15097228|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097229|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15097230|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097231|NCT02319616|Clobetasol|clobetasol|mesh-list
15097232|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097233|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
15097234|NCT02319616|Hormones|hormones|mesh-ancestor
15097235|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097236|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097237|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15097238|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15097239|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097240|NCT02319707|Oxytocin|oxytocin|mesh-list
15097241|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
15097242|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15097243|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097244|NCT02319772|Galidesivir|galidesivir|mesh-list
15097245|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
15097246|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097247|NCT02319889|Paclitaxel|paclitaxel|mesh-list
15097248|NCT02319889|Carboplatin|carboplatin|mesh-list
15097249|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15097250|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15097251|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097252|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
15097253|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
15097254|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
15097255|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269059|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269060|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14269061|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
14269062|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269063|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
14269064|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269065|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269066|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097256|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
15097257|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15097258|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15097259|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097260|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
15097261|NCT02319915|Coagulants|coagulants|mesh-ancestor
15097262|NCT02319941|Clopidogrel|clopidogrel|mesh-list
15097263|NCT02319941|Ticagrelor|ticagrelor|mesh-list
15097264|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15097265|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15097266|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15097267|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15097268|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
15097269|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097270|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097271|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097272|NCT02320032|Aripiprazole|aripiprazole|mesh-list
15097273|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
15097274|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
15097275|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15097276|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15097277|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15097278|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097279|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097280|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
14269067|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
15097281|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
15097282|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097283|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097284|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15097285|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15097286|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
15097287|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15097288|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15097289|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15097290|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15097291|NCT02320045|Exenatide|exenatide|mesh-list
15097292|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15097293|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097294|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15097295|NCT02320045|Incretins|incretins|mesh-ancestor
15097296|NCT02320045|Hormones|hormones|mesh-ancestor
15097297|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097298|NCT02320084|Nitisinone|nitisinone|mesh-list
15097299|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097300|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097301|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15097302|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
15097303|NCT02320240|Citalopram|citalopram|mesh-list
15097304|NCT02320240|Fluoxetine|fluoxetine|mesh-list
15097305|NCT02320240|Paroxetine|paroxetine|mesh-list
15097306|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15097307|NCT02320240|Sertraline|sertraline|mesh-list
15097308|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15097309|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15097310|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269068|NCT00400946|Leucovorin|leucovorin|mesh-list
14269069|NCT00400946|Cytarabine|cytarabine|mesh-list
14269070|NCT00400946|Dexamethasone|dexamethasone|mesh-list
15097311|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15097312|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097313|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097314|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
15097315|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097316|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15097317|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
15097318|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15097319|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097320|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15097321|NCT02320240|Analgesics|analgesics|mesh-ancestor
15097322|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
15097323|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
15097324|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15097325|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15097326|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097327|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15097328|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15097329|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097330|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15097331|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15097332|NCT02320357|Clopidogrel|clopidogrel|mesh-list
15097333|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15097334|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15097335|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15097336|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15097337|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
15097338|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097339|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097340|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174174|NCT03999125|Dexamethasone|dexamethasone|mesh-list
15174175|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
15174176|NCT03999125|Ranibizumab|ranibizumab|mesh-list
15174177|NCT03999125|Aflibercept|aflibercept|mesh-list
15174178|NCT03999125|BB 1101|bb 1101|mesh-list
15174179|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174180|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
15174181|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
15174182|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174183|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174184|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269071|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
14269072|NCT00400946|Prednisolone|prednisolone|mesh-list
15097341|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15097342|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
15097343|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15097344|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
15097345|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097346|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097347|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15097348|NCT02320448|Cisplatin|cisplatin|mesh-list
15097349|NCT02320448|Doxorubicin|doxorubicin|mesh-list
15097350|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
15097351|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097352|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15097353|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15097354|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15097355|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097356|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097357|NCT02320474|Aflibercept|aflibercept|mesh-list
15097358|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15097359|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15097360|NCT02320474|Growth Substances|growth substances|mesh-ancestor
15097361|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097362|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
15097363|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097364|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15097365|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
15097366|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097367|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15097368|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15097369|NCT02320734|Rocuronium|rocuronium|mesh-list
15097370|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15097371|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15097372|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15097373|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097374|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097375|NCT02320773|Mirabegron|mirabegron|mesh-list
15097376|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15097377|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15097378|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15097379|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
15097380|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097381|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097382|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097383|NCT02320773|Urological Agents|urological agents|mesh-ancestor
15097384|NCT02320877|Methaqualone|methaqualone|mesh-list
15097385|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15097386|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097387|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097388|NCT02321176|Resveratrol|resveratrol|mesh-list
15097389|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
15097390|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097391|NCT02321176|Protective Agents|protective agents|mesh-ancestor
15097392|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097393|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097394|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15097395|NCT02321241|Aflibercept|aflibercept|mesh-list
15097396|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15097397|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15097398|NCT02321241|Growth Substances|growth substances|mesh-ancestor
15097399|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097400|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
15097401|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097402|NCT02321267|Ranibizumab|ranibizumab|mesh-list
15097403|NCT02321267|Aflibercept|aflibercept|mesh-list
15097404|NCT02321267|Verteporfin|verteporfin|mesh-list
15097405|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15097406|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15097407|NCT02321267|Growth Substances|growth substances|mesh-ancestor
15097408|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097409|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
15097410|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097411|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15097412|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
15097413|NCT02321280|Denosumab|denosumab|mesh-list
15097414|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15097415|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097416|NCT02321293|Curcumin|curcumin|mesh-list
15097417|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15097418|NCT02321293|Gefitinib|gefitinib|mesh-list
15097419|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097420|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15097421|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097422|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097423|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15097424|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15097425|NCT02321293|Analgesics|analgesics|mesh-ancestor
15097426|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
15097427|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097428|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097429|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097430|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15097431|NCT02321371|Rifaximin|rifaximin|mesh-list
15097432|NCT02321371|Lactulose|lactulose|mesh-list
15097433|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15097434|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097435|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097436|NCT02321384|Ritonavir|ritonavir|mesh-list
15097437|NCT02321384|Midazolam|midazolam|mesh-list
15097438|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15097439|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15097440|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097441|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097442|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15097443|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15097444|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269073|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
14269074|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14269075|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14269076|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14269077|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
14269078|NCT00400946|Doxorubicin|doxorubicin|mesh-list
14269079|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14269080|NCT00400946|Methotrexate|methotrexate|mesh-list
14269081|NCT00400946|Etoposide|etoposide|mesh-list
14269082|NCT00400946|Vincristine|vincristine|mesh-list
14269083|NCT00400946|Asparaginase|asparaginase|mesh-list
14269084|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
14269085|NCT00400946|Pegaspargase|pegaspargase|mesh-list
14269086|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
14269087|NCT00400946|Razoxane|razoxane|mesh-list
15097445|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15097446|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
15097447|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
15097448|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
15097449|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
15097450|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097451|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097452|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15097453|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15097454|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
15097455|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097456|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15097457|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15097458|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
15097459|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097460|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15097461|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15097462|NCT02321397|Oxycodone|oxycodone|mesh-list
15097463|NCT02321397|Naloxone|naloxone|mesh-list
15097464|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15097465|NCT02321397|Narcotics|narcotics|mesh-ancestor
15097466|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097467|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097468|NCT02321397|Analgesics|analgesics|mesh-ancestor
15097469|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
15097470|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097471|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15097472|NCT02321501|Everolimus|everolimus|mesh-list
15097473|NCT02321501|Ceritinib|ceritinib|mesh-list
15097474|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097475|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269088|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
15097476|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
14269089|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097477|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097478|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15097479|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097480|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097481|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
15097482|NCT02321579|Pyridoxal|pyridoxal|mesh-list
15097483|NCT02321579|Pyridoxine|pyridoxine|mesh-list
15097484|NCT02321579|Vitamins|vitamins|mesh-ancestor
15097485|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
15097486|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097487|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
15097488|NCT02321761|Amantadine|amantadine|mesh-list
15097489|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15097490|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15097491|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
15097492|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097493|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
15097494|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097495|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097496|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097497|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15097498|NCT02321761|Analgesics|analgesics|mesh-ancestor
15097499|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
15097500|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097501|NCT02321839|Ranibizumab|ranibizumab|mesh-list
15097502|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15097503|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15097504|NCT02321839|Growth Substances|growth substances|mesh-ancestor
15097505|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097506|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
15097507|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097508|NCT02321852|Mannitol|mannitol|mesh-list
15097509|NCT02321852|Triflusal|triflusal|mesh-list
15097510|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15097511|NCT02321852|Diuretics|diuretics|mesh-ancestor
15097512|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
15097513|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097514|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15097515|NCT02321878|Liraglutide|liraglutide|mesh-list
15097516|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15097517|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097518|NCT02321878|Incretins|incretins|mesh-ancestor
15097519|NCT02321878|Hormones|hormones|mesh-ancestor
15097520|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174185|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
15174186|NCT03999125|Hormones|hormones|mesh-ancestor
15174187|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174188|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15174189|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174190|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
15174191|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174192|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174193|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15174194|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15174195|NCT03999125|Growth Substances|growth substances|mesh-ancestor
15174196|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
15174197|NCT03998982|Dexamethasone|dexamethasone|mesh-list
15174198|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
15174199|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174200|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
15174201|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
15174202|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174203|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174204|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174205|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
15174206|NCT03998982|Hormones|hormones|mesh-ancestor
15174207|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174208|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15174209|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174210|NCT03998969|Pantoprazole|pantoprazole|mesh-list
15097521|NCT02322008|Adalimumab|adalimumab|mesh-list
15097522|NCT02322008|Infliximab|infliximab|mesh-list
15097523|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097524|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15097525|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
15097526|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097527|NCT02322099|Alendronate|alendronate|mesh-list
15097528|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
15097529|NCT02322099|Tenofovir|tenofovir|mesh-list
15097530|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
15097531|NCT02322099|Calcium|calcium|mesh-list
15097532|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15097533|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097534|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
15097535|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097536|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15097537|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15097538|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097539|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097540|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15097541|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15097542|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15097543|NCT02322099|Antacids|antacids|mesh-ancestor
15097544|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097545|NCT02322099|Vitamins|vitamins|mesh-ancestor
15097546|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
15097547|NCT02322203|Niacin|niacin|mesh-list
15097548|NCT02322203|Niacinamide|niacinamide|mesh-list
15097549|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
15097550|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15097551|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
15097552|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097553|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15097554|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
15097555|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
15097556|NCT02322203|Vitamins|vitamins|mesh-ancestor
15097557|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
15097558|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097559|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
15097560|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
15097561|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
15097562|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097563|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097564|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
15097565|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097566|NCT02322372|Bupivacaine|bupivacaine|mesh-list
15097567|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
15097568|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097569|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097570|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
15097571|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
15097572|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097573|NCT02322502|Propofol|propofol|mesh-list
15097574|NCT02322502|Sevoflurane|sevoflurane|mesh-list
15097575|NCT02322502|Desflurane|desflurane|mesh-list
15097576|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15097577|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097578|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097579|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15097580|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
15097581|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
15097582|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15097583|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15097584|NCT02322580|Etanercept|etanercept|mesh-list
15097585|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15097586|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15097587|NCT02322580|Analgesics|analgesics|mesh-ancestor
15097588|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
15097589|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097590|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097591|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097592|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15097593|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15097594|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097595|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
15097596|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
15097597|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15097598|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174211|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15097599|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15097600|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15097601|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097602|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097603|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097604|NCT02322645|Eszopiclone|eszopiclone|mesh-list
15097605|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15097606|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097607|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097608|NCT02322658|Eszopiclone|eszopiclone|mesh-list
15097609|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15097610|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097611|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097612|NCT02322671|Montelukast|montelukast|mesh-list
15097613|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15097614|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
15097615|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15097616|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
15097617|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097618|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097619|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15097620|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15097621|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097622|NCT02322853|Tamoxifen|tamoxifen|mesh-list
15097623|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15097624|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
15097625|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097626|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097627|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15097628|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097629|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15097630|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15097631|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15097632|NCT02323139|Azacitidine|azacitidine|mesh-list
15097633|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15097634|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
15097635|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097636|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097637|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097638|NCT02323191|Atezolizumab|atezolizumab|mesh-list
15097639|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097640|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
15097641|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097642|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
15097643|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097644|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15097645|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15097646|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
15097647|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097648|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097649|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15097650|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15097651|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
15097652|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097653|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
15097654|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097655|NCT02323282|Ropivacaine|ropivacaine|mesh-list
15097656|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
15097657|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
15097658|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097659|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097660|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
15097661|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097662|NCT02323347|Progesterone|progesterone|mesh-list
15097663|NCT02323347|Progestins|progestins|mesh-ancestor
15097664|NCT02323347|Hormones|hormones|mesh-ancestor
15097665|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097666|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097667|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
15097668|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15097669|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15097670|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097671|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
15097672|NCT02323373|Coagulants|coagulants|mesh-ancestor
15097673|NCT02323399|Phenylephrine|phenylephrine|mesh-list
15097674|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
15097675|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15097676|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
15097677|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
15097678|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097679|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097680|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
15097681|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15097682|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
15097683|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
15097684|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15097685|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15097686|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15097687|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
15097688|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097689|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097690|NCT02323399|Protective Agents|protective agents|mesh-ancestor
15097691|NCT02323412|Amoxicillin|amoxicillin|mesh-list
15097692|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15097693|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097694|NCT02323438|Menthol|menthol|mesh-list
15097695|NCT02323438|Nicotine|nicotine|mesh-list
15097696|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15097697|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
15097698|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097699|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097700|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15097701|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15097702|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
15097703|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097704|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097705|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
15097706|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
15097707|NCT02323451|Chitosan|chitosan|mesh-list
15097708|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
15097709|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15097710|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
15097711|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097712|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
15097713|NCT02323451|Protective Agents|protective agents|mesh-ancestor
15097714|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15097715|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15097716|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
15097717|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097718|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15097719|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
15097720|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
15097721|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
15097722|NCT02323451|Coagulants|coagulants|mesh-ancestor
15097723|NCT02323516|Aspirin|aspirin|mesh-list
15097724|NCT02323516|Loperamide|loperamide|mesh-list
15097725|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
15097726|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15097727|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15097728|NCT02323516|Analgesics|analgesics|mesh-ancestor
15097729|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
15097730|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097731|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097732|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097733|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15097734|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15097735|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15097736|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097737|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15097738|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15097739|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097740|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
15097741|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269090|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
15097742|NCT02323529|Nitisinone|nitisinone|mesh-list
15097743|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097744|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097745|NCT02323594|Asunaprevir|asunaprevir|mesh-list
15097746|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
15097747|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097748|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097749|NCT02323607|Cytarabine|cytarabine|mesh-list
15097750|NCT02323607|Decitabine|decitabine|mesh-list
15097751|NCT02323607|Daunorubicin|daunorubicin|mesh-list
15097752|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15097753|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
15097754|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097755|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097756|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
15097757|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097758|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097759|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
15097760|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097761|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097762|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15097763|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15097764|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15097765|NCT02323737|Cisplatin|cisplatin|mesh-list
14269091|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269092|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269093|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14269094|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
15097766|NCT02323737|Irinotecan|irinotecan|mesh-list
15097767|NCT02323737|Etoposide|etoposide|mesh-list
15097768|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097769|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15097770|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15097771|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097772|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097773|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15097774|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15174212|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174213|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15174214|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174215|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174216|NCT03998696|Cisplatin|cisplatin|mesh-list
15174217|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174218|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15174219|NCT03998709|Somatostatin|somatostatin|mesh-list
15174220|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174221|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15174222|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15174223|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15174224|NCT03998709|Hormones|hormones|mesh-ancestor
15174225|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174226|NCT03998670|Methamphetamine|methamphetamine|mesh-list
15174227|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15174228|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174229|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
15174230|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
15174231|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174232|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
15174233|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174234|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174235|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
15174236|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15174237|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15174238|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174239|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15174240|NCT03998761|Progesterone|progesterone|mesh-list
15174241|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
15174242|NCT03998761|Progestins|progestins|mesh-ancestor
15174243|NCT03998761|Hormones|hormones|mesh-ancestor
15174244|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174245|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174246|NCT03998826|Piroxicam|piroxicam|mesh-list
15174247|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15174248|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15174249|NCT03998826|Analgesics|analgesics|mesh-ancestor
15174250|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
15174251|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174252|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174253|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15097775|NCT02323906|Sorafenib|sorafenib|mesh-list
15097776|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097777|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15097778|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097779|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097780|NCT02323971|Ticagrelor|ticagrelor|mesh-list
15097781|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15097782|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15097783|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15097784|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15097785|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
15097786|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097787|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097788|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097789|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15097790|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15097791|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097792|NCT02324010|Incretins|incretins|mesh-ancestor
15097793|NCT02324010|Hormones|hormones|mesh-ancestor
15097794|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097795|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15097796|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
15097797|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097798|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097799|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
15097800|NCT02324088|Docetaxel|docetaxel|mesh-list
15097801|NCT02324088|Epirubicin|epirubicin|mesh-list
15097802|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097803|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
15097804|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097805|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15097806|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15097807|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
15097808|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097809|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097810|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15097811|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
15097812|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
15097813|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
15097814|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15097815|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15097816|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15097817|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097818|NCT02324166|Cefazolin|cefazolin|mesh-list
15097819|NCT02324166|Lidocaine|lidocaine|mesh-list
15097820|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
15097821|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
15097822|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097823|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097824|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
15097825|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097826|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15097827|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15097828|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15097829|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15097830|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097831|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15097832|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097833|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
15097834|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15097835|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097836|NCT02324296|Cisplatin|cisplatin|mesh-list
15097837|NCT02324296|Etoposide|etoposide|mesh-list
15097838|NCT02324296|Ifosfamide|ifosfamide|mesh-list
15097839|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097840|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15097841|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15097842|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15097843|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097844|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097845|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15097846|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
15097847|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
15097848|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15097849|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097850|NCT02324413|Clonidine|clonidine|mesh-list
15097851|NCT02324413|Analgesics|analgesics|mesh-ancestor
15097852|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
15097853|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097854|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097855|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15097856|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
15097857|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
15097858|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15097859|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15097860|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15097861|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
15097862|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097863|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097864|NCT02324452|Fluorouracil|fluorouracil|mesh-list
15097865|NCT02324452|Capecitabine|capecitabine|mesh-list
15097866|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
15097867|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097868|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15097869|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097870|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15097871|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
15097872|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097873|NCT02324491|CKD732|ckd732|mesh-list
15097874|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15097875|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15097876|NCT02324491|Growth Substances|growth substances|mesh-ancestor
15097877|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097878|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
15097879|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097880|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
15097881|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15097882|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097883|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15097884|NCT02324608|Cetuximab|cetuximab|mesh-list
15097885|NCT02324608|Antibodies|antibodies|mesh-list
15097886|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
15097887|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15097888|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
15097889|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097890|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097891|NCT02324621|TIC10 compound|tic10 compound|mesh-list
15097892|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097893|NCT02324686|Vitamin K|vitamin k|mesh-list
15097894|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
15097895|NCT02324686|Vitamins|vitamins|mesh-ancestor
15097896|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
15097897|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097898|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15097899|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15097900|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097901|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
15097902|NCT02324686|Coagulants|coagulants|mesh-ancestor
15097903|NCT02324738|Piperaquine|piperaquine|mesh-list
15097904|NCT02324738|Artenimol|artenimol|mesh-list
15097905|NCT02324738|Mefloquine|mefloquine|mesh-list
15097906|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
15097907|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15097908|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15097909|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097910|NCT02324933|Fentanyl|fentanyl|mesh-list
15097911|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15097912|NCT02324933|Narcotics|narcotics|mesh-ancestor
15097913|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15097914|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097915|NCT02324933|Analgesics|analgesics|mesh-ancestor
15097916|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
15097917|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097918|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15097919|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15097920|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
15097921|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
15097922|NCT02324998|Olaparib|olaparib|mesh-list
15097923|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15097924|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097925|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097926|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15097927|NCT02325011|Fluconazole|fluconazole|mesh-list
15097928|NCT02325011|Nabiximols|nabiximols|mesh-list
15097929|NCT02325011|Dronabinol|dronabinol|mesh-list
15097930|NCT02325011|Cannabidiol|cannabidiol|mesh-list
15097931|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
15097932|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097933|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15097934|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15097935|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097936|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097937|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15097938|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
15097939|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15097940|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097941|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15097942|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15097943|NCT02325011|Analgesics|analgesics|mesh-ancestor
15097944|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
15097945|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097946|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
15097947|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
15097948|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15097949|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15097950|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15097951|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15097952|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097953|NCT02325011|Hormones|hormones|mesh-ancestor
15097954|NCT02325024|Nabiximols|nabiximols|mesh-list
15097955|NCT02325024|Analgesics|analgesics|mesh-ancestor
15097956|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
15097957|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15097958|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097959|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
15097960|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15097961|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15097962|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097963|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
15097964|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15097965|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097966|NCT02325180|Lumefantrine|lumefantrine|mesh-list
15097967|NCT02325180|Artemether|artemether|mesh-list
15097968|NCT02325180|Piperaquine|piperaquine|mesh-list
15097969|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15097970|NCT02325180|Artenimol|artenimol|mesh-list
15097971|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
15097972|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15097973|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15097974|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097975|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
15097976|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15097977|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097978|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15097979|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097980|NCT02325245|Metformin|metformin|mesh-list
15097981|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15097982|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097983|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
15097984|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097985|NCT02325362|Miglustat|miglustat|mesh-list
15097986|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
14292369|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15097987|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15097988|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15097989|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15097990|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15097991|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
15097992|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15097993|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15097994|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15097995|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15097996|NCT02325440|Natalizumab|natalizumab|mesh-list
15097997|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15097998|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
15097999|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098000|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15098001|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098002|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15174254|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174255|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15174256|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174257|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174258|NCT03998592|Vaccines|vaccines|mesh-list
15174259|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
15174260|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174261|NCT03998176|Tenofovir|tenofovir|mesh-list
15174262|NCT03998176|Emtricitabine|emtricitabine|mesh-list
15174263|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15174264|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
15174265|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174266|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15174267|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15174268|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174269|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174270|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15174271|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15174272|NCT03998215|Vaccines|vaccines|mesh-list
15174273|NCT03998215|Immunologic Factors|immunologic factors|mesh-ancestor
15174274|NCT03998215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174275|NCT03998449|Vaccines|vaccines|mesh-list
15174276|NCT03998449|Immunologic Factors|immunologic factors|mesh-ancestor
15174277|NCT03998449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174278|NCT03998436|Esmolol|esmolol|mesh-list
15174279|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15174280|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15174281|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15174282|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
15174283|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174284|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174285|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174286|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
15174287|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174288|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15174289|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174290|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174291|NCT03997864|Prazosin|prazosin|mesh-list
15174292|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15174293|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15174294|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15174295|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15174296|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
15174297|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174298|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174299|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181403|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15181404|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15181405|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181406|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181407|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15181408|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
15181409|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181410|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181411|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15098003|NCT02325479|Enoxaparin|enoxaparin|mesh-list
15098004|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
15098005|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15098006|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15098007|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098008|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
15098009|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098010|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098011|NCT02325583|Midazolam|midazolam|mesh-list
15098012|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15098013|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15098014|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098015|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098016|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15098017|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15098018|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098019|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15098020|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
15098021|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
15098022|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
15098023|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
15098024|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098025|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098026|NCT02325882|Fentanyl|fentanyl|mesh-list
15098027|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
15098028|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15098029|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098030|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098031|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15098032|NCT02325882|Analgesics|analgesics|mesh-ancestor
15098033|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
14269095|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098034|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098035|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15098036|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15098037|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15098038|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14269096|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269097|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14269098|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269099|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
14269100|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
14269101|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098039|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098040|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098041|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15098042|NCT02325882|Narcotics|narcotics|mesh-ancestor
15098043|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15098044|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15098045|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
15098046|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
15098047|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15098048|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15098049|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15098050|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
15098051|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098052|NCT05144529|Nivolumab|nivolumab|mesh-list
15098053|NCT05144529|Ipilimumab|ipilimumab|mesh-list
15098054|NCT05144529|Evolocumab|evolocumab|mesh-list
15098055|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098056|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098057|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15098058|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098059|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15098060|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15098061|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
15098062|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15098063|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15098064|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098065|NCT05144282|Bevacizumab|bevacizumab|mesh-list
15098066|NCT05144282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098067|NCT05144282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098068|NCT05144282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098069|NCT05144282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098070|NCT05144282|Growth Substances|growth substances|mesh-ancestor
15098071|NCT05144282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098072|NCT05144282|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098073|NCT05144100|Cisplatin|cisplatin|mesh-list
15098074|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098075|NCT05143762|Acetaminophen|acetaminophen|mesh-list
15098076|NCT05143762|Dexamethasone|dexamethasone|mesh-list
15098077|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098078|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
15098079|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
15098080|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098081|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098082|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098083|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
15098084|NCT05143762|Hormones|hormones|mesh-ancestor
15098085|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098086|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15098087|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098088|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15098089|NCT05143762|Analgesics|analgesics|mesh-ancestor
15098090|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
15098091|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
15098092|NCT05143723|Hormones|hormones|mesh-list
15098093|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098094|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098095|NCT05143281|Dexamethasone|dexamethasone|mesh-list
15098096|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
15098097|NCT05143281|BB 1101|bb 1101|mesh-list
15098098|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098099|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
15098100|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
15098101|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098102|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098103|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098104|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
15098105|NCT05143281|Hormones|hormones|mesh-ancestor
15098106|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098107|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15098108|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098109|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
15098110|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098111|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098112|NCT05143164|Gentamicins|gentamicins|mesh-list
15098113|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15098114|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098115|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15098116|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098117|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098118|NCT05143125|Decitabine|decitabine|mesh-list
15098119|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14269102|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269103|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
14269104|NCT00400946|Hormones|hormones|mesh-ancestor
14269105|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269106|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14269107|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14269108|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14269109|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14269110|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269111|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15098120|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
15098121|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098122|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098123|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174300|NCT03997539|Vinorelbine|vinorelbine|mesh-list
15174301|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15174302|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174303|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
15174304|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
14269112|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
15174305|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
15098124|NCT05142904|Iodine|iodine|mesh-list
15098125|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
15098126|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15098127|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098128|NCT05142904|Trace Elements|trace elements|mesh-ancestor
15098129|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
15098130|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098131|NCT05142865|Carboplatin|carboplatin|mesh-list
15098132|NCT05142865|Etoposide|etoposide|mesh-list
15098133|NCT05142865|Apatinib|apatinib|mesh-list
15098134|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098135|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15098136|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15098137|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15098138|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098139|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098140|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15098141|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15098142|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098143|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098144|NCT05118737|Colchicine|colchicine|mesh-list
15098145|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
15098146|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098147|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
15098148|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
15098149|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
15098150|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098151|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098152|NCT05118685|Estrogens|estrogens|mesh-list
15098153|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15098154|NCT05118685|Hormones|hormones|mesh-ancestor
15098155|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098156|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098157|NCT05109364|Terazosin|terazosin|mesh-list
15098158|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15098159|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15098160|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15098161|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
15098162|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098163|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098164|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098165|NCT05109364|Urological Agents|urological agents|mesh-ancestor
15098166|NCT05042466|Psilocybin|psilocybin|mesh-list
15098167|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
15098168|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098169|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098170|NCT05037552|Hemostatics|hemostatics|mesh-list
15098171|NCT05037552|Coagulants|coagulants|mesh-ancestor
15098172|NCT05021926|Lidocaine|lidocaine|mesh-list
15098173|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
15098174|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
15098175|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
15098176|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098177|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098178|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
15098179|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098180|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15098181|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15098182|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15098183|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15098184|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098185|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15098186|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
15098187|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
15098188|NCT05021926|Protective Agents|protective agents|mesh-ancestor
15098189|NCT05021913|Lidocaine|lidocaine|mesh-list
15098190|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
15098191|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
15098192|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
15098193|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098194|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098195|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
15098196|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098197|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15098198|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15098199|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15098200|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15098201|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098202|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15098203|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
15098204|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
15098205|NCT05021913|Protective Agents|protective agents|mesh-ancestor
15098206|NCT04987931|Talazoparib|talazoparib|mesh-list
15098207|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15098208|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098209|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098210|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098211|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
15098212|NCT04929847|Emollients|emollients|mesh-list
15098213|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098214|NCT04929834|Emollients|emollients|mesh-list
15098215|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098216|NCT04881955|Ecopipam|ecopipam|mesh-list
15098217|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15098218|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15098219|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098220|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098221|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098222|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15098223|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
15098224|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098225|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098226|NCT04850222|Fluoxetine|fluoxetine|mesh-list
15098227|NCT04850222|Calcium|calcium|mesh-list
15098228|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15098229|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098230|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15098231|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15098232|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15098233|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098234|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098235|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
15098236|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15098237|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
15098238|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098239|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15098240|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15098241|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098242|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
15098243|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098244|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098245|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
15098246|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
15098247|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
15098248|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098249|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098250|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098251|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15098252|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
15098253|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
15098254|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098255|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098256|NCT04722952|Cytarabine|cytarabine|mesh-list
15098257|NCT04722952|Azacitidine|azacitidine|mesh-list
15098258|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
15098259|NCT04722952|Visilizumab|visilizumab|mesh-list
15098260|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15098261|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
15098262|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098263|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098264|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
15098265|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098266|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15098267|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
15098268|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098269|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098270|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15098271|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15098272|NCT04716933|Carboplatin|carboplatin|mesh-list
15098273|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
15098274|NCT04716933|Pemetrexed|pemetrexed|mesh-list
15098275|NCT04716933|Lenvatinib|lenvatinib|mesh-list
15098276|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098277|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098278|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098279|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098280|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15098281|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15098282|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15098283|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
15098284|NCT04715191|Fludarabine|fludarabine|mesh-list
15098285|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
15098286|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15098287|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
15098288|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098289|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098290|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15098291|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
15098292|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098293|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098294|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15098295|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15098296|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
15098297|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15098298|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
15098299|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098300|NCT04703361|Niacin|niacin|mesh-list
15098301|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15098302|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
15098303|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098304|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15098305|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
15098306|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
15098307|NCT04703361|Vitamins|vitamins|mesh-ancestor
15098308|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
15098309|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098310|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
15098311|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15098312|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098313|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098314|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15098315|NCT04674241|Analgesics|analgesics|mesh-ancestor
15098316|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
15098317|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098318|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15098319|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15098320|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15098321|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
15098322|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098323|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098324|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
15098325|NCT04670068|Fludarabine|fludarabine|mesh-list
15098326|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15098327|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
15098328|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098329|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098330|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15098331|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
15098332|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098333|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098334|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15098335|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
15174306|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174307|NCT03997500|Norepinephrine|norepinephrine|mesh-list
15174308|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15174309|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15174310|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
15174311|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174312|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174313|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174314|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
15174315|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
15174316|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174317|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15098336|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
15098337|NCT04641728|Olaparib|olaparib|mesh-list
15098338|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098339|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098340|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15098341|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098342|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098343|NCT04600895|Favipiravir|favipiravir|mesh-list
15098344|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
15098345|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098346|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
15098347|NCT04558359|Giapreza|giapreza|mesh-list
15098348|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
15098349|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15098350|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15098351|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
15098352|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098353|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098354|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
15098355|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15098356|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15098357|NCT04551144|Estradiol|estradiol|mesh-list
15098358|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15098359|NCT04551144|Testosterone|testosterone|mesh-list
15098360|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
15098361|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
15098362|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15098363|NCT04551144|Estrogens|estrogens|mesh-ancestor
15098364|NCT04551144|Hormones|hormones|mesh-ancestor
15098365|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098366|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098367|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15098368|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
15098369|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15098370|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15098371|NCT04551144|Androgens|androgens|mesh-ancestor
15098372|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15098373|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098374|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
15098375|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15098376|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
15098377|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098378|NCT04534881|Progesterone|progesterone|mesh-list
15098379|NCT04534881|Progestins|progestins|mesh-ancestor
15098380|NCT04534881|Hormones|hormones|mesh-ancestor
15098381|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098382|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098383|NCT04532502|Anesthetics|anesthetics|mesh-list
15098384|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
15098385|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098386|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098387|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
15098388|NCT04496908|Misoprostol|misoprostol|mesh-list
15098389|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15098390|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
15098391|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15098392|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098393|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15098394|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098395|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
15098396|NCT04452747|Dinoprostone|dinoprostone|mesh-list
15098397|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
15098398|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15098399|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098400|NCT04384107|Vaccines|vaccines|mesh-list
15098401|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
15098402|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098403|NCT04382924|Ifenprodil|ifenprodil|mesh-list
15098404|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15098405|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15098406|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
15098407|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098408|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098409|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098410|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
15098411|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15098412|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15098413|NCT04371640|Sirolimus|sirolimus|mesh-list
15098414|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15098415|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098416|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15098417|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098418|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
15098419|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15098420|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
15098421|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098422|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15098423|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15098424|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15098425|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15098426|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15098427|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098428|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098429|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098430|NCT04364997|Analgesics|analgesics|mesh-ancestor
15098431|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
15098432|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098433|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
15098434|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098435|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
15098436|NCT04356196|Verapamil|verapamil|mesh-list
15098437|NCT04356196|Bisoprolol|bisoprolol|mesh-list
15098438|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15098439|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15098440|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15098441|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098442|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15098443|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098444|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
15098445|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15098446|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
15098447|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
15098448|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098449|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15098450|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15098451|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15098452|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
15098453|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098454|NCT04306315|Brodalumab|brodalumab|mesh-list
15098455|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098456|NCT04258410|Quercetin|quercetin|mesh-list
15098457|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
15098458|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098459|NCT04258410|Protective Agents|protective agents|mesh-ancestor
15098460|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098461|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15098462|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15098463|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15098464|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15098465|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098466|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098467|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098468|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15098469|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
15098470|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098471|NCT04191616|Dexamethasone|dexamethasone|mesh-list
15098472|NCT04191616|Pomalidomide|pomalidomide|mesh-list
15098473|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098474|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
15098475|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
15098476|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098477|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098478|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098479|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
15098480|NCT04191616|Hormones|hormones|mesh-ancestor
15098481|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098482|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15098483|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098484|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
15098485|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098486|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098487|NCT04191616|Growth Substances|growth substances|mesh-ancestor
15098488|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098489|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
15098490|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15098491|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098492|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15098493|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098494|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15098495|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
15098496|NCT04120454|Ramucirumab|ramucirumab|mesh-list
15098497|NCT04120454|Antibodies|antibodies|mesh-list
15098498|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
15098499|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15098500|NCT04120454|Lexatumumab|lexatumumab|mesh-list
15098501|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
15098502|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098503|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098504|NCT04107168|Bevacizumab|bevacizumab|mesh-list
15098505|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
15098506|NCT04107168|Nivolumab|nivolumab|mesh-list
15098507|NCT04107168|Ipilimumab|ipilimumab|mesh-list
15098508|NCT04107168|Durvalumab|durvalumab|mesh-list
15098509|NCT04107168|Atezolizumab|atezolizumab|mesh-list
15098510|NCT04107168|Tremelimumab|tremelimumab|mesh-list
15098511|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098512|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098513|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098514|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098515|NCT04107168|Growth Substances|growth substances|mesh-ancestor
14269113|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14269114|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14269115|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
14269116|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098516|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098517|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098518|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15098519|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098520|NCT04098237|Pancrelipase|pancrelipase|mesh-list
15098521|NCT04098237|Pancreatin|pancreatin|mesh-list
15098522|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098523|NCT04097730|Riboflavin|riboflavin|mesh-list
14269117|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15098524|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
15098525|NCT04097730|Difluprednate|difluprednate|mesh-list
15098526|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15098527|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098528|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15098529|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15098530|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098531|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098532|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098533|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098534|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
15098535|NCT04097730|Vitamins|vitamins|mesh-ancestor
15098536|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
15098537|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15098538|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098539|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
15098540|NCT04097730|Hormones|hormones|mesh-ancestor
15098541|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098542|NCT04034459|Leucovorin|leucovorin|mesh-list
15098543|NCT04034459|Folic Acid|folic acid|mesh-list
15098544|NCT04034459|Bevacizumab|bevacizumab|mesh-list
15098545|NCT04034459|Cetuximab|cetuximab|mesh-list
15098546|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
15098547|NCT04034459|Irinotecan|irinotecan|mesh-list
15098548|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
15098549|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098550|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269118|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15098551|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098552|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098553|NCT04034459|Growth Substances|growth substances|mesh-ancestor
15098554|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098555|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098556|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15098557|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15098558|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098559|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098560|NCT04034459|Antidotes|antidotes|mesh-ancestor
15098561|NCT04034459|Protective Agents|protective agents|mesh-ancestor
15098562|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
15098563|NCT04034459|Vitamins|vitamins|mesh-ancestor
15098564|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
15098565|NCT04034459|Hematinics|hematinics|mesh-ancestor
15098566|NCT04030052|Factor VIII|factor viii|mesh-list
15098567|NCT04030052|Coagulants|coagulants|mesh-ancestor
15098568|NCT04005729|Cangrelor|cangrelor|mesh-list
15098569|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15098570|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15098571|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15098572|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15098573|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
15098574|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098575|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098576|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098577|NCT04000737|Sorafenib|sorafenib|mesh-list
15098578|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098579|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15098580|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098581|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098582|NCT03950076|Edoxaban|edoxaban|mesh-list
15098583|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15098584|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
15098585|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15098586|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
15098587|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098588|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098589|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
15098590|NCT03914885|Fludarabine|fludarabine|mesh-list
15098591|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15098592|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098593|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098594|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15098595|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
15098596|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
15098597|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098598|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098599|NCT03885089|Infliximab|infliximab|mesh-list
15098600|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098601|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098602|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098603|NCT03866239|Atezolizumab|atezolizumab|mesh-list
15098604|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
15098605|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098606|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098607|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15098608|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15098609|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15098610|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098611|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098612|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
15098613|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098614|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15098615|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15098616|NCT03823534|Acetaminophen|acetaminophen|mesh-list
15098617|NCT03823534|Ketorolac|ketorolac|mesh-list
15098618|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15098619|NCT03823534|Morphine|morphine|mesh-list
15098620|NCT03823534|Oxycodone|oxycodone|mesh-list
15098621|NCT03823534|Hydrocodone|hydrocodone|mesh-list
15098622|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15098623|NCT03823534|Narcotics|narcotics|mesh-ancestor
15098624|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098625|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098626|NCT03823534|Analgesics|analgesics|mesh-ancestor
15098627|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
15098628|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098629|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15098630|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
15098631|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15098632|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098633|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098634|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15098635|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098636|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098637|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
15098638|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
15098639|NCT03812991|Calcitonin|calcitonin|mesh-list
15098640|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
15098641|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15098642|NCT03812991|Katacalcin|katacalcin|mesh-list
15098643|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15098644|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098645|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15098646|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
15098647|NCT03779243|Melatonin|melatonin|mesh-list
15098648|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
15098649|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098650|NCT03779243|Protective Agents|protective agents|mesh-ancestor
15098651|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098652|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098653|NCT03757013|Apremilast|apremilast|mesh-list
15098654|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15098655|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15098656|NCT03757013|Analgesics|analgesics|mesh-ancestor
15098657|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
15098658|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098659|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098660|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098661|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098662|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15098663|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15098664|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098665|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174318|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15174319|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15174320|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15174321|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174322|NCT03997279|Amoxicillin|amoxicillin|mesh-list
15174323|NCT03997279|Metronidazole|metronidazole|mesh-list
15174324|NCT03997279|Clarithromycin|clarithromycin|mesh-list
15174325|NCT03997279|Rabeprazole|rabeprazole|mesh-list
15174326|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15174327|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174328|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15174329|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15174330|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15174331|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174332|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174333|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15174334|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15174335|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15174336|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174337|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15174338|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
15174339|NCT03997019|Narcotics|narcotics|mesh-ancestor
15174340|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174341|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174342|NCT03997019|Analgesics|analgesics|mesh-ancestor
15174343|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
15174344|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174345|NCT03997006|Atropine|atropine|mesh-list
15174346|NCT03997006|Aminophylline|aminophylline|mesh-list
15174347|NCT03997006|Acefyllin piperazinate|acefyllin piperazinate|mesh-list
15174348|NCT03997006|Neostigmine|neostigmine|mesh-list
15174349|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15174350|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15174351|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15174352|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
15174353|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174354|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174355|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15174356|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
14292370|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
15174357|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
15098666|NCT03738228|Cisplatin|cisplatin|mesh-list
15098667|NCT03738228|Atezolizumab|atezolizumab|mesh-list
15098668|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15098669|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098670|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
15098671|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098672|NCT03729271|Rifaximin|rifaximin|mesh-list
15098673|NCT03729271|Lactulose|lactulose|mesh-list
15098674|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15098675|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098676|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098677|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
15098678|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15098679|NCT03696784|Fludarabine|fludarabine|mesh-list
15098680|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15098681|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
15098682|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098683|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098684|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15098685|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
15098686|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098687|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098688|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15098689|NCT03693846|Nivolumab|nivolumab|mesh-list
15098690|NCT03693846|Ipilimumab|ipilimumab|mesh-list
15098691|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098692|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098693|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15098694|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098695|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
15098696|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15098697|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
15098698|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098699|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098700|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15098701|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
15098702|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15098703|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15098704|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15098705|NCT03635788|Rilpivirine|rilpivirine|mesh-list
15098706|NCT03635788|Cabotegravir|cabotegravir|mesh-list
15098707|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15098708|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15098709|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098710|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098711|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
15098712|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098713|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15098714|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15098715|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15098716|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15098717|NCT03602157|Fludarabine|fludarabine|mesh-list
15098718|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15098719|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098720|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098721|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15098722|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
15098723|NCT03601455|Durvalumab|durvalumab|mesh-list
15098724|NCT03601455|Ipilimumab|ipilimumab|mesh-list
15098725|NCT03601455|Tremelimumab|tremelimumab|mesh-list
15098726|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
15098727|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15098728|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
15098729|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098730|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098731|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
15098732|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098733|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15098734|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098735|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
15098736|NCT03594162|Fludarabine|fludarabine|mesh-list
15098737|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15098738|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
15098739|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098740|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098741|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15098742|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
15098743|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098744|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098745|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15098746|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
15098747|NCT03519997|Bavituximab|bavituximab|mesh-list
15098748|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098749|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098750|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
15098751|NCT03437330|Empagliflozin|empagliflozin|mesh-list
15098752|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15098753|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098754|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15098755|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098756|NCT03405714|Brivaracetam|brivaracetam|mesh-list
15098757|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
15098758|NCT03261830|Clindamycin|clindamycin|mesh-list
15098759|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
15098760|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
15098761|NCT03261830|Cefazolin|cefazolin|mesh-list
15098762|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15098763|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098764|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15098765|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098766|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098767|NCT03219528|Rifaximin|rifaximin|mesh-list
15098768|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15098769|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15098770|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098771|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
15098772|NCT03111732|Capecitabine|capecitabine|mesh-list
15098773|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
15098774|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098775|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098776|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15098777|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
15098778|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098779|NCT03088059|Durvalumab|durvalumab|mesh-list
15098780|NCT03088059|Palbociclib|palbociclib|mesh-list
15098781|NCT03088059|Niraparib|niraparib|mesh-list
15098782|NCT03088059|Afatinib|afatinib|mesh-list
15098783|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098784|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098785|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15098786|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098787|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098788|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15098789|NCT03065244|Infliximab|infliximab|mesh-list
15098790|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
15098791|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15098792|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
15098793|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15098794|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
15098795|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098796|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098797|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098798|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098799|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
15098800|NCT03007732|Prednisone|prednisone|mesh-list
15098801|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
15098802|NCT03007732|Leuprolide|leuprolide|mesh-list
15098803|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
15098804|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
15098805|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15098806|NCT03007732|Androgens|androgens|mesh-list
15098807|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098808|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098809|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098810|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
15098811|NCT03007732|Hormones|hormones|mesh-ancestor
15098812|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098813|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098814|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15098815|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15098816|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
15098817|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15098818|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15098819|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098820|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098821|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
15098822|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15098823|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
15098824|NCT03007732|Protective Agents|protective agents|mesh-ancestor
15098825|NCT03007732|Vitamins|vitamins|mesh-ancestor
15098826|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
15098827|NCT03007732|Estrogens|estrogens|mesh-ancestor
15098828|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
15098829|NCT02952924|Midazolam|midazolam|mesh-list
15098830|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15098831|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15098832|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098833|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098834|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15098835|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15098836|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098837|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15098838|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
15098839|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
15098840|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
15098841|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
15098842|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098843|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098844|NCT02934529|Leucovorin|leucovorin|mesh-list
15098845|NCT02934529|Folic Acid|folic acid|mesh-list
15098846|NCT02934529|Bevacizumab|bevacizumab|mesh-list
15098847|NCT02934529|Cetuximab|cetuximab|mesh-list
15098848|NCT02934529|Fluorouracil|fluorouracil|mesh-list
15098849|NCT02934529|Capecitabine|capecitabine|mesh-list
15098850|NCT02934529|Irinotecan|irinotecan|mesh-list
15098851|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
15098852|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098853|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098854|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098855|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098856|NCT02934529|Growth Substances|growth substances|mesh-ancestor
15098857|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098858|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098859|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
15098860|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098861|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15098862|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15098863|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
15098864|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15098865|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15098866|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15098867|NCT02934529|Antidotes|antidotes|mesh-ancestor
15098868|NCT02934529|Protective Agents|protective agents|mesh-ancestor
15098869|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
15098870|NCT02934529|Vitamins|vitamins|mesh-ancestor
15098871|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
15098872|NCT02934529|Hematinics|hematinics|mesh-ancestor
15098873|NCT02816736|Valsartan|valsartan|mesh-list
15098874|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15098875|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15098876|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15098877|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15098878|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098879|NCT02774421|Trastuzumab|trastuzumab|mesh-list
15098880|NCT02774421|Molgramostim|molgramostim|mesh-list
15098881|NCT02774421|Sargramostim|sargramostim|mesh-list
15098882|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098883|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098884|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
15098885|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098886|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15098887|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
15098888|NCT02713373|Cetuximab|cetuximab|mesh-list
15098889|NCT02713373|Antibodies|antibodies|mesh-list
15098890|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
15098891|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15098892|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
15098893|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098894|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098895|NCT02681302|Nivolumab|nivolumab|mesh-list
15098896|NCT02681302|Ipilimumab|ipilimumab|mesh-list
15098897|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098898|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098899|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15098900|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098901|NCT02590094|Bevacizumab|bevacizumab|mesh-list
15098902|NCT02590094|Aflibercept|aflibercept|mesh-list
15098903|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098904|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098905|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098906|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098907|NCT02590094|Growth Substances|growth substances|mesh-ancestor
15098908|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098909|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098910|NCT02431702|Haloperidol|haloperidol|mesh-list
15098911|NCT02431702|Olanzapine|olanzapine|mesh-list
15098912|NCT02431702|Risperidone|risperidone|mesh-list
15098913|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15098914|NCT02431702|Aripiprazole|aripiprazole|mesh-list
15098915|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15098916|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
15098917|NCT02431702|Perphenazine|perphenazine|mesh-list
15098918|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15098919|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
15098920|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15098921|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098922|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098923|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15098924|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15098925|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098926|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15098927|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15098928|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
15098929|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
15098930|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
15098931|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098932|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098933|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15098934|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15098935|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15098936|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
15098937|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
15098938|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15098939|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15098940|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15098941|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15098942|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15098943|NCT02136069|Infliximab|infliximab|mesh-list
15098944|NCT02136069|Etrolizumab|etrolizumab|mesh-list
15098945|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
15098946|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15098947|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15098948|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
15098949|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098950|NCT02096874|Bevacizumab|bevacizumab|mesh-list
15098951|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15098952|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098953|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098954|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098955|NCT02096874|Growth Substances|growth substances|mesh-ancestor
15098956|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098957|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098958|NCT02086552|Lenalidomide|lenalidomide|mesh-list
15098959|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
15098960|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098961|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15098962|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15098963|NCT02086552|Growth Substances|growth substances|mesh-ancestor
15098964|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
15098965|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15098966|NCT01024608|Beclomethasone|beclomethasone|mesh-list
15098967|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098968|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
15098969|NCT01024608|Hormones|hormones|mesh-ancestor
15098970|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098971|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098972|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15098973|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
15098974|NCT00988247|Beclomethasone|beclomethasone|mesh-list
15098975|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15098976|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
15098977|NCT00988247|Hormones|hormones|mesh-ancestor
15098978|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15098979|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098980|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15098981|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
15098982|NCT00838981|Methadone|methadone|mesh-list
15098983|NCT00838981|Modafinil|modafinil|mesh-list
15098984|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15098985|NCT00838981|Narcotics|narcotics|mesh-ancestor
15098986|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15098987|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15098988|NCT00838981|Analgesics|analgesics|mesh-ancestor
15098989|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
15098990|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15098991|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
15098992|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
15098993|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15098994|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15098995|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15098996|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15098997|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15098998|NCT00730639|Nivolumab|nivolumab|mesh-list
15098999|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099000|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099001|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15099002|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099003|NCT00363038|Vitamins|vitamins|mesh-list
15099004|NCT00363038|Vitamin K|vitamin k|mesh-list
15099005|NCT00363038|Vitamin A|vitamin a|mesh-list
15099006|NCT00363038|Petrolatum|petrolatum|mesh-list
15099007|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
15099008|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099009|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15099010|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15099011|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099012|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
15099013|NCT00363038|Coagulants|coagulants|mesh-ancestor
15099014|NCT00363038|Emollients|emollients|mesh-ancestor
15099015|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
15099016|NCT05146453|Anesthetics|anesthetics|mesh-list
15099017|NCT05146453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099018|NCT05146453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099019|NCT05146271|Anesthetics|anesthetics|mesh-list
15099020|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099021|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099022|NCT05146245|Risperidone|risperidone|mesh-list
15099023|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15099024|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
15099025|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099026|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099027|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099028|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15099029|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15099030|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099031|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15099032|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15099033|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
15174358|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
15174359|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15174360|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15174361|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
15174362|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174363|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174364|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15174365|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174366|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15174367|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14292371|NCT00560404|Hematinics|hematinics|mesh-ancestor
15099034|NCT05146089|Bosentan|bosentan|mesh-list
15099035|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15099036|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15099037|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099038|NCT05145660|Cisplatin|cisplatin|mesh-list
15099039|NCT05145660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099040|NCT05145634|Anticoagulants|anticoagulants|mesh-list
15099041|NCT05145543|Dexamethasone|dexamethasone|mesh-list
15099042|NCT05145543|Fentanyl|fentanyl|mesh-list
15099043|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
15099044|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099045|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
15099046|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
15099047|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099048|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099049|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099050|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
15099051|NCT05145543|Hormones|hormones|mesh-ancestor
15099052|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099053|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099054|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099055|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15099056|NCT05145543|Narcotics|narcotics|mesh-ancestor
15099057|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099058|NCT05145543|Analgesics|analgesics|mesh-ancestor
15099059|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
15099060|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15099061|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15099062|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
15099063|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
15099064|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099065|NCT05145296|Daratumumab|daratumumab|mesh-list
15099066|NCT05145296|Abatacept|abatacept|mesh-list
15099067|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099068|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15099069|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099070|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099071|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
15099072|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099073|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099074|NCT05145270|Sulforaphane|sulforaphane|mesh-list
15099075|NCT05145270|Dexetimide|dexetimide|mesh-list
15099076|NCT05145270|Citalopram|citalopram|mesh-list
15099077|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15099078|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15099079|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099080|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099081|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099082|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
15099083|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099084|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15099085|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
15099086|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15099087|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15099088|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15099089|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
15099090|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
15099091|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099092|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15099093|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15099094|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
15099095|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15099096|NCT05145270|Protective Agents|protective agents|mesh-ancestor
15099097|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099098|NCT05131386|Trabectedin|trabectedin|mesh-list
15099099|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15099100|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
15099101|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099102|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099103|NCT05100134|Ceritinib|ceritinib|mesh-list
15099104|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099105|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15099106|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099107|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099108|NCT05079620|Amoxicillin|amoxicillin|mesh-list
15099109|NCT05079620|Vancomycin|vancomycin|mesh-list
15099110|NCT05079620|Levofloxacin|levofloxacin|mesh-list
15099111|NCT05079620|Ofloxacin|ofloxacin|mesh-list
15099112|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
15099113|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15099114|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
15099115|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
15099116|NCT05079620|Cefepime|cefepime|mesh-list
15099117|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15099118|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099119|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15099120|NCT05079620|Renal Agents|renal agents|mesh-ancestor
15099121|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15099122|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15099123|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099124|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099125|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099126|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15099127|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15099128|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15099129|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
15099130|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
15099131|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
15099132|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15099133|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15099134|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099135|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099136|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099137|NCT05019430|Cocaine|cocaine|mesh-list
15099138|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
15099139|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099140|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
15099141|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099142|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099143|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
15099144|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099145|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15099146|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15099147|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15099148|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099149|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099150|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
15099151|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099152|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15099153|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15099154|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
15099155|NCT04991480|Talazoparib|talazoparib|mesh-list
15099156|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15099157|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099158|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099159|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099160|NCT04987294|Rasburicase|rasburicase|mesh-list
15099161|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
15099162|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099163|NCT04956302|Dexamethasone|dexamethasone|mesh-list
15099164|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
15099165|NCT04956302|Bortezomib|bortezomib|mesh-list
15099166|NCT04956302|Daratumumab|daratumumab|mesh-list
15099167|NCT04956302|Panobinostat|panobinostat|mesh-list
15099168|NCT04956302|Ichthammol|ichthammol|mesh-list
15099169|NCT04956302|BB 1101|bb 1101|mesh-list
15099170|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15099171|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099172|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
15099173|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
15099174|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099175|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099176|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099177|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
15099178|NCT04956302|Hormones|hormones|mesh-ancestor
15099179|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099180|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099181|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099182|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
15099183|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099184|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099185|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
15099186|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15099187|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
15099188|NCT04907032|Mirabegron|mirabegron|mesh-list
15099189|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15099190|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15099191|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15099192|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
15099193|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099194|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099195|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099196|NCT04907032|Urological Agents|urological agents|mesh-ancestor
15099197|NCT04834362|Insulin|insulin|mesh-list
15099198|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15099199|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
15099200|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
15099201|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15099202|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099203|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15099204|NCT04826354|Ezetimibe|ezetimibe|mesh-list
15099205|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15099206|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15099207|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
15099208|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099209|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15099210|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15099211|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099212|NCT04802356|Dexamethasone|dexamethasone|mesh-list
15099213|NCT04802356|Lenalidomide|lenalidomide|mesh-list
15099214|NCT04802356|Bortezomib|bortezomib|mesh-list
15099215|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099216|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
15099217|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
15099218|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099219|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099220|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099221|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
15099222|NCT04802356|Hormones|hormones|mesh-ancestor
15099223|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099224|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099225|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099226|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
15099227|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15099228|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15099229|NCT04802356|Growth Substances|growth substances|mesh-ancestor
15099230|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
15099231|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15099232|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15099233|NCT04777006|Amitriptyline|amitriptyline|mesh-list
15099234|NCT04777006|Fluoxetine|fluoxetine|mesh-list
15099235|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
15099236|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15099237|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15099238|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099239|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099240|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099241|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
15099242|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099243|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15099244|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15099245|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15099246|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15099247|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099248|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15099249|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15099250|NCT04777006|Analgesics|analgesics|mesh-ancestor
15099251|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
15099252|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099253|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15099254|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
15099255|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
15099256|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15099257|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099258|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
15099259|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099260|NCT04708613|Corticosterone|corticosterone|mesh-list
15099261|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174368|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15174369|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15174370|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15174371|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
15174372|NCT03997006|Protective Agents|protective agents|mesh-ancestor
15174373|NCT03997058|Estazolam|estazolam|mesh-list
15174374|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
15174375|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15174376|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15174377|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174378|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174379|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15174380|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
15174381|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
15174382|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174383|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174384|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
15174385|NCT03996772|Apixaban|apixaban|mesh-list
15174386|NCT03996772|Edoxaban|edoxaban|mesh-list
15174387|NCT03996772|Dabigatran|dabigatran|mesh-list
14269119|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14269120|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
14269121|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269122|NCT00400946|Antidotes|antidotes|mesh-ancestor
14269123|NCT00400946|Protective Agents|protective agents|mesh-ancestor
14269124|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
15174388|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15174389|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
15174390|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15174391|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
15174392|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174393|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174394|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
15174395|NCT03996993|Bicalutamide|bicalutamide|mesh-list
15174396|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
15174397|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
15174398|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174399|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174400|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174401|NCT03996538|Metformin|metformin|mesh-list
15174402|NCT03996538|Vaccines|vaccines|mesh-list
15174403|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
15174404|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174405|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15174406|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
15174407|NCT03996421|Trace Elements|trace elements|mesh-ancestor
15174408|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
15174409|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174410|NCT03996577|Lidocaine|lidocaine|mesh-list
15174411|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
15174412|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
15174413|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174414|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174415|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
15174416|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174417|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15174418|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15174419|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15174420|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174421|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174422|NCT03996603|Estrogens|estrogens|mesh-list
15174423|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15174424|NCT03996603|Hormones|hormones|mesh-ancestor
15174425|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174426|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174427|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
15174428|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
15174429|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
15174430|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15174431|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
15174432|NCT03996486|Paraproteins|paraproteins|mesh-list
15174433|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
14269125|NCT00400946|Vitamins|vitamins|mesh-ancestor
14269126|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
15174434|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099262|NCT04681482|Apixaban|apixaban|mesh-list
15099263|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15099264|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
15099265|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15099266|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
15099267|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099268|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099269|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
15099270|NCT04635943|Ivermectin|ivermectin|mesh-list
15099271|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15099272|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099273|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
15099274|NCT04629729|Fludarabine|fludarabine|mesh-list
15099275|NCT04629729|Interleukin-2|interleukin-2|mesh-list
15099276|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099277|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
15099278|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099279|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099280|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15099281|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
15099282|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099283|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099284|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15099285|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15099286|NCT04629729|Analgesics|analgesics|mesh-ancestor
15099287|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
15099288|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099289|NCT04512534|Antibodies|antibodies|mesh-list
15099290|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15099291|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
15099292|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099293|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099294|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099295|NCT04510506|Pancrelipase|pancrelipase|mesh-list
15099296|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099297|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
15099298|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099299|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099300|NCT04425447|Anesthetics|anesthetics|mesh-list
15099301|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099302|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099303|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15099304|NCT04355728|Heparin|heparin|mesh-list
15099305|NCT04355728|Calcium heparin|calcium heparin|mesh-list
15099306|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
15099307|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15099308|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15099309|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099310|NCT04328714|Interferons|interferons|mesh-list
15099311|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
15099312|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099313|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
15099314|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099315|NCT04303780|Docetaxel|docetaxel|mesh-list
15099316|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099317|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
15099318|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
15099319|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
15099320|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099321|NCT04227288|Betamethasone|betamethasone|mesh-list
15099322|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
15099323|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15099324|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
15099325|NCT04227288|Calcipotriene|calcipotriene|mesh-list
15099326|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15099327|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099328|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
15099329|NCT04227288|Hormones|hormones|mesh-ancestor
15099330|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099331|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099332|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15099333|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
15099334|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
15099335|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
15099336|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099337|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099338|NCT04194554|Leuprolide|leuprolide|mesh-list
15099339|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
15099340|NCT04194554|Niraparib|niraparib|mesh-list
15099341|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15099342|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
15099343|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15099344|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099345|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099346|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099347|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15099348|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099349|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099350|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
15099351|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099352|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15099353|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15099354|NCT04182997|Dexamethasone|dexamethasone|mesh-list
15099355|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099356|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
15099357|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
15099358|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099359|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099360|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099361|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
15099362|NCT04182997|Hormones|hormones|mesh-ancestor
15099363|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099364|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099365|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099366|NCT04137354|Vitamins|vitamins|mesh-list
15099367|NCT04137354|Vitamin A|vitamin a|mesh-list
15099368|NCT04137354|Iron|iron|mesh-list
15099369|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
15099370|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
15099371|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099372|NCT04137354|Trace Elements|trace elements|mesh-ancestor
15099373|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
15099374|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099375|NCT04137354|Protective Agents|protective agents|mesh-ancestor
15099376|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15099377|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099378|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
15099379|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15099380|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099381|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099382|NCT04033068|Vaccines|vaccines|mesh-list
15099383|NCT04033068|Immunologic Factors|immunologic factors|mesh-ancestor
15099384|NCT04033068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099385|NCT04023227|Valsartan|valsartan|mesh-list
15099386|NCT04023227|Enalapril|enalapril|mesh-list
15099387|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15099388|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15099389|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15099390|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099391|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15099392|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
15099393|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099394|NCT04002037|Dexamethasone|dexamethasone|mesh-list
15099395|NCT04002037|Triamcinolone|triamcinolone|mesh-list
15099396|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15099397|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15099398|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15099399|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099400|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
15099401|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
15099402|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099403|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099404|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099405|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
15099406|NCT04002037|Hormones|hormones|mesh-ancestor
15099407|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099408|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099409|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099410|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099411|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
15099412|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099413|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099414|NCT03961516|Pancrelipase|pancrelipase|mesh-list
15099415|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099416|NCT03954938|Cocaine|cocaine|mesh-list
15099417|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099418|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
15099419|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099420|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099421|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
15099422|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099423|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15099424|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15099425|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15099426|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099427|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099428|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
15099429|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099430|NCT03937986|Cocaine|cocaine|mesh-list
15099431|NCT03937986|Suvorexant|suvorexant|mesh-list
15099432|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099433|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
15099434|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099435|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099436|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
15099437|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099438|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15099439|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15099440|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15099441|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099442|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099443|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
15099444|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099445|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15099446|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15099447|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15099448|NCT03822897|Cisplatin|cisplatin|mesh-list
15099449|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099450|NCT03749616|Acetaminophen|acetaminophen|mesh-list
15099451|NCT03749616|Ibuprofen|ibuprofen|mesh-list
15099452|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15099453|NCT03749616|Analgesics|analgesics|mesh-ancestor
15099454|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
15099455|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099456|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099457|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
15099458|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15099459|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099460|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099461|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15099462|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099463|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099464|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
15099465|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099466|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15099467|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099468|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099469|NCT03612466|Plerixafor|plerixafor|mesh-list
15099470|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
15099471|NCT03612466|Calcium|calcium|mesh-list
15099472|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15099473|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099474|NCT03612466|Antacids|antacids|mesh-ancestor
15099475|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099476|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099477|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15099478|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15099479|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
15099480|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099481|NCT03599635|Bupivacaine|bupivacaine|mesh-list
15099482|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099483|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
15099484|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174435|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
15099485|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099486|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
15099487|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174436|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15174437|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15174438|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174439|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15174440|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
15174441|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174442|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15174443|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
15174444|NCT03996564|Acetaminophen|acetaminophen|mesh-list
15174445|NCT03996564|Diclofenac|diclofenac|mesh-list
15174446|NCT03996564|Ketorolac|ketorolac|mesh-list
15174447|NCT03996564|Diazepam|diazepam|mesh-list
15174448|NCT03996564|Hydrocodone|hydrocodone|mesh-list
15174449|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15174450|NCT03996564|Analgesics|analgesics|mesh-ancestor
15174451|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
15174452|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174453|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174454|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
15174455|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15174456|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174457|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174458|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15174459|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174460|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174461|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15174462|NCT03996564|Narcotics|narcotics|mesh-ancestor
15174463|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174464|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
15174465|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
15174466|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15174467|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
15174468|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
15174469|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
15174470|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174471|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15174472|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15174473|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15174474|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15174475|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15174476|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15174477|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15174478|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
15174479|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
15174480|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
15174481|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
15174482|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174483|NCT03996434|Cetrorelix|cetrorelix|mesh-list
15174484|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15174485|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
15174486|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15174487|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174488|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
15174489|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174490|NCT03996655|Neostigmine|neostigmine|mesh-list
15174491|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15174492|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174493|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174494|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
15174495|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174496|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174497|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15174498|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
15174499|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174500|NCT03996057|Methenamine|methenamine|mesh-list
15174501|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
15174502|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
15174503|NCT03996057|Estrogens|estrogens|mesh-list
15174504|NCT03996057|Hormones|hormones|mesh-ancestor
15174505|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174506|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174507|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15174508|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174509|NCT03996057|Renal Agents|renal agents|mesh-ancestor
15099488|NCT03570632|Metformin|metformin|mesh-list
15099489|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15099490|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099491|NCT03565835|Prednisone|prednisone|mesh-list
15099492|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
15099493|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099494|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
15099495|NCT03565835|Hormones|hormones|mesh-ancestor
15099496|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099497|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099498|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099499|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099500|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15099501|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099502|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099503|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
15099504|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15099505|NCT03546829|Vancomycin|vancomycin|mesh-list
15099506|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15099507|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099508|NCT03543839|Belimumab|belimumab|mesh-list
15099509|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099510|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
15099511|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099512|NCT03499119|Erenumab|erenumab|mesh-list
15099513|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15099514|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099515|NCT03499119|Analgesics|analgesics|mesh-ancestor
15099516|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
15099517|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099518|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099519|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15099520|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15099521|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15099522|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099523|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099524|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
15099525|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099526|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15099527|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15099528|NCT03451825|Avelumab|avelumab|mesh-list
15099529|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15099530|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099531|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099532|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
15099533|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099534|NCT03439046|Letrozole|letrozole|mesh-list
15099535|NCT03439046|Fulvestrant|fulvestrant|mesh-list
15099536|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099537|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15099538|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15099539|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099540|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099541|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15099542|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
15099543|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099544|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099545|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099546|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15099547|NCT03350984|Insulin|insulin|mesh-list
15099548|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15099549|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
15099550|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
15099551|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
15099552|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
15099553|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
15099554|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15099555|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099556|NCT03328845|Insulin|insulin|mesh-list
15099557|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15099558|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
15099559|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
15099560|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15099561|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099562|NCT03305341|Molgramostim|molgramostim|mesh-list
15099563|NCT03305341|Sargramostim|sargramostim|mesh-list
15099564|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
15099565|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099566|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099567|NCT03300427|Valsartan|valsartan|mesh-list
15099568|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15099569|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15099570|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15099571|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15099572|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099573|NCT03288324|Tofacitinib|tofacitinib|mesh-list
15099574|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15099575|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099576|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099577|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
15099578|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15099579|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15099580|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15099581|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099582|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099583|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
15099584|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099585|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099586|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15099587|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099588|NCT03277261|Teriflunomide|teriflunomide|mesh-list
15099589|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15099590|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15099591|NCT03277261|Analgesics|analgesics|mesh-ancestor
15099592|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
15099593|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099594|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099595|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099596|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099597|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099598|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
15099599|NCT03277248|Teriflunomide|teriflunomide|mesh-list
15099600|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15099601|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15099602|NCT03277248|Analgesics|analgesics|mesh-ancestor
15099603|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
15099604|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099605|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099606|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099607|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099608|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099609|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
15099610|NCT03229499|Anastrozole|anastrozole|mesh-list
15099611|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15099612|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099613|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15099614|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15099615|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099616|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099617|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15099618|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
15099619|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099620|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099621|NCT03203850|Deferasirox|deferasirox|mesh-list
15099622|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15099623|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
15099624|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
15099625|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099626|NCT03190174|Sirolimus|sirolimus|mesh-list
15099627|NCT03190174|Nivolumab|nivolumab|mesh-list
15099628|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099629|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099630|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15099631|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099632|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15099633|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099634|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15099635|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
15099636|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099637|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
15099638|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099639|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15099640|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15099641|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099642|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15099643|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15099644|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099645|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099646|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
15099647|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099648|NCT03148899|Oxytocin|oxytocin|mesh-list
15099649|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
15099650|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15099651|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099652|NCT03136627|Nivolumab|nivolumab|mesh-list
15099653|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099654|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099655|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15099656|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099657|NCT03084549|Ropivacaine|ropivacaine|mesh-list
15099658|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099659|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
15099660|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099661|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099662|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
15099663|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099664|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15099665|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099666|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099667|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
15099668|NCT03026348|Vaccines|vaccines|mesh-list
15099669|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
15099670|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099671|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15099672|NCT03026348|Antacids|antacids|mesh-ancestor
15099673|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099674|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099675|NCT02966548|Nivolumab|nivolumab|mesh-list
15099676|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099677|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099678|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15099679|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099680|NCT02959164|Gemcitabine|gemcitabine|mesh-list
15099681|NCT02959164|Decitabine|decitabine|mesh-list
15099682|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15099683|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
15099684|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099685|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099686|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
15099687|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099688|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099689|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099690|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
15099691|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099692|NCT02922985|Acetaminophen|acetaminophen|mesh-list
15099693|NCT02922985|Ketorolac|ketorolac|mesh-list
15099694|NCT02922985|Bupivacaine|bupivacaine|mesh-list
15099695|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099696|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
15099697|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099698|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099699|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
15099700|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099701|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15099702|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15099703|NCT02922985|Analgesics|analgesics|mesh-ancestor
15099704|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099705|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099706|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15099707|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099708|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099709|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
15099710|NCT02837783|Linaclotide|linaclotide|mesh-list
15099711|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15099712|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
15099713|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099714|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099715|NCT02827201|Gemcitabine|gemcitabine|mesh-list
15099716|NCT02827201|Paclitaxel|paclitaxel|mesh-list
15099717|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15099718|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099719|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
15099720|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
15099721|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
15099722|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099723|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15099724|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
15099725|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
15099726|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099727|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099728|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099729|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
15099730|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099731|NCT02786537|Ritonavir|ritonavir|mesh-list
15099732|NCT02786537|Ribavirin|ribavirin|mesh-list
15099733|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
15099734|NCT02786537|Grazoprevir|grazoprevir|mesh-list
15099735|NCT02786537|Ledipasvir|ledipasvir|mesh-list
15099736|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15099737|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15099738|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
15099739|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099740|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099741|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15099742|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15099743|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
15099744|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099745|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15099746|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15099747|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
15099748|NCT02710084|Oxytocin|oxytocin|mesh-list
15099749|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
15099750|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15099751|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099752|NCT02645474|Ropivacaine|ropivacaine|mesh-list
15099753|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099754|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
15099755|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099756|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099757|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
15099758|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099759|NCT02494258|Azacitidine|azacitidine|mesh-list
15099760|NCT02494258|Cc-486|cc-486|mesh-list
15099761|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15099762|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
15099763|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099764|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099765|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099766|NCT02352337|Gemcitabine|gemcitabine|mesh-list
15099767|NCT02352337|Folfirinox|folfirinox|mesh-list
15099768|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15099769|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
15099770|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099771|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099772|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
15099773|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099774|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099775|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099776|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
15099777|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099778|NCT02338609|Everolimus|everolimus|mesh-list
15099779|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099780|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099781|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
15099782|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099783|NCT02229149|Paclitaxel|paclitaxel|mesh-list
15099784|NCT02229149|Vinorelbine|vinorelbine|mesh-list
15099785|NCT02229149|Docetaxel|docetaxel|mesh-list
15099786|NCT02229149|Capecitabine|capecitabine|mesh-list
15099787|NCT02229149|Trastuzumab|trastuzumab|mesh-list
15099788|NCT02229149|Pertuzumab|pertuzumab|mesh-list
15099789|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15099790|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099791|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
15099792|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
15099793|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
15099794|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099795|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15099796|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
15099797|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099798|NCT02187991|Paclitaxel|paclitaxel|mesh-list
15099799|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15099800|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099801|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
15099802|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
15099803|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
15099804|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099805|NCT02184416|Everolimus|everolimus|mesh-list
15099806|NCT02184416|Sorafenib|sorafenib|mesh-list
15099807|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099808|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099809|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
15099810|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099811|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15099812|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099813|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099814|NCT02182687|Doxorubicin|doxorubicin|mesh-list
15099815|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15099816|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15099817|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099818|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15099819|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15099820|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099821|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099822|NCT01976273|Glycolic acid|glycolic acid|mesh-list
15099823|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
15099824|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
15099825|NCT01802086|Lidocaine|lidocaine|mesh-list
15099826|NCT01802086|Prilocaine|prilocaine|mesh-list
15099827|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15099828|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
15099829|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
15099830|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15099831|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099832|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
15099833|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099834|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15099835|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15099836|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15099837|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099838|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099839|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15099840|NCT01525316|Lactoferrin|lactoferrin|mesh-list
15099841|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099842|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15099843|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15099844|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15099845|NCT01388491|Desogestrel|desogestrel|mesh-list
15099846|NCT01388491|Estradiol|estradiol|mesh-list
15099847|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15099848|NCT01388491|Estrogens|estrogens|mesh-ancestor
15099849|NCT01388491|Hormones|hormones|mesh-ancestor
15099850|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15099851|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099852|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15099853|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
15099854|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15099855|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15099856|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15099857|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15099858|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15099859|NCT01388491|Progestins|progestins|mesh-ancestor
15174510|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15099860|NCT01373151|Adalimumab|adalimumab|mesh-list
15099861|NCT01373151|Methotrexate|methotrexate|mesh-list
15099862|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15099863|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
15099864|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15099865|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099866|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15099867|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
15099868|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099869|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269127|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
14269128|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
14269129|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
14269130|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14269131|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15099870|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
15099871|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099872|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15099873|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099874|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
15099875|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099876|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15099877|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15099878|NCT01351103|Spartalizumab|spartalizumab|mesh-list
15099879|NCT01351103|LGK974|lgk974|mesh-list
15099880|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15099881|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099882|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099883|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099884|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
15099885|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15099886|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15099887|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15099888|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099889|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099890|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
15099891|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099892|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099893|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15099894|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099895|NCT00960297|Paclitaxel|paclitaxel|mesh-list
15099896|NCT00960297|Bevacizumab|bevacizumab|mesh-list
15099897|NCT00960297|Carboplatin|carboplatin|mesh-list
15099898|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15099899|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099900|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
15099901|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
15099902|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
15099903|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099904|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15099905|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15099906|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15099907|NCT00960297|Growth Substances|growth substances|mesh-ancestor
15099908|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099909|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
15099910|NCT00910650|Aldesleukin|aldesleukin|mesh-list
15099911|NCT00910650|Interleukin-2|interleukin-2|mesh-list
15099912|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099913|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15099914|NCT00910650|Analgesics|analgesics|mesh-ancestor
15099915|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
15099916|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099917|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099918|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15099919|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15099920|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
15099921|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099922|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
15099923|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
15099924|NCT00703326|Docetaxel|docetaxel|mesh-list
15099925|NCT00703326|Ramucirumab|ramucirumab|mesh-list
15099926|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099927|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
15099928|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
15099929|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
15099930|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099931|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
15099932|NCT00602667|Cisplatin|cisplatin|mesh-list
15099933|NCT00602667|Carboplatin|carboplatin|mesh-list
15099934|NCT00602667|Methotrexate|methotrexate|mesh-list
15099935|NCT00602667|Etoposide|etoposide|mesh-list
15099936|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
15099937|NCT00602667|Vincristine|vincristine|mesh-list
15099938|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15099939|NCT00602667|Topotecan|topotecan|mesh-list
15099940|NCT00602667|Vinblastine|vinblastine|mesh-list
15099941|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15099942|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
15099943|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099944|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15099945|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15099946|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
15099947|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099948|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15099949|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15099950|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15099951|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
15099952|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15099953|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15099954|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
15099955|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
15099956|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15099957|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15099958|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15099959|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15099960|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15099961|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15099962|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
15099963|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
15099964|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
15099965|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15099966|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15099967|NCT00472186|Lansoprazole|lansoprazole|mesh-list
15099968|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
15099969|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15099970|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099971|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15099972|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269132|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
14269133|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14269134|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14269135|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269136|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
14269137|NCT00401193|Coagulants|coagulants|mesh-ancestor
14269138|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14269139|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14269140|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15099973|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099974|NCT05148000|Botulinum Toxins|botulinum toxins|mesh-list
15099975|NCT05148000|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14561654|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14561655|NCT00002801|Leucovorin|leucovorin|mesh-list
14561656|NCT00002801|Tegafur|tegafur|mesh-list
14561657|NCT00002801|Calcium|calcium|mesh-list
14561658|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
14561659|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14561660|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561661|NCT00002801|Antidotes|antidotes|mesh-ancestor
14561662|NCT00002801|Protective Agents|protective agents|mesh-ancestor
14561663|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
14561664|NCT00002801|Vitamins|vitamins|mesh-ancestor
14561665|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
14561666|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561667|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
14561668|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099976|NCT05148000|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15099977|NCT05148000|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15099978|NCT05148000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15099979|NCT05148000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15099980|NCT05148000|Cholinergic Agents|cholinergic agents|mesh-ancestor
15099981|NCT05148000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15099982|NCT05148000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099983|NCT05148000|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15099984|NCT05148000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15099985|NCT05147857|Misoprostol|misoprostol|mesh-list
15099986|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15099987|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
15099988|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15099989|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15099990|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15099991|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15099992|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
15099993|NCT05147753|Moxonidine|moxonidine|mesh-list
15099994|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15099995|NCT05147727|Fluconazole|fluconazole|mesh-list
15099996|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
15099997|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15099998|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15099999|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15100000|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100001|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100002|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15100003|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
15100004|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100005|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100006|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15100007|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15100008|NCT05147194|Trimetazidine|trimetazidine|mesh-list
15100009|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
15100010|NCT05147090|Empagliflozin|empagliflozin|mesh-list
15100011|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15100012|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100013|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100014|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100015|NCT05146895|Imiquimod|imiquimod|mesh-list
15100016|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15100017|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
15100018|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100019|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100020|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
15100021|NCT05146713|Propolis|propolis|mesh-list
15100022|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15100023|NCT05146713|Eusol|eusol|mesh-list
15100024|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100025|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
15100026|NCT05145608|Lamotrigine|lamotrigine|mesh-list
15100027|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
15100028|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15100029|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15100030|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100031|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15100032|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100033|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15100034|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15100035|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100036|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15100037|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15100038|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
15100039|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100040|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100041|NCT05118308|Liver Extracts|liver extracts|mesh-list
15100042|NCT05118308|Hematinics|hematinics|mesh-ancestor
15100043|NCT05116800|Gemcitabine|gemcitabine|mesh-list
15100044|NCT05116800|Docetaxel|docetaxel|mesh-list
15100045|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15100046|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
15100047|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100048|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100049|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
15100050|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100051|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100052|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15100053|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
15100054|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100055|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
15100056|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
15100057|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
15100058|NCT05112861|Bevacizumab|bevacizumab|mesh-list
15100059|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100060|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100061|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15100062|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15100063|NCT05112861|Growth Substances|growth substances|mesh-ancestor
15100064|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100065|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
15100066|NCT05089565|Interferons|interferons|mesh-list
15100067|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
15100068|NCT05089565|Antibodies|antibodies|mesh-list
15100069|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
15100070|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
15100071|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100072|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100073|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
15100074|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100075|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
15100076|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15100077|NCT05085327|Protective Agents|protective agents|mesh-ancestor
15100078|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100079|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
15100080|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15100081|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
15100082|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
15100083|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
15100084|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100085|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100086|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
15100087|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100088|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15100089|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15100090|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
15100091|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100092|NCT05078463|Protective Agents|protective agents|mesh-ancestor
15174511|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
15174512|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15174513|NCT03996252|Calcitriol|calcitriol|mesh-list
15174514|NCT03996252|Fluorouracil|fluorouracil|mesh-list
15174515|NCT03996252|Calcipotriene|calcipotriene|mesh-list
15174516|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
15174517|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174518|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15174519|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174520|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15174521|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
15174522|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174523|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
15174524|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15174525|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15174526|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174527|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15174528|NCT03996252|Vitamins|vitamins|mesh-ancestor
15174529|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
15174530|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15174531|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
15174532|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
15174533|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174534|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15181412|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15181413|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
15181414|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15181415|NCT03929835|Protective Agents|protective agents|mesh-ancestor
15181416|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181417|NCT03929419|Insulin|insulin|mesh-list
15181418|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15181419|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181420|NCT03929640|Acetaminophen|acetaminophen|mesh-list
15181421|NCT03929640|Ibuprofen|ibuprofen|mesh-list
15181422|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181423|NCT03929640|Analgesics|analgesics|mesh-ancestor
15181424|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
15181425|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181426|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181427|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
15181428|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15100093|NCT04984837|Gemcitabine|gemcitabine|mesh-list
15100094|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
15100095|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15100096|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
15100097|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100098|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100099|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
15100100|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100101|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100102|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15100103|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
15100104|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100105|NCT04948463|Vancomycin|vancomycin|mesh-list
15100106|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
15100107|NCT04948463|Tazobactam|tazobactam|mesh-list
15100108|NCT04948463|Piperacillin|piperacillin|mesh-list
15100109|NCT04948463|Amikacin|amikacin|mesh-list
15100110|NCT04948463|Ceftazidime|ceftazidime|mesh-list
15100111|NCT04948463|Cefepime|cefepime|mesh-list
15100112|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15100113|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100114|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15100115|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15100116|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100117|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100118|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100119|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15100120|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15100121|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15100122|NCT04941261|Vaccines|vaccines|mesh-list
15100123|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
15100124|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100125|NCT04939363|Venetoclax|venetoclax|mesh-list
15100126|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
15100127|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100128|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100129|NCT04894721|Ivermectin|ivermectin|mesh-list
15100130|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15100131|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100132|NCT04874311|Doxorubicin|doxorubicin|mesh-list
15100133|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15100134|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100135|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15100136|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15100137|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100138|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100139|NCT04825197|Poractant alfa|poractant alfa|mesh-list
15100140|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15100141|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
15100142|NCT04817956|Trastuzumab|trastuzumab|mesh-list
15100143|NCT04817956|Pertuzumab|pertuzumab|mesh-list
15100144|NCT04817956|Atezolizumab|atezolizumab|mesh-list
15100145|NCT04817956|Vemurafenib|vemurafenib|mesh-list
15100146|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15100147|NCT04817956|Entrectinib|entrectinib|mesh-list
15100148|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100149|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100150|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100151|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
15100152|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100153|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100154|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100155|NCT04793659|Fasudil|fasudil|mesh-list
15100156|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
15100157|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15100158|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15100159|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100160|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15100161|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100162|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
15100163|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100164|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100165|NCT04789148|Oxytocin|oxytocin|mesh-list
15100166|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
15100167|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15100168|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100169|NCT04783675|Rituximab|rituximab|mesh-list
15100170|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100171|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100172|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
15100173|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100174|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100175|NCT04776148|Trifluridine|trifluridine|mesh-list
15100176|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
15100177|NCT04776148|Lenvatinib|lenvatinib|mesh-list
15100178|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100179|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100180|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100181|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100182|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100183|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
15100184|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
15100185|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100186|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
15100187|NCT04742140|Analgesics|analgesics|mesh-ancestor
15100188|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
15100189|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100190|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100191|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
15100192|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100193|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15100194|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
15100195|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15100196|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15100197|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100198|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15100199|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
15100200|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15100201|NCT04715230|Lorazepam|lorazepam|mesh-list
15100202|NCT04715230|Haloperidol|haloperidol|mesh-list
15100203|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
15100204|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
15100205|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
15100206|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100207|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100208|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15100209|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15100210|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15100211|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100212|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15100213|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15100214|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
15100215|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100216|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100217|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15100218|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
15100219|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15100220|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15100221|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
15100222|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
15100223|NCT04677387|Naloxone|naloxone|mesh-list
15100224|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15100225|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100226|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
15100227|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100228|NCT04643379|Carboplatin|carboplatin|mesh-list
15100229|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
15100230|NCT04643379|Olaparib|olaparib|mesh-list
15100231|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100232|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100233|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15100234|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100235|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100236|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
15100237|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100238|NCT04590274|Azithromycin|azithromycin|mesh-list
15100239|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
15100240|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15100241|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100242|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
15100243|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15100244|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15100245|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100246|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100247|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100248|NCT04567784|Cannabidiol|cannabidiol|mesh-list
15100249|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
15100250|NCT04526899|Cemiplimab|cemiplimab|mesh-list
15100251|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100252|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100253|NCT04474470|Cetuximab|cetuximab|mesh-list
15100254|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100255|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100256|NCT04440358|Carboplatin|carboplatin|mesh-list
15100257|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100258|NCT04381832|Docetaxel|docetaxel|mesh-list
15100259|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100260|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
15100261|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
15100262|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
15100263|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100264|NCT04339140|Zafirlukast|zafirlukast|mesh-list
15100265|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15100266|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
15100267|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15100268|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
15100269|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100270|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100271|NCT04294810|Atezolizumab|atezolizumab|mesh-list
15100272|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100273|NCT04283617|Insulin|insulin|mesh-list
15100274|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100275|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100276|NCT04246372|Tofacitinib|tofacitinib|mesh-list
15100277|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100278|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100279|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100280|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15100281|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100282|NCT04182321|Metformin|metformin|mesh-list
15100283|NCT04182321|Entecavir|entecavir|mesh-list
15100284|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100285|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100286|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
15100287|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174535|NCT03995628|Dexamethasone|dexamethasone|mesh-list
15174536|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174537|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
15174538|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
15174539|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174540|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174541|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174542|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
15174543|NCT03995628|Hormones|hormones|mesh-ancestor
15174544|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174545|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15174546|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174547|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
15174548|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
15174549|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174550|NCT03995563|Dexamethasone|dexamethasone|mesh-list
15174551|NCT03995563|Ropivacaine|ropivacaine|mesh-list
15174552|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174553|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
15174554|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
15174555|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174556|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174557|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174558|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
15174559|NCT03995563|Hormones|hormones|mesh-ancestor
15174560|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174561|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15174562|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174563|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
15174564|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
15174565|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174566|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
15174567|NCT03995251|Testosterone|testosterone|mesh-list
15174568|NCT03995251|Androgens|androgens|mesh-ancestor
15100288|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15100289|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100290|NCT04143282|Metformin|metformin|mesh-list
15100291|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100292|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100293|NCT04124588|Hemostatics|hemostatics|mesh-list
15100294|NCT04124588|Coagulants|coagulants|mesh-ancestor
15100295|NCT04062279|Autoantibodies|autoantibodies|mesh-list
15100296|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
15100297|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100298|NCT04035278|Vaccines|vaccines|mesh-list
15100299|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
15100300|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100301|NCT03989414|Dexamethasone|dexamethasone|mesh-list
15100302|NCT03989414|Bortezomib|bortezomib|mesh-list
15100303|NCT03989414|Daratumumab|daratumumab|mesh-list
15100304|NCT03989414|Elotuzumab|elotuzumab|mesh-list
15100305|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15100306|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
15100307|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
15100308|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100309|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100310|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15100311|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
15100312|NCT03989414|Hormones|hormones|mesh-ancestor
15100313|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100314|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15100315|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100316|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
15100317|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15100318|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
15100319|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100320|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100321|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15100322|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
15100323|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
15100324|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15100325|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
15100326|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100327|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100328|NCT03916341|Nicotine|nicotine|mesh-list
15100329|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15100330|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
15100331|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100332|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100333|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15100334|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15100335|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
15100336|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100337|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100338|NCT03881020|Fluorides|fluorides|mesh-list
15100339|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
15100340|NCT03881020|Protective Agents|protective agents|mesh-ancestor
15100341|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100342|NCT03872401|Evolocumab|evolocumab|mesh-list
15100343|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15100344|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15100345|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
15100346|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100347|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15100348|NCT03797261|Venetoclax|venetoclax|mesh-list
15100349|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100350|NCT03719924|Paclitaxel|paclitaxel|mesh-list
15100351|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15100352|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100353|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
15100354|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
15100355|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
15100356|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100357|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
15100358|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
15100359|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15100360|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15100361|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100362|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100363|NCT03686306|Urological Agents|urological agents|mesh-ancestor
15100364|NCT03661138|Upadacitinib|upadacitinib|mesh-list
15100365|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15100366|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100367|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100368|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100369|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100370|NCT03589976|Sirolimus|sirolimus|mesh-list
15100371|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15100372|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100373|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15100374|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100375|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
15100376|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15100377|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
15100378|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100379|NCT03579615|Insulin|insulin|mesh-list
15100380|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
15100381|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100382|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100383|NCT03532139|Enoxaparin|enoxaparin|mesh-list
15100384|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
15100385|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15100386|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15100387|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15100388|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
15100389|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100390|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15100391|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15100392|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100393|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
15100394|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15100395|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15100396|NCT03475953|Avelumab|avelumab|mesh-list
15100397|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15100398|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100399|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100400|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
15100401|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100402|NCT03447574|Ethanol|ethanol|mesh-list
15100403|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15100404|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100405|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100406|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100407|NCT03368729|Trastuzumab|trastuzumab|mesh-list
15100408|NCT03368729|Niraparib|niraparib|mesh-list
15100409|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100410|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100411|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15100412|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100413|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100414|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
15100415|NCT03344341|Acarbose|acarbose|mesh-list
15100416|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15100417|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100418|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100419|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100420|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15100421|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100422|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
15100423|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100424|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100425|NCT03276468|Atezolizumab|atezolizumab|mesh-list
15100426|NCT03276468|Venetoclax|venetoclax|mesh-list
15100427|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
15100428|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100429|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100430|NCT03260881|Liraglutide|liraglutide|mesh-list
15100431|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100432|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100433|NCT03260881|Incretins|incretins|mesh-ancestor
15100434|NCT03260881|Hormones|hormones|mesh-ancestor
15100435|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100436|NCT03238495|Metformin|metformin|mesh-list
15100437|NCT03238495|Carboplatin|carboplatin|mesh-list
15100438|NCT03238495|Docetaxel|docetaxel|mesh-list
15100439|NCT03238495|Trastuzumab|trastuzumab|mesh-list
15100440|NCT03238495|Pertuzumab|pertuzumab|mesh-list
15100441|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100442|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100443|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100444|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
15100445|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
15100446|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
15100447|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100448|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100449|NCT03232138|Sulforaphane|sulforaphane|mesh-list
15100450|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15100451|NCT03232138|Protective Agents|protective agents|mesh-ancestor
15100452|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100453|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100454|NCT03212963|Clobetasol|clobetasol|mesh-list
13996169|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269141|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15100455|NCT03212963|Halobetasol|halobetasol|mesh-list
15100456|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15100457|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15100458|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
15100459|NCT03212963|Hormones|hormones|mesh-ancestor
15100460|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100461|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100462|NCT03135262|Rituximab|rituximab|mesh-list
15100463|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
15100464|NCT03135262|Venetoclax|venetoclax|mesh-list
15100465|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100466|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100467|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
15100468|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100469|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100470|NCT03104075|Vaccines|vaccines|mesh-list
15100471|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15100472|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
15100473|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100474|NCT03077620|Suvorexant|suvorexant|mesh-list
15100475|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15100476|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15100477|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100478|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100479|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15100480|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100481|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100482|NCT03072628|Nicotine|nicotine|mesh-list
15100483|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15100484|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
15100485|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100486|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100487|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15100488|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15100489|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
15100490|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269142|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100491|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100492|NCT02981472|Vitamin K|vitamin k|mesh-list
15100493|NCT02981472|Heparin|heparin|mesh-list
15100494|NCT02981472|Enoxaparin|enoxaparin|mesh-list
15100495|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15100496|NCT02981472|Tinzaparin|tinzaparin|mesh-list
15100497|NCT02981472|Dalteparin|dalteparin|mesh-list
15100498|NCT02981472|Warfarin|warfarin|mesh-list
15100499|NCT02981472|Apixaban|apixaban|mesh-list
15100500|NCT02981472|Vitamins|vitamins|mesh-ancestor
15100501|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
15100502|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100503|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
15100504|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15100505|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15100506|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100507|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15100508|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
15100509|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15100510|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
15100511|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100512|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15100513|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
15100514|NCT02981472|Coagulants|coagulants|mesh-ancestor
15100515|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15100516|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15100517|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100518|NCT02907983|Bupivacaine|bupivacaine|mesh-list
15100519|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
15100520|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
15100521|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100522|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100523|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
15100524|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100525|NCT02880540|Fentanyl|fentanyl|mesh-list
15100526|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
15100527|NCT02880540|Morphine|morphine|mesh-list
15100528|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15100529|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100530|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100531|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15100532|NCT02880540|Analgesics|analgesics|mesh-ancestor
15100533|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
15100534|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100535|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15100536|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15100537|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15100538|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
15100539|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100540|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100541|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15100542|NCT02880540|Narcotics|narcotics|mesh-ancestor
15100543|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15100544|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15100545|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
15100546|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
15100547|NCT02841215|Ivermectin|ivermectin|mesh-list
15100548|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15100549|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100550|NCT02802566|Vitamins|vitamins|mesh-list
15100551|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
15100552|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174569|NCT03995251|Hormones|hormones|mesh-ancestor
15174570|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174571|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174572|NCT03995147|Prednisone|prednisone|mesh-list
15174573|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
15174574|NCT03995147|Doxorubicin|doxorubicin|mesh-list
15174575|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
15174576|NCT03995147|Vincristine|vincristine|mesh-list
15174577|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15174578|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
15174579|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174580|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174581|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15174582|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
15174583|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174584|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174585|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15174586|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174587|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15174588|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15174589|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15174590|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174591|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174592|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
15174593|NCT03995147|Hormones|hormones|mesh-ancestor
15174594|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174595|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15174596|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15174597|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
15174598|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
15174599|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
15174600|NCT03995277|Biotin|biotin|mesh-list
15174601|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
15174602|NCT03995277|Vitamins|vitamins|mesh-ancestor
15174603|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
15174604|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174605|NCT03995134|Remifentanil|remifentanil|mesh-list
15174606|NCT03995134|Propofol|propofol|mesh-list
15100553|NCT02799641|Lidocaine|lidocaine|mesh-list
15100554|NCT02799641|Diazepam|diazepam|mesh-list
15100555|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
15100556|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
15100557|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100558|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100559|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
15100560|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100561|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15100562|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15100563|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15100564|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15100565|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100566|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15100567|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
15100568|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
15100569|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
15100570|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15100571|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15100572|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15100573|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15100574|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15100575|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15100576|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15100577|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15100578|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
15100579|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
15100580|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
15100581|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100582|NCT02782663|Upadacitinib|upadacitinib|mesh-list
15100583|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15100584|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100585|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100586|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100587|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100588|NCT02755844|Metformin|metformin|mesh-list
15100589|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
15100590|NCT02755844|Olaparib|olaparib|mesh-list
15100591|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15100592|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
15100593|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100594|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100595|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15100596|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
15100597|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100598|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100599|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15100600|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100601|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15100602|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100603|NCT02741388|Gemcitabine|gemcitabine|mesh-list
15100604|NCT02741388|Cytarabine|cytarabine|mesh-list
15100605|NCT02741388|Dexamethasone|dexamethasone|mesh-list
15100606|NCT02741388|Rituximab|rituximab|mesh-list
15100607|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
15100608|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100609|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15100610|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
15100611|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
15100612|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100613|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100614|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15100615|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
15100616|NCT02741388|Hormones|hormones|mesh-ancestor
15100617|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100618|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15100619|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100620|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
15100621|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100622|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15100623|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
15100624|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100625|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
15100626|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100627|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100628|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15100629|NCT02686346|Etoposide|etoposide|mesh-list
15100630|NCT02686346|Ifosfamide|ifosfamide|mesh-list
15100631|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15100632|NCT02686346|Carboplatin|carboplatin|mesh-list
15100633|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15100634|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100635|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15100636|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15100637|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100638|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100639|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15100640|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
15100641|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100642|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15100643|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
15100644|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100645|NCT02536339|Trastuzumab|trastuzumab|mesh-list
15100646|NCT02536339|Pertuzumab|pertuzumab|mesh-list
15100647|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100648|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100649|NCT02333370|Tamoxifen|tamoxifen|mesh-list
15100650|NCT02333370|Letrozole|letrozole|mesh-list
15100651|NCT02333370|Fulvestrant|fulvestrant|mesh-list
15100652|NCT02333370|Goserelin|goserelin|mesh-list
15100653|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100654|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15100655|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15100656|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100657|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100658|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15100659|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
15100660|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100661|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100662|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15100663|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15100664|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15100665|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15100666|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15100667|NCT02229136|Prednisolone|prednisolone|mesh-list
15100668|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
15100669|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15100670|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
15100671|NCT02229136|Hormones|hormones|mesh-ancestor
15100672|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100673|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100674|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15100675|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100676|NCT02189798|Imidacloprid|imidacloprid|mesh-list
15100677|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
15100678|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100679|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100680|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100681|NCT02050308|Nicotine|nicotine|mesh-list
15100682|NCT02050308|Varenicline|varenicline|mesh-list
15100683|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15100684|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
15100685|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100686|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100687|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15100688|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15100689|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
15100690|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100691|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100692|NCT01958021|Letrozole|letrozole|mesh-list
15100693|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100694|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15100695|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15100696|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100697|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100698|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15100699|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
15100700|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100701|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100702|NCT01869361|Indomethacin|indomethacin|mesh-list
15100703|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15100704|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15100705|NCT01869361|Analgesics|analgesics|mesh-ancestor
15100706|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
15100707|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100708|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100709|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15100710|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100711|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
15100712|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
15100713|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15100714|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15100715|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100716|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100717|NCT01828099|Carboplatin|carboplatin|mesh-list
15100718|NCT01828099|Pemetrexed|pemetrexed|mesh-list
15100719|NCT01828099|Ceritinib|ceritinib|mesh-list
15100720|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100721|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100722|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100723|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15100724|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15100725|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100726|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
15100727|NCT01593254|Dasatinib|dasatinib|mesh-list
15100728|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100729|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100730|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100731|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100732|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15100733|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100734|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100735|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
15100736|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100737|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100738|NCT00943618|Bupropion|bupropion|mesh-list
15100739|NCT00943618|Varenicline|varenicline|mesh-list
15100740|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15100741|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
15100742|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15100743|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15100744|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15100745|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15100746|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100747|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
15100748|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100749|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100750|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15100751|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15100752|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100753|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15100754|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15100755|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
15100756|NCT00914823|Hormones|hormones|mesh-list
15100757|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100758|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100759|NCT00529763|Dasatinib|dasatinib|mesh-list
15100760|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100761|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100762|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100763|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100764|NCT05149378|Azacitidine|azacitidine|mesh-list
15100765|NCT05149378|Venetoclax|venetoclax|mesh-list
15100766|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15100767|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
14269143|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269144|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269145|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
14269146|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269147|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14269148|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15100768|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292372|NCT00560417|Insulin|insulin|mesh-list
15100769|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100770|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100771|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
15100772|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15100773|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100774|NCT05149339|Vitamins|vitamins|mesh-ancestor
15100775|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
15100776|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15100777|NCT05149248|Vaccines|vaccines|mesh-list
15100778|NCT05149248|Immunologic Factors|immunologic factors|mesh-ancestor
15100779|NCT05149248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100780|NCT05149170|Antibodies|antibodies|mesh-list
15100781|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15100782|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
15100783|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100784|NCT05149092|Caseins|caseins|mesh-list
15100785|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
15100786|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
15100787|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100788|NCT05148910|Copper|copper|mesh-list
15100789|NCT05148910|Trace Elements|trace elements|mesh-ancestor
15100790|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
15100791|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174607|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15174608|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174609|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174610|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15174611|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
15174612|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
15174613|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15174614|NCT03995134|Narcotics|narcotics|mesh-ancestor
15174615|NCT03995134|Analgesics|analgesics|mesh-ancestor
15174616|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
15174617|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174618|NCT03994965|Pimavanserin|pimavanserin|mesh-list
15174619|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15174620|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15174621|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15174622|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15174623|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174624|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174625|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15174626|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15174627|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15174628|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
15174629|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174630|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174631|NCT03994731|Methotrexate|methotrexate|mesh-list
15174632|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15174633|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
15174634|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15174635|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174636|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15174637|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
15174638|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174639|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174640|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
15174641|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174642|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15174643|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15174644|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
15174645|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174646|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15174647|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
15174648|NCT03994783|Rituximab|rituximab|mesh-list
15174649|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
15174650|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15174651|NCT03994783|Antibodies|antibodies|mesh-list
15174652|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
15174653|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15174654|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174655|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174656|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
15174657|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174658|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174659|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174660|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
15100792|NCT05148884|Befiradol|befiradol|mesh-list
15100793|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15100794|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15100795|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
15100796|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100797|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100798|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100799|NCT05148767|Irinotecan|irinotecan|mesh-list
15100800|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15100801|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15100802|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100803|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100804|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100805|NCT05148715|Tacrolimus|tacrolimus|mesh-list
15100806|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15100807|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
15100808|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100809|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15100810|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100811|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100812|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15100813|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15100814|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100815|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
15100816|NCT05148689|Phenylephrine|phenylephrine|mesh-list
15100817|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
15100818|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15100819|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15100820|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
15100821|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100822|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100823|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100824|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
15100825|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
14269149|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269150|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269151|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269152|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269153|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269154|NCT00401258|Analgesics|analgesics|mesh-ancestor
14269155|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
14269156|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269157|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
14269158|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269159|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
15100826|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100827|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
15100828|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15100829|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
15100830|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15100831|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
15100832|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15100833|NCT05148689|Protective Agents|protective agents|mesh-ancestor
15100834|NCT05148442|Azacitidine|azacitidine|mesh-list
15100835|NCT05148442|Decitabine|decitabine|mesh-list
15100836|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15100837|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
15100838|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100839|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100840|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100841|NCT05148403|Glyburide|glyburide|mesh-list
15100842|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15100843|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100844|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
15100845|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15100846|NCT05148169|Sulforaphane|sulforaphane|mesh-list
15100847|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15100848|NCT05148169|Protective Agents|protective agents|mesh-ancestor
15100849|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100850|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100851|NCT05148143|Raltitrexed|raltitrexed|mesh-list
15100852|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15100853|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
15100854|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100855|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100856|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15100857|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100858|NCT05148026|Heparin|heparin|mesh-list
15100859|NCT05148026|Calcium heparin|calcium heparin|mesh-list
15100860|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
15100861|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
15100862|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15100863|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15100864|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100865|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15100866|NCT05145218|Paclitaxel|paclitaxel|mesh-list
15100867|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15100868|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100869|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
15100870|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
15100871|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
15100872|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100873|NCT05136040|Bupivacaine|bupivacaine|mesh-list
15100874|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
15100875|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
15100876|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15100877|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100878|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
15100879|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100880|NCT05121298|Upadacitinib|upadacitinib|mesh-list
15100881|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15100882|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100883|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100884|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100885|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100886|NCT05103644|Atorvastatin|atorvastatin|mesh-list
15100887|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15100888|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15100889|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
15100890|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100891|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15100892|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15100893|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100894|NCT05100264|Acetic Acid|acetic acid|mesh-list
15100895|NCT05100264|Retinol acetate|retinol acetate|mesh-list
15100896|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15100897|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100898|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15100899|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
15100900|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100901|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15100902|NCT05100264|Protective Agents|protective agents|mesh-ancestor
15100903|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100904|NCT05084521|Famotidine|famotidine|mesh-list
15100905|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15100906|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15100907|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15100908|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
15100909|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
15100910|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100911|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100912|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100913|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
15100914|NCT05078931|Lenvatinib|lenvatinib|mesh-list
15100915|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100916|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100917|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100918|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100919|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100920|NCT05029856|Vaccines|vaccines|mesh-list
15100921|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
15100922|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100923|NCT05012631|Losartan|losartan|mesh-list
15100924|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15100925|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15100926|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15100927|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15100928|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100929|NCT04992260|Vaccines|vaccines|mesh-list
15100930|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
15100931|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100932|NCT04989491|Rituximab|rituximab|mesh-list
15100933|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100934|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100935|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
14269160|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
14269161|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14269162|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269163|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
14269164|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15100936|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100937|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15100938|NCT04989322|Carboplatin|carboplatin|mesh-list
15100939|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
15100940|NCT04989322|Pemetrexed|pemetrexed|mesh-list
15100941|NCT04989322|Lenvatinib|lenvatinib|mesh-list
15100942|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100943|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100944|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100945|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100946|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15100947|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15100948|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100949|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15100950|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15100951|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15100952|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100953|NCT04935112|Pantoprazole|pantoprazole|mesh-list
15100954|NCT04935112|Famotidine|famotidine|mesh-list
15100955|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15100956|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15100957|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15100958|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100959|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100960|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15100961|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
15100962|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
15100963|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15100964|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174661|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
15174662|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174663|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174664|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
15174665|NCT03994783|Hormones|hormones|mesh-ancestor
15174666|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174667|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15174668|NCT03994783|Protective Agents|protective agents|mesh-ancestor
15174669|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
15174670|NCT03994705|Fludarabine|fludarabine|mesh-list
15174671|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15174672|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
15174673|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174674|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174675|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15174676|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
15174677|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174678|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174679|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15174680|NCT03994692|Ether|ether|mesh-list
15174681|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15174682|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
15174683|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
15174684|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174685|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174686|NCT03994744|Metformin|metformin|mesh-list
15174687|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15174688|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15174689|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174690|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174691|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174692|NCT03994211|Itraconazole|itraconazole|mesh-list
15174693|NCT03994211|Rifampin|rifampin|mesh-list
15174694|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
14269165|NCT00401401|Zalutumumab|zalutumumab|mesh-list
15100965|NCT04931511|Betamethasone|betamethasone|mesh-list
15100966|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
15100967|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15100968|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
15100969|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15100970|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15100971|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
15100972|NCT04931511|Hormones|hormones|mesh-ancestor
15100973|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15100974|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15100975|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15100976|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
15100977|NCT04920942|Ivermectin|ivermectin|mesh-list
15100978|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15100979|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15100980|NCT04901754|Apatinib|apatinib|mesh-list
15100981|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100982|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15100983|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100984|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100985|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
15100986|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
15100987|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15100988|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100989|NCT04804709|Panobinostat|panobinostat|mesh-list
15100990|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15100991|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15100992|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15100993|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15100994|NCT04731103|Lamivudine|lamivudine|mesh-list
15100995|NCT04731103|Zidovudine|zidovudine|mesh-list
15100996|NCT04731103|Abacavir|abacavir|mesh-list
15100997|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
15100998|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15100999|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15101000|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101001|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101002|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
15101003|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101004|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15101005|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15101006|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
15101007|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
15101008|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101009|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101010|NCT04690673|Acetaminophen|acetaminophen|mesh-list
15101011|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15101012|NCT04690673|Analgesics|analgesics|mesh-ancestor
15101013|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
15101014|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101015|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101016|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
15101017|NCT04682288|Levofloxacin|levofloxacin|mesh-list
15101018|NCT04682288|Ofloxacin|ofloxacin|mesh-list
15101019|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15101020|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101021|NCT04682288|Renal Agents|renal agents|mesh-ancestor
15101022|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15101023|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15101024|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15101025|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101026|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101027|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101028|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15101029|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15101030|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15101031|NCT04608409|Paclitaxel|paclitaxel|mesh-list
15101032|NCT04608409|Lapatinib|lapatinib|mesh-list
15101033|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101034|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101035|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101036|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101037|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101038|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101039|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101040|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101041|NCT04606576|Insulin|insulin|mesh-list
15101042|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15101043|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15101044|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101045|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
15101046|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15101047|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101048|NCT04580992|Ajmaline|ajmaline|mesh-list
15101049|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15101050|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15101051|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15101052|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101053|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101054|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
15101055|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101056|NCT04554732|Mitogens|mitogens|mesh-list
15101057|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101058|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101059|NCT04544111|Trametinib|trametinib|mesh-list
15101060|NCT04544111|Dabrafenib|dabrafenib|mesh-list
15101061|NCT04544111|Spartalizumab|spartalizumab|mesh-list
15101062|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101063|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101064|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101065|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101066|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101067|NCT04536467|Goserelin|goserelin|mesh-list
15101068|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15101069|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101070|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
15101071|NCT04523480|Testosterone|testosterone|mesh-list
15101072|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
15101073|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
15101074|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15101075|NCT04523480|Androgens|androgens|mesh-ancestor
15101076|NCT04523480|Hormones|hormones|mesh-ancestor
15101077|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101078|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101079|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15101080|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101081|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
15101082|NCT04469634|Antibodies|antibodies|mesh-list
15101083|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
15101084|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101085|NCT04455178|Indapamide|indapamide|mesh-list
15101086|NCT04455178|Spironolactone|spironolactone|mesh-list
15101087|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15101088|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
15101089|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101090|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101091|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15101092|NCT04455178|Diuretics|diuretics|mesh-ancestor
15101093|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
15101094|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15101095|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15101096|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101097|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101098|NCT04400110|Amoxicillin|amoxicillin|mesh-list
15101099|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
15101100|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
15101101|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15101102|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101103|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101104|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101105|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15101106|NCT04388501|Atorvastatin|atorvastatin|mesh-list
15101107|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15101108|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15101109|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
15101110|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101111|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15101112|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15101113|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101114|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
15101115|NCT04308837|Promethazine|promethazine|mesh-list
15101116|NCT04308837|Dexamethasone|dexamethasone|mesh-list
15101117|NCT04308837|Paclitaxel|paclitaxel|mesh-list
15101118|NCT04308837|Carboplatin|carboplatin|mesh-list
15101119|NCT04308837|Palonosetron|palonosetron|mesh-list
15101120|NCT04308837|Famotidine|famotidine|mesh-list
15101121|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101122|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101123|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101124|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101125|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101126|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101127|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101128|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
15101129|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
15101130|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101131|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101132|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15101133|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
15101134|NCT04308837|Hormones|hormones|mesh-ancestor
15101135|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101136|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15101137|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15101138|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15101139|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101140|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
15101141|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
15101142|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
15101143|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15101144|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
15101145|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
15101146|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101147|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15101148|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
15101149|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
15101150|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15101151|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15101152|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
15101153|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15101154|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15101155|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
15101156|NCT04303000|Naloxone|naloxone|mesh-list
15101157|NCT04303000|Narcotics|narcotics|mesh-ancestor
15101158|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101159|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101160|NCT04303000|Analgesics|analgesics|mesh-ancestor
15101161|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
15101162|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101163|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15101164|NCT04298034|Labetalol|labetalol|mesh-list
15101165|NCT04298034|Nifedipine|nifedipine|mesh-list
15101166|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15101167|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101168|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101169|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15101170|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101171|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
15101172|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
15101173|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15101174|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15101175|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15101176|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
15101177|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101178|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15101179|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
15101180|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
15101181|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101182|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15101183|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15101184|NCT04254549|Rifaximin|rifaximin|mesh-list
15101185|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15101186|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996170|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
15101187|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15101188|NCT04252287|Canagliflozin|canagliflozin|mesh-list
15101189|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15101190|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101191|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15101192|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101193|NCT04231318|Triamcinolone|triamcinolone|mesh-list
15101194|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15101195|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15101196|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15101197|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101198|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
15101199|NCT04231318|Hormones|hormones|mesh-ancestor
15101200|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101201|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101202|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101203|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
15101204|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101205|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101206|NCT04198649|Azithromycin|azithromycin|mesh-list
15101207|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15101208|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101209|NCT04177654|Albendazole|albendazole|mesh-list
15101210|NCT04177654|Mebendazole|mebendazole|mesh-list
15101211|NCT04177654|Benzimidazole|benzimidazole|mesh-list
15101212|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
15101213|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15101214|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101215|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
15101216|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15101217|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15101218|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101219|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101220|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101221|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101222|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101223|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
15101224|NCT04172402|Gemcitabine|gemcitabine|mesh-list
15101225|NCT04172402|Nivolumab|nivolumab|mesh-list
15101226|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15101227|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
15101228|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101229|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101230|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
15101231|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101232|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101233|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101234|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
15101235|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101236|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101237|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101238|NCT04111419|Amlodipine|amlodipine|mesh-list
15101239|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
15101240|NCT04111419|Atorvastatin|atorvastatin|mesh-list
15101241|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15101242|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15101243|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
15101244|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101245|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15101246|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15101247|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101248|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15101249|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15101250|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101251|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15101252|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101253|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
15174695|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174696|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15174697|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15174698|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174699|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174700|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15174701|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
15174702|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174703|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101254|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15101255|NCT04071613|Plasminogen|plasminogen|mesh-list
15101256|NCT04071613|Tenecteplase|tenecteplase|mesh-list
15101257|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15101258|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15101259|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101260|NCT04062708|Durvalumab|durvalumab|mesh-list
15101261|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101262|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101263|NCT04040231|Nivolumab|nivolumab|mesh-list
15101264|NCT04040231|Sargramostim|sargramostim|mesh-list
15101265|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101266|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101267|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101268|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101269|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
15101270|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101271|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
15101272|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15101273|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
15101274|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101275|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
15101276|NCT04026191|Protective Agents|protective agents|mesh-ancestor
15101277|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
15101278|NCT04006769|Entacapone|entacapone|mesh-list
15101279|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101280|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101281|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101282|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101283|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15101284|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15101285|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15101286|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
15101287|NCT03970746|Pemetrexed|pemetrexed|mesh-list
15101288|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101289|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101290|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101291|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101292|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15101293|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15101294|NCT03962894|Prednisolone|prednisolone|mesh-list
15101295|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101296|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
15101297|NCT03962894|Hormones|hormones|mesh-ancestor
15101298|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101299|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101300|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15101301|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101302|NCT03916627|Cemiplimab|cemiplimab|mesh-list
15101303|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101304|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101305|NCT03893318|Lidocaine|lidocaine|mesh-list
15101306|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
15101307|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
15101308|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101309|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101310|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
15101311|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101312|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15101313|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15101314|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15101315|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101316|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101317|NCT03832010|Triamcinolone|triamcinolone|mesh-list
15101318|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
15101319|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101320|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
15101321|NCT03832010|Hormones|hormones|mesh-ancestor
15101322|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101323|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101324|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15101325|NCT03817125|Vancomycin|vancomycin|mesh-list
15101326|NCT03817125|Nivolumab|nivolumab|mesh-list
15101327|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101328|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101329|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101330|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101331|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101332|NCT03783026|Apremilast|apremilast|mesh-list
15101333|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15101334|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15101335|NCT03783026|Analgesics|analgesics|mesh-ancestor
15101336|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
15101337|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101338|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101339|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101340|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15101341|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15101342|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15101343|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101344|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101345|NCT03733132|Metformin|metformin|mesh-list
15101346|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15101347|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101348|NCT03625466|Ivacaftor|ivacaftor|mesh-list
15101349|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15101350|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101351|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101352|NCT03605719|Dexamethasone|dexamethasone|mesh-list
15101353|NCT03605719|Nivolumab|nivolumab|mesh-list
15101354|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101355|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
15101356|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
15101357|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101358|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101359|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15101360|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
15101361|NCT03605719|Hormones|hormones|mesh-ancestor
15101362|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101363|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15101364|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101365|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101366|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101367|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101368|NCT03529890|Nivolumab|nivolumab|mesh-list
15101369|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101370|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101371|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101372|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101373|NCT03476239|Blinatumomab|blinatumomab|mesh-list
15101374|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101375|NCT03451799|Temozolomide|temozolomide|mesh-list
15101376|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15101377|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
15101378|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101379|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101380|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
15101381|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
15101382|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15101383|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15101384|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101385|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101386|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101387|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15101388|NCT03417479|Gabapentin|gabapentin|mesh-list
15101389|NCT03417479|Analgesics|analgesics|mesh-ancestor
15101390|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
15101391|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101392|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101393|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
15101394|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15101395|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15101396|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101397|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15101398|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15101399|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15101400|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101401|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101402|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
15101403|NCT03400306|Paclitaxel|paclitaxel|mesh-list
15101404|NCT03400306|Carboplatin|carboplatin|mesh-list
15101405|NCT03400306|Veliparib|veliparib|mesh-list
15101406|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101407|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101408|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101409|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101410|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101411|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101412|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15101413|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101414|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
15101415|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
15101416|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15101417|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15101418|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101419|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
15101420|NCT03317795|Coagulants|coagulants|mesh-ancestor
15101421|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15101422|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
15101423|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15101424|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101425|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15101426|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15101427|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15101428|NCT03214250|Gemcitabine|gemcitabine|mesh-list
15101429|NCT03214250|Paclitaxel|paclitaxel|mesh-list
15101430|NCT03214250|Nivolumab|nivolumab|mesh-list
15101431|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101432|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101433|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101434|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101435|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101436|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101437|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15101438|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
15101439|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
15101440|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101441|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101442|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101443|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
15101444|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101445|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101446|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101447|NCT03174275|Paclitaxel|paclitaxel|mesh-list
15101448|NCT03174275|Carboplatin|carboplatin|mesh-list
15101449|NCT03174275|Durvalumab|durvalumab|mesh-list
15101450|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101451|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101452|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101453|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101454|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101455|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101456|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101457|NCT03115294|Theophylline|theophylline|mesh-list
15101458|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15101459|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
15101460|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101461|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101462|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15101463|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
15101464|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15101465|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101466|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101467|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
15101468|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15101469|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15101470|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
15101471|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101472|NCT03087656|Levofloxacin|levofloxacin|mesh-list
15101473|NCT03087656|Ofloxacin|ofloxacin|mesh-list
15101474|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
15101475|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15101476|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101477|NCT03087656|Renal Agents|renal agents|mesh-ancestor
15101478|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15101479|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15101480|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15101481|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101482|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101483|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101484|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15101485|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15101486|NCT03033069|Sertraline|sertraline|mesh-list
15101487|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
15101488|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
15101489|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15101490|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15101491|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15101492|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101493|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101494|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101495|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
15101496|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101497|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
15101498|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
15101499|NCT02946424|Simvastatin|simvastatin|mesh-list
15101500|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15101501|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15101502|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
15101503|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101504|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15101505|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15101506|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101507|NCT02891954|Canagliflozin|canagliflozin|mesh-list
15101508|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15101509|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101510|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15101511|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101512|NCT02863770|Pancrelipase|pancrelipase|mesh-list
15101513|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15101514|NCT02663622|Methotrexate|methotrexate|mesh-list
15101515|NCT02663622|Tacrolimus|tacrolimus|mesh-list
15101516|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15101517|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
15101518|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15101519|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101520|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15101521|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
15101522|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101523|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101524|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
15101525|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101526|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15101527|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101528|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
15101529|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15101530|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15101531|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15101532|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
15101533|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101534|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101535|NCT02587598|Cytarabine|cytarabine|mesh-list
15101536|NCT02587598|Azacitidine|azacitidine|mesh-list
15101537|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15101538|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
15101539|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101540|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101541|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
15101542|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101543|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101544|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
15101545|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101546|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174704|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15174705|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15101547|NCT02485574|Calcium|calcium|mesh-list
15101548|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15101549|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101550|NCT02350764|Nivolumab|nivolumab|mesh-list
15101551|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101552|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101553|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101554|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101555|NCT02091934|Dipivefrin|dipivefrin|mesh-list
15101556|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15101557|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
15101558|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101559|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101560|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101561|NCT02023996|Trastuzumab|trastuzumab|mesh-list
15101562|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101563|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101564|NCT01639690|Busulfan|busulfan|mesh-list
15101565|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
15101566|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101567|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101568|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
15101569|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101570|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15101571|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101572|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15101573|NCT01612351|Paclitaxel|paclitaxel|mesh-list
15101574|NCT01612351|Cisplatin|cisplatin|mesh-list
15101575|NCT01612351|Carboplatin|carboplatin|mesh-list
15101576|NCT01612351|Lapatinib|lapatinib|mesh-list
15101577|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101578|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101579|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101580|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101581|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101582|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101583|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101584|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101585|NCT01460160|Dasatinib|dasatinib|mesh-list
15101586|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101587|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101588|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101589|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101590|NCT01291004|Drospirenone|drospirenone|mesh-list
15101591|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15101592|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15101593|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
15101594|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15101595|NCT01291004|Desogestrel|desogestrel|mesh-list
15101596|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
15101597|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
15101598|NCT01291004|Estradiol|estradiol|mesh-list
15101599|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15101600|NCT01291004|Estrogens|estrogens|mesh-ancestor
15101601|NCT01291004|Hormones|hormones|mesh-ancestor
15101602|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101603|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101604|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15101605|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15101606|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15101607|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15101608|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15101609|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15101610|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
15101611|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15101612|NCT01291004|Diuretics|diuretics|mesh-ancestor
15101613|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
15101614|NCT01291004|Progestins|progestins|mesh-ancestor
15101615|NCT01170702|Ropivacaine|ropivacaine|mesh-list
15101616|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
15101617|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
15101618|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101619|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101620|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
15101621|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101622|NCT01018563|Farletuzumab|farletuzumab|mesh-list
15101623|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101624|NCT00805961|Bevacizumab|bevacizumab|mesh-list
15101625|NCT00805961|Everolimus|everolimus|mesh-list
15101626|NCT00805961|Temozolomide|temozolomide|mesh-list
15101627|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101628|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101629|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15101630|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15101631|NCT00805961|Growth Substances|growth substances|mesh-ancestor
15101632|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101633|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
15101634|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101635|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
15101636|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15101637|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
15101638|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101639|NCT00600496|Sirolimus|sirolimus|mesh-list
15101640|NCT00600496|Docetaxel|docetaxel|mesh-list
15101641|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15101642|NCT00600496|Dacarbazine|dacarbazine|mesh-list
15101643|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101644|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101645|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101646|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101647|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101648|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101649|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101650|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15101651|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101652|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15101653|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
15101654|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101655|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
15101656|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101657|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15101658|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
15101659|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
15101660|NCT00374660|Irofulven|irofulven|mesh-list
15101661|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101662|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15101663|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
15101664|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101665|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
15101666|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
15101667|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101668|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101669|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15101670|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
15101671|NCT00109668|Beclomethasone|beclomethasone|mesh-list
15101672|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101673|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
15101674|NCT00109668|Hormones|hormones|mesh-ancestor
15101675|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101676|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101677|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15101678|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
15101679|NCT05152472|Atezolizumab|atezolizumab|mesh-list
15101680|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
15101681|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101682|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101683|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101684|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101685|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
15101686|NCT05152420|Apixaban|apixaban|mesh-list
15101687|NCT05152420|Edoxaban|edoxaban|mesh-list
15101688|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15101689|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
15101690|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15101691|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
15101692|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101693|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101694|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
15101695|NCT05152355|Budesonide|budesonide|mesh-list
15101696|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101697|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15101698|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
15101699|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101700|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101701|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15101702|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
15101703|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
15101704|NCT05152355|Hormones|hormones|mesh-ancestor
15101705|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101706|NCT05152303|Propofol|propofol|mesh-list
15101707|NCT05152303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15101708|NCT05152303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101709|NCT05152303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101710|NCT05152303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15101711|NCT05152303|Anesthetics, General|anesthetics, general|mesh-ancestor
15101712|NCT05152303|Anesthetics|anesthetics|mesh-ancestor
15101713|NCT05152264|Analgesics|analgesics|mesh-list
15101714|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
15101715|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101716|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101717|NCT05152186|Disinfectants|disinfectants|mesh-list
15101718|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101719|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15101720|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15101721|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15101722|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101723|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101724|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
15101725|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101726|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101727|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15101728|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101729|NCT05151796|Aspirin|aspirin|mesh-list
15101730|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15101731|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15101732|NCT05151796|Analgesics|analgesics|mesh-ancestor
15101733|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
15101734|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101735|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101736|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101737|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15101738|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15101739|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15101740|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101741|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15101742|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15101743|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101744|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
15101745|NCT05151679|Iron|iron|mesh-list
15101746|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15101747|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
15101748|NCT05151679|Trace Elements|trace elements|mesh-ancestor
15101749|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
15101750|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101751|NCT05151679|Hematinics|hematinics|mesh-ancestor
15101752|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
15101753|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
15101754|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101755|NCT05151614|Colchicine|colchicine|mesh-list
15101756|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
15101757|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15101758|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101759|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101760|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101761|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101762|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101763|NCT05151549|Carboplatin|carboplatin|mesh-list
15101764|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101765|NCT05151510|Lidocaine|lidocaine|mesh-list
15101766|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
15101767|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
15101768|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101769|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101770|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
15101771|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101772|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15101773|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15101774|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15101775|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15101776|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101777|NCT05151393|Vitamin D|vitamin d|mesh-list
15101778|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
15101779|NCT05151393|Vitamins|vitamins|mesh-ancestor
15101780|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
15101781|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101782|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15101783|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15101784|NCT05151328|Plecanatide|plecanatide|mesh-list
15101785|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15101786|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
15101787|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101788|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15101789|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
15101790|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101791|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
15101792|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
15101793|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
15101794|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15101795|NCT05151016|Mifepristone|mifepristone|mesh-list
15101796|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15101797|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
15101798|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15101799|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101800|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15101801|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15101802|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15101803|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
15101804|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15101805|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15101806|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
15101807|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101808|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
15101809|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15101810|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15101811|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15101812|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174706|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
15174707|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15174708|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
15174709|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15174710|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15174711|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15174712|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15174713|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15174714|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15174715|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15174716|NCT03994107|Paclitaxel|paclitaxel|mesh-list
15174717|NCT03994107|Doxorubicin|doxorubicin|mesh-list
15174718|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15174719|NCT03994107|Trastuzumab|trastuzumab|mesh-list
15174720|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15174721|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15174722|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174723|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
15174724|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
15174725|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
15174726|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174727|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15174728|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15174729|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15174730|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174731|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174732|NCT03994055|Antioxidants|antioxidants|mesh-list
15174733|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174734|NCT03994055|Protective Agents|protective agents|mesh-ancestor
15174735|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174736|NCT03994393|Durvalumab|durvalumab|mesh-list
15174737|NCT03994393|Tremelimumab|tremelimumab|mesh-list
15101813|NCT05150899|Fexofenadine|fexofenadine|mesh-list
15101814|NCT05150899|Tamsulosin|tamsulosin|mesh-list
15101815|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15101816|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15101817|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15101818|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
15101819|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101820|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101821|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101822|NCT05150899|Urological Agents|urological agents|mesh-ancestor
15101823|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15101824|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15101825|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15101826|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
15101827|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
15101828|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
15101829|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15101830|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15101831|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
15101832|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101833|NCT05133817|Norepinephrine|norepinephrine|mesh-list
15101834|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15101835|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15101836|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15101837|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
15101838|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101839|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101840|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101841|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
15101842|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
15101843|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101844|NCT05108740|Everolimus|everolimus|mesh-list
15101845|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101846|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101847|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
15101848|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101849|NCT05076513|Niraparib|niraparib|mesh-list
15101850|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15101851|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101852|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101853|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101854|NCT05051891|Prednisone|prednisone|mesh-list
15101855|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
15101856|NCT05051891|Vincristine|vincristine|mesh-list
15101857|NCT05051891|Rituximab|rituximab|mesh-list
15101858|NCT05051891|Doxorubicin|doxorubicin|mesh-list
15101859|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101860|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
15101861|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101862|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15101863|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15101864|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
15101865|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101866|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101867|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15101868|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15101869|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
15101870|NCT05051891|Hormones|hormones|mesh-ancestor
15101871|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15101872|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15101873|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101874|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101875|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101876|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101877|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101878|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15101879|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15101880|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15101881|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101882|NCT04998981|Fenofibrate|fenofibrate|mesh-list
15101883|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15101884|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
15101885|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101886|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14292373|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15101887|NCT04991350|Bevacizumab|bevacizumab|mesh-list
15101888|NCT04991350|Ranibizumab|ranibizumab|mesh-list
15101889|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101890|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101891|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15101892|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15101893|NCT04991350|Growth Substances|growth substances|mesh-ancestor
15101894|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101895|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
15101896|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15101897|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15101898|NCT04940572|Valproic Acid|valproic acid|mesh-list
15101899|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
15101900|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101901|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101902|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
15101903|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15101904|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101905|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
15101906|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15101907|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101908|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15101909|NCT04936685|Vaccines|vaccines|mesh-list
15101910|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
15101911|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101912|NCT04933058|Acetaminophen|acetaminophen|mesh-list
15101913|NCT04933058|Fentanyl|fentanyl|mesh-list
15101914|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15101915|NCT04933058|Narcotics|narcotics|mesh-ancestor
15101916|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101917|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101918|NCT04933058|Analgesics|analgesics|mesh-ancestor
15101919|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
15101920|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101921|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15101922|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15101923|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
15101924|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
15101925|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15101926|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
15101927|NCT04924062|Gemcitabine|gemcitabine|mesh-list
15101928|NCT04924062|Cisplatin|cisplatin|mesh-list
15101929|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
15101930|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101931|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15101932|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
15101933|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101934|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
15101935|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101936|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101937|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101938|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
15101939|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101940|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101941|NCT04899583|Sirolimus|sirolimus|mesh-list
15101942|NCT04899583|Paclitaxel|paclitaxel|mesh-list
15101943|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15101944|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101945|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
15101946|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
15101947|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
15101948|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101949|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15101950|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101951|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15101952|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
15101953|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15101954|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
15101955|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101956|NCT04891991|Infliximab|infliximab|mesh-list
15101957|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
15101958|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15101959|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15101960|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
15101961|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101962|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101963|NCT04777851|Nivolumab|nivolumab|mesh-list
15101964|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15101965|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101966|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15101967|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174738|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174739|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181429|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181430|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181431|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15181432|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181433|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181434|NCT03929744|Midazolam|midazolam|mesh-list
15181435|NCT03929744|Atorvastatin|atorvastatin|mesh-list
15181436|NCT03929744|Simvastatin|simvastatin|mesh-list
15181437|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15181438|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15181439|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
15181440|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181441|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15181442|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15181443|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181444|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15181445|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15181446|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181447|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181448|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15181449|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15181450|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15181451|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15181452|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
15181453|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
15181454|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
15181455|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
15181456|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181457|NCT03929575|Calcium|calcium|mesh-list
15181458|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15181459|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181460|NCT03929666|Leucovorin|leucovorin|mesh-list
15181461|NCT03929666|Gemcitabine|gemcitabine|mesh-list
15181462|NCT03929666|Bevacizumab|bevacizumab|mesh-list
15181463|NCT03929666|Fluorouracil|fluorouracil|mesh-list
15181464|NCT03929666|Capecitabine|capecitabine|mesh-list
15181465|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
15181466|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15181467|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181468|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15181469|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15181470|NCT03929666|Growth Substances|growth substances|mesh-ancestor
15181471|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181472|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
15181473|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15181474|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
15181475|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181476|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
15181477|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181478|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181479|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15181480|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
15181481|NCT03929666|Antidotes|antidotes|mesh-ancestor
15181482|NCT03929666|Protective Agents|protective agents|mesh-ancestor
15181483|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
15181484|NCT03929666|Vitamins|vitamins|mesh-ancestor
15181485|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
15181486|NCT03929224|Bacitracin|bacitracin|mesh-list
15181487|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15181488|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181489|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181490|NCT03929094|Gemcitabine|gemcitabine|mesh-list
15181491|NCT03929094|Paclitaxel|paclitaxel|mesh-list
15181492|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15181493|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15181494|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181495|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
15181496|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
15181497|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
15181498|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181499|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15101968|NCT04761887|Ropivacaine|ropivacaine|mesh-list
15101969|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
15101970|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
15101971|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15101972|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15101973|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
15101974|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15101975|NCT04750759|Niclosamide|niclosamide|mesh-list
15101976|NCT04750759|Camostat|camostat|mesh-list
15101977|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
15101978|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15101979|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
15101980|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15101981|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15101982|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
15101983|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
15101984|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101985|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101986|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15101987|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15101988|NCT04720716|Sorafenib|sorafenib|mesh-list
15101989|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101990|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15101991|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15101992|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101993|NCT04614909|Temozolomide|temozolomide|mesh-list
15101994|NCT04614909|Olaparib|olaparib|mesh-list
15101995|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15101996|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
15101997|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15101998|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15101999|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15102000|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102001|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15102002|NCT04602975|Vaccines|vaccines|mesh-list
15102003|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
15102004|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102005|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15102006|NCT04602975|Antacids|antacids|mesh-ancestor
15102007|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102008|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102009|NCT04597372|Tamsulosin|tamsulosin|mesh-list
15102010|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15102011|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15102012|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15102013|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
15102014|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102015|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102016|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102017|NCT04597372|Urological Agents|urological agents|mesh-ancestor
15102018|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
15102019|NCT04591626|Dulaglutide|dulaglutide|mesh-list
15102020|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15102021|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102022|NCT04574154|Anesthetics|anesthetics|mesh-list
15102023|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102024|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102025|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
15102026|NCT04558866|Testosterone|testosterone|mesh-list
15102027|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
15102028|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
15102029|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14269166|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269167|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269168|NCT00401414|Warfarin|warfarin|mesh-list
14269169|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
14269170|NCT00401531|Vaccines|vaccines|mesh-list
14269171|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14269172|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
14269173|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269174|NCT00401544|Dextrans|dextrans|mesh-list
14269175|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
14269176|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
14269177|NCT00401544|Hematinics|hematinics|mesh-ancestor
14269178|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
14269179|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
14269180|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
15102030|NCT04558866|Androgens|androgens|mesh-ancestor
15102031|NCT04558866|Hormones|hormones|mesh-ancestor
15102032|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102033|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102034|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15102035|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102036|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
15102037|NCT04556370|Norepinephrine|norepinephrine|mesh-list
15102038|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15102039|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15102040|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
15102041|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102042|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102043|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102044|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
15102045|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
15102046|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102047|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15102048|NCT04526821|Lactoferrin|lactoferrin|mesh-list
15102049|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102050|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15102051|NCT04445389|Vaccines|vaccines|mesh-list
15102052|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
15102053|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102054|NCT04365088|Deflazacort|deflazacort|mesh-list
15102055|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102056|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102057|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
15102058|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102059|NCT04349579|Rifamycins|rifamycins|mesh-list
15102060|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
15102061|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15102062|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102063|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102064|NCT04234529|Caffeine|caffeine|mesh-list
15102065|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15102066|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102067|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15102068|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102069|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102070|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15102071|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15102072|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
15102073|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102074|NCT04217954|Bevacizumab|bevacizumab|mesh-list
15102075|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102076|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102077|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15102078|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15102079|NCT04217954|Growth Substances|growth substances|mesh-ancestor
15102080|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102081|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
15102082|NCT04192110|Diuretics|diuretics|mesh-list
15102083|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
15102084|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102085|NCT04182100|Aspirin|aspirin|mesh-list
15102086|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15102087|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15102088|NCT04182100|Analgesics|analgesics|mesh-ancestor
15102089|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
15102090|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102091|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102092|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102093|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102094|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15102095|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15102096|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102097|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15102098|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15102099|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102100|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
15102101|NCT04179019|Amlodipine|amlodipine|mesh-list
15102102|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15102103|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15102104|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15102105|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102106|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15102107|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102108|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
15102109|NCT04127578|Sirolimus|sirolimus|mesh-list
15102110|NCT04127578|Prednisone|prednisone|mesh-list
15102111|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
15102112|NCT04127578|Rituximab|rituximab|mesh-list
15102113|NCT04127578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102114|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102115|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
15102116|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102117|NCT04127578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102118|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102119|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
15102120|NCT04127578|Hormones|hormones|mesh-ancestor
15102121|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102122|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15102123|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15102124|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102125|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15102126|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
15102127|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102128|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
15102129|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
15102130|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102131|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102132|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15102133|NCT04127578|Protective Agents|protective agents|mesh-ancestor
15102134|NCT04084717|Crizotinib|crizotinib|mesh-list
15102135|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102136|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15102137|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102138|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102139|NCT04056182|Lofexidine|lofexidine|mesh-list
15102140|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15102141|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15102142|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102143|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
15102144|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102145|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15102146|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15102147|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15102148|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
15102149|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102150|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102151|NCT04049851|Ivermectin|ivermectin|mesh-list
15102152|NCT04049851|Moxidectin|moxidectin|mesh-list
15102153|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15102154|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102155|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
15102156|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
15102157|NCT03966625|Autoantibodies|autoantibodies|mesh-list
15102158|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
15102159|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102160|NCT03961568|Cenobamate|cenobamate|mesh-list
15102161|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
15102162|NCT03959358|Lenalidomide|lenalidomide|mesh-list
15102163|NCT03959358|Pomalidomide|pomalidomide|mesh-list
15102164|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
15102165|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102166|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15102167|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15102168|NCT03959358|Growth Substances|growth substances|mesh-ancestor
15102169|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
15102170|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102171|NCT03954106|Defibrotide|defibrotide|mesh-list
15102172|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15102173|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15102174|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102175|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15174740|NCT03993431|Methamphetamine|methamphetamine|mesh-list
15174741|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15174742|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174743|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
15174744|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
15102176|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
15102177|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102178|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
15102179|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102180|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102181|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15102182|NCT03944356|Trametinib|trametinib|mesh-list
15102183|NCT03944356|Dabrafenib|dabrafenib|mesh-list
15102184|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102185|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15102186|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102187|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102188|NCT03930498|Antibodies|antibodies|mesh-list
15102189|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
15102190|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
15102191|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102192|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15102193|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
15102194|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102195|NCT03831932|Osimertinib|osimertinib|mesh-list
15102196|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102197|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15102198|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102199|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102200|NCT03817554|Dopamine|dopamine|mesh-list
15102201|NCT03817554|Pramipexole|pramipexole|mesh-list
15102202|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
15102203|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
15102204|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102205|NCT03817554|Protective Agents|protective agents|mesh-ancestor
15102206|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102207|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15102208|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15102209|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
15102210|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102211|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15102212|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
15102213|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
15102214|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102215|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
15102216|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102217|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
15102218|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102219|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102220|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15102221|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
15102222|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15102223|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102224|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15102225|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102226|NCT03778294|Temozolomide|temozolomide|mesh-list
15102227|NCT03778294|Levodopa|levodopa|mesh-list
15102228|NCT03778294|Fluorides|fluorides|mesh-list
15102229|NCT03778294|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
15102230|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15102231|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
15102232|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102233|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102234|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
15102235|NCT03778294|Protective Agents|protective agents|mesh-ancestor
15102236|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102237|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
15102238|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102239|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15102240|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15102241|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
15102242|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15102243|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
15102244|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
15102245|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102246|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102247|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15102248|NCT03736538|Analgesics|analgesics|mesh-ancestor
15102249|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
15102250|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102251|NCT03717896|Thiamine|thiamine|mesh-list
15102252|NCT03717896|Vitamins|vitamins|mesh-ancestor
15102253|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
15102254|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102255|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
15102256|NCT03678753|Cenobamate|cenobamate|mesh-list
15102257|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
15102258|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
15102259|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15102260|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15102261|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15102262|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15102263|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102264|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
15102265|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102266|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102267|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15102268|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102269|NCT03593252|Metronidazole|metronidazole|mesh-list
15102270|NCT03593252|Cefazolin|cefazolin|mesh-list
15102271|NCT03593252|Neomycin|neomycin|mesh-list
15102272|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
15102273|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
15102274|NCT03593252|Citric Acid|citric acid|mesh-list
15102275|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
15102276|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102277|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15102278|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15102279|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15102280|NCT03593252|Cathartics|cathartics|mesh-ancestor
15102281|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102282|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
15102283|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15102284|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
15102285|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
15102286|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102287|NCT03593252|Antacids|antacids|mesh-ancestor
15102288|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15102289|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102290|NCT03582488|Corticosterone|corticosterone|mesh-list
15102291|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102292|NCT03574792|Oxycodone|oxycodone|mesh-list
15102293|NCT03574792|Methadone|methadone|mesh-list
15102294|NCT03574792|Gabapentin|gabapentin|mesh-list
15102295|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15102296|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15102297|NCT03574792|Narcotics|narcotics|mesh-ancestor
15102298|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102299|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102300|NCT03574792|Analgesics|analgesics|mesh-ancestor
15102301|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
15102302|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102303|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
15102304|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15102305|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15102306|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15102307|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15102308|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15102309|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102310|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102311|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
15102312|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
15102313|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
15102314|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15102315|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15102316|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15102317|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15102318|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
15102319|NCT03450707|Thiamine|thiamine|mesh-list
15102320|NCT03450707|Vitamins|vitamins|mesh-ancestor
15102321|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
15102322|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102323|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
15102324|NCT03391479|Avelumab|avelumab|mesh-list
15102325|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102326|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102327|NCT03368066|Cosyntropin|cosyntropin|mesh-list
15102328|NCT03368066|Hormones|hormones|mesh-ancestor
15102329|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102330|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102331|NCT03365622|Acetaminophen|acetaminophen|mesh-list
15102332|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15102333|NCT03365622|Analgesics|analgesics|mesh-ancestor
15102334|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
15102335|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102336|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102337|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
15102338|NCT03361436|Halichondrin B|halichondrin b|mesh-list
15102339|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
15102340|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
15102341|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
15102342|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102343|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102344|NCT03356483|Niacin|niacin|mesh-list
15102345|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
15102346|NCT03356483|Psilocybin|psilocybin|mesh-list
15102347|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15102348|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
15102349|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102350|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15102351|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
15102352|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
15102353|NCT03356483|Vitamins|vitamins|mesh-ancestor
15102354|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
15102355|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102356|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
15102357|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15102358|NCT03289650|Tacrolimus|tacrolimus|mesh-list
15102359|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102360|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
15102361|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102362|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15102363|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102364|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102365|NCT03276052|Bromides|bromides|mesh-list
15102366|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
15102367|NCT03275857|Cisplatin|cisplatin|mesh-list
15102368|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102369|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
15102370|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
15102371|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102372|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102373|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102374|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15102375|NCT03219437|Methotrexate|methotrexate|mesh-list
15102376|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15102377|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
15102378|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15102379|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102380|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15102381|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
15102382|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102383|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102384|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
15102385|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102386|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15102387|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102388|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
15102389|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102390|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15102391|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
15102392|NCT03202537|Lansoprazole|lansoprazole|mesh-list
15102393|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15102394|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102395|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15102396|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102397|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102398|NCT03150511|Tesamorelin|tesamorelin|mesh-list
15102399|NCT03150511|Growth Substances|growth substances|mesh-ancestor
15102400|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102401|NCT03042819|Doxorubicin|doxorubicin|mesh-list
15102402|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15102403|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102404|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15102405|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15102406|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102407|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102408|NCT03030222|Empagliflozin|empagliflozin|mesh-list
15102409|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15102410|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102411|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15102412|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102413|NCT02892604|Insulin|insulin|mesh-list
15102414|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15102415|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102416|NCT02832687|Acetaminophen|acetaminophen|mesh-list
15102417|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15102418|NCT02832687|Analgesics|analgesics|mesh-ancestor
15102419|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
15102420|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102421|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102422|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
15102423|NCT02830477|Factor VIII|factor viii|mesh-list
15102424|NCT02830477|Coagulants|coagulants|mesh-ancestor
15102425|NCT02789345|Osimertinib|osimertinib|mesh-list
15102426|NCT02789345|Ramucirumab|ramucirumab|mesh-list
15102427|NCT02789345|Necitumumab|necitumumab|mesh-list
15102428|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102429|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15102430|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102431|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102432|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102433|NCT02703220|Acetazolamide|acetazolamide|mesh-list
15102434|NCT02703220|Finasteride|finasteride|mesh-list
15102435|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
15102436|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15102437|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102438|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102439|NCT02703220|Diuretics|diuretics|mesh-ancestor
15102440|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
15102441|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102442|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15102443|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15102444|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
15102445|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102446|NCT02703220|Urological Agents|urological agents|mesh-ancestor
15102447|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
15102448|NCT02650986|Decitabine|decitabine|mesh-list
15102449|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102450|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
15102451|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102452|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102453|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15102454|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
15102455|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102456|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102457|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15102458|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15102459|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
15102460|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102461|NCT02568449|Nintedanib|nintedanib|mesh-list
15102462|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102463|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15102464|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102465|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102466|NCT02546622|Factor VIII|factor viii|mesh-list
15102467|NCT02546622|Coagulants|coagulants|mesh-ancestor
15102468|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
15102469|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
15102470|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15102471|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
15102472|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102473|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102474|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102475|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
15102476|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102477|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
15102478|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102479|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102480|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15102481|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
15102482|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
15102483|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102484|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102485|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15102486|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15102487|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15102488|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
15102489|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174745|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174746|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
15174747|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174748|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174749|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
15174750|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15174751|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15174752|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174753|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15174754|NCT03993626|Nivolumab|nivolumab|mesh-list
15174755|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174756|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174757|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15174758|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174759|NCT03993535|Serotonin|serotonin|mesh-list
15174760|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15174761|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15174762|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
15174763|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174764|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174765|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174766|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15174767|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174768|NCT03993327|Iodine|iodine|mesh-list
15174769|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15174770|NCT03993327|Antibodies|antibodies|mesh-list
15174771|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
15174772|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15174773|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
15174774|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174775|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174776|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15174777|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174778|NCT03993327|Trace Elements|trace elements|mesh-ancestor
15174779|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
15174780|NCT03993366|Pramlintide|pramlintide|mesh-list
15174781|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
15174782|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15174783|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174784|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
15174785|NCT03993353|Tadalafil|tadalafil|mesh-list
15174786|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174787|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174788|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
15174789|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15174790|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15174791|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174792|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174793|NCT03993353|Urological Agents|urological agents|mesh-ancestor
15174794|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15174795|NCT03993236|Ezetimibe|ezetimibe|mesh-list
15174796|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15174797|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15174798|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
15174799|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174800|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15174801|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15174802|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174803|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
15174804|NCT03992937|Progesterone|progesterone|mesh-list
15174805|NCT03992937|Progestins|progestins|mesh-ancestor
15174806|NCT03992937|Hormones|hormones|mesh-ancestor
15174807|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174808|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174809|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15174810|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
15102490|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15102491|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
15102492|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102493|NCT01530997|Cisplatin|cisplatin|mesh-list
15102494|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102495|NCT01331616|Bevacizumab|bevacizumab|mesh-list
15102496|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102497|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102498|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15102499|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15102500|NCT01331616|Growth Substances|growth substances|mesh-ancestor
15102501|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102502|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
15102503|NCT01109004|Dexamethasone|dexamethasone|mesh-list
15102504|NCT01109004|Lenalidomide|lenalidomide|mesh-list
15102505|NCT01109004|Bortezomib|bortezomib|mesh-list
15102506|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102507|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
15102508|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
15102509|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102510|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102511|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102512|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
15102513|NCT01109004|Hormones|hormones|mesh-ancestor
15102514|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102515|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15102516|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102517|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
15102518|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15102519|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15102520|NCT01109004|Growth Substances|growth substances|mesh-ancestor
15102521|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
15102522|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
15102523|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
15102524|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15102525|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
15102526|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102527|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102528|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102529|NCT00593905|Bosentan|bosentan|mesh-list
15102530|NCT00593905|Ambrisentan|ambrisentan|mesh-list
15102531|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
15102532|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15102533|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15102534|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102535|NCT00548912|Spironolactone|spironolactone|mesh-list
15102536|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15102537|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
15102538|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102539|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102540|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15102541|NCT00548912|Diuretics|diuretics|mesh-ancestor
15102542|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
15102543|NCT00501826|Cytarabine|cytarabine|mesh-list
15102544|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
15102545|NCT00501826|Dexamethasone|dexamethasone|mesh-list
15102546|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
15102547|NCT00501826|Prednisone|prednisone|mesh-list
15102548|NCT00501826|Cortisone|cortisone|mesh-list
15102549|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
15102550|NCT00501826|Doxorubicin|doxorubicin|mesh-list
15102551|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15102552|NCT00501826|Methotrexate|methotrexate|mesh-list
15102553|NCT00501826|Vincristine|vincristine|mesh-list
15102554|NCT00501826|Asparaginase|asparaginase|mesh-list
15102555|NCT00501826|Venetoclax|venetoclax|mesh-list
15102556|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
15102557|NCT00501826|Pegaspargase|pegaspargase|mesh-list
15102558|NCT00501826|BB 1101|bb 1101|mesh-list
15102559|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102560|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
15102561|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102562|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102563|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15102564|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
15102565|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102566|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102567|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15102568|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102569|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
15102570|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
15102571|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102572|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102573|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
15102574|NCT00501826|Hormones|hormones|mesh-ancestor
15102575|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102576|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15102577|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
15102578|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102579|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15102580|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15102581|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15102582|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15102583|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
15102584|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15102585|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15102586|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
15102587|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
15102588|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15102589|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15102590|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
15102591|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102592|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15102593|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
15102594|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
15102595|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
15102596|NCT05153928|Norethindrone|norethindrone|mesh-list
15102597|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
15102598|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15102599|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15102600|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15102601|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
15102602|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15102603|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102604|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15102605|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15102606|NCT05153785|Lidocaine|lidocaine|mesh-list
15102607|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
15102608|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
15102609|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102610|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102611|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
15102612|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102613|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15102614|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15102615|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15102616|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15102617|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102618|NCT05153668|Everolimus|everolimus|mesh-list
15102619|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102620|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102621|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
15102622|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102623|NCT05153603|Olaparib|olaparib|mesh-list
15102624|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15102625|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102626|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102627|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102628|NCT05153486|Ethanol|ethanol|mesh-list
15102629|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15102630|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102631|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102632|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102633|NCT05153304|Nivolumab|nivolumab|mesh-list
15102634|NCT05153304|Ipilimumab|ipilimumab|mesh-list
15102635|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102636|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102637|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15102638|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102639|NCT05153200|Adalimumab|adalimumab|mesh-list
15102640|NCT05153200|Upadacitinib|upadacitinib|mesh-list
15102641|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102642|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102643|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15102644|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15102645|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102646|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102647|NCT05153070|Cyclosporine|cyclosporine|mesh-list
15102648|NCT05153070|Cyclosporins|cyclosporins|mesh-list
15102649|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102650|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102651|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102652|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
15102653|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102654|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
15102655|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102656|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
15102657|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15102658|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15102659|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
15102660|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15102661|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102662|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15102663|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102664|NCT05152901|Epinephrine|epinephrine|mesh-list
15102665|NCT05152901|Racepinephrine|racepinephrine|mesh-list
15102666|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
15102667|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15102668|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15102669|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
15102670|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102671|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102672|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102673|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15102674|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15102675|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
15102676|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102677|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15102678|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
15102679|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
15102680|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
15102681|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15102682|NCT05152667|Dienogest|dienogest|mesh-list
15102683|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
15102684|NCT05152667|Progestins|progestins|mesh-list
15102685|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15102686|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
15102687|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15102688|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102689|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15102690|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15102691|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15102692|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15102693|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15102694|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
15102695|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102696|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15102697|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102698|NCT05152667|Hormones|hormones|mesh-ancestor
15102699|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
15102700|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15102701|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102702|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102703|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15102704|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15102705|NCT05152511|Protective Agents|protective agents|mesh-ancestor
15102706|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102707|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
15102708|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15102709|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
15102710|NCT05132985|Carboplatin|carboplatin|mesh-list
15102711|NCT05132985|Pemetrexed|pemetrexed|mesh-list
15102712|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102713|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102714|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102715|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15102716|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15102717|NCT05118399|Bupivacaine|bupivacaine|mesh-list
15102718|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
15102719|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
15102720|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102721|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102722|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
15102723|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102724|NCT05096468|Pregabalin|pregabalin|mesh-list
15102725|NCT05096468|Ketamine|ketamine|mesh-list
15102726|NCT05096468|Esketamine|esketamine|mesh-list
15102727|NCT05096468|Analgesics|analgesics|mesh-ancestor
15102728|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
15102729|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102730|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102731|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15102732|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15102733|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
15102734|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
15102735|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102736|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15102737|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15102738|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102739|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102740|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
15102741|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15102742|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15102743|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15102744|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15102745|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15102746|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15102747|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
15102748|NCT05095922|Valsartan|valsartan|mesh-list
15102749|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
15102750|NCT05095922|Calcium|calcium|mesh-list
15102751|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15102752|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102753|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15102754|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15102755|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15102756|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102757|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
15102758|NCT05095922|Coagulants|coagulants|mesh-ancestor
15174811|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15174812|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15174813|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15174814|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15174815|NCT03992885|Pemetrexed|pemetrexed|mesh-list
15174816|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174817|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174818|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174819|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15174820|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15174821|NCT03992911|Carboplatin|carboplatin|mesh-list
15174822|NCT03992911|Etoposide|etoposide|mesh-list
15174823|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
15174824|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174825|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15174826|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15174827|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15174828|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174829|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174830|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15174831|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
15174832|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
15174833|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15174834|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174835|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
15174836|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174837|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15174838|NCT03992586|Methamphetamine|methamphetamine|mesh-list
15174839|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15174840|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174841|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
15174842|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
15102759|NCT05010304|Amoxicillin|amoxicillin|mesh-list
15102760|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15102761|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102762|NCT04947631|Tadalafil|tadalafil|mesh-list
15102763|NCT04947631|Dutasteride|dutasteride|mesh-list
15102764|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
15102765|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15102766|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15102767|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102768|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102769|NCT04947631|Urological Agents|urological agents|mesh-ancestor
15102770|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15102771|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15102772|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
15102773|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102774|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102775|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
15102776|NCT04905316|Durvalumab|durvalumab|mesh-list
15102777|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102778|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102779|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
15102780|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102781|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102782|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
15102783|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15102784|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
15102785|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
15102786|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102787|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102788|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15102789|NCT04884893|Analgesics|analgesics|mesh-ancestor
15102790|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
15102791|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102792|NCT04877379|Ceftibuten|ceftibuten|mesh-list
15102793|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15102794|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102795|NCT04852679|Lanreotide|lanreotide|mesh-list
15102796|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102797|NCT04814446|Vaccines|vaccines|mesh-list
15102798|NCT04814446|Immunologic Factors|immunologic factors|mesh-ancestor
15102799|NCT04814446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102800|NCT04778267|Dexamethasone|dexamethasone|mesh-list
15102801|NCT04778267|Bupivacaine|bupivacaine|mesh-list
15102802|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15102803|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102804|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
15102805|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
15102806|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102807|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102808|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102809|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
15102810|NCT04778267|Hormones|hormones|mesh-ancestor
15102811|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102812|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15102813|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102814|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
15102815|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
15102816|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102817|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
15102818|NCT04760717|Spironolactone|spironolactone|mesh-list
15102819|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15102820|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
15102821|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102822|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102823|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15102824|NCT04760717|Diuretics|diuretics|mesh-ancestor
15102825|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
15102826|NCT04732182|Donepezil|donepezil|mesh-list
15102827|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15102828|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102829|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996171|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292374|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
15102830|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
15102831|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181500|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
15102832|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102833|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
15102834|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
15102835|NCT04702256|Prednisone|prednisone|mesh-list
15102836|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
15102837|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15102838|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15102839|NCT04702256|Prednisolone|prednisolone|mesh-list
15102840|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
15102841|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
15102842|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15102843|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
15102844|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
15102845|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15102846|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
15102847|NCT04702256|Hormones|hormones|mesh-ancestor
15102848|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15102849|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102850|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15102851|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102852|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15102853|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15102854|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
15102855|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15102856|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102857|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102858|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102859|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
15102860|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
15102861|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102862|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102863|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15102864|NCT04702256|Protective Agents|protective agents|mesh-ancestor
15102865|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102866|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15102867|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
15102868|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
15102869|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102870|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
15102871|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
15102872|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102873|NCT05259709|Cemiplimab|cemiplimab|mesh-list
15102874|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15102875|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102876|NCT05259319|Atezolizumab|atezolizumab|mesh-list
15102877|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102878|NCT05259241|Thrombin|thrombin|mesh-list
15102879|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
15102880|NCT05259241|Coagulants|coagulants|mesh-ancestor
15174843|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174844|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
15174845|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174846|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174847|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
15174848|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15174849|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15174850|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174851|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15174852|NCT03992755|Treprostinil|treprostinil|mesh-list
15174853|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15174854|NCT03992170|Daratumumab|daratumumab|mesh-list
15174855|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174856|NCT03992131|Rucaparib|rucaparib|mesh-list
15174857|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15174858|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174859|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174860|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174861|NCT03992144|Amoxicillin|amoxicillin|mesh-list
15174862|NCT03992144|Metronidazole|metronidazole|mesh-list
15174863|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15174864|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174865|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15174866|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15174867|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
15174868|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
15174869|NCT03992066|Hematinics|hematinics|mesh-ancestor
15174870|NCT03992196|Rotigotine|rotigotine|mesh-list
15102881|NCT05259137|Enalapril|enalapril|mesh-list
15102882|NCT05259137|Enalaprilat|enalaprilat|mesh-list
15102883|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15102884|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
15102885|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102886|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102887|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15102888|NCT05259098|Sufentanil|sufentanil|mesh-list
15102889|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15102890|NCT05259098|Narcotics|narcotics|mesh-ancestor
15102891|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15102892|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102893|NCT05259098|Analgesics|analgesics|mesh-ancestor
15102894|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
15102895|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102896|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15102897|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15102898|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
15102899|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
15102900|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
15102901|NCT05259046|Vitamin K|vitamin k|mesh-list
15102902|NCT05259046|Vitamin MK 7|vitamin mk 7|mesh-list
15102903|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15102904|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15102905|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102906|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
15102907|NCT05259046|Coagulants|coagulants|mesh-ancestor
15102908|NCT05259046|Vitamins|vitamins|mesh-ancestor
15102909|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
15102910|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102911|NCT05259007|Amoxicillin|amoxicillin|mesh-list
15102912|NCT05259007|Clarithromycin|clarithromycin|mesh-list
15102913|NCT05259007|Propolis|propolis|mesh-list
15102914|NCT05259007|Lansoprazole|lansoprazole|mesh-list
15102915|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
15102916|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15102917|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102918|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15102919|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102920|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102921|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15102922|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15102923|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15102924|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102925|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15102926|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
15102927|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15102928|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15102929|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102930|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
15102931|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
15102932|NCT05258799|Cytarabine|cytarabine|mesh-list
15102933|NCT05258799|Decitabine|decitabine|mesh-list
15102934|NCT05258799|Aclarubicin|aclarubicin|mesh-list
15102935|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15102936|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
15102937|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102938|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102939|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
15102940|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102941|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15102942|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
15102943|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102944|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15102945|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15102946|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15102947|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15102948|NCT05258773|Azasetron|azasetron|mesh-list
15102949|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
15102950|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
15102951|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15102952|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102953|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15102954|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15102955|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
15102956|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15102957|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102958|NCT05258721|Fluorides|fluorides|mesh-list
15102959|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
15102960|NCT05258721|Protective Agents|protective agents|mesh-ancestor
15102961|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102962|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
15102963|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15102964|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
15102965|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15102966|NCT05258682|Expectorants|expectorants|mesh-ancestor
15102967|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
15102968|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15102969|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
15102970|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102971|NCT05258682|Protective Agents|protective agents|mesh-ancestor
15102972|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102973|NCT05258682|Antidotes|antidotes|mesh-ancestor
15102974|NCT05258565|Plasminogen|plasminogen|mesh-list
15102975|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15102976|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15102977|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15102978|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102979|NCT05258474|Niacinamide|niacinamide|mesh-list
15102980|NCT05258474|Niacin|niacin|mesh-list
15102981|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
15102982|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
15102983|NCT05258474|Vitamins|vitamins|mesh-ancestor
15102984|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
15102985|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102986|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15102987|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
15102988|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15102989|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15102990|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
15102991|NCT05258292|Insulin|insulin|mesh-list
15102992|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15102993|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15102994|NCT05258279|Carboplatin|carboplatin|mesh-list
15102995|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
15102996|NCT05258279|Pemetrexed|pemetrexed|mesh-list
14811254|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15102997|NCT05258279|Lenvatinib|lenvatinib|mesh-list
15102998|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15102999|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103000|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103001|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103002|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15103003|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15103004|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103005|NCT05258136|Antibodies|antibodies|mesh-list
15103006|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15103007|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
14811255|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811256|NCT00844454|Ethanol|ethanol|mesh-list
14811257|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14811258|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811259|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811260|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811261|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
14811262|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14811263|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811264|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
14811265|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14811266|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
14811267|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811268|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103008|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103009|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15103010|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15103011|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103012|NCT05257148|Nebivolol|nebivolol|mesh-list
15103013|NCT05257148|Zofenopril|zofenopril|mesh-list
15103014|NCT05257148|Captopril|captopril|mesh-list
15103015|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15103016|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
15103017|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15103018|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15103019|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15103020|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
15103021|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103022|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103023|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103024|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15103025|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
15103026|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103027|NCT05256056|Bupivacaine|bupivacaine|mesh-list
15103028|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
15103029|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
15103030|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103031|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103032|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
15103033|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103034|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
15103035|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
15103036|NCT05231980|Clomiphene|clomiphene|mesh-list
15103037|NCT05231980|Enclomiphene|enclomiphene|mesh-list
15103038|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
15103039|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103040|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15103041|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
15103042|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103043|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103044|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15103045|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
15103046|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15103047|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15103048|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15103049|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
15103050|NCT05231980|Protective Agents|protective agents|mesh-ancestor
15103051|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
15103052|NCT05231980|Vitamins|vitamins|mesh-ancestor
15103053|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
15103054|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15103055|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103056|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15103057|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15103058|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
15103059|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15103060|NCT05231629|Dexamethasone|dexamethasone|mesh-list
15103061|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
15103062|NCT05231629|Melphalan|melphalan|mesh-list
15103063|NCT05231629|Lenalidomide|lenalidomide|mesh-list
15103064|NCT05231629|Bortezomib|bortezomib|mesh-list
15103065|NCT05231629|Daratumumab|daratumumab|mesh-list
15103066|NCT05231629|BB 1101|bb 1101|mesh-list
15103067|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15103068|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103069|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
15103070|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
15103071|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103072|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103073|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103074|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
15103075|NCT05231629|Hormones|hormones|mesh-ancestor
15103076|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103077|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103078|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103079|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
15103080|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103081|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103082|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15103083|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
15103084|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15103085|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103086|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
15103087|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15103088|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15103089|NCT05231629|Growth Substances|growth substances|mesh-ancestor
15103090|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
15103091|NCT05222139|Vaccines|vaccines|mesh-list
15103092|NCT05222139|Immunologic Factors|immunologic factors|mesh-ancestor
15103093|NCT05222139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103094|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
15103095|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
15103096|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15103097|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15103098|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103099|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15103100|NCT05211609|Methyldopa|methyldopa|mesh-list
15103101|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15103102|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
15103103|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
15103104|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103105|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103106|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15103107|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15103108|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15103109|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
15103110|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103111|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103112|NCT05195450|Tenofovir|tenofovir|mesh-list
15103113|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
15103114|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103115|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15103116|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15103117|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103118|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103119|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15103120|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15103121|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
15103122|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103123|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103124|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103125|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174871|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
15174872|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
15174873|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174874|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174875|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174876|NCT03992261|Halobetasol|halobetasol|mesh-list
15174877|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15174878|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
15174879|NCT03992326|Fludarabine|fludarabine|mesh-list
15174880|NCT03992326|Interleukin-2|interleukin-2|mesh-list
15174881|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15174882|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
15174883|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174884|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174885|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15174886|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
15174887|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174888|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174889|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15174890|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15174891|NCT03992326|Analgesics|analgesics|mesh-ancestor
15174892|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
15174893|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174894|NCT03992365|Bisacodyl|bisacodyl|mesh-list
15174895|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
15174896|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15174897|NCT03992365|Cathartics|cathartics|mesh-ancestor
15174898|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15174899|NCT03992365|Laxatives|laxatives|mesh-ancestor
15174900|NCT03991936|Triamcinolone|triamcinolone|mesh-list
15103126|NCT05137626|Digoxin|digoxin|mesh-list
15103127|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15103128|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15103129|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103130|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103131|NCT05137626|Protective Agents|protective agents|mesh-ancestor
15103132|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103133|NCT05084599|Metaraminol|metaraminol|mesh-list
15103134|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
15103135|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
15103136|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103137|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103138|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15103139|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15103140|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15103141|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15103142|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
15103143|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103144|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103145|NCT05033808|Epirubicin|epirubicin|mesh-list
15103146|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15103147|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103148|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15103149|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15103150|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103151|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103152|NCT05012644|Palbociclib|palbociclib|mesh-list
15103153|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15103154|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103155|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103156|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103157|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103158|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15103159|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15103160|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
15103161|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103162|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103163|NCT05008003|Vitamin D|vitamin d|mesh-list
15103164|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
15103165|NCT05008003|Vitamins|vitamins|mesh-ancestor
15103166|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
15103167|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103168|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15103169|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15103170|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
15103171|NCT04990804|Analgesics|analgesics|mesh-list
15103172|NCT04990804|Narcotics|narcotics|mesh-ancestor
15103173|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103174|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103175|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
15103176|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103177|NCT04988035|Remdesivir|remdesivir|mesh-list
15103178|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
15103179|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103180|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
15103181|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103182|NCT04950465|Fluorides|fluorides|mesh-list
15103183|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
15103184|NCT04950465|Protective Agents|protective agents|mesh-ancestor
15103185|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103186|NCT04907851|Denosumab|denosumab|mesh-list
15103187|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15103188|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103189|NCT04906278|Oxytocin|oxytocin|mesh-list
15103190|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
15103191|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15103192|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103193|NCT04859608|Eculizumab|eculizumab|mesh-list
15103194|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15103195|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103196|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
15103197|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103198|NCT04827953|Gemcitabine|gemcitabine|mesh-list
15103199|NCT04827953|Paclitaxel|paclitaxel|mesh-list
15103200|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15103201|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103202|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
15103203|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
15103204|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
15103205|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103206|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103207|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
15103208|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
15103209|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103210|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103211|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103212|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
15103213|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103214|NCT04820452|Aflibercept|aflibercept|mesh-list
15103215|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15103216|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15103217|NCT04820452|Growth Substances|growth substances|mesh-ancestor
15103218|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103219|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
15103220|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103221|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
15103222|NCT04818177|Antibodies|antibodies|mesh-list
15103223|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
15103224|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15103225|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15103226|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
15103227|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103228|NCT04780061|Vitamin D|vitamin d|mesh-list
15103229|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
15103230|NCT04780061|Vitamins|vitamins|mesh-list
14269181|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14269182|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14269183|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269184|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269185|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269186|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269187|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269188|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14269189|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
14269190|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269191|NCT00401752|Esomeprazole|esomeprazole|mesh-list
14269192|NCT00401752|Ranitidine|ranitidine|mesh-list
14269193|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14269194|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14269195|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811269|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14811270|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
15103231|NCT04780061|Vitamin K|vitamin k|mesh-list
15103232|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
15103233|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
15103234|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103235|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15103236|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15103237|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103238|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15103239|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15103240|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
15103241|NCT04780061|Coagulants|coagulants|mesh-ancestor
15103242|NCT04754386|Antibodies|antibodies|mesh-list
15103243|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
15103244|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103245|NCT04738149|Bimatoprost|bimatoprost|mesh-list
15103246|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15103247|NCT04711356|Vaccines|vaccines|mesh-list
15103248|NCT04711356|Immunologic Factors|immunologic factors|mesh-ancestor
15103249|NCT04711356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103250|NCT04660747|Anticoagulants|anticoagulants|mesh-list
14811271|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811272|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811273|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14811274|NCT00844662|Sevelamer|sevelamer|mesh-list
14811275|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
14811276|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
14292375|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
15103251|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
15103252|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103253|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174901|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15174902|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15174903|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15174904|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15174905|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
15174906|NCT03991936|Hormones|hormones|mesh-ancestor
15174907|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174908|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174909|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15174910|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
15174911|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174912|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174913|NCT03991845|Levocetirizine|levocetirizine|mesh-list
15174914|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15174915|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15174916|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
15174917|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
15174918|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174919|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174920|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174921|NCT03991910|Ramipril|ramipril|mesh-list
15174922|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15174923|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
15174924|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174925|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174926|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15174927|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
15174928|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174929|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174930|NCT03991442|Amlodipine|amlodipine|mesh-list
15174931|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15174932|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15174933|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174934|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174935|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15174936|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174937|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
15181501|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
15181502|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181503|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181504|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15181505|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
15181506|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181507|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
15181508|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
15181509|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15181510|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15181511|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181512|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181513|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181514|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181515|NCT03929068|Levodopa|levodopa|mesh-list
15181516|NCT03929068|Carbidopa|carbidopa|mesh-list
15181517|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15181518|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15181519|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15181520|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
15181521|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181522|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181523|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181524|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15181525|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181526|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15181527|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
15181528|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
15182267|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182268|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15182269|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15182270|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182271|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182272|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15103254|NCT04594733|Minocycline|minocycline|mesh-list
15103255|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15103256|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103257|NCT04583969|Remdesivir|remdesivir|mesh-list
15103258|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
15103259|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103260|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
15103261|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103262|NCT04583956|Remdesivir|remdesivir|mesh-list
15103263|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
15103264|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103265|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
15103266|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103267|NCT04526574|Vaccines|vaccines|mesh-list
15103268|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15103269|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
15103270|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103271|NCT04524455|Dexamethasone|dexamethasone|mesh-list
15103272|NCT04524455|Blinatumomab|blinatumomab|mesh-list
15103273|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103274|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
15103275|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
15103276|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103277|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103278|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103279|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
15103280|NCT04524455|Hormones|hormones|mesh-ancestor
15103281|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103282|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103283|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103284|NCT04482673|Vitamin D|vitamin d|mesh-list
15103285|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
15103286|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
15103287|NCT04482673|Vitamins|vitamins|mesh-list
15103288|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
15103289|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103290|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15103291|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15103292|NCT04472299|Ropivacaine|ropivacaine|mesh-list
15103293|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
15103294|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
15103295|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103296|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103297|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
15103298|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103299|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15103300|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15103301|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15103302|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
15103303|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103304|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103305|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15103306|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15103307|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
15103308|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103309|NCT04431258|Folfirinox|folfirinox|mesh-list
15103310|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103311|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15103312|NCT04401553|Vancomycin|vancomycin|mesh-list
15103313|NCT04401553|Cephalosporins|cephalosporins|mesh-list
15103314|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103315|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15103316|NCT04390646|Hormones|hormones|mesh-ancestor
15103317|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103318|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103319|NCT04379011|Brivaracetam|brivaracetam|mesh-list
15103320|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
15103321|NCT04370418|Fluorouracil|fluorouracil|mesh-list
15103322|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
15103323|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103324|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103325|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103326|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103327|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
15103328|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103329|NCT04364230|Poly ICLC|poly iclc|mesh-list
15103330|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
15103331|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103332|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
15103333|NCT04337580|Omeprazole|omeprazole|mesh-list
15103334|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15103335|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103336|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15103337|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103338|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103339|NCT04294550|Naloxegol|naloxegol|mesh-list
15103340|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15103341|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103342|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
15103343|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103344|NCT04282187|Azacitidine|azacitidine|mesh-list
15103345|NCT04282187|Decitabine|decitabine|mesh-list
15103346|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15103347|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103348|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
15103349|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103350|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103351|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103352|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103353|NCT04207190|Talazoparib|talazoparib|mesh-list
15103354|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
15103355|NCT04207190|Calicheamicins|calicheamicins|mesh-list
15103356|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15103357|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103358|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103359|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103360|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103361|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15103362|NCT04175431|Prednisone|prednisone|mesh-list
15103363|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
15103364|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103365|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
15103366|NCT04175431|Hormones|hormones|mesh-ancestor
15103367|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103368|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103369|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103370|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103371|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15103372|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103373|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103374|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
15103375|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15103376|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15103377|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103378|NCT04125836|Octreotide|octreotide|mesh-list
15103379|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103380|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103381|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103382|NCT04107038|Anesthetics|anesthetics|mesh-list
15103383|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103384|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103385|NCT04076462|Octreotide|octreotide|mesh-list
15103386|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103387|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103388|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103389|NCT04058067|Aflibercept|aflibercept|mesh-list
15103390|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15103391|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15103392|NCT04058067|Growth Substances|growth substances|mesh-ancestor
15103393|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103394|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
15103395|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103396|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
15103397|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103398|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15103399|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103400|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103401|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
15103402|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103403|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174938|NCT03991364|Methamphetamine|methamphetamine|mesh-list
15103404|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15103405|NCT03993717|Vaccines|vaccines|mesh-list
15103406|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
15103407|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103408|NCT03993262|Bortezomib|bortezomib|mesh-list
15103409|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103410|NCT03954899|Melatonin|melatonin|mesh-list
15103411|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
15103412|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103413|NCT03954899|Protective Agents|protective agents|mesh-ancestor
15103414|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103415|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103416|NCT03951025|Melatonin|melatonin|mesh-list
15103417|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
15103418|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103419|NCT03951025|Protective Agents|protective agents|mesh-ancestor
15103420|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103421|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103422|NCT03948074|Dronabinol|dronabinol|mesh-list
15103423|NCT03948074|Cannabidiol|cannabidiol|mesh-list
15103424|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
15103425|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
15103426|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103427|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15103428|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15103429|NCT03948074|Analgesics|analgesics|mesh-ancestor
15103430|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
15103431|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103432|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15103433|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15103434|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103435|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103436|NCT03948074|Hormones|hormones|mesh-ancestor
15103437|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103438|NCT03908307|Dexamethasone|dexamethasone|mesh-list
15103439|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
15103440|NCT03908307|BB 1101|bb 1101|mesh-list
15103441|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103442|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
15103443|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
15103444|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103445|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103446|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103447|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
15103448|NCT03908307|Hormones|hormones|mesh-ancestor
15103449|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103450|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103451|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103452|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
15103453|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103454|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103455|NCT03878979|Nivolumab|nivolumab|mesh-list
15103456|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103457|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103458|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15103459|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103460|NCT03865940|Lidocaine|lidocaine|mesh-list
15103461|NCT03865940|Guanfacine|guanfacine|mesh-list
15103462|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
15103463|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
15103464|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103465|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103466|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
15103467|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103468|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15103469|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15103470|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15103471|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15103472|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103473|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15103474|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15103475|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15103476|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15103477|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
15103478|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103479|NCT03792750|Nivolumab|nivolumab|mesh-list
15103480|NCT03792750|Linrodostat|linrodostat|mesh-list
15103481|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103482|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103483|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15103484|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103485|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174939|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15174940|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174941|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
15174942|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
15174943|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15174944|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
15174945|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15174946|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174947|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
15174948|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15174949|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15174950|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15174951|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15174952|NCT03991559|Manganese|manganese|mesh-list
15174953|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15174954|NCT03991559|Antibodies|antibodies|mesh-list
15174955|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
15174956|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
15174957|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174958|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174959|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174960|NCT03991559|Trace Elements|trace elements|mesh-ancestor
15174961|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
15174962|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15174963|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15174964|NCT03991312|Itraconazole|itraconazole|mesh-list
15174965|NCT03991312|Rifampin|rifampin|mesh-list
15174966|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
15174967|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174968|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15174969|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15174970|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15174971|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15174972|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15174973|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
15174974|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15174975|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15174976|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15174977|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15174978|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
15174979|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15174980|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
15174981|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15174982|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15174983|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15174984|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15174985|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15174986|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15174987|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15174988|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
15174989|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15174990|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
15174991|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
15174992|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15174993|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15174994|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15174995|NCT03991130|Nivolumab|nivolumab|mesh-list
15174996|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15174997|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15174998|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15174999|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175000|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
15175001|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103486|NCT03779854|Vidarabine|vidarabine|mesh-list
15103487|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
15103488|NCT03779854|Busulfan|busulfan|mesh-list
15103489|NCT03779854|Thiotepa|thiotepa|mesh-list
15103490|NCT03779854|Methotrexate|methotrexate|mesh-list
15103491|NCT03779854|Fludarabine|fludarabine|mesh-list
15103492|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
15103493|NCT03779854|Tacrolimus|tacrolimus|mesh-list
15103494|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103495|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
15103496|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103497|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103498|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15103499|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
15103500|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103501|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103502|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15103503|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15103504|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
15103505|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15103506|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103507|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
15103508|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
15103509|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103510|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15103511|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15103512|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15103513|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
15103514|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103515|NCT03765619|Aspirin|aspirin|mesh-list
15103516|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15103517|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15103518|NCT03765619|Analgesics|analgesics|mesh-ancestor
15103519|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
15103520|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103521|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103522|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103523|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103524|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15103525|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15103526|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103527|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15103528|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15103529|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103530|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
15103531|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
15103532|NCT03761056|Fludarabine|fludarabine|mesh-list
15103533|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103534|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
15103535|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103536|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103537|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15103538|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
15103539|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103540|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103541|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15103542|NCT03739593|Dexamethasone|dexamethasone|mesh-list
15103543|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
15103544|NCT03739593|BB 1101|bb 1101|mesh-list
15103545|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103546|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
15103547|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
15103548|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103549|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103550|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103551|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
15103552|NCT03739593|Hormones|hormones|mesh-ancestor
15103553|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103554|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103555|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103556|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
15103557|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103558|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103559|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
15103560|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103561|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103562|NCT03737994|Cisplatin|cisplatin|mesh-list
15103563|NCT03737994|Carboplatin|carboplatin|mesh-list
15103564|NCT03737994|Pemetrexed|pemetrexed|mesh-list
15103565|NCT03737994|Crizotinib|crizotinib|mesh-list
15103566|NCT03737994|Ceritinib|ceritinib|mesh-list
15103567|NCT03737994|Ensartinib|ensartinib|mesh-list
15103568|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103569|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103570|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103571|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15103572|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15103573|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103574|NCT03724019|Ketamine|ketamine|mesh-list
15103575|NCT03724019|Analgesics|analgesics|mesh-ancestor
15103576|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
15103577|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103578|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103579|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15103580|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15103581|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
15103582|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
15103583|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103584|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15103585|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15103586|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103587|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103588|NCT03660930|Sirolimus|sirolimus|mesh-list
15103589|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15103590|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103591|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15103592|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103593|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
15103594|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103595|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
15103596|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103597|NCT03655197|Doxycycline|doxycycline|mesh-list
15103598|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15103599|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103600|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
15103601|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15103602|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15103603|NCT03617718|Glycine|glycine|mesh-list
15103604|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
15103605|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103606|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103607|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103608|NCT03614728|Azacitidine|azacitidine|mesh-list
15103609|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
15103610|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103611|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
15103612|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103613|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103614|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103615|NCT03535272|Bismuth|bismuth|mesh-list
15103616|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
15103617|NCT03535272|Antacids|antacids|mesh-ancestor
15103618|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103619|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103620|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
15103621|NCT03520842|Methotrexate|methotrexate|mesh-list
15103622|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15103623|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
15103624|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15103625|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103626|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103627|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
15103628|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103629|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103630|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
15103631|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103632|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15103633|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103634|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
15103635|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103636|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15103637|NCT03518086|Mirikizumab|mirikizumab|mesh-list
15103638|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15103639|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15103640|NCT03518086|Analgesics|analgesics|mesh-ancestor
15103641|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
15103642|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103643|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103644|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103645|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103646|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15103647|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103648|NCT03473730|Daratumumab|daratumumab|mesh-list
15103649|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103650|NCT03450122|Aldesleukin|aldesleukin|mesh-list
15103651|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
15103652|NCT03450122|Interleukin-2|interleukin-2|mesh-list
15103653|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103654|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
15103655|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103656|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103657|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15103658|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
15103659|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103660|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103661|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15103662|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15103663|NCT03450122|Analgesics|analgesics|mesh-ancestor
15103664|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
15103665|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103666|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15103667|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15103668|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
15103669|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103670|NCT03447808|Daratumumab|daratumumab|mesh-list
15103671|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103672|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15103673|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15103674|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103675|NCT03389477|Cisplatin|cisplatin|mesh-list
15103676|NCT03389477|Cetuximab|cetuximab|mesh-list
15103677|NCT03389477|Palbociclib|palbociclib|mesh-list
15103678|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103679|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103680|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103681|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103682|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103683|NCT03347123|Nivolumab|nivolumab|mesh-list
15103684|NCT03347123|Ipilimumab|ipilimumab|mesh-list
15103685|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103686|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103687|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15103688|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103689|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
15103690|NCT03330028|Promethazine|promethazine|mesh-list
15103691|NCT03330028|Dexamethasone|dexamethasone|mesh-list
15103692|NCT03330028|Paclitaxel|paclitaxel|mesh-list
15103693|NCT03330028|Cisplatin|cisplatin|mesh-list
15103694|NCT03330028|Mitomycins|mitomycins|mesh-list
15103695|NCT03330028|Mitomycin|mitomycin|mesh-list
15103696|NCT03330028|Famotidine|famotidine|mesh-list
15103697|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15103698|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103699|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
15103700|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
15103701|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
15103702|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103703|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103704|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
15103705|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
15103706|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103707|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103708|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103709|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
15103710|NCT03330028|Hormones|hormones|mesh-ancestor
15103711|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103712|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103713|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15103714|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
15103715|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15103716|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103717|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15103718|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15103719|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103720|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
15103721|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
15103722|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
15103723|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15103724|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
15103725|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
15103726|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103727|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15103728|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
15103729|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
15103730|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15103731|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15103732|NCT03309007|Metformin|metformin|mesh-list
15103733|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
15103734|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15103735|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103736|NCT03309007|Antacids|antacids|mesh-ancestor
15103737|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103738|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103739|NCT03307616|Nivolumab|nivolumab|mesh-list
15103740|NCT03307616|Ipilimumab|ipilimumab|mesh-list
15103741|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103742|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103743|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15103744|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103745|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
15103746|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15103747|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
15103748|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103749|NCT03306979|Expectorants|expectorants|mesh-ancestor
15103750|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
15103751|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15103752|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
15103753|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103754|NCT03306979|Protective Agents|protective agents|mesh-ancestor
15103755|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103756|NCT03306979|Antidotes|antidotes|mesh-ancestor
15103757|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15103758|NCT03290937|Cetuximab|cetuximab|mesh-list
15103759|NCT03290937|Irinotecan|irinotecan|mesh-list
15103760|NCT03290937|Camptothecin|camptothecin|mesh-list
15103761|NCT03290937|Antibodies|antibodies|mesh-list
15103762|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
15103763|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15103764|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
15103765|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
15103766|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103767|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103768|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15103769|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15103770|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103771|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103772|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15103773|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
15103774|NCT03260894|Sunitinib|sunitinib|mesh-list
15103775|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103776|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103777|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15103778|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15103779|NCT03260894|Growth Substances|growth substances|mesh-ancestor
15103780|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103781|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
15103782|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103783|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103784|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103785|NCT03252587|BMS-986165|bms-986165|mesh-list
15103786|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
15103787|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15103788|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103789|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103790|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
15103791|NCT03240211|Decitabine|decitabine|mesh-list
15103792|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103793|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103794|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103795|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
15103796|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103797|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103798|NCT03177460|Daratumumab|daratumumab|mesh-list
15103799|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103800|NCT03150732|Nalbuphine|nalbuphine|mesh-list
15103801|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15103802|NCT03150732|Narcotics|narcotics|mesh-ancestor
15103803|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103804|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103805|NCT03150732|Analgesics|analgesics|mesh-ancestor
15103806|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
15103807|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103808|NCT03125902|Paclitaxel|paclitaxel|mesh-list
15103809|NCT03125902|Atezolizumab|atezolizumab|mesh-list
15103810|NCT03125902|Antibodies|antibodies|mesh-list
15103811|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15103812|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15103813|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103814|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
15103815|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
15103816|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
15103817|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103818|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
15103819|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103820|NCT03047993|Azacitidine|azacitidine|mesh-list
15103821|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103822|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
15103823|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103824|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103825|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103826|NCT03015740|Nivolumab|nivolumab|mesh-list
15103827|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103828|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103829|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15103830|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103831|NCT02986269|Anesthetics|anesthetics|mesh-list
15103832|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15103833|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103834|NCT02940496|Ribavirin|ribavirin|mesh-list
15103835|NCT02940496|Grazoprevir|grazoprevir|mesh-list
15103836|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
15103837|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103838|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103839|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
15103840|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103841|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
15103842|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103843|NCT02899299|Carboplatin|carboplatin|mesh-list
15103844|NCT02899299|Nivolumab|nivolumab|mesh-list
15103845|NCT02899299|Pemetrexed|pemetrexed|mesh-list
15103846|NCT02899299|Ipilimumab|ipilimumab|mesh-list
15103847|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103848|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103849|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15103850|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103851|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103852|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15103853|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15103854|NCT02891226|Mirikizumab|mirikizumab|mesh-list
15103855|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15103856|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15103857|NCT02891226|Analgesics|analgesics|mesh-ancestor
15103858|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
15103859|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103860|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103861|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15103862|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15103863|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15103864|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15103865|NCT02761694|Paclitaxel|paclitaxel|mesh-list
15103866|NCT02761694|Fulvestrant|fulvestrant|mesh-list
15103867|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15103868|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103869|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
15103870|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
15103871|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
15103872|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103873|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103874|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15103875|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15103876|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
15103877|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15103878|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175002|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
15175003|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175004|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175005|NCT03991013|Dolutegravir|dolutegravir|mesh-list
15175006|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15175007|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15175008|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175009|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175010|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15175011|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15175012|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
15175013|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175014|NCT03990701|Metomidate|metomidate|mesh-list
15175015|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15175016|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175017|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175018|NCT03990922|Morphine|morphine|mesh-list
15175019|NCT03990922|Ropivacaine|ropivacaine|mesh-list
15175020|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15175021|NCT03990922|Narcotics|narcotics|mesh-ancestor
15175022|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175023|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175024|NCT03990922|Analgesics|analgesics|mesh-ancestor
15175025|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
15175026|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175027|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
15175028|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
15175029|NCT03990480|Amlodipine|amlodipine|mesh-list
15175030|NCT03990480|Valsartan|valsartan|mesh-list
15175031|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15175032|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15175033|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15175034|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175035|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15175036|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175037|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
15175038|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15175039|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15175040|NCT03990623|Liver Extracts|liver extracts|mesh-list
15175041|NCT03990623|Hematinics|hematinics|mesh-ancestor
15175042|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15175043|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15175044|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
15175045|NCT03990129|Dipyrone|dipyrone|mesh-list
15175046|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15175047|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175048|NCT03990129|Analgesics|analgesics|mesh-ancestor
15175049|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
15175050|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175051|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175052|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175053|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175054|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
15175055|NCT03990194|Leuprolide|leuprolide|mesh-list
15175056|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15175057|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
15175058|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15175059|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175060|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15175061|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175062|NCT03990103|Paclitaxel|paclitaxel|mesh-list
15175063|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15175064|NCT03990103|Bevacizumab|bevacizumab|mesh-list
15175065|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
15175066|NCT03990103|Tegafur|tegafur|mesh-list
15103879|NCT02553161|Citalopram|citalopram|mesh-list
15103880|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15103881|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15103882|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15103883|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103884|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103885|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
15103886|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103887|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15103888|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
15103889|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15103890|NCT02549092|Levodopa|levodopa|mesh-list
15103891|NCT02549092|Carbidopa|carbidopa|mesh-list
15103892|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15103893|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15103894|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15103895|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
15103896|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103897|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103898|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103899|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15103900|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103901|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15103902|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
15103903|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
15103904|NCT02518555|Vaccines|vaccines|mesh-list
15103905|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
15103906|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103907|NCT02515773|Metformin|metformin|mesh-list
15103908|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15103909|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103910|NCT02478788|Amphetamine|amphetamine|mesh-list
15103911|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15103912|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103913|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
15103914|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
15103915|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103916|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
15103917|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103918|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103919|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
15103920|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15103921|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15103922|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15103923|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15103924|NCT02431715|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
15103925|NCT02431715|Dopamine Agents|dopamine agents|mesh-ancestor
15103926|NCT02431715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103927|NCT02431715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103928|NCT02431715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103929|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
15103930|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
15103931|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15103932|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15103933|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103934|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103935|NCT02335242|Urological Agents|urological agents|mesh-ancestor
15103936|NCT02323126|Nivolumab|nivolumab|mesh-list
15103937|NCT02323126|Nazartinib|nazartinib|mesh-list
15103938|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15103939|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103940|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15103941|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103942|NCT01902290|Brodalumab|brodalumab|mesh-list
15103943|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
15103944|NCT01712763|Goserelin|goserelin|mesh-list
15103945|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15103946|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15103947|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103948|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
15103949|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15103950|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
15103951|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15181529|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15103952|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103953|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15103954|NCT01366612|Vidarabine|vidarabine|mesh-list
15103955|NCT01366612|Fludarabine|fludarabine|mesh-list
15103956|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
15103957|NCT01366612|Busulfan|busulfan|mesh-list
15103958|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103959|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103960|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
15103961|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103962|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103963|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
15103964|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103965|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
15103966|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103967|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
15103968|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15103969|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15103970|NCT01126749|Gemcitabine|gemcitabine|mesh-list
15103971|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15103972|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15103973|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
15103974|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103975|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
15103976|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15103977|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15103978|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15103979|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
15103980|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103981|NCT01064245|Mannitol|mannitol|mesh-list
15103982|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
15103983|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15103984|NCT01064245|Diuretics|diuretics|mesh-ancestor
15103985|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
15103986|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15103987|NCT01064245|Miotics|miotics|mesh-ancestor
15103988|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
15103989|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15103990|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15103991|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15103992|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
15103993|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15103994|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15103995|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
15103996|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15103997|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15103998|NCT01059448|Brodalumab|brodalumab|mesh-list
15103999|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
15104000|NCT00821587|Cyclosporine|cyclosporine|mesh-list
15104001|NCT00821587|Tacrolimus|tacrolimus|mesh-list
15104002|NCT00821587|Cyclosporins|cyclosporins|mesh-list
15104003|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104004|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
15104005|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104006|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15104007|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104008|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104009|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
15104010|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104011|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
15104012|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104013|NCT00585195|Itraconazole|itraconazole|mesh-list
15104014|NCT00585195|Rifampin|rifampin|mesh-list
15104015|NCT00585195|Crizotinib|crizotinib|mesh-list
15104016|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
15104017|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104018|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15104019|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15104020|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104021|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104022|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15104023|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
15104024|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104025|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104026|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15104027|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15104028|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
15104029|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15104030|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
15104031|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15104032|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15104033|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15104034|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15104035|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15104036|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15104037|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15104038|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104039|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104040|NCT00278915|Fulvestrant|fulvestrant|mesh-list
15104041|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15104042|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104043|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15104044|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15104045|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
15104046|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104047|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104048|NCT04570839|Nivolumab|nivolumab|mesh-list
15104049|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104050|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104051|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15104052|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104053|NCT04561180|Dexamethasone|dexamethasone|mesh-list
15104054|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104055|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
15104056|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
15104057|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104058|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104059|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104060|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
15104061|NCT04561180|Hormones|hormones|mesh-ancestor
15104062|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104063|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15104064|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104065|NCT04527003|Cannabidiol|cannabidiol|mesh-list
15104066|NCT04527003|Norethindrone|norethindrone|mesh-list
15104067|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
15104068|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
15104069|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15104070|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15104071|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15104072|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
15104073|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15104074|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104075|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15104076|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15104077|NCT04457323|Metoprolol|metoprolol|mesh-list
15104078|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15104079|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15104080|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
15104081|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
15104082|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104083|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104084|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15104085|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15104086|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15104087|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
15104088|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104089|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104090|NCT04448431|Vortioxetine|vortioxetine|mesh-list
15104091|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15104092|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
15104093|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104094|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15104095|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15104096|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104097|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104098|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15104099|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15104100|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15104101|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104102|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104103|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
15104104|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15104105|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15104106|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15104107|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15104108|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15104109|NCT04372017|Vitamin D|vitamin d|mesh-list
15104110|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
15104111|NCT04372017|Vitamins|vitamins|mesh-ancestor
13996172|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15104112|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
15104113|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104114|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15104115|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
15104116|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15104117|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15104118|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104119|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104120|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104121|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104122|NCT04339049|Lidocaine|lidocaine|mesh-list
15104123|NCT04339049|Misoprostol|misoprostol|mesh-list
15104124|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
15104125|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
15104126|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104127|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104128|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
15104129|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104130|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15104131|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15104132|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15104133|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15104134|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104135|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15104136|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
15104137|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15104138|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15104139|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104140|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
15104141|NCT04312971|Norepinephrine|norepinephrine|mesh-list
15104142|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15104143|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15104144|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
15104145|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104146|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104147|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104148|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
15104149|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
15104150|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104151|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15104152|NCT04282278|Apatinib|apatinib|mesh-list
15104153|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104154|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104155|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104156|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104157|NCT04243629|Pramlintide|pramlintide|mesh-list
15104158|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
15104159|NCT04243629|Pancrelipase|pancrelipase|mesh-list
15104160|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15104161|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104162|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104163|NCT04194528|Acetaminophen|acetaminophen|mesh-list
15104164|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15104165|NCT04194528|Oxycodone|oxycodone|mesh-list
15104166|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15104167|NCT04194528|Analgesics|analgesics|mesh-ancestor
15104168|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
15104169|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104170|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104171|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
15104172|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15104173|NCT04194528|Narcotics|narcotics|mesh-ancestor
15104174|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104175|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15104176|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104177|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175067|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15175068|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175069|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
15175070|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
15175071|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
15175072|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175073|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175074|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15175075|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15175076|NCT03990103|Growth Substances|growth substances|mesh-ancestor
15175077|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175078|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
15175079|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15175080|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
15175081|NCT03990038|Ropivacaine|ropivacaine|mesh-list
15175082|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
15175083|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
15175084|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175085|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175086|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
15175087|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175088|NCT03990571|Avelumab|avelumab|mesh-list
15175089|NCT03990571|Axitinib|axitinib|mesh-list
15175090|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15175091|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175092|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175093|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15175094|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175095|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175096|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
15175097|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175098|NCT03989609|Midazolam|midazolam|mesh-list
15175099|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
15175100|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15175101|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175102|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175103|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175104|NCT03989609|Analgesics|analgesics|mesh-ancestor
15175105|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
15175106|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175107|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15175108|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15175109|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15175110|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
15175111|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175112|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175113|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15175114|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15175115|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15175116|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15175117|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15175118|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
15175119|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
15175120|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
15175121|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
15181530|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15181531|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15181532|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15181533|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181534|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
15181535|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181536|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181537|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15182273|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
15104178|NCT04179162|Gemcitabine|gemcitabine|mesh-list
15104179|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
15104180|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15104181|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
15104182|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104183|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104184|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
15104185|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104186|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104187|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104188|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
15104189|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104190|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15104191|NCT04170998|Metformin|metformin|mesh-list
15104192|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
15104193|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15104194|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104195|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15104196|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104197|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15104198|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15104199|NCT04082442|Evolocumab|evolocumab|mesh-list
15104200|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15104201|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15104202|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
15104203|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104204|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15104205|NCT04070573|Aspirin|aspirin|mesh-list
15104206|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15104207|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15104208|NCT04070573|Analgesics|analgesics|mesh-ancestor
15104209|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
15104210|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104211|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104212|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104213|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104214|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15104215|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15104216|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104217|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15104218|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15104219|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104220|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
15104221|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
15104222|NCT04070443|Ponatinib|ponatinib|mesh-list
15104223|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104224|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104225|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104226|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104227|NCT03990077|Docetaxel|docetaxel|mesh-list
15104228|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104229|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
15104230|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
15104231|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
15104232|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104233|NCT03954613|Memantine|memantine|mesh-list
15104234|NCT03954613|Donepezil|donepezil|mesh-list
15104235|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15104236|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104237|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104238|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
15104239|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104240|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104241|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
15104242|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15104243|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15104244|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
15104245|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15104246|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15104247|NCT03842696|Cyclosporine|cyclosporine|mesh-list
15104248|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
15104249|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
15104250|NCT03842696|Methotrexate|methotrexate|mesh-list
15104251|NCT03842696|Vorinostat|vorinostat|mesh-list
15104252|NCT03842696|Tacrolimus|tacrolimus|mesh-list
15104253|NCT03842696|Cyclosporins|cyclosporins|mesh-list
15104254|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104255|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
15104256|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104257|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104258|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15104259|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
15104260|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104261|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104262|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15104263|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15104264|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
15104265|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15104266|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15104267|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
15104268|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
15104269|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104270|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15104271|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15104272|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15104273|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
15104274|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104275|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15104276|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15104277|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
15104278|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15104279|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15104280|NCT03761277|Morphine|morphine|mesh-list
15104281|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15104282|NCT03761277|Narcotics|narcotics|mesh-ancestor
15104283|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104284|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104285|NCT03761277|Analgesics|analgesics|mesh-ancestor
15104286|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
15104287|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104288|NCT03729258|Amantadine|amantadine|mesh-list
15104289|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15104290|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15104291|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
15104292|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104293|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
15104294|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104295|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104296|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104297|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15104298|NCT03729258|Analgesics|analgesics|mesh-ancestor
15104299|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
15104300|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104301|NCT03716349|Anesthetics|anesthetics|mesh-list
15104302|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
15104303|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104304|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104305|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
15104306|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104307|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
15104308|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104309|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
15104310|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104311|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104312|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15104313|NCT03573960|Lenvatinib|lenvatinib|mesh-list
15104314|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104315|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104316|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104317|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104318|NCT03527238|Tacrolimus|tacrolimus|mesh-list
15104319|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104320|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
15104321|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104322|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15104323|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104324|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104325|NCT03490864|Melatonin|melatonin|mesh-list
15104326|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
15104327|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104328|NCT03490864|Protective Agents|protective agents|mesh-ancestor
15104329|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104330|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104331|NCT03455764|Trametinib|trametinib|mesh-list
15104332|NCT03455764|Dabrafenib|dabrafenib|mesh-list
15104333|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104334|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104335|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104336|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104337|NCT03380507|Thiamine|thiamine|mesh-list
15104338|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
15104339|NCT03380507|Vitamins|vitamins|mesh-ancestor
15104340|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
15104341|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104342|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104343|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
15104344|NCT03363503|Fluticasone|fluticasone|mesh-list
15104345|NCT03363503|Xhance|xhance|mesh-list
15104346|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15104347|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104348|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15104349|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
15104350|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104351|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104352|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15104353|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
15104354|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
15104355|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15104356|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15104357|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15104358|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15104359|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
15104360|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104361|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104362|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
15104363|NCT03321630|Lenvatinib|lenvatinib|mesh-list
15104364|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104365|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104366|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104367|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104368|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104369|NCT03194165|Ritonavir|ritonavir|mesh-list
15104370|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15104371|NCT03194165|Darunavir|darunavir|mesh-list
15104372|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
15104373|NCT03194165|Nevirapine|nevirapine|mesh-list
15104374|NCT03194165|Dolutegravir|dolutegravir|mesh-list
15104375|NCT03194165|Rilpivirine|rilpivirine|mesh-list
15104376|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15104377|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15104378|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
15104379|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104380|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104381|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15104382|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15104383|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
15104384|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104385|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15104386|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15104387|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15104388|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15104389|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15104390|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15104391|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15104392|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15104393|NCT03179475|Oxycodone|oxycodone|mesh-list
15104394|NCT03179475|Naloxone|naloxone|mesh-list
15104395|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15104396|NCT03179475|Narcotics|narcotics|mesh-ancestor
15104397|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104398|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104399|NCT03179475|Analgesics|analgesics|mesh-ancestor
15104400|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
15104401|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104402|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15104403|NCT03177746|Tadalafil|tadalafil|mesh-list
15104404|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
15104405|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15104406|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15104407|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104408|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104409|NCT03177746|Urological Agents|urological agents|mesh-ancestor
15104410|NCT03136497|Rituximab|rituximab|mesh-list
15104411|NCT03136497|Venetoclax|venetoclax|mesh-list
15104412|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104413|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104414|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
15104415|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104416|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104417|NCT03132129|Manganese|manganese|mesh-list
15104418|NCT03132129|Calcium|calcium|mesh-list
15104419|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15104420|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104421|NCT03132129|Trace Elements|trace elements|mesh-ancestor
15104422|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
15175122|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
15175123|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15175124|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
15175125|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15175126|NCT03989817|Protective Agents|protective agents|mesh-ancestor
15175127|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175128|NCT03989778|Vitamin D|vitamin d|mesh-list
15175129|NCT03989778|Vitamins|vitamins|mesh-ancestor
15175130|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
15175131|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175132|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15175133|NCT03989830|Endostatins|endostatins|mesh-list
15175134|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15175135|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15175136|NCT03989830|Growth Substances|growth substances|mesh-ancestor
15175137|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175138|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
15175139|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175140|NCT03989336|Manganese|manganese|mesh-list
15175141|NCT03989336|Paclitaxel|paclitaxel|mesh-list
15175142|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15175143|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15175144|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15175145|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175146|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
15175147|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
15175148|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
15175149|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175150|NCT03989336|Trace Elements|trace elements|mesh-ancestor
15175151|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
15175152|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175153|NCT03989310|Manganese|manganese|mesh-list
15175154|NCT03989310|Gemcitabine|gemcitabine|mesh-list
15175155|NCT03989310|Paclitaxel|paclitaxel|mesh-list
15175156|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15175157|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15175158|NCT03989310|Antibodies|antibodies|mesh-list
15175159|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
15175160|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15175161|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175162|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
15175163|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
15175164|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
15175165|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175166|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
15175167|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175168|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15175169|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
15175170|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
15175171|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175172|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175173|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15175174|NCT03989310|Trace Elements|trace elements|mesh-ancestor
15175175|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
15175176|NCT03989700|Thiamine|thiamine|mesh-list
15175177|NCT03989700|Vitamins|vitamins|mesh-ancestor
15175178|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
15175179|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175180|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
15175181|NCT03989557|Aspirin|aspirin|mesh-list
15175182|NCT03989557|Clopidogrel|clopidogrel|mesh-list
15175183|NCT03989557|Ticagrelor|ticagrelor|mesh-list
15104423|NCT02910700|Nivolumab|nivolumab|mesh-list
15104424|NCT02910700|Trametinib|trametinib|mesh-list
15104425|NCT02910700|Dabrafenib|dabrafenib|mesh-list
15104426|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104427|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104428|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15104429|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104430|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104431|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104432|NCT02898207|Olaparib|olaparib|mesh-list
15104433|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15104434|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104435|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104436|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104437|NCT02777372|Sertraline|sertraline|mesh-list
15104438|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
15104439|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104440|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15104441|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15104442|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15104443|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104444|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104445|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
15104446|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104447|NCT02744092|Enoxaparin|enoxaparin|mesh-list
15104448|NCT02744092|Dalteparin|dalteparin|mesh-list
15104449|NCT02744092|PENTA|penta|mesh-list
15104450|NCT02744092|Warfarin|warfarin|mesh-list
15104451|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
15104452|NCT02744092|Dabigatran|dabigatran|mesh-list
15104453|NCT02744092|Apixaban|apixaban|mesh-list
15104454|NCT02744092|Edoxaban|edoxaban|mesh-list
15104455|NCT02744092|Fondaparinux|fondaparinux|mesh-list
15104456|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
15104457|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15104458|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
15104459|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15104460|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
15104461|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104462|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104463|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15104464|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15104465|NCT02682901|Bromocriptine|bromocriptine|mesh-list
15104466|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15104467|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15104468|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
15104469|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104470|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104471|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
15104472|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
15104473|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104474|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104475|NCT02567825|Amoxicillin|amoxicillin|mesh-list
15104476|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
15104477|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
15104478|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
15104479|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15104480|NCT02567825|Ofloxacin|ofloxacin|mesh-list
15104481|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15104482|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104483|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15104484|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104485|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104486|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15104487|NCT02567825|Renal Agents|renal agents|mesh-ancestor
15104488|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15104489|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15104490|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104491|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15104492|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15104493|NCT02555657|Gemcitabine|gemcitabine|mesh-list
15104494|NCT02555657|Capecitabine|capecitabine|mesh-list
15104495|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
15104496|NCT02555657|Vinorelbine|vinorelbine|mesh-list
15104497|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15104498|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
15104499|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104500|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104501|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
15104502|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104503|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104504|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104505|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
15104506|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104507|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104508|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15104509|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
15104510|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
15104511|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
15104512|NCT02457156|Octreotide|octreotide|mesh-list
15104513|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104514|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15104515|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104516|NCT02272348|Insulin|insulin|mesh-list
15104517|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15104518|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104519|NCT02190721|Lenograstim|lenograstim|mesh-list
15104520|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15104521|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
15104522|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104523|NCT02109744|Decitabine|decitabine|mesh-list
15104524|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15104525|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
15104526|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104527|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104528|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104529|NCT01740557|Aldesleukin|aldesleukin|mesh-list
15104530|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
15104531|NCT01740557|Fludarabine|fludarabine|mesh-list
15104532|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
15104533|NCT01740557|Interleukin-2|interleukin-2|mesh-list
15104534|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104535|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
15104536|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104537|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104538|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15104539|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
15104540|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104541|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104542|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15104543|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15104544|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
15104545|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15104546|NCT01740557|Analgesics|analgesics|mesh-ancestor
15104547|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
15104548|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104549|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15104550|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15104551|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
15104552|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104553|NCT00308516|Leucovorin|leucovorin|mesh-list
15104554|NCT00308516|Bevacizumab|bevacizumab|mesh-list
15104555|NCT00308516|Fluorouracil|fluorouracil|mesh-list
15104556|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
15104557|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104558|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104559|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15104560|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15104561|NCT00308516|Growth Substances|growth substances|mesh-ancestor
15104562|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104563|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
15104564|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
15104565|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104566|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15104567|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104568|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
15104569|NCT00308516|Antidotes|antidotes|mesh-ancestor
15104570|NCT00308516|Protective Agents|protective agents|mesh-ancestor
15104571|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
15104572|NCT00308516|Vitamins|vitamins|mesh-ancestor
15104573|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
15104574|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
15104575|NCT02325960|Exenatide|exenatide|mesh-list
15104576|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15104577|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104578|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15104579|NCT02325960|Incretins|incretins|mesh-ancestor
15104580|NCT02325960|Hormones|hormones|mesh-ancestor
15104581|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104582|NCT05155592|Adalimumab|adalimumab|mesh-list
15104583|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104584|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104585|NCT05155579|Vaccines|vaccines|mesh-list
15104586|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
15104587|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104588|NCT05155527|Ivermectin|ivermectin|mesh-list
15104589|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15104590|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104591|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
15104592|NCT05155215|Fludarabine|fludarabine|mesh-list
15104593|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15104594|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
15104595|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104596|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104597|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15104598|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
15104599|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104600|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104601|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15104602|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
15104603|NCT05155124|Cetuximab|cetuximab|mesh-list
15104604|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104605|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104606|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15104607|NCT05154747|Rilpivirine|rilpivirine|mesh-list
15104608|NCT05154747|Cabotegravir|cabotegravir|mesh-list
15104609|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15104610|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15104611|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104612|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104613|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
15104614|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104615|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15104616|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15104617|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15104618|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15104619|NCT05154682|Acetaminophen|acetaminophen|mesh-list
15104620|NCT05154682|Naproxen|naproxen|mesh-list
15104621|NCT05154682|Oxycodone|oxycodone|mesh-list
15104622|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15104623|NCT05154682|Analgesics|analgesics|mesh-ancestor
15104624|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
15104625|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104626|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104627|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
15104628|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15104629|NCT05154682|Narcotics|narcotics|mesh-ancestor
15104630|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104631|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15104632|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104633|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104634|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
15104635|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15104636|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104637|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104638|NCT05154487|Fulvestrant|fulvestrant|mesh-list
15104639|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15104640|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104641|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15104642|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15104643|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
15104644|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104645|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104646|NCT05154396|Loperamide|loperamide|mesh-list
15104647|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
15104648|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104649|NCT05154383|Vaccines|vaccines|mesh-list
15104650|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
15104651|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104652|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
15104653|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
15104654|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175184|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15175185|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175186|NCT03989557|Analgesics|analgesics|mesh-ancestor
15175187|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
15175188|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175189|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175190|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175191|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175192|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15175193|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15175194|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175195|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15175196|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15175197|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175198|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
15175199|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15175200|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15175201|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15175202|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
15175203|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175204|NCT03989271|Quercetin|quercetin|mesh-list
15175205|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
15175206|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175207|NCT03989271|Protective Agents|protective agents|mesh-ancestor
15175208|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175209|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15175210|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
15175211|NCT03989466|Antibodies|antibodies|mesh-list
15175212|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
15175213|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15175214|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
15175215|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175216|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175217|NCT03989115|Osimertinib|osimertinib|mesh-list
15175218|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175219|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15175220|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175221|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175222|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
15175223|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175224|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175225|NCT03989037|Carboplatin|carboplatin|mesh-list
15175226|NCT03989037|Docetaxel|docetaxel|mesh-list
15175227|NCT03989037|Trastuzumab|trastuzumab|mesh-list
15175228|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175229|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
15175230|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
15175231|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
15175232|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175233|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175234|NCT03989024|Clomiphene|clomiphene|mesh-list
15175235|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15175236|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15175237|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
15175238|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175239|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175240|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15175241|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
15175242|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15175243|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15175244|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15175245|NCT03989024|Hormones|hormones|mesh-ancestor
15175246|NCT03988725|Vitamin E|vitamin e|mesh-list
15175247|NCT03988725|Vitamins|vitamins|mesh-ancestor
15175248|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
15175249|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175250|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
15175251|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175252|NCT03988725|Protective Agents|protective agents|mesh-ancestor
15175253|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
15175254|NCT03988530|Scopolamine|scopolamine|mesh-list
15175255|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15175256|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15175257|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
15104655|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15104656|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15104657|NCT05134584|Lactulose|lactulose|mesh-list
15104658|NCT05134584|Linaclotide|linaclotide|mesh-list
15104659|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104660|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15104661|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
15104662|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104663|NCT05134415|Menthol|menthol|mesh-list
15104664|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
15104665|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
15104666|NCT05052710|Midazolam|midazolam|mesh-list
15104667|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15104668|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15104669|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104670|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104671|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15104672|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15104673|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104674|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15104675|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
15104676|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
15104677|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
15104678|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
15104679|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104680|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104681|NCT05051293|Testosterone|testosterone|mesh-list
15104682|NCT05051293|Estrogens|estrogens|mesh-list
15104683|NCT05051293|Androgens|androgens|mesh-ancestor
15104684|NCT05051293|Hormones|hormones|mesh-ancestor
15104685|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104686|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104687|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
15104688|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
15104689|NCT05005897|Vitamins|vitamins|mesh-ancestor
15104690|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
15104691|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104692|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
15104693|NCT05005897|Hematinics|hematinics|mesh-ancestor
15104694|NCT04960215|Ubiquinone|ubiquinone|mesh-list
15104695|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
15104696|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
15104697|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104698|NCT04960215|Vitamins|vitamins|mesh-ancestor
15104699|NCT04881032|Temozolomide|temozolomide|mesh-list
15104700|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15104701|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
15104702|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104703|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104704|NCT04849650|Amisulpride|amisulpride|mesh-list
15104705|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15104706|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15104707|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104708|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104709|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104710|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15104711|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
15104712|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104713|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104714|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15104715|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
15104716|NCT04765137|Atorvastatin|atorvastatin|mesh-list
15104717|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15104718|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15104719|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
15104720|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104721|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15104722|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15104723|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104724|NCT04721821|Tofacitinib|tofacitinib|mesh-list
15104725|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104726|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104727|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104728|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
15104729|NCT04721457|Listerine|listerine|mesh-list
15104730|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15104731|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
15104732|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15104733|NCT04721457|Eusol|eusol|mesh-list
15104734|NCT04721457|Povidone|povidone|mesh-list
15104735|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
15104736|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
15104737|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
15104738|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15104739|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104740|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
15104741|NCT04721457|Protective Agents|protective agents|mesh-ancestor
15104742|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104743|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
15104744|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
15104745|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15104746|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
15104747|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104748|NCT04627922|Expectorants|expectorants|mesh-ancestor
15104749|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
15104750|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15104751|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
15104752|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104753|NCT04627922|Protective Agents|protective agents|mesh-ancestor
15104754|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104755|NCT04627922|Antidotes|antidotes|mesh-ancestor
15104756|NCT04586920|Itraconazole|itraconazole|mesh-list
15104757|NCT04586920|Midazolam|midazolam|mesh-list
15104758|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15104759|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15104760|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104761|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104762|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15104763|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15104764|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104765|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15104766|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
15104767|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
15104768|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
15104769|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
15104770|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104771|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104772|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
15104773|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104774|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15104775|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15104776|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104777|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15104778|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
15104779|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104780|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15104781|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
15104782|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15104783|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
15104784|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104785|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15104786|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104787|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15104788|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104789|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15104790|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104791|NCT04454905|Apatinib|apatinib|mesh-list
15104792|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104793|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104794|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104795|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104796|NCT04418167|Dabrafenib|dabrafenib|mesh-list
15104797|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104798|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15104799|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104800|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175258|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
15175259|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175260|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175261|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15175262|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
15175263|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15175264|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
15175265|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175266|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175267|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15175268|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
15175269|NCT03988387|Tenofovir|tenofovir|mesh-list
15175270|NCT03988387|Emtricitabine|emtricitabine|mesh-list
15175271|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
15175272|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175273|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15175274|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15175275|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175276|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175277|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15175278|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15175279|NCT03988231|Enoxaparin|enoxaparin|mesh-list
15175280|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
15175281|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15175282|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15175283|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175284|NCT03988205|Cytarabine|cytarabine|mesh-list
15175285|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15175286|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
15175287|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175288|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175289|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
15175290|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175291|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15175292|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
15175293|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175294|NCT03988452|Ritonavir|ritonavir|mesh-list
15175295|NCT03988452|Darunavir|darunavir|mesh-list
15175296|NCT03988452|Tenofovir|tenofovir|mesh-list
15175297|NCT03988452|Lamivudine|lamivudine|mesh-list
15175298|NCT03988452|Zidovudine|zidovudine|mesh-list
15175299|NCT03988452|Dolutegravir|dolutegravir|mesh-list
15175300|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15175301|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15175302|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
15175303|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175304|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175305|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15175306|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15175307|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
15175308|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175309|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15175310|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15175311|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15175312|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15175313|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
15175314|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15175315|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15175316|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15175317|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15175318|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15175319|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
15175320|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175321|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15175322|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15175323|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175324|NCT03988010|Amantadine|amantadine|mesh-list
15175325|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15175326|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15175327|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
15175328|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175329|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
15175330|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175331|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104801|NCT04309409|Nivolumab|nivolumab|mesh-list
15104802|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104803|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104804|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15104805|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104806|NCT04285684|Ketamine|ketamine|mesh-list
15104807|NCT04285684|Analgesics|analgesics|mesh-ancestor
15104808|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
15104809|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104810|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104811|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15104812|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15104813|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
15104814|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
15104815|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104816|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15104817|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15104818|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104819|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104820|NCT04144023|Molgramostim|molgramostim|mesh-list
15104821|NCT04144023|Vaccines|vaccines|mesh-list
15104822|NCT04144023|Sargramostim|sargramostim|mesh-list
15104823|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
15104824|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104825|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104826|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15104827|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15104828|NCT04079218|Estradiol|estradiol|mesh-list
15104829|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15104830|NCT04079218|Estrogens|estrogens|mesh-ancestor
15104831|NCT04079218|Hormones|hormones|mesh-ancestor
15104832|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104833|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104834|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15104835|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
15104836|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15104837|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15104838|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
15104839|NCT04013555|Tryptophan|tryptophan|mesh-list
15104840|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15104841|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
15104842|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104843|NCT04013555|Expectorants|expectorants|mesh-ancestor
15104844|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
15104845|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15104846|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
15104847|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104848|NCT04013555|Protective Agents|protective agents|mesh-ancestor
15104849|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104850|NCT04013555|Antidotes|antidotes|mesh-ancestor
15104851|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15104852|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
15104853|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104854|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
15104855|NCT03994172|Vitamin D|vitamin d|mesh-list
15104856|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
15104857|NCT03994172|Teriparatide|teriparatide|mesh-list
15104858|NCT03994172|Citric Acid|citric acid|mesh-list
15104859|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
15104860|NCT03994172|Calcium|calcium|mesh-list
15104861|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
15104862|NCT03994172|Cinacalcet|cinacalcet|mesh-list
15104863|NCT03994172|Hormones|hormones|mesh-list
15104864|NCT03994172|Vitamins|vitamins|mesh-ancestor
15104865|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
15104866|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104867|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15104868|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15104869|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
15104870|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15104871|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
15104872|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
15104873|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269196|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15104874|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104875|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15104876|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
15104877|NCT03924947|Pancrelipase|pancrelipase|mesh-list
15104878|NCT03924947|Pancreatin|pancreatin|mesh-list
15104879|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104880|NCT03919435|Trimethoprim|trimethoprim|mesh-list
15104881|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15104882|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
15104883|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15104884|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104885|NCT03919435|Renal Agents|renal agents|mesh-ancestor
15104886|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
15104887|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15104888|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15104889|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15104890|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104891|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104892|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15104893|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15104894|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15104895|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15104896|NCT03887936|Testosterone|testosterone|mesh-list
15104897|NCT03887936|Androgens|androgens|mesh-ancestor
15104898|NCT03887936|Hormones|hormones|mesh-ancestor
15104899|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104900|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104901|NCT03884439|Infliximab|infliximab|mesh-list
15104902|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
15104903|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104904|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15104905|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
15104906|NCT03831711|Bombesin|bombesin|mesh-list
15104907|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104908|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104909|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104910|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15104911|NCT03829462|Irinotecan|irinotecan|mesh-list
15104912|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15104913|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15104914|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104915|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104916|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104917|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
15104918|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104919|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104920|NCT03774641|Lamotrigine|lamotrigine|mesh-list
15104921|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
15104922|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15104923|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15104924|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104925|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15104926|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104927|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15104928|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15104929|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104930|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15104931|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15104932|NCT03643965|Budesonide|budesonide|mesh-list
15104933|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15104934|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15104935|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
15104936|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104937|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104938|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15104939|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
15104940|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
15104941|NCT03643965|Hormones|hormones|mesh-ancestor
15104942|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15104943|NCT03595566|Vancomycin|vancomycin|mesh-list
15104944|NCT03595566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15104945|NCT03595566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104946|NCT03595553|Vancomycin|vancomycin|mesh-list
15104947|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15104948|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104949|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15104950|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15175332|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104951|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104952|NCT03530397|Carboplatin|carboplatin|mesh-list
15104953|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
15104954|NCT03530397|Pemetrexed|pemetrexed|mesh-list
15104955|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15104956|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15104957|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104958|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104959|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15104960|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15104961|NCT03516292|Mitogens|mitogens|mesh-list
15104962|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
15104963|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104964|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15104965|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104966|NCT03336541|Ketamine|ketamine|mesh-list
15104967|NCT03336541|Analgesics|analgesics|mesh-ancestor
15104968|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
15104969|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15104970|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104971|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15104972|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15104973|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
15104974|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
15104975|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15104976|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15104977|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15104978|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15104979|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104980|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
15104981|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15104982|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15104983|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
15104984|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104985|NCT03241732|Expectorants|expectorants|mesh-ancestor
15104986|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
15104987|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15104988|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
15104989|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104990|NCT03241732|Protective Agents|protective agents|mesh-ancestor
15104991|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15104992|NCT03241732|Antidotes|antidotes|mesh-ancestor
15104993|NCT03230916|Relebactam|relebactam|mesh-list
15104994|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15104995|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15104996|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15104997|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15104998|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15104999|NCT03202667|Empagliflozin|empagliflozin|mesh-list
15105000|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15105001|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105002|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15105003|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105004|NCT03021993|Nivolumab|nivolumab|mesh-list
15105005|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105006|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105007|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15105008|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105009|NCT02954081|Apremilast|apremilast|mesh-list
15105010|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15105011|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15105012|NCT02954081|Analgesics|analgesics|mesh-ancestor
15105013|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
15105014|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105015|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105016|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105017|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105018|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15105019|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15105020|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105021|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105022|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
15105023|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15105024|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105025|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105026|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
15105027|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105028|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105029|NCT02763319|Rituximab|rituximab|mesh-list
15105030|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15105031|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105032|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105033|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
15105034|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105035|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105036|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15105037|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
15105038|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105039|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15105040|NCT02673567|Antibodies|antibodies|mesh-list
15105041|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
15105042|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15105043|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
15105044|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105045|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105046|NCT02628626|Clonidine|clonidine|mesh-list
15105047|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
15105048|NCT02628626|Analgesics|analgesics|mesh-ancestor
15105049|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
15105050|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105051|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105052|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105053|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
15105054|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
15105055|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15105056|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15105057|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15105058|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
15105059|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105060|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105061|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15105062|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15105063|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
15105064|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15175333|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175334|NCT03988010|Analgesics|analgesics|mesh-ancestor
15175335|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
15175336|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175337|NCT03987867|Paclitaxel|paclitaxel|mesh-list
15175338|NCT03987867|Carboplatin|carboplatin|mesh-list
15175339|NCT03987867|Pemetrexed|pemetrexed|mesh-list
15175340|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15175341|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15175342|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175343|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
15175344|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
15175345|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
15175346|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175347|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175348|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15175349|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15175350|NCT03988075|Acetaminophen|acetaminophen|mesh-list
15175351|NCT03988075|Ibuprofen|ibuprofen|mesh-list
15175352|NCT03988075|Hydrocodone|hydrocodone|mesh-list
15175353|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175354|NCT03988075|Analgesics|analgesics|mesh-ancestor
15175355|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
15175356|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175357|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175358|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
15175359|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15175360|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175361|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175362|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15175363|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175364|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175365|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15175366|NCT03988075|Narcotics|narcotics|mesh-ancestor
15105065|NCT02536183|Doxorubicin|doxorubicin|mesh-list
15105066|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15105067|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15105068|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105069|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15105070|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14269197|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269198|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269199|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14269200|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
14269201|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
14269202|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105071|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105072|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105073|NCT02523313|Nivolumab|nivolumab|mesh-list
15105074|NCT02523313|Ipilimumab|ipilimumab|mesh-list
15105075|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105076|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105077|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15105078|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105079|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
15105080|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15105081|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
15105082|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105083|NCT02445651|Expectorants|expectorants|mesh-ancestor
15105084|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
15105085|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15105086|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
15105087|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105088|NCT02445651|Protective Agents|protective agents|mesh-ancestor
15105089|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105090|NCT02445651|Antidotes|antidotes|mesh-ancestor
15105091|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
15105092|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105093|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105094|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15105095|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15105096|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105097|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105098|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15105099|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105100|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105101|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
15105102|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105103|NCT01602666|Carboplatin|carboplatin|mesh-list
15105104|NCT01602666|Etoposide|etoposide|mesh-list
15105105|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
15105106|NCT01602666|Ifosfamide|ifosfamide|mesh-list
15105107|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
15105108|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
15105109|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105110|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15105111|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15105112|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15105113|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105114|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105115|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15105116|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
15105117|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
15105118|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
15105119|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105120|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105121|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105122|NCT01489813|Genistein|genistein|mesh-list
15105123|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15105124|NCT01489813|Protective Agents|protective agents|mesh-ancestor
15105125|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105126|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105127|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15105128|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105129|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105130|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
15105131|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14292376|NCT00560417|Protamines|protamines|mesh-list
15105132|NCT01489813|Estrogens|estrogens|mesh-ancestor
15105133|NCT01489813|Hormones|hormones|mesh-ancestor
15105134|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105135|NCT01375959|Resveratrol|resveratrol|mesh-list
15105136|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
15105137|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105138|NCT01375959|Protective Agents|protective agents|mesh-ancestor
15105139|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105140|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105141|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15105142|NCT00380653|Sapacitabine|sapacitabine|mesh-list
15105143|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105144|NCT00354835|Dactinomycin|dactinomycin|mesh-list
15105145|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
15105146|NCT00354835|Irinotecan|irinotecan|mesh-list
15105147|NCT00354835|Vincristine|vincristine|mesh-list
15105148|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105149|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
15105150|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105151|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105152|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15105153|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
15105154|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105155|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105156|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15105157|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15105158|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15105159|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105160|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15105161|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105162|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105163|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105164|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15105165|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105166|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15105167|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15105168|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15105169|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
15105170|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15105171|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105172|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
15105173|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15105174|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105175|NCT05156970|Carboplatin|carboplatin|mesh-list
15105176|NCT05156970|Docetaxel|docetaxel|mesh-list
15105177|NCT05156970|Apatinib|apatinib|mesh-list
15105178|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105179|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105180|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105181|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105182|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105183|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15105184|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105185|NCT05156892|Tamoxifen|tamoxifen|mesh-list
15105186|NCT05156892|Itraconazole|itraconazole|mesh-list
15105187|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15105188|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
15105189|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105190|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105191|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15105192|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105193|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15105194|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15105195|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15105196|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
15105197|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105198|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15105199|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15105200|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105201|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105202|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15105203|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15105204|NCT05156788|Lenvatinib|lenvatinib|mesh-list
15105205|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105206|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15105207|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105208|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105209|NCT05156749|Calpastatin|calpastatin|mesh-list
15105210|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
15105211|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
15105212|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105213|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105214|NCT05156658|Etonogestrel|etonogestrel|mesh-list
15105215|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15105216|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
15105217|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15105218|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105219|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15105220|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15105221|NCT05156632|Vaccines|vaccines|mesh-list
15105222|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
15105223|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105224|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15105225|NCT05156632|Antacids|antacids|mesh-ancestor
15105226|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105227|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105228|NCT05156606|Testosterone|testosterone|mesh-list
15105229|NCT05156606|Androgens|androgens|mesh-ancestor
15105230|NCT05156606|Hormones|hormones|mesh-ancestor
15105231|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105232|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105233|NCT05156541|Interferons|interferons|mesh-list
15105234|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
15105235|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105236|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
15105237|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105238|NCT05156450|Prednisone|prednisone|mesh-list
15105239|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
15105240|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105241|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
15105242|NCT05156450|Hormones|hormones|mesh-ancestor
15105243|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105244|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105245|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15105246|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105247|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15105248|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105249|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105250|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
15105251|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15105252|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
15105253|NCT05156021|Bevacizumab|bevacizumab|mesh-list
15105254|NCT05156021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105255|NCT05156021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105256|NCT05156021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15105257|NCT05156021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15105258|NCT05156021|Growth Substances|growth substances|mesh-ancestor
15105259|NCT05156021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105260|NCT05156021|Growth Inhibitors|growth inhibitors|mesh-ancestor
15105261|NCT05155969|Ketamine|ketamine|mesh-list
15105262|NCT05155969|Esketamine|esketamine|mesh-list
15105263|NCT05155969|Analgesics|analgesics|mesh-ancestor
15105264|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
15105265|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105266|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105267|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15105268|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15105269|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
15105270|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
15105271|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105272|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15105273|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15105274|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105275|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105276|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
15105277|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15105278|NCT05150496|Vaccines|vaccines|mesh-list
15105279|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
15105280|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105281|NCT05112913|Vaccines|vaccines|mesh-list
15105282|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
15105283|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105284|NCT05112549|Nivolumab|nivolumab|mesh-list
15105285|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105286|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105287|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15105288|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175367|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175368|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
15175369|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
15175370|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15175371|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
15175372|NCT03988036|Trastuzumab|trastuzumab|mesh-list
15175373|NCT03988036|Pertuzumab|pertuzumab|mesh-list
15175374|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175375|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175376|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15175377|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15175378|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175379|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175380|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15175381|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
15175382|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175383|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175384|NCT03987893|Lactulose|lactulose|mesh-list
15175385|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15175386|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15175387|NCT03987893|Laxatives|laxatives|mesh-ancestor
15181538|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181539|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
15181540|NCT03928691|Analgesics|analgesics|mesh-ancestor
15181541|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
15181542|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181543|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181544|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
15181545|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181546|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15181547|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
15181548|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15181549|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15181550|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181551|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15181552|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
15181553|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15181554|NCT03928340|Metformin|metformin|mesh-list
15181555|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15181556|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181557|NCT03928353|Ticagrelor|ticagrelor|mesh-list
15181558|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15181559|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15181560|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15181561|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15181562|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
15181563|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181564|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181565|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181566|NCT03928366|Remifentanil|remifentanil|mesh-list
15181567|NCT03928366|Propofol|propofol|mesh-list
15181568|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15181569|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181570|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181571|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15181572|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
15181573|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
15181574|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15181575|NCT03928366|Narcotics|narcotics|mesh-ancestor
15181576|NCT03928366|Analgesics|analgesics|mesh-ancestor
15181577|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
15181578|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181579|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15181580|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
15181581|NCT03928145|Amiloride|amiloride|mesh-list
15181582|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15181583|NCT03928145|Diuretics|diuretics|mesh-ancestor
15181584|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
15105289|NCT04952324|Folic Acid|folic acid|mesh-list
15105290|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
15105291|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
15105292|NCT04952324|Vitamins|vitamins|mesh-ancestor
15105293|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
15105294|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105295|NCT04952324|Hematinics|hematinics|mesh-ancestor
15105296|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
15105297|NCT04934020|Metronidazole|metronidazole|mesh-list
15105298|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105299|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15105300|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15105301|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15105302|NCT04910061|Niacinamide|niacinamide|mesh-list
15105303|NCT04910061|Niacin|niacin|mesh-list
15105304|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
15105305|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
15105306|NCT04910061|Vitamins|vitamins|mesh-ancestor
15105307|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
15105308|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105309|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15105310|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
15105311|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105312|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15105313|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
15105314|NCT04901702|Irinotecan|irinotecan|mesh-list
15105315|NCT04901702|Temozolomide|temozolomide|mesh-list
15105316|NCT04901702|Talazoparib|talazoparib|mesh-list
15105317|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15105318|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15105319|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105320|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105321|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105322|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15105323|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
15105324|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15105325|NCT04862338|Niacinamide|niacinamide|mesh-list
15105326|NCT04862338|Niacin|niacin|mesh-list
15105327|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
15105328|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
15105329|NCT04862338|Vitamins|vitamins|mesh-ancestor
15105330|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
15105331|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105332|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15105333|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
15105334|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105335|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15105336|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
15105337|NCT04843423|Cariprazine|cariprazine|mesh-list
15105338|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15105339|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15105340|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105341|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105342|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15105343|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
15105344|NCT04798469|Testosterone|testosterone|mesh-list
15105345|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
15105346|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
15105347|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15105348|NCT04798469|Androgens|androgens|mesh-ancestor
15105349|NCT04798469|Hormones|hormones|mesh-ancestor
15105350|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105351|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105352|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15105353|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105354|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
15105355|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15105356|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
15105357|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105358|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105359|NCT04774250|Zonisamide|zonisamide|mesh-list
15105360|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
15105361|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15105362|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105363|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105364|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15105365|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105366|NCT04768569|Zonisamide|zonisamide|mesh-list
15105367|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
15105368|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15105369|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105370|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105371|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15105372|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105373|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
15105374|NCT04645602|Lenvatinib|lenvatinib|mesh-list
15105375|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105376|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105377|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15105378|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105379|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105380|NCT04560725|Choline|choline|mesh-list
15105381|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
15105382|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15105383|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
15105384|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105385|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105386|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15105387|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
15105388|NCT04549051|Anesthetics|anesthetics|mesh-list
15105389|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
15105390|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105391|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105392|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
15105393|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105394|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
15105395|NCT04530539|Melatonin|melatonin|mesh-list
15105396|NCT04530539|Vitamins|vitamins|mesh-ancestor
15105397|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
15105398|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105399|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
15105400|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105401|NCT04530539|Protective Agents|protective agents|mesh-ancestor
15105402|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105403|NCT04518306|Amlodipine|amlodipine|mesh-list
15105404|NCT04518306|Telmisartan|telmisartan|mesh-list
15105405|NCT04518306|Indapamide|indapamide|mesh-list
15105406|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105407|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15105408|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105409|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105410|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14269203|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269204|NCT00401778|Everolimus|everolimus|mesh-list
14269205|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269206|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269207|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
14269208|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269209|NCT00401817|Bevacizumab|bevacizumab|mesh-list
14269210|NCT00401817|Rituximab|rituximab|mesh-list
14269211|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269212|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269213|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14269214|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15105411|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105412|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
15105413|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15105414|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15105415|NCT04518306|Diuretics|diuretics|mesh-ancestor
15105416|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
15105417|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15105418|NCT04518293|Amlodipine|amlodipine|mesh-list
15105419|NCT04518293|Telmisartan|telmisartan|mesh-list
15105420|NCT04518293|Indapamide|indapamide|mesh-list
15105421|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105422|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15105423|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105424|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105425|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15105426|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105427|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
15105428|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14269215|NCT00401817|Growth Substances|growth substances|mesh-ancestor
15105429|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15105430|NCT04518293|Diuretics|diuretics|mesh-ancestor
15105431|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
15105432|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15105433|NCT04506138|Paclitaxel|paclitaxel|mesh-list
15105434|NCT04506138|Carboplatin|carboplatin|mesh-list
15105435|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15105436|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105437|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105438|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105439|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105440|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105441|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15105442|NCT04503707|Hormones|hormones|mesh-ancestor
15105443|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105444|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105445|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
15105446|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105447|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105448|NCT04456153|Atovaquone|atovaquone|mesh-list
15105449|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105450|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
15105451|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15105452|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15105453|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105454|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105455|NCT04455464|Midodrine|midodrine|mesh-list
15105456|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
15105457|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
15105458|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105459|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105460|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15105461|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15105462|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15105463|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15105464|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
15105465|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105466|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105467|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
15105468|NCT04403971|Listerine|listerine|mesh-list
15105469|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15105470|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105471|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
15105472|NCT04351243|Gimsilumab|gimsilumab|mesh-list
15105473|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105474|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
15105475|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105476|NCT04351061|Acetazolamide|acetazolamide|mesh-list
15105477|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
15105478|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15105479|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105480|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105481|NCT04351061|Diuretics|diuretics|mesh-ancestor
15105482|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
15105483|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175388|NCT03987815|Nivolumab|nivolumab|mesh-list
15175389|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175390|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175391|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15175392|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175393|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15175394|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175395|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175396|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
15175397|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15175398|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175399|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15175400|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
15175401|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105484|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15105485|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105486|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105487|NCT04325659|Lofexidine|lofexidine|mesh-list
15105488|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105489|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15105490|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105491|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
15105492|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105493|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15105494|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15105495|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15105496|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
15105497|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105498|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105499|NCT04321174|Ritonavir|ritonavir|mesh-list
15105500|NCT04321174|Lopinavir|lopinavir|mesh-list
15105501|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15105502|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15105503|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
15105504|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105505|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105506|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15105507|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15105508|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
15105509|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105510|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15105511|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15105512|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15105513|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
15105514|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
15105515|NCT04206761|Bromides|bromides|mesh-list
15105516|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
15105517|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105518|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
15105519|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15105520|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15105521|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15105522|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15105523|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
15105524|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105525|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105526|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105527|NCT04194814|Betamethasone|betamethasone|mesh-list
15105528|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
15105529|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15105530|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
15105531|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15105532|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105533|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
15105534|NCT04194814|Hormones|hormones|mesh-ancestor
15105535|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105536|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105537|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15105538|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
15105539|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
15105540|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105541|NCT04143204|Insulin|insulin|mesh-list
15105542|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15105543|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105544|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
13996173|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15105545|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
15105546|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105547|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15105548|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105549|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105550|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15105551|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
15105552|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105553|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
15105554|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105555|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105556|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
15105557|NCT04093752|Tirzepatide|tirzepatide|mesh-list
15105558|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15105559|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105560|NCT04093752|Incretins|incretins|mesh-ancestor
15105561|NCT04093752|Hormones|hormones|mesh-ancestor
15105562|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105563|NCT04055428|Valsartan|valsartan|mesh-list
15105564|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105565|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15105566|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15105567|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105568|NCT03998293|Somatostatin|somatostatin|mesh-list
15105569|NCT03998293|Hormones|hormones|mesh-ancestor
15105570|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105571|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105572|NCT03962998|Lactulose|lactulose|mesh-list
15105573|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105574|NCT03925246|Nivolumab|nivolumab|mesh-list
15105575|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105576|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105577|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15105578|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105579|NCT03815175|Aspirin|aspirin|mesh-list
15105580|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15105581|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15105582|NCT03815175|Analgesics|analgesics|mesh-ancestor
15105583|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
15105584|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105585|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105586|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105587|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105588|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15105589|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15105590|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105591|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15105592|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15105593|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105594|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
15105595|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15105596|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105597|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
15105598|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
15105599|NCT03743402|Narcotics|narcotics|mesh-ancestor
15105600|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105601|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105602|NCT03743402|Analgesics|analgesics|mesh-ancestor
15105603|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
15105604|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105605|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
15105606|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15105607|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105608|NCT03742505|Vitamins|vitamins|mesh-ancestor
15105609|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
15105610|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15105611|NCT03668639|Dexamethasone|dexamethasone|mesh-list
15105612|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105613|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
15105614|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
15105615|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105616|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105617|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105618|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
15105619|NCT03668639|Hormones|hormones|mesh-ancestor
15105620|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105621|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15105622|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105623|NCT03618693|Anesthetics|anesthetics|mesh-list
15105624|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105625|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105626|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15105627|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105628|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
15105629|NCT03600714|Interferons|interferons|mesh-list
15105630|NCT03600714|Ritonavir|ritonavir|mesh-list
15105631|NCT03600714|Lonafarnib|lonafarnib|mesh-list
15105632|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105633|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
15105634|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105635|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15105636|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15105637|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
15105638|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105639|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105640|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15105641|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15105642|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15105643|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15105644|NCT03530124|Vaccines|vaccines|mesh-list
15105645|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15105646|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
15105647|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105648|NCT03518203|Eculizumab|eculizumab|mesh-list
15105649|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15105650|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105651|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
15105652|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105653|NCT03479307|Ketotifen|ketotifen|mesh-list
15105654|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15105655|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15105656|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
15105657|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
15105658|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15105659|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
15105660|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
15105661|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105662|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105663|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105664|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15105665|NCT03474640|Antibodies|antibodies|mesh-list
15105666|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15105667|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
15105668|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105669|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15105670|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
15175402|NCT03987529|Propofol|propofol|mesh-list
15175403|NCT03987529|Sevoflurane|sevoflurane|mesh-list
15175404|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15175405|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175406|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175407|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15175408|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
15175409|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
15175410|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15175411|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15175412|NCT03987152|Sirolimus|sirolimus|mesh-list
15175413|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15175414|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175415|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15175416|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175417|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
15175418|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15175419|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
15175420|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175421|NCT03986970|Tenofovir|tenofovir|mesh-list
15175422|NCT03986970|Emtricitabine|emtricitabine|mesh-list
15175423|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
15175424|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175425|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15175426|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15175427|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175428|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175429|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15175430|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15175431|NCT03987022|Acetaminophen|acetaminophen|mesh-list
15175432|NCT03987022|Ketorolac|ketorolac|mesh-list
15175433|NCT03987022|Oxycodone|oxycodone|mesh-list
15175434|NCT03987022|Hydromorphone|hydromorphone|mesh-list
15175435|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15175436|NCT03987022|Narcotics|narcotics|mesh-ancestor
15175437|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175438|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175439|NCT03987022|Analgesics|analgesics|mesh-ancestor
15175440|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
15105671|NCT03393741|Paclitaxel|paclitaxel|mesh-list
15105672|NCT03393741|Vinorelbine|vinorelbine|mesh-list
15105673|NCT03393741|Docetaxel|docetaxel|mesh-list
15105674|NCT03393741|Epothilones|epothilones|mesh-list
15105675|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
15105676|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15105677|NCT03393741|Taxane|taxane|mesh-list
15105678|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15105679|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105680|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105681|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105682|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105683|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105684|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15105685|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
15105686|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
15105687|NCT03379389|Methenamine|methenamine|mesh-list
15105688|NCT03379389|Acriflavine|acriflavine|mesh-list
15105689|NCT03379389|Methylene Blue|methylene blue|mesh-list
15105690|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105691|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105692|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105693|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15105694|NCT03379389|Renal Agents|renal agents|mesh-ancestor
15105695|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15105696|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15105697|NCT03377803|Cantharidin|cantharidin|mesh-list
15105698|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105699|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105700|NCT03283371|Natalizumab|natalizumab|mesh-list
15105701|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
15105702|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105703|NCT03257254|Polidocanol|polidocanol|mesh-list
15105704|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15105705|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15105706|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15105707|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
15105708|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
15105709|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105710|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
15105711|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15105712|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15105713|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
15105714|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105715|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105716|NCT03153319|Adalimumab|adalimumab|mesh-list
15105717|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105718|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105719|NCT03084718|Beclomethasone|beclomethasone|mesh-list
15105720|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105721|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
15105722|NCT03084718|Hormones|hormones|mesh-ancestor
15105723|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105724|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105725|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15105726|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
15105727|NCT03059511|Nalbuphine|nalbuphine|mesh-list
15105728|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15105729|NCT03059511|Narcotics|narcotics|mesh-ancestor
15105730|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105731|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105732|NCT03059511|Analgesics|analgesics|mesh-ancestor
15105733|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
15105734|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105735|NCT03033303|Isotretinoin|isotretinoin|mesh-list
15105736|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
15105737|NCT02944578|Curcumin|curcumin|mesh-list
15105738|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15105739|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15105740|NCT02944578|Analgesics|analgesics|mesh-ancestor
15105741|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
15105742|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105743|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105744|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105745|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105746|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105747|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105748|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105749|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
15105750|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105751|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105752|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
15105753|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15105754|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15105755|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105756|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
15105757|NCT02866838|Coagulants|coagulants|mesh-ancestor
15105758|NCT02824679|Scopolamine|scopolamine|mesh-list
15105759|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15105760|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15105761|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
15105762|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
15105763|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105764|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105765|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105766|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
15105767|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15105768|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
15105769|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105770|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105771|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15105772|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
15105773|NCT02754141|Nivolumab|nivolumab|mesh-list
15105774|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105775|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105776|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15105777|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105778|NCT02684461|Paclitaxel|paclitaxel|mesh-list
15105779|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
15105780|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15105781|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105782|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105783|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105784|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105785|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105786|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105787|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15105788|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
15105789|NCT02445131|Idelalisib|idelalisib|mesh-list
15105790|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15105791|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
15105792|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105793|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105794|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105795|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105796|NCT02437318|Fulvestrant|fulvestrant|mesh-list
15105797|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15105798|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105799|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15105800|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15105801|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
15105802|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105803|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105804|NCT02422615|Fulvestrant|fulvestrant|mesh-list
15105805|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15105806|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105807|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13996174|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13996175|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
15105808|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15105809|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
15105810|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105811|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105812|NCT02259517|Guanfacine|guanfacine|mesh-list
15105813|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15105814|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15105815|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105816|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15105817|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15105818|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105819|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105820|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
15105821|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105822|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15105823|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15105824|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15105825|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15105826|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
15105827|NCT02209545|Pyridoxine|pyridoxine|mesh-list
15105828|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
15105829|NCT02209545|Misoprostol|misoprostol|mesh-list
15105830|NCT02209545|Vitamins|vitamins|mesh-ancestor
15105831|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
15105832|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105833|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15105834|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
15105835|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15105836|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15105837|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105838|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
15105839|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
15105840|NCT01796197|Paclitaxel|paclitaxel|mesh-list
15105841|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
15105842|NCT01796197|Doxorubicin|doxorubicin|mesh-list
15105843|NCT01796197|Trastuzumab|trastuzumab|mesh-list
15105844|NCT01796197|Pertuzumab|pertuzumab|mesh-list
15105845|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15105846|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105847|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105848|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105849|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105850|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105851|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105852|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
15105853|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105854|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105855|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15105856|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
15105857|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15105858|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15105859|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15105860|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15105861|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105862|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15105863|NCT01585805|Gemcitabine|gemcitabine|mesh-list
15105864|NCT01585805|Cisplatin|cisplatin|mesh-list
15105865|NCT01585805|Veliparib|veliparib|mesh-list
15105866|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105867|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15105868|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
15105869|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105870|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
15105871|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105872|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105873|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105874|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
15105875|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105876|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15105877|NCT01147822|Sunitinib|sunitinib|mesh-list
15105878|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105879|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15105880|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15105881|NCT01147822|Growth Substances|growth substances|mesh-ancestor
15105882|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105883|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
15105884|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15105885|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105886|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105887|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
15105888|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105889|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
15105890|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105891|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105892|NCT00695279|Vaccines|vaccines|mesh-list
15105893|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
15105894|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105895|NCT00521846|Cimetidine|cimetidine|mesh-list
15105896|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15105897|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105898|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15105899|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
15105900|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
15105901|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105902|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105903|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105904|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15105905|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15105906|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105907|NCT00328653|Cyclosporine|cyclosporine|mesh-list
15105908|NCT00328653|Cyclosporins|cyclosporins|mesh-list
15105909|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105910|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105911|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105912|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
15105913|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105914|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
15105915|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15105916|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
15105917|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105918|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15105919|NCT05159050|Paclitaxel|paclitaxel|mesh-list
14269216|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269217|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269218|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
14269219|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269220|NCT00401830|Lacosamide|lacosamide|mesh-list
14269221|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
14269222|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14269223|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14269224|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292377|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15105920|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15105921|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105922|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
15105923|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
15105924|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
15105925|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105926|NCT05158777|Vaccines|vaccines|mesh-list
15105927|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
15105928|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175441|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175442|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15175443|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175444|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175445|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175446|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15175447|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175448|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175449|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
15175450|NCT03986996|Amoxicillin|amoxicillin|mesh-list
15175451|NCT03986996|Metronidazole|metronidazole|mesh-list
15175452|NCT03986996|Doxycycline|doxycycline|mesh-list
15175453|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15175454|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175455|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15105929|NCT05158699|Dexamethasone|dexamethasone|mesh-list
15105930|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
15105931|NCT05158699|Triamcinolone|triamcinolone|mesh-list
15105932|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15105933|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15105934|NCT05158699|Ketorolac|ketorolac|mesh-list
15105935|NCT05158699|Bromfenac|bromfenac|mesh-list
15105936|NCT05158699|Phenylephrine|phenylephrine|mesh-list
15105937|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15105938|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15105939|NCT05158699|BB 1101|bb 1101|mesh-list
15105940|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15105941|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15105942|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
15105943|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
15105944|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105945|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105946|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105947|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
15105948|NCT05158699|Hormones|hormones|mesh-ancestor
15105949|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15105950|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15105951|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15105952|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
15105953|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15105954|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105955|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15105956|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
15105957|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15105958|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15105959|NCT05158699|Analgesics|analgesics|mesh-ancestor
15105960|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
15105961|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15105962|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15105963|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15105964|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
15105965|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
15105966|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15105967|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
15105968|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
15105969|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15105970|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15105971|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15105972|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
15105973|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15105974|NCT05158699|Protective Agents|protective agents|mesh-ancestor
15105975|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
15105976|NCT05158647|Analgesics|analgesics|mesh-ancestor
15105977|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
15105978|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15105979|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105980|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
15105981|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105982|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15105983|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
15105984|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15105985|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15105986|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15105987|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15105988|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
15105989|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15105990|NCT05158517|Vedolizumab|vedolizumab|mesh-list
15105991|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15105992|NCT05158426|Propofol|propofol|mesh-list
15105993|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15105994|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15105995|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15105996|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15105997|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
15105998|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
15105999|NCT05158348|Lidocaine|lidocaine|mesh-list
15106000|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
15106001|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
15106002|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
15106003|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106004|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106005|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
15106006|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106007|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15106008|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15106009|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15106010|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106011|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106012|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15106013|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15106014|NCT05158348|Analgesics|analgesics|mesh-ancestor
15106015|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15106016|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15106017|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15106018|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
15106019|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106020|NCT05157893|Analgesics|analgesics|mesh-list
15106021|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
15106022|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106023|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106024|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
15106025|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15106026|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
15106027|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106028|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106029|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
15106030|NCT05157711|Phenylephrine|phenylephrine|mesh-list
15106031|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
15106032|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
15106033|NCT05157711|Bismuth|bismuth|mesh-list
15106034|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15106035|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
15106036|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
15106037|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106038|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106039|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
15106040|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15106041|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
15106042|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
15106043|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15106044|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15106045|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15106046|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
15106047|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106048|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106049|NCT05157711|Protective Agents|protective agents|mesh-ancestor
15106050|NCT05157711|Antacids|antacids|mesh-ancestor
15106051|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15106052|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106053|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
15106054|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15106055|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106056|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
15106057|NCT05157711|Coagulants|coagulants|mesh-ancestor
15106058|NCT05157581|Methoxsalen|methoxsalen|mesh-list
15106059|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15106060|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106061|NCT05157542|Paclitaxel|paclitaxel|mesh-list
15106062|NCT05157542|Durvalumab|durvalumab|mesh-list
15106063|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15106064|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15106065|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106066|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
15106067|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
15106068|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
15106069|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106070|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106071|NCT05157360|Vitamins|vitamins|mesh-list
15106072|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
15106073|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
15106074|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106075|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15106076|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15106077|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15106078|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15106079|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106080|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106081|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15106082|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106083|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106084|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
15106085|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106086|NCT05080946|Aspirin|aspirin|mesh-list
15106087|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15106088|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15106089|NCT05080946|Analgesics|analgesics|mesh-ancestor
15106090|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
15106091|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106092|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106093|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15106094|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106095|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15106096|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15106097|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106098|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15106099|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15106100|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106101|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
15106102|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
15106103|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
15106104|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106105|NCT05079126|Protective Agents|protective agents|mesh-ancestor
15106106|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106107|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15106108|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106109|NCT05076253|Ivermectin|ivermectin|mesh-list
15106110|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15106111|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106112|NCT05071183|Trametinib|trametinib|mesh-list
15106113|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106114|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15106115|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106116|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106117|NCT05022563|Warfarin|warfarin|mesh-list
15106118|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
15106119|NCT05022563|Dabigatran|dabigatran|mesh-list
15106120|NCT05022563|Apixaban|apixaban|mesh-list
15106121|NCT05022563|Edoxaban|edoxaban|mesh-list
15106122|NCT05022563|Anticoagulants|anticoagulants|mesh-list
15106123|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15106124|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
15106125|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15106126|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
15106127|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106128|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106129|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
15106130|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106131|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106132|NCT04983498|Ondansetron|ondansetron|mesh-list
15106133|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
15106134|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
15106135|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106136|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106137|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15106138|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
15106139|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106140|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15106141|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
15106142|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106143|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106144|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15106145|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15106146|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106147|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15106148|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15106149|NCT04963439|Macitentan|macitentan|mesh-list
15106150|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15106151|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15106152|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106153|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15106154|NCT04947592|Fluconazole|fluconazole|mesh-list
15106155|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
15106156|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175456|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15106157|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15106158|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15106159|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106160|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106161|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15106162|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
15106163|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15106164|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106165|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15106166|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15106167|NCT04865939|Gemcitabine|gemcitabine|mesh-list
15106168|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106169|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
15106170|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106171|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106172|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
15106173|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106174|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106175|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106176|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
15106177|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106178|NCT04831892|Isosorbide|isosorbide|mesh-list
15106179|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15106180|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15106181|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15106182|NCT04831892|Diuretics|diuretics|mesh-ancestor
15106183|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
15106184|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106185|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
15106186|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15106187|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175457|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
15175458|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
15175459|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
15175460|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15175461|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175462|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175463|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175464|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15175465|NCT03986905|Scopolamine|scopolamine|mesh-list
15175466|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15175467|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15175468|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
15175469|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
15175470|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175471|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175472|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15175473|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
15175474|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15175475|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
15175476|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175477|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175478|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15175479|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
15175480|NCT03986515|Apatinib|apatinib|mesh-list
15175481|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175482|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15175483|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175484|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175485|NCT03986268|Vitamin D|vitamin d|mesh-list
15175486|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
15175487|NCT03986268|Vitamins|vitamins|mesh-ancestor
15175488|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
15175489|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175490|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15175491|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15175492|NCT03986385|Capecitabine|capecitabine|mesh-list
15175493|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
15175494|NCT03986385|Apatinib|apatinib|mesh-list
15175495|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15175496|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
15175497|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175498|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175499|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15106188|NCT04761627|Ustekinumab|ustekinumab|mesh-list
15106189|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106190|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
15106191|NCT04761614|Leucovorin|leucovorin|mesh-list
15106192|NCT04761614|Folic Acid|folic acid|mesh-list
15106193|NCT04761614|Bevacizumab|bevacizumab|mesh-list
15106194|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15106195|NCT04761614|Fluorouracil|fluorouracil|mesh-list
15106196|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
15106197|NCT04761614|Riluzole|riluzole|mesh-list
15106198|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
15106199|NCT04761614|Antibodies|antibodies|mesh-list
15106200|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
15106201|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15106202|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
15106203|NCT04761614|Calcium|calcium|mesh-list
15106204|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
15106205|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106206|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15106207|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15106208|NCT04761614|Growth Substances|growth substances|mesh-ancestor
15106209|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106210|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
15106211|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
15106212|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15106213|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15106214|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
15106215|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106216|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106217|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106218|NCT04761614|Antidotes|antidotes|mesh-ancestor
15106219|NCT04761614|Protective Agents|protective agents|mesh-ancestor
15106220|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
15106221|NCT04761614|Vitamins|vitamins|mesh-ancestor
15106222|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
15106223|NCT04761614|Hematinics|hematinics|mesh-ancestor
15106224|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
15106225|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15106226|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15106227|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106228|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15106229|NCT04694248|Aspirin|aspirin|mesh-list
15106230|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
15106231|NCT04694248|Anticoagulants|anticoagulants|mesh-list
15106232|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15106233|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15106234|NCT04694248|Analgesics|analgesics|mesh-ancestor
15106235|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
15106236|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106237|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106238|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15106239|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106240|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15106241|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15106242|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106243|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15106244|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15106245|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106246|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
15106247|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15106248|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
15106249|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15106250|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
15106251|NCT04650152|Fenofibrate|fenofibrate|mesh-list
15106252|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15106253|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
15106254|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106255|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15106256|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15106257|NCT04631601|Androgens|androgens|mesh-list
15106258|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
14292378|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106259|NCT04631601|Hormones|hormones|mesh-ancestor
15106260|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15106261|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106262|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106263|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106264|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
15106265|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
15106266|NCT04615624|Furosemide|furosemide|mesh-list
15106267|NCT04615624|Diuretics|diuretics|mesh-ancestor
15106268|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
15106269|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106270|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15106271|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106272|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106273|NCT04608955|Bedaquiline|bedaquiline|mesh-list
15106274|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
15106275|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15106276|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106277|NCT04579783|Triamcinolone|triamcinolone|mesh-list
15106278|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15106279|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15106280|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15106281|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15106282|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
15106283|NCT04579783|Hormones|hormones|mesh-ancestor
15106284|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15106285|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106286|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106287|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
15106288|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106289|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106290|NCT04559347|Bupivacaine|bupivacaine|mesh-list
15106291|NCT04559347|Ropivacaine|ropivacaine|mesh-list
15106292|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
15106293|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
15106294|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106295|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106296|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
15106297|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106298|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
15106299|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
15106300|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15106301|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15106302|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106303|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106304|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106305|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106306|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
15106307|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15106308|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15106309|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106310|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
15106311|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106312|NCT04345861|Azithromycin|azithromycin|mesh-list
15106313|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
15106314|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15106315|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106316|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
15106317|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15106318|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15106319|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106320|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106321|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106322|NCT04278404|Metformin|metformin|mesh-list
15106323|NCT04278404|Interferons|interferons|mesh-list
15106324|NCT04278404|Ritonavir|ritonavir|mesh-list
15106325|NCT04278404|Ribavirin|ribavirin|mesh-list
15106326|NCT04278404|Lopinavir|lopinavir|mesh-list
15106327|NCT04278404|Oseltamivir|oseltamivir|mesh-list
15106328|NCT04278404|Remdesivir|remdesivir|mesh-list
15106329|NCT04278404|Azithromycin|azithromycin|mesh-list
15106330|NCT04278404|Clindamycin|clindamycin|mesh-list
15106331|NCT04278404|Meropenem|meropenem|mesh-list
15106332|NCT04278404|Voriconazole|voriconazole|mesh-list
15106333|NCT04278404|Ceftazidime|ceftazidime|mesh-list
15106334|NCT04278404|Fosfomycin|fosfomycin|mesh-list
15106335|NCT04278404|Cefepime|cefepime|mesh-list
15106336|NCT04278404|Cefdinir|cefdinir|mesh-list
15106337|NCT04278404|Dexamethasone|dexamethasone|mesh-list
15106338|NCT04278404|Budesonide|budesonide|mesh-list
15106339|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
15106340|NCT04278404|Colchicine|colchicine|mesh-list
15106341|NCT04278404|Amiodarone|amiodarone|mesh-list
15106342|NCT04278404|Bosentan|bosentan|mesh-list
15106343|NCT04278404|Guanfacine|guanfacine|mesh-list
15106344|NCT04278404|Labetalol|labetalol|mesh-list
15106345|NCT04278404|Nicardipine|nicardipine|mesh-list
15106346|NCT04278404|Nifedipine|nifedipine|mesh-list
15106347|NCT04278404|Milrinone|milrinone|mesh-list
15106348|NCT04278404|Furosemide|furosemide|mesh-list
15106349|NCT04278404|Spironolactone|spironolactone|mesh-list
15106350|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
15106351|NCT04278404|Oxycodone|oxycodone|mesh-list
15106352|NCT04278404|Gabapentin|gabapentin|mesh-list
15106353|NCT04278404|Nalbuphine|nalbuphine|mesh-list
15106354|NCT04278404|Clobazam|clobazam|mesh-list
15106355|NCT04278404|Zolpidem|zolpidem|mesh-list
15106356|NCT04278404|Risperidone|risperidone|mesh-list
15106357|NCT04278404|Amphetamine|amphetamine|mesh-list
15106358|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
15106359|NCT04278404|Sertraline|sertraline|mesh-list
15106360|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
15106361|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
15106362|NCT04278404|Terbutaline|terbutaline|mesh-list
15106363|NCT04278404|Sevelamer|sevelamer|mesh-list
15106364|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15106365|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
15106366|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
15106367|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106368|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106369|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15106370|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
15106371|NCT04278404|Hormones|hormones|mesh-ancestor
15106372|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15106373|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15106374|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106375|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
15106376|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106377|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106378|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15106379|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
15106380|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106381|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15106382|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106383|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15106384|NCT04278404|Analgesics|analgesics|mesh-ancestor
15106385|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
15106386|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15106387|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15106388|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15106389|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
15106390|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106391|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106392|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15106393|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15106394|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15106395|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15106396|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15106397|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15106398|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15106399|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15106400|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
15106401|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15106402|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15106403|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
15106404|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15106405|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15106406|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
15106407|NCT04278404|Coagulants|coagulants|mesh-ancestor
15106408|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15106409|NCT04278404|Narcotics|narcotics|mesh-ancestor
15106410|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15106411|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
15106412|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15106413|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15106414|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15106415|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15106416|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
15106417|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
15106418|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15106419|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15106420|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15106421|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
15106422|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
15106423|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15106424|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15106425|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106426|NCT04278404|Diuretics|diuretics|mesh-ancestor
15106427|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
15106428|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15106429|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15106430|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
15106431|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15106432|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
15106433|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
15106434|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
15106435|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
15106436|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15106437|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15106438|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15106439|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
15106440|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
15106441|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15106442|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
15106443|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15106444|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15106445|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15106446|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15106447|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
15106448|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
15106449|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15106450|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15106451|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15106452|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15106453|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15106454|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15106455|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15106456|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
15106457|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15106458|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15106459|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15106460|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15106461|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
15106462|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
15106463|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15106464|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15106465|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15106466|NCT04278404|Protective Agents|protective agents|mesh-ancestor
15106467|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15106468|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15106469|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15106470|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15106471|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15106472|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15106473|NCT04266379|Insulin|insulin|mesh-list
15106474|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15106475|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15106476|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106477|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
15106478|NCT04240093|Narcotics|narcotics|mesh-ancestor
15106479|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106480|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106481|NCT04240093|Analgesics|analgesics|mesh-ancestor
15106482|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
15106483|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106484|NCT04234477|Metoprolol|metoprolol|mesh-list
15106485|NCT04234477|Verapamil|verapamil|mesh-list
15106486|NCT04234477|Diltiazem|diltiazem|mesh-list
15106487|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
15106488|NCT04234477|Calcium|calcium|mesh-list
15106489|NCT04234477|Esmolol|esmolol|mesh-list
15106490|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15106491|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15106492|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106493|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15106494|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15106495|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
15106496|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
15106497|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106498|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15106499|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15106500|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
15106501|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106502|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106503|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106504|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
15106505|NCT04217967|Lenalidomide|lenalidomide|mesh-list
15106506|NCT04217967|Ixazomib|ixazomib|mesh-list
15106507|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
15106508|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106509|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15106510|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15106511|NCT04217967|Growth Substances|growth substances|mesh-ancestor
15106512|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
15106513|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106514|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
15106515|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106516|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106517|NCT04156698|Docetaxel|docetaxel|mesh-list
15106518|NCT04156698|Capecitabine|capecitabine|mesh-list
15106519|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106520|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
15106521|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
15106522|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
15106523|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106524|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106525|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
15106526|NCT04046614|Nivolumab|nivolumab|mesh-list
15106527|NCT04046614|Nintedanib|nintedanib|mesh-list
15106528|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106529|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106530|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15106531|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106532|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15106533|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175500|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175501|NCT03986294|Leucovorin|leucovorin|mesh-list
15175502|NCT03986294|Antidotes|antidotes|mesh-ancestor
15175503|NCT03986294|Protective Agents|protective agents|mesh-ancestor
15175504|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175505|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
15175506|NCT03986294|Vitamins|vitamins|mesh-ancestor
15175507|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
15175508|NCT03986073|Linagliptin|linagliptin|mesh-list
15175509|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15175510|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175511|NCT03986073|Incretins|incretins|mesh-ancestor
15175512|NCT03986073|Hormones|hormones|mesh-ancestor
15175513|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175514|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15175515|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
15175516|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175517|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175518|NCT03985891|Antibodies|antibodies|mesh-list
15175519|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15175520|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
15175521|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175522|NCT03986008|Liraglutide|liraglutide|mesh-list
15175523|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15175524|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175525|NCT03986008|Incretins|incretins|mesh-ancestor
15175526|NCT03986008|Hormones|hormones|mesh-ancestor
15175527|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175528|NCT03985969|Indomethacin|indomethacin|mesh-list
15175529|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15175530|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175531|NCT03985969|Analgesics|analgesics|mesh-ancestor
15175532|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
15175533|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175534|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175535|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175536|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175537|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
15175538|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
15175539|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15175540|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15175541|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106534|NCT03916185|Vaccines|vaccines|mesh-list
15106535|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
15106536|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106537|NCT03915860|Trifarotene|trifarotene|mesh-list
15106538|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106539|NCT03852901|Empagliflozin|empagliflozin|mesh-list
15106540|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15106541|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106542|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15106543|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106544|NCT03795233|Vancomycin|vancomycin|mesh-list
15106545|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15106546|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106547|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
15106548|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
15106549|NCT03783091|Hematinics|hematinics|mesh-ancestor
15106550|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
15106551|NCT03783091|Vitamins|vitamins|mesh-ancestor
15106552|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
15106553|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106554|NCT03770286|Fluorides|fluorides|mesh-list
15106555|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
15106556|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
15106557|NCT03770286|Protective Agents|protective agents|mesh-ancestor
15106558|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106559|NCT03769376|Salvin|salvin|mesh-list
15106560|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15106561|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106562|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
15106563|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106564|NCT03769376|Protective Agents|protective agents|mesh-ancestor
15106565|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106566|NCT03683251|Ranibizumab|ranibizumab|mesh-list
15106567|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15106568|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15106569|NCT03683251|Growth Substances|growth substances|mesh-ancestor
15106570|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106571|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
15106572|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106573|NCT03645863|Iron|iron|mesh-list
15106574|NCT03645863|Trace Elements|trace elements|mesh-ancestor
15106575|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
15106576|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106577|NCT03565991|Avelumab|avelumab|mesh-list
15106578|NCT03565991|Talazoparib|talazoparib|mesh-list
15106579|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106580|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106581|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15106582|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106583|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106584|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15106585|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106586|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15106587|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106588|NCT03476369|Fentanyl|fentanyl|mesh-list
15106589|NCT03476369|Ticagrelor|ticagrelor|mesh-list
15106590|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15106591|NCT03476369|Narcotics|narcotics|mesh-ancestor
15106592|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106593|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106594|NCT03476369|Analgesics|analgesics|mesh-ancestor
15106595|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
15106596|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106597|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15106598|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15106599|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
15106600|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
15106601|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15106602|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15106603|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15106604|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15106605|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
15106606|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106607|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106608|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
15106609|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15106610|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15106611|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106612|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15106613|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106614|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15106615|NCT03423355|Diuretics|diuretics|mesh-ancestor
15106616|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
15106617|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15106618|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106619|NCT03365635|Ribavirin|ribavirin|mesh-list
15106620|NCT03365635|Grazoprevir|grazoprevir|mesh-list
15106621|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
15106622|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
15106623|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106624|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
15106625|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106626|NCT03324373|Everolimus|everolimus|mesh-list
15106627|NCT03324373|Lenvatinib|lenvatinib|mesh-list
15106628|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106629|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106630|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
15106631|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106632|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15106633|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106634|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106635|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
15106636|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106637|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106638|NCT03254667|Brodalumab|brodalumab|mesh-list
15106639|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106640|NCT03238534|Omeprazole|omeprazole|mesh-list
15106641|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15106642|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15106643|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15106644|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106645|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106646|NCT03223350|Capsaicin|capsaicin|mesh-list
15106647|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
15106648|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106649|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
15106650|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106651|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106652|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
15106653|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106654|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106655|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
15106656|NCT03193931|Methotrexate|methotrexate|mesh-list
15106657|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106658|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106659|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15106660|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
15106661|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15106662|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106663|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106664|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
15106665|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106666|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106667|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106668|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15106669|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106670|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
15106671|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106672|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15106673|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
15106674|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106675|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106676|NCT03181529|Psilocybin|psilocybin|mesh-list
15106677|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
15106678|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106679|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15106680|NCT03164928|Denosumab|denosumab|mesh-list
15106681|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15106682|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106683|NCT03043729|Leucovorin|leucovorin|mesh-list
15106684|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
15106685|NCT03043729|Aflibercept|aflibercept|mesh-list
15106686|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106687|NCT03043729|Antidotes|antidotes|mesh-ancestor
15106688|NCT03043729|Protective Agents|protective agents|mesh-ancestor
15106689|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106690|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
15106691|NCT03043729|Vitamins|vitamins|mesh-ancestor
15106692|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
15106693|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15106694|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15106695|NCT03043729|Growth Substances|growth substances|mesh-ancestor
15106696|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
15106697|NCT02973789|Docetaxel|docetaxel|mesh-list
15106698|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15106699|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106700|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
15106701|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
15106702|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
15106703|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106704|NCT02932475|Metformin|metformin|mesh-list
15106705|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15106706|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106707|NCT02914938|Rituximab|rituximab|mesh-list
15106708|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
15106709|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15106710|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106711|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
15106712|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106713|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106714|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15106715|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106716|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106717|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15106718|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
15106719|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106720|NCT02891538|Protective Agents|protective agents|mesh-ancestor
15106721|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106722|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15106723|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15106724|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106725|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15106726|NCT02840136|Meropenem|meropenem|mesh-list
15106727|NCT02840136|Tazobactam|tazobactam|mesh-list
15106728|NCT02840136|Piperacillin|piperacillin|mesh-list
15106729|NCT02840136|Ceftazidime|ceftazidime|mesh-list
15106730|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15106731|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15106732|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106733|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15106734|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106735|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106736|NCT02820961|Exemestane|exemestane|mesh-list
15106737|NCT02820961|Entinostat|entinostat|mesh-list
15106738|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106739|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15106740|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15106741|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106742|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106743|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15106744|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
15106745|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15106746|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106747|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15106748|NCT02804932|Methamphetamine|methamphetamine|mesh-list
15106749|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15106750|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106751|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
15106752|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
15106753|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106754|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
15106755|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106756|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106757|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
15106758|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15106759|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15106760|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106761|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15175542|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175543|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
15175544|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15175545|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15175546|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15175547|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15175548|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175549|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
15175550|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175551|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175552|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15175553|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181585|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181586|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15181587|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15181588|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181589|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15181590|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15181591|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15181592|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15181593|NCT03928262|Benralizumab|benralizumab|mesh-list
15181594|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15181595|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
15181596|NCT03928275|Aldesleukin|aldesleukin|mesh-list
15181597|NCT03928275|Interleukin-2|interleukin-2|mesh-list
15181598|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
15181599|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181600|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181601|NCT03928275|Analgesics|analgesics|mesh-ancestor
15181602|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
15181603|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181604|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181605|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15181606|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15181607|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
15181608|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181609|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15181610|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
15181611|NCT03928288|Cabergoline|cabergoline|mesh-list
15181612|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15181613|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15181614|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
15181615|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
15181616|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181617|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181618|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181619|NCT03928210|Digoxin|digoxin|mesh-list
15181620|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15181621|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15181622|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181623|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181624|NCT03928210|Protective Agents|protective agents|mesh-ancestor
15181625|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181626|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
15181627|NCT03927963|Propofol|propofol|mesh-list
15181628|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15181629|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181630|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181631|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15181632|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
15181633|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
15181634|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181635|NCT03927963|Analgesics|analgesics|mesh-ancestor
15181636|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
15181637|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181638|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15181639|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15181640|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15106762|NCT02722941|Panobinostat|panobinostat|mesh-list
15106763|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106764|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15106765|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106766|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106767|NCT02704390|Methylphenidate|methylphenidate|mesh-list
15106768|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15106769|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106770|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15106771|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15106772|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15106773|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106774|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
15106775|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106776|NCT02643381|Ketamine|ketamine|mesh-list
15106777|NCT02643381|Etomidate|etomidate|mesh-list
15106778|NCT02643381|Analgesics|analgesics|mesh-ancestor
15106779|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
15106780|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106781|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106782|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15106783|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15106784|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
15106785|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
15106786|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106787|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15106788|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15106789|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15106790|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106791|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15106792|NCT02603900|Bupivacaine|bupivacaine|mesh-list
15106793|NCT02603900|Ropivacaine|ropivacaine|mesh-list
15106794|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
15106795|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
15106796|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15106797|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106798|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
15106799|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106800|NCT02595372|Omeprazole|omeprazole|mesh-list
15106801|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15106802|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15106803|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15106804|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106805|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106806|NCT02334722|Levetiracetam|levetiracetam|mesh-list
15106807|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
15106808|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
15106809|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
15106810|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
15106811|NCT02251821|Melphalan|melphalan|mesh-list
15106812|NCT02251821|Busulfan|busulfan|mesh-list
15106813|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
15106814|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15106815|NCT02251821|Methotrexate|methotrexate|mesh-list
15106816|NCT02251821|Fludarabine|fludarabine|mesh-list
15106817|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
15106818|NCT02251821|Tacrolimus|tacrolimus|mesh-list
15106819|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106820|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
15106821|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106822|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106823|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15106824|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
15106825|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106826|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106827|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15106828|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15106829|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
15106830|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15106831|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106832|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
15106833|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106834|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106835|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15106836|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15106837|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15106838|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15106839|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15106840|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
15106841|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15106842|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106843|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
15106844|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106845|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
15106846|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106847|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106848|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15106849|NCT01952288|Simvastatin|simvastatin|mesh-list
15106850|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15106851|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15106852|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
15106853|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106854|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15106855|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15106856|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106857|NCT01858740|Methotrexate|methotrexate|mesh-list
15106858|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
15106859|NCT01858740|Fludarabine|fludarabine|mesh-list
15106860|NCT01858740|Thiotepa|thiotepa|mesh-list
15106861|NCT01858740|Tacrolimus|tacrolimus|mesh-list
15106862|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15106863|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
15106864|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15106865|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106866|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106867|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
15106868|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106869|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106870|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106871|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106872|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15106873|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106874|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
15106875|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106876|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15106877|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15106878|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15106879|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
15106880|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15106881|NCT01846663|Rifaximin|rifaximin|mesh-list
15106882|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15106883|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106884|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15106885|NCT01844518|Abatacept|abatacept|mesh-list
15106886|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15106887|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106888|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106889|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106890|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
15106891|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106892|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106893|NCT01717586|Pravastatin|pravastatin|mesh-list
15106894|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15106895|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15106896|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
15106897|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106898|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15106899|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15106900|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106901|NCT01398839|Riboflavin|riboflavin|mesh-list
15106902|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
15106903|NCT01398839|Vitamins|vitamins|mesh-ancestor
15106904|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
15106905|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106906|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15106907|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106908|NCT01349959|Azacitidine|azacitidine|mesh-list
15106909|NCT01349959|Entinostat|entinostat|mesh-list
15106910|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15106911|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106912|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
15106913|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106914|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106915|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106916|NCT01331018|Plerixafor|plerixafor|mesh-list
15106917|NCT01331018|Prednisone|prednisone|mesh-list
15106918|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
15106919|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15106920|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15106921|NCT01331018|Prednisolone|prednisolone|mesh-list
15106922|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
15106923|NCT01331018|Cortisone|cortisone|mesh-list
15106924|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15106925|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
15106926|NCT01331018|Lenograstim|lenograstim|mesh-list
15106927|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15106928|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
15106929|NCT01331018|Hormones|hormones|mesh-ancestor
15106930|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15106931|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106932|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15106933|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106934|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15106935|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
15106936|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
15106937|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
15106938|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15106939|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15106940|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15106941|NCT01331018|Protective Agents|protective agents|mesh-ancestor
15106942|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15106943|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15106944|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
15106945|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15106946|NCT01327781|Tamoxifen|tamoxifen|mesh-list
15106947|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15106948|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
15106949|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15106950|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106951|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15106952|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106953|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15106954|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15106955|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15106956|NCT01281176|Paclitaxel|paclitaxel|mesh-list
15106957|NCT01281176|Carboplatin|carboplatin|mesh-list
15106958|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15106959|NCT01281176|Vorinostat|vorinostat|mesh-list
15106960|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14269225|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269226|NCT00401843|Dexamethasone|dexamethasone|mesh-list
14269227|NCT00401843|Bortezomib|bortezomib|mesh-list
14269228|NCT00401843|Siltuximab|siltuximab|mesh-list
14269229|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269230|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
14269231|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
14269232|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269233|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269234|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269235|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
14269236|NCT00401843|Hormones|hormones|mesh-ancestor
14269237|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269238|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14269239|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269240|NCT00401882|Metoprolol|metoprolol|mesh-list
14269241|NCT00401882|Epinephrine|epinephrine|mesh-list
14269242|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14269243|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14269244|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14269245|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269246|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106961|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106962|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
15106963|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
15106964|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
15106965|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106966|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15106967|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106968|NCT01168219|Methotrexate|methotrexate|mesh-list
15106969|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
15106970|NCT01168219|Azacitidine|azacitidine|mesh-list
15106971|NCT01168219|Fludarabine|fludarabine|mesh-list
15106972|NCT01168219|Busulfan|busulfan|mesh-list
15106973|NCT01168219|Tacrolimus|tacrolimus|mesh-list
15106974|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15106975|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15106976|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
15106977|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15106978|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15106979|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15106980|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
15106981|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15106982|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15106983|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
15106984|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15106985|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15106986|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15106987|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
15106988|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15106989|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15106990|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15106991|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
15106992|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15106993|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15106994|NCT01081262|Paclitaxel|paclitaxel|mesh-list
15106995|NCT01081262|Bevacizumab|bevacizumab|mesh-list
15106996|NCT01081262|Carboplatin|carboplatin|mesh-list
15106997|NCT01081262|Capecitabine|capecitabine|mesh-list
15106998|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
15106999|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15107000|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15107001|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
15107002|NCT01081262|Antibodies|antibodies|mesh-list
15107003|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
15107004|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15107005|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
15107006|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15107007|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107008|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
15107009|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
15107010|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
15107011|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107012|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15107013|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15107014|NCT01081262|Growth Substances|growth substances|mesh-ancestor
15107015|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107016|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
15107017|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
15107018|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107019|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
15107020|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
15107021|NCT01023737|Vorinostat|vorinostat|mesh-list
15107022|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
15107023|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15107024|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15107025|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107026|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107027|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107028|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107029|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107030|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15107031|NCT00741988|Bevacizumab|bevacizumab|mesh-list
15107032|NCT00741988|Carboplatin|carboplatin|mesh-list
15107033|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107034|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107035|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15107036|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15107037|NCT00741988|Growth Substances|growth substances|mesh-ancestor
15107038|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107039|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
15107040|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
15107041|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15107042|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107043|NCT00568997|Analgesics|analgesics|mesh-ancestor
15107044|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
15107045|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107046|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107047|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107048|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107049|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
15107050|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107051|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
15107052|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15107053|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107054|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107055|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15107056|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
15107057|NCT00563576|Estradiol|estradiol|mesh-list
15107058|NCT00563576|Estrogens|estrogens|mesh-ancestor
15107059|NCT00563576|Hormones|hormones|mesh-ancestor
15107060|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107061|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107062|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15107063|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
15107064|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15107065|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15107066|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15107067|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15107068|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15107069|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15107070|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15107071|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107072|NCT00455403|Chloroquine|chloroquine|mesh-list
15107073|NCT00455403|Amebicides|amebicides|mesh-ancestor
15107074|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15107075|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15107076|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107077|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
15107078|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107079|NCT00238420|Paclitaxel|paclitaxel|mesh-list
15107080|NCT00238420|Trastuzumab|trastuzumab|mesh-list
15107081|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15107082|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15107083|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15107084|NCT00238420|Antibodies|antibodies|mesh-list
14269247|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269248|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14269249|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14269250|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
14269251|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269252|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14269253|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
14269254|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
14269255|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
14269256|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15107085|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
15107086|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15107087|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15107088|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107089|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
15107090|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
15107091|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
15107092|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107093|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
15107094|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107095|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15107096|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15107097|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
15107098|NCT05160623|Povidone|povidone|mesh-list
15107099|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
15107100|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
15107101|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15107102|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107103|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
15107104|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269257|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14269258|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15107105|NCT05160493|Pregabalin|pregabalin|mesh-list
15107106|NCT05160493|Ketamine|ketamine|mesh-list
15107107|NCT05160493|Esketamine|esketamine|mesh-list
15107108|NCT05160493|Analgesics|analgesics|mesh-ancestor
15107109|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
15107110|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107111|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107112|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15107113|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15107114|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
15107115|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
15107116|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15107117|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15107118|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15107119|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107120|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107121|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
15107122|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15107123|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15107124|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15107125|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15107126|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15107127|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15107128|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
15107129|NCT05160298|Ropivacaine|ropivacaine|mesh-list
15107130|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
15107131|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
15107132|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15107133|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107134|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
15107135|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107136|NCT05160285|Nivolumab|nivolumab|mesh-list
15107137|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107138|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107139|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15107140|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107141|NCT05160220|Psilocybin|psilocybin|mesh-list
15107142|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
15107143|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107144|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15107145|NCT05160090|Bupropion|bupropion|mesh-list
15107146|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15107147|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
15107148|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15107149|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15107150|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15107151|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15107152|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107153|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
15107154|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107155|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107156|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15107157|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15107158|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107159|NCT05160051|FAPI-46|fapi-46|mesh-list
15107160|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15107161|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175554|NCT03985865|Quinine|quinine|mesh-list
15175555|NCT03985865|Denatonium|denatonium|mesh-list
15175556|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
15175557|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15175558|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15175559|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175560|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15175561|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175562|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15181641|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
15107162|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
15107163|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15107164|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107165|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15107166|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107167|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15107168|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15107169|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15107170|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15107171|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107172|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
15107173|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107174|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107175|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
15107176|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15107177|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107178|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15107179|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107180|NCT05159674|Analgesics|analgesics|mesh-ancestor
15107181|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
15107182|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107183|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15107184|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15107185|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15107186|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
15107187|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107188|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107189|NCT05159531|Tenofovir|tenofovir|mesh-list
15107190|NCT05159531|Emtricitabine|emtricitabine|mesh-list
15107191|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
15107192|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107193|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15107194|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15107195|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107196|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107197|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15107198|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15107199|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
15107200|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
15107201|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
15107202|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107203|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15107204|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
15107205|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107206|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
15107207|NCT05159284|Protective Agents|protective agents|mesh-ancestor
15107208|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15107209|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15107210|NCT05159219|Colchicine|colchicine|mesh-list
15107211|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
15107212|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107213|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
15107214|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
15107215|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
15107216|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107217|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107218|NCT05157087|Omalizumab|omalizumab|mesh-list
15107219|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15107220|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15107221|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
15107222|NCT05150431|Parecoxib|parecoxib|mesh-list
15107223|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15107224|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15107225|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107226|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107227|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15107228|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107229|NCT05150431|Analgesics|analgesics|mesh-ancestor
15107230|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
15107231|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107232|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107233|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107234|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107235|NCT05146687|Bevacizumab|bevacizumab|mesh-list
15107236|NCT05146687|Ranibizumab|ranibizumab|mesh-list
15107237|NCT05146687|Aflibercept|aflibercept|mesh-list
15107238|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107239|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107240|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15107241|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15107242|NCT05146687|Growth Substances|growth substances|mesh-ancestor
15107243|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107244|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
15107245|NCT05142098|Dexamethasone|dexamethasone|mesh-list
15107246|NCT05142098|Etoricoxib|etoricoxib|mesh-list
15107247|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
15107248|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
15107249|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107250|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
15107251|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
15107252|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107253|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107254|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15107255|NCT05142098|Hormones|hormones|mesh-ancestor
15107256|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107257|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15107258|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107259|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15107260|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107261|NCT05142098|Analgesics|analgesics|mesh-ancestor
15107262|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
15107263|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107264|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15107265|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107266|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107267|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15107268|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15107269|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107270|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107271|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
15107272|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107273|NCT05141240|Palbociclib|palbociclib|mesh-list
15107274|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107275|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15107276|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107277|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107278|NCT05137080|Dexamethasone|dexamethasone|mesh-list
15107279|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107280|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
15107281|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
15107282|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107283|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107284|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15107285|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
15107286|NCT05137080|Hormones|hormones|mesh-ancestor
15107287|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107288|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15107289|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107290|NCT05124340|Vaccines|vaccines|mesh-list
15107291|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
15107292|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107293|NCT05117450|Heparin|heparin|mesh-list
15107294|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
15107295|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15107296|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15107297|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107298|NCT05116930|Atropine|atropine|mesh-list
15107299|NCT05116930|Neostigmine|neostigmine|mesh-list
15107300|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15107301|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15107302|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15107303|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
15107304|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107305|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107306|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15107307|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
15107308|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
15107309|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
15107310|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15107311|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15107312|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
15107313|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107314|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107315|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15107316|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107317|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15107318|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
15107319|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15107320|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15107321|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107322|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107323|NCT05111431|Analgesics|analgesics|mesh-ancestor
15107324|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
15107325|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107326|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15107327|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15107328|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15107329|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
15107330|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107331|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107332|NCT05096039|Valsartan|valsartan|mesh-list
15107333|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15107334|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15107335|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15107336|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15107337|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107338|NCT05070650|Acetaminophen|acetaminophen|mesh-list
15107339|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
15107340|NCT05070650|Phenylephrine|phenylephrine|mesh-list
15107341|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
15107342|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15107343|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107344|NCT05070650|Analgesics|analgesics|mesh-ancestor
15107345|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
15107346|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107347|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107348|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
15107349|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
15107350|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107351|NCT05070650|Expectorants|expectorants|mesh-ancestor
15107352|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
15107353|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15107354|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
15107355|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107356|NCT05070650|Protective Agents|protective agents|mesh-ancestor
15107357|NCT05070650|Antidotes|antidotes|mesh-ancestor
15107358|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15107359|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
15107360|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
15107361|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
15107362|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15107363|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
15107364|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15107365|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15107366|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15107367|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
15107368|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107369|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
15107370|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15107371|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107372|NCT05022472|Vaccines|vaccines|mesh-list
15107373|NCT05022472|Immunologic Factors|immunologic factors|mesh-ancestor
15107374|NCT05022472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107375|NCT05003453|Palmidrol|palmidrol|mesh-list
15107376|NCT05003453|Analgesics|analgesics|mesh-ancestor
15107377|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
15107378|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107379|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107380|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15107381|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107382|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107383|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107384|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
15107385|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107386|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15107387|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15107388|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107389|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107390|NCT05003453|Hormones|hormones|mesh-ancestor
15107391|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107392|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
15107393|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
15107394|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107395|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15107396|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107397|NCT04888377|Aspirin|aspirin|mesh-list
15107398|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15107399|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107400|NCT04888377|Analgesics|analgesics|mesh-ancestor
15107401|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
15107402|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107403|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107404|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107405|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107406|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15107407|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15107408|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107409|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15107410|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15107411|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107412|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
15107413|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
15107414|NCT04859582|Fluorouracil|fluorouracil|mesh-list
15107415|NCT04859582|Capecitabine|capecitabine|mesh-list
15107416|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
15107417|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107418|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107419|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
15107420|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107421|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107422|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107423|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
15107424|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175563|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175564|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175565|NCT03985865|Analgesics|analgesics|mesh-ancestor
15175566|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
15175567|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
15175568|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175569|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
15175570|NCT03985735|Anesthetics|anesthetics|mesh-list
15175571|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175572|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175573|NCT03985722|Trabectedin|trabectedin|mesh-list
15175574|NCT03985722|Olaratumab|olaratumab|mesh-list
15175575|NCT03985722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15175576|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15175577|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
15175578|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175579|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175580|NCT03985722|Immunologic Factors|immunologic factors|mesh-ancestor
15175581|NCT03985722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175582|NCT03985319|Esomeprazole|esomeprazole|mesh-list
15175583|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15175584|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15175585|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15175586|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175587|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175588|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
15175589|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15175590|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175591|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15175592|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15175593|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175594|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175595|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175596|NCT03985280|Anesthetics|anesthetics|mesh-list
15107425|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
15107426|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15107427|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
15107428|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15107429|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
15107430|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107431|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107432|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
15107433|NCT04713137|Erythritol|erythritol|mesh-list
15107434|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
15107435|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15107436|NCT04682847|Hematinics|hematinics|mesh-ancestor
15107437|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15107438|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15107439|NCT04622553|Mexiletine|mexiletine|mesh-list
15107440|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15107441|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15107442|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15107443|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15107444|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107445|NCT04557085|Cenobamate|cenobamate|mesh-list
15107446|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
15107447|NCT04524351|Phenserine|phenserine|mesh-list
15107448|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15107449|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107450|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107451|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
15107452|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107453|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107454|NCT04499677|Ritonavir|ritonavir|mesh-list
15107455|NCT04499677|Lopinavir|lopinavir|mesh-list
15107456|NCT04499677|Favipiravir|favipiravir|mesh-list
15107457|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15107458|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15107459|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
15107460|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107461|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107462|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15107463|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15107464|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
15107465|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107466|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15107467|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15107468|NCT04491526|Tamsulosin|tamsulosin|mesh-list
15107469|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15107470|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15107471|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15107472|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
15107473|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107474|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107475|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107476|NCT04491526|Urological Agents|urological agents|mesh-ancestor
15107477|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15107478|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107479|NCT04481113|Niraparib|niraparib|mesh-list
15107480|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15107481|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107482|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107483|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107484|NCT04478266|Letrozole|letrozole|mesh-list
15107485|NCT04478266|Palbociclib|palbociclib|mesh-list
15107486|NCT04478266|Goserelin|goserelin|mesh-list
15107487|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107488|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15107489|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15107490|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107491|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107492|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15107493|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
15107494|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107495|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107496|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15107497|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15107498|NCT04477343|Nivolumab|nivolumab|mesh-list
15107499|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107500|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107501|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15107502|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107503|NCT04452877|Trametinib|trametinib|mesh-list
15107504|NCT04452877|Dabrafenib|dabrafenib|mesh-list
15107505|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107506|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14269259|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
15107507|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107508|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107509|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
15107510|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
15107511|NCT04384692|Melphalan|melphalan|mesh-list
15107512|NCT04384692|Busulfan|busulfan|mesh-list
15107513|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
15107514|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15107515|NCT04384692|Methotrexate|methotrexate|mesh-list
15107516|NCT04384692|Fludarabine|fludarabine|mesh-list
15107517|NCT04384692|Tacrolimus|tacrolimus|mesh-list
15107518|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107519|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
15107520|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107521|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269260|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14269261|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14269262|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14269263|NCT00401960|Daptomycin|daptomycin|mesh-list
14269264|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269265|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269266|NCT00401973|Metformin|metformin|mesh-list
14269267|NCT00401973|Amantadine|amantadine|mesh-list
14269268|NCT00401973|Zonisamide|zonisamide|mesh-list
14269269|NCT00401973|Olanzapine|olanzapine|mesh-list
14269270|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14269271|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269272|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
14269273|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
14269274|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269275|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269276|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14269277|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14269278|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269279|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269280|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14269281|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269282|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269283|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269284|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269285|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
14269286|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15107522|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15107523|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
15107524|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107525|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107526|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15107527|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15107528|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
15107529|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15107530|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107531|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
15107532|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
15107533|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107534|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15107535|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15107536|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15107537|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15107538|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15107539|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
15107540|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15107541|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107542|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
15107543|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
15107544|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
15107545|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15107546|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14269287|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15107547|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107548|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107549|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107550|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107551|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
15107552|NCT04328961|Protective Agents|protective agents|mesh-ancestor
15107553|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107554|NCT04328961|Vitamins|vitamins|mesh-ancestor
15107555|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
15107556|NCT04274361|Ketamine|ketamine|mesh-list
15107557|NCT04274361|Analgesics|analgesics|mesh-ancestor
15107558|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
15107559|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107560|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107561|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15107562|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15107563|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
15107564|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
15107565|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15107566|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15107567|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15107568|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107569|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107570|NCT04263792|Trimethoprim|trimethoprim|mesh-list
15107571|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15107572|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107573|NCT04263792|Renal Agents|renal agents|mesh-ancestor
15107574|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
15107575|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15107576|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15107577|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15107578|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107579|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107580|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15107581|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15107582|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15107583|NCT04259996|Estradiol|estradiol|mesh-list
15107584|NCT04259996|Progesterone|progesterone|mesh-list
15107585|NCT04259996|Estrogens|estrogens|mesh-ancestor
15107586|NCT04259996|Hormones|hormones|mesh-ancestor
15107587|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107588|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107589|NCT04259996|Progestins|progestins|mesh-ancestor
15107590|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15107591|NCT04253626|Hematinics|hematinics|mesh-ancestor
15107592|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15107593|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15107594|NCT04192136|Niacinamide|niacinamide|mesh-list
15107595|NCT04192136|Niacin|niacin|mesh-list
15107596|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
15107597|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
15107598|NCT04192136|Vitamins|vitamins|mesh-ancestor
15107599|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
15107600|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107601|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15107602|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
15107603|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107604|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15107605|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
15107606|NCT04142983|Vaccines|vaccines|mesh-list
15107607|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
15107608|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107609|NCT04076579|Olaparib|olaparib|mesh-list
15107610|NCT04076579|Trabectedin|trabectedin|mesh-list
15107611|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15107612|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107613|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107614|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107615|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15107616|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
15107617|NCT04047472|Aflibercept|aflibercept|mesh-list
15107618|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15107619|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15107620|NCT04047472|Growth Substances|growth substances|mesh-ancestor
15107621|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107622|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
15107623|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107624|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15107625|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
15107626|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107627|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15107628|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15107629|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107630|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107631|NCT03945448|Fluconazole|fluconazole|mesh-list
15107632|NCT03945448|Amphotericin B|amphotericin b|mesh-list
15107633|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15107634|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
15107635|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107636|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15107637|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15107638|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107639|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107640|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15107641|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
15107642|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107643|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107644|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15107645|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15107646|NCT03945448|Amebicides|amebicides|mesh-ancestor
15107647|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15107648|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15107649|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15107650|NCT03909334|Osimertinib|osimertinib|mesh-list
15107651|NCT03909334|Ramucirumab|ramucirumab|mesh-list
15107652|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107653|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15107654|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107655|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107656|NCT03829722|Paclitaxel|paclitaxel|mesh-list
15107657|NCT03829722|Carboplatin|carboplatin|mesh-list
15107658|NCT03829722|Nivolumab|nivolumab|mesh-list
15107659|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15107660|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107661|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
15107662|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
15107663|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
15107664|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107665|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107666|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15107667|NCT03818399|Buprenorphine|buprenorphine|mesh-list
15107668|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15107669|NCT03818399|Narcotics|narcotics|mesh-ancestor
15107670|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15107671|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107672|NCT03818399|Analgesics|analgesics|mesh-ancestor
15107673|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
15107674|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107675|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15107676|NCT03782636|Aldesleukin|aldesleukin|mesh-list
15107677|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107678|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15107679|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15107680|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
15107681|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107682|NCT03761810|Tretinoin|tretinoin|mesh-list
15107683|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15107684|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
15107685|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107686|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
15107687|NCT03761784|Tretinoin|tretinoin|mesh-list
15107688|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15107689|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
15107690|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107691|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
15175597|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
15175598|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175599|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175600|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
15175601|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175602|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15175603|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
15175604|NCT03985514|Tazobactam|tazobactam|mesh-list
15107692|NCT03739099|Pancrelipase|pancrelipase|mesh-list
15107693|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15107694|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
15107695|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
15107696|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15107697|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15107698|NCT03703778|Androgens|androgens|mesh-list
15107699|NCT03703778|Hormones|hormones|mesh-ancestor
15107700|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107701|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107702|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
15107703|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107704|NCT03703778|Protective Agents|protective agents|mesh-ancestor
15107705|NCT03703778|Vitamins|vitamins|mesh-ancestor
15107706|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
15107707|NCT03703778|Estrogens|estrogens|mesh-ancestor
15107708|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15107709|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107710|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
15107711|NCT03702283|Penicillins|penicillins|mesh-list
15107712|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15107713|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107714|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
15107715|NCT03675737|Fluorouracil|fluorouracil|mesh-list
15107716|NCT03675737|Capecitabine|capecitabine|mesh-list
15107717|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
15107718|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107719|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107720|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
15107721|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107722|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107723|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107724|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
15107725|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107726|NCT03576261|Polygeline|polygeline|mesh-list
15107727|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
15107728|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
15107729|NCT03527186|Risperidone|risperidone|mesh-list
15107730|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15107731|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
15107732|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107733|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107734|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107735|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15107736|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15107737|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15107738|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15107739|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15107740|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
15107741|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
15107742|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107743|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107744|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15107745|NCT03320070|Hormones|hormones|mesh-ancestor
15107746|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107747|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107748|NCT03294304|Gemcitabine|gemcitabine|mesh-list
15107749|NCT03294304|Nivolumab|nivolumab|mesh-list
15107750|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107751|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107752|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
15107753|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107754|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
15107755|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107756|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107757|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107758|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
15107759|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107760|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107761|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15107762|NCT03252756|Cannabidiol|cannabidiol|mesh-list
15107763|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
15107764|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
15107765|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15107766|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107767|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107768|NCT03188796|Vitamin D|vitamin d|mesh-list
15107769|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
15107770|NCT03188796|Vitamins|vitamins|mesh-ancestor
15107771|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
15107772|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107773|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15107774|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15107775|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15107776|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15107777|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107778|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
15107779|NCT03122431|Thalidomide|thalidomide|mesh-list
15107780|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
15107781|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15107782|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15107783|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107784|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107785|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107786|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107787|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107788|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
15107789|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107790|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
15107791|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15107792|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15107793|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15107794|NCT03122431|Growth Substances|growth substances|mesh-ancestor
15107795|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
15107796|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107797|NCT03119363|Methamphetamine|methamphetamine|mesh-list
15107798|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15107799|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107800|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
15107801|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
15107802|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107803|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
15107804|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15107805|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107806|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
15107807|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15107808|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15107809|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15107810|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15107811|NCT03099356|Sirolimus|sirolimus|mesh-list
15107812|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
15107813|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107814|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
15107815|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107816|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107817|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15107818|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
15107819|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107820|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107821|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15107822|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15107823|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107824|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15107825|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
15107826|NCT03009201|Doxorubicin|doxorubicin|mesh-list
15107827|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15107828|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15107829|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107830|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15107831|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15107832|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107833|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107834|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15107835|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15107836|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
15107837|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107838|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107839|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15107840|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15107841|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15107842|NCT02956382|Venetoclax|venetoclax|mesh-list
15107843|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107844|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
15107845|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15107846|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15107847|NCT02936843|Analgesics|analgesics|mesh-ancestor
15107848|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
15107849|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15107850|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107851|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107852|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107853|NCT02896855|Docetaxel|docetaxel|mesh-list
15107854|NCT02896855|Trastuzumab|trastuzumab|mesh-list
15107855|NCT02896855|Pertuzumab|pertuzumab|mesh-list
15107856|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107857|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
14269288|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
14269289|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269290|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
14269291|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14269292|NCT00401973|Analgesics|analgesics|mesh-ancestor
14269293|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
14269294|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
15107858|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
15107859|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
15107860|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107861|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107862|NCT02871778|Ivacaftor|ivacaftor|mesh-list
15107863|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15107864|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15107865|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107866|NCT02756208|Vaccines|vaccines|mesh-list
15107867|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
15107868|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107869|NCT02714218|Nivolumab|nivolumab|mesh-list
15107870|NCT02714218|Ipilimumab|ipilimumab|mesh-list
15107871|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107872|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107873|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15107874|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107875|NCT02621151|Gemcitabine|gemcitabine|mesh-list
15107876|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
15107877|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107878|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
15107879|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107880|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107881|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
15107882|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107883|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107884|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107885|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
15107886|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107887|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107888|NCT02564263|Paclitaxel|paclitaxel|mesh-list
15107889|NCT02564263|Docetaxel|docetaxel|mesh-list
15107890|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
15107891|NCT02564263|Irinotecan|irinotecan|mesh-list
15107892|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15107893|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107894|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
15107895|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
15107896|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
15107897|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107898|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107899|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15107900|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15107901|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107902|NCT02421341|Fentanyl|fentanyl|mesh-list
15107903|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
15107904|NCT02421341|Analgesics|analgesics|mesh-list
15107905|NCT02421341|Narcotics|narcotics|mesh-ancestor
15107906|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269295|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15107907|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107908|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
15107909|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292379|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
15107910|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15107911|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15107912|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
15107913|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
15107914|NCT02149121|Rituximab|rituximab|mesh-list
15107915|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107916|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107917|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
15107918|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107919|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107920|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15107921|NCT01935921|Cetuximab|cetuximab|mesh-list
15107922|NCT01935921|Ipilimumab|ipilimumab|mesh-list
15107923|NCT01935921|Antibodies|antibodies|mesh-list
15107924|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
15107925|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15107926|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
15107927|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107928|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107929|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15107930|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107931|NCT01889186|Venetoclax|venetoclax|mesh-list
15107932|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107933|NCT01850004|Dasatinib|dasatinib|mesh-list
15107934|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107935|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15107936|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107937|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107938|NCT01844505|Nivolumab|nivolumab|mesh-list
15107939|NCT01844505|Ipilimumab|ipilimumab|mesh-list
15107940|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107941|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107942|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15107943|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175605|NCT03985514|Piperacillin|piperacillin|mesh-list
15175606|NCT03985514|Metronidazole|metronidazole|mesh-list
15175607|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15175608|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15175609|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175610|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
15175611|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15175612|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15175613|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175614|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175615|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175616|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15175617|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15175618|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15175619|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15175620|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15175621|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
15175622|NCT03985358|Narcotics|narcotics|mesh-ancestor
15175623|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175624|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175625|NCT03985358|Analgesics|analgesics|mesh-ancestor
15175626|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
15175627|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175628|NCT03984955|Mannitol|mannitol|mesh-list
15175629|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
15175630|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15175631|NCT03984955|Diuretics|diuretics|mesh-ancestor
15175632|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
15175633|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175634|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15175635|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
15175636|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
15175637|NCT03984955|Protective Agents|protective agents|mesh-ancestor
15175638|NCT03984656|Lidocaine|lidocaine|mesh-list
15175639|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
15175640|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
15175641|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175642|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175643|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
15175644|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175645|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15175646|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15107944|NCT01757535|Azacitidine|azacitidine|mesh-list
15107945|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107946|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
15107947|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107948|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107949|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107950|NCT01660971|Gemcitabine|gemcitabine|mesh-list
15107951|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15107952|NCT01660971|Dasatinib|dasatinib|mesh-list
15107953|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15107954|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
15107955|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15107956|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107957|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
15107958|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15107959|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107960|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107961|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
15107962|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107963|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15107964|NCT01523977|Prednisone|prednisone|mesh-list
15107965|NCT01523977|Doxorubicin|doxorubicin|mesh-list
15107966|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
15107967|NCT01523977|Vincristine|vincristine|mesh-list
15107968|NCT01523977|Everolimus|everolimus|mesh-list
15107969|NCT01523977|Asparaginase|asparaginase|mesh-list
15107970|NCT01523977|Pegaspargase|pegaspargase|mesh-list
15107971|NCT01523977|Razoxane|razoxane|mesh-list
15107972|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15107973|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107974|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15107975|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15107976|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15107977|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811277|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811278|NCT00844675|Rabeprazole|rabeprazole|mesh-list
15107978|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15107979|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
15107980|NCT01523977|Hormones|hormones|mesh-ancestor
15107981|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15107982|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107983|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15107984|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15107985|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
15107986|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
15107987|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
15107988|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15107989|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
15107990|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15107991|NCT01523977|Protective Agents|protective agents|mesh-ancestor
15107992|NCT01510184|Rituximab|rituximab|mesh-list
15107993|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15107994|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15107995|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15107996|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
15107997|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15107998|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15107999|NCT01471444|Vidarabine|vidarabine|mesh-list
15108000|NCT01471444|Methotrexate|methotrexate|mesh-list
15108001|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
15108002|NCT01471444|Clofarabine|clofarabine|mesh-list
15108003|NCT01471444|Fludarabine|fludarabine|mesh-list
15108004|NCT01471444|Busulfan|busulfan|mesh-list
15108005|NCT01471444|Tacrolimus|tacrolimus|mesh-list
15108006|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
15108007|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15108008|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15108009|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
15108010|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15108011|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108012|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108013|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
14811279|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15108014|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108015|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108016|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108017|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108018|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15108019|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108020|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
15108021|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15108022|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15108023|NCT01471444|Antiviral Agents|antiviral agents|mesh-ancestor
15108024|NCT01471444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108025|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15108026|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
15108027|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15108028|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15108029|NCT01238211|Cytarabine|cytarabine|mesh-list
15108030|NCT01238211|Daunorubicin|daunorubicin|mesh-list
15108031|NCT01238211|Dasatinib|dasatinib|mesh-list
15108032|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108033|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
15108034|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108035|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108036|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
15108037|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108038|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108039|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
15108040|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108041|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15108042|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15108043|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15108044|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108045|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15108046|NCT05162872|Niraparib|niraparib|mesh-list
15108047|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15108048|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108049|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108050|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108051|NCT05162742|Colchicine|colchicine|mesh-list
15108052|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
15108053|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15108054|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
15108055|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
15108056|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
15108057|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108058|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108059|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
15108060|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15108061|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108062|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15108063|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108064|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
15108065|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
15108066|NCT05162625|Cefazolin|cefazolin|mesh-list
15108067|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15108068|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15108069|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15108070|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108071|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15108072|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15108073|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108074|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108075|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108076|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15108077|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15108078|NCT05162456|Antibodies|antibodies|mesh-list
15108079|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
15108080|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
15108081|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
15108082|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108083|NCT05162430|Propofol|propofol|mesh-list
15108084|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15108085|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108086|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108087|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15108088|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
15108089|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
15108090|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
15108091|NCT05162417|Methylene Blue|methylene blue|mesh-list
15108092|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108093|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108094|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
15108095|NCT05162417|Coagulants|coagulants|mesh-ancestor
15108096|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
15108097|NCT05162196|Niraparib|niraparib|mesh-list
15108098|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15108099|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108100|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108101|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108102|NCT05162183|Liraglutide|liraglutide|mesh-list
15108103|NCT05162183|Glimepiride|glimepiride|mesh-list
15108104|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15108105|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108106|NCT05162183|Incretins|incretins|mesh-ancestor
15108107|NCT05162183|Hormones|hormones|mesh-ancestor
15108108|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108109|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15108110|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108111|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
15108112|NCT05162053|Clopidogrel|clopidogrel|mesh-list
15108113|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15108114|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15108115|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15108116|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15108117|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
15108118|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108119|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108120|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108121|NCT05162001|Disulfiram|disulfiram|mesh-list
15108122|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15108123|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15108124|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108125|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108126|NCT05161975|Vitamin K|vitamin k|mesh-list
15108127|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
15108128|NCT05161975|Vitamins|vitamins|mesh-ancestor
15108129|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
15108130|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108131|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15108132|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15108133|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108134|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
15108135|NCT05161975|Coagulants|coagulants|mesh-ancestor
15108136|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
15108137|NCT05161572|Tegafur|tegafur|mesh-list
15108138|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108139|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108140|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
15108141|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108142|NCT05161533|Cisplatin|cisplatin|mesh-list
15108143|NCT05161533|Carboplatin|carboplatin|mesh-list
15108144|NCT05161533|Etoposide|etoposide|mesh-list
15108145|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
15108146|NCT05161533|Durvalumab|durvalumab|mesh-list
15108147|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
15108148|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
15108149|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15108150|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
15108151|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108152|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15108153|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15108154|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561669|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561670|NCT00002802|Cobalt|cobalt|mesh-list
14561671|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
14561672|NCT00002802|Melphalan|melphalan|mesh-list
14561673|NCT00002802|Ifosfamide|ifosfamide|mesh-list
14561674|NCT00002802|Dacarbazine|dacarbazine|mesh-list
14561675|NCT00002802|Carboplatin|carboplatin|mesh-list
14561676|NCT00002802|Doxorubicin|doxorubicin|mesh-list
14561677|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561678|NCT00002802|Etoposide|etoposide|mesh-list
14561679|NCT00002802|Vincristine|vincristine|mesh-list
14561680|NCT00002802|Vindesine|vindesine|mesh-list
14561681|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561682|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
14561683|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561684|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561685|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561686|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
14561687|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561688|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108155|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108156|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108157|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108158|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
15108159|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108160|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
15108161|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108162|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
15108163|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
15108164|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
15108165|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
15108166|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15108167|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
15108168|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108169|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
15108170|NCT05161403|Protective Agents|protective agents|mesh-ancestor
15108171|NCT05161221|Acetaminophen|acetaminophen|mesh-list
15108172|NCT05161221|Naproxen|naproxen|mesh-list
15108173|NCT05161221|Oxycodone|oxycodone|mesh-list
15108174|NCT05161221|Bupivacaine|bupivacaine|mesh-list
15108175|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
15108176|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
15108177|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108178|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108179|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
15108180|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108181|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15108182|NCT05161221|Narcotics|narcotics|mesh-ancestor
15108183|NCT05161221|Analgesics|analgesics|mesh-ancestor
15108184|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15108185|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15108186|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15108187|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15108188|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
15108189|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15108190|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108191|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108192|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
15108193|NCT05161156|Bromides|bromides|mesh-list
15108194|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
15108195|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15108196|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
15108197|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108198|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108199|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15108200|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108201|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
15108202|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15108203|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
15108204|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108205|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108206|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
15108207|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15108208|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108209|NCT05141838|Vitamin D|vitamin d|mesh-list
15108210|NCT05141838|Vitamins|vitamins|mesh-ancestor
15108211|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
15108212|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108213|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15108214|NCT05137886|Decitabine|decitabine|mesh-list
15108215|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15108216|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108217|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
15108218|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108219|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108220|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108221|NCT05132231|Brodalumab|brodalumab|mesh-list
15108222|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
15175647|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15175648|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15175649|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175650|NCT03984760|Sevelamer|sevelamer|mesh-list
15175651|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
15175652|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
15108223|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
15108224|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15108225|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108226|NCT05096728|Nifedipine|nifedipine|mesh-list
15108227|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15108228|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15108229|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108230|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15108231|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108232|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
15108233|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
15108234|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15108235|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
15108236|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15108237|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108238|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
15108239|NCT05067270|Treprostinil|treprostinil|mesh-list
15108240|NCT05067270|Citric Acid|citric acid|mesh-list
15108241|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
15108242|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
15108243|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15108244|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
15108245|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
15108246|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108247|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15108248|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108249|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15108250|NCT05063851|Memantine|memantine|mesh-list
15108251|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15108252|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15108253|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
15108254|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108255|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108256|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108257|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15108258|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15108259|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15108260|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15108261|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108262|NCT05046522|Palmidrol|palmidrol|mesh-list
15108263|NCT05046522|Analgesics|analgesics|mesh-ancestor
15108264|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
15108265|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108266|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108267|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15108268|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15108269|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15108270|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15108271|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
15108272|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108273|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15108274|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15108275|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108276|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108277|NCT05046522|Hormones|hormones|mesh-ancestor
15108278|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108279|NCT05041946|Methylphenidate|methylphenidate|mesh-list
15108280|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15108281|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108282|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15108283|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269296|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14269297|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14269298|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269299|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269300|NCT00402051|Carboplatin|carboplatin|mesh-list
14269301|NCT00402051|Pemetrexed|pemetrexed|mesh-list
14269302|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269303|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108284|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15108285|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108286|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
14269304|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108287|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108288|NCT04998786|Dexamethasone|dexamethasone|mesh-list
15108289|NCT04998786|Ixazomib|ixazomib|mesh-list
15108290|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15108291|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
15108292|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
15108293|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108294|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108295|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15108296|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
15108297|NCT04998786|Hormones|hormones|mesh-ancestor
15108298|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108299|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15108300|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108301|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
15108302|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108303|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108304|NCT04991974|Buprenorphine|buprenorphine|mesh-list
15108305|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15108306|NCT04991974|Naloxone|naloxone|mesh-list
15108307|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15108308|NCT04991974|Narcotics|narcotics|mesh-ancestor
15108309|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108310|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108311|NCT04991974|Analgesics|analgesics|mesh-ancestor
15108312|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
15108313|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108314|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15108315|NCT04976192|Omalizumab|omalizumab|mesh-list
15108316|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15108317|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15108318|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108319|NCT04869488|Prednisone|prednisone|mesh-list
15108320|NCT04869488|Apatinib|apatinib|mesh-list
15108321|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
15108322|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15108323|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
15108324|NCT04869488|Hormones|hormones|mesh-ancestor
15108325|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108326|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108327|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15108328|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108329|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15108330|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108331|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108332|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15108333|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
15108334|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15108335|NCT04867798|Tenofovir|tenofovir|mesh-list
15108336|NCT04867798|Lamivudine|lamivudine|mesh-list
15108337|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
15108338|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108339|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15108340|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15108341|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108342|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108343|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15108344|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15108345|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
15108346|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108347|NCT04821284|Leucovorin|leucovorin|mesh-list
15108348|NCT04821284|Gemcitabine|gemcitabine|mesh-list
15108349|NCT04821284|Paclitaxel|paclitaxel|mesh-list
15108350|NCT04821284|Fluorouracil|fluorouracil|mesh-list
15108351|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
15108352|NCT04821284|Irinotecan|irinotecan|mesh-list
15108353|NCT04821284|Calcium|calcium|mesh-list
15108354|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
15108355|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15108356|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108357|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
15108358|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
15108359|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
15108360|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108361|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108362|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
15108363|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
15108364|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108365|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108366|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108367|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
15108368|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108369|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15108370|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15108371|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15108372|NCT04821284|Antidotes|antidotes|mesh-ancestor
15108373|NCT04821284|Protective Agents|protective agents|mesh-ancestor
15108374|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
15108375|NCT04821284|Vitamins|vitamins|mesh-ancestor
15108376|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
15108377|NCT04738123|Xanomeline|xanomeline|mesh-list
15108378|NCT04738123|Trospium chloride|trospium chloride|mesh-list
15108379|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
15108380|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
15108381|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108382|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108383|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15108384|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15108385|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
15108386|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108387|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108388|NCT04738123|Urological Agents|urological agents|mesh-ancestor
15108389|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15108390|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15108391|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15108392|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15108393|NCT04729621|Denosumab|denosumab|mesh-list
15108394|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15108395|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108396|NCT04648826|Azacitidine|azacitidine|mesh-list
15108397|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108398|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
15108399|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108400|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108401|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108402|NCT04606394|Albuterol|albuterol|mesh-list
15108403|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15108404|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
15108405|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108406|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108407|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15108408|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108409|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
15108410|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15108411|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15108412|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15108413|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15108414|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
15108415|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108416|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108417|NCT04577690|Epinephrine|epinephrine|mesh-list
15108418|NCT04577690|Racepinephrine|racepinephrine|mesh-list
15108419|NCT04577690|Bupivacaine|bupivacaine|mesh-list
15108420|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
15108421|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
15108422|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
15108423|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108424|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108425|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
15108426|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108427|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15108428|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15108429|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
15108430|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108431|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108432|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15108433|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15108434|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
15108435|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15108436|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108437|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
15108438|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
15108439|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15108440|NCT04574856|Temozolomide|temozolomide|mesh-list
15108441|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15108442|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
15108443|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108444|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108445|NCT04551482|Oxytocin|oxytocin|mesh-list
15108446|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
15108447|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15108448|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108449|NCT04523922|Oxytocin|oxytocin|mesh-list
15108450|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
15108451|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15108452|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108453|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15108454|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108455|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108456|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108457|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15108458|NCT04496596|Suramin|suramin|mesh-list
15108459|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
15108460|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
15108461|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15108462|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108463|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108464|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15108465|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15175653|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175654|NCT03984591|Eplerenone|eplerenone|mesh-list
15175655|NCT03984591|Spironolactone|spironolactone|mesh-list
15175656|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15175657|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
15175658|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175659|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175660|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15175661|NCT03984591|Diuretics|diuretics|mesh-ancestor
15175662|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
15175663|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15175664|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
15175665|NCT03984578|Capecitabine|capecitabine|mesh-list
15175666|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175667|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175668|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15175669|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
15175670|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175671|NCT03984526|Atropine|atropine|mesh-list
15175672|NCT03984526|Ephedrine|ephedrine|mesh-list
15175673|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15175674|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15175675|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15175676|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
15175677|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175678|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175679|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15175680|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
15175681|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
15175682|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
15175683|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15175684|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15175685|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
15175686|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175687|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175688|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15175689|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
15175690|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15175691|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
15175692|NCT03984188|Theophylline|theophylline|mesh-list
15175693|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15175694|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
15175695|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175696|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175697|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15175698|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
15175699|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15175700|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175701|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108466|NCT04447053|Belimumab|belimumab|mesh-list
15108467|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108468|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
15108469|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108470|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
15108471|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15108472|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15108473|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108474|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
15108475|NCT04410042|Coagulants|coagulants|mesh-ancestor
15108476|NCT04393298|Leucovorin|leucovorin|mesh-list
15108477|NCT04393298|Trifluridine|trifluridine|mesh-list
15108478|NCT04393298|Fluorouracil|fluorouracil|mesh-list
15108479|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108480|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
15108481|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108482|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108483|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108484|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108485|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
15108486|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
15108487|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108488|NCT04393298|Antidotes|antidotes|mesh-ancestor
15108489|NCT04393298|Protective Agents|protective agents|mesh-ancestor
15108490|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
15108491|NCT04393298|Vitamins|vitamins|mesh-ancestor
15108492|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
15108493|NCT04361799|Insulin|insulin|mesh-list
15108494|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15108495|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108496|NCT04306510|Antibodies|antibodies|mesh-list
15108497|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
15108498|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15108499|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
15108500|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108501|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
15108502|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108503|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15108504|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108505|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108506|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15108507|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
15108508|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108509|NCT04132817|Paclitaxel|paclitaxel|mesh-list
15108510|NCT04132817|Nivolumab|nivolumab|mesh-list
15108511|NCT04132817|Ipilimumab|ipilimumab|mesh-list
15108512|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15108513|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108514|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
15108515|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
15108516|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
15108517|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108518|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108519|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15108520|NCT04101890|Allantoin|allantoin|mesh-list
15108521|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
15108522|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108523|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
15108524|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15108525|NCT04101890|Protective Agents|protective agents|mesh-ancestor
15108526|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108527|NCT04017442|Morphine|morphine|mesh-list
15108528|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15108529|NCT04017442|Narcotics|narcotics|mesh-ancestor
15108530|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108531|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108532|NCT04017442|Analgesics|analgesics|mesh-ancestor
15108533|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
15108534|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108535|NCT03993314|Bupivacaine|bupivacaine|mesh-list
15108536|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
15108537|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
15108538|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
15108539|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108540|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108541|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
15108542|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108543|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
15108544|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15108545|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
15108546|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15108547|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
15108548|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108549|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108550|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
15108551|NCT03949894|Tolvaptan|tolvaptan|mesh-list
15108552|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15108553|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108554|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
15108555|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108556|NCT03942224|Dexamethasone|dexamethasone|mesh-list
15108557|NCT03942224|Bortezomib|bortezomib|mesh-list
15108558|NCT03942224|Daratumumab|daratumumab|mesh-list
15108559|NCT03942224|Ixazomib|ixazomib|mesh-list
15108560|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15108561|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
15108562|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
15108563|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108564|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108565|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15108566|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
15108567|NCT03942224|Hormones|hormones|mesh-ancestor
15108568|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108569|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15108570|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108571|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
15108572|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108573|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108574|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
15108575|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15108576|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108577|NCT03879109|Folfirinox|folfirinox|mesh-list
15108578|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108579|NCT03856359|Rifaximin|rifaximin|mesh-list
15108580|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15108581|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108582|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15108583|NCT03846505|Oxytocin|oxytocin|mesh-list
15108584|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
15108585|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15108586|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108587|NCT03837015|Estradiol|estradiol|mesh-list
15108588|NCT03837015|Estrogens|estrogens|mesh-ancestor
15108589|NCT03837015|Hormones|hormones|mesh-ancestor
15108590|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108591|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108592|NCT03690011|Cyclophosphamide|cyclophosphamide|mesh-list
15108593|NCT03690011|Fludarabine|fludarabine|mesh-list
15108594|NCT03690011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108595|NCT03690011|Immunologic Factors|immunologic factors|mesh-ancestor
15108596|NCT03690011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108597|NCT03690011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15108598|NCT03690011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15108599|NCT03690011|Alkylating Agents|alkylating agents|mesh-ancestor
15108600|NCT03690011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108601|NCT03690011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108602|NCT03690011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15108603|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
15108604|NCT03654729|Edetic Acid|edetic acid|mesh-list
15108605|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
15108606|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15108607|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
15108608|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
15108609|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108610|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
15108611|NCT03654729|Vitamins|vitamins|mesh-ancestor
15108612|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
15108613|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175702|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
15175703|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15175704|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15175705|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
15175706|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175707|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
15175708|NCT03984409|Diuretics|diuretics|mesh-ancestor
15175709|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
15108614|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
14269305|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14269306|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14269307|NCT00402103|Amlodipine|amlodipine|mesh-list
14269308|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14269309|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14269310|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14269311|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269312|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269313|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14269314|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108615|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108616|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108617|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
15108618|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15108619|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15108620|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14269315|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
14269316|NCT00402103|Diuretics|diuretics|mesh-ancestor
14269317|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
14269318|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14811280|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15108621|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15108622|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108623|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
15108624|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108625|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108626|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15108627|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108628|NCT03406286|Tolvaptan|tolvaptan|mesh-list
15108629|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15108630|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108631|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
15108632|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108633|NCT03376763|Aripiprazole|aripiprazole|mesh-list
15108634|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
15108635|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15108636|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15108637|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15108638|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108639|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108640|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
15108641|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
15108642|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108643|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108644|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15108645|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15108646|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
15108647|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15108648|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15108649|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15108650|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15108651|NCT03296033|Enoxaparin|enoxaparin|mesh-list
15108652|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
15108653|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
15108654|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15108655|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15108656|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108657|NCT03237286|Ketamine|ketamine|mesh-list
15108658|NCT03237286|Analgesics|analgesics|mesh-ancestor
15108659|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
15108660|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108661|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108662|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15108663|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15108664|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
15108665|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
15108666|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108667|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15108668|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15108669|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108670|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108671|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
15108672|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
15108673|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108674|NCT03155061|Nivolumab|nivolumab|mesh-list
15108675|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108676|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108677|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15108678|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108679|NCT03141424|Fluticasone|fluticasone|mesh-list
15108680|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
15108681|NCT03141424|Ciclesonide|ciclesonide|mesh-list
15108682|NCT03141424|Budesonide|budesonide|mesh-list
15108683|NCT03141424|Beclomethasone|beclomethasone|mesh-list
15108684|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15108685|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15108686|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
15108687|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108688|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108689|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15108690|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108691|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108692|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15108693|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
15108694|NCT03141424|Hormones|hormones|mesh-ancestor
15108695|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108696|NCT03106688|Carfentanil|carfentanil|mesh-list
15108697|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15108698|NCT03106688|Narcotics|narcotics|mesh-ancestor
15108699|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108700|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108701|NCT03106688|Analgesics|analgesics|mesh-ancestor
15108702|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
15108703|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108704|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
15108705|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108706|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
15108707|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15108708|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
15108709|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108710|NCT03032601|Expectorants|expectorants|mesh-ancestor
15108711|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108712|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15108713|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
15108714|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108715|NCT03032601|Protective Agents|protective agents|mesh-ancestor
15108716|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108717|NCT03032601|Antidotes|antidotes|mesh-ancestor
15108718|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
15108719|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15108720|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
15108721|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108722|NCT02966873|Expectorants|expectorants|mesh-ancestor
15108723|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108724|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15108725|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
15108726|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108727|NCT02966873|Protective Agents|protective agents|mesh-ancestor
15108728|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108729|NCT02966873|Antidotes|antidotes|mesh-ancestor
15108730|NCT02685735|Gabapentin|gabapentin|mesh-list
15108731|NCT02685735|Analgesics|analgesics|mesh-ancestor
15108732|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
15108733|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108734|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108735|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
15108736|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15108737|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15108738|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108739|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15108740|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15108741|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15108742|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108743|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108744|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
15108745|NCT02631070|Luspatercept|luspatercept|mesh-list
15108746|NCT02631070|Hematinics|hematinics|mesh-ancestor
15108747|NCT02630641|Hormones|hormones|mesh-list
15108748|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15108749|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108750|NCT02616185|Tremelimumab|tremelimumab|mesh-list
15108751|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108752|NCT02513667|Ceritinib|ceritinib|mesh-list
15108753|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108754|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15108755|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108756|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108757|NCT02513329|Bupivacaine|bupivacaine|mesh-list
15108758|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
15108759|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
15108760|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108761|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108762|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
15108763|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108764|NCT02297139|Dasatinib|dasatinib|mesh-list
15108765|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108766|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15108767|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108768|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108769|NCT02281955|Cisplatin|cisplatin|mesh-list
15108770|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108771|NCT02097134|Melphalan|melphalan|mesh-list
15108772|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
15108773|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15108774|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15108775|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
15108776|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108777|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108778|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15108779|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108780|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
15108781|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108782|NCT01588431|Bevacizumab|bevacizumab|mesh-list
15108783|NCT01588431|Cetuximab|cetuximab|mesh-list
15108784|NCT01588431|Cisplatin|cisplatin|mesh-list
15108785|NCT01588431|Docetaxel|docetaxel|mesh-list
15108786|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108787|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108788|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15108789|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15108790|NCT01588431|Growth Substances|growth substances|mesh-ancestor
15108791|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108792|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
15108793|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
15108794|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
15108795|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
15108796|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108797|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
15108798|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15108799|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
15108800|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15108801|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108802|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15108803|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15108804|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15108805|NCT00983437|Modafinil|modafinil|mesh-list
15108806|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15108807|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108808|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15108809|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15108810|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15108811|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108812|NCT00893789|Modafinil|modafinil|mesh-list
15108813|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15108814|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108815|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15108816|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15108817|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15108818|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108819|NCT00805129|Everolimus|everolimus|mesh-list
15108820|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108821|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108822|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
15108823|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108824|NCT00708448|Bevacizumab|bevacizumab|mesh-list
15108825|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15108826|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108827|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108828|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15108829|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15108830|NCT00708448|Growth Substances|growth substances|mesh-ancestor
15108831|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108832|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
15108833|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15108834|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108835|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108836|NCT05164614|Teriparatide|teriparatide|mesh-list
15108837|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15108838|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108839|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15108840|NCT05164367|Atropine|atropine|mesh-list
15108841|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15108842|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15108843|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15108844|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
15108845|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108846|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108847|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15108848|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
15108849|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
15108850|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
15108851|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15108852|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15108853|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
15108854|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108855|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175710|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175711|NCT03984409|Expectorants|expectorants|mesh-ancestor
15175712|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
15175713|NCT03984110|Dexamethasone|dexamethasone|mesh-list
15175714|NCT03984110|Aflibercept|aflibercept|mesh-list
15175715|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175716|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
15175717|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
15175718|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175719|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175720|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15175721|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
15175722|NCT03984110|Hormones|hormones|mesh-ancestor
15175723|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175724|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15175725|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175726|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15175727|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15175728|NCT03984110|Growth Substances|growth substances|mesh-ancestor
15175729|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
15175730|NCT03984357|Gemcitabine|gemcitabine|mesh-list
15175731|NCT03984357|Antibodies|antibodies|mesh-list
15175732|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
15175733|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
15175734|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175735|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175736|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15175737|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
15175738|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175739|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
15175740|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175741|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175742|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15175743|NCT03984097|Dexamethasone|dexamethasone|mesh-list
15175744|NCT03984097|Lenalidomide|lenalidomide|mesh-list
15175745|NCT03984097|Bortezomib|bortezomib|mesh-list
15175746|NCT03984097|Pomalidomide|pomalidomide|mesh-list
15175747|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175748|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
15175749|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
15175750|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108856|NCT05164198|Adalimumab|adalimumab|mesh-list
15108857|NCT05164198|Etanercept|etanercept|mesh-list
15108858|NCT05164198|Golimumab|golimumab|mesh-list
15108859|NCT05164198|Infliximab|infliximab|mesh-list
15108860|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15108861|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15108862|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108863|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15108864|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15108865|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15108866|NCT05164198|Analgesics|analgesics|mesh-ancestor
15108867|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
15108868|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108869|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108870|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15108871|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
15108872|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15108873|NCT05164159|Propofol|propofol|mesh-list
15108874|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15108875|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108876|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108877|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15108878|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
15108879|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
15108880|NCT05164146|Propofol|propofol|mesh-list
15108881|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15108882|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108883|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108884|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15108885|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
15108886|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
15108887|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15108888|NCT05164081|Clindamycin|clindamycin|mesh-list
15108889|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
15108890|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
15108891|NCT05164081|Gentamicins|gentamicins|mesh-list
15108892|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15108893|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108894|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
15108895|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15108896|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108897|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108898|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
15108899|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15108900|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108901|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108902|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15108903|NCT05163704|Analgesics|analgesics|mesh-ancestor
15108904|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
15108905|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108906|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15108907|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15108908|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15108909|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
15108910|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108911|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108912|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
15108913|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
15108914|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108915|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15108916|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15108917|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
15108918|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108919|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108920|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15108921|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15108922|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108923|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108924|NCT05163405|Bortezomib|bortezomib|mesh-list
15108925|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108926|NCT05163366|Ketamine|ketamine|mesh-list
15108927|NCT05163366|Morphine|morphine|mesh-list
15108928|NCT05163366|Analgesics|analgesics|mesh-ancestor
15108929|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
15108930|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15108931|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108932|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15108933|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15108934|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
15108935|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
15108936|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15108937|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15108938|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15108939|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15108940|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108941|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15108942|NCT05163366|Narcotics|narcotics|mesh-ancestor
15108943|NCT05163249|Osimertinib|osimertinib|mesh-list
15108944|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108945|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15108946|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108947|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108948|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
15108949|NCT05163223|Capecitabine|capecitabine|mesh-list
15108950|NCT05163223|Sargramostim|sargramostim|mesh-list
15108951|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108952|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108953|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15108954|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
15108955|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108956|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
15108957|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108958|NCT05162937|Antibodies|antibodies|mesh-list
15108959|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
15108960|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108961|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
15108962|NCT05161611|Astringents|astringents|mesh-ancestor
15108963|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108964|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
15108965|NCT05160727|Irinotecan|irinotecan|mesh-list
15108966|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15108967|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15108968|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108969|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108970|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108971|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15108972|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
15108973|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108974|NCT05141422|Efavirenz|efavirenz|mesh-list
15108975|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15108976|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15108977|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15108978|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15108979|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
15108980|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15108981|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15108982|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15108983|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15108984|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15108985|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15108986|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15108987|NCT05137678|Glyburide|glyburide|mesh-list
14269319|NCT00402116|Temozolomide|temozolomide|mesh-list
14269320|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14269321|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
15108988|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15108989|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108990|NCT05101018|Denosumab|denosumab|mesh-list
15108991|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15108992|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15108993|NCT05097651|Cannabidiol|cannabidiol|mesh-list
15108994|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
15108995|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
15108996|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15108997|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15108998|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15108999|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14269322|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109000|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
15109001|NCT05040360|Capecitabine|capecitabine|mesh-list
15109002|NCT05040360|Temozolomide|temozolomide|mesh-list
15109003|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109004|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
15109005|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109006|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109007|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15109008|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
15109009|NCT04965064|Capecitabine|capecitabine|mesh-list
15109010|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109011|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
15109012|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109013|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109014|NCT04959760|Antibodies|antibodies|mesh-list
15109015|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
15109016|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
15109017|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
15109018|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175751|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175752|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15175753|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
15175754|NCT03984097|Hormones|hormones|mesh-ancestor
15175755|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175756|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15175757|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175758|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
15175759|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15175760|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15175761|NCT03984097|Growth Substances|growth substances|mesh-ancestor
15175762|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
15175763|NCT03983954|Durvalumab|durvalumab|mesh-list
15175764|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
15175765|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15175766|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
15175767|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175768|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175769|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
15175770|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175771|NCT03983889|Fentanyl|fentanyl|mesh-list
15175772|NCT03983889|Midazolam|midazolam|mesh-list
15175773|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
15175774|NCT03983889|Remifentanil|remifentanil|mesh-list
15175775|NCT03983889|Propofol|propofol|mesh-list
15175776|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15175777|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175778|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175779|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15175780|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
15175781|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
15175782|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175783|NCT03983889|Analgesics|analgesics|mesh-ancestor
15175784|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
15175785|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175786|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15175787|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15175788|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15175789|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
15175790|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175791|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175792|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15175793|NCT03983889|Narcotics|narcotics|mesh-ancestor
15175794|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15175795|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15175796|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15175797|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15175798|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
15175799|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
15181642|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181643|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181644|NCT03928093|Pregabalin|pregabalin|mesh-list
15181645|NCT03928093|Analgesics|analgesics|mesh-ancestor
15181646|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
15181647|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181648|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181649|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
15181650|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15181651|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15109019|NCT04820179|Atezolizumab|atezolizumab|mesh-list
15109020|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109021|NCT04809051|Metronidazole|metronidazole|mesh-list
15109022|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109023|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15109024|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15109025|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15109026|NCT04760730|Vaccines|vaccines|mesh-list
15109027|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
15109028|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109029|NCT04735367|Letrozole|letrozole|mesh-list
15109030|NCT04735367|Palbociclib|palbociclib|mesh-list
15109031|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109032|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15109033|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15109034|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109035|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109036|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15109037|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
15109038|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109039|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109040|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15109041|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
15109042|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
15109043|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109044|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15109045|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15109046|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
15109047|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109048|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109049|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15109050|NCT04662086|Camostat|camostat|mesh-list
15109051|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
15109052|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109053|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109054|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15109055|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15109056|NCT04662073|Camostat|camostat|mesh-list
15109057|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
15109058|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109059|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109060|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15109061|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15109062|NCT04658173|Alfentanil|alfentanil|mesh-list
15109063|NCT04658173|Propofol|propofol|mesh-list
15109064|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15109065|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109066|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109067|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15109068|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
14269323|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269324|NCT00402168|Cyclosporine|cyclosporine|mesh-list
14269325|NCT00402168|Abatacept|abatacept|mesh-list
14269326|NCT00402168|Tacrolimus|tacrolimus|mesh-list
14269327|NCT00402168|Cyclosporins|cyclosporins|mesh-list
14269328|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269329|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
14269330|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269331|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14269332|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269333|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269334|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
14269335|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269336|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14269337|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109069|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
15109070|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15109071|NCT04658173|Narcotics|narcotics|mesh-ancestor
15109072|NCT04658173|Analgesics|analgesics|mesh-ancestor
15109073|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
15109074|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109075|NCT04627285|Lacosamide|lacosamide|mesh-list
15109076|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
15109077|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15109078|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14269338|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15109079|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15109080|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109081|NCT04612751|Carboplatin|carboplatin|mesh-list
15109082|NCT04612751|Durvalumab|durvalumab|mesh-list
15109083|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109084|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109085|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
15109086|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109087|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15109088|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109089|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109090|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15109091|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15109092|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15109093|NCT04587687|Antibodies|antibodies|mesh-list
15109094|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
15109095|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15109096|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
15109097|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
15109098|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109099|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109100|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15109101|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
15109102|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109103|NCT04578600|Lenalidomide|lenalidomide|mesh-list
15109104|NCT04578600|Azacitidine|azacitidine|mesh-list
15109105|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
15109106|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
15109107|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109108|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15109109|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15109110|NCT04578600|Growth Substances|growth substances|mesh-ancestor
15109111|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
15109112|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109113|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109114|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
15109115|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109116|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109117|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109118|NCT04565392|Famotidine|famotidine|mesh-list
15109119|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15109120|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15109121|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15109122|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
15109123|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
15109124|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109125|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109126|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109127|NCT04478942|Misoprostol|misoprostol|mesh-list
15109128|NCT04478942|Oxytocin|oxytocin|mesh-list
15109129|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
15109130|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15109131|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109132|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15109133|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
15109134|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15109135|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15109136|NCT04467593|Gemcitabine|gemcitabine|mesh-list
15109137|NCT04467593|Paclitaxel|paclitaxel|mesh-list
15109138|NCT04467593|Folfirinox|folfirinox|mesh-list
15109139|NCT04467593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109140|NCT04467593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109141|NCT04467593|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109142|NCT04467593|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109143|NCT04467593|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109144|NCT04467593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109145|NCT04467593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109146|NCT04467593|Antimetabolites|antimetabolites|mesh-ancestor
15109147|NCT04467593|Antiviral Agents|antiviral agents|mesh-ancestor
15109148|NCT04467593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109149|NCT04467593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109150|NCT04467593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109151|NCT04467593|Immunologic Factors|immunologic factors|mesh-ancestor
15109152|NCT04467593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109153|NCT04463693|Etonogestrel|etonogestrel|mesh-list
15109154|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15109155|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
15109156|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15109157|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109158|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15109159|NCT04463498|Methamphetamine|methamphetamine|mesh-list
15109160|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15109161|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109162|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
15109163|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
15109164|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109165|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
15109166|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109167|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109168|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
15109169|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15109170|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15109171|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15109172|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15109173|NCT04453137|Adalimumab|adalimumab|mesh-list
15109174|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109175|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109176|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
15109177|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109178|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109179|NCT04373707|Enoxaparin|enoxaparin|mesh-list
15109180|NCT04373707|Dalteparin|dalteparin|mesh-list
15109181|NCT04373707|Tinzaparin|tinzaparin|mesh-list
15109182|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15109183|NCT04373707|Nadroparin|nadroparin|mesh-list
15109184|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
15109185|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
15109186|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15109187|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15109188|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109189|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
15109190|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15109191|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109192|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109193|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109194|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
15109195|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109196|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109197|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
15109198|NCT04287816|Antithrombins|antithrombins|mesh-list
15109199|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15109200|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
15109201|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109202|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109203|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
15109204|NCT04220489|Ketamine|ketamine|mesh-list
15109205|NCT04220489|Analgesics|analgesics|mesh-ancestor
15109206|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
15109207|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109208|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109209|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15109210|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15109211|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
15109212|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
15109213|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109214|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15109215|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15109216|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109217|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109218|NCT04218786|Colchicine|colchicine|mesh-list
15109219|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
15109220|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109221|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109222|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109223|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109224|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109225|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109226|NCT04206813|Vaccines|vaccines|mesh-list
15109227|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
15109228|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109229|NCT04133376|Nicotine|nicotine|mesh-list
15109230|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15109231|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
15109232|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109233|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109234|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15109235|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15109236|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
15109237|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109238|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109239|NCT04050085|Nivolumab|nivolumab|mesh-list
15109240|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109241|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109242|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15109243|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109244|NCT04002362|Triamcinolone|triamcinolone|mesh-list
15109245|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15109246|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15109247|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15109248|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109249|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
15109250|NCT04002362|Hormones|hormones|mesh-ancestor
15109251|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109252|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109253|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109254|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
15109255|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109256|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109257|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15109258|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109259|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109260|NCT03940690|Bevacizumab|bevacizumab|mesh-list
15109261|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109262|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109263|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15109264|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15109265|NCT03940690|Growth Substances|growth substances|mesh-ancestor
15109266|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109267|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
15109268|NCT03901144|Glycerol|glycerol|mesh-list
15109269|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15109270|NCT03901144|Protective Agents|protective agents|mesh-ancestor
15109271|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175800|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
15175801|NCT03983915|Remifentanil|remifentanil|mesh-list
15175802|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15175803|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175804|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175805|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15175806|NCT03983915|Analgesics|analgesics|mesh-ancestor
15175807|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
15175808|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175809|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15175810|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15175811|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15175812|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
15175813|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175814|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175815|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15175816|NCT03983915|Narcotics|narcotics|mesh-ancestor
15175817|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15175818|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
15175819|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175820|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175821|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15175822|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175823|NCT03983460|Betamethasone|betamethasone|mesh-list
15175824|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
15175825|NCT03983460|Clobetasol|clobetasol|mesh-list
15175826|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175827|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
15175828|NCT03983460|Hormones|hormones|mesh-ancestor
15175829|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175830|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109272|NCT03765632|Busulfan|busulfan|mesh-list
15109273|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
15109274|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109275|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109276|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
15109277|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109278|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15109279|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109280|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15109281|NCT03695250|Nivolumab|nivolumab|mesh-list
15109282|NCT03695250|Linrodostat|linrodostat|mesh-list
15109283|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109284|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109285|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15109286|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109287|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109288|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
15109289|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109290|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109291|NCT03603912|Metformin|metformin|mesh-list
15109292|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109293|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109294|NCT03558152|Vedolizumab|vedolizumab|mesh-list
15109295|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15109296|NCT03549000|Spartalizumab|spartalizumab|mesh-list
15109297|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15109298|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109299|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109300|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
15109301|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
15109302|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
15109303|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109304|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109305|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15109306|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109307|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109308|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
15109309|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109310|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109311|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15109312|NCT03519295|Atezolizumab|atezolizumab|mesh-list
15109313|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109314|NCT03462459|Vancomycin|vancomycin|mesh-list
15109315|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15109316|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109317|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
15109318|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15109319|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109320|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109321|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15109322|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109323|NCT03323398|Durvalumab|durvalumab|mesh-list
15109324|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109325|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109326|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15109327|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
15109328|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109329|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15109330|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
15109331|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109332|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109333|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15109334|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15109335|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15109336|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
15109337|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
15109338|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15109339|NCT03166085|Paclitaxel|paclitaxel|mesh-list
15109340|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
15109341|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109342|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109343|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109344|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109345|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109346|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109347|NCT03161054|Prednisone|prednisone|mesh-list
15109348|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
15109349|NCT03161054|Rituximab|rituximab|mesh-list
15109350|NCT03161054|Etoposide|etoposide|mesh-list
15109351|NCT03161054|Vinorelbine|vinorelbine|mesh-list
15109352|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109353|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
15109354|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109355|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109356|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15109357|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
15109358|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109359|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109360|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15109361|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109362|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109363|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
15109364|NCT03161054|Hormones|hormones|mesh-ancestor
15109365|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109366|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15109367|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109368|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15109369|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15109370|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109371|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109372|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109373|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109374|NCT03050814|Leucovorin|leucovorin|mesh-list
15109375|NCT03050814|Bevacizumab|bevacizumab|mesh-list
15109376|NCT03050814|Avelumab|avelumab|mesh-list
15109377|NCT03050814|Fluorouracil|fluorouracil|mesh-list
15109378|NCT03050814|Capecitabine|capecitabine|mesh-list
15109379|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
15109380|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109381|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109382|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15109383|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15109384|NCT03050814|Growth Substances|growth substances|mesh-ancestor
15109385|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109386|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
15109387|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
15109388|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109389|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109390|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109391|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
15109392|NCT03050814|Antidotes|antidotes|mesh-ancestor
15109393|NCT03050814|Protective Agents|protective agents|mesh-ancestor
15109394|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
15109395|NCT03050814|Vitamins|vitamins|mesh-ancestor
15109396|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
15109397|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15109398|NCT02791568|Hematinics|hematinics|mesh-ancestor
15109399|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15109400|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15109401|NCT02724241|Nicotine|nicotine|mesh-list
15109402|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15109403|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
15109404|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109405|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109406|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15109407|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15109408|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
15109409|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109410|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109411|NCT02639910|Venetoclax|venetoclax|mesh-list
15109412|NCT02639910|Idelalisib|idelalisib|mesh-list
15109413|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109414|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109415|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109416|NCT02618980|Hemostatics|hemostatics|mesh-list
15109417|NCT02618980|Coagulants|coagulants|mesh-ancestor
15109418|NCT02613598|Bortezomib|bortezomib|mesh-list
15109419|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109420|NCT02595320|Capecitabine|capecitabine|mesh-list
15109421|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109422|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
15109423|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109424|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109425|NCT02594384|Rituximab|rituximab|mesh-list
15109426|NCT02594384|Atezolizumab|atezolizumab|mesh-list
15109427|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109428|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109429|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
15109430|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109431|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109432|NCT02586623|Droxidopa|droxidopa|mesh-list
15109433|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15109434|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15109435|NCT02492867|Paclitaxel|paclitaxel|mesh-list
15109436|NCT02492867|Carboplatin|carboplatin|mesh-list
15109437|NCT02492867|Durvalumab|durvalumab|mesh-list
15109438|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109439|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109440|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109441|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109442|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109443|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109444|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109445|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
15109446|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15109447|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15109448|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
15109449|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109450|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109451|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109452|NCT02426892|Nivolumab|nivolumab|mesh-list
15109453|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109454|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109455|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15109456|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109457|NCT02409368|Nivolumab|nivolumab|mesh-list
15109458|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109459|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109460|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15109461|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109462|NCT02375555|Dexamethasone|dexamethasone|mesh-list
15109463|NCT02375555|Lenalidomide|lenalidomide|mesh-list
15109464|NCT02375555|Bortezomib|bortezomib|mesh-list
15109465|NCT02375555|Elotuzumab|elotuzumab|mesh-list
15109466|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109467|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
15109468|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
15109469|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109470|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109471|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15109472|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
15109473|NCT02375555|Hormones|hormones|mesh-ancestor
15109474|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109475|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15109476|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109477|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
15109478|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15109479|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15109480|NCT02375555|Growth Substances|growth substances|mesh-ancestor
15109481|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
15109482|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
15109483|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109484|NCT02220894|Paclitaxel|paclitaxel|mesh-list
15109485|NCT02220894|Carboplatin|carboplatin|mesh-list
15109486|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
15109487|NCT02220894|Pemetrexed|pemetrexed|mesh-list
15109488|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109489|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109490|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109491|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109492|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109493|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109494|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109495|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109496|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15109497|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15109498|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
15109499|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15109500|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15109501|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109502|NCT01772004|Avelumab|avelumab|mesh-list
15109503|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109504|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109505|NCT01750567|Metformin|metformin|mesh-list
15109506|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109507|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109508|NCT01721759|Nivolumab|nivolumab|mesh-list
15109509|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109510|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109511|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15109512|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109513|NCT01633541|Carboplatin|carboplatin|mesh-list
15109514|NCT01633541|Docetaxel|docetaxel|mesh-list
15109515|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109516|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109517|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109518|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109519|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109520|NCT01539447|Naproxen|naproxen|mesh-list
15109521|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15109522|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15109523|NCT01539447|Analgesics|analgesics|mesh-ancestor
15109524|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
15109525|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109526|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109527|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109528|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109529|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
15109530|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15109531|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109532|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109533|NCT01322971|Metronidazole|metronidazole|mesh-list
15109534|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109535|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15109536|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15109537|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15109538|NCT01285102|Irinotecan|irinotecan|mesh-list
15109539|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15109540|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15109541|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109542|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109543|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109544|NCT00952692|Lapatinib|lapatinib|mesh-list
15109545|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109546|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15109547|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109548|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109549|NCT00424099|Methylphenidate|methylphenidate|mesh-list
15109550|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15109551|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109552|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15109553|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15109554|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15109555|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109556|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
15109557|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175831|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15175832|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
15175833|NCT03983239|Efavirenz|efavirenz|mesh-list
15175834|NCT03983239|Rifampin|rifampin|mesh-list
15175835|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15175836|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15175837|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175838|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175839|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
15175840|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175841|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15175842|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15109558|NCT05166096|Aspirin|aspirin|mesh-list
15109559|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15109560|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15109561|NCT05166096|Analgesics|analgesics|mesh-ancestor
15109562|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
15109563|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109564|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109565|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109566|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109567|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15109568|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15109569|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109570|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15109571|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15109572|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109573|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
15109574|NCT05166083|Testosterone|testosterone|mesh-list
15109575|NCT05166083|Androgens|androgens|mesh-ancestor
15109576|NCT05166083|Hormones|hormones|mesh-ancestor
15109577|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109578|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109579|NCT05166005|Vitamin D|vitamin d|mesh-list
15109580|NCT05166005|Vitamins|vitamins|mesh-ancestor
15109581|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
15109582|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109583|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15109584|NCT05165914|Midazolam|midazolam|mesh-list
15109585|NCT05165914|Anesthetics|anesthetics|mesh-list
15109586|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109587|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109588|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15109589|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15109590|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15109591|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15109592|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15109593|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15109594|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
15109595|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
15109596|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
15109597|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109598|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109599|NCT05165732|Vaccines|vaccines|mesh-list
15109600|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
15109601|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109602|NCT05165641|Anesthetics|anesthetics|mesh-list
15109603|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109604|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109605|NCT05165615|Insulin|insulin|mesh-list
15109606|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109607|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109608|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
15109609|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109610|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109611|NCT05165303|Lidocaine|lidocaine|mesh-list
15109612|NCT05165303|Propofol|propofol|mesh-list
15109613|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
15109614|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
15109615|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109616|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109617|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
15109618|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109619|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15109620|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15109621|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15109622|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15109623|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109624|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15109625|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15109626|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
15109627|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15109628|NCT05165290|Latanoprost|latanoprost|mesh-list
15109629|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15109630|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15109631|NCT05165082|Timolol|timolol|mesh-list
15109632|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15109633|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15109634|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15109635|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15109636|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
15109637|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109638|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109639|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109640|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15109641|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15109642|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
15109643|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15109644|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109645|NCT05164848|Afatinib|afatinib|mesh-list
15109646|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109647|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15109648|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109649|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109650|NCT05164770|Prednisone|prednisone|mesh-list
15109651|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
15109652|NCT05164770|Vincristine|vincristine|mesh-list
15109653|NCT05164770|Rituximab|rituximab|mesh-list
15109654|NCT05164770|Doxorubicin|doxorubicin|mesh-list
15109655|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
15109656|NCT05164770|Etoposide|etoposide|mesh-list
15109657|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109658|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
15109659|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109660|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109661|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15109662|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
15109663|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109664|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109665|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15109666|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109667|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
15109668|NCT05164770|Hormones|hormones|mesh-ancestor
15109669|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109670|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15109671|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109672|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109673|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109674|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109675|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109676|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15109677|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15109678|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15109679|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109680|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15109681|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
15109682|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
15109683|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15109684|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109685|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109686|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15109687|NCT05164627|Analgesics|analgesics|mesh-ancestor
15109688|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
15109689|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109690|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15109691|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15109692|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15109693|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
15109694|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109695|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109696|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
15109697|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15109698|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
15109699|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15109700|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15109701|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15109702|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
15109703|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15109704|NCT05164263|Empagliflozin|empagliflozin|mesh-list
15109705|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15109706|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109707|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109708|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109709|NCT05161741|Insulin|insulin|mesh-list
15109710|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109711|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109712|NCT05153590|Liraglutide|liraglutide|mesh-list
15109713|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109714|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109715|NCT05153590|Incretins|incretins|mesh-ancestor
15109716|NCT05153590|Hormones|hormones|mesh-ancestor
15109717|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109718|NCT05153135|Palbociclib|palbociclib|mesh-list
15109719|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109720|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15109721|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109722|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109723|NCT05146479|Fluorides|fluorides|mesh-list
15109724|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
15109725|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
15109726|NCT05146479|Protective Agents|protective agents|mesh-ancestor
15109727|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109728|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15109729|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15109730|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109731|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109732|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
15109733|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109734|NCT05110209|Bevacizumab|bevacizumab|mesh-list
15109735|NCT05110209|Ranibizumab|ranibizumab|mesh-list
15109736|NCT05110209|Aflibercept|aflibercept|mesh-list
15109737|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109738|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109739|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15109740|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15109741|NCT05110209|Growth Substances|growth substances|mesh-ancestor
15109742|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109743|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
15109744|NCT05096143|Valsartan|valsartan|mesh-list
15109745|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15109746|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15109747|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15109748|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109749|NCT05056974|UB-421|ub-421|mesh-list
15109750|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15109751|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
15109752|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175843|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15175844|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15175845|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15175846|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15175847|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15175848|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
15175849|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15175850|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
15175851|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15175852|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15175853|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15175854|NCT03982992|Blinatumomab|blinatumomab|mesh-list
15175855|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175856|NCT03983031|Rituximab|rituximab|mesh-list
15175857|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175858|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175859|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
15175860|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175861|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175862|NCT03983057|Antibodies|antibodies|mesh-list
15175863|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15175864|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
15175865|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175866|NCT03983018|Rituximab|rituximab|mesh-list
15175867|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175868|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175869|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
15109753|NCT05039944|Irinotecan|irinotecan|mesh-list
15109754|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15109755|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15109756|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109757|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109758|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109759|NCT05023343|Ropivacaine|ropivacaine|mesh-list
15109760|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
15109761|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
15109762|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109763|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109764|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
15109765|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109766|NCT05007145|Paclitaxel|paclitaxel|mesh-list
15109767|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15109768|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15109769|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109770|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109771|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109772|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109773|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109774|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109775|NCT04968951|Metronidazole|metronidazole|mesh-list
15109776|NCT04968951|Vancomycin|vancomycin|mesh-list
15109777|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109778|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15109779|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15109780|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15109781|NCT04952857|Vitamin D|vitamin d|mesh-list
15109782|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
15109783|NCT04952857|Vitamins|vitamins|mesh-ancestor
15109784|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
15109785|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109786|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15109787|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15109788|NCT04928261|Trastuzumab|trastuzumab|mesh-list
15109789|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109790|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109791|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
15109792|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15109793|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109794|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109795|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109796|NCT04825262|Tacrolimus|tacrolimus|mesh-list
15109797|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109798|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
15109799|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109800|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15109801|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109802|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109803|NCT04821830|Levodopa|levodopa|mesh-list
15109804|NCT04821830|Carbidopa|carbidopa|mesh-list
15109805|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15109806|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15109807|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15109808|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
15109809|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109810|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109811|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109812|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15109813|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109814|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15109815|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
15109816|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
15109817|NCT04803994|Bevacizumab|bevacizumab|mesh-list
15109818|NCT04803994|Atezolizumab|atezolizumab|mesh-list
15109819|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109820|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109821|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15109822|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15109823|NCT04803994|Growth Substances|growth substances|mesh-ancestor
15109824|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109825|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
15109826|NCT04693507|Antarelix|antarelix|mesh-list
15109827|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
15109828|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109829|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109830|NCT04618016|Vitamins|vitamins|mesh-list
15109831|NCT04618016|Vitamin E|vitamin e|mesh-list
15109832|NCT04618016|Tocopherols|tocopherols|mesh-list
15109833|NCT04618016|Tocotrienols|tocotrienols|mesh-list
15109834|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
15109835|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
15109836|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109837|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
15109838|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109839|NCT04618016|Protective Agents|protective agents|mesh-ancestor
15109840|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15109841|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15109842|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109843|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
15109844|NCT04527289|Amantadine|amantadine|mesh-list
15109845|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15109846|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15109847|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
15109848|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109849|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
15109850|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109851|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109852|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109853|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15109854|NCT04527289|Analgesics|analgesics|mesh-ancestor
15109855|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
15109856|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109857|NCT04525898|Methadone|methadone|mesh-list
15109858|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15109859|NCT04525898|Narcotics|narcotics|mesh-ancestor
15109860|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109861|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109862|NCT04525898|Analgesics|analgesics|mesh-ancestor
15109863|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
15109864|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109865|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
15109866|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
15109867|NCT04518124|Propranolol|propranolol|mesh-list
15109868|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15109869|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15109870|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
15109871|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15109872|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109873|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109874|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15109875|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15109876|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
15109877|NCT04511052|Carotenoids|carotenoids|mesh-list
15109878|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
15109879|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109880|NCT04511052|Protective Agents|protective agents|mesh-ancestor
15109881|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109882|NCT04460326|Insulin|insulin|mesh-list
15109883|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15109884|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
15109885|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
15109886|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15109887|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109888|NCT04433858|Psilocybin|psilocybin|mesh-list
15109889|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
15109890|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109891|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15109892|NCT04339270|Azithromycin|azithromycin|mesh-list
15109893|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15109894|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109895|NCT04282070|Gemcitabine|gemcitabine|mesh-list
15109896|NCT04282070|Paclitaxel|paclitaxel|mesh-list
15109897|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15109898|NCT04282070|Cisplatin|cisplatin|mesh-list
15109899|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15109900|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109901|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109902|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109903|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109904|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109905|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109906|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
15109907|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
15109908|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15109909|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109910|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109911|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
15109912|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109913|NCT04259255|Edaravone|edaravone|mesh-list
15109914|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15109915|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
15109916|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109917|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15109918|NCT04259255|Protective Agents|protective agents|mesh-ancestor
15109919|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109920|NCT04246554|Acetaminophen|acetaminophen|mesh-list
15109921|NCT04246554|Ketorolac|ketorolac|mesh-list
15109922|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15109923|NCT04246554|Oxycodone|oxycodone|mesh-list
15109924|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15109925|NCT04246554|Analgesics|analgesics|mesh-ancestor
15109926|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
15109927|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15109928|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109929|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
15109930|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15109931|NCT04246554|Narcotics|narcotics|mesh-ancestor
15109932|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15109933|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15109934|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15109935|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109936|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15109937|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109938|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175870|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175871|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175872|NCT03982862|Triamcinolone|triamcinolone|mesh-list
15175873|NCT03982862|Lidocaine|lidocaine|mesh-list
15175874|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
15175875|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15175876|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15175877|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
15175878|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
15175879|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175880|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175881|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
15175882|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175883|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15175884|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15175885|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15175886|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15175887|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175888|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15175889|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
15175890|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15175891|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15175892|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
15175893|NCT03982862|Hormones|hormones|mesh-ancestor
15175894|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15175895|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15175896|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
15175897|NCT03982771|Bortezomib|bortezomib|mesh-list
15175898|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15175899|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
15175900|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175901|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175902|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15175903|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
15175904|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175905|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175906|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15175907|NCT03982849|Silymarin|silymarin|mesh-list
15175908|NCT03982849|Hydroquinone|hydroquinone|mesh-list
15175909|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
15175910|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109939|NCT04101721|Aflibercept|aflibercept|mesh-list
15109940|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15109941|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15109942|NCT04101721|Growth Substances|growth substances|mesh-ancestor
15109943|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109944|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
15109945|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109946|NCT04093570|Decitabine|decitabine|mesh-list
15109947|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15109948|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
15109949|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109950|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109951|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109952|NCT04078906|SMOFlipid|smoflipid|mesh-list
15109953|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
15109954|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15109955|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15109956|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
15109957|NCT04024462|Docetaxel|docetaxel|mesh-list
15109958|NCT04024462|Doxorubicin|doxorubicin|mesh-list
15109959|NCT04024462|Trastuzumab|trastuzumab|mesh-list
15109960|NCT04024462|Pertuzumab|pertuzumab|mesh-list
15109961|NCT04024462|Hormones|hormones|mesh-list
15109962|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15109963|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
15109964|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109965|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15109966|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15109967|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
15109968|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109969|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109970|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15109971|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
15109972|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
15109973|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
15109974|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15109975|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15109976|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15109977|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109978|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109979|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15109980|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
15109981|NCT03978624|Entinostat|entinostat|mesh-list
15109982|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109983|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109984|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15109985|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15109986|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109987|NCT03976310|Benralizumab|benralizumab|mesh-list
15109988|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15109989|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
15109990|NCT03941132|Ustekinumab|ustekinumab|mesh-list
15109991|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
15109992|NCT03934671|Antioxidants|antioxidants|mesh-list
15109993|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15109994|NCT03934671|Protective Agents|protective agents|mesh-ancestor
15109995|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15109996|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
15109997|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15109998|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15109999|NCT03737461|Lidocaine|lidocaine|mesh-list
15110000|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
15110001|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
15110002|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110003|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110004|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
15110005|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110006|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15110007|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15110008|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15110009|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15110010|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110011|NCT03712098|Liraglutide|liraglutide|mesh-list
15110012|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15110013|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110014|NCT03712098|Incretins|incretins|mesh-ancestor
15110015|NCT03712098|Hormones|hormones|mesh-ancestor
15110016|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110017|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
15110018|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110019|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110020|NCT03679091|Clopidogrel|clopidogrel|mesh-list
15110021|NCT03679091|Ticagrelor|ticagrelor|mesh-list
15110022|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15110023|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15110024|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15110025|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15110026|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
15110027|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110028|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110029|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110030|NCT03651518|Rituximab|rituximab|mesh-list
15110031|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15110032|NCT03651518|Ustekinumab|ustekinumab|mesh-list
15110033|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110034|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110035|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
15110036|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110037|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110038|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
15110039|NCT03624517|Octreotide|octreotide|mesh-list
15110040|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110041|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110042|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110043|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15110044|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
15110045|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15110046|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15110047|NCT03592212|Albuterol|albuterol|mesh-list
15110048|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15110049|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
15110050|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110051|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110052|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15110053|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
15110054|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
15110055|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15110056|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15110057|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15110058|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15110059|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
15110060|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110061|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110062|NCT03475381|Ivacaftor|ivacaftor|mesh-list
15110063|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15110064|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15110065|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110066|NCT03465540|Dexamethasone|dexamethasone|mesh-list
15110067|NCT03465540|Azacitidine|azacitidine|mesh-list
15110068|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110069|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
15110070|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
15110071|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110072|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110073|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110074|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
15110075|NCT03465540|Hormones|hormones|mesh-ancestor
15110076|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110077|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110078|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110079|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15110080|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
15110081|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110082|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110083|NCT03436199|Amantadine|amantadine|mesh-list
15110084|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15110085|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15110086|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
15110087|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110088|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
15110089|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110090|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110091|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110092|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15110093|NCT03436199|Analgesics|analgesics|mesh-ancestor
15110094|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
15110095|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110096|NCT03353233|Ropivacaine|ropivacaine|mesh-list
15110097|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
15110098|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
15110099|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110100|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110101|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
15110102|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110103|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
15110104|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110105|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110106|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
15110107|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15110108|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
15110109|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15110110|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
15110111|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110112|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110113|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
15110114|NCT03255252|Cisplatin|cisplatin|mesh-list
15110115|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110116|NCT03250273|Nivolumab|nivolumab|mesh-list
15110117|NCT03250273|Entinostat|entinostat|mesh-list
15110118|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110119|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110120|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15110121|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110122|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15110123|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110124|NCT03217136|Metronidazole|metronidazole|mesh-list
15110125|NCT03217136|Meropenem|meropenem|mesh-list
15110126|NCT03217136|Tazobactam|tazobactam|mesh-list
15110127|NCT03217136|Ceftolozane|ceftolozane|mesh-list
15110128|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
15110129|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110130|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110131|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15110132|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15110133|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15110134|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110135|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110136|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15110137|NCT03217136|Renal Agents|renal agents|mesh-ancestor
15110138|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
15110139|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110140|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110141|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
15110142|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110143|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110144|NCT02979977|Cetuximab|cetuximab|mesh-list
15110145|NCT02979977|Afatinib|afatinib|mesh-list
15110146|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110147|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110148|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15110149|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110150|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110151|NCT02975492|Vitamin D|vitamin d|mesh-list
15110152|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
15110153|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
15110154|NCT02975492|Vitamins|vitamins|mesh-list
15110155|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
15110156|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110157|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15110158|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15175911|NCT03982849|Protective Agents|protective agents|mesh-ancestor
15175912|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175913|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15175914|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15110159|NCT02866682|Tacrolimus|tacrolimus|mesh-list
15110160|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110161|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
15110162|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110163|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15110164|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110165|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110166|NCT02864251|Carboplatin|carboplatin|mesh-list
15110167|NCT02864251|Nivolumab|nivolumab|mesh-list
15110168|NCT02864251|Pemetrexed|pemetrexed|mesh-list
15110169|NCT02864251|Ipilimumab|ipilimumab|mesh-list
15110170|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110171|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110172|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15110173|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110174|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110175|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15110176|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15110177|NCT02855229|Methylphenidate|methylphenidate|mesh-list
15110178|NCT02855229|Modafinil|modafinil|mesh-list
15110179|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15110180|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110181|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15110182|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15110183|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15110184|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110185|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
15110186|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110187|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15110188|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15110189|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15110190|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15110191|NCT02827526|Ketamine|ketamine|mesh-list
15110192|NCT02827526|Analgesics|analgesics|mesh-ancestor
15110193|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
15110194|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110195|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110196|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15110197|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15110198|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
15110199|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
15110200|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110201|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15110202|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15110203|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110204|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110205|NCT02743923|Paclitaxel|paclitaxel|mesh-list
15110206|NCT02743923|Bevacizumab|bevacizumab|mesh-list
15110207|NCT02743923|Carboplatin|carboplatin|mesh-list
15110208|NCT02743923|Pemetrexed|pemetrexed|mesh-list
15110209|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15110210|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110211|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
15110212|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
15110213|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
15110214|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110215|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110216|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15110217|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15110218|NCT02743923|Growth Substances|growth substances|mesh-ancestor
15110219|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110220|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
15110221|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110222|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15110223|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15110224|NCT02735707|Aspirin|aspirin|mesh-list
15110225|NCT02735707|Vitamins|vitamins|mesh-list
15110226|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
15110227|NCT02735707|Interferons|interferons|mesh-list
15110228|NCT02735707|Ritonavir|ritonavir|mesh-list
15110229|NCT02735707|Lopinavir|lopinavir|mesh-list
15110230|NCT02735707|Interferon-beta|interferon-beta|mesh-list
15110231|NCT02735707|Oseltamivir|oseltamivir|mesh-list
15110232|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
15110233|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
15110234|NCT02735707|Amoxicillin|amoxicillin|mesh-list
15110235|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
15110236|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
15110237|NCT02735707|Levofloxacin|levofloxacin|mesh-list
15110238|NCT02735707|Ivermectin|ivermectin|mesh-list
15110239|NCT02735707|Tazobactam|tazobactam|mesh-list
15110240|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
15110241|NCT02735707|Piperacillin|piperacillin|mesh-list
15110242|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
15110243|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
15110244|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15110245|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15110246|NCT02735707|Apremilast|apremilast|mesh-list
15110247|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
15110248|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15110249|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15110250|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15110251|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15110252|NCT02735707|Losartan|losartan|mesh-list
15110253|NCT02735707|Valsartan|valsartan|mesh-list
15110254|NCT02735707|Telmisartan|telmisartan|mesh-list
15110255|NCT02735707|Candesartan|candesartan|mesh-list
15110256|NCT02735707|Ramipril|ramipril|mesh-list
15110257|NCT02735707|Olmesartan|olmesartan|mesh-list
15110258|NCT02735707|Enalapril|enalapril|mesh-list
15110259|NCT02735707|Lisinopril|lisinopril|mesh-list
15110260|NCT02735707|Irbesartan|irbesartan|mesh-list
15110261|NCT02735707|Perindopril|perindopril|mesh-list
15110262|NCT02735707|Captopril|captopril|mesh-list
15110263|NCT02735707|Trandolapril|trandolapril|mesh-list
15110264|NCT02735707|Clopidogrel|clopidogrel|mesh-list
15110265|NCT02735707|Ticagrelor|ticagrelor|mesh-list
15110266|NCT02735707|Simvastatin|simvastatin|mesh-list
15110267|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15110268|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
15110269|NCT02735707|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15110270|NCT02735707|Antibodies|antibodies|mesh-list
15110271|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15110272|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15110273|NCT02735707|Cysteamine|cysteamine|mesh-list
15110274|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
15110275|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110276|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110277|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110278|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15110279|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15110280|NCT02735707|Analgesics|analgesics|mesh-ancestor
15110281|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
15110282|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110283|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110284|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110285|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15110286|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15110287|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110288|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15110289|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15110290|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
15110291|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15110292|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15110293|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
15110294|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15110295|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15110296|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15110297|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15110298|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15110299|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15110300|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15110301|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
15110302|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110303|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110304|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15110305|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15110306|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
15110307|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15110308|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15110309|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15110310|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15110311|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
15110312|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15110313|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15110314|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
15110315|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15110316|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15110317|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15110318|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
15110319|NCT02735707|Protective Agents|protective agents|mesh-ancestor
15110320|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15110321|NCT02735707|Renal Agents|renal agents|mesh-ancestor
15110322|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15110323|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15110324|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15110325|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15110326|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15110327|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15110328|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
15110329|NCT02431247|Tenofovir|tenofovir|mesh-list
15110330|NCT02431247|Emtricitabine|emtricitabine|mesh-list
15110331|NCT02431247|Darunavir|darunavir|mesh-list
15110332|NCT02431247|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15110333|NCT02431247|Cobicistat|cobicistat|mesh-list
15110334|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15110335|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
15110336|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110337|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15110338|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15110339|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110340|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110341|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15110342|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15110343|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15110344|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15110345|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
15110346|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15110347|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15110348|NCT02397226|Anesthetics|anesthetics|mesh-list
15110349|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110350|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110351|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
15110352|NCT02345850|Methotrexate|methotrexate|mesh-list
15110353|NCT02345850|Tacrolimus|tacrolimus|mesh-list
15110354|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110355|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
15110356|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110357|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110358|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15110359|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
15110360|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110361|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110362|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15110363|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15110364|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
15110365|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15110366|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15110367|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
15110368|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
15110369|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110370|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15110371|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15110372|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15110373|NCT02281084|Azacitidine|azacitidine|mesh-list
15110374|NCT02281084|Durvalumab|durvalumab|mesh-list
15110375|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15110376|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
15110377|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110378|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110379|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110380|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110381|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
15110382|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
15110383|NCT02220985|Thiotepa|thiotepa|mesh-list
15110384|NCT02220985|Methotrexate|methotrexate|mesh-list
15110385|NCT02220985|Fludarabine|fludarabine|mesh-list
15110386|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
15110387|NCT02220985|Tacrolimus|tacrolimus|mesh-list
15110388|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110389|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
15110390|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110391|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110392|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15110393|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
15110394|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110395|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110396|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15110397|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15110398|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
15110399|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15110400|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15110401|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
15110402|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
15110403|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110404|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15110405|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15110406|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15110407|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15110408|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15110409|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
15110410|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110411|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110412|NCT02109081|Dexamethasone|dexamethasone|mesh-list
15110413|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110414|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
15110415|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
15110416|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110417|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110418|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110419|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
15110420|NCT02109081|Hormones|hormones|mesh-ancestor
15110421|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110422|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110423|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110424|NCT01962792|Dexamethasone|dexamethasone|mesh-list
15110425|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110426|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
15110427|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
15110428|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110429|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110430|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110431|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
15110432|NCT01962792|Hormones|hormones|mesh-ancestor
15110433|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110434|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110435|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110436|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
15110437|NCT01850108|Sirolimus|sirolimus|mesh-list
15110438|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
15110439|NCT01850108|Fludarabine|fludarabine|mesh-list
15110440|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
15110441|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110442|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
15110443|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110444|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110445|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15110446|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
15110447|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110448|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110449|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15110450|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15110451|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15110452|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
15110453|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110454|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110455|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110456|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
15110457|NCT01546948|Methadone|methadone|mesh-list
15110458|NCT01546948|Hydromorphone|hydromorphone|mesh-list
15110459|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15110460|NCT01546948|Narcotics|narcotics|mesh-ancestor
15110461|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110462|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110463|NCT01546948|Analgesics|analgesics|mesh-ancestor
15110464|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
15110465|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110466|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
15110467|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
15110468|NCT01495676|Gemcitabine|gemcitabine|mesh-list
15110469|NCT01495676|Cisplatin|cisplatin|mesh-list
15110470|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110471|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15110472|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
15110473|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110474|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
15110475|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110476|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110477|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110478|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
15110479|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110480|NCT01464164|Prednisone|prednisone|mesh-list
15110481|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110482|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
15110483|NCT01464164|Hormones|hormones|mesh-ancestor
15110484|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110485|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110486|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110487|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110488|NCT01318317|Plerixafor|plerixafor|mesh-list
15110489|NCT01318317|Rituximab|rituximab|mesh-list
15110490|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15110491|NCT01318317|Antibodies|antibodies|mesh-list
15110492|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
15110493|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15110494|NCT01318317|Lenograstim|lenograstim|mesh-list
15110495|NCT01318317|Sargramostim|sargramostim|mesh-list
15110496|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
15110497|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110498|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110499|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110500|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15110501|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15110502|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15110503|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
15110504|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110505|NCT01111565|Aripiprazole|aripiprazole|mesh-list
15110506|NCT01111565|Citalopram|citalopram|mesh-list
15110507|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15110508|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15110509|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15110510|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110511|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110512|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
15110513|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110514|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15110515|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
15110516|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15110517|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15110518|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15110519|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110520|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
15110521|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
15110522|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15110523|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15110524|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15110525|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15110526|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15110527|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15110528|NCT00950989|Folic Acid|folic acid|mesh-list
15110529|NCT00950989|Methotrexate|methotrexate|mesh-list
15110530|NCT00950989|Brodalumab|brodalumab|mesh-list
15110531|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15110532|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
15110533|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15110534|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110535|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15110536|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
15110537|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110538|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110539|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
13996176|NCT02922348|Norgestimate|norgestimate|mesh-list
15110540|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110541|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15110542|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110543|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
15110544|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110545|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15110546|NCT00950989|Hematinics|hematinics|mesh-ancestor
15110547|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
15110548|NCT00950989|Vitamins|vitamins|mesh-ancestor
15110549|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
15110550|NCT00904046|Pioglitazone|pioglitazone|mesh-list
15110551|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
15110552|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15110553|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110554|NCT00489307|Dexamethasone|dexamethasone|mesh-list
15110555|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110556|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
15110557|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
15110558|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110559|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110560|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110561|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
15110562|NCT00489307|Hormones|hormones|mesh-ancestor
15110563|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110564|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110565|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110566|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15110567|NCT00072410|Antibodies|antibodies|mesh-list
15110568|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
15110569|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15110570|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
15110571|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110572|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110573|NCT05171400|Insulin|insulin|mesh-list
15110574|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15110575|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110576|NCT05171374|Trametinib|trametinib|mesh-list
15110577|NCT05171374|Dabrafenib|dabrafenib|mesh-list
15110578|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110579|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15110580|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110581|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110582|NCT05171335|Lenvatinib|lenvatinib|mesh-list
15110583|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110584|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15110585|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110586|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110587|NCT05171309|Apatinib|apatinib|mesh-list
15110588|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110589|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15110590|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110591|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110592|NCT05171179|Lidocaine|lidocaine|mesh-list
15110593|NCT05171179|Bupivacaine|bupivacaine|mesh-list
15110594|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
15110595|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
15110596|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110597|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110598|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
15110599|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110600|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15110601|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15110602|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15110603|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15110604|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110605|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
15110606|NCT05170828|Sirolimus|sirolimus|mesh-list
15110607|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
15110608|NCT05170828|Busulfan|busulfan|mesh-list
15110609|NCT05170828|Fludarabine|fludarabine|mesh-list
15110610|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110611|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
15110612|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110613|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110614|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15110615|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
15110616|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110617|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110618|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15110619|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15110620|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15110621|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
15110622|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110623|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110624|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110625|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
15110626|NCT05170789|Dexamethasone|dexamethasone|mesh-list
15110627|NCT05170789|Elotuzumab|elotuzumab|mesh-list
15110628|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110629|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
15110630|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
15110631|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110632|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110633|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110634|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
15110635|NCT05170789|Hormones|hormones|mesh-ancestor
15110636|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110637|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110638|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110639|NCT05170607|Antibodies|antibodies|mesh-list
15110640|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
15110641|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110642|NCT05170594|Bevacizumab|bevacizumab|mesh-list
15110643|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
15110644|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110645|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110646|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15110647|NCT05170594|Growth Substances|growth substances|mesh-ancestor
15110648|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110649|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
15110650|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15110651|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110652|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110653|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15110654|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
15110655|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15110656|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175915|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15175916|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175917|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
15175918|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
15175919|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15175920|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
15175921|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175922|NCT03982537|Expectorants|expectorants|mesh-ancestor
15175923|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
15175924|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15175925|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
15175926|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175927|NCT03982537|Protective Agents|protective agents|mesh-ancestor
15175928|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175929|NCT03982537|Antidotes|antidotes|mesh-ancestor
15175930|NCT03982784|Morphine|morphine|mesh-list
15175931|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15175932|NCT03982784|Narcotics|narcotics|mesh-ancestor
15175933|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15175934|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175935|NCT03982784|Analgesics|analgesics|mesh-ancestor
15175936|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
15175937|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15175938|NCT03982381|Metformin|metformin|mesh-list
15175939|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
15175940|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15175941|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175942|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15175943|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175944|NCT03982680|Gemcitabine|gemcitabine|mesh-list
15175945|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15175946|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
15175947|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175948|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110657|NCT05170256|Trastuzumab|trastuzumab|mesh-list
15110658|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110659|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110660|NCT05170217|Cannabidiol|cannabidiol|mesh-list
15110661|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
15110662|NCT05170113|Caffeine|caffeine|mesh-list
15110663|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15110664|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110665|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15110666|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110667|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110668|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15110669|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15110670|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
15110671|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110672|NCT05170061|Valsartan|valsartan|mesh-list
15110673|NCT05170061|Nebivolol|nebivolol|mesh-list
15110674|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15110675|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15110676|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15110677|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110678|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
15110679|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15110680|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15110681|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15110682|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
15110683|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110684|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110685|NCT05170009|Oseltamivir|oseltamivir|mesh-list
15110686|NCT05170009|Baloxavir|baloxavir|mesh-list
15110687|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
15110688|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110689|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110690|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110691|NCT05169801|Paclitaxel|paclitaxel|mesh-list
15110692|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15110693|NCT05169801|Carboplatin|carboplatin|mesh-list
15110694|NCT05169801|Bevacizumab|bevacizumab|mesh-list
15110695|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15110696|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110697|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
15110698|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
15110699|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
15110700|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110701|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110702|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15110703|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15110704|NCT05169801|Growth Substances|growth substances|mesh-ancestor
15110705|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110706|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
15110707|NCT05169593|Adalimumab|adalimumab|mesh-list
15110708|NCT05169593|Infliximab|infliximab|mesh-list
15110709|NCT05169593|Ustekinumab|ustekinumab|mesh-list
15110710|NCT05169593|Vedolizumab|vedolizumab|mesh-list
15110711|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110712|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110713|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
15110714|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110715|NCT05169554|Amoxicillin|amoxicillin|mesh-list
15110716|NCT05169554|Clarithromycin|clarithromycin|mesh-list
15110717|NCT05169554|Rifampin|rifampin|mesh-list
15110718|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
15110719|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
15110720|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15110721|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110722|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110723|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15110724|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110725|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110726|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15110727|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15110728|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15110729|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
15110730|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
15110731|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15110732|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15110733|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15110734|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15110735|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15110736|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15110737|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15110738|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15110739|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15110740|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110741|NCT05169229|Vancomycin|vancomycin|mesh-list
15110742|NCT05169229|Tobramycin|tobramycin|mesh-list
15110743|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110744|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110745|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
15110746|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15110747|NCT05169112|Leuprolide|leuprolide|mesh-list
15110748|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15110749|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
15110750|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15110751|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110752|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110753|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110754|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
15110755|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15110756|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15110757|NCT05169060|Analgesics|analgesics|mesh-ancestor
15110758|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
15110759|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110760|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110761|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110762|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110763|NCT05169021|Folic Acid|folic acid|mesh-list
15110764|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
15110765|NCT05169021|Amlodipine|amlodipine|mesh-list
15110766|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
15110767|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15110768|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15110769|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110770|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15110771|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110772|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
15110773|NCT05169021|Hematinics|hematinics|mesh-ancestor
15110774|NCT05169021|Vitamins|vitamins|mesh-ancestor
15110775|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
15110776|NCT05168787|Valsartan|valsartan|mesh-list
15110777|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15110778|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15110779|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15110780|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110781|NCT05168566|Maleic acid|maleic acid|mesh-list
15110782|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110783|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110784|NCT05168475|Rituximab|rituximab|mesh-list
15110785|NCT05168475|Infliximab|infliximab|mesh-list
15110786|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110787|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110788|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
15110789|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110790|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110791|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
15110792|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110793|NCT05168176|Dolutegravir|dolutegravir|mesh-list
15110794|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15110795|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15110796|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110797|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110798|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15110799|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15110800|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
15110801|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110802|NCT05168137|Colchicine|colchicine|mesh-list
15110803|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
15110804|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110805|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
15110806|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
15110807|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
15110808|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110809|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110810|NCT05168059|Clevidipine|clevidipine|mesh-list
15110811|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15110812|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15110813|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110814|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15110815|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110816|NCT05168007|Cariprazine|cariprazine|mesh-list
15110817|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15110818|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15110819|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110820|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110821|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15110822|NCT05167851|Lazertinib|lazertinib|mesh-list
15110823|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15110824|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110825|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110826|NCT05167760|Apraclonidine|apraclonidine|mesh-list
15110827|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15110828|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15110829|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15110830|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
15110831|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110832|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110833|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175949|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
15175950|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175951|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175952|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15175953|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
15175954|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175955|NCT03982134|Panobinostat|panobinostat|mesh-list
15175956|NCT03982134|Spartalizumab|spartalizumab|mesh-list
15175957|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15175958|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15175959|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175960|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175961|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15175962|NCT03982277|Rifampin|rifampin|mesh-list
15175963|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15175964|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
15175965|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15175966|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15175967|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
15175968|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15175969|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15175970|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175971|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15175972|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15175973|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15175974|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15175975|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15175976|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15175977|NCT03982082|Coal Tar|coal tar|mesh-list
15175978|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
15175979|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
15175980|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
15175981|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
15175982|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15175983|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
15175984|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175985|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15175986|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15175987|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
15175988|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15175989|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
15175990|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15175991|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15175992|NCT03982173|Durvalumab|durvalumab|mesh-list
15175993|NCT03982173|Tremelimumab|tremelimumab|mesh-list
15175994|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15175995|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110834|NCT05167513|Metformin|metformin|mesh-list
15110835|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15110836|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15110837|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110838|NCT05167513|Incretins|incretins|mesh-ancestor
15110839|NCT05167513|Hormones|hormones|mesh-ancestor
15110840|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110841|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15110842|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
15110843|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110844|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110845|NCT05167175|Prednisone|prednisone|mesh-list
15110846|NCT05167175|Olaparib|olaparib|mesh-list
15110847|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
15110848|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110849|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
15110850|NCT05167175|Hormones|hormones|mesh-ancestor
15110851|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110852|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110853|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110854|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110855|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15110856|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110857|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110858|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15110859|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
15110860|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15110861|NCT05167123|Calcium|calcium|mesh-list
15110862|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15110863|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110864|NCT05166668|Letrozole|letrozole|mesh-list
15110865|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110866|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15110867|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15110868|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15110869|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110870|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15110871|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
15110872|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110873|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110874|NCT05166538|Clopidogrel|clopidogrel|mesh-list
15110875|NCT05166538|Ticagrelor|ticagrelor|mesh-list
15110876|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15110877|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15110878|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15110879|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15110880|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
15110881|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110882|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110883|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110884|NCT05161429|Insulin|insulin|mesh-list
15110885|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15110886|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110887|NCT05159453|Insulin|insulin|mesh-list
15110888|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15110889|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15110890|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110891|NCT05148949|Vaccines|vaccines|mesh-list
15110892|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
15110893|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110894|NCT05148377|Heparin|heparin|mesh-list
15110895|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
15110896|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15110897|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15110898|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110899|NCT05144698|Sirolimus|sirolimus|mesh-list
15110900|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110901|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110902|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15110903|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110904|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
15110905|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110906|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
15110907|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110908|NCT05141721|Bevacizumab|bevacizumab|mesh-list
15110909|NCT05141721|Ipilimumab|ipilimumab|mesh-list
15110910|NCT05141721|Oxaliplatin|oxaliplatin|mesh-list
15110911|NCT05141721|Atezolizumab|atezolizumab|mesh-list
15110912|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110913|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110914|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15110915|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15110916|NCT05141721|Growth Substances|growth substances|mesh-ancestor
15110917|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110918|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
15110919|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15110920|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110921|NCT05133531|Ravulizumab|ravulizumab|mesh-list
15110922|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15110923|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15110924|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
15110925|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110926|NCT05132920|Dexamethasone|dexamethasone|mesh-list
15110927|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110928|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
15110929|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
15110930|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110931|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110932|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110933|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
15110934|NCT05132920|Hormones|hormones|mesh-ancestor
15110935|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110936|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15110937|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110938|NCT05116059|Amphotericin B|amphotericin b|mesh-list
15110939|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15110940|NCT05116059|Amebicides|amebicides|mesh-ancestor
15110941|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15110942|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15110943|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15110944|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15110945|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
15110946|NCT05111912|Liraglutide|liraglutide|mesh-list
15110947|NCT05111912|Glucagon|glucagon|mesh-list
15110948|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15110949|NCT05111912|Incretins|incretins|mesh-ancestor
15110950|NCT05111912|Hormones|hormones|mesh-ancestor
15110951|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15110952|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110953|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15110954|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14269339|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269340|NCT00402194|Losartan|losartan|mesh-list
14269341|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14269342|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14269343|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14269344|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14269345|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269346|NCT00402233|Pramipexole|pramipexole|mesh-list
15110955|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
15110956|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15110957|NCT05105672|Cisplatin|cisplatin|mesh-list
15110958|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110959|NCT05093517|Volagidemab|volagidemab|mesh-list
15110960|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15110961|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15175996|NCT03982238|Metformin|metformin|mesh-list
15175997|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
15175998|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15175999|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176000|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15176001|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176002|NCT03982121|Nivolumab|nivolumab|mesh-list
15176003|NCT03982121|Ipilimumab|ipilimumab|mesh-list
15176004|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176005|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176006|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15176007|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181652|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269347|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
15110962|NCT05075161|Pirfenidone|pirfenidone|mesh-list
15110963|NCT05075161|Analgesics|analgesics|mesh-ancestor
15110964|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
15110965|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110966|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110967|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15110968|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15110969|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15110970|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15110971|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110972|NCT05070156|Vaccines|vaccines|mesh-list
15110973|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
14269348|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269349|NCT00402233|Protective Agents|protective agents|mesh-ancestor
14269350|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269351|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15110974|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110975|NCT05067920|Antibodies|antibodies|mesh-list
15110976|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
15110977|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110978|NCT05061550|Durvalumab|durvalumab|mesh-list
15110979|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15110980|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15110981|NCT05053828|Clopidogrel|clopidogrel|mesh-list
15110982|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15110983|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15110984|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15110985|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15110986|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
15110987|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15110988|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15110989|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110990|NCT05051189|Fentanyl|fentanyl|mesh-list
15110991|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15110992|NCT05051189|Narcotics|narcotics|mesh-ancestor
15110993|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15110994|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15110995|NCT05051189|Analgesics|analgesics|mesh-ancestor
15110996|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
15110997|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15110998|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15110999|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15111000|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
15111001|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
15111002|NCT05031078|Lidocaine|lidocaine|mesh-list
15111003|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111004|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
15111005|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
15111006|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111007|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
15111008|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111009|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15111010|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15111011|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15111012|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15111013|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111014|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15111015|NCT05024188|Metronidazole|metronidazole|mesh-list
15111016|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
15111017|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111018|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15111019|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15111020|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15111021|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15111022|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111023|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111024|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111025|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15111026|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15111027|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15111028|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
15111029|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15111030|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15111031|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
15111032|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111033|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15111034|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15111035|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111036|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15111037|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15111038|NCT04982367|Sirolimus|sirolimus|mesh-list
15111039|NCT04982367|Paclitaxel|paclitaxel|mesh-list
15111040|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15111041|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111042|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111043|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111044|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111045|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111046|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111047|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111048|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111049|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15111050|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
15111051|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111052|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
15111053|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111054|NCT04975152|Cemiplimab|cemiplimab|mesh-list
15111055|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111056|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111057|NCT04965506|Dulaglutide|dulaglutide|mesh-list
15111058|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15111059|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111060|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15111061|NCT04960930|Minocycline|minocycline|mesh-list
15111062|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111063|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111064|NCT04957368|Midazolam|midazolam|mesh-list
15111065|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
15111066|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15111067|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15111068|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111069|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111070|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15111071|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15111072|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15111073|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15111074|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
15111075|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
15111076|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
15111077|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
15111078|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111079|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111080|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15111081|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15111082|NCT04957368|Analgesics|analgesics|mesh-ancestor
15111083|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
15111084|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111085|NCT04933682|Rifampin|rifampin|mesh-list
15111086|NCT04933682|Fluconazole|fluconazole|mesh-list
15111087|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15111088|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
15111089|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111090|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111091|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
15111092|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15111093|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111094|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111095|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15111096|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15111097|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15111098|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15111099|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15111100|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15111101|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
15111102|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15111103|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15111104|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15111105|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
15111106|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111107|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111108|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15111109|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15111110|NCT04929600|Amlodipine|amlodipine|mesh-list
15111111|NCT04929600|Valsartan|valsartan|mesh-list
15111112|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15111113|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15111114|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15111115|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111116|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15111117|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111118|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
15111119|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15111120|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15111121|NCT04928521|Bupivacaine|bupivacaine|mesh-list
15111122|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
15111123|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
15111124|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111125|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111126|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
15111127|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111128|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
15111129|NCT04889118|Lenvatinib|lenvatinib|mesh-list
15111130|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111131|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111132|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15111133|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111134|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111135|NCT04885530|Fluticasone|fluticasone|mesh-list
15111136|NCT04885530|Xhance|xhance|mesh-list
15111137|NCT04885530|Ivermectin|ivermectin|mesh-list
15111138|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
15111139|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15111140|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15111141|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
15111142|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111143|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111144|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15111145|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
15111146|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
15111147|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15111148|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111149|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111150|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15111151|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111152|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15111153|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15111154|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111155|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15111156|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15111157|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15111158|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15111159|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111160|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
15111161|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15111162|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
15111163|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15111164|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15111165|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15111166|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15111167|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
15111168|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
15111169|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111170|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15111171|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
15111172|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111173|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111174|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15111175|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15176008|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
15111176|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15111177|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176009|NCT03982004|Imiquimod|imiquimod|mesh-list
15176010|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176011|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176012|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15176013|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
15176014|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176015|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
15176016|NCT03981887|Nafithromycin|nafithromycin|mesh-list
15176017|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269352|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14269353|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
14269354|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
14269355|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269356|NCT00402285|Lycopene|lycopene|mesh-list
14269357|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269358|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
14269359|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176018|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176019|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15176020|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176021|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176022|NCT03981900|Tofacitinib|tofacitinib|mesh-list
15176023|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15176024|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176025|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176026|NCT03981601|Lovastatin|lovastatin|mesh-list
15176027|NCT03981601|L 647318|l 647318|mesh-list
15176028|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
15176029|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15176030|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15176031|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
15176032|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176033|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15176034|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15176035|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176036|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
15176037|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15176038|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176039|NCT03981770|Anesthetics|anesthetics|mesh-list
15176040|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176041|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176042|NCT03981484|Thrombin|thrombin|mesh-list
15176043|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
15176044|NCT03981484|Coagulants|coagulants|mesh-ancestor
15176045|NCT03981523|Benzonidazole|benzonidazole|mesh-list
15176046|NCT03981523|Nifurtimox|nifurtimox|mesh-list
15176047|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15176048|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
15176049|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176050|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15176051|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15176052|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15176053|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176054|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
15176055|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15176056|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
15176057|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176058|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
15176059|NCT03981458|Protective Agents|protective agents|mesh-ancestor
15176060|NCT03981146|Nivolumab|nivolumab|mesh-list
15176061|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176062|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176063|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15176064|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176065|NCT03981068|Nimorazole|nimorazole|mesh-list
15176066|NCT03981068|Cisplatin|cisplatin|mesh-list
15176067|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176068|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15176069|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15176070|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15176071|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176072|NCT03981081|Prednisone|prednisone|mesh-list
15176073|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176074|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
14269360|NCT00402285|Protective Agents|protective agents|mesh-ancestor
15176075|NCT03981081|Hormones|hormones|mesh-ancestor
15111178|NCT04817241|Cytarabine|cytarabine|mesh-list
15111179|NCT04817241|Decitabine|decitabine|mesh-list
15111180|NCT04817241|Daunorubicin|daunorubicin|mesh-list
15111181|NCT04817241|Venetoclax|venetoclax|mesh-list
15111182|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111183|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
15111184|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111185|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111186|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
15111187|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111188|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111189|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
15111190|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111191|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111192|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15111193|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15111194|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15111195|NCT04812002|Bevacizumab|bevacizumab|mesh-list
15111196|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15111197|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111198|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111199|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15111200|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15111201|NCT04812002|Growth Substances|growth substances|mesh-ancestor
15111202|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111203|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
15111204|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111205|NCT04809311|Insulin|insulin|mesh-list
15111206|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15111207|NCT04809311|Glucagon|glucagon|mesh-list
15111208|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15111209|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15111210|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111211|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15111212|NCT04809311|Hormones|hormones|mesh-ancestor
15111213|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111214|NCT04809311|Incretins|incretins|mesh-ancestor
15111215|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15111216|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15111217|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111218|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15111219|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
15111220|NCT04784208|Hormones|hormones|mesh-list
15111221|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111222|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111223|NCT04780321|Antibodies|antibodies|mesh-list
15111224|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15111225|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
15111226|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111227|NCT04780204|Tenofovir|tenofovir|mesh-list
15111228|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
15111229|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111230|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15111231|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15111232|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111233|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111234|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15111235|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15111236|NCT04772547|Vigabatrin|vigabatrin|mesh-list
15111237|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
15111238|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111239|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111240|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
15111241|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111242|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111243|NCT04769206|Galantamine|galantamine|mesh-list
15111244|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15111245|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111246|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111247|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
15111248|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111249|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111250|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15111251|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
15111252|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111253|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
15111254|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15111255|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15111256|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111257|NCT04757090|Trastuzumab|trastuzumab|mesh-list
15111258|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111259|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111260|NCT04727307|Bevacizumab|bevacizumab|mesh-list
15111261|NCT04727307|Atezolizumab|atezolizumab|mesh-list
15111262|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15111263|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111264|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111265|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15111266|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15111267|NCT04727307|Growth Substances|growth substances|mesh-ancestor
15111268|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111269|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
15111270|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
15111271|NCT04726969|Ivermectin|ivermectin|mesh-list
15111272|NCT04726969|Albendazole|albendazole|mesh-list
15111273|NCT04726969|Moxidectin|moxidectin|mesh-list
15111274|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15111275|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111276|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
15111277|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
15111278|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15111279|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15111280|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111281|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111282|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111283|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111284|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111285|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
15111286|NCT04691960|Metformin|metformin|mesh-list
15111287|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15111288|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111289|NCT04679012|Prednisone|prednisone|mesh-list
15111290|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
15111291|NCT04679012|Rituximab|rituximab|mesh-list
15111292|NCT04679012|Doxorubicin|doxorubicin|mesh-list
15111293|NCT04679012|Etoposide|etoposide|mesh-list
15111294|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15111295|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111296|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
15111297|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111298|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111299|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15111300|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
15111301|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111302|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111303|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15111304|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111305|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15111306|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15111307|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15111308|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111309|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15111310|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
15111311|NCT04679012|Hormones|hormones|mesh-ancestor
15111312|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111313|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15111314|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111315|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
15111316|NCT04673617|Rituximab|rituximab|mesh-list
15111317|NCT04673617|Fludarabine|fludarabine|mesh-list
15111318|NCT04673617|Interleukin-2|interleukin-2|mesh-list
15111319|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111320|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
15111321|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111322|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111323|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15111324|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
15111325|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111326|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111327|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15111328|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111329|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15111330|NCT04673617|Analgesics|analgesics|mesh-ancestor
15111331|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
15111332|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111333|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
15111334|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
15111335|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111336|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15111337|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15111338|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
15111339|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111340|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111341|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15111342|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15111343|NCT04648930|Omalizumab|omalizumab|mesh-list
15111344|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15111345|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15111346|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
15111347|NCT04648033|Atovaquone|atovaquone|mesh-list
15111348|NCT04648033|Cisplatin|cisplatin|mesh-list
15111349|NCT04648033|Vinorelbine|vinorelbine|mesh-list
15111350|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111351|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111352|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111353|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111354|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111355|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111356|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111357|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
15111358|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15111359|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15111360|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111361|NCT04645212|Aflibercept|aflibercept|mesh-list
15111362|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15111363|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15111364|NCT04645212|Growth Substances|growth substances|mesh-ancestor
15111365|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111366|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
15111367|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111368|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
15111369|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
15111370|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111371|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
15111372|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111373|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111374|NCT04632706|Ivermectin|ivermectin|mesh-list
15111375|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15111376|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111377|NCT04629781|Docetaxel|docetaxel|mesh-list
15111378|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111379|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111380|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111381|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111382|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111383|NCT04620187|Cisplatin|cisplatin|mesh-list
15111384|NCT04620187|Carboplatin|carboplatin|mesh-list
15111385|NCT04620187|Trastuzumab|trastuzumab|mesh-list
15111386|NCT04620187|Maytansine|maytansine|mesh-list
15111387|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111388|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111389|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111390|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111391|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111392|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111393|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111394|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15111395|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111396|NCT04588818|Adalimumab|adalimumab|mesh-list
15111397|NCT04588818|Methotrexate|methotrexate|mesh-list
15111398|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15111399|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
15111400|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15111401|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111402|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111403|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
15111404|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111405|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111406|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
15111407|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111408|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15111409|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111410|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
15111411|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111412|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15111413|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176076|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176077|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176078|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15176079|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176080|NCT03981094|Pirfenidone|pirfenidone|mesh-list
15176081|NCT03981094|Analgesics|analgesics|mesh-ancestor
15176082|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
15176083|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176084|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176085|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15176086|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15176087|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176088|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176089|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176090|NCT03981029|Folic Acid|folic acid|mesh-list
15176091|NCT03981029|Hematinics|hematinics|mesh-ancestor
15176092|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
15176093|NCT03981029|Vitamins|vitamins|mesh-ancestor
15176094|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
15176095|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176096|NCT03980847|Alendronate|alendronate|mesh-list
15176097|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15176098|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176099|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
15176100|NCT03980951|Narcotics|narcotics|mesh-ancestor
15176101|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176102|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176103|NCT03980951|Analgesics|analgesics|mesh-ancestor
15176104|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
15176105|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176106|NCT03980990|Metformin|metformin|mesh-list
15176107|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15176108|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176109|NCT03980756|Esomeprazole|esomeprazole|mesh-list
14269361|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269362|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15176110|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15176111|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176112|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15176113|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176114|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176115|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
15176116|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176117|NCT03980379|Rituximab|rituximab|mesh-list
15176118|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176119|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176120|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
15176121|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176122|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176123|NCT03980496|Omeprazole|omeprazole|mesh-list
15176124|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15176125|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176126|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15176127|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176128|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176129|NCT03980223|Doxycycline|doxycycline|mesh-list
15176130|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269363|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14269364|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269365|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14269366|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
14269367|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176131|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176132|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
15111414|NCT04579510|Vaccines|vaccines|mesh-list
15111415|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
15111416|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111417|NCT04540835|Calcium|calcium|mesh-list
15111418|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15111419|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111420|NCT04539730|Bupivacaine|bupivacaine|mesh-list
15111421|NCT04539730|Ropivacaine|ropivacaine|mesh-list
15111422|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
15111423|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
15111424|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111425|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111426|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
15111427|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111428|NCT04535791|Vitamin D|vitamin d|mesh-list
15111429|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
15111430|NCT04535791|Vitamins|vitamins|mesh-ancestor
15111431|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
15111432|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111433|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15111434|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15111435|NCT04523246|Vaccines|vaccines|mesh-list
15111436|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
15111437|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111438|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
15111439|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15111440|NCT04500847|Emtricitabine|emtricitabine|mesh-list
15111441|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
15111442|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111443|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15111444|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15111445|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111446|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111447|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15111448|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15111449|NCT04484675|Milrinone|milrinone|mesh-list
15111450|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15111451|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15111452|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
15111453|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15111454|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15111455|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111456|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111457|NCT04484675|Protective Agents|protective agents|mesh-ancestor
15111458|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111459|NCT04483115|Tadalafil|tadalafil|mesh-list
15111460|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
15111461|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15111462|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15111463|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111464|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111465|NCT04483115|Urological Agents|urological agents|mesh-ancestor
15111466|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
15111467|NCT04475939|Niraparib|niraparib|mesh-list
15111468|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111469|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111470|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15111471|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111472|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111473|NCT04452383|Ketamine|ketamine|mesh-list
15111474|NCT04452383|Propofol|propofol|mesh-list
15111475|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15111476|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111477|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111478|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15111479|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
15111480|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
15111481|NCT04452383|Analgesics|analgesics|mesh-ancestor
15111482|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
15111483|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111484|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15111485|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15111486|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15111487|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111488|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111489|NCT04438824|Palbociclib|palbociclib|mesh-list
15111490|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111491|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15111492|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111493|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111494|NCT04418401|Antibodies|antibodies|mesh-list
15111495|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
15111496|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111497|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
15111498|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15111499|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15111500|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
15111501|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15111502|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111503|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
15111504|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15111505|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111506|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15111507|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111508|NCT04363840|Aspirin|aspirin|mesh-list
15111509|NCT04363840|Vitamin D|vitamin d|mesh-list
15111510|NCT04363840|Vitamins|vitamins|mesh-ancestor
15111511|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
15111512|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111513|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15111514|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15111515|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15111516|NCT04363840|Analgesics|analgesics|mesh-ancestor
15111517|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
15111518|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111519|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15111520|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111521|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15111522|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15111523|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111524|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15111525|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15111526|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111527|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
15111528|NCT04337060|Lidocaine|lidocaine|mesh-list
15111529|NCT04337060|Morphine|morphine|mesh-list
15111530|NCT04337060|Bupivacaine|bupivacaine|mesh-list
15111531|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
15111532|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
15111533|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111534|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111535|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
15111536|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111537|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15111538|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15111539|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15111540|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15111541|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111542|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15111543|NCT04337060|Narcotics|narcotics|mesh-ancestor
15111544|NCT04337060|Analgesics|analgesics|mesh-ancestor
15111545|NCT04330183|Ketamine|ketamine|mesh-list
15111546|NCT04330183|Analgesics|analgesics|mesh-ancestor
15111547|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
15111548|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111549|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111550|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15111551|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15111552|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
15111553|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
15111554|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111555|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15111556|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15111557|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111558|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111559|NCT04311723|Anesthetics|anesthetics|mesh-list
15111560|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111561|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111562|NCT04300595|Anesthetics|anesthetics|mesh-list
15111563|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111564|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111565|NCT04297293|Ramosetron|ramosetron|mesh-list
15111566|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
15111567|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
15111568|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111569|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111570|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15111571|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15111572|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
15111573|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111574|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111575|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
15111576|NCT04295863|Nivolumab|nivolumab|mesh-list
15111577|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111578|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111579|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15111580|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111581|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
15111582|NCT04249297|Progestins|progestins|mesh-ancestor
15111583|NCT04249297|Hormones|hormones|mesh-ancestor
15111584|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111585|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111586|NCT04245514|Durvalumab|durvalumab|mesh-list
15111587|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111588|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176133|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15176134|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15176135|NCT03980249|Carvedilol|carvedilol|mesh-list
15176136|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15176137|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15176138|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176139|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176140|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176141|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176142|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15176143|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
15176144|NCT03980249|Protective Agents|protective agents|mesh-ancestor
15176145|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15176146|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176147|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15176148|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
15176149|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15176150|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15176151|NCT03980041|Nivolumab|nivolumab|mesh-list
15176152|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176153|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176154|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15176155|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176156|NCT03980184|Guanfacine|guanfacine|mesh-list
15176157|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15176158|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15176159|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15176160|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15176161|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176162|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176163|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176164|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176165|NCT03979976|Ramipril|ramipril|mesh-list
15176166|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15176167|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15176168|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
15176169|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176170|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15181653|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15181654|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15181655|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15181656|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181657|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15181658|NCT03927807|Misoprostol|misoprostol|mesh-list
15181659|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15111589|NCT04238390|Meropenem|meropenem|mesh-list
15111590|NCT04238390|Tazobactam|tazobactam|mesh-list
15111591|NCT04238390|Ceftolozane|ceftolozane|mesh-list
15111592|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
15111593|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111594|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111595|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15111596|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111597|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111598|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15111599|NCT04238390|Renal Agents|renal agents|mesh-ancestor
15111600|NCT04233216|Islatravir|islatravir|mesh-list
15111601|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
15111602|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111603|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111604|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111605|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15111606|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15111607|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15111608|NCT04226248|Rivastigmine|rivastigmine|mesh-list
15111609|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15111610|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111611|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111612|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
15111613|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111614|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111615|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15111616|NCT04226248|Protective Agents|protective agents|mesh-ancestor
15111617|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15111618|NCT04197687|Trastuzumab|trastuzumab|mesh-list
15111619|NCT04197687|Pertuzumab|pertuzumab|mesh-list
15111620|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15111621|NCT04197687|Maytansine|maytansine|mesh-list
15111622|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15111623|NCT04197687|Vaccines|vaccines|mesh-list
15111624|NCT04197687|Antibodies|antibodies|mesh-list
15111625|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
15111626|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15111627|NCT04197687|Sargramostim|sargramostim|mesh-list
15111628|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
15111629|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
15111630|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111631|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111632|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111633|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111634|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111635|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111636|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111637|NCT04191928|Apixaban|apixaban|mesh-list
15111638|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15111639|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
15111640|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15111641|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
15111642|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111643|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111644|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
15111645|NCT04170348|Vitamin D|vitamin d|mesh-list
15111646|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
15111647|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
15111648|NCT04170348|Vitamins|vitamins|mesh-list
15111649|NCT04170348|Trientine|trientine|mesh-list
15111650|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
15111651|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111652|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15111653|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15111654|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
15111655|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
15111656|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111657|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
15111658|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15111659|NCT04167761|Glipizide|glipizide|mesh-list
15111660|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111661|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15111662|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111663|NCT04160052|Azacitidine|azacitidine|mesh-list
15111664|NCT04160052|Venetoclax|venetoclax|mesh-list
15111665|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111666|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
15111667|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111668|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111669|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111670|NCT04156334|Anesthetics|anesthetics|mesh-list
15111671|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111672|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111673|NCT04147546|Artenimol|artenimol|mesh-list
15111674|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
15111675|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15111676|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15111677|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111678|NCT04139304|Prednisone|prednisone|mesh-list
15111679|NCT04139304|Cortisone|cortisone|mesh-list
15111680|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
15111681|NCT04139304|Doxorubicin|doxorubicin|mesh-list
15111682|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15111683|NCT04139304|Etoposide|etoposide|mesh-list
15111684|NCT04139304|Vincristine|vincristine|mesh-list
15111685|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
15111686|NCT04139304|Daunorubicin|daunorubicin|mesh-list
15111687|NCT04139304|Daratumumab|daratumumab|mesh-list
15111688|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
15111689|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111690|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
15111691|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111692|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111693|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15111694|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
15111695|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111696|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111697|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15111698|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15111699|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15111700|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15111701|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111702|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15111703|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
15111704|NCT04139304|Hormones|hormones|mesh-ancestor
15111705|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111706|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15111707|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111708|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111709|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111710|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111711|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
15111712|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
15111713|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
15111714|NCT04134325|Nivolumab|nivolumab|mesh-list
15111715|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111716|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111717|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15111718|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111719|NCT04122170|Aspirin|aspirin|mesh-list
15111720|NCT04122170|Ticagrelor|ticagrelor|mesh-list
15111721|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15111722|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15111723|NCT04122170|Analgesics|analgesics|mesh-ancestor
15111724|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
15111725|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111726|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111727|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15111728|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111729|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15111730|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15111731|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111732|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15111733|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15111734|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111735|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
15111736|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15111737|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15111738|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15111739|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
15111740|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15111741|NCT04060758|Latanoprost|latanoprost|mesh-list
15111742|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15111743|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15111744|NCT04058990|Paclitaxel|paclitaxel|mesh-list
15111745|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15111746|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111747|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111748|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111749|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111750|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111751|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111752|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15111753|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15111754|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
15111755|NCT04055116|Lidocaine|lidocaine|mesh-list
15111756|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
15111757|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
15111758|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15111759|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111760|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
15111761|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111762|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15111763|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15111764|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15111765|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15111766|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111767|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
15111768|NCT04047628|Ofatumumab|ofatumumab|mesh-list
15111769|NCT04047628|Cladribine|cladribine|mesh-list
15111770|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
15111771|NCT04047628|Natalizumab|natalizumab|mesh-list
15111772|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111773|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111774|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
15111775|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111776|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111777|NCT04035837|Interferons|interferons|mesh-list
15111778|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
15111779|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111780|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
15111781|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111782|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
15111783|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111784|NCT04019327|Temozolomide|temozolomide|mesh-list
15111785|NCT04019327|Talazoparib|talazoparib|mesh-list
15111786|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15111787|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
15111788|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111789|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111790|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15111791|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111792|NCT04019288|Durvalumab|durvalumab|mesh-list
15111793|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
15111794|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15111795|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
15111796|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111797|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111798|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
15111799|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111800|NCT03991403|Paclitaxel|paclitaxel|mesh-list
15111801|NCT03991403|Bevacizumab|bevacizumab|mesh-list
15111802|NCT03991403|Carboplatin|carboplatin|mesh-list
15111803|NCT03991403|Pemetrexed|pemetrexed|mesh-list
15111804|NCT03991403|Atezolizumab|atezolizumab|mesh-list
15111805|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111806|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111807|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
15111808|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
15111809|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
15111810|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111811|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111812|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15111813|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15111814|NCT03991403|Growth Substances|growth substances|mesh-ancestor
15111815|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111816|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
15111817|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111818|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15111819|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15111820|NCT03978091|Ceftazidime|ceftazidime|mesh-list
15111821|NCT03978091|Avibactam|avibactam|mesh-list
15111822|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
15111823|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111824|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111825|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15111826|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111827|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111828|NCT03961204|Cladribine|cladribine|mesh-list
15111829|NCT03961204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111830|NCT03961204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111831|NCT03961204|Immunologic Factors|immunologic factors|mesh-ancestor
15111832|NCT03961204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111833|NCT03945357|Gemcitabine|gemcitabine|mesh-list
15111834|NCT03945357|Clindamycin|clindamycin|mesh-list
15111835|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
15111836|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
15111837|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111838|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
15111839|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111840|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111841|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
15111842|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111843|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111844|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111845|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
15111846|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111847|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111848|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15111849|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15111850|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15111851|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111852|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111853|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
15111854|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111855|NCT03934814|Rituximab|rituximab|mesh-list
15111856|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
15111857|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111858|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111859|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
15111860|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111861|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111862|NCT03930771|Capecitabine|capecitabine|mesh-list
15111863|NCT03930771|Temozolomide|temozolomide|mesh-list
15111864|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111865|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
15111866|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111867|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111868|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15111869|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
15111870|NCT03926624|Cytarabine|cytarabine|mesh-list
15111871|NCT03926624|Fludarabine|fludarabine|mesh-list
15111872|NCT03926624|Etoposide|etoposide|mesh-list
15111873|NCT03926624|Azacitidine|azacitidine|mesh-list
15111874|NCT03926624|Decitabine|decitabine|mesh-list
15111875|NCT03926624|Venetoclax|venetoclax|mesh-list
15111876|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
15111877|NCT03926624|Idarubicin|idarubicin|mesh-list
15111878|NCT03926624|Cladribine|cladribine|mesh-list
15111879|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111880|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111881|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
15111882|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111883|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111884|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
15111885|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111886|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15111887|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15111888|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15111889|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111890|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
15111891|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111892|NCT03926624|Analgesics|analgesics|mesh-ancestor
15111893|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
15111894|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111895|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15111896|NCT03905902|Vaccines|vaccines|mesh-list
15111897|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
15111898|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176171|NCT03980171|Lenalidomide|lenalidomide|mesh-list
15176172|NCT03980171|Venetoclax|venetoclax|mesh-list
15176173|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
15176174|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
15176175|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176176|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15176177|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15176178|NCT03980171|Growth Substances|growth substances|mesh-ancestor
15176179|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
15176180|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176181|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176182|NCT03980002|Thalidomide|thalidomide|mesh-list
15176183|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15176184|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
15176185|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176186|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
15176187|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15176188|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176189|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15176190|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15176191|NCT03980002|Growth Substances|growth substances|mesh-ancestor
15176192|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
15176193|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176194|NCT03979859|Nafithromycin|nafithromycin|mesh-list
15176195|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15176196|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176197|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15176198|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176199|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176200|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14269368|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15176201|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176202|NCT03979989|Tapentadol|tapentadol|mesh-list
15176203|NCT03979989|Omeprazole|omeprazole|mesh-list
15176204|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15176205|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176206|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15176207|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176208|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176209|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15176210|NCT03979989|Narcotics|narcotics|mesh-ancestor
15176211|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176212|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176213|NCT03979989|Analgesics|analgesics|mesh-ancestor
15176214|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
15176215|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176216|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15176217|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15176218|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176219|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176220|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176221|NCT03979664|Dexamethasone|dexamethasone|mesh-list
15176222|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176223|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
15176224|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
15176225|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176226|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176227|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176228|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
15176229|NCT03979664|Hormones|hormones|mesh-ancestor
15176230|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176231|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15176232|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176233|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
15176234|NCT03979651|Trametinib|trametinib|mesh-list
15176235|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
15176236|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15176237|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15176238|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176239|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111899|NCT03889743|Dexamethasone|dexamethasone|mesh-list
15111900|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15111901|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
15111902|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
15111903|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111904|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111905|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15111906|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
15111907|NCT03889743|Hormones|hormones|mesh-ancestor
15111908|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111909|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15111910|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111911|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
15111912|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111913|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111914|NCT03867201|Erenumab|erenumab|mesh-list
15111915|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15111916|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111917|NCT03867201|Analgesics|analgesics|mesh-ancestor
15111918|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
15111919|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15111920|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111921|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
15111922|NCT03858049|Progestins|progestins|mesh-ancestor
15111923|NCT03858049|Hormones|hormones|mesh-ancestor
15111924|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15111925|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111926|NCT03852888|Methotrexate|methotrexate|mesh-list
15111927|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
15111928|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15111929|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
15111930|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15111931|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111932|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111933|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
15111934|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111935|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111936|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
15111937|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111938|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15111939|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111940|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
15111941|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111942|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15111943|NCT03850418|Azacitidine|azacitidine|mesh-list
15111944|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15111945|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
15111946|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111947|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111948|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111949|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
15111950|NCT03850379|Levofloxacin|levofloxacin|mesh-list
15111951|NCT03850379|Ofloxacin|ofloxacin|mesh-list
15111952|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111953|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111954|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15111955|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15111956|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15111957|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15111958|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111959|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15111960|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15111961|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15111962|NCT03850379|Renal Agents|renal agents|mesh-ancestor
15111963|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
15111964|NCT03850366|Bortezomib|bortezomib|mesh-list
15111965|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15111966|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
15111967|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111968|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15111969|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15111970|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
15111971|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181660|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
15111972|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111973|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15111974|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
15111975|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111976|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111977|NCT03840148|Meropenem|meropenem|mesh-list
15111978|NCT03840148|Cefepime|cefepime|mesh-list
15111979|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15111980|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15111981|NCT03832127|Fludarabine|fludarabine|mesh-list
15111982|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111983|NCT03824522|BAX 855|bax 855|mesh-list
15111984|NCT03824522|Coagulants|coagulants|mesh-ancestor
15111985|NCT03823365|Blinatumomab|blinatumomab|mesh-list
15111986|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111987|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
15111988|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15111989|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
15111990|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15111991|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15111992|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15111993|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15111994|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15111995|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
15111996|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15111997|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15111998|NCT03808077|Rocuronium|rocuronium|mesh-list
15111999|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15112000|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15112001|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15112002|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112003|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112004|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15112005|NCT03804268|Pilocarpine|pilocarpine|mesh-list
15112006|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15112007|NCT03804268|Miotics|miotics|mesh-ancestor
15112008|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
15112009|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112010|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112011|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15112012|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15112013|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
15112014|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112015|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112016|NCT05239390|Dronabinol|dronabinol|mesh-list
15112017|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
15112018|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112019|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15112020|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112021|NCT05239390|Analgesics|analgesics|mesh-ancestor
15112022|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
15112023|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112024|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15112025|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15112026|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112027|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112028|NCT05239390|Hormones|hormones|mesh-ancestor
15112029|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112030|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
15112031|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15112032|NCT05239286|Anesthetics|anesthetics|mesh-list
15112033|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112034|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112035|NCT05239078|Anesthetics|anesthetics|mesh-list
15112036|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
15112037|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112038|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112039|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
15112040|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112041|NCT05238948|Midazolam|midazolam|mesh-list
15112042|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15112043|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15112044|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112045|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112046|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15112047|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15112048|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15112049|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15112050|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
15112051|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
15112052|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
15112053|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
15112054|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112055|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112056|NCT05238727|Mepivacaine|mepivacaine|mesh-list
15112057|NCT05238727|Carticaine|carticaine|mesh-list
15112058|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
15112059|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
15112060|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112061|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112062|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
15112063|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112064|NCT05238467|Antibodies|antibodies|mesh-list
15112065|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
15112066|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112067|NCT05238363|Cetuximab|cetuximab|mesh-list
15112068|NCT05238363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112069|NCT05238363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112070|NCT05238220|Valganciclovir|valganciclovir|mesh-list
15112071|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
15112072|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112073|NCT05238207|Psyllium|psyllium|mesh-list
15112074|NCT05238207|Cathartics|cathartics|mesh-ancestor
15112075|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15112076|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
15112077|NCT05238064|Doxorubicin|doxorubicin|mesh-list
15112078|NCT05238064|Vincristine|vincristine|mesh-list
15112079|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112080|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
15112081|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112082|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112083|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15112084|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
15112085|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112086|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112087|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15112088|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15112089|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15112090|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15112091|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112092|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15112093|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
15112094|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
15112095|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
15112096|NCT05238012|Atorvastatin|atorvastatin|mesh-list
15112097|NCT05238012|Calcium|calcium|mesh-list
15112098|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15112099|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112100|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15112101|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15112102|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
15112103|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112104|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15112105|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15112106|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112107|NCT05237960|Metformin|metformin|mesh-list
15112108|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15112109|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112110|NCT05237843|Aspirin|aspirin|mesh-list
15112111|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
15112112|NCT05237843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112113|NCT05237843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112114|NCT05237843|Analgesics|analgesics|mesh-ancestor
15112115|NCT05237843|Sensory System Agents|sensory system agents|mesh-ancestor
15112116|NCT05237843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112117|NCT05237843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112118|NCT05237843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112119|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112120|NCT05237843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15112121|NCT05237843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15112122|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112123|NCT05237843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15112124|NCT05237843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112125|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112126|NCT05237843|Antipyretics|antipyretics|mesh-ancestor
15112127|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
15112128|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15112129|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15112130|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176240|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176241|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176242|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176243|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15176244|NCT03979456|Rituximab|rituximab|mesh-list
15176245|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176246|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176247|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
15176248|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176249|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176250|NCT03979469|Fentanyl|fentanyl|mesh-list
15176251|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
15176252|NCT03979469|Ketamine|ketamine|mesh-list
15176253|NCT03979469|Remifentanil|remifentanil|mesh-list
15176254|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15176255|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176256|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176257|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15176258|NCT03979469|Analgesics|analgesics|mesh-ancestor
15176259|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
15176260|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176261|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15176262|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15176263|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15176264|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176265|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176266|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176267|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15176268|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15176269|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
15176270|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
15176271|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15176272|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15176273|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15176274|NCT03979469|Narcotics|narcotics|mesh-ancestor
15176275|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15176276|NCT03979248|BMS-986165|bms-986165|mesh-list
15176277|NCT03979248|Rabeprazole|rabeprazole|mesh-list
15176278|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15176279|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176280|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15176281|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176282|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176283|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
15176284|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15176285|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
15176286|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15176287|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
15176288|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176289|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
15176290|NCT03979586|Protective Agents|protective agents|mesh-ancestor
15176291|NCT03979352|Empagliflozin|empagliflozin|mesh-list
15176292|NCT03979352|Pancrelipase|pancrelipase|mesh-list
15176293|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15176294|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176295|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15176296|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176297|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176298|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
15176299|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
15176300|NCT03979599|Analgesics|analgesics|mesh-ancestor
15176301|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
15176302|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176303|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176304|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
15176305|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176306|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15176307|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
15112131|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
15112132|NCT05237791|Analgesics|analgesics|mesh-ancestor
15112133|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
15112134|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112135|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112136|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
15112137|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112138|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15112139|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
15112140|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15112141|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15112142|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112143|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15112144|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
15112145|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15112146|NCT05237492|Tramadol|tramadol|mesh-list
15112147|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15112148|NCT05237492|Narcotics|narcotics|mesh-ancestor
15112149|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112150|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112151|NCT05237492|Analgesics|analgesics|mesh-ancestor
15112152|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
15112153|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112154|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
15112155|NCT05237323|Azathioprine|azathioprine|mesh-list
15112156|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15112157|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112158|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15112159|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
15112160|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15112161|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112162|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112163|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112164|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
15112165|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15112166|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112167|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
15112168|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112169|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112170|NCT05237297|Celecoxib|celecoxib|mesh-list
15112171|NCT05237297|Naproxen|naproxen|mesh-list
15112172|NCT05237297|Aceclofenac|aceclofenac|mesh-list
15112173|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112174|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112175|NCT05237297|Analgesics|analgesics|mesh-ancestor
15112176|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
15112177|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112178|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112179|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112180|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112181|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15112182|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112183|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112184|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112185|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
15112186|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
15112187|NCT05216328|Antacids|antacids|mesh-ancestor
15112188|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112189|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15112190|NCT05215990|Metformin|metformin|mesh-list
15112191|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15112192|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112193|NCT05215834|Remifentanil|remifentanil|mesh-list
15112194|NCT05215834|Propofol|propofol|mesh-list
15112195|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15112196|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112197|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112198|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15112199|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
15112200|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
15112201|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15112202|NCT05215834|Narcotics|narcotics|mesh-ancestor
15112203|NCT05215834|Analgesics|analgesics|mesh-ancestor
15112204|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
15112205|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112206|NCT05215431|Antioxidants|antioxidants|mesh-list
15112207|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112208|NCT05215431|Protective Agents|protective agents|mesh-ancestor
15112209|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112210|NCT05214183|Rituximab|rituximab|mesh-list
15112211|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
15112212|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112213|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112214|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
15112215|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112216|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112217|NCT05213208|Propofol|propofol|mesh-list
15112218|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15112219|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112220|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112221|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15112222|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
15112223|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
15112224|NCT05200143|Nivolumab|nivolumab|mesh-list
15112225|NCT05200143|Ipilimumab|ipilimumab|mesh-list
15112226|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112227|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112228|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15112229|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112230|NCT05189509|Plasminogen|plasminogen|mesh-list
15112231|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15112232|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15112233|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15112234|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112235|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15112236|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
15112237|NCT05181527|Serotonin|serotonin|mesh-list
15112238|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15112239|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
15112240|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
15112241|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15112242|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15112243|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112244|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112245|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112246|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15112247|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
15112248|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15112249|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15112250|NCT05131204|Eculizumab|eculizumab|mesh-list
15112251|NCT05131204|Ravulizumab|ravulizumab|mesh-list
15112252|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15112253|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112254|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
15112255|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112256|NCT05097768|Dexamethasone|dexamethasone|mesh-list
15112257|NCT05097768|Ibuprofen|ibuprofen|mesh-list
15112258|NCT05097768|Ketorolac|ketorolac|mesh-list
15112259|NCT05097768|Meloxicam|meloxicam|mesh-list
15112260|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112261|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
15112262|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
15112263|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112264|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112265|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15112266|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
15112267|NCT05097768|Hormones|hormones|mesh-ancestor
15112268|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112269|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15112270|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112271|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112272|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112273|NCT05097768|Analgesics|analgesics|mesh-ancestor
15112274|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
15112275|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112276|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112277|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112278|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112279|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15112280|NCT05093582|Cromakalim|cromakalim|mesh-list
15112281|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15112282|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15112283|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
15112284|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112285|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112286|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15112287|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
15112288|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
15112289|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
15112290|NCT05069831|Abrocitinib|abrocitinib|mesh-list
15112291|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15112292|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112293|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112294|NCT05069350|Bupivacaine|bupivacaine|mesh-list
15112295|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
15112296|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
15112297|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112298|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112299|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
15112300|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112301|NCT05040282|Etonogestrel|etonogestrel|mesh-list
15112302|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15112303|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
15112304|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15112305|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112306|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15112307|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
15112308|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15112309|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
15112310|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112311|NCT04982172|Infliximab|infliximab|mesh-list
15112312|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
15112313|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15112314|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112315|NCT04978272|Piperaquine|piperaquine|mesh-list
15112316|NCT04978272|Artenimol|artenimol|mesh-list
15112317|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
15112318|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15112319|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15112320|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112321|NCT04934800|Cladribine|cladribine|mesh-list
15112322|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112323|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112324|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
15112325|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112326|NCT04915144|Edotreotide|edotreotide|mesh-list
15112327|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15112328|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176308|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15176309|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176310|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176311|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15176312|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
15176313|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15176314|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
15176315|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
15176316|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176317|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
15176318|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15176319|NCT03978988|Aspirin|aspirin|mesh-list
15176320|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15176321|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15176322|NCT03978988|Analgesics|analgesics|mesh-ancestor
15176323|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
15176324|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176325|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176326|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176327|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176328|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15176329|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15176330|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176331|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15176332|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15176333|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176334|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
15176335|NCT03979105|Ketamine|ketamine|mesh-list
15176336|NCT03979105|Analgesics|analgesics|mesh-ancestor
15112329|NCT04883645|Imiquimod|imiquimod|mesh-list
15112330|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15112331|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
15112332|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112333|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112334|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
15112335|NCT04874480|Decitabine|decitabine|mesh-list
15112336|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15112337|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
15112338|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112339|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112340|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112341|NCT04861584|Gemcitabine|gemcitabine|mesh-list
15112342|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112343|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15112344|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
15112345|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112346|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
15112347|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112348|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112349|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112350|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
15112351|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112352|NCT04848584|Vaccines|vaccines|mesh-list
15112353|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
15112354|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112355|NCT04817410|Naltrexone|naltrexone|mesh-list
15112356|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15112357|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15112358|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112359|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
15112360|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112361|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
15112362|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
15112363|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15112364|NCT04808414|Polymyxins|polymyxins|mesh-list
15112365|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112366|NCT04770012|Aspirin|aspirin|mesh-list
15112367|NCT04770012|Clopidogrel|clopidogrel|mesh-list
15112368|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112369|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112370|NCT04770012|Analgesics|analgesics|mesh-ancestor
15112371|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
15112372|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112373|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112374|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112375|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112376|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15112377|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15112378|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112379|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15112380|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112381|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112382|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
15112383|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15112384|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15112385|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15112386|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
15112387|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112388|NCT04760626|Insulin|insulin|mesh-list
15112389|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15112390|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
15112391|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15112392|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112393|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
15112394|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15112395|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
15112396|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112397|NCT04755972|Expectorants|expectorants|mesh-ancestor
15112398|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
15112399|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15112400|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
13996177|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
15112401|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112402|NCT04755972|Protective Agents|protective agents|mesh-ancestor
15112403|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112404|NCT04755972|Antidotes|antidotes|mesh-ancestor
15112405|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15112406|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15112407|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112408|NCT04709250|Bupivacaine|bupivacaine|mesh-list
15112409|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
15112410|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
15112411|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112412|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112413|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
15112414|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112415|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15112416|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15112417|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112418|NCT04652245|Fluticasone|fluticasone|mesh-list
15112419|NCT04652245|Xhance|xhance|mesh-list
15112420|NCT04652245|Azelastine|azelastine|mesh-list
15112421|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112422|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15112423|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
15112424|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112425|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112426|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15112427|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
15112428|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
15112429|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15112430|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15112431|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112432|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112433|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15112434|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15112435|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
15112436|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
15112437|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112438|NCT04647643|Paclitaxel|paclitaxel|mesh-list
15112439|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15112440|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112441|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
15112442|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
15112443|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
15112444|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112445|NCT04631536|Folic Acid|folic acid|mesh-list
15112446|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
15112447|NCT04631536|Nicorandil|nicorandil|mesh-list
15112448|NCT04631536|Nebivolol|nebivolol|mesh-list
15112449|NCT04631536|Atorvastatin|atorvastatin|mesh-list
15112450|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15112451|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15112452|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
15112453|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112454|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15112455|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15112456|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112457|NCT04631536|Hematinics|hematinics|mesh-ancestor
15112458|NCT04631536|Vitamins|vitamins|mesh-ancestor
15112459|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
15112460|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112461|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15112462|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
15112463|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15112464|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15112465|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15112466|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
15112467|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112468|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15112469|NCT04592809|Midazolam|midazolam|mesh-list
15112470|NCT04592809|Ketamine|ketamine|mesh-list
15112471|NCT04592809|Analgesics|analgesics|mesh-ancestor
15112472|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
15112473|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112474|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112475|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15112476|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13996178|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
15112477|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
15112478|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
15112479|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112480|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15112481|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15112482|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112483|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112484|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15112485|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15112486|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15112487|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15112488|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15112489|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
15112490|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
15112491|NCT04567992|Bupivacaine|bupivacaine|mesh-list
15112492|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
15112493|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
15112494|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112495|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112496|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
15112497|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112498|NCT04565600|Etoricoxib|etoricoxib|mesh-list
15112499|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112500|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112501|NCT04565600|Analgesics|analgesics|mesh-ancestor
15112502|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
15112503|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112504|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112505|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112506|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112507|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15112508|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112509|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112510|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112511|NCT04501211|Granisetron|granisetron|mesh-list
15112512|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
15112513|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
15112514|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112515|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112516|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15112517|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15112518|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
15112519|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112520|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112521|NCT04460885|Insulin|insulin|mesh-list
15112522|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15112523|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
15112524|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15112525|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112526|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
15112527|NCT04456296|Testosterone|testosterone|mesh-list
15112528|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
15112529|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
15112530|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15112531|NCT04456296|Androgens|androgens|mesh-ancestor
15112532|NCT04456296|Hormones|hormones|mesh-ancestor
15112533|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112534|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112535|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15112536|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112537|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
15112538|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
15112539|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
15112540|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15112541|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15112542|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112543|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112544|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112545|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112546|NCT04409262|Remdesivir|remdesivir|mesh-list
15112547|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
15112548|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112549|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
15112550|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112551|NCT04408508|Amoxicillin|amoxicillin|mesh-list
15112552|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269369|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
15112553|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112554|NCT04352439|Aspirin|aspirin|mesh-list
15112555|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112556|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112557|NCT04352439|Analgesics|analgesics|mesh-ancestor
15112558|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
15112559|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112560|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112561|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112562|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112563|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15112564|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15112565|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112566|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15112567|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112568|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112569|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
15112570|NCT04330430|Nivolumab|nivolumab|mesh-list
15112571|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112572|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112573|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15112574|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112575|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15112576|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
15176337|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
15176338|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176339|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176340|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15176341|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15176342|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
15176343|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
15176344|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176345|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15176346|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15176347|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176348|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176349|NCT03978884|Losartan|losartan|mesh-list
15176350|NCT03978884|Amlodipine|amlodipine|mesh-list
15176351|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15176352|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15176353|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15176354|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176355|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176356|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15176357|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176358|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
15176359|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15176360|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15176361|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15176362|NCT03978884|Diuretics|diuretics|mesh-ancestor
15176363|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
15176364|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15176365|NCT03979131|Avelumab|avelumab|mesh-list
15176366|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176367|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176368|NCT03978845|Lidocaine|lidocaine|mesh-list
15176369|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
15176370|NCT03978845|Anesthetics|anesthetics|mesh-list
15176371|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176372|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176373|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
15176374|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176375|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15176376|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15176377|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15176378|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176379|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176380|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
15176381|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176382|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176383|NCT03978442|Bupropion|bupropion|mesh-list
15176384|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15176385|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
15176386|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15112577|NCT04219540|Buprenorphine|buprenorphine|mesh-list
15112578|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15112579|NCT04219540|Narcotics|narcotics|mesh-ancestor
15112580|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112581|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112582|NCT04219540|Analgesics|analgesics|mesh-ancestor
15112583|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
15112584|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112585|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15112586|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
15112587|NCT04146298|Fludarabine|fludarabine|mesh-list
15112588|NCT04146298|Antibodies|antibodies|mesh-list
15112589|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15112590|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112591|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
15112592|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112593|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112594|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15112595|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
15112596|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112597|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112598|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15112599|NCT03994146|Remifentanil|remifentanil|mesh-list
15112600|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15112601|NCT03994146|Narcotics|narcotics|mesh-ancestor
15112602|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112603|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112604|NCT03994146|Analgesics|analgesics|mesh-ancestor
15112605|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
15112606|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112607|NCT03987919|Tirzepatide|tirzepatide|mesh-list
15112608|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15112609|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112610|NCT03987919|Incretins|incretins|mesh-ancestor
15112611|NCT03987919|Hormones|hormones|mesh-ancestor
15112612|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112613|NCT03987711|Warfarin|warfarin|mesh-list
15112614|NCT03987711|Apixaban|apixaban|mesh-list
15112615|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
15112616|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15112617|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
15112618|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15112619|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
15112620|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112621|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112622|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
15112623|NCT03873818|Ipilimumab|ipilimumab|mesh-list
13996179|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13996180|NCT02922348|Hormones|hormones|mesh-list
15112624|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112625|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112626|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15112627|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112628|NCT03861039|Tirzepatide|tirzepatide|mesh-list
15112629|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15112630|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112631|NCT03861039|Incretins|incretins|mesh-ancestor
15112632|NCT03861039|Hormones|hormones|mesh-ancestor
15112633|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112634|NCT03759587|Niraparib|niraparib|mesh-list
15112635|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15112636|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112637|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112638|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112639|NCT03733314|Quetmolimab|quetmolimab|mesh-list
15112640|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112641|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
15112642|NCT03730662|Tirzepatide|tirzepatide|mesh-list
15112643|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15112644|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112645|NCT03730662|Incretins|incretins|mesh-ancestor
15112646|NCT03730662|Hormones|hormones|mesh-ancestor
15112647|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112648|NCT03717623|Posaconazole|posaconazole|mesh-list
15112649|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
15112650|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112651|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15112652|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15112653|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15112654|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15112655|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15112656|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112657|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112658|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15112659|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
15112660|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112661|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112662|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15112663|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15112664|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112665|NCT03673462|Vaccines|vaccines|mesh-list
15112666|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
15112667|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112668|NCT03613506|Captopril|captopril|mesh-list
15112669|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15112670|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
15112671|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112672|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112673|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15112674|NCT03571633|Paclitaxel|paclitaxel|mesh-list
15112675|NCT03571633|Trastuzumab|trastuzumab|mesh-list
15112676|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15112677|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112678|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
15112679|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
15112680|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
15112681|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112682|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112683|NCT03537833|Pemetrexed|pemetrexed|mesh-list
15112684|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112685|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112686|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112687|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15112688|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15112689|NCT03521570|Nivolumab|nivolumab|mesh-list
15112690|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112691|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112692|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15112693|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112694|NCT03446040|Nivolumab|nivolumab|mesh-list
15112695|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112696|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112697|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15112698|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112699|NCT03439085|Durvalumab|durvalumab|mesh-list
15112700|NCT03439085|Interleukin-12|interleukin-12|mesh-list
15112701|NCT03439085|Vaccines|vaccines|mesh-list
15112702|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
15112703|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15112704|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
15112705|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
15112706|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112707|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112708|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112709|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15112710|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15112711|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15112712|NCT03439085|Growth Substances|growth substances|mesh-ancestor
15112713|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
15112714|NCT03433183|Sirolimus|sirolimus|mesh-list
15112715|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15112716|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112717|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15112718|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112719|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
15112720|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112721|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
15112722|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112723|NCT03427736|Ketorolac|ketorolac|mesh-list
15112724|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15112725|NCT03427736|Ketamine|ketamine|mesh-list
15112726|NCT03427736|Morphine|morphine|mesh-list
15112727|NCT03427736|Oxycodone|oxycodone|mesh-list
15112728|NCT03427736|Hydromorphone|hydromorphone|mesh-list
15112729|NCT03427736|Analgesics|analgesics|mesh-ancestor
15112730|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
15112731|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112732|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112733|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15112734|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15112735|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
15112736|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
15112737|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15112738|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15112739|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15112740|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112741|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112742|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15112743|NCT03427736|Narcotics|narcotics|mesh-ancestor
15112744|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112745|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112746|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112747|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112748|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112749|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176387|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15176388|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15176389|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176390|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176391|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
15176392|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176393|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176394|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15176395|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15176396|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176397|NCT03978494|Tacrolimus|tacrolimus|mesh-list
15176398|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15176399|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
15176400|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176401|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15176402|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176403|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176404|NCT03978559|Trimethoprim|trimethoprim|mesh-list
15176405|NCT03978559|Caspofungin|caspofungin|mesh-list
15176406|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
15176407|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
15176408|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176409|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
15176410|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
15176411|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176412|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176413|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176414|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
15176415|NCT03978559|Hormones|hormones|mesh-ancestor
15176416|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176417|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15176418|NCT03978559|Protective Agents|protective agents|mesh-ancestor
15176419|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15176420|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176421|NCT03978559|Renal Agents|renal agents|mesh-ancestor
15176422|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
15176423|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15176424|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15176425|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15176426|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176427|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176428|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15176429|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15176430|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13996181|NCT02922348|Estradiol|estradiol|mesh-list
15112750|NCT03421639|Leuprolide|leuprolide|mesh-list
15112751|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15112752|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15112753|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15112754|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
15112755|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15112756|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112757|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15112758|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112759|NCT03421639|Hormones|hormones|mesh-ancestor
15112760|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112761|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15112762|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112763|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112764|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15112765|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
15112766|NCT03367156|Dexamethasone|dexamethasone|mesh-list
15112767|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
15112768|NCT03367156|Ichthammol|ichthammol|mesh-list
15112769|NCT03367156|BB 1101|bb 1101|mesh-list
15112770|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112771|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
15112772|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
15112773|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112774|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112775|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15112776|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
15112777|NCT03367156|Hormones|hormones|mesh-ancestor
15112778|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112779|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15112780|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112781|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
15112782|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112783|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112784|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
15112785|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
15112786|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112787|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
15112788|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15112789|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
15112790|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112791|NCT03252925|Expectorants|expectorants|mesh-ancestor
15112792|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
15112793|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15112794|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
15112795|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112796|NCT03252925|Protective Agents|protective agents|mesh-ancestor
15112797|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112798|NCT03252925|Antidotes|antidotes|mesh-ancestor
15112799|NCT03217565|Tedizolid|tedizolid|mesh-list
15112800|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
15112801|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
15112802|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15112803|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112804|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15112805|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112806|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112807|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
15112808|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
15112809|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112810|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
15112811|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112812|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112813|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15112814|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
15112815|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112816|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112817|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15112818|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112819|NCT02976337|Naloxone|naloxone|mesh-list
15112820|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15112821|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112822|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
15112823|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112824|NCT02963714|Vaccines|vaccines|mesh-list
15112825|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
15112826|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112827|NCT02959918|Sirolimus|sirolimus|mesh-list
15112828|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15112829|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112830|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15112831|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112832|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
15112833|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112834|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
15112835|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112836|NCT02859896|Calcitriol|calcitriol|mesh-list
15112837|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
15112838|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15112839|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112840|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15112841|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15112842|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112843|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15112844|NCT02859896|Vitamins|vitamins|mesh-ancestor
15112845|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
15112846|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15112847|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
15112848|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
15112849|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112850|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
15112851|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112852|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112853|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
15112854|NCT02817789|Clopidogrel|clopidogrel|mesh-list
15112855|NCT02817789|Ticagrelor|ticagrelor|mesh-list
15112856|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15112857|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15112858|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15112859|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15112860|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
15112861|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112862|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112863|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112864|NCT02817789|Analgesics|analgesics|mesh-ancestor
15112865|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
15112866|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112867|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15112868|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15112869|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112870|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112871|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15112872|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112873|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
15112874|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15112875|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15112876|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
15112877|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112878|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112879|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15112880|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
15112881|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
15112882|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15112883|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
15112884|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15112885|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112886|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
15112887|NCT02813200|Hormones|hormones|mesh-ancestor
15112888|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112889|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
15112890|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
15112891|NCT02744742|Busulfan|busulfan|mesh-list
15112892|NCT02744742|Decitabine|decitabine|mesh-list
15112893|NCT02744742|Sargramostim|sargramostim|mesh-list
15112894|NCT02744742|Lenograstim|lenograstim|mesh-list
15112895|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112896|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
15112897|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112898|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112899|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15112900|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
15112901|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112902|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112903|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15112904|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15112905|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
15112906|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112907|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15112908|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
15112909|NCT02687386|Analgesics|analgesics|mesh-ancestor
15112910|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
15112911|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15112912|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112913|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112914|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15112915|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15112916|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112917|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112918|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
15112919|NCT02678143|Sirolimus|sirolimus|mesh-list
15112920|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
15112921|NCT02678143|Fludarabine|fludarabine|mesh-list
15112922|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
15112923|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15112924|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
15112925|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112926|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112927|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15112928|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
15112929|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112930|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112931|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15112932|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15112933|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15112934|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
15112935|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15112936|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15112937|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112938|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
15112939|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112940|NCT02628405|Rituximab|rituximab|mesh-list
15112941|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15112942|NCT02628405|Carboplatin|carboplatin|mesh-list
15112943|NCT02628405|Etoposide|etoposide|mesh-list
15112944|NCT02628405|Lenalidomide|lenalidomide|mesh-list
15112945|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
15112946|NCT02628405|Ifosfamide|ifosfamide|mesh-list
15112947|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
15112948|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
15112949|NCT02628405|Antibodies|antibodies|mesh-list
15112950|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
15112951|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15112952|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
15112953|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112954|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112955|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15112956|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15112957|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15112958|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15112959|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112960|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112961|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15112962|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15112963|NCT02628405|Growth Substances|growth substances|mesh-ancestor
15112964|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
15112965|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15112966|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
15112967|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
15112968|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
15112969|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
15112970|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
15112971|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
15112972|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
15112973|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15112974|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112975|NCT02523040|Lenalidomide|lenalidomide|mesh-list
15112976|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
15112977|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112978|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15112979|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15112980|NCT02523040|Growth Substances|growth substances|mesh-ancestor
15112981|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
15112982|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112983|NCT02520778|Osimertinib|osimertinib|mesh-list
15112984|NCT02520778|Navitoclax|navitoclax|mesh-list
15112985|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112986|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15112987|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15112988|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15112989|NCT02485691|Prednisone|prednisone|mesh-list
15112990|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
15112991|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15112992|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
15112993|NCT02485691|Hormones|hormones|mesh-ancestor
15112994|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15112995|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15112996|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15112997|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15112998|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15112999|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113000|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113001|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113002|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15113003|NCT02479646|Lenograstim|lenograstim|mesh-list
15113004|NCT02479646|Sargramostim|sargramostim|mesh-list
15113005|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15113006|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
15113007|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113008|NCT02472964|Paclitaxel|paclitaxel|mesh-list
15113009|NCT02472964|Docetaxel|docetaxel|mesh-list
15113010|NCT02472964|Trastuzumab|trastuzumab|mesh-list
15113011|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15113012|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113013|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
15113014|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
15113015|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
15113016|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113017|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113018|NCT02467868|Lenograstim|lenograstim|mesh-list
15113019|NCT02467868|Sargramostim|sargramostim|mesh-list
15113020|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15113021|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
15113022|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113023|NCT02421263|Psilocybin|psilocybin|mesh-list
15113024|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
15113025|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113026|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15113027|NCT02402920|Cisplatin|cisplatin|mesh-list
15113028|NCT02402920|Carboplatin|carboplatin|mesh-list
15113029|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
15113030|NCT02402920|Etoposide|etoposide|mesh-list
15113031|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
15113032|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
15113033|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113034|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113035|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15113036|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15113037|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15113038|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113039|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113040|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
15113041|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
15113042|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
15113043|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
15113044|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
15113045|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
15113046|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113047|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113048|NCT01889303|Docetaxel|docetaxel|mesh-list
15113049|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113050|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
15113051|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
15113052|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
15176431|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
15113053|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113054|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15113055|NCT01787500|Cetuximab|cetuximab|mesh-list
15113056|NCT01787500|Irinotecan|irinotecan|mesh-list
15113057|NCT01787500|Camptothecin|camptothecin|mesh-list
15113058|NCT01787500|Vemurafenib|vemurafenib|mesh-list
15113059|NCT01787500|Antibodies|antibodies|mesh-list
15113060|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
15113061|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15113062|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
15113063|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113064|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113065|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15113066|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15113067|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113068|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113069|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15113070|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15113071|NCT01303341|Sorafenib|sorafenib|mesh-list
15113072|NCT01303341|Riluzole|riluzole|mesh-list
15113073|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269370|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269371|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269372|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14269373|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269374|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269375|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14269376|NCT00402324|Valproic Acid|valproic acid|mesh-list
14269377|NCT00402324|Olanzapine|olanzapine|mesh-list
14269378|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
14269379|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
14269380|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269381|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113074|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15113075|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113076|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113077|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
15113078|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15113079|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15113080|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113081|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113082|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15113083|NCT01303341|Protective Agents|protective agents|mesh-ancestor
15113084|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
15113085|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
15113086|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15113087|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
15113088|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113089|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113090|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113091|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113092|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15113093|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15113094|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15113095|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
15113096|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113097|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113098|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113099|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
15113100|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15113101|NCT01104922|Cetuximab|cetuximab|mesh-list
15113102|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113103|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113104|NCT00862251|Atorvastatin|atorvastatin|mesh-list
15113105|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15113106|NCT00862251|Simvastatin|simvastatin|mesh-list
15113107|NCT00862251|Ezetimibe|ezetimibe|mesh-list
15113108|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113109|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113110|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
15113111|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113112|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113113|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14269382|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15113114|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113115|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15113116|NCT00783263|Ezetimibe|ezetimibe|mesh-list
15113117|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113118|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113119|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
15113120|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113121|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113122|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113123|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113124|NCT00782184|Atorvastatin|atorvastatin|mesh-list
15113125|NCT00782184|Simvastatin|simvastatin|mesh-list
15113126|NCT00782184|Ezetimibe|ezetimibe|mesh-list
15113127|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
15113128|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113129|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113130|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
15113131|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113132|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113133|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113134|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113135|NCT00664937|Montelukast|montelukast|mesh-list
15113136|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113137|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113138|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113139|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113140|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113141|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113142|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113143|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113144|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113145|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
15113146|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
15113147|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15113148|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
15113149|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113150|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113151|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113152|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113153|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15113154|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15113155|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15113156|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
15113157|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113158|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113159|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113160|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
15113161|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15113162|NCT00586391|Ipilimumab|ipilimumab|mesh-list
15113163|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113164|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113165|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15113166|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113167|NCT00545324|Fluticasone|fluticasone|mesh-list
15113168|NCT00545324|Montelukast|montelukast|mesh-list
15113169|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113170|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15113171|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
15113172|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113173|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113174|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113175|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113176|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
15113177|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15113178|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113179|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113180|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113181|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113182|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113183|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113184|NCT00540839|Fluticasone|fluticasone|mesh-list
15113185|NCT00540839|Xhance|xhance|mesh-list
15113186|NCT00540839|Montelukast|montelukast|mesh-list
15113187|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113188|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15113189|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
15113190|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113191|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113192|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113193|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113194|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
15113195|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15113196|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113197|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113198|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113199|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113200|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113201|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113202|NCT00535405|Atorvastatin|atorvastatin|mesh-list
15113203|NCT00535405|Simvastatin|simvastatin|mesh-list
15113204|NCT00535405|Ezetimibe|ezetimibe|mesh-list
15113205|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113206|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113207|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
15113208|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113209|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113210|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113211|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113212|NCT00496730|Atorvastatin|atorvastatin|mesh-list
15113213|NCT00496730|Simvastatin|simvastatin|mesh-list
15113214|NCT00496730|Ezetimibe|ezetimibe|mesh-list
15113215|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113216|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113217|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
15113218|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113219|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113220|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113221|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113222|NCT00462748|Atorvastatin|atorvastatin|mesh-list
15113223|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15113224|NCT00462748|Simvastatin|simvastatin|mesh-list
15113225|NCT00462748|Ezetimibe|ezetimibe|mesh-list
15113226|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113227|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113228|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
15113229|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113230|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113231|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113232|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113233|NCT00446186|Montelukast|montelukast|mesh-list
15113234|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113235|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113236|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113237|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113238|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113239|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113240|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113241|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113242|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113243|NCT00445107|Montelukast|montelukast|mesh-list
15113244|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113245|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113246|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113247|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113248|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113249|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113250|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113251|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113252|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113253|NCT00418834|Atorvastatin|atorvastatin|mesh-list
15113254|NCT00418834|Ezetimibe|ezetimibe|mesh-list
15113255|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113256|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113257|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
14269383|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15113258|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113259|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113260|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113261|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113262|NCT00409773|Atorvastatin|atorvastatin|mesh-list
14269384|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14269385|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269386|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269387|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14269388|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14561689|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561690|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561691|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561692|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15113263|NCT00409773|Simvastatin|simvastatin|mesh-list
15113264|NCT00409773|Ezetimibe|ezetimibe|mesh-list
15113265|NCT00409773|Calcium|calcium|mesh-list
15113266|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15113267|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113268|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113269|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113270|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
15113271|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113272|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113273|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113274|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113275|NCT00398151|Montelukast|montelukast|mesh-list
15113276|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113277|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113278|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113279|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113280|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113281|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113282|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113283|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113284|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113285|NCT00394160|Montelukast|montelukast|mesh-list
15113286|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113287|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113288|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113289|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113290|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113291|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113292|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113293|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113294|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113295|NCT00380705|Montelukast|montelukast|mesh-list
15113296|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113297|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113298|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113299|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113300|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113301|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113302|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113303|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113304|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113305|NCT00276484|Atorvastatin|atorvastatin|mesh-list
15113306|NCT00276484|Ezetimibe|ezetimibe|mesh-list
15113307|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113308|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113309|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
15113310|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113311|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113312|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113313|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113314|NCT00276458|Atorvastatin|atorvastatin|mesh-list
15113315|NCT00276458|Ezetimibe|ezetimibe|mesh-list
15113316|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113317|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113318|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
15113319|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113320|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113321|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113322|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113323|NCT00271817|Niacin|niacin|mesh-list
15113324|NCT00271817|Niacinamide|niacinamide|mesh-list
15113325|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
15113326|NCT00271817|Simvastatin|simvastatin|mesh-list
15113327|NCT00271817|Ezetimibe|ezetimibe|mesh-list
15113328|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
15113329|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15113330|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113331|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
15113332|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113333|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113334|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15113335|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113336|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
15113337|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
15113338|NCT00271817|Vitamins|vitamins|mesh-ancestor
15113339|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
15113340|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113341|NCT00157937|Theophylline|theophylline|mesh-list
15113342|NCT00157937|Montelukast|montelukast|mesh-list
15113343|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113344|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113345|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113346|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
15113347|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269389|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269390|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269391|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113348|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113349|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113350|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113351|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113352|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113353|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113354|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113355|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15113356|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15113357|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113358|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
15113359|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15113360|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15113361|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
15113362|NCT00127647|Montelukast|montelukast|mesh-list
15113363|NCT00127647|Pranlukast|pranlukast|mesh-list
15113364|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113365|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113366|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113367|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113368|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113369|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113370|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113371|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113372|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113373|NCT00092989|Montelukast|montelukast|mesh-list
15113374|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113375|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113376|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113377|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113378|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113379|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113380|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113381|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113382|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113383|NCT00092144|Montelukast|montelukast|mesh-list
15113384|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113385|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113386|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113387|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113388|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15113389|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113390|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113391|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15113392|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15176432|NCT03978364|Azacitidine|azacitidine|mesh-list
15176433|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15176434|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
15176435|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176436|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176437|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176438|NCT03978286|Vortioxetine|vortioxetine|mesh-list
15176439|NCT03978286|Sertraline|sertraline|mesh-list
15176440|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
15176441|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15176442|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15176443|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15176444|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176445|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176446|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176447|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
15176448|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176449|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15176450|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15176451|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176452|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15176453|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15176454|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15176455|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15176456|NCT03978208|Naproxen|naproxen|mesh-list
15176457|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15176458|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15176459|NCT03978208|Analgesics|analgesics|mesh-ancestor
15176460|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
15176461|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176462|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176463|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176464|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176465|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
15113393|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
15113394|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15113395|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
15113396|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113397|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113398|NCT03754153|Atropine|atropine|mesh-list
15113399|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15113400|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15113401|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15113402|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
15113403|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113404|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113405|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15113406|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
15113407|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
15113408|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
15113409|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15113410|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15113411|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
15113412|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113413|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113414|NCT03753074|Tenofovir|tenofovir|mesh-list
15113415|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
15113416|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113417|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15113418|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15113419|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113420|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113421|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15113422|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15113423|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
15113424|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15113425|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
15113426|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15113427|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
15113428|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113429|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113430|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
15113431|NCT03731923|Liver Extracts|liver extracts|mesh-list
15113432|NCT03731923|Hematinics|hematinics|mesh-ancestor
15113433|NCT03727633|Idarubicin|idarubicin|mesh-list
15113434|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
15113435|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15113436|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113437|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15113438|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15113439|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113440|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113441|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
15113442|NCT03713593|Lenvatinib|lenvatinib|mesh-list
15113443|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113444|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113445|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15113446|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113447|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113448|NCT03713086|Vaccines|vaccines|mesh-list
15113449|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
15113450|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113451|NCT03699540|Ethanol|ethanol|mesh-list
15113452|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15113453|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113454|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15113455|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113456|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
15113457|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15113458|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
15113459|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113460|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
15113461|NCT03697876|Protective Agents|protective agents|mesh-ancestor
15113462|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
15113463|NCT03690765|Progestins|progestins|mesh-ancestor
15113464|NCT03690765|Hormones|hormones|mesh-ancestor
15113465|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113466|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113467|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
15113468|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113469|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
15113470|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15113471|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15113472|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113473|NCT03686813|Urological Agents|urological agents|mesh-ancestor
15113474|NCT03679624|Daratumumab|daratumumab|mesh-list
15113475|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113476|NCT03658304|Mitomycins|mitomycins|mesh-list
15113477|NCT03658304|Mitomycin|mitomycin|mesh-list
15113478|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15113479|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113480|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
15113481|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113482|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15113483|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113484|NCT03642028|Suvorexant|suvorexant|mesh-list
15113485|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15113486|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15113487|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15113488|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113489|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15113490|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113491|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113492|NCT03636451|Lidocaine|lidocaine|mesh-list
15113493|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
15113494|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
15113495|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15113496|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113497|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
15113498|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113499|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15113500|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15113501|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15113502|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15113503|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113504|NCT03629340|Metformin|metformin|mesh-list
15113505|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15113506|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113507|NCT03629171|Cytarabine|cytarabine|mesh-list
15113508|NCT03629171|Daunorubicin|daunorubicin|mesh-list
15113509|NCT03629171|Venetoclax|venetoclax|mesh-list
15113510|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15113511|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
15113512|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113513|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113514|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
15113515|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113516|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15113517|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
15113518|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113519|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15113520|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15113521|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15113522|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113523|NCT03622775|Daratumumab|daratumumab|mesh-list
15113524|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113525|NCT03618134|Durvalumab|durvalumab|mesh-list
15113526|NCT03618134|Ipilimumab|ipilimumab|mesh-list
15113527|NCT03618134|Tremelimumab|tremelimumab|mesh-list
15113528|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
15113529|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15113530|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
15113531|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113532|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113533|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
15113534|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113535|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15113536|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113537|NCT03603509|Vaccines|vaccines|mesh-list
15113538|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
15113539|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113540|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
15113541|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
15113542|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
15113543|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
15113544|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15113545|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113546|NCT03572049|Itraconazole|itraconazole|mesh-list
15113547|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15113548|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
15113549|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113550|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15113551|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15113552|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113553|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113554|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15113555|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113556|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113557|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113558|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15113559|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15113560|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15113561|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113562|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113563|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15113564|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15113565|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113566|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
15113567|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113568|NCT03570619|Nivolumab|nivolumab|mesh-list
15113569|NCT03570619|Ipilimumab|ipilimumab|mesh-list
15113570|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113571|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113572|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15113573|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113574|NCT03565783|Cemiplimab|cemiplimab|mesh-list
15113575|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113576|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113577|NCT03511196|Prednisone|prednisone|mesh-list
15113578|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
15113579|NCT03511196|Androgens|androgens|mesh-list
15113580|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113581|NCT03511196|Hormones|hormones|mesh-ancestor
15113582|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113583|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113584|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15113585|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113586|NCT03493126|Estradiol|estradiol|mesh-list
15113587|NCT03493126|Estrogens|estrogens|mesh-ancestor
15113588|NCT03493126|Hormones|hormones|mesh-ancestor
15113589|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113590|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113591|NCT03483012|Atezolizumab|atezolizumab|mesh-list
15113592|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113593|NCT03474029|Rifampin|rifampin|mesh-list
15113594|NCT03474029|Rifapentine|rifapentine|mesh-list
15113595|NCT03474029|Isoniazid|isoniazid|mesh-list
15113596|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15113597|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
15113598|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15113599|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113600|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
15113601|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15113602|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113603|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113604|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15113605|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15113606|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15113607|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15113608|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15113609|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15113610|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15113611|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15113612|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
15113613|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15113614|NCT03467789|Vitamin D|vitamin d|mesh-list
15113615|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
15113616|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
15113617|NCT03467789|Vitamins|vitamins|mesh-list
15113618|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
15113619|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113620|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15113621|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15113622|NCT03460015|Propofol|propofol|mesh-list
15113623|NCT03460015|Sevoflurane|sevoflurane|mesh-list
15113624|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15113625|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15113626|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113627|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15113628|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
15113629|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
15113630|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15113631|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15113632|NCT03459859|Cytarabine|cytarabine|mesh-list
15113633|NCT03459859|Pevonedistat|pevonedistat|mesh-list
15113634|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15113635|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
15113636|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113637|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113638|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
15113639|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113640|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15113641|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
15113642|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113643|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113644|NCT03452865|Esomeprazole|esomeprazole|mesh-list
15113645|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15113646|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15113647|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15113648|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113649|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113650|NCT03452839|Meropenem|meropenem|mesh-list
15113651|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15113652|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113653|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
15113654|NCT03401710|Hematinics|hematinics|mesh-ancestor
15113655|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15113656|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15113657|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113658|NCT03358563|Docetaxel|docetaxel|mesh-list
15113659|NCT03358563|Bicalutamide|bicalutamide|mesh-list
15113660|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15113661|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113662|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
15113663|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
15113664|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
15113665|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113666|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
15113667|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
15113668|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113669|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113670|NCT03358563|Hematinics|hematinics|mesh-ancestor
15113671|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15113672|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15113673|NCT03354728|Vaccines|vaccines|mesh-list
15113674|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
15113675|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113676|NCT03346135|Melphalan|melphalan|mesh-list
15113677|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
15113678|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15113679|NCT03346135|Daratumumab|daratumumab|mesh-list
15113680|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15113681|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
15113682|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113683|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113684|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15113685|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15113686|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
15113687|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113688|NCT03339284|Dexamethasone|dexamethasone|mesh-list
15113689|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
15113690|NCT03339284|Ropivacaine|ropivacaine|mesh-list
15113691|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15113692|NCT03339284|BB 1101|bb 1101|mesh-list
15113693|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113694|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
15113695|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
15113696|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113697|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113698|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15113699|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
15113700|NCT03339284|Hormones|hormones|mesh-ancestor
15113701|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113702|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15113703|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113704|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
15113705|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
15113706|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15113707|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
15113708|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
15113709|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113710|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113711|NCT03316586|Nivolumab|nivolumab|mesh-list
15113712|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113713|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113714|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15113715|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113716|NCT03301857|Denosumab|denosumab|mesh-list
15113717|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
15113718|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
15113719|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
15113720|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113721|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15113722|NCT03277066|Diclofenac|diclofenac|mesh-list
15113723|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15113724|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15113725|NCT03277066|Analgesics|analgesics|mesh-ancestor
15113726|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
15113727|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113728|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113729|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113730|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15113731|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15113732|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113733|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176466|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15176467|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176468|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176469|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15176470|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
15176471|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176472|NCT03978052|Protective Agents|protective agents|mesh-ancestor
15176473|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176474|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15176475|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15176476|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176477|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15176478|NCT03978156|Dronabinol|dronabinol|mesh-list
15176479|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
15176480|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176481|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15176482|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15176483|NCT03978156|Analgesics|analgesics|mesh-ancestor
15176484|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
15176485|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176486|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15176487|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15176488|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176489|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176490|NCT03978156|Hormones|hormones|mesh-ancestor
15176491|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176492|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15176493|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15176494|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15176495|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15113734|NCT03268811|Teduglutide|teduglutide|mesh-list
15113735|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15113736|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15113737|NCT03268811|Protective Agents|protective agents|mesh-ancestor
15113738|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113739|NCT03267433|Rituximab|rituximab|mesh-list
15113740|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113741|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113742|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
15113743|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113744|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15113745|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
15113746|NCT03231085|Trace Elements|trace elements|mesh-ancestor
15113747|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
15113748|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113749|NCT03207347|Niraparib|niraparib|mesh-list
15113750|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15113751|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113752|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113753|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113754|NCT03193333|Timolol|timolol|mesh-list
15113755|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15113756|NCT03193333|Dorzolamide|dorzolamide|mesh-list
15113757|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15113758|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15113759|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15113760|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15113761|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
15113762|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113763|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113764|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113765|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15113766|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15113767|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15113768|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15113769|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15113770|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15113771|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113772|NCT03177291|Pirfenidone|pirfenidone|mesh-list
15113773|NCT03177291|Paclitaxel|paclitaxel|mesh-list
15113774|NCT03177291|Carboplatin|carboplatin|mesh-list
15113775|NCT03177291|Pemetrexed|pemetrexed|mesh-list
15113776|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15113777|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113778|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
15113779|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
15113780|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
15113781|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113782|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113783|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15113784|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15113785|NCT03177291|Analgesics|analgesics|mesh-ancestor
15113786|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
15113787|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113788|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113789|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15113790|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15113791|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113792|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15113793|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
15113794|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113795|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113796|NCT03110744|Palbociclib|palbociclib|mesh-list
15113797|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113798|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15113799|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113800|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113801|NCT03093246|Aspirin|aspirin|mesh-list
15113802|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15113803|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15113804|NCT03093246|Analgesics|analgesics|mesh-ancestor
15113805|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
15113806|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113807|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113808|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113809|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15113810|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15113811|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15113812|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113813|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15113814|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15113815|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113816|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
15113817|NCT03090997|Vitamins|vitamins|mesh-list
15113818|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
15113819|NCT03090997|Resveratrol|resveratrol|mesh-list
15113820|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
15113821|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113822|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
15113823|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113824|NCT03090997|Protective Agents|protective agents|mesh-ancestor
15113825|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113826|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15113827|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
15113828|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15113829|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113830|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15113831|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113832|NCT02991599|Vaccines|vaccines|mesh-list
15113833|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
15113834|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113835|NCT02970500|Methylphenidate|methylphenidate|mesh-list
15113836|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15113837|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113838|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15113839|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15113840|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15113841|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113842|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
15113843|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113844|NCT02969928|Amoxicillin|amoxicillin|mesh-list
15113845|NCT02969928|Metronidazole|metronidazole|mesh-list
15113846|NCT02969928|Clarithromycin|clarithromycin|mesh-list
15113847|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15113848|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113849|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15113850|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15113851|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15113852|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113853|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113854|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15113855|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15113856|NCT02968446|Vitamin D|vitamin d|mesh-list
15113857|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
15113858|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
15113859|NCT02968446|Vitamins|vitamins|mesh-ancestor
15113860|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
15113861|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113862|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15113863|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15113864|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
15113865|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113866|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15113867|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113868|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
15113869|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113870|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113871|NCT02939183|Dexamethasone|dexamethasone|mesh-list
15113872|NCT02939183|Pomalidomide|pomalidomide|mesh-list
15113873|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15113874|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
15113875|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
15113876|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113877|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113878|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15113879|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
15113880|NCT02939183|Hormones|hormones|mesh-ancestor
15113881|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113882|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15113883|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113884|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
15113885|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15113886|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15113887|NCT02939183|Growth Substances|growth substances|mesh-ancestor
15113888|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
15113889|NCT02935309|Capecitabine|capecitabine|mesh-list
15113890|NCT02935309|Lenvatinib|lenvatinib|mesh-list
15113891|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15113892|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
15113893|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113894|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113895|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15113896|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113897|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
15113898|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
15113899|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113900|NCT02857426|Nivolumab|nivolumab|mesh-list
15113901|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113902|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113903|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15113904|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113905|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
15113906|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113907|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113908|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
15113909|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113910|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
15113911|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
15113912|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
15113913|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
15113914|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113915|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15113916|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
15113917|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15113918|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15113919|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
15113920|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113921|NCT02710331|Ethanol|ethanol|mesh-list
15113922|NCT02710331|Dronabinol|dronabinol|mesh-list
15113923|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15113924|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113925|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15113926|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113927|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
15113928|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15113929|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15113930|NCT02710331|Analgesics|analgesics|mesh-ancestor
15113931|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
15113932|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15113933|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15113934|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15113935|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15113936|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113937|NCT02710331|Hormones|hormones|mesh-ancestor
15113938|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15113939|NCT02705300|Leucovorin|leucovorin|mesh-list
15113940|NCT02705300|Tocotrienols|tocotrienols|mesh-list
15113941|NCT02705300|Vitamin E|vitamin e|mesh-list
15113942|NCT02705300|Tocopherols|tocopherols|mesh-list
15113943|NCT02705300|Fluorouracil|fluorouracil|mesh-list
15113944|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
15113945|NCT02705300|Irinotecan|irinotecan|mesh-list
15113946|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
15113947|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113948|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
15113949|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113950|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15113951|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113952|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15113953|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
15113954|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15113955|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15113956|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113957|NCT02705300|Antidotes|antidotes|mesh-ancestor
15113958|NCT02705300|Protective Agents|protective agents|mesh-ancestor
15113959|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
15113960|NCT02705300|Vitamins|vitamins|mesh-ancestor
15113961|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
15113962|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
15113963|NCT02678533|Plerixafor|plerixafor|mesh-list
15113964|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15113965|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15113966|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
15113967|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113968|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
15113969|NCT02593123|Molgramostim|molgramostim|mesh-list
15113970|NCT02593123|Lenograstim|lenograstim|mesh-list
15113971|NCT02593123|Sargramostim|sargramostim|mesh-list
15113972|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15113973|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
15113974|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15113975|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15113976|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113977|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15113978|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
15113979|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15113980|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113981|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113982|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113983|NCT02591147|Fluorides|fluorides|mesh-list
15113984|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
15113985|NCT02591147|Protective Agents|protective agents|mesh-ancestor
15113986|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176496|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176497|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
15176498|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176499|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176500|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15176501|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181661|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15181662|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181663|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15181664|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15181665|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
15181666|NCT03928015|Analgesics|analgesics|mesh-list
15181667|NCT03928015|Dronabinol|dronabinol|mesh-list
15181668|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
15181669|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181670|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181671|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
15181672|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15181673|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181674|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15181675|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15181676|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181677|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181678|NCT03928015|Hormones|hormones|mesh-ancestor
15181679|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181680|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
15181681|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15181682|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
15181683|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
15181684|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181685|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181686|NCT03927352|Adalimumab|adalimumab|mesh-list
15181687|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181688|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181689|NCT03927456|Fulvestrant|fulvestrant|mesh-list
15181690|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15181691|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181692|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15181693|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15181694|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
15181695|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181696|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181697|NCT03927495|Paclitaxel|paclitaxel|mesh-list
15181698|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15181699|NCT03927495|Cisplatin|cisplatin|mesh-list
15181700|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15181701|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181702|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
15181703|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
15113987|NCT02574455|Gemcitabine|gemcitabine|mesh-list
15113988|NCT02574455|Capecitabine|capecitabine|mesh-list
15113989|NCT02574455|Vinorelbine|vinorelbine|mesh-list
15113990|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15113991|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
15113992|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15113993|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15113994|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
15113995|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15113996|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15113997|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269392|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
15113998|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
15113999|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114000|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15114001|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
15114002|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
15114003|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114004|NCT02527798|Furosemide|furosemide|mesh-list
15114005|NCT02527798|Diuretics|diuretics|mesh-ancestor
15114006|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
15114007|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114008|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15114009|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15114010|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114011|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
15114012|NCT02457598|Idelalisib|idelalisib|mesh-list
15114013|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114014|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114015|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114016|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114017|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
15114018|NCT02451982|Nivolumab|nivolumab|mesh-list
15114019|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
15114020|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114021|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114022|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15114023|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15114024|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
15114025|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114026|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114027|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15114028|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114029|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15114030|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15114031|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15114032|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114033|NCT02346630|Levodopa|levodopa|mesh-list
15114034|NCT02346630|Carbidopa|carbidopa|mesh-list
15114035|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15114036|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15114037|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
15114038|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114039|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114040|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114041|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15114042|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114043|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
15114044|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15114045|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15114046|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15114047|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15114048|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114049|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
15114050|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114051|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114052|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15114053|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114054|NCT02067975|Tryptophan|tryptophan|mesh-list
15114055|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15114056|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
15114057|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15114058|NCT02035137|Irinotecan|irinotecan|mesh-list
15114059|NCT02035137|Vincristine|vincristine|mesh-list
14269393|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
15114060|NCT02035137|Vorinostat|vorinostat|mesh-list
15114061|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15114062|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15114063|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114064|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114065|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114066|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114067|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15114068|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
15114069|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
15114070|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114071|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15114072|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15114073|NCT01999179|Heparin|heparin|mesh-list
15114074|NCT01999179|Enoxaparin|enoxaparin|mesh-list
15114075|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15114076|NCT01999179|Tinzaparin|tinzaparin|mesh-list
15114077|NCT01999179|Dalteparin|dalteparin|mesh-list
15114078|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
15114079|NCT01999179|Dabigatran|dabigatran|mesh-list
15114080|NCT01999179|Apixaban|apixaban|mesh-list
15114081|NCT01999179|Edoxaban|edoxaban|mesh-list
15114082|NCT01999179|Anticoagulants|anticoagulants|mesh-list
15114083|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15114084|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15114085|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114086|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15114087|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
15114088|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15114089|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
15114090|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114091|NCT01964807|Nicotine|nicotine|mesh-list
15114092|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15114093|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
15114094|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114095|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114096|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15114097|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15114098|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
15114099|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114100|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114101|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
15114102|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15114103|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114104|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15114105|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114106|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114107|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114108|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114109|NCT01921335|Trastuzumab|trastuzumab|mesh-list
15114110|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114111|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114112|NCT01907360|Methylphenidate|methylphenidate|mesh-list
15114113|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15114114|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114115|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15114116|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15114117|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15114118|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114119|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
15114120|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114121|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15114122|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
15114123|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
15114124|NCT01873170|Etonogestrel|etonogestrel|mesh-list
15114125|NCT01873170|Desogestrel|desogestrel|mesh-list
15114126|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
15114127|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15114128|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15114129|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114130|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15114131|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15114132|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15114133|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15114134|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15114135|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114136|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15114137|NCT01873170|Progestins|progestins|mesh-ancestor
15114138|NCT01873170|Hormones|hormones|mesh-ancestor
15114139|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114140|NCT01835041|Leucovorin|leucovorin|mesh-list
15114141|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
15114142|NCT01835041|Fluorouracil|fluorouracil|mesh-list
15114143|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
15114144|NCT01835041|Irinotecan|irinotecan|mesh-list
15114145|NCT01835041|Calcium|calcium|mesh-list
15114146|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
15114147|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15114148|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114149|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
15114150|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114151|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114152|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114153|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114154|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
15114155|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15114156|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114157|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114158|NCT01835041|Antidotes|antidotes|mesh-ancestor
15114159|NCT01835041|Protective Agents|protective agents|mesh-ancestor
15114160|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
15114161|NCT01835041|Vitamins|vitamins|mesh-ancestor
15114162|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
15114163|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
15114164|NCT01808820|Imiquimod|imiquimod|mesh-list
15114165|NCT01808820|Vaccines|vaccines|mesh-list
15114166|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
15114167|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114168|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15114169|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114170|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
15114171|NCT01481272|Leucovorin|leucovorin|mesh-list
15114172|NCT01481272|Cytarabine|cytarabine|mesh-list
15114173|NCT01481272|Methotrexate|methotrexate|mesh-list
15114174|NCT01481272|Etoposide|etoposide|mesh-list
15114175|NCT01481272|Ofatumumab|ofatumumab|mesh-list
15114176|NCT01481272|Sargramostim|sargramostim|mesh-list
15114177|NCT01481272|Lenograstim|lenograstim|mesh-list
15114178|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15114179|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
15114180|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15114181|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114182|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114183|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
15114184|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114185|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114186|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
15114187|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114188|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15114189|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114190|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
15114191|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15114192|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15114193|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15114194|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15114195|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114196|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
15114197|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114198|NCT01481272|Antidotes|antidotes|mesh-ancestor
15114199|NCT01481272|Protective Agents|protective agents|mesh-ancestor
15114200|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
15114201|NCT01481272|Vitamins|vitamins|mesh-ancestor
15114202|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
15114203|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15114204|NCT01434316|Veliparib|veliparib|mesh-list
15114205|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15114206|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114207|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114208|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114209|NCT01380028|Prednisone|prednisone|mesh-list
15114210|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114211|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
15114212|NCT01380028|Hormones|hormones|mesh-ancestor
15114213|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114214|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114215|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15114216|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114217|NCT01305460|Azacitidine|azacitidine|mesh-list
15114218|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114219|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
15114220|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114221|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114222|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114223|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
15114224|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15114225|NCT01300143|Estrogens|estrogens|mesh-ancestor
15114226|NCT01300143|Hormones|hormones|mesh-ancestor
15114227|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114228|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114229|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15114230|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114231|NCT01295944|Bevacizumab|bevacizumab|mesh-list
15114232|NCT01295944|Carboplatin|carboplatin|mesh-list
15114233|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114234|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114235|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15114236|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15114237|NCT01295944|Growth Substances|growth substances|mesh-ancestor
15114238|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114239|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
15114240|NCT01269424|Temozolomide|temozolomide|mesh-list
15114241|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
15114242|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15114243|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
15114244|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114245|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114246|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114247|NCT01199302|Brodalumab|brodalumab|mesh-list
15114248|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
15114249|NCT01164995|Carboplatin|carboplatin|mesh-list
15114250|NCT01164995|Adavosertib|adavosertib|mesh-list
15114251|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114252|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114253|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114254|NCT01123707|Aripiprazole|aripiprazole|mesh-list
15114255|NCT01123707|Citalopram|citalopram|mesh-list
15114256|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15114257|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15114258|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15114259|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114260|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114261|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
15114262|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114263|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15114264|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
15114265|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15114266|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15114267|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15114268|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114269|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
15114270|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
15114271|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15114272|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15114273|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15114274|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15114275|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15114276|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15114277|NCT00999401|Roscovitine|roscovitine|mesh-list
15114278|NCT00999401|Sapacitabine|sapacitabine|mesh-list
15114279|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114280|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
15114281|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114282|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15114283|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114284|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114285|NCT00885963|Sapacitabine|sapacitabine|mesh-list
15114286|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114287|NCT00725127|Aspirin|aspirin|mesh-list
15114288|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15114289|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15114290|NCT00725127|Analgesics|analgesics|mesh-ancestor
15114291|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
15114292|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114293|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114294|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114295|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15114296|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15114297|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15114298|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114299|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15114300|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15114301|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114302|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
15114303|NCT00476554|Sapacitabine|sapacitabine|mesh-list
15114304|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114305|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
15114306|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15114307|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114308|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15114309|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114310|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114311|NCT00372073|Roscovitine|roscovitine|mesh-list
15114312|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114313|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
15114314|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114315|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15114316|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114317|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114318|NCT00364637|Anesthetics|anesthetics|mesh-list
15114319|NCT00364637|Sevoflurane|sevoflurane|mesh-list
15114320|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114321|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114322|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15114323|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15114324|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
15114325|NCT00280761|Fluorouracil|fluorouracil|mesh-list
15114326|NCT00280761|Capecitabine|capecitabine|mesh-list
15114327|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
15114328|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114329|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114330|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114331|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114332|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
15114333|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114334|NCT00248287|Carboplatin|carboplatin|mesh-list
15114335|NCT00248287|Irinotecan|irinotecan|mesh-list
14269394|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114336|NCT00248287|Cetuximab|cetuximab|mesh-list
15114337|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114338|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15114339|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114340|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114341|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114342|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114343|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
15114344|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15114345|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
15114346|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114347|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
15114348|NCT00225095|Protective Agents|protective agents|mesh-ancestor
15114349|NCT00038727|Metformin|metformin|mesh-list
15114350|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15114351|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176502|NCT03977675|Ketamine|ketamine|mesh-list
15176503|NCT03977675|Analgesics|analgesics|mesh-ancestor
15176504|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
15176505|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176506|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176507|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15176508|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15176509|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
15176510|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
15176511|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176512|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15176513|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15176514|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176515|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176516|NCT03977792|Docosanol|docosanol|mesh-list
15176517|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
15176518|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176519|NCT03977649|Erenumab|erenumab|mesh-list
15176520|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15176521|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176522|NCT03977649|Analgesics|analgesics|mesh-ancestor
15176523|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
15176524|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176525|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176526|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15176527|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15176528|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176529|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176530|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15176531|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176532|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176533|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
15176534|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176535|NCT03977441|Pramipexole|pramipexole|mesh-list
15176536|NCT03977441|S 20098|s 20098|mesh-list
15176537|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
15176538|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176539|NCT03977441|Protective Agents|protective agents|mesh-ancestor
15176540|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176541|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15176542|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15176543|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
15176544|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
15176545|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176546|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15176547|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176548|NCT03977571|Nivolumab|nivolumab|mesh-list
15176549|NCT03977571|Ipilimumab|ipilimumab|mesh-list
15176550|NCT03977571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176551|NCT03977571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176552|NCT03977571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15176553|NCT03977571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176554|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
15176555|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15176556|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176557|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
15176558|NCT03977220|Paclitaxel|paclitaxel|mesh-list
15176559|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15176560|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114352|NCT05174312|Diuretics|diuretics|mesh-list
15114353|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
15114354|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114355|NCT05174195|Desogestrel|desogestrel|mesh-list
15114356|NCT05174195|Etonogestrel|etonogestrel|mesh-list
15114357|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15114358|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15114359|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15114360|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
15114361|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15114362|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114363|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15114364|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15114365|NCT05174195|Progestins|progestins|mesh-ancestor
15114366|NCT05174195|Hormones|hormones|mesh-ancestor
15114367|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114368|NCT05174156|Paclitaxel|paclitaxel|mesh-list
15114369|NCT05174156|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15114370|NCT05174156|Cisplatin|cisplatin|mesh-list
15114371|NCT05174156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15114372|NCT05174156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114373|NCT05174156|Tubulin Modulators|tubulin modulators|mesh-ancestor
15114374|NCT05174156|Antimitotic Agents|antimitotic agents|mesh-ancestor
15114375|NCT05174156|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114376|NCT05174156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114377|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
15114378|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15114379|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114380|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15114381|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114382|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
15114383|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15114384|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15114385|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114386|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
15114387|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
15114388|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114389|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15114390|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
15114391|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114392|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15114393|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
15114394|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114395|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114396|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15114397|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15114398|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15114399|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
15114400|NCT05173688|Propofol|propofol|mesh-list
15114401|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15114402|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114403|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114404|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15114405|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
15114406|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
15114407|NCT05173584|Albuterol|albuterol|mesh-list
15114408|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15114409|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
15114410|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114411|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114412|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15114413|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
15114414|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
15114415|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15114416|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15114417|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15114418|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15114419|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
15114420|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114421|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114422|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
15114423|NCT05173545|Analgesics|analgesics|mesh-ancestor
15114424|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
15114425|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114426|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114427|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114428|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15114429|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114430|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114431|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114432|NCT05173337|Nefopam|nefopam|mesh-list
15114433|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15114434|NCT05173337|Analgesics|analgesics|mesh-ancestor
15114435|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
15114436|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114437|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114438|NCT05173246|Paclitaxel|paclitaxel|mesh-list
15114439|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15114440|NCT05173246|Cisplatin|cisplatin|mesh-list
15114441|NCT05173246|Carboplatin|carboplatin|mesh-list
15114442|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15114443|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114444|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
15114445|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
15114446|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114447|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114448|NCT05173090|Ropivacaine|ropivacaine|mesh-list
15114449|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
15114450|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
15114451|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114452|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114453|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
14269395|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
14269396|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
14269397|NCT00402337|Linaclotide|linaclotide|mesh-list
14269398|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14269399|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
14269400|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269401|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269402|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
14269403|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14269404|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
14269405|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15114454|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114455|NCT05172934|Tenecteplase|tenecteplase|mesh-list
15114456|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15114457|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15114458|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114459|NCT05172817|Adalimumab|adalimumab|mesh-list
15114460|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114461|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15114462|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15114463|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114464|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
15114465|NCT05172739|Anesthetics|anesthetics|mesh-list
15114466|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114467|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114468|NCT05172739|Narcotics|narcotics|mesh-ancestor
15114469|NCT05172739|Analgesics|analgesics|mesh-ancestor
15114470|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
15114471|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114472|NCT05172570|Gabapentin|gabapentin|mesh-list
15114473|NCT05172570|Analgesics|analgesics|mesh-ancestor
15114474|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
15114475|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114476|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114477|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
15114478|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15114479|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15114480|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114481|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15114482|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15114483|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15114484|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114485|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114486|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
15114487|NCT05172531|Cisatracurium|cisatracurium|mesh-list
15114488|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14269406|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
14269407|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114489|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15114490|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114491|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114492|NCT05172518|Capecitabine|capecitabine|mesh-list
15114493|NCT05172518|Taxane|taxane|mesh-list
15114494|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114495|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
15114496|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114497|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114498|NCT05172440|Axitinib|axitinib|mesh-list
15114499|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114500|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15114501|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114502|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114503|NCT05172401|Triamcinolone|triamcinolone|mesh-list
15114504|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15114505|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15114506|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15114507|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114508|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
15114509|NCT05172401|Hormones|hormones|mesh-ancestor
15114510|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114511|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114512|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114513|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
15114514|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114515|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114516|NCT05172310|FAPI-46|fapi-46|mesh-list
15114517|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15114518|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176561|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
15176562|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
15176563|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
15176564|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176565|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
15176566|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15176567|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176568|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
15176569|NCT03977454|Ropivacaine|ropivacaine|mesh-list
15176570|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
15176571|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
15176572|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176573|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176574|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
15176575|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176576|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
15176577|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15176578|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176579|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
15176580|NCT03977012|Buprenorphine|buprenorphine|mesh-list
15176581|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15176582|NCT03977012|Narcotics|narcotics|mesh-ancestor
15176583|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176584|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176585|NCT03977012|Analgesics|analgesics|mesh-ancestor
15176586|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
15176587|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176588|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15176589|NCT03977233|Leucovorin|leucovorin|mesh-list
15176590|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
15176591|NCT03977233|Irinotecan|irinotecan|mesh-list
15176592|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176593|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15176594|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15176595|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176596|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176597|NCT03977233|Antidotes|antidotes|mesh-ancestor
15176598|NCT03977233|Protective Agents|protective agents|mesh-ancestor
15176599|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176600|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
15176601|NCT03977233|Vitamins|vitamins|mesh-ancestor
15176602|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
15176603|NCT03976713|Bromides|bromides|mesh-list
14561693|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176604|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
15176605|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15176606|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
15114519|NCT05172115|Heparin|heparin|mesh-list
15114520|NCT05172115|Enoxaparin|enoxaparin|mesh-list
15114521|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15114522|NCT05172115|Tinzaparin|tinzaparin|mesh-list
15114523|NCT05172115|Dalteparin|dalteparin|mesh-list
15114524|NCT05172115|Plasminogen|plasminogen|mesh-list
15114525|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15114526|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
15114527|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15114528|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15114529|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114530|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
15114531|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15114532|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114533|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114534|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15114535|NCT05171985|Analgesics|analgesics|mesh-ancestor
15114536|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
15114537|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114538|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15114539|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15114540|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15114541|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
15114542|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114543|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114544|NCT05171946|Vaccines|vaccines|mesh-list
15114545|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
15114546|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114547|NCT05171751|Octreotide|octreotide|mesh-list
15114548|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15114549|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15114550|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114551|NCT05171660|Capecitabine|capecitabine|mesh-list
15114552|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
15114553|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114554|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114555|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
15114556|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114557|NCT05171530|Lenvatinib|lenvatinib|mesh-list
15114558|NCT05171530|Taxane|taxane|mesh-list
15114559|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114560|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15114561|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114562|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114563|NCT05164653|Valsartan|valsartan|mesh-list
15114564|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
15114565|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15114566|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15114567|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15114568|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15114569|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15114570|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114571|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15114572|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
15114573|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114574|NCT05155293|Aflibercept|aflibercept|mesh-list
15114575|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15114576|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15114577|NCT05155293|Growth Substances|growth substances|mesh-ancestor
15114578|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114579|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
15114580|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114581|NCT05151588|Docetaxel|docetaxel|mesh-list
15114582|NCT05151588|Fluorouracil|fluorouracil|mesh-list
15114583|NCT05151588|Cisplatin|cisplatin|mesh-list
15114584|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114585|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
15114586|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
15114587|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114588|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114589|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
15114590|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114591|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114592|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
15114593|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114594|NCT05145348|Vaccines|vaccines|mesh-list
15114595|NCT05145348|Immunologic Factors|immunologic factors|mesh-ancestor
15114596|NCT05145348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114597|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
15114598|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15114599|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114600|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
15114601|NCT05137938|Ketamine|ketamine|mesh-list
15114602|NCT05137938|Analgesics|analgesics|mesh-ancestor
15114603|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
15114604|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114605|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114606|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15114607|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15114608|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
15114609|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
15114610|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114611|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15114612|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15114613|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114614|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114615|NCT05133804|Methylphenidate|methylphenidate|mesh-list
15114616|NCT05133804|Reboxetine|reboxetine|mesh-list
15114617|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15114618|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114619|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15114620|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15114621|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15114622|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114623|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
15114624|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114625|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
15114626|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15114627|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15114628|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
15114629|NCT05117307|Bupivacaine|bupivacaine|mesh-list
15114630|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
15114631|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
15114632|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114633|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114634|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
15114635|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114636|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15114637|NCT05105633|Tenecteplase|tenecteplase|mesh-list
15114638|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15114639|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15114640|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114641|NCT05085054|Osimertinib|osimertinib|mesh-list
15114642|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114643|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15114644|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114645|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114646|NCT05077332|Celecoxib|celecoxib|mesh-list
15114647|NCT05077332|Famotidine|famotidine|mesh-list
15114648|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15114649|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15114650|NCT05077332|Analgesics|analgesics|mesh-ancestor
15114651|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
15114652|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114653|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114654|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114655|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15114656|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15114657|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15114658|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114659|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114660|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15114661|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15114662|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15114663|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
15114664|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
15114665|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114666|NCT05054374|Fulvestrant|fulvestrant|mesh-list
15114667|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15114668|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114669|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15114670|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15114671|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
15114672|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114673|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114674|NCT05030272|Nicotine|nicotine|mesh-list
15114675|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15114676|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
15114677|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114678|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114679|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15114680|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15114681|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
15114682|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114683|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114684|NCT05027425|Durvalumab|durvalumab|mesh-list
15114685|NCT05027425|Tremelimumab|tremelimumab|mesh-list
15114686|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114687|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114688|NCT05024513|Fluorouracil|fluorouracil|mesh-list
15114689|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
15114690|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
15114691|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114692|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114693|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114694|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114695|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
15114696|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114697|NCT04995003|Cyclophosphamide|cyclophosphamide|mesh-list
15114698|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
15114699|NCT04995003|Nivolumab|nivolumab|mesh-list
15114700|NCT04995003|Fludarabine|fludarabine|mesh-list
15114701|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15114702|NCT04995003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114703|NCT04995003|Immunologic Factors|immunologic factors|mesh-ancestor
15114704|NCT04995003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114705|NCT04995003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15114706|NCT04995003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15114707|NCT04995003|Alkylating Agents|alkylating agents|mesh-ancestor
15114708|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114709|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114710|NCT04995003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15114711|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114712|NCT04994561|Niacinamide|niacinamide|mesh-list
15114713|NCT04994561|Metformin|metformin|mesh-list
15114714|NCT04994561|Dasatinib|dasatinib|mesh-list
15114715|NCT04994561|Resveratrol|resveratrol|mesh-list
15114716|NCT04994561|Quercetin|quercetin|mesh-list
15114717|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15114718|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114719|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114720|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15114721|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114722|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114723|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
15114724|NCT04994561|Protective Agents|protective agents|mesh-ancestor
15114725|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15114726|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
15114727|NCT04994561|Vitamins|vitamins|mesh-ancestor
15114728|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
15114729|NCT04991662|Phenylephrine|phenylephrine|mesh-list
15114730|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
15114731|NCT04991662|Norepinephrine|norepinephrine|mesh-list
15114732|NCT04991662|Metaraminol|metaraminol|mesh-list
15114733|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15114734|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
15114735|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
15114736|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114737|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114738|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
15114739|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15114740|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
15114741|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
14269408|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269409|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
14269410|NCT00402688|Levofloxacin|levofloxacin|mesh-list
14269411|NCT00402688|Ofloxacin|ofloxacin|mesh-list
14269412|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14269413|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269414|NCT00402688|Renal Agents|renal agents|mesh-ancestor
14269415|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269416|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15114742|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15114743|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15114744|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15114745|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
15114746|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114747|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114748|NCT04991662|Protective Agents|protective agents|mesh-ancestor
15176607|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176608|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176609|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15176610|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
15176611|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
15176612|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15176613|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
15176614|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176615|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176616|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
15176617|NCT03976518|Atezolizumab|atezolizumab|mesh-list
15176618|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176619|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15176620|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15176621|NCT03976544|Estradiol|estradiol|mesh-list
15176622|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15176623|NCT03976544|Progesterone|progesterone|mesh-list
15176624|NCT03976544|Estrogens|estrogens|mesh-ancestor
15176625|NCT03976544|Hormones|hormones|mesh-ancestor
15176626|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176627|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176628|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15176629|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
15176630|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15176631|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15176632|NCT03976544|Progestins|progestins|mesh-ancestor
15176633|NCT03976245|Etanercept|etanercept|mesh-list
15176634|NCT03976245|Tofacitinib|tofacitinib|mesh-list
15176635|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15176636|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15176637|NCT03976245|Analgesics|analgesics|mesh-ancestor
15176638|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
15176639|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176640|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176641|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176642|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176643|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176644|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15176645|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
15176646|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15176647|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176648|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176649|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15176650|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176651|NCT03976258|Naltrexone|naltrexone|mesh-list
15176652|NCT03976258|Buprenorphine|buprenorphine|mesh-list
15176653|NCT03976258|Methadone|methadone|mesh-list
15176654|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15176655|NCT03976258|Heroin|heroin|mesh-list
15176656|NCT03976258|Naloxone|naloxone|mesh-list
15176657|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15176658|NCT03976258|Narcotics|narcotics|mesh-ancestor
15176659|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176660|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176661|NCT03976258|Analgesics|analgesics|mesh-ancestor
15176662|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
15114749|NCT04947072|Anesthetics|anesthetics|mesh-list
15114750|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114751|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114752|NCT04942158|Eugenol|eugenol|mesh-list
15114753|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
15114754|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
15114755|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
15114756|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15114757|NCT04942158|Protective Agents|protective agents|mesh-ancestor
15114758|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114759|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114760|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
15114761|NCT04941703|Cathartics|cathartics|mesh-ancestor
15114762|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15114763|NCT04911166|Atezolizumab|atezolizumab|mesh-list
15114764|NCT04911166|Interleukin-12|interleukin-12|mesh-list
15114765|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114766|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15114767|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
15114768|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114769|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15114770|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15114771|NCT04911166|Growth Substances|growth substances|mesh-ancestor
15114772|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
15114773|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
15114774|NCT04827836|Povidone|povidone|mesh-list
15114775|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15114776|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15114777|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
15114778|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
15114779|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15114780|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114781|NCT04810208|Docetaxel|docetaxel|mesh-list
15114782|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114783|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
15114784|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
15114785|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114786|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114787|NCT04802161|Cytarabine|cytarabine|mesh-list
15114788|NCT04802161|Daunorubicin|daunorubicin|mesh-list
15114789|NCT04802161|Pomalidomide|pomalidomide|mesh-list
15114790|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114791|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
15114792|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114793|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114794|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
15114795|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114796|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114797|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
15114798|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114799|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15114800|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15114801|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114802|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114803|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15114804|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15114805|NCT04802161|Growth Substances|growth substances|mesh-ancestor
15114806|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
15114807|NCT04787835|Anesthetics|anesthetics|mesh-list
15114808|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
15114809|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15114810|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269417|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14269418|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114811|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
15114812|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114813|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15114814|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
15114815|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114816|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
15114817|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15114818|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114819|NCT04741997|Nivolumab|nivolumab|mesh-list
15114820|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114821|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114822|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15181704|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114823|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114824|NCT04708054|Fludarabine|fludarabine|mesh-list
15114825|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
15114826|NCT04708054|Busulfan|busulfan|mesh-list
15114827|NCT04708054|Venetoclax|venetoclax|mesh-list
15114828|NCT04708054|Thiotepa|thiotepa|mesh-list
15114829|NCT04708054|Cladribine|cladribine|mesh-list
15114830|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
15114831|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114832|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114833|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
15114834|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114835|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114836|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
15114837|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114838|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
15114839|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15114840|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15114841|NCT04703621|Daratumumab|daratumumab|mesh-list
15114842|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114843|NCT04691804|Prednisone|prednisone|mesh-list
15114844|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
15114845|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114846|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
15114847|NCT04691804|Hormones|hormones|mesh-ancestor
15114848|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114849|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114850|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15114851|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114852|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15114853|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114854|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114855|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
15114856|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15114857|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
15114858|NCT04671030|Neostigmine|neostigmine|mesh-list
15114859|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15114860|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114861|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114862|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
15114863|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114864|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114865|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15114866|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
15114867|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114868|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15114869|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15114870|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15114871|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
15114872|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15114873|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15114874|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114875|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15114876|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15114877|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114878|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114879|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114880|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15114881|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
15114882|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15114883|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114884|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15114885|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15114886|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15114887|NCT04652206|Gemcitabine|gemcitabine|mesh-list
15114888|NCT04652206|Paclitaxel|paclitaxel|mesh-list
15114889|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15114890|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114891|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
15114892|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
15114893|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
15114894|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114895|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15114896|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
15114897|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
15114898|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114899|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114900|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15114901|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
15114902|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114903|NCT04647903|Amphetamine|amphetamine|mesh-list
15114904|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
15114905|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15114906|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114907|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
15114908|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
15114909|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114910|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
15114911|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15114912|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114913|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
15114914|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15114915|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15114916|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15114917|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15114918|NCT04632264|Oxytocin|oxytocin|mesh-list
15114919|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
15114920|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15114921|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114922|NCT04616248|Poly I-C|poly i-c|mesh-list
15114923|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15114924|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15114925|NCT04616248|Antibodies|antibodies|mesh-list
15114926|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
15114927|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15114928|NCT04616248|Poly ICLC|poly iclc|mesh-list
15114929|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
15114930|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
15114931|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114932|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114933|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
15114934|NCT04616248|Laxatives|laxatives|mesh-ancestor
15114935|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15114936|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
15114937|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15114938|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15114939|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15114940|NCT04616248|Protective Agents|protective agents|mesh-ancestor
15114941|NCT04607928|Pirfenidone|pirfenidone|mesh-list
15114942|NCT04607928|Analgesics|analgesics|mesh-ancestor
15114943|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
15114944|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114945|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114946|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15114947|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15114948|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114949|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15114950|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114951|NCT04552223|Nivolumab|nivolumab|mesh-list
15114952|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114953|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114954|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15114955|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114956|NCT04537026|Dexamethasone|dexamethasone|mesh-list
15114957|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
15114958|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15114959|NCT04537026|BB 1101|bb 1101|mesh-list
15114960|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15114961|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
15114962|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
15114963|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15114964|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114965|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15114966|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
15114967|NCT04537026|Hormones|hormones|mesh-ancestor
15114968|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15114969|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15114970|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114971|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
15114972|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15114973|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114974|NCT04526730|Nivolumab|nivolumab|mesh-list
15114975|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15114976|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114977|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15114978|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114979|NCT04506086|Blinatumomab|blinatumomab|mesh-list
15114980|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176663|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176664|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15176665|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15176666|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
15176667|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
15181705|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181706|NCT03927118|Dexamethasone|dexamethasone|mesh-list
15181707|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
15181708|NCT03927118|BB 1101|bb 1101|mesh-list
15181709|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181710|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
15181711|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
15181712|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181713|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181714|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15181715|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
15181716|NCT03927118|Hormones|hormones|mesh-ancestor
15181717|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181718|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15181719|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181720|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
15181721|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181722|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181723|NCT03927170|Metformin|metformin|mesh-list
15181724|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15181725|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15181726|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181727|NCT03927170|Incretins|incretins|mesh-ancestor
15181728|NCT03927170|Hormones|hormones|mesh-ancestor
15181729|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181730|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15181731|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
15181732|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181733|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181734|NCT03927313|Aspirin|aspirin|mesh-list
15181735|NCT03927313|Rifampin|rifampin|mesh-list
15181736|NCT03927313|Linezolid|linezolid|mesh-list
15181737|NCT03927313|Dexamethasone|dexamethasone|mesh-list
15181738|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181739|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
15181740|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
15181741|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181742|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181743|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15181744|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
15181745|NCT03927313|Hormones|hormones|mesh-ancestor
15181746|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181747|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15181748|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181749|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15181750|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181751|NCT03927313|Analgesics|analgesics|mesh-ancestor
15181752|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
15181753|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181754|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15181755|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15181756|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181757|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15181758|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15181759|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181760|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
15181761|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15181762|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
15181763|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181764|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181765|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
15114981|NCT04498780|Valsartan|valsartan|mesh-list
15114982|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15114983|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15114984|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15114985|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15114986|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15114987|NCT04448717|Antibodies|antibodies|mesh-list
15114988|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
15114989|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114990|NCT04436965|Cisplatin|cisplatin|mesh-list
15114991|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15114992|NCT04420741|Iloprost|iloprost|mesh-list
15114993|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15114994|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
15114995|NCT04409041|Naltrexone|naltrexone|mesh-list
15114996|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15114997|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15114998|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15114999|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
15115000|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115001|NCT04407286|Vitamin D|vitamin d|mesh-list
15115002|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
15115003|NCT04407286|Vitamins|vitamins|mesh-ancestor
15115004|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
15115005|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115006|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15115007|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15115008|NCT04373369|Atezolizumab|atezolizumab|mesh-list
15115009|NCT04373369|Vorolanib|vorolanib|mesh-list
15115010|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115011|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115012|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115013|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115014|NCT04317404|Triamcinolone|triamcinolone|mesh-list
15115015|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15115016|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15115017|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15115018|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115019|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
15115020|NCT04317404|Hormones|hormones|mesh-ancestor
15115021|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115022|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115023|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115024|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
15115025|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115026|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115027|NCT04282239|Lidocaine|lidocaine|mesh-list
15115028|NCT04282239|Epinephrine|epinephrine|mesh-list
15115029|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
15115030|NCT04282239|Ropivacaine|ropivacaine|mesh-list
15115031|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
15115032|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
15115033|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115034|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115035|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
15115036|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115037|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15115038|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15115039|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15115040|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15115041|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115042|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15115043|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115044|NCT04282239|Analgesics|analgesics|mesh-ancestor
15115045|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15115046|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15115047|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15115048|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
15115049|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115050|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15115051|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15115052|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
15115053|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15115054|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
15115055|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
15115056|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
15115057|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15115058|NCT04232072|Ibuprofen|ibuprofen|mesh-list
15115059|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15115060|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115061|NCT04232072|Analgesics|analgesics|mesh-ancestor
15115062|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
15115063|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115064|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115065|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115066|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15115067|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15115068|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115069|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115070|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
15115071|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115072|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115073|NCT04182633|Vancomycin|vancomycin|mesh-list
15115074|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15115075|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115076|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115077|NCT04182633|Laxatives|laxatives|mesh-ancestor
15115078|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115079|NCT04179864|Prednisone|prednisone|mesh-list
15115080|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115081|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
15115082|NCT04179864|Hormones|hormones|mesh-ancestor
15115083|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115084|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115085|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15115086|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115087|NCT04143477|Peficitinib|peficitinib|mesh-list
15115088|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115089|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115090|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115091|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
15115092|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115093|NCT04132427|Vancomycin|vancomycin|mesh-list
15115094|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
15115095|NCT04132427|Citric Acid|citric acid|mesh-list
15115096|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
15115097|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
15115098|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15115099|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
15115100|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
15115101|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115102|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115103|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115104|NCT04132427|Cathartics|cathartics|mesh-ancestor
15115105|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115106|NCT04122755|Buprenorphine|buprenorphine|mesh-list
15115107|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15115108|NCT04122755|Narcotics|narcotics|mesh-ancestor
15115109|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115110|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115111|NCT04122755|Analgesics|analgesics|mesh-ancestor
15115112|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
15115113|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115114|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15115115|NCT04099836|Bevacizumab|bevacizumab|mesh-list
15115116|NCT04099836|Atezolizumab|atezolizumab|mesh-list
15115117|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115118|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115119|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15115120|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15115121|NCT04099836|Growth Substances|growth substances|mesh-ancestor
15115122|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115123|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
15115124|NCT04097470|Decitabine|decitabine|mesh-list
15115125|NCT04097470|Midostaurin|midostaurin|mesh-list
15115126|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15115127|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
15115128|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115129|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115130|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996182|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15176668|NCT03976102|Rituximab|rituximab|mesh-list
15115131|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115132|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
15115133|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
15115134|NCT04054999|Methylene Blue|methylene blue|mesh-list
15115135|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115136|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115137|NCT04054999|Hematinics|hematinics|mesh-ancestor
15115138|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
15115139|NCT04054999|Vitamins|vitamins|mesh-ancestor
15115140|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
15115141|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115142|NCT03947385|Crizotinib|crizotinib|mesh-list
15115143|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115144|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115145|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115146|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115147|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15115148|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115149|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15115150|NCT03857542|Pilocarpine|pilocarpine|mesh-list
15115151|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15115152|NCT03857542|Miotics|miotics|mesh-ancestor
15115153|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
15115154|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115155|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115156|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15115157|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15115158|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
15115159|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115160|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115161|NCT03848832|Cannabidiol|cannabidiol|mesh-list
15115162|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
15115163|NCT03835013|Exenatide|exenatide|mesh-list
15115164|NCT03835013|Glucagon|glucagon|mesh-list
15115165|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15115166|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15115167|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115168|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15115169|NCT03835013|Incretins|incretins|mesh-ancestor
15115170|NCT03835013|Hormones|hormones|mesh-ancestor
15115171|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115172|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176669|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176670|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176671|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
15176672|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176673|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176674|NCT03976063|Nifedipine|nifedipine|mesh-list
15176675|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15176676|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176677|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176678|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15176679|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176680|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
15176681|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
15176682|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15176683|NCT03976037|Misoprostol|misoprostol|mesh-list
15176684|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15176685|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
15176686|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15176687|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176688|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15176689|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176690|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
15176691|NCT03975374|Tobramycin|tobramycin|mesh-list
15176692|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
15176693|NCT03975374|Dexamethasone|dexamethasone|mesh-list
15176694|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15176695|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176696|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
15176697|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
15176698|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176699|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176700|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176701|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
15176702|NCT03975374|Hormones|hormones|mesh-ancestor
15181766|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15115173|NCT03810807|Osimertinib|osimertinib|mesh-list
15115174|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115175|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115176|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115177|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115178|NCT03794388|Pregabalin|pregabalin|mesh-list
15115179|NCT03794388|Capsaicin|capsaicin|mesh-list
15115180|NCT03794388|Analgesics|analgesics|mesh-ancestor
15115181|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
15115182|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115183|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115184|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
15115185|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15115186|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15115187|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115188|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15115189|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15115190|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15115191|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115192|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15115193|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
15115194|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
15115195|NCT03712943|Nivolumab|nivolumab|mesh-list
15115196|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115197|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115198|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15115199|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115200|NCT03700541|Morphine|morphine|mesh-list
15115201|NCT03700541|Pirinitramide|pirinitramide|mesh-list
15115202|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15115203|NCT03700541|Narcotics|narcotics|mesh-ancestor
15115204|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115205|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115206|NCT03700541|Analgesics|analgesics|mesh-ancestor
15115207|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
15115208|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115209|NCT03700411|Morphine|morphine|mesh-list
15115210|NCT03700411|Pirinitramide|pirinitramide|mesh-list
15115211|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15115212|NCT03700411|Narcotics|narcotics|mesh-ancestor
15115213|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115214|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115215|NCT03700411|Analgesics|analgesics|mesh-ancestor
15115216|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
15115217|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115218|NCT03691051|Capecitabine|capecitabine|mesh-list
15115219|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15115220|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
15115221|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115222|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115223|NCT03688802|Varenicline|varenicline|mesh-list
15115224|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15115225|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15115226|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
15115227|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115228|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115229|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115230|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
15115231|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15115232|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115233|NCT03630666|Hormones|hormones|mesh-list
15115234|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15115235|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115236|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115237|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
15115238|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15115239|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115240|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115241|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15115242|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15115243|NCT03625648|Protective Agents|protective agents|mesh-ancestor
15115244|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115245|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
13996183|NCT02922348|Progestins|progestins|mesh-list
15115246|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15115247|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
15115248|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
15115249|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15115250|NCT03595917|Prednisone|prednisone|mesh-list
15115251|NCT03595917|Dasatinib|dasatinib|mesh-list
15115252|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115253|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
15115254|NCT03595917|Hormones|hormones|mesh-ancestor
15115255|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115256|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115257|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15115258|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115259|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115260|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115261|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115262|NCT03562195|Albuterol|albuterol|mesh-list
15115263|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15115264|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
15115265|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115266|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115267|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15115268|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
15115269|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
15115270|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15115271|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15115272|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15115273|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15115274|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
15115275|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115276|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115277|NCT03541083|Blinatumomab|blinatumomab|mesh-list
15115278|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115279|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
15115280|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15115281|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115282|NCT03465111|Hormones|hormones|mesh-list
15115283|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15115284|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15115285|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
15115286|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115287|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115288|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115289|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115290|NCT03446612|Nitroprusside|nitroprusside|mesh-list
15115291|NCT03446612|Acetylcholine|acetylcholine|mesh-list
15115292|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
15115293|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
15115294|NCT03446612|Hematinics|hematinics|mesh-ancestor
15115295|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15115296|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
15115297|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15115298|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115299|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15115300|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
15115301|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115302|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115303|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115304|NCT03436433|Lacosamide|lacosamide|mesh-list
15115305|NCT03436433|Levetiracetam|levetiracetam|mesh-list
15115306|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
15115307|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
15115308|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15115309|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15115310|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15115311|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115312|NCT03408886|Vancomycin|vancomycin|mesh-list
15115313|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115314|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115315|NCT03387774|Urinastatin|urinastatin|mesh-list
15115316|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15115317|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15115318|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
15115319|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115320|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115321|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15115322|NCT03387579|SMOFlipid|smoflipid|mesh-list
15115323|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
15115324|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15115325|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15115326|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
15115327|NCT03290079|Lenvatinib|lenvatinib|mesh-list
15115328|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115329|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115330|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115331|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115332|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115333|NCT03255512|Isosorbide|isosorbide|mesh-list
15115334|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15115335|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15115336|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15115337|NCT03255512|Diuretics|diuretics|mesh-ancestor
15115338|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
15115339|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115340|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
15115341|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15115342|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115343|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
15115344|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
15115345|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115346|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115347|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115348|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115349|NCT03230266|Insulin|insulin|mesh-list
15115350|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15115351|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115352|NCT03112590|Interferons|interferons|mesh-list
15115353|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
15115354|NCT03112590|Paclitaxel|paclitaxel|mesh-list
15115355|NCT03112590|Trastuzumab|trastuzumab|mesh-list
15115356|NCT03112590|Pertuzumab|pertuzumab|mesh-list
15115357|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15115358|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115359|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
15115360|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
15115361|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
15115362|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115363|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115364|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
15115365|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115366|NCT03111212|Iloprost|iloprost|mesh-list
15115367|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15115368|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
15115369|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
15115370|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15115371|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115372|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115373|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
15115374|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15115375|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
15115376|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115377|NCT03063021|Expectorants|expectorants|mesh-ancestor
15115378|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
15115379|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15115380|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
15115381|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115382|NCT03063021|Protective Agents|protective agents|mesh-ancestor
15115383|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115384|NCT03063021|Antidotes|antidotes|mesh-ancestor
15115385|NCT02997358|Doxorubicin|doxorubicin|mesh-list
15115386|NCT02997358|Trabectedin|trabectedin|mesh-list
15115387|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15115388|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115389|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15115390|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15115391|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115392|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115393|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15115394|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
15115395|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
15115396|NCT02963610|Lenalidomide|lenalidomide|mesh-list
15115397|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115398|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115399|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
15115400|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115401|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15115402|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15115403|NCT02963610|Growth Substances|growth substances|mesh-ancestor
15115404|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
15115405|NCT02945800|Gemcitabine|gemcitabine|mesh-list
15115406|NCT02945800|Paclitaxel|paclitaxel|mesh-list
15115407|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15115408|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115409|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
15115410|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
15115411|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
14269419|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115412|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115413|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15115414|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
15115415|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
15115416|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115417|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115418|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115419|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
15115420|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115421|NCT02903160|Prednisone|prednisone|mesh-list
15115422|NCT02903160|Carboplatin|carboplatin|mesh-list
15115423|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
15115424|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15115425|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115426|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115427|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
15115428|NCT02903160|Hormones|hormones|mesh-ancestor
15115429|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115430|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115431|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15115432|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15115433|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115434|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115435|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
15115436|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15115437|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
15115438|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15115439|NCT02836925|Ledipasvir|ledipasvir|mesh-list
15115440|NCT02836925|Velpatasvir|velpatasvir|mesh-list
15115441|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
15115442|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115443|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
15115444|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
15115445|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115446|NCT02814695|Protective Agents|protective agents|mesh-ancestor
15115447|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115448|NCT02814695|Vitamins|vitamins|mesh-ancestor
15115449|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
15115450|NCT02798536|Paclitaxel|paclitaxel|mesh-list
15115451|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15115452|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115453|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
15115454|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
15115455|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
15115456|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115457|NCT02766335|Docetaxel|docetaxel|mesh-list
15115458|NCT02766335|Durvalumab|durvalumab|mesh-list
15115459|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
15115460|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15115461|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
15115462|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115463|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
15115464|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
15115465|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
15115466|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115467|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115468|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
15115469|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115470|NCT02736422|Xenon|xenon|mesh-list
15115471|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15115472|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
15115473|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
15115474|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115475|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269420|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269421|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14269422|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14269423|NCT00402714|Pentostatin|pentostatin|mesh-list
14269424|NCT00402714|Methoxsalen|methoxsalen|mesh-list
15115476|NCT02710643|Ofatumumab|ofatumumab|mesh-list
15115477|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176703|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176704|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15176705|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176706|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15176707|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176708|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15176709|NCT03975283|Bupivacaine|bupivacaine|mesh-list
15176710|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
15176711|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
15176712|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176713|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176714|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
15176715|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176716|NCT03975270|Paclitaxel|paclitaxel|mesh-list
15176717|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15176718|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176719|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
15176720|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
15176721|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
15176722|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176723|NCT03975114|Durvalumab|durvalumab|mesh-list
15176724|NCT03975114|Tremelimumab|tremelimumab|mesh-list
15176725|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15176726|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176727|NCT03975088|Ranibizumab|ranibizumab|mesh-list
15176728|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15176729|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15176730|NCT03975088|Growth Substances|growth substances|mesh-ancestor
15176731|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176732|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
15176733|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176734|NCT03975166|Fluticasone|fluticasone|mesh-list
15176735|NCT03975166|Xhance|xhance|mesh-list
15176736|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15176737|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15176738|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176739|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15176740|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
15176741|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176742|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176743|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15176744|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
15176745|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
15176746|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15176747|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15176748|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15176749|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15176750|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176751|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176752|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269425|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115478|NCT02675439|Ipilimumab|ipilimumab|mesh-list
15115479|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115480|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115481|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15115482|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115483|NCT02651740|Rifaximin|rifaximin|mesh-list
15115484|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115485|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115486|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115487|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
15115488|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
15115489|NCT02606136|Mitogens|mitogens|mesh-list
15115490|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
15115491|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115492|NCT02493426|Oxytocin|oxytocin|mesh-list
15115493|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
15115494|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15115495|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115496|NCT02432378|Celecoxib|celecoxib|mesh-list
15115497|NCT02432378|Cisplatin|cisplatin|mesh-list
15115498|NCT02432378|Vaccines|vaccines|mesh-list
15115499|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
15115500|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115501|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115502|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15115503|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115504|NCT02432378|Analgesics|analgesics|mesh-ancestor
15115505|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
15115506|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115507|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115508|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15115509|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15115510|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15115511|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115512|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115513|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15115514|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15115515|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115516|NCT02090998|Lidocaine|lidocaine|mesh-list
15115517|NCT02090998|Amitriptyline|amitriptyline|mesh-list
15115518|NCT02090998|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15115519|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
15115520|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
15115521|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115522|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115523|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
15115524|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115525|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15115526|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15115527|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13996184|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996185|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996186|NCT02922348|Estrogens|estrogens|mesh-ancestor
13996187|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13996188|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996189|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13996190|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13996191|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13996192|NCT02922387|Varenicline|varenicline|mesh-list
15115528|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15115529|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115530|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15115531|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
15115532|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15115533|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115534|NCT02090998|Analgesics|analgesics|mesh-ancestor
15115535|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15115536|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15115537|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
15115538|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115539|NCT02090998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15115540|NCT02090998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15115541|NCT02063685|Prednisone|prednisone|mesh-list
15115542|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
15115543|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15115544|NCT02063685|Rituximab|rituximab|mesh-list
15115545|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15115546|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115547|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
15115548|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115549|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15115550|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15115551|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
15115552|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115553|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115554|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14269426|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14269427|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115555|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115556|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115557|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
15115558|NCT02063685|Hormones|hormones|mesh-ancestor
15115559|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115560|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15115561|NCT02051309|Guanfacine|guanfacine|mesh-list
15115562|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14269428|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269429|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14269430|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14269431|NCT00402727|Amoxicillin|amoxicillin|mesh-list
14269432|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
15115563|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15115564|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15115565|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15115566|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
15115567|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115568|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115569|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115570|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
15115571|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115572|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115573|NCT01900002|Sorafenib|sorafenib|mesh-list
15115574|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115575|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115576|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115577|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115578|NCT01595061|Gemcitabine|gemcitabine|mesh-list
15115579|NCT01595061|Cisplatin|cisplatin|mesh-list
15115580|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115581|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15115582|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
15115583|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115584|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
15115585|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115586|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115587|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115588|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
15115589|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115590|NCT01587352|Vorinostat|vorinostat|mesh-list
15115591|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115592|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15115593|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115594|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115595|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
15115596|NCT00902044|Fludarabine|fludarabine|mesh-list
15115597|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115598|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
15115599|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115600|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15115601|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15115602|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
15115603|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115604|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115605|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15115606|NCT00165724|Donepezil|donepezil|mesh-list
15115607|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15115608|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269433|NCT00402727|Tazobactam|tazobactam|mesh-list
15115609|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115610|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
15115611|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115612|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115613|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
15115614|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
15115615|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15115616|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
15115617|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15115618|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
15115619|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115620|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115621|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
15115622|NCT04527133|Aprotinin|aprotinin|mesh-list
15115623|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
15115624|NCT04527133|Coagulants|coagulants|mesh-ancestor
15115625|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15115626|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15115627|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
15115628|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115629|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115630|NCT04527055|Metronidazole|metronidazole|mesh-list
15115631|NCT04527055|Tetracycline|tetracycline|mesh-list
15115632|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
15115633|NCT04527055|Esomeprazole|esomeprazole|mesh-list
15115634|NCT04527055|Bismuth|bismuth|mesh-list
15115635|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115636|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115637|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15115638|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15115639|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15115640|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115641|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15115642|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115643|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115644|NCT04527055|Antacids|antacids|mesh-ancestor
15115645|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15115646|NCT04526951|Aspirin|aspirin|mesh-list
15115647|NCT04526951|Tenecteplase|tenecteplase|mesh-list
15115648|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15115649|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115650|NCT04526951|Analgesics|analgesics|mesh-ancestor
15115651|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
15115652|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115653|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115654|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115655|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15115656|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15115657|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15115658|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115659|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15115660|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15115661|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115662|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
15115663|NCT04527068|Bevacizumab|bevacizumab|mesh-list
15115664|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115665|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115666|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15115667|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14269434|NCT00402727|Piperacillin|piperacillin|mesh-list
14269435|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
14269436|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
15115668|NCT04527068|Growth Substances|growth substances|mesh-ancestor
15115669|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115670|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
15115671|NCT04526470|Paclitaxel|paclitaxel|mesh-list
15115672|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15115673|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115674|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
15115675|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
15115676|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
15115677|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115678|NCT04526353|Oxybutynin|oxybutynin|mesh-list
13996193|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15115679|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
15115680|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
15115681|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115682|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115683|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15115684|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15115685|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
15115686|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115687|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115688|NCT04526353|Urological Agents|urological agents|mesh-ancestor
15115689|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
15115690|NCT04526210|Choline|choline|mesh-list
15115691|NCT04526210|Bupropion|bupropion|mesh-list
15115692|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15115693|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
15115694|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15115695|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15115696|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15115697|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15115698|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115699|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
15115700|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115701|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115702|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15115703|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15115704|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115705|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
15115706|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15115707|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
15115708|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115709|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15115710|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
15115711|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
15115712|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
15115713|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15115714|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15115715|NCT04526210|Growth Substances|growth substances|mesh-ancestor
15115716|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
15115717|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115718|NCT04526028|Fulvestrant|fulvestrant|mesh-list
15115719|NCT04526028|Palbociclib|palbociclib|mesh-list
15115720|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15115721|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115722|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15115723|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15115724|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
15115725|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115726|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115727|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115728|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115729|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115730|NCT04526119|Z 338|z 338|mesh-list
15115731|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15115732|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115733|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115734|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
15115735|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115736|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115737|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115738|NCT04526236|Methadone|methadone|mesh-list
15115739|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15115740|NCT04526236|Narcotics|narcotics|mesh-ancestor
15115741|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115742|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115743|NCT04526236|Analgesics|analgesics|mesh-ancestor
15115744|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
15115745|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115746|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
15115747|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
15115748|NCT04525820|Vitamin D|vitamin d|mesh-list
15115749|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
15115750|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
15115751|NCT04525820|Vitamins|vitamins|mesh-list
15115752|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15115753|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
15115754|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115755|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15115756|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15115757|NCT04525664|Amoxicillin|amoxicillin|mesh-list
15115758|NCT04525664|Clarithromycin|clarithromycin|mesh-list
15115759|NCT04525664|Omeprazole|omeprazole|mesh-list
15115760|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115761|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115762|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15115763|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115764|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15115765|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115766|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269437|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14269438|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14269439|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269440|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115767|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15115768|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15115769|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15176753|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
15176754|NCT03975166|Hormones|hormones|mesh-ancestor
15176755|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176756|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
15176757|NCT03975205|Doxorubicin|doxorubicin|mesh-list
15176758|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15176759|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176760|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15176761|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14269441|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14269442|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14269443|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269444|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269445|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269446|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14269447|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
14269448|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15176762|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176763|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176764|NCT03975036|Antibodies|antibodies|mesh-list
15176765|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
15176766|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176767|NCT03975010|Naltrexone|naltrexone|mesh-list
15176768|NCT03975010|Buprenorphine|buprenorphine|mesh-list
15176769|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15176770|NCT03975010|Narcotics|narcotics|mesh-ancestor
15176771|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176772|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176773|NCT03975010|Analgesics|analgesics|mesh-ancestor
15176774|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
15176775|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176776|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15176777|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15176778|NCT03975062|Dabigatran|dabigatran|mesh-list
15176779|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
15176780|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15176781|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
15176782|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176783|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176784|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
15176785|NCT03974984|Anesthetics|anesthetics|mesh-list
15176786|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176787|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176788|NCT03974789|Dexamethasone|dexamethasone|mesh-list
15176789|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176790|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
15176791|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
15176792|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176793|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176794|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176795|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
15176796|NCT03974789|Hormones|hormones|mesh-ancestor
15176797|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176798|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15176799|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115770|NCT04525729|Rituximab|rituximab|mesh-list
15115771|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115772|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115773|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
15115774|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115775|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15115776|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
15115777|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15115778|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115779|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
15115780|NCT04525495|Dopamine|dopamine|mesh-list
15115781|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15115782|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
15115783|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
15115784|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115785|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115786|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
15115787|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115788|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115789|NCT04525495|Protective Agents|protective agents|mesh-ancestor
15115790|NCT04525638|Nivolumab|nivolumab|mesh-list
15115791|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15115792|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115793|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115794|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15115795|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115796|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15115797|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
15115798|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15115799|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
15115800|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115801|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
15115802|NCT04525066|Protective Agents|protective agents|mesh-ancestor
15115803|NCT04525235|Tolbutamide|tolbutamide|mesh-list
15115804|NCT04525235|Rifampin|rifampin|mesh-list
15115805|NCT04525235|Digoxin|digoxin|mesh-list
15115806|NCT04525235|Midazolam|midazolam|mesh-list
15115807|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
15115808|NCT04525235|Caffeine|caffeine|mesh-list
15115809|NCT04525235|Omeprazole|omeprazole|mesh-list
15115810|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15115811|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15115812|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115813|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115814|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15115815|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15115816|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15115817|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15115818|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
15115819|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
15115820|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
15115821|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
15115822|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115823|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115824|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15115825|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15115826|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15115827|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115828|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15115829|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15115830|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15115831|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15115832|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
15115833|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15115834|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
15115835|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115836|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115837|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
15115838|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15115839|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15115840|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15115841|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15115842|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15115843|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15115844|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15115845|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15115846|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15115847|NCT04525235|Protective Agents|protective agents|mesh-ancestor
15115848|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
15115849|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
15115850|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15115851|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15115852|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15115853|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
15115854|NCT04525274|Ketamine|ketamine|mesh-list
15115855|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15115856|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115857|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115858|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115859|NCT04525274|Analgesics|analgesics|mesh-ancestor
15115860|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
15115861|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115862|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15115863|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15115864|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15115865|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
15115866|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115867|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115868|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15115869|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15115870|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
15115871|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
15115872|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15115873|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15115874|NCT04525326|Bevacizumab|bevacizumab|mesh-list
15115875|NCT04525326|Cetuximab|cetuximab|mesh-list
15115876|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15115877|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115878|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15115879|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15115880|NCT04525326|Growth Substances|growth substances|mesh-ancestor
15115881|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115882|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
15115883|NCT04525300|Liraglutide|liraglutide|mesh-list
15115884|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15115885|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115886|NCT04525300|Incretins|incretins|mesh-ancestor
15115887|NCT04525300|Hormones|hormones|mesh-ancestor
15115888|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115889|NCT04524728|Letrozole|letrozole|mesh-list
15115890|NCT04524728|Fulvestrant|fulvestrant|mesh-list
15115891|NCT04524728|Palbociclib|palbociclib|mesh-list
15115892|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115893|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15115894|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15115895|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115896|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115897|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15115898|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
15115899|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115900|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115901|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15115902|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15115903|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115904|NCT04524897|Triamcinolone|triamcinolone|mesh-list
15115905|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15115906|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15115907|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15115908|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115909|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
15115910|NCT04524897|Hormones|hormones|mesh-ancestor
15115911|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115912|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115913|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115914|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
15115915|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115916|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115917|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15115918|NCT04524169|Thymalfasin|thymalfasin|mesh-list
15115919|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15115920|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
15115921|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115922|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
15115923|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15115924|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15115925|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15115926|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15115927|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115928|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115929|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115930|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15115931|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15115932|NCT04524026|Letrozole|letrozole|mesh-list
15115933|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15115934|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115935|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15115936|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115937|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115938|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15115939|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
15115940|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15115941|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115942|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15115943|NCT04523844|Brinzolamide|brinzolamide|mesh-list
15115944|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15115945|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15115946|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15115947|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15115948|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
15115949|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15115950|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115951|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115952|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15115953|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115954|NCT04523818|Fluorouracil|fluorouracil|mesh-list
15115955|NCT04523818|Capecitabine|capecitabine|mesh-list
15115956|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
15115957|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115958|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15115959|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115960|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15115961|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
15115962|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115963|NCT04523792|Buprenorphine|buprenorphine|mesh-list
15115964|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15115965|NCT04523792|Narcotics|narcotics|mesh-ancestor
15115966|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115967|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115968|NCT04523792|Analgesics|analgesics|mesh-ancestor
15115969|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
15115970|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115971|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15115972|NCT04523740|Acetaminophen|acetaminophen|mesh-list
15115973|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115974|NCT04523740|Analgesics|analgesics|mesh-ancestor
15115975|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
15115976|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115977|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115978|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
15115979|NCT04523623|Ibuprofen|ibuprofen|mesh-list
15115980|NCT04523623|Oxycodone|oxycodone|mesh-list
15115981|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15115982|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15115983|NCT04523623|Analgesics|analgesics|mesh-ancestor
15115984|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
15115985|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15115986|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15115987|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15115988|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15115989|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15115990|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15115991|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15115992|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15115993|NCT04523623|Narcotics|narcotics|mesh-ancestor
15115994|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15115995|NCT04523662|Apatinib|apatinib|mesh-list
15115996|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15115997|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15115998|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269449|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269450|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14269451|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14269452|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14269453|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15115999|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116000|NCT04523493|Lenvatinib|lenvatinib|mesh-list
15116001|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116002|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116003|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116004|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116005|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
15116006|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15116007|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
15116008|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116009|NCT04523675|Expectorants|expectorants|mesh-ancestor
15116010|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
15116011|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15116012|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
15116013|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116014|NCT04523675|Protective Agents|protective agents|mesh-ancestor
15116015|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116016|NCT04523675|Antidotes|antidotes|mesh-ancestor
15116017|NCT04523701|SMOFlipid|smoflipid|mesh-list
15116018|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15116019|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15116020|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15116021|NCT04523688|Temozolomide|temozolomide|mesh-list
15116022|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15116023|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
15116024|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116025|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116026|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
15116027|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
15116028|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15116029|NCT04523467|Growth Substances|growth substances|mesh-ancestor
15116030|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116031|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
15116032|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116033|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15176800|NCT03974854|Gemcitabine|gemcitabine|mesh-list
15176801|NCT03974854|Capecitabine|capecitabine|mesh-list
15176802|NCT03974854|Irinotecan|irinotecan|mesh-list
15176803|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15176804|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
15176805|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176806|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176807|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
15176808|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15176809|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176810|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15176811|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
15176812|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176813|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15176814|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15176815|NCT03974932|Acetaminophen|acetaminophen|mesh-list
15176816|NCT03974932|Ibuprofen|ibuprofen|mesh-list
15176817|NCT03974932|Celecoxib|celecoxib|mesh-list
15176818|NCT03974932|Bupivacaine|bupivacaine|mesh-list
15176819|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
15176820|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
15176821|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176822|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176823|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
15176824|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176825|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15176826|NCT03974932|Analgesics|analgesics|mesh-ancestor
15176827|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
15176828|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13996194|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15176829|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116034|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
15116035|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15116036|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116037|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116038|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
15116039|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116040|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116041|NCT04523233|Vitamins|vitamins|mesh-list
15116042|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
15116043|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116044|NCT04523272|Sunitinib|sunitinib|mesh-list
15116045|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116046|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15116047|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15116048|NCT04523272|Growth Substances|growth substances|mesh-ancestor
15116049|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116050|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
15116051|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116052|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116053|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116054|NCT04523077|Antibodies|antibodies|mesh-list
15116055|NCT04523077|Hormones|hormones|mesh-list
15116056|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
15116057|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116058|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116059|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15116060|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15116061|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
15116062|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15116063|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116064|NCT04522882|Insulin|insulin|mesh-list
15116065|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15116066|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116067|NCT04523064|Empagliflozin|empagliflozin|mesh-list
15116068|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15116069|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116070|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15116071|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116072|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15116073|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116074|NCT04522622|Teriparatide|teriparatide|mesh-list
15116075|NCT04522622|Listerine|listerine|mesh-list
15116076|NCT04522622|Fluorides|fluorides|mesh-list
15116077|NCT04522622|Sodium Fluoride|sodium fluoride|mesh-list
15116078|NCT04522622|Cariostatic Agents|cariostatic agents|mesh-ancestor
15116079|NCT04522622|Protective Agents|protective agents|mesh-ancestor
15116080|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116081|NCT04522622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15116082|NCT04522622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116083|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15116084|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15116085|NCT04522544|Durvalumab|durvalumab|mesh-list
15116086|NCT04522544|Tremelimumab|tremelimumab|mesh-list
15116087|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116088|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116089|NCT04522336|Docetaxel|docetaxel|mesh-list
15116090|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
15116091|NCT04522336|Fluorouracil|fluorouracil|mesh-list
15116092|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
15116093|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116094|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
15116095|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
15116096|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
15116097|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116098|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116099|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
15116100|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116101|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116102|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
15116103|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116104|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
14269454|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14269455|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269456|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116105|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
15116106|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15116107|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15116108|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116109|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116110|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116111|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116112|NCT04522297|Octreotide|octreotide|mesh-list
15116113|NCT04522297|Epinephrine|epinephrine|mesh-list
15116114|NCT04522297|Midodrine|midodrine|mesh-list
15116115|NCT04522297|Norepinephrine|norepinephrine|mesh-list
15116116|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15116117|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15116118|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
15116119|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116120|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116121|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116122|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15116123|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15116124|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
15116125|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116126|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15116127|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
15116128|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
15116129|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
15116130|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15116131|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15116132|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15116133|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116134|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15116135|NCT04522206|Oxycodone|oxycodone|mesh-list
15116136|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15116137|NCT04522206|Narcotics|narcotics|mesh-ancestor
15116138|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116139|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116140|NCT04522206|Analgesics|analgesics|mesh-ancestor
15116141|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
15116142|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116143|NCT04521868|Sulforaphane|sulforaphane|mesh-list
15116144|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15116145|NCT04521868|Protective Agents|protective agents|mesh-ancestor
15116146|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116147|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116148|NCT04522050|Gemcitabine|gemcitabine|mesh-list
15116149|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116150|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116151|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
15116152|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116153|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
15116154|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116155|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116156|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116157|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
15116158|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116159|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
15116160|NCT04521946|Fludarabine|fludarabine|mesh-list
15116161|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
15116162|NCT04521946|Etoposide|etoposide|mesh-list
15116163|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
15116164|NCT04521946|Melphalan|melphalan|mesh-list
15116165|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
15116166|NCT04521946|Thiotepa|thiotepa|mesh-list
15116167|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
15116168|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15116169|NCT04521946|Tacrolimus|tacrolimus|mesh-list
15116170|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
15116171|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15116172|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
15116173|NCT04521946|Antibodies|antibodies|mesh-list
15116174|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
15116175|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15116176|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15116177|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116178|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116179|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
15116180|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116181|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116182|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
15116183|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116184|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15116185|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15116186|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15116187|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116188|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15116189|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15116190|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15116191|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
15116192|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15116193|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116194|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15116195|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
15116196|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15116197|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
15116198|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
15116199|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
15116200|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
15116201|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
15116202|NCT04522037|Morphine|morphine|mesh-list
15116203|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15116204|NCT04522037|Narcotics|narcotics|mesh-ancestor
15116205|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116206|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116207|NCT04522037|Analgesics|analgesics|mesh-ancestor
15116208|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
15116209|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116210|NCT04521400|Interferons|interferons|mesh-list
15116211|NCT04521400|Ritonavir|ritonavir|mesh-list
15116212|NCT04521400|Lopinavir|lopinavir|mesh-list
15116213|NCT04521400|Interferon-beta|interferon-beta|mesh-list
15116214|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
15116215|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116216|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
15116217|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116218|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15116219|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15116220|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
15116221|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116222|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116223|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15116224|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15116225|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15116226|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15116227|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
15116228|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116229|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15116230|NCT04521569|Regadenoson|regadenoson|mesh-list
15116231|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15116232|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15116233|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
15116234|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
15116235|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116236|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116237|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116238|NCT04521556|Morphine|morphine|mesh-list
15116239|NCT04521556|Tramadol|tramadol|mesh-list
15116240|NCT04521556|Anesthetics|anesthetics|mesh-list
15116241|NCT04521556|Ropivacaine|ropivacaine|mesh-list
15116242|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116243|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116244|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15116245|NCT04521556|Narcotics|narcotics|mesh-ancestor
15116246|NCT04521556|Analgesics|analgesics|mesh-ancestor
15116247|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
15116248|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116249|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116250|NCT04521582|Amlodipine|amlodipine|mesh-list
15116251|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15116252|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15116253|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116254|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116255|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15116256|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116257|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
15116258|NCT04521751|Acarbose|acarbose|mesh-list
15116259|NCT04521751|Orlistat|orlistat|mesh-list
15116260|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15116261|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116262|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116263|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15116264|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116265|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15116266|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15116267|NCT04521517|Imidacloprid|imidacloprid|mesh-list
15116268|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
15116269|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116270|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116271|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116272|NCT04521491|Leucovorin|leucovorin|mesh-list
15116273|NCT04521491|Fluorouracil|fluorouracil|mesh-list
15116274|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
15116275|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
15116276|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116277|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116278|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116279|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116280|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
15116281|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116282|NCT04521491|Antidotes|antidotes|mesh-ancestor
15116283|NCT04521491|Protective Agents|protective agents|mesh-ancestor
15116284|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
15116285|NCT04521491|Vitamins|vitamins|mesh-ancestor
15116286|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
15176830|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176831|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15176832|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176833|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176834|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15176835|NCT03974685|Niacinamide|niacinamide|mesh-list
15176836|NCT03974685|Niacin|niacin|mesh-list
15176837|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
15176838|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
15176839|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
15176840|NCT03974685|Vitamins|vitamins|mesh-ancestor
15176841|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
15176842|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176843|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15176844|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
15176845|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176846|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15176847|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
15176848|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176849|NCT03974867|Prednisone|prednisone|mesh-list
15176850|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
15176851|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15176852|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15176853|NCT03974867|Prednisolone|prednisolone|mesh-list
15176854|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
15176855|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15176856|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
15176857|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15176858|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
15176859|NCT03974867|Hormones|hormones|mesh-ancestor
15176860|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176861|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176862|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15176863|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176864|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
15176865|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
15176866|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176867|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176868|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15176869|NCT03974867|Protective Agents|protective agents|mesh-ancestor
15176870|NCT03974217|Talazoparib|talazoparib|mesh-list
15176871|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15176872|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176873|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176874|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176875|NCT03974360|Erenumab|erenumab|mesh-list
15176876|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15176877|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176878|NCT03974360|Analgesics|analgesics|mesh-ancestor
15116287|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
15116288|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15116289|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
15116290|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116291|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
15116292|NCT04521387|Protective Agents|protective agents|mesh-ancestor
15116293|NCT04521075|Nivolumab|nivolumab|mesh-list
15116294|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116295|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116296|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15116297|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116298|NCT04521140|Dexamethasone|dexamethasone|mesh-list
15116299|NCT04521140|Prednisolone|prednisolone|mesh-list
15116300|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15116301|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
15116302|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15116303|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
15116304|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15116305|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
15116306|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116307|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
15116308|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
15116309|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116310|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116311|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15116312|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
15116313|NCT04521140|Hormones|hormones|mesh-ancestor
15116314|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116315|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15116316|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116317|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15116318|NCT04521140|Protective Agents|protective agents|mesh-ancestor
15116319|NCT04521348|Antibodies|antibodies|mesh-list
15116320|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
15116321|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
15116322|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116323|NCT04521309|Antibodies|antibodies|mesh-list
15116324|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
15116325|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116326|NCT04521153|Apatinib|apatinib|mesh-list
15116327|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116328|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116329|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116330|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116331|NCT04521049|Saxagliptin|saxagliptin|mesh-list
15116332|NCT04521049|Incretins|incretins|mesh-ancestor
15116333|NCT04521049|Hormones|hormones|mesh-ancestor
15116334|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116335|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116336|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15116337|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
15116338|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116339|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116340|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15116341|NCT04520646|Empagliflozin|empagliflozin|mesh-list
15116342|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15116343|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116344|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15116345|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116346|NCT04520620|Enoxaparin|enoxaparin|mesh-list
15116347|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
15116348|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15116349|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15116350|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116351|NCT04520880|Antibodies|antibodies|mesh-list
15116352|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
15116353|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
15116354|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
15116355|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116356|NCT04520919|Anesthetics|anesthetics|mesh-list
15116357|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116358|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116359|NCT04520503|Propofol|propofol|mesh-list
15116360|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15116361|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116362|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116363|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15116364|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
15116365|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
15116366|NCT04520230|Budesonide|budesonide|mesh-list
15116367|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
15116368|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
15116369|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15116370|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116371|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15116372|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
15116373|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116374|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116375|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15116376|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
15116377|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
15116378|NCT04520230|Hormones|hormones|mesh-ancestor
15116379|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116380|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15116381|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15116382|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15116383|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
15116384|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116385|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116386|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
15116387|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15116388|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
15116389|NCT04520490|Exenatide|exenatide|mesh-list
15116390|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15116391|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116392|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15116393|NCT04520490|Incretins|incretins|mesh-ancestor
15116394|NCT04520490|Hormones|hormones|mesh-ancestor
15116395|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116396|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
15116397|NCT04520074|Carboplatin|carboplatin|mesh-list
15116398|NCT04520074|Etoposide|etoposide|mesh-list
15116399|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116400|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
15116401|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116402|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116403|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15116404|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
15116405|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116406|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116407|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15116408|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15116409|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15116410|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15116411|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116412|NCT04520451|Prednisone|prednisone|mesh-list
15116413|NCT04520451|Prednisolone|prednisolone|mesh-list
15116414|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
15116415|NCT04520451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116416|NCT04520451|Hormones|hormones|mesh-ancestor
15116417|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116418|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116419|NCT04520451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15116420|NCT04520451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116421|NCT04520048|Acetylcholine|acetylcholine|mesh-list
15116422|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
15116423|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15116424|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
15116425|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116426|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116427|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116428|NCT04520178|Carbidopa|carbidopa|mesh-list
15116429|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
15116430|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15116431|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15116432|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
15116433|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116434|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116435|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116436|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15116437|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116438|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14269457|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269458|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269459|NCT00402896|Mitogens|mitogens|mesh-list
14269460|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
14269461|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
14269462|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269463|NCT00402896|Growth Substances|growth substances|mesh-ancestor
15116439|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
15116440|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15116441|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
15116442|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116443|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
15116444|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116445|NCT04520126|Protective Agents|protective agents|mesh-ancestor
15116446|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116447|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15116448|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
15116449|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15116450|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
15116451|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116452|NCT04520139|Expectorants|expectorants|mesh-ancestor
15116453|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
15116454|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15116455|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
15116456|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116457|NCT04520139|Protective Agents|protective agents|mesh-ancestor
15116458|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116459|NCT04520139|Antidotes|antidotes|mesh-ancestor
15116460|NCT04519983|Osimertinib|osimertinib|mesh-list
15116461|NCT04519983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116462|NCT04519983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116463|NCT04519983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116464|NCT04519983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116465|NCT04520035|Paclitaxel|paclitaxel|mesh-list
15116466|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15116467|NCT04520035|Cisplatin|cisplatin|mesh-list
15116468|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15116469|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116470|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
15116471|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
15116472|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
15116473|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116474|NCT04519463|Lidocaine|lidocaine|mesh-list
15116475|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116476|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
15116477|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116478|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116479|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
15116480|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116481|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15116482|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15116483|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15116484|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116485|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116486|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15116487|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116488|NCT04519710|Rituximab|rituximab|mesh-list
15116489|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
15116490|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116491|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116492|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
15116493|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116494|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15176879|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
15176880|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116495|NCT04519125|Tenofovir|tenofovir|mesh-list
15116496|NCT04519125|Emtricitabine|emtricitabine|mesh-list
15116497|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
15116498|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116499|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15116500|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15116501|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116502|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116503|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15116504|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15116505|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
15116506|NCT04519151|Lenvatinib|lenvatinib|mesh-list
15116507|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116508|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116509|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116510|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116511|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116512|NCT04519281|Ascorbic Acid|ascorbic acid|mesh-list
15116513|NCT04519281|Vitamins|vitamins|mesh-ancestor
15116514|NCT04519281|Micronutrients|micronutrients|mesh-ancestor
15116515|NCT04519281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116516|NCT04519281|Antioxidants|antioxidants|mesh-ancestor
15116517|NCT04519281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116518|NCT04519281|Protective Agents|protective agents|mesh-ancestor
15116519|NCT04519385|Dexamethasone|dexamethasone|mesh-list
15116520|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116521|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
15116522|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
15116523|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116524|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116525|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15116526|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
15116527|NCT04519385|Hormones|hormones|mesh-ancestor
15116528|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116529|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15116530|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116531|NCT04518852|Sorafenib|sorafenib|mesh-list
15116532|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116533|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116534|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116535|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116536|NCT04518735|Anticoagulants|anticoagulants|mesh-list
15116537|NCT04518618|Fentanyl|fentanyl|mesh-list
15116538|NCT04518618|Naloxone|naloxone|mesh-list
15116539|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15116540|NCT04518618|Narcotics|narcotics|mesh-ancestor
15116541|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116542|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116543|NCT04518618|Analgesics|analgesics|mesh-ancestor
15116544|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
15116545|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116546|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15116547|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15116548|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
15116549|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
15116550|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15116551|NCT04518982|Lenalidomide|lenalidomide|mesh-list
15116552|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
15116553|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116554|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15116555|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15116556|NCT04518982|Growth Substances|growth substances|mesh-ancestor
15116557|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
15116558|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116559|NCT04518280|Capecitabine|capecitabine|mesh-list
15116560|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
15116561|NCT04518280|Antibodies|antibodies|mesh-list
15116562|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
15116563|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116564|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116565|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
15116566|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116567|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116568|NCT04518319|Olanzapine|olanzapine|mesh-list
15116569|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
15116570|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
15116571|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116572|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116573|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15116574|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15116575|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15116576|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116577|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15116578|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15116579|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15116580|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116581|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116582|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116583|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
15116584|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
15116585|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116586|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
15116587|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
15116588|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116589|NCT04518540|Protective Agents|protective agents|mesh-ancestor
15116590|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116591|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
15116592|NCT04518540|Vitamins|vitamins|mesh-ancestor
15116593|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
15116594|NCT04518475|Rituximab|rituximab|mesh-list
15116595|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116596|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116597|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
15116598|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116599|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116600|NCT04518462|Bupivacaine|bupivacaine|mesh-list
15116601|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116602|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
15116603|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116604|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116605|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
15116606|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116607|NCT04518202|Lidocaine|lidocaine|mesh-list
15116608|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116609|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
15116610|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116611|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116612|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
15116613|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116614|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15116615|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15116616|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15116617|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116618|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116619|NCT04518189|Lidocaine|lidocaine|mesh-list
15116620|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116621|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
15116622|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116623|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116624|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
15116625|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116626|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15116627|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15116628|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15116629|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116630|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116631|NCT04517890|Lidocaine|lidocaine|mesh-list
15116632|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116633|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
15116634|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116635|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116636|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
15116637|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116638|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15116639|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15116640|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15116641|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269464|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116642|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269465|NCT00402987|Celecoxib|celecoxib|mesh-list
14269466|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14269467|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14269468|NCT00402987|Analgesics|analgesics|mesh-ancestor
14269469|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
14269470|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269471|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269472|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269473|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116643|NCT04518176|Oxytocin|oxytocin|mesh-list
15116644|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
15116645|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15116646|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116647|NCT04517851|Elotuzumab|elotuzumab|mesh-list
15116648|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116649|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
15116650|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15116651|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15116652|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116653|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
15116654|NCT04518163|Coagulants|coagulants|mesh-ancestor
15116655|NCT04517526|Bevacizumab|bevacizumab|mesh-list
15116656|NCT04517526|Durvalumab|durvalumab|mesh-list
15116657|NCT04517526|Carboplatin|carboplatin|mesh-list
15116658|NCT04517526|Pemetrexed|pemetrexed|mesh-list
15116659|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116660|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116661|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15116662|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15116663|NCT04517526|Growth Substances|growth substances|mesh-ancestor
15116664|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116665|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
15116666|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116667|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116668|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15116669|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15116670|NCT04517292|Gemcitabine|gemcitabine|mesh-list
15116671|NCT04517292|Cisplatin|cisplatin|mesh-list
15116672|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116673|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116674|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
15116675|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116676|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
15116677|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116678|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116679|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116680|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
15116681|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116682|NCT04517227|Durvalumab|durvalumab|mesh-list
15116683|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116684|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116685|NCT04517214|Gemcitabine|gemcitabine|mesh-list
15116686|NCT04517214|Capecitabine|capecitabine|mesh-list
15116687|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116688|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116689|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
15116690|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116691|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
15116692|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116693|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116694|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116695|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
15116696|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116697|NCT04517201|Insulin|insulin|mesh-list
15116698|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15116699|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15116700|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116701|NCT04517110|Pregabalin|pregabalin|mesh-list
15116702|NCT04517110|Analgesics|analgesics|mesh-ancestor
15116703|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
15116704|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116705|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269474|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15116706|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
15116707|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15116708|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116709|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116710|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15116711|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15116712|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15116713|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116714|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15176881|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176882|NCT03974425|Aflibercept|aflibercept|mesh-list
15176883|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15176884|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15176885|NCT03974425|Growth Substances|growth substances|mesh-ancestor
15176886|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176887|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
15176888|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181767|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15181768|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15181769|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15181770|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15181771|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15181772|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15181773|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15181774|NCT03927222|Temozolomide|temozolomide|mesh-list
15181775|NCT03927222|Molgramostim|molgramostim|mesh-list
15181776|NCT03927222|Sargramostim|sargramostim|mesh-list
15181777|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
15181778|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181779|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15181780|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
15181781|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181782|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181783|NCT03927248|Nivolumab|nivolumab|mesh-list
15181784|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15181785|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181786|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15181787|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181788|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15181789|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15181790|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181791|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
15181792|NCT03926780|Warfarin|warfarin|mesh-list
15181793|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
15181794|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
15181795|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15181796|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
15181797|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15181798|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
15181799|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181800|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182274|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182275|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182276|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15182277|NCT03922815|Fentanyl|fentanyl|mesh-list
15182278|NCT03922815|Propofol|propofol|mesh-list
15182279|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15182280|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182281|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182282|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15182283|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
15182284|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
15182285|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15182286|NCT03922815|Narcotics|narcotics|mesh-ancestor
15182287|NCT03922815|Analgesics|analgesics|mesh-ancestor
15182288|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
15182289|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182290|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15182291|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
15182292|NCT03922919|Cefotaxime|cefotaxime|mesh-list
15182293|NCT03922919|Cefoxitin|cefoxitin|mesh-list
15182294|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15182295|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182310|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182311|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15182312|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15182313|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116715|NCT04517188|Iodine|iodine|mesh-list
15116716|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
15116717|NCT04517188|Povidone|povidone|mesh-list
15116718|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15116719|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116720|NCT04517188|Trace Elements|trace elements|mesh-ancestor
15116721|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
15116722|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116723|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
15116724|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
15116725|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15116726|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15116727|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
15116728|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116729|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15116730|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
15116731|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116732|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116733|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15116734|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15116735|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116736|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
15116737|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15116738|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15116739|NCT04516941|Colchicine|colchicine|mesh-list
15116740|NCT04516941|Edoxaban|edoxaban|mesh-list
15116741|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
15116742|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116743|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
15116744|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
15116745|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
15116746|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116747|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116748|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15116749|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
15116750|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15116751|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
15116752|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116753|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
15116754|NCT04516915|Oseltamivir|oseltamivir|mesh-list
15116755|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
15116756|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116757|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116758|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116759|NCT04517162|Povidone|povidone|mesh-list
15116760|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
15116761|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
15116762|NCT04516616|Paclitaxel|paclitaxel|mesh-list
15116763|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15116764|NCT04516616|Cisplatin|cisplatin|mesh-list
15116765|NCT04516616|Antibodies|antibodies|mesh-list
15116766|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15116767|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15116768|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116769|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
15116770|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
15116771|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
15116772|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116773|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
15116774|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116775|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
15116776|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116777|NCT04516681|Vitamins|vitamins|mesh-ancestor
15116778|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
15116779|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
15116780|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116781|NCT04516681|Protective Agents|protective agents|mesh-ancestor
15116782|NCT04516655|Rituximab|rituximab|mesh-list
15116783|NCT04516655|Methotrexate|methotrexate|mesh-list
15116784|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116785|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116786|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
15116787|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116788|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116789|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15116790|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
15116791|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15176889|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
15116792|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116793|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
15116794|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116795|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
15116796|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116797|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15116798|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116799|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15116800|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
14269475|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14269476|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269477|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269478|NCT00403117|Naltrexone|naltrexone|mesh-list
14269479|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14269480|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15116801|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15116802|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116803|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116804|NCT04516304|Equol|equol|mesh-list
15116805|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
15116806|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15116807|NCT04516304|Estrogens|estrogens|mesh-ancestor
15116808|NCT04516304|Hormones|hormones|mesh-ancestor
15116809|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116810|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116811|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
15116812|NCT04516174|Ropivacaine|ropivacaine|mesh-list
15116813|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15116814|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116815|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116816|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15116817|NCT04516174|Analgesics|analgesics|mesh-ancestor
15116818|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
15116819|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116820|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15116821|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15116822|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15116823|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
15116824|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116825|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116826|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116827|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
15116828|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15116829|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15116830|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116831|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
15116832|NCT04516148|Clindamycin|clindamycin|mesh-list
15116833|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
15116834|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
15116835|NCT04516148|Cefazolin|cefazolin|mesh-list
15116836|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15116837|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116838|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15116839|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116840|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116841|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
15116842|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15116843|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15116844|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116845|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
15116846|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
15116847|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
15116848|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15116849|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15116850|NCT04515966|Prednisolone|prednisolone|mesh-list
15116851|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
15116852|NCT04515966|Lidocaine|lidocaine|mesh-list
15116853|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15116854|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
15116855|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
15116856|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
15116857|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116858|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116859|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
15116860|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116861|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15116862|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15116863|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15116864|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116865|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116866|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116867|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
15116868|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
15116869|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15116870|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
15116871|NCT04515966|Hormones|hormones|mesh-ancestor
15116872|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15116873|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15116874|NCT04515966|Protective Agents|protective agents|mesh-ancestor
15116875|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15116876|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116877|NCT04515719|Belimumab|belimumab|mesh-list
15116878|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15116879|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
15116880|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116881|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
15116882|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116883|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116884|NCT04515836|Olaparib|olaparib|mesh-list
15116885|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15116886|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116887|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116888|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116889|NCT04515368|Vaccines|vaccines|mesh-list
15116890|NCT04515368|Immunologic Factors|immunologic factors|mesh-ancestor
15116891|NCT04515368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116892|NCT04515732|Apremilast|apremilast|mesh-list
15116893|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15116894|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15116895|NCT04515732|Analgesics|analgesics|mesh-ancestor
15116896|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
15116897|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116898|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116899|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116900|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116901|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15116902|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15116903|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116904|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116905|NCT04515420|Norepinephrine|norepinephrine|mesh-list
15116906|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15116907|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15116908|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
15116909|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116910|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116911|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116912|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
15116913|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
15116914|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116915|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15116916|NCT04515641|Islatravir|islatravir|mesh-list
15116917|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
15116918|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116919|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116920|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116921|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15116922|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15116923|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15116924|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
15116925|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15116926|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15116927|NCT04515238|Venetoclax|venetoclax|mesh-list
15116928|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
15116929|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
15116930|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15116931|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
15116932|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116933|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176890|NCT03973840|Testosterone|testosterone|mesh-list
15116934|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116935|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15116936|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116937|NCT04514835|Capecitabine|capecitabine|mesh-list
15116938|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116939|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15116940|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
15116941|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176891|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
15176892|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
15176893|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15176894|NCT03973840|Androgens|androgens|mesh-ancestor
15176895|NCT03973840|Hormones|hormones|mesh-ancestor
15176896|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15176897|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176898|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15176899|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176900|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
15176901|NCT03973775|Permethrin|permethrin|mesh-list
15176902|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176903|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176904|NCT03973879|Atezolizumab|atezolizumab|mesh-list
15176905|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176906|NCT03973957|Fentanyl|fentanyl|mesh-list
15176907|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15176908|NCT03973957|Narcotics|narcotics|mesh-ancestor
15176909|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176910|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176911|NCT03973957|Analgesics|analgesics|mesh-ancestor
15176912|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
15176913|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176914|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15176915|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15176916|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
15176917|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
15176918|NCT03974035|Ropivacaine|ropivacaine|mesh-list
15176919|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
15176920|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
15176921|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176922|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176923|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
15176924|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176925|NCT03973489|Methamphetamine|methamphetamine|mesh-list
15176926|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14269481|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269482|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
14269483|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269484|NCT00403130|Gemcitabine|gemcitabine|mesh-list
14269485|NCT00403130|Paclitaxel|paclitaxel|mesh-list
14269486|NCT00403130|Bevacizumab|bevacizumab|mesh-list
14269487|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14269488|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269489|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
14269490|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
14269491|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
14269492|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269493|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269494|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14269495|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14269496|NCT00403130|Growth Substances|growth substances|mesh-ancestor
14269497|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269498|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269499|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14269500|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
14269501|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
14269502|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269503|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269504|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269505|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
14269506|NCT00403234|Buprenorphine|buprenorphine|mesh-list
14269507|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14269508|NCT00403234|Narcotics|narcotics|mesh-ancestor
14269509|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269510|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269511|NCT00403234|Analgesics|analgesics|mesh-ancestor
15116942|NCT04514770|Misoprostol|misoprostol|mesh-list
15116943|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15116944|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
15116945|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15116946|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116947|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15116948|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15116949|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
15116950|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
15116951|NCT04514731|Analgesics|analgesics|mesh-ancestor
15116952|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
15116953|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15116954|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116955|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
15116956|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15116957|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15116958|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
15116959|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15116960|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15116961|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116962|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15116963|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
15116964|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15116965|NCT04514796|Adalimumab|adalimumab|mesh-list
15116966|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116967|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15116968|NCT04514419|Docetaxel|docetaxel|mesh-list
15116969|NCT04514419|Trastuzumab|trastuzumab|mesh-list
15116970|NCT04514419|Pertuzumab|pertuzumab|mesh-list
15116971|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15116972|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
15116973|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
15116974|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
15116975|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116976|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15116977|NCT04514588|Caffeine|caffeine|mesh-list
15116978|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15116979|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116980|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15116981|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15116982|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116983|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15116984|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15116985|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
15116986|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15116987|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15116988|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15116989|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15116990|NCT04514094|Fluorides|fluorides|mesh-list
15116991|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
15116992|NCT04514094|Protective Agents|protective agents|mesh-ancestor
15116993|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15116994|NCT04514029|Dexamethasone|dexamethasone|mesh-list
15116995|NCT04514029|Simvastatin|simvastatin|mesh-list
15116996|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15116997|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
15116998|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
15116999|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117000|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117001|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117002|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
15117003|NCT04514029|Hormones|hormones|mesh-ancestor
15117004|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117005|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15117006|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117007|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15117008|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15117009|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
15117010|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117011|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15117012|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15117013|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117014|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15117015|NCT04514081|Decitabine|decitabine|mesh-list
15181801|NCT03926806|Vitamins|vitamins|mesh-list
15117016|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117017|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
15117018|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117019|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117020|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117021|NCT04513821|Ethanol|ethanol|mesh-list
15117022|NCT04513821|Minocycline|minocycline|mesh-list
15117023|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15117024|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117025|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117026|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117027|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15117028|NCT04513808|Anesthetics|anesthetics|mesh-list
15117029|NCT04513808|Propofol|propofol|mesh-list
15117030|NCT04513808|Sevoflurane|sevoflurane|mesh-list
15117031|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117032|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117033|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15117034|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15117035|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
15117036|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15117037|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15117038|NCT04513652|Carticaine|carticaine|mesh-list
15117039|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
15117040|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
15117041|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117042|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117043|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
15117044|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117045|NCT04513639|Dexamethasone|dexamethasone|mesh-list
15117046|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
15117047|NCT04513639|Daratumumab|daratumumab|mesh-list
15117048|NCT04513639|BB 1101|bb 1101|mesh-list
15117049|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15117050|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117051|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
15117052|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
15117053|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117054|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117055|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117056|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
15117057|NCT04513639|Hormones|hormones|mesh-ancestor
15117058|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117059|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15117060|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117061|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
15117062|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117063|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117064|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
15117065|NCT04513509|Propranolol|propranolol|mesh-list
15117066|NCT04513509|Metoprolol|metoprolol|mesh-list
15117067|NCT04513509|Digoxin|digoxin|mesh-list
15117068|NCT04513509|Atenolol|atenolol|mesh-list
15117069|NCT04513509|Verapamil|verapamil|mesh-list
15117070|NCT04513509|Nebivolol|nebivolol|mesh-list
15117071|NCT04513509|Diltiazem|diltiazem|mesh-list
15117072|NCT04513509|Bisoprolol|bisoprolol|mesh-list
15117073|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15117074|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15117075|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
15117076|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117077|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117078|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117079|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117080|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15117081|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
15117082|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
15117083|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
15117084|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117085|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15117086|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15117087|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117088|NCT04513509|Protective Agents|protective agents|mesh-ancestor
15117089|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15117090|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15117091|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15117092|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15117093|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15117094|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15117095|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
15117096|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15117097|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15117098|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
15117099|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117100|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15117101|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15117102|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117103|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117104|NCT04513457|Liver Extracts|liver extracts|mesh-list
15117105|NCT04513457|Hematinics|hematinics|mesh-ancestor
15117106|NCT04513340|Levodopa|levodopa|mesh-list
15117107|NCT04513340|Carbidopa|carbidopa|mesh-list
15117108|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15117109|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15117110|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
15117111|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117112|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117113|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117114|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15117115|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117116|NCT04513379|Efavirenz|efavirenz|mesh-list
15117117|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15117118|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15117119|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117120|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117121|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
15117122|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117123|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15117124|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15117125|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15117126|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15117127|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15117128|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15117129|NCT04513015|Antioxidants|antioxidants|mesh-list
15117130|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117131|NCT04513015|Protective Agents|protective agents|mesh-ancestor
15117132|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117133|NCT04513184|Dexamethasone|dexamethasone|mesh-list
15117134|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
15117135|NCT04513184|BB 1101|bb 1101|mesh-list
15117136|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117137|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
15117138|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
15117139|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117140|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117141|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117142|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
15117143|NCT04513184|Hormones|hormones|mesh-ancestor
15117144|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117145|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14269512|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
15117146|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117147|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
14269513|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269514|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14269515|NCT00403260|Artesunate|artesunate|mesh-list
14269516|NCT00403260|Mefloquine|mefloquine|mesh-list
14269517|NCT00403260|Pyronaridine|pyronaridine|mesh-list
14269518|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
14269519|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14269520|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14269521|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269522|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117148|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117149|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117150|NCT04512872|Denosumab|denosumab|mesh-list
15117151|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15117152|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117153|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15117154|NCT04512638|Amoxicillin|amoxicillin|mesh-list
15117155|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
14269523|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
15117156|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15117157|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117158|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15117159|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
15117160|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
15176927|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176928|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
15176929|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
15176930|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176931|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
15176932|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176933|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176934|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176935|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15176936|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15176937|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176938|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15176939|NCT03973567|Norepinephrine|norepinephrine|mesh-list
15176940|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
15176941|NCT03973567|Serotonin|serotonin|mesh-list
15176942|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15176943|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15176944|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15176945|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
15176946|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176947|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176948|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176949|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15176950|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15176951|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
15176952|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
15176953|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
15176954|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176955|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15176956|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15176957|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15176958|NCT03973138|Ranibizumab|ranibizumab|mesh-list
15176959|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15176960|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15176961|NCT03973138|Growth Substances|growth substances|mesh-ancestor
15176962|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176963|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
15176964|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15176965|NCT03973411|Ondansetron|ondansetron|mesh-list
15176966|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
15176967|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
15176968|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15176969|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176970|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15176971|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
15176972|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
15176973|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15176974|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
15176975|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15176976|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176977|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15176978|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15176979|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15176980|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15176981|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15176982|NCT03973203|Niacin|niacin|mesh-list
15176983|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
15176984|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15176985|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
15176986|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176987|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15176988|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
15176989|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
15176990|NCT03973203|Vitamins|vitamins|mesh-ancestor
15176991|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
15176992|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15176993|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
15176994|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15176995|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15176996|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181802|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
15117161|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
15117162|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15117163|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15117164|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
15117165|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117166|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117167|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15117168|NCT04512313|Rocuronium|rocuronium|mesh-list
15117169|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15117170|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15117171|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15117172|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117173|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117174|NCT04512105|Venetoclax|venetoclax|mesh-list
15117175|NCT04512105|Pitavastatin|pitavastatin|mesh-list
15117176|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117177|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15117178|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15117179|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15117180|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
15117181|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117182|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117183|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15117184|NCT04512365|Dronabinol|dronabinol|mesh-list
15117185|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
15117186|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117187|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15117188|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15117189|NCT04512365|Analgesics|analgesics|mesh-ancestor
15117190|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
15117191|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117192|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15117193|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15117194|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117195|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117196|NCT04512365|Hormones|hormones|mesh-ancestor
15117197|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117198|NCT04511975|Azacitidine|azacitidine|mesh-list
15117199|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117200|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
15117201|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117202|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117203|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117204|NCT04511832|Diclofenac|diclofenac|mesh-list
15117205|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15117206|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15117207|NCT04511832|Analgesics|analgesics|mesh-ancestor
15117208|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
15117209|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117210|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117211|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117212|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15117213|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15117214|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117215|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117216|NCT04511715|Bevacizumab|bevacizumab|mesh-list
15117217|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117218|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117219|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15117220|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15117221|NCT04511715|Growth Substances|growth substances|mesh-ancestor
15117222|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117223|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
15117224|NCT04511897|Expectorants|expectorants|mesh-list
15117225|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
15117226|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15117227|NCT04511728|Propofol|propofol|mesh-list
15117228|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15117229|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117230|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117231|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15117232|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
15117233|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
15117234|NCT04511923|Heparin|heparin|mesh-list
15117235|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
15117236|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15117237|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15117238|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117239|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
15117240|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15117241|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
15117242|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15117243|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
15117244|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117245|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117246|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
15117247|NCT04511468|Ascorbic Acid|ascorbic acid|mesh-list
15117248|NCT04511468|Copper|copper|mesh-list
15117249|NCT04511468|Chromium|chromium|mesh-list
15117250|NCT04511468|Vitamins|vitamins|mesh-ancestor
15117251|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
15117252|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117253|NCT04511468|Antioxidants|antioxidants|mesh-ancestor
15117254|NCT04511468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117255|NCT04511468|Protective Agents|protective agents|mesh-ancestor
15117256|NCT04511468|Trace Elements|trace elements|mesh-ancestor
15117257|NCT04511416|Metformin|metformin|mesh-list
15117258|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15117259|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117260|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
15117261|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15117262|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
15117263|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15117264|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
15117265|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117266|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117267|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
15117268|NCT04511299|SMOFlipid|smoflipid|mesh-list
15117269|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15117270|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15117271|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15117272|NCT04511000|Atorvastatin|atorvastatin|mesh-list
15117273|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15117274|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15117275|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
15117276|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117277|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15117278|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15117279|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117280|NCT04510935|Anesthetics|anesthetics|mesh-list
15117281|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117282|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117283|NCT04510844|Evolocumab|evolocumab|mesh-list
15117284|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15117285|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15117286|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
15117287|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117288|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15117289|NCT04511195|Diclofenac|diclofenac|mesh-list
15117290|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15117291|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15117292|NCT04511195|Analgesics|analgesics|mesh-ancestor
15117293|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
15117294|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117295|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117296|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117297|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15117298|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14561694|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561695|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561696|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561697|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561698|NCT00002802|Trace Elements|trace elements|mesh-ancestor
15117299|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117300|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117301|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
15117302|NCT04510870|Hematinics|hematinics|mesh-ancestor
14561699|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
15117303|NCT04510922|Droxidopa|droxidopa|mesh-list
15117304|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15117305|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15117306|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15117307|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
15117308|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117309|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117310|NCT04510649|Rifampin|rifampin|mesh-list
15117311|NCT04510649|Rabeprazole|rabeprazole|mesh-list
15117312|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15117313|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117314|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15117315|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117316|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117317|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15117318|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
15117319|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15117320|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117321|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
15117322|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15117323|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15117324|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15117325|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15117326|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15117327|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15117328|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15117329|NCT04510818|Capecitabine|capecitabine|mesh-list
15117330|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117331|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
15117332|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117333|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117334|NCT04510610|Decitabine|decitabine|mesh-list
15117335|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117336|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
15117337|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117338|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117339|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15176997|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15176998|NCT03973086|Protective Agents|protective agents|mesh-ancestor
15176999|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177000|NCT03972748|Itraconazole|itraconazole|mesh-list
15177001|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
15177002|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177003|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15177004|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15177005|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177006|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177007|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15177008|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
15177009|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177010|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177011|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15177012|NCT03972982|Insulin|insulin|mesh-list
15177013|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15177014|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15177015|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177016|NCT03973047|Ondansetron|ondansetron|mesh-list
15177017|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
15177018|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
15177019|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177020|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177021|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15177022|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
15177023|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
15177024|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15177025|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
15177026|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177027|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177028|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15177029|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15177030|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177031|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15177032|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15177033|NCT03972592|Sirolimus|sirolimus|mesh-list
15117340|NCT04510662|Telmisartan|telmisartan|mesh-list
15117341|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15117342|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15117343|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15117344|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117345|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
15117346|NCT04510285|Trastuzumab|trastuzumab|mesh-list
15117347|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117348|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117349|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
15117350|NCT04510428|Antibodies|antibodies|mesh-list
15117351|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
15117352|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15117353|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15117354|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
15117355|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117356|NCT04510220|Ofatumumab|ofatumumab|mesh-list
15117357|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117358|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
15117359|NCT04510337|Rocuronium|rocuronium|mesh-list
15117360|NCT04510337|Analgesics|analgesics|mesh-ancestor
15117361|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
15117362|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117363|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117364|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
15117365|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117366|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117367|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
15117368|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15117369|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15117370|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117371|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15117372|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
15117373|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15117374|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15117375|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15117376|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15117377|NCT04510233|Ivermectin|ivermectin|mesh-list
15117378|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15117379|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117380|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
15117381|NCT04510051|Fludarabine|fludarabine|mesh-list
15117382|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15117383|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
15117384|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117385|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15117386|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15117387|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
15117388|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117389|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117390|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15117391|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
15117392|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15117393|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117394|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
15117395|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
15117396|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117397|NCT04509999|Bicalutamide|bicalutamide|mesh-list
15117398|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
15117399|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
15117400|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117401|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117402|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117403|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
15117404|NCT04509466|Pegaspargase|pegaspargase|mesh-list
15117405|NCT04509466|Asparaginase|asparaginase|mesh-list
15117406|NCT04509466|Analgesics|analgesics|mesh-ancestor
15117407|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
15117408|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117409|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117410|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117411|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15117412|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15117413|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117414|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117415|NCT04509583|Vitamin E|vitamin e|mesh-list
15117416|NCT04509583|Vitamins|vitamins|mesh-ancestor
15117417|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
15117418|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117419|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
15117420|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117421|NCT04509583|Protective Agents|protective agents|mesh-ancestor
15117422|NCT04509622|Cytarabine|cytarabine|mesh-list
15117423|NCT04509622|Venetoclax|venetoclax|mesh-list
15117424|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117425|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
15117426|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117427|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117428|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
15117429|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117430|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15117431|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
15117432|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117433|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
15117434|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
15117435|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117436|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117437|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15117438|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
15117439|NCT04509596|Capecitabine|capecitabine|mesh-list
15117440|NCT04509596|Trastuzumab|trastuzumab|mesh-list
15117441|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117442|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
15117443|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117444|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117445|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117446|NCT04509635|Cetuximab|cetuximab|mesh-list
15117447|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117448|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117449|NCT04509440|Triamcinolone|triamcinolone|mesh-list
15117450|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15117451|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15117452|NCT04509440|Anesthetics|anesthetics|mesh-list
15117453|NCT04509440|Mepivacaine|mepivacaine|mesh-list
15117454|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
15117455|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15117456|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117457|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117458|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117459|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
15117460|NCT04509440|Hormones|hormones|mesh-ancestor
15117461|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117462|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15117463|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
15117464|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117465|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117466|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
15117467|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117468|NCT04509102|Adderall|adderall|mesh-list
15117469|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15117470|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117471|NCT04509323|Huperzine A|huperzine a|mesh-list
15117472|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15117473|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117474|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117475|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
15117476|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117477|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117478|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15117479|NCT04509323|Protective Agents|protective agents|mesh-ancestor
15117480|NCT04508946|Ascorbic Acid|ascorbic acid|mesh-list
15117481|NCT04508946|Thiamine|thiamine|mesh-list
15117482|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
15117483|NCT04508946|Vitamins|vitamins|mesh-ancestor
15117484|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
15117485|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117486|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117487|NCT04508946|Antioxidants|antioxidants|mesh-ancestor
15117488|NCT04508946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117489|NCT04508946|Protective Agents|protective agents|mesh-ancestor
15117490|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
15117491|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
15117492|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15117493|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15117494|NCT04509219|Prednisolone|prednisolone|mesh-list
15117495|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
15117496|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15117497|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
15117498|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117499|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
15117500|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
15117501|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117502|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117503|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117504|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
15117505|NCT04509219|Hormones|hormones|mesh-ancestor
15117506|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117507|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15117508|NCT04509219|Protective Agents|protective agents|mesh-ancestor
15117509|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15117510|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117511|NCT04509232|Fluorides|fluorides|mesh-list
15117512|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
15117513|NCT04509232|Protective Agents|protective agents|mesh-ancestor
15117514|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117515|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
15117516|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
15117517|NCT04509258|Ondansetron|ondansetron|mesh-list
15117518|NCT04509258|Mineral Oil|mineral oil|mesh-list
15117519|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15117520|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
15117521|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
15117522|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117523|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117524|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117525|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
15117526|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
15117527|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15117528|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
15117529|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117530|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117531|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15117532|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15117533|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117534|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15117535|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15117536|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
15117537|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117538|NCT04509258|Expectorants|expectorants|mesh-ancestor
15117539|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
15117540|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15117541|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
15117542|NCT04509258|Protective Agents|protective agents|mesh-ancestor
15117543|NCT04509258|Antidotes|antidotes|mesh-ancestor
15117544|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
15117545|NCT04509258|Vitamins|vitamins|mesh-ancestor
15117546|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
15117547|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
15117548|NCT04509258|Emollients|emollients|mesh-ancestor
15117549|NCT04509193|Warfarin|warfarin|mesh-list
15117550|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
15117551|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
15117552|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15117553|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
15117554|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15117555|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
15117556|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117557|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117558|NCT04508803|Trastuzumab|trastuzumab|mesh-list
15117559|NCT04508803|Niraparib|niraparib|mesh-list
15117560|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117561|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117562|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15117563|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117564|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117565|NCT04508829|Cetuximab|cetuximab|mesh-list
15117566|NCT04508829|Antibodies|antibodies|mesh-list
15117567|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15117568|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
15117569|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117570|NCT04508829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117571|NCT04508829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117572|NCT04508816|Cetuximab|cetuximab|mesh-list
15117573|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
15117574|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117575|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117576|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
15117577|NCT04508894|Ketamine|ketamine|mesh-list
15117578|NCT04508894|Bupivacaine|bupivacaine|mesh-list
15117579|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
15117580|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
15117581|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117582|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117583|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
15117584|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117585|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15117586|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15117587|NCT04508894|Analgesics|analgesics|mesh-ancestor
15117588|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15117589|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15117590|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15117591|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
15117592|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117593|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117594|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15117595|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15117596|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
15117597|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15117598|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15117599|NCT04508686|Capecitabine|capecitabine|mesh-list
15117600|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117601|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
15117602|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117603|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177034|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177035|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177036|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15177037|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177038|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
15177039|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15177040|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
15177041|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177042|NCT03972683|Atropine|atropine|mesh-list
15177043|NCT03972683|Adenosine|adenosine|mesh-list
15177044|NCT03972683|Nitroprusside|nitroprusside|mesh-list
15177045|NCT03972683|Phenylephrine|phenylephrine|mesh-list
15177046|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
15177047|NCT03972683|Acetylcholine|acetylcholine|mesh-list
15177048|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15177049|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
15177050|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
15177051|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177052|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177053|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
15177054|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15177055|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
15177056|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
15177057|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15177058|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15177059|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15177060|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
15177061|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177062|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177063|NCT03972683|Protective Agents|protective agents|mesh-ancestor
15177064|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15177065|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15177066|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15177067|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15177068|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
15177069|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15177070|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15177071|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
15177072|NCT03972683|Analgesics|analgesics|mesh-ancestor
15177073|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
15177074|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
15177075|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15117604|NCT04508439|Heparin|heparin|mesh-list
15117605|NCT04508439|Enoxaparin|enoxaparin|mesh-list
15117606|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15117607|NCT04508439|Tinzaparin|tinzaparin|mesh-list
15117608|NCT04508439|Dalteparin|dalteparin|mesh-list
15117609|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
15117610|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15117611|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15117612|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117613|NCT04508400|Dexamethasone|dexamethasone|mesh-list
15117614|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
15117615|NCT04508400|Ondansetron|ondansetron|mesh-list
15117616|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
15117617|NCT04508400|Aprepitant|aprepitant|mesh-list
15117618|NCT04508400|BB 1101|bb 1101|mesh-list
15117619|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117620|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
15117621|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
15117622|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117623|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117624|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117625|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
15117626|NCT04508400|Hormones|hormones|mesh-ancestor
15117627|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117628|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15117629|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117630|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
15117631|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117632|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117633|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
15117634|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
15117635|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15117636|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
15117637|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117638|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15117639|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15117640|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117641|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15117642|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15117643|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15117644|NCT04508452|Bevacizumab|bevacizumab|mesh-list
15117645|NCT04508452|Capecitabine|capecitabine|mesh-list
15117646|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
15117647|NCT04508452|Irinotecan|irinotecan|mesh-list
15117648|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117649|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117650|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15117651|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15117652|NCT04508452|Growth Substances|growth substances|mesh-ancestor
15117653|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117654|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
15117655|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117656|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
15117657|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117658|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15117659|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15117660|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117661|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
15117662|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
15117663|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15117664|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117665|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117666|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15117667|NCT04508166|Analgesics|analgesics|mesh-ancestor
15117668|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
15117669|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117670|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15117671|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15117672|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15117673|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
15117674|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117675|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117676|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15117677|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15117678|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
15117679|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
15117680|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
15117681|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117682|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117683|NCT04508244|Propranolol|propranolol|mesh-list
15117684|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15117685|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15117686|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
15117687|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117688|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117689|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117690|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117691|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15117692|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
15117693|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
15117694|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15117695|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15117696|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117697|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
15117698|NCT04508036|Coagulants|coagulants|mesh-ancestor
15117699|NCT04507906|Nivolumab|nivolumab|mesh-list
15117700|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117701|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117702|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15117703|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117704|NCT04508231|Hormones|hormones|mesh-list
15117705|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117706|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117707|NCT04507919|Dabrafenib|dabrafenib|mesh-list
15117708|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117709|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15117710|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117711|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117712|NCT04507607|Tenofovir|tenofovir|mesh-list
15117713|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
15117714|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117715|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15117716|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15117717|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117718|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117719|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15117720|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15117721|NCT04507477|Rituximab|rituximab|mesh-list
15117722|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117723|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117724|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
15117725|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117726|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15117727|NCT04507750|Apatinib|apatinib|mesh-list
15117728|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117729|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15117730|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117731|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117732|NCT04507412|Dexamethasone|dexamethasone|mesh-list
15117733|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117734|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
15117735|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
15117736|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117737|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117738|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117739|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
15117740|NCT04507412|Hormones|hormones|mesh-ancestor
15117741|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117742|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15117743|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117744|NCT04507217|Carboplatin|carboplatin|mesh-list
15117745|NCT04507217|Pemetrexed|pemetrexed|mesh-list
15117746|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117747|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117748|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117749|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15117750|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15117751|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
15117752|NCT04507165|Anesthetics|anesthetics|mesh-list
15117753|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117754|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117755|NCT04507165|Narcotics|narcotics|mesh-ancestor
15117756|NCT04507165|Analgesics|analgesics|mesh-ancestor
15117757|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
15117758|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117759|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
15117760|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15117761|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
15117762|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117763|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
15117764|NCT04506827|Protective Agents|protective agents|mesh-ancestor
15117765|NCT04506554|Nivolumab|nivolumab|mesh-list
15117766|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117767|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117768|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15117769|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117770|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15117771|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15117772|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177076|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
15177077|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
15177078|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15177079|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15177080|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15177081|NCT03972397|Bupivacaine|bupivacaine|mesh-list
15177082|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
15177083|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
15177084|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177085|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177086|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
15177087|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177088|NCT03972358|Misoprostol|misoprostol|mesh-list
15177089|NCT03972358|Mifepristone|mifepristone|mesh-list
15177090|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15177091|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
15177092|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15177093|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177094|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15177095|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15177096|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
15177097|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15117773|NCT04506450|Anesthetics|anesthetics|mesh-list
15117774|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117775|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117776|NCT04506034|Lidocaine|lidocaine|mesh-list
15117777|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
15117778|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
15117779|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117780|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117781|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
15117782|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117783|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117784|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15117785|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15117786|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15117787|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117788|NCT04506242|Apatinib|apatinib|mesh-list
15117789|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117790|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15117791|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117792|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117793|NCT04505930|Vaccines|vaccines|mesh-list
15117794|NCT04505930|Immunologic Factors|immunologic factors|mesh-ancestor
15117795|NCT04505930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117796|NCT04505904|Oxytocin|oxytocin|mesh-list
15117797|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
15117798|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15117799|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117800|NCT04505943|Isoniazid|isoniazid|mesh-list
15117801|NCT04505943|Misoprostol|misoprostol|mesh-list
15117802|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15117803|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
15117804|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15117805|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117806|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15117807|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117808|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
15117809|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
15117810|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15117811|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117812|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15117813|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15117814|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
15117815|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117816|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15117817|NCT04505995|Azacitidine|azacitidine|mesh-list
15117818|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
15117819|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15117820|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
15117821|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117822|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117823|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117824|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15117825|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15117826|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15117827|NCT04505514|Hematinics|hematinics|mesh-ancestor
15117828|NCT04505644|Lidocaine|lidocaine|mesh-list
15117829|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
15117830|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
15117831|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117832|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117833|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
15117834|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117835|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117836|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15117837|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15117838|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15117839|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117840|NCT04505475|Hemostatics|hemostatics|mesh-list
15117841|NCT04505475|Coagulants|coagulants|mesh-ancestor
15117842|NCT04505800|Tryptophan|tryptophan|mesh-list
15117843|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15117844|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
15117845|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15117846|NCT04505917|Misoprostol|misoprostol|mesh-list
15117847|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15117848|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
15117849|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15117850|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117851|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15117852|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15117853|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
15117854|NCT04505592|Tenecteplase|tenecteplase|mesh-list
15117855|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15117856|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15117857|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117858|NCT04505683|Ertapenem|ertapenem|mesh-list
15117859|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15117860|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117861|NCT04505657|Celecoxib|celecoxib|mesh-list
15117862|NCT04505657|Lidocaine|lidocaine|mesh-list
15117863|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
15117864|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
15117865|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117866|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117867|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
15117868|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117869|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117870|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15117871|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15117872|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15117873|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117874|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15117875|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15117876|NCT04505657|Analgesics|analgesics|mesh-ancestor
15117877|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15117878|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15117879|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15117880|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15117881|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117882|NCT04505189|Psilocybin|psilocybin|mesh-list
15117883|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
15117884|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117885|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15117886|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
15117887|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15117888|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15117889|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117890|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
15117891|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
15117892|NCT04505410|Tofacitinib|tofacitinib|mesh-list
15117893|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15117894|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117895|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117896|NCT04505228|Atropine|atropine|mesh-list
15117897|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15117898|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117899|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15117900|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
15117901|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117902|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117903|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15117904|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
15117905|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
15117906|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
15117907|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15117908|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15117909|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
15117910|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117911|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117912|NCT04504877|Cannabidiol|cannabidiol|mesh-list
15117913|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
15117914|NCT04504851|Rifampin|rifampin|mesh-list
15117915|NCT04504851|Isoniazid|isoniazid|mesh-list
15117916|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
15117917|NCT04504851|Ethambutol|ethambutol|mesh-list
15117918|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15117919|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15117920|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15117921|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
15117922|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181803|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
15117923|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15117924|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15117925|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117926|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15117927|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
15117928|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15117929|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117930|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
15117931|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15117932|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15117933|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15117934|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15117935|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15117936|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15117937|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15117938|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15117939|NCT04504552|Avelumab|avelumab|mesh-list
15117940|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117941|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15117942|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15117943|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15117944|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117945|NCT04504045|Metformin|metformin|mesh-list
15117946|NCT04504045|Efavirenz|efavirenz|mesh-list
15117947|NCT04504045|Losartan|losartan|mesh-list
15117948|NCT04504045|Metoprolol|metoprolol|mesh-list
15117949|NCT04504045|Midazolam|midazolam|mesh-list
15117950|NCT04504045|Caffeine|caffeine|mesh-list
15117951|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15117952|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117953|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15117954|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15117955|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15117956|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15117957|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15117958|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15117959|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15117960|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
15117961|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
15117962|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
15117963|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
15117964|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15117965|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15117966|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15117967|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15117968|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15117969|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15117970|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15117971|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15117972|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15117973|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15117974|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15117975|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
15117976|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15117977|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15117978|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
15117979|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15117980|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15117981|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15117982|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15117983|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15117984|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15117985|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15117986|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
15117987|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
15117988|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15117989|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15117990|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15117991|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15117992|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
15177098|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15177099|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15177100|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15117993|NCT04503915|Estrogens|estrogens|mesh-list
15117994|NCT04503915|Hormones|hormones|mesh-ancestor
15117995|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15117996|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15117997|NCT04503967|Nivolumab|nivolumab|mesh-list
15117998|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15117999|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118000|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15118001|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118002|NCT04503850|Mirabegron|mirabegron|mesh-list
15118003|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
15118004|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15118005|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15118006|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15118007|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118008|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118009|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118010|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118011|NCT04503850|Urological Agents|urological agents|mesh-ancestor
15118012|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15118013|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
15118014|NCT04503616|Abatacept|abatacept|mesh-list
15118015|NCT04503616|Tacrolimus|tacrolimus|mesh-list
15118016|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118017|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
15118018|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118019|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118020|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15118021|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
15118022|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118023|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118024|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15118025|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15118026|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118027|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15118028|NCT04503694|Nivolumab|nivolumab|mesh-list
15118029|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15118030|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118031|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15118032|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118033|NCT04503629|Rabeprazole|rabeprazole|mesh-list
15118034|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15118035|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118036|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15118037|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118038|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118039|NCT04503460|Fluticasone|fluticasone|mesh-list
15118040|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15118041|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15118042|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118043|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15118044|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
15118045|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118046|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118047|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15118048|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
15118049|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
15118050|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15118051|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15118052|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15118053|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15118054|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118055|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118056|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118057|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
15118058|NCT04503460|Hormones|hormones|mesh-ancestor
15118059|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118060|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
15118061|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15118062|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15118063|NCT04503161|Estradiol|estradiol|mesh-list
15118064|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15118065|NCT04503161|Estrogens|estrogens|mesh-ancestor
15118066|NCT04503161|Hormones|hormones|mesh-ancestor
15118067|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118068|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118069|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15118070|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
15118071|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118072|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15118073|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
15118074|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15118075|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118076|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
15118077|NCT04502771|Clotrimazole|clotrimazole|mesh-list
15118078|NCT04502771|Miconazole|miconazole|mesh-list
15118079|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118080|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15118081|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15118082|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15118083|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118084|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118085|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15118086|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
15118087|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118088|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118089|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15118090|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15118091|NCT04502849|Vitamin E|vitamin e|mesh-list
15118092|NCT04502849|Tocopherols|tocopherols|mesh-list
15118093|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
15118094|NCT04502849|Vitamins|vitamins|mesh-ancestor
15118095|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
15118096|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118097|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
15118098|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118099|NCT04502849|Protective Agents|protective agents|mesh-ancestor
15118100|NCT04502641|Docetaxel|docetaxel|mesh-list
15118101|NCT04502641|Fluorouracil|fluorouracil|mesh-list
15118102|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118103|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
15118104|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
15118105|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
15118106|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118107|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
15118108|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15118109|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118110|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
15118111|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118112|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
15118113|NCT04502537|Hematinics|hematinics|mesh-ancestor
15118114|NCT04502589|Disulfiram|disulfiram|mesh-list
15118115|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15118116|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15118117|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118118|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118119|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
15118120|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15118121|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15118122|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15118123|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15118124|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118125|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
15118126|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118127|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118128|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15118129|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118130|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15118131|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15118132|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118133|NCT04502277|Fluconazole|fluconazole|mesh-list
15118134|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
15118135|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118136|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13996195|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
15118137|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15118138|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118139|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118140|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15118141|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
15118142|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118143|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118144|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15118145|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15118146|NCT04502251|Naltrexone|naltrexone|mesh-list
15118147|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15118148|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15118149|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118150|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
15118151|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118152|NCT04502017|Clopidogrel|clopidogrel|mesh-list
15118153|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15118154|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15118155|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15118156|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15118157|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
15118158|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118159|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118160|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118161|NCT04501965|Azithromycin|azithromycin|mesh-list
15118162|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
15118163|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118164|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118165|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
15118166|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15118167|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15118168|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118169|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118170|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118171|NCT04502095|Levofloxacin|levofloxacin|mesh-list
15118172|NCT04502095|Ofloxacin|ofloxacin|mesh-list
14269524|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
14269525|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14269526|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
14292380|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292381|NCT00560417|Coagulants|coagulants|mesh-ancestor
14292382|NCT00560508|Pramipexole|pramipexole|mesh-list
14292383|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
14292384|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292385|NCT00560508|Protective Agents|protective agents|mesh-ancestor
14292386|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292387|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14292388|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14292389|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
14292390|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
14292391|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118173|NCT04502095|Trimethoprim|trimethoprim|mesh-list
15118174|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15118175|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
15118176|NCT04502095|Clindamycin|clindamycin|mesh-list
15118177|NCT04502095|Ertapenem|ertapenem|mesh-list
15118178|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
15118179|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15118180|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118181|NCT04502095|Renal Agents|renal agents|mesh-ancestor
15118182|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118183|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15118184|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15118185|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118186|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118187|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118188|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15118189|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15118190|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15118191|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
15118192|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15118193|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15118194|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15118195|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15118196|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15118197|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15118198|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118199|NCT04501900|Clopidogrel|clopidogrel|mesh-list
15118200|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15118201|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15118202|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15118203|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15118204|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
15118205|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118206|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118207|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118208|NCT04501809|Misoprostol|misoprostol|mesh-list
15118209|NCT04501809|Oxytocin|oxytocin|mesh-list
15118210|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
15118211|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118212|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118213|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15118214|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
15118215|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15118216|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118217|NCT04501783|Favipiravir|favipiravir|mesh-list
15118218|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
15118219|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177101|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
15177102|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15177103|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15177104|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
15177105|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177106|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
15177107|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15177108|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15177109|NCT03972462|Sirolimus|sirolimus|mesh-list
15177110|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177111|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177112|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15177113|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177114|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
15177115|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15177116|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
15177117|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181804|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181805|NCT03926962|Nafithromycin|nafithromycin|mesh-list
15181806|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181807|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181808|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15181809|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181810|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181811|NCT03926936|Fulvestrant|fulvestrant|mesh-list
15181812|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15181813|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181814|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15181815|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15181816|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
15181817|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181818|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181819|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
15181820|NCT03926663|Bupivacaine|bupivacaine|mesh-list
15181821|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
15181822|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
15181823|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181824|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181825|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
15181826|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181827|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15181828|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181829|NCT03926663|Analgesics|analgesics|mesh-ancestor
15181830|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15181831|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15181832|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15181833|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
15181834|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181835|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181836|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
15182296|NCT03923036|Cetuximab|cetuximab|mesh-list
15118220|NCT04501523|Capecitabine|capecitabine|mesh-list
15118221|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15118222|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
15118223|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118224|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118225|NCT04501224|Tenofovir|tenofovir|mesh-list
15118226|NCT04501224|Entecavir|entecavir|mesh-list
15118227|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
15118228|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118229|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15118230|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15118231|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118232|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118233|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15118234|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15118235|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
15118236|NCT04501289|Analgesics|analgesics|mesh-ancestor
15118237|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
15118238|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118239|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118240|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
15118241|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118242|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15118243|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
15118244|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15118245|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15118246|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118247|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15118248|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
15118249|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118250|NCT04501380|Rifamycins|rifamycins|mesh-list
15118251|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
15118252|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118253|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118254|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118255|NCT04501367|Dexamethasone|dexamethasone|mesh-list
15118256|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
15118257|NCT04501367|Prednisone|prednisone|mesh-list
15118258|NCT04501367|BB 1101|bb 1101|mesh-list
15118259|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118260|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
15118261|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
15118262|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118263|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118264|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118265|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
15118266|NCT04501367|Hormones|hormones|mesh-ancestor
15118267|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118268|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15118269|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118270|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
15118271|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118272|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118273|NCT04501107|Insulin|insulin|mesh-list
15118274|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15118275|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
15118276|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15118277|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118278|NCT04501250|Insulin|insulin|mesh-list
15118279|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15118280|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15118281|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118282|NCT04500860|Tadalafil|tadalafil|mesh-list
15118283|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
15118284|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15118285|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15118286|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118287|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118288|NCT04500860|Urological Agents|urological agents|mesh-ancestor
15118289|NCT04501406|Pioglitazone|pioglitazone|mesh-list
15118290|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15118291|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118292|NCT04500808|Macitentan|macitentan|mesh-list
15118293|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15118294|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15118295|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118296|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15118297|NCT04500717|Carboplatin|carboplatin|mesh-list
15118298|NCT04500717|Pemetrexed|pemetrexed|mesh-list
15118299|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118300|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118301|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118302|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15118303|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15118304|NCT04500496|Isoniazid|isoniazid|mesh-list
15118305|NCT04500496|Dinoprostone|dinoprostone|mesh-list
15118306|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
15118307|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118308|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118309|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
15118310|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118311|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118312|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15118313|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15118314|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
15118315|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118316|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15118317|NCT04500704|Carboplatin|carboplatin|mesh-list
15118318|NCT04500704|Pemetrexed|pemetrexed|mesh-list
15118319|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118320|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118321|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118322|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15118323|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15118324|NCT04500743|Leuprolide|leuprolide|mesh-list
15118325|NCT04500743|Dienogest|dienogest|mesh-list
15118326|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15118327|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
15118328|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118329|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118330|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15118331|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118332|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15118333|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
15118334|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15118335|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15118336|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15118337|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15118338|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
15118339|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118340|NCT04500522|Isoniazid|isoniazid|mesh-list
15118341|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
15118342|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118343|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118344|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15118345|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15118346|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
15118347|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118348|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15118349|NCT04500561|Gemcitabine|gemcitabine|mesh-list
15118350|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
15118351|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15118352|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
15118353|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118354|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118355|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
15118356|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118357|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118358|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118359|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
15118360|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118361|NCT04500275|Vancomycin|vancomycin|mesh-list
15118362|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118363|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118364|NCT04499989|Isoniazid|isoniazid|mesh-list
15118365|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
15118366|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118367|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118368|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15118369|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15118370|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
15118371|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118372|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15118373|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
15118374|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
15118375|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118376|NCT04500613|Dexamethasone|dexamethasone|mesh-list
15118377|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
15118378|NCT04500613|Bupivacaine|bupivacaine|mesh-list
15118379|NCT04500613|BB 1101|bb 1101|mesh-list
15118380|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118381|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
15118382|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
15118383|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118384|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118385|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118386|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
15118387|NCT04500613|Hormones|hormones|mesh-ancestor
15118388|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118389|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15118390|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118391|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
15118392|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118393|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118394|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
15118395|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
15118396|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118397|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
15118398|NCT04500678|Metformin|metformin|mesh-list
15118399|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15118400|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118401|NCT04500002|Isoniazid|isoniazid|mesh-list
15118402|NCT04500002|Misoprostol|misoprostol|mesh-list
15118403|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15118404|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
15118405|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118406|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118407|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15118408|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118409|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
15118410|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
15118411|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118412|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118413|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15118414|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15118415|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
15118416|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118417|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15118418|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
15118419|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15118420|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118421|NCT04499898|Carvedilol|carvedilol|mesh-list
15118422|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15118423|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15118424|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118425|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118426|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118427|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118428|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15118429|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
15118430|NCT04499898|Protective Agents|protective agents|mesh-ancestor
15118431|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15118432|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15118433|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15118434|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
15118435|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15118436|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15118437|NCT04499885|Mineral Oil|mineral oil|mesh-list
15118438|NCT04499885|Emollients|emollients|mesh-ancestor
15118439|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
15118440|NCT04499586|Irinotecan|irinotecan|mesh-list
15118441|NCT04499586|Raltitrexed|raltitrexed|mesh-list
15118442|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15118443|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15118444|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118445|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118446|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118447|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15118448|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
15118449|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15118450|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15118451|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15118452|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15118453|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
15118454|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118455|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15118456|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15118457|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118458|NCT04499573|Cytarabine|cytarabine|mesh-list
15118459|NCT04499573|Dexamethasone|dexamethasone|mesh-list
15118460|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
15118461|NCT04499573|Fludarabine|fludarabine|mesh-list
15118462|NCT04499573|Etoposide|etoposide|mesh-list
15118463|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118464|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
15118465|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118466|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118467|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15118468|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
15118469|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118470|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118471|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15118472|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118473|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
15118474|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
15118475|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118476|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118477|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
15118478|NCT04499573|Hormones|hormones|mesh-ancestor
15118479|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118480|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14811281|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14811282|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811283|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811284|NCT00844688|Gemcitabine|gemcitabine|mesh-list
14811285|NCT00844688|Sorafenib|sorafenib|mesh-list
14811286|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14811287|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
14811288|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811289|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811290|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
15118481|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811291|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118482|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15118483|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
15118484|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15118485|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15118486|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15118487|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
15118488|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177118|NCT03972046|Trametinib|trametinib|mesh-list
15177119|NCT03972046|Dabrafenib|dabrafenib|mesh-list
15177120|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15177121|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177122|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15177123|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177124|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177125|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15177126|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
15177127|NCT03971708|Lidocaine|lidocaine|mesh-list
15177128|NCT03971708|Ropivacaine|ropivacaine|mesh-list
15177129|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
15177130|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
15177131|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177132|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177133|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
15177134|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177135|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15177136|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14811292|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811293|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118489|NCT04499976|Misoprostol|misoprostol|mesh-list
15118490|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15118491|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
15118492|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118493|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811294|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
14811295|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811296|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15118494|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15118495|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118496|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
15118497|NCT04499053|Durvalumab|durvalumab|mesh-list
15118498|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15118499|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118500|NCT04499118|Paclitaxel|paclitaxel|mesh-list
15118501|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15118502|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15118503|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118504|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
15118505|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
15118506|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
15118507|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118508|NCT04499313|Dexamethasone|dexamethasone|mesh-list
15118509|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
15118510|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15118511|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15118512|NCT04499313|Prednisolone|prednisolone|mesh-list
15118513|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
15118514|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15118515|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
15118516|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118517|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
15118518|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
15118519|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118520|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118521|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118522|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
15118523|NCT04499313|Hormones|hormones|mesh-ancestor
15118524|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118525|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15118526|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118527|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15118528|NCT04499313|Protective Agents|protective agents|mesh-ancestor
15118529|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
15118530|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118531|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
15118532|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15118533|NCT04499209|Naproxen|naproxen|mesh-list
15118534|NCT04499209|Pregabalin|pregabalin|mesh-list
15118535|NCT04499209|Analgesics|analgesics|mesh-ancestor
15118536|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
15118537|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118538|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118539|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
15118540|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15118541|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15118542|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118543|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15118544|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15118545|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15118546|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118547|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15118548|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15118549|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15118550|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118551|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118552|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
15118553|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15118554|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118555|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
15118556|NCT04498936|Ledipasvir|ledipasvir|mesh-list
15118557|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15118558|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
15118559|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
15118560|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118561|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15118562|NCT04498897|Acamprosate|acamprosate|mesh-list
15118563|NCT04498897|Vortioxetine|vortioxetine|mesh-list
15118564|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
15118565|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15118566|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15118567|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15118568|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118569|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118570|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15118571|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15118572|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15118573|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118574|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118575|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
15118576|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15118577|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15118578|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15118579|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15118580|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15118581|NCT04498689|Gemcitabine|gemcitabine|mesh-list
15118582|NCT04498689|Paclitaxel|paclitaxel|mesh-list
15118583|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15118584|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118585|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
15118586|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
15118587|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
15118588|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118589|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15118590|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
15118591|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
15118592|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118593|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118594|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118595|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
15118596|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118597|NCT04498793|Paclitaxel|paclitaxel|mesh-list
15118598|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
15118599|NCT04498793|Doxorubicin|doxorubicin|mesh-list
15118600|NCT04498793|Epirubicin|epirubicin|mesh-list
15118601|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15118602|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118603|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
15118604|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
15118605|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
15118606|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118607|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118608|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
15118609|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118610|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118611|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15118612|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
15118613|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15118614|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15118615|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15118616|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15118617|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118618|NCT04498884|Insulin|insulin|mesh-list
15118619|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15118620|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15118621|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118622|NCT04498325|Antibodies|antibodies|mesh-list
15118623|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
15118624|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118625|NCT04498286|Antibodies|antibodies|mesh-list
15118626|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
15118627|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118628|NCT04498520|Fulvestrant|fulvestrant|mesh-list
15118629|NCT04498520|Palbociclib|palbociclib|mesh-list
15118630|NCT04498520|Abexinostat|abexinostat|mesh-list
15118631|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15118632|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118633|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15118634|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15118635|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
15118636|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118637|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118638|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15118639|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118640|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118641|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15118642|NCT04498234|Bupivacaine|bupivacaine|mesh-list
15118643|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
15118644|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
15118645|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118646|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118647|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
15118648|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118649|NCT04498260|Triamcinolone|triamcinolone|mesh-list
15118650|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15118651|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15118652|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15118653|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118654|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
15118655|NCT04498260|Hormones|hormones|mesh-ancestor
15118656|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118657|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118658|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118659|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
15118660|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118661|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118662|NCT04497831|Morphine|morphine|mesh-list
15118663|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15118664|NCT04497831|Narcotics|narcotics|mesh-ancestor
15118665|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118666|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118667|NCT04497831|Analgesics|analgesics|mesh-ancestor
15118668|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
15118669|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118670|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
15118671|NCT04497766|Analgesics|analgesics|mesh-ancestor
15118672|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
15118673|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118674|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118675|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
15118676|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118677|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15118678|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
15118679|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15118680|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15118681|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118682|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15118683|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
15118684|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118685|NCT04497792|Metformin|metformin|mesh-list
15118686|NCT04497792|Empagliflozin|empagliflozin|mesh-list
15118687|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15118688|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118689|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15118690|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177137|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15177138|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15177139|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177140|NCT03971604|Vitamins|vitamins|mesh-list
15177141|NCT03971604|Vitamin E|vitamin e|mesh-list
15177142|NCT03971604|Vitamin A|vitamin a|mesh-list
15177143|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
15177144|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177145|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
15177146|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177147|NCT03971604|Protective Agents|protective agents|mesh-ancestor
15177148|NCT03971409|Doxorubicin|doxorubicin|mesh-list
15177149|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15177150|NCT03971409|Avelumab|avelumab|mesh-list
15177151|NCT03971409|Camptothecin|camptothecin|mesh-list
15177152|NCT03971409|Antibodies|antibodies|mesh-list
15177153|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15177154|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
15177155|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
15177156|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
15177157|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118691|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
15118692|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
15118693|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118694|NCT04497012|Iron|iron|mesh-list
15118695|NCT04497012|Trace Elements|trace elements|mesh-ancestor
15118696|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
15118697|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118698|NCT04497142|Levetiracetam|levetiracetam|mesh-list
15118699|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
15118700|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
15118701|NCT04496921|Vitamins|vitamins|mesh-list
15118702|NCT04496921|Vitamin K|vitamin k|mesh-list
15118703|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
15118704|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118705|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15118706|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15118707|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118708|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
15118709|NCT04496921|Coagulants|coagulants|mesh-ancestor
15118710|NCT04496882|Tenofovir|tenofovir|mesh-list
15118711|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
15118712|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118713|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15118714|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15118715|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118716|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118717|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15118718|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15118719|NCT04496401|Tacrolimus|tacrolimus|mesh-list
15118720|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15118721|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
15118722|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118723|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15118724|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118725|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118726|NCT04496492|Tocotrienols|tocotrienols|mesh-list
15118727|NCT04496492|Vitamin E|vitamin e|mesh-list
15118728|NCT04496492|Tocopherols|tocopherols|mesh-list
15118729|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
15118730|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118731|NCT04496492|Protective Agents|protective agents|mesh-ancestor
15118732|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118733|NCT04496492|Vitamins|vitamins|mesh-ancestor
15118734|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
15118735|NCT04496141|Antibodies|antibodies|mesh-list
15118736|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
15118737|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118738|NCT04496037|Rituximab|rituximab|mesh-list
15118739|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15118740|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118741|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
15118742|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118743|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118744|NCT04496050|Alprostadil|alprostadil|mesh-list
15118745|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15118746|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
15118747|NCT04496050|Urological Agents|urological agents|mesh-ancestor
15118748|NCT04495894|Ketorolac|ketorolac|mesh-list
15118749|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15118750|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15118751|NCT04495894|Analgesics|analgesics|mesh-ancestor
15118752|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
15118753|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118754|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118755|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118756|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118757|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15118758|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118759|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118760|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15118761|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15118762|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118763|NCT04495881|Incretins|incretins|mesh-ancestor
15118764|NCT04495881|Hormones|hormones|mesh-ancestor
15118765|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118766|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15118767|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
15118768|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118769|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118770|NCT04496063|Ustekinumab|ustekinumab|mesh-list
15118771|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
15118772|NCT04495933|Vaccines|vaccines|mesh-list
15118773|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
15118774|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
15118775|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118776|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15118777|NCT04495608|Fluconazole|fluconazole|mesh-list
15118778|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
15118779|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118780|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15118781|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15118782|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118783|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118784|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15118785|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
15118786|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118787|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118788|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15118789|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15118790|NCT04496024|Ofloxacin|ofloxacin|mesh-list
15118791|NCT04496024|Levofloxacin|levofloxacin|mesh-list
15118792|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15118793|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118794|NCT04496024|Renal Agents|renal agents|mesh-ancestor
15118795|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118796|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15118797|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15118798|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118799|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118800|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118801|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15118802|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15118803|NCT04495569|Antibodies|antibodies|mesh-list
15118804|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15118805|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
15118806|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118807|NCT04495478|Ramucirumab|ramucirumab|mesh-list
15118808|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15118809|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118810|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
15118811|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118812|NCT04495504|Ropivacaine|ropivacaine|mesh-list
15118813|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
15118814|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
15118815|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118816|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118817|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
15118818|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177158|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15177159|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177160|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15177161|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15177162|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177163|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177164|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15177165|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15177166|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15177167|NCT03971370|Vaccines|vaccines|mesh-list
15177168|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
15177169|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177170|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
15177171|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
15177172|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177173|NCT03971201|Sorafenib|sorafenib|mesh-list
15177174|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177175|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15177176|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177177|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177178|NCT03971279|Dexamethasone|dexamethasone|mesh-list
15177179|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15177180|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
15118819|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
15118820|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15118821|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118822|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118823|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15118824|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15118825|NCT04494958|Palbociclib|palbociclib|mesh-list
15118826|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118827|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15118828|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118829|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118830|NCT04495010|Nivolumab|nivolumab|mesh-list
15118831|NCT04495010|Ipilimumab|ipilimumab|mesh-list
15118832|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15118833|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118834|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15118835|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118836|NCT04494880|Bupivacaine|bupivacaine|mesh-list
15118837|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
15118838|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
15118839|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118840|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118841|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
15118842|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118843|NCT04494659|Rifampin|rifampin|mesh-list
15118844|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15118845|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
15118846|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15118847|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118848|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
15118849|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15118850|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118851|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118852|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15118853|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15118854|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15118855|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15118856|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15118857|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15118858|NCT04494763|Propranolol|propranolol|mesh-list
15118859|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15118860|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15118861|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118862|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118863|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118864|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118865|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15118866|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15118867|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
15118868|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
15118869|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15118870|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118871|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118872|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15118873|NCT04494828|Analgesics|analgesics|mesh-ancestor
15118874|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
15118875|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118876|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15118877|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15118878|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15118879|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118880|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118881|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118882|NCT04494529|Betamethasone|betamethasone|mesh-list
15118883|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
15118884|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15118885|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
15118886|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15118887|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118888|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
15118889|NCT04494529|Hormones|hormones|mesh-ancestor
15118890|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118891|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118892|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15118893|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
15118894|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
15118895|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118896|NCT04494503|Rituximab|rituximab|mesh-list
15118897|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15118898|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118899|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
15118900|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118901|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118902|NCT04494321|Budesonide|budesonide|mesh-list
15118903|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
15118904|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15118905|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15118906|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
15118907|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118908|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118909|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15118910|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
15118911|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
15118912|NCT04494321|Hormones|hormones|mesh-ancestor
15118913|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15118914|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15118915|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15118916|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15118917|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118918|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118919|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118920|NCT04494100|Lidocaine|lidocaine|mesh-list
15118921|NCT04494100|Epinephrine|epinephrine|mesh-list
15118922|NCT04494100|Ropivacaine|ropivacaine|mesh-list
15118923|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
15118924|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
15118925|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15118926|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118927|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
15118928|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15118929|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15118930|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15118931|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15118932|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15118933|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118934|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15118935|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15118936|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118937|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118938|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15118939|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15118940|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
15118941|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15118942|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
15118943|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
15118944|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
15118945|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15118946|NCT04494438|Rituximab|rituximab|mesh-list
15118947|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15118948|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118949|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
15118950|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118951|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15118952|NCT04494243|Rabeprazole|rabeprazole|mesh-list
15118953|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15118954|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15118955|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15118956|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15118957|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118958|NCT04494399|Interferons|interferons|mesh-list
15118959|NCT04494399|Ribavirin|ribavirin|mesh-list
15118960|NCT04494399|Interferon-beta|interferon-beta|mesh-list
15118961|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
15118962|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15118963|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
15118964|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15118965|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
15177181|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
15118966|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118967|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
15118968|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118969|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15118970|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
15118971|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15118972|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15118973|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118974|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
15118975|NCT04494126|Coagulants|coagulants|mesh-ancestor
15118976|NCT04493554|Vasopressins|vasopressins|mesh-list
15118977|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
15118978|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
15118979|NCT04493554|Coagulants|coagulants|mesh-ancestor
15118980|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15118981|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15118982|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
15118983|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118984|NCT04493515|Oxytocin|oxytocin|mesh-list
15118985|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
15118986|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15118987|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118988|NCT04493489|Propranolol|propranolol|mesh-list
15118989|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15118990|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15118991|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
15118992|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15118993|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15118994|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15118995|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15118996|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15118997|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
15118998|NCT04493528|Lidocaine|lidocaine|mesh-list
15118999|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
15119000|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
15119001|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119002|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119003|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
15119004|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119005|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15119006|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15119007|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15119008|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15119009|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119010|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
15119011|NCT04493333|Psyllium|psyllium|mesh-list
15119012|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15119013|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15119014|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
15119015|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119016|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
15119017|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119018|NCT04493333|Cathartics|cathartics|mesh-ancestor
15119019|NCT04493229|Oxytocin|oxytocin|mesh-list
15119020|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
15119021|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15119022|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177182|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177183|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177184|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15177185|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
15177186|NCT03971279|Hormones|hormones|mesh-ancestor
15177187|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177188|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15177189|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177190|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15177191|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177192|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177193|NCT03970798|Midazolam|midazolam|mesh-list
15177194|NCT03970798|Caffeine|caffeine|mesh-list
15177195|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15177196|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15119023|NCT04493125|Mosapride|mosapride|mesh-list
15119024|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119025|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119026|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15119027|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
15119028|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119029|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119030|NCT04493398|Erythritol|erythritol|mesh-list
15119031|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
15119032|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
15119033|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15119034|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15119035|NCT04493463|Prednisolone|prednisolone|mesh-list
15119036|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
15119037|NCT04493463|Ropivacaine|ropivacaine|mesh-list
15119038|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15119039|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
15119040|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
15119041|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
15119042|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119043|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119044|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
15119045|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119046|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119047|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
15119048|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
15119049|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119050|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
15119051|NCT04493463|Hormones|hormones|mesh-ancestor
15119052|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119053|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15119054|NCT04493463|Protective Agents|protective agents|mesh-ancestor
15119055|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15119056|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119057|NCT04493281|Edaravone|edaravone|mesh-list
15119058|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15119059|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
15119060|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119061|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15119062|NCT04493281|Protective Agents|protective agents|mesh-ancestor
15119063|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119064|NCT04493099|Decitabine|decitabine|mesh-list
15119065|NCT04493099|Venetoclax|venetoclax|mesh-list
15119066|NCT04493099|Alvocidib|alvocidib|mesh-list
15119067|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15119068|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
15119069|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119070|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119071|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119072|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
15119073|NCT04493099|Growth Substances|growth substances|mesh-ancestor
15119074|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119075|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15119076|NCT04493164|Cytarabine|cytarabine|mesh-list
15119077|NCT04493164|Daunorubicin|daunorubicin|mesh-list
15119078|NCT04493164|Ivosidenib|ivosidenib|mesh-list
15119079|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15119080|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
15119081|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119082|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119083|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
15119084|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119085|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15119086|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
15119087|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119088|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15119089|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15119090|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15119091|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119092|NCT04493073|Mitomycins|mitomycins|mesh-list
15119093|NCT04493073|Mitomycin|mitomycin|mesh-list
15119094|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15119095|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119096|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
15119097|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119098|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15119099|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119100|NCT04493060|Niraparib|niraparib|mesh-list
15119101|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
15119102|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
15119103|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
14269527|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
14269528|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14269529|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14269530|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14269531|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269532|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119104|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119105|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15119106|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119107|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119108|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119109|NCT04492774|Dexamethasone|dexamethasone|mesh-list
15119110|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119111|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
15119112|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
15119113|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119114|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119115|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119116|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
15119117|NCT04492774|Hormones|hormones|mesh-ancestor
15119118|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119119|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15119120|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119121|NCT04492813|Remifentanil|remifentanil|mesh-list
15119122|NCT04492813|Propofol|propofol|mesh-list
15119123|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15119124|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119125|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119126|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15119127|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
15119128|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
15119129|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15119130|NCT04492813|Narcotics|narcotics|mesh-ancestor
15119131|NCT04492813|Analgesics|analgesics|mesh-ancestor
15119132|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
15119133|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119134|NCT04492709|Midazolam|midazolam|mesh-list
15119135|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15119136|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15119137|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119138|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119139|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15119140|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15119141|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15119142|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15119143|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
15119144|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
15119145|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
15119146|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
15119147|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119148|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119149|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
15119150|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119151|NCT04492319|Neostigmine|neostigmine|mesh-list
15119152|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15119153|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119154|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119155|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
15119156|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119157|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119158|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15119159|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
15119160|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119161|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
15119162|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
15119163|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119164|NCT04492254|Enoxaparin|enoxaparin|mesh-list
13996196|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119165|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
15119166|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15119167|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15177197|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14269533|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
15119168|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119169|NCT04492566|Pancrelipase|pancrelipase|mesh-list
15119170|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119171|NCT04492358|Prednisone|prednisone|mesh-list
15119172|NCT04492358|Colchicine|colchicine|mesh-list
15119173|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119174|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
15119175|NCT04492358|Hormones|hormones|mesh-ancestor
15119176|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119177|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119178|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15119179|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119180|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
15119181|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119182|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
15119183|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
15119184|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
15119185|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119186|NCT04492501|Remdesivir|remdesivir|mesh-list
15119187|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
15119188|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119189|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
15119190|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119191|NCT04492072|Misoprostol|misoprostol|mesh-list
15119192|NCT04492072|Oxytocin|oxytocin|mesh-list
15119193|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
15119194|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15119195|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119196|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15119197|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
15119198|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15119199|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119200|NCT04492033|Paclitaxel|paclitaxel|mesh-list
15119201|NCT04492033|Irinotecan|irinotecan|mesh-list
15119202|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15119203|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119204|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
15119205|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
15119206|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
15119207|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119208|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15119209|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15119210|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119211|NCT04491773|Tadalafil|tadalafil|mesh-list
15119212|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
15119213|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15119214|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15119215|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119216|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119217|NCT04491773|Urological Agents|urological agents|mesh-ancestor
15119218|NCT04491786|Gabapentin|gabapentin|mesh-list
15119219|NCT04491786|Nefopam|nefopam|mesh-list
15119220|NCT04491786|Analgesics|analgesics|mesh-ancestor
15119221|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
15119222|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119223|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119224|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
15119225|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15119226|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15119227|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119228|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15119229|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15119230|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15119231|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119232|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119233|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
15119234|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15119235|NCT04491695|Tirofiban|tirofiban|mesh-list
15119236|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15119237|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15119238|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119239|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15119240|NCT04491682|Megestrol|megestrol|mesh-list
15119241|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
15119242|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15119243|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15119244|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15119245|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
15119246|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119247|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15119248|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15119249|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119250|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15119251|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15119252|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15119253|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
15119254|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15119255|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119256|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15119257|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15119258|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15119259|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119260|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
15119261|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15119262|NCT04491474|Lidocaine|lidocaine|mesh-list
15119263|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
15119264|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
15119265|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119266|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119267|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
15119268|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119269|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15119270|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15119271|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15119272|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15119273|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119274|NCT04491643|Megestrol|megestrol|mesh-list
15119275|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
15119276|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15119277|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15119278|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15119279|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
15119280|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119281|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15119282|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15119283|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119284|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15119285|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15119286|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14269534|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269535|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269536|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14269537|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269538|NCT00403403|Bevacizumab|bevacizumab|mesh-list
14269539|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269540|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269541|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15119287|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
15119288|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15119289|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119290|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15119291|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15119292|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15119293|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119294|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
15119295|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15119296|NCT04491084|Antibodies|antibodies|mesh-list
15119297|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
15119298|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
15119299|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119300|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15119301|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15119302|NCT04491084|Protective Agents|protective agents|mesh-ancestor
15177198|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292392|NCT00560573|Gemcitabine|gemcitabine|mesh-list
15119303|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
15119304|NCT04491357|Calcium|calcium|mesh-list
15119305|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15119306|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119307|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15119308|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
15119309|NCT04490967|Salicylates|salicylates|mesh-list
15119310|NCT04490967|Silybin|silybin|mesh-list
15119311|NCT04490967|Silymarin|silymarin|mesh-list
15119312|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
15119313|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119314|NCT04490967|Protective Agents|protective agents|mesh-ancestor
15119315|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119316|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119317|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
15119318|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
15119319|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
15119320|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15119321|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15119322|NCT04490967|Analgesics|analgesics|mesh-ancestor
15119323|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
15119324|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119325|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119326|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119327|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15119328|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119329|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15119330|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119331|NCT04490837|Antibodies|antibodies|mesh-list
15119332|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
15119333|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119334|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
15119335|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15119336|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119337|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15119338|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119339|NCT04490980|Butorphanol|butorphanol|mesh-list
15119340|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15119341|NCT04490980|Narcotics|narcotics|mesh-ancestor
15119342|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119343|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119344|NCT04490980|Analgesics|analgesics|mesh-ancestor
15119345|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
15119346|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119347|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
15119348|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
15119349|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15119350|NCT04490694|Lenvatinib|lenvatinib|mesh-list
15119351|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119352|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15119353|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119354|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119355|NCT04490590|Etoposide|etoposide|mesh-list
15119356|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15119357|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119358|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15119359|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15119360|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119361|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119362|NCT04490434|Celecoxib|celecoxib|mesh-list
15119363|NCT04490434|Naproxen|naproxen|mesh-list
15119364|NCT04490434|Meloxicam|meloxicam|mesh-list
15119365|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15119366|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15119367|NCT04490434|Analgesics|analgesics|mesh-ancestor
15119368|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
15119369|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119370|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119371|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119372|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119373|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15119374|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15119375|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119376|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119377|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
15119378|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15119379|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119380|NCT04490421|Etoposide|etoposide|mesh-list
15119381|NCT04490421|Apatinib|apatinib|mesh-list
15119382|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119383|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15119384|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15119385|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15119386|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119387|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119388|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15119389|NCT04490031|Ketamine|ketamine|mesh-list
15119390|NCT04490031|Analgesics|analgesics|mesh-ancestor
15119391|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
15119392|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119393|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119394|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15119395|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15119396|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
15119397|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
15119398|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119399|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15119400|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15119401|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119402|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119403|NCT04490057|Bupropion|bupropion|mesh-list
15119404|NCT04490057|Nicotine|nicotine|mesh-list
15119405|NCT04490057|Varenicline|varenicline|mesh-list
15119406|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15119407|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
15119408|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119409|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119410|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15119411|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15119412|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
15119413|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119414|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119415|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15119416|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
15119417|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15119418|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14269542|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15119419|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15119420|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15119421|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
15119422|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15119423|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15119424|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119425|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15119426|NCT04490213|Laxatives|laxatives|mesh-ancestor
15119427|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119428|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
15119429|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119430|NCT04489589|Midodrine|midodrine|mesh-list
15119431|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
15119432|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
15119433|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119434|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119435|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15119436|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15119437|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15119438|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15119439|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
15119440|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119441|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119442|NCT04489745|Androgens|androgens|mesh-list
15119443|NCT04489745|Hormones|hormones|mesh-ancestor
15119444|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119445|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119446|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
15119447|NCT04489797|Rabeprazole|rabeprazole|mesh-list
15119448|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15119449|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269543|NCT00403403|Growth Substances|growth substances|mesh-ancestor
15119450|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15119451|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119452|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119453|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119454|NCT04489849|Apixaban|apixaban|mesh-list
15119455|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15119456|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
15119457|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15119458|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
15119459|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119460|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119461|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
15119462|NCT04489459|Meropenem|meropenem|mesh-list
15119463|NCT04489459|Colistin|colistin|mesh-list
15119464|NCT04489459|Tigecycline|tigecycline|mesh-list
15119465|NCT04489459|Polymyxins|polymyxins|mesh-list
15119466|NCT04489459|Polymyxin B|polymyxin b|mesh-list
15119467|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15119468|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119469|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15119470|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119471|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119472|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
15119473|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
15119474|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15119475|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15119476|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119477|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119478|NCT04489446|Urological Agents|urological agents|mesh-ancestor
15119479|NCT04489147|Metformin|metformin|mesh-list
15119480|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15119481|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177199|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177200|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15177201|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15177202|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15177203|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15177204|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
15177205|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
15177206|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
15177207|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
15177208|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177209|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177210|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15177211|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15177212|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
15177213|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15177214|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15177215|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177216|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15177217|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15177218|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15177219|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15177220|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
15177221|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
15177222|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
15177223|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15177224|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
15177225|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177226|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15177227|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15177228|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
15177229|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177230|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177231|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15177232|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15177233|NCT03970954|Interleukin-2|interleukin-2|mesh-list
15177234|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177235|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15177236|NCT03970954|Analgesics|analgesics|mesh-ancestor
15177237|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
15177238|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177239|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177240|NCT03970772|Glucagon|glucagon|mesh-list
15177241|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15177242|NCT03970772|Hormones|hormones|mesh-ancestor
15119482|NCT04489121|Omalizumab|omalizumab|mesh-list
15119483|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15119484|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15119485|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
15119486|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
15119487|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15119488|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119489|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
15119490|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15119491|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15119492|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
15119493|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119494|NCT04488978|Amlodipine|amlodipine|mesh-list
15119495|NCT04488978|Irbesartan|irbesartan|mesh-list
15119496|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15119497|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15119498|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15119499|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119500|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15119501|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119502|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
15119503|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15119504|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15119505|NCT04488705|Albuterol|albuterol|mesh-list
15119506|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15119507|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
15119508|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119509|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119510|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15119511|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
15119512|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
15119513|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15119514|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15119515|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15119516|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15119517|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
15119518|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119519|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119520|NCT04488744|Nicotine|nicotine|mesh-list
15119521|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15119522|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
15119523|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119524|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119525|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15119526|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15119527|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
15119528|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119529|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119530|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
15119531|NCT04488614|Estrogens|estrogens|mesh-list
15119532|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15119533|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119534|NCT04488614|Hormones|hormones|mesh-ancestor
15119535|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119536|NCT04488926|Palmidrol|palmidrol|mesh-list
15119537|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15119538|NCT04488926|Analgesics|analgesics|mesh-ancestor
15119539|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
15119540|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119541|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119542|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15119543|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119544|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119545|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
15119546|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119547|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15119548|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15119549|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119550|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119551|NCT04488926|Hormones|hormones|mesh-ancestor
15119552|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119553|NCT04488874|Mannitol|mannitol|mesh-list
15119554|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15119555|NCT04488874|Diuretics|diuretics|mesh-ancestor
15119556|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
15119557|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119558|NCT04488601|Sirolimus|sirolimus|mesh-list
15119559|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15119560|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119561|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15119562|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119563|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
15119564|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15119565|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
15119566|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119567|NCT04488315|Dexamethasone|dexamethasone|mesh-list
15119568|NCT04488315|Dexamethasone acetate|dexamethasone acetate|mesh-list
15119569|NCT04488315|Ropivacaine|ropivacaine|mesh-list
15119570|NCT04488315|BB 1101|bb 1101|mesh-list
15119571|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119572|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
15119573|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
15119574|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119575|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119576|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119577|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
15119578|NCT04488315|Hormones|hormones|mesh-ancestor
15119579|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119580|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15119581|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119582|NCT04488315|Protease Inhibitors|protease inhibitors|mesh-ancestor
15119583|NCT04488315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119584|NCT04488315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119585|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
15119586|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
15119587|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119588|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
15119589|NCT04488107|Letrozole|letrozole|mesh-list
15119590|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119591|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15119592|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15119593|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119594|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119595|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15119596|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
15119597|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119598|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119599|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
15119600|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15119601|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15119602|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119603|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
15119604|NCT04488367|Coagulants|coagulants|mesh-ancestor
15119605|NCT04488081|Cyclosporine|cyclosporine|mesh-list
15119606|NCT04488081|Remdesivir|remdesivir|mesh-list
15119607|NCT04488081|Celecoxib|celecoxib|mesh-list
15119608|NCT04488081|Famotidine|famotidine|mesh-list
15119609|NCT04488081|Cyclosporins|cyclosporins|mesh-list
15119610|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119611|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119612|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15119613|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
15119614|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119615|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
15119616|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119617|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
15119618|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119619|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15119620|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15119621|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15119622|NCT04488081|Analgesics|analgesics|mesh-ancestor
15119623|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
15119624|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119625|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119626|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15119627|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15119628|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15119629|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119630|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15119631|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
15119632|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
15119633|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119634|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
15119635|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
15119636|NCT04488172|Vitamins|vitamins|mesh-list
15119637|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
15119638|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119639|NCT04487990|Heparin|heparin|mesh-list
15119640|NCT04487990|Calcium heparin|calcium heparin|mesh-list
15119641|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
15119642|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15119643|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15119644|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119645|NCT04487951|Vitamin D|vitamin d|mesh-list
15119646|NCT04487951|Vitamins|vitamins|mesh-ancestor
15119647|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
15119648|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119649|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15119650|NCT04487743|Liraglutide|liraglutide|mesh-list
15119651|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15119652|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119653|NCT04487743|Incretins|incretins|mesh-ancestor
15119654|NCT04487743|Hormones|hormones|mesh-ancestor
15119655|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119656|NCT04487834|Simethicone|simethicone|mesh-list
15119657|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
15119658|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119659|NCT04487834|Emollients|emollients|mesh-ancestor
15119660|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
15119661|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
15119662|NCT04487652|Vitamins|vitamins|mesh-ancestor
15119663|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
15119664|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119665|NCT04487756|Carboplatin|carboplatin|mesh-list
15119666|NCT04487756|Atezolizumab|atezolizumab|mesh-list
15119667|NCT04487756|Vaccines|vaccines|mesh-list
15119668|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
15119669|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119670|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119671|NCT04487587|Olaparib|olaparib|mesh-list
15119672|NCT04487587|Cediranib|cediranib|mesh-list
15119673|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15119674|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119675|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119676|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119677|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15119678|NCT04487236|Capecitabine|capecitabine|mesh-list
15119679|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15119680|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
15119681|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119682|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119683|NCT04487444|Thymalfasin|thymalfasin|mesh-list
15119684|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15119685|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
15119686|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177243|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177244|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177245|NCT03970616|Durvalumab|durvalumab|mesh-list
15177246|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15177247|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177248|NCT03970694|Capecitabine|capecitabine|mesh-list
15177249|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
15177250|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15177251|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
15177252|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177253|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177254|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
15177255|NCT03971019|Atorvastatin|atorvastatin|mesh-list
15177256|NCT03971019|Simvastatin|simvastatin|mesh-list
15177257|NCT03971019|Calcium|calcium|mesh-list
15177258|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15177259|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177260|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182297|NCT03923036|Panitumumab|panitumumab|mesh-list
15119687|NCT04487392|Estrogens|estrogens|mesh-list
15119688|NCT04487392|Hormones|hormones|mesh-ancestor
15119689|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119690|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119691|NCT04487106|Azacitidine|azacitidine|mesh-list
15119692|NCT04487106|Venetoclax|venetoclax|mesh-list
15119693|NCT04487106|Trametinib|trametinib|mesh-list
15119694|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15119695|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
15119696|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119697|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119698|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119699|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15119700|NCT04487093|Vaccines|vaccines|mesh-list
15119701|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
15119702|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119703|NCT04486690|Ketamine|ketamine|mesh-list
15119704|NCT04486690|Propofol|propofol|mesh-list
15119705|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15119706|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119707|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119708|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15119709|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
15119710|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
15119711|NCT04486690|Analgesics|analgesics|mesh-ancestor
15119712|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
15119713|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119714|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15119715|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15119716|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15119717|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119718|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119719|NCT04486651|Irinotecan|irinotecan|mesh-list
15119720|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15119721|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15119722|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119723|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119724|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119725|NCT04486508|Heparin|heparin|mesh-list
15119726|NCT04486508|Calcium heparin|calcium heparin|mesh-list
15119727|NCT04486508|Enoxaparin|enoxaparin|mesh-list
15119728|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
15119729|NCT04486508|Atorvastatin|atorvastatin|mesh-list
15119730|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
15119731|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15119732|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15119733|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
15119734|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119735|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15119736|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119737|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
15119738|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15119739|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15119740|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
15119741|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15119742|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119743|NCT04486612|Anesthetics|anesthetics|mesh-list
15119744|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119745|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119746|NCT04486430|Salicylates|salicylates|mesh-list
15119747|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15119748|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15119749|NCT04486430|Analgesics|analgesics|mesh-ancestor
15119750|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
15119751|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119752|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119753|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119754|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119755|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15119756|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119757|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119758|NCT04486521|Siltuximab|siltuximab|mesh-list
15119759|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119760|NCT04486092|Valproic Acid|valproic acid|mesh-list
15119761|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
15119762|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119763|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119764|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
15119765|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119766|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119767|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
15119768|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15119769|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119770|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15119771|NCT04485845|Metformin|metformin|mesh-list
15119772|NCT04485845|Vildagliptin|vildagliptin|mesh-list
15119773|NCT04485845|Captopril|captopril|mesh-list
15119774|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15119775|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119776|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15119777|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
15119778|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119779|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119780|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15119781|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15119782|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15119783|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15119784|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
15119785|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119786|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119787|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119788|NCT04485949|Temozolomide|temozolomide|mesh-list
15119789|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15119790|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
15119791|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119792|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119793|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
15119794|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15119795|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15119796|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15119797|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15119798|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119799|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
15119800|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119801|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119802|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15119803|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119804|NCT04485702|Midazolam|midazolam|mesh-list
15119805|NCT04485702|Ketamine|ketamine|mesh-list
15119806|NCT04485702|Analgesics|analgesics|mesh-ancestor
15119807|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
15119808|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119809|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119810|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15119811|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15119812|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
15119813|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
15119814|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119815|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15119816|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15119817|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119818|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119819|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15119820|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15119821|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15119822|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15119823|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15119824|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
15119825|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
14269544|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269545|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269546|NCT00403455|Paroxetine|paroxetine|mesh-list
14269547|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14269548|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14292393|NCT00560573|Pemetrexed|pemetrexed|mesh-list
15119826|NCT04485585|Tamsulosin|tamsulosin|mesh-list
15119827|NCT04485585|Mirabegron|mirabegron|mesh-list
15119828|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15119829|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15119830|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15119831|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
15119832|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119833|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119834|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119835|NCT04485585|Urological Agents|urological agents|mesh-ancestor
15119836|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15119837|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15119838|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15119839|NCT04485689|Capsaicin|capsaicin|mesh-list
15119840|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
15119841|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
15119842|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
15119843|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119844|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119845|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
15119846|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15119847|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119848|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
15119849|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
15119850|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15119851|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15119852|NCT04485429|Prednisolone|prednisolone|mesh-list
15119853|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
15119854|NCT04485429|Heparin|heparin|mesh-list
15119855|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15119856|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
15119857|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119858|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
15119859|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
15119860|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119861|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119862|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15119863|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
15119864|NCT04485429|Hormones|hormones|mesh-ancestor
15119865|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15119866|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15119867|NCT04485429|Protective Agents|protective agents|mesh-ancestor
15119868|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15119869|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119870|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
15119871|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15119872|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15119873|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119874|NCT04485130|Disulfiram|disulfiram|mesh-list
15119875|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15119876|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15119877|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119878|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119879|NCT04485273|Anesthetics|anesthetics|mesh-list
15119880|NCT04485273|Sevoflurane|sevoflurane|mesh-list
15119881|NCT04485273|Bupivacaine|bupivacaine|mesh-list
15119882|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
15119883|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15119884|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119885|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119886|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15119887|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15119888|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
15119889|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
15119890|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177261|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15177262|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15177263|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
15177264|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177265|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15177266|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15177267|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177268|NCT03970759|Fluorides|fluorides|mesh-list
15177269|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
15177270|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
15177271|NCT03970759|Protective Agents|protective agents|mesh-ancestor
15177272|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177273|NCT03970577|Prednisone|prednisone|mesh-list
15177274|NCT03970577|Rituximab|rituximab|mesh-list
15177275|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14561700|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
15119891|NCT04485299|Listerine|listerine|mesh-list
15119892|NCT04485299|Fluorides|fluorides|mesh-list
15119893|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
15119894|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
15119895|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
15119896|NCT04485299|Protective Agents|protective agents|mesh-ancestor
15119897|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119898|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15119899|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119900|NCT04485403|Ibuprofen|ibuprofen|mesh-list
15119901|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15119902|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15119903|NCT04485403|Analgesics|analgesics|mesh-ancestor
15119904|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
15119905|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119906|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119907|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119908|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15119909|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15119910|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119911|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119912|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
15119913|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15119914|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119915|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
15119916|NCT04485195|Procainamide|procainamide|mesh-list
15119917|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15119918|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15119919|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15119920|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15119921|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119922|NCT04485117|Anesthetics|anesthetics|mesh-list
15119923|NCT04485117|Propofol|propofol|mesh-list
15119924|NCT04485117|Sevoflurane|sevoflurane|mesh-list
15119925|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15119926|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119927|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15119928|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15119929|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
15119930|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15119931|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15119932|NCT04485156|Rifampin|rifampin|mesh-list
15119933|NCT04485156|Isoniazid|isoniazid|mesh-list
15119934|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
15119935|NCT04485156|Ethambutol|ethambutol|mesh-list
15119936|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15119937|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
15119938|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15119939|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119940|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
15119941|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15119942|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119943|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119944|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15119945|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15119946|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15119947|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15119948|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15119949|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15119950|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15119951|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15119952|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
15119953|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15119954|NCT04485065|Azacitidine|azacitidine|mesh-list
15119955|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15119956|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
15119957|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119958|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119959|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119960|NCT04485052|Azacitidine|azacitidine|mesh-list
15119961|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15119962|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
15119963|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119964|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15119965|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119966|NCT04484688|Bisoprolol|bisoprolol|mesh-list
15119967|NCT04484688|Perindopril|perindopril|mesh-list
15119968|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15119969|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
15119970|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
15119971|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15119972|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119973|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15119974|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15119975|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15119976|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
15119977|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15119978|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15119979|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15119980|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
15119981|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15119982|NCT04484779|Insulin|insulin|mesh-list
15119983|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
15119984|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
15119985|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15119986|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119987|NCT04484844|Listerine|listerine|mesh-list
15119988|NCT04484844|Fluorides|fluorides|mesh-list
15119989|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
15119990|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
15119991|NCT04484844|Protective Agents|protective agents|mesh-ancestor
15119992|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15119993|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15119994|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15119995|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
15119996|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15119997|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
15119998|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15119999|NCT04484506|Prednisone|prednisone|mesh-list
15120000|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
15120001|NCT04484506|Etoposide|etoposide|mesh-list
15120002|NCT04484506|Vincristine|vincristine|mesh-list
15120003|NCT04484506|Pegaspargase|pegaspargase|mesh-list
15120004|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120005|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
15120006|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120007|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120008|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15120009|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
15120010|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120011|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120012|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15120013|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120014|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
15120015|NCT04484506|Hormones|hormones|mesh-ancestor
15120016|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120017|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120018|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15120019|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15120020|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15120021|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120022|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
15120023|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
15120024|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
15120025|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
15120026|NCT04484610|Narcotics|narcotics|mesh-ancestor
15120027|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120028|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120029|NCT04484610|Analgesics|analgesics|mesh-ancestor
15120030|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
15120031|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120032|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15120033|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15120034|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15120035|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120036|NCT04484467|Menthol|menthol|mesh-list
15120037|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
15120038|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120039|NCT04484623|Dexamethasone|dexamethasone|mesh-list
15120040|NCT04484623|Bortezomib|bortezomib|mesh-list
15120041|NCT04484623|Pomalidomide|pomalidomide|mesh-list
15120042|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120043|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
15120044|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
14269549|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15120045|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120046|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120047|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120048|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
15120049|NCT04484623|Hormones|hormones|mesh-ancestor
15120050|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120051|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120052|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120053|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
15120054|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15120055|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15120056|NCT04484623|Growth Substances|growth substances|mesh-ancestor
15120057|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
15120058|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
15120059|NCT04484272|Narcotics|narcotics|mesh-ancestor
15120060|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120061|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120062|NCT04484272|Analgesics|analgesics|mesh-ancestor
15120063|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
15120064|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120065|NCT04484259|Aspirin|aspirin|mesh-list
15120066|NCT04484259|Clopidogrel|clopidogrel|mesh-list
15120067|NCT04484259|Ticagrelor|ticagrelor|mesh-list
15120068|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15120069|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15120070|NCT04484259|Analgesics|analgesics|mesh-ancestor
15120071|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
15120072|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120073|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120074|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120075|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120076|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15120077|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15120078|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120079|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15120080|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15120081|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120082|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
15120083|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15120084|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15120085|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15120086|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
15120087|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120088|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
15120089|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
14269550|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269551|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269552|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
14269553|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269554|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14269555|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
14269556|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269557|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14269558|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14269559|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120090|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15120091|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
15120092|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120093|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15120094|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15120095|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15120096|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15120097|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120098|NCT04483960|Nafamostat|nafamostat|mesh-list
15120099|NCT04483960|Enoxaparin|enoxaparin|mesh-list
15120100|NCT04483960|Dalteparin|dalteparin|mesh-list
15120101|NCT04483960|Tinzaparin|tinzaparin|mesh-list
15120102|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15120103|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
15120104|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15120105|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15120106|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120107|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15120108|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15120109|NCT04483960|Analgesics|analgesics|mesh-ancestor
15120110|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
15120111|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120112|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120113|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120114|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120115|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
15120116|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120117|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15120118|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15120119|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15120120|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120121|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
15120122|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
15120123|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120124|NCT04483765|Anesthetics|anesthetics|mesh-list
15120125|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120126|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120127|NCT04483596|Melatonin|melatonin|mesh-list
15120128|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
15120129|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120130|NCT04483596|Protective Agents|protective agents|mesh-ancestor
15120131|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120132|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120133|NCT04483427|Ketorolac|ketorolac|mesh-list
15120134|NCT04483427|Nalbuphine|nalbuphine|mesh-list
15120135|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15120136|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15120137|NCT04483427|Analgesics|analgesics|mesh-ancestor
15120138|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
15120139|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120140|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120141|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120142|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120143|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15120144|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120145|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120146|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15120147|NCT04483427|Narcotics|narcotics|mesh-ancestor
15120148|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120149|NCT04483635|Vitamin D|vitamin d|mesh-list
15120150|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
15120151|NCT04483635|Vitamins|vitamins|mesh-ancestor
15120152|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
15120153|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120154|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15120155|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15120156|NCT04483466|Methotrexate|methotrexate|mesh-list
15120157|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15120158|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
15120159|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15120160|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120161|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120162|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
15120163|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120164|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120165|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120166|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120167|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15120168|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120169|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
15120170|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120171|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15120172|NCT04483739|Dexamethasone|dexamethasone|mesh-list
14269560|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14269561|NCT00403481|Olmesartan|olmesartan|mesh-list
14269562|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14269563|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14269564|NCT00403481|Diuretics|diuretics|mesh-ancestor
14269565|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
15120173|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
15120174|NCT04483739|Lenalidomide|lenalidomide|mesh-list
15120175|NCT04483739|BB 1101|bb 1101|mesh-list
15120176|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120177|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
15120178|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
15120179|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120180|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120181|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120182|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
15120183|NCT04483739|Hormones|hormones|mesh-ancestor
15120184|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120185|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120186|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120187|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
15120188|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120189|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120190|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
15120191|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15120192|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15120193|NCT04483739|Growth Substances|growth substances|mesh-ancestor
15120194|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
15120195|NCT04483674|Tenofovir|tenofovir|mesh-list
15120196|NCT04483674|Emtricitabine|emtricitabine|mesh-list
15120197|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
15120198|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120199|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15120200|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15120201|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120202|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120203|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15120204|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15120205|NCT04483492|Caffeine|caffeine|mesh-list
15120206|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
15120207|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120208|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15120209|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120210|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15120211|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120212|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15120213|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15120214|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
15120215|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177276|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177277|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
15177278|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177279|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15177280|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15177281|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
15177282|NCT03970577|Hormones|hormones|mesh-ancestor
15177283|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177284|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15177285|NCT03970668|Insulin|insulin|mesh-list
15177286|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15177287|NCT03970668|Linagliptin|linagliptin|mesh-list
15177288|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15177289|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177290|NCT03970668|Incretins|incretins|mesh-ancestor
15177291|NCT03970668|Hormones|hormones|mesh-ancestor
15177292|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177293|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15177294|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
15177295|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177296|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177297|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15177298|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177299|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
15177300|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15120216|NCT04483258|Sevoflurane|sevoflurane|mesh-list
15120217|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15120218|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15120219|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
15120220|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
15120221|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120222|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120223|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
15120224|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15120225|NCT04483284|Estrogens|estrogens|mesh-ancestor
15120226|NCT04483284|Hormones|hormones|mesh-ancestor
15120227|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120228|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120229|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120230|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120231|NCT04483219|Antibodies|antibodies|mesh-list
15120232|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
15120233|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120234|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
15120235|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15120236|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15120237|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120238|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
15120239|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120240|NCT04482907|Hormones|hormones|mesh-list
15120241|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120242|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120243|NCT04482842|Warfarin|warfarin|mesh-list
15120244|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
15120245|NCT04482881|Isosorbide|isosorbide|mesh-list
15120246|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15120247|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15120248|NCT04482881|Misoprostol|misoprostol|mesh-list
15120249|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15120250|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
15120251|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15120252|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120253|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15120254|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120255|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
15120256|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15120257|NCT04482881|Diuretics|diuretics|mesh-ancestor
15120258|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
15120259|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
15120260|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15120261|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120262|NCT04482985|Meclizine|meclizine|mesh-list
15120263|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
15120264|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
15120265|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120266|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120267|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120268|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15120269|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
15120270|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
15120271|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120272|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120273|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15120274|NCT04482504|Vitamin D|vitamin d|mesh-list
15120275|NCT04482504|Vitamins|vitamins|mesh-ancestor
15120276|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
15120277|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120278|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15120279|NCT04482712|Sirolimus|sirolimus|mesh-list
15120280|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14561701|NCT00002803|Doxorubicin|doxorubicin|mesh-list
15120281|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120282|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15120283|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120284|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
15120285|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120286|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
15120287|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120288|NCT04482764|Valproic Acid|valproic acid|mesh-list
15120289|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
15120290|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120291|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120292|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
15120293|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120294|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120295|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
15120296|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15120297|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120298|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15120299|NCT04482543|Methotrexate|methotrexate|mesh-list
15120300|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15120301|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
15120302|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15120303|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120304|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120305|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
15120306|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120307|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120308|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120309|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120310|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15120311|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120312|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
15120313|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120314|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15120315|NCT04482413|Donepezil|donepezil|mesh-list
15120316|NCT04482413|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15120317|NCT04482413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120318|NCT04482413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120319|NCT04482413|Cholinergic Agents|cholinergic agents|mesh-ancestor
15120320|NCT04482413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120321|NCT04482413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120322|NCT04482413|Nootropic Agents|nootropic agents|mesh-ancestor
15120323|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
15120324|NCT04482296|Astringents|astringents|mesh-ancestor
15120325|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120326|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120327|NCT04482257|Irinotecan|irinotecan|mesh-list
15120328|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15120329|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15120330|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120331|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120332|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120333|NCT04481802|Acemannan|acemannan|mesh-list
15120334|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15120335|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
15120336|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120337|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120338|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
15120339|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120340|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120341|NCT04481815|Rituximab|rituximab|mesh-list
15120342|NCT04481815|Methotrexate|methotrexate|mesh-list
15120343|NCT04481815|Lenalidomide|lenalidomide|mesh-list
15120344|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15120345|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120346|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
15120347|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120348|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120349|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15120350|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
15120351|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15120352|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120353|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
15120354|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120355|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120356|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120357|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15120358|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120359|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15120360|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15120361|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15120362|NCT04481815|Growth Substances|growth substances|mesh-ancestor
15120363|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
15120364|NCT04481841|Vitamins|vitamins|mesh-list
15120365|NCT04481841|Vitamin E|vitamin e|mesh-list
15120366|NCT04481841|Riboflavin|riboflavin|mesh-list
15120367|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
15120368|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120369|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
15120370|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
15120371|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120372|NCT04481841|Protective Agents|protective agents|mesh-ancestor
15120373|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15120374|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120375|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
15120376|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15120377|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15120378|NCT04481724|Analgesics|analgesics|mesh-ancestor
15120379|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
15120380|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120381|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120382|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120383|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120384|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15120385|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
15120386|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120387|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15120388|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
15120389|NCT04481971|Prednisolone|prednisolone|mesh-list
15120390|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120391|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
15120392|NCT04481971|Hormones|hormones|mesh-ancestor
15120393|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120394|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120395|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120396|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120397|NCT04481555|Azithromycin|azithromycin|mesh-list
15120398|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15120399|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120400|NCT04481750|Edaravone|edaravone|mesh-list
15120401|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15120402|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
15120403|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120404|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15120405|NCT04481750|Protective Agents|protective agents|mesh-ancestor
15120406|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120407|NCT04481789|Furosemide|furosemide|mesh-list
15120408|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
15120409|NCT04481789|Edaravone|edaravone|mesh-list
15120410|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15120411|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15120412|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15120413|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
15120414|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120415|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15120416|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15120417|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120418|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
15120419|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15120420|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15120421|NCT04481789|Urological Agents|urological agents|mesh-ancestor
15120422|NCT04481789|Diuretics|diuretics|mesh-ancestor
15120423|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
15120424|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120425|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15120426|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15120427|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15120428|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
15120429|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15120430|NCT04481789|Protective Agents|protective agents|mesh-ancestor
15120431|NCT04481932|Trastuzumab|trastuzumab|mesh-list
15120432|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15120433|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120434|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15120435|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
15120436|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120437|NCT04481282|Terbutaline|terbutaline|mesh-list
15120438|NCT04481282|Danazol|danazol|mesh-list
15120439|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15120440|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
15120441|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120442|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120443|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15120444|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
15120445|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
15120446|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
15120447|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15120448|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15120449|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15120450|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15120451|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
15120452|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120453|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120454|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15120455|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
15120456|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120457|NCT04481204|Leucovorin|leucovorin|mesh-list
15120458|NCT04481204|Gemcitabine|gemcitabine|mesh-list
15120459|NCT04481204|Paclitaxel|paclitaxel|mesh-list
15120460|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15120461|NCT04481204|Cisplatin|cisplatin|mesh-list
15120462|NCT04481204|Fluorouracil|fluorouracil|mesh-list
15120463|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
15120464|NCT04481204|Irinotecan|irinotecan|mesh-list
15120465|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15120466|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120467|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
15120468|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
15120469|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
15120470|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120471|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120472|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
15120473|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
15120474|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120475|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120476|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120477|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
15120478|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120479|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15120480|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15120481|NCT04481204|Antidotes|antidotes|mesh-ancestor
15120482|NCT04481204|Protective Agents|protective agents|mesh-ancestor
15120483|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
15120484|NCT04481204|Vitamins|vitamins|mesh-ancestor
15120485|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
15120486|NCT04481451|Ropivacaine|ropivacaine|mesh-list
15120487|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
15120488|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
15120489|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120490|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120491|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
15120492|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177301|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15177302|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177303|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
15177304|NCT03970213|Coagulants|coagulants|mesh-ancestor
15177305|NCT03970239|Ketanserin|ketanserin|mesh-list
15177306|NCT03970239|Fluorides|fluorides|mesh-list
15177307|NCT03970239|Altanserin|altanserin|mesh-list
15177308|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
15177309|NCT03970239|Protective Agents|protective agents|mesh-ancestor
15177310|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177311|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15177312|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
15177313|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177314|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177315|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15177316|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15181837|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181838|NCT03926754|Mirabegron|mirabegron|mesh-list
15120493|NCT04481256|Paclitaxel|paclitaxel|mesh-list
15120494|NCT04481256|Carboplatin|carboplatin|mesh-list
15120495|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15120496|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120497|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
15120498|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
15120499|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
15120500|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120501|NCT04481100|Itraconazole|itraconazole|mesh-list
15120502|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
15120503|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120504|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15120505|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15120506|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120507|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120508|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15120509|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
15120510|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120511|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120512|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15120513|NCT04480827|Cholic Acids|cholic acids|mesh-list
15120514|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120515|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
15120516|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15120517|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15120518|NCT04480775|Prednisolone|prednisolone|mesh-list
15120519|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
15120520|NCT04480775|Triamcinolone|triamcinolone|mesh-list
15120521|NCT04480775|Bupivacaine|bupivacaine|mesh-list
15120522|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15120523|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
15120524|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
15120525|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
15120526|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120527|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120528|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
15120529|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120530|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120531|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
15120532|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
15120533|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120534|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
15120535|NCT04480775|Hormones|hormones|mesh-ancestor
15120536|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120537|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15120538|NCT04480775|Protective Agents|protective agents|mesh-ancestor
15120539|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120540|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120541|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15120542|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15120543|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120544|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120545|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
15120546|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120547|NCT04480593|Propolis|propolis|mesh-list
15120548|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120549|NCT04480450|Rituximab|rituximab|mesh-list
15120550|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15120551|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120552|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
15120553|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120554|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120555|NCT04480086|Navitoclax|navitoclax|mesh-list
15120556|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120557|NCT04480281|Lidocaine|lidocaine|mesh-list
15120558|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
15120559|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
15120560|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120561|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120562|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
15120563|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120564|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15120565|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15120566|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15120567|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15120568|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120569|NCT04480268|Gemcitabine|gemcitabine|mesh-list
15120570|NCT04480268|Paclitaxel|paclitaxel|mesh-list
15120571|NCT04480268|Capecitabine|capecitabine|mesh-list
15120572|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15120573|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120574|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
15120575|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
15120576|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
15120577|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120578|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120579|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
15120580|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
15120581|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120582|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120583|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120584|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
15120585|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120586|NCT04480463|Aflibercept|aflibercept|mesh-list
15120587|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15120588|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15120589|NCT04480463|Growth Substances|growth substances|mesh-ancestor
15120590|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120591|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
15120592|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120593|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
15120594|NCT04480333|Remdesivir|remdesivir|mesh-list
15120595|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
15120596|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120597|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
15120598|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120599|NCT04480333|Protective Agents|protective agents|mesh-ancestor
15120600|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120601|NCT04480372|Gemcitabine|gemcitabine|mesh-list
15120602|NCT04480372|Atezolizumab|atezolizumab|mesh-list
15120603|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120604|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
15120605|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120606|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120607|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
15120608|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120609|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120610|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120611|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
15120612|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120613|NCT04480138|Interferons|interferons|mesh-list
15120614|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120615|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
15120616|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120617|NCT04480359|Meloxicam|meloxicam|mesh-list
15120618|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15120619|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15120620|NCT04480359|Analgesics|analgesics|mesh-ancestor
15120621|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
15120622|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120623|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120624|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120625|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120626|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15120627|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15120628|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120629|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120630|NCT04479748|Dexamethasone|dexamethasone|mesh-list
15120631|NCT04479748|Prednisolone|prednisolone|mesh-list
15120632|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15120633|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
15120634|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15120635|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
15120636|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15120637|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
15120638|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120639|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
15120640|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
15120641|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120642|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120643|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120644|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
15120645|NCT04479748|Hormones|hormones|mesh-ancestor
15120646|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120647|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120648|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120649|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15120650|NCT04479748|Protective Agents|protective agents|mesh-ancestor
15120651|NCT04479657|Cefuroxime|cefuroxime|mesh-list
15120652|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
15120653|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15120654|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120655|NCT04479865|Donepezil|donepezil|mesh-list
15120656|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15120657|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120658|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120659|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
15120660|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120661|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120662|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
15120663|NCT04479891|Itraconazole|itraconazole|mesh-list
15120664|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
15120665|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120666|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15120667|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15120668|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120669|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120670|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15120671|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
15120672|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120673|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120674|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15120675|NCT04479813|Moxonidine|moxonidine|mesh-list
15120676|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15120677|NCT04479527|Apatinib|apatinib|mesh-list
15120678|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120679|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15120680|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120681|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120682|NCT04479202|Bentonite|bentonite|mesh-list
15120683|NCT04479202|Antidotes|antidotes|mesh-ancestor
15120684|NCT04479202|Protective Agents|protective agents|mesh-ancestor
15120685|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120686|NCT04479371|Bupivacaine|bupivacaine|mesh-list
15120687|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
15120688|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
15120689|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120690|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120691|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
15120692|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120693|NCT04479449|Otaplimastat|otaplimastat|mesh-list
15120694|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15120695|NCT04479449|Protective Agents|protective agents|mesh-ancestor
15120696|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177317|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
15177318|NCT03970044|Exenatide|exenatide|mesh-list
15177319|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15177320|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177321|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15177322|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177323|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15177324|NCT03970044|Incretins|incretins|mesh-ancestor
15177325|NCT03970044|Hormones|hormones|mesh-ancestor
15177326|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177327|NCT03969823|Osimertinib|osimertinib|mesh-list
15177328|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177329|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15177330|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177331|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177332|NCT03969758|Metronidazole|metronidazole|mesh-list
15177333|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
15177334|NCT03969758|Cefixime|cefixime|mesh-list
15177335|NCT03969758|Liver Extracts|liver extracts|mesh-list
15177336|NCT03969758|Hematinics|hematinics|mesh-ancestor
15177337|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120697|NCT04478617|Metronidazole|metronidazole|mesh-list
15120698|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120699|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15120700|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15120701|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15120702|NCT04478448|Favipiravir|favipiravir|mesh-list
15120703|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
15120704|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120705|NCT04478461|Antibodies|antibodies|mesh-list
15120706|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15120707|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
15120708|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120709|NCT04478526|Norepinephrine|norepinephrine|mesh-list
15120710|NCT04478526|Serotonin|serotonin|mesh-list
15120711|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15120712|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
15120713|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15120714|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15120715|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
15120716|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120717|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120718|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120719|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
15120720|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
15120721|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120722|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15120723|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15120724|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
15120725|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15120726|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15120727|NCT04478357|Fesoterodine|fesoterodine|mesh-list
15120728|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15120729|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15120730|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
15120731|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120732|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120733|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120734|NCT04478357|Urological Agents|urological agents|mesh-ancestor
15120735|NCT04478474|Ganciclovir|ganciclovir|mesh-list
15120736|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
15120737|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
15120738|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120739|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15120740|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120741|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120742|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
15120743|NCT04478292|Cisplatin|cisplatin|mesh-list
15120744|NCT04478292|Carboplatin|carboplatin|mesh-list
15120745|NCT04478292|Doxorubicin|doxorubicin|mesh-list
15120746|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15120747|NCT04478292|Fluorouracil|fluorouracil|mesh-list
15120748|NCT04478292|Irinotecan|irinotecan|mesh-list
15120749|NCT04478292|Vincristine|vincristine|mesh-list
15120750|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120751|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15120752|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15120753|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15120754|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120755|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120756|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
15120757|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120758|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120759|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
15120760|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120761|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15120762|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15120763|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
15120764|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
15120765|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
15120766|NCT04478292|Antidotes|antidotes|mesh-ancestor
15120767|NCT04478292|Protective Agents|protective agents|mesh-ancestor
15120768|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
15120769|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
15120770|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15120771|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120772|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
15120773|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
15120774|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
15120775|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15120776|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15120777|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120778|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120779|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15120780|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15120781|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15120782|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15120783|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120784|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120785|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
15120786|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15120787|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
15120788|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15120789|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15120790|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120791|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15120792|NCT04478500|Minocycline|minocycline|mesh-list
15120793|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15120794|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120795|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15120796|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15120797|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120798|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120799|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
15120800|NCT04477629|Abatacept|abatacept|mesh-list
15120801|NCT04477629|Tacrolimus|tacrolimus|mesh-list
15120802|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120803|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
15120804|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120805|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15120806|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120807|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120808|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15120809|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120810|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15120811|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
15120812|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15120813|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120814|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15120815|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120816|NCT04477642|Abatacept|abatacept|mesh-list
15120817|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15120818|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120819|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120820|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15120821|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
15120822|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120823|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120824|NCT04477811|Vitamins|vitamins|mesh-list
15120825|NCT04477811|Vitamin K|vitamin k|mesh-list
15120826|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
15120827|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
15120828|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
15120829|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120830|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15120831|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15120832|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120833|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
15120834|NCT04477811|Coagulants|coagulants|mesh-ancestor
15120835|NCT04477590|Metformin|metformin|mesh-list
15120836|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15120837|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120838|NCT04477525|Bupivacaine|bupivacaine|mesh-list
15120839|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
15120840|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
15120841|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120842|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120843|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
15120844|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120845|NCT04477317|Epinephrine|epinephrine|mesh-list
15120846|NCT04477317|Racepinephrine|racepinephrine|mesh-list
15120847|NCT04477317|Nordefrin|nordefrin|mesh-list
15120848|NCT04477317|Mepivacaine|mepivacaine|mesh-list
15120849|NCT04477317|Carticaine|carticaine|mesh-list
15120850|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
15120851|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15120852|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15120853|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
15120854|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120855|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120856|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120857|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15120858|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15120859|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
15120860|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120861|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15120862|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
15120863|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
15120864|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
15120865|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15120866|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
15120867|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
15120868|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120869|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
15120870|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
15120871|NCT04477304|Narcotics|narcotics|mesh-ancestor
15120872|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120873|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120874|NCT04477304|Analgesics|analgesics|mesh-ancestor
15120875|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
15120876|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120877|NCT04477096|Emtricitabine|emtricitabine|mesh-list
15120878|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
15120879|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120880|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15120881|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15120882|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120883|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120884|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15120885|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15120886|NCT04476979|Dexamethasone|dexamethasone|mesh-list
15120887|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120888|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
15120889|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
15120890|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120891|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120892|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15120893|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
15120894|NCT04476979|Hormones|hormones|mesh-ancestor
15120895|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120896|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15120897|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120898|NCT04476966|Mirabegron|mirabegron|mesh-list
15120899|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15120900|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15120901|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15120902|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
15120903|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15120904|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120905|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120906|NCT04476966|Urological Agents|urological agents|mesh-ancestor
15120907|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
15120908|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
15120909|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15120910|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15120911|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120912|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120913|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120914|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120915|NCT04477018|Ascorbic Acid|ascorbic acid|mesh-list
15120916|NCT04477018|Iron|iron|mesh-list
15120917|NCT04477018|Chelating Agents|chelating agents|mesh-list
15120918|NCT04477018|Vitamins|vitamins|mesh-ancestor
15120919|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
15120920|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120921|NCT04477018|Trace Elements|trace elements|mesh-ancestor
15120922|NCT04477018|Antioxidants|antioxidants|mesh-ancestor
15120923|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561702|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15120924|NCT04477018|Protective Agents|protective agents|mesh-ancestor
15120925|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
15120926|NCT04476628|Budesonide|budesonide|mesh-list
15120927|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120928|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15120929|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
15120930|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120931|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120932|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15120933|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
15120934|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
15120935|NCT04476628|Hormones|hormones|mesh-ancestor
15120936|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15120937|NCT04476550|Lenograstim|lenograstim|mesh-list
15120938|NCT04476550|Sargramostim|sargramostim|mesh-list
15120939|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15120940|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
15120941|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177338|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177339|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15177340|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15177341|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15177342|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15177343|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177344|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177345|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177346|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15177347|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15177348|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15177349|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15177350|NCT03969017|Interferons|interferons|mesh-list
15177351|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177352|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
15177353|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177354|NCT03968835|Bacitracin|bacitracin|mesh-list
15177355|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15177356|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177357|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177358|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
15177359|NCT03968640|Vitamins|vitamins|mesh-ancestor
15177360|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
15177361|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177362|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
15177363|NCT03968588|Tacrolimus|tacrolimus|mesh-list
15177364|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15177365|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
15177366|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177367|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15177368|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177369|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177370|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15177371|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177372|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15177373|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
15177374|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177375|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177376|NCT03968861|Xenon|xenon|mesh-list
15177377|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15177378|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
15177379|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
15177380|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177381|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177382|NCT03968263|Hydrocodone|hydrocodone|mesh-list
15177383|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15177384|NCT03968263|Narcotics|narcotics|mesh-ancestor
15177385|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177386|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177387|NCT03968263|Analgesics|analgesics|mesh-ancestor
15177388|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
15177389|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177390|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
15177391|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
15177392|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15177393|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177394|NCT03968185|Analgesics|analgesics|mesh-list
15177395|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
15182298|NCT03923036|Aflibercept|aflibercept|mesh-list
14561703|NCT00002803|Vincristine|vincristine|mesh-list
15120942|NCT04476680|Vitamin D|vitamin d|mesh-list
15120943|NCT04476680|Vitamins|vitamins|mesh-ancestor
15120944|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
15120945|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120946|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15120947|NCT04476459|Apatinib|apatinib|mesh-list
15120948|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15120949|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15120950|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120951|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120952|NCT04476121|Aspirin|aspirin|mesh-list
15120953|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15120954|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15120955|NCT04476121|Analgesics|analgesics|mesh-ancestor
15120956|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
15120957|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120958|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120959|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120960|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120961|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15120962|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15120963|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120964|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15120965|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15120966|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120967|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
15120968|NCT04476173|Morphine|morphine|mesh-list
15120969|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
15120970|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15120971|NCT04476173|Narcotics|narcotics|mesh-ancestor
15120972|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15120973|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120974|NCT04476173|Analgesics|analgesics|mesh-ancestor
15120975|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
15120976|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120977|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15120978|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
15120979|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
15120980|NCT04476186|Acyclovir|acyclovir|mesh-list
15120981|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
15120982|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15120983|NCT04476069|Ibuprofen|ibuprofen|mesh-list
15120984|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15120985|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15120986|NCT04476069|Analgesics|analgesics|mesh-ancestor
15120987|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
15120988|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15120989|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15120990|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15120991|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15120992|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15120993|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15120994|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15120995|NCT04476199|Decitabine|decitabine|mesh-list
15120996|NCT04476199|Venetoclax|venetoclax|mesh-list
15120997|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15120998|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
15120999|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121000|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121001|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121002|NCT04475887|Iron|iron|mesh-list
15121003|NCT04475887|Trace Elements|trace elements|mesh-ancestor
15121004|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
15121005|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121006|NCT04475835|Heparin|heparin|mesh-list
15121007|NCT04475835|Bivalirudin|bivalirudin|mesh-list
15121008|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
15121009|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15121010|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15121011|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121012|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
15121013|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15121014|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
15121015|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121016|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
15121017|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
15121018|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121019|NCT04475276|Protective Agents|protective agents|mesh-ancestor
15121020|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121021|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
15121022|NCT04475276|Vitamins|vitamins|mesh-ancestor
15121023|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
15121024|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
15121025|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15121026|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
15121027|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121028|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
15121029|NCT04475614|Vitamins|vitamins|mesh-ancestor
15121030|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
15121031|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121032|NCT04475224|Mitogens|mitogens|mesh-list
15121033|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
15121034|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121035|NCT04475016|Paclitaxel|paclitaxel|mesh-list
15121036|NCT04475016|Ifosfamide|ifosfamide|mesh-list
15121037|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15121038|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
15121039|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15121040|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121041|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
15121042|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
15121043|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
15121044|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121045|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15121046|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
15121047|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15121048|NCT04475107|Artesunate|artesunate|mesh-list
15121049|NCT04475107|Pyronaridine|pyronaridine|mesh-list
15121050|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
15121051|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15121052|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15121053|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121054|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121055|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
15121056|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
15121057|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15121058|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
15121059|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
15121060|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15121061|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121062|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15121063|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121064|NCT04475120|Lactoferrin|lactoferrin|mesh-list
15121065|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121066|NCT04474899|Amlodipine|amlodipine|mesh-list
15121067|NCT04474899|Moxonidine|moxonidine|mesh-list
15121068|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15121069|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15121070|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121071|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121072|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15121073|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121074|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
15121075|NCT04475029|Morphine|morphine|mesh-list
15121076|NCT04475029|Methadone|methadone|mesh-list
15121077|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15121078|NCT04475029|Narcotics|narcotics|mesh-ancestor
15121079|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121080|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121081|NCT04475029|Analgesics|analgesics|mesh-ancestor
15121082|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
15121083|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121084|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
15121085|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
15121086|NCT04474938|Dexamethasone|dexamethasone|mesh-list
15121087|NCT04474938|Bortezomib|bortezomib|mesh-list
15121088|NCT04474938|Daratumumab|daratumumab|mesh-list
15121089|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121090|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
15121091|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
14811297|NCT00844727|Rofecoxib|rofecoxib|mesh-list
15121092|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121093|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121094|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15121095|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
15121096|NCT04474938|Hormones|hormones|mesh-ancestor
15121097|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121098|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15121099|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121100|NCT04474600|Propofol|propofol|mesh-list
15121101|NCT04474600|Desflurane|desflurane|mesh-list
15121102|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15121103|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121104|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121105|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15121106|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
15121107|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
15121108|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15177396|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177397|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177398|NCT03968146|Acetaminophen|acetaminophen|mesh-list
15177399|NCT03968146|Ketorolac|ketorolac|mesh-list
15177400|NCT03968146|Fentanyl|fentanyl|mesh-list
15177401|NCT03968146|Meperidine|meperidine|mesh-list
15177402|NCT03968146|Morphine|morphine|mesh-list
15177403|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15177404|NCT03968146|Narcotics|narcotics|mesh-ancestor
15177405|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177406|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177407|NCT03968146|Analgesics|analgesics|mesh-ancestor
15177408|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
15177409|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177410|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15177411|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15177412|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
15177413|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
15177414|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15177415|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
15177416|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15177417|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15177418|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15177419|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15177420|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177421|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177422|NCT03968224|Metformin|metformin|mesh-list
15177423|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
15177424|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15177425|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177426|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15177427|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177428|NCT03968237|Buprenorphine|buprenorphine|mesh-list
15177429|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15177430|NCT03968237|Naloxone|naloxone|mesh-list
15177431|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15177432|NCT03968237|Narcotics|narcotics|mesh-ancestor
15177433|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177434|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177435|NCT03968237|Analgesics|analgesics|mesh-ancestor
15177436|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
15177437|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177438|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15181839|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15181840|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15181841|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15181842|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
15181843|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181844|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181845|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181846|NCT03926754|Urological Agents|urological agents|mesh-ancestor
15181847|NCT03926559|Morphine|morphine|mesh-list
15181848|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15181849|NCT03926559|Narcotics|narcotics|mesh-ancestor
15181850|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181851|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181852|NCT03926559|Analgesics|analgesics|mesh-ancestor
15181853|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
15181854|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181855|NCT03926377|Clobetasol|clobetasol|mesh-list
15181856|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181857|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
15181858|NCT03926377|Hormones|hormones|mesh-ancestor
15181859|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121109|NCT04474457|Favipiravir|favipiravir|mesh-list
15121110|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
15121111|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121112|NCT04474327|Montelukast|montelukast|mesh-list
15121113|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15121114|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
15121115|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15121116|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
15121117|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121118|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121119|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15121120|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15121121|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121122|NCT04474366|Ropivacaine|ropivacaine|mesh-list
15121123|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
15121124|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
15121125|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121126|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121127|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
15121128|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121129|NCT04474262|Midodrine|midodrine|mesh-list
15121130|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
15121131|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
15121132|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121133|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121134|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15121135|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15121136|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15121137|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15121138|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
15121139|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121140|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121141|NCT04474288|Antibodies|antibodies|mesh-list
15121142|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
15121143|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121144|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
15121145|NCT04474093|Methamphetamine|methamphetamine|mesh-list
15121146|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15121147|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121148|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
15121149|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
15121150|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121151|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
15121152|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121153|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121154|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
15121155|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15121156|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15121157|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121158|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15121159|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
15121160|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15121161|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121162|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
15121163|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15121164|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121165|NCT04473989|Teriparatide|teriparatide|mesh-list
15121166|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15121167|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121168|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15121169|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
15121170|NCT04473911|Sirolimus|sirolimus|mesh-list
15121171|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
14561704|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561705|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
14561706|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561707|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561708|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561709|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
14561710|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561711|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561712|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561713|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15121172|NCT04473911|Melphalan|melphalan|mesh-list
15121173|NCT04473911|Fludarabine|fludarabine|mesh-list
15121174|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121175|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
15121176|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121177|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121178|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15121179|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
15121180|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121181|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121182|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15121183|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15121184|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15121185|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
15121186|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121187|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121188|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121189|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
15121190|NCT04473950|Naloxone|naloxone|mesh-list
15121191|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15121192|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121193|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
15121194|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121195|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
15121196|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15121197|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121198|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15121199|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
15121200|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121201|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121202|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121203|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121204|NCT04473820|Lidocaine|lidocaine|mesh-list
15121205|NCT04473820|Prilocaine|prilocaine|mesh-list
15121206|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15121207|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
15121208|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
15121209|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121210|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121211|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
15121212|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121213|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15121214|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15121215|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15121216|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121217|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121218|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15121219|NCT04473846|Anesthetics|anesthetics|mesh-list
15121220|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121221|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121222|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
15121223|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15121224|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121225|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15121226|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121227|NCT04473274|Pioglitazone|pioglitazone|mesh-list
15121228|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15121229|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121230|NCT04473261|Iodine|iodine|mesh-list
15121231|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
15121232|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15121233|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121234|NCT04473261|Trace Elements|trace elements|mesh-ancestor
15121235|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
15121236|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121237|NCT04473053|Nafamostat|nafamostat|mesh-list
15121238|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15121239|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15121240|NCT04473053|Analgesics|analgesics|mesh-ancestor
15121241|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
15121242|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121243|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121244|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121245|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121246|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
15121247|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
15121248|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121249|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121250|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15121251|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15121252|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15121253|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121254|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
15121255|NCT04473144|Urinastatin|urinastatin|mesh-list
15121256|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15121257|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15121258|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
15121259|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121260|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121261|NCT04472910|Folfirinox|folfirinox|mesh-list
15121262|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121263|NCT04472949|Carboplatin|carboplatin|mesh-list
15121264|NCT04472949|Etoposide|etoposide|mesh-list
15121265|NCT04472949|Durvalumab|durvalumab|mesh-list
15121266|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121267|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15121268|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15121269|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15121270|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121271|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121272|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15121273|NCT04472585|Ivermectin|ivermectin|mesh-list
15121274|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15121275|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121276|NCT04472806|Endostar protein|endostar protein|mesh-list
15121277|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15121278|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15121279|NCT04472806|Growth Substances|growth substances|mesh-ancestor
15121280|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121281|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
15121282|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177439|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
15177440|NCT03967964|Testosterone|testosterone|mesh-list
15177441|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
15177442|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
15177443|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15177444|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15177445|NCT03967964|Androgens|androgens|mesh-ancestor
15177446|NCT03967964|Hormones|hormones|mesh-ancestor
15177447|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177448|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177449|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15177450|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177451|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
15177452|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15177453|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
15177454|NCT03967977|Gemcitabine|gemcitabine|mesh-list
15177455|NCT03967977|Carboplatin|carboplatin|mesh-list
15177456|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177457|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15177458|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
15177459|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177460|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
15177461|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177462|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177463|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15177464|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
15177465|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177466|NCT03967886|Esomeprazole|esomeprazole|mesh-list
15177467|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15177468|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15177469|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15177470|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177471|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177472|NCT03968042|Thiamine|thiamine|mesh-list
15177473|NCT03968042|Edaravone|edaravone|mesh-list
15177474|NCT03968042|Mitogens|mitogens|mesh-list
15177475|NCT03968042|Vitamins|vitamins|mesh-ancestor
15177476|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
15177477|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121283|NCT04472689|Lidocaine|lidocaine|mesh-list
15121284|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
15121285|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
15121286|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121287|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121288|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
15121289|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121290|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15121291|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15121292|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15121293|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121294|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121295|NCT04472611|Colchicine|colchicine|mesh-list
15121296|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15121297|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15121298|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15121299|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
15121300|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121301|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15121302|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15121303|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121304|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
15121305|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121306|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
15121307|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
15121308|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
15121309|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121310|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
15121311|NCT04472481|Vitamin D|vitamin d|mesh-list
15121312|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15121313|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121314|NCT04472481|Vitamins|vitamins|mesh-ancestor
15121315|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
15121316|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15121317|NCT04471922|Rabeprazole|rabeprazole|mesh-list
15121318|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15121319|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15121320|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15121321|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121322|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121323|NCT04472000|Ascorbic Acid|ascorbic acid|mesh-list
15121324|NCT04472000|Vitamins|vitamins|mesh-ancestor
15121325|NCT04472000|Micronutrients|micronutrients|mesh-ancestor
15121326|NCT04472000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121327|NCT04472000|Antioxidants|antioxidants|mesh-ancestor
15121328|NCT04472000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121329|NCT04472000|Protective Agents|protective agents|mesh-ancestor
15121330|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15121331|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121332|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121333|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
15121334|NCT04471441|Everolimus|everolimus|mesh-list
15121335|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121336|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121337|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
15121338|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121339|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15121340|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15121341|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
15121342|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121343|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121344|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121345|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121346|NCT04471415|Atezolizumab|atezolizumab|mesh-list
15121347|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121348|NCT04470908|Rifabutin|rifabutin|mesh-list
15121349|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
15121350|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121351|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15121352|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121353|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121354|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121355|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121356|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15177478|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
15121357|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
15121358|NCT04471246|Cephalexin|cephalexin|mesh-list
15121359|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121360|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121361|NCT04470973|Amikacin|amikacin|mesh-list
15121362|NCT04470973|Cefuroxime|cefuroxime|mesh-list
15121363|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
15121364|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121365|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121366|NCT04470843|Acetazolamide|acetazolamide|mesh-list
15121367|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
15121368|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15121369|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121370|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121371|NCT04470843|Diuretics|diuretics|mesh-ancestor
15121372|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
15121373|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121374|NCT04470479|Pilocarpine|pilocarpine|mesh-list
15121375|NCT04470479|Miotics|miotics|mesh-ancestor
15121376|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
15121377|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121378|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121379|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15121380|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15121381|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
15121382|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121383|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121384|NCT04470752|Capsaicin|capsaicin|mesh-list
15121385|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15121386|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
15121387|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
15121388|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
15121389|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121390|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121391|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15121392|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15121393|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121394|NCT04470531|Renal Agents|renal agents|mesh-ancestor
15121395|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121396|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
15121397|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15121398|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15121399|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
15121400|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15121401|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15121402|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121403|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
15121404|NCT04470557|Coagulants|coagulants|mesh-ancestor
15121405|NCT04470414|Antibodies|antibodies|mesh-list
15121406|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
15121407|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
15121408|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121409|NCT04470544|Camostat|camostat|mesh-list
15121410|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
15121411|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121412|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121413|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15121414|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15121415|NCT04470791|Antivenins|antivenins|mesh-list
15121416|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
15121417|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121418|NCT04470804|Cyclosporine|cyclosporine|mesh-list
15121419|NCT04470804|Sirolimus|sirolimus|mesh-list
15121420|NCT04470804|Cyclosporins|cyclosporins|mesh-list
15121421|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121422|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121423|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121424|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
15121425|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121426|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
15121427|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121428|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
15121429|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121430|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15121431|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15121432|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15121433|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121434|NCT04470609|Vaccines|vaccines|mesh-list
15121435|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
15121436|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121437|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15121438|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15121439|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15121440|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121441|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121442|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
15121443|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121444|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121445|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15121446|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121447|NCT04470076|Gemcitabine|gemcitabine|mesh-list
15121448|NCT04470076|Carboplatin|carboplatin|mesh-list
15121449|NCT04470076|Pemetrexed|pemetrexed|mesh-list
15121450|NCT04470076|Afatinib|afatinib|mesh-list
15121451|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121452|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15121453|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
15121454|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121455|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
15121456|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121457|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121458|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121459|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
15121460|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121461|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15121462|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15121463|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15177479|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177480|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
15177481|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15177482|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
15177483|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15177484|NCT03968042|Protective Agents|protective agents|mesh-ancestor
15177485|NCT03967847|Ketorolac|ketorolac|mesh-list
15177486|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15177487|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15177488|NCT03967847|Analgesics|analgesics|mesh-ancestor
15177489|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
15177490|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177491|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177492|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15177493|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15177494|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15177495|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177496|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177497|NCT03967938|Olaparib|olaparib|mesh-list
15177498|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15177499|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177500|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177501|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177502|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
15177503|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15177504|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
15177505|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177506|NCT03967665|Expectorants|expectorants|mesh-ancestor
15177507|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
15177508|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15177509|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
15177510|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177511|NCT03967665|Protective Agents|protective agents|mesh-ancestor
15177512|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177513|NCT03967665|Antidotes|antidotes|mesh-ancestor
15177514|NCT03967392|Lidocaine|lidocaine|mesh-list
15177515|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
15177516|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
15177517|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177518|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177519|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
15177520|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177521|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15177522|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15177523|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15121464|NCT04470310|Pioglitazone|pioglitazone|mesh-list
15121465|NCT04470310|Glimepiride|glimepiride|mesh-list
15121466|NCT04470310|Alogliptin|alogliptin|mesh-list
15121467|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15121468|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121469|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15121470|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121471|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
15121472|NCT04470310|Incretins|incretins|mesh-ancestor
15121473|NCT04470310|Hormones|hormones|mesh-ancestor
15121474|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121475|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15121476|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
15121477|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121478|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121479|NCT04470115|Anesthetics|anesthetics|mesh-list
15121480|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121481|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121482|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
15121483|NCT04469868|Narcotics|narcotics|mesh-ancestor
15121484|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121485|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121486|NCT04469868|Analgesics|analgesics|mesh-ancestor
15121487|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
15121488|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121489|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
15121490|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15121491|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121492|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121493|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15121494|NCT04470050|Analgesics|analgesics|mesh-ancestor
15121495|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
15121496|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121497|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15121498|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15121499|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15121500|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
15121501|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121502|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121503|NCT04470128|Fentanyl|fentanyl|mesh-list
15121504|NCT04470128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15121505|NCT04470128|Narcotics|narcotics|mesh-ancestor
15121506|NCT04470128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121507|NCT04470128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121508|NCT04470128|Analgesics|analgesics|mesh-ancestor
15121509|NCT04470128|Sensory System Agents|sensory system agents|mesh-ancestor
15121510|NCT04470128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121511|NCT04470128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15121512|NCT04470128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15121513|NCT04470128|Anesthetics, General|anesthetics, general|mesh-ancestor
15121514|NCT04470128|Anesthetics|anesthetics|mesh-ancestor
15121515|NCT04469829|Methotrexate|methotrexate|mesh-list
15121516|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15121517|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
15121518|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15121519|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121520|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15121521|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
15121522|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121523|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121524|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
15121525|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121526|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15121527|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121528|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
15121529|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121530|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15121531|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
15121532|NCT04469777|Hematinics|hematinics|mesh-ancestor
15121533|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
15121534|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15121535|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15121536|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15121537|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121538|NCT04469413|Acetaminophen|acetaminophen|mesh-list
15121539|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15121540|NCT04469413|Analgesics|analgesics|mesh-ancestor
15121541|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
15121542|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121543|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121544|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
15121545|NCT04469283|Caffeine|caffeine|mesh-list
15121546|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15121547|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121548|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15121549|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121550|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121551|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15121552|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15121553|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
15121554|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121555|NCT04469010|Ascorbic Acid|ascorbic acid|mesh-list
15121556|NCT04469010|Iron|iron|mesh-list
15121557|NCT04469010|Chelating Agents|chelating agents|mesh-list
15121558|NCT04469010|Vitamins|vitamins|mesh-ancestor
15121559|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
15121560|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121561|NCT04469010|Trace Elements|trace elements|mesh-ancestor
15121562|NCT04469010|Antioxidants|antioxidants|mesh-ancestor
15121563|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121564|NCT04469010|Protective Agents|protective agents|mesh-ancestor
15121565|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
15121566|NCT04469114|Tofacitinib|tofacitinib|mesh-list
15121567|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15121568|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121569|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121570|NCT04469062|Mirikizumab|mirikizumab|mesh-list
15121571|NCT04469062|Vedolizumab|vedolizumab|mesh-list
15121572|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15121573|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15121574|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15121575|NCT04469062|Analgesics|analgesics|mesh-ancestor
15121576|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
15121577|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121578|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121579|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121580|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121581|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15121582|NCT04468568|Terbutaline|terbutaline|mesh-list
15121583|NCT04468568|Atosiban|atosiban|mesh-list
15121584|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15121585|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
15121586|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121587|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121588|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15121589|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
15121590|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
15121591|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
15121592|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15121593|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15121594|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15121595|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15121596|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
15121597|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121598|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121599|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
15121600|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121601|NCT04468711|Vitamin D|vitamin d|mesh-list
15121602|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
15121603|NCT04468711|Vitamins|vitamins|mesh-ancestor
15121604|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
15121605|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121606|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15121607|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121608|NCT04468685|Ondansetron|ondansetron|mesh-list
15121609|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
15121610|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
15121611|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121612|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121613|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15121614|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
15121615|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
15121616|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15121617|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
15121618|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121619|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121620|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15121621|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15121622|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121623|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15121624|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15121625|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
15121626|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121627|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
15121628|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
15121629|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
15121630|NCT04468139|Ascorbic Acid|ascorbic acid|mesh-list
15121631|NCT04468139|Quercetin|quercetin|mesh-list
15121632|NCT04468139|Vitamins|vitamins|mesh-ancestor
15121633|NCT04468139|Micronutrients|micronutrients|mesh-ancestor
15121634|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121635|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
15121636|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121637|NCT04468139|Protective Agents|protective agents|mesh-ancestor
15121638|NCT04468542|Triamcinolone|triamcinolone|mesh-list
15121639|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15121640|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15121641|NCT04468542|Bupivacaine|bupivacaine|mesh-list
15121642|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15121643|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
15121644|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
15121645|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121646|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121647|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
15121648|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121649|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121650|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
15121651|NCT04468542|Hormones|hormones|mesh-ancestor
15121652|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121653|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121654|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
15121655|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121656|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121657|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15121658|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
15121659|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15121660|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
15121661|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121662|NCT04468438|Estrogens|estrogens|mesh-list
15121663|NCT04468438|Hormones|hormones|mesh-ancestor
15121664|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121665|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121666|NCT04468282|Vigabatrin|vigabatrin|mesh-list
15121667|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
15121668|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121669|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121670|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
15121671|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121672|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121673|NCT04467957|Xenon|xenon|mesh-list
15121674|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15121675|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
15121676|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
15121677|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121678|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177524|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15177525|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177526|NCT03967054|Ivermectin|ivermectin|mesh-list
15177527|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15177528|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177529|NCT03967171|Oxytocin|oxytocin|mesh-list
15177530|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
15177531|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15177532|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177533|NCT03967496|Metformin|metformin|mesh-list
15177534|NCT03967496|Amlodipine|amlodipine|mesh-list
15177535|NCT03967496|Lisinopril|lisinopril|mesh-list
15177536|NCT03967496|Bisoprolol|bisoprolol|mesh-list
15177537|NCT03967496|Hydralazine|hydralazine|mesh-list
15121679|NCT04467918|Cannabidiol|cannabidiol|mesh-list
15121680|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
15121681|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
15121682|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15121683|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15121684|NCT04467892|Prednisolone|prednisolone|mesh-list
15121685|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
15121686|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15121687|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
15121688|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121689|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
15121690|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
15121691|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121692|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121693|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15121694|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
15121695|NCT04467892|Hormones|hormones|mesh-ancestor
15121696|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121697|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15121698|NCT04467892|Protective Agents|protective agents|mesh-ancestor
15121699|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15121700|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121701|NCT04467931|Losartan|losartan|mesh-list
15121702|NCT04467931|Timolol|timolol|mesh-list
15121703|NCT04467931|Propranolol|propranolol|mesh-list
15121704|NCT04467931|Metoprolol|metoprolol|mesh-list
15121705|NCT04467931|Atenolol|atenolol|mesh-list
15121706|NCT04467931|Verapamil|verapamil|mesh-list
15121707|NCT04467931|Felodipine|felodipine|mesh-list
15121708|NCT04467931|Nadolol|nadolol|mesh-list
15121709|NCT04467931|Acebutolol|acebutolol|mesh-list
15121710|NCT04467931|Amlodipine|amlodipine|mesh-list
15121711|NCT04467931|Valsartan|valsartan|mesh-list
15121712|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15121713|NCT04467931|Telmisartan|telmisartan|mesh-list
15121714|NCT04467931|Clonidine|clonidine|mesh-list
15121715|NCT04467931|Carvedilol|carvedilol|mesh-list
15121716|NCT04467931|Candesartan|candesartan|mesh-list
15121717|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
15121718|NCT04467931|Ramipril|ramipril|mesh-list
15121719|NCT04467931|Olmesartan|olmesartan|mesh-list
15121720|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15121721|NCT04467931|Enalapril|enalapril|mesh-list
15121722|NCT04467931|Enalaprilat|enalaprilat|mesh-list
15121723|NCT04467931|Lisinopril|lisinopril|mesh-list
15121724|NCT04467931|Irbesartan|irbesartan|mesh-list
15121725|NCT04467931|Eplerenone|eplerenone|mesh-list
15121726|NCT04467931|Nebivolol|nebivolol|mesh-list
15121727|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
15121728|NCT04467931|Diltiazem|diltiazem|mesh-list
15121729|NCT04467931|Bisoprolol|bisoprolol|mesh-list
15121730|NCT04467931|Perindopril|perindopril|mesh-list
15121731|NCT04467931|Guanfacine|guanfacine|mesh-list
15121732|NCT04467931|Minoxidil|minoxidil|mesh-list
15121733|NCT04467931|Prazosin|prazosin|mesh-list
15121734|NCT04467931|Doxazosin|doxazosin|mesh-list
15121735|NCT04467931|Benazepril|benazepril|mesh-list
15121736|NCT04467931|Hydralazine|hydralazine|mesh-list
15121737|NCT04467931|Captopril|captopril|mesh-list
15121738|NCT04467931|Labetalol|labetalol|mesh-list
15121739|NCT04467931|Indapamide|indapamide|mesh-list
15121740|NCT04467931|Nicardipine|nicardipine|mesh-list
15121741|NCT04467931|Quinapril|quinapril|mesh-list
15121742|NCT04467931|Trandolapril|trandolapril|mesh-list
15121743|NCT04467931|Metolazone|metolazone|mesh-list
15121744|NCT04467931|Torsemide|torsemide|mesh-list
15121745|NCT04467931|Fosinopril|fosinopril|mesh-list
15121746|NCT04467931|Methyldopa|methyldopa|mesh-list
15121747|NCT04467931|Isradipine|isradipine|mesh-list
15121748|NCT04467931|Eprosartan|eprosartan|mesh-list
15121749|NCT04467931|Pindolol|pindolol|mesh-list
15121750|NCT04467931|Moexipril|moexipril|mesh-list
15121751|NCT04467931|Betaxolol|betaxolol|mesh-list
15121752|NCT04467931|Reserpine|reserpine|mesh-list
15121753|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
15121754|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
15121755|NCT04467931|Guanabenz|guanabenz|mesh-list
15121756|NCT04467931|Nisoldipine|nisoldipine|mesh-list
15121757|NCT04467931|Penbutolol|penbutolol|mesh-list
15121758|NCT04467931|Nifedipine|nifedipine|mesh-list
15121759|NCT04467931|Amiloride|amiloride|mesh-list
15121760|NCT04467931|Triamterene|triamterene|mesh-list
15121761|NCT04467931|Furosemide|furosemide|mesh-list
15121762|NCT04467931|Spironolactone|spironolactone|mesh-list
15121763|NCT04467931|Bumetanide|bumetanide|mesh-list
15121764|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
15121765|NCT04467931|Terazosin|terazosin|mesh-list
15121766|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
15121767|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15121768|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15121769|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15121770|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121771|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121772|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15121773|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121774|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
15121775|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15121776|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15121777|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15121778|NCT04467931|Diuretics|diuretics|mesh-ancestor
15121779|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
15121780|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15121781|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15121782|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15121783|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
15121784|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121785|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
15121786|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
15121787|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121788|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15121789|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15121790|NCT04467931|Analgesics|analgesics|mesh-ancestor
15121791|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
15121792|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15121793|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15121794|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15121795|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15121796|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
15121797|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121798|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15121799|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
15121800|NCT04467931|Protective Agents|protective agents|mesh-ancestor
15121801|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15121802|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15121803|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
15121804|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121805|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
15121806|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15121807|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15121808|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15121809|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15121810|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15121811|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15121812|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15121813|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
15121814|NCT04467931|Urological Agents|urological agents|mesh-ancestor
15121815|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
15121816|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15121817|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
15121818|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15121819|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15121820|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121821|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15121822|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15121823|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15121824|NCT04467983|Denosumab|denosumab|mesh-list
15121825|NCT04467983|Abaloparatide|abaloparatide|mesh-list
15121826|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15121827|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121828|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
15121829|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
15121830|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
15121831|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121832|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121833|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
15121834|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121835|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15121836|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
15121837|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15121838|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15121839|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15121840|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121841|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121842|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
15121843|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121844|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121845|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15121846|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121847|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121848|NCT04467281|Daratumumab|daratumumab|mesh-list
15121849|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121850|NCT04467346|Temozolomide|temozolomide|mesh-list
15121851|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15121852|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
15121853|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121854|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121855|NCT04467125|Lidocaine|lidocaine|mesh-list
15121856|NCT04467125|Prilocaine|prilocaine|mesh-list
15121857|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15121858|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
15121859|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
15121860|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121861|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121862|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
15121863|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121864|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15121865|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15121866|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15121867|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15121868|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121869|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15121870|NCT04467086|Propranolol|propranolol|mesh-list
15121871|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15121872|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15121873|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
15121874|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121875|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121876|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121877|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15121878|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15121879|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
15121880|NCT04466904|Dulaglutide|dulaglutide|mesh-list
15121881|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15121882|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121883|NCT04466917|Paclitaxel|paclitaxel|mesh-list
15121884|NCT04466917|Bevacizumab|bevacizumab|mesh-list
15121885|NCT04466917|Carboplatin|carboplatin|mesh-list
15121886|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15121887|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121888|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
15121889|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
15121890|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
15121891|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121892|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15121893|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15121894|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15121895|NCT04466917|Growth Substances|growth substances|mesh-ancestor
15121896|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121897|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
15121898|NCT04466943|Rocuronium|rocuronium|mesh-list
15121899|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121900|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15121901|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15121902|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15177538|NCT03967496|Anesthetics|anesthetics|mesh-list
15121903|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121904|NCT04466670|Aspirin|aspirin|mesh-list
15121905|NCT04466670|Heparin|heparin|mesh-list
15121906|NCT04466670|Calcium heparin|calcium heparin|mesh-list
15121907|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15121908|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15121909|NCT04466670|Analgesics|analgesics|mesh-ancestor
15121910|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
15121911|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121912|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121913|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121914|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121915|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15121916|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15121917|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121918|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15121919|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15121920|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121921|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
15121922|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
15121923|NCT04466436|Tryptophan|tryptophan|mesh-list
15121924|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15121925|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
15121926|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15121927|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
15121928|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121929|NCT04466046|Midazolam|midazolam|mesh-list
15121930|NCT04466046|Palonosetron|palonosetron|mesh-list
15121931|NCT04466046|Ramosetron|ramosetron|mesh-list
15121932|NCT04466046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15121933|NCT04466046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15121934|NCT04466046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15121935|NCT04466046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121936|NCT04466046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15121937|NCT04466046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15121938|NCT04466046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15121939|NCT04466046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15121940|NCT04466046|Anesthetics, General|anesthetics, general|mesh-ancestor
15121941|NCT04466046|Anesthetics|anesthetics|mesh-ancestor
15121942|NCT04466046|GABA Modulators|gaba modulators|mesh-ancestor
15121943|NCT04466046|GABA Agents|gaba agents|mesh-ancestor
15121944|NCT04466046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121945|NCT04466046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121946|NCT04466046|Antiemetics|antiemetics|mesh-ancestor
15121947|NCT04466046|Autonomic Agents|autonomic agents|mesh-ancestor
15121948|NCT04466046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121949|NCT04466046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15121950|NCT04466046|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15121951|NCT04466046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15121952|NCT04466046|Serotonin Agents|serotonin agents|mesh-ancestor
15121953|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
15121954|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
15121955|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121956|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
15121957|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
15121958|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15121959|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15121960|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15121961|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15121962|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121963|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15121964|NCT04466254|Cetuximab|cetuximab|mesh-list
15121965|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15121966|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15121967|NCT04466176|Fluticasone|fluticasone|mesh-list
15121968|NCT04466176|Xhance|xhance|mesh-list
15121969|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15121970|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15121971|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15121972|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15121973|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
15121974|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15121975|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15121976|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15121977|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
15121978|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
15121979|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15121980|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15121981|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15121982|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15121983|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
15121984|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15121985|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121986|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
15121987|NCT04466176|Hormones|hormones|mesh-ancestor
15121988|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15121989|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
15121990|NCT04466241|Ritonavir|ritonavir|mesh-list
15121991|NCT04466241|Lopinavir|lopinavir|mesh-list
15121992|NCT04466241|Telmisartan|telmisartan|mesh-list
15121993|NCT04466241|Atorvastatin|atorvastatin|mesh-list
15121994|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15121995|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15121996|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
15121997|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15121998|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15121999|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15122000|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122001|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15122002|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15122003|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
15122004|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15122005|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15122006|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
15122007|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122008|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15122009|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15122010|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15122011|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15122012|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15122013|NCT04465968|Durvalumab|durvalumab|mesh-list
15122014|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15122015|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122016|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122017|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
15122018|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122019|NCT04466085|Vaccines|vaccines|mesh-list
15122020|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
15122021|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122022|NCT04465916|Tenofovir|tenofovir|mesh-list
15122023|NCT04465916|Entecavir|entecavir|mesh-list
15122024|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
15122025|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122026|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15122027|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15122028|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122029|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122030|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15122031|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15122032|NCT04465942|Paclitaxel|paclitaxel|mesh-list
15122033|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
15122034|NCT04465942|Nivolumab|nivolumab|mesh-list
15122035|NCT04465942|Pemetrexed|pemetrexed|mesh-list
15122036|NCT04465942|Atezolizumab|atezolizumab|mesh-list
15122037|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15122038|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122039|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
15122040|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
15122041|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
15122042|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122043|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122044|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15122045|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122046|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15122047|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15177539|NCT03967496|Atorvastatin|atorvastatin|mesh-list
15177540|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15177541|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177542|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177543|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15177544|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15177545|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
15122048|NCT04465864|Dexamethasone|dexamethasone|mesh-list
15122049|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122050|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
15122051|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
15122052|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122053|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122054|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15122055|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
15122056|NCT04465864|Hormones|hormones|mesh-ancestor
15122057|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122058|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15122059|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122060|NCT04465734|Sorafenib|sorafenib|mesh-list
15122061|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122062|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15122063|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122064|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122065|NCT04465773|Remifentanil|remifentanil|mesh-list
15122066|NCT04465773|Propofol|propofol|mesh-list
15122067|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
15122068|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122069|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122070|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15122071|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15122072|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
15122073|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15122074|NCT04465773|Narcotics|narcotics|mesh-ancestor
15122075|NCT04465773|Analgesics|analgesics|mesh-ancestor
15122076|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
15122077|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122078|NCT04465643|Nivolumab|nivolumab|mesh-list
15122079|NCT04465643|Ipilimumab|ipilimumab|mesh-list
15122080|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122081|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122082|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15122083|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122084|NCT04465500|Androgens|androgens|mesh-list
15122085|NCT04465500|Hormones|hormones|mesh-ancestor
15122086|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122087|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122088|NCT04465695|Interferons|interferons|mesh-list
15122089|NCT04465695|Interferon-beta|interferon-beta|mesh-list
15122090|NCT04465695|Clofazimine|clofazimine|mesh-list
15122091|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
15122092|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122093|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
15122094|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122095|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
15122096|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122097|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15122098|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122099|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
15122100|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122101|NCT04465851|Curcumin|curcumin|mesh-list
15122102|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15122103|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15122104|NCT04465851|Analgesics|analgesics|mesh-ancestor
15122105|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
15122106|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122107|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122108|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122109|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122110|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122111|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122112|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122113|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
15122114|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
15122115|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122116|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
15122117|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
15122118|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15122119|NCT04465123|Spironolactone|spironolactone|mesh-list
15122120|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15122121|NCT04465123|Diuretics|diuretics|mesh-ancestor
15122122|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
15122123|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182299|NCT03923036|Capecitabine|capecitabine|mesh-list
15122124|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15122125|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122126|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122127|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15122128|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
15122129|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122130|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15122131|NCT04465357|Erenumab|erenumab|mesh-list
15122132|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15122133|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122134|NCT04465357|Analgesics|analgesics|mesh-ancestor
15122135|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
15122136|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122137|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122138|NCT04465318|Nicotine|nicotine|mesh-list
15122139|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15122140|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
15122141|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122142|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122143|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15122144|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15122145|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
15122146|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122147|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122148|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
15122149|NCT04465175|Analgesics|analgesics|mesh-ancestor
15122150|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
15122151|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122152|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122153|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
15122154|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122155|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15122156|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
15122157|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15122158|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122159|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122160|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15122161|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
15122162|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15122163|NCT04465396|Teduglutide|teduglutide|mesh-list
15122164|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15122165|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15122166|NCT04465396|Protective Agents|protective agents|mesh-ancestor
15122167|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122168|NCT04465383|Propofol|propofol|mesh-list
15122169|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15122170|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122171|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122172|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15122173|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
15122174|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
15122175|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15122176|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
15122177|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15122178|NCT04464967|Trastuzumab|trastuzumab|mesh-list
15122179|NCT04464967|Cetuximab|cetuximab|mesh-list
15122180|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122181|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122182|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
15122183|NCT04464759|Nivolumab|nivolumab|mesh-list
15122184|NCT04464759|Ipilimumab|ipilimumab|mesh-list
15122185|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122186|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122187|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15122188|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122189|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
15122190|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122191|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122192|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122193|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122194|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122195|NCT04464694|Ranibizumab|ranibizumab|mesh-list
15122196|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15122197|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15122198|NCT04464694|Growth Substances|growth substances|mesh-ancestor
15122199|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122200|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
15122201|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122202|NCT04464811|Furosemide|furosemide|mesh-list
15122203|NCT04464811|Diuretics|diuretics|mesh-ancestor
15122204|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
15122205|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122206|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15122207|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122208|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122209|NCT04465097|Exemestane|exemestane|mesh-list
15122210|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122211|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15122212|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15122213|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122214|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122215|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15122216|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
15122217|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122218|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122219|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
15122220|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15122221|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122222|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
15122223|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122224|NCT04465110|Protective Agents|protective agents|mesh-ancestor
15122225|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122226|NCT04464850|Iron|iron|mesh-list
15122227|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
15122228|NCT04464850|Folic Acid|folic acid|mesh-list
15122229|NCT04464850|Trace Elements|trace elements|mesh-ancestor
15122230|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
15122231|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122232|NCT04464850|Hematinics|hematinics|mesh-ancestor
15122233|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
15122234|NCT04464850|Vitamins|vitamins|mesh-ancestor
15122235|NCT04464863|Metronidazole|metronidazole|mesh-list
15122236|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122237|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122238|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122239|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122240|NCT04464629|Prednisolone|prednisolone|mesh-list
15122241|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15122242|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
15122243|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15122244|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
15122245|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15122246|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
15122247|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122248|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
15122249|NCT04464629|Hormones|hormones|mesh-ancestor
15122250|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122251|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122252|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15122253|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122254|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
15122255|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
15122256|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122257|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15122258|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15122259|NCT04464629|Protective Agents|protective agents|mesh-ancestor
15122260|NCT04464512|Sufentanil|sufentanil|mesh-list
15122261|NCT04464512|Buprenorphine|buprenorphine|mesh-list
15122262|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15122263|NCT04464512|Narcotics|narcotics|mesh-ancestor
15122264|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122265|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122266|NCT04464512|Analgesics|analgesics|mesh-ancestor
15122267|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
15122268|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122269|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15122270|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15122271|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15122272|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
15122273|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
15122274|NCT04464642|Methotrexate|methotrexate|mesh-list
15122275|NCT04464642|Tofacitinib|tofacitinib|mesh-list
15122276|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15122277|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
15122278|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15122279|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122280|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15122281|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
15122282|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122283|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122284|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
15122285|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122286|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15122287|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15122288|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
15122289|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122290|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15122291|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15122292|NCT04464616|Anesthetics|anesthetics|mesh-list
15122293|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122294|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122295|NCT04464135|Acetic Acid|acetic acid|mesh-list
15122296|NCT04464135|Retinol acetate|retinol acetate|mesh-list
15122297|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122298|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122299|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15122300|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
15122301|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122302|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15122303|NCT04464135|Protective Agents|protective agents|mesh-ancestor
15122304|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122305|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
15122306|NCT04464005|Analgesics|analgesics|mesh-ancestor
15122307|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
15122308|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122309|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122310|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
15122311|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122312|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15122313|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
15122314|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15122315|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122316|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122317|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15122318|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
15122319|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15122320|NCT04464122|Somatostatin|somatostatin|mesh-list
15122321|NCT04464122|Hormones|hormones|mesh-ancestor
15122322|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122323|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122324|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
15122325|NCT04463875|Riboflavin|riboflavin|mesh-list
15122326|NCT04463875|Ubiquinone|ubiquinone|mesh-list
15122327|NCT04463875|Andrographolide|andrographolide|mesh-list
14269566|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269567|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14269568|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269569|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122328|NCT04463875|Vitamins|vitamins|mesh-ancestor
15122329|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
15122330|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122331|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
15122332|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15122333|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
15122334|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122335|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15122336|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15122337|NCT04463875|Analgesics|analgesics|mesh-ancestor
15122338|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
15122339|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122340|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122341|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122342|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122343|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122344|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
15122345|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15122346|NCT04463784|Efavirenz|efavirenz|mesh-list
15122347|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15122348|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15122349|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122350|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122351|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
15122352|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122353|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15122354|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15122355|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15122356|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15122357|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15122358|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15177546|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177547|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15177548|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15177549|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177550|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15177551|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15177552|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15177553|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15177554|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
15177555|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15177556|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
15177557|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15177558|NCT03967496|Protective Agents|protective agents|mesh-ancestor
15177559|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
15177560|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
15177561|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177562|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15177563|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15177564|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15177565|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
15177566|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177567|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15177568|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15177569|NCT03967327|Morphine|morphine|mesh-list
15177570|NCT03967327|Buprenorphine|buprenorphine|mesh-list
15177571|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15177572|NCT03967327|Narcotics|narcotics|mesh-ancestor
15177573|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177574|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177575|NCT03967327|Analgesics|analgesics|mesh-ancestor
15177576|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
15177577|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177578|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15177579|NCT03967288|Bupivacaine|bupivacaine|mesh-list
15177580|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
15177581|NCT03967288|Procaine|procaine|mesh-list
15177582|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
15177583|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
15177584|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177585|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177586|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
15177587|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177588|NCT03967197|Lidocaine|lidocaine|mesh-list
15177589|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
15177590|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
15177591|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177592|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177593|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
15177594|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177595|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15177596|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15177597|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15177598|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15177599|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177600|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15177601|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14269570|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15122359|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
15122360|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15122361|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15122362|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122363|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
15122364|NCT04463966|Coagulants|coagulants|mesh-ancestor
15122365|NCT04463953|Dexamethasone|dexamethasone|mesh-list
15122366|NCT04463953|Ixazomib|ixazomib|mesh-list
15122367|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
15122368|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122369|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
15122370|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
15122371|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122372|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122373|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15122374|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
15122375|NCT04463953|Hormones|hormones|mesh-ancestor
15122376|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122377|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15122378|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122379|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
15122380|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122381|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122382|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15122383|NCT04463901|Mitomycins|mitomycins|mesh-list
15122384|NCT04463901|Mitomycin|mitomycin|mesh-list
15122385|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15122386|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122387|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
15122388|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122389|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15122390|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122391|NCT04463368|Nivolumab|nivolumab|mesh-list
15122392|NCT04463368|Ipilimumab|ipilimumab|mesh-list
15122393|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122394|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122395|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15122396|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122397|NCT04463615|Leflunomide|leflunomide|mesh-list
15122398|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122399|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122400|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15122401|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
15122402|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122403|NCT04463459|Vitamins|vitamins|mesh-list
15122404|NCT04463459|Ascorbic Acid|ascorbic acid|mesh-list
15122405|NCT04463459|Vitamin E|vitamin e|mesh-list
15122406|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
15122407|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122408|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
15122409|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122410|NCT04463459|Protective Agents|protective agents|mesh-ancestor
15122411|NCT04463342|Methamphetamine|methamphetamine|mesh-list
15122412|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15122413|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122414|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
15122415|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
15122416|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122417|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
15122418|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122419|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122420|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
15122421|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15122422|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15122423|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122424|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15122425|NCT04463030|Vitamins|vitamins|mesh-list
15122426|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
15122427|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
15122428|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122429|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
15122430|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122431|NCT04463030|Protective Agents|protective agents|mesh-ancestor
15122432|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
15122433|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122434|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122435|NCT04463056|Eculizumab|eculizumab|mesh-list
15122436|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15122437|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15122438|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
15122439|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122440|NCT04462939|Micronutrients|micronutrients|mesh-list
15122441|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122442|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15122443|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122444|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
15122445|NCT04462796|Cathartics|cathartics|mesh-ancestor
15122446|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15122447|NCT04462588|Metronidazole|metronidazole|mesh-list
15122448|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122449|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122450|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122451|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122452|NCT04462614|Heparin|heparin|mesh-list
15122453|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
15122454|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15122455|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15122456|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122457|NCT04462822|Fluticasone|fluticasone|mesh-list
15122458|NCT04462822|Xhance|xhance|mesh-list
15122459|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15122460|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15122461|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122462|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15122463|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
15122464|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122465|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122466|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15122467|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
15122468|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
15122469|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15122470|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15122471|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15122472|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15122473|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
15122474|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122475|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122476|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
15122477|NCT04462822|Hormones|hormones|mesh-ancestor
15122478|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122479|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
15122480|NCT04462809|Talazoparib|talazoparib|mesh-list
15122481|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15122482|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122483|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122484|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122485|NCT04462666|Etoricoxib|etoricoxib|mesh-list
15122486|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15122487|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15122488|NCT04462666|Analgesics|analgesics|mesh-ancestor
15122489|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
15122490|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122491|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122492|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122493|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122494|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15122495|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15122496|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122497|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122498|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
15122499|NCT04462250|Narcotics|narcotics|mesh-ancestor
15122500|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122501|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122502|NCT04462250|Analgesics|analgesics|mesh-ancestor
15122503|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
15122504|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122505|NCT04462627|Antibodies|antibodies|mesh-list
15122506|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
15122507|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122508|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
15122509|NCT04462406|Nivolumab|nivolumab|mesh-list
15122510|NCT04462406|Ipilimumab|ipilimumab|mesh-list
15122511|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122512|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122513|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15122514|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122515|NCT04462315|Cobalt|cobalt|mesh-list
15122516|NCT04462315|Chromium|chromium|mesh-list
15122517|NCT04462315|Everolimus|everolimus|mesh-list
15122518|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122519|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15122520|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
15122521|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122522|NCT04462315|Trace Elements|trace elements|mesh-ancestor
15122523|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
15122524|NCT04462276|Atezolizumab|atezolizumab|mesh-list
15122525|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122526|NCT04462523|Prednisolone|prednisolone|mesh-list
15122527|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122528|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
15122529|NCT04462523|Hormones|hormones|mesh-ancestor
15122530|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122531|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122532|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15122533|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122534|NCT04462094|Ketamine|ketamine|mesh-list
15122535|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
15122536|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122537|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122538|NCT04462094|Analgesics|analgesics|mesh-ancestor
15122539|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
15122540|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122541|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15122542|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15122543|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
15122544|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15122545|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15122546|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122547|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122548|NCT04462003|Enoxaparin|enoxaparin|mesh-list
15122549|NCT04462003|Apixaban|apixaban|mesh-list
15122550|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
15122551|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15122552|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15122553|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122554|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15122555|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
15122556|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15122557|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
15122558|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177602|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177603|NCT03966560|Timolol|timolol|mesh-list
15177604|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15177605|NCT03966560|Bimatoprost|bimatoprost|mesh-list
15177606|NCT03966560|Travoprost|travoprost|mesh-list
15177607|NCT03966560|Dorzolamide|dorzolamide|mesh-list
15177608|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15177609|NCT03966560|Latanoprost|latanoprost|mesh-list
15177610|NCT03966560|Brinzolamide|brinzolamide|mesh-list
15177611|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15177612|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15177613|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15177614|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
15177615|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177616|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177617|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177618|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15177619|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15177620|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177621|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15177622|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15177623|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15177624|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15177625|NCT03966859|Atorvastatin|atorvastatin|mesh-list
15177626|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15177627|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15177628|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
15177629|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122559|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15122560|NCT04461925|Azithromycin|azithromycin|mesh-list
15122561|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
15122562|NCT04461925|Dexamethasone|dexamethasone|mesh-list
15122563|NCT04461925|Enoxaparin|enoxaparin|mesh-list
15122564|NCT04461925|Anticoagulants|anticoagulants|mesh-list
15122565|NCT04461925|Hormones|hormones|mesh-list
15122566|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122567|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
15122568|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
15122569|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122570|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122571|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15122572|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
15122573|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122574|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15122575|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122576|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122577|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122578|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15122579|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15122580|NCT04461665|Vitamin D|vitamin d|mesh-list
15122581|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
15122582|NCT04461665|Vitamins|vitamins|mesh-list
15122583|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
15122584|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122585|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15122586|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15122587|NCT04461535|Hormones|hormones|mesh-list
15122588|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15122589|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15122590|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
15122591|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269571|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14269572|NCT00403494|Verapamil|verapamil|mesh-list
15122592|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122593|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122594|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122595|NCT04461249|Travoprost|travoprost|mesh-list
15122596|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15122597|NCT04461249|Latanoprost|latanoprost|mesh-list
15122598|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15122599|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15122600|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
15122601|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
15122602|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122603|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122604|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122605|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122606|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122607|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122608|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
15122609|NCT04461418|Hormones|hormones|mesh-ancestor
15122610|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122611|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122612|NCT04461379|Vaccines|vaccines|mesh-list
15122613|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
15122614|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
15122615|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122616|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15122617|NCT04461288|Nicotine|nicotine|mesh-list
15122618|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15122619|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
15122620|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122621|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122622|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15122623|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15122624|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
15122625|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122626|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122627|NCT04461340|Sirolimus|sirolimus|mesh-list
15122628|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122629|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122630|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15122631|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122632|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
15122633|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15122634|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
15122635|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122636|NCT04461041|Empagliflozin|empagliflozin|mesh-list
15122637|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15122638|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122639|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15122640|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122641|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
15122642|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15122643|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15122644|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
15122645|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122646|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122647|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15122648|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
15122649|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15122650|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
15122651|NCT04460963|Protective Agents|protective agents|mesh-ancestor
15122652|NCT04460781|Vaccines|vaccines|mesh-list
15122653|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
15122654|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122655|NCT04460820|Doxorubicin|doxorubicin|mesh-list
14269573|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14269574|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14269575|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122656|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15122657|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15122658|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122659|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15122660|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15122661|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122662|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122663|NCT04460807|Exemestane|exemestane|mesh-list
15122664|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122665|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15122666|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15122667|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122668|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122669|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15122670|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
15122671|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122672|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122673|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
15122674|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15122675|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15122676|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
15122677|NCT04460872|Testosterone|testosterone|mesh-list
15122678|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
15122679|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
15122680|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15122681|NCT04460872|Androgens|androgens|mesh-ancestor
15122682|NCT04460872|Hormones|hormones|mesh-ancestor
15122683|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122684|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122685|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15122686|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122687|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
15122688|NCT04460547|Interferons|interferons|mesh-list
15122689|NCT04460547|Interferon-beta|interferon-beta|mesh-list
15122690|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
15122691|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
15122692|NCT04460547|Ivermectin|ivermectin|mesh-list
15122693|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122694|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
15122695|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122696|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
15122697|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122698|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122699|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122700|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122701|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122702|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
15122703|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122704|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15122705|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
15122706|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
15122707|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122708|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
15122709|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15122710|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
15122711|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122712|NCT04460521|Expectorants|expectorants|mesh-ancestor
15122713|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
15122714|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15122715|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
15122716|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122717|NCT04460521|Protective Agents|protective agents|mesh-ancestor
15122718|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122719|NCT04460521|Antidotes|antidotes|mesh-ancestor
15122720|NCT04460001|Triamcinolone|triamcinolone|mesh-list
15122721|NCT04460001|Ranibizumab|ranibizumab|mesh-list
15122722|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15122723|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15122724|NCT04460001|Growth Substances|growth substances|mesh-ancestor
15122725|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122726|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
15122727|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122728|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122729|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
15122730|NCT04460001|Hormones|hormones|mesh-ancestor
15122731|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177630|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15177631|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15177632|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177633|NCT03966950|Melatonin|melatonin|mesh-list
15177634|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
15177635|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177636|NCT03966950|Protective Agents|protective agents|mesh-ancestor
15177637|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177638|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177639|NCT03966547|Anesthetics|anesthetics|mesh-list
15177640|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
15177641|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177642|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177643|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
15177644|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177645|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
15177646|NCT03966378|Calcium|calcium|mesh-list
15177647|NCT03966378|Caseins|caseins|mesh-list
15177648|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15177649|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177650|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
15177651|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
15177652|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177653|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15177654|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177655|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
15177656|NCT03966378|Protective Agents|protective agents|mesh-ancestor
15177657|NCT03966898|Letrozole|letrozole|mesh-list
15177658|NCT03966898|Anastrozole|anastrozole|mesh-list
15177659|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177660|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15177661|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15177662|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177663|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177664|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15177665|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
15177666|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177667|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177668|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15177669|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15177670|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
15177671|NCT03966326|Fentanyl|fentanyl|mesh-list
15177672|NCT03966326|Anesthetics|anesthetics|mesh-list
15177673|NCT03966326|Sevoflurane|sevoflurane|mesh-list
15177674|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182300|NCT03923036|Irinotecan|irinotecan|mesh-list
15122732|NCT04460092|Insulin|insulin|mesh-list
15122733|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15122734|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15122735|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122736|NCT04460079|Lenograstim|lenograstim|mesh-list
15122737|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15122738|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
15122739|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122740|NCT04459598|Efavirenz|efavirenz|mesh-list
15122741|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15122742|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15122743|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122744|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122745|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
15122746|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122747|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15122748|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15122749|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15122750|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15122751|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15122752|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15122753|NCT04459663|Axitinib|axitinib|mesh-list
15122754|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122755|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15122756|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122757|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122758|NCT04459702|Ritonavir|ritonavir|mesh-list
15122759|NCT04459702|Lopinavir|lopinavir|mesh-list
15122760|NCT04459702|Azithromycin|azithromycin|mesh-list
15122761|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
15122762|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15122763|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15122764|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
15122765|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122766|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122767|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15122768|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15122769|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
15122770|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122771|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15122772|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15122773|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122774|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
15122775|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122776|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122777|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122778|NCT04459676|Mitogens|mitogens|mesh-list
15122779|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
15122780|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122781|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
15122782|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
15122783|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122784|NCT04459312|Antibodies|antibodies|mesh-list
15122785|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
15122786|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122787|NCT04459078|Apatinib|apatinib|mesh-list
15122788|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15122789|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122790|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15122791|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122792|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122793|NCT04458948|Azithromycin|azithromycin|mesh-list
15122794|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
15122795|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122796|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122797|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
15122798|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15122799|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15122800|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122801|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122802|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122803|NCT04459377|Ketamine|ketamine|mesh-list
15122804|NCT04459377|Esketamine|esketamine|mesh-list
15122805|NCT04459377|Analgesics|analgesics|mesh-ancestor
15122806|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
15122807|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122808|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122809|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15122810|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15122811|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
15122812|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
15122813|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122814|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15122815|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15122816|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122817|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122818|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
15122819|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15122820|NCT04459273|FAPI-46|fapi-46|mesh-list
15122821|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15122822|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122823|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
15122824|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15122825|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122826|NCT04459026|Ropivacaine|ropivacaine|mesh-list
15122827|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
15122828|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
15122829|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122830|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122831|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
15122832|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122833|NCT04458454|Methocarbamol|methocarbamol|mesh-list
15122834|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15122835|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122836|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15122837|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122838|NCT04458558|Mifepristone|mifepristone|mesh-list
15122839|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15122840|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
15122841|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15122842|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122843|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15122844|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15122845|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15122846|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
15122847|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15122848|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15122849|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
15122850|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122851|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
15122852|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15122853|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15122854|NCT04458610|Rituximab|rituximab|mesh-list
15122855|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15122856|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
15122857|NCT04458610|Antibodies|antibodies|mesh-list
15122858|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
15122859|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15122860|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
15122861|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122862|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122863|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122864|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15122865|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122866|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122867|NCT04458545|Heroin|heroin|mesh-list
15122868|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15122869|NCT04458545|Narcotics|narcotics|mesh-ancestor
15122870|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122871|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122872|NCT04458545|Analgesics|analgesics|mesh-ancestor
15122873|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
15122874|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122875|NCT04458636|Prednisolone|prednisolone|mesh-list
15122876|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122877|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
15122878|NCT04458636|Hormones|hormones|mesh-ancestor
15122879|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15122880|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122881|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15122882|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122883|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
15122884|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
15122885|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122886|NCT04458324|Buspirone|buspirone|mesh-list
15122887|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15122888|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15122889|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122890|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122891|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15122892|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15122893|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
15122894|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122895|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122896|NCT04458285|Valsartan|valsartan|mesh-list
15122897|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15122898|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15122899|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15122900|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15122901|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122902|NCT04458116|Curcumin|curcumin|mesh-list
15122903|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15122904|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15122905|NCT04458116|Analgesics|analgesics|mesh-ancestor
15122906|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
15122907|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15122908|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122909|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15122910|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15122911|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122912|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122913|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177675|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177676|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15177677|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15177678|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
15177679|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15177680|NCT03966326|Narcotics|narcotics|mesh-ancestor
15177681|NCT03966326|Analgesics|analgesics|mesh-ancestor
15177682|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
15177683|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177684|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15177685|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15177686|NCT03966235|Melatonin|melatonin|mesh-list
15177687|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
15177688|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177689|NCT03966235|Protective Agents|protective agents|mesh-ancestor
15177690|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177691|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177692|NCT03966079|Plasminogen|plasminogen|mesh-list
15177693|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15177694|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15177695|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15177696|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181860|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181861|NCT03926403|Anesthetics|anesthetics|mesh-list
15181862|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181863|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181864|NCT03926338|Celecoxib|celecoxib|mesh-list
15181865|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
15181866|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15181867|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15181868|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181869|NCT03926338|Analgesics|analgesics|mesh-ancestor
15181870|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
15181871|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181872|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181873|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181874|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181875|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15122914|NCT04457609|Azithromycin|azithromycin|mesh-list
15122915|NCT04457609|Oseltamivir|oseltamivir|mesh-list
15122916|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15122917|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122918|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
15122919|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122920|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122921|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15122922|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15122923|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
15122924|NCT04457765|Povidone|povidone|mesh-list
15122925|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
15122926|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
15122927|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15122928|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122929|NCT04457258|FAPI-46|fapi-46|mesh-list
15122930|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15122931|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122932|NCT04457050|Ribavirin|ribavirin|mesh-list
15122933|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
15122934|NCT04457050|Ledipasvir|ledipasvir|mesh-list
15122935|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
15122936|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122937|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
15122938|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15122939|NCT04457180|Repaglinide|repaglinide|mesh-list
15122940|NCT04457180|Apatinib|apatinib|mesh-list
15122941|NCT04457180|Bupropion|bupropion|mesh-list
15122942|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15122943|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15122944|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122945|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122946|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15122947|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
15122948|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15122949|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15122950|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15122951|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122952|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
15122953|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122954|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122955|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15122956|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15122957|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15122958|NCT04457232|FAPI-46|fapi-46|mesh-list
15122959|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15122960|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122961|NCT04456985|Folic Acid|folic acid|mesh-list
15122962|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
15122963|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
15122964|NCT04456985|Vitamins|vitamins|mesh-ancestor
15122965|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
15122966|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122967|NCT04456985|Hematinics|hematinics|mesh-ancestor
15122968|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
15122969|NCT04456803|Sevelamer|sevelamer|mesh-list
15122970|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
15122971|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
15122972|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122973|NCT04456829|Resveratrol|resveratrol|mesh-list
15122974|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
15122975|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122976|NCT04456829|Protective Agents|protective agents|mesh-ancestor
15122977|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122978|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15122979|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15122980|NCT04456777|Vortioxetine|vortioxetine|mesh-list
15122981|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
15122982|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15122983|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15122984|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15122985|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15122986|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15122987|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15122988|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15122989|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15122990|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15122991|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15122992|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
15122993|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15122994|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15122995|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15122996|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15122997|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
15122998|NCT04456712|Levofloxacin|levofloxacin|mesh-list
15122999|NCT04456712|Ofloxacin|ofloxacin|mesh-list
15123000|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123001|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123002|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15123003|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15123004|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123005|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123006|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123007|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15123008|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15123009|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15123010|NCT04456712|Renal Agents|renal agents|mesh-ancestor
15123011|NCT04456608|Aspirin|aspirin|mesh-list
15123012|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15123013|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15123014|NCT04456608|Analgesics|analgesics|mesh-ancestor
15123015|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
15123016|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123017|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123018|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15123019|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15123020|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123021|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123022|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123023|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15123024|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15123025|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123026|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
15123027|NCT04456387|Factor VIII|factor viii|mesh-list
15123028|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15123029|NCT04456387|Coagulants|coagulants|mesh-ancestor
15123030|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
15123031|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123032|NCT04455932|Liver Extracts|liver extracts|mesh-list
15123033|NCT04455932|Hematinics|hematinics|mesh-ancestor
15123034|NCT04455802|Morphine|morphine|mesh-list
14561714|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561715|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561716|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561717|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561718|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561719|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561720|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561721|NCT00002804|Cobalt|cobalt|mesh-list
14561722|NCT00002804|Doxorubicin|doxorubicin|mesh-list
14561723|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561724|NCT00002804|Vincristine|vincristine|mesh-list
14561725|NCT00002804|Ifosfamide|ifosfamide|mesh-list
14561726|NCT00002804|Lenograstim|lenograstim|mesh-list
14561727|NCT00002804|Sargramostim|sargramostim|mesh-list
14561728|NCT00002804|Mesna|mesna|mesh-list
14561729|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561730|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561731|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561732|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561733|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561734|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561735|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14561736|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
14561737|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123035|NCT04455802|Buprenorphine|buprenorphine|mesh-list
15123036|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15123037|NCT04455802|Narcotics|narcotics|mesh-ancestor
14561738|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561739|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
15123038|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123039|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123040|NCT04455802|Analgesics|analgesics|mesh-ancestor
15123041|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
15123042|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123043|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15123044|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
15123045|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15123046|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
15123047|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123048|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123049|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15123050|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
15123051|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15123052|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
15123053|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123054|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123055|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15123056|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
15123057|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
15123058|NCT04456088|Protective Agents|protective agents|mesh-ancestor
15177697|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15177698|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177699|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177700|NCT03966040|Vaccines|vaccines|mesh-list
15177701|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
15177702|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177703|NCT03965962|Vaccines|vaccines|mesh-list
15177704|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
15177705|NCT03965962|Antibodies|antibodies|mesh-list
15177706|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
15177707|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15177708|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15177709|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
15177710|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177711|NCT03965871|Esketamine|esketamine|mesh-list
15177712|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
15177713|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15177714|NCT03966014|Amoxicillin|amoxicillin|mesh-list
15177715|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177716|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177717|NCT03966118|Paclitaxel|paclitaxel|mesh-list
15177718|NCT03966118|Avelumab|avelumab|mesh-list
15177719|NCT03966118|Ramucirumab|ramucirumab|mesh-list
15177720|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15177721|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177722|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
15177723|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
15177724|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
15177725|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177726|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15177727|NCT03965949|Hormones|hormones|mesh-list
15177728|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15177729|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177730|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
15177731|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15177732|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15177733|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177734|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
15177735|NCT03965767|Coagulants|coagulants|mesh-ancestor
15177736|NCT03965858|Esketamine|esketamine|mesh-list
15177737|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
15177738|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15177739|NCT03965819|Acetaminophen|acetaminophen|mesh-list
15177740|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15177741|NCT03965819|Analgesics|analgesics|mesh-ancestor
15177742|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
15177743|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177744|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177745|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
15177746|NCT03966066|Erythromycin|erythromycin|mesh-list
15177747|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
15177748|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15177749|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
15177750|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177751|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177752|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123059|NCT04455711|Lidocaine|lidocaine|mesh-list
15123060|NCT04455711|Remifentanil|remifentanil|mesh-list
15123061|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
15123062|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
15123063|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123064|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123065|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
15123066|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123067|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15123068|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15123069|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15123070|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15123071|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123072|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15123073|NCT04455711|Narcotics|narcotics|mesh-ancestor
15123074|NCT04455711|Analgesics|analgesics|mesh-ancestor
15123075|NCT04455555|Rotigotine|rotigotine|mesh-list
15123076|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
15123077|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
15123078|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123079|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123080|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123081|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15123082|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
15123083|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123084|NCT04455594|Carboplatin|carboplatin|mesh-list
15123085|NCT04455594|Pemetrexed|pemetrexed|mesh-list
15123086|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15123087|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123088|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123089|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123090|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15123091|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15123092|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15123093|NCT04455958|Ritonavir|ritonavir|mesh-list
15123094|NCT04455958|Lopinavir|lopinavir|mesh-list
15123095|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15123096|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15123097|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
15123098|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123099|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123100|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15123101|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15123102|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
15123103|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123104|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15123105|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15123106|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15123107|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15123108|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
15123109|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15123110|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
15123111|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123112|NCT04455243|Expectorants|expectorants|mesh-ancestor
15123113|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
15123114|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15123115|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
15123116|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123117|NCT04455243|Protective Agents|protective agents|mesh-ancestor
15123118|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123119|NCT04455243|Antidotes|antidotes|mesh-ancestor
15123120|NCT04454775|Protein C|protein c|mesh-list
15123121|NCT04454775|Antithrombins|antithrombins|mesh-list
15123122|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
15123123|NCT04454775|Protein S|protein s|mesh-list
15123124|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15123125|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
15123126|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123127|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123128|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
15123129|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123130|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123131|NCT04454840|Riluzole|riluzole|mesh-list
15123132|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
15123133|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15123134|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15123135|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123136|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123137|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123138|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15123139|NCT04454840|Protective Agents|protective agents|mesh-ancestor
15123140|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15123141|NCT04454788|Tenecteplase|tenecteplase|mesh-list
15123142|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123143|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123144|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123145|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15123146|NCT04454580|Azacitidine|azacitidine|mesh-list
15123147|NCT04454580|Decitabine|decitabine|mesh-list
15123148|NCT04454580|Venetoclax|venetoclax|mesh-list
15123149|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15123150|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
15123151|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123152|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123153|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123154|NCT04454307|Tramadol|tramadol|mesh-list
15123155|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15123156|NCT04454307|Narcotics|narcotics|mesh-ancestor
15123157|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123158|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123159|NCT04454307|Analgesics|analgesics|mesh-ancestor
15123160|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
15123161|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123162|NCT04454151|Azithromycin|azithromycin|mesh-list
15123163|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123164|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123165|NCT04454281|Naloxone|naloxone|mesh-list
15123166|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15123167|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123168|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
15123169|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123170|NCT04453930|Irinotecan|irinotecan|mesh-list
15123171|NCT04453930|Apatinib|apatinib|mesh-list
15123172|NCT04453930|Antibodies|antibodies|mesh-list
15123173|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
15123174|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123175|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15123176|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15123177|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123178|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123179|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123180|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15123181|NCT04453735|Atorvastatin|atorvastatin|mesh-list
15123182|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15123183|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15123184|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
15123185|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123186|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15123187|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15123188|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123189|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
15123190|NCT04453761|Vitamins|vitamins|mesh-ancestor
15123191|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
15123192|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177753|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15177754|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177755|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177756|NCT03965546|Sorafenib|sorafenib|mesh-list
15177757|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177758|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15177759|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177760|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177761|NCT03965624|Ixazomib|ixazomib|mesh-list
15177762|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177763|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
15177764|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177765|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177766|NCT03965442|Esmolol|esmolol|mesh-list
15177767|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15177768|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15177769|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15123193|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
15123194|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15123195|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123196|NCT04453280|Antibodies|antibodies|mesh-list
15123197|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
15123198|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123199|NCT04453423|Carboplatin|carboplatin|mesh-list
15123200|NCT04453423|Pemetrexed|pemetrexed|mesh-list
15123201|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123202|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123203|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123204|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15123205|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15123206|NCT04453306|Topiramate|topiramate|mesh-list
15123207|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
15123208|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15123209|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123210|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15123211|NCT04453371|Plasminogen|plasminogen|mesh-list
15123212|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123213|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123214|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123215|NCT04453345|Thalidomide|thalidomide|mesh-list
15123216|NCT04453345|Prednisone|prednisone|mesh-list
15123217|NCT04453345|Methotrexate|methotrexate|mesh-list
15123218|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15123219|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
15123220|NCT04453345|Hormones|hormones|mesh-ancestor
15123221|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15123222|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123223|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15123224|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123225|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15123226|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
15123227|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15123228|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15123229|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
15123230|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123231|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
15123232|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123233|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15123234|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123235|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
15123236|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15123237|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15123238|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
15123239|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123240|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123241|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15123242|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15123243|NCT04453345|Growth Substances|growth substances|mesh-ancestor
15123244|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
15123245|NCT04453436|Tenofovir|tenofovir|mesh-list
15123246|NCT04453436|Lamivudine|lamivudine|mesh-list
15123247|NCT04453436|Dolutegravir|dolutegravir|mesh-list
15123248|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
15123249|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123250|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15123251|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15123252|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123253|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123254|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15123255|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15123256|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15123257|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15123258|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15123259|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15123260|NCT04453332|Hormones|hormones|mesh-list
15123261|NCT04453332|Estradiol|estradiol|mesh-list
15123262|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15123263|NCT04453332|Progesterone|progesterone|mesh-list
15123264|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15123265|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123266|NCT04453332|Estrogens|estrogens|mesh-ancestor
15123267|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15123268|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
15123269|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15123270|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15123271|NCT04453332|Progestins|progestins|mesh-ancestor
15123272|NCT04453189|Lansoprazole|lansoprazole|mesh-list
15123273|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
15123274|NCT04453189|Famotidine|famotidine|mesh-list
15123275|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15123276|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123277|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15123278|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123279|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123280|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15123281|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
15123282|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
15123283|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123284|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123285|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
15123286|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123287|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
15123288|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15123289|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
15123290|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123291|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
15123292|NCT04453111|Protective Agents|protective agents|mesh-ancestor
15123293|NCT04452838|Fesoterodine|fesoterodine|mesh-list
15123294|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15123295|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15123296|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
15123297|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123298|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123299|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123300|NCT04452838|Urological Agents|urological agents|mesh-ancestor
15123301|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
15123302|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15123303|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123304|NCT04452929|Calcitonin|calcitonin|mesh-list
15123305|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
15123306|NCT04452929|Cilostazol|cilostazol|mesh-list
15123307|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15123308|NCT04452929|Erenumab|erenumab|mesh-list
15123309|NCT04452929|Katacalcin|katacalcin|mesh-list
15123310|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15123311|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
15123312|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123313|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123314|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15123315|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
15123316|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123317|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123318|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123319|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15123320|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
15123321|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15123322|NCT04452929|Protective Agents|protective agents|mesh-ancestor
15123323|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15123324|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15123325|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123326|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15123327|NCT04452929|Analgesics|analgesics|mesh-ancestor
15123328|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
15123329|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15123330|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15123331|NCT04452669|Epoprostenol|epoprostenol|mesh-list
15123332|NCT04452669|Tezosentan|tezosentan|mesh-list
15123333|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15123334|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15123335|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
15123336|NCT04452370|Etoposide|etoposide|mesh-list
15123337|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15123338|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123339|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15123340|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15123341|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123342|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123343|NCT04452461|Leucovorin|leucovorin|mesh-list
15123344|NCT04452461|Gemcitabine|gemcitabine|mesh-list
15123345|NCT04452461|Paclitaxel|paclitaxel|mesh-list
15123346|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
15123347|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15123348|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123349|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
15123350|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
15123351|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
15123352|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123353|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15123354|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
15123355|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
15123356|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123357|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123358|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123359|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
15123360|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123361|NCT04452461|Antidotes|antidotes|mesh-ancestor
15123362|NCT04452461|Protective Agents|protective agents|mesh-ancestor
15123363|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
15123364|NCT04452461|Vitamins|vitamins|mesh-ancestor
15123365|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
15123366|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
15123367|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15123368|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123369|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
15123370|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
15123371|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15123372|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15123373|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123374|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15123375|NCT04451655|Insulin|insulin|mesh-list
15123376|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15123377|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177770|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
15177771|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177772|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177773|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177774|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
15177775|NCT03965637|Vitamins|vitamins|mesh-ancestor
15177776|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
15177777|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177778|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
15177779|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177780|NCT03965637|Protective Agents|protective agents|mesh-ancestor
15177781|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
15177782|NCT03965286|Ledipasvir|ledipasvir|mesh-list
15177783|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15177784|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
15177785|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177786|NCT03965117|Norepinephrine|norepinephrine|mesh-list
15177787|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15177788|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15177789|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
15177790|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177791|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177792|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177793|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
15177794|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
15177795|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177796|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15177797|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15177798|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15177799|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15177800|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
15177801|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
15177802|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15177803|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177804|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177805|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
15177806|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15177807|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177808|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177809|NCT03965208|Heparin|heparin|mesh-list
15177810|NCT03965208|Calcium heparin|calcium heparin|mesh-list
15177811|NCT03965208|Bivalirudin|bivalirudin|mesh-list
15177812|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
15177813|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123378|NCT04451395|Micronutrients|micronutrients|mesh-list
15123379|NCT04451395|Trace Elements|trace elements|mesh-list
15123380|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123381|NCT04451447|SMOFlipid|smoflipid|mesh-list
15123382|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15123383|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15123384|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15123385|NCT04451200|Busulfan|busulfan|mesh-list
15123386|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
15123387|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123388|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123389|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
15123390|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123391|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15123392|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123393|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15123394|NCT04451239|Cyclosporine|cyclosporine|mesh-list
15123395|NCT04451239|Cyclosporins|cyclosporins|mesh-list
15123396|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123397|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123398|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123399|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
15123400|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123401|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
15123402|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123403|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
15123404|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15123405|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15123406|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15123407|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15123408|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15123409|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123410|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123411|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15123412|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15123413|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123414|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
15123415|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123416|NCT04451330|Doxycycline|doxycycline|mesh-list
15123417|NCT04451330|Trifarotene|trifarotene|mesh-list
15123418|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123419|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123420|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
15123421|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15123422|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15123423|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
15123424|NCT04451174|Prednisone|prednisone|mesh-list
15123425|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15123426|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
15123427|NCT04451174|Hormones|hormones|mesh-ancestor
15123428|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15123429|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123430|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15123431|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123432|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
15123433|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15123434|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123435|NCT04451083|Camostat|camostat|mesh-list
15123436|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
15123437|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123438|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123439|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15123440|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15123441|NCT04450836|Trifluridine|trifluridine|mesh-list
15123442|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
15123443|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123444|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
15123445|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123446|NCT04450680|Lactams|lactams|mesh-list
15123447|NCT04450680|beta-Lactams|beta-lactams|mesh-list
15123448|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123449|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123450|NCT04450446|Heparin|heparin|mesh-list
15123451|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15123452|NCT04450446|Tinzaparin|tinzaparin|mesh-list
15123453|NCT04450446|Dalteparin|dalteparin|mesh-list
15123454|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
15123455|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123456|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123457|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123458|NCT04450160|Temozolomide|temozolomide|mesh-list
15123459|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15123460|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
15123461|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123462|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123463|NCT04450134|Fexofenadine|fexofenadine|mesh-list
15123464|NCT04450134|Famotidine|famotidine|mesh-list
15123465|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15123466|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123467|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15123468|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
15123469|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
15123470|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123471|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123472|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123473|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15123474|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15123475|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15123476|NCT04450212|Vitamin K|vitamin k|mesh-list
15123477|NCT04450212|Vitamins|vitamins|mesh-ancestor
15123478|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
15123479|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123480|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15123481|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123482|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123483|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
15123484|NCT04450212|Coagulants|coagulants|mesh-ancestor
15123485|NCT04450095|Ambrisentan|ambrisentan|mesh-list
15123486|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15123487|NCT04450316|Naltrexone|naltrexone|mesh-list
15123488|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15123489|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15123490|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123491|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
15123492|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123493|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
15123494|NCT04449965|Povidone|povidone|mesh-list
15123495|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
15123496|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
15123497|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15123498|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123499|NCT04449952|Listerine|listerine|mesh-list
15123500|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
15123501|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
15123502|NCT04449952|Protective Agents|protective agents|mesh-ancestor
15123503|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123504|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15123505|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123506|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15123507|NCT04449718|Vitamin D|vitamin d|mesh-list
15123508|NCT04449718|Vitamins|vitamins|mesh-ancestor
15123509|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
15123510|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123511|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15123512|NCT04450199|Vitamin D|vitamin d|mesh-list
15123513|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
15123514|NCT04450199|Vitamins|vitamins|mesh-list
15123515|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
15123516|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123517|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15123518|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15123519|NCT04450355|Nefopam|nefopam|mesh-list
15123520|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15123521|NCT04450355|Analgesics|analgesics|mesh-ancestor
15123522|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
15123523|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123524|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177814|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15177815|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177816|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
15177817|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15177818|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
15177819|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177820|NCT03964935|Minocycline|minocycline|mesh-list
15123525|NCT04449536|Mesna|mesna|mesh-list
15123526|NCT04449536|Protective Agents|protective agents|mesh-ancestor
15123527|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123528|NCT04449198|Resveratrol|resveratrol|mesh-list
15123529|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
15123530|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123531|NCT04449198|Protective Agents|protective agents|mesh-ancestor
15123532|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123533|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123534|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15123535|NCT04449224|Etanercept|etanercept|mesh-list
15123536|NCT04449224|Abatacept|abatacept|mesh-list
15123537|NCT04449224|Tofacitinib|tofacitinib|mesh-list
15123538|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15123539|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15123540|NCT04449224|Analgesics|analgesics|mesh-ancestor
15123541|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
15123542|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123543|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123544|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15123545|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15123546|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123547|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123548|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
15123549|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15123550|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123551|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123552|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15123553|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123554|NCT04449289|Lidocaine|lidocaine|mesh-list
15123555|NCT04449289|Ropivacaine|ropivacaine|mesh-list
15123556|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
15123557|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
15123558|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123559|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123560|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
15123561|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123562|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15123563|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15123564|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15123565|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15123566|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123567|NCT04449471|Naproxen|naproxen|mesh-list
15123568|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15123569|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15123570|NCT04449471|Analgesics|analgesics|mesh-ancestor
15123571|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
15123572|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123573|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123574|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15123575|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15123576|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
15123577|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15123578|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123579|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123580|NCT04449185|Amoxicillin|amoxicillin|mesh-list
15123581|NCT04449185|Clarithromycin|clarithromycin|mesh-list
15123582|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123583|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123584|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15123585|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123586|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123587|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15123588|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15123589|NCT04449380|Interferons|interferons|mesh-list
15123590|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123591|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
15123592|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123593|NCT04448873|Sirolimus|sirolimus|mesh-list
15123594|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123595|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123596|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15123597|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123598|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
15177821|NCT03964935|Lycopene|lycopene|mesh-list
15123599|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123600|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
15123601|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123602|NCT04448821|Metformin|metformin|mesh-list
15123603|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15123604|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123605|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
15123606|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
15123607|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123608|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15123609|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15123610|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123611|NCT04448587|Incretins|incretins|mesh-ancestor
15123612|NCT04448587|Hormones|hormones|mesh-ancestor
15123613|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15123614|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15123615|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
15123616|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123617|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123618|NCT04448496|Dexamethasone|dexamethasone|mesh-list
15123619|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15123620|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
15123621|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
15123622|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123623|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123624|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123625|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
15123626|NCT04448496|Hormones|hormones|mesh-ancestor
15123627|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15123628|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15123629|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123630|NCT04448457|Sufentanil|sufentanil|mesh-list
15123631|NCT04448457|Oxycodone|oxycodone|mesh-list
15123632|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15123633|NCT04448457|Narcotics|narcotics|mesh-ancestor
15123634|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123635|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123636|NCT04448457|Analgesics|analgesics|mesh-ancestor
15123637|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
15123638|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123639|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15123640|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15123641|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
15123642|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
15123643|NCT04448379|Afatinib|afatinib|mesh-list
15123644|NCT04448379|Osimertinib|osimertinib|mesh-list
15123645|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123646|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15123647|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123648|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123649|NCT04448392|Valacyclovir|valacyclovir|mesh-list
15123650|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
15123651|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123652|NCT04448223|Latanoprost|latanoprost|mesh-list
15123653|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15123654|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15123655|NCT04448119|Favipiravir|favipiravir|mesh-list
15123656|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
15123657|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123658|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
15123659|NCT04448015|Narcotics|narcotics|mesh-ancestor
15123660|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123661|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123662|NCT04448015|Analgesics|analgesics|mesh-ancestor
15123663|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
15123664|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123665|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
15123666|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
15123667|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15123668|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15123669|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123670|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123671|NCT04447989|Urological Agents|urological agents|mesh-ancestor
15123672|NCT04447781|Citric Acid|citric acid|mesh-list
15123673|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
15123674|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
15123675|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15123676|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
15123677|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
15123678|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123679|NCT04448028|Esomeprazole|esomeprazole|mesh-list
15123680|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15123681|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15123682|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123683|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123684|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123685|NCT04447911|Empagliflozin|empagliflozin|mesh-list
15123686|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15123687|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123688|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15123689|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123690|NCT04447612|Gemcitabine|gemcitabine|mesh-list
15123691|NCT04447612|Durvalumab|durvalumab|mesh-list
15123692|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123693|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15123694|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
15123695|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123696|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
15123697|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123698|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123699|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123700|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
15123701|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123702|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15123703|NCT04447352|Leucovorin|leucovorin|mesh-list
15123704|NCT04447352|Docetaxel|docetaxel|mesh-list
15123705|NCT04447352|Fluorouracil|fluorouracil|mesh-list
15123706|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
15123707|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123708|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
15123709|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
15123710|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
15123711|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123712|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
15123713|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15123714|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123715|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
15123716|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123717|NCT04447352|Antidotes|antidotes|mesh-ancestor
15123718|NCT04447352|Protective Agents|protective agents|mesh-ancestor
15123719|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
15123720|NCT04447352|Vitamins|vitamins|mesh-ancestor
15123721|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
15177822|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177823|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177824|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15177825|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
15177826|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177827|NCT03964935|Protective Agents|protective agents|mesh-ancestor
15177828|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177829|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15177830|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15177831|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177832|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
15177833|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15177834|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177835|NCT03965195|Vaccines|vaccines|mesh-list
15177836|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
15177837|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177838|NCT03964753|Paclitaxel|paclitaxel|mesh-list
15177839|NCT03964753|Cisplatin|cisplatin|mesh-list
15177840|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15177841|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177842|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
15177843|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
15177844|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
15177845|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177846|NCT03964779|Antibodies|antibodies|mesh-list
15177847|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
15177848|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
15177849|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177850|NCT03964493|Vancomycin|vancomycin|mesh-list
15177851|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177852|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123722|NCT04447326|Endostar protein|endostar protein|mesh-list
15123723|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15123724|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15123725|NCT04447326|Growth Substances|growth substances|mesh-ancestor
15123726|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123727|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
15123728|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123729|NCT04447274|Apatinib|apatinib|mesh-list
15123730|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123731|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15123732|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123733|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123734|NCT04447443|Loperamide|loperamide|mesh-list
15123735|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
15123736|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123737|NCT04447235|Ivermectin|ivermectin|mesh-list
15123738|NCT04447235|Losartan|losartan|mesh-list
15123739|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15123740|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15123741|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15123742|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15123743|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123744|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15123745|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123746|NCT04447560|Bupivacaine|bupivacaine|mesh-list
15123747|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
15123748|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
15123749|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123750|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123751|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
15123752|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123753|NCT04447092|Leucovorin|leucovorin|mesh-list
15123754|NCT04447092|Gemcitabine|gemcitabine|mesh-list
15123755|NCT04447092|Paclitaxel|paclitaxel|mesh-list
15123756|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
15123757|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
15123758|NCT04447092|Irinotecan|irinotecan|mesh-list
15123759|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15123760|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123761|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
15123762|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
15123763|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
15123764|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123765|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15123766|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
15123767|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
15123768|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123769|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123770|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15123771|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
15123772|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123773|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15123774|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15123775|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15123776|NCT04447092|Antidotes|antidotes|mesh-ancestor
15123777|NCT04447092|Protective Agents|protective agents|mesh-ancestor
15123778|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
15123779|NCT04447092|Vitamins|vitamins|mesh-ancestor
15123780|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
15123781|NCT04447378|PENTA|penta|mesh-list
15123782|NCT04447378|Fondaparinux|fondaparinux|mesh-list
15123783|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15123784|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
15123785|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15123786|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
15123787|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123788|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123789|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
15123790|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15123791|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15123792|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15123793|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15123794|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123795|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
15123796|NCT04447105|Anesthetics|anesthetics|mesh-list
15123797|NCT04447105|Propofol|propofol|mesh-list
15123798|NCT04447105|Desflurane|desflurane|mesh-list
15123799|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123800|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123801|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15123802|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15123803|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
15123804|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15123805|NCT04446923|Propranolol|propranolol|mesh-list
15123806|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15123807|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15123808|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
15123809|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123810|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123811|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123812|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15123813|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15123814|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
15123815|NCT04446871|Methylene Blue|methylene blue|mesh-list
15123816|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123817|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123818|NCT04446663|Paclitaxel|paclitaxel|mesh-list
15123819|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15123820|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15123821|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123822|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
15123823|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
15123824|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
15123825|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123826|NCT04446715|Sufentanil|sufentanil|mesh-list
15123827|NCT04446715|Meperidine|meperidine|mesh-list
15123828|NCT04446715|Bupivacaine|bupivacaine|mesh-list
15123829|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
15123830|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
15123831|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123832|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123833|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
15123834|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123835|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15123836|NCT04446715|Narcotics|narcotics|mesh-ancestor
15123837|NCT04446715|Analgesics|analgesics|mesh-ancestor
15123838|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15123839|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15123840|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
15123841|NCT04446598|Tadalafil|tadalafil|mesh-list
15123842|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
15123843|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15123844|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15123845|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123846|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123847|NCT04446598|Urological Agents|urological agents|mesh-ancestor
15123848|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
15123849|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15123850|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15123851|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
15123852|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15123853|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123854|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
15123855|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
15123856|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15123857|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
15123858|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123859|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
15123860|NCT04446533|Protective Agents|protective agents|mesh-ancestor
15123861|NCT04446637|Albuterol|albuterol|mesh-list
15123862|NCT04446637|Ipratropium|ipratropium|mesh-list
15123863|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15123864|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
15123865|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123866|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123867|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15123868|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
15123869|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
15123870|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15123871|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15123872|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15123873|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15123874|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
15123875|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123876|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123877|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15123878|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
15123879|NCT04446416|Bevacizumab|bevacizumab|mesh-list
15123880|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15123881|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123882|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15123883|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15123884|NCT04446416|Growth Substances|growth substances|mesh-ancestor
15123885|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123886|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
15123887|NCT04446403|Anesthetics|anesthetics|mesh-list
15123888|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123889|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123890|NCT04446338|Antibodies|antibodies|mesh-list
15123891|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
15123892|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123893|NCT04446364|Disinfectants|disinfectants|mesh-list
15123894|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123895|NCT04445922|Anastrozole|anastrozole|mesh-list
15123896|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15123897|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123898|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15123899|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15123900|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123901|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123902|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15123903|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
15123904|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15123905|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123906|NCT04446234|Risperidone|risperidone|mesh-list
15123907|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15123908|NCT04446234|Aripiprazole|aripiprazole|mesh-list
15123909|NCT04446234|Ziprasidone|ziprasidone|mesh-list
15123910|NCT04446234|Amisulpride|amisulpride|mesh-list
15123911|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15123912|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
15123913|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123914|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123915|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123916|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15123917|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15123918|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123919|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15123920|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15123921|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
15123922|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
15123923|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
15123924|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15123925|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15123926|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15123927|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15123928|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15123929|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15123930|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
15123931|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123932|NCT04446065|Protective Agents|protective agents|mesh-ancestor
15123933|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123934|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15123935|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15123936|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15123937|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15123938|NCT04445948|Amoxicillin|amoxicillin|mesh-list
15123939|NCT04445948|Metronidazole|metronidazole|mesh-list
15123940|NCT04445948|Clarithromycin|clarithromycin|mesh-list
15123941|NCT04445948|Lactoferrin|lactoferrin|mesh-list
15123942|NCT04445948|Esomeprazole|esomeprazole|mesh-list
15123943|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15123944|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15123945|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15123946|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15123947|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15123948|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15123949|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15123950|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123951|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123952|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15123953|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15123954|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15123955|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15123956|NCT04446039|Vortioxetine|vortioxetine|mesh-list
15123957|NCT04446039|Mirtazapine|mirtazapine|mesh-list
15123958|NCT04446039|Citalopram|citalopram|mesh-list
15123959|NCT04446039|Bupropion|bupropion|mesh-list
15123960|NCT04446039|Fluoxetine|fluoxetine|mesh-list
15123961|NCT04446039|Paroxetine|paroxetine|mesh-list
15123962|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15123963|NCT04446039|Sertraline|sertraline|mesh-list
15123964|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15123965|NCT04446039|Tianeptine|tianeptine|mesh-list
15123966|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15123967|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15123968|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15123969|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15123970|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15123971|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
15123972|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15123973|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15123974|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
15123975|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15123976|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15123977|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15123978|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
15123979|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15123980|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15123981|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15123982|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15123983|NCT04446039|Analgesics|analgesics|mesh-ancestor
15123984|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
15123985|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15123986|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15123987|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15123988|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15123989|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15123990|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15123991|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15123992|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15123993|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
15123994|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
15123995|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15123996|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15123997|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15123998|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
15123999|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15124000|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15124001|NCT04446091|Irinotecan|irinotecan|mesh-list
15124002|NCT04446091|Apatinib|apatinib|mesh-list
15124003|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
15124004|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15124005|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15124006|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124007|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124008|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124009|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124010|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15124011|NCT04446091|Growth Substances|growth substances|mesh-ancestor
15124012|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124013|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
15124014|NCT04446104|Ascorbic Acid|ascorbic acid|mesh-list
15124015|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
15124016|NCT04446104|Ivermectin|ivermectin|mesh-list
15124017|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
15124018|NCT04446104|Povidone|povidone|mesh-list
15124019|NCT04446104|Vitamins|vitamins|mesh-ancestor
15124020|NCT04446104|Micronutrients|micronutrients|mesh-ancestor
15124021|NCT04446104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124022|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
15124023|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15124024|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124025|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124026|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124027|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124028|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124029|NCT04446104|Antioxidants|antioxidants|mesh-ancestor
15124030|NCT04446104|Protective Agents|protective agents|mesh-ancestor
15124031|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
15124032|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
15124033|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15124034|NCT04445935|Bivalirudin|bivalirudin|mesh-list
15124035|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
15124036|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15124037|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
15124038|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124039|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124040|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
15124041|NCT04446130|Decitabine|decitabine|mesh-list
15124042|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15124043|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
15124044|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124045|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124046|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124047|NCT04445857|Calcitonin|calcitonin|mesh-list
15124048|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
15124049|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15124050|NCT04445857|Katacalcin|katacalcin|mesh-list
15124051|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15124052|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124053|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15124054|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
15124055|NCT04445727|Ascorbic Acid|ascorbic acid|mesh-list
15124056|NCT04445727|Vitamins|vitamins|mesh-ancestor
15124057|NCT04445727|Micronutrients|micronutrients|mesh-ancestor
15124058|NCT04445727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124059|NCT04445727|Antioxidants|antioxidants|mesh-ancestor
15124060|NCT04445727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124061|NCT04445727|Protective Agents|protective agents|mesh-ancestor
15124062|NCT04445779|Ubiquinone|ubiquinone|mesh-list
15124063|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
15124064|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
15124065|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124066|NCT04445779|Vitamins|vitamins|mesh-ancestor
15124067|NCT04445467|Favipiravir|favipiravir|mesh-list
15124068|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
15124069|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124070|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15124071|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
15124072|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
15124073|NCT04445636|Morphine|morphine|mesh-list
15124074|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15124075|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124076|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124077|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15124078|NCT04445636|Analgesics|analgesics|mesh-ancestor
15124079|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
15124080|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124081|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15124082|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15124083|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15124084|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
15124085|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124086|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124087|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15124088|NCT04445636|Narcotics|narcotics|mesh-ancestor
15177853|NCT03964350|Ethanol|ethanol|mesh-list
15177854|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15177855|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177856|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15177857|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177858|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
15177859|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15177860|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
15177861|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177862|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177863|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15177864|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
15177865|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15124089|NCT04445506|Dexamethasone|dexamethasone|mesh-list
15124090|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124091|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
15124092|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
15124093|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124094|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124095|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15124096|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
15124097|NCT04445506|Hormones|hormones|mesh-ancestor
15124098|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124099|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124100|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124101|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15124102|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15124103|NCT04445311|Ivermectin|ivermectin|mesh-list
15124104|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124105|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124106|NCT04445194|Vaccines|vaccines|mesh-list
15124107|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
15124108|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124109|NCT04445025|Leuprolide|leuprolide|mesh-list
15124110|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15124111|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
15124112|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15124113|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124114|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124115|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124116|NCT04444986|Favipiravir|favipiravir|mesh-list
15124117|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
15124118|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124119|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
15124120|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15124121|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124122|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15124123|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
15124124|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15124125|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124126|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124127|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124128|NCT04444635|Fentanyl|fentanyl|mesh-list
15124129|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15124130|NCT04444635|Narcotics|narcotics|mesh-ancestor
15124131|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124132|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124133|NCT04444635|Analgesics|analgesics|mesh-ancestor
15124134|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
15124135|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124136|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15124137|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15124138|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
15124139|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
15124140|NCT04444726|Betamethasone|betamethasone|mesh-list
15124141|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
15124142|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15124143|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
15124144|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15124145|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124146|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
15124147|NCT04444726|Hormones|hormones|mesh-ancestor
15124148|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124149|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124150|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15124151|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
15124152|NCT04444830|Ketorolac|ketorolac|mesh-list
15124153|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15124154|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15124155|NCT04444830|Analgesics|analgesics|mesh-ancestor
15124156|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
15124157|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124158|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124159|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124160|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124161|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15124162|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124163|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124164|NCT04444817|Tacrolimus|tacrolimus|mesh-list
15124165|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124166|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
15124167|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124168|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15124169|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124170|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124171|NCT04444167|Lenvatinib|lenvatinib|mesh-list
15124172|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124173|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124174|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124175|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124176|NCT04444349|Ubiquinone|ubiquinone|mesh-list
15124177|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
15124178|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
15124179|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124180|NCT04444349|Vitamins|vitamins|mesh-ancestor
15124181|NCT04444284|Vaccines|vaccines|mesh-list
15124182|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
15124183|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124184|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
15124185|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15124186|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124187|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15124188|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15124189|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124190|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124191|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124192|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15124193|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15124194|NCT04444193|Durvalumab|durvalumab|mesh-list
15124195|NCT04444193|Lenvatinib|lenvatinib|mesh-list
15124196|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15124197|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15124198|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124199|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
15124200|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124201|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124202|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124203|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124204|NCT04444492|Ranibizumab|ranibizumab|mesh-list
15124205|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15124206|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15124207|NCT04444492|Growth Substances|growth substances|mesh-ancestor
15124208|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124209|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
15124210|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124211|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
15124212|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15124213|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15124214|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124215|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
15124216|NCT04443920|Coagulants|coagulants|mesh-ancestor
15124217|NCT04443946|Sufentanil|sufentanil|mesh-list
15124218|NCT04443946|Propofol|propofol|mesh-list
15124219|NCT04443946|Sevoflurane|sevoflurane|mesh-list
15124220|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15124221|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124222|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124223|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15124224|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
15124225|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
15124226|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15124227|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15124228|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15124229|NCT04443946|Narcotics|narcotics|mesh-ancestor
15124230|NCT04443946|Analgesics|analgesics|mesh-ancestor
15124231|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
15124232|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124233|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15124234|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
15124235|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
15124236|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
15124237|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15124238|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124239|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124240|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177866|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
15124241|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124242|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124243|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
15124244|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
15124245|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15124246|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
15124247|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124248|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124249|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15124250|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
15124251|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15124252|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
15124253|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124254|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124255|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15124256|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
15124257|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
15124258|NCT04443868|Protective Agents|protective agents|mesh-ancestor
15124259|NCT04443556|Tramadol|tramadol|mesh-list
15124260|NCT04443556|Anesthetics|anesthetics|mesh-list
15124261|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
15124262|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124263|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124264|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15124265|NCT04443556|Narcotics|narcotics|mesh-ancestor
15124266|NCT04443556|Analgesics|analgesics|mesh-ancestor
15124267|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
15124268|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124269|NCT04443634|Bupivacaine|bupivacaine|mesh-list
15124270|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
15124271|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
15124272|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124273|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124274|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
15124275|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124276|NCT04443673|Glycine|glycine|mesh-list
15124277|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
15124278|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124279|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124280|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124281|NCT04443517|Propofol|propofol|mesh-list
15124282|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
15124283|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124284|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124285|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15124286|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15124287|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
15177867|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177868|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177869|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15177870|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
15177871|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
15177872|NCT03964324|Protective Agents|protective agents|mesh-ancestor
15181876|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181877|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181878|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181879|NCT03926182|Aflutinib|aflutinib|mesh-list
15181880|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15181881|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181882|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181883|NCT03926156|Warfarin|warfarin|mesh-list
15181884|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
15181885|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
15181886|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15181887|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
15181888|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15181889|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
15181890|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181891|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181892|NCT03926000|Pregabalin|pregabalin|mesh-list
15181893|NCT03926000|Analgesics|analgesics|mesh-ancestor
15181894|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
15181895|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181896|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124288|NCT04444011|Amoxicillin|amoxicillin|mesh-list
15124289|NCT04444011|Clarithromycin|clarithromycin|mesh-list
15124290|NCT04444011|Bismuth|bismuth|mesh-list
15124291|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15124292|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124293|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15124294|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124295|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124296|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15124297|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15124298|NCT04444011|Antacids|antacids|mesh-ancestor
15124299|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15124300|NCT04443647|Oxytocin|oxytocin|mesh-list
15124301|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
15124302|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15124303|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124304|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15124305|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124306|NCT04443387|Vitamin D|vitamin d|mesh-list
15124307|NCT04443387|Vitamins|vitamins|mesh-ancestor
15124308|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
15124309|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124310|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15124311|NCT04443543|Fluorouracil|fluorouracil|mesh-list
15124312|NCT04443543|Capecitabine|capecitabine|mesh-list
15124313|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
15124314|NCT04443543|Irinotecan|irinotecan|mesh-list
15124315|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
15124316|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124317|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15124318|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124319|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124320|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
15124321|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124322|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15124323|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15124324|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124325|NCT04443270|Chloroquine|chloroquine|mesh-list
15124326|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15124327|NCT04443270|Amebicides|amebicides|mesh-ancestor
15124328|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15124329|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124330|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124331|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
15124332|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124333|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15124334|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15124335|NCT04443270|Analgesics|analgesics|mesh-ancestor
15124336|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
15124337|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124338|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124339|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124340|NCT04443270|Filaricides|filaricides|mesh-ancestor
15124341|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
15124342|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
15124343|NCT04443322|Durvalumab|durvalumab|mesh-list
15124344|NCT04443322|Lenvatinib|lenvatinib|mesh-list
15124345|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15124346|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15124347|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124348|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
15124349|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124350|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124351|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124352|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124353|NCT04443036|Paclitaxel|paclitaxel|mesh-list
15124354|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15124355|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15124356|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124357|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
15124358|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
15124359|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
15124360|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124361|NCT04443049|Mebendazole|mebendazole|mesh-list
15124362|NCT04443049|Piperazine|piperazine|mesh-list
15124363|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
15124364|NCT04443049|Lenvatinib|lenvatinib|mesh-list
15124365|NCT04443049|DMP 777|dmp 777|mesh-list
15124366|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124367|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124368|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124369|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124370|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
15124371|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
15124372|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124373|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124374|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
15124375|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
15124376|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
15124377|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
15124378|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15124379|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
15124380|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124381|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
15124382|NCT04443166|Protective Agents|protective agents|mesh-ancestor
15124383|NCT04442919|Morphine|morphine|mesh-list
15124384|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
15124385|NCT04442919|Ticagrelor|ticagrelor|mesh-list
15124386|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15124387|NCT04442919|Narcotics|narcotics|mesh-ancestor
15124388|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124389|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124390|NCT04442919|Analgesics|analgesics|mesh-ancestor
15124391|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
15124392|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124393|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15124394|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15124395|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15124396|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15124397|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
15124398|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124399|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124400|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15124401|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
15124402|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
15124403|NCT04442750|Bupivacaine|bupivacaine|mesh-list
15124404|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
15124405|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
15124406|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124407|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124408|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
15124409|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124410|NCT04442984|Leucovorin|leucovorin|mesh-list
15124411|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
15124412|NCT04442984|Irinotecan|irinotecan|mesh-list
15124413|NCT04442984|Fluorouracil|fluorouracil|mesh-list
15124414|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124415|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15124416|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15124417|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124418|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124419|NCT04442984|Antidotes|antidotes|mesh-ancestor
15124420|NCT04442984|Protective Agents|protective agents|mesh-ancestor
15124421|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124422|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
15124423|NCT04442984|Vitamins|vitamins|mesh-ancestor
15124424|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
15124425|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
15124426|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15124427|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124428|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
15124429|NCT04442906|Fentanyl|fentanyl|mesh-list
15124430|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
15124431|NCT04442906|Bupivacaine|bupivacaine|mesh-list
15124432|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
15124433|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
15124434|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124435|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124436|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
15124437|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124438|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15124439|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15124440|NCT04442906|Analgesics|analgesics|mesh-ancestor
14292394|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124441|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15124442|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15124443|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15124444|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
15124445|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124446|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124447|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15124448|NCT04442906|Narcotics|narcotics|mesh-ancestor
15124449|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15124450|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15124451|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
15124452|NCT04443309|Lenvatinib|lenvatinib|mesh-list
15124453|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124454|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124455|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124456|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124457|NCT04442412|Vitamin D|vitamin d|mesh-list
15124458|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
15124459|NCT04442412|Vitamins|vitamins|mesh-ancestor
15124460|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
15124461|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124462|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15124463|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15124464|NCT04442633|Miconazole|miconazole|mesh-list
15124465|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
15124466|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124467|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15124468|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15124469|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124470|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124471|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15124472|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
15124473|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124474|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124475|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15124476|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15124477|NCT04441918|Antibodies|antibodies|mesh-list
15124478|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15124479|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
15124480|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124481|NCT04441385|Maraviroc|maraviroc|mesh-list
15124482|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15124483|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15124484|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124485|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15124486|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15124487|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
15124488|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124489|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15124490|NCT04441424|Azithromycin|azithromycin|mesh-list
15124491|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
15124492|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15124493|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124494|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
15124495|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15124496|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124497|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124498|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124499|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15177873|NCT03964051|Omalizumab|omalizumab|mesh-list
15177874|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15177875|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15177876|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
15177877|NCT03963752|Megestrol|megestrol|mesh-list
15177878|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
15177879|NCT03963752|Leuprolide|leuprolide|mesh-list
15177880|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15177881|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15177882|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15177883|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
15177884|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15177885|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177886|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15177887|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15177888|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124500|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
15124501|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124502|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124503|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
15124504|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15124505|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
15124506|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124507|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
15124508|NCT04441528|Protective Agents|protective agents|mesh-ancestor
15124509|NCT04441112|Triamcinolone|triamcinolone|mesh-list
15124510|NCT04441112|Ketorolac|ketorolac|mesh-list
15124511|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124512|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
15124513|NCT04441112|Hormones|hormones|mesh-ancestor
15124514|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124515|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124516|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124517|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124518|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15124519|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15124520|NCT04441112|Analgesics|analgesics|mesh-ancestor
15124521|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
15124522|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124523|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124524|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15124525|NCT04440917|Apatinib|apatinib|mesh-list
15124526|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15124527|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124528|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124529|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124530|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124531|NCT04441138|Durvalumab|durvalumab|mesh-list
15124532|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15124533|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124534|NCT04441021|Penicillins|penicillins|mesh-list
15124535|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15124536|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124537|NCT04440371|Betamethasone|betamethasone|mesh-list
15124538|NCT04440371|Calcipotriene|calcipotriene|mesh-list
15124539|NCT04440371|Tacrolimus|tacrolimus|mesh-list
15124540|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124541|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
15124542|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124543|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15124544|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124545|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124546|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124547|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
15124548|NCT04440371|Hormones|hormones|mesh-ancestor
15124549|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124550|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15124551|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
15124552|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
15124553|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
15124554|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15124555|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124556|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124557|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15124558|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15124559|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
15124560|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
15124561|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
15124562|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124563|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
15124564|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15124565|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15124566|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15124567|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
15124568|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124569|NCT04440280|Expectorants|expectorants|mesh-ancestor
15124570|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
15124571|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15124572|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
15124573|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124574|NCT04440280|Protective Agents|protective agents|mesh-ancestor
15181897|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
15124575|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124576|NCT04440280|Antidotes|antidotes|mesh-ancestor
15124577|NCT04440267|Dexamethasone|dexamethasone|mesh-list
15124578|NCT04440267|Prednisone|prednisone|mesh-list
15124579|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
15124580|NCT04440267|Methotrexate|methotrexate|mesh-list
15124581|NCT04440267|Vincristine|vincristine|mesh-list
15124582|NCT04440267|Daunorubicin|daunorubicin|mesh-list
15124583|NCT04440267|Asparaginase|asparaginase|mesh-list
15124584|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
15124585|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124586|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
15124587|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124588|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124589|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15124590|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
15124591|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124592|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124593|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15124594|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124595|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
15124596|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
15124597|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124598|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15124599|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
15124600|NCT04440267|Hormones|hormones|mesh-ancestor
15124601|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124602|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124603|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15124604|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
15124605|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15124606|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15124607|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
15124608|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
15124609|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124610|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15124611|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15124612|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15124613|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
15124614|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
15124615|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
15124616|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15124617|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15124618|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15124619|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
15124620|NCT04440436|Fludarabine|fludarabine|mesh-list
15124621|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124622|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
15124623|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124624|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124625|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15124626|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
15124627|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124628|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124629|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15124630|NCT04440085|Midodrine|midodrine|mesh-list
15124631|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
15124632|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
15124633|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124634|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124635|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15124636|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15124637|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15124638|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15124639|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
15124640|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124641|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124642|NCT04439929|Adalimumab|adalimumab|mesh-list
15124643|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124644|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124645|NCT04439890|Carboplatin|carboplatin|mesh-list
15124646|NCT04439890|Pemetrexed|pemetrexed|mesh-list
15124647|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124648|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124649|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124650|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15124651|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15124652|NCT04439786|Lidocaine|lidocaine|mesh-list
15124653|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
15124654|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
15124655|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124656|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124657|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
15124658|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124659|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15124660|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15124661|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15124662|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124663|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124664|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
15124665|NCT04439799|Testosterone|testosterone|mesh-list
15124666|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
15124667|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
15124668|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15124669|NCT04439799|Androgens|androgens|mesh-ancestor
15124670|NCT04439799|Hormones|hormones|mesh-ancestor
15124671|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124672|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124673|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124674|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124675|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
15124676|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
15124677|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15124678|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124679|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124680|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
15124681|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124682|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124683|NCT04439773|Lidocaine|lidocaine|mesh-list
15124684|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
15124685|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
15124686|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124687|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124688|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
15124689|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124690|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15124691|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15124692|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14269576|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269577|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15124693|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124694|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124695|NCT04439474|Vitamin D|vitamin d|mesh-list
15124696|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
15124697|NCT04439474|Vitamins|vitamins|mesh-ancestor
15124698|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
15124699|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124700|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15124701|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15124702|NCT04439305|Dasatinib|dasatinib|mesh-list
15124703|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124704|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124705|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124706|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124707|NCT04439487|Anesthetics|anesthetics|mesh-list
15124708|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124709|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124710|NCT04439396|Ketorolac|ketorolac|mesh-list
15124711|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15124712|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15124713|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15124714|NCT04439396|Analgesics|analgesics|mesh-ancestor
15124715|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
15124716|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124717|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124718|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124719|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124720|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15124721|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124722|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177889|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177890|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
15177891|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15177892|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15177893|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
15177894|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
15177895|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15177896|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
15177897|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177898|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177899|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15177900|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
15177901|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15177902|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
15177903|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177904|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177905|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15177906|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
15177907|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
15177908|NCT03963648|Protective Agents|protective agents|mesh-ancestor
15177909|NCT03963375|Cladribine|cladribine|mesh-list
15177910|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177911|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15177912|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
15177913|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177914|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
15177915|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15177916|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15177917|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177918|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
15177919|NCT03963466|Coagulants|coagulants|mesh-ancestor
15177920|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
15177921|NCT03963479|Pyridoxal|pyridoxal|mesh-list
15177922|NCT03963479|Pyridoxine|pyridoxine|mesh-list
15177923|NCT03963479|Vitamins|vitamins|mesh-ancestor
15177924|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
15177925|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177926|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
15177927|NCT03963336|Acetazolamide|acetazolamide|mesh-list
15177928|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
15177929|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15177930|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177931|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177932|NCT03963336|Diuretics|diuretics|mesh-ancestor
15177933|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
15177934|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177935|NCT03963193|Cisplatin|cisplatin|mesh-list
15177936|NCT03963193|Irinotecan|irinotecan|mesh-list
15177937|NCT03963193|Etoposide|etoposide|mesh-list
15177938|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177939|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15177940|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15177941|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177942|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177943|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15177944|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15177945|NCT03963115|Epinephrine|epinephrine|mesh-list
15177946|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15177947|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15177948|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
15177949|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177950|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177951|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177952|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15177953|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15177954|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
15177955|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15177956|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15177957|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
15177958|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
15177959|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
15177960|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15177961|NCT03963024|Treosulfan|treosulfan|mesh-list
15177962|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15124723|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
15124724|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15124725|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15124726|NCT04438980|Prednisolone|prednisolone|mesh-list
15124727|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
15124728|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15124729|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
15124730|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124731|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
15124732|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
15124733|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124734|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124735|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15124736|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
15124737|NCT04438980|Hormones|hormones|mesh-ancestor
15124738|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124739|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15124740|NCT04438980|Protective Agents|protective agents|mesh-ancestor
15124741|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124742|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124743|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15124744|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124745|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
15124746|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
15124747|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15124748|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124749|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124750|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124751|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124752|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124753|NCT04438902|Osimertinib|osimertinib|mesh-list
15124754|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124755|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15124756|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124757|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124758|NCT04438733|Anastrozole|anastrozole|mesh-list
15124759|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124760|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124761|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15124762|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15124763|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124764|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124765|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15124766|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
15124767|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124768|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124769|NCT04438811|Anesthetics|anesthetics|mesh-list
15124770|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124771|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124772|NCT04438850|Ivermectin|ivermectin|mesh-list
15124773|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124774|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124775|NCT04438928|Micronutrients|micronutrients|mesh-list
15124776|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124777|NCT04438720|Nifedipine|nifedipine|mesh-list
15124778|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15124779|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124780|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124781|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15124782|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124783|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
15124784|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
15124785|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15124786|NCT04438772|Anesthetics|anesthetics|mesh-list
15124787|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124788|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124789|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
15124790|NCT04438213|Metolazone|metolazone|mesh-list
15124791|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15124792|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124793|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15124794|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124795|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15124796|NCT04438213|Diuretics|diuretics|mesh-ancestor
15124797|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
15124798|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15124799|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124800|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
15124801|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15124802|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15124803|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
15124804|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15124805|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124806|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
15124807|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
15124808|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15124809|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
15124810|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124811|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
15124812|NCT04438421|Protective Agents|protective agents|mesh-ancestor
15124813|NCT04438577|Lidocaine|lidocaine|mesh-list
15124814|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
15124815|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
15124816|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124817|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124818|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
15124819|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124820|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15124821|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15124822|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15124823|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124824|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124825|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
15124826|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15124827|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
15124828|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15124829|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15124830|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
15124831|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15124832|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124833|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
15124834|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
15124835|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15124836|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
15124837|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124838|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
15124839|NCT04438434|Protective Agents|protective agents|mesh-ancestor
15124840|NCT04437836|Rifampin|rifampin|mesh-list
15124841|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15124842|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
15124843|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15124844|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124845|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
15124846|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15124847|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124848|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124849|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15124850|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15124851|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15124852|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15124853|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15124854|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15124855|NCT04437758|Ascorbic Acid|ascorbic acid|mesh-list
15124856|NCT04437758|Vitamins|vitamins|mesh-ancestor
15124857|NCT04437758|Micronutrients|micronutrients|mesh-ancestor
15124858|NCT04437758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124859|NCT04437758|Antioxidants|antioxidants|mesh-ancestor
15124860|NCT04437758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124861|NCT04437758|Protective Agents|protective agents|mesh-ancestor
15124862|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
15124863|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
15124864|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15124865|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15124866|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15124867|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124868|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124869|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124870|NCT04437654|Apixaban|apixaban|mesh-list
15124871|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15124872|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
15124873|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15124874|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
15124875|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15124876|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124877|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
15124878|NCT04437329|Cisplatin|cisplatin|mesh-list
15124879|NCT04437329|Docetaxel|docetaxel|mesh-list
15124880|NCT04437329|Fluorouracil|fluorouracil|mesh-list
15124881|NCT04437329|Nedaplatin|nedaplatin|mesh-list
15124882|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124883|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
15124884|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
15124885|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
15124886|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124887|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
15124888|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15124889|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124890|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
15124891|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124892|NCT04437004|Fenfluramine|fenfluramine|mesh-list
15124893|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15124894|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15124895|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124896|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124897|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124898|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
15124899|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124900|NCT04437225|Glycolic acid|glycolic acid|mesh-list
15124901|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
15124902|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
15124903|NCT04437017|Dexamethasone|dexamethasone|mesh-list
15124904|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
15124905|NCT04437017|Olanzapine|olanzapine|mesh-list
15124906|NCT04437017|Serotonin|serotonin|mesh-list
15124907|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15124908|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
15124909|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
15124910|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124911|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124912|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15124913|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
15124914|NCT04437017|Hormones|hormones|mesh-ancestor
15124915|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15124916|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15124917|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15124918|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15124919|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15124920|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124921|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15124922|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15124923|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15124924|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124925|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124926|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124927|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
15124928|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15124929|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
15124930|NCT04437160|Epirubicin|epirubicin|mesh-list
15124931|NCT04437160|Pirarubicin|pirarubicin|mesh-list
15124932|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15124933|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
15124934|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124935|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15124936|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15124937|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
15124938|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124939|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996197|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124940|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15124941|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15124942|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15124943|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15124944|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177963|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
15177964|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177965|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177966|NCT03963128|Vitamin D|vitamin d|mesh-list
15177967|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
15177968|NCT03963128|Vitamins|vitamins|mesh-ancestor
15177969|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
15177970|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177971|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15177972|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15177973|NCT03962881|Vaccines|vaccines|mesh-list
15177974|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
15177975|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177976|NCT03962920|Tigecycline|tigecycline|mesh-list
15177977|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177978|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177979|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15177980|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177981|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177982|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
15177983|NCT03962907|Mupirocin|mupirocin|mesh-list
15177984|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15177985|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15177986|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
15177987|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15177988|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15177989|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15177990|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177991|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
15177992|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15177993|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
15177994|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15177995|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15177996|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15177997|NCT03962647|Letrozole|letrozole|mesh-list
15177998|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15177999|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15178000|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15178001|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178002|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178003|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15178004|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
15178005|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178006|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178007|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
15178008|NCT03962725|Ketamine|ketamine|mesh-list
15178009|NCT03962725|Propofol|propofol|mesh-list
15178010|NCT03962725|Anesthetics|anesthetics|mesh-list
15178011|NCT03962725|Rocuronium|rocuronium|mesh-list
15178012|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15178013|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15178014|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178015|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178016|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15178017|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
15178018|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178019|NCT03962725|Analgesics|analgesics|mesh-ancestor
15178020|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
15178021|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178022|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15178023|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15178024|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15178025|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
15178026|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178027|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178028|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15178029|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15178030|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15178031|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15124945|NCT04436796|Pancrelipase|pancrelipase|mesh-list
15124946|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15124947|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
15124948|NCT04436926|Narcotics|narcotics|mesh-ancestor
15124949|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124950|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124951|NCT04436926|Analgesics|analgesics|mesh-ancestor
15124952|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
15124953|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124954|NCT04436601|Lactulose|lactulose|mesh-list
15124955|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15124956|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
15124957|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
15124958|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124959|NCT04436419|Protective Agents|protective agents|mesh-ancestor
15124960|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124961|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
15124962|NCT04436419|Vitamins|vitamins|mesh-ancestor
15124963|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
15124964|NCT04436536|Methamphetamine|methamphetamine|mesh-list
15124965|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15124966|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124967|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
15124968|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
15124969|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124970|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
15124971|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124972|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124973|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
15124974|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15124975|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15124976|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15124977|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15124978|NCT04436172|Anesthetics|anesthetics|mesh-list
15124979|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124980|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124981|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
15124982|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15124983|NCT04436250|Ketamine|ketamine|mesh-list
15124984|NCT04436250|Esketamine|esketamine|mesh-list
15124985|NCT04436250|Analgesics|analgesics|mesh-ancestor
15124986|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
15124987|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15124988|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15124989|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15124990|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15124991|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
15124992|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
15124993|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15124994|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15124995|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15124996|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15124997|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15124998|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
15124999|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15125000|NCT04436107|Lenalidomide|lenalidomide|mesh-list
15125001|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
15125002|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
15125003|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125004|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15125005|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15125006|NCT04436107|Growth Substances|growth substances|mesh-ancestor
15125007|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
15125008|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125009|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15125010|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125011|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125012|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
15125013|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125014|NCT04435925|Fentanyl|fentanyl|mesh-list
15125015|NCT04435925|Remifentanil|remifentanil|mesh-list
15125016|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15125017|NCT04435925|Narcotics|narcotics|mesh-ancestor
15125018|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125019|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125020|NCT04435925|Analgesics|analgesics|mesh-ancestor
15125021|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
15125022|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125023|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15125024|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15125025|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
15125026|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
15125027|NCT04435743|Lenalidomide|lenalidomide|mesh-list
15125028|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
15125029|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125030|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15125031|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15125032|NCT04435743|Growth Substances|growth substances|mesh-ancestor
15125033|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
15125034|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125035|NCT04435704|Oxytocin|oxytocin|mesh-list
15125036|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
15125037|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125038|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125039|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15125040|NCT04435587|Ritonavir|ritonavir|mesh-list
15125041|NCT04435587|Darunavir|darunavir|mesh-list
15125042|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
15125043|NCT04435587|Ivermectin|ivermectin|mesh-list
15125044|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15125045|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15125046|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
15125047|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125048|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125049|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15125050|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15125051|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
15125052|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125053|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15125054|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15125055|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
15125056|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15125057|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125058|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125059|NCT04435652|Paclitaxel|paclitaxel|mesh-list
15125060|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15125061|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15125062|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125063|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
15125064|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
15125065|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
15125066|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125067|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
15125068|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125069|NCT04435522|Maraviroc|maraviroc|mesh-list
14269578|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269579|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
14269580|NCT00403546|Ziprasidone|ziprasidone|mesh-list
14269581|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14269582|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
14269583|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269584|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269585|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269586|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14269587|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14269588|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269589|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269590|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14269591|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
14269592|NCT00403585|Adefovir|adefovir|mesh-list
14269593|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14269594|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
14269595|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269596|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14269597|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14269598|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269599|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125070|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14269600|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15125071|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15125072|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125073|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15125074|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15125075|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
15125076|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125077|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15125078|NCT04435574|Lactoferrin|lactoferrin|mesh-list
15125079|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125080|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
15125081|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125082|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125083|NCT04435418|Apixaban|apixaban|mesh-list
15125084|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15125085|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
15125086|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15125087|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
15125088|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125089|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125090|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
15125091|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
15125092|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15125093|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125094|NCT04435015|Camostat|camostat|mesh-list
15125095|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
15125096|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125097|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125098|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15125099|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15178032|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15178033|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
15178034|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15178035|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178036|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
15178037|NCT03962803|Vaccines|vaccines|mesh-list
15178038|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
15178039|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178040|NCT03962816|Vaccines|vaccines|mesh-list
15178041|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
15178042|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178043|NCT03962686|Metformin|metformin|mesh-list
15178044|NCT03962686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15178045|NCT03962686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178046|NCT03962114|Niacinamide|niacinamide|mesh-list
15178047|NCT03962114|Vitamins|vitamins|mesh-ancestor
15178048|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
15178049|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178050|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
15178051|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
15178052|NCT03962296|Calcium|calcium|mesh-list
15178053|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15178054|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178055|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
15178056|NCT03962296|Coagulants|coagulants|mesh-ancestor
15178057|NCT03962283|Rifaximin|rifaximin|mesh-list
15178058|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178059|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178060|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178061|NCT03961867|Docetaxel|docetaxel|mesh-list
15178062|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
15178063|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178064|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
15178065|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
15178066|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
15178067|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181898|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15181899|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15181900|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181901|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15181902|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15181903|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15181904|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181905|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15181906|NCT03925818|Metronidazole|metronidazole|mesh-list
15181907|NCT03925818|Tetracycline|tetracycline|mesh-list
15181908|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
15181909|NCT03925818|Pantoprazole|pantoprazole|mesh-list
15181910|NCT03925818|Bismuth|bismuth|mesh-list
15181911|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181912|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181913|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15181914|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125100|NCT04435028|Ketotifen|ketotifen|mesh-list
15125101|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
15125102|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
15125103|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15125104|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
15125105|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
15125106|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125107|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125108|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125109|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15125110|NCT04435210|Hydralazine|hydralazine|mesh-list
15125111|NCT04435210|Nifedipine|nifedipine|mesh-list
15125112|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15125113|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15125114|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125115|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15125116|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125117|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
15125118|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
15125119|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125120|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15125121|NCT04434482|Temozolomide|temozolomide|mesh-list
15125122|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15125123|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
15125124|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125125|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125126|NCT04434560|Nivolumab|nivolumab|mesh-list
15125127|NCT04434560|Ipilimumab|ipilimumab|mesh-list
15125128|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15125129|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125130|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15125131|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125132|NCT04434378|Tamsulosin|tamsulosin|mesh-list
15125133|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15125134|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15125135|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15125136|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
15125137|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125138|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125139|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125140|NCT04434378|Urological Agents|urological agents|mesh-ancestor
15125141|NCT04434664|Metoprolol|metoprolol|mesh-list
15125142|NCT04434664|Amlodipine|amlodipine|mesh-list
15125143|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15125144|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15125145|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15125146|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125147|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15125148|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125149|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
15125150|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15125151|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
15125152|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
15125153|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125154|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15125155|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15125156|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15125157|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
15125158|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125159|NCT04434404|Silymarin|silymarin|mesh-list
15125160|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
15125161|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125162|NCT04434404|Protective Agents|protective agents|mesh-ancestor
15125163|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125164|NCT04434430|Gabapentin|gabapentin|mesh-list
15125165|NCT04434430|Analgesics|analgesics|mesh-ancestor
15125166|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
15125167|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125168|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125169|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
15125170|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15125171|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15125172|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125173|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15125174|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15125175|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15125176|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125177|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125178|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
15125179|NCT04434365|Aspirin|aspirin|mesh-list
15125180|NCT04434365|Clopidogrel|clopidogrel|mesh-list
15125181|NCT04434365|Atorvastatin|atorvastatin|mesh-list
15125182|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15125183|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15125184|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15125185|NCT04434365|Analgesics|analgesics|mesh-ancestor
15125186|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
15125187|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125188|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125189|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125190|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125191|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15125192|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15125193|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125194|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15125195|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15125196|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125197|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
15125198|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15125199|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15125200|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
15125201|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15125202|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15125203|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15125204|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15125205|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15125206|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
15125207|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125208|NCT04434248|Ritonavir|ritonavir|mesh-list
15125209|NCT04434248|Lopinavir|lopinavir|mesh-list
15125210|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
15125211|NCT04434248|Chloroquine|chloroquine|mesh-list
15125212|NCT04434248|Favipiravir|favipiravir|mesh-list
13996198|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996199|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
15125213|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15125214|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15125215|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
15125216|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125217|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125218|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15125219|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15125220|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
15125221|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125222|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15125223|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15125224|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
15125225|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15125226|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125227|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125228|NCT04434248|Amebicides|amebicides|mesh-ancestor
15125229|NCT04434105|Triamcinolone|triamcinolone|mesh-list
15125230|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15125231|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15125232|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15125233|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125234|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
15125235|NCT04434105|Hormones|hormones|mesh-ancestor
15125236|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125237|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125238|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15125239|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
15125240|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125241|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125242|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
15125243|NCT04434144|Azithromycin|azithromycin|mesh-list
15125244|NCT04434144|Doxycycline|doxycycline|mesh-list
15125245|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
15125246|NCT04434144|Ivermectin|ivermectin|mesh-list
15125247|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15125248|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125249|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
15125250|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15125251|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125252|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125253|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125254|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125255|NCT04434170|Valsartan|valsartan|mesh-list
15125256|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15125257|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15125258|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15125259|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15125260|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125261|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15125262|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15125263|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15125264|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
14269601|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14269602|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
14269603|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269604|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269605|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14269606|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
14269607|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14269608|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14269609|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14269610|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
14269611|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269612|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269613|NCT00403767|Warfarin|warfarin|mesh-list
14269614|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
14269615|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
14269616|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14269617|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
14269618|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15125265|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125266|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15125267|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15125268|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125269|NCT04433780|Tenofovir|tenofovir|mesh-list
15125270|NCT04433780|Lamivudine|lamivudine|mesh-list
15125271|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
15125272|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125273|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15125274|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15125275|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125276|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125277|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15125278|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15125279|NCT04433611|Lidocaine|lidocaine|mesh-list
15125280|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
15125281|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
15125282|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125283|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125284|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
15125285|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125286|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15125287|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15125288|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15125289|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15125290|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125291|NCT04433481|Dabigatran|dabigatran|mesh-list
15125292|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
15125293|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15125294|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
15125295|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125296|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125297|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
15125298|NCT04433494|Tamoxifen|tamoxifen|mesh-list
15125299|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15125300|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
15125301|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125302|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125303|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125304|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269619|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
14269620|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269621|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269622|NCT00404066|Dexamethasone|dexamethasone|mesh-list
14269623|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
14269624|NCT00404066|Docetaxel|docetaxel|mesh-list
14269625|NCT00404066|Doxorubicin|doxorubicin|mesh-list
14269626|NCT00404066|Trastuzumab|trastuzumab|mesh-list
14269627|NCT00404066|Lapatinib|lapatinib|mesh-list
14269628|NCT00404066|Lenograstim|lenograstim|mesh-list
14269629|NCT00404066|Sargramostim|sargramostim|mesh-list
14269630|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269631|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
14561740|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
15125305|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15125306|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15125307|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15125308|NCT04433741|Oxytocin|oxytocin|mesh-list
15125309|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
15125310|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125311|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125312|NCT04433572|Sirolimus|sirolimus|mesh-list
15125313|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15125314|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125315|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15125316|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125317|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
15125318|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15125319|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
15125320|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125321|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
15125322|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
15125323|NCT04433559|Tadalafil|tadalafil|mesh-list
15125324|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
15125325|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15125326|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15125327|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125328|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125329|NCT04433559|Urological Agents|urological agents|mesh-ancestor
15125330|NCT04433169|Tretinoin|tretinoin|mesh-list
15125331|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125332|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
15125333|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
15125334|NCT04433156|Prednisone|prednisone|mesh-list
15125335|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
15125336|NCT04433156|Rituximab|rituximab|mesh-list
15125337|NCT04433156|Bortezomib|bortezomib|mesh-list
15125338|NCT04433156|Epirubicin|epirubicin|mesh-list
15125339|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15125340|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
15125341|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125342|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125343|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15125344|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
15125345|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269632|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269633|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269634|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15125346|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125347|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15125348|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15125349|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125350|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
15125351|NCT04433156|Hormones|hormones|mesh-ancestor
15125352|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125353|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125354|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15125355|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15125356|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15125357|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178068|NCT03961958|Propofol|propofol|mesh-list
15178069|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15178070|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178071|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178072|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15178073|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
15178074|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
15178075|NCT03961919|Fludarabine|fludarabine|mesh-list
15178076|NCT03961919|Treosulfan|treosulfan|mesh-list
15178077|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178078|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178079|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15178080|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
15178081|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
15178082|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178083|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
15178084|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15178085|NCT03961828|Ledipasvir|ledipasvir|mesh-list
15178086|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
15178087|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178088|NCT03961659|Metformin|metformin|mesh-list
15178089|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
15178090|NCT03961659|Acarbose|acarbose|mesh-list
15178091|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15178092|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178093|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15178094|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178095|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15178096|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178097|NCT03961464|Cycloserine|cycloserine|mesh-list
15178098|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15178099|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178100|NCT03961464|Renal Agents|renal agents|mesh-ancestor
15178101|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15178102|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
15178103|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178104|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
15178105|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178106|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15178107|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15178108|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
15178109|NCT03961503|Vancomycin|vancomycin|mesh-list
15178110|NCT03961503|Daptomycin|daptomycin|mesh-list
15178111|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178112|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178113|NCT03961698|Paclitaxel|paclitaxel|mesh-list
15178114|NCT03961698|Bevacizumab|bevacizumab|mesh-list
15178115|NCT03961698|Atezolizumab|atezolizumab|mesh-list
15178116|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15178117|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178118|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
15178119|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
15178120|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
15178121|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178122|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14811298|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14811299|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14811300|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811301|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178123|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15178124|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15178125|NCT03961698|Growth Substances|growth substances|mesh-ancestor
15178126|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811302|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14811303|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14811304|NCT00844727|Analgesics|analgesics|mesh-ancestor
14811305|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
14811306|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811307|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811308|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811309|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125358|NCT04433143|Minocycline|minocycline|mesh-list
15125359|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269635|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
14269636|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811310|NCT00844740|Cinacalcet|cinacalcet|mesh-list
14811311|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14811312|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811313|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14811314|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
14811315|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811316|NCT00844792|Vitamin D|vitamin d|mesh-list
14811317|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
14811318|NCT00844792|Vitamins|vitamins|mesh-list
14811319|NCT00844792|Vitamin E|vitamin e|mesh-list
14811320|NCT00844792|Selenium|selenium|mesh-list
14811321|NCT00844792|Lycopene|lycopene|mesh-list
15125360|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125361|NCT04433078|Doxycycline|doxycycline|mesh-list
15125362|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15125363|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125364|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
15125365|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15125366|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125367|NCT04432714|Prednisone|prednisone|mesh-list
15125368|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
15125369|NCT04432714|Rituximab|rituximab|mesh-list
15125370|NCT04432714|Doxorubicin|doxorubicin|mesh-list
15125371|NCT04432714|Etoposide|etoposide|mesh-list
15125372|NCT04432714|Vincristine|vincristine|mesh-list
15125373|NCT04432714|Lenalidomide|lenalidomide|mesh-list
15125374|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15125375|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
15125376|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125377|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125378|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15125379|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
15125380|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125381|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125382|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15125383|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15125384|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15125385|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15125386|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15125387|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125388|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125389|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
15125390|NCT04432714|Hormones|hormones|mesh-ancestor
15125391|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125392|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125393|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15125394|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
15125395|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
14811322|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
15125396|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
15125397|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15125398|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15125399|NCT04432714|Growth Substances|growth substances|mesh-ancestor
15125400|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
15125401|NCT04432974|Anesthetics|anesthetics|mesh-list
15125402|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125403|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125404|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15125405|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15125406|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15125407|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811323|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125408|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125409|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15125410|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15125411|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15125412|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15125413|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
15125414|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125415|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125416|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15125417|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15125418|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
15125419|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15125420|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15125421|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
15125422|NCT04432662|Epoetin Alfa|epoetin alfa|mesh-list
15125423|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
15125424|NCT04432662|Hematinics|hematinics|mesh-ancestor
15125425|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
15125426|NCT04432506|Fludarabine|fludarabine|mesh-list
15125427|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15125428|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15125429|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
15125430|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125431|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125432|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15125433|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
15125434|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125435|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125436|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15125437|NCT04432415|Fluorides|fluorides|mesh-list
15125438|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
15125439|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
15125440|NCT04432415|Protective Agents|protective agents|mesh-ancestor
15125441|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125442|NCT04432558|Acetaminophen|acetaminophen|mesh-list
15125443|NCT04432558|Diclofenac|diclofenac|mesh-list
15125444|NCT04432558|Tramadol|tramadol|mesh-list
15125445|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15125446|NCT04432558|Analgesics|analgesics|mesh-ancestor
15125447|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
15125448|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125449|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125450|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
15125451|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15125452|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125453|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125454|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15125455|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125456|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125457|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15125458|NCT04432558|Narcotics|narcotics|mesh-ancestor
15125459|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125460|NCT04432402|Gemcitabine|gemcitabine|mesh-list
15125461|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
15125462|NCT04432402|Lenalidomide|lenalidomide|mesh-list
15125463|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125464|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
15125465|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125466|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15125467|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
15125468|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125469|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
15125470|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125471|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125472|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15125473|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15125474|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15125475|NCT04432402|Growth Substances|growth substances|mesh-ancestor
15125476|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
15125477|NCT04432428|Sufentanil|sufentanil|mesh-list
15125478|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15125479|NCT04432428|Narcotics|narcotics|mesh-ancestor
15125480|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125481|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125482|NCT04432428|Analgesics|analgesics|mesh-ancestor
15125483|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
15125484|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125485|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14811324|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14811325|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14811326|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
14811327|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811328|NCT00844792|Protective Agents|protective agents|mesh-ancestor
14811329|NCT00844792|Trace Elements|trace elements|mesh-ancestor
14811330|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811331|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14811332|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14811333|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811334|NCT00845104|Bevacizumab|bevacizumab|mesh-list
14811335|NCT00845104|Rituximab|rituximab|mesh-list
14811336|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14811337|NCT00845104|Fludarabine|fludarabine|mesh-list
14811338|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
14811339|NCT00845104|Antibodies|antibodies|mesh-list
15125486|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15125487|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
15125488|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
15125489|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
15125490|NCT04432324|Antibodies|antibodies|mesh-list
15125491|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
15125492|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15125493|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15125494|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
15125495|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125496|NCT04432220|Apixaban|apixaban|mesh-list
15125497|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15125498|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
15125499|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15125500|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
15125501|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269637|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269638|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14269639|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269640|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
14269641|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
14269642|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269643|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996200|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
15125502|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125503|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
15125504|NCT04432259|Dexamethasone|dexamethasone|mesh-list
15125505|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125506|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
15125507|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
15125508|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561741|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561742|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561743|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
14561744|NCT00002804|Protective Agents|protective agents|mesh-ancestor
14561745|NCT00002804|Trace Elements|trace elements|mesh-ancestor
14561746|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
14561747|NCT00002805|Cobalt|cobalt|mesh-list
14561748|NCT00002805|Cytarabine|cytarabine|mesh-list
14561749|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
14561750|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14561751|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14561752|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14561753|NCT00002805|Methotrexate|methotrexate|mesh-list
14561754|NCT00002805|Etoposide|etoposide|mesh-list
14561755|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
14561756|NCT00002805|Cladribine|cladribine|mesh-list
14561757|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561758|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561759|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561760|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561761|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561762|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
14561763|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125509|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125510|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15125511|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
13996201|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
14561764|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811340|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
14811341|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15125512|NCT04432259|Hormones|hormones|mesh-ancestor
15178127|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
15125513|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125514|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125515|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125516|NCT04432233|Metronidazole|metronidazole|mesh-list
15125517|NCT04432233|Levofloxacin|levofloxacin|mesh-list
15125518|NCT04432233|Ofloxacin|ofloxacin|mesh-list
15125519|NCT04432233|Esomeprazole|esomeprazole|mesh-list
15125520|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811342|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811343|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811344|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14811345|NCT00845104|Growth Substances|growth substances|mesh-ancestor
15125521|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15125522|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15125523|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125524|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15125525|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15125526|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15125527|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125528|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125529|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14269644|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
15125530|NCT04432233|Renal Agents|renal agents|mesh-ancestor
15125531|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15125532|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15125533|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125534|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15125535|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15125536|NCT04432155|Xenon|xenon|mesh-list
15125537|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15125538|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
15125539|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
15125540|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125541|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125542|NCT04432012|Dexamethasone|dexamethasone|mesh-list
15125543|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
15125544|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15125545|NCT04432012|BB 1101|bb 1101|mesh-list
15125546|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125547|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
15125548|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
15125549|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125550|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125551|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15125552|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
15125553|NCT04432012|Hormones|hormones|mesh-ancestor
15125554|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125555|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125556|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125557|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
15125558|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125559|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125560|NCT04431895|Tofacitinib|tofacitinib|mesh-list
15125561|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15125562|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125563|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125564|NCT04431713|Exenatide|exenatide|mesh-list
15125565|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15125566|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125567|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15125568|NCT04431713|Incretins|incretins|mesh-ancestor
15125569|NCT04431713|Hormones|hormones|mesh-ancestor
15125570|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125571|NCT04431349|Clopidogrel|clopidogrel|mesh-list
15125572|NCT04431349|Ticagrelor|ticagrelor|mesh-list
14269645|NCT00404066|Hormones|hormones|mesh-ancestor
14269646|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269647|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14269648|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
14269649|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14269650|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14269651|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14269652|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14269653|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15125573|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15125574|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15125575|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15125576|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15125577|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
15125578|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125579|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125580|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125581|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
15125582|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
15125583|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
15125584|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125585|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125586|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
15125587|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125588|NCT04431193|Oxytocin|oxytocin|mesh-list
15125589|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
15125590|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125591|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125592|NCT04431245|Entecavir|entecavir|mesh-list
15125593|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
15125594|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178128|NCT03961360|Aspirin|aspirin|mesh-list
15178129|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15178130|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178131|NCT03961360|Analgesics|analgesics|mesh-ancestor
15178132|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
15178133|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178134|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178135|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178136|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178137|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15178138|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15178139|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178140|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15178141|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15178142|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178143|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
15178144|NCT03960970|Azithromycin|azithromycin|mesh-list
15178145|NCT03960970|Cefoxitin|cefoxitin|mesh-list
15178146|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178147|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178148|NCT03961334|Aspirin|aspirin|mesh-list
15178149|NCT03961334|Dabigatran|dabigatran|mesh-list
15178150|NCT03961334|Apixaban|apixaban|mesh-list
15178151|NCT03961334|Edoxaban|edoxaban|mesh-list
15178152|NCT03961334|Clopidogrel|clopidogrel|mesh-list
15178153|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15178154|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178155|NCT03961334|Analgesics|analgesics|mesh-ancestor
15178156|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
15178157|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178158|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178159|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178160|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178161|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15178162|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15178163|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178164|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15178165|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15178166|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178167|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
15178168|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15178169|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15178170|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15178171|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
15178172|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178173|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
15178174|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15178175|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
15178176|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
15178177|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15178178|NCT03961126|Clobetasol|clobetasol|mesh-list
15178179|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178180|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
15178181|NCT03961126|Hormones|hormones|mesh-ancestor
15178182|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125595|NCT04431206|Oxytocin|oxytocin|mesh-list
15125596|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
15125597|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125598|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125599|NCT04430790|Doxapram|doxapram|mesh-list
15125600|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15125601|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125602|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
15125603|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
15125604|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15125605|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14269654|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269655|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269656|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14269657|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14269658|NCT00404092|Caspofungin|caspofungin|mesh-list
14269659|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
14269660|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269661|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269662|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269663|NCT00404235|Paclitaxel|paclitaxel|mesh-list
14269664|NCT00404235|Carboplatin|carboplatin|mesh-list
14269665|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14269666|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14269667|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269668|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14269669|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14269670|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14269671|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269672|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
14269673|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14269674|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
14269675|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269676|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269677|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
14269678|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269679|NCT00404495|Irinotecan|irinotecan|mesh-list
14269680|NCT00404495|Temozolomide|temozolomide|mesh-list
14269681|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14269682|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14269683|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269684|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269685|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125606|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125607|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
15125608|NCT04430777|Coagulants|coagulants|mesh-ancestor
15125609|NCT04430933|Paclitaxel|paclitaxel|mesh-list
15125610|NCT04430933|Docetaxel|docetaxel|mesh-list
15125611|NCT04430933|Carboplatin|carboplatin|mesh-list
15125612|NCT04430933|Pemetrexed|pemetrexed|mesh-list
15125613|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15125614|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125615|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
15125616|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
15125617|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
15125618|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125619|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125620|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15125621|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15125622|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
15125623|NCT04430998|Polaprezinc|polaprezinc|mesh-list
15125624|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15125625|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125626|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
15125627|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14269686|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14269687|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
14269688|NCT00404547|Ciclesonide|ciclesonide|mesh-list
14269689|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
14269690|NCT00404547|Hormones|hormones|mesh-ancestor
14269691|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269692|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269693|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14269694|NCT00404651|Vaccines|vaccines|mesh-list
14269695|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
14269696|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269697|NCT00404755|Citalopram|citalopram|mesh-list
15125628|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15125629|NCT04430621|Hormones|hormones|mesh-list
15125630|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15125631|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125632|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125633|NCT04430556|Sertraline|sertraline|mesh-list
15125634|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
15125635|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15125636|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15125637|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15125638|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15125639|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125640|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811346|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811347|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811348|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
15125641|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
15125642|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125643|NCT04430361|Dexamethasone|dexamethasone|mesh-list
15125644|NCT04430361|Megestrol|megestrol|mesh-list
15125645|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
14269698|NCT00404755|Bupropion|bupropion|mesh-list
14269699|NCT00404755|Imipramine|imipramine|mesh-list
15125646|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125647|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
15125648|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
15125649|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125650|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125651|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15125652|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
15125653|NCT04430361|Hormones|hormones|mesh-ancestor
15125654|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125655|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125656|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125657|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15125658|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15125659|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15125660|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
15125661|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125662|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15125663|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15125664|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
15125665|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15125666|NCT04430166|Antibodies|antibodies|mesh-list
14269700|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14269701|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269702|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269703|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269704|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125667|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15125668|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
15125669|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125670|NCT04430062|Anesthetics|anesthetics|mesh-list
15125671|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125672|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125673|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
15125674|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
14269705|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
14269706|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269707|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14269708|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
14269709|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269710|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14269711|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
14269712|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14269713|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14269714|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269715|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14269716|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14269717|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
14269718|NCT00404820|Vitamin D|vitamin d|mesh-list
14269719|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
14269720|NCT00404820|Alendronate|alendronate|mesh-list
14269721|NCT00404820|Calcium|calcium|mesh-list
14269722|NCT00404820|Vitamins|vitamins|mesh-ancestor
14269723|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
15125675|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15125676|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125677|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125678|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125679|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125680|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125681|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
15125682|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15125683|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125684|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15125685|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
15125686|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125687|NCT04429711|Ivermectin|ivermectin|mesh-list
15125688|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125689|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125690|NCT04429633|Candesartan|candesartan|mesh-list
15125691|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15125692|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15125693|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15125694|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125695|NCT04429516|Morphine|morphine|mesh-list
15125696|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15125697|NCT04429516|Narcotics|narcotics|mesh-ancestor
15125698|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125699|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125700|NCT04429516|Analgesics|analgesics|mesh-ancestor
15125701|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
15125702|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125703|NCT04429503|Aflibercept|aflibercept|mesh-list
15125704|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15125705|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15125706|NCT04429503|Growth Substances|growth substances|mesh-ancestor
15125707|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125708|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
15125709|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125710|NCT04429425|Anesthetics|anesthetics|mesh-list
15125711|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125712|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125713|NCT04429282|Ibuprofen|ibuprofen|mesh-list
15125714|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15125715|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15125716|NCT04429282|Analgesics|analgesics|mesh-ancestor
15125717|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
15125718|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125719|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125720|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125721|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125722|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15125723|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125724|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125725|NCT04429295|Vaccines|vaccines|mesh-list
15125726|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
15125727|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125728|NCT04429347|Gabapentin|gabapentin|mesh-list
15125729|NCT04429347|Tizanidine|tizanidine|mesh-list
15125730|NCT04429347|Analgesics|analgesics|mesh-ancestor
15125731|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
15125732|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125733|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125734|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
15125735|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15125736|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15125737|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125738|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15125739|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15125740|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15125741|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125742|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125743|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
15125744|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14811349|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125745|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15125746|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
14269724|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269725|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15125747|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
15125748|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15125749|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15125750|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15125751|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14269726|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14269727|NCT00405067|Ezetimibe|ezetimibe|mesh-list
14269728|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14269729|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14269730|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
14269731|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269732|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14269733|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
14269734|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
15125752|NCT04429334|Nangibotide|nangibotide|mesh-list
15125753|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178183|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178184|NCT03961048|Ropivacaine|ropivacaine|mesh-list
15178185|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15178186|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
15178187|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
15178188|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178189|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178190|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
15178191|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178192|NCT03960905|Meropenem|meropenem|mesh-list
15178193|NCT03960905|Ceftazidime|ceftazidime|mesh-list
15178194|NCT03960905|Cefepime|cefepime|mesh-list
15178195|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
15178196|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178197|NCT03961087|Ubiquinone|ubiquinone|mesh-list
15178198|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
15178199|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
15178200|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
15178201|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178202|NCT03961087|Vitamins|vitamins|mesh-ancestor
15178203|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15178204|NCT03961087|Protective Agents|protective agents|mesh-ancestor
15178205|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
15178206|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
15178207|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15178208|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178209|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178210|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178211|NCT03960775|Analgesics|analgesics|mesh-ancestor
15178212|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
15178213|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178214|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15178215|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15178216|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15178217|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
15178218|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178219|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178220|NCT03960866|Phentolamine|phentolamine|mesh-list
15178221|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15178222|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15178223|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15178224|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15178225|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
15178226|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178227|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178228|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178229|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15178230|NCT03960801|Remifentanil|remifentanil|mesh-list
15178231|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15178232|NCT03960801|Narcotics|narcotics|mesh-ancestor
15178233|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178234|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178235|NCT03960801|Analgesics|analgesics|mesh-ancestor
15178236|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
15178237|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269735|NCT00405275|Etanercept|etanercept|mesh-list
15178238|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
15178239|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15178240|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125754|NCT04429191|Antibodies|antibodies|mesh-list
15125755|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15125756|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
15125757|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125758|NCT04429152|Tenofovir|tenofovir|mesh-list
15125759|NCT04429152|Lamivudine|lamivudine|mesh-list
15125760|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
15125761|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125762|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15125763|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15125764|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125765|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125766|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15125767|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15125768|NCT04429035|Vitamin K|vitamin k|mesh-list
15125769|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
15125770|NCT04429035|Vitamins|vitamins|mesh-ancestor
15125771|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
15125772|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125773|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15125774|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15125775|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125776|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
15125777|NCT04429035|Coagulants|coagulants|mesh-ancestor
15125778|NCT04428879|Topotecan|topotecan|mesh-list
15125779|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15125780|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15125781|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125782|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125783|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125784|NCT04428814|Ustekinumab|ustekinumab|mesh-list
15125785|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
15125786|NCT04428437|Lenvatinib|lenvatinib|mesh-list
15125787|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125788|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15125789|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125790|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125791|NCT04428671|Cemiplimab|cemiplimab|mesh-list
15125792|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15125793|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125794|NCT04428684|Goserelin|goserelin|mesh-list
15125795|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125796|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125797|NCT04428372|Mannitol|mannitol|mesh-list
15125798|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15125799|NCT04428372|Diuretics|diuretics|mesh-ancestor
15125800|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
15125801|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125802|NCT04428268|Chloroquine|chloroquine|mesh-list
15125803|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15125804|NCT04428268|Losartan|losartan|mesh-list
15125805|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15125806|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15125807|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15125808|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15125809|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125810|NCT04428268|Amebicides|amebicides|mesh-ancestor
15125811|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15125812|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15125813|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125814|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
15125815|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125816|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15125817|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15125818|NCT04428268|Analgesics|analgesics|mesh-ancestor
15125819|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
15125820|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125821|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125822|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125823|NCT04428268|Filaricides|filaricides|mesh-ancestor
15125824|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
15125825|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
15125826|NCT04428086|Metformin|metformin|mesh-list
15125827|NCT04428086|Apatinib|apatinib|mesh-list
15125828|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15125829|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15125830|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125831|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15125832|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15125833|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
15125834|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125835|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15125836|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15125837|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125838|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125839|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15125840|NCT04428632|Berotralstat|berotralstat|mesh-list
15125841|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125842|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125843|NCT04427709|Oxytocin|oxytocin|mesh-list
15125844|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
15125845|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125846|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125847|NCT04427826|Morphine|morphine|mesh-list
15125848|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15125849|NCT04427826|Narcotics|narcotics|mesh-ancestor
15125850|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125851|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125852|NCT04427826|Analgesics|analgesics|mesh-ancestor
15125853|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
15125854|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125855|NCT04427865|Lactoferrin|lactoferrin|mesh-list
15125856|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125857|NCT04427787|Lanreotide|lanreotide|mesh-list
15125858|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125859|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
15125860|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15125861|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15125862|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125863|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
15125864|NCT04427618|Coagulants|coagulants|mesh-ancestor
15125865|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
15125866|NCT04427293|Lenvatinib|lenvatinib|mesh-list
15125867|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15125868|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125869|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15125870|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125871|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125872|NCT04427241|Amantadine|amantadine|mesh-list
15125873|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
15125874|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15125875|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15125876|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
15125877|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125878|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
15125879|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125880|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125881|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125882|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15125883|NCT04427241|Analgesics|analgesics|mesh-ancestor
15125884|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
15125885|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125886|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15125887|NCT04427241|Protective Agents|protective agents|mesh-ancestor
15125888|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
15125889|NCT04427540|Oxytocin|oxytocin|mesh-list
15125890|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
15125891|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15125892|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178241|NCT03960671|Midazolam|midazolam|mesh-list
15178242|NCT03960671|Diazepam|diazepam|mesh-list
15125893|NCT04426890|Omalizumab|omalizumab|mesh-list
15125894|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15125895|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15125896|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15125897|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
15125898|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
15125899|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125900|NCT04427020|Caseins|caseins|mesh-list
15125901|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
15125902|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
15125903|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125904|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15125905|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15125906|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125907|NCT04427098|Enoxaparin|enoxaparin|mesh-list
15125908|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
15125909|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
15125910|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15125911|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15125912|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125913|NCT04426734|Dexamethasone|dexamethasone|mesh-list
15125914|NCT04426734|Prednisolone|prednisolone|mesh-list
15125915|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15125916|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
15125917|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15125918|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
15125919|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14269736|NCT00405275|Methotrexate|methotrexate|mesh-list
14269737|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14269738|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
14269739|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14269740|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269741|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14269742|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
14269743|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269744|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269745|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
14269746|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269747|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14269748|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269749|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
14269750|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269751|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14269752|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
14269753|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14269754|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14269755|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269756|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14269757|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14269758|NCT00405275|Analgesics|analgesics|mesh-ancestor
14269759|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
14269760|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269761|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269762|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269763|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
14269764|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14269765|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15125920|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
15125921|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125922|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
15125923|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
15125924|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125925|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125926|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15125927|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
15125928|NCT04426734|Hormones|hormones|mesh-ancestor
15125929|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15125930|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15125931|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125932|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15125933|NCT04426734|Protective Agents|protective agents|mesh-ancestor
15125934|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
14269766|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14269767|NCT00405288|Pramoxine|pramoxine|mesh-list
14269768|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15125935|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15125936|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
15125937|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125938|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
15125939|NCT04426721|Protective Agents|protective agents|mesh-ancestor
15125940|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
15125941|NCT04426552|Sevoflurane|sevoflurane|mesh-list
15125942|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15125943|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125944|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125945|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15125946|NCT04426552|Analgesics|analgesics|mesh-ancestor
15125947|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
15125948|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125949|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15125950|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15125951|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15125952|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
15125953|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15125954|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125955|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15125956|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15125957|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
15125958|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
15125959|NCT04426578|Perhexiline|perhexiline|mesh-list
15125960|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15125961|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15125962|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125963|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15125964|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125965|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
15125966|NCT04426669|Aldesleukin|aldesleukin|mesh-list
15125967|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
15125968|NCT04426669|Fludarabine|fludarabine|mesh-list
15125969|NCT04426669|Interleukin-2|interleukin-2|mesh-list
15125970|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15125971|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
15125972|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125973|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15125974|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15125975|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
15125976|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15125977|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15125978|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15125979|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15125980|NCT04426669|Analgesics|analgesics|mesh-ancestor
15125981|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
15125982|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125983|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15125984|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15125985|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
15125986|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15125987|NCT04426422|Metformin|metformin|mesh-list
15125988|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15125989|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125990|NCT04426500|Bupivacaine|bupivacaine|mesh-list
15125991|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
15125992|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
15125993|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15125994|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15125995|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
15125996|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15125997|NCT04426409|Ofloxacin|ofloxacin|mesh-list
15125998|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15125999|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126000|NCT04426409|Renal Agents|renal agents|mesh-ancestor
15126001|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15126002|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15126003|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15126004|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126005|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126006|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126007|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15126008|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15126009|NCT04426487|Progesterone|progesterone|mesh-list
15126010|NCT04426487|Progestins|progestins|mesh-ancestor
15126011|NCT04426487|Hormones|hormones|mesh-ancestor
15126012|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126013|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126014|NCT04426097|Iodine|iodine|mesh-list
15126015|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15126016|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126017|NCT04426097|Trace Elements|trace elements|mesh-ancestor
15126018|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
15126019|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126020|NCT04425993|Indomethacin|indomethacin|mesh-list
15126021|NCT04425993|Isosorbide|isosorbide|mesh-list
15126022|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15126023|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15126024|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126025|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126026|NCT04425993|Analgesics|analgesics|mesh-ancestor
15126027|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
15126028|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126029|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126030|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126031|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126032|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
15126033|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
15126034|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15126035|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126036|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126037|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126038|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15126039|NCT04425993|Diuretics|diuretics|mesh-ancestor
15126040|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
15126041|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
15126042|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15126043|NCT04426955|Paclitaxel|paclitaxel|mesh-list
15126044|NCT04426955|Cisplatin|cisplatin|mesh-list
15126045|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126046|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126047|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
15126048|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
15126049|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
15126050|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126051|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
15126052|NCT04425902|Metoprolol|metoprolol|mesh-list
15126053|NCT04425902|Digoxin|digoxin|mesh-list
15126054|NCT04425902|Midazolam|midazolam|mesh-list
15126055|NCT04425902|Caffeine|caffeine|mesh-list
15126056|NCT04425902|Omeprazole|omeprazole|mesh-list
15126057|NCT04425902|Pravastatin|pravastatin|mesh-list
15126058|NCT04425902|Montelukast|montelukast|mesh-list
15126059|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15126060|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15126061|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126062|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126063|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15126064|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15126065|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15126066|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15126067|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
15126068|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
15126069|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
15126070|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
15126071|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126072|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126073|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15126074|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15126075|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15126076|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126077|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15126078|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15126079|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15126080|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15126081|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
15126082|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15126083|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
15126084|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14269769|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
15126085|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
15126086|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126087|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15126088|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15126089|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15126090|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15126091|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
14269770|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
14269771|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269772|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269773|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
14269774|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269775|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
14269776|NCT00405353|Testosterone|testosterone|mesh-list
14269777|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
14269778|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
14269779|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14269780|NCT00405353|Androgens|androgens|mesh-ancestor
14269781|NCT00405353|Hormones|hormones|mesh-ancestor
15126092|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
15126093|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126094|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15126095|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15126096|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15126097|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126098|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15126099|NCT04425902|Protective Agents|protective agents|mesh-ancestor
15126100|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15126101|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15126102|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
15126103|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15126104|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15126105|NCT04425902|Analgesics|analgesics|mesh-ancestor
15126106|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
15126107|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126108|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126109|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126110|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126111|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126112|NCT04426240|Cyclosporine|cyclosporine|mesh-list
15126113|NCT04426240|Cyclosporins|cyclosporins|mesh-list
15126114|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126115|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126116|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15126117|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
15126118|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126119|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
15126120|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126121|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
15126122|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126123|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15126124|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
15126125|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15126126|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15126127|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15126128|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15126129|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126130|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
15126131|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126132|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126133|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15126134|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126135|NCT04425564|Capecitabine|capecitabine|mesh-list
15126136|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
15126137|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15126138|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
15126139|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126140|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126141|NCT04425590|Aspirin|aspirin|mesh-list
15126142|NCT04425590|Atorvastatin|atorvastatin|mesh-list
15126143|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126144|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126145|NCT04425590|Analgesics|analgesics|mesh-ancestor
15126146|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
14269782|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269783|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126147|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126148|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126149|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126150|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126151|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15126152|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15126153|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126154|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15126155|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126156|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126157|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
15126158|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15126159|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15126160|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
15126161|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15126162|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15126163|NCT04425655|Fludarabine|fludarabine|mesh-list
15126164|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126165|NCT04425460|Favipiravir|favipiravir|mesh-list
15126166|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
15126167|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126168|NCT04425642|Methamphetamine|methamphetamine|mesh-list
15126169|NCT04425642|SMOFlipid|smoflipid|mesh-list
15126170|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15126171|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126172|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
15126173|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
15126174|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126175|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
15126176|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126177|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126178|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126179|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15126180|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15126181|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15126182|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15126183|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15126184|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15126185|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15126186|NCT04425681|Bevacizumab|bevacizumab|mesh-list
15126187|NCT04425681|Osimertinib|osimertinib|mesh-list
15126188|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126189|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126190|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15126191|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15126192|NCT04425681|Growth Substances|growth substances|mesh-ancestor
15126193|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126194|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
15126195|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15126196|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126197|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126198|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
15126199|NCT04425707|Ivermectin|ivermectin|mesh-list
15126200|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
15126201|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15126202|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15126203|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126204|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126205|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126206|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126207|NCT04425824|Rituximab|rituximab|mesh-list
15126208|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126209|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126210|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
15126211|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126212|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126213|NCT04425187|Bevacizumab|bevacizumab|mesh-list
15126214|NCT04425187|Gefitinib|gefitinib|mesh-list
15126215|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126216|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126217|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15126218|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15126219|NCT04425187|Growth Substances|growth substances|mesh-ancestor
15126220|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126221|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
15126222|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15126223|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126224|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126225|NCT04425473|Esketamine|esketamine|mesh-list
15126226|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
15126227|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15126228|NCT04425382|Ritonavir|ritonavir|mesh-list
15126229|NCT04425382|Lopinavir|lopinavir|mesh-list
15126230|NCT04425382|Darunavir|darunavir|mesh-list
15126231|NCT04425382|Cobicistat|cobicistat|mesh-list
15126232|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15126233|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15126234|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
14269784|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14269785|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126235|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126236|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126237|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15126238|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15126239|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
15126240|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126241|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15126242|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15126243|NCT04425135|Carboplatin|carboplatin|mesh-list
15126244|NCT04425135|Apatinib|apatinib|mesh-list
15126245|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126246|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15126247|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126248|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178243|NCT03960671|Propofol|propofol|mesh-list
15178244|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15178245|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178246|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178247|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15178248|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
15178249|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
15178250|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15178251|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15178252|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15178253|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15178254|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
15178255|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
15178256|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178257|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178258|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
15178259|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
15178260|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
15178261|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178262|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178263|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15178264|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15178265|NCT03960268|Brodalumab|brodalumab|mesh-list
15178266|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
15178267|NCT03960411|Doxycycline|doxycycline|mesh-list
15178268|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178269|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178270|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
15178271|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15178272|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15178273|NCT03960151|Dexamethasone|dexamethasone|mesh-list
15178274|NCT03960151|Olanzapine|olanzapine|mesh-list
14269786|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
15178275|NCT03960151|Palonosetron|palonosetron|mesh-list
15178276|NCT03960151|Rolapitant|rolapitant|mesh-list
15178277|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178278|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
15178279|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
15178280|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181915|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15126249|NCT04425070|Gemcitabine|gemcitabine|mesh-list
15126250|NCT04425070|Carboplatin|carboplatin|mesh-list
15126251|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
15126252|NCT04425070|Etoposide|etoposide|mesh-list
15126253|NCT04425070|Ifosfamide|ifosfamide|mesh-list
14269787|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
14269788|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14269789|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269790|NCT00405522|Remifentanil|remifentanil|mesh-list
14269791|NCT00405522|Propofol|propofol|mesh-list
14269792|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14269793|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269794|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269795|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14269796|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
14269797|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
14269798|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14269799|NCT00405522|Narcotics|narcotics|mesh-ancestor
14269800|NCT00405522|Analgesics|analgesics|mesh-ancestor
14269801|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
15126254|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126255|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15126256|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
15126257|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126258|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
15126259|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126260|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126261|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15126262|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
15126263|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126264|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126265|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15126266|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15126267|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15126268|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
15126269|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
15126270|NCT04425226|Lenvatinib|lenvatinib|mesh-list
15126271|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126272|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126273|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15126274|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126275|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126276|NCT04424901|Dipyridamole|dipyridamole|mesh-list
15126277|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15126278|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126279|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126280|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15126281|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
15126282|NCT04424875|Melatonin|melatonin|mesh-list
15126283|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
15126284|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126285|NCT04424875|Protective Agents|protective agents|mesh-ancestor
15126286|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126287|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126288|NCT04424420|Acetaminophen|acetaminophen|mesh-list
15126289|NCT04424420|Ibuprofen|ibuprofen|mesh-list
15126290|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126291|NCT04424420|Analgesics|analgesics|mesh-ancestor
15126292|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
15126293|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126294|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126295|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
14269802|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269803|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15126296|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126297|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126298|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126299|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126300|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126301|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126302|NCT04424511|Azithromycin|azithromycin|mesh-list
15126303|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15126304|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126305|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
15126306|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15126307|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15126308|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126309|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
15126310|NCT04424563|Coagulants|coagulants|mesh-ancestor
15126311|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
15126312|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15126313|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126314|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
15126315|NCT04424459|Narcotics|narcotics|mesh-ancestor
15126316|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126317|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126318|NCT04424459|Analgesics|analgesics|mesh-ancestor
15126319|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
15126320|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126321|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
15126322|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15126323|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
15126324|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15126325|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
15126326|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126327|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126328|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
15126329|NCT04424264|Tenofovir|tenofovir|mesh-list
15126330|NCT04424264|Lamivudine|lamivudine|mesh-list
15126331|NCT04424264|Emtricitabine|emtricitabine|mesh-list
15126332|NCT04424264|Efavirenz|efavirenz|mesh-list
15126333|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15126334|NCT04424264|Rifampin|rifampin|mesh-list
15126335|NCT04424264|Isoniazid|isoniazid|mesh-list
15126336|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
15126337|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126338|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15126339|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15126340|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126341|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126342|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15126343|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15126344|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15126345|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15126346|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15126347|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15126348|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15126349|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15126350|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15126351|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
15126352|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15126353|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
15126354|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15126355|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15126356|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15126357|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15126358|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15126359|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
15126360|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15126361|NCT04424303|Tofacitinib|tofacitinib|mesh-list
15126362|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15126363|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126364|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126365|NCT04423926|Prednisolone|prednisolone|mesh-list
15126366|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
15126367|NCT04423926|Doxorubicin|doxorubicin|mesh-list
15126368|NCT04423926|Vincristine|vincristine|mesh-list
15126369|NCT04423926|Lenalidomide|lenalidomide|mesh-list
15126370|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15126371|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
15126372|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126373|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126374|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15126375|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
15126376|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126377|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126378|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15126379|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15126380|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15126381|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15126382|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126383|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126384|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
15126385|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
15126386|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
15126387|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15126388|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15126389|NCT04423926|Growth Substances|growth substances|mesh-ancestor
15126390|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
15126391|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126392|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
15126393|NCT04423926|Hormones|hormones|mesh-ancestor
15126394|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126395|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15126396|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15126397|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126398|NCT04424017|Antibodies|antibodies|mesh-list
15126399|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
15126400|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126401|NCT04424134|Spironolactone|spironolactone|mesh-list
15126402|NCT04424134|Bromhexine|bromhexine|mesh-list
15126403|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15126404|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
15126405|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126406|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126407|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15126408|NCT04424134|Diuretics|diuretics|mesh-ancestor
15126409|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
15126410|NCT04424134|Expectorants|expectorants|mesh-ancestor
15126411|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
15126412|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15126413|NCT04423627|Clonidine|clonidine|mesh-list
15126414|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15126415|NCT04423627|Diuretics|diuretics|mesh-ancestor
15126416|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
15126417|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126418|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15126419|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15126420|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126421|NCT04423627|Analgesics|analgesics|mesh-ancestor
15126422|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
15126423|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126424|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
15126425|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
15126426|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15126427|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15126428|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15126429|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126430|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126431|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
15126432|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15126433|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126434|NCT04423731|Leucovorin|leucovorin|mesh-list
15126435|NCT04423731|Gemcitabine|gemcitabine|mesh-list
15126436|NCT04423731|Paclitaxel|paclitaxel|mesh-list
15126437|NCT04423731|Fluorouracil|fluorouracil|mesh-list
15126438|NCT04423731|Folfirinox|folfirinox|mesh-list
15126439|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126440|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126441|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
15126442|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
15126443|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
15126444|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126445|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15126446|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
15126447|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
15126448|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126449|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126450|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15126451|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
15126452|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126453|NCT04423731|Antidotes|antidotes|mesh-ancestor
15126454|NCT04423731|Protective Agents|protective agents|mesh-ancestor
15126455|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
15126456|NCT04423731|Vitamins|vitamins|mesh-ancestor
15126457|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
15126458|NCT04423510|Phenol|phenol|mesh-list
15126459|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15126460|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126461|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
15126462|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15126463|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15126464|NCT04423107|Acetaminophen|acetaminophen|mesh-list
15126465|NCT04423107|Ibuprofen|ibuprofen|mesh-list
15126466|NCT04423107|Oxycodone|oxycodone|mesh-list
15126467|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126468|NCT04423107|Analgesics|analgesics|mesh-ancestor
15126469|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
15126470|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126471|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126472|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
15126473|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126474|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126475|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126476|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126477|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126478|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126479|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15126480|NCT04423107|Narcotics|narcotics|mesh-ancestor
14269804|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
15126481|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126482|NCT04423276|Donepezil|donepezil|mesh-list
15126483|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15126484|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126485|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126486|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
15126487|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126488|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126489|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
15126490|NCT04423185|Atezolizumab|atezolizumab|mesh-list
15126491|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
15126492|NCT04423185|Palbociclib|palbociclib|mesh-list
15126493|NCT04423185|Niraparib|niraparib|mesh-list
15126494|NCT04423185|Vemurafenib|vemurafenib|mesh-list
15126495|NCT04423185|Crizotinib|crizotinib|mesh-list
15126496|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126497|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15126498|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126499|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126500|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15126501|NCT04423367|Dexamethasone|dexamethasone|mesh-list
15126502|NCT04423367|Bortezomib|bortezomib|mesh-list
15126503|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126504|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
15126505|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
15126506|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126507|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126508|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15126509|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
15126510|NCT04423367|Hormones|hormones|mesh-ancestor
15126511|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126512|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15126513|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178281|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178282|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178283|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
14269805|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178284|NCT03960151|Hormones|hormones|mesh-ancestor
15181916|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15126514|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
15126515|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126516|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15126517|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126518|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126519|NCT04422652|Bupropion|bupropion|mesh-list
15126520|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15126521|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
15126522|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15126523|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15126524|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15126525|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15126526|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126527|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
15126528|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126529|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126530|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15126531|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15126532|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126533|NCT04422275|Budesonide|budesonide|mesh-list
15126534|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126535|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15126536|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
15126537|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126538|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126539|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15126540|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
15126541|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
15126542|NCT04422275|Hormones|hormones|mesh-ancestor
15126543|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126544|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15126545|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15126546|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15126547|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126548|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126549|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15126550|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15126551|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126552|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
15126553|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126554|NCT04422392|Paclitaxel|paclitaxel|mesh-list
15126555|NCT04422392|Carboplatin|carboplatin|mesh-list
15126556|NCT04422392|Pemetrexed|pemetrexed|mesh-list
15126557|NCT04422392|Antibodies|antibodies|mesh-list
15126558|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126559|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126560|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
15126561|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
15126562|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
15126563|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126564|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
15126565|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126566|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126567|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15126568|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15126569|NCT04422028|Desogestrel|desogestrel|mesh-list
15126570|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15126571|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15126572|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15126573|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
15126574|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15126575|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126576|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15126577|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15126578|NCT04422028|Progestins|progestins|mesh-ancestor
15126579|NCT04422028|Hormones|hormones|mesh-ancestor
15126580|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126581|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
15126582|NCT04422184|Diuretics|diuretics|mesh-ancestor
15126583|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
15126584|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126585|NCT04422184|Expectorants|expectorants|mesh-ancestor
15126586|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
15126587|NCT04421872|Anesthetics|anesthetics|mesh-list
15126588|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126589|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126590|NCT04421716|Ursolic acid|ursolic acid|mesh-list
15126591|NCT04421716|Curcumin|curcumin|mesh-list
15126592|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126593|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126594|NCT04421716|Analgesics|analgesics|mesh-ancestor
15126595|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
15126596|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126597|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126598|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126599|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126600|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126601|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126602|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126603|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126604|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126605|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126606|NCT04421911|Diclofenac|diclofenac|mesh-list
15126607|NCT04421911|Ketoprofen|ketoprofen|mesh-list
15126608|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126609|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126610|NCT04421911|Analgesics|analgesics|mesh-ancestor
15126611|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
15126612|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126613|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126614|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126615|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126616|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126617|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126618|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126619|NCT04421742|Beclomethasone|beclomethasone|mesh-list
15126620|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
15126621|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15126622|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
15126623|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126624|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126625|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15126626|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
15126627|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15126628|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15126629|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15126630|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126631|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126632|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126633|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126634|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
15126635|NCT04421742|Hormones|hormones|mesh-ancestor
15126636|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126637|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
15126638|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126639|NCT04421547|Letrozole|letrozole|mesh-list
15126640|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126641|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15126642|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15126643|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126644|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126645|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15126646|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
15126647|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126648|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126649|NCT04421339|Melatonin|melatonin|mesh-list
15126650|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
15126651|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126652|NCT04421339|Protective Agents|protective agents|mesh-ancestor
15126653|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126654|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126655|NCT04421534|Lactoferrin|lactoferrin|mesh-list
15126656|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126657|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15126658|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
15126659|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15126660|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15126661|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
15126662|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126663|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
15126664|NCT04421300|Protective Agents|protective agents|mesh-ancestor
15126665|NCT04421209|Propranolol|propranolol|mesh-list
15126666|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15126667|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15126668|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126669|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126670|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126671|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126672|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15126673|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15126674|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
15126675|NCT04421079|Resveratrol|resveratrol|mesh-list
15126676|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
15126677|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126678|NCT04421079|Protective Agents|protective agents|mesh-ancestor
15126679|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126680|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126681|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15126682|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15126683|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
15126684|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126685|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15126686|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15126687|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
15126688|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126689|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126690|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15126691|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
15126692|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126693|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126694|NCT04420975|Nivolumab|nivolumab|mesh-list
15126695|NCT04420975|Immunologic Factors|immunologic factors|mesh-list
15126696|NCT04420975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
15126697|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126698|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126699|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15126700|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126701|NCT04420975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178285|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178286|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15178287|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178288|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15178289|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15178290|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178291|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15178292|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15178293|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15178294|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15178295|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178296|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178297|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
15178298|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15178299|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15178300|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15181917|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15181918|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181919|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181920|NCT03925818|Antacids|antacids|mesh-ancestor
15181921|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15181922|NCT03925714|Metformin|metformin|mesh-list
15181923|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15181924|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181925|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
15181926|NCT03925779|Remifentanil|remifentanil|mesh-list
15181927|NCT03925779|Propofol|propofol|mesh-list
15181928|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15181929|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126702|NCT04420936|Benzocaine|benzocaine|mesh-list
15126703|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
15126704|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
15126705|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126706|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126707|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
15126708|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126709|NCT04420871|Capecitabine|capecitabine|mesh-list
15126710|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15126711|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
15126712|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126713|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126714|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15126715|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
15126716|NCT04420585|Coagulants|coagulants|mesh-ancestor
15126717|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15126718|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
15126719|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126720|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
15126721|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
15126722|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126723|NCT04420533|Mirabegron|mirabegron|mesh-list
15126724|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15126725|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15126726|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15126727|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126728|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126729|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126730|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126731|NCT04420533|Urological Agents|urological agents|mesh-ancestor
15126732|NCT04419948|Ibuprofen|ibuprofen|mesh-list
15126733|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126734|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126735|NCT04419948|Analgesics|analgesics|mesh-ancestor
15126736|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
15126737|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126738|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126739|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126740|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126741|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126742|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126743|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126744|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15126745|NCT04420299|Bemiparin|bemiparin|mesh-list
15126746|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
15126747|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15126748|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15126749|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126750|NCT04420195|Tacrolimus|tacrolimus|mesh-list
15126751|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15126752|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
15126753|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126754|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15126755|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126756|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126757|NCT04420351|Aspirin|aspirin|mesh-list
15126758|NCT04420351|Clopidogrel|clopidogrel|mesh-list
15126759|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126760|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126761|NCT04420351|Analgesics|analgesics|mesh-ancestor
15126762|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
15126763|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126764|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126765|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126766|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126767|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15126768|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15126769|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126770|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15126771|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15126772|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126773|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
15126774|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15126775|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15126776|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15126777|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
15126778|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126779|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
15126780|NCT04420247|Chloroquine|chloroquine|mesh-list
15126781|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
15126782|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15126783|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15126784|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126785|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126786|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126787|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126788|NCT04420247|Amebicides|amebicides|mesh-ancestor
15126789|NCT04419662|Phenylephrine|phenylephrine|mesh-list
15126790|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
15126791|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15126792|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
15126793|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
15126794|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126795|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126796|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
15126797|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15126798|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
15126799|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
15126800|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15126801|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15126802|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15126803|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126804|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126805|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126806|NCT04419662|Protective Agents|protective agents|mesh-ancestor
15126807|NCT04419493|Heparin|heparin|mesh-list
15126808|NCT04419493|Calcium heparin|calcium heparin|mesh-list
15126809|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15126810|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
15126811|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14561765|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561766|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561767|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561768|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561769|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
15126812|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15126813|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561770|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126814|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15126815|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126816|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126817|NCT04419181|Carboplatin|carboplatin|mesh-list
15126818|NCT04419181|Docetaxel|docetaxel|mesh-list
15126819|NCT04419181|Trastuzumab|trastuzumab|mesh-list
15126820|NCT04419181|Pertuzumab|pertuzumab|mesh-list
15126821|NCT04419181|Maytansine|maytansine|mesh-list
15126822|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15126823|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126824|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
15126825|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
15126826|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
15126827|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126828|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126829|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126830|NCT04419259|Erenumab|erenumab|mesh-list
15126831|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15126832|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269806|NCT00405587|Vemurafenib|vemurafenib|mesh-list
14269807|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269808|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14269809|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269810|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269811|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15126833|NCT04419259|Analgesics|analgesics|mesh-ancestor
15126834|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
15126835|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126836|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126837|NCT04419389|Rituximab|rituximab|mesh-list
15126838|NCT04419389|Venetoclax|venetoclax|mesh-list
15126839|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
15126840|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126841|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126842|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
15126843|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126844|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126845|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
15126846|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15126847|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15126848|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126849|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
15126850|NCT04419246|Coagulants|coagulants|mesh-ancestor
15126851|NCT04419272|Methylphenidate|methylphenidate|mesh-list
15126852|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15126853|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126854|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15126855|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15126856|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15126857|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126858|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
15126859|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126860|NCT04419038|Mitomycins|mitomycins|mesh-list
15126861|NCT04419038|Mitomycin|mitomycin|mesh-list
15126862|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15126863|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126864|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
15126865|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126866|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15126867|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126868|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15126869|NCT04418999|Dexamethasone|dexamethasone|mesh-list
15126870|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126871|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
15126872|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
15126873|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126874|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126875|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15126876|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
15126877|NCT04418999|Hormones|hormones|mesh-ancestor
15126878|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126879|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15126880|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126881|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15126882|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
15126883|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15126884|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
15126885|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126886|NCT04419025|Expectorants|expectorants|mesh-ancestor
15126887|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
15126888|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15126889|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
15126890|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126891|NCT04419025|Protective Agents|protective agents|mesh-ancestor
15126892|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126893|NCT04419025|Antidotes|antidotes|mesh-ancestor
15126894|NCT04418908|Cetrorelix|cetrorelix|mesh-list
15126895|NCT04418908|Estradiol|estradiol|mesh-list
15126896|NCT04418908|Estrogens|estrogens|mesh-ancestor
15126897|NCT04418908|Hormones|hormones|mesh-ancestor
15126898|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15126899|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126900|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15126901|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15126902|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
15126903|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
15178301|NCT03959852|Fentanyl|fentanyl|mesh-list
15178302|NCT03959852|Ketamine|ketamine|mesh-list
15178303|NCT03959852|Analgesics|analgesics|mesh-ancestor
15178304|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
15178305|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178306|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178307|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15178308|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15178309|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
15178310|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
15178311|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178312|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15178313|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15178314|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178315|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178316|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15178317|NCT03959852|Narcotics|narcotics|mesh-ancestor
15178318|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15178319|NCT03959761|Nivolumab|nivolumab|mesh-list
15178320|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15178321|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178322|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15178323|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178324|NCT03959969|Ibuprofen|ibuprofen|mesh-list
15178325|NCT03959969|Oxycodone|oxycodone|mesh-list
15178326|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15178327|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178328|NCT03959969|Analgesics|analgesics|mesh-ancestor
15178329|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
15178330|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178331|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178332|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178333|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178334|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15178335|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178336|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178337|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15178338|NCT03959969|Narcotics|narcotics|mesh-ancestor
15178339|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178340|NCT03959865|Glucagon|glucagon|mesh-list
15178341|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15178342|NCT03959865|Incretins|incretins|mesh-ancestor
15178343|NCT03959865|Hormones|hormones|mesh-ancestor
15178344|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178345|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178346|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178347|NCT03959527|Azithromycin|azithromycin|mesh-list
15178348|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
15178349|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178350|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178351|NCT03959436|Carbetocin|carbetocin|mesh-list
15126904|NCT04418856|Methamphetamine|methamphetamine|mesh-list
15126905|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15126906|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126907|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
15126908|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
15126909|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126910|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
15126911|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126912|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126913|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
15126914|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15126915|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15126916|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15126917|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15126918|NCT04418557|Antibodies|antibodies|mesh-list
15126919|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
15126920|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126921|NCT04418674|Fentanyl|fentanyl|mesh-list
15126922|NCT04418674|Ketamine|ketamine|mesh-list
15126923|NCT04418674|Analgesics|analgesics|mesh-ancestor
15126924|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
15126925|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126926|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126927|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15126928|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15126929|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
15126930|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
15126931|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15126932|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15126933|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15126934|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15126935|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126936|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15126937|NCT04418674|Narcotics|narcotics|mesh-ancestor
15126938|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15126939|NCT04418531|Antibodies|antibodies|mesh-list
15126940|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
15126941|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15126942|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
15126943|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126944|NCT04418154|Paclitaxel|paclitaxel|mesh-list
15126945|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
15126946|NCT04418154|Epirubicin|epirubicin|mesh-list
15126947|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15126948|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15126949|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126950|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
15126951|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
15126952|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
15126953|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126954|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15126955|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
14269812|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
15178352|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
15126956|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126957|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126958|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15126959|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
15126960|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15126961|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15126962|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15126963|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15126964|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126965|NCT04418180|Fenofibrate|fenofibrate|mesh-list
15126966|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15126967|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
15126968|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126969|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15126970|NCT04418219|Interferons|interferons|mesh-list
15126971|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
15126972|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
15126973|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
15126974|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
15126975|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15126976|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
15126977|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126978|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126979|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15126980|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
15126981|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15126982|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15126983|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15126984|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15126985|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
15126986|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15126987|NCT04418128|Nafamostat|nafamostat|mesh-list
15126988|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15126989|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15126990|NCT04418128|Analgesics|analgesics|mesh-ancestor
15126991|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
15126992|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15126993|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15126994|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15126995|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15126996|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
15126997|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
15126998|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15126999|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127000|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15127001|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15127002|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15127003|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127004|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
15127005|NCT04417920|Mitomycins|mitomycins|mesh-list
15127006|NCT04417920|Mitomycin|mitomycin|mesh-list
15127007|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15127008|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127009|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
15127010|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127011|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15127012|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127013|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15127014|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15127015|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127016|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
15127017|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127018|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127019|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
15127020|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127021|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15127022|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15127023|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127024|NCT04418089|Simvastatin|simvastatin|mesh-list
15127025|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15127026|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15127027|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
15127028|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127029|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15127030|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15127031|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127032|NCT04417582|Liraglutide|liraglutide|mesh-list
15127033|NCT04417582|Orlistat|orlistat|mesh-list
15127034|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15127035|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127036|NCT04417582|Incretins|incretins|mesh-ancestor
15127037|NCT04417582|Hormones|hormones|mesh-ancestor
15127038|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127039|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127040|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127041|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15127042|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15127043|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
15127044|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127045|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127046|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127047|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
15127048|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15127049|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
15127050|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127051|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
15127052|NCT04417192|Olaparib|olaparib|mesh-list
15127053|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15127054|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127055|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15127056|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127057|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127058|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15127059|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15127060|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15127061|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
15127062|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127063|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15127064|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15127065|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127066|NCT04417517|Azacitidine|azacitidine|mesh-list
15127067|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127068|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
15127069|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127070|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127071|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127072|NCT04417348|Tretinoin|tretinoin|mesh-list
15127073|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127074|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
15127075|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
15127076|NCT04417543|Memantine|memantine|mesh-list
15127077|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15127078|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15127079|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
15127080|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127081|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127082|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127083|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15127084|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15127085|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
15127086|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127087|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127088|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127089|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178353|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15178354|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178355|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15178356|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178357|NCT03959540|Levodopa|levodopa|mesh-list
15178358|NCT03959540|Opicapone|opicapone|mesh-list
15178359|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15178360|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15178361|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
15178362|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178363|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178364|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127090|NCT04416568|Nivolumab|nivolumab|mesh-list
15127091|NCT04416568|Ipilimumab|ipilimumab|mesh-list
15127092|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15127093|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127094|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15127095|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127096|NCT04416334|Acetaminophen|acetaminophen|mesh-list
15127097|NCT04416334|Colchicine|colchicine|mesh-list
15127098|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15127099|NCT04416334|Analgesics|analgesics|mesh-ancestor
15127100|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
15127101|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127102|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127103|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
15127104|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
15127105|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15127106|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
15127107|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
15127108|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
15127109|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127110|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127111|NCT04416399|Budesonide|budesonide|mesh-list
15127112|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15127113|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15127114|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
15127115|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127116|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127117|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15127118|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
15127119|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
15127120|NCT04416399|Hormones|hormones|mesh-ancestor
15127121|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127122|NCT04416607|Menotropins|menotropins|mesh-list
15127123|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15127124|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
15127125|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15127126|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127127|NCT04416269|Insulin|insulin|mesh-list
15127128|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15127129|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15127130|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127131|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15127132|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15127133|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127134|NCT04415944|Carboplatin|carboplatin|mesh-list
15127135|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127136|NCT04415840|Acetic Acid|acetic acid|mesh-list
15127137|NCT04415840|Retinol acetate|retinol acetate|mesh-list
15127138|NCT04415840|Lugol's solution|lugol's solution|mesh-list
15127139|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127140|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127141|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15127142|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
15127143|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127144|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15127145|NCT04415840|Protective Agents|protective agents|mesh-ancestor
15127146|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127147|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
15127148|NCT04415840|Coagulants|coagulants|mesh-ancestor
15127149|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
15127150|NCT04415892|Capsaicin|capsaicin|mesh-list
15127151|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
15127152|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
15127153|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
15127154|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127155|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127156|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15127157|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127158|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15127159|NCT04415892|Protective Agents|protective agents|mesh-ancestor
15127160|NCT04415905|Propofol|propofol|mesh-list
15127161|NCT04415905|Sevoflurane|sevoflurane|mesh-list
15127162|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15127163|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127164|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127165|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15127166|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
15127167|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
15127168|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15127169|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15127170|NCT04416035|Paclitaxel|paclitaxel|mesh-list
15127171|NCT04416035|Bevacizumab|bevacizumab|mesh-list
15127172|NCT04416035|Carboplatin|carboplatin|mesh-list
15127173|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15127174|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127175|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
15127176|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
15127177|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
15127178|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127179|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15127180|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15127181|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15127182|NCT04416035|Growth Substances|growth substances|mesh-ancestor
15127183|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127184|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
15127185|NCT04415983|Metronidazole|metronidazole|mesh-list
15127186|NCT04415983|Clarithromycin|clarithromycin|mesh-list
15127187|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
15127188|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15127189|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127190|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127191|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15127192|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15127193|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15127194|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127195|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127196|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15127197|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15127198|NCT04415853|Irinotecan|irinotecan|mesh-list
15127199|NCT04415853|Tegafur|tegafur|mesh-list
15127200|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15127201|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15127202|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127203|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127204|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127205|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127206|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
15127207|NCT04415567|Lenvatinib|lenvatinib|mesh-list
15127208|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127209|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127210|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127211|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127212|NCT04415320|Ensartinib|ensartinib|mesh-list
15127213|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127214|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127215|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127216|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127217|NCT04415385|Apatinib|apatinib|mesh-list
15127218|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127219|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127220|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127221|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127222|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
15127223|NCT04415476|Sirolimus|sirolimus|mesh-list
15127224|NCT04415476|Prednisone|prednisone|mesh-list
15127225|NCT04415476|Tacrolimus|tacrolimus|mesh-list
15127226|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15127227|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
15127228|NCT04415476|Hormones|hormones|mesh-ancestor
15127229|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127230|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127231|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15127232|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127233|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127234|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
15127235|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15127236|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127237|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127238|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15127239|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15127240|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
15127241|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127242|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127243|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
15127244|NCT04414995|Acetaminophen|acetaminophen|mesh-list
15127245|NCT04414995|Ibuprofen|ibuprofen|mesh-list
15127246|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15127247|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15127248|NCT04414995|Analgesics|analgesics|mesh-ancestor
15127249|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
15127250|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127251|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127252|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15127253|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15127254|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15127255|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127256|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127257|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
15127258|NCT04414852|Apatinib|apatinib|mesh-list
15127259|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127260|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127261|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127262|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127263|NCT04415008|Cytarabine|cytarabine|mesh-list
15127264|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127265|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
15127266|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127267|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127268|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
15127269|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127270|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127271|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
15127272|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178365|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15178366|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178367|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15178368|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
15178369|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15178370|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178371|NCT03959501|Incretins|incretins|mesh-ancestor
15178372|NCT03959501|Hormones|hormones|mesh-ancestor
15178373|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178374|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15178375|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
15178376|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178377|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178378|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15178379|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
15178380|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15178381|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178382|NCT03959384|Poractant alfa|poractant alfa|mesh-list
15178383|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15127273|NCT04414969|Asparaginase|asparaginase|mesh-list
15127274|NCT04414969|Pegaspargase|pegaspargase|mesh-list
15127275|NCT04414969|Antibodies|antibodies|mesh-list
15127276|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
15127277|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
15127278|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127279|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127280|NCT04415060|Sevoflurane|sevoflurane|mesh-list
15127281|NCT04415060|Isoflurane|isoflurane|mesh-list
15127282|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15127283|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15127284|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
15127285|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
15127286|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127287|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127288|NCT04414956|Vitamin K|vitamin k|mesh-list
15127289|NCT04414956|Agglutinins|agglutinins|mesh-list
15127290|NCT04414956|Vitamins|vitamins|mesh-ancestor
15127291|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
15127292|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127293|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15127294|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15127295|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127296|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
15127297|NCT04414956|Coagulants|coagulants|mesh-ancestor
15127298|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
15127299|NCT04414800|Fentanyl|fentanyl|mesh-list
15127300|NCT04414800|Ketamine|ketamine|mesh-list
15127301|NCT04414800|Analgesics|analgesics|mesh-ancestor
15127302|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
15127303|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127304|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127305|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15127306|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15127307|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
15127308|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
15127309|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127310|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15127311|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15127312|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127313|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127314|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15127315|NCT04414800|Narcotics|narcotics|mesh-ancestor
15127316|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15127317|NCT04414943|Ketamine|ketamine|mesh-list
15127318|NCT04414943|Esketamine|esketamine|mesh-list
15127319|NCT04414943|Analgesics|analgesics|mesh-ancestor
15127320|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
15127321|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127322|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127323|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15127324|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15127325|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
15127326|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
15127327|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127328|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15127329|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15127330|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127331|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127332|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
15127333|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127334|NCT04414540|Metformin|metformin|mesh-list
15127335|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
15127336|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15127337|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127338|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15127339|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127340|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15127341|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
15127342|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127343|NCT04414566|Gemcitabine|gemcitabine|mesh-list
15127344|NCT04414566|Cisplatin|cisplatin|mesh-list
15127345|NCT04414566|Docetaxel|docetaxel|mesh-list
15127346|NCT04414566|Fluorouracil|fluorouracil|mesh-list
15127347|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127348|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127349|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
15127350|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127351|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
15127352|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127353|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127354|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127355|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
15127356|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127357|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
15127358|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
15127359|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
15127360|NCT04414579|Insulin|insulin|mesh-list
15127361|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15127362|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
15127363|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
15127364|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15127365|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15127366|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127367|NCT04414228|Anesthetics|anesthetics|mesh-list
15127368|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127369|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127370|NCT04414254|Cefprozil|cefprozil|mesh-list
15127371|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127372|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127373|NCT04414267|Vaccines|vaccines|mesh-list
15127374|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
15127375|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
15127376|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127377|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15127378|NCT04413734|Gemcitabine|gemcitabine|mesh-list
15127379|NCT04413734|Cisplatin|cisplatin|mesh-list
15127380|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127381|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127382|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
15127383|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127384|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
15127385|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127386|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127387|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127388|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
15127389|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127390|NCT04413838|Nivolumab|nivolumab|mesh-list
15127391|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15127392|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127393|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15127394|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127395|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
15127396|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15127397|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127398|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127399|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15127400|NCT04413864|Analgesics|analgesics|mesh-ancestor
15127401|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
15127402|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127403|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15127404|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15127405|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15127406|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
15127407|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127408|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127409|NCT04414020|Progesterone|progesterone|mesh-list
15127410|NCT04414020|Progestins|progestins|mesh-ancestor
15127411|NCT04414020|Hormones|hormones|mesh-ancestor
15127412|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127413|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127414|NCT04414137|Daptomycin|daptomycin|mesh-list
15127415|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127416|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127417|NCT04413890|Dinoprostone|dinoprostone|mesh-list
15127418|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
15127419|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15127420|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127421|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15127422|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127423|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15127424|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127425|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127426|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
15127427|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
15127428|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
15127429|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127430|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127431|NCT04413227|Docetaxel|docetaxel|mesh-list
15127432|NCT04413227|Endostatins|endostatins|mesh-list
15127433|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127434|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
15127435|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
15127436|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
15127437|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127438|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15127439|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15127440|NCT04413227|Growth Substances|growth substances|mesh-ancestor
15127441|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127442|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
15127443|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15127444|NCT04412876|Imipramine|imipramine|mesh-list
15127445|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15127446|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15127447|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15127448|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127449|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127450|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127451|NCT04412876|Analgesics|analgesics|mesh-ancestor
15127452|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
15127453|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127454|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
15127455|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127456|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
15127457|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15127458|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15127459|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
15127460|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
15127461|NCT04412850|Analgesics|analgesics|mesh-ancestor
15127462|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
15127463|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127464|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127465|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
15127466|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127467|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15127468|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
15127469|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15127470|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15127471|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127472|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15127473|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
15127474|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15178384|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
15178385|NCT03959293|Durvalumab|durvalumab|mesh-list
15178386|NCT03959293|Tremelimumab|tremelimumab|mesh-list
15182301|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
15127475|NCT04412538|Vaccines|vaccines|mesh-list
15127476|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
15127477|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127478|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
15127479|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15127480|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
15127481|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
15127482|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127483|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127484|NCT04412421|Vitamins|vitamins|mesh-list
15127485|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
15127486|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127487|NCT04412304|Dalteparin|dalteparin|mesh-list
15127488|NCT04412304|Tinzaparin|tinzaparin|mesh-list
15127489|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15127490|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
15127491|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15127492|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15127493|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127494|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15127495|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15127496|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127497|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15127498|NCT04412148|Triamcinolone|triamcinolone|mesh-list
15127499|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15127500|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15127501|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15127502|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15127503|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
15127504|NCT04412148|Hormones|hormones|mesh-ancestor
15127505|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127506|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127507|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127508|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
15127509|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127510|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127511|NCT04411953|Haloperidol|haloperidol|mesh-list
15127512|NCT04411953|Benztropine|benztropine|mesh-list
15127513|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
15127514|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
15127515|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
15127516|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127517|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127518|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15127519|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15127520|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15127521|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127522|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127523|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15127524|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
15127525|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127526|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127527|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15127528|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15127529|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
15127530|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15127531|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15127532|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
15127533|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15127534|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15127535|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15127536|NCT04411940|Haloperidol|haloperidol|mesh-list
15127537|NCT04411940|Benztropine|benztropine|mesh-list
15127538|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
15127539|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
15127540|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
15127541|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127542|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127543|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15127544|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15127545|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15127546|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127547|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127548|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15127549|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
15127550|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182314|NCT03922542|Riboflavin|riboflavin|mesh-list
15127551|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127552|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15127553|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15127554|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
15127555|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15127556|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15127557|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
15127558|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15127559|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15127560|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15127561|NCT04412252|Tofacitinib|tofacitinib|mesh-list
15127562|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127563|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127564|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127565|NCT04411875|Amlodipine|amlodipine|mesh-list
15127566|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15127567|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15127568|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15127569|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127570|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15127571|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127572|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
15127573|NCT04411693|Dexamethasone|dexamethasone|mesh-list
15127574|NCT04411693|Aflibercept|aflibercept|mesh-list
15127575|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15127576|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
15127577|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
15127578|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127579|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127580|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15127581|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
15127582|NCT04411693|Hormones|hormones|mesh-ancestor
15127583|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127584|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15127585|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127586|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15127587|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15127588|NCT04411693|Growth Substances|growth substances|mesh-ancestor
15127589|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
15127590|NCT04411706|Capecitabine|capecitabine|mesh-list
15127591|NCT04411706|Apatinib|apatinib|mesh-list
15127592|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127593|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
15127594|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127595|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127596|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127597|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127598|NCT04411524|Capecitabine|capecitabine|mesh-list
15127599|NCT04411524|Irinotecan|irinotecan|mesh-list
15127600|NCT04411524|Antibodies|antibodies|mesh-list
15127601|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
15127602|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127603|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127604|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
15127605|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127606|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127607|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15127608|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15127609|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127610|NCT04411550|Pertuzumab|pertuzumab|mesh-list
15127611|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15127612|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127613|NCT04411862|Choline|choline|mesh-list
15127614|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
15127615|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15127616|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
15127617|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127618|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15127619|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15127620|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
15127621|NCT04411758|Propolis|propolis|mesh-list
15127622|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127623|NCT04411537|Capecitabine|capecitabine|mesh-list
15127624|NCT04411537|Irinotecan|irinotecan|mesh-list
15127625|NCT04411537|Antibodies|antibodies|mesh-list
15127626|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
15127627|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127628|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127629|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
15127630|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127631|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127632|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15127633|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14811350|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15127634|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127635|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
15127636|NCT04411901|Vitamin D|vitamin d|mesh-list
15127637|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15127638|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127639|NCT04411901|Vitamins|vitamins|mesh-ancestor
15127640|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
15127641|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15127642|NCT04411433|Azithromycin|azithromycin|mesh-list
15127643|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
15127644|NCT04411433|Favipiravir|favipiravir|mesh-list
15127645|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127646|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127647|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
15127648|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15127649|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15127650|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127651|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127652|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15127653|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
15127654|NCT04411446|Vitamin D|vitamin d|mesh-list
15127655|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
15127656|NCT04411446|Vitamins|vitamins|mesh-ancestor
15127657|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
15127658|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127659|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15127660|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15127661|NCT04411329|Dexamethasone|dexamethasone|mesh-list
15127662|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
15127663|NCT04411329|Bupivacaine|bupivacaine|mesh-list
15127664|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15127665|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
15127666|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
15127667|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127668|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127669|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15127670|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
15127671|NCT04411329|Hormones|hormones|mesh-ancestor
15127672|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127673|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15127674|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127675|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
15127676|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
15127677|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127678|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
15127679|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15127680|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15127681|NCT04411329|Analgesics|analgesics|mesh-ancestor
15127682|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15127683|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15127684|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15127685|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
15127686|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127687|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127688|NCT04411225|Cannabidiol|cannabidiol|mesh-list
15127689|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
15127690|NCT04411160|Ascorbic Acid|ascorbic acid|mesh-list
15127691|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
15127692|NCT04411160|Vitamins|vitamins|mesh-ancestor
15127693|NCT04411160|Micronutrients|micronutrients|mesh-ancestor
15127694|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127695|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
15127696|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127697|NCT04411160|Protective Agents|protective agents|mesh-ancestor
15127698|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15127699|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
15127700|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127701|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15127702|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
15127703|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15127704|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127705|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15127706|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
15127707|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
15127708|NCT04411212|Sargramostim|sargramostim|mesh-list
15127709|NCT04411212|Lenograstim|lenograstim|mesh-list
15127710|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
15127711|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127712|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15127713|NCT04411069|Droperidol|droperidol|mesh-list
15127714|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15127715|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
15127716|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
15127717|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127718|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127719|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15127720|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15127721|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15127722|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127723|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127724|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15127725|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15127726|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
15127727|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127728|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127729|NCT04410874|Vaccines|vaccines|mesh-list
15127730|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
15127731|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127732|NCT04410887|Olaparib|olaparib|mesh-list
15127733|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15127734|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127735|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127736|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178387|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15178388|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178389|NCT03959397|Paclitaxel|paclitaxel|mesh-list
15178390|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15178391|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15178392|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178393|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
15178394|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
15178395|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
15178396|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178397|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15178398|NCT03959176|Phenylephrine|phenylephrine|mesh-list
15178399|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
15178400|NCT03959176|Tropicamide|tropicamide|mesh-list
15178401|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15178402|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
15178403|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
15178404|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178405|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178406|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
15178407|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15178408|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
15178409|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
15178410|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15178411|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15178412|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15178413|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
15178414|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178415|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178416|NCT03959176|Protective Agents|protective agents|mesh-ancestor
15178417|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15178418|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15178419|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15178420|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15178421|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
15178422|NCT03959150|Capecitabine|capecitabine|mesh-list
15178423|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15178424|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
15178425|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178426|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178427|NCT03958942|Bupivacaine|bupivacaine|mesh-list
15127737|NCT04411030|Itraconazole|itraconazole|mesh-list
15127738|NCT04411030|Midazolam|midazolam|mesh-list
15127739|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15127740|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15127741|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127742|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127743|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15127744|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15127745|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127746|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15127747|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
15127748|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
15127749|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
15127750|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
15127751|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127752|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127753|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
15127754|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127755|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15127756|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15127757|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127758|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15127759|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
15127760|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127761|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15127762|NCT04410588|Fentanyl|fentanyl|mesh-list
15127763|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
15127764|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15127765|NCT04410588|Narcotics|narcotics|mesh-ancestor
15127766|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127767|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127768|NCT04410588|Analgesics|analgesics|mesh-ancestor
15127769|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
15127770|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127771|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15127772|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15127773|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
15127774|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
15127775|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
15127776|NCT04410354|Remdesivir|remdesivir|mesh-list
15127777|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
15127778|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127779|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
15127780|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127781|NCT04409912|Sirolimus|sirolimus|mesh-list
15127782|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127783|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127784|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15127785|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127786|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
15127787|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127788|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
15127789|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127790|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15127791|NCT04409873|Listerine|listerine|mesh-list
15127792|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
15127793|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
15127794|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15127795|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127796|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
15127797|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
15127798|NCT04410081|Lazertinib|lazertinib|mesh-list
15127799|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127800|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127801|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127802|NCT04410094|Itraconazole|itraconazole|mesh-list
15127803|NCT04410094|Rifampin|rifampin|mesh-list
15127804|NCT04410094|Lazertinib|lazertinib|mesh-list
15127805|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
15127806|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127807|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15127808|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15127809|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127810|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127811|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15127812|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
15178428|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
15127813|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127814|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127815|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15127816|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15127817|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
15127818|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127819|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
15127820|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15127821|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15127822|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15127823|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15127824|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15127825|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15127826|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15127827|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127828|NCT04410211|Midazolam|midazolam|mesh-list
15127829|NCT04410211|Sevoflurane|sevoflurane|mesh-list
15127830|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15127831|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15127832|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269813|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269814|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
14269815|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14269816|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269817|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14269818|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
14269819|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269820|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269821|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269822|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269823|NCT00405704|Trimethoprim|trimethoprim|mesh-list
14269824|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14269825|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
14269826|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14269827|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269828|NCT00405704|Renal Agents|renal agents|mesh-ancestor
14269829|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
14269830|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14269831|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14269832|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15127833|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127834|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15127835|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15127836|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127837|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15127838|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
15127839|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
15127840|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
15127841|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
15127842|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127843|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127844|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15127845|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15127846|NCT04409522|Melatonin|melatonin|mesh-list
15127847|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
15127848|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127849|NCT04409522|Protective Agents|protective agents|mesh-ancestor
15127850|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127851|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127852|NCT04409431|Epinephrine|epinephrine|mesh-list
15127853|NCT04409431|Racepinephrine|racepinephrine|mesh-list
15127854|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
15127855|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15127856|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15127857|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
15127858|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127859|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127860|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127861|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15127862|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15127863|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
15127864|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127865|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15127866|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
15127867|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
15127868|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
15127869|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15127870|NCT04409691|Sirolimus|sirolimus|mesh-list
15127871|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127872|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127873|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15127874|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127875|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
15127876|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15127877|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
15127878|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127879|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
15127880|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15127881|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15127882|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127883|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
15127884|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127885|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127886|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
15127887|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
15127888|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
15127889|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15127890|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127891|NCT04409223|Sunitinib|sunitinib|mesh-list
15127892|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127893|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15127894|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15127895|NCT04409223|Growth Substances|growth substances|mesh-ancestor
15127896|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127897|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
15127898|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15127899|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127900|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127901|NCT04409483|Ritonavir|ritonavir|mesh-list
15127902|NCT04409483|Lopinavir|lopinavir|mesh-list
15127903|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15127904|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15127905|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
15127906|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127907|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127908|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15127909|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15127910|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
15127911|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15127912|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15127913|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15127914|NCT04409327|Dactolisib|dactolisib|mesh-list
15127915|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127916|NCT04408586|Topiramate|topiramate|mesh-list
15127917|NCT04408586|Phentermine|phentermine|mesh-list
15127918|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
15127919|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15127920|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178429|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
15127921|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15127922|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
15127923|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15127924|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
15127925|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
15127926|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127927|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
15127928|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127929|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127930|NCT04408989|Bevacizumab|bevacizumab|mesh-list
15127931|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15127932|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15127933|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15127934|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15127935|NCT04408989|Growth Substances|growth substances|mesh-ancestor
15127936|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127937|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
15127938|NCT04408911|Midazolam|midazolam|mesh-list
15127939|NCT04408911|Lormetazepam|lormetazepam|mesh-list
15127940|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15127941|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15127942|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127943|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127944|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15127945|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15127946|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15127947|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15127948|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
15127949|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
15127950|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
15127951|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
15127952|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15127953|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178430|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178431|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178432|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
15178433|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178434|NCT03959124|Memantine|memantine|mesh-list
15178435|NCT03959124|Rivastigmine|rivastigmine|mesh-list
15178436|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15178437|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15178438|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
15178439|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178440|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178441|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178442|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15178443|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15178444|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15178445|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178446|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
15178447|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15178448|NCT03959124|Protective Agents|protective agents|mesh-ancestor
15178449|NCT03958721|Capecitabine|capecitabine|mesh-list
15178450|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15178451|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
15178452|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178453|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178454|NCT03958708|Rifaximin|rifaximin|mesh-list
15178455|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178456|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178457|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178458|NCT03958513|Bupivacaine|bupivacaine|mesh-list
15178459|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
15178460|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
15178461|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178462|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178463|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
15178464|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178465|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
15178466|NCT03958500|Methylene Blue|methylene blue|mesh-list
15178467|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178468|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178469|NCT03958344|Prednisolone|prednisolone|mesh-list
15178470|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15178471|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
15127954|NCT04408313|Naltrexone|naltrexone|mesh-list
15127955|NCT04408313|Buprenorphine|buprenorphine|mesh-list
15127956|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15127957|NCT04408313|Narcotics|narcotics|mesh-ancestor
15127958|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15127959|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127960|NCT04408313|Analgesics|analgesics|mesh-ancestor
15127961|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
15127962|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15127963|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15127964|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15127965|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15127966|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
15127967|NCT04408326|Giapreza|giapreza|mesh-list
15127968|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
15127969|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15127970|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15127971|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15127972|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
15127973|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15127974|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127975|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
15127976|NCT04408144|Progestins|progestins|mesh-ancestor
15127977|NCT04408144|Hormones|hormones|mesh-ancestor
15127978|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127979|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127980|NCT04408443|Vitamin D|vitamin d|mesh-list
15127981|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
15127982|NCT04408443|Vitamins|vitamins|mesh-ancestor
15127983|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
15127984|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127985|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15127986|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15127987|NCT04408235|Enoxaparin|enoxaparin|mesh-list
15127988|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
15127989|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15127990|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15127991|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15127992|NCT04407975|Betamethasone|betamethasone|mesh-list
15127993|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15127994|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
15127995|NCT04407975|Hormones|hormones|mesh-ancestor
15127996|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15127997|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15127998|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15127999|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
15128000|NCT04407754|Inositol|inositol|mesh-list
15128001|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
15128002|NCT04407754|Vitamins|vitamins|mesh-ancestor
15128003|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
15128004|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128005|NCT04407650|Metformin|metformin|mesh-list
15128006|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15128007|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15128008|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128009|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15128010|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128011|NCT04408118|Paclitaxel|paclitaxel|mesh-list
15128012|NCT04408118|Bevacizumab|bevacizumab|mesh-list
15128013|NCT04408118|Atezolizumab|atezolizumab|mesh-list
15128014|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15128015|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128016|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
15128017|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
15128018|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
15128019|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128020|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15128021|NCT04408118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15128022|NCT04408118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15128023|NCT04408118|Growth Substances|growth substances|mesh-ancestor
15128024|NCT04408118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128025|NCT04408118|Growth Inhibitors|growth inhibitors|mesh-ancestor
15128026|NCT04407715|Anesthetics|anesthetics|mesh-list
15128027|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128028|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128029|NCT04407442|Dexamethasone|dexamethasone|mesh-list
15128030|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
15128031|NCT04407442|Azacitidine|azacitidine|mesh-list
15128032|NCT04407442|Daratumumab|daratumumab|mesh-list
15128033|NCT04407442|Ichthammol|ichthammol|mesh-list
15128034|NCT04407442|BB 1101|bb 1101|mesh-list
15128035|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128036|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
15128037|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
15128038|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128039|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128040|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128041|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
15128042|NCT04407442|Hormones|hormones|mesh-ancestor
15128043|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15128044|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15128045|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128046|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
15128047|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128048|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128049|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15128050|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
15128051|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
15128052|NCT04407312|Aspirin|aspirin|mesh-list
15128053|NCT04407312|Cilostazol|cilostazol|mesh-list
15128054|NCT04407312|Clopidogrel|clopidogrel|mesh-list
15128055|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15128056|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15128057|NCT04407312|Analgesics|analgesics|mesh-ancestor
15128058|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
15128059|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128060|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128061|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128062|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128063|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15128064|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15128065|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128066|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15128067|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15128068|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128069|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
15128070|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15128071|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15128072|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15128073|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
15128074|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128075|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15128076|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
15128077|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15128078|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
15128079|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128080|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15128081|NCT04407312|Protective Agents|protective agents|mesh-ancestor
15128082|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15128083|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15128084|NCT04407247|Infliximab|infliximab|mesh-list
15128085|NCT04407247|Vedolizumab|vedolizumab|mesh-list
15128086|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
15128087|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
15128088|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
15128089|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128090|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
15128091|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128092|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996202|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15128093|NCT04407234|Acetaminophen|acetaminophen|mesh-list
15128094|NCT04407234|Tirzepatide|tirzepatide|mesh-list
15128095|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15128096|NCT04407234|Analgesics|analgesics|mesh-ancestor
15128097|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
15128098|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128099|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128100|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
15128101|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15128102|NCT04407234|Incretins|incretins|mesh-ancestor
15128103|NCT04407234|Hormones|hormones|mesh-ancestor
15128104|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15128105|NCT04407130|Doxycycline|doxycycline|mesh-list
15128106|NCT04407130|Ivermectin|ivermectin|mesh-list
15128107|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128108|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128109|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
15128110|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15128111|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128112|NCT04407078|Neostigmine|neostigmine|mesh-list
15128113|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15128114|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128115|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128116|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
15128117|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128118|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128119|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15128120|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
15128121|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128122|NCT04407390|Niacinamide|niacinamide|mesh-list
15128123|NCT04407390|Niacin|niacin|mesh-list
15128124|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
15128125|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
15128126|NCT04407390|Vitamins|vitamins|mesh-ancestor
15128127|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
15128128|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128129|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15128130|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
15128131|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128132|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15128133|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128134|NCT04406779|Hormones|hormones|mesh-list
15128135|NCT04406779|Autoantibodies|autoantibodies|mesh-list
15128136|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15128137|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128138|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
15128139|NCT04406870|Sirolimus|sirolimus|mesh-list
15128140|NCT04406870|Propranolol|propranolol|mesh-list
15128141|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128142|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128143|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15128144|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128145|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
15128146|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15128147|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
15128148|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128149|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15128150|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15128151|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
15128152|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128153|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128154|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128155|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15128156|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128157|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15128158|NCT04406727|UB-421|ub-421|mesh-list
15128159|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
15128160|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128161|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15128162|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
15128163|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128164|NCT04407000|Favipiravir|favipiravir|mesh-list
15128165|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
15128166|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128167|NCT04406883|Simvastatin|simvastatin|mesh-list
15128168|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15128169|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15128170|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
15128171|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128172|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15128173|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15128174|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128175|NCT04406272|Bevacizumab|bevacizumab|mesh-list
15128176|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15128177|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128178|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15128179|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15128180|NCT04406272|Growth Substances|growth substances|mesh-ancestor
15128181|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128182|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
15128183|NCT04406389|Heparin|heparin|mesh-list
15128184|NCT04406389|Calcium heparin|calcium heparin|mesh-list
15128185|NCT04406389|Enoxaparin|enoxaparin|mesh-list
15128186|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
15128187|NCT04406389|Argatroban|argatroban|mesh-list
15128188|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
15128189|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15128190|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15128191|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128192|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
15128193|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15128194|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
15128195|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128196|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15128197|NCT04406376|Prednisone|prednisone|mesh-list
15128198|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128199|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
15128200|NCT04406376|Hormones|hormones|mesh-ancestor
15128201|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15128202|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128203|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15128204|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128205|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
15128206|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128207|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128208|NCT04406506|Erythromycin|erythromycin|mesh-list
15128209|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
15128210|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15128211|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
15128212|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128213|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128214|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128215|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15128216|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128217|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128218|NCT04406259|Verapamil|verapamil|mesh-list
15128219|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128220|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15128221|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128222|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128223|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15128224|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128225|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128226|NCT04406025|Anesthetics|anesthetics|mesh-list
15128227|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128228|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128229|NCT04406051|Norepinephrine|norepinephrine|mesh-list
15128230|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15128231|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15128232|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
15128233|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128234|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128235|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128236|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
15128237|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
15128238|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128239|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15128240|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
15128241|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
15128242|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15128243|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128244|NCT04405960|Vitamins|vitamins|mesh-ancestor
15128245|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
15128246|NCT04405843|Ivermectin|ivermectin|mesh-list
15128247|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128248|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128249|NCT04405921|Azithromycin|azithromycin|mesh-list
15128250|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
15128251|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128252|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128253|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
15128254|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15128255|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128256|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128257|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128258|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128259|NCT04405596|Ambroxol|ambroxol|mesh-list
15128260|NCT04405596|Expectorants|expectorants|mesh-ancestor
15128261|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
15128262|NCT04405622|Gemcitabine|gemcitabine|mesh-list
15128263|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15128264|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
15128265|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128266|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128267|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
15128268|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128269|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128270|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15128271|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
15128272|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128273|NCT04405505|Paclitaxel|paclitaxel|mesh-list
15128274|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15128275|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128276|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
15128277|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
15128278|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
15128279|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128280|NCT04405375|Dexamethasone|dexamethasone|mesh-list
15128281|NCT04405375|Etoposide|etoposide|mesh-list
15128282|NCT04405375|Pegaspargase|pegaspargase|mesh-list
15128283|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128284|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
15128285|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
15128286|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128287|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128288|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128289|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
15128290|NCT04405375|Hormones|hormones|mesh-ancestor
15128291|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15128292|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15128293|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128294|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15128295|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15128296|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15128297|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128298|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128299|NCT04405206|Capecitabine|capecitabine|mesh-list
15128300|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
15128301|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15128302|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
15128303|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128304|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128305|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
15128306|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15128307|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
15128308|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128309|NCT04405193|Expectorants|expectorants|mesh-ancestor
15128310|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
15128311|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15128312|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
15128313|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128314|NCT04405193|Protective Agents|protective agents|mesh-ancestor
15128315|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128316|NCT04405193|Antidotes|antidotes|mesh-ancestor
15128317|NCT04405271|Tenofovir|tenofovir|mesh-list
15128318|NCT04405271|Emtricitabine|emtricitabine|mesh-list
15128319|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15128320|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
15128321|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128322|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15128323|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15128324|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128325|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128326|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15128327|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15128328|NCT04405154|Cisplatin|cisplatin|mesh-list
15128329|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128330|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15128331|NCT04405245|Latanoprost|latanoprost|mesh-list
15128332|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15128333|NCT04405037|Alvimopan|alvimopan|mesh-list
15128334|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128335|NCT04405011|Entecavir|entecavir|mesh-list
15128336|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
15128337|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128338|NCT04405323|Itraconazole|itraconazole|mesh-list
15128339|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
15128340|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128341|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15128342|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15128343|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128344|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128345|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15128346|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
15128347|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15128348|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128349|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15128350|NCT04404946|Phenylephrine|phenylephrine|mesh-list
15128351|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
15128352|NCT04404946|Norepinephrine|norepinephrine|mesh-list
15128353|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15128354|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
15128355|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
15128356|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128357|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128358|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
15128359|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15128360|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
15128361|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
15128362|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15128363|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15128364|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15128365|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
15128366|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128367|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128368|NCT04404946|Protective Agents|protective agents|mesh-ancestor
15128369|NCT04404881|Bevacizumab|bevacizumab|mesh-list
15128370|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15128371|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128372|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15128373|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15128374|NCT04404881|Growth Substances|growth substances|mesh-ancestor
15128375|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128376|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
15128377|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15128378|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128379|NCT04404959|Ropivacaine|ropivacaine|mesh-list
15128380|NCT04404959|Anesthetics|anesthetics|mesh-list
15128381|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
15128382|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128383|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128384|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
15128385|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128386|NCT04404751|Folic Acid|folic acid|mesh-list
15128387|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
15128388|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
15128389|NCT04404751|Iron|iron|mesh-list
15128390|NCT04404751|Vitamins|vitamins|mesh-ancestor
15128391|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
15128392|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128393|NCT04404751|Trace Elements|trace elements|mesh-ancestor
15128394|NCT04404751|Hematinics|hematinics|mesh-ancestor
15128395|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
15178472|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15178473|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
15178474|NCT03958344|Triamcinolone|triamcinolone|mesh-list
15178475|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15178476|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
15178477|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178478|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
15178479|NCT03958344|Hormones|hormones|mesh-ancestor
15178480|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178481|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178482|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15178483|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178484|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
15178485|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
15178486|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178487|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178488|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15178489|NCT03958344|Protective Agents|protective agents|mesh-ancestor
15178490|NCT03958201|Rocuronium|rocuronium|mesh-list
15178491|NCT03958201|Neostigmine|neostigmine|mesh-list
15178492|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15178493|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15178494|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15178495|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178496|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178497|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15178498|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178499|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178500|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
15178501|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178502|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15178503|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
15178504|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
15178505|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15178506|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128396|NCT04404686|Indomethacin|indomethacin|mesh-list
15128397|NCT04404686|Nifedipine|nifedipine|mesh-list
15128398|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15128399|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128400|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128401|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15128402|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128403|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128404|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
15128405|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15128406|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15128407|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15128408|NCT04404686|Analgesics|analgesics|mesh-ancestor
15128409|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
15128410|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128411|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128412|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128413|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
15128414|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15128415|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128416|NCT04404517|Adalimumab|adalimumab|mesh-list
15128417|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128418|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128419|NCT04404491|Capecitabine|capecitabine|mesh-list
15128420|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15128421|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
15128422|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128423|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128424|NCT04404439|Topiramate|topiramate|mesh-list
15128425|NCT04404439|Verapamil|verapamil|mesh-list
15128426|NCT04404439|Paroxetine|paroxetine|mesh-list
15128427|NCT04404439|Nortriptyline|nortriptyline|mesh-list
15128428|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
15128429|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15128430|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128431|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15128432|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15128433|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128434|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128435|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128436|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
15128437|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15128438|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
15128439|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15128440|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15128441|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15128442|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128443|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128444|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15128445|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15128446|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128447|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15128448|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15128449|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
15128450|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15128451|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15128452|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128453|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128454|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
15128455|NCT04404387|Vitamins|vitamins|mesh-ancestor
15128456|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
15128457|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128458|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
15128459|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128460|NCT04404387|Protective Agents|protective agents|mesh-ancestor
15128461|NCT04404062|Antibodies|antibodies|mesh-list
15128462|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
15128463|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
15128464|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128465|NCT04404049|UB-421|ub-421|mesh-list
15128466|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15128467|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
15128468|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128469|NCT04404127|Basiliximab|basiliximab|mesh-list
15128470|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15128471|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
15128472|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128473|NCT04403776|Tofacitinib|tofacitinib|mesh-list
15128474|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15128475|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128476|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128477|NCT04403503|Thrombin|thrombin|mesh-list
15128478|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
15128479|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
15128480|NCT04403503|Coagulants|coagulants|mesh-ancestor
15128481|NCT04403724|Fentanyl|fentanyl|mesh-list
15128482|NCT04403724|Morphine|morphine|mesh-list
15128483|NCT04403724|Bupivacaine|bupivacaine|mesh-list
15128484|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
15128485|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
15128486|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128487|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128488|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
15128489|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128490|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15128491|NCT04403724|Narcotics|narcotics|mesh-ancestor
15128492|NCT04403724|Analgesics|analgesics|mesh-ancestor
15128493|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15128494|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15128495|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
15128496|NCT04403568|Ursolic acid|ursolic acid|mesh-list
15128497|NCT04403568|Curcumin|curcumin|mesh-list
15128498|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15128499|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15128500|NCT04403568|Analgesics|analgesics|mesh-ancestor
15128501|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
15128502|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128503|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128504|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128505|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128506|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128507|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128508|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128509|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128510|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15128511|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15128512|NCT04403555|Ivermectin|ivermectin|mesh-list
15128513|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128514|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128515|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
15128516|NCT04403711|Anesthetics|anesthetics|mesh-list
15128517|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
15128518|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15128519|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128520|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128521|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15128522|NCT04403711|Analgesics|analgesics|mesh-ancestor
15128523|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
15128524|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128525|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15128526|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15128527|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15128528|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
15128529|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128530|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128531|NCT04403347|Losartan|losartan|mesh-list
15128532|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
15128533|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128534|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15128535|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15128536|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128537|NCT04403087|Trimebutine|trimebutine|mesh-list
15128538|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128539|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
15128540|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
15128541|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128542|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128543|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
15128544|NCT04403334|Levofloxacin|levofloxacin|mesh-list
15128545|NCT04403334|Ofloxacin|ofloxacin|mesh-list
15128546|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128547|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128548|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15128549|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15128550|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128551|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128552|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128553|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15128554|NCT04403334|Renal Agents|renal agents|mesh-ancestor
15128555|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15128556|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15128557|NCT04403100|Ritonavir|ritonavir|mesh-list
15128558|NCT04403100|Lopinavir|lopinavir|mesh-list
15128559|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
15128560|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15128561|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15128562|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
15128563|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128564|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128565|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15128566|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15128567|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
15128568|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128569|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15128570|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15128571|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
13996203|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996204|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996205|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13996206|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13996207|NCT02921984|Docetaxel|docetaxel|mesh-list
13996208|NCT02921984|Pemetrexed|pemetrexed|mesh-list
15128572|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15128573|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128574|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128575|NCT04403243|Colchicine|colchicine|mesh-list
15128576|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
15128577|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128578|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
15128579|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
15128580|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
15128581|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128582|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996209|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996210|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
13996211|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
13996212|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
15128583|NCT04403282|Eflornithine|eflornithine|mesh-list
15128584|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128585|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15128586|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15128587|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128588|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996213|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128589|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
13996214|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128590|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128591|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128592|NCT04403191|Ondansetron|ondansetron|mesh-list
15128593|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
15128594|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
15128595|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128596|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128597|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128598|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
15128599|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
15128600|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15128601|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
15128602|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128603|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128604|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15128605|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15128606|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128607|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15128608|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15128609|NCT04403321|Cyclosporine|cyclosporine|mesh-list
15128610|NCT04403321|Tacrolimus|tacrolimus|mesh-list
15128611|NCT04403321|Cyclosporins|cyclosporins|mesh-list
15128612|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15128613|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
15128614|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128615|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15128616|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128617|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128618|NCT04403321|Antifungal Agents|antifungal agents|mesh-ancestor
15128619|NCT04403321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128620|NCT04403321|Dermatologic Agents|dermatologic agents|mesh-ancestor
15128621|NCT04403321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128622|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
15128623|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
15128624|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15128625|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128626|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128627|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
15128628|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15128629|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128630|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128631|NCT04402762|Enoxaparin|enoxaparin|mesh-list
15128632|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
15128633|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
15128634|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15128635|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15128636|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128637|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
15128638|NCT04402580|Rituximab|rituximab|mesh-list
15128639|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15128640|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128641|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
15128642|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128643|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128644|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15128645|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15128646|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
15128647|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128648|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128649|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128650|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128651|NCT04402671|Glutaral|glutaral|mesh-list
15128652|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
15128653|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178507|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178508|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15178509|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15178510|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178511|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178512|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178513|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15178514|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
15178515|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15178516|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178517|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15178518|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15128654|NCT04402723|Cytarabine|cytarabine|mesh-list
15128655|NCT04402723|Daunorubicin|daunorubicin|mesh-list
15128656|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15128657|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
15128658|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128659|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128660|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
15128661|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128662|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15128663|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
15128664|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128665|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15128666|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15128667|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15128668|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128669|NCT04402320|Midazolam|midazolam|mesh-list
15128670|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15128671|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15128672|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128673|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128674|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15128675|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15128676|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15128677|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15128678|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
15128679|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
15128680|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
15128681|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
15128682|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128683|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128684|NCT04402359|Meropenem|meropenem|mesh-list
15128685|NCT04402359|Ceftazidime|ceftazidime|mesh-list
15128686|NCT04402359|Avibactam|avibactam|mesh-list
15128687|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15128688|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128689|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15128690|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128691|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128692|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
15128693|NCT04402411|Narcotics|narcotics|mesh-ancestor
15128694|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128695|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128696|NCT04402411|Analgesics|analgesics|mesh-ancestor
15128697|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
15128698|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128699|NCT04402346|Pancrelipase|pancrelipase|mesh-list
15128700|NCT04402346|Pancreatin|pancreatin|mesh-list
15128701|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128702|NCT04402203|Favipiravir|favipiravir|mesh-list
15128703|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
15128704|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128705|NCT04402047|Diclofenac|diclofenac|mesh-list
15128706|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15128707|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15128708|NCT04402047|Analgesics|analgesics|mesh-ancestor
15128709|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
15128710|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128711|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128712|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15128713|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128714|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15128715|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128716|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128717|NCT04402112|Pitavastatin|pitavastatin|mesh-list
15128718|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15128719|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15128720|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15128721|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
15128722|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128723|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128724|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15128725|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
15128726|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128727|NCT04401878|Lidocaine|lidocaine|mesh-list
15128728|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
15128729|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
15128730|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128731|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128732|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
15128733|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128734|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128735|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15128736|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15128737|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128738|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128739|NCT04402073|Vincristine|vincristine|mesh-list
15128740|NCT04402073|Lomustine|lomustine|mesh-list
15128741|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128742|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15128743|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
15128744|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
15128745|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
15128746|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128747|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15128748|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
15128749|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
15128750|NCT04401852|Analgesics|analgesics|mesh-ancestor
15128751|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
15128752|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128753|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128754|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
15128755|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128756|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128757|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
15128758|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15128759|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128760|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128761|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15128762|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
15128763|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15128764|NCT04401839|Oxytocin|oxytocin|mesh-list
15128765|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
15128766|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15128767|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128768|NCT04401709|Gemcitabine|gemcitabine|mesh-list
15128769|NCT04401709|Capecitabine|capecitabine|mesh-list
15128770|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15128771|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
15128772|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128773|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128774|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
15128775|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128776|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128777|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15128778|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
15128779|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128780|NCT04401774|Nivolumab|nivolumab|mesh-list
15128781|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15128782|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128783|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15128784|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128785|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15128786|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
15128787|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128788|NCT04401657|Adenosine|adenosine|mesh-list
15128789|NCT04401657|Analgesics|analgesics|mesh-ancestor
15128790|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
15128791|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128792|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128793|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128794|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128795|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15128796|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
15128797|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
15128798|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128799|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128800|NCT04401137|Topiramate|topiramate|mesh-list
15128801|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
15128802|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15128803|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128804|NCT04401176|Lidocaine|lidocaine|mesh-list
15128805|NCT04401176|Heparin|heparin|mesh-list
15128806|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
15128807|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
15128808|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128809|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128810|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
15128811|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128812|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128813|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15128814|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15128815|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128816|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128817|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
15128818|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15128819|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15128820|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
15128821|NCT04401345|Bromides|bromides|mesh-list
15128822|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
15128823|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15128824|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15128825|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15128826|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
15128827|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128828|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128829|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128830|NCT04401085|Antibodies|antibodies|mesh-list
15128831|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
15128832|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128833|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15128834|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15128835|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
15128836|NCT04401007|Lidocaine|lidocaine|mesh-list
15128837|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
15128838|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
15128839|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128840|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128841|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
15128842|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128843|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15128844|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15128845|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15128846|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128847|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128848|NCT04400747|Vitamin D|vitamin d|mesh-list
15128849|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
15128850|NCT04400747|Vitamins|vitamins|mesh-ancestor
15128851|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
15128852|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128853|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15128854|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15128855|NCT04400721|Ropivacaine|ropivacaine|mesh-list
15128856|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
15128857|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
15128858|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128859|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128860|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
15128861|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128862|NCT04400994|Rituximab|rituximab|mesh-list
15128863|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15128864|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128865|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
15128866|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128867|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128868|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
15128869|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15128870|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15128871|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128872|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
15128873|NCT04400916|Coagulants|coagulants|mesh-ancestor
15128874|NCT04400929|Molgramostim|molgramostim|mesh-list
15128875|NCT04400929|Sargramostim|sargramostim|mesh-list
15128876|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
15128877|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128878|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128879|NCT04400890|Vitamin D|vitamin d|mesh-list
15128880|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
15128881|NCT04400890|Resveratrol|resveratrol|mesh-list
15128882|NCT04400890|Vitamins|vitamins|mesh-ancestor
15128883|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
15128884|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128885|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15128886|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15128887|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
15128888|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128889|NCT04400890|Protective Agents|protective agents|mesh-ancestor
15128890|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128891|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15178519|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15181930|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181931|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15181932|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
15181933|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
15181934|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181935|NCT03925779|Analgesics|analgesics|mesh-ancestor
15181936|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
15181937|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181938|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15181939|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15181940|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15181941|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
15181942|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181943|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181944|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15181945|NCT03925779|Narcotics|narcotics|mesh-ancestor
15181946|NCT03925740|Listerine|listerine|mesh-list
15181947|NCT03925740|Fluorides|fluorides|mesh-list
15181948|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
15181949|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
15181950|NCT03925740|Protective Agents|protective agents|mesh-ancestor
15181951|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181952|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15181953|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181954|NCT03925701|Metformin|metformin|mesh-list
15181955|NCT03925701|Vildagliptin|vildagliptin|mesh-list
15181956|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15181957|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181958|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15181959|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
15181960|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181961|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181962|NCT03925662|Mebendazole|mebendazole|mesh-list
15181963|NCT03925662|Piperazine|piperazine|mesh-list
15181964|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
15181965|NCT03925662|Bevacizumab|bevacizumab|mesh-list
15181966|NCT03925662|DMP 777|dmp 777|mesh-list
15181967|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15181968|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181969|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15181970|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15181971|NCT03925662|Growth Substances|growth substances|mesh-ancestor
15181972|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181973|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
15181974|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
15181975|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
15181976|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15181977|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181978|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
15181979|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
15181980|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
15181981|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181982|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181983|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15181984|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181985|NCT03925233|Tamoxifen|tamoxifen|mesh-list
15181986|NCT03925233|Toremifene|toremifene|mesh-list
15181987|NCT03925233|Gemcitabine|gemcitabine|mesh-list
15181988|NCT03925233|Vinorelbine|vinorelbine|mesh-list
15181989|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
15181990|NCT03925233|Bevacizumab|bevacizumab|mesh-list
15181991|NCT03925233|Carboplatin|carboplatin|mesh-list
15181992|NCT03925233|Doxorubicin|doxorubicin|mesh-list
15181993|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15181994|NCT03925233|Fluorouracil|fluorouracil|mesh-list
15181995|NCT03925233|Capecitabine|capecitabine|mesh-list
15128892|NCT04400201|Propofol|propofol|mesh-list
15128893|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15128894|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128895|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128896|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15128897|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
15128898|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
15128899|NCT04400175|Silicon|silicon|mesh-list
15128900|NCT04400175|Trace Elements|trace elements|mesh-ancestor
15128901|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
15128902|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128903|NCT04400188|Temozolomide|temozolomide|mesh-list
15128904|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15128905|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
15128906|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128907|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128908|NCT04400045|Treosulfan|treosulfan|mesh-list
15128909|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15128910|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
15128911|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128912|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15128913|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
15128914|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
15128915|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15128916|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15128917|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128918|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128919|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128920|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15128921|NCT04400136|Lansoprazole|lansoprazole|mesh-list
15128922|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
15128923|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15128924|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15128925|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15128926|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128927|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128928|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15128929|NCT04399187|Eusol|eusol|mesh-list
15128930|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
15128931|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15128932|NCT04399213|Histamine|histamine|mesh-list
15128933|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
15128934|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
15128935|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
15128936|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128937|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128938|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128939|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
15128940|NCT04399226|Ketamine|ketamine|mesh-list
15128941|NCT04399226|Propofol|propofol|mesh-list
15128942|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15128943|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15128944|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128945|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15128946|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
15128947|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
15128948|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15128949|NCT04399226|Analgesics|analgesics|mesh-ancestor
15128950|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
15128951|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128952|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15128953|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15128954|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15128955|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
15128956|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128957|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128958|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15128959|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15128960|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15128961|NCT04399395|Naltrexone|naltrexone|mesh-list
15128962|NCT04399395|Bupropion|bupropion|mesh-list
15128963|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15128964|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15128965|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128966|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
15128967|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15128968|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15128969|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
15128970|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15128971|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15128972|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15128973|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15128974|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128975|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
15128976|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128977|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15128978|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15128979|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15128980|NCT04399434|Insulin|insulin|mesh-list
15128981|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15128982|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128983|NCT04399525|Cetirizine|cetirizine|mesh-list
15128984|NCT04399525|Loratadine|loratadine|mesh-list
15128985|NCT04399525|Levocetirizine|levocetirizine|mesh-list
13996215|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13996216|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13996217|NCT02921906|Acetaminophen|acetaminophen|mesh-list
13996218|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13996219|NCT02921906|Analgesics|analgesics|mesh-ancestor
13996220|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
13996221|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996222|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996223|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
13996224|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
13996225|NCT02921763|Progestins|progestins|mesh-ancestor
13996226|NCT02921763|Hormones|hormones|mesh-ancestor
13996227|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996228|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996229|NCT02921659|Niacinamide|niacinamide|mesh-list
13996230|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
13996231|NCT02921659|Vitamins|vitamins|mesh-ancestor
13996232|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
13996233|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996234|NCT02921919|Talazoparib|talazoparib|mesh-list
13996235|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13996236|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996237|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996238|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996239|NCT02921269|Bevacizumab|bevacizumab|mesh-list
13996240|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13996241|NCT02921269|Atezolizumab|atezolizumab|mesh-list
13996242|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
13996243|NCT02921269|Antibodies|antibodies|mesh-list
13996244|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
13996245|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13996246|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
13996247|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996248|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13996249|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13996250|NCT02921269|Growth Substances|growth substances|mesh-ancestor
13996251|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996252|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
13996253|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
14023354|NCT02762864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15128986|NCT04399525|Desloratadine|desloratadine|mesh-list
15128987|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15128988|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14023355|NCT02762864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14023356|NCT02762864|Analgesics|analgesics|mesh-ancestor
15128989|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
15128990|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
15128991|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15128992|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15128993|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15128994|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15128995|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15128996|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
15128997|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
15128998|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
15128999|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
15129000|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15129001|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129002|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129003|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15129004|NCT04399343|Analgesics|analgesics|mesh-ancestor
15129005|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
15129006|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129007|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15129008|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15129009|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15129010|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
15129011|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129012|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129013|NCT04399148|Ketotifen|ketotifen|mesh-list
13996254|NCT02921282|Dopamine|dopamine|mesh-list
13996255|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13996256|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
13996257|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
13996258|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996259|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996260|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
13996261|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996262|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996263|NCT02921282|Protective Agents|protective agents|mesh-ancestor
13996264|NCT02921360|Aspirin|aspirin|mesh-list
13996265|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13996266|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13996267|NCT02921360|Analgesics|analgesics|mesh-ancestor
13996268|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
13996269|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996270|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996271|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996272|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996273|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13996274|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13996275|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996276|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13996277|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13996278|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129014|NCT04399148|Aprepitant|aprepitant|mesh-list
15129015|NCT04399148|Desloratadine|desloratadine|mesh-list
15129016|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
15129017|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
15129018|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129019|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129020|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15129021|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15129022|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129023|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129024|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15129025|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
15129026|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15129027|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15129028|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
15129029|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
15129030|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
15129031|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
15129032|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15129033|NCT04398823|Polidocanol|polidocanol|mesh-list
15129034|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15129035|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15129036|NCT04399070|Ketamine|ketamine|mesh-list
15129037|NCT04399070|Esketamine|esketamine|mesh-list
15129038|NCT04399070|Analgesics|analgesics|mesh-ancestor
15129039|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
15129040|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129041|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129042|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15129043|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15129044|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
15129045|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
15129046|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129047|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15129048|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15129049|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129050|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129051|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
15129052|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15129053|NCT04398927|Folfirinox|folfirinox|mesh-list
15129054|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129055|NCT04399083|Caffeine|caffeine|mesh-list
15129056|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15129057|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129058|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15129059|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129060|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129061|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15129062|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15129063|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
15129064|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129065|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15129066|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15129067|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
15129068|NCT04398537|Hormones|hormones|mesh-ancestor
15129069|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129070|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129071|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129072|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129073|NCT04398719|Capsaicin|capsaicin|mesh-list
15129074|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
15129075|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
15129076|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
15129077|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129078|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129079|NCT04398771|Valsartan|valsartan|mesh-list
15129080|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15129081|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15129082|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15129083|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
15129084|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129085|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15129086|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15129087|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129088|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15129089|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15129090|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15178520|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15178521|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15178522|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178523|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
15178524|NCT03958396|Remifentanil|remifentanil|mesh-list
15178525|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15178526|NCT03958396|Narcotics|narcotics|mesh-ancestor
15178527|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178528|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178529|NCT03958396|Analgesics|analgesics|mesh-ancestor
15178530|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
15178531|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178532|NCT03958097|Antibodies|antibodies|mesh-list
15178533|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
15178534|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178535|NCT03957902|Aspirin|aspirin|mesh-list
15178536|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15178537|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178538|NCT03957902|Analgesics|analgesics|mesh-ancestor
15178539|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
15178540|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178541|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178542|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178543|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178544|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15178545|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15178546|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178547|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15178548|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15178549|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178550|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
15178551|NCT03958045|Nivolumab|nivolumab|mesh-list
15178552|NCT03958045|Rucaparib|rucaparib|mesh-list
15178553|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15178554|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178555|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15178556|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178557|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15178558|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178559|NCT03957720|Penicillamine|penicillamine|mesh-list
15178560|NCT03957720|Succimer|succimer|mesh-list
15178561|NCT03957720|Antidotes|antidotes|mesh-ancestor
15178562|NCT03957720|Protective Agents|protective agents|mesh-ancestor
15129091|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
15129092|NCT04398589|Ropivacaine|ropivacaine|mesh-list
15129093|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15129094|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129095|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129096|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15129097|NCT04398589|Analgesics|analgesics|mesh-ancestor
15129098|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
15129099|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129100|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15129101|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15129102|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15129103|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
15129104|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129105|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129106|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
15129107|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
15129108|NCT04398251|Febuxostat|febuxostat|mesh-list
15129109|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
15129110|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129111|NCT04398108|Margetuximab|margetuximab|mesh-list
15129112|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129113|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
15129114|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15129115|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
13996279|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
15129116|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129117|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129118|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13996280|NCT02921204|Vitamin D|vitamin d|mesh-list
13996281|NCT02921204|Vitamins|vitamins|mesh-ancestor
13996282|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
13996283|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996284|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13996285|NCT02921191|Lenograstim|lenograstim|mesh-list
15129119|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
15129120|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13996286|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13996287|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
13996288|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996289|NCT02921178|Omalizumab|omalizumab|mesh-list
13996290|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13996291|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13996292|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
13996293|NCT02921165|Aspirin|aspirin|mesh-list
13996294|NCT02921165|Analgesics|analgesics|mesh-list
13996295|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13996296|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13996297|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
13996298|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996299|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996300|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996301|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996302|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13996303|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13996304|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996305|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15129121|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
15129122|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129123|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129124|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15129125|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
15129126|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
15129127|NCT04398290|Protective Agents|protective agents|mesh-ancestor
15129128|NCT04398316|Lidocaine|lidocaine|mesh-list
15129129|NCT04398316|Hydromorphone|hydromorphone|mesh-list
15129130|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
15129131|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
15129132|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129133|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129134|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
15129135|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129136|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15129137|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15129138|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15129139|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15129140|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129141|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15129142|NCT04398316|Narcotics|narcotics|mesh-ancestor
15129143|NCT04398316|Analgesics|analgesics|mesh-ancestor
15129144|NCT04398004|Clarithromycin|clarithromycin|mesh-list
15129145|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15129146|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129147|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15129148|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129149|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129150|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15129151|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15129152|NCT04397770|Temozolomide|temozolomide|mesh-list
15129153|NCT04397770|Apatinib|apatinib|mesh-list
15129154|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15129155|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
15129156|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129157|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129158|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15129159|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129160|NCT04397601|Bevacizumab|bevacizumab|mesh-list
15129161|NCT04397601|Aflibercept|aflibercept|mesh-list
15129162|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15129163|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129164|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15129165|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15129166|NCT04397601|Growth Substances|growth substances|mesh-ancestor
15129167|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129168|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
15129169|NCT04397991|Furosemide|furosemide|mesh-list
15129170|NCT04397991|Diuretics|diuretics|mesh-ancestor
15129171|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
15129172|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129173|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15129174|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15129175|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129176|NCT04397653|Ezetimibe|ezetimibe|mesh-list
15129177|NCT04397653|Evolocumab|evolocumab|mesh-list
15129178|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15129179|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15129180|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
15129181|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129182|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15129183|NCT04397679|Chloroquine|chloroquine|mesh-list
15129184|NCT04397679|Temozolomide|temozolomide|mesh-list
15129185|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15129186|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
15129187|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996306|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13996307|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996308|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
13996309|NCT02920931|Tenofovir|tenofovir|mesh-list
13996310|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
13996311|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996312|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13996313|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13996314|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996315|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269833|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269834|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269835|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15129188|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129189|NCT04397679|Amebicides|amebicides|mesh-ancestor
15129190|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129191|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129192|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129193|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
15129194|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129195|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
13996316|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13996317|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13996318|NCT02920827|Dapivirine|dapivirine|mesh-list
13996319|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13996320|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13996321|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
13996322|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996323|NCT02920801|Metformin|metformin|mesh-list
13996324|NCT02920801|Saxagliptin|saxagliptin|mesh-list
13996325|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13996326|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996327|NCT02920801|Incretins|incretins|mesh-ancestor
13996328|NCT02920801|Hormones|hormones|mesh-ancestor
13996329|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996330|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13996331|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
13996332|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996333|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996334|NCT02921022|Gemcitabine|gemcitabine|mesh-list
13996335|NCT02921022|Paclitaxel|paclitaxel|mesh-list
13996336|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13996337|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996338|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
13996339|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
13996340|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
13996341|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996342|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13996343|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
13996344|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
13996345|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996346|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996347|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996348|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
13996349|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996350|NCT02920905|Lidocaine|lidocaine|mesh-list
13996351|NCT02920905|Atracurium|atracurium|mesh-list
13996352|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
13996353|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
13996354|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996355|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996356|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
13996357|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996358|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13996359|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13996360|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13996361|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269836|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15129196|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14269837|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14269838|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269839|NCT00405756|Aspirin|aspirin|mesh-list
15129197|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
15129198|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129199|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129200|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15129201|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
15129202|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15129203|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
15129204|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129205|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129206|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15129207|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
15129208|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
15129209|NCT04397692|Protective Agents|protective agents|mesh-ancestor
15129210|NCT04397913|Acetaminophen|acetaminophen|mesh-list
15129211|NCT04397913|Ibuprofen|ibuprofen|mesh-list
15129212|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15129213|NCT04397913|Analgesics|analgesics|mesh-ancestor
15129214|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
15129215|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129216|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129217|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
15129218|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15129219|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129220|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129221|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15129222|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129223|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129224|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
15129225|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129226|NCT04397341|Docetaxel|docetaxel|mesh-list
15129227|NCT04397341|Fluorouracil|fluorouracil|mesh-list
15129228|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129229|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
15129230|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
15129231|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
15129232|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129233|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
15129234|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15129235|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129236|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
15129237|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129238|NCT04397458|Dexamethasone|dexamethasone|mesh-list
15129239|NCT04397458|Bupivacaine|bupivacaine|mesh-list
15129240|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129241|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
15129242|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
15129243|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129244|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129245|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15129246|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
15129247|NCT04397458|Hormones|hormones|mesh-ancestor
15129248|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129249|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15129250|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129251|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
15129252|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
15129253|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129254|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
15129255|NCT04397510|Heparin|heparin|mesh-list
15129256|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
15129257|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15129258|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15129259|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129260|NCT04397393|Midazolam|midazolam|mesh-list
15129261|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15129262|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14561771|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561772|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561773|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561774|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561775|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
14561776|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561777|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561778|NCT00002805|Analgesics|analgesics|mesh-ancestor
14561779|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
14561780|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561781|NCT00002805|Trace Elements|trace elements|mesh-ancestor
14561782|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
14561783|NCT00002806|Vincristine|vincristine|mesh-list
15129263|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129264|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129265|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15129266|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15129267|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15129268|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15129269|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
15129270|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
15129271|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
15129272|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
15129273|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129274|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129275|NCT04397289|Heparin|heparin|mesh-list
15129276|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
15129277|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
15129278|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15129279|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13996362|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996363|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13996364|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13996365|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13996366|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15129280|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129281|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15129282|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
15129283|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13996367|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13996368|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
13996369|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996370|NCT02920567|Octreotide|octreotide|mesh-list
13996371|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996372|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13996373|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996374|NCT02920515|Leuprolide|leuprolide|mesh-list
13996375|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13996376|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
13996377|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996378|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996379|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13996380|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996381|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13996382|NCT02920710|Hormones|hormones|mesh-ancestor
13996383|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996384|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996385|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
13996386|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13996387|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996388|NCT02920502|Vitamins|vitamins|mesh-ancestor
13996389|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
13996390|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15129284|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
15129285|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129286|NCT04397549|Morphine|morphine|mesh-list
15129287|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15129288|NCT04397549|Narcotics|narcotics|mesh-ancestor
15129289|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129290|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129291|NCT04397549|Analgesics|analgesics|mesh-ancestor
15129292|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
15129293|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129294|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
15129295|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
15129296|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129297|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129298|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129299|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129300|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129301|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129302|NCT04396990|Prednisolone|prednisolone|mesh-list
15129303|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129304|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
15129305|NCT04396990|Hormones|hormones|mesh-ancestor
15129306|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129307|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129308|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15129309|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129310|NCT04396938|Lamotrigine|lamotrigine|mesh-list
15129311|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
15129312|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15129313|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15129314|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129315|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15129316|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129317|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15129318|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15129319|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129320|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15129321|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15129322|NCT04396730|Cannabidiol|cannabidiol|mesh-list
15129323|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
15129324|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
15129325|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15181996|NCT03925233|Methotrexate|methotrexate|mesh-list
15129326|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15129327|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129328|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
15129329|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15129330|NCT04396743|Clotrimazole|clotrimazole|mesh-list
15129331|NCT04396743|Miconazole|miconazole|mesh-list
15129332|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15129333|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129334|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
15129335|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15129336|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15129337|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129338|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129339|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15129340|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
15129341|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129342|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129343|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15129344|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14269840|NCT00405756|Prednisone|prednisone|mesh-list
15129345|NCT04396977|Histamine|histamine|mesh-list
15129346|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
15129347|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
15129348|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129349|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129350|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129351|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
15129352|NCT04396457|Pemetrexed|pemetrexed|mesh-list
15129353|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15129354|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129355|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129356|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129357|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15129358|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15129359|NCT04396496|Daratumumab|daratumumab|mesh-list
15129360|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129361|NCT04396548|Midodrine|midodrine|mesh-list
15129362|NCT04396548|Anesthetics|anesthetics|mesh-list
15129363|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129364|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129365|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
15129366|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
15129367|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129368|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15129369|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15129370|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15129371|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15129372|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
15129373|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129374|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178563|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178564|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
15178565|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
15178566|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178567|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178568|NCT03957681|Brodalumab|brodalumab|mesh-list
15178569|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
15178570|NCT03957668|Lactulose|lactulose|mesh-list
15178571|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15178572|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178573|NCT03957668|Laxatives|laxatives|mesh-ancestor
15178574|NCT03957499|Dexamethasone|dexamethasone|mesh-list
15178575|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
15178576|NCT03957499|Bupivacaine|bupivacaine|mesh-list
15178577|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129375|NCT04396223|Methotrexate|methotrexate|mesh-list
15129376|NCT04396223|Avelumab|avelumab|mesh-list
15129377|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15129378|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
15129379|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15129380|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129381|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15129382|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
15129383|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129384|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129385|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
15129386|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129387|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15129388|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129389|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
15129390|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129391|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15129392|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15129393|NCT04396067|Tretinoin|tretinoin|mesh-list
15129394|NCT04396067|Isotretinoin|isotretinoin|mesh-list
15129395|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129396|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
15129397|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
15129398|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15129399|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15129400|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
15129401|NCT04395768|Vitamin D|vitamin d|mesh-list
15129402|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
15129403|NCT04395768|Vitamins|vitamins|mesh-list
15129404|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
15129405|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
15129406|NCT04395768|Hydroxocobalamin|hydroxocobalamin|mesh-list
15129407|NCT04395768|Azithromycin|azithromycin|mesh-list
15129408|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
15129409|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
15129410|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129411|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15129412|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129413|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15129414|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15129415|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129416|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
15129417|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13996391|NCT02920593|Vitamin D|vitamin d|mesh-list
13996392|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
13996393|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
13996394|NCT02920593|Vitamins|vitamins|mesh-list
13996395|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
13996396|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996397|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13996398|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13996399|NCT02920658|Betamethasone|betamethasone|mesh-list
13996400|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
13996401|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13996402|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
13996403|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13996404|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996405|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
13996406|NCT02920658|Hormones|hormones|mesh-ancestor
13996407|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996408|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996409|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13996410|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
13996411|NCT02920359|Leuprolide|leuprolide|mesh-list
13996412|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13996413|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
13996414|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996415|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996416|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13996417|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996418|NCT02920489|Sufentanil|sufentanil|mesh-list
13996419|NCT02920489|Dsuvia|dsuvia|mesh-list
13996420|NCT02920489|Ropivacaine|ropivacaine|mesh-list
13996421|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
13996422|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
13996423|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996424|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996425|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
13996426|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996427|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13996428|NCT02920489|Narcotics|narcotics|mesh-ancestor
13996429|NCT02920489|Analgesics|analgesics|mesh-ancestor
13996430|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13996431|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14269841|NCT00405756|Lenalidomide|lenalidomide|mesh-list
14269842|NCT00405756|Melphalan|melphalan|mesh-list
14269843|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996432|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
13996433|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
13996434|NCT02920372|Hematinics|hematinics|mesh-ancestor
13996435|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13996436|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13996437|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996438|NCT02919917|Midodrine|midodrine|mesh-list
13996439|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
14269844|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
15129418|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129419|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129420|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129421|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
15129422|NCT04395768|Protective Agents|protective agents|mesh-ancestor
15129423|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
15129424|NCT04395768|Hematinics|hematinics|mesh-ancestor
15129425|NCT04395989|Paclitaxel|paclitaxel|mesh-list
15129426|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15129427|NCT04395989|Capecitabine|capecitabine|mesh-list
15129428|NCT04395989|Everolimus|everolimus|mesh-list
13996440|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
13996441|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129429|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15129430|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129431|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
15129432|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
15129433|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
15129434|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129435|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15129436|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
15129437|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129438|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
15129439|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129440|NCT04395612|Niraparib|niraparib|mesh-list
15129441|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15129442|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129443|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129444|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269845|NCT00405756|Hormones|hormones|mesh-ancestor
15129445|NCT04395638|Vitamin D|vitamin d|mesh-list
15129446|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
15129447|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
15129448|NCT04395638|Vitamins|vitamins|mesh-list
15129449|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
15129450|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129451|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15129452|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15129453|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
15129454|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15129455|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
15129456|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129457|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
15129458|NCT04395417|Protective Agents|protective agents|mesh-ancestor
15129459|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15129460|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15129461|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129462|NCT04395365|Renal Agents|renal agents|mesh-ancestor
15129463|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15129464|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
15129465|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129466|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129467|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
15129468|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15129469|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
15129470|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15129471|NCT04395105|Dexamethasone|dexamethasone|mesh-list
15129472|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14269846|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269847|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129473|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
15129474|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
15129475|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129476|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129477|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14269848|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14269849|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269850|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15129478|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
15129479|NCT04395105|Hormones|hormones|mesh-ancestor
15129480|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129481|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15129482|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129483|NCT04395248|Anesthetics|anesthetics|mesh-list
15129484|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129485|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129486|NCT04394975|Sunitinib|sunitinib|mesh-list
15129487|NCT04394975|Axitinib|axitinib|mesh-list
14269851|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14269852|NCT00405756|Analgesics|analgesics|mesh-ancestor
14269853|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
14269854|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269855|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269856|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14269857|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14269858|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129488|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129489|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15129490|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15129491|NCT04394975|Growth Substances|growth substances|mesh-ancestor
15129492|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129493|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
15129494|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15129495|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129496|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129497|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
15129498|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15129499|NCT04395170|Antibodies|antibodies|mesh-list
15129500|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
14561784|NCT00002806|Lomustine|lomustine|mesh-list
14561785|NCT00002806|Procarbazine|procarbazine|mesh-list
14561786|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561787|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129501|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129502|NCT04395079|Durvalumab|durvalumab|mesh-list
15129503|NCT04395079|Ipilimumab|ipilimumab|mesh-list
15129504|NCT04395079|Tremelimumab|tremelimumab|mesh-list
15129505|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
15129506|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13996442|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996443|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13996444|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13996445|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13996446|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13996447|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
13996448|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996449|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996450|NCT02920047|Amlodipine|amlodipine|mesh-list
13996451|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13996452|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13996453|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996454|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996455|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13996456|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996457|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
15129507|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
15129508|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15129509|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129510|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
15129511|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129512|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15129513|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129514|NCT04394897|Remifentanil|remifentanil|mesh-list
15129515|NCT04394897|Propofol|propofol|mesh-list
15129516|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15129517|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129518|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129519|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15129520|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
15129521|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
15129522|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15129523|NCT04394897|Narcotics|narcotics|mesh-ancestor
15129524|NCT04394897|Analgesics|analgesics|mesh-ancestor
15129525|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
15129526|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129527|NCT04394728|Trabectedin|trabectedin|mesh-list
15129528|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15129529|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
15178578|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
15129530|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129531|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129532|NCT04394598|Capecitabine|capecitabine|mesh-list
15129533|NCT04394598|Irinotecan|irinotecan|mesh-list
15129534|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15129535|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
15129536|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129537|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129538|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15129539|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15129540|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129541|NCT04394533|Bupivacaine|bupivacaine|mesh-list
15129542|NCT04394533|Prilocaine|prilocaine|mesh-list
15129543|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
15129544|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
15129545|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129546|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129547|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
15129548|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129549|NCT04394234|Warfarin|warfarin|mesh-list
15129550|NCT04394234|Anticoagulants|anticoagulants|mesh-list
15178579|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
15178580|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178581|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178582|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178583|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
15178584|NCT03957499|Hormones|hormones|mesh-ancestor
15178585|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178586|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15178587|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178588|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
15178589|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
15178590|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178591|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
15178592|NCT03957499|Analgesics|analgesics|mesh-ancestor
15178593|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15178594|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
15178595|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15178596|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15178597|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561788|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561789|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561790|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
15129551|NCT04394208|Silymarin|silymarin|mesh-list
15129552|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
15129553|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129554|NCT04394208|Protective Agents|protective agents|mesh-ancestor
15129555|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129556|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
15129557|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
15129558|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129559|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129560|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561791|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561792|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561793|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
14561794|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
14561795|NCT00002809|Methotrexate|methotrexate|mesh-list
14561796|NCT00002809|Tacrolimus|tacrolimus|mesh-list
14561797|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14561798|NCT00002809|Sargramostim|sargramostim|mesh-list
15129561|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129562|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129563|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129564|NCT04394390|Vitamin D|vitamin d|mesh-list
15129565|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
15129566|NCT04394390|Vitamins|vitamins|mesh-list
13996458|NCT02920190|Liraglutide|liraglutide|mesh-list
15129567|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
15129568|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129569|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15129570|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15129571|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
15129572|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129573|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15129574|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129575|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129576|NCT04394377|Heparin|heparin|mesh-list
15129577|NCT04394377|Enoxaparin|enoxaparin|mesh-list
15129578|NCT04394377|Calcium heparin|calcium heparin|mesh-list
15129579|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
15129580|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
15129581|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
15129582|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15129583|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15129584|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129585|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15129586|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
15129587|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15129588|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
15129589|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129590|NCT04394143|Mannitol|mannitol|mesh-list
15129591|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15129592|NCT04394143|Diuretics|diuretics|mesh-ancestor
15129593|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
15129594|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129595|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
15129596|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15129597|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129598|NCT04393805|Heparin|heparin|mesh-list
15129599|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15129600|NCT04393805|Tinzaparin|tinzaparin|mesh-list
15129601|NCT04393805|Dalteparin|dalteparin|mesh-list
15129602|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
15129603|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15129604|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15129605|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129606|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
15129607|NCT04393792|Povidone|povidone|mesh-list
15129608|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
14561799|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
14561800|NCT00002809|Antibodies|antibodies|mesh-list
14561801|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
15129609|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
15129610|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15129611|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129612|NCT04393610|Lidocaine|lidocaine|mesh-list
15129613|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
15129614|NCT04393610|Fentanyl|fentanyl|mesh-list
15129615|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
15129616|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
15129617|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14561802|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14561803|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14561804|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561805|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
14561806|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561807|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561808|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561809|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
14561810|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561811|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561812|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561813|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561814|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561815|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561816|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561817|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
14561818|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561819|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561820|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561821|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561822|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14561823|NCT00002810|Melphalan|melphalan|mesh-list
14561824|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
15129618|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129619|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
15129620|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129621|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15129622|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15129623|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15129624|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15129625|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129626|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15129627|NCT04393610|Narcotics|narcotics|mesh-ancestor
15129628|NCT04393610|Analgesics|analgesics|mesh-ancestor
15129629|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15129630|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15129631|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
15129632|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
15129633|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15129634|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15129635|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
15129636|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15129637|NCT04393389|Paclitaxel|paclitaxel|mesh-list
15129638|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15129639|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129640|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
15129641|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
15129642|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
15129643|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129644|NCT04393506|Apatinib|apatinib|mesh-list
15129645|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15129646|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129647|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15129648|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129649|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129650|NCT04393454|Sirolimus|sirolimus|mesh-list
15129651|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15129652|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129653|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15129654|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129655|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
15129656|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129657|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
15129658|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129659|NCT04393584|Leucovorin|leucovorin|mesh-list
15129660|NCT04393584|Docetaxel|docetaxel|mesh-list
15129661|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
15129662|NCT04393584|Irinotecan|irinotecan|mesh-list
15129663|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129664|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
15129665|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
15129666|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
15129667|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129668|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15129669|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15129670|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129671|NCT04393584|Antidotes|antidotes|mesh-ancestor
13996459|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15129672|NCT04393584|Protective Agents|protective agents|mesh-ancestor
15129673|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129674|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
15129675|NCT04393584|Vitamins|vitamins|mesh-ancestor
15129676|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
15129677|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
15129678|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15129679|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15129680|NCT04393220|Bevacizumab|bevacizumab|mesh-list
15129681|NCT04393220|Nivolumab|nivolumab|mesh-list
15129682|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15129683|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129684|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15129685|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15129686|NCT04393220|Growth Substances|growth substances|mesh-ancestor
15129687|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129688|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
15129689|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15129690|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129691|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
15129692|NCT04393246|Ambrisentan|ambrisentan|mesh-list
15129693|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15129694|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129695|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15129696|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129697|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15129698|NCT04393207|Bupivacaine|bupivacaine|mesh-list
15129699|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
15129700|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
15129701|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129702|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129703|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
15129704|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129705|NCT04393025|Aspirin|aspirin|mesh-list
15129706|NCT04393025|Clopidogrel|clopidogrel|mesh-list
15129707|NCT04393025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15129708|NCT04393025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15129709|NCT04393025|Analgesics|analgesics|mesh-ancestor
15129710|NCT04393025|Sensory System Agents|sensory system agents|mesh-ancestor
15129711|NCT04393025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129712|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129713|NCT04393025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129714|NCT04393025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129715|NCT04393025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15129716|NCT04393025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15129717|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129718|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15129719|NCT04393025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15129720|NCT04393025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129721|NCT04393025|Antipyretics|antipyretics|mesh-ancestor
15129722|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15129723|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15129724|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15129725|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
15129726|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129727|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
15129728|NCT04392973|Favipiravir|favipiravir|mesh-list
15129729|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
15129730|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129731|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129732|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129733|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129734|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129735|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129736|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
15129737|NCT04392427|Ribavirin|ribavirin|mesh-list
15129738|NCT04392427|Ivermectin|ivermectin|mesh-list
15129739|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
15129740|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
15129741|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129742|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
15129743|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129744|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129745|NCT04392700|Tenofovir|tenofovir|mesh-list
15129746|NCT04392700|Entecavir|entecavir|mesh-list
15129747|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
15129748|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269859|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15129749|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15129750|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15129751|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181997|NCT03925233|Trastuzumab|trastuzumab|mesh-list
15129752|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129753|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15129754|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15178598|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15178599|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
15178600|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15178601|NCT03957629|Interferons|interferons|mesh-list
15178602|NCT03957629|Tenofovir|tenofovir|mesh-list
15178603|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
15178604|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
15178605|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15178606|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178607|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
15178608|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178609|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15178610|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15178611|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178612|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178613|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15178614|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15178615|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
15178616|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178617|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
15178618|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15178619|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178620|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
15178621|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15178622|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
15178623|NCT03957291|Povidone|povidone|mesh-list
15178624|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15178625|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129755|NCT04392648|Dexamethasone|dexamethasone|mesh-list
15129756|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
15129757|NCT04392648|Bortezomib|bortezomib|mesh-list
15129758|NCT04392648|Pomalidomide|pomalidomide|mesh-list
15129759|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129760|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
15129761|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129762|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129763|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15129764|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
15129765|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129766|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129767|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15129768|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129769|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
15129770|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
15129771|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129772|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15129773|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
15129774|NCT04392648|Hormones|hormones|mesh-ancestor
15129775|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129776|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15129777|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15129778|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15129779|NCT04392648|Growth Substances|growth substances|mesh-ancestor
15129780|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
15129781|NCT04392479|Aflibercept|aflibercept|mesh-list
15129782|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13996460|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996461|NCT02920190|Incretins|incretins|mesh-ancestor
13996462|NCT02920190|Hormones|hormones|mesh-ancestor
13996463|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996464|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
13996465|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13996466|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996467|NCT02920060|Levetiracetam|levetiracetam|mesh-list
13996468|NCT02920060|Valproic Acid|valproic acid|mesh-list
13996469|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
13996470|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
13996471|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996472|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996473|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
13996474|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996475|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996476|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
13996477|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13996478|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996479|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13996480|NCT02919878|Gemcitabine|gemcitabine|mesh-list
13996481|NCT02919878|Capecitabine|capecitabine|mesh-list
13996482|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13996483|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
13996484|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996485|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996486|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
13996487|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996488|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996489|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129783|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15129784|NCT04392479|Growth Substances|growth substances|mesh-ancestor
15129785|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129786|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
15129787|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129788|NCT04392557|Metformin|metformin|mesh-list
15129789|NCT04392557|Pioglitazone|pioglitazone|mesh-list
15129790|NCT04392557|Alogliptin|alogliptin|mesh-list
15129791|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15129792|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129793|NCT04392557|Incretins|incretins|mesh-ancestor
15129794|NCT04392557|Hormones|hormones|mesh-ancestor
15129795|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129796|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15129797|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
15129798|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129799|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129800|NCT04392713|Ivermectin|ivermectin|mesh-list
14269860|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14269861|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269862|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
14269863|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
14269864|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14269865|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14269866|NCT00405756|Growth Substances|growth substances|mesh-ancestor
14269867|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269868|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13996490|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
13996491|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996492|NCT02919605|Pentamidine|pentamidine|mesh-list
13996493|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
14269869|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
15129801|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129802|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996494|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996495|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129803|NCT04392375|Nifedipine|nifedipine|mesh-list
15129804|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15129805|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269870|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15129806|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129807|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15129808|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129809|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
15129810|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
15129811|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15129812|NCT04392531|Cyclosporine|cyclosporine|mesh-list
15129813|NCT04392531|Cyclosporins|cyclosporins|mesh-list
15129814|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129815|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129816|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129817|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
15129818|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269871|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269872|NCT00405821|Acyclovir|acyclovir|mesh-list
14269873|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
14269874|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269875|NCT00405938|Bevacizumab|bevacizumab|mesh-list
14269876|NCT00405938|Fulvestrant|fulvestrant|mesh-list
14269877|NCT00405938|Anastrozole|anastrozole|mesh-list
13996496|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13996497|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14023357|NCT02762864|Sensory System Agents|sensory system agents|mesh-ancestor
14023358|NCT02762864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269878|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14269879|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269880|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14269881|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14269882|NCT00405938|Growth Substances|growth substances|mesh-ancestor
14269883|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269884|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
14269885|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14269886|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14269887|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14269888|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
14269889|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14269890|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14269891|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14269892|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996498|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13996499|NCT02919787|Irinotecan|irinotecan|mesh-list
13996500|NCT02919787|Fluorouracil|fluorouracil|mesh-list
13996501|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
13996502|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13996503|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13996504|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996505|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996506|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996507|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
13996508|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13996509|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996510|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
13996511|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996512|NCT02919501|Vortioxetine|vortioxetine|mesh-list
13996513|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
13996514|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269893|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269894|NCT00406029|Levodopa|levodopa|mesh-list
15129819|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
15129820|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129821|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
15129822|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129823|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15129824|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
15129825|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
15129826|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129827|NCT04392102|Niraparib|niraparib|mesh-list
13996515|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13996516|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15178626|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
15129828|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15129829|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129830|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129831|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129832|NCT04392063|Melatonin|melatonin|mesh-list
15129833|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
15129834|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129835|NCT04392063|Protective Agents|protective agents|mesh-ancestor
15129836|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129837|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129838|NCT04392128|Azithromycin|azithromycin|mesh-list
15129839|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
15129840|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15129841|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129842|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
15129843|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129844|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129845|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129846|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129847|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129848|NCT04392297|Antibodies|antibodies|mesh-list
15129849|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
15129850|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
15129851|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129852|NCT04392037|Dexamethasone|dexamethasone|mesh-list
15129853|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
15129854|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129855|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
15129856|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129857|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15129858|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15129859|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
15129860|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129861|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129862|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15129863|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129864|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
15129865|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
15129866|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129867|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15129868|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
15129869|NCT04392037|Hormones|hormones|mesh-ancestor
15129870|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129871|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15129872|NCT04391998|Metronidazole|metronidazole|mesh-list
15129873|NCT04391998|Albendazole|albendazole|mesh-list
15129874|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129875|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15129876|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15129877|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129878|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
15129879|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
15129880|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15129881|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
15129882|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
15129883|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
15129884|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129885|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15129886|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
15129887|NCT04391868|Citric Acid|citric acid|mesh-list
15129888|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
15129889|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
15129890|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15129891|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
15129892|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
15129893|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129894|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
15129895|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15129896|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15129897|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129898|NCT04391868|Urological Agents|urological agents|mesh-ancestor
15129899|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
15129900|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
15129901|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15129902|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129903|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13996517|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129904|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15129905|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
14269895|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14269896|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14269897|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
14269898|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269899|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129906|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13996518|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129907|NCT04391621|Triamcinolone|triamcinolone|mesh-list
15129908|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15129909|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15129910|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15129911|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15129912|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
15129913|NCT04391621|Hormones|hormones|mesh-ancestor
15129914|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15129915|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996519|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13996520|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13996521|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996522|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996523|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996524|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
13996525|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13996526|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13996527|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13996528|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13996529|NCT02919579|Esketamine|esketamine|mesh-list
13996530|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
13996531|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13996532|NCT02919462|Cisplatin|cisplatin|mesh-list
13996533|NCT02919462|Pemetrexed|pemetrexed|mesh-list
13996534|NCT02919462|Vinorelbine|vinorelbine|mesh-list
13996535|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996536|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129916|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15129917|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
15129918|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129919|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129920|NCT04391660|Ethanol|ethanol|mesh-list
15129921|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15129922|NCT04391660|Eusol|eusol|mesh-list
15129923|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15129924|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15129925|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15129926|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129927|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129928|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
13996537|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996538|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13996539|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13996540|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13996541|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
13996542|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
13996543|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
15129929|NCT04391764|Naltrexone|naltrexone|mesh-list
15129930|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13996544|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
13996545|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15129931|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15129932|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129933|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
15129934|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129935|NCT04391569|Ganaxolone|ganaxolone|mesh-list
15129936|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
15129937|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129938|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129939|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129940|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
15129941|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
15129942|NCT04391478|Milrinone|milrinone|mesh-list
15129943|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
15129944|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
15129945|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15129946|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15129947|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129948|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129949|NCT04391478|Urological Agents|urological agents|mesh-ancestor
15129950|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15129951|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15129952|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15129953|NCT04391478|Protective Agents|protective agents|mesh-ancestor
15129954|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129955|NCT04391361|Atropine|atropine|mesh-list
15129956|NCT04391361|Scopolamine|scopolamine|mesh-list
15129957|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
15129958|NCT04391361|Edaravone|edaravone|mesh-list
15129959|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15129960|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15129961|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15129962|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15129963|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15129964|NCT04391361|Analgesics|analgesics|mesh-ancestor
15129965|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
15129966|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15129967|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15129968|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15129969|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15129970|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
15129971|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15129972|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996546|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15129973|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15129974|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15129975|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15129976|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
15129977|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15129978|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
15129979|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
15129980|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
15129981|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15129982|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15129983|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
14811351|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
15129984|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
15129985|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15129986|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15129987|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
15129988|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15129989|NCT04391361|Protective Agents|protective agents|mesh-ancestor
15129990|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15129991|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15129992|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129993|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
15129994|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15129995|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15129996|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15129997|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15129998|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15129999|NCT04391231|Protective Agents|protective agents|mesh-ancestor
15130000|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130001|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
15130002|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15130003|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
15130004|NCT04391283|Osimertinib|osimertinib|mesh-list
15130005|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130006|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130007|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130008|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130009|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130010|NCT04391127|Ivermectin|ivermectin|mesh-list
15130011|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
15130012|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130013|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130014|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130015|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178627|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
15130016|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130017|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130018|NCT04390789|Calcium|calcium|mesh-list
15130019|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15130020|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130021|NCT04390984|Apatinib|apatinib|mesh-list
15130022|NCT04390984|Gefitinib|gefitinib|mesh-list
15130023|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130024|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130025|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130026|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130027|NCT04390854|Clotrimazole|clotrimazole|mesh-list
15130028|NCT04390854|Miconazole|miconazole|mesh-list
15130029|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15130030|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130031|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
15130032|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15130033|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13996547|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996548|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
13996549|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
13996550|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996551|NCT02919293|Vaccines|vaccines|mesh-list
13996552|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
13996553|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996554|NCT02919371|Bevacizumab|bevacizumab|mesh-list
13996555|NCT02919371|Sunitinib|sunitinib|mesh-list
13996556|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13996557|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996558|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13996559|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13996560|NCT02919371|Growth Substances|growth substances|mesh-ancestor
13996561|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996562|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
13996563|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13996564|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996565|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996566|NCT02919202|Listerine|listerine|mesh-list
13996567|NCT02919202|Fluorides|fluorides|mesh-list
13996568|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
13996569|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
15130034|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996570|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
13996571|NCT02919202|Protective Agents|protective agents|mesh-ancestor
15130035|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130036|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15130037|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
15130038|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130039|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130040|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15130041|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15130042|NCT04390815|Insulin|insulin|mesh-list
15130043|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15130044|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15130045|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130046|NCT04390464|Ravulizumab|ravulizumab|mesh-list
15130047|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15130048|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15130049|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
15130050|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130051|NCT04390685|Tacrolimus|tacrolimus|mesh-list
15130052|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15130053|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
13996572|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996573|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13996574|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996575|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
13996576|NCT02919345|Glyburide|glyburide|mesh-list
13996577|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13996578|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996579|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13996580|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996581|NCT02919449|Atezolizumab|atezolizumab|mesh-list
13996582|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996583|NCT02919176|Pioglitazone|pioglitazone|mesh-list
13996584|NCT02919176|Mirabegron|mirabegron|mesh-list
13996585|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13996586|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996587|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13996588|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14561825|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561826|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561827|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
14561828|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561829|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561830|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561831|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561832|NCT00002812|Cytarabine|cytarabine|mesh-list
14561833|NCT00002812|Dexamethasone|dexamethasone|mesh-list
14561834|NCT00002812|Prednisone|prednisone|mesh-list
14561835|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
15130054|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130055|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15130056|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130057|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178628|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
15178629|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
15178630|NCT03957174|Rivastigmine|rivastigmine|mesh-list
15178631|NCT03957174|Reboxetine|reboxetine|mesh-list
15178632|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15178633|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178634|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178635|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
15178636|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181998|NCT03925233|Letrozole|letrozole|mesh-list
14561836|NCT00002812|Doxorubicin|doxorubicin|mesh-list
14561837|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561838|NCT00002812|Methotrexate|methotrexate|mesh-list
14561839|NCT00002812|Vincristine|vincristine|mesh-list
14561840|NCT00002812|Daunorubicin|daunorubicin|mesh-list
14561841|NCT00002812|Asparaginase|asparaginase|mesh-list
14561842|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
14561843|NCT00002812|Idarubicin|idarubicin|mesh-list
15130058|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
15130059|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15130060|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15130061|NCT04391439|Prednisolone|prednisolone|mesh-list
14561844|NCT00002812|Pegaspargase|pegaspargase|mesh-list
15130062|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
15130063|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15130064|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
15130065|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15130066|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
15130067|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
15130068|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130069|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130070|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15130071|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
15130072|NCT04391439|Hormones|hormones|mesh-ancestor
15130073|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130074|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15130075|NCT04391439|Protective Agents|protective agents|mesh-ancestor
15130076|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15130077|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130078|NCT04390334|Efavirenz|efavirenz|mesh-list
15130079|NCT04390334|Famotidine|famotidine|mesh-list
15130080|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15130081|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15130082|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130083|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130084|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
15130085|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130086|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15130087|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15130088|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15130089|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15130090|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15130091|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15130092|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15130093|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15130094|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15130095|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
15130096|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
15130097|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130098|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130099|NCT04390594|Nafamostat|nafamostat|mesh-list
15130100|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15130101|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15130102|NCT04390594|Analgesics|analgesics|mesh-ancestor
15130103|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
15130104|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130105|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130106|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15130107|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130108|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
15130109|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
15130110|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130111|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130112|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15130113|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15130114|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15130115|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15130116|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
15130117|NCT04390295|Metformin|metformin|mesh-list
15130118|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15130119|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130120|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
15130121|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130122|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
15130123|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15130124|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15130125|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130126|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
15130127|NCT04390217|Coagulants|coagulants|mesh-ancestor
15130128|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130129|NCT04390061|Tofacitinib|tofacitinib|mesh-list
15130130|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
15130131|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130132|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130133|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130134|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130135|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130136|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130137|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130138|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
15130139|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15130140|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
15130141|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130142|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
15130143|NCT04389866|Protective Agents|protective agents|mesh-ancestor
15130144|NCT04390152|Ritonavir|ritonavir|mesh-list
15130145|NCT04390152|Lopinavir|lopinavir|mesh-list
15130146|NCT04390152|Azithromycin|azithromycin|mesh-list
15130147|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130148|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15130149|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15130150|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
15130151|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130152|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130153|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15130154|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15130155|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
15130156|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130157|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15130158|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15130159|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15130160|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
15130161|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130162|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130163|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130164|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
15130165|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
15130166|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15130167|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
15130168|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130169|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
15130170|NCT04390100|Protective Agents|protective agents|mesh-ancestor
15130171|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
15130172|NCT04390100|Coagulants|coagulants|mesh-ancestor
15130173|NCT04389840|Heparin|heparin|mesh-list
15130174|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
15130175|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15130176|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15130177|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130178|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
15130179|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15130180|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15130181|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130182|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
15130183|NCT04389554|Coagulants|coagulants|mesh-ancestor
15130184|NCT04389567|Famotidine|famotidine|mesh-list
15130185|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15130186|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15130187|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15130188|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
15130189|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
15130190|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130191|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130192|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130193|NCT04389801|Deferoxamine|deferoxamine|mesh-list
15130194|NCT04389801|Siderophores|siderophores|mesh-ancestor
15130195|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15130196|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
15130197|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
15130198|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130199|NCT04389580|Tamoxifen|tamoxifen|mesh-list
15130200|NCT04389580|Isotretinoin|isotretinoin|mesh-list
14269900|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269901|NCT00406276|Docetaxel|docetaxel|mesh-list
14269902|NCT00406276|Everolimus|everolimus|mesh-list
14269903|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269904|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
13996589|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13996590|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130201|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15130202|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
15130203|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130204|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130205|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15130206|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130207|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15130208|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15130209|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15130210|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
15130211|NCT04389424|Tamoxifen|tamoxifen|mesh-list
15130212|NCT04389424|Anastrozole|anastrozole|mesh-list
15130213|NCT04389424|Exemestane|exemestane|mesh-list
15130214|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15130215|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
14269905|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
14269906|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
13996591|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996592|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996593|NCT02919176|Urological Agents|urological agents|mesh-ancestor
13996594|NCT02919072|Ropivacaine|ropivacaine|mesh-list
13996595|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
13996596|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
13996597|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
13996598|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996599|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996600|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
13996601|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996602|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
13996603|NCT02919059|Glimepiride|glimepiride|mesh-list
13996604|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13996605|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996606|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14269907|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269908|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269909|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
14269910|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269911|NCT00406315|Ziprasidone|ziprasidone|mesh-list
14269912|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14269913|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
14269914|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269915|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269916|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269917|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14269918|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14269919|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14269920|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14269921|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14269922|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
15130216|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130217|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269923|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15130218|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15130219|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130220|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15130221|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15130222|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13996607|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996608|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13996609|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996610|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
13996611|NCT02918955|Cisplatin|cisplatin|mesh-list
13996612|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996613|NCT02918812|Diclofenac|diclofenac|mesh-list
13996614|NCT02918812|Lidocaine|lidocaine|mesh-list
13996615|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
13996616|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
13996617|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996618|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996619|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
14269924|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15130223|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15130224|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15130225|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130226|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130227|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130228|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
15130229|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130230|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130231|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130232|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130233|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130234|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130235|NCT04389411|Montelukast|montelukast|mesh-list
15130236|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13996620|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996621|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13996622|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13996623|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13996624|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996625|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996626|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13996627|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13996628|NCT02918812|Analgesics|analgesics|mesh-ancestor
13996629|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996630|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996631|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13996632|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996633|NCT02918864|Oxytocin|oxytocin|mesh-list
13996634|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
13996635|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996636|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996637|NCT02918825|Olanzapine|olanzapine|mesh-list
13996638|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13996639|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
13996640|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
13996641|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996642|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996643|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996644|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13996645|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13996646|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996647|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15130237|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
15130238|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15130239|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
15130240|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130241|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130242|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15130243|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15130244|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130245|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130246|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
15130247|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130248|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130249|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130250|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130251|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130252|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130253|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
15130254|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15130255|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130256|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
15130257|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130258|NCT04389060|Protective Agents|protective agents|mesh-ancestor
15130259|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130260|NCT04389229|Aldesleukin|aldesleukin|mesh-list
14561845|NCT00002812|Thioguanine|thioguanine|mesh-list
14561846|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561847|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
14561848|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561849|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561850|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561851|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
14561852|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561853|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561854|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561855|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561856|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
14561857|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
15130261|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
15130262|NCT04389229|Fludarabine|fludarabine|mesh-list
15130263|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15130264|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
15130265|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130266|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130267|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15130268|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
15130269|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130270|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130271|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15130272|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15130273|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15130274|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
15130275|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130276|NCT04388774|Ketamine|ketamine|mesh-list
15130277|NCT04388774|Analgesics|analgesics|mesh-ancestor
15130278|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
15130279|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130280|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130281|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15130282|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15130283|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
15130284|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
15130285|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130286|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15130287|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15130288|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130289|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178637|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178638|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15178639|NCT03957174|Protective Agents|protective agents|mesh-ancestor
15178640|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
15130290|NCT04388709|Interferons|interferons|mesh-list
15130291|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130292|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
15130293|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130294|NCT04388176|Compound 21|compound 21|mesh-list
15130295|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15130296|NCT04388904|Tenofovir|tenofovir|mesh-list
15130297|NCT04388904|Emtricitabine|emtricitabine|mesh-list
15130298|NCT04388904|Darunavir|darunavir|mesh-list
15130299|NCT04388904|Cobicistat|cobicistat|mesh-list
15130300|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15130301|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
15130302|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130303|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15130304|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15130305|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130306|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130307|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15130308|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15130309|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15130310|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15130311|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
15130312|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15130313|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15130314|NCT04388202|Citalopram|citalopram|mesh-list
15130315|NCT04388202|Sertraline|sertraline|mesh-list
15130316|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15130317|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15130318|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15130319|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130320|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130321|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
15178641|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15130322|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130323|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15130324|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
15130325|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15130326|NCT04388124|Bosentan|bosentan|mesh-list
15130327|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15130328|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15130329|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130330|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15130331|NCT04388189|Bupropion|bupropion|mesh-list
15130332|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15130333|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
15130334|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15130335|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15130336|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15130337|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15130338|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130339|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
15130340|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130341|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130342|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15130343|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15130344|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130345|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15130346|NCT04388189|Analgesics|analgesics|mesh-ancestor
15130347|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
15130348|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130349|NCT04388111|Morphine|morphine|mesh-list
15130350|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15130351|NCT04388111|Narcotics|narcotics|mesh-ancestor
15130352|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130353|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130354|NCT04388111|Analgesics|analgesics|mesh-ancestor
15130355|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
15130356|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130357|NCT04387786|Albuterol|albuterol|mesh-list
15130358|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15130359|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
15130360|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130361|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130362|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15130363|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
15130364|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
15130365|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15130366|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15130367|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15130368|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15130369|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130370|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130371|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130372|NCT04387929|Antibodies|antibodies|mesh-list
15130373|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
15130374|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130375|NCT04387695|Sorafenib|sorafenib|mesh-list
15130376|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130377|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130378|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130379|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130380|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
15130381|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
15130382|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130383|NCT04388033|Temozolomide|temozolomide|mesh-list
15130384|NCT04388033|Interleukin-12|interleukin-12|mesh-list
15130385|NCT04388033|Vaccines|vaccines|mesh-list
15130386|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
15130387|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130388|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15130389|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
15130390|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996648|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15130391|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130392|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15130393|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15130394|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15130395|NCT04388033|Growth Substances|growth substances|mesh-ancestor
15130396|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
15130397|NCT04387617|Cannabidiol|cannabidiol|mesh-list
15130398|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
15130399|NCT04387604|Ranibizumab|ranibizumab|mesh-list
15130400|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15130401|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15130402|NCT04387604|Growth Substances|growth substances|mesh-ancestor
15130403|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130404|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
15130405|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130406|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
15130407|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15130408|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15130409|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130410|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
15130411|NCT04387305|Coagulants|coagulants|mesh-ancestor
15130412|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
15130413|NCT04387539|Simeprevir|simeprevir|mesh-list
15130414|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
15130415|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130416|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
15130417|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130418|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130419|NCT04387565|Vanadium|vanadium|mesh-list
15130420|NCT04387565|Trace Elements|trace elements|mesh-ancestor
15130421|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
15130422|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130423|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
15130424|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
15130425|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130426|NCT04387500|Axitinib|axitinib|mesh-list
15130427|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130428|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130429|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130430|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130431|NCT04387630|Metformin|metformin|mesh-list
15130432|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15130433|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130434|NCT04387240|Artesunate|artesunate|mesh-list
15130435|NCT04387240|Artemisinins|artemisinins|mesh-list
15130436|NCT04387240|Artemisinin|artemisinin|mesh-list
15130437|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
15130438|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130439|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130440|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130441|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130442|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
15130443|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
15130444|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15130445|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
15130446|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
15130447|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
15130448|NCT04387201|Dulaglutide|dulaglutide|mesh-list
15130449|NCT04387201|Vitamins|vitamins|mesh-ancestor
15130450|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
15130451|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130452|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
15130453|NCT04387201|Hematinics|hematinics|mesh-ancestor
15130454|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15130455|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
15130456|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15130457|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130458|NCT04387136|Sufentanil|sufentanil|mesh-list
15130459|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15130460|NCT04387136|Narcotics|narcotics|mesh-ancestor
15130461|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130462|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130463|NCT04387136|Analgesics|analgesics|mesh-ancestor
15130464|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
13996649|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15130465|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130466|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15130467|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15130468|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
15130469|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
15130470|NCT04386876|Ritonavir|ritonavir|mesh-list
15130471|NCT04386876|Lopinavir|lopinavir|mesh-list
15130472|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15130473|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15130474|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
15130475|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130476|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130477|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15130478|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15130479|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
15130480|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130481|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15130482|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15130483|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
15130484|NCT04387084|Nivolumab|nivolumab|mesh-list
15130485|NCT04387084|Durvalumab|durvalumab|mesh-list
15130486|NCT04387084|Avelumab|avelumab|mesh-list
15130487|NCT04387084|Cemiplimab|cemiplimab|mesh-list
15130488|NCT04387084|Atezolizumab|atezolizumab|mesh-list
15130489|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
15130490|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15130491|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
15130492|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15130493|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130494|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15130495|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130496|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
15130497|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130498|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
15130499|NCT04386850|Calcifediol|calcifediol|mesh-list
15130500|NCT04386850|Vitamins|vitamins|mesh-ancestor
15130501|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
15130502|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130503|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15178642|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15130504|NCT04386746|Gemcitabine|gemcitabine|mesh-list
15130505|NCT04386746|Docetaxel|docetaxel|mesh-list
15130506|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15130507|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
15130508|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130509|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130510|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
15130511|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130512|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996650|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996651|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996652|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996653|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
13996654|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13996655|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13996656|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13996657|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13996658|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
13996659|NCT02918760|Gabapentin|gabapentin|mesh-list
13996660|NCT02918760|Analgesics|analgesics|mesh-ancestor
14269925|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269926|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15130513|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15130514|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
15130515|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130516|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
15130517|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
15130518|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
15130519|NCT04387097|Remifentanil|remifentanil|mesh-list
15130520|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15130521|NCT04387097|Narcotics|narcotics|mesh-ancestor
15130522|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996661|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
13996662|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996663|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996664|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
13996665|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13996666|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13996667|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130523|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130524|NCT04387097|Analgesics|analgesics|mesh-ancestor
15130525|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
15130526|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130527|NCT04386499|Folic Acid|folic acid|mesh-list
13996668|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13996669|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13996670|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13996671|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996672|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996673|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
13996674|NCT02918747|Gemcitabine|gemcitabine|mesh-list
13996675|NCT02918747|Dexamethasone|dexamethasone|mesh-list
13996676|NCT02918747|Prednisone|prednisone|mesh-list
13996677|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
13996678|NCT02918747|Doxorubicin|doxorubicin|mesh-list
15130528|NCT04386499|Resveratrol|resveratrol|mesh-list
15130529|NCT04386499|Hematinics|hematinics|mesh-ancestor
13996679|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
13996680|NCT02918747|Vincristine|vincristine|mesh-list
15130530|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
15130531|NCT04386499|Vitamins|vitamins|mesh-ancestor
15130532|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
15130533|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130534|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
15130535|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130536|NCT04386499|Protective Agents|protective agents|mesh-ancestor
15130537|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130538|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15130539|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
15130540|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15130541|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15130542|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130543|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
15130544|NCT04386642|Coagulants|coagulants|mesh-ancestor
15130545|NCT04386577|Vitamin D|vitamin d|mesh-list
15130546|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
15130547|NCT04386577|Vitamins|vitamins|mesh-ancestor
15130548|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
15130549|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130550|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15130551|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15130552|NCT04386122|Loxoprofen|loxoprofen|mesh-list
15130553|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15130554|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15130555|NCT04386122|Analgesics|analgesics|mesh-ancestor
15130556|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
15130557|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130558|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130559|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15130560|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130561|NCT04386447|Oxytocin|oxytocin|mesh-list
15130562|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
15130563|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15130564|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130565|NCT04385940|Vitamin D|vitamin d|mesh-list
15130566|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
15130567|NCT04385940|Vitamins|vitamins|mesh-ancestor
15130568|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
15130569|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130570|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15130571|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15130572|NCT04385719|Remdesivir|remdesivir|mesh-list
15130573|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
15130574|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130575|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
15130576|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130577|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
15130578|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
15130579|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
15130580|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130581|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130582|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
15130583|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130584|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
15130585|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15130586|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130587|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130588|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15130589|NCT04385602|Analgesics|analgesics|mesh-ancestor
15130590|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
15130591|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130592|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15130593|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15130594|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15130595|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130596|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130597|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130598|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15130599|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
15130600|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15130601|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15130602|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
15130603|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130604|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130605|NCT04385654|Axitinib|axitinib|mesh-list
15130606|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130607|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130608|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130609|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130610|NCT04385563|Docetaxel|docetaxel|mesh-list
15130611|NCT04385563|Trastuzumab|trastuzumab|mesh-list
15130612|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130613|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
15130614|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
15130615|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
15130616|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130617|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15130618|NCT04385550|Paclitaxel|paclitaxel|mesh-list
15130619|NCT04385550|Docetaxel|docetaxel|mesh-list
15130620|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15130621|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130622|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
15130623|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
14269927|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269928|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
14269929|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269930|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269931|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15130624|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
15130625|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130626|NCT04385290|Cytarabine|cytarabine|mesh-list
15130627|NCT04385290|Daunorubicin|daunorubicin|mesh-list
15130628|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
15130629|NCT04385290|Midostaurin|midostaurin|mesh-list
15130630|NCT04385290|Staurosporine|staurosporine|mesh-list
15130631|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15130632|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
15130633|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130634|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130635|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
15130636|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130637|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15130638|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
15130639|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130640|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15130641|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15130642|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15130643|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130644|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15130645|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130646|NCT04385173|Temozolomide|temozolomide|mesh-list
15130647|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15130648|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
15130649|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130650|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130651|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130652|NCT04385264|Mannitol|mannitol|mesh-list
15130653|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
15130654|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130655|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130656|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130657|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130658|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130659|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130660|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15130661|NCT04385264|Diuretics|diuretics|mesh-ancestor
15130662|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
15130663|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130664|NCT04385407|Ribavirin|ribavirin|mesh-list
15130665|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
15130666|NCT04385407|Simeprevir|simeprevir|mesh-list
15130667|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
14269932|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14269933|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14269934|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130668|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130669|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
15130670|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130671|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
15130672|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130673|NCT04384744|Hormones|hormones|mesh-list
15130674|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130675|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130676|NCT04384783|Hormones|hormones|mesh-list
15130677|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130678|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178643|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15178644|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15178645|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
15178646|NCT03957057|Iron|iron|mesh-list
15178647|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15178648|NCT03957057|Trace Elements|trace elements|mesh-ancestor
15178649|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
15178650|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178651|NCT03957057|Hematinics|hematinics|mesh-ancestor
15178652|NCT03956966|Dexamethasone|dexamethasone|mesh-list
15178653|NCT03956966|Bupivacaine|bupivacaine|mesh-list
15178654|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178655|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
15178656|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
15178657|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178658|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178659|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178660|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
15178661|NCT03956966|Hormones|hormones|mesh-ancestor
15178662|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178663|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15178664|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178665|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
15178666|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
15178667|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178668|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
15178669|NCT03957109|Anesthetics|anesthetics|mesh-list
15178670|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178671|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178672|NCT03956953|BMS-986165|bms-986165|mesh-list
15178673|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
15178674|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15178675|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178676|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178677|NCT03956732|Vitamin D|vitamin d|mesh-list
15178678|NCT03956732|Caseins|caseins|mesh-list
15178679|NCT03956732|Vitamins|vitamins|mesh-ancestor
15178680|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
15178681|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178682|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15178683|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
15178684|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
15178685|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178686|NCT03956823|Amlodipine|amlodipine|mesh-list
15178687|NCT03956823|Telmisartan|telmisartan|mesh-list
15178688|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15178689|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15178690|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15178691|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130679|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15130680|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15130681|NCT04384666|Rotigotine|rotigotine|mesh-list
15130682|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
15130683|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
15130684|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130685|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130686|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130687|NCT04384562|Methylphenidate|methylphenidate|mesh-list
15130688|NCT04384562|Reboxetine|reboxetine|mesh-list
15130689|NCT04384562|Nicotine|nicotine|mesh-list
15130690|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15130691|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
15130692|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130693|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130694|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15130695|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15130696|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
15130697|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130698|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130699|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15130700|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15130701|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15130702|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15130703|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
15130704|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
15130705|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15130706|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15130707|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130708|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130709|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
15130710|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130711|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130712|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130713|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130714|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130715|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130716|NCT04384653|Furosemide|furosemide|mesh-list
15130717|NCT04384653|Diuretics|diuretics|mesh-ancestor
15130718|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
15130719|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130720|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15130721|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15130722|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130723|NCT04384367|Naproxen|naproxen|mesh-list
15130724|NCT04384367|Rizatriptan|rizatriptan|mesh-list
15130725|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15130726|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15130727|NCT04384367|Analgesics|analgesics|mesh-ancestor
15130728|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
15130729|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130730|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130731|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15130732|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130733|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
15130734|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15130735|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130736|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130737|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15130738|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
15130739|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130740|NCT04384731|Poractant alfa|poractant alfa|mesh-list
15130741|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15130742|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
15130743|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130744|NCT04384458|Ivermectin|ivermectin|mesh-list
15130745|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
15130746|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130747|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130748|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130749|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130750|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130751|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130752|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
15130753|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15130754|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
15130755|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130756|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130757|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15130758|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
15130759|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15130760|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
15130761|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130762|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130763|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15130764|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
15130765|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
15130766|NCT04384133|Protective Agents|protective agents|mesh-ancestor
15130767|NCT04383990|Insulin|insulin|mesh-list
15130768|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15130769|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130770|NCT04383977|Etoposide|etoposide|mesh-list
15130771|NCT04383977|Apatinib|apatinib|mesh-list
15130772|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15130773|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181999|NCT03925233|Apatinib|apatinib|mesh-list
15130774|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15130775|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15130776|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130777|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130778|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15130779|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
15130780|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
15130781|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15130782|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130783|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15130784|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15130785|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15130786|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130787|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130788|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15130789|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15130790|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15130791|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15130792|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130793|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130794|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130795|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15130796|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15130797|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
15130798|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15130799|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15130800|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
15130801|NCT04383717|Azithromycin|azithromycin|mesh-list
15130802|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130803|NCT04383717|Levamisole|levamisole|mesh-list
15130804|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
15130805|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15130806|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130807|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
15130808|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130809|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130810|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130811|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130812|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130813|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15130814|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
15130815|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130816|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
15130817|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
15130818|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
15130819|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
15130820|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15130821|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130822|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130823|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15130824|NCT04383418|Analgesics|analgesics|mesh-ancestor
15130825|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
15130826|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996681|NCT02918747|Pegaspargase|pegaspargase|mesh-list
13996682|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996683|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
13996684|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996685|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996686|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13996687|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
13996688|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996689|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996690|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13996691|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996692|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
13996693|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
13996694|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996695|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996696|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
13996697|NCT02918747|Hormones|hormones|mesh-ancestor
13996698|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996699|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13996700|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13996701|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
13996702|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
13996703|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996704|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996705|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13996706|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13996707|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13996708|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13996709|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
13996710|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
13996711|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
13996712|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13996713|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
13996714|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130827|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15130828|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15130829|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15130830|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130831|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130832|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130833|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
15130834|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13996715|NCT02918591|Empagliflozin|empagliflozin|mesh-list
15130835|NCT04383548|Antibodies|antibodies|mesh-list
15130836|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
15130837|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130838|NCT04383093|Tadalafil|tadalafil|mesh-list
15130839|NCT04383093|Tamsulosin|tamsulosin|mesh-list
15130840|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
15130841|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15130842|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15130843|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130844|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130845|NCT04383093|Urological Agents|urological agents|mesh-ancestor
15130846|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15130847|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15130848|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15130849|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130850|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130851|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130852|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15130853|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
13996716|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15130854|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130855|NCT04382768|Ibuprofen|ibuprofen|mesh-list
15130856|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15130857|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15130858|NCT04382768|Analgesics|analgesics|mesh-ancestor
15130859|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
15130860|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130861|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130862|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15130863|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130864|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15130865|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130866|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130867|NCT04383275|Capecitabine|capecitabine|mesh-list
15130868|NCT04383275|Trastuzumab|trastuzumab|mesh-list
15130869|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15130870|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
15130871|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130872|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130873|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15130874|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
15130875|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130876|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130877|NCT04383067|Aldesleukin|aldesleukin|mesh-list
15130878|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130879|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15130880|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15130881|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
15130882|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130883|NCT04382950|Tretinoin|tretinoin|mesh-list
15130884|NCT04382950|Isotretinoin|isotretinoin|mesh-list
15130885|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130886|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
15130887|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
15130888|NCT04382859|Bupivacaine|bupivacaine|mesh-list
15130889|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
15130890|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
15130891|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130892|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130893|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
15130894|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178692|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15178693|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130895|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
15130896|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15130897|NCT04382404|Velpatasvir|velpatasvir|mesh-list
15130898|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
15130899|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130900|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
15130901|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
15130902|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15130903|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130904|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130905|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130906|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130907|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130908|NCT04382443|Colchicine|colchicine|mesh-list
15130909|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
15130910|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15130911|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
15130912|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
15130913|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
15130914|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130915|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130916|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
15130917|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15130918|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130919|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130920|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15130921|NCT04382170|Analgesics|analgesics|mesh-ancestor
15130922|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
15130923|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130924|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15130925|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15130926|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15130927|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
15130928|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15130929|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130930|NCT04382079|Propolis|propolis|mesh-list
15130931|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130932|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15130933|NCT04382352|Trastuzumab|trastuzumab|mesh-list
15130934|NCT04382352|Antibodies|antibodies|mesh-list
15130935|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
15130936|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15130937|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
15130938|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130939|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023359|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130940|NCT04382209|Meperidine|meperidine|mesh-list
15130941|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15130942|NCT04382209|Narcotics|narcotics|mesh-ancestor
15130943|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130944|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130945|NCT04382209|Analgesics|analgesics|mesh-ancestor
15130946|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
15130947|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130948|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15130949|NCT04382300|Thalidomide|thalidomide|mesh-list
15130950|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15130951|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
15130952|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130953|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
15130954|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15130955|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130956|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15130957|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15130958|NCT04382300|Growth Substances|growth substances|mesh-ancestor
15130959|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
15130960|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130961|NCT04382027|Vitamins|vitamins|mesh-list
15130962|NCT04382027|Vitamin K|vitamin k|mesh-list
15130963|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
15130964|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
15130965|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130966|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15130967|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15130968|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130969|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
15130970|NCT04382027|Coagulants|coagulants|mesh-ancestor
15130971|NCT04381884|Ivermectin|ivermectin|mesh-list
15130972|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15130973|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130974|NCT04381962|Azithromycin|azithromycin|mesh-list
15130975|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15130976|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15130977|NCT04381910|Irinotecan|irinotecan|mesh-list
15130978|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15130979|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15130980|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15130981|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15130982|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15130983|NCT04381741|Antibodies|antibodies|mesh-list
15130984|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15130985|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
15130986|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130987|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
15130988|NCT04381845|Vaccines|vaccines|mesh-list
15130989|NCT04381845|Immunologic Factors|immunologic factors|mesh-ancestor
15130990|NCT04381845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130991|NCT04382144|Bupivacaine|bupivacaine|mesh-list
15130992|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
15130993|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
15130994|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15130995|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15130996|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
15130997|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15130998|NCT04382014|Curcumin|curcumin|mesh-list
15130999|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15131000|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131001|NCT04382014|Analgesics|analgesics|mesh-ancestor
15131002|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
15131003|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131004|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131005|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131006|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131007|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131008|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131009|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131010|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
15131011|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15131012|NCT04381858|Antibodies|antibodies|mesh-list
15131013|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
15131014|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131015|NCT04381377|Bromides|bromides|mesh-list
15131016|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
15131017|NCT04381234|Citric Acid|citric acid|mesh-list
15131018|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
15131019|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
15131020|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
15131021|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15131022|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
15131023|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
15131024|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131025|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15131026|NCT04380974|Bevacizumab|bevacizumab|mesh-list
15131027|NCT04380974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15131028|NCT04380974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131029|NCT04380974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15131030|NCT04380974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15131031|NCT04380974|Growth Substances|growth substances|mesh-ancestor
15131032|NCT04380974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131033|NCT04380974|Growth Inhibitors|growth inhibitors|mesh-ancestor
15131034|NCT04381104|Acetaminophen|acetaminophen|mesh-list
15131035|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131036|NCT04381104|Analgesics|analgesics|mesh-ancestor
15131037|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
15131038|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131039|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131040|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
15131041|NCT04380597|Betamethasone|betamethasone|mesh-list
15131042|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
15131043|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15131044|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
15131045|NCT04380597|Calcipotriene|calcipotriene|mesh-list
15131046|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15131047|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131048|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
15131049|NCT04380597|Hormones|hormones|mesh-ancestor
15131050|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131051|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131052|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15131053|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131054|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
15131055|NCT04380818|Ritonavir|ritonavir|mesh-list
15131056|NCT04380818|Lopinavir|lopinavir|mesh-list
15131057|NCT04380818|Azithromycin|azithromycin|mesh-list
15131058|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131059|NCT04380818|Heparin|heparin|mesh-list
15131060|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15131061|NCT04380818|Tinzaparin|tinzaparin|mesh-list
15131062|NCT04380818|Dalteparin|dalteparin|mesh-list
15131063|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15131064|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15131065|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
15131066|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131067|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131068|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15131069|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15131070|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
15131071|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131072|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15131073|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15131074|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
15131075|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15131076|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15131077|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15131078|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
15131079|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131080|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131081|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131082|NCT04380857|Dexamethasone|dexamethasone|mesh-list
15131083|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131084|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
15131085|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
15131086|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131087|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131088|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15131089|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
15131090|NCT04380857|Hormones|hormones|mesh-ancestor
15131091|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131092|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15131093|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178694|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
15178695|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15178696|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15178697|NCT03957083|Oxytocin|oxytocin|mesh-list
15178698|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
15178699|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15178700|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178701|NCT03956797|Anesthetics|anesthetics|mesh-list
15178702|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178703|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178704|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
15178705|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15178706|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
15131094|NCT04380402|Atorvastatin|atorvastatin|mesh-list
15131095|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15131096|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15131097|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
15131098|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131099|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15131100|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15131101|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131102|NCT04380467|Vitamin D|vitamin d|mesh-list
15131103|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
15131104|NCT04380467|Vitamins|vitamins|mesh-ancestor
15131105|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
15131106|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131107|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15131108|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14811352|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811353|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131109|NCT04380220|Protein C|protein c|mesh-list
15131110|NCT04380220|Antithrombins|antithrombins|mesh-list
15131111|NCT04380220|Protein S|protein s|mesh-list
15131112|NCT04380220|Factor VIII|factor viii|mesh-list
15131113|NCT04380220|Complement C3|complement c3|mesh-list
15131114|NCT04380220|Coagulants|coagulants|mesh-ancestor
15131115|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15131116|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
15131117|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131118|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131119|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
15131120|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15131121|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15131122|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
15131123|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131124|NCT04380376|Melphalan|melphalan|mesh-list
15131125|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15131126|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
15131127|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131128|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131129|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15131130|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131131|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
15131132|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131133|NCT04380181|Milrinone|milrinone|mesh-list
15131134|NCT04380181|Epinephrine|epinephrine|mesh-list
15131135|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15131136|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15131137|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
15131138|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131139|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131140|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131141|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15131142|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15131143|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
15131144|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131145|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15131146|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131147|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
15131148|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
15182000|NCT03925233|Epirubicin|epirubicin|mesh-list
15131149|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15131150|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15131151|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15131152|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
15131153|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15131154|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15131155|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131156|NCT04380181|Protective Agents|protective agents|mesh-ancestor
15131157|NCT04380311|Tacrolimus|tacrolimus|mesh-list
15131158|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131159|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
15131160|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131161|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15131162|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131163|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131164|NCT04380298|Ketorolac|ketorolac|mesh-list
15131165|NCT04380298|Epinephrine|epinephrine|mesh-list
15131166|NCT04380298|Ropivacaine|ropivacaine|mesh-list
15131167|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
15131168|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
15131169|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131170|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131171|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
15131172|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131173|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15131174|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15131175|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
15131176|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131177|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131178|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15131179|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15131180|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
15131181|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15131182|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131183|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
15131184|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
15131185|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15131186|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15131187|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131188|NCT04380298|Analgesics|analgesics|mesh-ancestor
15131189|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131190|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131191|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15131192|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131193|NCT04380103|Bevacizumab|bevacizumab|mesh-list
15131194|NCT04380103|Capecitabine|capecitabine|mesh-list
15131195|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
15131196|NCT04380103|Irinotecan|irinotecan|mesh-list
15131197|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15131198|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131199|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15131200|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15131201|NCT04380103|Growth Substances|growth substances|mesh-ancestor
15131202|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811354|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
14023360|NCT02762864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131203|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
15131204|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15131205|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
15131206|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131207|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15131208|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15131209|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131210|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
15131211|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131212|NCT04380012|Trastuzumab|trastuzumab|mesh-list
15131213|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15131214|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131215|NCT04380025|Pycnogenols|pycnogenols|mesh-list
15131216|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15131217|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
15131218|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131219|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
15131220|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131221|NCT04380025|Protective Agents|protective agents|mesh-ancestor
15131222|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15131223|NCT04379739|Apatinib|apatinib|mesh-list
15131224|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131225|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15131226|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131227|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131228|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131229|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
15131230|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131231|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131232|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131233|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131234|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131235|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131236|NCT04379180|Bosentan|bosentan|mesh-list
15131237|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
15131238|NCT04379180|Tadalafil|tadalafil|mesh-list
15131239|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
15131240|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15131241|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15131242|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131243|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131244|NCT04379180|Urological Agents|urological agents|mesh-ancestor
15131245|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15131246|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15131247|NCT04379271|Calcium|calcium|mesh-list
15131248|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15131249|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131250|NCT04379219|Methotrexate|methotrexate|mesh-list
15131251|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15131252|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
15131253|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15131254|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131255|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15131256|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
15131257|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131258|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131259|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
15131260|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131261|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15131262|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131263|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
15131264|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131265|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15131266|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
15131267|NCT04379310|Calcium|calcium|mesh-list
15131268|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15131269|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15131270|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131271|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
15131272|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182001|NCT03925233|Olaparib|olaparib|mesh-list
15131273|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131274|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15131275|NCT04378972|Vitamin D|vitamin d|mesh-list
15131276|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
15131277|NCT04378972|Curcumin|curcumin|mesh-list
15131278|NCT04378972|Tramiprosate|tramiprosate|mesh-list
15131279|NCT04378972|Vitamins|vitamins|mesh-ancestor
15131280|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
15131281|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131282|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15131283|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15131284|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15131285|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131286|NCT04378972|Analgesics|analgesics|mesh-ancestor
15131287|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
15131288|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131289|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131290|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131291|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131292|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131293|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131294|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
15131295|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
15131296|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
15131297|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131298|NCT04379102|Anesthetics|anesthetics|mesh-list
15131299|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
15131300|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131301|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131302|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
15131303|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131304|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15131305|NCT04378868|Metronidazole|metronidazole|mesh-list
15131306|NCT04378868|Cefuroxime|cefuroxime|mesh-list
15131307|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
15131308|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15131309|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131310|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
15131311|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131312|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131313|NCT04378608|Ribavirin|ribavirin|mesh-list
15131314|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
15131315|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131316|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
15131317|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131318|NCT04378621|Adalimumab|adalimumab|mesh-list
15131319|NCT04378621|Etanercept|etanercept|mesh-list
15131320|NCT04378621|Golimumab|golimumab|mesh-list
15131321|NCT04378621|Infliximab|infliximab|mesh-list
15131322|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
15131323|NCT04378621|Tofacitinib|tofacitinib|mesh-list
15131324|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15131325|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131326|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131327|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
15131328|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15131329|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15131330|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131331|NCT04378621|Analgesics|analgesics|mesh-ancestor
15131332|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
15131333|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131334|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996717|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996718|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13996719|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996720|NCT02918409|Tobramycin|tobramycin|mesh-list
13996721|NCT02918409|Colistin|colistin|mesh-list
13996722|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13996723|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996724|NCT02918331|Dexamethasone|dexamethasone|mesh-list
13996725|NCT02918331|Lenalidomide|lenalidomide|mesh-list
13996726|NCT02918331|Daratumumab|daratumumab|mesh-list
13996727|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996728|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
13996729|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
13996730|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996731|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996732|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996733|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
13996734|NCT02918331|Hormones|hormones|mesh-ancestor
13996735|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996736|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13996737|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996738|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
13996739|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13996740|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13996741|NCT02918331|Growth Substances|growth substances|mesh-ancestor
13996742|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
13996743|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
13996744|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
13996745|NCT02918045|Coagulants|coagulants|mesh-ancestor
13996746|NCT02918136|Cortisone|cortisone|mesh-list
13996747|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996748|NCT02918110|Misoprostol|misoprostol|mesh-list
13996749|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14269935|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14269936|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292395|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13996750|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
13996751|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996752|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996753|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13996754|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996755|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
13996756|NCT02917889|Caffeine|caffeine|mesh-list
13996757|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13996758|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996759|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13996760|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996761|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996762|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13996763|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15131335|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131336|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
15131337|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15131338|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131339|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131340|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13996764|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
13996765|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178707|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178708|NCT03956888|Expectorants|expectorants|mesh-ancestor
15178709|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131341|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15131342|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15131343|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15131344|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131345|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
15131346|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131347|NCT04378231|Amoxicillin|amoxicillin|mesh-list
15131348|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
15131349|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
15131350|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15131351|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15131352|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131353|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15131354|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131355|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131356|NCT04378283|Lidocaine|lidocaine|mesh-list
15131357|NCT04378283|Epinephrine|epinephrine|mesh-list
15131358|NCT04378283|Tetracaine|tetracaine|mesh-list
15131359|NCT04378283|Anesthetics|anesthetics|mesh-list
15131360|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
15131361|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131362|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131363|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
15131364|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131365|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15131366|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15131367|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15131368|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15131369|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131370|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15131371|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15131372|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
15131373|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131374|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15131375|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15131376|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
15131377|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15131378|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131379|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
15131380|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
15131381|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15131382|NCT04377867|Abatacept|abatacept|mesh-list
15131383|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15131384|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131385|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131386|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131387|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
15131388|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131389|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131390|NCT04377789|Quercetin|quercetin|mesh-list
15131391|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
15131392|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131393|NCT04377789|Protective Agents|protective agents|mesh-ancestor
15131394|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131395|NCT04377646|Zinc|zinc|mesh-list
15131396|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131397|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
15131398|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131399|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131400|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131401|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131402|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996766|NCT02918084|Letrozole|letrozole|mesh-list
15131403|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131404|NCT04377646|Trace Elements|trace elements|mesh-ancestor
15131405|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
15131406|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131407|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
15131408|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
15131409|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131410|NCT04377386|Vitamin D|vitamin d|mesh-list
15131411|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
15131412|NCT04377386|Vitamins|vitamins|mesh-list
15131413|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
15131414|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131415|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15131416|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15131417|NCT04377399|Vitamin D|vitamin d|mesh-list
15131418|NCT04377399|Vitamins|vitamins|mesh-ancestor
15131419|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
15131420|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131421|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15131422|NCT04377321|Colchicine|colchicine|mesh-list
15131423|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
15131424|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131425|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
15131426|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
15131427|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
15131428|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131429|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131430|NCT04377087|Olaparib|olaparib|mesh-list
15131431|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15131432|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131433|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131434|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131435|NCT04377308|Fluoxetine|fluoxetine|mesh-list
15131436|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15131437|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15131438|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15131439|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131440|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131441|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
15131442|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131443|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15131444|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
15131445|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15131446|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15131447|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15131448|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131449|NCT04376970|Fluorometholone|fluorometholone|mesh-list
15131450|NCT04376970|Cyclosporine|cyclosporine|mesh-list
15131451|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15131452|NCT04376970|Cyclosporins|cyclosporins|mesh-list
15131453|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131454|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131455|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131456|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
15131457|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131458|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
15131459|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131460|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
15131461|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131462|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15131463|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15131464|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131465|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
15131466|NCT04376970|Hormones|hormones|mesh-ancestor
15131467|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131468|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15131469|NCT04377048|Gemcitabine|gemcitabine|mesh-list
15131470|NCT04377048|Tegafur|tegafur|mesh-list
15131471|NCT04377048|Nivolumab|nivolumab|mesh-list
15131472|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15131473|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
15131474|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131475|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292396|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
15131476|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
15131477|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131478|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131479|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131480|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
15131481|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131482|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15131483|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15131484|NCT04376788|Methylene Blue|methylene blue|mesh-list
15131485|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131486|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178710|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15178711|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
15178712|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178713|NCT03956888|Protective Agents|protective agents|mesh-ancestor
15178714|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178715|NCT03956888|Antidotes|antidotes|mesh-ancestor
15178716|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
15178717|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
15178718|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
15178719|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178720|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178721|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
15178722|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178723|NCT03956680|Nivolumab|nivolumab|mesh-list
15178724|NCT03956680|Ipilimumab|ipilimumab|mesh-list
15178725|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15178726|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178727|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15178728|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178729|NCT03956212|Doxycycline|doxycycline|mesh-list
15178730|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178731|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178732|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
15178733|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15178734|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15178735|NCT03956446|Doxycycline|doxycycline|mesh-list
15178736|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178737|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178738|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
15178739|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15178740|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15178741|NCT03956017|Ubiquinone|ubiquinone|mesh-list
15178742|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
15178743|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
15178744|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178745|NCT03956017|Vitamins|vitamins|mesh-ancestor
15182002|NCT03925233|Fulvestrant|fulvestrant|mesh-list
15182003|NCT03925233|Anastrozole|anastrozole|mesh-list
15182004|NCT03925233|Exemestane|exemestane|mesh-list
15182005|NCT03925233|Endostatins|endostatins|mesh-list
15182006|NCT03925233|Pirarubicin|pirarubicin|mesh-list
15182007|NCT03925233|Citric Acid|citric acid|mesh-list
15182008|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
15182009|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15182010|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182011|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182012|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
15182013|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
15182014|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182015|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182016|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
15182017|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182018|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182019|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15182020|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
15182021|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15182022|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182023|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15182024|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15182025|NCT03925233|Growth Substances|growth substances|mesh-ancestor
15131487|NCT04376528|Cyclosporine|cyclosporine|mesh-list
15131488|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
15131489|NCT04376528|Cyclosporins|cyclosporins|mesh-list
15131490|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131491|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131492|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131493|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
15131494|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131495|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
15131496|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131497|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
15131498|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131499|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15131500|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15131501|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131502|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15131503|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
13996767|NCT02918084|Anastrozole|anastrozole|mesh-list
13996768|NCT02918084|Exemestane|exemestane|mesh-list
13996769|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996770|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13996771|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13996772|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996773|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996774|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13996775|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
13996776|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996777|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131504|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15131505|NCT04376814|Ritonavir|ritonavir|mesh-list
15131506|NCT04376814|Lopinavir|lopinavir|mesh-list
15131507|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131508|NCT04376814|Favipiravir|favipiravir|mesh-list
15131509|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15131510|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15131511|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
15131512|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131513|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131514|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15131515|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15131516|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
15131517|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131518|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15131519|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13996778|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15131520|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
15131521|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131522|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131523|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131524|NCT04376554|Amoxicillin|amoxicillin|mesh-list
15131525|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
15131526|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
15131527|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15131528|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15131529|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996779|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
13996780|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13996781|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15131530|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15131531|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131532|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131533|NCT04376541|Fentanyl|fentanyl|mesh-list
15131534|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15131535|NCT04376541|Narcotics|narcotics|mesh-ancestor
15131536|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131537|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131538|NCT04376541|Analgesics|analgesics|mesh-ancestor
15131539|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
15131540|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131541|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15131542|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15131543|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
15131544|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
15131545|NCT04376307|Anesthetics|anesthetics|mesh-list
15131546|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131547|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131548|NCT04376073|Niraparib|niraparib|mesh-list
15131549|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15131550|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131551|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131552|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131553|NCT04376086|Anesthetics|anesthetics|mesh-list
15131554|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131555|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023361|NCT02762864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131556|NCT04376216|Prednisone|prednisone|mesh-list
15131557|NCT04376216|Prednisolone|prednisolone|mesh-list
15131558|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131559|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
15131560|NCT04376216|Hormones|hormones|mesh-ancestor
15131561|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131562|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131563|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15131564|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131565|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
15131566|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15131567|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
15131568|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131569|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131570|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15131571|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131572|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15131573|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
15131574|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131575|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131576|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15131577|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
15131578|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
15131579|NCT04375995|Protective Agents|protective agents|mesh-ancestor
15131580|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15131581|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15131582|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131583|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996782|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996783|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
13996784|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996785|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996786|NCT02917772|Nivolumab|nivolumab|mesh-list
13996787|NCT02917772|Ipilimumab|ipilimumab|mesh-list
13996788|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13996789|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996790|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13996791|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996792|NCT02917746|Imiquimod|imiquimod|mesh-list
13996793|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13996794|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
13996795|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996796|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996797|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
13996798|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13996799|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13996800|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996801|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
13996802|NCT02917512|Cyclosporine|cyclosporine|mesh-list
13996803|NCT02917512|Cyclosporins|cyclosporins|mesh-list
15131584|NCT04375852|Autoantibodies|autoantibodies|mesh-list
13996804|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996805|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996806|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996807|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
13996808|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996809|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
13996810|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996811|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
13996812|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996813|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13996814|NCT02917525|Vitamin K|vitamin k|mesh-list
13996815|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
13996816|NCT02917525|Vitamins|vitamins|mesh-ancestor
13996817|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
13996818|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996819|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13996820|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13996821|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996822|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
13996823|NCT02917525|Coagulants|coagulants|mesh-ancestor
13996824|NCT02917564|Triamcinolone|triamcinolone|mesh-list
13996825|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13996826|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13996827|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13996828|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996829|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
13996830|NCT02917564|Hormones|hormones|mesh-ancestor
13996831|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996832|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996833|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996834|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
13996835|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996836|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996837|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
13996838|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13996839|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996840|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13996841|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13996842|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996843|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996844|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996845|NCT02917005|Palbociclib|palbociclib|mesh-list
13996846|NCT02917005|Exemestane|exemestane|mesh-list
13996847|NCT02917005|Goserelin|goserelin|mesh-list
13996848|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996849|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13996850|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131585|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
14023362|NCT02762864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15131586|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131587|NCT04375527|Nivolumab|nivolumab|mesh-list
15131588|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15131589|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996851|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996852|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13996853|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13996854|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13996855|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
13996856|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996857|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996858|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13996859|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
13996860|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15131590|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15131591|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131592|NCT04375605|Leucovorin|leucovorin|mesh-list
15131593|NCT04375605|Docetaxel|docetaxel|mesh-list
15131594|NCT04375605|Fluorouracil|fluorouracil|mesh-list
15131595|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
15131596|NCT04375605|Calcium|calcium|mesh-list
15131597|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
15131598|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131599|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
15131600|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
15131601|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
15131602|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131603|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15131604|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131605|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
15131606|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15131607|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15131608|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
15131609|NCT04375605|Antidotes|antidotes|mesh-ancestor
15131610|NCT04375605|Protective Agents|protective agents|mesh-ancestor
15131611|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
15131612|NCT04375605|Vitamins|vitamins|mesh-ancestor
13996861|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996862|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996863|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13996864|NCT02917018|Analgesics|analgesics|mesh-ancestor
15131613|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
15131614|NCT04374981|Celecoxib|celecoxib|mesh-list
15131615|NCT04374981|Montelukast|montelukast|mesh-list
15131616|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15131617|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131618|NCT04374981|Analgesics|analgesics|mesh-ancestor
15131619|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
15131620|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131621|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131622|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131623|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131624|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15131625|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13996865|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
13996866|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131626|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131627|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131628|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13996867|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13996868|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13996869|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13996870|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
13996871|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996872|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996873|NCT02917057|Exenatide|exenatide|mesh-list
13996874|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13996875|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996876|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13996877|NCT02917057|Incretins|incretins|mesh-ancestor
13996878|NCT02917057|Hormones|hormones|mesh-ancestor
13996879|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996880|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
13996881|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996882|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
13996883|NCT02916940|Hormones|hormones|mesh-ancestor
13996884|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996885|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996886|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
13996887|NCT02916862|Calcium|calcium|mesh-list
13996888|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13996889|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131629|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131630|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15131631|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
15131632|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131633|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15131634|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15131635|NCT04375267|Olaparib|olaparib|mesh-list
15131636|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15131637|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15131638|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131639|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131640|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131641|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15131642|NCT04375202|Colchicine|colchicine|mesh-list
15131643|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
15131644|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131645|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
15131646|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
15131647|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
15131648|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131649|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131650|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15131651|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
15131652|NCT04374929|Hormones|hormones|mesh-ancestor
15131653|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131654|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131655|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131656|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
15131657|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131658|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131659|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131660|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131661|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131662|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178746|NCT03955939|Midazolam|midazolam|mesh-list
13996890|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13996891|NCT02916979|Methotrexate|methotrexate|mesh-list
13996892|NCT02916979|Fludarabine|fludarabine|mesh-list
13996893|NCT02916979|Busulfan|busulfan|mesh-list
13996894|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
13996895|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13996896|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
13996897|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996898|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811355|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
15178747|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15178748|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15131663|NCT04374604|Mitogens|mitogens|mesh-list
15131664|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
15131665|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131666|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
15131667|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15131668|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131669|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131670|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131671|NCT04374318|Analgesics|analgesics|mesh-ancestor
15131672|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
15131673|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131674|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15131675|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15131676|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15131677|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
15131678|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131679|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131680|NCT04374474|Budesonide|budesonide|mesh-list
15131681|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131682|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15131683|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
15131684|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131685|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131686|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15131687|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131688|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
15131689|NCT04374474|Hormones|hormones|mesh-ancestor
15131690|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131691|NCT04374773|Dronabinol|dronabinol|mesh-list
15131692|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
15131693|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131694|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15131695|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131696|NCT04374773|Analgesics|analgesics|mesh-ancestor
15131697|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
15131698|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131699|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15131700|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15131701|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131702|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131703|NCT04374773|Hormones|hormones|mesh-ancestor
15131704|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131705|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
15131706|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15131707|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
15131708|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131709|NCT04374461|Expectorants|expectorants|mesh-ancestor
15131710|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
15131711|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15131712|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
15131713|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131714|NCT04374461|Protective Agents|protective agents|mesh-ancestor
15131715|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131716|NCT04374461|Antidotes|antidotes|mesh-ancestor
15131717|NCT04374799|Heparin|heparin|mesh-list
15131718|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
15131719|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15131720|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15131721|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131722|NCT04374279|Bicalutamide|bicalutamide|mesh-list
15131723|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
15131724|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
15131725|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131726|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131727|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131728|NCT04374552|Azithromycin|azithromycin|mesh-list
15131729|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131730|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15131731|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131732|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
15131733|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131734|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131735|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131736|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131737|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131738|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
15131739|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15131740|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15131741|NCT04374071|Prednisolone|prednisolone|mesh-list
15131742|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
15131743|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15131744|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
15131745|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131746|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
15131747|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
15131748|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996899|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13996900|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
13996901|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996902|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996903|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
13996904|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996905|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13996906|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996907|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
13996908|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996909|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13996910|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
13996911|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13996912|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13996913|NCT02916654|Iron|iron|mesh-list
13996914|NCT02916654|Trace Elements|trace elements|mesh-ancestor
13996915|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
13996916|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996917|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13996918|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13996919|NCT02916420|Dexamethasone|dexamethasone|mesh-list
13996920|NCT02916420|Pomalidomide|pomalidomide|mesh-list
13996921|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13996922|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
13996923|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
13996924|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13996925|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996926|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996927|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
13996928|NCT02916420|Hormones|hormones|mesh-ancestor
13996929|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996930|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13996931|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996932|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
14269937|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269938|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
15131749|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131750|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15131751|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
15131752|NCT04374071|Hormones|hormones|mesh-ancestor
15131753|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131754|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15131755|NCT04374071|Protective Agents|protective agents|mesh-ancestor
15131756|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15131757|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131758|NCT04373824|Ivermectin|ivermectin|mesh-list
15131759|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131760|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131761|NCT04374006|Propolis|propolis|mesh-list
15131762|NCT04374006|Dienogest|dienogest|mesh-list
15131763|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131764|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15131765|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
15131766|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15131767|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131768|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15131769|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15131770|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15131771|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15131772|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
15131773|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182026|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
15131774|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15131775|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131776|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
15131777|NCT04374188|Levofloxacin|levofloxacin|mesh-list
15131778|NCT04374188|Ofloxacin|ofloxacin|mesh-list
15131779|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15131780|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131781|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15131782|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15131783|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131784|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131785|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131786|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15131787|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15131788|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15131789|NCT04374188|Renal Agents|renal agents|mesh-ancestor
15131790|NCT04373967|Metformin|metformin|mesh-list
15131791|NCT04373967|Liraglutide|liraglutide|mesh-list
15131792|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15182315|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
15131793|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131794|NCT04373967|Incretins|incretins|mesh-ancestor
15131795|NCT04373967|Hormones|hormones|mesh-ancestor
15131796|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131797|NCT04373941|Lenograstim|lenograstim|mesh-list
15131798|NCT04373941|Sargramostim|sargramostim|mesh-list
15131799|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15131800|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
15131801|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131802|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15131803|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131804|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131805|NCT04373356|Listerine|listerine|mesh-list
15131806|NCT04373356|Fluorides|fluorides|mesh-list
15131807|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
15131808|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
15131809|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
15131810|NCT04373356|Protective Agents|protective agents|mesh-ancestor
15131811|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131812|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15131813|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131814|NCT04373083|Cemiplimab|cemiplimab|mesh-list
15131815|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15131816|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131817|NCT04372849|Insulin|insulin|mesh-list
15131818|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15131819|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131820|NCT04372836|Vasopressins|vasopressins|mesh-list
15131821|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
15131822|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
15131823|NCT04372836|Coagulants|coagulants|mesh-ancestor
15131824|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15131825|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15131826|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
15131827|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131828|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131829|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
15131830|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131831|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131832|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131833|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131834|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131835|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131836|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
15131837|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15131838|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15131839|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15131840|NCT04373018|Eusol|eusol|mesh-list
15131841|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15131842|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996933|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13996934|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13996935|NCT02916420|Growth Substances|growth substances|mesh-ancestor
13996936|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811356|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811357|NCT00845156|Protective Agents|protective agents|mesh-ancestor
14811358|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811359|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
14811360|NCT00845156|Vitamins|vitamins|mesh-ancestor
14811361|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
14811362|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
14811363|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811364|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14811365|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811366|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811367|NCT00845338|Darifenacin|darifenacin|mesh-list
14811368|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14811369|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14811370|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
14811371|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131843|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
15131844|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
15178749|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178750|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178751|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15178752|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15178753|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15178754|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15178755|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
15178756|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
15178757|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
15178758|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
15178759|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178760|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178761|NCT03955809|Ketamine|ketamine|mesh-list
15178762|NCT03955809|Analgesics|analgesics|mesh-ancestor
15178763|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
15131845|NCT04372732|Autoantibodies|autoantibodies|mesh-list
15131846|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
15131847|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131848|NCT04372589|Heparin|heparin|mesh-list
15131849|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
15131850|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15131851|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15131852|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131853|NCT04372342|Remifentanil|remifentanil|mesh-list
15131854|NCT04372342|Nalbuphine|nalbuphine|mesh-list
15131855|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15131856|NCT04372342|Narcotics|narcotics|mesh-ancestor
15131857|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15131858|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131859|NCT04372342|Analgesics|analgesics|mesh-ancestor
15131860|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
15131861|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131862|NCT04372264|Acetaminophen|acetaminophen|mesh-list
15131863|NCT04372264|Ibuprofen|ibuprofen|mesh-list
15131864|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15131865|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15131866|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131867|NCT04372264|Analgesics|analgesics|mesh-ancestor
15131868|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
15131869|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131870|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131871|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131872|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131873|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15131874|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131875|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131876|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
15131877|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
15131878|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
15131879|NCT04372316|Vitamins|vitamins|mesh-ancestor
15131880|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
15131881|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131882|NCT04372407|Itraconazole|itraconazole|mesh-list
15131883|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
15131884|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131885|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15131886|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15131887|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131888|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131889|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15131890|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
15131891|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131892|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131893|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15131894|NCT04371874|Aspirin|aspirin|mesh-list
15131895|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15131896|NCT04371874|Captopril|captopril|mesh-list
15131897|NCT04371874|Nitrendipine|nitrendipine|mesh-list
15131898|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15131899|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15131900|NCT04371874|Analgesics|analgesics|mesh-ancestor
15131901|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
15131902|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131903|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131904|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15131905|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131906|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15131907|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15131908|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131909|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15131910|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15131911|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131912|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
15131913|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15131914|NCT04371874|Diuretics|diuretics|mesh-ancestor
15131915|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
15131916|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15131917|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15131918|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15131919|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
15131920|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15131921|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15131922|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
15131923|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
15131924|NCT04371965|Povidone|povidone|mesh-list
15131925|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
15131926|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
15131927|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15131928|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131929|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131930|NCT04372082|Niclosamide|niclosamide|mesh-list
15131931|NCT04372082|Diltiazem|diltiazem|mesh-list
15131932|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
15131933|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131934|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131935|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131936|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131937|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131938|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131939|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15131940|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15131941|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15131942|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15131943|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131944|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
15131945|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
15131946|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13996937|NCT02916511|Paclitaxel|paclitaxel|mesh-list
13996938|NCT02916511|Carboplatin|carboplatin|mesh-list
13996939|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13996940|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996941|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
13996942|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
13996943|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
13996944|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996945|NCT02916485|Sirolimus|sirolimus|mesh-list
13996946|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13996947|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13996948|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13996949|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13996950|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
13996951|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13996952|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
13996953|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996954|NCT02916602|Losartan|losartan|mesh-list
13996955|NCT02916602|Amlodipine|amlodipine|mesh-list
13996956|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
13996957|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13996958|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13996959|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996960|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996961|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13996962|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996963|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
13996964|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13996965|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13996966|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13996967|NCT02916602|Diuretics|diuretics|mesh-ancestor
13996968|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
13996969|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13996970|NCT02916381|Anesthetics|anesthetics|mesh-list
13996971|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13996972|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996973|NCT02916251|Glucagon|glucagon|mesh-list
13996974|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13996975|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13996976|NCT02916251|Hormones|hormones|mesh-ancestor
13996977|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996978|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996979|NCT02916251|Incretins|incretins|mesh-ancestor
14023363|NCT02762864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14023364|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023365|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14023366|NCT02762864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14023367|NCT02762864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023368|NCT02762864|Antipyretics|antipyretics|mesh-ancestor
14023369|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14023370|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14023371|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14023372|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
14023373|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023374|NCT02762890|Iodine|iodine|mesh-list
14023375|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14023376|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023377|NCT02762890|Trace Elements|trace elements|mesh-ancestor
14023378|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
14023379|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023380|NCT02762942|Misoprostol|misoprostol|mesh-list
14023381|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14023382|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
14023383|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15131947|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
15131948|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
15131949|NCT04371978|Linagliptin|linagliptin|mesh-list
15131950|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15131951|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131952|NCT04371978|Incretins|incretins|mesh-ancestor
15131953|NCT04371978|Hormones|hormones|mesh-ancestor
14269939|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269940|NCT00406393|Sirolimus|sirolimus|mesh-list
14269941|NCT00406393|Methotrexate|methotrexate|mesh-list
14269942|NCT00406393|Tacrolimus|tacrolimus|mesh-list
14269943|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14269944|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
14269945|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14269946|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269947|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14269948|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
14269949|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131954|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131955|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15131956|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
15131957|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131958|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131959|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131960|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
15131961|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131962|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15131963|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131964|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131965|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131966|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131967|NCT04371757|Doxazosin|doxazosin|mesh-list
15131968|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
15131969|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15131970|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15131971|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15131972|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15131973|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15131974|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131975|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131976|NCT04371601|Oseltamivir|oseltamivir|mesh-list
15131977|NCT04371601|Hormones|hormones|mesh-list
15178764|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15131978|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15131979|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15131980|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
15131981|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131982|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131983|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131984|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
15131985|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
15131986|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15131987|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15182316|NCT03922542|Vitamins|vitamins|mesh-ancestor
15182317|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
15182318|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182319|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15182320|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
15182321|NCT03922373|Benzonatate|benzonatate|mesh-list
15182322|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
15182323|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
15182324|NCT03922048|Bupivacaine|bupivacaine|mesh-list
15182325|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
15182326|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
15182327|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182328|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182329|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
15131988|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15131989|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269950|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15131990|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131991|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15131992|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
15131993|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
15131994|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15131995|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
15131996|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15131997|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15131998|NCT04371224|Leucovorin|leucovorin|mesh-list
15131999|NCT04371224|Fluorouracil|fluorouracil|mesh-list
15132000|NCT04371224|Capecitabine|capecitabine|mesh-list
14561858|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561859|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14561860|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
14561861|NCT00002812|Hormones|hormones|mesh-ancestor
14561862|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14561863|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561864|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14269951|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14269952|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269953|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15132001|NCT04371224|Irinotecan|irinotecan|mesh-list
15132002|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
15132003|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132004|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15132005|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132006|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15132007|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
15132008|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132009|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15132010|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15132011|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132012|NCT04371224|Antidotes|antidotes|mesh-ancestor
15132013|NCT04371224|Protective Agents|protective agents|mesh-ancestor
15132014|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
15132015|NCT04371224|Vitamins|vitamins|mesh-ancestor
15132016|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
15132017|NCT04371575|Carbamazepine|carbamazepine|mesh-list
15132018|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
15132019|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
15132020|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
15132021|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15132022|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132023|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132024|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15132025|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15132026|NCT04371575|Analgesics|analgesics|mesh-ancestor
15132027|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
15132028|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132029|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15132030|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269954|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269955|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
14269956|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269957|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14269958|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14269959|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14269960|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14269961|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14269962|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
14269963|NCT00406419|Methotrexate|methotrexate|mesh-list
14269964|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
14269965|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14269966|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
14269967|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14269968|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132031|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132032|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15132033|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15132034|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15132035|NCT04371341|Bupivacaine|bupivacaine|mesh-list
15132036|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
15132037|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
15132038|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132039|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132040|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
15132041|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132042|NCT04371367|Avdoralimab|avdoralimab|mesh-list
14269969|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15132043|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15132044|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
15132045|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132046|NCT04371406|Azithromycin|azithromycin|mesh-list
15132047|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132048|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132049|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132050|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
15132051|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132052|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132053|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132054|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132055|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132056|NCT04371185|Ustekinumab|ustekinumab|mesh-list
15132057|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132058|NCT04371146|Methylphenidate|methylphenidate|mesh-list
15132059|NCT04371146|Reboxetine|reboxetine|mesh-list
15132060|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15132061|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132062|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15132063|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15132064|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15132065|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132066|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
14814419|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15132067|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996980|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13996981|NCT02916173|Hormones|hormones|mesh-list
13996982|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13996983|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996984|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13996985|NCT02916238|Fluoxetine|fluoxetine|mesh-list
13996986|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13996987|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13996988|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13996989|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13996990|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13996991|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
13996992|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13996993|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15132068|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
15132069|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15132070|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15132071|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
15132072|NCT04370977|Artesunate|artesunate|mesh-list
13996994|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
13996995|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13996996|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14811372|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811373|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811374|NCT00845338|Urological Agents|urological agents|mesh-ancestor
14811375|NCT00845351|Bexarotene|bexarotene|mesh-list
14814420|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
15132073|NCT04370977|Lumefantrine|lumefantrine|mesh-list
13996997|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13996998|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13996999|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13997000|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997001|NCT02916160|Valsartan|valsartan|mesh-list
13997002|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
13997003|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13997004|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13997005|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13997006|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997007|NCT02916121|Folic Acid|folic acid|mesh-list
13997008|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
13997009|NCT02916121|Vitamins|vitamins|mesh-ancestor
13997010|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
13997011|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132074|NCT04370977|Artemether|artemether|mesh-list
15132075|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15132076|NCT04370977|Amodiaquine|amodiaquine|mesh-list
15132077|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
15132078|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132079|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132080|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132081|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132082|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
15132083|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
15132084|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14561865|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15132085|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
15132086|NCT04370782|Azithromycin|azithromycin|mesh-list
15132087|NCT04370782|Doxycycline|doxycycline|mesh-list
15132088|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132089|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
15132090|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132091|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132092|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
15132093|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132094|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13997012|NCT02916121|Hematinics|hematinics|mesh-ancestor
13997013|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
13997014|NCT02916147|Propofol|propofol|mesh-list
13997015|NCT02916147|Sevoflurane|sevoflurane|mesh-list
13997016|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13997017|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997018|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997019|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13997020|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
13997021|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
13997022|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13997023|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13997024|NCT02915731|Vitamin A|vitamin a|mesh-list
13997025|NCT02915731|Vitamins|vitamins|mesh-ancestor
13997026|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
13997027|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997028|NCT02915666|Trametinib|trametinib|mesh-list
13997029|NCT02915666|Dabrafenib|dabrafenib|mesh-list
13997030|NCT02915666|Digoxin|digoxin|mesh-list
13997031|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997032|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13997033|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997034|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997035|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13997036|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13997037|NCT02915666|Protective Agents|protective agents|mesh-ancestor
13997038|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997039|NCT02915809|Vaccines|vaccines|mesh-list
13997040|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
13997041|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997042|NCT02915523|Avelumab|avelumab|mesh-list
13997043|NCT02915523|Entinostat|entinostat|mesh-list
13997044|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13997045|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997046|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13997047|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997048|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997049|NCT02915796|Lenograstim|lenograstim|mesh-list
13997050|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13997051|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
13997052|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997053|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
13997054|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
13997055|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997056|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
13997057|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997058|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561866|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561867|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811376|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997062|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
13997063|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13997064|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
13997065|NCT02915289|Povidone|povidone|mesh-list
13997066|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13997067|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997068|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
14811377|NCT00845364|Perhexiline|perhexiline|mesh-list
15132095|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997069|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
13997070|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
13997071|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
13997072|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
13997073|NCT02915224|Chlorambucil|chlorambucil|mesh-list
13997074|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13997075|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269970|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
15132096|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132097|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132098|NCT04370782|Astringents|astringents|mesh-ancestor
15132099|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132100|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
14269971|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269972|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269973|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
14269974|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14269975|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14269976|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269977|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
14269978|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14269979|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14269980|NCT00406640|Citalopram|citalopram|mesh-list
14269981|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15132101|NCT04371107|Azithromycin|azithromycin|mesh-list
13997076|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15132102|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132103|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132104|NCT04370483|Leflunomide|leflunomide|mesh-list
15132105|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132106|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132107|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15132108|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
14269982|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15132109|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132110|NCT04370431|Edaravone|edaravone|mesh-list
15132111|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15132112|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
15132113|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132114|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15132115|NCT04370431|Protective Agents|protective agents|mesh-ancestor
15132116|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178765|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178766|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15178767|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15178768|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
15178769|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
15178770|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178771|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15178772|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15132117|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
15132118|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15132119|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132120|NCT04370262|Famotidine|famotidine|mesh-list
15132121|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15132122|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15132123|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15132124|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
15132125|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
15132126|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132127|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132128|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132129|NCT04370093|Pioglitazone|pioglitazone|mesh-list
15132130|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15132131|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132132|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132133|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
15132134|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132135|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132136|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132137|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132138|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132139|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132140|NCT04370288|Ascorbic Acid|ascorbic acid|mesh-list
15132141|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
15132142|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15132143|NCT04370288|Methylene Blue|methylene blue|mesh-list
15132144|NCT04370288|Vitamins|vitamins|mesh-ancestor
13997077|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
13997078|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997079|NCT02915354|Etanercept|etanercept|mesh-list
13997080|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13997081|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997082|NCT02915354|Analgesics|analgesics|mesh-ancestor
13997083|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
13997084|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997085|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997086|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997087|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997088|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997089|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997090|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
13997091|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13997092|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997093|NCT02915172|Capecitabine|capecitabine|mesh-list
13997094|NCT02915172|Lenvatinib|lenvatinib|mesh-list
13997095|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13997096|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
13997097|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997098|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997099|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13997100|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997101|NCT02915055|Acetaminophen|acetaminophen|mesh-list
15132145|NCT04370288|Micronutrients|micronutrients|mesh-ancestor
13997102|NCT02915055|Ibuprofen|ibuprofen|mesh-list
15132146|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814421|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
14269983|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14269984|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14269985|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269986|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14269987|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
14269988|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14269989|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14269990|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
14269991|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15132147|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
15132148|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132149|NCT04370288|Protective Agents|protective agents|mesh-ancestor
15132150|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
15132151|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132152|NCT04370288|Expectorants|expectorants|mesh-ancestor
15132153|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
15132154|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15132155|NCT04370288|Antidotes|antidotes|mesh-ancestor
15132156|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132157|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
15132158|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15132159|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
15132160|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132161|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
15132162|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132163|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15132164|NCT04369950|Lidocaine|lidocaine|mesh-list
15132165|NCT04369950|Epinephrine|epinephrine|mesh-list
15132166|NCT04369950|Morphine|morphine|mesh-list
15132167|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
15132168|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
15132169|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
15132170|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132171|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132172|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
15132173|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132174|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15132175|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15132176|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15132177|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15132178|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132179|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15132180|NCT04369950|Narcotics|narcotics|mesh-ancestor
15132181|NCT04369950|Analgesics|analgesics|mesh-ancestor
15132182|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15132183|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15132184|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
15132185|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132186|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15132187|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15132188|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
15132189|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15132190|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
15132191|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
15132192|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
15132193|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15132194|NCT04369534|Clopidogrel|clopidogrel|mesh-list
15132195|NCT04369534|Ticagrelor|ticagrelor|mesh-list
13997103|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
13997104|NCT02915055|Oxycodone|oxycodone|mesh-list
13997105|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997106|NCT02915055|Analgesics|analgesics|mesh-ancestor
13997107|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
13997108|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997109|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997110|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
13997111|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13997112|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997113|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997114|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13997115|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997116|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997117|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13997118|NCT02915055|Narcotics|narcotics|mesh-ancestor
13997119|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997120|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
13997121|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14811378|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14811379|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811380|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997122|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997123|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997124|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997125|NCT02915042|Analgesics|analgesics|mesh-ancestor
13997126|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
13997127|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997128|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13997129|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13997130|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13997131|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
13997132|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997133|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997134|NCT02914886|Insulin|insulin|mesh-list
13997135|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13997136|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997137|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997138|NCT02914652|Albuterol|albuterol|mesh-list
13997139|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13997140|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
13997141|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997142|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997143|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13997144|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
13997145|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
13997146|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13997147|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13997148|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13997149|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13997150|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
13997151|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997152|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997153|NCT02914678|Fentanyl|fentanyl|mesh-list
13997154|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13997155|NCT02914678|Narcotics|narcotics|mesh-ancestor
13997156|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997157|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997158|NCT02914678|Analgesics|analgesics|mesh-ancestor
13997159|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
13997160|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997161|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13997162|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13997163|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
13997164|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
13997165|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13997166|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13997167|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15132196|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15132197|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15132198|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15132199|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15132200|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
15132201|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132202|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132203|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132204|NCT04369469|Ravulizumab|ravulizumab|mesh-list
15132205|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15132206|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15132207|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
15132208|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132209|NCT04370080|Fluorides|fluorides|mesh-list
15132210|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
15132211|NCT04370080|Protective Agents|protective agents|mesh-ancestor
15132212|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132213|NCT04370392|Anesthetics|anesthetics|mesh-list
15132214|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
15132215|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132216|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132217|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
15132218|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132219|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
15132220|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997168|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13997169|NCT02914626|Ranibizumab|ranibizumab|mesh-list
13997170|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13997171|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13997172|NCT02914626|Growth Substances|growth substances|mesh-ancestor
13997173|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997174|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
13997175|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132221|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132222|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14023384|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023385|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14023386|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023387|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
14023388|NCT02762656|Lidocaine|lidocaine|mesh-list
14023389|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
14023390|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
14023391|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023392|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023393|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
14023394|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023395|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14023396|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14023397|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14023398|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14023399|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023400|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14023401|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14023402|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
14023403|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023404|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023405|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14023406|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14023407|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14023408|NCT02762617|Tenofovir|tenofovir|mesh-list
14023409|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
14023410|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023411|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14023412|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15132223|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15132224|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132225|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132226|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132227|NCT04369222|Acetaminophen|acetaminophen|mesh-list
15132228|NCT04369222|Aspirin|aspirin|mesh-list
15132229|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
15132230|NCT04369222|Salicylates|salicylates|mesh-list
15132231|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15132232|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15132233|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15132234|NCT04369222|Analgesics|analgesics|mesh-ancestor
15132235|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
15132236|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132237|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132238|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
15132239|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132240|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
15132241|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
15132242|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132243|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132244|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15132245|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132246|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132247|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15132248|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15132249|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15132250|NCT04368819|Allopurinol|allopurinol|mesh-list
15132251|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
15132252|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132253|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132254|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
15132255|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132256|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15132257|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
15132258|NCT04368819|Protective Agents|protective agents|mesh-ancestor
15132259|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132260|NCT04368585|Simethicone|simethicone|mesh-list
15132261|NCT04368585|Omeprazole|omeprazole|mesh-list
15132262|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15132263|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
15132264|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
15132265|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
15132266|NCT04368585|TEMPO|tempo|mesh-list
15132267|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15132268|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15132269|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15132270|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132271|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132272|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
15132273|NCT04368585|Emollients|emollients|mesh-ancestor
15132274|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132275|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15132276|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
15132277|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132278|NCT04368585|Antacids|antacids|mesh-ancestor
15132279|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
15132280|NCT04368585|Protective Agents|protective agents|mesh-ancestor
15132281|NCT04368546|Sunitinib|sunitinib|mesh-list
15132282|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132283|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13997176|NCT02914366|Ambroxol|ambroxol|mesh-list
15132284|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15132285|NCT04368546|Growth Substances|growth substances|mesh-ancestor
15132286|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997177|NCT02914366|Expectorants|expectorants|mesh-ancestor
13997178|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
13997179|NCT02914158|Tamoxifen|tamoxifen|mesh-list
13997180|NCT02914158|Goserelin|goserelin|mesh-list
13997181|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13997182|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13997183|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
13997184|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132287|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
15132288|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15132289|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132290|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132291|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
15132292|NCT04368598|Dexamethasone|dexamethasone|mesh-list
15132293|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
15132294|NCT04368598|BB 1101|bb 1101|mesh-list
15132295|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15132296|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15132297|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
15132298|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
15132299|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132300|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132301|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811381|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14811382|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811383|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
14811384|NCT00845533|Piperaquine|piperaquine|mesh-list
14811385|NCT00845533|Artenimol|artenimol|mesh-list
14811386|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
14811387|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14811388|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14811389|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811390|NCT00845546|Loratadine|loratadine|mesh-list
14811391|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
14811392|NCT00845546|Ephedrine|ephedrine|mesh-list
14811393|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
14811394|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
14811395|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14811396|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14811397|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14811398|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
14811399|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
15132302|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
14811400|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811401|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132303|NCT04368598|Hormones|hormones|mesh-ancestor
15132304|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132305|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15132306|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132307|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132308|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132309|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132310|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
15132311|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132312|NCT04368598|Expectorants|expectorants|mesh-ancestor
13997185|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997186|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15132313|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
15132314|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15132315|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
15132316|NCT04368598|Protective Agents|protective agents|mesh-ancestor
15132317|NCT04368598|Antidotes|antidotes|mesh-ancestor
15132318|NCT04368520|Vitamin D|vitamin d|mesh-list
15132319|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
15132320|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
15132321|NCT04368520|Vitamins|vitamins|mesh-list
13997187|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997188|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15132322|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
15132323|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132324|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13997189|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13997190|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13997191|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13997192|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997193|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997194|NCT02914015|Morphine|morphine|mesh-list
13997195|NCT02914015|Ropivacaine|ropivacaine|mesh-list
13997196|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
13997197|NCT02914015|Anesthetics|anesthetics|mesh-list
13997198|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13997199|NCT02914015|Narcotics|narcotics|mesh-ancestor
13997200|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997201|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997202|NCT02914015|Analgesics|analgesics|mesh-ancestor
13997203|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
13997204|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132325|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15178773|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178774|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178775|NCT03956134|Tapentadol|tapentadol|mesh-list
15178776|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15178777|NCT03956134|Narcotics|narcotics|mesh-ancestor
15178778|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178779|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178780|NCT03956134|Analgesics|analgesics|mesh-ancestor
15178781|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
15178782|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178783|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15178784|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15178785|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15132326|NCT04368377|Aspirin|aspirin|mesh-list
15132327|NCT04368377|PENTA|penta|mesh-list
15132328|NCT04368377|Tirofiban|tirofiban|mesh-list
15132329|NCT04368377|Fondaparinux|fondaparinux|mesh-list
15132330|NCT04368377|Clopidogrel|clopidogrel|mesh-list
13997205|NCT02914054|Dexamethasone|dexamethasone|mesh-list
13997206|NCT02914054|Prednisone|prednisone|mesh-list
13997207|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997208|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
13997209|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
13997210|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997211|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997212|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997213|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
13997214|NCT02914054|Hormones|hormones|mesh-ancestor
15132331|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15132332|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15132333|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15132334|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15132335|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
15132336|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132337|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997215|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997216|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13997217|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997218|NCT02914145|Piperaquine|piperaquine|mesh-list
13997219|NCT02914145|Artenimol|artenimol|mesh-list
13997220|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
13997221|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13997222|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13997223|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997224|NCT02913885|Fluorides|fluorides|mesh-list
13997225|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
13997226|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
13997227|NCT02913885|Protective Agents|protective agents|mesh-ancestor
13997228|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997229|NCT02914028|Acetaminophen|acetaminophen|mesh-list
13997230|NCT02914028|Tramadol|tramadol|mesh-list
13997231|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997232|NCT02914028|Analgesics|analgesics|mesh-ancestor
13997233|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
15132338|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997234|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997235|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997236|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
13997237|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13997238|NCT02914028|Narcotics|narcotics|mesh-ancestor
13997239|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997240|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
13997241|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
13997242|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997243|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997244|NCT02913768|Ondansetron|ondansetron|mesh-list
13997245|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
13997246|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
13997247|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997248|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997249|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15132339|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15132340|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15132341|NCT04368377|Analgesics|analgesics|mesh-ancestor
15132342|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
15132343|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132344|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15132345|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132346|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15132347|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15132348|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15132349|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132350|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
15132351|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15132352|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
15132353|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15132354|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132355|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
15132356|NCT04368403|Brodalumab|brodalumab|mesh-list
15132357|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132358|NCT04368273|Antibodies|antibodies|mesh-list
15132359|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
15132360|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132361|NCT04368078|Lenvatinib|lenvatinib|mesh-list
15132362|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132363|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15132364|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132365|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132366|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15132367|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15132368|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132369|NCT04368351|Azithromycin|azithromycin|mesh-list
15132370|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132371|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132372|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132373|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
15132374|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132375|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132376|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132377|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132378|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132379|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
15132380|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15132381|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132382|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132383|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15132384|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15132385|NCT04367935|Protective Agents|protective agents|mesh-ancestor
15132386|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132387|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
15132388|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15132389|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
15132390|NCT04368364|Morphine|morphine|mesh-list
15132391|NCT04368364|Bupivacaine|bupivacaine|mesh-list
15132392|NCT04368364|Ropivacaine|ropivacaine|mesh-list
15132393|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
15132394|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
15132395|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132396|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132397|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
15132398|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132399|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14269992|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14269993|NCT00406653|Abatacept|abatacept|mesh-list
14269994|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13997250|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
15132400|NCT04368364|Narcotics|narcotics|mesh-ancestor
15132401|NCT04368364|Analgesics|analgesics|mesh-ancestor
15132402|NCT04367831|Heparin|heparin|mesh-list
15132403|NCT04367831|Calcium heparin|calcium heparin|mesh-list
15132404|NCT04367831|Enoxaparin|enoxaparin|mesh-list
15132405|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
15132406|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
15132407|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15132408|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15132409|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132410|NCT04367818|Anesthetics|anesthetics|mesh-list
15132411|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
15132412|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132413|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132414|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
15132415|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132416|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
15132417|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15132418|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15132419|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132420|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
15132421|NCT04367155|Coagulants|coagulants|mesh-ancestor
15132422|NCT04367103|Phenylephrine|phenylephrine|mesh-list
15132423|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
15132424|NCT04367103|Norepinephrine|norepinephrine|mesh-list
15132425|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15132426|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
15132427|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
15132428|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132429|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132430|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
15132431|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15132432|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
13997251|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132433|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
15132434|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15132435|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15132436|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15132437|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
15132438|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132439|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132440|NCT04367103|Protective Agents|protective agents|mesh-ancestor
15132441|NCT04367051|Spironolactone|spironolactone|mesh-list
15132442|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15132443|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
15132444|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132445|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132446|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15132447|NCT04367051|Diuretics|diuretics|mesh-ancestor
15132448|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
15132449|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
15132450|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132451|NCT04367168|Colchicine|colchicine|mesh-list
13997252|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13997253|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
13997254|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997255|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997256|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13997257|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13997258|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997259|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13997260|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13997261|NCT02913417|Nivolumab|nivolumab|mesh-list
13997262|NCT02913417|Ipilimumab|ipilimumab|mesh-list
13997263|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13997264|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997265|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13997266|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997267|NCT02913573|Bupivacaine|bupivacaine|mesh-list
13997268|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
13997269|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
13997270|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997271|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997272|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
13997273|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997274|NCT02913430|Tamoxifen|tamoxifen|mesh-list
13997275|NCT02913430|Fulvestrant|fulvestrant|mesh-list
13997276|NCT02913430|Palbociclib|palbociclib|mesh-list
13997277|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13997278|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
13997279|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997280|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997281|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13997282|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132452|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
15132453|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132454|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
15132455|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
15132456|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
15132457|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132458|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132459|NCT04366609|Methylphenidate|methylphenidate|mesh-list
15132460|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13997283|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13997284|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13997285|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13997286|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13997287|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13997288|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997289|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997290|NCT02913469|Morphine|morphine|mesh-list
13997291|NCT02913469|Metoclopramide|metoclopramide|mesh-list
13997292|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13997293|NCT02913469|Narcotics|narcotics|mesh-ancestor
13997294|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997295|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997296|NCT02913469|Analgesics|analgesics|mesh-ancestor
13997297|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
13997298|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997299|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
13997300|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
13997301|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997302|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13997303|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13997304|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
15132461|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132462|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15132463|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15132464|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13997305|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997306|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997307|NCT02913508|Vedolizumab|vedolizumab|mesh-list
13997308|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997309|NCT02913300|Lidocaine|lidocaine|mesh-list
13997310|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13997311|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
13997312|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
15132465|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132466|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
13997313|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132467|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132468|NCT04366622|Riociguat|riociguat|mesh-list
15132469|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
15132470|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132471|NCT04366596|Paclitaxel|paclitaxel|mesh-list
15132472|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15132473|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132474|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
15132475|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
15132476|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
15132477|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132478|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
15132479|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
15132480|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
15132481|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132482|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132483|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15132484|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15132485|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15132486|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132487|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15132488|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15132489|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
15132490|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132491|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132492|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
15132493|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132494|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
15132495|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
15132496|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132497|NCT04366726|Abaloparatide|abaloparatide|mesh-list
15132498|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15132499|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132500|NCT04366960|Enoxaparin|enoxaparin|mesh-list
15132501|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
15132502|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15132503|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15132504|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178786|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997314|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997315|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
13997316|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997317|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13997318|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13997319|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15132505|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15132506|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132507|NCT04366089|Azithromycin|azithromycin|mesh-list
15132508|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132509|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132510|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132511|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
15132512|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132513|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132514|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132515|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132516|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132517|NCT04366050|Ramipril|ramipril|mesh-list
15132518|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15132519|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132520|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132521|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132522|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15132523|NCT04365933|Interferons|interferons|mesh-list
15132524|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
15132525|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
15132526|NCT04365933|Entecavir|entecavir|mesh-list
15132527|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15132528|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132529|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
15132530|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132531|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
15132532|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132533|NCT04365686|Propofol|propofol|mesh-list
15132534|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15132535|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132536|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132537|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15132538|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
15132539|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
15132540|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15132541|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15132542|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132543|NCT04365517|Incretins|incretins|mesh-ancestor
15132544|NCT04365517|Hormones|hormones|mesh-ancestor
15132545|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132546|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15132547|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132548|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132549|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132550|NCT04365582|Ritonavir|ritonavir|mesh-list
15132551|NCT04365582|Lopinavir|lopinavir|mesh-list
15132552|NCT04365582|Azithromycin|azithromycin|mesh-list
15132553|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132554|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15132555|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15132556|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132557|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132558|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132559|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14269995|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14269996|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14269997|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14269998|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
14269999|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270000|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270001|NCT00406692|Zonisamide|zonisamide|mesh-list
15132560|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15132561|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
14023413|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132562|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132563|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15132564|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15132565|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132566|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
15132567|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132568|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132569|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132570|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
15132571|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15132572|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
15132573|NCT04365270|Chitosan|chitosan|mesh-list
15132574|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15132575|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132576|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
15132577|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132578|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15132579|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15132580|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
15132581|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132582|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15132583|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
15132584|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
15132585|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
15132586|NCT04365270|Coagulants|coagulants|mesh-ancestor
15132587|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
15132588|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15132589|NCT04365270|Protective Agents|protective agents|mesh-ancestor
15132590|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132591|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15132592|NCT04365127|Progesterone|progesterone|mesh-list
15132593|NCT04365127|Progestins|progestins|mesh-ancestor
15132594|NCT04365127|Hormones|hormones|mesh-ancestor
15132595|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132596|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132597|NCT04365309|Aspirin|aspirin|mesh-list
13997320|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13997321|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997322|NCT02913690|Vitamin E|vitamin e|mesh-list
13997323|NCT02913690|Vitamins|vitamins|mesh-ancestor
13997324|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
13997325|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997326|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
13997327|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997328|NCT02913690|Protective Agents|protective agents|mesh-ancestor
13997329|NCT02913196|Prednisone|prednisone|mesh-list
13997330|NCT02913196|Docetaxel|docetaxel|mesh-list
13997331|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
13997332|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997333|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
13997334|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
13997335|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
13997336|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997337|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997338|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
13997339|NCT02913196|Hormones|hormones|mesh-ancestor
13997340|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997341|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997342|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14270002|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
15132598|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13997343|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15132599|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15132600|NCT04365309|Analgesics|analgesics|mesh-ancestor
15132601|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
15132602|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132603|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132604|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15132605|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132606|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15132607|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15132608|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132609|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15132610|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15132611|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132612|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
15132613|NCT04365231|Azithromycin|azithromycin|mesh-list
13997344|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997345|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
13997346|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13997347|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
13997348|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
13997349|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13997350|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13997351|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997352|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997353|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997354|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997355|NCT02913118|Amoxicillin|amoxicillin|mesh-list
13997356|NCT02913118|Azithromycin|azithromycin|mesh-list
15132614|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132615|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132616|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132617|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
15132618|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132619|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132620|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132621|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132622|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132623|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
15132624|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
15132625|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15132626|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132627|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15132628|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15132629|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15132630|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15132631|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132632|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132633|NCT04364906|Anesthetics|anesthetics|mesh-list
15132634|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132635|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132636|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132637|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
15132638|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132639|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132640|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132641|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132642|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132643|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132644|NCT04365049|Gemcitabine|gemcitabine|mesh-list
15132645|NCT04365049|Apatinib|apatinib|mesh-list
15132646|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132647|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15132648|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
15132649|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132650|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
15132651|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132652|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132653|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15132654|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
15132655|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132656|NCT04365049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15132657|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
15132658|NCT04364945|Remifentanil|remifentanil|mesh-list
15132659|NCT04364945|Sevoflurane|sevoflurane|mesh-list
15132660|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15132661|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132662|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997357|NCT02913118|Doxycycline|doxycycline|mesh-list
13997358|NCT02913118|Minocycline|minocycline|mesh-list
13997359|NCT02913118|Cephalosporins|cephalosporins|mesh-list
15132663|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15132664|NCT04364945|Analgesics|analgesics|mesh-ancestor
15132665|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
15132666|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132667|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15132668|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15132669|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15132670|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
15132671|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132672|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132673|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15132674|NCT04364945|Narcotics|narcotics|mesh-ancestor
15132675|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15132676|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15132677|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
15132678|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
15132679|NCT04364802|Iodine|iodine|mesh-list
15132680|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
15132681|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
15132682|NCT04364802|Povidone|povidone|mesh-list
15132683|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15132684|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132685|NCT04364802|Trace Elements|trace elements|mesh-ancestor
15132686|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
15132687|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132688|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
15132689|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
15132690|NCT04364620|Docetaxel|docetaxel|mesh-list
13997360|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
13997361|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997362|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997363|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
13997364|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13997365|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13997366|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13997367|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997368|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997369|NCT02913066|Cisplatin|cisplatin|mesh-list
13997370|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997371|NCT02912793|Betadex|betadex|mesh-list
13997372|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
13997373|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997374|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
13997375|NCT02912663|Verapamil|verapamil|mesh-list
13997376|NCT02912663|Analgesics|analgesics|mesh-ancestor
13997377|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
13997378|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997379|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997380|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
15132691|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132692|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
15132693|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
15132694|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
15132695|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132696|NCT04365036|Gemcitabine|gemcitabine|mesh-list
15132697|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
15132698|NCT04365036|Pegaspargase|pegaspargase|mesh-list
15132699|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15132700|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
15132701|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132702|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997381|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997382|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13997383|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
13997384|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13997385|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15132703|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
15132704|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132705|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132706|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15132707|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
15132708|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132709|NCT04364516|Vitamin K|vitamin k|mesh-list
15132710|NCT04364516|Anticoagulants|anticoagulants|mesh-list
15132711|NCT04364516|Vitamins|vitamins|mesh-ancestor
14811402|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132712|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
15132713|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132714|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15132715|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15132716|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132717|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
15132718|NCT04364516|Coagulants|coagulants|mesh-ancestor
15132719|NCT04364607|Neostigmine|neostigmine|mesh-list
15132720|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15132721|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132722|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132723|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
15132724|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132725|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132726|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15132727|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
15132728|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132729|NCT04364399|Vaccines|vaccines|mesh-list
15132730|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
15132731|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178787|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
15178788|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178789|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15178790|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178791|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
15178792|NCT03956121|Analgesics|analgesics|mesh-ancestor
15178793|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
15178794|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178795|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178796|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
15178797|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178798|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15178799|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
15132732|NCT04364477|Anesthetics|anesthetics|mesh-list
15132733|NCT04364477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132734|NCT04364477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132735|NCT04364360|Sulforaphane|sulforaphane|mesh-list
15132736|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13997386|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997387|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13997388|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
13997389|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13997390|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
14023414|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023415|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14023416|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14023417|NCT02762591|Pimavanserin|pimavanserin|mesh-list
14023418|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14023419|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14023420|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14023421|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14023422|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023423|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023424|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14023425|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14023426|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14023427|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
14023428|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023429|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023430|NCT02762344|Heparin|heparin|mesh-list
14023431|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
14023432|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14023433|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14023434|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023435|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
14023436|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023437|NCT02762474|Paclitaxel|paclitaxel|mesh-list
14023438|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14023439|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023440|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
14023441|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
14023442|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
14023443|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023444|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14023445|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
14023446|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023447|NCT02762448|Asunaprevir|asunaprevir|mesh-list
14023448|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
14023449|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023450|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023451|NCT02762253|Riboflavin|riboflavin|mesh-list
14023452|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
14023453|NCT02762253|Vitamins|vitamins|mesh-ancestor
14023454|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
14023455|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023456|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14023457|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023458|NCT02762006|Durvalumab|durvalumab|mesh-list
14023459|NCT02762006|Tremelimumab|tremelimumab|mesh-list
14023460|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14023461|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023462|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
14023463|NCT02762123|Digoxin|digoxin|mesh-list
14023464|NCT02762123|Midazolam|midazolam|mesh-list
14023465|NCT02762123|Omeprazole|omeprazole|mesh-list
14023466|NCT02762123|Montelukast|montelukast|mesh-list
14023467|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14023468|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14023469|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132737|NCT04364360|Protective Agents|protective agents|mesh-ancestor
15132738|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132739|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132740|NCT04364451|Asparaginase|asparaginase|mesh-list
15132741|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132742|NCT04364464|Riociguat|riociguat|mesh-list
15132743|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
15132744|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132745|NCT04364425|Triamcinolone|triamcinolone|mesh-list
15132746|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15132747|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15132748|NCT04364425|Lidocaine|lidocaine|mesh-list
15132749|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15132750|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
15132751|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
15132752|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132753|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132754|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
15132755|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132756|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13997391|NCT02912637|Xenon|xenon|mesh-list
13997392|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15132757|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15132758|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15132759|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15132760|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132761|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15132762|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
15132763|NCT04364425|Hormones|hormones|mesh-ancestor
15132764|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132765|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15132766|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
13997393|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
15132767|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132768|NCT04364321|Diazepam|diazepam|mesh-list
15132769|NCT04364321|Clonazepam|clonazepam|mesh-list
15132770|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15132771|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
15132772|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
15132773|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
15132774|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132775|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132776|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15132777|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15132778|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132779|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15132780|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15132781|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15132782|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15132783|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15132784|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15132785|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
15132786|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
15132787|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
15132788|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
15132789|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132790|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132791|NCT04364139|Metoprolol|metoprolol|mesh-list
15132792|NCT04364139|Amlodipine|amlodipine|mesh-list
15132793|NCT04364139|Ramipril|ramipril|mesh-list
15132794|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15132795|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15132796|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15132797|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997394|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
13997395|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997396|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132798|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15132799|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132800|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
15132801|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15132802|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
15132803|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
15132804|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132805|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15132806|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15132807|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15132808|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
15132809|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15132810|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15132811|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132812|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132813|NCT04364581|Letrozole|letrozole|mesh-list
15132814|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997397|NCT02912715|Paclitaxel|paclitaxel|mesh-list
13997398|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13997399|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997400|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
13997401|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
13997402|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
13997403|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997404|NCT02912910|Labetalol|labetalol|mesh-list
13997405|NCT02912910|Nifedipine|nifedipine|mesh-list
13997406|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13997407|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13997408|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997409|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13997410|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997411|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
13997412|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
13997413|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13997414|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13997415|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13997416|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
13997417|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997418|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13997419|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
13997420|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
13997421|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997422|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15132815|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13997423|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13997424|NCT02912702|Dexamethasone|dexamethasone|mesh-list
13997425|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
13997426|NCT02912702|Doxorubicin|doxorubicin|mesh-list
13997427|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13997428|NCT02912702|Etoposide|etoposide|mesh-list
15132816|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15132817|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132818|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132819|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15132820|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
15132821|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132822|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132823|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13997429|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
13997430|NCT02912702|Pegaspargase|pegaspargase|mesh-list
13997431|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997432|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
13997433|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
15132824|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132825|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132826|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
15132827|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132828|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132829|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132830|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132831|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132832|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132833|NCT04364113|Benzocaine|benzocaine|mesh-list
15132834|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
15132835|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
15132836|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15132837|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132838|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
15132839|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132840|NCT04364022|Ritonavir|ritonavir|mesh-list
15132841|NCT04364022|Lopinavir|lopinavir|mesh-list
15132842|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15132843|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15132844|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
15132845|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132846|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132847|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15132848|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15132849|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
15132850|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132851|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15132852|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15132853|NCT04364035|Vesatolimod|vesatolimod|mesh-list
15132854|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
15132855|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132856|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132857|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
15132858|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132859|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14270003|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14811403|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14811404|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
15132860|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132861|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132862|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132863|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132864|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
15132865|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132866|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
15132867|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
15132868|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
15132869|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132870|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
15132871|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132872|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132873|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132874|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132875|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132876|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132877|NCT04363203|Azithromycin|azithromycin|mesh-list
15132878|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132879|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132880|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132881|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
15132882|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15132883|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15132884|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132885|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132886|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132887|NCT04363255|Cisplatin|cisplatin|mesh-list
15132888|NCT04363255|Carboplatin|carboplatin|mesh-list
15132889|NCT04363255|Etoposide|etoposide|mesh-list
15132890|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
15132891|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132892|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15132893|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15132894|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15132895|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132896|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132897|NCT04363359|Vaccines|vaccines|mesh-list
15132898|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
15132899|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132900|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
15132901|NCT04363216|Vitamins|vitamins|mesh-ancestor
15132902|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
15132903|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132904|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
15132905|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132906|NCT04363216|Protective Agents|protective agents|mesh-ancestor
15132907|NCT04363060|Amoxicillin|amoxicillin|mesh-list
15132908|NCT04363060|Azithromycin|azithromycin|mesh-list
15132909|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
15132910|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
15132911|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15132912|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132913|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132914|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15132915|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997434|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997435|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997436|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997437|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
13997438|NCT02912702|Hormones|hormones|mesh-ancestor
13997439|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997440|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13997441|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997442|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13997443|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13997444|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13997445|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997446|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997447|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13997448|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13997449|NCT02912702|Protective Agents|protective agents|mesh-ancestor
13997450|NCT02912572|Avelumab|avelumab|mesh-list
13997451|NCT02912572|Axitinib|axitinib|mesh-list
13997452|NCT02912572|Talazoparib|talazoparib|mesh-list
13997453|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13997454|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132916|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132917|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15132918|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132919|NCT04362735|Vedolizumab|vedolizumab|mesh-list
15132920|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15132921|NCT04362527|Milrinone|milrinone|mesh-list
15132922|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15132923|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15132924|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15132925|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
15132926|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15132927|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13997455|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13997456|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997457|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997458|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13997459|NCT02912676|Methotrexate|methotrexate|mesh-list
13997460|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
13997461|NCT02912676|Thioguanine|thioguanine|mesh-list
13997462|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13997463|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
13997464|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13997465|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997466|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13997467|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
13997468|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997469|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997470|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
13997471|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997472|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13997473|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997474|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
13997475|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997476|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13997477|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
15132928|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132929|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132930|NCT04362527|Protective Agents|protective agents|mesh-ancestor
15132931|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132932|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15132933|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
15178800|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15178801|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182027|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270004|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270005|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270006|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270007|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270008|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14270009|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14270010|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14270011|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270012|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270013|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270014|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270015|NCT00406848|Analgesics|analgesics|mesh-ancestor
14270016|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
14270017|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270018|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
14270019|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270020|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
14270021|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15132934|NCT04362384|Vitamin E|vitamin e|mesh-list
15132935|NCT04362384|Prednisolone|prednisolone|mesh-list
15132936|NCT04362384|Vitamins|vitamins|mesh-ancestor
15132937|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
15132938|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270022|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14270023|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14270024|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270025|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132939|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15132940|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
15132941|NCT04362384|Hormones|hormones|mesh-ancestor
15132942|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132943|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15132944|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132945|NCT04362384|Protective Agents|protective agents|mesh-ancestor
15132946|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
15132947|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132948|NCT04362241|Prednisolone|prednisolone|mesh-list
15132949|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15132950|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
15132951|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15132952|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
15132953|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15132954|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
15132955|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15132956|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
15132957|NCT04362241|Hormones|hormones|mesh-ancestor
15132958|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15132959|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132960|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15132961|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132962|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
15132963|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
15132964|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15132965|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15132966|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15132967|NCT04362241|Protective Agents|protective agents|mesh-ancestor
15132968|NCT04362293|Sirolimus|sirolimus|mesh-list
15132969|NCT04362293|Plerixafor|plerixafor|mesh-list
15132970|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
15132971|NCT04362293|Thiotepa|thiotepa|mesh-list
15132972|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
15132973|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
15132974|NCT04362293|Azathioprine|azathioprine|mesh-list
15132975|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15132976|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
15132977|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15132978|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15132979|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15132980|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
15132981|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15132982|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15132983|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15132984|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15132985|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15132986|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15132987|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
15132988|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15132989|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
15132990|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15132991|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15132992|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
15132993|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15132994|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15132995|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15132996|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
15132997|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
15132998|NCT04362332|Chloroquine|chloroquine|mesh-list
15132999|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15133000|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
15133001|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133002|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133003|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133004|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133005|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133006|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997478|NCT02912494|Hematinics|hematinics|mesh-ancestor
13997479|NCT02912156|Voriconazole|voriconazole|mesh-list
13997480|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
13997481|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997482|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13997483|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13997484|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997485|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997486|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13997487|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
13997488|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997489|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997490|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13997491|NCT02912169|Anesthetics|anesthetics|mesh-list
13997492|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997493|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997494|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13997495|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997496|NCT02912182|Prednisolone|prednisolone|mesh-list
13997497|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13997498|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
13997499|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13997500|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
13997501|NCT02912182|Betamethasone|betamethasone|mesh-list
13997502|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13997503|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
13997504|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997505|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
13997506|NCT02912182|Hormones|hormones|mesh-ancestor
13997507|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997508|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997509|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13997510|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997511|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
13997512|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
13997513|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997514|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997515|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13997516|NCT02912182|Protective Agents|protective agents|mesh-ancestor
13997517|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13997518|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
13997519|NCT02912247|Adalimumab|adalimumab|mesh-list
13997520|NCT02912247|Antibodies|antibodies|mesh-list
13997521|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13997522|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
15133007|NCT04362332|Amebicides|amebicides|mesh-ancestor
15133008|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15133009|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15133010|NCT04362332|Analgesics|analgesics|mesh-ancestor
15133011|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
15133012|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133013|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133014|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133015|NCT04362332|Filaricides|filaricides|mesh-ancestor
15133016|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
15133017|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
15133018|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
14270026|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14270027|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270028|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270029|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
14270030|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270031|NCT00407355|Ranibizumab|ranibizumab|mesh-list
14270032|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270033|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14561868|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14561869|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561870|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561871|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561872|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
14561873|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561874|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15133019|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15133020|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
15133021|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133022|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13997523|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997524|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997525|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997526|NCT02912234|Clarithromycin|clarithromycin|mesh-list
13997527|NCT02912234|Apixaban|apixaban|mesh-list
13997528|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997529|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997530|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13997531|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997532|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997533|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13997534|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13997535|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13997536|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
13997537|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13997538|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
13997539|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
13997540|NCT02912026|Olorofim|olorofim|mesh-list
13997541|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
13997542|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997543|NCT02911961|Acetaminophen|acetaminophen|mesh-list
13997544|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997545|NCT02911961|Analgesics|analgesics|mesh-ancestor
13997546|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
13997547|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997548|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997549|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
13997550|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
15133023|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
13997551|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997552|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133024|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133025|NCT04361825|Durvalumab|durvalumab|mesh-list
15133026|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133027|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133028|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
15133029|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
15133030|NCT04361708|Leucovorin|leucovorin|mesh-list
15133031|NCT04361708|Docetaxel|docetaxel|mesh-list
15133032|NCT04361708|Fluorouracil|fluorouracil|mesh-list
15133033|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
15133034|NCT04361708|Irinotecan|irinotecan|mesh-list
15133035|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133036|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
15133037|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
15133038|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
15133039|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133040|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
15133041|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133042|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133043|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
15133044|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133045|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15133046|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15133047|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133048|NCT04361708|Antidotes|antidotes|mesh-ancestor
15133049|NCT04361708|Protective Agents|protective agents|mesh-ancestor
15133050|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
15133051|NCT04361708|Vitamins|vitamins|mesh-ancestor
15133052|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
15133053|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
15133054|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
15133055|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
15133056|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133057|NCT04361721|Erenumab|erenumab|mesh-list
15133058|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15133059|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133060|NCT04361721|Analgesics|analgesics|mesh-ancestor
15133061|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
14270034|NCT00407355|Growth Substances|growth substances|mesh-ancestor
15133062|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182028|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
13997553|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13997554|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13997555|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997556|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997557|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997558|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
13997559|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13997560|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13997561|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997562|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
13997563|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
13997564|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
13997565|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13997566|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13997567|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997568|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
13997569|NCT02911831|Coagulants|coagulants|mesh-ancestor
13997570|NCT02911792|Metformin|metformin|mesh-list
13997571|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
13997572|NCT02911792|Glipizide|glipizide|mesh-list
13997573|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997574|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997575|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13997576|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997577|NCT02911662|Cephalexin|cephalexin|mesh-list
13997578|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
13997579|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997580|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997581|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13997582|NCT02911662|Renal Agents|renal agents|mesh-ancestor
13997583|NCT02911701|Acetaminophen|acetaminophen|mesh-list
13997584|NCT02911701|Ibuprofen|ibuprofen|mesh-list
13997585|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997586|NCT02911701|Analgesics|analgesics|mesh-ancestor
13997587|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
13997588|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997589|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997590|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
13997591|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13997592|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997593|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997594|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13997595|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997596|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997597|NCT02911597|Naltrexone|naltrexone|mesh-list
13997598|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13997599|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13997600|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997601|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
13997602|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997603|NCT02911298|Metronidazole|metronidazole|mesh-list
15133063|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133064|NCT04361812|Omalizumab|omalizumab|mesh-list
15133065|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15133066|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15133067|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15133068|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
15133069|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
13997604|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997605|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997606|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13997607|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13997608|NCT02911350|Paclitaxel|paclitaxel|mesh-list
15133070|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997609|NCT02911350|Hormones|hormones|mesh-list
13997610|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15133071|NCT04361643|Lenalidomide|lenalidomide|mesh-list
15133072|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
13997611|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997612|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
13997613|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
13997614|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
13997615|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997616|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997617|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997618|NCT02911480|Oxytocin|oxytocin|mesh-list
13997619|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
13997620|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13997621|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997622|NCT02911272|Oxytocin|oxytocin|mesh-list
13997623|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
13997624|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13997625|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023470|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023471|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14023472|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14023473|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14023474|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14023475|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
14023476|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
14023477|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
14023478|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
14023479|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023480|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023481|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14270035|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270036|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270037|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270038|NCT00407381|Ranibizumab|ranibizumab|mesh-list
14270039|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270040|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270041|NCT00407381|Growth Substances|growth substances|mesh-ancestor
14270042|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270043|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270044|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270045|NCT00407485|Aflibercept|aflibercept|mesh-list
14270046|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15133073|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133074|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15133075|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15133076|NCT04361643|Growth Substances|growth substances|mesh-ancestor
15133077|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
15133078|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133079|NCT04361513|Triamcinolone|triamcinolone|mesh-list
15133080|NCT04361513|Bupivacaine|bupivacaine|mesh-list
15133081|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
15133082|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
15133083|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133084|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133085|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
15133086|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133087|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133088|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
15133089|NCT04361513|Hormones|hormones|mesh-ancestor
15133090|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133091|NCT04361175|Letrozole|letrozole|mesh-list
15133092|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133093|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133094|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15133095|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15133096|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133097|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15133098|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
15133099|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133100|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133101|NCT04361461|Azithromycin|azithromycin|mesh-list
15133102|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
15133103|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15133104|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133105|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
15133106|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133107|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133108|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133109|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133110|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133111|NCT04361279|Rituximab|rituximab|mesh-list
15133112|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133113|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133114|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
15133115|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133116|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133117|NCT04361188|Anesthetics|anesthetics|mesh-list
15133118|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133119|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133120|NCT04361422|Isotretinoin|isotretinoin|mesh-list
15133121|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
15133122|NCT04361331|Lenvatinib|lenvatinib|mesh-list
15133123|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133124|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15133125|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133126|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133127|NCT04361214|Leflunomide|leflunomide|mesh-list
15133128|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133129|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133130|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133131|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
15133132|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133133|NCT04361305|Tadalafil|tadalafil|mesh-list
15133134|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
15133135|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15133136|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15133137|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133138|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133139|NCT04361305|Urological Agents|urological agents|mesh-ancestor
15133140|NCT04361370|Bevacizumab|bevacizumab|mesh-list
15133141|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
15133142|NCT04361370|Olaparib|olaparib|mesh-list
15133143|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133144|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133145|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15133146|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15133147|NCT04361370|Growth Substances|growth substances|mesh-ancestor
15133148|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133149|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
15133150|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15133151|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133152|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133153|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
15133154|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
15133155|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
15133156|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133157|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133158|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133159|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133160|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133161|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133162|NCT04361149|Capsaicin|capsaicin|mesh-list
15133163|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
14270047|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270048|NCT00407485|Growth Substances|growth substances|mesh-ancestor
13997626|NCT02910778|Ticagrelor|ticagrelor|mesh-list
13997627|NCT02910778|Atorvastatin|atorvastatin|mesh-list
13997628|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13997629|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13997630|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
13997631|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997632|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13997633|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13997634|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997635|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13997636|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13997637|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13997638|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13997639|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
13997640|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997641|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997642|NCT02910882|Gemcitabine|gemcitabine|mesh-list
13997643|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13997644|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
13997645|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997646|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997647|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
13997648|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997649|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997650|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997651|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
13997652|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997653|NCT02910817|Metformin|metformin|mesh-list
13997654|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997655|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997656|NCT02910765|Methylene Blue|methylene blue|mesh-list
13997657|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997658|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997659|NCT02910518|Insulin|insulin|mesh-list
13997660|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13997661|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
13997662|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
13997663|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
13997664|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
13997665|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
13997666|NCT02910518|Heparin|heparin|mesh-list
13997667|NCT02910518|Calcium heparin|calcium heparin|mesh-list
13997668|NCT02910518|Glucagon|glucagon|mesh-list
13997669|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997670|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997671|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
13997672|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13997673|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13997674|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997675|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997676|NCT02910518|Hormones|hormones|mesh-ancestor
13997677|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997678|NCT02910414|Ethanol|ethanol|mesh-list
13997679|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13997680|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997681|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133164|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
13997682|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133165|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
13997683|NCT02910596|Bethanechol|bethanechol|mesh-list
13997684|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15133166|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133167|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133168|NCT04361474|Budesonide|budesonide|mesh-list
15133169|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133170|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15133171|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
15133172|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133173|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133174|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15133175|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
15133176|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
15133177|NCT04361474|Hormones|hormones|mesh-ancestor
15133178|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133179|NCT04361058|Nivolumab|nivolumab|mesh-list
15133180|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133181|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133182|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15133183|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133184|NCT04361409|Gemcitabine|gemcitabine|mesh-list
15133185|NCT04361409|Rituximab|rituximab|mesh-list
15133186|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133187|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133188|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
15133189|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133190|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133191|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133192|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
15133193|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133194|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
15133195|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133196|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133197|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133198|NCT04361162|Nivolumab|nivolumab|mesh-list
15133199|NCT04361162|Ipilimumab|ipilimumab|mesh-list
15133200|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133201|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133202|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15133203|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133204|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
15133205|NCT04360759|Chloroquine|chloroquine|mesh-list
15133206|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
15133207|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133208|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133209|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133210|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182029|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
13997685|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
15133211|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133212|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133213|NCT04360759|Amebicides|amebicides|mesh-ancestor
15133214|NCT04361032|Deferoxamine|deferoxamine|mesh-list
15133215|NCT04361032|Siderophores|siderophores|mesh-ancestor
15133216|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15133217|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
15133218|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
15133219|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133220|NCT04360941|Palbociclib|palbociclib|mesh-list
15133221|NCT04360941|Avelumab|avelumab|mesh-list
13997686|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997687|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997688|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13997689|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13997690|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
13997691|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997692|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997693|NCT02910570|Liraglutide|liraglutide|mesh-list
13997694|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997695|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997696|NCT02910570|Incretins|incretins|mesh-ancestor
13997697|NCT02910570|Hormones|hormones|mesh-ancestor
13997698|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133222|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133223|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15133224|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133225|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133226|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133227|NCT04360824|Enoxaparin|enoxaparin|mesh-list
15133228|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
15133229|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15133230|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15133231|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133232|NCT04360889|Tocopherols|tocopherols|mesh-list
13997699|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
13997700|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
13997701|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997702|NCT02910531|Protective Agents|protective agents|mesh-ancestor
13997703|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997704|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
13997705|NCT02910531|Vitamins|vitamins|mesh-ancestor
13997706|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
15133233|NCT04360889|Vitamin E|vitamin e|mesh-list
15133234|NCT04360889|Tocotrienols|tocotrienols|mesh-list
15133235|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
15133236|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
15133237|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133238|NCT04360889|Protective Agents|protective agents|mesh-ancestor
15133239|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133240|NCT04360889|Vitamins|vitamins|mesh-ancestor
15133241|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
13997707|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
13997708|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
15133242|NCT04360785|Methotrexate|methotrexate|mesh-list
15133243|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15133244|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
15133245|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133246|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133247|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133248|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
15182030|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997709|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13997710|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133249|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133250|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133251|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
15133252|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133253|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15133254|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133255|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
15133256|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133257|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15133258|NCT04360655|Antibodies|antibodies|mesh-list
15133259|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13997711|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997712|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997713|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997714|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997715|NCT02910141|Insulin|insulin|mesh-list
13997716|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13997717|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997718|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997719|NCT02910115|Oxytocin|oxytocin|mesh-list
13997720|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
14270049|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270050|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270051|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270052|NCT00407511|Pregabalin|pregabalin|mesh-list
13997721|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133260|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
15133261|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178802|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178803|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15178804|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
15178805|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15178806|NCT03955575|Liraglutide|liraglutide|mesh-list
15178807|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
15178808|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15178809|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178810|NCT03955575|Incretins|incretins|mesh-ancestor
15178811|NCT03955575|Hormones|hormones|mesh-ancestor
15178812|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178813|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15178814|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15178815|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
15178816|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178817|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15178818|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
15178819|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15178820|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
15178821|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178822|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178823|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15178824|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
15178825|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178826|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178827|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15178828|NCT03955705|Nefopam|nefopam|mesh-list
15178829|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178830|NCT03955705|Analgesics|analgesics|mesh-ancestor
15178831|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
15178832|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178833|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270053|NCT00407511|Analgesics|analgesics|mesh-ancestor
15133262|NCT04360317|Docetaxel|docetaxel|mesh-list
15133263|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133264|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
15133265|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
15133266|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
15133267|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133268|NCT04360551|Telmisartan|telmisartan|mesh-list
15133269|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15133270|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15133271|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15133272|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133273|NCT04360421|Bupivacaine|bupivacaine|mesh-list
15133274|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
15133275|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
15133276|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133277|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133278|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
15133279|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133280|NCT04359979|Tamsulosin|tamsulosin|mesh-list
15133281|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15133282|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15133283|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15133284|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
15133285|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15133286|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133287|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133288|NCT04359979|Urological Agents|urological agents|mesh-ancestor
15133289|NCT04359953|Azithromycin|azithromycin|mesh-list
15133290|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
15133291|NCT04359953|Telmisartan|telmisartan|mesh-list
13997722|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997723|NCT02910206|Sufentanil|sufentanil|mesh-list
15133292|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997724|NCT02910206|Propofol|propofol|mesh-list
15133293|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133294|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
15133295|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133296|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133297|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133298|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270054|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
15133299|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133300|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15133301|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15133302|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15133303|NCT04359966|Amoxicillin|amoxicillin|mesh-list
15133304|NCT04359966|Metronidazole|metronidazole|mesh-list
15133305|NCT04359966|Clarithromycin|clarithromycin|mesh-list
15133306|NCT04359966|Levofloxacin|levofloxacin|mesh-list
15133307|NCT04359966|Ofloxacin|ofloxacin|mesh-list
15133308|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
13997725|NCT02910206|Etomidate|etomidate|mesh-list
13997726|NCT02910206|Cisatracurium|cisatracurium|mesh-list
13997727|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13997728|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997729|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997730|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13997731|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
13997732|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
13997733|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13997734|NCT02910206|Narcotics|narcotics|mesh-ancestor
13997735|NCT02910206|Analgesics|analgesics|mesh-ancestor
13997736|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
13997737|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997738|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13997739|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13997740|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13997741|NCT02909972|Cytarabine|cytarabine|mesh-list
13997742|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13997743|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
13997744|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997745|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133309|NCT04359966|Esomeprazole|esomeprazole|mesh-list
15133310|NCT04359966|Bismuth|bismuth|mesh-list
15133311|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15133312|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133313|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133314|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133315|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15133316|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15133317|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15133318|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133319|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133320|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13997746|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
13997747|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133321|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15133322|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15133323|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15133324|NCT04359966|Renal Agents|renal agents|mesh-ancestor
15133325|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15133326|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15133327|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133328|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15133329|NCT04359966|Antacids|antacids|mesh-ancestor
15133330|NCT04359862|Propofol|propofol|mesh-list
15133331|NCT04359862|Sevoflurane|sevoflurane|mesh-list
15133332|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15133333|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133334|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133335|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15133336|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
15133337|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
15133338|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15133339|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15133340|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
15133341|NCT04360031|Tacrolimus|tacrolimus|mesh-list
15133342|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133343|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
15133344|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133345|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15133346|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133347|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133348|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15133349|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133350|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15133351|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
15133352|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15133353|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133354|NCT04360122|Levamisole|levamisole|mesh-list
15133355|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
15133356|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15133357|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
15133358|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133359|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
14270055|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270056|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270057|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
14270058|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270059|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270060|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270061|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14561875|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561876|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
15133360|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
15133361|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133362|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133363|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133364|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
15133365|NCT04360135|Acetaminophen|acetaminophen|mesh-list
15133366|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15133367|NCT04360135|Analgesics|analgesics|mesh-ancestor
15133368|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
15133369|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133370|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133371|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
15133372|NCT04360356|Ivermectin|ivermectin|mesh-list
15133373|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
15133374|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133375|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561877|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133376|NCT04360876|Dexamethasone|dexamethasone|mesh-list
15133377|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
14561878|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561879|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561880|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561881|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561882|NCT00002813|Vinorelbine|vinorelbine|mesh-list
14561883|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561884|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561885|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561886|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561887|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561888|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561889|NCT00002814|Paclitaxel|paclitaxel|mesh-list
14561890|NCT00002814|Topotecan|topotecan|mesh-list
13997748|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997749|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
13997750|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997751|NCT02910050|Letrozole|letrozole|mesh-list
13997752|NCT02910050|Anastrozole|anastrozole|mesh-list
13997753|NCT02910050|Exemestane|exemestane|mesh-list
13997754|NCT02910050|Bicalutamide|bicalutamide|mesh-list
13997755|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13997756|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997757|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13997758|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997759|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997760|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13997761|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
13997762|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997763|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561891|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561892|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133378|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133379|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
15133380|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
15133381|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133382|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133383|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15133384|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
15133385|NCT04360876|Hormones|hormones|mesh-ancestor
13997764|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15178834|NCT03955406|Anesthetics|anesthetics|mesh-list
15133386|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133387|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15133388|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133389|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
15133390|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133391|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133392|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
15133393|NCT04359615|Favipiravir|favipiravir|mesh-list
15133394|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
15133395|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133396|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133397|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133398|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133399|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997765|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
15133400|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133401|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
15133402|NCT04359823|Lovastatin|lovastatin|mesh-list
15133403|NCT04359823|L 647318|l 647318|mesh-list
15133404|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
15133405|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15133406|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15133407|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
15133408|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133409|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15133410|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15133411|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133412|NCT04359576|Hemostatics|hemostatics|mesh-list
15133413|NCT04359576|Coagulants|coagulants|mesh-ancestor
15133414|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
14270062|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14270063|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270064|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270065|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270066|NCT00407537|Amlodipine|amlodipine|mesh-list
14270067|NCT00407537|Atorvastatin|atorvastatin|mesh-list
14270068|NCT00407537|Calcium|calcium|mesh-list
14561893|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
15133415|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
15133416|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133417|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133418|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133419|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133420|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133421|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133422|NCT04359485|Glycolic acid|glycolic acid|mesh-list
15133423|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
15133424|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
15133425|NCT04359511|Prednisone|prednisone|mesh-list
13997766|NCT02909933|Metformin|metformin|mesh-list
14270069|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15133426|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
15133427|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133428|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
15133429|NCT04359511|Hormones|hormones|mesh-ancestor
15133430|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133431|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133432|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15133433|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133434|NCT04359550|Antibodies|antibodies|mesh-list
15133435|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15133436|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
15133437|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133438|NCT04359524|Vitamin D|vitamin d|mesh-list
15133439|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
15133440|NCT04359524|Vitamins|vitamins|mesh-ancestor
15133441|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
15133442|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133443|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15133444|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15133445|NCT04359199|Cisplatin|cisplatin|mesh-list
15133446|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
15133447|NCT04359199|Nivolumab|nivolumab|mesh-list
15133448|NCT04359199|Cetuximab|cetuximab|mesh-list
15133449|NCT04359199|Durvalumab|durvalumab|mesh-list
15133450|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133451|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133452|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15133453|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133454|NCT04359095|Tenofovir|tenofovir|mesh-list
15133455|NCT04359095|Emtricitabine|emtricitabine|mesh-list
15133456|NCT04359095|Colchicine|colchicine|mesh-list
15133457|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15133458|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
15133459|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133460|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15133461|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15133462|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133463|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133464|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15133465|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15133466|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15133467|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15133468|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
15133469|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15133470|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15133471|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
15133472|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133473|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
15133474|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
15133475|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
15133476|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133477|NCT04359212|Heparin|heparin|mesh-list
15133478|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15133479|NCT04359212|Tinzaparin|tinzaparin|mesh-list
15133480|NCT04359212|Dalteparin|dalteparin|mesh-list
15133481|NCT04359212|PENTA|penta|mesh-list
15133482|NCT04359212|Fondaparinux|fondaparinux|mesh-list
15133483|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
15133484|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15133485|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15133486|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133487|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15133488|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
15133489|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15133490|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
15133491|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133492|NCT04359316|Azithromycin|azithromycin|mesh-list
15133493|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
15133494|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15133495|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133496|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
15133497|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133498|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133499|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997767|NCT02909933|Liraglutide|liraglutide|mesh-list
13997768|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13997769|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997770|NCT02909933|Incretins|incretins|mesh-ancestor
13997771|NCT02909933|Hormones|hormones|mesh-ancestor
13997772|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997773|NCT02910245|Prednisone|prednisone|mesh-list
13997774|NCT02910245|Mesalamine|mesalamine|mesh-list
15133500|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133501|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133502|NCT04358965|Misoprostol|misoprostol|mesh-list
15133503|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
15133504|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15133505|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15133506|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997775|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
13997776|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997777|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
13997778|NCT02910245|Hormones|hormones|mesh-ancestor
15133507|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
15133508|NCT04358965|Coagulants|coagulants|mesh-ancestor
15133509|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15133510|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
15133511|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133512|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133513|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15133514|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15133515|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
15133516|NCT04358614|Ritonavir|ritonavir|mesh-list
15133517|NCT04358614|Lopinavir|lopinavir|mesh-list
15133518|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15133519|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15133520|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
15133521|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133522|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133523|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15133524|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13997779|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997780|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997781|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13997782|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997783|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
13997784|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997785|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13997786|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997787|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
13997788|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13997789|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133525|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
15133526|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133527|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15133528|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15133529|NCT04358796|Perflubron|perflubron|mesh-list
15133530|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15133531|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
15133532|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15133533|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133534|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133535|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15133536|NCT04358627|Analgesics|analgesics|mesh-ancestor
15133537|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
15133538|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133539|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15133540|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15133541|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15133542|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
15133543|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15133544|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133545|NCT04358718|Anesthetics|anesthetics|mesh-list
15133546|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270070|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270071|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14270072|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14270073|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
14270074|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133547|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133548|NCT04358770|Clocortolone|clocortolone|mesh-list
15133549|NCT04358770|Fluocortolone|fluocortolone|mesh-list
15133550|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
15133551|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133552|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
15133553|NCT04358770|Hormones|hormones|mesh-ancestor
15133554|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133555|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178835|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178836|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178837|NCT03955354|Apatinib|apatinib|mesh-list
15178838|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178839|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15178840|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178841|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178842|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
15178843|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15178844|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178845|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
15178846|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
15178847|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15178848|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178849|NCT03955458|Bupivacaine|bupivacaine|mesh-list
15178850|NCT03955458|Ropivacaine|ropivacaine|mesh-list
15178851|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
15178852|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
15178853|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178854|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178855|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
15178856|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178857|NCT03955172|Everolimus|everolimus|mesh-list
15178858|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133556|NCT04358562|Gefitinib|gefitinib|mesh-list
15133557|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133558|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15133559|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133560|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133561|NCT04358146|Locust bean gum|locust bean gum|mesh-list
15133562|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
15133563|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15133564|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
15133565|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15133566|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023482|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997790|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13997791|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997792|NCT02910245|Analgesics|analgesics|mesh-ancestor
13997793|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
13997794|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997795|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997796|NCT02909751|Tocotrienols|tocotrienols|mesh-list
13997797|NCT02909751|Vitamin E|vitamin e|mesh-list
13997798|NCT02909751|Tocopherols|tocopherols|mesh-list
13997799|NCT02909751|Docetaxel|docetaxel|mesh-list
13997800|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
13997801|NCT02909751|Trastuzumab|trastuzumab|mesh-list
13997802|NCT02909751|Epirubicin|epirubicin|mesh-list
13997803|NCT02909751|Pertuzumab|pertuzumab|mesh-list
13997804|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997805|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
15133567|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133568|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15133569|NCT04358367|Analgesics|analgesics|mesh-ancestor
15133570|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
15133571|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997806|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
13997807|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
14023483|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15133572|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15133573|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15133574|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15133575|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
15133576|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15133577|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133578|NCT04358341|Doxorubicin|doxorubicin|mesh-list
15133579|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15133580|NCT04358341|Fluorouracil|fluorouracil|mesh-list
15133581|NCT04358341|Irinotecan|irinotecan|mesh-list
15133582|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15133583|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133584|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15133585|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15133586|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133587|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133588|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
15133589|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133590|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133591|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
15133592|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133593|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15133594|NCT04358432|Ezetimibe|ezetimibe|mesh-list
15133595|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15133596|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15133597|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
15133598|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133599|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15133600|NCT04358354|Fluorouracil|fluorouracil|mesh-list
15133601|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
15133602|NCT04358354|Irinotecan|irinotecan|mesh-list
15133603|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
13997808|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997809|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997810|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
15133604|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133605|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133606|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133607|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133608|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
15133609|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133610|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15133611|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15133612|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133613|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
15133614|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
15133615|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133616|NCT04358497|Ibuprofen|ibuprofen|mesh-list
15133617|NCT04358497|Polidocanol|polidocanol|mesh-list
15133618|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15133619|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15133620|NCT04358497|Analgesics|analgesics|mesh-ancestor
15133621|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
15133622|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133623|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133624|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133625|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133626|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15133627|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133628|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133629|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15133630|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15133631|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
15133632|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15133633|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
15133634|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133635|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
15133636|NCT04358120|Protective Agents|protective agents|mesh-ancestor
15133637|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
15133638|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15133639|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
15133640|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133641|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
15133642|NCT04358055|Protective Agents|protective agents|mesh-ancestor
15133643|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
15133644|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133645|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
15133646|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15133647|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15133648|NCT04358016|Terlipressin|terlipressin|mesh-list
15133649|NCT04358016|Somatostatin|somatostatin|mesh-list
15133650|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15133651|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15133652|NCT04358016|Hormones|hormones|mesh-ancestor
15133653|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133654|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133655|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
15133656|NCT04357873|Vorinostat|vorinostat|mesh-list
15133657|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133658|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133659|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15133660|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133661|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133662|NCT04357522|Vaccines|vaccines|mesh-list
15133663|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15133664|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
15133665|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133666|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
15133667|NCT04357535|Giapreza|giapreza|mesh-list
15133668|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15133669|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
14561894|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561895|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561896|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561897|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14561898|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561899|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133670|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15133671|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15133672|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133673|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15133674|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15133675|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
15133676|NCT04357483|Thrombin|thrombin|mesh-list
15133677|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
15133678|NCT04357483|Coagulants|coagulants|mesh-ancestor
15133679|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15133680|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133681|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15133682|NCT04357392|Prednisone|prednisone|mesh-list
15133683|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133684|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133685|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
15133686|NCT04357392|Hormones|hormones|mesh-ancestor
15133687|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133688|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15133689|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133690|NCT04357093|Listerine|listerine|mesh-list
15133691|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
15133692|NCT04357093|Fluorides|fluorides|mesh-list
15133693|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
15133694|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
15133695|NCT04357093|Protective Agents|protective agents|mesh-ancestor
15133696|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133697|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15133698|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133699|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15133700|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133701|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
15133702|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133703|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
15133704|NCT04357002|Dinoprostone|dinoprostone|mesh-list
14561900|NCT00002816|Leucovorin|leucovorin|mesh-list
15133705|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14561901|NCT00002816|Cobalt|cobalt|mesh-list
14561902|NCT00002816|Cytarabine|cytarabine|mesh-list
14561903|NCT00002816|Dexamethasone|dexamethasone|mesh-list
14561904|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
15133706|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15133707|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133708|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
15133709|NCT04357002|Coagulants|coagulants|mesh-ancestor
15133710|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
15133711|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133712|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133713|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15133714|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
15133715|NCT04357015|Carbetocin|carbetocin|mesh-list
15133716|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15133717|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15133718|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133719|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
15133720|NCT04357015|Coagulants|coagulants|mesh-ancestor
15133721|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
15133722|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133723|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133724|NCT04356872|Doxorubicin|doxorubicin|mesh-list
15133725|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15133726|NCT04356872|Ifosfamide|ifosfamide|mesh-list
15133727|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561905|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14561906|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14561907|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15133728|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133729|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15133730|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15133731|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133732|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133733|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15133734|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
15133735|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
15133736|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
15133737|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15133738|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15133739|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133740|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133741|NCT04356716|Urological Agents|urological agents|mesh-ancestor
15133742|NCT04356729|Bevacizumab|bevacizumab|mesh-list
15133743|NCT04356729|Atezolizumab|atezolizumab|mesh-list
15133744|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133745|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133746|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15133747|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15133748|NCT04356729|Growth Substances|growth substances|mesh-ancestor
15133749|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133750|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
15133751|NCT04356508|Nivolumab|nivolumab|mesh-list
15133752|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133753|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133754|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15133755|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133756|NCT04356677|Ribavirin|ribavirin|mesh-list
15133757|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
15133758|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133759|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
15133760|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133761|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15133762|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
15133763|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15133764|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
15133765|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133766|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133767|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15133768|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15133769|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133770|NCT04356833|Plasminogen|plasminogen|mesh-list
15133771|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15133772|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15133773|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15133774|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023484|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561908|NCT00002816|Methotrexate|methotrexate|mesh-list
14561909|NCT00002816|Etoposide|etoposide|mesh-list
13997811|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997812|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13997813|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13997814|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
13997815|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13997816|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13997817|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13997818|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13997819|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13997820|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133775|NCT04356352|Lidocaine|lidocaine|mesh-list
15133776|NCT04356352|Esmolol|esmolol|mesh-list
15133777|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
15133778|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
15133779|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133780|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133781|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
13997821|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
13997822|NCT02909751|Protective Agents|protective agents|mesh-ancestor
13997823|NCT02909751|Vitamins|vitamins|mesh-ancestor
13997824|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
13997825|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
13997826|NCT02909712|Piperaquine|piperaquine|mesh-list
13997827|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
13997828|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
13997829|NCT02909712|Artenimol|artenimol|mesh-list
13997830|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
13997831|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13997832|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13997833|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997834|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13997835|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997836|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997837|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13997838|NCT02909712|Renal Agents|renal agents|mesh-ancestor
13997839|NCT02909465|Midazolam|midazolam|mesh-list
13997840|NCT02909465|Ketamine|ketamine|mesh-list
13997841|NCT02909465|Haloperidol|haloperidol|mesh-list
13997842|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
13997843|NCT02909465|Analgesics|analgesics|mesh-ancestor
13997844|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
13997845|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997846|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133782|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133783|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15133784|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15133785|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15133786|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13997847|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13997848|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13997849|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
13997850|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
13997851|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997852|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13997853|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13997854|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997855|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997856|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13997857|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13997858|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13997859|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13997860|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13997861|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
14561910|NCT00002816|Vincristine|vincristine|mesh-list
15133787|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133788|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15133789|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15133790|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15133791|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
15133792|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15133793|NCT04356417|Antimalarials|antimalarials|mesh-list
15133794|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15133795|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15133796|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133797|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15133798|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15133799|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15133800|NCT04356222|Methotrexate|methotrexate|mesh-list
15133801|NCT04356222|Durvalumab|durvalumab|mesh-list
15133802|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15133803|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
15133804|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133805|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133806|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133807|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
15133808|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133809|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133810|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
15133811|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133812|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15133813|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133814|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
15133815|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133816|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15133817|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15133818|NCT04356144|Thrombin|thrombin|mesh-list
15133819|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
15133820|NCT04356144|Coagulants|coagulants|mesh-ancestor
15133821|NCT04356118|Methotrexate|methotrexate|mesh-list
15133822|NCT04356118|Endostatins|endostatins|mesh-list
15133823|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15133824|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
15133825|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15133826|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133827|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133828|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
15133829|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133830|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133831|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
15133832|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133833|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15133834|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133835|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
15133836|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133837|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15133838|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15133839|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15133840|NCT04356118|Growth Substances|growth substances|mesh-ancestor
15133841|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
15133842|NCT04356170|Docetaxel|docetaxel|mesh-list
15133843|NCT04356170|Fluorouracil|fluorouracil|mesh-list
15133844|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133845|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
15133846|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
15133847|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
15133848|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133849|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
15133850|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15133851|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133852|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
15133853|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133854|NCT04355845|Sumatriptan|sumatriptan|mesh-list
15133855|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15133856|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15133857|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15133858|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
15133859|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15133860|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133861|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133862|NCT04355962|Sevoflurane|sevoflurane|mesh-list
15133863|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15133864|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15133865|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
15133866|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
15133867|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133868|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133869|NCT04355949|Vitamin D|vitamin d|mesh-list
15133870|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
15133871|NCT04355949|Vitamins|vitamins|mesh-list
15133872|NCT04355949|Folic Acid|folic acid|mesh-list
15133873|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
15133874|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
15133875|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
13997862|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
15133876|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
15182031|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133877|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133878|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15133879|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15133880|NCT04355949|Hematinics|hematinics|mesh-ancestor
15133881|NCT04355936|Telmisartan|telmisartan|mesh-list
15133882|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15133883|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15133884|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15133885|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133886|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15133887|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15133888|NCT04355806|Vaccines|vaccines|mesh-list
15133889|NCT04355806|Antibodies|antibodies|mesh-list
15133890|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
15133891|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15133892|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
15133893|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133894|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133895|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133896|NCT04355598|Lidocaine|lidocaine|mesh-list
15133897|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
15133898|NCT04355598|Prilocaine|prilocaine|mesh-list
15133899|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15133900|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
15133901|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
15133902|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133903|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133904|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
15133905|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133906|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15133907|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15133908|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15133909|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15133910|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133911|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
15133912|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15133913|NCT04355637|Budesonide|budesonide|mesh-list
15133914|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133915|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15133916|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
15133917|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133918|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133919|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15133920|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
15133921|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
15133922|NCT04355637|Hormones|hormones|mesh-ancestor
15133923|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133924|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
15133925|NCT04355468|Anesthetics|anesthetics|mesh-list
15133926|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15133927|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133928|NCT04355468|Narcotics|narcotics|mesh-ancestor
15133929|NCT04355468|Analgesics|analgesics|mesh-ancestor
15133930|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
15133931|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133932|NCT04355416|Curcumin|curcumin|mesh-list
15133933|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15133934|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15133935|NCT04355416|Analgesics|analgesics|mesh-ancestor
15133936|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
15133937|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133938|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133939|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133940|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15133941|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133942|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15133943|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133944|NCT04355494|Eculizumab|eculizumab|mesh-list
15133945|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15133946|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15133947|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
15133948|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133949|NCT04355520|Fulvestrant|fulvestrant|mesh-list
15133950|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15133951|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133952|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15133953|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15133954|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
15133955|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133956|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133957|NCT04355273|Heparin|heparin|mesh-list
15133958|NCT04355273|Calcium heparin|calcium heparin|mesh-list
15133959|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
15133960|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15133961|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15133962|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133963|NCT04355429|Captopril|captopril|mesh-list
15133964|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15133965|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
15133966|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270075|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14270076|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14270077|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270078|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14270079|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270080|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270081|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
14270082|NCT00407550|Gemcitabine|gemcitabine|mesh-list
15133967|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133968|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15133969|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
15133970|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15133971|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15133972|NCT04355247|Prednisolone|prednisolone|mesh-list
15133973|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
15133974|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15133975|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
15133976|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15133977|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
15133978|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
15133979|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15133980|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133981|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15133982|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
15133983|NCT04355247|Hormones|hormones|mesh-ancestor
15133984|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15133985|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15133986|NCT04355247|Protective Agents|protective agents|mesh-ancestor
15133987|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15133988|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15133989|NCT04355455|Citalopram|citalopram|mesh-list
15133990|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15133991|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15133992|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15133993|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15133994|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15133995|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
15133996|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15133997|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15133998|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
15133999|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15134000|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134001|NCT04355026|Bromhexine|bromhexine|mesh-list
15134002|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
15134003|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134004|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134005|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134006|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134007|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134008|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134009|NCT04355026|Expectorants|expectorants|mesh-ancestor
15134010|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
15134011|NCT04355052|Azithromycin|azithromycin|mesh-list
15134012|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134013|NCT04355052|Camostat|camostat|mesh-list
15134014|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134015|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134016|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
15134017|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134018|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134019|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134020|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134021|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134022|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134023|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15134024|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15134025|NCT04354961|Paclitaxel|paclitaxel|mesh-list
15134026|NCT04354961|Carboplatin|carboplatin|mesh-list
15134027|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15134028|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134029|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
15134030|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
15134031|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
15134032|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134033|NCT04355039|Dexamethasone|dexamethasone|mesh-list
15134034|NCT04355039|Pomalidomide|pomalidomide|mesh-list
15134035|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134036|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
15134037|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
15134038|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134039|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134040|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134041|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
15134042|NCT04355039|Hormones|hormones|mesh-ancestor
15134043|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134044|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134045|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134046|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
15134047|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15134048|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15134049|NCT04355039|Growth Substances|growth substances|mesh-ancestor
15134050|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
15134051|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
15134052|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
15134053|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
15134054|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134055|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134056|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134057|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15134058|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15134059|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134060|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15134061|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15134062|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
15134063|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134064|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134065|NCT04355156|Axitinib|axitinib|mesh-list
15134066|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134067|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15134068|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134069|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134070|NCT04354662|Leucovorin|leucovorin|mesh-list
15134071|NCT04354662|Docetaxel|docetaxel|mesh-list
15134072|NCT04354662|Fluorouracil|fluorouracil|mesh-list
15134073|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
15134074|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134075|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
15134076|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
15134077|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
15134078|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134079|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
15134080|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15134081|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15134082|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
15134083|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134084|NCT04354662|Antidotes|antidotes|mesh-ancestor
15134085|NCT04354662|Protective Agents|protective agents|mesh-ancestor
15134086|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
15134087|NCT04354662|Vitamins|vitamins|mesh-ancestor
15134088|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
15134089|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134090|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
15134091|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134092|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134093|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134094|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134095|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134096|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178859|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15178860|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
14270083|NCT00407550|Pemetrexed|pemetrexed|mesh-list
15134097|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15134098|NCT04354545|Lifitegrast|lifitegrast|mesh-list
15134099|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15134100|NCT04354350|Telmisartan|telmisartan|mesh-list
15134101|NCT04354350|Ramipril|ramipril|mesh-list
15134102|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15134103|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15134104|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15134105|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134106|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15134107|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134108|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134109|NCT04354428|Folic Acid|folic acid|mesh-list
15134110|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
15134111|NCT04354428|Ritonavir|ritonavir|mesh-list
15134112|NCT04354428|Lopinavir|lopinavir|mesh-list
15134113|NCT04354428|Azithromycin|azithromycin|mesh-list
15134114|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134115|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15134116|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15134117|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134118|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134119|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134120|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15134121|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15134122|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
15134123|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134124|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14270084|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270085|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
14270086|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270087|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134125|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134126|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134127|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
15134128|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134129|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134130|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134131|NCT04354428|Hematinics|hematinics|mesh-ancestor
15134132|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
15134133|NCT04354428|Vitamins|vitamins|mesh-ancestor
15134134|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
15134135|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134136|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
15134137|NCT04354428|Protective Agents|protective agents|mesh-ancestor
15134138|NCT04354376|Telmisartan|telmisartan|mesh-list
15134139|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
15134140|NCT04354376|Diuretics|diuretics|mesh-list
15134141|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
15134142|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
15134143|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15134144|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15134145|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15134146|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134147|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
15134148|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134149|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15134150|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15134151|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14561911|NCT00002816|Asparaginase|asparaginase|mesh-list
14561912|NCT00002816|Ifosfamide|ifosfamide|mesh-list
14561913|NCT00002816|Idarubicin|idarubicin|mesh-list
14561914|NCT00002816|Pegaspargase|pegaspargase|mesh-list
14561915|NCT00002816|Thioguanine|thioguanine|mesh-list
14561916|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
14561917|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14561918|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
14561919|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
14561920|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561921|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561922|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14561923|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
14561924|NCT00002816|Hormones|hormones|mesh-ancestor
14561925|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134152|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
15134153|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
15134154|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134155|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
15134156|NCT04353986|Ledipasvir|ledipasvir|mesh-list
15134157|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15134158|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
15134159|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134160|NCT04353817|Ivacaftor|ivacaftor|mesh-list
15134161|NCT04353817|Elexacaftor|elexacaftor|mesh-list
15134162|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15134163|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15134164|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134165|NCT04353505|Dexamethasone|dexamethasone|mesh-list
15134166|NCT04353505|Ketorolac|ketorolac|mesh-list
15134167|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134168|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
15134169|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
15134170|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134171|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134172|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134173|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
15134174|NCT04353505|Hormones|hormones|mesh-ancestor
15134175|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134176|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134177|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134178|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15134179|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15134180|NCT04353505|Analgesics|analgesics|mesh-ancestor
15134181|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
15134182|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134183|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14561926|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14561927|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134184|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270088|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
15134185|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134186|NCT04353479|Decitabine|decitabine|mesh-list
15134187|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15134188|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15134189|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
15134190|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134191|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134192|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134193|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15134194|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15134195|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134196|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134197|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134198|NCT04353362|Amoxicillin|amoxicillin|mesh-list
15134199|NCT04353362|Metronidazole|metronidazole|mesh-list
15134200|NCT04353362|Ofloxacin|ofloxacin|mesh-list
15134201|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134202|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134203|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134204|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134205|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15134206|NCT04353362|Renal Agents|renal agents|mesh-ancestor
15134207|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15134208|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15134209|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134210|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134211|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134212|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15134213|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134214|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15134215|NCT04353713|Laxatives|laxatives|mesh-ancestor
15134216|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134217|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134218|NCT04353336|Chloroquine|chloroquine|mesh-list
15134219|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15134220|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
15134221|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134222|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134223|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134224|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134225|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134226|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134227|NCT04353336|Amebicides|amebicides|mesh-ancestor
15134228|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15134229|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15134230|NCT04353336|Analgesics|analgesics|mesh-ancestor
15134231|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
15134232|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134233|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134234|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134235|NCT04353336|Filaricides|filaricides|mesh-ancestor
15134236|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
15134237|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
15134238|NCT04352959|Betadex|betadex|mesh-list
15134239|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
15134240|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134241|NCT04353180|Tretinoin|tretinoin|mesh-list
15134242|NCT04353180|Isotretinoin|isotretinoin|mesh-list
15134243|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134244|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
15134245|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
15134246|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
13997863|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
13997864|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
13997865|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997866|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15134247|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
15134248|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134249|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15134250|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15134251|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
13997867|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13997868|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
13997869|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13997870|NCT02909413|Sevoflurane|sevoflurane|mesh-list
13997871|NCT02909413|Desflurane|desflurane|mesh-list
13997872|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13997873|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15134252|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134253|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134254|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15134255|NCT04353193|Octreotide|octreotide|mesh-list
15134256|NCT04353193|Terlipressin|terlipressin|mesh-list
15134257|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134258|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134259|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134260|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15134261|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15134262|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134263|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
15134264|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134265|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134266|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134267|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134268|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134269|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134270|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134271|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
15134272|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134273|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134274|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134275|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134276|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134277|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134278|NCT04352855|Tazobactam|tazobactam|mesh-list
15134279|NCT04352855|Ceftolozane|ceftolozane|mesh-list
15134280|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
15134281|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134282|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134283|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15134284|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134285|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134286|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15134287|NCT04352855|Renal Agents|renal agents|mesh-ancestor
15134288|NCT04352777|Fulvestrant|fulvestrant|mesh-list
15134289|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15134290|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134291|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134292|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15134293|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15134294|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
15134295|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134296|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134297|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15134298|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134299|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134300|NCT04352686|Buspirone|buspirone|mesh-list
15134301|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15134302|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15134303|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134304|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134305|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15134306|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15134307|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
15134308|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134309|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134310|NCT04352621|Ketamine|ketamine|mesh-list
15134311|NCT04352621|Analgesics|analgesics|mesh-ancestor
15134312|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
15134313|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134314|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134315|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15134316|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15134317|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
15134318|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
15134319|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134320|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15134321|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15134322|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134323|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178861|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178862|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
15178863|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15178864|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
15178865|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178866|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
15178867|NCT03955497|Protective Agents|protective agents|mesh-ancestor
15178868|NCT03954990|Metronidazole|metronidazole|mesh-list
15178869|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178870|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15178871|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15178872|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15178873|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
15178874|NCT03954964|Narcotics|narcotics|mesh-ancestor
15178875|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178876|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178877|NCT03954964|Analgesics|analgesics|mesh-ancestor
15178878|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
15178879|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178880|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
15178881|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15178882|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15178883|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178884|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
15178885|NCT03954860|Coagulants|coagulants|mesh-ancestor
15178886|NCT03954873|Glucagon|glucagon|mesh-list
15178887|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15178888|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178889|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178890|NCT03954873|Hormones|hormones|mesh-ancestor
15134324|NCT04352400|Nafamostat|nafamostat|mesh-list
15134325|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15134326|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15134327|NCT04352400|Analgesics|analgesics|mesh-ancestor
15134328|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
15134329|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134330|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134331|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134332|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134333|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
15134334|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134335|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134336|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134337|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15134338|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15134339|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15134340|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15134341|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
15134342|NCT04352153|Febuxostat|febuxostat|mesh-list
15134343|NCT04352153|Citric Acid|citric acid|mesh-list
15134344|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
15134345|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15134346|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
15134347|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
15134348|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134349|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
15134350|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134351|NCT04352205|Thalidomide|thalidomide|mesh-list
15134352|NCT04352205|Dexamethasone|dexamethasone|mesh-list
15134353|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
15134354|NCT04352205|Lenalidomide|lenalidomide|mesh-list
15134355|NCT04352205|Bortezomib|bortezomib|mesh-list
15134356|NCT04352205|Daratumumab|daratumumab|mesh-list
15134357|NCT04352205|Ichthammol|ichthammol|mesh-list
15134358|NCT04352205|BB 1101|bb 1101|mesh-list
15134359|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134360|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
15134361|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
14270089|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270090|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134362|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134363|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134364|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134365|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
15134366|NCT04352205|Hormones|hormones|mesh-ancestor
15134367|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134368|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134369|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134370|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134371|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134372|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134373|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
15134374|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15134375|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15134376|NCT04352205|Growth Substances|growth substances|mesh-ancestor
15134377|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
15134378|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997874|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
13997875|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
13997876|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997877|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997878|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
13997879|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
13997880|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997881|NCT02909400|Protective Agents|protective agents|mesh-ancestor
15134379|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
15134380|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134381|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134382|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
15134383|NCT04352465|Methotrexate|methotrexate|mesh-list
15134384|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15134385|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
13997882|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997883|NCT02909257|Bupivacaine|bupivacaine|mesh-list
13997884|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
13997885|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
13997886|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997887|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997888|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
13997889|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023485|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14023486|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
14023487|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14023488|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
14023489|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023490|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14023491|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14023492|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14023493|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14023494|NCT02762123|Protective Agents|protective agents|mesh-ancestor
14023495|NCT02762123|Analgesics|analgesics|mesh-ancestor
14023496|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
14023497|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023498|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14023499|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14023500|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023501|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023502|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14026154|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026155|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026156|NCT02744638|Metronidazole|metronidazole|mesh-list
14026157|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026158|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14026159|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134386|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15134387|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134388|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15134389|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
15134390|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134391|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134392|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
15134393|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134394|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15134395|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15134396|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
14026160|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14026161|NCT02744937|Aspirin|aspirin|mesh-list
14026162|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14026163|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14026164|NCT02744937|Analgesics|analgesics|mesh-ancestor
14026165|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
14026166|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026167|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026168|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14026169|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026170|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14026171|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14026172|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026173|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14026174|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14026175|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026176|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
14026177|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14026178|NCT02744625|Propofol|propofol|mesh-list
14026179|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14026180|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026181|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026182|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14026183|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
14026184|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
14026185|NCT02744417|Bupropion|bupropion|mesh-list
15134397|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134398|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15134399|NCT04351724|Ritonavir|ritonavir|mesh-list
15134400|NCT04351724|Lopinavir|lopinavir|mesh-list
15134401|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134402|NCT04351724|Chloroquine|chloroquine|mesh-list
15134403|NCT04351724|Remdesivir|remdesivir|mesh-list
15134404|NCT04351724|Candesartan|candesartan|mesh-list
15134405|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
15134406|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
15134407|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15134408|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15134409|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134410|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182032|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14270091|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270092|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
14270093|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270094|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14270095|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14270096|NCT00407563|Paclitaxel|paclitaxel|mesh-list
14270097|NCT00407563|Bevacizumab|bevacizumab|mesh-list
13997890|NCT02909478|Dexamethasone|dexamethasone|mesh-list
13997891|NCT02909478|Aprepitant|aprepitant|mesh-list
13997892|NCT02909478|Tropisetron|tropisetron|mesh-list
13997893|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997894|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
13997895|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
13997896|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134411|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134412|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15134413|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15134414|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
15134415|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134416|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15134417|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134418|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
15134419|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134420|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134421|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134422|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15134423|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
15134424|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15134425|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
15134426|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15134427|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15134428|NCT04351724|Amebicides|amebicides|mesh-ancestor
15134429|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
15134430|NCT04351763|Amiodarone|amiodarone|mesh-list
15134431|NCT04351763|Verapamil|verapamil|mesh-list
15134432|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15134433|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
15134434|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15134435|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15134436|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134437|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13997897|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997898|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997899|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
13997900|NCT02909478|Hormones|hormones|mesh-ancestor
13997901|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997902|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13997903|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997904|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13997905|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997906|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997907|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13997908|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13997909|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
13997910|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
13997911|NCT02909335|Prednisone|prednisone|mesh-list
13997912|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
13997913|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13997914|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13997915|NCT02909335|Prednisolone|prednisolone|mesh-list
13997916|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
13997917|NCT02909335|Everolimus|everolimus|mesh-list
13997918|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13997919|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
13997920|NCT02909335|Tacrolimus|tacrolimus|mesh-list
13997921|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13997922|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
13997923|NCT02909335|Hormones|hormones|mesh-ancestor
15134438|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14270098|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14270099|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14270100|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270101|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14270102|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14270103|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561928|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15134439|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134440|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134441|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15134442|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15134443|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15134444|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15134445|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15134446|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134447|NCT04352062|Amoxicillin|amoxicillin|mesh-list
15134448|NCT04352062|Levofloxacin|levofloxacin|mesh-list
15134449|NCT04352062|Ofloxacin|ofloxacin|mesh-list
15134450|NCT04352062|Melatonin|melatonin|mesh-list
15134451|NCT04352062|Pantoprazole|pantoprazole|mesh-list
15134452|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134453|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134454|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
15134455|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134456|NCT04352062|Protective Agents|protective agents|mesh-ancestor
15134457|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561929|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
14561930|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14561931|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561932|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
14561933|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561934|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561935|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561936|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14561937|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561938|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
14561939|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561940|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14561941|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561942|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561943|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561944|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
14561945|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561946|NCT00002816|Antidotes|antidotes|mesh-ancestor
14561947|NCT00002816|Protective Agents|protective agents|mesh-ancestor
14561948|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
14561949|NCT00002816|Vitamins|vitamins|mesh-ancestor
14561950|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
14561951|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561952|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561953|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
14561954|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561955|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
14561956|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14561957|NCT00002816|Trace Elements|trace elements|mesh-ancestor
14561958|NCT00002817|Sargramostim|sargramostim|mesh-list
14561959|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
14561960|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561961|NCT00002818|Cytarabine|cytarabine|mesh-list
14561962|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14561963|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
14561964|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561965|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14561966|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
14561967|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14561968|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14561969|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
14561970|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134458|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134459|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15134460|NCT04352062|Renal Agents|renal agents|mesh-ancestor
15134461|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15134462|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15134463|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134464|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134465|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15134466|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134467|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15134468|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134469|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15134470|NCT04351919|Azithromycin|azithromycin|mesh-list
15134471|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134472|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134473|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134474|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
14023503|NCT02761512|Lansoprazole|lansoprazole|mesh-list
15134475|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134476|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134477|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134478|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134479|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134480|NCT04351867|Docetaxel|docetaxel|mesh-list
15134481|NCT04351867|Capecitabine|capecitabine|mesh-list
15134482|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
15134483|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134484|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
15134485|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
15134486|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
15134487|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134488|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15134489|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
15134490|NCT04351737|Dexamethasone|dexamethasone|mesh-list
15134491|NCT04351737|Prednisolone|prednisolone|mesh-list
15134492|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15134493|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
15134494|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15134495|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
15134496|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15134497|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
15134498|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134499|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
15134500|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
15134501|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134502|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134503|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134504|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
15134505|NCT04351737|Hormones|hormones|mesh-ancestor
15134506|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134507|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134508|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997924|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13997925|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997926|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13997927|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997928|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13997929|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
13997930|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13997931|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997932|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997933|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13997934|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13997935|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
13997936|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13997937|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13997938|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
13997939|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
13997940|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997941|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997942|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15134509|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15134510|NCT04351737|Protective Agents|protective agents|mesh-ancestor
15134511|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134512|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
15134513|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134514|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134515|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134516|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134517|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134518|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134519|NCT04351412|Fluorides|fluorides|mesh-list
15134520|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
15134521|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
15134522|NCT04351412|Protective Agents|protective agents|mesh-ancestor
15134523|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134524|NCT04351594|Menthol|menthol|mesh-list
15134525|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
15134526|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
15134527|NCT04351347|Ivermectin|ivermectin|mesh-list
15134528|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134529|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134530|NCT04351308|Apatinib|apatinib|mesh-list
15134531|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134532|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15134533|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134534|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134535|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134536|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
13997943|NCT02909335|Protective Agents|protective agents|mesh-ancestor
13997944|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
15134537|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14023504|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
15134538|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134539|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134540|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134541|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134542|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134543|NCT04351256|Durvalumab|durvalumab|mesh-list
15134544|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15134545|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134546|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
15134547|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15134548|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134549|NCT04351490|Vitamins|vitamins|mesh-ancestor
15134550|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
15134551|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15134552|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134553|NCT04351191|Chloroquine|chloroquine|mesh-list
15134554|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
15134555|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134556|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134557|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134558|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134559|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134560|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134561|NCT04351191|Amebicides|amebicides|mesh-ancestor
15134562|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15134563|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134564|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023505|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15134565|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561971|NCT00002819|Paclitaxel|paclitaxel|mesh-list
15134566|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
15134567|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15134568|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
15134569|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134570|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
15134571|NCT04351126|Bromocriptine|bromocriptine|mesh-list
15134572|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15134573|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14561972|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
14561973|NCT00002819|Carboplatin|carboplatin|mesh-list
13997945|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13997946|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997947|NCT02908945|Ketamine|ketamine|mesh-list
13997948|NCT02908945|Analgesics|analgesics|mesh-ancestor
13997949|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
13997950|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997951|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997952|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13997953|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13997954|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
13997955|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
13997956|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13997957|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13997958|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13997959|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13997960|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997961|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13997962|NCT05312762|Chitosan|chitosan|mesh-list
13997963|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13997964|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13997965|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
13997966|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997967|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13997968|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
13997969|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
13997970|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
15134574|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
15134575|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134576|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134577|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
15134578|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
15134579|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134580|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134581|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134582|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
15134583|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134584|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
15134585|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15134586|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15134587|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134588|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
15134589|NCT04350645|Coagulants|coagulants|mesh-ancestor
15134590|NCT04350320|Colchicine|colchicine|mesh-list
15134591|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
15134592|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134593|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
15134594|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
15134595|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
15134596|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134597|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178891|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178892|NCT03954873|Incretins|incretins|mesh-ancestor
15178893|NCT03954639|Bupivacaine|bupivacaine|mesh-list
15178894|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
15178895|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
15178896|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178897|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178898|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
15178899|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997971|NCT05312762|Coagulants|coagulants|mesh-ancestor
13997972|NCT05312762|Laxatives|laxatives|mesh-ancestor
14270104|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270105|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15178900|NCT03954366|Rucaparib|rucaparib|mesh-list
15178901|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13997973|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13997974|NCT05312671|Cisplatin|cisplatin|mesh-list
13997975|NCT05312671|Carboplatin|carboplatin|mesh-list
13997976|NCT05312671|Etoposide|etoposide|mesh-list
13997977|NCT05312671|Atezolizumab|atezolizumab|mesh-list
13997978|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
13997979|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13997980|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13997981|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14026186|NCT02744417|Nicotine|nicotine|mesh-list
14270106|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14561974|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
15134598|NCT04350528|Pentobarbital|pentobarbital|mesh-list
15134599|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
15134600|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
15134601|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
15134602|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134603|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134604|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134605|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15134606|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15134607|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134608|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15134609|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15134610|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
15134611|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134612|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134613|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15134614|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15134615|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
13997982|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13997983|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13997984|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13997985|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
13997986|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
13997987|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
13997988|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
13997989|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
13997990|NCT05312645|Diclofenac|diclofenac|mesh-list
13997991|NCT05312645|Petrolatum|petrolatum|mesh-list
13997992|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13997993|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13997994|NCT05312645|Analgesics|analgesics|mesh-ancestor
13997995|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
13997996|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13997997|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13997998|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134616|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
15134617|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
15134618|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15134619|NCT04350580|Antibodies|antibodies|mesh-list
15134620|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
15134621|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134622|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15134623|NCT04350502|Amoxicillin|amoxicillin|mesh-list
15134624|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
15134625|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
13997999|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13998000|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13998001|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998002|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998003|NCT05312645|Emollients|emollients|mesh-ancestor
13998004|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
13998005|NCT05312541|Bupivacaine|bupivacaine|mesh-list
15134626|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15134627|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134628|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134629|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134630|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15134631|NCT04350684|Interferons|interferons|mesh-list
15134632|NCT04350684|Ritonavir|ritonavir|mesh-list
15134633|NCT04350684|Lopinavir|lopinavir|mesh-list
15134634|NCT04350684|Interferon-beta|interferon-beta|mesh-list
15134635|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
15134636|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134637|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134638|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
15134639|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998006|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
13998007|NCT05312541|Anesthetics|anesthetics|mesh-list
13998008|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998009|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998010|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
13998011|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998012|NCT05312398|Irinotecan|irinotecan|mesh-list
13998013|NCT05312398|Cetuximab|cetuximab|mesh-list
13998014|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13998015|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13998016|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998017|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998018|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134640|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13998019|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15134641|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15134642|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134643|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134644|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134645|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15134646|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15134647|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15134648|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134649|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
15134650|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134651|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134652|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134653|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
13998029|NCT05312372|Paclitaxel|paclitaxel|mesh-list
13998030|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13998031|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998032|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
13998033|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
13998034|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
13998035|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998036|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
13998037|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
13998038|NCT05312346|Hematinics|hematinics|mesh-ancestor
13998039|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
13998040|NCT05312346|Vitamins|vitamins|mesh-ancestor
13998041|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
13998042|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998043|NCT05312294|Vaccines|vaccines|mesh-list
13998044|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
13998045|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998046|NCT05312268|Rasburicase|rasburicase|mesh-list
13998047|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
13998048|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270107|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270108|NCT00407563|Growth Substances|growth substances|mesh-ancestor
14270109|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270110|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270111|NCT00407654|Aflibercept|aflibercept|mesh-list
14270112|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
14270113|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270114|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270115|NCT00407654|Growth Substances|growth substances|mesh-ancestor
14270116|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998059|NCT05312242|Folic Acid|folic acid|mesh-list
13998060|NCT05312242|Micronutrients|micronutrients|mesh-list
13998061|NCT05312242|Trace Elements|trace elements|mesh-list
13998062|NCT05312242|Hematinics|hematinics|mesh-ancestor
13998063|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
13998064|NCT05312242|Vitamins|vitamins|mesh-ancestor
13998065|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998066|NCT05312216|Durvalumab|durvalumab|mesh-list
13998067|NCT05312216|Lenvatinib|lenvatinib|mesh-list
13998068|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998069|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998070|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998071|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998072|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998073|NCT05312190|Progesterone|progesterone|mesh-list
13998074|NCT05312190|Progestins|progestins|mesh-ancestor
13998075|NCT05312190|Hormones|hormones|mesh-ancestor
13998076|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998077|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998078|NCT05312151|Psilocybin|psilocybin|mesh-list
13998079|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
13998080|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998081|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998082|NCT05312112|Venetoclax|venetoclax|mesh-list
13998083|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998084|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
13998085|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13998086|NCT05312008|Oxytocin|oxytocin|mesh-list
13998087|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
13998088|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13998089|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998090|NCT05311852|Palmidrol|palmidrol|mesh-list
13998091|NCT05311852|Antioxidants|antioxidants|mesh-list
13998092|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998093|NCT05311852|Protective Agents|protective agents|mesh-ancestor
13998094|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998095|NCT05311852|Analgesics|analgesics|mesh-ancestor
13998096|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
13998097|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998098|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15134654|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134655|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15134656|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
13998099|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13998100|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998101|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13998102|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
13998103|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998104|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13998105|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13998106|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998107|NCT05311852|Hormones|hormones|mesh-ancestor
13998108|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998109|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13998110|NCT05311774|Tramadol|tramadol|mesh-list
13998111|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13998112|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13998113|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13998114|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998115|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998116|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998117|NCT05311774|Analgesics|analgesics|mesh-ancestor
15134657|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
15134658|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134659|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134660|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134661|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134662|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134663|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134664|NCT04350671|Interferons|interferons|mesh-list
15134665|NCT04350671|Ritonavir|ritonavir|mesh-list
15134666|NCT04350671|Lopinavir|lopinavir|mesh-list
15134667|NCT04350671|Interferon-beta|interferon-beta|mesh-list
15134668|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
15134669|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134670|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998118|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
13998119|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998120|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
13998121|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998122|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
13998123|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13998124|NCT05311774|Narcotics|narcotics|mesh-ancestor
13998125|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998126|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
15134671|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
15134672|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134673|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15134674|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15134675|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
15134676|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134677|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134678|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15134679|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15134680|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13998127|NCT05311722|Ketamine|ketamine|mesh-list
13998128|NCT05311722|Tramadol|tramadol|mesh-list
13998129|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13998130|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998131|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998132|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13998133|NCT05311722|Analgesics|analgesics|mesh-ancestor
13998134|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
13998135|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998136|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13998137|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13998138|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13998139|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
13998140|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998141|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998142|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13998143|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998144|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
15134681|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134682|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
13998145|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
13998146|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13998147|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13998148|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13998149|NCT05311722|Narcotics|narcotics|mesh-ancestor
13998150|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
13998151|NCT05311540|Astringents|astringents|mesh-ancestor
13998152|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998153|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
13998154|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13998155|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13998156|NCT05311436|Iron|iron|mesh-list
13998157|NCT05311436|Folic Acid|folic acid|mesh-list
13998158|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998159|NCT05311436|Trace Elements|trace elements|mesh-ancestor
13998160|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
13998161|NCT05311436|Hematinics|hematinics|mesh-ancestor
13998162|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
13998163|NCT05311436|Vitamins|vitamins|mesh-ancestor
14023506|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023507|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14023508|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023509|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023510|NCT02761486|Aspirin|aspirin|mesh-list
14023511|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14023512|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14023513|NCT02761486|Analgesics|analgesics|mesh-ancestor
14023514|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
14023515|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023516|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023517|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023518|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023519|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15134683|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134684|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14023520|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14023521|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023522|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14023523|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14023524|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023525|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
14023526|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
14023527|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14023528|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
14023529|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023530|NCT02761577|Expectorants|expectorants|mesh-ancestor
14023531|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
14023532|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14023533|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
14023534|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023535|NCT02761577|Protective Agents|protective agents|mesh-ancestor
14023536|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023537|NCT02761577|Antidotes|antidotes|mesh-ancestor
14023538|NCT02761161|Mianserin|mianserin|mesh-list
14023539|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14023540|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14023541|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
14023542|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023543|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023544|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023545|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14023546|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
14023547|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
14023548|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14023549|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
14023550|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14023551|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
14023552|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14023553|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14023554|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14023555|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14023556|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14023557|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14023558|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
14023559|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023560|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026187|NCT02744417|Varenicline|varenicline|mesh-list
13998164|NCT05311254|Fosfomycin|fosfomycin|mesh-list
13998165|NCT05311254|Calcium|calcium|mesh-list
13998166|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13998167|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998168|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13998169|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998170|NCT05311228|Azithromycin|azithromycin|mesh-list
13998171|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13998172|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998173|NCT05311189|Trastuzumab|trastuzumab|mesh-list
13998174|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998175|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134685|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134686|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
13998176|NCT05311085|Nicotine|nicotine|mesh-list
13998177|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13998178|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
13998179|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998180|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998181|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13998182|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13998183|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
13998184|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134687|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134688|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15134689|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
15134690|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15134691|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134692|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134693|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15134694|NCT04350086|Analgesics|analgesics|mesh-ancestor
15134695|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
15134696|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134697|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15134698|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15134699|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15134700|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
15134701|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134702|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134703|NCT04350190|Apatinib|apatinib|mesh-list
15134704|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134705|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15134706|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998185|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998186|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
13998187|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13998188|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13998189|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998190|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
13998191|NCT05311033|Coagulants|coagulants|mesh-ancestor
13998192|NCT05310929|Labetalol|labetalol|mesh-list
13998193|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
13998194|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
13998195|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13998196|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13998197|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
13998198|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998199|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998200|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134707|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134708|NCT04350281|Interferons|interferons|mesh-list
15134709|NCT04350281|Interferon-beta|interferon-beta|mesh-list
15134710|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134711|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
15134712|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134713|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
15134714|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134715|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
15134716|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13998201|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13998202|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
13998203|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
15134717|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134718|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134719|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134720|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13998204|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998205|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13998206|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15134721|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
15134722|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134723|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15134724|NCT04349930|Cannabidiol|cannabidiol|mesh-list
15134725|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
13998212|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
13998213|NCT05310786|Narcotics|narcotics|mesh-ancestor
13998214|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998215|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998216|NCT05310786|Analgesics|analgesics|mesh-ancestor
13998217|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
13998218|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998219|NCT05310643|Nivolumab|nivolumab|mesh-list
13998220|NCT05310643|Ipilimumab|ipilimumab|mesh-list
13998221|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998222|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998223|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13998224|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998225|NCT05310591|Nivolumab|nivolumab|mesh-list
13998226|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998227|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998228|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13998229|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998230|NCT05303727|Cyclosporine|cyclosporine|mesh-list
13998231|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
13998232|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
13998233|NCT05303727|Melphalan|melphalan|mesh-list
13998234|NCT05303727|Busulfan|busulfan|mesh-list
13998235|NCT05303727|Thiotepa|thiotepa|mesh-list
13998236|NCT05303727|Methotrexate|methotrexate|mesh-list
13998237|NCT05303727|Fludarabine|fludarabine|mesh-list
13998238|NCT05303727|Topotecan|topotecan|mesh-list
13998239|NCT05303727|Tacrolimus|tacrolimus|mesh-list
15134726|NCT04349592|Azithromycin|azithromycin|mesh-list
15134727|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
13998240|NCT05303727|Cyclosporins|cyclosporins|mesh-list
13998241|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13998242|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13998243|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
13998244|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998245|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13998246|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13998247|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
13998248|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998249|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998250|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13998251|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13998252|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
13998253|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13998254|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13998255|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
13998256|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
13998257|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998258|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13998259|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13998260|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13998261|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
13998262|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998263|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13998264|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13998265|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
13998266|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13998267|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13998268|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13998269|NCT05299008|Bethanechol|bethanechol|mesh-list
13998270|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13998271|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
13998272|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998273|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998274|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13998275|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13998276|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
14270117|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
15134728|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13998277|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998278|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998279|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
13998280|NCT05296512|Lenvatinib|lenvatinib|mesh-list
13998281|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998282|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998283|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998284|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998285|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998286|NCT05296278|Lenvatinib|lenvatinib|mesh-list
13998287|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998288|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998289|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998290|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998291|NCT05296213|Calcium|calcium|mesh-list
13998292|NCT05296213|Fluorides|fluorides|mesh-list
13998293|NCT05296213|Caseins|caseins|mesh-list
13998294|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13998295|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998296|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
13998297|NCT05296213|Protective Agents|protective agents|mesh-ancestor
13998298|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
13998299|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
13998300|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998301|NCT05289830|Citalopram|citalopram|mesh-list
13998302|NCT05289830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13998303|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13998304|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13998305|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998306|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998307|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
13998308|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998309|NCT05289830|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13998310|NCT05289830|Antidepressive Agents|antidepressive agents|mesh-ancestor
13998311|NCT05289830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998312|NCT05289193|Nivolumab|nivolumab|mesh-list
13998313|NCT05289193|Ipilimumab|ipilimumab|mesh-list
13998314|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998315|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998316|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13998317|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998318|NCT05287568|Venetoclax|venetoclax|mesh-list
13998319|NCT05287568|Cc-486|cc-486|mesh-list
13998320|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998321|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13998322|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
13998323|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998324|NCT05282121|Empagliflozin|empagliflozin|mesh-list
13998325|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13998326|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998327|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13998328|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023561|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023562|NCT02761395|Deferasirox|deferasirox|mesh-list
14023563|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15134729|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134730|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
15134731|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134732|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134733|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134734|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134735|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134736|NCT04349696|Mitiglinide|mitiglinide|mesh-list
15134737|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15134738|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134739|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134740|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
15134741|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134742|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134743|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134744|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134745|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134746|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023564|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
14270118|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270119|NCT00407745|Pregabalin|pregabalin|mesh-list
14270120|NCT00407745|Analgesics|analgesics|mesh-ancestor
14270121|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
14270122|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270123|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270124|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
14270125|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270126|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15134747|NCT04349410|Interferons|interferons|mesh-list
15134748|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
15134749|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
15134750|NCT04349410|Remdesivir|remdesivir|mesh-list
15134751|NCT04349410|Azithromycin|azithromycin|mesh-list
15134752|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134753|NCT04349410|Doxycycline|doxycycline|mesh-list
14270127|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270128|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270129|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14270130|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270131|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270132|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270133|NCT00407797|Pregabalin|pregabalin|mesh-list
13998345|NCT05277623|Mannitol|mannitol|mesh-list
13998346|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13998347|NCT05277623|Diuretics|diuretics|mesh-ancestor
13998348|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
13998349|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998350|NCT05276206|Anesthetics|anesthetics|mesh-list
13998351|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
13998352|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998353|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998354|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
13998355|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998356|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
13998357|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13998358|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998359|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13998360|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998361|NCT05264870|Norepinephrine|norepinephrine|mesh-list
13998362|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13998363|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13998364|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
13998365|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998366|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998367|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998368|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
13998369|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
13998370|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998371|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13998372|NCT05262400|Letrozole|letrozole|mesh-list
13998373|NCT05262400|Fulvestrant|fulvestrant|mesh-list
13998374|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998375|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13998376|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13998377|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998378|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998379|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13998380|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
13998381|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998382|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998383|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13998384|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13998385|NCT05260320|Anesthetics|anesthetics|mesh-list
13998386|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998387|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134754|NCT04349410|Clindamycin|clindamycin|mesh-list
15134755|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
15134756|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
15134757|NCT04349410|Primaquine|primaquine|mesh-list
13998388|NCT05259631|Propofol|propofol|mesh-list
13998389|NCT05259631|Sevoflurane|sevoflurane|mesh-list
13998390|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15134758|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
15134759|NCT04349410|Losartan|losartan|mesh-list
15134760|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134761|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
13998391|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998392|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998393|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998394|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
13998395|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
13998396|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13998397|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13998398|NCT05258110|Midazolam|midazolam|mesh-list
13998399|NCT05258110|BI 425809|bi 425809|mesh-list
13998400|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13998401|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13998402|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998403|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998404|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13998405|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13998406|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998407|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998408|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
13998409|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
13998410|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
13998411|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
13998412|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998413|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998414|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
13998415|NCT05247268|Letrozole|letrozole|mesh-list
13998416|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13998417|NCT05247268|Megestrol|megestrol|mesh-list
13998418|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
13998419|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
15134762|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134763|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134764|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
15134765|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
13998420|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998421|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13998422|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13998423|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998424|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998425|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13998426|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
13998427|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998428|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998429|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13998430|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13998431|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13998432|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
13998433|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13998434|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13998435|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13998436|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13998437|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13998438|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
13998439|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13998440|NCT05246293|Tofacitinib|tofacitinib|mesh-list
13998441|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998442|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134766|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998443|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998444|NCT05231122|Bevacizumab|bevacizumab|mesh-list
13998445|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13998446|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
13998447|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
13998448|NCT05231122|Antibodies|antibodies|mesh-list
13998449|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
13998450|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13998451|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
13998452|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998453|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13998454|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13998455|NCT05231122|Growth Substances|growth substances|mesh-ancestor
13998456|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998457|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
13998458|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
13998459|NCT05214976|Paclitaxel|paclitaxel|mesh-list
13998460|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13998461|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998462|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
13998463|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
13998464|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
13998465|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134767|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134768|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134769|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
13998469|NCT05202353|Liraglutide|liraglutide|mesh-list
13998470|NCT05202353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13998471|NCT05202353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998472|NCT05202353|Incretins|incretins|mesh-ancestor
13998473|NCT05202353|Hormones|hormones|mesh-ancestor
13998474|NCT05202353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998475|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
15134770|NCT04349410|Hormones|hormones|mesh-ancestor
15134771|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134772|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15134773|NCT04349410|Protective Agents|protective agents|mesh-ancestor
15134774|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
15134775|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134776|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
15134777|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134778|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134779|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134780|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134781|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134782|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15134783|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15134784|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15134785|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13998476|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13998477|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998478|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13998479|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998480|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13998481|NCT05189717|Everolimus|everolimus|mesh-list
13998482|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998483|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13998484|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
13998485|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998486|NCT05184842|Decitabine|decitabine|mesh-list
13998487|NCT05184842|Venetoclax|venetoclax|mesh-list
13998488|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13998489|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
13998490|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998491|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998492|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998493|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
13998494|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
13998495|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998496|NCT05174065|Apremilast|apremilast|mesh-list
13998497|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13998498|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13998499|NCT05174065|Analgesics|analgesics|mesh-ancestor
13998500|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
13998501|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998502|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998503|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998504|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13998505|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13998506|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13998507|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998508|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998509|NCT05171387|Androgens|androgens|mesh-list
13998510|NCT05171387|Hormones|hormones|mesh-ancestor
13998511|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998512|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998513|NCT05168813|Vaccines|vaccines|mesh-list
13998514|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
13998515|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998516|NCT05158998|Propofol|propofol|mesh-list
13998517|NCT05158998|Sevoflurane|sevoflurane|mesh-list
13998518|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13998519|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998520|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998521|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998522|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
13998523|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
13998524|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13998525|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13998526|NCT05148195|Leucovorin|leucovorin|mesh-list
13998527|NCT05148195|Docetaxel|docetaxel|mesh-list
13998528|NCT05148195|Irinotecan|irinotecan|mesh-list
13998529|NCT05148195|Calcium|calcium|mesh-list
13998530|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
13998531|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998532|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
13998533|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
13998534|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
13998535|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998536|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13998537|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998538|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13998539|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13998540|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998541|NCT05148195|Antidotes|antidotes|mesh-ancestor
13998542|NCT05148195|Protective Agents|protective agents|mesh-ancestor
13998543|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
13998544|NCT05148195|Vitamins|vitamins|mesh-ancestor
13998545|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
14023565|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
14023566|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023567|NCT02761317|Bisacodyl|bisacodyl|mesh-list
14023568|NCT02761317|Cathartics|cathartics|mesh-ancestor
14023569|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023570|NCT02761317|Laxatives|laxatives|mesh-ancestor
14023571|NCT02761070|Bevacizumab|bevacizumab|mesh-list
14023572|NCT02761070|Temozolomide|temozolomide|mesh-list
14023573|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14023574|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023575|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14023576|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14023577|NCT02761070|Growth Substances|growth substances|mesh-ancestor
14023578|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023579|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
14023580|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14023581|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
14023582|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023583|NCT02760888|Diclofenac|diclofenac|mesh-list
14023584|NCT02760888|Tramadol|tramadol|mesh-list
14023585|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14023586|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14023587|NCT02760888|Analgesics|analgesics|mesh-ancestor
14023588|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
14023589|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023590|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023591|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023592|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023593|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14023594|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023595|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023596|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14023597|NCT02760888|Narcotics|narcotics|mesh-ancestor
14023598|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023599|NCT02761291|Gemcitabine|gemcitabine|mesh-list
14023600|NCT02761291|Valganciclovir|valganciclovir|mesh-list
14023601|NCT02761291|Valproic Acid|valproic acid|mesh-list
13998546|NCT05139420|Topiramate|topiramate|mesh-list
13998547|NCT05139420|Phentermine|phentermine|mesh-list
13998548|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
13998549|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13998550|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998551|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13998552|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
13998553|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13998554|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
13998555|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
13998556|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998557|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
13998558|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998559|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998560|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
13998561|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13998562|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
13998563|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998564|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
13998565|NCT05130814|Protective Agents|protective agents|mesh-ancestor
13998566|NCT05124067|Dexamethasone|dexamethasone|mesh-list
13998567|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
13998568|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
13998569|NCT05124067|Ondansetron|ondansetron|mesh-list
13998570|NCT05124067|BB 1101|bb 1101|mesh-list
13998571|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998572|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
13998573|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
13998574|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998575|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998576|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13998577|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
13998578|NCT05124067|Hormones|hormones|mesh-ancestor
15134786|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15134787|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
13998579|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998580|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13998581|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998582|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
13998583|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998584|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998585|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13998586|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998587|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13998588|NCT05124067|Analgesics|analgesics|mesh-ancestor
13998589|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
13998590|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13998591|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13998592|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13998593|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
13998594|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998595|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
13998596|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
13998597|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13998598|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
13998599|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13998600|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13998601|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998602|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13998603|NCT05123040|Prednisone|prednisone|mesh-list
13998604|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
13998605|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998606|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
13998607|NCT05123040|Hormones|hormones|mesh-ancestor
13998608|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998609|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998610|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13998611|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998612|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
13998613|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
13998614|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998615|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134788|NCT04349241|Favipiravir|favipiravir|mesh-list
13998616|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13998617|NCT05123040|Protective Agents|protective agents|mesh-ancestor
13998618|NCT05117736|Valsartan|valsartan|mesh-list
13998619|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15134789|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
13998620|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13998621|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13998622|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998623|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
13998624|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13998625|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13998626|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998627|NCT05107193|Afatinib|afatinib|mesh-list
13998628|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998629|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998630|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998631|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998632|NCT05105061|Ketamine|ketamine|mesh-list
13998633|NCT05105061|Analgesics|analgesics|mesh-ancestor
13998634|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
13998635|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998636|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998637|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13998638|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998639|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
13998640|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
13998641|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134790|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134791|NCT04349826|Azithromycin|azithromycin|mesh-list
15134792|NCT04349826|Cefixime|cefixime|mesh-list
15134793|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134794|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134795|NCT04348786|Amoxicillin|amoxicillin|mesh-list
15134796|NCT04348786|Doxycycline|doxycycline|mesh-list
15134797|NCT04348786|Levofloxacin|levofloxacin|mesh-list
15134798|NCT04348786|Ofloxacin|ofloxacin|mesh-list
15134799|NCT04348786|Esomeprazole|esomeprazole|mesh-list
15134800|NCT04348786|Bismuth|bismuth|mesh-list
15134801|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
15134802|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134803|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998642|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13998643|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13998644|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998645|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998646|NCT05098470|Metformin|metformin|mesh-list
13998647|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
13998648|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13998649|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998650|NCT05095961|Prednisone|prednisone|mesh-list
13998651|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998652|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
13998653|NCT05095961|Hormones|hormones|mesh-ancestor
13998654|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998655|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998656|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13998657|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998658|NCT05091528|Capecitabine|capecitabine|mesh-list
13998659|NCT05091528|Trastuzumab|trastuzumab|mesh-list
13998660|NCT05091528|Tucatinib|tucatinib|mesh-list
13998661|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13998662|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
13998663|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998664|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998665|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998666|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998667|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998668|NCT05087992|Bevacizumab|bevacizumab|mesh-list
13998669|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998670|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998671|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13998672|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13998673|NCT05087992|Growth Substances|growth substances|mesh-ancestor
13998674|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998675|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
13998676|NCT05056584|Glucagon|glucagon|mesh-list
13998677|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13998678|NCT05056584|Hormones|hormones|mesh-ancestor
15134804|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15134805|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178902|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
13998679|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998680|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998681|NCT05054881|Iodine|iodine|mesh-list
13998682|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13998683|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998684|NCT05054881|Trace Elements|trace elements|mesh-ancestor
13998685|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
13998686|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998687|NCT05046535|Nicotine|nicotine|mesh-list
13998688|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13998689|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
13998690|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998691|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134806|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15134807|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134808|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134809|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
15134810|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13998692|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13998693|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13998694|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
13998695|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998696|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270134|NCT00407797|Analgesics|analgesics|mesh-ancestor
14270135|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
14270136|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270137|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270138|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
14270139|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270140|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270141|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270142|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270143|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14270144|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270145|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270146|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270147|NCT00407888|Paclitaxel|paclitaxel|mesh-list
14270148|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14270149|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
14270150|NCT00407888|Doxorubicin|doxorubicin|mesh-list
14270151|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14270152|NCT00407888|Trastuzumab|trastuzumab|mesh-list
14270153|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14270154|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270155|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14270156|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14270157|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14270158|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270159|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270160|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
14270161|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270162|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270163|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14270164|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
14270165|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14270166|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14270167|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14270168|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14270169|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270170|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270171|NCT00407966|Cytarabine|cytarabine|mesh-list
14270172|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
14270173|NCT00407966|Alvocidib|alvocidib|mesh-list
15134811|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134812|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15134813|NCT04348786|Renal Agents|renal agents|mesh-ancestor
15134814|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15134815|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15134816|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134817|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15134818|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15134819|NCT04348786|Antacids|antacids|mesh-ancestor
14270174|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270175|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
15134820|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
13998741|NCT05039177|Cetuximab|cetuximab|mesh-list
13998742|NCT05039177|Palbociclib|palbociclib|mesh-list
13998743|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13998744|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998745|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998746|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998747|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998748|NCT05022784|Nintedanib|nintedanib|mesh-list
13998749|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998750|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998751|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998752|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998753|NCT05011214|Ketamine|ketamine|mesh-list
13998754|NCT05011214|Sevoflurane|sevoflurane|mesh-list
13998755|NCT05011214|Esketamine|esketamine|mesh-list
13998756|NCT05011214|Analgesics|analgesics|mesh-ancestor
15134821|NCT04348695|Simvastatin|simvastatin|mesh-list
15134822|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13998757|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
13998758|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998759|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998760|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13998761|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998762|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
13998763|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
13998764|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998765|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13998766|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13998767|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998768|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998769|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13998770|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13998771|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
13998772|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998773|NCT05009992|Panobinostat|panobinostat|mesh-list
13998774|NCT05009992|TIC10 compound|tic10 compound|mesh-list
13998775|NCT05009992|Dopamine|dopamine|mesh-list
13998776|NCT05009992|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
13998777|NCT05009992|GDC-0084|gdc-0084|mesh-list
13998778|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998779|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998780|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998781|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13998782|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
13998783|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
13998784|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998785|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998786|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
13998787|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998788|NCT05009992|Protective Agents|protective agents|mesh-ancestor
13998789|NCT04980040|Alogliptin|alogliptin|mesh-list
13998790|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13998791|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998792|NCT04980040|Incretins|incretins|mesh-ancestor
13998793|NCT04980040|Hormones|hormones|mesh-ancestor
13998794|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998795|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13998796|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
13998797|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998798|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023602|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14023603|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
14023604|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023605|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023606|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
14023607|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023608|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023609|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14023610|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
14023611|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023612|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
14023613|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
14023614|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023615|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
15134823|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14023616|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13998799|NCT04965155|Dexamethasone|dexamethasone|mesh-list
13998800|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998801|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
13998802|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
13998803|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998804|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998805|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13998806|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
13998807|NCT04965155|Hormones|hormones|mesh-ancestor
13998808|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998809|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13998810|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998811|NCT04951492|Olaparib|olaparib|mesh-list
13998812|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13998813|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998814|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998815|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998816|NCT04951206|Clobetasol|clobetasol|mesh-list
13998817|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998818|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
13998819|NCT04951206|Hormones|hormones|mesh-ancestor
13998820|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998821|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998822|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15134824|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
15134825|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134826|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15134827|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15134828|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134829|NCT04348877|Antibodies|antibodies|mesh-list
15134830|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
15134831|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134832|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
13998823|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998824|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
13998825|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13998826|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13998827|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
13998828|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998829|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13998830|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13998831|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
13998832|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998833|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998834|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13998835|NCT04933227|Capecitabine|capecitabine|mesh-list
13998836|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
13998837|NCT04933227|Atezolizumab|atezolizumab|mesh-list
13998838|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13998839|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
13998840|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998841|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998842|NCT04932083|Fentanyl|fentanyl|mesh-list
13998843|NCT04932083|Midazolam|midazolam|mesh-list
13998844|NCT04932083|Nalbuphine|nalbuphine|mesh-list
13998845|NCT04932083|Bupivacaine|bupivacaine|mesh-list
13998846|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
13998847|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
13998848|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15134833|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15134834|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134835|NCT04348292|Sirolimus|sirolimus|mesh-list
15134836|NCT04348292|Durvalumab|durvalumab|mesh-list
15134837|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
15134838|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15134839|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
15134840|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134841|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134842|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15134843|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134844|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
13998849|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998850|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
15134845|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13998851|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134846|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
13998852|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13998853|NCT04932083|Narcotics|narcotics|mesh-ancestor
13998854|NCT04932083|Analgesics|analgesics|mesh-ancestor
13998855|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13998856|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998857|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
13998858|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13998859|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13998860|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13998861|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998862|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
13998863|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
13998864|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998865|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998866|NCT04925960|Epalrestat|epalrestat|mesh-list
13998867|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998868|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270176|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270177|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270178|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
14270179|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270180|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270181|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
14270182|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270183|NCT00407966|Analgesics|analgesics|mesh-ancestor
14270184|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
14270185|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270186|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14270187|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14270188|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270189|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270190|NCT00407966|Growth Substances|growth substances|mesh-ancestor
14270191|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270192|NCT00408070|Paclitaxel|paclitaxel|mesh-list
14270193|NCT00408070|Bevacizumab|bevacizumab|mesh-list
14270194|NCT00408070|Carboplatin|carboplatin|mesh-list
13998888|NCT04910425|Fluorides|fluorides|mesh-list
13998889|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
13998890|NCT04910425|Protective Agents|protective agents|mesh-ancestor
13998891|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998892|NCT04907253|Quercetin|quercetin|mesh-list
13998893|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
13998894|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998895|NCT04907253|Protective Agents|protective agents|mesh-ancestor
13998896|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998897|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
13998898|NCT04890873|Antacids|antacids|mesh-ancestor
13998899|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998900|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13998901|NCT04885972|Triamcinolone|triamcinolone|mesh-list
13998902|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13998903|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13998904|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13998905|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13998906|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
13998907|NCT04885972|Hormones|hormones|mesh-ancestor
13998908|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998909|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998910|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13998911|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
13998912|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998913|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998914|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
13998915|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13998916|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13998917|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998918|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
13998919|NCT04863339|Coagulants|coagulants|mesh-ancestor
13998920|NCT04862780|Osimertinib|osimertinib|mesh-list
13998921|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998922|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13998923|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998924|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998925|NCT04862143|Fulvestrant|fulvestrant|mesh-list
13998926|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13998927|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998928|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13998929|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13998930|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
13998931|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13998932|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998933|NCT04858490|Diazepam|diazepam|mesh-list
13998934|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13998935|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
13998936|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
13998937|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
13998938|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13998939|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998940|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13998941|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13998942|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13998943|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13998944|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13998945|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13998946|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13998947|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13998948|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13998949|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
13998950|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
13998951|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
13998952|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
13998953|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13998954|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998955|NCT04858425|Niclosamide|niclosamide|mesh-list
13998956|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
13998957|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13998958|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
13998959|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13998960|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998961|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
13998962|NCT04844957|Vitamin D|vitamin d|mesh-list
13998963|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
13998964|NCT04844957|Vitamins|vitamins|mesh-list
13998965|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
13998966|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998967|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13998968|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13998969|NCT04832854|Gemcitabine|gemcitabine|mesh-list
13998970|NCT04832854|Paclitaxel|paclitaxel|mesh-list
13998971|NCT04832854|Carboplatin|carboplatin|mesh-list
13998972|NCT04832854|Pemetrexed|pemetrexed|mesh-list
13998973|NCT04832854|Atezolizumab|atezolizumab|mesh-list
13998974|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13998975|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13998976|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
13998977|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
13998978|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
13998979|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13998980|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13998981|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
13998982|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
13998983|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13998984|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13998985|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13998986|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
13998987|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13998988|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13998989|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13998990|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
13998991|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13998992|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13998993|NCT04826588|Prednisolone|prednisolone|mesh-list
13998994|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
13998995|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13998996|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
13998997|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
13998998|NCT04826588|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13998999|NCT04826588|Antibodies|antibodies|mesh-list
13999000|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999001|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
15134847|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999002|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
13999003|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178903|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
13999004|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999005|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999006|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
13999007|NCT04826588|Hormones|hormones|mesh-ancestor
13999008|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13999009|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13999010|NCT04826588|Protective Agents|protective agents|mesh-ancestor
13999011|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13999012|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999013|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
13999014|NCT04823845|Adapalene|adapalene|mesh-list
13999015|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13999016|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999017|NCT04823845|Analgesics|analgesics|mesh-ancestor
13999018|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
13999019|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999020|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999021|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999022|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134848|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15134849|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
13999023|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
13999024|NCT04819399|Catumaxomab|catumaxomab|mesh-list
13999025|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999026|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
13999027|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13999028|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
13999029|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999030|NCT04795245|Afatinib|afatinib|mesh-list
13999031|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999032|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999033|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999034|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999035|NCT04794790|Buprenorphine|buprenorphine|mesh-list
13999036|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13999037|NCT04794790|Naloxone|naloxone|mesh-list
13999038|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13999039|NCT04794790|Narcotics|narcotics|mesh-ancestor
13999040|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999041|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999042|NCT04794790|Analgesics|analgesics|mesh-ancestor
13999043|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
13999044|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999045|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13999046|NCT04790045|Venetoclax|venetoclax|mesh-list
13999047|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999048|NCT04772274|Ustekinumab|ustekinumab|mesh-list
13999049|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
13999050|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
13999051|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999052|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999053|NCT04759833|Prucalopride|prucalopride|mesh-list
13999054|NCT04759833|Laxatives|laxatives|mesh-ancestor
13999055|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999056|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
13999057|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13999058|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
13999059|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13999060|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999061|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999062|NCT04758975|Rituximab|rituximab|mesh-list
13999063|NCT04758975|Venetoclax|venetoclax|mesh-list
15134850|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15134851|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15178904|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15178905|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15178906|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
15178907|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178908|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15178909|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15178910|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178911|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13999064|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999065|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999066|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
13999067|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999068|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023617|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023618|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14023619|NCT02760992|Baclofen|baclofen|mesh-list
14023620|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14023621|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023622|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14023623|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023624|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14023625|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
14023626|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
14023627|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023628|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023629|NCT02760979|Denosumab|denosumab|mesh-list
14023630|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14023631|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023632|NCT02760953|Epirubicin|epirubicin|mesh-list
14023633|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14023634|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023635|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14023636|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14023637|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023638|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023639|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
14023640|NCT02760901|Mannitol|mannitol|mesh-list
14023641|NCT02760901|Acetazolamide|acetazolamide|mesh-list
14023642|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14023643|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
14023644|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023645|NCT02760901|Expectorants|expectorants|mesh-ancestor
14023646|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
14023647|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14023648|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
14023649|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023650|NCT02760901|Protective Agents|protective agents|mesh-ancestor
14023651|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023652|NCT02760901|Antidotes|antidotes|mesh-ancestor
14023653|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14023654|NCT02760901|Diuretics|diuretics|mesh-ancestor
14023655|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
14023656|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
14023657|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14023658|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023659|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
14023660|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
14023661|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023662|NCT02760823|Protective Agents|protective agents|mesh-ancestor
14023663|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023664|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
14023665|NCT02760823|Vitamins|vitamins|mesh-ancestor
14023666|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
14023667|NCT02760667|Cisplatin|cisplatin|mesh-list
14023668|NCT02760667|Carboplatin|carboplatin|mesh-list
14023669|NCT02760667|Docetaxel|docetaxel|mesh-list
14023670|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023671|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
14023672|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
14023673|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
14023674|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023675|NCT02760420|Amoxicillin|amoxicillin|mesh-list
14023676|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14023677|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023678|NCT02760342|Metformin|metformin|mesh-list
14023679|NCT02760342|Peficitinib|peficitinib|mesh-list
14023680|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14023681|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023682|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023683|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023684|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14023685|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
14023686|NCT02760615|Losartan|losartan|mesh-list
14023687|NCT02760615|Midazolam|midazolam|mesh-list
14023688|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
14023689|NCT02760615|Caffeine|caffeine|mesh-list
14023690|NCT02760615|Omeprazole|omeprazole|mesh-list
14023691|NCT02760615|Vedolizumab|vedolizumab|mesh-list
14023692|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14023693|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13999069|NCT04751383|Dinutuximab|dinutuximab|mesh-list
13999070|NCT04751383|Magrolimab|magrolimab|mesh-list
13999071|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999072|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14561975|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14561976|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270195|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14270196|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270197|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
14270198|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
14270199|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14270200|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270201|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270202|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270203|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270204|NCT00408070|Growth Substances|growth substances|mesh-ancestor
14270205|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270206|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270207|NCT00408200|Sotalol|sotalol|mesh-list
14270208|NCT00408200|Flecainide|flecainide|mesh-list
14270209|NCT00408200|Propafenone|propafenone|mesh-list
14270210|NCT00408200|Dofetilide|dofetilide|mesh-list
14270211|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14270212|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14561977|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
14561978|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
14561979|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
13999089|NCT04739150|Nintedanib|nintedanib|mesh-list
13999090|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999091|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999092|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999093|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999094|NCT04729595|Tempol|tempol|mesh-list
13999095|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
13999096|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999097|NCT04729595|Protective Agents|protective agents|mesh-ancestor
13999098|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999099|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15134852|NCT04348370|Vaccines|vaccines|mesh-list
15134853|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
15134854|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
15134855|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134856|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15134857|NCT04348383|Defibrotide|defibrotide|mesh-list
15134858|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13999100|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999101|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13999102|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13999103|NCT04727229|Bupivacaine|bupivacaine|mesh-list
13999104|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
13999105|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
13999106|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999107|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999108|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
13999109|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270213|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
14270214|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270215|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270216|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270217|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14270218|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
14270219|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
14270220|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270221|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14270222|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14270223|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270224|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14270225|NCT00408317|Pancrelipase|pancrelipase|mesh-list
14270226|NCT00408317|Pancreatin|pancreatin|mesh-list
14270227|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14270228|NCT00408408|Gemcitabine|gemcitabine|mesh-list
14270229|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
14270230|NCT00408408|Bevacizumab|bevacizumab|mesh-list
15134859|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14270231|NCT00408408|Docetaxel|docetaxel|mesh-list
14270232|NCT00408408|Doxorubicin|doxorubicin|mesh-list
15178912|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270233|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14270234|NCT00408408|Capecitabine|capecitabine|mesh-list
14270235|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270236|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
14270237|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270238|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270239|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14270240|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
14270241|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270242|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134860|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134861|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15134862|NCT04348474|Azithromycin|azithromycin|mesh-list
15134863|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134864|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134865|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134866|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
15134867|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134868|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134869|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134870|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270243|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14270244|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270245|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270246|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270247|NCT00408408|Growth Substances|growth substances|mesh-ancestor
14270248|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270249|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270250|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
14270251|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
14270252|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270253|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270254|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14270255|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14270256|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14270257|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14270258|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14270259|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14270260|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14270261|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13999135|NCT04685577|Nefopam|nefopam|mesh-list
13999136|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999137|NCT04685577|Analgesics|analgesics|mesh-ancestor
13999138|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
13999139|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999140|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999141|NCT04677972|Ebselen|ebselen|mesh-list
13999142|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13999143|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999144|NCT04677972|Analgesics|analgesics|mesh-ancestor
13999145|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
13999146|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999147|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999148|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999149|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999150|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13999151|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999152|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
13999153|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14561980|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134871|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134872|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
13999154|NCT04677972|Protective Agents|protective agents|mesh-ancestor
13999155|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13999156|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999157|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13999158|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
13999159|NCT04669210|Tacrolimus|tacrolimus|mesh-list
13999160|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13999161|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
13999162|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999163|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13999164|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999165|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999166|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13999167|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999168|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13999169|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
13999170|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13999171|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999172|NCT04660760|Trifluridine|trifluridine|mesh-list
13999173|NCT04660760|Paclitaxel|paclitaxel|mesh-list
13999174|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13999175|NCT04660760|Ramucirumab|ramucirumab|mesh-list
13999176|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13999177|NCT04660760|Antibodies|antibodies|mesh-list
13999178|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
13999179|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13999180|NCT04660760|Lexatumumab|lexatumumab|mesh-list
13999181|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13999182|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999183|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
13999184|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
13999185|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
13999186|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999187|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
13999188|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999189|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
13999190|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
13999191|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999192|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
13999193|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999194|NCT04656951|Daratumumab|daratumumab|mesh-list
13999195|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999196|NCT04640779|Salicylates|salicylates|mesh-list
13999197|NCT04640779|Choline|choline|mesh-list
13999198|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
13999199|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13999200|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
13999201|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999202|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999203|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13999204|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
13999205|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13999206|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999207|NCT04640779|Analgesics|analgesics|mesh-ancestor
13999208|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
13999209|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999210|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999211|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999212|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999213|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13999214|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999215|NCT04630964|Niacin|niacin|mesh-list
13999216|NCT04630964|Psilocybin|psilocybin|mesh-list
13999217|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13999218|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
13999219|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999220|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13999221|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
13999222|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
13999223|NCT04630964|Vitamins|vitamins|mesh-ancestor
13999224|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
13999225|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999226|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
13999227|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13999228|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
13999229|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13999230|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13999231|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
13999232|NCT04613596|Adagrasib|adagrasib|mesh-list
13999233|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999234|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999235|NCT04609020|Lidocaine|lidocaine|mesh-list
13999236|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
13999237|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
13999238|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999239|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561981|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13999240|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
13999241|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999242|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13999243|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13999244|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13999245|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13999246|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999247|NCT04607252|Metformin|metformin|mesh-list
13999248|NCT04607252|Megestrol|megestrol|mesh-list
13999249|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
13999250|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13999251|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999252|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13999253|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13999254|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13999255|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
13999256|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13999257|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13999258|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13999259|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13999260|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999261|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
13999262|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15134873|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134874|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134875|NCT04347915|Clevudine|clevudine|mesh-list
15134876|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
15134877|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134878|NCT04348006|Dexamethasone|dexamethasone|mesh-list
15134879|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
15134880|NCT04348006|Lenalidomide|lenalidomide|mesh-list
15134881|NCT04348006|Bortezomib|bortezomib|mesh-list
15134882|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15134883|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
15134884|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134885|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134886|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15134887|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
15134888|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134889|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134890|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15134891|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134892|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
15134893|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
15134894|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134895|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134896|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
15134897|NCT04348006|Hormones|hormones|mesh-ancestor
15134898|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134899|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134900|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15134901|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15134902|NCT04348006|Growth Substances|growth substances|mesh-ancestor
15134903|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
15134904|NCT04347733|Triamcinolone|triamcinolone|mesh-list
15134905|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13999280|NCT04580121|Acetaminophen|acetaminophen|mesh-list
13999281|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
13999282|NCT04580121|Promethazine|promethazine|mesh-list
13999283|NCT04580121|Dexamethasone|dexamethasone|mesh-list
13999284|NCT04580121|Dasatinib|dasatinib|mesh-list
13999285|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999286|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
13999287|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
13999288|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999289|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134906|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15134907|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15134908|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134909|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
15134910|NCT04347733|Hormones|hormones|mesh-ancestor
15178913|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13999290|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999291|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
13999292|NCT04580121|Hormones|hormones|mesh-ancestor
13999293|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13999294|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13999295|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999296|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999297|NCT04580121|Analgesics|analgesics|mesh-ancestor
15134911|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134912|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134913|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15134914|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
15134915|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999298|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
13999299|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
13999300|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999301|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999302|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999303|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13999304|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13999305|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999306|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
13999307|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
13999308|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13999309|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
13999310|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
13999311|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13999312|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13999313|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
13999314|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
14270262|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14270263|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270264|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270265|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270266|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270267|NCT00408421|Analgesics|analgesics|mesh-ancestor
14270268|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
14270269|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270270|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
14270271|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270272|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
14270273|NCT00408434|Efatutazone|efatutazone|mesh-list
14270274|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270275|NCT00408460|Paclitaxel|paclitaxel|mesh-list
13999329|NCT04573556|Lemborexant|lemborexant|mesh-list
13999330|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13999331|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13999332|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999333|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13999334|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13999335|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999336|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270276|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
14270277|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14270278|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270279|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
14270280|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
14270281|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
14270282|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270283|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270284|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270285|NCT00408499|Cetuximab|cetuximab|mesh-list
14270286|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14270287|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270288|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270289|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270290|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270291|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270292|NCT00408564|Gemcitabine|gemcitabine|mesh-list
14270293|NCT00408564|Capecitabine|capecitabine|mesh-list
14270294|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
15134916|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270295|NCT00408564|Cetuximab|cetuximab|mesh-list
14561982|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
14270296|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270297|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
14270298|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999360|NCT04567160|Propofol|propofol|mesh-list
13999361|NCT04567160|Sevoflurane|sevoflurane|mesh-list
13999362|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13999363|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999364|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999365|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13999366|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
13999367|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
13999368|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13999369|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13999370|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
13999371|NCT04566250|Analgesics|analgesics|mesh-ancestor
13999372|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
13999373|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999374|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999375|NCT04564755|Abrocitinib|abrocitinib|mesh-list
13999376|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999377|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999378|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999379|NCT04559581|Nintedanib|nintedanib|mesh-list
13999380|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999381|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999382|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999383|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999384|NCT04556084|Blinatumomab|blinatumomab|mesh-list
13999385|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999386|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
15134917|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
15134918|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15134919|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15134920|NCT04348045|Durvalumab|durvalumab|mesh-list
15134921|NCT04348045|Olaparib|olaparib|mesh-list
15134922|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15134923|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134924|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15134925|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134926|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134927|NCT04347889|Ascorbic Acid|ascorbic acid|mesh-list
13999387|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999388|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
13999389|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999390|NCT04545866|Budesonide|budesonide|mesh-list
13999391|NCT04545866|Poractant alfa|poractant alfa|mesh-list
13999392|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
13999393|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999394|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13999395|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
13999396|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999397|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999398|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13999399|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
13999400|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
13999401|NCT04545866|Hormones|hormones|mesh-ancestor
13999402|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13999403|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
13999404|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999405|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
13999406|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999407|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
13999408|NCT04541355|Cisplatin|cisplatin|mesh-list
13999409|NCT04541355|Antidotes|antidotes|mesh-list
13999410|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999411|NCT04541355|Protective Agents|protective agents|mesh-ancestor
13999412|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999413|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
13999414|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999415|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
13999416|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13999417|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999418|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
13999419|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
14270299|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134928|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134929|NCT04347889|Vitamins|vitamins|mesh-ancestor
15134930|NCT04347889|Micronutrients|micronutrients|mesh-ancestor
15134931|NCT04347889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270300|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
14270301|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270302|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270303|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270304|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
14270305|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270306|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270307|NCT00408629|Adalimumab|adalimumab|mesh-list
14270308|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14270309|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270310|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
14270311|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
14270312|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270313|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270314|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270315|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
14270316|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270317|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270318|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270319|NCT00408694|Bevacizumab|bevacizumab|mesh-list
14270320|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14270321|NCT00408694|Cisplatin|cisplatin|mesh-list
14270322|NCT00408694|Fluorouracil|fluorouracil|mesh-list
14270323|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
15134932|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
15134933|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134934|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134935|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134936|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134937|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999420|NCT04532528|Dabigatran|dabigatran|mesh-list
13999421|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
13999422|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13999423|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
13999424|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999425|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999426|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
13999427|NCT04531059|Metronidazole|metronidazole|mesh-list
15134938|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134939|NCT04347889|Antioxidants|antioxidants|mesh-ancestor
15134940|NCT04347889|Protective Agents|protective agents|mesh-ancestor
15134941|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134942|NCT04347980|Dexamethasone|dexamethasone|mesh-list
15134943|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134944|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
13999428|NCT04531059|Minocycline|minocycline|mesh-list
13999429|NCT04531059|Tetracycline|tetracycline|mesh-list
13999430|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
13999431|NCT04531059|Esomeprazole|esomeprazole|mesh-list
13999432|NCT04531059|Bismuth|bismuth|mesh-list
13999433|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134945|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
15134946|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134947|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134948|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15134949|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
15134950|NCT04347980|Hormones|hormones|mesh-ancestor
15134951|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15134952|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15134953|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15134954|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
15134955|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15134956|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15134957|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15134958|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134959|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134960|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134961|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
15134962|NCT04347798|Chloroquine|chloroquine|mesh-list
15134963|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
15134964|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13999434|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270324|NCT00408694|Antibodies|antibodies|mesh-list
15134965|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13999435|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15134966|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999436|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13999437|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13999438|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13999439|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999440|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13999441|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999442|NCT04531059|Antacids|antacids|mesh-ancestor
13999443|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13999444|NCT04531059|Diuretics|diuretics|mesh-ancestor
13999445|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
13999446|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999447|NCT04531059|Expectorants|expectorants|mesh-ancestor
15134967|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134968|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134969|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134970|NCT04347798|Amebicides|amebicides|mesh-ancestor
15134971|NCT04347720|Acetaminophen|acetaminophen|mesh-list
15134972|NCT04347720|Ibuprofen|ibuprofen|mesh-list
15134973|NCT04347720|Indomethacin|indomethacin|mesh-list
15134974|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15134975|NCT04347720|Analgesics|analgesics|mesh-ancestor
15134976|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
13999448|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
13999449|NCT04515576|Dulaglutide|dulaglutide|mesh-list
13999450|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13999451|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999452|NCT04513925|Atezolizumab|atezolizumab|mesh-list
13999453|NCT04513925|Durvalumab|durvalumab|mesh-list
13999454|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999455|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270325|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
14270326|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14270327|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
14270328|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270329|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270330|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270331|NCT00408694|Growth Substances|growth substances|mesh-ancestor
14270332|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270333|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270334|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
14270335|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
14270336|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134977|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134978|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270337|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270338|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270339|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14270340|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14270341|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15134979|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
15134980|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13999469|NCT04460560|Terlipressin|terlipressin|mesh-list
13999470|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13999471|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13999472|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
13999473|NCT04460456|Cemiplimab|cemiplimab|mesh-list
13999474|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999475|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999476|NCT04416633|Durvalumab|durvalumab|mesh-list
13999477|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999478|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999479|NCT04414475|Dexamethasone|dexamethasone|mesh-list
13999480|NCT04414475|Bortezomib|bortezomib|mesh-list
13999481|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999482|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
13999483|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
13999484|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999485|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999486|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999487|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
15134981|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15134982|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15134983|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13999488|NCT04414475|Hormones|hormones|mesh-ancestor
13999489|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13999490|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13999491|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270342|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15134984|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15134985|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134986|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
15134987|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
15134988|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15134989|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15134990|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15134991|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15134992|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15134993|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15134994|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15134995|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270343|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270344|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270345|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270346|NCT00408876|Analgesics|analgesics|mesh-ancestor
14270347|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
14270348|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270349|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
14270350|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270351|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
14270352|NCT00408928|Bortezomib|bortezomib|mesh-list
14270353|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999504|NCT04401995|Nivolumab|nivolumab|mesh-list
13999505|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999506|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999507|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13999508|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999509|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
13999510|NCT04390698|Anesthetics|anesthetics|mesh-list
13999511|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999512|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15134996|NCT04347577|Analgesics|analgesics|mesh-ancestor
15134997|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
15134998|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15134999|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
15135000|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15135001|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
13999513|NCT04390698|Narcotics|narcotics|mesh-ancestor
13999514|NCT04390698|Analgesics|analgesics|mesh-ancestor
13999515|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
13999516|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999517|NCT04366713|Capecitabine|capecitabine|mesh-list
13999518|NCT04366713|Loperamide|loperamide|mesh-list
13999519|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
13999520|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13999521|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
13999522|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999523|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999524|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999525|NCT04356326|Aspirin|aspirin|mesh-list
13999526|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13999527|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999528|NCT04356326|Analgesics|analgesics|mesh-ancestor
13999529|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
13999530|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999531|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999532|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999533|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999534|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13999535|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13999536|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999537|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13999538|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13999539|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999540|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
13999541|NCT04325217|Nintedanib|nintedanib|mesh-list
13999542|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999543|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999544|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999545|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999546|NCT04322123|Azithromycin|azithromycin|mesh-list
13999547|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
13999548|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13999549|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999550|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
13999551|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13999552|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13999553|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999554|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999555|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999556|NCT04299880|Leucovorin|leucovorin|mesh-list
13999557|NCT04299880|Gemcitabine|gemcitabine|mesh-list
13999558|NCT04299880|Paclitaxel|paclitaxel|mesh-list
13999559|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13999560|NCT04299880|Bevacizumab|bevacizumab|mesh-list
13999561|NCT04299880|Fluorouracil|fluorouracil|mesh-list
13999562|NCT04299880|Nivolumab|nivolumab|mesh-list
13999563|NCT04299880|Irinotecan|irinotecan|mesh-list
13999564|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13999565|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999566|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
13999567|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
13999568|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
13999569|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999570|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999571|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13999572|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13999573|NCT04299880|Growth Substances|growth substances|mesh-ancestor
13999574|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999575|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
13999576|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13999577|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
13999578|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
13999579|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999580|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999581|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13999582|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
13999583|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13999584|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13999585|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13999586|NCT04299880|Antidotes|antidotes|mesh-ancestor
13999587|NCT04299880|Protective Agents|protective agents|mesh-ancestor
13999588|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
13999589|NCT04299880|Vitamins|vitamins|mesh-ancestor
13999590|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
13999591|NCT04273139|Venetoclax|venetoclax|mesh-list
13999592|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999593|NCT04268706|Fludarabine|fludarabine|mesh-list
13999594|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13999595|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999596|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999597|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13999598|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
13999599|NCT04265053|Ketorolac|ketorolac|mesh-list
13999600|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13999601|NCT04265053|Estradiol|estradiol|mesh-list
13999602|NCT04265053|Testosterone|testosterone|mesh-list
13999603|NCT04265053|Ganirelix|ganirelix|mesh-list
13999604|NCT04265053|Estrogens|estrogens|mesh-ancestor
13999605|NCT04265053|Hormones|hormones|mesh-ancestor
15135002|NCT04347512|Azithromycin|azithromycin|mesh-list
15135003|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135004|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135005|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135006|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
15135007|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135008|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135009|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999606|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13999607|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999608|NCT04265053|Androgens|androgens|mesh-ancestor
13999609|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13999610|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999611|NCT04265053|Analgesics|analgesics|mesh-ancestor
13999612|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
13999613|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999614|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999615|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999616|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13999617|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182033|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15135010|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135011|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999618|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999619|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
13999620|NCT04259138|Vedolizumab|vedolizumab|mesh-list
13999621|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999622|NCT04256707|Docetaxel|docetaxel|mesh-list
13999623|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
13999624|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999625|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
13999626|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
13999627|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
13999628|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999629|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999630|NCT04244630|Antioxidants|antioxidants|mesh-list
13999631|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999632|NCT04244630|Protective Agents|protective agents|mesh-ancestor
13999633|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999634|NCT04243616|Paclitaxel|paclitaxel|mesh-list
13999635|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
13999636|NCT04243616|Carboplatin|carboplatin|mesh-list
13999637|NCT04243616|Doxorubicin|doxorubicin|mesh-list
13999638|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13999639|NCT04243616|Cemiplimab|cemiplimab|mesh-list
13999640|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13999641|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999642|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
13999643|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
13999644|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
13999645|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999646|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13999647|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
13999648|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999649|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999650|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13999651|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
13999652|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13999653|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13999654|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13999655|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13999656|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999657|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999658|NCT04239053|Bupivacaine|bupivacaine|mesh-list
13999659|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
13999660|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
13999661|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999662|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999663|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
13999664|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999665|NCT04237623|Sargramostim|sargramostim|mesh-list
13999666|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
13999667|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999668|NCT04235036|Rituximab|rituximab|mesh-list
13999669|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999670|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999671|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
13999672|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999673|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023694|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14023695|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023696|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14023697|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14023698|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14023699|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14023700|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
14023701|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
14023702|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
14023703|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
14023704|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023705|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023706|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14023707|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14023708|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14023709|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14023710|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13999674|NCT04226950|Interferons|interferons|mesh-list
13999675|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
13999676|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
13999677|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
13999678|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999679|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
13999680|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999681|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
13999682|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270354|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14270355|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14270356|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14270357|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270358|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270359|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270360|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270361|NCT00408993|Analgesics|analgesics|mesh-ancestor
14270362|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
14270363|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270364|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
15135012|NCT04347434|Atorvastatin|atorvastatin|mesh-list
13999695|NCT04172532|Peposertib|peposertib|mesh-list
13999696|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999697|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999698|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999699|NCT04167670|Amoxicillin|amoxicillin|mesh-list
13999700|NCT04167670|Clarithromycin|clarithromycin|mesh-list
13999701|NCT04167670|Lansoprazole|lansoprazole|mesh-list
13999702|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
13999703|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13999704|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999705|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15135013|NCT04347434|Ezetimibe|ezetimibe|mesh-list
15135014|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15135015|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15135016|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
15135017|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135018|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15135019|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15135020|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135021|NCT04347252|Glucagon|glucagon|mesh-list
15135022|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135023|NCT04347252|Hormones|hormones|mesh-ancestor
15135024|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135025|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135026|NCT04346914|Carboplatin|carboplatin|mesh-list
13999706|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999707|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999708|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13999709|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13999710|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13999711|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13999712|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13999713|NCT04148495|Acetaminophen|acetaminophen|mesh-list
13999714|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999715|NCT04148495|Analgesics|analgesics|mesh-ancestor
13999716|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
13999717|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999718|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999719|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
13999720|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
13999721|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13999722|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
13999723|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999724|NCT04119284|Protective Agents|protective agents|mesh-ancestor
13999725|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999726|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
13999727|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999728|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999729|NCT04105270|Carboplatin|carboplatin|mesh-list
13999730|NCT04105270|Pemetrexed|pemetrexed|mesh-list
13999731|NCT04105270|Durvalumab|durvalumab|mesh-list
13999732|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999733|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999734|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999735|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13999736|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13999737|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999738|NCT04105114|Buspirone|buspirone|mesh-list
13999739|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13999740|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13999741|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999742|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999743|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13999744|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13999745|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
13999746|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13999747|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999748|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
13999749|NCT04087096|Denosumab|denosumab|mesh-list
13999750|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13999751|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999752|NCT04072835|Etripamil|etripamil|mesh-list
13999753|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13999754|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13999755|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999756|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13999757|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999758|NCT04045028|Rituximab|rituximab|mesh-list
13999759|NCT04045028|Atezolizumab|atezolizumab|mesh-list
13999760|NCT04045028|Daratumumab|daratumumab|mesh-list
13999761|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999762|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999763|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
13999764|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999765|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999766|NCT04023669|Gemcitabine|gemcitabine|mesh-list
13999767|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
13999768|NCT04023669|Lenograstim|lenograstim|mesh-list
13999769|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13999770|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
13999771|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999772|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999773|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13999774|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
13999775|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999776|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999777|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13999778|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13999779|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
13999780|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
13999781|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999782|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999783|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13999784|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
13999785|NCT04019379|Calcium|calcium|mesh-list
13999786|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13999787|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999788|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13999789|NCT04000009|Pimavanserin|pimavanserin|mesh-list
13999790|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13999791|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13999792|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15135027|NCT04346914|Etoposide|etoposide|mesh-list
13999793|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13999794|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999795|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999796|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13999797|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13999798|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13999799|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
13999800|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13999801|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999802|NCT03989362|Ipilimumab|ipilimumab|mesh-list
13999803|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999804|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999805|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13999806|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999807|NCT03984565|Cannabidiol|cannabidiol|mesh-list
15135028|NCT04346914|Antibodies|antibodies|mesh-list
15135029|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15135030|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
15135031|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135032|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135033|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13999808|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
14270365|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270366|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
14270367|NCT00409006|Pemetrexed|pemetrexed|mesh-list
14270368|NCT00409006|Gefitinib|gefitinib|mesh-list
14270369|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999814|NCT03974139|Metformin|metformin|mesh-list
13999815|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13999816|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999817|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13999818|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999819|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999820|NCT03936998|Vancomycin|vancomycin|mesh-list
13999821|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13999822|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13999823|NCT03910998|Rocuronium|rocuronium|mesh-list
13999824|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13999825|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13999826|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13999827|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999828|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999829|NCT03888079|Anesthetics|anesthetics|mesh-list
13999830|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
13999831|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
13999832|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999833|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999834|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
13999835|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999836|NCT03883893|Acetaminophen|acetaminophen|mesh-list
13999837|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999838|NCT03883893|Analgesics|analgesics|mesh-ancestor
13999839|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
13999840|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999841|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999842|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
13999848|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13999849|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
13999850|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13999851|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
13999852|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999853|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
13999854|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13999855|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13999856|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135034|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14270370|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135035|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15135036|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135037|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135038|NCT04346901|Methimazole|methimazole|mesh-list
15135039|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
15135040|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
15135041|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135042|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135043|NCT04347031|Azithromycin|azithromycin|mesh-list
15135044|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135045|NCT04347031|Mefloquine|mefloquine|mesh-list
15135046|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135047|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135048|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
15135049|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135050|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135051|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270371|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270372|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15135052|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023711|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023712|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14023713|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023714|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14023715|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14023716|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14023717|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14023718|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
14023719|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
14023720|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
14023721|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14023722|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14023723|NCT02760355|Ribavirin|ribavirin|mesh-list
14023724|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
14023725|NCT02760355|Ledipasvir|ledipasvir|mesh-list
14023726|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
14023727|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023728|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
14023729|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023730|NCT02760459|Dexamethasone|dexamethasone|mesh-list
14023731|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023732|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
14023733|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
14023734|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023735|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023736|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023737|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
14023738|NCT02760459|Hormones|hormones|mesh-ancestor
14023739|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023740|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023741|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023742|NCT02760316|Prednisolone|prednisolone|mesh-list
14023743|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14023744|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
14023745|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14023746|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
14023747|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14023748|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
14023749|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023750|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
15135053|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135054|NCT04347005|Allopurinol|allopurinol|mesh-list
15135055|NCT04347005|Febuxostat|febuxostat|mesh-list
14023751|NCT02760316|Hormones|hormones|mesh-ancestor
14023752|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023753|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023754|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023755|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023756|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
14023757|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
14023758|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023759|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023760|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14023761|NCT02760316|Protective Agents|protective agents|mesh-ancestor
15135056|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
15135057|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135058|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135059|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
14023762|NCT02760472|SMOFlipid|smoflipid|mesh-list
14023763|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13999880|NCT03794999|Benralizumab|benralizumab|mesh-list
13999881|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13999882|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
13999883|NCT03782740|Melatonin|melatonin|mesh-list
13999884|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
13999885|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999886|NCT03782740|Protective Agents|protective agents|mesh-ancestor
13999887|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999888|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13999889|NCT03778424|Rufinamide|rufinamide|mesh-list
13999890|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
13999891|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13999892|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13999893|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13999894|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999895|NCT03777904|Iron|iron|mesh-list
13999896|NCT03777904|Trace Elements|trace elements|mesh-ancestor
13999897|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
13999898|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270373|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14270374|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270375|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
14270376|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270377|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
14270378|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270379|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270380|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14270381|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
14270382|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270383|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270384|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14270385|NCT00409292|Everolimus|everolimus|mesh-list
14270386|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270387|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270388|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
14270389|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270390|NCT00409565|Bevacizumab|bevacizumab|mesh-list
14270391|NCT00409565|Cetuximab|cetuximab|mesh-list
14270392|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999919|NCT03766581|Aspirin|aspirin|mesh-list
13999920|NCT03766581|Clopidogrel|clopidogrel|mesh-list
13999921|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13999922|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13999923|NCT03766581|Analgesics|analgesics|mesh-ancestor
15135060|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135061|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15135062|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
15135063|NCT04347005|Protective Agents|protective agents|mesh-ancestor
15135064|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135065|NCT04347200|Anticoagulants|anticoagulants|mesh-list
15135066|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15135067|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
15135068|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
15135069|NCT04346862|Vitamins|vitamins|mesh-ancestor
15135070|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
15135071|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135072|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
15135073|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
15135074|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15135075|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15135076|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999924|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
13999925|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13999926|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999927|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13999928|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13999929|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13999930|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13999931|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999932|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13999933|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13999934|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999935|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
15135077|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
15135078|NCT04347122|Coagulants|coagulants|mesh-ancestor
15135079|NCT04346823|Sevoflurane|sevoflurane|mesh-list
13999936|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13999937|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13999938|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13999939|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
13999940|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13999941|NCT03737643|Paclitaxel|paclitaxel|mesh-list
15135080|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15135081|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15135082|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
15135083|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
15135084|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135085|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999942|NCT03737643|Bevacizumab|bevacizumab|mesh-list
13999943|NCT03737643|Carboplatin|carboplatin|mesh-list
13999944|NCT03737643|Durvalumab|durvalumab|mesh-list
13999945|NCT03737643|Olaparib|olaparib|mesh-list
13999946|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13999947|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13999948|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999949|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
13999950|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
13999951|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
13999952|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999953|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999954|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13999955|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13999956|NCT03737643|Growth Substances|growth substances|mesh-ancestor
13999957|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999958|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
13999959|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
13999960|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13999961|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999962|NCT03732820|Olaparib|olaparib|mesh-list
13999963|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
13999964|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13999965|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999966|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999967|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999968|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13999969|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
13999970|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13999971|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999972|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13999973|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13999974|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999975|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999976|NCT03719092|Vitamins|vitamins|mesh-list
13999977|NCT03719092|Vitamin A|vitamin a|mesh-list
13999978|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
13999979|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
13999980|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13999981|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
13999982|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999983|NCT03719092|Protective Agents|protective agents|mesh-ancestor
13999984|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13999985|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999986|NCT03710824|Nintedanib|nintedanib|mesh-list
13999987|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999988|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13999989|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13999990|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13999991|NCT03694262|Bevacizumab|bevacizumab|mesh-list
13999992|NCT03694262|Atezolizumab|atezolizumab|mesh-list
13999993|NCT03694262|Rucaparib|rucaparib|mesh-list
13999994|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13999995|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13999996|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13999997|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13999998|NCT03694262|Growth Substances|growth substances|mesh-ancestor
13999999|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000000|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
15135086|NCT04347187|Anticoagulants|anticoagulants|mesh-list
14000001|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14000002|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135087|NCT04346797|Eculizumab|eculizumab|mesh-list
14000003|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000004|NCT03686150|Vitamin D|vitamin d|mesh-list
14000005|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
15135088|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15135089|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000006|NCT03686150|Vitamins|vitamins|mesh-ancestor
14000007|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
14000008|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000009|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14000010|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14000011|NCT03685253|Niacinamide|niacinamide|mesh-list
14000012|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
14000013|NCT03685253|Vitamins|vitamins|mesh-ancestor
14000014|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
14000015|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000016|NCT03674112|Trastuzumab|trastuzumab|mesh-list
14000017|NCT03674112|Pertuzumab|pertuzumab|mesh-list
14000018|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000019|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000020|NCT03669367|Abatacept|abatacept|mesh-list
14000021|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14000022|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000023|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000024|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000025|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
14000026|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135090|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
15135091|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178914|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15178915|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178916|NCT03954756|Apatinib|apatinib|mesh-list
15178917|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178918|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15178919|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15178920|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178921|NCT03954483|Triazolam|triazolam|mesh-list
14000027|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000028|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
14000029|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000030|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270393|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270394|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270395|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270396|NCT00409565|Growth Substances|growth substances|mesh-ancestor
14270397|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270398|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270399|NCT00409578|Valsartan|valsartan|mesh-list
14270400|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14270401|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14270402|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14270403|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270404|NCT00409617|Adalimumab|adalimumab|mesh-list
14270405|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14270406|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270407|NCT00409682|Adalimumab|adalimumab|mesh-list
15178922|NCT03954483|Buspirone|buspirone|mesh-list
15178923|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15178924|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15178925|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178926|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178927|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15178928|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15178929|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
15178930|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178931|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178932|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14270408|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14270409|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270410|NCT00409708|Methylphenidate|methylphenidate|mesh-list
15178933|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
14000050|NCT03641560|Androgens|androgens|mesh-list
14000051|NCT03641560|Hormones|hormones|mesh-ancestor
15178934|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
14000052|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000053|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178935|NCT03954197|Hormones|hormones|mesh-list
15135092|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135093|NCT04346667|Chloroquine|chloroquine|mesh-list
15135094|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
15135095|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135096|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14000054|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
14000055|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000056|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000057|NCT03618641|Nivolumab|nivolumab|mesh-list
14000058|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000059|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000060|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14000061|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000062|NCT03617445|Vancomycin|vancomycin|mesh-list
14000063|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135097|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135098|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135099|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135100|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135101|NCT04346667|Amebicides|amebicides|mesh-ancestor
15135102|NCT04346407|Dronabinol|dronabinol|mesh-list
15135103|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
15135104|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135105|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15135106|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14000064|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000065|NCT03464045|Empagliflozin|empagliflozin|mesh-list
14000066|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14000067|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14000068|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000069|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14000070|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000071|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
14000072|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561983|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14561984|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14561985|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14561986|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
14561987|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14561988|NCT00002819|Analgesics|analgesics|mesh-ancestor
14561989|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
14561990|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14561991|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14561992|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14561993|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14561994|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
14561995|NCT00002822|Ifosfamide|ifosfamide|mesh-list
14000086|NCT03392246|Osimertinib|osimertinib|mesh-list
14000087|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000088|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000089|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000090|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000091|NCT03384914|Vaccines|vaccines|mesh-list
14000092|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
14000093|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000094|NCT03218826|Docetaxel|docetaxel|mesh-list
14000095|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000096|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000097|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000098|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
14000099|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000100|NCT03205137|Amlodipine|amlodipine|mesh-list
14000101|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14000102|NCT03205137|Telmisartan|telmisartan|mesh-list
14000103|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14000104|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
14000105|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14000106|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14000107|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14000108|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000109|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15135107|NCT04346407|Analgesics|analgesics|mesh-ancestor
15135108|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
15135109|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135110|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14000110|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000111|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
14000112|NCT03205137|Diuretics|diuretics|mesh-ancestor
14000113|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
14000114|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14000115|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14000116|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14000117|NCT03165721|Guadecitabine|guadecitabine|mesh-list
14000118|NCT03165721|Azacitidine|azacitidine|mesh-list
14000119|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000120|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14000121|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
14000122|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000123|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000124|NCT03138733|Daptomycin|daptomycin|mesh-list
14000125|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
14000126|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14000127|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14000128|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000129|NCT03130959|Nivolumab|nivolumab|mesh-list
14000130|NCT03130959|Ipilimumab|ipilimumab|mesh-list
14000131|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000132|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000133|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14000134|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000135|NCT02955797|Vaccines|vaccines|mesh-list
14000136|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
14000137|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000138|NCT02884908|Pregabalin|pregabalin|mesh-list
14000139|NCT02884908|Analgesics|analgesics|mesh-ancestor
14000140|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
14000141|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000142|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000143|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
14000144|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14000145|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14000146|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000147|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14000148|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14000149|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14000150|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000151|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14000152|NCT02867813|Evolocumab|evolocumab|mesh-list
14000153|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14000154|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14000155|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
14000156|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000157|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14000158|NCT02859415|Plicamycin|plicamycin|mesh-list
14000159|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14000160|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000161|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14000162|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000163|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14000164|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000165|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000166|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14000167|NCT02859064|Lanreotide|lanreotide|mesh-list
14000168|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000169|NCT02842866|Vaccines|vaccines|mesh-list
14270411|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14270412|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270413|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14000170|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
14000171|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000172|NCT02842853|Vaccines|vaccines|mesh-list
14000173|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
14000174|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000175|NCT02834559|Fluorouracil|fluorouracil|mesh-list
14000176|NCT02834559|Heparin|heparin|mesh-list
14000177|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14000178|NCT02834559|Tinzaparin|tinzaparin|mesh-list
14000179|NCT02834559|Dalteparin|dalteparin|mesh-list
14000180|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
14000181|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000182|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14000183|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000184|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15135111|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15135112|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135113|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135114|NCT04346407|Hormones|hormones|mesh-ancestor
15182034|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14000185|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
14000186|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000187|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
14000188|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14000189|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14000190|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
14000191|NCT02828592|Fludarabine|fludarabine|mesh-list
14000192|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
14000193|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000194|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
14000195|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000196|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000197|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14000198|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
14000199|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000200|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000201|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14000202|NCT02817451|Vaccines|vaccines|mesh-list
14000203|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
14000204|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000205|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
14000206|NCT02771197|Fludarabine|fludarabine|mesh-list
14000207|NCT02771197|Melphalan|melphalan|mesh-list
14000208|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000209|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000210|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000211|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000212|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
14000213|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000214|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14000215|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
14000216|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14000217|NCT02759185|Dronabinol|dronabinol|mesh-list
14000218|NCT02759185|Cannabidiol|cannabidiol|mesh-list
14000219|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
14000220|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
14000221|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000222|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14000223|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14000224|NCT02759185|Analgesics|analgesics|mesh-ancestor
14000225|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
14000226|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000227|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14000228|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14000229|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000230|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000231|NCT02759185|Hormones|hormones|mesh-ancestor
14000232|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000233|NCT02752906|Vaccines|vaccines|mesh-list
14000234|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
14000235|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000236|NCT02716012|Sorafenib|sorafenib|mesh-list
14000237|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000238|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000239|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000240|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023764|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14023765|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14023766|NCT02760381|Acetic Acid|acetic acid|mesh-list
14023767|NCT02760381|Retinol acetate|retinol acetate|mesh-list
14023768|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14023769|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023770|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14023771|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
14023772|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023773|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14023774|NCT02760381|Protective Agents|protective agents|mesh-ancestor
15135115|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000241|NCT02632721|Decitabine|decitabine|mesh-list
14000242|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14000243|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
14000244|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000245|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000246|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000247|NCT02627092|Copper|copper|mesh-list
14000248|NCT02627092|Trace Elements|trace elements|mesh-ancestor
14000249|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
15135116|NCT04346589|Antibodies|antibodies|mesh-list
15135117|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
15135118|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15135119|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
15135120|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135121|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15135122|NCT04346004|Hematinics|hematinics|mesh-ancestor
15135123|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135124|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
15135125|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135126|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135127|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000250|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000251|NCT02607722|Nintedanib|nintedanib|mesh-list
14000252|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000253|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000254|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000255|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000256|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
14000257|NCT02581007|Melphalan|melphalan|mesh-list
14000258|NCT02581007|Fludarabine|fludarabine|mesh-list
14000259|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000260|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
14000261|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000262|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000263|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14000264|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
14000265|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000266|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000267|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14000268|NCT02540330|Fulvestrant|fulvestrant|mesh-list
14000269|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14000270|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000271|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14000272|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14000273|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
14000274|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000275|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000276|NCT02483260|Ribavirin|ribavirin|mesh-list
14000277|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
14000278|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000279|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
15135128|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135129|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135130|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135131|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
15135132|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15135133|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135134|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135135|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15135136|NCT04346290|Analgesics|analgesics|mesh-ancestor
14000280|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000281|NCT02483247|Paclitaxel|paclitaxel|mesh-list
14000282|NCT02483247|Doxorubicin|doxorubicin|mesh-list
14000283|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
14000284|NCT02483247|Capecitabine|capecitabine|mesh-list
14000285|NCT02483247|Nivolumab|nivolumab|mesh-list
14000286|NCT02483247|Sunitinib|sunitinib|mesh-list
14000287|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14000288|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000289|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000290|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000291|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
14000292|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135137|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
14000293|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14000294|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14000295|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14000296|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135138|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000297|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000298|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14000299|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
14000300|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14000301|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14000302|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14000303|NCT02483247|Growth Substances|growth substances|mesh-ancestor
14000304|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000305|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
14000306|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000307|NCT02474368|Cisplatin|cisplatin|mesh-list
14000308|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000309|NCT02469519|Dexamethasone|dexamethasone|mesh-list
14000310|NCT02469519|Betamethasone|betamethasone|mesh-list
14000311|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14000312|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
14000313|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
14000314|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000315|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000316|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14000317|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
14000318|NCT02469519|Hormones|hormones|mesh-ancestor
14000319|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000320|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14000321|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000322|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14000323|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
14000324|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
14000325|NCT02467361|Nivolumab|nivolumab|mesh-list
14000326|NCT02467361|Ipilimumab|ipilimumab|mesh-list
14000327|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000328|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000329|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14000330|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000331|NCT02388906|Nivolumab|nivolumab|mesh-list
14000332|NCT02388906|Ipilimumab|ipilimumab|mesh-list
14000333|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000334|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000335|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14000336|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000337|NCT02352753|Denosumab|denosumab|mesh-list
14000338|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14000339|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000340|NCT02352558|Dexamethasone|dexamethasone|mesh-list
14000341|NCT02352558|Bortezomib|bortezomib|mesh-list
14000342|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
14000343|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14000344|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
14000345|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
14000346|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000347|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000348|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14000349|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
14000350|NCT02352558|Hormones|hormones|mesh-ancestor
14000351|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000352|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14000353|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000354|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000355|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000356|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000357|NCT02343042|Clarithromycin|clarithromycin|mesh-list
14000358|NCT02343042|Dexamethasone|dexamethasone|mesh-list
14000359|NCT02343042|Lenalidomide|lenalidomide|mesh-list
14000360|NCT02343042|Bortezomib|bortezomib|mesh-list
14000361|NCT02343042|Daratumumab|daratumumab|mesh-list
14000362|NCT02343042|Pomalidomide|pomalidomide|mesh-list
14000363|NCT02343042|Ixazomib|ixazomib|mesh-list
14000364|NCT02343042|Elotuzumab|elotuzumab|mesh-list
14000365|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14000366|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
14000367|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
14000368|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000369|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135139|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15135140|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15135141|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15135142|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
14000370|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14000371|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
14000372|NCT02343042|Hormones|hormones|mesh-ancestor
14000373|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000374|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14000375|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000376|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
14000377|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14000378|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14000379|NCT02343042|Growth Substances|growth substances|mesh-ancestor
14000380|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
14000381|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14000382|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000383|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14000384|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000385|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000386|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14000387|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14000388|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
14000389|NCT02324283|Propofol|propofol|mesh-list
14000390|NCT02324283|Desflurane|desflurane|mesh-list
14000391|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14000392|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000393|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000394|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14000395|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
14000396|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
14000397|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14000398|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14000399|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000400|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000401|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14000402|NCT02304302|Memantine|memantine|mesh-list
14000403|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14000404|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14000405|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
14000406|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000407|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000408|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000409|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14000410|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14000411|NCT02269670|Tamoxifen|tamoxifen|mesh-list
14000412|NCT02269670|Everolimus|everolimus|mesh-list
14000413|NCT02269670|Letrozole|letrozole|mesh-list
14000414|NCT02269670|Fulvestrant|fulvestrant|mesh-list
14000415|NCT02269670|Anastrozole|anastrozole|mesh-list
14000416|NCT02269670|Megestrol|megestrol|mesh-list
14000417|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
14000418|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000419|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000420|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000421|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
14000422|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000423|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14000424|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14000425|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000426|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14000427|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
14000428|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000429|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14000430|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14000431|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14000432|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14000433|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14000434|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14000435|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14000436|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14000437|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
14000438|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14000439|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14000440|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14000441|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
14000442|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14000443|NCT02240407|Acetaminophen|acetaminophen|mesh-list
14000444|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
14000445|NCT02240407|Promethazine|promethazine|mesh-list
14000446|NCT02240407|Sirolimus|sirolimus|mesh-list
14000447|NCT02240407|Rituximab|rituximab|mesh-list
14000448|NCT02240407|Lidocaine|lidocaine|mesh-list
14000449|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000450|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000451|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
14000452|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000453|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000454|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
14000455|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
14000456|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000457|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
14000458|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000459|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14000460|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14000461|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14000462|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14000463|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000464|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14000465|NCT02240407|Analgesics|analgesics|mesh-ancestor
14000466|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
14000467|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14000468|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000469|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14000470|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
14000471|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000472|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14000473|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14000474|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
14000475|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
14000476|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14000477|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14000478|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
14000479|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
14000480|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000481|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14000482|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
14000483|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
14000484|NCT02231723|Leucovorin|leucovorin|mesh-list
14000485|NCT02231723|Gemcitabine|gemcitabine|mesh-list
14000486|NCT02231723|Paclitaxel|paclitaxel|mesh-list
14000487|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14000488|NCT02231723|Fluorouracil|fluorouracil|mesh-list
14000489|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
14000490|NCT02231723|Irinotecan|irinotecan|mesh-list
14000491|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14000492|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000493|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000494|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000495|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
14000496|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000497|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14000498|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
14000499|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
14000500|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000501|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000502|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000503|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
14000504|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000505|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14000506|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14000507|NCT02231723|Antidotes|antidotes|mesh-ancestor
14000508|NCT02231723|Protective Agents|protective agents|mesh-ancestor
14000509|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
14000510|NCT02231723|Vitamins|vitamins|mesh-ancestor
14000511|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
14000512|NCT02086175|Rituximab|rituximab|mesh-list
14000513|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000514|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000515|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
14000516|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000517|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000518|NCT02072148|Cisplatin|cisplatin|mesh-list
15135143|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135144|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135145|NCT04346277|Antibodies|antibodies|mesh-list
15135146|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15135147|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
15135148|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135149|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
15135150|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
15135151|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
15135152|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135153|NCT04345926|Propofol|propofol|mesh-list
15135154|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15135155|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135156|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135157|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15135158|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
15135159|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
14000519|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000520|NCT02051218|Denosumab|denosumab|mesh-list
14000521|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14000522|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000523|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14000524|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14000525|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000526|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
14000527|NCT01860976|Abatacept|abatacept|mesh-list
14000528|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14000529|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000530|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135160|NCT04346030|Triamcinolone|triamcinolone|mesh-list
15135161|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15135162|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15135163|NCT04346030|Lidocaine|lidocaine|mesh-list
15135164|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15135165|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
15135166|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
15135167|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000531|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000532|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
14000533|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000534|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000535|NCT01853826|Afatinib|afatinib|mesh-list
14000536|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000537|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000538|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000539|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000540|NCT01761266|Sorafenib|sorafenib|mesh-list
14000541|NCT01761266|Lenvatinib|lenvatinib|mesh-list
14000542|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000543|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000544|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000545|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000546|NCT01550289|Vaccines|vaccines|mesh-list
14000547|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
14000548|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000549|NCT01325441|Paclitaxel|paclitaxel|mesh-list
14000550|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14000551|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000552|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000553|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000554|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
14000555|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000556|NCT01101438|Metformin|metformin|mesh-list
14000557|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14000558|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000559|NCT01081951|Paclitaxel|paclitaxel|mesh-list
14000560|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14000561|NCT01081951|Carboplatin|carboplatin|mesh-list
14000562|NCT01081951|Olaparib|olaparib|mesh-list
14000563|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14000564|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000565|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000566|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000567|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
15135168|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000568|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000569|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14000570|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000571|NCT01074190|Fentanyl|fentanyl|mesh-list
14000572|NCT01074190|Bupivacaine|bupivacaine|mesh-list
14000573|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
14000574|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
14000575|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000576|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000577|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
14000578|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000579|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14000580|NCT01074190|Narcotics|narcotics|mesh-ancestor
14000581|NCT01074190|Analgesics|analgesics|mesh-ancestor
14000582|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14000583|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14000584|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
14000585|NCT00875524|Vaccines|vaccines|mesh-list
14000586|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
14000587|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000588|NCT00842530|Vaccines|vaccines|mesh-list
14000589|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
14000590|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000591|NCT00788151|Vaccines|vaccines|mesh-list
14000592|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14000593|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
14000594|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000595|NCT00781612|Paclitaxel|paclitaxel|mesh-list
14000596|NCT00781612|Maytansine|maytansine|mesh-list
14000597|NCT00781612|Docetaxel|docetaxel|mesh-list
14000598|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14000599|NCT00781612|Trastuzumab|trastuzumab|mesh-list
14000600|NCT00781612|Atezolizumab|atezolizumab|mesh-list
14000601|NCT00781612|Pertuzumab|pertuzumab|mesh-list
14000602|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14000603|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000604|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000605|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000606|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
14000607|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000608|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14000609|NCT00539591|Interferons|interferons|mesh-list
14000610|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
14000611|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
14000612|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14000613|NCT00539591|Temozolomide|temozolomide|mesh-list
14000614|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000615|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
14000616|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000617|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14000618|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
14000619|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000620|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
14000621|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000622|NCT02909088|Ecopipam|ecopipam|mesh-list
14000623|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14000624|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14000625|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000626|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000627|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14000628|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14000629|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
14000630|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000631|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023775|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023776|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
14023777|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14023778|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026188|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14026189|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
14026190|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026191|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026192|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14026193|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14026194|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
14026195|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026196|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026197|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14000632|NCT02909049|Midazolam|midazolam|mesh-list
14000633|NCT02909049|Ketamine|ketamine|mesh-list
14000634|NCT02909049|Mepivacaine|mepivacaine|mesh-list
14000635|NCT02909049|Analgesics|analgesics|mesh-ancestor
14000636|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
14000637|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000638|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000639|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14000640|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14000641|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
14000642|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
14000643|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000644|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14000645|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14000646|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000647|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000648|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14000649|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14000650|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14000651|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14000652|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14000653|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
14000654|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
14000655|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
14000656|NCT02908581|Folic Acid|folic acid|mesh-list
14000657|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
14000658|NCT02908581|Hematinics|hematinics|mesh-ancestor
14000659|NCT02908581|Vitamins|vitamins|mesh-ancestor
14000660|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
14000661|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000662|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
14000663|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14000664|NCT02908711|Ropivacaine|ropivacaine|mesh-list
14000665|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
14000666|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
14000667|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000668|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000669|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
14000670|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000671|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14000672|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14000673|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
14000674|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000675|NCT02908698|Prednisone|prednisone|mesh-list
14000676|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14000677|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
14000678|NCT02908698|Hormones|hormones|mesh-ancestor
14000679|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000680|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000681|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14000682|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000683|NCT02908438|Hormones|hormones|mesh-list
14000684|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000685|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000686|NCT02908412|Bupivacaine|bupivacaine|mesh-list
14000687|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
14000688|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
14000689|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000690|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000691|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
14000692|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000693|NCT02908191|Tenofovir|tenofovir|mesh-list
14000694|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14000695|NCT02908191|Entecavir|entecavir|mesh-list
14000696|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
14000697|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000698|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14000699|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14000700|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000701|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000702|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14000703|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14000704|NCT02908295|Misoprostol|misoprostol|mesh-list
14000705|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14000706|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
14000707|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14000708|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000709|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14000710|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14000711|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
14000712|NCT02908165|Sorafenib|sorafenib|mesh-list
14000713|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
14000714|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000715|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000716|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000717|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000718|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14000719|NCT02908165|Estrogens|estrogens|mesh-ancestor
14000720|NCT02908165|Hormones|hormones|mesh-ancestor
14000721|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000722|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000723|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14000724|NCT02908282|Povidone|povidone|mesh-list
14000725|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
14000726|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
14000727|NCT02908152|Curcumin|curcumin|mesh-list
14000728|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14000729|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14000730|NCT02908152|Analgesics|analgesics|mesh-ancestor
14000731|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
14000732|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000733|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000734|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14000735|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000736|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000737|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000738|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000739|NCT02908126|Oxytocin|oxytocin|mesh-list
14000740|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
14000741|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14000742|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000743|NCT02907957|Anesthetics|anesthetics|mesh-list
14000744|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000745|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000746|NCT02908035|Sirolimus|sirolimus|mesh-list
14000747|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14000748|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000749|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14000750|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000751|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
14000752|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000753|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
14000754|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000755|NCT02907749|Carvedilol|carvedilol|mesh-list
14000756|NCT02907749|Spironolactone|spironolactone|mesh-list
14000757|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14000758|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
14000759|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000760|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000761|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14000762|NCT02907749|Diuretics|diuretics|mesh-ancestor
14000763|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
14000764|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14000765|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14000766|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
14000767|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000768|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000769|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15135169|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
15135170|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000770|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
14000771|NCT02907749|Protective Agents|protective agents|mesh-ancestor
14000772|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14000773|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14000774|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14000775|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
14000776|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14000777|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14000778|NCT02907593|Budesonide|budesonide|mesh-list
14000779|NCT02907593|Calfactant|calfactant|mesh-list
15135171|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15182035|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14000780|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14000781|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14000782|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
14000783|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000784|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000785|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14000786|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
14000787|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
14000788|NCT02907593|Hormones|hormones|mesh-ancestor
14000789|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000790|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14000791|NCT02907710|Endostar protein|endostar protein|mesh-list
14000792|NCT02907710|Endostatins|endostatins|mesh-list
14000793|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14000794|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14000795|NCT02907710|Growth Substances|growth substances|mesh-ancestor
14000796|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000797|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
14000798|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000799|NCT02907554|Cyclosporine|cyclosporine|mesh-list
14000800|NCT02907554|Cyclosporins|cyclosporins|mesh-list
14000801|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000802|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000803|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000804|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
14000805|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000806|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
14000807|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000808|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
14000809|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14000810|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14000811|NCT02907632|Metoclopramide|metoclopramide|mesh-list
15135172|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15135173|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15135174|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15135175|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135176|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135177|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
15135178|NCT04346030|Hormones|hormones|mesh-ancestor
15135179|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135180|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15135181|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
14000812|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
14000813|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
14000814|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000815|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000816|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14000817|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14000818|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14000819|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
14000820|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000821|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000822|NCT02907437|Minocycline|minocycline|mesh-list
14000823|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14000824|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000825|NCT02907307|Clotrimazole|clotrimazole|mesh-list
14000826|NCT02907307|Miconazole|miconazole|mesh-list
14000827|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14000828|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000829|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
14000830|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14000831|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14270414|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14270415|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270416|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270417|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
14270418|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135182|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135183|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15135184|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135185|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135186|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
14000832|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023779|NCT02760043|Dexamethasone|dexamethasone|mesh-list
14270419|NCT00409747|Minocycline|minocycline|mesh-list
14270420|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14270421|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000833|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000834|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14000835|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
14000836|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000837|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000838|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14000839|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14023780|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023781|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
14023782|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
14023783|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023784|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023785|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023786|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
14023787|NCT02760043|Hormones|hormones|mesh-ancestor
14023788|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023789|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023790|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023791|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
14023792|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14023793|NCT02759861|Ledipasvir|ledipasvir|mesh-list
14023794|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
14023795|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023796|NCT02760121|Acetazolamide|acetazolamide|mesh-list
14023797|NCT02760121|Methazolamide|methazolamide|mesh-list
14023798|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
14023799|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14023800|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023801|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023802|NCT02760121|Diuretics|diuretics|mesh-ancestor
14023803|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
14023804|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023805|NCT02759991|Vaccines|vaccines|mesh-list
14023806|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
14023807|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023808|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14023809|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14023810|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023811|NCT02760030|Fulvestrant|fulvestrant|mesh-list
14023812|NCT02760030|Palbociclib|palbociclib|mesh-list
14023813|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14023814|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14023815|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023816|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14023817|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14023818|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
14023819|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023820|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023821|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14023822|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023823|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023824|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14023825|NCT02760095|Vitamin A|vitamin a|mesh-list
14023826|NCT02760095|Acetic Acid|acetic acid|mesh-list
14023827|NCT02760095|Retinol acetate|retinol acetate|mesh-list
14023828|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
14023829|NCT02760095|Vitamins|vitamins|mesh-ancestor
14023830|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
14023831|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023832|NCT02760095|Protective Agents|protective agents|mesh-ancestor
14023833|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14023834|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023835|NCT02760095|Astringents|astringents|mesh-ancestor
14023836|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
14023837|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14023838|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
14023839|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14023840|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023841|NCT02759926|Quinine|quinine|mesh-list
14023842|NCT02759926|Denatonium|denatonium|mesh-list
14023843|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
14292397|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000840|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14000841|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14000842|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14000843|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000844|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000845|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000846|NCT02906722|Colistin|colistin|mesh-list
14000847|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14000848|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000849|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
14000850|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14000851|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000852|NCT02906995|Nicotine|nicotine|mesh-list
14000853|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14000854|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
14000855|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000856|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135187|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
15135188|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135189|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
15135190|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135191|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15135192|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135193|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135194|NCT04345848|Heparin|heparin|mesh-list
15135195|NCT04345848|Enoxaparin|enoxaparin|mesh-list
15135196|NCT04345848|Calcium heparin|calcium heparin|mesh-list
15135197|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
15135198|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15135199|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15135200|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000857|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14000858|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14000859|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
14000860|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14000861|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000862|NCT02906800|Digoxin|digoxin|mesh-list
14000863|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14000864|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14000865|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000866|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000867|NCT02906800|Protective Agents|protective agents|mesh-ancestor
14000868|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000869|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14000870|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
14000871|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
14000872|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
14000873|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
14000874|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15135201|NCT04345783|Apatinib|apatinib|mesh-list
15135202|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135203|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15135204|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135205|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000875|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000876|NCT02906150|Cisplatin|cisplatin|mesh-list
14000877|NCT02906150|Carboplatin|carboplatin|mesh-list
14000878|NCT02906150|Pemetrexed|pemetrexed|mesh-list
14000879|NCT02906150|Thymalfasin|thymalfasin|mesh-list
14000880|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000881|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000882|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000883|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14000884|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14000885|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14000886|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
14000887|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000888|NCT02906059|Irinotecan|irinotecan|mesh-list
14000889|NCT02906059|Adavosertib|adavosertib|mesh-list
14000890|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14000891|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14000892|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000893|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000894|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135206|NCT04345432|Gabapentin|gabapentin|mesh-list
15135207|NCT04345432|Analgesics|analgesics|mesh-ancestor
15135208|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
15135209|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000895|NCT02906176|Voriconazole|voriconazole|mesh-list
14000896|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
14000897|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000898|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14000899|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14000900|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000901|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000902|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14000903|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
14000904|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000905|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000906|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14000907|NCT02905994|Cytarabine|cytarabine|mesh-list
14000908|NCT02905994|Idarubicin|idarubicin|mesh-list
14000909|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14000910|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
14000911|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000912|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000913|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
14000914|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000915|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14000916|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
14000917|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000918|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14000919|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14000920|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14000921|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000922|NCT02905890|Norethindrone|norethindrone|mesh-list
14000923|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
14000924|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
14000925|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14000926|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14000927|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14000928|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
14000929|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14000930|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000931|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14000932|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14000933|NCT02906163|Gefitinib|gefitinib|mesh-list
14000934|NCT02906163|Afatinib|afatinib|mesh-list
14000935|NCT02906163|Thymalfasin|thymalfasin|mesh-list
14000936|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000937|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14000938|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14000939|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000940|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14000941|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
14000942|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000943|NCT02905864|Liraglutide|liraglutide|mesh-list
14000944|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14000945|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000946|NCT02905864|Incretins|incretins|mesh-ancestor
14000947|NCT02905864|Hormones|hormones|mesh-ancestor
14000948|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14000949|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
14000950|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
14000951|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
14000952|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14000953|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000954|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
14000955|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14000956|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14000957|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
14000958|NCT02905682|Coagulants|coagulants|mesh-ancestor
14000959|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14000960|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
14000961|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000962|NCT02905708|Charcoal|charcoal|mesh-list
14000963|NCT02905708|Antidotes|antidotes|mesh-ancestor
14000964|NCT02905708|Protective Agents|protective agents|mesh-ancestor
14000965|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135210|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000966|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
14000967|NCT02905591|Paclitaxel|paclitaxel|mesh-list
14000968|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14000969|NCT02905591|Carboplatin|carboplatin|mesh-list
14000970|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14000971|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000972|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000973|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000974|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
14000975|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000976|NCT02905591|Vitamins|vitamins|mesh-ancestor
14000977|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
14000978|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000979|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
14000980|NCT02905591|Protective Agents|protective agents|mesh-ancestor
14000981|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14000982|NCT02905539|Hematinics|hematinics|mesh-ancestor
14000983|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
14000984|NCT02905578|Gemcitabine|gemcitabine|mesh-list
14000985|NCT02905578|Paclitaxel|paclitaxel|mesh-list
14000986|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14000987|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14000988|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
14000989|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
14000990|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
14000991|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14000992|NCT02905578|Vitamins|vitamins|mesh-ancestor
14000993|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
14000994|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14000995|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14000996|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
14000997|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
14000998|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14000999|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001000|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001001|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
14001002|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
14001003|NCT02905578|Protective Agents|protective agents|mesh-ancestor
14001004|NCT02905734|Nicotine|nicotine|mesh-list
14001005|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14001006|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
14001007|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001008|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001009|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14001010|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14001011|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
14001012|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001013|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001014|NCT02905760|Furosemide|furosemide|mesh-list
14001015|NCT02905760|Diuretics|diuretics|mesh-list
14001016|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
14001017|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001018|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14001019|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14001020|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001021|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
14001022|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001023|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001024|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
14001025|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001026|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001027|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
14001028|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001029|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023844|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14023845|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14023846|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023847|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14023848|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023849|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14023850|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023851|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14023852|NCT02759926|Analgesics|analgesics|mesh-ancestor
14023853|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
14023854|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
14023855|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001030|NCT02905305|Dexamethasone|dexamethasone|mesh-list
14001031|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001032|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
14001033|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
14001034|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001035|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001036|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14001037|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
14001038|NCT02905305|Hormones|hormones|mesh-ancestor
14001039|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001040|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14001041|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001042|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
14001043|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14001044|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14001045|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
14001046|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001047|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001048|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001049|NCT02905058|Ketoprofen|ketoprofen|mesh-list
14001050|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14001051|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001052|NCT02905058|Analgesics|analgesics|mesh-ancestor
14001053|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
14001054|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270422|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14270423|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14270424|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14270425|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
14270426|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001055|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001056|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001057|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001058|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14001059|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001060|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001061|NCT02905045|Ketoprofen|ketoprofen|mesh-list
14001062|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14001063|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001064|NCT02905045|Analgesics|analgesics|mesh-ancestor
14001065|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
15135211|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
15135212|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15135213|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15135214|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135215|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15135216|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15135217|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15135218|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135219|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135220|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
14001066|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001067|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001068|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001069|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001070|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14001071|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001072|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001073|NCT02904772|Cyclosporine|cyclosporine|mesh-list
14001074|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
14001075|NCT02904772|Prednisolone|prednisolone|mesh-list
14001076|NCT02904772|Cyclosporins|cyclosporins|mesh-list
14001077|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001078|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001079|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001080|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
14001081|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001082|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
14001083|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001084|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
14001085|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001086|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14001087|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14001088|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001089|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14001090|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
14001091|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001092|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001093|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
14001094|NCT02904772|Hormones|hormones|mesh-ancestor
14001095|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001096|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14001097|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14001098|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
14001099|NCT02904759|Coagulants|coagulants|mesh-ancestor
14001100|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14001101|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
14001102|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001103|NCT02904564|Fluorouracil|fluorouracil|mesh-list
14001104|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
14001105|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001106|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001107|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001108|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001109|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
14001110|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001111|NCT02904538|Dexamethasone|dexamethasone|mesh-list
14001112|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001113|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
14001114|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
14001115|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001116|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001117|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14001118|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
14001119|NCT02904538|Hormones|hormones|mesh-ancestor
14001120|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001121|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14001122|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001123|NCT02904499|Dabigatran|dabigatran|mesh-list
14001124|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
14001125|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14001126|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
14001127|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001128|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001129|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
14001130|NCT02904369|Tenofovir|tenofovir|mesh-list
14001131|NCT02904369|Emtricitabine|emtricitabine|mesh-list
14001132|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
14001133|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001134|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15135221|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135222|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
15135223|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135224|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135225|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135226|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135227|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001135|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14001136|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001137|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001138|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14001139|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14001140|NCT02904291|Amlodipine|amlodipine|mesh-list
14001141|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14001142|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14001143|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14001144|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001145|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14001146|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001147|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
14001148|NCT02904304|Ibuprofen|ibuprofen|mesh-list
14001149|NCT02904304|Phenylephrine|phenylephrine|mesh-list
14001150|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
14001151|NCT02904304|Desloratadine|desloratadine|mesh-list
14001152|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14001153|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001154|NCT02904304|Analgesics|analgesics|mesh-ancestor
15135228|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135229|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
14001155|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
14001156|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001157|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001158|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001159|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001160|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15135230|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15135231|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15135232|NCT04345445|Prednisolone|prednisolone|mesh-list
15135233|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
15135234|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14001161|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001162|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001163|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14001164|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
14001165|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
14001166|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
14001167|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14001168|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
14001169|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14001170|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14001171|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14001172|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14001173|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
14001174|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001175|NCT02904304|Protective Agents|protective agents|mesh-ancestor
14001176|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15135235|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
15135236|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135237|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
15135238|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
15135239|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135240|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001177|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
14001178|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14001179|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14001180|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
14001181|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
14001182|NCT02904031|Leucovorin|leucovorin|mesh-list
14001183|NCT02904031|Fluorouracil|fluorouracil|mesh-list
14001184|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
14001185|NCT02904031|Panitumumab|panitumumab|mesh-list
14001186|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
14001187|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
14001188|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001189|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001190|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001191|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001192|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
14001193|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001194|NCT02904031|Antidotes|antidotes|mesh-ancestor
14001195|NCT02904031|Protective Agents|protective agents|mesh-ancestor
14001196|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
14001197|NCT02904031|Vitamins|vitamins|mesh-ancestor
14001198|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
14001199|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001200|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
14001201|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14001202|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
14001203|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001204|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001205|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14001206|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14001207|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14001208|NCT02904109|Mannitol|mannitol|mesh-list
14001209|NCT02904109|Triflusal|triflusal|mesh-list
14001210|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14001211|NCT02904109|Diuretics|diuretics|mesh-ancestor
14001212|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
14001213|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001214|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14001215|NCT02903901|Melatonin|melatonin|mesh-list
15135241|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135242|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
14001216|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
14001217|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001218|NCT02903901|Protective Agents|protective agents|mesh-ancestor
15135243|NCT04345445|Hormones|hormones|mesh-ancestor
14001219|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001220|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001221|NCT02903498|Tegafur|tegafur|mesh-list
14001222|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001223|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
14001224|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001225|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001226|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
14001227|NCT02903524|Doxorubicin|doxorubicin|mesh-list
14001228|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14001229|NCT02903524|Pirarubicin|pirarubicin|mesh-list
14001230|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001231|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
14001232|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001233|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001234|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15135244|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135245|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15135246|NCT04345445|Protective Agents|protective agents|mesh-ancestor
15135247|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15135248|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135249|NCT04345588|Dexamethasone|dexamethasone|mesh-list
15135250|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
15135251|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135252|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
15135253|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
15135254|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135255|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135256|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135257|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
15135258|NCT04345588|Hormones|hormones|mesh-ancestor
15135259|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135260|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15135261|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135262|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
15135263|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15135264|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15135265|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135266|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
15135267|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
15135268|NCT04345458|Etanercept|etanercept|mesh-list
15135269|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135270|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001235|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
14001236|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001237|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001238|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14001239|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14001240|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14001241|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14001242|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001243|NCT02903680|Dexamethasone|dexamethasone|mesh-list
14001244|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
14001245|NCT02903680|BB 1101|bb 1101|mesh-list
14001246|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001247|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
14001248|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
14001249|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001250|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001251|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14001252|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
14001253|NCT02903680|Hormones|hormones|mesh-ancestor
14001254|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001255|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14001256|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001257|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
14001258|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135271|NCT04345458|Analgesics|analgesics|mesh-ancestor
15135272|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
15135273|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135274|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001259|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135275|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135276|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001260|NCT02903485|Anesthetics|anesthetics|mesh-list
14001261|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001262|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001263|NCT02903719|Ropivacaine|ropivacaine|mesh-list
14001264|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
14001265|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
14001266|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001267|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001268|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
14001269|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001270|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
14001271|NCT02903537|Interferons|interferons|mesh-list
14001272|NCT02903537|Interferon-beta|interferon-beta|mesh-list
14001273|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001274|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
14001275|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001276|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
14001277|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001278|NCT02903537|Vitamins|vitamins|mesh-ancestor
15135277|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135278|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15135279|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
15135280|NCT04345419|Remdesivir|remdesivir|mesh-list
15135281|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
14001279|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
14001280|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14001281|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14001282|NCT02903251|Oxytocin|oxytocin|mesh-list
14001283|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
14001284|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001285|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001286|NCT02903004|Gemcitabine|gemcitabine|mesh-list
14001287|NCT02903004|Paclitaxel|paclitaxel|mesh-list
14001288|NCT02903004|Carboplatin|carboplatin|mesh-list
14001289|NCT02903004|Doxorubicin|doxorubicin|mesh-list
14001290|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14001291|NCT02903004|Topotecan|topotecan|mesh-list
14001292|NCT02903004|Trabectedin|trabectedin|mesh-list
14001293|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14001294|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001295|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14001296|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14001297|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14001298|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001299|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001300|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
14001301|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
14001302|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001303|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001304|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001305|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
14001306|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001307|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14001308|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14001309|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14001310|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14001311|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14001312|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
14001313|NCT02902861|Methotrexate|methotrexate|mesh-list
14001314|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14001315|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
14001316|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001317|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001318|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001319|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
14001320|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001321|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001322|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
14001323|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001324|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14001325|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001326|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
14001327|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001328|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14001329|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
14292398|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
15135282|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001330|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14001331|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14001332|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001333|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
14001334|NCT02903017|Coagulants|coagulants|mesh-ancestor
14001335|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14001336|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001337|NCT02903069|Temozolomide|temozolomide|mesh-list
14001338|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14001339|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
14001340|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001341|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001342|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14001343|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001344|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
14001345|NCT02902744|Hormones|hormones|mesh-ancestor
14001346|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001347|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001348|NCT02902666|Acetaminophen|acetaminophen|mesh-list
14001349|NCT02902666|Codeine|codeine|mesh-list
14001350|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001351|NCT02902666|Analgesics|analgesics|mesh-ancestor
14001352|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
14001353|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001354|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001355|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
14001356|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14001357|NCT02902666|Narcotics|narcotics|mesh-ancestor
14001358|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001359|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
14001360|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
14001361|NCT02902653|Misoprostol|misoprostol|mesh-list
14001362|NCT02902653|Dinoprostone|dinoprostone|mesh-list
14001363|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14001364|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
14001365|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001366|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001367|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14001368|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14001369|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
14001370|NCT02902640|Trimethoprim|trimethoprim|mesh-list
14001371|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
14001372|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
14001373|NCT02902640|Guaifenesin|guaifenesin|mesh-list
14001374|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14001375|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14001376|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001377|NCT02902640|Renal Agents|renal agents|mesh-ancestor
14001378|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
14001379|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14001380|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14001381|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14001382|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001383|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001384|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14001385|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14001386|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14001387|NCT02902640|Expectorants|expectorants|mesh-ancestor
14001388|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
14001389|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14001390|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14001391|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
14001392|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001393|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001394|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
14001395|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14001396|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
14001397|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
14001398|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001399|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
14001400|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14001401|NCT02902354|Nifedipine|nifedipine|mesh-list
14001402|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14001403|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14001404|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001405|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14001406|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001407|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
14001408|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
14001409|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001410|NCT02902315|Vitamins|vitamins|mesh-list
14001411|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
14001412|NCT02902315|Tocopherols|tocopherols|mesh-list
14001413|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
14001414|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
14001415|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001416|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
14001417|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001418|NCT02902315|Protective Agents|protective agents|mesh-ancestor
14001419|NCT02902302|Ibuprofen|ibuprofen|mesh-list
14001420|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14001421|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001422|NCT02902302|Analgesics|analgesics|mesh-ancestor
14001423|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
14001424|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001425|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001426|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001427|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001428|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14001429|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001430|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001431|NCT02902523|Tenofovir|tenofovir|mesh-list
14001432|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
14001433|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001434|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14001435|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14001436|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001437|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001438|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14001439|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14001440|NCT02902432|Endostar protein|endostar protein|mesh-list
14001441|NCT02902432|Endostatins|endostatins|mesh-list
14001442|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14001443|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14001444|NCT02902432|Growth Substances|growth substances|mesh-ancestor
14001445|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001446|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
14001447|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001448|NCT02902484|Nintedanib|nintedanib|mesh-list
14001449|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001450|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14001451|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001452|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001453|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
14001454|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14001455|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001456|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001457|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001458|NCT02902380|Analgesics|analgesics|mesh-ancestor
14001459|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
15135283|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
15135284|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135285|NCT04345406|Chloroquine|chloroquine|mesh-list
15135286|NCT04345406|Enalapril|enalapril|mesh-list
15135287|NCT04345406|Captopril|captopril|mesh-list
14001460|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001461|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14001462|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14001463|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14001464|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
14001465|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001466|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001467|NCT02902289|Ibuprofen|ibuprofen|mesh-list
14001468|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14001469|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001470|NCT02902289|Analgesics|analgesics|mesh-ancestor
14001471|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
14001472|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135288|NCT04345406|Amebicides|amebicides|mesh-ancestor
15135289|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135290|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14001473|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001474|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001475|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001476|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14001477|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001478|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001479|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
14001480|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001481|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001482|NCT02902029|Atezolizumab|atezolizumab|mesh-list
14001483|NCT02902029|Vemurafenib|vemurafenib|mesh-list
14001484|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001485|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14001486|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001487|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001488|NCT02902133|Acetazolamide|acetazolamide|mesh-list
14001489|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
14001490|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14001491|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001492|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001493|NCT02902133|Diuretics|diuretics|mesh-ancestor
14001494|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
14001495|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023856|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
14023857|NCT02759614|Bevacizumab|bevacizumab|mesh-list
14023858|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14023859|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14023860|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023861|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14023862|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14023863|NCT02759614|Growth Substances|growth substances|mesh-ancestor
14023864|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023865|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
14023866|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14023867|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023868|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023869|NCT02759510|Phenylephrine|phenylephrine|mesh-list
14023870|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
14023871|NCT02759510|Norepinephrine|norepinephrine|mesh-list
14023872|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14023873|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
14023874|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
14023875|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023876|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023877|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
14023878|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14023879|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
14023880|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
14023881|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14023882|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14023883|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14023884|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
14023885|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023886|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023887|NCT02759510|Protective Agents|protective agents|mesh-ancestor
14023888|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
14023889|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14023890|NCT02759380|Estrogens|estrogens|mesh-ancestor
14023891|NCT02759380|Hormones|hormones|mesh-ancestor
14023892|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023893|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023894|NCT02759224|Irsogladine|irsogladine|mesh-list
14023895|NCT02759224|Lafutidine|lafutidine|mesh-list
14023896|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023897|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14023898|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135291|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135292|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
15135293|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023899|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14023900|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
14023901|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
14023902|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023903|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182036|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
14001496|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
14001497|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14001498|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001499|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001500|NCT02901977|Ramipril|ramipril|mesh-list
14001501|NCT02901977|Doxazosin|doxazosin|mesh-list
14001502|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14001503|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
14001504|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001505|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001506|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14001507|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14001508|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14001509|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14001510|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
14001511|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001512|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001513|NCT02902198|Quinine|quinine|mesh-list
14001514|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
14001515|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14001516|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14001517|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001518|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14270427|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270428|NCT00409825|Progestins|progestins|mesh-ancestor
14270429|NCT00409825|Hormones|hormones|mesh-ancestor
14270430|NCT00409838|Methotrexate|methotrexate|mesh-list
14270431|NCT00409838|Abatacept|abatacept|mesh-list
14270432|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14270433|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
14270434|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14270435|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135294|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15135295|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
15135296|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135297|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135298|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15135299|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15135300|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15135301|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15135302|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15135303|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135304|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135305|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135306|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
15135307|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15135308|NCT04344951|Chloroquine|chloroquine|mesh-list
14270436|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270437|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
14270438|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270439|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270440|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14270441|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135309|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15135310|NCT04344951|Amebicides|amebicides|mesh-ancestor
15135311|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135312|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135313|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135314|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
15135315|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135316|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135317|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15135318|NCT04344951|Analgesics|analgesics|mesh-ancestor
15135319|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
15135320|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001519|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001520|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14001521|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001522|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001523|NCT02902198|Analgesics|analgesics|mesh-ancestor
14001524|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
14001525|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14001526|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
14001527|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14001528|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14001529|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14001530|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001531|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001532|NCT02901561|Misoprostol|misoprostol|mesh-list
14001533|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14001534|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
14001535|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14001536|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001537|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14001538|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14001539|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
14001540|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
14001541|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
14001542|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001543|NCT02901366|Dotinurad|dotinurad|mesh-list
14001544|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
14001545|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
14001546|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001547|NCT02901366|Renal Agents|renal agents|mesh-ancestor
14001548|NCT02901379|Atorvastatin|atorvastatin|mesh-list
14001549|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14001550|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14001551|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
14001552|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001553|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14001554|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14001555|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001556|NCT02901353|Sirolimus|sirolimus|mesh-list
14001557|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001558|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001559|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14001560|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001561|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
14001562|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001563|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
15135321|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001564|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001565|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14001566|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14001567|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001568|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
14001569|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001570|NCT02901288|Levofloxacin|levofloxacin|mesh-list
14001571|NCT02901288|Ofloxacin|ofloxacin|mesh-list
14001572|NCT02901288|Rifampin|rifampin|mesh-list
14001573|NCT02901288|Isoniazid|isoniazid|mesh-list
14001574|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
14001575|NCT02901288|Ethambutol|ethambutol|mesh-list
14001576|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14001577|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001578|NCT02901288|Renal Agents|renal agents|mesh-ancestor
14001579|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001580|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14001581|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14001582|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001583|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001584|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001585|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14001586|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14001587|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14001588|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
14001589|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
15135322|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135323|NCT04344951|Filaricides|filaricides|mesh-ancestor
15135324|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
15135325|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
15135326|NCT04345094|Hydroquinone|hydroquinone|mesh-list
14001590|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14001591|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14001592|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14001593|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14001594|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14001595|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15135327|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
14001596|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14001597|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14001598|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14001599|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
14001600|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14001601|NCT02901184|Spironolactone|spironolactone|mesh-list
14001602|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14001603|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
14001604|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001605|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001606|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14001607|NCT02901184|Diuretics|diuretics|mesh-ancestor
14001608|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
14001609|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
14001610|NCT02901145|Nivolumab|nivolumab|mesh-list
14001611|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001612|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
14001613|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001614|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001615|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14001616|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
14001617|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001618|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001619|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14001620|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001621|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14001622|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
14001623|NCT02901301|Capecitabine|capecitabine|mesh-list
14001624|NCT02901301|Trastuzumab|trastuzumab|mesh-list
14001625|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001626|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001627|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001628|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
14001629|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001630|NCT02901236|Bevacizumab|bevacizumab|mesh-list
14001631|NCT02901236|Mitomycins|mitomycins|mesh-list
14001632|NCT02901236|Mitomycin|mitomycin|mesh-list
14001633|NCT02901236|Antimetabolites|antimetabolites|mesh-list
14001634|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001635|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001636|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14001637|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14001638|NCT02901236|Growth Substances|growth substances|mesh-ancestor
14001639|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001640|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
15135328|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135329|NCT04345094|Protective Agents|protective agents|mesh-ancestor
15135330|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135331|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15135332|NCT04345146|Bevacizumab|bevacizumab|mesh-list
15135333|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15135334|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135335|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15135336|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15135337|NCT04345146|Growth Substances|growth substances|mesh-ancestor
15135338|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135339|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
15135340|NCT04345276|Ritonavir|ritonavir|mesh-list
15135341|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15135342|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15135343|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
15135344|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135345|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135346|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15135347|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15135348|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
14001641|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14001642|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
14001643|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001644|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14001645|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001646|NCT02900976|Rituximab|rituximab|mesh-list
14001647|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14001648|NCT02900976|Antibodies|antibodies|mesh-list
14001649|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
14001650|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14001651|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
14001652|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001653|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001654|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001655|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14001656|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14001657|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001658|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
14270442|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14270443|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270444|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
14270445|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270446|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14270447|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14270448|NCT00410046|Etanercept|etanercept|mesh-list
14270449|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14270450|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14270451|NCT00410046|Analgesics|analgesics|mesh-ancestor
14270452|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
14001659|NCT02900729|Losartan|losartan|mesh-list
14001660|NCT02900729|Amlodipine|amlodipine|mesh-list
14001661|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14001662|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14001663|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14001664|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14001665|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001666|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14001667|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001668|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
14001669|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14001670|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14001671|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14001672|NCT02900729|Diuretics|diuretics|mesh-ancestor
14001673|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
14001674|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14001675|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
14001676|NCT02900560|Azacitidine|azacitidine|mesh-list
14001677|NCT02900560|Cc-486|cc-486|mesh-list
14001678|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001679|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001680|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001681|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
14001682|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001683|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001684|NCT02900742|Gemcitabine|gemcitabine|mesh-list
14001685|NCT02900742|Docetaxel|docetaxel|mesh-list
14001686|NCT02900742|Pemetrexed|pemetrexed|mesh-list
14001687|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001688|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
14001689|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001690|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001691|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
14001692|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001693|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001694|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001695|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
14001696|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001697|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
14001698|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
14001699|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
14001700|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14001701|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14001702|NCT02900209|Vaccines|vaccines|mesh-list
14001703|NCT02900209|Immunologic Factors|immunologic factors|mesh-ancestor
14001704|NCT02900209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023904|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023905|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14023906|NCT02759224|Protective Agents|protective agents|mesh-ancestor
14023907|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14023908|NCT02759393|Lansoprazole|lansoprazole|mesh-list
14023909|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
14023910|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14023911|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14023912|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14001705|NCT02900352|Zonisamide|zonisamide|mesh-list
14001706|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
14001707|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14001708|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14001709|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001710|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14001711|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001712|NCT02900469|Denosumab|denosumab|mesh-list
14001713|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14001714|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001715|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
14001716|NCT02900443|Azathioprine|azathioprine|mesh-list
14001717|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14001718|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001719|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14001720|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
14001721|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001722|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001723|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001724|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001725|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
14001726|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14001727|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14001728|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
14001729|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001730|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001731|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14001732|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14001733|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001734|NCT02900417|Incretins|incretins|mesh-ancestor
14001735|NCT02900417|Hormones|hormones|mesh-ancestor
14001736|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001737|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14001738|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
14001739|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001740|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001741|NCT02900157|Durvalumab|durvalumab|mesh-list
14001742|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001743|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001744|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
14001745|NCT02900430|Clotrimazole|clotrimazole|mesh-list
14001746|NCT02900430|Miconazole|miconazole|mesh-list
14001747|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001748|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14001749|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14001750|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14001751|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001752|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001753|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14001754|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
14001755|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001756|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001757|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14001758|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14001759|NCT02900105|Letrozole|letrozole|mesh-list
14001760|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001761|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14001762|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14001763|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001764|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001765|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14001766|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
14001767|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001768|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001769|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14001770|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
14001771|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001772|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
14001773|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001774|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001775|NCT02899611|Valproic Acid|valproic acid|mesh-list
14001776|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
14001777|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001778|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001779|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
14001780|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001781|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001782|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
14001783|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14001784|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001785|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14001786|NCT02899507|Amoxicillin|amoxicillin|mesh-list
14001787|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14001788|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
14001789|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
14001790|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001791|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001792|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14001793|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001794|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001795|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14001796|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14001797|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001798|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
14001799|NCT02899364|Antidotes|antidotes|mesh-ancestor
14001800|NCT02899364|Protective Agents|protective agents|mesh-ancestor
14001801|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001802|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
14001803|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001804|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
14001805|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001806|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001807|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
14001808|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
14001809|NCT02899286|BCT-100|bct-100|mesh-list
14001810|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001811|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
14001812|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14001813|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
14001814|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
14001815|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001816|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001817|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001818|NCT02899182|Analgesics|analgesics|mesh-ancestor
14001819|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
14001820|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001821|NCT02899169|Tretinoin|tretinoin|mesh-list
14001822|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
14001823|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
14001824|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001825|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
14001826|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
15135349|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135350|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15135351|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14001827|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
14001828|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001829|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001830|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14001831|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14001832|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001833|NCT02899000|Doxycycline|doxycycline|mesh-list
14001834|NCT02899000|Adapalene|adapalene|mesh-list
14001835|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14001836|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001837|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001838|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
14001839|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14001840|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14001841|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
14001842|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14001843|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14001844|NCT02899000|Analgesics|analgesics|mesh-ancestor
15135352|NCT04345198|Epinephrine|epinephrine|mesh-list
14001845|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
14001846|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001847|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001848|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001849|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001850|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14001851|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001852|NCT02899026|Prednisone|prednisone|mesh-list
14001853|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14001854|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001855|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
14001856|NCT02899026|Hormones|hormones|mesh-ancestor
14001857|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001858|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001859|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14001860|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001861|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
14001862|NCT02898961|Gentamicins|gentamicins|mesh-list
14001863|NCT02898961|Amikacin|amikacin|mesh-list
14001864|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14001865|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001866|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14001867|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001868|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023913|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023914|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023915|NCT02759042|Leronlimab|leronlimab|mesh-list
14023916|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14023917|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14023918|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023919|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14023920|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14023921|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
14023922|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023923|NCT02759107|Dulaglutide|dulaglutide|mesh-list
14023924|NCT02759107|Tirzepatide|tirzepatide|mesh-list
14023925|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14023926|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023927|NCT02759107|Incretins|incretins|mesh-ancestor
14023928|NCT02759107|Hormones|hormones|mesh-ancestor
14023929|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14023930|NCT02758951|Bevacizumab|bevacizumab|mesh-list
14023931|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14023932|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023933|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14023934|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14023935|NCT02758951|Growth Substances|growth substances|mesh-ancestor
14023936|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023937|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
14023938|NCT02758925|Cytarabine|cytarabine|mesh-list
14023939|NCT02758925|Rituximab|rituximab|mesh-list
14023940|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14023941|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14023942|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14023943|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
14023944|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023945|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14023946|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14023947|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
14023948|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023949|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
14023950|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14023951|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14023952|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15135353|NCT04345198|Racepinephrine|racepinephrine|mesh-list
15135354|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
15135355|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15135356|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15135357|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
15135358|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135359|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135360|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023953|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
14023954|NCT02758990|Vitamin D|vitamin d|mesh-list
14023955|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
14023956|NCT02758990|Vitamins|vitamins|mesh-list
14023957|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
14023958|NCT02758990|Vitamin E|vitamin e|mesh-list
14023959|NCT02758990|Tocopherols|tocopherols|mesh-list
14023960|NCT02758990|Vitamin A|vitamin a|mesh-list
14023961|NCT02758990|Niacinamide|niacinamide|mesh-list
14001869|NCT02898792|Remifentanil|remifentanil|mesh-list
14001870|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14001871|NCT02898792|Narcotics|narcotics|mesh-ancestor
14001872|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001873|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001874|NCT02898792|Analgesics|analgesics|mesh-ancestor
14001875|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
14001876|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001877|NCT02898779|Primaquine|primaquine|mesh-list
14001878|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
14001879|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14001880|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14001881|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001882|NCT02898571|Ascorbic Acid|ascorbic acid|mesh-list
14001883|NCT02898571|Vitamins|vitamins|mesh-ancestor
14001884|NCT02898571|Micronutrients|micronutrients|mesh-ancestor
14001885|NCT02898571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001886|NCT02898571|Antioxidants|antioxidants|mesh-ancestor
14001887|NCT02898571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001888|NCT02898571|Protective Agents|protective agents|mesh-ancestor
14001889|NCT02898376|Tocopherols|tocopherols|mesh-list
14001890|NCT02898376|Vitamin E|vitamin e|mesh-list
14001891|NCT02898376|Tocotrienols|tocotrienols|mesh-list
14001892|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
14001893|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
14001894|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14001895|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001896|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001897|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14001898|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14001899|NCT02898376|Protective Agents|protective agents|mesh-ancestor
14001900|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001901|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
14001902|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14001903|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
14001904|NCT02898376|Vitamins|vitamins|mesh-ancestor
14001905|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
14001906|NCT02898610|Colchicine|colchicine|mesh-list
14001907|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
14001908|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14001909|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14001910|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14001911|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14001912|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001913|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001914|NCT02897934|Bupivacaine|bupivacaine|mesh-list
14001915|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
14001916|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
14001917|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001918|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001919|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
14001920|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001921|NCT02897986|Vinorelbine|vinorelbine|mesh-list
14001922|NCT02897986|Propranolol|propranolol|mesh-list
14001923|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14001924|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001925|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
14001926|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
14001927|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
14001928|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001929|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14001930|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14001931|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
14001932|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001933|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001934|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14001935|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14001936|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
14001937|NCT02898012|Bevacizumab|bevacizumab|mesh-list
14001938|NCT02898012|Temozolomide|temozolomide|mesh-list
14001939|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14001940|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001941|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14001942|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14001943|NCT02898012|Growth Substances|growth substances|mesh-ancestor
14001944|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001945|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
14023962|NCT02758990|Niacin|niacin|mesh-list
14001946|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14001947|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
14001948|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135361|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15135362|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15135363|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
15135364|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135365|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14001954|NCT02897869|Amikacin|amikacin|mesh-list
14001955|NCT02897869|Murepavadin|murepavadin|mesh-list
14001956|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135366|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
15135367|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
15135368|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
15135369|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14001957|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14001958|NCT02897856|Midazolam|midazolam|mesh-list
14001959|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14001960|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14001961|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14001962|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001963|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14001964|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15135370|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
15135371|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15135372|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15135373|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270453|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270454|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270455|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001965|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14001966|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14001967|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
14001968|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
14001969|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
14001970|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
14001971|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14001972|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001973|NCT02897830|Dexamethasone|dexamethasone|mesh-list
14001974|NCT02897830|Lenalidomide|lenalidomide|mesh-list
14001975|NCT02897830|Ixazomib|ixazomib|mesh-list
14001976|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14001977|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
14001978|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
14001979|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14001980|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001981|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14001982|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
14001983|NCT02897830|Hormones|hormones|mesh-ancestor
14001984|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14001985|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14001986|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14001987|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
14001988|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14001989|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14001990|NCT02897830|Growth Substances|growth substances|mesh-ancestor
14001991|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14001992|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
14001993|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14001994|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14001995|NCT02897765|Nivolumab|nivolumab|mesh-list
14001996|NCT02897765|Poly ICLC|poly iclc|mesh-list
14001997|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
14001998|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14001999|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14002000|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002001|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14002002|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002003|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
14002004|NCT02897557|Pancrelipase|pancrelipase|mesh-list
14002005|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002006|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
14002007|NCT02897700|Doxorubicin|doxorubicin|mesh-list
14002008|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14002009|NCT02897700|Fluorouracil|fluorouracil|mesh-list
15135374|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
15135375|NCT04344860|Coagulants|coagulants|mesh-ancestor
14002010|NCT02897700|Methotrexate|methotrexate|mesh-list
14002011|NCT02897700|Epirubicin|epirubicin|mesh-list
14002012|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002013|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
14002014|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002015|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002016|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14002017|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
14002018|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002019|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002020|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14002021|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14002022|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14002023|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14002024|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002025|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
14002026|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14002027|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14002028|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
14002029|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14002030|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
14002031|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14002032|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14002033|NCT02897596|Grazoprevir|grazoprevir|mesh-list
15135376|NCT04344821|Calcium|calcium|mesh-list
15135377|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15135378|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178936|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178937|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178938|NCT03953989|Ranolazine|ranolazine|mesh-list
15178939|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15178940|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15178941|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002034|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
14002035|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002036|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
14002037|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14023963|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
14023964|NCT02758990|Pyridoxine|pyridoxine|mesh-list
14023965|NCT02758990|Pyridoxal|pyridoxal|mesh-list
14023966|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
14023967|NCT02758990|Caffeine|caffeine|mesh-list
14023968|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
14023969|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023970|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14023971|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14023972|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
14023973|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14023974|NCT02758990|Protective Agents|protective agents|mesh-ancestor
14023975|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14023976|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14023977|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023978|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14023979|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14023980|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
14023981|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14023982|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
14023983|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14023984|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
15182037|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15182038|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
15182039|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15182040|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14023985|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14023986|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
14023987|NCT02759198|Celecoxib|celecoxib|mesh-list
14023988|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14023989|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14023990|NCT02759198|Analgesics|analgesics|mesh-ancestor
14023991|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
14023992|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14023993|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14023994|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14023995|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002038|NCT02897206|Imipenem|imipenem|mesh-list
14002039|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14002040|NCT02897206|Cilastatin|cilastatin|mesh-list
14002041|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14002042|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002043|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
14002044|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002045|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002046|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
14002047|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
14002048|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002049|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
14002050|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002051|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002052|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
14002053|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14002054|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002055|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14002056|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002057|NCT02897063|Midodrine|midodrine|mesh-list
14002058|NCT02897063|Droxidopa|droxidopa|mesh-list
14002059|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
14002060|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
14002061|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002062|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002063|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14002064|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14002065|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14002066|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14002067|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
14002068|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002069|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002070|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14002071|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14002072|NCT02897076|Betamethasone|betamethasone|mesh-list
14002073|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
14002074|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14002075|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
14002076|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14002077|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002078|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
14002079|NCT02897076|Hormones|hormones|mesh-ancestor
14002080|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002081|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002082|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14002083|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
14002084|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
14002085|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002086|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14002087|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002088|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002089|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
14002090|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002091|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14002092|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002093|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002094|NCT02896803|Fluorouracil|fluorouracil|mesh-list
14002095|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
14002096|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
14002097|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002098|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14002099|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002100|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002101|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
14002102|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002103|NCT02897037|Heparin|heparin|mesh-list
14002104|NCT02897037|Bivalirudin|bivalirudin|mesh-list
14002105|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
14002106|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14002107|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14002108|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002109|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
15135379|NCT04344483|Lidocaine|lidocaine|mesh-list
14002110|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14002111|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
14002112|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002113|NCT02897011|Methotrexate|methotrexate|mesh-list
14002114|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14002115|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
14002116|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14002117|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002118|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14002119|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
14002120|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002121|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002122|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
14002123|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002124|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14002125|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002126|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
14002127|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002128|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14002129|NCT02896621|Amlodipine|amlodipine|mesh-list
14002130|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
14002131|NCT02896621|Amiloride|amiloride|mesh-list
14002132|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14002133|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14002134|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14002135|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002136|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14002137|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002138|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
14002139|NCT02896621|Diuretics|diuretics|mesh-ancestor
14002140|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
14002141|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14002142|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14002143|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14002144|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14002145|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14002146|NCT02896582|Cytarabine|cytarabine|mesh-list
14002147|NCT02896582|Dexamethasone|dexamethasone|mesh-list
14002148|NCT02896582|Etoposide|etoposide|mesh-list
14002149|NCT02896582|Melphalan|melphalan|mesh-list
14002150|NCT02896582|Cisplatin|cisplatin|mesh-list
14002151|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
14002152|NCT02896582|Carmustine|carmustine|mesh-list
14002153|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002154|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
14002155|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
14002156|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002157|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002158|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002159|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
14002160|NCT02896582|Hormones|hormones|mesh-ancestor
14002161|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002162|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14002163|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002164|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14002165|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14002166|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14002167|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002168|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002169|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14002170|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
14002171|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
14002172|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002173|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002174|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
14002175|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14002176|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
14002177|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14002178|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15135380|NCT04344483|Epinephrine|epinephrine|mesh-list
15135381|NCT04344483|Racepinephrine|racepinephrine|mesh-list
15135382|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
15135383|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
15135384|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
14002179|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
15135385|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135386|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135387|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
15135388|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135389|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15135390|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15135391|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15135392|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15135393|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135394|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15135395|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15135396|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
15135397|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002180|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14002181|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002182|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002183|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14002184|NCT02896413|Analgesics|analgesics|mesh-ancestor
14002185|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
14002186|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002187|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14002188|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14002189|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14002190|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
14002191|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002192|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002193|NCT02896270|Valproic Acid|valproic acid|mesh-list
14002194|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
14002195|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002196|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135398|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15135399|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15135400|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
15135401|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15135402|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
15135403|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
14002197|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
14002198|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002199|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002200|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
14002201|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14002202|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002203|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14002204|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
14002205|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14002206|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002207|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14002208|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
14002209|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14002210|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002211|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002212|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002213|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
14002214|NCT02896101|Tacrolimus|tacrolimus|mesh-list
14002215|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14002216|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14002217|NCT02896101|Analgesics|analgesics|mesh-ancestor
14002218|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
14002219|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002220|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002221|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002222|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002223|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14002224|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002225|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
14002226|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15135404|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
15135405|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15135406|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135407|NCT04344457|Azithromycin|azithromycin|mesh-list
15135408|NCT04344457|Indomethacin|indomethacin|mesh-list
15135409|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
15135410|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14002227|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023996|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15135411|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135412|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135413|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135414|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135415|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002228|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002229|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14002230|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
14002231|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002232|NCT02896023|Menotropins|menotropins|mesh-list
14002233|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14002234|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
14002235|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14002236|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002237|NCT02895659|Norepinephrine|norepinephrine|mesh-list
14002238|NCT02895659|Epinephrine|epinephrine|mesh-list
14002239|NCT02895659|Racepinephrine|racepinephrine|mesh-list
14002240|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
14002241|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14002242|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14002243|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
14002244|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002245|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002246|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002247|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
14002248|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
14002249|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002250|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14002251|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14002252|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14002253|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14002254|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
14002255|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
14002256|NCT02895529|Itraconazole|itraconazole|mesh-list
14002257|NCT02895529|Caspofungin|caspofungin|mesh-list
14002258|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
14002259|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002260|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14002261|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14002262|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002263|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002264|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14002265|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
14002266|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002267|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002268|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14002269|NCT02895672|Exenatide|exenatide|mesh-list
14002270|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14002271|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002272|NCT02895672|Incretins|incretins|mesh-ancestor
14002273|NCT02895672|Hormones|hormones|mesh-ancestor
14002274|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002275|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14023997|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14023998|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14023999|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024000|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14024001|NCT02758873|Montelukast|montelukast|mesh-list
14024002|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14024003|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
14024004|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024005|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024006|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14024007|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
14024008|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14024009|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14024010|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14024011|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14024012|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024013|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024014|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14024015|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
14024016|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024017|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14002276|NCT02895750|Metformin|metformin|mesh-list
14002277|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14002278|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002279|NCT02895191|Urinastatin|urinastatin|mesh-list
14002280|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
14002281|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14002282|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
14002283|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002284|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002285|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
15135416|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135417|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15135418|NCT04344457|Analgesics|analgesics|mesh-ancestor
15135419|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
15135420|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135421|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135422|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135423|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
15135424|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
15135425|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15135426|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15135427|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14002286|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14002287|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14002288|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002289|NCT02895061|Vitamins|vitamins|mesh-ancestor
14002290|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
14002291|NCT02895113|Aspirin|aspirin|mesh-list
14002292|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14002293|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14002294|NCT02895113|Analgesics|analgesics|mesh-ancestor
14002295|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
14002296|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002297|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002298|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002299|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002300|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14002301|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14002302|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002303|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14002304|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14002305|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002306|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
14002307|NCT02895321|Listerine|listerine|mesh-list
14002308|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
14002309|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
14002310|NCT02895321|Protective Agents|protective agents|mesh-ancestor
14002311|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002312|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14002313|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002314|NCT02894983|Calpastatin|calpastatin|mesh-list
14002315|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14002316|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
15135428|NCT04344717|Apixaban|apixaban|mesh-list
15135429|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15135430|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
15135431|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15135432|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
15135433|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135434|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135435|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
15135436|NCT04344756|Heparin|heparin|mesh-list
15135437|NCT04344756|Calcium heparin|calcium heparin|mesh-list
15135438|NCT04344756|Tinzaparin|tinzaparin|mesh-list
15135439|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15135440|NCT04344756|Dalteparin|dalteparin|mesh-list
15135441|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
15135442|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15135443|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15135444|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135445|NCT04344782|Bevacizumab|bevacizumab|mesh-list
15135446|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15135447|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002317|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002318|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135448|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14002319|NCT02895022|Lidocaine|lidocaine|mesh-list
14002320|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
14002321|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
14002322|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135449|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15135450|NCT04344782|Growth Substances|growth substances|mesh-ancestor
15135451|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135452|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
15135453|NCT04344730|Dexamethasone|dexamethasone|mesh-list
15135454|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
15135455|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135456|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
15135457|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
15135458|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135459|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135460|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135461|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
15135462|NCT04344730|Hormones|hormones|mesh-ancestor
15135463|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002323|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002324|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
14002325|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002326|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14002327|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14002328|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14002329|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14002330|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002331|NCT02894957|Varenicline|varenicline|mesh-list
14002332|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14002333|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14002334|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
14002335|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002336|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002337|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002338|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
14002339|NCT02895074|Tropicamide|tropicamide|mesh-list
14002340|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
14002341|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
14002342|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002343|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002344|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14002345|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14002346|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
15135464|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15135465|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135466|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
15135467|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
15135468|NCT04344236|Povidone|povidone|mesh-list
14002347|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002348|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002349|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
14002350|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
14002351|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002352|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
14002353|NCT02894892|Esomeprazole|esomeprazole|mesh-list
14002354|NCT02894892|Bismuth|bismuth|mesh-list
14002355|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14002356|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002357|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14002358|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002359|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002360|NCT02894892|Antacids|antacids|mesh-ancestor
14002361|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
14002362|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
14002363|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002364|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14002365|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
14002366|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002367|NCT02894593|Ethanol|ethanol|mesh-list
14002368|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
14002369|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14002370|NCT02894593|Listerine|listerine|mesh-list
15135469|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15135470|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135471|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
14002371|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
14002372|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14002373|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002374|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002375|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002376|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
14002377|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
14002378|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
14002379|NCT02894593|Protective Agents|protective agents|mesh-ancestor
14002380|NCT02894554|Lamivudine|lamivudine|mesh-list
14002381|NCT02894554|Telbivudine|telbivudine|mesh-list
14002382|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14002383|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14002384|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002385|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002386|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
14002387|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002388|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14002389|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14002390|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
14002391|NCT02894606|Basiliximab|basiliximab|mesh-list
14002392|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
14002393|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002394|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002395|NCT02894684|Aztreonam|aztreonam|mesh-list
14002396|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14002397|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002398|NCT02894710|Lidocaine|lidocaine|mesh-list
14002399|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
14002400|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
14002401|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002402|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002403|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
14002404|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002405|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14002406|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14002407|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14002408|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14002409|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002410|NCT02894645|Cytarabine|cytarabine|mesh-list
14002411|NCT02894645|Dexamethasone|dexamethasone|mesh-list
14002412|NCT02894645|Prednisolone|prednisolone|mesh-list
14002413|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
14002414|NCT02894645|Doxorubicin|doxorubicin|mesh-list
14002415|NCT02894645|Methotrexate|methotrexate|mesh-list
14002416|NCT02894645|Fludarabine|fludarabine|mesh-list
14002417|NCT02894645|Vincristine|vincristine|mesh-list
14002418|NCT02894645|Daunorubicin|daunorubicin|mesh-list
14002419|NCT02894645|Asparaginase|asparaginase|mesh-list
14002420|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
14002421|NCT02894645|Thioguanine|thioguanine|mesh-list
14002422|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002423|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
14002424|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002425|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002426|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14002427|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
14002428|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002429|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002430|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14002431|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002432|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
14002433|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
14002434|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002435|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002436|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
14002437|NCT02894645|Hormones|hormones|mesh-ancestor
14002438|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002439|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14002440|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14002441|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14002442|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14002443|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002444|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14002445|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
14002446|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14002447|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14002448|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
14002449|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
14002450|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14002451|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14002452|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
14002453|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135472|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
15135473|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
15135474|NCT04344288|Prednisone|prednisone|mesh-list
15135475|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135476|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
15135477|NCT04344288|Hormones|hormones|mesh-ancestor
15135478|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135479|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135480|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15135481|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002454|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14002455|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
14002456|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
14002457|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
14002458|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14002459|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14002460|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14002461|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002462|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
14002463|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14002464|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
14002465|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14002466|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
14002467|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002468|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002469|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
14002470|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14002471|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
14002472|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15135482|NCT04344405|Vitamin D|vitamin d|mesh-list
15135483|NCT04344405|Vitamins|vitamins|mesh-ancestor
15135484|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
14002473|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14002474|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14002475|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
14002476|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14002477|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002478|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14002479|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14002480|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14002481|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14002482|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024018|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14024019|NCT02758769|Abatacept|abatacept|mesh-list
14024020|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14024021|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024022|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024023|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024024|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
15135485|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135486|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14024025|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024026|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024027|NCT02758782|Celecoxib|celecoxib|mesh-list
14024028|NCT02758782|Golimumab|golimumab|mesh-list
14024029|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14024030|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14024031|NCT02758782|Analgesics|analgesics|mesh-ancestor
14024032|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
14024033|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024034|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024035|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024036|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024037|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14024038|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14024039|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024040|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024041|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15135487|NCT04344379|Azithromycin|azithromycin|mesh-list
14002483|NCT02893995|Treprostinil|treprostinil|mesh-list
14002484|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14002485|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14002486|NCT02894268|Doxycycline|doxycycline|mesh-list
14002487|NCT02894268|Furazolidone|furazolidone|mesh-list
15135488|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135489|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135490|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135491|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
15135492|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135493|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135494|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135495|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002488|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14002489|NCT02894268|Esomeprazole|esomeprazole|mesh-list
14002490|NCT02894268|Bismuth|bismuth|mesh-list
14002491|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002492|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14002493|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002494|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14002495|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002496|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002497|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
14002498|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14002499|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14002500|NCT02894268|Antacids|antacids|mesh-ancestor
14002501|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14002502|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14002503|NCT02894268|Renal Agents|renal agents|mesh-ancestor
14002504|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14002505|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14002506|NCT02893618|Diazoxide|diazoxide|mesh-list
14002507|NCT02893618|Choline|choline|mesh-list
14002508|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
14002509|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14002510|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
14002511|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002512|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002513|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14002514|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
14002515|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14002516|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
14002517|NCT02893722|Oxytocin|oxytocin|mesh-list
14002518|NCT02893722|Atosiban|atosiban|mesh-list
14002519|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
14002520|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15135496|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135497|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
15135498|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15135499|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135500|NCT04344041|Vitamins|vitamins|mesh-ancestor
15135501|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
15135502|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14002521|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002522|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
14002523|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002524|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
14002525|NCT02893709|Omeprazole|omeprazole|mesh-list
14002526|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14002527|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002528|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14002529|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002530|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002531|NCT02893826|Nimodipine|nimodipine|mesh-list
14002532|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14002533|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15135503|NCT04343976|Interferons|interferons|mesh-list
15135504|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135505|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
15135506|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135507|NCT04343885|Docetaxel|docetaxel|mesh-list
15135508|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
15135509|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002534|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14002535|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002536|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14002537|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135510|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14002538|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
15135511|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
15135512|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
15135513|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002539|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14002540|NCT02893332|Gefitinib|gefitinib|mesh-list
14002541|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002542|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14002543|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002544|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002545|NCT02893280|Aspirin|aspirin|mesh-list
14002546|NCT02893280|Enoxaparin|enoxaparin|mesh-list
14002547|NCT02893280|Streptokinase|streptokinase|mesh-list
14002548|NCT02893280|Clopidogrel|clopidogrel|mesh-list
14002549|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14002550|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14002551|NCT02893280|Analgesics|analgesics|mesh-ancestor
14002552|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
14002553|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002554|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002555|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002556|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002557|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14002558|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14002559|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002560|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14002561|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14002562|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002563|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
14002564|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14002565|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14002566|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14002567|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
14002568|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002569|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
14002570|NCT02893553|Midodrine|midodrine|mesh-list
14002571|NCT02893553|Bromides|bromides|mesh-list
14002572|NCT02893553|Mirabegron|mirabegron|mesh-list
14002573|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14002574|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
14002575|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14002576|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14002577|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14002578|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
14002579|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002580|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002581|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002582|NCT02893553|Urological Agents|urological agents|mesh-ancestor
14002583|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
14002584|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
15135514|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15135515|NCT04344158|Sorafenib|sorafenib|mesh-list
15135516|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135517|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15135518|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135519|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135520|NCT04343872|Metformin|metformin|mesh-list
15135521|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15135522|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002585|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002586|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14002587|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14002588|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14002589|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14002590|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002591|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
14002592|NCT02893540|Capecitabine|capecitabine|mesh-list
14002593|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14002594|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
14002595|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002596|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002597|NCT02893371|Lamotrigine|lamotrigine|mesh-list
15135523|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
15135524|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
14002598|NCT02893371|Carbamazepine|carbamazepine|mesh-list
14002599|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
15135525|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
15135526|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135527|NCT04343768|Interferons|interferons|mesh-list
15135528|NCT04343768|Ritonavir|ritonavir|mesh-list
15135529|NCT04343768|Lopinavir|lopinavir|mesh-list
15135530|NCT04343768|Interferon-beta|interferon-beta|mesh-list
15135531|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
14002600|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14002601|NCT02893371|Valproic Acid|valproic acid|mesh-list
14002602|NCT02893371|Haloperidol|haloperidol|mesh-list
14002603|NCT02893371|Olanzapine|olanzapine|mesh-list
14002604|NCT02893371|Risperidone|risperidone|mesh-list
14002605|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14002606|NCT02893371|Aripiprazole|aripiprazole|mesh-list
14002607|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14002608|NCT02893371|Ziprasidone|ziprasidone|mesh-list
14002609|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15135532|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135533|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
14270456|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270457|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14270458|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270459|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
14270460|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14270461|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270462|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270463|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270464|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270465|NCT00410072|Tenofovir|tenofovir|mesh-list
14270466|NCT00410072|Entecavir|entecavir|mesh-list
14270467|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
14270468|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270469|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14270470|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14002610|NCT02893371|Clozapine|clozapine|mesh-list
14002611|NCT02893371|Asenapine|asenapine|mesh-list
14002612|NCT02893371|Perphenazine|perphenazine|mesh-list
14002613|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
14002614|NCT02893371|Mirtazapine|mirtazapine|mesh-list
14002615|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
14002616|NCT02893371|Doxepin|doxepin|mesh-list
14002617|NCT02893371|Citalopram|citalopram|mesh-list
15135534|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002618|NCT02893371|Bupropion|bupropion|mesh-list
14002619|NCT02893371|Sertraline|sertraline|mesh-list
14002620|NCT02893371|Fluoxetine|fluoxetine|mesh-list
14002621|NCT02893371|Paroxetine|paroxetine|mesh-list
14002622|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14002623|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14002624|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14002625|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14002626|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
14002627|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002628|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002629|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002630|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14002631|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15135535|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
15135536|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135537|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15135538|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15135539|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
14002632|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002633|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14002634|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14002635|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
14002636|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14002637|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14002638|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14002639|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14002640|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
14002641|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14002642|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
14002643|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002644|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
14002645|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002646|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14002647|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15135540|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135541|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002648|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14002649|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002650|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
14002651|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14002652|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14002653|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14002654|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14002655|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14002656|NCT02893371|Analgesics|analgesics|mesh-ancestor
14002657|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
14002658|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
14002659|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
14002660|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14002661|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14002662|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14002663|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
14002664|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14002665|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
14002666|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
14002667|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14002668|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14002669|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14002670|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14002671|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14002672|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14002673|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14002674|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14002675|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14002676|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
14002677|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14002678|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14002679|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14002680|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14002681|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14002682|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14002683|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14002684|NCT02893293|Hematinics|hematinics|mesh-ancestor
14002685|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14002686|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14002687|NCT02893423|Ropivacaine|ropivacaine|mesh-list
14002688|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
14002689|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
14002690|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002691|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002692|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
14002693|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002694|NCT02893176|Macitentan|macitentan|mesh-list
14002695|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14002696|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14002697|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002698|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14002699|NCT02893384|Anesthetics|anesthetics|mesh-list
14002700|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
14002701|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002702|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002703|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
14002704|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002705|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
14002706|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
14002707|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
14002708|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002709|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002710|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
14002711|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002712|NCT02893488|Lamivudine|lamivudine|mesh-list
14002713|NCT02893488|Dolutegravir|dolutegravir|mesh-list
14002714|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14002715|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14002716|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002717|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002718|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
14002719|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002720|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14002721|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14002722|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14002723|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14002724|NCT02893254|Adalimumab|adalimumab|mesh-list
14002725|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002726|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002727|NCT02893111|Bortezomib|bortezomib|mesh-list
14002728|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002729|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14002730|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14002731|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
14002732|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002733|NCT02892916|Ketamine|ketamine|mesh-list
14002734|NCT02892916|Analgesics|analgesics|mesh-ancestor
14002735|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
14002736|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002737|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002738|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14002739|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14002740|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
14002741|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
14002742|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002743|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14002744|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14002745|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002746|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002747|NCT02892942|Cetrorelix|cetrorelix|mesh-list
14002748|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14002749|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
14002750|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14002751|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002752|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
14002753|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002754|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14002755|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
14002756|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024042|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024043|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
14024044|NCT02758665|Venetoclax|venetoclax|mesh-list
14024045|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
14024046|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024047|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024048|NCT02758522|Insulin|insulin|mesh-list
14024049|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14024050|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14024051|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024052|NCT02758691|Insulin|insulin|mesh-list
14024053|NCT02758691|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14024054|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14024055|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024056|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
14024057|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024058|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026198|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
14026199|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14026200|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14026201|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14026202|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026203|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
14026204|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14026205|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14026206|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026207|NCT02744339|Riociguat|riociguat|mesh-list
14026208|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
14026209|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270471|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270472|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270473|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14270474|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14270475|NCT00410124|Everolimus|everolimus|mesh-list
14270476|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270477|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270478|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
14270479|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270480|NCT00410150|Albuterol|albuterol|mesh-list
14002757|NCT02892591|Oxycodone|oxycodone|mesh-list
14002758|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14002759|NCT02892591|Narcotics|narcotics|mesh-ancestor
14002760|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002761|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002762|NCT02892591|Analgesics|analgesics|mesh-ancestor
14002763|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
14002764|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002765|NCT02892357|Omeprazole|omeprazole|mesh-list
14002766|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14002767|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14002768|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14002769|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002770|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002771|NCT02892318|Atezolizumab|atezolizumab|mesh-list
14002772|NCT02892318|Guadecitabine|guadecitabine|mesh-list
14002773|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002774|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
14002775|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14002776|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002777|NCT02891967|Z 350|z 350|mesh-list
14002778|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14002779|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14002780|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002781|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002782|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
14002783|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002784|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002785|NCT02891980|Vaccines|vaccines|mesh-list
14002786|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
14002787|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002788|NCT02891785|Antipain|antipain|mesh-list
15135542|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15135543|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15135544|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15135545|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15135546|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
15135547|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135548|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135549|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135550|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
15135551|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135552|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15135553|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
15135554|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15135555|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15135556|NCT04343729|Prednisolone|prednisolone|mesh-list
15135557|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
15135558|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15135559|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
15135560|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135561|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
15135562|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
15135563|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135564|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135565|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135566|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
15135567|NCT04343729|Hormones|hormones|mesh-ancestor
15135568|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135569|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15135570|NCT04343729|Protective Agents|protective agents|mesh-ancestor
15135571|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15135572|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135573|NCT04343963|Bromides|bromides|mesh-list
15135574|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
15135575|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
15135576|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14002789|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
14002790|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002791|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002792|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14002793|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14024059|NCT02758509|Interferons|interferons|mesh-list
15135577|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135578|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002794|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002795|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
14002796|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002797|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14002798|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002799|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002800|NCT02891161|Durvalumab|durvalumab|mesh-list
14002801|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14002802|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002803|NCT02891278|Cytarabine|cytarabine|mesh-list
14002804|NCT02891278|Sertraline|sertraline|mesh-list
15135579|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
15135580|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002805|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14002806|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
14002807|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135581|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135582|NCT04343651|Leronlimab|leronlimab|mesh-list
15135583|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15135584|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15135585|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135586|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15135587|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15135588|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
15135589|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135590|NCT04343326|Menthol|menthol|mesh-list
15135591|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
14002808|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002809|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
14002810|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002811|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002812|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
14002813|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002814|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
14002815|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14002816|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14002817|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14002818|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14002819|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14002820|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
14002821|NCT02891018|Paclitaxel|paclitaxel|mesh-list
14002822|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14002823|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14002824|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002825|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14002826|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14002827|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14002828|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002829|NCT02891083|Paclitaxel|paclitaxel|mesh-list
14002830|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14002831|NCT02891083|Cisplatin|cisplatin|mesh-list
14002832|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14002833|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002834|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14002835|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14002836|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14002837|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002838|NCT02891005|Paclitaxel|paclitaxel|mesh-list
14002839|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14002840|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002841|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14002842|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14002843|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14002844|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024060|NCT02758509|Ritonavir|ritonavir|mesh-list
14024061|NCT02758509|Ribavirin|ribavirin|mesh-list
14024062|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
14024063|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
14024064|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
14024065|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15135592|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
15135593|NCT04343170|Folic Acid|folic acid|mesh-list
14024066|NCT02758509|Ledipasvir|ledipasvir|mesh-list
14024067|NCT02758509|Simeprevir|simeprevir|mesh-list
14024068|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14024069|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135594|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
14002845|NCT02890875|Ethanol|ethanol|mesh-list
14002846|NCT02890875|Heparin|heparin|mesh-list
14002847|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
14002848|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14002849|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14002850|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002851|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14002852|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002853|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002854|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002855|NCT02890719|Ribavirin|ribavirin|mesh-list
14002856|NCT02890719|Grazoprevir|grazoprevir|mesh-list
14002857|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
14002858|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002859|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
14002860|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14002861|NCT02890745|Empagliflozin|empagliflozin|mesh-list
14002862|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14002863|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002864|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14002865|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002866|NCT02890771|Turmeric extract|turmeric extract|mesh-list
14002867|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
14002868|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002869|NCT02890771|Protective Agents|protective agents|mesh-ancestor
14002870|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002871|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
14002872|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14002873|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002874|NCT02890823|Vitamins|vitamins|mesh-ancestor
14002875|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
14002876|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14002877|NCT02890602|Prednisolone|prednisolone|mesh-list
14002878|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
14002879|NCT02890602|Vincristine|vincristine|mesh-list
14002880|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
14002881|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14002882|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
14002883|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002884|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14002885|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14002886|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
14002887|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002888|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002889|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14002890|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14002891|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
14002892|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
14002893|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
15135595|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
15135596|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
15135597|NCT04343170|Vitamins|vitamins|mesh-ancestor
15135598|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
15135599|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135600|NCT04343170|Hematinics|hematinics|mesh-ancestor
15135601|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
15135602|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
14002894|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14002895|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
14002896|NCT02890602|Hormones|hormones|mesh-ancestor
14002897|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002898|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14002899|NCT02890602|Hematinics|hematinics|mesh-ancestor
14002900|NCT02890784|Dasatinib|dasatinib|mesh-list
14002901|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002902|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14002903|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002904|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002905|NCT02890589|Chromium|chromium|mesh-list
14002906|NCT02890589|Everolimus|everolimus|mesh-list
14002907|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002908|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15135603|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14002909|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
14002910|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135604|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135605|NCT04343001|Aspirin|aspirin|mesh-list
14002911|NCT02890589|Trace Elements|trace elements|mesh-ancestor
14002912|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
14002913|NCT02890173|Eplerenone|eplerenone|mesh-list
14002914|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14002915|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
14002916|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002917|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002918|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14002919|NCT02890173|Diuretics|diuretics|mesh-ancestor
14002920|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
14002921|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14002922|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
14002923|NCT02890238|Citric Acid|citric acid|mesh-list
14002924|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
14002925|NCT02890238|Clomiphene|clomiphene|mesh-list
14002926|NCT02890238|Enclomiphene|enclomiphene|mesh-list
14002927|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
14002928|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
14002929|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14002930|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
14002931|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
14002932|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135606|NCT04343001|Losartan|losartan|mesh-list
15135607|NCT04343001|Simvastatin|simvastatin|mesh-list
15135608|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135609|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15135610|NCT04343001|Analgesics|analgesics|mesh-ancestor
15135611|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
15135612|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135613|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135614|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135615|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135616|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15135617|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14002933|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
14002934|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14002935|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14002936|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14002937|NCT02890238|Urological Agents|urological agents|mesh-ancestor
14002938|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14002939|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
14002940|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14002941|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002942|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14002943|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
14002944|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14002945|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14002946|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14002947|NCT02890511|Paclitaxel|paclitaxel|mesh-list
14002948|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14002949|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14002950|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
14002951|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
14002952|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
14002953|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002954|NCT02890212|Selenium|selenium|mesh-list
14002955|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
14002956|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002957|NCT02890212|Protective Agents|protective agents|mesh-ancestor
14002958|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002959|NCT02890212|Trace Elements|trace elements|mesh-ancestor
14002960|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
14002961|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
14002962|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14002963|NCT02890277|Chitosan|chitosan|mesh-list
14002964|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14002965|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14270481|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14270482|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
15135618|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135619|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14270483|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135620|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15135621|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135622|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
14002966|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
14002967|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002968|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14002969|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
14002970|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
14002971|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
14002972|NCT02890277|Coagulants|coagulants|mesh-ancestor
14002973|NCT02890186|Remifentanil|remifentanil|mesh-list
14002974|NCT02890186|Propofol|propofol|mesh-list
14002975|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14002976|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002977|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002978|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14002979|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
14002980|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
14002981|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14002982|NCT02890186|Narcotics|narcotics|mesh-ancestor
14002983|NCT02890186|Analgesics|analgesics|mesh-ancestor
14002984|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
14002985|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002986|NCT02890199|Lidocaine|lidocaine|mesh-list
14002987|NCT02890199|Bupivacaine|bupivacaine|mesh-list
14002988|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
14002989|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
14002990|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14002991|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14002992|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
14002993|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14002994|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14002995|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14002996|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14002997|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14002998|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14002999|NCT02890082|Tamoxifen|tamoxifen|mesh-list
14003000|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14003001|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
14003002|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003003|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003004|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14003005|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003006|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14003007|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14003008|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14003009|NCT02890368|Interferons|interferons|mesh-list
14003010|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14003011|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14003012|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
14003013|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003014|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
14003015|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003016|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14003017|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
14003018|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003019|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003020|NCT02889666|Gemcitabine|gemcitabine|mesh-list
14003021|NCT02889666|Cisplatin|cisplatin|mesh-list
14003022|NCT02889666|Carboplatin|carboplatin|mesh-list
14003023|NCT02889666|Docetaxel|docetaxel|mesh-list
14003024|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
14003025|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003026|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003027|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
14003028|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003029|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
14003030|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003031|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003032|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003033|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
14003034|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003035|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
14003036|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
14003037|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
14003038|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
14003039|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14003040|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003041|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
14003042|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14003043|NCT02889692|Gefitinib|gefitinib|mesh-list
14003044|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003045|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14003046|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003047|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003048|NCT02889822|Alprostadil|alprostadil|mesh-list
14003049|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14003050|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
14003051|NCT02889822|Urological Agents|urological agents|mesh-ancestor
14003052|NCT02889653|Anticoagulants|anticoagulants|mesh-list
14003053|NCT02889523|Prednisolone|prednisolone|mesh-list
14003054|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
14003055|NCT02889523|Rituximab|rituximab|mesh-list
14003056|NCT02889523|Doxorubicin|doxorubicin|mesh-list
14003057|NCT02889523|Vincristine|vincristine|mesh-list
14003058|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003059|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
14003060|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003061|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003062|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14003063|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
14003064|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003065|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003066|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14003067|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14003068|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14003069|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14003070|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14003071|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003072|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14003073|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
14003074|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
14003075|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
14003076|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003077|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
14003078|NCT02889523|Hormones|hormones|mesh-ancestor
14003079|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003080|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14003081|NCT02889549|Clopidogrel|clopidogrel|mesh-list
14003082|NCT02889549|Ticagrelor|ticagrelor|mesh-list
14003083|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14003084|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14003085|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14003086|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14003087|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
14003088|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003089|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003090|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003091|NCT02889432|Melatonin|melatonin|mesh-list
14003092|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
14003093|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003094|NCT02889432|Protective Agents|protective agents|mesh-ancestor
14003095|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003096|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003097|NCT02889497|Vaccines|vaccines|mesh-list
14003098|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
15135623|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15135624|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15135625|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
15135626|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15135627|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15135628|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15135629|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15135630|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15135631|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14003099|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024070|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
14024071|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024072|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14024073|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14024074|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
14024075|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135632|NCT04343235|Labetalol|labetalol|mesh-list
14024076|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003100|NCT02889367|Odalasvir|odalasvir|mesh-list
14003101|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
14003102|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003103|NCT02889081|Vitamin D|vitamin d|mesh-list
14003104|NCT02889081|Vitamins|vitamins|mesh-ancestor
14003105|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
14003106|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003107|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14003108|NCT02889159|Imiquimod|imiquimod|mesh-list
14003109|NCT02889159|Histamine|histamine|mesh-list
15135633|NCT04343235|Furosemide|furosemide|mesh-list
15135634|NCT04343235|Diuretics|diuretics|mesh-ancestor
15135635|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
15135636|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135637|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15135638|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15135639|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135640|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14003110|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
14003111|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14003112|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
14003113|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003114|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003115|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
14003116|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
14003117|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
14003118|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003119|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003120|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
14003121|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003122|NCT02888990|Dasatinib|dasatinib|mesh-list
15135641|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15135642|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
15135643|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135644|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15135645|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
15135646|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
15135647|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135648|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15135649|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15135650|NCT04343144|Nivolumab|nivolumab|mesh-list
15135651|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15135652|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003123|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003124|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14003125|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003126|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003127|NCT02888899|Loperamide|loperamide|mesh-list
14003128|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
14003129|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
14003130|NCT02888899|Psyllium|psyllium|mesh-list
14003131|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003132|NCT02888899|Cathartics|cathartics|mesh-ancestor
14003133|NCT02889003|Pioglitazone|pioglitazone|mesh-list
14003134|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15135653|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15135654|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135655|NCT04342910|Paclitaxel|paclitaxel|mesh-list
15135656|NCT04342910|Irinotecan|irinotecan|mesh-list
15135657|NCT04342910|Apatinib|apatinib|mesh-list
14003135|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135658|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15135659|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135660|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
15135661|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
15135662|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14003136|NCT02888704|Remestemcel-l|remestemcel-l|mesh-list
14003137|NCT02888704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003138|NCT02888704|Antiviral Agents|antiviral agents|mesh-ancestor
14003139|NCT02888704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003140|NCT02888730|Tobramycin|tobramycin|mesh-list
14003141|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14003142|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003143|NCT02888652|Clopidogrel|clopidogrel|mesh-list
14003144|NCT02888652|Ticagrelor|ticagrelor|mesh-list
14003145|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14003146|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14003147|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14003148|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14003149|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
14003150|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003151|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003152|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003153|NCT02888574|Oxytocin|oxytocin|mesh-list
14003154|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
14003155|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14003156|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003157|NCT02888301|Clofarabine|clofarabine|mesh-list
14003158|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003159|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
14003160|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003161|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003162|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
14003163|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14003164|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14003165|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14003166|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14003167|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003168|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
14003169|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003170|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003171|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14003172|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003173|NCT02888327|Oseltamivir|oseltamivir|mesh-list
14003174|NCT02888327|Digoxin|digoxin|mesh-list
14003175|NCT02888327|Midazolam|midazolam|mesh-list
14003176|NCT02888327|Pitavastatin|pitavastatin|mesh-list
14003177|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14003178|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14003179|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003180|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003181|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14003182|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14003183|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14003184|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14003185|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
14003186|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
14003187|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
14003188|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
14003189|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135663|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135664|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15135665|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15135666|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135667|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15135668|NCT04342676|Panitumumab|panitumumab|mesh-list
15135669|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15135670|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178942|NCT03953950|Losartan|losartan|mesh-list
15178943|NCT03953950|Spironolactone|spironolactone|mesh-list
15178944|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15178945|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15178946|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15178947|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15178948|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003190|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003191|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14003192|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14003193|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003194|NCT02888327|Protective Agents|protective agents|mesh-ancestor
14003195|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
14003196|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003197|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14003198|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14003199|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14003200|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
14003201|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14003202|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
14003203|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14003204|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003205|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003206|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003207|NCT02888275|Analgesics|analgesics|mesh-ancestor
14003208|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
14003209|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003210|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14003211|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14003212|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14003213|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
14003214|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003215|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003216|NCT02888561|Dobutamine|dobutamine|mesh-list
14003217|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14003218|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
14003219|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
14003220|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003221|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003222|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14003223|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14003224|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14003225|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
14003226|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003227|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003228|NCT02888561|Protective Agents|protective agents|mesh-ancestor
14003229|NCT02888444|Varenicline|varenicline|mesh-list
14003230|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14003231|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15135671|NCT04342598|Vitamin D|vitamin d|mesh-list
15135672|NCT04342598|Vitamins|vitamins|mesh-ancestor
15135673|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
14003232|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
14003233|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003234|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003235|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003236|NCT02888054|Allopurinol|allopurinol|mesh-list
14003237|NCT02888054|Lesinurad|lesinurad|mesh-list
14003238|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
14003239|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003240|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003241|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
14003242|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003243|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14003244|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
14003245|NCT02888054|Protective Agents|protective agents|mesh-ancestor
14003246|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003247|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
14003248|NCT02888054|Renal Agents|renal agents|mesh-ancestor
14003249|NCT02888392|Psyllium|psyllium|mesh-list
14003250|NCT02888392|Cathartics|cathartics|mesh-ancestor
14003251|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135674|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135675|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15135676|NCT04342858|Listerine|listerine|mesh-list
15135677|NCT04342858|Fluorides|fluorides|mesh-list
15135678|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
15135679|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
15135680|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003252|NCT02888223|Factor VIII|factor viii|mesh-list
14003253|NCT02888223|Coagulants|coagulants|mesh-ancestor
14003254|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
14003255|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14003256|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15135681|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
15135682|NCT04342858|Protective Agents|protective agents|mesh-ancestor
15135683|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15135684|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135685|NCT04342728|Vitamins|vitamins|mesh-list
15135686|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
15135687|NCT04342728|Zinc|zinc|mesh-list
15135688|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
15135689|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135690|NCT04342728|Trace Elements|trace elements|mesh-ancestor
15135691|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
14003257|NCT02887976|Prednisolone|prednisolone|mesh-list
14003258|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
14003259|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
14003260|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14003261|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
15135692|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135693|NCT04342728|Protective Agents|protective agents|mesh-ancestor
15135694|NCT04342650|Chloroquine|chloroquine|mesh-list
14003262|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003263|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
14003264|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
14003265|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003266|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003267|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003268|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
14003269|NCT02887976|Hormones|hormones|mesh-ancestor
14003270|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003271|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14003272|NCT02887976|Protective Agents|protective agents|mesh-ancestor
14003273|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14003274|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003275|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14003276|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003277|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003278|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
14003279|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14003280|NCT02888041|Dinoprostone|dinoprostone|mesh-list
14003281|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
14003282|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14003283|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003284|NCT02887807|Cyclosporine|cyclosporine|mesh-list
15135695|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15135696|NCT04342650|Amebicides|amebicides|mesh-ancestor
15135697|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135698|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135699|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135700|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
15135701|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135702|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135703|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15135704|NCT04342650|Analgesics|analgesics|mesh-ancestor
15135705|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
14003285|NCT02887807|Cyclosporins|cyclosporins|mesh-list
14003286|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003287|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003288|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003289|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
14003290|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003291|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
14003292|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003293|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
14003294|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003295|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14024077|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14024078|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14024079|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14024080|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14024081|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
14024082|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
14024083|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024084|NCT02758444|Micronutrients|micronutrients|mesh-list
14024085|NCT02758444|Trace Elements|trace elements|mesh-list
14024086|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024087|NCT02758340|Misoprostol|misoprostol|mesh-list
14024088|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14024089|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
14024090|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14024091|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024092|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14024093|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024094|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
14024095|NCT02758249|Propofol|propofol|mesh-list
14024096|NCT02758249|Sevoflurane|sevoflurane|mesh-list
14024097|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14024098|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135706|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135707|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135708|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135709|NCT04342650|Filaricides|filaricides|mesh-ancestor
15135710|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
15135711|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
15135712|NCT04342819|Empagliflozin|empagliflozin|mesh-list
14024099|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024100|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14003296|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
14003297|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14003298|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003299|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003300|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003301|NCT02887573|Mosapride|mosapride|mesh-list
14003302|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003303|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003304|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14003305|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
14003306|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003307|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135713|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15135714|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135715|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003308|NCT02887534|Tizanidine|tizanidine|mesh-list
14003309|NCT02887534|Analgesics|analgesics|mesh-ancestor
14003310|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
14003311|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003312|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003313|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
14003314|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14003315|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14003316|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
14003317|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
14003318|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14003319|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14003320|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14003321|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
14003322|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003323|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003324|NCT02887443|Midazolam|midazolam|mesh-list
14003325|NCT02887443|Idebenone|idebenone|mesh-list
14003326|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14003327|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14003328|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003329|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003330|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14003331|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14003332|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14003333|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14003334|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
14003335|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
14003336|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
15135716|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135717|NCT04342065|Celecoxib|celecoxib|mesh-list
15135718|NCT04342065|Pregabalin|pregabalin|mesh-list
15135719|NCT04342065|Analgesics|analgesics|mesh-ancestor
15135720|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
15135721|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135722|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135723|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
15135724|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15135725|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15135726|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135727|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15135728|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15135729|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15135730|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15135731|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15135732|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135733|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003337|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
14003338|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003339|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003340|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
14003341|NCT02887443|Protective Agents|protective agents|mesh-ancestor
14003342|NCT02887365|Tegafur|tegafur|mesh-list
14003343|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003344|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
14003345|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003346|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003347|NCT02887625|Insulin|insulin|mesh-list
14003348|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
14003349|NCT02887625|Pioglitazone|pioglitazone|mesh-list
14003350|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
14003351|NCT02887625|Exenatide|exenatide|mesh-list
14003352|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003353|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003354|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14003355|NCT02887625|Incretins|incretins|mesh-ancestor
14003356|NCT02887625|Hormones|hormones|mesh-ancestor
14003357|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003358|NCT02887222|Bupivacaine|bupivacaine|mesh-list
14003359|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
14003360|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
15135734|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003361|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003362|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003363|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
14003364|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003365|NCT02887313|Leucovorin|leucovorin|mesh-list
14003366|NCT02887313|Fluorouracil|fluorouracil|mesh-list
14003367|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
14003368|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
14003369|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003370|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003371|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003372|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003373|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
14003374|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003375|NCT02887313|Antidotes|antidotes|mesh-ancestor
14003376|NCT02887313|Protective Agents|protective agents|mesh-ancestor
14003377|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
14003378|NCT02887313|Vitamins|vitamins|mesh-ancestor
14003379|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
14003380|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
14003381|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14003382|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14003383|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14003384|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14003385|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003386|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
14003387|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003388|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003389|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14003390|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003391|NCT02886897|Antibodies|antibodies|mesh-list
14003392|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
14003393|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003394|NCT02886962|Vitamin K|vitamin k|mesh-list
14003395|NCT02886962|Vitamins|vitamins|mesh-ancestor
14003396|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
14003397|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003398|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14003399|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14003400|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003401|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
14003402|NCT02886962|Coagulants|coagulants|mesh-ancestor
14003403|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
14003404|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14003405|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003406|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
14003407|NCT02886429|Bupivacaine|bupivacaine|mesh-list
14003408|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
14003409|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
14003410|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003411|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003412|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
14003413|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003414|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14003415|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003416|NCT02886429|Analgesics|analgesics|mesh-ancestor
14003417|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14003418|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15135735|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003419|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14003420|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14003421|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003422|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003423|NCT02886377|Antibodies|antibodies|mesh-list
14003424|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
14003425|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003426|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
14003427|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14003428|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
14003429|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
14003430|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003431|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003432|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003433|NCT02886351|Analgesics|analgesics|mesh-ancestor
14003434|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
14003435|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003436|NCT02886195|Pemetrexed|pemetrexed|mesh-list
14003437|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14003438|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003439|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003440|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003441|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14003442|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14003443|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14024101|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
14024102|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
14024103|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14024104|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14024105|NCT02758366|Doxorubicin|doxorubicin|mesh-list
14024106|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14024107|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024108|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14024109|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14024110|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024111|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024112|NCT02758405|Fentanyl|fentanyl|mesh-list
14024113|NCT02758405|Bupivacaine|bupivacaine|mesh-list
14024114|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
14024115|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
14024116|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024117|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024118|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
14024119|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024120|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14024121|NCT02758405|Narcotics|narcotics|mesh-ancestor
14024122|NCT02758405|Analgesics|analgesics|mesh-ancestor
14024123|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14024124|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14024125|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
14024126|NCT02758470|Acetazolamide|acetazolamide|mesh-list
14024127|NCT02758470|Methazolamide|methazolamide|mesh-list
14024128|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
14024129|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14024130|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024131|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024132|NCT02758470|Diuretics|diuretics|mesh-ancestor
14024133|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
14024134|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024135|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14024136|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14024137|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
14024138|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15135736|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15135737|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15135738|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135739|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135740|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
15135741|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135742|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135743|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135744|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135745|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135746|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135747|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
14024139|NCT02758327|Laxatives|laxatives|mesh-ancestor
14024140|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024141|NCT02758145|Vaccines|vaccines|mesh-list
14024142|NCT02758145|Immunologic Factors|immunologic factors|mesh-ancestor
14024143|NCT02758145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024144|NCT02758015|Betaine|betaine|mesh-list
14024145|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003444|NCT02886299|Simvastatin|simvastatin|mesh-list
14003445|NCT02886299|Fenofibrate|fenofibrate|mesh-list
14003446|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14003447|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14003448|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
14003449|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003450|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14003451|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14003452|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003453|NCT02886065|Lenalidomide|lenalidomide|mesh-list
14003454|NCT02886065|Poly ICLC|poly iclc|mesh-list
14003455|NCT02886065|Citarinostat|citarinostat|mesh-list
14003456|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
14003457|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003458|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14003459|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14003460|NCT02886065|Growth Substances|growth substances|mesh-ancestor
14003461|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
14003462|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003463|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
14003464|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14003465|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003466|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003467|NCT02885974|Gemcitabine|gemcitabine|mesh-list
14003468|NCT02885974|Celecoxib|celecoxib|mesh-list
14003469|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003470|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003471|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
14003472|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003473|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
14003474|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003475|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003476|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003477|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
14003478|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003479|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14003480|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003481|NCT02885974|Analgesics|analgesics|mesh-ancestor
14003482|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
14003483|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003484|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003485|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003486|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14003487|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14003488|NCT02885961|Dabigatran|dabigatran|mesh-list
14003489|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
14003490|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14003491|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
14003492|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003493|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003494|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
14003495|NCT02885727|Durvalumab|durvalumab|mesh-list
14003496|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14003497|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135748|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
15135749|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135750|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14003498|NCT02885909|Insulin|insulin|mesh-list
14003499|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003500|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003501|NCT02885740|Adenosine|adenosine|mesh-list
14003502|NCT02885740|Analgesics|analgesics|mesh-ancestor
14003503|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
15135751|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135752|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135753|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135754|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135755|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
15135756|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15135757|NCT04342247|Testosterone|testosterone|mesh-list
14003504|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003505|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003506|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14003507|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
14003508|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15135758|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
14003509|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
14003510|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
14003511|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003512|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003513|NCT02885948|Naloxone|naloxone|mesh-list
14003514|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14003515|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003516|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
14003517|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003518|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14003519|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003520|NCT02885441|Ketorolac|ketorolac|mesh-list
14003521|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14003522|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003523|NCT02885441|Analgesics|analgesics|mesh-ancestor
14003524|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
14003525|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003526|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003527|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003528|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003529|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14003530|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003531|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003532|NCT02885688|Insulin|insulin|mesh-list
14003533|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003534|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003535|NCT02885597|Methotrexate|methotrexate|mesh-list
14003536|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14003537|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
14003538|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14003539|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003540|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003541|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
14270484|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270485|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14270486|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
14270487|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
14270488|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14270489|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15135759|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
15135760|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15135761|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135762|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
15135763|NCT04342247|Hormones|hormones|mesh-ancestor
15135764|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135765|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135766|NCT04342247|Androgens|androgens|mesh-ancestor
15135767|NCT04342351|Valsartan|valsartan|mesh-list
15135768|NCT04342351|Perindopril|perindopril|mesh-list
14003542|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003543|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003544|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
14003545|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003546|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14003547|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003548|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
14003549|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003550|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14003551|NCT02885558|Efonidipine|efonidipine|mesh-list
14003552|NCT02885558|Nifedipine|nifedipine|mesh-list
14003553|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14003554|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14003555|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003556|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14003557|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003558|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
14003559|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
14003560|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14003561|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14003562|NCT02885558|Diuretics|diuretics|mesh-ancestor
14003563|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
14003564|NCT02885545|Anticoagulants|anticoagulants|mesh-list
14003565|NCT02885454|Simeprevir|simeprevir|mesh-list
14003566|NCT02885454|Odalasvir|odalasvir|mesh-list
14003567|NCT02885454|Drospirenone|drospirenone|mesh-list
14003568|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14003569|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14003570|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14003571|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14003572|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14003573|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
14003574|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14003575|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003576|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14003577|NCT02885454|Estrogens|estrogens|mesh-ancestor
14003578|NCT02885454|Hormones|hormones|mesh-ancestor
14003579|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003580|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14003581|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
14003582|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14003583|NCT02885454|Diuretics|diuretics|mesh-ancestor
14003584|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
14003585|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
14003586|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003587|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
14003588|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003589|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003590|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14003591|NCT02885168|Phenylephrine|phenylephrine|mesh-list
14003592|NCT02885168|Protein C|protein c|mesh-list
14003593|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
14003594|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14003595|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
14003596|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
14003597|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003598|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003599|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
14003600|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14003601|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
14003602|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
14003603|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14003604|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14003605|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14003606|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
14003607|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003608|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003609|NCT02885168|Protective Agents|protective agents|mesh-ancestor
14003610|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
14003611|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14003612|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14003613|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003614|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
14003615|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14003616|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14003617|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003618|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
14003619|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
14003620|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003621|NCT02885311|Naltrexone|naltrexone|mesh-list
14003622|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14003623|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14003624|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003625|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
14003626|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003627|NCT02884986|Etoricoxib|etoricoxib|mesh-list
14003628|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14003629|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003630|NCT02884986|Analgesics|analgesics|mesh-ancestor
14003631|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
14003632|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003633|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003634|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003635|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003636|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14003637|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14003638|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003639|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003640|NCT02884921|Acetaminophen|acetaminophen|mesh-list
14003641|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003642|NCT02884921|Analgesics|analgesics|mesh-ancestor
15135769|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15135770|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14003643|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
14003644|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003645|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003646|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
14003647|NCT02884596|Serotonin|serotonin|mesh-list
14003648|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14003649|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14003650|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
14003651|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003652|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003653|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003654|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14003655|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14003656|NCT02884817|Listerine|listerine|mesh-list
14003657|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14003658|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024146|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
14024147|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14024148|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
14024149|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024150|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14024151|NCT02758067|Risperidone|risperidone|mesh-list
14024152|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
14024153|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14024154|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
14024155|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024156|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024157|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024158|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14024159|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14024160|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024161|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14024162|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14024163|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
14024164|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
14024165|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14024166|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14024167|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024168|NCT02757703|Terlipressin|terlipressin|mesh-list
14024169|NCT02757703|Pantoprazole|pantoprazole|mesh-list
14024170|NCT02757703|Somatostatin|somatostatin|mesh-list
14024171|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14024172|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024173|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14024174|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024175|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024176|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14024177|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14024178|NCT02757703|Hormones|hormones|mesh-ancestor
14024179|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024180|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024181|NCT02757534|Domperidone|domperidone|mesh-list
14024182|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
14024183|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
14024184|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024185|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024186|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024187|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14024188|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
14024189|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024190|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024191|NCT02757508|Vitamins|vitamins|mesh-list
14024192|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
15135771|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15135772|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135773|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15135774|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
15135775|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135776|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135777|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
15135778|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14024193|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003659|NCT02884713|Doxycycline|doxycycline|mesh-list
14003660|NCT02884713|Levofloxacin|levofloxacin|mesh-list
14003661|NCT02884713|Ofloxacin|ofloxacin|mesh-list
14003662|NCT02884713|Esomeprazole|esomeprazole|mesh-list
14003663|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14003664|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003665|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14003666|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003667|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003668|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14003669|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003670|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
14003671|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14003672|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14003673|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14003674|NCT02884713|Renal Agents|renal agents|mesh-ancestor
14003675|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14003676|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14003677|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003678|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14003679|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14003680|NCT02884388|Anesthetics|anesthetics|mesh-list
14003681|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003682|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003683|NCT02884440|Ropivacaine|ropivacaine|mesh-list
14003684|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
14003685|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003686|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003687|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
14003688|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
14003689|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003690|NCT02884635|Methotrexate|methotrexate|mesh-list
14003691|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14003692|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
14003693|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14003694|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003695|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003696|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
14003697|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003698|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003699|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
14003700|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003701|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14003702|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003703|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
14003704|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003705|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14003706|NCT02884479|Docetaxel|docetaxel|mesh-list
14003707|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003708|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
14003709|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
14003710|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
14003711|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003712|NCT02884310|Remifentanil|remifentanil|mesh-list
14003713|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14003714|NCT02884310|Narcotics|narcotics|mesh-ancestor
14003715|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003716|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003717|NCT02884310|Analgesics|analgesics|mesh-ancestor
14003718|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
14003719|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003720|NCT02884219|Ibuprofen|ibuprofen|mesh-list
14003721|NCT02884219|Indomethacin|indomethacin|mesh-list
14003722|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
14003723|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14003724|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003725|NCT02884219|Analgesics|analgesics|mesh-ancestor
14003726|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
14003727|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003728|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003729|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003730|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003731|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003732|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003733|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
15135779|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135780|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135781|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135782|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003734|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
14003735|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14003736|NCT02884245|Estrogens|estrogens|mesh-list
14003737|NCT02884245|Hormones|hormones|mesh-ancestor
14003738|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003739|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003740|NCT02884050|Topiramate|topiramate|mesh-list
14003741|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
14003742|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003743|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003744|NCT02884115|Penicillins|penicillins|mesh-list
14003745|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14003746|NCT02884115|Penicillin G|penicillin g|mesh-list
14003747|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
14003748|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14003749|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270490|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14270491|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14270492|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
14270493|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270494|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270495|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
14270496|NCT00410163|Fludarabine|fludarabine|mesh-list
14003750|NCT02884128|Leucovorin|leucovorin|mesh-list
14003751|NCT02884128|Fluorouracil|fluorouracil|mesh-list
14003752|NCT02884128|Irinotecan|irinotecan|mesh-list
14003753|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
14003754|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003755|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003756|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003757|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003758|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
14003759|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003760|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14003761|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14003762|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003763|NCT02884128|Antidotes|antidotes|mesh-ancestor
14003764|NCT02884128|Protective Agents|protective agents|mesh-ancestor
14003765|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
14003766|NCT02884128|Vitamins|vitamins|mesh-ancestor
14003767|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
14003768|NCT02884037|Rifaximin|rifaximin|mesh-list
14003769|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14003770|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003771|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003772|NCT02884180|Dexamethasone|dexamethasone|mesh-list
14003773|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003774|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
14003775|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
14003776|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003777|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003778|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003779|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
14003780|NCT02884180|Hormones|hormones|mesh-ancestor
14003781|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003782|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14003783|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003784|NCT02883647|Tenofovir|tenofovir|mesh-list
14003785|NCT02883647|Entecavir|entecavir|mesh-list
14003786|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
14003787|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003788|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14003789|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14003790|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135783|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135784|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
15135785|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135786|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135787|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15135788|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14003791|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003792|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14003793|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14003794|NCT02883595|Thymalfasin|thymalfasin|mesh-list
14003795|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14003796|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
14003797|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003798|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
14003799|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14003800|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003801|NCT02883569|Ibuprofen|ibuprofen|mesh-list
14003802|NCT02883569|Aceclofenac|aceclofenac|mesh-list
14003803|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14003804|NCT02883569|Tramadol|tramadol|mesh-list
14003805|NCT02883569|Codeine|codeine|mesh-list
14003806|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14003807|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14003808|NCT02883569|Analgesics|analgesics|mesh-ancestor
14003809|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
14003810|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003811|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003812|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003813|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14003814|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14003815|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003816|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003817|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15135789|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135790|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135791|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135792|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
15135793|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135794|NCT04341870|Azithromycin|azithromycin|mesh-list
15135795|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135796|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135797|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135798|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
14003818|NCT02883569|Narcotics|narcotics|mesh-ancestor
14003819|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003820|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
14003821|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
14003822|NCT02883478|Riboflavin|riboflavin|mesh-list
14003823|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
14003824|NCT02883478|Vitamins|vitamins|mesh-ancestor
14003825|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
14003826|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003827|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14003828|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14003829|NCT02883179|Lidocaine|lidocaine|mesh-list
14003830|NCT02883179|Prilocaine|prilocaine|mesh-list
14003831|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14003832|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
14003833|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
14003834|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003835|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003836|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
14003837|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003838|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14003839|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14003840|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14003841|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14003842|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003843|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14003844|NCT02883192|Ondansetron|ondansetron|mesh-list
14003845|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
14003846|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
14003847|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003848|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003849|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14003850|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
14003851|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
14003852|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14003853|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
14003854|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003855|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003856|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14003857|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270497|NCT00410163|Ofatumumab|ofatumumab|mesh-list
14270498|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14024194|NCT02757313|Dronabinol|dronabinol|mesh-list
15135799|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14003858|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003859|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14003860|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14003861|NCT02883439|Fluticasone|fluticasone|mesh-list
14003862|NCT02883439|Xhance|xhance|mesh-list
14003863|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14003864|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14003865|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
14003866|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003867|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003868|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14003869|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
14003870|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14003871|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14024195|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
14024196|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024197|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14024198|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14024199|NCT02757313|Analgesics|analgesics|mesh-ancestor
14024200|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
14024201|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024202|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14024203|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14024204|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024205|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024206|NCT02757313|Hormones|hormones|mesh-ancestor
14024207|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024208|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
14024209|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14024210|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024211|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024212|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14024213|NCT02757495|Analgesics|analgesics|mesh-ancestor
14024214|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
14024215|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024216|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14024217|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14024218|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14024219|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
14024220|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024221|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024222|NCT02757209|Fluticasone|fluticasone|mesh-list
14024223|NCT02757209|Xhance|xhance|mesh-list
14024224|NCT02757209|Budesonide|budesonide|mesh-list
14024225|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
14024226|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14024227|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14024228|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024229|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14024230|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
14024231|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024232|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024233|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14024234|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14024235|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
14024236|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14024237|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
14024238|NCT02757209|Hormones|hormones|mesh-ancestor
14024239|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024240|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14024241|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14024242|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14024243|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14024244|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024245|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024246|NCT02757287|Desogestrel|desogestrel|mesh-list
14024247|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14024248|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14024249|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14024250|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
14024251|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14024252|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024253|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14003872|NCT02883426|Vaccines|vaccines|mesh-list
14003873|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
14003874|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003875|NCT02883114|Itraconazole|itraconazole|mesh-list
14003876|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
14003877|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003878|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14003879|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14003880|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003881|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811405|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811406|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14811407|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
14811408|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
14811409|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14811410|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14811411|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
14811412|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
14811413|NCT00845559|Exenatide|exenatide|mesh-list
14811414|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14811415|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003882|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14003883|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
14003884|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003885|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003886|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14003887|NCT02883023|Bleomycin|bleomycin|mesh-list
14003888|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14003889|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003890|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14003891|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14003892|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14003893|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003894|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003895|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14003896|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14003897|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003898|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
14003899|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14003900|NCT02882828|Tacrolimus|tacrolimus|mesh-list
14003901|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14003902|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
14003903|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003904|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14003905|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003906|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003907|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14003908|NCT02882984|Gefitinib|gefitinib|mesh-list
14003909|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003910|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14003911|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003912|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003913|NCT02882789|Delpazolid|delpazolid|mesh-list
14003914|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
14003915|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14003916|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003917|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14003918|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003919|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003920|NCT02882737|Glucagon|glucagon|mesh-list
14003921|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14003922|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135800|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14003923|NCT02882737|Hormones|hormones|mesh-ancestor
14003924|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003925|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003926|NCT02882737|Incretins|incretins|mesh-ancestor
14003927|NCT02882555|Capsaicin|capsaicin|mesh-list
14003928|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
14003929|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
14003930|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
14003931|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135801|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182041|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
14003932|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003933|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14003934|NCT02882308|Durvalumab|durvalumab|mesh-list
14003935|NCT02882308|Olaparib|olaparib|mesh-list
14003936|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003937|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14003938|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14003939|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003940|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003941|NCT02882581|Metformin|metformin|mesh-list
14003942|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003943|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003944|NCT02882347|Somatostatin|somatostatin|mesh-list
14003945|NCT02882347|Hormones|hormones|mesh-ancestor
14003946|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003947|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003948|NCT02882477|Metformin|metformin|mesh-list
14003949|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14003950|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
14003951|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14003952|NCT02882477|Deferiprone|deferiprone|mesh-list
15135802|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135803|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135804|NCT04341935|Linagliptin|linagliptin|mesh-list
15135805|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15135806|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135807|NCT04341935|Incretins|incretins|mesh-ancestor
14003953|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14003954|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003955|NCT02882477|Incretins|incretins|mesh-ancestor
14003956|NCT02882477|Hormones|hormones|mesh-ancestor
14003957|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14003958|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14003959|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
14003960|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003961|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003962|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
14003963|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14003964|NCT02882477|Expectorants|expectorants|mesh-ancestor
14003965|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
14003966|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14003967|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
14003968|NCT02882477|Protective Agents|protective agents|mesh-ancestor
14003969|NCT02882477|Antidotes|antidotes|mesh-ancestor
14003970|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14003971|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
14003972|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
14003973|NCT02882425|Selexipag|selexipag|mesh-list
14003974|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14003975|NCT02882451|Ascorbic Acid|ascorbic acid|mesh-list
14003976|NCT02882451|Pinaverium|pinaverium|mesh-list
14003977|NCT02882451|Bromides|bromides|mesh-list
14003978|NCT02882451|Vitamins|vitamins|mesh-ancestor
14003979|NCT02882451|Micronutrients|micronutrients|mesh-ancestor
14003980|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003981|NCT02882451|Antioxidants|antioxidants|mesh-ancestor
14003982|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135808|NCT04341935|Hormones|hormones|mesh-ancestor
15135809|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135810|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15135811|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
15135812|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14003983|NCT02882451|Protective Agents|protective agents|mesh-ancestor
14003984|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
14003985|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14003986|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14003987|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14003988|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
14003989|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
14003990|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14003991|NCT02882269|Capecitabine|capecitabine|mesh-list
14003992|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14003993|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
14003994|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14003995|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14003996|NCT02882594|Anesthetics|anesthetics|mesh-list
14003997|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14003998|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14003999|NCT02882100|Vaccines|vaccines|mesh-list
14004000|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
14004001|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004002|NCT02882113|Tacrolimus|tacrolimus|mesh-list
14004003|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004004|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
14004005|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004006|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14004007|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004008|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004009|NCT02882217|Histamine|histamine|mesh-list
14004010|NCT02882217|Glutarimide|glutarimide|mesh-list
14004011|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
14004012|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
14004013|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004014|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004015|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004016|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14004017|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004018|NCT02881866|Furosemide|furosemide|mesh-list
14004019|NCT02881866|Diuretics|diuretics|mesh-ancestor
14004020|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
14004021|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004022|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14004023|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14004024|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004025|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
14004026|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14004027|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
14004028|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14004029|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
14004030|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14004031|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004032|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14004033|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14004034|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14004035|NCT02882126|Treprostinil|treprostinil|mesh-list
14004036|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14004037|NCT02882230|Dolutegravir|dolutegravir|mesh-list
14004038|NCT02882230|Rilpivirine|rilpivirine|mesh-list
14004039|NCT02882230|Elvitegravir|elvitegravir|mesh-list
15135813|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135814|NCT04341831|Teicoplanin|teicoplanin|mesh-list
15135815|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135816|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135817|NCT04341844|Methylene Blue|methylene blue|mesh-list
15135818|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135819|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135820|NCT04341857|Antibodies|antibodies|mesh-list
15135821|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15135822|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
14004040|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14004041|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14004042|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004043|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004044|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14004045|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14004046|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
14004047|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004048|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14004049|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14004050|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
14004051|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
14004052|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004053|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14004054|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004055|NCT02881762|Maraviroc|maraviroc|mesh-list
14004056|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14004057|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14004058|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004059|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14004060|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14004061|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
14004062|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004063|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14004064|NCT02882087|Methotrexate|methotrexate|mesh-list
14004065|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14004066|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
14004067|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14004068|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004069|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14004070|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
14004071|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004072|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004073|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
14004074|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004075|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14004076|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004077|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
14004078|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004079|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15135823|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135824|NCT04341883|Paclitaxel|paclitaxel|mesh-list
15135825|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15135826|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15135827|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135828|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
15135829|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
14024254|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14024255|NCT02757287|Progestins|progestins|mesh-ancestor
14024256|NCT02757287|Hormones|hormones|mesh-ancestor
14024257|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024258|NCT02757365|Aspirin|aspirin|mesh-list
14024259|NCT02757365|Levofloxacin|levofloxacin|mesh-list
14024260|NCT02757365|Ofloxacin|ofloxacin|mesh-list
14024261|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14024262|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14024263|NCT02757365|Analgesics|analgesics|mesh-ancestor
14024264|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
14024265|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024266|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135830|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
15135831|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135832|NCT04341779|Tenofovir|tenofovir|mesh-list
15135833|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
14024267|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024268|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024269|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14024270|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14024271|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024272|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14024273|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14024274|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024275|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
14024276|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14024277|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024278|NCT02757365|Renal Agents|renal agents|mesh-ancestor
14024279|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024280|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14024281|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15135834|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135835|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15135836|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15135837|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024282|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024283|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14024284|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14024285|NCT02757469|Drospirenone|drospirenone|mesh-list
14024286|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14024287|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14024288|NCT02757469|Estradiol|estradiol|mesh-list
14024289|NCT02757469|Estrogens|estrogens|mesh-ancestor
14024290|NCT02757469|Hormones|hormones|mesh-ancestor
14024291|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135838|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135839|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14004080|NCT02881346|Betamethasone|betamethasone|mesh-list
14004081|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
14004082|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14004083|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
14004084|NCT02881346|Calcipotriene|calcipotriene|mesh-list
14004085|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14004086|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004087|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
14004088|NCT02881346|Hormones|hormones|mesh-ancestor
14004089|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14004090|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004091|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14004092|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
14004093|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
14004094|NCT02881528|Metformin|metformin|mesh-list
14004095|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14004096|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004097|NCT02881619|Etodolac|etodolac|mesh-list
14004098|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14004099|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004100|NCT02881619|Analgesics|analgesics|mesh-ancestor
14004101|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
14004102|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004103|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004104|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004105|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004106|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14004107|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14004108|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004109|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004110|NCT02881242|Trametinib|trametinib|mesh-list
14004111|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004112|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14004113|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004114|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004115|NCT02880995|Amisulpride|amisulpride|mesh-list
14004116|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14004117|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14004118|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004119|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004120|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14004121|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14004122|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
14004123|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004124|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004125|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14004126|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
14004127|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14004128|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004129|NCT02881177|Oxytocin|oxytocin|mesh-list
14004130|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
14004131|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14004132|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004133|NCT02881125|Paclitaxel|paclitaxel|mesh-list
14004134|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15135840|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15135841|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
15135842|NCT04341402|Clotrimazole|clotrimazole|mesh-list
15135843|NCT04341402|Miconazole|miconazole|mesh-list
15135844|NCT04341402|Diclofenac|diclofenac|mesh-list
14004135|NCT02881125|Nortriptyline|nortriptyline|mesh-list
14004136|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14004137|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004138|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14004139|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14004140|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14004141|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004142|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14004143|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
14004144|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14004145|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14004146|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15135845|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135846|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15135847|NCT04341402|Analgesics|analgesics|mesh-ancestor
14004147|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14004148|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14004149|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004150|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004151|NCT02880787|Rocuronium|rocuronium|mesh-list
14004152|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14004153|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14004154|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14004155|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004156|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004157|NCT02880800|Morphine|morphine|mesh-list
14004158|NCT02880800|Hydromorphone|hydromorphone|mesh-list
14004159|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14004160|NCT02880800|Narcotics|narcotics|mesh-ancestor
14004161|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004162|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004163|NCT02880800|Analgesics|analgesics|mesh-ancestor
14004164|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
14004165|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004166|NCT02880462|Sulforaphane|sulforaphane|mesh-list
14004167|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15135848|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
15135849|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135850|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135851|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004168|NCT02880462|Protective Agents|protective agents|mesh-ancestor
14004169|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004170|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004171|NCT02880410|Temozolomide|temozolomide|mesh-list
14004172|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14004173|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
14004174|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004175|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004176|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
14004177|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14004178|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004179|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
14004180|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14004181|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004182|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14004183|NCT02880280|Menotropins|menotropins|mesh-list
14004184|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14004185|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004186|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14004187|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
14004188|NCT02879955|Acarbose|acarbose|mesh-list
14004189|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14004190|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004191|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004192|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14004193|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004194|NCT02880033|Deferiprone|deferiprone|mesh-list
14004195|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14004196|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
14004197|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
14004198|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024292|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024293|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14024294|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
14024295|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14024296|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14024297|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14024298|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14024299|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14024300|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
14024301|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14024302|NCT02757469|Diuretics|diuretics|mesh-ancestor
14024303|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
14024304|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14024305|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14024306|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024307|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026219|NCT02744508|Dexamethasone|dexamethasone|mesh-list
15135852|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004199|NCT02879981|Trimethoprim|trimethoprim|mesh-list
14004200|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
14004201|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
14004202|NCT02879981|Guaifenesin|guaifenesin|mesh-list
14004203|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14004204|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14004205|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004206|NCT02879981|Renal Agents|renal agents|mesh-ancestor
14004207|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
14004208|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14004209|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004210|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15135853|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15135854|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135855|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004211|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004212|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004213|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14004214|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14004215|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14004216|NCT02879981|Expectorants|expectorants|mesh-ancestor
14004217|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
14004218|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14004219|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14004220|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
14004221|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004222|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004223|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
14004224|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14004225|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
14004226|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
14004227|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004228|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
14004229|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14004230|NCT02880007|Cisplatin|cisplatin|mesh-list
14004231|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004232|NCT02880085|Lidocaine|lidocaine|mesh-list
14004233|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
14004234|NCT02880085|Anesthetics|anesthetics|mesh-list
14004235|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004236|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004237|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
14004238|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004239|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14004240|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15135856|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135857|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15135858|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15135859|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15135860|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15135861|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
15135862|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135863|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15135864|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15135865|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14004241|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14004242|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14004243|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004244|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
14004245|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
14004246|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
14004247|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004248|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004249|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
14004250|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004251|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
14004252|NCT02879669|Carboplatin|carboplatin|mesh-list
14004253|NCT02879669|Pemetrexed|pemetrexed|mesh-list
14004254|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004255|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
14004256|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004257|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026220|NCT02744508|Palonosetron|palonosetron|mesh-list
14004258|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14004259|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
14004260|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004261|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004262|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14004263|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004264|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14004265|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14004266|NCT02879435|Bupivacaine|bupivacaine|mesh-list
14004267|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
14004268|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
14004269|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004270|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004271|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
14004272|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004273|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
14004274|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14004275|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004276|NCT02879513|Paclitaxel|paclitaxel|mesh-list
14004277|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
14004278|NCT02879513|Epirubicin|epirubicin|mesh-list
14004279|NCT02879513|Fluorouracil|fluorouracil|mesh-list
14004280|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14004281|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004282|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
14004283|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
15135866|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135867|NCT04341428|Lansoprazole|lansoprazole|mesh-list
15135868|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
15135869|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15135870|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135871|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15135872|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135873|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004284|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
14004285|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004286|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004287|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
14004288|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004289|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004290|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14004291|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
14004292|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14004293|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14004294|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14004295|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14004296|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004297|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
14004298|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14004299|NCT02879643|Vincristine|vincristine|mesh-list
14004300|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14004301|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004302|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
14004303|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
14004304|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
14004305|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004306|NCT02879721|Candesartan|candesartan|mesh-list
14004307|NCT02879721|Enalapril|enalapril|mesh-list
14004308|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14004309|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14004310|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14004311|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004312|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14004313|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
14004314|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135874|NCT04341571|Metformin|metformin|mesh-list
15135875|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15135876|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135877|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135878|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
15135879|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
15135880|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135881|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135882|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135883|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135884|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135885|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135886|NCT04341675|Sirolimus|sirolimus|mesh-list
15135887|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135888|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135889|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15135890|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135891|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
15135892|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004333|NCT02879292|Anesthetics|anesthetics|mesh-list
14004334|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004335|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004336|NCT02879227|Cisplatin|cisplatin|mesh-list
14004337|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
14004338|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004339|NCT02879110|Sulforaphane|sulforaphane|mesh-list
14004340|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14004341|NCT02879110|Protective Agents|protective agents|mesh-ancestor
14004342|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004343|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004344|NCT02879097|Paclitaxel|paclitaxel|mesh-list
14004345|NCT02879097|Carboplatin|carboplatin|mesh-list
14004346|NCT02879097|Bevacizumab|bevacizumab|mesh-list
14004347|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14004348|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004349|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
14004350|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
14004351|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
14004352|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004353|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14004354|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14004355|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14004356|NCT02879097|Growth Substances|growth substances|mesh-ancestor
14004357|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004358|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
14004359|NCT02879006|Omalizumab|omalizumab|mesh-list
14004360|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14004361|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14004362|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
14004363|NCT02878837|Midazolam|midazolam|mesh-list
14004364|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
14004365|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14004366|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004367|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004368|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004369|NCT02878837|Analgesics|analgesics|mesh-ancestor
14004370|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
14004371|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004372|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14004373|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14004374|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14004375|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
14004376|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135893|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
14811416|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14811417|NCT00845559|Incretins|incretins|mesh-ancestor
14811418|NCT00845559|Hormones|hormones|mesh-ancestor
14811419|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811420|NCT00845572|Risperidone|risperidone|mesh-list
14811421|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14811422|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
14811423|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15135894|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135895|NCT04341818|Vitamin D|vitamin d|mesh-list
14270499|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270500|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
14270501|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270502|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270503|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14270504|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
14270505|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270506|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811424|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135896|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
15135897|NCT04341818|Vitamins|vitamins|mesh-list
15135898|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
15135899|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135900|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15135901|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15135902|NCT04341727|Azithromycin|azithromycin|mesh-list
15135903|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135904|NCT04341727|Chloroquine|chloroquine|mesh-list
15135905|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15135906|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135907|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135908|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
15135909|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15135910|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15135911|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135912|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135913|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135914|NCT04341727|Amebicides|amebicides|mesh-ancestor
15135915|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15135916|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15135917|NCT04341727|Analgesics|analgesics|mesh-ancestor
15135918|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
15135919|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135920|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135921|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135922|NCT04341727|Filaricides|filaricides|mesh-ancestor
15135923|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
15135924|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
15135925|NCT04341545|Letrozole|letrozole|mesh-list
15135926|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135927|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15135928|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15135929|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135930|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135931|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15135932|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
14004377|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004378|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14004379|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14004380|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14004381|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14004382|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14004383|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
14004384|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
14004385|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
14004386|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
14004387|NCT02878785|Decitabine|decitabine|mesh-list
14004388|NCT02878785|Talazoparib|talazoparib|mesh-list
14004389|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14004390|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
14004391|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004392|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004393|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004394|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14004395|NCT02878863|Peoniflorin|peoniflorin|mesh-list
14004396|NCT02878863|Silymarin|silymarin|mesh-list
14004397|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
14004398|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004399|NCT02878863|Protective Agents|protective agents|mesh-ancestor
14004400|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004401|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14004402|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004403|NCT02878863|Analgesics|analgesics|mesh-ancestor
14004404|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
14004405|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004406|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004407|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004408|NCT02878772|Aspirin|aspirin|mesh-list
14004409|NCT02878772|Vinpocetine|vinpocetine|mesh-list
14004410|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14004411|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004412|NCT02878772|Analgesics|analgesics|mesh-ancestor
14004413|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
14004414|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004415|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135933|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135934|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004416|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004417|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004418|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14004419|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14004420|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004421|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14004422|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14004423|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004424|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
14004425|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14004426|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
14004427|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14004428|NCT02878772|Protective Agents|protective agents|mesh-ancestor
14004429|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
14004430|NCT02878564|Praziquantel|praziquantel|mesh-list
14004431|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
14004432|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004433|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004434|NCT02878512|Anesthetics|anesthetics|mesh-list
14004435|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004436|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004437|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
15135935|NCT04341207|Azithromycin|azithromycin|mesh-list
15135936|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
15135937|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15135938|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15135939|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
14004438|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14004439|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004440|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004441|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004442|NCT02878707|Analgesics|analgesics|mesh-ancestor
14004443|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
14004444|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004445|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14004446|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14004447|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14004448|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
14004449|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004450|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004451|NCT02878681|Ranibizumab|ranibizumab|mesh-list
14004452|NCT02878681|Aflibercept|aflibercept|mesh-list
14004453|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14004454|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14004455|NCT02878681|Growth Substances|growth substances|mesh-ancestor
14004456|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004457|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
14004458|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004459|NCT02878421|Nicotine|nicotine|mesh-list
14004460|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14004461|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
14004462|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004463|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004464|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14004465|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14004466|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
14004467|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004468|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004469|NCT02878538|Deferiprone|deferiprone|mesh-list
14004470|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14004471|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
14004472|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
14004473|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024308|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14024309|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14024310|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024311|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14024312|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024313|NCT02757391|Aldesleukin|aldesleukin|mesh-list
14024314|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
14024315|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
14024316|NCT02757391|Interleukin-2|interleukin-2|mesh-list
15135940|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14024317|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
14024318|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15135941|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004474|NCT02878200|Piperaquine|piperaquine|mesh-list
14004475|NCT02878200|Artenimol|artenimol|mesh-list
14004476|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
14004477|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14811425|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811426|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14811427|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14811428|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811429|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14811430|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14811431|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
14811432|NCT00845598|Fluticasone|fluticasone|mesh-list
14811433|NCT00845598|Xhance|xhance|mesh-list
14811434|NCT00845598|Azelastine|azelastine|mesh-list
14811435|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811436|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14811437|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
14811438|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811439|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811440|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14811441|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
14811442|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14811443|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14811444|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14811445|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811446|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004478|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004479|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004480|NCT02878291|Vaccines|vaccines|mesh-list
14004481|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
14004482|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004483|NCT02878083|Adalimumab|adalimumab|mesh-list
14004484|NCT02878083|Vedolizumab|vedolizumab|mesh-list
14004485|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004486|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004487|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14004488|NCT02878265|Vitamins|vitamins|mesh-list
14004489|NCT02878265|Vitamin A|vitamin a|mesh-list
14004490|NCT02878265|Zinc|zinc|mesh-list
14004491|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
14004492|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
14004493|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004494|NCT02878265|Trace Elements|trace elements|mesh-ancestor
14004495|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
14004496|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135942|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135943|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004497|NCT02878265|Protective Agents|protective agents|mesh-ancestor
14004498|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14004499|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004500|NCT02878161|Prednisone|prednisone|mesh-list
14004501|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
14004502|NCT02878161|Adalimumab|adalimumab|mesh-list
14004503|NCT02878161|Etanercept|etanercept|mesh-list
15135944|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15135945|NCT04341311|Panobinostat|panobinostat|mesh-list
15135946|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135947|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15135948|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135949|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135950|NCT04341181|Trastuzumab|trastuzumab|mesh-list
15135951|NCT04341181|Avelumab|avelumab|mesh-list
15135952|NCT04341181|Pertuzumab|pertuzumab|mesh-list
15135953|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15135954|NCT04341181|Atezolizumab|atezolizumab|mesh-list
15135955|NCT04341181|Axitinib|axitinib|mesh-list
15135956|NCT04341181|Niraparib|niraparib|mesh-list
15135957|NCT04341181|Vemurafenib|vemurafenib|mesh-list
15135958|NCT04341181|Maytansine|maytansine|mesh-list
15135959|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15135960|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135961|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15135962|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135963|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004504|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14004505|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14811447|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15135964|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14004506|NCT02878161|Methotrexate|methotrexate|mesh-list
14004507|NCT02878161|Infliximab|infliximab|mesh-list
14004508|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
14004509|NCT02878161|Leflunomide|leflunomide|mesh-list
14004510|NCT02878161|Hormones|hormones|mesh-ancestor
14004511|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14004512|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004513|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14004514|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004515|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14004516|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
14004517|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14004518|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14004519|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
14004520|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004521|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
14004522|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004523|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14004524|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004525|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
14004526|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004527|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14004528|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
14004529|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
14004530|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004531|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14004532|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14004533|NCT02878161|Protective Agents|protective agents|mesh-ancestor
14004534|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004535|NCT02878161|Analgesics|analgesics|mesh-ancestor
14004536|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
14004537|NCT02878018|Hormones|hormones|mesh-list
14004538|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
14004539|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14004540|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14004541|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14004542|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004543|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004544|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004545|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
14004546|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
14004547|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004548|NCT02878031|Amoxicillin|amoxicillin|mesh-list
14004549|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14004550|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004551|NCT02878122|Carboplatin|carboplatin|mesh-list
14004552|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004553|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14004554|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14004555|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14004556|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
14004557|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004558|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004559|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004560|NCT02877901|Urological Agents|urological agents|mesh-ancestor
14004561|NCT02877888|Fluorides|fluorides|mesh-list
14004562|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
14004563|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
14004564|NCT02877888|Protective Agents|protective agents|mesh-ancestor
14004565|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004566|NCT02877615|S44819|s44819|mesh-list
14004567|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
14004568|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
14004569|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
14004570|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004571|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004572|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135965|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15135966|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
15135967|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
15135968|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
15135969|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
14004573|NCT02877771|Insulin|insulin|mesh-list
14004574|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14004575|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004576|NCT02877537|Albuterol|albuterol|mesh-list
15135970|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14004577|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14004578|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
14004579|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004580|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004581|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14004582|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
14004583|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
14004584|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14004585|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14004586|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14004587|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14004588|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
14004589|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004590|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004591|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
14004592|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14004593|NCT02877511|Protective Agents|protective agents|mesh-ancestor
14004594|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004595|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
14004596|NCT02877641|Vitamin D|vitamin d|mesh-list
14004597|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
14004598|NCT02877641|Vitamins|vitamins|mesh-list
14004599|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
14004600|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004601|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14004602|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14004603|NCT02877238|Sevoflurane|sevoflurane|mesh-list
14004604|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
14004605|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004606|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004607|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15135971|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15135972|NCT04341038|Prednisolone|prednisolone|mesh-list
15135973|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
15135974|NCT04341038|Tacrolimus|tacrolimus|mesh-list
15135975|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15135976|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
15135977|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15135978|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
15135979|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135980|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15135981|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15135982|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15135983|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15135984|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
14004608|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14004609|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
14004610|NCT02877173|Alprostadil|alprostadil|mesh-list
14004611|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14004612|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
14004613|NCT02877173|Urological Agents|urological agents|mesh-ancestor
14004614|NCT02877277|Ascorbic Acid|ascorbic acid|mesh-list
14004615|NCT02877277|Vitamins|vitamins|mesh-ancestor
14004616|NCT02877277|Micronutrients|micronutrients|mesh-ancestor
14004617|NCT02877277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15135985|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
15135986|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15135987|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15135988|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
15135989|NCT04341038|Hormones|hormones|mesh-ancestor
15135990|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15135991|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15135992|NCT04341038|Protective Agents|protective agents|mesh-ancestor
15135993|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15135994|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15135995|NCT04341155|Dexamethasone|dexamethasone|mesh-list
14004618|NCT02877277|Antioxidants|antioxidants|mesh-ancestor
14004619|NCT02877277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004620|NCT02877277|Protective Agents|protective agents|mesh-ancestor
14004621|NCT02877303|Cytarabine|cytarabine|mesh-list
14004622|NCT02877303|Dexamethasone|dexamethasone|mesh-list
14004623|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
14004624|NCT02877303|Prednisone|prednisone|mesh-list
14004625|NCT02877303|Cortisone|cortisone|mesh-list
15135996|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
15135997|NCT04341155|BB 1101|bb 1101|mesh-list
15135998|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004626|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
14004627|NCT02877303|Rituximab|rituximab|mesh-list
14004628|NCT02877303|Doxorubicin|doxorubicin|mesh-list
14004629|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14004630|NCT02877303|Methotrexate|methotrexate|mesh-list
14004631|NCT02877303|Vincristine|vincristine|mesh-list
14004632|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
14004633|NCT02877303|Ofatumumab|ofatumumab|mesh-list
14004634|NCT02877303|Blinatumomab|blinatumomab|mesh-list
14004635|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14004636|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14004637|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
14004638|NCT02877303|Antibodies|antibodies|mesh-list
14004639|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
14004640|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14004641|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14004642|NCT02877303|BB 1101|bb 1101|mesh-list
14004643|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004644|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
14004645|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004646|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004647|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14004648|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
14004649|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004650|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004651|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14004652|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004653|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
14004654|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
14004655|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004656|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14004657|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
14004658|NCT02877303|Hormones|hormones|mesh-ancestor
14004659|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14004660|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14004661|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
14004662|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004663|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14004664|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14004665|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14004666|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14004667|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
14004668|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14004669|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14004670|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
14004671|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
14004672|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14004673|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14004674|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
14004675|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004676|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14004677|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
14004678|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
14004679|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
14004680|NCT02876991|Listerine|listerine|mesh-list
14004681|NCT02876991|Fluorides|fluorides|mesh-list
14004682|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
14004683|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
14270507|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14270508|NCT00410202|Tenofovir|tenofovir|mesh-list
14270509|NCT00410202|Lamivudine|lamivudine|mesh-list
14270510|NCT00410202|Entecavir|entecavir|mesh-list
14270511|NCT00410202|Adefovir|adefovir|mesh-list
14270512|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
14270513|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270514|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14270515|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14270516|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270517|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270518|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14270519|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14270520|NCT00410384|Belimumab|belimumab|mesh-list
14004684|NCT02876991|Protective Agents|protective agents|mesh-ancestor
14270521|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270522|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
14004685|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004686|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14004687|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270523|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004688|NCT02876770|Melatonin|melatonin|mesh-list
14004689|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
14004690|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004691|NCT02876770|Protective Agents|protective agents|mesh-ancestor
14004692|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004693|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004694|NCT02876822|Vitamin D|vitamin d|mesh-list
14004695|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
14004696|NCT02876822|Vitamins|vitamins|mesh-ancestor
14004697|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
14004698|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004699|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14004700|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14004701|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
14004702|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14004703|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
14004704|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14004705|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
15135999|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
15136000|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
15136001|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136002|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136003|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15136004|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
14004706|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004707|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004708|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
14004709|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
14004710|NCT02876978|Fludarabine|fludarabine|mesh-list
14004711|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004712|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
14004713|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004714|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004715|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14004716|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
14004717|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004718|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004719|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14024319|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024320|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024321|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14024322|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
14024323|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024324|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024325|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14024326|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024327|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14024328|NCT02757391|Analgesics|analgesics|mesh-ancestor
14024329|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
14024330|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024331|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14024332|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14024333|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
14024334|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024335|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
14024336|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14024337|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14024338|NCT02757196|Prednisolone|prednisolone|mesh-list
14024339|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
14024340|NCT02757196|Rituximab|rituximab|mesh-list
14024341|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14024342|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
14024343|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024344|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024345|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
14024346|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024347|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024348|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024349|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
14024350|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
14024351|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024352|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15136005|NCT04341155|Hormones|hormones|mesh-ancestor
14024353|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
14024354|NCT02757196|Hormones|hormones|mesh-ancestor
15136006|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136007|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15136008|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136009|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
15136010|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136011|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136012|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136013|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
15136014|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136015|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004720|NCT02876679|Cyclosporine|cyclosporine|mesh-list
14004721|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
14004722|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
14004723|NCT02876679|Cyclosporins|cyclosporins|mesh-list
14004724|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14004725|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004726|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
14004727|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004728|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004729|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14004730|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
14004731|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004732|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004733|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14004734|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004735|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
14004736|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004737|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
14004738|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14004739|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14004740|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14004741|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
14004742|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14004743|NCT02876796|Firsocostat|firsocostat|mesh-list
14004744|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004745|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136016|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136017|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136018|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136019|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15178949|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15178950|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
15178951|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178952|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178953|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14004746|NCT02876549|Chloroquine|chloroquine|mesh-list
14004747|NCT02876549|Primaquine|primaquine|mesh-list
14004748|NCT02876549|Amebicides|amebicides|mesh-ancestor
14004749|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14004750|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004751|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178954|NCT03953950|Diuretics|diuretics|mesh-ancestor
15178955|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
15178956|NCT03953833|Antibodies|antibodies|mesh-list
15178957|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15178958|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
14004752|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
14004753|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004754|NCT02876432|Diclofenac|diclofenac|mesh-list
14004755|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14004756|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178959|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178960|NCT03954262|Propofol|propofol|mesh-list
15178961|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15178962|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178963|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178964|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15178965|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
15178966|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
15178967|NCT03953807|Dexamethasone|dexamethasone|mesh-list
15178968|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004757|NCT02876432|Analgesics|analgesics|mesh-ancestor
15178969|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
15178970|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
14270524|NCT00410410|Abatacept|abatacept|mesh-list
14004758|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
14270525|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15178971|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136020|NCT04340869|Theobromine|theobromine|mesh-list
14004759|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004760|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004761|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004762|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004763|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14004764|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004765|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136021|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15136022|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
15136023|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136024|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136025|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14004766|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
14004767|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14004768|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
14004769|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004770|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
14004771|NCT02876276|Protective Agents|protective agents|mesh-ancestor
14004772|NCT02876354|Vitamin K|vitamin k|mesh-list
14004773|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
14004774|NCT02876354|Vitamins|vitamins|mesh-ancestor
14004775|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
14004776|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004777|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14004778|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14004779|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004780|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
14004781|NCT02876354|Coagulants|coagulants|mesh-ancestor
14004782|NCT02876224|Bevacizumab|bevacizumab|mesh-list
14004783|NCT02876224|Atezolizumab|atezolizumab|mesh-list
14004784|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14004785|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004786|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14004787|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14004788|NCT02876224|Growth Substances|growth substances|mesh-ancestor
14004789|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004790|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
14004791|NCT02876250|Cyclosporine|cyclosporine|mesh-list
14004792|NCT02876250|Cyclosporins|cyclosporins|mesh-list
14004793|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004794|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004795|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004796|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
14004797|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004798|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
14004799|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004800|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14004801|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004802|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14004803|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14004804|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14004805|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14004806|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14004807|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
14004808|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004809|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14004810|NCT02876484|Cathartics|cathartics|mesh-ancestor
14004811|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14004812|NCT02876211|Vitamin D|vitamin d|mesh-list
14004813|NCT02876211|Vitamins|vitamins|mesh-ancestor
14004814|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
15136026|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
15136027|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
15136028|NCT04340778|Lidocaine|lidocaine|mesh-list
15136029|NCT04340778|Prilocaine|prilocaine|mesh-list
15136030|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15136031|NCT04340778|Dinoprostone|dinoprostone|mesh-list
14004815|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004816|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14004817|NCT02876094|Celecoxib|celecoxib|mesh-list
14004818|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14292399|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004819|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004820|NCT02876094|Analgesics|analgesics|mesh-ancestor
14004821|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
15136032|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
15136033|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
14004822|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004823|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004824|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004825|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004826|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14004827|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14004828|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004829|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004830|NCT02876081|Afatinib|afatinib|mesh-list
14004831|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004832|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14004833|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136034|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004834|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004835|NCT02876146|Albendazole|albendazole|mesh-list
14004836|NCT02876146|Benzimidazole|benzimidazole|mesh-list
14004837|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
14004838|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004839|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004840|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
14004841|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14004842|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14004843|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14004844|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14004845|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14004846|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004847|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004848|NCT02875756|Ivermectin|ivermectin|mesh-list
14004849|NCT02875756|Selamectin|selamectin|mesh-list
14004850|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004851|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004852|NCT02875743|Posaconazole|posaconazole|mesh-list
14004853|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
14004854|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004855|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14004856|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14004857|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004858|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15136035|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136036|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
15136037|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136038|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15136039|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15136040|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15136041|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15136042|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136043|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
15136044|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15136045|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15136046|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
15136047|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15136048|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136049|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15136050|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136051|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
15136052|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136053|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136054|NCT04340401|Capecitabine|capecitabine|mesh-list
15136055|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
15136056|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15136057|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
15136058|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136059|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136060|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136061|NCT04340349|Bromhexine|bromhexine|mesh-list
15136062|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
15136063|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136064|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136065|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136066|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136067|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136068|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136069|NCT04340349|Expectorants|expectorants|mesh-ancestor
15136070|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
14004859|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14004860|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004861|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004862|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14004863|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
14004864|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14004865|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004866|NCT02875821|Metformin|metformin|mesh-list
14004867|NCT02875821|Pioglitazone|pioglitazone|mesh-list
14004868|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
14004869|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14004870|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004871|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14004872|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004873|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14004874|NCT02875886|Amiloride|amiloride|mesh-list
14004875|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14004876|NCT02875886|Diuretics|diuretics|mesh-ancestor
14004877|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
14004878|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004879|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14004880|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14004881|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004882|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14004883|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14004884|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14004885|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14004886|NCT02875873|Methamphetamine|methamphetamine|mesh-list
14004887|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
14004888|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14004889|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004890|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
14004891|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
14004892|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004893|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
14004894|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004895|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004896|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14004897|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14004898|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14004899|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14004900|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14004901|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14004902|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14004903|NCT02875457|Cisplatin|cisplatin|mesh-list
14004904|NCT02875457|Etoposide|etoposide|mesh-list
14004905|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
14004906|NCT02875457|Apatinib|apatinib|mesh-list
14004907|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004908|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14004909|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14004910|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14004911|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004912|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004913|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14004914|NCT02875587|Cabergoline|cabergoline|mesh-list
14004915|NCT02875587|Calcium|calcium|mesh-list
14270526|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270527|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136071|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14004916|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14004917|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004918|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14004919|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14004920|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
14004921|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
14004922|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14004923|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004924|NCT02876107|Paclitaxel|paclitaxel|mesh-list
14004925|NCT02876107|Carboplatin|carboplatin|mesh-list
14004926|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14004927|NCT02876107|Panitumumab|panitumumab|mesh-list
15136072|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14004928|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14004929|NCT02876107|Antibodies|antibodies|mesh-list
14004930|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
14004931|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15136073|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14004932|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14004933|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004934|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14004935|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
15136074|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136075|NCT04340388|Tenofovir|tenofovir|mesh-list
15136076|NCT04340388|Lamivudine|lamivudine|mesh-list
15136077|NCT04340388|Zidovudine|zidovudine|mesh-list
15136078|NCT04340388|Darunavir|darunavir|mesh-list
15136079|NCT04340388|Abacavir|abacavir|mesh-list
15136080|NCT04340388|Dolutegravir|dolutegravir|mesh-list
15136081|NCT04340388|Cobicistat|cobicistat|mesh-list
15136082|NCT04340388|Rilpivirine|rilpivirine|mesh-list
14004936|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14004937|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004938|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
14004939|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004940|NCT02875717|Aspirin|aspirin|mesh-list
14004941|NCT02875717|Heparin|heparin|mesh-list
14004942|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14004943|NCT02875717|Tinzaparin|tinzaparin|mesh-list
14004944|NCT02875717|Dalteparin|dalteparin|mesh-list
14004945|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
14004946|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14004947|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14004948|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004949|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14004950|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14004951|NCT02875717|Analgesics|analgesics|mesh-ancestor
14004952|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
14004953|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004954|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004955|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14004956|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14004957|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14004958|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14004959|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14004960|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
14004961|NCT02875262|Deferoxamine|deferoxamine|mesh-list
14004962|NCT02875262|Siderophores|siderophores|mesh-ancestor
14004963|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14004964|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
14004965|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
14004966|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004967|NCT02875093|Cytarabine|cytarabine|mesh-list
14004968|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14004969|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
14004970|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004971|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004972|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
14004973|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004974|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14004975|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
14004976|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004977|NCT02875288|Bupivacaine|bupivacaine|mesh-list
14004978|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
14004979|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
14004980|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004981|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004982|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
14004983|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024355|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024356|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14024357|NCT02757196|Protective Agents|protective agents|mesh-ancestor
14024358|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14024359|NCT02757144|Esomeprazole|esomeprazole|mesh-list
14024360|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14024361|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024362|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14024363|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136083|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15136084|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
15136085|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14004984|NCT02875015|Lidocaine|lidocaine|mesh-list
14004985|NCT02875015|Bupivacaine|bupivacaine|mesh-list
14004986|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
14004987|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
14004988|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14004989|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14004990|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
14004991|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14004992|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14004993|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14004994|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14004995|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14004996|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14004997|NCT02875002|Belinostat|belinostat|mesh-list
14004998|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14004999|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14005000|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005001|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005002|NCT02874989|Dasatinib|dasatinib|mesh-list
14005003|NCT02874989|Quercetin|quercetin|mesh-list
14005004|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005005|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14005006|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005007|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005008|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
14005009|NCT02874989|Protective Agents|protective agents|mesh-ancestor
14005010|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005011|NCT02874963|Ethanol|ethanol|mesh-list
14005012|NCT02874963|Listerine|listerine|mesh-list
14005013|NCT02874963|Eucalyptol|eucalyptol|mesh-list
14005014|NCT02874963|Salicylates|salicylates|mesh-list
15136086|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15136087|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15136088|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136089|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005015|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
14005016|NCT02874963|Menthol|menthol|mesh-list
14005017|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14005018|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005019|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005020|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005021|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
14005022|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
15136090|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15136091|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
14005023|NCT02874963|Protective Agents|protective agents|mesh-ancestor
14005024|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14005025|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14005026|NCT02874963|Analgesics|analgesics|mesh-ancestor
14005027|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
14005028|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005029|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005030|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14005031|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14005032|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005033|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005034|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
14005035|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
14005036|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
14005037|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
14005038|NCT02874768|Propofol|propofol|mesh-list
14005039|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14005040|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005041|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005042|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14005043|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
14005044|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
14005045|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14005046|NCT02874768|Analgesics|analgesics|mesh-ancestor
14005047|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
14005048|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005049|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14005050|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14005051|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14005052|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
14005053|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005054|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005055|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14005056|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
14005057|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005058|NCT02874690|Methylphenidate|methylphenidate|mesh-list
14005059|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14005060|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005061|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14005062|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14005063|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14005064|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005065|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
14005066|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005067|NCT02874807|Empagliflozin|empagliflozin|mesh-list
14005068|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14005069|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005070|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14005071|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005072|NCT02874820|Idazoxan|idazoxan|mesh-list
14005073|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14005074|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14005075|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14005076|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
14005077|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005078|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005079|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005080|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
14005081|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14005082|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005083|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005084|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14005085|NCT02874378|Analgesics|analgesics|mesh-ancestor
14005086|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
14005087|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005088|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14005089|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14005090|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14005091|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
14005092|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005093|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005094|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
14005095|NCT02874144|Fluticasone|fluticasone|mesh-list
14005096|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005097|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
14005098|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14005099|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14005100|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
14005101|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005102|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005103|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14005104|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
14005105|NCT02874326|Octreotide|octreotide|mesh-list
14005106|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005107|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005108|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005109|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
14005110|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
14005111|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14005112|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14005113|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005114|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005115|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005116|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14005117|NCT02874248|Drospirenone|drospirenone|mesh-list
14005118|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14005119|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
14005120|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005121|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005122|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14005123|NCT02874248|Diuretics|diuretics|mesh-ancestor
14005124|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
14005125|NCT02873598|Gemcitabine|gemcitabine|mesh-list
14005126|NCT02873598|Paclitaxel|paclitaxel|mesh-list
14005127|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14005128|NCT02873598|Folfirinox|folfirinox|mesh-list
14005129|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14005130|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005131|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
14005132|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14005133|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
14005134|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005135|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14005136|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
14005137|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
14005138|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005139|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005140|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005141|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
14005142|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005143|NCT02873650|Dabrafenib|dabrafenib|mesh-list
14005144|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005145|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14005146|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005147|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005148|NCT02873806|Tobramycin|tobramycin|mesh-list
14005149|NCT02873806|Dexamethasone|dexamethasone|mesh-list
14005150|NCT02873806|Travoprost|travoprost|mesh-list
14005151|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005152|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
14005153|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
14005154|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005155|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005156|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005157|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
14005158|NCT02873806|Hormones|hormones|mesh-ancestor
15136092|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15136093|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15136094|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
14005159|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005160|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005161|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005162|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14005163|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14005164|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005165|NCT02873559|Testosterone|testosterone|mesh-list
14005166|NCT02873559|Androgens|androgens|mesh-ancestor
14005167|NCT02873559|Hormones|hormones|mesh-ancestor
14005168|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005169|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136095|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15136096|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15136097|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15136098|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15136099|NCT04340141|Leucovorin|leucovorin|mesh-list
15136100|NCT04340141|Fluorouracil|fluorouracil|mesh-list
15136101|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
15136102|NCT04340141|Irinotecan|irinotecan|mesh-list
15136103|NCT04340141|Calcium|calcium|mesh-list
15136104|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
15136105|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15136106|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136107|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
15136108|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136109|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15136110|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136111|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136112|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
15136113|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15136114|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15136115|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136116|NCT04340141|Antidotes|antidotes|mesh-ancestor
15136117|NCT04340141|Protective Agents|protective agents|mesh-ancestor
15136118|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
15136119|NCT04340141|Vitamins|vitamins|mesh-ancestor
14005170|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14292400|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136120|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
15136121|NCT04339816|Azithromycin|azithromycin|mesh-list
15136122|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
14005171|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005172|NCT02873871|Hemostatics|hemostatics|mesh-list
14005173|NCT02873871|Coagulants|coagulants|mesh-ancestor
14270528|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270529|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
14270530|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270531|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136123|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136124|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270532|NCT00410423|Cytarabine|cytarabine|mesh-list
15136125|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
15136126|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136127|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136128|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136129|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136130|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136131|NCT04339868|Terlipressin|terlipressin|mesh-list
15136132|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15136133|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15136134|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15136135|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270533|NCT00410423|Etoposide|etoposide|mesh-list
14270534|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
14270535|NCT00410423|Bortezomib|bortezomib|mesh-list
14270536|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14270537|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270538|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14270539|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14270540|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270541|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270542|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270543|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
14270544|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
14270545|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136136|NCT04339361|Lidocaine|lidocaine|mesh-list
15136137|NCT04339361|Dinoprostone|dinoprostone|mesh-list
15136138|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
15136139|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
15136140|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136141|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136142|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
15136143|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136144|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15136145|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15136146|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15136147|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15136148|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136149|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
15136150|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15136151|NCT04339062|Sirolimus|sirolimus|mesh-list
15136152|NCT04339062|Prednisone|prednisone|mesh-list
15136153|NCT04339062|Everolimus|everolimus|mesh-list
15136154|NCT04339062|Cemiplimab|cemiplimab|mesh-list
15136155|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136156|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
15136157|NCT04339062|Hormones|hormones|mesh-ancestor
15136158|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136159|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136160|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15136161|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136162|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136163|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
15136164|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136165|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136166|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15136167|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
15136168|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136169|NCT04339348|Lidocaine|lidocaine|mesh-list
15136170|NCT04339348|Prilocaine|prilocaine|mesh-list
15136171|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15136172|NCT04339348|Misoprostol|misoprostol|mesh-list
15136173|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
14005174|NCT02873273|Dexamethasone|dexamethasone|mesh-list
14005175|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005176|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
14005177|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
14005178|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005179|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005180|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005181|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
14005182|NCT02873273|Hormones|hormones|mesh-ancestor
14005183|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005184|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005185|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005186|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
14005187|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024364|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024365|NCT02757248|Romidepsin|romidepsin|mesh-list
14024366|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14024367|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024368|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
14024369|NCT02757443|Anesthetics|anesthetics|mesh-list
14024370|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024371|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024372|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14024373|NCT02757443|Protective Agents|protective agents|mesh-ancestor
14024374|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
14024375|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024376|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
14024377|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
14024378|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
14024379|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
14024380|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024381|NCT02757066|Melatonin|melatonin|mesh-list
14024382|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
14024383|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024384|NCT02757066|Protective Agents|protective agents|mesh-ancestor
14024385|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024386|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024387|NCT02757079|Melatonin|melatonin|mesh-list
14024388|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
14024389|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024390|NCT02757079|Protective Agents|protective agents|mesh-ancestor
14024391|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024392|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024393|NCT02756962|Cytarabine|cytarabine|mesh-list
14024394|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14024395|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
14024396|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024397|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024398|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
14024399|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024400|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024401|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
14024402|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024403|NCT02756598|Sufentanil|sufentanil|mesh-list
14024404|NCT02756598|Dsuvia|dsuvia|mesh-list
14024405|NCT02756598|Propofol|propofol|mesh-list
14024406|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14024407|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136174|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
15136175|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136176|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136177|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
15136178|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136179|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15136180|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14024408|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024409|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14024410|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
15136181|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15136182|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14024411|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
14024412|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14024413|NCT02756598|Narcotics|narcotics|mesh-ancestor
14024414|NCT02756598|Analgesics|analgesics|mesh-ancestor
14024415|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
14024416|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024417|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14024418|NCT02756728|Melphalan|melphalan|mesh-list
14024419|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14024420|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
14005188|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
14005189|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14005190|NCT02873364|Vitamin D|vitamin d|mesh-list
14005191|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
15136183|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136184|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15136185|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
15136186|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15136187|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15136188|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15136189|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
15136190|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15136191|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
15136192|NCT04338633|Calcium|calcium|mesh-list
15136193|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15136194|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136195|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15136196|NCT04338711|Tofacitinib|tofacitinib|mesh-list
15136197|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136198|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136199|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136200|NCT04338763|Gemcitabine|gemcitabine|mesh-list
15136201|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15136202|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
15136203|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136204|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136205|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
15136206|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005192|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
14005193|NCT02873364|Vitamins|vitamins|mesh-list
14005194|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
14005195|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005196|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14005197|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14005198|NCT02873351|Levodopa|levodopa|mesh-list
14005199|NCT02873351|Carbidopa|carbidopa|mesh-list
14005200|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14005201|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14005202|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14005203|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
14005204|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005205|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005206|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005207|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14005208|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005209|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14005210|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
14005211|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
14005212|NCT02873091|Sufentanil|sufentanil|mesh-list
14005213|NCT02873091|Ropivacaine|ropivacaine|mesh-list
14005214|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
14005215|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
14005216|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005217|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005218|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
14005219|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005220|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14005221|NCT02873091|Narcotics|narcotics|mesh-ancestor
14005222|NCT02873091|Analgesics|analgesics|mesh-ancestor
14005223|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14005224|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14005225|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
14005226|NCT02873065|Amoxicillin|amoxicillin|mesh-list
14005227|NCT02873065|Clarithromycin|clarithromycin|mesh-list
15136207|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136208|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136209|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
15136210|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136211|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136212|NCT04338906|Camostat|camostat|mesh-list
15136213|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
15136214|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136215|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14005228|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
14005229|NCT02873065|Bismuth|bismuth|mesh-list
14005230|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136216|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136217|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136218|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136219|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136220|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
14270546|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270547|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
14270548|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270549|NCT00410423|Analgesics|analgesics|mesh-ancestor
14270550|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
14270551|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270552|NCT00410488|Dexamethasone|dexamethasone|mesh-list
14270553|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
14270554|NCT00410488|Doxorubicin|doxorubicin|mesh-list
14270555|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14270556|NCT00410488|Vincristine|vincristine|mesh-list
14005231|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14005232|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005233|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14005234|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005235|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14005236|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14005237|NCT02873065|Antacids|antacids|mesh-ancestor
14005238|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005239|NCT02873065|Diuretics|diuretics|mesh-ancestor
14005240|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
14005241|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005242|NCT02873065|Expectorants|expectorants|mesh-ancestor
14005243|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
14005244|NCT02872818|Metformin|metformin|mesh-list
14005245|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14005246|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14005247|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14005248|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
14005249|NCT02872818|Estradiol|estradiol|mesh-list
14005250|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14005251|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14005252|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005253|NCT02872818|Estrogens|estrogens|mesh-ancestor
14005254|NCT02872818|Hormones|hormones|mesh-ancestor
14005255|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005256|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14005257|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
14005258|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14005259|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15136221|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15136222|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15136223|NCT04338802|Nintedanib|nintedanib|mesh-list
15136224|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136225|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136226|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136227|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136228|NCT04338919|Aspirin|aspirin|mesh-list
15136229|NCT04338919|Ticagrelor|ticagrelor|mesh-list
14005260|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14005261|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14005262|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14005263|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14005264|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15136230|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15136231|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15136232|NCT04338919|Analgesics|analgesics|mesh-ancestor
15136233|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
15136234|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136235|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136236|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136237|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136238|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15136239|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15136240|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136241|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15136242|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15136243|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136244|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
15136245|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14270557|NCT00410488|Ifosfamide|ifosfamide|mesh-list
14270558|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
15136246|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15136247|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15136248|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
15136249|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005265|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005266|NCT02873026|Triamcinolone|triamcinolone|mesh-list
14005267|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14005268|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14005269|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14005270|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005271|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
14005272|NCT02873026|Hormones|hormones|mesh-ancestor
14005273|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005274|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005275|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005276|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
14005277|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005278|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005279|NCT02872584|Prednisone|prednisone|mesh-list
14005280|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005281|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
14005282|NCT02872584|Hormones|hormones|mesh-ancestor
14005283|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005284|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005285|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005286|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005287|NCT02872597|Dexamethasone|dexamethasone|mesh-list
14005288|NCT02872597|Prednisone|prednisone|mesh-list
14005289|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
14005290|NCT02872597|Prednisolone|prednisolone|mesh-list
14005291|NCT02872597|Albuterol|albuterol|mesh-list
14005292|NCT02872597|Ipratropium|ipratropium|mesh-list
14005293|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005294|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
14005295|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
14005296|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005297|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005298|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005299|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
14005300|NCT02872597|Hormones|hormones|mesh-ancestor
14005301|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005302|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005303|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005304|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005305|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14005306|NCT02872597|Protective Agents|protective agents|mesh-ancestor
14005307|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14005308|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14005309|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
14005310|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
14005311|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14005312|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14005313|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14005314|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14005315|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
14005316|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005317|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14005318|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
14005319|NCT02872649|Warfarin|warfarin|mesh-list
14005320|NCT02872649|Dabigatran|dabigatran|mesh-list
14005321|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
14005322|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
14005323|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
14005324|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14005325|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
14005326|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005327|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005328|NCT02872389|Sevoflurane|sevoflurane|mesh-list
14005329|NCT02872389|Desflurane|desflurane|mesh-list
14005330|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14005331|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14005332|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
14005333|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
14005334|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005335|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005336|NCT02872272|Amikacin|amikacin|mesh-list
14005337|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14005338|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005339|NCT02872428|Valproic Acid|valproic acid|mesh-list
14005340|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
14005341|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005342|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005343|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
14005344|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005345|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005346|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
14005347|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14005348|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005349|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14005350|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
14005351|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005352|NCT02871869|Buformin|buformin|mesh-list
14005353|NCT02871869|Prednisone|prednisone|mesh-list
14270559|NCT00410488|Palonosetron|palonosetron|mesh-list
15136250|NCT04338620|Paclitaxel|paclitaxel|mesh-list
15136251|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15136252|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15136253|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136254|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
15136255|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
15136256|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
15136257|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136258|NCT04338373|Atropine|atropine|mesh-list
15136259|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15136260|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15136261|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15136262|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
15136263|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136264|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136265|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15136266|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
15136267|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
15136268|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
15136269|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15136270|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15136271|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
15136272|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15136273|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136274|NCT04338191|Leucovorin|leucovorin|mesh-list
15136275|NCT04338191|Fluorouracil|fluorouracil|mesh-list
15136276|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
15136277|NCT04338191|Irinotecan|irinotecan|mesh-list
15136278|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
15136279|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
15136280|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136281|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15136282|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136283|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136284|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
14005354|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
14005355|NCT02871869|Rituximab|rituximab|mesh-list
14005356|NCT02871869|Epirubicin|epirubicin|mesh-list
14005357|NCT02871869|Vindesine|vindesine|mesh-list
14005358|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005359|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
14005360|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005361|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14005362|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14005363|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
14005364|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005365|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005366|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14005367|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14005368|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005369|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
14005370|NCT02871869|Hormones|hormones|mesh-ancestor
14005371|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136285|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136286|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14005372|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005373|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15136287|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15136288|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136289|NCT04338191|Antidotes|antidotes|mesh-ancestor
15136290|NCT04338191|Protective Agents|protective agents|mesh-ancestor
14005374|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14005375|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14005376|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005377|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14005378|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
14005379|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
14005380|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
14005381|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14005382|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
14005383|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
14005384|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14005385|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
14005386|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005387|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005388|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14005389|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
14005390|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
14005391|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14005392|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
14005393|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005394|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005395|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14005396|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14005397|NCT02871791|Everolimus|everolimus|mesh-list
14005398|NCT02871791|Palbociclib|palbociclib|mesh-list
14005399|NCT02871791|Exemestane|exemestane|mesh-list
14005400|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005401|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270560|NCT00410488|BB 1101|bb 1101|mesh-list
14270561|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14270562|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
14270563|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
14270564|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270565|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270566|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14270567|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
14270568|NCT00410488|Hormones|hormones|mesh-ancestor
14270569|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14270570|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14270571|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270572|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
14270573|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270574|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270575|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14270576|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14270577|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14270578|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14270579|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
14270580|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
14270581|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
14270582|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14270583|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
14270584|NCT00410488|Protective Agents|protective agents|mesh-ancestor
14270585|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14270586|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14270587|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
14270588|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270589|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14270590|NCT00410514|Mirabegron|mirabegron|mesh-list
14270591|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14270592|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14270593|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14270594|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
14270595|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270596|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270597|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270598|NCT00410514|Urological Agents|urological agents|mesh-ancestor
14270599|NCT00410605|Dexamethasone|dexamethasone|mesh-list
14270600|NCT00410605|Bevacizumab|bevacizumab|mesh-list
14270601|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14270602|NCT00410605|Lenalidomide|lenalidomide|mesh-list
14270603|NCT00410605|Antibodies|antibodies|mesh-list
14270604|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
14005402|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
14005403|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005404|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14005405|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005406|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005407|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14005408|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14005409|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14005410|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
14005411|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005412|NCT02872064|Verteporfin|verteporfin|mesh-list
14005413|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14005414|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
14005415|NCT02871843|Temozolomide|temozolomide|mesh-list
14005416|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14005417|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
14005418|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005419|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005420|NCT02871661|Amitriptyline|amitriptyline|mesh-list
14005421|NCT02871661|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14005422|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14005423|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
14005424|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14005425|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14005426|NCT02871661|Analgesics|analgesics|mesh-ancestor
14005427|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
14005428|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005429|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005430|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14005431|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14005432|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14005433|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005434|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
14005435|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005436|NCT02871661|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14005437|NCT02871661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14005438|NCT02871661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005439|NCT02871986|Estrogens|estrogens|mesh-list
14005440|NCT02871986|Hormones|hormones|mesh-ancestor
14005441|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005442|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005443|NCT02871713|Morphine|morphine|mesh-list
15136291|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
15136292|NCT04338191|Vitamins|vitamins|mesh-ancestor
15136293|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
15136294|NCT04338438|Apatinib|apatinib|mesh-list
14005444|NCT02871713|Ropivacaine|ropivacaine|mesh-list
14005445|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14005446|NCT02871713|Narcotics|narcotics|mesh-ancestor
14005447|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005448|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005449|NCT02871713|Analgesics|analgesics|mesh-ancestor
14005450|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
14005451|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005452|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
14005453|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
14005454|NCT02871765|Warfarin|warfarin|mesh-list
14005455|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
14024421|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024422|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024423|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14024424|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024425|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
14024426|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026221|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14026222|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
14026223|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
14026224|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026225|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136295|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136296|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136297|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026226|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15136298|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005456|NCT02871687|Simvastatin|simvastatin|mesh-list
14005457|NCT02871687|Pravastatin|pravastatin|mesh-list
14005458|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14005459|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14005460|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
14005461|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005462|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14005463|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14005464|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005465|NCT02872038|Cefazolin|cefazolin|mesh-list
14005466|NCT02872038|Ceftazidime|ceftazidime|mesh-list
14005467|NCT02872038|Cefepime|cefepime|mesh-list
14005468|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14005469|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005470|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
14005471|NCT02871648|Eplerenone|eplerenone|mesh-list
14005472|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14005473|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
14005474|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005475|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005476|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14005477|NCT02871648|Diuretics|diuretics|mesh-ancestor
14005478|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
14005479|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14005480|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005484|NCT02871323|Durvalumab|durvalumab|mesh-list
14005485|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
14005486|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14005487|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
14005488|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14005489|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136299|NCT04338165|Evolocumab|evolocumab|mesh-list
15136300|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15136301|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15136302|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
15136303|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136304|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15136305|NCT04337970|Axitinib|axitinib|mesh-list
15136306|NCT04337970|Talazoparib|talazoparib|mesh-list
15136307|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136308|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136309|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136310|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136311|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15136312|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
15136313|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15136314|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15136315|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136316|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
15136317|NCT04338126|Coagulants|coagulants|mesh-ancestor
15136318|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
15136319|NCT04337879|Irinotecan|irinotecan|mesh-list
15136320|NCT04337879|Calcium|calcium|mesh-list
15136321|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15136322|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136323|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136324|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15136325|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15136326|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136327|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136328|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
15136329|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15136330|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15136331|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
15136332|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136333|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136334|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15136335|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
15136336|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15136337|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
15136338|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005490|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
14005491|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005492|NCT02871518|Cisplatin|cisplatin|mesh-list
14005493|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005494|NCT02871505|Penicillins|penicillins|mesh-list
14005495|NCT02871505|Penicillin G|penicillin g|mesh-list
14005496|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14005497|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
14005498|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14005499|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005500|NCT02871349|Propranolol|propranolol|mesh-list
14005501|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14005502|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14005503|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
14005504|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005505|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005506|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005507|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14005508|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15136339|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15136340|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15136341|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
15136342|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
15136343|NCT04337918|Protective Agents|protective agents|mesh-ancestor
15136344|NCT04337814|Ibuprofen|ibuprofen|mesh-list
15136345|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15136346|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15136347|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14005509|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
14005510|NCT02871193|Dexamethasone|dexamethasone|mesh-list
14005511|NCT02871193|Ropivacaine|ropivacaine|mesh-list
14005512|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005513|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
14005514|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
14005515|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005516|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005517|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005518|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
14005519|NCT02871193|Hormones|hormones|mesh-ancestor
14005520|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005521|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005522|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005523|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
14005524|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
14005525|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005526|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
14005527|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
14005528|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14005529|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
14005530|NCT02870829|Vitamin K|vitamin k|mesh-list
14005531|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
14005532|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14005533|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14005534|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005535|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
14005536|NCT02870829|Coagulants|coagulants|mesh-ancestor
14005537|NCT02870829|Vitamins|vitamins|mesh-ancestor
14005538|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
14005539|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005540|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
14005541|NCT02870907|Thiotepa|thiotepa|mesh-list
14005542|NCT02870907|Carboplatin|carboplatin|mesh-list
14005543|NCT02870907|Etoposide|etoposide|mesh-list
14005544|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
14005545|NCT02870907|Vincristine|vincristine|mesh-list
14005546|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005547|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
14005548|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005549|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14005550|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14005551|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
14005552|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005553|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005554|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14005555|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14005556|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14005557|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15136348|NCT04337814|Analgesics|analgesics|mesh-ancestor
15136349|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
14005558|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005559|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14005560|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14005561|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14005562|NCT02870634|Copper|copper|mesh-list
14005563|NCT02870634|Trace Elements|trace elements|mesh-ancestor
14005564|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
14005565|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005566|NCT02870478|Atropine|atropine|mesh-list
14270605|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14270606|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270607|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270608|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270609|NCT00410605|Growth Substances|growth substances|mesh-ancestor
14270610|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270611|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270612|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
14270613|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14270614|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
14270615|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
14270616|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270617|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14270618|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
14270619|NCT00410605|Hormones|hormones|mesh-ancestor
14270620|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14270621|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14270622|NCT00410813|Dasatinib|dasatinib|mesh-list
14270623|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270624|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270625|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270626|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270627|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15136350|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136351|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136352|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14270628|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270629|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270630|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136353|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136354|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15136355|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136356|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136357|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
14270631|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270632|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
14270633|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14270634|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270635|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14270636|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14270637|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14270638|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14270639|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270640|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270641|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270642|NCT00410904|Pemetrexed|pemetrexed|mesh-list
14270643|NCT00410904|Cediranib|cediranib|mesh-list
14270644|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270645|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270646|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270647|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14270648|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14270649|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270650|NCT00411086|Rituximab|rituximab|mesh-list
14270651|NCT00411086|Molgramostim|molgramostim|mesh-list
14270652|NCT00411086|Sargramostim|sargramostim|mesh-list
14270653|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270654|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270655|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
14270656|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270657|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270658|NCT00411151|Sunitinib|sunitinib|mesh-list
14270659|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270660|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270661|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270662|NCT00411151|Growth Substances|growth substances|mesh-ancestor
15136358|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
14005567|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15136359|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005568|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14005569|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14005570|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14005571|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14005572|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
14005573|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005574|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005575|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14005576|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
15136360|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15136361|NCT04337593|Pegaspargase|pegaspargase|mesh-list
15136362|NCT04337593|Basiliximab|basiliximab|mesh-list
15136363|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136364|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136365|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
15136366|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136367|NCT04337632|Paclitaxel|paclitaxel|mesh-list
14005577|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
14005578|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
14005579|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14005580|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14005581|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
14005582|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005583|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005584|NCT02870673|Triamcinolone|triamcinolone|mesh-list
14005585|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14005586|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14005587|NCT02870673|Lidocaine|lidocaine|mesh-list
14005588|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14270663|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270664|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
15136368|NCT04337632|Carboplatin|carboplatin|mesh-list
15136369|NCT04337632|Doxorubicin|doxorubicin|mesh-list
15136370|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15136371|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15136372|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136373|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
15136374|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
15136375|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
15136376|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270665|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270666|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270667|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270668|NCT00411398|Memantine|memantine|mesh-list
14270669|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14270670|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14270671|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
14270672|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270673|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270674|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270675|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14270676|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14270677|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14270678|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14270679|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270680|NCT00411411|Incretins|incretins|mesh-ancestor
14270681|NCT00411411|Hormones|hormones|mesh-ancestor
14270682|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14270683|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14270684|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
14270685|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270686|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270687|NCT00411450|Panitumumab|panitumumab|mesh-list
14561996|NCT00002822|Carboplatin|carboplatin|mesh-list
15136377|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15136378|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14005589|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005590|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
14005591|NCT02870673|Hormones|hormones|mesh-ancestor
14005592|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005593|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005594|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005595|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
14005596|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005597|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005598|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
14005599|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
14005600|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005601|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
14005602|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005603|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14811448|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14811449|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
14811450|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
14811451|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811452|NCT00845689|Adenosine|adenosine|mesh-list
14811453|NCT00845689|Analgesics|analgesics|mesh-ancestor
14811454|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
14811455|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005604|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14005605|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14005606|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14005607|NCT02870361|Insulin|insulin|mesh-list
14005608|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14005609|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005610|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14005611|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14005612|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14005613|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005614|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005615|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
14005616|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005617|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14005618|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14005619|NCT02870231|Liraglutide|liraglutide|mesh-list
14005620|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14005621|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005622|NCT02870231|Incretins|incretins|mesh-ancestor
14005623|NCT02870231|Hormones|hormones|mesh-ancestor
14005624|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005625|NCT02869984|Ramosetron|ramosetron|mesh-list
14005626|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
14005627|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
14005628|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005629|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005630|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005631|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14005632|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
14005633|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005634|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005635|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
14005636|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024427|NCT02756663|Dexamethasone|dexamethasone|mesh-list
14024428|NCT02756663|Panobinostat|panobinostat|mesh-list
14024429|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024430|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
14024431|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
14024432|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024433|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024434|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024435|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
14024436|NCT02756663|Hormones|hormones|mesh-ancestor
14024437|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024438|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14024439|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024440|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14024441|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024442|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024443|NCT02756715|Propofol|propofol|mesh-list
14024444|NCT02756715|Desflurane|desflurane|mesh-list
14024445|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14024446|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024447|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024448|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14024449|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
14024450|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
14024451|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14005637|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
14005638|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
14005639|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
14005640|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005641|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005642|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
14005643|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005644|NCT02870036|Leucovorin|leucovorin|mesh-list
14005645|NCT02870036|Thalidomide|thalidomide|mesh-list
14005646|NCT02870036|Fluorouracil|fluorouracil|mesh-list
14005647|NCT02870036|Calcium|calcium|mesh-list
14005648|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
14005649|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14005650|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005651|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
14005652|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005653|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14005654|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005655|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005656|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
14005657|NCT02870036|Antidotes|antidotes|mesh-ancestor
14005658|NCT02870036|Protective Agents|protective agents|mesh-ancestor
14005659|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
14005660|NCT02870036|Vitamins|vitamins|mesh-ancestor
14005661|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
14005662|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
14005663|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14005664|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005665|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14005666|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14005667|NCT02870036|Growth Substances|growth substances|mesh-ancestor
14005668|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
14005669|NCT02869815|Methylene Blue|methylene blue|mesh-list
15136379|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15136380|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136381|NCT04337658|Capecitabine|capecitabine|mesh-list
15136382|NCT04337658|Trastuzumab|trastuzumab|mesh-list
15136383|NCT04337658|Fulvestrant|fulvestrant|mesh-list
15136384|NCT04337658|Pertuzumab|pertuzumab|mesh-list
14005670|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136385|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15136386|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
15136387|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136388|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136389|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136390|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15136391|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15136392|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15136393|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
15136394|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136395|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136396|NCT04337450|Lamivudine|lamivudine|mesh-list
15136397|NCT04337450|Dolutegravir|dolutegravir|mesh-list
15136398|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15136399|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15136400|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136401|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136402|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
15136403|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136404|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15136405|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15136406|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15136407|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15136408|NCT04337606|Decitabine|decitabine|mesh-list
15136409|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15136410|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
15136411|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136412|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136413|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136414|NCT04337268|Glucagon|glucagon|mesh-list
15136415|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15136416|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15136417|NCT04337268|Hormones|hormones|mesh-ancestor
14005671|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136418|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136419|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005672|NCT02869763|Ethanol|ethanol|mesh-list
14005673|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14005674|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005675|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005676|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005677|NCT02869672|Vaccines|vaccines|mesh-list
14005678|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
14005679|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005680|NCT02869347|Complement C1s|complement c1s|mesh-list
14005681|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14005682|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14005683|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
14005684|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005685|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14005686|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005687|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
14005688|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14005689|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005690|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
14005691|NCT02869204|Ascorbic Acid|ascorbic acid|mesh-list
15136420|NCT04337268|Incretins|incretins|mesh-ancestor
15136421|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
15136422|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15136423|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15136424|NCT04336891|Estradiol|estradiol|mesh-list
15136425|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15136426|NCT04336891|Testosterone|testosterone|mesh-list
15136427|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
14005692|NCT02869204|Vitamins|vitamins|mesh-ancestor
14005693|NCT02869204|Micronutrients|micronutrients|mesh-ancestor
14005694|NCT02869204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005695|NCT02869204|Antioxidants|antioxidants|mesh-ancestor
14005696|NCT02869204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005697|NCT02869204|Protective Agents|protective agents|mesh-ancestor
14005698|NCT02869321|Fentanyl|fentanyl|mesh-list
14005699|NCT02869321|Morphine|morphine|mesh-list
14005700|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14005701|NCT02869321|Narcotics|narcotics|mesh-ancestor
14005702|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005703|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005704|NCT02869321|Analgesics|analgesics|mesh-ancestor
14005705|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
14005706|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005707|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14005708|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14005709|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
14005710|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
14005711|NCT02869165|Estrogens|estrogens|mesh-list
14005712|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14005713|NCT02869165|Hormones|hormones|mesh-ancestor
14005714|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005715|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005716|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14005717|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14005718|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005719|NCT02869100|Listerine|listerine|mesh-list
14005720|NCT02869100|Fluorides|fluorides|mesh-list
14005721|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
14005722|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
14005723|NCT02869100|Protective Agents|protective agents|mesh-ancestor
14005724|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005725|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14005726|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136428|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
15136429|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15136430|NCT04336891|Estrogens|estrogens|mesh-ancestor
15136431|NCT04336891|Hormones|hormones|mesh-ancestor
15136432|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136433|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136434|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15136435|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
15136436|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14005727|NCT02868944|Sufentanil|sufentanil|mesh-list
14005728|NCT02868944|Morphine|morphine|mesh-list
14005729|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
14005730|NCT02868944|Anesthetics|anesthetics|mesh-list
14005731|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
14005732|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14005733|NCT02868944|Narcotics|narcotics|mesh-ancestor
14005734|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005735|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005736|NCT02868944|Analgesics|analgesics|mesh-ancestor
14005737|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
14005738|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005739|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14005740|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14005741|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
14005742|NCT02868931|Insulin|insulin|mesh-list
14005743|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14005744|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005745|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
14005746|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14005747|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
14005748|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005749|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
15136437|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15136438|NCT04336891|Androgens|androgens|mesh-ancestor
15136439|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15136440|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136441|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
15136442|NCT04336904|Favipiravir|favipiravir|mesh-list
15136443|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
15136444|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136445|NCT04336917|Lidocaine|lidocaine|mesh-list
15136446|NCT04336917|Bupivacaine|bupivacaine|mesh-list
15136447|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
15136448|NCT04336917|Anesthetics|anesthetics|mesh-list
15136449|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136450|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136451|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
15136452|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136453|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15136454|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15136455|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15136456|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15136457|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136458|NCT04337099|Tempol|tempol|mesh-list
15136459|NCT04337099|TEMPO|tempo|mesh-list
15136460|NCT04337099|TEMPOL-H|tempol-h|mesh-list
15136461|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
15136462|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136463|NCT04337099|Protective Agents|protective agents|mesh-ancestor
15136464|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136465|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15136466|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136467|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15136468|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15178972|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178973|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15178974|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
15178975|NCT03953807|Hormones|hormones|mesh-ancestor
15178976|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15178977|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15178978|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15178979|NCT03953781|Levetiracetam|levetiracetam|mesh-list
15178980|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
15178981|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
15178982|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
15178983|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15178984|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15178985|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15178986|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15178987|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15178988|NCT03953677|Analgesics|analgesics|mesh-ancestor
15178989|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
15178990|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15178991|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15178992|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15178993|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15178994|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
15178995|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15178996|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15178997|NCT03953729|Ibuprofen|ibuprofen|mesh-list
14005750|NCT02868749|Protective Agents|protective agents|mesh-ancestor
14005751|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14005752|NCT02869035|Citalopram|citalopram|mesh-list
14005753|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15136469|NCT04336566|Melatonin|melatonin|mesh-list
15136470|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
15136471|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136472|NCT04336566|Protective Agents|protective agents|mesh-ancestor
15136473|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136474|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136475|NCT04336332|Azithromycin|azithromycin|mesh-list
15136476|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136477|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136478|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136479|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
15136480|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136481|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14005754|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14005755|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14005756|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005757|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005758|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
14005759|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005760|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14005761|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
14005762|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14005763|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270688|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270689|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270690|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14270691|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
14270692|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270693|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14270694|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270695|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270696|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136482|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136483|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136484|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136485|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15136486|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
15136487|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136488|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
15136489|NCT04336488|Hormones|hormones|mesh-ancestor
15136490|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136491|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136492|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136493|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
15136494|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270697|NCT00411554|Inositol|inositol|mesh-list
14270698|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14270699|NCT00411554|Voglibose|voglibose|mesh-list
15136495|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136496|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
15136497|NCT04336605|Analgesics|analgesics|mesh-list
15136498|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
15136499|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136500|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136501|NCT04336228|Dexetimide|dexetimide|mesh-list
15136502|NCT04336228|Citalopram|citalopram|mesh-list
15136503|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136504|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15136505|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15136506|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15136507|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136508|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15136509|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
15136510|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15136511|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
15136512|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15136513|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15136514|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15136515|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
15136516|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
14005764|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15136517|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136518|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15136519|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15136520|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
15136521|NCT04336046|Bupivacaine|bupivacaine|mesh-list
15136522|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
15136523|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
15136524|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136525|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136526|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
15136527|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136528|NCT04335968|Melatonin|melatonin|mesh-list
15136529|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
15136530|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136531|NCT04335968|Protective Agents|protective agents|mesh-ancestor
15136532|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136533|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136534|NCT04335786|Valsartan|valsartan|mesh-list
15136535|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15136536|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15136537|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15136538|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136539|NCT04335461|Anesthetics|anesthetics|mesh-list
15136540|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
15136541|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136542|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136543|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
15136544|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136545|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
15136546|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15136547|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15136548|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
15136549|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136550|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15136551|NCT04335292|Pemetrexed|pemetrexed|mesh-list
15136552|NCT04335292|Osimertinib|osimertinib|mesh-list
15136553|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136554|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136555|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136556|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15136557|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15136558|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136559|NCT04335383|Antibodies|antibodies|mesh-list
15136560|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
15136561|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136562|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
15136563|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136564|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136565|NCT04335123|Losartan|losartan|mesh-list
15136566|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15136567|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15136568|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15136569|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15136570|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136571|NCT04335513|Insulin|insulin|mesh-list
15136572|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15136573|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136574|NCT04335006|Paclitaxel|paclitaxel|mesh-list
15136575|NCT04335006|Apatinib|apatinib|mesh-list
15136576|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15136577|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136578|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
15136579|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
15136580|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
15136581|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005765|NCT02869035|Analgesics|analgesics|mesh-ancestor
14005766|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
14005767|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
14005768|NCT02868996|Kallikreins|kallikreins|mesh-list
14005769|NCT02868996|Coagulants|coagulants|mesh-ancestor
14005770|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14005771|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
14005772|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14005773|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005774|NCT02868814|Pregabalin|pregabalin|mesh-list
14005775|NCT02868814|Analgesics|analgesics|mesh-ancestor
14005776|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
14005777|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005778|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005779|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
14005780|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14005781|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14005782|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005783|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14005784|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14005785|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14005786|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005787|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14005788|NCT02868801|Pregabalin|pregabalin|mesh-list
14005789|NCT02868801|Analgesics|analgesics|mesh-ancestor
14005790|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
14005791|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005792|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005793|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
14005794|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14005795|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14005796|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005797|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14005798|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14005799|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14005800|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005801|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14005802|NCT02868580|Lamivudine|lamivudine|mesh-list
14005803|NCT02868580|Abacavir|abacavir|mesh-list
14005804|NCT02868580|Dolutegravir|dolutegravir|mesh-list
14005805|NCT02868580|Triumeq|triumeq|mesh-list
14005806|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14005807|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14005808|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005809|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005810|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
14005811|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005812|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14005813|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14005814|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14005815|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14005816|NCT02868827|Vitamin D|vitamin d|mesh-list
14005817|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
14005818|NCT02868827|Vitamins|vitamins|mesh-ancestor
14005819|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
14005820|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005821|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15136582|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136583|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136584|NCT04334993|Blinatumomab|blinatumomab|mesh-list
15136585|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136586|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14005822|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14005823|NCT02868606|Insulin|insulin|mesh-list
14005824|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14005825|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14005826|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024452|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
14024453|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
14024454|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
14024455|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024456|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
14024457|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024458|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024459|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15136587|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15136588|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15136589|NCT04334824|Diuretics|diuretics|mesh-ancestor
15136590|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
15136591|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136592|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14024460|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
14026227|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
14005827|NCT02868385|Praziquantel|praziquantel|mesh-list
14005828|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
14005829|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14005830|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005831|NCT02868632|Durvalumab|durvalumab|mesh-list
14005832|NCT02868632|Tremelimumab|tremelimumab|mesh-list
14005833|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14005834|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005835|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
14005836|NCT02868372|Povidone|povidone|mesh-list
14005837|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
14005838|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
14005839|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14005840|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005841|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
14005842|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14005843|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
15136593|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14005844|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005845|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
14005846|NCT02868437|Protective Agents|protective agents|mesh-ancestor
14005847|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
14005848|NCT02868151|Vitamins|vitamins|mesh-ancestor
14005849|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
14005850|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005851|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
14005852|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005853|NCT02868151|Protective Agents|protective agents|mesh-ancestor
14005854|NCT02868073|Vaccines|vaccines|mesh-list
14005855|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
14005856|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005857|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15136594|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136595|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
15136596|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136597|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
15136598|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136599|NCT04334967|Vitamins|vitamins|mesh-ancestor
15136600|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
15136601|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136602|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
15136603|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136604|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136605|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136606|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136607|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136608|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136609|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
15136610|NCT04334967|Protective Agents|protective agents|mesh-ancestor
15136611|NCT04334928|Tenofovir|tenofovir|mesh-list
15136612|NCT04334928|Emtricitabine|emtricitabine|mesh-list
15136613|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15136614|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136615|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
15136616|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136617|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15136618|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15136619|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136620|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136621|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15136622|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15136623|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
15136624|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136625|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136626|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136627|NCT04334863|Tyrphostins|tyrphostins|mesh-list
15136628|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136629|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136630|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136631|NCT04334629|Ibuprofen|ibuprofen|mesh-list
15136632|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15136633|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15136634|NCT04334629|Analgesics|analgesics|mesh-ancestor
15136635|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
14005858|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005859|NCT02867956|Etoposide|etoposide|mesh-list
14005860|NCT02867956|Apatinib|apatinib|mesh-list
15136636|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005861|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14005862|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005863|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14005864|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14005865|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005866|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136637|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136638|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136639|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136640|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15136641|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136642|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136643|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15136644|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15178998|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15178999|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15179000|NCT03953729|Analgesics|analgesics|mesh-ancestor
15179001|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
15179002|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179003|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179004|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179005|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179006|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15179007|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179008|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179009|NCT03953716|Desogestrel|desogestrel|mesh-list
15179010|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15179011|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15179012|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15179013|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
15179014|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15179015|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179016|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15179017|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15179018|NCT03953716|Progestins|progestins|mesh-ancestor
15179019|NCT03953716|Hormones|hormones|mesh-ancestor
15179020|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179021|NCT03953261|Curcumin|curcumin|mesh-list
15179022|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14005867|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14005868|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
14005869|NCT02867930|Ketamine|ketamine|mesh-list
14005870|NCT02867930|Propofol|propofol|mesh-list
14005871|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14005872|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005873|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005874|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14005875|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
14005876|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
14005877|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14005878|NCT02867930|Analgesics|analgesics|mesh-ancestor
14005879|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
14005880|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005881|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14005882|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14005883|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15179023|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15179024|NCT03953261|Analgesics|analgesics|mesh-ancestor
15179025|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
15179026|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179027|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179028|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179029|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179030|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179031|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179032|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179033|NCT03953300|Benralizumab|benralizumab|mesh-list
15179034|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15179035|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179036|NCT03953326|Nitroprusside|nitroprusside|mesh-list
15179037|NCT03953326|Acetylcholine|acetylcholine|mesh-list
14005884|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
15179038|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179039|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
14005885|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005886|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005887|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14005888|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14005889|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14005890|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
14005891|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14005892|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14005893|NCT02867904|Prednisolone|prednisolone|mesh-list
14005894|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
14005895|NCT02867904|Bupivacaine|bupivacaine|mesh-list
14005896|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14005897|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
14005898|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14005899|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
14005900|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
14005901|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005902|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005903|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14005904|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
14005905|NCT02867904|Hormones|hormones|mesh-ancestor
14005906|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005907|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14005908|NCT02867904|Protective Agents|protective agents|mesh-ancestor
14005909|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14005910|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005911|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
15136645|NCT04334512|Vitamin D|vitamin d|mesh-list
15136646|NCT04334512|Vitamins|vitamins|mesh-list
15136647|NCT04334512|Ascorbic Acid|ascorbic acid|mesh-list
15136648|NCT04334512|Azithromycin|azithromycin|mesh-list
15136649|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136650|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
15136651|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136652|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15136653|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136654|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136655|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
15136656|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136657|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136658|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136659|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136660|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136661|NCT04334512|Antioxidants|antioxidants|mesh-ancestor
15136662|NCT04334512|Protective Agents|protective agents|mesh-ancestor
15136663|NCT04334330|Trastuzumab|trastuzumab|mesh-list
15136664|NCT04334330|Fulvestrant|fulvestrant|mesh-list
15136665|NCT04334330|Lapatinib|lapatinib|mesh-list
15136666|NCT04334330|Palbociclib|palbociclib|mesh-list
15136667|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136668|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136669|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15136670|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15136671|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15136672|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
14270700|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14270701|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270702|NCT00411554|Incretins|incretins|mesh-ancestor
14270703|NCT00411554|Hormones|hormones|mesh-ancestor
14270704|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14270705|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14270706|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
14270707|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136673|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136674|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136675|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136676|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136677|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136678|NCT04334382|Azithromycin|azithromycin|mesh-list
15136679|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136680|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136681|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005912|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
15136682|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
15136683|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136684|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136685|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136686|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136687|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136688|NCT04334005|Vitamin D|vitamin d|mesh-list
15136689|NCT04334005|Vitamins|vitamins|mesh-ancestor
14005913|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14005914|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
14005915|NCT02867878|Adenosine|adenosine|mesh-list
14005916|NCT02867878|Analgesics|analgesics|mesh-ancestor
14005917|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
14005918|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14005919|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005920|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14005921|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
14005922|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14005923|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
14005924|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
14005925|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14005926|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005927|NCT02867865|Gemcitabine|gemcitabine|mesh-list
14005928|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005929|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14005930|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
14005931|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005932|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
14005933|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14005934|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005935|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005936|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
14005937|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005938|NCT02867917|Psyllium|psyllium|mesh-list
14005939|NCT02867917|Cathartics|cathartics|mesh-ancestor
14005940|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14270708|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270709|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14270710|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
14270711|NCT00411554|Vitamins|vitamins|mesh-ancestor
14270712|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
14270713|NCT00411619|Everolimus|everolimus|mesh-list
14270714|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270715|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270716|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
14270717|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270718|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15136690|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
14005941|NCT02867566|Rituximab|rituximab|mesh-list
14005942|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14005943|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005944|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
14005945|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005946|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14005947|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
14270719|NCT00411632|Bexarotene|bexarotene|mesh-list
14270720|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270721|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270722|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270723|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270724|NCT00411645|Maribavir|maribavir|mesh-list
14270725|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
14270726|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270727|NCT00411671|Sorafenib|sorafenib|mesh-list
14270728|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270729|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270730|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270731|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270732|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
14270733|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14270734|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
15136691|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136692|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15136693|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
15136694|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15179040|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14005948|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005949|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14005950|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005951|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005952|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
14005953|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14005954|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005955|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14005956|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14005957|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14005958|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
14005959|NCT02867553|Rituximab|rituximab|mesh-list
14005960|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136695|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136696|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15136697|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136698|NCT04333992|Remifentanil|remifentanil|mesh-list
15136699|NCT04333992|Propofol|propofol|mesh-list
14005961|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005962|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
14005963|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005964|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14005965|NCT02867800|Acetaminophen|acetaminophen|mesh-list
14005966|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
14005967|NCT02867800|Promethazine|promethazine|mesh-list
14005968|NCT02867800|Cyclosporine|cyclosporine|mesh-list
14005969|NCT02867800|Sirolimus|sirolimus|mesh-list
14005970|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
14005971|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
14005972|NCT02867800|Methotrexate|methotrexate|mesh-list
15136700|NCT04333992|Sevoflurane|sevoflurane|mesh-list
15136701|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15136702|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136703|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136704|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15136705|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
15136706|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
15136707|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15136708|NCT04333992|Narcotics|narcotics|mesh-ancestor
15136709|NCT04333992|Analgesics|analgesics|mesh-ancestor
15136710|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
15136711|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136712|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15136713|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15136714|NCT04333628|Chloroquine|chloroquine|mesh-list
15136715|NCT04333628|Amebicides|amebicides|mesh-ancestor
15136716|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136717|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136718|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136719|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
15136720|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136721|NCT04333550|Deferoxamine|deferoxamine|mesh-list
15136722|NCT04333550|Siderophores|siderophores|mesh-ancestor
15136723|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15136724|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
15136725|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
15136726|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136727|NCT04333589|Favipiravir|favipiravir|mesh-list
15136728|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
15136729|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136730|NCT04332978|Fluticasone|fluticasone|mesh-list
15136731|NCT04332978|Xhance|xhance|mesh-list
15136732|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136733|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15136734|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
15136735|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136736|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136737|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15136738|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
15136739|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
15136740|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15136741|NCT04332874|Dactinomycin|dactinomycin|mesh-list
15136742|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
15136743|NCT04332874|Melphalan|melphalan|mesh-list
15136744|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136745|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005973|NCT02867800|Fludarabine|fludarabine|mesh-list
14005974|NCT02867800|Melphalan|melphalan|mesh-list
15136746|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15136747|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
14005975|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
15136748|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005976|NCT02867800|Thiotepa|thiotepa|mesh-list
14005977|NCT02867800|Abatacept|abatacept|mesh-list
14005978|NCT02867800|Meperidine|meperidine|mesh-list
14005979|NCT02867800|Tacrolimus|tacrolimus|mesh-list
14005980|NCT02867800|Cyclosporins|cyclosporins|mesh-list
14005981|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
14005982|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14005983|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
14005984|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14005985|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14005986|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14005987|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
14005988|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14005989|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14005990|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
14005991|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14005992|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14005993|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14005994|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
14005995|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14005996|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14005997|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14005998|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
14005999|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006000|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006001|NCT02867800|Analgesics|analgesics|mesh-ancestor
14006002|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
14006003|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006004|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
14006005|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14006006|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14006007|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
14006008|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14006009|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006010|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
14006011|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
15136749|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15136750|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136751|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
15136752|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136753|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136754|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136755|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15136756|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15136757|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136758|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15136759|NCT04333095|Bupivacaine|bupivacaine|mesh-list
15136760|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
15136761|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
15136762|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136763|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136764|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
15136765|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136766|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
15136767|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136768|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136769|NCT04332627|Neostigmine|neostigmine|mesh-list
15136770|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15136771|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136772|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136773|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
15136774|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15136775|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136776|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15136777|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
15136778|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136779|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15136780|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15136781|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
15136782|NCT04332536|Codeine|codeine|mesh-list
15136783|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15136784|NCT04332536|Narcotics|narcotics|mesh-ancestor
15136785|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136786|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136787|NCT04332536|Analgesics|analgesics|mesh-ancestor
15136788|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
14006012|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006013|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
14006014|NCT02867800|Hormones|hormones|mesh-ancestor
14006015|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006016|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14006017|NCT02867800|Protective Agents|protective agents|mesh-ancestor
14006018|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14006019|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
14006020|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14006021|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14006022|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14006023|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15136789|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136790|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
15136791|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
15136792|NCT04332809|Gentamicins|gentamicins|mesh-list
15136793|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136794|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136795|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15136796|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136797|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179041|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179042|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15179043|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
15179044|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179045|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179046|NCT03953235|Nivolumab|nivolumab|mesh-list
15179047|NCT03953235|Ipilimumab|ipilimumab|mesh-list
15179048|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179049|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179050|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15179051|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179052|NCT03953170|Teduglutide|teduglutide|mesh-list
15179053|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15179054|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15179055|NCT03953170|Protective Agents|protective agents|mesh-ancestor
15179056|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179057|NCT03953001|Lidocaine|lidocaine|mesh-list
15179058|NCT03953001|Epinephrine|epinephrine|mesh-list
15179059|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
15179060|NCT03953001|Anesthetics|anesthetics|mesh-list
15179061|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179062|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179063|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
15179064|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179065|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15179066|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15179067|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15179068|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179069|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179070|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15179071|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15179072|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
15179073|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179074|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15179075|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15179076|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
15179077|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15179078|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179079|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
15179080|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
15179081|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15179082|NCT03953287|Acetaminophen|acetaminophen|mesh-list
15179083|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15179084|NCT03953287|Analgesics|analgesics|mesh-ancestor
15179085|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
15179086|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179087|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179088|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
15179089|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
15179090|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
15179091|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
14006024|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14006025|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006026|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006027|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
14006028|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14006029|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
14006030|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
14006031|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006032|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14006033|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
14006034|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14006035|NCT02867800|Narcotics|narcotics|mesh-ancestor
14006036|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14006037|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
14006038|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006039|NCT02867176|Ketorolac|ketorolac|mesh-list
14006040|NCT02867176|Gabapentin|gabapentin|mesh-list
14006041|NCT02867176|Analgesics|analgesics|mesh-ancestor
14006042|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
14006043|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136798|NCT04332276|Dopamine|dopamine|mesh-list
15136799|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15136800|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
15136801|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
15136802|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136803|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136804|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
15136805|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15136806|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136807|NCT04332276|Protective Agents|protective agents|mesh-ancestor
15136808|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
15136809|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136810|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15136811|NCT04332289|Protective Agents|protective agents|mesh-ancestor
15136812|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136813|NCT04332042|Tofacitinib|tofacitinib|mesh-list
15136814|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15136815|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136816|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006044|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006045|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
14006046|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14006047|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006048|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006049|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006050|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14006051|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14006052|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006053|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006054|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
14006055|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14006056|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15136817|NCT04332393|Metformin|metformin|mesh-list
15136818|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15136819|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136820|NCT04332094|Azithromycin|azithromycin|mesh-list
15136821|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136822|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15136823|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136824|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
15136825|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136826|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136827|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136828|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136829|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136830|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136831|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
15136832|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136833|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136834|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136835|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136836|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136837|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136838|NCT04331652|Anesthetics|anesthetics|mesh-list
14006057|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006058|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136839|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006059|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14006060|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006061|NCT02867293|Anesthetics|anesthetics|mesh-list
14006062|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006063|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006064|NCT02867306|Methotrexate|methotrexate|mesh-list
14006065|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14006066|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
14006067|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14006068|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006069|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14006070|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
14006071|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006072|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006073|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14561997|NCT00002822|Doxorubicin|doxorubicin|mesh-list
15136840|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136841|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
15136842|NCT04331743|Analgesics|analgesics|mesh-ancestor
15136843|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
15136844|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136845|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136846|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136847|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15136848|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15136849|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136850|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136851|NCT04331730|Aflibercept|aflibercept|mesh-list
15136852|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15136853|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15136854|NCT04331730|Growth Substances|growth substances|mesh-ancestor
15136855|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136856|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
15136857|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136858|NCT04331626|Gemcitabine|gemcitabine|mesh-list
15136859|NCT04331626|Nivolumab|nivolumab|mesh-list
15136860|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15136861|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
15136862|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136863|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136864|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
15136865|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136866|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136867|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15136868|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
15136869|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136870|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15136871|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15136872|NCT04331691|Amiloride|amiloride|mesh-list
15136873|NCT04331691|Spironolactone|spironolactone|mesh-list
15136874|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15136875|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
15136876|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136877|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136878|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15136879|NCT04331691|Diuretics|diuretics|mesh-ancestor
15136880|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
15136881|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15136882|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15136883|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15136884|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136885|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15136886|NCT04331600|Chloroquine|chloroquine|mesh-list
15136887|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15136888|NCT04331600|Amebicides|amebicides|mesh-ancestor
15136889|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136890|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136891|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136892|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
15136893|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136894|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15136895|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15136896|NCT04331600|Analgesics|analgesics|mesh-ancestor
15136897|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
14811456|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811457|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14006074|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006075|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14006076|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006077|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
14006078|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006079|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14006080|NCT02867267|Thymalfasin|thymalfasin|mesh-list
14006081|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14006082|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
14006083|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006084|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
14006085|NCT02867397|Epirubicin|epirubicin|mesh-list
14006086|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136898|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136899|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136900|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136901|NCT04331600|Filaricides|filaricides|mesh-ancestor
15136902|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
15136903|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
15136904|NCT04331639|Vitamin D|vitamin d|mesh-list
15136905|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
15136906|NCT04331639|Vitamins|vitamins|mesh-ancestor
15136907|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
15136908|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136909|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15136910|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15136911|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
15136912|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15136913|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15136914|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136915|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15136916|NCT04331418|Analgesics|analgesics|mesh-ancestor
15136917|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
15136918|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136919|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15136920|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15136921|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15136922|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
15136923|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15136924|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136925|NCT04331470|Ritonavir|ritonavir|mesh-list
15136926|NCT04331470|Lopinavir|lopinavir|mesh-list
15136927|NCT04331470|Chloroquine|chloroquine|mesh-list
15136928|NCT04331470|Levamisole|levamisole|mesh-list
15136929|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
15136930|NCT04331470|Budesonide|budesonide|mesh-list
15136931|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
15136932|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15136933|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15136934|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
15136935|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136936|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136937|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15136938|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15136939|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
15136940|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15136941|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15136942|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15136943|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136944|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15136945|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
15136946|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136947|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136948|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15136949|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
15136950|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
15136951|NCT04331470|Hormones|hormones|mesh-ancestor
15136952|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136953|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15136954|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15136955|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14006087|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14006088|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15136956|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006089|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14006090|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006091|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006092|NCT02867280|Sorafenib|sorafenib|mesh-list
15136957|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15136958|NCT04331470|Amebicides|amebicides|mesh-ancestor
15136959|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15136960|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15136961|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
15136962|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136963|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
15136964|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
15136965|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15136966|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
15136967|NCT04331327|Mitogens|mitogens|mesh-list
15136968|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
15136969|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136970|NCT04331197|Letrozole|letrozole|mesh-list
15136971|NCT04331197|Clomiphene|clomiphene|mesh-list
15136972|NCT04331197|Enclomiphene|enclomiphene|mesh-list
15136973|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
15136974|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15136975|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15136976|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15136977|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15136978|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136979|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15136980|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
15136981|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15136982|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136983|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15136984|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
15136985|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15136986|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15136987|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15136988|NCT04331210|Diclofenac|diclofenac|mesh-list
15136989|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15136990|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15136991|NCT04331210|Analgesics|analgesics|mesh-ancestor
15136992|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
15136993|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15136994|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15136995|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15136996|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15136997|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15136998|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15136999|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137000|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15137001|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15137002|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
15137003|NCT04331132|Tolvaptan|tolvaptan|mesh-list
15137004|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15137005|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137006|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
15137007|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137008|NCT04330872|Aspirin|aspirin|mesh-list
15137009|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137010|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137011|NCT04330872|Analgesics|analgesics|mesh-ancestor
15137012|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
15137013|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137014|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137015|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137016|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137017|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137018|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15137019|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137020|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14270735|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14270736|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270737|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14270738|NCT00411762|Capecitabine|capecitabine|mesh-list
14561998|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14561999|NCT00002822|Etoposide|etoposide|mesh-list
14006093|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006094|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14006095|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006096|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006097|NCT02867124|Naltrexone|naltrexone|mesh-list
14006098|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14006099|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14006100|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006101|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
14006102|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006103|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
14006104|NCT02867332|Interleukin-2|interleukin-2|mesh-list
14006105|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006106|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
14006107|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006108|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006109|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14006110|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
15137021|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15137022|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137023|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
15137024|NCT04330820|Venetoclax|venetoclax|mesh-list
15137025|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137026|NCT04331093|Apatinib|apatinib|mesh-list
15137027|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137028|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15137029|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137030|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137031|NCT04330729|Aspirin|aspirin|mesh-list
15137032|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137033|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137034|NCT04330729|Analgesics|analgesics|mesh-ancestor
15137035|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
15137036|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137037|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137038|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137039|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137040|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137041|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15137042|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137043|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15137044|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15137045|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137046|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
15137047|NCT04330690|Artesunate|artesunate|mesh-list
15137048|NCT04330690|Dexamethasone|dexamethasone|mesh-list
15137049|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
15137050|NCT04330690|Infliximab|infliximab|mesh-list
15137051|NCT04330690|Losartan|losartan|mesh-list
15137052|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137053|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
15137054|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
15137055|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137056|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137057|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137058|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
15137059|NCT04330690|Hormones|hormones|mesh-ancestor
15137060|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137061|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15137062|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137063|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15137064|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137065|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137066|NCT04330690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15137067|NCT04330690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15137068|NCT04330690|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15137069|NCT04330690|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15137070|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
15137071|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137072|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
15137073|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137074|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14270739|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270740|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
15137075|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137076|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
14006111|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006112|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006113|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14006114|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006115|NCT02867332|Analgesics|analgesics|mesh-ancestor
14006116|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
14006117|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006118|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
14006119|NCT02867345|Interleukin-2|interleukin-2|mesh-list
14006120|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006121|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
14006122|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006123|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006124|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14006125|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
14006126|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006127|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137077|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
15137078|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15137079|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
15137080|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
15137081|NCT04330755|Simendan|simendan|mesh-list
15137082|NCT04330755|Analgesics|analgesics|mesh-ancestor
15137083|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
15137084|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137085|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137086|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
15137087|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15137088|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15137089|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
15137090|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15137091|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15137092|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137093|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15137094|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
15137095|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15137096|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15137097|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
15137098|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15137099|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15137100|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137101|NCT04330755|Protective Agents|protective agents|mesh-ancestor
15137102|NCT04330300|Losartan|losartan|mesh-list
15137103|NCT04330300|Verapamil|verapamil|mesh-list
15137104|NCT04330300|Felodipine|felodipine|mesh-list
15137105|NCT04330300|Amlodipine|amlodipine|mesh-list
15137106|NCT04330300|Valsartan|valsartan|mesh-list
15137107|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15137108|NCT04330300|Telmisartan|telmisartan|mesh-list
15137109|NCT04330300|Candesartan|candesartan|mesh-list
15137110|NCT04330300|Ramipril|ramipril|mesh-list
15137111|NCT04330300|Olmesartan|olmesartan|mesh-list
15137112|NCT04330300|Enalapril|enalapril|mesh-list
15137113|NCT04330300|Lisinopril|lisinopril|mesh-list
15137114|NCT04330300|Irbesartan|irbesartan|mesh-list
15137115|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
15137116|NCT04330300|Diltiazem|diltiazem|mesh-list
15137117|NCT04330300|Perindopril|perindopril|mesh-list
15137118|NCT04330300|Benazepril|benazepril|mesh-list
15137119|NCT04330300|Captopril|captopril|mesh-list
15137120|NCT04330300|Indapamide|indapamide|mesh-list
15137121|NCT04330300|Nicardipine|nicardipine|mesh-list
15137122|NCT04330300|Nimodipine|nimodipine|mesh-list
15137123|NCT04330300|Quinapril|quinapril|mesh-list
15137124|NCT04330300|Trandolapril|trandolapril|mesh-list
15137125|NCT04330300|Metolazone|metolazone|mesh-list
15137126|NCT04330300|Fosinopril|fosinopril|mesh-list
15137127|NCT04330300|Eprosartan|eprosartan|mesh-list
15137128|NCT04330300|Nitrendipine|nitrendipine|mesh-list
15137129|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
15137130|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
15137131|NCT04330300|Nifedipine|nifedipine|mesh-list
15137132|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
15137133|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15137134|NCT04330300|Diuretics|diuretics|mesh-list
15137135|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15137136|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15137137|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137138|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15137139|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15137140|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006128|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14006129|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006130|NCT02867345|Analgesics|analgesics|mesh-ancestor
14006131|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
14006132|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024461|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024462|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024463|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14024464|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024465|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
14024466|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14024467|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14024468|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024469|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024470|NCT02756312|Anesthetics|anesthetics|mesh-list
14024471|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024472|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137141|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
15137142|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15137143|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15137144|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
15137145|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15137146|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
15137147|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137148|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
15137149|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15137150|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15137151|NCT04330300|Protective Agents|protective agents|mesh-ancestor
15137152|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
15137153|NCT04330547|Analgesics|analgesics|mesh-list
15137154|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
15137155|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137156|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137157|NCT04330586|Ciclesonide|ciclesonide|mesh-list
15137158|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
15137159|NCT04330586|Hormones|hormones|mesh-ancestor
15137160|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137161|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137162|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15137163|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15137164|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
15137165|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
15137166|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
15137167|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137168|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137169|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137170|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137171|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137172|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137173|NCT04330677|Oxytocin|oxytocin|mesh-list
15137174|NCT04330677|Estrogens|estrogens|mesh-list
15137175|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
15137176|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15137177|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137178|NCT04330677|Hormones|hormones|mesh-ancestor
15137179|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179092|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179093|NCT03953209|Spironolactone|spironolactone|mesh-list
15179094|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15179095|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
15179096|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179097|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179098|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15179099|NCT03953209|Diuretics|diuretics|mesh-ancestor
15179100|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
15179101|NCT03953066|Melatonin|melatonin|mesh-list
15179102|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
15179103|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179104|NCT03953066|Protective Agents|protective agents|mesh-ancestor
15179105|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179106|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179107|NCT03952715|Ibuprofen|ibuprofen|mesh-list
15179108|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15179109|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006133|NCT02866903|Bevacizumab|bevacizumab|mesh-list
14006134|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
14006135|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14006136|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006137|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15137180|NCT04330027|Mitogens|mitogens|mesh-list
15137181|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137182|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137183|NCT04330638|Siltuximab|siltuximab|mesh-list
15137184|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15137185|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137186|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137187|NCT04330326|Sorbitol|sorbitol|mesh-list
15137188|NCT04330326|Cathartics|cathartics|mesh-ancestor
15137189|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137190|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
15137191|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15137192|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137193|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15137194|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137195|NCT04329624|Simendan|simendan|mesh-list
15137196|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15137197|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
15137198|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15137199|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15137200|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137201|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137202|NCT04329624|Protective Agents|protective agents|mesh-ancestor
15137203|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137204|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
15137205|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
15137206|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137207|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137208|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137209|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137210|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137211|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137212|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
15137213|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15137214|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15137215|NCT04329650|Prednisolone|prednisolone|mesh-list
15137216|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
15137217|NCT04329650|Siltuximab|siltuximab|mesh-list
15137218|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15137219|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
15137220|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137221|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
15137222|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
15137223|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137224|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137225|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137226|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
15137227|NCT04329650|Hormones|hormones|mesh-ancestor
15137228|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137229|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15137230|NCT04329650|Protective Agents|protective agents|mesh-ancestor
15137231|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15137232|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137233|NCT04329949|Paclitaxel|paclitaxel|mesh-list
15137234|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15137235|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137236|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
15137237|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137238|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137239|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137240|NCT04329858|Methamphetamine|methamphetamine|mesh-list
15137241|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15137242|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137243|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
15137244|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
15137245|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137246|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
15137247|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15137248|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024473|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
14006138|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14006139|NCT02866903|Growth Substances|growth substances|mesh-ancestor
15137249|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
15137250|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15137251|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15137252|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15137253|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15137254|NCT04329806|Amlodipine|amlodipine|mesh-list
14006140|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006141|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
14006142|NCT02867046|Dexamethasone|dexamethasone|mesh-list
14006143|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006144|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
14006145|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
14006146|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006147|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006148|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006149|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
14006150|NCT02867046|Hormones|hormones|mesh-ancestor
14006151|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006152|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14006153|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006154|NCT02867020|Prednisone|prednisone|mesh-list
14006155|NCT02867020|Goserelin|goserelin|mesh-list
14006156|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006157|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
14006158|NCT02867020|Hormones|hormones|mesh-ancestor
14006159|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006160|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006161|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14006162|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006163|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
14006164|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006165|NCT02866955|Tamoxifen|tamoxifen|mesh-list
14006166|NCT02866955|Estramustine|estramustine|mesh-list
14006167|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14006168|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
14006169|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006170|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006171|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14006172|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006173|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15137255|NCT04329806|Moxonidine|moxonidine|mesh-list
15137256|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15137257|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15137258|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15137259|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137260|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14006174|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14006175|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14006176|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14006177|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
14006178|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006179|NCT02866786|Metformin|metformin|mesh-list
14006180|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
14006181|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14006182|NCT02866786|Estradiol|estradiol|mesh-list
14006183|NCT02866786|Cyproterone|cyproterone|mesh-list
14006184|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14006185|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006186|NCT02866786|Estrogens|estrogens|mesh-ancestor
14006187|NCT02866786|Hormones|hormones|mesh-ancestor
14006188|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006189|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14006190|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
14006191|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14006192|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14006193|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15137261|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137262|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
15137263|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
14006194|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14562000|NCT00002822|Vincristine|vincristine|mesh-list
14811458|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
15137264|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
15137265|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137266|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14006195|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
14006196|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
14006197|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006198|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14006199|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
14006200|NCT02866409|Bupivacaine|bupivacaine|mesh-list
14270741|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270742|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270743|NCT00411788|Sirolimus|sirolimus|mesh-list
14270744|NCT00411788|Trastuzumab|trastuzumab|mesh-list
14270745|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14270746|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270747|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14270748|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270749|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14270750|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
14270751|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270752|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
14270753|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270754|NCT00412061|Everolimus|everolimus|mesh-list
14270755|NCT00412061|Octreotide|octreotide|mesh-list
14270756|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270757|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270758|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
14270759|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270760|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14270761|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14270762|NCT00412074|Vitamin D|vitamin d|mesh-list
14270763|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
14270764|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
14270765|NCT00412074|Vitamins|vitamins|mesh-list
14270766|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
14270767|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270768|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14270769|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270770|NCT00412087|Vitamin D|vitamin d|mesh-list
14270771|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
14270772|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
14270773|NCT00412087|Vitamins|vitamins|mesh-list
14270774|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
14270775|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270776|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14270777|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270778|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
15137267|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137268|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137269|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137270|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270779|NCT00412113|Amlodipine|amlodipine|mesh-list
14270780|NCT00412113|Atorvastatin|atorvastatin|mesh-list
14270781|NCT00412113|Calcium|calcium|mesh-list
14270782|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270783|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270784|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14270785|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15137271|NCT04329585|Flumazenil|flumazenil|mesh-list
15137272|NCT04329585|Antidotes|antidotes|mesh-ancestor
15137273|NCT04329585|Protective Agents|protective agents|mesh-ancestor
15137274|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137275|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
15137276|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
15137277|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270786|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14270787|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
14270788|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270789|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14270790|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14270791|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137278|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137279|NCT04329572|Azithromycin|azithromycin|mesh-list
14270792|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14270793|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270794|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15137280|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
14006201|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006202|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
14006203|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006204|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006205|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
14006206|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006207|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14006208|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006209|NCT02866409|Analgesics|analgesics|mesh-ancestor
14006210|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14006211|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14006212|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14006213|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006214|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006215|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006216|NCT02866214|Febuxostat|febuxostat|mesh-list
14006217|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
14006218|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006219|NCT02866448|Aspirin|aspirin|mesh-list
14006220|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14006221|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006222|NCT02866448|Analgesics|analgesics|mesh-ancestor
14006223|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
14006224|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006225|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006226|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006227|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006228|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14006229|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14006230|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137281|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15137282|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137283|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
15137284|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14006231|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14006232|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14006233|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006234|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
14006235|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
14006236|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006237|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
14006238|NCT02866435|Protective Agents|protective agents|mesh-ancestor
14006239|NCT02866370|Paclitaxel|paclitaxel|mesh-list
14006240|NCT02866370|Carboplatin|carboplatin|mesh-list
14006241|NCT02866370|Doxorubicin|doxorubicin|mesh-list
14006242|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14006243|NCT02866370|Topotecan|topotecan|mesh-list
14006244|NCT02866370|Nintedanib|nintedanib|mesh-list
14006245|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14006246|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006247|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
14006248|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
14006249|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
14006250|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006251|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14006252|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14006253|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14006254|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006255|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14006256|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14006257|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14006258|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14006259|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
14006260|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006261|NCT02866396|Pregabalin|pregabalin|mesh-list
14006262|NCT02866396|Analgesics|analgesics|mesh-ancestor
14006263|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
14006264|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006265|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006266|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
14006267|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14006268|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14006269|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137285|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14006270|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14006271|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14006272|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006273|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006274|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006275|NCT02866136|Carboplatin|carboplatin|mesh-list
14006276|NCT02866136|Etoposide|etoposide|mesh-list
14006277|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
14006278|NCT02866136|Melphalan|melphalan|mesh-list
14006279|NCT02866136|Vincristine|vincristine|mesh-list
14006280|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006281|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14006282|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14006283|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14006284|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006285|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006286|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14006287|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
14006288|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15137286|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137287|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137288|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137289|NCT04329403|Adapalene|adapalene|mesh-list
15137290|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137291|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137292|NCT04329403|Analgesics|analgesics|mesh-ancestor
14006289|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006290|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
14006291|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006292|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
14006293|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
14006294|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
14006295|NCT02865824|Aspirin|aspirin|mesh-list
14006296|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14006297|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006298|NCT02865824|Analgesics|analgesics|mesh-ancestor
14006299|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
14006300|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006301|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006302|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006303|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006304|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14006305|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14006306|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006307|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14006308|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14006309|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006310|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
14006311|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
14006312|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14006313|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006314|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14006315|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14006316|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14006317|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14006318|NCT02866032|Ciclopirox|ciclopirox|mesh-list
14006319|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
14006320|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006321|NCT02866006|Topotecan|topotecan|mesh-list
14006322|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14006323|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14006324|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137293|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
15137294|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006325|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006326|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006327|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
14006328|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14006329|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006330|NCT02866071|Ketamine|ketamine|mesh-list
14006331|NCT02866071|Analgesics|analgesics|mesh-ancestor
14006332|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
14006333|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006334|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006335|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15137295|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006336|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14006337|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
14006338|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
14006339|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006340|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14006341|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15137296|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137297|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137298|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
15137299|NCT04329390|Anticoagulants|anticoagulants|mesh-list
15137300|NCT04329442|Tenofovir|tenofovir|mesh-list
15137301|NCT04329442|Emtricitabine|emtricitabine|mesh-list
15137302|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
15137303|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137304|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15137305|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15137306|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137307|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137308|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15137309|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15137310|NCT04329130|Lenalidomide|lenalidomide|mesh-list
15137311|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
15137312|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006342|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006343|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006344|NCT02865733|Treprostinil|treprostinil|mesh-list
14006345|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14006346|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
14006347|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14006348|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
14006349|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006350|NCT02865629|Expectorants|expectorants|mesh-ancestor
15137313|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15137314|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15137315|NCT04329130|Growth Substances|growth substances|mesh-ancestor
15137316|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
14006351|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
14006352|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14006353|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
14006354|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006355|NCT02865629|Protective Agents|protective agents|mesh-ancestor
15137317|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137318|NCT04329429|Trastuzumab|trastuzumab|mesh-list
15137319|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15137320|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137321|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
15137322|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15137323|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15137324|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137325|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137326|NCT04329091|Analgesics|analgesics|mesh-ancestor
15137327|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
15137328|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006356|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006357|NCT02865629|Antidotes|antidotes|mesh-ancestor
14006358|NCT02865681|Letrozole|letrozole|mesh-list
14006359|NCT02865681|Clomiphene|clomiphene|mesh-list
14006360|NCT02865681|Enclomiphene|enclomiphene|mesh-list
14006361|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
14006362|NCT02865681|Menotropins|menotropins|mesh-list
14006363|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006364|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006365|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14006366|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14006367|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006368|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14006369|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
14006370|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006371|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006372|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14006373|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
14006374|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14006375|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15137329|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15137330|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14006376|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14006377|NCT02865642|Citalopram|citalopram|mesh-list
14006378|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14006379|NCT02865642|Serotonin|serotonin|mesh-list
14006380|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14006381|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14006382|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006383|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006384|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
14006385|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006386|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14006387|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
14006388|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006389|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14006390|NCT02865668|Metformin|metformin|mesh-list
14006391|NCT02865668|Canagliflozin|canagliflozin|mesh-list
14006392|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14006393|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006394|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14006395|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006396|NCT02865564|Gentamicins|gentamicins|mesh-list
14006397|NCT02865564|Ampicillin|ampicillin|mesh-list
14006398|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14006399|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270795|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
14270796|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14270797|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270798|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14270799|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270800|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270801|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
15137331|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15137332|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
15137333|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270802|NCT00412243|Clofarabine|clofarabine|mesh-list
14270803|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270804|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
14270805|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270806|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270807|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14270808|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
14270809|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270810|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270811|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14270812|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14270813|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
14270814|NCT00412360|Cyclosporine|cyclosporine|mesh-list
14270815|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
14270816|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
14270817|NCT00412360|Fludarabine|fludarabine|mesh-list
14270818|NCT00412360|Cyclosporins|cyclosporins|mesh-list
14270819|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270820|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
14270821|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270822|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14270823|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14270824|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
14270825|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270826|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270827|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14270828|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137334|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137335|NCT04328870|Oxytocin|oxytocin|mesh-list
15137336|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137337|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
15137338|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15137339|NCT04328805|Ibuprofen|ibuprofen|mesh-list
15137340|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137341|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137342|NCT04328805|Analgesics|analgesics|mesh-ancestor
15137343|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
15137344|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270829|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
14270830|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270831|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
15137345|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137346|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137347|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137348|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15137349|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137350|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137351|NCT04329000|Esomeprazole|esomeprazole|mesh-list
15137352|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15137353|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006400|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14006401|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006402|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006403|NCT02865616|Vancomycin|vancomycin|mesh-list
14006404|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14006405|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006406|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
14006407|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
14006408|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006409|NCT02865460|Vitamins|vitamins|mesh-ancestor
14006410|NCT02865369|Asunaprevir|asunaprevir|mesh-list
14006411|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
14006412|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006413|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024474|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14024475|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
14024476|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14024477|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024478|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
14024479|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
14024480|NCT02756104|Vitamin D|vitamin d|mesh-list
14024481|NCT02756104|Vitamins|vitamins|mesh-ancestor
14024482|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
14024483|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024484|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14024485|NCT02756130|Carboplatin|carboplatin|mesh-list
14024486|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024487|NCT02756026|Micronutrients|micronutrients|mesh-list
14024488|NCT02756026|Trace Elements|trace elements|mesh-list
14024489|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024490|NCT02755753|Lansoprazole|lansoprazole|mesh-list
14024491|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
14024492|NCT02755753|Rebamipide|rebamipide|mesh-list
14024493|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14024494|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024495|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14024496|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024497|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024498|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
15137354|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15137355|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137356|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024499|NCT02755753|Protective Agents|protective agents|mesh-ancestor
14024500|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024501|NCT02755714|Bromides|bromides|mesh-list
14024502|NCT02755714|Ipratropium|ipratropium|mesh-list
14024503|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
14024504|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14024505|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
15137357|NCT04328883|Aspirin|aspirin|mesh-list
15137358|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137359|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137360|NCT04328883|Analgesics|analgesics|mesh-ancestor
15137361|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
15137362|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137363|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137364|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137365|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137366|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137367|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15137368|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137369|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14024506|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024507|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024508|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14024509|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
14024510|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14024511|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
14006414|NCT02865356|Cyclosporine|cyclosporine|mesh-list
14006415|NCT02865356|Cyclosporins|cyclosporins|mesh-list
14006416|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006417|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006418|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006419|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
14006420|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006421|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
14006422|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006423|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
14006424|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006425|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14006426|NCT02865304|Endostar protein|endostar protein|mesh-list
14006427|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14006428|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14006429|NCT02865304|Growth Substances|growth substances|mesh-ancestor
14006430|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006431|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
14006432|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006433|NCT02865174|Heparin|heparin|mesh-list
14006434|NCT02865174|Enoxaparin|enoxaparin|mesh-list
14006435|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14006436|NCT02865174|Tinzaparin|tinzaparin|mesh-list
14006437|NCT02865174|Dalteparin|dalteparin|mesh-list
14006438|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
14006439|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
14006440|NCT02865174|Thrombin|thrombin|mesh-list
14006441|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
14006442|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14006443|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14006444|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006445|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14006446|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
14006447|NCT02865174|Coagulants|coagulants|mesh-ancestor
14006448|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
14006449|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006450|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14006451|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006452|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14006453|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006454|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006455|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006456|NCT02865005|Dapsone|dapsone|mesh-list
14006457|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006458|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
14006459|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14006460|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14006461|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14006462|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006463|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006464|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
14006465|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14006466|NCT02864927|Vaccines|vaccines|mesh-list
14006467|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
14006468|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006469|NCT02864849|Capecitabine|capecitabine|mesh-list
14006470|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
14006471|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14006472|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
14006473|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006474|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006475|NCT02865018|Cetirizine|cetirizine|mesh-list
14006476|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14006477|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14006478|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14006479|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
14006480|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
14006481|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270832|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15137370|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15137371|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137372|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
14006482|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006483|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006484|NCT02864758|Vitamin K|vitamin k|mesh-list
14006485|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
14006486|NCT02864758|Dabigatran|dabigatran|mesh-list
14006487|NCT02864758|Vitamins|vitamins|mesh-ancestor
14270833|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14006488|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
14006489|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006490|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14006491|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
14006492|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14006493|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
14006494|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006495|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006496|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
14006497|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14006498|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14006499|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
14006500|NCT02864758|Coagulants|coagulants|mesh-ancestor
14006501|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
14006502|NCT02864784|Calcium|calcium|mesh-list
14006503|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14006504|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006505|NCT02864784|Antacids|antacids|mesh-ancestor
14006506|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006507|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006508|NCT02864602|Dexamethasone|dexamethasone|mesh-list
14006509|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
14006510|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14006511|NCT02864602|BB 1101|bb 1101|mesh-list
14006512|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006513|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
14006514|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
14006515|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006516|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006517|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006518|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
14006519|NCT02864602|Hormones|hormones|mesh-ancestor
14006520|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006521|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14006522|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006523|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
14006524|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006525|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006526|NCT02864472|Ranibizumab|ranibizumab|mesh-list
14006527|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14006528|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14006529|NCT02864472|Growth Substances|growth substances|mesh-ancestor
14006530|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006531|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
14006532|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006533|NCT02864550|Doxycycline|doxycycline|mesh-list
15137373|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
15137374|NCT04328636|Analgesics|analgesics|mesh-ancestor
14006534|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14006535|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006536|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
14006537|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14006538|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14006539|NCT02864264|Interferons|interferons|mesh-list
14006540|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
14006541|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006542|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
14006543|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006544|NCT02864199|Ribavirin|ribavirin|mesh-list
14006545|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14006546|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
14006547|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006548|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
14006549|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006550|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
14006551|NCT02863861|Ketamine|ketamine|mesh-list
14006552|NCT02863861|Propofol|propofol|mesh-list
14006553|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14006554|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006555|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006556|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14006557|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
14006558|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
14006559|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006560|NCT02863861|Analgesics|analgesics|mesh-ancestor
14006561|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
14006562|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026228|NCT02744508|Hormones|hormones|mesh-ancestor
14006563|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14006564|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14006565|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14006566|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006567|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006568|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006569|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14006570|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14006571|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15137375|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
15137376|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137377|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006572|NCT02864147|Imiquimod|imiquimod|mesh-list
14006573|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14006574|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
14006575|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006576|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006577|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
14006578|NCT02864095|Epinephrine|epinephrine|mesh-list
14006579|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
14006580|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14006581|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14006582|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006583|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006584|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006585|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006586|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14006587|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14006588|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
14006589|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006590|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14006591|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
14270834|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14270835|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
14270836|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15137378|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
15137379|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15137380|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15137381|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
15137382|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270837|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14270838|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14270839|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270840|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270841|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137383|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15137384|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137385|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15137386|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
15137387|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15137388|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
15137389|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15137390|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137391|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
15137392|NCT04328493|Chloroquine|chloroquine|mesh-list
15137393|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14270842|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270843|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14270844|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14270845|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
14270846|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270847|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270848|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14270849|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14270850|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
14270851|NCT00412425|Palonosetron|palonosetron|mesh-list
14270852|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
14270853|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
14270854|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14270855|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270856|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137394|NCT04328493|Amebicides|amebicides|mesh-ancestor
15137395|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137396|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14006592|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
14006593|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
14006594|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14006595|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14006596|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14006597|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
14006598|NCT02864095|Coagulants|coagulants|mesh-ancestor
14006599|NCT02863835|Albuterol|albuterol|mesh-list
14006600|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14006601|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
14006602|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006603|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006604|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14006605|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
14006606|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
14270857|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14270858|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14270859|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
14270860|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14270861|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270862|NCT00412451|Plasminogen|plasminogen|mesh-list
14270863|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14270864|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14270865|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270866|NCT00412464|PENTA|penta|mesh-list
14270867|NCT00412464|Fondaparinux|fondaparinux|mesh-list
14270868|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14270869|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
14270870|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14270871|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
14270872|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270873|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270874|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
14270875|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14270876|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14270877|NCT00412529|Entecavir|entecavir|mesh-list
14270878|NCT00412529|Telbivudine|telbivudine|mesh-list
14270879|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
14270880|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270881|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14270882|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270883|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270884|NCT00412542|Thalidomide|thalidomide|mesh-list
14270885|NCT00412542|Irinotecan|irinotecan|mesh-list
14270886|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14270887|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14270888|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270889|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270890|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270891|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14270892|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
14270893|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270894|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
14270895|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14270896|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270897|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270898|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270899|NCT00412542|Growth Substances|growth substances|mesh-ancestor
14270900|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270901|NCT00412737|Oseltamivir|oseltamivir|mesh-list
14270902|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
14270903|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270904|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270905|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270906|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14270907|NCT00412750|Telbivudine|telbivudine|mesh-list
14270908|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
14270909|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270910|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14270911|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270912|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270913|NCT00412841|Atorvastatin|atorvastatin|mesh-list
14270914|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14270915|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14270916|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
14006607|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14006608|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14006609|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14006610|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14006611|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006612|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006613|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006614|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
14006615|NCT02863913|Interleukin-2|interleukin-2|mesh-list
14006616|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006617|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
14006618|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006619|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006620|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14006621|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
14006622|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006623|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006624|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14006625|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006626|NCT02863913|Analgesics|analgesics|mesh-ancestor
14006627|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
14006628|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006629|NCT02863614|Ibuprofen|ibuprofen|mesh-list
14006630|NCT02863614|Lorazepam|lorazepam|mesh-list
14006631|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14006632|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006633|NCT02863614|Analgesics|analgesics|mesh-ancestor
14006634|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
14006635|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006636|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006637|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006638|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006639|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14006640|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006641|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006642|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
14006643|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
14006644|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
14006645|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006646|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14006647|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006648|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14006649|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006650|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006651|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
14006652|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
14006653|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006654|NCT02863809|Riboflavin|riboflavin|mesh-list
14006655|NCT02863809|Dextrans|dextrans|mesh-list
14006656|NCT02863809|Vitamins|vitamins|mesh-ancestor
14006657|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
14006658|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006659|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
14006660|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14006661|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
14006662|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
14006663|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
14006664|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
14024512|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024513|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024514|NCT02755909|Anesthetics|anesthetics|mesh-list
14024515|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024516|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024517|NCT02756000|Dobutamine|dobutamine|mesh-list
14024518|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14024519|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
14024520|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
14024521|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024522|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024523|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14024524|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14024525|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14024526|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
14024527|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024528|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024529|NCT02756000|Protective Agents|protective agents|mesh-ancestor
14024530|NCT02755857|Itraconazole|itraconazole|mesh-list
14006665|NCT02863367|Gemcitabine|gemcitabine|mesh-list
14006666|NCT02863367|Apatinib|apatinib|mesh-list
14006667|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14006668|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
14006669|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006670|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006671|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
14006672|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006673|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006674|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006675|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
14006676|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006677|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14006678|NCT02863679|Tetracaine|tetracaine|mesh-list
14006679|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006680|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
14006681|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006682|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006683|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
14006684|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006685|NCT02863705|Timolol|timolol|mesh-list
14006686|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14006687|NCT02863705|Bimatoprost|bimatoprost|mesh-list
14006688|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15137397|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137398|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
15137399|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137400|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137401|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137402|NCT04328493|Analgesics|analgesics|mesh-ancestor
15137403|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
15137404|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137405|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137406|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137407|NCT04328493|Filaricides|filaricides|mesh-ancestor
15137408|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
15137409|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
15137410|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
15137411|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15137412|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
15137413|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137414|NCT04328285|Ritonavir|ritonavir|mesh-list
15137415|NCT04328285|Lopinavir|lopinavir|mesh-list
15137416|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
15137417|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15137418|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15137419|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
15137420|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137421|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006689|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14006690|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14006691|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14006692|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006693|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006694|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006695|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006696|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14006697|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14006698|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14006699|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14006700|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14006701|NCT02863471|Gemcitabine|gemcitabine|mesh-list
14006702|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14006703|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
14006704|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137422|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15137423|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14006705|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006706|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
14006707|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006708|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006709|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006710|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
14006711|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006712|NCT02863276|Insulin|insulin|mesh-list
15137424|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
15179110|NCT03952715|Analgesics|analgesics|mesh-ancestor
14006713|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15137425|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137426|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15137427|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15137428|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
15137429|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14006714|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15137430|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137431|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137432|NCT04328480|Colchicine|colchicine|mesh-list
15137433|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
15137434|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137435|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
15137436|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137437|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137438|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137439|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006715|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006716|NCT02863055|Nintedanib|nintedanib|mesh-list
14006717|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006718|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14006719|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006720|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006721|NCT02862977|Ketoprofen|ketoprofen|mesh-list
14006722|NCT02862977|Amitriptyline|amitriptyline|mesh-list
14006723|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
14006724|NCT02862977|Caffeine|caffeine|mesh-list
14006725|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14006726|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006727|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14006728|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006729|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006730|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14006731|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14006732|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
14006733|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006734|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14006735|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006736|NCT02862977|Analgesics|analgesics|mesh-ancestor
14006737|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
14006738|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006739|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006740|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006741|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14006742|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14006743|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
14006744|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006745|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14006746|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14006747|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006748|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006749|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14006750|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14006751|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14006752|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006753|NCT02863120|Bupivacaine|bupivacaine|mesh-list
14006754|NCT02863120|Ropivacaine|ropivacaine|mesh-list
14006755|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006756|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
14006757|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006758|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006759|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
14006760|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137440|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14006761|NCT02863185|Atorvastatin|atorvastatin|mesh-list
14006762|NCT02863185|Pitavastatin|pitavastatin|mesh-list
14006763|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14006764|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14006765|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
14006766|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006767|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14006768|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14006769|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137441|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14006770|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14006771|NCT02862665|Hematinics|hematinics|mesh-ancestor
14006772|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14006773|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14006774|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
14006775|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14270917|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270918|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14270919|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14270920|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270921|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14270922|NCT00412867|Plasminogen|plasminogen|mesh-list
14270923|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137442|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15137443|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15179111|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
15179112|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179113|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179114|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179115|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179116|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15179117|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179118|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179119|NCT03953118|Azithromycin|azithromycin|mesh-list
15179120|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14270924|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14270925|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270926|NCT00412893|Voriconazole|voriconazole|mesh-list
14270927|NCT00412893|Isavuconazole|isavuconazole|mesh-list
14270928|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
14270929|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14270930|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14270931|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14270932|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270933|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270934|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14270935|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
14270936|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14270937|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270938|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14270939|NCT00412958|Plasminogen|plasminogen|mesh-list
14270940|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
14270941|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14270942|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14270943|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270944|NCT00412984|Warfarin|warfarin|mesh-list
14270945|NCT00412984|Apixaban|apixaban|mesh-list
14270946|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
14270947|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14270948|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
14270949|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14270950|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
14270951|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270952|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270953|NCT00413010|Pregabalin|pregabalin|mesh-list
14270954|NCT00413010|Analgesics|analgesics|mesh-ancestor
14270955|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
14270956|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179121|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179122|NCT03952832|Leflunomide|leflunomide|mesh-list
15179123|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006776|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
14006777|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14006778|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006779|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14006780|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14006781|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006782|NCT02862873|Ondansetron|ondansetron|mesh-list
14006783|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006784|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006785|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
14006786|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
14024531|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
14006787|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006788|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006789|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
14006790|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
14006791|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14006792|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
14006793|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006794|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006795|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14006796|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006797|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006798|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14006799|NCT02862691|Acetaminophen|acetaminophen|mesh-list
14006800|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14006801|NCT02862691|Oxycodone|oxycodone|mesh-list
15137444|NCT04328272|Azithromycin|azithromycin|mesh-list
15137445|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
14006802|NCT02862691|Analgesics|analgesics|mesh-list
14006803|NCT02862691|Bupivacaine|bupivacaine|mesh-list
14006804|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
14006805|NCT02862691|Anesthetics|anesthetics|mesh-list
14006806|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006807|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006808|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
14006809|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006810|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006811|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
14006812|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14006813|NCT02862691|Narcotics|narcotics|mesh-ancestor
14006814|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14006815|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006816|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14006817|NCT02862769|Lidocaine|lidocaine|mesh-list
14006818|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006819|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
14006820|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006821|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006822|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
14006823|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006824|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14006825|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14006826|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14006827|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14006828|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006829|NCT02862483|Tadalafil|tadalafil|mesh-list
14006830|NCT02862483|Tamsulosin|tamsulosin|mesh-list
14006831|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
14006832|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14006833|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14006834|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006835|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006836|NCT02862483|Urological Agents|urological agents|mesh-ancestor
14006837|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14006838|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14006839|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14006840|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006841|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006842|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006843|NCT02862509|Budesonide|budesonide|mesh-list
14006844|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006845|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14006846|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
14006847|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006848|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006849|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14006850|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
14006851|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
14006852|NCT02862509|Hormones|hormones|mesh-ancestor
14006853|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006854|NCT02862145|Dexamethasone|dexamethasone|mesh-list
14006855|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006856|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
14006857|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
14006858|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006859|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006860|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006861|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
14006862|NCT02862145|Hormones|hormones|mesh-ancestor
14006863|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006864|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14006865|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006866|NCT02862327|Dexamethasone|dexamethasone|mesh-list
14006867|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
14006868|NCT02862327|Ropivacaine|ropivacaine|mesh-list
14006869|NCT02862327|BB 1101|bb 1101|mesh-list
14006870|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006871|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
14006872|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
14006873|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006874|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006875|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14270957|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270958|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
14270959|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270960|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270961|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270962|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270963|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14270964|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14270965|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14270966|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14270967|NCT00413036|Lenalidomide|lenalidomide|mesh-list
14270968|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
14270969|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270970|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14270971|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14270972|NCT00413036|Growth Substances|growth substances|mesh-ancestor
14270973|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
14270974|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14270975|NCT00413049|Amlodipine|amlodipine|mesh-list
14270976|NCT00413049|Valsartan|valsartan|mesh-list
14270977|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14270978|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14270979|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14270980|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270981|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14270982|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14270983|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14270984|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14270985|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14270986|NCT00413153|Ritonavir|ritonavir|mesh-list
15137446|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15137447|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137448|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
15137449|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137450|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137451|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137452|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137453|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137454|NCT04328194|Thrombin|thrombin|mesh-list
15137455|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
15137456|NCT04328194|Coagulants|coagulants|mesh-ancestor
15137457|NCT04327791|Baloxavir|baloxavir|mesh-list
15137458|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
15137459|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137460|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270987|NCT00413153|Lopinavir|lopinavir|mesh-list
14270988|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14270989|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14270990|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14270991|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
14270992|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14270993|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14270994|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14270995|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14270996|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
14270997|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006876|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
14006877|NCT02862327|Hormones|hormones|mesh-ancestor
14024532|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137461|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006878|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14006879|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14006880|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006881|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
14006882|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006883|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006884|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006885|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
14006886|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006887|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
14006888|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
14006889|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
14006890|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14006891|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006892|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006893|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
14006894|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006895|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006896|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006897|NCT02861950|Bupivacaine|bupivacaine|mesh-list
14006898|NCT02861950|Ropivacaine|ropivacaine|mesh-list
14006899|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006900|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
14006901|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006902|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006903|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
14006904|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024533|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14024534|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14024535|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024536|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024537|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14024538|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14024539|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024540|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024541|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14024542|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
14024543|NCT02755545|Adapalene|adapalene|mesh-list
14024544|NCT02755545|Salicylates|salicylates|mesh-list
14024545|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137462|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
15137463|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15137464|NCT04327934|Testosterone|testosterone|mesh-list
15137465|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
15137466|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
15137467|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15137468|NCT04327934|Hormones|hormones|mesh-ancestor
15137469|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137470|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137471|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15137472|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137473|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
15137474|NCT04327934|Androgens|androgens|mesh-ancestor
15137475|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
15137476|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15137477|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
15137478|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137479|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
15137480|NCT04327947|Protective Agents|protective agents|mesh-ancestor
15137481|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15137482|NCT04328064|Calcium|calcium|mesh-list
15137483|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15137484|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137485|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15137486|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15137487|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
15137488|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137489|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15137490|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15137491|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137492|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
15137493|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14006905|NCT02862015|Gemcitabine|gemcitabine|mesh-list
14006906|NCT02862015|Folfirinox|folfirinox|mesh-list
14006907|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14006908|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
14006909|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006910|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006911|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
14006912|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006913|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14006914|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14006915|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
14006916|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006917|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
14006918|NCT02861976|Narcotics|narcotics|mesh-ancestor
14006919|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006920|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006921|NCT02861976|Analgesics|analgesics|mesh-ancestor
14006922|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
14006923|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006924|NCT02861859|Olanzapine|olanzapine|mesh-list
14006925|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
14006926|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
14006927|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006928|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006929|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006930|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14006931|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14006932|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006933|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15137494|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15137495|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137496|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137497|NCT04327726|Analgesics|analgesics|mesh-ancestor
15137498|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
15137499|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137500|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15137501|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14006934|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14006935|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14006936|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14006937|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006938|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006939|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
14006940|NCT02861482|Oxytocin|oxytocin|mesh-list
14006941|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
14006942|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
14006943|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14006944|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006945|NCT02861716|Fentanyl|fentanyl|mesh-list
14006946|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
14006947|NCT02861716|Bupivacaine|bupivacaine|mesh-list
14006948|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006949|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
14270998|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14270999|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14271000|NCT00413166|Idarubicin|idarubicin|mesh-list
14271001|NCT00413166|Tretinoin|tretinoin|mesh-list
14271002|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
14271003|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
14271004|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14271005|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271006|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14271007|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14271008|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271009|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271010|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
14271011|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
14271012|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271013|NCT00413218|Voriconazole|voriconazole|mesh-list
14271014|NCT00413218|Caspofungin|caspofungin|mesh-list
14271015|NCT00413218|Isavuconazole|isavuconazole|mesh-list
14271016|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
15137502|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15137503|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006950|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271017|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14006951|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006952|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
14006953|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006954|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14006955|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14006956|NCT02861716|Analgesics|analgesics|mesh-ancestor
15137504|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15137505|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137506|NCT04327245|Tagatose|tagatose|mesh-list
14006957|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14006958|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14006959|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15137507|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15137508|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
15137509|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
15137510|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137511|NCT04327401|Dexamethasone|dexamethasone|mesh-list
15137512|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14006960|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
14006961|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006962|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006963|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14006964|NCT02861716|Narcotics|narcotics|mesh-ancestor
14006965|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14006966|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14006967|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
14006968|NCT02861690|Paclitaxel|paclitaxel|mesh-list
15137513|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
15137514|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
14006969|NCT02861690|Nedaplatin|nedaplatin|mesh-list
14006970|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14006971|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14006972|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14006973|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14006974|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14006975|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006976|NCT02861261|Promethazine|promethazine|mesh-list
14006977|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
14006978|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
14006979|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
14006980|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14006981|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
14006982|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
14006983|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14006984|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14006985|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14006986|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14006987|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14006988|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14006989|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14006990|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
14006991|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
14006992|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
14006993|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14006994|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
14006995|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
14006996|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14006997|NCT02861222|Doxorubicin|doxorubicin|mesh-list
14006998|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14006999|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007000|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14007001|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14007002|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007003|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007004|NCT02861378|Phentolamine|phentolamine|mesh-list
14007005|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14007006|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14007007|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
14007008|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007009|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007010|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137515|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137516|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007011|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14007012|NCT02861105|Enoxaparin|enoxaparin|mesh-list
14007013|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14007014|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
14007015|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137517|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137518|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
15137519|NCT04327401|Hormones|hormones|mesh-ancestor
15137520|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137521|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15137522|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137523|NCT04327427|Aspirin|aspirin|mesh-list
15137524|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137525|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137526|NCT04327427|Analgesics|analgesics|mesh-ancestor
15137527|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
15137528|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007016|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14007017|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007018|NCT02860936|Lenvatinib|lenvatinib|mesh-list
14007019|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007020|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14007021|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007022|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007023|NCT02860949|Ketorolac|ketorolac|mesh-list
14007024|NCT02860949|Epinephrine|epinephrine|mesh-list
14007025|NCT02860949|Morphine|morphine|mesh-list
14007026|NCT02860949|Bupivacaine|bupivacaine|mesh-list
14007027|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
15137529|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137530|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137531|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137532|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137533|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15137534|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137535|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15137536|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15137537|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137538|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
15137539|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15137540|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15137541|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137542|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
15137543|NCT04327232|Spironolactone|spironolactone|mesh-list
15137544|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15137545|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
15137546|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007028|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
14007029|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007030|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007031|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
14007032|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007033|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14007034|NCT02860949|Narcotics|narcotics|mesh-ancestor
14007035|NCT02860949|Analgesics|analgesics|mesh-ancestor
14007036|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14007037|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14007038|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
14007039|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007040|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007041|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14007042|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14007043|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
14007044|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14007045|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
14007046|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
14007047|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
14007048|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14007049|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14007050|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14007051|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007052|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14007053|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14007054|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137547|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007055|NCT02860923|Exenatide|exenatide|mesh-list
14007056|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14007057|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007058|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14007059|NCT02860923|Incretins|incretins|mesh-ancestor
14007060|NCT02860923|Hormones|hormones|mesh-ancestor
14007061|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007062|NCT02861040|Vincristine|vincristine|mesh-list
14007063|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14007064|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007065|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
14007066|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
14007067|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007068|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007069|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
14007070|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
14007071|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
14007072|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14007073|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14007074|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007075|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007076|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007077|NCT02860858|Aflibercept|aflibercept|mesh-list
14007078|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15137548|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15137549|NCT04327232|Diuretics|diuretics|mesh-ancestor
14007079|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14007080|NCT02860858|Growth Substances|growth substances|mesh-ancestor
14007081|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007082|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
14007083|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007084|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14007085|NCT02860897|Estrogens|estrogens|mesh-ancestor
14007086|NCT02860897|Hormones|hormones|mesh-ancestor
14007087|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007088|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007089|NCT02860819|Gemcitabine|gemcitabine|mesh-list
14007090|NCT02860819|Carboplatin|carboplatin|mesh-list
14007091|NCT02860819|Veliparib|veliparib|mesh-list
14007092|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007093|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14007094|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
14007095|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271018|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14271019|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14271020|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271021|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271022|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14271023|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
14292401|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137550|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
14007096|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
14007097|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007098|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007099|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007100|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
14007101|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007102|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14007103|NCT02860663|Vitamin D|vitamin d|mesh-list
14007104|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
14007105|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
15137551|NCT04326920|Sargramostim|sargramostim|mesh-list
15137552|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
14007106|NCT02860663|Vitamins|vitamins|mesh-list
14007107|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
14007108|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007109|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14007110|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14007111|NCT02860624|Esomeprazole|esomeprazole|mesh-list
14007112|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14007113|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14007114|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14007115|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007116|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007117|NCT02860494|Everolimus|everolimus|mesh-list
14007118|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007119|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007120|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
14007121|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024546|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14024547|NCT02755545|Analgesics|analgesics|mesh-ancestor
14024548|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
14024549|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024550|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024551|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024552|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024553|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
14024554|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024555|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
14024556|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
14024557|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14024558|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024559|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024560|NCT02755532|Bupivacaine|bupivacaine|mesh-list
14024561|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
14024562|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
14024563|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024564|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024565|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
14024566|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024567|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
14024568|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14024569|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
14024570|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024571|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
14024572|NCT02755376|Protective Agents|protective agents|mesh-ancestor
14024573|NCT02755298|Acetazolamide|acetazolamide|mesh-list
14271024|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271025|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271026|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14271027|NCT00413244|Testosterone|testosterone|mesh-list
14271028|NCT00413244|Androgens|androgens|mesh-ancestor
14271029|NCT00413244|Hormones|hormones|mesh-ancestor
14271030|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271031|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271032|NCT00413283|Gemcitabine|gemcitabine|mesh-list
14271033|NCT00413283|Carboplatin|carboplatin|mesh-list
14271034|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271035|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271036|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
14271037|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271038|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
14271039|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271040|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271041|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271042|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
14271043|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562001|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562002|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
14562003|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562004|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137553|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137554|NCT04327011|Flucytosine|flucytosine|mesh-list
15137555|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
15137556|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024574|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
14562005|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562006|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
14562007|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137557|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
14024575|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14024576|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024577|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024578|NCT02755298|Diuretics|diuretics|mesh-ancestor
14024579|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
14024580|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024581|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14024582|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14271044|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
14007122|NCT02860234|Capecitabine|capecitabine|mesh-list
14007123|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
14007124|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14007125|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
14007126|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007127|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007128|NCT02860299|Heparin|heparin|mesh-list
14007129|NCT02860299|Calcium heparin|calcium heparin|mesh-list
14007130|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
14007131|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007132|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14007133|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14007134|NCT02860117|Ketamine|ketamine|mesh-list
14007135|NCT02860117|Analgesics|analgesics|mesh-ancestor
14007136|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
14007137|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007138|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007139|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14007140|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14007141|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
14007142|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
14007143|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007144|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14007145|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14007146|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007147|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007148|NCT02860221|Epinephrine|epinephrine|mesh-list
14007149|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
14007150|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14007151|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14007152|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
14007153|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007154|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007155|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007156|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14007157|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14007158|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
14007159|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137558|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137559|NCT04326959|Triamcinolone|triamcinolone|mesh-list
15137560|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15137561|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15137562|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14007160|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14007161|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
14007162|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
14271045|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14271046|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271047|NCT00413374|Enoxaparin|enoxaparin|mesh-list
14271048|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
14271049|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137563|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137564|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
14271050|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14271051|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271052|NCT00413400|Etanercept|etanercept|mesh-list
14271053|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14271054|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14271055|NCT00413400|Analgesics|analgesics|mesh-ancestor
14271056|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
14271057|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271058|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271059|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271060|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271061|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271062|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271063|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
14271064|NCT00413413|Amlodipine|amlodipine|mesh-list
14271065|NCT00413413|Valsartan|valsartan|mesh-list
14271066|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14271067|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14271068|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271069|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137565|NCT04326959|Hormones|hormones|mesh-ancestor
14007163|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
14007164|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14007165|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14007166|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14007167|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
14007168|NCT02860221|Coagulants|coagulants|mesh-ancestor
14007169|NCT02859792|Riluzole|riluzole|mesh-list
14007170|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
14007171|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14007172|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14007173|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007174|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007175|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007176|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14007177|NCT02859792|Protective Agents|protective agents|mesh-ancestor
14007178|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
15137566|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137567|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137568|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137569|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
15137570|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137571|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137572|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
15137573|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15137574|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
15137575|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137576|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
15137577|NCT04326985|Protective Agents|protective agents|mesh-ancestor
15137578|NCT04326894|Methotrexate|methotrexate|mesh-list
15137579|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15137580|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
14007179|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14007180|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
14007181|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137581|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15137582|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137583|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15137584|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
15137585|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137586|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137587|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
15137588|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137589|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15137590|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137591|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
15137592|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137593|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15137594|NCT04326868|Albendazole|albendazole|mesh-list
15137595|NCT04326868|Mebendazole|mebendazole|mesh-list
15137596|NCT04326868|Benzimidazole|benzimidazole|mesh-list
15137597|NCT04326868|Pyrantel|pyrantel|mesh-list
15137598|NCT04326868|Anthelmintics|anthelmintics|mesh-list
14007182|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14007183|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14007184|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14007185|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
14007186|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007187|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14007188|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14007189|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007190|NCT02859402|Fludarabine|fludarabine|mesh-list
14007191|NCT02859402|Busulfan|busulfan|mesh-list
14007192|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007193|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007194|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007195|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
14007196|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007197|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
14007198|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14007199|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14007200|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
14007201|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14007202|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14007203|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14007204|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137599|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137600|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137601|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
14007205|NCT02859571|Oxytocin|oxytocin|mesh-list
14007206|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
14007207|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14007208|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007209|NCT02859285|Estradiol|estradiol|mesh-list
14007210|NCT02859285|Estrogens|estrogens|mesh-ancestor
14007211|NCT02859285|Hormones|hormones|mesh-ancestor
15137602|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15137603|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137604|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
15137605|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137606|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137607|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137608|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137609|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
14007212|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007213|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007214|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14007215|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14007216|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14007217|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14007218|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
14007219|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007220|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14007221|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14007222|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007223|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14007224|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14007225|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14007226|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14007227|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14007228|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007229|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007230|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007231|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
14007232|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14007233|NCT02859259|Fostemsavir|fostemsavir|mesh-list
14007234|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14007235|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14007236|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
14007237|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007238|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14007239|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14007240|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007241|NCT02859077|Gemcitabine|gemcitabine|mesh-list
14007242|NCT02859077|Carboplatin|carboplatin|mesh-list
14007243|NCT02859077|Pemetrexed|pemetrexed|mesh-list
14007244|NCT02859077|Gefitinib|gefitinib|mesh-list
14007245|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007246|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14007247|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
14007248|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007249|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
14007250|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007251|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007252|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007253|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
14007254|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137610|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15137611|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15137612|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14007255|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14007256|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14007257|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14007258|NCT02858843|Ivacaftor|ivacaftor|mesh-list
14007259|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14007260|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14007261|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007262|NCT02858817|Atovaquone|atovaquone|mesh-list
14007263|NCT02858817|Proguanil|proguanil|mesh-list
15137613|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137614|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137615|NCT04326764|Panobinostat|panobinostat|mesh-list
14007264|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14007265|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007266|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
14007267|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14007268|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14007269|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007270|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007271|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
14007272|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
14007273|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007274|NCT02858856|Mitogens|mitogens|mesh-ancestor
14007275|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007276|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007277|NCT02858622|Fentanyl|fentanyl|mesh-list
14007278|NCT02858622|Meperidine|meperidine|mesh-list
14007279|NCT02858622|Bupivacaine|bupivacaine|mesh-list
14007280|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
14007281|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
14007282|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007283|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007284|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
14007285|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007286|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14007287|NCT02858622|Narcotics|narcotics|mesh-ancestor
14007288|NCT02858622|Analgesics|analgesics|mesh-ancestor
14007289|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14007290|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14007291|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
14024583|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14024584|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024585|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024586|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
14024587|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024588|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14024589|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14024590|NCT02755311|Cisplatin|cisplatin|mesh-list
14024591|NCT02755311|Carboplatin|carboplatin|mesh-list
14024592|NCT02755311|Fluorouracil|fluorouracil|mesh-list
14024593|NCT02755311|Epirubicin|epirubicin|mesh-list
14024594|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
14024595|NCT02755311|Pirarubicin|pirarubicin|mesh-list
14024596|NCT02755311|Doxorubicin|doxorubicin|mesh-list
14024597|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14024598|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024599|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
14024600|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024601|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14024602|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024603|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
14024604|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024605|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14024606|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14024607|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14024608|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024609|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
14024610|NCT02755311|Coagulants|coagulants|mesh-ancestor
14024611|NCT02755259|Acetazolamide|acetazolamide|mesh-list
14024612|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
14024613|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14024614|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024615|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024616|NCT02755259|Diuretics|diuretics|mesh-ancestor
14024617|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
14024618|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024619|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14024620|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14024621|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14024622|NCT02754882|Paclitaxel|paclitaxel|mesh-list
15137616|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137617|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14024623|NCT02754882|Bevacizumab|bevacizumab|mesh-list
14024624|NCT02754882|Carboplatin|carboplatin|mesh-list
14024625|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15137618|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024626|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007292|NCT02858804|Cytarabine|cytarabine|mesh-list
14007293|NCT02858804|Thalidomide|thalidomide|mesh-list
14007294|NCT02858804|Dexamethasone|dexamethasone|mesh-list
14007295|NCT02858804|Prednisone|prednisone|mesh-list
14007296|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
15137619|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137620|NCT04326790|Colchicine|colchicine|mesh-list
15137621|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
14271070|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14271071|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271072|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
14271073|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14271074|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14271075|NCT00413478|Azacitidine|azacitidine|mesh-list
14271076|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271077|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
14271078|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271079|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271080|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271081|NCT00413634|Anagrelide|anagrelide|mesh-list
14271082|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14271083|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14271084|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271085|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14271086|NCT00413660|Tofacitinib|tofacitinib|mesh-list
14271087|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271088|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271089|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271090|NCT00413777|Tolvaptan|tolvaptan|mesh-list
14271091|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14271092|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271093|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
14271094|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271095|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
14271096|NCT00413894|Hematinics|hematinics|mesh-ancestor
14271097|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
14271098|NCT00413920|Prednisone|prednisone|mesh-list
14271099|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271100|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
14271101|NCT00413920|Hormones|hormones|mesh-ancestor
14271102|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271103|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137622|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137623|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
15137624|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137625|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137626|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137627|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137628|NCT04326803|Vaccines|vaccines|mesh-list
15137629|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
15137630|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137631|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
15137632|NCT04326673|Testosterone|testosterone|mesh-list
15137633|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
15137634|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
15137635|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15137636|NCT04326673|Androgens|androgens|mesh-ancestor
15137637|NCT04326673|Hormones|hormones|mesh-ancestor
15137638|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007297|NCT02858804|Rituximab|rituximab|mesh-list
14271104|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14271105|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271106|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14271107|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14271108|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
14271109|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14271110|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271111|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271112|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271113|NCT00413959|Dexamethasone|dexamethasone|mesh-list
14271114|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
14271115|NCT00413959|Rituximab|rituximab|mesh-list
15137639|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137640|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14007298|NCT02858804|Doxorubicin|doxorubicin|mesh-list
14007299|NCT02858804|Etoposide|etoposide|mesh-list
14007300|NCT02858804|Vincristine|vincristine|mesh-list
14007301|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007302|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
14007303|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007304|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14007305|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14007306|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
14007307|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007308|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007309|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15137641|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137642|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
15137643|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
15137644|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
15137645|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137646|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14007310|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007311|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
14007312|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
14007313|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007314|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14007315|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
14007316|NCT02858804|Hormones|hormones|mesh-ancestor
14007317|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007318|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14007319|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007320|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14007321|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14007322|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15137647|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007323|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007324|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14007325|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14007326|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
14007327|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
14007328|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007329|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
14007330|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
14007331|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007332|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
14007333|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14007334|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14007335|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14007336|NCT02858804|Growth Substances|growth substances|mesh-ancestor
14007337|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
14007338|NCT02858505|Iron|iron|mesh-list
14007339|NCT02858505|Trace Elements|trace elements|mesh-ancestor
14007340|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
14007341|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007342|NCT02858258|Rituximab|rituximab|mesh-list
14007343|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007344|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007345|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
14007346|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007347|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14007348|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
14007349|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14007350|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14007351|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14007352|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14007353|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007354|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
14007355|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007356|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007357|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14007358|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007359|NCT02858297|Triamcinolone|triamcinolone|mesh-list
14007360|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14007361|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14007362|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14007363|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007364|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
14007365|NCT02858297|Hormones|hormones|mesh-ancestor
14007366|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137648|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007367|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007368|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007369|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
14007370|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007371|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007372|NCT02858193|Carbocysteine|carbocysteine|mesh-list
14007373|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14007374|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007375|NCT02858193|Expectorants|expectorants|mesh-ancestor
14007376|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
14007377|NCT02858024|Dapivirine|dapivirine|mesh-list
14007378|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14007379|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14007380|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
14007381|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007382|NCT02858206|Paclitaxel|paclitaxel|mesh-list
14007383|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
14007384|NCT02858206|Nedaplatin|nedaplatin|mesh-list
14007385|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14007386|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007387|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14007388|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14007389|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007390|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007391|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007392|NCT02857959|Penicillins|penicillins|mesh-list
14007393|NCT02857959|Penicillin G|penicillin g|mesh-list
14007394|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14007395|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
14007396|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14271116|NCT00413959|Bortezomib|bortezomib|mesh-list
14271117|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271118|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
14271119|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271120|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271121|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14271122|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
14271123|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271124|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271125|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14271126|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271127|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
14271128|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
14271129|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137649|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137650|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137651|NCT04326296|Lenalidomide|lenalidomide|mesh-list
14271130|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271131|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
14271132|NCT00413959|Hormones|hormones|mesh-ancestor
14271133|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271134|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14271135|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271136|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
14271137|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
14271138|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14271139|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271140|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14271141|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14271142|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271143|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271144|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271145|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14271146|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14271147|NCT00414050|Vaccines|vaccines|mesh-list
14271148|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
14271149|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271150|NCT00414076|Letrozole|letrozole|mesh-list
14271151|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271152|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14271153|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14271154|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271155|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007397|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007398|NCT02857946|Linagliptin|linagliptin|mesh-list
14007399|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14007400|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007401|NCT02857946|Incretins|incretins|mesh-ancestor
14007402|NCT02857946|Hormones|hormones|mesh-ancestor
14007403|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007404|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14007405|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
14271156|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14271157|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
14271158|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271159|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271160|NCT00414167|Bupropion|bupropion|mesh-list
14271161|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14271162|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
14271163|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271164|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14271165|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14271166|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271167|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271168|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
14271169|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271170|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271171|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14271172|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14271173|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271174|NCT00414206|Mecamylamine|mecamylamine|mesh-list
14271175|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14271176|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14271177|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
14271178|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137652|NCT04326296|Antibodies|antibodies|mesh-list
15137653|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15137654|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
15137655|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137656|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15137657|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15137658|NCT04326296|Growth Substances|growth substances|mesh-ancestor
15137659|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
15137660|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137661|NCT04326439|Cytarabine|cytarabine|mesh-list
15137662|NCT04326439|Etoposide|etoposide|mesh-list
15137663|NCT04326439|Daunorubicin|daunorubicin|mesh-list
15137664|NCT04326439|Sorafenib|sorafenib|mesh-list
15137665|NCT04326439|Asparaginase|asparaginase|mesh-list
15137666|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
14007406|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007407|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007408|NCT02857712|Axitinib|axitinib|mesh-list
15137667|NCT04326439|Calicheamicins|calicheamicins|mesh-list
14007409|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007410|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14007411|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007412|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007413|NCT02857920|Bevacizumab|bevacizumab|mesh-list
14007414|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007415|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007416|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14007417|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14007418|NCT02857920|Growth Substances|growth substances|mesh-ancestor
14007419|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007420|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
14007421|NCT02857829|Caffeine|caffeine|mesh-list
14007422|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14007423|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007424|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14007425|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007426|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007427|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14007428|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14007429|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
15137668|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15137669|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137670|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15137671|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15137672|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137673|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137674|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15137675|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
15137676|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
15137677|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137678|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137679|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
15137680|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137681|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15137682|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15137683|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15137684|NCT04326478|Azithromycin|azithromycin|mesh-list
15137685|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15137686|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179124|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179125|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15179126|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
15179127|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179128|NCT03952650|Chloroquine|chloroquine|mesh-list
14007430|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007431|NCT02857842|Prednisolone|prednisolone|mesh-list
14007432|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007433|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
14007434|NCT02857842|Hormones|hormones|mesh-ancestor
14007435|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007436|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007437|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14007438|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007439|NCT02857777|Esketamine|esketamine|mesh-list
14007440|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
14007441|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14007442|NCT02857686|Anesthetics|anesthetics|mesh-list
14007443|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007444|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007445|NCT02857582|Metronidazole|metronidazole|mesh-list
14007446|NCT02857582|Vancomycin|vancomycin|mesh-list
14007447|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007448|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14007449|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14007450|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14007451|NCT02857569|Nivolumab|nivolumab|mesh-list
14007452|NCT02857569|Ipilimumab|ipilimumab|mesh-list
14007453|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007454|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007455|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14007456|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007457|NCT02857491|Ranibizumab|ranibizumab|mesh-list
14007458|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14007459|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14007460|NCT02857491|Growth Substances|growth substances|mesh-ancestor
14007461|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007462|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
14007463|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007464|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15179129|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15179130|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
15179131|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15179132|NCT03952650|Ibuprofen|ibuprofen|mesh-list
15179133|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14007465|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14007466|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
14007467|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007468|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
14007469|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007470|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007471|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14007472|NCT02857309|Diuretics|diuretics|mesh-ancestor
14007473|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
14007474|NCT02857309|Hormones|hormones|mesh-ancestor
14007475|NCT02857465|Dexamethasone|dexamethasone|mesh-list
14007476|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
14007477|NCT02857465|Sufentanil|sufentanil|mesh-list
14007478|NCT02857465|Dsuvia|dsuvia|mesh-list
14007479|NCT02857465|Ropivacaine|ropivacaine|mesh-list
14007480|NCT02857465|BB 1101|bb 1101|mesh-list
14007481|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007482|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
14007483|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
14007484|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007485|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007486|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14007487|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
14007488|NCT02857465|Hormones|hormones|mesh-ancestor
14007489|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007490|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14007491|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137687|NCT04326166|Metformin|metformin|mesh-list
15137688|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15137689|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137690|NCT04325984|Dexamethasone|dexamethasone|mesh-list
15137691|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137692|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
15137693|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
15137694|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137695|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137696|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137697|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
14007492|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
14007493|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007494|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007495|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
14007496|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
14007497|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007498|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
14007499|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14007500|NCT02857465|Narcotics|narcotics|mesh-ancestor
14007501|NCT02857465|Analgesics|analgesics|mesh-ancestor
15137698|NCT04325984|Hormones|hormones|mesh-ancestor
15137699|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137700|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15137701|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137702|NCT04325932|Kallikreins|kallikreins|mesh-list
15137703|NCT04325932|Coagulants|coagulants|mesh-ancestor
15137704|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14007502|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14007503|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14007504|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
14007505|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14007506|NCT02857218|Hematinics|hematinics|mesh-ancestor
14007507|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14007508|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14007509|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14007510|NCT02857244|Modafinil|modafinil|mesh-list
14007511|NCT02857244|Donepezil|donepezil|mesh-list
14007512|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14007513|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14007514|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14007515|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007516|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007517|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007518|NCT02857244|Analgesics|analgesics|mesh-ancestor
14007519|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
14007520|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007521|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
14007522|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14007523|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
14007524|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14007525|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007526|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
14007527|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
14007528|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14007529|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14007530|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14007531|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14007532|NCT02857361|Ketamine|ketamine|mesh-list
14007533|NCT02857361|Analgesics|analgesics|mesh-ancestor
14007534|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
14007535|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024627|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
15137705|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
14007536|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007537|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14007538|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14007539|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
14007540|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
14007541|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007542|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14007543|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14007544|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007545|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007546|NCT02857270|Gemcitabine|gemcitabine|mesh-list
15137706|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15137707|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137708|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
15137709|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
15137710|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137711|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137712|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137713|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137714|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137715|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137716|NCT04325633|Naproxen|naproxen|mesh-list
15137717|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137718|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137719|NCT04325633|Analgesics|analgesics|mesh-ancestor
15137720|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
15137721|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137722|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137723|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137724|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137725|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
15137726|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15137727|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137728|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137729|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
15137730|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
15137731|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137732|NCT04325503|Levodopa|levodopa|mesh-list
15137733|NCT04325503|Carbidopa|carbidopa|mesh-list
15137734|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15137735|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15137736|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
15137737|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007547|NCT02857270|Paclitaxel|paclitaxel|mesh-list
14007548|NCT02857270|Cetuximab|cetuximab|mesh-list
14007549|NCT02857270|Midazolam|midazolam|mesh-list
14007550|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14007551|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137738|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137739|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137740|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15137741|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137742|NCT04325698|Paclitaxel|paclitaxel|mesh-list
15137743|NCT04325698|Bevacizumab|bevacizumab|mesh-list
15137744|NCT04325698|Carboplatin|carboplatin|mesh-list
15137745|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15137746|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137747|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
15137748|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137749|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137750|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137751|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15137752|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15137753|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15137754|NCT04325698|Growth Substances|growth substances|mesh-ancestor
15137755|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137756|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
14007552|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
14007553|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
14007554|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007555|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007556|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15137757|NCT04325581|Liraglutide|liraglutide|mesh-list
15137758|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15137759|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007557|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
14007558|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
14007559|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007560|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007561|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007562|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
14007563|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007564|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14007565|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14007566|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007567|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14007568|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14007569|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14007570|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14007571|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
14007572|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
14007573|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
14007574|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
14007575|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007576|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007577|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14007578|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14007579|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14007580|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14007581|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14007582|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14007583|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007584|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137760|NCT04325581|Incretins|incretins|mesh-ancestor
15137761|NCT04325581|Hormones|hormones|mesh-ancestor
15137762|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007585|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024628|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137763|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
15137764|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15137765|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137766|NCT04325425|Carboplatin|carboplatin|mesh-list
15137767|NCT04325425|Etoposide|etoposide|mesh-list
15137768|NCT04325425|Folfirinox|folfirinox|mesh-list
15137769|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137770|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14024629|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
14024630|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024631|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024632|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14024633|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14024634|NCT02754882|Growth Substances|growth substances|mesh-ancestor
14024635|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024636|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
14026229|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026230|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14026231|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026232|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14026233|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14026234|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
14026235|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026236|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026237|NCT02744378|Clobetasol|clobetasol|mesh-list
14271179|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271180|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14271181|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14271182|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
14271183|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271184|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271185|NCT00414271|Docetaxel|docetaxel|mesh-list
14271186|NCT00414271|Capecitabine|capecitabine|mesh-list
14271187|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271188|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14271189|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
14271190|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
14271191|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271192|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271193|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
14007586|NCT02856854|Cocaine|cocaine|mesh-list
14007587|NCT02856854|Oxazepam|oxazepam|mesh-list
14007588|NCT02856854|Metyrapone|metyrapone|mesh-list
14007589|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
14007590|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
14007591|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007592|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007593|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
14007594|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007595|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14007596|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14007597|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14007598|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14007599|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007600|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
14007601|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007602|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
14007603|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007604|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14007605|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14271194|NCT00414310|Decitabine|decitabine|mesh-list
14271195|NCT00414310|Valproic Acid|valproic acid|mesh-list
14271196|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271197|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
14271198|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271199|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271200|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271201|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
14271202|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
14271203|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271204|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271205|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
14271206|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14271207|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271208|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271209|NCT00414388|Sorafenib|sorafenib|mesh-list
14271210|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271211|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271212|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271213|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271214|NCT00414440|Everolimus|everolimus|mesh-list
14271215|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271216|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271217|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
14271218|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271219|NCT00414466|Gabapentin|gabapentin|mesh-list
14271220|NCT00414466|Analgesics|analgesics|mesh-ancestor
14271221|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
14271222|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271223|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007606|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14007607|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271224|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
14271225|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14271226|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14271227|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271228|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271229|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14271230|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14271231|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271232|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271233|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
14271234|NCT00414518|Ritonavir|ritonavir|mesh-list
14271235|NCT00414518|Lopinavir|lopinavir|mesh-list
14271236|NCT00414518|Tenofovir|tenofovir|mesh-list
14271237|NCT00414518|Emtricitabine|emtricitabine|mesh-list
14271238|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14271239|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14007608|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
14007609|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
14007610|NCT02857062|Emollients|emollients|mesh-list
14007611|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
14007612|NCT02856893|Gefitinib|gefitinib|mesh-list
14007613|NCT02856893|Osimertinib|osimertinib|mesh-list
14271240|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
14271241|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271242|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007614|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007615|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14007616|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007617|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007618|NCT02857166|Antibodies|antibodies|mesh-list
14007619|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14007620|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
14007621|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137771|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15137772|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15137773|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137774|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137775|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
15137776|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
15137777|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
15137778|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15137779|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137780|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
15137781|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137782|NCT04325191|Melatonin|melatonin|mesh-list
15137783|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
14007622|NCT02856932|Methamphetamine|methamphetamine|mesh-list
14007623|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14007624|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007625|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
14007626|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
14007627|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007628|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
14007629|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007630|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007631|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
14007632|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14007633|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14007634|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14007635|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14007636|NCT02856867|Leucovorin|leucovorin|mesh-list
14007637|NCT02856867|Fluorouracil|fluorouracil|mesh-list
14007638|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
14007639|NCT02856867|Nintedanib|nintedanib|mesh-list
14007640|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
14007641|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137784|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137785|NCT04325191|Protective Agents|protective agents|mesh-ancestor
15137786|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137787|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15137788|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
15137789|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
15137790|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15137791|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15137792|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137793|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137794|NCT04325243|Urological Agents|urological agents|mesh-ancestor
15137795|NCT04325061|Dexamethasone|dexamethasone|mesh-list
15137796|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
14007642|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14007643|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007644|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007645|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
14007646|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007647|NCT02856867|Antidotes|antidotes|mesh-ancestor
14007648|NCT02856867|Protective Agents|protective agents|mesh-ancestor
14007649|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
14007650|NCT02856867|Vitamins|vitamins|mesh-ancestor
14007651|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
14007652|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14007653|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007654|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
14007655|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007656|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
14007657|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
15137797|NCT04325061|BB 1101|bb 1101|mesh-list
15137798|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137799|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
15137800|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
14007658|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14271243|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14007659|NCT02857153|Urapidil|urapidil|mesh-list
14007660|NCT02857153|Phenylephrine|phenylephrine|mesh-list
14007661|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
14007662|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14007663|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
14007664|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
14007665|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007666|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007667|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
14007668|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14007669|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
14007670|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
14007671|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14007672|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14007673|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14007674|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
14007675|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007676|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007677|NCT02857153|Protective Agents|protective agents|mesh-ancestor
14007678|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14007679|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
14007680|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14007681|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
14007682|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14007683|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14007684|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15137801|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137802|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137803|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137804|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
15137805|NCT04325061|Hormones|hormones|mesh-ancestor
14007685|NCT02856698|Midazolam|midazolam|mesh-list
14007686|NCT02856698|Morphine|morphine|mesh-list
14007687|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14007688|NCT02856698|Narcotics|narcotics|mesh-ancestor
14007689|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007690|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007691|NCT02856698|Analgesics|analgesics|mesh-ancestor
14007692|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
15137806|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137807|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15137808|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137809|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
15137810|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137811|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137812|NCT04325009|Atorvastatin|atorvastatin|mesh-list
14007693|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007694|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14007695|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14007696|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14007697|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14007698|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14007699|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14007700|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
15137813|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15137814|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15137815|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
15137816|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137817|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14007701|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
14271244|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14007702|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
14007703|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
14007704|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007705|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007706|NCT02856789|Hemostatics|hemostatics|mesh-list
14007707|NCT02856789|Coagulants|coagulants|mesh-ancestor
14007708|NCT02856724|Dinoprostone|dinoprostone|mesh-list
14007709|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
14007710|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14007711|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007712|NCT02856776|Vitamin D|vitamin d|mesh-list
14007713|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
14007714|NCT02856776|Vitamins|vitamins|mesh-ancestor
14007715|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
14007716|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007717|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14024637|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
14007718|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14007719|NCT02856750|Gabapentin|gabapentin|mesh-list
14007720|NCT02856750|Analgesics|analgesics|mesh-ancestor
14007721|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
14007722|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007723|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007724|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
14007725|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14007726|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14007727|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007728|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14007729|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14007730|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14007731|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007732|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007733|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
14007734|NCT02856581|Varenicline|varenicline|mesh-list
14007735|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14007736|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14007737|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
14007738|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007739|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007740|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007741|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
14007742|NCT02856685|Analgesics|analgesics|mesh-ancestor
14007743|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
14007744|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007745|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007746|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007747|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14007748|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14007749|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007750|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007751|NCT02856568|Gemcitabine|gemcitabine|mesh-list
14007752|NCT02856568|Cisplatin|cisplatin|mesh-list
14007753|NCT02856568|Ricolinostat|ricolinostat|mesh-list
14271245|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
14271246|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271247|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14271248|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14271249|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14271250|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14292402|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
14292403|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292404|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14292405|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14292406|NCT00560612|Paroxetine|paroxetine|mesh-list
14292407|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14292408|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14292409|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292410|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292411|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007754|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292412|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
14292413|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292414|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14292415|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
14292416|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292417|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14292418|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14292419|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292420|NCT00560703|Doxycycline|doxycycline|mesh-list
14292421|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14292422|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292423|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
14292424|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14292425|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14292426|NCT00560794|Blinatumomab|blinatumomab|mesh-list
14292427|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14292428|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292429|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
14292430|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007755|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14007756|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
14007757|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007758|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
14007759|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007760|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007761|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14007762|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
14007763|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007764|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14007765|NCT02856451|Nivolumab|nivolumab|mesh-list
14007766|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007767|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007768|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14007769|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007770|NCT02856295|Enoxaparin|enoxaparin|mesh-list
14007771|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
14007772|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14007773|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14007774|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007775|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
14007776|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007777|NCT02856503|Vitamin D|vitamin d|mesh-list
14007778|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
14007779|NCT02856503|Vitamins|vitamins|mesh-ancestor
14007780|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
14007781|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007782|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14007783|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14007784|NCT02856178|Caspofungin|caspofungin|mesh-list
14007785|NCT02856178|Olorofim|olorofim|mesh-list
14007786|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
14007787|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007788|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007789|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007790|NCT02856542|Betamethasone|betamethasone|mesh-list
14007791|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
14007792|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14007793|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
14007794|NCT02856542|Calcipotriene|calcipotriene|mesh-list
14007795|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14007796|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007797|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
14007798|NCT02856542|Hormones|hormones|mesh-ancestor
14007799|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007800|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007801|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14007802|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
14007803|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
14007804|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
14007805|NCT02856425|Nintedanib|nintedanib|mesh-list
14007806|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007807|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007808|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14007809|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007810|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007811|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14007812|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007813|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14007814|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
14007815|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14007816|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
14007817|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14007818|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007819|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14007820|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14007821|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007822|NCT02856230|Paclitaxel|paclitaxel|mesh-list
14007823|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14007824|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007825|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14007826|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14007827|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007828|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007829|NCT02856126|Sorafenib|sorafenib|mesh-list
14007830|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007831|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14007832|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007833|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007834|NCT02856087|Remifentanil|remifentanil|mesh-list
14007835|NCT02856087|Naloxone|naloxone|mesh-list
14007836|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14007837|NCT02856087|Narcotics|narcotics|mesh-ancestor
14007838|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007839|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007840|NCT02856087|Analgesics|analgesics|mesh-ancestor
14007841|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
14007842|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007843|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15137818|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15137819|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137820|NCT04324411|Sirolimus|sirolimus|mesh-list
15137821|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15137822|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137823|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15137824|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137825|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
14007844|NCT02855632|Hormones|hormones|mesh-list
14007845|NCT02855632|Progesterone|progesterone|mesh-list
14007846|NCT02855632|Sargramostim|sargramostim|mesh-list
14007847|NCT02855632|Lenograstim|lenograstim|mesh-list
14007848|NCT02855632|Estrogens|estrogens|mesh-list
14007849|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007850|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007851|NCT02855632|Progestins|progestins|mesh-ancestor
14007852|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
14007853|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14007854|NCT02855684|Insulin|insulin|mesh-list
15137826|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137827|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
15137828|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137829|NCT04324346|Paclitaxel|paclitaxel|mesh-list
15137830|NCT04324346|Docetaxel|docetaxel|mesh-list
15137831|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15137832|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007855|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14007856|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
14007857|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14007858|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007859|NCT02855866|Acetaminophen|acetaminophen|mesh-list
14007860|NCT02855866|Dexamethasone|dexamethasone|mesh-list
14007861|NCT02855866|Cortisone|cortisone|mesh-list
14007862|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
14007863|NCT02855866|BB 1101|bb 1101|mesh-list
14007864|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007865|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
14007866|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
14271251|NCT00414661|Tofacitinib|tofacitinib|mesh-list
15137833|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
15137834|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137835|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137836|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137837|NCT04324229|Liraglutide|liraglutide|mesh-list
15137838|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15137839|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137840|NCT04324229|Incretins|incretins|mesh-ancestor
15137841|NCT04324229|Hormones|hormones|mesh-ancestor
15137842|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137843|NCT04324307|Gemcitabine|gemcitabine|mesh-list
15137844|NCT04324307|Paclitaxel|paclitaxel|mesh-list
14007867|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007868|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007869|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14007870|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
14007871|NCT02855866|Hormones|hormones|mesh-ancestor
14007872|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007873|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14007874|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007875|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14007876|NCT02855866|Analgesics|analgesics|mesh-ancestor
14007877|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
15137845|NCT04324307|Fluorouracil|fluorouracil|mesh-list
15137846|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
15137847|NCT04324307|Irinotecan|irinotecan|mesh-list
14007878|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
14007879|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
14007880|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007881|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007882|NCT02855788|Leucovorin|leucovorin|mesh-list
14007883|NCT02855788|Paclitaxel|paclitaxel|mesh-list
14007884|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
14007885|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14007886|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007887|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
14007888|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
14007889|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007890|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007891|NCT02855788|Antidotes|antidotes|mesh-ancestor
14007892|NCT02855788|Protective Agents|protective agents|mesh-ancestor
14007893|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007894|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
14007895|NCT02855788|Vitamins|vitamins|mesh-ancestor
14007896|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
14007897|NCT02855502|Prednisolone|prednisolone|mesh-list
14007898|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007899|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
14007900|NCT02855502|Hormones|hormones|mesh-ancestor
14007901|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007902|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007903|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14007904|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024638|NCT02754765|Levofloxacin|levofloxacin|mesh-list
14024639|NCT02754765|Ofloxacin|ofloxacin|mesh-list
14024640|NCT02754765|Linezolid|linezolid|mesh-list
14024641|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
14024642|NCT02754765|Bedaquiline|bedaquiline|mesh-list
14024643|NCT02754765|Clofazimine|clofazimine|mesh-list
14024644|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024645|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024646|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14024647|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14024648|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024649|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024650|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024651|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14024652|NCT02754765|Renal Agents|renal agents|mesh-ancestor
14024653|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14024654|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14024655|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14024656|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
14024657|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024658|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
14024659|NCT02754817|Liraglutide|liraglutide|mesh-list
14024660|NCT02754817|Xultophy|xultophy|mesh-list
14024661|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14024662|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024663|NCT02754817|Incretins|incretins|mesh-ancestor
14024664|NCT02754817|Hormones|hormones|mesh-ancestor
14024665|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024666|NCT02754960|Thalidomide|thalidomide|mesh-list
14024667|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024668|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
14271252|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271253|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271254|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271255|NCT00414765|Aldesleukin|aldesleukin|mesh-list
14271256|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271257|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14271258|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14271259|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
14271260|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271261|NCT00414908|Pancrelipase|pancrelipase|mesh-list
14271262|NCT00414908|Pancreatin|pancreatin|mesh-list
14271263|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271264|NCT00414973|Teriparatide|teriparatide|mesh-list
14271265|NCT00414973|Calcitonin|calcitonin|mesh-list
14271266|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
14271267|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14271268|NCT00414973|Katacalcin|katacalcin|mesh-list
14271269|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14024669|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024670|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
15137848|NCT04324307|Folfirinox|folfirinox|mesh-list
15137849|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15137850|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137851|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
14007905|NCT02855515|Anesthetics|anesthetics|mesh-list
14007906|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007907|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137852|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
15137853|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
14007908|NCT02855346|Dapivirine|dapivirine|mesh-list
14007909|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
14007910|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14007911|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
14007912|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14007913|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007914|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14007915|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14007916|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14007917|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14007918|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14007919|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
14007920|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14007921|NCT02855307|Insulin|insulin|mesh-list
14007922|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14007923|NCT02855307|Hormones|hormones|mesh-list
14007924|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14007925|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007926|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007927|NCT02855294|Drospirenone|drospirenone|mesh-list
14007928|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14007929|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
14007930|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007931|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007932|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14007933|NCT02855294|Diuretics|diuretics|mesh-ancestor
14007934|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
14007935|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
14007936|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14007937|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14007938|NCT02855138|Isotretinoin|isotretinoin|mesh-list
14007939|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
14007940|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
14007941|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14007942|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
14007943|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007944|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
14007945|NCT02855073|Protective Agents|protective agents|mesh-ancestor
14007946|NCT02854995|Triamcinolone|triamcinolone|mesh-list
14007947|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14007948|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
14007949|NCT02854995|Hormones|hormones|mesh-ancestor
14007950|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14007951|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007952|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
14007953|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14007954|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14007955|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007956|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14007957|NCT02854904|Analgesics|analgesics|mesh-ancestor
14007958|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
14007959|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007960|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14007961|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14007962|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14007963|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
14007964|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14007965|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007966|NCT02854670|Capsaicin|capsaicin|mesh-list
14007967|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
14007968|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14007969|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
14007970|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14007971|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137854|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007972|NCT02854761|Vitamin D|vitamin d|mesh-list
14007973|NCT02854761|Vitamins|vitamins|mesh-ancestor
14007974|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
14007975|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007976|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14007977|NCT02854748|Empagliflozin|empagliflozin|mesh-list
14007978|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14007979|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007980|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14007981|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007982|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14007983|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15137855|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15137856|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
15137857|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
15137858|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137859|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14007984|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14007985|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14007986|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
14007987|NCT02854722|Vitamin D|vitamin d|mesh-list
14007988|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
14007989|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
14007990|NCT02854722|Vitamins|vitamins|mesh-list
14007991|NCT02854722|Calcium|calcium|mesh-list
14007992|NCT02854722|Deferasirox|deferasirox|mesh-list
14007993|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
14007994|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14007995|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14007996|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14007997|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14007998|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
14007999|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
14008000|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008001|NCT02854696|Insulin|insulin|mesh-list
14008002|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008003|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008004|NCT02854787|Phenylephrine|phenylephrine|mesh-list
14008005|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
14008006|NCT02854787|Norepinephrine|norepinephrine|mesh-list
14008007|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14008008|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
14008009|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
14008010|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008011|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008012|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
14008013|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14008014|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
14008015|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
14008016|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14008017|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14008018|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14008019|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
14008020|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008021|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008022|NCT02854787|Protective Agents|protective agents|mesh-ancestor
14008023|NCT02854241|Liver Extracts|liver extracts|mesh-list
14008024|NCT02854241|Hematinics|hematinics|mesh-ancestor
14008025|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
14008026|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14008027|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008028|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
14008029|NCT02853864|Propofol|propofol|mesh-list
14008030|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14008031|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008032|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008033|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14008034|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
14008035|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
14008036|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14008037|NCT02853864|Analgesics|analgesics|mesh-ancestor
14008038|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
14008039|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008040|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14008041|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14008042|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14008043|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
14008044|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008045|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008046|NCT02854072|Gemcitabine|gemcitabine|mesh-list
14008047|NCT02854072|Capecitabine|capecitabine|mesh-list
14008048|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14008049|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
14008050|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008051|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008052|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
14008053|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008054|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008055|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14008056|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
14008057|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024671|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024672|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024673|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14024674|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14024675|NCT02754960|Growth Substances|growth substances|mesh-ancestor
14024676|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
14024677|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024678|NCT02755064|Erythromycin|erythromycin|mesh-list
14024679|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
14024680|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14024681|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
14024682|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
14024683|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024684|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024685|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024686|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14024687|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024688|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024689|NCT02754726|Gemcitabine|gemcitabine|mesh-list
14024690|NCT02754726|Paclitaxel|paclitaxel|mesh-list
14024691|NCT02754726|Nivolumab|nivolumab|mesh-list
14024692|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14024693|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14024694|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024695|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
14024696|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
14024697|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
14024698|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271270|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137860|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137861|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
15137862|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137863|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15137864|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15137865|NCT04324476|Bevacizumab|bevacizumab|mesh-list
15137866|NCT04324476|Capecitabine|capecitabine|mesh-list
15137867|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
15137868|NCT04324476|Irinotecan|irinotecan|mesh-list
15137869|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15137870|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137871|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15137872|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15137873|NCT04324476|Growth Substances|growth substances|mesh-ancestor
15137874|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024699|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14024700|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
14024701|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
14024702|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024703|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024704|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024705|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
14024706|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024707|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024708|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14024709|NCT02754739|Pravastatin|pravastatin|mesh-list
14024710|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14024711|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14024712|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
14024713|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024714|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15137875|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
14008058|NCT02853799|Insulin|insulin|mesh-list
15137876|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15137877|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
15137878|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008059|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008060|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008061|NCT02853630|Metformin|metformin|mesh-list
14008062|NCT02853630|Vildagliptin|vildagliptin|mesh-list
14008063|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008064|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008065|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14008066|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
14008067|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008068|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008069|NCT02853539|Denosumab|denosumab|mesh-list
14008070|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14008071|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008072|NCT02853526|Propranolol|propranolol|mesh-list
14008073|NCT02853526|Warfarin|warfarin|mesh-list
14008074|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
14008075|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14008076|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14008077|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
14008078|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008079|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008080|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008081|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14008082|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14008083|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
14008084|NCT02853552|Misoprostol|misoprostol|mesh-list
14008085|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14008086|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
14008087|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14008088|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008089|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14008090|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008091|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
14008092|NCT02853253|SMOFlipid|smoflipid|mesh-list
14008093|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14008094|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14008095|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14008096|NCT02853370|Rituximab|rituximab|mesh-list
14008097|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14008098|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14008099|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008100|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
14008101|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008102|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008103|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14008104|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
14008105|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008106|NCT02853578|Budesonide|budesonide|mesh-list
14008107|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008108|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14008109|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
14008110|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008111|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008112|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14008113|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
14008114|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
14008115|NCT02853578|Hormones|hormones|mesh-ancestor
14008116|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008117|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
14008118|NCT02853136|BI 409306|bi 409306|mesh-list
14008119|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14008120|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14008121|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008122|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008123|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14008124|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15137879|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15137880|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14008125|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14292431|NCT00560833|Mirtazapine|mirtazapine|mesh-list
14008126|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14008127|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008128|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008129|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
14008130|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14008131|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
14008132|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14008133|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14008134|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008135|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14008136|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14008137|NCT02853071|Estramustine|estramustine|mesh-list
14008138|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14008139|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
14008140|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008141|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008142|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14008143|NCT02852837|Daratumumab|daratumumab|mesh-list
14008144|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008145|NCT02852798|Docetaxel|docetaxel|mesh-list
14008146|NCT02852798|Apatinib|apatinib|mesh-list
14008147|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008148|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14008149|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14008150|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14008151|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008152|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14008153|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008154|NCT02852681|Drospirenone|drospirenone|mesh-list
14008155|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14008156|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
14008157|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008158|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008159|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14008160|NCT02852681|Diuretics|diuretics|mesh-ancestor
14008161|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
14008162|NCT02852694|Adalimumab|adalimumab|mesh-list
14008163|NCT02852694|Methotrexate|methotrexate|mesh-list
14008164|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
14008165|NCT02852694|Azathioprine|azathioprine|mesh-list
14008166|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14008167|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
14008168|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14008169|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008170|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14008171|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
15137881|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137882|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
14008172|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008173|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008174|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
14008175|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008176|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14008177|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14008178|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
14008179|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008180|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14008181|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008182|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
14008183|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14008184|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008185|NCT02852720|Anesthetics|anesthetics|mesh-list
14008186|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
14008187|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008188|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008189|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008190|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
15137883|NCT04324086|Calcium|calcium|mesh-list
14008191|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008192|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
14008193|NCT02852564|Diuretics|diuretics|mesh-ancestor
14008194|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
14008195|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008196|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026238|NCT02744378|Tacrolimus|tacrolimus|mesh-list
14008197|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008198|NCT02852577|Clonazepam|clonazepam|mesh-list
14008199|NCT02852577|Paroxetine|paroxetine|mesh-list
14008200|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14008201|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14008202|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14008203|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008204|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008205|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
14008206|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008207|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14008208|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
14008209|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14008210|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14008211|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14008212|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008213|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
14008214|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
14008215|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
14008216|NCT02852486|Pioglitazone|pioglitazone|mesh-list
14008217|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
14008218|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008219|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008220|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008221|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271271|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14271272|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
15137884|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15137885|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137886|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15179134|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15179135|NCT03952650|Analgesics|analgesics|mesh-ancestor
15179136|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
15179137|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179138|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271273|NCT00415168|Pemetrexed|pemetrexed|mesh-list
14271274|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271275|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271276|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271277|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14271278|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14271279|NCT00415194|Pemetrexed|pemetrexed|mesh-list
14271280|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271281|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271282|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271283|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14271284|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14271285|NCT00415506|Rituximab|rituximab|mesh-list
14271286|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271287|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271288|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
14271289|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271290|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271291|NCT00415519|Edaravone|edaravone|mesh-list
14271292|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14271293|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
14271294|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271295|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14271296|NCT00415519|Protective Agents|protective agents|mesh-ancestor
14271297|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271298|NCT00415597|Naltrexone|naltrexone|mesh-list
14271299|NCT00415597|Morphine|morphine|mesh-list
14271300|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14271301|NCT00415597|Narcotics|narcotics|mesh-ancestor
14271302|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271303|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271304|NCT00415597|Analgesics|analgesics|mesh-ancestor
14271305|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
14271306|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271307|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14271308|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14271309|NCT00415610|Nicardipine|nicardipine|mesh-list
14271310|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14271311|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14008222|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008223|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024715|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14024716|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024717|NCT02754583|Azithromycin|azithromycin|mesh-list
14024718|NCT02754583|Tetracycline|tetracycline|mesh-list
14024719|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024720|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024721|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14024722|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024723|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024724|NCT02754596|Timolol|timolol|mesh-list
15137887|NCT04324060|Danazol|danazol|mesh-list
15137888|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15137889|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
14024725|NCT02754596|Travoprost|travoprost|mesh-list
14024726|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14024727|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14024728|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14024729|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14024730|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14024731|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024732|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024733|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024734|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14024735|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14024736|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
14024737|NCT02754687|Nandrolone|nandrolone|mesh-list
14024738|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
14024739|NCT02754687|Androgens|androgens|mesh-ancestor
14024740|NCT02754687|Hormones|hormones|mesh-ancestor
14024741|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024742|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024743|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
14024744|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14024745|NCT02754362|Bevacizumab|bevacizumab|mesh-list
14024746|NCT02754362|Poly ICLC|poly iclc|mesh-list
14024747|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14024748|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14024749|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024750|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137890|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137891|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137892|NCT04324294|Pancrelipase|pancrelipase|mesh-list
15137893|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137894|NCT04323748|Rituximab|rituximab|mesh-list
15137895|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15137896|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137897|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
15137898|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024751|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14024752|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14024753|NCT02754362|Growth Substances|growth substances|mesh-ancestor
14024754|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024755|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
14024756|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
14024757|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
14024758|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14024759|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14024760|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024761|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
14024762|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14024763|NCT02754102|Protective Agents|protective agents|mesh-ancestor
14024764|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024765|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
14024766|NCT02754258|Methylphenidate|methylphenidate|mesh-list
14024767|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14024768|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024769|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14024770|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14024771|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271312|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15137899|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137900|NCT04323956|Prednisone|prednisone|mesh-list
15137901|NCT04323956|Cortisone|cortisone|mesh-list
15137902|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
15137903|NCT04323956|Rituximab|rituximab|mesh-list
15137904|NCT04323956|Doxorubicin|doxorubicin|mesh-list
15137905|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15137906|NCT04323956|Vincristine|vincristine|mesh-list
14008224|NCT02852083|Pioglitazone|pioglitazone|mesh-list
14008225|NCT02852083|Clarithromycin|clarithromycin|mesh-list
14008226|NCT02852083|Nivolumab|nivolumab|mesh-list
14008227|NCT02852083|Treosulfan|treosulfan|mesh-list
14008228|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14008229|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008230|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14008231|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008232|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008233|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008234|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14008235|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008236|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14008237|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008238|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14008239|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14008240|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14008241|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
14008242|NCT02852239|Dabrafenib|dabrafenib|mesh-list
14008243|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008244|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14008245|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008246|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008247|NCT02852122|Choline|choline|mesh-list
14008248|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
14008249|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14008250|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
14008251|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008252|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008253|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14008254|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
14008255|NCT02852382|Morphine|morphine|mesh-list
14008256|NCT02852382|Bupivacaine|bupivacaine|mesh-list
14008257|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008258|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
14008259|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008260|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008261|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
14008262|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008263|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14008264|NCT02852382|Narcotics|narcotics|mesh-ancestor
14008265|NCT02852382|Analgesics|analgesics|mesh-ancestor
14008266|NCT02851888|Ropivacaine|ropivacaine|mesh-list
14008267|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
14008268|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008269|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008270|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008271|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
14008272|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008273|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
14008274|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14008275|NCT02851914|Serotonin|serotonin|mesh-list
14008276|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14008277|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14008278|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14008279|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
14008280|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008281|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008282|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008283|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14008284|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14008285|NCT02851745|Linagliptin|linagliptin|mesh-list
14008286|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008287|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008288|NCT02851745|Incretins|incretins|mesh-ancestor
14008289|NCT02851745|Hormones|hormones|mesh-ancestor
14008290|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008291|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14008292|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
14008293|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008294|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008295|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
14008296|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14008297|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
14008298|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008299|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008300|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14008301|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
14008302|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14008303|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
15137907|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15137908|NCT04323956|Antibodies|antibodies|mesh-list
15137909|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
15137910|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15137911|NCT04323956|Lenograstim|lenograstim|mesh-list
15137912|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137913|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
14008304|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008305|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008306|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14008307|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
14008308|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
14008309|NCT02851472|Protective Agents|protective agents|mesh-ancestor
14008310|NCT02851459|Vaccines|vaccines|mesh-list
14008311|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
14008312|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008313|NCT02851433|Anesthetics|anesthetics|mesh-list
14008314|NCT02851433|Propofol|propofol|mesh-list
14008315|NCT02851433|Sevoflurane|sevoflurane|mesh-list
14008316|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008317|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008318|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14008319|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14008320|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
14008321|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14008322|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14008323|NCT02851095|Metformin|metformin|mesh-list
14008324|NCT02851095|Canagliflozin|canagliflozin|mesh-list
14008325|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008326|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008327|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14008328|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008329|NCT02851394|Tramadol|tramadol|mesh-list
14008330|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
14008331|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14811459|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14811460|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
14811461|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
14811462|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811463|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137914|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137915|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137916|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15137917|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
15137918|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137919|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008332|NCT02851394|Narcotics|narcotics|mesh-ancestor
14008333|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811464|NCT00845754|Ketorolac|ketorolac|mesh-list
14811465|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14811466|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14811467|NCT00845754|Analgesics|analgesics|mesh-ancestor
14811468|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
14811469|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008334|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008335|NCT02851394|Analgesics|analgesics|mesh-ancestor
14008336|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
14008337|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008338|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008339|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
14008340|NCT02851303|Morphine|morphine|mesh-list
14008341|NCT02851303|Methadone|methadone|mesh-list
15137920|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14008342|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14008343|NCT02851303|Narcotics|narcotics|mesh-ancestor
15137921|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14811470|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811471|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811472|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811473|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14811474|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811475|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008344|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008345|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008346|NCT02851303|Analgesics|analgesics|mesh-ancestor
14008347|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
14008348|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008349|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
14008350|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
14008351|NCT02851212|Metformin|metformin|mesh-list
14008352|NCT02851212|Canagliflozin|canagliflozin|mesh-list
14008353|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008354|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008355|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14008356|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008357|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
14008358|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14008359|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008360|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
15137922|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15137923|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15137924|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15137925|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137926|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
15137927|NCT04323956|Hormones|hormones|mesh-ancestor
15137928|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15137929|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15137930|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14008361|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
14008362|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14008363|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14008364|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008365|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008366|NCT02850718|Urological Agents|urological agents|mesh-ancestor
14008367|NCT02850744|Temozolomide|temozolomide|mesh-list
14008368|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14008369|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
14008370|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008371|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008372|NCT02850887|Anesthetics|anesthetics|mesh-list
14008373|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008374|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024772|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024773|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
14024774|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024775|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
14024776|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14024777|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14024778|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024779|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024780|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15137931|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15137932|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
14024781|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
14024782|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
14024783|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024784|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024785|NCT02753803|Pioglitazone|pioglitazone|mesh-list
14024786|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14024787|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024788|NCT02754154|Warfarin|warfarin|mesh-list
14024789|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
14024790|NCT02754154|Dabigatran|dabigatran|mesh-list
14024791|NCT02754154|Apixaban|apixaban|mesh-list
14024792|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
14811476|NCT00845780|Amiodarone|amiodarone|mesh-list
15137933|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
14024793|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14008375|NCT02850913|Doxycycline|doxycycline|mesh-list
14008376|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14008377|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008378|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
14008379|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14008380|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14008381|NCT02850848|Entecavir|entecavir|mesh-list
14008382|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
14008383|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562008|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562009|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562010|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562011|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562012|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562013|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562014|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562015|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562016|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562017|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562018|NCT00002823|Etoposide|etoposide|mesh-list
14008395|NCT02850250|Cefuroxime|cefuroxime|mesh-list
14008396|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
14008397|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14008398|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008399|NCT02850445|Olanzapine|olanzapine|mesh-list
14008400|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
14008401|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
14008402|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008403|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008404|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15137934|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
15137935|NCT04323566|Rituximab|rituximab|mesh-list
15137936|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15137937|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137938|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
15137939|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137940|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008405|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14008406|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14008407|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008408|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14008409|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14008410|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14008411|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14008412|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008413|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008414|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
14008415|NCT02850211|Ibuprofen|ibuprofen|mesh-list
14008416|NCT02850211|Celecoxib|celecoxib|mesh-list
14008417|NCT02850211|Tramadol|tramadol|mesh-list
15137941|NCT04323761|Remdesivir|remdesivir|mesh-list
15137942|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
14008418|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14008419|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14008420|NCT02850211|Analgesics|analgesics|mesh-ancestor
14008421|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
14008422|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008423|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008424|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008425|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008426|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14008427|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008428|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008429|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14008430|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14811477|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14811478|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
14811479|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14811480|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811481|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811482|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15137943|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008431|NCT02850211|Narcotics|narcotics|mesh-ancestor
14008432|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008433|NCT02850289|Interferons|interferons|mesh-list
14008434|NCT02850289|Ribavirin|ribavirin|mesh-list
14562019|NCT00002823|Vinorelbine|vinorelbine|mesh-list
14008435|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008436|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
14008437|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008438|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
14008439|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008440|NCT02850484|Budesonide|budesonide|mesh-list
14008441|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
14008442|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008443|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14008444|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
15137944|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
15137945|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137946|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
15137947|NCT04323657|Fludarabine|fludarabine|mesh-list
15137948|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15137949|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
15137950|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137951|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137952|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15137953|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
15137954|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137955|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137956|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15137957|NCT04323527|Chloroquine|chloroquine|mesh-list
15137958|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15137959|NCT04323527|Amebicides|amebicides|mesh-ancestor
15137960|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15137961|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137962|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137963|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
15137964|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137965|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15137966|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15137967|NCT04323527|Analgesics|analgesics|mesh-ancestor
15137968|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
15137969|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15137970|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137971|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137972|NCT04323527|Filaricides|filaricides|mesh-ancestor
15137973|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
15137974|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
15137975|NCT04323514|Ascorbic Acid|ascorbic acid|mesh-list
15137976|NCT04323514|Vitamins|vitamins|mesh-ancestor
15137977|NCT04323514|Micronutrients|micronutrients|mesh-ancestor
15137978|NCT04323514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15137979|NCT04323514|Antioxidants|antioxidants|mesh-ancestor
15137980|NCT04323514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137981|NCT04323514|Protective Agents|protective agents|mesh-ancestor
14008445|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271313|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271314|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14271315|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271316|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
14271317|NCT00415636|Pemetrexed|pemetrexed|mesh-list
14271318|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271319|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271320|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271321|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14271322|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14271323|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14271324|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
14271325|NCT00415857|Vaccines|vaccines|mesh-list
14271326|NCT00415857|Sargramostim|sargramostim|mesh-list
14271327|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
14271328|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271329|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271330|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271331|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271332|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271333|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
14271334|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137982|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
15137983|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
14271335|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
14271336|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137984|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14008446|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008447|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14008448|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
14008449|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
14008450|NCT02850484|Hormones|hormones|mesh-ancestor
14008451|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008452|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14008453|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14008454|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14008455|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
14008456|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008457|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008458|NCT02850081|Atorvastatin|atorvastatin|mesh-list
14008459|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14008460|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14008461|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14008462|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
14008463|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137985|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15137986|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15137987|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008464|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14008465|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008466|NCT02849873|Tazarotene|tazarotene|mesh-list
14008467|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
14008468|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
14008469|NCT02850016|Romidepsin|romidepsin|mesh-list
14008470|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14008471|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14008472|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008473|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008474|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008475|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
15137988|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137989|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15137990|NCT04322955|Nivolumab|nivolumab|mesh-list
15137991|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15137992|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15137993|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15137994|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15137995|NCT04323280|Dexamethasone|dexamethasone|mesh-list
15137996|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15137997|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
15137998|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
15137999|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138000|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138001|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138002|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
15138003|NCT04323280|Hormones|hormones|mesh-ancestor
15138004|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138005|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138006|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138007|NCT04323228|Antioxidants|antioxidants|mesh-list
15138008|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138009|NCT04323228|Protective Agents|protective agents|mesh-ancestor
15138010|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008476|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14008477|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14008478|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008479|NCT02849899|Vildagliptin|vildagliptin|mesh-list
14008480|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008481|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008482|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14008483|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14008484|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008485|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008486|NCT02849743|Oxytocin|oxytocin|mesh-list
14008487|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
14008488|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14008489|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008490|NCT02849483|Ramosetron|ramosetron|mesh-list
14008491|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
14008492|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
15138011|NCT04322760|Lidocaine|lidocaine|mesh-list
15138012|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
15138013|NCT04322760|Bupivacaine|bupivacaine|mesh-list
15138014|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
14271337|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271338|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271339|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271340|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14271341|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14271342|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271343|NCT00416494|Bevacizumab|bevacizumab|mesh-list
14271344|NCT00416494|Capecitabine|capecitabine|mesh-list
14008493|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008494|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008495|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008496|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14008497|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
14008498|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008499|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008500|NCT02849730|Fentanyl|fentanyl|mesh-list
14008501|NCT02849730|Analgesics|analgesics|mesh-list
14008502|NCT02849730|Ropivacaine|ropivacaine|mesh-list
14008503|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008504|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
14008505|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008506|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008507|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
14008508|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008509|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14008510|NCT02849730|Narcotics|narcotics|mesh-ancestor
14008511|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14008512|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14008513|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
14008514|NCT02849457|Vigabatrin|vigabatrin|mesh-list
14008515|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
14008516|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008517|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008518|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
14008519|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008520|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008521|NCT02849470|Complement Factor H|complement factor h|mesh-list
14008522|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14008523|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14008524|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
14008525|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008526|NCT02849548|Suvorexant|suvorexant|mesh-list
14008527|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14008528|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14008529|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008530|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008531|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14008532|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008533|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024794|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
14024795|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14024796|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14024797|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024798|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024799|NCT02753855|Telavancin|telavancin|mesh-list
14024800|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024801|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024802|NCT02754180|Gemcitabine|gemcitabine|mesh-list
14024803|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14024804|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
14024805|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024806|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024807|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
14024808|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024809|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024810|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024811|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
14024812|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024813|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14024814|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14271345|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
15138015|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
14008534|NCT02849236|Ropivacaine|ropivacaine|mesh-list
14008535|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008536|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
14008537|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008538|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008539|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
14008540|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008541|NCT02848963|Ketamine|ketamine|mesh-list
14008542|NCT02848963|Propofol|propofol|mesh-list
14008543|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14008544|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138016|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138017|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138018|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
14008545|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008546|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14008547|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
14008548|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
14008549|NCT02848963|Analgesics|analgesics|mesh-ancestor
14008550|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
14008551|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008552|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14008553|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14008554|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14008555|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008556|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008557|NCT02848937|Citric Acid|citric acid|mesh-list
14008558|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
14008559|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
14008560|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14008561|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
14008562|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
14008563|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008564|NCT02848950|Metformin|metformin|mesh-list
14008565|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008566|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008567|NCT02849132|Entecavir|entecavir|mesh-list
14008568|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
14008569|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008570|NCT02849171|Choline|choline|mesh-list
14008571|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
14008572|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14008573|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
14008574|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008575|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008576|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14008577|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
14008578|NCT02848612|Heparin|heparin|mesh-list
14008579|NCT02848612|Calcium heparin|calcium heparin|mesh-list
15138019|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138020|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15138021|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14008580|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
14008581|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14008582|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14008583|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008584|NCT02848794|Irinotecan|irinotecan|mesh-list
14008585|NCT02848794|Apatinib|apatinib|mesh-list
14008586|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14008587|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14008588|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008589|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008590|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008591|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14008592|NCT02848820|Amoxicillin|amoxicillin|mesh-list
14008593|NCT02848820|Gentamicins|gentamicins|mesh-list
14008594|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14008595|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
14008596|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
14008597|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14008598|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008599|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14008600|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008601|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008602|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14008603|NCT02848560|Xenon|xenon|mesh-list
14008604|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14008605|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
14008606|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
14008607|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008608|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008609|NCT02848768|Sunitinib|sunitinib|mesh-list
14008610|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008611|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14008612|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14008613|NCT02848768|Growth Substances|growth substances|mesh-ancestor
14008614|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008615|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
14008616|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15138022|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15138023|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15138024|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008617|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008618|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008619|NCT02848508|Metformin|metformin|mesh-list
14008620|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008621|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008622|NCT02848443|Trifluridine|trifluridine|mesh-list
14008623|NCT02848443|Bevacizumab|bevacizumab|mesh-list
14008624|NCT02848443|Nivolumab|nivolumab|mesh-list
14008625|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
14008626|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14008627|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008628|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14008629|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14008630|NCT02848443|Growth Substances|growth substances|mesh-ancestor
14008631|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008632|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
14008633|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14008634|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008635|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
14008636|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
14008637|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008638|NCT02848183|Cytarabine|cytarabine|mesh-list
14008639|NCT02848183|Etoposide|etoposide|mesh-list
14008640|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
14008641|NCT02848183|Idarubicin|idarubicin|mesh-list
14008642|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14008643|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008644|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14008645|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14008646|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008647|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008648|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14008649|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
14008650|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
14008651|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008652|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14008653|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
14008654|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008655|NCT02848183|Analgesics|analgesics|mesh-ancestor
14008656|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
14008657|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008658|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14008659|NCT02848417|Curcumin|curcumin|mesh-list
14008660|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14008661|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14008662|NCT02848417|Analgesics|analgesics|mesh-ancestor
14008663|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
14008664|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008665|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008666|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008667|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008668|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008669|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008670|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008671|NCT02848209|Phenol|phenol|mesh-list
14008672|NCT02848209|Croton Oil|croton oil|mesh-list
14008673|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15138025|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14008674|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008675|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
14008676|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14008677|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14008678|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
14008679|NCT02848300|Bimatoprost|bimatoprost|mesh-list
14008680|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14008681|NCT02848131|Dasatinib|dasatinib|mesh-list
14008682|NCT02848131|Quercetin|quercetin|mesh-list
14008683|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008684|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14008685|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008686|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008687|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
14008688|NCT02848131|Protective Agents|protective agents|mesh-ancestor
14008689|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008690|NCT02848170|Olmesartan|olmesartan|mesh-list
14008691|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14008692|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14008693|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14008694|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14008695|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008696|NCT02848339|Aspirin|aspirin|mesh-list
14008697|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14008698|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14008699|NCT02848339|Analgesics|analgesics|mesh-ancestor
14008700|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
14008701|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008702|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008703|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008704|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008705|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14008706|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14008707|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008708|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14008709|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14008710|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008711|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
14008712|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
14008713|NCT02848157|Ropivacaine|ropivacaine|mesh-list
14271346|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271347|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271348|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14271349|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14271350|NCT00416494|Growth Substances|growth substances|mesh-ancestor
14271351|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271352|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
14271353|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271354|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
14271355|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271356|NCT00416520|Sevelamer|sevelamer|mesh-list
14271357|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
15138026|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138027|NCT04322760|Analgesics|analgesics|mesh-ancestor
15138028|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15138029|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15138030|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15138031|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
15138032|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138033|NCT04322565|Colchicine|colchicine|mesh-list
15138034|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
15138035|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138036|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
15138037|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
15138038|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
15138039|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138040|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008714|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14008715|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008716|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008717|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14008718|NCT02848157|Analgesics|analgesics|mesh-ancestor
14008719|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
15138041|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
15138042|NCT04322643|Nivolumab|nivolumab|mesh-list
14271358|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
14562020|NCT00002823|Vinblastine|vinblastine|mesh-list
15138043|NCT04322643|Durvalumab|durvalumab|mesh-list
14008720|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138044|NCT04322643|Avelumab|avelumab|mesh-list
15138045|NCT04322643|Atezolizumab|atezolizumab|mesh-list
14008721|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14008722|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14008723|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14008724|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14008725|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008726|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008727|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008728|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
14008729|NCT02848287|Ropivacaine|ropivacaine|mesh-list
14008730|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008731|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
14008732|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008733|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008734|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
14008735|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008736|NCT02847884|Infliximab|infliximab|mesh-list
14008737|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14008738|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008739|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008740|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
14008741|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008742|NCT02847806|Insulin|insulin|mesh-list
14008743|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14008744|NCT02847806|Estradiol|estradiol|mesh-list
14008745|NCT02847806|Testosterone|testosterone|mesh-list
14008746|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008747|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008748|NCT02847806|Estrogens|estrogens|mesh-ancestor
14008749|NCT02847806|Hormones|hormones|mesh-ancestor
14008750|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008751|NCT02847806|Androgens|androgens|mesh-ancestor
14024815|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024816|NCT02753725|Fentanyl|fentanyl|mesh-list
14024817|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14024818|NCT02753725|Narcotics|narcotics|mesh-ancestor
14024819|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024820|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024821|NCT02753725|Analgesics|analgesics|mesh-ancestor
14024822|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
15138046|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15138047|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138048|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15138049|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138050|NCT04322552|Apatinib|apatinib|mesh-list
15138051|NCT04322552|Digoxin|digoxin|mesh-list
15138052|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138053|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15138054|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138055|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138056|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15138057|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15138058|NCT04322552|Protective Agents|protective agents|mesh-ancestor
15138059|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024823|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024824|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14024825|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15138060|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15138061|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
15138062|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138063|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024826|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
14024827|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
14024828|NCT02753764|Prednisone|prednisone|mesh-list
14024829|NCT02753764|AZD7624|azd7624|mesh-list
14024830|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024831|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
14024832|NCT02753764|Hormones|hormones|mesh-ancestor
14024833|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024834|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024835|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14024836|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024837|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14024838|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138064|NCT04322422|Montelukast|montelukast|mesh-list
15138065|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14008752|NCT02847702|Naproxen|naproxen|mesh-list
14008753|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14008754|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14008755|NCT02847702|Analgesics|analgesics|mesh-ancestor
14008756|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
14008757|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008758|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008759|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008760|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008761|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
14008762|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14008763|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008764|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008765|NCT02847442|Levodopa|levodopa|mesh-list
14008766|NCT02847442|Opicapone|opicapone|mesh-list
14008767|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
14008768|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
14008769|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14008770|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14008771|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
14008772|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008773|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008774|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008775|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14008776|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008777|NCT02847455|Rabeprazole|rabeprazole|mesh-list
15138066|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
15138067|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15138068|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
14008778|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14008779|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008780|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14008781|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008782|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008783|NCT02847429|Crenolanib|crenolanib|mesh-list
14008784|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008785|NCT02847403|Exenatide|exenatide|mesh-list
14008786|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008787|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008788|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14008789|NCT02847403|Incretins|incretins|mesh-ancestor
14008790|NCT02847403|Hormones|hormones|mesh-ancestor
14008791|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008792|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14008793|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14008794|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008795|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
14008796|NCT02847338|Amlodipine|amlodipine|mesh-list
14008797|NCT02847338|Lisinopril|lisinopril|mesh-list
14008798|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
14008799|NCT02847338|Amiloride|amiloride|mesh-list
14008800|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14008801|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14008802|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14008803|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008804|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14008805|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008806|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
15138069|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138070|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138071|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15138072|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15138073|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138074|NCT04322175|Meloxicam|meloxicam|mesh-list
15138075|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15138076|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138077|NCT04322175|Analgesics|analgesics|mesh-ancestor
15138078|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
15138079|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008807|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14008808|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
14008809|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008810|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14008811|NCT02847338|Protective Agents|protective agents|mesh-ancestor
14008812|NCT02847338|Diuretics|diuretics|mesh-ancestor
14008813|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
14008814|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14008815|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14008816|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14008817|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14008818|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14008819|NCT02847104|Insulin|insulin|mesh-list
15138080|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138081|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138082|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138083|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14271359|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271360|NCT00416598|Cytarabine|cytarabine|mesh-list
14271361|NCT00416598|Etoposide|etoposide|mesh-list
15138084|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15138085|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138086|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138087|NCT04322214|Cobicistat|cobicistat|mesh-list
15138088|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15138089|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15138090|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
15138091|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138092|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14008820|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14008821|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008822|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008823|NCT02847013|Bupivacaine|bupivacaine|mesh-list
14008824|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
14008825|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
14008826|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008827|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008828|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
14008829|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008830|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
14008831|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008832|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008833|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14008834|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008835|NCT02846909|Progesterone|progesterone|mesh-list
14008836|NCT02846909|Progestins|progestins|mesh-ancestor
14008837|NCT02846909|Hormones|hormones|mesh-ancestor
14008838|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008839|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008840|NCT02846935|Decitabine|decitabine|mesh-list
15138093|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15138094|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138095|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138096|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
15138097|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
15138098|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138099|NCT04322240|Protective Agents|protective agents|mesh-ancestor
15138100|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138101|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
15138102|NCT04322240|Vitamins|vitamins|mesh-ancestor
15138103|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
15179139|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008841|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
14008842|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14008843|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
14008844|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008845|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008846|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008847|NCT02847286|Dapivirine|dapivirine|mesh-list
14008848|NCT02847286|Clotrimazole|clotrimazole|mesh-list
14008849|NCT02847286|Miconazole|miconazole|mesh-list
14008850|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14008851|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14008852|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
14008853|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271362|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
14008854|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15138104|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
15138105|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
15138106|NCT04321785|Caffeine|caffeine|mesh-list
14008855|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
14008856|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15138107|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15138108|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138109|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15138110|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138111|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138112|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15138113|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15138114|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
15138115|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138116|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
15138117|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138118|NCT04321655|Ibuprofen|ibuprofen|mesh-list
15138119|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15138120|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138121|NCT04321655|Analgesics|analgesics|mesh-ancestor
15138122|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
15138123|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138124|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138125|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138126|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138127|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15138128|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138129|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138130|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
15138131|NCT04321642|Entonox|entonox|mesh-list
15138132|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15138133|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
15138134|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138135|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138136|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15138137|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
15138138|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138139|NCT04321642|Analgesics|analgesics|mesh-ancestor
15138140|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
15138141|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138142|NCT04321850|Zinc|zinc|mesh-list
14008857|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14008858|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008859|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008860|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14008861|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
14008862|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008863|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138143|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
15138144|NCT04321850|Trace Elements|trace elements|mesh-ancestor
15138145|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
15138146|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138147|NCT04321850|Astringents|astringents|mesh-ancestor
15138148|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
15138149|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
15138150|NCT04321616|Remdesivir|remdesivir|mesh-list
15138151|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
15138152|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15138153|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15138154|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138155|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138156|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138157|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138158|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
14008864|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14008865|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14008866|NCT02847000|Decitabine|decitabine|mesh-list
14008867|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
14008868|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14008869|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
14008870|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138159|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
15138160|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
15138161|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
15138162|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138163|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15138164|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138165|NCT04321837|Vitamin D|vitamin d|mesh-list
15138166|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
15138167|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
15138168|NCT04321837|Vitamins|vitamins|mesh-ancestor
15138169|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
15138170|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008871|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008872|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008873|NCT02847143|Oxytocin|oxytocin|mesh-list
14008874|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
14008875|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14008876|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008877|NCT02846857|Insulin|insulin|mesh-list
14008878|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14008879|NCT02846857|Glucagon|glucagon|mesh-list
14008880|NCT02846857|Hormones|hormones|mesh-list
14008881|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008882|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008883|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008884|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14008885|NCT02846623|Atezolizumab|atezolizumab|mesh-list
14008886|NCT02846623|Venetoclax|venetoclax|mesh-list
14008887|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
14008888|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14008889|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008890|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
14008891|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008892|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14008893|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14008894|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14008895|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14008896|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14008897|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008898|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008899|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008900|NCT02846701|Analgesics|analgesics|mesh-ancestor
14008901|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
14008902|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008903|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
15138171|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15138172|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15138173|NCT04321551|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15138174|NCT04321551|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15138175|NCT04321551|Hormones|hormones|mesh-list
15138176|NCT04321551|Estradiol|estradiol|mesh-list
15138177|NCT04321551|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14008904|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14008905|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
14008906|NCT02846831|Insulin|insulin|mesh-list
14008907|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14008908|NCT02846831|Hormones|hormones|mesh-list
14008909|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008910|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008911|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008912|NCT02846766|Lenvatinib|lenvatinib|mesh-list
14008913|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008914|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14008915|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008916|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008917|NCT02846493|Dexamethasone|dexamethasone|mesh-list
14008918|NCT02846493|Bromocriptine|bromocriptine|mesh-list
14008919|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14008920|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
14008921|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
14008922|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14008923|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008924|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138178|NCT04321551|Progesterone|progesterone|mesh-list
15138179|NCT04321551|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15138180|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138181|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008925|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
15138182|NCT04321551|Estrogens|estrogens|mesh-ancestor
15138183|NCT04321551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15138184|NCT04321551|Contraceptive Agents|contraceptive agents|mesh-ancestor
14008926|NCT02846493|Hormones|hormones|mesh-ancestor
14008927|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14008928|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14008929|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008930|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14008931|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14008932|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
15138185|NCT04321551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15138186|NCT04321551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15138187|NCT04321551|Progestins|progestins|mesh-ancestor
15138188|NCT04321746|Ketamine|ketamine|mesh-list
15138189|NCT04321746|Analgesics|analgesics|mesh-ancestor
15138190|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
14008933|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
14008934|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
14008935|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14008936|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008937|NCT02846519|Rifampin|rifampin|mesh-list
14008938|NCT02846519|Esketamine|esketamine|mesh-list
14008939|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14008940|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
14008941|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14008942|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14008943|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
14008944|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14008945|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008946|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008947|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14008948|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14008949|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14008950|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14008951|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14008952|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14008953|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
14008954|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14008955|NCT02846506|Metformin|metformin|mesh-list
14008956|NCT02846506|Canagliflozin|canagliflozin|mesh-list
14008957|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14008958|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008959|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14008960|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008961|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
14008962|NCT02846428|Docetaxel|docetaxel|mesh-list
14008963|NCT02846428|Fluorouracil|fluorouracil|mesh-list
14008964|NCT02846428|Capecitabine|capecitabine|mesh-list
14008965|NCT02846428|Epirubicin|epirubicin|mesh-list
14008966|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14008967|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
14008968|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008969|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14008970|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14008971|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
14008972|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008973|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008974|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14008975|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14008976|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
15138191|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138192|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008977|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14008978|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
14008979|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14008980|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14008981|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14008982|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14008983|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14008984|NCT02846376|Nivolumab|nivolumab|mesh-list
14008985|NCT02846376|Ipilimumab|ipilimumab|mesh-list
14008986|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14008987|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14008988|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15138193|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14008989|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008990|NCT02846155|Simethicone|simethicone|mesh-list
14008991|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
14008992|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14008993|NCT02846155|Emollients|emollients|mesh-ancestor
15138194|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15138195|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
15138196|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
14008994|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
14008995|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
14008996|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14008997|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14008998|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14008999|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009000|NCT02846090|Analgesics|analgesics|mesh-ancestor
14009001|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
14009002|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009003|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14009004|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14009005|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009006|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009007|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009008|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009009|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
14009010|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14009011|NCT02846142|Estradiol|estradiol|mesh-list
14009012|NCT02846142|Estrogens|estrogens|mesh-ancestor
14009013|NCT02846142|Hormones|hormones|mesh-ancestor
14009014|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009015|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009016|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14009017|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
14009018|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14009019|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14009020|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14009021|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14009022|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14024839|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024840|NCT02753738|Citalopram|citalopram|mesh-list
14024841|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14024842|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14024843|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14024844|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024845|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024846|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
14024847|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024848|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14024849|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
14024850|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14024851|NCT02753686|Tamoxifen|tamoxifen|mesh-list
14024852|NCT02753686|Everolimus|everolimus|mesh-list
14024853|NCT02753686|Letrozole|letrozole|mesh-list
14024854|NCT02753686|Fulvestrant|fulvestrant|mesh-list
14024855|NCT02753686|Anastrozole|anastrozole|mesh-list
14024856|NCT02753686|Exemestane|exemestane|mesh-list
14024857|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024858|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024859|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
14024860|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024861|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14024862|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14024863|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024864|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024865|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14024866|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
14024867|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14024868|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14024869|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14024870|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14024871|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14271363|NCT00416598|Daunorubicin|daunorubicin|mesh-list
14271364|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
15138197|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009023|NCT02846025|Folic Acid|folic acid|mesh-list
14009024|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
14009025|NCT02846025|Antioxidants|antioxidants|mesh-list
14009026|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009027|NCT02846025|Protective Agents|protective agents|mesh-ancestor
14271365|NCT00416598|Busulfan|busulfan|mesh-list
14271366|NCT00416598|Decitabine|decitabine|mesh-list
14271367|NCT00416598|Lenograstim|lenograstim|mesh-list
14271368|NCT00416598|Sargramostim|sargramostim|mesh-list
14271369|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14271370|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271371|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14271372|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14271373|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271374|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271375|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271376|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
14271377|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
14271378|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271379|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271380|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
14271381|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271382|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14271383|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
14271384|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14271385|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14271386|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14271387|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
14271388|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14271389|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
14271390|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14271391|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
14271392|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
14271393|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
14271394|NCT00416624|Hematinics|hematinics|mesh-ancestor
14271395|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
14271396|NCT00416715|Vitamin D|vitamin d|mesh-list
14271397|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
14271398|NCT00416715|Letrozole|letrozole|mesh-list
14271399|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
14271400|NCT00416715|Citric Acid|citric acid|mesh-list
14271401|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
14271402|NCT00416715|Calcium|calcium|mesh-list
14271403|NCT00416715|Vitamins|vitamins|mesh-ancestor
14271404|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
14271405|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271406|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14271407|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14271408|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
14271409|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14271410|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
14271411|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
14271412|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271413|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138198|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15138199|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15138200|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138201|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271414|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14271415|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14271416|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271417|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14271418|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
14271419|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271420|NCT00416715|Antacids|antacids|mesh-ancestor
14271421|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271422|NCT00416793|Carboplatin|carboplatin|mesh-list
14271423|NCT00416793|Bortezomib|bortezomib|mesh-list
14271424|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271425|NCT00416884|Fludarabine|fludarabine|mesh-list
15138202|NCT04321408|Ziconotide|ziconotide|mesh-list
14271426|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
14271427|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009028|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009029|NCT02846025|Hematinics|hematinics|mesh-ancestor
14009030|NCT02846025|Vitamins|vitamins|mesh-ancestor
14009031|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
14009032|NCT02845804|Everolimus|everolimus|mesh-list
14009033|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009034|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14009035|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
14009036|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009037|NCT02845856|Cetuximab|cetuximab|mesh-list
14009038|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009039|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009040|NCT02845843|Interferons|interferons|mesh-list
14009041|NCT02845843|Ritonavir|ritonavir|mesh-list
14009042|NCT02845843|Lopinavir|lopinavir|mesh-list
14009043|NCT02845843|Interferon-beta|interferon-beta|mesh-list
14009044|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
14009045|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009046|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
14009047|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009048|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14009049|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14009050|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
14009051|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009052|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009053|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14009054|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14009055|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14009056|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14009057|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
14009058|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009059|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14009060|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
14009061|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14009062|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009063|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009064|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009065|NCT02845661|Analgesics|analgesics|mesh-ancestor
14009066|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
14009067|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009068|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14009069|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14009070|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009071|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009072|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009073|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009074|NCT02845908|Leucovorin|leucovorin|mesh-list
14009075|NCT02845908|Fluorouracil|fluorouracil|mesh-list
14009076|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
14009077|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
14009078|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009079|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14009080|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009081|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14009082|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
14009083|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009084|NCT02845908|Antidotes|antidotes|mesh-ancestor
14009085|NCT02845908|Protective Agents|protective agents|mesh-ancestor
14009086|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
14009087|NCT02845908|Vitamins|vitamins|mesh-ancestor
14009088|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
14009089|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
14009090|NCT02845999|Fludarabine|fludarabine|mesh-list
14009091|NCT02845999|Cetuximab|cetuximab|mesh-list
14009092|NCT02845999|Interleukin-2|interleukin-2|mesh-list
14009093|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14009094|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
14009095|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009096|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14009097|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14009098|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
14009099|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009100|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009101|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14009102|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15138203|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15138204|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15138205|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138206|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14009103|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009104|NCT02845999|Analgesics|analgesics|mesh-ancestor
14009105|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
14009106|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009107|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14009108|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
15138207|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138208|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15138209|NCT04321408|Protective Agents|protective agents|mesh-ancestor
15138210|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009109|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009110|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009111|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009112|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
14009113|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009114|NCT02845778|Melatonin|melatonin|mesh-list
14009115|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
14009116|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009117|NCT02845778|Protective Agents|protective agents|mesh-ancestor
14009118|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009119|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009120|NCT02845713|Ivermectin|ivermectin|mesh-list
14009121|NCT02845713|Albendazole|albendazole|mesh-list
14009122|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
14009123|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14009124|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009125|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
14009126|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
14009127|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14009128|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14009129|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
14009130|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
14009131|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
14009132|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009133|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009134|NCT02845713|Filaricides|filaricides|mesh-ancestor
14009135|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
14009136|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14009137|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009138|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14009139|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14009140|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009141|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009142|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14009143|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14009144|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009145|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
14009146|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14009147|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14009148|NCT02845388|Estradiol|estradiol|mesh-list
14009149|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14009150|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009151|NCT02845388|Estrogens|estrogens|mesh-ancestor
14009152|NCT02845388|Hormones|hormones|mesh-ancestor
14009153|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009154|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009155|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14009156|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
14009157|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14009158|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14009159|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
14009160|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14009161|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14009162|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009163|NCT02845388|Urological Agents|urological agents|mesh-ancestor
14009164|NCT02845466|Becaplermin|becaplermin|mesh-list
14009165|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
14009166|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14009167|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14009168|NCT02845466|Growth Substances|growth substances|mesh-ancestor
14009169|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009170|NCT02845349|Vortioxetine|vortioxetine|mesh-list
14009171|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
14009172|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15138211|NCT04321408|Analgesics|analgesics|mesh-ancestor
15138212|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
14009173|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15138213|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138214|NCT04321278|Azithromycin|azithromycin|mesh-list
15138215|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
15138216|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14009174|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14009175|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009176|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009177|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14009178|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14009179|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14009180|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009181|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009182|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
14009183|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14009184|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14009185|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14009186|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14009187|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14009188|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14009189|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14009190|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
14009191|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14009192|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009193|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14009194|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14009195|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14009196|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14009197|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14009198|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14009199|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14009200|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14009201|NCT02845024|Doxycycline|doxycycline|mesh-list
14009202|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14009203|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009204|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
14811483|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14811484|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14811485|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811486|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14811487|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14811488|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14811489|NCT00845819|Iodine|iodine|mesh-list
14811490|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
14811491|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14811492|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
14811493|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
14811494|NCT00845819|Nystatin|nystatin|mesh-list
14009205|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14009206|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14009207|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
14009208|NCT02844894|Esmolol|esmolol|mesh-list
14009209|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14009210|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009211|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009212|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009213|NCT02844894|Analgesics|analgesics|mesh-ancestor
14009214|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
14009215|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009216|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14009217|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14009218|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009219|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009220|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009221|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009222|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14009223|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14009224|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14009225|NCT02844790|Insulin|insulin|mesh-list
14009226|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
14009227|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15138217|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138218|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
14009228|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009229|NCT02844933|Cannabidiol|cannabidiol|mesh-list
14009230|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
14009231|NCT02844881|Apatinib|apatinib|mesh-list
14009232|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009233|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14009234|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009235|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009236|NCT02844712|beta-Lactams|beta-lactams|mesh-list
14009237|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14009238|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009239|NCT02845050|Cisplatin|cisplatin|mesh-list
14009240|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009241|NCT02844621|Omeprazole|omeprazole|mesh-list
14009242|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15138219|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15138220|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15138221|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138222|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138223|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138224|NCT04321070|Clindamycin|clindamycin|mesh-list
15138225|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
15138226|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
14009243|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14009244|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14009245|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009246|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009247|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
14009248|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009249|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
14009250|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009251|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009252|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14009253|NCT02844803|Metformin|metformin|mesh-list
14009254|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14009255|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009256|NCT02844530|Epratuzumab|epratuzumab|mesh-list
14009257|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14009258|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009259|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009260|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
14009261|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
14009262|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009263|NCT02844517|Pancrelipase|pancrelipase|mesh-list
14009264|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14024872|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14024873|NCT02753712|Fluticasone|fluticasone|mesh-list
14024874|NCT02753712|Xhance|xhance|mesh-list
14024875|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
14024876|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024877|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14024878|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
14024879|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024880|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024881|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14024882|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
14024883|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
14024884|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14024885|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14024886|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14024887|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14024888|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
14024889|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024890|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024891|NCT02753647|Prednisone|prednisone|mesh-list
14024892|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
14024893|NCT02753647|Rituximab|rituximab|mesh-list
14024894|NCT02753647|Doxorubicin|doxorubicin|mesh-list
14024895|NCT02753647|Vincristine|vincristine|mesh-list
14024896|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024897|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
14024898|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024899|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14024900|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14024901|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
14024902|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138227|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15138228|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138229|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15138230|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138231|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138232|NCT04321096|Camostat|camostat|mesh-list
15138233|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
15138234|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009265|NCT02844634|Tenofovir|tenofovir|mesh-list
14009266|NCT02844634|Emtricitabine|emtricitabine|mesh-list
14009267|NCT02844634|Doxycycline|doxycycline|mesh-list
14009268|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
14009269|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009270|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14009271|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14009272|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009273|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271428|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271429|NCT00417079|Prednisone|prednisone|mesh-list
14271430|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
14271431|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271432|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
14271433|NCT00417079|Hormones|hormones|mesh-ancestor
14271434|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271435|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271436|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14271437|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271438|NCT00417079|Analgesics|analgesics|mesh-ancestor
14271439|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
14271440|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271441|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14271442|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14271443|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271444|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271445|NCT00417170|Amlodipine|amlodipine|mesh-list
14271446|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14271447|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14271448|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271449|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271450|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14271451|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271452|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
14271453|NCT00417274|Quinacrine|quinacrine|mesh-list
14271454|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
14271455|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14271456|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
14271457|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14271458|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271459|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
14271460|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14271461|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
14271462|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271463|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271464|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138235|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138236|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15138237|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15138238|NCT04320914|Ibuprofen|ibuprofen|mesh-list
15138239|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15138240|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138241|NCT04320914|Analgesics|analgesics|mesh-ancestor
15138242|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
15138243|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138244|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138245|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138246|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138247|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15138248|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271465|NCT00417417|Rilonacept|rilonacept|mesh-list
14271466|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271467|NCT00417482|Risperidone|risperidone|mesh-list
15138249|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138250|NCT04320706|Oxytocin|oxytocin|mesh-list
15138251|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
14009274|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14009275|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14009276|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14009277|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
14009278|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14009279|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14009280|NCT02844153|Metformin|metformin|mesh-list
14009281|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14009282|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009283|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14009284|NCT02844322|Rituximab|rituximab|mesh-list
14009285|NCT02844322|Bortezomib|bortezomib|mesh-list
14009286|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009287|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009288|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
14009289|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009290|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14009291|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
14009292|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009293|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009294|NCT02844309|Thalidomide|thalidomide|mesh-list
14009295|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14009296|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
14009297|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009298|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
14009299|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14009300|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009301|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14009302|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14009303|NCT02844309|Growth Substances|growth substances|mesh-ancestor
14009304|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
14009305|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009306|NCT05242926|Docetaxel|docetaxel|mesh-list
14009307|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009308|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
14009309|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
14009310|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
14009311|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009312|NCT05242783|Terlipressin|terlipressin|mesh-list
14009313|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14009314|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14009315|NCT05242718|Palmidrol|palmidrol|mesh-list
14009316|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
14009317|NCT05242718|Curcumin|curcumin|mesh-list
14009318|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14009319|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14009320|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009321|NCT05242718|Analgesics|analgesics|mesh-ancestor
14009322|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
14009323|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009324|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009325|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14009326|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14009327|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009328|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009329|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009330|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
14009331|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009332|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14009333|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14009334|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009335|NCT05242718|Hormones|hormones|mesh-ancestor
14009336|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009337|NCT05242718|Expectorants|expectorants|mesh-ancestor
14009338|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
14009339|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14009340|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
14009341|NCT05242718|Protective Agents|protective agents|mesh-ancestor
14009342|NCT05242718|Antidotes|antidotes|mesh-ancestor
15138252|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14009345|NCT05242419|Huperzine A|huperzine a|mesh-list
14009346|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14009347|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009348|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009349|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
14009350|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009351|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138253|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138254|NCT04320745|Testosterone|testosterone|mesh-list
15138255|NCT04320745|Androgens|androgens|mesh-ancestor
15138256|NCT04320745|Hormones|hormones|mesh-ancestor
15138257|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138258|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138259|NCT04320602|Eculizumab|eculizumab|mesh-list
15138260|NCT04320602|Ravulizumab|ravulizumab|mesh-list
15138261|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15138262|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15138263|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
14009352|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14009353|NCT05242419|Protective Agents|protective agents|mesh-ancestor
14009354|NCT05242133|Interferons|interferons|mesh-list
14009355|NCT05242133|Interferon-beta|interferon-beta|mesh-list
14009356|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
14009357|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009358|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
14009359|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009360|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
14009361|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009362|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14009363|NCT05242120|Anesthetics|anesthetics|mesh-list
14009364|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009365|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009366|NCT05242081|Fentanyl|fentanyl|mesh-list
14009367|NCT05242081|Ketamine|ketamine|mesh-list
14009368|NCT05242081|Esketamine|esketamine|mesh-list
14009369|NCT05242081|Analgesics|analgesics|mesh-ancestor
14009370|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
14009371|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009372|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009373|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14009374|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14009375|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
14009376|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
14009377|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009378|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14009379|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14009380|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009381|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009382|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14009383|NCT05242081|Narcotics|narcotics|mesh-ancestor
14009384|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14009385|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
14009386|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14009387|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14009388|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14009389|NCT05241912|Dobutamine|dobutamine|mesh-list
14009390|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15138264|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138265|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
15138266|NCT04320589|Anesthetics|anesthetics|mesh-list
15138267|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
15138268|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14009391|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
14009392|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
14009393|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009394|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009395|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14009396|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14009397|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009398|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009399|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009400|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009401|NCT05241912|Protective Agents|protective agents|mesh-ancestor
14009402|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14009403|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14009404|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024903|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024904|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14024905|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024906|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562021|NCT00002823|Vindesine|vindesine|mesh-list
15138269|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138270|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009405|NCT05239182|Gemcitabine|gemcitabine|mesh-list
14009406|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14009407|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14009408|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
14009409|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009410|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009411|NCT05239182|Antiviral Agents|antiviral agents|mesh-ancestor
14009412|NCT05239182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009413|NCT05239182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009414|NCT05239182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14009415|NCT05239182|Immunologic Factors|immunologic factors|mesh-ancestor
15138271|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138272|NCT04320589|Analgesics|analgesics|mesh-ancestor
15138273|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
15138274|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138275|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14009416|NCT05239182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009417|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
14009418|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14009419|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009420|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14009421|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009422|NCT05201547|Paclitaxel|paclitaxel|mesh-list
14009423|NCT05201547|Carboplatin|carboplatin|mesh-list
14009424|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14009425|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009426|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
14009427|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
14009428|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
14009429|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009430|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
14009431|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009432|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009433|NCT05168462|Norepinephrine|norepinephrine|mesh-list
14009434|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14009435|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009436|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009437|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009438|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009439|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009440|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
14009441|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
14009442|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009443|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14009444|NCT05150236|Nivolumab|nivolumab|mesh-list
14009445|NCT05150236|Ipilimumab|ipilimumab|mesh-list
14009446|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
14009447|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009448|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009449|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14009450|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009451|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14009452|NCT05135104|Palbociclib|palbociclib|mesh-list
14009453|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009454|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14009455|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009456|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009457|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
14009458|NCT05114421|Lenvatinib|lenvatinib|mesh-list
14009459|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009460|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009461|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14009462|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009463|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009464|NCT05109052|Bevacizumab|bevacizumab|mesh-list
14009465|NCT05109052|Atezolizumab|atezolizumab|mesh-list
14009466|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009467|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009468|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14009469|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14009470|NCT05109052|Growth Substances|growth substances|mesh-ancestor
14271468|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14271469|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
14271470|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009471|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009472|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
14009473|NCT05104047|Lobeline|lobeline|mesh-list
14009474|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14009475|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
14009476|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009477|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009478|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14009479|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14009480|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
14009481|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138276|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15138277|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15138278|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
15138279|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138280|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138281|NCT04320238|Interferons|interferons|mesh-list
15138282|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
15138283|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
15138284|NCT04320238|Thymalfasin|thymalfasin|mesh-list
15138285|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138286|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
15138287|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138288|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
15138289|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138290|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15138291|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
15138292|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009482|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009483|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14009484|NCT05083754|Temozolomide|temozolomide|mesh-list
14009485|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14009486|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
14009487|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009488|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009489|NCT05078502|Vitamin D|vitamin d|mesh-list
14009490|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
14009491|NCT05078502|Vitamins|vitamins|mesh-ancestor
14009492|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
14009493|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009494|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14009495|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14009496|NCT05040880|Telmisartan|telmisartan|mesh-list
14009497|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14009498|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14009499|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14009500|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271471|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138293|NCT04320277|Ritonavir|ritonavir|mesh-list
15138294|NCT04320277|Lopinavir|lopinavir|mesh-list
15138295|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15138296|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15138297|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
15138298|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138299|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138300|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15138301|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14271472|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271473|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14271474|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14271475|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271476|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14009508|NCT05007509|Vaccines|vaccines|mesh-list
14009509|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
14009510|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009511|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14009512|NCT04985760|Vaccines|vaccines|mesh-list
14009513|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
14009514|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
14009515|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009516|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14009517|NCT04985760|Antacids|antacids|mesh-ancestor
14009518|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009519|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14009520|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
14009521|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14009522|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009523|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
14009524|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14009525|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
14009526|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14009527|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
14009528|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009529|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009530|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
14009531|NCT04954365|Amisulpride|amisulpride|mesh-list
14009532|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14009533|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14009534|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009535|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009536|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14009537|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14009538|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
14009539|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009540|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009541|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14009542|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
14009543|NCT04947527|Fluorides|fluorides|mesh-list
14009544|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
14009545|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
14009546|NCT04947527|Protective Agents|protective agents|mesh-ancestor
14009547|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009548|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
14009549|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009550|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024907|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14024908|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14024909|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14024910|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14024911|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
14024912|NCT02753647|Hormones|hormones|mesh-ancestor
14024913|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138302|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
15138303|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138304|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15138305|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14024914|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14024915|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14024916|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
14024917|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
14024918|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
14024919|NCT02753426|Doxycycline|doxycycline|mesh-list
14024920|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024921|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179140|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179141|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15179142|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179143|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179144|NCT03952650|Amebicides|amebicides|mesh-ancestor
14024922|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
14024923|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14024924|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14026239|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026240|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
14026241|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026242|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14026243|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026244|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179145|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15179146|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15179147|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179148|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
15179149|NCT03952650|Filaricides|filaricides|mesh-ancestor
15179150|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
15179151|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
14026245|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14026246|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
14271477|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15179152|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14026247|NCT02744378|Hormones|hormones|mesh-ancestor
15179153|NCT03952572|Prednisone|prednisone|mesh-list
14009551|NCT04930900|Epinephrine|epinephrine|mesh-list
14009552|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14009553|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009554|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009555|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009556|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009557|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138306|NCT04320225|Dexamethasone|dexamethasone|mesh-list
15138307|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138308|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
15138309|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
14009558|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14009559|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14009560|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
14009561|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009562|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14009563|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
14009564|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
14009565|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
14009566|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14009567|NCT04918810|Docetaxel|docetaxel|mesh-list
14009568|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009569|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14009570|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14009571|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14009572|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009573|NCT04905446|Niacinamide|niacinamide|mesh-list
14009574|NCT04905446|Niacin|niacin|mesh-list
14009575|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
14009576|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
14009577|NCT04905446|Vitamins|vitamins|mesh-ancestor
14009578|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
14009579|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009580|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14009581|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
14009582|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009583|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14009584|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
14009585|NCT04887402|Clomiphene|clomiphene|mesh-list
14009586|NCT04887402|Enclomiphene|enclomiphene|mesh-list
14009587|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
14009588|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14009589|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
14009590|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009591|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009592|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14009593|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
14009594|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14009595|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14009596|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14009607|NCT04793568|Interferons|interferons|mesh-list
14009608|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
14009609|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009610|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
14009611|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009612|NCT04793490|Acetaminophen|acetaminophen|mesh-list
14009613|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009614|NCT04793490|Analgesics|analgesics|mesh-ancestor
14009615|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
14009616|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009617|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138310|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138311|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009618|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
14009619|NCT04782700|Prednisone|prednisone|mesh-list
14009620|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14009621|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
14009622|NCT04782700|Hormones|hormones|mesh-ancestor
15138312|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138313|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
15138314|NCT04320225|Hormones|hormones|mesh-ancestor
15138315|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138316|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138317|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138318|NCT04319978|Dexamethasone|dexamethasone|mesh-list
15138319|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
15138320|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138321|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
14009623|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009624|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009625|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14009626|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009627|NCT04760782|Abaloparatide|abaloparatide|mesh-list
14009628|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14009629|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009630|NCT04750005|Listerine|listerine|mesh-list
14009631|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14009632|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009633|NCT04748783|Listerine|listerine|mesh-list
14009634|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
14009635|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14009636|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14009637|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
14009638|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
14009639|NCT04748783|Protective Agents|protective agents|mesh-ancestor
14009640|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009641|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14009642|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009643|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
14009644|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
14009645|NCT04739384|Ticagrelor|ticagrelor|mesh-list
14009646|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14009647|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14009648|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14009649|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14009650|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
14009651|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009652|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009653|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009654|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14009655|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
14009656|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009657|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14009658|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
14009659|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009660|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14009661|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271478|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
14271479|NCT00417885|Sunitinib|sunitinib|mesh-list
14271480|NCT00417885|Exemestane|exemestane|mesh-list
14271481|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009666|NCT04646967|Acetaminophen|acetaminophen|mesh-list
14009667|NCT04646967|Ibuprofen|ibuprofen|mesh-list
14009668|NCT04646967|Ketorolac|ketorolac|mesh-list
14009669|NCT04646967|Bupivacaine|bupivacaine|mesh-list
14009670|NCT04646967|Sevoflurane|sevoflurane|mesh-list
14009671|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
14009672|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
14009673|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009674|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009675|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
14009676|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009677|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009678|NCT04646967|Analgesics|analgesics|mesh-ancestor
14009679|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
14009680|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14009681|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14009682|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14009683|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14009684|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009685|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009686|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14009687|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14009688|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
14009689|NCT04646655|Enoxaparin|enoxaparin|mesh-list
14009690|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
14009691|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14009692|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14009693|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009694|NCT04646356|Tacrolimus|tacrolimus|mesh-list
14009695|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14009696|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
14009697|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271482|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14009698|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14009699|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009700|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009701|NCT04635241|Heparin|heparin|mesh-list
14009702|NCT04635241|Calcium heparin|calcium heparin|mesh-list
14009703|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
14009704|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14009705|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14009706|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009707|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
14009708|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14009709|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009710|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009711|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009712|NCT04628663|Analgesics|analgesics|mesh-ancestor
14009713|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
15138322|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
15138323|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138324|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138325|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138326|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
15138327|NCT04319978|Hormones|hormones|mesh-ancestor
15138328|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138329|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138330|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138331|NCT04320173|Lidocaine|lidocaine|mesh-list
15138332|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138333|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
15138334|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138335|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138336|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
15138337|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138338|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15138339|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15138340|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15138341|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15138342|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138343|NCT04319926|Lidocaine|lidocaine|mesh-list
15138344|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138345|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
15138346|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138347|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138348|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
15138349|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138350|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15138351|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15138352|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15138353|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14009714|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009715|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14009716|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14009717|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009718|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009719|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009720|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009721|NCT04616560|Trastuzumab|trastuzumab|mesh-list
14009722|NCT04616560|Camptothecin|camptothecin|mesh-list
14009723|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
14009724|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009725|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009726|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14009727|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15138354|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009728|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14009729|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138355|NCT04319900|Chloroquine|chloroquine|mesh-list
15138356|NCT04319900|Favipiravir|favipiravir|mesh-list
15138357|NCT04319900|Amebicides|amebicides|mesh-ancestor
15138358|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15138359|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14009730|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009731|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
14009732|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138360|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138361|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
15138362|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138363|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
15138364|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
15138365|NCT04319757|Fludarabine|fludarabine|mesh-list
15138366|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15138367|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
15138368|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138369|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138370|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15138371|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
15138372|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138373|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138374|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15138375|NCT04319471|Capecitabine|capecitabine|mesh-list
15138376|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15138377|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
15138378|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138379|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138380|NCT04319588|Anesthetics|anesthetics|mesh-list
15138381|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
15138382|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138383|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138384|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
15138385|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138386|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
15138387|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15138388|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
15138389|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138390|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
15138391|NCT04319770|Protective Agents|protective agents|mesh-ancestor
15138392|NCT04319484|Lenvatinib|lenvatinib|mesh-list
15138393|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138394|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15138395|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138396|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138397|NCT04319601|Rituximab|rituximab|mesh-list
15138398|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15138399|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138400|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
15138401|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138402|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138403|NCT04319692|Acetic Acid|acetic acid|mesh-list
15138404|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15138405|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138406|NCT04319705|Azithromycin|azithromycin|mesh-list
15138407|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15138408|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138409|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
15138410|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15138411|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15138412|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138413|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
15138414|NCT04319614|Coagulants|coagulants|mesh-ancestor
15138415|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
15138416|NCT04319328|Cefazolin|cefazolin|mesh-list
15138417|NCT04319328|Ceftazidime|ceftazidime|mesh-list
15138418|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15138419|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138420|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15138421|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15138422|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138423|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138424|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138425|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15138426|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15138427|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15138428|NCT04319549|Eusol|eusol|mesh-list
14271483|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14271484|NCT00417885|Growth Substances|growth substances|mesh-ancestor
14271485|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138429|NCT04319549|Ketorolac|ketorolac|mesh-list
14009759|NCT04590404|Nicotine|nicotine|mesh-list
14009760|NCT04590404|Varenicline|varenicline|mesh-list
14009761|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15138430|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15138431|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15138432|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138433|NCT04319549|Analgesics|analgesics|mesh-ancestor
15138434|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
15138435|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138436|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138437|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138438|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138439|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15138440|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138441|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138442|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
15138443|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138444|NCT04319289|Vitamin D|vitamin d|mesh-list
15138445|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
15138446|NCT04319289|Vitamins|vitamins|mesh-list
15138447|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
15138448|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138449|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15138450|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15138451|NCT04319224|Nivolumab|nivolumab|mesh-list
15138452|NCT04319224|Ipilimumab|ipilimumab|mesh-list
15138453|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009762|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
14009763|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009764|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009765|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14009766|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14009767|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14009768|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009769|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009770|NCT04570176|Epinephrine|epinephrine|mesh-list
14009771|NCT04570176|Racepinephrine|racepinephrine|mesh-list
14009772|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
14009773|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14009774|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14009775|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009776|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009777|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009778|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009779|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14009780|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14009781|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
14009782|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009783|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14009784|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
14009785|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
14009786|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
14009787|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14009788|NCT04561362|Nivolumab|nivolumab|mesh-list
14009789|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009790|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009791|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14009792|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009793|NCT04553133|Letrozole|letrozole|mesh-list
14009794|NCT04553133|Fulvestrant|fulvestrant|mesh-list
14009795|NCT04553133|Palbociclib|palbociclib|mesh-list
14009796|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009797|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14009798|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14009799|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009800|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009801|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14009802|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
14009803|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009804|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009805|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14009806|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14009807|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14009808|NCT04545541|Heparin|heparin|mesh-list
15138454|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009809|NCT04545541|Calcium heparin|calcium heparin|mesh-list
15179154|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
15138455|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15138456|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138457|NCT04319419|Micronutrients|micronutrients|mesh-list
14009810|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
14009811|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14009812|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14009813|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009814|NCT04522167|Aflibercept|aflibercept|mesh-list
14009815|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14009816|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15138458|NCT04319419|Trace Elements|trace elements|mesh-list
14811495|NCT00845819|Povidone|povidone|mesh-list
14811496|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14811497|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811498|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
14811499|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
14811500|NCT00845819|Trace Elements|trace elements|mesh-ancestor
14811501|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
14811502|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811503|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
14811504|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
14009817|NCT04522167|Growth Substances|growth substances|mesh-ancestor
14009818|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009819|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14009820|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024925|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
14024926|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14024927|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024928|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
14024929|NCT02753309|Sirolimus|sirolimus|mesh-list
14024930|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14024931|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14024932|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14024933|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024934|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
14024935|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14024936|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
14024937|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024938|NCT02753283|Vitamin D|vitamin d|mesh-list
14024939|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
14024940|NCT02753283|Denosumab|denosumab|mesh-list
14024941|NCT02753283|Calcium|calcium|mesh-list
14024942|NCT02753283|Vitamins|vitamins|mesh-ancestor
14024943|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
14024944|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024945|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14024946|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14024947|NCT02753140|Docetaxel|docetaxel|mesh-list
14024948|NCT02753140|Cetuximab|cetuximab|mesh-list
14024949|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14024950|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14024951|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14024952|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14024953|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024954|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14024955|NCT02753114|Ketamine|ketamine|mesh-list
14024956|NCT02753114|Analgesics|analgesics|mesh-ancestor
14024957|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
14024958|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024959|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024960|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14024961|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14024962|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
14024963|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
14024964|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024965|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14024966|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14024967|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024968|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024969|NCT02753218|Midazolam|midazolam|mesh-list
14024970|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14024971|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14024972|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14024973|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024974|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14811505|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14811506|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
14562022|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562023|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562024|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562025|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562026|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562027|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562028|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562029|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562030|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562031|NCT00002824|Ganciclovir|ganciclovir|mesh-list
14562032|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14562033|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
14562034|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562035|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14009835|NCT04481308|Fentanyl|fentanyl|mesh-list
14009836|NCT04481308|Propofol|propofol|mesh-list
15138459|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138460|NCT04318847|Ondansetron|ondansetron|mesh-list
15138461|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
15138462|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
15138463|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138464|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138465|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138466|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
15138467|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
15138468|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15138469|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
15138470|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138471|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138472|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15138473|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15138474|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009837|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14009838|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009839|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009840|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14009841|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
14009842|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
14009843|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14009844|NCT04481308|Narcotics|narcotics|mesh-ancestor
14009845|NCT04481308|Analgesics|analgesics|mesh-ancestor
14009846|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
14009847|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009848|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14009849|NCT04475848|Midazolam|midazolam|mesh-list
14009850|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14009851|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14009852|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009853|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009854|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14009855|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14009856|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14009857|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14009858|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
14009859|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
14009860|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
14009861|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
14009862|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009863|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009864|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14009865|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14009866|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
14009867|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14009868|NCT04452565|Dexamethasone|dexamethasone|mesh-list
14009869|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
14009870|NCT04452565|BB 1101|bb 1101|mesh-list
14271486|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
14271487|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271488|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271489|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271490|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14271491|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14009871|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271492|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14009872|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
14271493|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
14009873|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
15138475|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15138476|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14009874|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009875|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009876|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14009877|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
14009878|NCT04452565|Hormones|hormones|mesh-ancestor
14009879|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009880|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14009881|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009882|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
14009883|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009884|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009885|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14009886|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14009887|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14009888|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14009889|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
14009890|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14009891|NCT04425018|Paclitaxel|paclitaxel|mesh-list
14009892|NCT04425018|Trastuzumab|trastuzumab|mesh-list
14009893|NCT04425018|Pertuzumab|pertuzumab|mesh-list
14009894|NCT04425018|Margetuximab|margetuximab|mesh-list
14009895|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14009896|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009897|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14009898|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14009899|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14009900|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009901|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14009902|NCT04410328|Aspirin|aspirin|mesh-list
14009903|NCT04410328|Dipyridamole|dipyridamole|mesh-list
14009904|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14009905|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14009906|NCT04410328|Analgesics|analgesics|mesh-ancestor
14009907|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
14009908|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009909|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009910|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14009911|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138477|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
15138478|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
15138479|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14009912|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14009913|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14009914|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009915|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14009916|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14009917|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138480|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15138481|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138482|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138483|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138484|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138485|NCT04318730|Apatinib|apatinib|mesh-list
15138486|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138487|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15138488|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138489|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138490|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
14009918|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
14009919|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14009920|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
14009921|NCT04400474|Atezolizumab|atezolizumab|mesh-list
14009922|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009923|NCT04393285|Letrozole|letrozole|mesh-list
14009924|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009925|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14009926|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14009927|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009928|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009929|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14009930|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
15138491|NCT04318678|Rituximab|rituximab|mesh-list
15138492|NCT04318678|Fludarabine|fludarabine|mesh-list
15138493|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14009931|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009932|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009933|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
15138494|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
15138495|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138496|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138497|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15138498|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
15138499|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138500|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138501|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15138502|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15138503|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
15138504|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15138505|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15138506|NCT04318652|Prednisolone|prednisolone|mesh-list
14009934|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14009935|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14009936|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009937|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009938|NCT04375787|Atorvastatin|atorvastatin|mesh-list
15138507|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
15138508|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15138509|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14009939|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14009940|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14009941|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
14009942|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009943|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14009944|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14009945|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14009946|NCT04355143|Colchicine|colchicine|mesh-list
14009947|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
14009948|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14009949|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
14009950|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
14009951|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
14009952|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009953|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009954|NCT04345796|Empagliflozin|empagliflozin|mesh-list
14009955|NCT04345796|Carvedilol|carvedilol|mesh-list
14009956|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14009957|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14009958|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15138510|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
15138511|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138512|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
15138513|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
15138514|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138515|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138516|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138517|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
15138518|NCT04318652|Hormones|hormones|mesh-ancestor
14009959|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009960|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14009961|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14009962|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
14009963|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14009964|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14009965|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
14009966|NCT04345796|Protective Agents|protective agents|mesh-ancestor
14009967|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14009968|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14009969|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14009970|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
15138519|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138520|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14009971|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14009972|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14009973|NCT04327063|Ropivacaine|ropivacaine|mesh-list
14009974|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
14009975|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
15138521|NCT04318652|Protective Agents|protective agents|mesh-ancestor
14009976|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009977|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009978|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
14009979|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009980|NCT04307576|Dexamethasone|dexamethasone|mesh-list
15138522|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138523|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138524|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15138525|NCT04318158|Fentanyl|fentanyl|mesh-list
15138526|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
15138527|NCT04318158|Bupivacaine|bupivacaine|mesh-list
15138528|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138529|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
15138530|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14009981|NCT04307576|Doxorubicin|doxorubicin|mesh-list
15138531|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138532|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
15138533|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138534|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15138535|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138536|NCT04318158|Analgesics|analgesics|mesh-ancestor
15138537|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15138538|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15138539|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15138540|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
15138541|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138542|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138543|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15138544|NCT04318158|Narcotics|narcotics|mesh-ancestor
15138545|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14009982|NCT04307576|Vincristine|vincristine|mesh-list
14009983|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
14009984|NCT04307576|Blinatumomab|blinatumomab|mesh-list
14009985|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14009986|NCT04307576|Thioguanine|thioguanine|mesh-list
14009987|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14009988|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
14009989|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
14009990|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14009991|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14009992|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14009993|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
14009994|NCT04307576|Hormones|hormones|mesh-ancestor
14009995|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14009996|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14009997|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14009998|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14009999|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14010000|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14010001|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010002|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010003|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14010004|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
14010005|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
14010006|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14010007|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14010008|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010009|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14010010|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
14010011|NCT04280601|Vitamin D|vitamin d|mesh-list
14010012|NCT04280601|Vitamins|vitamins|mesh-ancestor
14010013|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
14010014|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010015|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14010016|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
14010017|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
14010018|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010019|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
14010020|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010021|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010022|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14010023|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
14024975|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15138546|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15138547|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
15138548|NCT04318210|Tenofovir|tenofovir|mesh-list
14010024|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010025|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010026|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14010027|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010028|NCT04252612|Pramlintide|pramlintide|mesh-list
14010029|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14010030|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010031|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
14010032|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14010033|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010034|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14010035|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010036|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14010037|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14010038|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14010039|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14010040|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010041|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010042|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010043|NCT04224584|Analgesics|analgesics|mesh-ancestor
14010044|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
14010045|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010046|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14010047|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14010048|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
14010049|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
14010050|NCT04195568|Antacids|antacids|mesh-ancestor
14010051|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010052|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14010053|NCT04191421|Spartalizumab|spartalizumab|mesh-list
14010054|NCT04191421|Siltuximab|siltuximab|mesh-list
14010055|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14010056|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010057|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010058|NCT04139434|Azacitidine|azacitidine|mesh-list
14010059|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14010060|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
14010061|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010062|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010063|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010064|NCT04135937|Bupropion|bupropion|mesh-list
14010065|NCT04135937|Nicotine|nicotine|mesh-list
14010066|NCT04135937|Varenicline|varenicline|mesh-list
14010067|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14010068|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
14010069|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010070|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010071|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14010072|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14010073|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010074|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010075|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010076|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14010077|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
14010078|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14010079|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14010080|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14010081|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14010082|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
14010083|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14010084|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14010085|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010086|NCT04135495|Ivacaftor|ivacaftor|mesh-list
14010087|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14010088|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14010089|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010090|NCT04129437|Ibuprofen|ibuprofen|mesh-list
14010091|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14010092|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14010093|NCT04129437|Analgesics|analgesics|mesh-ancestor
14010094|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
14010095|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010096|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010097|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010098|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010099|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14010100|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010101|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010102|NCT04073290|Rifaximin|rifaximin|mesh-list
14010103|NCT04073290|Lactulose|lactulose|mesh-list
14010104|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14010105|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010106|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14010107|NCT04066348|Etanercept|etanercept|mesh-list
14010108|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14010109|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14010110|NCT04066348|Analgesics|analgesics|mesh-ancestor
14010111|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
14010112|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010113|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010114|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010115|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010116|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14010117|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010118|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
14010119|NCT03998488|Psyllium|psyllium|mesh-list
14010120|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
14010121|NCT03998488|Cathartics|cathartics|mesh-ancestor
14010122|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14010123|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
14010124|NCT03987685|Topotecan|topotecan|mesh-list
14010125|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14010126|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14010127|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010128|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010129|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010130|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
14010131|NCT03967223|Fludarabine|fludarabine|mesh-list
14010132|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15138549|NCT04318210|Emtricitabine|emtricitabine|mesh-list
15138550|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
15138551|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138552|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15138553|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15138554|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138555|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138556|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15138557|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15138558|NCT04318223|Palbociclib|palbociclib|mesh-list
15138559|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138560|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15138561|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138562|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179155|NCT03952572|Doxorubicin|doxorubicin|mesh-list
15179156|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15179157|NCT03952572|Vincristine|vincristine|mesh-list
15179158|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15179159|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
14010133|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
14010134|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010135|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010136|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14010137|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
14010138|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010139|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010140|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14024976|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14024977|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14024978|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
14024979|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
14024980|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
14024981|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
14024982|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024983|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024984|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
14024985|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14024986|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14562036|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010141|NCT03936790|Fentanyl|fentanyl|mesh-list
14010142|NCT03936790|Ropivacaine|ropivacaine|mesh-list
14010143|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
14010144|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
14010145|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14010146|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010147|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
14010148|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010149|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14010150|NCT03936790|Narcotics|narcotics|mesh-ancestor
14010151|NCT03936790|Analgesics|analgesics|mesh-ancestor
14010152|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14010153|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14010154|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
14010155|NCT03931057|Midazolam|midazolam|mesh-list
14010156|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14010157|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14010158|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14010159|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010160|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14010161|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14010162|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14010163|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14010164|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
14010165|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
14010166|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
14010167|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
14010168|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010169|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010170|NCT03904498|Tolcapone|tolcapone|mesh-list
14010171|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14010172|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14010173|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14010174|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010175|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010176|NCT03904329|Anticoagulants|anticoagulants|mesh-list
14010177|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14010178|NCT03896880|Clotrimazole|clotrimazole|mesh-list
14010179|NCT03896880|Miconazole|miconazole|mesh-list
14010180|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
14010181|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010182|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14010183|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14010184|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14010185|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010186|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010187|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14010188|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
15138563|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15138564|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010189|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010190|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010191|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14010192|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14010193|NCT03866668|Esomeprazole|esomeprazole|mesh-list
14010194|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14010195|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14010196|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14010197|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010198|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010199|NCT03845894|Bupivacaine|bupivacaine|mesh-list
14010200|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
14010201|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
14010202|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14010203|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010204|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
14010205|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010206|NCT03845582|Vitamin A|vitamin a|mesh-list
14010207|NCT03845582|Retinol acetate|retinol acetate|mesh-list
14010208|NCT03845582|Vitamins|vitamins|mesh-ancestor
14010209|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
14811507|NCT00845819|Ionophores|ionophores|mesh-ancestor
15138565|NCT04318067|Melatonin|melatonin|mesh-list
14010210|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010211|NCT03845582|Protective Agents|protective agents|mesh-ancestor
14811508|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14010212|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14010213|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010214|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14010215|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
14010216|NCT03809481|Danaparoid|danaparoid|mesh-list
14010217|NCT03809481|Argatroban|argatroban|mesh-list
14010218|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
14010219|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14010220|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
14010221|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010222|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010223|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
14010224|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14010225|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14010226|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14010227|NCT03789110|Nivolumab|nivolumab|mesh-list
14010228|NCT03789110|Ipilimumab|ipilimumab|mesh-list
14010229|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010230|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010231|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14010232|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010233|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14010234|NCT03773237|SMOFlipid|smoflipid|mesh-list
14010235|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14010236|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14010237|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14010238|NCT03721406|Ropivacaine|ropivacaine|mesh-list
14010239|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
14010240|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
14010241|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14010242|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010243|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
14010244|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010245|NCT03708549|Metformin|metformin|mesh-list
14010246|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14010247|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010248|NCT03673124|Letrozole|letrozole|mesh-list
14010249|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010250|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14010251|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14010252|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010253|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010254|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14010255|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14010256|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010257|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010258|NCT03635489|Paclitaxel|paclitaxel|mesh-list
14010259|NCT03635489|Bevacizumab|bevacizumab|mesh-list
14010260|NCT03635489|Carboplatin|carboplatin|mesh-list
14010261|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14010262|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010263|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14010264|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14010265|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14010266|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010267|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010268|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14271494|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271495|NCT00417976|Gemcitabine|gemcitabine|mesh-list
14271496|NCT00417976|Bevacizumab|bevacizumab|mesh-list
14271497|NCT00417976|Fluorouracil|fluorouracil|mesh-list
14271498|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271499|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271500|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14271501|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14271502|NCT00417976|Growth Substances|growth substances|mesh-ancestor
14271503|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271504|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
14271505|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271506|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
14271507|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271508|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
14271509|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271510|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138566|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
14010269|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14010270|NCT03635489|Growth Substances|growth substances|mesh-ancestor
14010271|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010272|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
14010273|NCT03610061|Durvalumab|durvalumab|mesh-list
14010274|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010275|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010276|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
14010277|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14010278|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14010279|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010280|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
14010281|NCT03582293|Coagulants|coagulants|mesh-ancestor
14010282|NCT03574337|Neostigmine|neostigmine|mesh-list
14010283|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14010284|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010285|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010286|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
15138567|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138568|NCT04318067|Protective Agents|protective agents|mesh-ancestor
15138569|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138570|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138571|NCT04317872|Dexamethasone|dexamethasone|mesh-list
15138572|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
15138573|NCT04317872|BB 1101|bb 1101|mesh-list
14010287|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010288|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010289|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14010290|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
14010291|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010292|NCT03567876|Venetoclax|venetoclax|mesh-list
14010293|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010294|NCT03557294|Varenicline|varenicline|mesh-list
14010295|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14010296|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14010297|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010298|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010299|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010300|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010301|NCT03530696|Palbociclib|palbociclib|mesh-list
14010302|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010303|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14010304|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010305|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010306|NCT03418649|Eplerenone|eplerenone|mesh-list
14010307|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14010308|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
14010309|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010310|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010311|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14271511|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271512|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
15138574|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138575|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
15138576|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
15138577|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138578|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138579|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138580|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
15138581|NCT04317872|Hormones|hormones|mesh-ancestor
15138582|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138583|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138584|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138585|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
15138586|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138587|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138588|NCT04317703|Metformin|metformin|mesh-list
15138589|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15138590|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138591|NCT04317300|Varenicline|varenicline|mesh-list
15138592|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15138593|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15138594|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
14271513|NCT00418028|Capecitabine|capecitabine|mesh-list
14010312|NCT03418649|Diuretics|diuretics|mesh-ancestor
14010313|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
14010314|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14010315|NCT03213457|Norethindrone|norethindrone|mesh-list
14010316|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
14010317|NCT03213457|Estradiol|estradiol|mesh-list
14010318|NCT03213457|Estrogens|estrogens|mesh-ancestor
14010319|NCT03213457|Hormones|hormones|mesh-ancestor
14010320|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010321|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010322|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14010323|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
14010324|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14010325|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14010326|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14010327|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14010328|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14010329|NCT03193190|Leucovorin|leucovorin|mesh-list
14010330|NCT03193190|Gemcitabine|gemcitabine|mesh-list
14010331|NCT03193190|Paclitaxel|paclitaxel|mesh-list
14010332|NCT03193190|Bevacizumab|bevacizumab|mesh-list
14010333|NCT03193190|Fluorouracil|fluorouracil|mesh-list
14010334|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
14010335|NCT03193190|Atezolizumab|atezolizumab|mesh-list
14010336|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14010337|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010338|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
14010339|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
14010340|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
14010341|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010342|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010343|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14010344|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14010345|NCT03193190|Growth Substances|growth substances|mesh-ancestor
14010346|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010347|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
14010348|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14010349|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
14010350|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
14010351|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010352|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010353|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010354|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
14010355|NCT03193190|Antidotes|antidotes|mesh-ancestor
14010356|NCT03193190|Protective Agents|protective agents|mesh-ancestor
14010357|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
14010358|NCT03193190|Vitamins|vitamins|mesh-ancestor
14010359|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
14010360|NCT03191786|Gemcitabine|gemcitabine|mesh-list
14010361|NCT03191786|Atezolizumab|atezolizumab|mesh-list
14010362|NCT03191786|Vinorelbine|vinorelbine|mesh-list
14010363|NCT03191786|Antibodies|antibodies|mesh-list
14010364|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14010365|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
14010366|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010367|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14010368|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
14010369|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010370|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010371|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
14010372|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010373|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010374|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010375|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14271514|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271515|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
14271516|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271517|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271518|NCT00418093|Gemcitabine|gemcitabine|mesh-list
14271519|NCT00418093|Bevacizumab|bevacizumab|mesh-list
14271520|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
14271521|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271522|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010376|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
14811509|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010377|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
14010378|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
14010379|NCT03126110|Nivolumab|nivolumab|mesh-list
15138595|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138596|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271523|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14271524|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15138597|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010380|NCT03126110|Ipilimumab|ipilimumab|mesh-list
14010381|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010382|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010383|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15138598|NCT04317508|Benzocaine|benzocaine|mesh-list
15138599|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138600|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
15138601|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138602|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138603|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
15138604|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138605|NCT04317430|Niclosamide|niclosamide|mesh-list
15138606|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
15138607|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15138608|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
14010384|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010385|NCT03038100|Paclitaxel|paclitaxel|mesh-list
14010386|NCT03038100|Bevacizumab|bevacizumab|mesh-list
14010387|NCT03038100|Carboplatin|carboplatin|mesh-list
14010388|NCT03038100|Atezolizumab|atezolizumab|mesh-list
14010389|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14010390|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14010391|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010392|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
14010393|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
14010394|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
14010395|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010396|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010397|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14010398|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14010399|NCT03038100|Growth Substances|growth substances|mesh-ancestor
14010400|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010401|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
14010402|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
14010403|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14010404|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
14010405|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010406|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010407|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
14010408|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811510|NCT00845884|Bevacizumab|bevacizumab|mesh-list
15138609|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15138610|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138611|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
14811511|NCT00845884|Cisplatin|cisplatin|mesh-list
14811512|NCT00845884|Docetaxel|docetaxel|mesh-list
14811513|NCT00845884|Capecitabine|capecitabine|mesh-list
15138612|NCT04317235|Ropivacaine|ropivacaine|mesh-list
15138613|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138614|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
15138615|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138616|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138617|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
15138618|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138619|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
15138620|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15138621|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
15138622|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138623|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138624|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15138625|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
14010409|NCT02825940|Gemcitabine|gemcitabine|mesh-list
14811514|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14811515|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811516|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811517|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15138626|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010410|NCT02825940|Atezolizumab|atezolizumab|mesh-list
14010411|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010412|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14811518|NCT00845884|Growth Substances|growth substances|mesh-ancestor
14010413|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
14010414|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010415|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
15138627|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138628|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15138629|NCT04316936|Dexamethasone|dexamethasone|mesh-list
15138630|NCT04316936|Prednisolone|prednisolone|mesh-list
15138631|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15138632|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
15138633|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15138634|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
15138635|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15138636|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
15138637|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138638|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
15138639|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
15138640|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138641|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138642|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138643|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
15138644|NCT04316936|Hormones|hormones|mesh-ancestor
14010416|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010417|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010418|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010419|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
14010420|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010421|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
14010422|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14010423|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
14010424|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010425|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010426|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14010427|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010428|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14010429|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
14010430|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010431|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010432|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14010433|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
15138645|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138646|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138647|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138648|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14010434|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
14010435|NCT02760329|Protective Agents|protective agents|mesh-ancestor
14010436|NCT02721342|Ramipril|ramipril|mesh-list
14010437|NCT02721342|Irbesartan|irbesartan|mesh-list
14010438|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14010439|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
14010440|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010441|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010442|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14010443|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14010444|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14010445|NCT02594371|Paclitaxel|paclitaxel|mesh-list
14010446|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14010447|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14010448|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010449|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
14010450|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
14010451|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
14010452|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010453|NCT02390869|Rituximab|rituximab|mesh-list
14010454|NCT02390869|Lenalidomide|lenalidomide|mesh-list
14010455|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010456|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010457|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
14010458|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010459|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010460|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14010461|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14010462|NCT02390869|Growth Substances|growth substances|mesh-ancestor
14010463|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
14271525|NCT00418093|Growth Substances|growth substances|mesh-ancestor
15138649|NCT04316936|Protective Agents|protective agents|mesh-ancestor
14010464|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
14010465|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14010466|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010467|NCT02223208|Prednisone|prednisone|mesh-list
14010468|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
14010469|NCT02223208|Doxorubicin|doxorubicin|mesh-list
14010470|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14010471|NCT02223208|Etoposide|etoposide|mesh-list
14010472|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
14010473|NCT02223208|Romidepsin|romidepsin|mesh-list
14010474|NCT02223208|Vincristine|vincristine|mesh-list
14010475|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010476|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
14010477|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010478|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010479|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14010480|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
14010481|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010482|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010483|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14271526|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271527|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
14271528|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271529|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
14271530|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271531|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
14271532|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271533|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271534|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271535|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
14271536|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14271537|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14271538|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14271539|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271540|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271541|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
14271542|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271543|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271544|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
14271545|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271546|NCT00418457|Anesthetics|anesthetics|mesh-list
14271547|NCT00418457|Propofol|propofol|mesh-list
14271548|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271549|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271550|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14271551|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14271552|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
14271553|NCT00418522|Insulin|insulin|mesh-list
14271554|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14271555|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
14271556|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14271557|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271558|NCT00418574|Abagovomab|abagovomab|mesh-list
14271559|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14271560|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271561|NCT00418691|Methylphenidate|methylphenidate|mesh-list
14271562|NCT00418691|Modafinil|modafinil|mesh-list
14271563|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14271564|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271565|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14271566|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14271567|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271568|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271569|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
14271570|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271571|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14271572|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14271573|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14271574|NCT00418717|Etanercept|etanercept|mesh-list
14271575|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14271576|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14271577|NCT00418717|Analgesics|analgesics|mesh-ancestor
14010484|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14010485|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14010486|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15138650|NCT04317157|Caffeine|caffeine|mesh-list
15138651|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15138652|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138653|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15138654|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010487|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010488|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138655|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138656|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15138657|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15138658|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
15138659|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138660|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
15138661|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138662|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
15138663|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138664|NCT04317079|Protective Agents|protective agents|mesh-ancestor
14010489|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
14271578|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
14271579|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271580|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271581|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271582|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271583|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271584|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271585|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
14271586|NCT00418886|Pemetrexed|pemetrexed|mesh-list
14271587|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138665|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138666|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15138667|NCT04317183|Miconazole|miconazole|mesh-list
15138668|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
15138669|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138670|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15138671|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15138672|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138673|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138674|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15138675|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
15138676|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138677|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138678|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15138679|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15138680|NCT04317001|Modafinil|modafinil|mesh-list
15138681|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15138682|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138683|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15138684|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15138685|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15138686|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138687|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
15138688|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15138689|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138690|NCT04316390|Vitamins|vitamins|mesh-list
15138691|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
15138692|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
15138693|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138694|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
15138695|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138696|NCT04316390|Protective Agents|protective agents|mesh-ancestor
15138697|NCT04316676|Regadenoson|regadenoson|mesh-list
15138698|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14271588|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271589|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271590|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14271591|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14271592|NCT00418938|Leucovorin|leucovorin|mesh-list
14271593|NCT00418938|Bevacizumab|bevacizumab|mesh-list
14271594|NCT00418938|Panitumumab|panitumumab|mesh-list
14271595|NCT00418938|Fluorouracil|fluorouracil|mesh-list
14271596|NCT00418938|Irinotecan|irinotecan|mesh-list
14271597|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15138699|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15138700|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
14010490|NCT02223208|Hormones|hormones|mesh-ancestor
14010491|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010492|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14010493|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14010494|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
14010495|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
14010496|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
14010497|NCT02153645|Amantadine|amantadine|mesh-list
14010498|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14010499|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14010500|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
14010501|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010502|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
14010503|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010504|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010505|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010506|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14010507|NCT02153645|Analgesics|analgesics|mesh-ancestor
14010508|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
14010509|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010510|NCT02153632|Amantadine|amantadine|mesh-list
14010511|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14010512|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14010513|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
14010514|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010515|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
14010516|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010517|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010518|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010519|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14010520|NCT02153632|Analgesics|analgesics|mesh-ancestor
14010521|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
14010522|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010523|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
14010524|NCT02065362|Fludarabine|fludarabine|mesh-list
14010525|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010526|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
14010527|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010528|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010529|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14010530|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
14010531|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010532|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010533|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14010534|NCT02013141|Telavancin|telavancin|mesh-list
14010535|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14010536|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010537|NCT01942135|Fulvestrant|fulvestrant|mesh-list
14010538|NCT01942135|Palbociclib|palbociclib|mesh-list
14010539|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14010540|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010541|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14010542|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14010543|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
14010544|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010545|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010546|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14010547|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010548|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010549|NCT01934452|Sunitinib|sunitinib|mesh-list
14010550|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010551|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14010552|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14010553|NCT01934452|Growth Substances|growth substances|mesh-ancestor
14010554|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010555|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
14010556|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14010557|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010558|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010559|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14010560|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010561|NCT01773083|Heparin|heparin|mesh-list
14010562|NCT01773083|Calcium heparin|calcium heparin|mesh-list
14010563|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
15138701|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
15138702|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138703|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138704|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138705|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
15138706|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
15138707|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15138708|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15138709|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138710|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138711|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138712|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138713|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15138714|NCT04316702|Analgesics|analgesics|mesh-ancestor
15138715|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
15138716|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138717|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138718|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15138719|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138720|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15138721|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15138722|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15138723|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138724|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
15138725|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
15138726|NCT04316351|Pemetrexed|pemetrexed|mesh-list
15138727|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138728|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138729|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138730|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14010564|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14010565|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14010566|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024987|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14024988|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14024989|NCT02753205|Analgesics|analgesics|mesh-ancestor
14024990|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
14024991|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14024992|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14024993|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14024994|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14024995|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
14024996|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14024997|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14024998|NCT02752971|Diclofenac|diclofenac|mesh-list
14024999|NCT02752971|Bupivacaine|bupivacaine|mesh-list
14025000|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025001|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
14025002|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025003|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025004|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
14025005|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025006|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14025007|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025008|NCT02752971|Analgesics|analgesics|mesh-ancestor
14025009|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025010|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025011|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14025012|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025013|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271598|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271599|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14271600|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14271601|NCT00418938|Growth Substances|growth substances|mesh-ancestor
14271602|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271603|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
14271604|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
14271605|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271606|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14271607|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14010567|NCT01723579|Estradiol|estradiol|mesh-list
14010568|NCT01723579|Estrogens|estrogens|mesh-ancestor
14010569|NCT01723579|Hormones|hormones|mesh-ancestor
14010570|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010571|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010572|NCT01689909|Zolpidem|zolpidem|mesh-list
14010573|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14010574|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14010575|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138731|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15138732|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
15138733|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
15138734|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010576|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010577|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14010578|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
14010579|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
14010580|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010581|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010582|NCT01615874|Prednisone|prednisone|mesh-list
14010583|NCT01615874|Prednisolone|prednisolone|mesh-list
14010584|NCT01615874|Montelukast|montelukast|mesh-list
14010585|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
14010586|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010587|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
14010588|NCT01615874|Hormones|hormones|mesh-ancestor
14010589|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010590|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010591|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14010592|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010593|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
14010594|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010595|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14010596|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010597|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14010598|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
14010599|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14010600|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14010601|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010602|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14010603|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
14010604|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
14010605|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
14010606|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14010607|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
14010608|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010609|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010610|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14010611|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010612|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14010613|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14010614|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14010615|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14010616|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010617|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010618|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010619|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010620|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010621|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
14010622|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010623|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010624|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010625|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
14010626|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138735|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
15138736|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15138737|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
15138738|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15138739|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
15138740|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138741|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138742|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
15179160|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010627|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14010628|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010629|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010630|NCT01236430|Atorvastatin|atorvastatin|mesh-list
14010631|NCT01236430|Ezetimibe|ezetimibe|mesh-list
14010632|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010633|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010634|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
14010635|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010636|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010637|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14010638|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010639|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
14010640|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010641|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010642|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010643|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
14010644|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010645|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010646|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010647|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
14010648|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010649|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010650|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010651|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
14010652|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010653|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010654|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010655|NCT00867165|Ezetimibe|ezetimibe|mesh-list
14010656|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010657|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010658|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
14010659|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010660|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010661|NCT00817076|Desloratadine|desloratadine|mesh-list
14010662|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010663|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010664|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010665|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010666|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010667|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010668|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010669|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010670|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
14010671|NCT00817050|Fluticasone|fluticasone|mesh-list
14010672|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
14010673|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010674|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14010675|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
14010676|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010677|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010678|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14010679|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010680|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010681|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010682|NCT00816972|Loratadine|loratadine|mesh-list
14010683|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
14010684|NCT00816972|Oxybutynin|oxybutynin|mesh-list
14010685|NCT00816972|Desloratadine|desloratadine|mesh-list
15138743|NCT04316013|Lidocaine|lidocaine|mesh-list
15138744|NCT04316013|Propofol|propofol|mesh-list
15138745|NCT04316013|Sevoflurane|sevoflurane|mesh-list
15138746|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138747|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
15138748|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14010686|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
14010687|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
14010688|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010689|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010690|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14010691|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010692|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010693|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010694|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138749|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010695|NCT00816972|Urological Agents|urological agents|mesh-ancestor
15138750|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
14010696|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14010697|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010698|NCT00816972|Renal Agents|renal agents|mesh-ancestor
15138751|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138752|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15138753|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15138754|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15138755|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15138756|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138757|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15138758|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15138759|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
15138760|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15138761|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15138762|NCT04316039|Temozolomide|temozolomide|mesh-list
15138763|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15138764|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
15138765|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138766|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138767|NCT04315935|Fentanyl|fentanyl|mesh-list
15138768|NCT04315935|Butorphanol|butorphanol|mesh-list
15138769|NCT04315935|Propofol|propofol|mesh-list
15138770|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14010699|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010700|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010701|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010702|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
14010703|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
14010704|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010705|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010706|NCT00805324|Desloratadine|desloratadine|mesh-list
14010707|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010708|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010709|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010710|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010711|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010712|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010713|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010714|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010715|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
14010716|NCT00794794|Cetirizine|cetirizine|mesh-list
14010717|NCT00794794|Desloratadine|desloratadine|mesh-list
14010718|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010719|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010720|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010721|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010722|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
14010723|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010724|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010725|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010726|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010727|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010728|NCT00794378|Cetirizine|cetirizine|mesh-list
14010729|NCT00794378|Desloratadine|desloratadine|mesh-list
14010730|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010731|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010732|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010733|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010734|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
14010735|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010736|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010737|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010738|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010739|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010740|NCT00789152|Levocetirizine|levocetirizine|mesh-list
14010741|NCT00789152|Desloratadine|desloratadine|mesh-list
14010742|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010743|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010744|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010745|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
14010746|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010747|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010748|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010749|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010750|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010751|NCT00783458|Fluticasone|fluticasone|mesh-list
14010752|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
14010753|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010754|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14010755|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
14010756|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010757|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271608|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
14271609|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14271610|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14271611|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271612|NCT00418938|Antidotes|antidotes|mesh-ancestor
14271613|NCT00418938|Protective Agents|protective agents|mesh-ancestor
14271614|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
14271615|NCT00418938|Vitamins|vitamins|mesh-ancestor
14271616|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
15138771|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138772|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138773|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14010758|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14271617|NCT00418951|Voriconazole|voriconazole|mesh-list
14271618|NCT00418951|Amphotericin B|amphotericin b|mesh-list
14271619|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14271620|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
14271621|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271622|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14271623|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14271624|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271625|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271626|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14271627|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
14271628|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271629|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271630|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14271631|NCT00418951|Amebicides|amebicides|mesh-ancestor
14271632|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14271633|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14271634|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14271635|NCT00419003|Lamotrigine|lamotrigine|mesh-list
14271636|NCT00419003|Ketamine|ketamine|mesh-list
14271637|NCT00419003|Riluzole|riluzole|mesh-list
14271638|NCT00419003|Analgesics|analgesics|mesh-ancestor
14271639|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
14271640|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271641|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271642|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14271643|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14271644|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
14271645|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
14271646|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271647|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14271648|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14271649|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271650|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271651|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
14271652|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14271653|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271654|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14271655|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14271656|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14271657|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271658|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14271659|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14271660|NCT00419003|Protective Agents|protective agents|mesh-ancestor
14271661|NCT00419094|Levetiracetam|levetiracetam|mesh-list
14271662|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
14271663|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
14271664|NCT00419159|Everolimus|everolimus|mesh-list
14271665|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271666|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271667|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
14271668|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811519|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271669|NCT00419263|Peramivir|peramivir|mesh-list
14271670|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
14010759|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010760|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010761|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010762|NCT00783211|Fexofenadine|fexofenadine|mesh-list
14010763|NCT00783211|Desloratadine|desloratadine|mesh-list
14010764|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010765|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010766|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010767|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010768|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010769|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010770|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010771|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010772|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
14010773|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010774|NCT00783146|Fexofenadine|fexofenadine|mesh-list
14010775|NCT00783146|Desloratadine|desloratadine|mesh-list
14010776|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010777|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010778|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010779|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010780|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010781|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010782|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010783|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010784|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
14010785|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010786|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
14010787|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010788|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010789|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010790|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
14010791|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010792|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010793|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010794|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
14010795|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14010796|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14010797|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14010798|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14010799|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14010800|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010801|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010802|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14010803|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14010804|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
14010805|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14010806|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010807|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14010808|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14010809|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14010810|NCT00751218|Cetirizine|cetirizine|mesh-list
14010811|NCT00751218|Desloratadine|desloratadine|mesh-list
14010812|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010813|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010814|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010815|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010816|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
14010817|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010818|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010819|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010820|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010821|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010822|NCT00751166|Cetirizine|cetirizine|mesh-list
14010823|NCT00751166|Desloratadine|desloratadine|mesh-list
14010824|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010825|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14010826|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14010827|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
14010828|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
14010829|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010830|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010831|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010832|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14010833|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
14010834|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
14010835|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010836|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010837|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010838|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
14010839|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138774|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
15138775|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
15138776|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15138777|NCT04315935|Narcotics|narcotics|mesh-ancestor
15138778|NCT04315935|Analgesics|analgesics|mesh-ancestor
15138779|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
15138780|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138781|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15138782|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
15138783|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
15138784|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15138785|NCT04315909|Vitamin E|vitamin e|mesh-list
15138786|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15138787|NCT04315909|Vitamins|vitamins|mesh-ancestor
14010840|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010841|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010842|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
14010843|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010844|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010845|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010846|NCT00726856|Ezetimibe|ezetimibe|mesh-list
14010847|NCT00726856|Fenofibrate|fenofibrate|mesh-list
14010848|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010849|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010850|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
14010851|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010852|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010853|NCT00705211|Ezetimibe|ezetimibe|mesh-list
14010854|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010855|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010856|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
14010857|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010858|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010859|NCT00704444|Ezetimibe|ezetimibe|mesh-list
14010860|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010861|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010862|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
14010863|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010864|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010865|NCT00654095|Atorvastatin|atorvastatin|mesh-list
14010866|NCT00654095|Ezetimibe|ezetimibe|mesh-list
14010867|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010868|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010869|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
14010870|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010871|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010872|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14010873|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010874|NCT00653913|Ezetimibe|ezetimibe|mesh-list
14010875|NCT00653913|Pitavastatin|pitavastatin|mesh-list
14010876|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010877|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010878|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
14010879|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010880|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010881|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14010882|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010883|NCT00653523|Simvastatin|simvastatin|mesh-list
14010884|NCT00653523|Ezetimibe|ezetimibe|mesh-list
14010885|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010886|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010887|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
14010888|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010889|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15138788|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
15138789|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010890|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14010891|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010892|NCT00652431|Niacin|niacin|mesh-list
14010893|NCT00652431|Niacinamide|niacinamide|mesh-list
15138790|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
15179161|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14010894|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
14010895|NCT00652431|Simvastatin|simvastatin|mesh-list
14010896|NCT00652431|Ezetimibe|ezetimibe|mesh-list
14010897|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14010898|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010899|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010900|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
14010901|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010902|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010903|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14010904|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010905|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
14010906|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
14010907|NCT00652431|Vitamins|vitamins|mesh-ancestor
14010908|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
14010909|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010910|NCT00651378|Atorvastatin|atorvastatin|mesh-list
14010911|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14010912|NCT00651378|Ezetimibe|ezetimibe|mesh-list
14010913|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010914|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010915|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
14010916|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010917|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010918|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14010919|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010920|NCT00651274|Ezetimibe|ezetimibe|mesh-list
14010921|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010922|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010923|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
14010924|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010925|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010926|NCT00650819|Simvastatin|simvastatin|mesh-list
14010927|NCT00650819|Ezetimibe|ezetimibe|mesh-list
14010928|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14010929|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14010930|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
14010931|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010932|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14010933|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15138791|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138792|NCT04315909|Protective Agents|protective agents|mesh-ancestor
15138793|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
15138794|NCT04315909|Coagulants|coagulants|mesh-ancestor
15138795|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
15138796|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15138797|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
15138798|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15138799|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138800|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010934|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010935|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
14010936|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010937|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010938|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010939|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
14010940|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010941|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010942|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010943|NCT00546052|Losartan|losartan|mesh-list
14010944|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14010945|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14010946|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14010947|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14010948|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14010949|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010950|NCT00546052|Diuretics|diuretics|mesh-ancestor
14010951|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
14010952|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010953|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14010954|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14010955|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
14010956|NCT00442117|Budesonide|budesonide|mesh-list
14010957|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010958|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14010959|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
14010960|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14010961|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010962|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14010963|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010964|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
14010965|NCT00442117|Hormones|hormones|mesh-ancestor
14010966|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010967|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010968|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010969|NCT00424008|Fluticasone|fluticasone|mesh-list
14010970|NCT00424008|Xhance|xhance|mesh-list
14010971|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
14010972|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
14010973|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14010974|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14010975|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14010976|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14010977|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
14010978|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138801|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
15138802|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
15138803|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138804|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
15138805|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138806|NCT04315831|Buprenorphine|buprenorphine|mesh-list
15138807|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15138808|NCT04315831|Narcotics|narcotics|mesh-ancestor
15138809|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138810|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138811|NCT04315831|Analgesics|analgesics|mesh-ancestor
15138812|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
15138813|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138814|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15138815|NCT04315558|Bromides|bromides|mesh-list
15138816|NCT04315558|Ipratropium|ipratropium|mesh-list
15138817|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
15138818|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15138819|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
15138820|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138821|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138822|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15138823|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010979|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14010980|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14010981|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010982|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
14010983|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14010984|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14010985|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14010986|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14010987|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
14010988|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010989|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010990|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
15138824|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15138825|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
15138826|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14010991|NCT00424008|Hormones|hormones|mesh-ancestor
14010992|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14010993|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
14010994|NCT00423995|Loratadine|loratadine|mesh-list
15138827|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138828|NCT04315688|Insulin|insulin|mesh-list
15138829|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15138830|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138831|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
15138832|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138833|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
15138834|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138835|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138836|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
15138837|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138838|NCT04315493|Maleic acid|maleic acid|mesh-list
15138839|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14010995|NCT00423995|Montelukast|montelukast|mesh-list
15138840|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14010996|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14010997|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
14010998|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14010999|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
14811520|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811521|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
14811522|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14811523|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
15138841|NCT04315194|Clarithromycin|clarithromycin|mesh-list
15138842|NCT04315194|Oseltamivir|oseltamivir|mesh-list
15138843|NCT04315194|Naproxen|naproxen|mesh-list
14811524|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811525|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15138844|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14011000|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14011001|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011002|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14011003|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14011004|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011005|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
14011006|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
14011007|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14011008|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14011009|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14011010|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
14011011|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
14011012|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011013|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14011014|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14011015|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011016|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
14271671|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271672|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271673|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271674|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
14271675|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14271676|NCT00419341|Antibodies|antibodies|mesh-list
14271677|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
14271678|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271679|NCT00419393|Levetiracetam|levetiracetam|mesh-list
14271680|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
14271681|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
14271682|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
14271683|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14271684|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14271685|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
14271686|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271687|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271688|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271689|NCT00419562|Insulin|insulin|mesh-list
14271690|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14271691|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271692|NCT00419666|Calcitriol|calcitriol|mesh-list
14271693|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14271694|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271695|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14271696|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271697|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271698|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14271699|NCT00419666|Vitamins|vitamins|mesh-ancestor
14271700|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
14271701|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14271702|NCT00419744|Budesonide|budesonide|mesh-list
14271703|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
14271704|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14271705|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271706|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14271707|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
15138845|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138846|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14271708|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271709|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271710|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14011017|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
14011018|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
14011019|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14011020|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
14011021|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011022|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011023|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14011024|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
14011025|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14011026|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14011027|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14011028|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14011029|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011030|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011031|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011032|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
14011033|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14011034|NCT00380627|Etoricoxib|etoricoxib|mesh-list
14011035|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011036|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011037|NCT00380627|Analgesics|analgesics|mesh-ancestor
14011038|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
14011039|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011040|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011041|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011042|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011043|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011044|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011045|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011046|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011047|NCT00380523|Etoricoxib|etoricoxib|mesh-list
14011048|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011049|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011050|NCT00380523|Analgesics|analgesics|mesh-ancestor
14011051|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
14011052|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011053|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011054|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011055|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011056|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011057|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011058|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011059|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011060|NCT00319995|Loratadine|loratadine|mesh-list
14011061|NCT00319995|Montelukast|montelukast|mesh-list
14011062|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14011063|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
14011064|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14011065|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
14011066|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14011067|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011068|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14011069|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14011070|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011071|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
14011072|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
14011073|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14011074|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14011075|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14011076|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
14011077|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
14011078|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011079|NCT00311844|Desloratadine|desloratadine|mesh-list
14011080|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14011081|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
14011082|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271711|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
14811526|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
15138847|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138848|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138849|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15138850|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14011083|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011084|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011085|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14011086|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14011087|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
14011088|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
14011089|NCT00212836|Olanzapine|olanzapine|mesh-list
14011090|NCT00212836|Asenapine|asenapine|mesh-list
14011091|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
14011092|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
14011093|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011094|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011095|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011096|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14011097|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14011098|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011099|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14011100|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14011101|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14011102|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14011103|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011104|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011105|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
14011106|NCT00212784|Olanzapine|olanzapine|mesh-list
14011107|NCT00212784|Asenapine|asenapine|mesh-list
14011108|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
14011109|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
14011110|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011111|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011112|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011113|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14011114|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14011115|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011116|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14011117|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14011118|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14011119|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14011120|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011121|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011122|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
14011123|NCT00212771|Olanzapine|olanzapine|mesh-list
14011124|NCT00212771|Asenapine|asenapine|mesh-list
14011125|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
14011126|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
14011127|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011128|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011129|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011130|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14011131|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14271712|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
14271713|NCT00419744|Hormones|hormones|mesh-ancestor
14271714|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271715|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14271716|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14271717|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14271718|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
14271719|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271720|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271721|NCT00419757|Budesonide|budesonide|mesh-list
14271722|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
14271723|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14271724|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271725|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14271726|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
14271727|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271728|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271729|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14271730|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
14271731|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
14811527|NCT00845910|Bevacizumab|bevacizumab|mesh-list
14011132|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011133|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14011134|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14011135|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14011136|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14011137|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138851|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15138852|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138853|NCT04315194|Analgesics|analgesics|mesh-ancestor
14011138|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011139|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
14011140|NCT00202904|Ezetimibe|ezetimibe|mesh-list
14011141|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011142|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011143|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
14011144|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011145|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011146|NCT00157924|Atorvastatin|atorvastatin|mesh-list
14011147|NCT00157924|Simvastatin|simvastatin|mesh-list
14011148|NCT00157924|Ezetimibe|ezetimibe|mesh-list
14011149|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011150|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011151|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
14011152|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011153|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011154|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14011155|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138854|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
15138855|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138856|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138857|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138858|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138859|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
15138860|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15138861|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
15138862|NCT04315155|Nivolumab|nivolumab|mesh-list
15138863|NCT04315155|Ipilimumab|ipilimumab|mesh-list
15138864|NCT04315155|Belinostat|belinostat|mesh-list
15138865|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15138866|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138867|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15138868|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138869|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15138870|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138871|NCT04315116|Loperamide|loperamide|mesh-list
15138872|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
15138873|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138874|NCT04314713|Scopolamine|scopolamine|mesh-list
15138875|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15138876|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15138877|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
15138878|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
15138879|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011156|NCT00157911|Simvastatin|simvastatin|mesh-list
14011157|NCT00157911|Ezetimibe|ezetimibe|mesh-list
14011158|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011159|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011160|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
14011161|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011162|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011163|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14011164|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011165|NCT00156117|Olanzapine|olanzapine|mesh-list
14011166|NCT00156117|Asenapine|asenapine|mesh-list
15138880|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138881|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15138882|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
15138883|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15138884|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
15138885|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138886|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138887|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15138888|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
15138889|NCT04314739|Resveratrol|resveratrol|mesh-list
15138890|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
15138891|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138892|NCT04314739|Protective Agents|protective agents|mesh-ancestor
14811528|NCT00845910|Docetaxel|docetaxel|mesh-list
14011167|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
14011168|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
14811529|NCT00845910|Capecitabine|capecitabine|mesh-list
15138893|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138894|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138895|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15138896|NCT04314570|Ropivacaine|ropivacaine|mesh-list
15138897|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138898|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
15138899|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011169|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011170|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011171|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011172|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15138900|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138901|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
15138902|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011173|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14011174|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011175|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14011176|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14011177|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14011178|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14011179|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011180|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011181|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
14011182|NCT00156104|Haloperidol|haloperidol|mesh-list
14011183|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
14011184|NCT00156104|Asenapine|asenapine|mesh-list
14011185|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
14011186|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
14011187|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011188|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011189|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011190|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14011191|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14011192|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011193|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14011194|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14011195|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
14011196|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011197|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011198|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14011199|NCT00156091|Olanzapine|olanzapine|mesh-list
14011200|NCT00156091|Asenapine|asenapine|mesh-list
14011201|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
14011202|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
14011203|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011204|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011205|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011206|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14011207|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14011208|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011209|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14011210|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15138903|NCT04314310|Tenoxicam|tenoxicam|mesh-list
15138904|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15138905|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15138906|NCT04314310|Analgesics|analgesics|mesh-ancestor
15138907|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
15138908|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011211|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14011212|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271732|NCT00419757|Hormones|hormones|mesh-ancestor
14271733|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271734|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14271735|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14271736|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14271737|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
14271738|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271739|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271740|NCT00419770|Amphotericin B|amphotericin b|mesh-list
14271741|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14271742|NCT00419770|Deferasirox|deferasirox|mesh-list
14271743|NCT00419770|Amebicides|amebicides|mesh-ancestor
14271744|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14271745|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14011213|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011214|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011215|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
14011216|NCT00142558|Indomethacin|indomethacin|mesh-list
14011217|NCT00142558|Etoricoxib|etoricoxib|mesh-list
14011218|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011219|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011220|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011221|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011222|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011223|NCT00142558|Analgesics|analgesics|mesh-ancestor
15138909|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138910|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138911|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138912|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15138913|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138914|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138915|NCT04314375|Budesonide|budesonide|mesh-list
15138916|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138917|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15138918|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
15138919|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011224|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
14011225|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011226|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011227|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
14011228|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
14011229|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14011230|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011231|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011232|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011233|NCT00140985|Losartan|losartan|mesh-list
14011234|NCT00140985|Amlodipine|amlodipine|mesh-list
14011235|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14011236|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14011237|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14011238|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011239|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14011240|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011241|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
14011242|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14011243|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14011244|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14011245|NCT00140972|Diclofenac|diclofenac|mesh-list
14011246|NCT00140972|Etoricoxib|etoricoxib|mesh-list
14011247|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011248|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011249|NCT00140972|Analgesics|analgesics|mesh-ancestor
14011250|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
14011251|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011252|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011253|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011254|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011255|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011256|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011257|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011258|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011259|NCT00140959|Losartan|losartan|mesh-list
14011260|NCT00140959|Atenolol|atenolol|mesh-list
14011261|NCT00140959|Amlodipine|amlodipine|mesh-list
14011262|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14011263|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14011264|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14011265|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011266|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14011267|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011268|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
14011269|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14011270|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14011271|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14011272|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14011273|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011274|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
14011275|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011276|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
15138920|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138921|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15138922|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
15138923|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
15138924|NCT04314375|Hormones|hormones|mesh-ancestor
15138925|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138926|NCT04314297|Durvalumab|durvalumab|mesh-list
15138927|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15138928|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179162|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15179163|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
15179164|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011277|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14011278|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14011279|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14011280|NCT00140907|Losartan|losartan|mesh-list
14011281|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14011282|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179165|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179166|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15179167|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15179168|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15179169|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15179170|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179171|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179172|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
15179173|NCT03952572|Hormones|hormones|mesh-ancestor
15179174|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179175|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15179176|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15179177|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
14011283|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14011284|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14011285|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011286|NCT00132717|Atorvastatin|atorvastatin|mesh-list
14011287|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14011288|NCT00132717|Simvastatin|simvastatin|mesh-list
14011289|NCT00132717|Ezetimibe|ezetimibe|mesh-list
14011290|NCT00132717|Pravastatin|pravastatin|mesh-list
14011291|NCT00132717|Lovastatin|lovastatin|mesh-list
14011292|NCT00132717|L 647318|l 647318|mesh-list
14011293|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
14011294|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011295|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011296|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
14011297|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011298|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011299|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14011300|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011301|NCT00127179|Finasteride|finasteride|mesh-list
14011302|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011303|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011304|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14011305|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14011306|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011307|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
14011308|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14011309|NCT00127179|Urological Agents|urological agents|mesh-ancestor
14011310|NCT00110435|Atorvastatin|atorvastatin|mesh-list
14011311|NCT00110435|Simvastatin|simvastatin|mesh-list
14011312|NCT00110435|Ezetimibe|ezetimibe|mesh-list
14011313|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011314|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011315|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
14011316|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011317|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011318|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14011319|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011320|NCT00095017|Etoricoxib|etoricoxib|mesh-list
14011321|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011322|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011323|NCT00095017|Analgesics|analgesics|mesh-ancestor
14011324|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
14011325|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011326|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011327|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011328|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011329|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011330|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011331|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011332|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011333|NCT00093899|Simvastatin|simvastatin|mesh-list
14011334|NCT00093899|Ezetimibe|ezetimibe|mesh-list
14011335|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011336|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15138929|NCT04314674|Mannitol|mannitol|mesh-list
15138930|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15138931|NCT04314674|Diuretics|diuretics|mesh-ancestor
15138932|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
15138933|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138934|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
15138935|NCT04314505|Narcotics|narcotics|mesh-ancestor
15138936|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138937|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138938|NCT04314505|Analgesics|analgesics|mesh-ancestor
15138939|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
15138940|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15138941|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
15138942|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138943|NCT04313959|Dexamethasone|dexamethasone|mesh-list
15138944|NCT04313959|Ropivacaine|ropivacaine|mesh-list
15138945|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138946|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
15138947|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
15138948|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011337|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
14011338|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011339|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011340|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14011341|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011342|NCT00092898|Ezetimibe|ezetimibe|mesh-list
14011343|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011344|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011345|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
14011346|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271746|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271747|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14271748|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
14271749|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14271750|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
14271751|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
14271752|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271753|NCT00419926|Cyclosporine|cyclosporine|mesh-list
14271754|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
14271755|NCT00419926|Prednisone|prednisone|mesh-list
14271756|NCT00419926|Cyclosporins|cyclosporins|mesh-list
14271757|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271758|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
14271759|NCT00419926|Hormones|hormones|mesh-ancestor
14271760|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271761|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271762|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14271763|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271764|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271765|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271766|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15138949|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138950|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011347|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011348|NCT00092820|Ezetimibe|ezetimibe|mesh-list
14011349|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011350|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011351|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
14011352|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271767|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
15138951|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
15138952|NCT04313959|Hormones|hormones|mesh-ancestor
14011353|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011354|NCT00092807|Ezetimibe|ezetimibe|mesh-list
14011355|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011356|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011357|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
14011358|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011359|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011360|NCT00092781|Celecoxib|celecoxib|mesh-list
14011361|NCT00092781|Etoricoxib|etoricoxib|mesh-list
14011362|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011363|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011364|NCT00092781|Analgesics|analgesics|mesh-ancestor
14011365|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
14011366|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011367|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011368|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011369|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011370|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011371|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011372|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011373|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011374|NCT00092768|Celecoxib|celecoxib|mesh-list
14011375|NCT00092768|Etoricoxib|etoricoxib|mesh-list
14011376|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011377|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011378|NCT00092768|Analgesics|analgesics|mesh-ancestor
14011379|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
14011380|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011381|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011382|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011383|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011384|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011385|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011386|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011387|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011388|NCT00092755|Ibuprofen|ibuprofen|mesh-list
14011389|NCT00092755|Etoricoxib|etoricoxib|mesh-list
14011390|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011391|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011392|NCT00092755|Analgesics|analgesics|mesh-ancestor
14011393|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
14011394|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011395|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011396|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011397|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011398|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011399|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011400|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011401|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011402|NCT00092742|Diclofenac|diclofenac|mesh-list
14011403|NCT00092742|Etoricoxib|etoricoxib|mesh-list
14011404|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011405|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011406|NCT00092742|Analgesics|analgesics|mesh-ancestor
14011407|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
14011408|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011409|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011410|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011411|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011412|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011413|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011414|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011415|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011416|NCT00092729|Naproxen|naproxen|mesh-list
14011417|NCT00092729|Etoricoxib|etoricoxib|mesh-list
14011418|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011419|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011420|NCT00092729|Analgesics|analgesics|mesh-ancestor
14011421|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
14011422|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011423|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011424|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011425|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011426|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
14011427|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011428|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011429|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011430|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011431|NCT00092703|Diclofenac|diclofenac|mesh-list
14011432|NCT00092703|Etoricoxib|etoricoxib|mesh-list
14011433|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011434|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011435|NCT00092703|Analgesics|analgesics|mesh-ancestor
14011436|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
14011437|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011438|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011439|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011440|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011441|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011442|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011443|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011444|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011445|NCT02844270|Sirolimus|sirolimus|mesh-list
14011446|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14011447|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011448|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14011449|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011450|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
14011451|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011452|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
14011453|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011454|NCT02843984|Lactoferrin|lactoferrin|mesh-list
14011455|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271768|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
14271769|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271770|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
14271771|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271772|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14271773|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14271774|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14271775|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
14271776|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14271777|NCT00419952|Budesonide|budesonide|mesh-list
14271778|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
14271779|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14271780|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271781|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14271782|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
14271783|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271784|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271785|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14271786|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
14271787|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
14271788|NCT00419952|Hormones|hormones|mesh-ancestor
14271789|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271790|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14271791|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14271792|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14271793|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
14271794|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179178|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
14271795|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271796|NCT00420004|Citalopram|citalopram|mesh-list
14271797|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14271798|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14271799|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271800|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271801|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271802|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
14025038|NCT02753166|Dexamethasone|dexamethasone|mesh-list
14025039|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025040|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
14025041|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
14025042|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025043|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025044|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14025045|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
14025046|NCT02753166|Hormones|hormones|mesh-ancestor
14011456|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
14011457|NCT02844062|Fludarabine|fludarabine|mesh-list
14011458|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011459|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
14011460|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011461|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011462|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14011463|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
14011464|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011465|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011466|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14011467|NCT02844114|Gemcitabine|gemcitabine|mesh-list
14011468|NCT02844114|Cisplatin|cisplatin|mesh-list
14011469|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011470|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14011471|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
14011472|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011473|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
14011474|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011475|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011476|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011477|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
14011478|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011479|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
14011480|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14011481|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011482|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011483|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011484|NCT02843698|Analgesics|analgesics|mesh-ancestor
14011485|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
15138953|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179179|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
14011486|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011487|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14011488|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14011489|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14011490|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14011491|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011492|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011493|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14011494|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011495|NCT02843321|Vaccines|vaccines|mesh-list
14011496|NCT02843321|Immunologic Factors|immunologic factors|mesh-ancestor
14011497|NCT02843321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011498|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14011499|NCT02843490|Ranibizumab|ranibizumab|mesh-list
14011500|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14011501|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14011502|NCT02843490|Growth Substances|growth substances|mesh-ancestor
14011503|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011504|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
14011505|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011506|NCT02842983|Esmolol|esmolol|mesh-list
14011507|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14011508|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14011509|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
14011510|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011511|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011512|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011513|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14011514|NCT02843126|Trastuzumab|trastuzumab|mesh-list
14011515|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011516|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011517|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
14011518|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011519|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011520|NCT02843061|Rituximab|rituximab|mesh-list
14011521|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011522|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011523|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
14011524|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011525|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011526|NCT02842931|Prednisone|prednisone|mesh-list
14271803|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138954|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138955|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011527|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
14011528|NCT02842931|Doxorubicin|doxorubicin|mesh-list
14011529|NCT02842931|Etoposide|etoposide|mesh-list
14011530|NCT02842931|Vincristine|vincristine|mesh-list
14011531|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011532|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
14011533|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011534|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011535|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14011536|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
14011537|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011538|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011539|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14011540|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14011541|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14011542|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14011543|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138956|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
15138957|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
15138958|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15138959|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
15138960|NCT04314193|Prednisolone|prednisolone|mesh-list
15138961|NCT04314193|Methotrexate|methotrexate|mesh-list
15138962|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15138963|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
15138964|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15138965|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138966|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15138967|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
15138968|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138969|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15138970|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
15138971|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15138972|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15138973|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15138974|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
15138975|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15138976|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15138977|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15138978|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
15138979|NCT04314193|Hormones|hormones|mesh-ancestor
15138980|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15138981|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15138982|NCT04313907|Clonazepam|clonazepam|mesh-list
14011544|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14011545|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011546|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
14011547|NCT02842931|Hormones|hormones|mesh-ancestor
14011548|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271804|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14271805|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
14271806|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271807|NCT00420017|Amiodarone|amiodarone|mesh-list
14271808|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14271809|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
14271810|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14271811|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15138983|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
14011549|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14271812|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271813|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14271814|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14271815|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14271816|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271817|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14271818|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14271819|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14271820|NCT00420056|Palbociclib|palbociclib|mesh-list
14271821|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271822|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14271823|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011550|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
14011551|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
14011552|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
14011553|NCT02842749|Everolimus|everolimus|mesh-list
14011554|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011555|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011556|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
14011557|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011558|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
14011559|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
14011560|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
14011561|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14011562|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14011563|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011564|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011565|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011566|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011567|NCT02842814|Hormones|hormones|mesh-ancestor
14011568|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14011569|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011570|NCT02842567|Vitamin E|vitamin e|mesh-list
14011571|NCT02842567|Tocopherols|tocopherols|mesh-list
14011572|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
14011573|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
14011574|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
14011575|NCT02842567|Vitamins|vitamins|mesh-ancestor
14011576|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
14011577|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011578|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
14011579|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011580|NCT02842567|Protective Agents|protective agents|mesh-ancestor
14011581|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011582|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14011583|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14011584|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
14011585|NCT02842580|Leucovorin|leucovorin|mesh-list
14011586|NCT02842580|Bevacizumab|bevacizumab|mesh-list
14011587|NCT02842580|Capecitabine|capecitabine|mesh-list
14011588|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
14011589|NCT02842580|Irinotecan|irinotecan|mesh-list
14011590|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
14011591|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011592|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011593|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14011594|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14011595|NCT02842580|Growth Substances|growth substances|mesh-ancestor
14011596|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011597|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
14011598|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14011599|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
14011600|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011601|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14011602|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14011603|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011604|NCT02842580|Antidotes|antidotes|mesh-ancestor
14011605|NCT02842580|Protective Agents|protective agents|mesh-ancestor
14011606|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
14011607|NCT02842580|Vitamins|vitamins|mesh-ancestor
14011608|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
14025047|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025048|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14025049|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025050|NCT02752828|Insulin|insulin|mesh-list
14025051|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14271824|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271825|NCT00420095|Insulin|insulin|mesh-list
14271826|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14271827|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
14271828|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14271829|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271830|NCT00420199|Abatacept|abatacept|mesh-list
14271831|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14271832|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025052|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
14025053|NCT02752828|Lixisenatide|lixisenatide|mesh-list
14025054|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14025055|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025056|NCT02752815|Prednisone|prednisone|mesh-list
14011609|NCT02842281|Levan|levan|mesh-list
14011610|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011611|NCT02842294|Bevacizumab|bevacizumab|mesh-list
14011612|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011613|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011614|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14011615|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14011616|NCT02842294|Growth Substances|growth substances|mesh-ancestor
14011617|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011618|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
14011619|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
14011620|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14011621|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011622|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011623|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011624|NCT02842437|Analgesics|analgesics|mesh-ancestor
14011625|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
14011626|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011627|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14011628|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14011629|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14011630|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
14011631|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011632|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011633|NCT02842424|Ramipril|ramipril|mesh-list
14011634|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14011635|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
14011636|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011637|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011638|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14011639|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
14011640|NCT02842125|Nivolumab|nivolumab|mesh-list
14011641|NCT02842125|Capecitabine|capecitabine|mesh-list
14011642|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011643|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011644|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14011645|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
14011646|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011647|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14011648|NCT02841982|Morphine|morphine|mesh-list
14011649|NCT02841982|Ropivacaine|ropivacaine|mesh-list
14011650|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14011651|NCT02841982|Narcotics|narcotics|mesh-ancestor
14011652|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011653|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011654|NCT02841982|Analgesics|analgesics|mesh-ancestor
14011655|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
14011656|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011657|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
14011658|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
14011659|NCT02841839|Fluorides|fluorides|mesh-list
14011660|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
14011661|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
14011662|NCT02841839|Protective Agents|protective agents|mesh-ancestor
14011663|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011664|NCT02841488|Fentanyl|fentanyl|mesh-list
14011665|NCT02841488|Ropivacaine|ropivacaine|mesh-list
14011666|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
14011667|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
14011668|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011669|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011670|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
14011671|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011672|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14011673|NCT02841488|Narcotics|narcotics|mesh-ancestor
14011674|NCT02841488|Analgesics|analgesics|mesh-ancestor
14011675|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14011676|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14011677|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
14011678|NCT02841722|Sargramostim|sargramostim|mesh-list
14011679|NCT02841722|Lenograstim|lenograstim|mesh-list
14011680|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
14011681|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011682|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14011683|NCT02841579|Osimertinib|osimertinib|mesh-list
14011684|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011685|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14011686|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011687|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011688|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14011689|NCT02841774|Pravastatin|pravastatin|mesh-list
14011690|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14011691|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14011692|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
14011693|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011694|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011695|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14011696|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011697|NCT02841800|Phenobarbital|phenobarbital|mesh-list
14011698|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
14011699|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14011700|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011701|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011702|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14011703|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14011704|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011705|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011706|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
14011707|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
14011708|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14011709|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14011710|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14011711|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14011712|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14011713|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011714|NCT02841332|Misonidazole|misonidazole|mesh-list
14011715|NCT02841332|Bevacizumab|bevacizumab|mesh-list
14011716|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011717|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011718|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14011719|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14011720|NCT02841332|Growth Substances|growth substances|mesh-ancestor
14011721|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011722|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14011723|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14011724|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14011725|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011726|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
14011727|NCT02840994|Nivolumab|nivolumab|mesh-list
14011728|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011729|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011730|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14011731|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011732|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
14011733|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
14011734|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14011735|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14011736|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011737|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14011738|NCT02841137|Progesterone|progesterone|mesh-list
14011739|NCT02841137|Progestins|progestins|mesh-ancestor
14011740|NCT02841137|Hormones|hormones|mesh-ancestor
14011741|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14011742|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011743|NCT02841176|Golimumab|golimumab|mesh-list
14011744|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14011745|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011746|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011747|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
14011748|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011749|NCT02840929|Esomeprazole|esomeprazole|mesh-list
14011750|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14011751|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011752|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14011753|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011754|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025057|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
14025058|NCT02752815|Rituximab|rituximab|mesh-list
14025059|NCT02752815|Vincristine|vincristine|mesh-list
14025060|NCT02752815|Epirubicin|epirubicin|mesh-list
14025061|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14811530|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14811531|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811532|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811533|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15138984|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
15138985|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
15138986|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15138987|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138988|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811534|NCT00845910|Growth Substances|growth substances|mesh-ancestor
14811535|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811536|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811537|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14811538|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14811539|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14811540|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15138989|NCT04313790|Heparin|heparin|mesh-list
15138990|NCT04313790|Calcium heparin|calcium heparin|mesh-list
15138991|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
15138992|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15138993|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14811541|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14811542|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
14811543|NCT00845936|Metformin|metformin|mesh-list
14811544|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14811545|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811546|NCT00845962|Bupivacaine|bupivacaine|mesh-list
14811547|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
14811548|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
14811549|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
14811550|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811551|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15138994|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011755|NCT02840708|Sargramostim|sargramostim|mesh-list
14011756|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
14011757|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011758|NCT02840539|Cytarabine|cytarabine|mesh-list
14011759|NCT02840539|Dexamethasone|dexamethasone|mesh-list
14011760|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
14011761|NCT02840539|Bortezomib|bortezomib|mesh-list
14011762|NCT02840539|BB 1101|bb 1101|mesh-list
14011763|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011764|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
14011765|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
14011766|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011767|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011768|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011769|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
14011770|NCT02840539|Hormones|hormones|mesh-ancestor
14011771|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14011772|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14011773|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011774|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
14011775|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011776|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011777|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14011778|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
14011779|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
14011780|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011781|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011782|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
14011783|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14011784|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
14011785|NCT02840240|Gabapentin|gabapentin|mesh-list
14011786|NCT02840240|Analgesics|analgesics|mesh-ancestor
14011787|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
14011788|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011789|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011790|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
14011791|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14011792|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14011793|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011794|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14011795|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14025062|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
14811552|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
14011796|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14011797|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011798|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011799|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
14011800|NCT02840526|Acetaminophen|acetaminophen|mesh-list
14011801|NCT02840526|Fentanyl|fentanyl|mesh-list
14011802|NCT02840526|Bupivacaine|bupivacaine|mesh-list
14011803|NCT02840526|Propofol|propofol|mesh-list
14011804|NCT02840526|Sevoflurane|sevoflurane|mesh-list
14011805|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
14011806|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
14011807|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011808|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011809|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
14011810|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011811|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14011812|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14011813|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
14011814|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14011815|NCT02840526|Narcotics|narcotics|mesh-ancestor
14011816|NCT02840526|Analgesics|analgesics|mesh-ancestor
14011817|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14011818|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011819|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
14011820|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14011821|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14011822|NCT02840409|Bevacizumab|bevacizumab|mesh-list
14011823|NCT02840409|Vinblastine|vinblastine|mesh-list
14011824|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14011825|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011826|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14011827|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14011828|NCT02840409|Growth Substances|growth substances|mesh-ancestor
14271833|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271834|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271835|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
14271836|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271837|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271838|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14271839|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
14271840|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271841|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
14271842|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271843|NCT00420238|Etanercept|etanercept|mesh-list
14271844|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14271845|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14271846|NCT00420238|Analgesics|analgesics|mesh-ancestor
14271847|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
14271848|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271849|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271850|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271851|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271852|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271853|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271854|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
14271855|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14271856|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271857|NCT00420303|Etanercept|etanercept|mesh-list
14271858|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14271859|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14271860|NCT00420303|Analgesics|analgesics|mesh-ancestor
14271861|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
14271862|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271863|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271864|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271865|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14271866|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271867|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14271868|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
14271869|NCT00420316|Vaccines|vaccines|mesh-list
14271870|NCT00420316|Immunologic Factors|immunologic factors|mesh-ancestor
14271871|NCT00420316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271872|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14271873|NCT00420342|Drospirenone|drospirenone|mesh-list
14271874|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14271875|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14271876|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
14011829|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011830|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
14011831|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14011832|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
14011833|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
14011834|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
14011835|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011836|NCT02840175|Adalimumab|adalimumab|mesh-list
14011837|NCT02840175|Etanercept|etanercept|mesh-list
14011838|NCT02840175|Abatacept|abatacept|mesh-list
14011839|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011840|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011841|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011842|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011843|NCT02840175|Analgesics|analgesics|mesh-ancestor
14011844|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
14011845|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011846|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011847|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011848|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011849|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
14271877|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14271878|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15138995|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15138996|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
15138997|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15138998|NCT04313764|Bupivacaine|bupivacaine|mesh-list
15138999|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
14271879|NCT00420342|Estradiol|estradiol|mesh-list
14271880|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14271881|NCT00420342|Estrogens|estrogens|mesh-ancestor
14271882|NCT00420342|Hormones|hormones|mesh-ancestor
14271883|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271884|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271885|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14271886|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
14271887|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14271888|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14271889|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14271890|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14271891|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14271892|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14271893|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14271894|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271895|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14271896|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
14271897|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14271898|NCT00420342|Diuretics|diuretics|mesh-ancestor
14271899|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
14271900|NCT00420407|Vasopressins|vasopressins|mesh-list
14271901|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
14271902|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
14271903|NCT00420407|Coagulants|coagulants|mesh-ancestor
14271904|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14271905|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14271906|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
14271907|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271908|NCT00420459|Aripiprazole|aripiprazole|mesh-list
14271909|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
14271910|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271911|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14271912|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14271913|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271914|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271915|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
14271916|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
14271917|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271918|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271919|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14271920|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14271921|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
14271922|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15139000|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
14271923|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15139001|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011850|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14011851|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011852|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011853|NCT02840162|Celecoxib|celecoxib|mesh-list
14011854|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
14011855|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15139002|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139003|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
15139004|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139005|NCT04313504|Niraparib|niraparib|mesh-list
15139006|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15139007|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139008|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139009|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139010|NCT04313452|Insulin|insulin|mesh-list
15139011|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15139012|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011856|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011857|NCT02840162|Analgesics|analgesics|mesh-ancestor
14011858|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
14011859|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011860|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011861|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011862|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011863|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011864|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011865|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011866|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011867|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14011868|NCT02840006|Anesthetics|anesthetics|mesh-list
14011869|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011870|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011871|NCT02839928|Ketamine|ketamine|mesh-list
14011872|NCT02839928|Analgesics|analgesics|mesh-list
14011873|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14011874|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
14011875|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011876|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011877|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14011878|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14011879|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
14011880|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
14011881|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011882|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14011883|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14011884|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011885|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011886|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
14011887|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14011888|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
14011889|NCT02839941|Tacrolimus|tacrolimus|mesh-list
14011890|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
14011891|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14011892|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
14011893|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011894|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14011895|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011896|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011897|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14011898|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011899|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14011900|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
14011901|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14011902|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011903|NCT02839941|Hormones|hormones|mesh-ancestor
14011904|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14011905|NCT02839694|Celecoxib|celecoxib|mesh-list
14011906|NCT02839694|Decitabine|decitabine|mesh-list
14011907|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
14011908|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011909|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011910|NCT02839694|Analgesics|analgesics|mesh-ancestor
15139013|NCT04313634|Dasatinib|dasatinib|mesh-list
15139014|NCT04313634|Quercetin|quercetin|mesh-list
14011911|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
14011912|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011913|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011914|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011915|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011916|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14011917|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011918|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011919|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011920|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139015|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139016|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15139017|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139018|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139019|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
15139020|NCT04313634|Protective Agents|protective agents|mesh-ancestor
15139021|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139022|NCT04313270|Evolocumab|evolocumab|mesh-list
14011921|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
14011922|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011923|NCT02839785|Ibuprofen|ibuprofen|mesh-list
14011924|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14011925|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011926|NCT02839785|Analgesics|analgesics|mesh-ancestor
14011927|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
14011928|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011929|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011930|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14011931|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14011932|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14011933|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011934|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011935|NCT02839668|Acetaminophen|acetaminophen|mesh-list
14011936|NCT02839668|Lidocaine|lidocaine|mesh-list
14011937|NCT02839668|Atropine|atropine|mesh-list
14011938|NCT02839668|Tramadol|tramadol|mesh-list
14011939|NCT02839668|Sevoflurane|sevoflurane|mesh-list
14011940|NCT02839668|Neostigmine|neostigmine|mesh-list
15139023|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15139024|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15139025|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
15139026|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139027|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14011941|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
14011942|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
14011943|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14011944|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011945|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
14011946|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14011947|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14011948|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14011949|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14011950|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14011951|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011952|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14011953|NCT02839668|Analgesics|analgesics|mesh-ancestor
14011954|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
14011955|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14011956|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14011957|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
14011958|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14011959|NCT02839668|Narcotics|narcotics|mesh-ancestor
15139028|NCT04313218|Misoprostol|misoprostol|mesh-list
15139029|NCT04313218|Carbetocin|carbetocin|mesh-list
15139030|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15139031|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
15139032|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15139033|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139034|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15139035|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14011960|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14011961|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14011962|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
14011963|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14011964|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
14011965|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
14011966|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
14011967|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14011968|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14011969|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
14011970|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011971|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14011972|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011973|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14011974|NCT02839642|Rivastigmine|rivastigmine|mesh-list
14011975|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14011976|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011977|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011978|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
14011979|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011980|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011981|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14011982|NCT02839642|Protective Agents|protective agents|mesh-ancestor
14011983|NCT02839538|Anesthetics|anesthetics|mesh-list
14011984|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139036|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
15139037|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15139038|NCT04313374|Morphine|morphine|mesh-list
15139039|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15139040|NCT04313374|Narcotics|narcotics|mesh-ancestor
15139041|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139042|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011985|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14011986|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
14011987|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14011988|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14011989|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14011990|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14011991|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14011992|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14011993|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14011994|NCT02839356|Epinephrine|epinephrine|mesh-list
14011995|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14011996|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14011997|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
14811553|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811554|NCT00845988|Aripiprazole|aripiprazole|mesh-list
14811555|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
14811556|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15139043|NCT04313374|Analgesics|analgesics|mesh-ancestor
15139044|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
15139045|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139046|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139047|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15139048|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15139049|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15139050|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15139051|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15139052|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15139053|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139054|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139055|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139056|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139057|NCT04313335|Analgesics|analgesics|mesh-ancestor
15139058|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
15139059|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139060|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
15139061|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15139062|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
15139063|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
15139064|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
15139065|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
15139066|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
15139067|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
15139068|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15139069|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14811557|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14811558|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14011998|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14011999|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012000|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012001|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14012002|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14012003|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
14012004|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012005|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14012006|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
14012007|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
14012008|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
14012009|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14012010|NCT02839408|Azithromycin|azithromycin|mesh-list
14012011|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012012|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012013|NCT02839239|Vitamin D|vitamin d|mesh-list
14012014|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
14012015|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
14012016|NCT02839239|Vitamins|vitamins|mesh-list
14012017|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
14012018|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012019|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14012020|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14012021|NCT02839213|Scopolamine|scopolamine|mesh-list
14012022|NCT02839213|Bromides|bromides|mesh-list
14012023|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14012024|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
14012025|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14012026|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
14012027|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
14012028|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012029|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012030|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012031|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
14012032|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14012033|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
14012034|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139070|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139071|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
15139072|NCT04312880|Coagulants|coagulants|mesh-ancestor
15139073|NCT04313036|Defibrotide|defibrotide|mesh-list
15139074|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15139075|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15139076|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139077|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15139078|NCT04312841|Acetic Acid|acetic acid|mesh-list
15139079|NCT04312841|Letermovir|letermovir|mesh-list
15139080|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15139081|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139082|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139083|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139084|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139085|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15139086|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
15139087|NCT04312750|Lidocaine|lidocaine|mesh-list
14012035|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012036|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14012037|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
14012038|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14012039|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14012040|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
14012041|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012042|NCT02839161|Antacids|antacids|mesh-ancestor
14012043|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012044|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012045|NCT02839486|Vancomycin|vancomycin|mesh-list
14012046|NCT02839486|Cefoxitin|cefoxitin|mesh-list
14012047|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012048|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012049|NCT02839122|Tadalafil|tadalafil|mesh-list
14271924|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14271925|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14292432|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292433|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
15139088|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
14012050|NCT02839122|Dutasteride|dutasteride|mesh-list
14012051|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
14012052|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14012053|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15139089|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
15139090|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139091|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012054|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012055|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012056|NCT02839122|Urological Agents|urological agents|mesh-ancestor
14012057|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14012058|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14012059|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
14012060|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012061|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012062|NCT02839135|Scopolamine|scopolamine|mesh-list
14012063|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14012064|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14012065|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
14012066|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
14012067|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012068|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012069|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012070|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
14012071|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14012072|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
14012073|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012074|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012075|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14012076|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
14025063|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025064|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025065|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14025066|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
14025067|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025068|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025069|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14025070|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025071|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025072|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
14025073|NCT02752815|Hormones|hormones|mesh-ancestor
14025074|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025075|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14025076|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14025077|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14025078|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14025079|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14025080|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14025081|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14025082|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14025083|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025084|NCT02752685|Paclitaxel|paclitaxel|mesh-list
14025085|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
14025086|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14025087|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025088|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
14025089|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
14025090|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
14025091|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025092|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025093|NCT02752763|Dextrans|dextrans|mesh-list
14025094|NCT02752763|Povidone|povidone|mesh-list
14025095|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14025096|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
14025097|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14025098|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
14025099|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
14025100|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
14271926|NCT00420511|Metformin|metformin|mesh-list
14271927|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14271928|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14271929|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271930|NCT00420511|Incretins|incretins|mesh-ancestor
14271931|NCT00420511|Hormones|hormones|mesh-ancestor
15139092|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
14271932|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179180|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14012077|NCT02838823|Antibodies|antibodies|mesh-list
14012078|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14012079|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
14012080|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012081|NCT02838992|Cyclosporine|cyclosporine|mesh-list
14012082|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
14012083|NCT02838992|Cyclosporins|cyclosporins|mesh-list
14012084|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
14012085|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012086|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
14012087|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012088|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012089|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14012090|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
14012091|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012092|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012093|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14012094|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012095|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
14012096|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012097|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
14012098|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14012099|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
14012100|NCT02839044|Vitamin K|vitamin k|mesh-list
14012101|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
14012102|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14012103|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14012104|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012105|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
14012106|NCT02839044|Coagulants|coagulants|mesh-ancestor
14012107|NCT02839044|Vitamins|vitamins|mesh-ancestor
14012108|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
14012109|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012110|NCT02838940|Cefazolin|cefazolin|mesh-list
14012111|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012112|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012113|NCT02838758|Lidocaine|lidocaine|mesh-list
14012114|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
14012115|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
14012116|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012117|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012118|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
15139093|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139094|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15139095|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15139096|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15139097|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139098|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139099|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
15139100|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
15139101|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
15139102|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012119|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012120|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14012121|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14012122|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14012123|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14012124|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012125|NCT02838719|Dexamethasone|dexamethasone|mesh-list
14012126|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
14012127|NCT02838719|BB 1101|bb 1101|mesh-list
14012128|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012129|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
14012130|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
14012131|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012132|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012133|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012134|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
14012135|NCT02838719|Hormones|hormones|mesh-ancestor
14012136|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012137|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14012138|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012139|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14012140|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012141|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012142|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
14012143|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14012144|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
14012145|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012146|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012147|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012148|NCT02838589|Exenatide|exenatide|mesh-list
14012149|NCT02838589|Glucagon|glucagon|mesh-list
14012150|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14012151|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14012152|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012153|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14012154|NCT02838589|Incretins|incretins|mesh-ancestor
14012155|NCT02838589|Hormones|hormones|mesh-ancestor
14012156|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012157|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012158|NCT02838576|Estrogens|estrogens|mesh-list
14012159|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14012160|NCT02838576|Hormones|hormones|mesh-ancestor
14012161|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012162|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139103|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15139104|NCT04312347|Tamoxifen|tamoxifen|mesh-list
15139105|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15139106|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
15139107|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139108|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012163|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
14012164|NCT02838472|Vitamins|vitamins|mesh-ancestor
14012165|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
14012166|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012167|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
14012168|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012169|NCT02838472|Protective Agents|protective agents|mesh-ancestor
14012170|NCT02838238|Capecitabine|capecitabine|mesh-list
14012171|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14012172|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
14012173|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012174|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012175|NCT02838329|Ropivacaine|ropivacaine|mesh-list
14012176|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
14012177|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
14012178|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012179|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012180|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
14012181|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012182|NCT02838342|Interferons|interferons|mesh-list
14012183|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
14012184|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
14012185|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012186|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
14012187|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012188|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012189|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14012190|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
14012191|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012192|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012193|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14012194|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
14012195|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012196|NCT02838615|Dexamethasone|dexamethasone|mesh-list
14012197|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012198|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
14012199|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
14012200|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012201|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012202|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012203|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
14012204|NCT02838615|Hormones|hormones|mesh-ancestor
14012205|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012206|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14012207|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012208|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
14012209|NCT02838225|Docetaxel|docetaxel|mesh-list
14012210|NCT02838225|Doxorubicin|doxorubicin|mesh-list
15139109|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15139110|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139111|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15139112|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15139113|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15139114|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
15139115|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14012211|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14012212|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012213|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
14012214|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012215|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012216|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14012217|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
14012218|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012219|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012220|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14012221|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14012222|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14012223|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14012224|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14012225|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14012226|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14012227|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012228|NCT02838264|Itraconazole|itraconazole|mesh-list
14012229|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
14012230|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012231|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14012232|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14012233|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012234|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139116|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
15139117|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139118|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139119|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15139120|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
15139121|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15139122|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
15139123|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139124|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139125|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15139126|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139127|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
15139128|NCT04312243|Protective Agents|protective agents|mesh-ancestor
15139129|NCT04312438|Caseins|caseins|mesh-list
15139130|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
14012235|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14012236|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
14012237|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012238|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012239|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14012240|NCT02837978|Methotrexate|methotrexate|mesh-list
14012241|NCT02837978|Tacrolimus|tacrolimus|mesh-list
14012242|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14012243|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
15139131|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
15139132|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139133|NCT04312360|Metronidazole|metronidazole|mesh-list
15139134|NCT04312360|Fosfomycin|fosfomycin|mesh-list
15139135|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139136|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15139137|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15139138|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15179181|NCT03952481|Lifitegrast|lifitegrast|mesh-list
15179182|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15179183|NCT03952403|Bevacizumab|bevacizumab|mesh-list
15179184|NCT03952403|Carboplatin|carboplatin|mesh-list
15179185|NCT03952403|Pemetrexed|pemetrexed|mesh-list
15179186|NCT03952403|Antibodies|antibodies|mesh-list
15179187|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179188|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179189|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15179190|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15179191|NCT03952403|Growth Substances|growth substances|mesh-ancestor
14012244|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14012245|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012246|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14012247|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
14012248|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012249|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012250|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
14012251|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012252|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14012253|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012254|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
14012255|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012256|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14012257|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14012258|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
14012259|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14012260|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012261|NCT02837965|Doxycycline|doxycycline|mesh-list
14012262|NCT02837965|Prednisone|prednisone|mesh-list
14012263|NCT02837965|Methotrexate|methotrexate|mesh-list
14012264|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811559|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811560|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811561|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
14811562|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
14811563|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811564|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811565|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14811566|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14811567|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
14811568|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14811569|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14811570|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14811571|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14811572|NCT00846079|Regadenoson|regadenoson|mesh-list
14811573|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14811574|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14012265|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
14012266|NCT02837965|Hormones|hormones|mesh-ancestor
14012267|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012268|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012269|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14012270|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012271|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14012272|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
14012273|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14012274|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14012275|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
14012276|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012277|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
14012278|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012279|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14012280|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012281|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
14012282|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012283|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14012284|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012285|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012286|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
14012287|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14012288|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14012289|NCT02838173|Ropivacaine|ropivacaine|mesh-list
14012290|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
14012291|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
14012292|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012293|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012294|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
14012295|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012296|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
14012297|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012298|NCT02838030|Aspirin|aspirin|mesh-list
14012299|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14012300|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139139|NCT04312204|Gemcitabine|gemcitabine|mesh-list
15139140|NCT04312204|Carboplatin|carboplatin|mesh-list
15139141|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139142|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139143|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
15139144|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139145|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
15139146|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139147|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139148|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15139149|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
15139150|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139151|NCT04312282|Itraconazole|itraconazole|mesh-list
15139152|NCT04312282|Rifampin|rifampin|mesh-list
15139153|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
15139154|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139155|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15139156|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15139157|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139158|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139159|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15139160|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
15139161|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139162|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139163|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15139164|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15139165|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
15139166|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15139167|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
15139168|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15139169|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15139170|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15139171|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15139172|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15139173|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15139174|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15139175|NCT04312152|Vitamins|vitamins|mesh-list
14012301|NCT02838030|Analgesics|analgesics|mesh-ancestor
14012302|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
14012303|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012304|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012305|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271933|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14271934|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
14271935|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271936|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271937|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14271938|NCT00420628|Tobramycin|tobramycin|mesh-list
14271939|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14271940|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271941|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14271942|NCT00420641|Paroxetine|paroxetine|mesh-list
14271943|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14271944|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14271945|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271946|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271947|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271948|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
14271949|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271950|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14271951|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
14271952|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271953|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14271954|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14271955|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14271956|NCT00420771|Gabapentin|gabapentin|mesh-list
14271957|NCT00420771|Analgesics|analgesics|mesh-ancestor
15139176|NCT04312152|Vitamin E|vitamin e|mesh-list
14012306|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012307|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14012308|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14012309|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012310|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14012311|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14012312|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012313|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
14012314|NCT02837835|Ceftazidime|ceftazidime|mesh-list
14012315|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012316|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139177|NCT04312152|Tocopherols|tocopherols|mesh-list
15139178|NCT04312152|Folic Acid|folic acid|mesh-list
15139179|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
14012317|NCT02837614|Acetaminophen|acetaminophen|mesh-list
14012318|NCT02837614|Amoxicillin|amoxicillin|mesh-list
14012319|NCT02837614|Dexamethasone|dexamethasone|mesh-list
14012320|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
14012321|NCT02837614|BB 1101|bb 1101|mesh-list
14012322|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012323|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
14012324|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
14012325|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012326|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012327|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012328|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
14012329|NCT02837614|Hormones|hormones|mesh-ancestor
14012330|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012331|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14012332|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012333|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
14012334|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012335|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012336|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012337|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012338|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14012339|NCT02837614|Analgesics|analgesics|mesh-ancestor
14012340|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
14012341|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
14012342|NCT02837640|Levodopa|levodopa|mesh-list
14012343|NCT02837640|Carbidopa|carbidopa|mesh-list
14012344|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14012345|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14012346|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14012347|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
14012348|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012349|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012350|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012351|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14012352|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012353|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14012354|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
14012355|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
14012356|NCT02837770|Diclofenac|diclofenac|mesh-list
14012357|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14012358|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
14012359|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15139180|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
15139181|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139182|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
15139183|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139184|NCT04312152|Protective Agents|protective agents|mesh-ancestor
15139185|NCT04312152|Hematinics|hematinics|mesh-ancestor
15139186|NCT04311762|Cisplatin|cisplatin|mesh-list
15139187|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139188|NCT04312009|Losartan|losartan|mesh-list
15139189|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15139190|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15139191|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15139192|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15139193|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139194|NCT04312048|Isosorbide|isosorbide|mesh-list
15139195|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15139196|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15139197|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15139198|NCT04312048|Diuretics|diuretics|mesh-ancestor
15139199|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
14012360|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14012361|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139200|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139201|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139202|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14012362|NCT02837770|Analgesics|analgesics|mesh-ancestor
14012363|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
14012364|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012365|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012366|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012367|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012368|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14012369|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012370|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025101|NCT02753062|Rituximab|rituximab|mesh-list
14025102|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14025103|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025104|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025105|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
14025106|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025107|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025108|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14025109|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
14025110|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025111|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
14025112|NCT02753088|Mannitol|mannitol|mesh-list
14025113|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
14025114|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14025115|NCT02753088|Diuretics|diuretics|mesh-ancestor
14025116|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
14025117|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025118|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14025119|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
14025120|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14025121|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025122|NCT02752646|Ketorolac|ketorolac|mesh-list
14025123|NCT02752646|Nepafenac|nepafenac|mesh-list
14025124|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14025125|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025126|NCT02752646|Analgesics|analgesics|mesh-ancestor
14025127|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
15139203|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139204|NCT04312061|Tramadol|tramadol|mesh-list
15139205|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14025128|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025129|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025130|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025131|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025132|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14025133|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025134|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025135|NCT02752841|Vitamin D|vitamin d|mesh-list
14025136|NCT02752841|Vitamins|vitamins|mesh-ancestor
14025137|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
14025138|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025139|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14025140|NCT02752503|Nalmefene|nalmefene|mesh-list
14025141|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14025142|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025143|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
14025144|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025145|NCT02752555|Antioxidants|antioxidants|mesh-list
14025146|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025147|NCT02752555|Protective Agents|protective agents|mesh-ancestor
14025148|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025149|NCT02752724|Ketamine|ketamine|mesh-list
14025150|NCT02752724|Methohexital|methohexital|mesh-list
14025151|NCT02752724|Analgesics|analgesics|mesh-ancestor
14025152|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
14025153|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025154|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025155|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14025156|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14025157|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
14025158|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
14025159|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025160|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14025161|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14025162|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292434|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14012371|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
14012372|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14012373|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012374|NCT02837146|Methotrexate|methotrexate|mesh-list
14012375|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14012376|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
14012377|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14012378|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012379|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14012380|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
14012381|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012382|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012383|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
14012384|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012385|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14012386|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012387|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
14012388|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012389|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14012390|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
14012391|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14012392|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
14012393|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14012394|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012395|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
14012396|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14012397|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14271958|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
14271959|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271960|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271961|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
14271962|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14271963|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14271964|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14271965|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14271966|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14271967|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14271968|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14271969|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271970|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
14271971|NCT00420784|Interferons|interferons|mesh-list
14271972|NCT00420784|Ribavirin|ribavirin|mesh-list
14271973|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
14271974|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
14271975|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14271976|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271977|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
14271978|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14271979|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
14271980|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14271981|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
14271982|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271983|NCT00420849|Dexamethasone|dexamethasone|mesh-list
14271984|NCT00420849|Lenalidomide|lenalidomide|mesh-list
15139206|NCT04312061|Narcotics|narcotics|mesh-ancestor
15139207|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139208|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139209|NCT04312061|Analgesics|analgesics|mesh-ancestor
15139210|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
14271985|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14271986|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
14271987|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
14271988|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271989|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14271990|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14271991|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
14271992|NCT00420849|Hormones|hormones|mesh-ancestor
14271993|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14271994|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14271995|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14271996|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
15139211|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14271997|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14271998|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14271999|NCT00420849|Growth Substances|growth substances|mesh-ancestor
14012398|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012399|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
14012400|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012401|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012402|NCT02837198|Dotinurad|dotinurad|mesh-list
14012403|NCT02837198|FYX-051|fyx-051|mesh-list
14012404|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
14012405|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
14012406|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012407|NCT02837198|Renal Agents|renal agents|mesh-ancestor
14012408|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012409|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012410|NCT02837094|Insulin|insulin|mesh-list
14012411|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14012412|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012413|NCT02837003|Aspirin|aspirin|mesh-list
14012414|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14012415|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14012416|NCT02837003|Analgesics|analgesics|mesh-ancestor
14012417|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
14012418|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012419|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012420|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012421|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012422|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14012423|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14012424|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012425|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14012426|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14012427|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012428|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
14012429|NCT02836977|Tegafur|tegafur|mesh-list
14012430|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14012431|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
14012432|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012433|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012434|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
14012435|NCT02836639|Etoposide|etoposide|mesh-list
14012436|NCT02836639|Busulfan|busulfan|mesh-list
14012437|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14012438|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14012439|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012440|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14012441|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14012442|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012443|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012444|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
14012445|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012446|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
14012447|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012448|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14012449|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14012450|NCT02836847|Trastuzumab|trastuzumab|mesh-list
14012451|NCT02836847|Cetuximab|cetuximab|mesh-list
14012452|NCT02836847|Everolimus|everolimus|mesh-list
14012453|NCT02836847|Sorafenib|sorafenib|mesh-list
14012454|NCT02836847|Lapatinib|lapatinib|mesh-list
14012455|NCT02836847|Gefitinib|gefitinib|mesh-list
14012456|NCT02836847|Crizotinib|crizotinib|mesh-list
14012457|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14012458|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012459|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012460|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
14012461|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012462|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14012463|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012464|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012465|NCT02836821|Rifampin|rifampin|mesh-list
14012466|NCT02836821|Apatinib|apatinib|mesh-list
14012467|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012468|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14012469|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012470|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012471|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14012472|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
14012473|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012474|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012475|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
14012476|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14012477|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14012478|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14012479|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14012480|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14012481|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14012482|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14012483|NCT02836548|Vorinostat|vorinostat|mesh-list
14012484|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14012485|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012486|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012487|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012488|NCT02836743|Melatonin|melatonin|mesh-list
14012489|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
14012490|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012491|NCT02836743|Protective Agents|protective agents|mesh-ancestor
14012492|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012493|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012494|NCT02836704|Metformin|metformin|mesh-list
14012495|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
14012496|NCT02836704|Acarbose|acarbose|mesh-list
14012497|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14012498|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012499|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14012500|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012501|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012502|NCT02836795|Antibodies|antibodies|mesh-list
14012503|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14012504|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
14012505|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012506|NCT02836509|Acetaminophen|acetaminophen|mesh-list
14012507|NCT02836509|Ibuprofen|ibuprofen|mesh-list
14012508|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14012509|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14012510|NCT02836509|Analgesics|analgesics|mesh-ancestor
14012511|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
14012512|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012513|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012514|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012515|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012516|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14012517|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012518|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012519|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
14012520|NCT02836483|Linezolid|linezolid|mesh-list
14012521|NCT02836483|Delpazolid|delpazolid|mesh-list
14012522|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
14012523|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012524|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139212|NCT04311489|Ularitide|ularitide|mesh-list
14012525|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14012526|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012527|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012528|NCT02836171|Itraconazole|itraconazole|mesh-list
14012529|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14012530|NCT02836171|Apatinib|apatinib|mesh-list
14012531|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012532|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14012533|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012534|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012535|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
14012536|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139213|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15139214|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
14012537|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14012538|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14012539|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14012540|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
14012541|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012542|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012543|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14012544|NCT02836288|Ketamine|ketamine|mesh-list
14012545|NCT02836288|Analgesics|analgesics|mesh-ancestor
14012546|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
14012547|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012548|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012549|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14012550|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14012551|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
14012552|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
14012553|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012554|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14012555|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14012556|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012557|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012558|NCT02836184|Niacin|niacin|mesh-list
14012559|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
14012560|NCT02836184|Niacinamide|niacinamide|mesh-list
14012561|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
14012562|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012563|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14012564|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
14012565|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012566|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14012567|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
14012568|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
14012569|NCT02836184|Vitamins|vitamins|mesh-ancestor
14012570|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
14012571|NCT02836184|Antacids|antacids|mesh-ancestor
14012572|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012573|NCT02836353|Rifaximin|rifaximin|mesh-list
14012574|NCT02836353|Somatostatin|somatostatin|mesh-list
14012575|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012576|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012577|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012578|NCT02836353|Hormones|hormones|mesh-ancestor
14012579|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012580|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012581|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
14012582|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14012583|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012584|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012585|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14012586|NCT02836431|Analgesics|analgesics|mesh-ancestor
14012587|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
14012588|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012589|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14012590|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14012591|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14012592|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
14012593|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012594|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012595|NCT02835794|Azacitidine|azacitidine|mesh-list
14012596|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
14012597|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14012598|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
14012599|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012600|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012601|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012602|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14012603|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14012604|NCT02836028|Temozolomide|temozolomide|mesh-list
14012605|NCT02836028|Talazoparib|talazoparib|mesh-list
14012606|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14012607|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
14012608|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012609|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012610|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14012611|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025163|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025164|NCT02752529|Tacrolimus|tacrolimus|mesh-list
14025165|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14025166|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
14025167|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272000|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
14272001|NCT00420927|Adalimumab|adalimumab|mesh-list
15139215|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139216|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139217|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14562037|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562038|NCT00002825|Docetaxel|docetaxel|mesh-list
14012612|NCT02835833|Bevacizumab|bevacizumab|mesh-list
14012613|NCT02835833|Nintedanib|nintedanib|mesh-list
14012614|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14012615|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012616|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14012617|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14012618|NCT02835833|Growth Substances|growth substances|mesh-ancestor
14012619|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012620|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
14012621|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14012622|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012623|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012624|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
14012625|NCT02836002|Piperaquine|piperaquine|mesh-list
14012626|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
14562039|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562040|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562041|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14012627|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14012628|NCT02836002|Atovaquone|atovaquone|mesh-list
14012629|NCT02836002|Proguanil|proguanil|mesh-list
14012630|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14012631|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
14012632|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14012633|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14012634|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012635|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14012636|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012637|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012638|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14012639|NCT02836002|Renal Agents|renal agents|mesh-ancestor
14012640|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
14012641|NCT02835742|Sargramostim|sargramostim|mesh-list
14012642|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
14012643|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012644|NCT02835729|Cytarabine|cytarabine|mesh-list
14012645|NCT02835729|Idarubicin|idarubicin|mesh-list
14012646|NCT02835729|Tryptophan|tryptophan|mesh-list
14012647|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14012648|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
14012649|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562042|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562043|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562044|NCT00002826|Paclitaxel|paclitaxel|mesh-list
14562045|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562046|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562047|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562048|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562049|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
14012650|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012651|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
14272002|NCT00420927|Methotrexate|methotrexate|mesh-list
14272003|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14272004|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
14272005|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14272006|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272007|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272008|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
14272009|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272010|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272011|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272012|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272013|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14272014|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272015|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
14272016|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272017|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14272018|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012652|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012653|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012654|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
14012655|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012656|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14012657|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14012658|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14012659|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012660|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14012661|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
14012662|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14012663|NCT02835716|Ustekinumab|ustekinumab|mesh-list
14012664|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
14012665|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
14012666|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012667|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012668|NCT02835469|Menotropins|menotropins|mesh-list
14012669|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14012670|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
14012671|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14012672|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012673|NCT02835664|Niacinamide|niacinamide|mesh-list
14012674|NCT02835664|Niacin|niacin|mesh-list
14012675|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
14012676|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
14012677|NCT02835664|Vitamins|vitamins|mesh-ancestor
14012678|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
14012679|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012680|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14012681|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
14012682|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012683|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14012684|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
14012685|NCT02835586|Paclitaxel|paclitaxel|mesh-list
14012686|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14012687|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012688|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
14012689|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
14012690|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
14012691|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012692|NCT02835521|Triamcinolone|triamcinolone|mesh-list
14012693|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14012694|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14012695|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14012696|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012697|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
14012698|NCT02835521|Hormones|hormones|mesh-ancestor
14012699|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012700|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012701|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012702|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
14012703|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012704|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562050|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562051|NCT00002827|Cobalt|cobalt|mesh-list
14012705|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14012706|NCT02835534|Plasminogen|plasminogen|mesh-list
14012707|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14012708|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14012709|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562052|NCT00002827|Doxorubicin|doxorubicin|mesh-list
14562053|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14562054|NCT00002827|Bleomycin|bleomycin|mesh-list
14562055|NCT00002827|Etoposide|etoposide|mesh-list
14562056|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
14562057|NCT00002827|Vincristine|vincristine|mesh-list
14562058|NCT00002827|Razoxane|razoxane|mesh-list
14562059|NCT00002827|Lenograstim|lenograstim|mesh-list
14562060|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15139218|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
15139219|NCT04311489|Diuretics|diuretics|mesh-ancestor
15139220|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
15139221|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15139222|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15139223|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012710|NCT02835404|Nedaplatin|nedaplatin|mesh-list
14012711|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562061|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562062|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14012712|NCT02835391|Surgiflo|surgiflo|mesh-list
14012713|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
14012714|NCT02835391|Coagulants|coagulants|mesh-ancestor
14012715|NCT02835079|Tamoxifen|tamoxifen|mesh-list
14012716|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14012717|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
14811575|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
14811576|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
14012718|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012719|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012720|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14012721|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012722|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14012723|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14012724|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14012725|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
14012726|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14012727|NCT02835170|Antibodies|antibodies|mesh-list
14272019|NCT00420992|Naltrexone|naltrexone|mesh-list
14272020|NCT00420992|Morphine|morphine|mesh-list
14272021|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14272022|NCT00420992|Narcotics|narcotics|mesh-ancestor
14272023|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14272024|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272025|NCT00420992|Analgesics|analgesics|mesh-ancestor
14272026|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
14272027|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272028|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14272029|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14272030|NCT00421148|Bromides|bromides|mesh-list
14272031|NCT00421148|Rocuronium|rocuronium|mesh-list
14272032|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
14272033|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14272034|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14272035|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14272036|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272037|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272038|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
14272039|NCT00421174|Etanercept|etanercept|mesh-list
14272040|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272041|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
14272042|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
14272043|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272044|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272045|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272046|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
14272047|NCT00421174|Hormones|hormones|mesh-ancestor
14272048|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272049|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14272050|NCT00421174|Protective Agents|protective agents|mesh-ancestor
14272051|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14272052|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14272053|NCT00421174|Analgesics|analgesics|mesh-ancestor
14272054|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
14272055|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272056|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272057|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
14272058|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
14272059|NCT00421343|Alendronate|alendronate|mesh-list
14272060|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
14272061|NCT00421343|Calcium|calcium|mesh-list
14272062|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14272063|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272064|NCT00421343|Vitamins|vitamins|mesh-ancestor
14272065|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
14272066|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14272067|NCT00421343|Antacids|antacids|mesh-ancestor
14272068|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272069|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272070|NCT00421603|Topiramate|topiramate|mesh-list
14272071|NCT00421603|Adderall|adderall|mesh-list
14012728|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
14012729|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012730|NCT02835183|Insulin|insulin|mesh-list
14272072|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
14811577|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272073|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14272074|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012731|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14012732|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012733|NCT02835131|Pasireotide|pasireotide|mesh-list
14012734|NCT02835131|Hormones|hormones|mesh-ancestor
14012735|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012736|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012737|NCT02834676|Ethanol|ethanol|mesh-list
14012738|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14012739|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012740|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14272075|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14272076|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
14272077|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14272078|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272079|NCT00421733|Vitamins|vitamins|mesh-ancestor
14272080|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
14272081|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14272082|NCT00421889|Paclitaxel|paclitaxel|mesh-list
14272083|NCT00421889|Carboplatin|carboplatin|mesh-list
14272084|NCT00421889|Belinostat|belinostat|mesh-list
14272085|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14272086|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272087|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
14272088|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
14272089|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
14272090|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272091|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14272092|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272093|NCT00421928|Oxycodone|oxycodone|mesh-list
14272094|NCT00421928|Tapentadol|tapentadol|mesh-list
14272095|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14272096|NCT00421928|Narcotics|narcotics|mesh-ancestor
14272097|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14272098|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272099|NCT00421928|Analgesics|analgesics|mesh-ancestor
14272100|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
14012741|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012742|NCT02834637|Vaccines|vaccines|mesh-list
14012743|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
14012744|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012745|NCT02834754|Vedolizumab|vedolizumab|mesh-list
14012746|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012747|NCT02834845|Sevoflurane|sevoflurane|mesh-list
14012748|NCT02834845|Desflurane|desflurane|mesh-list
14012749|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14012750|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14012751|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
14012752|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
14012753|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012754|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012755|NCT02834507|Levodopa|levodopa|mesh-list
14012756|NCT02834507|Carbidopa|carbidopa|mesh-list
14012757|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14012758|NCT02834507|Entacapone|entacapone|mesh-list
14012759|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14012760|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14012761|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
14012762|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012763|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012764|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012765|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14012766|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012767|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14012768|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
14012769|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
14012770|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14012771|NCT02834546|Sorafenib|sorafenib|mesh-list
14012772|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012773|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14012774|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012775|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012776|NCT02834260|Dexamethasone|dexamethasone|mesh-list
14012777|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012778|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
14012779|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
14272101|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012780|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012781|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012782|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012783|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
14012784|NCT02834260|Hormones|hormones|mesh-ancestor
14012785|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012786|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14012787|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025168|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14025169|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025170|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025171|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14025172|NCT02752191|Hematinics|hematinics|mesh-ancestor
14025173|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14025174|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14025175|NCT02752113|Metformin|metformin|mesh-list
14025176|NCT02752113|Empagliflozin|empagliflozin|mesh-list
14025177|NCT02752113|Linagliptin|linagliptin|mesh-list
14025178|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14025179|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025180|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14025181|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025182|NCT02752113|Incretins|incretins|mesh-ancestor
14025183|NCT02752113|Hormones|hormones|mesh-ancestor
14025184|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025185|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14025186|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
14025187|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025188|NCT02752204|Rituximab|rituximab|mesh-list
14025189|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025190|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025191|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
14025192|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025193|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025194|NCT02752308|Atropine|atropine|mesh-list
14025195|NCT02752308|Epinephrine|epinephrine|mesh-list
14025196|NCT02752308|Fentanyl|fentanyl|mesh-list
14025197|NCT02752308|Bupivacaine|bupivacaine|mesh-list
14025198|NCT02752308|Neostigmine|neostigmine|mesh-list
14025199|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025200|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
14025201|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025202|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025203|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
14025204|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025205|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14025206|NCT02752308|Narcotics|narcotics|mesh-ancestor
14025207|NCT02752308|Analgesics|analgesics|mesh-ancestor
14025208|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14025209|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14025210|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
14025211|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14025212|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14025213|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
14025214|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025215|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025216|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14025217|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14025218|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
14025219|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14025220|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
14025221|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
14025222|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
14025223|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14025224|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14025225|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
14025226|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14025227|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14025228|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
14025229|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14025230|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025231|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14025232|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
14025233|NCT02752334|Bupivacaine|bupivacaine|mesh-list
14025234|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025235|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
15139224|NCT04311671|Ivermectin|ivermectin|mesh-list
14012788|NCT02834286|Dexamethasone|dexamethasone|mesh-list
14012789|NCT02834286|Rituximab|rituximab|mesh-list
14012790|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012791|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
14012792|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
14012793|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012794|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012795|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012796|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
14012797|NCT02834286|Hormones|hormones|mesh-ancestor
14012798|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012799|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14012800|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012801|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14012802|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
14012803|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012804|NCT02834052|Poly I-C|poly i-c|mesh-list
14012805|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
14012806|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14012807|NCT02834052|Poly ICLC|poly iclc|mesh-list
14012808|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14012809|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012810|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
14012811|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
14012812|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012813|NCT02834052|Laxatives|laxatives|mesh-ancestor
14012814|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14012815|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
14012816|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012817|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
14272102|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14272103|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14272104|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14272105|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272106|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
14272107|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272108|NCT00421993|Adapalene|adapalene|mesh-list
14272109|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14272110|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14272111|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272112|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14272113|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14272114|NCT00421993|Analgesics|analgesics|mesh-ancestor
14272115|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
14272116|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272117|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272118|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272119|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272120|NCT00422032|Clofarabine|clofarabine|mesh-list
14272121|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272122|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
14272123|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272124|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272125|NCT00422058|Liraglutide|liraglutide|mesh-list
14272126|NCT00422058|Orlistat|orlistat|mesh-list
14272127|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14272128|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272129|NCT00422058|Incretins|incretins|mesh-ancestor
14272130|NCT00422058|Hormones|hormones|mesh-ancestor
14272131|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272132|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272133|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272134|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14272135|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14272136|NCT00422084|Artesunate|artesunate|mesh-list
14272137|NCT00422084|Lumefantrine|lumefantrine|mesh-list
14012818|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012819|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012820|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14012821|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14012822|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272138|NCT00422084|Artemether|artemether|mesh-list
14272139|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14012823|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012824|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139225|NCT04311671|Moxidectin|moxidectin|mesh-list
15139226|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15139227|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139228|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
15139229|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
15139230|NCT04311697|Phentolamine|phentolamine|mesh-list
15139231|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
15139232|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15139233|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15139234|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
15139235|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139236|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139237|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139238|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15139239|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15139240|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139241|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15139242|NCT04311697|Protective Agents|protective agents|mesh-ancestor
14012825|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
14012826|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
14012827|NCT02833805|Fludarabine|fludarabine|mesh-list
14012828|NCT02833805|Tacrolimus|tacrolimus|mesh-list
14012829|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
14012830|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14012831|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012832|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
14012833|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012834|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14012835|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14012836|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
14012837|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012838|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012839|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14012840|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14012841|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012842|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14012843|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14012844|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
14012845|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012846|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012847|NCT02833987|Warfarin|warfarin|mesh-list
14012848|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
14012849|NCT02833987|Dabigatran|dabigatran|mesh-list
14012850|NCT02833987|Apixaban|apixaban|mesh-list
14012851|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
14012852|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15139243|NCT04311580|Mitomycins|mitomycins|mesh-list
15139244|NCT04311580|Mitomycin|mitomycin|mesh-list
15139245|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15139246|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139247|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
14012853|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
14012854|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14012855|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139248|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139249|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15139250|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139251|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
15139252|NCT04311632|Tacrolimus|tacrolimus|mesh-list
15139253|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15139254|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
15139255|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139256|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15139257|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272140|NCT00422084|Pyronaridine|pyronaridine|mesh-list
14272141|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
14272142|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14272143|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14272144|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272145|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272146|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
14272147|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
14272148|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15139258|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012856|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139259|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14012857|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012858|NCT02833766|Doxorubicin|doxorubicin|mesh-list
14272149|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
14272150|NCT00422097|Epothilones|epothilones|mesh-list
15139260|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139261|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15139262|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
14272151|NCT00422097|Famotidine|famotidine|mesh-list
14272152|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
14272153|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
15139263|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272154|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
14272155|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272156|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272157|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14272158|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272159|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14272160|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
14272161|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
14272162|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272163|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272164|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14811578|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012859|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14012860|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012861|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14012862|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14012863|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012864|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012865|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
14012866|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012867|NCT02833610|Denosumab|denosumab|mesh-list
14012868|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14012869|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012870|NCT02833480|Fluticasone|fluticasone|mesh-list
14012871|NCT02833480|Budesonide|budesonide|mesh-list
14012872|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
14012873|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012874|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14012875|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
14012876|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012877|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012878|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14012879|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
14012880|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
14012881|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14012882|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
14012883|NCT02833480|Hormones|hormones|mesh-ancestor
14012884|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14012885|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14012886|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14012887|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14012888|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
14012889|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811579|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811580|NCT00846118|Pitavastatin|pitavastatin|mesh-list
15139264|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012890|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012891|NCT02833506|Sirolimus|sirolimus|mesh-list
14012892|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14012893|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012894|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14012895|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012896|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
14012897|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14012898|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
14012899|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012900|NCT02833701|Vitamins|vitamins|mesh-list
14012901|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
14012902|NCT02833701|Bevacizumab|bevacizumab|mesh-list
14012903|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14012904|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
14012905|NCT02833701|Antibodies|antibodies|mesh-list
14012906|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
14012907|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15139265|NCT04311424|Tirzepatide|tirzepatide|mesh-list
14012908|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
14292435|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15139266|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15139267|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139268|NCT04311424|Incretins|incretins|mesh-ancestor
15139269|NCT04311424|Hormones|hormones|mesh-ancestor
14012909|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012910|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14012911|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14012912|NCT02833701|Growth Substances|growth substances|mesh-ancestor
14012913|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012914|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
14012915|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
14012916|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
14012917|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012918|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
14012919|NCT02833701|Protective Agents|protective agents|mesh-ancestor
14012920|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
14811581|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14811582|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14811583|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14811584|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
15139270|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139271|NCT04311658|Isosorbide|isosorbide|mesh-list
14012921|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14012922|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012923|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012924|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14012925|NCT02833688|Analgesics|analgesics|mesh-ancestor
14012926|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
14012927|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012928|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14012929|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15139272|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15139273|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15139274|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15139275|NCT04311658|Diuretics|diuretics|mesh-ancestor
14012930|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14012931|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14012932|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14012933|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012934|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
14012935|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14012936|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14012937|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
14012938|NCT02833233|Nivolumab|nivolumab|mesh-list
14012939|NCT02833233|Ipilimumab|ipilimumab|mesh-list
15139276|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
15139277|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139278|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139279|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14012940|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14012941|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012942|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14012943|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012944|NCT02833584|Acetaminophen|acetaminophen|mesh-list
14012945|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14012946|NCT02833584|Analgesics|analgesics|mesh-ancestor
14012947|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
14012948|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012949|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012950|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
14012951|NCT02833025|Thrombin|thrombin|mesh-list
14012952|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
14012953|NCT02833025|Coagulants|coagulants|mesh-ancestor
14012954|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
14012955|NCT02833038|Analgesics|analgesics|mesh-ancestor
14012956|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
14012957|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012958|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012959|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
14012960|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14012961|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14272165|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15139280|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012962|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
14012963|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14012964|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14012965|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012966|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14012967|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
14012968|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14012969|NCT02833103|Pinaverium|pinaverium|mesh-list
14012970|NCT02833103|Bromides|bromides|mesh-list
14012971|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
14012972|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14012973|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14012974|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012975|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14012976|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012977|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
14012978|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
14012979|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012980|NCT02833155|Exemestane|exemestane|mesh-list
14012981|NCT02833155|Entinostat|entinostat|mesh-list
14012982|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14012983|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14012984|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14012985|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14012986|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14012987|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14012988|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
14012989|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139281|NCT04311645|Charcoal|charcoal|mesh-list
15139282|NCT04311645|Antidotes|antidotes|mesh-ancestor
15139283|NCT04311645|Protective Agents|protective agents|mesh-ancestor
15139284|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139285|NCT04311255|Anesthetics|anesthetics|mesh-list
14012990|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012991|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14012992|NCT02833116|Dexamethasone|dexamethasone|mesh-list
14012993|NCT02833116|Betamethasone|betamethasone|mesh-list
14012994|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14012995|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
14012996|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
14012997|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14012998|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14012999|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14013000|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
14013001|NCT02833116|Hormones|hormones|mesh-ancestor
14013002|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013003|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14013004|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013005|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14013006|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
14811585|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811586|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811587|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14811588|NCT00846131|Sorafenib|sorafenib|mesh-list
14811589|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811590|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14811591|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811592|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814422|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814423|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814424|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139286|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139287|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139288|NCT04310995|Nicorandil|nicorandil|mesh-list
14013007|NCT02832973|Ramipril|ramipril|mesh-list
14013008|NCT02832973|Bisoprolol|bisoprolol|mesh-list
14013009|NCT02832973|Amiloride|amiloride|mesh-list
14013010|NCT02832973|Furosemide|furosemide|mesh-list
14013011|NCT02832973|Spironolactone|spironolactone|mesh-list
14013012|NCT02832973|Diuretics|diuretics|mesh-list
14013013|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14013014|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
14272166|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14272167|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139289|NCT04310995|Diltiazem|diltiazem|mesh-list
14292436|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
15139290|NCT04310995|Isosorbide|isosorbide|mesh-list
14013015|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013016|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14013017|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14013018|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013019|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14272168|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272169|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272170|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272171|NCT00422162|Analgesics|analgesics|mesh-ancestor
14272172|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
14272173|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272174|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
14272175|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14272176|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
14272177|NCT00422201|Mifepristone|mifepristone|mesh-list
14272178|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14272179|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
14272180|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14272181|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272182|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14272183|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14272184|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14272185|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
14272186|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14272187|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14272188|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
14272189|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272190|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
14272191|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14272192|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14272193|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
14272194|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
14272195|NCT00422227|Etanercept|etanercept|mesh-list
14272196|NCT00422227|Methotrexate|methotrexate|mesh-list
14272197|NCT00422227|Leflunomide|leflunomide|mesh-list
14272198|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14272199|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
14272200|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14272201|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272202|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272203|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
14272204|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272205|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272206|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272207|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272208|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14272209|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272210|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
14272211|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272212|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14272213|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
14272214|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14272215|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14272216|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272217|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14272218|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14272219|NCT00422227|Analgesics|analgesics|mesh-ancestor
14272220|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
14272221|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272222|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272223|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272224|NCT00422292|Vaccines|vaccines|mesh-list
14272225|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
14272226|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272227|NCT00422383|Rituximab|rituximab|mesh-list
14272228|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272229|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272230|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
14811593|NCT00846144|Copper|copper|mesh-list
14013020|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
14013021|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013022|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14013023|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139291|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14013024|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013025|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14013026|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
14013027|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
14013028|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013029|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14013030|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14013031|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14013032|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
14013033|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013034|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14013035|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14013036|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14013037|NCT02832778|Tenofovir|tenofovir|mesh-list
14013038|NCT02832778|Lamivudine|lamivudine|mesh-list
14013039|NCT02832778|Zidovudine|zidovudine|mesh-list
14013040|NCT02832778|Emtricitabine|emtricitabine|mesh-list
14013041|NCT02832778|Efavirenz|efavirenz|mesh-list
14013042|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14013043|NCT02832778|Isoniazid|isoniazid|mesh-list
14013044|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
14013045|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013046|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14013047|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14013048|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013049|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013050|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14013051|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14013052|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
14013053|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14013054|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15139292|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15139293|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15139294|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14013055|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14013056|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14013057|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14013058|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14013059|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
14013060|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15139295|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139296|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139297|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15139298|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139299|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139300|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15139301|NCT04310995|Diuretics|diuretics|mesh-ancestor
15139302|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
15139303|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15139304|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15139305|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
15139306|NCT04310995|Vitamins|vitamins|mesh-ancestor
15139307|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
15139308|NCT04310930|Azithromycin|azithromycin|mesh-list
15139309|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
15139310|NCT04310930|Clarithromycin|clarithromycin|mesh-list
15139311|NCT04310930|Doxycycline|doxycycline|mesh-list
15139312|NCT04310930|Linezolid|linezolid|mesh-list
15139313|NCT04310930|Imipenem|imipenem|mesh-list
15139314|NCT04310930|Amikacin|amikacin|mesh-list
15139315|NCT04310930|Ethambutol|ethambutol|mesh-list
15139316|NCT04310930|Rifabutin|rifabutin|mesh-list
15139317|NCT04310930|Tigecycline|tigecycline|mesh-list
15139318|NCT04310930|Bedaquiline|bedaquiline|mesh-list
15139319|NCT04310930|Clofazimine|clofazimine|mesh-list
15139320|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15139321|NCT04310930|Cefoxitin|cefoxitin|mesh-list
15139322|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14013061|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14013062|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14013063|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15139323|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139324|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15139325|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15139326|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139327|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013064|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
14013065|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14013066|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
14013067|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14013068|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
14013069|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013070|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013071|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
14013072|NCT02832999|Liraglutide|liraglutide|mesh-list
14013073|NCT02832999|Vildagliptin|vildagliptin|mesh-list
14013074|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14013075|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013076|NCT02832999|Incretins|incretins|mesh-ancestor
14013077|NCT02832999|Hormones|hormones|mesh-ancestor
14013078|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013079|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14013080|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
14013081|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272231|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272232|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272233|NCT00422422|Brivaracetam|brivaracetam|mesh-list
14272234|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
15139328|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139329|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15139330|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15139331|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15139332|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
15139333|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15139334|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15139335|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
15139336|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15139337|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15139338|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
14013082|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025236|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025237|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025238|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
14025239|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025240|NCT02752334|Analgesics|analgesics|mesh-ancestor
15139339|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15139340|NCT04310930|Renal Agents|renal agents|mesh-ancestor
15139341|NCT04310943|Paclitaxel|paclitaxel|mesh-list
15139342|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15139343|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139344|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
15139345|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
15139346|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
15139347|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025241|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14025242|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
14025243|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14025244|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025245|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025246|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14025247|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
14025248|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14025249|NCT02751996|Tenofovir|tenofovir|mesh-list
14025250|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
14025251|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025252|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14025253|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14025254|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025255|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025256|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14025257|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14025258|NCT02751918|Doxorubicin|doxorubicin|mesh-list
14025259|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14025260|NCT02751918|Maytansine|maytansine|mesh-list
14025261|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14025262|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139348|NCT04311099|Ropivacaine|ropivacaine|mesh-list
15139349|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025263|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15139350|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
15139351|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013083|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
14013084|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14013085|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14013086|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
14013087|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14013088|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14013089|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013090|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
14013091|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013092|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013093|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14013094|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
14013095|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
14013096|NCT02832713|Protective Agents|protective agents|mesh-ancestor
14013097|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14013098|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013099|NCT02832700|Caseins|caseins|mesh-list
14013100|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
14013101|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
14013102|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013103|NCT02832531|Aspirin|aspirin|mesh-list
14013104|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
14013105|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14013106|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14013107|NCT02832531|Analgesics|analgesics|mesh-ancestor
14013108|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
14013109|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013110|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013111|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013112|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14013113|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14013114|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14013115|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013116|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14013117|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14013118|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013119|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
14013120|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14013121|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
14013122|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14013123|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
14013124|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
14013125|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
14013126|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
14013127|NCT02832726|Vitamins|vitamins|mesh-ancestor
14013128|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
14013129|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013130|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
14013131|NCT02832726|Hematinics|hematinics|mesh-ancestor
14013132|NCT02832544|Vitamin K|vitamin k|mesh-list
14013133|NCT02832544|Warfarin|warfarin|mesh-list
14013134|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
14013135|NCT02832544|Vitamins|vitamins|mesh-ancestor
14013136|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
14013137|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013138|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
14013139|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14013140|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
14013141|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14013142|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
14013143|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013144|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013145|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14013146|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14013147|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
15139352|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139353|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
15139354|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139355|NCT04311177|Losartan|losartan|mesh-list
15139356|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15139357|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15139358|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14013148|NCT02832544|Coagulants|coagulants|mesh-ancestor
14013149|NCT02832635|Temozolomide|temozolomide|mesh-list
14013150|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14013151|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
14013152|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013153|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013154|NCT02832336|Caffeine|caffeine|mesh-list
14013155|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
14013156|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139359|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15139360|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139361|NCT04310683|Hormones|hormones|mesh-list
15139362|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139363|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139364|NCT04310579|Midazolam|midazolam|mesh-list
15139365|NCT04310579|Oxycodone|oxycodone|mesh-list
15139366|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15139367|NCT04310579|Paroxetine|paroxetine|mesh-list
15139368|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15139369|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15139370|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139371|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139372|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15139373|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15139374|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15139375|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15139376|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
15139377|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
15139378|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
15139379|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
15139380|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139381|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139382|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15139383|NCT04310579|Narcotics|narcotics|mesh-ancestor
15139384|NCT04310579|Analgesics|analgesics|mesh-ancestor
15139385|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
15139386|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139387|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
15139388|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15139389|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15139390|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15139391|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139392|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
15139393|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15139394|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15139395|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15139396|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139397|NCT04310709|Nivolumab|nivolumab|mesh-list
15139398|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15139399|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139400|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15139401|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139402|NCT04310774|Tegafur|tegafur|mesh-list
15139403|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139404|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
15139405|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139406|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179192|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179193|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
15179194|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
15179195|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179196|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179197|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15179198|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15179199|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
15179200|NCT03952325|Nivolumab|nivolumab|mesh-list
15179201|NCT03952325|Atezolizumab|atezolizumab|mesh-list
15179202|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013157|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14013158|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013159|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14013160|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013161|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14013162|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14013163|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
14013164|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013165|NCT02832596|Norepinephrine|norepinephrine|mesh-list
14272235|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
14013166|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14013167|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14013168|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14013169|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013170|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013171|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013172|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
14013173|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
14013174|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139407|NCT04310254|Edetic Acid|edetic acid|mesh-list
15139408|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15139409|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
15139410|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
15139411|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15139412|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
15139413|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
14013175|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14013176|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
14013177|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
14013178|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14013179|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14013180|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013181|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013182|NCT02832570|Urological Agents|urological agents|mesh-ancestor
14013183|NCT02832401|Caffeine|caffeine|mesh-list
14013184|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14013185|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013186|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14013187|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013188|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013189|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14013190|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14013191|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
14013192|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013193|NCT02832089|Carvedilol|carvedilol|mesh-list
14013194|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14013195|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14013196|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
14013197|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013198|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013199|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013200|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14013201|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
14013202|NCT02832089|Protective Agents|protective agents|mesh-ancestor
14013203|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14013204|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14013205|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14013206|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
14013207|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14013208|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14013209|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14013210|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013211|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013212|NCT02831972|Itraconazole|itraconazole|mesh-list
14013213|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
14013214|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013215|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14013216|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14013217|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013218|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013219|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14013220|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
14025264|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15139414|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139415|NCT04310254|Antidotes|antidotes|mesh-ancestor
15139416|NCT04310254|Protective Agents|protective agents|mesh-ancestor
15139417|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139418|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15139419|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
15139420|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15139421|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139422|NCT04310228|Favipiravir|favipiravir|mesh-list
15139423|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
14013221|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013222|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013223|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14013224|NCT02831933|Valacyclovir|valacyclovir|mesh-list
14013225|NCT02831933|Nivolumab|nivolumab|mesh-list
14013226|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013227|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013228|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14013229|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013230|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
14013231|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013232|NCT02831842|Bevacizumab|bevacizumab|mesh-list
14013233|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013234|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013235|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14013236|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14013237|NCT02831842|Growth Substances|growth substances|mesh-ancestor
14013238|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013239|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
14013240|NCT02831751|Vaccines|vaccines|mesh-list
14013241|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
14013242|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013243|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
14013244|NCT02831712|Trace Elements|trace elements|mesh-ancestor
14013245|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
14013246|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013247|NCT02831686|Dexamethasone|dexamethasone|mesh-list
14013248|NCT02831686|Ixazomib|ixazomib|mesh-list
14013249|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013250|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
14013251|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
14013252|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013253|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013254|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14013255|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
14013256|NCT02831686|Hormones|hormones|mesh-ancestor
14013257|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013258|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14013259|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139424|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139425|NCT04310176|Bevacizumab|bevacizumab|mesh-list
15139426|NCT04310176|Fluorouracil|fluorouracil|mesh-list
15139427|NCT04310176|Capecitabine|capecitabine|mesh-list
15139428|NCT04310176|Valproic Acid|valproic acid|mesh-list
15139429|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013260|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
14013261|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013262|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013263|NCT02831543|Mosapride|mosapride|mesh-list
14013264|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013265|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14013266|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14013267|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
14013268|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013269|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013270|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
14013271|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14013272|NCT02831478|Protective Agents|protective agents|mesh-ancestor
14013273|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013274|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14013275|NCT02831361|Metformin|metformin|mesh-list
14013276|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14013277|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013278|NCT02831374|Anesthetics|anesthetics|mesh-list
14013279|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013280|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013281|NCT02831205|Cobalt|cobalt|mesh-list
14013282|NCT02831205|Chromium|chromium|mesh-list
14013283|NCT02831205|Everolimus|everolimus|mesh-list
14013284|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013285|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14013286|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
14013287|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013288|NCT02831205|Trace Elements|trace elements|mesh-ancestor
14013289|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
15139430|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139431|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15139432|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15139433|NCT04310176|Growth Substances|growth substances|mesh-ancestor
15139434|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139435|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
15139436|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
14013290|NCT02831218|Aspirin|aspirin|mesh-list
14013291|NCT02831218|Clopidogrel|clopidogrel|mesh-list
14013292|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14013293|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14013294|NCT02831218|Analgesics|analgesics|mesh-ancestor
14013295|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
14013296|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013297|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013298|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013299|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14013300|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14013301|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14013302|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013303|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14013304|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14013305|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013306|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
14013307|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14013308|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14013309|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14013310|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
14272236|NCT00422513|Hematinics|hematinics|mesh-ancestor
14272237|NCT00422591|Cytarabine|cytarabine|mesh-list
14272238|NCT00422591|Idarubicin|idarubicin|mesh-list
14272239|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272240|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
15139437|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139438|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139439|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15139440|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
15139441|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
15139442|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272241|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272242|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272243|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
14272244|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272245|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272246|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
14272247|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272248|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14272249|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14272250|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14272251|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272252|NCT00422734|Tadalafil|tadalafil|mesh-list
14272253|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
14272254|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14272255|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14272256|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272257|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272258|NCT00422734|Urological Agents|urological agents|mesh-ancestor
14272259|NCT00422799|Rituximab|rituximab|mesh-list
14272260|NCT00422799|Bortezomib|bortezomib|mesh-list
14272261|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272262|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272263|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
14272264|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272265|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272266|NCT00422903|Letrozole|letrozole|mesh-list
14272267|NCT00422903|Lapatinib|lapatinib|mesh-list
14272268|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272269|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14272270|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14272271|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139443|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
15139444|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272272|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272273|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14272274|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
15139445|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
14013311|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013312|NCT02831491|Docetaxel|docetaxel|mesh-list
14013313|NCT02831491|Ramucirumab|ramucirumab|mesh-list
14013314|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013315|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
14013316|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
14013317|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
14013318|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013319|NCT02831101|Sufentanil|sufentanil|mesh-list
14013320|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14013321|NCT02831101|Narcotics|narcotics|mesh-ancestor
14013322|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013323|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013324|NCT02831101|Analgesics|analgesics|mesh-ancestor
14013325|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
14013326|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139446|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15139447|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139448|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15139449|NCT04310397|Trametinib|trametinib|mesh-list
15139450|NCT04310397|Dabrafenib|dabrafenib|mesh-list
15139451|NCT04310397|Spartalizumab|spartalizumab|mesh-list
15139452|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139453|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15139454|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139455|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139456|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15139457|NCT04309838|Treprostinil|treprostinil|mesh-list
15139458|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15139459|NCT04310059|Folic Acid|folic acid|mesh-list
15139460|NCT04310059|Hematinics|hematinics|mesh-ancestor
15139461|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
15139462|NCT04310059|Vitamins|vitamins|mesh-ancestor
15139463|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
15139464|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139465|NCT04310293|Hormones|hormones|mesh-list
15139466|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139467|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139468|NCT04309929|Analgesics|analgesics|mesh-list
15139469|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
15139470|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139471|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272275|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272276|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272277|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14272278|NCT00423085|Rivastigmine|rivastigmine|mesh-list
14272279|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14272280|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272281|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272282|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
15139472|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
15139473|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15139474|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
15139475|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
15139476|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15139477|NCT04309643|Estradiol|estradiol|mesh-list
15139478|NCT04309643|Estrogens|estrogens|mesh-ancestor
15139479|NCT04309643|Hormones|hormones|mesh-ancestor
15139480|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139481|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013327|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14013328|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14013329|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
14013330|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
14013331|NCT02831088|Salicylates|salicylates|mesh-list
14013332|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14013333|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14013334|NCT02831088|Analgesics|analgesics|mesh-ancestor
14013335|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
14013336|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013337|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013338|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013339|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14013340|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14013341|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139482|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14013342|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025265|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025266|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025267|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14025268|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
14025269|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14025270|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14025271|NCT02751840|Caffeine|caffeine|mesh-list
14025272|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14025273|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025274|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14025275|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025276|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025277|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14025278|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14025279|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
14025280|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025281|NCT02752477|Anesthetics|anesthetics|mesh-list
14025282|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
14025283|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025284|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025285|NCT02752412|Insulin|insulin|mesh-list
14025286|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14025287|NCT02752412|Metformin|metformin|mesh-list
14025288|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
14025289|NCT02752412|Lixisenatide|lixisenatide|mesh-list
14025290|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14025291|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026248|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026249|NCT02744456|Losartan|losartan|mesh-list
14026250|NCT02744456|Amlodipine|amlodipine|mesh-list
14026251|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15139483|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15139484|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14026252|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14026253|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14026254|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026255|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026256|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14026257|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026258|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
14026259|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14026260|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14026261|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14026262|NCT02744456|Diuretics|diuretics|mesh-ancestor
14026263|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
14026264|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14026265|NCT02744222|Interferons|interferons|mesh-list
14026266|NCT02744222|Interferon-beta|interferon-beta|mesh-list
14026267|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
14026268|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026269|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
14026270|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026271|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
14026272|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026273|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14026274|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
14026275|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14026276|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026277|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026278|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14026279|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139485|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15139486|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15139487|NCT04309708|Nimodipine|nimodipine|mesh-list
15139488|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15139489|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15139490|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139491|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139492|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15139493|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013343|NCT02831179|Capecitabine|capecitabine|mesh-list
14013344|NCT02831179|Temozolomide|temozolomide|mesh-list
14013345|NCT02831179|Veliparib|veliparib|mesh-list
15139494|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139495|NCT04309578|Capecitabine|capecitabine|mesh-list
15139496|NCT04309578|Trastuzumab|trastuzumab|mesh-list
15139497|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139498|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139499|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
15139500|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139501|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15139502|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15139503|NCT04309357|Plasminogen|plasminogen|mesh-list
15139504|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15139505|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15139506|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139507|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
15139508|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15139509|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
15139510|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15139511|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139512|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139513|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139514|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
15139515|NCT04308954|Flumazenil|flumazenil|mesh-list
15139516|NCT04308954|Antidotes|antidotes|mesh-ancestor
15139517|NCT04308954|Protective Agents|protective agents|mesh-ancestor
15139518|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139519|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
15139520|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
15139521|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139522|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139523|NCT04309058|Vitamin D|vitamin d|mesh-list
15139524|NCT04309058|Vitamins|vitamins|mesh-ancestor
15139525|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
15139526|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139527|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15139528|NCT04308863|Chitosan|chitosan|mesh-list
15139529|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139530|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15139531|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15139532|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
15139533|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15139534|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
15139535|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
15139536|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
15139537|NCT04308863|Coagulants|coagulants|mesh-ancestor
15139538|NCT04308551|Aspirin|aspirin|mesh-list
15139539|NCT04308551|Indobufen|indobufen|mesh-list
15139540|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15139541|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139542|NCT04308551|Analgesics|analgesics|mesh-ancestor
15139543|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
14013346|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14013347|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
14013348|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013349|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013350|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14013351|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
14013352|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14013353|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013354|NCT02831231|Xanomeline|xanomeline|mesh-list
14013355|NCT02831231|Trospium chloride|trospium chloride|mesh-list
14013356|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
14013357|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
14013358|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013359|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013360|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14013361|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14013362|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
14013363|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139544|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139545|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139546|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15139547|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15139548|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15139549|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14272283|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272284|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272285|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14811594|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
14811595|NCT00846144|Trace Elements|trace elements|mesh-ancestor
14811596|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
14013364|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013365|NCT02831231|Urological Agents|urological agents|mesh-ancestor
14013366|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14811597|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013367|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14013368|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14013369|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14013370|NCT02830906|Ondansetron|ondansetron|mesh-list
14013371|NCT02830906|Ramosetron|ramosetron|mesh-list
14013372|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
14013373|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
14013374|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013375|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013376|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14013377|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
14013378|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14013379|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14013380|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
14013381|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013382|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013383|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14013384|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14013385|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013386|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14013387|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14013388|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
14013389|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
14013390|NCT02830789|Calcium|calcium|mesh-list
14013391|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14013392|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013393|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14013394|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013395|NCT02830789|Antacids|antacids|mesh-ancestor
14013396|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14013397|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
14013398|NCT02831023|Piperaquine|piperaquine|mesh-list
14013399|NCT02831023|Primaquine|primaquine|mesh-list
14013400|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
14013401|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14013402|NCT02831023|Amodiaquine|amodiaquine|mesh-list
14013403|NCT02831023|Artenimol|artenimol|mesh-list
14013404|NCT02831023|Methylene Blue|methylene blue|mesh-list
14013405|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
14013406|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14013407|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14013408|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013409|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14013410|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013411|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013412|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14013413|NCT02831023|Renal Agents|renal agents|mesh-ancestor
14013414|NCT02830932|Vaccines|vaccines|mesh-list
14013415|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
14013416|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013417|NCT02830360|Amiodarone|amiodarone|mesh-list
14013418|NCT02830360|Sotalol|sotalol|mesh-list
14013419|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14013420|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
14013421|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14013422|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14013423|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013424|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14013425|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14013426|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14013427|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013428|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14013429|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14272286|NCT00423085|Protective Agents|protective agents|mesh-ancestor
14272287|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
14272288|NCT00423098|Prednisone|prednisone|mesh-list
14272289|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
14013430|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14013431|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14013432|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14013433|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
14013434|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013435|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013436|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
14013437|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
14013438|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013439|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
14013440|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013441|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013442|NCT02830347|Amoxicillin|amoxicillin|mesh-list
14013443|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14013444|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013445|NCT02830230|Azithromycin|azithromycin|mesh-list
14013446|NCT02830230|Cefixime|cefixime|mesh-list
14013447|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14013448|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013449|NCT02830243|Sevoflurane|sevoflurane|mesh-list
14013450|NCT02830243|Desflurane|desflurane|mesh-list
14013451|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14013452|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14013453|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
14013454|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
14013455|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013456|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013457|NCT02830048|Glyburide|glyburide|mesh-list
14013458|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14013459|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013460|NCT02830126|Anesthetics|anesthetics|mesh-list
14013461|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013462|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013463|NCT02829879|Listerine|listerine|mesh-list
14013464|NCT02829879|Fluorides|fluorides|mesh-list
14013465|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
14013466|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
14013467|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
14013468|NCT02829879|Protective Agents|protective agents|mesh-ancestor
14013469|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013470|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14013471|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013472|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
14013473|NCT02829957|Apixaban|apixaban|mesh-list
14013474|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14013475|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
14013476|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14013477|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
14013478|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013479|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013480|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
14013481|NCT02830139|Capecitabine|capecitabine|mesh-list
14013482|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
14013483|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013484|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14013485|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
14013486|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013487|NCT02829840|Azacitidine|azacitidine|mesh-list
14013488|NCT02829840|Ponatinib|ponatinib|mesh-list
14013489|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14013490|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
14013491|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013492|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013493|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013494|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14013495|NCT02829385|Apatinib|apatinib|mesh-list
14013496|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013497|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14013498|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013499|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013500|NCT02829424|Methotrexate|methotrexate|mesh-list
14013501|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15139550|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013502|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
14013503|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14013504|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272290|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15139551|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15139552|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15139553|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139554|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
15139555|NCT04308850|Vitamin D|vitamin d|mesh-list
15139556|NCT04308850|Vitamins|vitamins|mesh-ancestor
15139557|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
15139558|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139559|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15179203|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179204|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15179205|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179206|NCT03952273|Sirolimus|sirolimus|mesh-list
15179207|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15179208|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179209|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15179210|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179211|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
15179212|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15179213|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
15179214|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013505|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14013506|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
14013507|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013508|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013509|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
14013510|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013511|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14013512|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14013513|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
14013514|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14013515|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14025292|NCT02751593|Dexamethasone|dexamethasone|mesh-list
14025293|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025294|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
14025295|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
14025296|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025297|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025298|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15182042|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15182043|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
15182044|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
15182045|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15182046|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15182047|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15182048|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
15182049|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182050|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15182051|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15182052|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15182053|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15182054|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182055|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15182056|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15182057|NCT03925285|Bevacizumab|bevacizumab|mesh-list
14025299|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
14025300|NCT02751593|Hormones|hormones|mesh-ancestor
14025301|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025302|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14025303|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025304|NCT02751632|Fluoxetine|fluoxetine|mesh-list
14025305|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14025306|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14025307|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025308|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272291|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14272292|NCT00423098|Prednisolone|prednisolone|mesh-list
14272293|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
14272294|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14272295|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
14272296|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272297|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
14272298|NCT00423098|Hormones|hormones|mesh-ancestor
14013516|NCT02829359|Entecavir|entecavir|mesh-list
14013517|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
14013518|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013519|NCT02829372|Antibodies|antibodies|mesh-list
14013520|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14013521|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14013522|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
14013523|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013524|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
14013525|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14013526|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14013527|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013528|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
14013529|NCT02829346|Coagulants|coagulants|mesh-ancestor
14013530|NCT02829333|Anesthetics|anesthetics|mesh-list
14013531|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013532|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013533|NCT02829697|Ropivacaine|ropivacaine|mesh-list
14013534|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
14013535|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
14013536|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013537|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013538|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
14013539|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013540|NCT02829151|Aspirin|aspirin|mesh-list
14013541|NCT02829151|Cilostazol|cilostazol|mesh-list
14013542|NCT02829151|Clopidogrel|clopidogrel|mesh-list
14013543|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14013544|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14013545|NCT02829151|Analgesics|analgesics|mesh-ancestor
14013546|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
14013547|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013548|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013549|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013550|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14013551|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14013552|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14013553|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013554|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14013555|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14013556|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013557|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
14013558|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14013559|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14013560|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14013561|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
14013562|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013563|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14013564|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
14013565|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14013566|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
14013567|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
14013568|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14013569|NCT02829151|Protective Agents|protective agents|mesh-ancestor
14013570|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14013571|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14013572|NCT02829177|Allopurinol|allopurinol|mesh-list
14013573|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
14013574|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013575|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139560|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
15139561|NCT04308525|Narcotics|narcotics|mesh-ancestor
15139562|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139563|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139564|NCT04308525|Analgesics|analgesics|mesh-ancestor
15139565|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
15139566|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139567|NCT04308317|Tetrandrine|tetrandrine|mesh-list
15139568|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
15139569|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15139570|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15139571|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139572|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14013576|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
14013577|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15139573|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013578|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14013579|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
14013580|NCT02829177|Protective Agents|protective agents|mesh-ancestor
14013581|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013582|NCT02829281|Triamcinolone|triamcinolone|mesh-list
14013583|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14013584|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14013585|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
14013586|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15139574|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
15139575|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15139576|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139577|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139578|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15139579|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139580|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15139581|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
15139582|NCT04308343|Methotrexate|methotrexate|mesh-list
15139583|NCT04308343|Letrozole|letrozole|mesh-list
15139584|NCT04308343|Cetrorelix|cetrorelix|mesh-list
15139585|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15139586|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
15139587|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15139588|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139589|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139590|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
15139591|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139592|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139593|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
15139594|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139595|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15139596|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15139597|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
15139598|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15139599|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14013587|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14013588|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14013589|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14013590|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14013591|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013592|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
14013593|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013594|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013595|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013596|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
14013597|NCT02829281|Hormones|hormones|mesh-ancestor
14013598|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013599|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14013600|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
14013601|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013602|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14013603|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013604|NCT02829060|Gentamicins|gentamicins|mesh-list
14013605|NCT02829060|Ampicillin|ampicillin|mesh-list
14013606|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
14013607|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14013608|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013609|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14013610|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013611|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013612|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14013613|NCT02829060|Renal Agents|renal agents|mesh-ancestor
14013614|NCT02829008|Bevacizumab|bevacizumab|mesh-list
14013615|NCT02829008|Pemetrexed|pemetrexed|mesh-list
14013616|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013617|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013618|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14013619|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14013620|NCT02829008|Growth Substances|growth substances|mesh-ancestor
14013621|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292437|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
14013622|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
14013623|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013624|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013625|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14013626|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14013627|NCT02828384|Psyllium|psyllium|mesh-list
14013628|NCT02828384|Cathartics|cathartics|mesh-ancestor
14013629|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14013630|NCT02828566|Ketamine|ketamine|mesh-list
14013631|NCT02828566|Analgesics|analgesics|mesh-ancestor
14013632|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
14013633|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013634|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013635|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14013636|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14013637|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
14272299|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272300|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272301|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14272302|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272303|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14272304|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14272305|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
14272306|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272307|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272308|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272309|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139600|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15139601|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15139602|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15139603|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
15139604|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139605|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15139606|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
15139607|NCT04308174|Durvalumab|durvalumab|mesh-list
14272310|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
14272311|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
14272312|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272313|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272314|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14272315|NCT00423098|Protective Agents|protective agents|mesh-ancestor
14272316|NCT00423150|Temozolomide|temozolomide|mesh-list
15139608|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15139609|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139610|NCT04308161|Vitamin D|vitamin d|mesh-list
15139611|NCT04308161|Miconazole|miconazole|mesh-list
15139612|NCT04308161|Vitamins|vitamins|mesh-ancestor
15139613|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
14272317|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14272318|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
14272319|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272320|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272321|NCT00423189|Ranibizumab|ranibizumab|mesh-list
14272322|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14272323|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14272324|NCT00423189|Growth Substances|growth substances|mesh-ancestor
14272325|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272326|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14272327|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272328|NCT00423267|Fluconazole|fluconazole|mesh-list
14272329|NCT00423267|Posaconazole|posaconazole|mesh-list
14272330|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
14272331|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272332|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14272333|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14272334|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272335|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272336|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14272337|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
14272338|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272339|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272340|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15139614|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139615|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14013638|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
14013639|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013640|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14013641|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14013642|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013643|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013644|NCT02828163|Triamcinolone|triamcinolone|mesh-list
14013645|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14013646|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14013647|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14013648|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013649|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
14013650|NCT02828163|Hormones|hormones|mesh-ancestor
14013651|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013652|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013653|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14013654|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
14013655|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013656|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013657|NCT02828176|Anesthetics|anesthetics|mesh-list
14013658|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013659|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013660|NCT02828059|Ropivacaine|ropivacaine|mesh-list
14013661|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
14013662|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
14013663|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013664|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013665|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
14013666|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013667|NCT02828228|Vitamin D|vitamin d|mesh-list
14013668|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
15139616|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
15139617|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139618|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15139619|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15139620|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139621|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139622|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15139623|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
14013669|NCT02828228|Vitamins|vitamins|mesh-ancestor
14013670|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
14013671|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013672|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14013673|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14013674|NCT02827903|Metformin|metformin|mesh-list
14013675|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14013676|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14013677|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013678|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14013679|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14013680|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
14013681|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013682|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14013683|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14013684|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013685|NCT02828033|Rilonacept|rilonacept|mesh-list
14013686|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013687|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14013688|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14013689|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013690|NCT02827890|Incretins|incretins|mesh-ancestor
15139624|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139625|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15139626|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15139627|NCT04308031|Digoxin|digoxin|mesh-list
15139628|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15139629|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15139630|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139631|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139632|NCT04308031|Protective Agents|protective agents|mesh-ancestor
15139633|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139634|NCT04308070|Hemostatics|hemostatics|mesh-list
15139635|NCT04308070|Coagulants|coagulants|mesh-ancestor
15139636|NCT04307693|Ritonavir|ritonavir|mesh-list
14013691|NCT02827890|Hormones|hormones|mesh-ancestor
14811598|NCT00846144|Antidotes|antidotes|mesh-ancestor
14013692|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013693|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14013694|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
14013695|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013696|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013697|NCT02827877|Copper|copper|mesh-list
14013698|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14013699|NCT02827877|Trastuzumab|trastuzumab|mesh-list
15139637|NCT04307693|Lopinavir|lopinavir|mesh-list
14013700|NCT02827877|Pertuzumab|pertuzumab|mesh-list
14013701|NCT02827877|Antibodies|antibodies|mesh-list
14013702|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
14013703|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14013704|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
14013705|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013706|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013707|NCT02827877|Trace Elements|trace elements|mesh-ancestor
14013708|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
14025309|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025310|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
14025311|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139638|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
15139639|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15139640|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15139641|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139642|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139643|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139644|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15139645|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15139646|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
15139647|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139648|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15139649|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15139650|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
15139651|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15139652|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15139653|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15139654|NCT04307550|Ethanol|ethanol|mesh-list
15139655|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15139656|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025312|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14025313|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-ancestor
14025314|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14025315|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14025316|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14025317|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025318|NCT02751619|Lidocaine|lidocaine|mesh-list
14025319|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025320|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
14025321|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025322|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025323|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
14025324|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025325|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14272341|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14272342|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14272343|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14272344|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14272345|NCT00423293|Fluorouracil|fluorouracil|mesh-list
14272346|NCT00423293|Mitomycins|mitomycins|mesh-list
14272347|NCT00423293|Mitomycin|mitomycin|mesh-list
14272348|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
14272349|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272350|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272351|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272352|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272353|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
14272354|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139657|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139658|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139659|NCT04307238|Anesthetics|anesthetics|mesh-list
15139660|NCT04307238|Propofol|propofol|mesh-list
15139661|NCT04307238|Sevoflurane|sevoflurane|mesh-list
15139662|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139663|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139664|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14013709|NCT02827643|Vitamin D|vitamin d|mesh-list
14013710|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
14013711|NCT02827643|Lamivudine|lamivudine|mesh-list
14013712|NCT02827643|Calcium|calcium|mesh-list
14013713|NCT02827643|Vitamins|vitamins|mesh-ancestor
14013714|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
14013715|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013716|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14013717|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14013718|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14013719|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14013720|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139665|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15139666|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
15139667|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15139668|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15139669|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
15139670|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15139671|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139672|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139673|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139674|NCT04307290|Analgesics|analgesics|mesh-ancestor
15139675|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
15139676|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139677|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15139678|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15139679|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15139680|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
15139681|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139682|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139683|NCT04307147|Capecitabine|capecitabine|mesh-list
15139684|NCT04307147|Vinorelbine|vinorelbine|mesh-list
14013721|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013722|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
14013723|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013724|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14013725|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14013726|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14013727|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
14013728|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14013729|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
14013730|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14013731|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013732|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14013733|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14013734|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013735|NCT02827747|Vitamin A|vitamin a|mesh-list
14013736|NCT02827747|Antioxidants|antioxidants|mesh-list
14013737|NCT02827747|Vitamins|vitamins|mesh-ancestor
14013738|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
14013739|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013740|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013741|NCT02827747|Protective Agents|protective agents|mesh-ancestor
14013742|NCT02827578|Tamsulosin|tamsulosin|mesh-list
14013743|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
15139685|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139686|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
15139687|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013744|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14013745|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14013746|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14013747|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
14013748|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013749|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013750|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013751|NCT02827578|Urological Agents|urological agents|mesh-ancestor
14013752|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15139688|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139689|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15139690|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
15139691|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
15139692|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
15139693|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
14013753|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14013754|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
14013755|NCT02827682|Anesthetics|anesthetics|mesh-list
14013756|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013757|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013758|NCT02827435|Bromides|bromides|mesh-list
14013759|NCT02827435|Rocuronium|rocuronium|mesh-list
14013760|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
14013761|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14013762|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14013763|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14013764|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013765|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013766|NCT02827487|Celecoxib|celecoxib|mesh-list
14013767|NCT02827487|Tramadol|tramadol|mesh-list
14013768|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14013769|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14013770|NCT02827487|Analgesics|analgesics|mesh-ancestor
14013771|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
14013772|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013773|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013774|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14013775|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14013776|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14013777|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14013778|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013779|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013780|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14811599|NCT00846144|Protective Agents|protective agents|mesh-ancestor
14811600|NCT00846144|Emetics|emetics|mesh-ancestor
14811601|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
14811602|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811603|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811604|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
14811605|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
14811606|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14013781|NCT02827487|Narcotics|narcotics|mesh-ancestor
14013782|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013783|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
14013784|NCT02827266|Hematinics|hematinics|mesh-ancestor
14013785|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14013786|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
14811607|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811608|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811609|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14811610|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811611|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14811612|NCT00846235|Glycerol|glycerol|mesh-list
14811613|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14811614|NCT00846235|Protective Agents|protective agents|mesh-ancestor
14811615|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811616|NCT00846248|Chromium|chromium|mesh-list
14811617|NCT00846248|Trace Elements|trace elements|mesh-ancestor
14811618|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
15139694|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
15139695|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013787|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
14013788|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14013789|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013790|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013791|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14013792|NCT02827942|Amoxicillin|amoxicillin|mesh-list
14013793|NCT02827942|Metronidazole|metronidazole|mesh-list
14013794|NCT02827942|Clarithromycin|clarithromycin|mesh-list
15139696|NCT04307069|Oxytocin|oxytocin|mesh-list
15139697|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
15139698|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15139699|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139700|NCT04306965|Apremilast|apremilast|mesh-list
15139701|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15139702|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139703|NCT04306965|Analgesics|analgesics|mesh-ancestor
14013795|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14013796|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013797|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14013798|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14013799|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14811619|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139704|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
14013800|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013801|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013802|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14013803|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14013804|NCT02827136|Lidocaine|lidocaine|mesh-list
15139705|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139706|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139707|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15139708|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15139709|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15139710|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15139711|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139712|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139713|NCT04306900|Gemcitabine|gemcitabine|mesh-list
14013805|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
14013806|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
14013807|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013808|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013809|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
14013810|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013811|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14013812|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14013813|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14013814|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139714|NCT04306900|Paclitaxel|paclitaxel|mesh-list
15139715|NCT04306900|Docetaxel|docetaxel|mesh-list
15139716|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15139717|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
15139718|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15139719|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139720|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
15139721|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
15139722|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
15139723|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139724|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139725|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
15139726|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
15139727|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139728|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139729|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15139730|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
15139731|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139732|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15139733|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
15139734|NCT04306913|Esmolol|esmolol|mesh-list
15139735|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15139736|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15139737|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15139738|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
15139739|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139740|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139741|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139742|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15139743|NCT04306666|Anesthetics|anesthetics|mesh-list
15139744|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139745|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139746|NCT04306653|Betamethasone|betamethasone|mesh-list
15139747|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15139748|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
15139749|NCT04306653|Hormones|hormones|mesh-ancestor
15139750|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139751|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139752|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15139753|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
15139754|NCT04306731|Trimethoprim|trimethoprim|mesh-list
15139755|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15139756|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139757|NCT04306731|Renal Agents|renal agents|mesh-ancestor
15139758|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
15139759|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15139760|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15139761|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15139762|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811620|NCT00846274|Antithrombins|antithrombins|mesh-list
14013815|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013816|NCT02826902|Remifentanil|remifentanil|mesh-list
14013817|NCT02826902|Propofol|propofol|mesh-list
14013818|NCT02826902|Desflurane|desflurane|mesh-list
14013819|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14013820|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013821|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013822|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14013823|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
14013824|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
14013825|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14013826|NCT02826902|Narcotics|narcotics|mesh-ancestor
14013827|NCT02826902|Analgesics|analgesics|mesh-ancestor
14013828|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
14013829|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013830|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14013831|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
14013832|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013833|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013834|NCT02826616|Trimetazidine|trimetazidine|mesh-list
14013835|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
14013836|NCT02826772|Androgens|androgens|mesh-list
14013837|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
14013838|NCT02826772|Hormones|hormones|mesh-ancestor
14013839|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013840|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013841|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
14013842|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
14013843|NCT02826876|Ropivacaine|ropivacaine|mesh-list
14013844|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
14013845|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
14013846|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013847|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013848|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
14013849|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013850|NCT02826759|Insulin|insulin|mesh-list
14013851|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14013852|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013853|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
14013854|NCT02826746|Analgesics|analgesics|mesh-ancestor
14013855|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
14013856|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013857|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013858|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
14013859|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013860|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14013861|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
14013862|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14013863|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14013864|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013865|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14013866|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
14013867|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14013868|NCT02826837|Bevacizumab|bevacizumab|mesh-list
14013869|NCT02826837|Cetuximab|cetuximab|mesh-list
14013870|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013871|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013872|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14013873|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14013874|NCT02826837|Growth Substances|growth substances|mesh-ancestor
14013875|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013876|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
15139763|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139764|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15139765|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15139766|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15139767|NCT04306692|Inositol|inositol|mesh-list
15139768|NCT04306692|Clomiphene|clomiphene|mesh-list
15139769|NCT04306692|Enclomiphene|enclomiphene|mesh-list
15139770|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
15139771|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14013887|NCT02826408|Rabeprazole|rabeprazole|mesh-list
14013888|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14013889|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14013890|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14013891|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013892|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013893|NCT02826434|Durvalumab|durvalumab|mesh-list
14013894|NCT02826434|Poly ICLC|poly iclc|mesh-list
14013895|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14013896|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013897|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
14013898|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
14013899|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013900|NCT02826343|Xenon|xenon|mesh-list
14013901|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14013902|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14013903|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
14013904|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
14013905|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013906|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013907|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14013908|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
14013909|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013910|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14013911|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
14013912|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
15139772|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
15139773|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139774|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139775|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15139776|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
15139777|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15139778|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15139779|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15139780|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
15139781|NCT04306692|Vitamins|vitamins|mesh-ancestor
15139782|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
15139783|NCT04306627|Amlodipine|amlodipine|mesh-list
15139784|NCT04306627|Perindopril|perindopril|mesh-list
15139785|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
15139786|NCT04306627|Atorvastatin|atorvastatin|mesh-list
15139787|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15139788|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15139789|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
15139790|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139791|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15139792|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15139793|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139794|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15139795|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15139796|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139797|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15139798|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139799|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139800|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15139801|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139802|NCT04306354|Oxytocin|oxytocin|mesh-list
15139803|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
15139804|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15139805|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139806|NCT04306276|Dienogest|dienogest|mesh-list
15139807|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15139808|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
15139809|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14013913|NCT02826343|Hormones|hormones|mesh-ancestor
14013914|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14013915|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
14025326|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14025327|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14025328|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025329|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025330|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
14025331|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14025332|NCT02751541|Protective Agents|protective agents|mesh-ancestor
14272355|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15139810|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139811|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15139812|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14013916|NCT02826252|Iloprost|iloprost|mesh-list
14013917|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15139813|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15139814|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15139815|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
14272356|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
14272357|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14272358|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272359|NCT00423319|Enoxaparin|enoxaparin|mesh-list
14272360|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
14272361|NCT00423319|Apixaban|apixaban|mesh-list
14272362|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
14272363|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14272364|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14272365|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272366|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14272367|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
14272368|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14272369|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
14272370|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272371|NCT00423332|Cediranib|cediranib|mesh-list
14272372|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272373|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14272374|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272375|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272376|NCT00423358|Vitamin D|vitamin d|mesh-list
14272377|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
14272378|NCT00423358|Vitamins|vitamins|mesh-ancestor
14272379|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
14272380|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272381|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14272382|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15139816|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139817|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15139818|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139819|NCT04306471|Evolocumab|evolocumab|mesh-list
15139820|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15139821|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15139822|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
15139823|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139824|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15139825|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
15139826|NCT04306367|Olaparib|olaparib|mesh-list
15139827|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15139828|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139829|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15139830|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139831|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179215|NCT03952260|Anesthetics|anesthetics|mesh-list
15179216|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179217|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179218|NCT03951987|Charcoal|charcoal|mesh-list
15179219|NCT03951987|Antidotes|antidotes|mesh-ancestor
15179220|NCT03951987|Protective Agents|protective agents|mesh-ancestor
15179221|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179222|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15179223|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179224|NCT03951558|Diuretics|diuretics|mesh-ancestor
15179225|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
15179226|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179227|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15179228|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179229|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179230|NCT03951831|Docetaxel|docetaxel|mesh-list
15179231|NCT03951831|Leuprolide|leuprolide|mesh-list
15179232|NCT03951831|Cemiplimab|cemiplimab|mesh-list
15179233|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14013918|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
14013919|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
14272383|NCT00423449|Gemcitabine|gemcitabine|mesh-list
14272384|NCT00423449|Vorinostat|vorinostat|mesh-list
14272385|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272386|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
14013920|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
14013921|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14013922|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
14013923|NCT02826070|Adefovir|adefovir|mesh-list
14013924|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14013925|NCT02826070|Telbivudine|telbivudine|mesh-list
14013926|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
14013927|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14013928|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14013929|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14013930|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013931|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013932|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
14013933|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
14013934|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013935|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013936|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14013937|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
14013938|NCT02825979|Sotalol|sotalol|mesh-list
14013939|NCT02825979|Flecainide|flecainide|mesh-list
14013940|NCT02825979|Dronedarone|dronedarone|mesh-list
14013941|NCT02825979|Propafenone|propafenone|mesh-list
14013942|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14013943|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14013944|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14013945|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
14013946|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013947|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013948|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013949|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
14013950|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
14013951|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013952|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14013953|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14013954|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14013955|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14013956|NCT02826174|Anesthetics|anesthetics|mesh-list
14013957|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14013958|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013959|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
14013960|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14013961|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
14013962|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013963|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
14013964|NCT02826031|Protective Agents|protective agents|mesh-ancestor
14013965|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
14013966|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
14013967|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14013968|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14013969|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013970|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
14013971|NCT02825719|Coagulants|coagulants|mesh-ancestor
14013972|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14013973|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
14013974|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14013975|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013976|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14013977|NCT02825914|Caseins|caseins|mesh-list
14013978|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
14013979|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
14013980|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013981|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
14013982|NCT02825576|Neostigmine|neostigmine|mesh-list
14013983|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14013984|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14013985|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14013986|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
14013987|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14013988|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14013989|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14013990|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
14013991|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14013992|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14013993|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14013994|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14013995|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14013996|NCT02825797|Antibodies|antibodies|mesh-list
14013997|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
14811621|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
14013998|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14013999|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
14014000|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014001|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014002|NCT02825394|Ecarin|ecarin|mesh-list
14014003|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14014004|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14014005|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014006|NCT02825147|Dexamethasone|dexamethasone|mesh-list
14014007|NCT02825147|Methotrexate|methotrexate|mesh-list
14014008|NCT02825147|Etoposide|etoposide|mesh-list
14014009|NCT02825147|Pegaspargase|pegaspargase|mesh-list
14014010|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014011|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
14014012|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
14014013|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014014|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139832|NCT04306159|Anesthetics|anesthetics|mesh-list
15139833|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139834|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139835|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15139836|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15139837|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15139838|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139839|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139840|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15139841|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15139842|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139843|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
15139844|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139845|NCT04305964|Silicon|silicon|mesh-list
15139846|NCT04305964|Trace Elements|trace elements|mesh-ancestor
15139847|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
15139848|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139849|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
15139850|NCT04306042|Nivolumab|nivolumab|mesh-list
15139851|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15139852|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139853|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15139854|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139855|NCT04305691|Ixazomib|ixazomib|mesh-list
15139856|NCT04305691|Glycine|glycine|mesh-list
15139857|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139858|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139859|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139860|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139861|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
15139862|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139863|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139864|NCT04306081|Evolocumab|evolocumab|mesh-list
15139865|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15139866|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15139867|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
15139868|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139869|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15139870|NCT04305587|Clopidogrel|clopidogrel|mesh-list
15139871|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15139872|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15139873|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15139874|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15139875|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
15139876|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139877|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139878|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139879|NCT04305236|Fulvestrant|fulvestrant|mesh-list
15139880|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15139881|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139882|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15139883|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15139884|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
15179234|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
14014015|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014016|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
14014017|NCT02825147|Hormones|hormones|mesh-ancestor
14014018|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014019|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14014020|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014021|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14014022|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
14014023|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14014024|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14014025|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
14014026|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014027|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
14014028|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014029|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14014030|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14014031|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
14014032|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014033|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14014034|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14014035|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14014036|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14014037|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14014038|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14014039|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
14014040|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14014041|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
14014042|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14014043|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014044|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14014045|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14014046|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139885|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139886|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139887|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
14014047|NCT02825342|Citalopram|citalopram|mesh-list
14014048|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14014049|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14014050|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14014051|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014052|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014053|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014054|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
14014055|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014056|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14014057|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
14014058|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14014059|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014060|NCT02825225|Anesthetics|anesthetics|mesh-list
14014061|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014062|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014063|NCT02825186|Dexamethasone|dexamethasone|mesh-list
14014064|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15139888|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15139889|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
15139890|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139891|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139892|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15139893|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
15139894|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15139895|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
15139896|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139897|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15139898|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15139899|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
15139900|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
15139901|NCT04305457|Protective Agents|protective agents|mesh-ancestor
15139902|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
15139903|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15139904|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
15139905|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
15139906|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139907|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139908|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139909|NCT04305158|Analgesics|analgesics|mesh-ancestor
15139910|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
14014065|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
14014066|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
14014067|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014068|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014069|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014070|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
14014071|NCT02825186|Hormones|hormones|mesh-ancestor
14014072|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014073|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14014074|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014075|NCT02825095|Lidocaine|lidocaine|mesh-list
14014076|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014077|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
14014078|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014079|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014080|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
14014081|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014082|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014083|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14014084|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14014085|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014086|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014087|NCT02825121|Iodine|iodine|mesh-list
14014088|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14014089|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014090|NCT02825121|Trace Elements|trace elements|mesh-ancestor
14014091|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
14014092|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014093|NCT02825199|Caffeine|caffeine|mesh-list
14014094|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14014095|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014096|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14014097|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014098|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014099|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14014100|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14014101|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
14014102|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014103|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
14014104|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14014105|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139911|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139912|NCT04305028|Aspirin|aspirin|mesh-list
15139913|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
15139914|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15139915|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15139916|NCT04305028|Analgesics|analgesics|mesh-ancestor
15139917|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
15139918|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139919|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139920|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15139921|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15139922|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15139923|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15139924|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139925|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15139926|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15139927|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139928|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
15139929|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15139930|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
15139931|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15139932|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139933|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
15139934|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15139935|NCT04304807|Melatonin|melatonin|mesh-list
15139936|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15139937|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
15139938|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139939|NCT04304807|Protective Agents|protective agents|mesh-ancestor
15139940|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139941|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139942|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
14014106|NCT02825056|Morphine|morphine|mesh-list
15139943|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
14014107|NCT02825056|Bupivacaine|bupivacaine|mesh-list
14014108|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014109|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
14014110|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014111|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014112|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
14014113|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014114|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14014115|NCT02825056|Narcotics|narcotics|mesh-ancestor
15139944|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139945|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139946|NCT04305106|Bevacizumab|bevacizumab|mesh-list
15139947|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15139948|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139949|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15139950|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15139951|NCT04305106|Growth Substances|growth substances|mesh-ancestor
15139952|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139953|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
15139954|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
15139955|NCT04305015|Narcotics|narcotics|mesh-ancestor
15139956|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139957|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139958|NCT04305015|Analgesics|analgesics|mesh-ancestor
15139959|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
15139960|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15139961|NCT04304716|Anesthetics|anesthetics|mesh-list
15139962|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139963|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139964|NCT04305002|Exenatide|exenatide|mesh-list
15139965|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15139966|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139967|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15139968|NCT04305002|Incretins|incretins|mesh-ancestor
15139969|NCT04305002|Hormones|hormones|mesh-ancestor
15139970|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15139971|NCT04304573|Calcium|calcium|mesh-list
15139972|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15139973|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139974|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
15139975|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15139976|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139977|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15139978|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139979|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
15139980|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15139981|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15139982|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139983|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15139984|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139985|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
15139986|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15139987|NCT04304209|Capecitabine|capecitabine|mesh-list
15139988|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
15139989|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15139990|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
15139991|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15139992|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15139993|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
15139994|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15139995|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15139996|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15139997|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14272387|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272388|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272389|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
15139998|NCT04304157|Analgesics|analgesics|mesh-ancestor
15139999|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
15140000|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140001|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14014116|NCT02825056|Analgesics|analgesics|mesh-ancestor
14014117|NCT02824926|Ketoconazole|ketoconazole|mesh-list
14014118|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
14014119|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014120|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14014121|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14014122|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014123|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014124|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14014125|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
14014126|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014127|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014128|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14014129|NCT02824601|Calcium|calcium|mesh-list
14014130|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14014131|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014132|NCT02824770|Tramadol|tramadol|mesh-list
14014133|NCT02824770|Bupivacaine|bupivacaine|mesh-list
14014134|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014135|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
14014136|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014137|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014138|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
14014139|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014140|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15140002|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15140003|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15140004|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
15140005|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140006|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140007|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
15140008|NCT04304352|Capecitabine|capecitabine|mesh-list
15140009|NCT04304352|Vinorelbine|vinorelbine|mesh-list
15140010|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15140011|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
15140012|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140013|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15140014|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15140015|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
15140016|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140017|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140018|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15140019|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140020|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
15140021|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140022|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140023|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140024|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
15140025|NCT04304261|Metformin|metformin|mesh-list
15140026|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
15140027|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15140028|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140029|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15140030|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140031|NCT04304248|Paclitaxel|paclitaxel|mesh-list
15140032|NCT04304248|Carboplatin|carboplatin|mesh-list
15140033|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15140034|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140035|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140036|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140037|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140038|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
15140039|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179235|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
15179236|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
15179237|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179238|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15179239|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
15179240|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15179241|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179242|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15179243|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179244|NCT03951636|Chlorhexidine|chlorhexidine|mesh-list
15179245|NCT03951636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15179246|NCT03951636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014141|NCT02824770|Narcotics|narcotics|mesh-ancestor
14014142|NCT02824770|Analgesics|analgesics|mesh-ancestor
14014143|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14014144|NCT02824536|Antibodies|antibodies|mesh-list
14014145|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
14014146|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14014147|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
14014148|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014149|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025333|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025334|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
14025335|NCT02751476|Disinfectants|disinfectants|mesh-list
14025336|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025337|NCT02751528|Vaccines|vaccines|mesh-list
14025338|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
14025339|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025340|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
14025341|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14025342|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025343|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14025344|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025345|NCT02751294|Tafenoquine|tafenoquine|mesh-list
14025346|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
14025347|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14025348|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14025349|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025350|NCT02751307|Metformin|metformin|mesh-list
14025351|NCT02751307|Clozapine|clozapine|mesh-list
14025352|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14025353|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025354|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14025355|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
14025356|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025357|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025358|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14025359|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14025360|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025361|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14025362|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
14025363|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
14025364|NCT02751268|Ropivacaine|ropivacaine|mesh-list
14025365|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025366|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
14025367|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025368|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025369|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
14025370|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025371|NCT02751255|Tretinoin|tretinoin|mesh-list
14025372|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025373|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
14025374|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14025375|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14025376|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14025377|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14025378|NCT02750904|Nicotine|nicotine|mesh-list
14025379|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14025380|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
14025381|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025382|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025383|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14025384|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15140040|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
15140041|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140042|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
15140043|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15140044|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15140045|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140046|NCT04304313|Urological Agents|urological agents|mesh-ancestor
15140047|NCT04304196|TEMPO|tempo|mesh-list
15140048|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
15179247|NCT03951636|Disinfectants|disinfectants|mesh-ancestor
14025385|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
14025386|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025387|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025388|NCT02750969|Lidocaine|lidocaine|mesh-list
14025389|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025390|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
14025391|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014150|NCT02824666|Fallypride|fallypride|mesh-list
14014151|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14014152|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14014153|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
14014154|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014155|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014156|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014157|NCT02824718|Teriparatide|teriparatide|mesh-list
14014158|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
14272390|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272391|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272392|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272393|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
14272394|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272395|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15140049|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140050|NCT04304196|Protective Agents|protective agents|mesh-ancestor
15140051|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140052|NCT04303741|Apatinib|apatinib|mesh-list
15140053|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140054|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15140055|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140056|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140057|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15140058|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15140059|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15140060|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
15140061|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140062|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15140063|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15140064|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272396|NCT00423592|Ambrisentan|ambrisentan|mesh-list
14272397|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14272398|NCT00423657|Vancomycin|vancomycin|mesh-list
14272399|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14272400|NCT00423657|Aztreonam|aztreonam|mesh-list
14272401|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272402|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272403|NCT00423670|Ribavirin|ribavirin|mesh-list
14272404|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15140065|NCT04304040|Antibodies|antibodies|mesh-list
15140066|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15140067|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
15140068|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140069|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
15140070|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15140071|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140072|NCT04303845|Erenumab|erenumab|mesh-list
15140073|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15140074|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140075|NCT04303845|Analgesics|analgesics|mesh-ancestor
15140076|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
15140077|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140078|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140079|NCT04303988|Bevacizumab|bevacizumab|mesh-list
15140080|NCT04303988|Carboplatin|carboplatin|mesh-list
15140081|NCT04303988|Temozolomide|temozolomide|mesh-list
15140082|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15140083|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140084|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15140085|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15140086|NCT04303988|Growth Substances|growth substances|mesh-ancestor
15179248|NCT03951753|Tirzepatide|tirzepatide|mesh-list
14014159|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14272405|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
14272406|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272407|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
14272408|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272409|NCT00423683|PENTA|penta|mesh-list
14272410|NCT00423683|Fondaparinux|fondaparinux|mesh-list
14272411|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14272412|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
14272413|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14272414|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
14272415|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292438|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140087|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140088|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
15140089|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15140090|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
15140091|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140092|NCT04303819|Exenatide|exenatide|mesh-list
15140093|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15140094|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140095|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15140096|NCT04303819|Incretins|incretins|mesh-ancestor
15140097|NCT04303819|Hormones|hormones|mesh-ancestor
15140098|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140099|NCT04303767|Calcium|calcium|mesh-list
15140100|NCT04303767|Caseins|caseins|mesh-list
14014160|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
14014161|NCT02824718|Diuretics|diuretics|mesh-list
14014162|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
14014163|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14014164|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014165|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14014166|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
14014167|NCT02824718|Vitamins|vitamins|mesh-ancestor
14014168|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
14014169|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014170|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014171|NCT02824627|Oxytocin|oxytocin|mesh-list
14014172|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
14014173|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14014174|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140101|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15140102|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140103|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
15140104|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
15140105|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140106|NCT04304014|Sulfalene|sulfalene|mesh-list
15140107|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140108|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15140109|NCT04304014|Renal Agents|renal agents|mesh-ancestor
15140110|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
15140111|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15140112|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15140113|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
15140114|NCT04303520|Fludarabine|fludarabine|mesh-list
15140115|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15140116|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
15140117|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140118|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15140119|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15140120|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
15140121|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140122|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140123|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15140124|NCT04303390|Cefazolin|cefazolin|mesh-list
15140125|NCT04303390|Cefuroxime|cefuroxime|mesh-list
15140126|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
15140127|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15140128|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140129|NCT04303377|Evolocumab|evolocumab|mesh-list
15140130|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15140131|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15140132|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
15140133|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140134|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15140135|NCT04303312|Benzydamine|benzydamine|mesh-list
15140136|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140137|NCT04303494|Vaccines|vaccines|mesh-list
15140138|NCT04303494|Immunologic Factors|immunologic factors|mesh-ancestor
15140139|NCT04303494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140140|NCT04303403|Trametinib|trametinib|mesh-list
15140141|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140142|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15140143|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140144|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140145|NCT04303429|Capecitabine|capecitabine|mesh-list
15140146|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140147|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
14014175|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14014176|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14014177|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014178|NCT02824874|Incretins|incretins|mesh-ancestor
14014179|NCT02824874|Hormones|hormones|mesh-ancestor
14014180|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014181|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14014182|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
14014183|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014184|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014185|NCT02824614|Erythritol|erythritol|mesh-list
14014186|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
14014187|NCT02824510|Insulin|insulin|mesh-list
14014188|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14014189|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
14014190|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14014191|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014192|NCT02824523|Aspirin|aspirin|mesh-list
14014193|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014194|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014195|NCT02824523|Analgesics|analgesics|mesh-ancestor
14014196|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
14014197|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014198|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014199|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014200|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014201|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15140148|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140149|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140150|NCT04303598|Tenofovir|tenofovir|mesh-list
15140151|NCT04303598|Lamivudine|lamivudine|mesh-list
15140152|NCT04303598|Efavirenz|efavirenz|mesh-list
15140153|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
15140154|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140155|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15140156|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15140157|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140158|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140159|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15140160|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15140161|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15140162|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15140163|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15140164|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15140165|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15140166|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15140167|NCT04302870|Memantine|memantine|mesh-list
15140168|NCT04302870|Trazodone|trazodone|mesh-list
14272416|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140169|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15140170|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15140171|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15140172|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
15140173|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140174|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140175|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140176|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15140177|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15140178|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15140179|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15140180|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140181|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15140182|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15140183|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15140184|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15140185|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
15140186|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15140187|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
15140188|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
15140189|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15140190|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140191|NCT04303130|Endostar protein|endostar protein|mesh-list
14014202|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14014203|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014204|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14014205|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14014206|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014207|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
14014208|NCT02824458|Apatinib|apatinib|mesh-list
14014209|NCT02824458|Gefitinib|gefitinib|mesh-list
14014210|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014211|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14014212|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014213|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014214|NCT02824094|Crizotinib|crizotinib|mesh-list
14014215|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014216|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14014217|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014218|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140192|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15140193|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15140194|NCT04303130|Growth Substances|growth substances|mesh-ancestor
15140195|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140196|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
15140197|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140198|NCT04303065|Dexamethasone|dexamethasone|mesh-list
15140199|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140200|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
15140201|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
14014219|NCT02824315|Simeprevir|simeprevir|mesh-list
14014220|NCT02824315|Odalasvir|odalasvir|mesh-list
14014221|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
14014222|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014223|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
14014224|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014225|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014226|NCT02824406|Acetazolamide|acetazolamide|mesh-list
14014227|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
14014228|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14014229|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014230|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014231|NCT02824406|Diuretics|diuretics|mesh-ancestor
14014232|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
14014233|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014234|NCT02824354|Nalmefene|nalmefene|mesh-list
14014235|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14014236|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014237|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
14014238|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140202|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140203|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140204|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140205|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
15140206|NCT04303065|Hormones|hormones|mesh-ancestor
15140207|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140208|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15140209|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140210|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
15140211|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15140212|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
14014239|NCT02824276|Morphine|morphine|mesh-list
14014240|NCT02824276|Oxycodone|oxycodone|mesh-list
14014241|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14014242|NCT02824276|Narcotics|narcotics|mesh-ancestor
14014243|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014244|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014245|NCT02824276|Analgesics|analgesics|mesh-ancestor
14014246|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
14014247|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014248|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
14014249|NCT02823977|Ketamine|ketamine|mesh-list
14014250|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014251|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014252|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014253|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014254|NCT02823977|Analgesics|analgesics|mesh-ancestor
14014255|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
14014256|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179249|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14014257|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14014258|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14014259|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14014260|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
14014261|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014262|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014263|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14014264|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14014265|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
14014266|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
14014267|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14014268|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14014269|NCT02823808|Glimepiride|glimepiride|mesh-list
14014270|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14272417|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
15140213|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140214|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15140215|NCT04302532|Ubiquinone|ubiquinone|mesh-list
15140216|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
15140217|NCT04302532|Clomiphene|clomiphene|mesh-list
15140218|NCT04302532|Enclomiphene|enclomiphene|mesh-list
15140219|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
15140220|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15140221|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
15140222|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140223|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140224|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15140225|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
15140226|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15140227|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15140228|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15140229|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
15140230|NCT04302532|Vitamins|vitamins|mesh-ancestor
15140231|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
15140232|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15140233|NCT04302402|Rifaximin|rifaximin|mesh-list
15140234|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15140235|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140236|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140237|NCT04302441|Capecitabine|capecitabine|mesh-list
15140238|NCT04302441|Vinorelbine|vinorelbine|mesh-list
15140239|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140240|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
15140241|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140242|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140243|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140244|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140245|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140246|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
15140247|NCT04302675|Vaccines|vaccines|mesh-list
15140248|NCT04302675|Immunologic Factors|immunologic factors|mesh-ancestor
15140249|NCT04302675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140250|NCT04302584|Vasopressins|vasopressins|mesh-list
15140251|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
15140252|NCT04302584|Norepinephrine|norepinephrine|mesh-list
15140253|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15140254|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15140255|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
15140256|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140257|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140258|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140259|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
15140260|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
15140261|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140262|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15140263|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
15140264|NCT04302584|Coagulants|coagulants|mesh-ancestor
15140265|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15140266|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
15140267|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
15140268|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15140269|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
15140270|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
14014271|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15140271|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140272|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140273|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15140274|NCT04302350|Analgesics|analgesics|mesh-ancestor
15140275|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
15140276|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140277|NCT04302116|Prednisolone|prednisolone|mesh-list
15140278|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15140279|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
15140280|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15140281|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
15140282|NCT04302116|Vigabatrin|vigabatrin|mesh-list
15140283|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15140284|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
15140285|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140286|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
15140287|NCT04302116|Hormones|hormones|mesh-ancestor
15140288|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140289|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014272|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014273|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14014274|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
14014275|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14014276|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
14014277|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14014278|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
14014279|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014280|NCT02823912|Capsaicin|capsaicin|mesh-list
14014281|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
14014282|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
14014283|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14014284|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
14014285|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014286|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014287|NCT02823912|Antacids|antacids|mesh-ancestor
14014288|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014289|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014290|NCT02823743|Aspirin|aspirin|mesh-list
15140290|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15140291|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140292|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
15140293|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
15140294|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140295|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140296|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15140297|NCT04302116|Protective Agents|protective agents|mesh-ancestor
15140298|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
15140299|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140300|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140301|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
15140302|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179250|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179251|NCT03951753|Incretins|incretins|mesh-ancestor
15179252|NCT03951753|Hormones|hormones|mesh-ancestor
15179253|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179254|NCT03951597|Gemcitabine|gemcitabine|mesh-list
15179255|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
15179256|NCT03951597|Lenvatinib|lenvatinib|mesh-list
15179257|NCT03951597|Antibodies|antibodies|mesh-list
15179258|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
15179259|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179260|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15179261|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
15179262|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179263|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179264|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
15179265|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179266|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179267|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15179268|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15179269|NCT03951415|Durvalumab|durvalumab|mesh-list
15179270|NCT03951415|Olaparib|olaparib|mesh-list
15179271|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15179272|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179273|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179274|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014291|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014292|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182058|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14014293|NCT02823743|Analgesics|analgesics|mesh-ancestor
14014294|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
14014295|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014296|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014297|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014298|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014299|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14014300|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15140303|NCT04301908|Interferons|interferons|mesh-list
15140304|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140305|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
15140306|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140307|NCT04302181|Ropivacaine|ropivacaine|mesh-list
15140308|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
15140309|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
15140310|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140311|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140312|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
15140313|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140314|NCT04301895|Remifentanil|remifentanil|mesh-list
15140315|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15140316|NCT04301895|Narcotics|narcotics|mesh-ancestor
15140317|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140318|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140319|NCT04301895|Analgesics|analgesics|mesh-ancestor
15140320|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
15140321|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140322|NCT04301882|Interferons|interferons|mesh-list
15140323|NCT04301882|Ribavirin|ribavirin|mesh-list
15140324|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
15140325|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140326|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140327|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
15140328|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140329|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15140330|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140331|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
15140332|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15140333|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15140334|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15140335|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140336|NCT04301492|Vortioxetine|vortioxetine|mesh-list
15140337|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
15140338|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15140339|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15140340|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15140341|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140342|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140343|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15140344|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15140345|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15140346|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140347|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140348|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
15140349|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15140350|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15140351|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15140352|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15140353|NCT04301661|Tenofovir|tenofovir|mesh-list
15140354|NCT04301661|Lamivudine|lamivudine|mesh-list
15140355|NCT04301661|Emtricitabine|emtricitabine|mesh-list
15140356|NCT04301661|Abacavir|abacavir|mesh-list
15140357|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
15140358|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140359|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15140360|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15140361|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140362|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140363|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14014301|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014302|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14014303|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14014304|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140364|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15140365|NCT04301739|Paclitaxel|paclitaxel|mesh-list
15140366|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
15140367|NCT04301739|Carboplatin|carboplatin|mesh-list
14014305|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
14014306|NCT02823665|Atropine|atropine|mesh-list
14014307|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14014308|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014309|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14014310|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
14014311|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014312|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811622|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14811623|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
14811624|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811625|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811626|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
15140368|NCT04301739|Doxorubicin|doxorubicin|mesh-list
15140369|NCT04301739|Epirubicin|epirubicin|mesh-list
15140370|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140371|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140372|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140373|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140374|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
15140375|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140376|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15140377|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
15140378|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140379|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15140380|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15140381|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
15140382|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15140383|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15140384|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15140385|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15140386|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140387|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
15140388|NCT04301583|Procyanidin|procyanidin|mesh-list
15140389|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
15140390|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140391|NCT04301583|Protective Agents|protective agents|mesh-ancestor
15140392|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140393|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15140394|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15140395|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140396|NCT04301557|Capecitabine|capecitabine|mesh-list
15140397|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
15140398|NCT04301557|Antibodies|antibodies|mesh-list
15140399|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
15140400|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140401|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140402|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
15140403|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140404|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140405|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
15140406|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15140407|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15140408|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15140409|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140410|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
15140411|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140412|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140413|NCT04301349|Misoprostol|misoprostol|mesh-list
15140414|NCT04301349|Dinoprostone|dinoprostone|mesh-list
15140415|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15140416|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
15140417|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15140418|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140419|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15140420|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140421|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
15140422|NCT04301336|Zinc|zinc|mesh-list
15140423|NCT04301336|Folic Acid|folic acid|mesh-list
15140424|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
15140425|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
15140426|NCT04301336|Morphine|morphine|mesh-list
15140427|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
14014313|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14811627|NCT00846326|Fluticasone|fluticasone|mesh-list
15140428|NCT04301336|Simvastatin|simvastatin|mesh-list
14811628|NCT00846326|Xhance|xhance|mesh-list
14811629|NCT00846326|Phenylephrine|phenylephrine|mesh-list
14811630|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
14811631|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811632|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15140429|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15140430|NCT04301336|Narcotics|narcotics|mesh-ancestor
15140431|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140432|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140433|NCT04301336|Analgesics|analgesics|mesh-ancestor
15140434|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
15140435|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140436|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15140437|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15140438|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
15140439|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140440|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15140441|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15140442|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140443|NCT04301336|Trace Elements|trace elements|mesh-ancestor
15140444|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
15140445|NCT04301336|Hematinics|hematinics|mesh-ancestor
15140446|NCT04301336|Vitamins|vitamins|mesh-ancestor
15140447|NCT04301336|Astringents|astringents|mesh-ancestor
15140448|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
15140449|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140450|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
15140451|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15140452|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
15140453|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15140454|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
15140455|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
15140456|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14272418|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14272419|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14272420|NCT00423735|Dasatinib|dasatinib|mesh-list
14272421|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272422|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15140457|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140458|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15140459|NCT04301024|Analgesics|analgesics|mesh-ancestor
15140460|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
15140461|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140462|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15140463|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15140464|NCT04300959|Gemcitabine|gemcitabine|mesh-list
15140465|NCT04300959|Cisplatin|cisplatin|mesh-list
15140466|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140467|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140468|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
15140469|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140470|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
15140471|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140472|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140473|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15140474|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
15140475|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140476|NCT04301375|Paclitaxel|paclitaxel|mesh-list
15140477|NCT04301375|Trastuzumab|trastuzumab|mesh-list
15140478|NCT04301375|Pertuzumab|pertuzumab|mesh-list
15140479|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140480|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140481|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140482|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140483|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
15140484|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140485|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15140486|NCT04300686|Adalimumab|adalimumab|mesh-list
15140487|NCT04300686|Antibodies|antibodies|mesh-list
15140488|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
15140489|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
14272423|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272424|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140490|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140491|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140492|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811633|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
15140493|NCT04300881|Eplerenone|eplerenone|mesh-list
14811634|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811635|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811636|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14811637|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
14811638|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
14811639|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14014314|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
14014315|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
15140494|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15140495|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
15140496|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140497|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140498|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15140499|NCT04300881|Diuretics|diuretics|mesh-ancestor
15140500|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
15140501|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15140502|NCT04300452|Carbetocin|carbetocin|mesh-list
15140503|NCT04300452|Ergonovine|ergonovine|mesh-list
15140504|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
15140505|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15140506|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140507|NCT04300374|Anesthetics|anesthetics|mesh-list
15140508|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140509|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140510|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
15140511|NCT04300751|Narcotics|narcotics|mesh-ancestor
15140512|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140513|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140514|NCT04300751|Analgesics|analgesics|mesh-ancestor
15140515|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
15140516|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140517|NCT04300322|Progesterone|progesterone|mesh-list
15140518|NCT04300322|Progestins|progestins|mesh-ancestor
15140519|NCT04300322|Hormones|hormones|mesh-ancestor
15140520|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140521|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179275|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179276|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
15179277|NCT03951402|Tapentadol|tapentadol|mesh-list
15179278|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15179279|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15179280|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179281|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15179282|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15179283|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179284|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179285|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179286|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15179287|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
15179288|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15179289|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179290|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15179291|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15179292|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15179293|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15179294|NCT03951402|Narcotics|narcotics|mesh-ancestor
15179295|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179296|NCT03951402|Analgesics|analgesics|mesh-ancestor
14014316|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
14014317|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14014318|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14014319|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
14272425|NCT00423800|Interferons|interferons|mesh-list
14272426|NCT00423800|Ribavirin|ribavirin|mesh-list
14272427|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
14272428|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
14272429|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14272430|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179297|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
15179298|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179299|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15179300|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15179301|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179302|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14014320|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014321|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014322|NCT02823626|Spironolactone|spironolactone|mesh-list
14014323|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14014324|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
14014325|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014326|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014327|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14014328|NCT02823626|Diuretics|diuretics|mesh-ancestor
14014329|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
14014330|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
14014331|NCT02823925|Pamidronate|pamidronate|mesh-list
14014332|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14014333|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014334|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
14014335|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15140522|NCT04300192|Vaccines|vaccines|mesh-list
15140523|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
15140524|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140525|NCT04300231|Hydromorphone|hydromorphone|mesh-list
15140526|NCT04300231|Bupivacaine|bupivacaine|mesh-list
15140527|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
15140528|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
15140529|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140530|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140531|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
15140532|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140533|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15140534|NCT04300231|Narcotics|narcotics|mesh-ancestor
15140535|NCT04300231|Analgesics|analgesics|mesh-ancestor
15140536|NCT04300049|Glucagon|glucagon|mesh-list
15140537|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15140538|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140539|NCT04300049|Hormones|hormones|mesh-ancestor
15140540|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140541|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140542|NCT04300049|Incretins|incretins|mesh-ancestor
15140543|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15140544|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
15140545|NCT04299971|Methotrexate|methotrexate|mesh-list
15140546|NCT04299971|Tofacitinib|tofacitinib|mesh-list
15140547|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15140548|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
15140549|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15140550|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140551|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140552|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
15140553|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140554|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140555|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
15140556|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140557|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15140558|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15140559|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
15140560|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15140561|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15140562|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15140563|NCT04299633|Calcium|calcium|mesh-list
15140564|NCT04299633|Sevelamer|sevelamer|mesh-list
15140565|NCT04299633|Calcium acetate|calcium acetate|mesh-list
15140566|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15140567|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140568|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
15140569|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
15140570|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140571|NCT04299854|Dinoprostone|dinoprostone|mesh-list
15140572|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
15140573|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15140574|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140575|NCT04298775|Morphine|morphine|mesh-list
15140576|NCT04298775|Anesthetics|anesthetics|mesh-list
15140577|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014336|NCT02823496|Protective Agents|protective agents|mesh-ancestor
15140578|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140579|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15140580|NCT04298775|Narcotics|narcotics|mesh-ancestor
14014337|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014338|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14014339|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
14014340|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14014341|NCT02823483|Protective Agents|protective agents|mesh-ancestor
14014342|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014343|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
14014344|NCT02823691|Metformin|metformin|mesh-list
14014345|NCT02823691|Lanreotide|lanreotide|mesh-list
14014346|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14014347|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014348|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014349|NCT02824042|Itraconazole|itraconazole|mesh-list
14014350|NCT02824042|Maytansine|maytansine|mesh-list
14014351|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
14014352|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014353|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14014354|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14014355|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014356|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014357|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14014358|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
14014359|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140581|NCT04298775|Analgesics|analgesics|mesh-ancestor
15140582|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
15140583|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140584|NCT04298528|Dronabinol|dronabinol|mesh-list
15140585|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
15140586|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140587|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15140588|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15140589|NCT04298528|Analgesics|analgesics|mesh-ancestor
15140590|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
15140591|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140592|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15140593|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15140594|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140595|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140596|NCT04298528|Hormones|hormones|mesh-ancestor
15140597|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140598|NCT04298684|Metformin|metformin|mesh-list
15140599|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15140600|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15140601|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140602|NCT04298684|Incretins|incretins|mesh-ancestor
15140603|NCT04298684|Hormones|hormones|mesh-ancestor
15140604|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140605|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15140606|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
15140607|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140608|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140609|NCT04298372|Lenalidomide|lenalidomide|mesh-list
15140610|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
15140611|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140612|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15140613|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15140614|NCT04298372|Growth Substances|growth substances|mesh-ancestor
15140615|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
15140616|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179303|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179304|NCT03951285|Niacinamide|niacinamide|mesh-list
15179305|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
15179306|NCT03951285|Vitamins|vitamins|mesh-ancestor
15179307|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
15179308|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179309|NCT03951207|Amlodipine|amlodipine|mesh-list
15179310|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
15179311|NCT03951207|Atorvastatin|atorvastatin|mesh-list
15179312|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15179313|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15179314|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
15179315|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179316|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15182059|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272431|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
14014360|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014361|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14014362|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140617|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15140618|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15140619|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15140620|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140621|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140622|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
14014363|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014364|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14014365|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14014366|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14014367|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
14014368|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14014369|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140623|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140624|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15140625|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15140626|NCT04298021|Durvalumab|durvalumab|mesh-list
15140627|NCT04298021|Olaparib|olaparib|mesh-list
15140628|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15140629|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140630|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15140631|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140632|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140633|NCT04298008|Durvalumab|durvalumab|mesh-list
15140634|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15140635|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140636|NCT04297839|Heparin|heparin|mesh-list
15140637|NCT04297839|Calcium heparin|calcium heparin|mesh-list
15140638|NCT04297839|Citric Acid|citric acid|mesh-list
15140639|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
15140640|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
15140641|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14014370|NCT02823236|Triamcinolone|triamcinolone|mesh-list
14014371|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14014372|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14014373|NCT02823236|Pirfenidone|pirfenidone|mesh-list
14272432|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140642|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
15140643|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
15140644|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140645|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15140646|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15140647|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
15140648|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15140649|NCT04297215|Chitosan|chitosan|mesh-list
15140650|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15140651|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15140652|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
15140653|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140654|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15140655|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
15140656|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
15140657|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
15140658|NCT04297215|Coagulants|coagulants|mesh-ancestor
15140659|NCT04297202|Apatinib|apatinib|mesh-list
15140660|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140661|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15140662|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272433|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
15140663|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140664|NCT04297176|Vancomycin|vancomycin|mesh-list
15140665|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15140666|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140667|NCT04297254|Lenvatinib|lenvatinib|mesh-list
15140668|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140669|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15140670|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140671|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140672|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14811640|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15140673|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
15140674|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140675|NCT04297462|Oseltamivir|oseltamivir|mesh-list
14272434|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272435|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
14272436|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272437|NCT00423852|Paclitaxel|paclitaxel|mesh-list
15140676|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
15140677|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140678|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140679|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140680|NCT04297267|Gemcitabine|gemcitabine|mesh-list
15140681|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140682|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140683|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
15140684|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140685|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
15140686|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140687|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140688|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15140689|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
15140690|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140691|NCT04297332|Nicotine|nicotine|mesh-list
15140692|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15140693|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
15140694|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140695|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140696|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15140697|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15140698|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
15140699|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140700|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140701|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
15140702|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15140703|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
15140704|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15140705|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
15140706|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140707|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140708|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
15140709|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15140710|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15140711|NCT04297033|Lovastatin|lovastatin|mesh-list
15140712|NCT04297033|L 647318|l 647318|mesh-list
15140713|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
15140714|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15140715|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15140716|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
15140717|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140718|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15140719|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15140720|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140721|NCT04296851|Niclosamide|niclosamide|mesh-list
15140722|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
15140723|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15140724|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
15140725|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15140726|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140727|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
15140728|NCT04296422|Ibuprofen|ibuprofen|mesh-list
15140729|NCT04296422|Diclofenac|diclofenac|mesh-list
15140730|NCT04296422|Naproxen|naproxen|mesh-list
15140731|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15140732|NCT04296422|Piroxicam|piroxicam|mesh-list
15140733|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
15140734|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
15140735|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15140736|NCT04296422|Analgesics|analgesics|mesh-ancestor
15140737|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
15140738|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140739|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140740|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140741|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15140742|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15140743|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140744|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140745|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
15140746|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15140747|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14014374|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14014375|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140748|NCT04296578|Selenious Acid|selenious acid|mesh-list
14014376|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
14014377|NCT02823236|Hormones|hormones|mesh-ancestor
15140749|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
15140750|NCT04296578|Prednisone|prednisone|mesh-list
15140751|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
15140752|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140753|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
15140754|NCT04296578|Hormones|hormones|mesh-ancestor
15140755|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014378|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014379|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140756|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140757|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15140758|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140759|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15140760|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140761|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140762|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
14014380|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14014381|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
14014382|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014383|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014384|NCT02823236|Analgesics|analgesics|mesh-ancestor
14014385|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
14014386|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014387|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014388|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014389|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014390|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014391|NCT02823249|Erythritol|erythritol|mesh-list
14014392|NCT02823249|Tryptophan|tryptophan|mesh-list
14014393|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14014394|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
14014395|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14014396|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
14014397|NCT02823353|Fenofibrate|fenofibrate|mesh-list
14014398|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14014399|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
14014400|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014401|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14025392|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025393|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
14025394|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025395|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14025396|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14272438|NCT00423852|Carboplatin|carboplatin|mesh-list
14272439|NCT00423852|Ifosfamide|ifosfamide|mesh-list
14272440|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14272441|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272442|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14272443|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14272444|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14272445|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272446|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14272447|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
14272448|NCT00423878|Olanzapine|olanzapine|mesh-list
14272449|NCT00423878|Risperidone|risperidone|mesh-list
14272450|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14272451|NCT00423878|Aripiprazole|aripiprazole|mesh-list
14272452|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14272453|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
14272454|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272455|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272456|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272457|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14272458|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14272459|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14272460|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14272461|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14272462|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
14272463|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
14272464|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
14014402|NCT02823028|Nicotine|nicotine|mesh-list
14014403|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14014404|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
14014405|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014406|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014407|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14014408|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14014409|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
14014410|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014411|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014412|NCT02823106|Verapamil|verapamil|mesh-list
14014413|NCT02823106|Choline|choline|mesh-list
14014414|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14014415|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
14014416|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14014417|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
14014418|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014419|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014420|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14014421|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
14014422|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014423|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14014424|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014425|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14014426|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014427|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14014428|NCT02823366|Fenofibrate|fenofibrate|mesh-list
14014429|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14014430|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
14014431|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014432|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14014433|NCT02823145|Fenfluramine|fenfluramine|mesh-list
14014434|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14014435|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14014436|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014437|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014438|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014439|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
14014440|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014441|NCT02822729|Timolol|timolol|mesh-list
14014442|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14014443|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14014444|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14014445|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14014446|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14014447|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014448|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014449|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014450|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014451|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14014452|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14014453|NCT02822742|Latanoprost|latanoprost|mesh-list
15140763|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15140764|NCT04296578|Trace Elements|trace elements|mesh-ancestor
15140765|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
15140766|NCT04296695|Tenofovir|tenofovir|mesh-list
15140767|NCT04296695|Efavirenz|efavirenz|mesh-list
15140768|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
15140769|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140770|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15140771|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15140772|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140773|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140774|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14014454|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14014455|NCT02822937|Triazolam|triazolam|mesh-list
14014456|NCT02822937|Methylphenidate|methylphenidate|mesh-list
14014457|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14014458|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014459|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14014460|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15140775|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14014461|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811641|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14014462|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014463|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
14014464|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014465|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14014466|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14014467|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14014468|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014469|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14014470|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
14014471|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
14014472|NCT02822482|Cetuximab|cetuximab|mesh-list
14014473|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14014474|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014475|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15140776|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15140777|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15140778|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15140779|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15140780|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15140781|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15179317|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15179318|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179319|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179320|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15179321|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179322|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15179323|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179324|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
15179325|NCT03950830|Disulfiram|disulfiram|mesh-list
15179326|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15179327|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15179328|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179329|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014476|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
14014477|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014478|NCT02822573|Donepezil|donepezil|mesh-list
14014479|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14014480|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014481|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014482|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
14014483|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014484|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014485|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
14014486|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14014487|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14014488|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014489|NCT02822131|Sevelamer|sevelamer|mesh-list
14014490|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
14014491|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
14014492|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014493|NCT02821923|Erythritol|erythritol|mesh-list
14014494|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
14014495|NCT02821897|Anesthetics|anesthetics|mesh-list
14014496|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014497|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014498|NCT02821858|Odalasvir|odalasvir|mesh-list
14014499|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
14014500|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014501|NCT02822144|Lidocaine|lidocaine|mesh-list
14014502|NCT02822144|Remifentanil|remifentanil|mesh-list
14014503|NCT02822144|Propofol|propofol|mesh-list
14014504|NCT02822144|Etomidate|etomidate|mesh-list
14014505|NCT02822144|Succinylcholine|succinylcholine|mesh-list
14014506|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014507|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
14014508|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014509|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014510|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
14014511|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014512|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014513|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14014514|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14014515|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025397|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14014516|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014517|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014518|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14014519|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
14014520|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14014521|NCT02822144|Narcotics|narcotics|mesh-ancestor
14014522|NCT02822144|Analgesics|analgesics|mesh-ancestor
14014523|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14014524|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14014525|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14014526|NCT02822196|Lidocaine|lidocaine|mesh-list
14014527|NCT02822196|Bupivacaine|bupivacaine|mesh-list
14014528|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014529|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
14014530|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014531|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140782|NCT04296214|Azacitidine|azacitidine|mesh-list
15140783|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140784|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
15140785|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140786|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140787|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140788|NCT04296240|Capecitabine|capecitabine|mesh-list
14014532|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
14014533|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014534|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014535|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14014536|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14014537|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014538|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014539|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
14014540|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14014541|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14014542|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
14014543|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014544|NCT02822157|Gemcitabine|gemcitabine|mesh-list
14014545|NCT02822157|Paclitaxel|paclitaxel|mesh-list
14014546|NCT02822157|Carboplatin|carboplatin|mesh-list
14014547|NCT02822157|Doxorubicin|doxorubicin|mesh-list
14014548|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14014549|NCT02822157|Topotecan|topotecan|mesh-list
14014550|NCT02822157|Olaparib|olaparib|mesh-list
14014551|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14014552|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014553|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
14014554|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
14014555|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
14014556|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014557|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14014558|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
14014559|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
14014560|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014561|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014562|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14014563|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
14014564|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014565|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14014566|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14014567|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14014568|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14014569|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14014570|NCT02821689|Pirfenidone|pirfenidone|mesh-list
14014571|NCT02821689|Analgesics|analgesics|mesh-ancestor
14014572|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
14014573|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014574|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014575|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014576|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014577|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014578|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014579|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014580|NCT02821520|Verteporfin|verteporfin|mesh-list
14014581|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14014582|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
14014583|NCT02821533|Cisplatin|cisplatin|mesh-list
15140789|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
15140790|NCT04296240|Antiemetics|antiemetics|mesh-list
15140791|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140792|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
14014584|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
14014585|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14014586|NCT02821468|Acetaminophen|acetaminophen|mesh-list
14014587|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14014588|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014589|NCT02821468|Analgesics|analgesics|mesh-ancestor
14014590|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
14014591|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014592|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014593|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
14014594|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14014595|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014596|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014597|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014598|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014599|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025398|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025399|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025400|NCT02750917|Etoricoxib|etoricoxib|mesh-list
14025401|NCT02750917|Lornoxicam|lornoxicam|mesh-list
14025402|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14025403|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025404|NCT02750917|Analgesics|analgesics|mesh-ancestor
14025405|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
14025406|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272465|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272466|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272467|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14272468|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14272469|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14272470|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
14272471|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
14272472|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14272473|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14272474|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14272475|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14272476|NCT00423891|Entecavir|entecavir|mesh-list
14272477|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
14272478|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272479|NCT00423917|Bevacizumab|bevacizumab|mesh-list
14272480|NCT00423917|Fulvestrant|fulvestrant|mesh-list
14272481|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272482|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272483|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14272484|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14272485|NCT00423917|Growth Substances|growth substances|mesh-ancestor
14272486|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272487|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
14272488|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562063|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562064|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562065|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562066|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562067|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14562068|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
14811642|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
14272489|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14272490|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14272491|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
14272492|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272493|NCT00423930|Bevacizumab|bevacizumab|mesh-list
14272494|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272495|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272496|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14272497|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14272498|NCT00423930|Growth Substances|growth substances|mesh-ancestor
14272499|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272500|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
14272501|NCT00423943|Modafinil|modafinil|mesh-list
14272502|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14562069|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140793|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140794|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014600|NCT02821676|Anesthetics|anesthetics|mesh-list
14014601|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014602|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014603|NCT02821559|Bevacizumab|bevacizumab|mesh-list
14014604|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
14014605|NCT02821559|Raltitrexed|raltitrexed|mesh-list
14014606|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272503|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272504|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14272505|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14272506|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14272507|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272508|NCT00424021|Ambrisentan|ambrisentan|mesh-list
14272509|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14272510|NCT00424047|Dexamethasone|dexamethasone|mesh-list
14272511|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
14272512|NCT00424047|Lenalidomide|lenalidomide|mesh-list
14272513|NCT00424047|BB 1101|bb 1101|mesh-list
14272514|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272515|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
14272516|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
14272517|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272518|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272519|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272520|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
15140795|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
15140796|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140797|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140798|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140799|NCT04296370|Apatinib|apatinib|mesh-list
14272521|NCT00424047|Hormones|hormones|mesh-ancestor
14272522|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811643|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140800|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140801|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15140802|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140803|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811644|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811645|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
15140804|NCT04296383|Azithromycin|azithromycin|mesh-list
14272523|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14272524|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272525|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
14272526|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272527|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272528|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
14272529|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14272530|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14272531|NCT00424047|Growth Substances|growth substances|mesh-ancestor
14272532|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
14272533|NCT00424190|Vancomycin|vancomycin|mesh-list
14272534|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14272535|NCT00424190|Aztreonam|aztreonam|mesh-list
14272536|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272537|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272538|NCT00424255|Lapatinib|lapatinib|mesh-list
14272539|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272540|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14272541|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272542|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272543|NCT00424294|Celecoxib|celecoxib|mesh-list
14272544|NCT00424294|Methotrexate|methotrexate|mesh-list
14272545|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14272546|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
14272547|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14272548|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014607|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014608|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14014609|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14014610|NCT02821559|Growth Substances|growth substances|mesh-ancestor
14014611|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140805|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15140806|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140807|NCT04296175|Paclitaxel|paclitaxel|mesh-list
15140808|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15140809|NCT04296175|Carboplatin|carboplatin|mesh-list
15140810|NCT04296175|Epirubicin|epirubicin|mesh-list
15140811|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140812|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140813|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140814|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140815|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
14014612|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
14014613|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14014614|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
14014615|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014616|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14014617|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014618|NCT02821390|Nepafenac|nepafenac|mesh-list
14014619|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14014620|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
14014621|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14014622|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014623|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014624|NCT02821390|Analgesics|analgesics|mesh-ancestor
14014625|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
15140816|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140817|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15140818|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15140819|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15140820|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140821|NCT04296162|Capecitabine|capecitabine|mesh-list
15140822|NCT04296162|Trastuzumab|trastuzumab|mesh-list
15140823|NCT04296162|Vinorelbine|vinorelbine|mesh-list
15140824|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14014626|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014627|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014628|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014629|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014630|NCT02821312|DA-8010|da-8010|mesh-list
14014631|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14014632|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14014633|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
14014634|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014635|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140825|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
15140826|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140827|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140828|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15140829|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140830|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140831|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140832|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
15140833|NCT04295993|Norepinephrine|norepinephrine|mesh-list
15140834|NCT04295993|Methylene Blue|methylene blue|mesh-list
15140835|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15140836|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15140837|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
15140838|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140839|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140840|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140841|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
15140842|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
15140843|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140844|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15140845|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140846|NCT04295850|Aspirin|aspirin|mesh-list
15140847|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15140848|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15140849|NCT04295850|Analgesics|analgesics|mesh-ancestor
15140850|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
15140851|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140852|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014636|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140853|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140854|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15140855|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15140856|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15140857|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140858|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15140859|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15140860|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140861|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
15140862|NCT04295967|Formaldehyde|formaldehyde|mesh-list
15140863|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
15140864|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140865|NCT04296149|Octreotide|octreotide|mesh-list
15140866|NCT04296149|Edotreotide|edotreotide|mesh-list
14014637|NCT02821377|Furosemide|furosemide|mesh-list
14014638|NCT02821377|Diuretics|diuretics|mesh-ancestor
14014639|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
14811646|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
14811647|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14811648|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14811649|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
14811650|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14811651|NCT00846326|Protective Agents|protective agents|mesh-ancestor
14811652|NCT00846339|Bupropion|bupropion|mesh-list
14811653|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14811654|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
15140867|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140868|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15140869|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140870|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15140871|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140872|NCT04295408|Ropivacaine|ropivacaine|mesh-list
15140873|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
15140874|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
15140875|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140876|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140877|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
14014640|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811655|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14811656|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14811657|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14811658|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014641|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14014642|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014643|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014644|NCT02820987|Meropenem|meropenem|mesh-list
14014645|NCT02820987|Tazobactam|tazobactam|mesh-list
14014646|NCT02820987|Piperacillin|piperacillin|mesh-list
14014647|NCT02820987|Cefepime|cefepime|mesh-list
14014648|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14014649|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14014650|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014651|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14014652|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014653|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014654|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
14014655|NCT02821026|Sirolimus|sirolimus|mesh-list
14014656|NCT02821026|Etanercept|etanercept|mesh-list
14014657|NCT02821026|Tacrolimus|tacrolimus|mesh-list
14014658|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
14014659|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14014660|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14014661|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
14014662|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014663|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14014664|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014665|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014666|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14014667|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014668|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14014669|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
14014670|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14014671|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014672|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
14272549|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272550|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
15140878|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140879|NCT04295317|Capecitabine|capecitabine|mesh-list
14014673|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014674|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014675|NCT02821026|Analgesics|analgesics|mesh-ancestor
14014676|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
14014677|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014678|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014679|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014680|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014681|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
14014682|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14014683|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
14014684|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014685|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014686|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14014687|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
14014688|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14014689|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
14014690|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014691|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140880|NCT04295317|Antibodies|antibodies|mesh-list
15140881|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
15140882|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
15140883|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140884|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15140885|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
15140886|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140887|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140888|NCT04295551|Ritonavir|ritonavir|mesh-list
15140889|NCT04295551|Lopinavir|lopinavir|mesh-list
15140890|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15140891|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15140892|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
15140893|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014692|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14014693|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
14014694|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
14014695|NCT02821156|Protective Agents|protective agents|mesh-ancestor
14014696|NCT02821169|Ropivacaine|ropivacaine|mesh-list
14014697|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014698|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
14014699|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140894|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140895|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15140896|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15140897|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
15140898|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15140899|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15140900|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15140901|NCT04295330|Lidocaine|lidocaine|mesh-list
14014700|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014701|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
14014702|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014703|NCT02820935|Itraconazole|itraconazole|mesh-list
14014704|NCT02820935|Rifampin|rifampin|mesh-list
14014705|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
14014706|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014707|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14014708|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14014709|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140902|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014710|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014711|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14014712|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
15140903|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
15140904|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140905|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014713|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014714|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014715|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14014716|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14014717|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
14014718|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15140906|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
15179330|NCT03950960|Itraconazole|itraconazole|mesh-list
14014719|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
15140907|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014720|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14014721|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14014722|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14014723|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14014724|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14014725|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14014726|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14014727|NCT02821052|Insulin|insulin|mesh-list
14014728|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
14014729|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14014730|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014731|NCT02820948|Vitamins|vitamins|mesh-list
14014732|NCT02820948|Vitamin E|vitamin e|mesh-list
14014733|NCT02820948|Tocopherols|tocopherols|mesh-list
14014734|NCT02820948|Tocotrienols|tocotrienols|mesh-list
14014735|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
14014736|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
14014737|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014738|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
14014739|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014740|NCT02820948|Protective Agents|protective agents|mesh-ancestor
14014741|NCT02820922|Anesthetics|anesthetics|mesh-list
14014742|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014743|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014744|NCT02821247|Aflibercept|aflibercept|mesh-list
14014745|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14014746|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14014747|NCT02821247|Growth Substances|growth substances|mesh-ancestor
14014748|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014749|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
14014750|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014751|NCT02820883|Vaccines|vaccines|mesh-list
14014752|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
14014753|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014754|NCT02820519|Loxapine|loxapine|mesh-list
14014755|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14014756|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14014757|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014758|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014759|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15140908|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15140909|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15140910|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15140911|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15140912|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140913|NCT04295629|Anesthetics|anesthetics|mesh-list
15140914|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140915|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140916|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
15140917|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140918|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15140919|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140920|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140921|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
15140922|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140923|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140924|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15140925|NCT04294784|Paclitaxel|paclitaxel|mesh-list
14014760|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14014761|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
14014762|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014763|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014764|NCT02820688|Bupivacaine|bupivacaine|mesh-list
14014765|NCT02820688|Prilocaine|prilocaine|mesh-list
14014766|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014767|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
14014768|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014769|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014770|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
14014771|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014772|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
14014773|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
14014774|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014775|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014776|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014777|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014778|NCT02820610|Analgesics|analgesics|mesh-ancestor
14014779|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
14014780|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014781|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14014782|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14014783|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14014784|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
14014785|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014786|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014787|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
14014788|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014789|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
14014790|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14014791|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014792|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14014793|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
14014794|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14014795|NCT02820493|Vedolizumab|vedolizumab|mesh-list
14014796|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014797|NCT02820441|Zopiclone|zopiclone|mesh-list
14014798|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014799|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014800|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014801|NCT02820558|Substance P|substance p|mesh-list
14014802|NCT02820558|Neurokinin A|neurokinin a|mesh-list
14272551|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272552|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272553|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272554|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272555|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14272556|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272557|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
15140926|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15140927|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15140928|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15140929|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140930|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
15140931|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
15140932|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
15140933|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272558|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272559|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14272560|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14272561|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14272562|NCT00424294|Analgesics|analgesics|mesh-ancestor
14272563|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
14272564|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272565|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272566|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14272567|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14272568|NCT00424372|Pregabalin|pregabalin|mesh-list
14272569|NCT00424372|Analgesics|analgesics|mesh-ancestor
14272570|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
14272571|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272572|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272573|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
14272574|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14272575|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14272576|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272577|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14272578|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14272579|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14272580|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14272581|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14272582|NCT00424385|Sorafenib|sorafenib|mesh-list
14272583|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
14272584|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179331|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
14014803|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014804|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014805|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014806|NCT02820259|Tacrolimus|tacrolimus|mesh-list
14014807|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14014808|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
14014809|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014810|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14014811|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014812|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014813|NCT02820077|Hemostatics|hemostatics|mesh-list
14014814|NCT02820077|Coagulants|coagulants|mesh-ancestor
14014815|NCT02819999|Etoposide|etoposide|mesh-list
14014816|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014817|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14014818|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14014819|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14014820|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014821|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014822|NCT02820025|Doxapram|doxapram|mesh-list
14014823|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14014824|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272585|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14014825|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
14014826|NCT02820051|Lidocaine|lidocaine|mesh-list
14014827|NCT02820051|Midazolam|midazolam|mesh-list
14014828|NCT02820051|Nalbuphine|nalbuphine|mesh-list
14014829|NCT02820051|Propofol|propofol|mesh-list
14014830|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014831|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
14014832|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014833|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014834|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
14014835|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014836|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14014837|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14014838|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14014839|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014840|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014841|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014842|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14014843|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
14014844|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14014845|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14014846|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14014847|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14014848|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
14014849|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
14014850|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014851|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14014852|NCT02820051|Narcotics|narcotics|mesh-ancestor
14014853|NCT02820051|Analgesics|analgesics|mesh-ancestor
14025407|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025408|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025409|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025410|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14025411|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14025412|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025413|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025414|NCT02751034|Lidocaine|lidocaine|mesh-list
14025415|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025416|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
14025417|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025418|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025419|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
14025420|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025421|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14025422|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14025423|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14025424|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025425|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025426|NCT02750995|Azacitidine|azacitidine|mesh-list
14025427|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14025428|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
14272586|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014854|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14014855|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14014856|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14014857|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14014858|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014859|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014860|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014861|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
14014862|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14014863|NCT02819856|Ebselen|ebselen|mesh-list
14014864|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14014865|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014866|NCT02819856|Analgesics|analgesics|mesh-ancestor
14014867|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
14014868|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014869|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014870|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014871|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14014872|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14014873|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014874|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
14014875|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014876|NCT02819856|Protective Agents|protective agents|mesh-ancestor
14014877|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14014878|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014879|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14014880|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14014881|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14014882|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014883|NCT02819661|Morphine|morphine|mesh-list
14272587|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272588|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
14272589|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15140934|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15140935|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140936|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140937|NCT04294823|Esomeprazole|esomeprazole|mesh-list
15140938|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15140939|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140940|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15140941|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140942|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140943|NCT04294836|Curcumin|curcumin|mesh-list
15140944|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15140945|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15140946|NCT04294836|Analgesics|analgesics|mesh-ancestor
15140947|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
15140948|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140949|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140950|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15140951|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15140952|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15140953|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15140954|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140955|NCT04294966|Dronabinol|dronabinol|mesh-list
15140956|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
15140957|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140958|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15140959|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014884|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15140960|NCT04294966|Analgesics|analgesics|mesh-ancestor
15140961|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
15140962|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014885|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272590|NCT00424463|Edaravone|edaravone|mesh-list
14272591|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14272592|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
14272593|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272594|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14272595|NCT00424463|Protective Agents|protective agents|mesh-ancestor
14272596|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140963|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15140964|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15140965|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140966|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140967|NCT04294966|Hormones|hormones|mesh-ancestor
15140968|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15140969|NCT04294732|Bupivacaine|bupivacaine|mesh-list
15140970|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
15140971|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
15140972|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014886|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14014887|NCT02819661|Narcotics|narcotics|mesh-ancestor
14014888|NCT02819661|Analgesics|analgesics|mesh-ancestor
14014889|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
14014890|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014891|NCT02819869|Metformin|metformin|mesh-list
14014892|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14014893|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014894|NCT02819648|Prednisolone|prednisolone|mesh-list
14014895|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
14014896|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014897|NCT02819648|Hormones|hormones|mesh-ancestor
14014898|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014899|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014900|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14014901|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014902|NCT02819414|Acetaminophen|acetaminophen|mesh-list
14014903|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014904|NCT02819414|Analgesics|analgesics|mesh-ancestor
14014905|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
14014906|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014907|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014908|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
14014909|NCT02819544|Ropivacaine|ropivacaine|mesh-list
14014910|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
14014911|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
14014912|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014913|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014914|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
14014915|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014916|NCT02819570|Ampicillin|ampicillin|mesh-list
15140973|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140974|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
15140975|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140976|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15140977|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15140978|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15140979|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15140980|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15140981|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15140982|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140983|NCT04294953|Analgesics|analgesics|mesh-ancestor
15140984|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
15140985|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140986|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
14014917|NCT02819570|Cefuroxime|cefuroxime|mesh-list
14014918|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
14014919|NCT02819570|Roxithromycin|roxithromycin|mesh-list
14014920|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14014921|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14014922|NCT02819375|Ketamine|ketamine|mesh-list
14014923|NCT02819375|Remifentanil|remifentanil|mesh-list
14014924|NCT02819375|Propofol|propofol|mesh-list
14014925|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014926|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014927|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014928|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14014929|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
14014930|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
14014931|NCT02819375|Analgesics|analgesics|mesh-ancestor
14014932|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
14014933|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014934|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14014935|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14014936|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14014937|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014938|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014939|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14014940|NCT02819375|Narcotics|narcotics|mesh-ancestor
14014941|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
14014942|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14014943|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014944|NCT02819115|Vaccines|vaccines|mesh-list
14014945|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
14014946|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014947|NCT02819102|Berotralstat|berotralstat|mesh-list
14014948|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14014949|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014950|NCT02818985|Dexamethasone|dexamethasone|mesh-list
14014951|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
14014952|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14014953|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
15140987|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15140988|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
15140989|NCT04294992|Ondansetron|ondansetron|mesh-list
15140990|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
14014954|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
14014955|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014956|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014957|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14014958|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
14014959|NCT02818985|Hormones|hormones|mesh-ancestor
14014960|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14014961|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14014962|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14014963|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014964|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014965|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014966|NCT02818985|Analgesics|analgesics|mesh-ancestor
15140991|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
15140992|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15140993|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15140994|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15140995|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
15140996|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
15140997|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15140998|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
15140999|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141000|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141001|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15141002|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15141003|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141004|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15141005|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14014967|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
14014968|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14014969|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14014970|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14014971|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
14014972|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014973|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014974|NCT02819180|Vaccines|vaccines|mesh-list
14014975|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
14014976|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014977|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
14014978|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14014979|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14014980|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014981|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14014982|NCT02819089|Analgesics|analgesics|mesh-ancestor
14014983|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
14014984|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014985|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14014986|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14014987|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14014988|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
14014989|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014990|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14014991|NCT02818881|Methamphetamine|methamphetamine|mesh-list
14014992|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14014993|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14014994|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
14014995|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
14014996|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14014997|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
14014998|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14014999|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015000|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015001|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14015002|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14015003|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015004|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14015005|NCT02818725|Cisplatin|cisplatin|mesh-list
14015006|NCT02818725|Doxorubicin|doxorubicin|mesh-list
14015007|NCT02818725|Methotrexate|methotrexate|mesh-list
14015008|NCT02818725|Panitumumab|panitumumab|mesh-list
15141006|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15141007|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141008|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141009|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15141010|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141011|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141012|NCT04294537|Anesthetics|anesthetics|mesh-list
15141013|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141014|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179332|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179333|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14015009|NCT02818725|Vinblastine|vinblastine|mesh-list
14015010|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015011|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14015012|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14015013|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14015014|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015015|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015016|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14015017|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
14015018|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14015019|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015020|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14015021|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
14015022|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
14015023|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14015024|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14015025|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
14015026|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272597|NCT00424476|Belimumab|belimumab|mesh-list
14272598|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272599|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
14272600|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272601|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
14272602|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14272603|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14272604|NCT00424489|Prednisolone|prednisolone|mesh-list
14272605|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
14272606|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
14272607|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14272608|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
14272609|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272610|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
14272611|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272612|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272613|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14272614|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
14272615|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272616|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272617|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14272618|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272619|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
14272620|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
14272621|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272622|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272623|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
14272624|NCT00424489|Hormones|hormones|mesh-ancestor
14292439|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015027|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14015028|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14015029|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14015030|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
14015031|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
14015032|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
14015033|NCT02818803|Propolis|propolis|mesh-list
14015034|NCT02818803|Miconazole|miconazole|mesh-list
14015035|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015036|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
14015037|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14015038|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14015039|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015040|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015041|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14015042|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
14015043|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015044|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015045|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14015046|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14015047|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14015048|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14811659|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811660|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
14811661|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811662|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811663|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14811664|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14811665|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811666|NCT00846430|Interferons|interferons|mesh-list
14811667|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
14811668|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
14811669|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14811670|NCT00846430|Celecoxib|celecoxib|mesh-list
14811671|NCT00846430|Vincristine|vincristine|mesh-list
14015049|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14015050|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14015051|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015052|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14015053|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14015054|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15141015|NCT04294329|Bupivacaine|bupivacaine|mesh-list
15141016|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
15141017|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
15141018|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141019|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141020|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
15141021|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141022|NCT04294056|Propofol|propofol|mesh-list
15141023|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141024|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141025|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141026|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14015055|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015056|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015057|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015058|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015059|NCT02818816|Laxatives|laxatives|mesh-ancestor
14015060|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015061|NCT02818660|Cosyntropin|cosyntropin|mesh-list
14015062|NCT02818660|Hormones|hormones|mesh-ancestor
15141027|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
15141028|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
15141029|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
15141030|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15141031|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
15141032|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141033|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141034|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141035|NCT04293809|Bupivacaine|bupivacaine|mesh-list
14026280|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15141036|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
14811672|NCT00846430|Temozolomide|temozolomide|mesh-list
15141037|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
14015063|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015064|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015065|NCT02818751|Citalopram|citalopram|mesh-list
14015066|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14015067|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14015068|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015069|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015070|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015071|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
14015072|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015073|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14015074|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
14015075|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14015076|NCT02818738|Levamisole|levamisole|mesh-list
14015077|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14015078|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
14015079|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015080|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
14015081|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
14015082|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14015083|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015084|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14015085|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
14015086|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14015087|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015088|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015089|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14015090|NCT02818621|Analgesics|analgesics|mesh-ancestor
14015091|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
14015092|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141038|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141039|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141040|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
15141041|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141042|NCT04293822|Cetirizine|cetirizine|mesh-list
15141043|NCT04293822|Minoxidil|minoxidil|mesh-list
15141044|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15141045|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15141046|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15141047|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
15141048|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
15141049|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141050|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015093|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14015094|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14015095|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15141051|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141052|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15141053|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
15141054|NCT04293887|Interferons|interferons|mesh-list
15141055|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141056|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
15141057|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141058|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14015096|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015097|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015098|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015099|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
14015100|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14015101|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
14015102|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015103|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
14015104|NCT02818556|Protective Agents|protective agents|mesh-ancestor
14015105|NCT02818491|Dexamethasone|dexamethasone|mesh-list
14015106|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
14015107|NCT02818491|Ropivacaine|ropivacaine|mesh-list
14015108|NCT02818491|BB 1101|bb 1101|mesh-list
14015109|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015110|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
14015111|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
14015112|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015113|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272625|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141059|NCT04293549|Mitogens|mitogens|mesh-list
14015114|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015115|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
14015116|NCT02818491|Hormones|hormones|mesh-ancestor
14015117|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015118|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015119|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015120|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
14015121|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015122|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015123|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015124|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
14015125|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015126|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
14015127|NCT02818309|Lesogaberan|lesogaberan|mesh-list
14015128|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015129|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14015130|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
14015131|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
14015132|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015133|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015134|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015135|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
14015136|NCT02818270|Albuterol|albuterol|mesh-list
14015137|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14015138|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
14015139|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015140|NCT02818270|Expectorants|expectorants|mesh-ancestor
14015141|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
14015142|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14015143|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
14015144|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015145|NCT02818270|Protective Agents|protective agents|mesh-ancestor
14015146|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015147|NCT02818270|Antidotes|antidotes|mesh-ancestor
14015148|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14015149|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
14015150|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015151|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14015152|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
14015153|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14015154|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14015155|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14015156|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14015157|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015158|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015159|NCT02818387|Midazolam|midazolam|mesh-list
14015160|NCT02818387|Remifentanil|remifentanil|mesh-list
14015161|NCT02818387|Propofol|propofol|mesh-list
14015162|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14015163|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015164|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015165|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14015166|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
14015167|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
14015168|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14015169|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15141060|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
15141061|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141062|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15141063|NCT04293419|Durvalumab|durvalumab|mesh-list
15141064|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15141065|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141066|NCT04293081|Maleic acid|maleic acid|mesh-list
15141067|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141068|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141069|NCT04293172|Ticagrelor|ticagrelor|mesh-list
14015170|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14015171|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14015172|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
14015173|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
15141070|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15141071|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14015174|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015175|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015176|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14015177|NCT02818387|Narcotics|narcotics|mesh-ancestor
14015178|NCT02818387|Analgesics|analgesics|mesh-ancestor
14015179|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
14015180|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015181|NCT02818348|Darunavir|darunavir|mesh-list
14015182|NCT02818348|Cobicistat|cobicistat|mesh-list
14015183|NCT02818348|Etravirine|etravirine|mesh-list
14015184|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14015185|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14015186|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
14015187|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015188|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015189|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14015190|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14015191|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
14015192|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015193|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14015194|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14015195|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14015196|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14015197|NCT02818140|Ropivacaine|ropivacaine|mesh-list
14015198|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015199|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
14015200|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015201|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015202|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
14015203|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025429|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025430|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025431|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025432|NCT02750748|Naltrexone|naltrexone|mesh-list
14025433|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14025434|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14025435|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025436|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
14025437|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025438|NCT02750696|Acetaminophen|acetaminophen|mesh-list
14025439|NCT02750696|Tramadol|tramadol|mesh-list
14025440|NCT02750696|Codeine|codeine|mesh-list
14025441|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025442|NCT02750696|Analgesics|analgesics|mesh-ancestor
14025443|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
14025444|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025445|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025446|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
14025447|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14025448|NCT02750696|Narcotics|narcotics|mesh-ancestor
14025449|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025450|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
14025451|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
14025452|NCT02750670|Gemcitabine|gemcitabine|mesh-list
14025453|NCT02750670|Dexamethasone|dexamethasone|mesh-list
14025454|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
14025455|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025456|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141072|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15141073|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15141074|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
15141075|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141076|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025457|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
14025458|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
14025459|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025460|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025461|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14025462|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
14025463|NCT02750670|Hormones|hormones|mesh-ancestor
14025464|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025465|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14025466|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14025467|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
14025468|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025469|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
14025470|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025471|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272626|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14015204|NCT02817932|Ranolazine|ranolazine|mesh-list
14015205|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14015206|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015207|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015208|NCT02817750|Zolpidem|zolpidem|mesh-list
14015209|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14015210|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14015211|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015212|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015213|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14015214|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
14015215|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
14015216|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015217|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015218|NCT02817477|Ketamine|ketamine|mesh-list
14015219|NCT02817477|Morphine|morphine|mesh-list
14015220|NCT02817477|Analgesics|analgesics|mesh-ancestor
14015221|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
14015222|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141077|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015223|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015224|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14015225|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14015226|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
14015227|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
14015228|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015229|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14015230|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14015231|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015232|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015233|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14015234|NCT02817477|Narcotics|narcotics|mesh-ancestor
14015235|NCT02817503|Folic Acid|folic acid|mesh-list
14015236|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
14015237|NCT02817503|Amlodipine|amlodipine|mesh-list
14015238|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14015239|NCT02817503|Enalapril|enalapril|mesh-list
14015240|NCT02817503|Enalaprilat|enalaprilat|mesh-list
14015241|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015242|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14015243|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015244|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015245|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14015246|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015247|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
14015248|NCT02817503|Diuretics|diuretics|mesh-ancestor
14015249|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
14015250|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14015251|NCT02817503|Hematinics|hematinics|mesh-ancestor
14015252|NCT02817503|Vitamins|vitamins|mesh-ancestor
14015253|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
14015254|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15141078|NCT04292990|Fentanyl|fentanyl|mesh-list
15141079|NCT04292990|Morphine|morphine|mesh-list
14015255|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
14015256|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015257|NCT02817321|Morphine|morphine|mesh-list
14015258|NCT02817321|Ropivacaine|ropivacaine|mesh-list
14015259|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14015260|NCT02817321|Narcotics|narcotics|mesh-ancestor
14015261|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015262|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015263|NCT02817321|Analgesics|analgesics|mesh-ancestor
14015264|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
14015265|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015266|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015267|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
15141080|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15141081|NCT04292990|Narcotics|narcotics|mesh-ancestor
15141082|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141083|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141084|NCT04292990|Analgesics|analgesics|mesh-ancestor
15141085|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
15141086|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015268|NCT02817360|Losartan|losartan|mesh-list
14015269|NCT02817360|Valsartan|valsartan|mesh-list
14015270|NCT02817360|Carvedilol|carvedilol|mesh-list
14015271|NCT02817360|Candesartan|candesartan|mesh-list
14015272|NCT02817360|Ramipril|ramipril|mesh-list
14015273|NCT02817360|Enalapril|enalapril|mesh-list
14015274|NCT02817360|Lisinopril|lisinopril|mesh-list
14015275|NCT02817360|Irbesartan|irbesartan|mesh-list
14015276|NCT02817360|Nebivolol|nebivolol|mesh-list
14015277|NCT02817360|Bisoprolol|bisoprolol|mesh-list
14015278|NCT02817360|Perindopril|perindopril|mesh-list
14015279|NCT02817360|Captopril|captopril|mesh-list
14015280|NCT02817360|Quinapril|quinapril|mesh-list
14015281|NCT02817360|Trandolapril|trandolapril|mesh-list
14015282|NCT02817360|Fosinopril|fosinopril|mesh-list
14015283|NCT02817360|Eprosartan|eprosartan|mesh-list
14015284|NCT02817360|Zofenopril|zofenopril|mesh-list
14015285|NCT02817360|Spirapril|spirapril|mesh-list
14015286|NCT02817360|Cilazapril|cilazapril|mesh-list
14015287|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14015288|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015289|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14015290|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14015291|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015292|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14015293|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14015294|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015295|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015296|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015297|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
14015298|NCT02817360|Protective Agents|protective agents|mesh-ancestor
14015299|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14015300|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015301|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14015302|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
14015303|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14015304|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14015305|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14015306|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
14015307|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272627|NCT00424489|Protective Agents|protective agents|mesh-ancestor
14272628|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14272629|NCT00424502|Rituximab|rituximab|mesh-list
14272630|NCT00424502|Methotrexate|methotrexate|mesh-list
14272631|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272632|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272633|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
14272634|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272635|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272636|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14272637|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
14272638|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14272639|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272640|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
14272641|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272642|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272643|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272644|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14272645|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272646|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14272647|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
14272648|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272649|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14272650|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272651|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272652|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
14272653|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
14272654|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14272655|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
14272656|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272657|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272658|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14272659|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
14272660|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
14272661|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14272662|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
14272663|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272664|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814425|NCT00863187|Rituximab|rituximab|mesh-list
14015308|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14015309|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14015310|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14015311|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14015312|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
14015313|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
14015314|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015315|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14015316|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14015317|NCT02816970|Vildagliptin|vildagliptin|mesh-list
14015318|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14015319|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015320|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14015321|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
14015322|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015323|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015324|NCT02817191|Tobramycin|tobramycin|mesh-list
14015325|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14015326|NCT02817191|Dexamethasone|dexamethasone|mesh-list
14015327|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
14015328|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14015329|NCT02817191|BB 1101|bb 1101|mesh-list
14015330|NCT02817191|Dipivefrin|dipivefrin|mesh-list
14015331|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015332|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
14015333|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
14015334|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015335|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015336|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015337|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
14015338|NCT02817191|Hormones|hormones|mesh-ancestor
14015339|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015340|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015341|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015342|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
14015343|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015344|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015345|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14015346|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15141087|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15141088|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15141089|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
15141090|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
15141091|NCT04292886|Tamoxifen|tamoxifen|mesh-list
15141092|NCT04292886|Ascorbic Acid|ascorbic acid|mesh-list
15141093|NCT04292886|Vitamins|vitamins|mesh-ancestor
14015347|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015348|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14015349|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015350|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015351|NCT02817217|Valsartan|valsartan|mesh-list
14015352|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015353|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14015354|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14015355|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015356|NCT02817256|Vitamins|vitamins|mesh-list
14015357|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
14015358|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015359|NCT02817243|Simvastatin|simvastatin|mesh-list
14015360|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14015361|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14015362|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
14015363|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015364|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14015365|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14015366|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015367|NCT02817100|Itraconazole|itraconazole|mesh-list
14015368|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
14015369|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015370|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14015371|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14015372|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015373|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015374|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14015375|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141094|NCT04292886|Micronutrients|micronutrients|mesh-ancestor
15141095|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811673|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811674|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
14811675|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811676|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14811677|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
14811678|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
14811679|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
14811680|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811681|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14811682|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
14811683|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
14811684|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015376|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015377|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015378|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14015379|NCT02817113|Fluorouracil|fluorouracil|mesh-list
14015380|NCT02817113|Cetuximab|cetuximab|mesh-list
14015381|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
14015382|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015383|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14015384|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015385|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14015386|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
14015387|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015388|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14015389|NCT02816905|Fluorometholone|fluorometholone|mesh-list
14015390|NCT02816905|Dexamethasone|dexamethasone|mesh-list
14015391|NCT02816905|Rimexolone|rimexolone|mesh-list
14015392|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015393|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
14015394|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
14015395|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015396|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015397|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015398|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
14015399|NCT02816905|Hormones|hormones|mesh-ancestor
14015400|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015401|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015402|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015403|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14015404|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14015405|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
14015406|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015407|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
14015408|NCT02816853|Domperidone|domperidone|mesh-list
14015409|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14015410|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015411|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14015412|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14015413|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015414|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015415|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015416|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015417|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
14272665|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14272666|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14272667|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14272668|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
14272669|NCT00424554|Temozolomide|temozolomide|mesh-list
14272670|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14272671|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
14272672|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272673|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272674|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14272675|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14272676|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14272677|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14272678|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272679|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272680|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272681|NCT00424593|Analgesics|analgesics|mesh-ancestor
14272682|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
14015418|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
14015419|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015420|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015421|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15141096|NCT04292886|Antioxidants|antioxidants|mesh-ancestor
15141097|NCT04292886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141098|NCT04292886|Protective Agents|protective agents|mesh-ancestor
15141099|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15141100|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
14015422|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
14015423|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015424|NCT02816476|Daratumumab|daratumumab|mesh-list
14015425|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015426|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15141101|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141102|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15141103|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141104|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15141105|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15141106|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15141107|NCT04292756|Triamcinolone|triamcinolone|mesh-list
15141108|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15141109|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15141110|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14015427|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
14015428|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14015429|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025472|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14025473|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
14025474|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025475|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
14025476|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14025477|NCT02750475|Protective Agents|protective agents|mesh-ancestor
14025478|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025479|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14025480|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
14025481|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14025482|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025483|NCT02750293|Vitamins|vitamins|mesh-ancestor
14025484|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
14025485|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14025486|NCT02750254|Plerixafor|plerixafor|mesh-list
14025487|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
14025488|NCT02750254|Melphalan|melphalan|mesh-list
14025489|NCT02750254|Busulfan|busulfan|mesh-list
14025490|NCT02750254|Fludarabine|fludarabine|mesh-list
14025491|NCT02750254|Azacitidine|azacitidine|mesh-list
14025492|NCT02750254|Sargramostim|sargramostim|mesh-list
14025493|NCT02750254|Lenograstim|lenograstim|mesh-list
14025494|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15141111|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141112|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
14025495|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
14025496|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025497|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025498|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14025499|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
14025500|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025501|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141113|NCT04292756|Hormones|hormones|mesh-ancestor
15141114|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141115|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141116|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15141117|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
15141118|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141119|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141120|NCT04292743|Leucovorin|leucovorin|mesh-list
15141121|NCT04292743|Fluorouracil|fluorouracil|mesh-list
15141122|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
15141123|NCT04292743|Irinotecan|irinotecan|mesh-list
15141124|NCT04292743|Folfirinox|folfirinox|mesh-list
15141125|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
14025502|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14025503|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15141126|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025504|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
14025505|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141127|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15141128|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141129|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14015430|NCT02816567|Sufentanil|sufentanil|mesh-list
14015431|NCT02816567|Propofol|propofol|mesh-list
14015432|NCT02816567|Cisatracurium|cisatracurium|mesh-list
14015433|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14015434|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015435|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015436|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14015437|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
14015438|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
14015439|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14015440|NCT02816567|Narcotics|narcotics|mesh-ancestor
14015441|NCT02816567|Analgesics|analgesics|mesh-ancestor
14015442|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
14015443|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015444|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14015445|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14015446|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14015447|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
14015448|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14015449|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015450|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14015451|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14015452|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015453|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015454|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015455|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14015456|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14015457|NCT02816411|Caseins|caseins|mesh-list
14015458|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
14015459|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
14015460|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015461|NCT02816424|TEMPO|tempo|mesh-list
14015462|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
14015463|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015464|NCT02816424|Protective Agents|protective agents|mesh-ancestor
14015465|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015466|NCT02815865|Oxytocin|oxytocin|mesh-list
14015467|NCT02815865|Dinoprostone|dinoprostone|mesh-list
14015468|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
14015469|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14292440|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15141130|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
15141131|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141132|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15141133|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15141134|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141135|NCT04292743|Antidotes|antidotes|mesh-ancestor
15141136|NCT04292743|Protective Agents|protective agents|mesh-ancestor
15141137|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
15141138|NCT04292743|Vitamins|vitamins|mesh-ancestor
15141139|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
15141140|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
15141141|NCT04292418|Tacrolimus|tacrolimus|mesh-list
15141142|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15141143|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
15141144|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141145|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15141146|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141147|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141148|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15141149|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141150|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15141151|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
15141152|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15141153|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141154|NCT04292457|Propofol|propofol|mesh-list
15141155|NCT04292457|Sevoflurane|sevoflurane|mesh-list
15141156|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141157|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141158|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141159|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14015470|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015471|NCT02815657|Valsartan|valsartan|mesh-list
14015472|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015473|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15141160|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
15141161|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
15141162|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15141163|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15141164|NCT04292444|Oxytocin|oxytocin|mesh-list
15141165|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
15141166|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15141167|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141168|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
14015474|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14015475|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015476|NCT02815787|Glyburide|glyburide|mesh-list
14015477|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14015478|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015479|NCT02815722|Simvastatin|simvastatin|mesh-list
14015480|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14015481|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14015482|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
14015483|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015484|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15141169|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15141170|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
15141171|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
15141172|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141173|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141174|NCT04292691|Ropivacaine|ropivacaine|mesh-list
15141175|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
15141176|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
14015485|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14015486|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015487|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14015488|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14015489|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14015490|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015491|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015492|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14015493|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015494|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015495|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
14015496|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015497|NCT02816203|Hemostatics|hemostatics|mesh-list
14015498|NCT02816203|Coagulants|coagulants|mesh-ancestor
14015499|NCT02815566|Tenofovir|tenofovir|mesh-list
14015500|NCT02815566|Emtricitabine|emtricitabine|mesh-list
14015501|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
14015502|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015503|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14015504|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14015505|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015506|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015507|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14015508|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14015509|NCT02815319|Dexamethasone|dexamethasone|mesh-list
14015510|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015511|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
14015512|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
14015513|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015514|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015515|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015516|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
14015517|NCT02815319|Hormones|hormones|mesh-ancestor
14015518|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015519|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015520|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015521|NCT02815410|Levetiracetam|levetiracetam|mesh-list
14015522|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
14015523|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
14015524|NCT02815475|Curcumin|curcumin|mesh-list
14015525|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14015526|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14015527|NCT02815475|Analgesics|analgesics|mesh-ancestor
14015528|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
14015529|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141177|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015530|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015531|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015532|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14015533|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015534|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015535|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015536|NCT02815449|Iron|iron|mesh-list
14015537|NCT02815449|Trace Elements|trace elements|mesh-ancestor
14015538|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
14015539|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015540|NCT02815332|Minocycline|minocycline|mesh-list
14015541|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14015542|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015543|NCT02815189|Acetaminophen|acetaminophen|mesh-list
14015544|NCT02815189|Ibuprofen|ibuprofen|mesh-list
15141178|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141179|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
15141180|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141181|NCT04292769|Decitabine|decitabine|mesh-list
15141182|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15141183|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
15141184|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141185|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141186|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179334|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15179335|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179336|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179337|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15179338|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
15179339|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179340|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179341|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14015545|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14015546|NCT02815189|Analgesics|analgesics|mesh-ancestor
14015547|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
14015548|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015549|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015550|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
15179342|NCT03951051|Olmesartan|olmesartan|mesh-list
15179343|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14015551|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14015552|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015553|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272683|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272684|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
15179344|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179345|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15179346|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15179347|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179348|NCT03950700|Epinephrine|epinephrine|mesh-list
15179349|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15179350|NCT03950700|Bupivacaine|bupivacaine|mesh-list
15179351|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15179352|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
14272685|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14272686|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
14272687|NCT00424619|Vitamin D|vitamin d|mesh-list
14272688|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
14272689|NCT00424619|Vitamins|vitamins|mesh-list
14015554|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14015555|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015556|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015557|NCT02815111|Acetaminophen|acetaminophen|mesh-list
14015558|NCT02815111|Lidocaine|lidocaine|mesh-list
14015559|NCT02815111|Ketamine|ketamine|mesh-list
14015560|NCT02815111|Gabapentin|gabapentin|mesh-list
14015561|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015562|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
14015563|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015564|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015565|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
14015566|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272690|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
14272691|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272692|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14015567|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14015568|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14015569|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14015570|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15141187|NCT04292704|Clotrimazole|clotrimazole|mesh-list
15141188|NCT04292704|Miconazole|miconazole|mesh-list
15141189|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15141190|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141191|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
15141192|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15141193|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15141194|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141195|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141196|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15141197|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141198|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141199|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015571|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015572|NCT02815111|Analgesics|analgesics|mesh-ancestor
14015573|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14015574|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14015575|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
14015576|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14015577|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14015578|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015579|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14015580|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
14015581|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
14015582|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14015583|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14015584|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14015585|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
14015586|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
14015587|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
14015588|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14015589|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14015590|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14015591|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015592|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015593|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
15141200|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15141201|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15141202|NCT04292119|Crizotinib|crizotinib|mesh-list
15141203|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141204|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15141205|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141206|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141207|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
15141208|NCT04292184|Antidotes|antidotes|mesh-ancestor
15141209|NCT04292184|Protective Agents|protective agents|mesh-ancestor
15141210|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141211|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
15141212|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141213|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
15141214|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14015594|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015595|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015596|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14015597|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015598|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14811685|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14811686|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14811687|NCT00846430|Analgesics|analgesics|mesh-ancestor
14811688|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
14811689|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811690|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811691|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811692|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14811693|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14811694|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811695|NCT00846443|Cisplatin|cisplatin|mesh-list
14811696|NCT00846443|Pemetrexed|pemetrexed|mesh-list
15141215|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811697|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811698|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015599|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025506|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14025507|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14025508|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14025509|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
14025510|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025511|NCT02750202|Vaccines|vaccines|mesh-list
14025512|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
14025513|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025514|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14025515|NCT02749994|Ezetimibe|ezetimibe|mesh-list
14025516|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14025517|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14025518|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
14025519|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025520|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14025521|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14025522|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026281|NCT02744495|Betamethasone|betamethasone|mesh-list
14026282|NCT02744495|Droperidol|droperidol|mesh-list
14026283|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14026284|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
14026285|NCT02744495|Hormones|hormones|mesh-ancestor
14026286|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026287|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026288|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14272693|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14272694|NCT00424749|Prednisone|prednisone|mesh-list
14272695|NCT00424749|Rituximab|rituximab|mesh-list
14272696|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14026289|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
14026290|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14026291|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
14026292|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
14026293|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272697|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272698|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
14272699|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272700|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272701|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141216|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
15141217|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
15141218|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
15141219|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
15141220|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15141221|NCT04292236|Protective Agents|protective agents|mesh-ancestor
15141222|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141223|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141224|NCT04292054|Cefazolin|cefazolin|mesh-list
15141225|NCT04292054|Tazobactam|tazobactam|mesh-list
15141226|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15141227|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141228|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15141229|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141230|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026294|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14026295|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14811699|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811700|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14811701|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14811702|NCT00846508|Cisplatin|cisplatin|mesh-list
14811703|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811704|NCT00846612|Bevacizumab|bevacizumab|mesh-list
14811705|NCT00846612|Doxorubicin|doxorubicin|mesh-list
14811706|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15141231|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
14026296|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14026297|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026298|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15141232|NCT04292314|Deferoxamine|deferoxamine|mesh-list
14026299|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14272702|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
14272703|NCT00424749|Hormones|hormones|mesh-ancestor
15141233|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141234|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
14015600|NCT02815059|Prednisone|prednisone|mesh-list
14015601|NCT02815059|Dasatinib|dasatinib|mesh-list
14015602|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015603|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
14015604|NCT02815059|Hormones|hormones|mesh-ancestor
14015605|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015606|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015607|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015608|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015609|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14015610|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015611|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015612|NCT02814500|Amlodipine|amlodipine|mesh-list
14015613|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14015614|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015615|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14015616|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015617|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015618|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14015619|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015620|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
14015621|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15141235|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141236|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141237|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15141238|NCT04292314|Siderophores|siderophores|mesh-ancestor
15141239|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15141240|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
15141241|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
15141242|NCT04291794|Propofol|propofol|mesh-list
15141243|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141244|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141245|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141246|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15141247|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
15141248|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
15141249|NCT04291729|Interferons|interferons|mesh-list
15141250|NCT04291729|Ritonavir|ritonavir|mesh-list
15141251|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141252|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
15141253|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141254|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15141255|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15141256|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14015622|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14015623|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
14015624|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14015625|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14015626|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015627|NCT02814669|Atezolizumab|atezolizumab|mesh-list
14015628|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14015629|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015630|NCT02814461|Axitinib|axitinib|mesh-list
14015631|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015632|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14015633|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015634|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015635|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14015636|NCT02814409|Plasminogen|plasminogen|mesh-list
14015637|NCT02814409|Tenecteplase|tenecteplase|mesh-list
14015638|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14811707|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015639|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14015640|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015641|NCT02814630|Omalizumab|omalizumab|mesh-list
14015642|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14015643|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14015644|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14015645|NCT02814058|Zolpidem|zolpidem|mesh-list
14015646|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14811708|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811709|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14015647|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141257|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141258|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015648|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015649|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015650|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14015651|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
14015652|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
14015653|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015654|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015655|NCT02814110|Lenograstim|lenograstim|mesh-list
14015656|NCT02814110|Sargramostim|sargramostim|mesh-list
14015657|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14015658|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
14015659|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015660|NCT02813863|Metformin|metformin|mesh-list
14015661|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14015662|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015663|NCT02813824|Aspirin|aspirin|mesh-list
15141259|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15141260|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15141261|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15141262|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15141263|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15141264|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15141265|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141266|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
15141267|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
15141268|NCT04291755|Nivolumab|nivolumab|mesh-list
15141269|NCT04291755|Ipilimumab|ipilimumab|mesh-list
15141270|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15141271|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141272|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15141273|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141274|NCT04291664|Prednisone|prednisone|mesh-list
15141275|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
15141276|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141277|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
15141278|NCT04291664|Hormones|hormones|mesh-ancestor
15141279|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141280|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141281|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015664|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
14015665|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15141282|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141283|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15141284|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141285|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141286|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141287|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15141288|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
15141289|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15141290|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141291|NCT04291313|Vitamin D|vitamin d|mesh-list
15141292|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
15141293|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
15141294|NCT04291313|Vitamins|vitamins|mesh-list
15141295|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
14015666|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14015667|NCT02813824|Analgesics|analgesics|mesh-ancestor
14015668|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
14015669|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015670|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015671|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015672|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14015673|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14015674|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14015675|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811710|NCT00846612|Growth Substances|growth substances|mesh-ancestor
14811711|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811712|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811713|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14811714|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14811715|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15141296|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811716|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025523|NCT02750137|Tetracaine|tetracaine|mesh-list
15179353|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
14015676|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14015677|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14015678|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015679|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
14015680|NCT02813356|Naloxegol|naloxegol|mesh-list
14015681|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14015682|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015683|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
14015684|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015685|NCT02813369|Naloxegol|naloxegol|mesh-list
14015686|NCT02813369|Laxatives|laxatives|mesh-list
14015687|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14015688|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015689|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
14015690|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015691|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015692|NCT02813382|Bupivacaine|bupivacaine|mesh-list
14015693|NCT02813382|Prilocaine|prilocaine|mesh-list
14015694|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
14015695|NCT02813382|Procaine|procaine|mesh-list
14015696|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015697|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
14015698|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015699|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015700|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
14015701|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015702|NCT02813135|Carboplatin|carboplatin|mesh-list
14015703|NCT02813135|Nivolumab|nivolumab|mesh-list
14015704|NCT02813135|Irinotecan|irinotecan|mesh-list
14015705|NCT02813135|Temozolomide|temozolomide|mesh-list
14015706|NCT02813135|Topotecan|topotecan|mesh-list
14015707|NCT02813135|Olaparib|olaparib|mesh-list
14015708|NCT02813135|Adavosertib|adavosertib|mesh-list
14015709|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015710|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14015711|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14015712|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015713|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14015714|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14015715|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015716|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14015717|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
14015718|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14015719|NCT02813486|Vaccines|vaccines|mesh-list
14015720|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
14015721|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015722|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14015723|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14015724|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
14015725|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14015726|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
14015727|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14015728|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015729|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14015730|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015731|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015732|NCT02813018|Ropivacaine|ropivacaine|mesh-list
14015733|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015734|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
14015735|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015736|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015737|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
14015738|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025524|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025525|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
14025526|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025527|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025528|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
14025529|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025530|NCT02750059|Tenofovir|tenofovir|mesh-list
14025531|NCT02750059|Lamivudine|lamivudine|mesh-list
15141297|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15179354|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025532|NCT02750059|Efavirenz|efavirenz|mesh-list
14025533|NCT02750059|Telmisartan|telmisartan|mesh-list
14025534|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
14025535|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025536|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14015739|NCT02813148|Naloxegol|naloxegol|mesh-list
14015740|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15141298|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15141299|NCT04291456|Minocycline|minocycline|mesh-list
14015741|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015742|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
14015743|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015744|NCT02813044|Anesthetics|anesthetics|mesh-list
14015745|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015746|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015747|NCT02812888|Propranolol|propranolol|mesh-list
14015748|NCT02812888|Methimazole|methimazole|mesh-list
14015749|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
14015750|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14015751|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14015752|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015753|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015754|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015755|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015756|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14015757|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015758|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
14015759|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
14015760|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
14015761|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015762|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
14015763|NCT02812979|Albuterol|albuterol|mesh-list
14015764|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14015765|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
14015766|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015767|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015768|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14015769|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
14015770|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
14015771|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14015772|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15141300|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15141301|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141302|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
15141303|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15141304|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
15141305|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141306|NCT04291209|Expectorants|expectorants|mesh-ancestor
15141307|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14015773|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14015774|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14015775|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015776|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015777|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141308|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14811717|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811718|NCT00846625|Triamcinolone|triamcinolone|mesh-list
14015778|NCT02812940|Everolimus|everolimus|mesh-list
14015779|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015780|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14015781|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
14015782|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015783|NCT02812654|Doxorubicin|doxorubicin|mesh-list
14015784|NCT02812654|Ifosfamide|ifosfamide|mesh-list
14015785|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14015786|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015787|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14015788|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14015789|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015790|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015791|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14015792|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
14015793|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
14015794|NCT02812719|Salicylates|salicylates|mesh-list
14015795|NCT02812719|Glycolic acid|glycolic acid|mesh-list
14015796|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015797|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
15141309|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
15141310|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015798|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
14015799|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14015800|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14015801|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14015802|NCT02812719|Analgesics|analgesics|mesh-ancestor
14015803|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
14015804|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015805|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015806|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015807|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14015808|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14015809|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015810|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015811|NCT02812992|Gemcitabine|gemcitabine|mesh-list
14015812|NCT02812992|Paclitaxel|paclitaxel|mesh-list
14015813|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14015814|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811719|NCT00846625|Ranibizumab|ranibizumab|mesh-list
14811720|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811721|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15141311|NCT04291209|Protective Agents|protective agents|mesh-ancestor
14015815|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14015816|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14015817|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14015818|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015819|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14015820|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
14015821|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
14015822|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015823|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015824|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14015825|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
14015826|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015827|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
14015828|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
14015829|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14015830|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015831|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14015832|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015833|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015834|NCT02812641|Bevacizumab|bevacizumab|mesh-list
14015835|NCT02812641|Cisplatin|cisplatin|mesh-list
14015836|NCT02812641|Fluorouracil|fluorouracil|mesh-list
14015837|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14015838|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015839|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14015840|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14015841|NCT02812641|Growth Substances|growth substances|mesh-ancestor
14015842|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272704|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14272705|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14272706|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
14272707|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14272708|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272709|NCT00424775|Vorinostat|vorinostat|mesh-list
14272710|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272711|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14272712|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811722|NCT00846625|Growth Substances|growth substances|mesh-ancestor
15141312|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141313|NCT04291209|Antidotes|antidotes|mesh-ancestor
14015843|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
14015844|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
15141314|NCT04290819|Caffeine|caffeine|mesh-list
15141315|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15141316|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141317|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15141318|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015845|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015846|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14015847|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14015848|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
14015849|NCT02812602|Lidocaine|lidocaine|mesh-list
15141319|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141320|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14015850|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015851|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
14015852|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015853|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015854|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
14015855|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015856|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14015857|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14015858|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14015859|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015860|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015861|NCT02812368|Clonidine|clonidine|mesh-list
14015862|NCT02812368|Analgesics|analgesics|mesh-ancestor
14015863|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
14015864|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015865|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015866|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015867|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
14015868|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
14015869|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14015870|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14015871|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14015872|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015873|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015874|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015875|NCT02812394|Levodopa|levodopa|mesh-list
14015876|NCT02812394|Carbidopa|carbidopa|mesh-list
14272713|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272714|NCT00424827|Gemcitabine|gemcitabine|mesh-list
14272715|NCT00424827|Fluorouracil|fluorouracil|mesh-list
14272716|NCT00424827|Cetuximab|cetuximab|mesh-list
14272717|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272718|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
14272719|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272720|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272721|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
14272722|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272723|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272724|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272725|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
14272726|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272727|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272728|NCT00424840|Bevacizumab|bevacizumab|mesh-list
14272729|NCT00424840|Carboplatin|carboplatin|mesh-list
14272730|NCT00424840|Bortezomib|bortezomib|mesh-list
15141321|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15141322|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
15141323|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141324|NCT04290936|Tenofovir|tenofovir|mesh-list
15141325|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
15141326|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141327|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15141328|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15141329|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141330|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141331|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15141332|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14272731|NCT00424840|Docetaxel|docetaxel|mesh-list
14272732|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272733|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272734|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14272735|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14272736|NCT00424840|Growth Substances|growth substances|mesh-ancestor
14272737|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272738|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
14272739|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
14272740|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
14272741|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
14272742|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141333|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
15141334|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14272743|NCT00425113|Metronidazole|metronidazole|mesh-list
14272744|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141335|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
15141336|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015877|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14015878|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14015879|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14015880|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
14015881|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015882|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015883|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015884|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14015885|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015886|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15141337|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141338|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15141339|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
15141340|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15141341|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
15141342|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141343|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015887|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
14015888|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
14015889|NCT02812199|Lidocaine|lidocaine|mesh-list
14015890|NCT02812199|Epinephrine|epinephrine|mesh-list
14015891|NCT02812199|Racepinephrine|racepinephrine|mesh-list
14015892|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
14015893|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
14015894|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
14015895|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14015896|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015897|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
14015898|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015899|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14015900|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14015901|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14015902|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015903|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015904|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14015905|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14015906|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
14015907|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015908|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14015909|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14015910|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
14015911|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14015912|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
14015913|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
14015914|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
14015915|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14015916|NCT02812212|Diuretics|diuretics|mesh-list
14015917|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
14015918|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015919|NCT02812147|Droxidopa|droxidopa|mesh-list
14015920|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14015921|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14015922|NCT02812043|Amorolfine|amorolfine|mesh-list
14015923|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
14015924|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14015925|NCT02811978|Dexamethasone|dexamethasone|mesh-list
14015926|NCT02811978|Bortezomib|bortezomib|mesh-list
14015927|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14015928|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
14015929|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
14015930|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015931|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015932|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14015933|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
14015934|NCT02811978|Hormones|hormones|mesh-ancestor
14015935|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14015936|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015937|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015938|NCT02812355|Heparin|heparin|mesh-list
14015939|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
14015940|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14015941|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14015942|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015943|NCT02811731|Amlodipine|amlodipine|mesh-list
14015944|NCT02811731|Candesartan|candesartan|mesh-list
14015945|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14015946|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14015947|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14015948|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015949|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14015950|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015951|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
14015952|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14015953|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14015954|NCT02811809|Leuprolide|leuprolide|mesh-list
14015955|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14015956|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
14015957|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14015958|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015959|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14015960|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015961|NCT02811991|Acetaminophen|acetaminophen|mesh-list
14015962|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14015963|NCT02811991|Analgesics|analgesics|mesh-ancestor
14015964|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
14015965|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14015966|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015967|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
14015968|NCT02811692|Aflibercept|aflibercept|mesh-list
14015969|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14015970|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14015971|NCT02811692|Growth Substances|growth substances|mesh-ancestor
14015972|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015973|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
15141344|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15141345|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
15141346|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
15141347|NCT04290871|Protective Agents|protective agents|mesh-ancestor
15141348|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
15141349|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14015974|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015975|NCT02811627|Memantine|memantine|mesh-list
14015976|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14015977|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15141350|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141351|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
15141352|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141353|NCT04291066|Expectorants|expectorants|mesh-ancestor
14015978|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
14015979|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14015980|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015981|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015982|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14015983|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14015984|NCT02811497|Azacitidine|azacitidine|mesh-list
14015985|NCT02811497|Durvalumab|durvalumab|mesh-list
14015986|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14015987|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
14015988|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015989|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14015990|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14015991|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025537|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14025538|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141354|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
15141355|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15141356|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
15141357|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141358|NCT04291066|Protective Agents|protective agents|mesh-ancestor
15141359|NCT04291066|Antidotes|antidotes|mesh-ancestor
15141360|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
15141361|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15141362|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15141363|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141364|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
15141365|NCT04290884|Coagulants|coagulants|mesh-ancestor
15141366|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
15141367|NCT04290793|Trastuzumab|trastuzumab|mesh-list
15141368|NCT04290793|Epirubicin|epirubicin|mesh-list
15141369|NCT04290793|Taxane|taxane|mesh-list
15141370|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14015992|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
14015993|NCT02811484|Exenatide|exenatide|mesh-list
14015994|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14015995|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14015996|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14015997|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14015998|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14015999|NCT02811484|Incretins|incretins|mesh-ancestor
14016000|NCT02811484|Hormones|hormones|mesh-ancestor
14016001|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016002|NCT02811289|Mirabegron|mirabegron|mesh-list
14016003|NCT02811289|Glycerol|glycerol|mesh-list
14016004|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14016005|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14016006|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14016007|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
14016008|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016009|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016010|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016011|NCT02811289|Urological Agents|urological agents|mesh-ancestor
14016012|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14016013|NCT02811289|Protective Agents|protective agents|mesh-ancestor
14016014|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14016015|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14016016|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016017|NCT02811341|Scopolamine|scopolamine|mesh-list
14016018|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14016019|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14016020|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
14016021|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
14016022|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016023|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016024|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016025|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
14016026|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14016027|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
14016028|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016029|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016030|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14016031|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
14016032|NCT02811354|Osimertinib|osimertinib|mesh-list
14016033|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016034|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14016035|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016036|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016037|NCT02811055|Aprepitant|aprepitant|mesh-list
14016038|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
14016039|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
14016040|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016041|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016042|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016043|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14016044|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016045|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016046|NCT02811016|Budesonide|budesonide|mesh-list
14016047|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016048|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14016049|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
14016050|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016051|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016052|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14016053|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14016054|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
14016055|NCT02811016|Hormones|hormones|mesh-ancestor
14016056|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016057|NCT02810808|Ranibizumab|ranibizumab|mesh-list
14016058|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15141371|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
15141372|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016059|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14016060|NCT02810808|Growth Substances|growth substances|mesh-ancestor
14016061|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016062|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
14016063|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016064|NCT02810886|Edetic Acid|edetic acid|mesh-list
14016065|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14016066|NCT02810886|Anticoagulants|anticoagulants|mesh-ancestor
14016067|NCT02810886|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14016068|NCT02810886|Chelating Agents|chelating agents|mesh-ancestor
14016069|NCT02810886|Sequestering Agents|sequestering agents|mesh-ancestor
14016070|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016071|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14016072|NCT02810782|Morphine|morphine|mesh-list
14016073|NCT02810782|Phenobarbital|phenobarbital|mesh-list
14016074|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
14016075|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14016076|NCT02810782|Narcotics|narcotics|mesh-ancestor
14016077|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016078|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016079|NCT02810782|Analgesics|analgesics|mesh-ancestor
14016080|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
14016081|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016082|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
14016083|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14016084|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14016085|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14016086|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016087|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016088|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
14016089|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
14016090|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14016091|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14016092|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14016093|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
14016094|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
14016095|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016096|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14016097|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14016098|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14016099|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14016100|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
14016101|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
14016102|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14016103|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016104|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016105|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016106|NCT02810899|Analgesics|analgesics|mesh-ancestor
14016107|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
14016108|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016109|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14016110|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14016111|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14016112|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14016113|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016114|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016115|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14016116|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016117|NCT02810704|Aspirin|aspirin|mesh-list
14016118|NCT02810704|Warfarin|warfarin|mesh-list
14016119|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
14016120|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14016121|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016122|NCT02810704|Analgesics|analgesics|mesh-ancestor
14016123|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
14016124|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016125|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016126|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016127|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016128|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14016129|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14016130|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141373|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15141374|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15141375|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
15141376|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141377|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016131|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14016132|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15141378|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15141379|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15141380|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15141381|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15141382|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15141383|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016133|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016134|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
14016135|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
14016136|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14016137|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
14016138|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14272745|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272746|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14272747|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14272748|NCT00425308|Cyclosporine|cyclosporine|mesh-list
14272749|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
14272750|NCT00425308|Everolimus|everolimus|mesh-list
14272751|NCT00425308|Cyclosporins|cyclosporins|mesh-list
14272752|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272753|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272754|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272755|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
14272756|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272757|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
14272758|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272759|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272760|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272761|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14272762|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272763|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14272764|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14272765|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
14272766|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272767|NCT00425373|Amlodipine|amlodipine|mesh-list
14272768|NCT00425373|Valsartan|valsartan|mesh-list
14272769|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14272770|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14272771|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14272772|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272773|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14272774|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272775|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
14272776|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14272777|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14292441|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14292442|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292443|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14292444|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14292445|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14292446|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292447|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14292448|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14292449|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
14292450|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14292451|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14292452|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
14292453|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292454|NCT00561002|Vaccines|vaccines|mesh-list
14292455|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
14292456|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292457|NCT00561015|Ribavirin|ribavirin|mesh-list
14292458|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
14292459|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14292460|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
14292461|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292462|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
14292463|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292464|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292465|NCT00561080|Vaccines|vaccines|mesh-list
15141384|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
14016139|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
14016140|NCT02810548|Mitogens|mitogens|mesh-list
14016141|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
14016142|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016143|NCT02810275|Leucovorin|leucovorin|mesh-list
14016144|NCT02810275|Folic Acid|folic acid|mesh-list
14016145|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
14016146|NCT02810275|Antidotes|antidotes|mesh-ancestor
14016147|NCT02810275|Protective Agents|protective agents|mesh-ancestor
14016148|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016149|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
14016150|NCT02810275|Vitamins|vitamins|mesh-ancestor
14016151|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
14016152|NCT02810275|Hematinics|hematinics|mesh-ancestor
14016153|NCT02810483|Topiramate|topiramate|mesh-list
14016154|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
14016155|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14016156|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016157|NCT02810132|Metformin|metformin|mesh-list
14016158|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14016159|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016160|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
14016161|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14016162|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14016163|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14016164|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14016165|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016166|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14016167|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016168|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016169|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14016170|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016171|NCT02809781|Etanercept|etanercept|mesh-list
14016172|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14016173|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016174|NCT02809781|Analgesics|analgesics|mesh-ancestor
14016175|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
14016176|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016177|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016178|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016179|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016180|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15141385|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15141386|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
15141387|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141388|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141389|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15141390|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
15141391|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15141392|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
15141393|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141394|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141395|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15141396|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
14016181|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016182|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
14016183|NCT02809768|Itraconazole|itraconazole|mesh-list
14016184|NCT02809768|Fluconazole|fluconazole|mesh-list
14016185|NCT02809768|Rifampin|rifampin|mesh-list
14016186|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
14016187|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016188|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14016189|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14016190|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016191|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016192|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14016193|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
14016194|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016195|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016196|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14016197|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14016198|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
14016199|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016200|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
14016201|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14016202|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14272778|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14272779|NCT00425386|Sunitinib|sunitinib|mesh-list
14272780|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272781|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14026300|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14016203|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14016204|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14016205|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14016206|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14016207|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14016208|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14016209|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14016210|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
14016211|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14016212|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016213|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016214|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016215|NCT02809937|Analgesics|analgesics|mesh-ancestor
14016216|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
14016217|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016218|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14016219|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14016220|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14016221|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
14016222|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016223|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016224|NCT02809963|Eplerenone|eplerenone|mesh-list
14016225|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14016226|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141397|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
15141398|NCT04290858|Protective Agents|protective agents|mesh-ancestor
15141399|NCT04291118|Budesonide|budesonide|mesh-list
15141400|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141401|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15141402|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
15141403|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141404|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141405|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15141406|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
15141407|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
15141408|NCT04291118|Hormones|hormones|mesh-ancestor
15141409|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141410|NCT04290442|Ropivacaine|ropivacaine|mesh-list
15141411|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
15141412|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
15141413|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141414|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141415|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
15141416|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179355|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179356|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
14016227|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016228|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016229|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14016230|NCT02809963|Diuretics|diuretics|mesh-ancestor
14016231|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
14016232|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14025539|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025540|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14025541|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14025542|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14025543|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14025544|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14025545|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14025546|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14025547|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14025548|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14025549|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14025550|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15179357|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179358|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15179359|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15179360|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
15179361|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14562070|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
14016233|NCT02809742|Ropivacaine|ropivacaine|mesh-list
14016234|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
14016235|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
14016236|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016237|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016238|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
14016239|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016240|NCT02809755|Lidocaine|lidocaine|mesh-list
14016241|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
14016242|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
14016243|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016244|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016245|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
14016246|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016247|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14016248|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14016249|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14016250|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14016251|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016252|NCT02809690|Clevudine|clevudine|mesh-list
14016253|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
14016254|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016255|NCT02809729|Cefazolin|cefazolin|mesh-list
14016256|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016257|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016258|NCT02809573|Prednisone|prednisone|mesh-list
14016259|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
14016260|NCT02809573|Vincristine|vincristine|mesh-list
14016261|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016262|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
14016263|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016264|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016265|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14016266|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
14016267|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016268|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016269|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14016270|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141417|NCT04290455|Castor Oil|castor oil|mesh-list
15141418|NCT04290455|Cathartics|cathartics|mesh-ancestor
15141419|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15141420|NCT04290429|Teduglutide|teduglutide|mesh-list
15141421|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15141422|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15141423|NCT04290429|Protective Agents|protective agents|mesh-ancestor
15141424|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141425|NCT04290572|Isotretinoin|isotretinoin|mesh-list
15141426|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
15141427|NCT04290390|Itraconazole|itraconazole|mesh-list
14016271|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
14016272|NCT02809573|Hormones|hormones|mesh-ancestor
14016273|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016274|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14016275|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14016276|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
14016277|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
14016278|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
14016279|NCT02809378|Remifentanil|remifentanil|mesh-list
14016280|NCT02809378|Thiopental|thiopental|mesh-list
14016281|NCT02809378|Palonosetron|palonosetron|mesh-list
14016282|NCT02809378|Propofol|propofol|mesh-list
14016283|NCT02809378|Sevoflurane|sevoflurane|mesh-list
14016284|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14016285|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016286|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016287|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15141428|NCT04290390|Rifampin|rifampin|mesh-list
15141429|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15141430|NCT04290390|Estradiol|estradiol|mesh-list
15141431|NCT04290390|Estrogens|estrogens|mesh-ancestor
15141432|NCT04290390|Hormones|hormones|mesh-ancestor
15141433|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141434|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141435|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15141436|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
15141437|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15141438|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15141439|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
15141440|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141441|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15141442|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15141443|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141444|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141445|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15141446|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141447|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15141448|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15141449|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
15141450|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15141451|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
15141452|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15141453|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15141454|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15141455|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15141456|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15141457|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15141458|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15141459|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14016288|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
14016289|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
14016290|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14016291|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14016292|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14016293|NCT02809378|Narcotics|narcotics|mesh-ancestor
14016294|NCT02809378|Analgesics|analgesics|mesh-ancestor
14016295|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
14016296|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016297|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
14016298|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
14016299|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016300|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14016301|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14016302|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
14016303|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016304|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016305|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
14016306|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
14016307|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
14016308|NCT02809404|Everolimus|everolimus|mesh-list
14016309|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016310|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016311|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
14016312|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016313|NCT02809456|Nicorandil|nicorandil|mesh-list
14016314|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14016315|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14016316|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
14016317|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
14016318|NCT02809456|Vitamins|vitamins|mesh-ancestor
14016319|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
14016320|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016321|NCT02809469|Apixaban|apixaban|mesh-list
14016322|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14016323|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
14016324|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14016325|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
14016326|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016327|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016328|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
14016329|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
14016330|NCT02809079|Prednisone|prednisone|mesh-list
14016331|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016332|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
14016333|NCT02809079|Hormones|hormones|mesh-ancestor
14016334|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016335|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016336|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14016337|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016338|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14811723|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016339|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14016340|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
14016341|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016342|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016343|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016344|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016345|NCT02809105|Linaclotide|linaclotide|mesh-list
14016346|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14016347|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
14016348|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016349|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016350|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
14016351|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14016352|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016353|NCT02808949|Dapivirine|dapivirine|mesh-list
14016354|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14016355|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14016356|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
15141460|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15141461|NCT04290195|Aflibercept|aflibercept|mesh-list
15141462|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15141463|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15141464|NCT04290195|Growth Substances|growth substances|mesh-ancestor
15141465|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141466|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
15141467|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141468|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
14016357|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016358|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
14016359|NCT02809066|Calcium|calcium|mesh-list
14016360|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14016361|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016362|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14016363|NCT02808871|Pirfenidone|pirfenidone|mesh-list
15141469|NCT04290013|Norethindrone|norethindrone|mesh-list
15141470|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
15141471|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15141472|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15141473|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141474|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
15141475|NCT04290013|Coagulants|coagulants|mesh-ancestor
14016364|NCT02808871|Analgesics|analgesics|mesh-ancestor
14016365|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
14016366|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016367|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016368|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14016369|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016370|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016371|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016372|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016373|NCT02808767|Ticagrelor|ticagrelor|mesh-list
14016374|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14016375|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14016376|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14016377|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14016378|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14016379|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
14016380|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016381|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016382|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016383|NCT02808741|Olorofim|olorofim|mesh-list
14016384|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
14016385|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016386|NCT02808728|Bupivacaine|bupivacaine|mesh-list
14016387|NCT02808728|Ropivacaine|ropivacaine|mesh-list
14016388|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
14016389|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
14016390|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016391|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272782|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272783|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272784|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14272785|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14272786|NCT00425386|Growth Substances|growth substances|mesh-ancestor
15141476|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14272787|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016392|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
14016393|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016394|NCT02808676|Vitamin D|vitamin d|mesh-list
14272788|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
14272789|NCT00425477|Bexarotene|bexarotene|mesh-list
14272790|NCT00425477|Sargramostim|sargramostim|mesh-list
14272791|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
14272792|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272793|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272794|NCT00425503|Bortezomib|bortezomib|mesh-list
14272795|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272796|NCT00425555|Panobinostat|panobinostat|mesh-list
15141477|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15141478|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15141479|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
14272797|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272798|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14272799|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272800|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272801|NCT00425607|Lonafarnib|lonafarnib|mesh-list
14272802|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272803|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272804|NCT00425672|Interleukin-2|interleukin-2|mesh-list
14272805|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
14272806|NCT00425672|Immunotoxins|immunotoxins|mesh-list
14272807|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272808|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14272809|NCT00425672|Analgesics|analgesics|mesh-ancestor
14272810|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
14272811|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272812|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272813|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
14272814|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
14272815|NCT00425698|Hematinics|hematinics|mesh-ancestor
14272816|NCT00425750|Docetaxel|docetaxel|mesh-list
14272817|NCT00425750|Bortezomib|bortezomib|mesh-list
14272818|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141480|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15141481|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141482|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15141483|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15141484|NCT04290208|Acetaminophen|acetaminophen|mesh-list
15141485|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14272819|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14272820|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14272821|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14272822|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272823|NCT00425802|Cyclosporine|cyclosporine|mesh-list
14272824|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
14272825|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
14272826|NCT00425802|Rituximab|rituximab|mesh-list
14272827|NCT00425802|Fludarabine|fludarabine|mesh-list
14272828|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
15141486|NCT04290208|Analgesics|analgesics|mesh-ancestor
15141487|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
15141488|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141489|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141490|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
15141491|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
15141492|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14272829|NCT00425802|Cyclosporins|cyclosporins|mesh-list
14272830|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14272831|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272832|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
14272833|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016395|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
14016396|NCT02808676|Vitamins|vitamins|mesh-ancestor
14016397|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
14016398|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016399|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14016400|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14016401|NCT02808611|Propranolol|propranolol|mesh-list
14016402|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14016403|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14272834|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14272835|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14272836|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
14272837|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016404|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
14016405|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016406|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016407|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016408|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14016409|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14016410|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
14016411|NCT02808533|Topiramate|topiramate|mesh-list
14016412|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
14016413|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14016414|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016415|NCT02808364|Vaccines|vaccines|mesh-list
14016416|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
14016417|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016418|NCT02808325|Polygeline|polygeline|mesh-list
14016419|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
14016420|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
14016421|NCT02808247|Ifosfamide|ifosfamide|mesh-list
14016422|NCT02808247|Nintedanib|nintedanib|mesh-list
14016423|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14016424|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
14016425|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016426|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016427|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14016428|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016429|NCT02808091|Bortezomib|bortezomib|mesh-list
14016430|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016431|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
14016432|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14016433|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
14016434|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14016435|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016436|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14016437|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
14016438|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016439|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
14016440|NCT02808065|Tacrolimus|tacrolimus|mesh-list
14016441|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016442|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
14016443|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016444|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14016445|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016446|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016447|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14016448|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016449|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14016450|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
14016451|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016452|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025551|NCT02749825|Goserelin|goserelin|mesh-list
14025552|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14025553|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14025554|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025555|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14025556|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025557|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
14025558|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15141493|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15141494|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15141495|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15141496|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141497|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
15141498|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141499|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141500|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15141501|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141502|NCT04290104|Ampicillin|ampicillin|mesh-list
15141503|NCT04290104|Sulbactam|sulbactam|mesh-list
15141504|NCT04290104|Sultamicillin|sultamicillin|mesh-list
15141505|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15141506|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025559|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
14025560|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14025561|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
14025562|NCT02749890|Lixisenatide|lixisenatide|mesh-list
14025563|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14016453|NCT02808117|Micronutrients|micronutrients|mesh-list
14016454|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016455|NCT02807909|Itraconazole|itraconazole|mesh-list
14016456|NCT02807909|Diltiazem|diltiazem|mesh-list
14016457|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
14016458|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016459|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14016460|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14016461|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016462|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016463|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14016464|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
14016465|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016466|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016467|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14016468|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15141507|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15141508|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141509|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141510|NCT04290026|Metoclopramide|metoclopramide|mesh-list
14016469|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14016470|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15141511|NCT04290026|Granisetron|granisetron|mesh-list
15141512|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
15141513|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
15141514|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141515|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141516|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15141517|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15141518|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15141519|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
15141520|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141521|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141522|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15141523|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
15141524|NCT04289805|Letrozole|letrozole|mesh-list
15141525|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141526|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15141527|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15141528|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141529|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141530|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15141531|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141532|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141533|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141534|NCT04289675|Interferons|interferons|mesh-list
15141535|NCT04289675|Interferon-beta|interferon-beta|mesh-list
15141536|NCT04289675|Teriflunomide|teriflunomide|mesh-list
15141537|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15141538|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141539|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
15141540|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141541|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
15141542|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141543|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
15141544|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15141545|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15141546|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15141547|NCT04289675|Analgesics|analgesics|mesh-ancestor
15141548|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
15141549|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141550|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141551|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15141552|NCT04289974|Fulvestrant|fulvestrant|mesh-list
15141553|NCT04289974|Palbociclib|palbociclib|mesh-list
15141554|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15141555|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141556|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15141557|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15141558|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141559|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141560|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141561|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14016471|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14016472|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
14016473|NCT02807922|Zopiclone|zopiclone|mesh-list
14016474|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14016475|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016476|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016477|NCT02808104|Mazindol|mazindol|mesh-list
14016478|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14016479|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016480|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14016481|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14016482|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14016483|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016484|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14016485|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016486|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14016487|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
14016488|NCT02807870|Methylphenidate|methylphenidate|mesh-list
14016489|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14016490|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016491|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14016492|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14016493|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14016494|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016495|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
14016496|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016497|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14016498|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14016499|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14016500|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14016501|NCT02807610|Propofol|propofol|mesh-list
14016502|NCT02807610|Etomidate|etomidate|mesh-list
14016503|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14016504|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016505|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016506|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14016507|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
14016508|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
14016509|NCT02807571|Anesthetics|anesthetics|mesh-list
14016510|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016511|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016512|NCT02807558|Azacitidine|azacitidine|mesh-list
14016513|NCT02807558|Daratumumab|daratumumab|mesh-list
14016514|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14016515|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
14016516|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016517|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141562|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141563|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141564|NCT04289883|Calcium|calcium|mesh-list
15141565|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15141566|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141567|NCT04289792|Gemcitabine|gemcitabine|mesh-list
15141568|NCT04289792|Paclitaxel|paclitaxel|mesh-list
15141569|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15141570|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141571|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
15141572|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
15141573|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
15141574|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141575|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15141576|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
15141577|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
15141578|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141579|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141580|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15141581|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
15141582|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141583|NCT04289103|Inolimomab|inolimomab|mesh-list
15141584|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016518|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016519|NCT02807441|Aspirin|aspirin|mesh-list
14016520|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14016521|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016522|NCT02807441|Analgesics|analgesics|mesh-ancestor
14016523|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
14016524|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016525|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016526|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016527|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016528|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14016529|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14016530|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016531|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14016532|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14016533|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016534|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
14272838|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272839|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14272840|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272841|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14272842|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
14272843|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272844|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
14272845|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272846|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272847|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14272848|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14272849|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14272850|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
14272851|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272852|NCT00425854|Afatinib|afatinib|mesh-list
14272853|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272854|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14272855|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272856|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272857|NCT00425945|Pycnogenols|pycnogenols|mesh-list
15141585|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
14016556|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
14016557|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
14016558|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016559|NCT02807415|Ivacaftor|ivacaftor|mesh-list
14016560|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14016561|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14016562|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016563|NCT02807272|Tipifarnib|tipifarnib|mesh-list
14016564|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016565|NCT02807298|Lidocaine|lidocaine|mesh-list
14016566|NCT02807298|Epinephrine|epinephrine|mesh-list
14016567|NCT02807298|Carticaine|carticaine|mesh-list
14016568|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14016569|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14016570|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14016571|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016572|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016573|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016574|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14016575|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14016576|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
14016577|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016578|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14016579|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
14016580|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
14016581|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
14016582|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14016583|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
14016584|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
14016585|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016586|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
14016587|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14016588|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14016589|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14016590|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15141586|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016591|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
14016592|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016593|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016594|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14016595|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14016596|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016597|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016598|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016599|NCT02806999|Insulin|insulin|mesh-list
14016600|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14016601|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14016602|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016603|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
14016604|NCT02807103|Rituximab|rituximab|mesh-list
14016605|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016606|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
14016607|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016608|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016609|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14016610|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
14272858|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14272859|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
14272860|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272861|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
14272862|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272863|NCT00425945|Protective Agents|protective agents|mesh-ancestor
14272864|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14272865|NCT00426127|Docetaxel|docetaxel|mesh-list
14272866|NCT00426127|Doxorubicin|doxorubicin|mesh-list
14272867|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14272868|NCT00426127|Enoxaparin|enoxaparin|mesh-list
14272869|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272870|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
14272871|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
14272872|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
14272873|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272874|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14272875|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14272876|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14272877|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272878|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
14272879|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14272880|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14272881|NCT00426153|Octreotide|octreotide|mesh-list
14272882|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14272883|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14272884|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272885|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
14272886|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
14272887|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272888|NCT00426283|Fluticasone|fluticasone|mesh-list
14272889|NCT00426283|Xhance|xhance|mesh-list
14272890|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14272891|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14272892|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
14272893|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272894|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272895|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14272896|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
14272897|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14272898|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14272899|NCT00426361|Vaccines|vaccines|mesh-list
14272900|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
14272901|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272902|NCT00426517|Sirolimus|sirolimus|mesh-list
14272903|NCT00426517|Busulfan|busulfan|mesh-list
14272904|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
14272905|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14272906|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272907|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14272908|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272909|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
14272910|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15141587|NCT04289467|Fenfluramine|fenfluramine|mesh-list
15141588|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15141589|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15141590|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14272911|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
14272912|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272913|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
14292466|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
14016611|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016612|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016613|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14016614|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14016615|NCT02807194|Anesthetics|anesthetics|mesh-list
14016616|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016617|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016618|NCT02807116|Rifampin|rifampin|mesh-list
14016619|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14016620|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
14016621|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016622|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016623|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
14016624|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14016625|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016626|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016627|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14016628|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14016629|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14272914|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272915|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14272916|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14272917|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272918|NCT00426556|Paclitaxel|paclitaxel|mesh-list
14272919|NCT00426556|Trastuzumab|trastuzumab|mesh-list
14272920|NCT00426556|Everolimus|everolimus|mesh-list
14272921|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14272922|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272923|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14272924|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14272925|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14272926|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272927|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14272928|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14272929|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
15141591|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141592|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141593|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
15141594|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141595|NCT04289090|Propofol|propofol|mesh-list
15141596|NCT04289090|Sevoflurane|sevoflurane|mesh-list
15141597|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141598|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141599|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141600|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15141601|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
15141602|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
15141603|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15141604|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15141605|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15141606|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15141607|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141608|NCT04289207|Danazol|danazol|mesh-list
15141609|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15141610|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141611|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141612|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141613|NCT04288999|Capecitabine|capecitabine|mesh-list
15141614|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15141615|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
15141616|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141617|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141618|NCT04288765|Dexamethasone|dexamethasone|mesh-list
14272930|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272931|NCT00426660|Maraviroc|maraviroc|mesh-list
14272932|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14272933|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14272934|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272935|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14272936|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14272937|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
15141619|NCT04288765|Lenalidomide|lenalidomide|mesh-list
15141620|NCT04288765|Daratumumab|daratumumab|mesh-list
14016630|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14016631|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14016632|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14016633|NCT02807051|Clarithromycin|clarithromycin|mesh-list
14016634|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016635|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016636|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14016637|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016638|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016639|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14016640|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14016641|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14016642|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016643|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141621|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141622|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
15141623|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
15141624|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141625|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141626|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15141627|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
15141628|NCT04288765|Hormones|hormones|mesh-ancestor
15141629|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141630|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15141631|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141632|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
15141633|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15141634|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15141635|NCT04288765|Growth Substances|growth substances|mesh-ancestor
15141636|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
14016644|NCT02806791|Lenograstim|lenograstim|mesh-list
14016645|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14016646|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
14016647|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016648|NCT02806817|Bevacizumab|bevacizumab|mesh-list
14016649|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14016650|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016651|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14016652|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15179362|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179363|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15179364|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15179365|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
15179366|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15179367|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179368|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
15179369|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
15179370|NCT03950804|Eculizumab|eculizumab|mesh-list
15179371|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15179372|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15179373|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
15179374|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179375|NCT03950505|Pioglitazone|pioglitazone|mesh-list
15179376|NCT03950505|Alogliptin|alogliptin|mesh-list
15179377|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15179378|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179379|NCT03950505|Incretins|incretins|mesh-ancestor
15179380|NCT03950505|Hormones|hormones|mesh-ancestor
15179381|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179382|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15179383|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
15179384|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179385|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179386|NCT03950518|Levamisole|levamisole|mesh-list
15179387|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15179388|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
15179389|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179390|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
15179391|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
14016653|NCT02806817|Growth Substances|growth substances|mesh-ancestor
14016654|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016655|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
14016656|NCT02806804|Vaccines|vaccines|mesh-list
14016657|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
15179392|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15141637|NCT04288700|Timolol|timolol|mesh-list
15141638|NCT04288700|Propranolol|propranolol|mesh-list
15141639|NCT04288700|Captopril|captopril|mesh-list
15141640|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14016658|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016659|NCT02806648|Palbociclib|palbociclib|mesh-list
14016660|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016661|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14016662|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016663|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016664|NCT02806752|Triamcinolone|triamcinolone|mesh-list
14016665|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14016666|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14016667|NCT02806752|Ranibizumab|ranibizumab|mesh-list
14016668|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14016669|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14016670|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14016671|NCT02806752|Growth Substances|growth substances|mesh-ancestor
14016672|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016673|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
14016674|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016675|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016676|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
14016677|NCT02806752|Hormones|hormones|mesh-ancestor
14016678|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016679|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016680|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
14016681|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016682|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016683|NCT02806596|Sevoflurane|sevoflurane|mesh-list
14016684|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14016685|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14016686|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
14016687|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
14016688|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016689|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016690|NCT02806492|Phenylephrine|phenylephrine|mesh-list
14016691|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
14016692|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14016693|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
14016694|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
14016695|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016696|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016697|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
14016698|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14016699|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
14016700|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
14016701|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14016702|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14016703|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14016704|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
14016705|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016706|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016707|NCT02806492|Protective Agents|protective agents|mesh-ancestor
14016708|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14016709|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
14016710|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016711|NCT02806440|Naltrexone|naltrexone|mesh-list
14016712|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14016713|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14016714|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016715|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
14016716|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025564|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025565|NCT02750163|Acetaminophen|acetaminophen|mesh-list
14025566|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025567|NCT02750163|Analgesics|analgesics|mesh-ancestor
14025568|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
14025569|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025570|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025571|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
15141641|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14025572|NCT02749747|Sulpiride|sulpiride|mesh-list
14025573|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14025574|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15141642|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14016717|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
14016718|NCT02806375|Busulfan|busulfan|mesh-list
14016719|NCT02806375|Fludarabine|fludarabine|mesh-list
14016720|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
14016721|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016722|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
14016723|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016724|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016725|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14016726|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
14016727|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016728|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016729|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14016730|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14016731|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
14016732|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14016733|NCT02806349|Cathartics|cathartics|mesh-ancestor
14016734|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016735|NCT02806362|Ritonavir|ritonavir|mesh-list
14016736|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14016737|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14016738|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
14016739|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016740|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016741|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14016742|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14016743|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
14016744|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016745|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14016746|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14016747|NCT02806206|Prucalopride|prucalopride|mesh-list
14016748|NCT02806206|Laxatives|laxatives|mesh-ancestor
14016749|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016750|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14016751|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14016752|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
14016753|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016754|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016755|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016756|NCT02806141|Colistin|colistin|mesh-list
14016757|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016758|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016759|NCT02806128|Kallikreins|kallikreins|mesh-list
14016760|NCT02806128|Coagulants|coagulants|mesh-ancestor
14016761|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14016762|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
14016763|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14016764|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016765|NCT02806115|Acetic Acid|acetic acid|mesh-list
14016766|NCT02806115|Retinol acetate|retinol acetate|mesh-list
14016767|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14016768|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016769|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14016770|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
14016771|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016772|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14016773|NCT02806115|Protective Agents|protective agents|mesh-ancestor
14016774|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016775|NCT02806050|Letrozole|letrozole|mesh-list
14016776|NCT02806050|Palbociclib|palbociclib|mesh-list
14016777|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016778|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14016779|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14016780|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016781|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016782|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14016783|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
14016784|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016785|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016786|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14016787|NCT02805946|Posaconazole|posaconazole|mesh-list
14016788|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
14016789|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016790|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14016791|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14016792|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14016793|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14016794|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14016795|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016796|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016797|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14016798|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
14016799|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14016800|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016801|NCT02805738|Tenofovir|tenofovir|mesh-list
14016802|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
14016803|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016804|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14016805|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14016806|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016807|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016808|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14016809|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14016810|NCT02805920|Bupivacaine|bupivacaine|mesh-list
14016811|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
14016812|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
14016813|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016814|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016815|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
14016816|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016817|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14016818|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14016819|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016820|NCT02805842|Tacrolimus|tacrolimus|mesh-list
14016821|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016822|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
14016823|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016824|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14016825|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016826|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016827|NCT02805829|Trastuzumab|trastuzumab|mesh-list
14016828|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14016829|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016830|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
14016831|NCT02805725|Trabectedin|trabectedin|mesh-list
14016832|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016833|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
14016834|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016835|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016836|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14016837|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
14016838|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016839|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016840|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14016841|NCT02805868|Siltuximab|siltuximab|mesh-list
14016842|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14016843|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016844|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
14016845|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016846|NCT02805556|Fostemsavir|fostemsavir|mesh-list
14016847|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14016848|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14016849|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
14016850|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016851|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14016852|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14016853|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016854|NCT02805426|Misoprostol|misoprostol|mesh-list
14016855|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
14016856|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14016857|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14016858|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016859|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
14016860|NCT02805426|Coagulants|coagulants|mesh-ancestor
14016861|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14016862|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
14016863|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14016864|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016865|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14016866|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016867|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
14016868|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
14016869|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14016870|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14016871|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
14016872|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14016873|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016874|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016875|NCT02805452|Urological Agents|urological agents|mesh-ancestor
14016876|NCT02805049|Caspofungin|caspofungin|mesh-list
14016877|NCT02805049|Micafungin|micafungin|mesh-list
14016878|NCT02805049|Echinocandins|echinocandins|mesh-list
14016879|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
14016880|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016881|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016882|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016883|NCT02805231|Vitamin D|vitamin d|mesh-list
14016884|NCT02805231|Vitamins|vitamins|mesh-ancestor
14016885|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
14016886|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016887|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14016888|NCT02805010|Abatacept|abatacept|mesh-list
14016889|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14016890|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016891|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016892|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14016893|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
14016894|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016895|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016896|NCT02804815|Aspirin|aspirin|mesh-list
14016897|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14016898|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016899|NCT02804815|Analgesics|analgesics|mesh-ancestor
14016900|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
14016901|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016902|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016903|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016904|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14016905|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14016906|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14016907|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016908|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14016909|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14016910|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016911|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
14016912|NCT02804841|Vitamin D|vitamin d|mesh-list
14016913|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
14016914|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
14016915|NCT02804841|Vitamins|vitamins|mesh-list
14016916|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
14016917|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016918|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14016919|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14025575|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025576|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025577|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14025578|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14025579|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
14025580|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025581|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025582|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14025583|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
14025584|NCT02749526|Tegafur|tegafur|mesh-list
14025585|NCT02749526|Endostar protein|endostar protein|mesh-list
14025586|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025587|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14025588|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
14025589|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025590|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14025591|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14025592|NCT02749526|Growth Substances|growth substances|mesh-ancestor
14025593|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025594|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
14025595|NCT02749578|Atorvastatin|atorvastatin|mesh-list
14016920|NCT02804711|Vaccines|vaccines|mesh-list
14272938|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272939|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14272940|NCT00426751|Abciximab|abciximab|mesh-list
14272941|NCT00426751|Eptifibatide|eptifibatide|mesh-list
14272942|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
14272943|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14272944|NCT00426764|Romidepsin|romidepsin|mesh-list
14272945|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14272946|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272947|NCT00426842|Midodrine|midodrine|mesh-list
14272948|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
14272949|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
14272950|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14272951|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272952|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14272953|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14272954|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14272955|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14272956|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
14272957|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14272958|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272959|NCT00426855|Bortezomib|bortezomib|mesh-list
14272960|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14272961|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14272962|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14272963|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
14272964|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272965|NCT00427037|Vitamin D|vitamin d|mesh-list
14272966|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
14272967|NCT00427037|Vitamins|vitamins|mesh-ancestor
14272968|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
14272969|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272970|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14272971|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14272972|NCT00427297|Ritonavir|ritonavir|mesh-list
14272973|NCT00427297|Lopinavir|lopinavir|mesh-list
14272974|NCT00427297|Tenofovir|tenofovir|mesh-list
14272975|NCT00427297|Lamivudine|lamivudine|mesh-list
14272976|NCT00427297|Zidovudine|zidovudine|mesh-list
14272977|NCT00427297|Nevirapine|nevirapine|mesh-list
14272978|NCT00427297|Abacavir|abacavir|mesh-list
14272979|NCT00427297|Stavudine|stavudine|mesh-list
14272980|NCT00427297|Didanosine|didanosine|mesh-list
14272981|NCT00427297|Efavirenz|efavirenz|mesh-list
14272982|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
14272983|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14272984|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14272985|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
14272986|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14272987|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14272988|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14272989|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14272990|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
14272991|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14272992|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14272993|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14272994|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14272995|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15141643|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15141644|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
15141645|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141646|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141647|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14272996|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
14272997|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14272998|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14272999|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15141648|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14016921|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
14016922|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016923|NCT02804776|Gefitinib|gefitinib|mesh-list
14016924|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016925|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14016926|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016927|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016928|NCT02804633|Acetaminophen|acetaminophen|mesh-list
14016929|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016930|NCT02804633|Analgesics|analgesics|mesh-ancestor
14016931|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
14016932|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016933|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016934|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
14016935|NCT02804646|Carboplatin|carboplatin|mesh-list
14016936|NCT02804646|Pemetrexed|pemetrexed|mesh-list
14016937|NCT02804646|Endostatins|endostatins|mesh-list
14016938|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016939|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14016940|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016941|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14016942|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14016943|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14016944|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14016945|NCT02804646|Growth Substances|growth substances|mesh-ancestor
14016946|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016947|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
15141649|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15141650|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141651|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
15141652|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15141653|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
15141654|NCT04288349|Epinephrine|epinephrine|mesh-list
15141655|NCT04288349|Racepinephrine|racepinephrine|mesh-list
15141656|NCT04288349|Ropivacaine|ropivacaine|mesh-list
15141657|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
15141658|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
15141659|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
14016948|NCT02804490|Vitamin A|vitamin a|mesh-list
14016949|NCT02804490|Beta Carotene|beta carotene|mesh-list
14016950|NCT02804490|Provitamins|provitamins|mesh-list
14016951|NCT02804490|Carotenoids|carotenoids|mesh-list
14016952|NCT02804490|Vitamins|vitamins|mesh-ancestor
14016953|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
14016954|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016955|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
14016956|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14016957|NCT02804490|Protective Agents|protective agents|mesh-ancestor
14016958|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
14016959|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
14016960|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14016961|NCT02804360|Dexamethasone|dexamethasone|mesh-list
14016962|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
14016963|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016964|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
14016965|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
14016966|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016967|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016968|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14016969|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
14016970|NCT02804360|Hormones|hormones|mesh-ancestor
14016971|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141660|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141661|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141662|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
15141663|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141664|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15141665|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15141666|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
15141667|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141668|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141669|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14562071|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562072|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562073|NCT00002827|Trace Elements|trace elements|mesh-ancestor
14562074|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
14016972|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562075|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15141670|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15141671|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
15141672|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14016973|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14016974|NCT02804373|Oxytocin|oxytocin|mesh-list
14016975|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
14016976|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14562076|NCT00002827|Protective Agents|protective agents|mesh-ancestor
14016977|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016978|NCT02804165|Vaccines|vaccines|mesh-list
14016979|NCT02804165|Immunologic Factors|immunologic factors|mesh-ancestor
14016980|NCT02804165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016981|NCT02804126|Acetaminophen|acetaminophen|mesh-list
14016982|NCT02804126|Dipyrone|dipyrone|mesh-list
14016983|NCT02804126|Ketoprofen|ketoprofen|mesh-list
14016984|NCT02804126|Morphine|morphine|mesh-list
14016985|NCT02804126|Bupivacaine|bupivacaine|mesh-list
14016986|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
14016987|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
14016988|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14016989|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14016990|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
14016991|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14016992|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14016993|NCT02804126|Narcotics|narcotics|mesh-ancestor
14016994|NCT02804126|Analgesics|analgesics|mesh-ancestor
14016995|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14016996|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
14016997|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14016998|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14016999|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017000|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14017001|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017002|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017003|NCT02803918|Metformin|metformin|mesh-list
14017004|NCT02803918|Lixisenatide|lixisenatide|mesh-list
14017005|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017006|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017007|NCT02803944|Azithromycin|azithromycin|mesh-list
14017008|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14017009|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017010|NCT02803892|Vildagliptin|vildagliptin|mesh-list
14017011|NCT02803892|Sirolimus|sirolimus|mesh-list
14017012|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14017013|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017014|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14017015|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017016|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
14017017|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017018|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
14017019|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017020|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017021|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14017022|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
14017023|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017024|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017025|NCT02803788|Dexamethasone|dexamethasone|mesh-list
14017026|NCT02803788|Ondansetron|ondansetron|mesh-list
14017027|NCT02803788|Ramosetron|ramosetron|mesh-list
14017028|NCT02803788|Antiemetics|antiemetics|mesh-list
14017029|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017030|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
14017031|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017032|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017033|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562077|NCT00002828|Fluorouracil|fluorouracil|mesh-list
15141673|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
15141674|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
15141675|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
15141676|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15141677|NCT04288232|Aflibercept|aflibercept|mesh-list
15141678|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15141679|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15141680|NCT04288232|Growth Substances|growth substances|mesh-ancestor
15141681|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141682|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
15141683|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141684|NCT04288219|Nifedipine|nifedipine|mesh-list
15141685|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15141686|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15141687|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017034|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
15141688|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14017035|NCT02803788|Hormones|hormones|mesh-ancestor
14017036|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017037|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14017038|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017039|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
14017040|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
14017041|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14017042|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
14017043|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017044|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017045|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14017046|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14017047|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017048|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14017049|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14017050|NCT02803502|Thrombin|thrombin|mesh-list
14017051|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
14017052|NCT02803502|Coagulants|coagulants|mesh-ancestor
15141689|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141690|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
15141691|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
15141692|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15141693|NCT04287894|Pemetrexed|pemetrexed|mesh-list
15141694|NCT04287894|Durvalumab|durvalumab|mesh-list
15141695|NCT04287894|Tremelimumab|tremelimumab|mesh-list
15141696|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141697|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017053|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
14017054|NCT02803385|Anesthetics|anesthetics|mesh-list
14017055|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
14017056|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017057|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017058|NCT02803385|Narcotics|narcotics|mesh-ancestor
14017059|NCT02803385|Analgesics|analgesics|mesh-ancestor
14017060|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
14017061|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017062|NCT02803216|Amoxicillin|amoxicillin|mesh-list
14017063|NCT02803216|Clarithromycin|clarithromycin|mesh-list
14017064|NCT02803216|Omeprazole|omeprazole|mesh-list
14017065|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14017066|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017067|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14017068|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017069|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14017070|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017071|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017072|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14017073|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14017074|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14025596|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14025597|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14025598|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
14025599|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025600|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14025601|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14025602|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025603|NCT02749656|Desoximetasone|desoximetasone|mesh-list
14025604|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025605|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
14025606|NCT02749656|Hormones|hormones|mesh-ancestor
14025607|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025608|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025609|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
14025610|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14025611|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14025612|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14025613|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025614|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025615|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
14025616|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025617|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025618|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14025619|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025620|NCT02749292|Rituximab|rituximab|mesh-list
14025621|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15141698|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025622|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025623|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
15141699|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14017075|NCT02802995|Thrombin|thrombin|mesh-list
14017076|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
14017077|NCT02802995|Coagulants|coagulants|mesh-ancestor
14017078|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
14017079|NCT02803073|Testosterone|testosterone|mesh-list
14017080|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
14017081|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
14017082|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14017083|NCT02803073|Androgens|androgens|mesh-ancestor
14017084|NCT02803073|Hormones|hormones|mesh-ancestor
14017085|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017086|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017087|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14017088|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017089|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
14017090|NCT02802943|Imiquimod|imiquimod|mesh-list
14017091|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14017092|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
14017093|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017094|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017095|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
14017096|NCT02802748|Letrozole|letrozole|mesh-list
14017097|NCT02802748|Vinorelbine|vinorelbine|mesh-list
14017098|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017099|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14017100|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14017101|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017102|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017103|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14017104|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
14017105|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141700|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15141701|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15141702|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
15141703|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15141704|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
15141705|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
15141706|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017106|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017107|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14017108|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14017109|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14017110|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14017111|NCT02802631|Minocycline|minocycline|mesh-list
14017112|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14017113|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017114|NCT02802722|Vitamin D|vitamin d|mesh-list
14017115|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
14017116|NCT02802722|Vitamins|vitamins|mesh-ancestor
14017117|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
14017118|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017119|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14017120|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14017121|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14017122|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017123|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017124|NCT02802644|Incretins|incretins|mesh-ancestor
14017125|NCT02802644|Hormones|hormones|mesh-ancestor
14017126|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017127|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14017128|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
14017129|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017130|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017131|NCT02802683|Phenylephrine|phenylephrine|mesh-list
14017132|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
14017133|NCT02802683|Bupivacaine|bupivacaine|mesh-list
14017134|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
14273000|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14273001|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14273002|NCT00427336|Vidarabine|vidarabine|mesh-list
14273003|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
14273004|NCT00427336|Fludarabine|fludarabine|mesh-list
14273005|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
14273006|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
14017135|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
14017136|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
14273007|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14017137|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017138|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017139|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
14017140|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017141|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14017142|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
14017143|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
14017144|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
14017145|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14017146|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
14017147|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
14017148|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14017149|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14017150|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14017151|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
14017152|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017153|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017154|NCT02802683|Protective Agents|protective agents|mesh-ancestor
14017155|NCT02802696|Furosemide|furosemide|mesh-list
14017156|NCT02802696|Diuretics|diuretics|mesh-ancestor
14017157|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
14017158|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017159|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14273008|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273009|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
15141707|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141708|NCT04287790|Naltrexone|naltrexone|mesh-list
15141709|NCT04287790|Disulfiram|disulfiram|mesh-list
15141710|NCT04287790|Acamprosate|acamprosate|mesh-list
15141711|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15141712|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15141713|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141714|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
14273010|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273011|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273012|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273013|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
14273014|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273015|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273016|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273017|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14273018|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
14273019|NCT00427336|Antiviral Agents|antiviral agents|mesh-ancestor
14273020|NCT00427336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273021|NCT00427349|Octreotide|octreotide|mesh-list
14273022|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
14273023|NCT00427349|Imetelstat|imetelstat|mesh-list
14273024|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14273025|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14273026|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273027|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15141715|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141716|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15141717|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141718|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141719|NCT04287777|Mupirocin|mupirocin|mesh-list
15141720|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15141721|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141722|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15141723|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141724|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141725|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
15141726|NCT04287829|Lenvatinib|lenvatinib|mesh-list
15141727|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15141728|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141729|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15141730|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141731|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141732|NCT04287842|Sevoflurane|sevoflurane|mesh-list
15141733|NCT04287842|Desflurane|desflurane|mesh-list
15141734|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15141735|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15141736|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
14811724|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
15141737|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
14273028|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273029|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017160|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14017161|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017162|NCT02802605|Bemiparin|bemiparin|mesh-list
14017163|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
14017164|NCT02802540|Nabilone|nabilone|mesh-list
14017165|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
14017166|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
14017167|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017168|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017169|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017170|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14017171|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14273030|NCT00427557|Vidarabine|vidarabine|mesh-list
14273031|NCT00427557|Rituximab|rituximab|mesh-list
14562078|NCT00002828|Raltitrexed|raltitrexed|mesh-list
14562079|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
14562080|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562081|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562082|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562083|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562084|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
14562085|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562086|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14562087|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562088|NCT00002829|Interferons|interferons|mesh-list
14562089|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
14562090|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
14562091|NCT00002829|Etoposide|etoposide|mesh-list
14562092|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562093|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
14562094|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562095|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562096|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562097|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
14562098|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562099|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562100|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562101|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562102|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562103|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562104|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562105|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
14562106|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562107|NCT00002831|Cyclosporine|cyclosporine|mesh-list
14562108|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
14562109|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14562110|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14562111|NCT00002831|Prednisolone|prednisolone|mesh-list
14562112|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
14562113|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
14562114|NCT00002831|Busulfan|busulfan|mesh-list
14562115|NCT00002831|Methotrexate|methotrexate|mesh-list
14562116|NCT00002831|Decitabine|decitabine|mesh-list
14562117|NCT00002831|Tacrolimus|tacrolimus|mesh-list
14562118|NCT00002831|Cyclosporins|cyclosporins|mesh-list
14562119|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14562120|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
14562121|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562122|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
14562123|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562124|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562125|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562126|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
14562127|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562128|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562129|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562130|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14562131|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
15141738|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141739|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141740|NCT04287426|Remifentanil|remifentanil|mesh-list
14562132|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14562133|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15141741|NCT04287426|Rocuronium|rocuronium|mesh-list
14273032|NCT00427557|Fludarabine|fludarabine|mesh-list
14017172|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017173|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14017174|NCT02802215|Folic Acid|folic acid|mesh-list
14017175|NCT02802215|Metformin|metformin|mesh-list
14017176|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017177|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017178|NCT02802215|Hematinics|hematinics|mesh-ancestor
14017179|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
14017180|NCT02802215|Vitamins|vitamins|mesh-ancestor
14017181|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
14017182|NCT02802163|Dexamethasone|dexamethasone|mesh-list
14017183|NCT02802163|Lenalidomide|lenalidomide|mesh-list
14017184|NCT02802163|Panobinostat|panobinostat|mesh-list
14017185|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017186|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
14017187|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
14017188|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017189|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017190|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017191|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
14017192|NCT02802163|Hormones|hormones|mesh-ancestor
14017193|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017194|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14017195|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017196|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
14017197|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14017198|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14017199|NCT02802163|Growth Substances|growth substances|mesh-ancestor
14017200|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
14017201|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14017202|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017203|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017204|NCT02802072|Aspirin|aspirin|mesh-list
14017205|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14017206|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017207|NCT02802072|Analgesics|analgesics|mesh-ancestor
14017208|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
14017209|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017210|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017211|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017212|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017213|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14017214|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14017215|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017216|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14017217|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14017218|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017219|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
14017220|NCT02802137|Timolol|timolol|mesh-list
14017221|NCT02802137|Dorzolamide|dorzolamide|mesh-list
14017222|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14017223|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14017224|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
14017225|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017226|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017227|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017228|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14017229|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14017230|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14017231|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017232|NCT02801799|Ropivacaine|ropivacaine|mesh-list
14017233|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
14017234|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
14017235|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017236|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017237|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
14017238|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017239|NCT02801786|Tamoxifen|tamoxifen|mesh-list
14017240|NCT02801786|Lidocaine|lidocaine|mesh-list
14017241|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
14017242|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
14017243|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017244|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017245|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
14017246|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017247|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14017248|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14017249|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14017250|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14017251|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017252|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14017253|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
14017254|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017255|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14017256|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017257|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14017258|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14017259|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14017260|NCT02801838|Morphine|morphine|mesh-list
14017261|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14017262|NCT02801838|Narcotics|narcotics|mesh-ancestor
14017263|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017264|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017265|NCT02801838|Analgesics|analgesics|mesh-ancestor
14017266|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
14017267|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017268|NCT02802098|Bevacizumab|bevacizumab|mesh-list
14017269|NCT02802098|Durvalumab|durvalumab|mesh-list
14017270|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14017271|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017272|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14017273|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14017274|NCT02802098|Growth Substances|growth substances|mesh-ancestor
14017275|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017276|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
15141742|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15141743|NCT04287426|Narcotics|narcotics|mesh-ancestor
15141744|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141745|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141746|NCT04287426|Analgesics|analgesics|mesh-ancestor
15141747|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
15141748|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141749|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15141750|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15141751|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15141752|NCT04287543|Melatonin|melatonin|mesh-list
15141753|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
15141754|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141755|NCT04287543|Protective Agents|protective agents|mesh-ancestor
14017277|NCT02801487|Cisplatin|cisplatin|mesh-list
14017278|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017279|NCT02801526|Amlodipine|amlodipine|mesh-list
14017280|NCT02801526|Candesartan|candesartan|mesh-list
14017281|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14017282|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14017283|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14017284|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017285|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14017286|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017287|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
14017288|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14017289|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14017290|NCT02801357|Lofexidine|lofexidine|mesh-list
14017291|NCT02801357|Buprenorphine|buprenorphine|mesh-list
14017292|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15141756|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017293|NCT02801357|Narcotics|narcotics|mesh-ancestor
14017294|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017295|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017296|NCT02801357|Analgesics|analgesics|mesh-ancestor
14017297|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
14017298|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017299|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14017300|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14017301|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14017302|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14017303|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14017304|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
15141757|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017305|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017306|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025624|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025625|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025626|NCT02749409|Parecoxib|parecoxib|mesh-list
14025627|NCT02749409|Morphine|morphine|mesh-list
14025628|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14025629|NCT02749409|Narcotics|narcotics|mesh-ancestor
14025630|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025631|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025632|NCT02749409|Analgesics|analgesics|mesh-ancestor
14025633|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
14025634|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025635|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14025636|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14025637|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025638|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025639|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14025640|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025641|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025642|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025643|NCT02749396|Interferons|interferons|mesh-list
14025644|NCT02749396|Interferon-beta|interferon-beta|mesh-list
14025645|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
14025646|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
14025647|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025648|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
14025649|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025650|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
14025651|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025652|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15141758|NCT04287361|Clonazepam|clonazepam|mesh-list
15141759|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
15141760|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
14025653|NCT02749123|Lidocaine|lidocaine|mesh-list
14025654|NCT02749123|Menthol|menthol|mesh-list
14025655|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025656|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
14025657|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025658|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025659|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
14025660|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025661|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14025662|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14025663|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14025664|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025665|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025666|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
14025667|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
14025668|NCT02749032|Metformin|metformin|mesh-list
14025669|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14025670|NCT02749032|Vildagliptin|vildagliptin|mesh-list
14025671|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14025672|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025673|NCT02749032|Incretins|incretins|mesh-ancestor
14025674|NCT02749032|Hormones|hormones|mesh-ancestor
14025675|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025676|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14025677|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
14025678|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025679|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025680|NCT02749162|Acetaminophen|acetaminophen|mesh-list
14025681|NCT02749162|Dexamethasone|dexamethasone|mesh-list
14025682|NCT02749162|Lidocaine|lidocaine|mesh-list
14025683|NCT02749162|Morphine|morphine|mesh-list
14025684|NCT02749162|Ropivacaine|ropivacaine|mesh-list
14025685|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14025686|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025687|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
14025688|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
14025689|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025690|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025691|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15141761|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
15141762|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141763|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141764|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141765|NCT04287387|Pioglitazone|pioglitazone|mesh-list
15141766|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15141767|NCT04287387|Metformin|metformin|mesh-list
15141768|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
15141769|NCT04287387|Glimepiride|glimepiride|mesh-list
15141770|NCT04287387|Acarbose|acarbose|mesh-list
15141771|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15141772|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141773|NCT04287387|Incretins|incretins|mesh-ancestor
15141774|NCT04287387|Hormones|hormones|mesh-ancestor
15141775|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141776|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15141777|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
15141778|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141779|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141780|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15141781|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15141782|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017307|NCT02801383|Interferons|interferons|mesh-list
14017308|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017309|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
14017310|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017314|NCT02801409|Anesthetics|anesthetics|mesh-list
14017315|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017316|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017317|NCT02801292|Ketamine|ketamine|mesh-list
14017318|NCT02801292|Analgesics|analgesics|mesh-ancestor
14017319|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
14017320|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017321|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017322|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14017323|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14017324|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
14017325|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
14017326|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017327|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14017328|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14017329|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017330|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017331|NCT02801305|Diltiazem|diltiazem|mesh-list
14017332|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
14017333|NCT02801305|Petrolatum|petrolatum|mesh-list
14017334|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
14017335|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14017336|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14273033|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
14273034|NCT00427557|Melphalan|melphalan|mesh-list
14273035|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273036|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273037|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
14273038|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273039|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273040|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14273041|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
14273042|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273043|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273044|NCT00427557|Antiviral Agents|antiviral agents|mesh-ancestor
14273045|NCT00427557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273046|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273047|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
14273048|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273049|NCT00427635|Esomeprazole|esomeprazole|mesh-list
14273050|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15141783|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
15141784|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15141785|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
15141786|NCT04287205|Progestins|progestins|mesh-ancestor
14273051|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15141787|NCT04287205|Hormones|hormones|mesh-ancestor
14017337|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025692|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
14017338|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017339|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14017340|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017341|NCT02801305|Emollients|emollients|mesh-ancestor
14017342|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14017343|NCT02801227|Oxytocin|oxytocin|mesh-list
14017344|NCT02801227|Dinoprostone|dinoprostone|mesh-list
14017345|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
14017346|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14017347|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017348|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
14017349|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14017350|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017351|NCT02801201|Midazolam|midazolam|mesh-list
14017352|NCT02801201|Bupivacaine|bupivacaine|mesh-list
14017353|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
14017354|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
14017355|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017356|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179393|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017357|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
14017358|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017359|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14017360|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14017361|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14017362|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14017363|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14017364|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14017365|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
14017366|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
14017367|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
14017368|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017369|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017370|NCT02801097|Irinotecan|irinotecan|mesh-list
14017371|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14017372|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14017373|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017374|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017375|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017376|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
14017377|NCT02801188|Bupivacaine|bupivacaine|mesh-list
14017378|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
14017379|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
14017380|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017381|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017382|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
14017383|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017384|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14017385|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017386|NCT02801188|Analgesics|analgesics|mesh-ancestor
14017387|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14017388|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14017389|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14017390|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
14017391|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017392|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017393|NCT02800902|Atorvastatin|atorvastatin|mesh-list
14017394|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14017395|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14017396|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14017397|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
14017398|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017399|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14017400|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14017401|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017402|NCT02801032|Tadalafil|tadalafil|mesh-list
14017403|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
14017404|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14017405|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14017406|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017407|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017408|NCT02801032|Urological Agents|urological agents|mesh-ancestor
14017409|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
14017410|NCT02800785|Metronidazole|metronidazole|mesh-list
14017411|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
14017412|NCT02800785|Levofloxacin|levofloxacin|mesh-list
14017413|NCT02800785|Cefazolin|cefazolin|mesh-list
14017414|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
14017415|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
14017416|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
14017417|NCT02800785|Ertapenem|ertapenem|mesh-list
14017418|NCT02800785|Cefuroxime|cefuroxime|mesh-list
14017419|NCT02800785|Tigecycline|tigecycline|mesh-list
14017420|NCT02800785|Cefotaxime|cefotaxime|mesh-list
14017421|NCT02800785|Cefoxitin|cefoxitin|mesh-list
14017422|NCT02800785|Ticarcillin|ticarcillin|mesh-list
14017423|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
14017424|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14017425|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017426|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14017427|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14017428|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017429|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017430|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017431|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14017432|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14017433|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14017434|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14017435|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14017436|NCT02800785|Renal Agents|renal agents|mesh-ancestor
14017437|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14017438|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14017439|NCT02800889|Pixantrone|pixantrone|mesh-list
14017440|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14017441|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14017442|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017443|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017444|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017445|NCT02800447|Procarbazine|procarbazine|mesh-list
14017446|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017447|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
14017448|NCT02800408|Provitamins|provitamins|mesh-ancestor
14017449|NCT02800408|Vitamins|vitamins|mesh-ancestor
14017450|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
14017451|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017452|NCT02800772|Acetic Acid|acetic acid|mesh-list
14017453|NCT02800772|Retinol acetate|retinol acetate|mesh-list
14017454|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14017455|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017456|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14017457|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
14017458|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017459|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14017460|NCT02800772|Protective Agents|protective agents|mesh-ancestor
14017461|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017462|NCT02800590|Abp-700|abp-700|mesh-list
14017463|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14017464|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
14017465|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
14017466|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017467|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017468|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017469|NCT02800694|Fentanyl|fentanyl|mesh-list
14017470|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14017471|NCT02800694|Narcotics|narcotics|mesh-ancestor
14017472|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017473|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017474|NCT02800694|Analgesics|analgesics|mesh-ancestor
14017475|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
14017476|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017477|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14017478|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14017479|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
14017480|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
14017481|NCT02800486|Cetuximab|cetuximab|mesh-list
14017482|NCT02800486|Mannitol|mannitol|mesh-list
14017483|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14017484|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017485|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14017486|NCT02800486|Diuretics|diuretics|mesh-ancestor
14017487|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
14017488|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017489|NCT02800252|Aspirin|aspirin|mesh-list
14017490|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14017491|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017492|NCT02800252|Analgesics|analgesics|mesh-ancestor
14017493|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
14017494|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017495|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017496|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017497|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017498|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14017499|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14017500|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017501|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14017502|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14017503|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017504|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
14017505|NCT02800174|Aspirin|aspirin|mesh-list
14017506|NCT02800174|Clopidogrel|clopidogrel|mesh-list
14017507|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14017508|NCT02800174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14017509|NCT02800174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017510|NCT02800174|Analgesics|analgesics|mesh-ancestor
14017511|NCT02800174|Sensory System Agents|sensory system agents|mesh-ancestor
14017512|NCT02800174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017513|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017514|NCT02800174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017515|NCT02800174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017516|NCT02800174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14017517|NCT02800174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14017518|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017519|NCT02800174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14017520|NCT02800174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017521|NCT02800174|Antipyretics|antipyretics|mesh-ancestor
14017522|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14017523|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14017524|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14017525|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
14017526|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017527|NCT02800330|Esomeprazole|esomeprazole|mesh-list
14017528|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14017529|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017530|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14017531|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017532|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017533|NCT02799862|Paclitaxel|paclitaxel|mesh-list
14017534|NCT02799862|Carboplatin|carboplatin|mesh-list
14017535|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14017536|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017537|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
14017538|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
14017539|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
14017540|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017541|NCT02799927|Calcium|calcium|mesh-list
14017542|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14017543|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017544|NCT02799888|Cyclosporine|cyclosporine|mesh-list
14017545|NCT02799888|Maraviroc|maraviroc|mesh-list
14017546|NCT02799888|Methotrexate|methotrexate|mesh-list
14017547|NCT02799888|Tacrolimus|tacrolimus|mesh-list
14017548|NCT02799888|Cyclosporins|cyclosporins|mesh-list
14017549|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14017550|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
14017551|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14017552|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017553|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14017554|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
14017555|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017556|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017557|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
14017558|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017559|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14017560|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017561|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
14017562|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017563|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14017564|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14017565|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
15141788|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15141789|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141790|NCT04287062|Suvorexant|suvorexant|mesh-list
15141791|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15141792|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141793|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141794|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141795|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15141796|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141797|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141798|NCT04286711|Paclitaxel|paclitaxel|mesh-list
15141799|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15141800|NCT04286711|Apatinib|apatinib|mesh-list
15141801|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15141802|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017566|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017567|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14017568|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14017569|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14017570|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14017571|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
14017572|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14025693|NCT02749162|Hormones|hormones|mesh-ancestor
14025694|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025695|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14025696|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025697|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
15141803|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
15141804|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
15141805|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
15141806|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141807|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15141808|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179394|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179395|NCT03950427|Bupropion|bupropion|mesh-list
15179396|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15179397|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
14025698|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
14025699|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025700|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
14025701|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14025702|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14025703|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14025704|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025705|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025706|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14025707|NCT02749162|Narcotics|narcotics|mesh-ancestor
14025708|NCT02749162|Analgesics|analgesics|mesh-ancestor
14025709|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025710|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
14025711|NCT02749136|Gemcitabine|gemcitabine|mesh-list
14025712|NCT02749136|Folfirinox|folfirinox|mesh-list
14025713|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14025714|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
14025715|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025716|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025717|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
14025718|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811725|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811726|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179398|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14025719|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025720|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14025721|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
15179399|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15179400|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15179401|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179402|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179403|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
15179404|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179405|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811727|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
14017573|NCT02800135|Furosemide|furosemide|mesh-list
14273052|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14273053|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273054|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273055|NCT00427648|Lidocaine|lidocaine|mesh-list
14273056|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
14273057|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
14273058|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14273059|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273060|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
14273061|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273062|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14273063|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14273064|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14273065|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273066|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273067|NCT00427661|Cyclosporine|cyclosporine|mesh-list
14273068|NCT00427661|Fludarabine|fludarabine|mesh-list
14273069|NCT00427661|Busulfan|busulfan|mesh-list
14273070|NCT00427661|Cyclosporins|cyclosporins|mesh-list
14273071|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273072|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273073|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273074|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
14273075|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273076|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273077|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
14273078|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273079|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
14273080|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273081|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14273082|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
14273083|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273084|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273085|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14273086|NCT00427700|Clomiphene|clomiphene|mesh-list
14273087|NCT00427700|Enclomiphene|enclomiphene|mesh-list
14273088|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
14273089|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14273090|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
14273091|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273092|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273093|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14273094|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
14273095|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14273096|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14273097|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14273098|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14273099|NCT00427765|Melphalan|melphalan|mesh-list
14273100|NCT00427765|Busulfan|busulfan|mesh-list
14273101|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273102|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
14273103|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273104|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273105|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273106|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273107|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
14273108|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273109|NCT00427791|Rituximab|rituximab|mesh-list
14273110|NCT00427791|Etoposide|etoposide|mesh-list
14273111|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273112|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273113|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
14273114|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273115|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273116|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273117|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14017574|NCT02800135|Diuretics|diuretics|mesh-ancestor
14017575|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
14017576|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017577|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14017578|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14017579|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017580|NCT02799901|Nivolumab|nivolumab|mesh-list
14017581|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14017582|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017583|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14017584|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017585|NCT02800265|Sulforaphane|sulforaphane|mesh-list
14017586|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14017587|NCT02800265|Protective Agents|protective agents|mesh-ancestor
14017588|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017589|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017590|NCT02799797|Sufentanil|sufentanil|mesh-list
14017591|NCT02799797|Dsuvia|dsuvia|mesh-list
14017592|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14017593|NCT02799797|Narcotics|narcotics|mesh-ancestor
14017594|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017595|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017596|NCT02799797|Analgesics|analgesics|mesh-ancestor
14017597|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
14017598|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017599|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14017600|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14017601|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
14017602|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
14017603|NCT02799615|Infliximab|infliximab|mesh-list
14017604|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
14017605|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017606|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017607|NCT02799758|Pitavastatin|pitavastatin|mesh-list
14017608|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14017609|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14017610|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14017611|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
14017612|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017613|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017614|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14017615|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
14017616|NCT02799589|Remifentanil|remifentanil|mesh-list
14017617|NCT02799589|Ropivacaine|ropivacaine|mesh-list
14017618|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14017619|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017620|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017621|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017622|NCT02799589|Analgesics|analgesics|mesh-ancestor
14017623|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
14273118|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14273119|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273120|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273121|NCT00427804|Calcitriol|calcitriol|mesh-list
14273122|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14273123|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273124|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14273125|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273126|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273127|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14273128|NCT00427804|Vitamins|vitamins|mesh-ancestor
14273129|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
14273130|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14273131|NCT00427895|Vaccines|vaccines|mesh-list
15141809|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15141810|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
15141811|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15141812|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15141813|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15141814|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15141815|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
15141816|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141817|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141818|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141819|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15141820|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
15141821|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141822|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15141823|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
14017624|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026301|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
15141824|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
15141825|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141826|NCT04286178|Vitamins|vitamins|mesh-ancestor
15141827|NCT04286503|Ritonavir|ritonavir|mesh-list
15141828|NCT04286503|Lopinavir|lopinavir|mesh-list
15141829|NCT04286503|Chloroquine|chloroquine|mesh-list
15141830|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15141831|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15141832|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15141833|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
14017625|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14017626|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14017627|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15141834|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141835|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141836|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15141837|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15141838|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
15141839|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141840|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14017628|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
14017629|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017630|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017631|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
14017632|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
14017633|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14017634|NCT02799589|Narcotics|narcotics|mesh-ancestor
14017635|NCT02799459|Anesthetics|anesthetics|mesh-list
14017636|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14017637|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017638|NCT02799446|Reslizumab|reslizumab|mesh-list
14017639|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14017640|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
14017641|NCT02799355|Interferons|interferons|mesh-list
14017642|NCT02799355|Ribavirin|ribavirin|mesh-list
14017643|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
14017644|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017645|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
14017646|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017647|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
14017648|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017649|NCT02799498|Etanercept|etanercept|mesh-list
14017650|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14017651|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017652|NCT02799498|Analgesics|analgesics|mesh-ancestor
14017653|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
14017654|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017655|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017656|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017657|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017658|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017659|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017660|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
14017661|NCT02799316|Antibodies|antibodies|mesh-list
14017662|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
14017663|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017664|NCT02799238|Temozolomide|temozolomide|mesh-list
14017665|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14017666|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
14017667|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017668|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017669|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14017670|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14017671|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14017672|NCT02799277|Testosterone|testosterone|mesh-list
14017673|NCT02799277|Androgens|androgens|mesh-ancestor
14017674|NCT02799277|Hormones|hormones|mesh-ancestor
14017675|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017676|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017677|NCT02799147|Fludarabine|fludarabine|mesh-list
14017678|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
14017679|NCT02799147|Busulfan|busulfan|mesh-list
14017680|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14292467|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017681|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017682|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15141841|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14017683|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
14017684|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017685|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017686|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
14017687|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017688|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
14017689|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14017690|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14017691|NCT02798913|Clopidogrel|clopidogrel|mesh-list
14017692|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14017693|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14017694|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14017695|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14017696|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
14017697|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017698|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017699|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017700|NCT02798874|Clopidogrel|clopidogrel|mesh-list
14017701|NCT02798874|Ticagrelor|ticagrelor|mesh-list
14017702|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14017703|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14017704|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14017705|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14017706|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
14017707|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14017708|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017709|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017710|NCT02799264|Cabotegravir|cabotegravir|mesh-list
14017711|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14017712|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14017713|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017714|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017715|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14017716|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14017717|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
14017718|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017719|NCT02798653|Progesterone|progesterone|mesh-list
14017720|NCT02798653|Progestins|progestins|mesh-ancestor
14017721|NCT02798653|Hormones|hormones|mesh-ancestor
14017722|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017723|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017724|NCT02798744|Empagliflozin|empagliflozin|mesh-list
14017725|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14017726|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017727|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017728|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017729|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
14017730|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14017731|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017732|NCT02798510|Gemcitabine|gemcitabine|mesh-list
14017733|NCT02798510|Capecitabine|capecitabine|mesh-list
14017734|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14017735|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
14017736|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017737|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017738|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
14017739|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017740|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017741|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017742|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
14017743|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017744|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
14017745|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14017746|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017747|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017748|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017749|NCT02798367|Melatonin|melatonin|mesh-list
14017750|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
14017751|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017752|NCT02798367|Protective Agents|protective agents|mesh-ancestor
14017753|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017754|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141842|NCT04286503|Amebicides|amebicides|mesh-ancestor
15141843|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15141844|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15141845|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
15141846|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15141847|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15141848|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15141849|NCT04286503|Analgesics|analgesics|mesh-ancestor
15141850|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
15141851|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141852|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141853|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15141854|NCT04286503|Filaricides|filaricides|mesh-ancestor
15141855|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
15141856|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
14017755|NCT02798250|Insulin|insulin|mesh-list
14017756|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14017757|NCT02798250|Glucagon|glucagon|mesh-list
14017758|NCT02798250|Hormones|hormones|mesh-list
14017759|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017760|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017761|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017762|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017763|NCT02798055|Bosentan|bosentan|mesh-list
14017764|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14017765|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14017766|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017767|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
14017768|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017769|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
14017770|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14017771|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14017772|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017773|NCT02798159|Urological Agents|urological agents|mesh-ancestor
14017774|NCT02798172|Metformin|metformin|mesh-list
14017775|NCT02798172|Alogliptin|alogliptin|mesh-list
14017776|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017777|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017778|NCT02798172|Incretins|incretins|mesh-ancestor
14017779|NCT02798172|Hormones|hormones|mesh-ancestor
14017780|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017781|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14017782|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
14017783|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017784|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017785|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
14017786|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14017787|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14017788|NCT02798068|Prednisolone|prednisolone|mesh-list
14017789|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
14017790|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14017791|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
14017792|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017793|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
14017794|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
14017795|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017796|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017797|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14017798|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
14017799|NCT02798068|Hormones|hormones|mesh-ancestor
14017800|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017801|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14017802|NCT02798068|Protective Agents|protective agents|mesh-ancestor
14017803|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14017804|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017805|NCT02797704|Aflibercept|aflibercept|mesh-list
14017806|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14017807|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14017808|NCT02797704|Growth Substances|growth substances|mesh-ancestor
14017809|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141857|NCT04286035|Bupivacaine|bupivacaine|mesh-list
15141858|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
14017810|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14017811|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141859|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
15141860|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141861|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141862|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
15141863|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141864|NCT04286087|Anesthetics|anesthetics|mesh-list
15141865|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141866|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141867|NCT04285853|Oxycodone|oxycodone|mesh-list
15141868|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15141869|NCT04285853|Narcotics|narcotics|mesh-ancestor
15141870|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141871|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141872|NCT04285853|Analgesics|analgesics|mesh-ancestor
15141873|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
15141874|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017812|NCT02797717|Prednisone|prednisone|mesh-list
14017813|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
14017814|NCT02797717|Dacarbazine|dacarbazine|mesh-list
14017815|NCT02797717|Doxorubicin|doxorubicin|mesh-list
14017816|NCT02797717|Etoposide|etoposide|mesh-list
14017817|NCT02797717|Vincristine|vincristine|mesh-list
14017818|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017819|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
14017820|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017821|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017822|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14017823|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
14017824|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017825|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017826|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14017827|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14017828|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14017829|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14017830|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017831|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017832|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
14017833|NCT02797717|Hormones|hormones|mesh-ancestor
14017834|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14017835|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14017836|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14017837|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14017838|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14017839|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14017840|NCT02797860|Rocuronium|rocuronium|mesh-list
14017841|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14017842|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14017843|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14017844|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017845|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017846|NCT02797782|Antibodies|antibodies|mesh-list
14017847|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
15141875|NCT04286152|Mirabegron|mirabegron|mesh-list
15141876|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15141877|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15141878|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15141879|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
15141880|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141881|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017848|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017849|NCT02797977|Gemcitabine|gemcitabine|mesh-list
15141882|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017850|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017851|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14017852|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
14017853|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017854|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
14017855|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017856|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017857|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017858|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
14017859|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273132|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14273133|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
14292468|NCT00561353|Ribavirin|ribavirin|mesh-list
14017860|NCT02797587|Nicotine|nicotine|mesh-list
14017861|NCT02797587|Varenicline|varenicline|mesh-list
15141883|NCT04286152|Urological Agents|urological agents|mesh-ancestor
15141884|NCT04285528|Lidocaine|lidocaine|mesh-list
15141885|NCT04285528|Fentanyl|fentanyl|mesh-list
15141886|NCT04285528|Ketamine|ketamine|mesh-list
15141887|NCT04285528|Propofol|propofol|mesh-list
15141888|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
15141889|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
15141890|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141891|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141892|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
14017862|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14017863|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
14017864|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017865|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017866|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14017867|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14017868|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
14017869|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141893|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141894|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15141895|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15141896|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15141897|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15141898|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141899|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141900|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15141901|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
15141902|NCT04285528|Analgesics|analgesics|mesh-ancestor
15141903|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15141904|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15141905|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15141906|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141907|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15141908|NCT04285528|Narcotics|narcotics|mesh-ancestor
14017870|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017871|NCT02797548|Aspirin|aspirin|mesh-list
14017872|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14017873|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017874|NCT02797548|Analgesics|analgesics|mesh-ancestor
14017875|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
14017876|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017877|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017878|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017879|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017880|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14017881|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14017882|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017883|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14017884|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14017885|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017886|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
14017887|NCT02797470|Cytarabine|cytarabine|mesh-list
14017888|NCT02797470|Etoposide|etoposide|mesh-list
14017889|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
14017890|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
14017891|NCT02797470|Melphalan|melphalan|mesh-list
14017892|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
14017893|NCT02797470|Carmustine|carmustine|mesh-list
14017894|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14017895|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14017896|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017897|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14017898|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14017899|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017900|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017901|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14017902|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
14017903|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
14017904|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017905|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017906|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
15141909|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14017907|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017908|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14017909|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
15141910|NCT04285450|Vitamin K|vitamin k|mesh-list
14017910|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14017911|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
14017912|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
14017913|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14017914|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14017915|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14017916|NCT02797236|Vaccines|vaccines|mesh-list
14017917|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
15141911|NCT04285450|Vitamins|vitamins|mesh-ancestor
15141912|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
15141913|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141914|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15141915|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15141916|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141917|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
14017918|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017919|NCT02797249|Aspirin|aspirin|mesh-list
14017920|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
14017921|NCT02797249|Salicylates|salicylates|mesh-list
14017922|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14017923|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017924|NCT02797249|Analgesics|analgesics|mesh-ancestor
14017925|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
14017926|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017927|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017928|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017929|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017930|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14017931|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14017932|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017933|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14017934|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14017935|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017936|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
14017937|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14017938|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
14017939|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
14017940|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
14017941|NCT02797340|Metformin|metformin|mesh-list
14017942|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14017943|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017944|NCT02797145|Digoxin|digoxin|mesh-list
14017945|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14017946|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14017947|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017948|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017949|NCT02797145|Protective Agents|protective agents|mesh-ancestor
14017950|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017951|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
14017952|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14017953|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14017954|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017955|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
14017956|NCT02797119|Coagulants|coagulants|mesh-ancestor
14017957|NCT02797067|Indomethacin|indomethacin|mesh-list
14017958|NCT02797067|Glycerol|glycerol|mesh-list
14017959|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14017960|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14017961|NCT02797067|Analgesics|analgesics|mesh-ancestor
14017962|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
14017963|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14017964|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017965|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14017966|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017967|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
14017968|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
14017969|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14017970|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14273134|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273135|NCT00427921|Adalimumab|adalimumab|mesh-list
14273136|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14273137|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15141918|NCT04285450|Coagulants|coagulants|mesh-ancestor
14017971|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017972|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017973|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14273138|NCT00427934|Maraviroc|maraviroc|mesh-list
14017974|NCT02797067|Protective Agents|protective agents|mesh-ancestor
14017975|NCT02797028|Allopurinol|allopurinol|mesh-list
14017976|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
14017977|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017978|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14017979|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
14017980|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14017981|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14017982|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
14017983|NCT02797028|Protective Agents|protective agents|mesh-ancestor
14017984|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017985|NCT02797015|Ozanimod|ozanimod|mesh-list
14017986|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14017987|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14017988|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14017989|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
14017990|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017991|NCT02797041|Bortezomib|bortezomib|mesh-list
14017992|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017993|NCT02796794|Genistein|genistein|mesh-list
14017994|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14017995|NCT02796794|Protective Agents|protective agents|mesh-ancestor
14017996|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14017997|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14017998|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14017999|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018000|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018001|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
14018002|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14018003|NCT02796794|Estrogens|estrogens|mesh-ancestor
14018004|NCT02796794|Hormones|hormones|mesh-ancestor
15141919|NCT04285281|Gabapentin|gabapentin|mesh-list
15141920|NCT04285281|Analgesics|analgesics|mesh-ancestor
15141921|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
14018005|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018006|NCT02796833|SMOFlipid|smoflipid|mesh-list
14018007|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14018008|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14018009|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14018010|NCT02796950|Acipimox|acipimox|mesh-list
14018011|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14018012|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
14018013|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141922|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141923|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141924|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
15141925|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15141926|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15141927|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141928|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15141929|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14018014|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14018015|NCT02796859|Siltuximab|siltuximab|mesh-list
14018016|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018017|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
14018018|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
14018019|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
14018020|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018021|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018022|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
14018023|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018024|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
14018025|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14018026|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018027|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018028|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15141930|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15141931|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15141932|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141933|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
15141934|NCT04285073|Paclitaxel|paclitaxel|mesh-list
15141935|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14018029|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14018030|NCT02796469|Protective Agents|protective agents|mesh-ancestor
14018031|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141936|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141937|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
15141938|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
15141939|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
14018032|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
14018033|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14018034|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
14025722|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141940|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141941|NCT04285268|Rituximab|rituximab|mesh-list
15141942|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15141943|NCT04285268|Bortezomib|bortezomib|mesh-list
15141944|NCT04285268|Venetoclax|venetoclax|mesh-list
15141945|NCT04285268|Antibodies|antibodies|mesh-list
15141946|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
15141947|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15141948|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
15141949|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141950|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141951|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15141952|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15141953|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15141954|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15141955|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
14025739|NCT02748772|Thalidomide|thalidomide|mesh-list
14025740|NCT02748772|Endostar protein|endostar protein|mesh-list
14025741|NCT02748772|Endostatins|endostatins|mesh-list
14025742|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14025743|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
14025744|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025745|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
14025746|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14025747|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025748|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14025749|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14025750|NCT02748772|Growth Substances|growth substances|mesh-ancestor
14025751|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
14025752|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025753|NCT02748564|Aldesleukin|aldesleukin|mesh-list
14025754|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
14025755|NCT02748564|Interleukin-2|interleukin-2|mesh-list
14025756|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025757|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025758|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025759|NCT02748564|Analgesics|analgesics|mesh-ancestor
14025760|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
14025761|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025762|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025763|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14025764|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14025765|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
14025766|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026302|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026303|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026304|NCT02744196|Methotrexate|methotrexate|mesh-list
14026305|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026306|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
14026307|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026308|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026309|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14026310|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
14026311|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14026312|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14026313|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
14026314|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026315|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14026316|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026317|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14026318|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026319|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14026320|NCT02744183|Benzocaine|benzocaine|mesh-list
14026321|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
14026322|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
15141956|NCT04285346|Ganaxolone|ganaxolone|mesh-list
15141957|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
14292469|NCT00561353|Simeprevir|simeprevir|mesh-list
15141958|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179406|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14018035|NCT02796378|Ubiquinone|ubiquinone|mesh-list
14018036|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
14018037|NCT02796378|Simvastatin|simvastatin|mesh-list
14018038|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14018039|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14018040|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
14018041|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018042|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14018043|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14018044|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018045|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
14018046|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018047|NCT02796378|Vitamins|vitamins|mesh-ancestor
14018048|NCT02796157|Everolimus|everolimus|mesh-list
14018049|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018050|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018051|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
14018052|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018053|NCT02796196|Coal Tar|coal tar|mesh-list
14018054|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
14018055|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14018056|NCT02796183|Bevacizumab|bevacizumab|mesh-list
14018057|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14018058|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018059|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14018060|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14018061|NCT02796183|Growth Substances|growth substances|mesh-ancestor
14018062|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018063|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
14018064|NCT02796105|Ganirelix|ganirelix|mesh-list
14018065|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
14018066|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018067|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018068|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14018069|NCT02795949|Amoxicillin|amoxicillin|mesh-list
14018070|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
14018071|NCT02795949|Meropenem|meropenem|mesh-list
14018072|NCT02795949|Tazobactam|tazobactam|mesh-list
14018073|NCT02795949|Piperacillin|piperacillin|mesh-list
14018074|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
14018075|NCT02795949|Imipenem|imipenem|mesh-list
14018076|NCT02795949|Ceftazidime|ceftazidime|mesh-list
14018077|NCT02795949|Ampicillin|ampicillin|mesh-list
14018078|NCT02795949|Ertapenem|ertapenem|mesh-list
14018079|NCT02795949|Cefepime|cefepime|mesh-list
14018080|NCT02795949|Cefuroxime|cefuroxime|mesh-list
14018081|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14018082|NCT02795949|Lactams|lactams|mesh-list
14018083|NCT02795949|Aztreonam|aztreonam|mesh-list
14018084|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14018085|NCT02795949|beta-Lactams|beta-lactams|mesh-list
14018086|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14018087|NCT02795949|Trimethoprim|trimethoprim|mesh-list
14018088|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
14018089|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018090|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
14018091|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14018092|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14018093|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018094|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018095|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018096|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15141959|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141960|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141961|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
15141962|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
15141963|NCT04284839|Warfarin|warfarin|mesh-list
15141964|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
15141965|NCT04284839|Dabigatran|dabigatran|mesh-list
15141966|NCT04284839|Apixaban|apixaban|mesh-list
15141967|NCT04284839|Edoxaban|edoxaban|mesh-list
15141968|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
14018097|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14018098|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14018099|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14018100|NCT02795949|Renal Agents|renal agents|mesh-ancestor
14018101|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
14018102|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14018103|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15141969|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14018104|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14018105|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14018106|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14018107|NCT02795884|Cisplatin|cisplatin|mesh-list
14018108|NCT02795884|Pemetrexed|pemetrexed|mesh-list
14018109|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14018110|NCT02795884|Vinorelbine|vinorelbine|mesh-list
14018111|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018112|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018113|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018114|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14018115|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14018116|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14018117|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14018118|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
14018119|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14018120|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
14018121|NCT02795572|Vitamin D|vitamin d|mesh-list
14018122|NCT02795572|Vitamins|vitamins|mesh-list
14018123|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
14018124|NCT02795572|Hydroxocobalamin|hydroxocobalamin|mesh-list
14018125|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
14018126|NCT02795572|Pyridoxal|pyridoxal|mesh-list
14018127|NCT02795572|Pyridoxine|pyridoxine|mesh-list
14018128|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
14018129|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
14018130|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018131|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14018132|NCT02795572|Hematinics|hematinics|mesh-ancestor
14018133|NCT02795754|Ritonavir|ritonavir|mesh-list
14018134|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
14018135|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14018136|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14018137|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
14018138|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018139|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018140|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14018141|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14018142|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
14018143|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018144|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14018145|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14018146|NCT02795546|Alendronate|alendronate|mesh-list
14018147|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14018148|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018149|NCT02795299|Folic Acid|folic acid|mesh-list
14018150|NCT02795299|Methotrexate|methotrexate|mesh-list
14018151|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14018152|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
14018153|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14018154|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018155|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14018156|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
14018157|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018158|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018159|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
14018160|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018161|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14018162|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018163|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
14018164|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14018165|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14018166|NCT02795299|Hematinics|hematinics|mesh-ancestor
14018167|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
14018168|NCT02795299|Vitamins|vitamins|mesh-ancestor
15141970|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
14018169|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
14018170|NCT02795143|Isotretinoin|isotretinoin|mesh-list
14018171|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14018172|NCT02795429|Spartalizumab|spartalizumab|mesh-list
14018173|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14018174|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018175|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018176|NCT02795039|Fulvestrant|fulvestrant|mesh-list
14018177|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14018178|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018179|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14018180|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14018181|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
14018182|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018183|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018184|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
14018185|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018186|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273139|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14273140|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14273141|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273142|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14273143|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14273144|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
14273145|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273146|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14273147|NCT00427960|Atorvastatin|atorvastatin|mesh-list
14273148|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14273149|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14273150|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14273151|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
14273152|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273153|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14273154|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14273155|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273156|NCT00427973|Cediranib|cediranib|mesh-list
14273157|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273158|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273159|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273160|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273161|NCT00427999|Pioglitazone|pioglitazone|mesh-list
14273162|NCT00427999|Dexamethasone|dexamethasone|mesh-list
14273163|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
14273164|NCT00427999|Etoricoxib|etoricoxib|mesh-list
14273165|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
14273166|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14273167|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
14273168|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
14273169|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273170|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273171|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14273172|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
14273173|NCT00427999|Hormones|hormones|mesh-ancestor
14273174|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273175|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14273176|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273177|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14273178|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273179|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273180|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273181|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14273182|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14273183|NCT00427999|Analgesics|analgesics|mesh-ancestor
14273184|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
14273185|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273186|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14273187|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14273188|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
14273189|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14273190|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273191|NCT00428220|Sunitinib|sunitinib|mesh-list
14273192|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273193|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273194|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273195|NCT00428220|Growth Substances|growth substances|mesh-ancestor
14273196|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273197|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273198|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273199|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273200|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273201|NCT00428298|Valacyclovir|valacyclovir|mesh-list
14273202|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
14273203|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273204|NCT00428389|Rivastigmine|rivastigmine|mesh-list
14273205|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15141971|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15141972|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
15141973|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15141974|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018187|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018188|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018189|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
15141975|NCT04284826|Mitomycins|mitomycins|mesh-list
15141976|NCT04284826|Mitomycin|mitomycin|mesh-list
15141977|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14018190|NCT02794922|Vitamins|vitamins|mesh-ancestor
14018191|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
14018192|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018193|NCT02794896|Fentanyl|fentanyl|mesh-list
14018194|NCT02794896|Propofol|propofol|mesh-list
14018195|NCT02794896|Sevoflurane|sevoflurane|mesh-list
14018196|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14018197|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018198|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018199|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14018200|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
14018201|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
14018202|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14018203|NCT02794896|Narcotics|narcotics|mesh-ancestor
14018204|NCT02794896|Analgesics|analgesics|mesh-ancestor
14018205|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
14018206|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018207|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14018208|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14018209|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14018210|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14018211|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14018212|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
14018213|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018214|NCT02795065|Enoxaparin|enoxaparin|mesh-list
14018215|NCT02795065|Bemiparin|bemiparin|mesh-list
14018216|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
14018217|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14018218|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14018219|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025767|NCT02748265|Epoprostenol|epoprostenol|mesh-list
14025768|NCT02748265|Phenylephrine|phenylephrine|mesh-list
14025769|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
14025770|NCT02748265|Tezosentan|tezosentan|mesh-list
14025771|NCT02748265|Propofol|propofol|mesh-list
14025772|NCT02748265|Sevoflurane|sevoflurane|mesh-list
14025773|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14025774|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025775|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025776|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14025777|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
14025778|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
14025779|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14025780|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14025781|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14025782|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
14025783|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
14025784|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025785|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
14025786|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14025787|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
14025788|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
14025789|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14025790|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14025791|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14025792|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
14025793|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025794|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025795|NCT02748265|Protective Agents|protective agents|mesh-ancestor
14025796|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14025797|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
14025798|NCT02748304|Aspirin|aspirin|mesh-list
14025799|NCT02748304|Sorafenib|sorafenib|mesh-list
14025800|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14025801|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025802|NCT02748304|Analgesics|analgesics|mesh-ancestor
14025803|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
14025804|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018220|NCT02794792|Metformin|metformin|mesh-list
14018221|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
14018222|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018223|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018224|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14018225|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018226|NCT02794779|Oxytocin|oxytocin|mesh-list
14018227|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
14018228|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14018229|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018230|NCT02794714|Rocuronium|rocuronium|mesh-list
14018231|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14018232|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14018233|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14018234|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018235|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018236|NCT02794571|Paclitaxel|paclitaxel|mesh-list
14018237|NCT02794571|Etoposide|etoposide|mesh-list
14018238|NCT02794571|Bevacizumab|bevacizumab|mesh-list
14018239|NCT02794571|Carboplatin|carboplatin|mesh-list
14018240|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
14018241|NCT02794571|Capecitabine|capecitabine|mesh-list
14018242|NCT02794571|Pemetrexed|pemetrexed|mesh-list
14018243|NCT02794571|Atezolizumab|atezolizumab|mesh-list
14018244|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14018245|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018246|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
14018247|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14018248|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
14018249|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018250|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14018251|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14018252|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14018253|NCT02794571|Growth Substances|growth substances|mesh-ancestor
14018254|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018255|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
14018256|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14018257|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
14018258|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14018259|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14018260|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018261|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14018262|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14018263|NCT02794610|Tacrolimus|tacrolimus|mesh-list
14018264|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018265|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
14018266|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018267|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14018268|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018269|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018270|NCT02794402|Exenatide|exenatide|mesh-list
14018271|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018272|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018273|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14018274|NCT02794402|Incretins|incretins|mesh-ancestor
14018275|NCT02794402|Hormones|hormones|mesh-ancestor
14018276|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018277|NCT02794428|Eflornithine|eflornithine|mesh-list
14018278|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018279|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14018280|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14018281|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14018282|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018283|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14018284|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018285|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018286|NCT02794506|Propolis|propolis|mesh-list
14018287|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018288|NCT02794584|Sufentanil|sufentanil|mesh-list
14018289|NCT02794584|Dsuvia|dsuvia|mesh-list
14018290|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
14273206|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018291|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811728|NCT00846625|Hormones|hormones|mesh-ancestor
14018292|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018293|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14018294|NCT02794584|Narcotics|narcotics|mesh-ancestor
14018295|NCT02794584|Analgesics|analgesics|mesh-ancestor
14018296|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
14018297|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018298|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15141978|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15141979|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
15141980|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15141981|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15141982|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018299|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14018300|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
14018301|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
14018302|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14018303|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
14018304|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018305|NCT02794389|Expectorants|expectorants|mesh-ancestor
14018306|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
14018307|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14018308|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
14018309|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018310|NCT02794389|Protective Agents|protective agents|mesh-ancestor
14018311|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018312|NCT02794389|Antidotes|antidotes|mesh-ancestor
14018313|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
14018314|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018315|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
14018316|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018317|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14018318|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14018319|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
14018320|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018321|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018322|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562134|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
14562135|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
14562136|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562137|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14562138|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14018328|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
14018329|NCT02793986|Propofol|propofol|mesh-list
14018330|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14018331|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018332|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018333|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14018334|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
14273207|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273208|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
14273209|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273210|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273211|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14273212|NCT00428389|Protective Agents|protective agents|mesh-ancestor
14273213|NCT00428441|Warfarin|warfarin|mesh-list
14273214|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
14273215|NCT00428584|Interferons|interferons|mesh-list
14273216|NCT00428584|Interferon-beta|interferon-beta|mesh-list
14273217|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
14273218|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273219|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
14273220|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273221|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
14273222|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273223|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14273224|NCT00428597|Sunitinib|sunitinib|mesh-list
15141983|NCT04284644|Propofol|propofol|mesh-list
15141984|NCT04284644|Sevoflurane|sevoflurane|mesh-list
15141985|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15141986|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15141987|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141988|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15141989|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
14273225|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814426|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273226|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273227|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273228|NCT00428597|Growth Substances|growth substances|mesh-ancestor
14273229|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018335|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
14018336|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14018337|NCT02793986|Analgesics|analgesics|mesh-ancestor
14018338|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
14018339|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018340|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14018341|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14018342|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14018343|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
14018344|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018345|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018346|NCT02794025|Esmolol|esmolol|mesh-list
14018347|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14018348|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14018349|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14018350|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
14018351|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018352|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018353|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018354|NCT02794220|Nicotine|nicotine|mesh-list
14018355|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14018356|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
14018357|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15141990|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
15141991|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15141992|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15141993|NCT04284722|Metformin|metformin|mesh-list
15141994|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15141995|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15141996|NCT04284761|Bicalutamide|bicalutamide|mesh-list
15141997|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
15141998|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
15141999|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142000|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142001|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142002|NCT04284852|Niraparib|niraparib|mesh-list
15142003|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15142004|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142005|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142006|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142007|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15142008|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15142009|NCT04284215|Paclitaxel|paclitaxel|mesh-list
15142010|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15142011|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15142012|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142013|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
15142014|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
15142015|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
15142016|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142017|NCT04284202|Dasatinib|dasatinib|mesh-list
14018358|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018359|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14018360|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14018361|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
14018362|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018363|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018364|NCT02794155|Insulin|insulin|mesh-list
14018365|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14018366|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
14018367|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018368|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018369|NCT02793843|Dexamethasone|dexamethasone|mesh-list
15142018|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018370|NCT02793843|Ondansetron|ondansetron|mesh-list
14018371|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14018372|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
14018373|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
14018374|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018375|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018376|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14018377|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
14018378|NCT02793843|Hormones|hormones|mesh-ancestor
14018379|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273230|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
14018380|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14018381|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018382|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018383|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018384|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
14018385|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
14018386|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14018387|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
14018388|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018389|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14018390|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14018391|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14018392|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14018393|NCT02793908|Progesterone|progesterone|mesh-list
14018394|NCT02793908|Progestins|progestins|mesh-ancestor
14018395|NCT02793908|Hormones|hormones|mesh-ancestor
14018396|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018397|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018398|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
14018399|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
14018400|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018401|NCT02793687|Protective Agents|protective agents|mesh-ancestor
14018402|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142019|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15142020|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142021|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179407|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14018403|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14018404|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14018405|NCT02793765|Docetaxel|docetaxel|mesh-list
14018406|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018407|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
14018408|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
14018409|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
14018410|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018411|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
14018412|NCT02793544|Sirolimus|sirolimus|mesh-list
14018413|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
14018414|NCT02793544|Busulfan|busulfan|mesh-list
14018415|NCT02793544|Fludarabine|fludarabine|mesh-list
14018416|NCT02793544|Mesna|mesna|mesh-list
14018417|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018418|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
14018419|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018420|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14018421|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14018422|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
14018423|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018424|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018425|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14018426|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14018427|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14018428|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
14018429|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14018430|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018431|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018432|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
14018433|NCT02793544|Protective Agents|protective agents|mesh-ancestor
14018434|NCT02793388|Primaquine|primaquine|mesh-list
14018435|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
14018436|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14273231|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273232|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273233|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273234|NCT00428792|Methylphenidate|methylphenidate|mesh-list
14273235|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14273236|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018437|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14018438|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018439|NCT02793648|Vitamins|vitamins|mesh-list
14273237|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14273238|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15179408|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018440|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
14018441|NCT02793648|Vitamin E|vitamin e|mesh-list
14018442|NCT02793648|Tocopherols|tocopherols|mesh-list
14018443|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
14018444|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
14018445|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018446|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
14018447|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018448|NCT02793648|Protective Agents|protective agents|mesh-ancestor
14018449|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
14018450|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14018451|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
14018452|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018453|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
14018454|NCT02793739|Protective Agents|protective agents|mesh-ancestor
14018455|NCT02793323|Anesthetics|anesthetics|mesh-list
14018456|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018457|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018458|NCT02793375|Montelukast|montelukast|mesh-list
14018459|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14018460|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
14018461|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14018462|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
14018463|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018464|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018465|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14018466|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14018467|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018468|NCT02793440|Cortivazol|cortivazol|mesh-list
14018469|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14018470|NCT02793505|Metformin|metformin|mesh-list
14018471|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018472|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018473|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14018474|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14018475|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018476|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
14018477|NCT02793466|Durvalumab|durvalumab|mesh-list
14018478|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14018479|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14018480|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018481|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
14018482|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025805|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025806|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025807|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025808|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14025809|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14025810|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142022|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
15142023|NCT04284098|Bupivacaine|bupivacaine|mesh-list
15142024|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025811|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14025812|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14025813|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025814|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
14025815|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025816|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14025817|NCT02748395|Triamcinolone|triamcinolone|mesh-list
14025818|NCT02748395|Lidocaine|lidocaine|mesh-list
14025819|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
14025820|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
14025821|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025822|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025823|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
14025824|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025825|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14025826|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14025827|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14025828|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025829|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025830|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025831|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
14025832|NCT02748395|Hormones|hormones|mesh-ancestor
14025833|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14025834|NCT02748330|Aspirin|aspirin|mesh-list
15142025|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
14018483|NCT02793219|Docetaxel|docetaxel|mesh-list
14018484|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018485|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
14018486|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
14018487|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
14018488|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018489|NCT02793050|Trabectedin|trabectedin|mesh-list
14018490|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273239|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273240|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273241|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
14273242|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273243|NCT00428844|Vancomycin|vancomycin|mesh-list
14273244|NCT00428844|Daptomycin|daptomycin|mesh-list
14273245|NCT00428844|Teicoplanin|teicoplanin|mesh-list
14273246|NCT00428844|Floxacillin|floxacillin|mesh-list
14273247|NCT00428844|Oxacillin|oxacillin|mesh-list
14273248|NCT00428844|Nafcillin|nafcillin|mesh-list
14273249|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14273250|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273251|NCT00428922|Bevacizumab|bevacizumab|mesh-list
14273252|NCT00428922|Trastuzumab|trastuzumab|mesh-list
14273253|NCT00428922|Docetaxel|docetaxel|mesh-list
14273254|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273255|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273256|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273257|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273258|NCT00428922|Growth Substances|growth substances|mesh-ancestor
14273259|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273260|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273261|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273262|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273263|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273264|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273265|NCT00428948|Tolvaptan|tolvaptan|mesh-list
14273266|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14273267|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273268|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
14273269|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273270|NCT00429104|Trastuzumab|trastuzumab|mesh-list
14273271|NCT00429104|Sargramostim|sargramostim|mesh-list
14273272|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273273|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273274|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
14273275|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142026|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142027|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142028|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
15142029|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142030|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15142031|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142032|NCT04284098|Analgesics|analgesics|mesh-ancestor
15142033|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14273276|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
14273277|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
14273278|NCT00429143|Tacrolimus|tacrolimus|mesh-list
14273279|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273280|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
14273281|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273282|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273283|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273284|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
14273285|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273286|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273287|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273288|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14273289|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273290|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14273291|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14273292|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
14273293|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14273294|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273295|NCT00429169|Bupropion|bupropion|mesh-list
14273296|NCT00429169|Paroxetine|paroxetine|mesh-list
14273297|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14273298|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
14018491|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
14018492|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018493|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018494|NCT02793011|Dexamethasone|dexamethasone|mesh-list
14018495|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14018496|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
14018497|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
14018498|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018499|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018500|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14018501|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
14018502|NCT02793011|Hormones|hormones|mesh-ancestor
14018503|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018504|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14018505|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018506|NCT02792816|Artesunate|artesunate|mesh-list
14018507|NCT02792816|Artemether|artemether|mesh-list
14018508|NCT02792816|Piperaquine|piperaquine|mesh-list
14018509|NCT02792816|Artenimol|artenimol|mesh-list
14018510|NCT02792816|Mefloquine|mefloquine|mesh-list
14018511|NCT02792816|Antimalarials|antimalarials|mesh-list
14018512|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14018513|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14018514|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018515|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018516|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
14018517|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
14018518|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14018519|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
14018520|NCT02792712|Clopidogrel|clopidogrel|mesh-list
14018521|NCT02792712|Ticagrelor|ticagrelor|mesh-list
14018522|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14018523|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14018524|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14018525|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14018526|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
14018527|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018528|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018529|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018530|NCT02792491|Prednisone|prednisone|mesh-list
14018531|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
14018532|NCT02792491|Rituximab|rituximab|mesh-list
14018533|NCT02792491|Doxorubicin|doxorubicin|mesh-list
14018534|NCT02792491|Vincristine|vincristine|mesh-list
14018535|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018536|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
14018537|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018538|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14018539|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14018540|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
14018541|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018542|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018543|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14018544|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14018545|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14018546|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14018547|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14018548|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018549|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14018550|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
14018551|NCT02792491|Hormones|hormones|mesh-ancestor
14018552|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018553|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14018554|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14018555|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
14018556|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
14018557|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
14018558|NCT02792803|Latanoprost|latanoprost|mesh-list
14018559|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14018560|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14018561|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
14018562|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14018563|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
14018564|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018565|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
14018566|NCT02792673|Protective Agents|protective agents|mesh-ancestor
14018567|NCT02792621|Acipimox|acipimox|mesh-list
14018568|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14018569|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
14018570|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018571|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14018572|NCT02792426|Nicotine|nicotine|mesh-list
14018573|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14018574|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
14018575|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018576|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018577|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14018578|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14018579|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
14018580|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018581|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018582|NCT02792465|Fulvestrant|fulvestrant|mesh-list
14018583|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14018584|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018585|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14018586|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14018587|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
14018588|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018589|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018590|NCT02792400|Empagliflozin|empagliflozin|mesh-list
14018591|NCT02792400|Linagliptin|linagliptin|mesh-list
14018592|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14018593|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018594|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018595|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018596|NCT02792400|Incretins|incretins|mesh-ancestor
14018597|NCT02792400|Hormones|hormones|mesh-ancestor
14018598|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018599|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14018600|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
14018601|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018602|NCT02792335|Warfarin|warfarin|mesh-list
14018603|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
14018604|NCT02792335|Dabigatran|dabigatran|mesh-list
14018605|NCT02792335|Apixaban|apixaban|mesh-list
14018606|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
14018607|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14018608|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
15142034|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15142035|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15142036|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
15142037|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142038|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142039|NCT04284150|Midazolam|midazolam|mesh-list
14018609|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14018610|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
14018611|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018612|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018613|NCT02792088|Tenofovir|tenofovir|mesh-list
14018614|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
14018615|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018616|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14018617|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14018618|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018619|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018620|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14018621|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14018622|NCT02792036|Carboplatin|carboplatin|mesh-list
14018623|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018624|NCT02792153|Estradiol|estradiol|mesh-list
14018625|NCT02792153|Estrogens|estrogens|mesh-ancestor
14018626|NCT02792153|Hormones|hormones|mesh-ancestor
14018627|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018628|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018629|NCT02792257|Dronabinol|dronabinol|mesh-list
14018630|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
14018631|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018632|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14018633|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142040|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
15179409|NCT03950544|Meropenem|meropenem|mesh-list
14018634|NCT02792257|Analgesics|analgesics|mesh-ancestor
14273299|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142041|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15142042|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142043|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142044|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142045|NCT04284150|Analgesics|analgesics|mesh-ancestor
15142046|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
15142047|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142048|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15142049|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14018635|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
15142050|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15142051|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
15142052|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142053|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142054|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15142055|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14018636|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018637|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14018638|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14018639|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018640|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142056|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15142057|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142058|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142059|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
15142060|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
15142061|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
15142062|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
15142063|NCT04284059|Vitamin D|vitamin d|mesh-list
15142064|NCT04284059|Vitamins|vitamins|mesh-list
15142065|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
15142066|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018641|NCT02792257|Hormones|hormones|mesh-ancestor
14018642|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018643|NCT02791958|Ramipril|ramipril|mesh-list
14018644|NCT02791958|Atorvastatin|atorvastatin|mesh-list
14018645|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14018646|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14018647|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
14018648|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018649|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14018650|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14018651|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018652|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14018653|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
14018654|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14018655|NCT02792140|Naltrexone|naltrexone|mesh-list
14018656|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14018657|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14018658|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018659|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
14018660|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018661|NCT02791919|Cytarabine|cytarabine|mesh-list
14018662|NCT02791919|Fludarabine|fludarabine|mesh-list
14018663|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
14018664|NCT02791919|Lenograstim|lenograstim|mesh-list
14018665|NCT02791919|Sargramostim|sargramostim|mesh-list
14018666|NCT02791919|Adavosertib|adavosertib|mesh-list
14018667|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273300|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14273301|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14273302|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273303|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273304|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
14273305|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273306|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273307|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14273308|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14273309|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273310|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14273311|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
14273312|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
14273313|NCT00429182|Thiotepa|thiotepa|mesh-list
15142067|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15142068|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
14018668|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14018669|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
14018670|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018671|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018672|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
14018673|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018674|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
14018675|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018676|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14018677|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018678|NCT02791737|Coal Tar|coal tar|mesh-list
14018679|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
14018680|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
15142069|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15142070|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142071|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142072|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
15142073|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142074|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142075|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
15142076|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14018681|NCT02791815|Selexipag|selexipag|mesh-list
14018682|NCT02791815|Midazolam|midazolam|mesh-list
14018683|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14018684|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14018685|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018686|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018687|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14018688|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14018689|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14018690|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14018691|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
14018692|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
14018693|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
15142077|NCT04283747|Antibodies|antibodies|mesh-list
15142078|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
15142079|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142080|NCT04284007|Dexamethasone|dexamethasone|mesh-list
15142081|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
14018694|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
14018695|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018696|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018697|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14025835|NCT02748330|Clopidogrel|clopidogrel|mesh-list
14025836|NCT02748330|Ticagrelor|ticagrelor|mesh-list
14025837|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14025838|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025839|NCT02748330|Analgesics|analgesics|mesh-ancestor
14025840|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
15142082|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
15142083|NCT04284007|BB 1101|bb 1101|mesh-list
15142084|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142085|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
15142086|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
15142087|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142088|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142089|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142090|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
15142091|NCT04284007|Hormones|hormones|mesh-ancestor
15142092|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142093|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15142094|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142095|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14025841|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025842|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025843|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025844|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025845|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14025846|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14025847|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025848|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14025849|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14025850|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142096|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025851|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
14025852|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15142097|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142098|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
15142099|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
15142100|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142101|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
15142102|NCT04283877|Methylphenidate|methylphenidate|mesh-list
15142103|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15142104|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142105|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15142106|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15142107|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142108|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018698|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
14018699|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14018700|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018701|NCT02791243|Finasteride|finasteride|mesh-list
14018702|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14018703|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14018704|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018705|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018706|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
14018707|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018708|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018709|NCT02791243|Urological Agents|urological agents|mesh-ancestor
14018710|NCT02791334|Ramucirumab|ramucirumab|mesh-list
14018711|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273314|NCT00429182|Carboplatin|carboplatin|mesh-list
14273315|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273316|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
14273317|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273318|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273319|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273320|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
14273321|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273322|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273323|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273324|NCT00429273|Guanfacine|guanfacine|mesh-list
14273325|NCT00429273|Methylphenidate|methylphenidate|mesh-list
14273326|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14273327|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15142109|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
15142110|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142111|NCT04283630|Ascorbic Acid|ascorbic acid|mesh-list
15142112|NCT04283630|Vitamins|vitamins|mesh-ancestor
15142113|NCT04283630|Micronutrients|micronutrients|mesh-ancestor
15142114|NCT04283630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142115|NCT04283630|Antioxidants|antioxidants|mesh-ancestor
15142116|NCT04283630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142117|NCT04283630|Protective Agents|protective agents|mesh-ancestor
15142118|NCT04283604|Methylphenidate|methylphenidate|mesh-list
15142119|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15142120|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142121|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15142122|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15142123|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142124|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142125|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
14273328|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273329|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14273330|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14273331|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273332|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273333|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
14273334|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273335|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14273336|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14273337|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14273338|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14273339|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
14273340|NCT00429299|Paclitaxel|paclitaxel|mesh-list
14273341|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
14273342|NCT00429299|Fluorouracil|fluorouracil|mesh-list
14018712|NCT02791373|Gemcitabine|gemcitabine|mesh-list
14018713|NCT02791373|Vinorelbine|vinorelbine|mesh-list
14018714|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14018715|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
14018716|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018717|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018718|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
14018719|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018720|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018721|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018722|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
14018723|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018724|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14018725|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
14018726|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
14018727|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
14018728|NCT02791256|Ribavirin|ribavirin|mesh-list
15142126|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142127|NCT04283487|Levan|levan|mesh-list
15142128|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142129|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
15142130|NCT04283331|Propoxycaine|propoxycaine|mesh-list
15142131|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
15142132|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
15142133|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142134|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142135|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
15142136|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018729|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14018730|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
15142137|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
15142138|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15142139|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15142140|NCT04283435|Estradiol|estradiol|mesh-list
15142141|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14018731|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018732|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
14018733|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018734|NCT02790853|Proflavine|proflavine|mesh-list
14018735|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14018736|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018737|NCT02790957|Plerixafor|plerixafor|mesh-list
14018738|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14018739|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14018740|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
14018741|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018742|NCT02790996|Vancomycin|vancomycin|mesh-list
14018743|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14018744|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018745|NCT02790775|Bevacizumab|bevacizumab|mesh-list
14018746|NCT02790775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14018747|NCT02790775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018748|NCT02790775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14018749|NCT02790775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14018750|NCT02790775|Growth Substances|growth substances|mesh-ancestor
14018751|NCT02790775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018752|NCT02790775|Growth Inhibitors|growth inhibitors|mesh-ancestor
14018753|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
14018754|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14018755|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018756|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018757|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018758|NCT02790840|Omeprazole|omeprazole|mesh-list
15142142|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018759|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14018760|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14018761|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14018762|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018763|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018764|NCT02790710|Propranolol|propranolol|mesh-list
14018765|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14018766|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14018767|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
14018768|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018769|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142143|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018770|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018771|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14018772|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14018773|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
14018774|NCT02790684|Firuglipel|firuglipel|mesh-list
14018775|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018776|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018777|NCT02790671|Firuglipel|firuglipel|mesh-list
14018778|NCT02790671|Itraconazole|itraconazole|mesh-list
14018779|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
14018780|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018781|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14018782|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14018783|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018784|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018785|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14018786|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
14018787|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018788|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018789|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14018790|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14018791|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
14018792|NCT02790580|Doxorubicin|doxorubicin|mesh-list
14018793|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14018794|NCT02790580|Sunitinib|sunitinib|mesh-list
14018795|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14018796|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
14018797|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018798|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14018799|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14018800|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
14018801|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018802|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018803|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14018804|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14018805|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14018806|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14018807|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018808|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14018809|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14018810|NCT02790580|Growth Substances|growth substances|mesh-ancestor
14018811|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
14018812|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14018813|NCT02790450|Benzbromarone|benzbromarone|mesh-list
14018814|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
14018815|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
14018816|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14018817|NCT02790450|Renal Agents|renal agents|mesh-ancestor
14018818|NCT02790632|Nimodipine|nimodipine|mesh-list
14018819|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14018820|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14018821|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14018822|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018823|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14018824|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018825|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
14018826|NCT02790528|Atorvastatin|atorvastatin|mesh-list
14018827|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14018828|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14018829|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
14018830|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018831|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14018832|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14018833|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018834|NCT02790099|Morphine|morphine|mesh-list
14018835|NCT02790099|Bupivacaine|bupivacaine|mesh-list
14018836|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
14018837|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
14018838|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018839|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018840|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
14018841|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018842|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14018843|NCT02790099|Narcotics|narcotics|mesh-ancestor
14018844|NCT02790099|Analgesics|analgesics|mesh-ancestor
14018845|NCT02790203|Celecoxib|celecoxib|mesh-list
14018846|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14018847|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14018848|NCT02790203|Analgesics|analgesics|mesh-ancestor
14018849|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
14018850|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018851|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018852|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14273343|NCT00429299|Trastuzumab|trastuzumab|mesh-list
14273344|NCT00429299|Lapatinib|lapatinib|mesh-list
14273345|NCT00429299|Epirubicin|epirubicin|mesh-list
14273346|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273347|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273348|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273349|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273350|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273351|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273352|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142144|NCT04283435|Estrogens|estrogens|mesh-ancestor
15142145|NCT04283435|Hormones|hormones|mesh-ancestor
15142146|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142147|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15142148|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
15142149|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15142150|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15142151|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
15142152|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15142153|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15142154|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142155|NCT04283435|Urological Agents|urological agents|mesh-ancestor
15142156|NCT04283292|Capsaicin|capsaicin|mesh-list
15142157|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
15142158|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
14273353|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
14273354|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273355|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273356|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273357|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
14273358|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273359|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
14273360|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14273361|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273362|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273363|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142159|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
15142160|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142161|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142162|NCT04283526|Decitabine|decitabine|mesh-list
14273364|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14273365|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14273366|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14273367|NCT00429364|Losartan|losartan|mesh-list
14273368|NCT00429364|Atenolol|atenolol|mesh-list
14273369|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14273370|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14273371|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14273372|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14273373|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273374|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
14273375|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
14273376|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273377|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142163|NCT04283526|Spartalizumab|spartalizumab|mesh-list
15142164|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15142165|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
15142166|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142167|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142168|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142169|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15142170|NCT04283513|Ribavirin|ribavirin|mesh-list
15142171|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
15142172|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142173|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
14018853|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15142174|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142175|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
15142176|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
15142177|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15142178|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15142179|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142180|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142181|NCT04283240|Urological Agents|urological agents|mesh-ancestor
15142182|NCT04282902|Pirfenidone|pirfenidone|mesh-list
15142183|NCT04282902|Analgesics|analgesics|mesh-ancestor
15142184|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
15142185|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142186|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142187|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15142188|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142189|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142190|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15142191|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142192|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
15142193|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
15142194|NCT04283162|Calcium|calcium|mesh-list
15142195|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15142196|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142197|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15142198|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
15142199|NCT04283162|Coagulants|coagulants|mesh-ancestor
15142200|NCT04282824|Edetic Acid|edetic acid|mesh-list
14018854|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14018855|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14018856|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018857|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018858|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
14018859|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14018860|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
14018861|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018862|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
14018863|NCT02790177|Protective Agents|protective agents|mesh-ancestor
14018864|NCT02790164|Rocuronium|rocuronium|mesh-list
14018865|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14018866|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14018867|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14018868|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018869|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025853|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14025854|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14025855|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
14025856|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025857|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14025858|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
14025859|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025860|NCT02747953|Afatinib|afatinib|mesh-list
14025861|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025862|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14025863|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025864|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025865|NCT02747940|Pregabalin|pregabalin|mesh-list
14025866|NCT02747940|Flunarizine|flunarizine|mesh-list
14025867|NCT02747940|Analgesics|analgesics|mesh-ancestor
14025868|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
14025869|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025870|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025871|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
14025872|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14025873|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025874|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025875|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14025876|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14025877|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14025878|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025879|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14025880|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15142201|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15142202|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
14025881|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
15142203|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
15142204|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142205|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
15142206|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14018870|NCT02789969|Fentanyl|fentanyl|mesh-list
14018871|NCT02789969|Hydromorphone|hydromorphone|mesh-list
14018872|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14018873|NCT02789969|Narcotics|narcotics|mesh-ancestor
14018874|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018875|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018876|NCT02789969|Analgesics|analgesics|mesh-ancestor
14018877|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
14018878|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018879|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14018880|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14018881|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
14018882|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
15142207|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15142208|NCT04283058|Ketamine|ketamine|mesh-list
15142209|NCT04283058|Anesthetics|anesthetics|mesh-list
15142210|NCT04283058|Analgesics|analgesics|mesh-ancestor
15142211|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
15142212|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142213|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142214|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14018883|NCT02789982|Propranolol|propranolol|mesh-list
14018884|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
14018885|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14018886|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14018887|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018888|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018889|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018890|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14018891|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14018892|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
14018893|NCT02789878|Prednisone|prednisone|mesh-list
14018894|NCT02789878|Goserelin|goserelin|mesh-list
14018895|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14018896|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
14018897|NCT02789878|Hormones|hormones|mesh-ancestor
14018898|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14018899|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018900|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14018901|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018902|NCT02789865|Metronidazole|metronidazole|mesh-list
14018903|NCT02789865|Levofloxacin|levofloxacin|mesh-list
14018904|NCT02789865|Ofloxacin|ofloxacin|mesh-list
14018905|NCT02789865|Ertapenem|ertapenem|mesh-list
14018906|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018907|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14018908|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14018909|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14018910|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14018911|NCT02789865|Renal Agents|renal agents|mesh-ancestor
14018912|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14018913|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14018914|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018915|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018916|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142215|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142216|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
14018917|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14018918|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14018919|NCT02789930|Anesthetics|anesthetics|mesh-list
14018920|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018921|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018922|NCT02789813|Valproic Acid|valproic acid|mesh-list
14018923|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
14018924|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018925|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018926|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
14018927|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018928|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018929|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
14018930|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14025882|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
15142217|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018931|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018932|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142218|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15142219|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15142220|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142221|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142222|NCT04282954|Esomeprazole|esomeprazole|mesh-list
15142223|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15142224|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142225|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15142226|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142227|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018944|NCT02789592|Clonazepam|clonazepam|mesh-list
14018945|NCT02789592|Melatonin|melatonin|mesh-list
14018946|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
14018947|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018948|NCT02789592|Protective Agents|protective agents|mesh-ancestor
14018949|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018950|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14018951|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
14018952|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
14018953|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
14018954|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018955|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14018956|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14018957|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14018958|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14018959|NCT02789579|Levofloxacin|levofloxacin|mesh-list
14018960|NCT02789579|Ofloxacin|ofloxacin|mesh-list
14018961|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
14018962|NCT02789579|Cefuroxime|cefuroxime|mesh-list
14018963|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
14018964|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14018965|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14018966|NCT02789579|Renal Agents|renal agents|mesh-ancestor
14018967|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14018968|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14018969|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14018970|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14018971|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018972|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14018973|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14018974|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14018975|NCT02789150|Norepinephrine|norepinephrine|mesh-list
14018976|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14018977|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14018978|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
14018979|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018980|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018981|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018982|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
14018983|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
14018984|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018985|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14018986|NCT02789358|Adenosine|adenosine|mesh-list
14018987|NCT02789358|Analgesics|analgesics|mesh-ancestor
14018988|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
14018989|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14018990|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14018991|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14018992|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
14018993|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14018994|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
14018995|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
14018996|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14018997|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14018998|NCT02789475|Amlodipine|amlodipine|mesh-list
14018999|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14273378|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14273379|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14273380|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14273381|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
14273382|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019000|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14019001|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14019002|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019003|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019004|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14019005|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019006|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
14019007|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14019008|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14019009|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
14019010|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14019011|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14019012|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019013|NCT02789332|Paclitaxel|paclitaxel|mesh-list
14019014|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14019015|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
14019016|NCT02789332|Carboplatin|carboplatin|mesh-list
14019017|NCT02789332|Epirubicin|epirubicin|mesh-list
14019018|NCT02789332|Olaparib|olaparib|mesh-list
14019019|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14019020|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019021|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14019022|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14019023|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14019024|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019025|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019026|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
14019027|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019028|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019029|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14019030|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
14019031|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14019032|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14019033|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14019034|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14019035|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019036|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14019037|NCT02789397|Rituximab|rituximab|mesh-list
15142228|NCT04282941|Ibuprofen|ibuprofen|mesh-list
15142229|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15142230|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142231|NCT04282941|Analgesics|analgesics|mesh-ancestor
15142232|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
15142233|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142234|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142235|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142236|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15142237|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15142238|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142239|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142240|NCT04283110|Midazolam|midazolam|mesh-list
15142241|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15142242|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15142243|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142244|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142245|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15142246|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15142247|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142248|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142249|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
15142250|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
15142251|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
15142252|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
14019038|NCT02789397|Azathioprine|azathioprine|mesh-list
14019039|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14019040|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019041|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
14019042|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019043|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019044|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
14019045|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019046|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15142253|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142254|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142255|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15142256|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142257|NCT04282746|Ketamine|ketamine|mesh-list
15142258|NCT04282746|Analgesics|analgesics|mesh-ancestor
15142259|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
15142260|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142261|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142262|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15142263|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142264|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
15142265|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
15142266|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142267|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15142268|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15142269|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142270|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179410|NCT03950544|Fosfomycin|fosfomycin|mesh-list
15179411|NCT03950544|Tigecycline|tigecycline|mesh-list
15179412|NCT03950544|Polymyxins|polymyxins|mesh-list
15179413|NCT03950544|Polymyxin B|polymyxin b|mesh-list
15179414|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15179415|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179416|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15179417|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179418|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179419|NCT03950141|Apatinib|apatinib|mesh-list
15179420|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273383|NCT00429403|Goserelin|goserelin|mesh-list
14273384|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15179421|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15179422|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179423|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179424|NCT03950362|Avelumab|avelumab|mesh-list
15179425|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179426|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179427|NCT03950154|Bevacizumab|bevacizumab|mesh-list
15179428|NCT03950154|Capecitabine|capecitabine|mesh-list
15179429|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
15179430|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179431|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179432|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15179433|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15179434|NCT03950154|Growth Substances|growth substances|mesh-ancestor
15179435|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179436|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
15179437|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14019047|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019048|NCT02789566|Primaquine|primaquine|mesh-list
14019049|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
14019050|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14019051|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14019052|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019053|NCT02789202|Fluorides|fluorides|mesh-list
14019054|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
14019055|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
14019056|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
14019057|NCT02789202|Protective Agents|protective agents|mesh-ancestor
14019058|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019059|NCT02789189|Gemcitabine|gemcitabine|mesh-list
14019060|NCT02789189|Nedaplatin|nedaplatin|mesh-list
14019061|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14019062|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
14019063|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019064|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019065|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
14019066|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019067|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019068|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019069|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
14019070|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019071|NCT02788864|Piperaquine|piperaquine|mesh-list
14019072|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
14019073|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14019074|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14019075|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179438|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
15179439|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019076|NCT02788851|Guanfacine|guanfacine|mesh-list
14019077|NCT02788851|Methylphenidate|methylphenidate|mesh-list
14019078|NCT02788851|Amphetamine|amphetamine|mesh-list
14019079|NCT02788851|Adderall|adderall|mesh-list
14019080|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
14019081|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14273385|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273386|NCT00429416|Cytarabine|cytarabine|mesh-list
14273387|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
14273388|NCT00429416|Fludarabine|fludarabine|mesh-list
14273389|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
14273390|NCT00429416|Molgramostim|molgramostim|mesh-list
14273391|NCT00429416|Tacrolimus|tacrolimus|mesh-list
14273392|NCT00429416|Sargramostim|sargramostim|mesh-list
14273393|NCT00429416|Mesna|mesna|mesh-list
14273394|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273395|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
14273396|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273397|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273398|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15142271|NCT04282291|Morphine|morphine|mesh-list
15142272|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15142273|NCT04282291|Narcotics|narcotics|mesh-ancestor
14273399|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
14273400|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273401|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273402|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273403|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14273404|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
14273405|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
14273406|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273407|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14273408|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273409|NCT00429416|Protective Agents|protective agents|mesh-ancestor
14273410|NCT00429494|Leuprolide|leuprolide|mesh-list
14273411|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14273412|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
14273413|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14273414|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273415|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14273416|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273417|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14273418|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14273419|NCT00429507|Analgesics|analgesics|mesh-ancestor
14273420|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
14273421|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273422|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273423|NCT00429572|Fludarabine|fludarabine|mesh-list
14273424|NCT00429572|Melphalan|melphalan|mesh-list
14273425|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273426|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273427|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142274|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142275|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142276|NCT04282291|Analgesics|analgesics|mesh-ancestor
15142277|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
15142278|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273428|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
14273429|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273430|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273431|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
14273432|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273433|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
14273434|NCT00429702|Promethazine|promethazine|mesh-list
14273435|NCT00429702|Dexamethasone|dexamethasone|mesh-list
14273436|NCT00429702|Lorazepam|lorazepam|mesh-list
14273437|NCT00429702|Ondansetron|ondansetron|mesh-list
14273438|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14273439|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
14273440|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
14273441|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273442|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273443|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14273444|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
14273445|NCT00429702|Hormones|hormones|mesh-ancestor
15142279|NCT04282200|Ketorolac|ketorolac|mesh-list
14019082|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14019083|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019084|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14019085|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14019086|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019087|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019088|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
14019089|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019090|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
14019091|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
14019092|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019093|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019094|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14019095|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14019096|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14019097|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14019098|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14019099|NCT02788877|Aflibercept|aflibercept|mesh-list
14019100|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14019101|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14019102|NCT02788877|Growth Substances|growth substances|mesh-ancestor
15142280|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15142281|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142282|NCT04282200|Analgesics|analgesics|mesh-ancestor
15142283|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
15142284|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142285|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142286|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019103|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019104|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
14019105|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019106|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
14019107|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14019108|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
14019109|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14019110|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019111|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
14019112|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
14019113|NCT02788552|Vitamins|vitamins|mesh-list
14019114|NCT02788552|Thiamine|thiamine|mesh-list
14019115|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
14019116|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142287|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15142288|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15142289|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019117|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
14019118|NCT02788305|Misoprostol|misoprostol|mesh-list
14019119|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14019120|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
14019121|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15142290|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142291|NCT04282096|Caseins|caseins|mesh-list
15142292|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
15142293|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
15142294|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142295|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
15142296|NCT04282174|Melphalan|melphalan|mesh-list
15142297|NCT04282174|Busulfan|busulfan|mesh-list
15142298|NCT04282174|Thiotepa|thiotepa|mesh-list
15142299|NCT04282174|Fludarabine|fludarabine|mesh-list
15142300|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142301|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
15142302|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019122|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019123|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14019124|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019125|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
14025883|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025884|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
14025885|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14025886|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025887|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14025888|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
14025889|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025890|NCT02747823|Bevacizumab|bevacizumab|mesh-list
14025891|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15142303|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025892|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025893|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15142304|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14292470|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
14019126|NCT02788240|Meropenem|meropenem|mesh-list
14019127|NCT02788240|Terlipressin|terlipressin|mesh-list
14019128|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14019129|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019130|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14019131|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14019132|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
14019133|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14019134|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
14019135|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019136|NCT02788292|Expectorants|expectorants|mesh-ancestor
14019137|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
14019138|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14019139|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
14019140|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019141|NCT02788292|Protective Agents|protective agents|mesh-ancestor
14019142|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019143|NCT02788292|Antidotes|antidotes|mesh-ancestor
14019144|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14019145|NCT02787824|Hematinics|hematinics|mesh-ancestor
14019146|NCT02787967|Beclomethasone|beclomethasone|mesh-list
14019147|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
14019148|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14019149|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
14019150|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019151|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019152|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14019153|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
14019154|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14019155|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14019156|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14019157|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019158|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019159|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019160|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019161|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
14019162|NCT02787967|Hormones|hormones|mesh-ancestor
14019163|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14019164|NCT02787928|Hydromorphone|hydromorphone|mesh-list
14019165|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14019166|NCT02787928|Narcotics|narcotics|mesh-ancestor
14019167|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019168|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019169|NCT02787928|Analgesics|analgesics|mesh-ancestor
14019170|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
14019171|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019172|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14019173|NCT02788123|Pantoprazole|pantoprazole|mesh-list
14019174|NCT02788123|Bismuth|bismuth|mesh-list
14019175|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14019176|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019177|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14019178|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019179|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019180|NCT02788123|Antacids|antacids|mesh-ancestor
14019181|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019182|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14019183|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14019184|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019185|NCT02788058|Gefitinib|gefitinib|mesh-list
14019186|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019187|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14019188|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019189|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019190|NCT02787642|Olaparib|olaparib|mesh-list
14019191|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14019192|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019193|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019194|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019195|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14019196|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019197|NCT02787746|Donepezil|donepezil|mesh-list
14019198|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14019199|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019200|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019201|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
14019202|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019203|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019204|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
14019205|NCT02787798|Valsartan|valsartan|mesh-list
14019206|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14019207|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14019208|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14019209|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14019210|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019211|NCT02787473|Docetaxel|docetaxel|mesh-list
15142305|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
15142306|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142307|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142308|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15142309|NCT04281862|Prednisolone|prednisolone|mesh-list
15142310|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142311|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
15142312|NCT04281862|Hormones|hormones|mesh-ancestor
15142313|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142314|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142315|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14019212|NCT02787473|Pemetrexed|pemetrexed|mesh-list
14019213|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019214|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
14019215|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
14019216|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
14019217|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019218|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019219|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14019220|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14019221|NCT02787447|Gefitinib|gefitinib|mesh-list
14019222|NCT02787447|Thymalfasin|thymalfasin|mesh-list
14019223|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019224|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14019225|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019226|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019227|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14019228|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
14019229|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019230|NCT02787369|Idelalisib|idelalisib|mesh-list
14019231|NCT02787369|Ricolinostat|ricolinostat|mesh-list
14019232|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019233|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019234|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019235|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15142316|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142317|NCT04282031|Letrozole|letrozole|mesh-list
15142318|NCT04282031|Fulvestrant|fulvestrant|mesh-list
15142319|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142320|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15142321|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15142322|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142323|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142324|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15142325|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
15142326|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142327|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142328|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15142329|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15142330|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
15142331|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15142332|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15142333|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15142334|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142335|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142336|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
14019236|NCT02787317|Heparin|heparin|mesh-list
14019237|NCT02787317|Bivalirudin|bivalirudin|mesh-list
14019238|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
14019239|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14019240|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14019241|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019242|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
14019243|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14019244|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
14019245|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019246|NCT02787356|Lidocaine|lidocaine|mesh-list
14019247|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019248|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
14019249|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019250|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019251|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
14019252|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019253|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14019254|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14019255|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14019256|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019257|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019258|NCT02787239|Rituximab|rituximab|mesh-list
14019259|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14019260|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019261|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
14019262|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019263|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019264|NCT02787278|Otaplimastat|otaplimastat|mesh-list
14273446|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273447|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14273448|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273449|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273450|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
14273451|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
14273452|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14273453|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
14273454|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273455|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14273456|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14273457|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14273458|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14273459|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14273460|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14273461|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14273462|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
14273463|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
14273464|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
14273465|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14273466|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
14273467|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
14273468|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14273469|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
14273470|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
14273471|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
14273472|NCT00429793|Sirolimus|sirolimus|mesh-list
14273473|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14273474|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273475|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14273476|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273477|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
14273478|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273479|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
14273480|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273481|NCT00429949|Dasatinib|dasatinib|mesh-list
14273482|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273483|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273484|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273485|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273486|NCT00430183|Docetaxel|docetaxel|mesh-list
14273487|NCT00430183|Leuprolide|leuprolide|mesh-list
14273488|NCT00430183|Goserelin|goserelin|mesh-list
14273489|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273490|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273491|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273492|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273493|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273494|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14273495|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
14273496|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14273497|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273498|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14273499|NCT00430248|Allopurinol|allopurinol|mesh-list
15142337|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142338|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142339|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15142340|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019265|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14019266|NCT02787278|Protective Agents|protective agents|mesh-ancestor
14019267|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019268|NCT02786979|Aspirin|aspirin|mesh-list
14019269|NCT02786979|Beraprost|beraprost|mesh-list
14019270|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14019271|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019272|NCT02786979|Analgesics|analgesics|mesh-ancestor
14019273|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
14019274|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019275|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019276|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019277|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019278|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14019279|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14019280|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019281|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14019282|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14019283|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019284|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
14019285|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
14019286|NCT02787226|Bupivacaine|bupivacaine|mesh-list
14019287|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019288|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
14019289|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019290|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019291|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
14019292|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019293|NCT02787018|Dexamethasone|dexamethasone|mesh-list
14019294|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
14019295|NCT02787018|Ropivacaine|ropivacaine|mesh-list
14019296|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019297|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
14019298|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
14019299|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019300|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019301|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019302|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
14019303|NCT02787018|Hormones|hormones|mesh-ancestor
14019304|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14019305|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14019306|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019307|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14019308|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019309|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019310|NCT02787018|Analgesics|analgesics|mesh-ancestor
14019311|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
14019312|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14019313|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14019314|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14019315|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019316|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019317|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019318|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019319|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
14019320|NCT02787031|Anesthetics|anesthetics|mesh-list
14019321|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019322|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019323|NCT02786992|Misoprostol|misoprostol|mesh-list
14019324|NCT02786992|Oxytocin|oxytocin|mesh-list
14019325|NCT02786992|Carbetocin|carbetocin|mesh-list
14019326|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
14019327|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14019328|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019329|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14019330|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
14019331|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14019332|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019333|NCT02786823|Folic Acid|folic acid|mesh-list
15142341|NCT04281576|Capecitabine|capecitabine|mesh-list
14019334|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
14019335|NCT02786823|Hydroxocobalamin|hydroxocobalamin|mesh-list
14019336|NCT02786823|Metformin|metformin|mesh-list
15142342|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
15142343|NCT04281576|Trastuzumab|trastuzumab|mesh-list
15142344|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15142345|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
14019337|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14019338|NCT02786823|Vitamins|vitamins|mesh-ancestor
14019339|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
15142346|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142347|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142348|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15142349|NCT04281706|Propofol|propofol|mesh-list
15142350|NCT04281706|Etomidate|etomidate|mesh-list
15142351|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15142352|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142353|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142354|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142355|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
14019340|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019341|NCT02786823|Hematinics|hematinics|mesh-ancestor
14019342|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
14025894|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14025895|NCT02747823|Growth Substances|growth substances|mesh-ancestor
14025896|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025897|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
14025898|NCT02747511|Haloperidol|haloperidol|mesh-list
14025899|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
14025900|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
14025901|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
14025902|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025903|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025904|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14025905|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14025906|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14025907|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14273500|NCT00430248|Febuxostat|febuxostat|mesh-list
14273501|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
14273502|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273503|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273504|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
14273505|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273506|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14273507|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
14273508|NCT00430248|Protective Agents|protective agents|mesh-ancestor
14273509|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273510|NCT00430352|Rituximab|rituximab|mesh-list
14273511|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273512|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273513|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
14273514|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273515|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273516|NCT00430521|Vaccines|vaccines|mesh-list
14273517|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
14273518|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273519|NCT00430573|Cycloserine|cycloserine|mesh-list
14273520|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14273521|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273522|NCT00430573|Renal Agents|renal agents|mesh-ancestor
14273523|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14273524|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
14273525|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14273526|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
14273527|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273528|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14273529|NCT00430638|Olmesartan|olmesartan|mesh-list
14273530|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14273531|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14273532|NCT00430638|Diuretics|diuretics|mesh-ancestor
14273533|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
14273534|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273535|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14273536|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273537|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273538|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14273539|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15142356|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
14025908|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14019343|NCT02786732|Ustekinumab|ustekinumab|mesh-list
14019344|NCT02786732|Brodalumab|brodalumab|mesh-list
14019345|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14019346|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14019347|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
14019348|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019349|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
14019350|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14019351|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14019352|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14019353|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019354|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019355|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
14019356|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019357|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019358|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14019359|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019360|NCT02786667|Rotigotine|rotigotine|mesh-list
14019361|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
14019362|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
14019363|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019364|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019365|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019366|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
14019367|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14019368|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14019369|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14019370|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019371|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019372|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
14019373|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019374|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019375|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14019376|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019377|NCT02786641|Cisplatin|cisplatin|mesh-list
14019378|NCT02786641|Docetaxel|docetaxel|mesh-list
14019379|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019380|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
15142357|NCT04281628|Ketamine|ketamine|mesh-list
15142358|NCT04281628|Analgesics|analgesics|mesh-ancestor
15142359|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
15142360|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142361|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142362|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15142363|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142364|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
15142365|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
15142366|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142367|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15142368|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15142369|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142370|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142371|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15142372|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019381|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
14019382|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
14019383|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019384|NCT02786446|Naproxen|naproxen|mesh-list
14019385|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14019386|NCT02786446|Lidocaine|lidocaine|mesh-list
14019387|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019388|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
14019389|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019390|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019391|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
14019392|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019393|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14019394|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14019395|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14019396|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019397|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019398|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019399|NCT02786446|Analgesics|analgesics|mesh-ancestor
14019400|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019401|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019402|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
14019403|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14019404|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019405|NCT02786264|Fentanyl|fentanyl|mesh-list
14019406|NCT02786264|Midazolam|midazolam|mesh-list
14019407|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
14019408|NCT02786264|Propofol|propofol|mesh-list
14019409|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14019410|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019411|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019412|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14019413|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
14019414|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
14019415|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019416|NCT02786264|Analgesics|analgesics|mesh-ancestor
14019417|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
14019418|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019419|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14019420|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14019421|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14019422|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019423|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019424|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019425|NCT02786264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14019426|NCT02786264|Narcotics|narcotics|mesh-ancestor
14019427|NCT02786264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14019428|NCT02786264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14019429|NCT02786264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14019430|NCT02786264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14019431|NCT02786264|GABA Modulators|gaba modulators|mesh-ancestor
14019432|NCT02786264|GABA Agents|gaba agents|mesh-ancestor
14019433|NCT02785978|Levodopa|levodopa|mesh-list
14019434|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14019435|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14019436|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
14019437|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019438|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019439|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019440|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
14019441|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14019442|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019443|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019444|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019445|NCT02786212|Analgesics|analgesics|mesh-ancestor
14019446|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
14019447|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019448|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14019449|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14019450|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14019451|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019452|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019453|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142373|NCT04281680|Octreotide|octreotide|mesh-list
15142374|NCT04281680|Pasireotide|pasireotide|mesh-list
14019454|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14019455|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14019456|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14019457|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019458|NCT02785757|Thrombin|thrombin|mesh-list
14019459|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
15142375|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142376|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15142377|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142378|NCT04281680|Hormones|hormones|mesh-ancestor
15142379|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142380|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142381|NCT04281290|Bleomycin|bleomycin|mesh-list
15142382|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14019460|NCT02785757|Coagulants|coagulants|mesh-ancestor
14019461|NCT02785601|Trazodone|trazodone|mesh-list
14019462|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14019463|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14019464|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142383|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019465|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019466|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14019467|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14019468|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14019469|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019470|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019471|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019472|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
14019473|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14019474|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
14019475|NCT02785705|Vaccines|vaccines|mesh-list
14019476|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
14019477|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019478|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
14019479|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
14019480|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14019481|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019482|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14019483|NCT02785666|Ribavirin|ribavirin|mesh-list
14019484|NCT02785666|Grazoprevir|grazoprevir|mesh-list
14019485|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
14019486|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019487|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
14019488|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019489|NCT02785614|Trazodone|trazodone|mesh-list
14019490|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14019491|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14019492|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019493|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019494|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14019495|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14019496|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14019497|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019498|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019499|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019500|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
14019501|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14019502|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
14019503|NCT02785653|Sevoflurane|sevoflurane|mesh-list
14019504|NCT02785653|Rocuronium|rocuronium|mesh-list
14019505|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14019506|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14019507|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
15142384|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
15142385|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15142386|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142387|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15142388|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15142389|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142390|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142391|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142392|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15142393|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15142394|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142395|NCT04281017|Anesthetics|anesthetics|mesh-list
15142396|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142397|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142398|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
15142399|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15142400|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15142401|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15142402|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142403|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142404|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
15142405|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142406|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142407|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15142408|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142409|NCT04280874|Dinoprostone|dinoprostone|mesh-list
15142410|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
15142411|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15142412|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142413|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15142414|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14019508|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
14019509|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019510|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019511|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14019512|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14019513|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14019514|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019515|NCT02785718|Hemostatics|hemostatics|mesh-list
14019516|NCT02785718|Coagulants|coagulants|mesh-ancestor
14019517|NCT02785549|Acetaminophen|acetaminophen|mesh-list
14019518|NCT02785549|Amoxicillin|amoxicillin|mesh-list
14019519|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
14019520|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
14019521|NCT02785549|Ibuprofen|ibuprofen|mesh-list
14019522|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019523|NCT02785549|Analgesics|analgesics|mesh-ancestor
14019524|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
14019525|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019526|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019527|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
14019528|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14019529|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019530|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019531|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14019532|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142415|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019533|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019534|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14019535|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019536|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14019537|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
14019538|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019539|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
14019540|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019541|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019542|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14019543|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
14019544|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273540|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
14273541|NCT00430677|Prednisone|prednisone|mesh-list
14273542|NCT00430677|Prednisolone|prednisolone|mesh-list
14273543|NCT00430677|Abatacept|abatacept|mesh-list
14273544|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14273545|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
14273546|NCT00430677|Hormones|hormones|mesh-ancestor
14273547|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273548|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273549|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14273550|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273551|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14273552|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14273553|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
14273554|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14273555|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273556|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273557|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273558|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14273559|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273560|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
14273561|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273562|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
14273563|NCT00430716|Citric Acid|citric acid|mesh-list
14273564|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
14273565|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
14273566|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14273567|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
14273568|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
14273569|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273570|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
14273571|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14273572|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14273573|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273574|NCT00430716|Urological Agents|urological agents|mesh-ancestor
14273575|NCT00430781|Lapatinib|lapatinib|mesh-list
14273576|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019545|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019546|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14019547|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
14019548|NCT02785146|Leucovorin|leucovorin|mesh-list
14019549|NCT02785146|Fluorouracil|fluorouracil|mesh-list
14019550|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
14019551|NCT02785146|Calcium|calcium|mesh-list
14019552|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
14019553|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14273577|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273578|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273579|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273580|NCT00430937|Vancomycin|vancomycin|mesh-list
14019554|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019555|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14019556|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
14019557|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019558|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14019559|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019560|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019561|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
14019562|NCT02785146|Antidotes|antidotes|mesh-ancestor
14273581|NCT00430937|Daptomycin|daptomycin|mesh-list
14273582|NCT00430937|Teicoplanin|teicoplanin|mesh-list
14273583|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14273584|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273585|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
14273586|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14273587|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
14273588|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
14273589|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14273590|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273591|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14273592|NCT00430989|Analgesics|analgesics|mesh-ancestor
14273593|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
14273594|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273595|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
14273596|NCT00431041|Oxybutynin|oxybutynin|mesh-list
14273597|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14273598|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14273599|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
14273600|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273601|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273602|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273603|NCT00431041|Urological Agents|urological agents|mesh-ancestor
14273604|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
14273605|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
14273606|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273607|NCT00431067|Afatinib|afatinib|mesh-list
14273608|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273609|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273610|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273611|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273612|NCT00431132|Estradiol|estradiol|mesh-list
14273613|NCT00431132|Estrogens|estrogens|mesh-ancestor
14273614|NCT00431132|Hormones|hormones|mesh-ancestor
14273615|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273616|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273617|NCT00431184|Pentazocine|pentazocine|mesh-list
14273618|NCT00431184|Lorazepam|lorazepam|mesh-list
14273619|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
14273620|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
14273621|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
14273622|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273623|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273624|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14273625|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14273626|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14273627|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14273628|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14273629|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14273630|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
14273631|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
14273632|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273633|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019563|NCT02785146|Protective Agents|protective agents|mesh-ancestor
14273634|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15142416|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142417|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
14019564|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
14019565|NCT02785146|Vitamins|vitamins|mesh-ancestor
14019566|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
14019567|NCT02785393|Doxazosin|doxazosin|mesh-list
14019568|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14019569|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14019570|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14019571|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14019572|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019573|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019574|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019575|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019576|NCT02785276|Ropivacaine|ropivacaine|mesh-list
14019577|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019578|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
14019579|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019580|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019581|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
14019582|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019583|NCT02784899|Iloprost|iloprost|mesh-list
14019584|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14019585|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
14019586|NCT02784860|Lidocaine|lidocaine|mesh-list
14019587|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019588|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
14019589|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019590|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019591|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
14019592|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019593|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14019594|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14019595|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14019596|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019597|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025909|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14025910|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
14025911|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025912|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025913|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14025914|NCT02747537|Irinotecan|irinotecan|mesh-list
14025915|NCT02747537|Sorafenib|sorafenib|mesh-list
14025916|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14025917|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15142418|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142419|NCT04280406|Azithromycin|azithromycin|mesh-list
15142420|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15142421|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142422|NCT04280289|Cannabidiol|cannabidiol|mesh-list
15142423|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
14025918|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025919|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025920|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025921|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14025922|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
14025923|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14025924|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14025925|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025926|NCT02747381|Vitamins|vitamins|mesh-ancestor
14025927|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
14025928|NCT02747316|Iron|iron|mesh-list
14025929|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14025930|NCT02747316|Trace Elements|trace elements|mesh-ancestor
14025931|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
15142424|NCT04279938|Rituximab|rituximab|mesh-list
15142425|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
15142426|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15142427|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142428|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
15142429|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142430|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025932|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025933|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14025934|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14025935|NCT02746744|Rituximab|rituximab|mesh-list
15179440|NCT03950271|Capecitabine|capecitabine|mesh-list
14019598|NCT02785055|Hydromorphone|hydromorphone|mesh-list
14019599|NCT02785055|Bupivacaine|bupivacaine|mesh-list
14019600|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019601|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
14019602|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019603|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019604|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
14019605|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019606|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15142431|NCT04280263|Caffeine|caffeine|mesh-list
15142432|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15142433|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142434|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15142435|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142436|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142437|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15142438|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15142439|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
15142440|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142441|NCT04280055|Psilocybin|psilocybin|mesh-list
15142442|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
15142443|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142444|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142445|NCT04279054|Morphine|morphine|mesh-list
15142446|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15142447|NCT04279054|Narcotics|narcotics|mesh-ancestor
14019607|NCT02785055|Narcotics|narcotics|mesh-ancestor
14019608|NCT02785055|Analgesics|analgesics|mesh-ancestor
14019609|NCT02785003|Acetaminophen|acetaminophen|mesh-list
14019610|NCT02785003|Ketamine|ketamine|mesh-list
14019611|NCT02785003|Morphine|morphine|mesh-list
14019612|NCT02785003|Narcotics|narcotics|mesh-list
14019613|NCT02785003|Alvimopan|alvimopan|mesh-list
14019614|NCT02785003|Analgesics|analgesics|mesh-ancestor
14019615|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
14019616|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019617|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019618|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14019619|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14019620|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
14019621|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
14019622|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019623|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14019624|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14019625|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019626|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019627|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14019628|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019629|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
14019630|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019631|NCT02785068|Leucovorin|leucovorin|mesh-list
14019632|NCT02785068|Fluorouracil|fluorouracil|mesh-list
14019633|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
14019634|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019635|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14019636|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019637|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019638|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
14019639|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019640|NCT02785068|Antidotes|antidotes|mesh-ancestor
14019641|NCT02785068|Protective Agents|protective agents|mesh-ancestor
14019642|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
14019643|NCT02785068|Vitamins|vitamins|mesh-ancestor
14019644|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
14019645|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14019646|NCT02784821|Gentamicins|gentamicins|mesh-list
14019647|NCT02784821|Ampicillin|ampicillin|mesh-list
14019648|NCT02784821|Cefotaxime|cefotaxime|mesh-list
14019649|NCT02784821|Cefoxitin|cefoxitin|mesh-list
14019650|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14019651|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019652|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
14019653|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14019654|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019655|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019656|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
14019657|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14019658|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
14019659|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14019660|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
14019661|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019662|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019663|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
14019664|NCT02784795|Gemcitabine|gemcitabine|mesh-list
14019665|NCT02784795|Carboplatin|carboplatin|mesh-list
14019666|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019667|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14019668|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
14019669|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019670|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
14019671|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019672|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019673|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019674|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
14019675|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019676|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
14019677|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
14019678|NCT02784626|Propofol|propofol|mesh-list
14019679|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14019680|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019681|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019682|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14019683|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
14019684|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
14019685|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019686|NCT02784626|Analgesics|analgesics|mesh-ancestor
14019687|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
14019688|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019689|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14019690|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14019691|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14019692|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019693|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019694|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019695|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
14019696|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14019697|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019698|NCT02784457|Cetrorelix|cetrorelix|mesh-list
14019699|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14019700|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
14019701|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14019702|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019703|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
14019704|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14019705|NCT02784743|Ivermectin|ivermectin|mesh-list
14019706|NCT02784743|Albendazole|albendazole|mesh-list
14019707|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15142448|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142449|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142450|NCT04279054|Analgesics|analgesics|mesh-ancestor
15142451|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
15142452|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142453|NCT04279379|Decitabine|decitabine|mesh-list
14019708|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019709|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
14019710|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
14019711|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14019712|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14019713|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
14019714|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
14019715|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
14019716|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019717|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019718|NCT02784483|Atezolizumab|atezolizumab|mesh-list
14019719|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019720|NCT02784561|Vidarabine|vidarabine|mesh-list
14019721|NCT02784561|Cytarabine|cytarabine|mesh-list
14019722|NCT02784561|Fludarabine|fludarabine|mesh-list
14019723|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
14019724|NCT02784561|Busulfan|busulfan|mesh-list
14019725|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
14019726|NCT02784561|Sargramostim|sargramostim|mesh-list
14019727|NCT02784561|Lenograstim|lenograstim|mesh-list
14019728|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179441|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
14019729|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14019730|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
14019731|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019732|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019733|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
14019734|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019735|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
14019736|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019737|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
14019738|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14019739|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15142454|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15142455|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
15142456|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142457|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142458|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142459|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
15142460|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15142461|NCT04279106|Listerine|listerine|mesh-list
15142462|NCT04279106|Fluorides|fluorides|mesh-list
15142463|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
14019740|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14019741|NCT02784340|Dexamethasone|dexamethasone|mesh-list
14019742|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
14019743|NCT02784340|Bupivacaine|bupivacaine|mesh-list
14019744|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14019745|NCT02784340|BB 1101|bb 1101|mesh-list
14019746|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019747|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
14019748|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
14019749|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019750|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019751|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019752|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
14019753|NCT02784340|Hormones|hormones|mesh-ancestor
14019754|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14019755|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14019756|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019757|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
14019758|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019759|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019760|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019761|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
14019762|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019763|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
14019764|NCT02784327|Ropivacaine|ropivacaine|mesh-list
14019765|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
14019766|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
14019767|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019768|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019769|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
14019770|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019771|NCT02784223|Choline|choline|mesh-list
14019772|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
14019773|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14019774|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
14019775|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019776|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019777|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14019778|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
14019779|NCT02784392|Metoclopramide|metoclopramide|mesh-list
14019780|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
14019781|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
14019782|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019783|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019784|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019785|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14019786|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14019787|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
14019788|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019789|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019790|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
14019791|NCT02784054|Melphalan|melphalan|mesh-list
14019792|NCT02784054|Thiotepa|thiotepa|mesh-list
14019793|NCT02784054|Carboplatin|carboplatin|mesh-list
14019794|NCT02784054|Etoposide|etoposide|mesh-list
14019795|NCT02784054|Bleomycin|bleomycin|mesh-list
14019796|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019797|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
14019798|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019799|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019800|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14811729|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811730|NCT00846677|Vitamin D|vitamin d|mesh-list
14811731|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
14811732|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
14811733|NCT00846677|Vitamins|vitamins|mesh-list
14811734|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
14811735|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811736|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14811737|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14811738|NCT00846690|Lidocaine|lidocaine|mesh-list
14811739|NCT00846690|Phenylephrine|phenylephrine|mesh-list
14811740|NCT00846690|Benzocaine|benzocaine|mesh-list
14019801|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
14811741|NCT00846690|Tetracaine|tetracaine|mesh-list
14811742|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
14811743|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
14019802|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019803|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019804|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14019805|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14019806|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14019807|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14019808|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019809|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14019810|NCT02784080|Isoantibodies|isoantibodies|mesh-list
14019811|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
14019812|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273635|NCT00431184|Narcotics|narcotics|mesh-ancestor
14273636|NCT00431184|Analgesics|analgesics|mesh-ancestor
14273637|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
14273638|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14273639|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15142464|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
15142465|NCT04279106|Protective Agents|protective agents|mesh-ancestor
15142466|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142467|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14019813|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
14019814|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14292471|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292472|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
14292473|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292474|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
14292475|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292476|NCT00561392|Rivastigmine|rivastigmine|mesh-list
14292477|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14292478|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292479|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292480|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
14292481|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292482|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292483|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14292484|NCT00561392|Protective Agents|protective agents|mesh-ancestor
14292485|NCT00561418|Vorinostat|vorinostat|mesh-list
14292486|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292487|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14292488|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019815|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019816|NCT02783924|Vitamins|vitamins|mesh-ancestor
14019817|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
14019818|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14019819|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
14019820|NCT02784015|Melphalan|melphalan|mesh-list
14019821|NCT02784015|Ifosfamide|ifosfamide|mesh-list
14019822|NCT02784015|Thiotepa|thiotepa|mesh-list
14019823|NCT02784015|Carboplatin|carboplatin|mesh-list
14019824|NCT02784015|Doxorubicin|doxorubicin|mesh-list
14019825|NCT02784015|Etoposide|etoposide|mesh-list
14019826|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14019827|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
14019828|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811744|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14811745|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019829|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14019830|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14019831|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
14019832|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019833|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019834|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14019835|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14019836|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14019837|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14019838|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019839|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14019840|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
14019841|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14019842|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
14019843|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019844|NCT02783989|Protective Agents|protective agents|mesh-ancestor
14019845|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019846|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
14019847|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
14019848|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019849|NCT02783937|Lenograstim|lenograstim|mesh-list
14019850|NCT02783937|Sargramostim|sargramostim|mesh-list
14019851|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14019852|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
14019853|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019854|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
14019855|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14019856|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019857|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019858|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019859|NCT02783846|Analgesics|analgesics|mesh-ancestor
14019860|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
14019861|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019862|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14019863|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14019864|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14019865|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
14019866|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019867|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019868|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
14019869|NCT02783378|Antacids|antacids|mesh-ancestor
14019870|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019871|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142468|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142469|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
15142470|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14019872|NCT02783508|Meperidine|meperidine|mesh-list
14019873|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
14019874|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14019875|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
14019876|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
14019877|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019878|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019879|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019880|NCT02783508|Analgesics|analgesics|mesh-ancestor
14019881|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
14019882|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019883|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14019884|NCT02783508|Narcotics|narcotics|mesh-ancestor
14019885|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14019886|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
14019887|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
14019888|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14019889|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14019890|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
14019891|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019892|NCT02783586|Bupivacaine|bupivacaine|mesh-list
14019893|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
15142471|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
15142472|NCT04278950|Povidone|povidone|mesh-list
15142473|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
15142474|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
15142475|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15142476|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019894|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
14019895|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019896|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019897|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
14019898|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273640|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
14273641|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14273642|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14273643|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273644|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14273645|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
14273646|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273647|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14273648|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14273649|NCT00431496|Cinacalcet|cinacalcet|mesh-list
14273650|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14273651|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273652|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14273653|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
14273654|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273655|NCT00431626|Dutasteride|dutasteride|mesh-list
14273656|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15142477|NCT04278729|Apixaban|apixaban|mesh-list
15142478|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15142479|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
15142480|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15142481|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
15142482|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142483|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142484|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
15142485|NCT04278859|Antibodies|antibodies|mesh-list
15142486|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15142487|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
15142488|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142489|NCT04278703|Oxycodone|oxycodone|mesh-list
15142490|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15142491|NCT04278703|Narcotics|narcotics|mesh-ancestor
15142492|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142493|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142494|NCT04278703|Analgesics|analgesics|mesh-ancestor
15142495|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
15142496|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142497|NCT04278807|Anesthetics|anesthetics|mesh-list
15142498|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142499|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142500|NCT04278677|Melatonin|melatonin|mesh-list
15142501|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
15142502|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142503|NCT04278677|Protective Agents|protective agents|mesh-ancestor
15142504|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142505|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142506|NCT04278833|Dexamethasone|dexamethasone|mesh-list
15142507|NCT04278833|Triamcinolone|triamcinolone|mesh-list
15142508|NCT04278833|Betamethasone|betamethasone|mesh-list
14273657|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14273658|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273659|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273660|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
14273661|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273662|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273663|NCT00431847|Anesthetics|anesthetics|mesh-list
14273664|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14273665|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273666|NCT00431964|Azithromycin|azithromycin|mesh-list
15142509|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142510|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
15142511|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
14019899|NCT02783547|Azacitidine|azacitidine|mesh-list
14019900|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14019901|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
14019902|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019903|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019904|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019905|NCT02783430|Ketamine|ketamine|mesh-list
14019906|NCT02783430|Milnacipran|milnacipran|mesh-list
14019907|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
14019908|NCT02783430|Analgesics|analgesics|mesh-ancestor
14019909|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
14019910|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019911|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019912|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14019913|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14019914|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
14019915|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
14019916|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019917|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14019918|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14019919|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019920|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019921|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14019922|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14019923|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019924|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14019925|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
14019926|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14019927|NCT02783638|Pregabalin|pregabalin|mesh-list
14019928|NCT02783638|Analgesics|analgesics|mesh-ancestor
14019929|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
14019930|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019931|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019932|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
14019933|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14019934|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14019935|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019936|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14019937|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14019938|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14019939|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019940|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14019941|NCT02783404|Amoxicillin|amoxicillin|mesh-list
14019942|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
14019943|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
14019944|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14019945|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14019946|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14019947|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019948|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019949|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
14019950|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
14019951|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14019952|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019953|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019954|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025936|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14025937|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14025938|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14025939|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
14025940|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025941|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15142512|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025942|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14025943|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026323|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026324|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026325|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
14026326|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026327|NCT02744131|Metformin|metformin|mesh-list
14026328|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
14026329|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
14026330|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
14026331|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14026332|NCT02744131|Estradiol|estradiol|mesh-list
14026333|NCT02744131|Cyproterone|cyproterone|mesh-list
14026334|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026335|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026336|NCT02744131|Estrogens|estrogens|mesh-ancestor
14026337|NCT02744131|Hormones|hormones|mesh-ancestor
14273667|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14019955|NCT02783053|Metformin|metformin|mesh-list
14019956|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14019957|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019958|NCT02783144|Dexamethasone|dexamethasone|mesh-list
14019959|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
14019960|NCT02783144|BB 1101|bb 1101|mesh-list
14019961|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14019962|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
14019963|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
14019964|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14019965|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019966|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019967|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
14019968|NCT02783144|Hormones|hormones|mesh-ancestor
14019969|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14019970|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14019971|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14019972|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
14019973|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019974|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019975|NCT02783040|Digoxin|digoxin|mesh-list
14019976|NCT02783040|Midazolam|midazolam|mesh-list
14019977|NCT02783040|BI 425809|bi 425809|mesh-list
14019978|NCT02783040|Omeprazole|omeprazole|mesh-list
14019979|NCT02783040|Warfarin|warfarin|mesh-list
14019980|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14019981|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14019982|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14019983|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14019984|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14019985|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14019986|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14019987|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14019988|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
14019989|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
14019990|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
14019991|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
14019992|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14019993|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14019994|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
14019995|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14019996|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14019997|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14019998|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14019999|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14020000|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14020001|NCT02783040|Protective Agents|protective agents|mesh-ancestor
14020002|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
14020003|NCT02783183|Pregabalin|pregabalin|mesh-list
14020004|NCT02783183|Analgesics|analgesics|mesh-ancestor
14020005|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
14020006|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020007|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020008|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
14020009|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14020010|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14020011|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020012|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14020013|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14020014|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14020015|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020016|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14020017|NCT02783092|Cannabidiol|cannabidiol|mesh-list
14020018|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
14020019|NCT02783196|Liraglutide|liraglutide|mesh-list
14020020|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14020021|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020022|NCT02783196|Incretins|incretins|mesh-ancestor
14020023|NCT02783196|Hormones|hormones|mesh-ancestor
14020024|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020025|NCT02783222|Paclitaxel|paclitaxel|mesh-list
14020026|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14020027|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020028|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
14020029|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
14020030|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
14020031|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020032|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14020033|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
14020034|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14020035|NCT02782897|Antibodies|antibodies|mesh-list
14020036|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
14020037|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020038|NCT02782624|Empagliflozin|empagliflozin|mesh-list
14020039|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14020040|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020041|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14020042|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020043|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
14020044|NCT02782754|Carboplatin|carboplatin|mesh-list
14020045|NCT02782754|Etoposide|etoposide|mesh-list
14020046|NCT02782754|Bleomycin|bleomycin|mesh-list
14020047|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020048|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
14020049|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020050|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020051|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14020052|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
14020053|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020054|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020055|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14020056|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14020057|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14020058|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14020059|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020060|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14020061|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
14020062|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
14020063|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14020064|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15142513|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142514|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142515|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
15142516|NCT04278833|Hormones|hormones|mesh-ancestor
15142517|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142518|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15142519|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142520|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15142521|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
15142522|NCT04278846|Bupivacaine|bupivacaine|mesh-list
15142523|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
15142524|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
15142525|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142526|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142527|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
15142528|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142529|NCT04278599|Zinc|zinc|mesh-list
14020065|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020066|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020067|NCT02782559|Urological Agents|urological agents|mesh-ancestor
14020068|NCT02782338|Diclofenac|diclofenac|mesh-list
14020069|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020070|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020071|NCT02782338|Analgesics|analgesics|mesh-ancestor
14020072|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
14020073|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020074|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020075|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020076|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020077|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020078|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020079|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020080|NCT02782260|Dipyridamole|dipyridamole|mesh-list
14020081|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14020082|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020083|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020084|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14020085|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
14020086|NCT02782273|Ketorolac|ketorolac|mesh-list
14020087|NCT02782273|Morphine|morphine|mesh-list
15142530|NCT04278599|Trace Elements|trace elements|mesh-ancestor
14020088|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14020089|NCT02782273|Narcotics|narcotics|mesh-ancestor
14020090|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020091|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020092|NCT02782273|Analgesics|analgesics|mesh-ancestor
14020093|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
14020094|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020095|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020096|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020097|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020098|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020099|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020100|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020101|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020102|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14020103|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14020104|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
14020105|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020106|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020107|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14020108|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14020109|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
14020110|NCT02782312|Hormones|hormones|mesh-ancestor
14020111|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020112|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
14020113|NCT02782403|Axitinib|axitinib|mesh-list
14020114|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020115|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14020116|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020117|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020118|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
14020119|NCT02782546|Tacrolimus|tacrolimus|mesh-list
14020120|NCT02782546|Sargramostim|sargramostim|mesh-list
14020121|NCT02782546|Lenograstim|lenograstim|mesh-list
14020122|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020123|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
14020124|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020125|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14020126|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020127|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020128|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14020129|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020130|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14020131|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
14020132|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14020133|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020134|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15142531|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
15142532|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142533|NCT04278937|Azithromycin|azithromycin|mesh-list
15142534|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15142535|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142536|NCT04278378|Folic Acid|folic acid|mesh-list
15142537|NCT04278378|Riboflavin|riboflavin|mesh-list
15142538|NCT04278378|Hematinics|hematinics|mesh-ancestor
15142539|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
15142540|NCT04278378|Vitamins|vitamins|mesh-ancestor
15142541|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
14020135|NCT02782481|Levodopa|levodopa|mesh-list
14020136|NCT02782481|Carbidopa|carbidopa|mesh-list
14020137|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14020138|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14020139|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14020140|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
14020141|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020142|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020143|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020144|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14020145|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273668|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273669|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
14273670|NCT00432172|Carboplatin|carboplatin|mesh-list
14273671|NCT00432172|Docetaxel|docetaxel|mesh-list
14020146|NCT02782286|Ketorolac|ketorolac|mesh-list
14273672|NCT00432172|Epirubicin|epirubicin|mesh-list
15142542|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142543|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14020147|NCT02782286|Morphine|morphine|mesh-list
14020148|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14020149|NCT02782286|Narcotics|narcotics|mesh-ancestor
14020150|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020151|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020152|NCT02782286|Analgesics|analgesics|mesh-ancestor
14020153|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
14020154|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020155|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020156|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020157|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020158|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020159|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020160|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020161|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020162|NCT02782429|Ketamine|ketamine|mesh-list
14020163|NCT02782429|Analgesics|analgesics|mesh-ancestor
14020164|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
14020165|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020166|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020167|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14020168|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14020169|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
14020170|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
14020171|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020172|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14020173|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14020174|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020175|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020176|NCT02782221|Hormones|hormones|mesh-list
14020177|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020178|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020179|NCT02782208|Acipimox|acipimox|mesh-list
14020180|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14020181|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
14020182|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020183|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14020184|NCT02782182|Leucovorin|leucovorin|mesh-list
14020185|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
14020186|NCT02782182|Irinotecan|irinotecan|mesh-list
14020187|NCT02782182|Folfirinox|folfirinox|mesh-list
14020188|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020189|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14020190|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14020191|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020192|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142544|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
15142545|NCT04278755|Drospirenone|drospirenone|mesh-list
15142546|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15142547|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15142548|NCT04278755|Estradiol|estradiol|mesh-list
15142549|NCT04278755|Estrogens|estrogens|mesh-ancestor
15142550|NCT04278755|Hormones|hormones|mesh-ancestor
15142551|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142552|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020193|NCT02782182|Antidotes|antidotes|mesh-ancestor
14020194|NCT02782182|Protective Agents|protective agents|mesh-ancestor
14020195|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020196|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
14020197|NCT02782182|Vitamins|vitamins|mesh-ancestor
14020198|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
14020199|NCT02782078|Clindamycin|clindamycin|mesh-list
14020200|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
14020201|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
14020202|NCT02782078|Rifampin|rifampin|mesh-list
14020203|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14020204|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020205|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14020206|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020207|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020208|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15142553|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15142554|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
15142555|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15142556|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14020209|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
14020210|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
14020211|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14020212|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14020213|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14020214|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14020215|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14020216|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14020217|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14020218|NCT02782052|Bromides|bromides|mesh-list
14273673|NCT00432172|Exemestane|exemestane|mesh-list
14273674|NCT00432172|Goserelin|goserelin|mesh-list
14273675|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273676|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
14273677|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273678|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273679|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273680|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
14273681|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273682|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273683|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273684|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273685|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273686|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273687|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14273688|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14273689|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14273690|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273691|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14273692|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14273693|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14273694|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
14273695|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273696|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14273697|NCT00432276|Metformin|metformin|mesh-list
14273698|NCT00432276|Pioglitazone|pioglitazone|mesh-list
14273699|NCT00432276|Alogliptin|alogliptin|mesh-list
14273700|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14273701|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273702|NCT00432276|Incretins|incretins|mesh-ancestor
14273703|NCT00432276|Hormones|hormones|mesh-ancestor
14273704|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273705|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14273706|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
14273707|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273708|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273709|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
14273710|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14273711|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14273712|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14273713|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273714|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142557|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15142558|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15179442|NCT03950271|Trastuzumab|trastuzumab|mesh-list
14273715|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
14273716|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273717|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273718|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14273719|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273720|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
14273721|NCT00432458|Thalidomide|thalidomide|mesh-list
14273722|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273723|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
14273724|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273725|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
14273726|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14273727|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14273728|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273729|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273730|NCT00432458|Growth Substances|growth substances|mesh-ancestor
14273731|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273732|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273733|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14020219|NCT02782052|Albuterol|albuterol|mesh-list
15142559|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15142560|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
15142561|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15142562|NCT04278755|Diuretics|diuretics|mesh-ancestor
15142563|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
15142564|NCT04278287|Paclitaxel|paclitaxel|mesh-list
15142565|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14020220|NCT02782052|Ipratropium|ipratropium|mesh-list
14020221|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
14020222|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14020223|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
14020224|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020225|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020226|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14020227|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14020228|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
14020229|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14020230|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14020231|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14020232|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14020233|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
14020234|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020235|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020236|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14020237|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
14020238|NCT02781909|Ibuprofen|ibuprofen|mesh-list
14020239|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020240|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020241|NCT02781909|Analgesics|analgesics|mesh-ancestor
14020242|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
14020243|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020244|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020245|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020246|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020247|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020248|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020249|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020250|NCT02781766|Thrombin|thrombin|mesh-list
14020251|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
14020252|NCT02781766|Coagulants|coagulants|mesh-ancestor
14020253|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
14020254|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14020255|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14020256|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020257|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
14020258|NCT02781597|Coagulants|coagulants|mesh-ancestor
14020259|NCT02781805|Alendronate|alendronate|mesh-list
14020260|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14020261|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020262|NCT02781493|Prucalopride|prucalopride|mesh-list
14020263|NCT02781493|Laxatives|laxatives|mesh-ancestor
14020264|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020265|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14020266|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14020267|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
14020268|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020269|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020270|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020271|NCT02781753|Interferons|interferons|mesh-list
14020272|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
14020273|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
14020274|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020275|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
14020276|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020277|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
14020278|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020279|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14020280|NCT02781779|Laxatives|laxatives|mesh-ancestor
14020281|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020282|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
14020283|NCT02781467|Fludarabine|fludarabine|mesh-list
14020284|NCT02781467|Interleukin-2|interleukin-2|mesh-list
14020285|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020286|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
14020287|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142566|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14020288|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020289|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14020290|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
14020291|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142567|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142568|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
15142569|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
15142570|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
15142571|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142572|NCT04278508|Progesterone|progesterone|mesh-list
15142573|NCT04278508|Progestins|progestins|mesh-ancestor
15142574|NCT04278508|Hormones|hormones|mesh-ancestor
15142575|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142576|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142577|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15142578|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
14020292|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020293|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14020294|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020295|NCT02781467|Analgesics|analgesics|mesh-ancestor
14020296|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
14020297|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025944|NCT02746783|Vaccines|vaccines|mesh-list
14025945|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
14025946|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025947|NCT02746250|Amitriptyline|amitriptyline|mesh-list
14025948|NCT02746250|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14025949|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
14025950|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14025951|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14025952|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025953|NCT02746250|Analgesics|analgesics|mesh-ancestor
14025954|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
14025955|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025956|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14025957|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14025958|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14025959|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14025960|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025961|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14025962|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025963|NCT02746250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14025964|NCT02746250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14025965|NCT02746250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14025966|NCT02746185|Heparin|heparin|mesh-list
14025967|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14025968|NCT02746185|Tinzaparin|tinzaparin|mesh-list
14025969|NCT02746185|Dalteparin|dalteparin|mesh-list
14025970|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
14025971|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
14025972|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14025973|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14025974|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025975|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14025976|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
14025977|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14025978|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
14025979|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14025980|NCT02746276|Metronidazole|metronidazole|mesh-list
14025981|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
14025982|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14025983|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14025984|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14025985|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14025986|NCT02746380|Adalimumab|adalimumab|mesh-list
14025987|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14025988|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14025989|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
14025990|NCT02745990|Hematinics|hematinics|mesh-ancestor
14025991|NCT02745925|Ibuprofen|ibuprofen|mesh-list
14025992|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14025993|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14025994|NCT02745925|Analgesics|analgesics|mesh-ancestor
14025995|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
14025996|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14025997|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020298|NCT02781506|Nivolumab|nivolumab|mesh-list
14020299|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020300|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020301|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14020302|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020303|NCT02781415|Morphine|morphine|mesh-list
14020304|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14020305|NCT02781415|Narcotics|narcotics|mesh-ancestor
14020306|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020307|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020308|NCT02781415|Analgesics|analgesics|mesh-ancestor
14020309|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
14020310|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020311|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
14020312|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14020313|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020314|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020315|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020316|NCT02781246|Analgesics|analgesics|mesh-ancestor
14020317|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
14020318|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020319|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15142579|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142580|NCT04278495|Losartan|losartan|mesh-list
15142581|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15142582|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15142583|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15142584|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15142585|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142586|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
15142587|NCT04278547|Valganciclovir|valganciclovir|mesh-list
15142588|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
14020320|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14020321|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14020322|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
14020323|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020324|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020325|NCT02781064|Atorvastatin|atorvastatin|mesh-list
14020326|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14020327|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14020328|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
14020329|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020330|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14020331|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14020332|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020333|NCT02780804|Entinostat|entinostat|mesh-list
14020334|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14020335|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020336|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020337|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020338|NCT02780882|Pasireotide|pasireotide|mesh-list
14020339|NCT02780882|Hormones|hormones|mesh-ancestor
14020340|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020341|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273734|NCT00432562|Vinorelbine|vinorelbine|mesh-list
14273735|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273736|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273737|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273738|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273739|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273740|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273741|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14273742|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14273743|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273744|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273745|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14273746|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273747|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273748|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
14273749|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273750|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
14273751|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14273752|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273753|NCT00432991|Ephedrine|ephedrine|mesh-list
14273754|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14273755|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273756|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
14273757|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
14273758|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273759|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14273760|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
14273761|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273762|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273763|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
14273764|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14273765|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
14273766|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14273767|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273768|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14273769|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14273770|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14273771|NCT00433017|Ranibizumab|ranibizumab|mesh-list
14273772|NCT00433017|Verteporfin|verteporfin|mesh-list
14273773|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273774|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273775|NCT00433017|Growth Substances|growth substances|mesh-ancestor
14273776|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273777|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273778|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273779|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14273780|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
14273781|NCT00433160|Teriparatide|teriparatide|mesh-list
14273782|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14273783|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273784|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14273785|NCT00433199|Testosterone|testosterone|mesh-list
14273786|NCT00433199|Androgens|androgens|mesh-ancestor
14273787|NCT00433199|Hormones|hormones|mesh-ancestor
14273788|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273789|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273790|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14273791|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14273792|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14273793|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273794|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273795|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273796|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273797|NCT00433290|Analgesics|analgesics|mesh-ancestor
14273798|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
14273799|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273800|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
14273801|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14273802|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
14273803|NCT00433329|Bosentan|bosentan|mesh-list
14273804|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
14273805|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
14273806|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14273807|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14273808|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273809|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273810|NCT00433329|Urological Agents|urological agents|mesh-ancestor
14273811|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14273812|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14273813|NCT00433381|Bevacizumab|bevacizumab|mesh-list
14273814|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14273815|NCT00433381|Irinotecan|irinotecan|mesh-list
14273816|NCT00433381|Temozolomide|temozolomide|mesh-list
14273817|NCT00433381|Camptothecin|camptothecin|mesh-list
14273818|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
14273819|NCT00433381|Antibodies|antibodies|mesh-list
14273820|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
14273821|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14273822|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
14273823|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273824|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273825|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15142589|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179443|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15179444|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
15179445|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179446|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179447|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182060|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15182061|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15182062|NCT03925285|Growth Substances|growth substances|mesh-ancestor
15182063|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182064|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273826|NCT00433381|Growth Substances|growth substances|mesh-ancestor
14273827|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273828|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273829|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
14273830|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14273831|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14273832|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273833|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273834|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273835|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
14273836|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273837|NCT00433446|Siltuximab|siltuximab|mesh-list
14273838|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273839|NCT00433537|Dexamethasone|dexamethasone|mesh-list
14273840|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
14273841|NCT00433537|Rituximab|rituximab|mesh-list
14273842|NCT00433537|Doxorubicin|doxorubicin|mesh-list
14273843|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15182065|NCT03925428|Entinostat|entinostat|mesh-list
15182066|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15182067|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182068|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182069|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182070|NCT03925090|Cisplatin|cisplatin|mesh-list
15182071|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273844|NCT00433537|Vincristine|vincristine|mesh-list
14273845|NCT00433537|Bortezomib|bortezomib|mesh-list
14273846|NCT00433537|Lenograstim|lenograstim|mesh-list
14273847|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14273848|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
14273849|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273850|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14273851|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273852|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
14273853|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273854|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273855|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14273856|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14273857|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
14273858|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
14273859|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14273860|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14273861|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
14273862|NCT00433537|Hormones|hormones|mesh-ancestor
15182072|NCT03925155|Iodine|iodine|mesh-list
15182073|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
15182074|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15182075|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182076|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
15182077|NCT03925155|Trace Elements|trace elements|mesh-ancestor
15182078|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
15182079|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182080|NCT03925051|Denosumab|denosumab|mesh-list
15182081|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182082|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182083|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
15182084|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15182085|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182302|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182303|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15182304|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273863|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273864|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15182305|NCT03923036|Growth Substances|growth substances|mesh-ancestor
14273865|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273866|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14273867|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14273868|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14273869|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273870|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14273871|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273872|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273873|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273874|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273875|NCT00433550|Capecitabine|capecitabine|mesh-list
14273876|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
14273877|NCT00433550|Irinotecan|irinotecan|mesh-list
14273878|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14273879|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
14273880|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273881|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273882|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14273883|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14273884|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273885|NCT00433745|Vaccines|vaccines|mesh-list
14273886|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
14273887|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273888|NCT00433836|Valsartan|valsartan|mesh-list
14273889|NCT00433836|Enalapril|enalapril|mesh-list
15142590|NCT04278092|Paclitaxel|paclitaxel|mesh-list
15142591|NCT04278092|Cetuximab|cetuximab|mesh-list
15142592|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15142593|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142594|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273890|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14273891|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14273892|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14273893|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273894|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14273895|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
14273896|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273897|NCT00433914|Vaccines|vaccines|mesh-list
14273898|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
14273899|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273900|NCT00433966|Paclitaxel|paclitaxel|mesh-list
14273901|NCT00433966|Heparin|heparin|mesh-list
14273902|NCT00433966|Calcium heparin|calcium heparin|mesh-list
14273903|NCT00433966|Bivalirudin|bivalirudin|mesh-list
14273904|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273905|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273906|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273907|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273908|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273909|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273910|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
14273911|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14273912|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14273913|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
14273914|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14273915|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
14273916|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273917|NCT00434109|Sunitinib|sunitinib|mesh-list
14273918|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273919|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273920|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273921|NCT00434109|Growth Substances|growth substances|mesh-ancestor
15142595|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
15142596|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
15142597|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142598|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15142599|NCT04278053|Inositol|inositol|mesh-list
15142600|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
15142601|NCT04278053|Vitamins|vitamins|mesh-ancestor
15142602|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
15142603|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142604|NCT04278040|Melphalan|melphalan|mesh-list
15142605|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14273922|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273923|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
15142606|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
15179448|NCT03950050|Ambroxol|ambroxol|mesh-list
14273924|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273925|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273926|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273927|NCT00434148|Pasireotide|pasireotide|mesh-list
14273928|NCT00434148|Hormones|hormones|mesh-ancestor
14273929|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14273930|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273931|NCT00434213|Methylphenidate|methylphenidate|mesh-list
14273932|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14273933|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273934|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14273935|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14273936|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14273937|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273938|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
14273939|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14273940|NCT00434252|Paclitaxel|paclitaxel|mesh-list
14273941|NCT00434252|Bevacizumab|bevacizumab|mesh-list
14273942|NCT00434252|Carboplatin|carboplatin|mesh-list
14273943|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273944|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273945|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273946|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273947|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14273948|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273949|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273950|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273951|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273952|NCT00434252|Growth Substances|growth substances|mesh-ancestor
14273953|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273954|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273955|NCT00434304|Ropinirole|ropinirole|mesh-list
14273956|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14273957|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14273958|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
14273959|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
14273960|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142607|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142608|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142609|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15142610|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142611|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
14273961|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273962|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273963|NCT00434356|Paclitaxel|paclitaxel|mesh-list
14273964|NCT00434356|Bevacizumab|bevacizumab|mesh-list
14273965|NCT00434356|Sunitinib|sunitinib|mesh-list
14273966|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14273967|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273968|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
14273969|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
14273970|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
15142612|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142613|NCT04277884|Firibastat|firibastat|mesh-list
15142614|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15142615|NCT04277845|Dexamethasone|dexamethasone|mesh-list
14273971|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14273972|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273973|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273974|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273975|NCT00434356|Growth Substances|growth substances|mesh-ancestor
14273976|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273977|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
14273978|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14273979|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14273980|NCT00434434|Omalizumab|omalizumab|mesh-list
14273981|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14273982|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14273983|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14273984|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
14273985|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
14273986|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273987|NCT00434577|Vaccines|vaccines|mesh-list
14273988|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
14273989|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273990|NCT00434642|Gemcitabine|gemcitabine|mesh-list
14273991|NCT00434642|Bevacizumab|bevacizumab|mesh-list
14273992|NCT00434642|Carboplatin|carboplatin|mesh-list
14273993|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14273994|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14273995|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14273996|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14273997|NCT00434642|Growth Substances|growth substances|mesh-ancestor
14273998|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14273999|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274000|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274001|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
14274002|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274003|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
14274004|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274005|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274006|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274007|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
14274008|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15142616|NCT04277845|Bortezomib|bortezomib|mesh-list
15142617|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142618|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
15142619|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
15142620|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020342|NCT02780778|Docetaxel|docetaxel|mesh-list
14020343|NCT02780778|Apatinib|apatinib|mesh-list
14020344|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274009|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
14274010|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274011|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14274012|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14274013|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14274014|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274015|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
14274016|NCT00434954|Exenatide|exenatide|mesh-list
14274017|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14274018|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274019|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14274020|NCT00434954|Incretins|incretins|mesh-ancestor
14274021|NCT00434954|Hormones|hormones|mesh-ancestor
14274022|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274023|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14274024|NCT00434967|Candesartan|candesartan|mesh-list
14274025|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
14274026|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14274027|NCT00434967|Diuretics|diuretics|mesh-ancestor
14274028|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
14274029|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274030|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14274031|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274032|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274033|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14020345|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
14020346|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
14020347|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14020348|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020349|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14020350|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274034|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14274035|NCT00434993|Albuterol|albuterol|mesh-list
14274036|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14274037|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
14274038|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274039|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274040|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14274041|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
14274042|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
14274043|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14274044|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14274045|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14274046|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14274047|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
14274048|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142621|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179449|NCT03950050|Expectorants|expectorants|mesh-ancestor
14274049|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274050|NCT00435019|Insulin|insulin|mesh-list
14274051|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14274052|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
14274053|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
14274054|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
14274055|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
14274056|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
14274057|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14274058|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274059|NCT00435045|Atorvastatin|atorvastatin|mesh-list
14274060|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14274061|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14274062|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
14274063|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274064|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15142622|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142623|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
15142624|NCT04277845|Hormones|hormones|mesh-ancestor
15142625|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142626|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15142627|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142628|NCT04277702|Montelukast|montelukast|mesh-list
15142629|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15142630|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
15142631|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15142632|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
15142633|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142634|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142635|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15142636|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15142637|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142638|NCT04277663|Interferons|interferons|mesh-list
15142639|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142640|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
15142641|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142642|NCT04277923|SMOFlipid|smoflipid|mesh-list
15142643|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15142644|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15142645|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15142646|NCT04277533|Calcium|calcium|mesh-list
15142647|NCT04277533|Bilirubin|bilirubin|mesh-list
15142648|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14274065|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15142649|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142650|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
14274066|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274067|NCT00435162|Valsartan|valsartan|mesh-list
14274068|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14274069|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14274070|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14274071|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274072|NCT00435370|Tropisetron|tropisetron|mesh-list
14274073|NCT00435370|Risperidone|risperidone|mesh-list
14274074|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14274075|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
14274076|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274077|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274078|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274079|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14274080|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14274081|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14274082|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274083|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14274084|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
14274085|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
14274086|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
14274087|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274088|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14274089|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14274090|NCT00435409|Capecitabine|capecitabine|mesh-list
14274091|NCT00435409|Sunitinib|sunitinib|mesh-list
15142651|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274092|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274093|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
14274094|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274095|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142652|NCT04277533|Protective Agents|protective agents|mesh-ancestor
15142653|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
14274096|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274097|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14274098|NCT00435409|Growth Substances|growth substances|mesh-ancestor
14274099|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274100|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274101|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274102|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274103|NCT00435461|Fluticasone|fluticasone|mesh-list
14274104|NCT00435461|Xhance|xhance|mesh-list
14274105|NCT00435461|Fexofenadine|fexofenadine|mesh-list
14274106|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14274107|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14274108|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
14274109|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274110|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274111|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14274112|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
14274113|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274114|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14274115|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14274116|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14274117|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
14274118|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
14274119|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274120|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274121|NCT00435487|Heparin|heparin|mesh-list
14274122|NCT00435487|Calcium heparin|calcium heparin|mesh-list
14274123|NCT00435487|Dalteparin|dalteparin|mesh-list
14274124|NCT00435487|Tinzaparin|tinzaparin|mesh-list
14274125|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14274126|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
14274127|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14274128|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14274129|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274130|NCT00435539|Plasminogen|plasminogen|mesh-list
14274131|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
14274132|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14274133|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14274134|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274135|NCT00435591|Conivaptan|conivaptan|mesh-list
14274136|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14274137|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274138|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
14274139|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274140|NCT00435812|Vaccines|vaccines|mesh-list
14274141|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
14274142|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274143|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14274144|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
14274145|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274146|NCT00435929|Ritonavir|ritonavir|mesh-list
14274147|NCT00435929|Saquinavir|saquinavir|mesh-list
14274148|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14274149|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14274150|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
14274151|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274152|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274153|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14274154|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14274155|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
14274156|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274157|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14274158|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14274159|NCT00435994|Epinephrine|epinephrine|mesh-list
14274160|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14274161|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15142654|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14274162|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
14274163|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274164|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142655|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14274165|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274166|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14274167|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14274168|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
14274169|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274170|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14274171|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
14274172|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
14274173|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
14274174|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14274175|NCT00436007|Vaccines|vaccines|mesh-list
14274176|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
14274177|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274178|NCT00436046|Interferons|interferons|mesh-list
14274179|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274180|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
14020351|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
14020352|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14020353|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020354|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020355|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020356|NCT02780427|Analgesics|analgesics|mesh-ancestor
14020357|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
14274181|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274182|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14274183|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
14274184|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274185|NCT00436215|Bevacizumab|bevacizumab|mesh-list
14274186|NCT00436215|Sorafenib|sorafenib|mesh-list
14274187|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274188|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274189|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274190|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14274191|NCT00436215|Growth Substances|growth substances|mesh-ancestor
14274192|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274193|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274194|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15142656|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15142657|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142658|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142659|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
15142660|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182086|NCT03924544|Mitomycins|mitomycins|mesh-list
14020358|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274195|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274196|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274197|NCT00436280|Gemcitabine|gemcitabine|mesh-list
14274198|NCT00436280|Rituximab|rituximab|mesh-list
14274199|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
14274200|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274201|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274202|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
14274203|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274204|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274205|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274206|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
14274207|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274208|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
14274209|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274210|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274211|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274212|NCT00436332|Bevacizumab|bevacizumab|mesh-list
14274213|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14274214|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274215|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274216|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274217|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14274218|NCT00436332|Growth Substances|growth substances|mesh-ancestor
14274219|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274220|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274221|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274222|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274223|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020359|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14274224|NCT00436345|Remifentanil|remifentanil|mesh-list
14274225|NCT00436345|Propofol|propofol|mesh-list
14274226|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14274227|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14274228|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274229|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14274230|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
14274231|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
14274232|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14274233|NCT00436345|Narcotics|narcotics|mesh-ancestor
14274234|NCT00436345|Analgesics|analgesics|mesh-ancestor
14274235|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
14274236|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274237|NCT00436436|Temozolomide|temozolomide|mesh-list
14274238|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14274239|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14274240|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
14274241|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274242|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274243|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274244|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
14274245|NCT00436475|Vitamin D|vitamin d|mesh-list
14274246|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
14274247|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
14274248|NCT00436475|Vitamins|vitamins|mesh-list
14274249|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
14274250|NCT00436475|Calcium|calcium|mesh-list
14274251|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
14274252|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274253|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14274254|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14274255|NCT00436475|Antacids|antacids|mesh-ancestor
14274256|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274257|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14274258|NCT00436501|Docetaxel|docetaxel|mesh-list
14274259|NCT00436501|Aflibercept|aflibercept|mesh-list
14274260|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
15142661|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142662|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15142663|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142664|NCT04277143|Daptomycin|daptomycin|mesh-list
15142665|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15142666|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142667|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
15142668|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15142669|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142670|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142671|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142672|NCT04276883|Analgesics|analgesics|mesh-ancestor
15142673|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
15142674|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142675|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15142676|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15142677|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15142678|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
15142679|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274261|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274262|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
14274263|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274264|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274265|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142680|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142681|NCT04276857|Leucovorin|leucovorin|mesh-list
15142682|NCT04276857|Gemcitabine|gemcitabine|mesh-list
15142683|NCT04276857|Paclitaxel|paclitaxel|mesh-list
15142684|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
15142685|NCT04276857|Irinotecan|irinotecan|mesh-list
15142686|NCT04276857|Folfirinox|folfirinox|mesh-list
14274266|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274267|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14274268|NCT00436501|Growth Substances|growth substances|mesh-ancestor
14274269|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274270|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274271|NCT00436553|Ranibizumab|ranibizumab|mesh-list
15142687|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14274272|NCT00436553|Verteporfin|verteporfin|mesh-list
14274273|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274274|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15142688|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142689|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
15142690|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
15142691|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
15142692|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142693|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15142694|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
15142695|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
15142696|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274275|NCT00436553|Growth Substances|growth substances|mesh-ancestor
14274276|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274277|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274278|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274279|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14274280|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274281|NCT00436566|Paclitaxel|paclitaxel|mesh-list
14274282|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
14274283|NCT00436566|Doxorubicin|doxorubicin|mesh-list
14274284|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14274285|NCT00436566|Trastuzumab|trastuzumab|mesh-list
14274286|NCT00436566|Lapatinib|lapatinib|mesh-list
14274287|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14274288|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274289|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
14274290|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274291|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274292|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274293|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274294|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
14274295|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274296|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274297|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14274298|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
14274299|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14274300|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14274301|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14274302|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14274303|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274304|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274305|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274306|NCT00436605|Dasatinib|dasatinib|mesh-list
14274307|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274308|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274309|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274310|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274311|NCT00436618|Everolimus|everolimus|mesh-list
15142697|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142698|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142699|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
15142700|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274312|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274313|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274314|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
14274315|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274316|NCT00436644|Topotecan|topotecan|mesh-list
14274317|NCT00436644|Lapatinib|lapatinib|mesh-list
14274318|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14274319|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14274320|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274321|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274322|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274323|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274324|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
14274325|NCT00436748|Hematinics|hematinics|mesh-ancestor
14274326|NCT00436904|Rituximab|rituximab|mesh-list
14274327|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
14274328|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274329|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274330|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
14274331|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274332|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274333|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
14274334|NCT00436917|Letrozole|letrozole|mesh-list
14274335|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274336|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14811746|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
14274337|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14274338|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274339|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274340|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14274341|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
14274342|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274343|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274344|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14274345|NCT00436956|Prednisone|prednisone|mesh-list
14274346|NCT00436956|Cediranib|cediranib|mesh-list
14274347|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14274348|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
14274349|NCT00436956|Hormones|hormones|mesh-ancestor
14274350|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274351|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274352|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14274353|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274354|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274355|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274356|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274357|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
14274358|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14274359|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
14274360|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274361|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
14274362|NCT00436969|Protective Agents|protective agents|mesh-ancestor
14292489|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292490|NCT00561470|Leucovorin|leucovorin|mesh-list
14292491|NCT00561470|Fluorouracil|fluorouracil|mesh-list
14292492|NCT00561470|Irinotecan|irinotecan|mesh-list
14292493|NCT00561470|Aflibercept|aflibercept|mesh-list
14292494|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
14292495|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
14020360|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14292496|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292497|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14292498|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292499|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292500|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
14292501|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292502|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14292503|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14292504|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020361|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14020362|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
14020363|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020364|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292505|NCT00561470|Antidotes|antidotes|mesh-ancestor
14292506|NCT00561470|Protective Agents|protective agents|mesh-ancestor
14292507|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
14292508|NCT00561470|Vitamins|vitamins|mesh-ancestor
14292509|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
14292510|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14292511|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14292512|NCT00561470|Growth Substances|growth substances|mesh-ancestor
14292513|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
14292514|NCT00561574|Mirtazapine|mirtazapine|mesh-list
14292515|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
14292516|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292517|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14292518|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
14292519|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
14292520|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292521|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292522|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292523|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14292524|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14292525|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292526|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14292527|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14292528|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14292529|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292530|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14292531|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14292532|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
15142701|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14274363|NCT00437034|Aflibercept|aflibercept|mesh-list
14274364|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
14274365|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274366|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14274367|NCT00437034|Growth Substances|growth substances|mesh-ancestor
14274368|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274369|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274370|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274371|NCT00437073|Capecitabine|capecitabine|mesh-list
14274372|NCT00437073|Topotecan|topotecan|mesh-list
14274373|NCT00437073|Lapatinib|lapatinib|mesh-list
14274374|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274375|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
14274376|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274377|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274378|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14274379|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14274380|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274381|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274382|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14274383|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14274384|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14274385|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274386|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274387|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274388|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274389|NCT00437125|Analgesics|analgesics|mesh-ancestor
14274390|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
14274391|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274392|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
14274393|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274394|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
14274395|NCT00437203|Gemcitabine|gemcitabine|mesh-list
14274396|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274397|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
14274398|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274399|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274400|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
14274401|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274402|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274403|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274404|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
14274405|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274406|NCT00437268|Irinotecan|irinotecan|mesh-list
14274407|NCT00437268|Cetuximab|cetuximab|mesh-list
14274408|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14274409|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14274410|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274411|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274412|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274413|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274414|NCT00437281|Pregabalin|pregabalin|mesh-list
14274415|NCT00437281|Analgesics|analgesics|mesh-ancestor
14274416|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
14274417|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274418|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274419|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
14274420|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14274421|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274422|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274423|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14274424|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14274425|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14274426|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14274427|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274428|NCT00437294|Capecitabine|capecitabine|mesh-list
14274429|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274430|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
14274431|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274432|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274433|NCT00437489|Insulin|insulin|mesh-list
14274434|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14274435|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14274436|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274437|NCT00437645|Amlodipine|amlodipine|mesh-list
14274438|NCT00437645|Valsartan|valsartan|mesh-list
14274439|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14274440|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14274441|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274442|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274443|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14274444|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274445|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
14274446|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14274447|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14274448|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14274449|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
14274450|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14274451|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14274452|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14274453|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
14274454|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14274455|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274456|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14274457|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14274458|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14274459|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14274460|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274461|NCT00438100|Capecitabine|capecitabine|mesh-list
14274462|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274463|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
14274464|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274465|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274466|NCT00438204|Gemcitabine|gemcitabine|mesh-list
14274467|NCT00438204|Bevacizumab|bevacizumab|mesh-list
14274468|NCT00438204|Pemetrexed|pemetrexed|mesh-list
14274469|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274470|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274471|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274472|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14274473|NCT00438204|Growth Substances|growth substances|mesh-ancestor
14274474|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142702|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14274475|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274476|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274477|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
14274478|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274479|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
14274480|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274481|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274482|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274483|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
14274484|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14274485|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14274486|NCT00438256|Capecitabine|capecitabine|mesh-list
14274487|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274488|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
14274489|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274490|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274491|NCT00438360|Cyclosporine|cyclosporine|mesh-list
14274492|NCT00438360|Cyclosporins|cyclosporins|mesh-list
14274493|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274494|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274495|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274496|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
14274497|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274498|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
14274499|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274500|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274501|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274502|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14274503|NCT00438451|Lamotrigine|lamotrigine|mesh-list
15142703|NCT04276857|Antidotes|antidotes|mesh-ancestor
14274504|NCT00438451|Carbamazepine|carbamazepine|mesh-list
14274505|NCT00438451|Levetiracetam|levetiracetam|mesh-list
14274506|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
14274507|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
14274508|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14274509|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274510|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274511|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14274512|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274513|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14274514|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14274515|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14274516|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274517|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14274518|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
14274519|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15142704|NCT04276857|Protective Agents|protective agents|mesh-ancestor
15142705|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
15142706|NCT04276857|Vitamins|vitamins|mesh-ancestor
15142707|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
15142708|NCT04276688|Interferons|interferons|mesh-list
15142709|NCT04276688|Ritonavir|ritonavir|mesh-list
15142710|NCT04276688|Ribavirin|ribavirin|mesh-list
15142711|NCT04276688|Lopinavir|lopinavir|mesh-list
15142712|NCT04276688|Interferon-beta|interferon-beta|mesh-list
15142713|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
15142714|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142715|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
15142716|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142717|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15142718|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15142719|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
15142720|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142721|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142722|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15142723|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15142724|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15142725|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15142726|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
14274520|NCT00438451|Analgesics|analgesics|mesh-ancestor
15142727|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
15142728|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142729|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15142730|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
15142731|NCT04276649|Antacids|antacids|mesh-ancestor
15142732|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142733|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142734|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
15142735|NCT04276636|Antacids|antacids|mesh-ancestor
15142736|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142737|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142738|NCT04276389|Paclitaxel|paclitaxel|mesh-list
15142739|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15142740|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15142741|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142742|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
15142743|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274521|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
14274522|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274523|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14274524|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14274525|NCT00438464|Finasteride|finasteride|mesh-list
14274526|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14274527|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14274528|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274529|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274530|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
14274531|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274532|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274533|NCT00438464|Urological Agents|urological agents|mesh-ancestor
14274534|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
14274535|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14274536|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274537|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14274538|NCT00438672|Dexamethasone|dexamethasone|mesh-list
14274539|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14274540|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
14274541|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
14274542|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142744|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274543|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274544|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14274545|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
14274546|NCT00438672|Hormones|hormones|mesh-ancestor
14274547|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274548|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14274549|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274550|NCT00438802|Alefacept|alefacept|mesh-list
14274551|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274552|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
14274553|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274554|NCT00438815|Complement C1s|complement c1s|mesh-list
14274555|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14274556|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14274557|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
14274558|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274559|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14274560|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274561|NCT00438854|Dasatinib|dasatinib|mesh-list
14274562|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274563|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274564|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274565|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274566|NCT00438880|Rituximab|rituximab|mesh-list
14274567|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14274568|NCT00438880|Antibodies|antibodies|mesh-list
14274569|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
14274570|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14274571|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
14274572|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274573|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274574|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274575|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14274576|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14274577|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14274578|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274579|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274580|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274581|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274582|NCT00438971|Analgesics|analgesics|mesh-ancestor
15142745|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142746|NCT04276376|Atezolizumab|atezolizumab|mesh-list
15142747|NCT04276376|Rucaparib|rucaparib|mesh-list
15142748|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142749|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15142750|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142751|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274583|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
14274584|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274585|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
14274586|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274587|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
14274588|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
14274589|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14274590|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14274591|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14274592|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274593|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274594|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
14274595|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274596|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274597|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14274598|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274599|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
15142752|NCT04276298|Metronidazole|metronidazole|mesh-list
15142753|NCT04276298|Lidocaine|lidocaine|mesh-list
15142754|NCT04276298|Diltiazem|diltiazem|mesh-list
15142755|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
15142756|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
14274600|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274601|NCT00439231|Lenalidomide|lenalidomide|mesh-list
14274602|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
14274603|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142757|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14274604|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14274605|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14274606|NCT00439231|Growth Substances|growth substances|mesh-ancestor
14274607|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274608|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274609|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
14274610|NCT00439244|Teriparatide|teriparatide|mesh-list
14274611|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14274612|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274613|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14274614|NCT00439270|Docetaxel|docetaxel|mesh-list
14274615|NCT00439270|Dasatinib|dasatinib|mesh-list
14274616|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274617|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
14274618|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274619|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274620|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142758|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142759|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
15142760|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142761|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14274621|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14274622|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274623|NCT00439296|Cytarabine|cytarabine|mesh-list
14274624|NCT00439296|Dexamethasone|dexamethasone|mesh-list
14274625|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
14274626|NCT00439296|Doxorubicin|doxorubicin|mesh-list
14274627|NCT00439296|Methotrexate|methotrexate|mesh-list
14274628|NCT00439296|Asparaginase|asparaginase|mesh-list
14274629|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
14274630|NCT00439296|Thioguanine|thioguanine|mesh-list
14274631|NCT00439296|Pegaspargase|pegaspargase|mesh-list
14274632|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274633|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
14274634|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274635|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274636|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14274637|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
14274638|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274639|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274640|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14274641|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14274642|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
15142762|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15142763|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15142764|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142765|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142766|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274643|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
14274644|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274645|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14274646|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
15142767|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15142768|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15142769|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15142770|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15142771|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15142772|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15142773|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
15142774|NCT04276480|Tazobactam|tazobactam|mesh-list
15142775|NCT04276480|Piperacillin|piperacillin|mesh-list
15142776|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15142777|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15142778|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142779|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15142780|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142781|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142782|NCT04276428|Insulin|insulin|mesh-list
15142783|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14274647|NCT00439296|Hormones|hormones|mesh-ancestor
14274648|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274649|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14020365|NCT02780479|Dexamethasone|dexamethasone|mesh-list
14274650|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14274651|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14274652|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14274653|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274654|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14274655|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
14274656|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14274657|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274658|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
14274659|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274660|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14274661|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14274662|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
14274663|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274664|NCT00439309|Thrombin|thrombin|mesh-list
14274665|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14274666|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
14274667|NCT00439309|Coagulants|coagulants|mesh-ancestor
14274668|NCT00439335|Vaccines|vaccines|mesh-list
14274669|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
14274670|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274671|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14274672|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14274673|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14274674|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
14274675|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274676|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274677|NCT00439374|Progestins|progestins|mesh-ancestor
14274678|NCT00439374|Hormones|hormones|mesh-ancestor
14274679|NCT00439413|Selegiline|selegiline|mesh-list
14274680|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
14274681|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274682|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14274683|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14274684|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14274685|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274686|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274687|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14274688|NCT00439413|Protective Agents|protective agents|mesh-ancestor
14274689|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274690|NCT00439517|Cetuximab|cetuximab|mesh-list
14274691|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274692|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274693|NCT00439556|Cytarabine|cytarabine|mesh-list
14274694|NCT00439556|Rituximab|rituximab|mesh-list
14274695|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14274696|NCT00439556|Methotrexate|methotrexate|mesh-list
14274697|NCT00439556|Etoposide|etoposide|mesh-list
14274698|NCT00439556|Bortezomib|bortezomib|mesh-list
14274699|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
14274700|NCT00439556|Melphalan|melphalan|mesh-list
14274701|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
14274702|NCT00439556|Carmustine|carmustine|mesh-list
14274703|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
14274704|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14274705|NCT00439556|Antibodies|antibodies|mesh-list
14274706|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
14274707|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14274708|NCT00439556|Lenograstim|lenograstim|mesh-list
14274709|NCT00439556|Tacrolimus|tacrolimus|mesh-list
14274710|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
14274711|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14274712|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
14274713|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274714|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274715|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274716|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14274717|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
14274718|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14274719|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274720|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
14274721|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274722|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274723|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142784|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274724|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14274725|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142785|NCT04276597|Edotreotide|edotreotide|mesh-list
14274726|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14274727|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14274728|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14274729|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14274730|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
14274731|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274732|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14274733|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14274734|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14274735|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
14274736|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14274737|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
14274738|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14274739|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274740|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274741|NCT00439608|Paclitaxel|paclitaxel|mesh-list
14274742|NCT00439608|Carboplatin|carboplatin|mesh-list
14274743|NCT00439608|Cetuximab|cetuximab|mesh-list
14274744|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14274745|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142786|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15142787|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142788|NCT04276363|Nicotine|nicotine|mesh-list
15142789|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15142790|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
15142791|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142792|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274746|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
14274747|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274748|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274749|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274750|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274751|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
14274752|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14274753|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274754|NCT00439673|Azacitidine|azacitidine|mesh-list
14274755|NCT00439673|Valproic Acid|valproic acid|mesh-list
14274756|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274757|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
14274758|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274759|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274760|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274761|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
14274762|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
14274763|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274764|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274765|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
14274766|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14274767|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14274768|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274769|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
14274770|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14562139|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14562140|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
14562141|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562142|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562143|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
14562144|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
14562145|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562146|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562147|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
14562148|NCT00002831|Hormones|hormones|mesh-ancestor
14562149|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562150|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14562151|NCT00002831|Protective Agents|protective agents|mesh-ancestor
14562152|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15142793|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15142794|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15142795|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
14274771|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
14274772|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14274773|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
14274774|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274775|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274776|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
14274777|NCT00439777|Enoxaparin|enoxaparin|mesh-list
14274778|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
14274779|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14274780|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
14274781|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14274782|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
14274783|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274784|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274785|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
14274786|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14274787|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14274788|NCT00439946|Treprostinil|treprostinil|mesh-list
14274789|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14274790|NCT00440011|Bimatoprost|bimatoprost|mesh-list
14274791|NCT00440011|Travoprost|travoprost|mesh-list
14274792|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14274793|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14274794|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14274795|NCT00440115|Bupropion|bupropion|mesh-list
14274796|NCT00440115|Nicotine|nicotine|mesh-list
14274797|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14274798|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
14274799|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274800|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274801|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14274802|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14274803|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
14274804|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274805|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274806|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14274807|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
14274808|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14274809|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14274810|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14274811|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274812|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
14274813|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14274814|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14274815|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274816|NCT00440180|Anastrozole|anastrozole|mesh-list
14274817|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14274818|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274819|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14274820|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14274821|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274822|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274823|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14274824|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
14274825|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274826|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274827|NCT00440193|Enoxaparin|enoxaparin|mesh-list
14274828|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
14274829|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14274830|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
14274831|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14274832|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
14274833|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274834|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274835|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
14274836|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14274837|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14274838|NCT00440232|Frovatriptan|frovatriptan|mesh-list
14274839|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14274840|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
14274841|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274842|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274843|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274844|NCT00440310|Talaporfin|talaporfin|mesh-list
14274845|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142796|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142797|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179450|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14274846|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14274847|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274848|NCT00440401|Thrombin|thrombin|mesh-list
14274849|NCT00440401|Hemostatics|hemostatics|mesh-list
14274850|NCT00440401|Coagulants|coagulants|mesh-ancestor
14274851|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
14274852|NCT00440466|Hematinics|hematinics|mesh-ancestor
14274853|NCT00440505|Nicotine|nicotine|mesh-list
14274854|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14274855|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
14274856|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274857|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274858|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14274859|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14274860|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
14274861|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274862|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274863|NCT00440518|Lacosamide|lacosamide|mesh-list
14274864|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
14274865|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14274866|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14274867|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14274868|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274869|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
14274870|NCT00440557|Hematinics|hematinics|mesh-ancestor
14274871|NCT00440726|Cytarabine|cytarabine|mesh-list
14274872|NCT00440726|Dexamethasone|dexamethasone|mesh-list
14274873|NCT00440726|Doxorubicin|doxorubicin|mesh-list
14274874|NCT00440726|Methotrexate|methotrexate|mesh-list
14274875|NCT00440726|Vincristine|vincristine|mesh-list
14274876|NCT00440726|Bortezomib|bortezomib|mesh-list
14274877|NCT00440726|Asparaginase|asparaginase|mesh-list
14274878|NCT00440726|Pegaspargase|pegaspargase|mesh-list
14274879|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14274880|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
14274881|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
14274882|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274883|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274884|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14274885|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
14274886|NCT00440726|Hormones|hormones|mesh-ancestor
14274887|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274888|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14274889|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274890|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14274891|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14274892|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15142798|NCT04276545|Midazolam|midazolam|mesh-list
15142799|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15142800|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15142801|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142802|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142803|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15142804|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15142805|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142806|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142807|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
15142808|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
15142809|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
15142810|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
15142811|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142812|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142813|NCT04276090|Dexamethasone|dexamethasone|mesh-list
15142814|NCT04276090|Floxuridine|floxuridine|mesh-list
15142815|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142816|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
15142817|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
15142818|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142819|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142820|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142821|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
15142822|NCT04276090|Hormones|hormones|mesh-ancestor
15142823|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15142824|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15142825|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274893|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142826|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15142827|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
15142828|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142829|NCT04276155|Anticoagulants|anticoagulants|mesh-list
14274894|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274895|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14274896|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
14274897|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14274898|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14274899|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
14274900|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
14274901|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14274902|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14274903|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
14274904|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274905|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14274906|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
14274907|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274908|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14274909|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
14274910|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274911|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274912|NCT00440830|Nicotine|nicotine|mesh-list
14274913|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14274914|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
14274915|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274916|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274917|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14274918|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14274919|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
14274920|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14274921|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274922|NCT00440947|Ritonavir|ritonavir|mesh-list
14274923|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14274924|NCT00440947|Lamivudine|lamivudine|mesh-list
14274925|NCT00440947|Abacavir|abacavir|mesh-list
14274926|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
14274927|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15142830|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15142831|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15142832|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142833|NCT04275960|Selitrectinib|selitrectinib|mesh-list
15142834|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142835|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142836|NCT04275713|Metformin|metformin|mesh-list
15142837|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15142838|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142839|NCT04275414|Bevacizumab|bevacizumab|mesh-list
15142840|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14274928|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14274929|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
14274930|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274931|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274932|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14274933|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14274934|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
14274935|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274936|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14274937|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14274938|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14274939|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14274940|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
14274941|NCT00440999|Artesunate|artesunate|mesh-list
14274942|NCT00440999|Chloroquine|chloroquine|mesh-list
14274943|NCT00440999|Pyronaridine|pyronaridine|mesh-list
14274944|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
14274945|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14274946|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14274947|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274948|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274949|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
14274950|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
14274951|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14274952|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
14274953|NCT00440999|Amebicides|amebicides|mesh-ancestor
15142841|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020366|NCT02780479|Prednisone|prednisone|mesh-list
14020367|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020368|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
14020369|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
14020370|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020371|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020372|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020373|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
14020374|NCT02780479|Hormones|hormones|mesh-ancestor
14274954|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14274955|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
14274956|NCT00441103|Interferon-beta|interferon-beta|mesh-list
14274957|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14274958|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
14274959|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274960|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274961|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
14274962|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14274963|NCT00441116|Dutasteride|dutasteride|mesh-list
14274964|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14274965|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14274966|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14274967|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274968|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
14274969|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274970|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274971|NCT00441129|Insulin|insulin|mesh-list
14274972|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14274973|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274974|NCT00441142|Temozolomide|temozolomide|mesh-list
14274975|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14274976|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
14274977|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14274978|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274979|NCT00441168|Dexamethasone|dexamethasone|mesh-list
14274980|NCT00441168|Vincristine|vincristine|mesh-list
14274981|NCT00441168|Doxorubicin|doxorubicin|mesh-list
14274982|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14274983|NCT00441168|Bortezomib|bortezomib|mesh-list
14274984|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15142842|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15142843|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15142844|NCT04275414|Growth Substances|growth substances|mesh-ancestor
15142845|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142846|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
14274985|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
14274986|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
14274987|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14274988|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14274989|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14274990|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
14274991|NCT00441168|Hormones|hormones|mesh-ancestor
14274992|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14274993|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14274994|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274995|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14274996|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
15142847|NCT04275518|Cytarabine|cytarabine|mesh-list
15142848|NCT04275518|Azacitidine|azacitidine|mesh-list
15142849|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15142850|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
15142851|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142852|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14274997|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
14274998|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
14274999|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275000|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14275001|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14275002|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14275003|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275004|NCT00441285|Albendazole|albendazole|mesh-list
14275005|NCT00441285|Praziquantel|praziquantel|mesh-list
14275006|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
14275007|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14275008|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275009|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
14275010|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14275011|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15142853|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
15142854|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142855|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15142856|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
14275012|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
15142857|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275013|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14275014|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14275015|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275016|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142858|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142859|NCT04275375|Anesthetics|anesthetics|mesh-list
15142860|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142861|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275017|NCT00441337|Nivolumab|nivolumab|mesh-list
14275018|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275019|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275020|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14275021|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275022|NCT00441363|Bromocriptine|bromocriptine|mesh-list
14275023|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14275024|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14275025|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
14275026|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275027|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275028|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
14275029|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
14275030|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275031|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275032|NCT00441441|Fluticasone|fluticasone|mesh-list
14275033|NCT00441441|Xhance|xhance|mesh-list
14275034|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14275035|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275036|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14275037|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
14275038|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275039|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275040|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14275041|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
14275042|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
14275043|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14275044|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14275045|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14275046|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14275047|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
14275048|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275049|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275050|NCT00441545|Sevelamer|sevelamer|mesh-list
14275051|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
14275052|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
14275053|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275054|NCT00441584|Ribavirin|ribavirin|mesh-list
14275055|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14275056|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
15142862|NCT04275388|Interferons|interferons|mesh-list
15142863|NCT04275388|Ritonavir|ritonavir|mesh-list
15142864|NCT04275388|Lopinavir|lopinavir|mesh-list
15142865|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
15142866|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
15142867|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142868|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
15142869|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275057|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
14275058|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275059|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
14275060|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275061|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
14275062|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275063|NCT00441727|Esomeprazole|esomeprazole|mesh-list
14275064|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14275065|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275066|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14275067|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275068|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275069|NCT00441792|Midazolam|midazolam|mesh-list
14275070|NCT00441792|Etomidate|etomidate|mesh-list
14275071|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14275072|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14275073|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14275074|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142870|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14275075|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14275076|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14275077|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14275078|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14275079|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
14275080|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
14275081|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
14275082|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
14275083|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275084|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275085|NCT00441883|Latanoprost|latanoprost|mesh-list
14275086|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14275087|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14275088|NCT00441974|Adefovir|adefovir|mesh-list
14275089|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14275090|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
14275091|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275092|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15142871|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15142872|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
15142873|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142874|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142875|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15142876|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15142877|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15142878|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15142879|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
15142880|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142881|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15142882|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
15142883|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142884|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
15142885|NCT04275258|Narcotics|narcotics|mesh-ancestor
15142886|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142887|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142888|NCT04275258|Analgesics|analgesics|mesh-ancestor
15142889|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
15142890|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142891|NCT04275492|Pramipexole|pramipexole|mesh-list
15142892|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
15142893|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142894|NCT04275492|Protective Agents|protective agents|mesh-ancestor
15142895|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142896|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15142897|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15142898|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
15142899|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
15142900|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142901|NCT04275362|Cimetidine|cimetidine|mesh-list
15142902|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15142903|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142904|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15142905|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
15142906|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
15142907|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142908|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142909|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142910|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15142911|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15142912|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142913|NCT04275115|Midazolam|midazolam|mesh-list
14275093|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14275094|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142914|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15142915|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15142916|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15142917|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142918|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15142919|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15142920|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142921|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15142922|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
15142923|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
15142924|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
14275095|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275096|NCT00442013|Lansoprazole|lansoprazole|mesh-list
14275097|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
14275098|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14275099|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275100|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14275101|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275102|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275103|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14275104|NCT00442364|Polidocanol|polidocanol|mesh-list
14275105|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14275106|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14292533|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14292534|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
14292535|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14292536|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292537|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292538|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14292539|NCT00561678|Analgesics|analgesics|mesh-ancestor
14292540|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
14292541|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292542|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14292543|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14292544|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14292545|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292546|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292547|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292548|NCT00561730|Pantoprazole|pantoprazole|mesh-list
14292549|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14292550|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292551|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14292552|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292553|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292554|NCT00561821|Mirtazapine|mirtazapine|mesh-list
14292555|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
14292556|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292557|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14292558|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
14292559|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
14292560|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292561|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292562|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292563|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14292564|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14292565|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292566|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14292567|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14292568|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14292569|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292570|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14292571|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14292572|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
15142925|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
15142926|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142927|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142928|NCT04275180|Argatroban|argatroban|mesh-list
15142929|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
14292573|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14292574|NCT00561834|Ranibizumab|ranibizumab|mesh-list
14292575|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14292576|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14292577|NCT00561834|Growth Substances|growth substances|mesh-ancestor
14292578|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292579|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
14292580|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292581|NCT00561925|Nevirapine|nevirapine|mesh-list
14292582|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14292583|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14292584|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292585|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292586|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
15142930|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15142931|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
15142932|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179451|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
14275107|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
14275108|NCT00442416|Hematinics|hematinics|mesh-ancestor
14275109|NCT00442507|Bevacizumab|bevacizumab|mesh-list
14275110|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14275111|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275112|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275113|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275114|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275115|NCT00442507|Growth Substances|growth substances|mesh-ancestor
14275116|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275117|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275118|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275119|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275120|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275121|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14275122|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
14275123|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275124|NCT00442611|Abatacept|abatacept|mesh-list
14275125|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14275126|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275127|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275128|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275129|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
14275130|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275131|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275132|NCT00442689|Flutamide|flutamide|mesh-list
14275133|NCT00442689|Drospirenone|drospirenone|mesh-list
14275134|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14275135|NCT00442689|Estradiol|estradiol|mesh-list
14275136|NCT00442689|Estrogens|estrogens|mesh-ancestor
14275137|NCT00442689|Hormones|hormones|mesh-ancestor
14275138|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275139|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275140|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14275141|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
14275142|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14275143|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14275144|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14275145|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14275146|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14275147|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
14275148|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14275149|NCT00442689|Diuretics|diuretics|mesh-ancestor
14275150|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
14275151|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
14275152|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14275153|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275154|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
14275155|NCT00442702|Hematinics|hematinics|mesh-ancestor
14275156|NCT00442767|Insulin|insulin|mesh-list
14275157|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14275158|NCT00442767|Pramlintide|pramlintide|mesh-list
14275159|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14275160|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14275161|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275162|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
14275163|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14275164|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14275165|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275166|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
14275167|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
14275168|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14275169|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14275170|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
14275171|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275172|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275173|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275174|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275175|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14275176|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275177|NCT00442962|Tenofovir|tenofovir|mesh-list
14275178|NCT00442962|Emtricitabine|emtricitabine|mesh-list
14275179|NCT00442962|Efavirenz|efavirenz|mesh-list
14275180|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14275181|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
14275182|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142933|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142934|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
15142935|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15142936|NCT04274933|Capecitabine|capecitabine|mesh-list
15142937|NCT04274933|Venetoclax|venetoclax|mesh-list
15142938|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275183|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14275184|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14275185|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275186|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275187|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14275188|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14275189|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14275190|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14275191|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14275192|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14275193|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14275194|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14275195|NCT00443053|PENTA|penta|mesh-list
14275196|NCT00443053|Fondaparinux|fondaparinux|mesh-list
14275197|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14275198|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
14275199|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14275200|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
14275201|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15142939|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
15142940|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142941|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142942|NCT04274920|Calcium|calcium|mesh-list
15142943|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15142944|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142945|NCT04275024|Calcipotriene|calcipotriene|mesh-list
15142946|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
15142947|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
15142948|NCT04274907|Venetoclax|venetoclax|mesh-list
15142949|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275202|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275203|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
14275204|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15142950|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142951|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
15142952|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15142953|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14275205|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14275206|NCT00443209|Rizatriptan|rizatriptan|mesh-list
15142954|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15142955|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142956|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142957|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
15142958|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142959|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142960|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15142961|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15142962|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15142963|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
15142964|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15142965|NCT04274816|Tremelimumab|tremelimumab|mesh-list
14275207|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14275208|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
14275209|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275210|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275211|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275212|NCT00443261|Azacitidine|azacitidine|mesh-list
14275213|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275214|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275215|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
14275216|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275217|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275218|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14275219|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14275220|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15142966|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142967|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14275221|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275222|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275223|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275224|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275225|NCT00443352|Analgesics|analgesics|mesh-ancestor
14275226|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
14275227|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275228|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
14275229|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14275230|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
14275231|NCT00443430|Prednisone|prednisone|mesh-list
14275232|NCT00443430|Prednisolone|prednisolone|mesh-list
14275233|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14275234|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
14275235|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14275236|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
14275237|NCT00443430|Etanercept|etanercept|mesh-list
14275238|NCT00443430|Methotrexate|methotrexate|mesh-list
14275239|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14275240|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
14275241|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275242|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
14275243|NCT00443430|Hormones|hormones|mesh-ancestor
14275244|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275245|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275246|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14275247|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275248|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14275249|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
14275250|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14275251|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275252|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
14275253|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275254|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
14275255|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275256|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14275257|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275258|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
14275259|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275260|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14275261|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
14275262|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
14275263|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275264|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275265|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14275266|NCT00443430|Protective Agents|protective agents|mesh-ancestor
14275267|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14275268|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14275269|NCT00443430|Analgesics|analgesics|mesh-ancestor
14275270|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
14275271|NCT00443456|Amlodipine|amlodipine|mesh-list
14275272|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14275273|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14275274|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275275|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142968|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14275276|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14275277|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275278|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
14275279|NCT00443534|Sunitinib|sunitinib|mesh-list
14275280|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275281|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275282|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275283|NCT00443534|Growth Substances|growth substances|mesh-ancestor
14275284|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275285|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275286|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275287|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275288|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275289|NCT00443560|Fentanyl|fentanyl|mesh-list
14275290|NCT00443560|Bupivacaine|bupivacaine|mesh-list
14275291|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
14275292|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
14275293|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14275294|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275295|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
14275296|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275297|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14275298|NCT00443560|Narcotics|narcotics|mesh-ancestor
14275299|NCT00443560|Analgesics|analgesics|mesh-ancestor
14275300|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14275301|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14275302|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
14275303|NCT00443599|Insulin|insulin|mesh-list
14275304|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14275305|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14275306|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275307|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14275308|NCT00443651|Rituximab|rituximab|mesh-list
14275309|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275310|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275311|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
14275312|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275313|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275314|NCT00443703|Ritonavir|ritonavir|mesh-list
14275315|NCT00443703|Lopinavir|lopinavir|mesh-list
14275316|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
14275317|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14275318|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14275319|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
14275320|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275321|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275322|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14275323|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14275324|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
14275325|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275326|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14275327|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14275328|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14275329|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14275330|NCT00443729|Ritonavir|ritonavir|mesh-list
14275331|NCT00443729|Lopinavir|lopinavir|mesh-list
14275332|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
14275333|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14275334|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14275335|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14275336|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275337|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275338|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14275339|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14275340|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
14275341|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275342|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14275343|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14275344|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14275345|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14275346|NCT00443755|Metformin|metformin|mesh-list
14275347|NCT00443755|Pioglitazone|pioglitazone|mesh-list
14275348|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14275349|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275350|NCT00443781|Anesthetics|anesthetics|mesh-list
14275351|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14275352|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275353|NCT00443820|Terbinafine|terbinafine|mesh-list
14275354|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
14275355|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275356|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275357|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275358|NCT00443872|Selegiline|selegiline|mesh-list
14275359|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
14275360|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14275361|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14275362|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14275363|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14275364|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275365|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275366|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14275367|NCT00443872|Protective Agents|protective agents|mesh-ancestor
14275368|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275369|NCT00443898|Terbinafine|terbinafine|mesh-list
14275370|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
14275371|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275372|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275373|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020375|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020376|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14275374|NCT00444028|Loxapine|loxapine|mesh-list
14275375|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14275376|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14275377|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14275378|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275379|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15142969|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15142970|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15142971|NCT04274270|Endostar protein|endostar protein|mesh-list
15142972|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15142973|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15142974|NCT04274270|Growth Substances|growth substances|mesh-ancestor
15142975|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142976|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
15142977|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179452|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15179453|NCT03949764|Velpatasvir|velpatasvir|mesh-list
15179454|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
15179455|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179456|NCT03949985|Hemostatics|hemostatics|mesh-list
15179457|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
15179458|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15179459|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179460|NCT03949985|Coagulants|coagulants|mesh-ancestor
15179461|NCT03949855|Rituximab|rituximab|mesh-list
15179462|NCT03949855|Belimumab|belimumab|mesh-list
15179463|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179464|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179465|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
15179466|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179467|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179468|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15179469|NCT03949686|Bupivacaine|bupivacaine|mesh-list
15179470|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
15179471|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
15179472|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179473|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179474|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
15179475|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179476|NCT03949842|Fluticasone|fluticasone|mesh-list
15179477|NCT03949842|Xhance|xhance|mesh-list
15179478|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
15179479|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
15179480|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
15179481|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179482|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15179483|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
15179484|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179485|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179486|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15179487|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179488|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
15179489|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15179490|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179491|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020377|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020378|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
14020379|NCT02780505|Vitamins|vitamins|mesh-ancestor
14020380|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
14020381|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020382|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
14020383|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020384|NCT02780505|Protective Agents|protective agents|mesh-ancestor
14020385|NCT02780102|Methylphenidate|methylphenidate|mesh-list
14020386|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15179492|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15179493|NCT03949517|Piperidine|piperidine|mesh-list
15179494|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15179495|NCT03949517|Bombesin|bombesin|mesh-list
14275380|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14275381|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
14275382|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275383|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275384|NCT00444106|Artesunate|artesunate|mesh-list
14275385|NCT00444106|Lumefantrine|lumefantrine|mesh-list
14275386|NCT00444106|Artemether|artemether|mesh-list
14275387|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14275388|NCT00444106|Mefloquine|mefloquine|mesh-list
14275389|NCT00444106|Atovaquone|atovaquone|mesh-list
14275390|NCT00444106|Proguanil|proguanil|mesh-list
14275391|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14275392|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
14275393|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14275394|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14275395|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275396|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275397|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
14275398|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
14275399|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14275400|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
14275401|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275402|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275403|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
14275404|NCT00444145|Lansoprazole|lansoprazole|mesh-list
14275405|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14275406|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275407|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14275408|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275409|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275410|NCT00444275|Esomeprazole|esomeprazole|mesh-list
14275411|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14275412|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15142978|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15142979|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
15142980|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142981|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
15142982|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15142983|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142984|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142985|NCT04274257|Rituximab|rituximab|mesh-list
15142986|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15142987|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15142988|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
15142989|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15142990|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15142991|NCT04274179|Lamotrigine|lamotrigine|mesh-list
15142992|NCT04274179|Valproic Acid|valproic acid|mesh-list
15142993|NCT04274179|Ethosuximide|ethosuximide|mesh-list
15142994|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
15142995|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15142996|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15142997|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15142998|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15142999|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143000|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15143001|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15143002|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143003|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15143004|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15143005|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275413|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14275414|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275415|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275416|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14275417|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
14275418|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275419|NCT00444535|Bevacizumab|bevacizumab|mesh-list
14275420|NCT00444535|Lapatinib|lapatinib|mesh-list
14275421|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275422|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275423|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275424|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15143006|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
15143007|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275425|NCT00444535|Growth Substances|growth substances|mesh-ancestor
14275426|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275427|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
15143008|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
15143009|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
15143010|NCT04273880|Methylphenidate|methylphenidate|mesh-list
15143011|NCT04273880|Vitamins|vitamins|mesh-ancestor
15143012|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
15143013|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143014|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
15143015|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275428|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275429|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275430|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275431|NCT00444587|Trastuzumab|trastuzumab|mesh-list
14275432|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275433|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275434|NCT00444600|Triamcinolone|triamcinolone|mesh-list
14275435|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14275436|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14275437|NCT00444600|Bevacizumab|bevacizumab|mesh-list
14275438|NCT00444600|Ranibizumab|ranibizumab|mesh-list
14275439|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14275440|NCT00444600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275441|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275442|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275443|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275444|NCT00444600|Growth Substances|growth substances|mesh-ancestor
14275445|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275446|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275447|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275448|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
14275449|NCT00444600|Hormones|hormones|mesh-ancestor
14275450|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275451|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275452|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
14275453|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275454|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275455|NCT00444626|Lidocaine|lidocaine|mesh-list
14275456|NCT00444626|Prilocaine|prilocaine|mesh-list
14275457|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14275458|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
14275459|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
14275460|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
14275461|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14275462|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275463|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
14275464|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275465|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14275466|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14275467|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14275468|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275469|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275470|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14275471|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
14275472|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
14275473|NCT00444626|Protective Agents|protective agents|mesh-ancestor
14275474|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14275475|NCT00444678|Capecitabine|capecitabine|mesh-list
14275476|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
14275477|NCT00444678|Cetuximab|cetuximab|mesh-list
14275478|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275479|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
14275480|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275481|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143016|NCT04273880|Protective Agents|protective agents|mesh-ancestor
15143017|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15143018|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15143019|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15143020|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15143021|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
15143022|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143023|NCT04273997|Metronidazole|metronidazole|mesh-list
15143024|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275482|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182087|NCT03924544|Mitomycin|mitomycin|mesh-list
14275483|NCT00444795|Sunitinib|sunitinib|mesh-list
14275484|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275485|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275486|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275487|NCT00444795|Growth Substances|growth substances|mesh-ancestor
14275488|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275489|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275490|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275491|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275492|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275493|NCT00444912|Plerixafor|plerixafor|mesh-list
14275494|NCT00444912|Rituximab|rituximab|mesh-list
14275495|NCT00444912|Lenograstim|lenograstim|mesh-list
14275496|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275497|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275498|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
14275499|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275500|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275501|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14275502|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14275503|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15143025|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143026|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15143027|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15143028|NCT04273984|Misoprostol|misoprostol|mesh-list
15143029|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15143030|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
15143031|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15143032|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143033|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15143034|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143035|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
15143036|NCT04273776|Zolpidem|zolpidem|mesh-list
15143037|NCT04273776|Suvorexant|suvorexant|mesh-list
15143038|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15143039|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15143040|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14275504|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
14275505|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275506|NCT00444925|Fesoterodine|fesoterodine|mesh-list
14275507|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14275508|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14275509|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14275510|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
14275511|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275512|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275513|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275514|NCT00444925|Urological Agents|urological agents|mesh-ancestor
14275515|NCT00444951|Vaccines|vaccines|mesh-list
14275516|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
14275517|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275518|NCT00444964|Hormones|hormones|mesh-list
14275519|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275520|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275521|NCT00445003|Triamcinolone|triamcinolone|mesh-list
14275522|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14275523|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14275524|NCT00445003|Ranibizumab|ranibizumab|mesh-list
14275525|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14275526|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275527|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275528|NCT00445003|Growth Substances|growth substances|mesh-ancestor
14275529|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275530|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275531|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143041|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143042|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15143043|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
15143044|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
15143045|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143046|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143047|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14275532|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143048|NCT04273763|Interferons|interferons|mesh-list
15143049|NCT04273763|Bromhexine|bromhexine|mesh-list
14275533|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
15143050|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275534|NCT00445003|Hormones|hormones|mesh-ancestor
14275535|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275536|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562153|NCT00002832|Cyclosporine|cyclosporine|mesh-list
14562154|NCT00002832|Decitabine|decitabine|mesh-list
14562155|NCT00002832|Cyclosporins|cyclosporins|mesh-list
14562156|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
14562157|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562158|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562159|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562160|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562161|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
14562162|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562163|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
14562164|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562165|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14562166|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562167|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
14562168|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562169|NCT00002833|Cytarabine|cytarabine|mesh-list
14562170|NCT00002833|Cyclosporine|cyclosporine|mesh-list
14562171|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
14562172|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14562173|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14562174|NCT00002833|Prednisolone|prednisolone|mesh-list
14562175|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
14562176|NCT00002833|Fludarabine|fludarabine|mesh-list
14562177|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
14562178|NCT00002833|Idarubicin|idarubicin|mesh-list
14562179|NCT00002833|Cladribine|cladribine|mesh-list
14562180|NCT00002833|Cyclosporins|cyclosporins|mesh-list
14562181|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14562182|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
14562183|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562184|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562185|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
14562186|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562187|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562188|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
14562189|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562190|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
14562191|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562192|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562193|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
14562194|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
14562195|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562196|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14562197|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562198|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
14562199|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
14562200|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562201|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562202|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
14562203|NCT00002833|Hormones|hormones|mesh-ancestor
14562204|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562205|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14562206|NCT00002833|Protective Agents|protective agents|mesh-ancestor
14562207|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562208|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562209|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562210|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562211|NCT00002835|Leucovorin|leucovorin|mesh-list
14562212|NCT00002835|Interferons|interferons|mesh-list
14562213|NCT00002835|Cytarabine|cytarabine|mesh-list
14562214|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
14562215|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
14562216|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14562217|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14562218|NCT00002835|Prednisolone|prednisolone|mesh-list
14562219|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
14562220|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
14562221|NCT00002835|Melphalan|melphalan|mesh-list
14562222|NCT00002835|Ifosfamide|ifosfamide|mesh-list
14562223|NCT00002835|Carmustine|carmustine|mesh-list
14562224|NCT00002835|Cisplatin|cisplatin|mesh-list
14562225|NCT00002835|Methotrexate|methotrexate|mesh-list
14562226|NCT00002835|Etoposide|etoposide|mesh-list
14562227|NCT00002835|Vincristine|vincristine|mesh-list
14562228|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
14562229|NCT00002835|Idarubicin|idarubicin|mesh-list
14562230|NCT00002835|Bleomycin|bleomycin|mesh-list
14562231|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
14275537|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
14275538|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275539|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275540|NCT00445068|Panobinostat|panobinostat|mesh-list
14275541|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143051|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
15143052|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143053|NCT04273763|Expectorants|expectorants|mesh-ancestor
15143054|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
15143055|NCT04273581|Thalidomide|thalidomide|mesh-list
14275542|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14275543|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275544|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275545|NCT00445146|Elvitegravir|elvitegravir|mesh-list
14275546|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14275547|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14275548|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
14275549|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275550|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14275551|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275552|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275553|NCT00445211|Heparin|heparin|mesh-list
14275554|NCT00445211|Calcium heparin|calcium heparin|mesh-list
14275555|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
14275556|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14275557|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14275558|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275559|NCT00445263|Tirofiban|tirofiban|mesh-list
14275560|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14275561|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14275562|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275563|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14275564|NCT00445302|Plerixafor|plerixafor|mesh-list
14275565|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14275566|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14275567|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
14275568|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275569|NCT00445328|Heparin|heparin|mesh-list
14275570|NCT00445328|Calcium heparin|calcium heparin|mesh-list
14275571|NCT00445328|Dalteparin|dalteparin|mesh-list
14275572|NCT00445328|Tinzaparin|tinzaparin|mesh-list
14275573|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14275574|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
14275575|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14275576|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14275577|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275578|NCT00445341|Alvocidib|alvocidib|mesh-list
14275579|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275580|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275581|NCT00445341|Growth Substances|growth substances|mesh-ancestor
15143056|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15143057|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
15143058|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275582|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275583|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275584|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275585|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275586|NCT00445432|Adalimumab|adalimumab|mesh-list
14275587|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275588|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275589|NCT00445458|Paclitaxel|paclitaxel|mesh-list
14275590|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14275591|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275592|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
14275593|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
14275594|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
14275595|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275596|NCT00445484|Lenalidomide|lenalidomide|mesh-list
14275597|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14275598|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
14275599|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275600|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275601|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275602|NCT00445484|Growth Substances|growth substances|mesh-ancestor
14275603|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
15143059|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
15143060|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143061|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143062|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15143063|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275604|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275605|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14275606|NCT00445588|Sorafenib|sorafenib|mesh-list
14275607|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275608|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275609|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275610|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275611|NCT00445601|Gemcitabine|gemcitabine|mesh-list
14275612|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275613|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
14275614|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275615|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275616|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
14275617|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275618|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275619|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275620|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
14275621|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275622|NCT00445679|Paroxetine|paroxetine|mesh-list
14275623|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14275624|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14275625|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275626|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275627|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275628|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
14275629|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275630|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14275631|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
14275632|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14275633|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14275634|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14275635|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275636|NCT00445692|Clarithromycin|clarithromycin|mesh-list
14275637|NCT00445692|Dexamethasone|dexamethasone|mesh-list
14275638|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
14275639|NCT00445692|Lenalidomide|lenalidomide|mesh-list
14275640|NCT00445692|Ichthammol|ichthammol|mesh-list
14275641|NCT00445692|BB 1101|bb 1101|mesh-list
14275642|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275643|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
14275644|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
14275645|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275646|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275647|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275648|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
14275649|NCT00445692|Hormones|hormones|mesh-ancestor
14275650|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275651|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14275652|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275653|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
14275654|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275655|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275656|NCT00445692|Growth Substances|growth substances|mesh-ancestor
14275657|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275658|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14275659|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275660|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14275661|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275662|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275663|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14275664|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14275665|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
14275666|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
14275667|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
14275668|NCT00445744|Busulfan|busulfan|mesh-list
14275669|NCT00445744|Methotrexate|methotrexate|mesh-list
14275670|NCT00445744|Tacrolimus|tacrolimus|mesh-list
14275671|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275672|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
14275673|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275674|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15143064|NCT04273581|Growth Substances|growth substances|mesh-ancestor
15143065|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275675|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14275676|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
14275677|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275678|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275679|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14275680|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14275681|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
14275682|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14275683|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275684|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
14275685|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14275686|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275687|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14275688|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14275689|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14275690|NCT00445770|Etanercept|etanercept|mesh-list
14275691|NCT00445770|Methotrexate|methotrexate|mesh-list
14275692|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14275693|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
14275694|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14275695|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275696|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275697|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
14275698|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275699|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275700|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
14275701|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275702|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14275703|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275704|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
14275705|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275706|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14275707|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14275708|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14275709|NCT00445770|Analgesics|analgesics|mesh-ancestor
14275710|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
14275711|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275712|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275713|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275714|NCT00445848|Bevacizumab|bevacizumab|mesh-list
14275715|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14275716|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15143066|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143067|NCT04273607|Heparin|heparin|mesh-list
15143068|NCT04273607|Calcium heparin|calcium heparin|mesh-list
15143069|NCT04273607|Enoxaparin|enoxaparin|mesh-list
14275717|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275718|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275719|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275720|NCT00445848|Growth Substances|growth substances|mesh-ancestor
14275721|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275722|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275723|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275724|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275725|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275726|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
14275727|NCT00445887|Norgestrel|norgestrel|mesh-list
14275728|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14275729|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
14275730|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14275731|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275732|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14275733|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14275734|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14275735|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14275736|NCT00445939|Adalimumab|adalimumab|mesh-list
14275737|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275738|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275739|NCT00445978|Verapamil|verapamil|mesh-list
15143070|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
15143071|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15143072|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15143073|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143074|NCT04273529|Thalidomide|thalidomide|mesh-list
14275740|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14275741|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14275742|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275743|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275744|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14275745|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275746|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
14275747|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
14275748|NCT00446030|Bevacizumab|bevacizumab|mesh-list
14275749|NCT00446030|Carboplatin|carboplatin|mesh-list
14275750|NCT00446030|Docetaxel|docetaxel|mesh-list
14275751|NCT00446030|Doxorubicin|doxorubicin|mesh-list
14275752|NCT00446030|Trastuzumab|trastuzumab|mesh-list
14275753|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275754|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
14275755|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275756|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275757|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14275758|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
14275759|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275760|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275761|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14275762|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15143075|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15143076|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
14275763|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275764|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275765|NCT00446030|Growth Substances|growth substances|mesh-ancestor
14275766|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275767|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14275768|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14275769|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14275770|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14275771|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14275772|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14275773|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275774|NCT00446134|Ribavirin|ribavirin|mesh-list
14275775|NCT00446134|Taribavirin|taribavirin|mesh-list
14275776|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
14275777|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275778|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
14275779|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275780|NCT00446147|Pyridoxine|pyridoxine|mesh-list
14275781|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
14275782|NCT00446147|Vitamins|vitamins|mesh-ancestor
14275783|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
14275784|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275785|NCT00446199|Drospirenone|drospirenone|mesh-list
14275786|NCT00446199|Estradiol|estradiol|mesh-list
14275787|NCT00446199|Estrogens|estrogens|mesh-ancestor
14275788|NCT00446199|Hormones|hormones|mesh-ancestor
14275789|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275790|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275791|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14275792|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
14275793|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14275794|NCT00446199|Diuretics|diuretics|mesh-ancestor
14275795|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
14275796|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
14275797|NCT00446251|Rituximab|rituximab|mesh-list
14275798|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275799|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275800|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
15143077|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143078|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
15143079|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143080|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143081|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15143082|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15143083|NCT04273529|Growth Substances|growth substances|mesh-ancestor
15143084|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
15143085|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143086|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
14275801|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275802|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275803|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14275804|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14275805|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
14275806|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14275807|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275808|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275809|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275810|NCT00446264|Sirolimus|sirolimus|mesh-list
14275811|NCT00446264|Tacrolimus|tacrolimus|mesh-list
14275812|NCT00446264|Daclizumab|daclizumab|mesh-list
14275813|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275814|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
14275815|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275816|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14275817|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275818|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275819|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14275820|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275821|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14275822|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275823|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
14275824|NCT00446290|Docetaxel|docetaxel|mesh-list
14275825|NCT00446290|Capecitabine|capecitabine|mesh-list
14275826|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
14275827|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275828|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
14275829|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
14275830|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
14275831|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275832|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275833|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
14275834|NCT00446446|Panitumumab|panitumumab|mesh-list
14275835|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275836|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275837|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
14275838|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14275839|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275840|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14275841|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
14275842|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14275843|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14275844|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275845|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275846|NCT00446511|Valsartan|valsartan|mesh-list
14275847|NCT00446511|Enalapril|enalapril|mesh-list
14275848|NCT00446511|Enalaprilat|enalaprilat|mesh-list
14275849|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14275850|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14275851|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14275852|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275853|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14275854|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
14275855|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275856|NCT00446563|Losartan|losartan|mesh-list
14275857|NCT00446563|Amlodipine|amlodipine|mesh-list
14275858|NCT00446563|Valsartan|valsartan|mesh-list
14275859|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14275860|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14275861|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15143087|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15143088|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15143089|NCT04273321|Prednisolone|prednisolone|mesh-list
15143090|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
15143091|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15143092|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
15143093|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143094|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
15143095|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
15143096|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143097|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143098|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143099|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
15143100|NCT04273321|Hormones|hormones|mesh-ancestor
15143101|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14275862|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275863|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275864|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14275865|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275866|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
14275867|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14275868|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14275869|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14275870|NCT00446563|Diuretics|diuretics|mesh-ancestor
14275871|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
14275872|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14275873|NCT00446641|Cilostazol|cilostazol|mesh-list
14275874|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14275875|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
14275876|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275877|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275878|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14275879|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
14275880|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14275881|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14275882|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275883|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14275884|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
14275885|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14275886|NCT00446641|Protective Agents|protective agents|mesh-ancestor
14275887|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14275888|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14275889|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275890|NCT00446797|Celecoxib|celecoxib|mesh-list
14275891|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14275892|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14275893|NCT00446797|Analgesics|analgesics|mesh-ancestor
14275894|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
14275895|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275896|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275897|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275898|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275899|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14275900|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14275901|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275902|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275903|NCT00446849|Mesalamine|mesalamine|mesh-list
14275904|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14275905|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14275906|NCT00446849|Analgesics|analgesics|mesh-ancestor
14275907|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
14275908|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275909|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275910|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275911|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275912|NCT00446992|Olanzapine|olanzapine|mesh-list
14275913|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
14275914|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
14275915|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275916|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275917|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275918|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14275919|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14275920|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14275921|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15143102|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15143103|NCT04273321|Protective Agents|protective agents|mesh-ancestor
15143104|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15143105|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143106|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
15143107|NCT04273282|Dexamethasone|dexamethasone|mesh-list
14275922|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14275923|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14275924|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275925|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275926|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275927|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
14275928|NCT00447005|Axitinib|axitinib|mesh-list
14275929|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275930|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15143108|NCT04273282|Prednisolone|prednisolone|mesh-list
14275931|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275932|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275933|NCT00447057|Pemetrexed|pemetrexed|mesh-list
14275934|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14275935|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275936|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275937|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275938|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14275939|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14275940|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275941|NCT00447226|Lapatinib|lapatinib|mesh-list
14275942|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275943|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14275944|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14275945|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275946|NCT00447265|Etanercept|etanercept|mesh-list
14275947|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14275948|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14275949|NCT00447265|Analgesics|analgesics|mesh-ancestor
15143109|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15143110|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
15143111|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15143112|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
15143113|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15143114|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
14275950|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
14275951|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14275952|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275953|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14275954|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14275955|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14275956|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14275957|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
14275958|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15143115|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143116|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
15143117|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
15143118|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143119|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143120|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143121|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
15143122|NCT04273282|Hormones|hormones|mesh-ancestor
15143123|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143124|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14275959|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14275960|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14275961|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275962|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275963|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
14275964|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14275965|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292587|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292588|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14292589|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14292590|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15143125|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143126|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15143127|NCT04273282|Protective Agents|protective agents|mesh-ancestor
15143128|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143129|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143130|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15143131|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15143132|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143133|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143134|NCT04273256|Inositol|inositol|mesh-list
15143135|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
15143136|NCT04273256|Vitamins|vitamins|mesh-ancestor
15143137|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
15143138|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143139|NCT04273191|Brexanolone|brexanolone|mesh-list
15143140|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
15143141|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143142|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275966|NCT00447330|Bevacizumab|bevacizumab|mesh-list
14275967|NCT00447330|Capecitabine|capecitabine|mesh-list
14275968|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
14275969|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14275970|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275971|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14275972|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14275973|NCT00447330|Growth Substances|growth substances|mesh-ancestor
14275974|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14275975|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14275976|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14275977|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
14275978|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275979|NCT00447382|Insulin|insulin|mesh-list
14275980|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14275981|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
14275982|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
14275983|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14275984|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143143|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143144|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
15143145|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
15143146|NCT04273100|Lenvatinib|lenvatinib|mesh-list
15143147|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275985|NCT00447499|Lanreotide|lanreotide|mesh-list
14275986|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14275987|NCT00447694|Deferasirox|deferasirox|mesh-list
14275988|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14275989|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
14275990|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
14275991|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275992|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
14275993|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14275994|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14275995|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14275996|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14275997|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14275998|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
14275999|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276000|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276001|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14276002|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276003|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
14276004|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14276005|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14276006|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14276007|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276008|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276009|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
14276010|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276011|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276012|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14276013|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276014|NCT00447902|Ritonavir|ritonavir|mesh-list
14276015|NCT00447902|Tipranavir|tipranavir|mesh-list
14276016|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14276017|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14276018|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
14276019|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276020|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276021|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14276022|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14276023|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
14276024|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276025|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14276026|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14276027|NCT00448019|Vidarabine|vidarabine|mesh-list
14276028|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
15143148|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15143149|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276029|NCT00448019|Bevacizumab|bevacizumab|mesh-list
14276030|NCT00448019|Rituximab|rituximab|mesh-list
14276031|NCT00448019|Fludarabine|fludarabine|mesh-list
14276032|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
14276033|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276034|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
14276035|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276036|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276037|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276038|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
14276039|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276040|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276041|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276042|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276043|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276044|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276045|NCT00448019|Growth Substances|growth substances|mesh-ancestor
14276046|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276047|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276048|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
14276049|NCT00448019|Antiviral Agents|antiviral agents|mesh-ancestor
14276050|NCT00448019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276051|NCT00448123|Tamsulosin|tamsulosin|mesh-list
14276052|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14276053|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14276054|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14276055|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
14276056|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276057|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276058|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276059|NCT00448123|Urological Agents|urological agents|mesh-ancestor
14276060|NCT00448136|Bevacizumab|bevacizumab|mesh-list
14276061|NCT00448136|Streptozocin|streptozocin|mesh-list
14276062|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276063|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143150|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143151|NCT04273035|Midazolam|midazolam|mesh-list
15143152|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14276064|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15143153|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15143154|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143155|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143156|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15143157|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15143158|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15143159|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15143160|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
15143161|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
15143162|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
15143163|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
15143164|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143165|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143166|NCT04273061|Atezolizumab|atezolizumab|mesh-list
15143167|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143168|NCT04272788|Infliximab|infliximab|mesh-list
15143169|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
15143170|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143171|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15143172|NCT04272645|Atezolizumab|atezolizumab|mesh-list
15143173|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143174|NCT04272567|Norepinephrine|norepinephrine|mesh-list
15143175|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15143176|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15143177|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
15143178|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143179|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143180|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143181|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
15143182|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
15143183|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143184|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15143185|NCT04272476|Fluoxetine|fluoxetine|mesh-list
15143186|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15143187|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15143188|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15143189|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143190|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143191|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
15143192|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143193|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14276065|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276066|NCT00448136|Growth Substances|growth substances|mesh-ancestor
14276067|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276068|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276069|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14276070|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14276071|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14276072|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14276073|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
14276074|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276075|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276076|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276077|NCT00448175|Urological Agents|urological agents|mesh-ancestor
14276078|NCT00448201|Methotrexate|methotrexate|mesh-list
14276079|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
14276080|NCT00448201|Fludarabine|fludarabine|mesh-list
14276081|NCT00448201|Busulfan|busulfan|mesh-list
14276082|NCT00448201|Tacrolimus|tacrolimus|mesh-list
14276083|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14276084|NCT00448201|Sargramostim|sargramostim|mesh-list
14276085|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14276086|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
14276087|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14276088|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276089|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276090|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
14276091|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276092|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276093|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276094|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276095|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14276096|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276097|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
14276098|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276099|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14276100|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14276101|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
14276102|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276103|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276104|NCT00448227|Famciclovir|famciclovir|mesh-list
14276105|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
14276106|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276107|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14276108|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276109|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276110|NCT00448279|Trastuzumab|trastuzumab|mesh-list
14276111|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276112|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276113|NCT00448357|Methotrexate|methotrexate|mesh-list
14276114|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
14276115|NCT00448357|Fludarabine|fludarabine|mesh-list
14276116|NCT00448357|Busulfan|busulfan|mesh-list
14276117|NCT00448357|Tacrolimus|tacrolimus|mesh-list
14276118|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14276119|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
14276120|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14276121|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
14276122|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14276123|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276124|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276125|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
14276126|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276127|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276128|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276129|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276130|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14276131|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276132|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
14276133|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276134|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14276135|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14276136|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
14276137|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276138|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276139|NCT00448435|Fluticasone|fluticasone|mesh-list
14276140|NCT00448435|Xhance|xhance|mesh-list
14276141|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14276142|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14276143|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276144|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14276145|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
14276146|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276147|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276148|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14276149|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
14276150|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276151|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14276152|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14276153|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14276154|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14276155|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
14276156|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276157|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143194|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
15143195|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15143196|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15143197|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15143198|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143199|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15143200|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179496|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179497|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15179498|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179499|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276158|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
15179500|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15179501|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179502|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15179503|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15179504|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15179505|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15179506|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
14276159|NCT00448435|Hormones|hormones|mesh-ancestor
14276160|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276161|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
14276162|NCT00448539|Rufinamide|rufinamide|mesh-list
14276163|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
14276164|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14276165|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14276166|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811747|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179507|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179508|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15179509|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15179510|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179511|NCT03949634|Paclitaxel|paclitaxel|mesh-list
15179512|NCT03949634|Docetaxel|docetaxel|mesh-list
15179513|NCT03949634|Doxorubicin|doxorubicin|mesh-list
15179514|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15179515|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179516|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
15179517|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
15179518|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
15179519|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179520|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15179521|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15179522|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15179523|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179524|NCT03949478|Ibuprofen|ibuprofen|mesh-list
15179525|NCT03949478|Nifedipine|nifedipine|mesh-list
15179526|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15179527|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15179528|NCT03949478|Analgesics|analgesics|mesh-ancestor
15179529|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
15179530|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179531|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276167|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276168|NCT00448591|Bevacizumab|bevacizumab|mesh-list
14811748|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14276169|NCT00448591|Taxane|taxane|mesh-list
14276170|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276171|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276172|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276173|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276174|NCT00448591|Growth Substances|growth substances|mesh-ancestor
14276175|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276176|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276177|NCT00448669|Tenofovir|tenofovir|mesh-list
14276178|NCT00448669|Emtricitabine|emtricitabine|mesh-list
15143201|NCT04272372|Ketoprofen|ketoprofen|mesh-list
15143202|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15143203|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143204|NCT04272372|Analgesics|analgesics|mesh-ancestor
15143205|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
15143206|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143207|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143208|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143209|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15143210|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14276179|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
14276180|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276181|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14276182|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14276183|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276184|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276185|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14276186|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14276187|NCT00448708|Paclitaxel|paclitaxel|mesh-list
14276188|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14276189|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14276190|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276191|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14276192|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14276193|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562232|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15143211|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143212|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143213|NCT04272255|Scopolamine|scopolamine|mesh-list
15143214|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15143215|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15143216|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
15143217|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
15143218|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143219|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143220|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143221|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
15143222|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15143223|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
15143224|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143225|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143226|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14276194|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276195|NCT00448760|Leucovorin|leucovorin|mesh-list
14276196|NCT00448760|Docetaxel|docetaxel|mesh-list
14276197|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
14276198|NCT00448760|Floxuridine|floxuridine|mesh-list
14276199|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276200|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
14276201|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
14276202|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
14276203|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276204|NCT00448760|Antidotes|antidotes|mesh-ancestor
14276205|NCT00448760|Protective Agents|protective agents|mesh-ancestor
14276206|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276207|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
14276208|NCT00448760|Vitamins|vitamins|mesh-ancestor
14276209|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
14276210|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276211|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
14276212|NCT00448864|Ecallantide|ecallantide|mesh-list
14276213|NCT00448864|Analgesics|analgesics|mesh-ancestor
14276214|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
14276215|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143227|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
14276216|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276217|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14276218|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14276219|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276220|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276221|NCT00448916|Pregabalin|pregabalin|mesh-list
14276222|NCT00448916|Analgesics|analgesics|mesh-ancestor
14276223|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
14276224|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276225|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276226|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
14276227|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14276228|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276229|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276230|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14276231|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14276232|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14276233|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14276234|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14276235|NCT00449007|Bupropion|bupropion|mesh-list
14276236|NCT00449007|Fluoxetine|fluoxetine|mesh-list
14276237|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14276238|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
14276239|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14276240|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14276241|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14276242|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276243|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276244|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
14276245|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276246|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276247|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14276248|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14276249|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276250|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14276251|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
14276252|NCT00449033|Gemcitabine|gemcitabine|mesh-list
14276253|NCT00449033|Sorafenib|sorafenib|mesh-list
14276254|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276255|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276256|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
14276257|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276258|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
14276259|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276260|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276261|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276262|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
14276263|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276264|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14276265|NCT00449046|Fluticasone|fluticasone|mesh-list
14276266|NCT00449046|Xhance|xhance|mesh-list
14276267|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14276268|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276269|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14276270|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
14276271|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276272|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276273|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14276274|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
14276275|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276276|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14276277|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14276278|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14276279|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14276280|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
14276281|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276282|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276283|NCT00449072|Loratadine|loratadine|mesh-list
14276284|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
14276285|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276286|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14276287|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14276288|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14276289|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
14276290|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
14276291|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276292|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276293|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276294|NCT00449150|Cetrorelix|cetrorelix|mesh-list
14276295|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14276296|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
14276297|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14276298|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276299|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
14276300|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276301|NCT00449163|Leucovorin|leucovorin|mesh-list
14276302|NCT00449163|Bevacizumab|bevacizumab|mesh-list
14276303|NCT00449163|Irinotecan|irinotecan|mesh-list
14276304|NCT00449163|Floxuridine|floxuridine|mesh-list
14276305|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
14276306|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276307|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276308|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276309|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276310|NCT00449163|Growth Substances|growth substances|mesh-ancestor
14276311|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276312|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276313|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14276314|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14276315|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276316|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276317|NCT00449163|Antidotes|antidotes|mesh-ancestor
14276318|NCT00449163|Protective Agents|protective agents|mesh-ancestor
14276319|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
14276320|NCT00449163|Vitamins|vitamins|mesh-ancestor
14276321|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
14276322|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276323|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
14276324|NCT00449176|Oxycodone|oxycodone|mesh-list
15143228|NCT04272086|Bupivacaine|bupivacaine|mesh-list
15143229|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
15143230|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
15143231|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143232|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143233|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
15143234|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143235|NCT04272320|Bupivacaine|bupivacaine|mesh-list
15143236|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
15143237|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
15143238|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143239|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143240|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
15143241|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276325|NCT00449176|Tapentadol|tapentadol|mesh-list
14276326|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14276327|NCT00449176|Narcotics|narcotics|mesh-ancestor
14276328|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14276329|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276330|NCT00449176|Analgesics|analgesics|mesh-ancestor
14276331|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
14276332|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276333|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14276334|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14276335|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15143242|NCT04271917|Acetaminophen|acetaminophen|mesh-list
15143243|NCT04271917|Ibuprofen|ibuprofen|mesh-list
15143244|NCT04271917|Cannabidiol|cannabidiol|mesh-list
15143245|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143246|NCT04271917|Analgesics|analgesics|mesh-ancestor
15143247|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
15143248|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143249|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143250|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
15143251|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15143252|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143253|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15143254|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14276336|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276337|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
15143255|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276338|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276339|NCT00449644|Bedaquiline|bedaquiline|mesh-list
14276340|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
14276341|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14276342|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276343|NCT00449670|Vaccines|vaccines|mesh-list
14276344|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
14276345|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276346|NCT00449748|Everolimus|everolimus|mesh-list
14276347|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276348|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276349|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
14276350|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276351|NCT00449761|Panobinostat|panobinostat|mesh-list
14276352|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276353|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14276354|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276355|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143256|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143257|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
15143258|NCT04271839|Fluticasone|fluticasone|mesh-list
15143259|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
15143260|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143261|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15143262|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
15143263|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143264|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143265|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15143266|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
15143267|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
15143268|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14276356|NCT00449787|Naproxen|naproxen|mesh-list
14276357|NCT00449787|Sumatriptan|sumatriptan|mesh-list
14276358|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14276359|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14276360|NCT00449787|Analgesics|analgesics|mesh-ancestor
14276361|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
14276362|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276363|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276364|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276365|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276366|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
14276367|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14276368|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276369|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276370|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14276371|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14276372|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14276373|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
14276374|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143269|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14276375|NCT00449930|Metformin|metformin|mesh-list
14562233|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
14562234|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562235|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
14562236|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562237|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562238|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15143270|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15143271|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15143272|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
14562239|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
14562240|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562241|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562242|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562243|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14562244|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
14562245|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14562246|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15143273|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143274|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143275|NCT04272021|Methylphenidate|methylphenidate|mesh-list
14562247|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
14562248|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276376|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14276377|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14276378|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276379|NCT00449930|Incretins|incretins|mesh-ancestor
14276380|NCT00449930|Hormones|hormones|mesh-ancestor
14276381|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276382|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14276383|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
14276384|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143276|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15143277|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143278|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15143279|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15143280|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15143281|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276385|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276386|NCT00449956|Timolol|timolol|mesh-list
14276387|NCT00449956|Dorzolamide|dorzolamide|mesh-list
14276388|NCT00449956|Maleic acid|maleic acid|mesh-list
14276389|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14276390|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14276391|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
14276392|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276393|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276394|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276395|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14276396|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14276397|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276398|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14276399|NCT00450073|Vitamin D|vitamin d|mesh-list
14276400|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
14276401|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
14276402|NCT00450073|Vitamins|vitamins|mesh-list
14276403|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
14276404|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276405|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14276406|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14276407|NCT00450216|Ibuprofen|ibuprofen|mesh-list
14276408|NCT00450216|Famotidine|famotidine|mesh-list
14276409|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14276410|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14276411|NCT00450216|Analgesics|analgesics|mesh-ancestor
14276412|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
14276413|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276414|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143282|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
15143283|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143284|NCT04271332|Baclofen|baclofen|mesh-list
15143285|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15143286|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143287|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15143288|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143289|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15143290|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
15143291|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
15143292|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143293|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143294|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
15143295|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143296|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
15143297|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15143298|NCT04270994|Misoprostol|misoprostol|mesh-list
15143299|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15143300|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
15143301|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15143302|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143303|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15143304|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143305|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
15143306|NCT04271189|Metformin|metformin|mesh-list
15143307|NCT04271189|Pioglitazone|pioglitazone|mesh-list
15143308|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15143309|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15143310|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143311|NCT04271189|Incretins|incretins|mesh-ancestor
14276415|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276416|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276417|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14276418|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276419|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276420|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14276421|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14276422|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14276423|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
14276424|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
14276425|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276426|NCT00450242|Lidocaine|lidocaine|mesh-list
14276427|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
14276428|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
14276429|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14276430|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276431|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
14276432|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276433|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14276434|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14276435|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14276436|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276437|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276438|NCT00450255|Aflibercept|aflibercept|mesh-list
14276439|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
14276440|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276441|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276442|NCT00450255|Growth Substances|growth substances|mesh-ancestor
15143312|NCT04271189|Hormones|hormones|mesh-ancestor
15143313|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143314|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15143315|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
15143316|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143317|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143318|NCT04271384|Nivolumab|nivolumab|mesh-list
15143319|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15143320|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143321|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15143322|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143323|NCT04270864|Nivolumab|nivolumab|mesh-list
15143324|NCT04270864|Ipilimumab|ipilimumab|mesh-list
15143325|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15143326|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143327|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15143328|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143329|NCT04270877|Naltrexone|naltrexone|mesh-list
15143330|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15143331|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15143332|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143333|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
15143334|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143335|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15143336|NCT04270929|Folfirinox|folfirinox|mesh-list
15143337|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143338|NCT04270656|Insulin|insulin|mesh-list
15143339|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15143340|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143341|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
15143342|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15143343|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143344|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143345|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143346|NCT04270708|Analgesics|analgesics|mesh-ancestor
15143347|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
15143348|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143349|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15143350|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15143351|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15143352|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
15143353|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143354|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143355|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
14276443|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276444|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276445|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276446|NCT00450385|Prednisone|prednisone|mesh-list
14276447|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
14276448|NCT00450385|Rituximab|rituximab|mesh-list
14276449|NCT00450385|Doxorubicin|doxorubicin|mesh-list
14276450|NCT00450385|Vincristine|vincristine|mesh-list
14276451|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276452|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
14276453|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276454|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276455|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276456|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
14276457|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276458|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276459|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276460|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276461|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14276462|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14276463|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14276464|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276465|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276466|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
14276467|NCT00450385|Hormones|hormones|mesh-ancestor
14276468|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276469|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14276470|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14276471|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
14276472|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
14276473|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
15143356|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15143357|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
15143358|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143359|NCT04270487|Octylonium|octylonium|mesh-list
15143360|NCT04270487|Bromides|bromides|mesh-list
14276479|NCT00450463|Metronidazole|metronidazole|mesh-list
14276480|NCT00450463|Molgramostim|molgramostim|mesh-list
14276481|NCT00450463|Flutamide|flutamide|mesh-list
14276482|NCT00450463|Sargramostim|sargramostim|mesh-list
14276483|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
14276484|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276485|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276486|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276487|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14276488|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14276489|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14276490|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
14276491|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
14276492|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276493|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14276494|NCT00450580|Ritonavir|ritonavir|mesh-list
14276495|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
14276496|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14276497|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14276498|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
14276499|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276500|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276501|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14276502|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14276503|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
14276504|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276505|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14276506|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14276507|NCT00450619|Metronidazole|metronidazole|mesh-list
14276508|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14276509|NCT00450619|Vaccines|vaccines|mesh-list
14276510|NCT00450619|Sargramostim|sargramostim|mesh-list
14276511|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
14276512|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276513|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276514|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14276515|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14276516|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14276517|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14276518|NCT00450619|Analgesics|analgesics|mesh-ancestor
14276519|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
14276520|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143361|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
15143362|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15143363|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15143364|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276521|NCT00450658|Ibuprofen|ibuprofen|mesh-list
14276522|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14276523|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14276524|NCT00450658|Analgesics|analgesics|mesh-ancestor
14276525|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
14276526|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276527|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276528|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276529|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276530|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14276531|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276532|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276533|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14276534|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14276535|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276536|NCT00450749|Lycopene|lycopene|mesh-list
14276537|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276538|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
14276539|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276540|NCT00450749|Protective Agents|protective agents|mesh-ancestor
14276541|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276542|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14276543|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14276544|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276545|NCT00450801|Leucovorin|leucovorin|mesh-list
14276546|NCT00450801|Cytarabine|cytarabine|mesh-list
14276547|NCT00450801|Thalidomide|thalidomide|mesh-list
15143365|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15143366|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143367|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143368|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
15143369|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
15143370|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143371|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15143372|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15143373|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
15143374|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143375|NCT04270370|Atorvastatin|atorvastatin|mesh-list
15143376|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15143377|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15143378|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
15143379|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143380|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15143381|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15143382|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143383|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
15143384|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
15179532|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179533|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179534|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15179535|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179536|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179537|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15179538|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179539|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15179540|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
15179541|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
15179542|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15179543|NCT03949101|Atropine|atropine|mesh-list
15179544|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15179545|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15179546|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15179547|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15179548|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15179549|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
15179550|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179551|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179552|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14276548|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
14276549|NCT00450801|Ifosfamide|ifosfamide|mesh-list
14276550|NCT00450801|Rituximab|rituximab|mesh-list
14276551|NCT00450801|Doxorubicin|doxorubicin|mesh-list
14276552|NCT00450801|Methotrexate|methotrexate|mesh-list
14276553|NCT00450801|Etoposide|etoposide|mesh-list
14276554|NCT00450801|Vincristine|vincristine|mesh-list
14276555|NCT00450801|Granisetron|granisetron|mesh-list
14276556|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276557|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
14276558|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276559|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276560|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276561|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
14276562|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276563|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276564|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276565|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276566|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14276567|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14276568|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14276569|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276570|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14276571|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
14276572|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14276573|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276574|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
14276575|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276576|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14276577|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15143385|NCT04270344|Valsartan|valsartan|mesh-list
15143386|NCT04270344|Pitavastatin|pitavastatin|mesh-list
15143387|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15143388|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15143389|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15143390|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143391|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15143392|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15143393|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15143394|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
15143395|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276578|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14276579|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
14276580|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276581|NCT00450801|Antidotes|antidotes|mesh-ancestor
14276582|NCT00450801|Protective Agents|protective agents|mesh-ancestor
14276583|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
14276584|NCT00450801|Vitamins|vitamins|mesh-ancestor
14276585|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
14276586|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
14276587|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
14276588|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
14276589|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
14276590|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
15143396|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15143397|NCT04270175|Dexamethasone|dexamethasone|mesh-list
15143398|NCT04270175|Daratumumab|daratumumab|mesh-list
15143399|NCT04270175|Pomalidomide|pomalidomide|mesh-list
15143400|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143401|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
15143402|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
15143403|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143404|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143405|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143406|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
15143407|NCT04270175|Hormones|hormones|mesh-ancestor
15143408|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143409|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15143410|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143411|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
15143412|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15143413|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15143414|NCT04270175|Growth Substances|growth substances|mesh-ancestor
15143415|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
15143416|NCT04269954|Heparin|heparin|mesh-list
14276591|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276592|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14276593|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
14276594|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14276595|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276596|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276597|NCT00450801|Growth Substances|growth substances|mesh-ancestor
14276598|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276599|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14276600|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
15143417|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15143418|NCT04269954|Tinzaparin|tinzaparin|mesh-list
15143419|NCT04269954|Dalteparin|dalteparin|mesh-list
15143420|NCT04269954|Batroxobin|batroxobin|mesh-list
15143421|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
15143422|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15143423|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14276601|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276602|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
14276603|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276604|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
14276605|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276606|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276607|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276608|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
14276609|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276610|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276611|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276612|NCT00450866|Epothilones|epothilones|mesh-list
14276613|NCT00450866|Epothilone B|epothilone b|mesh-list
14276614|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
14276615|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
14276616|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14276617|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276618|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276619|NCT00450983|Methotrexate|methotrexate|mesh-list
14276620|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
14276621|NCT00450983|Fludarabine|fludarabine|mesh-list
14276622|NCT00450983|Thiotepa|thiotepa|mesh-list
14276623|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
14276624|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14276625|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
14276626|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14276627|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276628|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276629|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
14276630|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276631|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276632|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276633|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276634|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14276635|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276636|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
14276637|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276638|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14276639|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276640|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
14276641|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276642|NCT00451035|Panobinostat|panobinostat|mesh-list
14276643|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276644|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14276645|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276646|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276647|NCT00451048|Sunitinib|sunitinib|mesh-list
14276648|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276649|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276650|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276651|NCT00451048|Growth Substances|growth substances|mesh-ancestor
15143424|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143425|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
15143426|NCT04269954|Coagulants|coagulants|mesh-ancestor
15143427|NCT04270318|Pemetrexed|pemetrexed|mesh-list
15143428|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143429|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143430|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143431|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14276652|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143432|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15143433|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
14276653|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276654|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14276655|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276656|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276657|NCT00451178|Prednisone|prednisone|mesh-list
15143434|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
15143435|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15143436|NCT04270019|Laxatives|laxatives|mesh-ancestor
15143437|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143438|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15143439|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15143440|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276658|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
14276659|NCT00451178|Rituximab|rituximab|mesh-list
14276660|NCT00451178|Doxorubicin|doxorubicin|mesh-list
15143441|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143442|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
15143443|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143444|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143445|NCT04269863|Aspirin|aspirin|mesh-list
15143446|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15143447|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143448|NCT04269863|Analgesics|analgesics|mesh-ancestor
15143449|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
15143450|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143451|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276661|NCT00451178|Vincristine|vincristine|mesh-list
14276662|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276663|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
14276664|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276665|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276666|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14276667|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
14276668|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276669|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276670|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14276671|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276672|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14276673|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14276674|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14276675|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276676|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276677|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
14276678|NCT00451178|Hormones|hormones|mesh-ancestor
14276679|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276680|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14276681|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14276682|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
14276683|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
14276684|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
14276685|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
14276686|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14276687|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14276688|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14276689|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276690|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276691|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
14276692|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276693|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276694|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14276695|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276696|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
14276697|NCT00451204|Estrogens|estrogens|mesh-list
14276698|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
14276699|NCT00451204|Hormones|hormones|mesh-ancestor
14276700|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276701|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276702|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14276703|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
14276704|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276705|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276706|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
14276707|NCT00451217|Neostigmine|neostigmine|mesh-list
14276708|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14276709|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276710|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276711|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
14276712|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276713|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276714|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14276715|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
14276716|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276717|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14276718|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14276719|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14276720|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
14276721|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14276722|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
14276723|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276724|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276725|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
14276726|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276727|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14276728|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276729|NCT00451555|Fulvestrant|fulvestrant|mesh-list
14276730|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14276731|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276732|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14276733|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14276734|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
14276735|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276736|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276737|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
14276738|NCT00451698|Hematinics|hematinics|mesh-ancestor
14276739|NCT00451906|Bevacizumab|bevacizumab|mesh-list
14276740|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276741|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276742|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276743|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276744|NCT00451906|Growth Substances|growth substances|mesh-ancestor
14276745|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276746|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276747|NCT00451958|Leuprolide|leuprolide|mesh-list
15143452|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143453|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15143454|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15143455|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15143456|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143457|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15143458|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15143459|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143460|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
15143461|NCT04269928|Epinephrine|epinephrine|mesh-list
15143462|NCT04269928|Racepinephrine|racepinephrine|mesh-list
15143463|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
15143464|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15143465|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15143466|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
15143467|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143468|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143469|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143470|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15143471|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15143472|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
15143473|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143474|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15143475|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
15143476|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
15143477|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
15143478|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15143479|NCT04269369|Fluorouracil|fluorouracil|mesh-list
15143480|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
15143481|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143482|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15143483|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143484|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15143485|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
15143486|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143487|NCT04269460|Bupivacaine|bupivacaine|mesh-list
14276748|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14276749|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
14276750|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14276751|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276752|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14276753|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276754|NCT00452335|Lubiprostone|lubiprostone|mesh-list
14276755|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14276756|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276757|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276758|NCT00452348|Fluticasone|fluticasone|mesh-list
14276759|NCT00452348|Xhance|xhance|mesh-list
14276760|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14276761|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14276762|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276763|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14276764|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
14276765|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276766|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276767|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14276768|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
14276769|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276770|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14276771|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14276772|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14276773|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14276774|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
14276775|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276776|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276777|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
14276778|NCT00452348|Hormones|hormones|mesh-ancestor
14276779|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276780|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
14276781|NCT00452374|Vidarabine|vidarabine|mesh-list
14276782|NCT00452374|Cytarabine|cytarabine|mesh-list
14276783|NCT00452374|Rituximab|rituximab|mesh-list
14276784|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
14276785|NCT00452374|Fludarabine|fludarabine|mesh-list
14276786|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
14276787|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276788|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143488|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
15143489|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
15143490|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14276789|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
14276790|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276791|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14276792|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276793|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
14276794|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276795|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14276796|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
15143491|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143492|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
15143493|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143494|NCT04269187|Theophylline|theophylline|mesh-list
15143495|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15143496|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
15143497|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143498|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143499|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14276797|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276798|NCT00452387|Prednisone|prednisone|mesh-list
14276799|NCT00452387|Sorafenib|sorafenib|mesh-list
14276800|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
14276801|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276802|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
14276803|NCT00452387|Hormones|hormones|mesh-ancestor
14276804|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276805|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276806|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14276807|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276808|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14276809|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276810|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276811|NCT00452387|Analgesics|analgesics|mesh-ancestor
14276812|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
14276813|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276814|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14276815|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14276816|NCT00452400|Olodaterol|olodaterol|mesh-list
14276817|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14276818|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
14276819|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276820|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276821|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14276822|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
14276823|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14276824|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276825|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14276826|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276827|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276828|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
14276829|NCT00452426|Narcotics|narcotics|mesh-ancestor
14276830|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14276831|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276832|NCT00452426|Analgesics|analgesics|mesh-ancestor
14276833|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
14276834|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276835|NCT00452439|Vitamin D|vitamin d|mesh-list
14276836|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
14276837|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
14276838|NCT00452439|Calcium|calcium|mesh-list
14276839|NCT00452439|Vitamins|vitamins|mesh-ancestor
14276840|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
14276841|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276842|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14276843|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14276844|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14276845|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276846|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276847|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14276848|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
15143500|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
15143501|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15143502|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143503|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143504|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
15143505|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15143506|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14276849|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276850|NCT00452530|Enoxaparin|enoxaparin|mesh-list
14276851|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
14276852|NCT00452530|Apixaban|apixaban|mesh-list
14276853|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
14276854|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14276855|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14276856|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276857|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15143507|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
15143508|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143509|NCT04268966|Brincidofovir|brincidofovir|mesh-list
15143510|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
15143511|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143512|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
15143513|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15143514|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143515|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143516|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143517|NCT04269278|Analgesics|analgesics|mesh-ancestor
15143518|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
15143519|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143520|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15143521|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15143522|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15143523|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
15143524|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143525|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143526|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
15143527|NCT04269109|Narcotics|narcotics|mesh-ancestor
15143528|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143529|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143530|NCT04269109|Analgesics|analgesics|mesh-ancestor
15143531|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
15143532|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143533|NCT04268888|Nivolumab|nivolumab|mesh-list
15143534|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
14276858|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
14276859|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14276860|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
14276861|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276862|NCT00452543|Acamprosate|acamprosate|mesh-list
14276863|NCT00452543|Dexetimide|dexetimide|mesh-list
14276864|NCT00452543|Citalopram|citalopram|mesh-list
14276865|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14276866|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14276867|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14276868|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276869|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276870|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
14276871|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143535|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15143536|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143537|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15143538|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143539|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15143540|NCT04268888|Estrogens|estrogens|mesh-ancestor
15143541|NCT04268888|Hormones|hormones|mesh-ancestor
15143542|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143543|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143544|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15143545|NCT04268927|Letrozole|letrozole|mesh-list
15143546|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
15143547|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15143548|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143549|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15143550|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15143551|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143552|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143553|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15143554|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
15143555|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143556|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143557|NCT04268927|Hormones|hormones|mesh-ancestor
15143558|NCT04268602|Anesthetics|anesthetics|mesh-list
15143559|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
15143560|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143561|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143562|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
15143563|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143564|NCT04268407|Amoxicillin|amoxicillin|mesh-list
15143565|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
15143566|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
15143567|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15143568|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143569|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143570|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15143571|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143572|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143573|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
15143574|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15143575|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143576|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143577|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143578|NCT04268303|Analgesics|analgesics|mesh-ancestor
15143579|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
15143580|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276872|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14276873|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
14276874|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14276875|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14276876|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14276877|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
14276878|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
14276879|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276880|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15143581|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15143582|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15143583|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15143584|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
15143585|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143586|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276881|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14276882|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
14276883|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14276884|NCT00452673|Capecitabine|capecitabine|mesh-list
14276885|NCT00452673|Dasatinib|dasatinib|mesh-list
14276886|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14276887|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
15143587|NCT04268524|Miltefosine|miltefosine|mesh-list
15143588|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
15143589|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143590|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143591|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15143592|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15143593|NCT04268563|Metformin|metformin|mesh-list
15143594|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15143595|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15143596|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143597|NCT04268563|Incretins|incretins|mesh-ancestor
15143598|NCT04268563|Hormones|hormones|mesh-ancestor
15143599|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143600|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15143601|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
15143602|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143603|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143604|NCT04268472|Darunavir|darunavir|mesh-list
15143605|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15143606|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15143607|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
15143608|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143609|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143610|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15143611|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15143612|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
15143613|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143614|NCT04268537|Antibodies|antibodies|mesh-list
15143615|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
15143616|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
15143617|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179553|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179554|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
15179555|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
15179556|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15179557|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15179558|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
15179559|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179560|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179561|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15179562|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
15179563|NCT03949062|Rituximab|rituximab|mesh-list
15179564|NCT03949062|Lenalidomide|lenalidomide|mesh-list
15179565|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179566|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179567|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
15179568|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179569|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179570|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15179571|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15179572|NCT03949062|Growth Substances|growth substances|mesh-ancestor
15179573|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
15179574|NCT03949075|Enalapril|enalapril|mesh-list
15179575|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15179576|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
15179577|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179578|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292591|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14276888|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276889|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276890|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14276891|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276892|NCT00452699|Fluticasone|fluticasone|mesh-list
14276893|NCT00452699|Xhance|xhance|mesh-list
14276894|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14276895|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14276896|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14276897|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
14276898|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14276899|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276900|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14276901|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
14276902|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276903|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14276904|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14276905|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14276906|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14276907|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
14276908|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276909|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276910|NCT00452790|Vaccines|vaccines|mesh-list
14276911|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14276912|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
14276913|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276914|NCT00452868|Donepezil|donepezil|mesh-list
14276915|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14276916|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276917|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276918|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
14276919|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14276920|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276921|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
15143618|NCT04268394|Metformin|metformin|mesh-list
15143619|NCT04268394|Itraconazole|itraconazole|mesh-list
15143620|NCT04268394|Rifampin|rifampin|mesh-list
15143621|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
15143622|NCT04268394|Methotrexate|methotrexate|mesh-list
15143623|NCT04268394|Digoxin|digoxin|mesh-list
15143624|NCT04268394|Midazolam|midazolam|mesh-list
15143625|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15143626|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15143627|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143628|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15143629|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
15143630|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15143631|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15143632|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
15143633|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143634|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143635|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
15143636|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143637|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15143638|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15143639|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
15143640|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15143641|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15143642|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15143643|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15143644|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143645|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15143646|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15143647|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15143648|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15143649|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
15143650|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
15143651|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
15143652|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
15143653|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143654|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15143655|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15143656|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15143657|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15143658|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
15143659|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276922|NCT00453102|Rituximab|rituximab|mesh-list
14276923|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276924|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276925|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
14276926|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276927|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292592|NCT00561951|Fesoterodine|fesoterodine|mesh-list
14292593|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14292594|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14292595|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
14292596|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292597|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292598|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292599|NCT00561951|Urological Agents|urological agents|mesh-ancestor
14292600|NCT00562094|Pantoprazole|pantoprazole|mesh-list
14292601|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14292602|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292603|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14292604|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292605|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292606|NCT00562120|Fexofenadine|fexofenadine|mesh-list
14292607|NCT00562120|Terfenadine|terfenadine|mesh-list
14292608|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14292609|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15143660|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15143661|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15143662|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15143663|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
15143664|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143665|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15143666|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15143667|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
15143668|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143669|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
15143670|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15143671|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15143672|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15143673|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15143674|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15143675|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15143676|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15143677|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15143678|NCT04268394|Protective Agents|protective agents|mesh-ancestor
15143679|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15143680|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143681|NCT04268394|Analgesics|analgesics|mesh-ancestor
15143682|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
15143683|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143684|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143685|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143686|NCT04268199|Bortezomib|bortezomib|mesh-list
15143687|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143688|NCT04267991|Tacrolimus|tacrolimus|mesh-list
15143689|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15143690|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
15143691|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143692|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15143693|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143694|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143695|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15143696|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15143697|NCT04267653|Lactoferrin|lactoferrin|mesh-list
15143698|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143699|NCT04267679|Cannabidiol|cannabidiol|mesh-list
15143700|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
15143701|NCT04267913|Dexamethasone|dexamethasone|mesh-list
15143702|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
15143703|NCT04267913|Docetaxel|docetaxel|mesh-list
15143704|NCT04267913|Ramucirumab|ramucirumab|mesh-list
15143705|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15143706|NCT04267913|Antibodies|antibodies|mesh-list
15143707|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
14292610|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15143708|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15143709|NCT04267913|BB 1101|bb 1101|mesh-list
14276928|NCT00453154|Cisplatin|cisplatin|mesh-list
14276929|NCT00453154|Carboplatin|carboplatin|mesh-list
14276930|NCT00453154|Etoposide|etoposide|mesh-list
14276931|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
14276932|NCT00453154|Sunitinib|sunitinib|mesh-list
14276933|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
14276934|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276935|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14276936|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14276937|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14276938|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276939|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276940|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15143710|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
15143711|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143712|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143713|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
15143714|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
15143715|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143716|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143717|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
15143718|NCT04267913|Hormones|hormones|mesh-ancestor
15143719|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143720|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15143721|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143722|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
15143723|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143724|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143725|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
15143726|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
15143727|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
15143728|NCT04267614|Etanercept|etanercept|mesh-list
14276941|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276942|NCT00453154|Growth Substances|growth substances|mesh-ancestor
14276943|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276944|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276945|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14276946|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
14276947|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276948|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
14276949|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
14276950|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
14276951|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
14276952|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14276953|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
14276954|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276955|NCT00453180|Expectorants|expectorants|mesh-ancestor
15143729|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15143730|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143731|NCT04267614|Analgesics|analgesics|mesh-ancestor
15143732|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
15143733|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143734|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143735|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143736|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15143737|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143738|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15143739|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
15143740|NCT04267809|Metformin|metformin|mesh-list
15143741|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14276956|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
14276957|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14276958|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
14276959|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276960|NCT00453180|Protective Agents|protective agents|mesh-ancestor
14276961|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276962|NCT00453180|Antidotes|antidotes|mesh-ancestor
14276963|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
14276964|NCT00453193|Pentostatin|pentostatin|mesh-list
14276965|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14276966|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276967|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14276968|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276969|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276970|NCT00453310|Sunitinib|sunitinib|mesh-list
14276971|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143742|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143743|NCT04267497|Amphotericin B|amphotericin b|mesh-list
15143744|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14276972|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14276973|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14276974|NCT00453310|Growth Substances|growth substances|mesh-ancestor
14276975|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14276976|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
14276977|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14276978|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143745|NCT04267497|Amebicides|amebicides|mesh-ancestor
15143746|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15143747|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15143748|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143749|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143750|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
15143751|NCT04267549|Paclitaxel|paclitaxel|mesh-list
15143752|NCT04267549|Apatinib|apatinib|mesh-list
15143753|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15143754|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143755|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
15143756|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
15143757|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14276979|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276980|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14276981|NCT00453336|Trioxsalen|trioxsalen|mesh-list
14276982|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276983|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14276984|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14276985|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
15143758|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143759|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15143760|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143761|NCT04267237|Atezolizumab|atezolizumab|mesh-list
15143762|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143763|NCT04267224|Ticagrelor|ticagrelor|mesh-list
15143764|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15143765|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15143766|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15143767|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15143768|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
15143769|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143770|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143771|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143772|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
15143773|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15143774|NCT04267250|Estradiol|estradiol|mesh-list
15143775|NCT04267250|PF-06700841|pf-06700841|mesh-list
15143776|NCT04267250|Estrogens|estrogens|mesh-ancestor
15143777|NCT04267250|Hormones|hormones|mesh-ancestor
15143778|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143779|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143780|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15143781|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
15143782|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15143783|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15143784|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15143785|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15143786|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15143787|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15143788|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143789|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143790|NCT04267042|Budesonide|budesonide|mesh-list
15143791|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143792|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15143793|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
15143794|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143795|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143796|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15143797|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
15143798|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
15143799|NCT04267042|Hormones|hormones|mesh-ancestor
15143800|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14276986|NCT00453349|Metronidazole|metronidazole|mesh-list
14276987|NCT00453349|Levofloxacin|levofloxacin|mesh-list
15143801|NCT04267081|Venetoclax|venetoclax|mesh-list
14276988|NCT00453349|Ofloxacin|ofloxacin|mesh-list
14276989|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14276990|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14276991|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14276992|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14276993|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14276994|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14276995|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14276996|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14276997|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14276998|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
14276999|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14277000|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277001|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14277002|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14277003|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14277004|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14277005|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14277006|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14277007|NCT00453349|Renal Agents|renal agents|mesh-ancestor
14277008|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14277009|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14277010|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14277011|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277012|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277013|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277014|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277015|NCT00453388|Cyclosporine|cyclosporine|mesh-list
14277016|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
14277017|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
14277018|NCT00453388|Fludarabine|fludarabine|mesh-list
14277019|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
14277020|NCT00453388|Cyclosporins|cyclosporins|mesh-list
14277021|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277022|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
14277023|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277024|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277025|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14277026|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
14277027|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277028|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277029|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14277030|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14277031|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
14277032|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277033|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
14277034|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277035|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
14277036|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14277037|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14277038|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15143802|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143803|NCT04267146|Nivolumab|nivolumab|mesh-list
15143804|NCT04267146|Temozolomide|temozolomide|mesh-list
15143805|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15143806|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143807|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15143808|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143809|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15143810|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
15143811|NCT04266977|Dexamethasone|dexamethasone|mesh-list
15143812|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143813|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
15143814|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
15143815|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143816|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143817|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143818|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
15143819|NCT04266977|Hormones|hormones|mesh-ancestor
15143820|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15143821|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15143822|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143823|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14277039|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
15143824|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
15143825|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277040|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14277041|NCT00453895|Sunitinib|sunitinib|mesh-list
14277042|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277043|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277044|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277045|NCT00453895|Growth Substances|growth substances|mesh-ancestor
14277046|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277047|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277048|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277049|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277050|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277051|NCT00453921|Methylphenidate|methylphenidate|mesh-list
15143826|NCT04266756|Selexipag|selexipag|mesh-list
15143827|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15143828|NCT04266353|Resveratrol|resveratrol|mesh-list
15143829|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
15143830|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143831|NCT04266353|Protective Agents|protective agents|mesh-ancestor
15143832|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143833|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143834|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15143835|NCT04266509|Rifampin|rifampin|mesh-list
15143836|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15143837|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
15143838|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143839|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143840|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
15143841|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15143842|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143843|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143844|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15143845|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15143846|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15143847|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15143848|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15143849|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15179579|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179580|NCT03948685|Carvedilol|carvedilol|mesh-list
15179581|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15179582|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15179583|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
15179584|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179585|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179586|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179587|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179588|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
15179589|NCT03948685|Protective Agents|protective agents|mesh-ancestor
15179590|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15179591|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179592|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15179593|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
15179594|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15179595|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15179596|NCT03948737|Tocopherols|tocopherols|mesh-list
15179597|NCT03948737|Vitamin E|vitamin e|mesh-list
15179598|NCT03948737|Tocotrienols|tocotrienols|mesh-list
15179599|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
15179600|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
15179601|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179602|NCT03948737|Protective Agents|protective agents|mesh-ancestor
15179603|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277052|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14277053|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277054|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14277055|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14277056|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277057|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277058|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
14277059|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277060|NCT00453999|Oseltamivir|oseltamivir|mesh-list
14277061|NCT00453999|Peramivir|peramivir|mesh-list
14277062|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
14277063|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277064|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277065|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277066|NCT00454051|Omalizumab|omalizumab|mesh-list
14277067|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14277068|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14277069|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14277070|NCT00454181|Interferons|interferons|mesh-list
14277071|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
14277072|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277073|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
14277074|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277075|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
14277076|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277077|NCT00454194|Pemetrexed|pemetrexed|mesh-list
14277078|NCT00454194|Sorafenib|sorafenib|mesh-list
14277079|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277080|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277081|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277082|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14277083|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14277084|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277085|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
14277086|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277087|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
14277088|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14277089|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14277090|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277091|NCT00454207|Urological Agents|urological agents|mesh-ancestor
15143850|NCT04266236|Ropivacaine|ropivacaine|mesh-list
15143851|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
15143852|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143853|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277092|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
14277093|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
14277094|NCT00454246|Hematinics|hematinics|mesh-ancestor
15143854|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
15143855|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
15143856|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143857|NCT04266288|Ketamine|ketamine|mesh-list
15143858|NCT04266288|Analgesics|analgesics|mesh-ancestor
15143859|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
15143860|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143861|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143862|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15143863|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15143864|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
15143865|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
15143866|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143867|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15143868|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15143869|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143870|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143871|NCT04266340|Midazolam|midazolam|mesh-list
15143872|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
15143873|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15143874|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143875|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143876|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143877|NCT04266340|Analgesics|analgesics|mesh-ancestor
15143878|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
15143879|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143880|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15143881|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15143882|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15143883|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
15143884|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15143885|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143886|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15143887|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15143888|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15143889|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14277095|NCT00454324|Paclitaxel|paclitaxel|mesh-list
14277096|NCT00454324|Carboplatin|carboplatin|mesh-list
14277097|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15143890|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15143891|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
15143892|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
15143893|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
15143894|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
15143895|NCT04266132|Bupivacaine|bupivacaine|mesh-list
15143896|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
15143897|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
15143898|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143899|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143900|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
15143901|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143902|NCT04265833|Calcium|calcium|mesh-list
15143903|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15143904|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143905|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15143906|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
15143907|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143908|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
15143909|NCT04265872|Bortezomib|bortezomib|mesh-list
15143910|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143911|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15143912|NCT04265456|Acetaminophen|acetaminophen|mesh-list
15143913|NCT04265456|Pregabalin|pregabalin|mesh-list
15143914|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15143915|NCT04265456|Analgesics|analgesics|mesh-ancestor
15143916|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
15143917|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143918|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143919|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
15143920|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
15143921|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15143922|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15143923|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143924|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15143925|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15143926|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15143927|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143928|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15143929|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15143930|NCT04265612|Laxatives|laxatives|mesh-ancestor
15143931|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15143932|NCT04265508|Hemostatics|hemostatics|mesh-list
15143933|NCT04265508|Coagulants|coagulants|mesh-ancestor
15143934|NCT04265274|Copper|copper|mesh-list
15143935|NCT04265274|Disulfiram|disulfiram|mesh-list
15143936|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143937|NCT04265274|Trace Elements|trace elements|mesh-ancestor
15143938|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
15143939|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143940|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15143941|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15143942|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143943|NCT04265105|Fluticasone|fluticasone|mesh-list
15143944|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143945|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15143946|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
15143947|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143948|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143949|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15143950|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
15143951|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
15143952|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15143953|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
15143954|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15143955|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
15143956|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143957|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
15143958|NCT04265001|Protective Agents|protective agents|mesh-ancestor
15143959|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
15143960|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15143961|NCT04264858|Antibodies|antibodies|mesh-list
15143962|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
15143963|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
14277098|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15143964|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143965|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
15143966|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
14277099|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277100|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277101|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277102|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277103|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277104|NCT00454584|Etanercept|etanercept|mesh-list
14277105|NCT00454584|Ustekinumab|ustekinumab|mesh-list
14277106|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14277107|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14277108|NCT00454584|Analgesics|analgesics|mesh-ancestor
14277109|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
14277110|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277111|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143967|NCT04264988|Protective Agents|protective agents|mesh-ancestor
15143968|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143969|NCT04265027|Opicapone|opicapone|mesh-list
15143970|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15143971|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15143972|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143973|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15143974|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15143975|NCT04264806|Azacitidine|azacitidine|mesh-list
15143976|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15143977|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
15143978|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143979|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15143980|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277112|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15143981|NCT04264676|Metronidazole|metronidazole|mesh-list
15143982|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15143983|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15143984|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15143985|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15143986|NCT04264481|Lidocaine|lidocaine|mesh-list
15143987|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
15143988|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
15143989|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15143990|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15143991|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
15143992|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15143993|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15143994|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15143995|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15143996|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15143997|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15143998|NCT04264624|Erythritol|erythritol|mesh-list
15143999|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
15179604|NCT03948737|Vitamins|vitamins|mesh-ancestor
15179605|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
15179606|NCT03948620|Penicillins|penicillins|mesh-list
15179607|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15179608|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179609|NCT03948477|Pantoprazole|pantoprazole|mesh-list
15179610|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15179611|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15179612|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15179613|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179614|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179615|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15179616|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15179617|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
15179618|NCT03948243|Tolbutamide|tolbutamide|mesh-list
15179619|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
15179620|NCT03948243|Alprazolam|alprazolam|mesh-list
15179621|NCT03948243|Caffeine|caffeine|mesh-list
15179622|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15179623|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179624|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15179625|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179626|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179627|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15179628|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15179629|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
15179630|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179631|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
14277113|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144000|NCT04264078|Fludarabine|fludarabine|mesh-list
15144001|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
15144002|NCT04264078|Melphalan|melphalan|mesh-list
15144003|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144004|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144005|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144006|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
15144007|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144008|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144009|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15144010|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
15144011|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15144012|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15144013|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
15144014|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144015|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15144016|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
15144017|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144018|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144019|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15144020|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15144021|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15144022|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
15144023|NCT04264039|Fludarabine|fludarabine|mesh-list
15144024|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
15144025|NCT04264039|Melphalan|melphalan|mesh-list
14277114|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277115|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277116|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
14277117|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
14277118|NCT00454636|Cisplatin|cisplatin|mesh-list
14277119|NCT00454636|Docetaxel|docetaxel|mesh-list
14277120|NCT00454636|Capecitabine|capecitabine|mesh-list
15144026|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144027|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144028|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144029|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
15144030|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144031|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144032|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15144033|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
15144034|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15144035|NCT04264260|Colchicine|colchicine|mesh-list
15144036|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
15144037|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144038|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144039|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
15144040|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
15144041|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144042|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144043|NCT04264130|Artesunate|artesunate|mesh-list
15144044|NCT04264130|Lumefantrine|lumefantrine|mesh-list
15144045|NCT04264130|Artemether|artemether|mesh-list
15144046|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15144047|NCT04264130|Pyronaridine|pyronaridine|mesh-list
15144048|NCT04264130|Artefenomel|artefenomel|mesh-list
15144049|NCT04264130|Ferroquine|ferroquine|mesh-list
15144050|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
15144051|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15144052|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15144053|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144054|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144055|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
15144056|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
15144057|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15144058|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
15144059|NCT04264286|Esmolol|esmolol|mesh-list
15144060|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15144061|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15144062|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15144063|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
15144064|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144065|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144066|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144067|NCT04263870|Capecitabine|capecitabine|mesh-list
15144068|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
14277121|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
14277122|NCT00454636|Epirubicin|epirubicin|mesh-list
14277123|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277124|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277125|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277126|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277127|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277128|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14277129|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
14277130|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14277131|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14277132|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15144069|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144070|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
15144071|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144072|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144073|NCT04263844|Midazolam|midazolam|mesh-list
15144074|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
15144075|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15144076|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144077|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144078|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15144079|NCT04263844|Analgesics|analgesics|mesh-ancestor
15144080|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
15144081|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144082|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14277133|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277134|NCT00454649|Gemcitabine|gemcitabine|mesh-list
14277135|NCT00454649|Paclitaxel|paclitaxel|mesh-list
14277136|NCT00454649|Docetaxel|docetaxel|mesh-list
14277137|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14277138|NCT00454649|Cisplatin|cisplatin|mesh-list
14277139|NCT00454649|Carboplatin|carboplatin|mesh-list
14277140|NCT00454649|Capecitabine|capecitabine|mesh-list
14277141|NCT00454649|Pemetrexed|pemetrexed|mesh-list
14277142|NCT00454649|Axitinib|axitinib|mesh-list
14277143|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14277144|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277145|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277146|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277147|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277148|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277149|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14277150|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
14277151|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
14277152|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277153|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277154|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277155|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
14277156|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277157|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14277158|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14277159|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277160|NCT00454779|Cisplatin|cisplatin|mesh-list
14277161|NCT00454779|Docetaxel|docetaxel|mesh-list
14277162|NCT00454779|Panitumumab|panitumumab|mesh-list
15144083|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15144084|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15144085|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
15144086|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144087|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144088|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14277163|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277164|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277165|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562249|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562250|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14562251|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14562252|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562253|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562254|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562255|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
14562256|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562257|NCT00002835|Antidotes|antidotes|mesh-ancestor
14562258|NCT00002835|Protective Agents|protective agents|mesh-ancestor
14277166|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277167|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277168|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277169|NCT00454805|Fulvestrant|fulvestrant|mesh-list
14277170|NCT00454805|Cediranib|cediranib|mesh-list
14277171|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14277172|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277173|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14277174|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14277175|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
14277176|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277177|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277178|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277179|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277180|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277181|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
14277182|NCT00455013|Sirolimus|sirolimus|mesh-list
14277183|NCT00455013|Abatacept|abatacept|mesh-list
14277184|NCT00455013|Tacrolimus|tacrolimus|mesh-list
14277185|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
14277186|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277187|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
14277188|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277189|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14277190|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277191|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277192|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14277193|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277194|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14277195|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
14277196|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14277197|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277198|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
14277199|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14277200|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277201|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
14277202|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
14277203|NCT00455312|Fludarabine|fludarabine|mesh-list
14277204|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
14277205|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
14277206|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14277207|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277208|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
14277209|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277210|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277211|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14277212|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
14277213|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277214|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277215|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15144089|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15144090|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15144091|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15144092|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15144093|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
15144094|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
15144095|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
15144096|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
14277216|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277217|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
14277218|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
14277219|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277220|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277221|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
14277222|NCT00455312|Hormones|hormones|mesh-ancestor
14277223|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277224|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14277225|NCT00455312|Protective Agents|protective agents|mesh-ancestor
14277226|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277227|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14277228|NCT00455520|Tapentadol|tapentadol|mesh-list
14277229|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14277230|NCT00455520|Narcotics|narcotics|mesh-ancestor
14277231|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144097|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15144098|NCT04264208|Bombesin|bombesin|mesh-list
14277232|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277233|NCT00455520|Analgesics|analgesics|mesh-ancestor
15144099|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14277234|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
14277235|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277236|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14277237|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14277238|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277239|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277240|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
14277241|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277242|NCT00455533|Paclitaxel|paclitaxel|mesh-list
14277243|NCT00455533|Epothilones|epothilones|mesh-list
14277244|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
14277245|NCT00455533|Doxorubicin|doxorubicin|mesh-list
14277246|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14277247|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277248|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277249|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277250|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277251|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277252|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277253|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
14277254|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277255|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277256|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14277257|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
14277258|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14277259|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14277260|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14277261|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14277262|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277263|NCT00455650|Mecamylamine|mecamylamine|mesh-list
14277264|NCT00455650|Varenicline|varenicline|mesh-list
14277265|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14277266|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14277267|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
14277268|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277269|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277270|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277271|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14277272|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14277273|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
14277274|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277275|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14277276|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14277277|NCT00455689|Leuprolide|leuprolide|mesh-list
14277278|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14277279|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
14277280|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14277281|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277282|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14277283|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277284|NCT00455702|Cycloserine|cycloserine|mesh-list
14277285|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14277286|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277287|NCT00455702|Renal Agents|renal agents|mesh-ancestor
14277288|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14277289|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
14277290|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14277291|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
14277292|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277293|NCT00455741|Estradiol|estradiol|mesh-list
14277294|NCT00455741|Progesterone|progesterone|mesh-list
14277295|NCT00455741|Estrogens|estrogens|mesh-ancestor
14277296|NCT00455741|Hormones|hormones|mesh-ancestor
14277297|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277298|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277299|NCT00455741|Progestins|progestins|mesh-ancestor
14277300|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
14277301|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14277302|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277303|NCT00455923|Fluticasone|fluticasone|mesh-list
14277304|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14277305|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14277306|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
14277307|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277308|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277309|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14277310|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
14277311|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
14277312|NCT00455923|Hormones|hormones|mesh-ancestor
14277313|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277314|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
14277315|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277316|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
14277317|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14277318|NCT00455962|Estradiol|estradiol|mesh-list
14277319|NCT00455962|Progesterone|progesterone|mesh-list
14277320|NCT00455962|Estrogens|estrogens|mesh-ancestor
14277321|NCT00455962|Hormones|hormones|mesh-ancestor
14277322|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277323|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277324|NCT00455962|Progestins|progestins|mesh-ancestor
14277325|NCT00455975|Bevacizumab|bevacizumab|mesh-list
14277326|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277327|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277328|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277329|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277330|NCT00455975|Growth Substances|growth substances|mesh-ancestor
14277331|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277332|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277333|NCT00456014|Citalopram|citalopram|mesh-list
14277334|NCT00456014|Desipramine|desipramine|mesh-list
14277335|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14277336|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15144100|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144101|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144102|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144103|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15144104|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
15144105|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144106|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
15144107|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144108|NCT04263519|Tacrolimus|tacrolimus|mesh-list
15144109|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144110|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
15144111|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144112|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15144113|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277337|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277338|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277339|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277340|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
14277341|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277342|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14277343|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
14277344|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14277345|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14277346|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277347|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15144114|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144115|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
15144116|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15144117|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15144118|NCT04263402|Prednisolone|prednisolone|mesh-list
15144119|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
14277348|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
14277349|NCT00456092|Apremilast|apremilast|mesh-list
14277350|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14277351|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14277352|NCT00456092|Analgesics|analgesics|mesh-ancestor
14277353|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
14277354|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277355|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277356|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277357|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277358|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14277359|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14277360|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277361|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277362|NCT00456261|Gemcitabine|gemcitabine|mesh-list
14277363|NCT00456261|Bevacizumab|bevacizumab|mesh-list
14277364|NCT00456261|Carboplatin|carboplatin|mesh-list
14277365|NCT00456261|Pemetrexed|pemetrexed|mesh-list
14277366|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277367|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277368|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277369|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277370|NCT00456261|Growth Substances|growth substances|mesh-ancestor
14277371|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277372|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277373|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14277374|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
14277375|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277376|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
14277377|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277378|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144120|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15144121|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
15144122|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15144123|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
15144124|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
15144125|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144126|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144127|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15144128|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
15144129|NCT04263402|Hormones|hormones|mesh-ancestor
15144130|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15144131|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15144132|NCT04263402|Protective Agents|protective agents|mesh-ancestor
15144133|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14277379|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277380|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
14277381|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14277382|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14277383|NCT00456300|Exenatide|exenatide|mesh-list
14277384|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14277385|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277386|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14277387|NCT00456300|Incretins|incretins|mesh-ancestor
14277388|NCT00456300|Hormones|hormones|mesh-ancestor
14277389|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277390|NCT00456365|Pravastatin|pravastatin|mesh-list
14277391|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14277392|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14277393|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
14277394|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277395|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14277396|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14277397|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277398|NCT00456495|Ranibizumab|ranibizumab|mesh-list
14277399|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277400|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277401|NCT00456495|Growth Substances|growth substances|mesh-ancestor
14277402|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277403|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277404|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277405|NCT00456508|Ecallantide|ecallantide|mesh-list
14277406|NCT00456508|Analgesics|analgesics|mesh-ancestor
14277407|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
14277408|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277409|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277410|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14277411|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14277412|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277413|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277414|NCT00456521|Naltrexone|naltrexone|mesh-list
14277415|NCT00456521|Bupropion|bupropion|mesh-list
14277416|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14277417|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14277418|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277419|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
15144134|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144135|NCT04263051|Nivolumab|nivolumab|mesh-list
14277420|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144136|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277421|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14277422|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
14277423|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14277424|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14277425|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14277426|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277427|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277428|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
14277429|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277430|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14277431|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14277432|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277433|NCT00456599|Gemcitabine|gemcitabine|mesh-list
14277434|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
14277435|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14277436|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
14277437|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277438|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277439|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
14277440|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277441|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277442|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277443|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
14277444|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277445|NCT00456625|Vaccines|vaccines|mesh-list
14277446|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
14277447|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277448|NCT00456807|Vaccines|vaccines|mesh-list
14277449|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
14277450|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277451|NCT00456846|Paclitaxel|paclitaxel|mesh-list
14277452|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14277453|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14277454|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277455|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277456|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277457|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277458|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277459|NCT00456885|Exenatide|exenatide|mesh-list
14277460|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14277461|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277462|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14277463|NCT00456885|Incretins|incretins|mesh-ancestor
14277464|NCT00456885|Hormones|hormones|mesh-ancestor
14277465|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277466|NCT00457002|Enoxaparin|enoxaparin|mesh-list
14277467|NCT00457002|Apixaban|apixaban|mesh-list
14277468|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
14277469|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14277470|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14277471|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277472|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14277473|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
15144137|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277474|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14277475|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
14277476|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277477|NCT00457015|Ecallantide|ecallantide|mesh-list
14277478|NCT00457015|Analgesics|analgesics|mesh-ancestor
14277479|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
14277480|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277481|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277482|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14277483|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14277484|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277485|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277486|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14277487|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
15144138|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15144139|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144140|NCT04263298|Capecitabine|capecitabine|mesh-list
15144141|NCT04263298|Fulvestrant|fulvestrant|mesh-list
14277488|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14277489|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14277490|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15144142|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144143|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
15144144|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144145|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144146|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15144147|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15144148|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15144149|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
15144150|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15144151|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144152|NCT04262999|Levetiracetam|levetiracetam|mesh-list
15144153|NCT04262999|Valproic Acid|valproic acid|mesh-list
15144154|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
15144155|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
15144156|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277491|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14277492|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277493|NCT00457366|Lorazepam|lorazepam|mesh-list
14277494|NCT00457366|Haloperidol|haloperidol|mesh-list
14277495|NCT00457366|Benztropine|benztropine|mesh-list
14277496|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14277497|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
14277498|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
14277499|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14277500|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14277501|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14277502|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14277503|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277504|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
14277505|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
14277506|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277507|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277508|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14277509|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
15144157|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144158|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
15144159|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144160|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144161|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
15144162|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15144163|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144164|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15144165|NCT04262934|Vitamin D|vitamin d|mesh-list
15144166|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
14277510|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277511|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277512|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14277513|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
14277514|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14277515|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14277516|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
14277517|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
14277518|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14277519|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
14277520|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14277521|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14277522|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
14277523|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14277524|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14277525|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277526|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14277527|NCT00457392|Sunitinib|sunitinib|mesh-list
14277528|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277529|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277530|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277531|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277532|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277533|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277534|NCT00457392|Growth Substances|growth substances|mesh-ancestor
14277535|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277536|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277537|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14277538|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
14277539|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144167|NCT04262934|Vitamins|vitamins|mesh-ancestor
14277540|NCT00457626|Valsartan|valsartan|mesh-list
14277541|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14277542|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14277543|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15144168|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
15144169|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144170|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14277544|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277545|NCT00457639|Cholic Acids|cholic acids|mesh-list
14277546|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277547|NCT00457665|Efavirenz|efavirenz|mesh-list
15144171|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15144172|NCT04262635|Capecitabine|capecitabine|mesh-list
14277548|NCT00457665|Nelfinavir|nelfinavir|mesh-list
14277549|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14277550|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14277551|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277552|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277553|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
14277554|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277555|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14277556|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14277557|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14277558|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14277559|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14277560|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14277561|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14277562|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14277563|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
14277564|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14277565|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14277566|NCT00457691|Leucovorin|leucovorin|mesh-list
14277567|NCT00457691|Fluorouracil|fluorouracil|mesh-list
14277568|NCT00457691|Irinotecan|irinotecan|mesh-list
14277569|NCT00457691|Sunitinib|sunitinib|mesh-list
14277570|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
14277571|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
14277572|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277573|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14277574|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277575|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277576|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
14277577|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277578|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14277579|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14277580|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277581|NCT00457691|Antidotes|antidotes|mesh-ancestor
14277582|NCT00457691|Protective Agents|protective agents|mesh-ancestor
14277583|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
14277584|NCT00457691|Vitamins|vitamins|mesh-ancestor
14277585|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
14277586|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277587|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277588|NCT00457691|Growth Substances|growth substances|mesh-ancestor
14277589|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277590|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277591|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14277592|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14277593|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14277594|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277595|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277596|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277597|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277598|NCT00457730|Analgesics|analgesics|mesh-ancestor
14277599|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
14277600|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144173|NCT04262635|Cetuximab|cetuximab|mesh-list
15144174|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144175|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
15144176|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144177|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144178|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277601|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
14277602|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14277603|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
14277604|NCT00457743|Sunitinib|sunitinib|mesh-list
14277605|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277606|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277607|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277608|NCT00457743|Growth Substances|growth substances|mesh-ancestor
14277609|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277610|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277611|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277612|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277613|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277614|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14277615|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14277616|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14277617|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14277618|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14277619|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
14277620|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277621|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277622|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277623|NCT00457821|Ivacaftor|ivacaftor|mesh-list
15144179|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
15144180|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15144181|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144182|NCT04262817|Nicotine|nicotine|mesh-list
15144183|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14277624|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14277625|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277626|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277627|NCT00457977|Vaccines|vaccines|mesh-list
14277628|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14277629|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
14277630|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277631|NCT00458211|Ziprasidone|ziprasidone|mesh-list
14277632|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14277633|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
14277634|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277635|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277636|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277637|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14277638|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14277639|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14277640|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14277641|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14277642|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
14277643|NCT00458237|Trastuzumab|trastuzumab|mesh-list
14277644|NCT00458237|Everolimus|everolimus|mesh-list
14277645|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277646|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277647|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277648|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
14277649|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277650|NCT00458302|Darunavir|darunavir|mesh-list
14277651|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14277652|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14277653|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
14277654|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277655|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277656|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14277657|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14277658|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
14277659|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277660|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14277661|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14277662|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14277663|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277664|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277665|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
14277666|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277667|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15144184|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
15144185|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144186|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277668|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14277669|NCT00458705|Thalidomide|thalidomide|mesh-list
14277670|NCT00458705|Dexamethasone|dexamethasone|mesh-list
14277671|NCT00458705|Doxorubicin|doxorubicin|mesh-list
14277672|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14277673|NCT00458705|Bortezomib|bortezomib|mesh-list
14277674|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277675|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
14277676|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
14277677|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277678|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144187|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15144188|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15144189|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
14277679|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277680|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
14277681|NCT00458705|Hormones|hormones|mesh-ancestor
14277682|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277683|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14277684|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277685|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14277686|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14277687|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14277688|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277689|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277690|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277691|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
14277692|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
14277693|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14277694|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277695|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277696|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277697|NCT00458705|Growth Substances|growth substances|mesh-ancestor
14277698|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277699|NCT00458822|Dexamethasone|dexamethasone|mesh-list
14277700|NCT00458822|Bortezomib|bortezomib|mesh-list
14277701|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277702|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
15144190|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144191|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144192|NCT04262843|Vidarabine|vidarabine|mesh-list
15144193|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
15144194|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
15144195|NCT04262843|Fludarabine|fludarabine|mesh-list
15144196|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
15144197|NCT04262843|Tacrolimus|tacrolimus|mesh-list
15144198|NCT04262843|Lenograstim|lenograstim|mesh-list
15144199|NCT04262843|Sargramostim|sargramostim|mesh-list
14277703|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
14277704|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277705|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277706|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277707|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
14277708|NCT00458822|Hormones|hormones|mesh-ancestor
14277709|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277710|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14277711|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277712|NCT00458848|Prednisone|prednisone|mesh-list
14277713|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
14277714|NCT00458848|Methotrexate|methotrexate|mesh-list
14277715|NCT00458848|Etoposide|etoposide|mesh-list
14277716|NCT00458848|Vincristine|vincristine|mesh-list
14277717|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
14277718|NCT00458848|Daunorubicin|daunorubicin|mesh-list
14277719|NCT00458848|Asparaginase|asparaginase|mesh-list
14277720|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
14277721|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
14277722|NCT00458848|Idarubicin|idarubicin|mesh-list
14277723|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277724|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
14277725|NCT00458848|Hormones|hormones|mesh-ancestor
14277726|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277727|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277728|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14277729|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277730|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14277731|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
15144200|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144201|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
14277732|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14277733|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14277734|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
14277735|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277736|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
14277737|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277738|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14277739|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277740|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
14277741|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277742|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14277743|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14277744|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14277745|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14277746|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277747|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277748|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277749|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
14277750|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
14277751|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277752|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277753|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14277754|NCT00458848|Protective Agents|protective agents|mesh-ancestor
14277755|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277756|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14277757|NCT00458848|Analgesics|analgesics|mesh-ancestor
14277758|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
14277759|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14277760|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277761|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277762|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277763|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14277764|NCT00459043|Docetaxel|docetaxel|mesh-list
14277765|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277766|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277767|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277768|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277769|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277770|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14277771|NCT00459056|Carvedilol|carvedilol|mesh-list
14277772|NCT00459056|Lisinopril|lisinopril|mesh-list
14277773|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14277774|NCT00459056|Diuretics|diuretics|mesh-ancestor
14277775|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
14277776|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277777|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14277778|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14277779|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277780|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14277781|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14277782|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
14277783|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277784|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
14277785|NCT00459056|Protective Agents|protective agents|mesh-ancestor
14277786|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14277787|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14277788|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
14277789|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14277790|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14277791|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14277792|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
14277793|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277794|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14277795|NCT00459108|Dasatinib|dasatinib|mesh-list
14277796|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277797|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277798|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277799|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277800|NCT00459186|Prednisone|prednisone|mesh-list
14277801|NCT00459186|Docetaxel|docetaxel|mesh-list
14277802|NCT00459186|Everolimus|everolimus|mesh-list
14277803|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277804|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277805|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277806|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277807|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277808|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277809|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
14277810|NCT00459186|Hormones|hormones|mesh-ancestor
14277811|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277812|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277813|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14277814|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277815|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
14277816|NCT00459290|Mifepristone|mifepristone|mesh-list
14277817|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14277818|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
14277819|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14277820|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277821|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14277822|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14277823|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14277824|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
14277825|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14277826|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14277827|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
14277828|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277829|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
14277830|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14277831|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14292611|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
14292612|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
14292613|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292614|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292615|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292616|NCT00562159|Fluticasone|fluticasone|mesh-list
14292617|NCT00562159|Xhance|xhance|mesh-list
14292618|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
14292619|NCT00562159|Loratadine|loratadine|mesh-list
14292620|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14292621|NCT00562159|Prednisone|prednisone|mesh-list
14292622|NCT00562159|Albuterol|albuterol|mesh-list
14292623|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14292624|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
14292625|NCT00562159|Hormones|hormones|mesh-ancestor
14292626|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292627|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292628|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292629|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292630|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14292631|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
14292632|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292633|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14292634|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
14292635|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14292636|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14292637|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
14292638|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14292639|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14292640|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14292641|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14292642|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292643|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292644|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292645|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
14292646|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14292647|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15144202|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144203|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144204|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15144205|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
15144206|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144207|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144208|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15144209|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144210|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
15144211|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
15144212|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277832|NCT00459342|Dasatinib|dasatinib|mesh-list
14277833|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277834|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277835|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277836|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277837|NCT00459537|Terbinafine|terbinafine|mesh-list
14277838|NCT00459537|Amorolfine|amorolfine|mesh-list
14277839|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
14277840|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277841|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277842|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277843|NCT00459667|Interferons|interferons|mesh-list
14277844|NCT00459667|Interferon-beta|interferon-beta|mesh-list
14277845|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
14277846|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277847|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
14277848|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277849|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
14277850|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277851|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14277852|NCT00459706|Etanercept|etanercept|mesh-list
14277853|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14562259|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
14562260|NCT00002835|Vitamins|vitamins|mesh-ancestor
14562261|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
14562262|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562263|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562264|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562265|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562266|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
14562267|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
14562268|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562269|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562270|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
14562271|NCT00002835|Hormones|hormones|mesh-ancestor
14562272|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562273|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14562274|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562275|NCT00002835|Analgesics|analgesics|mesh-ancestor
14562276|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
14562277|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15144213|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15144214|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144215|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15144216|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15144217|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
15144218|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15144219|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15144220|NCT04262765|Amlodipine|amlodipine|mesh-list
15144221|NCT04262765|Ramipril|ramipril|mesh-list
15144222|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
15144223|NCT04262765|Atorvastatin|atorvastatin|mesh-list
15144224|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14562278|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
14562279|NCT00002836|Thiotepa|thiotepa|mesh-list
14562280|NCT00002836|Carmustine|carmustine|mesh-list
14562281|NCT00002836|Cisplatin|cisplatin|mesh-list
14562282|NCT00002836|Etoposide|etoposide|mesh-list
14562283|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562284|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
14562285|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144225|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15144226|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
15144227|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144228|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15144229|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15144230|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144231|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15144232|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15144233|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15144234|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14277854|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14277855|NCT00459706|Analgesics|analgesics|mesh-ancestor
14562286|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562287|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562288|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
15144235|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144236|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
15144237|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15144238|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
15144239|NCT04262804|Gemcitabine|gemcitabine|mesh-list
15144240|NCT04262804|Capecitabine|capecitabine|mesh-list
15144241|NCT04262804|Trastuzumab|trastuzumab|mesh-list
14020387|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277856|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
14277857|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277858|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277859|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277860|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277861|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14277862|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14277863|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
14277864|NCT00459732|Zinc|zinc|mesh-list
14277865|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
14277866|NCT00459732|Trace Elements|trace elements|mesh-ancestor
14277867|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
14277868|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277869|NCT00459732|Astringents|astringents|mesh-ancestor
14277870|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14277871|NCT00459810|Paclitaxel|paclitaxel|mesh-list
14277872|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14277873|NCT00459810|Estradiol|estradiol|mesh-list
14277874|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14277875|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277876|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277877|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277878|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14277879|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277880|NCT00459810|Estrogens|estrogens|mesh-ancestor
14277881|NCT00459810|Hormones|hormones|mesh-ancestor
14277882|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277883|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277884|NCT00459875|Sunitinib|sunitinib|mesh-list
14277885|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277886|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277887|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277888|NCT00459875|Growth Substances|growth substances|mesh-ancestor
14277889|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277890|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277891|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277892|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277893|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277894|NCT00459953|Nicotine|nicotine|mesh-list
14277895|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14277896|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
14277897|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277898|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277899|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14277900|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14277901|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
14277902|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277903|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277904|NCT00459979|Sunitinib|sunitinib|mesh-list
14277905|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277906|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277907|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277908|NCT00459979|Growth Substances|growth substances|mesh-ancestor
14277909|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277910|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277911|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277912|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277913|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277914|NCT00460031|Ketoconazole|ketoconazole|mesh-list
14277915|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
14277916|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14277917|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14277918|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14277919|NCT00460031|Lenalidomide|lenalidomide|mesh-list
14277920|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
14277921|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277922|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277923|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15144242|NCT04262804|Vinorelbine|vinorelbine|mesh-list
14277924|NCT00460031|Growth Substances|growth substances|mesh-ancestor
14277925|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277926|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277927|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14277928|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
14277929|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14277930|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14277931|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14277932|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277933|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277934|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14277935|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
14277936|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14277937|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14277938|NCT00460109|Rituximab|rituximab|mesh-list
14277939|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
14277940|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277941|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277942|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
14277943|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277944|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14277945|NCT00460239|Morphine|morphine|mesh-list
14277946|NCT00460239|Buprenorphine|buprenorphine|mesh-list
14277947|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14277948|NCT00460239|Narcotics|narcotics|mesh-ancestor
14277949|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14277950|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277951|NCT00460239|Analgesics|analgesics|mesh-ancestor
14277952|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
14277953|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144243|NCT04262804|Margetuximab|margetuximab|mesh-list
15144244|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144245|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
15144246|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144247|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144248|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
15144249|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144250|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277954|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14277955|NCT00460551|Zalutumumab|zalutumumab|mesh-list
14277956|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277957|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277958|NCT00460577|Bromides|bromides|mesh-list
14277959|NCT00460577|Fenoterol|fenoterol|mesh-list
14277960|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
14277961|NCT00460577|Ipratropium|ipratropium|mesh-list
14277962|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14277963|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
14277964|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14277965|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277966|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14277967|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
14277968|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14277969|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14277970|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15144251|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144252|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
15144253|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144254|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144255|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15144256|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
14277971|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
14277972|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14277973|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277974|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
14277975|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14277976|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
14277977|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
14277978|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
14277979|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14277980|NCT00460603|Bevacizumab|bevacizumab|mesh-list
14277981|NCT00460603|Axitinib|axitinib|mesh-list
15144257|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
14277982|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14277983|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14277984|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14277985|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14277986|NCT00460603|Growth Substances|growth substances|mesh-ancestor
14277987|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14277988|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
14277989|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14277990|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277991|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14277992|NCT00460746|Ritonavir|ritonavir|mesh-list
14277993|NCT00460746|Darunavir|darunavir|mesh-list
14277994|NCT00460746|Etravirine|etravirine|mesh-list
14277995|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14277996|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14277997|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
14277998|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14277999|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278000|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14278001|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14278002|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
14278003|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278004|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14278005|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14278006|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14278007|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14278008|NCT00460798|Sunitinib|sunitinib|mesh-list
14278009|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278010|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278011|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278012|NCT00460798|Growth Substances|growth substances|mesh-ancestor
14278013|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278014|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278015|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278016|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278017|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278018|NCT00460811|Linaclotide|linaclotide|mesh-list
14278019|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14278020|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
14278021|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278022|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14278023|NCT00460993|Eszopiclone|eszopiclone|mesh-list
14278024|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14278025|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278026|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278027|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14278028|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
14278029|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14278030|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14278031|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278032|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278033|NCT00461123|Urological Agents|urological agents|mesh-ancestor
14278034|NCT00461253|Copper|copper|mesh-list
14278035|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
14278036|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14278037|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
14278038|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14278039|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278040|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14278041|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14278042|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14278043|NCT00461253|Trace Elements|trace elements|mesh-ancestor
14278044|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
14278045|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
14278046|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14278047|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14278048|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14278049|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14278050|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278051|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
14278052|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278053|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278054|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14278055|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278056|NCT00461305|Drospirenone|drospirenone|mesh-list
14278057|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14278058|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
14278059|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278060|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278061|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14278062|NCT00461305|Diuretics|diuretics|mesh-ancestor
14278063|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
14278064|NCT00461331|Insulin|insulin|mesh-list
14278065|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14278066|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
14278067|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
14278068|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14278069|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
14278070|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14278071|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278072|NCT00461500|Fluticasone|fluticasone|mesh-list
14278073|NCT00461500|Xhance|xhance|mesh-list
14278074|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14278075|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278076|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14278077|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
14278078|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278079|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278080|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14278081|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
14278082|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
14278083|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14278084|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14278085|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14278086|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14278087|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
14278088|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278089|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278090|NCT00461591|Apaziquone|apaziquone|mesh-list
14278091|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278092|NCT00461630|Niacin|niacin|mesh-list
14278093|NCT00461630|Simvastatin|simvastatin|mesh-list
14278094|NCT00461630|Ezetimibe|ezetimibe|mesh-list
14278095|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14278096|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14278097|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14278098|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
14278099|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278100|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14278101|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14278102|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278103|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
14278104|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
14278105|NCT00461630|Vitamins|vitamins|mesh-ancestor
14278106|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
14278107|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278108|NCT00461708|Gemcitabine|gemcitabine|mesh-list
14278109|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14278110|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278111|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
14278112|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278113|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278114|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
14278115|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144258|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
15144259|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
15144260|NCT04262492|Apixaban|apixaban|mesh-list
15144261|NCT04262492|Edoxaban|edoxaban|mesh-list
14278116|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278117|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278118|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
14278119|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278120|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278121|NCT00461773|Bevacizumab|bevacizumab|mesh-list
14278122|NCT00461773|Letrozole|letrozole|mesh-list
14278123|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278124|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278125|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278126|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278127|NCT00461773|Growth Substances|growth substances|mesh-ancestor
15144262|NCT04262492|Dabigatran|dabigatran|mesh-list
15144263|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15144264|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
15144265|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15144266|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
15144267|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144268|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144269|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
14278128|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278129|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278130|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14278131|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14278132|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278133|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278134|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14278135|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14278136|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278137|NCT00461786|Pemetrexed|pemetrexed|mesh-list
14278138|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278139|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278140|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278141|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14278142|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14278143|NCT00461851|Gemcitabine|gemcitabine|mesh-list
14278144|NCT00461851|Carboplatin|carboplatin|mesh-list
14278145|NCT00461851|Sorafenib|sorafenib|mesh-list
14278146|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278147|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278148|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
14278149|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278150|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
14278151|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278152|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278153|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278154|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
14278155|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278156|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15144270|NCT04262388|Durvalumab|durvalumab|mesh-list
15144271|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144272|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278157|NCT00461981|Vaccines|vaccines|mesh-list
14278158|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
14278159|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278160|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14278161|NCT00462020|Metronidazole|metronidazole|mesh-list
14278162|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
14278163|NCT00462020|Ampicillin|ampicillin|mesh-list
14278164|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
14278165|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
14278166|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14278167|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278168|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
14278169|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14278170|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14278171|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278172|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278173|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14278174|NCT00462072|Infliximab|infliximab|mesh-list
14278175|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
14278176|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14278177|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278178|NCT00462228|Memantine|memantine|mesh-list
14278179|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14278180|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14278181|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
14278182|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278183|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278184|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278185|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14278186|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14278187|NCT00462280|Lovastatin|lovastatin|mesh-list
14278188|NCT00462280|L 647318|l 647318|mesh-list
14278189|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
15179632|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179633|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15179634|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14278190|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14278191|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14278192|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
14278193|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278194|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14278195|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14278196|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278197|NCT00462332|Vidarabine|vidarabine|mesh-list
14278198|NCT00462332|Fludarabine|fludarabine|mesh-list
14278199|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
14278200|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
14278201|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278202|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278203|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
14278204|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278205|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278206|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
14278207|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278208|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
14278209|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278210|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278211|NCT00462345|Rituximab|rituximab|mesh-list
14278212|NCT00462345|Methotrexate|methotrexate|mesh-list
14278213|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278214|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278215|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
14278216|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278217|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278218|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15144273|NCT04262375|Durvalumab|durvalumab|mesh-list
15144274|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144275|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144276|NCT04262193|Suvorexant|suvorexant|mesh-list
14278219|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
14278220|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14278221|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278222|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
14278223|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278224|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
14278225|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278226|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14278227|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278228|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14278229|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
14278230|NCT00462384|Hematinics|hematinics|mesh-ancestor
14278231|NCT00462423|Bevacizumab|bevacizumab|mesh-list
14278232|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14278233|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278234|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278235|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278236|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278237|NCT00462423|Growth Substances|growth substances|mesh-ancestor
14278238|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278239|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278240|NCT00462462|Ethanol|ethanol|mesh-list
14278241|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14278242|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278243|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278244|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278245|NCT00462501|Leucovorin|leucovorin|mesh-list
14278246|NCT00462501|Bevacizumab|bevacizumab|mesh-list
14278247|NCT00462501|Fluorouracil|fluorouracil|mesh-list
14278248|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
14278249|NCT00462501|Calcium|calcium|mesh-list
14278250|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
14278251|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278252|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278253|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278254|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278255|NCT00462501|Growth Substances|growth substances|mesh-ancestor
14278256|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278257|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278258|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14278259|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
15144277|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14278260|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278261|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278262|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278263|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
14278264|NCT00462501|Antidotes|antidotes|mesh-ancestor
14278265|NCT00462501|Protective Agents|protective agents|mesh-ancestor
14278266|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
14278267|NCT00462501|Vitamins|vitamins|mesh-ancestor
14278268|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
14278269|NCT00462605|Entinostat|entinostat|mesh-list
14278270|NCT00462605|Sargramostim|sargramostim|mesh-list
14278271|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14278272|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
14278273|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278274|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278275|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278276|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278277|NCT00462644|Fentanyl|fentanyl|mesh-list
14278278|NCT00462644|Midazolam|midazolam|mesh-list
14278279|NCT00462644|Etomidate|etomidate|mesh-list
14278280|NCT00462644|Succinylcholine|succinylcholine|mesh-list
14278281|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14278282|NCT00462644|Narcotics|narcotics|mesh-ancestor
14278283|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278284|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278285|NCT00462644|Analgesics|analgesics|mesh-ancestor
14278286|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
14278287|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278288|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14278289|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14278290|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
14278291|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
14278292|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14278293|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14278294|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14278295|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14278296|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
14278297|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
14278298|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278299|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278300|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14278301|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14278302|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14278303|NCT00462670|Tolvaptan|tolvaptan|mesh-list
14278304|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14278305|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278306|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
14278307|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278308|NCT00462709|Complement C1s|complement c1s|mesh-list
14278309|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14278310|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14278311|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
14278312|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278313|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14278314|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278315|NCT00462722|Ibuprofen|ibuprofen|mesh-list
14278316|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14278317|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14278318|NCT00462722|Analgesics|analgesics|mesh-ancestor
14278319|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
14278320|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278321|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278322|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278323|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278324|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14278325|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278326|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278327|NCT00462735|Fluorouracil|fluorouracil|mesh-list
14278328|NCT00462735|Cetuximab|cetuximab|mesh-list
14278329|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
14278330|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
14278331|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278332|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278333|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278334|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278335|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
14278336|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278337|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278338|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
14278339|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278340|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14278341|NCT00462826|Aflibercept|aflibercept|mesh-list
14278342|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
14278343|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278344|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278345|NCT00462826|Growth Substances|growth substances|mesh-ancestor
14278346|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278347|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278348|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278349|NCT00462865|Gemcitabine|gemcitabine|mesh-list
14278350|NCT00462865|Bevacizumab|bevacizumab|mesh-list
14278351|NCT00462865|Capecitabine|capecitabine|mesh-list
14278352|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278353|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278354|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15144278|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15144279|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144280|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278355|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278356|NCT00462865|Growth Substances|growth substances|mesh-ancestor
14278357|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278358|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278359|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278360|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
14278361|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278362|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
14278363|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278364|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278365|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278366|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
14278367|NCT00462982|Sunitinib|sunitinib|mesh-list
14278368|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278369|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278370|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278371|NCT00462982|Growth Substances|growth substances|mesh-ancestor
14278372|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278373|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278374|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278375|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278376|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278377|NCT00463047|Fentanyl|fentanyl|mesh-list
14278378|NCT00463047|Oxycodone|oxycodone|mesh-list
14278379|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14278380|NCT00463047|Narcotics|narcotics|mesh-ancestor
14278381|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278382|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278383|NCT00463047|Analgesics|analgesics|mesh-ancestor
14278384|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
14278385|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278386|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14278387|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14278388|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
14278389|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
14278390|NCT00463060|Sunitinib|sunitinib|mesh-list
14278391|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278392|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278393|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278394|NCT00463060|Growth Substances|growth substances|mesh-ancestor
14278395|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278396|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278397|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278398|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278399|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278400|NCT00463151|Rebamipide|rebamipide|mesh-list
15144281|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15144282|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144283|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144284|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
15144285|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144286|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278401|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14278402|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14278403|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
14278404|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278405|NCT00463151|Protective Agents|protective agents|mesh-ancestor
14278406|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278407|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278408|NCT00463346|Acamprosate|acamprosate|mesh-list
14278409|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14278410|NCT00463385|Thalidomide|thalidomide|mesh-list
14278411|NCT00463385|Prednisone|prednisone|mesh-list
14278412|NCT00463385|Pomalidomide|pomalidomide|mesh-list
14278413|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278414|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
14278415|NCT00463385|Hormones|hormones|mesh-ancestor
14278416|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278417|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278418|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14278419|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278420|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
14278421|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278422|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278423|NCT00463385|Growth Substances|growth substances|mesh-ancestor
14278424|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278425|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278426|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
14278427|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14278428|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278429|NCT00463437|Vaccines|vaccines|mesh-list
14278430|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14278431|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
14278432|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278433|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
14278434|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
14278435|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14278436|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
14278437|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278438|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278439|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14278440|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
15144287|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
14278441|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14278442|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14278443|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14278444|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14278445|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278446|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278447|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
14278448|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14278449|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
14278450|NCT00463580|Infliximab|infliximab|mesh-list
14278451|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
14278452|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14278453|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278454|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
14278455|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14278456|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
14278457|NCT00463606|Calcium|calcium|mesh-list
14278458|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14278459|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278460|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14278461|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14278462|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14278463|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
14278464|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278465|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14278466|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14278467|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278468|NCT00463684|Vaccines|vaccines|mesh-list
14278469|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
14278470|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278471|NCT00463788|Cisplatin|cisplatin|mesh-list
14278472|NCT00463788|Cetuximab|cetuximab|mesh-list
14278473|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278474|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278475|NCT00463801|Daptomycin|daptomycin|mesh-list
14278476|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14278477|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278478|NCT00463840|Fluorouracil|fluorouracil|mesh-list
14278479|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
14278480|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
14278481|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278482|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14278483|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278484|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278485|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
14278486|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278487|NCT00463866|Budesonide|budesonide|mesh-list
14278488|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
14278489|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278490|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14278491|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
14278492|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278493|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278494|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14278495|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
14278496|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
14278497|NCT00463866|Hormones|hormones|mesh-ancestor
14278498|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278499|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14278500|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14278501|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14278502|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
14278503|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278504|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278505|NCT00464087|Heparin|heparin|mesh-list
14278506|NCT00464087|Calcium heparin|calcium heparin|mesh-list
14278507|NCT00464087|PENTA|penta|mesh-list
14278508|NCT00464087|Bivalirudin|bivalirudin|mesh-list
14278509|NCT00464087|Fondaparinux|fondaparinux|mesh-list
14278510|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
14278511|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14278512|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14278513|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278514|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
14278515|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14278516|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
14278517|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278518|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14278519|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14278520|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
14278521|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
14278522|NCT00464269|Brivaracetam|brivaracetam|mesh-list
14278523|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
14278524|NCT00464308|Esomeprazole|esomeprazole|mesh-list
14278525|NCT00464308|Rabeprazole|rabeprazole|mesh-list
14278526|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14278527|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14278528|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14278529|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144288|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
15144289|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144290|NCT04261907|Ritonavir|ritonavir|mesh-list
15144291|NCT04261907|Lopinavir|lopinavir|mesh-list
15144292|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15144293|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15144294|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
15144295|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144296|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144297|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15144298|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15144299|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
15144300|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144301|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15144302|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15144303|NCT04261855|Avelumab|avelumab|mesh-list
15144304|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15144305|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144306|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144307|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15144308|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144309|NCT04261634|Mitogens|mitogens|mesh-list
14562289|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278530|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278531|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
14278532|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
14278533|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14278534|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14278535|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278536|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14278537|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14278538|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278539|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278540|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278541|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14292648|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
14292649|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
14292650|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14292651|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14292652|NCT00562159|Analgesics|analgesics|mesh-ancestor
14292653|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
14292654|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292655|NCT00562328|Rituximab|rituximab|mesh-list
14292656|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
14292657|NCT00562328|Sargramostim|sargramostim|mesh-list
14292658|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14292659|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292660|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
14292661|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292662|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292663|NCT00562588|Dipyridamole|dipyridamole|mesh-list
14292664|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
14292665|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14292666|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292667|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292668|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14292669|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
14292670|NCT00562627|Ketorolac|ketorolac|mesh-list
14292671|NCT00562627|Epinephrine|epinephrine|mesh-list
14292672|NCT00562627|Racepinephrine|racepinephrine|mesh-list
14292673|NCT00562627|Fentanyl|fentanyl|mesh-list
14292674|NCT00562627|Morphine|morphine|mesh-list
14292675|NCT00562627|Bupivacaine|bupivacaine|mesh-list
14292676|NCT00562627|Ropivacaine|ropivacaine|mesh-list
14292677|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
14292678|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
14292679|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
14292680|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292681|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292682|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
14292683|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292684|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14292685|NCT00562627|Narcotics|narcotics|mesh-ancestor
14292686|NCT00562627|Analgesics|analgesics|mesh-ancestor
14292687|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14292688|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14292689|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
14292690|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14292691|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14292692|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292693|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292694|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292695|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14292696|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14292697|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
14292698|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14292699|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
14562290|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562291|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562292|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562293|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562294|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562295|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562296|NCT00002837|Paclitaxel|paclitaxel|mesh-list
14562297|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
14562298|NCT00002837|Doxorubicin|doxorubicin|mesh-list
14562299|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15144310|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292700|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
14292701|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
14292702|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14292703|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14562300|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14278542|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
14278543|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15144311|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144312|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
15144313|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15144314|NCT04261426|Antibodies|antibodies|mesh-list
14278544|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278545|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278546|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14278547|NCT00464490|Analgesics|analgesics|mesh-ancestor
14278548|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
14278549|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278550|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14278551|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15144315|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
15144316|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15144317|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
15144318|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144319|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15144320|NCT04261465|Paclitaxel|paclitaxel|mesh-list
15144321|NCT04261465|Carboplatin|carboplatin|mesh-list
15144322|NCT04261465|Olaparib|olaparib|mesh-list
15144323|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15144324|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144325|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144326|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
15144327|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
14278552|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14278553|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
14278554|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278555|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278556|NCT00464542|Metronidazole|metronidazole|mesh-list
14278557|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278558|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14278559|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14278560|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14278561|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
14278562|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14278563|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14278564|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278565|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278566|NCT00464620|Dasatinib|dasatinib|mesh-list
14278567|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278568|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278569|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278570|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278571|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
15144328|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144329|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15144330|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144331|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
15144332|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
15144333|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15144334|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15144335|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144336|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144337|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144338|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144339|NCT04261270|Ritonavir|ritonavir|mesh-list
15144340|NCT04261270|Oseltamivir|oseltamivir|mesh-list
15144341|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15144342|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14278572|NCT00464646|Bevacizumab|bevacizumab|mesh-list
14278573|NCT00464646|Docetaxel|docetaxel|mesh-list
14278574|NCT00464646|Trastuzumab|trastuzumab|mesh-list
14278575|NCT00464646|Epirubicin|epirubicin|mesh-list
14278576|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14278577|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
14278578|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278579|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278580|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14278581|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
15144343|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
14278582|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278583|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278584|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14278585|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278586|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278587|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278588|NCT00464646|Growth Substances|growth substances|mesh-ancestor
14278589|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278590|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144344|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144345|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144346|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14278591|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
14278592|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
14278593|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14278594|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14278595|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14278596|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278597|NCT00464672|Vaccines|vaccines|mesh-list
14278598|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
14278599|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278600|NCT00464685|Dexamethasone|dexamethasone|mesh-list
14278601|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278602|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
14278603|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
15144347|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15144348|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
14278604|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278605|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278606|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14278607|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
14278608|NCT00464685|Hormones|hormones|mesh-ancestor
14278609|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278610|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14278611|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144349|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278612|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14278613|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14278614|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14278615|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14278616|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278617|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278618|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278619|NCT00464698|Analgesics|analgesics|mesh-ancestor
14278620|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
14278621|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278622|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
14278623|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14278624|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
14278625|NCT00464711|Citalopram|citalopram|mesh-list
14278626|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14278627|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14278628|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14278629|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278630|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278631|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
14278632|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278633|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14278634|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
14278635|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14278636|NCT00464737|Rotigotine|rotigotine|mesh-list
14278637|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
14278638|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
14278639|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278640|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278641|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278642|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14278643|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
14278644|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278645|NCT00465088|Niacin|niacin|mesh-list
14278646|NCT00465088|Niacinamide|niacinamide|mesh-list
14278647|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
14278648|NCT00465088|Atorvastatin|atorvastatin|mesh-list
15144350|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14278649|NCT00465088|Simvastatin|simvastatin|mesh-list
14278650|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14278651|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14278652|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
14278653|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144351|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15144352|NCT04261023|Abatacept|abatacept|mesh-list
15144353|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15144354|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144355|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144356|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144357|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
15144358|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144359|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144360|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
15144361|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
15144362|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144363|NCT04261036|Protective Agents|protective agents|mesh-ancestor
15144364|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144365|NCT04261036|Vitamins|vitamins|mesh-ancestor
15144366|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
15144367|NCT04261049|Triamcinolone|triamcinolone|mesh-list
15144368|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15144369|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15144370|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15144371|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15144372|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
15144373|NCT04261049|Hormones|hormones|mesh-ancestor
15144374|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15144375|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278654|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14278655|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14278656|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278657|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
14278658|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
14278659|NCT00465088|Vitamins|vitamins|mesh-ancestor
14278660|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
14278661|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278662|NCT00465179|Sunitinib|sunitinib|mesh-list
14278663|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278664|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278665|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278666|NCT00465179|Growth Substances|growth substances|mesh-ancestor
14278667|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278668|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278669|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278670|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278671|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278672|NCT00465530|Gentamicins|gentamicins|mesh-list
14278673|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14278674|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278675|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14278676|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278677|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278678|NCT00465595|Psilocybin|psilocybin|mesh-list
14278679|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14278680|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
14278681|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278682|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14278683|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14278684|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
14278685|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278686|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278687|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14278688|NCT00465647|Hydromorphone|hydromorphone|mesh-list
14278689|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14278690|NCT00465647|Narcotics|narcotics|mesh-ancestor
14278691|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278692|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278693|NCT00465647|Analgesics|analgesics|mesh-ancestor
14278694|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
14278695|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144376|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144377|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
14278696|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
14278697|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14278698|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14278699|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14278700|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14278701|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14278702|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278703|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
14278704|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278705|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278706|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14278707|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278708|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14278709|NCT00465894|Estradiol|estradiol|mesh-list
14278710|NCT00465894|Estrogens|estrogens|mesh-ancestor
14278711|NCT00465894|Hormones|hormones|mesh-ancestor
14278712|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278713|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278714|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14278715|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14278716|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
14278717|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278718|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278719|NCT00465894|Urological Agents|urological agents|mesh-ancestor
14278720|NCT00465972|Doxepin|doxepin|mesh-list
14278721|NCT00465972|Temazepam|temazepam|mesh-list
14278722|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14278723|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14278724|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278725|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278726|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14278727|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
14278728|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14278729|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
14278730|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
14278731|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278732|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278733|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14278734|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14278735|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
14278736|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
14278737|NCT00466167|Pramipexole|pramipexole|mesh-list
14278738|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
14278739|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278740|NCT00466167|Protective Agents|protective agents|mesh-ancestor
14278741|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278742|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14278743|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14278744|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
14278745|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
14278746|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278747|NCT00466193|Zolpidem|zolpidem|mesh-list
14278748|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14278749|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14278750|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278751|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278752|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14278753|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
14278754|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
14278755|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278756|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278757|NCT00466310|Risperidone|risperidone|mesh-list
14278758|NCT00466310|Aripiprazole|aripiprazole|mesh-list
14278759|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14278760|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
14278761|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278762|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278763|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278764|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14278765|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14278766|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14278767|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14278768|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14278769|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
14278770|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
14278771|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
15144378|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144379|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144380|NCT04260828|Aspirin|aspirin|mesh-list
15144381|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15144382|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14278772|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14278773|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14278774|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14278775|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14278776|NCT00466440|Prednisone|prednisone|mesh-list
14278777|NCT00466440|Docetaxel|docetaxel|mesh-list
14278778|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278779|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
14278780|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
14278781|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
14278782|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144383|NCT04260828|Analgesics|analgesics|mesh-ancestor
15144384|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
15144385|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278783|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278784|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
14278785|NCT00466440|Hormones|hormones|mesh-ancestor
14278786|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278787|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144386|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278788|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14278789|NCT00466505|Celecoxib|celecoxib|mesh-list
14278790|NCT00466505|Cetuximab|cetuximab|mesh-list
14278791|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278792|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278793|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14278794|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14278795|NCT00466505|Analgesics|analgesics|mesh-ancestor
14278796|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
14278797|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278798|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278799|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278800|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278801|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14278802|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14278803|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278804|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278805|NCT00466661|Acamprosate|acamprosate|mesh-list
14278806|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14278807|NCT00466687|Bevacizumab|bevacizumab|mesh-list
14278808|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14278809|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14278810|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278811|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278812|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278813|NCT00466687|Growth Substances|growth substances|mesh-ancestor
14278814|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278815|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278816|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278817|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278818|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278819|NCT00466726|Sargramostim|sargramostim|mesh-list
14278820|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
14278821|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278822|NCT00466752|Sorafenib|sorafenib|mesh-list
14278823|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278824|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278825|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278826|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278827|NCT00466817|Valganciclovir|valganciclovir|mesh-list
15144387|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15144388|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144389|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15144390|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15144391|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144392|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14278828|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
14278829|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278830|NCT00466921|Lenalidomide|lenalidomide|mesh-list
14278831|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
14278832|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278833|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14278834|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14278835|NCT00466921|Growth Substances|growth substances|mesh-ancestor
14278836|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
14278837|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278838|NCT00466947|Vaccines|vaccines|mesh-list
14278839|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14278840|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
14278841|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278842|NCT00466960|Paclitaxel|paclitaxel|mesh-list
14278843|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14278844|NCT00466960|Sargramostim|sargramostim|mesh-list
14278845|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14278846|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278847|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
14278848|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
14278849|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
14278850|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278851|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
14278852|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278853|NCT00467051|Paclitaxel|paclitaxel|mesh-list
14278854|NCT00467051|Carboplatin|carboplatin|mesh-list
14278855|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14278856|NCT00467051|Ifosfamide|ifosfamide|mesh-list
14278857|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
14278858|NCT00467051|Lenograstim|lenograstim|mesh-list
14278859|NCT00467051|Sargramostim|sargramostim|mesh-list
14278860|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14278861|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278862|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
14278863|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
14278864|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
14278865|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278866|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14278867|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
14278868|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278869|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14278870|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
14278871|NCT00467077|Interferons|interferons|mesh-list
14278872|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
14278873|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
14278874|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14278875|NCT00467077|Gefitinib|gefitinib|mesh-list
14278876|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14278877|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
14278878|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278879|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
14278880|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278881|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14278882|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278883|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278884|NCT00467259|Testosterone|testosterone|mesh-list
14278885|NCT00467259|Androgens|androgens|mesh-ancestor
14278886|NCT00467259|Hormones|hormones|mesh-ancestor
14278887|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14278888|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278889|NCT00467272|Daptomycin|daptomycin|mesh-list
14278890|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14278891|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14278892|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14278893|NCT00467350|Laxatives|laxatives|mesh-ancestor
14278894|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14278895|NCT00467363|Aspirin|aspirin|mesh-list
14278896|NCT00467363|Folic Acid|folic acid|mesh-list
14278897|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14278898|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14278899|NCT00467363|Analgesics|analgesics|mesh-ancestor
14278900|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
14278901|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278902|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278903|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278904|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278905|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15144393|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15144394|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144395|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
15144396|NCT04260711|Interferons|interferons|mesh-list
15144397|NCT04260711|Teriflunomide|teriflunomide|mesh-list
15144398|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
15144399|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14278906|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14278907|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278908|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14278909|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14278910|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278911|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
14278912|NCT00467363|Hematinics|hematinics|mesh-ancestor
14278913|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
14278914|NCT00467363|Vitamins|vitamins|mesh-ancestor
14278915|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
14278916|NCT00467389|Donepezil|donepezil|mesh-list
14278917|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14278918|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278919|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278920|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
14278921|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278922|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278923|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
14278924|NCT00467558|Naltrexone|naltrexone|mesh-list
14278925|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14278926|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14278927|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278928|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
14278929|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278930|NCT00467584|Aspirin|aspirin|mesh-list
14278931|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14278932|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14278933|NCT00467584|Analgesics|analgesics|mesh-ancestor
14278934|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
14278935|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278936|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278937|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14278938|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14278939|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14278940|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14278941|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278942|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14278943|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14278944|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14278945|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
14278946|NCT00467597|Levodopa|levodopa|mesh-list
14278947|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14278948|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14278949|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
14278950|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278951|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278952|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278953|NCT00467649|Insulin|insulin|mesh-list
14278954|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14278955|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
14278956|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
14278957|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
14278958|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
14278959|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
14278960|NCT00467649|Pramlintide|pramlintide|mesh-list
14278961|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
14278962|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14278963|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278964|NCT00467740|Olodaterol|olodaterol|mesh-list
14278965|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14278966|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
14278967|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278968|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278969|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14278970|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
14278971|NCT00467779|Midazolam|midazolam|mesh-list
14278972|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
14278973|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14278974|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14278975|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144400|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
14278976|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14278977|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14278978|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14278979|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14278980|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14278981|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
14278982|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
14278983|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
14278984|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
14278985|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14278986|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14278987|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
14278988|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
14278989|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14278990|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15144401|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144402|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
15144403|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144404|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15144405|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
15144406|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144407|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144408|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144409|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15144410|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15144411|NCT04260711|Analgesics|analgesics|mesh-ancestor
15144412|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
15144413|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14278991|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
14278992|NCT00467831|Erythromycin|erythromycin|mesh-list
14278993|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
14278994|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14278995|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
14278996|NCT00467831|Zileuton|zileuton|mesh-list
14278997|NCT00467831|Losartan|losartan|mesh-list
14278998|NCT00467831|Pravastatin|pravastatin|mesh-list
14278999|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14279000|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14279001|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14279002|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14279003|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14279004|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279005|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
15144414|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15144415|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
15144416|NCT04260607|Ketamine|ketamine|mesh-list
15144417|NCT04260607|Analgesics|analgesics|mesh-ancestor
15144418|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
15144419|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144420|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279006|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279007|NCT00467831|Expectorants|expectorants|mesh-ancestor
14279008|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
14279009|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14279010|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
14279011|NCT00467831|Protective Agents|protective agents|mesh-ancestor
14279012|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279013|NCT00467831|Antidotes|antidotes|mesh-ancestor
14279014|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14279015|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14279016|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
14279017|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14279018|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14279019|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279020|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14279021|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14279022|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14279023|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14279024|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14279025|NCT00467831|Analgesics|analgesics|mesh-ancestor
14279026|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
14279027|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279028|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279029|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279030|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15144421|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14279031|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14279032|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
14279033|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279034|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
14279035|NCT00467870|Testosterone|testosterone|mesh-list
14279036|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
14279037|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
14279038|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14279039|NCT00467870|Androgens|androgens|mesh-ancestor
14279040|NCT00467870|Hormones|hormones|mesh-ancestor
15144422|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15144423|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
15144424|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
15144425|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144426|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15144427|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15144428|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144429|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144430|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
14279041|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279042|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279043|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14279044|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279045|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
14279046|NCT00467896|Iloprost|iloprost|mesh-list
14279047|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14279048|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
14279049|NCT00468052|Fentanyl|fentanyl|mesh-list
14279050|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
14279051|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14279052|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14279053|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279054|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14279055|NCT00468052|Analgesics|analgesics|mesh-ancestor
14279056|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
14279057|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279058|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14279059|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14279060|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14279061|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
14279062|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279063|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279064|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14279065|NCT00468052|Narcotics|narcotics|mesh-ancestor
14279066|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14279067|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14279068|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
14279069|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
14279070|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14279071|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14279072|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14279073|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279074|NCT00468143|Adderall|adderall|mesh-list
14279075|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14279076|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279077|NCT00468169|Cetuximab|cetuximab|mesh-list
14279078|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
14279079|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279080|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14279081|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
14279082|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279083|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279084|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14279085|NCT00468208|Abatacept|abatacept|mesh-list
14279086|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14279087|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279088|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279089|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279090|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
14279091|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279092|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279093|NCT00468299|Misoprostol|misoprostol|mesh-list
15144431|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14562301|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279094|NCT00468299|Mifepristone|mifepristone|mesh-list
14279095|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14279096|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
14279097|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14279098|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279099|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14279100|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14279101|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
14279102|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14279103|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14279104|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14279105|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14279106|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
14279107|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14279108|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14279109|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
14279110|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279111|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
14279112|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14279113|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14279114|NCT00468481|Drospirenone|drospirenone|mesh-list
14279115|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14279116|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14279117|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14279118|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14279119|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14279120|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
14279121|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14279122|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279123|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14279124|NCT00468481|Estrogens|estrogens|mesh-ancestor
14279125|NCT00468481|Hormones|hormones|mesh-ancestor
14279126|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279127|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14279128|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
14279129|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14279130|NCT00468481|Diuretics|diuretics|mesh-ancestor
14279131|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
14279132|NCT00468546|Methotrexate|methotrexate|mesh-list
14279133|NCT00468546|Rituximab|rituximab|mesh-list
14279134|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14279135|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
14279136|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14279137|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279138|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279139|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
14279140|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279141|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279142|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
14279143|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279144|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14279145|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279146|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
14279147|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279148|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14279149|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14279150|NCT00468559|Esomeprazole|esomeprazole|mesh-list
14279151|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14279152|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14279153|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14279154|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279155|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279156|NCT00468585|Bevacizumab|bevacizumab|mesh-list
14279157|NCT00468585|Capecitabine|capecitabine|mesh-list
14279158|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14279159|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279160|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14279161|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14279162|NCT00468585|Growth Substances|growth substances|mesh-ancestor
14279163|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279164|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
14279165|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144432|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
14279166|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
14279167|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279168|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
14279169|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279170|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
14279171|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14279172|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14279173|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279174|NCT00468650|Urological Agents|urological agents|mesh-ancestor
14279175|NCT00468728|Vancomycin|vancomycin|mesh-list
14279176|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14279177|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279178|NCT00468845|Pregabalin|pregabalin|mesh-list
14279179|NCT00468845|Analgesics|analgesics|mesh-ancestor
14279180|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
14279181|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279182|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279183|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
14279184|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15144433|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144434|NCT04260516|Expectorants|expectorants|mesh-ancestor
15144435|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
15144436|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15144437|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
15144438|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144439|NCT04260516|Protective Agents|protective agents|mesh-ancestor
15144440|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279185|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14279186|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279187|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14279188|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14279189|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14279190|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14279191|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14279192|NCT00468910|Aspirin|aspirin|mesh-list
14279193|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15144441|NCT04260516|Antidotes|antidotes|mesh-ancestor
15144442|NCT04260581|Amantadine|amantadine|mesh-list
15144443|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15144444|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14279194|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14279195|NCT00468910|Analgesics|analgesics|mesh-ancestor
14279196|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
14279197|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279198|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279199|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279200|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279201|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14279202|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14279203|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279204|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14279205|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14279206|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279207|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
14279208|NCT00469014|Vidarabine|vidarabine|mesh-list
14279209|NCT00469014|Fludarabine|fludarabine|mesh-list
14279210|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
14279211|NCT00469014|Busulfan|busulfan|mesh-list
14279212|NCT00469014|Clofarabine|clofarabine|mesh-list
14279213|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
14279214|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14279215|NCT00469014|Lenograstim|lenograstim|mesh-list
14279216|NCT00469014|Sargramostim|sargramostim|mesh-list
14279217|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279218|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279219|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
14279220|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279221|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279222|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
14279223|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279224|NCT00469014|Antiviral Agents|antiviral agents|mesh-ancestor
14279225|NCT00469014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279226|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14279227|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
15144445|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
14562302|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
14279228|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14279229|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14279230|NCT00469079|Nicotine|nicotine|mesh-list
14279231|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14279232|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
14279233|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279234|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279235|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14279236|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14279237|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
14279238|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279239|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144446|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279240|NCT00469092|Insulin|insulin|mesh-list
14279241|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14279242|NCT00469092|Metformin|metformin|mesh-list
14279243|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
14279244|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
14279245|NCT00469092|Glimepiride|glimepiride|mesh-list
14279246|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
14279247|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14279248|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279249|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14279250|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279251|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
14279252|NCT00469144|Fludarabine|fludarabine|mesh-list
14279253|NCT00469144|Busulfan|busulfan|mesh-list
14279254|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279255|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279256|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279257|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
14279258|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279259|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
14279260|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14279261|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14279262|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
14279263|NCT00469209|Bortezomib|bortezomib|mesh-list
14279264|NCT00469209|Melphalan|melphalan|mesh-list
14279265|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
14279266|NCT00469209|Vitamins|vitamins|mesh-ancestor
14279267|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
14279268|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279269|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279270|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14279271|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
14279272|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279273|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14279274|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279275|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
14279276|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
14279277|NCT00469209|Protective Agents|protective agents|mesh-ancestor
14279278|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14279279|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14279280|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279281|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
14279282|NCT00469456|Memantine|memantine|mesh-list
14279283|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14279284|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14279285|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
14279286|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279287|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279288|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279289|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14279290|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14279291|NCT00469508|Modafinil|modafinil|mesh-list
14279292|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14279293|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279294|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14279295|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14279296|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14279297|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279298|NCT00469833|Insulin|insulin|mesh-list
14279299|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14279300|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
14279301|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
14279302|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15144447|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
14279303|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279304|NCT00469859|Cytarabine|cytarabine|mesh-list
14279305|NCT00469859|Idarubicin|idarubicin|mesh-list
14279306|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279307|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
14279308|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279309|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279310|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
14279311|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279312|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279313|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
14279314|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279315|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14279316|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14279317|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14279318|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279319|NCT00469898|Carboplatin|carboplatin|mesh-list
14279320|NCT00469898|Irinotecan|irinotecan|mesh-list
14279321|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279322|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14279323|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14279324|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279325|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279326|NCT00470054|Dasatinib|dasatinib|mesh-list
14279327|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279328|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279329|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279330|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279331|NCT00470093|Interferons|interferons|mesh-list
14279332|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279333|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
14279334|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292704|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14292705|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14292706|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292707|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14292708|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292709|NCT00562718|Capecitabine|capecitabine|mesh-list
14292710|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14292711|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
14292712|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292713|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292714|NCT00562861|Lamotrigine|lamotrigine|mesh-list
14292715|NCT00562861|Carbamazepine|carbamazepine|mesh-list
14292716|NCT00562861|Valproic Acid|valproic acid|mesh-list
14292717|NCT00562861|Citalopram|citalopram|mesh-list
14292718|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
14292719|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14292720|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292721|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292722|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14292723|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292724|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14292725|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14292726|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292727|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292728|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14292729|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14292730|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14292731|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292732|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
15144448|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144449|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144450|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144451|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14292733|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14292734|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
14292735|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292736|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292737|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
14292738|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
14292739|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15144452|NCT04260581|Analgesics|analgesics|mesh-ancestor
14292740|NCT00562861|Analgesics|analgesics|mesh-ancestor
14292741|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
14279335|NCT00470158|Iron|iron|mesh-list
14279336|NCT00470158|Zinc|zinc|mesh-list
14279337|NCT00470158|Trace Elements|trace elements|mesh-ancestor
14279338|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
14279339|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279340|NCT00470184|Capecitabine|capecitabine|mesh-list
14279341|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
14279342|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279343|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
14279344|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279345|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279346|NCT00470262|Pioglitazone|pioglitazone|mesh-list
14279347|NCT00470262|Fenofibrate|fenofibrate|mesh-list
14279348|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14279349|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279350|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14279351|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
14279352|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144453|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
15144454|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279353|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14279354|NCT00470275|Cytarabine|cytarabine|mesh-list
14279355|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279356|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
14279357|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562303|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562304|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562305|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562306|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562307|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
14562308|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562309|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562310|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562311|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
14562312|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562313|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562314|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562315|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562316|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562317|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
14562318|NCT00002838|Fludarabine|fludarabine|mesh-list
14562319|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
14562320|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562321|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
14562322|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562323|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562324|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562325|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
14562326|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562327|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562328|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562329|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562330|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
14562331|NCT00002839|Fluorouracil|fluorouracil|mesh-list
14562332|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562333|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
14562334|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562335|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562336|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562337|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
14562338|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562339|NCT00002840|Vincristine|vincristine|mesh-list
14562340|NCT00002840|Lomustine|lomustine|mesh-list
14562341|NCT00002840|Procarbazine|procarbazine|mesh-list
14562342|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562343|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562344|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562345|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562346|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562347|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562348|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562349|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
15144455|NCT04260412|Psyllium|psyllium|mesh-list
15144456|NCT04260412|Cathartics|cathartics|mesh-ancestor
14279358|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279359|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
14279360|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279361|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279362|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
14279363|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279364|NCT00470301|Paclitaxel|paclitaxel|mesh-list
14279365|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
14279366|NCT00470301|Doxorubicin|doxorubicin|mesh-list
14279367|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15144457|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15144458|NCT04260685|Lidocaine|lidocaine|mesh-list
15144459|NCT04260685|Esmolol|esmolol|mesh-list
15144460|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
15144461|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
15144462|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144463|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144464|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
14279368|NCT00470301|Tipifarnib|tipifarnib|mesh-list
14279369|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14279370|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279371|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
14279372|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
15144465|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144466|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15144467|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15144468|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14279373|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
14279374|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279375|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279376|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
14279377|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279378|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279379|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14279380|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
14279381|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14279382|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14279383|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14279384|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14279385|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279386|NCT00470366|Paclitaxel|paclitaxel|mesh-list
14279387|NCT00470366|Ifosfamide|ifosfamide|mesh-list
14279388|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14279389|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279390|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
14279391|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
14279392|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
14279393|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279394|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14279395|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
14279396|NCT00470392|Clobetasol|clobetasol|mesh-list
14279397|NCT00470392|Imiquimod|imiquimod|mesh-list
14279398|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14279399|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
14279400|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279401|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279402|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
14279403|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279404|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
14279405|NCT00470392|Hormones|hormones|mesh-ancestor
14279406|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279407|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
14279408|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279409|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279410|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279411|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279412|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14279413|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279414|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279415|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279416|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279417|NCT00470548|Paclitaxel|paclitaxel|mesh-list
14279418|NCT00470548|Pemetrexed|pemetrexed|mesh-list
14279419|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14279420|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14279421|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279422|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
14279423|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
14279424|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
14279425|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279426|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279427|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14279428|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14279429|NCT00470600|Ibuprofen|ibuprofen|mesh-list
15144469|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15144470|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144471|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15144472|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14279430|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14279431|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14279432|NCT00470600|Analgesics|analgesics|mesh-ancestor
14279433|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
14279434|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279435|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279436|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279437|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279438|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14279439|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279440|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279441|NCT00470834|Bicalutamide|bicalutamide|mesh-list
14279442|NCT00470834|Dutasteride|dutasteride|mesh-list
14279443|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
14279444|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
14279445|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279446|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279447|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279448|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14279449|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14279450|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279451|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279452|NCT00470847|Trastuzumab|trastuzumab|mesh-list
14279453|NCT00470847|Lapatinib|lapatinib|mesh-list
14279454|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14279455|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279456|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279457|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279458|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279459|NCT00471068|Timolol|timolol|mesh-list
14279460|NCT00471068|Travoprost|travoprost|mesh-list
14279461|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14279462|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14279463|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
14279464|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279465|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279466|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279467|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14279468|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14279469|NCT00471146|Gemcitabine|gemcitabine|mesh-list
14279470|NCT00471146|Axitinib|axitinib|mesh-list
14279471|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279472|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
14279473|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279474|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279475|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
14279476|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279477|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279478|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279479|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
14279480|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279481|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279482|NCT00471237|Alendronate|alendronate|mesh-list
14279483|NCT00471237|Teriparatide|teriparatide|mesh-list
14279484|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14279485|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279486|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14279487|NCT00471276|Sunitinib|sunitinib|mesh-list
14279488|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279489|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14279490|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14279491|NCT00471276|Growth Substances|growth substances|mesh-ancestor
14279492|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279493|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
14279494|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279495|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279496|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279497|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14279498|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14279499|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14279500|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14279501|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279502|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279503|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279504|NCT00471315|Analgesics|analgesics|mesh-ancestor
14279505|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
14279506|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279507|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
14279508|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14279509|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
14279510|NCT00471328|Sunitinib|sunitinib|mesh-list
14279511|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
14279512|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279513|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14279514|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14279515|NCT00471328|Growth Substances|growth substances|mesh-ancestor
14279516|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279517|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
14279518|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279519|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279520|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279521|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14279522|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14279523|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14279524|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14279525|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279526|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
14279527|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279528|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279529|NCT00471380|Timolol|timolol|mesh-list
14279530|NCT00471380|Travoprost|travoprost|mesh-list
14279531|NCT00471380|Dorzolamide|dorzolamide|mesh-list
14279532|NCT00471380|Brinzolamide|brinzolamide|mesh-list
14279533|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14279534|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14279535|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
14279536|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279537|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279538|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279539|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14279540|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14279541|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14279542|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279543|NCT00471445|Ketamine|ketamine|mesh-list
14279544|NCT00471445|Amitriptyline|amitriptyline|mesh-list
14279545|NCT00471445|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14279546|NCT00471445|Analgesics|analgesics|mesh-ancestor
14279547|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
14279548|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279549|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279550|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14279551|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14279552|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
14279553|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
14279554|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14279555|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14279556|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14279557|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279558|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279559|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14279560|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
14279561|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14279562|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14279563|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15144473|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15144474|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
15144475|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179635|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15179636|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179637|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15179638|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14279564|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14279565|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14279566|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
14279567|NCT00471445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14279568|NCT00471445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14279569|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
14279570|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279571|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279572|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279573|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279574|NCT00471705|Miltefosine|miltefosine|mesh-list
14279575|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14279576|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
14279577|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279578|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279579|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14279580|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14279581|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
14279582|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14279583|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
14279584|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279585|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279586|NCT00471887|Tremelimumab|tremelimumab|mesh-list
14279587|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279588|NCT00472030|Omalizumab|omalizumab|mesh-list
14279589|NCT00472030|Prednisone|prednisone|mesh-list
14279590|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279591|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
14279592|NCT00472030|Hormones|hormones|mesh-ancestor
14279593|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279594|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279595|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14279596|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279597|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14279598|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14279599|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
14279600|NCT00472056|Cytarabine|cytarabine|mesh-list
14279601|NCT00472056|Rituximab|rituximab|mesh-list
14279602|NCT00472056|Etoposide|etoposide|mesh-list
14279603|NCT00472056|Melphalan|melphalan|mesh-list
14279604|NCT00472056|Carmustine|carmustine|mesh-list
14279605|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14279606|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279607|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
14279608|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279609|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279610|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14279611|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14279612|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14279613|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279614|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279615|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279616|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
14279617|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
14279618|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279619|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279620|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14279621|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
14279622|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14279623|NCT00472199|Pramipexole|pramipexole|mesh-list
14279624|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
14279625|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279626|NCT00472199|Protective Agents|protective agents|mesh-ancestor
14279627|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279628|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14279629|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14279630|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
14279631|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
14279632|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279633|NCT00472303|Morphine|morphine|mesh-list
14279634|NCT00472303|Tapentadol|tapentadol|mesh-list
14279635|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14279636|NCT00472303|Narcotics|narcotics|mesh-ancestor
14279637|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14279638|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279639|NCT00472303|Analgesics|analgesics|mesh-ancestor
14279640|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
14279641|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279642|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14279643|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14279644|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14279645|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279646|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
14279647|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279648|NCT00472420|Rituximab|rituximab|mesh-list
14279649|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14279650|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279651|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
14279652|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279653|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279654|NCT00472641|Ziprasidone|ziprasidone|mesh-list
14279655|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14279656|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
14279657|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279658|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279659|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279660|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14279661|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14279662|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14279663|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14279664|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14279665|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
14279666|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
14279667|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14279668|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
14279669|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279670|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279671|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
14279672|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279673|NCT00472849|Cytarabine|cytarabine|mesh-list
14279674|NCT00472849|Rituximab|rituximab|mesh-list
14279675|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
14279676|NCT00472849|Fludarabine|fludarabine|mesh-list
14279677|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144476|NCT04260360|Docetaxel|docetaxel|mesh-list
14279678|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279679|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
14279680|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279681|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279682|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14279683|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
14279684|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279685|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279686|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
14279687|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279688|NCT00473083|Minocycline|minocycline|mesh-list
14279689|NCT00473083|Clindamycin|clindamycin|mesh-list
14279690|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
14279691|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
14279692|NCT00473083|Triamcinolone|triamcinolone|mesh-list
14279693|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14279694|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14279695|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
14279696|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14279697|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144477|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144478|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144479|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
15144480|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
15144481|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144482|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
15144483|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15144484|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
14279698|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279699|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279700|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
14279701|NCT00473083|Hormones|hormones|mesh-ancestor
14279702|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279703|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279704|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279705|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
14279706|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14279707|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279708|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14279709|NCT00473265|Teriparatide|teriparatide|mesh-list
14279710|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14279711|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279712|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14279713|NCT00473330|Ranibizumab|ranibizumab|mesh-list
14279714|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14279715|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14279716|NCT00473330|Growth Substances|growth substances|mesh-ancestor
14279717|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279718|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14279719|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279720|NCT00473382|Ranibizumab|ranibizumab|mesh-list
14279721|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14279722|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14279723|NCT00473382|Growth Substances|growth substances|mesh-ancestor
14279724|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279725|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
14279726|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279727|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14279728|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14279729|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14279730|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14279731|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279732|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14279733|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14279734|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14279735|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
14279736|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279737|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279738|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14279739|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14279740|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
14279741|NCT00473512|Dexamethasone|dexamethasone|mesh-list
14279742|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
14279743|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279744|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
14279745|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
14279746|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279747|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279748|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14279749|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
14279750|NCT00473512|Hormones|hormones|mesh-ancestor
14279751|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15144485|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15144486|NCT04260035|Protective Agents|protective agents|mesh-ancestor
15144487|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144488|NCT04260269|Trifluridine|trifluridine|mesh-list
15144489|NCT04260269|Fluorouracil|fluorouracil|mesh-list
15144490|NCT04260269|Capecitabine|capecitabine|mesh-list
15144491|NCT04260269|Tegafur|tegafur|mesh-list
15144492|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
15144493|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144494|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144495|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279752|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14279753|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279754|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14279755|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279756|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279757|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
14279758|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14279759|NCT00473590|Bevacizumab|bevacizumab|mesh-list
14279760|NCT00473590|Bortezomib|bortezomib|mesh-list
15144496|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144497|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
15179639|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14279761|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14279762|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279763|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14279764|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14279765|NCT00473590|Growth Substances|growth substances|mesh-ancestor
14279766|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279767|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
14279768|NCT00473642|Ranibizumab|ranibizumab|mesh-list
14279769|NCT00473642|Verteporfin|verteporfin|mesh-list
15144498|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144499|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
15144500|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144501|NCT04260113|Apatinib|apatinib|mesh-list
15144502|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144503|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15144504|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144505|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144506|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
15144507|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15144508|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
15144509|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144510|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144511|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15144512|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
15144513|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15144514|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
15144515|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144516|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144517|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15144518|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
15144519|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
14279770|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14279771|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14279772|NCT00473642|Growth Substances|growth substances|mesh-ancestor
14279773|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279774|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
14279775|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279776|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15144520|NCT04259684|Protective Agents|protective agents|mesh-ancestor
15144521|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
15144522|NCT04259606|Antacids|antacids|mesh-ancestor
15144523|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144524|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15144525|NCT04259398|Propofol|propofol|mesh-list
14279777|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
14279778|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14279779|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14279780|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14279781|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
14279782|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279783|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14279784|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14279785|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279786|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
14279787|NCT00473694|Rocuronium|rocuronium|mesh-list
14279788|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
14279789|NCT00473694|Neostigmine|neostigmine|mesh-list
14279790|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14279791|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14279792|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14279793|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279794|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279795|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14279796|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279797|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279798|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14279799|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279800|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14279801|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
14279802|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14279803|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14279804|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14279805|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15144526|NCT04259398|Sevoflurane|sevoflurane|mesh-list
15144527|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14279806|NCT00473746|Dexamethasone|dexamethasone|mesh-list
14279807|NCT00473746|Prednisone|prednisone|mesh-list
14279808|NCT00473746|Prednisolone|prednisolone|mesh-list
14279809|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
14279810|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14279811|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
14279812|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
14279813|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279814|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279815|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14279816|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
14279817|NCT00473746|Hormones|hormones|mesh-ancestor
14279818|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279819|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14279820|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279821|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14279822|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279823|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279824|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
14279825|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14279826|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
14279827|NCT00473824|Antibodies|antibodies|mesh-list
14279828|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
14279829|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14279830|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14279831|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
14279832|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279833|NCT00473837|Chloroquine|chloroquine|mesh-list
14279834|NCT00473837|Amebicides|amebicides|mesh-ancestor
14279835|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14279836|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14279837|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279838|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
14279839|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14279840|NCT00473876|Metformin|metformin|mesh-list
14279841|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14279842|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279843|NCT00473889|Paclitaxel|paclitaxel|mesh-list
14279844|NCT00473889|Carboplatin|carboplatin|mesh-list
14279845|NCT00473889|Vorinostat|vorinostat|mesh-list
14279846|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14279847|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279848|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
14279849|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
14279850|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
14279851|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279852|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14279853|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279854|NCT00474045|Insulin|insulin|mesh-list
14279855|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14279856|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
14279857|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
14279858|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
14279859|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
14279860|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
14279861|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14279862|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279863|NCT00474058|Rotigotine|rotigotine|mesh-list
14279864|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
14279865|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
14279866|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279867|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279868|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279869|NCT00474123|Simvastatin|simvastatin|mesh-list
14279870|NCT00474123|Ezetimibe|ezetimibe|mesh-list
14279871|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14279872|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14279873|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
14279874|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279875|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14279876|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14279877|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279878|NCT00474175|Benzocaine|benzocaine|mesh-list
14279879|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
14279880|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
14279881|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14279882|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279883|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
14279884|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279885|NCT00474201|Ritonavir|ritonavir|mesh-list
14279886|NCT00474201|Lopinavir|lopinavir|mesh-list
14279887|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
14279888|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14279889|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14279890|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
14279891|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279892|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279893|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14279894|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14279895|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
14279896|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279897|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14279898|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14279899|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14279900|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
14279901|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14279902|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14279903|NCT00474240|Atorvastatin|atorvastatin|mesh-list
14279904|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14279905|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14279906|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
14279907|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279908|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14279909|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14279910|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279911|NCT00474253|Rocuronium|rocuronium|mesh-list
14279912|NCT00474253|Succinylcholine|succinylcholine|mesh-list
14279913|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14279914|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14279915|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14279916|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144528|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144529|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144530|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15144531|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
15144532|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
15144533|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15144534|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14279917|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279918|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14279919|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
14279920|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
14279921|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279922|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14279923|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279924|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279925|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
14279926|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279927|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279928|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14279929|NCT00474383|Hormones|hormones|mesh-ancestor
14279930|NCT00474487|Vaccines|vaccines|mesh-list
14279931|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
14279932|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279933|NCT00474526|Vaccines|vaccines|mesh-list
14279934|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14279935|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
14279936|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279937|NCT00474539|Vaccines|vaccines|mesh-list
14279938|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14279939|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
14279940|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279941|NCT00474630|Naltrexone|naltrexone|mesh-list
14279942|NCT00474630|Bupropion|bupropion|mesh-list
14279943|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14279944|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14279945|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279946|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
14279947|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14279948|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14279949|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
14279950|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15144535|NCT04259476|Ketamine|ketamine|mesh-list
15144536|NCT04259476|Analgesics|analgesics|mesh-ancestor
15144537|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
15144538|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144539|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144540|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14279951|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14279952|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14279953|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14279954|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279955|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
14279956|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279957|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14279958|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14279959|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279960|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14279961|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14279962|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14279963|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14279964|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279965|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14279966|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279967|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14279968|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
14279969|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14279970|NCT00474786|Sirolimus|sirolimus|mesh-list
14279971|NCT00474786|Sorafenib|sorafenib|mesh-list
14279972|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279973|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279974|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279975|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279976|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14279977|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14279978|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14279979|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
14279980|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14279981|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
14279982|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279983|NCT00474812|Dasatinib|dasatinib|mesh-list
14279984|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14279985|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14279986|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14279987|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14279988|NCT00474851|Norethindrone|norethindrone|mesh-list
14279989|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
14279990|NCT00474851|Estrogens|estrogens|mesh-list
14279991|NCT00474851|Hormones|hormones|mesh-ancestor
14279992|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14279993|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14279994|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14279995|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14279996|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14279997|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
14279998|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14279999|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14280000|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14280001|NCT00474903|Aspirin|aspirin|mesh-list
14280002|NCT00474903|Esomeprazole|esomeprazole|mesh-list
14280003|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14280004|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280005|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14280006|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280007|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280008|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14280009|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280010|NCT00474903|Analgesics|analgesics|mesh-ancestor
14280011|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
14280012|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280013|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280014|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280015|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144541|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14280016|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14280017|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14280018|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14280019|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14280020|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
14280021|NCT00474929|Everolimus|everolimus|mesh-list
14280022|NCT00474929|Sorafenib|sorafenib|mesh-list
14280023|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280024|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280025|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
14280026|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280027|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280028|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280029|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280030|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14280031|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
14280032|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280033|NCT00474994|Sunitinib|sunitinib|mesh-list
14280034|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280035|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14280036|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14280037|NCT00474994|Growth Substances|growth substances|mesh-ancestor
14280038|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280039|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
14280040|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280041|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280042|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280043|NCT00475020|Vidarabine|vidarabine|mesh-list
14280044|NCT00475020|Fludarabine|fludarabine|mesh-list
14280045|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
14280046|NCT00475020|Busulfan|busulfan|mesh-list
14280047|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
14280048|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14280049|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280050|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280051|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
14280052|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280053|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280054|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
14280055|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280056|NCT00475020|Antiviral Agents|antiviral agents|mesh-ancestor
14280057|NCT00475020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280058|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
14280059|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14280060|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14280061|NCT00475033|Vaccines|vaccines|mesh-list
14280062|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14280063|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
14280064|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280065|NCT00475085|Dexamethasone|dexamethasone|mesh-list
14280066|NCT00475085|Aprepitant|aprepitant|mesh-list
14280067|NCT00475085|Palonosetron|palonosetron|mesh-list
14280068|NCT00475085|Granisetron|granisetron|mesh-list
14280069|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
14280070|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280071|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
14280072|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
14280073|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280074|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280075|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15144542|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
15144543|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
15144544|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179640|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
14280076|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
14280077|NCT00475085|Hormones|hormones|mesh-ancestor
14280078|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280079|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280080|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280081|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14280082|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280083|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280084|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14280085|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14280086|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
14280087|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14280088|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14280089|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280090|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280091|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14280092|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
14280093|NCT00475150|Cediranib|cediranib|mesh-list
14280094|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280095|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280096|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280097|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280098|NCT00475176|Ribavirin|ribavirin|mesh-list
14280099|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14280100|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
14280101|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280102|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
14280103|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280104|NCT00475215|Rocuronium|rocuronium|mesh-list
14280105|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14280106|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14280107|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14280108|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280109|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280110|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
14280111|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14280112|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
14280113|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14280114|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280115|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14280116|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14280117|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14280118|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
14280119|NCT00475306|Promethazine|promethazine|mesh-list
14280120|NCT00475306|Metoclopramide|metoclopramide|mesh-list
14280121|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14280122|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14280123|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280124|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280125|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
14280126|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
14280127|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
14562350|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
14562351|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562352|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
14562353|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562354|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562355|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562356|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
14562357|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562358|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562359|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562360|NCT00002845|Aldesleukin|aldesleukin|mesh-list
14562361|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562362|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14562363|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14562364|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
14562365|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562366|NCT00002846|Aldesleukin|aldesleukin|mesh-list
15144545|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15144546|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15144547|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144548|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144549|NCT04259333|Acetaminophen|acetaminophen|mesh-list
14562367|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562368|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14562369|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14562370|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
14562371|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562372|NCT00002847|Interferons|interferons|mesh-list
14562373|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
14562374|NCT00002847|Aldesleukin|aldesleukin|mesh-list
14562375|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562376|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
14562377|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562378|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
14562379|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562380|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14280128|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280129|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
14280130|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
14280131|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280132|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14280133|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
14280134|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
14280135|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280136|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280137|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14280138|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
14280139|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14280140|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14280141|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14280142|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
14280143|NCT00475319|Rebamipide|rebamipide|mesh-list
14280144|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14280145|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280146|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
14280147|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280148|NCT00475319|Protective Agents|protective agents|mesh-ancestor
14280149|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280150|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280151|NCT00475423|Rituximab|rituximab|mesh-list
14280152|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14280153|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280154|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
14280155|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280156|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280157|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
14280158|NCT00475501|Finasteride|finasteride|mesh-list
14280159|NCT00475501|Testosterone|testosterone|mesh-list
14280160|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
14280161|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
15144550|NCT04259333|Celecoxib|celecoxib|mesh-list
15144551|NCT04259333|Codeine|codeine|mesh-list
15144552|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15144553|NCT04259333|Analgesics|analgesics|mesh-ancestor
14280162|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14280163|NCT00475501|Androgens|androgens|mesh-ancestor
14280164|NCT00475501|Hormones|hormones|mesh-ancestor
14280165|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280166|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280167|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280168|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280169|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
14280170|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14280171|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14280172|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280173|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280174|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
14280175|NCT00475501|Urological Agents|urological agents|mesh-ancestor
14292742|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14292743|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14292744|NCT00562965|Dexamethasone|dexamethasone|mesh-list
14292745|NCT00562965|Prednisone|prednisone|mesh-list
14292746|NCT00562965|Prednisolone|prednisolone|mesh-list
14292747|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
14292748|NCT00562965|Rituximab|rituximab|mesh-list
14292749|NCT00562965|Fludarabine|fludarabine|mesh-list
14292750|NCT00562965|Vincristine|vincristine|mesh-list
14292751|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
14292752|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14292753|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292754|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
14292755|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292756|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292757|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14292758|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
14292759|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292760|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292761|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14292762|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14292763|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
14292764|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
14562381|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14562382|NCT00002849|Interferons|interferons|mesh-list
15144554|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
15144555|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144556|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280176|NCT00475670|Paclitaxel|paclitaxel|mesh-list
14280177|NCT00475670|Docetaxel|docetaxel|mesh-list
14280178|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14280179|NCT00475670|Trastuzumab|trastuzumab|mesh-list
14280180|NCT00475670|Taxane|taxane|mesh-list
14280181|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14280182|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280183|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
14280184|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
14280185|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
14280186|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280187|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14280188|NCT00475735|Methylphenidate|methylphenidate|mesh-list
14280189|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14280190|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280191|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14280192|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14280193|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280194|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280195|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
14280196|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280197|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14280198|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
14280199|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280200|NCT00475865|Teriflunomide|teriflunomide|mesh-list
14280201|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
14280202|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
14280203|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14280204|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
14280205|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280206|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280207|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280208|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14280209|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280210|NCT00475865|Analgesics|analgesics|mesh-ancestor
14280211|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
14280212|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280213|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280214|NCT00475878|Citalopram|citalopram|mesh-list
14280215|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14280216|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14280217|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280218|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280219|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280220|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
14280221|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280222|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14280223|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
14280224|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280225|NCT00475904|Gabapentin|gabapentin|mesh-list
14280226|NCT00475904|Analgesics|analgesics|mesh-ancestor
14280227|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
14280228|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280229|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280230|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
14280231|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14280232|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14280233|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280234|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280235|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14280236|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14280237|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280238|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280239|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
14280240|NCT00476008|Memantine|memantine|mesh-list
14280241|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14280242|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14280243|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
14280244|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280245|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280246|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144557|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
14280247|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14280248|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14280249|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
14280250|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15144558|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15144559|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15144560|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144561|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15144562|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15144563|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144564|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144565|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15144566|NCT04259333|Narcotics|narcotics|mesh-ancestor
15144567|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280251|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
14280252|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14280253|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280254|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14280255|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14280256|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14280257|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
14280258|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280259|NCT00476086|Gemcitabine|gemcitabine|mesh-list
14280260|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
14280261|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280262|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
14280263|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280264|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280265|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
14280266|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280267|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280268|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280269|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
14280270|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280271|NCT00476151|Ketamine|ketamine|mesh-list
14280272|NCT00476151|Amitriptyline|amitriptyline|mesh-list
14280273|NCT00476151|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14280274|NCT00476151|Analgesics|analgesics|mesh-ancestor
14280275|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
14280276|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280277|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280278|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14280279|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14280280|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
14280281|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
14280282|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280283|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14280284|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15144568|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
15144569|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
15144570|NCT04259073|Pregabalin|pregabalin|mesh-list
14280285|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280286|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280287|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14280288|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
14280289|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280290|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280291|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14280292|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14280293|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280294|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
14280295|NCT00476151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14280296|NCT00476151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14280297|NCT00476229|Rituximab|rituximab|mesh-list
14280298|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
14280299|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14280300|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14280301|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280302|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
15144571|NCT04259073|Analgesics|analgesics|mesh-ancestor
15144572|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
15144573|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144574|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562383|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
14280303|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280304|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280305|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280306|NCT00476242|Naltrexone|naltrexone|mesh-list
14280307|NCT00476242|Memantine|memantine|mesh-list
14280308|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14280309|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14280310|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
14280311|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280312|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280313|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280314|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14280315|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14280316|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14280317|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14280318|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
14280319|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280320|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14280321|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280322|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280323|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280324|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280325|NCT00476593|Dexamethasone|dexamethasone|mesh-list
14280326|NCT00476593|Diclofenac|diclofenac|mesh-list
14280327|NCT00476593|Lactitol|lactitol|mesh-list
14280328|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14280329|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280330|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
14280331|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
14280332|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280333|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280334|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280335|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
14280336|NCT00476593|Hormones|hormones|mesh-ancestor
14280337|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280338|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280339|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280340|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14280341|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14280342|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280343|NCT00476593|Analgesics|analgesics|mesh-ancestor
14280344|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
14280345|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15144575|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
15144576|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15144577|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15144578|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144579|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15144580|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15144581|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15144582|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280346|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14280347|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280348|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144583|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15144584|NCT04258956|Avelumab|avelumab|mesh-list
15144585|NCT04258956|Axitinib|axitinib|mesh-list
15144586|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144587|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144588|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15144589|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179641|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
14280349|NCT00476593|Cathartics|cathartics|mesh-ancestor
14280350|NCT00476645|Fulvestrant|fulvestrant|mesh-list
14280351|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280352|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280353|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14280354|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14280355|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
14280356|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280357|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280358|NCT00476788|Insulin|insulin|mesh-list
14280359|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14280360|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14562384|NCT00002849|Dexamethasone|dexamethasone|mesh-list
14280361|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280362|NCT00476957|Sirolimus|sirolimus|mesh-list
14280363|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14280364|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280365|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14280366|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144590|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144591|NCT04259008|Manganese|manganese|mesh-list
14280367|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
14280368|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280369|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
14280370|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280371|NCT00476996|Methotrexate|methotrexate|mesh-list
14280372|NCT00476996|Leflunomide|leflunomide|mesh-list
14280373|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
14280374|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14280375|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
14280376|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14280377|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280378|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280379|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
14280380|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280381|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280382|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
14280383|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280384|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14280385|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280386|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
14280387|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280388|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14280389|NCT00477087|Molgramostim|molgramostim|mesh-list
14280390|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
14280391|NCT00477087|Sargramostim|sargramostim|mesh-list
14280392|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
14280393|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280394|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280395|NCT00477087|Analgesics|analgesics|mesh-ancestor
14280396|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
14280397|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280398|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14280399|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14280400|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280401|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280402|NCT00477165|Citalopram|citalopram|mesh-list
14280403|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14280404|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14280405|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280406|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280407|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280408|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
14280409|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280410|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14280411|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
14280412|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280413|NCT00477191|Etanercept|etanercept|mesh-list
14280414|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14280415|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280416|NCT00477191|Analgesics|analgesics|mesh-ancestor
14280417|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
14280418|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144592|NCT04259008|Trace Elements|trace elements|mesh-ancestor
15144593|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
15144594|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144595|NCT04258930|Calcium|calcium|mesh-list
15144596|NCT04258930|Calcium acetate|calcium acetate|mesh-list
14280419|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280420|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280421|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280422|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280423|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280424|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
14280425|NCT00477204|Simvastatin|simvastatin|mesh-list
15144597|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
14280426|NCT00477204|Ezetimibe|ezetimibe|mesh-list
15144598|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15144599|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144600|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
15144601|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
15144602|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144603|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15144604|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
15144605|NCT04258657|Paclitaxel|paclitaxel|mesh-list
15144606|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15144607|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144608|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144609|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
15144610|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
15144611|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144612|NCT04258553|Antioxidants|antioxidants|mesh-list
15144613|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144614|NCT04258553|Protective Agents|protective agents|mesh-ancestor
15144615|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280427|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14280428|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14280429|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14280430|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
14280431|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280432|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14280433|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14280434|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280435|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
14280436|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280437|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280438|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280439|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280440|NCT00477295|Carbamazepine|carbamazepine|mesh-list
14280441|NCT00477295|Zonisamide|zonisamide|mesh-list
14280442|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
14280443|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
14280444|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14280445|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280446|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280447|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280448|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280449|NCT00477295|Analgesics|analgesics|mesh-ancestor
14280450|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
14280451|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280452|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14280453|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280454|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280455|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14280456|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14280457|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14280458|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14280459|NCT00477334|Famciclovir|famciclovir|mesh-list
14280460|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
14280461|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280462|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14280463|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280464|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280465|NCT00477386|Decitabine|decitabine|mesh-list
14280466|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280467|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
14280468|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280469|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280470|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280471|NCT00477451|Alprazolam|alprazolam|mesh-list
14280472|NCT00477451|Doxapram|doxapram|mesh-list
14280473|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14280474|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280475|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280476|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14280477|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14280478|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280479|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
14280480|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
14280481|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144616|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
14280482|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280483|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14280484|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
14280485|NCT00477464|Capecitabine|capecitabine|mesh-list
14280486|NCT00477464|Lapatinib|lapatinib|mesh-list
14280487|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280488|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
14280489|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280490|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280491|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280492|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280493|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14280494|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
14280495|NCT00477490|Coagulants|coagulants|mesh-ancestor
14280496|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14280497|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
14280498|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280499|NCT00477594|Mipomersen|mipomersen|mesh-list
14280500|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14280501|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14280502|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
14280503|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280504|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14280505|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
14280506|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
14280507|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280508|NCT00477607|Protective Agents|protective agents|mesh-ancestor
14280509|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280510|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
14280511|NCT00477607|Vitamins|vitamins|mesh-ancestor
14280512|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
15144617|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
15144618|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280513|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14280514|NCT00477633|Norethindrone|norethindrone|mesh-list
14280515|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
14280516|NCT00477633|Estradiol|estradiol|mesh-list
14280517|NCT00477633|Estrogens|estrogens|mesh-ancestor
14280518|NCT00477633|Hormones|hormones|mesh-ancestor
14280519|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280520|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280521|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14280522|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
14280523|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14280524|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14280525|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14280526|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14280527|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14280528|NCT00477659|Donepezil|donepezil|mesh-list
14280529|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14280530|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280531|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280532|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14280533|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280534|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280535|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
14280536|NCT00477672|Pimavanserin|pimavanserin|mesh-list
14280537|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14280538|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14280539|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15144619|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144620|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144621|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
15144622|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
14280540|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14280541|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280542|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280543|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280544|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14280545|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14280546|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
14280547|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280548|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280549|NCT00477750|Prednisone|prednisone|mesh-list
14280550|NCT00477750|Lenalidomide|lenalidomide|mesh-list
14280551|NCT00477750|Melphalan|melphalan|mesh-list
14280552|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280553|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
14280554|NCT00477750|Hormones|hormones|mesh-ancestor
14280555|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280556|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280557|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280558|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280559|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
14280560|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14280561|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14280562|NCT00477750|Growth Substances|growth substances|mesh-ancestor
14280563|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
14280564|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14280565|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
14280566|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280567|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14280568|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280569|NCT00477971|Dexamethasone|dexamethasone|mesh-list
14280570|NCT00477971|Melphalan|melphalan|mesh-list
14280571|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280572|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
14280573|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
14280574|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280575|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280576|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280577|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
14280578|NCT00477971|Hormones|hormones|mesh-ancestor
14280579|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280580|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280581|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280582|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
14280583|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14280584|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
14280585|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280586|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14280587|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280588|NCT00478023|Morphine|morphine|mesh-list
14280589|NCT00478023|Tapentadol|tapentadol|mesh-list
14280590|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14280591|NCT00478023|Narcotics|narcotics|mesh-ancestor
15144623|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
15144624|NCT04258475|Calcium|calcium|mesh-list
15144625|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15144626|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144627|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15144628|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15144629|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
15144630|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144631|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15144632|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14280592|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280593|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280594|NCT00478023|Analgesics|analgesics|mesh-ancestor
14280595|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
14280596|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280597|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14280598|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14280599|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280600|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280601|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14280602|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280603|NCT00478036|Prednisolone|prednisolone|mesh-list
14280604|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
14280605|NCT00478036|Ketorolac|ketorolac|mesh-list
14280606|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14280607|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14280608|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280609|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
14280610|NCT00478036|Hormones|hormones|mesh-ancestor
14280611|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280612|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280613|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15144633|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280614|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280615|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280616|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280617|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14280618|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280619|NCT00478036|Analgesics|analgesics|mesh-ancestor
14280620|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
14280621|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280622|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14280623|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280624|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280625|NCT00478036|Laxatives|laxatives|mesh-ancestor
14280626|NCT00478140|Trastuzumab|trastuzumab|mesh-list
14280627|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14280628|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280629|NCT00478192|Conivaptan|conivaptan|mesh-list
14280630|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15144634|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144635|NCT04258644|Paclitaxel|paclitaxel|mesh-list
15144636|NCT04258644|Apatinib|apatinib|mesh-list
15144637|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15144638|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144639|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144640|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
15144641|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
15144642|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144643|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15144644|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144645|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
15144646|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144647|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144648|NCT04258631|Hydromorphone|hydromorphone|mesh-list
15144649|NCT04258631|Bupivacaine|bupivacaine|mesh-list
15144650|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
15144651|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
15144652|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144653|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144654|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
15144655|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144656|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14280631|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280632|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
14280633|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280634|NCT00478205|Donepezil|donepezil|mesh-list
14280635|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14280636|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280637|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280638|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
14280639|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280640|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280641|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
14280642|NCT00478218|Dexamethasone|dexamethasone|mesh-list
14280643|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
14280644|NCT00478218|Lenalidomide|lenalidomide|mesh-list
14280645|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280646|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
14280647|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280648|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280649|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14280650|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
14280651|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280652|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280653|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14280654|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280655|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
14280656|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
14280657|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280658|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280659|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
14280660|NCT00478218|Hormones|hormones|mesh-ancestor
14280661|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280662|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280663|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15144657|NCT04258631|Narcotics|narcotics|mesh-ancestor
15144658|NCT04258631|Analgesics|analgesics|mesh-ancestor
15144659|NCT04258163|Gemcitabine|gemcitabine|mesh-list
15144660|NCT04258163|Capecitabine|capecitabine|mesh-list
15144661|NCT04258163|Doxorubicin|doxorubicin|mesh-list
15144662|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14280664|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14280665|NCT00478218|Growth Substances|growth substances|mesh-ancestor
14280666|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
15144663|NCT04258163|Letrozole|letrozole|mesh-list
15144664|NCT04258163|Fulvestrant|fulvestrant|mesh-list
15144665|NCT04258163|Anastrozole|anastrozole|mesh-list
15144666|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144667|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
15144668|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144669|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280667|NCT00478231|Maraviroc|maraviroc|mesh-list
14280668|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14280669|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14280670|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280671|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14280672|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14280673|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
14280674|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280675|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14020388|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14020389|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14020390|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280676|NCT00478244|Vidarabine|vidarabine|mesh-list
14280677|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
14280678|NCT00478244|Busulfan|busulfan|mesh-list
14280679|NCT00478244|Fludarabine|fludarabine|mesh-list
14280680|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
14280681|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280682|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
14280683|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280684|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280685|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14280686|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
14280687|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280688|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280689|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14280690|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280691|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
14280692|NCT00478244|Antiviral Agents|antiviral agents|mesh-ancestor
14280693|NCT00478244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280694|NCT00478335|Calcitonin|calcitonin|mesh-list
14280695|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
15144670|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
15144671|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144672|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020391|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020392|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
14020393|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020394|NCT02780128|Ceritinib|ceritinib|mesh-list
14020395|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144673|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144674|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
15144675|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144676|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15144677|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15144678|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15144679|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14280696|NCT00478335|Indomethacin|indomethacin|mesh-list
14280697|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14280698|NCT00478335|Amiloride|amiloride|mesh-list
14280699|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
14280700|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14280701|NCT00478335|Katacalcin|katacalcin|mesh-list
14280702|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
14280703|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14280704|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14280705|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280706|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280707|NCT00478335|Urological Agents|urological agents|mesh-ancestor
14280708|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15144680|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14280709|NCT00478335|Diuretics|diuretics|mesh-ancestor
14280710|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
14280711|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280712|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14280713|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280714|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14280715|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280716|NCT00478335|Analgesics|analgesics|mesh-ancestor
14280717|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
14280718|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280719|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280720|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14280721|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
14280722|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
14280723|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14280724|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14280725|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14280726|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15144681|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15144682|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
15144683|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15144684|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15144685|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15144686|NCT04258241|Bupivacaine|bupivacaine|mesh-list
15144687|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
15144688|NCT04258241|Anesthetics|anesthetics|mesh-list
14280727|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15144689|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15144690|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144691|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144692|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
15144693|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179642|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15182088|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15182089|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182090|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
15182091|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182092|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15182093|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182094|NCT03924596|Boswellic acid|boswellic acid|mesh-list
15182095|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15182096|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182097|NCT03924596|Analgesics|analgesics|mesh-ancestor
15182098|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
15182099|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182100|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182101|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182102|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182103|NCT03924323|Citalopram|citalopram|mesh-list
15182104|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15182105|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14280728|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14280729|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14280730|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14280731|NCT00478361|Gemcitabine|gemcitabine|mesh-list
14280732|NCT00478361|Paclitaxel|paclitaxel|mesh-list
14280733|NCT00478361|Doxorubicin|doxorubicin|mesh-list
14280734|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14280735|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14280736|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280737|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
14280738|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
14280739|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
14280740|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280741|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280742|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
14280743|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
14280744|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280745|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280746|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280747|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
14280748|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182106|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280749|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14280750|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14280751|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14280752|NCT00478426|Sunitinib|sunitinib|mesh-list
14280753|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280754|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14280755|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14280756|NCT00478426|Growth Substances|growth substances|mesh-ancestor
14280757|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280758|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
14280759|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280760|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280761|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280762|NCT00478569|Hormones|hormones|mesh-list
14280763|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
14280764|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280765|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280766|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14280767|NCT00478608|Sirolimus|sirolimus|mesh-list
14280768|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14280769|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280770|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14280771|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280772|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
14280773|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14280774|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
14280775|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280776|NCT00478777|Dexamethasone|dexamethasone|mesh-list
14280777|NCT00478777|Lenalidomide|lenalidomide|mesh-list
14280778|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280779|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
14280780|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
14280781|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280782|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144694|NCT04258423|Everolimus|everolimus|mesh-list
15144695|NCT04258423|Tacrolimus|tacrolimus|mesh-list
15144696|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144697|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
15144698|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144699|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15144700|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144701|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144702|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144703|NCT04258306|Resveratrol|resveratrol|mesh-list
15144704|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
15144705|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144706|NCT04258306|Protective Agents|protective agents|mesh-ancestor
15144707|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144708|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144709|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15144710|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
15144711|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15144712|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144713|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15144714|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144715|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14280783|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280784|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
14280785|NCT00478777|Hormones|hormones|mesh-ancestor
14280786|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280787|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280788|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280789|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
14280790|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14280791|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14280792|NCT00478777|Growth Substances|growth substances|mesh-ancestor
14280793|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
14280794|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14280795|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
14280796|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14280797|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14280798|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280799|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144716|NCT04258098|Metronidazole|metronidazole|mesh-list
15144717|NCT04258098|Streptomycin|streptomycin|mesh-list
15144718|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144719|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15144720|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15144721|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15144722|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144723|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280800|NCT00478881|Urological Agents|urological agents|mesh-ancestor
14280801|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
14280802|NCT00479037|Hormones|hormones|mesh-list
14280803|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
14280804|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280805|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280806|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14280807|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14020396|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14020397|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020398|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020399|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
14280808|NCT00479089|Dexamethasone|dexamethasone|mesh-list
14280809|NCT00479089|Docetaxel|docetaxel|mesh-list
14280810|NCT00479089|Gefitinib|gefitinib|mesh-list
14280811|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14280812|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
14280813|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
14280814|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280815|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280816|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14280817|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
14280818|NCT00479089|Hormones|hormones|mesh-ancestor
14280819|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280820|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14280821|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280822|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144724|NCT04258111|Antibodies|antibodies|mesh-list
15144725|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
15144726|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
15144727|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144728|NCT04258007|Neostigmine|neostigmine|mesh-list
15144729|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15144730|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144731|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144732|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
15144733|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144734|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144735|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15144736|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
15144737|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144738|NCT04257838|Meropenem|meropenem|mesh-list
15144739|NCT04257838|Tazobactam|tazobactam|mesh-list
15144740|NCT04257838|Piperacillin|piperacillin|mesh-list
15144741|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15144742|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15144743|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020400|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14020401|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14020402|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020403|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
14020404|NCT02780245|Coagulants|coagulants|mesh-ancestor
14020405|NCT02780323|Celecoxib|celecoxib|mesh-list
14020406|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020407|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020408|NCT02780323|Analgesics|analgesics|mesh-ancestor
14020409|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
14020410|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020411|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020412|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020413|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020414|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14020415|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020416|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020417|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280823|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14280824|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14280825|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280826|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280827|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280828|NCT00479115|Plerixafor|plerixafor|mesh-list
14280829|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14280830|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14280831|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
14280832|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280833|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
14280834|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14280835|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14280836|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14280837|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14280838|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280839|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
14280840|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280841|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280842|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14280843|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280844|NCT00479232|Decitabine|decitabine|mesh-list
14280845|NCT00479232|Vorinostat|vorinostat|mesh-list
14280846|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280847|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
14280848|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280849|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280850|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280851|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14280852|NCT00479336|Tolvaptan|tolvaptan|mesh-list
14280853|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14280854|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280855|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
14280856|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280857|NCT00479388|Niacin|niacin|mesh-list
14280858|NCT00479388|Atorvastatin|atorvastatin|mesh-list
15144744|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15144745|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144746|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144747|NCT04257851|Sumatriptan|sumatriptan|mesh-list
15144748|NCT04257851|Theophylline|theophylline|mesh-list
15144749|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15144750|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14280859|NCT00479388|Simvastatin|simvastatin|mesh-list
14280860|NCT00479388|Calcium|calcium|mesh-list
14280861|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14280862|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280863|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14280864|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14280865|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
14280866|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280867|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14280868|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14280869|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280870|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
14280871|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
14280872|NCT00479388|Vitamins|vitamins|mesh-ancestor
14280873|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
14280874|NCT00479401|Pramipexole|pramipexole|mesh-list
14280875|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
14280876|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280877|NCT00479401|Protective Agents|protective agents|mesh-ancestor
14280878|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280879|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14280880|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14280881|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
14280882|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
14280883|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280884|NCT00479466|Metformin|metformin|mesh-list
14280885|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14280886|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280887|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
14280888|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14280889|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
14280890|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280891|NCT00479674|Paclitaxel|paclitaxel|mesh-list
14280892|NCT00479674|Bevacizumab|bevacizumab|mesh-list
14280893|NCT00479674|Carboplatin|carboplatin|mesh-list
14280894|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14280895|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562385|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562386|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
14562387|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
14562388|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562389|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562390|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562391|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
15144751|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15144752|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
15144753|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15144754|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144755|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144756|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15144757|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
14562392|NCT00002849|Hormones|hormones|mesh-ancestor
14562393|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562394|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562395|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562396|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
14562397|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562398|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
14562399|NCT00002852|Paclitaxel|paclitaxel|mesh-list
14562400|NCT00002852|Carboplatin|carboplatin|mesh-list
14562401|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562402|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562403|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562404|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562405|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562406|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562407|NCT00002854|Paclitaxel|paclitaxel|mesh-list
14562408|NCT00002854|Etoposide|etoposide|mesh-list
14562409|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
14562410|NCT00002854|Carboplatin|carboplatin|mesh-list
14562411|NCT00002854|Ifosfamide|ifosfamide|mesh-list
14562412|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562413|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562414|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562415|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562416|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562417|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144758|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144759|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15144760|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
15144761|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15144762|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144763|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
15144764|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15144765|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15144766|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
15144767|NCT04257812|Tazobactam|tazobactam|mesh-list
15144768|NCT04257812|Ceftolozane|ceftolozane|mesh-list
15144769|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
15144770|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15144771|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144772|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14562418|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562419|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
14562420|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562421|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562422|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562423|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
14562424|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562425|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562426|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562427|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562428|NCT00002855|Ketoconazole|ketoconazole|mesh-list
14562429|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
14562430|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14562431|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14562432|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14562433|NCT00002855|Doxorubicin|doxorubicin|mesh-list
14562434|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14280896|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280897|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14280898|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14280899|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14280900|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280901|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14280902|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14280903|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14280904|NCT00479674|Growth Substances|growth substances|mesh-ancestor
14280905|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280906|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
14280907|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
14280908|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14280909|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
14280910|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280911|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
15144773|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144774|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144775|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14280912|NCT00479687|Protective Agents|protective agents|mesh-ancestor
14280913|NCT00479765|Paclitaxel|paclitaxel|mesh-list
14280914|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14280915|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280916|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
14280917|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
14280918|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
14280919|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280920|NCT00479856|Paclitaxel|paclitaxel|mesh-list
14280921|NCT00479856|Docetaxel|docetaxel|mesh-list
14280922|NCT00479856|Capecitabine|capecitabine|mesh-list
14280923|NCT00479856|Lapatinib|lapatinib|mesh-list
14280924|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14280925|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14280926|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
14280927|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
14280928|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
14280929|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280930|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14280931|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
14280932|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14280933|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280934|NCT00479882|Simvastatin|simvastatin|mesh-list
14280935|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14280936|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14280937|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
14280938|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280939|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14280940|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14280941|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14280942|NCT00480441|Dronabinol|dronabinol|mesh-list
14280943|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
14280944|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280945|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14280946|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280947|NCT00480441|Analgesics|analgesics|mesh-ancestor
14280948|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
14280949|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280950|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14280951|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14280952|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280953|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280954|NCT00480441|Hormones|hormones|mesh-ancestor
14280955|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280956|NCT00480532|Doxycycline|doxycycline|mesh-list
14280957|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
14280958|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14280959|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14280960|NCT00480532|Estradiol|estradiol|mesh-list
14280961|NCT00480532|Estrogens|estrogens|mesh-ancestor
14280962|NCT00480532|Hormones|hormones|mesh-ancestor
14280963|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14280964|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280965|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14280966|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
14280967|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14280968|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14280969|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14280970|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14280971|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
14280972|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14280973|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14280974|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14280975|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14280976|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14280977|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14280978|NCT00480636|Dalteparin|dalteparin|mesh-list
14280979|NCT00480636|Tinzaparin|tinzaparin|mesh-list
14280980|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14280981|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
14280982|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14280983|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14280984|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280985|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
14280986|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14280987|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14280988|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14280989|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14280990|NCT00480740|Analgesics|analgesics|mesh-ancestor
14280991|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
14280992|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14280993|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14280994|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14280995|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14280996|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
14280997|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14280998|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14280999|NCT00480857|Docetaxel|docetaxel|mesh-list
14281000|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281001|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144776|NCT04257812|Renal Agents|renal agents|mesh-ancestor
15144777|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
15144778|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15144779|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144780|NCT04257461|Capecitabine|capecitabine|mesh-list
14281002|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281003|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
14281004|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281005|NCT00480987|Vidarabine|vidarabine|mesh-list
14281006|NCT00480987|Cytarabine|cytarabine|mesh-list
14281007|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
14281008|NCT00480987|Fludarabine|fludarabine|mesh-list
14281009|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
14281010|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281011|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14281012|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
14281013|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281014|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281015|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
14281016|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281017|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
14281018|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281019|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14281020|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14281021|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
14281022|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281023|NCT00481078|Paclitaxel|paclitaxel|mesh-list
14281024|NCT00481078|Carboplatin|carboplatin|mesh-list
14281025|NCT00481078|Vorinostat|vorinostat|mesh-list
14281026|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14281027|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281028|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14281029|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281030|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14281031|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281032|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14281033|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281034|NCT00481195|Modafinil|modafinil|mesh-list
14281035|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14281036|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144781|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
14281037|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14281038|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14281039|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14281040|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281041|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
14281042|NCT00481247|Dasatinib|dasatinib|mesh-list
14281043|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281044|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281045|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281046|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281047|NCT00481351|Simvastatin|simvastatin|mesh-list
14281048|NCT00481351|Ezetimibe|ezetimibe|mesh-list
14281049|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14281050|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14281051|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
14281052|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281053|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14281054|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14281055|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281056|NCT00481676|Omalizumab|omalizumab|mesh-list
14281057|NCT00481676|Loratadine|loratadine|mesh-list
14281058|NCT00481676|Clemastine|clemastine|mesh-list
14281059|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14281060|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14281061|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14281062|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
14281063|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
14281064|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281065|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
14281066|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281067|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14281068|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14281069|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
14281070|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
14281071|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281072|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281073|NCT00481767|Vaccines|vaccines|mesh-list
14281074|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
14281075|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281076|NCT00481832|Cyclosporine|cyclosporine|mesh-list
14281077|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
14281078|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
14281079|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14281080|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14281081|NCT00481832|Prednisolone|prednisolone|mesh-list
14281082|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
14281083|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
14281084|NCT00481832|Carmustine|carmustine|mesh-list
14281085|NCT00481832|Rituximab|rituximab|mesh-list
14281086|NCT00481832|Etoposide|etoposide|mesh-list
14281087|NCT00481832|Cyclosporins|cyclosporins|mesh-list
14281088|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14281089|NCT00481832|Lenograstim|lenograstim|mesh-list
14281090|NCT00481832|Sargramostim|sargramostim|mesh-list
14281091|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14281092|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
14281093|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281094|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
14281095|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281096|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281097|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14281098|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
14281099|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281100|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281101|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14281102|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14281103|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14281104|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14281105|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14281106|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281107|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14281108|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
14281109|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281110|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281111|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14281112|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14281113|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15144782|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144783|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
15144784|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144785|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144786|NCT04257682|Bupivacaine|bupivacaine|mesh-list
15144787|NCT04257682|Ropivacaine|ropivacaine|mesh-list
15144788|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
15144789|NCT04257682|Mepivacaine|mepivacaine|mesh-list
15144790|NCT04257682|Anesthetics|anesthetics|mesh-list
15144791|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144792|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144793|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
15144794|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281114|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
14281115|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14281116|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281117|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
14281118|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
14281119|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281120|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14281121|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
14281122|NCT00481832|Hormones|hormones|mesh-ancestor
14281123|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14281124|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14281125|NCT00481832|Protective Agents|protective agents|mesh-ancestor
14281126|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14281127|NCT00481845|Anastrozole|anastrozole|mesh-list
14281128|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14281129|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281130|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14281131|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14281132|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281133|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281134|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14281135|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
14281136|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14281137|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292765|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292766|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292767|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
14292768|NCT00562965|Hormones|hormones|mesh-ancestor
14292769|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292770|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292771|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14292772|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292773|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
14292774|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
14292775|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292776|NCT00562965|Analgesics|analgesics|mesh-ancestor
14292777|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
14292778|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14292779|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14292780|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292781|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14292782|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
14292783|NCT00562978|Etoposide|etoposide|mesh-list
14292784|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292785|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
14292786|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292787|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292788|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14292789|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
14292790|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292791|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292792|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14292793|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292794|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14292795|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14292796|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292797|NCT00563290|Dasatinib|dasatinib|mesh-list
15144795|NCT04257448|Gemcitabine|gemcitabine|mesh-list
15144796|NCT04257448|Paclitaxel|paclitaxel|mesh-list
15144797|NCT04257448|Lenalidomide|lenalidomide|mesh-list
15144798|NCT04257448|Azacitidine|azacitidine|mesh-list
14281138|NCT00481871|Vitamins|vitamins|mesh-list
14281139|NCT00481871|Folic Acid|folic acid|mesh-list
14281140|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
14281141|NCT00481871|Hydroxocobalamin|hydroxocobalamin|mesh-list
14281142|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
14281143|NCT00481871|Gemcitabine|gemcitabine|mesh-list
14281144|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14281145|NCT00481871|Aminopterin|aminopterin|mesh-list
14281146|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
14281147|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281148|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14281149|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
14281150|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281151|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281152|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
14281153|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020418|NCT02780310|Lenvatinib|lenvatinib|mesh-list
14020419|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020420|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14020421|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020422|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020423|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
14020424|NCT02779751|Anastrozole|anastrozole|mesh-list
14281154|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281155|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281156|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
14281157|NCT00481871|Hematinics|hematinics|mesh-ancestor
14281158|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14281159|NCT00482001|Donepezil|donepezil|mesh-list
14281160|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14281161|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281162|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281163|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
14281164|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281165|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281166|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
14281167|NCT00482014|Carboplatin|carboplatin|mesh-list
14281168|NCT00482014|Pemetrexed|pemetrexed|mesh-list
14281169|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281170|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281171|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281172|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14281173|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14281174|NCT00482053|Acetaminophen|acetaminophen|mesh-list
14281175|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
14281176|NCT00482053|Promethazine|promethazine|mesh-list
14281177|NCT00482053|Cyclosporine|cyclosporine|mesh-list
14281178|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
14281179|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
14281180|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14281181|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
14281182|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
15144799|NCT04257448|Durvalumab|durvalumab|mesh-list
15144800|NCT04257448|Romidepsin|romidepsin|mesh-list
15144801|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15144802|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144803|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
15144804|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
15144805|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
15144806|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144807|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144808|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
15144809|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
15144810|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144811|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144812|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144813|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
15144814|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144815|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15144816|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15144817|NCT04257448|Growth Substances|growth substances|mesh-ancestor
14020425|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020426|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281183|NCT00482053|Carmustine|carmustine|mesh-list
14281184|NCT00482053|Rituximab|rituximab|mesh-list
14281185|NCT00482053|Etoposide|etoposide|mesh-list
14281186|NCT00482053|Cyclosporins|cyclosporins|mesh-list
14281187|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14281188|NCT00482053|Lenograstim|lenograstim|mesh-list
14281189|NCT00482053|Sargramostim|sargramostim|mesh-list
14281190|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281191|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
14281192|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144818|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
15144819|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144820|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15144821|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14281193|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281194|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14281195|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
14281196|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281197|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281198|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14281199|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14281200|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15144822|NCT04257500|Etonogestrel|etonogestrel|mesh-list
15144823|NCT04257500|NuvaRing|nuvaring|mesh-list
15144824|NCT04257500|Estradiol|estradiol|mesh-list
15144825|NCT04257500|Estrogens|estrogens|mesh-ancestor
15144826|NCT04257500|Hormones|hormones|mesh-ancestor
15144827|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15144828|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144829|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15144830|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
15144831|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15144832|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15144833|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15144834|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15144835|NCT04257656|Remdesivir|remdesivir|mesh-list
15144836|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
15144837|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281201|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14281202|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14281203|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281204|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14281205|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
14281206|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281207|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281208|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14281209|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14281210|NCT00482053|Analgesics|analgesics|mesh-ancestor
14281211|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
14281212|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281213|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
14281214|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14281215|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14281216|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
14281217|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14281218|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281219|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
14281220|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
14281221|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14281222|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
14281223|NCT00482053|Hormones|hormones|mesh-ancestor
14281224|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14281225|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14281226|NCT00482053|Protective Agents|protective agents|mesh-ancestor
14281227|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14281228|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14281229|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14281230|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281231|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
14281232|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
14281233|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14281234|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
14281235|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
14281236|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281237|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14281238|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
14281239|NCT00482170|Etanercept|etanercept|mesh-list
14281240|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15144838|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
15144839|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281241|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14281242|NCT00482170|Analgesics|analgesics|mesh-ancestor
14281243|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
14281244|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281245|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281246|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281247|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281248|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14281249|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281250|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
14281251|NCT00482274|Docetaxel|docetaxel|mesh-list
14281252|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281253|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
14281254|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281255|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
14281256|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281257|NCT00482391|Paclitaxel|paclitaxel|mesh-list
14281258|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
14281259|NCT00482391|Doxorubicin|doxorubicin|mesh-list
14281260|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14281261|NCT00482391|Trastuzumab|trastuzumab|mesh-list
14281262|NCT00482391|Lapatinib|lapatinib|mesh-list
14281263|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14281264|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281265|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
14281266|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281267|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
15144840|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
15144841|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
15144842|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15144843|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
15144844|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144845|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15144846|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15144847|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15144848|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15144849|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144850|NCT04257188|Anesthetics|anesthetics|mesh-list
15144851|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144852|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144853|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15144854|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144855|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
15144856|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15144857|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281268|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281269|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144858|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
15144859|NCT04257032|Dabigatran|dabigatran|mesh-list
15144860|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15144861|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15144862|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15144863|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
15144864|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144865|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15144866|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15144867|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144868|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
15144869|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15144870|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
15144871|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
15144872|NCT04256642|Morphine|morphine|mesh-list
15144873|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14020427|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14281270|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
14281271|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281272|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281273|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14281274|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
14281275|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14281276|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14281277|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14281278|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14281279|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281280|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14281281|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15144874|NCT04256642|Narcotics|narcotics|mesh-ancestor
14281282|NCT00482612|Mirtazapine|mirtazapine|mesh-list
14281283|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
14281284|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14281285|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14281286|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
14281287|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
14281288|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281289|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281290|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281291|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14281292|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14281293|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281294|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14281295|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14281296|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14281297|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14281298|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14281299|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14281300|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
14281301|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14281302|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14281303|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281304|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281305|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281306|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281307|NCT00482677|Temozolomide|temozolomide|mesh-list
14281308|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14281309|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
14281310|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281311|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281312|NCT00482703|Dasatinib|dasatinib|mesh-list
14281313|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281314|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281315|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281316|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281317|NCT00482729|Metformin|metformin|mesh-list
14281318|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14281319|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14281320|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281321|NCT00482729|Incretins|incretins|mesh-ancestor
14281322|NCT00482729|Hormones|hormones|mesh-ancestor
14281323|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14281324|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14281325|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14281326|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281327|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281328|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
14281329|NCT00482911|Lenalidomide|lenalidomide|mesh-list
14281330|NCT00482911|Sunitinib|sunitinib|mesh-list
14281331|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281332|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
14281333|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281334|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281335|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14281336|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
14281337|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281338|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281339|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14281340|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14281341|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14281342|NCT00482911|Growth Substances|growth substances|mesh-ancestor
14281343|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14281344|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281345|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281346|NCT00483002|Varenicline|varenicline|mesh-list
14281347|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14281348|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14281349|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
14281350|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281351|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281352|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281353|NCT00483223|Carboplatin|carboplatin|mesh-list
14281354|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281355|NCT00483262|Bortezomib|bortezomib|mesh-list
14281356|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281357|NCT00483327|Megestrol|megestrol|mesh-list
14281358|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
14281359|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14281360|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14281361|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14281362|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
14281363|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14281364|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281365|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14281366|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14281367|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14281368|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281369|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
14281370|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14281371|NCT00483405|Capecitabine|capecitabine|mesh-list
14281372|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
14281373|NCT00483405|Cetuximab|cetuximab|mesh-list
14281374|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14281375|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
14281376|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281377|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281378|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14281379|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
14281380|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
14281381|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14281382|NCT00483496|Protective Agents|protective agents|mesh-ancestor
14281383|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281384|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281385|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14281386|NCT00483509|Doxorubicin|doxorubicin|mesh-list
14281387|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14281388|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281389|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14281390|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14281391|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281392|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281393|NCT00483548|Ziprasidone|ziprasidone|mesh-list
14281394|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14281395|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
14281396|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281397|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281398|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281399|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14281400|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14281401|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281402|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14281403|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14281404|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
14281405|NCT00483561|Etoposide|etoposide|mesh-list
14281406|NCT00483561|Gefitinib|gefitinib|mesh-list
14281407|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14281408|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281409|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14281410|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14281411|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020428|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14020429|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14020430|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281412|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281413|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281414|NCT00483574|Vaccines|vaccines|mesh-list
14281415|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
14281416|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281417|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
14281418|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14281419|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281420|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281421|NCT00483717|Ketorolac|ketorolac|mesh-list
14281422|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14281423|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14281424|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020431|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281425|NCT00483717|Analgesics|analgesics|mesh-ancestor
14281426|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
14281427|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281428|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281429|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281430|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281431|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14281432|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281433|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281434|NCT00483756|Cyclosporine|cyclosporine|mesh-list
14281435|NCT00483756|Cyclosporins|cyclosporins|mesh-list
14281436|NCT00483756|Tofacitinib|tofacitinib|mesh-list
14281437|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281438|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281439|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281440|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
14281441|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281442|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
14281443|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281444|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281445|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281446|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14281447|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281448|NCT00483938|Interferons|interferons|mesh-list
14281449|NCT00483938|Ribavirin|ribavirin|mesh-list
14281450|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
14281451|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
14281452|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14281453|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281454|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
14281455|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281456|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
14020432|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14020433|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
14020434|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020435|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020436|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14020437|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020438|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020439|NCT02779881|Caseins|caseins|mesh-list
15144875|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144876|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144877|NCT04256642|Analgesics|analgesics|mesh-ancestor
15144878|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
14281457|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281458|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
14281459|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281460|NCT00484094|Sirolimus|sirolimus|mesh-list
14281461|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14281462|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281463|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14281464|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281465|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
14281466|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281467|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
14281468|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281469|NCT00484159|Lidocaine|lidocaine|mesh-list
14281470|NCT00484159|Bupivacaine|bupivacaine|mesh-list
14281471|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
14281472|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
14281473|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281474|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281475|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
14281476|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281477|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14281478|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14281479|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14281480|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281481|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281482|NCT00484198|Pioglitazone|pioglitazone|mesh-list
14281483|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14281484|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281485|NCT00484289|Abatacept|abatacept|mesh-list
15144879|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281486|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14281487|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281488|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281489|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281490|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
14281491|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281492|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281493|NCT00484315|Paclitaxel|paclitaxel|mesh-list
14281494|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14281495|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14281496|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281497|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14281498|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281499|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14281500|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281501|NCT00484393|Tetracaine|tetracaine|mesh-list
14281502|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
14281503|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
14281504|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281505|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281506|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
14281507|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281508|NCT00484679|Triamcinolone|triamcinolone|mesh-list
14281509|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14281510|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14281511|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14281512|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281513|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
14281514|NCT00484679|Hormones|hormones|mesh-ancestor
14281515|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14281516|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281517|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281518|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
14281519|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281520|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281521|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
14281522|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281523|NCT00484939|Bevacizumab|bevacizumab|mesh-list
14281524|NCT00484939|Capecitabine|capecitabine|mesh-list
14281525|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14281526|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144880|NCT04256733|Capsaicin|capsaicin|mesh-list
15144881|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
15144882|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281527|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14281528|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14281529|NCT00484939|Growth Substances|growth substances|mesh-ancestor
15144883|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
15144884|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144885|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144886|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15144887|NCT04256473|Saruplase|saruplase|mesh-list
15144888|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15144889|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15144890|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144891|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
15144892|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144893|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14281530|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281531|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14281532|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14281533|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
14281534|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281535|NCT00485069|Levodopa|levodopa|mesh-list
14281536|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14281537|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14281538|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
14281539|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281540|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281541|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281542|NCT00485134|Vaccines|vaccines|mesh-list
14281543|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
14281544|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281545|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
14020440|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
14281546|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14281547|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14281548|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
14281549|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281550|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14281551|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14281552|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281553|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281554|NCT00485303|Prednisone|prednisone|mesh-list
14281555|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
14281556|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281557|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
14281558|NCT00485303|Hormones|hormones|mesh-ancestor
14281559|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14281560|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281561|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14281562|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281563|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14281564|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281565|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281566|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
14281567|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14281568|NCT00485433|Epinephrine|epinephrine|mesh-list
14281569|NCT00485433|Bupivacaine|bupivacaine|mesh-list
14281570|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
14281571|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
14281572|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281573|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281574|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
14281575|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281576|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14281577|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14281578|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
14281579|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281580|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281581|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14281582|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14281583|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
14281584|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14281585|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
14281586|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
14281587|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
14281588|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14281589|NCT00485472|Lacosamide|lacosamide|mesh-list
14281590|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
14281591|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14281592|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14281593|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281594|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281595|NCT00485485|Docetaxel|docetaxel|mesh-list
14281596|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
14281597|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281598|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
14281599|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281600|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
14281601|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281602|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281603|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281604|NCT00485589|Methotrexate|methotrexate|mesh-list
14281605|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
14281606|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14281607|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
14281608|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14281609|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281610|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14281611|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
14281612|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281613|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281614|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281615|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281616|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14281617|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281618|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
14281619|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562435|NCT00002855|Bicalutamide|bicalutamide|mesh-list
14562436|NCT00002855|Vinblastine|vinblastine|mesh-list
14020441|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
14020442|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281620|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15144894|NCT04256343|Protective Agents|protective agents|mesh-ancestor
15144895|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144896|NCT04256252|Rituximab|rituximab|mesh-list
15144897|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144898|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144899|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
15144900|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281621|NCT00485693|Epinephrine|epinephrine|mesh-list
14281622|NCT00485693|Bupivacaine|bupivacaine|mesh-list
14281623|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
15144901|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179643|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
15179644|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
15179645|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15179646|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15179647|NCT03948191|Prednisolone|prednisolone|mesh-list
15179648|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
15179649|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15179650|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
15179651|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
14281624|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
14281625|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281626|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281627|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
14281628|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281629|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14281630|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14281631|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
14281632|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281633|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281634|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14281635|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14281636|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
14281637|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14281638|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
14281639|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
14281640|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
14281641|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14281642|NCT00485732|Vaccines|vaccines|mesh-list
14281643|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
14281644|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281645|NCT00485758|Niacin|niacin|mesh-list
14281646|NCT00485758|Niacinamide|niacinamide|mesh-list
14281647|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
15179652|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179653|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
15179654|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
15179655|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281648|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14281649|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
14281650|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281651|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14281652|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
14281653|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
14281654|NCT00485758|Vitamins|vitamins|mesh-ancestor
14281655|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
14281656|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281657|NCT00485836|Ranibizumab|ranibizumab|mesh-list
14281658|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14281659|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14281660|NCT00485836|Growth Substances|growth substances|mesh-ancestor
14281661|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281662|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
14281663|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281664|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
14281665|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14281666|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281667|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281668|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14281669|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179656|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562437|NCT00002855|Flutamide|flutamide|mesh-list
15179657|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15144902|NCT04256525|Aspirin|aspirin|mesh-list
15144903|NCT04256525|Heparin|heparin|mesh-list
15144904|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
15144905|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15144906|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15144907|NCT04256525|Analgesics|analgesics|mesh-ancestor
14281670|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14281671|NCT00486018|Ranibizumab|ranibizumab|mesh-list
14281672|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14281673|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14281674|NCT00486018|Growth Substances|growth substances|mesh-ancestor
14281675|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281676|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
14281677|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281678|NCT00486031|Balsalazide|balsalazide|mesh-list
14281679|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14281680|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14281681|NCT00486031|Analgesics|analgesics|mesh-ancestor
14281682|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
14281683|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281684|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281685|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281686|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281687|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14281688|NCT00486044|Simvastatin|simvastatin|mesh-list
15144908|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
15144909|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144910|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144911|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281689|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14281690|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14281691|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
14281692|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281693|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14281694|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14281695|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281696|NCT00486330|Ritonavir|ritonavir|mesh-list
14281697|NCT00486330|Tipranavir|tipranavir|mesh-list
14281698|NCT00486330|Buprenorphine|buprenorphine|mesh-list
14281699|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14281700|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14281701|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
14281702|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811749|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14811750|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14811751|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811752|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811753|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14811754|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
14811755|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
15144912|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281703|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281704|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14281705|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14281706|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
14281707|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281708|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14281709|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14281710|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14281711|NCT00486330|Narcotics|narcotics|mesh-ancestor
14281712|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281713|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281714|NCT00486330|Analgesics|analgesics|mesh-ancestor
14281715|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
14281716|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281717|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14281718|NCT00486434|Calcitonin|calcitonin|mesh-list
14281719|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
14281720|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14281721|NCT00486434|Katacalcin|katacalcin|mesh-list
14281722|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14281723|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281724|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14020443|NCT02779777|Tipifarnib|tipifarnib|mesh-list
14281725|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
14281726|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
14281727|NCT00486603|Temozolomide|temozolomide|mesh-list
14281728|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14281729|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
14281730|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281731|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281732|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
14281733|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14281734|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14281735|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144913|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15144914|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15144915|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144916|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15144917|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15144918|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15144919|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
15144920|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
15144921|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15144922|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
15144923|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15144924|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
15144925|NCT04256200|Dienogest|dienogest|mesh-list
15144926|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
15144927|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
15144928|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14281736|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281737|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281738|NCT00486642|Bicalutamide|bicalutamide|mesh-list
14281739|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
14281740|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
14281741|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14281742|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281743|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281744|NCT00486720|Vorinostat|vorinostat|mesh-list
14281745|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281746|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14281747|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281748|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281749|NCT00486759|Bevacizumab|bevacizumab|mesh-list
14281750|NCT00486759|Rituximab|rituximab|mesh-list
14562438|NCT00002855|Estramustine|estramustine|mesh-list
14562439|NCT00002855|Nilutamide|nilutamide|mesh-list
14562440|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562441|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562442|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562443|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562444|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562445|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562446|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562447|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
14562448|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562449|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14562450|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14562451|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14562452|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
14562453|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562454|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562455|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14562456|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
14562457|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562458|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562459|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562460|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562461|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562462|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562463|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
14562464|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
14562465|NCT00002858|Doxorubicin|doxorubicin|mesh-list
14562466|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14562467|NCT00002858|Etoposide|etoposide|mesh-list
14562468|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562469|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
14811756|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
15144929|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14281751|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14281752|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281753|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14281754|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14281755|NCT00486759|Growth Substances|growth substances|mesh-ancestor
14281756|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281757|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
14281758|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
14281759|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281760|NCT00486811|Oxycodone|oxycodone|mesh-list
14281761|NCT00486811|Tapentadol|tapentadol|mesh-list
14281762|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14281763|NCT00486811|Narcotics|narcotics|mesh-ancestor
14281764|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281765|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281766|NCT00486811|Analgesics|analgesics|mesh-ancestor
14281767|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
14281768|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281769|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14281770|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14281771|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281772|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281773|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
14281774|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281775|NCT00486824|Indomethacin|indomethacin|mesh-list
14281776|NCT00486824|Nifedipine|nifedipine|mesh-list
14281777|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14281778|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281779|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281780|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14281781|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281782|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
14281783|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
14281784|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14281785|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14281786|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14281787|NCT00486824|Analgesics|analgesics|mesh-ancestor
14281788|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
14281789|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281790|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281791|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281792|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
14281793|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14281794|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281795|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
14281796|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14281797|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281798|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281799|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14281800|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14281801|NCT00486863|Praziquantel|praziquantel|mesh-list
14281802|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
14281803|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14281804|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281805|NCT00486902|Ketamine|ketamine|mesh-list
14281806|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
14281807|NCT00486902|Analgesics|analgesics|mesh-ancestor
14281808|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
14281809|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281810|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281811|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14281812|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14281813|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
14281814|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
15144930|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144931|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15144932|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15144933|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15144934|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15144935|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
15144936|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15144937|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14281815|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281816|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14281817|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14281818|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281819|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281820|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14281821|NCT00486954|Paclitaxel|paclitaxel|mesh-list
15144938|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144939|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
15144940|NCT04256057|Analgesics|analgesics|mesh-ancestor
15144941|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
15144942|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15144943|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144944|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
15144945|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144946|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15144947|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
15144948|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15144949|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15144950|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144951|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15144952|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
15144953|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14281822|NCT00486954|Lapatinib|lapatinib|mesh-list
14281823|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14281824|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281825|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
14281826|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281827|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14281828|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281829|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14281830|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281831|NCT00487084|Lidocaine|lidocaine|mesh-list
14281832|NCT00487084|Morphine|morphine|mesh-list
14281833|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
14281834|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
14281835|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281836|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281837|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
15144954|NCT04256213|Nivolumab|nivolumab|mesh-list
15144955|NCT04256213|Ipilimumab|ipilimumab|mesh-list
15144956|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144957|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144958|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15144959|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144960|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
15144961|NCT04255992|Vitamin D|vitamin d|mesh-list
15144962|NCT04255992|Calcium|calcium|mesh-list
14281838|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281839|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14281840|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14281841|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14281842|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281843|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281844|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14281845|NCT00487084|Narcotics|narcotics|mesh-ancestor
14281846|NCT00487084|Analgesics|analgesics|mesh-ancestor
14281847|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14281848|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
14281849|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
14281850|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281851|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14281852|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14281853|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281854|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14281855|NCT00487240|Insulin|insulin|mesh-list
14281856|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14281857|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
14281858|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
14281859|NCT00487240|Protamines|protamines|mesh-list
14281860|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14281861|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281862|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
15144963|NCT04255992|Vitamins|vitamins|mesh-ancestor
14281863|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281864|NCT00487240|Coagulants|coagulants|mesh-ancestor
14281865|NCT00487435|Tapentadol|tapentadol|mesh-list
14281866|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14281867|NCT00487435|Narcotics|narcotics|mesh-ancestor
14281868|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281869|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281870|NCT00487435|Analgesics|analgesics|mesh-ancestor
14281871|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
14281872|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281873|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14281874|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14281875|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14281876|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281877|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
14281878|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281879|NCT00487539|Golimumab|golimumab|mesh-list
15144964|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
15144965|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144966|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15144967|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15144968|NCT04255836|Durvalumab|durvalumab|mesh-list
14281880|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14281881|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14281882|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281883|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281884|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
14281885|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281886|NCT00487669|Paclitaxel|paclitaxel|mesh-list
14281887|NCT00487669|Pemetrexed|pemetrexed|mesh-list
14281888|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14281889|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14281890|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281891|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14281892|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14281893|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14281894|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281895|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281896|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14281897|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14281898|NCT00487721|Silymarin|silymarin|mesh-list
14281899|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
15144969|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15144970|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144971|NCT04255771|Gemcitabine|gemcitabine|mesh-list
15144972|NCT04255771|Cisplatin|cisplatin|mesh-list
15144973|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15144974|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15144975|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
15144976|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144977|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
15144978|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281900|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281901|NCT00487721|Protective Agents|protective agents|mesh-ancestor
14281902|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281903|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14281904|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
14281905|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281906|NCT00487825|Methotrexate|methotrexate|mesh-list
14281907|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14281908|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
14281909|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14281910|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281911|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14281912|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
14281913|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281914|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14281915|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
14281916|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281917|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14281918|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281919|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
14281920|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281921|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14281922|NCT00487942|Modafinil|modafinil|mesh-list
14281923|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15144979|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281924|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281925|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14281926|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14281927|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14281928|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15144980|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15144981|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
15144982|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144983|NCT04255589|Ethanol|ethanol|mesh-list
15144984|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15144985|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15144986|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15144987|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144988|NCT04255576|Vitamin D|vitamin d|mesh-list
15144989|NCT04255576|Calcium|calcium|mesh-list
15144990|NCT04255576|Vitamins|vitamins|mesh-ancestor
15144991|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
15144992|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15144993|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15144994|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15144995|NCT04255498|Etanercept|etanercept|mesh-list
14281929|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
14281930|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
14281931|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
14281932|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14281933|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14281934|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281935|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14281936|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14281937|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
14281938|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281939|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281940|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15144996|NCT04255498|Mifepristone|mifepristone|mesh-list
15144997|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15144998|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15144999|NCT04255498|Analgesics|analgesics|mesh-ancestor
15145000|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
15145001|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145002|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145003|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281941|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14281942|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14281943|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14281944|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281945|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14281946|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14281947|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14281948|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
14281949|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281950|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281951|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14281952|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14281953|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
15145004|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145005|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145006|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145007|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
15145008|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15145009|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
15145010|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15145011|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15145012|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15145013|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15145014|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
14281954|NCT00488345|Tigecycline|tigecycline|mesh-list
14281955|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14281956|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281957|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14281958|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281959|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292798|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145015|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14281960|NCT00488475|Etanercept|etanercept|mesh-list
14281961|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14281962|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14281963|NCT00488475|Analgesics|analgesics|mesh-ancestor
14281964|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
14281965|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281966|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281967|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281968|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281969|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14281970|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14281971|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
14281972|NCT00488488|Tigecycline|tigecycline|mesh-list
14281973|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14281974|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14281975|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14281976|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281977|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281978|NCT00488514|Naproxen|naproxen|mesh-list
14281979|NCT00488514|Sumatriptan|sumatriptan|mesh-list
14281980|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14281981|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14281982|NCT00488514|Analgesics|analgesics|mesh-ancestor
14281983|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
14281984|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14281985|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14281986|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14281987|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14281988|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
14281989|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14281990|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14281991|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14281992|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14281993|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14281994|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14281995|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
14281996|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14281997|NCT00488592|Molgramostim|molgramostim|mesh-list
14281998|NCT00488592|Sargramostim|sargramostim|mesh-list
14281999|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
14282000|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282001|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282002|NCT00488618|Cariprazine|cariprazine|mesh-list
14282003|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14282004|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14282005|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282006|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282007|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14282008|NCT00488631|Golimumab|golimumab|mesh-list
14282009|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14282010|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14282011|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282012|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282013|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
14282014|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282015|NCT00488683|Vaccines|vaccines|mesh-list
14282016|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
14282017|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282018|NCT00488774|Golimumab|golimumab|mesh-list
14282019|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14282020|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14282021|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282022|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282023|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
14282024|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282025|NCT00488826|Vaccines|vaccines|mesh-list
14282026|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14282027|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
14282028|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282029|NCT00488982|Docetaxel|docetaxel|mesh-list
14282030|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282031|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282032|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282033|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282034|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282035|NCT00489086|Tazarotene|tazarotene|mesh-list
14282036|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14282037|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
14282038|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
14282039|NCT00489281|Sirolimus|sirolimus|mesh-list
14282040|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
14282041|NCT00489281|Fludarabine|fludarabine|mesh-list
14282042|NCT00489281|Levetiracetam|levetiracetam|mesh-list
14282043|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
14282044|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14282045|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282046|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
15145016|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15145017|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
15145018|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145019|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
15145020|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15145021|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15145022|NCT04255368|Choline|choline|mesh-list
15145023|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
15145024|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15145025|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
15145026|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282047|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282048|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282049|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14282050|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
14282051|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282052|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282053|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14282054|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14282055|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14282056|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
14282057|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282058|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282059|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282060|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
14282061|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
14282062|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
14282063|NCT00489359|Carboplatin|carboplatin|mesh-list
14282064|NCT00489359|Pemetrexed|pemetrexed|mesh-list
14282065|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282066|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282067|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282068|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14282069|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14282070|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14282071|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14282072|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14282073|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14282074|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282075|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282076|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282077|NCT00489411|Analgesics|analgesics|mesh-ancestor
14282078|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
14282079|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282080|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
14282081|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14282082|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
14282083|NCT00489424|Acetaminophen|acetaminophen|mesh-list
14282084|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282085|NCT00489424|Analgesics|analgesics|mesh-ancestor
14282086|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
14282087|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282088|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282089|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
14282090|NCT00489476|Loxapine|loxapine|mesh-list
14282091|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14282092|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14282093|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282094|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145027|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145028|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15145029|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
14282095|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14282096|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14282097|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
14282098|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282099|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282100|NCT00489489|Interferons|interferons|mesh-list
14282101|NCT00489489|Interferon-beta|interferon-beta|mesh-list
15145030|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
15145031|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15145032|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145033|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15145034|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145035|NCT04255251|Fluorides|fluorides|mesh-list
15145036|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
14282102|NCT00489489|Teriflunomide|teriflunomide|mesh-list
14282103|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
14282104|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282105|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
14282106|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282107|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14282108|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
14282109|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282110|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14282111|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282112|NCT00489489|Analgesics|analgesics|mesh-ancestor
14282113|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
14282114|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282115|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282116|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282117|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282118|NCT00489541|Paclitaxel|paclitaxel|mesh-list
14282119|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14282120|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282121|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282122|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282123|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282124|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282125|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14282126|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
14282127|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282128|NCT00489736|Amiodarone|amiodarone|mesh-list
14282129|NCT00489736|Dronedarone|dronedarone|mesh-list
14282130|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14282131|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14282132|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14282133|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14282134|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282135|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14282136|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14282137|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14282138|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282139|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14282140|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14282141|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14282142|NCT00489853|Budesonide|budesonide|mesh-list
14282143|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
14282144|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282145|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14282146|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
14282147|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282148|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282149|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14282150|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
14282151|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
14282152|NCT00489853|Hormones|hormones|mesh-ancestor
14282153|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282154|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14282155|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14282156|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14282157|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
14282158|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282159|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145037|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
15145038|NCT04255251|Protective Agents|protective agents|mesh-ancestor
15145039|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282160|NCT00489866|Aripiprazole|aripiprazole|mesh-list
14282161|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14282162|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14282163|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14282164|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14282165|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282166|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282167|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
14282168|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
14282169|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282170|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282171|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14282172|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14282173|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
14282174|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14282175|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14282176|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14282177|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14282178|NCT00489918|Teriparatide|teriparatide|mesh-list
14282179|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14282180|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282181|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14282182|NCT00490009|Acetaminophen|acetaminophen|mesh-list
14282183|NCT00490009|Iodine|iodine|mesh-list
14282184|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
14282185|NCT00490009|Promethazine|promethazine|mesh-list
14282186|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
14282187|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
14282188|NCT00490009|Lugol's solution|lugol's solution|mesh-list
14282189|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14282190|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282191|NCT00490009|Analgesics|analgesics|mesh-ancestor
14282192|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
14282193|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282194|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282195|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
14282196|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14282197|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282198|NCT00490009|Trace Elements|trace elements|mesh-ancestor
14282199|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
14282200|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14282201|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14282202|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282203|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
14282204|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
14282205|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
14282206|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
14282207|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14282208|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14282209|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
14282210|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
14282211|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282212|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282213|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14282214|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
14282215|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14282216|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282217|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
14282218|NCT00490009|Coagulants|coagulants|mesh-ancestor
14282219|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
14282220|NCT00490022|Androgens|androgens|mesh-ancestor
14282221|NCT00490022|Hormones|hormones|mesh-ancestor
14282222|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282223|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282224|NCT00490035|Brivaracetam|brivaracetam|mesh-list
14282225|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
14282226|NCT00490061|Lapatinib|lapatinib|mesh-list
14282227|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282228|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14282229|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282230|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282231|NCT00490100|Mecasermin|mecasermin|mesh-list
14282232|NCT00490100|Growth Substances|growth substances|mesh-ancestor
14282233|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282234|NCT00490139|Trastuzumab|trastuzumab|mesh-list
14282235|NCT00490139|Lapatinib|lapatinib|mesh-list
14282236|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14282237|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282238|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14282239|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282240|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282241|NCT00490269|Dronabinol|dronabinol|mesh-list
14282242|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
14282243|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282244|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14282245|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282246|NCT00490269|Analgesics|analgesics|mesh-ancestor
14282247|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
14282248|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282249|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14282250|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14282251|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282252|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282253|NCT00490269|Hormones|hormones|mesh-ancestor
14282254|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282255|NCT00490477|Polymyxins|polymyxins|mesh-list
14282256|NCT00490477|Polymyxin B|polymyxin b|mesh-list
14282257|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282258|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282259|NCT00490490|Iodine|iodine|mesh-list
14282260|NCT00490490|Lugol's solution|lugol's solution|mesh-list
14282261|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14282262|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14282263|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282264|NCT00490490|Trace Elements|trace elements|mesh-ancestor
14282265|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
14282266|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282267|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
14282268|NCT00490490|Coagulants|coagulants|mesh-ancestor
14282269|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
14282270|NCT00490529|Rituximab|rituximab|mesh-list
14282271|NCT00490529|Vaccines|vaccines|mesh-list
14282272|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
14282273|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282274|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282275|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282276|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14282277|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
14282278|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282279|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282280|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14282281|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14282282|NCT00490542|Ziprasidone|ziprasidone|mesh-list
14282283|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14282284|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
14282285|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282286|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282287|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282288|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14282289|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14282290|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282291|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14282292|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14282293|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
14282294|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
14282295|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14282296|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
14282297|NCT00490555|Testosterone|testosterone|mesh-list
14282298|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
14282299|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
14282300|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14282301|NCT00490555|Dutasteride|dutasteride|mesh-list
14282302|NCT00490555|Androgens|androgens|mesh-ancestor
14282303|NCT00490555|Hormones|hormones|mesh-ancestor
14282304|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282305|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282306|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14282307|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282308|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
14282309|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14282310|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14282311|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292799|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14282312|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282313|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
14282314|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14282315|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14282316|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14282317|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
14282318|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14282319|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14282320|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14282321|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14282322|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
14282323|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14282324|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282325|NCT00490646|Docetaxel|docetaxel|mesh-list
14282326|NCT00490646|Trastuzumab|trastuzumab|mesh-list
14282327|NCT00490646|Epothilones|epothilones|mesh-list
14282328|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282329|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282330|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282331|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282332|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282333|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145040|NCT04255160|Estradiol|estradiol|mesh-list
15145041|NCT04255160|Estrogens|estrogens|mesh-ancestor
15145042|NCT04255160|Hormones|hormones|mesh-ancestor
14282334|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
14282335|NCT00490698|Atorvastatin|atorvastatin|mesh-list
14282336|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14282337|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14282338|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
14282339|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282340|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14282341|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14282342|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282343|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14282344|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282345|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14282346|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
14282347|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282348|NCT00490802|Oxytocin|oxytocin|mesh-list
14282349|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
14282350|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14282351|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282352|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14282353|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282354|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
14282355|NCT00490815|Hormones|hormones|mesh-ancestor
14282356|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282357|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282358|NCT00490919|Buprenorphine|buprenorphine|mesh-list
14282359|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14282360|NCT00490919|Narcotics|narcotics|mesh-ancestor
14282361|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282362|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282363|NCT00490919|Analgesics|analgesics|mesh-ancestor
14282364|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
14282365|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145043|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145044|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145045|NCT04255134|Adalimumab|adalimumab|mesh-list
15145046|NCT04255134|Abatacept|abatacept|mesh-list
15145047|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15145048|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145049|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15145050|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145051|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145052|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145053|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
15145054|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145055|NCT04255017|Ritonavir|ritonavir|mesh-list
15145056|NCT04255017|Lopinavir|lopinavir|mesh-list
15145057|NCT04255017|Oseltamivir|oseltamivir|mesh-list
15145058|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14282366|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14282367|NCT00490971|Olanzapine|olanzapine|mesh-list
15145059|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14282368|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14282369|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
14282370|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
14282371|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282372|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282373|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14282374|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14282375|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14282376|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282377|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14282378|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14282379|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14282380|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14282381|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145060|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
15145061|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145062|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145063|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15145064|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15145065|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
15145066|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145067|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15145068|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15145069|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
15145070|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15145071|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282382|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282383|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
14282384|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14282385|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14282386|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14282387|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14282388|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
15145072|NCT04255121|Lidocaine|lidocaine|mesh-list
15145073|NCT04255121|Epinephrine|epinephrine|mesh-list
15145074|NCT04255121|Racepinephrine|racepinephrine|mesh-list
15145075|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
15145076|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145077|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
15145078|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145079|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145080|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
15145081|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145082|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14282389|NCT00491075|Gemcitabine|gemcitabine|mesh-list
14282390|NCT00491075|Pemetrexed|pemetrexed|mesh-list
14282391|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14282392|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
14282393|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282394|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282395|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
14282396|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282397|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282398|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145083|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15145084|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15145085|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14282399|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
14282400|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282401|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14282402|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14282403|NCT00491179|Interferons|interferons|mesh-list
14282404|NCT00491179|Ribavirin|ribavirin|mesh-list
15145086|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145087|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14020444|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020445|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
14020446|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
14020447|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
14020448|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020449|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282405|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
14282406|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
14282407|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14282408|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282409|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
14282410|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282411|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
14282412|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282413|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
14282414|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282415|NCT00491244|Interferons|interferons|mesh-list
14282416|NCT00491244|Ribavirin|ribavirin|mesh-list
14282417|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
14282418|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
14282419|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14282420|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282421|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
14282422|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282423|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
14282424|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282425|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
14282426|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282427|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
14282428|NCT00491322|Vitamin D|vitamin d|mesh-list
14282429|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14282430|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282431|NCT00491322|Vitamins|vitamins|mesh-ancestor
14282432|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
14282433|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14282434|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
14282435|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282436|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
14282437|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14282438|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
14282439|NCT00491530|Atorvastatin|atorvastatin|mesh-list
14282440|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14282441|NCT00491530|Simvastatin|simvastatin|mesh-list
14282442|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
14282443|NCT00491530|Calcium|calcium|mesh-list
15145088|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15145089|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
15145090|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145091|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15145092|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15145093|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
15145094|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14282444|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14282445|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282446|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14282447|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14282448|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14282449|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
14282450|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282451|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14282452|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14282453|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282454|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14282455|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
14282456|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282457|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
14282458|NCT00491751|Atorvastatin|atorvastatin|mesh-list
14282459|NCT00491751|Vitamins|vitamins|mesh-ancestor
14282460|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
14282461|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282462|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14282463|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14282464|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
14282465|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282466|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14282467|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14282468|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282469|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
14282470|NCT00491751|Protective Agents|protective agents|mesh-ancestor
14282471|NCT00491764|Posaconazole|posaconazole|mesh-list
14282472|NCT00491764|Terbinafine|terbinafine|mesh-list
14282473|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
14282474|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145095|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
14282475|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14282476|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14282477|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14282478|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14282479|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14282480|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282481|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282482|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14282483|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
14282484|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145096|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
15145097|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
15145098|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15145099|NCT04254822|Carvedilol|carvedilol|mesh-list
15145100|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14282485|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282486|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
14282487|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14020450|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020451|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14020452|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14020453|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020454|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14020455|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14020456|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
14282488|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14282489|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14282490|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
14282491|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282492|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282493|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282494|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
14282495|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14282496|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282497|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282498|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14282499|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14282500|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282501|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282502|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282503|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14282504|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
14282505|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14282506|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282507|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14282508|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14282509|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14282510|NCT00492063|Vaccines|vaccines|mesh-list
14282511|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
14282512|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282513|NCT00492089|Bevacizumab|bevacizumab|mesh-list
14282514|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14282515|NCT00492089|Antibodies|antibodies|mesh-list
14282516|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
14282517|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14282518|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282519|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14282520|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14282521|NCT00492089|Growth Substances|growth substances|mesh-ancestor
15145101|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15145102|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
15145103|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145104|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145105|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145106|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15145107|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
15145108|NCT04254822|Protective Agents|protective agents|mesh-ancestor
15145109|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15145110|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145111|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15145112|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
15145113|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15145114|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15145115|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
15145116|NCT04255056|Epirubicin|epirubicin|mesh-list
15145117|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145118|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
15145119|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145120|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282522|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282523|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14282524|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
14282525|NCT00492206|Cetuximab|cetuximab|mesh-list
14282526|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14282527|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282528|NCT00492232|Zolpidem|zolpidem|mesh-list
14282529|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14282530|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14282531|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145121|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15145122|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
15145123|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145124|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145125|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15145126|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15145127|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15145128|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15145129|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145130|NCT04254913|Edaravone|edaravone|mesh-list
15145131|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15145132|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
15145133|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145134|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15145135|NCT04254913|Protective Agents|protective agents|mesh-ancestor
15145136|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145137|NCT04254874|Interferons|interferons|mesh-list
15145138|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282532|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282533|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14282534|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
14282535|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
14282536|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282537|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282538|NCT00492284|Dexamethasone|dexamethasone|mesh-list
14282539|NCT00492284|Ranibizumab|ranibizumab|mesh-list
14282540|NCT00492284|Verteporfin|verteporfin|mesh-list
14282541|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282542|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
14282543|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
14282544|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282545|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282546|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14282547|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
14282548|NCT00492284|Hormones|hormones|mesh-ancestor
14282549|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282550|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14282551|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282552|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14282553|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14282554|NCT00492284|Growth Substances|growth substances|mesh-ancestor
14282555|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
14282556|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14282557|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
14282558|NCT00492297|Sorafenib|sorafenib|mesh-list
14282559|NCT00492297|Dacarbazine|dacarbazine|mesh-list
14282560|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282561|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14282562|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282563|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282564|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14282565|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
14282566|NCT00492336|Rasagiline|rasagiline|mesh-list
14282567|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14282568|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282569|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282570|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15145139|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
15145140|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145141|NCT04254744|Sevoflurane|sevoflurane|mesh-list
15145142|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14282571|NCT00492336|Protective Agents|protective agents|mesh-ancestor
14282572|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282573|NCT00492401|Decitabine|decitabine|mesh-list
14282574|NCT00492401|Azacitidine|azacitidine|mesh-list
14282575|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14282576|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
14282577|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282578|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282579|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145143|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15145144|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
15145145|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
15145146|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145147|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145148|NCT04254523|Morphine|morphine|mesh-list
15145149|NCT04254523|Bupivacaine|bupivacaine|mesh-list
15145150|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145151|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
15145152|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145153|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145154|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
15145155|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145156|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15145157|NCT04254523|Narcotics|narcotics|mesh-ancestor
15145158|NCT04254523|Analgesics|analgesics|mesh-ancestor
15145159|NCT04254601|Erythromycin|erythromycin|mesh-list
15145160|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
15145161|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15145162|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
14282580|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
14282581|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14282582|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
14282583|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14282584|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282585|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282586|NCT00492531|Urological Agents|urological agents|mesh-ancestor
14282587|NCT00492544|Vaccines|vaccines|mesh-list
14282588|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
14282589|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282590|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14282591|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
14282592|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282593|NCT00492622|Omeprazole|omeprazole|mesh-list
14282594|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14282595|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14282596|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14282597|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282598|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282599|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
14282600|NCT00492726|Ertapenem|ertapenem|mesh-list
14282601|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14282602|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282603|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282604|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14282605|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14282606|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282607|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282608|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282609|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14282610|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
14282611|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14282612|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282613|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14282614|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14282615|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14282616|NCT00492752|Sorafenib|sorafenib|mesh-list
15145163|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15145164|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145165|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145166|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15145167|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145168|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145169|NCT04254692|Bupivacaine|bupivacaine|mesh-list
15145170|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145171|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
15145172|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282617|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282618|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14282619|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282620|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282621|NCT00492856|Methotrexate|methotrexate|mesh-list
14282622|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
14282623|NCT00492856|Tretinoin|tretinoin|mesh-list
14282624|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14282625|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
15145173|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145174|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
15145175|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282626|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14282627|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282628|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14282629|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
14282630|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282631|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282632|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
14282633|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282634|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14282635|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282636|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
14282637|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282638|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14282639|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
14282640|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
14282641|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282642|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
14282643|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282644|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282645|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14282646|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
14282647|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282648|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282649|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14282650|NCT00492973|Cefuroxime|cefuroxime|mesh-list
14282651|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
14282652|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14282653|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14282654|NCT00492973|Prednisolone|prednisolone|mesh-list
14282655|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
14282656|NCT00492973|Clonidine|clonidine|mesh-list
14282657|NCT00492973|Epinephrine|epinephrine|mesh-list
14282658|NCT00492973|Morphine|morphine|mesh-list
14282659|NCT00492973|Bupivacaine|bupivacaine|mesh-list
14282660|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14282661|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
14282662|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
14282663|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
14282664|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14282665|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145176|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
15145177|NCT04254679|Analgesics|analgesics|mesh-list
15145178|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
15145179|NCT04254679|Narcotics|narcotics|mesh-ancestor
15145180|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145181|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145182|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
15145183|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145184|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
15145185|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15145186|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179658|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
15179659|NCT03948191|Hormones|hormones|mesh-ancestor
15179660|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179661|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15179662|NCT03948191|Protective Agents|protective agents|mesh-ancestor
15179663|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15179664|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282666|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
15179665|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15179666|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14282667|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282668|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14282669|NCT00492973|Narcotics|narcotics|mesh-ancestor
14282670|NCT00492973|Analgesics|analgesics|mesh-ancestor
14282671|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282672|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
14282673|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
15145187|NCT04254471|Carboplatin|carboplatin|mesh-list
15145188|NCT04254471|Etoposide|etoposide|mesh-list
15145189|NCT04254471|Rabeprazole|rabeprazole|mesh-list
15145190|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145191|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15145192|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15145193|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15145194|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145195|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145196|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15145197|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145198|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15145199|NCT04254640|Cytarabine|cytarabine|mesh-list
15145200|NCT04254640|Cladribine|cladribine|mesh-list
14282674|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14282675|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
14282676|NCT00492973|Hormones|hormones|mesh-ancestor
14282677|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282678|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14282679|NCT00492973|Protective Agents|protective agents|mesh-ancestor
14282680|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14282681|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282682|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14282683|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14282684|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
14282685|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282686|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282687|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14282688|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14282689|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14282690|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
14282691|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
14282692|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
14282693|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14282694|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15145201|NCT04254640|Aclarubicin|aclarubicin|mesh-list
15145202|NCT04254640|Sargramostim|sargramostim|mesh-list
15145203|NCT04254640|Lenograstim|lenograstim|mesh-list
15145204|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15145205|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
15145206|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145207|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145208|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
15145209|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145210|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145211|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
14282695|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
14282696|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14282697|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282698|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282699|NCT00493012|Vitamin D|vitamin d|mesh-list
14282700|NCT00493012|Vitamins|vitamins|mesh-ancestor
14282701|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
14282702|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282703|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14282704|NCT00493038|Amoxicillin|amoxicillin|mesh-list
14282705|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
14282706|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
14282707|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
14282708|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14282709|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14282710|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282711|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282712|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14282713|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14282714|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282715|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282716|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282717|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14282718|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
15145212|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282719|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14282720|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282721|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14282722|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14282723|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14282724|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14282725|NCT00493064|Niacin|niacin|mesh-list
14282726|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
14282727|NCT00493064|Niacinamide|niacinamide|mesh-list
14282728|NCT00493064|Prednisolone|prednisolone|mesh-list
14282729|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14282730|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
14282731|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14282732|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
14282733|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14282734|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
14282735|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15145213|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15145214|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15145215|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15145216|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14282736|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
14282737|NCT00493064|Hormones|hormones|mesh-ancestor
14282738|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282739|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282740|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14282741|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282742|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
14282743|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
14282744|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282745|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14282746|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14282747|NCT00493064|Protective Agents|protective agents|mesh-ancestor
14282748|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15145217|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145218|NCT04254042|Perindopril|perindopril|mesh-list
15145219|NCT04254042|Zofenopril|zofenopril|mesh-list
15145220|NCT04254042|Captopril|captopril|mesh-list
15145221|NCT04254042|Calcium|calcium|mesh-list
15145222|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15145223|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145224|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14282749|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
14282750|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282751|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14282752|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
14282753|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
14282754|NCT00493064|Vitamins|vitamins|mesh-ancestor
14282755|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
14282756|NCT00493181|Oprelvekin|oprelvekin|mesh-list
14282757|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282758|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
15145225|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
14282759|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282760|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282761|NCT00493246|Acetaminophen|acetaminophen|mesh-list
14282762|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282763|NCT00493246|Analgesics|analgesics|mesh-ancestor
14282764|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
14282765|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282766|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282767|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
14282768|NCT00493311|Acetaminophen|acetaminophen|mesh-list
14282769|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282770|NCT00493311|Analgesics|analgesics|mesh-ancestor
14282771|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
14282772|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282773|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282774|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
14282775|NCT00493454|Rituximab|rituximab|mesh-list
14282776|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14282777|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14282778|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282779|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
14282780|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282781|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282782|NCT00493467|Rituximab|rituximab|mesh-list
14282783|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145226|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282784|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282785|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
14282786|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282787|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282788|NCT00493636|Gemcitabine|gemcitabine|mesh-list
14282789|NCT00493636|Capecitabine|capecitabine|mesh-list
14282790|NCT00493636|Sorafenib|sorafenib|mesh-list
14282791|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14282792|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
14282793|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282794|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282795|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
14282796|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282797|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282798|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282799|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
14282800|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282801|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14292800|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292801|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292802|NCT00563316|Irinotecan|irinotecan|mesh-list
14292803|NCT00563316|Panitumumab|panitumumab|mesh-list
14292804|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14292805|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14292806|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292807|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292808|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292809|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14292810|NCT00563368|Topiramate|topiramate|mesh-list
14292811|NCT00563368|Phentermine|phentermine|mesh-list
14292812|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
14292813|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14292814|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292815|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14292816|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
14292817|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14292818|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
14292819|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
14292820|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292821|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292822|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292823|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292824|NCT00563381|Bromides|bromides|mesh-list
14292825|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
14292826|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14292827|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15145227|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145228|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15145229|NCT04254081|Lidocaine|lidocaine|mesh-list
14292828|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
14292829|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292830|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292831|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14292832|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
14292833|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
14292834|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14292835|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
14292836|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292837|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292838|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14292839|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14292840|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14292841|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
14292842|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
14292843|NCT00563706|Risperidone|risperidone|mesh-list
14292844|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14292845|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
14292846|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292847|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292848|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292849|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14292850|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14292851|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292852|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292853|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14282802|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
14282803|NCT00493649|Docetaxel|docetaxel|mesh-list
14282804|NCT00493649|Trastuzumab|trastuzumab|mesh-list
14282805|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282806|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
14282807|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282808|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282809|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14282810|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
14282811|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282812|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282813|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14282814|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282815|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282816|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282817|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14282818|NCT00493805|Interferons|interferons|mesh-list
14282819|NCT00493805|Ribavirin|ribavirin|mesh-list
14282820|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
14282821|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
14282822|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14282823|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282824|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
14282825|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282826|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
14282827|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282828|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
14282829|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282830|NCT00493974|Zileuton|zileuton|mesh-list
14282831|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14282832|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282833|NCT00493974|Analgesics|analgesics|mesh-ancestor
14282834|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
14282835|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282836|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282837|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282838|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282839|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14282840|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282841|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282842|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14282843|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
14282844|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282845|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
14282846|NCT00494013|Protamines|protamines|mesh-list
14282847|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14282848|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282849|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
14282850|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282851|NCT00494013|Coagulants|coagulants|mesh-ancestor
14282852|NCT00494026|Carboplatin|carboplatin|mesh-list
14282853|NCT00494026|Pemetrexed|pemetrexed|mesh-list
14282854|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282855|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282856|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282857|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14282858|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14282859|NCT00494091|Sirolimus|sirolimus|mesh-list
14282860|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282861|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282862|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14282863|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282864|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
14282865|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282866|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
14282867|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282868|NCT00494221|Leucovorin|leucovorin|mesh-list
14282869|NCT00494221|Fluorouracil|fluorouracil|mesh-list
14282870|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
14282871|NCT00494221|Cediranib|cediranib|mesh-list
14282872|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
14282873|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
14282874|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282875|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14282876|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282877|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282878|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
14282879|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282880|NCT00494221|Antidotes|antidotes|mesh-ancestor
14282881|NCT00494221|Protective Agents|protective agents|mesh-ancestor
14282882|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
14282883|NCT00494221|Vitamins|vitamins|mesh-ancestor
14282884|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
14282885|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14282886|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282887|NCT00494299|Sorafenib|sorafenib|mesh-list
14282888|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282889|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14282890|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145230|NCT04254081|Buprenorphine|buprenorphine|mesh-list
14282891|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282892|NCT00494442|Olaparib|olaparib|mesh-list
14282893|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14282894|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282895|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282896|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282897|NCT00494481|Docetaxel|docetaxel|mesh-list
14282898|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282899|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282900|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282901|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282902|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282903|NCT00494494|Nepafenac|nepafenac|mesh-list
14282904|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14282905|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14282906|NCT00494494|Analgesics|analgesics|mesh-ancestor
14282907|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
14282908|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282909|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282910|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282911|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282912|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
14282913|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14282914|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282915|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282916|NCT00494676|Methamphetamine|methamphetamine|mesh-list
14282917|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14282918|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282919|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
14282920|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
14282921|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14282922|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
14282923|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14282924|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282925|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
14282926|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14282927|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14282928|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14282929|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14282930|NCT00494780|Prednisone|prednisone|mesh-list
14282931|NCT00494780|Prednisolone|prednisolone|mesh-list
14282932|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
14282933|NCT00494780|Doxorubicin|doxorubicin|mesh-list
14282934|NCT00494780|Vincristine|vincristine|mesh-list
14282935|NCT00494780|Ofatumumab|ofatumumab|mesh-list
14282936|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14282937|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
14282938|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282939|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14282940|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14282941|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
14282942|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282943|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282944|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14282945|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14282946|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14282947|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14282948|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282949|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14282950|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
14282951|NCT00494780|Hormones|hormones|mesh-ancestor
14292854|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
14282952|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14282953|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14282954|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14282955|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282956|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282957|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282958|NCT00494871|Warfarin|warfarin|mesh-list
14282959|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
14282960|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
14282961|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14282962|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
14282963|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15145231|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145232|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
15145233|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145234|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020457|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020458|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020459|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
14020460|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
14020461|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14282964|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
14282965|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14282966|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282967|NCT00495079|Vincristine|vincristine|mesh-list
14282968|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14282969|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14282970|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282971|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282972|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282973|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282974|NCT00495170|Paclitaxel|paclitaxel|mesh-list
14282975|NCT00495170|Carboplatin|carboplatin|mesh-list
14282976|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14282977|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145235|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
15145236|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145237|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15145238|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15145239|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15145240|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145241|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145242|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14282978|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14282979|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14282980|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14282981|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282982|NCT00495391|Ribavirin|ribavirin|mesh-list
14282983|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14282984|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
14282985|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
14282986|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14282987|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
14282988|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282989|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14282990|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14282991|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
14282992|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282993|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282994|NCT00495586|Amoxicillin|amoxicillin|mesh-list
14282995|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
14282996|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
14282997|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14282998|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14282999|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283000|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283001|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14283002|NCT00495612|Omalizumab|omalizumab|mesh-list
15145243|NCT04254081|Narcotics|narcotics|mesh-ancestor
15145244|NCT04254081|Analgesics|analgesics|mesh-ancestor
15145245|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15145246|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
14283003|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14020462|NCT02779634|Vitamins|vitamins|mesh-ancestor
14292855|NCT00563784|Paclitaxel|paclitaxel|mesh-list
15145247|NCT04253912|Povidone|povidone|mesh-list
15145248|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
15145249|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
15145250|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15145251|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145252|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15145253|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15145254|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145255|NCT04253678|Vortioxetine|vortioxetine|mesh-list
15145256|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
15145257|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15145258|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14283004|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14283005|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
14283006|NCT00495625|Sunitinib|sunitinib|mesh-list
14283007|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283008|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14283009|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14283010|NCT00495625|Growth Substances|growth substances|mesh-ancestor
14283011|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283012|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
14283013|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283014|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283015|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283016|NCT00495677|PF 232798|pf 232798|mesh-list
14283017|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14283018|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145259|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15145260|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145261|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145262|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15145263|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15145264|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145265|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145266|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145267|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
15145268|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15145269|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14283019|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14283020|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14283021|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
14283022|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283023|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
14283024|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283025|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283026|NCT00495820|Methylphenidate|methylphenidate|mesh-list
14283027|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14283028|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283029|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14283030|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14283031|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283032|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283033|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
14283034|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283035|NCT00496015|Acetaminophen|acetaminophen|mesh-list
15145270|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15145271|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15145272|NCT04253561|Trastuzumab|trastuzumab|mesh-list
14283036|NCT00496015|Vaccines|vaccines|mesh-list
14283037|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14283038|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
14283039|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283040|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14283041|NCT00496015|Analgesics|analgesics|mesh-ancestor
14283042|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
14283043|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283044|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
14283045|NCT00496054|Vaccines|vaccines|mesh-list
14283046|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
14283047|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283048|NCT00496197|Fluconazole|fluconazole|mesh-list
14283049|NCT00496197|Voriconazole|voriconazole|mesh-list
14283050|NCT00496197|Anidulafungin|anidulafungin|mesh-list
15145273|NCT04253561|Pertuzumab|pertuzumab|mesh-list
15145274|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283051|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
14283052|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283053|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14283054|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14283055|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283056|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283057|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14283058|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
15145275|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145276|NCT04253873|Temozolomide|temozolomide|mesh-list
15145277|NCT04253873|Apatinib|apatinib|mesh-list
15145278|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15145279|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
15145280|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145281|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145282|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15145283|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145284|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
15145285|NCT04253132|Analgesics|analgesics|mesh-ancestor
15145286|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
15145287|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145288|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283059|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145289|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15145290|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15145291|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283060|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283061|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14283062|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14283063|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14283064|NCT00496340|Rituximab|rituximab|mesh-list
14283065|NCT00496340|Busulfan|busulfan|mesh-list
14283066|NCT00496340|Pentostatin|pentostatin|mesh-list
14283067|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283068|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283069|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
14283070|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283071|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283072|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
14283073|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283074|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283075|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283076|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283077|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14283078|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283079|NCT00496366|Capecitabine|capecitabine|mesh-list
14283080|NCT00496366|Lapatinib|lapatinib|mesh-list
14283081|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283082|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
14283083|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283084|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283085|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283086|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283087|NCT00496379|Epothilones|epothilones|mesh-list
14283088|NCT00496379|Sagopilone|sagopilone|mesh-list
14283089|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283090|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283091|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283092|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283093|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283094|NCT00496470|Budesonide|budesonide|mesh-list
14283095|NCT00496470|Bromides|bromides|mesh-list
14283096|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
14283097|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
14283098|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14283099|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283100|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14283101|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
14283102|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283103|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145292|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145293|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14292856|NCT00563784|Carboplatin|carboplatin|mesh-list
14283104|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14283105|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
14283106|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
14283107|NCT00496470|Hormones|hormones|mesh-ancestor
14283108|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14283109|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14283110|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14283111|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14283112|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14283113|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283114|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283115|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
14562470|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562471|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562472|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562473|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
14562474|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562475|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562476|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562477|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562478|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562479|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562480|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562481|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562482|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
14562483|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562484|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562485|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562486|NCT00002864|Tamoxifen|tamoxifen|mesh-list
14562487|NCT00002864|Octreotide|octreotide|mesh-list
14562488|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14562489|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
14562490|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562491|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562492|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562493|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562494|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14562495|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14562496|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14562497|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562498|NCT00002865|Leucovorin|leucovorin|mesh-list
14562499|NCT00002865|Cobalt|cobalt|mesh-list
14562500|NCT00002865|Cytarabine|cytarabine|mesh-list
14562501|NCT00002865|Dexamethasone|dexamethasone|mesh-list
14562502|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
14562503|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14562504|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14562505|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14562506|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
14562507|NCT00002865|Ifosfamide|ifosfamide|mesh-list
14562508|NCT00002865|Doxorubicin|doxorubicin|mesh-list
14562509|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14562510|NCT00002865|Methotrexate|methotrexate|mesh-list
14562511|NCT00002865|Etoposide|etoposide|mesh-list
14562512|NCT00002865|Vincristine|vincristine|mesh-list
14562513|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
14562514|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562515|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
14562516|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562517|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562518|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562519|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
14562520|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562521|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562522|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562523|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562524|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
14562525|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
14562526|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562527|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562528|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
14562529|NCT00002865|Hormones|hormones|mesh-ancestor
14562530|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145294|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283116|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14283117|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
14283118|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
14283119|NCT00496483|Tacrolimus|tacrolimus|mesh-list
14283120|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283121|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
14283122|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283123|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14283124|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283125|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283126|NCT00496587|Gemcitabine|gemcitabine|mesh-list
14283127|NCT00496587|Bevacizumab|bevacizumab|mesh-list
14283128|NCT00496587|Capecitabine|capecitabine|mesh-list
14283129|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283130|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283131|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14283132|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14283133|NCT00496587|Growth Substances|growth substances|mesh-ancestor
14283134|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283135|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
14283136|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283137|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
14283138|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283139|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
14283140|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283141|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283142|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283143|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
14283144|NCT00496769|Aspirin|aspirin|mesh-list
14283145|NCT00496769|Apixaban|apixaban|mesh-list
14283146|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14283147|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14283148|NCT00496769|Analgesics|analgesics|mesh-ancestor
14283149|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
14283150|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283151|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283152|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283153|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283154|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14283155|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14283156|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283157|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14283158|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14283159|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283160|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
14283161|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14283162|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
14283163|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14283164|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
14283165|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
14283166|NCT00496808|Trastuzumab|trastuzumab|mesh-list
14283167|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283168|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283169|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
14283170|NCT00496873|Rituximab|rituximab|mesh-list
14283171|NCT00496873|Pentostatin|pentostatin|mesh-list
14283172|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283173|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
14283174|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283175|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283176|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283177|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
14283178|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283179|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283180|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283181|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283182|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14283183|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283184|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
14283185|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14283186|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14283187|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14283188|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283189|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182306|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283190|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
14283191|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283192|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283193|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14283194|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283195|NCT00497055|Aripiprazole|aripiprazole|mesh-list
14283196|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
14283197|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14283198|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14283199|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14283200|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283201|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283202|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
14283203|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
14283204|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283205|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283206|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14283207|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14283208|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
14283209|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14283210|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14283211|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14283212|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15145295|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145296|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15145297|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
15145298|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
15145299|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145300|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15145301|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
15145302|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145303|NCT04253145|Atezolizumab|atezolizumab|mesh-list
15145304|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145305|NCT04253457|Triamcinolone|triamcinolone|mesh-list
15145306|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15145307|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
14283213|NCT00497081|Mirtazapine|mirtazapine|mesh-list
14283214|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
14283215|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14283216|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14283217|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
14283218|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
14283219|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283220|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283221|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283222|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14283223|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14283224|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283225|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14283226|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14283227|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14283228|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14283229|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14283230|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14283231|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
14283232|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14283233|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
14283234|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14283235|NCT00497770|Pemetrexed|pemetrexed|mesh-list
14283236|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283237|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283238|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283239|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14283240|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14283241|NCT00497796|Ganciclovir|ganciclovir|mesh-list
14283242|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14283243|NCT00497796|Maribavir|maribavir|mesh-list
14283244|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
14283245|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283246|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14283247|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283248|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145308|NCT04253457|Hormones|hormones|mesh-ancestor
14283249|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14283250|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14283251|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14283252|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283253|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283254|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14283255|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283256|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283257|NCT00498186|Rotigotine|rotigotine|mesh-list
14283258|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
15145309|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145310|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145311|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15145312|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15145313|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15145314|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
15145315|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145316|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15145317|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15145318|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145319|NCT04253223|Volagidemab|volagidemab|mesh-list
15145320|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14283259|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
14283260|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283261|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283262|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283263|NCT00498355|Ranibizumab|ranibizumab|mesh-list
14283264|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14283265|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14283266|NCT00498355|Growth Substances|growth substances|mesh-ancestor
14283267|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283268|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
14283269|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283270|NCT00498368|Rituximab|rituximab|mesh-list
14283271|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
14283272|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283273|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283274|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
14283275|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283276|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283277|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14283278|NCT00498433|Amlodipine|amlodipine|mesh-list
14283279|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14283280|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14283281|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283282|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283283|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14283284|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283285|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
14283286|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
14283287|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14283288|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14283289|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
14283290|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
14283291|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283292|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283293|NCT00498550|Clozapine|clozapine|mesh-list
14283294|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14283295|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
14283296|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283297|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283298|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283299|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14283300|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14283301|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283302|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14283303|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
14283304|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
15145321|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145322|NCT04252963|Streptokinase|streptokinase|mesh-list
15145323|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15145324|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14283305|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
15145325|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145326|NCT04252664|Remdesivir|remdesivir|mesh-list
15145327|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
15145328|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145329|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
15145330|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145331|NCT04252768|Paclitaxel|paclitaxel|mesh-list
15145332|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15145333|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145334|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
15145335|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145336|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
15145337|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145338|NCT04252885|Ritonavir|ritonavir|mesh-list
15145339|NCT04252885|Lopinavir|lopinavir|mesh-list
14020463|NCT02779348|Warfarin|warfarin|mesh-list
14020464|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
14283306|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14283307|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
14283308|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283309|NCT00498615|Fasudil|fasudil|mesh-list
14283310|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14283311|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283312|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283313|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14283314|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283315|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
14283316|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283317|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283318|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14283319|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
14283320|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14283321|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14283322|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14283323|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283324|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283325|NCT00498797|Prednisolone|prednisolone|mesh-list
14283326|NCT00498797|Docetaxel|docetaxel|mesh-list
14283327|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283328|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283329|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283330|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283331|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283332|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283333|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
14283334|NCT00498797|Hormones|hormones|mesh-ancestor
14283335|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14283336|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283337|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14283338|NCT00498927|Temozolomide|temozolomide|mesh-list
14283339|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283340|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
14283341|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283342|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283343|NCT00499031|Cetuximab|cetuximab|mesh-list
14283344|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020465|NCT02779608|Docetaxel|docetaxel|mesh-list
14020466|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020467|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
14020468|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283345|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283346|NCT00499083|Tamoxifen|tamoxifen|mesh-list
14283347|NCT00499083|Paclitaxel|paclitaxel|mesh-list
14283348|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
14283349|NCT00499083|Doxorubicin|doxorubicin|mesh-list
14283350|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14283351|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14283352|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14283353|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283354|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283355|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283356|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283357|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283358|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283359|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
14283360|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283361|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283362|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283363|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
14283364|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283365|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14283366|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14283367|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14283368|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283369|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14283370|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
14283371|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14283372|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14283373|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14283374|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14283375|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14283376|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14283377|NCT00499109|Gemcitabine|gemcitabine|mesh-list
14283378|NCT00499109|Carboplatin|carboplatin|mesh-list
14283379|NCT00499109|Docetaxel|docetaxel|mesh-list
14283380|NCT00499109|Vinorelbine|vinorelbine|mesh-list
14283381|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
14283382|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283383|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
14283384|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283385|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
14283386|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283387|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283388|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283389|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
14283390|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283391|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
15145340|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15145341|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15145342|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
15145343|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145344|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145345|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15145346|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15145347|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
14283392|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283393|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283394|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14283395|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
14283396|NCT00499122|Docetaxel|docetaxel|mesh-list
14283397|NCT00499122|Doxorubicin|doxorubicin|mesh-list
14283398|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283399|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
14283400|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283401|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283402|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283403|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
14283404|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283405|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283406|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283407|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283408|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283409|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283410|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14283411|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14283412|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14283413|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283414|NCT00499252|Paclitaxel|paclitaxel|mesh-list
14283415|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14283416|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14283417|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283418|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283419|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283420|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283421|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283422|NCT00499343|Rituximab|rituximab|mesh-list
14283423|NCT00499343|Etoposide|etoposide|mesh-list
15145348|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283424|NCT00499343|Ifosfamide|ifosfamide|mesh-list
15145349|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15145350|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15145351|NCT04252586|Cannabidiol|cannabidiol|mesh-list
15145352|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
15145353|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
14283425|NCT00499343|Sargramostim|sargramostim|mesh-list
14283426|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283427|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283428|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
14283429|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283430|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283431|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14283432|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14283433|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14283434|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283435|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283436|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283437|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
14283438|NCT00499369|Leucovorin|leucovorin|mesh-list
14283439|NCT00499369|Bevacizumab|bevacizumab|mesh-list
14283440|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14283441|NCT00499369|Cetuximab|cetuximab|mesh-list
14283442|NCT00499369|Fluorouracil|fluorouracil|mesh-list
14283443|NCT00499369|Irinotecan|irinotecan|mesh-list
14283444|NCT00499369|Antibodies|antibodies|mesh-list
14283445|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
14283446|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14283447|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
14283448|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283449|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14283450|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14283451|NCT00499369|Growth Substances|growth substances|mesh-ancestor
14283452|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283453|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
14283454|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
14283455|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
14283456|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145354|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145355|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145356|NCT04252456|Leucovorin|leucovorin|mesh-list
14283457|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283458|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283459|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14283460|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14283461|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283462|NCT00499369|Antidotes|antidotes|mesh-ancestor
14283463|NCT00499369|Protective Agents|protective agents|mesh-ancestor
14283464|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
14283465|NCT00499369|Vitamins|vitamins|mesh-ancestor
14283466|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
14283467|NCT00499408|Vitamin D|vitamin d|mesh-list
14283468|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
14283469|NCT00499408|Vitamins|vitamins|mesh-ancestor
14283470|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
14283471|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145357|NCT04252456|Folic Acid|folic acid|mesh-list
15145358|NCT04252456|Fluorouracil|fluorouracil|mesh-list
15145359|NCT04252456|Aflibercept|aflibercept|mesh-list
15145360|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
14283472|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14283473|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14283474|NCT00499460|Oxycodone|oxycodone|mesh-list
14283475|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14283476|NCT00499460|Narcotics|narcotics|mesh-ancestor
14283477|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283478|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283479|NCT00499460|Analgesics|analgesics|mesh-ancestor
14283480|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
14283481|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283482|NCT00499473|Sunitinib|sunitinib|mesh-list
15145361|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
15145362|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145363|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15145364|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283483|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283484|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14562531|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15145365|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145366|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
14283485|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14283486|NCT00499473|Growth Substances|growth substances|mesh-ancestor
14283487|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283488|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
14283489|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283490|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283491|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283492|NCT00499486|Sirolimus|sirolimus|mesh-list
14283493|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14283494|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145367|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145368|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15145369|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15145370|NCT04252456|Growth Substances|growth substances|mesh-ancestor
15145371|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
15145372|NCT04252456|Antidotes|antidotes|mesh-ancestor
15145373|NCT04252456|Protective Agents|protective agents|mesh-ancestor
14283495|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14283496|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283497|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
14283498|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283499|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
14283500|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283501|NCT00499603|Paclitaxel|paclitaxel|mesh-list
14283502|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
14283503|NCT00499603|Fluorouracil|fluorouracil|mesh-list
14283504|NCT00499603|Epirubicin|epirubicin|mesh-list
14283505|NCT00499603|Everolimus|everolimus|mesh-list
14283506|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14283507|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283508|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283509|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283510|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283511|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283512|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283513|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
14283514|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283515|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283516|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283517|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
14283518|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283519|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
14283520|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283521|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14283522|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14283523|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14283524|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283525|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
14283526|NCT00499616|Carboplatin|carboplatin|mesh-list
14283527|NCT00499616|Doxorubicin|doxorubicin|mesh-list
14283528|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14283529|NCT00499616|Etoposide|etoposide|mesh-list
14283530|NCT00499616|Topotecan|topotecan|mesh-list
14283531|NCT00499616|Isotretinoin|isotretinoin|mesh-list
14283532|NCT00499616|Lenograstim|lenograstim|mesh-list
14283533|NCT00499616|Sargramostim|sargramostim|mesh-list
14283534|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283535|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
15145374|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
14283536|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283537|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283538|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283539|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
14283540|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283541|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283542|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283543|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14283544|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14283545|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14283546|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283547|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14283548|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15145375|NCT04252456|Vitamins|vitamins|mesh-ancestor
15145376|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
14283549|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14283550|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
15145377|NCT04252456|Hematinics|hematinics|mesh-ancestor
14283551|NCT00499655|Celecoxib|celecoxib|mesh-list
14283552|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14283553|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283554|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283555|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283556|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283557|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14283558|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14283559|NCT00499655|Analgesics|analgesics|mesh-ancestor
14283560|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
14283561|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283562|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283563|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283564|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283565|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14283566|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14283567|NCT00499681|Letrozole|letrozole|mesh-list
14283568|NCT00499681|Lapatinib|lapatinib|mesh-list
14283569|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283570|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14283571|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14283572|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283573|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283574|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14283575|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
14283576|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14283577|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283578|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283579|NCT00499694|Bevacizumab|bevacizumab|mesh-list
14283580|NCT00499694|Satraplatin|satraplatin|mesh-list
14283581|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283582|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283583|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14283584|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14283585|NCT00499694|Growth Substances|growth substances|mesh-ancestor
14283586|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283587|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
14283588|NCT00499746|Tramadol|tramadol|mesh-list
14283589|NCT00499746|Hydromorphone|hydromorphone|mesh-list
14283590|NCT00499746|Methylphenidate|methylphenidate|mesh-list
14283591|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14283592|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283593|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14283594|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14283595|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283596|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283597|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
14283598|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283599|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14283600|NCT00499746|Narcotics|narcotics|mesh-ancestor
14283601|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283602|NCT00499746|Analgesics|analgesics|mesh-ancestor
14283603|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
14283604|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283605|NCT00499863|Methylphenidate|methylphenidate|mesh-list
14283606|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14283607|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283608|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14283609|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14283610|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283611|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283612|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
14283613|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283614|NCT00499889|Vidarabine|vidarabine|mesh-list
14283615|NCT00499889|Methotrexate|methotrexate|mesh-list
14283616|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
14283617|NCT00499889|Fludarabine|fludarabine|mesh-list
14283618|NCT00499889|Busulfan|busulfan|mesh-list
14283619|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
14283620|NCT00499889|Tacrolimus|tacrolimus|mesh-list
14283621|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
14283622|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14283623|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15145378|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
14283624|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
14283625|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14283626|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283627|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283628|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
14283629|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283630|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283631|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
14283632|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283633|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14283634|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283635|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
14283636|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283637|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14283638|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
14283639|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283640|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14283641|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
14283642|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283643|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283644|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283645|NCT00500110|Docetaxel|docetaxel|mesh-list
14283646|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
14283647|NCT00500110|Leuprolide|leuprolide|mesh-list
14283648|NCT00500110|Goserelin|goserelin|mesh-list
14283649|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283650|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283651|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283652|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283653|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283654|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14283655|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283656|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14283657|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
14283658|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14283659|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283660|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14283661|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14283662|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14283663|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283664|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14283665|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14283666|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283667|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283668|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
14283669|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283670|NCT00500240|Insulin|insulin|mesh-list
14283671|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14283672|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
14283673|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
14283674|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14283675|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292857|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14292858|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292859|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292860|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
14292861|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
14292862|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292863|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292864|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14292865|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292866|NCT00563797|Mecamylamine|mecamylamine|mesh-list
14292867|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14292868|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14292869|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
14292870|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292871|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292872|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14292873|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14292874|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
14292875|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292876|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292877|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
14292878|NCT00564018|Protamines|protamines|mesh-list
14292879|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14283676|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14283677|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
14283678|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283679|NCT00500292|Leucovorin|leucovorin|mesh-list
14283680|NCT00500292|Folic Acid|folic acid|mesh-list
14283681|NCT00500292|Fluorouracil|fluorouracil|mesh-list
14283682|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
14283683|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
14283684|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
14283685|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283686|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283687|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283688|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283689|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
14283690|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283691|NCT00500292|Antidotes|antidotes|mesh-ancestor
14283692|NCT00500292|Protective Agents|protective agents|mesh-ancestor
14283693|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
15145379|NCT04252443|Analgesics|analgesics|mesh-list
15145380|NCT04252443|Narcotics|narcotics|mesh-ancestor
15145381|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145382|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145383|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
14283694|NCT00500292|Vitamins|vitamins|mesh-ancestor
14283695|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
14283696|NCT00500292|Hematinics|hematinics|mesh-ancestor
14283697|NCT00500318|Bromides|bromides|mesh-list
14283698|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
14283699|NCT00500331|Pioglitazone|pioglitazone|mesh-list
14283700|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14283701|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283702|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14283703|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
14283704|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283705|NCT00500370|Exenatide|exenatide|mesh-list
14283706|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14283707|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283708|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14283709|NCT00500370|Incretins|incretins|mesh-ancestor
14283710|NCT00500370|Hormones|hormones|mesh-ancestor
14283711|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14283712|NCT00500539|Omalizumab|omalizumab|mesh-list
14283713|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14283714|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14283715|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
14283716|NCT00500578|Ribavirin|ribavirin|mesh-list
14283717|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
14283718|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283719|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
14283720|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283721|NCT00500656|Icatibant|icatibant|mesh-list
14283722|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
14283723|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14283724|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15145384|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179667|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179668|NCT03947827|Minocycline|minocycline|mesh-list
15179669|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14283725|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283726|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
14283727|NCT00500656|Coagulants|coagulants|mesh-ancestor
14283728|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14283729|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14283730|NCT00500656|Analgesics|analgesics|mesh-ancestor
14283731|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
14283732|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283733|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283734|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283735|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283736|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14283737|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14283738|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14283739|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283740|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
14283741|NCT00500760|Panitumumab|panitumumab|mesh-list
14283742|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283743|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283744|NCT00501059|Aspirin|aspirin|mesh-list
15145385|NCT04252248|Decitabine|decitabine|mesh-list
15145386|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15145387|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
14283745|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14283746|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14283747|NCT00501059|Analgesics|analgesics|mesh-ancestor
14283748|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
14283749|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145388|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145389|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145390|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145391|NCT04252274|Darunavir|darunavir|mesh-list
15145392|NCT04252274|Cobicistat|cobicistat|mesh-list
15145393|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15145394|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15145395|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
15145396|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283750|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283751|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283752|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283753|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14283754|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14283755|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283756|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14283757|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14283758|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283759|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
14283760|NCT00501293|Methylphenidate|methylphenidate|mesh-list
14283761|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14283762|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283763|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14283764|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14283765|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283766|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283767|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
14283768|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283769|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
14283770|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
15145397|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145398|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15145399|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15145400|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
15145401|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145402|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15145403|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15145404|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15145405|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15145406|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15145407|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
15145408|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145409|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15145410|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15145411|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145412|NCT04252261|Sulforaphane|sulforaphane|mesh-list
15145413|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15145414|NCT04252261|Protective Agents|protective agents|mesh-ancestor
15145415|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145416|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145417|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15145418|NCT04252521|Ketoprofen|ketoprofen|mesh-list
15145419|NCT04252521|Metoclopramide|metoclopramide|mesh-list
15145420|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
15145421|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
15145422|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145423|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145424|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145425|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15145426|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15145427|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
15145428|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145429|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145430|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14283771|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14283772|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283773|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283774|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
14283775|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14283776|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14283777|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283778|NCT00501631|Naltrexone|naltrexone|mesh-list
14283779|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14283780|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14283781|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283782|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
14283783|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283784|NCT00501644|Interferons|interferons|mesh-list
14283785|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
14283786|NCT00501644|Carboplatin|carboplatin|mesh-list
14283787|NCT00501644|Molgramostim|molgramostim|mesh-list
14283788|NCT00501644|Sargramostim|sargramostim|mesh-list
14283789|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283790|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
14283791|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283792|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
14283793|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020469|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
14020470|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020471|NCT02779582|Progesterone|progesterone|mesh-list
14020472|NCT02779582|Progestins|progestins|mesh-ancestor
14020473|NCT02779582|Hormones|hormones|mesh-ancestor
14020474|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020475|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020476|NCT02779387|Goserelin|goserelin|mesh-list
14020477|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14020478|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020479|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
14283794|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
14283795|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
14283796|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14283797|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
14283798|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283799|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283800|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14283801|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
14283802|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
14283803|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14283804|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
14283805|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145431|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15145432|NCT04252521|Analgesics|analgesics|mesh-ancestor
15145433|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
15145434|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15145435|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145436|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15145437|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283806|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283807|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14283808|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14283809|NCT00501891|Bevacizumab|bevacizumab|mesh-list
14283810|NCT00501891|Temozolomide|temozolomide|mesh-list
14283811|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283812|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283813|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14283814|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14283815|NCT00501891|Growth Substances|growth substances|mesh-ancestor
14283816|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283817|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
14283818|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283819|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
14283820|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145438|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
15145439|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15145440|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145441|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145442|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020480|NCT02779283|Leucovorin|leucovorin|mesh-list
14283821|NCT00501943|Interferons|interferons|mesh-list
14020481|NCT02779283|Folic Acid|folic acid|mesh-list
15145443|NCT04251910|Analgesics|analgesics|mesh-ancestor
15145444|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
15145445|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283822|NCT00501943|Interferon-beta|interferon-beta|mesh-list
14283823|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
14283824|NCT00501943|Riluzole|riluzole|mesh-list
15145446|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15145447|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15145448|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15145449|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
14283825|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283826|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
15145450|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145451|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145452|NCT04251962|Fentanyl|fentanyl|mesh-list
15145453|NCT04251962|Bupivacaine|bupivacaine|mesh-list
15145454|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145455|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
15145456|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145457|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145458|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
15145459|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145460|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15145461|NCT04251962|Narcotics|narcotics|mesh-ancestor
15145462|NCT04251962|Analgesics|analgesics|mesh-ancestor
15145463|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15145464|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14283827|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283828|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
14283829|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283830|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14283831|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
14283832|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14283833|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14283834|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283835|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283836|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15145465|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
15145466|NCT04251871|Interferons|interferons|mesh-list
15145467|NCT04251871|Ritonavir|ritonavir|mesh-list
15145468|NCT04251871|Lopinavir|lopinavir|mesh-list
15145469|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
15145470|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
15145471|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145472|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
15145473|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283837|NCT00501943|Protective Agents|protective agents|mesh-ancestor
14283838|NCT00501969|Rotigotine|rotigotine|mesh-list
14283839|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
14283840|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
14283841|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283842|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283843|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283844|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
14283845|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283846|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
14283847|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283848|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283849|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283850|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
14283851|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283852|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283853|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15145474|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15145475|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15145476|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
15145477|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145478|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145479|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15145480|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14283854|NCT00502203|Paclitaxel|paclitaxel|mesh-list
14283855|NCT00502203|Carboplatin|carboplatin|mesh-list
14283856|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14283857|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145481|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15145482|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14283858|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
14283859|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
14283860|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
14283861|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283862|NCT00502216|Naltrexone|naltrexone|mesh-list
14283863|NCT00502216|Varenicline|varenicline|mesh-list
14283864|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14283865|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14283866|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283867|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
14283868|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283869|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14283870|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14283871|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
14283872|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283873|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283874|NCT00502242|Ramipril|ramipril|mesh-list
14283875|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14283876|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
14283877|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283878|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283879|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14283880|NCT00502671|Capecitabine|capecitabine|mesh-list
14283881|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283882|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
14283883|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283884|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283885|NCT00502775|Fluticasone|fluticasone|mesh-list
14283886|NCT00502775|Xhance|xhance|mesh-list
14283887|NCT00502775|Fexofenadine|fexofenadine|mesh-list
14283888|NCT00502775|Terfenadine|terfenadine|mesh-list
14283889|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283890|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14283891|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
14283892|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283893|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283894|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14283895|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14283896|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
14283897|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14283898|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14283899|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15145483|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
15145484|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145485|NCT04251819|Baclofen|baclofen|mesh-list
15145486|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15145487|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145488|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14283900|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
14283901|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
14283902|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14283903|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283904|NCT00502801|Doripenem|doripenem|mesh-list
14283905|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14283906|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283907|NCT00502840|Rituximab|rituximab|mesh-list
14283908|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283909|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283910|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
14283911|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283912|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283913|NCT00502853|Rituximab|rituximab|mesh-list
14283914|NCT00502853|Methotrexate|methotrexate|mesh-list
14283915|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145489|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145490|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15145491|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
15145492|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
15145493|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145494|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145495|NCT04251741|Adalimumab|adalimumab|mesh-list
15145496|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15145497|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283916|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283917|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
15145498|NCT04251845|Melatonin|melatonin|mesh-list
14283918|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283919|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283920|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14283921|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
14283922|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14283923|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283924|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
14283925|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283926|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
14283927|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283928|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14283929|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283930|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14283931|NCT00502905|Vidarabine|vidarabine|mesh-list
14283932|NCT00502905|Fludarabine|fludarabine|mesh-list
14283933|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
14283934|NCT00502905|Busulfan|busulfan|mesh-list
14283935|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283936|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283937|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
14283938|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283939|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283940|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
14283941|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283942|NCT00502905|Antiviral Agents|antiviral agents|mesh-ancestor
14283943|NCT00502905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14283944|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
14283945|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14283946|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14283947|NCT00502996|Rituximab|rituximab|mesh-list
14283948|NCT00502996|Methotrexate|methotrexate|mesh-list
14283949|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283950|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283951|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
14283952|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283953|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283954|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14283955|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
14283956|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14283957|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14283958|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
14283959|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283960|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
14283961|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14283962|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14283963|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283964|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14283965|NCT00503113|Alendronate|alendronate|mesh-list
14283966|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
14283967|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14283968|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283969|NCT00503139|Etanercept|etanercept|mesh-list
14283970|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14283971|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14283972|NCT00503139|Analgesics|analgesics|mesh-ancestor
14283973|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
14283974|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14283975|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283976|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14283977|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283978|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14283979|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14283980|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
14283981|NCT00503399|Teriparatide|teriparatide|mesh-list
14283982|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
14283983|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14283984|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283985|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14283986|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14283987|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14283988|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14283989|NCT00503425|Rituximab|rituximab|mesh-list
14283990|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145499|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
14283991|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283992|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
14283993|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14283994|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14283995|NCT00503685|Cetuximab|cetuximab|mesh-list
14283996|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14283997|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14283998|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14283999|NCT00503750|Vinorelbine|vinorelbine|mesh-list
14284000|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284001|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284002|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284003|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284004|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284005|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284006|NCT00503776|Amifostine|amifostine|mesh-list
14284007|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14284008|NCT00503776|Protective Agents|protective agents|mesh-ancestor
14284009|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145500|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145501|NCT04251845|Protective Agents|protective agents|mesh-ancestor
15145502|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145503|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145504|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
15145505|NCT04251832|Antidotes|antidotes|mesh-ancestor
14284010|NCT00503906|Gemcitabine|gemcitabine|mesh-list
14284011|NCT00503906|Paclitaxel|paclitaxel|mesh-list
14284012|NCT00503906|Bevacizumab|bevacizumab|mesh-list
14284013|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14284014|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284015|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284016|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284017|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284018|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284019|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284020|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284021|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14284022|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14284023|NCT00503906|Growth Substances|growth substances|mesh-ancestor
14284024|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284025|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
14284026|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284027|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
14284028|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
14284029|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284030|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284031|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284032|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
14284033|NCT00503984|Prednisone|prednisone|mesh-list
14284034|NCT00503984|Docetaxel|docetaxel|mesh-list
14284035|NCT00503984|Azacitidine|azacitidine|mesh-list
14284036|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284037|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284038|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284039|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284040|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284041|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284042|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
14284043|NCT00503984|Hormones|hormones|mesh-ancestor
14284044|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284045|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284046|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14284047|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284048|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
14284049|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284050|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
14284051|NCT00503997|Pemetrexed|pemetrexed|mesh-list
14284052|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284053|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284054|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284055|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14020482|NCT02779283|Cytarabine|cytarabine|mesh-list
14284056|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14284057|NCT00504023|Imiquimod|imiquimod|mesh-list
14284058|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14284059|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
14284060|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284061|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284062|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
14284063|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
14284064|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14284065|NCT00504075|Antibodies|antibodies|mesh-list
14284066|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
14284067|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14284068|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
14284069|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284070|NCT00504153|Dasatinib|dasatinib|mesh-list
14284071|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284072|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284073|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284074|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284075|NCT00504166|Alendronate|alendronate|mesh-list
14284076|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14284077|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284078|NCT00504257|Bevacizumab|bevacizumab|mesh-list
14284079|NCT00504257|Docetaxel|docetaxel|mesh-list
14284080|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284081|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284082|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14284083|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14284084|NCT00504257|Growth Substances|growth substances|mesh-ancestor
14284085|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284086|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
14284087|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284088|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284089|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284090|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284091|NCT00504348|Tacrolimus|tacrolimus|mesh-list
14284092|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284093|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
14284094|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284095|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14284096|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284097|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284098|NCT00504504|Rituximab|rituximab|mesh-list
14284099|NCT00504504|Doxorubicin|doxorubicin|mesh-list
14284100|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14284101|NCT00504504|Dacarbazine|dacarbazine|mesh-list
14284102|NCT00504504|Bleomycin|bleomycin|mesh-list
14284103|NCT00504504|Vinblastine|vinblastine|mesh-list
14284104|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284105|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284106|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
14284107|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284108|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284109|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14284110|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14284111|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14284112|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284113|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284114|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284115|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
14284116|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284117|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284118|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284119|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284120|NCT00504556|Warfarin|warfarin|mesh-list
14284121|NCT00504556|Edoxaban|edoxaban|mesh-list
15145506|NCT04251832|Protective Agents|protective agents|mesh-ancestor
15145507|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145508|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
14284122|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
14284123|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14284124|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
14284125|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14284126|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
14284127|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284128|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284132|NCT00504660|Celecoxib|celecoxib|mesh-list
15145509|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145510|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
15145511|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14284133|NCT00504660|Capecitabine|capecitabine|mesh-list
14284134|NCT00504660|Thioguanine|thioguanine|mesh-list
14284135|NCT00504660|Temozolomide|temozolomide|mesh-list
14284136|NCT00504660|Lomustine|lomustine|mesh-list
14284137|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284138|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
14284139|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284140|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284141|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284142|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
14284143|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14284144|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14284145|NCT00504660|Analgesics|analgesics|mesh-ancestor
14284146|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
14284147|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284148|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284149|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284150|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284151|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14284152|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14284153|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284154|NCT00504725|Ketamine|ketamine|mesh-list
14284155|NCT00504725|Analgesics|analgesics|mesh-ancestor
14284156|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
14284157|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284158|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284159|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14562532|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562533|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562534|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562535|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562536|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14562537|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
14562538|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14562539|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562540|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
14562541|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
14562542|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14562543|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14562544|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562545|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
14562546|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562547|NCT00002865|Antidotes|antidotes|mesh-ancestor
14562548|NCT00002865|Protective Agents|protective agents|mesh-ancestor
14562549|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
14562550|NCT00002865|Vitamins|vitamins|mesh-ancestor
14562551|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
14562552|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562553|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562554|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562555|NCT00002865|Trace Elements|trace elements|mesh-ancestor
14562556|NCT00002866|Docetaxel|docetaxel|mesh-list
14562557|NCT00002866|Epirubicin|epirubicin|mesh-list
14562558|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562559|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562560|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562561|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562562|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562563|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562564|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562565|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562566|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562567|NCT00002868|Interferons|interferons|mesh-list
14562568|NCT00002868|Cytarabine|cytarabine|mesh-list
14562569|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
14562570|NCT00002868|Etoposide|etoposide|mesh-list
14562571|NCT00002868|Idarubicin|idarubicin|mesh-list
14562572|NCT00002868|Busulfan|busulfan|mesh-list
14562573|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
14562574|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562575|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562576|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562577|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562578|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284160|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14562579|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562580|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
14284161|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
14284162|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
14284163|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14284164|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14284165|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14284166|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284167|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284168|NCT00504751|Dexamethasone|dexamethasone|mesh-list
14284169|NCT00504751|Rituximab|rituximab|mesh-list
14284170|NCT00504751|Etoposide|etoposide|mesh-list
14284171|NCT00504751|Bortezomib|bortezomib|mesh-list
14284172|NCT00504751|Ifosfamide|ifosfamide|mesh-list
14284173|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145512|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145513|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
15145514|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
15145515|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
14284174|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284175|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
14284176|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
14284177|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284178|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284179|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14284180|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
14284181|NCT00504751|Hormones|hormones|mesh-ancestor
14284182|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284183|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14284184|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284185|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
14284186|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284187|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284188|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14284189|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14284190|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284191|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284192|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284193|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
14284194|NCT00504777|Rituximab|rituximab|mesh-list
14284195|NCT00504777|Methotrexate|methotrexate|mesh-list
14284196|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284197|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284198|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
14284199|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284200|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284201|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14284202|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
14284203|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14284204|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284205|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
14284206|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284207|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14284208|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284209|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14284210|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284211|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14284212|NCT00504829|Atorvastatin|atorvastatin|mesh-list
14284213|NCT00504829|Fenofibrate|fenofibrate|mesh-list
14284214|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14284215|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14284216|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
14284217|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284218|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14284219|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14284220|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284221|NCT00504881|Brivaracetam|brivaracetam|mesh-list
14284222|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
14284223|NCT00504894|Thiopental|thiopental|mesh-list
14284224|NCT00504894|Propofol|propofol|mesh-list
14284225|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14284226|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14284227|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284228|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14284229|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
14284230|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
14284231|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
15182307|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
14020483|NCT02779283|Dexamethasone|dexamethasone|mesh-list
14020484|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
14284232|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
14284233|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
14284234|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284235|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284236|NCT00505375|Abatacept|abatacept|mesh-list
14284237|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14284238|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284239|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284240|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284241|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
14284242|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284243|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284244|NCT00505414|Morphine|morphine|mesh-list
14284245|NCT00505414|Tapentadol|tapentadol|mesh-list
14284246|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14284247|NCT00505414|Narcotics|narcotics|mesh-ancestor
14284248|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14284249|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284250|NCT00505414|Analgesics|analgesics|mesh-ancestor
14284251|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
14284252|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284253|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14284254|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14284255|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14284256|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284257|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
14284258|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284259|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
14284260|NCT00505635|Interferons|interferons|mesh-list
14284261|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
14284262|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
14020485|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14020486|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14020487|NCT02779283|Prednisolone|prednisolone|mesh-list
14020488|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
14020489|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
14284263|NCT00505635|Thalidomide|thalidomide|mesh-list
14284264|NCT00505635|Cisplatin|cisplatin|mesh-list
14284265|NCT00505635|Temozolomide|temozolomide|mesh-list
14284266|NCT00505635|Interleukin-2|interleukin-2|mesh-list
14284267|NCT00505635|Vinblastine|vinblastine|mesh-list
14284268|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284269|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
14284270|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284271|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284272|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
14284273|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284274|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
14284275|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284276|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14284277|NCT00505635|Analgesics|analgesics|mesh-ancestor
14284278|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
14284279|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284280|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284281|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
14284282|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14284283|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14284284|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14284285|NCT00505635|Growth Substances|growth substances|mesh-ancestor
14284286|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
14284287|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284288|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284289|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284290|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284291|NCT00505661|Letrozole|letrozole|mesh-list
14284292|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284293|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14284294|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14284295|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284296|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284297|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14020490|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
14284298|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
14284299|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020491|NCT02779283|Rituximab|rituximab|mesh-list
14284300|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284301|NCT00505687|Rotigotine|rotigotine|mesh-list
14284302|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
14284303|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
14284304|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284305|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284306|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284307|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14284308|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14284309|NCT00505752|Hormones|hormones|mesh-ancestor
14284310|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284311|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284312|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14284313|NCT00505778|Mesalamine|mesalamine|mesh-list
14284314|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14284315|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14284316|NCT00505778|Analgesics|analgesics|mesh-ancestor
14284317|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
14284318|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284319|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284320|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284321|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284322|NCT00505895|Vidarabine|vidarabine|mesh-list
14284323|NCT00505895|Rituximab|rituximab|mesh-list
14284324|NCT00505895|Fludarabine|fludarabine|mesh-list
14284325|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
14284326|NCT00505895|Melphalan|melphalan|mesh-list
14284327|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284328|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284329|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
14284330|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284331|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284332|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284333|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
14284334|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284335|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284336|NCT00505895|Antiviral Agents|antiviral agents|mesh-ancestor
14284337|NCT00505895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284338|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284339|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
14284340|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284341|NCT00505921|Cytarabine|cytarabine|mesh-list
14284342|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
14284343|NCT00505921|Melphalan|melphalan|mesh-list
14284344|NCT00505921|Carmustine|carmustine|mesh-list
14284345|NCT00505921|Fludarabine|fludarabine|mesh-list
14284346|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
15145516|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15145517|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15145518|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145519|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
15145520|NCT04251247|Coagulants|coagulants|mesh-ancestor
15145521|NCT04251169|Paclitaxel|paclitaxel|mesh-list
15145522|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
15145523|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15145524|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145525|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284347|NCT00505921|Etoposide|etoposide|mesh-list
14284348|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
14284349|NCT00505921|Molgramostim|molgramostim|mesh-list
14284350|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
14284351|NCT00505921|Sargramostim|sargramostim|mesh-list
14284352|NCT00505921|Lenograstim|lenograstim|mesh-list
14284353|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284354|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
14284355|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284356|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284357|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284358|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
15145526|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145527|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284359|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284360|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284361|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284362|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284363|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
15145528|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284364|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
14284365|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284366|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284367|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14284368|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14284369|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284370|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14284371|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284372|NCT00505934|Levetiracetam|levetiracetam|mesh-list
14284373|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
14284374|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
14284375|NCT00506129|Vidarabine|vidarabine|mesh-list
14284376|NCT00506129|Fludarabine|fludarabine|mesh-list
14284377|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
14284378|NCT00506129|Melphalan|melphalan|mesh-list
14284379|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
14284380|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14284381|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284382|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284383|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
14284384|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284385|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284386|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
14284387|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284388|NCT00506129|Antiviral Agents|antiviral agents|mesh-ancestor
14284389|NCT00506129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284390|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284391|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
14284392|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284393|NCT00506142|Vincristine|vincristine|mesh-list
14284394|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284395|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284396|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284397|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284398|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284399|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284400|NCT00506155|Bevacizumab|bevacizumab|mesh-list
14284401|NCT00506155|Cisplatin|cisplatin|mesh-list
14284402|NCT00506155|Doxorubicin|doxorubicin|mesh-list
14284403|NCT00506155|Methotrexate|methotrexate|mesh-list
14284404|NCT00506155|Vinblastine|vinblastine|mesh-list
14284405|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284406|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284407|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14284408|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14284409|NCT00506155|Growth Substances|growth substances|mesh-ancestor
14284410|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284411|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
14284412|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14284413|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14284414|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14284415|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284416|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284417|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14284418|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
14284419|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14284420|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284421|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
14284422|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
14284423|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14284424|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284425|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
14284426|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284427|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14284428|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15145529|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145530|NCT04251364|Acetazolamide|acetazolamide|mesh-list
15145531|NCT04251364|Atorvastatin|atorvastatin|mesh-list
15145532|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15145533|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15145534|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
15145535|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284429|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284430|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284431|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284432|NCT00506285|Methylphenidate|methylphenidate|mesh-list
15145536|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15145537|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15145538|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145539|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
15145540|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15145541|NCT04251364|Diuretics|diuretics|mesh-ancestor
14020492|NCT02779283|Doxorubicin|doxorubicin|mesh-list
14020493|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14020494|NCT02779283|Methotrexate|methotrexate|mesh-list
14020495|NCT02779283|Vincristine|vincristine|mesh-list
14020496|NCT02779283|Sorafenib|sorafenib|mesh-list
15145542|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
15145543|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145544|NCT04250948|Capecitabine|capecitabine|mesh-list
15145545|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
14020497|NCT02779283|Sunitinib|sunitinib|mesh-list
14020498|NCT02779283|Dasatinib|dasatinib|mesh-list
14020499|NCT02779283|Idarubicin|idarubicin|mesh-list
14020500|NCT02779283|Ponatinib|ponatinib|mesh-list
14020501|NCT02779283|Idelalisib|idelalisib|mesh-list
14284433|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14284434|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284435|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14284436|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14284437|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14284438|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284439|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
14284440|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284441|NCT00506350|Vaccines|vaccines|mesh-list
14284442|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
14284443|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284444|NCT00506389|Mirtazapine|mirtazapine|mesh-list
14284445|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
14284446|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14284447|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14284448|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
14284449|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
14284450|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284451|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284452|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284453|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14284454|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14284455|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14284456|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14284457|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14284458|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14284459|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
14284460|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14284461|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14284462|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
14284463|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14284464|NCT00506415|Rivastigmine|rivastigmine|mesh-list
15145546|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15145547|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
14020502|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14020503|NCT02779283|Antibodies|antibodies|mesh-list
14020504|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
14020505|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14020506|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14020507|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
14020508|NCT02779283|BB 1101|bb 1101|mesh-list
14020509|NCT02779283|Calcium|calcium|mesh-list
14020510|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
14020511|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020512|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
14020513|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020514|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020515|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14020516|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
14020517|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284465|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14284466|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020518|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020519|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14020520|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020521|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
14020522|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
14284467|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284468|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
14284469|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284470|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284471|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14284472|NCT00506415|Protective Agents|protective agents|mesh-ancestor
14292880|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292881|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
14292882|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292883|NCT00564018|Coagulants|coagulants|mesh-ancestor
14292884|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
14292885|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292886|NCT00564395|Insulin|insulin|mesh-list
14020523|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020524|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020525|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
14020526|NCT02779283|Hormones|hormones|mesh-ancestor
14020527|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020528|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292887|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14292888|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
15145548|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145549|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145550|NCT05253508|Lidocaine|lidocaine|mesh-list
15145551|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145552|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
15145553|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145554|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145555|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
15145556|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145557|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14292889|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14292890|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292891|NCT00564447|Azithromycin|azithromycin|mesh-list
14292892|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
14292893|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14292894|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292895|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14292896|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14292897|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292898|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292899|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292900|NCT00564486|Acetaminophen|acetaminophen|mesh-list
14292901|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14292902|NCT00564486|Analgesics|analgesics|mesh-ancestor
14292903|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
14292904|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292905|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292906|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
14292907|NCT00564629|Acetaminophen|acetaminophen|mesh-list
14562581|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562582|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562583|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
14562584|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562585|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
14562586|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562587|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
14562588|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562589|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562590|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562591|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
14562592|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14562593|NCT00002869|Interferons|interferons|mesh-list
14562594|NCT00002869|Cytarabine|cytarabine|mesh-list
14562595|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
14562596|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
14562597|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562598|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
14562599|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562600|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562601|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
14562602|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562603|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020529|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14284473|NCT00506519|Antithrombins|antithrombins|mesh-list
14284474|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
14284475|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14284476|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
14284477|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284478|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284479|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
14284480|NCT00506597|Asparaginase|asparaginase|mesh-list
15145558|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15145559|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15145560|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145561|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145562|NCT05253417|Cannabidiol|cannabidiol|mesh-list
14284481|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284482|NCT00506662|Insulin|insulin|mesh-list
15145563|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
15145564|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
15145565|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15145566|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15145567|NCT05253118|Pemetrexed|pemetrexed|mesh-list
15145568|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145569|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145570|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145571|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15145572|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15145573|NCT05253066|Docetaxel|docetaxel|mesh-list
15145574|NCT05253066|Epirubicin|epirubicin|mesh-list
15145575|NCT05253066|Exemestane|exemestane|mesh-list
15145576|NCT05253066|Goserelin|goserelin|mesh-list
15145577|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284483|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14284484|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
14284485|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
14284486|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
14284487|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
14284488|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14284489|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284490|NCT00506675|Atropine|atropine|mesh-list
14284491|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14284492|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14284493|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14284494|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
14284495|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284496|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284497|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14284498|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
14284499|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
14284500|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
14284501|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14284502|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14284503|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
14284504|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284505|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284506|NCT00506779|Paclitaxel|paclitaxel|mesh-list
14284507|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
14284508|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284509|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284510|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284511|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145578|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
15145579|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145580|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
15145581|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284512|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284513|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284514|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284515|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284516|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
14284517|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284518|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284519|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284520|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284521|NCT00506857|Vidarabine|vidarabine|mesh-list
14284522|NCT00506857|Fludarabine|fludarabine|mesh-list
14284523|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
15145582|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15145583|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14284524|NCT00506857|Busulfan|busulfan|mesh-list
14284525|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284526|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284527|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
14284528|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284529|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284530|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
14284531|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284532|NCT00506857|Antiviral Agents|antiviral agents|mesh-ancestor
14284533|NCT00506857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284534|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
14284535|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284536|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284537|NCT00506883|Colchicine|colchicine|mesh-list
14284538|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
14284539|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284540|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284541|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284542|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284543|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284544|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284545|NCT00506922|Methotrexate|methotrexate|mesh-list
14284546|NCT00506922|Pentostatin|pentostatin|mesh-list
14284547|NCT00506922|Tacrolimus|tacrolimus|mesh-list
14284548|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14284549|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
14284550|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14284551|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284552|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284553|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
14284554|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284555|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284556|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
14284557|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284558|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14284559|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284560|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
14284561|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284562|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14284563|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14284564|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
15145584|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15145585|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145586|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15145587|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14284565|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
14284566|NCT00506948|Sirolimus|sirolimus|mesh-list
14284567|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
14284568|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14284569|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14284570|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284571|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14284572|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
14284573|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14284574|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284575|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284576|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284577|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
14284578|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284579|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
14284580|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284581|NCT00507026|Diclofenac|diclofenac|mesh-list
14284582|NCT00507026|Ketorolac|ketorolac|mesh-list
14284583|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14284584|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14284585|NCT00507026|Analgesics|analgesics|mesh-ancestor
14284586|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
14284587|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284588|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284589|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284590|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284591|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14284592|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284593|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284594|NCT00507416|Thalidomide|thalidomide|mesh-list
14284595|NCT00507416|Dexamethasone|dexamethasone|mesh-list
14284596|NCT00507416|Prednisone|prednisone|mesh-list
14284597|NCT00507416|Bortezomib|bortezomib|mesh-list
14284598|NCT00507416|Melphalan|melphalan|mesh-list
14284599|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284600|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
14284601|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
14284602|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284603|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284604|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14284605|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
14284606|NCT00507416|Hormones|hormones|mesh-ancestor
14284607|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284608|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14284609|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284610|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284611|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
14284612|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284613|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284614|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284615|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
14284616|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
14284617|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15145588|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15145589|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
15145590|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145591|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145592|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15145593|NCT05253053|Paclitaxel|paclitaxel|mesh-list
15145594|NCT05253053|Atezolizumab|atezolizumab|mesh-list
15145595|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15145596|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145597|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
15145598|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145599|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284618|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284619|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14284620|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14284621|NCT00507416|Growth Substances|growth substances|mesh-ancestor
14284622|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
14284623|NCT00507429|Paclitaxel|paclitaxel|mesh-list
14284624|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
14284625|NCT00507429|Combretastatin|combretastatin|mesh-list
14284626|NCT00507429|Carboplatin|carboplatin|mesh-list
14284627|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284628|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284629|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284630|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284631|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284632|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284633|NCT00507442|Dexamethasone|dexamethasone|mesh-list
14284634|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
14284635|NCT00507442|Lenalidomide|lenalidomide|mesh-list
14284636|NCT00507442|Bortezomib|bortezomib|mesh-list
14284637|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284638|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
14284639|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284640|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284641|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284642|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
14284643|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284644|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284645|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284646|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284647|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
14284648|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
14284649|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145600|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179670|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179671|NCT03947775|Vaccines|vaccines|mesh-list
15179672|NCT03947775|Immunologic Factors|immunologic factors|mesh-ancestor
15179673|NCT03947775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179674|NCT03948178|Simendan|simendan|mesh-list
15179675|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14284650|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14284651|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
15145601|NCT05253014|Acetaminophen|acetaminophen|mesh-list
15145602|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15145603|NCT05253014|Analgesics|analgesics|mesh-ancestor
15145604|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
15145605|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145606|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145607|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
15145608|NCT05252845|Vaccines|vaccines|mesh-list
15145609|NCT05252845|Immunologic Factors|immunologic factors|mesh-ancestor
14284652|NCT00507442|Hormones|hormones|mesh-ancestor
14284653|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284654|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14284655|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14284656|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14284657|NCT00507442|Growth Substances|growth substances|mesh-ancestor
14284658|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
14284659|NCT00507455|Tamsulosin|tamsulosin|mesh-list
14284660|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
14284661|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15145610|NCT05252845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145611|NCT05252754|Indomethacin|indomethacin|mesh-list
15145612|NCT05252754|Tacrolimus|tacrolimus|mesh-list
15145613|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145614|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
15145615|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145616|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15145617|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145618|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284662|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14284663|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14284664|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
14284665|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284666|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284667|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284668|NCT00507455|Urological Agents|urological agents|mesh-ancestor
14284669|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14284670|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14284671|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
15145619|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15145620|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15145621|NCT05252754|Analgesics|analgesics|mesh-ancestor
15145622|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
15145623|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145624|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15145625|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145626|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
15145627|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
15145628|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15145629|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15145630|NCT05252715|Vaccines|vaccines|mesh-list
15145631|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
15145632|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145633|NCT05252598|Psilocybin|psilocybin|mesh-list
15145634|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
15145635|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284672|NCT00507507|Tenofovir|tenofovir|mesh-list
14284673|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
14284674|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284675|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14284676|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14284677|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284678|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284679|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14284680|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14284681|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
14284682|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14284683|NCT00507689|Antibodies|antibodies|mesh-list
14284684|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
14284685|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284686|NCT00507728|Bupropion|bupropion|mesh-list
14284687|NCT00507728|Varenicline|varenicline|mesh-list
14284688|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15145636|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15145637|NCT05252585|Everolimus|everolimus|mesh-list
15145638|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145639|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020530|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14020531|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14020532|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020533|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14020534|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14020535|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14284689|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
14284690|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14284691|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14284692|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14284693|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14284694|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284695|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
14284696|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284697|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284698|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14562604|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
14562605|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562606|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
14562607|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562608|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14562609|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
14562610|NCT00002870|Thiotepa|thiotepa|mesh-list
14562611|NCT00002870|Fluorouracil|fluorouracil|mesh-list
14562612|NCT00002870|Epirubicin|epirubicin|mesh-list
14562613|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562614|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
14562615|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562616|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562617|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562618|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
14562619|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562620|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562621|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562622|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
14562623|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562624|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562625|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562626|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562627|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562628|NCT00002872|Doxycycline|doxycycline|mesh-list
14562629|NCT00002872|Bleomycin|bleomycin|mesh-list
14562630|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15145640|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
15145641|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145642|NCT05252546|Loperamide|loperamide|mesh-list
15145643|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
15145644|NCT05252546|Bentonite|bentonite|mesh-list
15145645|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145646|NCT05252546|Antidotes|antidotes|mesh-ancestor
15145647|NCT05252546|Protective Agents|protective agents|mesh-ancestor
15145648|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145649|NCT05252429|Docetaxel|docetaxel|mesh-list
15145650|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
15145651|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145652|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562631|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562632|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
14562633|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14562634|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14562635|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562636|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562637|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
14562638|NCT00002875|Lomustine|lomustine|mesh-list
14562639|NCT00002875|Cisplatin|cisplatin|mesh-list
14562640|NCT00002875|Vincristine|vincristine|mesh-list
14562641|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562642|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
14562643|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145653|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145654|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
15145655|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145656|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020536|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
14562644|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145657|NCT05252416|Carboplatin|carboplatin|mesh-list
15145658|NCT05252416|Fulvestrant|fulvestrant|mesh-list
15145659|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145660|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15145661|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15145662|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15145663|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
15145664|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284699|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14284700|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284701|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14284702|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14284703|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
14284704|NCT00507767|Dasatinib|dasatinib|mesh-list
14284705|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284706|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284707|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284708|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284709|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
14284710|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
14284711|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14284712|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14284713|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284714|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284715|NCT00507819|Urological Agents|urological agents|mesh-ancestor
14284716|NCT00508027|Simvastatin|simvastatin|mesh-list
14284717|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14284718|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14284719|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
14284720|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284721|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14284722|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14284723|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284724|NCT00508118|Nicardipine|nicardipine|mesh-list
14284725|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14284726|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14284727|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14284728|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284729|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14284730|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284731|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
14284732|NCT00508144|Pemetrexed|pemetrexed|mesh-list
14284733|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284734|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284735|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284736|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14284737|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14284738|NCT00508157|Olanzapine|olanzapine|mesh-list
14284739|NCT00508157|Risperidone|risperidone|mesh-list
14284740|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14284741|NCT00508157|Aripiprazole|aripiprazole|mesh-list
14284742|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
15145665|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145666|NCT05252325|Lidocaine|lidocaine|mesh-list
15145667|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
15145668|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145669|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
15145670|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145671|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145672|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
15145673|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145674|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14284743|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14284744|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
14284745|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284746|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284747|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284748|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14284749|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14284750|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14284751|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14284752|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
14284753|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
14284754|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
15145675|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14284755|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284756|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145676|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15145677|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145678|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145679|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15145680|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
15145681|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
15145682|NCT05252325|Protective Agents|protective agents|mesh-ancestor
15145683|NCT05252117|Mepivacaine|mepivacaine|mesh-list
15145684|NCT05252117|Carticaine|carticaine|mesh-list
15145685|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145686|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
15145687|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145688|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145689|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
14284757|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14284758|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14284759|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14284760|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
14284761|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
14284762|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14284763|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14284764|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14284765|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14284766|NCT00508274|Capecitabine|capecitabine|mesh-list
14284767|NCT00508274|Lapatinib|lapatinib|mesh-list
14284768|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284769|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
14284770|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284771|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284772|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284773|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284774|NCT00508404|Panitumumab|panitumumab|mesh-list
14284775|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284776|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284777|NCT00508469|Timolol|timolol|mesh-list
14284778|NCT00508469|Travoprost|travoprost|mesh-list
14284779|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14284780|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14284781|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14284782|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14284783|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
14284784|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284785|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284786|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284787|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14284788|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14284789|NCT00508482|Lactulose|lactulose|mesh-list
14284790|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14284791|NCT00508742|Vaccines|vaccines|mesh-list
14284792|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14284793|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
14284794|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284795|NCT00508924|Heparin|heparin|mesh-list
14284796|NCT00508924|Argatroban|argatroban|mesh-list
14284797|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
14284798|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14284799|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14284800|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284801|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
14284802|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14284803|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
14284804|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145690|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145691|NCT05251766|Paclitaxel|paclitaxel|mesh-list
15145692|NCT05251766|Docetaxel|docetaxel|mesh-list
15145693|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15145694|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145695|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
15145696|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145697|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284805|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15145698|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145699|NCT05251662|Bevacizumab|bevacizumab|mesh-list
14284806|NCT00509002|Gefitinib|gefitinib|mesh-list
14284807|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284808|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284809|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284810|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284811|NCT00509028|Budesonide|budesonide|mesh-list
14284812|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284813|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14284814|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
14284815|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284816|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284817|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14284818|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
14284819|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
14284820|NCT00509028|Hormones|hormones|mesh-ancestor
14284821|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284822|NCT00509041|Dasatinib|dasatinib|mesh-list
14284823|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284824|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284825|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284826|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284827|NCT00509067|Olanzapine|olanzapine|mesh-list
14284828|NCT00509067|Risperidone|risperidone|mesh-list
14284829|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14284830|NCT00509067|Aripiprazole|aripiprazole|mesh-list
14284831|NCT00509067|Ziprasidone|ziprasidone|mesh-list
14284832|NCT00509067|Choline|choline|mesh-list
15145700|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145701|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145702|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15145703|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15145704|NCT05251662|Growth Substances|growth substances|mesh-ancestor
15145705|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145706|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
15145707|NCT05251636|Aflibercept|aflibercept|mesh-list
15145708|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15145709|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15145710|NCT05251636|Growth Substances|growth substances|mesh-ancestor
15145711|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145712|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
15145713|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145714|NCT05251610|Propranolol|propranolol|mesh-list
15145715|NCT05251610|Oxytocin|oxytocin|mesh-list
15145716|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
15145717|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14284833|NCT00509067|Galantamine|galantamine|mesh-list
14284834|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15145718|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145719|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15145720|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15145721|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
15145722|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145723|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145724|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15145725|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15145726|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
15145727|NCT05213507|Amikacin|amikacin|mesh-list
14020537|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14284835|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14284836|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
14284837|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14284838|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284839|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284840|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14284841|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14284842|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14284843|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14284844|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14284845|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
14284846|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
14284847|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
14284848|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284849|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14284850|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14284851|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15145728|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14284852|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14284853|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
14284854|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
14284855|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14284856|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14284857|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14284858|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14284859|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
14284860|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14284861|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
14284862|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14284863|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
14284864|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14284865|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145729|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145730|NCT05194293|Durvalumab|durvalumab|mesh-list
15145731|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
15145732|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15145733|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
15145734|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284866|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
14284867|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14284868|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
14284869|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284870|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14284871|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284872|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284873|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
14284874|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14284875|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15145735|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145736|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
14284876|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284877|NCT00509197|Fluticasone|fluticasone|mesh-list
14284878|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14284879|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14284880|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
14284881|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14284882|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284883|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14284884|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
14284885|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
14284886|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14284887|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14284888|NCT00509236|Glipizide|glipizide|mesh-list
14284889|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14284890|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284891|NCT00509236|Incretins|incretins|mesh-ancestor
14284892|NCT00509236|Hormones|hormones|mesh-ancestor
14284893|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284894|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14284895|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
14284896|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284897|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284898|NCT00509249|Aflibercept|aflibercept|mesh-list
14284899|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
14284900|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14284901|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14284902|NCT00509249|Growth Substances|growth substances|mesh-ancestor
14284903|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145737|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179676|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
15179677|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15179678|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15179679|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179680|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179681|NCT03948178|Protective Agents|protective agents|mesh-ancestor
15179682|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179683|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
15179684|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15179685|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15179686|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284904|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
14284905|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284906|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14284907|NCT00509262|Glipizide|glipizide|mesh-list
14284908|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14284909|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284910|NCT00509262|Incretins|incretins|mesh-ancestor
14284911|NCT00509262|Hormones|hormones|mesh-ancestor
14284912|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14284913|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14284914|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
14284915|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284916|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284917|NCT00509288|Aldesleukin|aldesleukin|mesh-list
14284918|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
14284919|NCT00509288|Fludarabine|fludarabine|mesh-list
14284920|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284921|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
14284922|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284923|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284924|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284925|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
14284926|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284927|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284928|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284929|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14284930|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14284931|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
14284932|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284933|NCT00509366|Gemcitabine|gemcitabine|mesh-list
14284934|NCT00509366|Cisplatin|cisplatin|mesh-list
14284935|NCT00509366|Docetaxel|docetaxel|mesh-list
14284936|NCT00509366|Pemetrexed|pemetrexed|mesh-list
14284937|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284938|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284939|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
14284940|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284941|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
14284942|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284943|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284944|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284945|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
14284946|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284947|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284948|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284949|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284950|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14284951|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14284952|NCT00509496|Aldesleukin|aldesleukin|mesh-list
14284953|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
14284954|NCT00509496|Fludarabine|fludarabine|mesh-list
14284955|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
14284956|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14284957|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
14284958|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284959|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14284960|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14284961|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
14284962|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284963|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284964|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14284965|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284966|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
14284967|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14284968|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14284969|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
14284970|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284971|NCT00509665|Gemcitabine|gemcitabine|mesh-list
14284972|NCT00509665|Doxorubicin|doxorubicin|mesh-list
14284973|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14284974|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14284975|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
14284976|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284977|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284978|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
14284979|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14284980|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14284981|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145738|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
14284982|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
14284983|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14284984|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14284985|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14284986|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14284987|NCT00509769|Trastuzumab|trastuzumab|mesh-list
14284988|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14284989|NCT00509769|Maytansine|maytansine|mesh-list
14284990|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14284991|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14284992|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14284993|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
14284994|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
14284995|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
14284996|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14284997|NCT00509795|Ranibizumab|ranibizumab|mesh-list
14284998|NCT00509795|Aflibercept|aflibercept|mesh-list
14284999|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285000|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285001|NCT00509795|Growth Substances|growth substances|mesh-ancestor
14285002|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285003|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285004|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285005|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
14285006|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14285007|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14285008|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14285009|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285010|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14285011|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285012|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285013|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285014|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285015|NCT00509925|Insulin|insulin|mesh-list
14285016|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14285017|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
14285018|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
14285019|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
14285020|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
14285021|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
14285022|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14285023|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285024|NCT00510068|Everolimus|everolimus|mesh-list
14285025|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285026|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285027|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
14285028|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285029|NCT00510146|Olanzapine|olanzapine|mesh-list
14285030|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
14285031|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
14285032|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285033|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285034|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285035|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14285036|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14285037|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285038|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14285039|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14285040|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14285041|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285042|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285043|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285044|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
14285045|NCT00510224|Octreotide|octreotide|mesh-list
14285046|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285047|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14285048|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285049|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14285050|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14285051|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14285052|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145739|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15145740|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285053|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285054|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
14285055|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285056|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285057|NCT00510289|Sorafenib|sorafenib|mesh-list
14285058|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285059|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14285060|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285061|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285062|NCT00510484|Pancrelipase|pancrelipase|mesh-list
15145741|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15145742|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145743|NCT04993352|Antibodies|antibodies|mesh-list
15145744|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14285063|NCT00510484|Pancreatin|pancreatin|mesh-list
14562645|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562646|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
14562647|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562648|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562649|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562650|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562651|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562652|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562653|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562654|NCT00002876|Etoposide|etoposide|mesh-list
14562655|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562656|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562657|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562658|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562659|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562660|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562661|NCT00002878|Dexamethasone|dexamethasone|mesh-list
14562662|NCT00002878|Doxorubicin|doxorubicin|mesh-list
14562663|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14562664|NCT00002878|Vincristine|vincristine|mesh-list
14562665|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562666|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
14562667|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
14562668|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562669|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562670|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14562671|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
14562672|NCT00002878|Hormones|hormones|mesh-ancestor
14562673|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562674|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562675|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562676|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562677|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562678|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562679|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562680|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562681|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562682|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562683|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562684|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562685|NCT00002879|Cladribine|cladribine|mesh-list
14562686|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562687|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562688|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
14562689|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562690|NCT00002880|Etoposide|etoposide|mesh-list
14562691|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
14562692|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562693|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562694|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562695|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15145745|NCT04993352|Mitogens|mitogens|mesh-list
15145746|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
15145747|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
15145748|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145749|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
15145750|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145751|NCT04993352|Growth Substances|growth substances|mesh-ancestor
14285064|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145752|NCT04982354|Fludarabine|fludarabine|mesh-list
15145753|NCT04982354|Melphalan|melphalan|mesh-list
14285065|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
15145754|NCT04982354|Busulfan|busulfan|mesh-list
15145755|NCT04982354|Midostaurin|midostaurin|mesh-list
15145756|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145757|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145758|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145759|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
15145760|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145761|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15145762|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
15145763|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15145764|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15145765|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145766|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
15145767|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15145768|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145769|NCT04962503|Afamelanotide|afamelanotide|mesh-list
15145770|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
15145771|NCT04938882|Lidocaine|lidocaine|mesh-list
15145772|NCT04938882|Ropivacaine|ropivacaine|mesh-list
15145773|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
14285066|NCT00510510|Bromides|bromides|mesh-list
14285067|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
14285068|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14285069|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14285070|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14285071|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
14285072|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285073|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285074|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285075|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
14285076|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285077|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14285078|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285079|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285080|NCT00510783|Phenytoin|phenytoin|mesh-list
14285081|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
14285082|NCT00510783|Levetiracetam|levetiracetam|mesh-list
14285083|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
14285084|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
14285085|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14285086|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14285087|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285088|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285089|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14285090|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14285091|NCT00510809|Ethanol|ethanol|mesh-list
14285092|NCT00510809|Policosanol|policosanol|mesh-list
14285093|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14285094|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14285095|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020538|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14020539|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
14020540|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14020541|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14020542|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14020543|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
14020544|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020545|NCT02779283|Antidotes|antidotes|mesh-ancestor
14020546|NCT02779283|Protective Agents|protective agents|mesh-ancestor
14020547|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
14020548|NCT02779283|Vitamins|vitamins|mesh-ancestor
14285096|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285097|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145774|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
15145775|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145776|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145777|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
15145778|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145779|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15145780|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15145781|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15145782|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145783|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145784|NCT04933903|Nivolumab|nivolumab|mesh-list
14020549|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
14285098|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14285099|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15145785|NCT04933903|Ipilimumab|ipilimumab|mesh-list
15145786|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145787|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145788|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15145789|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145790|NCT04911517|Capecitabine|capecitabine|mesh-list
15145791|NCT04911517|Antibodies|antibodies|mesh-list
15145792|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15145793|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
15145794|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145795|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15145796|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
14285100|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
14285101|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285102|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285103|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14285104|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14285105|NCT00510887|Dexamethasone|dexamethasone|mesh-list
14285106|NCT00510887|Rituximab|rituximab|mesh-list
14285107|NCT00510887|Fludarabine|fludarabine|mesh-list
14285108|NCT00510887|Bortezomib|bortezomib|mesh-list
14285109|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
14285110|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14285111|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
14285112|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
14285113|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285114|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285115|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285116|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
14285117|NCT00510887|Hormones|hormones|mesh-ancestor
14285118|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285119|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14285120|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285121|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285122|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
14285123|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285124|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285125|NCT00510887|Analgesics|analgesics|mesh-ancestor
14285126|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
14285127|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14285128|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285129|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285130|NCT00510952|Insulin|insulin|mesh-list
14285131|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14285132|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
14285133|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
14285134|NCT00510952|Protamines|protamines|mesh-list
14285135|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14285136|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285137|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
14285138|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285139|NCT00510952|Coagulants|coagulants|mesh-ancestor
14285140|NCT00511004|Albendazole|albendazole|mesh-list
14285141|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
15145797|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145798|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145799|NCT04865978|Warfarin|warfarin|mesh-list
15145800|NCT04865978|Apixaban|apixaban|mesh-list
15145801|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
15145802|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15145803|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
15145804|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15145805|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
15145806|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145807|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145808|NCT04816513|Ustekinumab|ustekinumab|mesh-list
15145809|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
15145810|NCT04804735|Anesthetics|anesthetics|mesh-list
15145811|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145812|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145813|NCT04740671|Ranibizumab|ranibizumab|mesh-list
14285142|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
14285143|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14285144|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145814|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15145815|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15145816|NCT04740671|Growth Substances|growth substances|mesh-ancestor
15145817|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145818|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
15145819|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145820|NCT04731844|Curcumin|curcumin|mesh-list
14285145|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
14285146|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14285147|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14285148|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285149|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285150|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285151|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285152|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285153|NCT00511004|Filaricides|filaricides|mesh-ancestor
15145821|NCT04731844|Piperine|piperine|mesh-list
15145822|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15145823|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15145824|NCT04731844|Analgesics|analgesics|mesh-ancestor
15145825|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
15145826|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285154|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
14285155|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14285156|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145827|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145828|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15145829|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145830|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145831|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285157|NCT00511108|Pioglitazone|pioglitazone|mesh-list
14285158|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14285159|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14285160|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285161|NCT00511108|Incretins|incretins|mesh-ancestor
14285162|NCT00511108|Hormones|hormones|mesh-ancestor
15145832|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145833|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15145834|NCT04674670|Naltrexone|naltrexone|mesh-list
15145835|NCT04674670|Bromocriptine|bromocriptine|mesh-list
15145836|NCT04674670|Amisulpride|amisulpride|mesh-list
15145837|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15145838|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15145839|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145840|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
15145841|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145842|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15145843|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15145844|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145845|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15145846|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15145847|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
14285163|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285164|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14285165|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
14285166|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285167|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285168|NCT00511134|Eszopiclone|eszopiclone|mesh-list
14285169|NCT00511134|Bupropion|bupropion|mesh-list
14285170|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14285171|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
14285172|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14285173|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14285174|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14285175|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285176|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285177|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
14285178|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285179|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285180|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14285181|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14285182|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145848|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145849|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179687|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15145850|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15145851|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
14285183|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14285184|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14292908|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14292909|NCT00564629|Analgesics|analgesics|mesh-ancestor
14292910|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
14292911|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292912|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292913|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
14292914|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
14292915|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14292916|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14292917|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15145852|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15145853|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15145854|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
15145855|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15145856|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
15145857|NCT04669132|Olanzapine|olanzapine|mesh-list
15145858|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
15145859|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
15145860|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145861|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145862|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292918|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292919|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292920|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
15145863|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15145864|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15145865|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145866|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15145867|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15145868|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15145869|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145870|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145871|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145872|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
15145873|NCT04648319|Nivolumab|nivolumab|mesh-list
15145874|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145875|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145876|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15145877|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145878|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
15145879|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
14292921|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292922|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292923|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14292924|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292925|NCT00564733|Gemcitabine|gemcitabine|mesh-list
14292926|NCT00564733|Paclitaxel|paclitaxel|mesh-list
14292927|NCT00564733|Docetaxel|docetaxel|mesh-list
14292928|NCT00564733|Carboplatin|carboplatin|mesh-list
14292929|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14292930|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14292931|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292932|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
14292933|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
14292934|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292935|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292936|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14292937|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
14292938|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
14292939|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14292940|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292941|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292942|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
14292943|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292944|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14292945|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14292946|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
14292947|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14292948|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
14562696|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285185|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
14285186|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14285187|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
14285188|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14285189|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
14285190|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285191|NCT00511173|Warfarin|warfarin|mesh-list
14285192|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
15145880|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15145881|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15145882|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145883|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
15145884|NCT04625530|Coagulants|coagulants|mesh-ancestor
15145885|NCT04625530|Hematinics|hematinics|mesh-ancestor
15145886|NCT04539873|Colchicine|colchicine|mesh-list
15145887|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
15145888|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145889|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
15145890|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
15145891|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
15145892|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145893|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145894|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15145895|NCT04538092|Analgesics|analgesics|mesh-list
15145896|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145897|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
15145898|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285193|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
14285194|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14285195|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285196|NCT00511706|Dexamethasone|dexamethasone|mesh-list
14285197|NCT00511706|Ranibizumab|ranibizumab|mesh-list
15145899|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145900|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15145901|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
15145902|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15145903|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
14285198|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14285199|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
14020550|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14020551|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
14020552|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
14020553|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
14020554|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14020555|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14020556|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14020557|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14020558|NCT02779283|Growth Substances|growth substances|mesh-ancestor
14020559|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
14020560|NCT02779283|Hematinics|hematinics|mesh-ancestor
14285200|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
14285201|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285202|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285203|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285204|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
14285205|NCT00511706|Hormones|hormones|mesh-ancestor
14285206|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285207|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15145904|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145905|NCT04405349|Atezolizumab|atezolizumab|mesh-list
15145906|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145907|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14285208|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285209|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285210|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285211|NCT00511706|Growth Substances|growth substances|mesh-ancestor
14285212|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285213|NCT00511836|Naltrexone|naltrexone|mesh-list
14285214|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14285215|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14285216|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285217|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
14285218|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285219|NCT00511875|Doxycycline|doxycycline|mesh-list
14285220|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14285221|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285222|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
14285223|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14285224|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14285225|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
14285226|NCT00511901|Hematinics|hematinics|mesh-ancestor
14285227|NCT00511992|Paclitaxel|paclitaxel|mesh-list
14285228|NCT00511992|Bevacizumab|bevacizumab|mesh-list
14285229|NCT00511992|Cisplatin|cisplatin|mesh-list
14285230|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14285231|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285232|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285233|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285234|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285235|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285236|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285237|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285238|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285239|NCT00511992|Growth Substances|growth substances|mesh-ancestor
14285240|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285241|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285242|NCT00512096|Paclitaxel|paclitaxel|mesh-list
14285243|NCT00512096|Cisplatin|cisplatin|mesh-list
14285244|NCT00512096|Ifosfamide|ifosfamide|mesh-list
14285245|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14285246|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285247|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285248|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285249|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285250|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285251|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14285252|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
14285253|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
14285254|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14285255|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14285256|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14285257|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14285258|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285259|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285260|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
14285261|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285262|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285263|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14285264|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285265|NCT00512252|Cytarabine|cytarabine|mesh-list
14285266|NCT00512252|Plerixafor|plerixafor|mesh-list
14285267|NCT00512252|Etoposide|etoposide|mesh-list
14285268|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
14285269|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14285270|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285271|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14285272|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285273|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285274|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285275|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285276|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
14285277|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
14285278|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285279|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285280|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
14285281|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285282|NCT00512252|Analgesics|analgesics|mesh-ancestor
14285283|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
14285284|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285285|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14285286|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14285287|NCT00512278|Infliximab|infliximab|mesh-list
14285288|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
14285289|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285290|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285291|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
14285292|NCT00512707|Testosterone|testosterone|mesh-list
14285293|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285294|NCT00512707|Androgens|androgens|mesh-ancestor
14285295|NCT00512707|Hormones|hormones|mesh-ancestor
14285296|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285297|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285298|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
15145908|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
15145909|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
15145910|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179688|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15179689|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
15179690|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179691|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179692|NCT03947242|Trastuzumab|trastuzumab|mesh-list
15179693|NCT03947242|Vinorelbine|vinorelbine|mesh-list
15179694|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285299|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14285300|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14285301|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285302|NCT00512707|Urological Agents|urological agents|mesh-ancestor
14285303|NCT00512798|Bortezomib|bortezomib|mesh-list
14285304|NCT00512798|Temozolomide|temozolomide|mesh-list
14285305|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285306|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14285307|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
14285308|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285309|NCT00512876|Bevacizumab|bevacizumab|mesh-list
14285310|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285311|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285312|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285313|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285314|NCT00512876|Growth Substances|growth substances|mesh-ancestor
14285315|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285316|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285317|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
14285318|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285319|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14285320|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285321|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285322|NCT00513019|Lamotrigine|lamotrigine|mesh-list
14285323|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
14285324|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14285325|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285326|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285327|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14285328|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285329|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14285330|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14285331|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285332|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14285333|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14285334|NCT00513071|Saracatinib|saracatinib|mesh-list
14285335|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285336|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285337|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285338|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
14285339|NCT00513240|Hematinics|hematinics|mesh-ancestor
14285340|NCT00513292|Paclitaxel|paclitaxel|mesh-list
14285341|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
14285342|NCT00513292|Trastuzumab|trastuzumab|mesh-list
14285343|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15179695|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179696|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15179697|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
15179698|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
15179699|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
15179700|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179701|NCT03947229|Clopidogrel|clopidogrel|mesh-list
14285344|NCT00513292|Epirubicin|epirubicin|mesh-list
14285345|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14285346|NCT00513292|Antibodies|antibodies|mesh-list
14285347|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
14285348|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14285349|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14285350|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285351|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562697|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562698|NCT00002881|Suramin|suramin|mesh-list
14562699|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
14562700|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14285352|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285353|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285354|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285355|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285356|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
14285357|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145911|NCT04173312|Bupivacaine|bupivacaine|mesh-list
15145912|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
15145913|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
15145914|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285358|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285359|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14285360|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
14285361|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14285362|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14285363|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14285364|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285365|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285366|NCT00513305|Cytarabine|cytarabine|mesh-list
14285367|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
14285368|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285369|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
14285370|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285371|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285372|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
14285373|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285374|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285375|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
14285376|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285377|NCT00513357|Melatonin|melatonin|mesh-list
14285378|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
14285379|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285380|NCT00513357|Protective Agents|protective agents|mesh-ancestor
14285381|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285382|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285383|NCT00513370|Adalimumab|adalimumab|mesh-list
14285384|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14285385|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285386|NCT00513435|Saracatinib|saracatinib|mesh-list
14285387|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285388|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285389|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285390|NCT00513474|Cyclosporine|cyclosporine|mesh-list
14285391|NCT00513474|Sirolimus|sirolimus|mesh-list
14285392|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
14285393|NCT00513474|Busulfan|busulfan|mesh-list
14285394|NCT00513474|Methotrexate|methotrexate|mesh-list
14285395|NCT00513474|Fludarabine|fludarabine|mesh-list
14285396|NCT00513474|Etoposide|etoposide|mesh-list
14285397|NCT00513474|Allopurinol|allopurinol|mesh-list
14285398|NCT00513474|Rasburicase|rasburicase|mesh-list
14285399|NCT00513474|Tacrolimus|tacrolimus|mesh-list
14285400|NCT00513474|Cyclosporins|cyclosporins|mesh-list
14285401|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285402|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
14285403|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285404|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285405|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14285406|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
14285407|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285408|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285409|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14285410|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14285411|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
14285412|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14285413|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285414|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
14285415|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
14285416|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285417|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14285418|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14285419|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15145915|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145916|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
15145917|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145918|NCT04171453|Pregabalin|pregabalin|mesh-list
14285420|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15145919|NCT04171453|Analgesics|analgesics|mesh-ancestor
14285421|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285422|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14285423|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
14285424|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285425|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14285426|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14285427|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
14285428|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14285429|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
14285430|NCT00513474|Protective Agents|protective agents|mesh-ancestor
14285431|NCT00513500|Amoxicillin|amoxicillin|mesh-list
14285432|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14285433|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14285434|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285435|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
14285436|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14285437|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14285438|NCT00513526|Vaccines|vaccines|mesh-list
14285439|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
14285440|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285441|NCT00513604|Aldesleukin|aldesleukin|mesh-list
14285442|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
14285443|NCT00513604|Fludarabine|fludarabine|mesh-list
15145920|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
15145921|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285444|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
15145922|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145923|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
15145924|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15145925|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15145926|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145927|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15145928|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15145929|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14285445|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285446|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
15145930|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15145931|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15145932|NCT04160325|Azathioprine|azathioprine|mesh-list
14285447|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285448|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285449|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14285450|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
14285451|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285452|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285453|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14285454|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285455|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
14285456|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14285457|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14285458|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
14285459|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285460|NCT00513682|Pancrelipase|pancrelipase|mesh-list
14285461|NCT00513682|Pancreatin|pancreatin|mesh-list
15145933|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
14285462|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285463|NCT00513695|Paclitaxel|paclitaxel|mesh-list
14285464|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
14285465|NCT00513695|Doxorubicin|doxorubicin|mesh-list
14285466|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14285467|NCT00513695|Sunitinib|sunitinib|mesh-list
14285468|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14285469|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285470|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285471|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285472|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285473|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285474|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285475|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
14285476|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285477|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285478|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15145934|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285479|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
14285480|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14285481|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14285482|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14285483|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285484|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285485|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285486|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285487|NCT00513695|Growth Substances|growth substances|mesh-ancestor
14285488|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285489|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14285490|NCT00513747|Rituximab|rituximab|mesh-list
14285491|NCT00513747|Fludarabine|fludarabine|mesh-list
14285492|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
14285493|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285494|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285495|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
15145935|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15145936|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145937|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15145938|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
15145939|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145940|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145941|NCT04126083|Lofexidine|lofexidine|mesh-list
15145942|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15145943|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15145944|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285496|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285497|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285498|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285499|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
14285500|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285501|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285502|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
14285503|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14285504|NCT00513799|Mupirocin|mupirocin|mesh-list
14285505|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14285506|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285507|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
14285508|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14285509|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15145945|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
15145946|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15145947|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15145948|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15145949|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15145950|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
15145951|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145952|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145953|NCT04099797|Cyclophosphamide|cyclophosphamide|mesh-list
15145954|NCT04099797|Fludarabine|fludarabine|mesh-list
15145955|NCT04099797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285510|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14285511|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285512|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285513|NCT00514020|Leucovorin|leucovorin|mesh-list
14285514|NCT00514020|Fluorouracil|fluorouracil|mesh-list
14285515|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
14285516|NCT00514020|Calcium|calcium|mesh-list
14285517|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
14020561|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
14285518|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14285519|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285520|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
14285521|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285522|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285523|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285524|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285525|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
14285526|NCT00514020|Antidotes|antidotes|mesh-ancestor
14285527|NCT00514020|Protective Agents|protective agents|mesh-ancestor
14285528|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
14285529|NCT00514020|Vitamins|vitamins|mesh-ancestor
14285530|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
14285531|NCT00514137|Sunitinib|sunitinib|mesh-list
14285532|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285533|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285534|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285535|NCT00514137|Growth Substances|growth substances|mesh-ancestor
15145956|NCT04099797|Immunologic Factors|immunologic factors|mesh-ancestor
15145957|NCT04099797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145958|NCT04099797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145959|NCT04099797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15145960|NCT04099797|Alkylating Agents|alkylating agents|mesh-ancestor
15145961|NCT04099797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145962|NCT04099797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145963|NCT04099797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14285536|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285537|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285538|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14285539|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285540|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285541|NCT00514215|Molgramostim|molgramostim|mesh-list
14285542|NCT00514215|Sargramostim|sargramostim|mesh-list
14285543|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
14285544|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285545|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285546|NCT00514449|Valacyclovir|valacyclovir|mesh-list
14285547|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
14285548|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285549|NCT00514514|Cyclosporine|cyclosporine|mesh-list
14285550|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
14285551|NCT00514514|Everolimus|everolimus|mesh-list
14285552|NCT00514514|Cyclosporins|cyclosporins|mesh-list
15145964|NCT04075292|Rituximab|rituximab|mesh-list
15145965|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
14285553|NCT00514514|Basiliximab|basiliximab|mesh-list
14285554|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285555|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285556|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285557|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
14285558|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285559|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
14285560|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15145966|NCT04075292|Chlorambucil|chlorambucil|mesh-list
15145967|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15145968|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145969|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
15145970|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145971|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15145972|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15145973|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
15145974|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145975|NCT04004845|Misoprostol|misoprostol|mesh-list
15145976|NCT04004845|Oxytocin|oxytocin|mesh-list
15145977|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
15145978|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15145979|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145980|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15145981|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
15145982|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15145983|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15145984|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
15145985|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285561|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
14285562|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285563|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14285564|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285565|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14285566|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14285567|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
14285568|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14285569|NCT00514540|Carboplatin|carboplatin|mesh-list
14285570|NCT00514540|Docetaxel|docetaxel|mesh-list
14285571|NCT00514540|Etoposide|etoposide|mesh-list
14285572|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145986|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15145987|NCT03854019|Quinidine|quinidine|mesh-list
15145988|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
15145989|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
14285573|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285574|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285575|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285576|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285577|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562701|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14285578|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14285579|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285580|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285581|NCT00514683|Nintedanib|nintedanib|mesh-list
14285582|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285583|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14285584|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285585|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285586|NCT00514709|Vaccines|vaccines|mesh-list
14285587|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
14285588|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285589|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14285590|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14285591|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
14285592|NCT00514852|Glycerol|glycerol|mesh-list
14285593|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14285594|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14285595|NCT00514852|Laxatives|laxatives|mesh-ancestor
14285596|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285597|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14285598|NCT00514852|Protective Agents|protective agents|mesh-ancestor
14285599|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285600|NCT00514904|Vaccines|vaccines|mesh-list
14285601|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
14285602|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285603|NCT00514917|Docetaxel|docetaxel|mesh-list
14285604|NCT00514917|Leuprolide|leuprolide|mesh-list
14285605|NCT00514917|Bicalutamide|bicalutamide|mesh-list
14285606|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285607|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285608|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285609|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285610|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285611|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14285612|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
14285613|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14285614|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285615|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14285616|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
14285617|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
14285618|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285619|NCT00514943|Cetuximab|cetuximab|mesh-list
14285620|NCT00514943|Afatinib|afatinib|mesh-list
14285621|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285622|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285623|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14285624|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15145990|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
15145991|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15145992|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15145993|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15145994|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15145995|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15145996|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15145997|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15145998|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
15145999|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15146000|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
15146001|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14285625|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285626|NCT00515021|Eplerenone|eplerenone|mesh-list
14285627|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14285628|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
14285629|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285630|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285631|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14285632|NCT00515021|Diuretics|diuretics|mesh-ancestor
14285633|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
14285634|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14285635|NCT00515034|Imipenem|imipenem|mesh-list
14285636|NCT00515034|Doripenem|doripenem|mesh-list
14285637|NCT00515034|Cilastatin|cilastatin|mesh-list
14285638|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14285639|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285640|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
14285641|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285642|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285643|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
14285644|NCT00515073|Promethazine|promethazine|mesh-list
14285645|NCT00515073|Dexamethasone|dexamethasone|mesh-list
14285646|NCT00515073|Paclitaxel|paclitaxel|mesh-list
14285647|NCT00515073|Cimetidine|cimetidine|mesh-list
14285648|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14285649|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285650|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285651|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285652|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285653|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285654|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14285655|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
14285656|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
14285657|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285658|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285659|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285660|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
14285661|NCT00515073|Hormones|hormones|mesh-ancestor
14285662|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285663|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14285664|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14285665|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14285666|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285667|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
14285668|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
14285669|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
14285670|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14285671|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
14285672|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
14285673|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285674|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14285675|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
14285676|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14285677|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14285678|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14285679|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14285680|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14285681|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146002|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15146003|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146004|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146005|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15146006|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15146007|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
15146008|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15146009|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15146010|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15146011|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15146012|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15146013|NCT03809429|Cetrorelix|cetrorelix|mesh-list
14285682|NCT00515086|Everolimus|everolimus|mesh-list
14285683|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285684|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285685|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
14285686|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285687|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
14285688|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14285689|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
14285690|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285691|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285692|NCT00515177|Eszopiclone|eszopiclone|mesh-list
14285693|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14285694|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285695|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285696|NCT00515216|Leucovorin|leucovorin|mesh-list
14285697|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14285698|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
14285699|NCT00515216|Fluorouracil|fluorouracil|mesh-list
14285700|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
14285701|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
15146014|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15146015|NCT03809429|Hormones|hormones|mesh-ancestor
14285702|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
14285703|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285704|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285705|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285706|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285707|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
14285708|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285709|NCT00515216|Antidotes|antidotes|mesh-ancestor
14285710|NCT00515216|Protective Agents|protective agents|mesh-ancestor
14285711|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
14285712|NCT00515216|Vitamins|vitamins|mesh-ancestor
15146016|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146017|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146018|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15146019|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
15146020|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14285713|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
14285714|NCT00515294|Caffeine|caffeine|mesh-list
14285715|NCT00515294|Methamphetamine|methamphetamine|mesh-list
14285716|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14285717|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285718|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14285719|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285720|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285721|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14285722|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14285723|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
14285724|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285725|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
14285726|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
15146021|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
15146022|NCT03737370|Docetaxel|docetaxel|mesh-list
15146023|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285727|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285728|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
14285729|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
14562702|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14562703|NCT00002881|Leuprolide|leuprolide|mesh-list
14562704|NCT00002881|Goserelin|goserelin|mesh-list
14562705|NCT00002881|Flutamide|flutamide|mesh-list
14562706|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14562707|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14562708|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
14562709|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14562710|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562711|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562712|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562713|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
14562714|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
14562715|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562716|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
14562717|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
14562718|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14562719|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562720|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14562721|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14562722|NCT00002882|Interferons|interferons|mesh-list
14562723|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
14562724|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
14562725|NCT00002882|Aldesleukin|aldesleukin|mesh-list
14562726|NCT00002882|Cisplatin|cisplatin|mesh-list
14562727|NCT00002882|Interleukin-2|interleukin-2|mesh-list
14562728|NCT00002882|Dacarbazine|dacarbazine|mesh-list
14562729|NCT00002882|Vinblastine|vinblastine|mesh-list
15146024|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
15146025|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
15146026|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
15146027|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146028|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15146029|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
15146030|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146031|NCT03662022|Rifampin|rifampin|mesh-list
15146032|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15146033|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
15146034|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14562730|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562731|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
14562732|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562733|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
14562734|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146035|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146036|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
15146037|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15146038|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146039|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146040|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15146041|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15146042|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15146043|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15146044|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15146045|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15146046|NCT03640312|Candesartan|candesartan|mesh-list
15146047|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15146048|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15146049|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15146050|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146051|NCT03568994|Cytarabine|cytarabine|mesh-list
15146052|NCT03568994|Atovaquone|atovaquone|mesh-list
15146053|NCT03568994|Etoposide|etoposide|mesh-list
15146054|NCT03568994|Daunorubicin|daunorubicin|mesh-list
15146055|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
15146056|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15146057|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146058|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15146059|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15146060|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146061|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146062|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146063|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
15146064|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
15146065|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285730|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14285731|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14285732|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285733|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14285734|NCT00515411|Leucovorin|leucovorin|mesh-list
14285735|NCT00515411|Cisplatin|cisplatin|mesh-list
14285736|NCT00515411|Docetaxel|docetaxel|mesh-list
14285737|NCT00515411|Fluorouracil|fluorouracil|mesh-list
14285738|NCT00515411|Trastuzumab|trastuzumab|mesh-list
14285739|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285740|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285741|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285742|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285743|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285744|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
14285745|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285746|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285747|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
14285748|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285749|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285750|NCT00515411|Antidotes|antidotes|mesh-ancestor
14285751|NCT00515411|Protective Agents|protective agents|mesh-ancestor
14285752|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
14285753|NCT00515411|Vitamins|vitamins|mesh-ancestor
14285754|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
14285755|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14285756|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
14285757|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14285758|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14285759|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14285760|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285761|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285762|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
14285763|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285764|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285765|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14285766|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285767|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14285768|NCT00515463|Denosumab|denosumab|mesh-list
14285769|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14285770|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285771|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
14285772|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14285773|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
14285774|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285775|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285776|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14285777|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
14285778|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
14285779|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14285780|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
14285781|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285782|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146066|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146067|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
15146068|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146069|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14285783|NCT00515619|Lacosamide|lacosamide|mesh-list
14285784|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
14285785|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14285786|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14285787|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285788|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285789|NCT00515697|Ramucirumab|ramucirumab|mesh-list
14285790|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285791|NCT00515723|Olanzapine|olanzapine|mesh-list
14285792|NCT00515723|Risperidone|risperidone|mesh-list
14285793|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14285794|NCT00515723|Ziprasidone|ziprasidone|mesh-list
14285795|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14285796|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
14285797|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285798|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285799|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285800|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14285801|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14285802|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285803|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14285804|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14285805|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
14285806|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
14285807|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
14285808|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285809|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14285810|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14285811|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14285812|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285813|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
14285814|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
14285815|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14285816|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14285817|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
14285818|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285819|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14285820|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14285821|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285822|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285823|NCT00515879|Cycloserine|cycloserine|mesh-list
14285824|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14285825|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285826|NCT00515879|Renal Agents|renal agents|mesh-ancestor
14285827|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14285828|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
14285829|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14285830|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
14285831|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285832|NCT00516048|Exenatide|exenatide|mesh-list
14285833|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14285834|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285835|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14285836|NCT00516048|Incretins|incretins|mesh-ancestor
14285837|NCT00516048|Hormones|hormones|mesh-ancestor
14285838|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285839|NCT00516074|Exenatide|exenatide|mesh-list
14285840|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14285841|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285842|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14285843|NCT00516074|Incretins|incretins|mesh-ancestor
14285844|NCT00516074|Hormones|hormones|mesh-ancestor
14285845|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14285846|NCT00516139|Lamotrigine|lamotrigine|mesh-list
14285847|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
14285848|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14285849|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285850|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285851|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14285852|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285853|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14285854|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14285855|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285856|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14285857|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14285858|NCT00516165|Everolimus|everolimus|mesh-list
14285859|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285860|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285861|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
14285862|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285863|NCT00516217|Galiximab|galiximab|mesh-list
14285864|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14285865|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285866|NCT00516269|Methylphenidate|methylphenidate|mesh-list
14285867|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14285868|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285869|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14285870|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14285871|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285872|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285873|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
14285874|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285875|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
14285876|NCT00516295|Bevacizumab|bevacizumab|mesh-list
14285877|NCT00516295|Vincristine|vincristine|mesh-list
14285878|NCT00516295|Topotecan|topotecan|mesh-list
14285879|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14285880|NCT00516295|Antibodies|antibodies|mesh-list
14285881|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
14285882|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14285883|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285884|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
14285885|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285886|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285887|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14285888|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
14285889|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285890|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285891|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14285892|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285893|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285894|NCT00516295|Growth Substances|growth substances|mesh-ancestor
14285895|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285896|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14285897|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285898|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285899|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285900|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14285901|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14285902|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285903|NCT00516386|Mecasermin|mecasermin|mesh-list
14285904|NCT00516386|Growth Substances|growth substances|mesh-ancestor
14285905|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285906|NCT00516503|Ketamine|ketamine|mesh-list
14285907|NCT00516503|Amitriptyline|amitriptyline|mesh-list
14285908|NCT00516503|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14285909|NCT00516503|Baclofen|baclofen|mesh-list
14285910|NCT00516503|Analgesics|analgesics|mesh-ancestor
14285911|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
14285912|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14285913|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285914|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14285915|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14285916|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
14285917|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
14285918|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14285919|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14285920|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14285921|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14285922|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285923|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14285924|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14285925|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14285926|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
14285927|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
14285928|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14285929|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
14285930|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14285931|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14285932|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14285933|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14285934|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14285935|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14285936|NCT00516503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14285937|NCT00516503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14285938|NCT00516893|Natalizumab|natalizumab|mesh-list
15146070|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146071|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
15146072|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15146073|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15146074|NCT03538899|Busulfan|busulfan|mesh-list
15146075|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
15146076|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285939|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
14285940|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285941|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
14285942|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14285943|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14285944|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285945|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
14285946|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14285947|NCT00516919|Orlistat|orlistat|mesh-list
14285948|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285949|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285950|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14285951|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14285952|NCT00517010|Ranibizumab|ranibizumab|mesh-list
14285953|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285954|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285955|NCT00517010|Growth Substances|growth substances|mesh-ancestor
14285956|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285957|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285958|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285959|NCT00517296|Adalimumab|adalimumab|mesh-list
14285960|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14285961|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14285962|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
14285963|NCT00517413|Hematinics|hematinics|mesh-ancestor
14285964|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
14285965|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285966|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285967|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
14285968|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
14285969|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14285970|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285971|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14285972|NCT00517595|Gemcitabine|gemcitabine|mesh-list
15146077|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146078|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
15146079|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285973|NCT00517595|Bevacizumab|bevacizumab|mesh-list
14285974|NCT00517595|Pemetrexed|pemetrexed|mesh-list
14285975|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14285976|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285977|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14285978|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14285979|NCT00517595|Growth Substances|growth substances|mesh-ancestor
14285980|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14285981|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
14285982|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14285983|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
14292949|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14285984|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14285985|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
14285986|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14285987|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14285988|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14285989|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
14285990|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14285991|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14292950|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292951|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15146080|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15146081|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146082|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15146083|NCT03432897|Olaparib|olaparib|mesh-list
15146084|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15146085|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146086|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146087|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146088|NCT03355157|Tamoxifen|tamoxifen|mesh-list
15146089|NCT03355157|Paclitaxel|paclitaxel|mesh-list
15146090|NCT03355157|Vinorelbine|vinorelbine|mesh-list
15146091|NCT03355157|Capecitabine|capecitabine|mesh-list
15146092|NCT03355157|Letrozole|letrozole|mesh-list
15146093|NCT03355157|Epirubicin|epirubicin|mesh-list
15146094|NCT03355157|Fulvestrant|fulvestrant|mesh-list
15146095|NCT03355157|Palbociclib|palbociclib|mesh-list
15146096|NCT03355157|Exemestane|exemestane|mesh-list
15146097|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15146098|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146099|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
14292952|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292953|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146100|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
15146101|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
14292954|NCT00564889|Dexamethasone|dexamethasone|mesh-list
14292955|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
14292956|NCT00564889|Lenalidomide|lenalidomide|mesh-list
14292957|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14292958|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
14292959|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292960|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292961|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14292962|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
14292963|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292964|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292965|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14292966|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14292967|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
14292968|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
14292969|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292970|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14292971|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
14292972|NCT00564889|Hormones|hormones|mesh-ancestor
14292973|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146102|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146103|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146104|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
15146105|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15146106|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15146107|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146108|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15146109|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
15146110|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146111|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292974|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14292975|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14292976|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14292977|NCT00564889|Growth Substances|growth substances|mesh-ancestor
14292978|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14292979|NCT00564954|Methylphenidate|methylphenidate|mesh-list
15146112|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15146113|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14292980|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
15146114|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15146115|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14285992|NCT00517829|Docetaxel|docetaxel|mesh-list
14285993|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
14285994|NCT00517829|Cetuximab|cetuximab|mesh-list
14285995|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14285996|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
14285997|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
14285998|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
14285999|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286000|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286001|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
14286002|NCT00517881|Hematinics|hematinics|mesh-ancestor
14286003|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
14286004|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286005|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
14286006|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14286007|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14286008|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286009|NCT00517933|Urological Agents|urological agents|mesh-ancestor
14286010|NCT00518011|Gemcitabine|gemcitabine|mesh-list
14286011|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14286012|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14286013|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
14286014|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286015|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286016|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
14286017|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286018|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286019|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286020|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
14286021|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286022|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286023|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
14286024|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14286025|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14286026|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14286027|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286028|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14286029|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14286030|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286031|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286032|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286033|NCT00518115|Exenatide|exenatide|mesh-list
14286034|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
14286035|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14286036|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286037|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14286038|NCT00518115|Incretins|incretins|mesh-ancestor
14286039|NCT00518115|Hormones|hormones|mesh-ancestor
14286040|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286041|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14286042|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14286043|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146116|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15146117|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15146118|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15146119|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15146120|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15146121|NCT03324035|Tramadol|tramadol|mesh-list
15146122|NCT03324035|Amitriptyline|amitriptyline|mesh-list
15146123|NCT03324035|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15146124|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15146125|NCT03324035|Narcotics|narcotics|mesh-ancestor
15146126|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146127|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146128|NCT03324035|Analgesics|analgesics|mesh-ancestor
15146129|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
14286044|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286045|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
14286046|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286047|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286048|NCT00518180|Lactitol|lactitol|mesh-list
14286049|NCT00518180|Vaccines|vaccines|mesh-list
14286050|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
14286051|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286052|NCT00518180|Cathartics|cathartics|mesh-ancestor
14286053|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14286054|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
15146130|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146131|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15146132|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
15146133|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15146134|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15146135|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15146136|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15146137|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15146138|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146139|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
15146140|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146141|NCT03324035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15146142|NCT03324035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15146143|NCT03320018|Minocycline|minocycline|mesh-list
15146144|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15146145|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146146|NCT03196180|Fluorouracil|fluorouracil|mesh-list
15146147|NCT03196180|Imiquimod|imiquimod|mesh-list
15146148|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
14286055|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286056|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
14286057|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286058|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286059|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286060|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
14286061|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286062|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286063|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14286064|NCT00518284|Paclitaxel|paclitaxel|mesh-list
14286065|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14286066|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14286067|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286068|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286069|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286070|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286071|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286072|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14286073|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14286074|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14286075|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286076|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286077|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286078|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14286079|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14286080|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
14286081|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286082|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286083|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14286084|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14286085|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
14286086|NCT00518531|Denosumab|denosumab|mesh-list
14286087|NCT00518531|Alendronate|alendronate|mesh-list
14286088|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14286089|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286090|NCT00518687|Vaccines|vaccines|mesh-list
14286091|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
14286092|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286093|NCT00518713|Clobazam|clobazam|mesh-list
14286094|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
14286095|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14286096|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14286097|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286098|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286099|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286100|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14286101|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
14286102|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
14286103|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286104|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286105|NCT00518882|Liraglutide|liraglutide|mesh-list
14286106|NCT00518882|Exenatide|exenatide|mesh-list
14286107|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14286108|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286109|NCT00518882|Incretins|incretins|mesh-ancestor
14286110|NCT00518882|Hormones|hormones|mesh-ancestor
14286111|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286112|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14286113|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14286114|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
14286115|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286116|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14286117|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14286118|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286119|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286120|NCT00518986|Modafinil|modafinil|mesh-list
14286121|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14286122|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286123|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14286124|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14286125|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14286126|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286127|NCT00519077|Gefitinib|gefitinib|mesh-list
14286128|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286129|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286130|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286131|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286132|NCT00519285|Prednisone|prednisone|mesh-list
14286133|NCT00519285|Prednisolone|prednisolone|mesh-list
14286134|NCT00519285|Docetaxel|docetaxel|mesh-list
14286135|NCT00519285|Aflibercept|aflibercept|mesh-list
14286136|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286137|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286138|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286139|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286140|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286141|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286142|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
14286143|NCT00519285|Hormones|hormones|mesh-ancestor
14286144|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286145|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286146|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14286147|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286148|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286149|NCT00519285|Growth Substances|growth substances|mesh-ancestor
14286150|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286151|NCT00519428|Dexetimide|dexetimide|mesh-list
14286152|NCT00519428|Citalopram|citalopram|mesh-list
14286153|NCT00519428|Bupropion|bupropion|mesh-list
14286154|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14286155|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14286156|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286157|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286158|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286159|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
14286160|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286161|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14286162|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
14286163|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286164|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14286165|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15146149|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146150|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146151|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146152|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146153|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
15146154|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146155|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15146156|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
15146157|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15146158|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146159|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146160|NCT03075423|Nivolumab|nivolumab|mesh-list
15146161|NCT03075423|Ipilimumab|ipilimumab|mesh-list
15146162|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146163|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286166|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
15146164|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14286167|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
14286168|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286169|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14286170|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14286171|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
14286172|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14286173|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
14286174|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14286175|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14286176|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286177|NCT00519532|Rotigotine|rotigotine|mesh-list
14286178|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
14286179|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
14286180|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286181|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286182|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286183|NCT00519584|Bupivacaine|bupivacaine|mesh-list
14286184|NCT00519584|Ropivacaine|ropivacaine|mesh-list
14286185|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
14286186|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
14286187|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286188|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286189|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
14286190|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286191|NCT00519623|Insulin|insulin|mesh-list
14286192|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14286193|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286194|NCT00519636|Fluticasone|fluticasone|mesh-list
14286195|NCT00519636|Xhance|xhance|mesh-list
14286196|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286197|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14286198|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
14286199|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286200|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286201|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14286202|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
14286203|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14286204|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14286205|NCT00519831|Cetuximab|cetuximab|mesh-list
14286206|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286207|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286208|NCT00519896|Sunitinib|sunitinib|mesh-list
14286209|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286210|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286211|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286212|NCT00519896|Growth Substances|growth substances|mesh-ancestor
14286213|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286214|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286215|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286216|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286217|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286218|NCT00520013|Paclitaxel|paclitaxel|mesh-list
14286219|NCT00520013|Bevacizumab|bevacizumab|mesh-list
14286220|NCT00520013|Carboplatin|carboplatin|mesh-list
14286221|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14286222|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14286223|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286224|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286225|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286226|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286227|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286228|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286229|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286230|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286231|NCT00520013|Growth Substances|growth substances|mesh-ancestor
14286232|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286233|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286234|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286235|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286236|NCT00520130|Cytarabine|cytarabine|mesh-list
14286237|NCT00520130|Cyclosporine|cyclosporine|mesh-list
14286238|NCT00520130|Rituximab|rituximab|mesh-list
14286239|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
14286240|NCT00520130|Fludarabine|fludarabine|mesh-list
14020562|NCT02779413|Insulin|insulin|mesh-list
14286241|NCT00520130|Cyclosporins|cyclosporins|mesh-list
14286242|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146165|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146166|NCT02980731|Venetoclax|venetoclax|mesh-list
15146167|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146168|NCT02923947|Osimertinib|osimertinib|mesh-list
15146169|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146170|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15146171|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146172|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146173|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
15146174|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15146175|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146176|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146177|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15146178|NCT02819141|Analgesics|analgesics|mesh-ancestor
15146179|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
15146180|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286243|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286244|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
14286245|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286246|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286247|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14286248|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
14286249|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286250|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286251|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
14286252|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286253|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286254|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
14286255|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
14286256|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14286257|NCT00520234|Caspofungin|caspofungin|mesh-list
14286258|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
14286259|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286260|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286261|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286262|NCT00520286|Modafinil|modafinil|mesh-list
14286263|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14286264|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286265|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14286266|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14286267|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14286268|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286269|NCT00520403|Interferons|interferons|mesh-list
14286270|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
14286271|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
14286272|NCT00520403|Bevacizumab|bevacizumab|mesh-list
14286273|NCT00520403|Vinblastine|vinblastine|mesh-list
14286274|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286275|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286276|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286277|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286278|NCT00520403|Growth Substances|growth substances|mesh-ancestor
14286279|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286280|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286281|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
14286282|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286283|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
15146181|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15146182|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15146183|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15146184|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
15146185|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146186|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146187|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
15146188|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15146189|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146190|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14286284|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14286285|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286286|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286287|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286288|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146191|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286289|NCT00520468|Cyclosporine|cyclosporine|mesh-list
14286290|NCT00520468|Prednisone|prednisone|mesh-list
14286291|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
14286292|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
14286293|NCT00520468|Cyclosporins|cyclosporins|mesh-list
14286294|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286295|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
14286296|NCT00520468|Hormones|hormones|mesh-ancestor
14286297|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286298|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286299|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14286300|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286301|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286302|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286303|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286304|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
14286305|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
14286306|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286307|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
14286308|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286309|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14286310|NCT00520468|Hematinics|hematinics|mesh-ancestor
14286311|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14286312|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
14286313|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286314|NCT00520533|Sunitinib|sunitinib|mesh-list
14286315|NCT00520533|Antibodies|antibodies|mesh-list
14286316|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14286317|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
14286318|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286319|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286320|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286321|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286322|NCT00520533|Growth Substances|growth substances|mesh-ancestor
14286323|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
14562735|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14562736|NCT00002882|Analgesics|analgesics|mesh-ancestor
14562737|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
14562738|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562739|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14562740|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14562741|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562742|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
14562743|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562744|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562745|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562746|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562747|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562748|NCT00002883|Fluorouracil|fluorouracil|mesh-list
14562749|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562750|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
14562751|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562752|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562753|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562754|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
14562755|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562756|NCT00002884|Fluorouracil|fluorouracil|mesh-list
14562757|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562758|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
14562759|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562760|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562761|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562762|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
14562763|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562764|NCT00002887|Etoposide|etoposide|mesh-list
14562765|NCT00002887|Vinorelbine|vinorelbine|mesh-list
14562766|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
14562767|NCT00002887|Vinblastine|vinblastine|mesh-list
14562768|NCT00002887|Vindesine|vindesine|mesh-list
14562769|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562770|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562771|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562772|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562773|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562774|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562775|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286324|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286325|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286326|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286327|NCT00520572|Etanercept|etanercept|mesh-list
14286328|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14286329|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14286330|NCT00520572|Analgesics|analgesics|mesh-ancestor
14286331|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
14286332|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286333|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286334|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286335|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286336|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14286337|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286338|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
14286339|NCT00520676|Carboplatin|carboplatin|mesh-list
14286340|NCT00520676|Docetaxel|docetaxel|mesh-list
14286341|NCT00520676|Pemetrexed|pemetrexed|mesh-list
14286342|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286343|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286344|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286345|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286346|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286347|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286348|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14286349|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14286350|NCT00520741|Lacosamide|lacosamide|mesh-list
14286351|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
14286352|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14286353|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14286354|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286355|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286356|NCT00520767|Dexamethasone|dexamethasone|mesh-list
14286357|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
14286358|NCT00520767|Bortezomib|bortezomib|mesh-list
14286359|NCT00520767|Melphalan|melphalan|mesh-list
14286360|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14286361|NCT00520767|BB 1101|bb 1101|mesh-list
14286362|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286363|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
14286364|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
14286365|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286366|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286367|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14286368|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
15146192|NCT02636946|Bimatoprost|bimatoprost|mesh-list
15146193|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15146194|NCT02631941|Budesonide|budesonide|mesh-list
14286369|NCT00520767|Hormones|hormones|mesh-ancestor
14286370|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286371|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14286372|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286373|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
14286374|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286375|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286376|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286377|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
14286378|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14286379|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286380|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
14286381|NCT00520845|Celecoxib|celecoxib|mesh-list
14286382|NCT00520845|Docetaxel|docetaxel|mesh-list
14286383|NCT00520845|Pemetrexed|pemetrexed|mesh-list
14286384|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286385|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286386|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286387|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286388|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146195|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
15146196|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15146197|NCT02631941|Charcoal|charcoal|mesh-list
15146198|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286389|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286390|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14286391|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14286392|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15146199|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15146200|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
14286393|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14286394|NCT00520845|Analgesics|analgesics|mesh-ancestor
14286395|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
14286396|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286397|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286398|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286399|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286400|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14286401|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14286402|NCT00520936|Pemetrexed|pemetrexed|mesh-list
14286403|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286404|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286405|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286406|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14286407|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14286408|NCT00520975|Paclitaxel|paclitaxel|mesh-list
14286409|NCT00520975|Bevacizumab|bevacizumab|mesh-list
14286410|NCT00520975|Carboplatin|carboplatin|mesh-list
14286411|NCT00520975|Trastuzumab|trastuzumab|mesh-list
14286412|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14286413|NCT00520975|Antibodies|antibodies|mesh-list
14286414|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
14286415|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14286416|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14286417|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286418|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286419|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286420|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286421|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286422|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286423|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286424|NCT00520975|Growth Substances|growth substances|mesh-ancestor
14286425|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286426|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286427|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
14286428|NCT00521001|Everolimus|everolimus|mesh-list
14286429|NCT00521001|Temozolomide|temozolomide|mesh-list
14286430|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286431|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286432|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
14286433|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286434|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286435|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
14286436|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286437|NCT00521014|Cytarabine|cytarabine|mesh-list
14286438|NCT00521014|Rituximab|rituximab|mesh-list
14286439|NCT00521014|Etoposide|etoposide|mesh-list
14286440|NCT00521014|Melphalan|melphalan|mesh-list
14286441|NCT00521014|Carmustine|carmustine|mesh-list
14286442|NCT00521014|Sargramostim|sargramostim|mesh-list
14286443|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286444|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286445|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
14286446|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286447|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286448|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14286449|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14286450|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14286451|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286452|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286453|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14286454|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
14286455|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
14286456|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286457|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286458|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286459|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
14286460|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14286461|NCT00521144|Topotecan|topotecan|mesh-list
14286462|NCT00521144|Obatoclax|obatoclax|mesh-list
14286463|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15146201|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286464|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14286465|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286466|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286467|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286468|NCT00521339|Apremilast|apremilast|mesh-list
14286469|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14286470|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14286471|NCT00521339|Analgesics|analgesics|mesh-ancestor
14286472|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
14286473|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286474|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286475|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286476|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286477|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14286478|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14286479|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286480|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286481|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14286482|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
14286483|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286484|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14286485|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14286486|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286487|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286488|NCT00521404|Gemcitabine|gemcitabine|mesh-list
14286489|NCT00521404|Antibodies|antibodies|mesh-list
14286490|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
14286491|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286492|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14286493|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
15146202|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146203|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15146204|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
15146205|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
15146206|NCT02631941|Hormones|hormones|mesh-ancestor
14286494|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286495|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286496|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
14286497|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286498|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286499|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286500|NCT00521456|Ketorolac|ketorolac|mesh-list
14286501|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14286502|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14286503|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14286504|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14286505|NCT00521456|Analgesics|analgesics|mesh-ancestor
14286506|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
14286507|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286508|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286509|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286510|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286511|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14286512|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286513|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286514|NCT00521586|Vaccines|vaccines|mesh-list
14286515|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14286516|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
14286517|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286518|NCT00521989|Prednisolone|prednisolone|mesh-list
14286519|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14286520|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
14286521|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14286522|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
14286523|NCT00521989|Dipyridamole|dipyridamole|mesh-list
14286524|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14286525|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
14286526|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286527|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
14286528|NCT00521989|Hormones|hormones|mesh-ancestor
15146207|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146208|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15146209|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15146210|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15146211|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
14286529|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146212|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146213|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146214|NCT02631941|Antidotes|antidotes|mesh-ancestor
15146215|NCT02631941|Protective Agents|protective agents|mesh-ancestor
15146216|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
15146217|NCT02623972|Doxorubicin|doxorubicin|mesh-list
15146218|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15146219|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146220|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
15146221|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146222|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15146223|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15146224|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
15146225|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146226|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146227|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15146228|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15146229|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15146230|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15146231|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146232|NCT02562378|Doxorubicin|doxorubicin|mesh-list
15146233|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15146234|NCT02562378|Trastuzumab|trastuzumab|mesh-list
15146235|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15146236|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286530|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286531|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14286532|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286533|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
14286534|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
14286535|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286536|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14286537|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14286538|NCT00521989|Protective Agents|protective agents|mesh-ancestor
14286539|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14286540|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286541|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286542|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14286543|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
14286544|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
14286545|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
14286546|NCT00522275|Lacosamide|lacosamide|mesh-list
14286547|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
14286548|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14286549|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14286550|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286551|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286552|NCT00522379|Rotigotine|rotigotine|mesh-list
14286553|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
14286554|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
14286555|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286556|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286557|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286558|NCT00522392|Dexamethasone|dexamethasone|mesh-list
14286559|NCT00522392|Lenalidomide|lenalidomide|mesh-list
14286560|NCT00522392|Bortezomib|bortezomib|mesh-list
14286561|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286562|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
14286563|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
14286564|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286565|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286566|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146237|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15146238|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15146239|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286567|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
14286568|NCT00522392|Hormones|hormones|mesh-ancestor
14286569|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286570|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14286571|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286572|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
14286573|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286574|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286575|NCT00522392|Growth Substances|growth substances|mesh-ancestor
14286576|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286577|NCT00522431|Testosterone|testosterone|mesh-list
14286578|NCT00522431|Androgens|androgens|mesh-ancestor
14286579|NCT00522431|Hormones|hormones|mesh-ancestor
14286580|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286581|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286582|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
14286583|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14286584|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286585|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14286586|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
14286587|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14286588|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286589|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286590|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286591|NCT00522795|Paclitaxel|paclitaxel|mesh-list
14286592|NCT00522795|Cisplatin|cisplatin|mesh-list
14286593|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14286594|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14286595|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286596|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286597|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286598|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286599|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286600|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
14286601|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14286602|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14286603|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
14286604|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286605|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14286606|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14286607|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286608|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286609|NCT00523341|Denosumab|denosumab|mesh-list
14286610|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15146240|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146241|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146242|NCT02527434|Durvalumab|durvalumab|mesh-list
15146243|NCT02527434|Tremelimumab|tremelimumab|mesh-list
14286611|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286612|NCT00523419|Pemetrexed|pemetrexed|mesh-list
14286613|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286614|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286615|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286616|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14286617|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14286618|NCT00523549|Amlodipine|amlodipine|mesh-list
14286619|NCT00523549|Valsartan|valsartan|mesh-list
14286620|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14286621|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14286622|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286623|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286624|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14286625|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286626|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
14286627|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14286628|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14286629|NCT00523640|Gemcitabine|gemcitabine|mesh-list
14286630|NCT00523640|Bevacizumab|bevacizumab|mesh-list
14286631|NCT00523640|Capecitabine|capecitabine|mesh-list
14286632|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286633|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286634|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286635|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286636|NCT00523640|Growth Substances|growth substances|mesh-ancestor
14286637|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286638|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286639|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14286640|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
14286641|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286642|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
14286643|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286644|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286645|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286646|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
14286647|NCT00523705|Citalopram|citalopram|mesh-list
14286648|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14286649|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14286650|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286651|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286652|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286653|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
14286654|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286655|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14286656|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
14286657|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286658|NCT00523718|Riluzole|riluzole|mesh-list
14286659|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
14286660|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14286661|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14286662|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286663|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286664|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286665|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14286666|NCT00523718|Protective Agents|protective agents|mesh-ancestor
14286667|NCT00523744|Amlodipine|amlodipine|mesh-list
14286668|NCT00523744|Valsartan|valsartan|mesh-list
14286669|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14286670|NCT00523744|Olmesartan|olmesartan|mesh-list
14286671|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14286672|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14286673|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14286674|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286675|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146244|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15146245|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146246|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146247|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
15146248|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020563|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14286676|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14286677|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286678|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
14286679|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14286680|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14286681|NCT00523744|Diuretics|diuretics|mesh-ancestor
14286682|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
14286683|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14286684|NCT00523848|Thalidomide|thalidomide|mesh-list
14286685|NCT00523848|Doxorubicin|doxorubicin|mesh-list
14286686|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14286687|NCT00523848|Bortezomib|bortezomib|mesh-list
14286688|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14286689|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286690|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14286691|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14286692|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286693|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286694|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286695|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
14286696|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286697|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
14286698|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14286699|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286700|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286701|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286702|NCT00523848|Growth Substances|growth substances|mesh-ancestor
14286703|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286704|NCT00523978|Sotalol|sotalol|mesh-list
14286705|NCT00523978|Flecainide|flecainide|mesh-list
14286706|NCT00523978|Propafenone|propafenone|mesh-list
14286707|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14286708|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14286709|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
14286710|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286711|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286712|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286713|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15179702|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14286714|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
15146249|NCT02387099|Everolimus|everolimus|mesh-list
15146250|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286715|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
14286716|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286717|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14286718|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14286719|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286720|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
14286721|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14286722|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
14286723|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286724|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286725|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14286726|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
14286727|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
14286728|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14286729|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
14286730|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286731|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286732|NCT00524017|Cetuximab|cetuximab|mesh-list
14286733|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146251|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146252|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
15146253|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146254|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
15146255|NCT02299414|Nifedipine|nifedipine|mesh-list
15146256|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15146257|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14020564|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020565|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
14020566|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14020567|NCT02779270|Protective Agents|protective agents|mesh-ancestor
14020568|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020569|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
14020570|NCT02779465|Vitamin D|vitamin d|mesh-list
14020571|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
14020572|NCT02779465|Vitamins|vitamins|mesh-ancestor
14020573|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
14020574|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286734|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146258|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146259|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15146260|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146261|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
15146262|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
15146263|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15146264|NCT02237508|Budesonide|budesonide|mesh-list
14286735|NCT00524030|Pregabalin|pregabalin|mesh-list
14286736|NCT00524030|Analgesics|analgesics|mesh-ancestor
14286737|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
14286738|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286739|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286740|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
14286741|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14286742|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286743|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286744|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14286745|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14286746|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14286747|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286748|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286749|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14286750|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14286751|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14286752|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286753|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286754|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286755|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14286756|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14286757|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
14286758|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020575|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15146265|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
15146266|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15146267|NCT02237508|Charcoal|charcoal|mesh-list
15146268|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15146269|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14286759|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286760|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14286761|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14286762|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
14286763|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14286764|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286765|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286766|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286767|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292981|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14292982|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292983|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14292984|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14292985|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292986|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292987|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
14292988|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292989|NCT00565084|Ibuprofen|ibuprofen|mesh-list
14292990|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14292991|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14292992|NCT00565084|Analgesics|analgesics|mesh-ancestor
14292993|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
14292994|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14292995|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292996|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14292997|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14292998|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14292999|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293000|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293001|NCT00565266|Beclomethasone|beclomethasone|mesh-list
14293002|NCT00565266|Bromides|bromides|mesh-list
14293003|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
14293004|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14293005|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14293006|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
14293007|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293008|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293009|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14293010|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293011|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
14293012|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14293013|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293014|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293015|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293016|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15146270|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
15146271|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146272|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146273|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15146274|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
15146275|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
15146276|NCT02237508|Hormones|hormones|mesh-ancestor
15146277|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146278|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15146279|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15146280|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15146281|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
15146282|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146283|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146284|NCT02237508|Antidotes|antidotes|mesh-ancestor
15146285|NCT02237508|Protective Agents|protective agents|mesh-ancestor
15146286|NCT02197234|Osimertinib|osimertinib|mesh-list
15146287|NCT02197234|Simvastatin|simvastatin|mesh-list
15146288|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15146289|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15146290|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
15146291|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286768|NCT00524173|Tenofovir|tenofovir|mesh-list
14286769|NCT00524173|Emtricitabine|emtricitabine|mesh-list
14286770|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
14286771|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286772|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14286773|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14286774|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286775|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286776|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14286777|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14286778|NCT00524225|Oprelvekin|oprelvekin|mesh-list
14286779|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286780|NCT00524264|Ketorolac|ketorolac|mesh-list
14286781|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14286782|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14286783|NCT00524264|Analgesics|analgesics|mesh-ancestor
14286784|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
14286785|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286786|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286787|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286788|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286789|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14286790|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286791|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286792|NCT00524303|Paclitaxel|paclitaxel|mesh-list
14286793|NCT00524303|Trastuzumab|trastuzumab|mesh-list
14286794|NCT00524303|Lapatinib|lapatinib|mesh-list
14286795|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14286796|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286797|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
14286798|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
14286799|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
14286800|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286801|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286802|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286803|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286804|NCT00524316|Doxorubicin|doxorubicin|mesh-list
14286805|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14286806|NCT00524316|Sunitinib|sunitinib|mesh-list
14286807|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14286808|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286809|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14286810|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14286811|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286812|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286813|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286814|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286815|NCT00524316|Growth Substances|growth substances|mesh-ancestor
14286816|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286817|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
15146292|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15146293|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15146294|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146295|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146296|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15146297|NCT02163733|Osimertinib|osimertinib|mesh-list
15146298|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146299|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286818|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286819|NCT00524342|Oprelvekin|oprelvekin|mesh-list
14286820|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286821|NCT00524368|Ritonavir|ritonavir|mesh-list
14286822|NCT00524368|Darunavir|darunavir|mesh-list
14286823|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14286824|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14286825|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
14286826|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286827|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286828|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14286829|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14286830|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
14286831|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286832|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14286833|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14286834|NCT00524472|Insulin|insulin|mesh-list
15146300|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146301|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146302|NCT02157883|Itraconazole|itraconazole|mesh-list
15146303|NCT02157883|Osimertinib|osimertinib|mesh-list
15146304|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
15146305|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146306|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15146307|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15146308|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146309|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286835|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14286836|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14286837|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286838|NCT00524576|Vaccines|vaccines|mesh-list
14286839|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
14286840|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286841|NCT00524589|Calcitriol|calcitriol|mesh-list
14286842|NCT00524589|Dexamethasone|dexamethasone|mesh-list
14286843|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286844|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
14286845|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
14286846|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286847|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286848|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14286849|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
14286850|NCT00524589|Hormones|hormones|mesh-ancestor
14286851|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286852|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14286853|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286854|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14286855|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14286856|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14286857|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286858|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14286859|NCT00524589|Vitamins|vitamins|mesh-ancestor
14286860|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
14286861|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14286862|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
14286863|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14286864|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286865|NCT00524680|Vitamins|vitamins|mesh-ancestor
14286866|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
14286867|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14286868|NCT00525031|Interferons|interferons|mesh-list
14286869|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
14286870|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
14286871|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14286872|NCT00525031|Temozolomide|temozolomide|mesh-list
14286873|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286874|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
14286875|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286876|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286877|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
14286878|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286879|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
14286880|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286881|NCT00525044|Ambroxol|ambroxol|mesh-list
14286882|NCT00525044|Expectorants|expectorants|mesh-ancestor
14286883|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
14286884|NCT00525057|Dalteparin|dalteparin|mesh-list
14286885|NCT00525057|Tinzaparin|tinzaparin|mesh-list
14286886|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14286887|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
14286888|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14286889|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14286890|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286891|NCT00525135|Valproic Acid|valproic acid|mesh-list
14286892|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
14286893|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286894|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286895|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
14286896|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286897|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286898|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
15146310|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14286899|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14286900|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14286901|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14286902|NCT00525148|Afatinib|afatinib|mesh-list
14286903|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286904|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286905|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286906|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286907|NCT00525161|Sorafenib|sorafenib|mesh-list
14286908|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286909|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286910|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286911|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286912|NCT00525265|Tolvaptan|tolvaptan|mesh-list
14286913|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14286914|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286915|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
14286916|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286917|NCT00525421|Curcumin|curcumin|mesh-list
14286918|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15146311|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
15146312|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146313|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146314|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15146315|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146316|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286919|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14286920|NCT00525421|Analgesics|analgesics|mesh-ancestor
14286921|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
14020576|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14020577|NCT02779530|Diclofenac|diclofenac|mesh-list
14020578|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020579|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14286922|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286923|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286924|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14286925|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286926|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286927|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286928|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286929|NCT00525499|Androgens|androgens|mesh-list
14286930|NCT00525499|Hormones|hormones|mesh-ancestor
14286931|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14286932|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286933|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
14286934|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14286935|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
14286936|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14286937|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286938|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14286939|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
14286940|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
14286941|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14286942|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
14286943|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14286944|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286945|NCT00525525|Bevacizumab|bevacizumab|mesh-list
14286946|NCT00525525|Temozolomide|temozolomide|mesh-list
14286947|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14286948|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286949|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146317|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15146318|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15146319|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15146320|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
15146321|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146322|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146323|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15146324|NCT01822288|Tibolone|tibolone|mesh-list
15146325|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
15146326|NCT01822288|Estradiol|estradiol|mesh-list
15146327|NCT01822288|Estrogens|estrogens|mesh-ancestor
15146328|NCT01822288|Hormones|hormones|mesh-ancestor
14286950|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14286951|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14286952|NCT00525525|Growth Substances|growth substances|mesh-ancestor
14286953|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286954|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
14286955|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286956|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
14286957|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286958|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14286959|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286960|NCT00525590|Carmustine|carmustine|mesh-list
14286961|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286962|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
14286963|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286964|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286965|NCT00525603|Vidarabine|vidarabine|mesh-list
14286966|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
14286967|NCT00525603|Rituximab|rituximab|mesh-list
14286968|NCT00525603|Fludarabine|fludarabine|mesh-list
14286969|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
14286970|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
14286971|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14286972|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
14286973|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14286974|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14286975|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14286976|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
14286977|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286978|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14286979|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14286980|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14286981|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14286982|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
14286983|NCT00525603|Antiviral Agents|antiviral agents|mesh-ancestor
14286984|NCT00525603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286985|NCT00525733|Ritonavir|ritonavir|mesh-list
14286986|NCT00525733|Darunavir|darunavir|mesh-list
14286987|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
14286988|NCT00525733|Maraviroc|maraviroc|mesh-list
14286989|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14286990|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14286991|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
14286992|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14286993|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14286994|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14286995|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14286996|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
14286997|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14286998|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14286999|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14287000|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14287001|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14287002|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14287003|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14287004|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14287005|NCT00525785|Leucovorin|leucovorin|mesh-list
14287006|NCT00525785|Folic Acid|folic acid|mesh-list
15146329|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146330|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287007|NCT00525785|Fluorouracil|fluorouracil|mesh-list
14287008|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
14287009|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
14287010|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
14287011|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287012|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287013|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287014|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287015|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
14287016|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287017|NCT00525785|Antidotes|antidotes|mesh-ancestor
14287018|NCT00525785|Protective Agents|protective agents|mesh-ancestor
14287019|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
14020580|NCT02779530|Analgesics|analgesics|mesh-ancestor
14287020|NCT00525785|Vitamins|vitamins|mesh-ancestor
14287021|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
14287022|NCT00525785|Hematinics|hematinics|mesh-ancestor
14562776|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
14287023|NCT00525798|Calcitonin|calcitonin|mesh-list
14287024|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
14287025|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14287026|NCT00525798|Katacalcin|katacalcin|mesh-list
14287027|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14287028|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287029|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14287030|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
14287031|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14287032|NCT00525824|Simvastatin|simvastatin|mesh-list
14287033|NCT00525824|Ezetimibe|ezetimibe|mesh-list
14287034|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14287035|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14287036|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
14287037|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287038|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14287039|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14287040|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287041|NCT00525837|Varenicline|varenicline|mesh-list
14287042|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14287043|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14287044|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
14287045|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287046|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287047|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287048|NCT00525876|Vidarabine|vidarabine|mesh-list
14287049|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
14287050|NCT00525876|Rituximab|rituximab|mesh-list
14287051|NCT00525876|Fludarabine|fludarabine|mesh-list
14287052|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
14287053|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
14562777|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562778|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
14562779|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14562780|NCT00002888|Paclitaxel|paclitaxel|mesh-list
14562781|NCT00002888|Fluorouracil|fluorouracil|mesh-list
14562782|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562783|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562784|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562785|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562786|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562787|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562788|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
14562789|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562790|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562791|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
14562792|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562793|NCT00002889|Leuprolide|leuprolide|mesh-list
14562794|NCT00002889|Goserelin|goserelin|mesh-list
14562795|NCT00002889|Flutamide|flutamide|mesh-list
14562796|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14562797|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
14562798|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14562799|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562800|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14562801|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562802|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
14562803|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
14562804|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14562805|NCT00002890|Lintuzumab|lintuzumab|mesh-list
14562806|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14562807|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562808|NCT00002892|Interferons|interferons|mesh-list
14562809|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
14562810|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562811|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
14562812|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562813|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
14562814|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562815|NCT00002893|Leucovorin|leucovorin|mesh-list
14562816|NCT00002893|Fluorouracil|fluorouracil|mesh-list
14562817|NCT00002893|Raltitrexed|raltitrexed|mesh-list
14562818|NCT00002893|Calcium|calcium|mesh-list
14562819|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
14562820|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14562821|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287054|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562822|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
15146331|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15146332|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
15146333|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15146334|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14287055|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
14287056|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287057|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287058|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15146335|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14287059|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
14287060|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287061|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287062|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14287063|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14287064|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287065|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
14287066|NCT00525876|Antiviral Agents|antiviral agents|mesh-ancestor
14287067|NCT00525876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287068|NCT00525902|Adalimumab|adalimumab|mesh-list
14287069|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287070|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287071|NCT00525915|Fluorouracil|fluorouracil|mesh-list
14287072|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
14287073|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
14287074|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287075|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287076|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287077|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287078|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
14287079|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287080|NCT00526058|Clotrimazole|clotrimazole|mesh-list
14287081|NCT00526058|Miconazole|miconazole|mesh-list
14287082|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14287083|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287084|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
14287085|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14287086|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14287087|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287088|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287089|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14287090|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
14287091|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287092|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287093|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14287094|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14287095|NCT00526097|Bisacodyl|bisacodyl|mesh-list
14287096|NCT00526097|Cathartics|cathartics|mesh-ancestor
14287097|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287098|NCT00526097|Laxatives|laxatives|mesh-ancestor
14287099|NCT00526110|Docetaxel|docetaxel|mesh-list
14287100|NCT00526110|Fluorouracil|fluorouracil|mesh-list
14287101|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
14287102|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287103|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14287104|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14287105|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14287106|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287107|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
14287108|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287109|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287110|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
14287111|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287112|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
14287113|NCT00526292|Fludarabine|fludarabine|mesh-list
14287114|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287115|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
14287116|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287117|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287118|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14287119|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
14287120|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287121|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287122|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14287123|NCT00526474|Vorapaxar|vorapaxar|mesh-list
14287124|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14287125|NCT00526591|Everolimus|everolimus|mesh-list
14287126|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287127|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287128|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
14287129|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287130|NCT00526630|Methylphenidate|methylphenidate|mesh-list
14287131|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14287132|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287133|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14287134|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14287135|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287136|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287137|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
14287138|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287139|NCT00526656|Sunitinib|sunitinib|mesh-list
14287140|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020581|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
14020582|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020583|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287141|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14287142|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14287143|NCT00526656|Growth Substances|growth substances|mesh-ancestor
14287144|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287145|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
14287146|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14287147|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287148|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287149|NCT00526669|Capecitabine|capecitabine|mesh-list
14287150|NCT00526669|Lapatinib|lapatinib|mesh-list
14287151|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287152|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
14287153|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287154|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287155|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14287156|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287157|NCT00526799|Sorafenib|sorafenib|mesh-list
14287158|NCT00526799|Topotecan|topotecan|mesh-list
14287159|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287160|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14287161|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287162|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287163|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14287164|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14287165|NCT00526890|Selenium|selenium|mesh-list
14287166|NCT00526890|Paclitaxel|paclitaxel|mesh-list
14287167|NCT00526890|Carboplatin|carboplatin|mesh-list
14287168|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14287169|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287170|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14287171|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14287172|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14287173|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287174|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
14287175|NCT00526890|Protective Agents|protective agents|mesh-ancestor
14287176|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287177|NCT00526890|Trace Elements|trace elements|mesh-ancestor
14287178|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
14287179|NCT00527072|Infliximab|infliximab|mesh-list
14287180|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
14287181|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287182|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287183|NCT00527111|Fluorouracil|fluorouracil|mesh-list
14287184|NCT00527111|Cetuximab|cetuximab|mesh-list
14287185|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
14287186|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287187|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287188|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287189|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287190|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
14287191|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287192|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14287193|NCT00527124|Prednisone|prednisone|mesh-list
14287194|NCT00527124|Docetaxel|docetaxel|mesh-list
14287195|NCT00527124|Cediranib|cediranib|mesh-list
14287196|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287197|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
14287198|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
14287199|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
14287200|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287201|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287202|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
14287203|NCT00527124|Hormones|hormones|mesh-ancestor
14287204|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287205|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287206|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14287207|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287208|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14287209|NCT00527332|Fentanyl|fentanyl|mesh-list
14287210|NCT00527332|Morphine|morphine|mesh-list
14287211|NCT00527332|Bupivacaine|bupivacaine|mesh-list
14287212|NCT00527332|Propofol|propofol|mesh-list
14287213|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
14287214|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
14287215|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14287216|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287217|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
14287218|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287219|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14287220|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14287221|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
14287222|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14287223|NCT00527332|Narcotics|narcotics|mesh-ancestor
14287224|NCT00527332|Analgesics|analgesics|mesh-ancestor
14287225|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14287226|NCT00527397|Insulin|insulin|mesh-list
14287227|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14287228|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287229|NCT00527423|Aflibercept|aflibercept|mesh-list
14287230|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14287231|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14287232|NCT00527423|Growth Substances|growth substances|mesh-ancestor
14287233|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287234|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14287235|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287236|NCT00527475|Ranibizumab|ranibizumab|mesh-list
14287237|NCT00527475|Verteporfin|verteporfin|mesh-list
14287238|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14287239|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14287240|NCT00527475|Growth Substances|growth substances|mesh-ancestor
14287241|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287242|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
14287243|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287244|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14287245|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14287246|NCT00527514|Amlodipine|amlodipine|mesh-list
14287247|NCT00527514|Olmesartan|olmesartan|mesh-list
14287248|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14287249|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14287250|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14287251|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287252|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287253|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14287254|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287255|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
14287256|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14287257|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14287258|NCT00527592|Travoprost|travoprost|mesh-list
14287259|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14287260|NCT00527592|Latanoprost|latanoprost|mesh-list
14287261|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14287262|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14287263|NCT00527605|Dutasteride|dutasteride|mesh-list
14287264|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14287265|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14287266|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287267|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287268|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
14287269|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287270|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287271|NCT00527618|Valacyclovir|valacyclovir|mesh-list
15146336|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14020584|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020585|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020586|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020587|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020588|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020589|NCT02779192|Ebselen|ebselen|mesh-list
14020590|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020591|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14287272|NCT00527618|Acyclovir|acyclovir|mesh-list
14287273|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
15146337|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14020592|NCT02779192|Analgesics|analgesics|mesh-ancestor
14020593|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
14287274|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287275|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14287276|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14287277|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
14287278|NCT00527644|Hormones|hormones|mesh-ancestor
14287279|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287280|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287281|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287282|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287283|NCT00527735|Paclitaxel|paclitaxel|mesh-list
14287284|NCT00527735|Carboplatin|carboplatin|mesh-list
14287285|NCT00527735|Ipilimumab|ipilimumab|mesh-list
14287286|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14287287|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287288|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
14287289|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
14287290|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
14287291|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287292|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14287293|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14287294|NCT00527787|Naproxen|naproxen|mesh-list
14287295|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14287296|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14287297|NCT00527787|Analgesics|analgesics|mesh-ancestor
14287298|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
14287299|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287300|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287301|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287302|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287303|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
14287304|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14287305|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287306|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287307|NCT00527826|Fluticasone|fluticasone|mesh-list
14287308|NCT00527826|Xhance|xhance|mesh-list
14287309|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14287310|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287311|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14287312|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
14287313|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287314|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287315|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14287316|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
14287317|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
14287318|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14287319|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14287320|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14287321|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14287322|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
14287323|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287324|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287325|NCT00527878|Ranitidine|ranitidine|mesh-list
14287326|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14287327|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14287328|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287329|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14287330|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
14287331|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
14287332|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287333|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287334|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287335|NCT00527904|Naproxen|naproxen|mesh-list
14287336|NCT00527904|Esomeprazole|esomeprazole|mesh-list
14287337|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14287338|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287339|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14287340|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287341|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287342|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14287343|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14287344|NCT00527904|Analgesics|analgesics|mesh-ancestor
14287345|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
14287346|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287347|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287348|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287349|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287350|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
14287351|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14287352|NCT00527943|Vorapaxar|vorapaxar|mesh-list
14287353|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14287354|NCT00528190|Itraconazole|itraconazole|mesh-list
14287355|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
14287356|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287357|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14287358|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14287359|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287360|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287361|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15146338|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15146339|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15146340|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146341|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
15146342|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
15146343|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15146344|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14287362|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
14287363|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287364|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287365|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14287366|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14287367|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287368|NCT00528372|Metformin|metformin|mesh-list
14287369|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
14287370|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14287371|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287372|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14287373|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287374|NCT00528398|Cytarabine|cytarabine|mesh-list
14287375|NCT00528398|Idarubicin|idarubicin|mesh-list
14287376|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287377|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
14287378|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287379|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287380|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
14287381|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287382|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287383|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
14287384|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287385|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14287386|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14287387|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14287388|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287389|NCT00528411|Aspirin|aspirin|mesh-list
14287390|NCT00528411|Clopidogrel|clopidogrel|mesh-list
14287391|NCT00528411|Ticagrelor|ticagrelor|mesh-list
14287392|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14287393|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14287394|NCT00528411|Analgesics|analgesics|mesh-ancestor
14287395|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
14287396|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287397|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287398|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287399|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287400|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14287401|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14287402|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287403|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14287404|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15146345|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
15146346|NCT01802632|Osimertinib|osimertinib|mesh-list
15146347|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146348|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15146349|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146350|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146351|NCT01625286|Paclitaxel|paclitaxel|mesh-list
15146352|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15146353|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15146354|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287405|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287406|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
14287407|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14287408|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15146355|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
15146356|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
14020594|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287409|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14287410|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
14287411|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287412|NCT00528450|Idarubicin|idarubicin|mesh-list
14287413|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
14287414|NCT00528450|Tretinoin|tretinoin|mesh-list
14287415|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14287416|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287417|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14287418|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14287419|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287420|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287421|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
14287422|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
14287423|NCT00528528|Ribavirin|ribavirin|mesh-list
14287424|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
14287425|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
14287426|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14287427|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14287428|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14020595|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020596|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020597|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020598|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14020599|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020600|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
14020601|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020602|NCT02779192|Protective Agents|protective agents|mesh-ancestor
14287429|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
14287430|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287431|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
14287432|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287433|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
14287434|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287435|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287436|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
14287437|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14287438|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14287439|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14287440|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287441|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146357|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
15146358|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146359|NCT01583283|Dexamethasone|dexamethasone|mesh-list
15146360|NCT01583283|Lenalidomide|lenalidomide|mesh-list
15146361|NCT01583283|Ricolinostat|ricolinostat|mesh-list
15146362|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15146363|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15146364|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
15146365|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
15146366|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146367|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287442|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
14287443|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146368|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146369|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
15146370|NCT01583283|Hormones|hormones|mesh-ancestor
15146371|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146372|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14287444|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287445|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14287446|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287447|NCT00528567|Bevacizumab|bevacizumab|mesh-list
14287448|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14287449|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287450|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14287451|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14287452|NCT00528567|Growth Substances|growth substances|mesh-ancestor
14287453|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287454|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
14287455|NCT00528580|Simvastatin|simvastatin|mesh-list
14287456|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14287457|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14287458|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
14287459|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287460|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14287461|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14287462|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287463|NCT00528645|Saracatinib|saracatinib|mesh-list
14287464|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287465|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287466|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287467|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14287468|NCT00528788|Vitamins|vitamins|mesh-ancestor
14287469|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
14287470|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287471|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14287472|NCT00528866|Docetaxel|docetaxel|mesh-list
14287473|NCT00528866|Bicalutamide|bicalutamide|mesh-list
14287474|NCT00528866|Flutamide|flutamide|mesh-list
14287475|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287476|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
14287477|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
14287478|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14287479|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287480|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
14287481|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
15146373|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146374|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
15146375|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15146376|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15146377|NCT01583283|Growth Substances|growth substances|mesh-ancestor
15146378|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
15146379|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146380|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146381|NCT01341600|Omeprazole|omeprazole|mesh-list
14287482|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287483|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287484|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14287485|NCT00528879|Metformin|metformin|mesh-list
14287486|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
14287487|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14287488|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146382|NCT01341600|Clopidogrel|clopidogrel|mesh-list
15146383|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15146384|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15146385|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15146386|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15146387|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
15146388|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146389|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146390|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146391|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15146392|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146393|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15146394|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146395|NCT01328626|Venetoclax|venetoclax|mesh-list
14287489|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14287490|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287491|NCT00528957|Tenofovir|tenofovir|mesh-list
14287492|NCT00528957|Zidovudine|zidovudine|mesh-list
14287493|NCT00528957|Stavudine|stavudine|mesh-list
14287494|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
14287495|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287496|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14287497|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14287498|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287499|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287500|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14287501|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14287502|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
14293017|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14293018|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14293019|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
14293020|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
14293021|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293022|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
14293023|NCT00565266|Hormones|hormones|mesh-ancestor
14293024|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293025|NCT00565370|Capecitabine|capecitabine|mesh-list
14293026|NCT00565370|Sorafenib|sorafenib|mesh-list
14293027|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293028|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293029|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
14293030|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293031|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293032|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293033|NCT00565409|Etanercept|etanercept|mesh-list
14293034|NCT00565409|Methotrexate|methotrexate|mesh-list
14293035|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14293036|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
14293037|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14293038|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293039|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293040|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
14293041|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293042|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293043|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14293044|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293045|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14293046|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293047|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
14293048|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293049|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14293050|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14293051|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14293052|NCT00565409|Analgesics|analgesics|mesh-ancestor
14293053|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
14293054|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293055|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293056|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293057|NCT00565448|Docetaxel|docetaxel|mesh-list
14293058|NCT00565448|Fluorouracil|fluorouracil|mesh-list
14293059|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293060|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14293061|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14293062|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14293063|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293064|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
14293065|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146396|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146397|NCT00529113|Gemcitabine|gemcitabine|mesh-list
15146398|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146399|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
15146400|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146401|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146402|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
15146403|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146404|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293066|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293067|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
15146405|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146406|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
14287503|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
14287504|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14287505|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287506|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
14287507|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287508|NCT00528996|Bromides|bromides|mesh-list
14287509|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
14287510|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14287511|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
14287512|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287513|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287514|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14287515|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
14287516|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
14287517|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14287518|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
14287519|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287520|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287521|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
14287522|NCT00529035|Interleukin-2|interleukin-2|mesh-list
14287523|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287524|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14287525|NCT00529035|Analgesics|analgesics|mesh-ancestor
14287526|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
14287527|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287528|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287529|NCT00529087|Bromides|bromides|mesh-list
14287530|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
14287531|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
14287532|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14287533|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287534|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
14287535|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287536|NCT00529100|Cisplatin|cisplatin|mesh-list
14287537|NCT00529100|Pemetrexed|pemetrexed|mesh-list
14287538|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287539|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287540|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287541|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14287542|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14287543|NCT00529126|Epinephrine|epinephrine|mesh-list
14287544|NCT00529126|Bupivacaine|bupivacaine|mesh-list
14287545|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
14287546|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
14287547|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14287548|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287549|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
14287550|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287551|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14287552|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14287553|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
14287554|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287555|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287556|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14287557|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14287558|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
14287559|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14287560|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
14287561|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
14287562|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
14287563|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14287564|NCT00529191|Atorvastatin|atorvastatin|mesh-list
14287565|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14287566|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14287567|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
14287568|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287569|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14287570|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14287571|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287572|NCT00529204|Exenatide|exenatide|mesh-list
14287573|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14287574|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287575|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15146407|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287576|NCT00529204|Incretins|incretins|mesh-ancestor
14287577|NCT00529204|Hormones|hormones|mesh-ancestor
14287578|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287579|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
14287580|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14287581|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14287582|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
14287583|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287584|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14287585|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14287586|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287587|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287588|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
14287589|NCT00529373|Vitamin D|vitamin d|mesh-list
14287590|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
14287591|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
14287592|NCT00529373|Calcium|calcium|mesh-list
14287593|NCT00529373|Vitamins|vitamins|mesh-ancestor
14287594|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
14287595|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287596|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14287597|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14287598|NCT00529373|Antacids|antacids|mesh-ancestor
14287599|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287600|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287601|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14287602|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
14287603|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14287604|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
14287605|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562823|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562824|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562825|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562826|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562827|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
14562828|NCT00002893|Antidotes|antidotes|mesh-ancestor
14562829|NCT00002893|Protective Agents|protective agents|mesh-ancestor
14562830|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
14562831|NCT00002893|Vitamins|vitamins|mesh-ancestor
14562832|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
14562833|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14562834|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562835|NCT00002894|Paclitaxel|paclitaxel|mesh-list
14562836|NCT00002894|Carboplatin|carboplatin|mesh-list
14562837|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562838|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562839|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562840|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562841|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562842|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562843|NCT00002896|Leucovorin|leucovorin|mesh-list
14562844|NCT00002896|Cobalt|cobalt|mesh-list
14562845|NCT00002896|Fluorouracil|fluorouracil|mesh-list
14562846|NCT00002896|Calcium|calcium|mesh-list
14562847|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
14562848|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14562849|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562850|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
14562851|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562852|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562853|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562854|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562855|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
14562856|NCT00002896|Antidotes|antidotes|mesh-ancestor
14562857|NCT00002896|Protective Agents|protective agents|mesh-ancestor
14562858|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
14562859|NCT00002896|Vitamins|vitamins|mesh-ancestor
14562860|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
14562861|NCT00002896|Trace Elements|trace elements|mesh-ancestor
14562862|NCT00002897|Fluorouracil|fluorouracil|mesh-list
14562863|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562864|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
14562865|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146408|NCT00288080|Dexamethasone|dexamethasone|mesh-list
15146409|NCT00288080|Prednisone|prednisone|mesh-list
14562866|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562867|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562868|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
14562869|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146410|NCT00288080|Docetaxel|docetaxel|mesh-list
14287606|NCT00529399|Antacids|antacids|mesh-ancestor
14287607|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287608|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287609|NCT00529451|Ramipril|ramipril|mesh-list
14287610|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14287611|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
14287612|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287613|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287614|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14287615|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14287616|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14287617|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
14287618|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287619|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287620|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14287621|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
14287622|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14287623|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14287624|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15146411|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
15146412|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15146413|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
15146414|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
15146415|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146416|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146417|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146418|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
15146419|NCT00288080|Hormones|hormones|mesh-ancestor
15146420|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287625|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14287626|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287627|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287628|NCT00529542|Atorvastatin|atorvastatin|mesh-list
14287629|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14287630|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14287631|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
14287632|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287633|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14287634|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14287635|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287636|NCT00529555|Minocycline|minocycline|mesh-list
14287637|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14287638|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287639|NCT00529633|Thalidomide|thalidomide|mesh-list
14287640|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287641|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
14287642|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287643|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
14287644|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14287645|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287646|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14287647|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14287648|NCT00529633|Growth Substances|growth substances|mesh-ancestor
14287649|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
14287650|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287651|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14287652|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14287653|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14287654|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287655|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287656|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287657|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287658|NCT00529789|Analgesics|analgesics|mesh-ancestor
14287659|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
14287660|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287661|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
14287662|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14287663|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
14287664|NCT00529802|Everolimus|everolimus|mesh-list
14287665|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287666|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287667|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
15146421|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14287668|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287669|NCT00530023|Insulin|insulin|mesh-list
14287670|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14287671|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287672|NCT00530075|Gusperimus|gusperimus|mesh-list
14287673|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14287674|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287675|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14287676|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287677|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287678|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
14287679|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14287680|NCT00530075|Protective Agents|protective agents|mesh-ancestor
14287681|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14287682|NCT00530088|Trioxsalen|trioxsalen|mesh-list
14287683|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287684|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
14287685|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14287686|NCT00530218|Ganciclovir|ganciclovir|mesh-list
14287687|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14287688|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
14287689|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287690|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14287691|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287692|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287693|NCT00530257|Methylphenidate|methylphenidate|mesh-list
14287694|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14287695|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287696|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14287697|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14287698|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287699|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287700|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
14287701|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287702|NCT00530270|Dexamethasone|dexamethasone|mesh-list
14287703|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287704|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
14287705|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
14287706|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287707|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287708|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287709|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
14287710|NCT00530270|Hormones|hormones|mesh-ancestor
14287711|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287712|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14287713|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287714|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14287715|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14287716|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14287717|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287718|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287719|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
14287720|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287721|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287722|NCT00530348|Interferons|interferons|mesh-list
14287723|NCT00530348|Interferon-beta|interferon-beta|mesh-list
14287724|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
14287725|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
14287726|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287727|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
14287728|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287729|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14287730|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
14287731|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287732|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14287733|NCT00530621|Pemetrexed|pemetrexed|mesh-list
14287734|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287735|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287736|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287737|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14287738|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14287739|NCT00530634|Gemcitabine|gemcitabine|mesh-list
14287740|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287741|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14287742|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
14287743|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287744|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
14287745|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287746|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287747|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287748|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
14287749|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287750|NCT00530764|Nabiximols|nabiximols|mesh-list
14287751|NCT00530764|Dronabinol|dronabinol|mesh-list
14287752|NCT00530764|Cannabidiol|cannabidiol|mesh-list
14287753|NCT00530764|Analgesics|analgesics|mesh-ancestor
14287754|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
14287755|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287756|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287757|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
14287758|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
14287759|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14287760|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14287761|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14287762|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14287763|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287764|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287765|NCT00530764|Hormones|hormones|mesh-ancestor
14287766|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287767|NCT00530777|Valacyclovir|valacyclovir|mesh-list
14287768|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
14287769|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287770|NCT00530790|Ropinirole|ropinirole|mesh-list
14287771|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14287772|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14287773|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
14287774|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
14287775|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287776|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287777|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287778|NCT00530803|Lidocaine|lidocaine|mesh-list
14287779|NCT00530803|Tetracaine|tetracaine|mesh-list
14287780|NCT00530803|Prilocaine|prilocaine|mesh-list
14287781|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14287782|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
14287783|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
14287784|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14287785|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287786|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
14287787|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287788|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14287789|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14287790|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14287791|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287792|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287793|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14287794|NCT00530842|Fluticasone|fluticasone|mesh-list
14287795|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
14287796|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14287797|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14287798|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287799|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14287800|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
14287801|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287802|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287803|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14287804|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
14287805|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
14287806|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14287807|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
14287808|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14287809|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
14287810|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287811|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287812|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14287813|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14287814|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14287815|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
14562870|NCT00002898|Dactinomycin|dactinomycin|mesh-list
14287816|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
14287817|NCT00530842|Hormones|hormones|mesh-ancestor
14287818|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287819|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
14287820|NCT00530855|Lacosamide|lacosamide|mesh-list
14287821|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
14287822|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14287823|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14287824|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287825|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287826|NCT00530920|Ritonavir|ritonavir|mesh-list
14287827|NCT00530920|Tipranavir|tipranavir|mesh-list
14287828|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14287829|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14287830|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
14287831|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287832|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287833|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14287834|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14287835|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
14287836|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287837|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14287838|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14287839|NCT00530946|Amlodipine|amlodipine|mesh-list
14287840|NCT00530946|Atorvastatin|atorvastatin|mesh-list
14287841|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14287842|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14287843|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
14287844|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287845|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14287846|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14287847|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287848|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14287849|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14287850|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287851|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14287852|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287853|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
14287854|NCT00531011|Paclitaxel|paclitaxel|mesh-list
14287855|NCT00531011|Everolimus|everolimus|mesh-list
14287856|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14287857|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287858|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14287859|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14287860|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14287861|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287862|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287863|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
14287864|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287865|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14287866|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14287867|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
14287868|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287869|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287870|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14287871|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14287872|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14287873|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14287874|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14287875|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
14287876|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287877|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287878|NCT00531206|Ritonavir|ritonavir|mesh-list
14287879|NCT00531206|Tipranavir|tipranavir|mesh-list
14287880|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14287881|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14287882|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
14287883|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287884|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287885|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14287886|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14287887|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
14287888|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287889|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14287890|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14287891|NCT00531284|Dexamethasone|dexamethasone|mesh-list
14287892|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14287893|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
14287894|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
14287895|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287896|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287897|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287898|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
14287899|NCT00531284|Hormones|hormones|mesh-ancestor
14287900|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287901|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14287902|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287903|NCT00531427|Buprenorphine|buprenorphine|mesh-list
14287904|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14287905|NCT00531427|Narcotics|narcotics|mesh-ancestor
14287906|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14287907|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287908|NCT00531427|Analgesics|analgesics|mesh-ancestor
14287909|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
14287910|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287911|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14287912|NCT00531453|Thalidomide|thalidomide|mesh-list
14287913|NCT00531453|Dexamethasone|dexamethasone|mesh-list
14287914|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
14287915|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
14287916|NCT00531453|Bortezomib|bortezomib|mesh-list
14287917|NCT00531453|BB 1101|bb 1101|mesh-list
14287918|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14287919|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
14287920|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287921|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14287922|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14287923|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
14287924|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287925|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287926|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14287927|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15146422|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287928|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
14287929|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
14287930|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14287931|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14287932|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
14287933|NCT00531453|Hormones|hormones|mesh-ancestor
14287934|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287935|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14287936|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
14287937|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287938|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
14287939|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14287940|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287941|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14287942|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14287943|NCT00531453|Growth Substances|growth substances|mesh-ancestor
14287944|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
14287945|NCT00531479|Voriconazole|voriconazole|mesh-list
14287946|NCT00531479|Anidulafungin|anidulafungin|mesh-list
14287947|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
14287948|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14287949|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14287950|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15146423|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
15146424|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
15146425|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
15146426|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146427|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
15146428|NCT00099437|Fulvestrant|fulvestrant|mesh-list
14287951|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287952|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146429|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15146430|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14287953|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14287954|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
14293068|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287955|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14287956|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287957|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14287958|NCT00531518|Lamotrigine|lamotrigine|mesh-list
14287959|NCT00531518|Aripiprazole|aripiprazole|mesh-list
14287960|NCT00531518|Bupropion|bupropion|mesh-list
14287961|NCT00531518|Fluoxetine|fluoxetine|mesh-list
14287962|NCT00531518|Sertraline|sertraline|mesh-list
14287963|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14287964|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
14287965|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14287966|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14287967|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14287968|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14287969|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14287970|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
14287971|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14287972|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14287973|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14287974|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14287975|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287976|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14287977|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14287978|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14287979|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
14287980|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14287981|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14287982|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
14287983|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14287984|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14287985|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14287986|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14287987|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14287988|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
14287989|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14287990|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14287991|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14287992|NCT00531843|PENTA|penta|mesh-list
14287993|NCT00531843|Fondaparinux|fondaparinux|mesh-list
14287994|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14287995|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
14287996|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14287997|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
14287998|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14287999|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288000|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
14288001|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14288002|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14288003|NCT00531882|Pioglitazone|pioglitazone|mesh-list
14288004|NCT00531882|Ibuprofen|ibuprofen|mesh-list
14288005|NCT00531882|Simvastatin|simvastatin|mesh-list
14288006|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14288007|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14288008|NCT00531882|Analgesics|analgesics|mesh-ancestor
14288009|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
14288010|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288011|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288012|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288013|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288014|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14288015|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288016|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288017|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14288018|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14288019|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
14288020|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14288021|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14288022|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14288023|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14288024|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146431|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15146432|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15146433|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
14288025|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15146434|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146435|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146436|NCT04250792|Naltrexone|naltrexone|mesh-list
14288026|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288027|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288028|NCT00531947|Selegiline|selegiline|mesh-list
14288029|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288030|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288031|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14288032|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15146437|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15146438|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15146439|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146440|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
15146441|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146442|NCT04250831|Chromium|chromium|mesh-list
15146443|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
15146444|NCT04250831|Trace Elements|trace elements|mesh-ancestor
15146445|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
15146446|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146447|NCT04250831|Cathartics|cathartics|mesh-ancestor
15146448|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146449|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
14020603|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14288033|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14288034|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288035|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288036|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14288037|NCT00531947|Protective Agents|protective agents|mesh-ancestor
14288038|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288039|NCT00531960|Bevacizumab|bevacizumab|mesh-list
14288040|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14288041|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288042|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146450|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14288043|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288044|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288045|NCT00531960|Growth Substances|growth substances|mesh-ancestor
14020604|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020605|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14020606|NCT02778906|Abatacept|abatacept|mesh-list
14020607|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14020608|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020609|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020610|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020611|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
14020612|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288046|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288047|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288048|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14288049|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288050|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288051|NCT00532129|Rituximab|rituximab|mesh-list
14288052|NCT00532129|Chlorambucil|chlorambucil|mesh-list
14288053|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146451|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146452|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15146453|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15146454|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146455|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146456|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146457|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15146458|NCT04250519|Eusol|eusol|mesh-list
15146459|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
15146460|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288054|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288055|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
14288056|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288057|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288058|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14288059|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
15146461|NCT04250246|Nivolumab|nivolumab|mesh-list
15146462|NCT04250246|Ipilimumab|ipilimumab|mesh-list
15146463|NCT04250246|Guadecitabine|guadecitabine|mesh-list
15146464|NCT04250246|Azacitidine|azacitidine|mesh-list
15146465|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146466|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146467|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15146468|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288060|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288061|NCT00532155|Dexamethasone|dexamethasone|mesh-list
14288062|NCT00532155|Docetaxel|docetaxel|mesh-list
14288063|NCT00532155|Aflibercept|aflibercept|mesh-list
14288064|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288065|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
14288066|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
14288067|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146469|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146470|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
15146471|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146472|NCT04250142|Methamphetamine|methamphetamine|mesh-list
14288068|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288069|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14288070|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
14288071|NCT00532155|Hormones|hormones|mesh-ancestor
14288072|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14288073|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14288074|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288075|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
14288076|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
14288077|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288078|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288079|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288080|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288081|NCT00532155|Growth Substances|growth substances|mesh-ancestor
14288082|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288083|NCT00532259|Pidilizumab|pidilizumab|mesh-list
14288084|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288085|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288086|NCT00532298|Vaccines|vaccines|mesh-list
14288087|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
14288088|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288089|NCT00532441|Docetaxel|docetaxel|mesh-list
14288090|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14288091|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288092|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
14288093|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
14288094|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288095|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288096|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14288097|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288098|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14288099|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14288100|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14288101|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288102|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288103|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288104|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288105|NCT00532480|Analgesics|analgesics|mesh-ancestor
14288106|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
14288107|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288108|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288109|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288110|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
14288111|NCT00532493|Prazosin|prazosin|mesh-list
14288112|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14288113|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14288114|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14288115|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14288116|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14288117|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288118|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288119|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020613|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020614|NCT02779569|Decitabine|decitabine|mesh-list
14020615|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14020616|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
14288120|NCT00532779|Naltrexone|naltrexone|mesh-list
14288121|NCT00532779|Bupropion|bupropion|mesh-list
14288122|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14288123|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15146473|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15146474|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146475|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
15146476|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
15146477|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288124|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288125|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
14288126|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288127|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14288128|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288129|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288130|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14288131|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14288132|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288133|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288134|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
14288135|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288136|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14288137|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14288138|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288139|NCT00532844|Vitamins|vitamins|mesh-list
14288140|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
14288141|NCT00532844|Verapamil|verapamil|mesh-list
14288142|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
14288143|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288144|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
14288145|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288146|NCT00532844|Protective Agents|protective agents|mesh-ancestor
14288147|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14288148|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14288149|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288150|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14288151|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
14288152|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
14288153|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288154|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
14288155|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288156|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288157|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14288158|NCT00532935|Metformin|metformin|mesh-list
14288159|NCT00532935|Pioglitazone|pioglitazone|mesh-list
14288160|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14288161|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14288162|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288163|NCT00532935|Incretins|incretins|mesh-ancestor
14288164|NCT00532935|Hormones|hormones|mesh-ancestor
14288165|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14288166|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14288167|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
14288168|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288169|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288170|NCT00532948|Capecitabine|capecitabine|mesh-list
14288171|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288172|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
14288173|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288174|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288175|NCT00533117|Fluoxetine|fluoxetine|mesh-list
14288176|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15146478|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
15146479|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146480|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288177|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14288178|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288179|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288180|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288181|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
14288182|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288183|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14288184|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288185|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15146481|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
15146482|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15146483|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15146484|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15146485|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15146486|NCT04250116|Apixaban|apixaban|mesh-list
15146487|NCT04250116|Clopidogrel|clopidogrel|mesh-list
15146488|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15146489|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14288186|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14288187|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14288188|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288189|NCT00533429|Bevacizumab|bevacizumab|mesh-list
14288190|NCT00533429|Carboplatin|carboplatin|mesh-list
14288191|NCT00533429|Pemetrexed|pemetrexed|mesh-list
14288192|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288193|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288194|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288195|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288196|NCT00533429|Growth Substances|growth substances|mesh-ancestor
14288197|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288198|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288199|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288200|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288201|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14288202|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14288203|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
14288204|NCT00533442|Sirolimus|sirolimus|mesh-list
14288205|NCT00533442|Tacrolimus|tacrolimus|mesh-list
14288206|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288207|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
14288208|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288209|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14288210|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288211|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288212|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14288213|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288214|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14288215|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
14288216|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14288217|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288218|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
14288219|NCT00533507|Vaccines|vaccines|mesh-list
14288220|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14288221|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
14288222|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288223|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14288224|NCT00533546|Protein C|protein c|mesh-list
14288225|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
14288226|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14288227|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14288228|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288229|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288230|NCT00533702|Dacarbazine|dacarbazine|mesh-list
14288231|NCT00533702|Ramucirumab|ramucirumab|mesh-list
14288232|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14288233|NCT00533702|Imidazole|imidazole|mesh-list
14288234|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14288235|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
14288236|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288237|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288238|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
14288239|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288240|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288241|NCT00533845|Bupivacaine|bupivacaine|mesh-list
14288242|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
14288243|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
14288244|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14288245|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288246|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
14288247|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288248|NCT00533897|Abatacept|abatacept|mesh-list
14288249|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15146490|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15146491|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15146492|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
15146493|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146494|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146495|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146496|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15146497|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
15146498|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15146499|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
15146500|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146501|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
15146502|NCT04250064|Bevacizumab|bevacizumab|mesh-list
15146503|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146504|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146505|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288250|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288251|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288252|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288253|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
14288254|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288255|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288256|NCT00533910|Rifaximin|rifaximin|mesh-list
14288257|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14288258|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288259|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14288260|NCT00533949|Paclitaxel|paclitaxel|mesh-list
14288261|NCT00533949|Carboplatin|carboplatin|mesh-list
14288262|NCT00533949|Cetuximab|cetuximab|mesh-list
14288263|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14288264|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288265|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
14288266|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
14288267|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288268|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288269|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288270|NCT00534001|Bupropion|bupropion|mesh-list
15146506|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15146507|NCT04250064|Growth Substances|growth substances|mesh-ancestor
15146508|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146509|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
15146510|NCT04250051|Vidarabine|vidarabine|mesh-list
15146511|NCT04250051|Cytarabine|cytarabine|mesh-list
15146512|NCT04250051|Fludarabine|fludarabine|mesh-list
14288271|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14288272|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288273|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14562871|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
14562872|NCT00002898|Ifosfamide|ifosfamide|mesh-list
14562873|NCT00002898|Carboplatin|carboplatin|mesh-list
14562874|NCT00002898|Etoposide|etoposide|mesh-list
14562875|NCT00002898|Vincristine|vincristine|mesh-list
14562876|NCT00002898|Epirubicin|epirubicin|mesh-list
14562877|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562878|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
14562879|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562880|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562881|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562882|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
14562883|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562884|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562885|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562886|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562887|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562888|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562889|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562890|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562891|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562892|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562893|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562894|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14562895|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146513|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
14562896|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14562897|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14562898|NCT00002901|Docetaxel|docetaxel|mesh-list
15146514|NCT04250051|Ivosidenib|ivosidenib|mesh-list
14288274|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14288275|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14288276|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288277|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288278|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
14288279|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288280|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288281|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14288282|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14288283|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288284|NCT00534313|Abatacept|abatacept|mesh-list
14288285|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14288286|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288287|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288288|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288289|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
14288290|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288291|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288292|NCT00534352|Ritonavir|ritonavir|mesh-list
14288293|NCT00534352|Darunavir|darunavir|mesh-list
14288294|NCT00534352|Etravirine|etravirine|mesh-list
14288295|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14288296|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14288297|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
14288298|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288299|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288300|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14288301|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14288302|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
14288303|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288304|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14288305|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14288306|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14288307|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14288308|NCT00534404|Nicotine|nicotine|mesh-list
14288309|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14288310|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
14288311|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288312|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288313|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14288314|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14288315|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14288316|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288317|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288318|NCT00534417|Capecitabine|capecitabine|mesh-list
14288319|NCT00534417|Fulvestrant|fulvestrant|mesh-list
14288320|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288321|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
14288322|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288323|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288324|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14288325|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14288326|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14288327|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
14288328|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14288329|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288330|NCT00534495|Rilonacept|rilonacept|mesh-list
14288331|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293069|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14293070|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
14293071|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14293072|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
14293073|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293074|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
14293075|NCT00565643|Protective Agents|protective agents|mesh-ancestor
14293076|NCT00565643|Laxatives|laxatives|mesh-ancestor
14293077|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293078|NCT00565669|Cyclosporine|cyclosporine|mesh-list
14293079|NCT00565669|Cyclosporins|cyclosporins|mesh-list
14293080|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293081|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293082|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293083|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
14288332|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14288333|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
14020617|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020618|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020619|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020620|NCT02778828|Linezolid|linezolid|mesh-list
14020621|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14020622|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288334|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288335|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14288336|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14288337|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14288338|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288339|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14288340|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14288341|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15146515|NCT04250051|Lenograstim|lenograstim|mesh-list
14288342|NCT00534794|Analgesics|analgesics|mesh-ancestor
14288343|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
14288344|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288345|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288346|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288347|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15146516|NCT04250051|Sargramostim|sargramostim|mesh-list
15146517|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146518|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146519|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
15146520|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146521|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146522|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
15146523|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146524|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
15146525|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146526|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15146527|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146528|NCT04249713|Brodalumab|brodalumab|mesh-list
15146529|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
15146530|NCT04249908|Maleic acid|maleic acid|mesh-list
15146531|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146532|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146533|NCT04249882|Naltrexone|naltrexone|mesh-list
15146534|NCT04249882|Varenicline|varenicline|mesh-list
15146535|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15146536|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15146537|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146538|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
15146539|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146540|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15146541|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15146542|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
15146543|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146544|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146545|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
15146546|NCT04249570|Povidone|povidone|mesh-list
15146547|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
15146548|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
15146549|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15146550|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179703|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15179704|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15179705|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15179706|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
15179707|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179708|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179709|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179710|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
15179711|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15179712|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15179713|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179714|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15179715|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14020623|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14288348|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15179716|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
15179717|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288349|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14288350|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14288351|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
14288352|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
14288353|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288354|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288355|NCT00534833|Vaccines|vaccines|mesh-list
14288356|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
14288357|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288358|NCT00535002|Yohimbine|yohimbine|mesh-list
14288359|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
14288360|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
14288361|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288362|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288363|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14288364|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14288365|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14288366|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
14288367|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288368|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288369|NCT00535002|Urological Agents|urological agents|mesh-ancestor
14288370|NCT00535132|Risperidone|risperidone|mesh-list
14288371|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14288372|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14288373|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
14288374|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288375|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288376|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020624|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020625|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020626|NCT02778789|Adalimumab|adalimumab|mesh-list
15146551|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
15146552|NCT04249804|Analgesics|analgesics|mesh-ancestor
15146553|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
15146554|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146555|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146556|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
15146557|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146558|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14288377|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14288378|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14288379|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14288380|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288381|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14288382|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
14288383|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14288384|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14288385|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14288386|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14288387|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14288388|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146559|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
14288389|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288390|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288391|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14288392|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14288393|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
14288394|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288395|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288396|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14288397|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14288398|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
14288399|NCT00535288|Mirtazapine|mirtazapine|mesh-list
14288400|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288401|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288402|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288403|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14288404|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
14288405|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
14288406|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288407|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288408|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15146560|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15146561|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15146562|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146563|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15146564|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
15146565|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15146566|NCT04249544|Pramipexole|pramipexole|mesh-list
15146567|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
15146568|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146569|NCT04249544|Protective Agents|protective agents|mesh-ancestor
15146570|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146571|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15146572|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15146573|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
15146574|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
15146575|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146576|NCT04249531|Amikacin|amikacin|mesh-list
14288409|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14288410|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14288411|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14288412|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14288413|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14288414|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
14288415|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14288416|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15146577|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15146578|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288417|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
14288418|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14288419|NCT00535392|Levetiracetam|levetiracetam|mesh-list
14288420|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
14288421|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
14288422|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14288423|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14288424|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288425|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288426|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
14288427|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288428|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288429|NCT00535613|Propofol|propofol|mesh-list
14288430|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14288431|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14288432|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288433|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14288434|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
14288435|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
14288436|NCT00535652|Ertapenem|ertapenem|mesh-list
14288437|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15146579|NCT04249427|Erenumab|erenumab|mesh-list
15146580|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15146581|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146582|NCT04249427|Analgesics|analgesics|mesh-ancestor
15146583|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
15146584|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146585|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146586|NCT04249622|Rifaximin|rifaximin|mesh-list
15146587|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15146588|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146589|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146590|NCT04249154|Leuprolide|leuprolide|mesh-list
15146591|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15146592|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
15146593|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15146594|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146595|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15146596|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146597|NCT04249284|BMS-986165|bms-986165|mesh-list
15146598|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
15146599|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15146600|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146601|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146602|NCT04248998|Metformin|metformin|mesh-list
15146603|NCT04248998|Paclitaxel|paclitaxel|mesh-list
15146604|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
15146605|NCT04248998|Doxorubicin|doxorubicin|mesh-list
15146606|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14288438|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288439|NCT00535730|Vaccines|vaccines|mesh-list
14288440|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14288441|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
14288442|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288443|NCT00535743|Bromides|bromides|mesh-list
14288444|NCT00535743|Rocuronium|rocuronium|mesh-list
14288445|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
14288446|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14288447|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14288448|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14288449|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288450|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288451|NCT00535782|Methotrexate|methotrexate|mesh-list
14288452|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14288453|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
14288454|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14288455|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288456|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288457|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
14288458|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288459|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288460|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
14288461|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288462|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14288463|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288464|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
14288465|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288466|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14288467|NCT00535847|Interferons|interferons|mesh-list
14288468|NCT00535847|Ribavirin|ribavirin|mesh-list
14288469|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
14288470|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
14288471|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14288472|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146607|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146608|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
15146609|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
15146610|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288473|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
15146611|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288474|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288475|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
14288476|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288477|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
14288478|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288479|NCT00535873|Lenalidomide|lenalidomide|mesh-list
14288480|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
14288481|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288482|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288483|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288484|NCT00535873|Growth Substances|growth substances|mesh-ancestor
14288485|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288486|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288487|NCT00535925|Aspirin|aspirin|mesh-list
14288488|NCT00535925|Atenolol|atenolol|mesh-list
14288489|NCT00535925|Amlodipine|amlodipine|mesh-list
14288490|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14288491|NCT00535925|Clonidine|clonidine|mesh-list
14288492|NCT00535925|Ramipril|ramipril|mesh-list
14288493|NCT00535925|Irbesartan|irbesartan|mesh-list
14288494|NCT00535925|Doxazosin|doxazosin|mesh-list
14288495|NCT00535925|Furosemide|furosemide|mesh-list
15146612|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146613|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
15146614|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146615|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15146616|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15146617|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
15146618|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15146619|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15146620|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14020627|NCT02778789|Etanercept|etanercept|mesh-list
14020628|NCT02778789|Golimumab|golimumab|mesh-list
14288496|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
14288497|NCT00535925|Simvastatin|simvastatin|mesh-list
14288498|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288499|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14288500|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14288501|NCT00535925|Analgesics|analgesics|mesh-ancestor
14288502|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
14288503|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288504|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288505|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288506|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14288507|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14288508|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288509|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14288510|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14288511|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288512|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
14288513|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14288514|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14288515|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15146621|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15146622|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15146623|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146624|NCT04249063|Lidocaine|lidocaine|mesh-list
15146625|NCT04249063|Anesthetics|anesthetics|mesh-list
15146626|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
14288516|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14288517|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
14288518|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14288519|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14288520|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
14288521|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14288522|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14288523|NCT00535925|Diuretics|diuretics|mesh-ancestor
14288524|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
14288525|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14288526|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14288527|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
14288528|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
14288529|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14288530|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14288531|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14288532|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
14288533|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146627|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146628|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146629|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
15146630|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146631|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15146632|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15146633|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15146634|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288534|NCT00535925|Hematinics|hematinics|mesh-ancestor
14288535|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14288536|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
14288537|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15146635|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146636|NCT04249037|Tenofovir|tenofovir|mesh-list
15146637|NCT04249037|Emtricitabine|emtricitabine|mesh-list
15146638|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15146639|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15146640|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
15146641|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146642|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15146643|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15146644|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146645|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146646|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15146647|NCT04248621|Goserelin|goserelin|mesh-list
15146648|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15146649|NCT04248621|Leuprolide|leuprolide|mesh-list
15146650|NCT04248621|Flutamide|flutamide|mesh-list
15146651|NCT04248621|Bicalutamide|bicalutamide|mesh-list
15146652|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
15146653|NCT04248621|Androgens|androgens|mesh-list
15146654|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15146655|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146656|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
14288538|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14288539|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14288540|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14288541|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14288542|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14288543|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14288544|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14288545|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
14288546|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14288547|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14288548|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14288549|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288550|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288551|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
14288552|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288553|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288554|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14288555|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288556|NCT00536107|Docetaxel|docetaxel|mesh-list
14288557|NCT00536107|Gefitinib|gefitinib|mesh-list
14288558|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288559|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14288560|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14288561|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288562|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288563|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14288564|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288565|NCT00536120|Natalizumab|natalizumab|mesh-list
14288566|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14288567|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
14288568|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288569|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14288570|NCT00536172|Citalopram|citalopram|mesh-list
14288571|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14288572|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14288573|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288574|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288575|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288576|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
14288577|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288578|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14288579|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288580|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288581|NCT00536198|Sertraline|sertraline|mesh-list
14288582|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288583|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288584|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14288585|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14288586|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288587|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288588|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288589|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
14288590|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288591|NCT00536263|Interferons|interferons|mesh-list
14288592|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
15146657|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146658|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146659|NCT04248621|Hormones|hormones|mesh-ancestor
15146660|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
15146661|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15146662|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
15146663|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15146664|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15146665|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15146666|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
15146667|NCT04248608|Morphine|morphine|mesh-list
15146668|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15146669|NCT04248608|Narcotics|narcotics|mesh-ancestor
15146670|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146671|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146672|NCT04248608|Analgesics|analgesics|mesh-ancestor
15146673|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
15146674|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288593|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
14288594|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14288595|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288596|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
14288597|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288598|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
15146675|NCT04248348|Heparin|heparin|mesh-list
15146676|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15146677|NCT04248348|Tinzaparin|tinzaparin|mesh-list
15146678|NCT04248348|Dalteparin|dalteparin|mesh-list
15146679|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
15146680|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15146681|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15146682|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146683|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
15146684|NCT04248452|Leucovorin|leucovorin|mesh-list
15146685|NCT04248452|Folic Acid|folic acid|mesh-list
14288599|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288600|NCT00536341|Rituximab|rituximab|mesh-list
14288601|NCT00536341|Fludarabine|fludarabine|mesh-list
14288602|NCT00536341|Lenalidomide|lenalidomide|mesh-list
14288603|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288604|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288605|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
15146686|NCT04248452|Fluorouracil|fluorouracil|mesh-list
14288606|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288607|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288608|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288609|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288610|NCT00536341|Growth Substances|growth substances|mesh-ancestor
14288611|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288612|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14288613|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15146687|NCT04248452|Capecitabine|capecitabine|mesh-list
15146688|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
15146689|NCT04248452|Calcium|calcium|mesh-list
15146690|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
15146691|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15146692|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146693|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15146694|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
15146695|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146696|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146697|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146698|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146699|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
15146700|NCT04248452|Antidotes|antidotes|mesh-ancestor
15146701|NCT04248452|Protective Agents|protective agents|mesh-ancestor
15146702|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
15146703|NCT04248452|Vitamins|vitamins|mesh-ancestor
15146704|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
15146705|NCT04248452|Hematinics|hematinics|mesh-ancestor
15146706|NCT04248309|Progesterone|progesterone|mesh-list
15146707|NCT04248309|Progestins|progestins|mesh-ancestor
15146708|NCT04248309|Hormones|hormones|mesh-ancestor
15146709|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146710|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146711|NCT04247867|Psyllium|psyllium|mesh-list
15146712|NCT04247867|Cathartics|cathartics|mesh-ancestor
15146713|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146714|NCT04248205|Ketamine|ketamine|mesh-list
15146715|NCT04248205|Analgesics|analgesics|mesh-ancestor
15146716|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
14288614|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14288615|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288616|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288617|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288618|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288619|NCT00536471|Analgesics|analgesics|mesh-ancestor
14288620|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
15146717|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146718|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146719|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15146720|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15146721|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
15146722|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
15146723|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146724|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15146725|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15146726|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146727|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146728|NCT04247984|Bevacizumab|bevacizumab|mesh-list
15146729|NCT04247984|Fluorouracil|fluorouracil|mesh-list
15146730|NCT04247984|Capecitabine|capecitabine|mesh-list
15146731|NCT04247984|Irinotecan|irinotecan|mesh-list
15146732|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288621|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288622|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288623|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288624|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
14288625|NCT00536484|Fesoterodine|fesoterodine|mesh-list
14288626|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14288627|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14288628|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
14288629|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288630|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288631|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288632|NCT00536484|Urological Agents|urological agents|mesh-ancestor
14288633|NCT00536510|Niacin|niacin|mesh-list
14288634|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14288635|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
14288636|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288637|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14288638|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
14288639|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
14288640|NCT00536510|Vitamins|vitamins|mesh-ancestor
14288641|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
14288642|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288643|NCT00536575|Bortezomib|bortezomib|mesh-list
14288644|NCT00536575|Sorafenib|sorafenib|mesh-list
14288645|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288646|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14288647|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288648|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288649|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
14288650|NCT00536601|Melphalan|melphalan|mesh-list
14288651|NCT00536601|Busulfan|busulfan|mesh-list
14288652|NCT00536601|Thiotepa|thiotepa|mesh-list
14288653|NCT00536601|Carmustine|carmustine|mesh-list
14288654|NCT00536601|Carboplatin|carboplatin|mesh-list
14288655|NCT00536601|Etoposide|etoposide|mesh-list
14288656|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
14288657|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288658|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
14288659|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288660|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15146733|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146734|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15146735|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15146736|NCT04247984|Growth Substances|growth substances|mesh-ancestor
15146737|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146738|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
15146739|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
15146740|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146741|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146742|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146743|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
15146744|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15146745|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15146746|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146747|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
15146748|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15146749|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146750|NCT04248179|Sufentanil|sufentanil|mesh-list
15146751|NCT04248179|Ropivacaine|ropivacaine|mesh-list
15146752|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
15146753|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
15146754|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146755|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146756|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
15146757|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146758|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15146759|NCT04248179|Narcotics|narcotics|mesh-ancestor
14020629|NCT02778789|Infliximab|infliximab|mesh-list
14288661|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14288662|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
14288663|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288664|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288665|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14288666|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14288667|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14288668|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14288669|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288670|NCT00536731|Budesonide|budesonide|mesh-list
14288671|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14288672|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14288673|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
14288674|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288675|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14288676|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
14288677|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288678|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288679|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
15146760|NCT04248179|Analgesics|analgesics|mesh-ancestor
15146761|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15146762|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15146763|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
15146764|NCT04247633|Palbociclib|palbociclib|mesh-list
15146765|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146766|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15146767|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146768|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146769|NCT04247646|Melatonin|melatonin|mesh-list
15146770|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
15146771|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146772|NCT04247646|Protective Agents|protective agents|mesh-ancestor
15146773|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146774|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179718|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179719|NCT03947411|Oseltamivir|oseltamivir|mesh-list
15179720|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
15179721|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179722|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179723|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179724|NCT03947125|Buprenorphine|buprenorphine|mesh-list
15179725|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15179726|NCT03947125|Narcotics|narcotics|mesh-ancestor
15179727|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179728|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179729|NCT03947125|Analgesics|analgesics|mesh-ancestor
15179730|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
15179731|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179732|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15179733|NCT03946878|Venetoclax|venetoclax|mesh-list
15179734|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
15179735|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179736|NCT03946657|Anesthetics|anesthetics|mesh-list
15179737|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
15179738|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179739|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179740|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
15179741|NCT03946826|Halometasone|halometasone|mesh-list
15179742|NCT03946826|Petrolatum|petrolatum|mesh-list
15179743|NCT03946826|Emollients|emollients|mesh-ancestor
15179744|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
15179745|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179746|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
15179747|NCT03946826|Hormones|hormones|mesh-ancestor
15179748|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179749|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179750|NCT03946514|Losartan|losartan|mesh-list
15179751|NCT03946514|Amlodipine|amlodipine|mesh-list
15179752|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15179753|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15179754|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15179755|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15179756|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179757|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15179758|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179759|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
15179760|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14288680|NCT00536731|Hormones|hormones|mesh-ancestor
14288681|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14288682|NCT00536809|Capecitabine|capecitabine|mesh-list
14288683|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
14288684|NCT00536809|Lapatinib|lapatinib|mesh-list
14288685|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288686|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
14288687|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288688|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288689|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14288690|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288691|NCT00536874|Gemcitabine|gemcitabine|mesh-list
14288692|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
14288693|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288694|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
14288695|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288696|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288697|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
14288698|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288699|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288700|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288701|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
14288702|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288703|NCT00536913|Budesonide|budesonide|mesh-list
14288704|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
14288705|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15146775|NCT04247815|Methotrexate|methotrexate|mesh-list
14288706|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288707|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14288708|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
14288709|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146776|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15146777|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
15146778|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15146779|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146780|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146781|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
15146782|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146783|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146784|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
15146785|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146786|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15146787|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146788|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
15146789|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15146790|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15146791|NCT04247373|Ropivacaine|ropivacaine|mesh-list
15146792|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
15146793|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
15146794|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146795|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146796|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
15146797|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020630|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
14020631|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020632|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288710|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288711|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14288712|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
14288713|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
14288714|NCT00536913|Hormones|hormones|mesh-ancestor
14020633|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
14020634|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15146798|NCT04247230|Tetracaine|tetracaine|mesh-list
15146799|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
15146800|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
15146801|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146802|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146803|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
15146804|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146805|NCT04247087|Vitamin K|vitamin k|mesh-list
15146806|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
14020635|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14288715|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15146807|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14020636|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020637|NCT02778789|Analgesics|analgesics|mesh-ancestor
14020638|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
14020639|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020640|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020641|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020642|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
14020643|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14020644|NCT02778958|Acetaminophen|acetaminophen|mesh-list
14288716|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14288717|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14288718|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14288719|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
14288720|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288721|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288722|NCT00536939|Paclitaxel|paclitaxel|mesh-list
14020645|NCT02778958|Ibuprofen|ibuprofen|mesh-list
14020646|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14288723|NCT00536939|Bevacizumab|bevacizumab|mesh-list
14288724|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14288725|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146808|NCT04247087|Vitamins|vitamins|mesh-ancestor
15146809|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
15146810|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146811|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15146812|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15146813|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146814|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
15146815|NCT04247087|Coagulants|coagulants|mesh-ancestor
15146816|NCT04247165|Gemcitabine|gemcitabine|mesh-list
15146817|NCT04247165|Paclitaxel|paclitaxel|mesh-list
15146818|NCT04247165|Nivolumab|nivolumab|mesh-list
15146819|NCT04247165|Ipilimumab|ipilimumab|mesh-list
15146820|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15146821|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146822|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
15146823|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
15146824|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
15146825|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146826|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146827|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
15146828|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
15146829|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146830|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146831|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146832|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
15146833|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146834|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146835|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15146836|NCT04246905|Sulforaphane|sulforaphane|mesh-list
15146837|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15146838|NCT04246905|Protective Agents|protective agents|mesh-ancestor
15146839|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020647|NCT02778958|Analgesics|analgesics|mesh-ancestor
14288726|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
15146840|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146841|NCT04246723|Ritonavir|ritonavir|mesh-list
15146842|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
15146843|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15146844|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15146845|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
15146846|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146847|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146848|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15146849|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15146850|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
15146851|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146852|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15146853|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15146854|NCT04246684|Leucovorin|leucovorin|mesh-list
15146855|NCT04246684|Folic Acid|folic acid|mesh-list
15146856|NCT04246684|Capecitabine|capecitabine|mesh-list
14288727|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
15146857|NCT04246684|Fluorouracil|fluorouracil|mesh-list
15146858|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
15146859|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
15146860|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146861|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
14288728|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288729|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288730|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288731|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288732|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288733|NCT00536939|Growth Substances|growth substances|mesh-ancestor
14288734|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288735|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288736|NCT00536991|Calcitriol|calcitriol|mesh-list
14288737|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14288738|NCT00536991|Ketoconazole|ketoconazole|mesh-list
14288739|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
14288740|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14288741|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14288742|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14288743|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288744|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
14288745|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288746|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14288747|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14288748|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288749|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288750|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14288751|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
14288752|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14288753|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288754|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14288755|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14288756|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14288757|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15146862|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146863|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146864|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146865|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
15146866|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146867|NCT04246684|Antidotes|antidotes|mesh-ancestor
15146868|NCT04246684|Protective Agents|protective agents|mesh-ancestor
15146869|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
15146870|NCT04246684|Vitamins|vitamins|mesh-ancestor
15146871|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
15146872|NCT04246684|Hematinics|hematinics|mesh-ancestor
15146873|NCT04246567|Fentanyl|fentanyl|mesh-list
15146874|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15146875|NCT04246567|Narcotics|narcotics|mesh-ancestor
15146876|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146877|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146878|NCT04246567|Analgesics|analgesics|mesh-ancestor
15146879|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
14288758|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14288759|NCT00536991|Vitamins|vitamins|mesh-ancestor
14288760|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
14288761|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14288762|NCT00537017|Levodopa|levodopa|mesh-list
14288763|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14288764|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14288765|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
15146880|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146881|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15146882|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15146883|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
15146884|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
15146885|NCT04246697|Acetaminophen|acetaminophen|mesh-list
15146886|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15146887|NCT04246697|Morphine|morphine|mesh-list
15146888|NCT04246697|Oxycodone|oxycodone|mesh-list
15146889|NCT04246697|Gabapentin|gabapentin|mesh-list
15146890|NCT04246697|Bupivacaine|bupivacaine|mesh-list
15146891|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
15146892|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
15146893|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146894|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146895|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
15146896|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146897|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15146898|NCT04246697|Narcotics|narcotics|mesh-ancestor
15146899|NCT04246697|Analgesics|analgesics|mesh-ancestor
15146900|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
15146901|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15146902|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15146903|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288766|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288767|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288768|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288769|NCT00537030|Asparaginase|asparaginase|mesh-list
14288770|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146904|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15146905|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15146906|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146907|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146908|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
15146909|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14288771|NCT00537056|Sunitinib|sunitinib|mesh-list
15146910|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
15146911|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15146912|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15146913|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15146914|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15146915|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146916|NCT04246502|Capecitabine|capecitabine|mesh-list
15146917|NCT04246502|Trastuzumab|trastuzumab|mesh-list
15146918|NCT04246502|Pertuzumab|pertuzumab|mesh-list
15146919|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146920|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
15146921|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146922|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146923|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146924|NCT04246255|Lidocaine|lidocaine|mesh-list
15146925|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
15146926|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
15146927|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146928|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146929|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
15146930|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146931|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15146932|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15146933|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15146934|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15146935|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146936|NCT04246229|Bilirubin|bilirubin|mesh-list
15146937|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
15146938|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146939|NCT04246229|Protective Agents|protective agents|mesh-ancestor
15146940|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146941|NCT04245787|Fluorides|fluorides|mesh-list
15146942|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
15146943|NCT04245787|Protective Agents|protective agents|mesh-ancestor
15146944|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146945|NCT04245774|Bupivacaine|bupivacaine|mesh-list
15146946|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
15146947|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
15146948|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
15146949|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146950|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146951|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
15146952|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146953|NCT04245371|Lidocaine|lidocaine|mesh-list
15146954|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
15146955|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
15146956|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15146957|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146958|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
15146959|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15146960|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15146961|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15146962|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14288772|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14288773|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288774|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288775|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288776|NCT00537056|Growth Substances|growth substances|mesh-ancestor
15146963|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288777|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288778|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288779|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14288780|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288781|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288782|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14288783|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15146964|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146965|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
15146966|NCT04245722|Rituximab|rituximab|mesh-list
15146967|NCT04245722|Fludarabine|fludarabine|mesh-list
15146968|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
15146969|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146970|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
15146971|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146972|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15146973|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15146974|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
15146975|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146976|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146977|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15146978|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15146979|NCT04245618|Gemcitabine|gemcitabine|mesh-list
15146980|NCT04245618|Cisplatin|cisplatin|mesh-list
15146981|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15146982|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15146983|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
15146984|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146985|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
15146986|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15146987|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15146988|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15146989|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
15146990|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146991|NCT04245709|Clenbuterol|clenbuterol|mesh-list
15146992|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15146993|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15146994|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
15146995|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15146996|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15146997|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15146998|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15146999|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
15147000|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147001|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15147002|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
15147003|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
15147004|NCT04246151|Vancomycin|vancomycin|mesh-list
15147005|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147006|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179761|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15179762|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15179763|NCT03946514|Diuretics|diuretics|mesh-ancestor
15179764|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
15179765|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15179766|NCT03946358|Atezolizumab|atezolizumab|mesh-list
15179767|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182107|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182108|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182109|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
15182110|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182111|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15182112|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
15182113|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15182114|NCT03924518|Granisetron|granisetron|mesh-list
14288784|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14288785|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288786|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288787|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
15182115|NCT03924518|Serotonin|serotonin|mesh-list
15182116|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
15182117|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
15182118|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182119|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288788|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288789|NCT00537238|Pregabalin|pregabalin|mesh-list
14288790|NCT00537238|Levetiracetam|levetiracetam|mesh-list
14288791|NCT00537238|Analgesics|analgesics|mesh-ancestor
14288792|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
14288793|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288794|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147007|NCT04245046|Amlodipine|amlodipine|mesh-list
15147008|NCT04245046|Candesartan|candesartan|mesh-list
15147009|NCT04245046|Atorvastatin|atorvastatin|mesh-list
15147010|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15147011|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15147012|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
15147013|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147014|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15147015|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15147016|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147017|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15147018|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15147019|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15147020|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15147021|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147022|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
15147023|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15147024|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15147025|NCT04245319|Acitretin|acitretin|mesh-list
15147026|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
15147027|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
15147028|NCT04244981|Thrombin|thrombin|mesh-list
15147029|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
15147030|NCT04244981|Coagulants|coagulants|mesh-ancestor
15147031|NCT04245280|Ropivacaine|ropivacaine|mesh-list
15147032|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15147033|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
15147034|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
15147035|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147036|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147037|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
15147038|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147039|NCT04245033|Piperaquine|piperaquine|mesh-list
15147040|NCT04245033|Artenimol|artenimol|mesh-list
15147041|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
15147042|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15147043|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15147044|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147045|NCT04244695|Dexamethasone|dexamethasone|mesh-list
15147046|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15147047|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
15147048|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
15147049|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147050|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147051|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15147052|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
15147053|NCT04244695|Hormones|hormones|mesh-ancestor
15147054|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147055|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147056|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147057|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
15147058|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14288795|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
14288796|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14288797|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288798|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288799|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14288800|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14288801|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14288802|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147059|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15147060|NCT04244591|Prednisolone|prednisolone|mesh-list
15147061|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
15147062|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15147063|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
15147064|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288803|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15147065|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
15147066|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
15179768|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
15147067|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147068|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147069|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14288804|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
14288805|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
14288806|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
14288807|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14288808|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14288809|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288810|NCT00537290|Rituximab|rituximab|mesh-list
14288811|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288812|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288813|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
14288814|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288815|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288816|NCT00537303|Insulin|insulin|mesh-list
14288817|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14288818|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
14288819|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
14288820|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14288821|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
14288822|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14288823|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288824|NCT00537316|Azathioprine|azathioprine|mesh-list
14288825|NCT00537316|Infliximab|infliximab|mesh-list
14288826|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
14288827|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14288828|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14288829|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
14288830|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288831|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288832|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288833|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288834|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
14288835|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288836|NCT00537329|Anidulafungin|anidulafungin|mesh-list
15147070|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
15147071|NCT04244591|Hormones|hormones|mesh-ancestor
15147072|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147073|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15147074|NCT04244591|Protective Agents|protective agents|mesh-ancestor
15147075|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147076|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147077|NCT04244708|Temozolomide|temozolomide|mesh-list
15147078|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15147079|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
15147080|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147081|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147082|NCT04244448|Emtricitabine|emtricitabine|mesh-list
15147083|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
15147084|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147085|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15147086|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15147087|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147088|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147089|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15147090|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15147091|NCT04243954|Morphine|morphine|mesh-list
15147092|NCT04243954|Hydromorphone|hydromorphone|mesh-list
15147093|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15147094|NCT04243954|Narcotics|narcotics|mesh-ancestor
15147095|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147096|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147097|NCT04243954|Analgesics|analgesics|mesh-ancestor
15147098|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
15147099|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147100|NCT04244058|Amantadine|amantadine|mesh-list
15147101|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15147102|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15147103|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
15147104|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288837|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
14288838|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147105|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
15147106|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288839|NCT00537381|Prednisone|prednisone|mesh-list
15147107|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147108|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147109|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15147110|NCT04244058|Analgesics|analgesics|mesh-ancestor
15147111|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
15147112|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147113|NCT04244097|Bupivacaine|bupivacaine|mesh-list
15147114|NCT04244097|Neostigmine|neostigmine|mesh-list
15147115|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
15147116|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
15147117|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147118|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147119|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
15147120|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147121|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15147122|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147123|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147124|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
15147125|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147126|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15147127|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
15147128|NCT04243993|Calcium|calcium|mesh-list
15147129|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15147130|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147131|NCT04243850|Empagliflozin|empagliflozin|mesh-list
15147132|NCT04243850|Caffeine|caffeine|mesh-list
15147133|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15147134|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147135|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15147136|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147137|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147138|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15147139|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15147140|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
15147141|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147142|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15147143|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15147144|NCT04243733|Pemetrexed|pemetrexed|mesh-list
15147145|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147146|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147147|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147148|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15147149|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15147150|NCT04243811|Anesthetics|anesthetics|mesh-list
14288840|NCT00537381|Docetaxel|docetaxel|mesh-list
14288841|NCT00537381|Intetumumab|intetumumab|mesh-list
14288842|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288843|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
14288844|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
14288845|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288846|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288847|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14288848|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
14288849|NCT00537381|Hormones|hormones|mesh-ancestor
14288850|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14288851|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147151|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147152|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147153|NCT04243434|Prednisone|prednisone|mesh-list
15147154|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
15147155|NCT04243434|Doxorubicin|doxorubicin|mesh-list
15147156|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15147157|NCT04243434|Vincristine|vincristine|mesh-list
15147158|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147159|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
15147160|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147161|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147162|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15147163|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
15147164|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147165|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147166|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15147167|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15179769|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15147168|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15147169|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15147170|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147171|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15147172|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
15147173|NCT04243434|Hormones|hormones|mesh-ancestor
14288852|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14288853|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288854|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
14288855|NCT00537394|Maraviroc|maraviroc|mesh-list
14288856|NCT00537394|Darunavir|darunavir|mesh-list
14288857|NCT00537394|Tipranavir|tipranavir|mesh-list
14288858|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
14288859|NCT00537394|Etravirine|etravirine|mesh-list
14288860|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14288861|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14288862|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
14288863|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288864|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14288865|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14288866|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288867|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288868|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14288869|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14288870|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14288871|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14288872|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14288873|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
14288874|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14288875|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14288876|NCT00537407|Ribavirin|ribavirin|mesh-list
14288877|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14288878|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
15147174|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147175|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147176|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15147177|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
15147178|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
15147179|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
15179770|NCT03945903|Golimumab|golimumab|mesh-list
15179771|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15179772|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15179773|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15179774|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
15179775|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179776|NCT03945656|Insulin|insulin|mesh-list
15179777|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15179778|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
15179779|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15179780|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179781|NCT03945955|Melatonin|melatonin|mesh-list
15179782|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
15179783|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179784|NCT03945955|Protective Agents|protective agents|mesh-ancestor
15179785|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179786|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179787|NCT03945539|Itraconazole|itraconazole|mesh-list
15179788|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
15179789|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179790|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15179791|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15179792|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179793|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179794|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15179795|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
15179796|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179797|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179798|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15179799|NCT03945513|Dienogest|dienogest|mesh-list
15179800|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15179801|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14020648|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
14020649|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288879|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288880|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
14288881|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14288882|NCT00537511|Etoposide|etoposide|mesh-list
14288883|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
14288884|NCT00537511|Pomalidomide|pomalidomide|mesh-list
14288885|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288886|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14288887|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14288888|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14288889|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288890|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288891|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
14288892|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288893|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288894|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288895|NCT00537511|Growth Substances|growth substances|mesh-ancestor
14288896|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
15147180|NCT04243109|Dexamethasone|dexamethasone|mesh-list
15147181|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
15147182|NCT04243109|Pomalidomide|pomalidomide|mesh-list
15147183|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147184|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
15147185|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147186|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147187|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15147188|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
15147189|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147190|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147191|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15147192|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15147193|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
15147194|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
15147195|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147196|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15147197|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
15147198|NCT04243109|Hormones|hormones|mesh-ancestor
15147199|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147200|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147201|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15147202|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15147203|NCT04243109|Growth Substances|growth substances|mesh-ancestor
15147204|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
15147205|NCT04242914|Midazolam|midazolam|mesh-list
15147206|NCT04242914|Ketamine|ketamine|mesh-list
15147207|NCT04242914|Analgesics|analgesics|mesh-ancestor
15147208|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
15147209|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147210|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147211|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15147212|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15147213|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
14288897|NCT00537680|Ubiquinone|ubiquinone|mesh-list
14288898|NCT00537680|Idebenone|idebenone|mesh-list
14288899|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
14288900|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147214|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
15147215|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147216|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15147217|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15147218|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147219|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147220|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15147221|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15147222|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15147223|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15147224|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288901|NCT00537680|Protective Agents|protective agents|mesh-ancestor
15147225|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
15147226|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
15147227|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
15147228|NCT04242927|Niacin|niacin|mesh-list
15147229|NCT04242927|Niacinamide|niacinamide|mesh-list
15147230|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
15147231|NCT04242927|Vitamins|vitamins|mesh-ancestor
14288902|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147232|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
15147233|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288903|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
14288904|NCT00537745|Naltrexone|naltrexone|mesh-list
14288905|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14288906|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14288907|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288908|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
14288909|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288910|NCT00537771|Tamoxifen|tamoxifen|mesh-list
14288911|NCT00537771|Anastrozole|anastrozole|mesh-list
14288912|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14288913|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
14288914|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14288915|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288916|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14288917|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288918|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14288919|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14288920|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14288921|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14288922|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14288923|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288924|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288925|NCT00537810|Sibutramine|sibutramine|mesh-list
14288926|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
14288927|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288928|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
14288929|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14288930|NCT00537823|Leucovorin|leucovorin|mesh-list
14288931|NCT00537823|Bevacizumab|bevacizumab|mesh-list
14288932|NCT00537823|Cetuximab|cetuximab|mesh-list
14288933|NCT00537823|Fluorouracil|fluorouracil|mesh-list
14288934|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
14288935|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288936|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288937|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14288938|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14288939|NCT00537823|Growth Substances|growth substances|mesh-ancestor
14288940|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288941|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
14288942|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
14288943|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288944|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288945|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14288946|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
15147234|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15147235|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
15147236|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147237|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15147238|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
15147239|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
15147240|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147241|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
15147242|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15147243|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15147244|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147245|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15147246|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147247|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15147248|NCT04242758|Diuretics|diuretics|mesh-ancestor
15147249|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
15147250|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15147251|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15147252|NCT04242212|Misoprostol|misoprostol|mesh-list
15147253|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15147254|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
15147255|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15147256|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147257|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15147258|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15147259|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
15147260|NCT04242368|Fluticasone|fluticasone|mesh-list
15147261|NCT04242368|Xhance|xhance|mesh-list
15147262|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020650|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288947|NCT00537823|Antidotes|antidotes|mesh-ancestor
14020651|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
14288948|NCT00537823|Protective Agents|protective agents|mesh-ancestor
14288949|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
14288950|NCT00537823|Vitamins|vitamins|mesh-ancestor
14288951|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
14288952|NCT00537940|Pregabalin|pregabalin|mesh-list
14288953|NCT00537940|Gabapentin|gabapentin|mesh-list
14288954|NCT00537940|Analgesics|analgesics|mesh-ancestor
14288955|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
14288956|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147263|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15147264|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
15147265|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147266|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147267|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15147268|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
15147269|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
15147270|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15147271|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15147272|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
15147273|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15147274|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
15147275|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15147276|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147277|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15147278|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147279|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147280|NCT04241705|Lumefantrine|lumefantrine|mesh-list
15147281|NCT04241705|Artemether|artemether|mesh-list
15147282|NCT04241705|Primaquine|primaquine|mesh-list
15147283|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15147284|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
15147285|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15147286|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15147287|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147288|NCT04241653|Sevoflurane|sevoflurane|mesh-list
15147289|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
15147290|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147291|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147292|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15147293|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15147294|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
15147295|NCT04241731|Cetuximab|cetuximab|mesh-list
15147296|NCT04241731|Raltitrexed|raltitrexed|mesh-list
15147297|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15147298|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147299|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15147300|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
15147301|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147302|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15147303|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147304|NCT04241744|Vancomycin|vancomycin|mesh-list
15147305|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147306|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147307|NCT04241887|Anesthetics|anesthetics|mesh-list
14562899|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562900|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562901|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562902|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562903|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562904|NCT00002902|Irinotecan|irinotecan|mesh-list
14562905|NCT00002902|Raltitrexed|raltitrexed|mesh-list
14562906|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14562907|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562908|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562909|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562910|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147308|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147309|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147310|NCT04241601|Aldesleukin|aldesleukin|mesh-list
15147311|NCT04241601|Interleukin-2|interleukin-2|mesh-list
15147312|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147313|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15147314|NCT04241601|Analgesics|analgesics|mesh-ancestor
15147315|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
14288957|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147316|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14288958|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
15147317|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147318|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15147319|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15147320|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
15147321|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179802|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15179803|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15179804|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
15179805|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15179806|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179807|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15179808|NCT03945513|Estrogens|estrogens|mesh-ancestor
15179809|NCT03945513|Hormones|hormones|mesh-ancestor
15179810|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179811|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15179812|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
15179813|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15179814|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179815|NCT03945604|Apatinib|apatinib|mesh-list
15179816|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179817|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15179818|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179819|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179820|NCT03945227|Spartalizumab|spartalizumab|mesh-list
15179821|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15179822|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179823|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179824|NCT03945019|Infliximab|infliximab|mesh-list
15179825|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
15179826|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15179827|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15179828|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
15179829|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15179830|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
15179831|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179832|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179833|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15179834|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179835|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
15179836|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15179837|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
15179838|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179839|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179840|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
15179841|NCT03945396|Antacids|antacids|mesh-ancestor
15179842|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179843|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15179844|NCT03945084|Niraparib|niraparib|mesh-list
15179845|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15179846|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179847|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179848|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179849|NCT03944980|Docetaxel|docetaxel|mesh-list
15179850|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179851|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
15179852|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
15179853|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
15179854|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179855|NCT03944889|Capsaicin|capsaicin|mesh-list
15179856|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
15179857|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
15179858|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
15179859|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179860|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179861|NCT03944915|Paclitaxel|paclitaxel|mesh-list
15179862|NCT03944915|Carboplatin|carboplatin|mesh-list
15179863|NCT03944915|Fluorouracil|fluorouracil|mesh-list
15179864|NCT03944915|Nivolumab|nivolumab|mesh-list
15179865|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
15179866|NCT03944915|Lenograstim|lenograstim|mesh-list
15179867|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15179868|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179869|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
15179870|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
15179871|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288959|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14288960|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14288961|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288962|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14288963|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14288964|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14288965|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147322|NCT04241523|Lenvatinib|lenvatinib|mesh-list
15147323|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147324|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15147325|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147326|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147327|NCT04241380|Heparin|heparin|mesh-list
15147328|NCT04241380|Anticoagulants|anticoagulants|mesh-list
15147329|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15147330|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15147331|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14288966|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14288967|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14288968|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14288969|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14288970|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
14288971|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
14288972|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14288973|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14288974|NCT00537979|Vitamins|vitamins|mesh-ancestor
15147332|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147333|NCT04241211|Denosumab|denosumab|mesh-list
14288975|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
14288976|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14288977|NCT00538291|Capecitabine|capecitabine|mesh-list
14288978|NCT00538291|Cetuximab|cetuximab|mesh-list
14562911|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14562912|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
14562913|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14562914|NCT00002903|Docetaxel|docetaxel|mesh-list
14562915|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562916|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
15147334|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15147335|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562917|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
15147336|NCT04241458|Midazolam|midazolam|mesh-list
15147337|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15147338|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15147339|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147340|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147341|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15147342|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15147343|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15147344|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15147345|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
15147346|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
15147347|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
15147348|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
15147349|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147350|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147351|NCT04241276|Gemcitabine|gemcitabine|mesh-list
15147352|NCT04241276|Paclitaxel|paclitaxel|mesh-list
15147353|NCT04241276|Tretinoin|tretinoin|mesh-list
15147354|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15147355|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147356|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
15147357|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
15147358|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
15147359|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147360|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15147361|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
15147362|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
15147363|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147364|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147365|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147366|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
15147367|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147368|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
15147369|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
14562918|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
14288979|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14288980|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
14288981|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288982|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288983|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14288984|NCT00538304|Bimatoprost|bimatoprost|mesh-list
14288985|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14288986|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14288987|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14288988|NCT00538434|Reslizumab|reslizumab|mesh-list
14288989|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14288990|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
15147370|NCT04240821|Theophylline|theophylline|mesh-list
15147371|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15147372|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
15147373|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147374|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147375|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15147376|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
15147377|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15147378|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147379|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147380|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
15147381|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15147382|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15147383|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
15147384|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147385|NCT04240756|Amphetamine|amphetamine|mesh-list
15147386|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15147387|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147388|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
15147389|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
15147390|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147391|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
15147392|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147393|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147394|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
15147395|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15147396|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15147397|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15147398|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15147399|NCT04240834|Aspirin|aspirin|mesh-list
15147400|NCT04240834|Ticagrelor|ticagrelor|mesh-list
15147401|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15147402|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15147403|NCT04240834|Analgesics|analgesics|mesh-ancestor
15147404|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
15147405|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147406|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147407|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15147408|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147409|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15147410|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15147411|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147412|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15147413|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15147414|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147415|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
15147416|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15147417|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15147418|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15147419|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
15147420|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147421|NCT04240496|Clozapine|clozapine|mesh-list
15147422|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15147423|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
15147424|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147425|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147426|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147427|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15147428|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15147429|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147430|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15147431|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
15147432|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
15147433|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15147434|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15147435|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15147436|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147437|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147438|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15147439|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15147440|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147441|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
15147442|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147443|NCT04239794|Propofol|propofol|mesh-list
15147444|NCT04239794|Sevoflurane|sevoflurane|mesh-list
15147445|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15147446|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14288991|NCT00538590|Mitomycins|mitomycins|mesh-list
14288992|NCT00538590|Mitomycin|mitomycin|mesh-list
14288993|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14288994|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14288995|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
14288996|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14288997|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14288998|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14288999|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
14289000|NCT00538616|Propofol|propofol|mesh-list
14289001|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14289002|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14289003|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289004|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14289005|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
14289006|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
14289007|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14289008|NCT00538616|Analgesics|analgesics|mesh-ancestor
14289009|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
14289010|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289011|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14289012|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14289013|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14289014|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
14289015|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289016|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289017|NCT00538642|Ziprasidone|ziprasidone|mesh-list
14289018|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14289019|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
14289020|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289021|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289022|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289023|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14289024|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14289025|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14289026|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14289027|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14289028|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
14289029|NCT00538681|Pemetrexed|pemetrexed|mesh-list
14289030|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289031|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147447|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147448|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15147449|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
15147450|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
15147451|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15147452|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15147453|NCT04239833|Gefitinib|gefitinib|mesh-list
14289032|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289033|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14289034|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14289035|NCT00538733|Clarithromycin|clarithromycin|mesh-list
14289036|NCT00538733|Thalidomide|thalidomide|mesh-list
15147454|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147455|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15147456|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289037|NCT00538733|Dexamethasone|dexamethasone|mesh-list
14289038|NCT00538733|Lenalidomide|lenalidomide|mesh-list
15147457|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289039|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289040|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
14289041|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
14289042|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289043|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289044|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14289045|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
14289046|NCT00538733|Hormones|hormones|mesh-ancestor
14289047|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289048|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14289049|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289050|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
14289051|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289052|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289053|NCT00538733|Growth Substances|growth substances|mesh-ancestor
14289054|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
14289055|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14289056|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289057|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14289058|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289059|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289060|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14289061|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14289062|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289063|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
14289064|NCT00538785|Palivizumab|palivizumab|mesh-list
14289065|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
14289066|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289067|NCT00538824|Thalidomide|thalidomide|mesh-list
14289068|NCT00538824|Dexamethasone|dexamethasone|mesh-list
14289069|NCT00538824|Lenalidomide|lenalidomide|mesh-list
14289070|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289071|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
14289072|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
14289073|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289074|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289075|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14289076|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
14289077|NCT00538824|Hormones|hormones|mesh-ancestor
14289078|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289079|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14289080|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289081|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
14289082|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289083|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289084|NCT00538824|Growth Substances|growth substances|mesh-ancestor
14289085|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
14289086|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289087|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
14289088|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14289089|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289090|NCT00538850|Fentanyl|fentanyl|mesh-list
14289091|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14289092|NCT00538850|Narcotics|narcotics|mesh-ancestor
14289093|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14289094|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289095|NCT00538850|Analgesics|analgesics|mesh-ancestor
14289096|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
14289097|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289098|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14289099|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14289100|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
14289101|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
14289102|NCT00538863|Fentanyl|fentanyl|mesh-list
14289103|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14289104|NCT00538863|Narcotics|narcotics|mesh-ancestor
14289105|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14289106|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289107|NCT00538863|Analgesics|analgesics|mesh-ancestor
14289108|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
14289109|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289110|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14289111|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14289112|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
14289113|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
14562919|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289114|NCT00538902|Adalimumab|adalimumab|mesh-list
14289115|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289116|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14289117|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
14289118|NCT00538915|Antibodies|antibodies|mesh-list
14289119|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
14289120|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14289121|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14289122|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
14289123|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289124|NCT00539006|Fluticasone|fluticasone|mesh-list
14289125|NCT00539006|Xhance|xhance|mesh-list
14289126|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289127|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14289128|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
14289129|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289130|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289131|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14289132|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
14289133|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
14289134|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14289135|NCT00539032|Vaccines|vaccines|mesh-list
14289136|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
14020652|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020653|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15147458|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
15147459|NCT04239872|Calcium|calcium|mesh-list
15147460|NCT04239872|Fluorides|fluorides|mesh-list
15147461|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15147462|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147463|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14020654|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020655|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020656|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020657|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020658|NCT02778971|Flutemetamol|flutemetamol|mesh-list
14020659|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15147464|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
15147465|NCT04239872|Protective Agents|protective agents|mesh-ancestor
15147466|NCT04240106|Niraparib|niraparib|mesh-list
15147467|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15147468|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15147469|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147470|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020660|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020661|NCT02778945|Rocuronium|rocuronium|mesh-list
14020662|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14020663|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14289137|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289138|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
14289139|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14289140|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
15147471|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147472|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15147473|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15147474|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
15147475|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147476|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147477|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
15147478|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15147479|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15147480|NCT04239859|Cyclosporine|cyclosporine|mesh-list
14289141|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289142|NCT00539188|Expectorants|expectorants|mesh-ancestor
14289143|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
15147481|NCT04239859|Methotrexate|methotrexate|mesh-list
15147482|NCT04239859|Acitretin|acitretin|mesh-list
15147483|NCT04239859|Cyclosporins|cyclosporins|mesh-list
15147484|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15147485|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
15147486|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14289144|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14562920|NCT00002904|Trabectedin|trabectedin|mesh-list
14289145|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
14562921|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562922|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
15147487|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147488|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15147489|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
15147490|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147491|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147492|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
15147493|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147494|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15147495|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147496|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
15147497|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147498|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15147499|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
15147500|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147501|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15147502|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
15147503|NCT04239560|Boron|boron|mesh-list
15147504|NCT04239560|Trace Elements|trace elements|mesh-ancestor
15147505|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
15147506|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147507|NCT04239599|Leuprolide|leuprolide|mesh-list
15147508|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15147509|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
15147510|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15147511|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147512|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147513|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147514|NCT04239625|Vitamin A|vitamin a|mesh-list
15147515|NCT04239625|Retinol acetate|retinol acetate|mesh-list
15147516|NCT04239625|Vitamins|vitamins|mesh-ancestor
15147517|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
15147518|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147519|NCT04239625|Protective Agents|protective agents|mesh-ancestor
15147520|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15147521|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147522|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15147523|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
15179872|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289146|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289147|NCT00539188|Protective Agents|protective agents|mesh-ancestor
14289148|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289149|NCT00539188|Antidotes|antidotes|mesh-ancestor
14289150|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
14289151|NCT00539240|Nortriptyline|nortriptyline|mesh-list
14289152|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14289153|NCT00539240|Rabeprazole|rabeprazole|mesh-list
14289154|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14289155|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14289156|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14289157|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289158|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289159|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14289160|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14289161|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14020664|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14020665|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020666|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020667|NCT02778776|Metformin|metformin|mesh-list
14289162|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14289163|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14289164|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289165|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289166|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
14289167|NCT00539305|Testosterone|testosterone|mesh-list
14289168|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
14289169|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
14289170|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14289171|NCT00539305|Androgens|androgens|mesh-ancestor
14289172|NCT00539305|Hormones|hormones|mesh-ancestor
14289173|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289174|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179873|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
15179874|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14020668|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14289175|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147524|NCT04239586|Glyburide|glyburide|mesh-list
14020669|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020670|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
14289176|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289177|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
14289178|NCT00539500|Carboplatin|carboplatin|mesh-list
14289179|NCT00539500|Etoposide|etoposide|mesh-list
14289180|NCT00539500|Melphalan|melphalan|mesh-list
14289181|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289182|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14289183|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14289184|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14289185|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289186|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289187|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14289188|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
14289189|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14289190|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289191|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
14289192|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289193|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
14289194|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14289195|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
14289196|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289197|NCT00539513|Expectorants|expectorants|mesh-ancestor
14289198|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
14289199|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14289200|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
14289201|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289202|NCT00539513|Protective Agents|protective agents|mesh-ancestor
14289203|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289204|NCT00539513|Antidotes|antidotes|mesh-ancestor
14289205|NCT00539526|Bimatoprost|bimatoprost|mesh-list
14289206|NCT00539526|Travoprost|travoprost|mesh-list
14289207|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14289208|NCT00539526|Latanoprost|latanoprost|mesh-list
14020671|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020672|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020673|NCT02778919|Leuprolide|leuprolide|mesh-list
14020674|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14289209|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14289210|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14293084|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293085|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
14293086|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293087|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
14293088|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293089|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14293090|NCT00565773|Sirolimus|sirolimus|mesh-list
14293091|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
14293092|NCT00565773|Abatacept|abatacept|mesh-list
14293093|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293094|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293095|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14293096|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293097|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
14293098|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293099|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
15147525|NCT04239586|Glipizide|glipizide|mesh-list
15147526|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293100|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293101|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293102|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14293103|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293104|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293105|NCT00565916|Estradiol|estradiol|mesh-list
14293106|NCT00565916|Estrogens|estrogens|mesh-list
14293107|NCT00565916|Progesterone|progesterone|mesh-list
14293108|NCT00565916|Hormones|hormones|mesh-ancestor
14293109|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293110|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293111|NCT00565916|Progestins|progestins|mesh-ancestor
14293112|NCT00566020|Lamotrigine|lamotrigine|mesh-list
15147527|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147528|NCT04239755|Doxycycline|doxycycline|mesh-list
14020675|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
14293113|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
14293114|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15147529|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147530|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147531|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
15147532|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15147533|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15147534|NCT04239443|Apatinib|apatinib|mesh-list
15147535|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14289211|NCT00539695|Aldesleukin|aldesleukin|mesh-list
14289212|NCT00539695|Interleukin-2|interleukin-2|mesh-list
14289213|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289214|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14289215|NCT00539695|Analgesics|analgesics|mesh-ancestor
14289216|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
14289217|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289218|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289219|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14289220|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14289221|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
14289222|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289223|NCT00539734|Ranibizumab|ranibizumab|mesh-list
14289224|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289225|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289226|NCT00539734|Growth Substances|growth substances|mesh-ancestor
14289227|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289228|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14289229|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289230|NCT00539864|Vaccines|vaccines|mesh-list
14289231|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
14289232|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
14289233|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289234|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
14289235|NCT00539942|PENTA|penta|mesh-list
14289236|NCT00539942|Fondaparinux|fondaparinux|mesh-list
14289237|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14289238|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
15147536|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289239|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14289240|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
14289241|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289242|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289243|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
14289244|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14289245|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14289246|NCT00539994|Retapamulin|retapamulin|mesh-list
14289247|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14289248|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289249|NCT00540007|Lenalidomide|lenalidomide|mesh-list
14289250|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
14289251|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289252|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289253|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289254|NCT00540007|Growth Substances|growth substances|mesh-ancestor
15147537|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15147538|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147539|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147540|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15147541|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147542|NCT04238988|Paclitaxel|paclitaxel|mesh-list
15147543|NCT04238988|Carboplatin|carboplatin|mesh-list
14289255|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
15147544|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
15147545|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15147546|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147547|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
15147548|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
15147549|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
15147550|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147551|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15147552|NCT04239118|Hemostatics|hemostatics|mesh-list
15147553|NCT04239118|Coagulants|coagulants|mesh-ancestor
15147554|NCT04239170|Gemcitabine|gemcitabine|mesh-list
15147555|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
15147556|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15147557|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
15147558|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289256|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289257|NCT00540046|Copper|copper|mesh-list
14289258|NCT00540046|Trace Elements|trace elements|mesh-ancestor
14289259|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
15147559|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289260|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289261|NCT00540124|Tadalafil|tadalafil|mesh-list
14289262|NCT00540124|Tamsulosin|tamsulosin|mesh-list
14289263|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
14289264|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14289265|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14289266|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289267|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289268|NCT00540124|Urological Agents|urological agents|mesh-ancestor
14289269|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14289270|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14289271|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14289272|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
14289273|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289274|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289275|NCT00540293|Atorvastatin|atorvastatin|mesh-list
14289276|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14289277|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14289278|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
14289279|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147560|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
15147561|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147562|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147563|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147564|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
15147565|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147566|NCT04239014|Olaparib|olaparib|mesh-list
14289280|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14289281|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14289282|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289283|NCT00540436|Ambrisentan|ambrisentan|mesh-list
14289284|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14289285|NCT00540449|Efavirenz|efavirenz|mesh-list
14289286|NCT00540449|Rilpivirine|rilpivirine|mesh-list
14289287|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14289288|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14289289|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289290|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289291|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
14289292|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289293|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14289294|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14289295|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14289296|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14289297|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14289298|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14289299|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14289300|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14289301|NCT00540514|Paclitaxel|paclitaxel|mesh-list
14289302|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14289303|NCT00540514|Carboplatin|carboplatin|mesh-list
14289304|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14289305|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289306|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
14289307|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289308|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289309|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289310|NCT00540579|Gemcitabine|gemcitabine|mesh-list
14289311|NCT00540579|Pomalidomide|pomalidomide|mesh-list
14289312|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14289313|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
14289314|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289315|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289316|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
14289317|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289318|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289319|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289320|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
14289321|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289322|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289323|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289324|NCT00540579|Growth Substances|growth substances|mesh-ancestor
15147567|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14289325|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
14289326|NCT00540644|Prednisone|prednisone|mesh-list
14289327|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
14289328|NCT00540644|Lenalidomide|lenalidomide|mesh-list
14289329|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289330|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
14289331|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289332|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14289333|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14289334|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
14289335|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289336|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289337|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14289338|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289339|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
14289340|NCT00540644|Hormones|hormones|mesh-ancestor
14289341|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289342|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14289343|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289344|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289345|NCT00540644|Growth Substances|growth substances|mesh-ancestor
14289346|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
14289347|NCT00540722|Acetic Acid|acetic acid|mesh-list
14289348|NCT00540722|Retinol acetate|retinol acetate|mesh-list
14289349|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
14289350|NCT00540722|Gossypol|gossypol|mesh-list
14289351|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14289352|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289353|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14289354|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
14289355|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289356|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14289357|NCT00540722|Protective Agents|protective agents|mesh-ancestor
14289358|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289359|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14289360|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
14289361|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14289362|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14289363|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14289364|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14289365|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14289366|NCT00540982|Vinorelbine|vinorelbine|mesh-list
14289367|NCT00540982|Lidocaine|lidocaine|mesh-list
14289368|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
14289369|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
14289370|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14289371|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289372|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
14289373|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289374|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14289375|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14289376|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14289377|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14289378|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289379|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14289380|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289381|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14289382|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289383|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289384|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
14289385|NCT00541034|Rituximab|rituximab|mesh-list
14289386|NCT00541034|Pentostatin|pentostatin|mesh-list
14289387|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289388|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
14289389|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289390|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14289391|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14289392|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
14289393|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289394|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289395|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14289396|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14289397|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14289398|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289399|NCT00541099|Bevacizumab|bevacizumab|mesh-list
14289400|NCT00541099|Docetaxel|docetaxel|mesh-list
14289401|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14289402|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289403|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289404|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289405|NCT00541099|Growth Substances|growth substances|mesh-ancestor
14289406|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289407|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
14289408|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
14289409|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289410|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289411|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289412|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14289413|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14289414|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289415|NCT00541229|Incretins|incretins|mesh-ancestor
14289416|NCT00541229|Hormones|hormones|mesh-ancestor
14289417|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289418|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14289419|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
14289420|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289421|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289422|NCT00541242|Bimatoprost|bimatoprost|mesh-list
14289423|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14289424|NCT00541242|Latanoprost|latanoprost|mesh-list
14289425|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14289426|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14289427|NCT00541307|Heparin|heparin|mesh-list
14289428|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
14289429|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14289430|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14289431|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289432|NCT00541346|Methylphenidate|methylphenidate|mesh-list
14289433|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14289434|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289435|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14289436|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14289437|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14289438|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289439|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
14289440|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289441|NCT00541385|Artesunate|artesunate|mesh-list
14289442|NCT00541385|Lumefantrine|lumefantrine|mesh-list
14289443|NCT00541385|Pyronaridine|pyronaridine|mesh-list
14289444|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
14289445|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14289446|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14289447|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289448|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289449|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
14289450|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
14289451|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14289452|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
14289453|NCT00541450|Metformin|metformin|mesh-list
14289454|NCT00541450|Pioglitazone|pioglitazone|mesh-list
14289455|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14289456|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14289457|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289458|NCT00541450|Incretins|incretins|mesh-ancestor
14289459|NCT00541450|Hormones|hormones|mesh-ancestor
14289460|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289461|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14289462|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
14289463|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289464|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289465|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
14289466|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
14289467|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14289468|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14289469|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289470|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15147568|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147569|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289471|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147570|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147571|NCT04238923|Vancomycin|vancomycin|mesh-list
14289472|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14289473|NCT00541671|Promethazine|promethazine|mesh-list
14289474|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
14289475|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
14289476|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14289477|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
14289478|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
14289479|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289480|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289481|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289482|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14289483|NCT00541775|Metformin|metformin|mesh-list
14289484|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14289485|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
14289486|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14289487|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289488|NCT00541775|Incretins|incretins|mesh-ancestor
14289489|NCT00541775|Hormones|hormones|mesh-ancestor
14289490|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289491|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14289492|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
14289493|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289494|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289495|NCT00541866|Cytarabine|cytarabine|mesh-list
14289496|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14289497|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
14289498|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289499|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289500|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
14289501|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289502|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289503|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
14289504|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147572|NCT04238923|Gentamicins|gentamicins|mesh-list
15147573|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147574|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147575|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14289505|NCT00541970|Vaccines|vaccines|mesh-list
14289506|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
14289507|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289508|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14289509|NCT00542178|Simvastatin|simvastatin|mesh-list
14289510|NCT00542178|Fenofibrate|fenofibrate|mesh-list
14289511|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14289512|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14289513|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
14289514|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147576|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147577|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147578|NCT04238975|Vaccines|vaccines|mesh-list
15147579|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
15147580|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147581|NCT04238767|Dolutegravir|dolutegravir|mesh-list
15147582|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15147583|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14289515|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14289516|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14289517|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289518|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289519|NCT00542191|Paclitaxel|paclitaxel|mesh-list
14289520|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
14289521|NCT00542191|Carboplatin|carboplatin|mesh-list
14289522|NCT00542191|Doxorubicin|doxorubicin|mesh-list
14289523|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14289524|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289525|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
14289526|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289527|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289528|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289529|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289530|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
14289531|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147584|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179875|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289532|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14289533|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14289534|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
14289535|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14289536|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14289537|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14289538|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14289539|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289540|NCT00542269|Amlodipine|amlodipine|mesh-list
14289541|NCT00542269|Ramipril|ramipril|mesh-list
14289542|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14289543|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14289544|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14289545|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289546|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14289547|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289548|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
14289549|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14289550|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
14289551|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289552|NCT00542308|Zalutumumab|zalutumumab|mesh-list
14289553|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14289554|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289555|NCT00542425|Teriparatide|teriparatide|mesh-list
14289556|NCT00542425|Abaloparatide|abaloparatide|mesh-list
14289557|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14289558|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14289559|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289560|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14289561|NCT00542620|Insulin|insulin|mesh-list
14289562|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14289563|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
14289564|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
14289565|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14289566|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
14289567|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14289568|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289569|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
14289570|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14289571|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
14289572|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289573|NCT00542750|Expectorants|expectorants|mesh-ancestor
14289574|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
14289575|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14289576|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
14289577|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289578|NCT00542750|Protective Agents|protective agents|mesh-ancestor
14289579|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289580|NCT00542750|Antidotes|antidotes|mesh-ancestor
14289581|NCT00542789|Esomeprazole|esomeprazole|mesh-list
14289582|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14289583|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15147585|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147586|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15147587|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15147588|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
15147589|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289584|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14289585|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289586|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289587|NCT00542815|Sevelamer|sevelamer|mesh-list
14289588|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
14289589|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
14289590|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147590|NCT04238754|Cannabidiol|cannabidiol|mesh-list
15147591|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15147592|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
15147593|NCT04238806|Desflurane|desflurane|mesh-list
15147594|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15147595|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
15147596|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
15147597|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147598|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147599|NCT04238832|Nicotine|nicotine|mesh-list
15147600|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15147601|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
14020676|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14020677|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289591|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
14289592|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
14289593|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14289594|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
14289595|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289596|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289597|NCT00542880|Fluticasone|fluticasone|mesh-list
14289598|NCT00542880|Budesonide|budesonide|mesh-list
14289599|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
14289600|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14289601|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14289602|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14289603|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289604|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14289605|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
14289606|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289607|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289608|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14289609|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
14289610|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
14289611|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14289612|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
14289613|NCT00542880|Hormones|hormones|mesh-ancestor
14289614|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289615|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14289616|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14289617|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14289618|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
14289619|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289620|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289621|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
14289622|NCT00542971|Cytarabine|cytarabine|mesh-list
14289623|NCT00542971|Sorafenib|sorafenib|mesh-list
14289624|NCT00542971|Idarubicin|idarubicin|mesh-list
14289625|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14289626|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
14289627|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289628|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289629|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
14289630|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289631|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289632|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
14289633|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289634|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14289635|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147602|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147603|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147604|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15147605|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15147606|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
15147607|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147608|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147609|NCT04238884|Voriconazole|voriconazole|mesh-list
15147610|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
14020678|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14020679|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020680|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14020681|NCT02779153|Hormones|hormones|mesh-ancestor
14289636|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14289637|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14289638|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14289639|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
14289640|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14289641|NCT00542997|Antibodies|antibodies|mesh-list
14289642|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
14289643|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289644|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
14289645|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
14289646|NCT00543062|Loxapine|loxapine|mesh-list
14643651|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15179876|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
14020682|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020683|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147611|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147612|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15147613|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15147614|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147615|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147616|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15147617|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
15147618|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147619|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147620|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15147621|NCT04238702|Empagliflozin|empagliflozin|mesh-list
14020684|NCT02778893|Thalidomide|thalidomide|mesh-list
14020685|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020686|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
14020687|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020688|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
14020689|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14020690|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020691|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14020692|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14020693|NCT02778893|Growth Substances|growth substances|mesh-ancestor
14020694|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
14020695|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020696|NCT02778659|Zolpidem|zolpidem|mesh-list
14020697|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14020698|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14020699|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020700|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147622|NCT04238702|Losartan|losartan|mesh-list
15147623|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15147624|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14020701|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14020702|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
14020703|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
14020704|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020705|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147625|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15147626|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15147627|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147628|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15147629|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14020706|NCT02778594|Levodopa|levodopa|mesh-list
14020707|NCT02778594|Benserazide|benserazide|mesh-list
14020708|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14020709|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14020710|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
14020711|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147630|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289647|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147631|NCT04238208|Lidocaine|lidocaine|mesh-list
15147632|NCT04238208|Capsaicin|capsaicin|mesh-list
15147633|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
15147634|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
15147635|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147636|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147637|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
15147638|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147639|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15147640|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15147641|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14289648|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289649|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14289650|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14289651|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289652|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289653|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289654|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289655|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
14289656|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
14289657|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289658|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020712|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289659|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14289660|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14289661|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14289662|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14289663|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14289664|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
14289665|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289666|NCT00543101|Darunavir|darunavir|mesh-list
14289667|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14289668|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14289669|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
14289670|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289671|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289672|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14289673|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14289674|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
14289675|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289676|NCT00543127|Fulvestrant|fulvestrant|mesh-list
14289677|NCT00543127|Anastrozole|anastrozole|mesh-list
14289678|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14289679|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289680|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14289681|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14289682|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
14289683|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289684|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289685|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14289686|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14289687|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289688|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289689|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14289690|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289691|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
14289692|NCT00543296|Hormones|hormones|mesh-ancestor
14289693|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289694|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289695|NCT00543309|Milrinone|milrinone|mesh-list
14289696|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14289697|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
14289698|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289699|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15147642|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14289700|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14289701|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
14289702|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14289703|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14289704|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289705|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289706|NCT00543309|Protective Agents|protective agents|mesh-ancestor
14289707|NCT00543387|Docetaxel|docetaxel|mesh-list
14289708|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289709|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14289710|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289711|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289712|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289713|NCT00543400|Heparin|heparin|mesh-list
14289714|NCT00543400|Calcium heparin|calcium heparin|mesh-list
14289715|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
14289716|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14289717|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14289718|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289719|NCT00543439|Factor VIII|factor viii|mesh-list
14289720|NCT00543439|Coagulants|coagulants|mesh-ancestor
14289721|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
14289722|NCT00543569|Alefacept|alefacept|mesh-list
14289723|NCT00543569|Tacrolimus|tacrolimus|mesh-list
15147643|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289724|NCT00543569|Basiliximab|basiliximab|mesh-list
14289725|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289726|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
14289727|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289728|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14289729|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289730|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289731|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14289732|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289733|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14289734|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
14289735|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14289736|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289737|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
14289738|NCT00543725|Efavirenz|efavirenz|mesh-list
14289739|NCT00543725|Rilpivirine|rilpivirine|mesh-list
14289740|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14289741|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14289742|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289743|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289744|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
14289745|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289746|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14289747|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14289748|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14289749|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15147644|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
15147645|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
15147646|NCT04238221|Doxofylline|doxofylline|mesh-list
15147647|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
15147648|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
15147649|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15147650|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
15147651|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147652|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147653|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15147654|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15147655|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289750|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14289751|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14289752|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14289753|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14289754|NCT00543855|Donepezil|donepezil|mesh-list
14289755|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14289756|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289757|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289758|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
14289759|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289760|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289761|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
14289762|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
14289763|NCT00544076|Alprostadil|alprostadil|mesh-list
14289764|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289765|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
14289766|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14289767|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14289768|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289769|NCT00544076|Urological Agents|urological agents|mesh-ancestor
14289770|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14289771|NCT00544167|Paclitaxel|paclitaxel|mesh-list
14289772|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
14289773|NCT00544167|Doxorubicin|doxorubicin|mesh-list
15147656|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147657|NCT04238169|Bevacizumab|bevacizumab|mesh-list
15147658|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15147659|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289774|NCT00544167|Sorafenib|sorafenib|mesh-list
14289775|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14289776|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289777|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
15147660|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15147661|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15147662|NCT04238169|Growth Substances|growth substances|mesh-ancestor
15147663|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289778|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289779|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289780|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289781|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289782|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
14289783|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289784|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14289785|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14289786|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
14289787|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14289788|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14289789|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15147664|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
15147665|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
15147666|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147667|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289790|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14289791|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289792|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15147668|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15147669|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15147670|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147671|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147672|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147673|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
15147674|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15147675|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147676|NCT04237987|Cyclosporine|cyclosporine|mesh-list
14289793|NCT00544440|Prednisone|prednisone|mesh-list
14289794|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
14289795|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289796|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
14289797|NCT00544440|Hormones|hormones|mesh-ancestor
14289798|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289799|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289800|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14289801|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289802|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14289803|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289804|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289805|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
14289806|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14289807|NCT00544544|Riluzole|riluzole|mesh-list
14289808|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
14289809|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14289810|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14289811|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289812|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289813|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289814|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14289815|NCT00544544|Protective Agents|protective agents|mesh-ancestor
14289816|NCT00544557|Etanercept|etanercept|mesh-list
14289817|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14289818|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15147677|NCT04237987|Aldesleukin|aldesleukin|mesh-list
15147678|NCT04237987|Interleukin-2|interleukin-2|mesh-list
15147679|NCT04237987|Cyclosporins|cyclosporins|mesh-list
15147680|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147681|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147682|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147683|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
15147684|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147685|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
15147686|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147687|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14289819|NCT00544557|Analgesics|analgesics|mesh-ancestor
14289820|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
14289821|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289822|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289823|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289824|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14289825|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14289826|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14289827|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
14289828|NCT00544648|Paclitaxel|paclitaxel|mesh-list
14289829|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14289830|NCT00544648|Carboplatin|carboplatin|mesh-list
15147688|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147689|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15147690|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147691|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15147692|NCT04237987|Analgesics|analgesics|mesh-ancestor
15147693|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
14289831|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14289832|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289833|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
14289834|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289835|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289836|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289837|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14289838|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
14289839|NCT00544713|Glycerol|glycerol|mesh-list
14289840|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14289841|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14289842|NCT00544713|Laxatives|laxatives|mesh-ancestor
14289843|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14289844|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14289845|NCT00544713|Protective Agents|protective agents|mesh-ancestor
14289846|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289847|NCT00544778|Doxorubicin|doxorubicin|mesh-list
14289848|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14289849|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
14289850|NCT00544778|Irinotecan|irinotecan|mesh-list
14289851|NCT00544778|Ifosfamide|ifosfamide|mesh-list
14289852|NCT00544778|Razoxane|razoxane|mesh-list
14289853|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14289854|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289855|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14289856|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14289857|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289858|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289859|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14289860|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289861|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14289862|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
14289863|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14289864|NCT00544778|Protective Agents|protective agents|mesh-ancestor
14289865|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
14289866|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289867|NCT00544817|Temozolomide|temozolomide|mesh-list
14289868|NCT00544817|Sorafenib|sorafenib|mesh-list
14289869|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14289870|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
14289871|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289872|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289873|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14289874|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289875|NCT00544869|Tolvaptan|tolvaptan|mesh-list
14289876|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14289877|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289878|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
14289879|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289880|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14289881|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14289882|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14289883|NCT00544882|Desogestrel|desogestrel|mesh-list
14289884|NCT00544882|Oviol|oviol|mesh-list
14289885|NCT00544882|Estradiol|estradiol|mesh-list
14289886|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14289887|NCT00544882|Estrogens|estrogens|mesh-ancestor
14289888|NCT00544882|Hormones|hormones|mesh-ancestor
14289889|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14289890|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289891|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14289892|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
14289893|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14289894|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14289895|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14289896|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14289897|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14289898|NCT00544882|Progestins|progestins|mesh-ancestor
14289899|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14289900|NCT00544908|Dasatinib|dasatinib|mesh-list
14289901|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289902|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14289903|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289904|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289905|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
14289906|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14289907|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289908|NCT00545064|Timolol|timolol|mesh-list
14289909|NCT00545064|Dorzolamide|dorzolamide|mesh-list
14289910|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14289911|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14289912|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
14289913|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289914|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289915|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020713|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020714|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020715|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14020716|NCT02778425|Somatostatin|somatostatin|mesh-list
14020717|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14020718|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
14020719|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020720|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020721|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020722|NCT02778425|Hormones|hormones|mesh-ancestor
14020723|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020724|NCT02778360|Methylphenidate|methylphenidate|mesh-list
14020725|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14020726|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020727|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14020728|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14020729|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14020730|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020731|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
14020732|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14025998|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289916|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14289917|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14289918|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289919|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14289920|NCT00545077|Bevacizumab|bevacizumab|mesh-list
14289921|NCT00545077|Letrozole|letrozole|mesh-list
14289922|NCT00545077|Fulvestrant|fulvestrant|mesh-list
14289923|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14289924|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289925|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14289926|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14289927|NCT00545077|Growth Substances|growth substances|mesh-ancestor
14289928|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289929|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
14289930|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14289931|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14289932|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289933|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14025999|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026000|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14026001|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026002|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026003|NCT02745912|Metformin|metformin|mesh-list
14026004|NCT02745912|Naltrexone|naltrexone|mesh-list
14026005|NCT02745912|Bupropion|bupropion|mesh-list
14026006|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026007|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026008|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14026009|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14026010|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
14026011|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026012|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14026013|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
14026014|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14026015|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14026016|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14026017|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026018|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026019|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
14026020|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026021|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14289934|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14020733|NCT02778308|Gemcitabine|gemcitabine|mesh-list
14020734|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020735|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14020736|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
14020737|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020738|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
14020739|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020740|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020741|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020742|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
14020743|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020744|NCT02778178|Clonidine|clonidine|mesh-list
14020745|NCT02778178|Ropivacaine|ropivacaine|mesh-list
14020746|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
14020747|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
14020748|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020749|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020750|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
14020751|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020752|NCT02778178|Analgesics|analgesics|mesh-ancestor
14020753|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14020754|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
14020755|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
14020756|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14020757|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14020758|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14020759|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
14020760|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020761|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020762|NCT02778191|Carboplatin|carboplatin|mesh-list
14020763|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020764|NCT02777814|Entecavir|entecavir|mesh-list
14020765|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
14020766|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020767|NCT02777866|Bupivacaine|bupivacaine|mesh-list
14020768|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
14020769|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
14020770|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020771|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020772|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
14020773|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020774|NCT02777801|Entecavir|entecavir|mesh-list
14020775|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
14020776|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020777|NCT02777788|Gemcitabine|gemcitabine|mesh-list
14020778|NCT02777788|Paclitaxel|paclitaxel|mesh-list
14020779|NCT02777788|Vinorelbine|vinorelbine|mesh-list
14020780|NCT02777788|Docetaxel|docetaxel|mesh-list
14020781|NCT02777788|Carboplatin|carboplatin|mesh-list
14020782|NCT02777788|Pemetrexed|pemetrexed|mesh-list
14020783|NCT02777788|Cisplatin|cisplatin|mesh-list
14020784|NCT02777788|Nedaplatin|nedaplatin|mesh-list
14289935|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
14289936|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147694|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147695|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15147696|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15147697|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
15147698|NCT04237922|Clopidogrel|clopidogrel|mesh-list
15147699|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15147700|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15147701|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15147702|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14020785|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14020786|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14289937|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14289938|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14289939|NCT00545103|Mesalamine|mesalamine|mesh-list
14289940|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14289941|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14289942|NCT00545103|Analgesics|analgesics|mesh-ancestor
14289943|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
14289944|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289945|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020787|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
14020788|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
14020789|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
14289946|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14289947|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14289948|NCT00545168|Permethrin|permethrin|mesh-list
14289949|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14289950|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289951|NCT00545181|Metronidazole|metronidazole|mesh-list
14289952|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289953|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14289954|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14289955|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14289956|NCT00545233|Pioglitazone|pioglitazone|mesh-list
14289957|NCT00545233|Ribavirin|ribavirin|mesh-list
14289958|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14289959|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
14289960|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289961|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
14289962|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14289963|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14289964|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289965|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
14289966|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14289967|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
14289968|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289969|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289970|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14289971|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
14289972|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14289973|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14289974|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14289975|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
14289976|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289977|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289978|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
14289979|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14289980|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
14289981|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14289982|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289983|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14289984|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
14289985|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14289986|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
14289987|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14289988|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14289989|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14289990|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
15147703|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15147704|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
15147705|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147706|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147707|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289991|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
14289992|NCT00545298|Protective Agents|protective agents|mesh-ancestor
14289993|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
14289994|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14289995|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14289996|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
14289997|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14289998|NCT00545402|Tacrolimus|tacrolimus|mesh-list
14289999|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290000|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
14290001|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290002|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14290003|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290004|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290005|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14290006|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290007|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14290008|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
14290009|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14562923|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562924|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562925|NCT00002905|Zidovudine|zidovudine|mesh-list
14020790|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290010|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290011|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290012|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
14020791|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14020792|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
14020793|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
14020794|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14020795|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020796|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020797|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
14020798|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020799|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14290013|NCT00545402|Hormones|hormones|mesh-ancestor
14290014|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290015|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14290016|NCT00545402|Protective Agents|protective agents|mesh-ancestor
14290017|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14290018|NCT00545532|Oseltamivir|oseltamivir|mesh-list
14290019|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
14290020|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290021|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290022|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290023|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
14290024|NCT00545571|Hematinics|hematinics|mesh-ancestor
14293115|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14293116|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293117|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14293118|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147708|NCT04237935|Clopidogrel|clopidogrel|mesh-list
15147709|NCT04237935|Ticagrelor|ticagrelor|mesh-list
15147710|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15147711|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15147712|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15147713|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15147714|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
15147715|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147716|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147717|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147718|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
15147719|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15147720|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147721|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293119|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14293120|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14293121|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14293122|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14293123|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14293124|NCT00566098|Melphalan|melphalan|mesh-list
14293125|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14293126|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
14293127|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293128|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293129|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14293130|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293131|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
14293132|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293133|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
14293134|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293135|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147722|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147723|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
15147724|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15147725|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14293136|NCT00566150|Levetiracetam|levetiracetam|mesh-list
14293137|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
14811757|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14293138|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
14293139|NCT00566254|Zonisamide|zonisamide|mesh-list
14293140|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
14293141|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14293142|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14562926|NCT00002905|Didanosine|didanosine|mesh-list
15147726|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147727|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15147728|NCT04237532|Analgesics|analgesics|mesh-ancestor
15147729|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
15147730|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147731|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15147732|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15147733|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15147734|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
15147735|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147736|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147737|NCT04237675|Anesthetics|anesthetics|mesh-list
15147738|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147739|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147740|NCT04237246|Tacrolimus|tacrolimus|mesh-list
15147741|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147742|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
15147743|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147744|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15147745|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147746|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179877|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179878|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15179879|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15179880|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15179881|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
15179882|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179883|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15179884|NCT03944954|Dronabinol|dronabinol|mesh-list
15179885|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
15179886|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179887|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15179888|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15179889|NCT03944954|Analgesics|analgesics|mesh-ancestor
15179890|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
15179891|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179892|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15179893|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15179894|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179895|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179896|NCT03944954|Hormones|hormones|mesh-ancestor
15179897|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15179898|NCT03944733|Iron|iron|mesh-list
15179899|NCT03944733|Trace Elements|trace elements|mesh-ancestor
15179900|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
15179901|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290025|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14290026|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14290027|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290028|NCT00545584|Incretins|incretins|mesh-ancestor
14290029|NCT00545584|Hormones|hormones|mesh-ancestor
14290030|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290031|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15179902|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15179903|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179904|NCT03944655|Anesthetics|anesthetics|mesh-list
15179905|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179906|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179907|NCT03944681|Droperidol|droperidol|mesh-list
15179908|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15179909|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
14562927|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
15179910|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
15179911|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179912|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179913|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15179914|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15179915|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15179916|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179917|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15179918|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15179919|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15179920|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
14562928|NCT00002905|Prednimustine|prednimustine|mesh-list
14290032|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
14290033|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290034|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290035|NCT00545662|Choline|choline|mesh-list
14290036|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14290037|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
14290038|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14290039|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
14290040|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290041|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14290042|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14290043|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
14290044|NCT00545688|Docetaxel|docetaxel|mesh-list
15147747|NCT04237376|Tenofovir|tenofovir|mesh-list
14290045|NCT00545688|Trastuzumab|trastuzumab|mesh-list
14290046|NCT00545688|Pertuzumab|pertuzumab|mesh-list
14290047|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290048|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
14290049|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
14290050|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
14290051|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290052|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290053|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
14290054|NCT00545714|Rituximab|rituximab|mesh-list
14290055|NCT00545714|Fludarabine|fludarabine|mesh-list
14290056|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290057|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
14290058|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290059|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290060|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14290061|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
15147748|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
15147749|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147750|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15147751|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15147752|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147753|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147754|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15147755|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15147756|NCT04237493|Insulin|insulin|mesh-list
15147757|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15147758|NCT04237493|Metformin|metformin|mesh-list
15147759|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
14290062|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290063|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290064|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14290065|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290066|NCT00545740|Mesalamine|mesalamine|mesh-list
14290067|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14290068|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14290069|NCT00545740|Analgesics|analgesics|mesh-ancestor
14290070|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
14290071|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290072|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290073|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290074|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290075|NCT00545753|Permethrin|permethrin|mesh-list
14290076|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290077|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290078|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
14290079|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14290080|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290081|NCT00545792|Bevacizumab|bevacizumab|mesh-list
14290082|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290083|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290084|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14290085|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14290086|NCT00545792|Growth Substances|growth substances|mesh-ancestor
14290087|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290088|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
14290089|NCT00545948|Cisplatin|cisplatin|mesh-list
14290090|NCT00545948|Pemetrexed|pemetrexed|mesh-list
14290091|NCT00545948|Vinorelbine|vinorelbine|mesh-list
15147760|NCT04237493|Glimepiride|glimepiride|mesh-list
14290092|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290093|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147761|NCT04237493|Vildagliptin|vildagliptin|mesh-list
14290094|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290095|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14290096|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14290097|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14290098|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
14290099|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
14290100|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
14290101|NCT00545974|Memantine|memantine|mesh-list
14290102|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14290103|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14290104|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
14290105|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290106|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020800|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14020801|NCT02777736|Methotrexate|methotrexate|mesh-list
14020802|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14020803|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
14020804|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14290107|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290108|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14290109|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14290110|NCT00546000|Fluticasone|fluticasone|mesh-list
14290111|NCT00546000|Xhance|xhance|mesh-list
14290112|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290113|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14290114|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
15147762|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15147763|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290115|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147764|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15147765|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290116|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290117|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14290118|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
14290119|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
14290120|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14290121|NCT00546078|Vaccines|vaccines|mesh-list
14290122|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
14290123|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290124|NCT00546104|Dasatinib|dasatinib|mesh-list
14290125|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290126|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290127|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290128|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290129|NCT00546117|Lansoprazole|lansoprazole|mesh-list
14290130|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
14290131|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14290132|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14290133|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14290134|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290135|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290136|NCT00546156|Paclitaxel|paclitaxel|mesh-list
14020805|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020806|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14020807|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
14020808|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020809|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020810|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14290137|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
14290138|NCT00546156|Bevacizumab|bevacizumab|mesh-list
14020811|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020812|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14020813|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020814|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
14290139|NCT00546156|Doxorubicin|doxorubicin|mesh-list
14290140|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14290141|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290142|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
14290143|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
14290144|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562929|NCT00002905|Doxorubicin|doxorubicin|mesh-list
15147766|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
15147767|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15147768|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
15147769|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147770|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147771|NCT04237480|Vitamin D|vitamin d|mesh-list
15147772|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
15147773|NCT04237480|Vitamins|vitamins|mesh-list
15147774|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
15147775|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147776|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15147777|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15147778|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
15147779|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15147780|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147781|NCT04237103|Methotrexate|methotrexate|mesh-list
15147782|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15147783|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
15147784|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15147785|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147786|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15147787|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
15147788|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147789|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147790|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
15147791|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147792|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14290145|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147793|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147794|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
14290146|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290147|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
14290148|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290149|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290150|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14290151|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
14290152|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14290153|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290154|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14290155|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14290156|NCT00546156|Growth Substances|growth substances|mesh-ancestor
15147795|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147796|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15147797|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
15147798|NCT04237090|Promethazine|promethazine|mesh-list
15147799|NCT04237090|Cetirizine|cetirizine|mesh-list
15147800|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15147801|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15147802|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147803|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147804|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
15147805|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
15147806|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
15147807|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147808|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
15147809|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
15147810|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15147811|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15147812|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
15147813|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
15147814|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147815|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147816|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15147817|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
15147818|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
15147819|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15147820|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
15147821|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15147822|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147823|NCT04236778|Vancomycin|vancomycin|mesh-list
14290157|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
14290158|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14290159|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14290160|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14290161|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290162|NCT00546351|Lacosamide|lacosamide|mesh-list
14290163|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
15147824|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147825|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290164|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14290165|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14290166|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290167|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290168|NCT00546364|Docetaxel|docetaxel|mesh-list
15147826|NCT04236453|Tenofovir|tenofovir|mesh-list
15147827|NCT04236453|Emtricitabine|emtricitabine|mesh-list
15147828|NCT04236453|Darunavir|darunavir|mesh-list
15147829|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15147830|NCT04236453|Cobicistat|cobicistat|mesh-list
15147831|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14290169|NCT00546364|Capecitabine|capecitabine|mesh-list
14290170|NCT00546364|Epothilones|epothilones|mesh-list
14020815|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020816|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14020817|NCT02777710|Durvalumab|durvalumab|mesh-list
14020818|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020819|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290171|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290172|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
14290173|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
14290174|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
14290175|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290176|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290177|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
14290178|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
14290179|NCT00546377|Rituximab|rituximab|mesh-list
14290180|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
14290181|NCT00546377|Pentostatin|pentostatin|mesh-list
14290182|NCT00546377|Sargramostim|sargramostim|mesh-list
14290183|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290184|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
14290185|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290186|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290187|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14290188|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
14290189|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290190|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290191|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14290192|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290193|NCT00546377|Analgesics|analgesics|mesh-ancestor
14290194|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
14290195|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290196|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15147832|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
15147833|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147834|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15147835|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15147836|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290197|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14290198|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290199|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14290200|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
14290201|NCT00546481|Hematinics|hematinics|mesh-ancestor
15147837|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147838|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14290202|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14290203|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
14290204|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290205|NCT00546637|Fesoterodine|fesoterodine|mesh-list
14290206|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14290207|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14290208|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
15147839|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15147840|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15147841|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15147842|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
15147843|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15147844|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15147845|NCT04236323|Remifentanil|remifentanil|mesh-list
15147846|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14020820|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
14020821|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14290209|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14562930|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14290210|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290211|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290212|NCT00546637|Urological Agents|urological agents|mesh-ancestor
14290213|NCT00546728|Metformin|metformin|mesh-list
14290214|NCT00546728|Exenatide|exenatide|mesh-list
14290215|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14290216|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290217|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14290218|NCT00546728|Incretins|incretins|mesh-ancestor
15147847|NCT04236323|Narcotics|narcotics|mesh-ancestor
15147848|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147849|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147850|NCT04236323|Analgesics|analgesics|mesh-ancestor
15147851|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
14290219|NCT00546728|Hormones|hormones|mesh-ancestor
14290220|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290221|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
14290222|NCT00546871|Antibodies|antibodies|mesh-list
14290223|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
14290224|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14290225|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14290226|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
14290227|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290228|NCT00546897|Lenalidomide|lenalidomide|mesh-list
15147852|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147853|NCT04236310|Trastuzumab|trastuzumab|mesh-list
15147854|NCT04236310|Anastrozole|anastrozole|mesh-list
15147855|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15147856|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290229|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
14290230|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290231|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14020822|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
14020823|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020824|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
14020825|NCT02777723|Protective Agents|protective agents|mesh-ancestor
14020826|NCT02777411|Vaccines|vaccines|mesh-list
14020827|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
15147857|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15147858|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15147859|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14020828|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020829|NCT02777489|Perindopril|perindopril|mesh-list
14020830|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14020831|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
14020832|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020833|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290232|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14290233|NCT00546897|Growth Substances|growth substances|mesh-ancestor
14290234|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14290235|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290236|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14290237|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15147860|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147861|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147862|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15147863|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
15147864|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147865|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147866|NCT04236219|Rasburicase|rasburicase|mesh-list
15147867|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
15147868|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15147869|NCT04236115|Felypressin|felypressin|mesh-list
15147870|NCT04236115|Carticaine|carticaine|mesh-list
15147871|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
15147872|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
15147873|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147874|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147875|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
15147876|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147877|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15147878|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
14020834|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15147879|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15147880|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14562931|NCT00002905|Etoposide|etoposide|mesh-list
14290238|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14290239|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290240|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290241|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
14290242|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290243|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290244|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14290245|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290246|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290247|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290248|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290249|NCT00547118|Rimonabant|rimonabant|mesh-list
14290250|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14290251|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14290252|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15147881|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147882|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
15147883|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
15147884|NCT04235816|Azithromycin|azithromycin|mesh-list
15147885|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15147886|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15147887|NCT04236258|Enalapril|enalapril|mesh-list
15147888|NCT04236258|Nifedipine|nifedipine|mesh-list
15147889|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15147890|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15147891|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147892|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15147893|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147894|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
15147895|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
15147896|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15147897|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15147898|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
15147899|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147900|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14290253|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290254|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290255|NCT00547118|Hormones|hormones|mesh-ancestor
14290256|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290257|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290258|NCT00547157|Cisplatin|cisplatin|mesh-list
14290259|NCT00547157|Panitumumab|panitumumab|mesh-list
14290260|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290261|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290262|NCT00547248|Vaccines|vaccines|mesh-list
14290263|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14290264|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
14290265|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147901|NCT04235868|Mitogens|mitogens|mesh-list
15147902|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
15147903|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147904|NCT04235959|Tirzepatide|tirzepatide|mesh-list
15147905|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15147906|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147907|NCT04235959|Incretins|incretins|mesh-ancestor
15147908|NCT04235959|Hormones|hormones|mesh-ancestor
15147909|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15147910|NCT04235478|Triamcinolone|triamcinolone|mesh-list
15147911|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15147912|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15147913|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
14290266|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
14290267|NCT00547365|Antibodies|antibodies|mesh-list
14290268|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
14290269|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14020835|NCT02777580|Tenecteplase|tenecteplase|mesh-list
14020836|NCT02777580|Clopidogrel|clopidogrel|mesh-list
14020837|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14020838|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14020839|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15147914|NCT04235478|Hormones|hormones|mesh-ancestor
15147915|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020840|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14290270|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14290271|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
14290272|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290273|NCT00547521|Methotrexate|methotrexate|mesh-list
14290274|NCT00547521|Abatacept|abatacept|mesh-list
14290275|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14290276|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
14290277|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14290278|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290279|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290280|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
14290281|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290282|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290283|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
14020841|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
14290284|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290285|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14290286|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290287|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
14290288|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290289|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14290290|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14290291|NCT00547534|Rituximab|rituximab|mesh-list
14290292|NCT00547534|Bortezomib|bortezomib|mesh-list
14290293|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14290294|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290295|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290296|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
14290297|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290298|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290299|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14290300|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
14290301|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290302|NCT00547586|Bromides|bromides|mesh-list
14290303|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
14290304|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
14290305|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14290306|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290307|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
14290308|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290309|NCT00547703|Nortriptyline|nortriptyline|mesh-list
14290310|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14290311|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
14290312|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290313|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14290314|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14290315|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14020842|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020843|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020844|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020845|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14020846|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14020847|NCT02777671|Gliclazide|gliclazide|mesh-list
14020848|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14020849|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
14020850|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14020851|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14020852|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14020853|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020854|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14290316|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290317|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
14290318|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290319|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290320|NCT00547911|Carbidopa|carbidopa|mesh-list
14290321|NCT00547911|Entacapone|entacapone|mesh-list
14290322|NCT00547911|Droxidopa|droxidopa|mesh-list
14290323|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14290324|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14290325|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
14290326|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290327|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290328|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290329|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14290330|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290331|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14290332|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
14290333|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14290334|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290335|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
14290336|NCT00548145|Ezetimibe|ezetimibe|mesh-list
14290337|NCT00548145|Pitavastatin|pitavastatin|mesh-list
14290338|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14290339|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14290340|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
14290341|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290342|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14290343|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14290344|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290345|NCT00548184|Trastuzumab|trastuzumab|mesh-list
14290346|NCT00548184|Lapatinib|lapatinib|mesh-list
14290347|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290348|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290349|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290350|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290351|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290352|NCT00548197|Bevacizumab|bevacizumab|mesh-list
14290353|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290354|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290355|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14290356|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14290357|NCT00548197|Growth Substances|growth substances|mesh-ancestor
14290358|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290359|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
14290360|NCT00548249|Iron|iron|mesh-list
14290361|NCT00548249|Trace Elements|trace elements|mesh-ancestor
14290362|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
14290363|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290364|NCT00548262|Voriconazole|voriconazole|mesh-list
14290365|NCT00548262|Anidulafungin|anidulafungin|mesh-list
14290366|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
14290367|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290368|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14290369|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14290370|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290371|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290372|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14290373|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
14290374|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290375|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290376|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14290377|NCT00548405|Interferons|interferons|mesh-list
14290378|NCT00548405|Interferon-beta|interferon-beta|mesh-list
14290379|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
14290380|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
14290381|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290382|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
14290383|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290384|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290385|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
14290386|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290387|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14290388|NCT00548418|Bevacizumab|bevacizumab|mesh-list
14290389|NCT00548418|Topotecan|topotecan|mesh-list
14290390|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290391|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290392|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14290393|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14290394|NCT00548418|Growth Substances|growth substances|mesh-ancestor
14290395|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290396|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
14290397|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14290398|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14290399|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290400|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290401|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
14290402|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
14290403|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290404|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290405|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290406|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290407|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
14290408|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290409|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14290410|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290411|NCT00548470|Varenicline|varenicline|mesh-list
14290412|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14290413|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14290414|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
14290415|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290416|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290417|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290418|NCT00548548|Bevacizumab|bevacizumab|mesh-list
14290419|NCT00548548|Fluorouracil|fluorouracil|mesh-list
14290420|NCT00548548|Capecitabine|capecitabine|mesh-list
14290421|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290422|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290423|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14290424|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14290425|NCT00548548|Growth Substances|growth substances|mesh-ancestor
14290426|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290427|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
14290428|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
14290429|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290430|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290431|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290432|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
14290433|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
14290434|NCT00548717|Sirolimus|sirolimus|mesh-list
14290435|NCT00548717|Bortezomib|bortezomib|mesh-list
14290436|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14290437|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290438|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14290439|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
14290440|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14290441|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290442|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290443|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290444|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
14290445|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290446|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
14290447|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290448|NCT00548808|Insulin|insulin|mesh-list
14290449|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14290450|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
14290451|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
14290452|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14290453|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290454|NCT00548847|Interferons|interferons|mesh-list
14290455|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
14290456|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
14290457|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14290458|NCT00548847|Molgramostim|molgramostim|mesh-list
14290459|NCT00548847|Sargramostim|sargramostim|mesh-list
14290460|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290461|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
14290462|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290463|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
14290464|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290465|NCT00549042|Hydromorphone|hydromorphone|mesh-list
14290466|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14290467|NCT00549042|Narcotics|narcotics|mesh-ancestor
14290468|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14290469|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290470|NCT00549042|Analgesics|analgesics|mesh-ancestor
14290471|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
14290472|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290473|NCT00549198|Tenofovir|tenofovir|mesh-list
14290474|NCT00549198|Lamivudine|lamivudine|mesh-list
14290475|NCT00549198|Emtricitabine|emtricitabine|mesh-list
14290476|NCT00549198|Efavirenz|efavirenz|mesh-list
15147916|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290477|NCT00549198|Abacavir|abacavir|mesh-list
14290478|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
14290479|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290480|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14290481|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14290482|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290483|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290484|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14290485|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14290486|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15147917|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15147918|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
15147919|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
15147920|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
15147921|NCT04235426|Diclofenac|diclofenac|mesh-list
15147922|NCT04235426|Vitamins|vitamins|mesh-ancestor
15147923|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
15147924|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147925|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14290487|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14290488|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14290489|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14290490|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14290491|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14290492|NCT00549302|Tadalafil|tadalafil|mesh-list
14290493|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
14290494|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14290495|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14290496|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290497|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290498|NCT00549302|Urological Agents|urological agents|mesh-ancestor
14290499|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
14290500|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14290501|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14290502|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290503|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
14290504|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14290505|NCT00549445|Azithromycin|azithromycin|mesh-list
14290506|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14290507|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290508|NCT00549549|Celecoxib|celecoxib|mesh-list
14290509|NCT00549549|Indomethacin|indomethacin|mesh-list
14290510|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14290511|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14290512|NCT00549549|Analgesics|analgesics|mesh-ancestor
14290513|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
14290514|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290515|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290516|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290517|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290518|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14290519|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14290520|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290521|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290522|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
14290523|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
14290524|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14290525|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14290526|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14290527|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14290528|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14290529|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290530|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290531|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14562932|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
15147926|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020855|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020856|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
14020857|NCT02777619|Propofol|propofol|mesh-list
14020858|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14020859|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020860|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020861|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14020862|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
14020863|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
15147927|NCT04235426|Analgesics|analgesics|mesh-ancestor
14020864|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020865|NCT02777619|Analgesics|analgesics|mesh-ancestor
14020866|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
14020867|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14020868|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14020869|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14020870|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14020871|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
14020872|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020873|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020874|NCT02777320|Acetaminophen|acetaminophen|mesh-list
15147928|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
15147929|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147930|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15147931|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020875|NCT02777320|Ibuprofen|ibuprofen|mesh-list
14020876|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020877|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020878|NCT02777320|Analgesics|analgesics|mesh-ancestor
14020879|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
14020880|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290532|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14290533|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
14290534|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290535|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290536|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14290537|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14290538|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
14290539|NCT00549601|Rivastigmine|rivastigmine|mesh-list
14290540|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14290541|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290542|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290543|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
14290544|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290545|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290546|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14290547|NCT00549601|Protective Agents|protective agents|mesh-ancestor
14290548|NCT00549640|Methylphenidate|methylphenidate|mesh-list
14290549|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14290550|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290551|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14290552|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14290553|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290554|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290555|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
14290556|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290557|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14290558|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14290559|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14290560|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147932|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15147933|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15147934|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147935|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
15147936|NCT04235426|Hematinics|hematinics|mesh-ancestor
15147937|NCT04235569|Enoxaparin|enoxaparin|mesh-list
14290561|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290562|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290563|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15147938|NCT04235569|Warfarin|warfarin|mesh-list
15147939|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
15147940|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
15147941|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15147942|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15147943|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147944|NCT04235673|Melatonin|melatonin|mesh-list
15147945|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
15147946|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147947|NCT04235673|Protective Agents|protective agents|mesh-ancestor
15147948|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147949|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15179921|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182120|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14020881|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290564|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14290565|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14290566|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
14290567|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290568|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290569|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14290570|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14290571|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
14290572|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14290573|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14290574|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
14290575|NCT00549770|Valsartan|valsartan|mesh-list
14290576|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14290577|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15147950|NCT04235270|Tadalafil|tadalafil|mesh-list
15147951|NCT04235270|Macitentan|macitentan|mesh-list
15147952|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
15147953|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15147954|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15147955|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290578|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14290579|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14290580|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290581|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
14290582|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14290583|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14290584|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14290585|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290586|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290587|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
14290588|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290589|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290590|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14290591|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290592|NCT00549822|Letrozole|letrozole|mesh-list
14290593|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290594|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14290595|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14290596|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290597|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290598|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14290599|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
14290600|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290601|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290602|NCT00549900|Vaccines|vaccines|mesh-list
14290603|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
14290604|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290605|NCT00549939|Alfuzosin|alfuzosin|mesh-list
14290606|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14290607|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14290608|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14290609|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
14290610|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290611|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290612|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290613|NCT00549939|Urological Agents|urological agents|mesh-ancestor
14290614|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14290615|NCT00550147|Methylphenidate|methylphenidate|mesh-list
14290616|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14290617|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290618|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14290619|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14290620|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290621|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290622|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
14290623|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290624|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
14290625|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290626|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15147956|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147957|NCT04235270|Urological Agents|urological agents|mesh-ancestor
14290627|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14290628|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14290629|NCT00550173|Pemetrexed|pemetrexed|mesh-list
14290630|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14290631|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147958|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14290632|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290633|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290634|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14290635|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14290636|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290637|NCT00550238|Pimavanserin|pimavanserin|mesh-list
14290638|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14290639|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14290640|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14290641|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14290642|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14290643|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290644|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290645|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14290646|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14290647|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
14290648|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290649|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290650|NCT00550277|Panobinostat|panobinostat|mesh-list
14290651|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290652|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14290653|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290654|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290655|NCT00550290|Cefazolin|cefazolin|mesh-list
14290656|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14290657|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290658|NCT00550394|Topiramate|topiramate|mesh-list
14290659|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14290660|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
14290661|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290662|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14290663|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14290664|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14290665|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290666|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
15147959|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15147960|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15147961|NCT04235296|Mitogens|mitogens|mesh-list
15147962|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
15147963|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147964|NCT04235894|Propofol|propofol|mesh-list
15147965|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15147966|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147967|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147968|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15147969|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
15147970|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
15147971|NCT04236050|Rocuronium|rocuronium|mesh-list
15147972|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147973|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15147974|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15147975|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15147976|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147977|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
14290667|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14290668|NCT00550407|Lamotrigine|lamotrigine|mesh-list
14290669|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
15147978|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15147979|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147980|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
15147981|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15147982|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15147983|NCT04234776|Ketamine|ketamine|mesh-list
15147984|NCT04234776|Aripiprazole|aripiprazole|mesh-list
15147985|NCT04234776|Citalopram|citalopram|mesh-list
15147986|NCT04234776|Analgesics|analgesics|mesh-ancestor
14290670|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14290671|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290672|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290673|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14290674|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290675|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14290676|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14290677|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14290678|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290679|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14290680|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
14290681|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14290682|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290683|NCT00550446|Adalimumab|adalimumab|mesh-list
14290684|NCT00550446|Tofacitinib|tofacitinib|mesh-list
14290685|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290686|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290687|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290688|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290689|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290690|NCT00550459|Tolvaptan|tolvaptan|mesh-list
14562933|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14562934|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
14562935|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562936|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14562937|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14562938|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
14562939|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562940|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562941|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14562942|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14562943|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562944|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562945|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562946|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562947|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
14562948|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14562949|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14562950|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
14562951|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14562952|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14562953|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14562954|NCT00002905|Analgesics|analgesics|mesh-ancestor
14562955|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
14562956|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562957|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
14562958|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14562959|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
14562960|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562961|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562962|NCT00002908|Vincristine|vincristine|mesh-list
14562963|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
14562964|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562965|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562966|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562967|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562968|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562969|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562970|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14562971|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
15147987|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
15147988|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15147989|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15147990|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15147991|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15147992|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
15147993|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
15147994|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15147995|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15147996|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15147997|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15147998|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15147999|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15148000|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15148001|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290691|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14290692|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290693|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
14290694|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290695|NCT00550537|Paclitaxel|paclitaxel|mesh-list
14290696|NCT00550537|Bevacizumab|bevacizumab|mesh-list
14290697|NCT00550537|Carboplatin|carboplatin|mesh-list
14290698|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14290699|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14290700|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290701|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14290702|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
14290703|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
14290704|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290705|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290706|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14290707|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14290708|NCT00550537|Growth Substances|growth substances|mesh-ancestor
14290709|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290710|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
14290711|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290712|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290713|NCT00550550|Fluticasone|fluticasone|mesh-list
14290714|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
14290715|NCT00550550|Loratadine|loratadine|mesh-list
15148002|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
15148003|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14290716|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14290717|NCT00550550|Prednisone|prednisone|mesh-list
14290718|NCT00550550|Albuterol|albuterol|mesh-list
14290719|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290720|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
14290721|NCT00550550|Hormones|hormones|mesh-ancestor
14290722|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290723|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290724|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14290725|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290726|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14290727|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
14290728|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290729|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14290730|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
14290731|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
15148004|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
15148005|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148006|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15148007|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15148008|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
15148009|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
14290732|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14290733|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
14290734|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14290735|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14290736|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14290737|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14290738|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
14290739|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290740|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290741|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
14290742|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14290743|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14290744|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
14290745|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
14290746|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14290747|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14290748|NCT00550550|Analgesics|analgesics|mesh-ancestor
14290749|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
14290750|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290751|NCT00550589|Cidofovir|cidofovir|mesh-list
14290752|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
14290753|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290754|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148010|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14020882|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14020883|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020884|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14811758|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
14290755|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293143|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293144|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14293145|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293146|NCT00566501|Donepezil|donepezil|mesh-list
14293147|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14293148|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293149|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293150|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293151|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293152|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293153|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
14293154|NCT00566540|Paclitaxel|paclitaxel|mesh-list
14293155|NCT00566540|Cisplatin|cisplatin|mesh-list
14293156|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14293157|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293158|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
14293159|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
14293160|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
14293161|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293162|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14293163|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14293164|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14293165|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14293166|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293167|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14293168|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14293169|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14293170|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
14293171|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293172|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293173|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14293174|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14293175|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
14293176|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
15148011|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15148012|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15148013|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15148014|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15148015|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14020885|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293177|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
14293178|NCT00566696|Melphalan|melphalan|mesh-list
14293179|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
14293180|NCT00566696|Thiotepa|thiotepa|mesh-list
14293181|NCT00566696|Rituximab|rituximab|mesh-list
14293182|NCT00566696|Fludarabine|fludarabine|mesh-list
14293183|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
14293184|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
14293185|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14293186|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
14293187|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293188|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
14293189|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293190|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293191|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14293192|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
14293193|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293194|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293195|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14293196|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293197|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14293198|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14293199|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
14293200|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293201|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293202|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293203|NCT00566722|Adalimumab|adalimumab|mesh-list
14293204|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293205|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293206|NCT00566735|Galantamine|galantamine|mesh-list
14293207|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14293208|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293209|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293210|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
15148016|NCT04234997|Suvorexant|suvorexant|mesh-list
15148017|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15148018|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15148019|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148020|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148021|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15148022|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148023|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148024|NCT04234932|Latanoprost|latanoprost|mesh-list
15148025|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15148026|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15148027|NCT04234321|Mitogens|mitogens|mesh-list
15148028|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148029|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148030|NCT04234594|Panitumumab|panitumumab|mesh-list
15148031|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148032|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148033|NCT04234607|Carboplatin|carboplatin|mesh-list
14020886|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020887|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
14020888|NCT02777229|Tenofovir|tenofovir|mesh-list
14020889|NCT02777229|Lamivudine|lamivudine|mesh-list
14020890|NCT02777229|Efavirenz|efavirenz|mesh-list
14290756|NCT00550615|Dasatinib|dasatinib|mesh-list
14290757|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290758|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290759|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290760|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290761|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
14290762|NCT00550680|Hematinics|hematinics|mesh-ancestor
14290763|NCT00550732|Posaconazole|posaconazole|mesh-list
14290764|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
14290765|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290766|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14290767|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14290768|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14290769|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14290770|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14290771|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290772|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290773|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14290774|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
14290775|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290776|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290777|NCT00550771|Paclitaxel|paclitaxel|mesh-list
14290778|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14290779|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
14290780|NCT00550771|Doxorubicin|doxorubicin|mesh-list
14290781|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14290782|NCT00550771|Trastuzumab|trastuzumab|mesh-list
14290783|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148034|NCT04234607|Etoposide|etoposide|mesh-list
15148035|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148036|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148037|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148038|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148039|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148040|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148041|NCT04234516|Morphine|morphine|mesh-list
15148042|NCT04234516|Buprenorphine|buprenorphine|mesh-list
15148043|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14290784|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290785|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14290786|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14290787|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14290788|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290789|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290790|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
14290791|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290792|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290793|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14290794|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
14290795|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15148044|NCT04234516|Naloxone|naloxone|mesh-list
15148045|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14020891|NCT02777229|Dolutegravir|dolutegravir|mesh-list
14290796|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14290797|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14290798|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14290799|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290800|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290801|NCT00550836|Gemcitabine|gemcitabine|mesh-list
14290802|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14290803|NCT00550836|Panitumumab|panitumumab|mesh-list
14290804|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290805|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
14290806|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290807|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290808|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
14290809|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290810|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290811|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290812|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
14290813|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290814|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14290815|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290816|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14290817|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14290818|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14290819|NCT00550953|Amlodipine|amlodipine|mesh-list
14290820|NCT00550953|Telmisartan|telmisartan|mesh-list
14290821|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14290822|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14290823|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14290824|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290825|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290826|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14290827|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290828|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
14290829|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14290830|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14290831|NCT00551031|Vaccines|vaccines|mesh-list
14290832|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
14290833|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290834|NCT00551135|Pregabalin|pregabalin|mesh-list
14290835|NCT00551135|Analgesics|analgesics|mesh-ancestor
14290836|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
14290837|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290838|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290839|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
14290840|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14290841|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14290842|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290843|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14290844|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14290845|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14290846|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14290847|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14290848|NCT00551161|Memantine|memantine|mesh-list
15148046|NCT04234516|Narcotics|narcotics|mesh-ancestor
15148047|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148048|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148049|NCT04234516|Analgesics|analgesics|mesh-ancestor
15148050|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
15148051|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148052|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15148053|NCT04234191|Buprenorphine|buprenorphine|mesh-list
14290849|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14290850|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14290851|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
14290852|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290853|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290854|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290855|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14290856|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14290857|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
14290858|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15148054|NCT04234191|Hydromorphone|hydromorphone|mesh-list
15148055|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14290859|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290860|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14290861|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290862|NCT00551213|Capecitabine|capecitabine|mesh-list
14290863|NCT00551213|Irinotecan|irinotecan|mesh-list
14290864|NCT00551213|Cetuximab|cetuximab|mesh-list
15148056|NCT04234191|Naloxone|naloxone|mesh-list
15148057|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15148058|NCT04234191|Narcotics|narcotics|mesh-ancestor
14290865|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290866|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
14290867|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290868|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290869|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14290870|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14290871|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290872|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148059|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148060|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148061|NCT04234191|Analgesics|analgesics|mesh-ancestor
15148062|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
15148063|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148064|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15148065|NCT04233996|Meropenem|meropenem|mesh-list
14290873|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
14290874|NCT00551291|Prednisone|prednisone|mesh-list
14290875|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
14290876|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290877|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
14290878|NCT00551291|Hormones|hormones|mesh-ancestor
14290879|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290880|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290881|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14290882|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290883|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14290884|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14290885|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
14290886|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14290887|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290888|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290889|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290890|NCT00551291|Hematinics|hematinics|mesh-ancestor
14290891|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14290892|NCT00551421|Cetuximab|cetuximab|mesh-list
14290893|NCT00551421|Pertuzumab|pertuzumab|mesh-list
14290894|NCT00551421|Irinotecan|irinotecan|mesh-list
14290895|NCT00551421|Antibodies|antibodies|mesh-list
14290896|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
14290897|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14290898|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
14290899|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290900|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290901|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14290902|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14290903|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290904|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290905|NCT00551460|Methotrexate|methotrexate|mesh-list
15148066|NCT04233996|Tazobactam|tazobactam|mesh-list
14290906|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
14290907|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
14290908|NCT00551460|Tretinoin|tretinoin|mesh-list
14290909|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
14290910|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14290911|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
14290912|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14290913|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290914|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290915|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
14290916|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290917|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290918|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
14290919|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290920|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14290921|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290922|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
14290923|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148067|NCT04233996|Piperacillin|piperacillin|mesh-list
15148068|NCT04233996|Cefepime|cefepime|mesh-list
15148069|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15148070|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15148071|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14290924|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14290925|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
14290926|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290927|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14290928|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14290929|NCT00551525|Analgesics|analgesics|mesh-ancestor
14290930|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
14290931|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290932|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290933|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
14290934|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14290935|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
14290936|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290937|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290938|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14290939|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
14290940|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14290941|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
14290942|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148072|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15148073|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148074|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148075|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
15148076|NCT04233866|Leucovorin|leucovorin|mesh-list
15148077|NCT04233866|Folic Acid|folic acid|mesh-list
15148078|NCT04233866|Gemcitabine|gemcitabine|mesh-list
15148079|NCT04233866|Paclitaxel|paclitaxel|mesh-list
15148080|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15148081|NCT04233866|Fluorouracil|fluorouracil|mesh-list
15148082|NCT04233866|Irinotecan|irinotecan|mesh-list
15148083|NCT04233866|Calcium|calcium|mesh-list
15148084|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
14290943|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14290944|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14290945|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
14290946|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
14290947|NCT00551642|Protective Agents|protective agents|mesh-ancestor
14290948|NCT00551707|Prednisolone|prednisolone|mesh-list
14290949|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14290950|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
14290951|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14290952|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
14290953|NCT00551707|Dipyridamole|dipyridamole|mesh-list
14290954|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14290955|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
14290956|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14290957|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
14290958|NCT00551707|Hormones|hormones|mesh-ancestor
14290959|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14290960|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290961|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14290962|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290963|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
14290964|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
15148085|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148086|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148087|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148088|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148089|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14290965|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14290966|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14290967|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14290968|NCT00551707|Protective Agents|protective agents|mesh-ancestor
14290969|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14290970|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14290971|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290972|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14290973|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
14290974|NCT00551759|Docetaxel|docetaxel|mesh-list
14290975|NCT00551759|Fluorouracil|fluorouracil|mesh-list
15148090|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290976|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
14290977|NCT00551759|Cetuximab|cetuximab|mesh-list
14290978|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290979|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
14290980|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
14290981|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
14290982|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14290983|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
14290984|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14290985|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290986|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
14290987|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290988|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14290989|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
14290990|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14290991|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
14290992|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14290993|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14290994|NCT00552071|Octreotide|octreotide|mesh-list
14290995|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14290996|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14290997|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14290998|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
14290999|NCT00552110|Phenylephrine|phenylephrine|mesh-list
14291000|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
14291001|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291002|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291003|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14291004|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14291005|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14291006|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291007|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291008|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291009|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291010|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
14291011|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
14291012|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291013|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
14291014|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14291015|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14291016|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14291017|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
14291018|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14291019|NCT00552110|Protective Agents|protective agents|mesh-ancestor
14291020|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14291021|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14291022|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14291023|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291024|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291025|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291026|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291027|NCT00552175|Analgesics|analgesics|mesh-ancestor
14291028|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
14291029|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291030|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
14291031|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14291032|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
14291033|NCT00552188|Atreleuton|atreleuton|mesh-list
14291034|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14291035|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291036|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291037|NCT00552240|Ritonavir|ritonavir|mesh-list
14291038|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14291039|NCT00552240|Tenofovir|tenofovir|mesh-list
14291040|NCT00552240|Emtricitabine|emtricitabine|mesh-list
14291041|NCT00552240|Nevirapine|nevirapine|mesh-list
14291042|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14291043|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14291044|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
14291045|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291046|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291047|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14291048|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14291049|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
14291050|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291051|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14291052|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14291053|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14291054|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14291055|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14291056|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14291057|NCT00552279|Vaccines|vaccines|mesh-list
14291058|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
14291059|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148091|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148092|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
15148093|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
15148094|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148095|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291060|NCT00552305|Lacosamide|lacosamide|mesh-list
14291061|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
14291062|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14291063|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14291064|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291065|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291066|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
14291067|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291068|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
14291069|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291070|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291071|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
14291072|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14291073|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291074|NCT00552409|Vitamins|vitamins|mesh-ancestor
14291075|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
14291076|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14291077|NCT00552422|Domperidone|domperidone|mesh-list
14291078|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
14291079|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
14291080|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291081|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291082|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14291083|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14291084|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
14291085|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291086|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291087|NCT00552578|Buprenorphine|buprenorphine|mesh-list
14291088|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14291089|NCT00552578|Naloxone|naloxone|mesh-list
14291090|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14291091|NCT00552578|Narcotics|narcotics|mesh-ancestor
14291092|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291093|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291094|NCT00552578|Analgesics|analgesics|mesh-ancestor
14291095|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
14291096|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291097|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14291098|NCT00552617|Rocuronium|rocuronium|mesh-list
14291099|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
14291100|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14291101|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14291102|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14291103|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291104|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291105|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14291106|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14291107|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
14291108|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291109|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291110|NCT00552669|Sirolimus|sirolimus|mesh-list
14291111|NCT00552669|Paclitaxel|paclitaxel|mesh-list
14291112|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14291113|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148096|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148097|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
14291114|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14291115|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14291116|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14291117|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562972|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148098|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291118|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14291119|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291120|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14291121|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
14291122|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291123|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
14291124|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148099|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15148100|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15148101|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15148102|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148103|NCT04233866|Antidotes|antidotes|mesh-ancestor
15148104|NCT04233866|Protective Agents|protective agents|mesh-ancestor
14291125|NCT00552695|Lidocaine|lidocaine|mesh-list
14291126|NCT00552695|Tetracaine|tetracaine|mesh-list
14291127|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
14291128|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
14291129|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291130|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291131|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
14291132|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291133|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14291134|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14291135|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14291136|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291137|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291138|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
14291139|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14291140|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
14291141|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291142|NCT00552786|Expectorants|expectorants|mesh-ancestor
14291143|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
14291144|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14291145|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
14291146|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291147|NCT00552786|Protective Agents|protective agents|mesh-ancestor
14291148|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291149|NCT00552786|Antidotes|antidotes|mesh-ancestor
14291150|NCT00553059|Dexamethasone|dexamethasone|mesh-list
14291151|NCT00553059|Dronabinol|dronabinol|mesh-list
14291152|NCT00553059|Palonosetron|palonosetron|mesh-list
14291153|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291154|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
14291155|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
14291156|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291157|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291158|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14291159|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
14291160|NCT00553059|Hormones|hormones|mesh-ancestor
14291161|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291162|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14291163|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291164|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14291165|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14291166|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
14291167|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291168|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291169|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
14291170|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14291171|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14291172|NCT00553059|Analgesics|analgesics|mesh-ancestor
14291173|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
14291174|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14291175|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14291176|NCT00553098|Cyclosporine|cyclosporine|mesh-list
14291177|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
14291178|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14291179|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
14291180|NCT00553098|Fludarabine|fludarabine|mesh-list
14291181|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
14291182|NCT00553098|Antibodies|antibodies|mesh-list
14291183|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
14291184|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14291185|NCT00553098|Cyclosporins|cyclosporins|mesh-list
14291186|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
14291187|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148105|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
14291188|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291189|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14291190|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
14291191|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148106|NCT04233866|Vitamins|vitamins|mesh-ancestor
15148107|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
15148108|NCT04233866|Hematinics|hematinics|mesh-ancestor
15148109|NCT04234048|Fenretinide|fenretinide|mesh-list
15148110|NCT04234048|Retinamide|retinamide|mesh-list
15148111|NCT04234048|Tretinoin|tretinoin|mesh-list
15148112|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148113|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15148114|NCT04234048|Protective Agents|protective agents|mesh-ancestor
15148115|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291192|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291193|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291194|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
14291195|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291196|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291197|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291198|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14291199|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14291200|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14291201|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
14291202|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14291203|NCT00553150|Everolimus|everolimus|mesh-list
14291204|NCT00553150|Temozolomide|temozolomide|mesh-list
14291205|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291206|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291207|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
14291208|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291209|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14291210|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
14562973|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14562974|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562975|NCT00002911|Marimastat|marimastat|mesh-list
14562976|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562977|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562978|NCT00002912|Etoposide|etoposide|mesh-list
14562979|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
14562980|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562981|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562982|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14562983|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14562984|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14562985|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562986|NCT00002912|Analgesics|analgesics|mesh-ancestor
14562987|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
14562988|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14562989|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14562990|NCT00002913|Paclitaxel|paclitaxel|mesh-list
14562991|NCT00002913|Topotecan|topotecan|mesh-list
14562992|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14562993|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14562994|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
14562995|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
14562996|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
14562997|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14562998|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14562999|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563000|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563001|NCT00002914|Piritrexim|piritrexim|mesh-list
14563002|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563003|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14563004|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563005|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563006|NCT00002915|Penclomedine|penclomedine|mesh-list
14563007|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563008|NCT00002917|Paclitaxel|paclitaxel|mesh-list
14563009|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563010|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148116|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
14563011|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563012|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148117|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
15148118|NCT04233697|Romidepsin|romidepsin|mesh-list
14563013|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563014|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563015|NCT00002919|Doxorubicin|doxorubicin|mesh-list
14563016|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14563017|NCT00002919|Methotrexate|methotrexate|mesh-list
14563018|NCT00002919|Vinblastine|vinblastine|mesh-list
14563019|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563020|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563021|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563022|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563023|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563024|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563025|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14563026|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
14563027|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563028|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563029|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563030|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
14563031|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563032|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14563033|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563034|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
15148119|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15148120|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148121|NCT04233892|Estrogens|estrogens|mesh-list
15148122|NCT04233892|Hormones|hormones|mesh-ancestor
15148123|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148124|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563035|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563036|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563037|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563038|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563039|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563040|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563041|NCT00002920|Tamoxifen|tamoxifen|mesh-list
14563042|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14563043|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
14563044|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14563045|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
14563046|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563047|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563048|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14563049|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563050|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14563051|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14563052|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14563053|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14563054|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14563055|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14563056|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
14563057|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563058|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14563059|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14563060|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14563061|NCT00002921|Suramin|suramin|mesh-list
14563062|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
14563063|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14563064|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14563065|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14563066|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14563067|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
14563068|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
14563069|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14563070|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563071|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563072|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14563073|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14563074|NCT00002922|Paclitaxel|paclitaxel|mesh-list
14563075|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563076|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563077|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563078|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563079|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148125|NCT04233294|Decitabine|decitabine|mesh-list
14563080|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563081|NCT00002923|KRN 5500|krn 5500|mesh-list
14563082|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563083|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14563084|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563085|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643652|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643653|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643654|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
14643655|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643656|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643657|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
14643658|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643659|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14643660|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643661|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
14643662|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643663|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14643664|NCT00189982|Factor VIII|factor viii|mesh-list
14643665|NCT00189982|Coagulants|coagulants|mesh-ancestor
14643666|NCT00189995|Haloperidol|haloperidol|mesh-list
14643667|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
14643668|NCT00189995|Clozapine|clozapine|mesh-list
14643669|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
14643670|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
14643671|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643672|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643673|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14643674|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14643675|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14643676|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14643677|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643678|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14643679|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
14643680|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643681|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643682|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14643683|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14643684|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
15148126|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148127|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
15148128|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148129|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148130|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148131|NCT04233463|Budesonide|budesonide|mesh-list
15148132|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148133|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15148134|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
15148135|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148136|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148137|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15148138|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
15148139|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
15148140|NCT04233463|Hormones|hormones|mesh-ancestor
15148141|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148142|NCT04233346|Ponatinib|ponatinib|mesh-list
15148143|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148144|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15148145|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148146|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148147|NCT04233203|Insulin|insulin|mesh-list
15148148|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15148149|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15148150|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643685|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
14643686|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
14643687|NCT00190008|Piracetam|piracetam|mesh-list
14643688|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14643689|NCT00190008|Protective Agents|protective agents|mesh-ancestor
14643690|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643691|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
14643692|NCT00190021|Donepezil|donepezil|mesh-list
15148151|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
14643693|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14643694|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148152|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15148153|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15148154|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563086|NCT00002925|Aldesleukin|aldesleukin|mesh-list
14563087|NCT00002925|Etoposide|etoposide|mesh-list
14563088|NCT00002925|Daunorubicin|daunorubicin|mesh-list
14563089|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563090|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563091|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563092|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563093|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563094|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563095|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563096|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14563097|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14563098|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
14563099|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563100|NCT00002926|Cytarabine|cytarabine|mesh-list
14563101|NCT00002926|Etoposide|etoposide|mesh-list
14563102|NCT00002926|Idarubicin|idarubicin|mesh-list
14563103|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563104|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563105|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563106|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563107|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563108|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563109|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563110|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
14563111|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
14563112|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563113|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563114|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
14563115|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563116|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563117|NCT00002928|Paclitaxel|paclitaxel|mesh-list
14563118|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563119|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563120|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563121|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563122|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563123|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563124|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14563125|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14563126|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148155|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
15148156|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
15148157|NCT04233359|Anesthetics|anesthetics|mesh-list
15148158|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
15148159|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148160|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148161|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
15148162|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14563127|NCT00002932|Cisplatin|cisplatin|mesh-list
14563128|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563129|NCT00002933|Irinotecan|irinotecan|mesh-list
14563130|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14563131|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563132|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563133|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563134|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563135|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14563136|NCT00002935|Trioxsalen|trioxsalen|mesh-list
14563137|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563138|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563139|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14563140|NCT00002936|Etoposide|etoposide|mesh-list
14563141|NCT00002936|Altretamine|altretamine|mesh-list
14563142|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563143|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563144|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563145|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563146|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563147|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148163|NCT04233229|Insulin|insulin|mesh-list
14563148|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563149|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
15148164|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14563150|NCT00002937|Paclitaxel|paclitaxel|mesh-list
14563151|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563152|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563153|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563154|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563155|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148165|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179922|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179923|NCT03944473|Neostigmine|neostigmine|mesh-list
15179924|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15179925|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563156|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563157|NCT00002939|Paclitaxel|paclitaxel|mesh-list
14563158|NCT00002939|Irinotecan|irinotecan|mesh-list
14563159|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563160|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563161|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563162|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563163|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563164|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563165|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14563166|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563167|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563168|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
14563169|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563170|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
14563171|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563172|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563173|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563174|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
14563175|NCT00002941|Carmustine|carmustine|mesh-list
14563176|NCT00002941|Etoposide|etoposide|mesh-list
14563177|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563178|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
14563179|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563180|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563181|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563182|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
14563183|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563184|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563185|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563186|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563187|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563188|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563189|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563190|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
14563191|NCT00002943|Carboplatin|carboplatin|mesh-list
14563192|NCT00002943|Etoposide|etoposide|mesh-list
14563193|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563194|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
14563195|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563196|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563197|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563198|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
14563199|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563200|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563201|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563202|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563203|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563204|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563205|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563206|NCT00002944|Carboplatin|carboplatin|mesh-list
14563207|NCT00002944|Vincristine|vincristine|mesh-list
14563208|NCT00002944|Thioguanine|thioguanine|mesh-list
14563209|NCT00002944|Lomustine|lomustine|mesh-list
14563210|NCT00002944|Procarbazine|procarbazine|mesh-list
14563211|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563212|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563213|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563214|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563215|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563216|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563217|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563218|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
14563219|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563220|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
15148166|NCT04233515|Anticoagulants|anticoagulants|mesh-list
15148167|NCT04233502|Melatonin|melatonin|mesh-list
15148168|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
15148169|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148170|NCT04233502|Protective Agents|protective agents|mesh-ancestor
15148171|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148172|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148173|NCT04232800|Riboflavin|riboflavin|mesh-list
14563221|NCT00002945|Cytarabine|cytarabine|mesh-list
14563222|NCT00002945|Aldesleukin|aldesleukin|mesh-list
14563223|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
14563224|NCT00002945|Melphalan|melphalan|mesh-list
14563225|NCT00002945|Etoposide|etoposide|mesh-list
14563226|NCT00002945|Idarubicin|idarubicin|mesh-list
14563227|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563228|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
14563229|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563230|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563231|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563232|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
14563233|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563234|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563235|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563236|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563237|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563238|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563239|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563240|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563241|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
14563242|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
14563243|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563244|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14563245|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14563246|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563247|NCT00002946|Penclomedine|penclomedine|mesh-list
14563248|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563249|NCT00002948|Topotecan|topotecan|mesh-list
14563250|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14563251|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563252|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563253|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563254|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563255|NCT00002949|Paclitaxel|paclitaxel|mesh-list
14563256|NCT00002949|Vinorelbine|vinorelbine|mesh-list
14563257|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563258|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563259|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563260|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563261|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563262|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563263|NCT00002950|Topotecan|topotecan|mesh-list
14563264|NCT00002950|Sargramostim|sargramostim|mesh-list
14563265|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14563266|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563267|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563268|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563269|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563270|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
14563271|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563272|NCT00002951|Fluorouracil|fluorouracil|mesh-list
14563273|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
14563274|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
14563275|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563276|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563277|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563278|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563279|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
14563280|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563281|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
14563282|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563283|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563284|NCT00002952|Interleukin-12|interleukin-12|mesh-list
15148174|NCT04232800|Vitamins|vitamins|mesh-ancestor
14563285|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14563286|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
15148175|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
14563287|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563288|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14563289|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14563290|NCT00002952|Growth Substances|growth substances|mesh-ancestor
14563291|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
14563292|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563293|NCT00002953|Paclitaxel|paclitaxel|mesh-list
14563294|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
14563295|NCT00002953|Epirubicin|epirubicin|mesh-list
14563296|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563297|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563298|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563299|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563300|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563301|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563302|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563303|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
14563304|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563305|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563306|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563307|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
14563308|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563309|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563310|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563311|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563312|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563313|NCT00002955|Leucovorin|leucovorin|mesh-list
14563314|NCT00002955|Trimetrexate|trimetrexate|mesh-list
14563315|NCT00002955|Fluorouracil|fluorouracil|mesh-list
15148176|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148177|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
15148178|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15148179|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
15148180|NCT04232943|Vaccines|vaccines|mesh-list
15148181|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
15148182|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148183|NCT04232813|Estradiol|estradiol|mesh-list
15148184|NCT04232813|Estrogens|estrogens|mesh-ancestor
15148185|NCT04232813|Hormones|hormones|mesh-ancestor
15148186|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148187|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563316|NCT00002955|Calcium|calcium|mesh-list
14563317|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
14563318|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14563319|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563320|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
14563321|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563322|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563323|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563324|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563325|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
14563326|NCT00002955|Antidotes|antidotes|mesh-ancestor
14563327|NCT00002955|Protective Agents|protective agents|mesh-ancestor
14563328|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
14563329|NCT00002955|Vitamins|vitamins|mesh-ancestor
14563330|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
14563331|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
14563332|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563333|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14563334|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563335|NCT00002961|Cyclosporine|cyclosporine|mesh-list
14563336|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
14563337|NCT00002961|Busulfan|busulfan|mesh-list
14563338|NCT00002961|Methotrexate|methotrexate|mesh-list
14563339|NCT00002961|Etoposide|etoposide|mesh-list
14563340|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
14563341|NCT00002961|Cyclosporins|cyclosporins|mesh-list
14563342|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563343|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
14563344|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563345|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563346|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563347|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
14563348|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563349|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563350|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15148188|NCT04233021|Osimertinib|osimertinib|mesh-list
15148189|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563351|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14563352|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
14563353|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563354|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563355|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
14563356|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563357|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563358|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14563359|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563360|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563361|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563362|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563363|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
14563364|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563365|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14563366|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14563367|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14563368|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563369|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14563370|NCT00002964|Trioxsalen|trioxsalen|mesh-list
14563371|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563372|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563373|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14563374|NCT00002965|Interferons|interferons|mesh-list
14563375|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
14563376|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
14563377|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14563378|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563379|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
14563380|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563381|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
14563382|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563383|NCT00002967|Tamoxifen|tamoxifen|mesh-list
14563384|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
14563385|NCT00002967|Doxorubicin|doxorubicin|mesh-list
14563386|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14563387|NCT00002967|Octreotide|octreotide|mesh-list
14563388|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563389|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
14563390|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563391|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563392|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563393|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
14563394|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563395|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563396|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563397|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563398|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563399|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563400|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563401|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14563402|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
14563403|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563404|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14563405|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14563406|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14563407|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14563408|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14563409|NCT00002968|Edrecolomab|edrecolomab|mesh-list
14563410|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14563411|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
14563412|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563413|NCT00002969|Paclitaxel|paclitaxel|mesh-list
14563414|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563415|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563416|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563417|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563418|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563419|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563420|NCT00002970|Cytarabine|cytarabine|mesh-list
14563421|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
14563422|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14563423|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14563424|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14563425|NCT00002970|Methotrexate|methotrexate|mesh-list
14563426|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14563427|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
14563428|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563429|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563430|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563431|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
14563432|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563433|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563434|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563435|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563436|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14563437|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563438|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
14563439|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563440|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563441|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
14563442|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563443|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14563444|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14563445|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563446|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563447|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563448|NCT00002972|Paclitaxel|paclitaxel|mesh-list
14563449|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563450|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563451|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148190|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15148191|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148192|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148193|NCT04232969|Exenatide|exenatide|mesh-list
15148194|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15148195|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148196|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14563452|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563453|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563454|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563455|NCT00002973|Melphalan|melphalan|mesh-list
14563456|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148197|NCT04232969|Incretins|incretins|mesh-ancestor
15148198|NCT04232969|Hormones|hormones|mesh-ancestor
15148199|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148200|NCT04232644|Amphetamine|amphetamine|mesh-list
15148201|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
15148202|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15148203|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148204|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
15148205|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
15148206|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148207|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
15148208|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148209|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148210|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
15148211|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14563457|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
14563458|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563459|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563460|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563461|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148212|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15148213|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14563462|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
14563463|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563464|NCT00002974|Carboplatin|carboplatin|mesh-list
14563465|NCT00002974|Etoposide|etoposide|mesh-list
14563466|NCT00002974|Ifosfamide|ifosfamide|mesh-list
14563467|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563468|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563469|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563470|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563471|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563472|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563473|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148214|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14563474|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
14563475|NCT00002976|Estrogens|estrogens|mesh-list
14563476|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14563477|NCT00002976|Hormones|hormones|mesh-ancestor
14563478|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563479|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563480|NCT00002977|Melphalan|melphalan|mesh-list
14563481|NCT00002977|Thiotepa|thiotepa|mesh-list
14563482|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
14563483|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563484|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563485|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
14563486|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563487|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563488|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563489|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563490|NCT00002980|Decitabine|decitabine|mesh-list
14563491|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563492|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
14563493|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563494|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563495|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563496|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14563497|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14563498|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563499|NCT00002982|Cytarabine|cytarabine|mesh-list
15148215|NCT04232722|Sorafenib|sorafenib|mesh-list
15148216|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148217|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15148218|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148219|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148220|NCT04232332|Mitogens|mitogens|mesh-list
15148221|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148222|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148223|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15148224|NCT04232150|Midazolam|midazolam|mesh-list
14563500|NCT00002982|Carboplatin|carboplatin|mesh-list
14563501|NCT00002982|Etoposide|etoposide|mesh-list
14020892|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
14563502|NCT00002982|Melphalan|melphalan|mesh-list
14563503|NCT00002982|Ifosfamide|ifosfamide|mesh-list
14563504|NCT00002982|Carmustine|carmustine|mesh-list
14563505|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563506|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563507|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563508|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563509|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563510|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563511|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563512|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
14563513|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
14563514|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563515|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148225|NCT04232150|Anesthetics|anesthetics|mesh-list
15148226|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148227|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148228|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15148229|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15148230|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15148231|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15148232|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148233|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15148234|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
15148235|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
15148236|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
15148237|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148238|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020893|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563516|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
14563517|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563518|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563519|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
14563520|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15148239|NCT04231864|Durvalumab|durvalumab|mesh-list
14563521|NCT00002984|Paclitaxel|paclitaxel|mesh-list
14563522|NCT00002984|Fluorouracil|fluorouracil|mesh-list
15148240|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
15148241|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14563523|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563524|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563525|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563526|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563527|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563528|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563529|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
14563530|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563531|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563532|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
14563533|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563534|NCT00002985|Doxorubicin|doxorubicin|mesh-list
14563535|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15148242|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
15148243|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148244|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148245|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
15148246|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148247|NCT04232033|Mitogens|mitogens|mesh-list
15148248|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148249|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148250|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
15148251|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
15148252|NCT04232085|Melphalan|melphalan|mesh-list
15148253|NCT04232085|Fludarabine|fludarabine|mesh-list
15148254|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
15148255|NCT04232085|Tacrolimus|tacrolimus|mesh-list
15148256|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148257|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
15148258|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148259|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148260|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563536|NCT00002985|Daunorubicin|daunorubicin|mesh-list
14563537|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563538|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563539|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563540|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563541|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563542|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563543|NCT00002986|Topotecan|topotecan|mesh-list
14563544|NCT00002986|Carmustine|carmustine|mesh-list
14563545|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14563546|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563547|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148261|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
15148262|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563548|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563549|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563550|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563551|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
14563552|NCT00002987|Prednisolone|prednisolone|mesh-list
14563553|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
14563554|NCT00002987|Doxorubicin|doxorubicin|mesh-list
14563555|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14563556|NCT00002987|Etoposide|etoposide|mesh-list
14563557|NCT00002987|Vincristine|vincristine|mesh-list
14563558|NCT00002987|Bleomycin|bleomycin|mesh-list
14563559|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563560|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
14563561|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563562|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563563|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563564|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
14563565|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563566|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563567|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563568|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563569|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563570|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563571|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563572|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148263|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563573|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148264|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15148265|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14563574|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563575|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563576|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14563577|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
14563578|NCT00002987|Hormones|hormones|mesh-ancestor
14563579|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563580|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14563581|NCT00002988|Irinotecan|irinotecan|mesh-list
14563582|NCT00002988|Carmustine|carmustine|mesh-list
14563583|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14563584|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563585|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563586|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563587|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563588|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148266|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148267|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15148268|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15148269|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
14563589|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
14563590|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
14563591|NCT00002989|Melphalan|melphalan|mesh-list
14563592|NCT00002989|Busulfan|busulfan|mesh-list
14563593|NCT00002989|Idarubicin|idarubicin|mesh-list
14563594|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563595|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
14563596|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563597|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563598|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563599|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
14563600|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563601|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563602|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563603|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563604|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563605|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563606|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563607|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
14563608|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14563609|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
14563610|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563611|NCT00002993|Doxorubicin|doxorubicin|mesh-list
14563612|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14563613|NCT00002993|Mitomycins|mitomycins|mesh-list
14563614|NCT00002993|Mitomycin|mitomycin|mesh-list
14563615|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563616|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563617|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563618|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563619|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563620|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563621|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
14563622|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563623|NCT00002994|Interleukin-2|interleukin-2|mesh-list
14563624|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563625|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14563626|NCT00002994|Analgesics|analgesics|mesh-ancestor
14563627|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
14563628|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14563629|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563630|NCT00002995|Dactinomycin|dactinomycin|mesh-list
14563631|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
14563632|NCT00002995|Vincristine|vincristine|mesh-list
14563633|NCT00002995|Sargramostim|sargramostim|mesh-list
14563634|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563635|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
14563636|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563637|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563638|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563639|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
14563640|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563641|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563642|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563643|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563644|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148270|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14563645|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563646|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563647|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14563648|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563649|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563650|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14563651|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563652|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563653|NCT00002996|Flecainide|flecainide|mesh-list
14563654|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14563655|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14563656|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14563657|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14563658|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563659|NCT00002998|Gemcitabine|gemcitabine|mesh-list
14563660|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563661|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563662|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
14563663|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563664|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
14563665|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563666|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563667|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563668|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
14563669|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563670|NCT00002999|Fluorouracil|fluorouracil|mesh-list
14563671|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563672|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
14563673|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563674|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563675|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563676|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
14563677|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563678|NCT00003000|Fentanyl|fentanyl|mesh-list
14563679|NCT00003000|Morphine|morphine|mesh-list
14563680|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14563681|NCT00003000|Narcotics|narcotics|mesh-ancestor
14563682|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14563683|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563684|NCT00003000|Analgesics|analgesics|mesh-ancestor
14563685|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
14563686|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14563687|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14563688|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14563689|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
14563690|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
14563691|NCT00003001|Leucovorin|leucovorin|mesh-list
14563692|NCT00003001|Gemcitabine|gemcitabine|mesh-list
14563693|NCT00003001|Fluorouracil|fluorouracil|mesh-list
15148271|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148272|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148273|NCT04231851|Cytarabine|cytarabine|mesh-list
15148274|NCT04231851|Daunorubicin|daunorubicin|mesh-list
15148275|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148276|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
15148277|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563694|NCT00003001|Calcium|calcium|mesh-list
14563695|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
14563696|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563697|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
14563698|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563699|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563700|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
14563701|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563702|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563703|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563704|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
14563705|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563706|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14563707|NCT00003001|Antidotes|antidotes|mesh-ancestor
14563708|NCT00003001|Protective Agents|protective agents|mesh-ancestor
14563709|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
15148278|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148279|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
14563710|NCT00003001|Vitamins|vitamins|mesh-ancestor
14563711|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
14563712|NCT00003002|Sargramostim|sargramostim|mesh-list
14563713|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
14563714|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563715|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
14563716|NCT00003003|Mitomycins|mitomycins|mesh-list
14563717|NCT00003003|Mitomycin|mitomycin|mesh-list
14563718|NCT00003003|Sargramostim|sargramostim|mesh-list
14563719|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
14563720|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563721|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563722|NCT00003003|Analgesics|analgesics|mesh-ancestor
14563723|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
14563724|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14563725|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14020894|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14020895|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563726|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563727|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563728|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563729|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563730|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
14563731|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563732|NCT00003004|Paclitaxel|paclitaxel|mesh-list
14563733|NCT00003004|Alvocidib|alvocidib|mesh-list
14563734|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563735|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563736|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563737|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563738|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563739|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563740|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
14563741|NCT00003004|Growth Substances|growth substances|mesh-ancestor
14563742|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563743|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14563744|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563745|NCT00003005|Cordycepin|cordycepin|mesh-list
14563746|NCT00003005|Pentostatin|pentostatin|mesh-list
14563747|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563748|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14563749|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563750|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563751|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
14563752|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563753|NCT00003007|Interferons|interferons|mesh-list
14563754|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
14563755|NCT00003007|Dexamethasone|dexamethasone|mesh-list
14563756|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
14563757|NCT00003007|Melphalan|melphalan|mesh-list
14563758|NCT00003007|Sargramostim|sargramostim|mesh-list
14563759|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563760|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
14563761|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563762|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563763|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563764|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
14563765|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563766|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563767|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563768|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14563769|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
14563770|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
14563771|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14563772|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14563773|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
14563774|NCT00003007|Hormones|hormones|mesh-ancestor
14563775|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563776|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14563777|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
14563778|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563779|NCT00003008|Ritonavir|ritonavir|mesh-list
14563780|NCT00003008|Nelfinavir|nelfinavir|mesh-list
14563781|NCT00003008|Indinavir|indinavir|mesh-list
14563782|NCT00003008|Saquinavir|saquinavir|mesh-list
14020896|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563783|NCT00003008|Paclitaxel|paclitaxel|mesh-list
14563784|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563785|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563786|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563787|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563788|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563789|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563790|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14563791|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14563792|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
14563793|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563794|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14563795|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14563796|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
14563797|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563798|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14563799|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14563800|NCT00003009|Aldesleukin|aldesleukin|mesh-list
14563801|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563802|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14563803|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14563804|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
15148280|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148281|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148282|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
15148283|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148284|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15148285|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148286|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148287|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148288|NCT04231643|Dronabinol|dronabinol|mesh-list
14563805|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14563806|NCT00003010|Marimastat|marimastat|mesh-list
14563807|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563808|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563809|NCT00003011|Marimastat|marimastat|mesh-list
14563810|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563811|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563812|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
14563813|NCT00003012|Fluorouracil|fluorouracil|mesh-list
14563814|NCT00003012|Methotrexate|methotrexate|mesh-list
14563815|NCT00003012|Epirubicin|epirubicin|mesh-list
14563816|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563817|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
14563818|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563819|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563820|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563821|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
14563822|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563823|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563824|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563825|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
14563826|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563827|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14563828|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
14563829|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563830|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563831|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148289|NCT04231643|Cannabidiol|cannabidiol|mesh-list
15148290|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
15148291|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148292|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148293|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15148294|NCT04231643|Analgesics|analgesics|mesh-ancestor
15148295|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
14563832|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14563833|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563834|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563835|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148296|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148297|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15148298|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15148299|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148300|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148301|NCT04231643|Hormones|hormones|mesh-ancestor
15148302|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148303|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
15148304|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
14563836|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148305|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148306|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148307|NCT04231435|Metformin|metformin|mesh-list
15148308|NCT04231435|Digoxin|digoxin|mesh-list
15148309|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15148310|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15148311|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148312|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15148313|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15148314|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
15148315|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148316|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15148317|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14563837|NCT00003013|Tamoxifen|tamoxifen|mesh-list
14563838|NCT00003013|Paclitaxel|paclitaxel|mesh-list
15148318|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148319|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15148320|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15148321|NCT04231435|Protective Agents|protective agents|mesh-ancestor
15148322|NCT04231617|Glyburide|glyburide|mesh-list
15148323|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15148324|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148325|NCT04231682|Denosumab|denosumab|mesh-list
15148326|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15148327|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148328|NCT04231448|Prednisone|prednisone|mesh-list
14563839|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
14563840|NCT00003013|Doxorubicin|doxorubicin|mesh-list
14563841|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14563842|NCT00003013|Fluorouracil|fluorouracil|mesh-list
14563843|NCT00003013|Methotrexate|methotrexate|mesh-list
14563844|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563845|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563846|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563847|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563848|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563849|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563850|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563851|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
14563852|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563853|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148329|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
15148330|NCT04231448|Rituximab|rituximab|mesh-list
15148331|NCT04231448|Doxorubicin|doxorubicin|mesh-list
15148332|NCT04231448|Vincristine|vincristine|mesh-list
14563854|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563855|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
14563856|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14563857|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563858|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14563859|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14563860|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563861|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
14563862|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563863|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14563864|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
14563865|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563866|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
14563867|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14563868|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563869|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14563870|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
14563871|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563872|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14563873|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14563874|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14563875|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14563876|NCT00003014|Carboplatin|carboplatin|mesh-list
14563877|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563878|NCT00003015|Carboplatin|carboplatin|mesh-list
14563879|NCT00003015|Vincristine|vincristine|mesh-list
14563880|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148333|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563881|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148334|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
15148335|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563882|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563883|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563884|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14563885|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563886|NCT00003016|Tamoxifen|tamoxifen|mesh-list
14563887|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14563888|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
15148336|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148337|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148338|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
15148339|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148340|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148341|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15148342|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148343|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15148344|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148345|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148346|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148347|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14563889|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563890|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563891|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14563892|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563893|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14563894|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14563895|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14563896|NCT00003017|Interleukin-12|interleukin-12|mesh-list
14563897|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14563898|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
14563899|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563900|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14563901|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14563902|NCT00003017|Growth Substances|growth substances|mesh-ancestor
14563903|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
14563904|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563905|NCT00003018|Leucovorin|leucovorin|mesh-list
14563906|NCT00003018|Fluorouracil|fluorouracil|mesh-list
14563907|NCT00003018|Mitomycins|mitomycins|mesh-list
14563908|NCT00003018|Mitomycin|mitomycin|mesh-list
14563909|NCT00003018|Dipyridamole|dipyridamole|mesh-list
14563910|NCT00003018|Calcium|calcium|mesh-list
14563911|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
14563912|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14563913|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563914|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
14563915|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563916|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563917|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563918|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563919|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
14563920|NCT00003018|Antidotes|antidotes|mesh-ancestor
14563921|NCT00003018|Protective Agents|protective agents|mesh-ancestor
14563922|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
14563923|NCT00003018|Vitamins|vitamins|mesh-ancestor
14563924|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
14563925|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563926|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
14563927|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563928|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563929|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14563930|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14563931|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
14563932|NCT00003019|Methotrexate|methotrexate|mesh-list
14563933|NCT00003019|Vinblastine|vinblastine|mesh-list
14563934|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14563935|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
14563936|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563937|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563938|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14563939|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
14563940|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563941|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563942|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
15148348|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
15148349|NCT04231448|Hormones|hormones|mesh-ancestor
14563943|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14563944|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15148350|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148351|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15148352|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148353|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148354|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148355|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148356|NCT04231370|Lenalidomide|lenalidomide|mesh-list
15148357|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
15148358|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148359|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15148360|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15148361|NCT04231370|Growth Substances|growth substances|mesh-ancestor
15148362|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
15148363|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563945|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14563946|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
14563947|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14563948|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14563949|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14563950|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
14563951|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
14563952|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148364|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
15148365|NCT04231214|Olodaterol|olodaterol|mesh-list
15148366|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15148367|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
15148368|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148369|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148370|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14563953|NCT00003020|Immunotoxins|immunotoxins|mesh-list
14563954|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
14563955|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563956|NCT00003021|Bizelesin|bizelesin|mesh-list
14563957|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14563958|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563959|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14563960|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
14563961|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563962|NCT00003022|Antibodies|antibodies|mesh-list
14563963|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14563964|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
14563965|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563966|NCT00003023|Vaccines|vaccines|mesh-list
14563967|NCT00003023|Antibodies|antibodies|mesh-list
14563968|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14563969|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
14563970|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
14563971|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563972|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14563973|NCT00003026|Bicalutamide|bicalutamide|mesh-list
14563974|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14563975|NCT00003026|Flutamide|flutamide|mesh-list
14563976|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
14563977|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
14563978|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14563979|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563980|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563981|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
14563982|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14563983|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
14563984|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14563985|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14563986|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14563987|NCT00003027|Interferons|interferons|mesh-list
14563988|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
14563989|NCT00003027|Aldesleukin|aldesleukin|mesh-list
14563990|NCT00003027|Dacarbazine|dacarbazine|mesh-list
14563991|NCT00003027|Vinblastine|vinblastine|mesh-list
14563992|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14563993|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
14563994|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148371|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
14563995|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
14020897|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14563996|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14563997|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14563998|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14563999|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564000|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
14564001|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564002|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564003|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564004|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564005|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564006|NCT00003029|Fluorouracil|fluorouracil|mesh-list
14564007|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564008|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
14564009|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564010|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564011|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564012|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
14564013|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564014|NCT00003031|Voriconazole|voriconazole|mesh-list
14564015|NCT00003031|Amphotericin B|amphotericin b|mesh-list
14564016|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14564017|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14564018|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
14564019|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
14564020|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148372|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
15148373|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15148374|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
15148375|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148376|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179926|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179927|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
15179928|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179929|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179930|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15179931|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
15179932|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179933|NCT03944512|Pravastatin|pravastatin|mesh-list
15179934|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15179935|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15179936|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
15179937|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179938|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15179939|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15179940|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179941|NCT03944317|Azithromycin|azithromycin|mesh-list
15179942|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
15179943|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
15179944|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15179945|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15179946|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15179947|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
15179948|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15179949|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15179950|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15179951|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179952|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179953|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15179954|NCT03944317|Renal Agents|renal agents|mesh-ancestor
15179955|NCT03944291|Bupivacaine|bupivacaine|mesh-list
15179956|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
15179957|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
15179958|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14564021|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14564022|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14564023|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564024|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564025|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14564026|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564027|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564028|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179959|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148377|NCT04231123|Anesthetics|anesthetics|mesh-list
15148378|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
15148379|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148380|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148381|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
15148382|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14564029|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14564030|NCT00003031|Amebicides|amebicides|mesh-ancestor
14564031|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14564032|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14564033|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14564034|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14564035|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14564036|NCT00003032|Tamoxifen|tamoxifen|mesh-list
14564037|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
14564038|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
14564039|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564040|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
14564041|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564042|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148383|NCT04231279|Secretin|secretin|mesh-list
15148384|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15148385|NCT04231279|Hormones|hormones|mesh-ancestor
15148386|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148387|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148388|NCT04230980|Gabapentin|gabapentin|mesh-list
15148389|NCT04230980|Analgesics|analgesics|mesh-ancestor
15148390|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
15148391|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148392|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148393|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
15148394|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15148395|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15148396|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148397|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148398|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14564043|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564044|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
14564045|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564046|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564047|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564048|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14564049|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564050|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564051|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564052|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14564053|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14564054|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14564055|NCT00003032|Analgesics|analgesics|mesh-ancestor
14564056|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
14564057|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14564058|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564059|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564060|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564061|NCT00003034|Doxorubicin|doxorubicin|mesh-list
14564062|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564063|NCT00003034|Ranpirnase|ranpirnase|mesh-list
14564064|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564065|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564066|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564067|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564068|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564069|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564070|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14564071|NCT00003035|Tamoxifen|tamoxifen|mesh-list
14564072|NCT00003035|Paclitaxel|paclitaxel|mesh-list
14564073|NCT00003035|Doxorubicin|doxorubicin|mesh-list
14564074|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564075|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564076|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564077|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564078|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564079|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564080|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564081|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564082|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148399|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15148400|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148401|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148402|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
15148403|NCT04230564|Azacitidine|azacitidine|mesh-list
14564083|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564084|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564085|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564086|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14564087|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564088|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564089|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564090|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14564091|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15148404|NCT04230564|Venetoclax|venetoclax|mesh-list
15148405|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148406|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
15148407|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148408|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148409|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148410|NCT04230759|Fluorouracil|fluorouracil|mesh-list
14564092|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14564093|NCT00003037|Gemcitabine|gemcitabine|mesh-list
14564094|NCT00003037|Docetaxel|docetaxel|mesh-list
14564095|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564096|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564097|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
14564098|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564099|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
14564100|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564101|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564102|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148411|NCT04230759|Durvalumab|durvalumab|mesh-list
15148412|NCT04230759|Mitomycins|mitomycins|mesh-list
15148413|NCT04230759|Mitomycin|mitomycin|mesh-list
15148414|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15148415|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
15148416|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148417|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148418|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148419|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148420|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
15148421|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148422|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148423|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15148424|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
15148425|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15148426|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148427|NCT04230460|Ethanol|ethanol|mesh-list
15148428|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15148429|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148430|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148431|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148432|NCT04230330|Gemcitabine|gemcitabine|mesh-list
15148433|NCT04230330|Dexamethasone|dexamethasone|mesh-list
14564103|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
14564104|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148434|NCT04230330|Nivolumab|nivolumab|mesh-list
14564105|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564106|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564107|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564108|NCT00003038|Suramin|suramin|mesh-list
14564109|NCT00003038|Doxorubicin|doxorubicin|mesh-list
14564110|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564111|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564112|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564113|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564114|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564115|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564116|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564117|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
15148435|NCT04230330|Asparaginase|asparaginase|mesh-list
15148436|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148437|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14564118|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
14564119|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14564120|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564121|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14564122|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14564123|NCT00003039|Alvocidib|alvocidib|mesh-list
14564124|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564125|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14564126|NCT00003039|Growth Substances|growth substances|mesh-ancestor
14564127|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564128|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14564129|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564130|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564131|NCT00003041|NSC 366140|nsc 366140|mesh-list
14564132|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564133|NCT00003044|Cisplatin|cisplatin|mesh-list
14564134|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643695|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148438|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
15148439|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
15148440|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148441|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148442|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15148443|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
14643696|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
14643697|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643698|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643699|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
14643700|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
14643701|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14643702|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
14643703|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643704|NCT00190034|Expectorants|expectorants|mesh-ancestor
14643705|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
14643706|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14643707|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
14643708|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643709|NCT00190034|Protective Agents|protective agents|mesh-ancestor
14643710|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643711|NCT00190034|Antidotes|antidotes|mesh-ancestor
15148444|NCT04230330|Hormones|hormones|mesh-ancestor
15148445|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148446|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15148447|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14020898|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14643712|NCT00190060|Testosterone|testosterone|mesh-list
14643713|NCT00190060|Androgens|androgens|mesh-ancestor
14643714|NCT00190060|Hormones|hormones|mesh-ancestor
14643715|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14020899|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14020900|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14020901|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14020902|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14643716|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643717|NCT00190099|Dexamethasone|dexamethasone|mesh-list
14643718|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14643719|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
14643720|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
14643721|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643722|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643723|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14643724|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
14643725|NCT00190099|Hormones|hormones|mesh-ancestor
14643726|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643727|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14643728|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643729|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
14643730|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643731|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643732|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14643733|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14643734|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148448|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
14643735|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564135|NCT00003046|Interleukin-12|interleukin-12|mesh-list
14564136|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14564137|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
14564138|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564139|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14564140|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14564141|NCT00003046|Growth Substances|growth substances|mesh-ancestor
14564142|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
14564143|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564144|NCT00003048|Amifostine|amifostine|mesh-list
14564145|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14564146|NCT00003048|Protective Agents|protective agents|mesh-ancestor
14564147|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564148|NCT00003049|Leucovorin|leucovorin|mesh-list
14564149|NCT00003049|Fluorouracil|fluorouracil|mesh-list
14564150|NCT00003049|Calcium|calcium|mesh-list
14564151|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
14564152|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14564153|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564154|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
14564155|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564156|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564157|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564158|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564159|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
14564160|NCT00003049|Antidotes|antidotes|mesh-ancestor
14564161|NCT00003049|Protective Agents|protective agents|mesh-ancestor
15148449|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148450|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
15148451|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148452|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148453|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148454|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
15148455|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148456|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15148457|NCT04230083|Dienogest|dienogest|mesh-list
15148458|NCT04230083|Nandrolone|nandrolone|mesh-list
15148459|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15148460|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
15148461|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15148462|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148463|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15148464|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15148465|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15148466|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14020903|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14020904|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14020905|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14564162|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
14564163|NCT00003049|Vitamins|vitamins|mesh-ancestor
14564164|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
14564165|NCT00003050|Tamoxifen|tamoxifen|mesh-list
14564166|NCT00003050|Paclitaxel|paclitaxel|mesh-list
14564167|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
15148467|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
14020906|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14564168|NCT00003050|Doxorubicin|doxorubicin|mesh-list
14564169|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564170|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564171|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564172|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564173|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564174|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564175|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564176|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564177|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
14564178|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564179|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564180|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564181|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
14564182|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564183|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564184|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564185|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564186|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564187|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14564188|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564189|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564190|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564191|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14564192|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14564193|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14564194|NCT00003052|Doxorubicin|doxorubicin|mesh-list
14564195|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564196|NCT00003052|Etoposide|etoposide|mesh-list
14564197|NCT00003052|Ifosfamide|ifosfamide|mesh-list
14564198|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564199|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564200|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564201|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564202|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564203|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564204|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564205|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564206|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
14564207|NCT00003053|Etoposide|etoposide|mesh-list
14564208|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564209|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564210|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564211|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564212|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564213|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564214|NCT00003054|Paclitaxel|paclitaxel|mesh-list
14564215|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564216|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564217|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564218|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564219|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564220|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564221|NCT00003055|Irinotecan|irinotecan|mesh-list
14564222|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564223|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564224|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564225|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564226|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564227|NCT00003056|Cyclosporine|cyclosporine|mesh-list
14564228|NCT00003056|Methotrexate|methotrexate|mesh-list
14564229|NCT00003056|Cyclosporins|cyclosporins|mesh-list
14564230|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14564231|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
14564232|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14564233|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291211|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291212|NCT00553202|Cyclosporine|cyclosporine|mesh-list
14291213|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
14291214|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14291215|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14291216|NCT00553202|Prednisolone|prednisolone|mesh-list
14291217|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
14291218|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
14291219|NCT00553202|Busulfan|busulfan|mesh-list
14291220|NCT00553202|Methotrexate|methotrexate|mesh-list
14291221|NCT00553202|Tacrolimus|tacrolimus|mesh-list
14564234|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564235|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
14564236|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564237|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564238|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14564239|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564240|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14564241|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564242|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
14564243|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564244|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14564245|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
15148468|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148469|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564246|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291222|NCT00553202|Cyclosporins|cyclosporins|mesh-list
14291223|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
14564247|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14564248|NCT00003057|Octreotide|octreotide|mesh-list
14564249|NCT00003057|Loperamide|loperamide|mesh-list
14564250|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
14564251|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14564252|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564253|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564254|NCT00003058|Troglitazone|troglitazone|mesh-list
14564255|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14564256|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564257|NCT00003060|Cyclosporine|cyclosporine|mesh-list
14564258|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
14564259|NCT00003060|Busulfan|busulfan|mesh-list
14564260|NCT00003060|Methotrexate|methotrexate|mesh-list
14564261|NCT00003060|Cyclosporins|cyclosporins|mesh-list
14564262|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564263|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
14564264|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564265|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564266|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564267|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
14564268|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564269|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564270|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564271|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14564272|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
14564273|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14564274|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564275|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
14564276|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
14564277|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564278|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14564279|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14564280|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
14564281|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564282|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14564283|NCT00003061|Cytarabine|cytarabine|mesh-list
14564284|NCT00003061|Methotrexate|methotrexate|mesh-list
14564285|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14564286|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
14564287|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14564288|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564289|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564290|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
14564291|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564292|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564293|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
14564294|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564295|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14564296|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564297|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
14564298|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564299|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14564300|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
14564301|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564302|NCT00003062|Temozolomide|temozolomide|mesh-list
14564303|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564304|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
14564305|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564306|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564307|NCT00003063|Leucovorin|leucovorin|mesh-list
14564308|NCT00003063|Interferons|interferons|mesh-list
14564309|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
14564310|NCT00003063|Levamisole|levamisole|mesh-list
14564311|NCT00003063|Fluorouracil|fluorouracil|mesh-list
14564312|NCT00003063|Calcium|calcium|mesh-list
14564313|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
14564314|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15148470|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564315|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564316|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
14564317|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564318|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564319|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148471|NCT04230083|Androgens|androgens|mesh-ancestor
14564320|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564321|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
15148472|NCT04230083|Hormones|hormones|mesh-ancestor
15148473|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
15148474|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15148475|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15148476|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
15148477|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15148478|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15148479|NCT04230070|Estradiol|estradiol|mesh-list
15148480|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15148481|NCT04230070|Estrogens|estrogens|mesh-ancestor
15148482|NCT04230070|Hormones|hormones|mesh-ancestor
15148483|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564322|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
14564323|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564324|NCT00003063|Antidotes|antidotes|mesh-ancestor
14564325|NCT00003063|Protective Agents|protective agents|mesh-ancestor
14564326|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
14564327|NCT00003063|Vitamins|vitamins|mesh-ancestor
14564328|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
14564329|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14564330|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
14564331|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
14564332|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14564333|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564334|NCT00003064|Paclitaxel|paclitaxel|mesh-list
14564335|NCT00003064|Etoposide|etoposide|mesh-list
14564336|NCT00003064|Carboplatin|carboplatin|mesh-list
14564337|NCT00003064|Topotecan|topotecan|mesh-list
14564338|NCT00003064|Thiotepa|thiotepa|mesh-list
14564339|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
14564340|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564341|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564342|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564343|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564344|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564345|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564346|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564347|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564348|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148484|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148485|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15148486|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
15148487|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15148488|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15148489|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14564349|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
14564350|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564351|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564352|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564353|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
14564354|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564355|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148490|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15148491|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15148492|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15148493|NCT04230187|Leucovorin|leucovorin|mesh-list
15148494|NCT04230187|Bevacizumab|bevacizumab|mesh-list
15148495|NCT04230187|Fluorouracil|fluorouracil|mesh-list
15148496|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
15148497|NCT04230187|Irinotecan|irinotecan|mesh-list
15148498|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
15148499|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148500|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148501|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15148502|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15148503|NCT04230187|Growth Substances|growth substances|mesh-ancestor
15148504|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148505|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
15148506|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
15148507|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148508|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148509|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148510|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
15148511|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564356|NCT00003065|Paclitaxel|paclitaxel|mesh-list
14564357|NCT00003065|Topotecan|topotecan|mesh-list
14564358|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564359|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148512|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148513|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148514|NCT04230187|Antidotes|antidotes|mesh-ancestor
15148515|NCT04230187|Protective Agents|protective agents|mesh-ancestor
15148516|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
15148517|NCT04230187|Vitamins|vitamins|mesh-ancestor
15148518|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
15148519|NCT04229979|Cytarabine|cytarabine|mesh-list
15148520|NCT04229979|Azacitidine|azacitidine|mesh-list
14564360|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564361|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564362|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564363|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564364|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564365|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564366|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564367|NCT00003066|Docetaxel|docetaxel|mesh-list
14564368|NCT00003066|Estramustine|estramustine|mesh-list
14564369|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564370|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564371|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564372|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564373|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564374|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564375|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
14564376|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564377|NCT00003067|Aldesleukin|aldesleukin|mesh-list
14564378|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564379|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14564380|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14564381|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
14564382|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564383|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
14564384|NCT00003068|Thiotepa|thiotepa|mesh-list
15148521|NCT04229979|Decitabine|decitabine|mesh-list
15148522|NCT04229979|Venetoclax|venetoclax|mesh-list
15148523|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148524|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
15148525|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148526|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148527|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
15148528|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148529|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148530|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
15148531|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148532|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148533|NCT04230213|Adalimumab|adalimumab|mesh-list
15148534|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148535|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148536|NCT04229758|Anticoagulants|anticoagulants|mesh-list
15148537|NCT04229719|Melatonin|melatonin|mesh-list
15148538|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
15148539|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148540|NCT04229719|Protective Agents|protective agents|mesh-ancestor
15148541|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148542|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148543|NCT04229459|Nivolumab|nivolumab|mesh-list
15148544|NCT04229459|Cetuximab|cetuximab|mesh-list
15148545|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148546|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148547|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15148548|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148549|NCT04229212|Cimetidine|cimetidine|mesh-list
15148550|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15148551|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15148552|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15148553|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
14564385|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
14564386|NCT00003068|Amifostine|amifostine|mesh-list
14564387|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564388|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
14564389|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148554|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
15148555|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148556|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564390|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564391|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148557|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564392|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
14564393|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564394|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564395|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564396|NCT00003068|Analgesics|analgesics|mesh-ancestor
14564397|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
14564398|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14564399|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564400|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564401|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564402|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14564403|NCT00003068|Protective Agents|protective agents|mesh-ancestor
14564404|NCT00003070|Enalapril|enalapril|mesh-list
14564405|NCT00003070|Enalaprilat|enalaprilat|mesh-list
14564406|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564407|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564408|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14564409|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14564410|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14564411|NCT00003072|Paclitaxel|paclitaxel|mesh-list
14564412|NCT00003072|Carboplatin|carboplatin|mesh-list
14564413|NCT00003072|Amifostine|amifostine|mesh-list
14564414|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14291224|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14291225|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14291226|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
14291227|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291228|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
14564415|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564416|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564417|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564418|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564419|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291229|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291230|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291231|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564420|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14564421|NCT00003072|Protective Agents|protective agents|mesh-ancestor
14564422|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564423|NCT00003073|Cytarabine|cytarabine|mesh-list
14564424|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564425|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
14564426|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564427|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564428|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
14564429|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564430|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564431|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
14564432|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564433|NCT00003075|Fenretinide|fenretinide|mesh-list
14564434|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564435|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14564436|NCT00003075|Protective Agents|protective agents|mesh-ancestor
14564437|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564438|NCT00003076|Eflornithine|eflornithine|mesh-list
14564439|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564440|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14564441|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14564442|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14564443|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564444|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14564445|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564446|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564447|NCT00003078|Fluorouracil|fluorouracil|mesh-list
14564448|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564449|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
14564450|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564451|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564452|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564453|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
14564454|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564455|NCT00003079|Cytarabine|cytarabine|mesh-list
14564456|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
14564457|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564458|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
15148558|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15148559|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15148560|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148561|NCT04229264|Apixaban|apixaban|mesh-list
15148562|NCT04229264|Clopidogrel|clopidogrel|mesh-list
15148563|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15148564|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15148565|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15148566|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15148567|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
15148568|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148569|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148570|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148571|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15148572|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
15148573|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15148574|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
15148575|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148576|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
15148577|NCT04229355|Sorafenib|sorafenib|mesh-list
15148578|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
15148579|NCT04229355|Lenvatinib|lenvatinib|mesh-list
15148580|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15148581|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148582|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15148583|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148584|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148585|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15148586|NCT04229355|Estrogens|estrogens|mesh-ancestor
15148587|NCT04229355|Hormones|hormones|mesh-ancestor
15148588|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564459|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564460|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564461|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
14564462|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564463|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564464|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
14564465|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564466|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14564467|NCT00003080|Tamoxifen|tamoxifen|mesh-list
14564468|NCT00003080|Melphalan|melphalan|mesh-list
14564469|NCT00003080|Thiotepa|thiotepa|mesh-list
14564470|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
14564471|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564472|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564473|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
14564474|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564475|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564476|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564477|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
14564478|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564479|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14564480|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564481|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564482|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564483|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14564484|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14564485|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14564486|NCT00003080|Analgesics|analgesics|mesh-ancestor
14564487|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
14564488|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14564489|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564490|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564491|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564492|NCT00003081|Melphalan|melphalan|mesh-list
14564493|NCT00003081|Busulfan|busulfan|mesh-list
14564494|NCT00003081|Thiotepa|thiotepa|mesh-list
14564495|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
14564496|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564497|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564498|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
14564499|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148589|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148590|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564500|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564501|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564502|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564503|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14564504|NCT00003082|Antibodies|antibodies|mesh-list
14564505|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
14564506|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14564507|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
14564508|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564509|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564510|NCT00003084|Ketoconazole|ketoconazole|mesh-list
14564511|NCT00003084|Paclitaxel|paclitaxel|mesh-list
14564512|NCT00003084|Etoposide|etoposide|mesh-list
14564513|NCT00003084|Vinblastine|vinblastine|mesh-list
14564514|NCT00003084|Doxorubicin|doxorubicin|mesh-list
14564515|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564516|NCT00003084|Estramustine|estramustine|mesh-list
14564517|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14811759|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
14811760|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14811761|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14811762|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14811763|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
14811764|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811765|NCT00846690|Protective Agents|protective agents|mesh-ancestor
14811766|NCT00846703|Dexamethasone|dexamethasone|mesh-list
14811767|NCT00846703|Methotrexate|methotrexate|mesh-list
14811768|NCT00846703|Vincristine|vincristine|mesh-list
14811769|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
14811770|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811771|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
14811772|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
14811773|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811774|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811775|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811776|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
14811777|NCT00846703|Hormones|hormones|mesh-ancestor
14811778|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811779|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14811780|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811781|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14811782|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
14811783|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14811784|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14811785|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
14811786|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811787|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
14811788|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811789|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14811790|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14811791|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
15148591|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15148592|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15148593|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15148594|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15148595|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148596|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148597|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148598|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15148599|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
15148600|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148601|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15148602|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148603|NCT04229407|Vitamins|vitamins|mesh-list
15148604|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
15148605|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
14811792|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811793|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14811794|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564518|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564519|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564520|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564521|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564522|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564523|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564524|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564525|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564526|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564527|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
14564528|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564529|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14564530|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14564531|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14564532|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564533|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564534|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564535|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14564536|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564537|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
14564538|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564539|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
14564540|NCT00003086|Carboplatin|carboplatin|mesh-list
14564541|NCT00003086|Doxorubicin|doxorubicin|mesh-list
14564542|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564543|NCT00003086|Fluorouracil|fluorouracil|mesh-list
14564544|NCT00003086|Melphalan|melphalan|mesh-list
14564545|NCT00003086|Ifosfamide|ifosfamide|mesh-list
14564546|NCT00003086|Thiotepa|thiotepa|mesh-list
14564547|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14564548|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564549|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564550|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564551|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
14564552|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564553|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564554|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564555|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
14564556|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564557|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564558|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14020907|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14564559|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564560|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564561|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
14564562|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564563|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14564564|NCT00003086|Analgesics|analgesics|mesh-ancestor
14564565|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
14564566|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14564567|NCT00003087|Paclitaxel|paclitaxel|mesh-list
14564568|NCT00003087|Cisplatin|cisplatin|mesh-list
14564569|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564570|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564571|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564572|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564573|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564574|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564575|NCT00003088|Paclitaxel|paclitaxel|mesh-list
14564576|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
14564577|NCT00003088|Doxorubicin|doxorubicin|mesh-list
14564578|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564579|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564580|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564581|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564582|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564583|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564584|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564585|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564586|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
14564587|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564588|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564589|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564590|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
14564591|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564592|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564593|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564594|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564595|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564596|NCT00003089|Paclitaxel|paclitaxel|mesh-list
14564597|NCT00003089|Carboplatin|carboplatin|mesh-list
14564598|NCT00003089|Amifostine|amifostine|mesh-list
14564599|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564600|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564601|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564602|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564603|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564604|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564605|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14564606|NCT00003089|Protective Agents|protective agents|mesh-ancestor
14564607|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564608|NCT00003090|Aldesleukin|aldesleukin|mesh-list
14564609|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564610|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14564611|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14564612|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
14564613|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564614|NCT00003091|Interferons|interferons|mesh-list
14564615|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
14564616|NCT00003091|Aldesleukin|aldesleukin|mesh-list
14564617|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564618|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
14564619|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564620|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
14564621|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564622|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14564623|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14564624|NCT00003092|Paclitaxel|paclitaxel|mesh-list
14564625|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564626|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564627|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564628|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564629|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564630|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564631|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
14564632|NCT00003093|Carboplatin|carboplatin|mesh-list
14564633|NCT00003093|Doxorubicin|doxorubicin|mesh-list
14564634|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564635|NCT00003093|Etoposide|etoposide|mesh-list
14564636|NCT00003093|Molgramostim|molgramostim|mesh-list
14564637|NCT00003093|Lenograstim|lenograstim|mesh-list
14564638|NCT00003093|Sargramostim|sargramostim|mesh-list
14564639|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564640|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
14564641|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564642|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148606|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564643|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564644|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
14564645|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564646|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564647|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564648|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564649|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564650|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564651|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564652|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564653|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14564654|NCT00003099|Tamoxifen|tamoxifen|mesh-list
14564655|NCT00003099|Fenretinide|fenretinide|mesh-list
14564656|NCT00003099|Retinamide|retinamide|mesh-list
14564657|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14564658|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564659|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564660|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564661|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564662|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564663|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14564664|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14564665|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14564666|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14564667|NCT00003099|Protective Agents|protective agents|mesh-ancestor
14564668|NCT00003101|Vincristine|vincristine|mesh-list
14564669|NCT00003101|Busulfan|busulfan|mesh-list
14564670|NCT00003101|Thiotepa|thiotepa|mesh-list
14564671|NCT00003101|Lomustine|lomustine|mesh-list
14564672|NCT00003101|Procarbazine|procarbazine|mesh-list
14564673|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
14564674|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564675|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564676|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564677|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564678|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564679|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148607|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15148608|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15148609|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
14811795|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
14811796|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
14811797|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564680|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564681|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
14564682|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564683|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564684|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564685|NCT00003103|Docetaxel|docetaxel|mesh-list
14564686|NCT00003103|Oblimersen|oblimersen|mesh-list
14564687|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564688|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564689|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
14811798|NCT00846716|Pioglitazone|pioglitazone|mesh-list
14811799|NCT00846716|Biguanides|biguanides|mesh-list
14811800|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14811801|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811802|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
14811803|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
14811804|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811805|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
14811806|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14811807|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811808|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811809|NCT00846859|Varenicline|varenicline|mesh-list
14811810|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14811811|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14811812|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
14811813|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14811814|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811815|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811816|NCT00846872|Mannitol|mannitol|mesh-list
14811817|NCT00846872|Hormones|hormones|mesh-list
14564690|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564691|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564692|NCT00003105|Gemcitabine|gemcitabine|mesh-list
14564693|NCT00003105|Paclitaxel|paclitaxel|mesh-list
14564694|NCT00003105|Doxorubicin|doxorubicin|mesh-list
14564695|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564696|NCT00003105|Ifosfamide|ifosfamide|mesh-list
14564697|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564698|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564699|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564700|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564701|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564702|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564703|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564704|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
14564705|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
14564706|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811818|NCT00846872|Secretagogues|secretagogues|mesh-list
14811819|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811820|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811821|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14811822|NCT00846872|Diuretics|diuretics|mesh-ancestor
14811823|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
14811824|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
14564707|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564708|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564709|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
14564710|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564711|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564712|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564713|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564714|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564715|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
14564716|NCT00003107|Interleukin-12|interleukin-12|mesh-list
14564717|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14564718|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
14564719|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564720|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14564721|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14564722|NCT00003107|Growth Substances|growth substances|mesh-ancestor
14564723|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
14564724|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564725|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
14564726|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564727|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14564728|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
14564729|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564730|NCT00003109|Irinotecan|irinotecan|mesh-list
14564731|NCT00003109|Raltitrexed|raltitrexed|mesh-list
14564732|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564733|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564734|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811825|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14811826|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14811827|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564735|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564736|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564737|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564738|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
14564739|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14564740|NCT00003110|Bleomycin|bleomycin|mesh-list
14564741|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564742|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564743|NCT00003111|Paclitaxel|paclitaxel|mesh-list
14564744|NCT00003111|Carboplatin|carboplatin|mesh-list
14564745|NCT00003111|Irinotecan|irinotecan|mesh-list
14564746|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564747|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811828|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14811829|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14811830|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811831|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811832|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811833|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14811834|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
14811835|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14811836|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811837|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14811838|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14811839|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14811840|NCT00846950|Lorazepam|lorazepam|mesh-list
15148610|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14564748|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564749|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564750|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564751|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564752|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564753|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564754|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564755|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
14564756|NCT00003113|Lomustine|lomustine|mesh-list
14564757|NCT00003113|Etoposide|etoposide|mesh-list
14564758|NCT00003113|Procarbazine|procarbazine|mesh-list
14564759|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564760|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
14564761|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564762|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564763|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564764|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
14564765|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564766|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564767|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564768|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564769|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564770|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564771|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148611|NCT04228757|Estrogens|estrogens|mesh-ancestor
14564772|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
14564773|NCT00003114|Lomustine|lomustine|mesh-list
14564774|NCT00003114|Etoposide|etoposide|mesh-list
14564775|NCT00003114|Procarbazine|procarbazine|mesh-list
14564776|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564777|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
14564778|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564779|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564780|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564781|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
15148612|NCT04228757|Hormones|hormones|mesh-ancestor
15148613|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148614|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148615|NCT04228315|Primaquine|primaquine|mesh-list
15148616|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
15148617|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15148618|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15148619|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148620|NCT04228263|Aspirin|aspirin|mesh-list
15148621|NCT04228263|Folic Acid|folic acid|mesh-list
15148622|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
15148623|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15148624|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15148625|NCT04228263|Analgesics|analgesics|mesh-ancestor
15148626|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
15148627|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148628|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148629|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148630|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148631|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15148632|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15148633|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148634|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15148635|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15148636|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148637|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
15148638|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
15148639|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15148640|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15148641|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148642|NCT04228263|Hematinics|hematinics|mesh-ancestor
14564782|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564783|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564784|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564785|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564786|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564787|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564788|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564789|NCT00003115|Hydromorphone|hydromorphone|mesh-list
14564790|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14564791|NCT00003115|Narcotics|narcotics|mesh-ancestor
14564792|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14564793|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564794|NCT00003115|Analgesics|analgesics|mesh-ancestor
14564795|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
14564796|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14564797|NCT00003116|Cyclosporine|cyclosporine|mesh-list
14564798|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
14564799|NCT00003116|Busulfan|busulfan|mesh-list
14564800|NCT00003116|Cyclosporins|cyclosporins|mesh-list
14564801|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564802|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
14564803|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564804|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564805|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564806|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
14564807|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564808|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564809|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564810|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564811|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
14564812|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564813|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
14564814|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14564815|NCT00003117|Paclitaxel|paclitaxel|mesh-list
14564816|NCT00003117|Carboplatin|carboplatin|mesh-list
14564817|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564818|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148643|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
15148644|NCT04228263|Vitamins|vitamins|mesh-ancestor
15148645|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
14564819|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564820|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564821|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564822|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564823|NCT00003118|Fluorouracil|fluorouracil|mesh-list
14564824|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564825|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
14564826|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564827|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564828|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564829|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
14564830|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564831|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
14564832|NCT00003119|Carboplatin|carboplatin|mesh-list
14564833|NCT00003119|Doxorubicin|doxorubicin|mesh-list
14564834|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564835|NCT00003119|Etoposide|etoposide|mesh-list
14564836|NCT00003119|Sargramostim|sargramostim|mesh-list
14564837|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564838|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
14564839|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564840|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564841|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564842|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
14564843|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564844|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564845|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564846|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564847|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564848|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564849|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564850|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564851|NCT00003120|Paclitaxel|paclitaxel|mesh-list
14564852|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564853|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564854|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564855|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564856|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564857|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564858|NCT00003123|Amifostine|amifostine|mesh-list
14564859|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14564860|NCT00003123|Protective Agents|protective agents|mesh-ancestor
14564861|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564862|NCT00003124|Leuprolide|leuprolide|mesh-list
14564863|NCT00003124|Flutamide|flutamide|mesh-list
14564864|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14564865|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
14564866|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14564867|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811841|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14811842|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
14811843|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
15148646|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
14564868|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14564869|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564870|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
14564871|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14564872|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14564873|NCT00003125|Aldesleukin|aldesleukin|mesh-list
14564874|NCT00003125|Vaccines|vaccines|mesh-list
14564875|NCT00003125|Sargramostim|sargramostim|mesh-list
14564876|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
14564877|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564878|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564879|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14564880|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14564881|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
14564882|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564883|NCT00003126|Aldesleukin|aldesleukin|mesh-list
14564884|NCT00003126|Interleukin-2|interleukin-2|mesh-list
15148647|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
14564885|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564886|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14564887|NCT00003126|Analgesics|analgesics|mesh-ancestor
14564888|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
14811844|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
15148648|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148649|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564889|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14564890|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564891|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14564892|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14564893|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
14564894|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564895|NCT00003127|Paclitaxel|paclitaxel|mesh-list
14020908|NCT02777190|Misoprostol|misoprostol|mesh-list
14020909|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14020910|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
14020911|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14020912|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020913|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14020914|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15148650|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148651|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148652|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
15148653|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148654|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15148655|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148656|NCT04228289|Oxytocin|oxytocin|mesh-list
15148657|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
15148658|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15148659|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148660|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
15148661|NCT04227990|Docetaxel|docetaxel|mesh-list
15148662|NCT04227990|Doxorubicin|doxorubicin|mesh-list
15148663|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148664|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
15148665|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148666|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148667|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148668|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
14020915|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
14564896|NCT00003127|Carboplatin|carboplatin|mesh-list
14564897|NCT00003127|Amifostine|amifostine|mesh-list
14564898|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148669|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148670|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148671|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15148672|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148673|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148674|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148675|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15148676|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148677|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148678|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148679|NCT04227886|Capecitabine|capecitabine|mesh-list
15148680|NCT04227886|Irinotecan|irinotecan|mesh-list
15148681|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148682|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
15148683|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148684|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148685|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564899|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564900|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564901|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564902|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564903|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564904|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14564905|NCT00003127|Protective Agents|protective agents|mesh-ancestor
14564906|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564907|NCT00003128|Paclitaxel|paclitaxel|mesh-list
14564908|NCT00003128|Ifosfamide|ifosfamide|mesh-list
14564909|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564910|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564911|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564912|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564913|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564914|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564915|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564916|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
15148686|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148687|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564917|NCT00003129|Valrubicin|valrubicin|mesh-list
14564918|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564919|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564920|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564921|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564922|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564923|NCT00003130|Paclitaxel|paclitaxel|mesh-list
14564924|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564925|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564926|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148688|NCT04227808|Lenvatinib|lenvatinib|mesh-list
15148689|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148690|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15148691|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148692|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148693|NCT04227678|Heparin|heparin|mesh-list
14564927|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148694|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
15148695|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14811845|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811846|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811847|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811848|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14811849|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14564928|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564929|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148696|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15148697|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148698|NCT04227704|Ketamine|ketamine|mesh-list
15148699|NCT04227704|Analgesics|analgesics|mesh-ancestor
15148700|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
15148701|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148702|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148703|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15148704|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15148705|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
15148706|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
15148707|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148708|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15148709|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14020916|NCT02777073|Liraglutide|liraglutide|mesh-list
14564930|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
14564931|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14564932|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564933|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
14564934|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564935|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14564936|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
14564937|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564938|NCT00003133|Gemcitabine|gemcitabine|mesh-list
14811850|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14811851|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14811852|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14811853|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
14811854|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
14564939|NCT00003133|Paclitaxel|paclitaxel|mesh-list
14564940|NCT00003133|Doxorubicin|doxorubicin|mesh-list
14564941|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564942|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14564943|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564944|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
14564945|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
14564946|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
14564947|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564948|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564949|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
14564950|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
14564951|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14564952|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564953|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564954|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
14564955|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564956|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14811855|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148710|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020917|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
14564957|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564958|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564959|NCT00003134|Irinotecan|irinotecan|mesh-list
14564960|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564961|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564962|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564963|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564964|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564965|NCT00003135|Doxorubicin|doxorubicin|mesh-list
14564966|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14564967|NCT00003135|Fluorouracil|fluorouracil|mesh-list
14020918|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14564968|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14564969|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564970|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14564971|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564972|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564973|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564974|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
14564975|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14564976|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564977|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
14564978|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564979|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
14564980|NCT00003136|Carboplatin|carboplatin|mesh-list
14564981|NCT00003136|Amifostine|amifostine|mesh-list
14564982|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14564983|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
14564984|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14564985|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14564986|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14564987|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
14564988|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14564989|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14564990|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14564991|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14564992|NCT00003136|Protective Agents|protective agents|mesh-ancestor
14564993|NCT00003137|Irinotecan|irinotecan|mesh-list
14564994|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14564995|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14564996|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14564997|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811856|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811857|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14811858|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
14811859|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
14811860|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14811861|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14811862|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14811863|NCT00846976|Bicalutamide|bicalutamide|mesh-list
14811864|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
14811865|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
14811866|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811867|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811868|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811869|NCT00847054|Antibodies|antibodies|mesh-list
14811870|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14811871|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
14811872|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811873|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14811874|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14811875|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811876|NCT00847080|Incretins|incretins|mesh-ancestor
14811877|NCT00847080|Hormones|hormones|mesh-ancestor
14811878|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811879|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14811880|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
14811881|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811882|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811883|NCT00847093|Lidocaine|lidocaine|mesh-list
14811884|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
14811885|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
14811886|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14564998|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811887|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811888|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
14811889|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811890|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14564999|NCT00003139|Pilocarpine|pilocarpine|mesh-list
14565000|NCT00003139|Miotics|miotics|mesh-ancestor
14565001|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
14565002|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14565003|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811891|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14811892|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14811893|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811894|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811895|NCT00847106|Daclizumab|daclizumab|mesh-list
14811896|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14811897|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
14811898|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565004|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14565005|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14565006|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
14565007|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14565008|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565009|NCT00003140|Letrozole|letrozole|mesh-list
14565010|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565011|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14565012|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14565013|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565014|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565015|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14565016|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
14565017|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811899|NCT00847119|Bevacizumab|bevacizumab|mesh-list
14811900|NCT00847119|Capecitabine|capecitabine|mesh-list
14811901|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14811902|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811903|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811904|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14811905|NCT00847119|Growth Substances|growth substances|mesh-ancestor
14811906|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811907|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811908|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14811909|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
14811910|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811911|NCT00847223|Tipifarnib|tipifarnib|mesh-list
14291232|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
14291233|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291234|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291235|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14291236|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14291237|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
14291238|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14291239|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14291240|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
14291241|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291242|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291243|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14291244|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14291245|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14291246|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
14291247|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291248|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291249|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
14291250|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
14291251|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291252|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14291253|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
14291254|NCT00553202|Hormones|hormones|mesh-ancestor
14291255|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291256|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14291257|NCT00553202|Protective Agents|protective agents|mesh-ancestor
14291258|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14291259|NCT00553267|Amlodipine|amlodipine|mesh-list
14291260|NCT00553267|Telmisartan|telmisartan|mesh-list
14565018|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565019|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
14565020|NCT00003141|Thiotepa|thiotepa|mesh-list
14565021|NCT00003141|Cisplatin|cisplatin|mesh-list
14565022|NCT00003141|Carboplatin|carboplatin|mesh-list
14565023|NCT00003141|Etoposide|etoposide|mesh-list
14565024|NCT00003141|Vincristine|vincristine|mesh-list
14565025|NCT00003141|Lenograstim|lenograstim|mesh-list
14565026|NCT00003141|Sargramostim|sargramostim|mesh-list
14565027|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565028|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
14565029|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565030|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565031|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565032|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
14811912|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811913|NCT00847262|Amlodipine|amlodipine|mesh-list
14811914|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14811915|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14811916|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14811917|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811918|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14811919|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811920|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
14811921|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
14811922|NCT00847314|Testosterone|testosterone|mesh-list
14811923|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
14811924|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
14811925|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14811926|NCT00847314|Androgens|androgens|mesh-ancestor
14811927|NCT00847314|Hormones|hormones|mesh-ancestor
14811928|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811929|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811930|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14811931|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565033|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565034|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565035|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565036|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565037|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565038|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565039|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148711|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148712|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15148713|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148714|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15148715|NCT04227912|Anesthetics|anesthetics|mesh-list
14565040|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565041|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565042|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565043|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565044|NCT00003143|Amifostine|amifostine|mesh-list
14565045|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14565046|NCT00003143|Protective Agents|protective agents|mesh-ancestor
14565047|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565048|NCT00003144|Gemcitabine|gemcitabine|mesh-list
14565049|NCT00003144|Amifostine|amifostine|mesh-list
14565050|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565051|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565052|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
14565053|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565054|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
14565055|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565056|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565057|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565058|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
14565059|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565060|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14565061|NCT00003144|Protective Agents|protective agents|mesh-ancestor
14565062|NCT00003145|Cyclosporine|cyclosporine|mesh-list
14565063|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
14811932|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
14811933|NCT00847418|Esketamine|esketamine|mesh-list
14565064|NCT00003145|Fludarabine|fludarabine|mesh-list
14565065|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
14565066|NCT00003145|Cyclosporins|cyclosporins|mesh-list
14811934|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
14811935|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14811936|NCT00847483|Bimatoprost|bimatoprost|mesh-list
14811937|NCT00847483|Travoprost|travoprost|mesh-list
14811938|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14811939|NCT00847483|Latanoprost|latanoprost|mesh-list
14811940|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14811941|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14811942|NCT00847639|Lenalidomide|lenalidomide|mesh-list
14811943|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
14811944|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811945|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14811946|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14811947|NCT00847639|Growth Substances|growth substances|mesh-ancestor
14811948|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
14811949|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14811950|NCT00847678|Amphotericin B|amphotericin b|mesh-list
14811951|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14811952|NCT00847678|Flucytosine|flucytosine|mesh-list
14811953|NCT00847678|Efungumab|efungumab|mesh-list
14811954|NCT00847678|Amebicides|amebicides|mesh-ancestor
14811955|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14811956|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14811957|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14811958|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15148716|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
15148717|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148718|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148719|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
15148720|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148721|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15148722|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15148723|NCT04227912|Analgesics|analgesics|mesh-ancestor
15148724|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148725|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148726|NCT04227652|Ibuprofen|ibuprofen|mesh-list
15148727|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020919|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020920|NCT02777073|Incretins|incretins|mesh-ancestor
14020921|NCT02777073|Hormones|hormones|mesh-ancestor
14020922|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148728|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15148729|NCT04227652|Analgesics|analgesics|mesh-ancestor
14565067|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565068|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565069|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
14565070|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565071|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148730|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
15148731|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148732|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148733|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148734|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148735|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14020923|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14565072|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
14565073|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565074|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565075|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
14565076|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565077|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14565078|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565079|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14565080|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565081|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14565082|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
14565083|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14565084|NCT00003146|Melphalan|melphalan|mesh-list
14565085|NCT00003146|Busulfan|busulfan|mesh-list
14565086|NCT00003146|Thiotepa|thiotepa|mesh-list
14565087|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565088|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
14565089|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565090|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565091|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14811959|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
14811960|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
14565092|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565093|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
14565094|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565095|NCT00003148|Aldesleukin|aldesleukin|mesh-list
14565096|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565097|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14565098|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14565099|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
15148736|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148737|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148738|NCT04227210|Vaccines|vaccines|mesh-list
15148739|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
15148740|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565100|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565101|NCT00003149|Interleukin-12|interleukin-12|mesh-list
14565102|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565103|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
14565104|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811961|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811962|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14811963|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
14811964|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14811965|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
14811966|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14811967|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811968|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14811969|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14811970|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14811971|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14811972|NCT00847834|Irbesartan|irbesartan|mesh-list
14811973|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14811974|NCT00847834|Diuretics|diuretics|mesh-ancestor
14811975|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
14811976|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811977|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14811978|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14565105|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14565106|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15148741|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
15148742|NCT04227275|Fludarabine|fludarabine|mesh-list
15148743|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15148744|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148745|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
14565107|NCT00003149|Growth Substances|growth substances|mesh-ancestor
14811979|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811980|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14811981|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14811982|NCT00847860|Aspirin|aspirin|mesh-list
14811983|NCT00847860|Cilostazol|cilostazol|mesh-list
14811984|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14565108|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
14565109|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565110|NCT00003150|Prednisone|prednisone|mesh-list
14565111|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
14565112|NCT00003150|Rituximab|rituximab|mesh-list
14565113|NCT00003150|Doxorubicin|doxorubicin|mesh-list
14565114|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14565115|NCT00003150|Vincristine|vincristine|mesh-list
14565116|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565117|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
14565118|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565119|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565120|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565121|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
14565122|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565123|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565124|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565125|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14565126|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565127|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565128|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565129|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565130|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14565131|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
14565132|NCT00003150|Hormones|hormones|mesh-ancestor
14565133|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14565134|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565135|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565136|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148746|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148747|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148748|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148749|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
15148750|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811985|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14811986|NCT00847860|Analgesics|analgesics|mesh-ancestor
14811987|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
14811988|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14811989|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14811990|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14811991|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14811992|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14811993|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14811994|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14811995|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14811996|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14811997|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14811998|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
14811999|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14812000|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
14812001|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14565137|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565138|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565139|NCT00003151|Amoxicillin|amoxicillin|mesh-list
14565140|NCT00003151|Metronidazole|metronidazole|mesh-list
14812002|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
14812003|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
14812004|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14812005|NCT00847860|Protective Agents|protective agents|mesh-ancestor
14812006|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14812007|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14812008|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
14812009|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14812010|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812011|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565141|NCT00003151|Clarithromycin|clarithromycin|mesh-list
14565142|NCT00003151|Tetracycline|tetracycline|mesh-list
14565143|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14565144|NCT00003151|Omeprazole|omeprazole|mesh-list
14565145|NCT00003151|Bismuth|bismuth|mesh-list
14565146|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14565147|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565148|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14565149|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14565150|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14565151|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14565152|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14565153|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814427|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814428|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
14814429|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814430|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814431|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14814432|NCT00863239|Interferons|interferons|mesh-list
14565154|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148751|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148752|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15148753|NCT04227483|Prednisolone|prednisolone|mesh-list
15148754|NCT04227483|Deflazacort|deflazacort|mesh-list
14814433|NCT00863239|Ribavirin|ribavirin|mesh-list
15148755|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148756|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
15148757|NCT04227483|Hormones|hormones|mesh-ancestor
15148758|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148759|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148760|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565155|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14565156|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14565157|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14565158|NCT00003151|Antacids|antacids|mesh-ancestor
14020924|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020925|NCT02776956|Atorvastatin|atorvastatin|mesh-list
14020926|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14020927|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14020928|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
14565159|NCT00003152|Interferons|interferons|mesh-list
14565160|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
14565161|NCT00003152|Prednisone|prednisone|mesh-list
14565162|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
14020929|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020930|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14565163|NCT00003152|Vincristine|vincristine|mesh-list
14020931|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14020932|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14020933|NCT02776917|Paclitaxel|paclitaxel|mesh-list
14020934|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14020935|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020936|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
14020937|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565164|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565165|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
14565166|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565167|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565168|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565169|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
14565170|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565171|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565172|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565173|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14565174|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
14565175|NCT00003152|Hormones|hormones|mesh-ancestor
14565176|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14565177|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565178|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
14565179|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565180|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565181|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565182|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565183|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565184|NCT00003156|Topotecan|topotecan|mesh-list
14565185|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14565186|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565187|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565188|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565189|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565190|NCT00003157|Gemcitabine|gemcitabine|mesh-list
14565191|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565192|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565193|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
14565194|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565195|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
14565196|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565197|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565198|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565199|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
14565200|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565201|NCT00003158|Paclitaxel|paclitaxel|mesh-list
14565202|NCT00003158|Etoposide|etoposide|mesh-list
14565203|NCT00003158|Carboplatin|carboplatin|mesh-list
14565204|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565205|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565206|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565207|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565208|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565209|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565210|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565211|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565212|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812012|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14812013|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
14565213|NCT00003159|Gemcitabine|gemcitabine|mesh-list
14565214|NCT00003159|Paclitaxel|paclitaxel|mesh-list
14565215|NCT00003159|Vinorelbine|vinorelbine|mesh-list
14565216|NCT00003159|Vinblastine|vinblastine|mesh-list
14812014|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14812015|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
14812016|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14812017|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
14812018|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812019|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812020|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14812021|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
14812022|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14812023|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
14812024|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812025|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812026|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14812027|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
14812028|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
14812029|NCT00848302|Protective Agents|protective agents|mesh-ancestor
14812030|NCT00848432|Risperidone|risperidone|mesh-list
14812031|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14812032|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
14812033|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812034|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812035|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812036|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14812037|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14020938|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
14020939|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812038|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812039|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14812040|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14812041|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
14565217|NCT00003159|Docetaxel|docetaxel|mesh-list
14565218|NCT00003159|Carboplatin|carboplatin|mesh-list
14565219|NCT00003159|Ifosfamide|ifosfamide|mesh-list
14565220|NCT00003159|Mitomycins|mitomycins|mesh-list
14565221|NCT00003159|Mitomycin|mitomycin|mesh-list
14565222|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565223|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565224|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565225|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
14812042|NCT00848458|Azelaic acid|azelaic acid|mesh-list
14812043|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812044|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14812045|NCT00848523|Panobinostat|panobinostat|mesh-list
14812046|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812047|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14812048|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812049|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812050|NCT00848562|Nicorandil|nicorandil|mesh-list
14812051|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14812052|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14812053|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
14812054|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
14565226|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565227|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565228|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565229|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
14565230|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
14565231|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565232|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565233|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565234|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
14565235|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565236|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565237|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
14565238|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565239|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14643736|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643737|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14643738|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14643739|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
14643740|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643741|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
14643742|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643743|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643744|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565240|NCT00003160|Paclitaxel|paclitaxel|mesh-list
14565241|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565242|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565243|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565244|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565245|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565246|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565247|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
14565248|NCT00003163|Melphalan|melphalan|mesh-list
14565249|NCT00003163|Sargramostim|sargramostim|mesh-list
14565250|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565251|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
14565252|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565253|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565254|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565255|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
14565256|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565257|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565258|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565259|NCT00003165|Doxorubicin|doxorubicin|mesh-list
14565260|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565261|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565262|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565263|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565264|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565265|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565266|NCT00003166|Vincristine|vincristine|mesh-list
14565267|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
14565268|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565269|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565270|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565271|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565272|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812055|NCT00848562|Vitamins|vitamins|mesh-ancestor
14812056|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
14812057|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812058|NCT00848640|Sorafenib|sorafenib|mesh-list
14812059|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812060|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14565273|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565274|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565275|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
14565276|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812061|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812062|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812063|NCT00848679|Lidocaine|lidocaine|mesh-list
14812064|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
14812065|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
14812066|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812067|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812068|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
14812069|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812070|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14812071|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14565277|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
14565278|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565279|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
14565280|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565281|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565282|NCT00003172|Interferons|interferons|mesh-list
14565283|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
14565284|NCT00003172|Docetaxel|docetaxel|mesh-list
14565285|NCT00003172|Doxorubicin|doxorubicin|mesh-list
14565286|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14565287|NCT00003172|Fluorouracil|fluorouracil|mesh-list
14565288|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
14565289|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565290|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565291|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565292|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565293|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565294|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565295|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565296|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565297|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565298|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
14565299|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565300|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565301|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
14565302|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565303|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
14565304|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565305|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
14565306|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14565307|NCT00003173|Thiotepa|thiotepa|mesh-list
14565308|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
14565309|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565310|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565311|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
14565312|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565313|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565314|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565315|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565316|NCT00003174|Cladribine|cladribine|mesh-list
14565317|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
14565318|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565319|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565320|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
14565321|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565322|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565323|NCT00003175|Fluorouracil|fluorouracil|mesh-list
14565324|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
14565325|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565326|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565327|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565328|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565329|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
14565330|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565331|NCT00003176|Temozolomide|temozolomide|mesh-list
14565332|NCT00003176|Carmustine|carmustine|mesh-list
14565333|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14812072|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14812073|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812074|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812075|NCT00848692|Rituximab|rituximab|mesh-list
14812076|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14812077|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812078|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
14812079|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812080|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812081|NCT00848770|Norepinephrine|norepinephrine|mesh-list
14812082|NCT00848770|Esmolol|esmolol|mesh-list
14812083|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14812084|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14812085|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
14812086|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020940|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
14020941|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14020942|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
14020943|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020944|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
14020945|NCT02776943|Protective Agents|protective agents|mesh-ancestor
14020946|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14020947|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14020948|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14020949|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291261|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14291262|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14291263|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14291264|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291265|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291266|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14291267|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291268|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
14291269|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14291270|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14291271|NCT00553280|Pregabalin|pregabalin|mesh-list
14291272|NCT00553280|Analgesics|analgesics|mesh-ancestor
14291273|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
14565334|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
14565335|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565336|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565337|NCT00003178|Idarubicin|idarubicin|mesh-list
14565338|NCT00003178|Cladribine|cladribine|mesh-list
14565339|NCT00003178|Lenograstim|lenograstim|mesh-list
14565340|NCT00003178|Sargramostim|sargramostim|mesh-list
14565341|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565342|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
14565343|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565344|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565345|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565346|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148761|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148762|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148763|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
15148764|NCT04227522|Rucaparib|rucaparib|mesh-list
15148765|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14565347|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565348|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565349|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565350|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565351|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14565352|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
14565353|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14812087|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148766|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148767|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148768|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148769|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
15148770|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148771|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148772|NCT04227184|Trospium chloride|trospium chloride|mesh-list
15148773|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
15148774|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
15148775|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148776|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148777|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14812088|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812089|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
14812090|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
15148778|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14565354|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14565355|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14565356|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
14565357|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14565358|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565359|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14565360|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14565361|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14565362|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565363|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565364|NCT00003181|Aldesleukin|aldesleukin|mesh-list
14565365|NCT00003181|Vinblastine|vinblastine|mesh-list
14565366|NCT00003181|Sargramostim|sargramostim|mesh-list
14565367|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
14565368|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565369|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565370|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14565371|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15148779|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
15148780|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148781|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148782|NCT04227184|Urological Agents|urological agents|mesh-ancestor
15148783|NCT04227431|Insulin|insulin|mesh-list
15148784|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15148785|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148786|NCT04227093|Acetazolamide|acetazolamide|mesh-list
15148787|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
15148788|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15148789|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15179960|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
14565372|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
14565373|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643745|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
14565374|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565375|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565376|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565377|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14020950|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565378|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565379|NCT00003182|Gemcitabine|gemcitabine|mesh-list
14565380|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565381|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565382|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
14565383|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565384|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
14565385|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565386|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565387|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565388|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
14565389|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565390|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
14565391|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565392|NCT00003183|Analgesics|analgesics|mesh-ancestor
14565393|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
14565394|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14565395|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565396|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565397|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565398|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565399|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565400|NCT00003184|Vaccines|vaccines|mesh-list
14565401|NCT00003184|Sargramostim|sargramostim|mesh-list
14812091|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812092|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14812093|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14812094|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14812095|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14812096|NCT00848796|Heparin|heparin|mesh-list
14812097|NCT00848796|Calcium heparin|calcium heparin|mesh-list
14812098|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
15148790|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148791|NCT04227093|Diuretics|diuretics|mesh-ancestor
15148792|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
15148793|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179961|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179962|NCT03944304|Paclitaxel|paclitaxel|mesh-list
15179963|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15179964|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179965|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
15179966|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
15179967|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
15179968|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182121|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15182122|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
15182123|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182124|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182125|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15182126|NCT03924245|Olaparib|olaparib|mesh-list
15182127|NCT03924245|Entinostat|entinostat|mesh-list
15182128|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15182129|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182130|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182131|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182132|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15182133|NCT03924492|Pregnanolone|pregnanolone|mesh-list
15182134|NCT03924492|Brexanolone|brexanolone|mesh-list
15182135|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
15182136|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182137|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182138|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182139|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
15182140|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
15182141|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
14565402|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
14565403|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
14565404|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565405|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565406|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
14565407|NCT00003185|Sargramostim|sargramostim|mesh-list
14565408|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565409|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
14565410|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565411|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565412|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565413|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
14565414|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565415|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565416|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565417|NCT00003187|Cytarabine|cytarabine|mesh-list
14565418|NCT00003187|Cyclosporine|cyclosporine|mesh-list
14565419|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
14565420|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
14565421|NCT00003187|Methotrexate|methotrexate|mesh-list
14565422|NCT00003187|Cyclosporins|cyclosporins|mesh-list
14565423|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565424|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
14565425|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565426|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565427|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565428|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
14565429|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565430|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565431|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565432|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14565433|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
14565434|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14565435|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565436|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
14565437|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
14565438|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565439|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15148794|NCT04227041|Capecitabine|capecitabine|mesh-list
15148795|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148796|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
15148797|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148798|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148799|NCT04226963|Ketamine|ketamine|mesh-list
15148800|NCT04226963|Analgesics|analgesics|mesh-ancestor
15148801|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
15148802|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148803|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148804|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15148805|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15148806|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
15148807|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
15148808|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148809|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14565440|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14565441|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
14565442|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565443|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
14565444|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14565445|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14565446|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
14565447|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
14565448|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14565449|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14565450|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
14565451|NCT00003187|Hormones|hormones|mesh-ancestor
14565452|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14565453|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14565454|NCT00003187|Protective Agents|protective agents|mesh-ancestor
14812099|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14812100|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14812101|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812102|NCT00848809|Vancomycin|vancomycin|mesh-list
14812103|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15148810|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14020951|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
14565455|NCT00003190|Cytarabine|cytarabine|mesh-list
14565456|NCT00003190|Etoposide|etoposide|mesh-list
14565457|NCT00003190|Daunorubicin|daunorubicin|mesh-list
14812104|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812105|NCT00848848|Vaccines|vaccines|mesh-list
14812106|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
14812107|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812108|NCT00848861|Midazolam|midazolam|mesh-list
14812109|NCT00848861|Meperidine|meperidine|mesh-list
14812110|NCT00848861|Propofol|propofol|mesh-list
14812111|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14812112|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812113|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812114|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14812115|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
14812116|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
14812117|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14812118|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14812119|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14812120|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14812121|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
14812122|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
14565458|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
14565459|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565460|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565461|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565462|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565463|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565464|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565465|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565466|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
14565467|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
14565468|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565469|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565470|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
14565471|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565472|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565473|NCT00003191|Fenretinide|fenretinide|mesh-list
14565474|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565475|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14565476|NCT00003191|Protective Agents|protective agents|mesh-ancestor
14565477|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565478|NCT00003193|Paclitaxel|paclitaxel|mesh-list
14565479|NCT00003193|Amifostine|amifostine|mesh-list
15148811|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15179969|NCT03944252|Cetuximab|cetuximab|mesh-list
14565480|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565481|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565482|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565483|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565484|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565485|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565486|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14565487|NCT00003193|Protective Agents|protective agents|mesh-ancestor
14565488|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565489|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
14565490|NCT00003194|Thiotepa|thiotepa|mesh-list
14565491|NCT00003194|Carboplatin|carboplatin|mesh-list
14565492|NCT00003194|Etoposide|etoposide|mesh-list
14565493|NCT00003194|Topotecan|topotecan|mesh-list
14565494|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565495|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
14565496|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565497|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565498|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565499|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
14565500|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565501|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565502|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565503|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565504|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565505|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565506|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565507|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14565508|NCT00003195|Interferons|interferons|mesh-list
14565509|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
14565510|NCT00003195|Busulfan|busulfan|mesh-list
14812123|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812124|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812125|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15179970|NCT03944252|Avelumab|avelumab|mesh-list
14565511|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565512|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
14565513|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565514|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
14565515|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565516|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
14565517|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565518|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565519|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565520|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565521|NCT00003196|Cyclosporine|cyclosporine|mesh-list
14812126|NCT00848861|Narcotics|narcotics|mesh-ancestor
14812127|NCT00848861|Analgesics|analgesics|mesh-ancestor
14812128|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
14812129|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148812|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565522|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
14565523|NCT00003196|Cyclosporins|cyclosporins|mesh-list
14565524|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565525|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565526|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565527|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
14565528|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565529|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
14565530|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565531|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14565532|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565533|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14565534|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565535|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565536|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15148813|NCT04226885|Fentanyl|fentanyl|mesh-list
15148814|NCT04226885|Midazolam|midazolam|mesh-list
15148815|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
15148816|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15148817|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148818|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148819|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15148820|NCT04226885|Analgesics|analgesics|mesh-ancestor
15148821|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
15148822|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148823|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15148824|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15148825|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14565537|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
14565538|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14565539|NCT00003198|Topotecan|topotecan|mesh-list
14565540|NCT00003198|Ifosfamide|ifosfamide|mesh-list
14565541|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14565542|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565543|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565544|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148826|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
15148827|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148828|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148829|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15148830|NCT04226885|Narcotics|narcotics|mesh-ancestor
15148831|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15148832|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15148833|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
14565545|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565546|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565547|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
14565548|NCT00003200|Docetaxel|docetaxel|mesh-list
15148834|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
15148835|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15148836|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15148837|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148838|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
15148839|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
15148840|NCT04226625|Propofol|propofol|mesh-list
15148841|NCT04226625|Desflurane|desflurane|mesh-list
14565549|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812130|NCT00848939|Treprostinil|treprostinil|mesh-list
15148842|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15148843|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148844|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148845|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15148846|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
15148847|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
15148848|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15148849|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
15148850|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15148851|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
15148852|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148853|NCT04226456|Expectorants|expectorants|mesh-ancestor
15148854|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
15148855|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15148856|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
15148857|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148858|NCT04226456|Protective Agents|protective agents|mesh-ancestor
15148859|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148860|NCT04226456|Antidotes|antidotes|mesh-ancestor
15148861|NCT04226443|Midazolam|midazolam|mesh-list
14291274|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291275|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291276|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
14291277|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14565550|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565551|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565552|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565553|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565554|NCT00003202|Gemcitabine|gemcitabine|mesh-list
14565555|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565556|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565557|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
15148862|NCT04226443|Remifentanil|remifentanil|mesh-list
15148863|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15148864|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15148865|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148866|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565558|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565559|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
14565560|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565561|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565562|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565563|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
14565564|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565565|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
14565566|NCT00003203|Cisplatin|cisplatin|mesh-list
14565567|NCT00003203|Carboplatin|carboplatin|mesh-list
14565568|NCT00003203|Vincristine|vincristine|mesh-list
14565569|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565570|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
14565571|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565572|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565573|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565574|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
14812131|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14812132|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
14812133|NCT00848991|Propofol|propofol|mesh-list
14812134|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14812135|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812136|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812137|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14812138|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
14812139|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
14812140|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14812141|NCT00848991|Analgesics|analgesics|mesh-ancestor
15148867|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15148868|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15148869|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148870|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14291278|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291279|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291280|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14291281|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14291282|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14291283|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291284|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14291285|NCT00553319|Amphetamine|amphetamine|mesh-list
14291286|NCT00553319|Adderall|adderall|mesh-list
14565575|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565576|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565577|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565578|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565579|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
14812142|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
14812143|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812144|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14812145|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14812146|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14812147|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
14812148|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14565580|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565581|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565582|NCT00003204|Prednisone|prednisone|mesh-list
14565583|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
14565584|NCT00003204|Rituximab|rituximab|mesh-list
14565585|NCT00003204|Fludarabine|fludarabine|mesh-list
14565586|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
14565587|NCT00003204|Vincristine|vincristine|mesh-list
14565588|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565589|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
14565590|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565591|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565592|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565593|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
15148871|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
15148872|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
15148873|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
14812149|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812150|NCT00849030|Tamoxifen|tamoxifen|mesh-list
14812151|NCT00849030|Anastrozole|anastrozole|mesh-list
15148874|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
15148875|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148876|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148877|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15148878|NCT04226443|Narcotics|narcotics|mesh-ancestor
15148879|NCT04226443|Analgesics|analgesics|mesh-ancestor
15148880|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
15148881|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148882|NCT04226105|Insulin|insulin|mesh-list
14565594|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565595|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565596|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565597|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14565598|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14565599|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
14565600|NCT00003204|Hormones|hormones|mesh-ancestor
15148883|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14291287|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14291288|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291289|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
14291290|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
14291291|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291292|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
14291293|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291294|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291295|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291296|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14291297|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14291298|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291299|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14565601|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812152|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14812153|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
14812154|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812155|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812156|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14812157|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814434|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
15148884|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
15148885|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
15148886|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15179971|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15148887|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
15148888|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15148889|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565602|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565603|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565604|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
14565605|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565606|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565607|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565608|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565609|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
14565610|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565611|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
14565612|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148890|NCT04226365|Nortriptyline|nortriptyline|mesh-list
15148891|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15148892|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
14565613|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565614|NCT00003206|Paclitaxel|paclitaxel|mesh-list
14565615|NCT00003206|Carboplatin|carboplatin|mesh-list
14565616|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565617|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565618|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565619|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565620|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565621|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565622|NCT00003207|Doxorubicin|doxorubicin|mesh-list
14565623|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14812158|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14812159|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14812160|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14812161|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15148893|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15148894|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15148895|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15148896|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15148897|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148898|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
15148899|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15148900|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148901|NCT04225780|Ganciclovir|ganciclovir|mesh-list
15148902|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
15148903|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
15148904|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148905|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15148906|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148907|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148908|NCT04225611|Dexamethasone|dexamethasone|mesh-list
15148909|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148910|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
15148911|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
15148912|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148913|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148914|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15148915|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
15148916|NCT04225611|Hormones|hormones|mesh-ancestor
15179972|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291300|NCT00553358|Paclitaxel|paclitaxel|mesh-list
14291301|NCT00553358|Trastuzumab|trastuzumab|mesh-list
14812162|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14812163|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812164|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812165|NCT00849082|Goserelin|goserelin|mesh-list
14291302|NCT00553358|Lapatinib|lapatinib|mesh-list
14291303|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14291304|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291305|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14291306|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14291307|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14291308|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291309|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14291310|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291311|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291312|NCT00553410|Letrozole|letrozole|mesh-list
15148917|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15148918|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565624|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565625|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565626|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565627|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565628|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812166|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
14812167|NCT00849082|Cyproterone|cyproterone|mesh-list
14812168|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14812169|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812170|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
14812171|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
14812172|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812173|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812174|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14812175|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
14812176|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14812177|NCT00849095|Budesonide|budesonide|mesh-list
14812178|NCT00849095|Terbutaline|terbutaline|mesh-list
14812179|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
14812180|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14812181|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14812182|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14812183|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
14812184|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812185|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812186|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14812187|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
15148919|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148920|NCT04225598|Buprenorphine|buprenorphine|mesh-list
15148921|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14565629|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565630|NCT00003209|Fluorouracil|fluorouracil|mesh-list
14565631|NCT00003209|Methotrexate|methotrexate|mesh-list
14565632|NCT00003209|Ifosfamide|ifosfamide|mesh-list
14565633|NCT00003209|Mitomycins|mitomycins|mesh-list
14565634|NCT00003209|Mitomycin|mitomycin|mesh-list
14565635|NCT00003209|Bleomycin|bleomycin|mesh-list
14565636|NCT00003209|Vinblastine|vinblastine|mesh-list
14565637|NCT00003209|Vindesine|vindesine|mesh-list
14565638|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565639|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
14565640|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565641|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565642|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565643|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
14565644|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565645|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14565646|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
14565647|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14565648|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
14565649|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565650|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14565651|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565652|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14565653|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565654|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
14565655|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565656|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565657|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565658|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565659|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565660|NCT00003210|Interleukin-12|interleukin-12|mesh-list
14565661|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565662|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
14565663|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565664|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14565665|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14565666|NCT00003210|Growth Substances|growth substances|mesh-ancestor
14565667|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
14565668|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565669|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
14565670|NCT00003211|Vincristine|vincristine|mesh-list
14565671|NCT00003211|Amifostine|amifostine|mesh-list
14812188|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
14812189|NCT00849095|Hormones|hormones|mesh-ancestor
14812190|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812191|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14812192|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14812193|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14812194|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
14812195|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812196|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812197|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
14812198|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
14565672|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565673|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
14565674|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565675|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565676|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565677|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
14565678|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565679|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812199|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14812200|NCT00849160|Darunavir|darunavir|mesh-list
14812201|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14812202|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14812203|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
14812204|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812205|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812206|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14812207|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14812208|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
14812209|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812210|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
14812211|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14812212|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565680|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565681|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565682|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565683|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565684|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565685|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14565686|NCT00003211|Protective Agents|protective agents|mesh-ancestor
14565687|NCT00003212|Doxorubicin|doxorubicin|mesh-list
15148922|NCT04225598|Narcotics|narcotics|mesh-ancestor
15148923|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15148924|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148925|NCT04225598|Analgesics|analgesics|mesh-ancestor
15148926|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
15148927|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148928|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15148929|NCT04225728|Iron|iron|mesh-list
15148930|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14020952|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565688|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14565689|NCT00003212|Ifosfamide|ifosfamide|mesh-list
14565690|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565691|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565692|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565693|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565694|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565695|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565696|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565697|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
14565698|NCT00003213|Dexamethasone|dexamethasone|mesh-list
14565699|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
14565700|NCT00003213|Metoclopramide|metoclopramide|mesh-list
14812213|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15148931|NCT04225728|Teferrol|teferrol|mesh-list
15148932|NCT04225728|Trace Elements|trace elements|mesh-ancestor
15148933|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
15148934|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148935|NCT04225728|Hematinics|hematinics|mesh-ancestor
15148936|NCT04225390|Dacarbazine|dacarbazine|mesh-list
15148937|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148938|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
14020953|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15148939|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15179973|NCT03944070|Ranibizumab|ranibizumab|mesh-list
14565701|NCT00003213|Granisetron|granisetron|mesh-list
14565702|NCT00003213|BB 1101|bb 1101|mesh-list
14812214|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
14812215|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14812216|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812217|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812218|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812219|NCT00849264|Fluorouracil|fluorouracil|mesh-list
14812220|NCT00849264|Endostar protein|endostar protein|mesh-list
14812221|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
14812222|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812223|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812224|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812225|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812226|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
14812227|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812228|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14812229|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14812230|NCT00849264|Growth Substances|growth substances|mesh-ancestor
14812231|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
14812232|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
14812233|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14812234|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812235|NCT00849329|Lapatinib|lapatinib|mesh-list
14812236|NCT00849329|Esomeprazole|esomeprazole|mesh-list
14812237|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14812238|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14812239|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14812240|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812241|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565703|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14565704|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
14565705|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
14565706|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14565707|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565708|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14565709|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
14565710|NCT00003213|Hormones|hormones|mesh-ancestor
14565711|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14565712|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565713|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565714|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
14565715|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565716|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812242|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812243|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14812244|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
14812245|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14812246|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812247|NCT00849355|Rituximab|rituximab|mesh-list
14812248|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14812249|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812250|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
14812251|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812252|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812253|NCT00849368|Azathioprine|azathioprine|mesh-list
14812254|NCT00849368|Allopurinol|allopurinol|mesh-list
14812255|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
14812256|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812257|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812258|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
14812259|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812260|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14812261|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
14812262|NCT00849368|Protective Agents|protective agents|mesh-ancestor
14812263|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812264|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812265|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812266|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812267|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
14812268|NCT00849459|Interleukin-12|interleukin-12|mesh-list
14812269|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14812270|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
14812271|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812272|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14814435|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
14812273|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14812274|NCT00849459|Growth Substances|growth substances|mesh-ancestor
14812275|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
14812276|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812277|NCT00849511|Melatonin|melatonin|mesh-list
14812278|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
14565717|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14565718|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14565719|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
14565720|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14565721|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14565722|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
14565723|NCT00003214|Paclitaxel|paclitaxel|mesh-list
14565724|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
14565725|NCT00003214|Carboplatin|carboplatin|mesh-list
14565726|NCT00003214|Doxorubicin|doxorubicin|mesh-list
14565727|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14565728|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565729|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565730|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565731|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565732|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565733|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565734|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565735|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
14565736|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148940|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148941|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
15148942|NCT04225468|Narcotics|narcotics|mesh-ancestor
14565737|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565738|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565739|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
14565740|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565741|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565742|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565743|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565744|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565745|NCT00003215|Leucovorin|leucovorin|mesh-list
14565746|NCT00003215|Cytarabine|cytarabine|mesh-list
14565747|NCT00003215|Prednisone|prednisone|mesh-list
14565748|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
14565749|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
14565750|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14565751|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14565752|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14565753|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
14565754|NCT00003215|Melphalan|melphalan|mesh-list
14565755|NCT00003215|Doxorubicin|doxorubicin|mesh-list
14565756|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14812279|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812280|NCT00849511|Protective Agents|protective agents|mesh-ancestor
14812281|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812282|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812283|NCT00849537|Triamcinolone|triamcinolone|mesh-list
14812284|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14812285|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
14812286|NCT00849537|Hormones|hormones|mesh-ancestor
14812287|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812288|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812289|NCT00849550|Bevacizumab|bevacizumab|mesh-list
14812290|NCT00849550|Capecitabine|capecitabine|mesh-list
14812291|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
14812292|NCT00849550|Everolimus|everolimus|mesh-list
14812293|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14812294|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812295|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14812296|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14812297|NCT00849550|Growth Substances|growth substances|mesh-ancestor
14812298|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812299|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
14812300|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15148943|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14565757|NCT00003215|Methotrexate|methotrexate|mesh-list
14565758|NCT00003215|Etoposide|etoposide|mesh-list
14565759|NCT00003215|Vincristine|vincristine|mesh-list
14565760|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
14565761|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
14565762|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812301|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
15148944|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148945|NCT04225468|Analgesics|analgesics|mesh-ancestor
15148946|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
15148947|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15148948|NCT04225364|Paclitaxel|paclitaxel|mesh-list
15148949|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15148950|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148951|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148952|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148953|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148954|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148955|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148956|NCT04225325|Dolutegravir|dolutegravir|mesh-list
15148957|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15148958|NCT04225325|Emtricitabine|emtricitabine|mesh-list
15148959|NCT04225325|Darunavir|darunavir|mesh-list
15148960|NCT04225325|Cobicistat|cobicistat|mesh-list
15148961|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15148962|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15148963|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148964|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15148965|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14291313|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291314|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14565763|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
14565764|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565765|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565766|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565767|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
14565768|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565769|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565770|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565771|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565772|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565773|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565774|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15148966|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15148967|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
15148968|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15148969|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15148970|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15148971|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15148972|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15148973|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
15148974|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15148975|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15148976|NCT04225312|Natalizumab|natalizumab|mesh-list
15148977|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
14291315|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14291316|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565775|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14565776|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
14565777|NCT00003215|Hormones|hormones|mesh-ancestor
14565778|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14565779|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565780|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14565781|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
14565782|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14565783|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565784|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
14565785|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
14565786|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14565787|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14565788|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565789|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
14565790|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565791|NCT00003215|Antidotes|antidotes|mesh-ancestor
14565792|NCT00003215|Protective Agents|protective agents|mesh-ancestor
15148978|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148979|NCT04224922|Paclitaxel|paclitaxel|mesh-list
15148980|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
14291317|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291318|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14291319|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
14565793|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
14565794|NCT00003215|Vitamins|vitamins|mesh-ancestor
14565795|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
14565796|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565797|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148981|NCT04224922|Epirubicin|epirubicin|mesh-list
15148982|NCT04224922|Carboplatin|carboplatin|mesh-list
15148983|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15148984|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15148985|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
15148986|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
15148987|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
15148988|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565798|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565799|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
14565800|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
14565801|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14565802|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14812302|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812303|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812304|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
14812305|NCT00849602|Chloroquine|chloroquine|mesh-list
14812306|NCT00849602|Amebicides|amebicides|mesh-ancestor
14812307|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14812308|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14812309|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812310|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
14812311|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812312|NCT00849615|Leucovorin|leucovorin|mesh-list
14812313|NCT00849615|Folic Acid|folic acid|mesh-list
14812314|NCT00849615|Docetaxel|docetaxel|mesh-list
14812315|NCT00849615|Fluorouracil|fluorouracil|mesh-list
14812316|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
14812317|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
14812318|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812319|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14812320|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14812321|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565803|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15148989|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15148990|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
15148991|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15148992|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15148993|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15148994|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
14565804|NCT00003215|Analgesics|analgesics|mesh-ancestor
14565805|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
14565806|NCT00003216|Gemcitabine|gemcitabine|mesh-list
14565807|NCT00003216|Fluorouracil|fluorouracil|mesh-list
14812322|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812323|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
14812324|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812325|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812326|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
14812327|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812328|NCT00849615|Antidotes|antidotes|mesh-ancestor
14812329|NCT00849615|Protective Agents|protective agents|mesh-ancestor
14812330|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
14020954|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14020955|NCT02776891|Citric Acid|citric acid|mesh-list
14020956|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
14020957|NCT02776891|Gallium citrate|gallium citrate|mesh-list
14020958|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
14020959|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14020960|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
14020961|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
14020962|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020963|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14565808|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565809|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
14565810|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565811|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565812|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
14565813|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565814|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565815|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565816|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
14812331|NCT00849615|Vitamins|vitamins|mesh-ancestor
14812332|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
15148995|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14812333|NCT00849615|Hematinics|hematinics|mesh-ancestor
14812334|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
14812335|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14812336|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565817|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565818|NCT00003217|Cytarabine|cytarabine|mesh-list
14565819|NCT00003217|Dexamethasone|dexamethasone|mesh-list
14565820|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
14565821|NCT00003217|Doxorubicin|doxorubicin|mesh-list
14565822|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14565823|NCT00003217|Methotrexate|methotrexate|mesh-list
14565824|NCT00003217|Vincristine|vincristine|mesh-list
14565825|NCT00003217|Lenograstim|lenograstim|mesh-list
14565826|NCT00003217|Sargramostim|sargramostim|mesh-list
14565827|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565828|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
14565829|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565830|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14565831|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565832|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
14565833|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565834|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565835|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14565836|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15148996|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15148997|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15148998|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15148999|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149000|NCT04225195|Amphotericin B|amphotericin b|mesh-list
15149001|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15149002|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
15149003|NCT04225195|Amebicides|amebicides|mesh-ancestor
15149004|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15149005|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15149006|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149007|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15149008|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
15149009|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15149010|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
15149011|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149012|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149013|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15149014|NCT04225195|Protective Agents|protective agents|mesh-ancestor
15149015|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149016|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179974|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14565837|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
14565838|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
14565839|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14565840|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15179975|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15179976|NCT03944070|Growth Substances|growth substances|mesh-ancestor
15179977|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179978|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
15179979|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15179980|NCT03944044|Acetaminophen|acetaminophen|mesh-list
15179981|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15179982|NCT03944044|Analgesics|analgesics|mesh-ancestor
15179983|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
15179984|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179985|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179986|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
15179987|NCT03943888|Atropine|atropine|mesh-list
15179988|NCT03943888|Neostigmine|neostigmine|mesh-list
15179989|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15179990|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15179991|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15179992|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
15179993|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15179994|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15179995|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15179996|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
15179997|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
15179998|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
15179999|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14565841|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
15180000|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15180001|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
15149017|NCT04225052|Varenicline|varenicline|mesh-list
15149018|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15149019|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15149020|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
14812337|NCT00849966|Celecoxib|celecoxib|mesh-list
14812338|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14812339|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14812340|NCT00849966|Analgesics|analgesics|mesh-ancestor
14812341|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
15149021|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149022|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149023|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565842|NCT00003217|Hormones|hormones|mesh-ancestor
14565843|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14565844|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565845|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565846|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565847|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565848|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565849|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14565850|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
15149024|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
15149025|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
15149026|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15149027|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565851|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14565852|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565853|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
14565854|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
14812342|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812343|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812344|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14812345|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812346|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14812347|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14812348|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812349|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812350|NCT00849992|Imiquimod|imiquimod|mesh-list
14812351|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14812352|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
14812353|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812354|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812355|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
14812356|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
14812357|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14812358|NCT00850005|Antibodies|antibodies|mesh-list
14812359|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
14812360|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14812361|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
14812362|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149028|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
14565855|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14565856|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14565857|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
14565858|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565859|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14565860|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565861|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565862|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565863|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565864|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
15149029|NCT04224831|Mitogens|mitogens|mesh-list
15149030|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565865|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565866|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565867|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565868|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
15149031|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149032|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15149033|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15149034|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
14565869|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14812363|NCT00850044|Ritonavir|ritonavir|mesh-list
15149035|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14812364|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14565870|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
14565871|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565872|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565873|NCT00003223|Fenretinide|fenretinide|mesh-list
14565874|NCT00003223|Retinamide|retinamide|mesh-list
14565875|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565876|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14565877|NCT00003223|Protective Agents|protective agents|mesh-ancestor
14565878|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565879|NCT00003225|Irinotecan|irinotecan|mesh-list
14565880|NCT00003225|Amifostine|amifostine|mesh-list
14812365|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14812366|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
14812367|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812368|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812369|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14812370|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14812371|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
14812372|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812373|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14812374|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14814436|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14814437|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814438|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
14814439|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814440|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
14814441|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814442|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
14814443|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814444|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
14814445|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14814446|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814447|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14814448|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
14814449|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14814450|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814451|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814452|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814453|NCT00863291|Buprenorphine|buprenorphine|mesh-list
14814454|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14814455|NCT00863291|Narcotics|narcotics|mesh-ancestor
14814456|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814457|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814458|NCT00863291|Analgesics|analgesics|mesh-ancestor
14814459|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
14814460|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814461|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14814462|NCT00863395|Lidocaine|lidocaine|mesh-list
14814463|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
14814464|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
14814465|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814466|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814467|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
14814468|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814469|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14565881|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14565882|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565883|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149036|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
14814470|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14814471|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14814472|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814587|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149037|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15149038|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149039|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15149040|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15149041|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149042|NCT04224701|Vaccines|vaccines|mesh-list
15149043|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
14020964|NCT02776722|Tagatose|tagatose|mesh-list
15149044|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149045|NCT04224649|Lidocaine|lidocaine|mesh-list
14020965|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14647434|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14812375|NCT00850122|Cefazolin|cefazolin|mesh-list
15149046|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
15149047|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
15149048|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
15149049|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14565884|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565885|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565886|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14565887|NCT00003225|Protective Agents|protective agents|mesh-ancestor
14565888|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149050|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149051|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
15149052|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149053|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15149054|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15149055|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15149056|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14565889|NCT00003229|Aldesleukin|aldesleukin|mesh-list
14812376|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14812377|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812378|NCT00850161|Insulin|insulin|mesh-list
14812379|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14812380|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
14812381|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14812382|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812383|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
14812384|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812385|NCT00850382|Cytarabine|cytarabine|mesh-list
14812386|NCT00850382|Daunorubicin|daunorubicin|mesh-list
14812387|NCT00850382|Dasatinib|dasatinib|mesh-list
14812388|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812389|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
14812390|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565890|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565891|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14565892|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14565893|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
14565894|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565895|NCT00003230|Paclitaxel|paclitaxel|mesh-list
14565896|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565897|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565898|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565899|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565900|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565901|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565902|NCT00003231|Docetaxel|docetaxel|mesh-list
14565903|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565904|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565905|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565906|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565907|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565908|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
14565909|NCT00003232|Prednisone|prednisone|mesh-list
14565910|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
14565911|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14565912|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
14812391|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812392|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
14812393|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812394|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812395|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
14812396|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812397|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14812398|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14812399|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14812400|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812401|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14812402|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
14812403|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
14812404|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565913|NCT00003232|Hormones|hormones|mesh-ancestor
14565914|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14565915|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565916|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14565917|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812405|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
14812406|NCT00850746|Z 338|z 338|mesh-list
14565918|NCT00003232|Analgesics|analgesics|mesh-ancestor
14565919|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
14565920|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14565921|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14565922|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14565923|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565924|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565925|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14565926|NCT00003234|Vinorelbine|vinorelbine|mesh-list
14565927|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565928|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565929|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
14812407|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14812408|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565930|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565931|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812409|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14812410|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14812411|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812412|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812413|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812414|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812415|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14812416|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
14020966|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
14020967|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
14026022|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14812417|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149057|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149058|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15149059|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
15149060|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
15149061|NCT04224649|Protective Agents|protective agents|mesh-ancestor
14812418|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14812419|NCT00850850|Physostigmine|physostigmine|mesh-list
14812420|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14812421|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812422|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812423|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
14812424|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812425|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812426|NCT00850850|Miotics|miotics|mesh-ancestor
14812427|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
14812428|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812429|NCT00851136|Bevacizumab|bevacizumab|mesh-list
14565932|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565933|NCT00003235|Paclitaxel|paclitaxel|mesh-list
14565934|NCT00003235|Carboplatin|carboplatin|mesh-list
14565935|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565936|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565937|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565938|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565939|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812430|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14812431|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812432|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14812433|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14812434|NCT00851136|Growth Substances|growth substances|mesh-ancestor
15149062|NCT04224636|Bevacizumab|bevacizumab|mesh-list
15149063|NCT04224636|Atezolizumab|atezolizumab|mesh-list
15149064|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15149065|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149066|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15149067|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15149068|NCT04224636|Growth Substances|growth substances|mesh-ancestor
15149069|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149070|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
14812435|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812436|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
14812437|NCT00851175|Caffeine|caffeine|mesh-list
14812438|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14812439|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14812440|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15149071|NCT04224571|Rituximab|rituximab|mesh-list
14812441|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
14812442|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812443|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14812444|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14812445|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812446|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14812447|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812448|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14812449|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14812450|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14812451|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
14812452|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812453|NCT00851227|Conivaptan|conivaptan|mesh-list
14812454|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14812455|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812456|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
14812457|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812458|NCT00851344|Cetirizine|cetirizine|mesh-list
14812459|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14812460|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14812461|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14812462|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
14812463|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
14812464|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812465|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149072|NCT04224571|Bortezomib|bortezomib|mesh-list
15149073|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15149074|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812466|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812467|NCT00851370|Omalizumab|omalizumab|mesh-list
14812468|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14812469|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14812470|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
14812471|NCT00851461|Goserelin|goserelin|mesh-list
14812472|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14812473|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812474|NCT00851487|Amoxicillin|amoxicillin|mesh-list
14812475|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14812476|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812477|NCT00851513|Lidocaine|lidocaine|mesh-list
14812478|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
14565940|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149075|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
15149076|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149077|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149078|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
15149079|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15149080|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149081|NCT04224675|Atenolol|atenolol|mesh-list
15149082|NCT04224675|Captopril|captopril|mesh-list
15149083|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15149084|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149085|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
14565941|NCT00003236|ISIS 5132|isis 5132|mesh-list
14565942|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812479|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
14812480|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812481|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812482|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
14812483|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812484|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14812485|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14812486|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14812487|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812488|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812489|NCT00851565|Infliximab|infliximab|mesh-list
15149086|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
14565943|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565944|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565945|NCT00003237|Paclitaxel|paclitaxel|mesh-list
14020968|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565946|NCT00003237|Cisplatin|cisplatin|mesh-list
14565947|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565948|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812490|NCT00851565|Antibodies|antibodies|mesh-list
14812491|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
14812492|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812493|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14812494|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14812495|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812496|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
14812497|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14812498|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
14812499|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812500|NCT00851708|Expectorants|expectorants|mesh-ancestor
14812501|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
14565949|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565950|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565951|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14565952|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565953|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
14565954|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812502|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14812503|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
14812504|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812505|NCT00851708|Protective Agents|protective agents|mesh-ancestor
14812506|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812507|NCT00851708|Antidotes|antidotes|mesh-ancestor
14812508|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14812509|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14812510|NCT00851864|Tinzaparin|tinzaparin|mesh-list
14812511|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14812512|NCT00851864|Dalteparin|dalteparin|mesh-list
14812513|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
14812514|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14812515|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14812516|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814473|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814474|NCT00863460|Cytarabine|cytarabine|mesh-list
14814475|NCT00863460|Prednisone|prednisone|mesh-list
14814476|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
14814477|NCT00863460|Busulfan|busulfan|mesh-list
14814478|NCT00863460|Thiotepa|thiotepa|mesh-list
14814479|NCT00863460|Carmustine|carmustine|mesh-list
14814480|NCT00863460|Methotrexate|methotrexate|mesh-list
14814481|NCT00863460|Etoposide|etoposide|mesh-list
14814482|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14814483|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
14814484|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814485|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814486|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14814487|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
14814488|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814489|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814490|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14814491|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814492|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
14814493|NCT00863460|Hormones|hormones|mesh-ancestor
14814494|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814495|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14814496|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14814497|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
14814498|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15149087|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149088|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149089|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15149090|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15149091|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15149092|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
15149093|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814499|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15149094|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149095|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14565955|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565956|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565957|NCT00003239|Interferons|interferons|mesh-list
14565958|NCT00003239|Cytarabine|cytarabine|mesh-list
14565959|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
14565960|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
14565961|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
14565962|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565963|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
14565964|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14565965|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565966|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
14565967|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565968|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14565969|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
14565970|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565971|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565972|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14565973|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565974|NCT00003240|Vinorelbine|vinorelbine|mesh-list
14565975|NCT00003240|Ifosfamide|ifosfamide|mesh-list
14565976|NCT00003240|Mitomycins|mitomycins|mesh-list
14565977|NCT00003240|Mitomycin|mitomycin|mesh-list
14565978|NCT00003240|Vinblastine|vinblastine|mesh-list
14565979|NCT00003240|Vindesine|vindesine|mesh-list
14812517|NCT00851929|Ambrisentan|ambrisentan|mesh-list
14812518|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14812519|NCT00851942|Cosyntropin|cosyntropin|mesh-list
14812520|NCT00851942|Hormones|hormones|mesh-ancestor
14812521|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812522|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812523|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
14812524|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14565980|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565981|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565982|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
14565983|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
14565984|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812525|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812526|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812527|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14812528|NCT00852046|Analgesics|analgesics|mesh-ancestor
14812529|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
14020969|NCT02776813|Rituximab|rituximab|mesh-list
14020970|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14020971|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14020972|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
14020973|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020974|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14020975|NCT02776761|Vaccines|vaccines|mesh-list
14812530|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812531|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14812532|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14812533|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14812534|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
14812535|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812536|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812537|NCT00852059|Methylphenidate|methylphenidate|mesh-list
14812538|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14812539|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812540|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14812541|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14812542|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812543|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812544|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
14812545|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812546|NCT00852163|Busulfan|busulfan|mesh-list
14812547|NCT00852163|Clofarabine|clofarabine|mesh-list
14812548|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
14812549|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812550|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812551|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
14812552|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812553|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14812554|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812555|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14812556|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812557|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
14020976|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
14020977|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14565985|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565986|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14565987|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
14565988|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14565989|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14565990|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14565991|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
14565992|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14565993|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
14565994|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14565995|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14565996|NCT00003242|Paclitaxel|paclitaxel|mesh-list
14565997|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
14565998|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14565999|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566000|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566001|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566002|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566003|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566004|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14566005|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
14566006|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566007|NCT00003243|Aldesleukin|aldesleukin|mesh-list
14566008|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
14566009|NCT00003243|Doxorubicin|doxorubicin|mesh-list
14566010|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14812558|NCT00852189|Folic Acid|folic acid|mesh-list
14812559|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
14812560|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
14566011|NCT00003243|Etoposide|etoposide|mesh-list
14566012|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14020978|NCT02776878|Dasatinib|dasatinib|mesh-list
14291320|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566013|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
14566014|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566015|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812561|NCT00852189|Hematinics|hematinics|mesh-ancestor
14812562|NCT00852189|Vitamins|vitamins|mesh-ancestor
14812563|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
14812564|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812565|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812566|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
14812567|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
14812568|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812569|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812570|NCT00852228|Cetuximab|cetuximab|mesh-list
14812571|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
14812572|NCT00852228|Irinotecan|irinotecan|mesh-list
14812573|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14812574|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812575|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14812576|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14812577|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812578|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812579|NCT00852332|Curcumin|curcumin|mesh-list
14812580|NCT00852332|Docetaxel|docetaxel|mesh-list
14812581|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812582|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14812583|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14812584|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812585|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812586|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14812587|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14812588|NCT00852332|Analgesics|analgesics|mesh-ancestor
14812589|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
14812590|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812591|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812592|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14812593|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291321|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291322|NCT00553462|Paclitaxel|paclitaxel|mesh-list
14291323|NCT00553462|Carboplatin|carboplatin|mesh-list
14291324|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14291325|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14291326|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14291327|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291328|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14812594|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812595|NCT00852345|Clofazimine|clofazimine|mesh-list
14812596|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14812597|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
14812598|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14812599|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812600|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
14812601|NCT00852371|Piperaquine|piperaquine|mesh-list
14812602|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
14566016|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566017|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
14566018|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566019|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566020|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566021|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566022|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566023|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566024|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566025|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566026|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14566027|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14566028|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
14566029|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566030|NCT00003245|Irinotecan|irinotecan|mesh-list
14566031|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14812603|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14812604|NCT00852371|Amodiaquine|amodiaquine|mesh-list
14812605|NCT00852371|Artenimol|artenimol|mesh-list
14812606|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
14812607|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14812608|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14812609|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812610|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14812611|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812612|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812613|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14812614|NCT00852371|Renal Agents|renal agents|mesh-ancestor
14812615|NCT00852410|Lidocaine|lidocaine|mesh-list
14812616|NCT00852410|Epinephrine|epinephrine|mesh-list
14020979|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291329|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14291330|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14291331|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291332|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291333|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566032|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566033|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566034|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566035|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566036|NCT00003248|Rituximab|rituximab|mesh-list
14566037|NCT00003248|Fludarabine|fludarabine|mesh-list
14566038|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
14566039|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14566040|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566041|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
14566042|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566043|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566044|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566045|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
14566046|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566047|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566048|NCT00003249|Ketoconazole|ketoconazole|mesh-list
14291334|NCT00553475|Pregabalin|pregabalin|mesh-list
14566049|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
14566050|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
14291335|NCT00553475|Analgesics|analgesics|mesh-ancestor
14566051|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566052|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14566053|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14812617|NCT00852410|Racepinephrine|racepinephrine|mesh-list
14812618|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
14291336|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
14291337|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291338|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291339|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
14291340|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14566054|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566055|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566056|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14566057|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
14566058|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566059|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566060|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14566061|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566062|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14566063|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14566064|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14566065|NCT00003250|Fenretinide|fenretinide|mesh-list
14566066|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566067|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14566068|NCT00003250|Protective Agents|protective agents|mesh-ancestor
14566069|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566070|NCT00003251|Paclitaxel|paclitaxel|mesh-list
14566071|NCT00003251|Amifostine|amifostine|mesh-list
14566072|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14812619|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
14812620|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
14812621|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812622|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812623|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
14812624|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812625|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14812626|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14812627|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14812628|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812629|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812630|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14812631|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14812632|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
14812633|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812634|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14812635|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14812636|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
14812637|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14812638|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
14812639|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
14812640|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
14812641|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14812642|NCT00852423|Artesunate|artesunate|mesh-list
14812643|NCT00852423|Lumefantrine|lumefantrine|mesh-list
14812644|NCT00852423|Artemether|artemether|mesh-list
14812645|NCT00852423|Piperaquine|piperaquine|mesh-list
14812646|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14812647|NCT00852423|Amodiaquine|amodiaquine|mesh-list
14812648|NCT00852423|Artenimol|artenimol|mesh-list
14812649|NCT00852423|Mefloquine|mefloquine|mesh-list
14812650|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
14812651|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14566073|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566074|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566075|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566076|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566077|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566078|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14566079|NCT00003251|Protective Agents|protective agents|mesh-ancestor
14566080|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566081|NCT00003252|Amifostine|amifostine|mesh-list
14566082|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14566083|NCT00003252|Protective Agents|protective agents|mesh-ancestor
14566084|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566085|NCT00003253|Paclitaxel|paclitaxel|mesh-list
14566086|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
14566087|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566088|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566089|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566090|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566091|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812652|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14812653|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812654|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812655|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
14812656|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
14812657|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14812658|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
14812659|NCT00852436|Pregabalin|pregabalin|mesh-list
15149096|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
14566092|NCT00003254|Fluorouracil|fluorouracil|mesh-list
14566093|NCT00003254|Eniluracil|eniluracil|mesh-list
14566094|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
14566095|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566096|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566097|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566098|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566099|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
14566100|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566101|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566102|NCT00003255|Carboplatin|carboplatin|mesh-list
14566103|NCT00003255|Topotecan|topotecan|mesh-list
14566104|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566105|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566106|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566107|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566108|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566109|NCT00003256|Alvocidib|alvocidib|mesh-list
14566110|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566111|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
14566112|NCT00003256|Growth Substances|growth substances|mesh-ancestor
14566113|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566114|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14566115|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149097|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149098|NCT04224337|Doxorubicin|doxorubicin|mesh-list
15149099|NCT04224337|Durvalumab|durvalumab|mesh-list
15149100|NCT04224337|Ifosfamide|ifosfamide|mesh-list
15149101|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15149102|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149103|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15149104|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15149105|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149106|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149107|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15149108|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15149109|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
15149110|NCT04224441|Temozolomide|temozolomide|mesh-list
15149111|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
15149112|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15149113|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
15149114|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149115|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149116|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
15149117|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
15149118|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149119|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149120|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15149121|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14566116|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566117|NCT00003259|Vinorelbine|vinorelbine|mesh-list
14566118|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566119|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566120|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566121|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566122|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566123|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566124|NCT00003260|Leucovorin|leucovorin|mesh-list
14566125|NCT00003260|Fluorouracil|fluorouracil|mesh-list
14566126|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
14020980|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14020981|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566127|NCT00003260|Irinotecan|irinotecan|mesh-list
15149122|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15149123|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14020982|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020983|NCT02776865|Lidocaine|lidocaine|mesh-list
14812660|NCT00852436|Analgesics|analgesics|mesh-ancestor
15149124|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14566128|NCT00003260|Calcium|calcium|mesh-list
14566129|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
14566130|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14566131|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566132|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
14566133|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812661|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
14812662|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812663|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812664|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
14812665|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14812666|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812667|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812668|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14812669|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14812670|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14812671|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812672|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14812673|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
14812674|NCT00852566|Dasatinib|dasatinib|mesh-list
14812675|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566134|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566135|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566136|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812676|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14812677|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812678|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812679|NCT00852579|Azithromycin|azithromycin|mesh-list
14812680|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14812681|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812682|NCT00852670|Ponesimod|ponesimod|mesh-list
14812683|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14812684|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812685|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812686|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
14812687|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566137|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
14566138|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566139|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566140|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566141|NCT00003260|Antidotes|antidotes|mesh-ancestor
14566142|NCT00003260|Protective Agents|protective agents|mesh-ancestor
14566143|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
14566144|NCT00003260|Vitamins|vitamins|mesh-ancestor
14566145|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
14566146|NCT00003261|Zidovudine|zidovudine|mesh-list
14566147|NCT00003261|Methotrexate|methotrexate|mesh-list
14566148|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14566149|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
14566150|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14566151|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566152|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566153|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
14566154|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566155|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566156|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
14566157|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566158|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14566159|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566160|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
14566161|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566162|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14566163|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14566164|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
14566165|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566166|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14566167|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14566168|NCT00003262|Prednisone|prednisone|mesh-list
14566169|NCT00003262|Doxorubicin|doxorubicin|mesh-list
14566170|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14566171|NCT00003262|Epirubicin|epirubicin|mesh-list
14566172|NCT00003262|Bleomycin|bleomycin|mesh-list
14566173|NCT00003262|Etoposide|etoposide|mesh-list
14566174|NCT00003262|Vincristine|vincristine|mesh-list
14812688|NCT00852683|Pregabalin|pregabalin|mesh-list
14812689|NCT00852683|Analgesics|analgesics|mesh-ancestor
14566175|NCT00003262|Vinblastine|vinblastine|mesh-list
14566176|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
14566177|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14812690|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
14812691|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812692|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812693|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
14812694|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14812695|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812696|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812697|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14812698|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14812699|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14812700|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812701|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14812702|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
14812703|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14812704|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14812705|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14812706|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
14812707|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812708|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812709|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812710|NCT00852696|Urological Agents|urological agents|mesh-ancestor
14812711|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
15149125|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15149126|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
15149127|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149128|NCT04224194|Adalimumab|adalimumab|mesh-list
15149129|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15149130|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149131|NCT04224415|Irinotecan|irinotecan|mesh-list
15149132|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15149133|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15149134|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149135|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149136|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149137|NCT04224428|Fexofenadine|fexofenadine|mesh-list
15149138|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15149139|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15149140|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15149141|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
15149142|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
15149143|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149144|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149145|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812712|NCT00852709|Clofarabine|clofarabine|mesh-list
14812713|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812714|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
14812715|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812716|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812717|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14812718|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
14812719|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812720|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812721|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14812722|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812723|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
14812724|NCT00852787|Digoxin|digoxin|mesh-list
14812725|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14812726|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14812727|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812728|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812729|NCT00852787|Protective Agents|protective agents|mesh-ancestor
14812730|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812731|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14812732|NCT00852956|Betahistine|betahistine|mesh-list
14812733|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
14812734|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
14812735|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
14812736|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812737|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812738|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812739|NCT00853008|Cytarabine|cytarabine|mesh-list
14812740|NCT00853008|Dexamethasone|dexamethasone|mesh-list
14812741|NCT00853008|Prednisone|prednisone|mesh-list
15149146|NCT04224051|Metformin|metformin|mesh-list
14812742|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
14812743|NCT00853008|Methotrexate|methotrexate|mesh-list
14812744|NCT00853008|Vincristine|vincristine|mesh-list
14812745|NCT00853008|Daunorubicin|daunorubicin|mesh-list
14812746|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
14812747|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
14812748|NCT00853008|Teniposide|teniposide|mesh-list
14812749|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14812750|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
14812751|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
14812752|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812753|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812754|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14812755|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
14812756|NCT00853008|Hormones|hormones|mesh-ancestor
14812757|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812758|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14812759|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812760|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14812761|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
14812762|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14812763|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812764|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
14812765|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812766|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
14812767|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812768|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14812769|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812770|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
14812771|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14812772|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14812773|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
14566178|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566179|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566180|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566181|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566182|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566183|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566184|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
14566185|NCT00003262|Hormones|hormones|mesh-ancestor
14566186|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566187|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566188|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14566189|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566190|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149147|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149148|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149149|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
15149150|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15149151|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
15149152|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149153|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149154|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15149155|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
14566191|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
14812774|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812775|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14812776|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14812777|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14812778|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812779|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14812780|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14812781|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14812782|NCT00853008|Analgesics|analgesics|mesh-ancestor
14812783|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
14812784|NCT00853177|Lidocaine|lidocaine|mesh-list
14812785|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
14812786|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812787|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812788|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
14812789|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
14812790|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812791|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14812792|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15149156|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14566192|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
14812793|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14812794|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812795|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812796|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
14812797|NCT00853190|Hydrocodone|hydrocodone|mesh-list
14812798|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812799|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812800|NCT00853190|Narcotics|narcotics|mesh-ancestor
14812801|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812802|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812803|NCT00853190|Analgesics|analgesics|mesh-ancestor
14812804|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
14812805|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812806|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
14812807|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
14812808|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
14812809|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
14812810|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14812811|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
14566193|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
14566194|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566195|NCT00003263|Interferons|interferons|mesh-list
14566196|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
14566197|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812812|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
14812813|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812814|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14812815|NCT00853216|Oxycodone|oxycodone|mesh-list
14812816|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812817|NCT00853216|Narcotics|narcotics|mesh-ancestor
14566198|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
14566199|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566200|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
14812818|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812819|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812820|NCT00853216|Analgesics|analgesics|mesh-ancestor
14812821|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
14812822|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812823|NCT00853268|Oxycodone|oxycodone|mesh-list
14812824|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812825|NCT00853268|Narcotics|narcotics|mesh-ancestor
14812826|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812827|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812828|NCT00853268|Analgesics|analgesics|mesh-ancestor
14812829|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
14812830|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812831|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
15149157|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
15149158|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149159|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149160|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15149161|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149162|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
15149163|NCT04224103|Protective Agents|protective agents|mesh-ancestor
15149164|NCT04224272|Fulvestrant|fulvestrant|mesh-list
15149165|NCT04224272|Palbociclib|palbociclib|mesh-list
15149166|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15149167|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149168|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15149169|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15149170|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
14812832|NCT00853294|Hydrocodone|hydrocodone|mesh-list
14566201|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566202|NCT00003264|Gemcitabine|gemcitabine|mesh-list
14566203|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566204|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566205|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
14566206|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566207|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
14566208|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812833|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149171|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149172|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812834|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812835|NCT00853294|Narcotics|narcotics|mesh-ancestor
15149173|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14812836|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812837|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812838|NCT00853294|Analgesics|analgesics|mesh-ancestor
14812839|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
14812840|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812841|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
14812842|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
14812843|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
14812844|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
14812845|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14812846|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
14812847|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
14812848|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812849|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14812850|NCT00853320|Oxycodone|oxycodone|mesh-list
14812851|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812852|NCT00853320|Narcotics|narcotics|mesh-ancestor
14812853|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812854|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812855|NCT00853320|Analgesics|analgesics|mesh-ancestor
14812856|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
14812857|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812858|NCT00853411|Prednisone|prednisone|mesh-list
14812859|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14812860|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
14812861|NCT00853411|Hormones|hormones|mesh-ancestor
14812862|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149174|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149175|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149176|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
15149177|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14812863|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812864|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14812865|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812866|NCT00853450|Clopidogrel|clopidogrel|mesh-list
14812867|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14812868|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14812869|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14812870|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14812871|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
14812872|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812873|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812874|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149178|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15149179|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149180|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
15149181|NCT04224116|Coagulants|coagulants|mesh-ancestor
15149182|NCT04224350|Tacrolimus|tacrolimus|mesh-list
15149183|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15149184|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
15149185|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149186|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15149187|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149188|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149189|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
15149190|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15149191|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15149192|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
15149193|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
15149194|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149195|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149196|NCT04223973|Insulin|insulin|mesh-list
15149197|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149198|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149199|NCT04223778|Islatravir|islatravir|mesh-list
15149200|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
15149201|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149202|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149203|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812875|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
14812876|NCT00853502|Testosterone|testosterone|mesh-list
14812877|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
15149204|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14812878|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
14812879|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14812880|NCT00853502|Androgens|androgens|mesh-ancestor
14812881|NCT00853502|Hormones|hormones|mesh-ancestor
14812882|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812883|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812884|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14812885|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812886|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
14812887|NCT00853554|Hydromorphone|hydromorphone|mesh-list
14812888|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812889|NCT00853554|Narcotics|narcotics|mesh-ancestor
14812890|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812891|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812892|NCT00853554|Analgesics|analgesics|mesh-ancestor
14812893|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
14812894|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812895|NCT00853684|Capecitabine|capecitabine|mesh-list
14812896|NCT00853684|Endostar protein|endostar protein|mesh-list
14812897|NCT00853684|Endostatins|endostatins|mesh-list
14812898|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14812899|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
14812900|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812901|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812902|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14812903|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14566209|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566210|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566211|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
14566212|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566213|NCT00003266|Methylphenidate|methylphenidate|mesh-list
14566214|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14812904|NCT00853684|Growth Substances|growth substances|mesh-ancestor
14812905|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812906|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14566215|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566216|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14566217|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14566218|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14566219|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566220|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
14566221|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14566222|NCT00003268|Cytarabine|cytarabine|mesh-list
14566223|NCT00003268|Idarubicin|idarubicin|mesh-list
14566224|NCT00003268|Amifostine|amifostine|mesh-list
14566225|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566226|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
14566227|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566228|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566229|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
14566230|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566231|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14812907|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
14812908|NCT00853697|Testosterone|testosterone|mesh-list
15149205|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15149206|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15149207|NCT04223791|Islatravir|islatravir|mesh-list
14020984|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
14020985|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
14020986|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149208|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
15149209|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149210|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149211|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149212|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14020987|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14020988|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
14020989|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149213|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15149214|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15149215|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
15149216|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15149217|NCT04223518|Antibodies|antibodies|mesh-list
14566232|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
14812909|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
15149218|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
15149219|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149220|NCT04223739|Amiodarone|amiodarone|mesh-list
15149221|NCT04223739|Landiolol|landiolol|mesh-list
15149222|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15149223|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149224|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15149225|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149226|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149227|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15149228|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15149229|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15149230|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149231|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15149232|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15149233|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14812910|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
14812911|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14812912|NCT00853697|Dutasteride|dutasteride|mesh-list
14812913|NCT00853697|Androgens|androgens|mesh-ancestor
14812914|NCT00853697|Hormones|hormones|mesh-ancestor
14812915|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812916|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812917|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14812918|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812919|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
14812920|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14812921|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14812922|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812923|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812924|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
14812925|NCT00853736|Oxycodone|oxycodone|mesh-list
14812926|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812927|NCT00853736|Narcotics|narcotics|mesh-ancestor
14812928|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812929|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812930|NCT00853736|Analgesics|analgesics|mesh-ancestor
14812931|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
14812932|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814500|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
14814501|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
14814502|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814503|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14814504|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14814505|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14814506|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14814507|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14814508|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
14814509|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814510|NCT00863499|Methylphenidate|methylphenidate|mesh-list
14814511|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14814512|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814513|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14814514|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814515|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814516|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814517|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
14814518|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814588|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566233|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566234|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566235|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566236|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566237|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566238|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14566239|NCT00003268|Protective Agents|protective agents|mesh-ancestor
14566240|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
14566241|NCT00003269|Etoposide|etoposide|mesh-list
14566242|NCT00003269|Sargramostim|sargramostim|mesh-list
14566243|NCT00003269|Amifostine|amifostine|mesh-list
14566244|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566245|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
14566246|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149234|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15149235|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15149236|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
15149237|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149238|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149239|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
15149240|NCT04223219|Fentanyl|fentanyl|mesh-list
14566247|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566248|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566249|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
14566250|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812933|NCT00853866|Reboxetine|reboxetine|mesh-list
14812934|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14812935|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14812936|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14812937|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14812938|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14812939|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812940|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
14812941|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14812942|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812943|NCT00853879|Vitamins|vitamins|mesh-list
14812944|NCT00853879|Folic Acid|folic acid|mesh-list
14812945|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
14812946|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
14812947|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
14812948|NCT00853879|Pyridoxal|pyridoxal|mesh-list
14812949|NCT00853879|Pyridoxine|pyridoxine|mesh-list
14812950|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
14812951|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
14812952|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812953|NCT00853879|Hematinics|hematinics|mesh-ancestor
14812954|NCT00853892|Oxycodone|oxycodone|mesh-list
14812955|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14812956|NCT00853892|Narcotics|narcotics|mesh-ancestor
14812957|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14812958|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812959|NCT00853892|Analgesics|analgesics|mesh-ancestor
14812960|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
14812961|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14812962|NCT00853931|Panitumumab|panitumumab|mesh-list
14812963|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14812964|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812965|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14812966|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14812967|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14812968|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14812969|NCT00853944|Incretins|incretins|mesh-ancestor
14812970|NCT00853944|Hormones|hormones|mesh-ancestor
14812971|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812972|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14812973|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812974|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812975|NCT00853983|Saracatinib|saracatinib|mesh-list
14812976|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14812977|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812978|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812979|NCT00854009|BLI-489|bli-489|mesh-list
14812980|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14812981|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812982|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812983|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14812984|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14812985|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14812986|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14812987|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149241|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
15149242|NCT04223219|Ketamine|ketamine|mesh-list
15149243|NCT04223219|Propofol|propofol|mesh-list
14566251|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566252|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566253|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566254|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566255|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566256|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566257|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14812988|NCT00854035|Incretins|incretins|mesh-ancestor
14812989|NCT00854035|Hormones|hormones|mesh-ancestor
14812990|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14812991|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14812992|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
14812993|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14812994|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14812995|NCT00854139|Cyclosporine|cyclosporine|mesh-list
14812996|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
14812997|NCT00854139|Cyclosporins|cyclosporins|mesh-list
14812998|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14812999|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813000|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
14813001|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813002|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813003|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14813004|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
14813005|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813006|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813007|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14813008|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813009|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
14813010|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813011|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
14813012|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14813013|NCT00854178|Anesthetics|anesthetics|mesh-list
14813014|NCT00854178|Isoflurane|isoflurane|mesh-list
14813015|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813016|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813017|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
14813018|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14813019|NCT00854204|Darunavir|darunavir|mesh-list
14813020|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14813021|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14813022|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
14813023|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813024|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813025|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14813026|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14813027|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
14813028|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813029|NCT00854230|Naltrexone|naltrexone|mesh-list
15149244|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15149245|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149246|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149247|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15149248|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
15149249|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
15149250|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15149251|NCT04223219|Analgesics|analgesics|mesh-ancestor
15149252|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
15149253|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149254|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15149255|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15149256|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15149257|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813030|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14813031|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14813032|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813033|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
14813034|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813035|NCT00854256|Mitomycins|mitomycins|mesh-list
14813036|NCT00854256|Mitomycin|mitomycin|mesh-list
14813037|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14813038|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813039|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
14813040|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813041|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14813042|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813043|NCT00854321|Rituximab|rituximab|mesh-list
14813044|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14813045|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149258|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813046|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
14813047|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149259|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149260|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15149261|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15149262|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15149263|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15149264|NCT04223219|Narcotics|narcotics|mesh-ancestor
15149265|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15149266|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15149267|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
15149268|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15149269|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149270|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15149271|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
15149272|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15149273|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
15149274|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14813048|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813049|NCT00854425|Asparaginase|asparaginase|mesh-list
14813050|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813051|NCT00854451|Amoxicillin|amoxicillin|mesh-list
14813052|NCT00854451|Omeprazole|omeprazole|mesh-list
14813053|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813054|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813055|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14813056|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14813057|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14813058|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813059|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813060|NCT00854477|Capecitabine|capecitabine|mesh-list
14813061|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14813062|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
14813063|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813064|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813065|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14813066|NCT00854503|Simvastatin|simvastatin|mesh-list
14813067|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14813068|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15149275|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15149276|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149277|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
15149278|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
15180002|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180003|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180004|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15180005|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566258|NCT00003269|Protective Agents|protective agents|mesh-ancestor
14566259|NCT00003273|Leucovorin|leucovorin|mesh-list
14566260|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
15180006|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15180007|NCT03944005|Anesthetics|anesthetics|mesh-list
15180008|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180009|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180010|NCT03943992|Esomeprazole|esomeprazole|mesh-list
15180011|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15180012|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180013|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15180014|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180015|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180016|NCT03943459|Atorvastatin|atorvastatin|mesh-list
15180017|NCT03943459|Quercetin|quercetin|mesh-list
15180018|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15180019|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15180020|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
14566261|NCT00003273|Temozolomide|temozolomide|mesh-list
14566262|NCT00003273|Thiotepa|thiotepa|mesh-list
14566263|NCT00003273|Carboplatin|carboplatin|mesh-list
14566264|NCT00003273|Methotrexate|methotrexate|mesh-list
14566265|NCT00003273|Etoposide|etoposide|mesh-list
14566266|NCT00003273|Vincristine|vincristine|mesh-list
14566267|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
14566268|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566269|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
14566270|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566271|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566272|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566273|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
14566274|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149279|NCT04222842|Vorolanib|vorolanib|mesh-list
15149280|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15149281|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149282|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149283|NCT04222855|Diltiazem|diltiazem|mesh-list
14813069|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
14813070|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813071|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14813072|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14813073|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813074|NCT00854529|Bevacizumab|bevacizumab|mesh-list
14813075|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14813076|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813077|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14813078|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14813079|NCT00854529|Growth Substances|growth substances|mesh-ancestor
14813080|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813081|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
14813082|NCT00854633|Lactoferrin|lactoferrin|mesh-list
14813083|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
14813084|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813085|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813086|NCT00854646|ON 01910|on 01910|mesh-list
14813087|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813088|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14813089|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813090|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813091|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
14813092|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14813093|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
14813094|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813095|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149284|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149285|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15149286|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149287|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149288|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15149289|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149290|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149291|NCT04222920|Adalimumab|adalimumab|mesh-list
15149292|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15149293|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149294|NCT04222517|Hemostatics|hemostatics|mesh-list
15149295|NCT04222517|Coagulants|coagulants|mesh-ancestor
15149296|NCT04222595|Vaccines|vaccines|mesh-list
14566275|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813096|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14813097|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
14813098|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14813099|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
15149297|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
15149298|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566276|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566277|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14566278|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
14566279|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14566280|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566281|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
14566282|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
14566283|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566284|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14566285|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14566286|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566287|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566288|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566289|NCT00003273|Antidotes|antidotes|mesh-ancestor
14566290|NCT00003273|Protective Agents|protective agents|mesh-ancestor
15149299|NCT04222686|Losartan|losartan|mesh-list
14566291|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
15149300|NCT04222686|Perindopril|perindopril|mesh-list
15149301|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15149302|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149303|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14566292|NCT00003273|Vitamins|vitamins|mesh-ancestor
14566293|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
14566294|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566295|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566296|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566297|NCT00003274|Sargramostim|sargramostim|mesh-list
14566298|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
14566299|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
14566300|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566301|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14566302|NCT00003276|Irinotecan|irinotecan|mesh-list
14566303|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566304|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566305|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566306|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813100|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813101|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813102|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14813103|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
14813104|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
14813105|NCT00854711|Protective Agents|protective agents|mesh-ancestor
14813106|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14813107|NCT00854750|Hormones|hormones|mesh-ancestor
14813108|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813109|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813110|NCT00854763|Olmesartan|olmesartan|mesh-list
14813111|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14813112|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14813113|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14813114|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813115|NCT00854776|Lansoprazole|lansoprazole|mesh-list
14566307|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566308|NCT00003278|Dexamethasone|dexamethasone|mesh-list
14566309|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566310|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
15149304|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15149305|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149306|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14566311|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
14566312|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566313|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566314|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14566315|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
14566316|NCT00003278|Hormones|hormones|mesh-ancestor
14566317|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566318|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14566319|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566320|NCT00003279|Antibodies|antibodies|mesh-list
14566321|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14566322|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
14566323|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
14566324|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149307|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
15149308|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149309|NCT04222062|Carmustine|carmustine|mesh-list
15149310|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566325|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14566326|NCT00003280|Rituximab|rituximab|mesh-list
14566327|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14813116|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
14813117|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14813118|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14813119|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14813120|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14813121|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813122|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813123|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14813124|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
14813125|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813126|NCT00854776|Antacids|antacids|mesh-ancestor
14813127|NCT00854802|Ribavirin|ribavirin|mesh-list
14813128|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14813129|NCT00854802|Cyclosporine|cyclosporine|mesh-list
14813130|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
14813131|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149311|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
14813132|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
14813133|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813134|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
14813135|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
14813136|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566328|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566329|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
14566330|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566331|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566332|NCT00003281|Paclitaxel|paclitaxel|mesh-list
14566333|NCT00003281|Topotecan|topotecan|mesh-list
14566334|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566335|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566336|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566337|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566338|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566339|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813137|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813138|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
14813139|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813140|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813141|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14813142|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
14813143|NCT00854841|Dasatinib|dasatinib|mesh-list
14813144|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813145|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14813146|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813147|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149312|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149313|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149314|NCT04222348|Metformin|metformin|mesh-list
15149315|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
15149316|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149317|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149318|NCT04222114|Catumaxomab|catumaxomab|mesh-list
14813148|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
14813149|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14813150|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813151|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813152|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14813153|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14813154|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813155|NCT00855049|Acetaminophen|acetaminophen|mesh-list
14813156|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14813157|NCT00855049|Analgesics|analgesics|mesh-ancestor
14813158|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
14566340|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566341|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566342|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813159|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813160|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813161|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
15149319|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15149320|NCT04222088|Chloroquine|chloroquine|mesh-list
15149321|NCT04222088|Lumefantrine|lumefantrine|mesh-list
15149322|NCT04222088|Amebicides|amebicides|mesh-ancestor
15149323|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15149324|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15149325|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149326|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
15149327|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149328|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
15149329|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14813162|NCT00855088|Ritonavir|ritonavir|mesh-list
14813163|NCT00855088|Darunavir|darunavir|mesh-list
14813164|NCT00855088|Etravirine|etravirine|mesh-list
14813165|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14813166|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14813167|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
14813168|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813169|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813170|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14813171|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15149330|NCT04222023|Antibodies|antibodies|mesh-list
15149331|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
14566343|NCT00003283|Prednisone|prednisone|mesh-list
14813172|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
14813173|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149332|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15149333|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
15149334|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149335|NCT04221906|Betamethasone|betamethasone|mesh-list
15149336|NCT04221906|Calcipotriene|calcipotriene|mesh-list
15149337|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15149338|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14813174|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14813175|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14813176|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14813177|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14813178|NCT00855101|Voriconazole|voriconazole|mesh-list
14813179|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
14813180|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813181|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14813182|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14813183|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813184|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813185|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14813186|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
14813187|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813188|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813189|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14813190|NCT00855114|Everolimus|everolimus|mesh-list
14813191|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813192|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813193|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
14813194|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813195|NCT00855153|Cycloserine|cycloserine|mesh-list
15149339|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
15149340|NCT04221906|Hormones|hormones|mesh-ancestor
15149341|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813196|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14813197|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813198|NCT00855153|Renal Agents|renal agents|mesh-ancestor
15149342|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149343|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15149344|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
15149345|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
15149346|NCT04222283|Emtricitabine|emtricitabine|mesh-list
15149347|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
15149348|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149349|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15149350|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15149351|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149352|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149353|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15149354|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15149355|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15149356|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15149357|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
15149358|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14020990|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14813199|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14813200|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
14813201|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813202|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
14813203|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149359|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149360|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149361|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
15149362|NCT04221971|Fludarabine|fludarabine|mesh-list
15149363|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15149364|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
15149365|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149366|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149367|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14020991|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14813204|NCT00855205|Rituximab|rituximab|mesh-list
14813205|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14813206|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813207|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
14814519|NCT00863577|Bemiparin|bemiparin|mesh-list
14813208|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813209|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813210|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
14813211|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14813212|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
14813213|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14813214|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14813215|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14813216|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
14813217|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813218|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813219|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813220|NCT00855361|Rabeprazole|rabeprazole|mesh-list
14813221|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14566344|NCT00003283|Octreotide|octreotide|mesh-list
14566345|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566346|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
14566347|NCT00003283|Hormones|hormones|mesh-ancestor
14566348|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566349|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566350|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14566351|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566352|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14566353|NCT00003284|Paclitaxel|paclitaxel|mesh-list
14566354|NCT00003284|Etoposide|etoposide|mesh-list
14566355|NCT00003284|Carboplatin|carboplatin|mesh-list
14813222|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14813223|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14813224|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813225|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813226|NCT00855387|Pancrelipase|pancrelipase|mesh-list
14813227|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14813228|NCT00855517|Latanoprost|latanoprost|mesh-list
14813229|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14813230|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14814520|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
14566356|NCT00003284|Ifosfamide|ifosfamide|mesh-list
14566357|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566358|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566359|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566360|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566361|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566362|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149368|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
15149369|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149370|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149371|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15149372|NCT04222010|Anesthetics|anesthetics|mesh-list
15149373|NCT04222010|Ropivacaine|ropivacaine|mesh-list
15149374|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14566363|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566364|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566365|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566366|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566367|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
14566368|NCT00003287|Leucovorin|leucovorin|mesh-list
14566369|NCT00003287|Fluorouracil|fluorouracil|mesh-list
14566370|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
14566371|NCT00003287|Calcium|calcium|mesh-list
14566372|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
15149375|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149376|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
15149377|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
15149378|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566373|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14566374|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566375|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
14814521|NCT00863629|Insulin|insulin|mesh-list
14814522|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14814523|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814524|NCT00863668|Tenofovir|tenofovir|mesh-list
14814525|NCT00863668|Emtricitabine|emtricitabine|mesh-list
14814526|NCT00863668|Efavirenz|efavirenz|mesh-list
14814527|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
14814528|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14026023|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647435|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14813231|NCT00855530|Amibegron|amibegron|mesh-list
14813232|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14813233|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14813234|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813235|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813236|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813237|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813238|NCT00855608|Adalimumab|adalimumab|mesh-list
14813239|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14813240|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813241|NCT00855660|Riociguat|riociguat|mesh-list
14813242|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
14291341|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291342|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291343|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14291344|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14291345|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14291346|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291347|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14813243|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813244|NCT00855686|Memantine|memantine|mesh-list
14813245|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14813246|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14566376|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566377|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566378|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566379|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566380|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
14566381|NCT00003287|Antidotes|antidotes|mesh-ancestor
14566382|NCT00003287|Protective Agents|protective agents|mesh-ancestor
14566383|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
14566384|NCT00003287|Vitamins|vitamins|mesh-ancestor
14566385|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
14566386|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
14566387|NCT00003288|Tirapazamine|tirapazamine|mesh-list
14566388|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566389|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
14566390|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566391|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566392|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566393|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
14566394|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566395|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566396|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566397|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14566398|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566399|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14566400|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566401|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566402|NCT00003290|Hormones|hormones|mesh-list
14566403|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566404|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643746|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643747|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643748|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14643749|NCT00190268|Amifampridine|amifampridine|mesh-list
14643750|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14643751|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643752|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643753|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14643754|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643755|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643756|NCT00190294|Misoprostol|misoprostol|mesh-list
14643757|NCT00190294|Mifepristone|mifepristone|mesh-list
14643758|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14643759|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
14643760|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14643761|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643762|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14643763|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14643764|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
14647436|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813247|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
15149379|NCT04221880|Lidocaine|lidocaine|mesh-list
15149380|NCT04221880|Bupivacaine|bupivacaine|mesh-list
15149381|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15149382|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
15149383|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
15149384|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149385|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149386|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
15149387|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149388|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15149389|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15149390|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15149391|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149392|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149393|NCT04221555|Docetaxel|docetaxel|mesh-list
14813248|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813249|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813250|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813251|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14813252|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14813253|NCT00855699|Acamprosate|acamprosate|mesh-list
14813254|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14813255|NCT00855777|Ibuprofen|ibuprofen|mesh-list
14813256|NCT00855777|Etoricoxib|etoricoxib|mesh-list
14813257|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14813258|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14813259|NCT00855777|Analgesics|analgesics|mesh-ancestor
14813260|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
14813261|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813262|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813263|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14813264|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813265|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14566405|NCT00003292|Ifosfamide|ifosfamide|mesh-list
14566406|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566407|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
14566408|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813266|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813267|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813268|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14813269|NCT00855881|Tegafur|tegafur|mesh-list
14813270|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14813271|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
14813272|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813273|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813274|NCT00855972|Naltrexone|naltrexone|mesh-list
14813275|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14813276|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14813277|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813278|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
14813279|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813280|NCT00856037|Doxorubicin|doxorubicin|mesh-list
14813281|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14813282|NCT00856037|Topotecan|topotecan|mesh-list
14813283|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566409|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566410|NCT00003293|Procarbazine|procarbazine|mesh-list
14566411|NCT00003293|Leflunomide|leflunomide|mesh-list
14566412|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566413|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566414|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566415|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
14566416|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566417|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566418|NCT00003294|Paclitaxel|paclitaxel|mesh-list
14566419|NCT00003294|Carboplatin|carboplatin|mesh-list
14566420|NCT00003294|Amifostine|amifostine|mesh-list
14566421|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566422|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566423|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566424|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
14813284|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149394|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
14566425|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149395|NCT04221555|Durvalumab|durvalumab|mesh-list
15149396|NCT04221555|Tremelimumab|tremelimumab|mesh-list
14813285|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14813286|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14813287|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813288|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813289|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14813290|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14813291|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14813292|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14813293|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14813294|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813295|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813296|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813297|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813298|NCT00856089|Retapamulin|retapamulin|mesh-list
14813299|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14566426|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566427|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566428|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14566429|NCT00003294|Protective Agents|protective agents|mesh-ancestor
14566430|NCT00003296|Doxorubicin|doxorubicin|mesh-list
14566431|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14566432|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566433|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813300|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813301|NCT00856271|Losartan|losartan|mesh-list
14813302|NCT00856271|Olmesartan|olmesartan|mesh-list
14813303|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14813304|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14813305|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14813306|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14813307|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14813308|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813309|NCT00856310|Fasinumab|fasinumab|mesh-list
14813310|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14813311|NCT00856310|Analgesics|analgesics|mesh-ancestor
15149397|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14566434|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566435|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566436|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566437|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566438|NCT00003297|Topotecan|topotecan|mesh-list
14566439|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
14566440|NCT00003297|Thiotepa|thiotepa|mesh-list
14566441|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566442|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566443|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566444|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566445|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149398|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149399|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149400|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566446|NCT00003297|Analgesics|analgesics|mesh-ancestor
14566447|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
14566448|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566449|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566450|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566451|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566452|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
14566453|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566454|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566455|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
14566456|NCT00003299|Paclitaxel|paclitaxel|mesh-list
14566457|NCT00003299|Etoposide|etoposide|mesh-list
14566458|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566459|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149401|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149402|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149403|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15149404|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
15149405|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149406|NCT04221672|Terlipressin|terlipressin|mesh-list
15149407|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149408|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14566460|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566461|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566462|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149409|NCT04221503|Niraparib|niraparib|mesh-list
15149410|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14020992|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14566463|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566464|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566465|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566466|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566467|NCT00003301|Irinotecan|irinotecan|mesh-list
14566468|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566469|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566470|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566471|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566472|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566473|NCT00003304|Temozolomide|temozolomide|mesh-list
14566474|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566475|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
14566476|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566477|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566478|NCT00003305|Leucovorin|leucovorin|mesh-list
14566479|NCT00003305|Calcium|calcium|mesh-list
14566480|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
14020993|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14020994|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14020995|NCT02776540|Aspirin|aspirin|mesh-list
14020996|NCT02776540|Clopidogrel|clopidogrel|mesh-list
14020997|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14020998|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14020999|NCT02776540|Analgesics|analgesics|mesh-ancestor
14021000|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
14566481|NCT00003305|Aminopterin|aminopterin|mesh-list
14566482|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14566483|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566484|NCT00003305|Antidotes|antidotes|mesh-ancestor
14813312|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
14813313|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813314|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813315|NCT00856362|Moxidectin|moxidectin|mesh-list
14813316|NCT00856362|Midazolam|midazolam|mesh-list
14813317|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14813318|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14813319|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813320|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813321|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14813322|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14813323|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14813324|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14813325|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
14813326|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
14813327|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
14813328|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
14813329|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813330|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813331|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
14813332|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14813333|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813334|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
14813335|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
14813336|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813337|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14813338|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
14813339|NCT00856505|Everolimus|everolimus|mesh-list
14813340|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813341|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813342|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
14813343|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813344|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14813345|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14813346|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
14813347|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813348|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149411|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813349|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021001|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813350|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813351|NCT00856570|Warfarin|warfarin|mesh-list
14813352|NCT00856570|Mirabegron|mirabegron|mesh-list
14813353|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
14813354|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14813355|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14813356|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14813357|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813358|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813359|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813360|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813361|NCT00856570|Urological Agents|urological agents|mesh-ancestor
14813362|NCT00856596|Sertaconazole|sertaconazole|mesh-list
14813363|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
14813364|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813365|NCT00856622|Timolol|timolol|mesh-list
14813366|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14813367|NCT00856622|Latanoprost|latanoprost|mesh-list
14813368|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14813369|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14566485|NCT00003305|Protective Agents|protective agents|mesh-ancestor
14566486|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
14566487|NCT00003305|Vitamins|vitamins|mesh-ancestor
14566488|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
14566489|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14566490|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149412|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149413|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149414|NCT04221438|Alovudine|alovudine|mesh-list
15149415|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
15149416|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149417|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
15149418|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
15149419|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14813370|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14813371|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813372|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813373|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813374|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813375|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14813376|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14813377|NCT00856687|Montelukast|montelukast|mesh-list
14813378|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14813379|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14813380|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15149420|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15149421|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149422|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149423|NCT04221256|Citalopram|citalopram|mesh-list
15149424|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15149425|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15149426|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149427|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149428|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149429|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
15149430|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149431|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15149432|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
15149433|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15149434|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
15149435|NCT04221165|Narcotics|narcotics|mesh-ancestor
15149436|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149437|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149438|NCT04221165|Analgesics|analgesics|mesh-ancestor
15149439|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
15149440|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149441|NCT04221321|Atorvastatin|atorvastatin|mesh-list
14566491|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566492|NCT00003307|Amifostine|amifostine|mesh-list
14566493|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14566494|NCT00003307|Protective Agents|protective agents|mesh-ancestor
14566495|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566496|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
14566497|NCT00003309|Etoposide|etoposide|mesh-list
14566498|NCT00003309|Vincristine|vincristine|mesh-list
15149442|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15149443|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14813381|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
14813382|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813383|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813384|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14813385|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14813386|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813387|NCT00856700|Incretins|incretins|mesh-list
14566499|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566500|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
14566501|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566502|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566503|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566504|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
14566505|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566506|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566507|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566508|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566509|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566510|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566511|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566512|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566513|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566514|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566515|NCT00003311|Cytarabine|cytarabine|mesh-list
14566516|NCT00003311|Dexamethasone|dexamethasone|mesh-list
14566517|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
14566518|NCT00003311|Doxorubicin|doxorubicin|mesh-list
14566519|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14566520|NCT00003311|Methotrexate|methotrexate|mesh-list
14566521|NCT00003311|Vincristine|vincristine|mesh-list
14566522|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566523|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
14566524|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566525|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566526|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566527|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
14566528|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149444|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
15149445|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149446|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15149447|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15149448|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149449|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15149450|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15149451|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
15149452|NCT04221529|Atezolizumab|atezolizumab|mesh-list
15149453|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149454|NCT04221152|Empagliflozin|empagliflozin|mesh-list
15149455|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15149456|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149457|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149458|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149459|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
15149460|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15149461|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149462|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149463|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
15149464|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149465|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149466|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
15149467|NCT04221035|Melphalan|melphalan|mesh-list
14566529|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813388|NCT00856700|Hormones|hormones|mesh-ancestor
14813389|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813390|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813391|NCT00856804|Ribavirin|ribavirin|mesh-list
14813392|NCT00856804|Thalidomide|thalidomide|mesh-list
14813393|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
14813394|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026024|NCT02745886|Metformin|metformin|mesh-list
14566530|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566531|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566532|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
14566533|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
14566534|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566535|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14566536|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
14566537|NCT00003311|Hormones|hormones|mesh-ancestor
14566538|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566539|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14566540|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566541|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566542|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566543|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566544|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14566545|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
14566546|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14566547|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566548|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
14566549|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14566550|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14566551|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14566552|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
14566553|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566554|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566555|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566556|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566557|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149468|NCT04221035|Busulfan|busulfan|mesh-list
15149469|NCT04221035|Ifosfamide|ifosfamide|mesh-list
15149470|NCT04221035|Thiotepa|thiotepa|mesh-list
15149471|NCT04221035|Dacarbazine|dacarbazine|mesh-list
15149472|NCT04221035|Carboplatin|carboplatin|mesh-list
14566558|NCT00003313|Paclitaxel|paclitaxel|mesh-list
14566559|NCT00003313|Carboplatin|carboplatin|mesh-list
14566560|NCT00003313|Amifostine|amifostine|mesh-list
14566561|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566562|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566563|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566564|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566565|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566566|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566567|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566568|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14566569|NCT00003313|Protective Agents|protective agents|mesh-ancestor
14566570|NCT00003315|Amphotericin B|amphotericin b|mesh-list
14566571|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14566572|NCT00003315|Sargramostim|sargramostim|mesh-list
14566573|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
14566574|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566575|NCT00003315|Amebicides|amebicides|mesh-ancestor
14566576|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14566577|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14566578|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566579|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14566580|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
15149473|NCT04221035|Doxorubicin|doxorubicin|mesh-list
15149474|NCT04221035|Etoposide|etoposide|mesh-list
15149475|NCT04221035|Vincristine|vincristine|mesh-list
15149476|NCT04221035|Vindesine|vindesine|mesh-list
15149477|NCT04221035|Dinutuximab|dinutuximab|mesh-list
14566581|NCT00003316|Gemcitabine|gemcitabine|mesh-list
14566582|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566583|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
14566584|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566585|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566586|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
14566587|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566588|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566589|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566590|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
14566591|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566592|NCT00003317|Paclitaxel|paclitaxel|mesh-list
15149478|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566593|NCT00003317|Carboplatin|carboplatin|mesh-list
14566594|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566595|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149479|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
15149480|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149481|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566596|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566597|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566598|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566599|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566600|NCT00003322|Paclitaxel|paclitaxel|mesh-list
14566601|NCT00003322|Cisplatin|cisplatin|mesh-list
14566602|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566603|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566604|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566605|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566606|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566607|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566608|NCT00003323|Flutamide|flutamide|mesh-list
14566609|NCT00003323|Finasteride|finasteride|mesh-list
14566610|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14566611|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14566612|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566613|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566614|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
14566615|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566616|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566617|NCT00003323|Urological Agents|urological agents|mesh-ancestor
14566618|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
14566619|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14566620|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566621|NCT00003326|Paclitaxel|paclitaxel|mesh-list
14813395|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
14813396|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813397|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813398|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
14813399|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813400|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
14813401|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813402|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14813403|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14813404|NCT00856804|Growth Substances|growth substances|mesh-ancestor
14566622|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566623|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566624|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566625|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566626|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566627|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566628|NCT00003327|Paclitaxel|paclitaxel|mesh-list
14566629|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566630|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566631|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566632|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566633|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566634|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566635|NCT00003328|Porfiromycin|porfiromycin|mesh-list
14566636|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566637|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566638|NCT00003330|Interleukin-12|interleukin-12|mesh-list
14566639|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14566640|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
14566641|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566642|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14566643|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14566644|NCT00003330|Growth Substances|growth substances|mesh-ancestor
14566645|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14566646|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813405|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
14813406|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813407|NCT00856882|Caseins|caseins|mesh-list
14813408|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
14813409|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
14813410|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813411|NCT00856960|Losartan|losartan|mesh-list
15149482|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15149483|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
15149484|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149485|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149486|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15149487|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14813412|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14813413|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149488|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15149489|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15149490|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149491|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15149492|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149493|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
15149494|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149495|NCT04220996|Vortioxetine|vortioxetine|mesh-list
15149496|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
15149497|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15149498|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15149499|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15149500|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813414|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14813415|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14813416|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813417|NCT00857038|Doxycycline|doxycycline|mesh-list
14813418|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813419|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813420|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
14813421|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14813422|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14813423|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
14813424|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
14813425|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14813426|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
14813427|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14813428|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14813429|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813430|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14813431|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813432|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813433|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14813434|NCT00857077|Renal Agents|renal agents|mesh-ancestor
14813435|NCT00857116|Albendazole|albendazole|mesh-list
14813436|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
14813437|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14813438|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813439|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
14813440|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14813441|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15149501|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149502|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15149503|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15149504|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149505|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149506|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149507|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
15149508|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15149509|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14813442|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149510|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15149511|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15180021|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813443|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14813444|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14813445|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813446|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813447|NCT00857142|Oxymorphone|oxymorphone|mesh-list
14813448|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14813449|NCT00857142|Narcotics|narcotics|mesh-ancestor
14813450|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813451|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813452|NCT00857142|Analgesics|analgesics|mesh-ancestor
14813453|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
14813454|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813455|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14813456|NCT00857155|Clopidogrel|clopidogrel|mesh-list
14813457|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14813458|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14813459|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14813460|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14813461|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
14813462|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813463|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813464|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813465|NCT00857168|Testosterone|testosterone|mesh-list
14813466|NCT00857168|Androgens|androgens|mesh-ancestor
14813467|NCT00857168|Hormones|hormones|mesh-ancestor
14813468|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813469|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813470|NCT00857324|Vorinostat|vorinostat|mesh-list
14813471|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813472|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14813473|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813474|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813475|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
14813476|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
14813477|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813478|NCT00857376|Protective Agents|protective agents|mesh-ancestor
14813479|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813480|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
14813481|NCT00857376|Vitamins|vitamins|mesh-ancestor
14813482|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
14813483|NCT00857428|Oxymorphone|oxymorphone|mesh-list
15149512|NCT04220827|Paclitaxel|paclitaxel|mesh-list
15149513|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15149514|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15149515|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149516|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
14813484|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14813485|NCT00857428|Narcotics|narcotics|mesh-ancestor
14813486|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813487|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813488|NCT00857428|Analgesics|analgesics|mesh-ancestor
14813489|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
14813490|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813491|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14813492|NCT00857519|Carboplatin|carboplatin|mesh-list
14813493|NCT00857519|Melphalan|melphalan|mesh-list
14813494|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813495|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14813496|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
14813497|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813498|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14813499|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813500|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
14813501|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813502|NCT00857558|Saxagliptin|saxagliptin|mesh-list
14813503|NCT00857558|Incretins|incretins|mesh-ancestor
14813504|NCT00857558|Hormones|hormones|mesh-ancestor
14813505|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813506|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813507|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14813508|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
14813509|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813510|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813511|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14813512|NCT00857597|Esomeprazole|esomeprazole|mesh-list
14813513|NCT00857597|Omeprazole|omeprazole|mesh-list
14813514|NCT00857597|Rabeprazole|rabeprazole|mesh-list
14813515|NCT00857597|Pantoprazole|pantoprazole|mesh-list
14813516|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14813517|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14566647|NCT00003331|Leucovorin|leucovorin|mesh-list
14566648|NCT00003331|Fluorouracil|fluorouracil|mesh-list
14566649|NCT00003331|Topotecan|topotecan|mesh-list
14566650|NCT00003331|Calcium|calcium|mesh-list
14566651|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
14566652|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14566653|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566654|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
14566655|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566656|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566657|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813518|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14813519|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813520|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813521|NCT00857753|Fentanyl|fentanyl|mesh-list
14021002|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021003|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021004|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021005|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14021006|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14021007|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021008|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14021009|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14291348|NCT00553501|Rituximab|rituximab|mesh-list
14291349|NCT00553501|Epratuzumab|epratuzumab|mesh-list
14813522|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14813523|NCT00857753|Narcotics|narcotics|mesh-ancestor
14813524|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813525|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813526|NCT00857753|Analgesics|analgesics|mesh-ancestor
14813527|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
14813528|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149517|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
15149518|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149519|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149520|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
15149521|NCT04220892|Pemetrexed|pemetrexed|mesh-list
15149522|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15149523|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149524|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149525|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149526|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15149527|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15149528|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
15149529|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15149530|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149531|NCT04220528|Capecitabine|capecitabine|mesh-list
15149532|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15149533|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
15149534|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149535|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149536|NCT04220398|Hormones|hormones|mesh-list
15149537|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149538|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149539|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
15149540|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149541|NCT04220632|Prednisone|prednisone|mesh-list
15149542|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
15149543|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14813529|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14813530|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14813531|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
14813532|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
14814529|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14814530|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
14814531|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
14814532|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814533|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14814534|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814535|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814536|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15149544|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15149545|NCT04220632|Prednisolone|prednisolone|mesh-list
15149546|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
15149547|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15149548|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
15149549|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15149550|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
14291350|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14291351|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291352|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
14291353|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291354|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291355|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14291356|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14814537|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14814538|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15149551|NCT04220632|Hormones|hormones|mesh-ancestor
15149552|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149553|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813533|NCT00857831|Vitamin D|vitamin d|mesh-list
14813534|NCT00857831|Calcium|calcium|mesh-list
14813535|NCT00857831|Vitamins|vitamins|mesh-ancestor
14813536|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
14566658|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566659|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
14566660|NCT00003331|Antidotes|antidotes|mesh-ancestor
14566661|NCT00003331|Protective Agents|protective agents|mesh-ancestor
14813537|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813538|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14813539|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14813540|NCT00857870|Metformin|metformin|mesh-list
14813541|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
14813542|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14813543|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813544|NCT00857909|Amiloride|amiloride|mesh-list
14813545|NCT00857909|Spironolactone|spironolactone|mesh-list
14813546|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14813547|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
14814539|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15149554|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15149555|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149556|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
15149557|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
15149558|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149559|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15149560|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15149561|NCT04220632|Protective Agents|protective agents|mesh-ancestor
15149562|NCT04220476|Letrozole|letrozole|mesh-list
15149563|NCT04220476|Palbociclib|palbociclib|mesh-list
15149564|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149565|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15149566|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15149567|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149568|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149569|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15149570|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
15149571|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149572|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149573|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15149574|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
15149575|NCT04220281|Propofol|propofol|mesh-list
15149576|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15149577|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149578|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149579|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15149580|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
15149581|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
15149582|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149583|NCT04220008|Gemcitabine|gemcitabine|mesh-list
15149584|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
15149585|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
15149586|NCT04220008|Busulfan|busulfan|mesh-list
15149587|NCT04220008|Rituximab|rituximab|mesh-list
15149588|NCT04220008|Vorinostat|vorinostat|mesh-list
14566662|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
14566663|NCT00003331|Vitamins|vitamins|mesh-ancestor
14566664|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
14566665|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566666|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566667|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566668|NCT00003332|Gemcitabine|gemcitabine|mesh-list
14566669|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566670|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566671|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
14566672|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566673|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
14566674|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566675|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566676|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566677|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
14566678|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566679|NCT00003334|Paclitaxel|paclitaxel|mesh-list
14566680|NCT00003334|Doxorubicin|doxorubicin|mesh-list
14566681|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14813548|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813549|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813550|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14813551|NCT00857909|Diuretics|diuretics|mesh-ancestor
14813552|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
14813553|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14813554|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14813555|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14813556|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813557|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14813558|NCT00857935|Permethrin|permethrin|mesh-list
14813559|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813560|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813561|NCT00857987|Expectorants|expectorants|mesh-list
14813562|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
14813563|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14813564|NCT00858195|Indomethacin|indomethacin|mesh-list
14813565|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14813566|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14813567|NCT00858195|Analgesics|analgesics|mesh-ancestor
14813568|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
14813569|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813570|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813571|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14813572|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813573|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
14813574|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
14813575|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14813576|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14813577|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813578|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813579|NCT00858273|Insulin|insulin|mesh-list
14813580|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14813581|NCT00858273|Antioxidants|antioxidants|mesh-list
14813582|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14813583|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813584|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813585|NCT00858273|Protective Agents|protective agents|mesh-ancestor
14813586|NCT00858299|Valsartan|valsartan|mesh-list
14813587|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14813588|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14813589|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14813590|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813591|NCT00858325|Daptomycin|daptomycin|mesh-list
14813592|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813593|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813594|NCT00858338|Floxuridine|floxuridine|mesh-list
14813595|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14813596|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
14813597|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813598|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813599|NCT00858377|Complement Factor H|complement factor h|mesh-list
14813600|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15149589|NCT04220008|Clofarabine|clofarabine|mesh-list
15149590|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15149591|NCT04220008|Tacrolimus|tacrolimus|mesh-list
15149592|NCT04220008|Antibodies|antibodies|mesh-list
15149593|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
14566682|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566683|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566684|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566685|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
15149594|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15149595|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15149596|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
15149597|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149598|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149599|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15149600|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
15180022|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14566686|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566687|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566688|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566689|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566690|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566691|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566692|NCT00003335|Cyclosporine|cyclosporine|mesh-list
14566693|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
14566694|NCT00003335|Melphalan|melphalan|mesh-list
14813601|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813602|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
14813603|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813604|NCT00858429|Capecitabine|capecitabine|mesh-list
14813605|NCT00858429|Doxifluridine|doxifluridine|mesh-list
14813606|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14813607|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
14813608|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813609|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813610|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813611|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
14813612|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813613|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
14813614|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14813615|NCT00858455|Dolutegravir|dolutegravir|mesh-list
14813616|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14813617|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14813618|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813619|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813620|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14813621|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15149601|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149602|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149603|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15149604|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14813622|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
14813623|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813624|NCT00858624|Ketamine|ketamine|mesh-list
15149605|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
15149606|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
15149607|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149608|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149609|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14813625|NCT00858624|Analgesics|analgesics|mesh-ancestor
14813626|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
14813627|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813628|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566695|NCT00003335|Busulfan|busulfan|mesh-list
14566696|NCT00003335|Cyclosporins|cyclosporins|mesh-list
14566697|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14566698|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566699|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566700|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813629|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14813630|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14813631|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
14813632|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
14813633|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813634|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14813635|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14813636|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813637|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813638|NCT00858663|Everolimus|everolimus|mesh-list
14813639|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813640|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813641|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
14813642|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813643|NCT00858676|Acarbose|acarbose|mesh-list
14813644|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14813645|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813646|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813647|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14813648|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813649|NCT00858715|Aspirin|aspirin|mesh-list
15149610|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15149611|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14566701|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
14813650|NCT00858715|Clopidogrel|clopidogrel|mesh-list
14813651|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14813652|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14813653|NCT00858715|Analgesics|analgesics|mesh-ancestor
14813654|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
14813655|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813656|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813657|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14813658|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813659|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14813660|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14813661|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813662|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14813663|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14813664|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813665|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
14813666|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14813667|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14813668|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14813669|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
14813670|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813671|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
14813672|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14813673|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813674|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
14813675|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813676|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
14813677|NCT00858767|Vitamin K|vitamin k|mesh-list
14813678|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
14813679|NCT00858767|Caseins|caseins|mesh-list
14813680|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
14813681|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
14813682|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813683|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14813684|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14813685|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
14813686|NCT00858767|Coagulants|coagulants|mesh-ancestor
14813687|NCT00858767|Vitamins|vitamins|mesh-ancestor
14813688|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
14813689|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813690|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
14813691|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813692|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14813693|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813694|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813695|NCT00858897|Insulin|insulin|mesh-list
14566702|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566703|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
14566704|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813696|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14813697|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14813698|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813699|NCT00859079|Insulin|insulin|mesh-list
14813700|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14813701|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14813702|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14813703|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813704|NCT00859079|Incretins|incretins|mesh-ancestor
14813705|NCT00859079|Hormones|hormones|mesh-ancestor
14813706|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813707|NCT00859105|Imiquimod|imiquimod|mesh-list
14813708|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14813709|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
14566705|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
14566706|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566707|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14566708|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566709|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
14566710|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
14566711|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566712|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14566713|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
14566714|NCT00003335|Hormones|hormones|mesh-ancestor
14566715|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566716|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14566717|NCT00003335|Protective Agents|protective agents|mesh-ancestor
14566718|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566719|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14813710|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813711|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813712|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
14813713|NCT00859118|Axitinib|axitinib|mesh-list
14813714|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813715|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14813716|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813717|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813718|NCT00859183|Sirolimus|sirolimus|mesh-list
14813719|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813720|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813721|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15149612|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
15149613|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15149614|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14813722|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813723|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
14813724|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813725|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
14813726|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813727|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
14813728|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14813729|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14813730|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813731|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
14813732|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
14813733|NCT00859274|Budesonide|budesonide|mesh-list
14813734|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14813735|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14813736|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
14813737|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149615|NCT04220021|Metformin|metformin|mesh-list
15149616|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149617|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149618|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
15149619|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15149620|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15149621|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149622|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
15149623|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
15149624|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149625|NCT04220073|Antibodies|antibodies|mesh-list
15149626|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15149627|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
15149628|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566720|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
14566721|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15149629|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
15149630|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15149631|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14566722|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
15149632|NCT04219995|Prednisolone|prednisolone|mesh-list
15149633|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
15149634|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15149635|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
15149636|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15149637|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
15149638|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
15149639|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149640|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149641|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15149642|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
14566723|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
14566724|NCT00003336|Melphalan|melphalan|mesh-list
14566725|NCT00003336|Busulfan|busulfan|mesh-list
14566726|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14566727|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566728|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
14566729|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566730|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566731|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566732|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
14566733|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566734|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566735|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566736|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566737|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
15149643|NCT04219995|Hormones|hormones|mesh-ancestor
15149644|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566738|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
14566739|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566740|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14813738|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813739|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14813740|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
14813741|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
14813742|NCT00859274|Hormones|hormones|mesh-ancestor
14813743|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813744|NCT00859352|Midazolam|midazolam|mesh-list
14813745|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14813746|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14813747|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813748|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813749|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14813750|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14813751|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14813752|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14813753|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
14813754|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
14813755|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
14813756|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
14813757|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813758|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813759|NCT00859534|Afamelanotide|afamelanotide|mesh-list
14813760|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
14813761|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
14813762|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14813763|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14813764|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813765|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14813766|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813767|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14813768|NCT00859807|Amodiaquine|amodiaquine|mesh-list
14813769|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
14813770|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14813771|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14813772|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814540|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14814541|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14814542|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14566741|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
14566742|NCT00003336|Hormones|hormones|mesh-ancestor
14566743|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566744|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14566745|NCT00003336|Protective Agents|protective agents|mesh-ancestor
14566746|NCT00003337|Epratuzumab|epratuzumab|mesh-list
14566747|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14566748|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566749|NCT00003338|Epratuzumab|epratuzumab|mesh-list
14566750|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14566751|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566752|NCT00003339|Interleukin-12|interleukin-12|mesh-list
14566753|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
14566754|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14566755|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
14566756|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566757|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14566758|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14566759|NCT00003339|Growth Substances|growth substances|mesh-ancestor
14566760|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
14566761|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566762|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
14566763|NCT00003340|Topotecan|topotecan|mesh-list
14566764|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566765|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
14566766|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566767|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566768|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566769|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
14566770|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813773|NCT00859872|Haloperidol|haloperidol|mesh-list
14813774|NCT00859872|Risperidone|risperidone|mesh-list
14813775|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
14813776|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14813777|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
14813778|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813779|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813780|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813781|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14813782|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14813783|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813784|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14813785|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14566771|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566772|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566773|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566774|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566775|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149645|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15149646|NCT04219995|Protective Agents|protective agents|mesh-ancestor
15149647|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15149648|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149649|NCT04219865|Edaravone|edaravone|mesh-list
15149650|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15149651|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
15149652|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149653|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15149654|NCT04219865|Protective Agents|protective agents|mesh-ancestor
15149655|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149656|NCT04219982|Scopolamine|scopolamine|mesh-list
14566776|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
14566777|NCT00003341|Hematinics|hematinics|mesh-ancestor
14566778|NCT00003342|Gemcitabine|gemcitabine|mesh-list
14566779|NCT00003342|Paclitaxel|paclitaxel|mesh-list
14566780|NCT00003342|Carboplatin|carboplatin|mesh-list
14566781|NCT00003342|Doxorubicin|doxorubicin|mesh-list
14566782|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14566783|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566784|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566785|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566786|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566787|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566788|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566789|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566790|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
14566791|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
14566792|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566793|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566794|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566795|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
14566796|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566797|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566798|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14813786|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
14813787|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
14813788|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
14813789|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813790|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14813791|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14813792|NCT00859885|Aspirin|aspirin|mesh-list
14813793|NCT00859885|Clopidogrel|clopidogrel|mesh-list
14813794|NCT00859885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14813795|NCT00859885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14813796|NCT00859885|Analgesics|analgesics|mesh-ancestor
14813797|NCT00859885|Sensory System Agents|sensory system agents|mesh-ancestor
14813798|NCT00859885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149657|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15149658|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15149659|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
15149660|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
15149661|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149662|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813799|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149663|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14566799|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14813800|NCT00859885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15149664|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
14813801|NCT00859885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813802|NCT00859885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14813803|NCT00859885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14813804|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813805|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14813806|NCT00859885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14813807|NCT00859885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813808|NCT00859885|Antipyretics|antipyretics|mesh-ancestor
14813809|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14813810|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14813811|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14813812|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
14813813|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813814|NCT00859911|Micronutrients|micronutrients|mesh-list
14813815|NCT00859911|Trace Elements|trace elements|mesh-list
14813816|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149665|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15149666|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
14813817|NCT00860119|Alprazolam|alprazolam|mesh-list
14813818|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14813819|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813820|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813821|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14813822|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14813823|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14813824|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
14813825|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
14813826|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813827|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813828|NCT00860223|Digoxin|digoxin|mesh-list
14566800|NCT00003343|Prednisone|prednisone|mesh-list
14566801|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
14566802|NCT00003343|Prinomastat|prinomastat|mesh-list
14813829|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14813830|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14813831|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813832|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813833|NCT00860223|Protective Agents|protective agents|mesh-ancestor
14813834|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813835|NCT00860275|Fluconazole|fluconazole|mesh-list
15149667|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149668|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566803|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566804|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
14566805|NCT00003343|Hormones|hormones|mesh-ancestor
14566806|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14566807|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566808|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14566809|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566810|NCT00003343|Analgesics|analgesics|mesh-ancestor
14566811|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
14566812|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566813|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566814|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566815|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149669|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15149670|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
15149671|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
15149672|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15149673|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15149674|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149675|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
15149676|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
15149677|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149678|NCT04219579|Antithrombins|antithrombins|mesh-list
15149679|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
15149680|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15149681|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
15149682|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566816|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566817|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
14566818|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
14566819|NCT00003344|Irinotecan|irinotecan|mesh-list
14566820|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14813836|NCT00860275|Ketoconazole|ketoconazole|mesh-list
14566821|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14813837|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
14813838|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566822|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566823|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566824|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566825|NCT00003345|Irinotecan|irinotecan|mesh-list
14566826|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566827|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566828|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566829|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566830|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566831|NCT00003346|Acetaminophen|acetaminophen|mesh-list
14566832|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
14566833|NCT00003346|Carmustine|carmustine|mesh-list
14566834|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14813839|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14813840|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14813841|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813842|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813843|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14813844|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
14813845|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813846|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813847|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14813848|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14813849|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14813850|NCT00860340|Spironolactone|spironolactone|mesh-list
14813851|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14813852|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
14813853|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813854|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813855|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14813856|NCT00860340|Diuretics|diuretics|mesh-ancestor
14813857|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
14813858|NCT00860366|Uric Acid|uric acid|mesh-list
14813859|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
14813860|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813861|NCT00860366|Protective Agents|protective agents|mesh-ancestor
14813862|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813863|NCT00860496|Cyclosporine|cyclosporine|mesh-list
14813864|NCT00860496|Tacrolimus|tacrolimus|mesh-list
14813865|NCT00860496|Cyclosporins|cyclosporins|mesh-list
14813866|NCT00860496|Tofacitinib|tofacitinib|mesh-list
14813867|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14813868|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
14813869|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813870|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14813871|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813872|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813873|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
14813874|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813875|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14813876|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14813877|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14813878|NCT00860626|Interferons|interferons|mesh-list
14813879|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813880|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
15149683|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813881|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813882|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
14813883|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14813884|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813885|NCT00860899|Clonidine|clonidine|mesh-list
14813886|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
14813887|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
14813888|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
14813889|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14813890|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813891|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
15149684|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
15149685|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
14566835|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14566836|NCT00003346|Analgesics|analgesics|mesh-ancestor
14813892|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813893|NCT00860899|Analgesics|analgesics|mesh-ancestor
14813894|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14813895|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
14813896|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
14813897|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14813898|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14813899|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14813900|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813901|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813902|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813903|NCT00860925|Clonidine|clonidine|mesh-list
14813904|NCT00860925|Analgesics|analgesics|mesh-ancestor
14813905|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
14813906|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813907|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813908|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14813909|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
14813910|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
14813911|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14813912|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14813913|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14813914|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813915|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813916|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813917|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14813918|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14813919|NCT00860964|Estradiol|estradiol|mesh-list
14813920|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14813921|NCT00860964|Estrogens|estrogens|mesh-ancestor
14813922|NCT00860964|Hormones|hormones|mesh-ancestor
14813923|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14813924|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813925|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14813926|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
14813927|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14813928|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14813929|NCT00860977|Valacyclovir|valacyclovir|mesh-list
14813930|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
14813931|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813932|NCT00861016|Metoprolol|metoprolol|mesh-list
14813933|NCT00861016|Felodipine|felodipine|mesh-list
14813934|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14813935|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149686|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15149687|NCT04219735|Minocycline|minocycline|mesh-list
15149688|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15149689|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149690|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
15149691|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15149692|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
14813936|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
14813937|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
14813938|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14813939|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813940|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14813941|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14813942|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14813943|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14813944|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14813945|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813946|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14813947|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14813948|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14813949|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
14813950|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
14813951|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14813952|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14813953|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14813954|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14813955|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14813956|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14813957|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149693|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813958|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813959|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14813960|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
14813961|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14813962|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813963|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14813964|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14813965|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14813966|NCT00861042|Lacosamide|lacosamide|mesh-list
14813967|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
14813968|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14813969|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14813970|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14813971|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813972|NCT00861068|Lacosamide|lacosamide|mesh-list
14813973|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
14813974|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14813975|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14813976|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14813977|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14813978|NCT00861094|Leucovorin|leucovorin|mesh-list
14813979|NCT00861094|Folic Acid|folic acid|mesh-list
14813980|NCT00861094|Fluorouracil|fluorouracil|mesh-list
14813981|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
14813982|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
15149694|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
15149695|NCT04219722|Protective Agents|protective agents|mesh-ancestor
15149696|NCT04219449|Protein C|protein c|mesh-list
15149697|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
15149698|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15149699|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15149700|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149701|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
15149702|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15149703|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149704|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149705|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149706|NCT04219358|Imiquimod|imiquimod|mesh-list
15149707|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
14813983|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14813984|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
14813985|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149708|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15149709|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
14566837|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
14566838|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566839|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566840|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
14566841|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
14566842|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566843|NCT00003346|Expectorants|expectorants|mesh-ancestor
14566844|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
14566845|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14566846|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
14566847|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566848|NCT00003346|Protective Agents|protective agents|mesh-ancestor
14566849|NCT00003346|Antidotes|antidotes|mesh-ancestor
14566850|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566851|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
14566852|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566853|NCT00003348|Carmustine|carmustine|mesh-list
14566854|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14566855|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15149710|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149711|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566856|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
14566857|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149712|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
15149713|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15149714|NCT04219358|Protective Agents|protective agents|mesh-ancestor
15149715|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
15149716|NCT04219280|Methylphenidate|methylphenidate|mesh-list
15149717|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14566858|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566859|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149718|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566860|NCT00003350|Paclitaxel|paclitaxel|mesh-list
14566861|NCT00003350|Doxorubicin|doxorubicin|mesh-list
14566862|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14566863|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566864|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566865|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566866|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566867|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566868|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566869|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566870|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566871|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566872|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566873|NCT00003351|Irinotecan|irinotecan|mesh-list
14566874|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566875|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566876|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566877|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566878|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566879|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
14566880|NCT00003352|Docetaxel|docetaxel|mesh-list
14566881|NCT00003352|Doxorubicin|doxorubicin|mesh-list
14566882|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14566883|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566884|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
14566885|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566886|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566887|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566888|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
14566889|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566890|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566891|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566892|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566893|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566894|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566895|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566896|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566897|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566898|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566899|NCT00003353|Melphalan|melphalan|mesh-list
14566900|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
14566901|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566902|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566903|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
14566904|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566905|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566906|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566907|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566908|NCT00003356|Aldesleukin|aldesleukin|mesh-list
14566909|NCT00003356|Rituximab|rituximab|mesh-list
14566910|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14566911|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566912|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
14566913|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566914|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566915|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14566916|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14566917|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
14566918|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566919|NCT00003358|Gemcitabine|gemcitabine|mesh-list
14566920|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566921|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566922|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
14566923|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566924|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
14566925|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14566926|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566927|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566928|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
14566929|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566930|NCT00003360|Antibodies|antibodies|mesh-list
14566931|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14566932|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
14566933|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149719|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14566934|NCT00003361|Decitabine|decitabine|mesh-list
14566935|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14566936|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
14566937|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566938|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566939|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566940|NCT00003362|Sargramostim|sargramostim|mesh-list
14566941|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
14566942|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
14566943|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566944|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14566945|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
14566946|NCT00003364|Doxorubicin|doxorubicin|mesh-list
14566947|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14566948|NCT00003364|Etoposide|etoposide|mesh-list
14566949|NCT00003364|Vincristine|vincristine|mesh-list
14566950|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14566951|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
14566952|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566953|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14566954|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14566955|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
14566956|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566957|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566958|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14566959|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14566960|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14566961|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566962|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566963|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14566964|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
14566965|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
14566966|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
14566967|NCT00003365|Curcumin|curcumin|mesh-list
14566968|NCT00003365|Sulindac|sulindac|mesh-list
14566969|NCT00003365|Quercetin|quercetin|mesh-list
14566970|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14566971|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14566972|NCT00003365|Analgesics|analgesics|mesh-ancestor
14566973|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
14566974|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14566975|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566976|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14566977|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149720|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15149721|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149722|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149723|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
15149724|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180023|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15180024|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180025|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
15180026|NCT03943459|Protective Agents|protective agents|mesh-ancestor
15180027|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180028|NCT03943537|Insulin|insulin|mesh-list
15180029|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180030|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180031|NCT03943784|Propranolol|propranolol|mesh-list
15180032|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15180033|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15180034|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
15180035|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180036|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180037|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180038|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15180039|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15180040|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
15180041|NCT03943823|Estrogens|estrogens|mesh-list
15180042|NCT03943823|Hormones|hormones|mesh-ancestor
15180043|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180044|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180045|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
14566978|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566979|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566980|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566981|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
14566982|NCT00003365|Protective Agents|protective agents|mesh-ancestor
14566983|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14566984|NCT00003367|Vitamin E|vitamin e|mesh-list
14566985|NCT00003367|Vitamins|vitamins|mesh-ancestor
14566986|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
14566987|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14566988|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
14566989|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566990|NCT00003367|Protective Agents|protective agents|mesh-ancestor
14566991|NCT00003368|Irinotecan|irinotecan|mesh-list
14566992|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14566993|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14566994|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14566995|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14566996|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149725|NCT04219046|Naloxegol|naloxegol|mesh-list
14566997|NCT00003369|Tirapazamine|tirapazamine|mesh-list
14566998|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14566999|NCT00003370|Irofulven|irofulven|mesh-list
14567000|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567001|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
14567002|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567003|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567004|NCT00003372|Topotecan|topotecan|mesh-list
14567005|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14567006|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567007|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567008|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567009|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567010|NCT00003375|Vincristine|vincristine|mesh-list
14567011|NCT00003375|Lomustine|lomustine|mesh-list
14567012|NCT00003375|Procarbazine|procarbazine|mesh-list
14567013|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567014|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567015|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567016|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567017|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567018|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021010|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021011|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
14021012|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14021013|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14021014|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14021015|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
14021016|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14567019|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567020|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
14567021|NCT00003376|Paclitaxel|paclitaxel|mesh-list
14567022|NCT00003376|Vinblastine|vinblastine|mesh-list
14567023|NCT00003376|Carboplatin|carboplatin|mesh-list
14567024|NCT00003376|Doxorubicin|doxorubicin|mesh-list
14567025|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14567026|NCT00003376|Methotrexate|methotrexate|mesh-list
14567027|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567028|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567029|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149726|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15149727|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149728|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
15149729|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149730|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
15149731|NCT04218890|Thromboplastin|thromboplastin|mesh-list
15149732|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15149733|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15149734|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149735|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
15149736|NCT04218890|Coagulants|coagulants|mesh-ancestor
15149737|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
15149738|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15149739|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
15149740|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567030|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567031|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149741|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15149742|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
14567032|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567033|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567034|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567035|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567036|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567037|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14567038|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
14567039|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14567040|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567041|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567042|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
14567043|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567044|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14567045|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567046|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
14567047|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567048|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14567049|NCT00003378|Gemcitabine|gemcitabine|mesh-list
14567050|NCT00003378|Paclitaxel|paclitaxel|mesh-list
14567051|NCT00003378|Carboplatin|carboplatin|mesh-list
14567052|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567053|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567054|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567055|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567056|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567057|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567058|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567059|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
14567060|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
14567061|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567062|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567063|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567064|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
14567065|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567066|NCT00003379|Paclitaxel|paclitaxel|mesh-list
14567067|NCT00003379|Cisplatin|cisplatin|mesh-list
14567068|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567069|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567070|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567071|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567072|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567073|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567074|NCT00003380|Doxorubicin|doxorubicin|mesh-list
14567075|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14567076|NCT00003380|Etoposide|etoposide|mesh-list
14567077|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567078|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567079|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567080|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15149743|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
15149744|NCT04218981|Paroxetine|paroxetine|mesh-list
15149745|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14567081|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567082|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567083|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567084|NCT00003382|Gemcitabine|gemcitabine|mesh-list
14567085|NCT00003382|Topotecan|topotecan|mesh-list
14567086|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567087|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
14567088|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567089|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567090|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
14567091|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567092|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567093|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567094|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
14567095|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567096|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14567097|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567098|NCT00003385|Paclitaxel|paclitaxel|mesh-list
14567099|NCT00003385|Carboplatin|carboplatin|mesh-list
14567100|NCT00003385|Doxorubicin|doxorubicin|mesh-list
14567101|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14567102|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15149746|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14567103|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567104|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567105|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567106|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149747|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149748|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149749|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149750|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
15149751|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149752|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15149753|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
15149754|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15149755|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15149756|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15149757|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149758|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15149759|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149760|NCT04218968|Carvedilol|carvedilol|mesh-list
15149761|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15149762|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15149763|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
15149764|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149765|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149766|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149767|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149768|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
15149769|NCT04218968|Protective Agents|protective agents|mesh-ancestor
15149770|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15149771|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149772|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15149773|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
14567107|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567108|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567109|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567110|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567111|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567112|NCT00003386|Paclitaxel|paclitaxel|mesh-list
14567113|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
14567114|NCT00003386|Carboplatin|carboplatin|mesh-list
14567115|NCT00003386|Vaccines|vaccines|mesh-list
14567116|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
14567117|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
14567118|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567119|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567120|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567121|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567122|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567123|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567124|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567125|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567126|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567127|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567128|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
14567129|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567130|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14567131|NCT00003387|Paclitaxel|paclitaxel|mesh-list
15149774|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15149775|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15149776|NCT04218513|Edaravone|edaravone|mesh-list
15149777|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15149778|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
15149779|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149780|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15149781|NCT04218513|Protective Agents|protective agents|mesh-ancestor
15149782|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149783|NCT04218500|Niacinamide|niacinamide|mesh-list
15149784|NCT04218500|Niacin|niacin|mesh-list
15149785|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
15149786|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
15149787|NCT04218500|Vitamins|vitamins|mesh-ancestor
15149788|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
15149789|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567132|NCT00003387|Carboplatin|carboplatin|mesh-list
14567133|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567134|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567135|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567136|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567137|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567138|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567139|NCT00003388|Cytarabine|cytarabine|mesh-list
14567140|NCT00003388|Prednisone|prednisone|mesh-list
14567141|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
14567142|NCT00003388|Doxorubicin|doxorubicin|mesh-list
14567143|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14567144|NCT00003388|Methotrexate|methotrexate|mesh-list
15149790|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15149791|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
15149792|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021017|NCT02776527|Apatinib|apatinib|mesh-list
15149793|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15149794|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149795|NCT04218435|Valsartan|valsartan|mesh-list
14567145|NCT00003388|Vincristine|vincristine|mesh-list
14567146|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567147|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
15149796|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149797|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15149798|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15149799|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149800|NCT04218760|Isosorbide|isosorbide|mesh-list
15149801|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15149802|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15149803|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15149804|NCT04218760|Diuretics|diuretics|mesh-ancestor
15149805|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
15149806|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149807|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149808|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15149809|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149810|NCT04218552|Amlodipine|amlodipine|mesh-list
14567148|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567149|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567150|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567151|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
14567152|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567153|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567154|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567155|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567156|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567157|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15149811|NCT04218552|Telmisartan|telmisartan|mesh-list
15149812|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15149813|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15149814|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149815|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567158|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567159|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567160|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
14567161|NCT00003388|Hormones|hormones|mesh-ancestor
14567162|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567163|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567164|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14567165|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
14567166|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14567167|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567168|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
15149816|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15149817|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149818|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149819|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14021018|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021019|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14021020|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021021|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021022|NCT02776163|Docetaxel|docetaxel|mesh-list
14021023|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567169|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567170|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14021024|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567171|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14567172|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
14567173|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567174|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567175|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567176|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567177|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567178|NCT00003390|Irofulven|irofulven|mesh-list
14567179|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567180|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
14567181|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567182|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567183|NCT00003391|Antibodies|antibodies|mesh-list
14567184|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14567185|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
14567186|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567187|NCT00003392|Paclitaxel|paclitaxel|mesh-list
14567188|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
14567189|NCT00003392|Carboplatin|carboplatin|mesh-list
14567190|NCT00003392|Melphalan|melphalan|mesh-list
14567191|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567192|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567193|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567194|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567195|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567196|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567197|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567198|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
14567199|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567200|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567201|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567202|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
14567203|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567204|NCT00003394|Paclitaxel|paclitaxel|mesh-list
14567205|NCT00003394|Carboplatin|carboplatin|mesh-list
14567206|NCT00003394|Leuprolide|leuprolide|mesh-list
14567207|NCT00003394|Goserelin|goserelin|mesh-list
14567208|NCT00003394|Estramustine|estramustine|mesh-list
14021025|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14021026|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14021027|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567209|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567210|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567211|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567212|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567213|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567214|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567215|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14567216|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
14567217|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14567218|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567219|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567220|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567221|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
14567222|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
14567223|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567224|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
14567225|NCT00003396|Melphalan|melphalan|mesh-list
14567226|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14567227|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567228|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
14567229|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567230|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567231|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567232|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
14567233|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567234|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567235|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567236|NCT00003397|Gemcitabine|gemcitabine|mesh-list
14567237|NCT00003397|Dexamethasone|dexamethasone|mesh-list
14567238|NCT00003397|Paclitaxel|paclitaxel|mesh-list
14567239|NCT00003397|Etoposide|etoposide|mesh-list
14567240|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
14567241|NCT00003397|Rituximab|rituximab|mesh-list
14567242|NCT00003397|Melphalan|melphalan|mesh-list
14021028|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
14567243|NCT00003397|Carmustine|carmustine|mesh-list
14567244|NCT00003397|Sargramostim|sargramostim|mesh-list
14567245|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567246|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567247|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567248|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567249|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567250|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567251|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567252|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
14567253|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567254|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567255|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567256|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
14567257|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567258|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567259|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
14567260|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
14567261|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567262|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567263|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
14567264|NCT00003397|Hormones|hormones|mesh-ancestor
14567265|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567266|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567267|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14567268|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567269|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
14567270|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
14567271|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567272|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567273|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567274|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567275|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
14567276|NCT00003398|Thiotepa|thiotepa|mesh-list
14567277|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14021029|NCT02776202|Sirolimus|sirolimus|mesh-list
14567278|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567279|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
14567280|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567281|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567282|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567283|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
14567284|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567285|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567286|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567287|NCT00003399|Dexamethasone|dexamethasone|mesh-list
14567288|NCT00003399|Paclitaxel|paclitaxel|mesh-list
14567289|NCT00003399|Etoposide|etoposide|mesh-list
14567290|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
14567291|NCT00003399|Melphalan|melphalan|mesh-list
14567292|NCT00003399|Carmustine|carmustine|mesh-list
14567293|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567294|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567295|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567296|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567297|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567298|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567299|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567300|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
14567301|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567302|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567303|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567304|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
14567305|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567306|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567307|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
14567308|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
14567309|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567310|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567311|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
14567312|NCT00003399|Hormones|hormones|mesh-ancestor
14567313|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567314|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567315|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567316|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567317|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567318|NCT00003400|Melphalan|melphalan|mesh-list
14021030|NCT02776202|Fludarabine|fludarabine|mesh-list
14567319|NCT00003400|Vinorelbine|vinorelbine|mesh-list
14567320|NCT00003400|Carmustine|carmustine|mesh-list
14567321|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567322|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
14567323|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567324|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567325|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
14567326|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567327|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567328|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567329|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567330|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567331|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567332|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567333|NCT00003401|Gemcitabine|gemcitabine|mesh-list
14567334|NCT00003401|Dexamethasone|dexamethasone|mesh-list
14567335|NCT00003401|Paclitaxel|paclitaxel|mesh-list
14567336|NCT00003401|Etoposide|etoposide|mesh-list
14567337|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
14567338|NCT00003401|Melphalan|melphalan|mesh-list
14567339|NCT00003401|Carmustine|carmustine|mesh-list
14567340|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567341|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567342|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567343|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567344|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567345|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567346|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567347|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
14567348|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567349|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567350|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567351|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
14567352|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567353|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567354|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
14567355|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
14567356|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567357|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567358|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
14567359|NCT00003401|Hormones|hormones|mesh-ancestor
14567360|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567361|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567362|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567363|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
14567364|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
14021031|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
14021032|NCT02776202|Melphalan|melphalan|mesh-list
14567365|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021033|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149820|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15149821|NCT04218734|Metformin|metformin|mesh-list
15149822|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149823|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149824|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
15149825|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15149826|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149827|NCT04218149|Bupivacaine|bupivacaine|mesh-list
15149828|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
15149829|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
15149830|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15149831|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149832|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
15149833|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149834|NCT04218162|Lasmiditan|lasmiditan|mesh-list
15149835|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14567366|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567367|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567368|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567369|NCT00003402|Dexamethasone|dexamethasone|mesh-list
14567370|NCT00003402|Paclitaxel|paclitaxel|mesh-list
14567371|NCT00003402|Etoposide|etoposide|mesh-list
14021034|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567372|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
14567373|NCT00003402|Melphalan|melphalan|mesh-list
14567374|NCT00003402|Carmustine|carmustine|mesh-list
14567375|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15149836|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
15180046|NCT03943472|Fludarabine|fludarabine|mesh-list
14567376|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567377|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567378|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567379|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567380|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567381|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567382|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
14567383|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567384|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567385|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567386|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
14567387|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567388|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567389|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
14567390|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
14567391|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567392|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567393|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
14567394|NCT00003402|Hormones|hormones|mesh-ancestor
14567395|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567396|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567397|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567398|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567399|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567400|NCT00003405|Interferons|interferons|mesh-list
14567401|NCT00003405|Cytarabine|cytarabine|mesh-list
14567402|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
14567403|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
14567404|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
14567405|NCT00003405|Idoxuridine|idoxuridine|mesh-list
14567406|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
14567407|NCT00003405|Idarubicin|idarubicin|mesh-list
14567408|NCT00003405|Isotretinoin|isotretinoin|mesh-list
14567409|NCT00003405|Amifostine|amifostine|mesh-list
14567410|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567411|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
14567412|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567413|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567414|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
14567415|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567416|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567417|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
14567418|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567419|NCT00003405|Analgesics|analgesics|mesh-ancestor
14567420|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
14567421|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567422|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567423|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567424|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567425|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567426|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567427|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14567428|NCT00003405|Protective Agents|protective agents|mesh-ancestor
14567429|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14567430|NCT00003406|Carboplatin|carboplatin|mesh-list
14567431|NCT00003406|Docetaxel|docetaxel|mesh-list
14567432|NCT00003406|Ifosfamide|ifosfamide|mesh-list
14567433|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567434|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567435|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567436|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567437|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567438|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567439|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
14567440|NCT00003407|Cytarabine|cytarabine|mesh-list
14567441|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
14567442|NCT00003407|Amifostine|amifostine|mesh-list
14567443|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567444|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
14567445|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567446|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567447|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
14567448|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567449|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567450|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
14567451|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567452|NCT00003407|Analgesics|analgesics|mesh-ancestor
14567453|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
14567454|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567455|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567456|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567457|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567458|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14567459|NCT00003407|Protective Agents|protective agents|mesh-ancestor
14567460|NCT00003408|Interferons|interferons|mesh-list
14567461|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
14567462|NCT00003408|Aldesleukin|aldesleukin|mesh-list
14567463|NCT00003408|Sargramostim|sargramostim|mesh-list
14567464|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567465|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
14567466|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567467|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
14567468|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567469|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14567470|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14567471|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
14567472|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567473|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14567474|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567475|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
14567476|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567477|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14567478|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567479|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
14567480|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567481|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14567482|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567483|NCT00003412|Interleukin-12|interleukin-12|mesh-list
14567484|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14567485|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
14567486|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567487|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14567488|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14567489|NCT00003412|Growth Substances|growth substances|mesh-ancestor
14567490|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
14567491|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567492|NCT00003413|Paclitaxel|paclitaxel|mesh-list
14567493|NCT00003413|Melphalan|melphalan|mesh-list
14567494|NCT00003413|Carmustine|carmustine|mesh-list
15149837|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149838|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021035|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
14026025|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15149839|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149840|NCT04217733|Ethosuximide|ethosuximide|mesh-list
15149841|NCT04217733|Mebeverine|mebeverine|mesh-list
15149842|NCT04217733|Alverine|alverine|mesh-list
15149843|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
14567495|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567496|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567497|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567498|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567499|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567500|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567501|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
14567502|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567503|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567504|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
14567505|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567506|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643765|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14643766|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14643767|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14643768|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14643769|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
15149844|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
15149845|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
15149846|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149847|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149848|NCT04217798|Etoposide|etoposide|mesh-list
15149849|NCT04217798|Niraparib|niraparib|mesh-list
15149850|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15149851|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643770|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14643771|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14567507|NCT00003414|Interferons|interferons|mesh-list
14567508|NCT00003414|Aldesleukin|aldesleukin|mesh-list
14567509|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
14567510|NCT00003414|Cyclosporine|cyclosporine|mesh-list
14567511|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
14567512|NCT00003414|Busulfan|busulfan|mesh-list
14567513|NCT00003414|Cyclosporins|cyclosporins|mesh-list
14567514|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567515|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
14567516|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567517|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567518|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567519|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
15149852|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14021036|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021037|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021038|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
14021039|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021040|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14021041|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14567520|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567521|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567522|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567523|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
14567524|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567525|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567526|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
14567527|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567528|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14567529|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14567530|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14567531|NCT00003415|Topotecan|topotecan|mesh-list
14567532|NCT00003415|Amifostine|amifostine|mesh-list
14567533|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14567534|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567535|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567536|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567537|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567538|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14567539|NCT00003415|Protective Agents|protective agents|mesh-ancestor
14567540|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567541|NCT00003416|Interferons|interferons|mesh-list
14567542|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
14567543|NCT00003416|Dexamethasone|dexamethasone|mesh-list
14567544|NCT00003416|Melphalan|melphalan|mesh-list
14567545|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567546|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
14567547|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
14567548|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567549|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567550|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567551|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
14567552|NCT00003416|Hormones|hormones|mesh-ancestor
14567553|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567554|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567555|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567556|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
14567557|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567558|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
14567559|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567560|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
14567561|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567562|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567563|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567564|NCT00003417|Carmustine|carmustine|mesh-list
14567565|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567566|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
14567567|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567568|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567569|NCT00003418|Tamoxifen|tamoxifen|mesh-list
14567570|NCT00003418|Exemestane|exemestane|mesh-list
14567571|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567572|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14567573|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
15149853|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14021042|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
14567574|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567575|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567576|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567577|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567578|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14567579|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14567580|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14567581|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14567582|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14567583|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567584|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
14567585|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567586|NCT00003421|Prednisolone|prednisolone|mesh-list
14567587|NCT00003421|Doxorubicin|doxorubicin|mesh-list
14567588|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14567589|NCT00003421|Bleomycin|bleomycin|mesh-list
14567590|NCT00003421|Etoposide|etoposide|mesh-list
14567591|NCT00003421|Vincristine|vincristine|mesh-list
14567592|NCT00003421|Dacarbazine|dacarbazine|mesh-list
14567593|NCT00003421|Vinblastine|vinblastine|mesh-list
14567594|NCT00003421|Procarbazine|procarbazine|mesh-list
14567595|NCT00003421|Chlorambucil|chlorambucil|mesh-list
14567596|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567597|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567598|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567599|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567600|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567601|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567602|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567603|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567604|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567605|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567606|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567607|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
14567608|NCT00003421|Hormones|hormones|mesh-ancestor
14567609|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567610|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567611|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567612|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567613|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
14567614|NCT00003422|Leucovorin|leucovorin|mesh-list
14567615|NCT00003422|Fluorouracil|fluorouracil|mesh-list
14567616|NCT00003422|Calcium|calcium|mesh-list
14567617|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
14567618|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14567619|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567620|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
14567621|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567622|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567623|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567624|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567625|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
14567626|NCT00003422|Antidotes|antidotes|mesh-ancestor
14567627|NCT00003422|Protective Agents|protective agents|mesh-ancestor
14567628|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
14567629|NCT00003422|Vitamins|vitamins|mesh-ancestor
14567630|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
14567631|NCT00003423|Cytarabine|cytarabine|mesh-list
14567632|NCT00003423|Dexamethasone|dexamethasone|mesh-list
14567633|NCT00003423|Prednisolone|prednisolone|mesh-list
14567634|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
14567635|NCT00003423|Methotrexate|methotrexate|mesh-list
14567636|NCT00003423|Etoposide|etoposide|mesh-list
14567637|NCT00003423|Vincristine|vincristine|mesh-list
14567638|NCT00003423|Daunorubicin|daunorubicin|mesh-list
14567639|NCT00003423|Asparaginase|asparaginase|mesh-list
14567640|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
14567641|NCT00003423|Thioguanine|thioguanine|mesh-list
14567642|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567643|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
14567644|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567645|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567646|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567647|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
14567648|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567649|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567650|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567651|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15149854|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567652|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
14567653|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
14567654|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567655|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567656|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
14567657|NCT00003423|Hormones|hormones|mesh-ancestor
14567658|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567659|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567660|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14567661|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
14567662|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14567663|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567664|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
14567665|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567666|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567667|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14567668|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14567669|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567670|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567671|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567672|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
14567673|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567674|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567675|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567676|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
14021043|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14021044|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021045|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021046|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
14021047|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14021048|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
14021049|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14021050|NCT02776189|Midazolam|midazolam|mesh-list
14021051|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
14021052|NCT02776189|Propofol|propofol|mesh-list
14021053|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14021054|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14567677|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567678|NCT00003424|Tamoxifen|tamoxifen|mesh-list
14567679|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15149855|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149856|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14567680|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
14567681|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567682|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567683|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567684|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567685|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14567686|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14567687|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14567688|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
14567689|NCT00003425|Melphalan|melphalan|mesh-list
14567690|NCT00003425|Amifostine|amifostine|mesh-list
14567691|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567692|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
14567693|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567694|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567695|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567696|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
14567697|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567698|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567699|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567700|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14567701|NCT00003425|Protective Agents|protective agents|mesh-ancestor
14567702|NCT00003426|Gemcitabine|gemcitabine|mesh-list
14567703|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567704|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
14567705|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567706|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567707|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
14567708|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149857|NCT04217668|Isosorbide|isosorbide|mesh-list
14021055|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567709|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567710|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567711|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
14567712|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567713|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
14567714|NCT00003427|Irinotecan|irinotecan|mesh-list
14567715|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567716|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14567717|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567718|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567719|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567720|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14567721|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14567722|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567723|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
14567724|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14567725|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
14567726|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567727|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14567728|NCT00003431|Protective Agents|protective agents|mesh-ancestor
14567729|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
14567730|NCT00003435|Melphalan|melphalan|mesh-list
14567731|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14567732|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567733|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
14567734|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567735|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567736|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567737|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567738|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
14567739|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567740|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567741|NCT00003436|Cytarabine|cytarabine|mesh-list
14567742|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
14567743|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14567744|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14567745|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14567746|NCT00003436|Methotrexate|methotrexate|mesh-list
14567747|NCT00003436|Etoposide|etoposide|mesh-list
14567748|NCT00003436|Daunorubicin|daunorubicin|mesh-list
14567749|NCT00003436|Asparaginase|asparaginase|mesh-list
14567750|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
14567751|NCT00003436|Amsacrine|amsacrine|mesh-list
14567752|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14567753|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
14567754|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14567755|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567756|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567757|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
14567758|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567759|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567760|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567761|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567762|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14567763|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567764|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
14567765|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567766|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14567767|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567768|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567769|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567770|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
14567771|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567772|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567773|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567774|NCT00003436|Analgesics|analgesics|mesh-ancestor
15149858|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15149859|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15149860|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15149861|NCT04217668|Diuretics|diuretics|mesh-ancestor
15149862|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
15149863|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149864|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
15149865|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14567775|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
14643772|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
14567776|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567777|NCT00003437|Cytarabine|cytarabine|mesh-list
14567778|NCT00003437|Dexamethasone|dexamethasone|mesh-list
14567779|NCT00003437|Prednisolone|prednisolone|mesh-list
14567780|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
14567781|NCT00003437|Doxorubicin|doxorubicin|mesh-list
14567782|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14567783|NCT00003437|Methotrexate|methotrexate|mesh-list
14567784|NCT00003437|Vincristine|vincristine|mesh-list
14567785|NCT00003437|Daunorubicin|daunorubicin|mesh-list
14567786|NCT00003437|Asparaginase|asparaginase|mesh-list
14567787|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
14567788|NCT00003437|Pegaspargase|pegaspargase|mesh-list
14567789|NCT00003437|Thioguanine|thioguanine|mesh-list
14567790|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567791|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
14567792|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567793|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14567794|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567795|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
14567796|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567797|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567798|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567799|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567800|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
14567801|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
14567802|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567803|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567804|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
14567805|NCT00003437|Hormones|hormones|mesh-ancestor
14567806|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567807|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567808|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14567809|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14567810|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567811|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567812|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14567813|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
14567814|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14567815|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567816|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
14567817|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14567818|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14567819|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14567820|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
14567821|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567822|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567823|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567824|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567825|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567826|NCT00003439|Interleukin-12|interleukin-12|mesh-list
14567827|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14567828|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
14567829|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567830|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14567831|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14567832|NCT00003439|Growth Substances|growth substances|mesh-ancestor
14567833|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
14567834|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567835|NCT00003440|Paclitaxel|paclitaxel|mesh-list
14567836|NCT00003440|Trastuzumab|trastuzumab|mesh-list
14567837|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567838|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567839|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567840|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567841|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567842|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567843|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14567844|NCT00003441|Irofulven|irofulven|mesh-list
14567845|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567846|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
14567847|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567848|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567849|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
14567850|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14567851|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
14567852|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149866|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149867|NCT04217694|Memantine|memantine|mesh-list
15149868|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14567853|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567854|NCT00003444|Interferons|interferons|mesh-list
14567855|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
14567856|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567857|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
14567858|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567859|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
14567860|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567861|NCT00003445|Docetaxel|docetaxel|mesh-list
14567862|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567863|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567864|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567865|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567866|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567867|NCT00003446|Leucovorin|leucovorin|mesh-list
14567868|NCT00003446|Trimetrexate|trimetrexate|mesh-list
14567869|NCT00003446|Fluorouracil|fluorouracil|mesh-list
14567870|NCT00003446|Calcium|calcium|mesh-list
14567871|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
14567872|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14567873|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567874|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
14567875|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567876|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567877|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567878|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567879|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
14567880|NCT00003446|Antidotes|antidotes|mesh-ancestor
15149869|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15149870|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
15149871|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149872|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149873|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149874|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15149875|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15149876|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15149877|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15149878|NCT04217265|Letrozole|letrozole|mesh-list
15149879|NCT04217265|Misoprostol|misoprostol|mesh-list
15149880|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149881|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15149882|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15149883|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149884|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149885|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15149886|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
14567881|NCT00003446|Protective Agents|protective agents|mesh-ancestor
14567882|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
14567883|NCT00003446|Vitamins|vitamins|mesh-ancestor
15149887|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149888|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149889|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14567884|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
14567885|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
14567886|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567887|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14567888|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021056|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14021057|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
14021058|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
14021059|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021060|NCT02776189|Analgesics|analgesics|mesh-ancestor
14021061|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
14567889|NCT00003447|Gemcitabine|gemcitabine|mesh-list
14567890|NCT00003447|Vinorelbine|vinorelbine|mesh-list
14567891|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567892|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
14567893|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567894|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567895|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
14567896|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567897|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567898|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567899|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
14567900|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567901|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567902|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567903|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567904|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567905|NCT00003449|Gemcitabine|gemcitabine|mesh-list
14567906|NCT00003449|Dexamethasone|dexamethasone|mesh-list
14567907|NCT00003449|Paclitaxel|paclitaxel|mesh-list
14567908|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14567909|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567910|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14567911|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14567912|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14567913|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567914|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14567915|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
15149890|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
15149891|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15149892|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15149893|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15149894|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
14567916|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
14567917|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567918|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567919|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14567920|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
14567921|NCT00003449|Hormones|hormones|mesh-ancestor
15149895|NCT04217447|Aspirin|aspirin|mesh-list
15149896|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15149897|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15149898|NCT04217447|Analgesics|analgesics|mesh-ancestor
15149899|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
15149900|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15149901|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149902|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15149903|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149904|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15149905|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15149906|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149907|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15149908|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15149909|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149910|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
15149911|NCT04217421|Allopurinol|allopurinol|mesh-list
15149912|NCT04217421|Mannitol|mannitol|mesh-list
15149913|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
14567922|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14567923|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14567924|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14567925|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
14567926|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
14567927|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567928|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567929|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567930|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
14567931|NCT00003451|Interferons|interferons|mesh-list
14567932|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
14567933|NCT00003451|Interleukin-12|interleukin-12|mesh-list
14567934|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567935|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
14567936|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14567937|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
14567938|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567939|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14567940|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14567941|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14567942|NCT00003451|Growth Substances|growth substances|mesh-ancestor
14567943|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
14567944|NCT00003461|Antibodies|antibodies|mesh-list
14567945|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14021062|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14567946|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
14567947|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567948|NCT00003462|Busulfan|busulfan|mesh-list
14567949|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
15149914|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567950|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567951|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14567952|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
14567953|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567954|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567955|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567956|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14567957|NCT00003463|Irinotecan|irinotecan|mesh-list
14567958|NCT00003463|Carmustine|carmustine|mesh-list
14567959|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14567960|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567961|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567962|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567963|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567964|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567965|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
14567966|NCT00003464|Temozolomide|temozolomide|mesh-list
14567967|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567968|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
14567969|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567970|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567971|NCT00003465|Temozolomide|temozolomide|mesh-list
14567972|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567973|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
14567974|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567975|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567976|NCT00003466|Temozolomide|temozolomide|mesh-list
14567977|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567978|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
14567979|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567980|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567981|NCT00003467|Carmustine|carmustine|mesh-list
14567982|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14567983|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
14567984|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14567985|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14567986|NCT00003478|Antibodies|antibodies|mesh-list
14567987|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14567988|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
14567989|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567990|NCT00003484|Irinotecan|irinotecan|mesh-list
14567991|NCT00003484|Carmustine|carmustine|mesh-list
14567992|NCT00003484|Antibodies|antibodies|mesh-list
14567993|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14567994|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
14567995|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14567996|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14567997|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14567998|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14567999|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568000|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568001|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568002|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
14568003|NCT00003490|Prednisone|prednisone|mesh-list
14568004|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
14568005|NCT00003490|Vincristine|vincristine|mesh-list
14568006|NCT00003490|Sargramostim|sargramostim|mesh-list
14568007|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568008|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
14568009|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568010|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568011|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568012|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
14568013|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568014|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568015|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568016|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568017|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
14568018|NCT00003490|Hormones|hormones|mesh-ancestor
15149915|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149916|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
14568019|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149917|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149918|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14568020|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568021|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568022|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568023|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568024|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568025|NCT00003493|Dexamethasone|dexamethasone|mesh-list
14568026|NCT00003493|Doxorubicin|doxorubicin|mesh-list
14568027|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14568028|NCT00003493|Vincristine|vincristine|mesh-list
14568029|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568030|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
14568031|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
14568032|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14568033|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568034|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14568035|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
14568036|NCT00003493|Hormones|hormones|mesh-ancestor
14568037|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568038|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568039|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568040|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568041|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568042|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568043|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568044|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568045|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568046|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568047|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568048|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568049|NCT00003517|Leuprolide|leuprolide|mesh-list
14568050|NCT00003517|Flutamide|flutamide|mesh-list
14568051|NCT00003517|Bicalutamide|bicalutamide|mesh-list
14568052|NCT00003517|Hormones|hormones|mesh-list
14568053|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
14568054|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568055|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568056|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14568057|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
14568058|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14568059|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568060|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568061|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
14568062|NCT00003518|Gemcitabine|gemcitabine|mesh-list
14568063|NCT00003518|Paclitaxel|paclitaxel|mesh-list
14568064|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568065|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568066|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568067|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568068|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568069|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568070|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568071|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
14568072|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
14568073|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568074|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568075|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568076|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
14568077|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568078|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
14568079|NCT00003519|Docetaxel|docetaxel|mesh-list
14568080|NCT00003519|Doxorubicin|doxorubicin|mesh-list
14568081|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14568082|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15149919|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
15149920|NCT04217421|Protective Agents|protective agents|mesh-ancestor
15149921|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149922|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15149923|NCT04217421|Diuretics|diuretics|mesh-ancestor
15149924|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
15149925|NCT04217512|Pantoprazole|pantoprazole|mesh-list
15149926|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15149927|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14568083|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
14568084|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568085|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149928|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15149929|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149930|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149931|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15149932|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15149933|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
14568086|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568087|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
14568088|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568089|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568090|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15149934|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149935|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149936|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
15149937|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149938|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
15149939|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568091|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568092|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568093|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568094|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568095|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568096|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568097|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568098|NCT00003528|Raltitrexed|raltitrexed|mesh-list
14568099|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568100|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
14568101|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568102|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568103|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14568104|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568105|NCT00003536|Methotrexate|methotrexate|mesh-list
14568106|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14568107|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
14568108|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14568109|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568110|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568111|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
14568112|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568113|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568114|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568115|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568116|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14568117|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568118|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
14568119|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568120|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14568121|NCT00003539|Paclitaxel|paclitaxel|mesh-list
14568122|NCT00003539|Trastuzumab|trastuzumab|mesh-list
14568123|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568124|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568125|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568126|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568127|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568128|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568129|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14568130|NCT00003540|Gemcitabine|gemcitabine|mesh-list
14568131|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568132|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
14568133|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568134|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568135|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
15149940|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149941|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15149942|NCT04217148|Dexamethasone|dexamethasone|mesh-list
15149943|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
15149944|NCT04217148|Tretinoin|tretinoin|mesh-list
15149945|NCT04217148|BB 1101|bb 1101|mesh-list
15149946|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021063|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14568136|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568137|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568138|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568139|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
14568140|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568141|NCT00003541|Prednisone|prednisone|mesh-list
14568142|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
14568143|NCT00003541|Ifosfamide|ifosfamide|mesh-list
14568144|NCT00003541|Carboplatin|carboplatin|mesh-list
14568145|NCT00003541|Doxorubicin|doxorubicin|mesh-list
14568146|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14568147|NCT00003541|Etoposide|etoposide|mesh-list
14568148|NCT00003541|Vincristine|vincristine|mesh-list
14568149|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568150|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
14568151|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568152|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568153|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568154|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
14568155|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568156|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568157|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568158|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568159|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568160|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568161|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568162|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568163|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
14568164|NCT00003541|Hormones|hormones|mesh-ancestor
14568165|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568166|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568167|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568168|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568169|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568170|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568171|NCT00003542|Interferons|interferons|mesh-list
14568172|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
14568173|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568174|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
14568175|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568176|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
14568177|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568178|NCT00003543|Fluorouracil|fluorouracil|mesh-list
14568179|NCT00003543|Vincristine|vincristine|mesh-list
14568180|NCT00003543|Carmustine|carmustine|mesh-list
14568181|NCT00003543|Streptozocin|streptozocin|mesh-list
14568182|NCT00003543|Antibodies|antibodies|mesh-list
14568183|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14568184|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
14568185|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568186|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
14568187|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568188|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568189|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568190|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568191|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568192|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568193|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568194|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568195|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568196|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
14568197|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568198|NCT00003544|Irinotecan|irinotecan|mesh-list
14568199|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14568200|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568201|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568202|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568203|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568204|NCT00003546|Gemcitabine|gemcitabine|mesh-list
14568205|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568206|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
14568207|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568208|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568209|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
15149947|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
15149948|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
15149949|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14568210|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568211|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568212|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568213|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
14568214|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568215|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
14568216|NCT00003549|Fluorouracil|fluorouracil|mesh-list
14568217|NCT00003549|Methotrexate|methotrexate|mesh-list
14568218|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568219|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
14568220|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568221|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568222|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568223|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
14568224|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568225|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568226|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568227|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
14568228|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568229|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14568230|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
14568231|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14568232|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568233|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568234|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14568235|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14568236|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
15149950|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149951|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15149952|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
15149953|NCT04217148|Hormones|hormones|mesh-ancestor
15149954|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15149955|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15149956|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149957|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
15149958|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149959|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149960|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
15149961|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
15180047|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180048|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
15180049|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180050|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568237|NCT00003552|Fludarabine|fludarabine|mesh-list
14568238|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14568239|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568240|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
14568241|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568242|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568243|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568244|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
14568245|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568246|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568247|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568248|NCT00003554|Prednisone|prednisone|mesh-list
14568249|NCT00003554|Rituximab|rituximab|mesh-list
14568250|NCT00003554|Melphalan|melphalan|mesh-list
14568251|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14568252|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568253|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
14568254|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568255|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568256|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568257|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
14568258|NCT00003554|Hormones|hormones|mesh-ancestor
14568259|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568260|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15180051|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15180052|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
14291357|NCT00553514|Hormones|hormones|mesh-ancestor
14291358|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291359|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291360|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14291361|NCT00553605|Ketoprofen|ketoprofen|mesh-list
14291362|NCT00553605|Parecoxib|parecoxib|mesh-list
14291363|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14291364|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14291365|NCT00553605|Analgesics|analgesics|mesh-ancestor
14291366|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
14568261|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568262|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
14568263|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568264|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568265|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568266|NCT00003555|Paclitaxel|paclitaxel|mesh-list
14568267|NCT00003555|Amifostine|amifostine|mesh-list
14568268|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568269|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568270|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568271|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568272|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568273|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568274|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14568275|NCT00003555|Protective Agents|protective agents|mesh-ancestor
14568276|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568277|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
14568278|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568279|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568280|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568281|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568282|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568283|NCT00003558|Leucovorin|leucovorin|mesh-list
14568284|NCT00003558|Paclitaxel|paclitaxel|mesh-list
14568285|NCT00003558|Etoposide|etoposide|mesh-list
14568286|NCT00003558|Carboplatin|carboplatin|mesh-list
14568287|NCT00003558|Fluorouracil|fluorouracil|mesh-list
14568288|NCT00003558|Calcium|calcium|mesh-list
14568289|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
14568290|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568291|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568292|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568293|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568294|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568295|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568296|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14568297|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568298|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
14568299|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568300|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568301|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
14568302|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568303|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568304|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568305|NCT00003558|Antidotes|antidotes|mesh-ancestor
14568306|NCT00003558|Protective Agents|protective agents|mesh-ancestor
14568307|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
14568308|NCT00003558|Vitamins|vitamins|mesh-ancestor
14568309|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
14643773|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643774|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
14643775|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14643776|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14643777|NCT00190307|Aspirin|aspirin|mesh-list
14643778|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14643779|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14643780|NCT00190307|Analgesics|analgesics|mesh-ancestor
14643781|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
14643782|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643783|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643784|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14643785|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14643786|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14643787|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14643788|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643789|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14643790|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14643791|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643792|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
14643793|NCT00190333|Citalopram|citalopram|mesh-list
14643794|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14643795|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643796|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643797|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643798|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15149962|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
14568310|NCT00003560|Carboplatin|carboplatin|mesh-list
14568311|NCT00003560|Docetaxel|docetaxel|mesh-list
14568312|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568313|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568314|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568315|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568316|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568317|NCT00003561|Interferons|interferons|mesh-list
14568318|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
14568319|NCT00003561|Sargramostim|sargramostim|mesh-list
14568320|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568321|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
14568322|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568323|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
14568324|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568325|NCT00003562|Carboplatin|carboplatin|mesh-list
14568326|NCT00003562|Docetaxel|docetaxel|mesh-list
14568327|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568328|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568329|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568330|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568331|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568332|NCT00003564|Procarbazine|procarbazine|mesh-list
14568333|NCT00003564|Isotretinoin|isotretinoin|mesh-list
14568334|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568335|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568336|NCT00003565|Docetaxel|docetaxel|mesh-list
14568337|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568338|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149963|NCT04216836|Antacids|antacids|mesh-ancestor
14568339|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568340|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568341|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568342|NCT00003567|Temozolomide|temozolomide|mesh-list
14568343|NCT00003567|Carmustine|carmustine|mesh-list
14568344|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14568345|NCT00003567|Sargramostim|sargramostim|mesh-list
14568346|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
14568347|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568348|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568349|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
14568350|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568351|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568352|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568353|NCT00003568|Aldesleukin|aldesleukin|mesh-list
14568354|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
14568355|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568356|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14568357|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14568358|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
14568359|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568360|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14568361|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
14568362|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568363|NCT00003569|Paclitaxel|paclitaxel|mesh-list
14568364|NCT00003569|Cisplatin|cisplatin|mesh-list
14568365|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568366|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568367|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568368|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568369|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568370|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568371|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
14568372|NCT00003572|Tacrolimus|tacrolimus|mesh-list
14568373|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568374|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
14568375|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568376|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14568377|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568378|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568379|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568380|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568381|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14568382|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
14568383|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14568384|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568385|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
14568386|NCT00003573|Cisplatin|cisplatin|mesh-list
14568387|NCT00003573|Etoposide|etoposide|mesh-list
14568388|NCT00003573|Vincristine|vincristine|mesh-list
14568389|NCT00003573|Lenograstim|lenograstim|mesh-list
14568390|NCT00003573|Sargramostim|sargramostim|mesh-list
14568391|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568392|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
14568393|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568394|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568395|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568396|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
14568397|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568398|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568399|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568400|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568401|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568402|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568403|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568404|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15149964|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149965|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15149966|NCT04217096|Paclitaxel|paclitaxel|mesh-list
14568405|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568406|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568407|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568408|NCT00003575|Etoposide|etoposide|mesh-list
14568409|NCT00003575|Ifosfamide|ifosfamide|mesh-list
14568410|NCT00003575|Interleukin-12|interleukin-12|mesh-list
14568411|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568412|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568413|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568414|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568415|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568416|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568417|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14568418|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
14568419|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568420|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568421|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
14568422|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14568423|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14568424|NCT00003575|Growth Substances|growth substances|mesh-ancestor
15149967|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15149968|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149969|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149970|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
15149971|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149972|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149973|NCT04216758|Gemcitabine|gemcitabine|mesh-list
14568425|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
14568426|NCT00003576|Fluorouracil|fluorouracil|mesh-list
14568427|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568428|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
14568429|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568430|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568431|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568432|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
14568433|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568434|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
14568435|NCT00003577|Fluorouracil|fluorouracil|mesh-list
14568436|NCT00003577|Methotrexate|methotrexate|mesh-list
14568437|NCT00003577|Epirubicin|epirubicin|mesh-list
14568438|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568439|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
14568440|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568441|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568442|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568443|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
14568444|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568445|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568446|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568447|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
14568448|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643799|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
15149974|NCT04216758|Paclitaxel|paclitaxel|mesh-list
15149975|NCT04216758|Tegafur|tegafur|mesh-list
14568449|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14568450|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
14568451|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14568452|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568453|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568454|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14568455|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14568456|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568457|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568458|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568459|NCT00003578|Cytarabine|cytarabine|mesh-list
14568460|NCT00003578|Prednisone|prednisone|mesh-list
14568461|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
14568462|NCT00003578|Melphalan|melphalan|mesh-list
14568463|NCT00003578|Carmustine|carmustine|mesh-list
14568464|NCT00003578|Doxorubicin|doxorubicin|mesh-list
14568465|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14568466|NCT00003578|Etoposide|etoposide|mesh-list
14568467|NCT00003578|Vincristine|vincristine|mesh-list
14568468|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568469|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
14568470|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568471|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15149976|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15149977|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15149978|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
15149979|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
15149980|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
15149981|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149982|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15149983|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
15149984|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
14568472|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568473|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
14568474|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568475|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568476|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568477|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568478|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568479|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568480|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568481|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568482|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
14568483|NCT00003578|Hormones|hormones|mesh-ancestor
14568484|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568485|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568486|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568487|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568488|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
14568489|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
14568490|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568491|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568492|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568493|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568494|NCT00003580|Amifostine|amifostine|mesh-list
14568495|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14568496|NCT00003580|Protective Agents|protective agents|mesh-ancestor
14568497|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568498|NCT00003582|Paclitaxel|paclitaxel|mesh-list
14568499|NCT00003582|Fluorouracil|fluorouracil|mesh-list
14568500|NCT00003582|Amifostine|amifostine|mesh-list
14568501|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568502|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568503|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568504|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
15149985|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149986|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15149987|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15149988|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
14021064|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14568505|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568506|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568507|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
14568508|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568509|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021065|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14568510|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
14568511|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568512|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14568513|NCT00003582|Protective Agents|protective agents|mesh-ancestor
14568514|NCT00003583|Etoposide|etoposide|mesh-list
14568515|NCT00003583|Amifostine|amifostine|mesh-list
14568516|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568517|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568518|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568519|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568520|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568521|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568522|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14568523|NCT00003583|Protective Agents|protective agents|mesh-ancestor
14568524|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568525|NCT00003584|Prednisone|prednisone|mesh-list
14568526|NCT00003584|Estramustine|estramustine|mesh-list
14568527|NCT00003584|Vinorelbine|vinorelbine|mesh-list
14568528|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568529|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
14568530|NCT00003584|Hormones|hormones|mesh-ancestor
14568531|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568532|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568533|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568534|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568535|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568536|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568537|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568538|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568539|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568540|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568541|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
14568542|NCT00003585|Interferons|interferons|mesh-list
14568543|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
14568544|NCT00003585|Aldesleukin|aldesleukin|mesh-list
14568545|NCT00003585|Fluorouracil|fluorouracil|mesh-list
14568546|NCT00003585|Isotretinoin|isotretinoin|mesh-list
14568547|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
14568548|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568549|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568550|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568551|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568552|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
14568553|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568554|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
14568555|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568556|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14568557|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14568558|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568559|NCT00003587|Gemcitabine|gemcitabine|mesh-list
14568560|NCT00003587|Paclitaxel|paclitaxel|mesh-list
14568561|NCT00003587|Vinorelbine|vinorelbine|mesh-list
14568562|NCT00003587|Docetaxel|docetaxel|mesh-list
14568563|NCT00003587|Carboplatin|carboplatin|mesh-list
14568564|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568565|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568566|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568567|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568568|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568569|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568570|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568571|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
14568572|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
14568573|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15149989|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149990|NCT04216784|Furosemide|furosemide|mesh-list
14568574|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568575|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568576|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
14568577|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568578|NCT00003589|Gemcitabine|gemcitabine|mesh-list
14568579|NCT00003589|Paclitaxel|paclitaxel|mesh-list
14568580|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568581|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568582|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568583|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
15149991|NCT04216784|Diuretics|diuretics|mesh-ancestor
14568584|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568585|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568586|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568587|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
14568588|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
14568589|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568590|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568591|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568592|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
14568593|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568594|NCT00003591|Paclitaxel|paclitaxel|mesh-list
14568595|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568596|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568597|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568598|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568599|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568600|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568601|NCT00003592|Paclitaxel|paclitaxel|mesh-list
14568602|NCT00003592|Methotrexate|methotrexate|mesh-list
14568603|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568604|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568605|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568606|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568607|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568608|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568609|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14568610|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
14568611|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14568612|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568613|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568614|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
14568615|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568616|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568617|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14568618|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568619|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
14568620|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568621|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14568622|NCT00003593|Cytarabine|cytarabine|mesh-list
14568623|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
14568624|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14568625|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14568626|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14568627|NCT00003593|Methotrexate|methotrexate|mesh-list
14568628|NCT00003593|Thioguanine|thioguanine|mesh-list
14568629|NCT00003593|Daunorubicin|daunorubicin|mesh-list
14568630|NCT00003593|Asparaginase|asparaginase|mesh-list
14568631|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14568632|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
14568633|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14568634|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568635|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568636|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
14568637|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568638|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568639|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568640|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568641|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14568642|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568643|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
14568644|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568645|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14568646|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
14568647|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568648|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568649|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568650|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568651|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568652|NCT00003594|Leucovorin|leucovorin|mesh-list
14568653|NCT00003594|Fluorouracil|fluorouracil|mesh-list
14568654|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
14568655|NCT00003594|Irinotecan|irinotecan|mesh-list
14568656|NCT00003594|Calcium|calcium|mesh-list
14021066|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
14021067|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14568657|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
14568658|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14568659|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568660|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
14568661|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568662|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568663|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568664|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568665|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
14568666|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14568667|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568668|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568669|NCT00003594|Antidotes|antidotes|mesh-ancestor
14568670|NCT00003594|Protective Agents|protective agents|mesh-ancestor
14568671|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
14568672|NCT00003594|Vitamins|vitamins|mesh-ancestor
14568673|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
14568674|NCT00003595|Prednisone|prednisone|mesh-list
14568675|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
14568676|NCT00003595|Rituximab|rituximab|mesh-list
14568677|NCT00003595|Doxorubicin|doxorubicin|mesh-list
14568678|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14568679|NCT00003595|Vincristine|vincristine|mesh-list
14568680|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568681|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
14568682|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568683|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568684|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568685|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
14568686|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568687|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568688|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568689|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14568690|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568691|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568692|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568693|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568694|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568695|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
14568696|NCT00003595|Hormones|hormones|mesh-ancestor
14568697|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568698|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568699|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568700|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568701|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568702|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568703|NCT00003596|Fluorouracil|fluorouracil|mesh-list
14568704|NCT00003596|Mitomycins|mitomycins|mesh-list
14568705|NCT00003596|Mitomycin|mitomycin|mesh-list
14568706|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568707|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
14568708|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568709|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568710|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568711|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
14568712|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568713|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568714|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
14568715|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14568716|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568717|NCT00003597|Carboplatin|carboplatin|mesh-list
14568718|NCT00003597|Etoposide|etoposide|mesh-list
14568719|NCT00003597|Ifosfamide|ifosfamide|mesh-list
14568720|NCT00003597|Sargramostim|sargramostim|mesh-list
14568721|NCT00003597|Lenograstim|lenograstim|mesh-list
14568722|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568723|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568724|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568725|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568726|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568727|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568728|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568729|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
14568730|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
14568731|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568732|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14568733|NCT00003598|Tretinoin|tretinoin|mesh-list
14568734|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568735|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
14568736|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568737|NCT00003599|Vitamin E|vitamin e|mesh-list
14568738|NCT00003599|Tocopherols|tocopherols|mesh-list
14568739|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
14568740|NCT00003599|Isotretinoin|isotretinoin|mesh-list
14568741|NCT00003599|Vitamins|vitamins|mesh-ancestor
14568742|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
14568743|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568744|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
14568745|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568746|NCT00003599|Protective Agents|protective agents|mesh-ancestor
14568747|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568748|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
14568749|NCT00003600|Hematinics|hematinics|mesh-ancestor
14568750|NCT00003601|Tretinoin|tretinoin|mesh-list
14568751|NCT00003601|Fenretinide|fenretinide|mesh-list
15149992|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
15149993|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15149994|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15149995|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15149996|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15149997|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
15149998|NCT04216706|Sympatholytics|sympatholytics|mesh-list
15149999|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15150000|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150001|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14568752|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568753|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
14568754|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568755|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14568756|NCT00003601|Protective Agents|protective agents|mesh-ancestor
14568757|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568758|NCT00003602|Cytarabine|cytarabine|mesh-list
14568759|NCT00003602|Etoposide|etoposide|mesh-list
14568760|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
14568761|NCT00003602|Idarubicin|idarubicin|mesh-list
14568762|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568763|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568764|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568765|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568766|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568767|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568768|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568769|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
14568770|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
14568771|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150002|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150003|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
15150004|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150005|NCT04216797|Diazepam|diazepam|mesh-list
15150006|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15150007|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
15150008|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
15150009|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
15150010|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150011|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150012|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150013|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15150014|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150015|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15150016|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15150017|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15150018|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15150019|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15150020|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15150021|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
15150022|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
15150023|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
15150024|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
15150025|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150026|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150027|NCT04216888|Ketamine|ketamine|mesh-list
14568772|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568773|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
14568774|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568775|NCT00003602|Analgesics|analgesics|mesh-ancestor
14568776|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
14568777|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14568778|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568779|NCT00003603|Dexamethasone|dexamethasone|mesh-list
14568780|NCT00003603|Prednisolone|prednisolone|mesh-list
14568781|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
14568782|NCT00003603|Melphalan|melphalan|mesh-list
14568783|NCT00003603|Lomustine|lomustine|mesh-list
14568784|NCT00003603|Idarubicin|idarubicin|mesh-list
14568785|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568786|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
14568787|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568788|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568789|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568790|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
14568791|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568792|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568793|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568794|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14568795|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
14568796|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
15150028|NCT04216888|Analgesics|analgesics|mesh-ancestor
15150029|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
15150030|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150031|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150032|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15150033|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15150034|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
15150035|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
15150036|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150037|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15150038|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14568797|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14568798|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14568799|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
14568800|NCT00003603|Hormones|hormones|mesh-ancestor
14568801|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14568802|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14568803|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568804|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568805|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568806|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568807|NCT00003604|Aldesleukin|aldesleukin|mesh-list
14568808|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568809|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14568810|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14568811|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
14568812|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568813|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
14568814|NCT00003605|Rituximab|rituximab|mesh-list
14568815|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568816|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
14568817|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568818|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568819|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568820|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
14568821|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568822|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568823|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568824|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14568825|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
14568826|NCT00003606|Etoposide|etoposide|mesh-list
14568827|NCT00003606|Epirubicin|epirubicin|mesh-list
14568828|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568829|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
14568830|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568831|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568832|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568833|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
14568834|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568835|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568836|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568837|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568838|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568839|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568840|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568841|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14568842|NCT00003610|Capsaicin|capsaicin|mesh-list
14568843|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
14568844|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568845|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
14568846|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14568847|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568848|NCT00003611|Acitretin|acitretin|mesh-list
14568849|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
14568850|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568851|NCT00003612|Paclitaxel|paclitaxel|mesh-list
14568852|NCT00003612|Carboplatin|carboplatin|mesh-list
14568853|NCT00003612|Trastuzumab|trastuzumab|mesh-list
14568854|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568855|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568856|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568857|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150039|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150040|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150041|NCT04216628|Oxytocin|oxytocin|mesh-list
15150042|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
15150043|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15150044|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150045|NCT04216693|Digoxin|digoxin|mesh-list
15150046|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150047|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15150048|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150049|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150050|NCT04216693|Protective Agents|protective agents|mesh-ancestor
15150051|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150052|NCT04216511|Autoantibodies|autoantibodies|mesh-list
15150053|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
15150054|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150055|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
15150056|NCT04216459|Ascorbic Acid|ascorbic acid|mesh-list
15150057|NCT04216459|Thiamine|thiamine|mesh-list
15150058|NCT04216459|Vitamins|vitamins|mesh-ancestor
15150059|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
15150060|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568858|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150061|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15150062|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15150063|NCT04216459|Antioxidants|antioxidants|mesh-ancestor
15150064|NCT04216459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150065|NCT04216459|Protective Agents|protective agents|mesh-ancestor
14568859|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568860|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14568861|NCT00003613|Carmustine|carmustine|mesh-list
14568862|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14568863|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568864|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
14568865|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568866|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568867|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568868|NCT00003614|Paclitaxel|paclitaxel|mesh-list
14568869|NCT00003614|Estramustine|estramustine|mesh-list
14568870|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150066|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
15150067|NCT04216355|Azacitidine|azacitidine|mesh-list
15150068|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150069|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
15150070|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150071|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568871|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568872|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568873|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568874|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568875|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568876|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568877|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
14568878|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15150072|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150073|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14568879|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
14568880|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568881|NCT00003616|Irinotecan|irinotecan|mesh-list
14568882|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14568883|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568884|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568885|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568886|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568887|NCT00003617|Clarithromycin|clarithromycin|mesh-list
14568888|NCT00003617|Tinidazole|tinidazole|mesh-list
14568889|NCT00003617|Chlorambucil|chlorambucil|mesh-list
14568890|NCT00003617|Omeprazole|omeprazole|mesh-list
14568891|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14568892|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14568893|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14568894|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568895|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568896|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14568897|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568898|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14568899|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14568900|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14568901|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568902|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
14568903|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291367|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291368|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291369|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291370|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291371|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14291372|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291373|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291374|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14291375|NCT00553644|Lenalidomide|lenalidomide|mesh-list
14291376|NCT00553644|Bortezomib|bortezomib|mesh-list
14568904|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14568905|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14568906|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14568907|NCT00003619|Vitamin E|vitamin e|mesh-list
14568908|NCT00003619|Cytarabine|cytarabine|mesh-list
14568909|NCT00003619|Fludarabine|fludarabine|mesh-list
14568910|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
14568911|NCT00003619|Etoposide|etoposide|mesh-list
14568912|NCT00003619|Busulfan|busulfan|mesh-list
14568913|NCT00003619|Topotecan|topotecan|mesh-list
14568914|NCT00003619|Isotretinoin|isotretinoin|mesh-list
14568915|NCT00003619|Vitamins|vitamins|mesh-ancestor
14568916|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
14568917|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568918|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568919|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14568920|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
14568921|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568922|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568923|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
14568924|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568925|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568926|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568927|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568928|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
14568929|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568930|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
14568931|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568932|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14568933|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14568934|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
14568935|NCT00003619|Protective Agents|protective agents|mesh-ancestor
14568936|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568937|NCT00003620|Alvocidib|alvocidib|mesh-list
14568938|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568939|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
14568940|NCT00003620|Growth Substances|growth substances|mesh-ancestor
14568941|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568942|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14568943|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568944|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568945|NCT00003621|Etoposide|etoposide|mesh-list
15150074|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15150075|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15150076|NCT04216771|Cytarabine|cytarabine|mesh-list
15150077|NCT04216771|Idarubicin|idarubicin|mesh-list
15150078|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150079|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
14568946|NCT00003621|Carmustine|carmustine|mesh-list
15150080|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568947|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568948|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568949|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568950|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568951|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568952|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568953|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14568954|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
14568955|NCT00003622|Paclitaxel|paclitaxel|mesh-list
14568956|NCT00003622|Vinorelbine|vinorelbine|mesh-list
14568957|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568958|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568959|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150081|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150082|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
15150083|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150084|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150085|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
15150086|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150087|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15150088|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150089|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150090|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150091|NCT04216550|Apatinib|apatinib|mesh-list
15150092|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150093|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15150094|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568960|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568961|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568962|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568963|NCT00003624|Paclitaxel|paclitaxel|mesh-list
14568964|NCT00003624|Amifostine|amifostine|mesh-list
14568965|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568966|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568967|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568968|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568969|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568970|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568971|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14568972|NCT00003624|Protective Agents|protective agents|mesh-ancestor
14568973|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568974|NCT00003625|Cyclosporine|cyclosporine|mesh-list
14568975|NCT00003625|Etoposide|etoposide|mesh-list
14568976|NCT00003625|Vincristine|vincristine|mesh-list
14568977|NCT00003625|Cyclosporins|cyclosporins|mesh-list
14568978|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14568979|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568980|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14568981|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14568982|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14568983|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568984|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150095|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150096|NCT04216472|Paclitaxel|paclitaxel|mesh-list
14291377|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
14291378|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291379|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14291380|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14291381|NCT00553644|Growth Substances|growth substances|mesh-ancestor
14291382|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
14291383|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291384|NCT00553696|Sunitinib|sunitinib|mesh-list
14291385|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291386|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14291387|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14291388|NCT00553696|Growth Substances|growth substances|mesh-ancestor
14291389|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150097|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15150098|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
15150099|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150100|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150101|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150102|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150103|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150104|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150105|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150106|NCT04216186|Ubiquinone|ubiquinone|mesh-list
15150107|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
15150108|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15150109|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15150110|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15150111|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15150112|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150113|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
15150114|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150115|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150116|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
14568985|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568986|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
14568987|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14568988|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
14568989|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14568990|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
15150117|NCT04216186|Vitamins|vitamins|mesh-ancestor
15150118|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15150119|NCT04216017|Lidocaine|lidocaine|mesh-list
15150120|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
15150121|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
15150122|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150123|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150124|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
15150125|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150126|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150127|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15150128|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15150129|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15150130|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14568991|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14568992|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
14568993|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14568994|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14568995|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
14568996|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14568997|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14568998|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14568999|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569000|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569001|NCT00003627|Fluorouracil|fluorouracil|mesh-list
14569002|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569003|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
14569004|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569005|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569006|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569007|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
14569008|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569009|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
14569010|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569011|NCT00003632|Cytarabine|cytarabine|mesh-list
14569012|NCT00003632|Methotrexate|methotrexate|mesh-list
14569013|NCT00003632|Etoposide|etoposide|mesh-list
14569014|NCT00003632|Melphalan|melphalan|mesh-list
14569015|NCT00003632|Carmustine|carmustine|mesh-list
14569016|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14569017|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569018|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569019|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150131|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150132|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
15150133|NCT04216017|Hormones|hormones|mesh-ancestor
15150134|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569020|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569021|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
14569022|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569023|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569024|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569025|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569026|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569027|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569028|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
14569029|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569030|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569031|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569032|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569033|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569034|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
14569035|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569036|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569037|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
14569038|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569039|NCT00003633|Prednisone|prednisone|mesh-list
14569040|NCT00003633|Docetaxel|docetaxel|mesh-list
14569041|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
14569042|NCT00003633|Estramustine|estramustine|mesh-list
14569043|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569044|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569045|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569046|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569047|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150135|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150136|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
15150137|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
14569048|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569049|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
14569050|NCT00003633|Hormones|hormones|mesh-ancestor
14569051|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569052|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569053|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569054|NCT00003633|Analgesics|analgesics|mesh-ancestor
14569055|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
14569056|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569057|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569058|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569059|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150138|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15150139|NCT04215653|Rabeprazole|rabeprazole|mesh-list
15150140|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15150141|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150142|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15150143|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150144|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150145|NCT04215731|Leucovorin|leucovorin|mesh-list
15150146|NCT04215731|Bevacizumab|bevacizumab|mesh-list
15150147|NCT04215731|Fluorouracil|fluorouracil|mesh-list
15150148|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
15150149|NCT04215731|Irinotecan|irinotecan|mesh-list
15150150|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
15150151|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150152|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150153|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15150154|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15150155|NCT04215731|Growth Substances|growth substances|mesh-ancestor
14291390|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
14291391|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291392|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291393|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291394|NCT00553735|Cyclosporine|cyclosporine|mesh-list
14291395|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
14291396|NCT00553735|Cyclosporins|cyclosporins|mesh-list
14291397|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291398|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291399|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291400|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
14291401|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291402|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
14291403|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291404|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291405|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291406|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14569060|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569061|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
14569062|NCT00003634|Oregovomab|oregovomab|mesh-list
14569063|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14569064|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569065|NCT00003636|Carboplatin|carboplatin|mesh-list
14569066|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569067|NCT00003637|Fluorouracil|fluorouracil|mesh-list
14569068|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569069|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
14569070|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569071|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569072|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569073|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
14569074|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569075|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
14569076|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14569077|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
14569078|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569079|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
14569080|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569081|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569082|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569083|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
14569084|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569085|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569086|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569087|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14569088|NCT00003639|Interferons|interferons|mesh-list
14569089|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
14569090|NCT00003639|Dexamethasone|dexamethasone|mesh-list
14569091|NCT00003639|Idarubicin|idarubicin|mesh-list
14569092|NCT00003639|Chlorambucil|chlorambucil|mesh-list
14569093|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569094|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
14569095|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
14569096|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569097|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569098|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569099|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
14569100|NCT00003639|Hormones|hormones|mesh-ancestor
14569101|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569102|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14021068|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021069|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14021070|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14569103|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569104|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
14569105|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569106|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
14569107|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569108|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569109|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569110|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569111|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569112|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569113|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
15150156|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150157|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
15150158|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
15150159|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150160|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150161|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150162|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
15150163|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15150164|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569114|NCT00003640|Doxorubicin|doxorubicin|mesh-list
14569115|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569116|NCT00003640|Methotrexate|methotrexate|mesh-list
14569117|NCT00003640|Vinblastine|vinblastine|mesh-list
14569118|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569119|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569120|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150165|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150166|NCT04215731|Antidotes|antidotes|mesh-ancestor
14569121|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569122|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569123|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569124|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14569125|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569126|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569127|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569128|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150167|NCT04215731|Protective Agents|protective agents|mesh-ancestor
15150168|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
15150169|NCT04215731|Vitamins|vitamins|mesh-ancestor
14569129|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
14569130|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569131|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569132|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569133|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
14569134|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569135|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569136|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569137|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569138|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569139|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569140|NCT00003642|Fluorouracil|fluorouracil|mesh-list
14569141|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569142|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
14569143|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569144|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569145|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569146|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
14569147|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569148|NCT00003643|Paclitaxel|paclitaxel|mesh-list
15150170|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
15150171|NCT04215614|Lidocaine|lidocaine|mesh-list
15150172|NCT04215614|Bupivacaine|bupivacaine|mesh-list
15150173|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
15150174|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
15150175|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150176|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150177|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
15150178|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150179|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150180|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15150181|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15150182|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15150183|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569149|NCT00003643|Etoposide|etoposide|mesh-list
14569150|NCT00003643|Bleomycin|bleomycin|mesh-list
14569151|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569152|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569153|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569154|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569155|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569156|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569157|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569158|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569159|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569160|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569161|NCT00003647|Dacarbazine|dacarbazine|mesh-list
14569162|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569163|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
14569164|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569165|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569166|NCT00003650|Cytarabine|cytarabine|mesh-list
14569167|NCT00003650|Dexamethasone|dexamethasone|mesh-list
14569168|NCT00003650|Prednisone|prednisone|mesh-list
14569169|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
14569170|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
14569171|NCT00003650|Methotrexate|methotrexate|mesh-list
14569172|NCT00003650|Etoposide|etoposide|mesh-list
14569173|NCT00003650|Vincristine|vincristine|mesh-list
14569174|NCT00003650|Daunorubicin|daunorubicin|mesh-list
14569175|NCT00003650|Asparaginase|asparaginase|mesh-list
14569176|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
14569177|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
14569178|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569179|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
14569180|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569181|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569182|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569183|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
14569184|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569185|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569186|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569187|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569188|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
14569189|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
14569190|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569191|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569192|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
14569193|NCT00003650|Hormones|hormones|mesh-ancestor
14569194|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569195|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569196|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15150184|NCT04215588|Hemostatics|hemostatics|mesh-list
15150185|NCT04215588|Coagulants|coagulants|mesh-ancestor
15150186|NCT04215835|Letrozole|letrozole|mesh-list
15150187|NCT04215835|Misoprostol|misoprostol|mesh-list
15150188|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150189|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15150190|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15150191|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150192|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150193|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15150194|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
15150195|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15150196|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150197|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15150198|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
15150199|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15150200|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15150201|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569197|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569198|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569199|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569200|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
14569201|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569202|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569203|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569204|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569205|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569206|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569207|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569208|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
14569209|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569210|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569211|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569212|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569213|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14569214|NCT00003650|Protective Agents|protective agents|mesh-ancestor
14569215|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569216|NCT00003650|Analgesics|analgesics|mesh-ancestor
14569217|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
14569218|NCT00003652|Fluorouracil|fluorouracil|mesh-list
14569219|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569220|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
14569221|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569222|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569223|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569224|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
14569225|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569226|NCT00003653|Leuprolide|leuprolide|mesh-list
14569227|NCT00003653|Goserelin|goserelin|mesh-list
14569228|NCT00003653|Flutamide|flutamide|mesh-list
14569229|NCT00003653|Bicalutamide|bicalutamide|mesh-list
14569230|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
14569231|NCT00003653|Nilutamide|nilutamide|mesh-list
14569232|NCT00003653|Buserelin|buserelin|mesh-list
14569233|NCT00003653|Cyproterone|cyproterone|mesh-list
14569234|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14569235|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
14569236|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569237|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150202|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
14569238|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569239|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569240|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
14569241|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
14569242|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569243|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14569244|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
14569245|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14569246|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14569247|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569248|NCT00003657|Carboplatin|carboplatin|mesh-list
14569249|NCT00003657|Etoposide|etoposide|mesh-list
14569250|NCT00003657|Ifosfamide|ifosfamide|mesh-list
14569251|NCT00003657|Amifostine|amifostine|mesh-list
14569252|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569253|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569254|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569255|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569256|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569257|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569258|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569259|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569260|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
14569261|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14569262|NCT00003657|Protective Agents|protective agents|mesh-ancestor
14569263|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
14569264|NCT00003658|Rituximab|rituximab|mesh-list
14569265|NCT00003658|Pentostatin|pentostatin|mesh-list
14569266|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569267|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
14569268|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569269|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569270|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569271|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
14569272|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569273|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569274|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569275|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14569276|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14569277|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569278|NCT00003661|Cyclosporine|cyclosporine|mesh-list
14569279|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
14569280|NCT00003661|Melphalan|melphalan|mesh-list
14569281|NCT00003661|Busulfan|busulfan|mesh-list
14569282|NCT00003661|Cyclosporins|cyclosporins|mesh-list
14569283|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14569284|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569285|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569286|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569287|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
14569288|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569289|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
14569290|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569291|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569292|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569293|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14569294|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569295|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
14569296|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
14569297|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569298|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569299|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
14569300|NCT00003661|Hormones|hormones|mesh-ancestor
14569301|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569302|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14569303|NCT00003661|Protective Agents|protective agents|mesh-ancestor
14569304|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569305|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569306|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
14569307|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569308|NCT00003662|Cyclosporine|cyclosporine|mesh-list
14569309|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
14569310|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
14569311|NCT00003662|Melphalan|melphalan|mesh-list
14569312|NCT00003662|Busulfan|busulfan|mesh-list
14569313|NCT00003662|Cyclosporins|cyclosporins|mesh-list
14569314|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14569315|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569316|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
14569317|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569318|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569319|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569320|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
14569321|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569322|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569323|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569324|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569325|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
14569326|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569327|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
15150203|NCT04215770|Penicillins|penicillins|mesh-list
15150204|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15150205|NCT04215770|Penicillin G|penicillin g|mesh-list
15150206|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
15150207|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
15150208|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15150209|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150210|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14569328|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14569329|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569330|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
14569331|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
14569332|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569333|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569334|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
14569335|NCT00003662|Hormones|hormones|mesh-ancestor
14569336|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569337|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14569338|NCT00003662|Protective Agents|protective agents|mesh-ancestor
14569339|NCT00003663|Dexamethasone|dexamethasone|mesh-list
14569340|NCT00003663|Rituximab|rituximab|mesh-list
14569341|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150211|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150212|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150213|NCT04215536|Empagliflozin|empagliflozin|mesh-list
15150214|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15150215|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15150216|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150217|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14021071|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14021072|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14021073|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
14021074|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
14291407|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14569342|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
14569343|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
14569344|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569345|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569346|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569347|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
14569348|NCT00003663|Hormones|hormones|mesh-ancestor
14569349|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569350|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569351|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569352|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14569353|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
14569354|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569355|NCT00003664|Gemcitabine|gemcitabine|mesh-list
14569356|NCT00003664|Interferons|interferons|mesh-list
14569357|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
14569358|NCT00003664|Aldesleukin|aldesleukin|mesh-list
14569359|NCT00003664|Fluorouracil|fluorouracil|mesh-list
14569360|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569361|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
14291408|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14291409|NCT00553839|Ketamine|ketamine|mesh-list
14291410|NCT00553839|Analgesics|analgesics|mesh-ancestor
14291411|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
14021075|NCT02776137|Docetaxel|docetaxel|mesh-list
14291412|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291413|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291414|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14569362|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569363|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569364|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
14569365|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569366|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569367|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569368|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
14569369|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569370|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14569371|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14569372|NCT00003666|Irofulven|irofulven|mesh-list
14021076|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021077|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14021078|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14021079|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14021080|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021081|NCT02776228|Brotizolam|brotizolam|mesh-list
14021082|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14021083|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021084|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150218|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150219|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
14021085|NCT02776436|Dexamethasone|dexamethasone|mesh-list
14021086|NCT02776436|Prednisone|prednisone|mesh-list
14021087|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021088|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
14021089|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
14021090|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021091|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021092|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021093|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
14021094|NCT02776436|Hormones|hormones|mesh-ancestor
14021095|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021096|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569373|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569374|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
14569375|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569376|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569377|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
14569378|NCT00003667|Doxorubicin|doxorubicin|mesh-list
14569379|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569380|NCT00003667|Vincristine|vincristine|mesh-list
14569381|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
14569382|NCT00003667|Razoxane|razoxane|mesh-list
14569383|NCT00003667|Glycerol|glycerol|mesh-list
14569384|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569385|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
14569386|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569387|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569388|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569389|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
15150220|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150221|NCT04215471|Antibodies|antibodies|mesh-list
15150222|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
15150223|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
15150224|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150225|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15150226|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15180053|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569390|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569391|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569392|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569393|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569394|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569395|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569396|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569397|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569398|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569399|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569400|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569401|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14569402|NCT00003667|Protective Agents|protective agents|mesh-ancestor
14021097|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180054|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021098|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
14569403|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14569404|NCT00003671|Leucovorin|leucovorin|mesh-list
14569405|NCT00003671|Cytarabine|cytarabine|mesh-list
14569406|NCT00003671|Dexamethasone|dexamethasone|mesh-list
14569407|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
14569408|NCT00003671|Methotrexate|methotrexate|mesh-list
14569409|NCT00003671|Vincristine|vincristine|mesh-list
14569410|NCT00003671|Daunorubicin|daunorubicin|mesh-list
14569411|NCT00003671|Asparaginase|asparaginase|mesh-list
14569412|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
14569413|NCT00003671|Thioguanine|thioguanine|mesh-list
14569414|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
14569415|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569416|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
14569417|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569418|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569419|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569420|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
14569421|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569422|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569423|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569424|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569425|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
14569426|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
14569427|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569428|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569429|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
14569430|NCT00003671|Hormones|hormones|mesh-ancestor
14569431|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569432|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569433|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14569434|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569435|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569436|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569437|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
14569438|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569439|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569440|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569441|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569442|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
14569443|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569444|NCT00003671|Antidotes|antidotes|mesh-ancestor
14569445|NCT00003671|Protective Agents|protective agents|mesh-ancestor
14569446|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
14569447|NCT00003671|Vitamins|vitamins|mesh-ancestor
14569448|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
14569449|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150227|NCT04215159|Gemcitabine|gemcitabine|mesh-list
15150228|NCT04215159|Trastuzumab|trastuzumab|mesh-list
15150229|NCT04215159|Irinotecan|irinotecan|mesh-list
15150230|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150231|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
15150232|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150233|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150234|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
15150235|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150236|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150237|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150238|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
15150239|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150240|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150241|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14569450|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569451|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569452|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569453|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569454|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569455|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569456|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
15150242|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150243|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
15150244|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15150245|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15150246|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150247|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14569457|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14569458|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569459|NCT00003674|Dalteparin|dalteparin|mesh-list
14569460|NCT00003674|Tinzaparin|tinzaparin|mesh-list
15150248|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150249|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
15150250|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150251|NCT04215445|Empagliflozin|empagliflozin|mesh-list
15150252|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14569461|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14569462|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
14569463|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15150253|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150254|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14569464|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14569465|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569466|NCT00003675|Topotecan|topotecan|mesh-list
14569467|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14569468|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569469|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569470|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569471|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569472|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
14569473|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569474|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569475|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569476|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569477|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569478|NCT00003678|Tamoxifen|tamoxifen|mesh-list
14569479|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14569480|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
14569481|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569482|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569483|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569484|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569485|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14569486|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14569487|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14569488|NCT00003679|Tamoxifen|tamoxifen|mesh-list
14569489|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
14569490|NCT00003679|Docetaxel|docetaxel|mesh-list
14569491|NCT00003679|Doxorubicin|doxorubicin|mesh-list
14569492|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569493|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569494|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
14569495|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569496|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569497|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569498|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
14569499|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569500|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569501|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569502|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569503|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569504|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569505|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569506|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569507|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569508|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150255|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150256|NCT04215432|Propolis|propolis|mesh-list
15150257|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150258|NCT04215237|Atorvastatin|atorvastatin|mesh-list
15150259|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15150260|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15150261|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
15150262|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150263|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15150264|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15150265|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150266|NCT04214938|Lidocaine|lidocaine|mesh-list
14569509|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14569510|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
14569511|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569512|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14813986|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150267|NCT04214938|Xylometazoline|xylometazoline|mesh-list
14569513|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14569514|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14569515|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14569516|NCT00003680|Tamoxifen|tamoxifen|mesh-list
14569517|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
14569518|NCT00003680|Thiotepa|thiotepa|mesh-list
14569519|NCT00003680|Fluorouracil|fluorouracil|mesh-list
14569520|NCT00003680|Methotrexate|methotrexate|mesh-list
14569521|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569522|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
14569523|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569524|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569525|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569526|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
14569527|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569528|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569529|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569530|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
14569531|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569532|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14569533|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569534|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569535|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569536|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569537|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569538|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569539|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14569540|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
14569541|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569542|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569543|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14569544|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14569545|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14569546|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
14569547|NCT00003681|Amifostine|amifostine|mesh-list
14569548|NCT00003681|Hematinics|hematinics|mesh-ancestor
14569549|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14569550|NCT00003681|Protective Agents|protective agents|mesh-ancestor
14569551|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643800|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643801|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14643802|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643803|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643804|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14643805|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14643806|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643807|NCT00190411|Celiprolol|celiprolol|mesh-list
14643808|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14643809|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14643810|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
14643811|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
14643812|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643813|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643814|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
14643815|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14643816|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14643817|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14643818|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
14643819|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643820|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643821|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
14643822|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14643823|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
14643824|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643825|NCT00190437|Amoxicillin|amoxicillin|mesh-list
14643826|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643827|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643828|NCT00190463|Amphotericin B|amphotericin b|mesh-list
14643829|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14643830|NCT00190463|Amebicides|amebicides|mesh-ancestor
14643831|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14643832|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14021099|NCT02775773|Oxytocin|oxytocin|mesh-list
14021100|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
15150268|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
14569552|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
14569553|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14569554|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14569555|NCT00003682|Prednisolone|prednisolone|mesh-list
14569556|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
14569557|NCT00003682|Doxorubicin|doxorubicin|mesh-list
14569558|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569559|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14569560|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
14569561|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569562|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569563|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569564|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569565|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569566|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569567|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569568|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
14569569|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
14569570|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569571|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569572|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569573|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
14569574|NCT00003682|Hormones|hormones|mesh-ancestor
14569575|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569576|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14569577|NCT00003682|Protective Agents|protective agents|mesh-ancestor
14569578|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569579|NCT00003683|Doxorubicin|doxorubicin|mesh-list
14569580|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569581|NCT00003683|Ifosfamide|ifosfamide|mesh-list
14569582|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569583|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569584|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569585|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569586|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569587|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569588|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569589|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
14569590|NCT00003684|Theophylline|theophylline|mesh-list
14569591|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14569592|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
14569593|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569594|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569595|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14569596|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
14569597|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14569598|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569599|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569600|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
14569601|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14569602|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14569603|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
14569604|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14569605|NCT00003686|Pilocarpine|pilocarpine|mesh-list
14569606|NCT00003686|Miotics|miotics|mesh-ancestor
14569607|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
14569608|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569609|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569610|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14569611|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14569612|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
14569613|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14569614|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569615|NCT00003687|Morphine|morphine|mesh-list
14569616|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
14569617|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14569618|NCT00003687|Narcotics|narcotics|mesh-ancestor
14569619|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14569620|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569621|NCT00003687|Analgesics|analgesics|mesh-ancestor
14569622|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
14569623|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569624|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
14569625|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14569626|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14569627|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14569628|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14569629|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569630|NCT00003688|Dactinomycin|dactinomycin|mesh-list
14569631|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14569632|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569633|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569634|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569635|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14569636|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569637|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569638|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569639|NCT00003690|Carboplatin|carboplatin|mesh-list
14569640|NCT00003690|Alvocidib|alvocidib|mesh-list
14569641|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569642|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
14569643|NCT00003690|Growth Substances|growth substances|mesh-ancestor
14569644|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150269|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
15150270|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150271|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150272|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
15150273|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150274|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150275|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14569645|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14569646|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569647|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569648|NCT00003691|Paclitaxel|paclitaxel|mesh-list
14569649|NCT00003691|Doxorubicin|doxorubicin|mesh-list
14569650|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569651|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569652|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569653|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569654|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569655|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569656|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569657|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569658|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569659|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569660|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569661|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
14569662|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569663|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569664|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569665|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569666|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569667|NCT00003694|Cytarabine|cytarabine|mesh-list
14569668|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
14569669|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569670|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
14569671|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569672|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569673|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
14569674|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569675|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569676|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
14569677|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569678|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569679|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14569680|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569681|NCT00003696|Paclitaxel|paclitaxel|mesh-list
14569682|NCT00003696|Etoposide|etoposide|mesh-list
14569683|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
14569684|NCT00003696|Carboplatin|carboplatin|mesh-list
14569685|NCT00003696|Doxorubicin|doxorubicin|mesh-list
14569686|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15150276|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15150277|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15150278|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150279|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
15150280|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15150281|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
14569687|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569688|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569689|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569690|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569691|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569692|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569693|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569694|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
14569695|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569696|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569697|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569698|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
14569699|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569700|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569701|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569702|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569703|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569704|NCT00003697|Vadimezan|vadimezan|mesh-list
14569705|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150282|NCT04214990|Aspirin|aspirin|mesh-list
15150283|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15150284|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14569706|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
14569707|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569708|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569709|NCT00003700|Leucovorin|leucovorin|mesh-list
14569710|NCT00003700|Cytarabine|cytarabine|mesh-list
14569711|NCT00003700|Prednisone|prednisone|mesh-list
14569712|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
14569713|NCT00003700|Methotrexate|methotrexate|mesh-list
14569714|NCT00003700|Vincristine|vincristine|mesh-list
14569715|NCT00003700|Daunorubicin|daunorubicin|mesh-list
14569716|NCT00003700|Asparaginase|asparaginase|mesh-list
14569717|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
14569718|NCT00003700|Allopurinol|allopurinol|mesh-list
14569719|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
14569720|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150285|NCT04214990|Analgesics|analgesics|mesh-ancestor
15150286|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
15150287|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150288|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150289|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150290|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569721|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
14569722|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569723|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569724|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569725|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
14569726|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569727|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569728|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569729|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569730|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
14569731|NCT00003700|Hormones|hormones|mesh-ancestor
14569732|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569733|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569734|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14569735|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569736|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569737|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569738|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
14569739|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569740|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569741|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569742|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569743|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
14569744|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569745|NCT00003700|Antidotes|antidotes|mesh-ancestor
14569746|NCT00003700|Protective Agents|protective agents|mesh-ancestor
14569747|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
14569748|NCT00003700|Vitamins|vitamins|mesh-ancestor
14569749|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
14569750|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150291|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14569751|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569752|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569753|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569754|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569755|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569756|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569757|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
14569758|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14569759|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
14569760|NCT00003701|Paclitaxel|paclitaxel|mesh-list
14569761|NCT00003701|Vinblastine|vinblastine|mesh-list
14569762|NCT00003701|Carboplatin|carboplatin|mesh-list
14569763|NCT00003701|Doxorubicin|doxorubicin|mesh-list
14569764|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569765|NCT00003701|Methotrexate|methotrexate|mesh-list
14569766|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569767|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569768|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569769|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569770|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569771|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569772|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569773|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569774|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569775|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569776|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14569777|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569778|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569779|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569780|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569781|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
15150292|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15150293|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150294|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15150295|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14569782|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569783|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569784|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569785|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
14569786|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569787|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569788|NCT00003704|Capecitabine|capecitabine|mesh-list
14569789|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569790|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
14569791|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569792|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569793|NCT00003706|Pemetrexed|pemetrexed|mesh-list
14569794|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569795|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569796|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569797|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569798|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569799|NCT00003707|Gemcitabine|gemcitabine|mesh-list
14569800|NCT00003707|Tipifarnib|tipifarnib|mesh-list
15150296|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150297|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
15150298|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
14021101|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14021102|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291415|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14291416|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
14291417|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
14021103|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14569801|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569802|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
14569803|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569804|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569805|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
14569806|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569807|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569808|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569809|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
14569810|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150299|NCT04214886|Fludarabine|fludarabine|mesh-list
14021104|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14291418|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291419|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14291420|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14291421|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150300|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150301|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
15150302|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150303|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150304|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569811|NCT00003708|Temozolomide|temozolomide|mesh-list
14569812|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569813|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
14569814|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569815|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569816|NCT00003709|Carbendazim|carbendazim|mesh-list
14569817|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
14569818|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
14569819|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14569820|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569821|NCT00003710|Irinotecan|irinotecan|mesh-list
14569822|NCT00003710|Mitomycins|mitomycins|mesh-list
14569823|NCT00003710|Mitomycin|mitomycin|mesh-list
14569824|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14569825|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569826|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569827|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569828|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569829|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569830|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
14569831|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569832|NCT00003711|Irinotecan|irinotecan|mesh-list
14569833|NCT00003711|Pemetrexed|pemetrexed|mesh-list
14569834|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14569835|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569836|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569837|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569838|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569839|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14569840|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14569841|NCT00003712|Sirolimus|sirolimus|mesh-list
14569842|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14569843|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569844|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569845|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569846|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
14569847|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569848|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
14569849|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150305|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
15150306|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150307|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150308|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15150309|NCT04214977|Anesthetics|anesthetics|mesh-list
15150310|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150311|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150312|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
15150313|NCT04214821|Levofloxacin|levofloxacin|mesh-list
15150314|NCT04214821|Ofloxacin|ofloxacin|mesh-list
15150315|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15150316|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15150317|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15150318|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150319|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150320|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150321|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569850|NCT00003714|NSC 366140|nsc 366140|mesh-list
14569851|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569852|NCT00003715|Interferons|interferons|mesh-list
14569853|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
14569854|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
14569855|NCT00003715|Vaccines|vaccines|mesh-list
14569856|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
14569857|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
14569858|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569859|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569860|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569861|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569862|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
14569863|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569864|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150322|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150323|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569865|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569866|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
14569867|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569868|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14569869|NCT00003716|Rituximab|rituximab|mesh-list
14569870|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14569871|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569872|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
14569873|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569874|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569875|NCT00003717|Paclitaxel|paclitaxel|mesh-list
14569876|NCT00003717|Estramustine|estramustine|mesh-list
14569877|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569878|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569879|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14569880|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14569881|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14569882|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569883|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569884|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
14569885|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569886|NCT00003718|Temozolomide|temozolomide|mesh-list
14569887|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569888|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
14569889|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569890|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569891|NCT00003719|Irinotecan|irinotecan|mesh-list
14569892|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14569893|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569894|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569895|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569896|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569897|NCT00003720|Semaxinib|semaxinib|mesh-list
14569898|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14569899|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14569900|NCT00003720|Growth Substances|growth substances|mesh-ancestor
14569901|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569902|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
14569903|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569904|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14569905|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569906|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569907|NCT00003723|Gemcitabine|gemcitabine|mesh-list
14569908|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569909|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
15150324|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15150325|NCT04214821|Renal Agents|renal agents|mesh-ancestor
15150326|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15150327|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15150328|NCT04214808|Dutasteride|dutasteride|mesh-list
15150329|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15150330|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14021105|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021106|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
14021107|NCT02775773|Coagulants|coagulants|mesh-ancestor
14021108|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14021109|NCT02775968|Azithromycin|azithromycin|mesh-list
14021110|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
14021111|NCT02775968|Erythromycin|erythromycin|mesh-list
14021112|NCT02775968|Cephalosporins|cephalosporins|mesh-list
14021113|NCT02775968|Cefamandole|cefamandole|mesh-list
14021114|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569910|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569911|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021115|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021116|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14021117|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021118|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569912|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
14569913|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021119|NCT02776059|Prednisolone|prednisolone|mesh-list
14569914|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569915|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569916|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
14569917|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569918|NCT00003725|Valrubicin|valrubicin|mesh-list
14569919|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569920|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569921|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569922|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569923|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569924|NCT00003727|Gemcitabine|gemcitabine|mesh-list
14569925|NCT00003727|Interferons|interferons|mesh-list
14813987|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150331|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150332|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150333|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
15150334|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15150335|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150336|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
15150337|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
15150338|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150339|NCT04214665|Protective Agents|protective agents|mesh-ancestor
15150340|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150341|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
15150342|NCT04214665|Vitamins|vitamins|mesh-ancestor
15150343|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
15150344|NCT04214834|Morphine|morphine|mesh-list
15150345|NCT04214834|Methadone|methadone|mesh-list
15150346|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15150347|NCT04214834|Narcotics|narcotics|mesh-ancestor
15150348|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150349|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150350|NCT04214834|Analgesics|analgesics|mesh-ancestor
15150351|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
15150352|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150353|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
15150354|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
14813988|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
14813989|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14813990|NCT00861094|Antidotes|antidotes|mesh-ancestor
14813991|NCT00861094|Protective Agents|protective agents|mesh-ancestor
14813992|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
14813993|NCT00861094|Vitamins|vitamins|mesh-ancestor
15150355|NCT04214626|Prednisone|prednisone|mesh-list
14569926|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
15150356|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
15150357|NCT04214626|Rituximab|rituximab|mesh-list
15150358|NCT04214626|Methotrexate|methotrexate|mesh-list
15150359|NCT04214626|Vincristine|vincristine|mesh-list
14569927|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
14569928|NCT00003727|Melphalan|melphalan|mesh-list
14569929|NCT00003727|Carmustine|carmustine|mesh-list
14569930|NCT00003727|Etoposide|etoposide|mesh-list
14569931|NCT00003727|Sargramostim|sargramostim|mesh-list
14569932|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569933|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
14569934|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569935|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569936|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569937|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
14569938|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569939|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569940|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569941|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14569942|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
14569943|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
14569944|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14569945|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569946|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14569947|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569948|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569949|NCT00003728|Leucovorin|leucovorin|mesh-list
14569950|NCT00003728|Cytarabine|cytarabine|mesh-list
15150360|NCT04214626|Lenalidomide|lenalidomide|mesh-list
14569951|NCT00003728|Dexamethasone|dexamethasone|mesh-list
14569952|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
14569953|NCT00003728|Prednisolone|prednisolone|mesh-list
14569954|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
14813994|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
15150361|NCT04214626|Epirubicin|epirubicin|mesh-list
15150362|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569955|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14569956|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14569957|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14569958|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
14569959|NCT00003728|Doxorubicin|doxorubicin|mesh-list
14569960|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14569961|NCT00003728|Methotrexate|methotrexate|mesh-list
14569962|NCT00003728|Etoposide|etoposide|mesh-list
14569963|NCT00003728|Vincristine|vincristine|mesh-list
14569964|NCT00003728|Daunorubicin|daunorubicin|mesh-list
14569965|NCT00003728|Asparaginase|asparaginase|mesh-list
14569966|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
14569967|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
14569968|NCT00003728|Thioguanine|thioguanine|mesh-list
14569969|NCT00003728|Vindesine|vindesine|mesh-list
14569970|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
14569971|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14569972|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
14569973|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14569974|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14569975|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14569976|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
14569977|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14569978|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14569979|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14569980|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14569981|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
14569982|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
14569983|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14569984|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14569985|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
14569986|NCT00003728|Hormones|hormones|mesh-ancestor
14569987|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14569988|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14569989|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14569990|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14569991|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14569992|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14569993|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14569994|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
14569995|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14569996|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150363|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
15150364|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150365|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150366|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15150367|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
15150368|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150369|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150370|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15150371|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150372|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150373|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
15150374|NCT04214626|Hormones|hormones|mesh-ancestor
15150375|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15150376|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15150377|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15150378|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
15150379|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15150380|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15150381|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
15150382|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
15150383|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150384|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15150385|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15150386|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150387|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150388|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150389|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150390|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15150391|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14569997|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
14569998|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
14569999|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14570000|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14021120|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021121|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
14021122|NCT02776059|Hormones|hormones|mesh-ancestor
14021123|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021124|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021125|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570001|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150392|NCT04214626|Growth Substances|growth substances|mesh-ancestor
14021126|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570002|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
14570003|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570004|NCT00003728|Antidotes|antidotes|mesh-ancestor
14570005|NCT00003728|Protective Agents|protective agents|mesh-ancestor
14570006|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570007|NCT00003728|Vitamins|vitamins|mesh-ancestor
14570008|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
14570009|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570010|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570011|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570012|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14570013|NCT00003728|Analgesics|analgesics|mesh-ancestor
14570014|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
14570015|NCT00003729|Cytarabine|cytarabine|mesh-list
14570016|NCT00003729|Fludarabine|fludarabine|mesh-list
14570017|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
14570018|NCT00003729|Idarubicin|idarubicin|mesh-list
14570019|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570020|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570021|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
14570022|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570023|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570024|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
14570025|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570026|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
14570027|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570028|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570029|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570030|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570031|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570032|NCT00003730|Fluorouracil|fluorouracil|mesh-list
14570033|NCT00003730|Vinorelbine|vinorelbine|mesh-list
14570034|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
14570035|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570036|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570037|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570038|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570039|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
14570040|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570041|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570042|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570043|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570044|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150393|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
15150394|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15150395|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150396|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150397|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15150398|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15150399|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
15150400|NCT04214678|Hormones|hormones|mesh-ancestor
14570045|NCT00003731|Temozolomide|temozolomide|mesh-list
14570046|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570047|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
14570048|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570049|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570050|NCT00003732|Paclitaxel|paclitaxel|mesh-list
14570051|NCT00003732|Carboplatin|carboplatin|mesh-list
14570052|NCT00003732|Topotecan|topotecan|mesh-list
15150401|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15150402|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150403|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150404|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150405|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15150406|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14021127|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
14570053|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570054|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570055|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
14021128|NCT02775734|Clomiphene|clomiphene|mesh-list
14021129|NCT02775734|Enclomiphene|enclomiphene|mesh-list
14291422|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570056|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570057|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570058|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570059|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570060|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570061|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570062|NCT00003733|Paclitaxel|paclitaxel|mesh-list
14570063|NCT00003733|Carboplatin|carboplatin|mesh-list
14570064|NCT00003733|Topotecan|topotecan|mesh-list
14570065|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570066|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570067|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570068|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570069|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570070|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570071|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570072|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150407|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150408|NCT04214145|Phenylephrine|phenylephrine|mesh-list
15150409|NCT04214145|Vasopressins|vasopressins|mesh-list
14291423|NCT00553969|Carvedilol|carvedilol|mesh-list
14570073|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570074|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14570075|NCT00003734|Flutamide|flutamide|mesh-list
14570076|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
14570077|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14570078|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
14570079|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14570080|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570081|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14570082|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570083|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570084|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
14570085|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
14570086|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570087|NCT00003735|Topotecan|topotecan|mesh-list
14570088|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
14570089|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570090|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570091|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150410|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
15150411|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
14021130|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
14291424|NCT00553969|Lisinopril|lisinopril|mesh-list
14291425|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14291426|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14291427|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291428|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291429|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291430|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291431|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14291432|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
14291433|NCT00553969|Protective Agents|protective agents|mesh-ancestor
14291434|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14291435|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14291436|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14291437|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
14291438|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14291439|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14291440|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14021131|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14021132|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021133|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14021134|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
14021135|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021136|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021137|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14021138|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
14570092|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570093|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570094|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570095|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
14570096|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570097|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14570098|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14570099|NCT00003739|Lenograstim|lenograstim|mesh-list
14570100|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14570101|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
14570102|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150412|NCT04214145|Norepinephrine|norepinephrine|mesh-list
15150413|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15150414|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
15150415|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
15150416|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150417|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150418|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
15150419|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15150420|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
14570103|NCT00003740|Trastuzumab|trastuzumab|mesh-list
14570104|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14570105|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570106|NCT00003741|Antibodies|antibodies|mesh-list
14570107|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14570108|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
14570109|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570110|NCT00003742|Paclitaxel|paclitaxel|mesh-list
14570111|NCT00003742|Irinotecan|irinotecan|mesh-list
14570112|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570113|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570114|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570115|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570116|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570117|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570118|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570119|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570120|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570121|NCT00003743|Aldesleukin|aldesleukin|mesh-list
14570122|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570123|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14570124|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14570125|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
14570126|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570127|NCT00003744|Gemcitabine|gemcitabine|mesh-list
14570128|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570129|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
14570130|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570131|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570132|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
14570133|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150421|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
15150422|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15150423|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15150424|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15150425|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
15150426|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150427|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150428|NCT04214145|Protective Agents|protective agents|mesh-ancestor
15150429|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
15150430|NCT04214145|Coagulants|coagulants|mesh-ancestor
15150431|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15150432|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
15150433|NCT04214444|Vaccines|vaccines|mesh-list
15150434|NCT04214444|Immunologic Factors|immunologic factors|mesh-ancestor
15150435|NCT04214444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150436|NCT04214106|Thiamine|thiamine|mesh-list
15150437|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
15150438|NCT04214106|Vitamins|vitamins|mesh-ancestor
14291441|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
14291442|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291443|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14291444|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14291445|NCT00554099|Mesalamine|mesalamine|mesh-list
14291446|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291447|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14291448|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14570134|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570135|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570136|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
14570137|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570138|NCT00003745|Topotecan|topotecan|mesh-list
14570139|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570140|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570141|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570142|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570143|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021139|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14021140|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14021141|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14021142|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
14021143|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021144|NCT02775734|Expectorants|expectorants|mesh-ancestor
14021145|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14021146|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14021147|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
14021148|NCT02775734|Protective Agents|protective agents|mesh-ancestor
14021149|NCT02775734|Antidotes|antidotes|mesh-ancestor
14021150|NCT02776397|Vitamin E|vitamin e|mesh-list
14021151|NCT02776397|Tocopherols|tocopherols|mesh-list
14021152|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
14021153|NCT02776397|Vitamins|vitamins|mesh-ancestor
14021154|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
14021155|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150439|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
15150440|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150441|NCT04213924|Ibuprofen|ibuprofen|mesh-list
15150442|NCT04213924|Lidocaine|lidocaine|mesh-list
15150443|NCT04213924|Bupivacaine|bupivacaine|mesh-list
15150444|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
15150445|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
15150446|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150447|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150448|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
15150449|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150450|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150451|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15150452|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15150453|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15150454|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570144|NCT00003746|Cladribine|cladribine|mesh-list
14570145|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570146|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570147|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
14570148|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570149|NCT00003747|Carboplatin|carboplatin|mesh-list
14570150|NCT00003747|Temozolomide|temozolomide|mesh-list
14570151|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570152|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570153|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
14021156|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
15150455|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15150456|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15150457|NCT04213924|Analgesics|analgesics|mesh-ancestor
15150458|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021157|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570154|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570155|NCT00003748|Irinotecan|irinotecan|mesh-list
14570156|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570157|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570158|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570159|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570160|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570161|NCT00003751|Penicillamine|penicillamine|mesh-list
14570162|NCT00003751|Antidotes|antidotes|mesh-ancestor
14570163|NCT00003751|Protective Agents|protective agents|mesh-ancestor
14570164|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570165|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
14570166|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
14813995|NCT00861094|Hematinics|hematinics|mesh-ancestor
15150459|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150460|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14021158|NCT02776397|Protective Agents|protective agents|mesh-ancestor
14813996|NCT00861107|Vaccines|vaccines|mesh-list
14570167|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150461|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150462|NCT04213937|Paclitaxel|paclitaxel|mesh-list
15150463|NCT04213937|Topotecan|topotecan|mesh-list
15150464|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150465|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570168|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570169|NCT00003752|Bexarotene|bexarotene|mesh-list
14570170|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570171|NCT00003753|Dexamethasone|dexamethasone|mesh-list
14570172|NCT00003753|Irinotecan|irinotecan|mesh-list
14570173|NCT00003753|Floxuridine|floxuridine|mesh-list
14570174|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14570175|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
15150466|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150467|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150468|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150469|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150470|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15150471|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150472|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570176|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
14570177|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14570178|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570179|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14570180|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
14570181|NCT00003753|Hormones|hormones|mesh-ancestor
14570182|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570183|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570184|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570185|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570186|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150473|NCT04214054|Calcium|calcium|mesh-list
15150474|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14570187|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570188|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570189|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570190|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
14570191|NCT00003754|Thalidomide|thalidomide|mesh-list
14570192|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
14570193|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570194|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
14570195|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570196|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570197|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570198|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
14570199|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570200|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570201|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570202|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
14570203|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14570204|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570205|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14570206|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14570207|NCT00003754|Growth Substances|growth substances|mesh-ancestor
14570208|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
14570209|NCT00003757|Rituximab|rituximab|mesh-list
15150475|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150476|NCT04213898|Paclitaxel|paclitaxel|mesh-list
15150477|NCT04213898|Epirubicin|epirubicin|mesh-list
15150478|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14570210|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14570211|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570212|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
14570213|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570214|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570215|NCT00003758|Cytarabine|cytarabine|mesh-list
14570216|NCT00003758|Idarubicin|idarubicin|mesh-list
14570217|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570218|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
14570219|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570220|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570221|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
14570222|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150479|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150480|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150481|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570223|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570224|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
14570225|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570226|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570227|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570228|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570229|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570230|NCT00003759|Valrubicin|valrubicin|mesh-list
14570231|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
14570232|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14570233|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
14570234|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570235|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570236|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570237|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570238|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570239|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570240|NCT00003760|Irofulven|irofulven|mesh-list
14570241|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570242|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
14570243|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570244|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570245|NCT00003762|Gemcitabine|gemcitabine|mesh-list
14570246|NCT00003762|Docetaxel|docetaxel|mesh-list
14570247|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570248|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
14570249|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570250|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570251|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
14570252|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570253|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570254|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570255|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
14570256|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570257|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570258|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570259|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570260|NCT00003763|Folic Acid|folic acid|mesh-list
14570261|NCT00003763|Hematinics|hematinics|mesh-ancestor
14570262|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570263|NCT00003763|Vitamins|vitamins|mesh-ancestor
14570264|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
14570265|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570266|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
14570267|NCT00003764|Fludarabine|fludarabine|mesh-list
14570268|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
14570269|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570270|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
14570271|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570272|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570273|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570274|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
14570275|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570276|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570277|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570278|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570279|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
14570280|NCT00003765|Carmustine|carmustine|mesh-list
14570281|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14570282|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570283|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
14570284|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570285|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570286|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570287|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14570288|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570289|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570290|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570291|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
14570292|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570293|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570294|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
14570295|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570296|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643833|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570297|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570298|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14570299|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14570300|NCT00003771|Norethindrone|norethindrone|mesh-list
14570301|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
14570302|NCT00003771|Estradiol|estradiol|mesh-list
14570303|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14570304|NCT00003771|Estrogens|estrogens|mesh-ancestor
14570305|NCT00003771|Hormones|hormones|mesh-ancestor
14570306|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570307|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570308|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14570309|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
14570310|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14570311|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14570312|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14570313|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14570314|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14570315|NCT00003775|Leflunomide|leflunomide|mesh-list
14570316|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570317|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570318|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021159|NCT02775695|Doxycycline|doxycycline|mesh-list
14570319|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
14570320|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570321|NCT00003776|Leucovorin|leucovorin|mesh-list
14570322|NCT00003776|Trimetrexate|trimetrexate|mesh-list
14570323|NCT00003776|Doxorubicin|doxorubicin|mesh-list
14570324|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14570325|NCT00003776|Methotrexate|methotrexate|mesh-list
14570326|NCT00003776|Ifosfamide|ifosfamide|mesh-list
14570327|NCT00003776|Calcium|calcium|mesh-list
14570328|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
14570329|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570330|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570331|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570332|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570333|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570334|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570335|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14570336|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570337|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14570338|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
14570339|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14570340|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570341|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
14570342|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
14570343|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14570344|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150482|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150483|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150484|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150485|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15150486|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570345|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
14570346|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570347|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14570348|NCT00003776|Antidotes|antidotes|mesh-ancestor
14570349|NCT00003776|Protective Agents|protective agents|mesh-ancestor
14570350|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570351|NCT00003776|Vitamins|vitamins|mesh-ancestor
14570352|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
14570353|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570354|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
14570355|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
14570356|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570357|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
14570358|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570359|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150487|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150488|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150489|NCT04213833|Lidocaine|lidocaine|mesh-list
15150490|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
15150491|NCT04213833|Propofol|propofol|mesh-list
14021160|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14570360|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150492|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
14570361|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150493|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
15150494|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150495|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150496|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
15150497|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150498|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150499|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15150500|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15150501|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15150502|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150503|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15150504|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15150505|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
15150506|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15150507|NCT04213833|Analgesics|analgesics|mesh-ancestor
15150508|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15150509|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15150510|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15150511|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
15150512|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150513|NCT04213781|Sufentanil|sufentanil|mesh-list
15150514|NCT04213781|Propofol|propofol|mesh-list
15150515|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15150516|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150517|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570362|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570363|NCT00003780|Gemcitabine|gemcitabine|mesh-list
14570364|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570365|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
14570366|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570367|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570368|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
14570369|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570370|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570371|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150518|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15150519|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
15150520|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
15150521|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15150522|NCT04213781|Narcotics|narcotics|mesh-ancestor
15150523|NCT04213781|Analgesics|analgesics|mesh-ancestor
15150524|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
15150525|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150526|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15150527|NCT04213885|Riboflavin|riboflavin|mesh-list
15150528|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
15150529|NCT04213885|Vitamins|vitamins|mesh-ancestor
14570372|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
14570373|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570374|NCT00003781|Docetaxel|docetaxel|mesh-list
14570375|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570376|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150530|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
14291449|NCT00554099|Analgesics|analgesics|mesh-ancestor
14291450|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
14291451|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291452|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291453|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291454|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291455|NCT00554216|Topiramate|topiramate|mesh-list
14291456|NCT00554216|Phentermine|phentermine|mesh-list
14291457|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
14291458|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14291459|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291460|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14291461|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
14291462|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14291463|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
14291464|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
14291465|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291466|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291467|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291468|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291469|NCT00554463|Etoposide|etoposide|mesh-list
14291470|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570377|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570378|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570379|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570380|NCT00003783|Leucovorin|leucovorin|mesh-list
14570381|NCT00003783|Cytarabine|cytarabine|mesh-list
14570382|NCT00003783|Dexamethasone|dexamethasone|mesh-list
14570383|NCT00003783|Prednisone|prednisone|mesh-list
14570384|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
14570385|NCT00003783|Methotrexate|methotrexate|mesh-list
14570386|NCT00003783|Etoposide|etoposide|mesh-list
14021161|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570387|NCT00003783|Vincristine|vincristine|mesh-list
14570388|NCT00003783|Daunorubicin|daunorubicin|mesh-list
14570389|NCT00003783|Asparaginase|asparaginase|mesh-list
14570390|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
14021162|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
14021163|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14021164|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14570391|NCT00003783|Idarubicin|idarubicin|mesh-list
14570392|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
14570393|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570394|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
14570395|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570396|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570397|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570398|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
14570399|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570400|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570401|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570402|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14570403|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
14570404|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
14570405|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14570406|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14570407|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
14570408|NCT00003783|Hormones|hormones|mesh-ancestor
14570409|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570410|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570411|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14570412|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
14570413|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14570414|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570415|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
14570416|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
14570417|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570418|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14570419|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14570420|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570421|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570422|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570423|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
14570424|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570425|NCT00003783|Antidotes|antidotes|mesh-ancestor
14570426|NCT00003783|Protective Agents|protective agents|mesh-ancestor
14570427|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570428|NCT00003783|Vitamins|vitamins|mesh-ancestor
14570429|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
14570430|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570431|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570432|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570433|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570434|NCT00003784|Prednisone|prednisone|mesh-list
14570435|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
14570436|NCT00003784|Doxorubicin|doxorubicin|mesh-list
14570437|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14570438|NCT00003784|Vincristine|vincristine|mesh-list
14570439|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
14570440|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570441|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
14570442|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570443|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150531|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150532|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15150533|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
14021165|NCT02775877|Letrozole|letrozole|mesh-list
14570444|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570445|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
14570446|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570447|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570448|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570449|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570450|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570451|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570452|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570453|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14570454|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
14570455|NCT00003784|Hormones|hormones|mesh-ancestor
14570456|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570457|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570458|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570459|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570460|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150534|NCT04213378|Paclitaxel|paclitaxel|mesh-list
15150535|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15150536|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150537|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150538|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150539|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150540|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150541|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150542|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
15150543|NCT04213716|Calcium|calcium|mesh-list
15150544|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15150545|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150546|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15150547|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
15150548|NCT04213612|Doxorubicin|doxorubicin|mesh-list
15150549|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15150550|NCT04213612|Vincristine|vincristine|mesh-list
15150551|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150552|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
15150553|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570461|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570462|NCT00003786|Irofulven|irofulven|mesh-list
14570463|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570464|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
14570465|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570466|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570467|NCT00003788|Carmustine|carmustine|mesh-list
14570468|NCT00003788|Lomustine|lomustine|mesh-list
14570469|NCT00003788|Procarbazine|procarbazine|mesh-list
14570470|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14570471|NCT00003788|Trioxsalen|trioxsalen|mesh-list
14570472|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570473|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
14570474|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570475|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570476|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
14570477|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14570478|NCT00003789|Melphalan|melphalan|mesh-list
14570479|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570480|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
14570481|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570482|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570483|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570484|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570485|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
14570486|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570487|NCT00003792|Lenograstim|lenograstim|mesh-list
14570488|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14570489|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
14570490|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643834|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14643835|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
14643836|NCT00190476|Docetaxel|docetaxel|mesh-list
14643837|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643838|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
14643839|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
14643840|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
14643841|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643842|NCT00190489|Docetaxel|docetaxel|mesh-list
14643843|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150554|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150555|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570491|NCT00003796|Irofulven|irofulven|mesh-list
14570492|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570493|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
15150556|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
15150557|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150558|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570494|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570495|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570496|NCT00003797|Gemcitabine|gemcitabine|mesh-list
14570497|NCT00003797|Trastuzumab|trastuzumab|mesh-list
14570498|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570499|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
14570500|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570501|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570502|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
14570503|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570504|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570505|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021166|NCT02775877|Clomiphene|clomiphene|mesh-list
14021167|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021168|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14021169|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14021170|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021171|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021172|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14021173|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
14570506|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
14570507|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570508|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14570509|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
14570510|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570511|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14570512|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14570513|NCT00003799|Leucovorin|leucovorin|mesh-list
14570514|NCT00003799|Fluorouracil|fluorouracil|mesh-list
14570515|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
14570516|NCT00003799|Calcium|calcium|mesh-list
14570517|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
14570518|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14570519|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570520|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
14570521|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570522|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570523|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570524|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570525|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
14570526|NCT00003799|Antidotes|antidotes|mesh-ancestor
14570527|NCT00003799|Protective Agents|protective agents|mesh-ancestor
14570528|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570529|NCT00003799|Vitamins|vitamins|mesh-ancestor
14570530|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
14570531|NCT00003802|NSC 366140|nsc 366140|mesh-list
14570532|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570533|NCT00003803|Gemcitabine|gemcitabine|mesh-list
14570534|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570535|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14021174|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021175|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021176|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14021177|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
14570536|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
15150559|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15150560|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15150561|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150562|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150563|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150564|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150565|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570537|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570538|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
14570539|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570540|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570541|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570542|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
14570543|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570544|NCT00003804|Dactinomycin|dactinomycin|mesh-list
14570545|NCT00003804|Vincristine|vincristine|mesh-list
14570546|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570547|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570548|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570549|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570550|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570551|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570552|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14570553|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570554|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570555|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14570556|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570557|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14570558|NCT00003805|Vancomycin|vancomycin|mesh-list
14570559|NCT00003805|Tazobactam|tazobactam|mesh-list
14570560|NCT00003805|Piperacillin|piperacillin|mesh-list
14570561|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14570562|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14570563|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570564|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14570565|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570566|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570567|NCT00003808|Theophylline|theophylline|mesh-list
14570568|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14570569|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
14570570|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14570571|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570572|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14570573|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
14570574|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14570575|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570576|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570577|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
14570578|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14570579|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14570580|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
14570581|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14570582|NCT00003809|Cetuximab|cetuximab|mesh-list
14570583|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570584|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150566|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150567|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
15180055|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15180056|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
15180057|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15180058|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
15180059|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180060|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
15180061|NCT03943186|Protective Agents|protective agents|mesh-ancestor
15180062|NCT03943407|Imiquimod|imiquimod|mesh-list
15180063|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
14291471|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14291472|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14291473|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14291474|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291475|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291476|NCT00554515|Aldesleukin|aldesleukin|mesh-list
14291477|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291478|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14291479|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14291480|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
14291481|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291482|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
14291483|NCT00554788|Thiotepa|thiotepa|mesh-list
14291484|NCT00554788|Cisplatin|cisplatin|mesh-list
14291485|NCT00554788|Carboplatin|carboplatin|mesh-list
14291486|NCT00554788|Etoposide|etoposide|mesh-list
14291487|NCT00554788|Vincristine|vincristine|mesh-list
14291488|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
14291489|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
14291490|NCT00554788|Lenograstim|lenograstim|mesh-list
14291491|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180064|NCT03943407|Doxepin|doxepin|mesh-list
14291492|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
15180065|NCT03943407|Menthol|menthol|mesh-list
14291493|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570585|NCT00003810|Gemcitabine|gemcitabine|mesh-list
14570586|NCT00003810|Docetaxel|docetaxel|mesh-list
14570587|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570588|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
14570589|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570590|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570591|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
14570592|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570593|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570594|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570595|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
14570596|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570597|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570598|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570599|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570600|NCT00003811|Etoposide|etoposide|mesh-list
14570601|NCT00003811|Bleomycin|bleomycin|mesh-list
14570602|NCT00003811|Amifostine|amifostine|mesh-list
14570603|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570604|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570605|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570606|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150568|NCT04213495|Anesthetics|anesthetics|mesh-list
15150569|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150570|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150571|NCT04213170|Bevacizumab|bevacizumab|mesh-list
14021178|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14021179|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14021180|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14021181|NCT02775474|Fentanyl|fentanyl|mesh-list
14570607|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150572|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14570608|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570609|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570610|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14570611|NCT00003811|Protective Agents|protective agents|mesh-ancestor
14570612|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570613|NCT00003812|Paclitaxel|paclitaxel|mesh-list
14570614|NCT00003812|Etoposide|etoposide|mesh-list
14570615|NCT00003812|Carboplatin|carboplatin|mesh-list
14570616|NCT00003812|Topotecan|topotecan|mesh-list
14570617|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570618|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570619|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570620|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570621|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570622|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570623|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570624|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570625|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570626|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570627|NCT00003814|Eflornithine|eflornithine|mesh-list
14570628|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570629|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14570630|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14570631|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14570632|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570633|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14570634|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570635|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570636|NCT00003815|Cytarabine|cytarabine|mesh-list
14570637|NCT00003815|Prednisolone|prednisolone|mesh-list
14570638|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
14570639|NCT00003815|Melphalan|melphalan|mesh-list
14570640|NCT00003815|Carmustine|carmustine|mesh-list
14570641|NCT00003815|Doxorubicin|doxorubicin|mesh-list
14570642|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14570643|NCT00003815|Etoposide|etoposide|mesh-list
14570644|NCT00003815|Vincristine|vincristine|mesh-list
14570645|NCT00003815|Bleomycin|bleomycin|mesh-list
14570646|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150573|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021182|NCT02775474|Methadone|methadone|mesh-list
14570647|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
14570648|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570649|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570650|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570651|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
15150574|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15150575|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15150576|NCT04213170|Growth Substances|growth substances|mesh-ancestor
15150577|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150578|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
15150579|NCT04213573|Fluorides|fluorides|mesh-list
15150580|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
15150581|NCT04213573|Protective Agents|protective agents|mesh-ancestor
15150582|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150583|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15150584|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150585|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14570652|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570653|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570654|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570655|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570656|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570657|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570658|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570659|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570660|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570661|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
14570662|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
14570663|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570664|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570665|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570666|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570667|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14570668|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
14570669|NCT00003815|Hormones|hormones|mesh-ancestor
14570670|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570671|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570672|NCT00003817|Ondansetron|ondansetron|mesh-list
14570673|NCT00003817|Granisetron|granisetron|mesh-list
14570674|NCT00003817|Tropisetron|tropisetron|mesh-list
14570675|NCT00003817|Dolasetron|dolasetron|mesh-list
14570676|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
14570677|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
14570678|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150586|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15150587|NCT04213287|Analgesics|analgesics|mesh-ancestor
15150588|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
15150589|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150590|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150591|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150592|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15150593|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150594|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150595|NCT04213391|Sulforaphane|sulforaphane|mesh-list
15150596|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15150597|NCT04213391|Protective Agents|protective agents|mesh-ancestor
15150598|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150599|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150600|NCT04213222|Bevacizumab|bevacizumab|mesh-list
15150601|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150602|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150603|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15150604|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15150605|NCT04213222|Growth Substances|growth substances|mesh-ancestor
15150606|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150607|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
15150608|NCT04213105|Denosumab|denosumab|mesh-list
15150609|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15150610|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150611|NCT04212793|Bevacizumab|bevacizumab|mesh-list
15150612|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150613|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150614|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15150615|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15150616|NCT04212793|Growth Substances|growth substances|mesh-ancestor
15150617|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570679|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570680|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150618|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
14570681|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
15150619|NCT04212832|Bupivacaine|bupivacaine|mesh-list
15150620|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
15150621|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
15150622|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150623|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150624|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
15150625|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150626|NCT04212845|Dexamethasone|dexamethasone|mesh-list
15150627|NCT04212845|Bupivacaine|bupivacaine|mesh-list
15150628|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150629|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
15150630|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
15150631|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150632|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150633|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150634|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
15150635|NCT04212845|Hormones|hormones|mesh-ancestor
15150636|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570682|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
14570683|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14570684|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
14570685|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14570686|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570687|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14570688|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14570689|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14570690|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14570691|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14570692|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14570693|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14570694|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14570695|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
14570696|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570697|NCT00003821|Aminopterin|aminopterin|mesh-list
14570698|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14570699|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570700|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570701|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14570702|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
14570703|NCT00003824|Cephalexin|cephalexin|mesh-list
14570704|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570705|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570706|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570707|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570708|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570709|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570710|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14570711|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14570712|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
15150637|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15150638|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150639|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
14570713|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
14570714|NCT00003827|Cytarabine|cytarabine|mesh-list
14570715|NCT00003827|Topotecan|topotecan|mesh-list
14570716|NCT00003827|Amifostine|amifostine|mesh-list
14570717|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570718|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
14570719|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570720|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570721|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
14570722|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570723|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570724|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
14570725|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570726|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15150640|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
15150641|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150642|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
15150643|NCT04212702|Everolimus|everolimus|mesh-list
15150644|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150645|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150646|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
15150647|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150648|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
15150649|NCT04212429|Levofloxacin|levofloxacin|mesh-list
15150650|NCT04212429|Ofloxacin|ofloxacin|mesh-list
15150651|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14570727|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570728|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570729|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14570730|NCT00003827|Protective Agents|protective agents|mesh-ancestor
14570731|NCT00003828|Vinorelbine|vinorelbine|mesh-list
14570732|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570733|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570734|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570735|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570736|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570737|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570738|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
14570739|NCT00003829|Fludarabine|fludarabine|mesh-list
14570740|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
14570741|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570742|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
15150652|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15150653|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15150654|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150655|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150656|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150657|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150658|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150659|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150660|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15150661|NCT04212429|Renal Agents|renal agents|mesh-ancestor
14570743|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570744|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570745|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570746|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
14570747|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570748|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570749|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570750|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570751|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
14570752|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
14570753|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
14570754|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
14570755|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570756|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570757|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570758|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
14570759|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570760|NCT00003834|Leucovorin|leucovorin|mesh-list
14570761|NCT00003834|Fluorouracil|fluorouracil|mesh-list
14570762|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
14570763|NCT00003834|Calcium|calcium|mesh-list
14570764|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
14570765|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14570766|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570767|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
14570768|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570769|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570770|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570771|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570772|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
14570773|NCT00003834|Antidotes|antidotes|mesh-ancestor
14570774|NCT00003834|Protective Agents|protective agents|mesh-ancestor
14570775|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570776|NCT00003834|Vitamins|vitamins|mesh-ancestor
14570777|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
14570778|NCT00003835|Leucovorin|leucovorin|mesh-list
14570779|NCT00003835|Fluorouracil|fluorouracil|mesh-list
14570780|NCT00003835|Irinotecan|irinotecan|mesh-list
14570781|NCT00003835|Calcium|calcium|mesh-list
14570782|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
15150662|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15150663|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15150664|NCT04212416|Leflunomide|leflunomide|mesh-list
15150665|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150666|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570783|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14570784|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570785|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
14570786|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570787|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570788|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570789|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570790|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
14570791|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570792|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570793|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570794|NCT00003835|Antidotes|antidotes|mesh-ancestor
14570795|NCT00003835|Protective Agents|protective agents|mesh-ancestor
14570796|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570797|NCT00003835|Vitamins|vitamins|mesh-ancestor
14570798|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
14570799|NCT00003842|Interleukin-4|interleukin-4|mesh-list
14570800|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14570801|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
14570802|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570803|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570804|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570805|NCT00003843|Irinotecan|irinotecan|mesh-list
14570806|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14570807|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570808|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570809|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570810|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570811|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
14570812|NCT00003846|Thiotepa|thiotepa|mesh-list
14570813|NCT00003846|Carboplatin|carboplatin|mesh-list
14570814|NCT00003846|Vincristine|vincristine|mesh-list
14570815|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570816|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
14570817|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570818|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570819|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570820|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
14570821|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570822|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570823|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570824|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570825|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570826|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570827|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570828|NCT00003847|Doxorubicin|doxorubicin|mesh-list
14570829|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15150667|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150668|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
15150669|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150670|NCT04212650|Losartan|losartan|mesh-list
15150671|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150672|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15150673|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15150674|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15150675|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150676|NCT04212403|Levofloxacin|levofloxacin|mesh-list
15150677|NCT04212403|Ofloxacin|ofloxacin|mesh-list
14570830|NCT00003847|Vincristine|vincristine|mesh-list
14570831|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570832|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570833|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570834|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570835|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570836|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570837|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570838|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150678|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15150679|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150680|NCT04212403|Renal Agents|renal agents|mesh-ancestor
15150681|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15150682|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150683|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150684|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150685|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150686|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570839|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570840|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570841|NCT00003849|Rituximab|rituximab|mesh-list
14570842|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14570843|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570844|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
14570845|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570846|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570847|NCT00003850|Thalidomide|thalidomide|mesh-list
14570848|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570849|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
14570850|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570851|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
14570852|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14570853|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570854|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14570855|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14570856|NCT00003850|Growth Substances|growth substances|mesh-ancestor
14570857|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
14570858|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570859|NCT00003851|Gemcitabine|gemcitabine|mesh-list
14570860|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570861|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
14570862|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570863|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150687|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15150688|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14291494|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291495|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570864|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
14570865|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14570866|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570867|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570868|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
14570869|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570870|NCT00003852|Paclitaxel|paclitaxel|mesh-list
14570871|NCT00003852|Etoposide|etoposide|mesh-list
14570872|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
14570873|NCT00003852|Carboplatin|carboplatin|mesh-list
14570874|NCT00003852|Epirubicin|epirubicin|mesh-list
14570875|NCT00003852|Ifosfamide|ifosfamide|mesh-list
14570876|NCT00003852|Thiotepa|thiotepa|mesh-list
14570877|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570878|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570879|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570880|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570881|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570882|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570883|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570884|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
14570885|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570886|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570887|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570888|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
14570889|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570890|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570891|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570892|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570893|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570894|NCT00003853|Esorubicin|esorubicin|mesh-list
14570895|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14570896|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570897|NCT00003856|Temoporfin|temoporfin|mesh-list
14291496|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
14291497|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291498|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291499|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14291500|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14291501|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14291502|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14291503|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291504|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14291505|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
14291506|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
14291507|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
14291508|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
14291509|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291510|NCT00554853|Pioglitazone|pioglitazone|mesh-list
14570898|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570899|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14570900|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
14570901|NCT00003857|Tamoxifen|tamoxifen|mesh-list
14570902|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14570903|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14570904|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570905|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570906|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570907|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570908|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14570909|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14570910|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14570911|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
14570912|NCT00003858|Analgesics|analgesics|mesh-ancestor
14570913|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
14570914|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14570915|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570916|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021183|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14021184|NCT02775474|Narcotics|narcotics|mesh-ancestor
14021185|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021186|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021187|NCT02775474|Analgesics|analgesics|mesh-ancestor
14021188|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
14021189|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021190|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14021191|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14021192|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
14021193|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
14570917|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150689|NCT04212533|Vitamin D|vitamin d|mesh-list
15150690|NCT04212533|Vitamins|vitamins|mesh-ancestor
15150691|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
15150692|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570918|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570919|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570920|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570921|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
14570922|NCT00003859|Carboplatin|carboplatin|mesh-list
14570923|NCT00003859|Etoposide|etoposide|mesh-list
14570924|NCT00003859|Vincristine|vincristine|mesh-list
14570925|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570926|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
14570927|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570928|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14570929|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570930|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
14570931|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570932|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570933|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14570934|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570935|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570936|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570937|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570938|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570939|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570940|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570941|NCT00003860|Carboplatin|carboplatin|mesh-list
14570942|NCT00003860|Etoposide|etoposide|mesh-list
14570943|NCT00003860|Ifosfamide|ifosfamide|mesh-list
14570944|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570945|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570946|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14570947|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570948|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570949|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570950|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14570951|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
14570952|NCT00003862|Leucovorin|leucovorin|mesh-list
15150693|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15150694|NCT04211896|Nivolumab|nivolumab|mesh-list
14570953|NCT00003862|Paclitaxel|paclitaxel|mesh-list
14021194|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
14570954|NCT00003862|Fluorouracil|fluorouracil|mesh-list
15150695|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150696|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150697|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15150698|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570955|NCT00003862|Calcium|calcium|mesh-list
14570956|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
14570957|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14570958|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570959|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570960|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570961|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570962|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570963|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14570964|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570965|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
14570966|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570967|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14570968|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
14570969|NCT00003862|Antidotes|antidotes|mesh-ancestor
14570970|NCT00003862|Protective Agents|protective agents|mesh-ancestor
14570971|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
14570972|NCT00003862|Vitamins|vitamins|mesh-ancestor
14570973|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
14570974|NCT00003864|Carboplatin|carboplatin|mesh-list
14570975|NCT00003864|Docetaxel|docetaxel|mesh-list
14570976|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570977|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
14570978|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
14570979|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
14570980|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570981|NCT00003865|Toremifene|toremifene|mesh-list
14570982|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14570983|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570984|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14570985|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14570986|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
14570987|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14570988|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14570989|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14570990|NCT00003867|Capecitabine|capecitabine|mesh-list
14570991|NCT00003867|Irinotecan|irinotecan|mesh-list
14570992|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14570993|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
14570994|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14570995|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14570996|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15150699|NCT04212026|Nivolumab|nivolumab|mesh-list
15150700|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150701|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150702|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15150703|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150704|NCT04212039|Bupivacaine|bupivacaine|mesh-list
15150705|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
15150706|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
15150707|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150708|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150709|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
15150710|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150711|NCT04212078|Levofloxacin|levofloxacin|mesh-list
15150712|NCT04212078|Ofloxacin|ofloxacin|mesh-list
15150713|NCT04212078|Cefuroxime|cefuroxime|mesh-list
15150714|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
15150715|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15150716|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150717|NCT04212078|Renal Agents|renal agents|mesh-ancestor
15150718|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15150719|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150720|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150721|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150722|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150723|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150724|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15150725|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15150726|NCT04211961|Scopolamine|scopolamine|mesh-list
15150727|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14570997|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14570998|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14570999|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
14571000|NCT00003868|Methotrexate|methotrexate|mesh-list
14571001|NCT00003868|Antibodies|antibodies|mesh-list
14571002|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15150728|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15150729|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
15150730|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
15150731|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150732|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150733|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150734|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
15150735|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15150736|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
14571003|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571004|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
14571005|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571006|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571007|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571008|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
14571009|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571010|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571011|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571012|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14571013|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
14571014|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14571015|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571016|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
14571017|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571018|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571019|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14571020|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571021|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
14571022|NCT00003870|Methotrexate|methotrexate|mesh-list
14571023|NCT00003870|Antibodies|antibodies|mesh-list
14571024|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14571025|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571026|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
14571027|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571028|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571029|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571030|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
14571031|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571032|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571033|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571034|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14571035|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
14571036|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14571037|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571038|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
14571039|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571040|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571041|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14571042|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571043|NCT00003871|Vaccines|vaccines|mesh-list
14571044|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
14571045|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571046|NCT00003873|Fluorouracil|fluorouracil|mesh-list
14571047|NCT00003873|Eniluracil|eniluracil|mesh-list
14571048|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
14571049|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571050|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571051|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571052|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571053|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
14571054|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150737|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021195|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
14021196|NCT02775539|Mirabegron|mirabegron|mesh-list
14021197|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14021198|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14021199|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14021200|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
14571055|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643844|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571056|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14021201|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021202|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021203|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021204|NCT02775539|Urological Agents|urological agents|mesh-ancestor
14021205|NCT02775500|Apremilast|apremilast|mesh-list
14571057|NCT00003874|Antibodies|antibodies|mesh-list
14571058|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
14571059|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14571060|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
14571061|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571062|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571063|NCT00003876|Carmustine|carmustine|mesh-list
14571064|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571065|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
14571066|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571067|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571068|NCT00003877|Paclitaxel|paclitaxel|mesh-list
14571069|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
14571070|NCT00003877|Carboplatin|carboplatin|mesh-list
14571071|NCT00003877|Thiotepa|thiotepa|mesh-list
14571072|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571073|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571074|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571075|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571076|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571077|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571078|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571079|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
14571080|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571081|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571082|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571083|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
14571084|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571085|NCT00003878|Carmustine|carmustine|mesh-list
14571086|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571087|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
14571088|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571089|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571090|NCT00003880|Paclitaxel|paclitaxel|mesh-list
14571091|NCT00003880|Carboplatin|carboplatin|mesh-list
14571092|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571093|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571094|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571095|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571096|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571097|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571098|NCT00003881|Paclitaxel|paclitaxel|mesh-list
14571099|NCT00003881|Carboplatin|carboplatin|mesh-list
14571100|NCT00003881|Trastuzumab|trastuzumab|mesh-list
14571101|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571102|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571103|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571104|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571105|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571106|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571107|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14571108|NCT00003883|Itraconazole|itraconazole|mesh-list
14571109|NCT00003883|Fluconazole|fluconazole|mesh-list
14571110|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
14571111|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571112|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14571113|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14571114|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571115|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571116|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14021206|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14813997|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
14813998|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180066|NCT03943407|Histamine|histamine|mesh-list
14021207|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14571117|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
14571118|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021208|NCT02775500|Analgesics|analgesics|mesh-ancestor
14571119|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571120|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14021209|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
14021210|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021211|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571121|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14571122|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14571123|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
14571124|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14571125|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571126|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
14571127|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571128|NCT00003888|Docetaxel|docetaxel|mesh-list
14571129|NCT00003888|Fluorouracil|fluorouracil|mesh-list
14571130|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571131|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571132|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571133|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571134|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571135|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
14571136|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14021212|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021213|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021214|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14021215|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14021216|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021217|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021218|NCT02775318|Bupivacaine|bupivacaine|mesh-list
14021219|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
14021220|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
14021221|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14571137|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571138|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
14571139|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571140|NCT00003891|Lurtotecan|lurtotecan|mesh-list
14571141|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571142|NCT00003892|ISIS 5132|isis 5132|mesh-list
14571143|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571144|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571145|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571146|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
14571147|NCT00003893|Doxorubicin|doxorubicin|mesh-list
14571148|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14571149|NCT00003893|Fluorouracil|fluorouracil|mesh-list
14571150|NCT00003893|Methotrexate|methotrexate|mesh-list
14571151|NCT00003893|Epirubicin|epirubicin|mesh-list
14571152|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
14571153|NCT00003893|Mitomycins|mitomycins|mesh-list
14571154|NCT00003893|Mitomycin|mitomycin|mesh-list
14571155|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571156|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
14571157|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021222|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021223|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
14021224|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021225|NCT02775292|Aldesleukin|aldesleukin|mesh-list
14021226|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
14021227|NCT02775292|Nivolumab|nivolumab|mesh-list
14021228|NCT02775292|Fludarabine|fludarabine|mesh-list
14021229|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
14021230|NCT02775292|Interleukin-2|interleukin-2|mesh-list
14021231|NCT02775292|Vaccines|vaccines|mesh-list
14571158|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150738|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150739|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15150740|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
15150741|NCT04211987|Cytarabine|cytarabine|mesh-list
14021232|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
14021233|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021234|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021235|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021236|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15150742|NCT04211987|Methotrexate|methotrexate|mesh-list
15150743|NCT04211987|Etoposide|etoposide|mesh-list
14021237|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
14571159|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15150744|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14021238|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021239|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021240|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14021241|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14021242|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14021243|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14021244|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
14021245|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021246|NCT02775292|Analgesics|analgesics|mesh-ancestor
14021247|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
14021248|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021249|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14021250|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14021251|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
14021252|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021253|NCT02775370|Apatinib|apatinib|mesh-list
14021254|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021255|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14021256|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021257|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021258|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
14021259|NCT02775227|Pasireotide|pasireotide|mesh-list
14021260|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14571160|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
14571161|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571162|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571163|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571164|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571165|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150745|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
15150746|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150747|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150748|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
15150749|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150750|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150751|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
15150752|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150753|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150754|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15150755|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15150756|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150757|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15150758|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
15150759|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14571166|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571167|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571168|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
14571169|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571170|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14571171|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
14571172|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14571173|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
15150760|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
15150761|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15150762|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150763|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15150764|NCT04212065|Buprenorphine|buprenorphine|mesh-list
15150765|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14571174|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14571175|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571176|NCT00003893|Analgesics|analgesics|mesh-ancestor
14571177|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
14571178|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14571179|NCT00003894|Thalidomide|thalidomide|mesh-list
14571180|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571181|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
14571182|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571183|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
14571184|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14571185|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571186|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14571187|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14571188|NCT00003894|Growth Substances|growth substances|mesh-ancestor
14021261|NCT02775227|Hormones|hormones|mesh-ancestor
14571189|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
14571190|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571191|NCT00003897|Sargramostim|sargramostim|mesh-list
14571192|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
14571193|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571194|NCT00003899|Paclitaxel|paclitaxel|mesh-list
14571195|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
14571196|NCT00003899|Melphalan|melphalan|mesh-list
14571197|NCT00003899|Thiotepa|thiotepa|mesh-list
14571198|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571199|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571200|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571201|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571202|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571203|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571204|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571205|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
14571206|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571207|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571208|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571209|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
14571210|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571211|NCT00003900|Docetaxel|docetaxel|mesh-list
14571212|NCT00003900|Irinotecan|irinotecan|mesh-list
14571213|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571214|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571215|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571216|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571217|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571218|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571219|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571220|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571221|NCT00003902|Capecitabine|capecitabine|mesh-list
14571222|NCT00003902|Vinorelbine|vinorelbine|mesh-list
14571223|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571224|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
14571225|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571226|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571227|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571228|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571229|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571230|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150766|NCT04212065|Narcotics|narcotics|mesh-ancestor
15150767|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150768|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150769|NCT04212065|Analgesics|analgesics|mesh-ancestor
15150770|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
15150771|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150772|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15150773|NCT04212000|Ketoconazole|ketoconazole|mesh-list
15150774|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
15150775|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150776|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15150777|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15150778|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150779|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150780|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15150781|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
15150782|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15150783|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150784|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15180067|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
15180068|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
15180069|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
15180070|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
15180071|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180072|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180073|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180074|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15180075|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
14571231|NCT00003906|Tamoxifen|tamoxifen|mesh-list
14571232|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14571233|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14571234|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
14643845|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571235|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571236|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571237|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14571238|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571239|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15150785|NCT04211805|Tenofovir|tenofovir|mesh-list
15150786|NCT04211805|Vaccines|vaccines|mesh-list
15150787|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
15150788|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150789|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
15150790|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150791|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15150792|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14021262|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021263|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021264|NCT02775110|Natalizumab|natalizumab|mesh-list
14021265|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
14021266|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021267|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
15150793|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150794|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150795|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14021268|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
14571240|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14571241|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14571242|NCT00003908|Carboplatin|carboplatin|mesh-list
14571243|NCT00003908|Docetaxel|docetaxel|mesh-list
14571244|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571245|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571246|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571247|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571248|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571249|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
14571250|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571251|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14571252|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571253|NCT00003912|Carboplatin|carboplatin|mesh-list
14571254|NCT00003912|Doxorubicin|doxorubicin|mesh-list
14571255|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14571256|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571257|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571258|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571259|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571260|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571261|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571262|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
14571263|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
14571264|NCT00003913|Busulfan|busulfan|mesh-list
14571265|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14571266|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571267|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
14571268|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571269|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571270|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571271|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
14571272|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571273|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571274|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571275|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150796|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15150797|NCT04211558|Ozanimod|ozanimod|mesh-list
15150798|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15150799|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150800|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150801|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
15150802|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150803|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
15150804|NCT04211844|Ledipasvir|ledipasvir|mesh-list
15150805|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
15150806|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150807|NCT04211545|Rabeprazole|rabeprazole|mesh-list
15150808|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14021269|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571276|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
14021270|NCT02775266|Protective Agents|protective agents|mesh-ancestor
14571277|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
14571278|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14571279|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14571280|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
14571281|NCT00003913|Hormones|hormones|mesh-ancestor
14571282|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571283|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14571284|NCT00003913|Protective Agents|protective agents|mesh-ancestor
14571285|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
14571286|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571287|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571288|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571289|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571290|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571291|NCT00003917|Topotecan|topotecan|mesh-list
14571292|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571293|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571294|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571295|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571296|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571297|NCT00003920|Cyclosporine|cyclosporine|mesh-list
14571298|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14571299|NCT00003920|Antibodies|antibodies|mesh-list
14571300|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
14571301|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14571302|NCT00003920|Cyclosporins|cyclosporins|mesh-list
14571303|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
14571304|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571305|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571306|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571307|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571308|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571309|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
14571310|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571311|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571312|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571313|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14571314|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14571315|NCT00003923|Trioxsalen|trioxsalen|mesh-list
14571316|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571317|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571318|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14571319|NCT00003924|Interferons|interferons|mesh-list
14571320|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
14571321|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150809|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150810|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15150811|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150812|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150813|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
15150814|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15150815|NCT04211272|Macitentan|macitentan|mesh-list
15150816|NCT04211272|Riociguat|riociguat|mesh-list
15150817|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15150818|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15150819|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
15150820|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150821|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15150822|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15150823|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150824|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
15150825|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15150826|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15150827|NCT04211272|Urological Agents|urological agents|mesh-ancestor
15150828|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15150829|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15150830|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15150831|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
15150832|NCT04211259|Loratadine|loratadine|mesh-list
15150833|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
15150834|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
15150835|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15150836|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14571322|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
14571323|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571324|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
14571325|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571326|NCT00003925|Leucovorin|leucovorin|mesh-list
14571327|NCT00003925|Gemcitabine|gemcitabine|mesh-list
14571328|NCT00003925|Tegafur|tegafur|mesh-list
14571329|NCT00003925|Calcium|calcium|mesh-list
14571330|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
14571331|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571332|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
14571333|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571334|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571335|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
14571336|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571337|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571338|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150837|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15150838|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
15150839|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
15150840|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150841|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150842|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150843|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
15150844|NCT04211298|Propofol|propofol|mesh-list
15150845|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15150846|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150847|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150848|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15150849|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
15150850|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
15150851|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021271|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021272|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
14021273|NCT02775266|Vitamins|vitamins|mesh-ancestor
14021274|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
14026026|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026027|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
14026028|NCT02745873|Vitamins|vitamins|mesh-ancestor
14026029|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
14026030|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026031|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
14026032|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026033|NCT02745873|Protective Agents|protective agents|mesh-ancestor
14026034|NCT02745860|Selexipag|selexipag|mesh-list
14026035|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15150852|NCT04211298|Analgesics|analgesics|mesh-ancestor
14026036|NCT02745639|Capecitabine|capecitabine|mesh-list
14026037|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
14026038|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14026039|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
14026040|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026041|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026042|NCT02745756|Vaccines|vaccines|mesh-list
14291511|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
15150853|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
15150854|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150855|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15150856|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15150857|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15150858|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291512|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026043|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
14291513|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291514|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
14291515|NCT00554970|Budesonide|budesonide|mesh-list
14291516|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291517|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14026044|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291518|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
14291519|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291520|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291521|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14291522|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
14291523|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
14291524|NCT00554970|Hormones|hormones|mesh-ancestor
14291525|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291526|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
14291527|NCT00555048|Busulfan|busulfan|mesh-list
14571339|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
15150859|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150860|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150861|NCT04211012|Paclitaxel|paclitaxel|mesh-list
15150862|NCT04211012|Cisplatin|cisplatin|mesh-list
15150863|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15150864|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150865|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
15150866|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
15150867|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
15150868|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150869|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
15150870|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15150871|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150872|NCT04211168|Lenvatinib|lenvatinib|mesh-list
15150873|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150874|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15150875|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150876|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150877|NCT04211090|Carboplatin|carboplatin|mesh-list
15150878|NCT04211090|Pemetrexed|pemetrexed|mesh-list
15150879|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15150880|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150881|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150882|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15150883|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15150884|NCT04210713|Minocycline|minocycline|mesh-list
15150885|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15150886|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150887|NCT04210739|Betamethasone|betamethasone|mesh-list
15150888|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
15150889|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15150890|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
15150891|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15150892|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
15150893|NCT04210739|Hormones|hormones|mesh-ancestor
15150894|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15150895|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150896|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150897|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15150898|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
15150899|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
15150900|NCT04210505|Povidone|povidone|mesh-list
15150901|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
15150902|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
15150903|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15150904|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150905|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15150906|NCT04210427|Laxatives|laxatives|mesh-ancestor
15150907|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150908|NCT04210453|Ascorbic Acid|ascorbic acid|mesh-list
15150909|NCT04210453|Vitamins|vitamins|mesh-ancestor
15150910|NCT04210453|Micronutrients|micronutrients|mesh-ancestor
15150911|NCT04210453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150912|NCT04210453|Antioxidants|antioxidants|mesh-ancestor
15150913|NCT04210453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150914|NCT04210453|Protective Agents|protective agents|mesh-ancestor
15150915|NCT04210765|Clomiphene|clomiphene|mesh-list
15150916|NCT04210765|Enclomiphene|enclomiphene|mesh-list
15150917|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
15150918|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15150919|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
15150920|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15150921|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150922|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15150923|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
14571340|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150924|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15150925|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15150926|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15150927|NCT04210544|Caseins|caseins|mesh-list
15150928|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
15150929|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
15150930|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571341|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15150931|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
14571342|NCT00003925|Antidotes|antidotes|mesh-ancestor
14571343|NCT00003925|Protective Agents|protective agents|mesh-ancestor
14571344|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
14571345|NCT00003925|Vitamins|vitamins|mesh-ancestor
14571346|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
14571347|NCT00003926|Melphalan|melphalan|mesh-list
14571348|NCT00003926|Busulfan|busulfan|mesh-list
14571349|NCT00003926|Thiotepa|thiotepa|mesh-list
14571350|NCT00003926|Lenograstim|lenograstim|mesh-list
14571351|NCT00003926|Sargramostim|sargramostim|mesh-list
14571352|NCT00003926|Amifostine|amifostine|mesh-list
14571353|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14571354|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
14571355|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571356|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571357|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
14571358|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571359|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571360|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571361|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571362|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14571363|NCT00003926|Protective Agents|protective agents|mesh-ancestor
14571364|NCT00003928|Gemcitabine|gemcitabine|mesh-list
15150932|NCT04209933|Bismuth|bismuth|mesh-list
15150933|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150934|NCT04209933|Antacids|antacids|mesh-ancestor
15150935|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150936|NCT04209933|Diuretics|diuretics|mesh-ancestor
15150937|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
15150938|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150939|NCT04209933|Expectorants|expectorants|mesh-ancestor
15150940|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
15150941|NCT04209920|Chromium|chromium|mesh-list
15150942|NCT04209920|Nickel|nickel|mesh-list
15150943|NCT04209920|Trace Elements|trace elements|mesh-ancestor
15150944|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
15150945|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150946|NCT04209699|BMS-986165|bms-986165|mesh-list
15150947|NCT04209699|Famotidine|famotidine|mesh-list
15150948|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15150949|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15150950|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15150951|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
15150952|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
15150953|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15150954|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150955|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150956|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
15150957|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15150958|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180076|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180077|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
15180078|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180079|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15180080|NCT03943407|Protective Agents|protective agents|mesh-ancestor
15180081|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15180082|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15180083|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180084|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15180085|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
15180086|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15180087|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
15180088|NCT03943043|Gemcitabine|gemcitabine|mesh-list
15180089|NCT03943043|Paclitaxel|paclitaxel|mesh-list
15180090|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
15180091|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180092|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180093|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
15180094|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
15180095|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
15180096|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180097|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15180098|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
15180099|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
14571365|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571366|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571367|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
14643846|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571368|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571369|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
14571370|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571371|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571372|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15150959|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15150960|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15150961|NCT04209959|Nifekalant|nifekalant|mesh-list
15150962|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15150963|NCT04209803|Minoxidil|minoxidil|mesh-list
15150964|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15150965|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
15150966|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15150967|NCT04209439|Bupivacaine|bupivacaine|mesh-list
15150968|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
14571373|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
14571374|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150969|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
15150970|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150971|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150972|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
15150973|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150974|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15150975|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15150976|NCT04209439|Analgesics|analgesics|mesh-ancestor
15150977|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15150978|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15150979|NCT04209478|Morphine|morphine|mesh-list
15150980|NCT04209478|Tramadol|tramadol|mesh-list
15150981|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15150982|NCT04209478|Narcotics|narcotics|mesh-ancestor
15150983|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150984|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150985|NCT04209478|Analgesics|analgesics|mesh-ancestor
15150986|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
15150987|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15150988|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
15150989|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
15150990|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15150991|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15150992|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15150993|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
15150994|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15150995|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15150996|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15150997|NCT04209426|Tacrine|tacrine|mesh-list
15150998|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15150999|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151000|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151001|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
15151002|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151003|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151004|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15151005|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
15151006|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151007|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
15151008|NCT04209218|Dexamethasone|dexamethasone|mesh-list
15151009|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
15151010|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151011|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
15151012|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
15151013|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151014|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151015|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15151016|NCT04209218|Hormones|hormones|mesh-ancestor
15151017|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151018|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15151019|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151020|NCT04209166|Norepinephrine|norepinephrine|mesh-list
15151021|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15151022|NCT04209166|Serotonin|serotonin|mesh-list
15151023|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14021275|NCT02774993|Doxycycline|doxycycline|mesh-list
15151024|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
15151025|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
15151026|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14571375|NCT00003929|Lomustine|lomustine|mesh-list
14571376|NCT00003929|Procarbazine|procarbazine|mesh-list
14571377|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571378|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
14571379|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571380|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571381|NCT00003930|Gemcitabine|gemcitabine|mesh-list
14571382|NCT00003930|Paclitaxel|paclitaxel|mesh-list
14571383|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571384|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571385|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571386|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571387|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571388|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571389|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571390|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
14571391|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
14571392|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571393|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571394|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571395|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
14571396|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643847|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643848|NCT00190502|Antibodies|antibodies|mesh-list
15151027|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15151028|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15151029|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151030|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151031|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15151032|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15151033|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151034|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151035|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151036|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
15151037|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
15151038|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151039|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15151040|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15151041|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
15151042|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15151043|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151044|NCT04209075|Metformin|metformin|mesh-list
14643849|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
14643850|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643851|NCT00190515|Leucovorin|leucovorin|mesh-list
14643852|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
14643853|NCT00190515|Antidotes|antidotes|mesh-ancestor
15151045|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15151046|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151047|NCT04209192|Amikacin|amikacin|mesh-list
15151048|NCT04209192|Fosfomycin|fosfomycin|mesh-list
15151049|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151050|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151051|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
15151052|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151053|NCT04208854|Vinorelbine|vinorelbine|mesh-list
15151054|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15151055|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151056|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
14021276|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14021277|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021278|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
14021279|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14021280|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14021281|NCT02775006|Docetaxel|docetaxel|mesh-list
14021282|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14021283|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021284|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
14021285|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
14643854|NCT00190515|Protective Agents|protective agents|mesh-ancestor
14813999|NCT00861120|Doxorubicin|doxorubicin|mesh-list
15151057|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
15151058|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
15151059|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151060|NCT04208776|Propranolol|propranolol|mesh-list
15151061|NCT04208776|Midodrine|midodrine|mesh-list
14021286|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
14026045|NCT02745717|Cyclosporine|cyclosporine|mesh-list
14571397|NCT00003934|Cytarabine|cytarabine|mesh-list
14571398|NCT00003934|Methotrexate|methotrexate|mesh-list
14571399|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
14571400|NCT00003934|Daunorubicin|daunorubicin|mesh-list
14571401|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
14571402|NCT00003934|Tretinoin|tretinoin|mesh-list
14571403|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14571404|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
14571405|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14571406|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571407|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571408|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
14571409|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571410|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571411|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571412|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571413|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14571414|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571415|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
14571416|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571417|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571418|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
14571419|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571420|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571421|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571422|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571423|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
14571424|NCT00003935|Etoposide|etoposide|mesh-list
14571425|NCT00003935|Vincristine|vincristine|mesh-list
14571426|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571427|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571428|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571429|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571430|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571431|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571432|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571433|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571434|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571435|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
14571436|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14571437|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
14571438|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571439|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571440|NCT00003937|Cisplatin|cisplatin|mesh-list
14571441|NCT00003937|Doxorubicin|doxorubicin|mesh-list
14571442|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14571443|NCT00003937|Methotrexate|methotrexate|mesh-list
14571444|NCT00003937|Etoposide|etoposide|mesh-list
15151062|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15151063|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15151064|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151065|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151066|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151067|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151068|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15151069|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15151070|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
15151071|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
15151072|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
15151073|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151074|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15151075|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15151076|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15151077|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15151078|NCT04208945|Colistin|colistin|mesh-list
15151079|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151080|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151081|NCT04208958|Vancomycin|vancomycin|mesh-list
15151082|NCT04208958|Nivolumab|nivolumab|mesh-list
15151083|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15151084|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026046|NCT02745717|Cyclosporins|cyclosporins|mesh-list
14571445|NCT00003937|Ifosfamide|ifosfamide|mesh-list
14571446|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
14571447|NCT00003937|Razoxane|razoxane|mesh-list
14571448|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571449|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15151085|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14571450|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571451|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571452|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571453|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571454|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14571455|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
15151086|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151087|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151088|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151089|NCT04208594|Propranolol|propranolol|mesh-list
15151090|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14571456|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14571457|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571458|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15151091|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15151092|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151093|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151094|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151095|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151096|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15151097|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15151098|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
15151099|NCT04208555|Terconazole|terconazole|mesh-list
15151100|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
15151101|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151102|NCT04208763|Imipenem|imipenem|mesh-list
15151103|NCT04208763|Colistin|colistin|mesh-list
15151104|NCT04208763|Tigecycline|tigecycline|mesh-list
15151105|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151106|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151107|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15151108|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151109|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151110|NCT04208373|Itraconazole|itraconazole|mesh-list
15151111|NCT04208373|Etravirine|etravirine|mesh-list
15151112|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
15151113|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151114|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15151115|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15151116|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151117|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151118|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15151119|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
15151120|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151121|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151122|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15151123|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15151124|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15151125|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
15151126|NCT04208581|Fluticasone|fluticasone|mesh-list
15151127|NCT04208581|Xhance|xhance|mesh-list
15151128|NCT04208581|Budesonide|budesonide|mesh-list
15151129|NCT04208581|Bromides|bromides|mesh-list
15151130|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
15151131|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
15151132|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15151133|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15151134|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021287|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151135|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15151136|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
15151137|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151138|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151139|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15151140|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
15151141|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
15151142|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15151143|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
15151144|NCT04208581|Hormones|hormones|mesh-ancestor
15151145|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151146|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15151147|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14021288|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14571459|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
14571460|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571461|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14571462|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571463|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
14571464|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571465|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571466|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571467|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571468|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
14571469|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14571470|NCT00003937|Protective Agents|protective agents|mesh-ancestor
14571471|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571472|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571473|NCT00003938|Amphotericin B|amphotericin b|mesh-list
14571474|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15151148|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15151149|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151150|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151151|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151152|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
15151153|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14021289|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021290|NCT02774902|Clarithromycin|clarithromycin|mesh-list
14021291|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14021292|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021293|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14021294|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021295|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291528|NCT00555048|Methotrexate|methotrexate|mesh-list
15151154|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
15151155|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
15151156|NCT04208334|Curcumin|curcumin|mesh-list
15151157|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151158|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151159|NCT04208334|Analgesics|analgesics|mesh-ancestor
15151160|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
15151161|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151162|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151163|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151164|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151165|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151166|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291529|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
15151167|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151168|NCT04208516|Dexamethasone|dexamethasone|mesh-list
15151169|NCT04208516|Lidocaine|lidocaine|mesh-list
15151170|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
15151171|NCT04208516|Ropivacaine|ropivacaine|mesh-list
15151172|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151173|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
15151174|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
15151175|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151176|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151177|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15151178|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
15151179|NCT04208516|Hormones|hormones|mesh-ancestor
15151180|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151181|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15151182|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151183|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
15151184|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
15151185|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151186|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
15151187|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15151188|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15151189|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15151190|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151191|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151192|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14291530|NCT00555048|Tacrolimus|tacrolimus|mesh-list
14291531|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291532|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
14291533|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571475|NCT00003938|Amebicides|amebicides|mesh-ancestor
14571476|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14571477|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14571478|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571479|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14571480|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
14571481|NCT00003939|Trabectedin|trabectedin|mesh-list
14571482|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15151193|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151194|NCT04208516|Analgesics|analgesics|mesh-ancestor
15151195|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15151196|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15151197|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15151198|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151199|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151200|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
15151201|NCT04208347|Apatinib|apatinib|mesh-list
15151202|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151203|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15151204|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151205|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151206|NCT04208178|Trastuzumab|trastuzumab|mesh-list
15151207|NCT04208178|Pertuzumab|pertuzumab|mesh-list
15151208|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15151209|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151210|NCT04208061|Ritonavir|ritonavir|mesh-list
15151211|NCT04208061|Darunavir|darunavir|mesh-list
15151212|NCT04208061|Dabigatran|dabigatran|mesh-list
15151213|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15151214|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15151215|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
15151216|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151217|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151218|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15151219|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15151220|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
15151221|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151222|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15151223|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15151224|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
15151225|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15151226|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
15151227|NCT04207957|Olorofim|olorofim|mesh-list
15151228|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
15151229|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151230|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
15151231|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15151232|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15151233|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15151234|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151235|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151236|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
15151237|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151238|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151239|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15151240|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151241|NCT04207684|Testosterone|testosterone|mesh-list
15151242|NCT04207684|Androgens|androgens|mesh-ancestor
14021296|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14021297|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14021298|NCT02774837|Tenofovir|tenofovir|mesh-list
14021299|NCT02774837|Telbivudine|telbivudine|mesh-list
14021300|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
14021301|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021302|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14021303|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14021304|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021305|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021306|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14021307|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14021308|NCT02774876|Insulin|insulin|mesh-list
14021309|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14021310|NCT02774876|Hormones|hormones|mesh-list
14021311|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026047|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
14571483|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
15151243|NCT04207684|Hormones|hormones|mesh-ancestor
15151244|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151245|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021312|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021313|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021314|NCT02774811|Bimatoprost|bimatoprost|mesh-list
14021315|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14021316|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14021317|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14571484|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151246|NCT04207411|Lidocaine|lidocaine|mesh-list
15151247|NCT04207411|Bupivacaine|bupivacaine|mesh-list
15151248|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
15151249|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
15151250|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151251|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151252|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
15151253|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151254|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15151255|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15151256|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15151257|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151258|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151259|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15151260|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15151261|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14571485|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571486|NCT00003941|Etoposide|etoposide|mesh-list
14571487|NCT00003941|Ifosfamide|ifosfamide|mesh-list
14571488|NCT00003941|Bleomycin|bleomycin|mesh-list
14571489|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571490|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571491|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571492|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571493|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571494|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571495|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571496|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
15151262|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151263|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151264|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151265|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151266|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15151267|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
15151268|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15151269|NCT04207515|Anesthetics|anesthetics|mesh-list
15151270|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151271|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151272|NCT04207450|Glutaral|glutaral|mesh-list
15151273|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
15151274|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151275|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15151276|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15151277|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151278|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151279|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151280|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021318|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
14021319|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291534|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151281|NCT04207723|Paroxetine|paroxetine|mesh-list
15151282|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15151283|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15151284|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151285|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151286|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151287|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
15151288|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151289|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15151290|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
15151291|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14291535|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14291536|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
14571497|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571498|NCT00003943|Paclitaxel|paclitaxel|mesh-list
15151292|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15151293|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15151294|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151295|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
15151296|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
15151297|NCT04207112|Linezolid|linezolid|mesh-list
15151298|NCT04207112|Bedaquiline|bedaquiline|mesh-list
15151299|NCT04207112|Clofazimine|clofazimine|mesh-list
15151300|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151301|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021320|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14021321|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14021322|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
14021323|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
14021324|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021325|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021326|NCT02774382|Vancomycin|vancomycin|mesh-list
14021327|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14021328|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021329|NCT02774460|Amlodipine|amlodipine|mesh-list
14291537|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151302|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15151303|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15151304|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151305|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151306|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151307|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15151308|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
15151309|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151310|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
15151311|NCT04207021|Curcumin|curcumin|mesh-list
15151312|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151313|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151314|NCT04207021|Analgesics|analgesics|mesh-ancestor
15151315|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
15151316|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151317|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151318|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151319|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151320|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151321|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151322|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151323|NCT04206865|Valsartan|valsartan|mesh-list
15151324|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
15151325|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15151326|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15151327|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15151328|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15151329|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151330|NCT04207060|Indomethacin|indomethacin|mesh-list
15151331|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151332|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151333|NCT04207060|Analgesics|analgesics|mesh-ancestor
15151334|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
15151335|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151336|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151337|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151338|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151339|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
15151340|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
15151341|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14021330|NCT02774460|Candesartan|candesartan|mesh-list
14291538|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291539|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14291540|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14291541|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
14291542|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14291543|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14291544|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
14291545|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291546|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021331|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
14571499|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
14571500|NCT00003943|Carboplatin|carboplatin|mesh-list
14571501|NCT00003943|Topotecan|topotecan|mesh-list
14571502|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571503|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571504|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571505|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571506|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571507|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571508|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571509|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
14571510|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571511|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571512|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571513|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
14571514|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571515|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571516|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571517|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571518|NCT00003944|Paclitaxel|paclitaxel|mesh-list
14571519|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
14571520|NCT00003944|Carboplatin|carboplatin|mesh-list
14571521|NCT00003944|Topotecan|topotecan|mesh-list
14571522|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571523|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571524|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571525|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571526|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
15151342|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15151343|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151344|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151345|NCT04206618|Denosumab|denosumab|mesh-list
15151346|NCT04206618|Teriparatide|teriparatide|mesh-list
15151347|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15151348|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151349|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15151350|NCT04206631|Doxycycline|doxycycline|mesh-list
15151351|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151352|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151353|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
15151354|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15151355|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15151356|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15151357|NCT04206228|Hematinics|hematinics|mesh-ancestor
15151358|NCT04206358|Molgramostim|molgramostim|mesh-list
15151359|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151360|NCT04206046|Anesthetics|anesthetics|mesh-list
15151361|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151362|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151363|NCT04206176|Ticagrelor|ticagrelor|mesh-list
15151364|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15151365|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15151366|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15151367|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15151368|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
15151369|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151370|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151371|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151372|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
15151373|NCT04205916|Dexamethasone|dexamethasone|mesh-list
15151374|NCT04205916|Ketorolac|ketorolac|mesh-list
15151375|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151376|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
15151377|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
15151378|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151379|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151380|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15151381|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
15151382|NCT04205916|Hormones|hormones|mesh-ancestor
15151383|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151384|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15151385|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151386|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151387|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571527|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151388|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571528|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571529|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
14571530|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571531|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571532|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571533|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
14571534|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571535|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571536|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571537|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571538|NCT00003945|Topotecan|topotecan|mesh-list
14571539|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571540|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571541|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571542|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571543|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571544|NCT00003946|Danazol|danazol|mesh-list
14571545|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14571546|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
14571547|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571548|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571549|NCT00003950|Cyclosporine|cyclosporine|mesh-list
14571550|NCT00003950|Irinotecan|irinotecan|mesh-list
14571551|NCT00003950|Cyclosporins|cyclosporins|mesh-list
14571552|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571553|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571554|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571555|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571556|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571557|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571558|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
15151389|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15151390|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151391|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151392|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151393|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151394|NCT04205916|Analgesics|analgesics|mesh-ancestor
15151395|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
15151396|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151397|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15151398|NCT04205903|Paclitaxel|paclitaxel|mesh-list
15151399|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15151400|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15151401|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151402|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
15151403|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
15151404|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
15151405|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151406|NCT04205929|Curcumin|curcumin|mesh-list
15151407|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151408|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151409|NCT04205929|Analgesics|analgesics|mesh-ancestor
15151410|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
15151411|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151412|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151413|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151414|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151415|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151416|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021332|NCT02774460|Lisinopril|lisinopril|mesh-list
14021333|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14021334|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14021335|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14021336|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021337|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14021338|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021339|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
14021340|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14021341|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14021342|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14571559|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571560|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
14571561|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571562|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
15151417|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151418|NCT04205643|Infliximab|infliximab|mesh-list
15151419|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
15151420|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15151421|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151422|NCT04205890|Ketamine|ketamine|mesh-list
14021343|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
14021344|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021345|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14021346|NCT02774460|Protective Agents|protective agents|mesh-ancestor
14021347|NCT02774499|Methadone|methadone|mesh-list
14021348|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14021349|NCT02774499|Narcotics|narcotics|mesh-ancestor
14021350|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021351|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021352|NCT02774499|Analgesics|analgesics|mesh-ancestor
14021353|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
14021354|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021355|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
14021356|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14021357|NCT02774525|Ethanol|ethanol|mesh-list
14021358|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14021359|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021360|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021361|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021362|NCT02774200|Apatinib|apatinib|mesh-list
14021363|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151423|NCT04205890|Analgesics|analgesics|mesh-ancestor
15151424|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
15151425|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151426|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151427|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15151428|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15151429|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
15151430|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
15151431|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151432|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15151433|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15151434|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151435|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151436|NCT04205682|Cannabidiol|cannabidiol|mesh-list
15151437|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
15180100|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180101|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180102|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180103|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
14021364|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14021365|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021366|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021367|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
14021368|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14021369|NCT02774239|Antibodies|antibodies|mesh-list
14021370|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
14021371|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
14021372|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021373|NCT02774044|Beractant|beractant|mesh-list
14021374|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
14021375|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14021376|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
14021377|NCT02774187|Leucovorin|leucovorin|mesh-list
14021378|NCT02774187|Fluorouracil|fluorouracil|mesh-list
14021379|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
14021380|NCT02774187|Sorafenib|sorafenib|mesh-list
14021381|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
14021382|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291547|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14021383|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14021384|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291548|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14291549|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14291550|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14291551|NCT00555061|Retapamulin|retapamulin|mesh-list
14291552|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14291553|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571563|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571564|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14571565|NCT00003951|Exatecan|exatecan|mesh-list
14571566|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571567|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571568|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571569|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571570|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571571|NCT00003953|Tamoxifen|tamoxifen|mesh-list
14571572|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
14571573|NCT00003953|Docetaxel|docetaxel|mesh-list
14571574|NCT00003953|Doxorubicin|doxorubicin|mesh-list
14571575|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14571576|NCT00003953|Fluorouracil|fluorouracil|mesh-list
14571577|NCT00003953|Methotrexate|methotrexate|mesh-list
14571578|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571579|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
14571580|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571581|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571582|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571583|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
14571584|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571585|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571586|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571587|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571588|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571589|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571590|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571591|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571592|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571593|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571594|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
14571595|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571596|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14571597|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
14571598|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14571599|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
14571600|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14571601|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571602|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14571603|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
14571604|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571605|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14571606|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14571607|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14571608|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14571609|NCT00003954|Cyclosporine|cyclosporine|mesh-list
14571610|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
14571611|NCT00003954|Melphalan|melphalan|mesh-list
14571612|NCT00003954|Cyclosporins|cyclosporins|mesh-list
14571613|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571614|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571615|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571616|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
14571617|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571618|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
14571619|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571620|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
14021385|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021386|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
14021387|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021388|NCT02774187|Antidotes|antidotes|mesh-ancestor
14021389|NCT02774187|Protective Agents|protective agents|mesh-ancestor
14021390|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
15151438|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
15151439|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15151440|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15151441|NCT04205578|Protective Agents|protective agents|mesh-ancestor
15151442|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151443|NCT04205565|Oxiracetam|oxiracetam|mesh-list
15151444|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15151445|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
14021391|NCT02774187|Vitamins|vitamins|mesh-ancestor
14021392|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
14571621|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814000|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15151446|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
14571622|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14571623|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571624|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571625|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14571626|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
14571627|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14571628|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571629|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
14571630|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571631|NCT00003955|Dactinomycin|dactinomycin|mesh-list
15151447|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15151448|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151449|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151450|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151451|NCT04205539|Analgesics|analgesics|mesh-ancestor
15151452|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
15151453|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151454|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15151455|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15151456|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15151457|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151458|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151459|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151460|NCT04205552|Nivolumab|nivolumab|mesh-list
15151461|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15151462|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15151463|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151464|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15151465|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151466|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
15151467|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
15151468|NCT04205240|Melphalan|melphalan|mesh-list
15151469|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
15151470|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15151471|NCT04205240|Fludarabine|fludarabine|mesh-list
15151472|NCT04205240|Daratumumab|daratumumab|mesh-list
15151473|NCT04205240|Tacrolimus|tacrolimus|mesh-list
15151474|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15151475|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
15151476|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151477|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151478|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15151479|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
15151480|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151481|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151482|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15151483|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15151484|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151485|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15151486|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15151487|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
15151488|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151489|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151490|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15151491|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15151492|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15151493|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15151494|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15151495|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151496|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151497|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151498|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151499|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
15151500|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15151501|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151502|NCT04205305|Labetalol|labetalol|mesh-list
15151503|NCT04205305|Nicardipine|nicardipine|mesh-list
15151504|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15151505|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15151506|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151507|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151508|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151509|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026048|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14571632|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
14571633|NCT00003955|Irinotecan|irinotecan|mesh-list
14571634|NCT00003955|Vincristine|vincristine|mesh-list
14571635|NCT00003955|Sargramostim|sargramostim|mesh-list
14571636|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571637|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
14571638|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151510|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15151511|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
15151512|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
15151513|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151514|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15151515|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15151516|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15151517|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151518|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15151519|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
15151520|NCT04205344|Bupivacaine|bupivacaine|mesh-list
15151521|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
15151522|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
15151523|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151524|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151525|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
15151526|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151527|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
15151528|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151529|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151530|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151531|NCT04205357|Analgesics|analgesics|mesh-ancestor
15151532|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
15151533|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151534|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151535|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151536|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151537|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15151538|NCT04205097|Neostigmine|neostigmine|mesh-list
15151539|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15151540|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151541|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151542|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
15151543|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151544|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151545|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15151546|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
15151547|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151548|NCT04204837|Nivolumab|nivolumab|mesh-list
15151549|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15151550|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151551|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15151552|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151553|NCT04204980|Daratumumab|daratumumab|mesh-list
15151554|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15151555|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151556|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
15151557|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151558|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
15151559|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
15151560|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151561|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151562|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15151563|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15151564|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151565|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151566|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151567|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15151568|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15151569|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15151570|NCT04205058|Caffeine|caffeine|mesh-list
14571639|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571640|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571641|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
14571642|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151571|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14814001|NCT00861120|Panitumumab|panitumumab|mesh-list
14571643|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571644|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571645|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571646|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571647|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571648|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571649|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571650|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571651|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571652|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14571653|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571654|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571655|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14571656|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571657|NCT00003956|Leucovorin|leucovorin|mesh-list
14571658|NCT00003956|Fluorouracil|fluorouracil|mesh-list
14571659|NCT00003956|Calcium|calcium|mesh-list
15151572|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151573|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15151574|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151575|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151576|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15151577|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15151578|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
15151579|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151580|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
15151581|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15151582|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151583|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151584|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151585|NCT04204798|Analgesics|analgesics|mesh-ancestor
15151586|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
15151587|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151588|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15151589|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15151590|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15151591|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
15151592|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151593|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151594|NCT04204772|Charcoal|charcoal|mesh-list
15151595|NCT04204772|Antidotes|antidotes|mesh-ancestor
15151596|NCT04204772|Protective Agents|protective agents|mesh-ancestor
15151597|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151598|NCT04204577|Apatinib|apatinib|mesh-list
15151599|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151600|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15151601|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151602|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151603|NCT04204902|Tepotinib|tepotinib|mesh-list
15151604|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151605|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
15151606|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15151607|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
15151608|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151609|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
15151610|NCT04204278|Protective Agents|protective agents|mesh-ancestor
15151611|NCT04204382|Levofloxacin|levofloxacin|mesh-list
15151612|NCT04204382|Ofloxacin|ofloxacin|mesh-list
15151613|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15151614|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151615|NCT04204382|Renal Agents|renal agents|mesh-ancestor
15151616|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151617|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15151618|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15151619|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151620|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151621|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151622|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15151623|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15151624|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15151625|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
15151626|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15151627|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14571660|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
15151628|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
14571661|NCT00003956|Lonafarnib|lonafarnib|mesh-list
14571662|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14571663|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571664|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
14571665|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571666|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571667|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571668|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571669|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
15151629|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151630|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151631|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
15151632|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15151633|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
15151634|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151635|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
15151636|NCT04204083|Protective Agents|protective agents|mesh-ancestor
15151637|NCT04204096|Vaccines|vaccines|mesh-list
15151638|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
15151639|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151640|NCT04204304|Isotretinoin|isotretinoin|mesh-list
15151641|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
15151642|NCT04204044|Folic Acid|folic acid|mesh-list
15151643|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
15151644|NCT04204044|Inositol|inositol|mesh-list
15151645|NCT04204044|Metformin|metformin|mesh-list
15151646|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15151647|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151648|NCT04204044|Hematinics|hematinics|mesh-ancestor
15151649|NCT04204044|Vitamins|vitamins|mesh-ancestor
15151650|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
15151651|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
15151652|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15151653|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
15151654|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151655|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
15151656|NCT04204265|Protective Agents|protective agents|mesh-ancestor
15151657|NCT04203732|Anesthetics|anesthetics|mesh-list
14021393|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15151658|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151659|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180104|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180105|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
15180106|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15180107|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15180108|NCT03942861|Prednisolone|prednisolone|mesh-list
15180109|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
15180110|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14021394|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021395|NCT02774291|Aldesleukin|aldesleukin|mesh-list
14571670|NCT00003956|Antidotes|antidotes|mesh-ancestor
14571671|NCT00003956|Protective Agents|protective agents|mesh-ancestor
15180111|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
15180112|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180113|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
15180114|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
15180115|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180116|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180117|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180118|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
15180119|NCT03942861|Hormones|hormones|mesh-ancestor
15180120|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180121|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15180122|NCT03942861|Protective Agents|protective agents|mesh-ancestor
15180123|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15180124|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180125|NCT03942991|Mepivacaine|mepivacaine|mesh-list
15180126|NCT03942991|Carticaine|carticaine|mesh-list
15180127|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
15180128|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
15180129|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180130|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180131|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
15180132|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180133|NCT03942757|Bilirubin|bilirubin|mesh-list
15180134|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
15180135|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021396|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
14571672|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
15151660|NCT04203771|Ibuprofen|ibuprofen|mesh-list
15151661|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151662|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151663|NCT04203771|Analgesics|analgesics|mesh-ancestor
15151664|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
15151665|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151666|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151667|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151668|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151669|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15151670|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151671|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151672|NCT04203914|Empagliflozin|empagliflozin|mesh-list
15151673|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15151674|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151675|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15151676|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151677|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
15151678|NCT04203680|Tryptophan|tryptophan|mesh-list
15151679|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15151680|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15151681|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
15151682|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15151683|NCT04203186|Lumefantrine|lumefantrine|mesh-list
15151684|NCT04203186|Artemether|artemether|mesh-list
15151685|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15151686|NCT04203186|Atovaquone|atovaquone|mesh-list
15151687|NCT04203186|Proguanil|proguanil|mesh-list
15151688|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
15151689|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
15151690|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15151691|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15151692|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151693|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571673|NCT00003956|Vitamins|vitamins|mesh-ancestor
14571674|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
14571675|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571676|NCT00003957|Cytarabine|cytarabine|mesh-list
14571677|NCT00003957|Paclitaxel|paclitaxel|mesh-list
14571678|NCT00003957|Etoposide|etoposide|mesh-list
14571679|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
14571680|NCT00003957|Melphalan|melphalan|mesh-list
14571681|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
15151694|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151695|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
15151696|NCT04203342|Ketoconazole|ketoconazole|mesh-list
15151697|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
15151698|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151699|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15151700|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15151701|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151702|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151703|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15151704|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
15151705|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151706|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151707|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15151708|NCT04203368|Adenosine|adenosine|mesh-list
15151709|NCT04203368|Verapamil|verapamil|mesh-list
15151710|NCT04203368|Analgesics|analgesics|mesh-ancestor
15151711|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
15151712|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151713|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151714|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15151715|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
15151716|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15151717|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
15151718|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
15151719|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151720|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151721|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14571682|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571683|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571684|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571685|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571686|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571687|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571688|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571689|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
14571690|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571691|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571692|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571693|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
14571694|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571695|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571696|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571697|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151722|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15151723|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15151724|NCT04203472|Budesonide|budesonide|mesh-list
15151725|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14571698|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571699|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
14571700|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
14571701|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571702|NCT00003957|Analgesics|analgesics|mesh-ancestor
14571703|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
14571704|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14571705|NCT00003958|Dactinomycin|dactinomycin|mesh-list
14571706|NCT00003958|Cactinomycin|cactinomycin|mesh-list
14571707|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
14571708|NCT00003958|Vincristine|vincristine|mesh-list
14571709|NCT00003958|Topotecan|topotecan|mesh-list
14571710|NCT00003958|Sargramostim|sargramostim|mesh-list
14571711|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571712|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
14571713|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571714|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571715|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571716|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
14571717|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571718|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571719|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571720|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571721|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571722|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571723|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571724|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571725|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571726|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571727|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14571728|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571729|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571730|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14571731|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14571732|NCT00003959|Sargramostim|sargramostim|mesh-list
14571733|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
14571734|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571735|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
14571736|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14571737|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14571738|NCT00003960|Prednisolone|prednisolone|mesh-list
14571739|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
14571740|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
14571741|NCT00003960|Busulfan|busulfan|mesh-list
14571742|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14571743|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
14571744|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571745|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
14571746|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571747|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571748|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571749|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
14571750|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571751|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151726|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15151727|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
15151728|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151729|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571752|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15151730|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15151731|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
14571753|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151732|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
15151733|NCT04203472|Hormones|hormones|mesh-ancestor
15151734|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151735|NCT04203212|Goserelin|goserelin|mesh-list
15151736|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15151737|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151738|NCT04203056|Aripiprazole|aripiprazole|mesh-list
15151739|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
15151740|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
15151741|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15151742|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15151743|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15151744|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151745|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151746|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
15151747|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
15151748|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151749|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571754|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
14571755|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
14571756|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14571757|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14571758|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
14571759|NCT00003960|Hormones|hormones|mesh-ancestor
14571760|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571761|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14571762|NCT00003960|Protective Agents|protective agents|mesh-ancestor
14571763|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14571764|NCT00003961|Sargramostim|sargramostim|mesh-list
14571765|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
14571766|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571767|NCT00003962|Aldesleukin|aldesleukin|mesh-list
15151750|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15151751|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15151752|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
15151753|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15151754|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15151755|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15151756|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15151757|NCT04203043|Pycnogenols|pycnogenols|mesh-list
15151758|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15151759|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
15151760|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151761|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
15151762|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151763|NCT04203043|Protective Agents|protective agents|mesh-ancestor
15151764|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15151765|NCT04202809|Durvalumab|durvalumab|mesh-list
15151766|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15151767|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571768|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571769|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14571770|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14571771|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
14571772|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571773|NCT00003963|Rituximab|rituximab|mesh-list
14571774|NCT00003963|Vinorelbine|vinorelbine|mesh-list
14571775|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14571776|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571777|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
14571778|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571779|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571780|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571781|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571782|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571783|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571784|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571785|NCT00003966|Defibrotide|defibrotide|mesh-list
14571786|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14571787|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14571788|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151768|NCT04202978|Capecitabine|capecitabine|mesh-list
14021397|NCT02774291|Fludarabine|fludarabine|mesh-list
14021398|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
14021399|NCT02774291|Interleukin-2|interleukin-2|mesh-list
14021400|NCT02774291|Lenograstim|lenograstim|mesh-list
14571789|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15151769|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
15151770|NCT04202978|Apatinib|apatinib|mesh-list
14571790|NCT00003967|Etoposide|etoposide|mesh-list
14571791|NCT00003967|Topotecan|topotecan|mesh-list
14571792|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571793|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571794|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571795|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571796|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571797|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571798|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571799|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
14571800|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14571801|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
14571802|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571803|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571804|NCT00003970|Irinotecan|irinotecan|mesh-list
14571805|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571806|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571807|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571808|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571809|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571810|NCT00003972|Tamoxifen|tamoxifen|mesh-list
14571811|NCT00003972|Paclitaxel|paclitaxel|mesh-list
14571812|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
14571813|NCT00003972|Carboplatin|carboplatin|mesh-list
14571814|NCT00003972|Melphalan|melphalan|mesh-list
14571815|NCT00003972|Busulfan|busulfan|mesh-list
14571816|NCT00003972|Thiotepa|thiotepa|mesh-list
14571817|NCT00003972|Sargramostim|sargramostim|mesh-list
14571818|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571819|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571820|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571821|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571822|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571823|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571824|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571825|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
14571826|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571827|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571828|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571829|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
14571830|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571831|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14571832|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
14571833|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571834|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14571835|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14571836|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14571837|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14571838|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
14571839|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571840|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
14571841|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571842|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571843|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571844|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
14571845|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571846|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571847|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571848|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14571849|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571850|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14571851|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571852|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571853|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
15151771|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571854|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151772|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
14021401|NCT02774291|Sargramostim|sargramostim|mesh-list
14571855|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14571856|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571857|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571858|NCT00003984|Lintuzumab|lintuzumab|mesh-list
14571859|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14571860|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571861|NCT00003985|KRN 7000|krn 7000|mesh-list
14571862|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14571863|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
14571864|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571865|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571866|NCT00003991|Aldesleukin|aldesleukin|mesh-list
14571867|NCT00003991|Histamine|histamine|mesh-list
14571868|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
14571869|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571870|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14571871|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14571872|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
14571873|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571874|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
14571875|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
14571876|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14571877|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571878|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571879|NCT00003992|Tamoxifen|tamoxifen|mesh-list
14571880|NCT00003992|Paclitaxel|paclitaxel|mesh-list
14571881|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
14571882|NCT00003992|Doxorubicin|doxorubicin|mesh-list
14571883|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14571884|NCT00003992|Trastuzumab|trastuzumab|mesh-list
14571885|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571886|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571887|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571888|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571889|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571890|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571891|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571892|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
14571893|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571894|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14571895|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571896|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
14571897|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14571898|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14571899|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571900|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571901|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291554|NCT00555152|Lapatinib|lapatinib|mesh-list
14291555|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291556|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291557|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571902|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14571903|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14571904|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
14571905|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571906|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14571907|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14571908|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14571909|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14571910|NCT00003993|Aldesleukin|aldesleukin|mesh-list
14571911|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
14571912|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571913|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14571914|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14571915|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
14571916|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14571917|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14571918|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
14571919|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571920|NCT00003994|Carboplatin|carboplatin|mesh-list
14571921|NCT00003994|Fluorouracil|fluorouracil|mesh-list
15180136|NCT03942757|Protective Agents|protective agents|mesh-ancestor
14291558|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291559|NCT00555217|Losartan|losartan|mesh-list
14291560|NCT00555217|Lisinopril|lisinopril|mesh-list
14291561|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14571922|NCT00003994|Vincristine|vincristine|mesh-list
14571923|NCT00003994|Amifostine|amifostine|mesh-list
14571924|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571925|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
14571926|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571927|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571928|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14571929|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
14571930|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571931|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571932|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571933|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571934|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571935|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14571936|NCT00003994|Protective Agents|protective agents|mesh-ancestor
14571937|NCT00003995|Trastuzumab|trastuzumab|mesh-list
14571938|NCT00003995|Irinotecan|irinotecan|mesh-list
14571939|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14571940|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571941|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14571942|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571943|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571944|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571945|NCT00003996|Etoposide|etoposide|mesh-list
14571946|NCT00003996|Carmustine|carmustine|mesh-list
14571947|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571948|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571949|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571950|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571951|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571952|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571953|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571954|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
14571955|NCT00003997|Irofulven|irofulven|mesh-list
14571956|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571957|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
14571958|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571959|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571960|NCT00003998|Paclitaxel|paclitaxel|mesh-list
14571961|NCT00003998|Docetaxel|docetaxel|mesh-list
14571962|NCT00003998|Carboplatin|carboplatin|mesh-list
14571963|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14571964|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571965|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571966|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571967|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571968|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571969|NCT00004001|Prednisone|prednisone|mesh-list
14571970|NCT00004001|Docetaxel|docetaxel|mesh-list
14571971|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
14571972|NCT00004001|Estramustine|estramustine|mesh-list
14571973|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571974|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
14571975|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
14571976|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
14571977|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14571978|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14571979|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
14571980|NCT00004001|Hormones|hormones|mesh-ancestor
14571981|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14571982|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14571983|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14571984|NCT00004001|Analgesics|analgesics|mesh-ancestor
14571985|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
14571986|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14571987|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14571988|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14571989|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14571990|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14571991|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
14571992|NCT00004002|Bortezomib|bortezomib|mesh-list
14571993|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571994|NCT00004003|Gemcitabine|gemcitabine|mesh-list
14571995|NCT00004003|Fluorouracil|fluorouracil|mesh-list
14571996|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14571997|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14571998|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
14571999|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021402|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021403|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
14021404|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021405|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021406|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572000|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
14572001|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572002|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572003|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572004|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
14572005|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572006|NCT00004004|Procarbazine|procarbazine|mesh-list
14572007|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572008|NCT00004005|Leucovorin|leucovorin|mesh-list
14572009|NCT00004005|Fluorouracil|fluorouracil|mesh-list
14572010|NCT00004005|Irinotecan|irinotecan|mesh-list
14572011|NCT00004005|Calcium|calcium|mesh-list
14572012|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
14572013|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14572014|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572015|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
14572016|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572017|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572018|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572019|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572020|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
14572021|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572022|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15151773|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151774|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151775|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15151776|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151777|NCT04203511|Paclitaxel|paclitaxel|mesh-list
14572023|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572024|NCT00004005|Antidotes|antidotes|mesh-ancestor
14572025|NCT00004005|Protective Agents|protective agents|mesh-ancestor
14572026|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
14572027|NCT00004005|Vitamins|vitamins|mesh-ancestor
14572028|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
14572029|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
14572030|NCT00004006|Carboplatin|carboplatin|mesh-list
14572031|NCT00004006|Doxorubicin|doxorubicin|mesh-list
14572032|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572033|NCT00004006|Etoposide|etoposide|mesh-list
14572034|NCT00004006|Topotecan|topotecan|mesh-list
14572035|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572036|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
14572037|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572038|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572039|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572040|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
14572041|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572042|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572043|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572044|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572045|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572046|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572047|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572048|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572049|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15151778|NCT04203511|Etoposide|etoposide|mesh-list
15151779|NCT04203511|Carboplatin|carboplatin|mesh-list
14572050|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
14572051|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14572052|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
14572053|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572054|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572055|NCT00004009|Tipifarnib|tipifarnib|mesh-list
14572056|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572057|NCT00004010|Prednisone|prednisone|mesh-list
15151780|NCT04203511|Pemetrexed|pemetrexed|mesh-list
15151781|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572058|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
14572059|NCT00004010|Dacarbazine|dacarbazine|mesh-list
14572060|NCT00004010|Doxorubicin|doxorubicin|mesh-list
14572061|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572062|NCT00004010|Etoposide|etoposide|mesh-list
14572063|NCT00004010|Vincristine|vincristine|mesh-list
14572064|NCT00004010|Bleomycin|bleomycin|mesh-list
14572065|NCT00004010|Vinblastine|vinblastine|mesh-list
14572066|NCT00004010|Procarbazine|procarbazine|mesh-list
14572067|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572068|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
14572069|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572070|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572071|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572072|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
14572073|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572074|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572075|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572076|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572077|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572078|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572079|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572080|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14572081|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
14572082|NCT00004010|Hormones|hormones|mesh-ancestor
14572083|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14572084|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14572085|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572086|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572087|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572088|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572089|NCT00004011|Paclitaxel|paclitaxel|mesh-list
14572090|NCT00004011|Carboplatin|carboplatin|mesh-list
14572091|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572092|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572093|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572094|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572095|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572096|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572097|NCT00004012|Capecitabine|capecitabine|mesh-list
14572098|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572099|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
14572100|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572101|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572102|NCT00004013|Paclitaxel|paclitaxel|mesh-list
14572103|NCT00004013|Trastuzumab|trastuzumab|mesh-list
14572104|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572105|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572106|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572107|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572108|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572109|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572110|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572111|NCT00004014|Doxorubicin|doxorubicin|mesh-list
14572112|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572113|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572114|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572115|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572116|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572117|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572118|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572119|NCT00004016|Interferons|interferons|mesh-list
14572120|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
14572121|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572122|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
14572123|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572124|NCT00004017|Antibodies|antibodies|mesh-list
14572125|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14572126|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
14572127|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572128|NCT00004022|Aldesleukin|aldesleukin|mesh-list
14572129|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
14572130|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572131|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14572132|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14572133|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
14572134|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572135|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
14572136|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572137|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572138|NCT00004024|Aldesleukin|aldesleukin|mesh-list
14572139|NCT00004024|Sargramostim|sargramostim|mesh-list
14572140|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
14572141|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
14572142|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572143|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572144|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14572145|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14572146|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
14572147|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572148|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572149|NCT00004025|Aldesleukin|aldesleukin|mesh-list
14572150|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572151|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14572152|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14572153|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
14572154|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572155|NCT00004028|Carmustine|carmustine|mesh-list
14572156|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572157|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
14572158|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572159|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572160|NCT00004029|Sargramostim|sargramostim|mesh-list
14572161|NCT00004029|Vaccines|vaccines|mesh-list
14572162|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
14572163|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572164|NCT00004030|Doxorubicin|doxorubicin|mesh-list
14572165|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572166|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572167|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572168|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572169|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572170|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572171|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572172|NCT00004032|Interferons|interferons|mesh-list
14572173|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
14572174|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572175|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
14572176|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572177|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
14572178|NCT00004036|Carboplatin|carboplatin|mesh-list
14572179|NCT00004036|Sargramostim|sargramostim|mesh-list
14572180|NCT00004036|Amifostine|amifostine|mesh-list
14572181|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572182|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
14572183|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572184|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572185|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572186|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
14572187|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572188|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572189|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572190|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14572191|NCT00004036|Protective Agents|protective agents|mesh-ancestor
14572192|NCT00004037|Docetaxel|docetaxel|mesh-list
14572193|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572194|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572195|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572196|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572197|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572198|NCT00004039|Interferons|interferons|mesh-list
14572199|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
14572200|NCT00004039|Prednisone|prednisone|mesh-list
14572201|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
14572202|NCT00004039|Rituximab|rituximab|mesh-list
14572203|NCT00004039|Doxorubicin|doxorubicin|mesh-list
14572204|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572205|NCT00004039|Vincristine|vincristine|mesh-list
14572206|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572207|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
14572208|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572209|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572210|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572211|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
14572212|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572213|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572214|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572215|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572216|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572217|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572218|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572219|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572220|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14572221|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
14572222|NCT00004039|Hormones|hormones|mesh-ancestor
14572223|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14572224|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14572225|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
14572226|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572227|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572228|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572229|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572230|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572231|NCT00004040|Interferons|interferons|mesh-list
14572232|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
14572233|NCT00004040|Rituximab|rituximab|mesh-list
14572234|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572235|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572236|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
14572237|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572238|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572239|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
14572240|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572241|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14572242|NCT00004042|Antibodies|antibodies|mesh-list
14572243|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
14572244|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14572245|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
14572246|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572247|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572248|NCT00004043|Calcitriol|calcitriol|mesh-list
14572249|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14572250|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572251|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14572252|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14572253|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572254|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14572255|NCT00004043|Vitamins|vitamins|mesh-ancestor
14572256|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
15151782|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151783|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572257|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14572258|NCT00004045|Exatecan|exatecan|mesh-list
14572259|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572260|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572261|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572262|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572263|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572264|NCT00004046|Exatecan|exatecan|mesh-list
14572265|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572266|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572267|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151784|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
15151785|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
15151786|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151787|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15151788|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15151789|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572268|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572269|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572270|NCT00004047|Exatecan|exatecan|mesh-list
14572271|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572272|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572273|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572274|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572275|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572276|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14572277|NCT00004048|Doxorubicin|doxorubicin|mesh-list
14572278|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572279|NCT00004048|Antibodies|antibodies|mesh-list
14572280|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
14572281|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14572282|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
14572283|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572284|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572285|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572286|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572287|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572288|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572289|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572290|NCT00004050|Interleukin-2|interleukin-2|mesh-list
14572291|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572292|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14572293|NCT00004050|Analgesics|analgesics|mesh-ancestor
14572294|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
14572295|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14572296|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572297|NCT00004051|Irinotecan|irinotecan|mesh-list
14572298|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572299|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572300|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572301|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572302|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572303|NCT00004055|Paclitaxel|paclitaxel|mesh-list
14572304|NCT00004055|Topotecan|topotecan|mesh-list
14572305|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572306|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572307|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572308|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572309|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572310|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572311|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572312|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572313|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572314|NCT00004056|Cytarabine|cytarabine|mesh-list
14572315|NCT00004056|Thioguanine|thioguanine|mesh-list
14572316|NCT00004056|Melphalan|melphalan|mesh-list
14572317|NCT00004056|Daunorubicin|daunorubicin|mesh-list
14572318|NCT00004056|Asparaginase|asparaginase|mesh-list
14572319|NCT00004056|Lenograstim|lenograstim|mesh-list
14572320|NCT00004056|Sargramostim|sargramostim|mesh-list
14572321|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572322|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
14572323|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572324|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572325|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
14572326|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572327|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572328|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
14572329|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572330|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14572331|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572332|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
14572333|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572334|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572335|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572336|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572337|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572338|NCT00004057|Paclitaxel|paclitaxel|mesh-list
14572339|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572340|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572341|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572342|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572343|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572344|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572345|NCT00004059|Fluorouracil|fluorouracil|mesh-list
14572346|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14572347|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
14572348|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572349|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572350|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572351|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572352|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
14572353|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572354|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14572355|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572356|NCT00004060|Exatecan|exatecan|mesh-list
14572357|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572358|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572359|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572360|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572361|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572362|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
14572363|NCT00004061|Ifosfamide|ifosfamide|mesh-list
14572364|NCT00004061|Etoposide|etoposide|mesh-list
14572365|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572366|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
14572367|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572368|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572369|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572370|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
14572371|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572372|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572373|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572374|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572375|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572376|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572377|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572378|NCT00004062|Azacitidine|azacitidine|mesh-list
14572379|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572380|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
14572381|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572382|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572383|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572384|NCT00004063|Gemcitabine|gemcitabine|mesh-list
14572385|NCT00004063|Interferons|interferons|mesh-list
14572386|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
14572387|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572388|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572389|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
14572390|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572391|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
14572392|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572393|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572394|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572395|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
14572396|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643855|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643856|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
14643857|NCT00190515|Vitamins|vitamins|mesh-ancestor
14643858|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
14643859|NCT00190554|Cisplatin|cisplatin|mesh-list
14643860|NCT00190554|Fluorouracil|fluorouracil|mesh-list
14643861|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643862|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
14643863|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643864|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643865|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14643866|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
14643867|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643868|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14643869|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643870|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643871|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643872|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643873|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643874|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643875|NCT00190567|Analgesics|analgesics|mesh-ancestor
14643876|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
14643877|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643878|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643879|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643880|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
14643881|NCT00190580|Valsartan|valsartan|mesh-list
14643882|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
14643883|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14643884|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14643885|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643886|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14643887|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14643888|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
14643889|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14643890|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151790|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15151791|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15151792|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
15151793|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
15151794|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572397|NCT00004064|Oregovomab|oregovomab|mesh-list
14572398|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572399|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572400|NCT00004066|Gemcitabine|gemcitabine|mesh-list
14572401|NCT00004066|Docetaxel|docetaxel|mesh-list
14572402|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572403|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
14572404|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572405|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572406|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
14572407|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572408|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572409|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572410|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
14572411|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572412|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572413|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572414|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572415|NCT00004067|Paclitaxel|paclitaxel|mesh-list
14572416|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
14572417|NCT00004067|Doxorubicin|doxorubicin|mesh-list
14572418|NCT00004067|Trastuzumab|trastuzumab|mesh-list
14572419|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572420|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15151795|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
15151796|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
15151797|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15151798|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15151799|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
15151800|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151801|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151802|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15151803|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
15151804|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151805|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151806|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15151807|NCT04203485|Paclitaxel|paclitaxel|mesh-list
15151808|NCT04203485|Carboplatin|carboplatin|mesh-list
15151809|NCT04203485|Pemetrexed|pemetrexed|mesh-list
15151810|NCT04203485|Apatinib|apatinib|mesh-list
15151811|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15151812|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151813|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
15151814|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
15151815|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
15151816|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151817|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151818|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15151819|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15151820|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15151821|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
15151822|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
14572421|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572422|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572423|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572424|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572425|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572426|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572427|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
14572428|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572429|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572430|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572431|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
14572432|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572433|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572434|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15151823|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15151824|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
15151825|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572435|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572436|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151826|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
14572437|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572438|NCT00004068|Irinotecan|irinotecan|mesh-list
14572439|NCT00004068|Temozolomide|temozolomide|mesh-list
14572440|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572441|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15151827|NCT04202692|Protective Agents|protective agents|mesh-ancestor
15151828|NCT04202692|Antacids|antacids|mesh-ancestor
15151829|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151830|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15151831|NCT04202887|Fentanyl|fentanyl|mesh-list
15151832|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15151833|NCT04202887|Narcotics|narcotics|mesh-ancestor
15151834|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151835|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151836|NCT04202887|Analgesics|analgesics|mesh-ancestor
15151837|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
15151838|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151839|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15151840|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15151841|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
15151842|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
15151843|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15151844|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151845|NCT04202536|Tenofovir|tenofovir|mesh-list
15151846|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
15151847|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151848|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14572442|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572443|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572444|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572445|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572446|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
14572447|NCT00004070|Interleukin-12|interleukin-12|mesh-list
14572448|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14572449|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
14572450|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572451|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14572452|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14572453|NCT00004070|Growth Substances|growth substances|mesh-ancestor
14572454|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
14572455|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572456|NCT00004071|Prednisone|prednisone|mesh-list
14572457|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
14572458|NCT00004071|Leflunomide|leflunomide|mesh-list
14572459|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14572460|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
14572461|NCT00004071|Hormones|hormones|mesh-ancestor
14572462|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14572463|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572464|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14572465|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572466|NCT00004071|Analgesics|analgesics|mesh-ancestor
14572467|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
14572468|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14572469|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572470|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572471|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572472|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572473|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572474|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
14572475|NCT00004072|Carmustine|carmustine|mesh-list
14572476|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14572477|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572478|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
14572479|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572480|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572481|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572482|NCT00004073|Suramin|suramin|mesh-list
14572483|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
14572484|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
14572485|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14572486|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572487|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572488|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14572489|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15151849|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14572490|NCT00004074|Carboplatin|carboplatin|mesh-list
14572491|NCT00004074|Trastuzumab|trastuzumab|mesh-list
14572492|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14572493|NCT00004074|Interleukin-12|interleukin-12|mesh-list
14572494|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572495|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572496|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14572497|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
14572498|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572499|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14572500|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14572501|NCT00004074|Growth Substances|growth substances|mesh-ancestor
14572502|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
14572503|NCT00004077|Paclitaxel|paclitaxel|mesh-list
14572504|NCT00004077|Ifosfamide|ifosfamide|mesh-list
14572505|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572506|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572507|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572508|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572509|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572510|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572511|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572512|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
14572513|NCT00004078|Irinotecan|irinotecan|mesh-list
14572514|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572515|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572516|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572517|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572518|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572519|NCT00004081|Docetaxel|docetaxel|mesh-list
14572520|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572521|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572522|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572523|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572524|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572525|NCT00004082|Gemcitabine|gemcitabine|mesh-list
14572526|NCT00004082|Carboplatin|carboplatin|mesh-list
14572527|NCT00004082|Docetaxel|docetaxel|mesh-list
14572528|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572529|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572530|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
14572531|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151850|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151851|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572532|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
14572533|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572534|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572535|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572536|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
14572537|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572538|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572539|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572540|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572541|NCT00004083|Cisplatin|cisplatin|mesh-list
14572542|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572543|NCT00004084|Epratuzumab|epratuzumab|mesh-list
14572544|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572545|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572546|NCT00004085|Antibodies|antibodies|mesh-list
14572547|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14572548|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
14572549|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572550|NCT00004086|Cytarabine|cytarabine|mesh-list
14021407|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
14021408|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021409|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572551|NCT00004086|Etoposide|etoposide|mesh-list
14572552|NCT00004086|Ifosfamide|ifosfamide|mesh-list
14572553|NCT00004086|Epratuzumab|epratuzumab|mesh-list
14572554|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572555|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15151852|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14021410|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572556|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572557|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572558|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151853|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14572559|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572560|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572561|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
14572562|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
14572563|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572564|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572565|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
14572566|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572567|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572568|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
14572569|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572570|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14572571|NCT00004087|Antibodies|antibodies|mesh-list
14572572|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
14572573|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14572574|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
14572575|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572576|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572577|NCT00004089|Paclitaxel|paclitaxel|mesh-list
14572578|NCT00004089|Fluorouracil|fluorouracil|mesh-list
14572579|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
14572580|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572581|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572582|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572583|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572584|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572585|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572586|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
14572587|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572588|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572589|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
14572590|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572591|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
14572592|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572593|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14572594|NCT00004090|Gemcitabine|gemcitabine|mesh-list
14572595|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572596|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572597|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
14572598|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572599|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
14572600|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572601|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572602|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15151854|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
15151855|NCT04202484|Tegafur|tegafur|mesh-list
15151856|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151857|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572603|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
14572604|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572605|NCT00004091|Antibodies|antibodies|mesh-list
14572606|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
14572607|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572608|NCT00004094|Paclitaxel|paclitaxel|mesh-list
14572609|NCT00004094|Carboplatin|carboplatin|mesh-list
14572610|NCT00004094|Fluorouracil|fluorouracil|mesh-list
14572611|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
14572612|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572613|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572614|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572615|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572616|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572617|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572618|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
14572619|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572620|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572621|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
14572622|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572623|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
14572624|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572625|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14572626|NCT00004095|Gemcitabine|gemcitabine|mesh-list
15151858|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
15151859|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572627|NCT00004095|Irinotecan|irinotecan|mesh-list
15151860|NCT04202380|Azithromycin|azithromycin|mesh-list
14572628|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572629|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
14572630|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572631|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572632|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
14572633|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572634|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572635|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572636|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
14572637|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572638|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572639|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572640|NCT00004097|Gemcitabine|gemcitabine|mesh-list
14572641|NCT00004097|Paclitaxel|paclitaxel|mesh-list
14572642|NCT00004097|Fluorouracil|fluorouracil|mesh-list
14572643|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572644|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572645|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572646|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572647|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572648|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151861|NCT04202380|Ampicillin|ampicillin|mesh-list
15151862|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151863|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026049|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572649|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572650|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
14572651|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
14572652|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572653|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572654|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572655|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
14572656|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572657|NCT00004099|Leucovorin|leucovorin|mesh-list
14572658|NCT00004099|Fluorouracil|fluorouracil|mesh-list
14572659|NCT00004099|Calcium|calcium|mesh-list
14572660|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
14572661|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572662|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14572663|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572664|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
14572665|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572666|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572667|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572668|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
14572669|NCT00004099|Antidotes|antidotes|mesh-ancestor
14572670|NCT00004099|Protective Agents|protective agents|mesh-ancestor
14572671|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
14572672|NCT00004099|Vitamins|vitamins|mesh-ancestor
14572673|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
14572674|NCT00004100|Gemcitabine|gemcitabine|mesh-list
14572675|NCT00004100|Vinorelbine|vinorelbine|mesh-list
14572676|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572677|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572678|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
14572679|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572680|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
14572681|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572682|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572683|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572684|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
14572685|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572686|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572687|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572688|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572689|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572690|NCT00004102|Leucovorin|leucovorin|mesh-list
14572691|NCT00004102|Fluorouracil|fluorouracil|mesh-list
14572692|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
14572693|NCT00004102|Calcium|calcium|mesh-list
14572694|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
14572695|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14572696|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572697|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
14572698|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572699|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15151864|NCT04202367|Bupivacaine|bupivacaine|mesh-list
15151865|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
15151866|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
15151867|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021411|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572700|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572701|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572702|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
14572703|NCT00004102|Antidotes|antidotes|mesh-ancestor
14572704|NCT00004102|Protective Agents|protective agents|mesh-ancestor
14572705|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
14572706|NCT00004102|Vitamins|vitamins|mesh-ancestor
14572707|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
14572708|NCT00004103|Irinotecan|irinotecan|mesh-list
14572709|NCT00004103|Floxuridine|floxuridine|mesh-list
14572710|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572711|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572712|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572713|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572714|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572715|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572716|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
14572717|NCT00004104|Interferons|interferons|mesh-list
14572718|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
14572719|NCT00004104|Interleukin-2|interleukin-2|mesh-list
14572720|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572721|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
14572722|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572723|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
14572724|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572725|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14572726|NCT00004104|Analgesics|analgesics|mesh-ancestor
14572727|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
14572728|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14572729|NCT00004105|Paclitaxel|paclitaxel|mesh-list
14572730|NCT00004105|Vinorelbine|vinorelbine|mesh-list
14572731|NCT00004105|Estramustine|estramustine|mesh-list
14572732|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572733|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572734|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572735|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572736|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572737|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572738|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572739|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
14572740|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14572741|NCT00004107|Epratuzumab|epratuzumab|mesh-list
15151868|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151869|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
15151870|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151871|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
15151872|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15151873|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151874|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
15151875|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
15151876|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
15151877|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151878|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151879|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15151880|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15151881|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
15151882|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15151883|NCT04202406|Acetaminophen|acetaminophen|mesh-list
15151884|NCT04202406|Codeine|codeine|mesh-list
15151885|NCT04202406|Caffeine|caffeine|mesh-list
15151886|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151887|NCT04202406|Analgesics|analgesics|mesh-ancestor
15151888|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
15151889|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151890|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151891|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
15151892|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15151893|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14572742|NCT00004107|Antibodies|antibodies|mesh-list
14572743|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15151894|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021412|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
14572744|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
15151895|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572745|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572746|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572747|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572748|NCT00004108|Exatecan|exatecan|mesh-list
14572749|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572750|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572751|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572752|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572753|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572754|NCT00004109|Doxorubicin|doxorubicin|mesh-list
14572755|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572756|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572757|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572758|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572759|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572760|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572761|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572762|NCT00004110|Etoposide|etoposide|mesh-list
14572763|NCT00004110|Isotretinoin|isotretinoin|mesh-list
14572764|NCT00004110|Antibodies|antibodies|mesh-list
14572765|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14572766|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
14572767|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572768|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572769|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572770|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572771|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572772|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572773|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572774|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14572775|NCT00004112|Prednisone|prednisone|mesh-list
14572776|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
15151896|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15151897|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15151898|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
15151899|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14572777|NCT00004112|Rituximab|rituximab|mesh-list
14572778|NCT00004112|Doxorubicin|doxorubicin|mesh-list
14572779|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572780|NCT00004112|Vincristine|vincristine|mesh-list
14572781|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572782|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
14572783|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572784|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15151900|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15151901|NCT04202406|Narcotics|narcotics|mesh-ancestor
15151902|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151903|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
15151904|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
15151905|NCT04202224|Acetaminophen|acetaminophen|mesh-list
15151906|NCT04202224|Ibuprofen|ibuprofen|mesh-list
15151907|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15151908|NCT04202224|Analgesics|analgesics|mesh-ancestor
15151909|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
15151910|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151911|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151912|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
14572785|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572786|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
14572787|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572788|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572789|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572790|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14572791|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572792|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572793|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572794|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572795|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14572796|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
14572797|NCT00004112|Hormones|hormones|mesh-ancestor
15151913|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15151914|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151915|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572798|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14572799|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14572800|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572801|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572802|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572803|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572804|NCT00004113|Temozolomide|temozolomide|mesh-list
14572805|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572806|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
14572807|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572808|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572809|NCT00004114|Cytarabine|cytarabine|mesh-list
14572810|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
14572811|NCT00004114|Fludarabine|fludarabine|mesh-list
14572812|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
14572813|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572814|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
14572815|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572816|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572817|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572818|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
14572819|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572820|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572821|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572822|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572823|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
14572824|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
14572825|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572826|NCT00004115|Antibodies|antibodies|mesh-list
14572827|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14572828|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
14572829|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151916|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15151917|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151918|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151919|NCT04201964|Tenecteplase|tenecteplase|mesh-list
15151920|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15151921|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15151922|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291562|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14291563|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14572830|NCT00004122|Interferons|interferons|mesh-list
14572831|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
14572832|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
14572833|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572834|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
14572835|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14572836|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
14572837|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572838|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14572839|NCT00004123|Doxorubicin|doxorubicin|mesh-list
14572840|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572841|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572842|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572843|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572844|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572845|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572846|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572847|NCT00004125|Tamoxifen|tamoxifen|mesh-list
14572848|NCT00004125|Paclitaxel|paclitaxel|mesh-list
14572849|NCT00004125|Docetaxel|docetaxel|mesh-list
14572850|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
14572851|NCT00004125|Doxorubicin|doxorubicin|mesh-list
14572852|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14572853|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572854|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572855|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572856|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14291564|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14291565|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291566|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14291567|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
14291568|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291569|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14291570|NCT00555217|Protective Agents|protective agents|mesh-ancestor
14291571|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291572|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
14291573|NCT00555321|Abatacept|abatacept|mesh-list
14572857|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572858|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572859|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572860|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
14572861|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572862|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572863|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572864|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
14572865|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572866|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572867|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572868|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572869|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572870|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14572871|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
14572872|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14572873|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14572874|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14572875|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14572876|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14572877|NCT00004126|Paclitaxel|paclitaxel|mesh-list
14572878|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
15151923|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
15151924|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15151925|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15151926|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151927|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
15151928|NCT04201951|Coagulants|coagulants|mesh-ancestor
14572879|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572880|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572881|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572882|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572883|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572884|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572885|NCT00004127|Leucovorin|leucovorin|mesh-list
14572886|NCT00004127|Fluorouracil|fluorouracil|mesh-list
14572887|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
14572888|NCT00004127|Calcium|calcium|mesh-list
14572889|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
14572890|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14572891|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572892|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
14572893|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572894|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572895|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572896|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572897|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
14572898|NCT00004127|Antidotes|antidotes|mesh-ancestor
14572899|NCT00004127|Protective Agents|protective agents|mesh-ancestor
14572900|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
14572901|NCT00004127|Vitamins|vitamins|mesh-ancestor
14572902|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
14572903|NCT00004128|Cytarabine|cytarabine|mesh-list
14572904|NCT00004128|Aldesleukin|aldesleukin|mesh-list
14572905|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
14572906|NCT00004128|Busulfan|busulfan|mesh-list
14572907|NCT00004128|Etoposide|etoposide|mesh-list
14572908|NCT00004128|Daunorubicin|daunorubicin|mesh-list
14572909|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572910|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
14572911|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572912|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572913|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572914|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
14572915|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572916|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572917|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572918|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572919|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572920|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572921|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572922|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572923|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
14572924|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
14572925|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151929|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
14572926|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14572927|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14572928|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14572929|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
15151930|NCT04202068|Sulbactam|sulbactam|mesh-list
15151931|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15151932|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151933|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15151934|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151935|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180137|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180138|NCT03942926|Sirolimus|sirolimus|mesh-list
15180139|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14572930|NCT00004132|Ifosfamide|ifosfamide|mesh-list
14572931|NCT00004132|Etoposide|etoposide|mesh-list
14572932|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572933|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
14572934|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572935|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572936|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14021413|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14021414|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021415|NCT02774291|Analgesics|analgesics|mesh-ancestor
14021416|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
14021417|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14572937|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
14572938|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572939|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572940|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14572941|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572942|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14572943|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572944|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572945|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
14021418|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14021419|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14021420|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
14021421|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021422|NCT02774096|Xenon|xenon|mesh-list
14021423|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14021424|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
14021425|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
14572946|NCT00004135|Fludarabine|fludarabine|mesh-list
14572947|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
14572948|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572949|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
14572950|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572951|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14572952|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572953|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
14572954|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572955|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572956|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15180140|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180141|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15180142|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180143|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
15180144|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180145|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
14572957|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572958|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
14572959|NCT00004137|Paclitaxel|paclitaxel|mesh-list
14572960|NCT00004137|Carboplatin|carboplatin|mesh-list
14572961|NCT00004137|Topotecan|topotecan|mesh-list
14572962|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14572963|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572964|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14572965|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572966|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572967|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572968|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572969|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14021426|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291574|NCT00555321|Tacrolimus|tacrolimus|mesh-list
14291575|NCT00555321|Basiliximab|basiliximab|mesh-list
14572970|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572971|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14572972|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14572973|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572974|NCT00004139|Gemcitabine|gemcitabine|mesh-list
14572975|NCT00004139|Docetaxel|docetaxel|mesh-list
14572976|NCT00004139|Irinotecan|irinotecan|mesh-list
14572977|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14572978|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
14572979|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572980|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572981|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
14572982|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151936|NCT04201808|Tenofovir|tenofovir|mesh-list
15151937|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
15151938|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15151939|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15151940|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15151941|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151942|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14572983|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14572984|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14572985|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
14572986|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572987|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
15151943|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15151944|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15151945|NCT04201860|Hemostatics|hemostatics|mesh-list
15151946|NCT04201860|Coagulants|coagulants|mesh-ancestor
15151947|NCT04201990|Apatinib|apatinib|mesh-list
15151948|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151949|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15151950|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15151951|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151952|NCT04201665|Oxytocin|oxytocin|mesh-list
14572988|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14572989|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14572990|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14572991|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14572992|NCT00004141|Dacarbazine|dacarbazine|mesh-list
14572993|NCT00004141|Molgramostim|molgramostim|mesh-list
14572994|NCT00004141|Sargramostim|sargramostim|mesh-list
14572995|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14572996|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
14572997|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14572998|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14572999|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
14573000|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573001|NCT00004142|Fluorouracil|fluorouracil|mesh-list
14573002|NCT00004142|Floxuridine|floxuridine|mesh-list
14573003|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
14573004|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573005|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573006|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573007|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573008|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
14573009|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573010|NCT00004144|Gemcitabine|gemcitabine|mesh-list
14573011|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
14573012|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573013|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
14573014|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573015|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573016|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
14573017|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573018|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573019|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573020|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
14573021|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573022|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573023|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
14573024|NCT00004145|Fludarabine|fludarabine|mesh-list
14573025|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
14573026|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14573027|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15151953|NCT04201665|Carbetocin|carbetocin|mesh-list
14573028|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
15151954|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
14573029|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573030|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573031|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573032|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
14573033|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573034|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15151955|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15151956|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573035|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573036|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573037|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
14573038|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
14573039|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573040|NCT00004150|Leucovorin|leucovorin|mesh-list
14573041|NCT00004150|Fluorouracil|fluorouracil|mesh-list
14573042|NCT00004150|Calcium|calcium|mesh-list
14573043|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
14573044|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14573045|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573046|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
15151957|NCT04201678|Anesthetics|anesthetics|mesh-list
15151958|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151959|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151960|NCT04201769|Dexamethasone|dexamethasone|mesh-list
15151961|NCT04201769|Palonosetron|palonosetron|mesh-list
14573047|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573048|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573049|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573050|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573051|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
14573052|NCT00004150|Antidotes|antidotes|mesh-ancestor
14573053|NCT00004150|Protective Agents|protective agents|mesh-ancestor
14573054|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
14573055|NCT00004150|Vitamins|vitamins|mesh-ancestor
14573056|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
14573057|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14573058|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14573059|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573060|NCT00004154|Fenretinide|fenretinide|mesh-list
14573061|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573062|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14573063|NCT00004154|Protective Agents|protective agents|mesh-ancestor
14573064|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573065|NCT00004157|Oprelvekin|oprelvekin|mesh-list
14573066|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573067|NCT00004158|Melphalan|melphalan|mesh-list
14573068|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573069|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
15151962|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15151963|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
15151964|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
15151965|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151966|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151967|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14573070|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573071|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573072|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573073|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573074|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
14573075|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573076|NCT00004159|Gemcitabine|gemcitabine|mesh-list
14573077|NCT00004159|Paclitaxel|paclitaxel|mesh-list
14573078|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573079|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573080|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573081|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
15151968|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
15151969|NCT04201769|Hormones|hormones|mesh-ancestor
15151970|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15151971|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15151972|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573082|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
15151973|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15151974|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14573083|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573084|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573085|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
14573086|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
14573087|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573088|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573089|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573090|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
14573091|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573092|NCT00004160|Gemcitabine|gemcitabine|mesh-list
14573093|NCT00004160|Paclitaxel|paclitaxel|mesh-list
14573094|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573095|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573096|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573097|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573098|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573099|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573100|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573101|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
14573102|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
14573103|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573104|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573105|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573106|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
14573107|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573108|NCT00004161|Fenretinide|fenretinide|mesh-list
14573109|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573110|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14573111|NCT00004161|Protective Agents|protective agents|mesh-ancestor
15151975|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
15151976|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15151977|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151978|NCT04201561|Selenious Acid|selenious acid|mesh-list
15151979|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
15151980|NCT04201561|Paclitaxel|paclitaxel|mesh-list
15151981|NCT04201561|Carboplatin|carboplatin|mesh-list
15151982|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15151983|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021427|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573112|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573113|NCT00004162|Doxorubicin|doxorubicin|mesh-list
14573114|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573115|NCT00004162|Methotrexate|methotrexate|mesh-list
14573116|NCT00004162|Vincristine|vincristine|mesh-list
14573117|NCT00004162|Sargramostim|sargramostim|mesh-list
14573118|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573119|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573120|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573121|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573122|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573123|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573124|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14573125|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
14573126|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14573127|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573128|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573129|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
14573130|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14573131|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14573132|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573133|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
14573134|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573135|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14573136|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573137|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573138|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573139|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573140|NCT00004163|Trastuzumab|trastuzumab|mesh-list
14573141|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14573142|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573143|NCT00004164|Leucovorin|leucovorin|mesh-list
14573144|NCT00004164|Docetaxel|docetaxel|mesh-list
14573145|NCT00004164|Fluorouracil|fluorouracil|mesh-list
14573146|NCT00004164|Calcium|calcium|mesh-list
14573147|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
14573148|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573149|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573150|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
15151984|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
15151985|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
15151986|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573151|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573152|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573153|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14573154|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573155|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
14573156|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573157|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573158|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
14573159|NCT00004164|Antidotes|antidotes|mesh-ancestor
14573160|NCT00004164|Protective Agents|protective agents|mesh-ancestor
14573161|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
14573162|NCT00004164|Vitamins|vitamins|mesh-ancestor
14573163|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
14573164|NCT00004173|Paclitaxel|paclitaxel|mesh-list
14573165|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
14573166|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573167|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573168|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573169|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573170|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573171|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151987|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15151988|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151989|NCT04201561|Trace Elements|trace elements|mesh-ancestor
15151990|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
15151991|NCT04201652|Anesthetics|anesthetics|mesh-list
15151992|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
15151993|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15151994|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15151995|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
15151996|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15151997|NCT04201054|Fluconazole|fluconazole|mesh-list
15151998|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
14573172|NCT00004174|Paclitaxel|paclitaxel|mesh-list
14573173|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
14573174|NCT00004174|Thiotepa|thiotepa|mesh-list
14573175|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573176|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573177|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573178|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573179|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573180|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573181|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573182|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
14573183|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573184|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573185|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573186|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
14573187|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573188|NCT00004176|Etoposide|etoposide|mesh-list
14573189|NCT00004176|Amifostine|amifostine|mesh-list
14573190|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573191|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573192|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15151999|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152000|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15152001|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15152002|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573193|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573194|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573195|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573196|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14573197|NCT00004176|Protective Agents|protective agents|mesh-ancestor
14573198|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573199|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14573200|NCT00004177|Antibodies|antibodies|mesh-list
14573201|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
14573202|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14573203|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
14573204|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152003|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573205|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573206|NCT00004179|Prednisone|prednisone|mesh-list
14573207|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
14573208|NCT00004179|Rituximab|rituximab|mesh-list
14573209|NCT00004179|Doxorubicin|doxorubicin|mesh-list
14573210|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573211|NCT00004179|Vincristine|vincristine|mesh-list
14573212|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573213|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
14573214|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573215|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573216|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573217|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
14573218|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573219|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573220|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573221|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14573222|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573223|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573224|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573225|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573226|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14573227|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
14573228|NCT00004179|Hormones|hormones|mesh-ancestor
14573229|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573230|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14573231|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573232|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573233|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573234|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573235|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
14573236|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14573237|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573238|NCT00004183|Capecitabine|capecitabine|mesh-list
14573239|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573240|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
14573241|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573242|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573243|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14573244|NCT00004184|Antibodies|antibodies|mesh-list
14573245|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14573246|NCT00004184|Sargramostim|sargramostim|mesh-list
14573247|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
14573248|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
14573249|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573250|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573251|NCT00004184|Antacids|antacids|mesh-ancestor
14573252|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573253|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14573254|NCT00004186|Carboplatin|carboplatin|mesh-list
14573255|NCT00004186|Etoposide|etoposide|mesh-list
14573256|NCT00004186|Topotecan|topotecan|mesh-list
14573257|NCT00004186|Ifosfamide|ifosfamide|mesh-list
14573258|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573259|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573260|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573261|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573262|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573263|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573264|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14573265|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573266|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
15152004|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15152005|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
15152006|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152007|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152008|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15152009|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15152010|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
15152011|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152012|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152013|NCT04201249|Piroxicam|piroxicam|mesh-list
15152014|NCT04201249|Lidocaine|lidocaine|mesh-list
14573267|NCT00004187|Capecitabine|capecitabine|mesh-list
14573268|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
14573269|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573270|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
15152015|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
15152016|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
15152017|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152018|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152019|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
15152020|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152021|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15152022|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15152023|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15152024|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15152025|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152026|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15152027|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15152028|NCT04201249|Analgesics|analgesics|mesh-ancestor
15152029|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152030|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15152031|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15152032|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152033|NCT04200885|Dexamethasone|dexamethasone|mesh-list
15152034|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15152035|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15152036|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152037|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
15152038|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
15152039|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152040|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152041|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15152042|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
15152043|NCT04200885|Hormones|hormones|mesh-ancestor
14573271|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573272|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573273|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
14573274|NCT00004188|Melphalan|melphalan|mesh-list
14573275|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
14573276|NCT00004188|Cisplatin|cisplatin|mesh-list
14573277|NCT00004188|Carboplatin|carboplatin|mesh-list
14573278|NCT00004188|Doxorubicin|doxorubicin|mesh-list
14573279|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573280|NCT00004188|Etoposide|etoposide|mesh-list
14573281|NCT00004188|Vincristine|vincristine|mesh-list
14573282|NCT00004188|Topotecan|topotecan|mesh-list
14573283|NCT00004188|Isotretinoin|isotretinoin|mesh-list
14573284|NCT00004188|Lenograstim|lenograstim|mesh-list
14573285|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573286|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
14573287|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573288|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573289|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573290|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
14573291|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573292|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573293|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573294|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573295|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573296|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573297|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573298|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573299|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573300|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573301|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573302|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573303|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14573304|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
14573305|NCT00004189|Cisplatin|cisplatin|mesh-list
14573306|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573307|NCT00004190|Gemcitabine|gemcitabine|mesh-list
14573308|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
14573309|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573310|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
14573311|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573312|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573313|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
15152044|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152045|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14573314|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573315|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573316|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573317|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
14573318|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573319|NCT00004192|Cytarabine|cytarabine|mesh-list
14573320|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
14573321|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14573322|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14573323|NCT00004192|Prednisolone|prednisolone|mesh-list
14573324|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
14573325|NCT00004192|Etoposide|etoposide|mesh-list
14573326|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14573327|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
14573328|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573329|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573330|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573331|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573332|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573333|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573334|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573335|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
14021428|NCT02773979|Chloroquine|chloroquine|mesh-list
14573336|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
14573337|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573338|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573339|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
14573340|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021429|NCT02773979|Amebicides|amebicides|mesh-ancestor
14021430|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14021431|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14021432|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573341|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14573342|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
14573343|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
14573344|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14573345|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14573346|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
14573347|NCT00004192|Hormones|hormones|mesh-ancestor
14573348|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573349|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14573350|NCT00004192|Protective Agents|protective agents|mesh-ancestor
14573351|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14573352|NCT00004194|Fludarabine|fludarabine|mesh-list
14573353|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
14573354|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573355|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573356|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
14573357|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573358|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573359|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
14573360|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573361|NCT00004195|Eniluracil|eniluracil|mesh-list
14573362|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573363|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573364|NCT00004196|Interferons|interferons|mesh-list
14573365|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
14573366|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573367|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
14573368|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573369|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
14573370|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573371|NCT00004197|Prednisone|prednisone|mesh-list
14573372|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
14573373|NCT00004197|Doxorubicin|doxorubicin|mesh-list
14573374|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573375|NCT00004197|Vincristine|vincristine|mesh-list
14573376|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
14573377|NCT00004197|Sargramostim|sargramostim|mesh-list
14573378|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14573379|NCT00004197|Vaccines|vaccines|mesh-list
14573380|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573381|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
14573382|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573383|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021433|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
14021434|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573384|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573385|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
14573386|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573387|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573388|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573389|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573390|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573391|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573392|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573393|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14573394|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
14573395|NCT00004197|Hormones|hormones|mesh-ancestor
14573396|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573397|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14573398|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573399|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573400|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573401|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152046|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152047|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15152048|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15152049|NCT04200885|Analgesics|analgesics|mesh-ancestor
15152050|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
15152051|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15152052|NCT04200833|Golimumab|golimumab|mesh-list
15152053|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15152054|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152055|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573402|NCT00004197|Analgesics|analgesics|mesh-ancestor
14573403|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
14573404|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14573405|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573406|NCT00004198|Sargramostim|sargramostim|mesh-list
14573407|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14573408|NCT00004198|Vaccines|vaccines|mesh-list
14573409|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
14573410|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573411|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573412|NCT00004199|Gemcitabine|gemcitabine|mesh-list
14021435|NCT02774005|Idebenone|idebenone|mesh-list
14021436|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
14021437|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021438|NCT02774005|Protective Agents|protective agents|mesh-ancestor
14021439|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021440|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
14021441|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14021442|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021443|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021444|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021445|NCT02773797|Analgesics|analgesics|mesh-ancestor
14021446|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
14021447|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021448|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14573413|NCT00004199|Prinomastat|prinomastat|mesh-list
14573414|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573415|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573416|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
14573417|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573418|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
14573419|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573420|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152056|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
15152057|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152058|NCT04200599|Oxytocin|oxytocin|mesh-list
15152059|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
15152060|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15152061|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152062|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
15152063|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15152064|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152065|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15152066|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152067|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
14573421|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573422|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
15152068|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15152069|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152070|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573423|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573424|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
14573425|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
14643891|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14643892|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14643893|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14643894|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14643895|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643896|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643897|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643898|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643899|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643900|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643901|NCT00190606|Analgesics|analgesics|mesh-ancestor
14643902|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
14643903|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643904|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643905|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643906|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
14643907|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14643908|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643909|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643910|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643911|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643912|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643913|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643914|NCT00190619|Analgesics|analgesics|mesh-ancestor
14643915|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
14643916|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643917|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643918|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643919|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
14643920|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14643921|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643922|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643923|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643924|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643925|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643926|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152071|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15152072|NCT04200235|Analgesics|analgesics|mesh-ancestor
15152073|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
15152074|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152075|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14643927|NCT00190632|Analgesics|analgesics|mesh-ancestor
14643928|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
14643929|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152076|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15152077|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15152078|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
15152079|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152080|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152081|NCT04200092|Granisetron|granisetron|mesh-list
15152082|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
15152083|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
15152084|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152085|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152086|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15152087|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14643930|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643931|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643932|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
14643933|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14643934|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643935|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643936|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643937|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152088|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
14021449|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15152089|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152090|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152091|NCT04200222|Vanadium|vanadium|mesh-list
15152092|NCT04200222|Trace Elements|trace elements|mesh-ancestor
15152093|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
15152094|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573426|NCT00004200|Temozolomide|temozolomide|mesh-list
14573427|NCT00004200|Prinomastat|prinomastat|mesh-list
15180146|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180147|NCT03942796|Pregabalin|pregabalin|mesh-list
15180148|NCT03942796|Analgesics|analgesics|mesh-ancestor
15180149|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
15180150|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180151|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180152|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
15180153|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15180154|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15180155|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180156|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15180157|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15180158|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15180159|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180160|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15180161|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
15180162|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15180163|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15180164|NCT03942887|Prednisolone|prednisolone|mesh-list
15180165|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
15180166|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
14573428|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573429|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
14573430|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573431|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573432|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
14573433|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
14573434|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573435|NCT00004201|Gemcitabine|gemcitabine|mesh-list
14573436|NCT00004201|Carboplatin|carboplatin|mesh-list
14573437|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573438|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573439|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
14573440|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573441|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
14573442|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573443|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573444|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573445|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
14573446|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573447|NCT00004202|Paclitaxel|paclitaxel|mesh-list
15180167|NCT03942887|Rituximab|rituximab|mesh-list
15180168|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14573448|NCT00004202|Carboplatin|carboplatin|mesh-list
14573449|NCT00004202|Efaproxiral|efaproxiral|mesh-list
14573450|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573451|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573452|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573453|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573454|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573455|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573456|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
14573457|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
14573458|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573459|NCT00004204|Temozolomide|temozolomide|mesh-list
14573460|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573461|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
14573462|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573463|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573464|NCT00004205|Tamoxifen|tamoxifen|mesh-list
14573465|NCT00004205|Letrozole|letrozole|mesh-list
14573466|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573467|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573468|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14573469|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14573470|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180169|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
14573471|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14573472|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
14573473|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573474|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573475|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14573476|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14573477|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14573478|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14573479|NCT00004206|Leucovorin|leucovorin|mesh-list
14573480|NCT00004206|Fluorouracil|fluorouracil|mesh-list
14573481|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
14573482|NCT00004206|Calcium|calcium|mesh-list
14573483|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
14573484|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14573485|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573486|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
14573487|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573488|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573489|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573490|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573491|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
14573492|NCT00004206|Antidotes|antidotes|mesh-ancestor
14573493|NCT00004206|Protective Agents|protective agents|mesh-ancestor
14573494|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
14573495|NCT00004206|Vitamins|vitamins|mesh-ancestor
14573496|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
14573497|NCT00004207|Daunorubicin|daunorubicin|mesh-list
14573498|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573499|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573500|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573501|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573502|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573503|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573504|NCT00004209|Mitomycins|mitomycins|mesh-list
14573505|NCT00004209|Mitomycin|mitomycin|mesh-list
14573506|NCT00004209|Vinblastine|vinblastine|mesh-list
14573507|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573508|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573509|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
14573510|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573511|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14573512|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573513|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573514|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573515|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573516|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573517|NCT00004212|Exatecan|exatecan|mesh-list
14573518|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14573519|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573520|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573521|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152095|NCT04200040|Dacarbazine|dacarbazine|mesh-list
15152096|NCT04200040|Molgramostim|molgramostim|mesh-list
15152097|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15152098|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
15152099|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152100|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152101|NCT04199819|Entecavir|entecavir|mesh-list
15152102|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
14021450|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14573522|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573523|NCT00004215|Cytarabine|cytarabine|mesh-list
14573524|NCT00004215|Daunorubicin|daunorubicin|mesh-list
14573525|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573526|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
14573527|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573528|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573529|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
14573530|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573531|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573532|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
14573533|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573534|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573535|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573536|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14021451|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
14573537|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152103|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152104|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15152105|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152106|NCT04199364|Poractant alfa|poractant alfa|mesh-list
15152107|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15152108|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152109|NCT04199325|Uric Acid|uric acid|mesh-list
15152110|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
15152111|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152112|NCT04199325|Protective Agents|protective agents|mesh-ancestor
15152113|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152114|NCT04199221|Vaccines|vaccines|mesh-list
15152115|NCT04199221|Immunologic Factors|immunologic factors|mesh-ancestor
15152116|NCT04199221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573538|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
14573539|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
14573540|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14573541|NCT00004216|Cefixime|cefixime|mesh-list
14573542|NCT00004216|Trimethoprim|trimethoprim|mesh-list
14573543|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
14573544|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14573545|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573546|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573547|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573548|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573549|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573550|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573551|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14573552|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14573553|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14573554|NCT00004216|Renal Agents|renal agents|mesh-ancestor
14573555|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
14573556|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14573557|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14573558|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14573559|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14573560|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14573561|NCT00004217|Cytarabine|cytarabine|mesh-list
14573562|NCT00004217|Daunorubicin|daunorubicin|mesh-list
14573563|NCT00004217|Sargramostim|sargramostim|mesh-list
14573564|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573565|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
14573566|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573567|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573568|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
14573569|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573570|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573571|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
14573572|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573573|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573574|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573575|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573576|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573577|NCT00004218|Prednisolone|prednisolone|mesh-list
14573578|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
15152117|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
15152118|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15152119|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
15152120|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
15152121|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152122|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152123|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15152124|NCT04199143|Analgesics|analgesics|mesh-ancestor
14573579|NCT00004218|Chlorambucil|chlorambucil|mesh-list
14573580|NCT00004218|Doxorubicin|doxorubicin|mesh-list
14573581|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573582|NCT00004218|Fludarabine|fludarabine|mesh-list
14573583|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
14573584|NCT00004218|Vincristine|vincristine|mesh-list
14573585|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573586|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
15152125|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
15152126|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152127|NCT04199013|Fentanyl|fentanyl|mesh-list
14573587|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573588|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15152128|NCT04199013|Ropivacaine|ropivacaine|mesh-list
14573589|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573590|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
14573591|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573592|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573593|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573594|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573595|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573596|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573597|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573598|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573599|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
14573600|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573601|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573602|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573603|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573604|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14573605|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
14573606|NCT00004218|Hormones|hormones|mesh-ancestor
14573607|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573608|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14573609|NCT00004219|Granisetron|granisetron|mesh-list
14573610|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
14573611|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
14573612|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14573613|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573614|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14573615|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14573616|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
14573617|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14573618|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573619|NCT00004220|Gemcitabine|gemcitabine|mesh-list
14573620|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
14573621|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573622|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
14573623|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573624|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573625|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
14573626|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573627|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573628|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573629|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
14573630|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573631|NCT00004221|Paclitaxel|paclitaxel|mesh-list
14573632|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
14573633|NCT00004221|Carboplatin|carboplatin|mesh-list
14573634|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14573635|NCT00004221|Topotecan|topotecan|mesh-list
14573636|NCT00004221|Lenograstim|lenograstim|mesh-list
14573637|NCT00004221|Sargramostim|sargramostim|mesh-list
14573638|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573639|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573640|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573641|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573642|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573643|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573644|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573645|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
14573646|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573647|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573648|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573649|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
14573650|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573651|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573652|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14573653|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573654|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573655|NCT00004223|Gemcitabine|gemcitabine|mesh-list
14573656|NCT00004223|Docetaxel|docetaxel|mesh-list
14573657|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573658|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
14573659|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573660|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573661|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
14573662|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573663|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573664|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573665|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
14573666|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573667|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573668|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573669|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573670|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
14573671|NCT00004224|Etoposide|etoposide|mesh-list
14573672|NCT00004224|Vincristine|vincristine|mesh-list
14573673|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573674|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
14573675|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573676|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573677|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573678|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
14573679|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573680|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573681|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573682|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573683|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573684|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573685|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573686|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573687|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573688|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573689|NCT00004227|Cetuximab|cetuximab|mesh-list
14573690|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14573691|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573692|NCT00004229|Endostatins|endostatins|mesh-list
15152129|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
15152130|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
15152131|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152132|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573693|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573694|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14573695|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14573696|NCT00004229|Growth Substances|growth substances|mesh-ancestor
14573697|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573698|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14573699|NCT00004232|Cyclosporine|cyclosporine|mesh-list
14573700|NCT00004232|Prednisone|prednisone|mesh-list
14573701|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
14573702|NCT00004232|Cyclosporins|cyclosporins|mesh-list
14573703|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14573704|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
14573705|NCT00004232|Hormones|hormones|mesh-ancestor
14573706|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573707|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573708|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14573709|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573710|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
14573711|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573712|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573713|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573714|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
14573715|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573716|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
14573717|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573718|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14573719|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
14573720|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
14573721|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14573722|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14573723|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14573724|NCT00004232|Protective Agents|protective agents|mesh-ancestor
14573725|NCT00004233|Leucovorin|leucovorin|mesh-list
14573726|NCT00004233|Fluorouracil|fluorouracil|mesh-list
14573727|NCT00004233|Calcium|calcium|mesh-list
14573728|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
14573729|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14573730|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573731|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
14573732|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573733|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573734|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573735|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573736|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
14573737|NCT00004233|Antidotes|antidotes|mesh-ancestor
14573738|NCT00004233|Protective Agents|protective agents|mesh-ancestor
15152133|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
15152134|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152135|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15152136|NCT04199013|Narcotics|narcotics|mesh-ancestor
15152137|NCT04199013|Analgesics|analgesics|mesh-ancestor
15152138|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15152139|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15152140|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
14573739|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
14573740|NCT00004233|Vitamins|vitamins|mesh-ancestor
14573741|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
14573742|NCT00004235|Docetaxel|docetaxel|mesh-list
14573743|NCT00004235|Irinotecan|irinotecan|mesh-list
14573744|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573745|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573746|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573747|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573748|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573749|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14573750|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573751|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573752|NCT00004236|Doxorubicin|doxorubicin|mesh-list
14573753|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573754|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573755|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573756|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573757|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573758|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573759|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573760|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
14573761|NCT00004237|Doxorubicin|doxorubicin|mesh-list
14573762|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573763|NCT00004237|Vinorelbine|vinorelbine|mesh-list
14573764|NCT00004237|Epirubicin|epirubicin|mesh-list
14573765|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
14573766|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573767|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
14573768|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573769|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573770|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573771|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
14573772|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573773|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573774|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573775|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573776|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573777|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573778|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573779|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573780|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573781|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573782|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573783|NCT00004237|Analgesics|analgesics|mesh-ancestor
14573784|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
14573785|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14573786|NCT00004242|Gemcitabine|gemcitabine|mesh-list
14573787|NCT00004242|Fluorouracil|fluorouracil|mesh-list
14573788|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
14573789|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573790|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
14573791|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573792|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573793|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
14573794|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573795|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573796|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573797|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
14573798|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573799|NCT00004243|Docetaxel|docetaxel|mesh-list
14573800|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
14573801|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573802|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573803|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573804|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152141|NCT04199169|Vaccines|vaccines|mesh-list
15152142|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
15152143|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152144|NCT04198844|Warfarin|warfarin|mesh-list
15152145|NCT04198844|Apixaban|apixaban|mesh-list
15152146|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
15152147|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15152148|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
15152149|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15152150|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
15152151|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152152|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152153|NCT04198662|Epinephrine|epinephrine|mesh-list
15152154|NCT04198662|Ropivacaine|ropivacaine|mesh-list
15152155|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
14021452|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021453|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021454|NCT02773875|Pancrelipase|pancrelipase|mesh-list
14021455|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021456|NCT02773927|Metformin|metformin|mesh-list
14021457|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14021458|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573805|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573806|NCT00004244|Interferons|interferons|mesh-list
14573807|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
14573808|NCT00004244|Interleukin-12|interleukin-12|mesh-list
14573809|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573810|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
14573811|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573812|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
14573813|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573814|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573815|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14573816|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14573817|NCT00004244|Growth Substances|growth substances|mesh-ancestor
14573818|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
14573819|NCT00004245|Salicylates|salicylates|mesh-list
14573820|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
14573821|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14573822|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14573823|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14573824|NCT00004245|Analgesics|analgesics|mesh-ancestor
14573825|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
14573826|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14573827|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573828|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14573829|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573830|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14573831|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573832|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573833|NCT00004246|Vidarabine|vidarabine|mesh-list
14573834|NCT00004246|Fludarabine|fludarabine|mesh-list
14573835|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
14573836|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021459|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
14291576|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573837|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573838|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
14573839|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573840|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573841|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
14573842|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573843|NCT00004246|Antiviral Agents|antiviral agents|mesh-ancestor
14573844|NCT00004246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573845|NCT00004248|Aldesleukin|aldesleukin|mesh-list
14573846|NCT00004248|Doxorubicin|doxorubicin|mesh-list
14573847|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14573848|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573849|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573850|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14573851|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14573852|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573853|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573854|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14573855|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14573856|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
14573857|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573858|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
15152156|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
14573859|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573860|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
14573861|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573862|NCT00004250|Dactinomycin|dactinomycin|mesh-list
14573863|NCT00004250|Melphalan|melphalan|mesh-list
14573864|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573865|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
14573866|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573867|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573868|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573869|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573870|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
14573871|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573872|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14573873|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573874|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14573875|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14573876|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573877|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14573878|NCT00004251|Letrozole|letrozole|mesh-list
14573879|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573880|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14573881|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14573882|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573883|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573884|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14573885|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
14573886|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573887|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573888|NCT00004252|Leucovorin|leucovorin|mesh-list
14573889|NCT00004252|Fluorouracil|fluorouracil|mesh-list
14573890|NCT00004252|Calcium|calcium|mesh-list
14573891|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
14573892|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14573893|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573894|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
14573895|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573896|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573897|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573898|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573899|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
14573900|NCT00004252|Antidotes|antidotes|mesh-ancestor
14573901|NCT00004252|Protective Agents|protective agents|mesh-ancestor
14573902|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
14573903|NCT00004252|Vitamins|vitamins|mesh-ancestor
14573904|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
14573905|NCT00004253|Paclitaxel|paclitaxel|mesh-list
14573906|NCT00004253|Carboplatin|carboplatin|mesh-list
14573907|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14573908|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573909|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573910|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573911|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573912|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573913|NCT00004254|Raltitrexed|raltitrexed|mesh-list
14573914|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573915|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
14573916|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573917|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573918|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14573919|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573920|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
14573921|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
14573922|NCT00004255|Fludarabine|fludarabine|mesh-list
14573923|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
14573924|NCT00004255|Tacrolimus|tacrolimus|mesh-list
14573925|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14573926|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573927|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
14573928|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573929|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573930|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14573931|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
14573932|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573933|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573934|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14573935|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573936|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
14573937|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14573938|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573939|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14573940|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
14573941|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
14573942|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14573943|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14573944|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
14573945|NCT00004255|Hormones|hormones|mesh-ancestor
14573946|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14573947|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14573948|NCT00004255|Protective Agents|protective agents|mesh-ancestor
14573949|NCT00004256|Sargramostim|sargramostim|mesh-list
14573950|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
14573951|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573952|NCT00004257|Fluorouracil|fluorouracil|mesh-list
14573953|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
14573954|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
14573955|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573956|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573957|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573958|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573959|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
14573960|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573961|NCT00004260|Rituximab|rituximab|mesh-list
14573962|NCT00004260|Interleukin-12|interleukin-12|mesh-list
14573963|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14573964|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573965|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
14573966|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573967|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14573968|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14573969|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14573970|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14573971|NCT00004260|Growth Substances|growth substances|mesh-ancestor
14573972|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
14573973|NCT00004261|Antibodies|antibodies|mesh-list
14573974|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
14573975|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573976|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
14573977|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573978|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14573979|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
14573980|NCT00004263|Cytarabine|cytarabine|mesh-list
14573981|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14573982|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14573983|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
14573984|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14573985|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573986|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
14573987|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14573988|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14573989|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
14573990|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14573991|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14573992|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14573993|NCT00004264|Docetaxel|docetaxel|mesh-list
14573994|NCT00004264|Amifostine|amifostine|mesh-list
14573995|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14573996|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
14573997|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
14573998|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
14573999|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574000|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14574001|NCT00004264|Protective Agents|protective agents|mesh-ancestor
14574002|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574003|NCT00004265|Paclitaxel|paclitaxel|mesh-list
14574004|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14574005|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574006|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
14574007|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
14574008|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
14574009|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574010|NCT00004266|Lisinopril|lisinopril|mesh-list
14574011|NCT00004266|Nifedipine|nifedipine|mesh-list
14574012|NCT00004266|Simvastatin|simvastatin|mesh-list
14574013|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14574014|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15152157|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152158|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152159|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
15152160|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152161|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15152162|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15152163|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
15152164|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152165|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152166|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15152167|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14021460|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14021461|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14021462|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14021463|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14021464|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021465|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
14021466|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021467|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021468|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14021469|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021470|NCT02773602|Dexamethasone|dexamethasone|mesh-list
14021471|NCT02773602|Clonidine|clonidine|mesh-list
14574015|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
14574016|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574017|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14574018|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14574019|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574020|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14574021|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574022|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574023|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574024|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
14574025|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
14574026|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574027|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14574028|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
14574029|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15152168|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
15152169|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15152170|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152171|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
15152172|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
15152173|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15152174|NCT04198727|Capecitabine|capecitabine|mesh-list
15152175|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15152176|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
15152177|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152178|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152179|NCT04198506|Tacrolimus|tacrolimus|mesh-list
14574030|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14574031|NCT00004266|Protective Agents|protective agents|mesh-ancestor
14574032|NCT00004268|Midodrine|midodrine|mesh-list
14574033|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
14574034|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
14574035|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574036|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574037|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14574038|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14574039|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14574040|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14574041|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
14574042|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574043|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574044|NCT00004274|Estrogens|estrogens|mesh-list
14574045|NCT00004274|Hormones|hormones|mesh-ancestor
14574046|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152180|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152181|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
14574047|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574048|NCT00004275|Hormones|hormones|mesh-list
14574049|NCT00004275|Oxandrolone|oxandrolone|mesh-list
14574050|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574051|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574052|NCT00004275|Androgens|androgens|mesh-ancestor
14574053|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
14574054|NCT00004276|Thalidomide|thalidomide|mesh-list
14574055|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14574056|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
14574057|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574058|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
14574059|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14574060|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574061|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14574062|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14574063|NCT00004276|Growth Substances|growth substances|mesh-ancestor
14574064|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
14574065|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574066|NCT00004278|Ganciclovir|ganciclovir|mesh-list
14574067|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14574068|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
14574069|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574070|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14574071|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574072|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574073|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
14574074|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
14574075|NCT00004284|Diuretics|diuretics|mesh-ancestor
14574076|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
14574077|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574078|NCT00004284|Expectorants|expectorants|mesh-ancestor
14574079|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
14574080|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
14574081|NCT00004284|Protective Agents|protective agents|mesh-ancestor
14574082|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
14574083|NCT00004286|Antibodies|antibodies|mesh-list
14574084|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
14574085|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14574086|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14574087|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
14574088|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574089|NCT00004288|Olsalazine|olsalazine|mesh-list
14574090|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14574091|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14574092|NCT00004288|Analgesics|analgesics|mesh-ancestor
14574093|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
14574094|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574095|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574096|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574097|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574098|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574099|NCT00004297|Diazepam|diazepam|mesh-list
14574100|NCT00004297|Lorazepam|lorazepam|mesh-list
14574101|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
14574102|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
14574103|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
14574104|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574105|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574106|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574107|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14574108|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14574109|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14574110|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14574111|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574112|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
14574113|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
14574114|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574115|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574116|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14574117|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14574118|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14574119|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14574120|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
14574121|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
14574122|NCT00004300|Bromocriptine|bromocriptine|mesh-list
14574123|NCT00004300|Sertraline|sertraline|mesh-list
14574124|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
14574125|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574126|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14574127|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14574128|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574129|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574130|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574131|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
14574132|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574133|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14574134|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14574135|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
14574136|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574137|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
14574138|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
14574139|NCT00004310|Clomipramine|clomipramine|mesh-list
14574140|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14574141|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
14574142|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574143|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14574144|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14574145|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574146|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574147|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574148|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
14574149|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574150|NCT00004311|Leuprolide|leuprolide|mesh-list
14574151|NCT00004311|Spironolactone|spironolactone|mesh-list
14574152|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14574153|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
14574154|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574155|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574156|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574157|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574158|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14574159|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
14574160|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574161|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14574162|NCT00004311|Diuretics|diuretics|mesh-ancestor
14574163|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
14574164|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14574165|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14574166|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
15152182|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152183|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15152184|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152185|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152186|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
15152187|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14574167|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574168|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14574169|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14574170|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574171|NCT00004316|Capsaicin|capsaicin|mesh-list
14574172|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
14574173|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
14574174|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
14574175|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574176|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574177|NCT00004317|Leucovorin|leucovorin|mesh-list
14574178|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
14574179|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
14574180|NCT00004317|Spiramycin|spiramycin|mesh-list
14574181|NCT00004317|Calcium|calcium|mesh-list
14574182|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
14574183|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574184|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574185|NCT00004317|Antidotes|antidotes|mesh-ancestor
14574186|NCT00004317|Protective Agents|protective agents|mesh-ancestor
14574187|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
14574188|NCT00004317|Vitamins|vitamins|mesh-ancestor
14574189|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
14574190|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
14574191|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15152188|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574192|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14574193|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574194|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14574195|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574196|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574197|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14574198|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
14574199|NCT00004323|Cyclosporine|cyclosporine|mesh-list
14574200|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
14574201|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
14574202|NCT00004323|Methotrexate|methotrexate|mesh-list
14574203|NCT00004323|Cyclosporins|cyclosporins|mesh-list
14574204|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14574205|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14574206|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
14574207|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574208|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574209|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14574210|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
14574211|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574212|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574213|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14574214|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14574215|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
14574216|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574217|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14574218|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
14021472|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021473|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
14021474|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
14021475|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021476|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021477|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021478|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
14021479|NCT02773602|Hormones|hormones|mesh-ancestor
14021480|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291577|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
14574219|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14574220|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574221|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14574222|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14574223|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
14574224|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574225|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14574226|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574227|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
14574228|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
14574229|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574230|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574231|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
14574232|NCT00004323|Hormones|hormones|mesh-ancestor
14574233|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574234|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14574235|NCT00004323|Protective Agents|protective agents|mesh-ancestor
14574236|NCT00004327|Octreotide|octreotide|mesh-list
14574237|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574238|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574239|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574240|NCT00004328|Enalapril|enalapril|mesh-list
14574241|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
15152189|NCT04198636|Denosumab|denosumab|mesh-list
15152190|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15152191|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152192|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
15152193|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14291578|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291579|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14291580|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291581|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291582|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14291583|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291584|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14291585|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
14291586|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14291587|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291588|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15152194|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
14574242|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14574243|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
14574244|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574245|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574246|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14574247|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
14574248|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
14574249|NCT00004330|Hormones|hormones|mesh-list
14574250|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574251|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643938|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643939|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643940|NCT00190645|Analgesics|analgesics|mesh-ancestor
14643941|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
14643942|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643943|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643944|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643945|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
14643946|NCT00190710|Gemcitabine|gemcitabine|mesh-list
14643947|NCT00190710|Carboplatin|carboplatin|mesh-list
14643948|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643949|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14643950|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
14643951|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152195|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152196|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
15152197|NCT04198467|Protective Agents|protective agents|mesh-ancestor
15152198|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15152199|NCT04198129|Amoxicillin|amoxicillin|mesh-list
15152200|NCT04198129|Clindamycin|clindamycin|mesh-list
15152201|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
15152202|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
15152203|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15152204|NCT04198129|Ampicillin|ampicillin|mesh-list
15152205|NCT04198129|Sultamicillin|sultamicillin|mesh-list
15152206|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15152207|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152208|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
15152209|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15152210|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152211|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152212|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15152213|NCT04198233|Diazepam|diazepam|mesh-list
15152214|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15152215|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
14643952|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
14643953|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643954|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643955|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152216|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
15152217|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
15152218|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152219|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643956|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
14643957|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643958|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14643959|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14643960|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643961|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643962|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643963|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
14643964|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643965|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643966|NCT00190762|Pemetrexed|pemetrexed|mesh-list
14643967|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643968|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643969|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643970|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14643971|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14643972|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
15152220|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15152221|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15152222|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14574252|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14574253|NCT00004339|Trientine|trientine|mesh-list
15152223|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15152224|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15152225|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15152226|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15152227|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15152228|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14574254|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
14574255|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
14574256|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574257|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574258|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14574259|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15152229|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
15152230|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
15152231|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
14574260|NCT00004339|Growth Substances|growth substances|mesh-ancestor
14574261|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574262|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
14574263|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574264|NCT00004340|Calcitriol|calcitriol|mesh-list
14574265|NCT00004340|Hormones|hormones|mesh-list
14574266|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574267|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574268|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574269|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14574270|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574271|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574272|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14574273|NCT00004340|Vitamins|vitamins|mesh-ancestor
14574274|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
14574275|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14574276|NCT00004344|Leuprolide|leuprolide|mesh-list
14574277|NCT00004344|Testosterone|testosterone|mesh-list
14574278|NCT00004344|Androgens|androgens|mesh-ancestor
14574279|NCT00004344|Hormones|hormones|mesh-ancestor
14574280|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574281|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574282|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574283|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574284|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14574285|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
14574286|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574287|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14574288|NCT00004346|Lovastatin|lovastatin|mesh-list
14574289|NCT00004346|L 647318|l 647318|mesh-list
14574290|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
14574291|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14574292|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14574293|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
14574294|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574295|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14574296|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14574297|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574298|NCT00004346|Cathartics|cathartics|mesh-ancestor
14574299|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574300|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
14574301|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14574302|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14574303|NCT00004357|Prednisolone|prednisolone|mesh-list
14574304|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
14574305|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14574306|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
14574307|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574308|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
14574309|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
15152232|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
15152233|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152234|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180170|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180171|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
15180172|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180173|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574310|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574311|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152235|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15152236|NCT04197817|Antibodies|antibodies|mesh-list
15152237|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
15152238|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15152239|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
15152240|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152241|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152242|NCT04197752|Anesthetics|anesthetics|mesh-list
15152243|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152244|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152245|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
15152246|NCT04197570|Analgesics|analgesics|mesh-list
15152247|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
15152248|NCT04197570|Anesthetics|anesthetics|mesh-list
15152249|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152250|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152251|NCT04197570|Narcotics|narcotics|mesh-ancestor
15152252|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
15152253|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152254|NCT04197882|Molgramostim|molgramostim|mesh-list
14574312|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574313|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
14574314|NCT00004357|Hormones|hormones|mesh-ancestor
14574315|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574316|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14574317|NCT00004357|Protective Agents|protective agents|mesh-ancestor
14574318|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574319|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574320|NCT00004358|Calcitonin|calcitonin|mesh-list
14574321|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
14574322|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14574323|NCT00004358|Katacalcin|katacalcin|mesh-list
14574324|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574325|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574326|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14574327|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
14574328|NCT00004359|Methoxsalen|methoxsalen|mesh-list
14574329|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14814002|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14814003|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814004|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14814005|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14814006|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814007|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152255|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152256|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14574330|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14574331|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
14574332|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14574333|NCT00004360|Diuretics|diuretics|mesh-ancestor
14574334|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
14574335|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574336|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14574337|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574338|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574339|NCT00004361|Citric Acid|citric acid|mesh-list
14574340|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
14574341|NCT00004361|Calcium|calcium|mesh-list
14574342|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574343|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574344|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
14574345|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14574346|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
14574347|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
14574348|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574349|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
14574350|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14574351|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
14574352|NCT00004363|Coagulants|coagulants|mesh-ancestor
14574353|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14574354|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
14574355|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152257|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15152258|NCT04197622|Diuretics|diuretics|mesh-ancestor
15152259|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
15152260|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574356|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14574357|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15152261|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15152262|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15152263|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152264|NCT04197739|Amikacin|amikacin|mesh-list
15152265|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15152266|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574358|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
14574359|NCT00004364|Coagulants|coagulants|mesh-ancestor
14574360|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14574361|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
14574362|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574363|NCT00004368|Colchicine|colchicine|mesh-list
14574364|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
14574365|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574366|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152267|NCT04197323|Alprostadil|alprostadil|mesh-list
15152268|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15152269|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
15152270|NCT04197323|Urological Agents|urological agents|mesh-ancestor
15152271|NCT04197349|Sumatriptan|sumatriptan|mesh-list
15152272|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15152273|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15152274|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15152275|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
14574367|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14574368|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14574369|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574370|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574371|NCT00004373|Alprazolam|alprazolam|mesh-list
14574372|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14574373|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14574374|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574375|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14574376|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14574377|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574378|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
14574379|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
14574380|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574381|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574382|NCT00004376|Guanfacine|guanfacine|mesh-list
14574383|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14574384|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14574385|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14574386|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14574387|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
14574388|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574389|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574390|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574391|NCT00004380|Methocarbamol|methocarbamol|mesh-list
14574392|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14574393|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574394|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14574395|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574396|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14574397|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574398|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574399|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
15152276|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291589|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291590|NCT00555425|Buprenorphine|buprenorphine|mesh-list
14291591|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14291592|NCT00555425|Naloxone|naloxone|mesh-list
14291593|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14291594|NCT00555425|Narcotics|narcotics|mesh-ancestor
14291595|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291596|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291597|NCT00555425|Analgesics|analgesics|mesh-ancestor
14291598|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
14291599|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291600|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14291601|NCT00555438|PENTA|penta|mesh-list
14291602|NCT00555438|Fondaparinux|fondaparinux|mesh-list
14291603|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14291604|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
14574400|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574401|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574402|NCT00004390|Morphine|morphine|mesh-list
14574403|NCT00004390|Methadone|methadone|mesh-list
14574404|NCT00004390|Nortriptyline|nortriptyline|mesh-list
14574405|NCT00004390|Desipramine|desipramine|mesh-list
14574406|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14574407|NCT00004390|Narcotics|narcotics|mesh-ancestor
14574408|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14574409|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152277|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152278|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152279|NCT04197089|Vitamin D|vitamin d|mesh-list
15152280|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
15152281|NCT04197089|Vitamins|vitamins|mesh-ancestor
15152282|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
15152283|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152284|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15152285|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15152286|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
15152287|NCT04197219|Axitinib|axitinib|mesh-list
14574410|NCT00004390|Analgesics|analgesics|mesh-ancestor
14574411|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
14574412|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574413|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
14574414|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
14574415|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14574416|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
14574417|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574418|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14574419|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14574420|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574421|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574422|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
14574423|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574424|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574425|NCT00004393|Risperidone|risperidone|mesh-list
14574426|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14574427|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
14574428|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574429|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574430|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574431|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14574432|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14574433|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14574434|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574435|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14574436|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
14574437|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14574438|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574439|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152288|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152289|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152290|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14574440|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14574441|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574442|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574443|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14574444|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574445|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574446|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
14574447|NCT00004399|Nimodipine|nimodipine|mesh-list
14574448|NCT00004399|Analgesics|analgesics|mesh-ancestor
14574449|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
14574450|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574451|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574452|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
14574453|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14574454|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14574455|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
14574456|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14574457|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15152291|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152292|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574458|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574459|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574460|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
14574461|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574462|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14574463|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
14574464|NCT00004400|Testosterone|testosterone|mesh-list
14574465|NCT00004400|Androgens|androgens|mesh-ancestor
14574466|NCT00004400|Hormones|hormones|mesh-ancestor
14574467|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574468|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574469|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
14574470|NCT00004401|Antibodies|antibodies|mesh-list
14574471|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
14574472|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14574473|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14574474|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
14574475|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574476|NCT00004402|Calcitriol|calcitriol|mesh-list
14574477|NCT00004402|Interferons|interferons|mesh-list
14574478|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
14574479|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574480|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
14574481|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574482|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574483|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574484|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14574485|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15152293|NCT04196855|Teriparatide|teriparatide|mesh-list
15152294|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15152295|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152296|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15152297|NCT04196829|Fluorides|fluorides|mesh-list
15152298|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
15152299|NCT04196829|Protective Agents|protective agents|mesh-ancestor
15152300|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152301|NCT04196946|Fentanyl|fentanyl|mesh-list
15152302|NCT04196946|Alfentanil|alfentanil|mesh-list
14574486|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574487|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14574488|NCT00004402|Vitamins|vitamins|mesh-ancestor
14574489|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
14574490|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14574491|NCT00004403|Albendazole|albendazole|mesh-list
14574492|NCT00004403|Dexamethasone|dexamethasone|mesh-list
14574493|NCT00004403|Phenytoin|phenytoin|mesh-list
14574494|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574495|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
14574496|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
14574497|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574498|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574499|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574500|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
14574501|NCT00004403|Hormones|hormones|mesh-ancestor
14574502|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574503|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574504|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574505|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
14574506|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14574507|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574508|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
14574509|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14574510|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14574511|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152303|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15152304|NCT04196946|Narcotics|narcotics|mesh-ancestor
15152305|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152306|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152307|NCT04196946|Analgesics|analgesics|mesh-ancestor
15152308|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
15152309|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152310|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14574512|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
14574513|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152311|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14574514|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574515|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
14574516|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14574517|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14574518|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574519|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14574520|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14574521|NCT00004404|Clotrimazole|clotrimazole|mesh-list
14574522|NCT00004404|Miconazole|miconazole|mesh-list
14574523|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
14574524|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574525|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
14574526|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574527|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574528|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14574529|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14574530|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574531|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
14574532|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14574533|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14574534|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14574535|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
14574536|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574537|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574538|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14574539|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14574540|NCT00004406|Hormones|hormones|mesh-list
14574541|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
14574542|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574543|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574544|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574545|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
14574546|NCT00004407|Antibodies|antibodies|mesh-list
14574547|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
14574548|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14574549|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14574550|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
14574551|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574552|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14574553|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
14574554|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574555|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14574556|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574557|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
14574558|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14574559|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14574560|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14574561|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574562|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574563|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
14574564|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574565|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574566|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14574567|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574568|NCT00004419|Mitogens|mitogens|mesh-list
14574569|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
14574570|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574571|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
14574572|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14574573|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14574574|NCT00004420|Analgesics|analgesics|mesh-ancestor
14574575|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
14574576|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574577|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574578|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574579|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574580|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14574581|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
14574582|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574583|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14574584|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
14574585|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
14574586|NCT00004422|Antibodies|antibodies|mesh-list
14574587|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
14574588|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14574589|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14574590|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
14574591|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574592|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14574593|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
14574594|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14574595|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574596|NCT00004424|Fentanyl|fentanyl|mesh-list
14574597|NCT00004424|Midazolam|midazolam|mesh-list
14574598|NCT00004424|Propofol|propofol|mesh-list
14574599|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14574600|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14574601|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152312|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
15152313|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
15152314|NCT04197050|Valsartan|valsartan|mesh-list
15152315|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15152316|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15152317|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14574602|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14574603|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
14574604|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
14574605|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14574606|NCT00004424|Narcotics|narcotics|mesh-ancestor
14574607|NCT00004424|Analgesics|analgesics|mesh-ancestor
14574608|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
14574609|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574610|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14574611|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14574612|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14574613|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574614|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
14574615|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
14574616|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574617|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574618|NCT00004426|Leuprolide|leuprolide|mesh-list
14574619|NCT00004426|Hormones|hormones|mesh-list
14574620|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574621|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574622|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14574623|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
14574624|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574625|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574626|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574627|NCT00004429|Hormones|hormones|mesh-list
14574628|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574629|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574630|NCT00004430|Prednisolone|prednisolone|mesh-list
14574631|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574632|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
14574633|NCT00004430|Hormones|hormones|mesh-ancestor
14574634|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574635|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574636|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574637|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574638|NCT00004431|Baclofen|baclofen|mesh-list
14574639|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14574640|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574641|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14574642|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574643|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14574644|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
14574645|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
14574646|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574647|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574648|NCT00004433|Pergolide|pergolide|mesh-list
14574649|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
14574650|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
14574651|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574652|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574653|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574654|NCT00004436|Prednisone|prednisone|mesh-list
15152318|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574655|NCT00004436|Leuprolide|leuprolide|mesh-list
14574656|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574657|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
14574658|NCT00004436|Hormones|hormones|mesh-ancestor
14574659|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574660|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574661|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574662|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574663|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14574664|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
14574665|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574666|NCT00004438|Leuprolide|leuprolide|mesh-list
14574667|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14574668|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
14574669|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14574670|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574671|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574672|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574673|NCT00004440|Ibuprofen|ibuprofen|mesh-list
14574674|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14574675|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14574676|NCT00004440|Analgesics|analgesics|mesh-ancestor
14574677|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
14574678|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574679|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574680|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574681|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574682|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14574683|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574684|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574685|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14574686|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14574687|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14574688|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574689|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
14574690|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574691|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14574692|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14574693|NCT00004442|Cholic Acids|cholic acids|mesh-list
14574694|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14574695|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574696|NCT00004442|Cathartics|cathartics|mesh-ancestor
14574697|NCT00004444|Paromomycin|paromomycin|mesh-list
14574698|NCT00004444|Streptomycin|streptomycin|mesh-list
14574699|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14574700|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574701|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14574702|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14574703|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14574704|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574705|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574706|NCT00004446|Fluoxetine|fluoxetine|mesh-list
14574707|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14574708|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14574709|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574710|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152319|NCT04197115|Vitamins|vitamins|mesh-list
15152320|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
15152321|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
14574711|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574712|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
14574713|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574714|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15152322|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
15152323|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15152324|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15152325|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15152326|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
15152327|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152328|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152329|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
15152330|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574715|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
14574716|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574717|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14574718|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14574719|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574720|NCT00004448|Prednisone|prednisone|mesh-list
14574721|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574722|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
14574723|NCT00004448|Hormones|hormones|mesh-ancestor
14574724|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574725|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574726|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574727|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574728|NCT00004450|Interferons|interferons|mesh-list
14574729|NCT00004450|Interferon-beta|interferon-beta|mesh-list
14574730|NCT00004450|Thalidomide|thalidomide|mesh-list
14574731|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574732|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
14574733|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574734|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152331|NCT04197115|Protective Agents|protective agents|mesh-ancestor
15152332|NCT04196998|Tenofovir|tenofovir|mesh-list
15152333|NCT04196998|Entecavir|entecavir|mesh-list
15152334|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
14021481|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574735|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
14574736|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574737|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
14574738|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14574739|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14574740|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14574741|NCT00004450|Growth Substances|growth substances|mesh-ancestor
14574742|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14574743|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
14574744|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14574745|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
14574746|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574747|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574748|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14574749|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
14574750|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574751|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574752|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14574753|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
14574754|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14574755|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574756|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574757|NCT00004466|Atorvastatin|atorvastatin|mesh-list
14574758|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14574759|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14574760|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
14574761|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574762|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14574763|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14021482|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574764|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574765|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
14574766|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14574767|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
14574768|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574769|NCT00004467|Expectorants|expectorants|mesh-ancestor
14574770|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
14574771|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14574772|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
14574773|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574774|NCT00004467|Protective Agents|protective agents|mesh-ancestor
14574775|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574776|NCT00004467|Antidotes|antidotes|mesh-ancestor
15152335|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152336|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15152337|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15152338|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152339|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152340|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15152341|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15152342|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
15152343|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15152344|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14021483|NCT02773602|Analgesics|analgesics|mesh-ancestor
15152345|NCT04196452|Ipilimumab|ipilimumab|mesh-list
15152346|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152347|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152348|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15152349|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152350|NCT04196400|Betamethasone|betamethasone|mesh-list
15152351|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574777|NCT00004468|Calcitriol|calcitriol|mesh-list
14574778|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574779|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574780|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14574781|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574782|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574783|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14574784|NCT00004468|Vitamins|vitamins|mesh-ancestor
14574785|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
14574786|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14574787|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
14574788|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14574789|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14574790|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
14574791|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574792|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574793|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14574794|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
14574795|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574796|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574797|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14574798|NCT00004478|Droxidopa|droxidopa|mesh-list
14574799|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14574800|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14574801|NCT00004479|Midodrine|midodrine|mesh-list
14574802|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
14574803|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
14574804|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574805|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574806|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14574807|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14574808|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14574809|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14574810|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
14574811|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574812|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574813|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
14574814|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14574815|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14574816|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14574817|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574818|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574819|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
14574820|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152352|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
15152353|NCT04196400|Hormones|hormones|mesh-ancestor
14574821|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574822|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14574823|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574824|NCT00004482|Cyclosporine|cyclosporine|mesh-list
14574825|NCT00004482|Prednisone|prednisone|mesh-list
14574826|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
14574827|NCT00004482|Cyclosporins|cyclosporins|mesh-list
14574828|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
14574829|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14574830|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
14574831|NCT00004482|Hormones|hormones|mesh-ancestor
14574832|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574833|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574834|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14574835|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574836|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574837|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152354|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152355|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152356|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14574838|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14574839|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
14574840|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
14574841|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574842|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
14574843|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574844|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14574845|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
14574846|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
14574847|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574848|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574849|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14574850|NCT00004482|Protective Agents|protective agents|mesh-ancestor
14574851|NCT00004485|Cyclosporine|cyclosporine|mesh-list
14574852|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
14574853|NCT00004485|Fludarabine|fludarabine|mesh-list
14574854|NCT00004485|Cyclosporins|cyclosporins|mesh-list
14574855|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574856|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574857|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14574858|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
14574859|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574860|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574861|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
14574862|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574863|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
14574864|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14574865|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14574866|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14574867|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14574868|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
14574869|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14574870|NCT00004486|Fluoxetine|fluoxetine|mesh-list
14574871|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14574872|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14574873|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574874|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574875|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574876|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
14574877|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574878|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14574879|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
14574880|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574881|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14574882|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14574883|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643973|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14643974|NCT00190801|Pemetrexed|pemetrexed|mesh-list
14643975|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14643976|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14643977|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643978|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14643979|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14643980|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14643981|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643982|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643983|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643984|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14643985|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643986|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14643987|NCT00190814|Analgesics|analgesics|mesh-ancestor
14643988|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
14643989|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14643990|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
14643991|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14643992|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
14643993|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14643994|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14643995|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14643996|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14643997|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152357|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152358|NCT04196426|Calcium|calcium|mesh-list
14574884|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
14574885|NCT00004488|Alendronate|alendronate|mesh-list
14574886|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
14574887|NCT00004488|Calcium|calcium|mesh-list
14574888|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574889|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574890|NCT00004488|Vitamins|vitamins|mesh-ancestor
14574891|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
14574892|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14574893|NCT00004488|Antacids|antacids|mesh-ancestor
14574894|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574895|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574896|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
14574897|NCT00004489|Alendronate|alendronate|mesh-list
14574898|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
14574899|NCT00004489|Calcium|calcium|mesh-list
14574900|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14574901|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574902|NCT00004489|Vitamins|vitamins|mesh-ancestor
14574903|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
14574904|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14574905|NCT00004489|Antacids|antacids|mesh-ancestor
14574906|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574907|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574908|NCT00004492|Clotrimazole|clotrimazole|mesh-list
14574909|NCT00004492|Miconazole|miconazole|mesh-list
14574910|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
14574911|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574912|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
14574913|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574914|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574915|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14574916|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14574917|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14574918|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
14574919|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14574920|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14574921|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14574922|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
14574923|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574924|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574925|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14574926|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14574927|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
14574928|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14574929|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
14574930|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14574931|NCT00004494|Protective Agents|protective agents|mesh-ancestor
14574932|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574933|NCT00004495|Folic Acid|folic acid|mesh-list
14574934|NCT00004495|Pyridoxine|pyridoxine|mesh-list
14574935|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
14574936|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
14574937|NCT00004495|Hematinics|hematinics|mesh-ancestor
14574938|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
14574939|NCT00004495|Vitamins|vitamins|mesh-ancestor
14574940|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
14574941|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574942|NCT00004496|Hormones|hormones|mesh-list
14574943|NCT00004496|alpha-MSH|alpha-msh|mesh-list
14574944|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14574945|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14574946|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
14574947|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14574948|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152359|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15152360|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152361|NCT04196309|Heparin|heparin|mesh-list
15152362|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15152363|NCT04196309|Tinzaparin|tinzaparin|mesh-list
15152364|NCT04196309|Dalteparin|dalteparin|mesh-list
15152365|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
15152366|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15152367|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14574949|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574950|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152368|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152369|NCT04196608|Tazobactam|tazobactam|mesh-list
14574951|NCT00004551|Nicotine|nicotine|mesh-list
14574952|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14574953|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
14574954|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574955|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574956|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14574957|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14574958|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
14574959|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574960|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574961|NCT00004552|Acamprosate|acamprosate|mesh-list
14574962|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14574963|NCT00004554|Naltrexone|naltrexone|mesh-list
14574964|NCT00004554|Sertraline|sertraline|mesh-list
14574965|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14574966|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14574967|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574968|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
14574969|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14574970|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
14574971|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14574972|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14574973|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14574974|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14574975|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574976|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574977|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
14574978|NCT00004564|Clopidogrel|clopidogrel|mesh-list
14574979|NCT00004564|Atorvastatin|atorvastatin|mesh-list
14574980|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14574981|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14574982|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
14574983|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14574984|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14574985|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14574986|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14574987|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14574988|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14574989|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14574990|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14574991|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
14574992|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14574993|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14574994|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
14574995|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14574996|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14574997|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14574998|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
14574999|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14575000|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575001|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575002|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575003|NCT00004573|Ganciclovir|ganciclovir|mesh-list
14575004|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14575005|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
14575006|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575007|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575008|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575009|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152370|NCT04196608|Imipenem|imipenem|mesh-list
15152371|NCT04196608|Ceftolozane|ceftolozane|mesh-list
15152372|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
15152373|NCT04196608|Relebactam|relebactam|mesh-list
15152374|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15152375|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152376|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15152377|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152378|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152379|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15152380|NCT04196608|Renal Agents|renal agents|mesh-ancestor
14575010|NCT00004575|Miconazole|miconazole|mesh-list
15152381|NCT04196270|Ropivacaine|ropivacaine|mesh-list
14575011|NCT00004575|Bradykinin|bradykinin|mesh-list
14575012|NCT00004575|Kininogens|kininogens|mesh-list
14575013|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575014|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575015|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
14575016|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575017|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14575018|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575019|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14575020|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
14575021|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575022|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575023|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14575024|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575025|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
14575026|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14575027|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575028|NCT00004578|Ritonavir|ritonavir|mesh-list
14575029|NCT00004578|Lopinavir|lopinavir|mesh-list
14575030|NCT00004578|Lamivudine|lamivudine|mesh-list
14575031|NCT00004578|Stavudine|stavudine|mesh-list
14575032|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14575033|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14575034|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575035|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575036|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575037|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575038|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575039|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
14575040|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575041|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575042|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575043|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575044|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575045|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
14575046|NCT00004580|Ritonavir|ritonavir|mesh-list
14575047|NCT00004580|Lopinavir|lopinavir|mesh-list
14575048|NCT00004580|Nevirapine|nevirapine|mesh-list
14575049|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14575050|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14575051|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575052|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575053|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575054|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575055|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575056|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
14575057|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575058|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575059|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575060|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575061|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575062|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575063|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575064|NCT00004581|Ritonavir|ritonavir|mesh-list
14575065|NCT00004581|Lopinavir|lopinavir|mesh-list
14575066|NCT00004581|Nevirapine|nevirapine|mesh-list
14575067|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14575068|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14575069|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575070|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575071|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575072|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575073|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575074|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
14575075|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575076|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575077|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575078|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575079|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575080|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575081|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575082|NCT00004582|Ritonavir|ritonavir|mesh-list
14575083|NCT00004582|Lopinavir|lopinavir|mesh-list
14575084|NCT00004582|Efavirenz|efavirenz|mesh-list
14021484|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
14021485|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14021486|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
14021487|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14021488|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14021489|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14575085|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14575086|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14575087|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575088|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575089|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575090|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575091|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575092|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
14575093|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575094|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575095|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575096|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575097|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575098|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14575099|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14575100|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14575101|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575102|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575103|NCT00004583|Ritonavir|ritonavir|mesh-list
14575104|NCT00004583|Lopinavir|lopinavir|mesh-list
14575105|NCT00004583|Nelfinavir|nelfinavir|mesh-list
14575106|NCT00004583|Lamivudine|lamivudine|mesh-list
14575107|NCT00004583|Stavudine|stavudine|mesh-list
14575108|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14575109|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15152382|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
15152383|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
15152384|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152385|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152386|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
15152387|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152388|NCT04196439|Anesthetics|anesthetics|mesh-list
14575110|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575111|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152389|NCT04196439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152390|NCT04196439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152391|NCT04196231|Insulin|insulin|mesh-list
15152392|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15152393|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15152394|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152395|NCT04195997|Heparin|heparin|mesh-list
15152396|NCT04195997|Bivalirudin|bivalirudin|mesh-list
15152397|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
15152398|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15152399|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15152400|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152401|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
15152402|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15152403|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
15152404|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152405|NCT04195828|Paclitaxel|paclitaxel|mesh-list
15152406|NCT04195828|Apatinib|apatinib|mesh-list
15152407|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15152408|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575112|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575113|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575114|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575115|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
15152409|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152410|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14575116|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575117|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575118|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575119|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575120|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575121|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
15152411|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152412|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021490|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
14575122|NCT00004585|Lamivudine|lamivudine|mesh-list
14575123|NCT00004585|Zidovudine|zidovudine|mesh-list
14575124|NCT00004585|Efavirenz|efavirenz|mesh-list
14575125|NCT00004585|Abacavir|abacavir|mesh-list
14575126|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
14575127|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14575128|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575129|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575130|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575131|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575132|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
14575133|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575134|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575135|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575136|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
14575137|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14575138|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575139|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14575140|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14575141|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575142|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575143|NCT00004637|Vitamin E|vitamin e|mesh-list
14575144|NCT00004637|Vitamins|vitamins|mesh-ancestor
14575145|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
14575146|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575147|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
14575148|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575149|NCT00004637|Protective Agents|protective agents|mesh-ancestor
14575150|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
14575151|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15152413|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15152414|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152415|NCT04195698|Upadacitinib|upadacitinib|mesh-list
15152416|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15152417|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15152418|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152419|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152420|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15180174|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15180175|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
15180176|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180177|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180178|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15180179|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15180180|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180181|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
15180182|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
15180183|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180184|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180185|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
15180186|NCT03942887|Hormones|hormones|mesh-ancestor
15180187|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180188|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14575152|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575153|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
14575154|NCT00004643|Cytarabine|cytarabine|mesh-list
14575155|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14575156|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
14575157|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575158|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575159|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
14575160|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575161|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575162|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
14575163|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575164|NCT00004644|Acyclovir|acyclovir|mesh-list
14575165|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
14575166|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575167|NCT00004646|Prednisone|prednisone|mesh-list
14575168|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575169|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
14575170|NCT00004646|Hormones|hormones|mesh-ancestor
14575171|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575172|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575173|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575174|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575175|NCT00004647|Mexiletine|mexiletine|mesh-list
14575176|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14575177|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14575178|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14575179|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575180|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575181|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14575182|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
14575183|NCT00004650|Estrogens|estrogens|mesh-list
14575184|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14575185|NCT00004650|Hormones|hormones|mesh-ancestor
14575186|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575187|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575188|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14575189|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14575190|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14575191|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
14575192|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575193|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14575194|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14575195|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14575196|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575197|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575198|NCT00004652|Pimozide|pimozide|mesh-list
14575199|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14575200|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14575201|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14575202|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575203|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14575204|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14575205|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
14575206|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575207|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152421|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15152422|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15152423|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
15152424|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152425|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152426|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15152427|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152428|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15152429|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15152430|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15152431|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
15152432|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575208|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14575209|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14575210|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14575211|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
14575212|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152433|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152434|NCT04195373|Flucytosine|flucytosine|mesh-list
15152435|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
15152436|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152437|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
15152438|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152439|NCT04195139|Nivolumab|nivolumab|mesh-list
15152440|NCT04195139|Temozolomide|temozolomide|mesh-list
15152441|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152442|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152443|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15152444|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152445|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15152446|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
15152447|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
15152448|NCT04195243|Empagliflozin|empagliflozin|mesh-list
15152449|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15152450|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152451|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15152452|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152453|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14575213|NCT00004664|Megestrol|megestrol|mesh-list
14575214|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14575215|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14575216|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14575217|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
14575218|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575219|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575220|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14575221|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14575222|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575223|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575224|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14575225|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14575226|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
14575227|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575228|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
14575229|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575230|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
14575231|NCT00004682|Antibodies|antibodies|mesh-list
14575232|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
14575233|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14575234|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14575235|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
14575236|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575237|NCT00004685|Albuterol|albuterol|mesh-list
14575238|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14575239|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
14575240|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575241|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575242|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14575243|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
14575244|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
14575245|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575246|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14575247|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14575248|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14575249|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
14575250|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575251|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575252|NCT00004686|Prednisone|prednisone|mesh-list
14575253|NCT00004686|Methotrexate|methotrexate|mesh-list
14575254|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575255|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
14575256|NCT00004686|Hormones|hormones|mesh-ancestor
14575257|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575258|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575259|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575260|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575261|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14575262|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
14575263|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575264|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14575265|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
14575266|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575267|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
14575268|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575269|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14575270|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575271|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
14575272|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575273|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575274|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
14575275|NCT00004688|Carmustine|carmustine|mesh-list
14575276|NCT00004688|Streptozocin|streptozocin|mesh-list
14575277|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
14575278|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575279|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14575280|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575281|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575282|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
14575283|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575284|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575285|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575286|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15152454|NCT04195100|Pilocarpine|pilocarpine|mesh-list
15152455|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15152456|NCT04195100|Miotics|miotics|mesh-ancestor
15152457|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
15152458|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152459|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152460|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15152461|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15152462|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
15152463|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152464|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575287|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
14575288|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14575289|NCT00004689|Clarithromycin|clarithromycin|mesh-list
14575290|NCT00004689|Rifampin|rifampin|mesh-list
14575291|NCT00004689|Ethambutol|ethambutol|mesh-list
14575292|NCT00004689|Streptomycin|streptomycin|mesh-list
14575293|NCT00004689|Thioacetazone|thioacetazone|mesh-list
14575294|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14575295|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575296|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14575297|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575298|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575299|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575300|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575301|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14575302|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
15152465|NCT04195321|Phenylephrine|phenylephrine|mesh-list
15152466|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
15152467|NCT04195321|Norepinephrine|norepinephrine|mesh-list
15152468|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15152469|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
14575303|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
14575304|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575305|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14575306|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575307|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15152470|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
15152471|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152472|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152473|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
15152474|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15152475|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
15152476|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152477|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15152478|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15152479|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15152480|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
15152481|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575308|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14575309|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14575310|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575311|NCT00004690|Monolaurin|monolaurin|mesh-list
14575312|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
14575313|NCT00004690|Protective Agents|protective agents|mesh-ancestor
14575314|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575315|NCT00004694|Heparin|heparin|mesh-list
14575316|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
14575317|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14575318|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14575319|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152482|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152483|NCT04195321|Protective Agents|protective agents|mesh-ancestor
15152484|NCT04195074|Tenofovir|tenofovir|mesh-list
15152485|NCT04195074|Entecavir|entecavir|mesh-list
15152486|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
15152487|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152488|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15152489|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575320|NCT00004695|Interleukin-2|interleukin-2|mesh-list
14575321|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152490|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152491|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152492|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15152493|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15152494|NCT04194827|Adalimumab|adalimumab|mesh-list
15152495|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152496|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15152497|NCT04194957|Fluorouracil|fluorouracil|mesh-list
15152498|NCT04194957|Capecitabine|capecitabine|mesh-list
15152499|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
15152500|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152501|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15152502|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575322|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14575323|NCT00004695|Analgesics|analgesics|mesh-ancestor
14575324|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
14575325|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575326|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152503|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152504|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
15152505|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152506|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15152507|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15152508|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
15152509|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15152510|NCT04194905|Estradiol|estradiol|mesh-list
15152511|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15152512|NCT04194905|Estrogens|estrogens|mesh-ancestor
14575327|NCT00004696|Morphine|morphine|mesh-list
14575328|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14575329|NCT00004696|Narcotics|narcotics|mesh-ancestor
14575330|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14575331|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575332|NCT00004696|Analgesics|analgesics|mesh-ancestor
15152513|NCT04194905|Hormones|hormones|mesh-ancestor
15152514|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575333|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
14575334|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575335|NCT00004697|Choline|choline|mesh-list
14575336|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
14575337|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14575338|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
15152515|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152516|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15152517|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
15152518|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15152519|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14575339|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575340|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14575341|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14575342|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
14575343|NCT00004699|Mitogens|mitogens|mesh-list
14575344|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
14575345|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575346|NCT00004700|Mitogens|mitogens|mesh-list
14575347|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14575348|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575349|NCT00004705|Amiloride|amiloride|mesh-list
14575350|NCT00004705|Diuretics|diuretics|mesh-ancestor
14575351|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
14575352|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575353|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14575354|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14575355|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575356|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575357|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14575358|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14575359|NCT00004727|Aspirin|aspirin|mesh-list
14575360|NCT00004727|Ticlopidine|ticlopidine|mesh-list
14575361|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14575362|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15152520|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15152521|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15152522|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15152523|NCT04194658|Letrozole|letrozole|mesh-list
15152524|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152525|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14575363|NCT00004727|Analgesics|analgesics|mesh-ancestor
14575364|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
14575365|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575366|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575367|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575368|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575369|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14575370|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14575371|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575372|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14575373|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14575374|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575375|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
14575376|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14575377|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14575378|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14575379|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
14575380|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575381|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14575382|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575383|NCT00004728|Aspirin|aspirin|mesh-list
14575384|NCT00004728|Warfarin|warfarin|mesh-list
14575385|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14575386|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14575387|NCT00004728|Analgesics|analgesics|mesh-ancestor
14575388|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
14575389|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575390|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575391|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575392|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575393|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14575394|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14575395|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575396|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14575397|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14575398|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575399|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
14575400|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
14575401|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
14575402|NCT00004730|Analgesics|analgesics|mesh-ancestor
14575403|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
14575404|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575405|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575406|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
14575407|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152526|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15152527|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152528|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575408|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14575409|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
14575410|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15152529|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15152530|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
15152531|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152532|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152533|NCT04194684|Paclitaxel|paclitaxel|mesh-list
15152534|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15152535|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152536|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152537|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
15152538|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152539|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575411|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575412|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575413|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14575414|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
14575415|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575416|NCT00004731|Ubiquinone|ubiquinone|mesh-list
14575417|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
14575418|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
15152540|NCT04194515|Metformin|metformin|mesh-list
15152541|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15152542|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152543|NCT04194359|Capecitabine|capecitabine|mesh-list
15152544|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
15152545|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180189|NCT03942887|Protective Agents|protective agents|mesh-ancestor
14575419|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575420|NCT00004731|Vitamins|vitamins|mesh-ancestor
14575421|NCT00004733|Levodopa|levodopa|mesh-list
14575422|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14575423|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14575424|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
14575425|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575426|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575427|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575428|NCT00004734|Folic Acid|folic acid|mesh-list
14575429|NCT00004734|Pyridoxine|pyridoxine|mesh-list
14575430|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
14575431|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
14575432|NCT00004734|Hematinics|hematinics|mesh-ancestor
14575433|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
14575434|NCT00004734|Vitamins|vitamins|mesh-ancestor
14575435|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
14575436|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575437|NCT00004736|Lamivudine|lamivudine|mesh-list
14575438|NCT00004736|Zidovudine|zidovudine|mesh-list
14575439|NCT00004736|Stavudine|stavudine|mesh-list
14575440|NCT00004736|Nelfinavir|nelfinavir|mesh-list
14575441|NCT00004736|Isoniazid|isoniazid|mesh-list
14575442|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
14575443|NCT00004736|Ethambutol|ethambutol|mesh-list
14575444|NCT00004736|Rifabutin|rifabutin|mesh-list
14575445|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575446|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575447|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575448|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575449|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
14575450|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575451|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575452|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575453|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
14575454|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
14575455|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14575456|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14575457|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14575458|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14575459|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14575460|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14575461|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575462|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14575463|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14575464|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
14575465|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575466|NCT00004740|Isoniazid|isoniazid|mesh-list
14575467|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
14575468|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14575469|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575470|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14575471|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14575472|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
14575473|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575474|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14575475|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
14575476|NCT00004744|Antibodies|antibodies|mesh-list
14575477|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
14575478|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14575479|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14575480|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
14575481|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575482|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
14575483|NCT00004747|Antibodies|antibodies|mesh-list
14575484|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
14575485|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14575486|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14575487|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
14575488|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575489|NCT00004748|Methotrexate|methotrexate|mesh-list
14575490|NCT00004748|Colchicine|colchicine|mesh-list
14575491|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14575492|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14575493|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
14575494|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575495|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575496|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14575497|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
14575498|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575499|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575500|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
14575501|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575502|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14575503|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575504|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
14575505|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575506|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575507|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
14575508|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14575509|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14575510|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14575511|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14575512|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14575513|NCT00004754|Epoprostenol|epoprostenol|mesh-list
14575514|NCT00004754|Tezosentan|tezosentan|mesh-list
14575515|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14575516|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14575517|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
14643998|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14643999|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644000|NCT00190827|Analgesics|analgesics|mesh-ancestor
14644001|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
14644002|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644003|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644004|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644005|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
14644006|NCT00190840|Pemetrexed|pemetrexed|mesh-list
14644007|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644008|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644009|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644010|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14644011|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644012|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644013|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644014|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644015|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644016|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644017|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644018|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644019|NCT00190853|Analgesics|analgesics|mesh-ancestor
14644020|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
14644021|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644022|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644023|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644024|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
14644025|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644026|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644027|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644028|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644029|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644030|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644031|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644032|NCT00190866|Analgesics|analgesics|mesh-ancestor
14644033|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
14644034|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644035|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644036|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644037|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
14644038|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644039|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644040|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644041|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644042|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644043|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644044|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644045|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644046|NCT00190892|Carbamazepine|carbamazepine|mesh-list
14644047|NCT00190892|Olanzapine|olanzapine|mesh-list
14644048|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
14644049|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
14644050|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644051|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575518|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14575519|NCT00004755|Allopurinol|allopurinol|mesh-list
14575520|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
14575521|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575522|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575523|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
14575524|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575525|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14575526|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
14575527|NCT00004755|Protective Agents|protective agents|mesh-ancestor
14575528|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575529|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14575530|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14575531|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575532|NCT00004757|Acyclovir|acyclovir|mesh-list
14575533|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
14575534|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575535|NCT00004758|Pyridoxine|pyridoxine|mesh-list
14575536|NCT00004758|Carbamazepine|carbamazepine|mesh-list
14575537|NCT00004758|Valproic Acid|valproic acid|mesh-list
14575538|NCT00004758|Nitrazepam|nitrazepam|mesh-list
14575539|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14575540|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
14575541|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575542|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575543|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
14575544|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575545|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575546|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
14575547|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14575548|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14575549|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14575550|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14575551|NCT00004758|Analgesics|analgesics|mesh-ancestor
14575552|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
15152546|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15152547|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
15152548|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152549|NCT04194424|Metformin|metformin|mesh-list
15152550|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15152551|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152552|NCT04194294|Lidocaine|lidocaine|mesh-list
14575553|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575554|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14575555|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575556|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575557|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575558|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
14575559|NCT00004758|Vitamins|vitamins|mesh-ancestor
14575560|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
14575561|NCT00004758|Hormones|hormones|mesh-ancestor
14575562|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575563|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14575564|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14575565|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
14575566|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
14575567|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14575568|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14575569|NCT00004759|Prednisolone|prednisolone|mesh-list
14575570|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
14575571|NCT00004759|Tirilazad|tirilazad|mesh-list
14575572|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14575573|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
14575574|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575575|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
14575576|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
14575577|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575578|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575579|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14575580|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
14575581|NCT00004759|Hormones|hormones|mesh-ancestor
14575582|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575583|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14575584|NCT00004759|Protective Agents|protective agents|mesh-ancestor
14575585|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575586|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575587|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
15152553|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
14575588|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575589|NCT00004762|Cladribine|cladribine|mesh-list
14575590|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575591|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575592|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
14575593|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575594|NCT00004763|Leuprolide|leuprolide|mesh-list
14575595|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14575596|NCT00004763|Norethindrone|norethindrone|mesh-list
14575597|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
14575598|NCT00004763|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14575599|NCT00004763|Norinyl|norinyl|mesh-list
14575600|NCT00004763|Estradiol|estradiol|mesh-list
14575601|NCT00004763|Estrogens|estrogens|mesh-ancestor
14575602|NCT00004763|Hormones|hormones|mesh-ancestor
14575603|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575604|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575605|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14575606|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
14575607|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575608|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14575609|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14575610|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
14575611|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575612|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575613|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14575614|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14575615|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14575616|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14575617|NCT00004763|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14575618|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
14575619|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
15152554|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
15152555|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152556|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152557|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
15152558|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575620|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
14575621|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575622|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14575623|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
14575624|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575625|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
15152559|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15152560|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15152561|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15152562|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15152563|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152564|NCT04194125|Edotreotide|edotreotide|mesh-list
15152565|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15152566|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152567|NCT04194086|Posaconazole|posaconazole|mesh-list
15152568|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
15152569|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152570|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15152571|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15152572|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15152573|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15152574|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15152575|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152576|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152577|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15152578|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
15152579|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152580|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152581|NCT04194216|Clindamycin|clindamycin|mesh-list
15152582|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
14575626|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575627|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
14575628|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
14575629|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152583|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
15152584|NCT04194216|Cephalexin|cephalexin|mesh-list
15152585|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15152586|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152587|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15152588|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152589|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152590|NCT04194034|Flucytosine|flucytosine|mesh-list
15152591|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
15152592|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152593|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
15152594|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152595|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
15152596|NCT04194255|Trace Elements|trace elements|mesh-ancestor
15152597|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
15152598|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152599|NCT04193930|Letrozole|letrozole|mesh-list
15152600|NCT04193930|Menotropins|menotropins|mesh-list
15152601|NCT04193930|Hormones|hormones|mesh-list
15152602|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15152603|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152604|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575630|NCT00004770|Protective Agents|protective agents|mesh-ancestor
14575631|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575632|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
14575633|NCT00004770|Vitamins|vitamins|mesh-ancestor
14575634|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
14575635|NCT00004771|Leuprolide|leuprolide|mesh-list
14575636|NCT00004771|Testosterone|testosterone|mesh-list
14575637|NCT00004771|Androgens|androgens|mesh-ancestor
14575638|NCT00004771|Hormones|hormones|mesh-ancestor
14575639|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575640|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575641|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575642|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575643|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14575644|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
14575645|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575646|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
14575647|NCT00004772|Antibodies|antibodies|mesh-list
14575648|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
14575649|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14575650|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14575651|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
14575652|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575653|NCT00004776|Topiramate|topiramate|mesh-list
14575654|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
14575655|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14575656|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575657|NCT00004778|Dexamethasone|dexamethasone|mesh-list
14575658|NCT00004778|Betamethasone|betamethasone|mesh-list
14575659|NCT00004778|Hormones|hormones|mesh-list
14575660|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
14575661|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575662|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
14575663|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
14575664|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575665|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575666|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14575667|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
14575668|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575669|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575670|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575671|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14575672|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
14575673|NCT00004784|Methotrexate|methotrexate|mesh-list
14575674|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14575675|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14575676|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
14575677|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14575678|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152605|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152606|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14575679|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14575680|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
14575681|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575682|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575683|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
14575684|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575685|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14575686|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575687|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
14575688|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575689|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575690|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15152607|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15152608|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575691|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14575692|NCT00004785|Dexamethasone|dexamethasone|mesh-list
14575693|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
14575694|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14575695|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14575696|NCT00004785|Prednisolone|prednisolone|mesh-list
14575697|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
14575698|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14575699|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
14575700|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575701|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
14575702|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
14575703|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575704|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575705|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14575706|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
14575707|NCT00004785|Hormones|hormones|mesh-ancestor
14575708|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575709|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575710|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575711|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14575712|NCT00004785|Protective Agents|protective agents|mesh-ancestor
14575713|NCT00004786|Iloprost|iloprost|mesh-list
14575714|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14575715|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
14575716|NCT00004787|Lenograstim|lenograstim|mesh-list
14575717|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14575718|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
14575719|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575720|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14575721|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575722|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575723|NCT00004794|Cidofovir|cidofovir|mesh-list
14575724|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
15152609|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152610|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15152611|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
15152612|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15152613|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
15152614|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15152615|NCT04193878|Budesonide|budesonide|mesh-list
15152616|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
15152617|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152618|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15152619|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
14575725|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575726|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575727|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575728|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14575729|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14575730|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
14575731|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152620|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152621|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152622|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15152623|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152624|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
15152625|NCT04193878|Hormones|hormones|mesh-ancestor
15180190|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14575732|NCT00004796|Lactulose|lactulose|mesh-list
14575733|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14575734|NCT00004799|Vaccines|vaccines|mesh-list
14575735|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
14575736|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575737|NCT00004800|Vaccines|vaccines|mesh-list
14575738|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
14575739|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575740|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
14575741|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14575742|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575743|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575744|NCT00004804|Interferons|interferons|mesh-list
14575745|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
14575746|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152626|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152627|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15152628|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15152629|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15152630|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
15152631|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575747|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
14575748|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575749|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
14575750|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575751|NCT00004807|Topiramate|topiramate|mesh-list
14575752|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
14575753|NCT00004807|Donepezil|donepezil|mesh-list
14575754|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14575755|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575756|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575757|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
14575758|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575759|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575760|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
14575761|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
14575762|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14575763|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
14575764|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
14575765|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14575766|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14575767|NCT00004808|Fluconazole|fluconazole|mesh-list
14575768|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
14575769|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575770|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14575771|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575772|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575773|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575774|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14575775|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
14575776|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575777|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575778|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14575779|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14575780|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14575781|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
14575782|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14575783|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575784|NCT00004811|Itraconazole|itraconazole|mesh-list
14575785|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
14575786|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575787|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14575788|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575789|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575790|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575791|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14575792|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
14575793|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575794|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575795|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575796|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
14575797|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
14575798|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14575799|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
14575800|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575801|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575802|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575803|NCT00004815|Hormones|hormones|mesh-list
14575804|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575805|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575806|NCT00004816|Antibodies|antibodies|mesh-list
14575807|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14575808|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
15152632|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152633|NCT04193774|Benoxinate|benoxinate|mesh-list
15152634|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15152635|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
15152636|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15152637|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
15152638|NCT04193774|Anesthetics|anesthetics|mesh-ancestor
14575809|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575810|NCT00004817|Phenytoin|phenytoin|mesh-list
14575811|NCT00004817|Valproic Acid|valproic acid|mesh-list
14575812|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
14575813|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575814|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575815|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
14575816|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575817|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575818|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
14575819|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14575820|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14575821|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14575822|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14575823|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14575824|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575825|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14575826|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575827|NCT00004825|Insulin|insulin|mesh-list
14575828|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14575829|NCT00004825|Mitogens|mitogens|mesh-list
14575830|NCT00004825|Mecasermin|mecasermin|mesh-list
14575831|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14575832|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575833|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14575834|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575835|NCT00004825|Growth Substances|growth substances|mesh-ancestor
14575836|NCT00004826|Clozapine|clozapine|mesh-list
14575837|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14575838|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
14575839|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575840|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575841|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575842|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14575843|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14575844|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14575845|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14575846|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
14575847|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
14575848|NCT00004829|Tobramycin|tobramycin|mesh-list
14575849|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14575850|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575851|NCT00004832|Amifampridine|amifampridine|mesh-list
14575852|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14575853|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021491|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021492|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575854|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575855|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14575856|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575857|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152639|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152640|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152641|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
14575858|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
14575859|NCT00004833|Antibodies|antibodies|mesh-list
14575860|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
14575861|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14575862|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14575863|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
14575864|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575865|NCT00004834|Imipramine|imipramine|mesh-list
14575866|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14575867|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
14575868|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15180191|NCT03942601|Sirolimus|sirolimus|mesh-list
14575869|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14575870|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14575871|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575872|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575873|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14575874|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575875|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575876|NCT00004838|Succimer|succimer|mesh-list
15152642|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152643|NCT04193982|Vitamin E|vitamin e|mesh-list
15152644|NCT04193982|Vitamins|vitamins|mesh-ancestor
15152645|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
15152646|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152647|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
15152648|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152649|NCT04193982|Protective Agents|protective agents|mesh-ancestor
15152650|NCT04193852|Dienogest|dienogest|mesh-list
15152651|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14575877|NCT00004838|Antidotes|antidotes|mesh-ancestor
14575878|NCT00004838|Protective Agents|protective agents|mesh-ancestor
14575879|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575880|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
14575881|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
14575882|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575883|NCT00004840|Hormones|hormones|mesh-list
14575884|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
14575885|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575886|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575887|NCT00004842|Budesonide|budesonide|mesh-list
14575888|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575889|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14575890|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
14575891|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575892|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575893|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14575894|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
14575895|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
14575896|NCT00004842|Hormones|hormones|mesh-ancestor
14575897|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14575898|NCT00004845|Naproxen|naproxen|mesh-list
14575899|NCT00004845|Rofecoxib|rofecoxib|mesh-list
14575900|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14575901|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14575902|NCT00004845|Analgesics|analgesics|mesh-ancestor
14575903|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
14575904|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14575905|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575906|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14575907|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14575908|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
14575909|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14575910|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575911|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575912|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14575913|NCT00004852|Lamivudine|lamivudine|mesh-list
14575914|NCT00004852|Zidovudine|zidovudine|mesh-list
14575915|NCT00004852|Efavirenz|efavirenz|mesh-list
14575916|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575917|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575918|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575919|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575920|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
14575921|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575922|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575923|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575924|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
14575925|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14575926|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575927|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14575928|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14575929|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14814008|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152652|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15152653|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14575930|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575931|NCT00004853|Lenograstim|lenograstim|mesh-list
14575932|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14575933|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
14575934|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575935|NCT00004854|Carvedilol|carvedilol|mesh-list
14575936|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14575937|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14575938|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
14575939|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14575940|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575941|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575942|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14575943|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
14575944|NCT00004854|Protective Agents|protective agents|mesh-ancestor
14575945|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14575946|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14575947|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14575948|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
14575949|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14575950|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14575951|NCT00004855|Ritonavir|ritonavir|mesh-list
14575952|NCT00004855|Lopinavir|lopinavir|mesh-list
14575953|NCT00004855|Lamivudine|lamivudine|mesh-list
14575954|NCT00004855|Nevirapine|nevirapine|mesh-list
14575955|NCT00004855|Abacavir|abacavir|mesh-list
14575956|NCT00004855|Stavudine|stavudine|mesh-list
14575957|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14575958|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14575959|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14575960|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575961|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575962|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14575963|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14575964|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
14575965|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14575966|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14575967|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14575968|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14575969|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14575970|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14575971|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14575972|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
14575973|NCT00004856|Trastuzumab|trastuzumab|mesh-list
14575974|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14575975|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575976|NCT00004857|Fludarabine|fludarabine|mesh-list
14575977|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
14575978|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
14575979|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575980|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14575981|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
14575982|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575983|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14575984|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
14575985|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575986|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14575987|NCT00004858|Genistein|genistein|mesh-list
14575988|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
14575989|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14575990|NCT00004858|Protective Agents|protective agents|mesh-ancestor
14575991|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14575992|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14575993|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14575994|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14575995|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14575996|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
14575997|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14575998|NCT00004858|Estrogens|estrogens|mesh-ancestor
14575999|NCT00004858|Hormones|hormones|mesh-ancestor
14576000|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576001|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
14576002|NCT00004860|Leucovorin|leucovorin|mesh-list
14576003|NCT00004860|Tegafur|tegafur|mesh-list
15152654|NCT04193852|Estradiol|estradiol|mesh-list
14576004|NCT00004860|Calcium|calcium|mesh-list
15152655|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15152656|NCT04193852|Nandrolone|nandrolone|mesh-list
15152657|NCT04193852|Estrogens|estrogens|mesh-ancestor
15152658|NCT04193852|Hormones|hormones|mesh-ancestor
14576005|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
14576006|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14576007|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576008|NCT00004860|Antidotes|antidotes|mesh-ancestor
14576009|NCT00004860|Protective Agents|protective agents|mesh-ancestor
14576010|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
14576011|NCT00004860|Vitamins|vitamins|mesh-ancestor
14576012|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
14576013|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576014|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
14576015|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576016|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576017|NCT00004861|Gemcitabine|gemcitabine|mesh-list
14576018|NCT00004861|Tacedinaline|tacedinaline|mesh-list
14576019|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576020|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
14576021|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576022|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576023|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
14576024|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576025|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576026|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576027|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
14576028|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576029|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14576030|NCT00004862|Cytarabine|cytarabine|mesh-list
14576031|NCT00004862|Fludarabine|fludarabine|mesh-list
14576032|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
14576033|NCT00004862|Oblimersen|oblimersen|mesh-list
14576034|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576035|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576036|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
14576037|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576038|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576039|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
14576040|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576041|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
14576042|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576043|NCT00004863|Paclitaxel|paclitaxel|mesh-list
14576044|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576045|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576046|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576047|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576048|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576049|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576050|NCT00004864|Docetaxel|docetaxel|mesh-list
14576051|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576052|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576053|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576054|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576055|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576056|NCT00004865|Paclitaxel|paclitaxel|mesh-list
14576057|NCT00004865|Fluorouracil|fluorouracil|mesh-list
15152659|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152660|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576058|NCT00004865|Cetuximab|cetuximab|mesh-list
14576059|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576060|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576061|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576062|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576063|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576064|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576065|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
14576066|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576067|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576068|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
14576069|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576070|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152661|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15152662|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
14576071|NCT00004866|Exatecan|exatecan|mesh-list
14576072|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576073|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576074|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576075|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576076|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576077|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14576078|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14576079|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576080|NCT00004868|Semaxinib|semaxinib|mesh-list
14576081|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14576082|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14576083|NCT00004868|Growth Substances|growth substances|mesh-ancestor
14576084|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576085|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
14576086|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576087|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14576088|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576089|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152663|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15152664|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15152665|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15152666|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15152667|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15152668|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
15152669|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14576090|NCT00004870|Irinotecan|irinotecan|mesh-list
14576091|NCT00004870|Oblimersen|oblimersen|mesh-list
14576092|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576093|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576094|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576095|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576096|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576097|NCT00004871|Azacitidine|azacitidine|mesh-list
14576098|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14576099|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576100|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
14576101|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576102|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576103|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576104|NCT00004872|Endostatins|endostatins|mesh-list
14576105|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576106|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14576107|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14576108|NCT00004872|Growth Substances|growth substances|mesh-ancestor
14576109|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576110|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
14576111|NCT00004873|Docetaxel|docetaxel|mesh-list
14576112|NCT00004873|Fluorouracil|fluorouracil|mesh-list
14576113|NCT00004873|Epirubicin|epirubicin|mesh-list
14576114|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576115|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576116|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576117|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576118|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576119|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
15152670|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152671|NCT04193852|Androgens|androgens|mesh-ancestor
14576120|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576121|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576122|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
14576123|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576124|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576125|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576126|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576127|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576128|NCT00004874|Iodine|iodine|mesh-list
14576129|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
14576130|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14576131|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576132|NCT00004874|Trace Elements|trace elements|mesh-ancestor
14576133|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
14576134|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576135|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576136|NCT00004875|Heparin|heparin|mesh-list
15152672|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
14576137|NCT00004875|Enoxaparin|enoxaparin|mesh-list
15180192|NCT03942601|Dexamethasone|dexamethasone|mesh-list
14576138|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
14576139|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14576140|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14576141|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576142|NCT00004876|Thalidomide|thalidomide|mesh-list
14576143|NCT00004876|Carboplatin|carboplatin|mesh-list
14576144|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576145|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576146|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
14576147|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576148|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
15152673|NCT04193631|Cannabidiol|cannabidiol|mesh-list
15152674|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
15152675|NCT04193592|Pirfenidone|pirfenidone|mesh-list
15152676|NCT04193592|Analgesics|analgesics|mesh-ancestor
14576149|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14576150|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576151|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14576152|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14576153|NCT00004876|Growth Substances|growth substances|mesh-ancestor
14576154|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
14576155|NCT00004878|Cytarabine|cytarabine|mesh-list
14576156|NCT00004878|Methotrexate|methotrexate|mesh-list
14576157|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
14576158|NCT00004878|Fludarabine|fludarabine|mesh-list
14576159|NCT00004878|Idarubicin|idarubicin|mesh-list
14576160|NCT00004878|Tacrolimus|tacrolimus|mesh-list
14576161|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14576162|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
14576163|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14576164|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576165|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576166|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
14576167|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576168|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576169|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
14576170|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576171|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14576172|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576173|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
14576174|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576175|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576176|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
14576177|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576178|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14576179|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576180|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576181|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576182|NCT00004879|Panitumumab|panitumumab|mesh-list
14576183|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14576184|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576185|NCT00004880|Vaccines|vaccines|mesh-list
14576186|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
14576187|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576188|NCT00004883|Trastuzumab|trastuzumab|mesh-list
14576189|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14576190|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576191|NCT00004884|Gemcitabine|gemcitabine|mesh-list
14576192|NCT00004884|Docetaxel|docetaxel|mesh-list
14576193|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576194|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576195|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
14576196|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576197|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
14576198|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576199|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576200|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576201|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
15152677|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
15152678|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152679|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152680|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15152681|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14576202|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576203|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576204|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576205|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576206|NCT00004885|Leucovorin|leucovorin|mesh-list
14576207|NCT00004885|Fluorouracil|fluorouracil|mesh-list
14576208|NCT00004885|Irinotecan|irinotecan|mesh-list
14576209|NCT00004885|Calcium|calcium|mesh-list
14576210|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
14576211|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14576212|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576213|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
14576214|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576215|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576216|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576217|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576218|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
15152682|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152683|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15152684|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152685|NCT04193501|Melatonin|melatonin|mesh-list
15152686|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
15152687|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152688|NCT04193501|Protective Agents|protective agents|mesh-ancestor
15152689|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152690|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152691|NCT04193553|Lenvatinib|lenvatinib|mesh-list
15152692|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152693|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15152694|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576219|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576220|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576221|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576222|NCT00004885|Antidotes|antidotes|mesh-ancestor
14576223|NCT00004885|Protective Agents|protective agents|mesh-ancestor
14576224|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
14576225|NCT00004885|Vitamins|vitamins|mesh-ancestor
14576226|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
14576227|NCT00004886|Docetaxel|docetaxel|mesh-list
14576228|NCT00004886|Dofequidar|dofequidar|mesh-list
14576229|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576230|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576231|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576232|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576233|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576234|NCT00004887|Paclitaxel|paclitaxel|mesh-list
14576235|NCT00004887|Vinblastine|vinblastine|mesh-list
14576236|NCT00004887|Carboplatin|carboplatin|mesh-list
14576237|NCT00004887|Ifosfamide|ifosfamide|mesh-list
14576238|NCT00004887|Mitomycins|mitomycins|mesh-list
14576239|NCT00004887|Mitomycin|mitomycin|mesh-list
14576240|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576241|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576242|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576243|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
15152695|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152696|NCT04193319|Fluconazole|fluconazole|mesh-list
15152697|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
15152698|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152699|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15152700|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15152701|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576244|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576245|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576246|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576247|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
14576248|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576249|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576250|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576251|NCT00004889|Rituximab|rituximab|mesh-list
14576252|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14576253|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576254|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
14576255|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576256|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14644052|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14644053|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14644054|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14644055|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14644056|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644057|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15152702|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152703|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15152704|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
15152705|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152706|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152707|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15152708|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15152709|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
15152710|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15152711|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152712|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15152713|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152714|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
15152715|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15152716|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152717|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152718|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152719|NCT04193215|Vaccines|vaccines|mesh-list
15152720|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
14576257|NCT00004890|Aldesleukin|aldesleukin|mesh-list
14576258|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576259|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576260|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576261|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
14576262|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576263|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14576264|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14576265|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576266|NCT00004892|Carmustine|carmustine|mesh-list
14576267|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14576268|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576269|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
14576270|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576271|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576272|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576273|NCT00004893|Interleukin-12|interleukin-12|mesh-list
14576274|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14576275|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
14576276|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576277|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14576278|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14576279|NCT00004893|Growth Substances|growth substances|mesh-ancestor
14576280|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
14576281|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576282|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
14576283|NCT00004900|Thiotepa|thiotepa|mesh-list
14576284|NCT00004900|Carboplatin|carboplatin|mesh-list
14576285|NCT00004900|Etoposide|etoposide|mesh-list
14576286|NCT00004900|Anastrozole|anastrozole|mesh-list
14576287|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576288|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
14576289|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576290|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576291|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576292|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
14576293|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576294|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576295|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14576296|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576297|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576298|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576299|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576300|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14576301|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14576302|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14576303|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14576304|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
14576305|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576306|NCT00004901|Fluorouracil|fluorouracil|mesh-list
14576307|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
14576308|NCT00004901|Eniluracil|eniluracil|mesh-list
14576309|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
14644058|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14576310|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576311|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576312|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576313|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576314|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
14576315|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576316|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
14576317|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576318|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576319|NCT00004903|Interferons|interferons|mesh-list
14576320|NCT00004903|Cytarabine|cytarabine|mesh-list
14576321|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
14576322|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
14576323|NCT00004903|Melphalan|melphalan|mesh-list
14576324|NCT00004903|Etoposide|etoposide|mesh-list
14576325|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576326|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
14576327|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576328|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576329|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576330|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
14576331|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576332|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576333|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14576334|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576335|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576336|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576337|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576338|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
14576339|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576340|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576341|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
14576342|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
14576343|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
14576344|NCT00004904|Etoposide|etoposide|mesh-list
14576345|NCT00004904|Cladribine|cladribine|mesh-list
14576346|NCT00004904|Tacrolimus|tacrolimus|mesh-list
14576347|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14576348|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576349|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
14576350|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576351|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576352|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576353|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
14576354|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576355|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576356|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14576357|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576358|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576359|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576360|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576361|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14576362|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14576363|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
14576364|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
14576365|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152721|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152722|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
15152723|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15152724|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152725|NCT04192981|GDC-0084|gdc-0084|mesh-list
15152726|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152727|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152728|NCT04193137|Captopril|captopril|mesh-list
15152729|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14021493|NCT02773459|Capecitabine|capecitabine|mesh-list
14576366|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14576367|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
14576368|NCT00004904|Hormones|hormones|mesh-ancestor
14576369|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576370|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14576371|NCT00004904|Protective Agents|protective agents|mesh-ancestor
14576372|NCT00004905|Interferons|interferons|mesh-list
14576373|NCT00004905|Cytarabine|cytarabine|mesh-list
14576374|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
14576375|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
14576376|NCT00004905|Etoposide|etoposide|mesh-list
14576377|NCT00004905|Idarubicin|idarubicin|mesh-list
14576378|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576379|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
14576380|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576381|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576382|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576383|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
14576384|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576385|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576386|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14021494|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14021495|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
14021496|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021497|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021498|NCT02773316|Morphine|morphine|mesh-list
14021499|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14021500|NCT02773316|Narcotics|narcotics|mesh-ancestor
14021501|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021502|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021503|NCT02773316|Analgesics|analgesics|mesh-ancestor
14576387|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576388|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15152730|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
15152731|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152732|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576389|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576390|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576391|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
14576392|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576393|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576394|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
14576395|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576396|NCT00004906|Pamidronate|pamidronate|mesh-list
14576397|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
14576398|NCT00004906|Thiotepa|thiotepa|mesh-list
14576399|NCT00004906|Carboplatin|carboplatin|mesh-list
14576400|NCT00004906|Docetaxel|docetaxel|mesh-list
14576401|NCT00004906|Doxorubicin|doxorubicin|mesh-list
14576402|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14576403|NCT00004906|Etoposide|etoposide|mesh-list
14576404|NCT00004906|Anastrozole|anastrozole|mesh-list
14576405|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576406|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
14576407|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576408|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576409|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576410|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
14576411|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576412|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576413|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14576414|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576415|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576416|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576417|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576418|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576419|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576420|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576421|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576422|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14576423|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14576424|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14576425|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14576426|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
14576427|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576428|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14576429|NCT00004913|Leucovorin|leucovorin|mesh-list
14576430|NCT00004913|Docetaxel|docetaxel|mesh-list
14576431|NCT00004913|Fluorouracil|fluorouracil|mesh-list
14576432|NCT00004913|Calcium|calcium|mesh-list
14576433|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
14576434|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576435|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152733|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14576436|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576437|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
14021504|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
14814009|NCT00861250|Dexamethasone|dexamethasone|mesh-list
15152734|NCT04193059|Paclitaxel|paclitaxel|mesh-list
14576438|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576439|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14576440|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576441|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
14576442|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576443|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576444|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
14576445|NCT00004913|Antidotes|antidotes|mesh-ancestor
14576446|NCT00004913|Protective Agents|protective agents|mesh-ancestor
14576447|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
14576448|NCT00004913|Vitamins|vitamins|mesh-ancestor
14576449|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
14576450|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
14576451|NCT00004917|Hematinics|hematinics|mesh-ancestor
14576452|NCT00004918|Sargramostim|sargramostim|mesh-list
14576453|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
14576454|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576455|NCT00004919|Irinotecan|irinotecan|mesh-list
14576456|NCT00004919|Amifostine|amifostine|mesh-list
14576457|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576458|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576459|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576460|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576461|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576462|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14576463|NCT00004919|Protective Agents|protective agents|mesh-ancestor
14576464|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576465|NCT00004920|Raltitrexed|raltitrexed|mesh-list
14576466|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576467|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576468|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
14576469|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576470|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14576471|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576472|NCT00004921|Paclitaxel|paclitaxel|mesh-list
14576473|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
14576474|NCT00004921|Carboplatin|carboplatin|mesh-list
14576475|NCT00004921|Melphalan|melphalan|mesh-list
14576476|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576477|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576478|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576479|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576480|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576481|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576482|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576483|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
14576484|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576485|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576486|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576487|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
14576488|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14576489|NCT00004922|Irinotecan|irinotecan|mesh-list
14576490|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576491|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576492|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576493|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576494|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576495|NCT00004923|Docetaxel|docetaxel|mesh-list
14576496|NCT00004923|Irinotecan|irinotecan|mesh-list
14576497|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576498|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576499|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576500|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576501|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576502|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576503|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576504|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576505|NCT00004924|Paclitaxel|paclitaxel|mesh-list
14576506|NCT00004924|Irinotecan|irinotecan|mesh-list
14576507|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576508|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576509|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576510|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576511|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576512|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152735|NCT04193059|Docetaxel|docetaxel|mesh-list
14576513|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576514|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576515|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576516|NCT00004925|Doxorubicin|doxorubicin|mesh-list
14576517|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14576518|NCT00004925|Trastuzumab|trastuzumab|mesh-list
14576519|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576520|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576521|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576522|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576523|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576524|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576525|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14576526|NCT00004926|Vitamin D|vitamin d|mesh-list
14576527|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
14576528|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
14576529|NCT00004926|Vitamins|vitamins|mesh-ancestor
14576530|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
14576531|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576532|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14576533|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14576534|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576535|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
14576536|NCT00004928|Calcitriol|calcitriol|mesh-list
14576537|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14576538|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576539|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15152736|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
15152737|NCT04193059|Carboplatin|carboplatin|mesh-list
15152738|NCT04193059|Trastuzumab|trastuzumab|mesh-list
15152739|NCT04193059|Epirubicin|epirubicin|mesh-list
15152740|NCT04193059|Pertuzumab|pertuzumab|mesh-list
15152741|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15152742|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152743|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152744|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
15152745|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152746|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152747|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152748|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
15152749|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152750|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15152751|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15152752|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
15152753|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15152754|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152755|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15152756|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576540|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14576541|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14576542|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291605|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14291606|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
14291607|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291608|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291609|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
14291610|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14291611|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14291612|NCT00555464|Prednisone|prednisone|mesh-list
14291613|NCT00555464|Prednisolone|prednisolone|mesh-list
14291614|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14291615|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
14291616|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14576543|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14576544|NCT00004928|Vitamins|vitamins|mesh-ancestor
14576545|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
14576546|NCT00004930|Doxorubicin|doxorubicin|mesh-list
14576547|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14576548|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576549|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576550|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576551|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15152757|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15152758|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576552|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576553|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576554|NCT00004931|Leucovorin|leucovorin|mesh-list
14576555|NCT00004931|Fluorouracil|fluorouracil|mesh-list
14576556|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
14576557|NCT00004931|Calcium|calcium|mesh-list
14576558|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
14576559|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14576560|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576561|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
14576562|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576563|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14576564|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576565|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576566|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
14576567|NCT00004931|Antidotes|antidotes|mesh-ancestor
14576568|NCT00004931|Protective Agents|protective agents|mesh-ancestor
14576569|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
14576570|NCT00004931|Vitamins|vitamins|mesh-ancestor
14576571|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
14576572|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
14576573|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576574|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14576575|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576576|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576577|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
14576578|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
14576579|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576580|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
14576581|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576582|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576583|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576584|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576585|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14576586|NCT00004934|Paclitaxel|paclitaxel|mesh-list
14576587|NCT00004934|Carboplatin|carboplatin|mesh-list
14576588|NCT00004934|Epirubicin|epirubicin|mesh-list
14576589|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576590|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576591|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576592|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576593|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576594|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576595|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576596|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576597|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576598|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576599|NCT00004938|Fluconazole|fluconazole|mesh-list
14576600|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
14576601|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576602|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14576603|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14576604|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576605|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576606|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14576607|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
14576608|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576609|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576610|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14576611|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14576612|NCT00004941|Infliximab|infliximab|mesh-list
14576613|NCT00004941|Antibodies|antibodies|mesh-list
14576614|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14576615|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
15152759|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
15152760|NCT04192916|Apixaban|apixaban|mesh-list
15152761|NCT04192916|Edoxaban|edoxaban|mesh-list
15152762|NCT04192916|Dabigatran|dabigatran|mesh-list
14576616|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576617|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
14576618|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14576619|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576620|NCT00004979|Paclitaxel|paclitaxel|mesh-list
14576621|NCT00004979|Topotecan|topotecan|mesh-list
15152763|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15152764|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
14576622|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576623|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152765|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14576624|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576625|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576626|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576627|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576628|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576629|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576630|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576631|NCT00004981|Lamivudine|lamivudine|mesh-list
14576632|NCT00004981|Zidovudine|zidovudine|mesh-list
14576633|NCT00004981|Abacavir|abacavir|mesh-list
14576634|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
14576635|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14576636|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576637|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576638|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576639|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576640|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
14576641|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576642|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576643|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576644|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
14576645|NCT00004984|Insulin|insulin|mesh-list
14576646|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14576647|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14576648|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576649|NCT00004985|Nelfinavir|nelfinavir|mesh-list
14576650|NCT00004985|Capravirine|capravirine|mesh-list
14576651|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14576652|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14576653|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
14576654|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576655|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576656|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576657|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576658|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
14576659|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576660|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576661|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576662|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
14576663|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14576664|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576665|NCT00004990|Dexamethasone|dexamethasone|mesh-list
14576666|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14576667|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
14576668|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
14576669|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14576670|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576671|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14576672|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
14576673|NCT00004990|Hormones|hormones|mesh-ancestor
14576674|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576675|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14576676|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576677|NCT00004992|Metformin|metformin|mesh-list
14576678|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14576679|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576680|NCT00004993|Hormones|hormones|mesh-list
14576681|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
14576682|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576683|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576684|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14576685|NCT00004997|Leucovorin|leucovorin|mesh-list
14576686|NCT00004997|Antidotes|antidotes|mesh-ancestor
14576687|NCT00004997|Protective Agents|protective agents|mesh-ancestor
14576688|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576689|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
14576690|NCT00004997|Vitamins|vitamins|mesh-ancestor
15152766|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
15152767|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152768|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152769|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
15152770|NCT04192812|Leuprolide|leuprolide|mesh-list
15152771|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14576691|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
14576692|NCT00004998|Lamivudine|lamivudine|mesh-list
14576693|NCT00004998|Zidovudine|zidovudine|mesh-list
15152772|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
15152773|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15152774|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576694|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14576695|NCT00004998|Capravirine|capravirine|mesh-list
14576696|NCT00004998|Nelfinavir|nelfinavir|mesh-list
14576697|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576698|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15152775|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15152776|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152777|NCT04192617|Methotrexate|methotrexate|mesh-list
15152778|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15152779|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
15152780|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15152781|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152782|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15152783|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
15152784|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152785|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576699|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576700|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576701|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
14576702|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576703|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576704|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576705|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
14576706|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14576707|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14576708|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
14576709|NCT00004999|Lamivudine|lamivudine|mesh-list
14576710|NCT00004999|Zidovudine|zidovudine|mesh-list
14576711|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
15152786|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
15152787|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152788|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15152789|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152790|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
15152791|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15152792|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15152793|NCT04192773|Lidocaine|lidocaine|mesh-list
15152794|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
15152795|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
15152796|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152797|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152798|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
15152799|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152800|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15152801|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15152802|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15152803|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15152804|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152805|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
15152806|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15152807|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15152808|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576712|NCT00004999|Capravirine|capravirine|mesh-list
14576713|NCT00004999|Nelfinavir|nelfinavir|mesh-list
14576714|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576715|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576716|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576717|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576718|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
14576719|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576720|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576721|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576722|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
14576723|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14576724|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15152809|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
15152810|NCT04192643|Coagulants|coagulants|mesh-ancestor
15152811|NCT04192266|Estradiol|estradiol|mesh-list
15152812|NCT04192266|Estrogens|estrogens|mesh-ancestor
14576725|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
14576726|NCT00005000|Lamivudine|lamivudine|mesh-list
14576727|NCT00005000|Zidovudine|zidovudine|mesh-list
14576728|NCT00005000|Efavirenz|efavirenz|mesh-list
14576729|NCT00005000|Stavudine|stavudine|mesh-list
15152813|NCT04192266|Hormones|hormones|mesh-ancestor
15152814|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152815|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152816|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
15152817|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15152818|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14576730|NCT00005000|Didanosine|didanosine|mesh-list
14576731|NCT00005000|Nelfinavir|nelfinavir|mesh-list
14576732|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14576733|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576734|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576735|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576736|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576737|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
14576738|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576739|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576740|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576741|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
14576742|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14576743|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14576744|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14576745|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14576746|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14576747|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14576748|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14576749|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14576750|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
14576751|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14576752|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
14576753|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576754|NCT00005002|Lamivudine|lamivudine|mesh-list
14576755|NCT00005002|Zidovudine|zidovudine|mesh-list
14576756|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14576757|NCT00005002|Nelfinavir|nelfinavir|mesh-list
14576758|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576759|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576760|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576761|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576762|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
14576763|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576764|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15152819|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152820|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
15152821|NCT04192435|Coagulants|coagulants|mesh-ancestor
14291617|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
14291618|NCT00555464|Vincristine|vincristine|mesh-list
14291619|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14291620|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
14291621|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152822|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15152823|NCT04192292|Gliclazide|gliclazide|mesh-list
15152824|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14291622|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
14291623|NCT00555464|Hormones|hormones|mesh-ancestor
14291624|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291625|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291626|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14291627|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291628|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14291629|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
14291630|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
14291631|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
14291632|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291633|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
14291634|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
14291635|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291636|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14291637|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14291638|NCT00555464|Protective Agents|protective agents|mesh-ancestor
14291639|NCT00555477|Anastrozole|anastrozole|mesh-list
14291640|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14291641|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291642|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14576765|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576766|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
14576767|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14576768|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14576769|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
14576770|NCT00005005|Alendronate|alendronate|mesh-list
14576771|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14576772|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576773|NCT00005006|Alendronate|alendronate|mesh-list
14576774|NCT00005006|Teriparatide|teriparatide|mesh-list
14576775|NCT00005006|Hormones|hormones|mesh-list
14576776|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
14576777|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14576778|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576779|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14576780|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14576781|NCT00005007|Etanercept|etanercept|mesh-list
14576782|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14576783|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14576784|NCT00005007|Analgesics|analgesics|mesh-ancestor
14576785|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
14576786|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14576787|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576788|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14576789|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576790|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14576791|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576792|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
14576793|NCT00005009|Vaccines|vaccines|mesh-list
14576794|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
14576795|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576796|NCT00005010|Irbesartan|irbesartan|mesh-list
14576797|NCT00005010|Pravastatin|pravastatin|mesh-list
14576798|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14576799|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14576800|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
14576801|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576802|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14576803|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14576804|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576805|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14576806|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14576807|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14576808|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14576809|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
14576810|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576811|NCT00005013|Sertraline|sertraline|mesh-list
14576812|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
14576813|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14576814|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14576815|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14576816|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14576817|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576818|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14576819|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
14576820|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576821|NCT00005014|Risperidone|risperidone|mesh-list
14576822|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14576823|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
14576824|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14576825|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576826|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576827|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14576828|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14576829|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14576830|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14576831|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14576832|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
14576833|NCT00005015|Fluoxetine|fluoxetine|mesh-list
14576834|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14576835|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14576836|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14576837|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152825|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14576838|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14576839|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
14576840|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576841|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14576842|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
14576843|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14576844|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14576845|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14576846|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576847|NCT00005017|Ritonavir|ritonavir|mesh-list
14576848|NCT00005017|Amprenavir|amprenavir|mesh-list
14576849|NCT00005017|Lamivudine|lamivudine|mesh-list
14576850|NCT00005017|Abacavir|abacavir|mesh-list
14576851|NCT00005017|Stavudine|stavudine|mesh-list
14576852|NCT00005017|Efavirenz|efavirenz|mesh-list
14576853|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14576854|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14576855|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
14576856|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576857|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576858|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576859|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576860|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
14576861|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576862|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14576863|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14576864|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576865|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576866|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14576867|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14576868|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14576869|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14576870|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14576871|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
14576872|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14576873|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
14576874|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14576875|NCT00005018|Efavirenz|efavirenz|mesh-list
14576876|NCT00005018|Abacavir|abacavir|mesh-list
14576877|NCT00005018|Didanosine|didanosine|mesh-list
14576878|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
14576879|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14576880|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576881|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576882|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576883|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
14576884|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576885|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14576886|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14576887|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14576888|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14576889|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14576890|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14576891|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14576892|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14576893|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576894|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
14576895|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
14576896|NCT00005021|Paclitaxel|paclitaxel|mesh-list
14576897|NCT00005021|Carboplatin|carboplatin|mesh-list
14576898|NCT00005021|Topotecan|topotecan|mesh-list
14576899|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576900|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576901|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576902|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576903|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576904|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576905|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576906|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576907|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576908|NCT00005022|Etoposide|etoposide|mesh-list
14576909|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576910|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576911|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576912|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576913|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576914|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576915|NCT00005023|Sargramostim|sargramostim|mesh-list
14576916|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
14576917|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576918|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
14576919|NCT00005024|Carboplatin|carboplatin|mesh-list
14576920|NCT00005024|Doxorubicin|doxorubicin|mesh-list
14576921|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14576922|NCT00005024|Granisetron|granisetron|mesh-list
14576923|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14576924|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
14576925|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576926|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14576927|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576928|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
14576929|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576930|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576931|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14576932|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14576933|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14576934|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576935|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576936|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
14576937|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
14576938|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14576939|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14576940|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14576941|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
14576942|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14576943|NCT00005025|Ganciclovir|ganciclovir|mesh-list
14576944|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14576945|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
14576946|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14576947|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14576948|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576949|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576950|NCT00005026|Paclitaxel|paclitaxel|mesh-list
14576951|NCT00005026|Carboplatin|carboplatin|mesh-list
14576952|NCT00005026|Topotecan|topotecan|mesh-list
14576953|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576954|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576955|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576956|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576957|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576958|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576959|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576960|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576961|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576962|NCT00005028|Paclitaxel|paclitaxel|mesh-list
14576963|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
14576964|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576965|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576966|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576967|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576968|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576969|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576970|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14576971|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
14576972|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14576973|NCT00005029|Topotecan|topotecan|mesh-list
14576974|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14576975|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14576976|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576977|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576978|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576979|NCT00005030|Lonafarnib|lonafarnib|mesh-list
14576980|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14576981|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576982|NCT00005031|Irofulven|irofulven|mesh-list
14576983|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14576984|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
14576985|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576986|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576987|NCT00005032|Paclitaxel|paclitaxel|mesh-list
14576988|NCT00005032|Oblimersen|oblimersen|mesh-list
15152826|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152827|NCT04192292|Incretins|incretins|mesh-ancestor
14576989|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14576990|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576991|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
14576992|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
14576993|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
14576994|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14576995|NCT00005033|Trastuzumab|trastuzumab|mesh-list
14576996|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14576997|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14576998|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
14576999|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577000|NCT00005036|Leucovorin|leucovorin|mesh-list
14577001|NCT00005036|Fluorouracil|fluorouracil|mesh-list
14577002|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
14577003|NCT00005036|Irinotecan|irinotecan|mesh-list
14577004|NCT00005036|Calcium|calcium|mesh-list
14577005|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
14577006|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15152828|NCT04192292|Hormones|hormones|mesh-ancestor
15152829|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152830|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
15152831|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152832|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152833|NCT04192253|Paclitaxel|paclitaxel|mesh-list
15152834|NCT04192253|Carboplatin|carboplatin|mesh-list
15152835|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15152836|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152837|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152838|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
15152839|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152840|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152841|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
15152842|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15152843|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15152844|NCT04192656|Prednisolone|prednisolone|mesh-list
15152845|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
15152846|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15152847|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
15152848|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152849|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
15152850|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
15152851|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152852|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152853|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15152854|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
15152855|NCT04192656|Hormones|hormones|mesh-ancestor
15152856|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152857|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15152858|NCT04192656|Protective Agents|protective agents|mesh-ancestor
15152859|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15152860|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152861|NCT04191889|Apatinib|apatinib|mesh-list
15152862|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152863|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15152864|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152865|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152866|NCT04191954|Fasudil|fasudil|mesh-list
15152867|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15152868|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
15152869|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15152870|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15152871|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14577007|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577008|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
14577009|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577010|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15152872|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152873|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15152874|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577011|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577012|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577013|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
14577014|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14577015|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577016|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577017|NCT00005036|Antidotes|antidotes|mesh-ancestor
14577018|NCT00005036|Protective Agents|protective agents|mesh-ancestor
14577019|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
14577020|NCT00005036|Vitamins|vitamins|mesh-ancestor
15152875|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
15152876|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15152877|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152878|NCT04192032|Nicotine|nicotine|mesh-list
15152879|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15152880|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
15152881|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152882|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152883|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15152884|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14577021|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
14577022|NCT00005037|Temozolomide|temozolomide|mesh-list
14577023|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577024|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
14577025|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577026|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577027|NCT00005038|Aldesleukin|aldesleukin|mesh-list
14577028|NCT00005038|Histamine|histamine|mesh-list
14577029|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
14577030|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577031|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14577032|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14577033|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
14577034|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577035|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
14577036|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
14577037|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14577038|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577039|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577040|NCT00005039|Vaccines|vaccines|mesh-list
14577041|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
14577042|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577043|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
14577044|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577045|NCT00005041|Tipifarnib|tipifarnib|mesh-list
14577046|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577047|NCT00005042|Semaxinib|semaxinib|mesh-list
14577048|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14577049|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14577050|NCT00005042|Growth Substances|growth substances|mesh-ancestor
14577051|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577052|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
14577053|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577054|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14577055|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577056|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577057|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
14577058|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291643|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14291644|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291645|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291646|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14291647|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
14291648|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291649|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291650|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
14291651|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291652|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291653|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291654|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291655|NCT00555620|Capecitabine|capecitabine|mesh-list
14291656|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
14291657|NCT00555620|Sunitinib|sunitinib|mesh-list
14291658|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577059|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14577060|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14577061|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577062|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14577063|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577064|NCT00005046|Paclitaxel|paclitaxel|mesh-list
14577065|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15152885|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
15152886|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152887|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152888|NCT04192019|Glucagon|glucagon|mesh-list
14577066|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577067|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577068|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577069|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577070|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577071|NCT00005048|Paclitaxel|paclitaxel|mesh-list
14577072|NCT00005048|Estramustine|estramustine|mesh-list
14577073|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577074|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577075|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577076|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577077|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577078|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577079|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577080|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
14577081|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577082|NCT00005049|Carboplatin|carboplatin|mesh-list
14577083|NCT00005049|Floxuridine|floxuridine|mesh-list
14577084|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577085|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577086|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
15152889|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15152890|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15152891|NCT04192019|Hormones|hormones|mesh-ancestor
15152892|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577087|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577088|NCT00005050|Fluorouracil|fluorouracil|mesh-list
14577089|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
14577090|NCT00005050|Eniluracil|eniluracil|mesh-list
14577091|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
14577092|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577093|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577094|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577095|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577096|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
14577097|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577098|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577099|NCT00005051|Paclitaxel|paclitaxel|mesh-list
14577100|NCT00005051|Carboplatin|carboplatin|mesh-list
14577101|NCT00005051|Topotecan|topotecan|mesh-list
14577102|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577103|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577104|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577105|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577106|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577107|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577108|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14577109|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577110|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644059|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644060|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644061|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644062|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
14644063|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
14644064|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
14644065|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14644066|NCT00190892|Analgesics|analgesics|mesh-ancestor
14644067|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
14644068|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14644069|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14644070|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14644071|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644072|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644073|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644074|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644075|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644076|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180193|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
14577111|NCT00005054|Temozolomide|temozolomide|mesh-list
14577112|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577113|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
14577114|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577115|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577116|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
14577117|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14577118|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
14577119|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577120|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577121|NCT00005057|Ganciclovir|ganciclovir|mesh-list
14577122|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14577123|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
14021505|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021506|NCT02773199|Bupivacaine|bupivacaine|mesh-list
14021507|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
14021508|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
14021509|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021510|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021511|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
14577124|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577125|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14577126|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152893|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152894|NCT04192019|Incretins|incretins|mesh-ancestor
15152895|NCT04192331|Paclitaxel|paclitaxel|mesh-list
15152896|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15152897|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15152898|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152899|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152900|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
15152901|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152902|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152903|NCT04191694|Ondansetron|ondansetron|mesh-list
15152904|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
15152905|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
15152906|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152907|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577127|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577128|NCT00005059|Paclitaxel|paclitaxel|mesh-list
14577129|NCT00005059|Carboplatin|carboplatin|mesh-list
14577130|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577131|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577132|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577133|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577134|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577135|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577136|NCT00005060|Docetaxel|docetaxel|mesh-list
14577137|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577138|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577139|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577140|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152908|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15152909|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
14577141|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577142|NCT00005061|Bevacizumab|bevacizumab|mesh-list
14577143|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14577144|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577145|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14577146|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14577147|NCT00005061|Growth Substances|growth substances|mesh-ancestor
14577148|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577149|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
14577150|NCT00005064|Bortezomib|bortezomib|mesh-list
14577151|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577152|NCT00005065|Paclitaxel|paclitaxel|mesh-list
14577153|NCT00005065|Carboplatin|carboplatin|mesh-list
14577154|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
14577155|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577156|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577157|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577158|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577159|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
15152910|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
15152911|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14021512|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152912|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
15152913|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152914|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152915|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14577160|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577161|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14577162|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577163|NCT00005066|Carmustine|carmustine|mesh-list
14577164|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14577165|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577166|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
14577167|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577168|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577169|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577170|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
14577171|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14577172|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577173|NCT00005068|Leucovorin|leucovorin|mesh-list
14577174|NCT00005068|Fluorouracil|fluorouracil|mesh-list
14577175|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
14577176|NCT00005068|Irinotecan|irinotecan|mesh-list
14577177|NCT00005068|Calcium|calcium|mesh-list
14577178|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
14577179|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14577180|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577181|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
14577182|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577183|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577184|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577185|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152916|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15152917|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152918|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14577186|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
14577187|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14577188|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577189|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577190|NCT00005068|Antidotes|antidotes|mesh-ancestor
14577191|NCT00005068|Protective Agents|protective agents|mesh-ancestor
14577192|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
15152919|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15180194|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15180195|NCT03942601|BB 1101|bb 1101|mesh-list
15180196|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180197|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
15180198|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
15180199|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180200|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180201|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180202|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
15180203|NCT03942601|Hormones|hormones|mesh-ancestor
15180204|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180205|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15180206|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180207|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15180208|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180209|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15180210|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
15180211|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180212|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
14021513|NCT02773550|Prednisone|prednisone|mesh-list
14021514|NCT02773550|Bortezomib|bortezomib|mesh-list
14021515|NCT02773550|Melphalan|melphalan|mesh-list
14577193|NCT00005068|Vitamins|vitamins|mesh-ancestor
14577194|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
14577195|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
14577196|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577197|NCT00005070|Irofulven|irofulven|mesh-list
14577198|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577199|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
14577200|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577201|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021516|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021517|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
14577202|NCT00005072|Interleukin-2|interleukin-2|mesh-list
14577203|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814010|NCT00861250|Bortezomib|bortezomib|mesh-list
15180213|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
14577204|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14577205|NCT00005072|Analgesics|analgesics|mesh-ancestor
14577206|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
14577207|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577208|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577209|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
14577210|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14577211|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577212|NCT00005074|Alvocidib|alvocidib|mesh-list
14577213|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577214|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
14577215|NCT00005074|Growth Substances|growth substances|mesh-ancestor
14577216|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577217|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14577218|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577219|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577220|NCT00005076|Irinotecan|irinotecan|mesh-list
14577221|NCT00005076|Cetuximab|cetuximab|mesh-list
14577222|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14577223|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577224|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577225|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577226|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577227|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14577228|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
14577229|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577230|NCT00005078|Paclitaxel|paclitaxel|mesh-list
14577231|NCT00005078|Carboplatin|carboplatin|mesh-list
14577232|NCT00005078|Tirapazamine|tirapazamine|mesh-list
14577233|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577234|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577235|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577236|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577237|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577238|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577239|NCT00005081|Carmustine|carmustine|mesh-list
14577240|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14577241|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577242|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
14577243|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577244|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577245|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577246|NCT00005086|Gemcitabine|gemcitabine|mesh-list
14577247|NCT00005086|Docetaxel|docetaxel|mesh-list
14577248|NCT00005086|Methotrexate|methotrexate|mesh-list
14577249|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577250|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577251|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
14577252|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577253|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
14577254|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577255|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577256|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577257|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
14577258|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577259|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577260|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577261|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577262|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14577263|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
14577264|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14577265|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577266|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14577267|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577268|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14577269|NCT00005087|Paclitaxel|paclitaxel|mesh-list
14577270|NCT00005087|Cisplatin|cisplatin|mesh-list
14577271|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577272|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577273|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577274|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577275|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577276|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577277|NCT00005088|Cisplatin|cisplatin|mesh-list
14577278|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577279|NCT00005089|Prednisone|prednisone|mesh-list
14577280|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
14577281|NCT00005089|Rituximab|rituximab|mesh-list
14577282|NCT00005089|Doxorubicin|doxorubicin|mesh-list
14577283|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14577284|NCT00005089|Vincristine|vincristine|mesh-list
14577285|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577286|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
14577287|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577288|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577289|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577290|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
14577291|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577292|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577293|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577294|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14577295|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577296|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577297|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577298|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577299|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14577300|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
14577301|NCT00005089|Hormones|hormones|mesh-ancestor
14577302|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577303|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577304|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577305|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
15152920|NCT04191681|Valsartan|valsartan|mesh-list
15152921|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15152922|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15152923|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15152924|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15152925|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152926|NCT04191863|Valproic Acid|valproic acid|mesh-list
15152927|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
15152928|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152929|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152930|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
15152931|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152932|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152933|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
15152934|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15152935|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15152936|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15152937|NCT04191447|Budesonide|budesonide|mesh-list
15152938|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
15180214|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577306|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577307|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577308|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
14577309|NCT00005090|Dacarbazine|dacarbazine|mesh-list
14577310|NCT00005090|Carmustine|carmustine|mesh-list
14577311|NCT00005090|Doxorubicin|doxorubicin|mesh-list
14577312|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14577313|NCT00005090|Etoposide|etoposide|mesh-list
14577314|NCT00005090|Bleomycin|bleomycin|mesh-list
14577315|NCT00005090|Vinblastine|vinblastine|mesh-list
14577316|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577317|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
14577318|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577319|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577320|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577321|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
14577322|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577323|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577324|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577325|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577326|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577327|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577328|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577329|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577330|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577331|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577332|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577333|NCT00005091|Exatecan|exatecan|mesh-list
14577334|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14577335|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577336|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577337|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577338|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577339|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
14577340|NCT00005092|Thiotepa|thiotepa|mesh-list
14577341|NCT00005092|Methoxsalen|methoxsalen|mesh-list
14577342|NCT00005092|Furocoumarins|furocoumarins|mesh-list
14577343|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577344|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
14577345|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577346|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577347|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577348|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
14577349|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577350|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577351|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577352|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14577353|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577354|NCT00005093|Gemcitabine|gemcitabine|mesh-list
14577355|NCT00005093|Tacedinaline|tacedinaline|mesh-list
14577356|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577357|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
14577358|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577359|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577360|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
14577361|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577362|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577363|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577364|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
14577365|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577366|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14577367|NCT00005094|Celecoxib|celecoxib|mesh-list
14577368|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14577369|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14577370|NCT00005094|Analgesics|analgesics|mesh-ancestor
14577371|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
14577372|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577373|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577374|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14577375|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577376|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14577377|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14577378|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577379|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577380|NCT00005096|Docetaxel|docetaxel|mesh-list
14577381|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577382|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577383|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577384|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577385|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152939|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15152940|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152941|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15152942|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
15152943|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152944|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152945|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14577386|NCT00005104|Metformin|metformin|mesh-list
14577387|NCT00005104|Clomiphene|clomiphene|mesh-list
14577388|NCT00005104|Enclomiphene|enclomiphene|mesh-list
14577389|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
14577390|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14577391|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577392|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14577393|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
14577394|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577395|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14577396|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
14577397|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14577398|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14577399|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14577400|NCT00005106|Lamivudine|lamivudine|mesh-list
14577401|NCT00005106|Zidovudine|zidovudine|mesh-list
14577402|NCT00005106|Abacavir|abacavir|mesh-list
14577403|NCT00005106|Stavudine|stavudine|mesh-list
14577404|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14577405|NCT00005106|Nelfinavir|nelfinavir|mesh-list
14577406|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14577407|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14577408|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577409|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577410|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
14577411|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577412|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14577413|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14577414|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
14577415|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14577416|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14577417|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
14577418|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
15152946|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152947|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
15152948|NCT04191447|Hormones|hormones|mesh-ancestor
15152949|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152950|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15152951|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15152952|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15152953|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
15152954|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152955|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152956|NCT04191434|Budesonide|budesonide|mesh-list
15152957|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
15152958|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15152959|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15152960|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15152961|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
15152962|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15152963|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152964|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15152965|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
15152966|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
15152967|NCT04191434|Hormones|hormones|mesh-ancestor
15152968|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152969|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14577419|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577420|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577421|NCT00005108|Estradiol|estradiol|mesh-list
14577422|NCT00005108|Progesterone|progesterone|mesh-list
14577423|NCT00005108|Estrogens|estrogens|mesh-ancestor
14577424|NCT00005108|Hormones|hormones|mesh-ancestor
14577425|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577426|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577427|NCT00005108|Progestins|progestins|mesh-ancestor
14577428|NCT00005110|Albuterol|albuterol|mesh-list
14577429|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14577430|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14577431|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
14577432|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577433|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577434|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14577435|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14577436|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14577437|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14577438|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14577439|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
14577440|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152970|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14577441|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577442|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
14577443|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14577444|NCT00005112|Hormones|hormones|mesh-list
14577445|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577446|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577447|NCT00005113|Cyclosporine|cyclosporine|mesh-list
14577448|NCT00005113|Sirolimus|sirolimus|mesh-list
14577449|NCT00005113|Tacrolimus|tacrolimus|mesh-list
14577450|NCT00005113|Cyclosporins|cyclosporins|mesh-list
14577451|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577452|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
14577453|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577454|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14577455|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577456|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577457|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
15152971|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15152972|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
15152973|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15152974|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152975|NCT04190927|Estradiol|estradiol|mesh-list
15152976|NCT04190927|Progesterone|progesterone|mesh-list
15152977|NCT04190927|Estrogens|estrogens|mesh-ancestor
15152978|NCT04190927|Hormones|hormones|mesh-ancestor
15152979|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15152980|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152981|NCT04190927|Progestins|progestins|mesh-ancestor
15152982|NCT04191135|Gemcitabine|gemcitabine|mesh-list
15152983|NCT04191135|Carboplatin|carboplatin|mesh-list
15152984|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
15152985|NCT04191135|Olaparib|olaparib|mesh-list
15152986|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15152987|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15152988|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
15152989|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15152990|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
15152991|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15152992|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15152993|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15152994|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
15152995|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15152996|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15152997|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15152998|NCT04191278|Varenicline|varenicline|mesh-list
15152999|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15153000|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15153001|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
14577458|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577459|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577460|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577461|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14577462|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577463|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577464|NCT00005117|Pravastatin|pravastatin|mesh-list
14577465|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15153002|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153003|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577466|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14577467|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
14577468|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577469|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14577470|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14577471|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577472|NCT00005118|Ritonavir|ritonavir|mesh-list
14577473|NCT00005118|Indinavir|indinavir|mesh-list
14577474|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14577475|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14577476|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
14577477|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577478|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577479|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14577480|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14577481|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
14577482|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577483|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15153004|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153005|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
15153006|NCT04191096|Androgens|androgens|mesh-list
15153007|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153008|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153009|NCT04191096|Hormones|hormones|mesh-ancestor
15153010|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153011|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577484|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15153012|NCT04190745|Paclitaxel|paclitaxel|mesh-list
14577485|NCT00005119|Calcium|calcium|mesh-list
14577486|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14577487|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577488|NCT00005120|Calanolide A|calanolide a|mesh-list
14577489|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14577490|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15153013|NCT04190745|Apatinib|apatinib|mesh-list
15153014|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15153015|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153016|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
15153017|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153018|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153019|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153020|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153021|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153022|NCT04190173|Prucalopride|prucalopride|mesh-list
15153023|NCT04190173|Laxatives|laxatives|mesh-ancestor
14577491|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
14577492|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644077|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644078|NCT00190905|Analgesics|analgesics|mesh-ancestor
14644079|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
14644080|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644081|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644082|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644083|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
14644084|NCT00190918|Pemetrexed|pemetrexed|mesh-list
14644085|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644086|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644087|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644088|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15153024|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153025|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15153026|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15153027|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
15153028|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153029|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153030|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153031|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15153032|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
14644089|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644090|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644091|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644092|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644093|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644094|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644095|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644096|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644097|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644098|NCT00190944|Teriparatide|teriparatide|mesh-list
14644099|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14644100|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644101|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14644102|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644103|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644104|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644105|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644106|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644107|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644108|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644109|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644110|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
14644111|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644112|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644113|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644114|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644115|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644116|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644117|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153033|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15153034|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
14021518|NCT02773550|Hormones|hormones|mesh-ancestor
14577493|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14577494|NCT00005520|Candesartan|candesartan|mesh-list
14577495|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14577496|NCT00005520|Diuretics|diuretics|mesh-ancestor
14577497|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
15153035|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15153036|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153037|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15153038|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15153039|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153040|NCT04190160|Xultophy|xultophy|mesh-list
15153041|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15153042|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153043|NCT04190160|Incretins|incretins|mesh-ancestor
15153044|NCT04190160|Hormones|hormones|mesh-ancestor
14577498|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577499|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14577500|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14577501|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577502|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14577503|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14577504|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14577505|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
14577506|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
14577507|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577508|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577509|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14577510|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14577511|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14577512|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
14577513|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577514|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14644118|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644119|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644120|NCT00190996|Analgesics|analgesics|mesh-ancestor
14644121|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
14644122|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644123|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644124|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644125|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
14644126|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15153045|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153046|NCT04190004|Vasopressins|vasopressins|mesh-list
15153047|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
15153048|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
15153049|NCT04190004|Coagulants|coagulants|mesh-ancestor
15153050|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15153051|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15153052|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
15153053|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180215|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180216|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
15180217|NCT03942354|Linezolid|linezolid|mesh-list
15180218|NCT03942354|Bedaquiline|bedaquiline|mesh-list
15180219|NCT03942354|Clofazimine|clofazimine|mesh-list
15180220|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15180221|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180222|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14644127|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644128|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644129|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644130|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644131|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291659|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14291660|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
14291661|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291662|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14644132|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644133|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644134|NCT00191022|Paroxetine|paroxetine|mesh-list
14644135|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15180223|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15180224|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577515|NCT00005571|Eculizumab|eculizumab|mesh-list
14577516|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14577517|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577518|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
14577519|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577520|NCT00005574|Gentamicins|gentamicins|mesh-list
14577521|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14577522|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577523|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14577524|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577525|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577526|NCT00005575|Imipramine|imipramine|mesh-list
14577527|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14577528|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
14577529|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14577530|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14577531|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14577532|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14577533|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577534|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
14577535|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14577536|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577537|NCT00005576|Aldesleukin|aldesleukin|mesh-list
15153054|NCT04189744|Metronidazole|metronidazole|mesh-list
15153055|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
15153056|NCT04189744|Piperaquine|piperaquine|mesh-list
15153057|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
15153058|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15153059|NCT04189744|Artenimol|artenimol|mesh-list
15153060|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153061|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15153062|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15153063|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15153064|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
15153065|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15153066|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153067|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153068|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14577538|NCT00005576|Interleukin-2|interleukin-2|mesh-list
14577539|NCT00005576|Dinutuximab|dinutuximab|mesh-list
14577540|NCT00005576|Isotretinoin|isotretinoin|mesh-list
14577541|NCT00005576|Antibodies|antibodies|mesh-list
14577542|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14577543|NCT00005576|Sargramostim|sargramostim|mesh-list
14577544|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
14577545|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577546|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577547|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14577548|NCT00005576|Analgesics|analgesics|mesh-ancestor
14577549|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
14577550|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577551|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14577552|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14577553|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
14577554|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577555|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577556|NCT00005577|Gemcitabine|gemcitabine|mesh-list
14577557|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577558|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
14577559|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577560|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577561|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
14577562|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577563|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153069|NCT04189744|Renal Agents|renal agents|mesh-ancestor
15153070|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
15153071|NCT04189588|Promethazine|promethazine|mesh-list
15153072|NCT04189588|Cetirizine|cetirizine|mesh-list
15153073|NCT04189588|Paclitaxel|paclitaxel|mesh-list
15153074|NCT04189588|Rituximab|rituximab|mesh-list
15153075|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15153076|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153077|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577564|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577565|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
14577566|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577567|NCT00005578|Prednisone|prednisone|mesh-list
15153078|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153079|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153080|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153081|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153082|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
15153083|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153084|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153085|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15153086|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15153087|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153088|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
15153089|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
15153090|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
15153091|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153092|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
15153093|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
14577568|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
14577569|NCT00005578|Doxorubicin|doxorubicin|mesh-list
14577570|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14577571|NCT00005578|Etoposide|etoposide|mesh-list
14577572|NCT00005578|Vincristine|vincristine|mesh-list
14577573|NCT00005578|Bleomycin|bleomycin|mesh-list
14577574|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
14577575|NCT00005578|Razoxane|razoxane|mesh-list
14577576|NCT00005578|Lenograstim|lenograstim|mesh-list
14577577|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577578|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
14577579|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577580|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577581|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577582|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
14577583|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577584|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577585|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577586|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577587|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577588|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577589|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577590|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14577591|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
14577592|NCT00005578|Hormones|hormones|mesh-ancestor
14577593|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577594|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577595|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577596|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14577597|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577598|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577599|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577600|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14577601|NCT00005578|Protective Agents|protective agents|mesh-ancestor
14577602|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
14577603|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577604|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577605|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577606|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577607|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577608|NCT00005580|Fludarabine|fludarabine|mesh-list
14577609|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
14577610|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
14577611|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577612|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577613|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
14577614|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577615|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577616|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
14577617|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577618|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14577619|NCT00005581|Paclitaxel|paclitaxel|mesh-list
14577620|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
14577621|NCT00005581|Fluorouracil|fluorouracil|mesh-list
14577622|NCT00005581|Epirubicin|epirubicin|mesh-list
14577623|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577624|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577625|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577626|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577627|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577628|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577629|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577630|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
14577631|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577632|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577633|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577634|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
14577635|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577636|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
14577637|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577638|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577639|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15153094|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153095|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15153096|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
15153097|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
15153098|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153099|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15153100|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
15153101|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
15153102|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14577640|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577641|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577642|NCT00005583|Doxorubicin|doxorubicin|mesh-list
14577643|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14577644|NCT00005583|Epirubicin|epirubicin|mesh-list
14577645|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577646|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577647|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577648|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577649|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577650|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577651|NCT00005584|Prednisone|prednisone|mesh-list
14577652|NCT00005584|Epirubicin|epirubicin|mesh-list
14577653|NCT00005584|Bleomycin|bleomycin|mesh-list
14577654|NCT00005584|Vinblastine|vinblastine|mesh-list
14577655|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14577656|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
14577657|NCT00005584|Hormones|hormones|mesh-ancestor
14577658|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577659|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577660|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577661|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577662|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577663|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577664|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577665|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577666|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577667|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577668|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577669|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577670|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577671|NCT00005585|Leucovorin|leucovorin|mesh-list
14577672|NCT00005585|Cytarabine|cytarabine|mesh-list
14577673|NCT00005585|Dexamethasone|dexamethasone|mesh-list
14577674|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
14577675|NCT00005585|Methotrexate|methotrexate|mesh-list
14577676|NCT00005585|Vincristine|vincristine|mesh-list
14577677|NCT00005585|Daunorubicin|daunorubicin|mesh-list
14577678|NCT00005585|Asparaginase|asparaginase|mesh-list
14577679|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
14577680|NCT00005585|Pegaspargase|pegaspargase|mesh-list
14577681|NCT00005585|Thioguanine|thioguanine|mesh-list
14577682|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
14577683|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577684|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
14577685|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577686|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577687|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577688|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
14577689|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577690|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153103|NCT04189783|Bupivacaine|bupivacaine|mesh-list
15153104|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
14577691|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577692|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14577693|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
14577694|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
14577695|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577696|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14577697|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
14577698|NCT00005585|Hormones|hormones|mesh-ancestor
14577699|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577700|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577701|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14577702|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
14577703|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14577704|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577705|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
14577706|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577707|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577708|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14577709|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14577710|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
14577711|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577712|NCT00005585|Antidotes|antidotes|mesh-ancestor
14577713|NCT00005585|Protective Agents|protective agents|mesh-ancestor
14577714|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
14577715|NCT00005585|Vitamins|vitamins|mesh-ancestor
14577716|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
14577717|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577718|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577719|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577720|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577721|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577722|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577723|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577724|NCT00005586|Leucovorin|leucovorin|mesh-list
14577725|NCT00005586|Fluorouracil|fluorouracil|mesh-list
14577726|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
14577727|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
14577728|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153105|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
15153106|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153107|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153108|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
15153109|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153110|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
15153111|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
14577729|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577730|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577731|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577732|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
14577733|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577734|NCT00005586|Antidotes|antidotes|mesh-ancestor
14577735|NCT00005586|Protective Agents|protective agents|mesh-ancestor
14577736|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
14577737|NCT00005586|Vitamins|vitamins|mesh-ancestor
14577738|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
14577739|NCT00005589|Cytarabine|cytarabine|mesh-list
14577740|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
14577741|NCT00005589|Melphalan|melphalan|mesh-list
14577742|NCT00005589|Carmustine|carmustine|mesh-list
14577743|NCT00005589|Rituximab|rituximab|mesh-list
14577744|NCT00005589|Etoposide|etoposide|mesh-list
14577745|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577746|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
14577747|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577748|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577749|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577750|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
14577751|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577752|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577753|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577754|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14577755|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577756|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577757|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577758|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577759|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153112|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577760|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
14577761|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
14577762|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577763|NCT00005590|Levofloxacin|levofloxacin|mesh-list
14577764|NCT00005590|Ofloxacin|ofloxacin|mesh-list
14577765|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14577766|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577767|NCT00005590|Renal Agents|renal agents|mesh-ancestor
14577768|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14577769|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577770|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577771|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577772|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577773|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577774|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14577775|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14577776|NCT00005591|Gemcitabine|gemcitabine|mesh-list
14577777|NCT00005591|Cetuximab|cetuximab|mesh-list
15153113|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
15153114|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
15153115|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153116|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
15153117|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153118|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153119|NCT04189484|Evolocumab|evolocumab|mesh-list
14577778|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577779|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
14577780|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577781|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577782|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
14577783|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577784|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577785|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577786|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
14577787|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577788|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14577789|NCT00005592|Rituximab|rituximab|mesh-list
14577790|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14577791|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14577792|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577793|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
14577794|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577795|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577796|NCT00005593|Carboplatin|carboplatin|mesh-list
14577797|NCT00005593|Fludarabine|fludarabine|mesh-list
14577798|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
14577799|NCT00005593|Topotecan|topotecan|mesh-list
14577800|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577801|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577802|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
14577803|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577804|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577805|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
14577806|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577807|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14577808|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577809|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577810|NCT00005596|Leucovorin|leucovorin|mesh-list
14577811|NCT00005596|Cytarabine|cytarabine|mesh-list
14577812|NCT00005596|Dexamethasone|dexamethasone|mesh-list
14577813|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
14577814|NCT00005596|Methotrexate|methotrexate|mesh-list
14577815|NCT00005596|Vincristine|vincristine|mesh-list
14577816|NCT00005596|Daunorubicin|daunorubicin|mesh-list
14577817|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
14577818|NCT00005596|Pegaspargase|pegaspargase|mesh-list
14577819|NCT00005596|Thioguanine|thioguanine|mesh-list
14577820|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
14577821|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577822|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
14577823|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577824|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577825|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15153120|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15153121|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15153122|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15153123|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
14577826|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
14577827|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577828|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577829|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577830|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14577831|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
14577832|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
14577833|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577834|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14577835|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
14577836|NCT00005596|Hormones|hormones|mesh-ancestor
14577837|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577838|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577839|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14577840|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
14577841|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14577842|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577843|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
14577844|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577845|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577846|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14577847|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14577848|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
14577849|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577850|NCT00005596|Antidotes|antidotes|mesh-ancestor
14577851|NCT00005596|Protective Agents|protective agents|mesh-ancestor
14577852|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
14577853|NCT00005596|Vitamins|vitamins|mesh-ancestor
14577854|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
14577855|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577856|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577857|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577858|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577859|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577860|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14577861|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577862|NCT00005597|Temozolomide|temozolomide|mesh-list
14577863|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577864|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
14577865|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577866|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577867|NCT00005598|Azacitidine|azacitidine|mesh-list
14577868|NCT00005598|Amifostine|amifostine|mesh-list
15153124|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153125|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15153126|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
15153127|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153128|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
15153129|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
15153130|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
15153131|NCT04189211|Trastuzumab|trastuzumab|mesh-list
15153132|NCT04189211|Maytansine|maytansine|mesh-list
14577869|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577870|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
14577871|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577872|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577873|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577874|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14577875|NCT00005598|Protective Agents|protective agents|mesh-ancestor
14577876|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577877|NCT00005599|Paclitaxel|paclitaxel|mesh-list
14577878|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
14577879|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577880|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577881|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577882|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577883|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577884|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577885|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14577886|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
14577887|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577888|NCT00005601|Cytarabine|cytarabine|mesh-list
14577889|NCT00005601|Dexamethasone|dexamethasone|mesh-list
14577890|NCT00005601|Rituximab|rituximab|mesh-list
14577891|NCT00005601|Sargramostim|sargramostim|mesh-list
14577892|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577893|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14577894|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
14577895|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
14577896|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577897|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577898|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14577899|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
14577900|NCT00005601|Hormones|hormones|mesh-ancestor
14577901|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577902|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577903|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14577904|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
14577905|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14577906|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577907|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
14577908|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577909|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
14577910|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577911|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577912|NCT00005602|Carboplatin|carboplatin|mesh-list
14577913|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577914|NCT00005603|Cytarabine|cytarabine|mesh-list
14577915|NCT00005603|Dexamethasone|dexamethasone|mesh-list
14577916|NCT00005603|Prednisone|prednisone|mesh-list
14577917|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
14577918|NCT00005603|Doxorubicin|doxorubicin|mesh-list
14577919|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14577920|NCT00005603|Methotrexate|methotrexate|mesh-list
14577921|NCT00005603|Vincristine|vincristine|mesh-list
14577922|NCT00005603|Daunorubicin|daunorubicin|mesh-list
14577923|NCT00005603|Asparaginase|asparaginase|mesh-list
14577924|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
15153133|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153134|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153135|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15153136|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
15153137|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153138|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153139|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577925|NCT00005603|Thioguanine|thioguanine|mesh-list
14577926|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577927|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
14577928|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577929|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814011|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814012|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
14814013|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
14814014|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814015|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814016|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14814017|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
14814018|NCT00861250|Hormones|hormones|mesh-ancestor
14814019|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814020|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14814021|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153140|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14577930|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14577931|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
14577932|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577933|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577934|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14577935|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153141|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
15153142|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153143|NCT04189094|Etoposide|etoposide|mesh-list
15153144|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153145|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577936|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
14577937|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
14577938|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577939|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14577940|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
14577941|NCT00005603|Hormones|hormones|mesh-ancestor
14577942|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14577943|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14577944|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14577945|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15153146|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15153147|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577946|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577947|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153148|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153149|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577948|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14577949|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
14577950|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14577951|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577952|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
14577953|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14577954|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14577955|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14577956|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
14577957|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577958|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14577959|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14577960|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14577961|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14577962|NCT00005604|Aldesleukin|aldesleukin|mesh-list
14577963|NCT00005604|Interleukin-2|interleukin-2|mesh-list
14577964|NCT00005604|Interleukin-12|interleukin-12|mesh-list
14577965|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577966|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14577967|NCT00005604|Analgesics|analgesics|mesh-ancestor
14577968|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
14577969|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14577970|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577971|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14577972|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14577973|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
14577974|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14577975|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14577976|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
14577977|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14577978|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14577979|NCT00005604|Growth Substances|growth substances|mesh-ancestor
14577980|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
14577981|NCT00005607|Leucovorin|leucovorin|mesh-list
14577982|NCT00005607|Fluorouracil|fluorouracil|mesh-list
14577983|NCT00005607|Irinotecan|irinotecan|mesh-list
14577984|NCT00005607|Calcium|calcium|mesh-list
14577985|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
14577986|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14577987|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14577988|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
15153150|NCT04189055|Irinotecan|irinotecan|mesh-list
15153151|NCT04189055|Cetuximab|cetuximab|mesh-list
15153152|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15153153|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577989|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14577990|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14577991|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14577992|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14577993|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
14577994|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14577995|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14577996|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14577997|NCT00005607|Antidotes|antidotes|mesh-ancestor
14577998|NCT00005607|Protective Agents|protective agents|mesh-ancestor
14577999|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
14578000|NCT00005607|Vitamins|vitamins|mesh-ancestor
14578001|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
14578002|NCT00005609|Rituximab|rituximab|mesh-list
14578003|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14578004|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578005|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
14578006|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578007|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578008|NCT00005610|Sargramostim|sargramostim|mesh-list
14578009|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
14578010|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578011|NCT00005612|Paclitaxel|paclitaxel|mesh-list
14578012|NCT00005612|Etoposide|etoposide|mesh-list
14578013|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
14578014|NCT00005612|Carboplatin|carboplatin|mesh-list
14578015|NCT00005612|Topotecan|topotecan|mesh-list
15153154|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578016|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15182142|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14578017|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578018|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578019|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578020|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153155|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153156|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153157|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153158|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
15153159|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153160|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153161|NCT04188782|Sevoflurane|sevoflurane|mesh-list
15153162|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15153163|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15153164|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
15153165|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
15153166|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153167|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153168|NCT04189666|Melatonin|melatonin|mesh-list
15153169|NCT04189666|Rivastigmine|rivastigmine|mesh-list
15153170|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
15153171|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153172|NCT04189666|Protective Agents|protective agents|mesh-ancestor
15153173|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153174|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153175|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15153176|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153177|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
15153178|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153179|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15153180|NCT04189198|Bupivacaine|bupivacaine|mesh-list
14578021|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578022|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578023|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
14578024|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578025|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578026|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578027|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
14578028|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578029|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578030|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578031|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153181|NCT04189198|Carticaine|carticaine|mesh-list
15153182|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
15153183|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
15153184|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153185|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153186|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
15153187|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153188|NCT04188730|Lofexidine|lofexidine|mesh-list
15153189|NCT04188730|Clonidine|clonidine|mesh-list
14578032|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578033|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
14578034|NCT00005613|Carmustine|carmustine|mesh-list
14578035|NCT00005613|Etoposide|etoposide|mesh-list
14578036|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578037|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
14578038|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578039|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578040|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578041|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
14578042|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578043|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578044|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578045|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578046|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578047|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578048|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578049|NCT00005614|Gemcitabine|gemcitabine|mesh-list
14578050|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578051|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
14578052|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578053|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578054|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
14578055|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578056|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578057|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153190|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14578058|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
14578059|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578060|NCT00005615|Interferons|interferons|mesh-list
14578061|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
14578062|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578063|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
14578064|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578065|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
14578066|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578067|NCT00005616|Antibodies|antibodies|mesh-list
14578068|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14578069|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
14578070|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578071|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
14578072|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578073|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
14578074|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578075|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
14578076|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578077|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578078|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578079|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
14578080|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578081|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578082|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578083|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
14578084|NCT00005623|Cyproterone|cyproterone|mesh-list
14578085|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
14578086|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
14578087|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578088|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578089|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578090|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14578091|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
14578092|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14578093|NCT00005624|Tacedinaline|tacedinaline|mesh-list
14578094|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14578095|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578096|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578097|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578098|NCT00005625|Trabectedin|trabectedin|mesh-list
14578099|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578100|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
14578101|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578102|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578103|NCT00005626|Irinotecan|irinotecan|mesh-list
14578104|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578105|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578106|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578107|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578108|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578109|NCT00005627|Carboplatin|carboplatin|mesh-list
14578110|NCT00005627|Docetaxel|docetaxel|mesh-list
14578111|NCT00005627|Estramustine|estramustine|mesh-list
14578112|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578113|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578114|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578115|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578116|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578117|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578118|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
14578119|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15153191|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15153192|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153193|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
15153194|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153195|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15153196|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15153197|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15153198|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
15153199|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14578120|NCT00005630|Sargramostim|sargramostim|mesh-list
14578121|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
14578122|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153200|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153201|NCT04188730|Analgesics|analgesics|mesh-ancestor
15153202|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
15153203|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
15153204|NCT04188691|Vaccines|vaccines|mesh-list
14578123|NCT00005631|Rituximab|rituximab|mesh-list
14578124|NCT00005631|Carboplatin|carboplatin|mesh-list
14578125|NCT00005631|Etoposide|etoposide|mesh-list
14578126|NCT00005631|Ifosfamide|ifosfamide|mesh-list
14578127|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14578128|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578129|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
14578130|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578131|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578132|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15153205|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
15153206|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153207|NCT04188483|Selenium|selenium|mesh-list
15153208|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153209|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
15153210|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153211|NCT04188483|Protective Agents|protective agents|mesh-ancestor
15153212|NCT04188483|Trace Elements|trace elements|mesh-ancestor
15153213|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
15153214|NCT04188431|Dexamethasone|dexamethasone|mesh-list
15153215|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153216|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
15153217|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
15153218|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153219|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153220|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153221|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
15153222|NCT04188431|Hormones|hormones|mesh-ancestor
15153223|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153224|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15153225|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153226|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
15153227|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15153228|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
15153229|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153230|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
15153231|NCT04188561|Protective Agents|protective agents|mesh-ancestor
15153232|NCT04188353|Mannitol|mannitol|mesh-list
15153233|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14578133|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578134|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578135|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578136|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578137|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578138|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
14578139|NCT00005634|Vorinostat|vorinostat|mesh-list
14578140|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578141|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14578142|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578143|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578144|NCT00005635|Paclitaxel|paclitaxel|mesh-list
14578145|NCT00005635|Trastuzumab|trastuzumab|mesh-list
14578146|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578147|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578148|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578149|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578150|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578151|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578152|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14578153|NCT00005636|Pemetrexed|pemetrexed|mesh-list
14578154|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578155|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578156|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578157|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14578158|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578159|NCT00005637|Temozolomide|temozolomide|mesh-list
15153234|NCT04188353|Diuretics|diuretics|mesh-ancestor
15153235|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
15153236|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153237|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
14291663|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14578160|NCT00005637|Carmustine|carmustine|mesh-list
14578161|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578162|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
14578163|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578164|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578165|NCT00005638|Irinotecan|irinotecan|mesh-list
14578166|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578167|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578168|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578169|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578170|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578171|NCT00005639|Azacitidine|azacitidine|mesh-list
14578172|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14578173|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578174|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
14578175|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578176|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578177|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578178|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14578179|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14578180|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578181|NCT00005641|Leucovorin|leucovorin|mesh-list
14578182|NCT00005641|Cyclosporine|cyclosporine|mesh-list
14578183|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
14578184|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
14578185|NCT00005641|Busulfan|busulfan|mesh-list
14578186|NCT00005641|Methotrexate|methotrexate|mesh-list
14578187|NCT00005641|Cyclosporins|cyclosporins|mesh-list
14578188|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14578189|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
14578190|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578191|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
14578192|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578193|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578194|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578195|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
14578196|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578197|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578198|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578199|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14578200|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
14578201|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14578202|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578203|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
15153238|NCT04188106|Varenicline|varenicline|mesh-list
15153239|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15153240|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14578204|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578205|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578206|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14578207|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578208|NCT00005641|Antidotes|antidotes|mesh-ancestor
14578209|NCT00005641|Protective Agents|protective agents|mesh-ancestor
14578210|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
14578211|NCT00005641|Vitamins|vitamins|mesh-ancestor
14578212|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
14578213|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
14578214|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578215|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14578216|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14578217|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
14578218|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
14578219|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153241|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
15153242|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153243|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153244|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153245|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
14578220|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14578221|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
14578222|NCT00005641|Hormones|hormones|mesh-ancestor
14578223|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578224|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15153246|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578225|NCT00005642|Semaxinib|semaxinib|mesh-list
14291664|NCT00555620|Growth Substances|growth substances|mesh-ancestor
14578226|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14578227|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14578228|NCT00005642|Growth Substances|growth substances|mesh-ancestor
14578229|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578230|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
14578231|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578232|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14578233|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578234|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578235|NCT00005643|Doxorubicin|doxorubicin|mesh-list
14578236|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14578237|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578238|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578239|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578240|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578241|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578242|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578243|NCT00005644|Gemcitabine|gemcitabine|mesh-list
14578244|NCT00005644|Paclitaxel|paclitaxel|mesh-list
14578245|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578246|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578247|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578248|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578249|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578250|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578251|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578252|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
14578253|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
14578254|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578255|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578256|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578257|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
14578258|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578259|NCT00005646|Paclitaxel|paclitaxel|mesh-list
15153247|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15153248|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
14578260|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578261|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578262|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578263|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578264|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578265|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578266|NCT00005647|Paclitaxel|paclitaxel|mesh-list
14578267|NCT00005647|Semaxinib|semaxinib|mesh-list
14578268|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578269|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578270|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578271|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578272|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578273|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578274|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14578275|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14578276|NCT00005647|Growth Substances|growth substances|mesh-ancestor
14578277|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578278|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
14578279|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153249|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
15153250|NCT04188249|Golimumab|golimumab|mesh-list
15153251|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15153252|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153253|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153254|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
15153255|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153256|NCT04188119|Aspirin|aspirin|mesh-list
15153257|NCT04188119|Avelumab|avelumab|mesh-list
15153258|NCT04188119|Lansoprazole|lansoprazole|mesh-list
15153259|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
15153260|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15153261|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15153262|NCT04188119|Analgesics|analgesics|mesh-ancestor
15153263|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
15153264|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578280|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578281|NCT00005648|Gemcitabine|gemcitabine|mesh-list
15153265|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578282|NCT00005648|Tipifarnib|tipifarnib|mesh-list
14578283|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153266|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153267|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153268|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15153269|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15153270|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153271|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15153272|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15153273|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153274|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
15153275|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153276|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153277|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15153278|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153279|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15153280|NCT04188158|Capecitabine|capecitabine|mesh-list
15153281|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
15153282|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153283|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
15153284|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153285|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153286|NCT04188184|Epinephrine|epinephrine|mesh-list
15153287|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
15153288|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15153289|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14578284|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
14578285|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578286|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578287|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
14578288|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578289|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153290|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
15153291|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153292|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153293|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153294|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15153295|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15153296|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
15153297|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153298|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15153299|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
15153300|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
15153301|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
15153302|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15153303|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14578290|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578291|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
14578292|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578293|NCT00005649|Paclitaxel|paclitaxel|mesh-list
14578294|NCT00005649|Capecitabine|capecitabine|mesh-list
14578295|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578296|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578297|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578298|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578299|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153304|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15153305|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
15153306|NCT04188184|Coagulants|coagulants|mesh-ancestor
15153307|NCT04188171|Polidocanol|polidocanol|mesh-list
15153308|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15153309|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15153310|NCT04188223|Vaccines|vaccines|mesh-list
15153311|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
15153312|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153313|NCT04188314|Desflurane|desflurane|mesh-list
15153314|NCT04188314|Isoflurane|isoflurane|mesh-list
15153315|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15153316|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
15153317|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
15153318|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153319|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180225|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180226|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180227|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15180228|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
14814022|NCT00861276|Nicotine|nicotine|mesh-list
15153320|NCT04187755|Ceftazidime|ceftazidime|mesh-list
15153321|NCT04187755|Cefepime|cefepime|mesh-list
15153322|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14578300|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578301|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578302|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
14578303|NCT00005652|Rituximab|rituximab|mesh-list
14578304|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14578305|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578306|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
14578307|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578308|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578309|NCT00005654|Metformin|metformin|mesh-list
14578310|NCT00005654|Clomiphene|clomiphene|mesh-list
14578311|NCT00005654|Enclomiphene|enclomiphene|mesh-list
14578312|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
14578313|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14578314|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578315|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14578316|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
14578317|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578318|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14578319|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
14578320|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14578321|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14578322|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14578323|NCT00005658|Glycine|glycine|mesh-list
14578324|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
14578325|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14578326|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578327|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578328|NCT00005663|Valacyclovir|valacyclovir|mesh-list
14578329|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
14578330|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578331|NCT00005665|Interferons|interferons|mesh-list
14578332|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
14578333|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578334|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
14578335|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578336|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
14578337|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578338|NCT00005668|Itraconazole|itraconazole|mesh-list
14578339|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
14578340|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578341|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14578342|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14578343|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578344|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578345|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14578346|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
14578347|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578348|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578349|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14578350|NCT00005673|Capravirine|capravirine|mesh-list
14578351|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14578352|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578353|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578354|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578355|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
14578356|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578357|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14578358|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14578359|NCT00005684|Heparin|heparin|mesh-list
14578360|NCT00005684|Warfarin|warfarin|mesh-list
14578361|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
14578362|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14578363|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14578364|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644136|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644137|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644138|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153323|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153324|NCT04187807|Melatonin|melatonin|mesh-list
15153325|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
15182143|NCT03923881|Cetuximab|cetuximab|mesh-list
15153326|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153327|NCT04187807|Protective Agents|protective agents|mesh-ancestor
14578365|NCT00005762|Ritonavir|ritonavir|mesh-list
14021519|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021520|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578366|NCT00005762|Nelfinavir|nelfinavir|mesh-list
14578367|NCT00005762|Indinavir|indinavir|mesh-list
14021521|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15153328|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153329|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153330|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
15153331|NCT04187898|Docetaxel|docetaxel|mesh-list
15153332|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153333|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
15153334|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153335|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578368|NCT00005762|Saquinavir|saquinavir|mesh-list
15153336|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15153337|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
15153338|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578369|NCT00005762|Amprenavir|amprenavir|mesh-list
14578370|NCT00005762|Efavirenz|efavirenz|mesh-list
14578371|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14578372|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14578373|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
14578374|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578375|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578376|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14578377|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14578378|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
14578379|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578380|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14578381|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14578382|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14578383|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578384|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14578385|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14578386|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14578387|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14578388|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14578389|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14578390|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
14578391|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14578392|NCT00005764|Lamivudine|lamivudine|mesh-list
14578393|NCT00005764|Zidovudine|zidovudine|mesh-list
14578394|NCT00005764|Abacavir|abacavir|mesh-list
14578395|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14578396|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14578397|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578398|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578399|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578400|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
14578401|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578402|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14578403|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14578404|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
14578405|NCT00005765|Nicotine|nicotine|mesh-list
14578406|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14578407|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
14578408|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578409|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578410|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14578411|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14578412|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
14578413|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14578414|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578415|NCT00005768|Estrogens|estrogens|mesh-list
14578416|NCT00005768|Hormones|hormones|mesh-ancestor
15153339|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153340|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578417|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021522|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578418|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578419|NCT00005769|Hormones|hormones|mesh-list
14578420|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578421|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578422|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
14578423|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14578424|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
14578425|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578426|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578427|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14578428|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14578429|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14578430|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
14578431|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578432|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153341|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
15153342|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153343|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153344|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
15153345|NCT04187469|Rifampin|rifampin|mesh-list
15153346|NCT04187469|Isoniazid|isoniazid|mesh-list
15153347|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
15153348|NCT04187469|Ethambutol|ethambutol|mesh-list
15153349|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15153350|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153351|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15153352|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15153353|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153354|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153355|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153356|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15153357|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
15153358|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
15153359|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15153360|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15153361|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15153362|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15153363|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15153364|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15153365|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15153366|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15153367|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15153368|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
15153369|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14578433|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14578434|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
14578435|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
14578436|NCT00005773|Protective Agents|protective agents|mesh-ancestor
14578437|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14578438|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
14578439|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
14578440|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14578441|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14578442|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
14578443|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14578444|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
14578445|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578446|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578447|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14578448|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
14578449|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15153370|NCT04187703|Azacitidine|azacitidine|mesh-list
15153371|NCT04187703|Decitabine|decitabine|mesh-list
14578450|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
14578451|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578452|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14578453|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14578454|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14578455|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
14578456|NCT00005776|Protective Agents|protective agents|mesh-ancestor
14578457|NCT00005777|Dexamethasone|dexamethasone|mesh-list
14578458|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14578459|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
15153372|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153373|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
14578460|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
14578461|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578462|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578463|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14578464|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
14578465|NCT00005777|Hormones|hormones|mesh-ancestor
14578466|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578467|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14578468|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578469|NCT00005779|Interleukin-12|interleukin-12|mesh-list
14578470|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14578471|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
14578472|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578473|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14578474|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14578475|NCT00005779|Growth Substances|growth substances|mesh-ancestor
14578476|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
14578477|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578478|NCT00005782|Sargramostim|sargramostim|mesh-list
14578479|NCT00005782|Lenograstim|lenograstim|mesh-list
14578480|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
14578481|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578482|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14578483|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
14578484|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578485|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
14578486|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
14578487|NCT00005787|Sargramostim|sargramostim|mesh-list
14578488|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14578489|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
14578490|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153374|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153375|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153376|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153377|NCT04187417|Tetracaine|tetracaine|mesh-list
15153378|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
15153379|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
15153380|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153381|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153382|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
15153383|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153384|NCT04187456|Midazolam|midazolam|mesh-list
15153385|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15153386|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15153387|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153388|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578491|NCT00005787|Hematinics|hematinics|mesh-ancestor
14578492|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14578493|NCT00005787|Protective Agents|protective agents|mesh-ancestor
14644139|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644140|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
14644141|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644142|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14644143|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
15153389|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15153390|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15153391|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15153392|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15153393|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
15153394|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
15153395|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
15153396|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
15153397|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153398|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153399|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
15153400|NCT04187105|Fludarabine|fludarabine|mesh-list
15153401|NCT04187105|Tacrolimus|tacrolimus|mesh-list
15153402|NCT04187105|Complement Factor H|complement factor h|mesh-list
15153403|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153404|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
15153405|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153406|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14644144|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15153407|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14644145|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14644146|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14644147|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578494|NCT00005791|Fluorouracil|fluorouracil|mesh-list
14578495|NCT00005791|Irinotecan|irinotecan|mesh-list
14578496|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578497|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
14578498|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578499|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578500|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578501|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
14578502|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578503|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578504|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578505|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578506|NCT00005792|Etoposide|etoposide|mesh-list
14578507|NCT00005792|Melphalan|melphalan|mesh-list
14578508|NCT00005792|Topotecan|topotecan|mesh-list
14578509|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
14578510|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578511|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578512|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578513|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578514|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578515|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578516|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578517|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
14578518|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578519|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578520|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
14578521|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578522|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578523|NCT00005793|Cytarabine|cytarabine|mesh-list
14578524|NCT00005793|Etoposide|etoposide|mesh-list
14578525|NCT00005793|Daunorubicin|daunorubicin|mesh-list
14578526|NCT00005793|Topotecan|topotecan|mesh-list
14578527|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578528|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578529|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578530|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578531|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578532|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578533|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578534|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
14578535|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
14578536|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578537|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578538|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
14578539|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578540|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578541|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578542|NCT00005796|Vincristine|vincristine|mesh-list
14578543|NCT00005796|Lomustine|lomustine|mesh-list
14578544|NCT00005796|Procarbazine|procarbazine|mesh-list
14578545|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578546|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578547|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14021523|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14021524|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
14021525|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021526|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578548|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578549|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578550|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578551|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578552|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
14578553|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
14578554|NCT00005797|Busulfan|busulfan|mesh-list
14578555|NCT00005797|Etoposide|etoposide|mesh-list
14578556|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578557|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
14578558|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578559|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578560|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578561|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
14578562|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578563|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578564|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578565|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578566|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578567|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578568|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578569|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
14578570|NCT00005798|Thiotepa|thiotepa|mesh-list
14578571|NCT00005798|Carboplatin|carboplatin|mesh-list
15153408|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
15153409|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153410|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153411|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15153412|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15153413|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578572|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578573|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
14578574|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578575|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578576|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578577|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
14578578|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578579|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578580|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578581|NCT00005799|Cyclosporine|cyclosporine|mesh-list
14578582|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
14578583|NCT00005799|Fludarabine|fludarabine|mesh-list
14578584|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
14578585|NCT00005799|Cyclosporins|cyclosporins|mesh-list
14578586|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578587|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578588|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
14578589|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578590|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578591|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
14578592|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578593|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578594|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
14578595|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578596|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578597|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578598|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14578599|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578600|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14578601|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
14578602|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14578603|NCT00005800|Docetaxel|docetaxel|mesh-list
14578604|NCT00005800|Doxorubicin|doxorubicin|mesh-list
14578605|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14578606|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578607|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578608|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578609|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578610|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578611|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578612|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578613|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578614|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578615|NCT00005802|Cytarabine|cytarabine|mesh-list
14578616|NCT00005802|Aldesleukin|aldesleukin|mesh-list
14578617|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
14578618|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14578619|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14578620|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14578621|NCT00005802|Methotrexate|methotrexate|mesh-list
14578622|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
15153414|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15153415|NCT04186702|Ranibizumab|ranibizumab|mesh-list
15153416|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15153417|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15153418|NCT04186702|Growth Substances|growth substances|mesh-ancestor
15153419|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153420|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
14021527|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578623|NCT00005802|Fludarabine|fludarabine|mesh-list
14021528|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
14578624|NCT00005802|Etoposide|etoposide|mesh-list
14578625|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
15153421|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578626|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14578627|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
14578628|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14578629|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578630|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578631|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
14578632|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578633|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578634|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578635|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578636|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14578637|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578638|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
14578639|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578640|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578641|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578642|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578643|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578644|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
14578645|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578646|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14578647|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14578648|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14578649|NCT00005802|Analgesics|analgesics|mesh-ancestor
14578650|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
14578651|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578652|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
14578653|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578654|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
14578655|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578656|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578657|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578658|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
14578659|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578660|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578661|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578662|NCT00005806|Paclitaxel|paclitaxel|mesh-list
14578663|NCT00005806|Carboplatin|carboplatin|mesh-list
14578664|NCT00005806|Gefitinib|gefitinib|mesh-list
14578665|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578666|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578667|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578668|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578669|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578670|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578671|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153422|NCT04186936|Simethicone|simethicone|mesh-list
15153423|NCT04186936|Loperamide|loperamide|mesh-list
15153424|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
15153425|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153426|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
15153427|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153428|NCT04186936|Emollients|emollients|mesh-ancestor
15153429|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
15153430|NCT04187053|Methylene Blue|methylene blue|mesh-list
15153431|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153432|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153433|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
15153434|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
15153435|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15153436|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15153437|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153438|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
15153439|NCT04187014|Coagulants|coagulants|mesh-ancestor
15153440|NCT04186598|Nifedipine|nifedipine|mesh-list
15153441|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14578672|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578673|NCT00005807|Epothilones|epothilones|mesh-list
14578674|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578675|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578676|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578677|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578678|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153442|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15153443|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153444|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15153445|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153446|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
15153447|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
15153448|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15153449|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
15153450|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15153451|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153452|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153453|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15153454|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15153455|NCT04186559|Protective Agents|protective agents|mesh-ancestor
15153456|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153457|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
15153458|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15153459|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
15153460|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
15153461|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153462|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
15153463|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
15153464|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578679|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
14578680|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14578681|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578682|NCT00005810|Carboplatin|carboplatin|mesh-list
14578683|NCT00005810|Docetaxel|docetaxel|mesh-list
14578684|NCT00005810|Estramustine|estramustine|mesh-list
14578685|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578686|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578687|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578688|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578689|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578690|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578691|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
14578692|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14578693|NCT00005811|Topotecan|topotecan|mesh-list
14578694|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578695|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578696|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578697|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578698|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578699|NCT00005812|Temozolomide|temozolomide|mesh-list
14578700|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578701|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
14578702|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578703|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578704|NCT00005813|Antibodies|antibodies|mesh-list
14578705|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14578706|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
15153465|NCT04186299|Clonidine|clonidine|mesh-list
15153466|NCT04186299|Epinephrine|epinephrine|mesh-list
15153467|NCT04186299|Carticaine|carticaine|mesh-list
15153468|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15153469|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15153470|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
15153471|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153472|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153473|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153474|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15153475|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15153476|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
15153477|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153478|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15153479|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
15153480|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
15153481|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
15153482|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15153483|NCT04186299|Analgesics|analgesics|mesh-ancestor
15153484|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
15153485|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14578707|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578708|NCT00005814|Cetuximab|cetuximab|mesh-list
14578709|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153486|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
14578710|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153487|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14578711|NCT00005815|Thalidomide|thalidomide|mesh-list
14578712|NCT00005815|Temozolomide|temozolomide|mesh-list
14578713|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578714|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
14578715|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578716|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578717|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578718|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
14578719|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578720|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
15153488|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
15153489|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
14578721|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14578722|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578723|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14578724|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14578725|NCT00005815|Growth Substances|growth substances|mesh-ancestor
14578726|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14578727|NCT00005818|Irinotecan|irinotecan|mesh-list
14578728|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578729|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578730|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578731|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578732|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578733|NCT00005819|Paclitaxel|paclitaxel|mesh-list
14578734|NCT00005819|Fenretinide|fenretinide|mesh-list
14578735|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578736|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578737|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578738|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578739|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578740|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578741|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14578742|NCT00005819|Protective Agents|protective agents|mesh-ancestor
14578743|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578744|NCT00005822|Tamoxifen|tamoxifen|mesh-list
14578745|NCT00005822|Doxorubicin|doxorubicin|mesh-list
14578746|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14578747|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578748|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578749|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578750|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578751|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578752|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578753|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14578754|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
14578755|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578756|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578757|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14578758|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14578759|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14578760|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14578761|NCT00005823|Cytarabine|cytarabine|mesh-list
14578762|NCT00005823|Etoposide|etoposide|mesh-list
14578763|NCT00005823|Daunorubicin|daunorubicin|mesh-list
14578764|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
14578765|NCT00005823|Idarubicin|idarubicin|mesh-list
14578766|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
14578767|NCT00005823|Tretinoin|tretinoin|mesh-list
14578768|NCT00005823|Thioguanine|thioguanine|mesh-list
14578769|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578770|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578771|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578772|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578773|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578774|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578775|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578776|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
14578777|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
14578778|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578779|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578780|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
14578781|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578782|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578783|NCT00005823|Analgesics|analgesics|mesh-ancestor
14578784|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
14578785|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578786|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
14578787|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578788|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
14578789|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578790|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
14578791|NCT00005824|Busulfan|busulfan|mesh-list
14578792|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578793|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
14578794|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578795|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578796|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578797|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
14578798|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578799|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578800|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578801|NCT00005825|Vinorelbine|vinorelbine|mesh-list
14578802|NCT00005825|Mitomycins|mitomycins|mesh-list
14578803|NCT00005825|Mitomycin|mitomycin|mesh-list
14578804|NCT00005825|Tretinoin|tretinoin|mesh-list
14578805|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578806|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578807|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578808|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578809|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578810|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578811|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578812|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
14578813|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14578814|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578815|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
14578816|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578817|NCT00005826|Rubitecan|rubitecan|mesh-list
14578818|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578819|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14578820|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578821|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578822|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578823|NCT00005827|Genistein|genistein|mesh-list
14578824|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14578825|NCT00005827|Protective Agents|protective agents|mesh-ancestor
14578826|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578827|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578828|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14578829|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578830|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578831|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
14578832|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14578833|NCT00005827|Estrogens|estrogens|mesh-ancestor
14578834|NCT00005827|Hormones|hormones|mesh-ancestor
14578835|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578836|NCT00005829|Gemcitabine|gemcitabine|mesh-list
14578837|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578838|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
14578839|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578840|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578841|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
14578842|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578843|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578844|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578845|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
14578846|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578847|NCT00005830|Doxorubicin|doxorubicin|mesh-list
14578848|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14578849|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578850|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14578851|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578852|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578853|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578854|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578855|NCT00005831|Gemcitabine|gemcitabine|mesh-list
14578856|NCT00005831|Paclitaxel|paclitaxel|mesh-list
14578857|NCT00005831|Carboplatin|carboplatin|mesh-list
14578858|NCT00005831|Trastuzumab|trastuzumab|mesh-list
14578859|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578860|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578861|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578862|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578863|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578864|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578865|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578866|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
14578867|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
14578868|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578869|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578870|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578871|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
14578872|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578873|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14578874|NCT00005832|Tipifarnib|tipifarnib|mesh-list
14578875|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578876|NCT00005833|Tipifarnib|tipifarnib|mesh-list
14578877|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578878|NCT00005834|Thalidomide|thalidomide|mesh-list
14578879|NCT00005834|Dexamethasone|dexamethasone|mesh-list
14578880|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
14578881|NCT00005834|Etoposide|etoposide|mesh-list
14578882|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578883|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
14578884|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578885|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14578886|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578887|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
14578888|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578889|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578890|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578891|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14578892|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
14578893|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
14578894|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578895|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14578896|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
14578897|NCT00005834|Hormones|hormones|mesh-ancestor
14578898|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14578899|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14578900|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578901|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578902|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578903|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578904|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
14578905|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14578906|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578907|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14578908|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14578909|NCT00005834|Growth Substances|growth substances|mesh-ancestor
14578910|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
14578911|NCT00005835|Melphalan|melphalan|mesh-list
14578912|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
14578913|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
14578914|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578915|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578916|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
14578917|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578918|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578919|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14578920|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14578921|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
14578922|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578923|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578924|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14578925|NCT00005835|Protective Agents|protective agents|mesh-ancestor
14578926|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
14578927|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578928|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
14578929|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578930|NCT00005838|Paclitaxel|paclitaxel|mesh-list
14578931|NCT00005838|Vinorelbine|vinorelbine|mesh-list
14578932|NCT00005838|Carboplatin|carboplatin|mesh-list
14578933|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578934|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578935|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578936|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578937|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578938|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578939|NCT00005839|Capecitabine|capecitabine|mesh-list
14578940|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
14578941|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14578942|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
14578943|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153490|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153491|NCT04186013|Atezolizumab|atezolizumab|mesh-list
15153492|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578944|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578945|NCT00005840|Paclitaxel|paclitaxel|mesh-list
14578946|NCT00005840|Cisplatin|cisplatin|mesh-list
14578947|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578948|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578949|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578950|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578951|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578952|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578953|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
14578954|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14578955|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
14578956|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578957|NCT00005842|Trastuzumab|trastuzumab|mesh-list
14578958|NCT00005842|Tipifarnib|tipifarnib|mesh-list
14578959|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14578960|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578961|NCT00005843|Tipifarnib|tipifarnib|mesh-list
14578962|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578963|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
14578964|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578965|NCT00005845|Tipifarnib|tipifarnib|mesh-list
14578966|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153493|NCT04186026|Glucagon|glucagon|mesh-list
15153494|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15153495|NCT04186026|Incretins|incretins|mesh-ancestor
15153496|NCT04186026|Hormones|hormones|mesh-ancestor
15153497|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153498|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153499|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180229|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180230|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
15182144|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182145|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182146|NCT03923842|Denosumab|denosumab|mesh-list
15182147|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14578967|NCT00005847|Interferons|interferons|mesh-list
14578968|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
14578969|NCT00005847|Paclitaxel|paclitaxel|mesh-list
14578970|NCT00005847|Vinorelbine|vinorelbine|mesh-list
14578971|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
14578972|NCT00005847|Estramustine|estramustine|mesh-list
14578973|NCT00005847|Isotretinoin|isotretinoin|mesh-list
14578974|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578975|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578976|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
14578977|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14578978|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14578979|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14578980|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
14578981|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14578982|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
14578983|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578984|NCT00005847|Analgesics|analgesics|mesh-ancestor
14578985|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
14578986|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14578987|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14578988|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14578989|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14578990|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14578991|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14578992|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
15182148|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14578993|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14578994|NCT00005848|Tipifarnib|tipifarnib|mesh-list
14578995|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14578996|NCT00005849|Paclitaxel|paclitaxel|mesh-list
14578997|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
14578998|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14578999|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579000|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579001|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579002|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579003|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579004|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14579005|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
14579006|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579007|NCT00005850|Gemcitabine|gemcitabine|mesh-list
14579008|NCT00005850|Fluoxetine|fluoxetine|mesh-list
14579009|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579010|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579011|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
14579012|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579013|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
14579014|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579015|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579016|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579017|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
14579018|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579019|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14579020|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14579021|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14579022|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14579023|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
14579024|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14579025|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
14579026|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14579027|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14579028|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14579029|NCT00005851|Cyclosporine|cyclosporine|mesh-list
14579030|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
14579031|NCT00005851|Fludarabine|fludarabine|mesh-list
14579032|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
14579033|NCT00005851|Cyclosporins|cyclosporins|mesh-list
14579034|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579035|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579036|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
14579037|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579038|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579039|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
14579040|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579041|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579042|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
14579043|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579044|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579045|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579046|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579047|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579048|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14579049|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
14579050|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14579051|NCT00005852|Cyclosporine|cyclosporine|mesh-list
14579052|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
14579053|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
14579054|NCT00005852|Cyclosporins|cyclosporins|mesh-list
14579055|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14579056|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
15153500|NCT04185857|Olmesartan|olmesartan|mesh-list
15153501|NCT04185857|Canrenone|canrenone|mesh-list
15153502|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15153503|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15153504|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15153505|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153506|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15153507|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
15153508|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153509|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153510|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15153511|NCT04185857|Diuretics|diuretics|mesh-ancestor
14579057|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579058|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
14579059|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579060|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579061|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579062|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
14579063|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579064|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579065|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579066|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579067|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
14579068|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579069|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579070|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579071|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579072|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
14579073|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
14579074|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14579075|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14579076|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
14579077|NCT00005852|Hormones|hormones|mesh-ancestor
14579078|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153512|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
15153513|NCT04185675|Anesthetics|anesthetics|mesh-list
15153514|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153515|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153516|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15153517|NCT04185831|Everolimus|everolimus|mesh-list
15153518|NCT04185831|Atezolizumab|atezolizumab|mesh-list
14579079|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14579080|NCT00005852|Protective Agents|protective agents|mesh-ancestor
14579081|NCT00005853|Etanercept|etanercept|mesh-list
14579082|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14579083|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14579084|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14579085|NCT00005853|Analgesics|analgesics|mesh-ancestor
14579086|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
14579087|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153519|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579088|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579089|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579090|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579091|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14579092|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579093|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
14579094|NCT00005854|Cyclosporine|cyclosporine|mesh-list
14579095|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
14579096|NCT00005854|Methotrexate|methotrexate|mesh-list
14579097|NCT00005854|Cyclosporins|cyclosporins|mesh-list
14579098|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579099|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
14579100|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579101|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579102|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579103|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
14579104|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579105|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579106|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579107|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14579108|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
14579109|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14579110|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579111|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
14579112|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579113|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579114|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14579115|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14579116|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
14579117|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579118|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579119|NCT00005855|Carmustine|carmustine|mesh-list
14579120|NCT00005855|Efaproxiral|efaproxiral|mesh-list
14579121|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579122|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
14579123|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579124|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153520|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579125|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
14579126|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
14579127|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579128|NCT00005857|Docetaxel|docetaxel|mesh-list
14579129|NCT00005857|Trastuzumab|trastuzumab|mesh-list
14579130|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579131|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579132|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579133|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579134|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579135|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14579136|NCT00005858|Immunotoxins|immunotoxins|mesh-list
14579137|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
14579138|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579139|NCT00005859|Tipifarnib|tipifarnib|mesh-list
14579140|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153521|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
15153522|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153523|NCT04185649|Capecitabine|capecitabine|mesh-list
15153524|NCT04185649|Lapatinib|lapatinib|mesh-list
15153525|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153526|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
14579141|NCT00005860|Leucovorin|leucovorin|mesh-list
14579142|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
14579143|NCT00005860|Floxuridine|floxuridine|mesh-list
14579144|NCT00005860|Calcium|calcium|mesh-list
14579145|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
14579146|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14579147|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579148|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579149|NCT00005860|Antidotes|antidotes|mesh-ancestor
14579150|NCT00005860|Protective Agents|protective agents|mesh-ancestor
14579151|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
14579152|NCT00005860|Vitamins|vitamins|mesh-ancestor
14579153|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
14579154|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579155|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
14579156|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579157|NCT00005861|Doxorubicin|doxorubicin|mesh-list
14579158|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14579159|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579160|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579161|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579162|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579163|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579164|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579165|NCT00005862|Semaxinib|semaxinib|mesh-list
14579166|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14579167|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14579168|NCT00005862|Growth Substances|growth substances|mesh-ancestor
14579169|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579170|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
14579171|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579172|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14579173|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579174|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579175|NCT00005863|Cytarabine|cytarabine|mesh-list
14579176|NCT00005863|Fludarabine|fludarabine|mesh-list
14579177|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
14579178|NCT00005863|Etoposide|etoposide|mesh-list
14579179|NCT00005863|Daunorubicin|daunorubicin|mesh-list
14579180|NCT00005863|Tretinoin|tretinoin|mesh-list
14579181|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579182|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579183|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
14579184|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579185|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579186|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
14579187|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579188|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579189|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15153527|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153528|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579190|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579191|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579192|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
14579193|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579194|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579195|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
14579196|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579197|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
14579198|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579199|NCT00005865|Vinorelbine|vinorelbine|mesh-list
14579200|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579201|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579202|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579203|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579204|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579205|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579206|NCT00005866|Cyclosporine|cyclosporine|mesh-list
14579207|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
14579208|NCT00005866|Busulfan|busulfan|mesh-list
14579209|NCT00005866|Methotrexate|methotrexate|mesh-list
14579210|NCT00005866|Cyclosporins|cyclosporins|mesh-list
14579211|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579212|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
14579213|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579214|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579215|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579216|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
14579217|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579218|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579219|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579220|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14579221|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
14579222|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14579223|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579224|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
14579225|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579226|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579227|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14579228|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14579229|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
14579230|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579231|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579232|NCT00005867|Prednisolone|prednisolone|mesh-list
14579233|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
14579234|NCT00005867|Doxorubicin|doxorubicin|mesh-list
14579235|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14579236|NCT00005867|Etoposide|etoposide|mesh-list
14579237|NCT00005867|Vincristine|vincristine|mesh-list
14579238|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
14579239|NCT00005867|Bleomycin|bleomycin|mesh-list
14579240|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579241|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
14579242|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579243|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579244|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579245|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
14579246|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579247|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579248|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579249|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579250|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579251|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579252|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579253|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579254|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579255|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153529|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153530|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153531|NCT04185350|Exenatide|exenatide|mesh-list
15153532|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14579256|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579257|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579258|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
14579259|NCT00005867|Hormones|hormones|mesh-ancestor
14579260|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579261|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14579262|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14579263|NCT00005867|Analgesics|analgesics|mesh-ancestor
14579264|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
14579265|NCT00005868|Docetaxel|docetaxel|mesh-list
15153533|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153534|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15153535|NCT04185350|Incretins|incretins|mesh-ancestor
15153536|NCT04185350|Hormones|hormones|mesh-ancestor
15153537|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153538|NCT04185402|Azithromycin|azithromycin|mesh-list
14579266|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579267|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579268|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579269|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579270|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579271|NCT00005869|Gemcitabine|gemcitabine|mesh-list
14579272|NCT00005869|Rubitecan|rubitecan|mesh-list
14579273|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579274|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
14579275|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579276|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579277|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
14579278|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579279|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153539|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15153540|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153541|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
15153542|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15153543|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
15153544|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
15153545|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153546|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153547|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15153548|NCT04185233|Analgesics|analgesics|mesh-ancestor
15153549|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
14579280|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579281|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
14579282|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579283|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579284|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579285|NCT00005870|Gemcitabine|gemcitabine|mesh-list
14579286|NCT00005870|Fluorouracil|fluorouracil|mesh-list
14579287|NCT00005870|Mitomycins|mitomycins|mesh-list
14579288|NCT00005870|Mitomycin|mitomycin|mesh-list
14579289|NCT00005870|Rubitecan|rubitecan|mesh-list
14579290|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579291|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
14579292|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579293|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579294|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
14579295|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579296|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579297|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579298|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
14579299|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579300|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579301|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
14579302|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15153550|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153551|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15153552|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153553|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15153554|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153555|NCT04185077|Heparin|heparin|mesh-list
15153556|NCT04185077|Calcium heparin|calcium heparin|mesh-list
15153557|NCT04185077|Bivalirudin|bivalirudin|mesh-list
15153558|NCT04185077|Antithrombins|antithrombins|mesh-list
15153559|NCT04185077|Thrombin|thrombin|mesh-list
15153560|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
15153561|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15153562|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15153563|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153564|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
15153565|NCT04185077|Coagulants|coagulants|mesh-ancestor
15153566|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15153567|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
15153568|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153569|NCT04185194|Lidocaine|lidocaine|mesh-list
14579303|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579304|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15153570|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
15153571|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
15180231|NCT03942289|Norepinephrine|norepinephrine|mesh-list
15153572|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153573|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579305|NCT00005871|Fluorouracil|fluorouracil|mesh-list
14579306|NCT00005871|Rubitecan|rubitecan|mesh-list
14579307|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
14579308|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579309|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579310|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579311|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579312|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
14579313|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579314|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579315|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579316|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579317|NCT00005872|Rubitecan|rubitecan|mesh-list
14579318|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579319|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579320|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579321|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579322|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579323|NCT00005873|Rubitecan|rubitecan|mesh-list
14579324|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579325|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579326|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579327|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579328|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579329|NCT00005874|Rubitecan|rubitecan|mesh-list
14579330|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579331|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579332|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579333|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579334|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579335|NCT00005875|Rubitecan|rubitecan|mesh-list
14579336|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579337|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579338|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579339|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579340|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579341|NCT00005876|Rubitecan|rubitecan|mesh-list
15153574|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
15153575|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14579342|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579343|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579344|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579345|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579346|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579347|NCT00005877|Rubitecan|rubitecan|mesh-list
14579348|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579349|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579350|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579351|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579352|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579353|NCT00005878|Celecoxib|celecoxib|mesh-list
14579354|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14579355|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14579356|NCT00005878|Analgesics|analgesics|mesh-ancestor
14579357|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
14579358|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153576|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15153577|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15153578|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15153579|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15153580|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153581|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15153582|NCT04184869|Belinostat|belinostat|mesh-list
15153583|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15153584|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15153585|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
15153586|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153587|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153588|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14579359|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579360|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153589|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15153590|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
15153591|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153592|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153593|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15153594|NCT04185103|Valsartan|valsartan|mesh-list
15153595|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14579361|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579362|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14579363|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14579364|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579365|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579366|NCT00005880|Budesonide|budesonide|mesh-list
14579367|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579368|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14579369|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
14579370|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14579371|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579372|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15153596|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15153597|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15153598|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15153599|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153600|NCT04184921|Aspirin|aspirin|mesh-list
15153601|NCT04184921|Osimertinib|osimertinib|mesh-list
15153602|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15153603|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15153604|NCT04184921|Analgesics|analgesics|mesh-ancestor
15153605|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
14579373|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
14579374|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
14579375|NCT00005880|Hormones|hormones|mesh-ancestor
14579376|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579377|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
14579378|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579379|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579380|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14579381|NCT00005883|Protective Agents|protective agents|mesh-ancestor
14579382|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579383|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579384|NCT00005884|Eflornithine|eflornithine|mesh-list
14579385|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579386|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14579387|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14579388|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14579389|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579390|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14579391|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579392|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579393|NCT00005886|Tamoxifen|tamoxifen|mesh-list
14579394|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14579395|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
14579396|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579397|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579398|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14579399|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579400|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14579401|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14579402|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14579403|NCT00005887|Efaproxiral|efaproxiral|mesh-list
14579404|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
14579405|NCT00005889|Glucagon|glucagon|mesh-list
14579406|NCT00005889|Glycerol|glycerol|mesh-list
14579407|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579408|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153606|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153607|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153608|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153609|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153610|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15153611|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15153612|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579409|NCT00005889|Hormones|hormones|mesh-ancestor
14579410|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153613|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15153614|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15153615|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153616|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
15153617|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153618|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153619|NCT04184518|Durvalumab|durvalumab|mesh-list
15153620|NCT04184518|Cediranib|cediranib|mesh-list
15153621|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153622|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153623|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153624|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153625|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153626|NCT04184466|Insulin|insulin|mesh-list
15153627|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15153628|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
15153629|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
14579411|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14579412|NCT00005889|Protective Agents|protective agents|mesh-ancestor
14579413|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14579414|NCT00005890|Hormones|hormones|mesh-ancestor
14579415|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579416|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579417|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
14579418|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579419|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
14579420|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579421|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579422|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579423|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
14579424|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579425|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579426|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579427|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
14579428|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579429|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
14579430|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579431|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579432|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579433|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
14579434|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579435|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579436|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579437|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
14579438|NCT00005893|Busulfan|busulfan|mesh-list
14579439|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14579440|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579441|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
14579442|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579443|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579444|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579445|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
14579446|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579447|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579448|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579449|NCT00005896|Lenograstim|lenograstim|mesh-list
14579450|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14579451|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
14579452|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579453|NCT00005898|Cyclosporine|cyclosporine|mesh-list
14579454|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
14579455|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
14579456|NCT00005898|Fludarabine|fludarabine|mesh-list
14579457|NCT00005898|Cyclosporins|cyclosporins|mesh-list
14579458|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14579459|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579460|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
15153630|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15153631|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15153632|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153633|NCT04184492|Insulin|insulin|mesh-list
15153634|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15153635|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
14579461|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579462|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579463|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579464|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
14579465|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579466|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579467|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579468|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579469|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
14579470|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579471|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579472|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579473|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579474|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
14579475|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
14579476|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14579477|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14579478|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
14579479|NCT00005898|Hormones|hormones|mesh-ancestor
14579480|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579481|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14579482|NCT00005898|Protective Agents|protective agents|mesh-ancestor
14644148|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644149|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644150|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644151|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644152|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644153|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644154|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644155|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644156|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644157|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644158|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644159|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15153636|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
15153637|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14644160|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644161|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644162|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644163|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644164|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644165|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644166|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644167|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644168|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644169|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644170|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644171|NCT00191061|Analgesics|analgesics|mesh-ancestor
14644172|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
14644173|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644174|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644175|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644176|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
14644177|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644178|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644179|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644180|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644181|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644182|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644183|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644184|NCT00191087|Analgesics|analgesics|mesh-ancestor
14644185|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
14644186|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644187|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644188|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644189|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
14644190|NCT00191126|Gemcitabine|gemcitabine|mesh-list
14644191|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644192|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644193|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
14579483|NCT00005912|Voriconazole|voriconazole|mesh-list
14579484|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
14579485|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579486|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14579487|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14579488|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579489|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153638|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
15153639|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
15153640|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
15153641|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15153642|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153643|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15153644|NCT04184505|Azacitidine|azacitidine|mesh-list
15153645|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153646|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
14579490|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14579491|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
14579492|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579493|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579494|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15153647|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153648|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153649|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153650|NCT04183881|Brodalumab|brodalumab|mesh-list
15153651|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
15153652|NCT04184141|Alprazolam|alprazolam|mesh-list
15153653|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
15153654|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14579495|NCT00005920|Caspofungin|caspofungin|mesh-list
14579496|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
14579497|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579498|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021529|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14021530|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
14021531|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14021532|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
14021533|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021534|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
14021535|NCT02773251|Protective Agents|protective agents|mesh-ancestor
14021536|NCT02773251|Laxatives|laxatives|mesh-ancestor
14021537|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021538|NCT02773407|Azithromycin|azithromycin|mesh-list
14021539|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14021540|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14021541|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579499|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579500|NCT00005921|Caspofungin|caspofungin|mesh-list
14579501|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
14579502|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579503|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579504|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579505|NCT00005922|Triamcinolone|triamcinolone|mesh-list
14579506|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14579507|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14579508|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14579509|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579510|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
14579511|NCT00005922|Hormones|hormones|mesh-ancestor
14579512|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579513|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579514|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579515|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
14579516|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021542|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14579517|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579518|NCT00005925|Muscimol|muscimol|mesh-list
14579519|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14579520|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
14579521|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
14579522|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14579523|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153655|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021543|NCT02773407|Renal Agents|renal agents|mesh-ancestor
14579524|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579525|NCT00005926|Gemcitabine|gemcitabine|mesh-list
14579526|NCT00005926|Trastuzumab|trastuzumab|mesh-list
14579527|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579528|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
14579529|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579530|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579531|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
14579532|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579533|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579534|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579535|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
14579536|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153656|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021544|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
14579537|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14579538|NCT00005928|Ramipril|ramipril|mesh-list
14579539|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14579540|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
14579541|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579542|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579543|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14579544|NCT00005931|Semaxinib|semaxinib|mesh-list
14579545|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14579546|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14579547|NCT00005931|Growth Substances|growth substances|mesh-ancestor
14579548|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579549|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
14579550|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579551|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14579552|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579553|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579554|NCT00005934|Azacitidine|azacitidine|mesh-list
14579555|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579556|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
14579557|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579558|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579559|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579560|NCT00005935|Cyclosporine|cyclosporine|mesh-list
14579561|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
14579562|NCT00005935|Cyclosporins|cyclosporins|mesh-list
14579563|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579564|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579565|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579566|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
14579567|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579568|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
14579569|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579570|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579571|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579572|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579573|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579574|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579575|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14579576|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
14579577|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14579578|NCT00005938|Exatecan|exatecan|mesh-list
14579579|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579580|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579581|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579582|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579583|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579584|NCT00005940|Iodine|iodine|mesh-list
14579585|NCT00005940|Cyclosporine|cyclosporine|mesh-list
14579586|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
14579587|NCT00005940|Busulfan|busulfan|mesh-list
14579588|NCT00005940|Methotrexate|methotrexate|mesh-list
14579589|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14579590|NCT00005940|Cyclosporins|cyclosporins|mesh-list
14579591|NCT00005940|Antibodies|antibodies|mesh-list
14579592|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
14579593|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14579594|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579595|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
14579596|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579597|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579598|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579599|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
14579600|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579601|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579602|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579603|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14579604|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
14579605|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14579606|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579607|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
14579608|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579609|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579610|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14579611|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14579612|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
14579613|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579614|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579615|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14579616|NCT00005940|Trace Elements|trace elements|mesh-ancestor
14579617|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
14579618|NCT00005941|Cyclosporine|cyclosporine|mesh-list
14579619|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
14579620|NCT00005941|Fludarabine|fludarabine|mesh-list
14579621|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
14579622|NCT00005941|Cyclosporins|cyclosporins|mesh-list
14579623|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579624|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579625|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
14579626|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579627|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579628|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
14579629|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579630|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579631|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
14579632|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579633|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579634|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579635|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14579636|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579637|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14579638|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
14579639|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14579640|NCT00005942|Daunorubicin|daunorubicin|mesh-list
14579641|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579642|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579643|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579644|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579645|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579646|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579647|NCT00005943|Aldesleukin|aldesleukin|mesh-list
14579648|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579649|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14579650|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14579651|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
14579652|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579653|NCT00005944|Leucovorin|leucovorin|mesh-list
14579654|NCT00005944|Fluorouracil|fluorouracil|mesh-list
14579655|NCT00005944|Mitomycins|mitomycins|mesh-list
14579656|NCT00005944|Mitomycin|mitomycin|mesh-list
14579657|NCT00005944|Calcium|calcium|mesh-list
14579658|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
14579659|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14579660|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579661|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
14579662|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579663|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579664|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579665|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021545|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14021546|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14026050|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026051|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153657|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14579666|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
14579667|NCT00005944|Antidotes|antidotes|mesh-ancestor
14579668|NCT00005944|Protective Agents|protective agents|mesh-ancestor
14579669|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
14579670|NCT00005944|Vitamins|vitamins|mesh-ancestor
14579671|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
14579672|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579673|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
14579674|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14579675|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579676|NCT00005945|Cytarabine|cytarabine|mesh-list
14579677|NCT00005945|Dexamethasone|dexamethasone|mesh-list
15153658|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15153659|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14579678|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
14579679|NCT00005945|Doxorubicin|doxorubicin|mesh-list
14579680|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14579681|NCT00005945|Methotrexate|methotrexate|mesh-list
14579682|NCT00005945|Vincristine|vincristine|mesh-list
14579683|NCT00005945|Daunorubicin|daunorubicin|mesh-list
14579684|NCT00005945|Asparaginase|asparaginase|mesh-list
14579685|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
14579686|NCT00005945|Pegaspargase|pegaspargase|mesh-list
14579687|NCT00005945|Thioguanine|thioguanine|mesh-list
14579688|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579689|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
14579690|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579691|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579692|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579693|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
14579694|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579695|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579696|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579697|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579698|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
14579699|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
14579700|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14579701|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14579702|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
14579703|NCT00005945|Hormones|hormones|mesh-ancestor
14579704|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579705|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14579706|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579707|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579708|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579709|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579710|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14579711|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
14579712|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14579713|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579714|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
14579715|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579716|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14579717|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14579718|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
14579719|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579720|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579721|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579722|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579723|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579724|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
14579725|NCT00005946|Etoposide|etoposide|mesh-list
14579726|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579727|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
14579728|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579729|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579730|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579731|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
14579732|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579733|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579734|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579735|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579736|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579737|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579738|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579739|NCT00005948|Interferons|interferons|mesh-list
14579740|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
14579741|NCT00005948|Aldesleukin|aldesleukin|mesh-list
15153660|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
14579742|NCT00005948|Busulfan|busulfan|mesh-list
14579743|NCT00005948|Sargramostim|sargramostim|mesh-list
14579744|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579745|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
14579746|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579747|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
14579748|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579749|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
14579750|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579751|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579752|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579753|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579754|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14579755|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14579756|NCT00005949|Aldesleukin|aldesleukin|mesh-list
14579757|NCT00005949|Interleukin-2|interleukin-2|mesh-list
14579758|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579759|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14579760|NCT00005949|Analgesics|analgesics|mesh-ancestor
14579761|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
14579762|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14579763|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579764|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14579765|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14579766|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
14579767|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579768|NCT00005951|Irinotecan|irinotecan|mesh-list
14579769|NCT00005951|Temozolomide|temozolomide|mesh-list
14579770|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579771|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579772|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579773|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579774|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579775|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579776|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
14579777|NCT00005952|Temozolomide|temozolomide|mesh-list
14579778|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579779|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
14579780|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579781|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579782|NCT00005954|Temozolomide|temozolomide|mesh-list
14579783|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579784|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
14579785|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579786|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579787|NCT00005955|Temozolomide|temozolomide|mesh-list
14579788|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579789|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
14579790|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579791|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579792|NCT00005958|Gemcitabine|gemcitabine|mesh-list
14579793|NCT00005958|Docetaxel|docetaxel|mesh-list
14579794|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579795|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
14579796|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579797|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579798|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
14579799|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579800|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579801|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579802|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
14579803|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579804|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579805|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579806|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579807|NCT00005959|Prednisone|prednisone|mesh-list
14579808|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
14579809|NCT00005959|Rituximab|rituximab|mesh-list
14579810|NCT00005959|Doxorubicin|doxorubicin|mesh-list
14579811|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14579812|NCT00005959|Vincristine|vincristine|mesh-list
14579813|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579814|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
14579815|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579816|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579817|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579818|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
15153661|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
14579819|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579820|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579821|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579822|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14579823|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579824|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579825|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579826|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579827|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579828|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
14579829|NCT00005959|Hormones|hormones|mesh-ancestor
14579830|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579831|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14579832|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579833|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579834|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579835|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579836|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
14579837|NCT00005960|Docetaxel|docetaxel|mesh-list
14579838|NCT00005960|Doxorubicin|doxorubicin|mesh-list
14579839|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14579840|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579841|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
14579842|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579843|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579844|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579845|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
14579846|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579847|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579848|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579849|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579850|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579851|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579852|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579853|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579854|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579855|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579856|NCT00005961|Carmustine|carmustine|mesh-list
14579857|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14579858|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579859|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
14579860|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579861|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579862|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579863|NCT00005962|Cytarabine|cytarabine|mesh-list
14579864|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
14579865|NCT00005962|Topotecan|topotecan|mesh-list
14579866|NCT00005962|Daunorubicin|daunorubicin|mesh-list
14579867|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
14579868|NCT00005962|Sargramostim|sargramostim|mesh-list
14579869|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579870|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
14579871|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579872|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579873|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579874|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
14579875|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579876|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579877|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579878|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14579879|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
14579880|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
14579881|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579882|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14579883|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579884|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579885|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579886|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579887|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14579888|NCT00005963|Carboplatin|carboplatin|mesh-list
14579889|NCT00005963|Docetaxel|docetaxel|mesh-list
14579890|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579891|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579892|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579893|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
15182149|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
14579894|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579895|NCT00005964|Prednisone|prednisone|mesh-list
14579896|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
14579897|NCT00005964|Doxorubicin|doxorubicin|mesh-list
14579898|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14579899|NCT00005964|Etoposide|etoposide|mesh-list
14579900|NCT00005964|Vincristine|vincristine|mesh-list
14579901|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579902|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
14579903|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579904|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579905|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579906|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
14579907|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579908|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579909|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579910|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579911|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14579912|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579913|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579914|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14579915|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
14579916|NCT00005964|Hormones|hormones|mesh-ancestor
14579917|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579918|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14579919|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579920|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579921|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579922|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579923|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
14579924|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579925|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14579926|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
14579927|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579928|NCT00005966|Interferons|interferons|mesh-list
14579929|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
14579930|NCT00005966|Thalidomide|thalidomide|mesh-list
14579931|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579932|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
14579933|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14579934|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
14579935|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579936|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579937|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
14579938|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14579939|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14579940|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14579941|NCT00005966|Growth Substances|growth substances|mesh-ancestor
14579942|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
14579943|NCT00005967|Tipifarnib|tipifarnib|mesh-list
14579944|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579945|NCT00005968|Irofulven|irofulven|mesh-list
14579946|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579947|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
14579948|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579949|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579950|NCT00005969|Tretinoin|tretinoin|mesh-list
14579951|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579952|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
14579953|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14579954|NCT00005970|Tamoxifen|tamoxifen|mesh-list
14579955|NCT00005970|Paclitaxel|paclitaxel|mesh-list
14579956|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
14579957|NCT00005970|Doxorubicin|doxorubicin|mesh-list
14579958|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14579959|NCT00005970|Trastuzumab|trastuzumab|mesh-list
14579960|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14579961|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14579962|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14579963|NCT00005970|Antibodies|antibodies|mesh-list
14579964|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
14579965|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14021547|NCT02773472|Morphine|morphine|mesh-list
14579966|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14579967|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14579968|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579969|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
14579970|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
14579971|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
14579972|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14579973|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14579974|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
14579975|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579976|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14579977|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14579978|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
14579979|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14579980|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14579981|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15153662|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153663|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153664|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
15153665|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
15153666|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15153667|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
14579982|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14579983|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579984|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14579985|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
14579986|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14579987|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14579988|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14579989|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14579990|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14579991|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14579992|NCT00005971|Alvocidib|alvocidib|mesh-list
14579993|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14579994|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
14579995|NCT00005971|Growth Substances|growth substances|mesh-ancestor
14579996|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14579997|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14579998|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14579999|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580000|NCT00005972|Gemcitabine|gemcitabine|mesh-list
14580001|NCT00005972|Irinotecan|irinotecan|mesh-list
14580002|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580003|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
14580004|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580005|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580006|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
14580007|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580008|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580009|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580010|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
14580011|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580012|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580013|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580014|NCT00005974|Alvocidib|alvocidib|mesh-list
14580015|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580016|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
14580017|NCT00005974|Growth Substances|growth substances|mesh-ancestor
14580018|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580019|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580020|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580021|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580022|NCT00005975|Megestrol|megestrol|mesh-list
14580023|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
14580024|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14580025|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14580026|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14580027|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
14580028|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14580029|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580030|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14580031|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14580032|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580033|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580034|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
14580035|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14580036|NCT00005976|Carboplatin|carboplatin|mesh-list
15153668|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
14580037|NCT00005976|NSC 366140|nsc 366140|mesh-list
14580038|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580039|NCT00005977|Leucovorin|leucovorin|mesh-list
14580040|NCT00005977|Cytarabine|cytarabine|mesh-list
14580041|NCT00005977|Dexamethasone|dexamethasone|mesh-list
14580042|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
14580043|NCT00005977|Ifosfamide|ifosfamide|mesh-list
14580044|NCT00005977|Doxorubicin|doxorubicin|mesh-list
14580045|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14580046|NCT00005977|Methotrexate|methotrexate|mesh-list
14580047|NCT00005977|Etoposide|etoposide|mesh-list
14580048|NCT00005977|Vincristine|vincristine|mesh-list
14580049|NCT00005977|Lenograstim|lenograstim|mesh-list
14580050|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
14580051|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580052|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
14580053|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580054|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580055|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580056|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
14580057|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580058|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580059|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580060|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580061|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
14580062|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
14580063|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580064|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580065|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
14580066|NCT00005977|Hormones|hormones|mesh-ancestor
14580067|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580068|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580069|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580070|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580071|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580072|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580073|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14580074|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
14580075|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14580076|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580077|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
14580078|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
14580079|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14580080|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14580081|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580082|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
14580083|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580084|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14580085|NCT00005977|Antidotes|antidotes|mesh-ancestor
14580086|NCT00005977|Protective Agents|protective agents|mesh-ancestor
14580087|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
14580088|NCT00005977|Vitamins|vitamins|mesh-ancestor
14580089|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
14580090|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580091|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580092|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580093|NCT00005978|Carboplatin|carboplatin|mesh-list
14580094|NCT00005978|Etoposide|etoposide|mesh-list
14580095|NCT00005978|Melphalan|melphalan|mesh-list
14580096|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14580097|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580098|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580099|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580100|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580101|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580102|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580103|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
14580104|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580105|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580106|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
14580107|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580108|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580109|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14580110|NCT00005979|Leucovorin|leucovorin|mesh-list
14580111|NCT00005979|Fluorouracil|fluorouracil|mesh-list
15153669|NCT04184115|Scopolamine|scopolamine|mesh-list
14580112|NCT00005979|Irinotecan|irinotecan|mesh-list
14580113|NCT00005979|Calcium|calcium|mesh-list
14580114|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
15153670|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15153671|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
15153672|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
15153673|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153674|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153675|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153676|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
15153677|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15153678|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
15153679|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153680|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153681|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15180232|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15180233|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15180234|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
15180235|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180236|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180237|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180238|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
15180239|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
14580115|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14580116|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180240|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180241|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15180242|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
14580117|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
14580118|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580119|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580120|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580121|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580122|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
14580123|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580124|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580125|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580126|NCT00005979|Antidotes|antidotes|mesh-ancestor
14580127|NCT00005979|Protective Agents|protective agents|mesh-ancestor
14580128|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
14580129|NCT00005979|Vitamins|vitamins|mesh-ancestor
14580130|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
14580131|NCT00005980|Doxorubicin|doxorubicin|mesh-list
14580132|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14580133|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580134|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580135|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580136|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15180243|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15180244|NCT03941925|Levan|levan|mesh-list
15180245|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580137|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580138|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580139|NCT00005981|Carmustine|carmustine|mesh-list
14580140|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14580141|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580142|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
14580143|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580144|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580145|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580146|NCT00005984|Interferons|interferons|mesh-list
14580147|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
14580148|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
14580149|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580150|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
14580151|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580152|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580153|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580154|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
14580155|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580156|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580157|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580158|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
14580159|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580160|NCT00005985|Cytarabine|cytarabine|mesh-list
15180246|NCT03941964|Azacitidine|azacitidine|mesh-list
15180247|NCT03941964|Decitabine|decitabine|mesh-list
15180248|NCT03941964|Venetoclax|venetoclax|mesh-list
14580161|NCT00005985|Dexamethasone|dexamethasone|mesh-list
15180249|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580162|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
15153682|NCT04183634|Rotigotine|rotigotine|mesh-list
15153683|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
14580163|NCT00005985|Carmustine|carmustine|mesh-list
14580164|NCT00005985|Etoposide|etoposide|mesh-list
14580165|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
14580166|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580167|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
14580168|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580169|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580170|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580171|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
14580172|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580173|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580174|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580175|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580176|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
14580177|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
14580178|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580179|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580180|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
14580181|NCT00005985|Hormones|hormones|mesh-ancestor
14580182|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580183|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580184|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580185|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580186|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580187|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580188|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580189|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
14580190|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
14580191|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580192|NCT00005985|Analgesics|analgesics|mesh-ancestor
14580193|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
14580194|NCT00005986|Interferons|interferons|mesh-list
15153684|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
15153685|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153686|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153687|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153688|NCT04183556|Naproxen|naproxen|mesh-list
15153689|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15153690|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15153691|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15153692|NCT04183556|Analgesics|analgesics|mesh-ancestor
15153693|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
15153694|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153695|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153696|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153697|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
15153698|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14580195|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
14580196|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
14580197|NCT00005986|Busulfan|busulfan|mesh-list
14580198|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580199|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
14580200|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580201|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580202|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580203|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
14580204|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580205|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580206|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580207|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
15153699|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153700|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153701|NCT04183725|Oseltamivir|oseltamivir|mesh-list
15153702|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
15153703|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153704|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153705|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153706|NCT04183608|Adalimumab|adalimumab|mesh-list
15153707|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153708|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021548|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14580208|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580209|NCT00005987|Interferons|interferons|mesh-list
14580210|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
14580211|NCT00005987|Dexamethasone|dexamethasone|mesh-list
14580212|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
14580213|NCT00005987|Carmustine|carmustine|mesh-list
14580214|NCT00005987|Etoposide|etoposide|mesh-list
14580215|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
14580216|NCT00005987|Sargramostim|sargramostim|mesh-list
14580217|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580218|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
14580219|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580220|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580221|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580222|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
14580223|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580224|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580225|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580226|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580227|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
14580228|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
14580229|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580230|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580231|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
14580232|NCT00005987|Hormones|hormones|mesh-ancestor
14580233|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580234|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580235|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580236|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580237|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580238|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580239|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
14580240|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580241|NCT00005987|Analgesics|analgesics|mesh-ancestor
14580242|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
14580243|NCT00005988|Leucovorin|leucovorin|mesh-list
14580244|NCT00005988|Cyclosporine|cyclosporine|mesh-list
14580245|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
14580246|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
14580247|NCT00005988|Methotrexate|methotrexate|mesh-list
14580248|NCT00005988|Cyclosporins|cyclosporins|mesh-list
14580249|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
14580250|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580251|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
14580252|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580253|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580254|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580255|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
14580256|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580257|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580258|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580259|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14580260|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
14580261|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14580262|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580263|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
14580264|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
14580265|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580266|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14580267|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14580268|NCT00005988|Antidotes|antidotes|mesh-ancestor
14580269|NCT00005988|Protective Agents|protective agents|mesh-ancestor
14580270|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
14580271|NCT00005988|Vitamins|vitamins|mesh-ancestor
14580272|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
14580273|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
14580274|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580275|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14580276|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580277|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
14580278|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
14580279|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580280|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580281|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
14580282|NCT00005988|Hormones|hormones|mesh-ancestor
14580283|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580284|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14580285|NCT00005989|Tipifarnib|tipifarnib|mesh-list
14580286|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580287|NCT00005990|Topotecan|topotecan|mesh-list
14580288|NCT00005990|Tipifarnib|tipifarnib|mesh-list
14580289|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580290|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580291|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580292|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580293|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580294|NCT00005991|Gemcitabine|gemcitabine|mesh-list
14580295|NCT00005991|Doxorubicin|doxorubicin|mesh-list
14580296|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14580297|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580298|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
14580299|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580300|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580301|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
14580302|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580303|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580304|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580305|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
14580306|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580307|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580308|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580309|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580310|NCT00005993|Aldesleukin|aldesleukin|mesh-list
14580311|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580312|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14580313|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14580314|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
14580315|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580316|NCT00005994|Ondansetron|ondansetron|mesh-list
14580317|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
14580318|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
14580319|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580320|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580321|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580322|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
14580323|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
14580324|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14580325|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
14580326|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14580327|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580328|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14580329|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14580330|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14580331|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14580332|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14580333|NCT00005996|Gemcitabine|gemcitabine|mesh-list
14580334|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580335|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580336|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
15153709|NCT04183738|Ritonavir|ritonavir|mesh-list
14580337|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580338|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
14580339|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580340|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580341|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580342|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
14580343|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580344|NCT00005998|Cytarabine|cytarabine|mesh-list
14580345|NCT00005998|Dexamethasone|dexamethasone|mesh-list
14580346|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
14580347|NCT00005998|Carmustine|carmustine|mesh-list
14580348|NCT00005998|Etoposide|etoposide|mesh-list
14580349|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
14580350|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580351|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
14580352|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580353|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580354|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580355|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
14580356|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153710|NCT04183738|Darunavir|darunavir|mesh-list
15153711|NCT04183738|Dolutegravir|dolutegravir|mesh-list
15153712|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15153713|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15153714|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
15153715|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580357|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580358|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580359|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580360|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
14580361|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
14580362|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580363|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580364|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
14580365|NCT00005998|Hormones|hormones|mesh-ancestor
14580366|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580367|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580368|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580369|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580370|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580371|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580372|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580373|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
14580374|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
14580375|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580376|NCT00005998|Analgesics|analgesics|mesh-ancestor
14580377|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
14580378|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
14580379|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580380|NCT00006000|Irinotecan|irinotecan|mesh-list
14580381|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580382|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580383|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580384|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580385|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580386|NCT00006001|Semaxinib|semaxinib|mesh-list
14580387|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14580388|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14580389|NCT00006001|Growth Substances|growth substances|mesh-ancestor
14580390|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580391|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
15153716|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153717|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15153718|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15153719|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
15153720|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153721|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14580392|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580393|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153722|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15153723|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15153724|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15153725|NCT04183491|Interferons|interferons|mesh-list
15153726|NCT04183491|Interferon-beta|interferon-beta|mesh-list
15153727|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
15153728|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153729|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
14580394|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580395|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580396|NCT00006002|Dexamethasone|dexamethasone|mesh-list
14580397|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580398|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
14580399|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
14580400|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580401|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580402|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580403|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
14580404|NCT00006002|Hormones|hormones|mesh-ancestor
14580405|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580406|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580407|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580408|NCT00006003|Semaxinib|semaxinib|mesh-list
14580409|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14580410|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14580411|NCT00006003|Growth Substances|growth substances|mesh-ancestor
14580412|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580413|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
14580414|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580415|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580416|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580417|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580418|NCT00006004|Gemcitabine|gemcitabine|mesh-list
14580419|NCT00006004|Paclitaxel|paclitaxel|mesh-list
14580420|NCT00006004|Carboplatin|carboplatin|mesh-list
14580421|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580422|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580423|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580424|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580425|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580426|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580427|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580428|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
14580429|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
14580430|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580431|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580432|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580433|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
14580434|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580435|NCT00006005|Thalidomide|thalidomide|mesh-list
14580436|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580437|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
14580438|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580439|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
14580440|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14580441|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580442|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14580443|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14580444|NCT00006005|Growth Substances|growth substances|mesh-ancestor
14580445|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
14580446|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580447|NCT00006006|Interferons|interferons|mesh-list
14580448|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
14580449|NCT00006006|Thalidomide|thalidomide|mesh-list
14580450|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580451|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
14580452|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580453|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
14580454|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580455|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580456|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
14580457|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15153730|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153731|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
15153732|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153733|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15153734|NCT04183361|Cortisone|cortisone|mesh-list
15153735|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580458|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14580459|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14580460|NCT00006006|Growth Substances|growth substances|mesh-ancestor
14580461|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
14580462|NCT00006007|Gemcitabine|gemcitabine|mesh-list
14580463|NCT00006007|Pemetrexed|pemetrexed|mesh-list
14580464|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580465|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
15153736|NCT04183192|Reslizumab|reslizumab|mesh-list
15153737|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15153738|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
15153739|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15153740|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
15153741|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580466|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580467|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580468|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
14580469|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580470|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580471|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580472|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
14580473|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580474|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14580475|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14580476|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
14580477|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580478|NCT00006009|Visilizumab|visilizumab|mesh-list
14580479|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
14814023|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14021549|NCT02773472|Narcotics|narcotics|mesh-ancestor
14580480|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580481|NCT00006010|Gemcitabine|gemcitabine|mesh-list
15153742|NCT04183387|Simvastatin|simvastatin|mesh-list
14580482|NCT00006010|Docetaxel|docetaxel|mesh-list
14580483|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580484|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
14580485|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580486|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580487|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
14580488|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580489|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580490|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580491|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
14580492|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580493|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580494|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580495|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580496|NCT00006012|Paclitaxel|paclitaxel|mesh-list
14580497|NCT00006012|Etoposide|etoposide|mesh-list
14580498|NCT00006012|Topotecan|topotecan|mesh-list
14580499|NCT00006012|Amifostine|amifostine|mesh-list
14580500|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580501|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580502|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580503|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580504|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580505|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580506|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580507|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580508|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580509|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580510|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580511|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14580512|NCT00006012|Protective Agents|protective agents|mesh-ancestor
14580513|NCT00006013|Semaxinib|semaxinib|mesh-list
14580514|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14580515|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14580516|NCT00006013|Growth Substances|growth substances|mesh-ancestor
14580517|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580518|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
14580519|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580520|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580521|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580522|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580523|NCT00006014|Semaxinib|semaxinib|mesh-list
14580524|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14580525|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14580526|NCT00006014|Growth Substances|growth substances|mesh-ancestor
14580527|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580528|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
14580529|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580530|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580531|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580532|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580533|NCT00006015|Leucovorin|leucovorin|mesh-list
14580534|NCT00006015|Fluorouracil|fluorouracil|mesh-list
14580535|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
14580536|NCT00006015|Trastuzumab|trastuzumab|mesh-list
14580537|NCT00006015|Calcium|calcium|mesh-list
14580538|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
14580539|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14580540|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580541|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
14580542|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580543|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580544|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580545|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580546|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
14580547|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14580548|NCT00006015|Antidotes|antidotes|mesh-ancestor
14580549|NCT00006015|Protective Agents|protective agents|mesh-ancestor
14580550|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
14580551|NCT00006015|Vitamins|vitamins|mesh-ancestor
14580552|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
14580553|NCT00006016|Thalidomide|thalidomide|mesh-list
14580554|NCT00006016|Doxorubicin|doxorubicin|mesh-list
14580555|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14580556|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580557|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580558|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580559|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580560|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580561|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580562|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153743|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15153744|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15153745|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
15153746|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153747|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14580563|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
14580564|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580565|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
14580566|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14580567|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153748|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15153749|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153750|NCT04183114|Vaccines|vaccines|mesh-list
15153751|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
15153752|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153753|NCT04183075|Vitamins|vitamins|mesh-list
14580568|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14580569|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14580570|NCT00006016|Growth Substances|growth substances|mesh-ancestor
14580571|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
15153754|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
15153755|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
15153756|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153757|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
15153758|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153759|NCT04183075|Protective Agents|protective agents|mesh-ancestor
15153760|NCT04183257|Vitamin D|vitamin d|mesh-list
15153761|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
15153762|NCT04183257|Vitamins|vitamins|mesh-list
14580572|NCT00006018|Paclitaxel|paclitaxel|mesh-list
14580573|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580574|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580575|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580576|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580577|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580578|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644194|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644195|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
14644196|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644197|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644198|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644199|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
14644200|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644201|NCT00191178|Insulin|insulin|mesh-list
15153763|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
15153764|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153765|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14644202|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14644203|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
14644204|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
14644205|NCT00191178|Protamines|protamines|mesh-list
14644206|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14644207|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644208|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
14644209|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644210|NCT00191178|Coagulants|coagulants|mesh-ancestor
14644211|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644212|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15153766|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15153767|NCT04183296|Propofol|propofol|mesh-list
15153768|NCT04183296|Sevoflurane|sevoflurane|mesh-list
15153769|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15153770|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153771|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153772|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15153773|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
15153774|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
14644213|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15153775|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15153776|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15153777|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
14580579|NCT00006019|Azacitidine|azacitidine|mesh-list
14580580|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14580581|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580582|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
14580583|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580584|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580585|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580586|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
14580587|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
14580588|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
14580589|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580590|NCT00006021|Protective Agents|protective agents|mesh-ancestor
14580591|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580592|NCT00006021|Vitamins|vitamins|mesh-ancestor
14580593|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
14580594|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580595|NCT00006022|Aldesleukin|aldesleukin|mesh-list
14580596|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
14580597|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580598|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14580599|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14580600|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
14580601|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021550|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021551|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021552|NCT02773472|Analgesics|analgesics|mesh-ancestor
14021553|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
14021554|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021555|NCT02773355|Liraglutide|liraglutide|mesh-list
14021556|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14580602|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14580603|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
14580604|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580605|NCT00006023|Capecitabine|capecitabine|mesh-list
14580606|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580607|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
14580608|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580609|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580610|NCT00006024|Temozolomide|temozolomide|mesh-list
14580611|NCT00006024|Lomustine|lomustine|mesh-list
14580612|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580613|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
14580614|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580615|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580616|NCT00006025|Irinotecan|irinotecan|mesh-list
14580617|NCT00006025|Temozolomide|temozolomide|mesh-list
14580618|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580619|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580620|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580621|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580622|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580623|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580624|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
14580625|NCT00006026|Rubitecan|rubitecan|mesh-list
14580626|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580627|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580628|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580629|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580630|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580631|NCT00006027|Paclitaxel|paclitaxel|mesh-list
14580632|NCT00006027|Cisplatin|cisplatin|mesh-list
14580633|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580634|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580635|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580636|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580637|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580638|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580639|NCT00006028|Gemcitabine|gemcitabine|mesh-list
14580640|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580641|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580642|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
14580643|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580644|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
14580645|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580646|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021557|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580647|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580648|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
14580649|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580650|NCT00006029|Gemcitabine|gemcitabine|mesh-list
14580651|NCT00006029|Doxorubicin|doxorubicin|mesh-list
14580652|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14580653|NCT00006029|Vinorelbine|vinorelbine|mesh-list
14580654|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580655|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
14580656|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580657|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580658|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
14580659|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580660|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580661|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580662|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
14580663|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580664|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580665|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580666|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580667|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580668|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580669|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580670|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580671|NCT00006030|Tamoxifen|tamoxifen|mesh-list
14580672|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14580673|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
14580674|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580675|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580676|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580677|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580678|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14580679|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14580680|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14580681|NCT00006032|Etoposide|etoposide|mesh-list
14580682|NCT00006032|Topotecan|topotecan|mesh-list
14580683|NCT00006032|Ifosfamide|ifosfamide|mesh-list
14580684|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580685|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580686|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580687|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580688|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580689|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580690|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580691|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580692|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
14580693|NCT00006033|Methotrexate|methotrexate|mesh-list
14580694|NCT00006033|Interleukin-2|interleukin-2|mesh-list
14580695|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14580696|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
14580697|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14580698|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580699|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580700|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
14580701|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580702|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580703|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
14580704|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580705|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14580706|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580707|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
14580708|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580709|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14580710|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14580711|NCT00006033|Analgesics|analgesics|mesh-ancestor
14580712|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
14580713|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580714|NCT00006034|Doxorubicin|doxorubicin|mesh-list
14580715|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14580716|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14580717|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580718|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580719|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580720|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580721|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580722|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580723|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14580724|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
14580725|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580726|NCT00006035|Bleomycin|bleomycin|mesh-list
14580727|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580728|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580729|NCT00006036|Lurtotecan|lurtotecan|mesh-list
14580730|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580731|NCT00006037|Fluorouracil|fluorouracil|mesh-list
14580732|NCT00006037|Irinotecan|irinotecan|mesh-list
14580733|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
14580734|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580735|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580736|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580737|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580738|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
14580739|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580740|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14580741|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580742|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580743|NCT00006038|Leucovorin|leucovorin|mesh-list
14580744|NCT00006038|Docetaxel|docetaxel|mesh-list
14580745|NCT00006038|Fluorouracil|fluorouracil|mesh-list
14580746|NCT00006038|Floxuridine|floxuridine|mesh-list
14580747|NCT00006038|Calcium|calcium|mesh-list
14580748|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
14580749|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580750|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580751|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14580752|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153778|NCT04182984|Prednisone|prednisone|mesh-list
15153779|NCT04182984|Azathioprine|azathioprine|mesh-list
15153780|NCT04182984|Bromides|bromides|mesh-list
15153781|NCT04182984|Tacrolimus|tacrolimus|mesh-list
15153782|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14580753|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580754|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14580755|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580756|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
14580757|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580758|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580759|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
14580760|NCT00006038|Antidotes|antidotes|mesh-ancestor
14580761|NCT00006038|Protective Agents|protective agents|mesh-ancestor
14580762|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
14580763|NCT00006038|Vitamins|vitamins|mesh-ancestor
14580764|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
14580765|NCT00006039|Interferons|interferons|mesh-list
14580766|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
14580767|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580768|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
14580769|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580770|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
14580771|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580772|NCT00006040|Etoposide|etoposide|mesh-list
14580773|NCT00006040|Antibodies|antibodies|mesh-list
14580774|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14580775|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
14580776|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580777|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580778|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580779|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580780|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580781|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580782|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580783|NCT00006041|Vaccines|vaccines|mesh-list
14580784|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
14580785|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
14580786|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580787|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14580788|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
15153783|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14580789|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
14580790|NCT00006042|Fludarabine|fludarabine|mesh-list
14580791|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
14580792|NCT00006042|Tacrolimus|tacrolimus|mesh-list
14580793|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153784|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580794|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
14580795|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580796|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580797|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580798|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
14580799|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580800|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580801|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580802|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580803|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
14580804|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14580805|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580806|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14580807|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14580808|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
14580809|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14580810|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580811|NCT00006043|Temozolomide|temozolomide|mesh-list
14580812|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580813|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
14580814|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153785|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
15153786|NCT04182984|Hormones|hormones|mesh-ancestor
15153787|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153788|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153789|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15153790|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153791|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
15153792|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15153793|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153794|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153795|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15153796|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15153797|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
15153798|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15153799|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15153800|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
15153801|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
15153802|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153803|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153804|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15153805|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
15153806|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153807|NCT04183062|Gemcitabine|gemcitabine|mesh-list
15153808|NCT04183062|Docetaxel|docetaxel|mesh-list
15153809|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153810|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
15153811|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580815|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580816|NCT00006044|Testosterone|testosterone|mesh-list
14580817|NCT00006044|Androgens|androgens|mesh-ancestor
14580818|NCT00006044|Hormones|hormones|mesh-ancestor
14580819|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580820|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580821|NCT00006045|Cytarabine|cytarabine|mesh-list
14580822|NCT00006045|Etoposide|etoposide|mesh-list
14580823|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
14580824|NCT00006045|Lintuzumab|lintuzumab|mesh-list
14580825|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580826|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580827|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580828|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580829|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291665|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021558|NCT02773355|Incretins|incretins|mesh-ancestor
14291666|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
14291667|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291668|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293211|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293212|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293213|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14293214|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
14293215|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293216|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
14580830|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580831|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580832|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
14580833|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
14580834|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580835|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580836|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
14580837|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580838|NCT00006045|Analgesics|analgesics|mesh-ancestor
14580839|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
14580840|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580841|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14580842|NCT00006047|Etoposide|etoposide|mesh-list
14580843|NCT00006047|Rubitecan|rubitecan|mesh-list
14580844|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
14580845|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580846|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580847|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580848|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580849|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580850|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580851|NCT00006048|Gemcitabine|gemcitabine|mesh-list
14580852|NCT00006048|Gefitinib|gefitinib|mesh-list
14580853|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580854|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580855|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
14580856|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580857|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
14580858|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580859|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580860|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580861|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
14580862|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580863|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580864|NCT00006049|Paclitaxel|paclitaxel|mesh-list
14580865|NCT00006049|Carboplatin|carboplatin|mesh-list
14580866|NCT00006049|Gefitinib|gefitinib|mesh-list
14580867|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580868|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580869|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580870|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153812|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153813|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
15153814|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580871|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
14580872|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580873|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580874|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580875|NCT00006050|Leucovorin|leucovorin|mesh-list
14580876|NCT00006050|Fluorouracil|fluorouracil|mesh-list
14580877|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
14580878|NCT00006050|Calcium|calcium|mesh-list
14580879|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
14580880|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14580881|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580882|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
14580883|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580884|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580885|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580886|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580887|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
14580888|NCT00006050|Antidotes|antidotes|mesh-ancestor
14580889|NCT00006050|Protective Agents|protective agents|mesh-ancestor
14580890|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
14580891|NCT00006050|Vitamins|vitamins|mesh-ancestor
14580892|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
14580893|NCT00006051|Fluorouracil|fluorouracil|mesh-list
14580894|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580895|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
14580896|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580897|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580898|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580899|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
14021559|NCT02773355|Hormones|hormones|mesh-ancestor
14580900|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580901|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
15153815|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153816|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153817|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
15153818|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580902|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580903|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580904|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580905|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580906|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
14580907|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580908|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14580909|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580910|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580911|NCT00006054|Cyclosporine|cyclosporine|mesh-list
14580912|NCT00006054|Prednisone|prednisone|mesh-list
15153819|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
15153820|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153821|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153822|NCT04182932|Vaccines|vaccines|mesh-list
15153823|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
15153824|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153825|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
15153826|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15153827|NCT04182737|Antibodies|antibodies|mesh-list
15153828|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
15153829|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153830|NCT04182568|Paclitaxel|paclitaxel|mesh-list
15153831|NCT04182568|Docetaxel|docetaxel|mesh-list
15153832|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
14580913|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
14580914|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
14580915|NCT00006054|Busulfan|busulfan|mesh-list
14580916|NCT00006054|Methotrexate|methotrexate|mesh-list
14580917|NCT00006054|Etoposide|etoposide|mesh-list
14580918|NCT00006054|Cyclosporins|cyclosporins|mesh-list
14580919|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14580920|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580921|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
14580922|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580923|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580924|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580925|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
14580926|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580927|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580928|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580929|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580930|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
14580931|NCT00006054|Hormones|hormones|mesh-ancestor
14580932|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580933|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580934|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14580935|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
14580936|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14580937|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14580938|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
14580939|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
14580940|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580941|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14580942|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14580943|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14580944|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14580945|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14580946|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
14580947|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580948|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14580949|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
14580950|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
14580951|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580952|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580953|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14580954|NCT00006054|Protective Agents|protective agents|mesh-ancestor
14580955|NCT00006055|Cyclosporine|cyclosporine|mesh-list
15153833|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15153834|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153835|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
14580956|NCT00006055|Prednisone|prednisone|mesh-list
14580957|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
14580958|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
15153836|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153837|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153838|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153839|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153840|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
15153841|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153842|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153843|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15153844|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
15153845|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15153846|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15153847|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15153848|NCT04182854|Diuretics|diuretics|mesh-ancestor
15153849|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
15153850|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153851|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15153852|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15153853|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153854|NCT04182724|Paclitaxel|paclitaxel|mesh-list
15153855|NCT04182724|Apatinib|apatinib|mesh-list
14580959|NCT00006055|Cyclosporins|cyclosporins|mesh-list
14580960|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14580961|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153856|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15153857|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153858|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
15153859|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
15153860|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153861|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580962|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
14580963|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580964|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580965|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580966|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
14580967|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14580968|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14580969|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14580970|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14580971|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
14580972|NCT00006055|Hormones|hormones|mesh-ancestor
14580973|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14580974|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14580975|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14580976|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
14580977|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14580978|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
14580979|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14580980|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
14580981|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
14580982|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14580983|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14580984|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14580985|NCT00006055|Protective Agents|protective agents|mesh-ancestor
14580986|NCT00006056|Cyclosporine|cyclosporine|mesh-list
14580987|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
14580988|NCT00006056|Busulfan|busulfan|mesh-list
14580989|NCT00006056|Methotrexate|methotrexate|mesh-list
15153862|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153863|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153864|NCT04182555|Bilirubin|bilirubin|mesh-list
15153865|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
15153866|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153867|NCT04182555|Protective Agents|protective agents|mesh-ancestor
15153868|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153869|NCT04182828|Lidocaine|lidocaine|mesh-list
15153870|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
15153871|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
15153872|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153873|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153874|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
15153875|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153876|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14580990|NCT00006056|Etoposide|etoposide|mesh-list
14580991|NCT00006056|Cyclosporins|cyclosporins|mesh-list
14580992|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14580993|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14580994|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
14580995|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14580996|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14580997|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14580998|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
14580999|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581000|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581001|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14581002|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14581003|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
14581004|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14581005|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581006|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
14581007|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14581008|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581009|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14581010|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581011|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581012|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581013|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581014|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
14581015|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581016|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14581017|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
14581018|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581019|NCT00006063|Pancrelipase|pancrelipase|mesh-list
14581020|NCT00006063|Pancreatin|pancreatin|mesh-list
14581021|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14581022|NCT00006066|Aldesleukin|aldesleukin|mesh-list
14581023|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581024|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581025|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581026|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
14581027|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581028|NCT00006070|Etanercept|etanercept|mesh-list
14581029|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14581030|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14581031|NCT00006070|Analgesics|analgesics|mesh-ancestor
14581032|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
14581033|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581034|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581035|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14581036|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14581037|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14581038|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581039|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
14581040|NCT00006072|Rituximab|rituximab|mesh-list
14291669|NCT00555672|Fluorouracil|fluorouracil|mesh-list
14291670|NCT00555672|Sunitinib|sunitinib|mesh-list
14291671|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291672|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
14291673|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291674|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581041|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14581042|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581043|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
14581044|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581045|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14581046|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
14581047|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14581048|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14581049|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581050|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
14581051|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
14581052|NCT00006077|Levodopa|levodopa|mesh-list
15153877|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14291675|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291676|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
14291677|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291678|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14291679|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14291680|NCT00555672|Growth Substances|growth substances|mesh-ancestor
14291681|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14291682|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15153878|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15153879|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14581053|NCT00006077|Domperidone|domperidone|mesh-list
14581054|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14581055|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14581056|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
14581057|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153880|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153881|NCT04182191|Tenoxicam|tenoxicam|mesh-list
15153882|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14581058|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581059|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581060|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
14581061|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
14581062|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581063|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14581064|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14581065|NCT00006078|Lycopene|lycopene|mesh-list
14581066|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14581067|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
14581068|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581069|NCT00006078|Protective Agents|protective agents|mesh-ancestor
14581070|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581071|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14581072|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14581073|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581074|NCT00006079|Eflornithine|eflornithine|mesh-list
14581075|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581076|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14581077|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15153883|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15153884|NCT04182191|Analgesics|analgesics|mesh-ancestor
15153885|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
15153886|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153887|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153888|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15153889|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153890|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15153891|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153892|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153893|NCT04182399|Zonisamide|zonisamide|mesh-list
15153894|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
15153895|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15153896|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15153897|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153898|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15153899|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180250|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
15180251|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581078|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14581079|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581080|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14581081|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581082|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581083|NCT00006080|Fenretinide|fenretinide|mesh-list
14581084|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180252|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581085|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14581086|NCT00006080|Protective Agents|protective agents|mesh-ancestor
14581087|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581088|NCT00006081|Paclitaxel|paclitaxel|mesh-list
14581089|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
14581090|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180253|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180254|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
15180255|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15180256|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
15180257|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
15180258|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180259|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180260|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14581091|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581092|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
14026052|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
14581093|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581094|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581095|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581096|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14021560|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581097|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
14581098|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581099|NCT00006082|Rubitecan|rubitecan|mesh-list
14581100|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581101|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14581102|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581103|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581104|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581105|NCT00006083|Dalteparin|dalteparin|mesh-list
14581106|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
14581107|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14581108|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14581109|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581110|NCT00006084|Lintuzumab|lintuzumab|mesh-list
14581111|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14581112|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581113|NCT00006086|Carboplatin|carboplatin|mesh-list
14581114|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581115|NCT00006088|Vinorelbine|vinorelbine|mesh-list
14581116|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581117|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581118|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581119|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581120|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581121|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581122|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14581123|NCT00006089|Trastuzumab|trastuzumab|mesh-list
14581124|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14581125|NCT00006089|Antibodies|antibodies|mesh-list
14581126|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
14581127|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14581128|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
14581129|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581130|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581131|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
14581132|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581133|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
14581134|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581135|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
14581136|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581137|NCT00006094|Fluorouracil|fluorouracil|mesh-list
14581138|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
14581139|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
14581140|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581141|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581142|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581143|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581144|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
14581145|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581146|NCT00006095|Irinotecan|irinotecan|mesh-list
14581147|NCT00006095|Vincristine|vincristine|mesh-list
14581148|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14581149|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581150|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581151|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581152|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581153|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581154|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581155|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581156|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581157|NCT00006096|Cisplatin|cisplatin|mesh-list
14581158|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581159|NCT00006098|Bortezomib|bortezomib|mesh-list
14581160|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581161|NCT00006100|Aldesleukin|aldesleukin|mesh-list
14581162|NCT00006100|Fludarabine|fludarabine|mesh-list
14581163|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
14581164|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581165|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581166|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
14581167|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581168|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581169|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
14581170|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581171|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581172|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581173|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
14581174|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581175|NCT00006103|Leucovorin|leucovorin|mesh-list
14581176|NCT00006103|Fluorouracil|fluorouracil|mesh-list
14581177|NCT00006103|Irinotecan|irinotecan|mesh-list
14581178|NCT00006103|Calcium|calcium|mesh-list
14581179|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
14581180|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14581181|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581182|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
14581183|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581184|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581185|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581186|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581187|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
14581188|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14581189|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581190|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581191|NCT00006103|Antidotes|antidotes|mesh-ancestor
14581192|NCT00006103|Protective Agents|protective agents|mesh-ancestor
14581193|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
14581194|NCT00006103|Vitamins|vitamins|mesh-ancestor
14581195|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
14581196|NCT00006104|Docetaxel|docetaxel|mesh-list
14581197|NCT00006104|Trastuzumab|trastuzumab|mesh-list
14581198|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581199|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581200|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581201|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581202|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581203|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14581204|NCT00006105|Gemcitabine|gemcitabine|mesh-list
14581205|NCT00006105|Amifostine|amifostine|mesh-list
14581206|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581207|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581208|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
14581209|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581210|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
14581211|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581212|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581213|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581214|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
14581215|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581216|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15153900|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15153901|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15153902|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153903|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15153904|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15153905|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15153906|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153907|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
14581217|NCT00006105|Protective Agents|protective agents|mesh-ancestor
14581218|NCT00006106|Fluorouracil|fluorouracil|mesh-list
14581219|NCT00006106|Dl1520|dl1520|mesh-list
14581220|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581221|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
14581222|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581223|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153908|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153909|NCT04181645|Gemcitabine|gemcitabine|mesh-list
15153910|NCT04181645|Paclitaxel|paclitaxel|mesh-list
15153911|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581224|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581225|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
15153912|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153913|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581226|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581227|NCT00006107|Docetaxel|docetaxel|mesh-list
14581228|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581229|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
15153914|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581230|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581231|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581232|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581233|NCT00006108|Paclitaxel|paclitaxel|mesh-list
14581234|NCT00006108|Capecitabine|capecitabine|mesh-list
14581235|NCT00006108|Trastuzumab|trastuzumab|mesh-list
14581236|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581237|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581238|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581239|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581240|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581241|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581242|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581243|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
14581244|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14581245|NCT00006111|Fluorouracil|fluorouracil|mesh-list
15153915|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
15153916|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153917|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15153918|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
15153919|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
15153920|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581246|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581247|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
14581248|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581249|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581250|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581251|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
14581252|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581253|NCT00006112|Leucovorin|leucovorin|mesh-list
14581254|NCT00006112|Fluorouracil|fluorouracil|mesh-list
14581255|NCT00006112|Mitomycins|mitomycins|mesh-list
14581256|NCT00006112|Mitomycin|mitomycin|mesh-list
14581257|NCT00006112|Calcium|calcium|mesh-list
14581258|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
14581259|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14581260|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581261|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
14581262|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581263|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581264|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153921|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15153922|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153923|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
15153924|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153925|NCT04181567|S 20098|s 20098|mesh-list
15153926|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15153927|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153928|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153929|NCT04181736|Guanfacine|guanfacine|mesh-list
15153930|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15153931|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15153932|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15153933|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15153934|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
15153935|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153936|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153937|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153938|NCT04181749|Aspirin|aspirin|mesh-list
15153939|NCT04181749|Atorvastatin|atorvastatin|mesh-list
15153940|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15153941|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15153942|NCT04181749|Analgesics|analgesics|mesh-ancestor
15153943|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
15153944|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153945|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153946|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14581265|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581266|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
14581267|NCT00006112|Antidotes|antidotes|mesh-ancestor
14581268|NCT00006112|Protective Agents|protective agents|mesh-ancestor
14581269|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
14581270|NCT00006112|Vitamins|vitamins|mesh-ancestor
14581271|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
14581272|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14581273|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
14581274|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581275|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581276|NCT00006113|Interferons|interferons|mesh-list
14581277|NCT00006113|Aldesleukin|aldesleukin|mesh-list
14581278|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
14581279|NCT00006113|Interleukin-4|interleukin-4|mesh-list
14581280|NCT00006113|Sargramostim|sargramostim|mesh-list
14581281|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581282|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
14581283|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581284|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
15153947|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153948|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15153949|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15153950|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153951|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15153952|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15153953|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581285|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153954|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
15153955|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15153956|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14581286|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581287|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581288|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14581289|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14581290|NCT00006114|Vinorelbine|vinorelbine|mesh-list
14581291|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
14581292|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581293|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581294|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581295|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581296|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581297|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581298|NCT00006114|Analgesics|analgesics|mesh-ancestor
14581299|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
14581300|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581301|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581302|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581303|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581304|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581305|NCT00006115|Leucovorin|leucovorin|mesh-list
14581306|NCT00006115|Fluorouracil|fluorouracil|mesh-list
14581307|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
14581308|NCT00006115|Irinotecan|irinotecan|mesh-list
14581309|NCT00006115|Calcium|calcium|mesh-list
14581310|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
14581311|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14581312|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581313|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
14581314|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581315|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581316|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581317|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581318|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
14581319|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15153957|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
15153958|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15153959|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15153960|NCT04181385|Bromocriptine|bromocriptine|mesh-list
15153961|NCT04181385|Olanzapine|olanzapine|mesh-list
15153962|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
15153963|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
15153964|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15153965|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153966|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15153967|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15153968|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15153969|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15153970|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15153971|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15153972|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15180261|NCT03941990|Analgesics|analgesics|mesh-ancestor
14581320|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581321|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581322|NCT00006115|Antidotes|antidotes|mesh-ancestor
14581323|NCT00006115|Protective Agents|protective agents|mesh-ancestor
14581324|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
14581325|NCT00006115|Vitamins|vitamins|mesh-ancestor
14581326|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
14581327|NCT00006116|Gemcitabine|gemcitabine|mesh-list
14581328|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581329|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581330|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
14581331|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581332|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
14581333|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581334|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581335|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581336|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
14581337|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581338|NCT00006117|Gemcitabine|gemcitabine|mesh-list
14581339|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
14581340|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581341|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
14581342|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581343|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581344|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
14581345|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581346|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581347|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581348|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
14581349|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581350|NCT00006118|Gemcitabine|gemcitabine|mesh-list
14581351|NCT00006118|Paclitaxel|paclitaxel|mesh-list
14581352|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581353|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581354|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581355|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581356|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581357|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581358|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581359|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
14581360|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
14581361|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581362|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581363|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581364|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
14581365|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581366|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
14581367|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581368|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
14581369|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581370|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581371|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581372|NCT00006120|Paclitaxel|paclitaxel|mesh-list
14581373|NCT00006120|Docetaxel|docetaxel|mesh-list
14581374|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581375|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581376|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581377|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581378|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581379|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581380|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
14581381|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581382|NCT00006122|Cytarabine|cytarabine|mesh-list
14581383|NCT00006122|Etoposide|etoposide|mesh-list
14581384|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
14581385|NCT00006122|Idarubicin|idarubicin|mesh-list
14581386|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
14581387|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581388|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581389|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581390|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581391|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581392|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581393|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581394|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
14581395|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
14581396|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581397|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581398|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
14581399|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581400|NCT00006122|Analgesics|analgesics|mesh-ancestor
14581401|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
14581402|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581403|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14581404|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14581405|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
14581406|NCT00006123|Thiotepa|thiotepa|mesh-list
14581407|NCT00006123|Carmustine|carmustine|mesh-list
14581408|NCT00006123|Carboplatin|carboplatin|mesh-list
14581409|NCT00006123|Trastuzumab|trastuzumab|mesh-list
14581410|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581411|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
14581412|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581413|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14581414|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14581415|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
14581416|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581417|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581418|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14581419|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14581420|NCT00006124|Celecoxib|celecoxib|mesh-list
14581421|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14581422|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14581423|NCT00006124|Analgesics|analgesics|mesh-ancestor
14581424|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
14581425|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581426|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581427|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14581428|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14581429|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14581430|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14581431|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581432|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581433|NCT00006125|Doxorubicin|doxorubicin|mesh-list
14581434|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14581435|NCT00006125|Topotecan|topotecan|mesh-list
14581436|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14581437|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581438|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581439|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581440|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581441|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581442|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14581443|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
14581444|NCT00006126|Busulfan|busulfan|mesh-list
14581445|NCT00006126|Fludarabine|fludarabine|mesh-list
14581446|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
14581447|NCT00006126|Etoposide|etoposide|mesh-list
14581448|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581449|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
14581450|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581451|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14581452|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14581453|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
14581454|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581455|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581456|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14581457|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581458|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
14581459|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581460|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581461|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581462|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581463|NCT00006127|Amifostine|amifostine|mesh-list
14581464|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14581465|NCT00006127|Protective Agents|protective agents|mesh-ancestor
14581466|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644214|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644215|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644216|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644217|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644218|NCT00191204|Analgesics|analgesics|mesh-ancestor
14644219|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
14644220|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644221|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
15153973|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14581467|NCT00006129|Testosterone|testosterone|mesh-list
14581468|NCT00006129|Androgens|androgens|mesh-ancestor
14581469|NCT00006129|Hormones|hormones|mesh-ancestor
14581470|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581471|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581472|NCT00006131|Valacyclovir|valacyclovir|mesh-list
14581473|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
14581474|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581475|NCT00006132|Acyclovir|acyclovir|mesh-list
14581476|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
14581477|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581478|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14581479|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14581480|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14581481|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14581482|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
14581483|NCT00006133|Norethindrone|norethindrone|mesh-list
14581484|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
14581485|NCT00006133|Estradiol|estradiol|mesh-list
14581486|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14581487|NCT00006133|Estrogens|estrogens|mesh-ancestor
14581488|NCT00006133|Hormones|hormones|mesh-ancestor
14581489|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581490|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581491|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14581492|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
14581493|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14581494|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14581495|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14581496|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14581497|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14581498|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14581499|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14581500|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581501|NCT00006135|Acyclovir|acyclovir|mesh-list
14581502|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
14581503|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581504|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
14581505|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
14581506|NCT00006136|Hematinics|hematinics|mesh-ancestor
14581507|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581508|NCT00006137|Enalapril|enalapril|mesh-list
14581509|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14581510|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
14581511|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581512|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581513|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14581514|NCT00006144|Ritonavir|ritonavir|mesh-list
14581515|NCT00006144|Lopinavir|lopinavir|mesh-list
14581516|NCT00006144|Emtricitabine|emtricitabine|mesh-list
14581517|NCT00006144|Stavudine|stavudine|mesh-list
14581518|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14581519|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14581520|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
14581521|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581522|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581523|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581524|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581525|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
14581526|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581527|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14581528|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14581529|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14581530|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581531|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
14581532|NCT00006145|Valganciclovir|valganciclovir|mesh-list
14581533|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
14581534|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581535|NCT00006152|Ritonavir|ritonavir|mesh-list
14581536|NCT00006152|Amprenavir|amprenavir|mesh-list
14581537|NCT00006152|Abacavir|abacavir|mesh-list
14581538|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14581539|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14581540|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
14581541|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581542|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581543|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581544|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581545|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
14581546|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581547|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14581548|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14581549|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14581550|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15153974|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153975|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15153976|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
15153977|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15153978|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15153979|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
15153980|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15153981|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
15153982|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
15153983|NCT04181489|Prednisolone|prednisolone|mesh-list
15153984|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
15153985|NCT04181489|Rituximab|rituximab|mesh-list
15153986|NCT04181489|Doxorubicin|doxorubicin|mesh-list
15153987|NCT04181489|Vincristine|vincristine|mesh-list
15153988|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15153989|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
15153990|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15153991|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15153992|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15153993|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
14581551|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14581552|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
14581553|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14581554|NCT00006154|Ritonavir|ritonavir|mesh-list
14581555|NCT00006154|Indinavir|indinavir|mesh-list
14581556|NCT00006154|Aldesleukin|aldesleukin|mesh-list
14581557|NCT00006154|Abacavir|abacavir|mesh-list
14581558|NCT00006154|Stavudine|stavudine|mesh-list
14581559|NCT00006154|Didanosine|didanosine|mesh-list
14581560|NCT00006154|Efavirenz|efavirenz|mesh-list
14581561|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14581562|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14581563|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14581564|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581565|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153994|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15153995|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15153996|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15153997|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15153998|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15153999|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15154000|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15154001|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154002|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15154003|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
15154004|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
15154005|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581566|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581567|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581568|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
14581569|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581570|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14581571|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14581572|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581573|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14581574|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581575|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14581576|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14581577|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14581578|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14581579|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14581580|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
14581581|NCT00006155|Carboplatin|carboplatin|mesh-list
14581582|NCT00006155|Semaxinib|semaxinib|mesh-list
14581583|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581584|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14581585|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14581586|NCT00006155|Growth Substances|growth substances|mesh-ancestor
14581587|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581588|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
14581589|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14581590|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581591|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581592|NCT00006157|Desipramine|desipramine|mesh-list
14581593|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14581594|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
14581595|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14581596|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581597|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581598|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14581599|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14581600|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14581601|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14581602|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14581603|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581604|NCT00006158|Testosterone|testosterone|mesh-list
14581605|NCT00006158|Androgens|androgens|mesh-ancestor
14581606|NCT00006158|Hormones|hormones|mesh-ancestor
14581607|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581608|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581609|NCT00006167|Oxandrolone|oxandrolone|mesh-list
14581610|NCT00006167|Androgens|androgens|mesh-ancestor
14581611|NCT00006167|Hormones|hormones|mesh-ancestor
14581612|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581613|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581614|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
15154006|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15154007|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
15154008|NCT04181489|Hormones|hormones|mesh-ancestor
14581615|NCT00006168|Methotrexate|methotrexate|mesh-list
14581616|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14581617|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
14581618|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14581619|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581620|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581621|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
14581622|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581623|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581624|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14581625|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581626|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14581627|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581628|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
14581629|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14581630|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581631|NCT00006174|Letrozole|letrozole|mesh-list
14581632|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581633|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14581634|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14581635|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581636|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581637|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14581638|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
14581639|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581640|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581641|NCT00006180|Alendronate|alendronate|mesh-list
14581642|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14581643|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581644|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
14581645|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14581646|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581647|NCT00006190|Lamivudine|lamivudine|mesh-list
14581648|NCT00006190|Efavirenz|efavirenz|mesh-list
14581649|NCT00006190|Stavudine|stavudine|mesh-list
14581650|NCT00006190|Nelfinavir|nelfinavir|mesh-list
14581651|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14581652|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581653|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581654|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581655|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
15180262|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
14581656|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581657|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581658|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581659|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14581660|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14581661|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14581662|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14581663|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14581664|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14581665|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
14581666|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14581667|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14581668|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
14581669|NCT00006195|Olanzapine|olanzapine|mesh-list
14581670|NCT00006195|Risperidone|risperidone|mesh-list
14581671|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14581672|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
14581673|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14581674|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581675|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581676|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14581677|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14581678|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14581679|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14581680|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14581681|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
14581682|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
14581683|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
14581684|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581685|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14581686|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14581687|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14581688|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14581689|NCT00006196|Vitamin D|vitamin d|mesh-list
14581690|NCT00006196|Vitamins|vitamins|mesh-ancestor
14581691|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
14581692|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581693|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14581694|NCT00006198|Thalidomide|thalidomide|mesh-list
14581695|NCT00006198|Doxorubicin|doxorubicin|mesh-list
14581696|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14581697|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581698|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581699|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581700|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581701|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581702|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581703|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
14581704|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581705|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
14581706|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14581707|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581708|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14581709|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14581710|NCT00006198|Growth Substances|growth substances|mesh-ancestor
14581711|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
14581712|NCT00006199|Topotecan|topotecan|mesh-list
14581713|NCT00006199|Tipifarnib|tipifarnib|mesh-list
14581714|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14581715|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581716|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581717|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581718|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581719|NCT00006200|Thalidomide|thalidomide|mesh-list
15154009|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154010|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154011|NCT04181346|Pregabalin|pregabalin|mesh-list
15154012|NCT04181346|Analgesics|analgesics|mesh-ancestor
15154013|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
15154014|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154015|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154016|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
15154017|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15154018|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14581720|NCT00006200|Dacarbazine|dacarbazine|mesh-list
14581721|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581722|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
14581723|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581724|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
14581725|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14581726|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581727|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14581728|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14581729|NCT00006200|Growth Substances|growth substances|mesh-ancestor
14581730|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
14581731|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581732|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14581733|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
14581734|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581735|NCT00006203|Naltrexone|naltrexone|mesh-list
14581736|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14581737|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14581738|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581739|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
14581740|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581741|NCT00006204|Naltrexone|naltrexone|mesh-list
14581742|NCT00006204|Fluoxetine|fluoxetine|mesh-list
14581743|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14581744|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14581745|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581746|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
14581747|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581748|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14581749|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14581750|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14581751|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581752|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14581753|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
14581754|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14581755|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
14581756|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14581757|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14581758|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14581759|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581760|NCT00006205|Topiramate|topiramate|mesh-list
14581761|NCT00006205|Ondansetron|ondansetron|mesh-list
14581762|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
14581763|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
14581764|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581765|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581766|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14581767|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
14581768|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
14581769|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14581770|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
14581771|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14581772|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581773|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14581774|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14581775|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14581776|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14581777|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14581778|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
14581779|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15154019|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154020|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15154021|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15154022|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14581780|NCT00006206|Naltrexone|naltrexone|mesh-list
14581781|NCT00006206|Acamprosate|acamprosate|mesh-list
14581782|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14581783|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14581784|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581785|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
14581786|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581787|NCT00006208|Emtricitabine|emtricitabine|mesh-list
14581788|NCT00006208|Efavirenz|efavirenz|mesh-list
14581789|NCT00006208|Stavudine|stavudine|mesh-list
14581790|NCT00006208|Didanosine|didanosine|mesh-list
14581791|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
14581792|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581793|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14581794|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581795|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581796|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581797|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581798|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581799|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14581800|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14581801|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14581802|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14581803|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14581804|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14581805|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
14581806|NCT00006211|Nelfinavir|nelfinavir|mesh-list
14581807|NCT00006211|Capravirine|capravirine|mesh-list
14581808|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14581809|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14581810|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
14581811|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581812|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581813|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581814|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581815|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
14581816|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581817|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14581818|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581819|NCT00006212|Vinblastine|vinblastine|mesh-list
14581820|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581821|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581822|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581823|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581824|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581825|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581826|NCT00006214|Flutamide|flutamide|mesh-list
14581827|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
14581828|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
14581829|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581830|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581831|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14581832|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581833|NCT00006215|Docetaxel|docetaxel|mesh-list
14581834|NCT00006215|Vinorelbine|vinorelbine|mesh-list
14581835|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581836|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581837|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581838|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581839|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581840|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581841|NCT00006216|Ganciclovir|ganciclovir|mesh-list
14581842|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14581843|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
14581844|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581845|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14581846|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581847|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581848|NCT00006219|Clarithromycin|clarithromycin|mesh-list
14581849|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14581850|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14581851|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581852|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14581853|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581854|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581855|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14581856|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14581857|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14581858|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
14581859|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581860|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
14581861|NCT00006220|Tretinoin|tretinoin|mesh-list
14581862|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581863|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
14581864|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
14581865|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
14581866|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14581867|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
14581868|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581869|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14581870|NCT00006223|Protective Agents|protective agents|mesh-ancestor
14581871|NCT00006224|Gemcitabine|gemcitabine|mesh-list
15154023|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154024|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154025|NCT04181203|Leuprolide|leuprolide|mesh-list
15154026|NCT04181203|Goserelin|goserelin|mesh-list
15154027|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15154028|NCT04181203|Hormones|hormones|mesh-list
15154029|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154030|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154031|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15154032|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
14581872|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581873|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
14581874|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581875|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581876|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
14581877|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581878|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581879|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581880|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
14581881|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581882|NCT00006226|Thalidomide|thalidomide|mesh-list
14581883|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581884|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
14581885|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581886|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
14581887|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14581888|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581889|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14581890|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14581891|NCT00006226|Growth Substances|growth substances|mesh-ancestor
14581892|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
14581893|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581894|NCT00006228|Aldesleukin|aldesleukin|mesh-list
14581895|NCT00006228|Trastuzumab|trastuzumab|mesh-list
14581896|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14581897|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581898|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14581899|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14581900|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
14581901|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581902|NCT00006229|Paclitaxel|paclitaxel|mesh-list
14581903|NCT00006229|Carboplatin|carboplatin|mesh-list
14581904|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581905|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581906|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581907|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581908|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581909|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581910|NCT00006230|Rubitecan|rubitecan|mesh-list
14581911|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581912|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14581913|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581914|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581915|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581916|NCT00006232|Dexamethasone|dexamethasone|mesh-list
14581917|NCT00006232|Doxorubicin|doxorubicin|mesh-list
14581918|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14581919|NCT00006232|Vincristine|vincristine|mesh-list
14581920|NCT00006232|Idarubicin|idarubicin|mesh-list
14581921|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14581922|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
14581923|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
14581924|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581925|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581926|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14581927|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
14581928|NCT00006232|Hormones|hormones|mesh-ancestor
14581929|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581930|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154033|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14581931|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581932|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14581933|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581934|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581935|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581936|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581937|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14581938|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
14581939|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
14581940|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
14581941|NCT00006233|Cyclosporine|cyclosporine|mesh-list
14581942|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
14581943|NCT00006233|Fludarabine|fludarabine|mesh-list
14581944|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
14581945|NCT00006233|Cyclosporins|cyclosporins|mesh-list
14581946|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581947|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14581948|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
14581949|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581950|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14581951|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
14581952|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581953|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581954|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
14581955|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14581956|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
14581957|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154034|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154035|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154036|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
15154037|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15154038|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
15154039|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15154040|NCT04180982|Febuxostat|febuxostat|mesh-list
15154041|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
15154042|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154043|NCT04181008|Amiloride|amiloride|mesh-list
15154044|NCT04181008|Diuretics|diuretics|mesh-ancestor
15154045|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
15154046|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154047|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15154048|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15154049|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14581958|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14581959|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14581960|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14581961|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
14581962|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14581963|NCT00006235|Carboplatin|carboplatin|mesh-list
14581964|NCT00006235|Doxorubicin|doxorubicin|mesh-list
14581965|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14581966|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581967|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14581968|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14581969|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14581970|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14581971|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14581972|NCT00006239|Tretinoin|tretinoin|mesh-list
14581973|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14581974|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581975|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
14581976|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14581977|NCT00006240|Dexamethasone|dexamethasone|mesh-list
14581978|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14581979|NCT00006240|Sargramostim|sargramostim|mesh-list
14581980|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14581981|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
14581982|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
14581983|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14581984|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581985|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14581986|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
14581987|NCT00006240|Hormones|hormones|mesh-ancestor
14581988|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14581989|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154050|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154051|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15154052|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15154053|NCT04180657|Protein C|protein c|mesh-list
15154054|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
15154055|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15154056|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15154057|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154058|NCT04180397|Furosemide|furosemide|mesh-list
15154059|NCT04180397|Diuretics|diuretics|mesh-ancestor
15154060|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
15154061|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154062|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15154063|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154064|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154065|NCT04180384|Paclitaxel|paclitaxel|mesh-list
14581990|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14581991|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
14581992|NCT00006241|Lenograstim|lenograstim|mesh-list
14581993|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14581994|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
14581995|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14581996|NCT00006243|Sargramostim|sargramostim|mesh-list
14581997|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
14581998|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
14581999|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582000|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14582001|NCT00006245|Paclitaxel|paclitaxel|mesh-list
14582002|NCT00006245|Alvocidib|alvocidib|mesh-list
14582003|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582004|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582005|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582006|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582007|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582008|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582009|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
15154066|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15154067|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15154068|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154069|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
15154070|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
15154071|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582010|NCT00006245|Growth Substances|growth substances|mesh-ancestor
14582011|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582012|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14582013|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582014|NCT00006246|Busulfan|busulfan|mesh-list
14582015|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
14582016|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582017|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582018|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
14582019|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582020|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582021|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582022|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582023|NCT00006247|Semaxinib|semaxinib|mesh-list
14582024|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14582025|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14582026|NCT00006247|Growth Substances|growth substances|mesh-ancestor
14582027|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582028|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
14582029|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582030|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14582031|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582032|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154072|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154073|NCT04180072|Bevacizumab|bevacizumab|mesh-list
15154074|NCT04180072|Atezolizumab|atezolizumab|mesh-list
15154075|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154076|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154077|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14582033|NCT00006248|Paclitaxel|paclitaxel|mesh-list
14582034|NCT00006248|Fluorouracil|fluorouracil|mesh-list
14582035|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582036|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582037|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582038|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582039|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582040|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582041|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
14582042|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582043|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582044|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
14582045|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582046|NCT00006249|Interferons|interferons|mesh-list
14582047|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
14582048|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582049|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
14582050|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582051|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
14582052|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582053|NCT00006250|Dexamethasone|dexamethasone|mesh-list
14582054|NCT00006250|Fludarabine|fludarabine|mesh-list
14582055|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
14582056|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
14582057|NCT00006250|Chlorambucil|chlorambucil|mesh-list
14582058|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14582059|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
14582060|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
14582061|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582062|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582063|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14582064|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
14582065|NCT00006250|Hormones|hormones|mesh-ancestor
14582066|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582067|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14582068|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582069|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582070|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
14582071|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582072|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582073|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
14582074|NCT00006250|Analgesics|analgesics|mesh-ancestor
14582075|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
14582076|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582077|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15154078|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15154079|NCT04180072|Growth Substances|growth substances|mesh-ancestor
15154080|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154081|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
15154082|NCT04180150|Entecavir|entecavir|mesh-list
14582078|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582079|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582080|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
14582081|NCT00006251|Cyclosporine|cyclosporine|mesh-list
14582082|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
14582083|NCT00006251|Fludarabine|fludarabine|mesh-list
14582084|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
14582085|NCT00006251|Cyclosporins|cyclosporins|mesh-list
14582086|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582087|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582088|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
14582089|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582090|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582091|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
14582092|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582093|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582094|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
14582095|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582096|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
14582097|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582098|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14582099|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14582100|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14582101|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
14582102|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14582103|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
14582104|NCT00006252|Fludarabine|fludarabine|mesh-list
14582105|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
14582106|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582107|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
14582108|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582109|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582110|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582111|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
14582112|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582113|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582114|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582115|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582116|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
14644222|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644223|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
14644224|NCT00191230|Gemcitabine|gemcitabine|mesh-list
14644225|NCT00191230|Carboplatin|carboplatin|mesh-list
14644226|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644227|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644228|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
14644229|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644230|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
14644231|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644232|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644233|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644234|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
14644235|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644236|NCT00191243|Gemcitabine|gemcitabine|mesh-list
14644237|NCT00191243|Docetaxel|docetaxel|mesh-list
14644238|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644239|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
14644240|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644241|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644242|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
14644243|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644244|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644245|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644246|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
14644247|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644248|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644249|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14644250|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644251|NCT00191256|Gemcitabine|gemcitabine|mesh-list
14644252|NCT00191256|Paclitaxel|paclitaxel|mesh-list
14644253|NCT00191256|Carboplatin|carboplatin|mesh-list
14644254|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14644255|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644256|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644257|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14644258|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644259|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644260|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644261|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
14644262|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
14644263|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644264|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644265|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644266|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
14644267|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644268|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644269|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644270|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15154083|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
15154084|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180263|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644271|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644272|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644273|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644274|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644275|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644276|NCT00191321|Teriparatide|teriparatide|mesh-list
14644277|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14644278|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644279|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14644280|NCT00191347|Gemcitabine|gemcitabine|mesh-list
14644281|NCT00191347|Pemetrexed|pemetrexed|mesh-list
14644282|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644283|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
14644284|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180264|NCT03942029|Fluconazole|fluconazole|mesh-list
15180265|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
14582117|NCT00006256|Paclitaxel|paclitaxel|mesh-list
14582118|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582119|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582120|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582121|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582122|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582123|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582124|NCT00006257|Paclitaxel|paclitaxel|mesh-list
14582125|NCT00006257|Semaxinib|semaxinib|mesh-list
14582126|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582127|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582128|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582129|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582130|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582131|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582132|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14582133|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14582134|NCT00006257|Growth Substances|growth substances|mesh-ancestor
14582135|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582136|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
14582137|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14582138|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582139|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
14582140|NCT00006258|Methotrexate|methotrexate|mesh-list
14582141|NCT00006258|Etoposide|etoposide|mesh-list
14582142|NCT00006258|Vincristine|vincristine|mesh-list
15154085|NCT04180007|Apatinib|apatinib|mesh-list
15154086|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154087|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15154088|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154089|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154090|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
15154091|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154092|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
15154093|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15154094|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15154095|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154096|NCT04179747|Urological Agents|urological agents|mesh-ancestor
15154097|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
15154098|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15154099|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
15154100|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154101|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154102|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15154103|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
15154104|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15154105|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
15154106|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154107|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154108|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15154109|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
15154110|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
15154111|NCT04179942|Protective Agents|protective agents|mesh-ancestor
15154112|NCT04179604|Simendan|simendan|mesh-list
15154113|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15154114|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
15154115|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15154116|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15154117|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582143|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582144|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
14582145|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582146|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582147|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582148|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
14582149|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582150|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582151|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582152|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15154118|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154119|NCT04179604|Protective Agents|protective agents|mesh-ancestor
15154120|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582153|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
14582154|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14582155|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582156|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
14582157|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
14582158|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582159|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14582160|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582161|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582162|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582163|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582164|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582165|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582166|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582167|NCT00006260|Etoposide|etoposide|mesh-list
14582168|NCT00006260|Ifosfamide|ifosfamide|mesh-list
14582169|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582170|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582171|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582172|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582173|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582174|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582175|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582176|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
14582177|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
14582178|NCT00006261|Docetaxel|docetaxel|mesh-list
14582179|NCT00006261|Doxorubicin|doxorubicin|mesh-list
14582180|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14582181|NCT00006261|Fludarabine|fludarabine|mesh-list
14582182|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
14582183|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582184|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
14582185|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582186|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582187|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582188|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
14582189|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582190|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582191|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582192|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582193|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582194|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582195|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14582196|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582197|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582198|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582199|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582200|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
14582201|NCT00006263|Carboplatin|carboplatin|mesh-list
14582202|NCT00006263|Temozolomide|temozolomide|mesh-list
14582203|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582204|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582205|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
14582206|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582207|NCT00006264|Zidovudine|zidovudine|mesh-list
14582208|NCT00006264|Aldesleukin|aldesleukin|mesh-list
14582209|NCT00006264|Ganciclovir|ganciclovir|mesh-list
14582210|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14582211|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
14582212|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582213|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582214|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582215|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582216|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
14582217|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154121|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
15154122|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
15154123|NCT04179500|Bedaquiline|bedaquiline|mesh-list
15154124|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15154125|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154126|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15154127|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15154128|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582218|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582219|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15154129|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154130|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582220|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582221|NCT00006265|Cytarabine|cytarabine|mesh-list
14582222|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
14582223|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582224|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
14582225|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582226|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582227|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
14582228|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582229|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582230|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
14582231|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154131|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
15154132|NCT04179513|Methotrexate|methotrexate|mesh-list
15154133|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15154134|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
14582232|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14582233|NCT00006267|Rubitecan|rubitecan|mesh-list
14582234|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582235|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14582236|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582237|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582238|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582239|NCT00006269|Irinotecan|irinotecan|mesh-list
14582240|NCT00006269|Octreotide|octreotide|mesh-list
14582241|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14582242|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582243|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582244|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582245|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582246|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14582247|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14582248|NCT00006270|Cosyntropin|cosyntropin|mesh-list
14582249|NCT00006270|Metyrapone|metyrapone|mesh-list
14582250|NCT00006270|Hormones|hormones|mesh-ancestor
14582251|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582252|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582253|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
14582254|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582255|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582256|NCT00006275|Calcitriol|calcitriol|mesh-list
14582257|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14582258|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582259|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14582260|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14582261|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582262|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14582263|NCT00006275|Vitamins|vitamins|mesh-ancestor
14582264|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
14582265|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14582266|NCT00006276|Paclitaxel|paclitaxel|mesh-list
14582267|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582268|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582269|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582270|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582271|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582272|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582273|NCT00006279|Nevirapine|nevirapine|mesh-list
14582274|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582275|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582276|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582277|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582278|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
14582279|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582280|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582281|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582282|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14582283|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14582284|NCT00006280|Tobramycin|tobramycin|mesh-list
14582285|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14582286|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582287|NCT00006286|Fluoxetine|fluoxetine|mesh-list
14582288|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15154135|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14582289|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15154136|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154137|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15154138|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
14582290|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14582291|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582292|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582293|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
14582294|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582295|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14582296|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
14582297|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14582298|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14582299|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14582300|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582301|NCT00006291|Aldesleukin|aldesleukin|mesh-list
14582302|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582303|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582304|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582305|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
14582306|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582307|NCT00006292|Infliximab|infliximab|mesh-list
14582308|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
14582309|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14582310|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582311|NCT00006294|Amlodipine|amlodipine|mesh-list
14582312|NCT00006294|Lisinopril|lisinopril|mesh-list
14582313|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
14582314|NCT00006294|Doxazosin|doxazosin|mesh-list
14582315|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14582316|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14582317|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14582318|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582319|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14582320|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154139|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154140|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154141|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
14582321|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
14582322|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14582323|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
14582324|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582325|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14582326|NCT00006294|Protective Agents|protective agents|mesh-ancestor
14582327|NCT00006294|Diuretics|diuretics|mesh-ancestor
14582328|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
14582329|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14582330|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14582331|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14582332|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15154142|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154143|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15154144|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154145|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
15154146|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154147|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15154148|NCT04179617|Nicotine|nicotine|mesh-list
15154149|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15154150|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
15154151|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154152|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154153|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15154154|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15154155|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
15154156|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154157|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154158|NCT04179071|Famotidine|famotidine|mesh-list
15154159|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15154160|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15154161|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15154162|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
15154163|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
15154164|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582333|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
14582334|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582335|NCT00006299|Celecoxib|celecoxib|mesh-list
14582336|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14582337|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14582338|NCT00006299|Analgesics|analgesics|mesh-ancestor
14582339|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
14582340|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582341|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582342|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14582343|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582344|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14582345|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14582346|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582347|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582348|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
14582349|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582350|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
14582351|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582352|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14582353|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
14582354|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14582355|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
14582356|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14582357|NCT00006324|Estradiol|estradiol|mesh-list
14582358|NCT00006324|Estrogens|estrogens|mesh-ancestor
14582359|NCT00006324|Hormones|hormones|mesh-ancestor
14582360|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582361|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582362|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14582363|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
14582364|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14582365|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14582366|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14582367|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14582368|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14582369|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14582370|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14582371|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582372|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14582373|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14582374|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
14582375|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582376|NCT00006326|Ritonavir|ritonavir|mesh-list
14582377|NCT00006326|Indinavir|indinavir|mesh-list
14582378|NCT00006326|Delavirdine|delavirdine|mesh-list
14582379|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14582380|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14582381|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
14582382|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582383|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582384|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582385|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582386|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
14582387|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582388|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14582389|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14582390|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582391|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582392|NCT00006330|Digoxin|digoxin|mesh-list
14582393|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14582394|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14582395|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582396|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582397|NCT00006330|Protective Agents|protective agents|mesh-ancestor
14582398|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582399|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14582400|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
14582401|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
14582402|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582403|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582404|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14582405|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14582406|NCT00006332|Growth Substances|growth substances|mesh-ancestor
14582407|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582408|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
15154165|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154166|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154167|NCT04178863|Timolol|timolol|mesh-list
14582409|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582410|NCT00006337|Levodopa|levodopa|mesh-list
14582411|NCT00006337|Istradefylline|istradefylline|mesh-list
14582412|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14582413|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14582414|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
14582415|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582416|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154168|NCT04178863|Latanoprost|latanoprost|mesh-list
15154169|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15154170|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15154171|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
15154172|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154173|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154174|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154175|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15154176|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15154177|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15154178|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15154179|NCT04179045|Sirolimus|sirolimus|mesh-list
15154180|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15154181|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154182|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15154183|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154184|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
15154185|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154186|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
15154187|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154188|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
15154189|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154190|NCT04178980|Simvastatin|simvastatin|mesh-list
15154191|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15154192|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15154193|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
15154194|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154195|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15154196|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15154197|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154198|NCT04178850|Folic Acid|folic acid|mesh-list
15154199|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
15154200|NCT04178850|Infliximab|infliximab|mesh-list
15154201|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
15154202|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15154203|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154204|NCT04178850|Hematinics|hematinics|mesh-ancestor
15154205|NCT04178850|Vitamins|vitamins|mesh-ancestor
15154206|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
14582417|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582418|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14582419|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14582420|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14582421|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
14582422|NCT00006339|Ritonavir|ritonavir|mesh-list
14582423|NCT00006339|Indinavir|indinavir|mesh-list
14582424|NCT00006339|Stavudine|stavudine|mesh-list
14582425|NCT00006339|Didanosine|didanosine|mesh-list
14582426|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
14582427|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14582428|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14582429|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
14582430|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582431|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582432|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582433|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582434|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
14582435|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582436|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14582437|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14582438|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582439|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
14582440|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15154207|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154208|NCT04178876|Ethanol|ethanol|mesh-list
15154209|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14582441|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
14582442|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582443|NCT00006340|Ganciclovir|ganciclovir|mesh-list
14582444|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14582445|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
14582446|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
14582447|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582448|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582449|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582450|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582451|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582452|NCT00006343|Interferons|interferons|mesh-list
14582453|NCT00006343|Cytarabine|cytarabine|mesh-list
14582454|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
14582455|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
14582456|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582457|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
14582458|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582459|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582460|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
14582461|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582462|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582463|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
14582464|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582465|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14582466|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582467|NCT00006345|Dexamethasone|dexamethasone|mesh-list
14582468|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
14582469|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14582470|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
14582471|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
14582472|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582473|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154210|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154211|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154212|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154213|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
15154214|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15154215|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15154216|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154217|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
15154218|NCT04178655|Coagulants|coagulants|mesh-ancestor
15154219|NCT04178785|Remifentanil|remifentanil|mesh-list
15154220|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14582474|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14582475|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
14582476|NCT00006345|Hormones|hormones|mesh-ancestor
14582477|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582478|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154221|NCT04178785|Narcotics|narcotics|mesh-ancestor
15154222|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154223|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154224|NCT04178785|Analgesics|analgesics|mesh-ancestor
15154225|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
15154226|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154227|NCT04178642|Idarubicin|idarubicin|mesh-list
15154228|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
15154229|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15154230|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154231|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582479|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582480|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14582481|NCT00006347|Antibodies|antibodies|mesh-list
14582482|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
14582483|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14582484|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
14582485|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154232|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15154233|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154234|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154235|NCT04178291|Erythritol|erythritol|mesh-list
15154236|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
14582486|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582487|NCT00006348|Ondansetron|ondansetron|mesh-list
14582488|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
14582489|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
15154237|NCT04178512|Dexamethasone|dexamethasone|mesh-list
14582490|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582491|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582492|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14582493|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
14582494|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
14582495|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14582496|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
15154238|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
15154239|NCT04178512|Fentanyl|fentanyl|mesh-list
15154240|NCT04178512|BB 1101|bb 1101|mesh-list
14582497|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582498|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582499|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14582500|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14582501|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14582502|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14582503|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14582504|NCT00006349|Vitamin E|vitamin e|mesh-list
14582505|NCT00006349|Donepezil|donepezil|mesh-list
14582506|NCT00006349|Vitamins|vitamins|mesh-ancestor
14582507|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
14582508|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582509|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14582510|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582511|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582512|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
14582513|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582514|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
14582515|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
14582516|NCT00006349|Protective Agents|protective agents|mesh-ancestor
14582517|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
14582518|NCT00006350|Tacrolimus|tacrolimus|mesh-list
14582519|NCT00006350|Daclizumab|daclizumab|mesh-list
15154241|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15154242|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
15154243|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
15154244|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154245|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154246|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15154247|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
15154248|NCT04178512|Hormones|hormones|mesh-ancestor
15154249|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154250|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154251|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154252|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
14582520|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582521|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
14582522|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582523|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14582524|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582525|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582526|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14582527|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582528|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14582529|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
14582530|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14582531|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154253|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154254|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154255|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15154256|NCT04178512|Narcotics|narcotics|mesh-ancestor
15154257|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154258|NCT04178512|Analgesics|analgesics|mesh-ancestor
15154259|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
15154260|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15154261|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15154262|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
15154263|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
15154264|NCT04178148|Amikacin|amikacin|mesh-list
15154265|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15154266|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154267|NCT04178200|Lidocaine|lidocaine|mesh-list
14582532|NCT00006351|Gemcitabine|gemcitabine|mesh-list
14582533|NCT00006351|Lonafarnib|lonafarnib|mesh-list
15154268|NCT04178200|Bupivacaine|bupivacaine|mesh-list
15154269|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15154270|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
15154271|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
14582534|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582535|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
14582536|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582537|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582538|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
14582539|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582540|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582541|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582542|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
14582543|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582544|NCT00006352|Antibodies|antibodies|mesh-list
14582545|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14582546|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
14582547|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
14582548|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582549|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14582550|NCT00006353|Temozolomide|temozolomide|mesh-list
14582551|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582552|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
14582553|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582554|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582555|NCT00006355|NSC 366140|nsc 366140|mesh-list
14582556|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582557|NCT00006356|Carboplatin|carboplatin|mesh-list
14582558|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154272|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154273|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154274|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
15154275|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154276|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15154277|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15154278|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15154279|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154280|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180266|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180267|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15180268|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15180269|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180270|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180271|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15180272|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
15180273|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180274|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180275|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14582559|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
14582560|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582561|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14582562|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582563|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582564|NCT00006358|Thalidomide|thalidomide|mesh-list
14582565|NCT00006358|Temozolomide|temozolomide|mesh-list
14582566|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582567|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
14582568|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582569|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582570|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582571|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
14582572|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582573|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
14582574|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14582575|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582576|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14582577|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14582578|NCT00006358|Growth Substances|growth substances|mesh-ancestor
14582579|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
14582580|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
14582581|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
14582582|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582583|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582584|NCT00006361|Semaxinib|semaxinib|mesh-list
14582585|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14814024|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
14582586|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14582587|NCT00006361|Growth Substances|growth substances|mesh-ancestor
14582588|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582589|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
15154281|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15154282|NCT04178057|Antibodies|antibodies|mesh-list
15154283|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
14582590|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582591|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14582592|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582593|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582594|NCT00006362|Bortezomib|bortezomib|mesh-list
14582595|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582596|NCT00006363|Cytarabine|cytarabine|mesh-list
14582597|NCT00006363|Aldesleukin|aldesleukin|mesh-list
14582598|NCT00006363|Etoposide|etoposide|mesh-list
14582599|NCT00006363|Daunorubicin|daunorubicin|mesh-list
14582600|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
14582601|NCT00006363|Busulfan|busulfan|mesh-list
14582602|NCT00006363|Interleukin-2|interleukin-2|mesh-list
14582603|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582604|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582605|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582606|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582607|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582608|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582609|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582610|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
14582611|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
14582612|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582613|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582614|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
14582615|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582616|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
14582617|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582618|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582619|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14582620|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14582621|NCT00006363|Analgesics|analgesics|mesh-ancestor
14582622|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
14582623|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582624|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582625|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582626|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
14582627|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582628|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582629|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14582630|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582631|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582632|NCT00006366|Fluorouracil|fluorouracil|mesh-list
14582633|NCT00006366|Irinotecan|irinotecan|mesh-list
14582634|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
14582635|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582636|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582637|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582638|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582639|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
14582640|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582641|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14582642|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582643|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582644|NCT00006367|Cytarabine|cytarabine|mesh-list
14582645|NCT00006367|Busulfan|busulfan|mesh-list
14582646|NCT00006367|Idarubicin|idarubicin|mesh-list
14582647|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582648|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
14582649|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582650|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582651|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
14582652|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154284|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15154285|NCT04178057|Mitogens|mitogens|mesh-list
15154286|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
15154287|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
15154288|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582653|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582654|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
14582655|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582656|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
14582657|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582658|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582659|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14582660|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582661|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582662|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582663|NCT00006368|Edotreotide|edotreotide|mesh-list
14582664|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14582665|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644285|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644286|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
14644287|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644288|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644289|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644290|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
14644291|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644292|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14644293|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644294|NCT00191373|Gemcitabine|gemcitabine|mesh-list
14644295|NCT00191373|Trastuzumab|trastuzumab|mesh-list
14644296|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644297|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
14644298|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644299|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644300|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
14644301|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644302|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644303|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644304|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
15154289|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154290|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
15154291|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154292|NCT04178057|Growth Substances|growth substances|mesh-ancestor
15154293|NCT04177875|Paclitaxel|paclitaxel|mesh-list
15154294|NCT04177875|Docetaxel|docetaxel|mesh-list
15154295|NCT04177875|Cisplatin|cisplatin|mesh-list
14644305|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644306|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14644307|NCT00191399|Olanzapine|olanzapine|mesh-list
14644308|NCT00191399|Fluoxetine|fluoxetine|mesh-list
14644309|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
14644310|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
14644311|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644312|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644313|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14644314|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14644315|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14644316|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14644317|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644318|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14644319|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644320|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154296|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15154297|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15154298|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154299|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
15154300|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
15154301|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644321|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644322|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644323|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
14644324|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14644325|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644326|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14644327|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14644328|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647437|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647438|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647439|NCT00199784|Protective Agents|protective agents|mesh-ancestor
14647440|NCT00199940|Ziprasidone|ziprasidone|mesh-list
15154302|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582666|NCT00006370|Edotreotide|edotreotide|mesh-list
14582667|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14582668|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582669|NCT00006371|Ketoconazole|ketoconazole|mesh-list
14582670|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
14582671|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14582672|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14582673|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14582674|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
14582675|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14582676|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
14582677|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582678|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14582679|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14582680|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582681|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582682|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14582683|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
14582684|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582685|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582686|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15154303|NCT04177641|Antioxidants|antioxidants|mesh-list
15154304|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154305|NCT04177641|Protective Agents|protective agents|mesh-ancestor
15154306|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582687|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14582688|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582689|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14582690|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14582691|NCT00006372|Gemcitabine|gemcitabine|mesh-list
14582692|NCT00006372|Doxorubicin|doxorubicin|mesh-list
14582693|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14582694|NCT00006372|Vinorelbine|vinorelbine|mesh-list
14582695|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582696|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
14582697|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582698|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582699|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
14582700|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582701|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582702|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582703|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
14582704|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582705|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14582706|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582707|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582708|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582709|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582710|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582711|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582712|NCT00006373|Etoposide|etoposide|mesh-list
14582713|NCT00006373|Topotecan|topotecan|mesh-list
14582714|NCT00006373|Ifosfamide|ifosfamide|mesh-list
14582715|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582716|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582717|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582718|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582719|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582720|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582721|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14582722|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582723|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
14582724|NCT00006374|Paclitaxel|paclitaxel|mesh-list
14582725|NCT00006374|Etoposide|etoposide|mesh-list
14582726|NCT00006374|Topotecan|topotecan|mesh-list
14582727|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582728|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582729|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582730|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582731|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582732|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582733|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582734|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582735|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154307|NCT04178109|Acetaminophen|acetaminophen|mesh-list
14582736|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14582737|NCT00006376|Tipifarnib|tipifarnib|mesh-list
14582738|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582739|NCT00006377|Paclitaxel|paclitaxel|mesh-list
14582740|NCT00006377|Carboplatin|carboplatin|mesh-list
14582741|NCT00006377|Doxorubicin|doxorubicin|mesh-list
14582742|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14582743|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582744|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582745|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582746|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582747|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582748|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582749|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14582750|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14582751|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582752|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582753|NCT00006378|Paclitaxel|paclitaxel|mesh-list
14582754|NCT00006378|Carboplatin|carboplatin|mesh-list
14582755|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582756|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582757|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582758|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14582759|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582760|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582761|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
14582762|NCT00006379|Fludarabine|fludarabine|mesh-list
14582763|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
14582764|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14582765|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582766|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
14582767|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582768|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582769|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582770|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
14582771|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582772|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582773|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582774|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14582775|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
14582776|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14582777|NCT00006380|Antibodies|antibodies|mesh-list
14582778|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
14582779|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14582780|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
14582781|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582782|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582783|NCT00006381|Celecoxib|celecoxib|mesh-list
14582784|NCT00006381|Trastuzumab|trastuzumab|mesh-list
14582785|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14582786|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582787|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14582788|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14582789|NCT00006381|Analgesics|analgesics|mesh-ancestor
14582790|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
14582791|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582792|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582793|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14582794|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582795|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14582796|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14582797|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582798|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582799|NCT00006383|Vincristine|vincristine|mesh-list
14582800|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14582801|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582802|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
14582803|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
15154308|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15154309|NCT04178109|Tramadol|tramadol|mesh-list
14582804|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
14582805|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582806|NCT00006384|Interferons|interferons|mesh-list
14582807|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
14582808|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582809|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
14582810|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582811|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
14582812|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582813|NCT00006385|Interferons|interferons|mesh-list
14582814|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
14582815|NCT00006385|Sargramostim|sargramostim|mesh-list
14582816|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
14582817|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582818|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
14582819|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582820|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
14582821|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582822|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14582823|NCT00006386|Carmustine|carmustine|mesh-list
14582824|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582825|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
14582826|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582827|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582828|NCT00006388|Tamoxifen|tamoxifen|mesh-list
14582829|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14582830|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
14582831|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582832|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582833|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14582834|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582835|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14582836|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14582837|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14582838|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
14582839|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
14582840|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14582841|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
14582842|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582843|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14582844|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14582845|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
14582846|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582847|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582848|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14582849|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14582850|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
14582851|NCT00006391|Topotecan|topotecan|mesh-list
14582852|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582853|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14582854|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14582855|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582856|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582857|NCT00006394|Hormones|hormones|mesh-list
14582858|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582859|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582860|NCT00006396|Zidovudine|zidovudine|mesh-list
14582861|NCT00006396|Nevirapine|nevirapine|mesh-list
14582862|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
14582863|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582864|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582865|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582866|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582867|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
14582868|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582869|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582870|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582871|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14582872|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14582873|NCT00006397|Ritonavir|ritonavir|mesh-list
14582874|NCT00006397|Indinavir|indinavir|mesh-list
14582875|NCT00006397|Stavudine|stavudine|mesh-list
14582876|NCT00006397|Didanosine|didanosine|mesh-list
14582877|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14582878|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14582879|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14582880|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582881|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582882|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582883|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582884|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
14582885|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582886|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14582887|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14582888|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
14582889|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582890|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582891|NCT00006398|Timolol|timolol|mesh-list
14582892|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14582893|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14582894|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
14582895|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582896|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582897|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582898|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14582899|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14582900|NCT00006399|Donepezil|donepezil|mesh-list
14582901|NCT00006399|Progesterone|progesterone|mesh-list
14582902|NCT00006399|Estrogens|estrogens|mesh-list
14582903|NCT00006399|Progestins|progestins|mesh-ancestor
14582904|NCT00006399|Hormones|hormones|mesh-ancestor
14582905|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14582906|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582907|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14582908|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582909|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582910|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
14582911|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582912|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
14582913|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
14582914|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14582915|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
14582916|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582917|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582918|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14582919|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
14582920|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14582921|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
14582922|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582923|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582924|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14582925|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
14582926|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
14582927|NCT00006401|Protective Agents|protective agents|mesh-ancestor
14582928|NCT00006412|Fenofibrate|fenofibrate|mesh-list
14582929|NCT00006412|Pravastatin|pravastatin|mesh-list
14582930|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14582931|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
14582932|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582933|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14582934|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14582935|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14582936|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582937|NCT00006427|Amitriptyline|amitriptyline|mesh-list
14582938|NCT00006427|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14582939|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14582940|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
14582941|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154310|NCT04178109|Ropivacaine|ropivacaine|mesh-list
15154311|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
15154312|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
15154313|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
14582942|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14582943|NCT00006427|Analgesics|analgesics|mesh-ancestor
14582944|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
14582945|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582946|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14582947|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14582948|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14582949|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14582950|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582951|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
14582952|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582953|NCT00006427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14582954|NCT00006427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14582955|NCT00006427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14582956|NCT00006428|Amitriptyline|amitriptyline|mesh-list
14582957|NCT00006428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14582958|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14582959|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
14582960|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14582961|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14582962|NCT00006428|Analgesics|analgesics|mesh-ancestor
14582963|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
14582964|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14582965|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154314|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154315|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154316|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
15154317|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154318|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15154319|NCT04178109|Analgesics|analgesics|mesh-ancestor
15154320|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
15154321|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15154322|NCT04178109|Narcotics|narcotics|mesh-ancestor
15154323|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15154324|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15154325|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154326|NCT04177719|Oxytocin|oxytocin|mesh-list
15154327|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
15154328|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15154329|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154330|NCT04177602|Trifluridine|trifluridine|mesh-list
15154331|NCT04177602|Capecitabine|capecitabine|mesh-list
15154332|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15154333|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
14582966|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14582967|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14582968|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14582969|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582970|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
14582971|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14582972|NCT00006428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14582973|NCT00006428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14582974|NCT00006428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14582975|NCT00006441|Lamivudine|lamivudine|mesh-list
14582976|NCT00006441|Zidovudine|zidovudine|mesh-list
14582977|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14582978|NCT00006441|Aldesleukin|aldesleukin|mesh-list
14582979|NCT00006441|Nelfinavir|nelfinavir|mesh-list
14582980|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582981|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582982|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14582983|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14582984|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
14582985|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14582986|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14582987|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14582988|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
14582989|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14582990|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14582991|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14582992|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
14582993|NCT00006443|Lamivudine|lamivudine|mesh-list
14582994|NCT00006443|Stavudine|stavudine|mesh-list
14582995|NCT00006443|Nelfinavir|nelfinavir|mesh-list
14582996|NCT00006443|Indinavir|indinavir|mesh-list
14582997|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14582998|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14582999|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583000|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583001|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
14583002|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583003|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583004|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583005|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
14583006|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14583007|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15180276|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14583008|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
14583009|NCT00006448|Methadone|methadone|mesh-list
14583010|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14583011|NCT00006448|Narcotics|narcotics|mesh-ancestor
14583012|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14583013|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583014|NCT00006448|Analgesics|analgesics|mesh-ancestor
14583015|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
14583016|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583017|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
14583018|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
14583019|NCT00006449|Naltrexone|naltrexone|mesh-list
14583020|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14583021|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14583022|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583023|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
14583024|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583025|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14583026|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583027|NCT00006451|Cyclosporine|cyclosporine|mesh-list
14583028|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
14583029|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
14583030|NCT00006451|Methotrexate|methotrexate|mesh-list
14583031|NCT00006451|Cyclosporins|cyclosporins|mesh-list
14583032|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14583033|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583034|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
14583035|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583036|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583037|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583038|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
14583039|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583040|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583041|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14583042|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14583043|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
14583044|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14583045|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15154334|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154335|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154336|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
15154337|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154338|NCT04177498|ON 01910|on 01910|mesh-list
14583046|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
14583047|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
14583048|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583049|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14583050|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583051|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
14583052|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583053|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14583054|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583055|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
15154339|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154340|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15154341|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154342|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583056|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
14583057|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583058|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14583059|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
14583060|NCT00006451|Hormones|hormones|mesh-ancestor
14583061|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14583062|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14583063|NCT00006451|Protective Agents|protective agents|mesh-ancestor
14583064|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
14583065|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583066|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14583067|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
14583068|NCT00006453|Gemcitabine|gemcitabine|mesh-list
14583069|NCT00006453|Carboplatin|carboplatin|mesh-list
14583070|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154343|NCT04177342|Fentanyl|fentanyl|mesh-list
14583071|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15154344|NCT04177342|Oxycodone|oxycodone|mesh-list
14583072|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
14644329|NCT00191412|Pemetrexed|pemetrexed|mesh-list
14583073|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583074|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
14583075|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583076|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583077|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583078|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
14583079|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583080|NCT00006454|Paclitaxel|paclitaxel|mesh-list
14583081|NCT00006454|Carboplatin|carboplatin|mesh-list
14583082|NCT00006454|Topotecan|topotecan|mesh-list
14583083|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583084|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583085|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583086|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583087|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583088|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583089|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14583090|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583091|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583092|NCT00006455|Leucovorin|leucovorin|mesh-list
14583093|NCT00006455|Cytarabine|cytarabine|mesh-list
14583094|NCT00006455|Dexamethasone|dexamethasone|mesh-list
14583095|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
14583096|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14583097|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14583098|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14583099|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
14583100|NCT00006455|Ifosfamide|ifosfamide|mesh-list
14583101|NCT00006455|Doxorubicin|doxorubicin|mesh-list
14583102|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14583103|NCT00006455|Methotrexate|methotrexate|mesh-list
14583104|NCT00006455|Etoposide|etoposide|mesh-list
14583105|NCT00006455|Vinblastine|vinblastine|mesh-list
14583106|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
14583107|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583108|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
14583109|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583110|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583111|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583112|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
14583113|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583114|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583115|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14583116|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583117|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
14583118|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
14583119|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583120|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14583121|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
14583122|NCT00006455|Hormones|hormones|mesh-ancestor
14583123|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14583124|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154345|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15154346|NCT04177342|Narcotics|narcotics|mesh-ancestor
14583125|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14583126|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583127|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583128|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583129|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14583130|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
14583131|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14583132|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583133|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
14583134|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
14583135|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14583136|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583137|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583138|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
14583139|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583140|NCT00006455|Antidotes|antidotes|mesh-ancestor
14583141|NCT00006455|Protective Agents|protective agents|mesh-ancestor
14583142|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
14583143|NCT00006455|Vitamins|vitamins|mesh-ancestor
14583144|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
14583145|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583146|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583147|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583148|NCT00006457|Oltipraz|oltipraz|mesh-list
15154347|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154348|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583149|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
14583150|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583151|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
14583152|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14583153|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
14583154|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14583155|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14583156|NCT00006457|Protective Agents|protective agents|mesh-ancestor
14583157|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583158|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583159|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14583160|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583161|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583162|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583163|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14583164|NCT00006458|Antibodies|antibodies|mesh-list
14583165|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
14583166|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14583167|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
14583168|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583169|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583170|NCT00006459|Gemcitabine|gemcitabine|mesh-list
14583171|NCT00006459|Paclitaxel|paclitaxel|mesh-list
14583172|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583173|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583174|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583175|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583176|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583177|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583178|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583179|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
14583180|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
14583181|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583182|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583183|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583184|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
14583185|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583186|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
14583187|NCT00006461|Etoposide|etoposide|mesh-list
14583188|NCT00006461|Vincristine|vincristine|mesh-list
14583189|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
14583190|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583191|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
14583192|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583193|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583194|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583195|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
14583196|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583197|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583198|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14583199|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583200|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583201|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583202|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583203|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583204|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583205|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583206|NCT00006462|Gemcitabine|gemcitabine|mesh-list
14583207|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583208|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
14583209|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583210|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583211|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
15154349|NCT04177342|Analgesics|analgesics|mesh-ancestor
15154350|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
15154351|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154352|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15154353|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15154354|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
15154355|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
15154356|NCT04177173|Methotrexate|methotrexate|mesh-list
15154357|NCT04177173|Simvastatin|simvastatin|mesh-list
14583212|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180277|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
14583213|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583214|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583215|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
14583216|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583217|NCT00006463|Trabectedin|trabectedin|mesh-list
14583218|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583219|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
14583220|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583221|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583222|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14583223|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583224|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14583225|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583226|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583227|NCT00006465|Capecitabine|capecitabine|mesh-list
14583228|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
14583229|NCT00006465|Irinotecan|irinotecan|mesh-list
14583230|NCT00006465|Camptothecin|camptothecin|mesh-list
14583231|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583232|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
14583233|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583234|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583235|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14583236|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583237|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583238|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583239|NCT00006467|Gemcitabine|gemcitabine|mesh-list
14583240|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583241|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
14583242|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583243|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583244|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
14583245|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583246|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583247|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583248|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
14583249|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583250|NCT00006468|Leucovorin|leucovorin|mesh-list
14583251|NCT00006468|Fluorouracil|fluorouracil|mesh-list
14583252|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
14583253|NCT00006468|Calcium|calcium|mesh-list
14583254|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
14583255|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14583256|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583257|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
14583258|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583259|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583260|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583261|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583262|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
14583263|NCT00006468|Antidotes|antidotes|mesh-ancestor
14583264|NCT00006468|Protective Agents|protective agents|mesh-ancestor
14583265|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
14583266|NCT00006468|Vitamins|vitamins|mesh-ancestor
14583267|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
14583268|NCT00006469|Paclitaxel|paclitaxel|mesh-list
14583269|NCT00006469|Carboplatin|carboplatin|mesh-list
14583270|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583271|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583272|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583273|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583274|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583275|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583276|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14583277|NCT00006470|Vaccines|vaccines|mesh-list
14583278|NCT00006470|Antibodies|antibodies|mesh-list
14583279|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
14583280|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14583281|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14583282|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
14583283|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583284|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583285|NCT00006471|Fenretinide|fenretinide|mesh-list
14583286|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583287|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14583288|NCT00006471|Protective Agents|protective agents|mesh-ancestor
15180278|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
15154358|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15154359|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
14583289|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583290|NCT00006472|Paclitaxel|paclitaxel|mesh-list
14583291|NCT00006472|Carboplatin|carboplatin|mesh-list
14583292|NCT00006472|Fluorouracil|fluorouracil|mesh-list
14583293|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583294|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583295|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583296|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583297|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583298|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583299|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
14583300|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583301|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583302|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
14583303|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583304|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
14583305|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583306|NCT00006474|Temozolomide|temozolomide|mesh-list
14583307|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14583308|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583309|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
14583310|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583311|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583312|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583313|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
14583314|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583315|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14583316|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583317|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583318|NCT00006476|Suramin|suramin|mesh-list
14583319|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
14583320|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
15154360|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15154361|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154362|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15154363|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
15154364|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154365|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154366|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
15154367|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154368|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15154369|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154370|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
15154371|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154372|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583321|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14583322|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583323|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583324|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14583325|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14583326|NCT00006479|Leucovorin|leucovorin|mesh-list
14583327|NCT00006479|Fluorouracil|fluorouracil|mesh-list
14583328|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
14583329|NCT00006479|Calcium|calcium|mesh-list
14583330|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
14583331|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14583332|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583333|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
14583334|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583335|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583336|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583337|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583338|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
14583339|NCT00006479|Antidotes|antidotes|mesh-ancestor
14583340|NCT00006479|Protective Agents|protective agents|mesh-ancestor
14583341|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
14583342|NCT00006479|Vitamins|vitamins|mesh-ancestor
14583343|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
14583344|NCT00006480|Aldesleukin|aldesleukin|mesh-list
15154373|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15154374|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14583345|NCT00006480|Ganciclovir|ganciclovir|mesh-list
14583346|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14583347|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583348|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583349|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583350|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
14583351|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583352|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583353|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583354|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644330|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644331|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644332|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644333|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14644334|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644335|NCT00191425|Teriparatide|teriparatide|mesh-list
14644336|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14644337|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14644338|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644339|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14644340|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14644341|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
14644342|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14644343|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14644344|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14644345|NCT00191438|Gemcitabine|gemcitabine|mesh-list
14644346|NCT00191438|Capecitabine|capecitabine|mesh-list
14644347|NCT00191438|Docetaxel|docetaxel|mesh-list
14644348|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644349|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
14644350|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644351|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644352|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
14644353|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644354|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154375|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15154376|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15154377|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
15154378|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15154379|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15154380|NCT04177433|Prednisolone|prednisolone|mesh-list
15154381|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
15154382|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15154383|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
15154384|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15154385|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
15154386|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
14644355|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644356|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
14644357|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644358|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644359|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
14644360|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644361|NCT00191464|Insulin|insulin|mesh-list
14644362|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14644363|NCT00191464|Metformin|metformin|mesh-list
14644364|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
14644365|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
14644366|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14644367|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644368|NCT00191490|Gemcitabine|gemcitabine|mesh-list
14644369|NCT00191490|Docetaxel|docetaxel|mesh-list
14644370|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644371|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644372|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
14644373|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644374|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
14644375|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644376|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644377|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644378|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
14644379|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644380|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644381|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
15154387|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644382|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644383|NCT00191503|Gemcitabine|gemcitabine|mesh-list
14644384|NCT00191503|Pemetrexed|pemetrexed|mesh-list
14644385|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583355|NCT00006482|Gemcitabine|gemcitabine|mesh-list
14583356|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583357|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583358|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
14583359|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583360|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
14583361|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583362|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583363|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583364|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
14583365|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583366|NCT00006483|Sargramostim|sargramostim|mesh-list
14583367|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
14583368|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583369|NCT00006484|Paclitaxel|paclitaxel|mesh-list
14583370|NCT00006484|Carboplatin|carboplatin|mesh-list
14583371|NCT00006484|Tirapazamine|tirapazamine|mesh-list
14583372|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583373|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583374|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583375|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583376|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583377|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583378|NCT00006485|Irinotecan|irinotecan|mesh-list
14583379|NCT00006485|Alvocidib|alvocidib|mesh-list
14583380|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14583381|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583382|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583383|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583384|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583385|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
14583386|NCT00006485|Growth Substances|growth substances|mesh-ancestor
15154388|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583387|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583388|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14583389|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
14583390|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583391|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14583392|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14583393|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583394|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14583395|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583396|NCT00006487|Etoposide|etoposide|mesh-list
14583397|NCT00006487|Tirapazamine|tirapazamine|mesh-list
14583398|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583399|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583400|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583401|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583402|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583403|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583404|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
14583405|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14583406|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583407|NCT00006508|Insulin|insulin|mesh-list
14583408|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14583409|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583410|NCT00006519|Capravirine|capravirine|mesh-list
14583411|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14583412|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583413|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583414|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583415|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
14583416|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583417|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583418|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583419|NCT00006578|Ritonavir|ritonavir|mesh-list
14583420|NCT00006578|Amprenavir|amprenavir|mesh-list
14583421|NCT00006578|Lamivudine|lamivudine|mesh-list
14583422|NCT00006578|Abacavir|abacavir|mesh-list
14583423|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14583424|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14583425|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
14583426|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021573|NCT02773095|Lactitol|lactitol|mesh-list
14583427|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154389|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14583428|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583429|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583430|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
14583431|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583432|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14583433|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14583434|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14583435|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583436|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14583437|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
14583438|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14583439|NCT00006591|Ritonavir|ritonavir|mesh-list
14583440|NCT00006591|Amprenavir|amprenavir|mesh-list
14583441|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14583442|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14583443|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
14583444|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583445|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583446|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583447|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583448|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
14583449|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021574|NCT02773095|Cathartics|cathartics|mesh-ancestor
14583450|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14583451|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14583452|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14583453|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
14583454|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14583455|NCT00006617|Lamivudine|lamivudine|mesh-list
14583456|NCT00006617|Zidovudine|zidovudine|mesh-list
14583457|NCT00006617|Abacavir|abacavir|mesh-list
14583458|NCT00006617|Amprenavir|amprenavir|mesh-list
14583459|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14583460|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583461|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583462|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583463|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
14583464|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583465|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583466|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583467|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
14583468|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14583469|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
14583470|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14583471|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14583472|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14583473|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
14583474|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
14583475|NCT00006630|Antibodies|antibodies|mesh-list
14583476|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
14583477|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14583478|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14583479|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
14583480|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583481|NCT00006656|Ethanol|ethanol|mesh-list
14583482|NCT00006656|Carmustine|carmustine|mesh-list
14583483|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14583484|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583485|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14583486|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583487|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583488|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
14583489|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583490|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583491|NCT00006669|Prednisone|prednisone|mesh-list
14583492|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
14583493|NCT00006669|Rituximab|rituximab|mesh-list
14583494|NCT00006669|Doxorubicin|doxorubicin|mesh-list
14583495|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14583496|NCT00006669|Etoposide|etoposide|mesh-list
14583497|NCT00006669|Vincristine|vincristine|mesh-list
14583498|NCT00006669|Sargramostim|sargramostim|mesh-list
14583499|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583500|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
14583501|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583502|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583503|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583504|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
14583505|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583506|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583507|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14583508|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14583509|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14583510|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583511|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583512|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583513|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583514|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
14583515|NCT00006669|Hormones|hormones|mesh-ancestor
14583516|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14583517|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14583518|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583519|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583520|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583521|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583522|NCT00006682|Docetaxel|docetaxel|mesh-list
14583523|NCT00006682|Vinorelbine|vinorelbine|mesh-list
14583524|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583525|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583526|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583527|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583528|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583529|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583530|NCT00006695|Iodine|iodine|mesh-list
14583531|NCT00006695|Cytarabine|cytarabine|mesh-list
14583532|NCT00006695|Etoposide|etoposide|mesh-list
14583533|NCT00006695|Melphalan|melphalan|mesh-list
14583534|NCT00006695|Carmustine|carmustine|mesh-list
14583535|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
14583536|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583537|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583538|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583539|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583540|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583541|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583542|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583543|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
14583544|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
14583545|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583546|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583547|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
14583548|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583549|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583550|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
14583551|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14583552|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15154390|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
15154391|NCT04177433|Hormones|hormones|mesh-ancestor
15154392|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154393|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15154394|NCT04177433|Protective Agents|protective agents|mesh-ancestor
15154395|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154396|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154397|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
15154398|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15154399|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154400|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154401|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
15154402|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154403|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154404|NCT04177004|Sirolimus|sirolimus|mesh-list
15154405|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
15154406|NCT04177004|Etoposide|etoposide|mesh-list
15154407|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
15154408|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
15154409|NCT04177004|Tacrolimus|tacrolimus|mesh-list
15154410|NCT04177004|Mitogens|mitogens|mesh-list
15154411|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154412|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
15154413|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154414|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583553|NCT00006695|Trace Elements|trace elements|mesh-ancestor
15154415|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583554|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
14583555|NCT00006708|Rituximab|rituximab|mesh-list
14583556|NCT00006708|Carboplatin|carboplatin|mesh-list
14583557|NCT00006708|Etoposide|etoposide|mesh-list
14583558|NCT00006708|Ifosfamide|ifosfamide|mesh-list
14583559|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14583560|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583561|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
14583562|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583563|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583564|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583565|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583566|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583567|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583568|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583569|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583570|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
14583571|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
14583572|NCT00006734|Ifosfamide|ifosfamide|mesh-list
14583573|NCT00006734|Doxorubicin|doxorubicin|mesh-list
14583574|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14583575|NCT00006734|Etoposide|etoposide|mesh-list
14583576|NCT00006734|Vincristine|vincristine|mesh-list
14583577|NCT00006734|Lenograstim|lenograstim|mesh-list
14583578|NCT00006734|Sargramostim|sargramostim|mesh-list
14583579|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583580|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
14583581|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583582|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583583|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583584|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
14583585|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583586|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583587|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14583588|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14583589|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583590|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583591|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583592|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583593|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14583594|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583595|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583596|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583597|NCT00006747|Cytarabine|cytarabine|mesh-list
14583598|NCT00006747|Methotrexate|methotrexate|mesh-list
14583599|NCT00006747|Etoposide|etoposide|mesh-list
14583600|NCT00006747|Melphalan|melphalan|mesh-list
14583601|NCT00006747|Carmustine|carmustine|mesh-list
14583602|NCT00006747|Tacrolimus|tacrolimus|mesh-list
14583603|NCT00006747|Sargramostim|sargramostim|mesh-list
14583604|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14583605|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
14583606|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14583607|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583608|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583609|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
14583610|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583611|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583612|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
14583613|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583614|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14583615|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583616|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
14583617|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583618|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583619|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583620|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14583621|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583622|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
14583623|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583624|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14583625|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583626|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
14583627|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14583628|NCT00006760|Vinorelbine|vinorelbine|mesh-list
14583629|NCT00006760|Ifosfamide|ifosfamide|mesh-list
14583630|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583631|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583632|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583633|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583634|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583635|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583636|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583637|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
14583638|NCT00006773|Bortezomib|bortezomib|mesh-list
14583639|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583640|NCT00006786|Leucovorin|leucovorin|mesh-list
14583641|NCT00006786|Bevacizumab|bevacizumab|mesh-list
14583642|NCT00006786|Fluorouracil|fluorouracil|mesh-list
14583643|NCT00006786|Irinotecan|irinotecan|mesh-list
14583644|NCT00006786|Calcium|calcium|mesh-list
14583645|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
14583646|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154416|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
15154417|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154418|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154419|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15154420|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15154421|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15154422|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583647|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583648|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14583649|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14583650|NCT00006786|Growth Substances|growth substances|mesh-ancestor
14583651|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583652|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14583653|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14583654|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
14583655|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583656|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583657|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583658|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
14583659|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14583660|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583661|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583662|NCT00006786|Antidotes|antidotes|mesh-ancestor
14583663|NCT00006786|Protective Agents|protective agents|mesh-ancestor
14583664|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
14583665|NCT00006786|Vitamins|vitamins|mesh-ancestor
14583666|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
14583667|NCT00006799|Megestrol|megestrol|mesh-list
14583668|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
14583669|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14583670|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14583671|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14583672|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
14583673|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14583674|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583675|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14583676|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14583677|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14583678|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583679|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
14583680|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14583681|NCT00006812|Capecitabine|capecitabine|mesh-list
14583682|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14583683|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
14583684|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583685|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583686|NCT00006825|Doxorubicin|doxorubicin|mesh-list
14583687|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14583688|NCT00006825|Trastuzumab|trastuzumab|mesh-list
14583689|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14583690|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583691|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15154423|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154424|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15154425|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15154426|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154427|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14583692|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14583693|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583694|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583695|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14583696|NCT00006864|Aldesleukin|aldesleukin|mesh-list
14583697|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583698|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583699|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583700|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
14583701|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154428|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
15154429|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
15154430|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
15154431|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
15154432|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
15154433|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583702|NCT00006877|Temozolomide|temozolomide|mesh-list
14583703|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583704|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
14583705|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583706|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583707|NCT00006890|Thalidomide|thalidomide|mesh-list
14583708|NCT00006890|Prednisone|prednisone|mesh-list
14583709|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583710|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
14583711|NCT00006890|Hormones|hormones|mesh-ancestor
14583712|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14583713|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583714|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14583715|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583716|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583717|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
14583718|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
14583719|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14583720|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583721|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14583722|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14583723|NCT00006890|Growth Substances|growth substances|mesh-ancestor
14583724|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
14583725|NCT00006929|Suramin|suramin|mesh-list
14583726|NCT00006929|Paclitaxel|paclitaxel|mesh-list
14583727|NCT00006929|Carboplatin|carboplatin|mesh-list
14583728|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14583729|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583730|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14583731|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14583732|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14583733|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583734|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
14583735|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
14583736|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14583737|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583738|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14583739|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14583740|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
14583741|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583742|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14583743|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
14583744|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583745|NCT00006968|Cyclosporine|cyclosporine|mesh-list
14583746|NCT00006968|Pentostatin|pentostatin|mesh-list
14583747|NCT00006968|Cyclosporins|cyclosporins|mesh-list
14583748|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
14583749|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583750|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583751|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583752|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583753|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
14583754|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583755|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
14583756|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583757|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14583758|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583759|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14583760|NCT00006981|Immunotoxins|immunotoxins|mesh-list
14583761|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
14583762|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583763|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
14583764|NCT00007033|Analgesics|analgesics|mesh-ancestor
14583765|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
15154434|NCT04177303|Metformin|metformin|mesh-list
15154435|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15154436|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154437|NCT04177043|Antibodies|antibodies|mesh-list
15154438|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
15154439|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
15154440|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154441|NCT04177082|Riboflavin|riboflavin|mesh-list
15154442|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
15154443|NCT04177082|Vitamins|vitamins|mesh-ancestor
15154444|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
15154445|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154446|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15154447|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
15154448|NCT04176835|Oxytocin|oxytocin|mesh-list
15154449|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
15154450|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14583766|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583767|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583768|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
14583769|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14583770|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14583771|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
14583772|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14583773|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14583774|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583775|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14583776|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
14583777|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14583778|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
14583779|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14583780|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583781|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14583782|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
14583783|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14583784|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583785|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583786|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583787|NCT00007189|Celecoxib|celecoxib|mesh-list
14583788|NCT00007189|Naproxen|naproxen|mesh-list
14583789|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14583790|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14583791|NCT00007189|Analgesics|analgesics|mesh-ancestor
14583792|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
14583793|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583794|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583795|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583796|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583797|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14583798|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14583799|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583800|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583801|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
14583802|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14583803|NCT00007202|Stavudine|stavudine|mesh-list
14583804|NCT00007202|Didanosine|didanosine|mesh-list
14583805|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14583806|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14583807|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
14583808|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583809|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583810|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583811|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583812|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
14583813|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583814|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
14583815|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14583816|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583817|NCT00007306|Hormones|hormones|mesh-list
14583818|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
14583819|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14583820|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154451|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154452|NCT04177095|Sirolimus|sirolimus|mesh-list
15154453|NCT04177095|Prednisone|prednisone|mesh-list
15154454|NCT04177095|Everolimus|everolimus|mesh-list
15154455|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583821|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14583822|NCT00007358|Dexamethasone|dexamethasone|mesh-list
14583823|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583824|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
14583825|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
14583826|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583827|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583828|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14583829|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
14583830|NCT00007358|Hormones|hormones|mesh-ancestor
14583831|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14583832|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14583833|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583834|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
14583835|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14583836|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
14583837|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583838|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14583839|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583840|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
14583841|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583842|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
14583843|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14583844|NCT00007423|Protective Agents|protective agents|mesh-ancestor
14583845|NCT00007436|Tenofovir|tenofovir|mesh-list
14583846|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
14583847|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583848|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14583849|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14583850|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583851|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583852|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14583853|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14583854|NCT00007527|Buprenorphine|buprenorphine|mesh-list
14583855|NCT00007527|Naloxone|naloxone|mesh-list
14583856|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14583857|NCT00007527|Narcotics|narcotics|mesh-ancestor
14583858|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14583859|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583860|NCT00007527|Analgesics|analgesics|mesh-ancestor
14583861|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
14583862|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583863|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14644386|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
14644387|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644388|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644389|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
14644390|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644391|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644392|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644393|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
14644394|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644395|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14644396|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644397|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644398|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644399|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644400|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154456|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
15154457|NCT04177095|Hormones|hormones|mesh-ancestor
15154458|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154459|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154460|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154461|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154462|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154463|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
15154464|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15154465|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15154466|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154467|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
15154468|NCT04176887|Phenytoin|phenytoin|mesh-list
14021575|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021576|NCT02772926|Benphothiamine|benphothiamine|mesh-list
15154469|NCT04176887|Levetiracetam|levetiracetam|mesh-list
15154470|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
14583864|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
14583865|NCT00007592|Furosemide|furosemide|mesh-list
14583866|NCT00007592|Diuretics|diuretics|mesh-ancestor
14583867|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
14583868|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583869|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14583870|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14583871|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583872|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14583873|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14583874|NCT00007605|Amiodarone|amiodarone|mesh-list
14583875|NCT00007605|Sotalol|sotalol|mesh-list
14583876|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14583877|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
14583878|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14583879|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154471|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
15154472|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15154473|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14021577|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14021578|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
14021579|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021580|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
15154474|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154475|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154476|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15154477|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15154478|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15154479|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14583880|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583881|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14583882|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14583883|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14583884|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583885|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14583886|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14583887|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14583888|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14583889|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14583890|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14583891|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14583892|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583893|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
14583894|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
14583895|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583896|NCT00007631|Tretinoin|tretinoin|mesh-list
14583897|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14583898|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
14583899|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14583900|NCT00007670|Lamotrigine|lamotrigine|mesh-list
14583901|NCT00007670|Carbamazepine|carbamazepine|mesh-list
15154480|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15154481|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
15154482|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154483|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15154484|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15154485|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154486|NCT04176354|Letrozole|letrozole|mesh-list
15154487|NCT04176354|Palbociclib|palbociclib|mesh-list
15154488|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14583902|NCT00007670|Gabapentin|gabapentin|mesh-list
14583903|NCT00007670|Analgesics|analgesics|mesh-ancestor
14583904|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
14583905|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583906|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583907|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
14583908|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14583909|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14583910|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14583911|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14583912|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14583913|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14583914|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021581|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
15154489|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154490|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14583915|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583916|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
14583917|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14583918|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154491|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154492|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154493|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15154494|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
15154495|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154496|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154497|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15154498|NCT04176224|Edaravone|edaravone|mesh-list
15154499|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15154500|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
15154501|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154502|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15154503|NCT04176224|Protective Agents|protective agents|mesh-ancestor
15154504|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154505|NCT04176393|Ivosidenib|ivosidenib|mesh-list
15154506|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154507|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154508|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154509|NCT04176367|Nicergoline|nicergoline|mesh-list
15154510|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14583919|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14583920|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14583921|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14583922|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14583923|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14583924|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14583925|NCT00007683|Aspirin|aspirin|mesh-list
14583926|NCT00007683|Warfarin|warfarin|mesh-list
14583927|NCT00007683|Clopidogrel|clopidogrel|mesh-list
14583928|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14583929|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14583930|NCT00007683|Analgesics|analgesics|mesh-ancestor
14583931|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
14583932|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583933|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583934|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14583935|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583936|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14583937|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14583938|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583939|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14583940|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14583941|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583942|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
14583943|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14583944|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15154511|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15154512|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
15154513|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154514|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154515|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154516|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
15154517|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
15154518|NCT04176016|Edetic Acid|edetic acid|mesh-list
14583945|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14583946|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
14583947|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14583948|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
14583949|NCT00007735|Doxycycline|doxycycline|mesh-list
14583950|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14583951|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583952|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
14583953|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14583954|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14583955|NCT00007774|Haloperidol|haloperidol|mesh-list
14583956|NCT00007774|Olanzapine|olanzapine|mesh-list
14583957|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
14583958|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
14583959|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
14583960|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14583961|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583962|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14583963|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14583964|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14583965|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14583966|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14583967|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14583968|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14583969|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14583970|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583971|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14583972|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
14583973|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14583974|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
14583975|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14583976|NCT00007787|Cyclosporine|cyclosporine|mesh-list
14583977|NCT00007787|Tacrolimus|tacrolimus|mesh-list
14583978|NCT00007787|Cyclosporins|cyclosporins|mesh-list
14583979|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
14583980|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583981|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
14583982|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583983|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14583984|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14583985|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14583986|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
14583987|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14583988|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
14583989|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583990|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
14583991|NCT00007813|Carboplatin|carboplatin|mesh-list
14583992|NCT00007813|Etoposide|etoposide|mesh-list
14583993|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14583994|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
14583995|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14583996|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14583997|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14583998|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
14583999|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584000|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584001|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584002|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584003|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584004|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584005|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584006|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14584007|NCT00007826|Vaccines|vaccines|mesh-list
14291683|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291684|NCT00555750|Eszopiclone|eszopiclone|mesh-list
14291685|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14291686|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291687|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291688|NCT00555880|Midodrine|midodrine|mesh-list
14291689|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
14584008|NCT00007826|Antibodies|antibodies|mesh-list
14584009|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14584010|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
14584011|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
14584012|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
14584013|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584014|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14584015|NCT00007826|Antacids|antacids|mesh-ancestor
14584016|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584017|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14584018|NCT00007852|Cytarabine|cytarabine|mesh-list
14584019|NCT00007852|Rituximab|rituximab|mesh-list
14584020|NCT00007852|Etoposide|etoposide|mesh-list
14584021|NCT00007852|Melphalan|melphalan|mesh-list
14584022|NCT00007852|Carmustine|carmustine|mesh-list
14584023|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14584024|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154519|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
14584025|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
14584026|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584027|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291690|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
14584028|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584029|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584030|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584031|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584032|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584033|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584034|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
15154520|NCT04176016|Antidotes|antidotes|mesh-ancestor
15154521|NCT04176016|Protective Agents|protective agents|mesh-ancestor
15154522|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154523|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
15154524|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
14584035|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
14584036|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584037|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584038|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584039|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
14584040|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584041|NCT00007865|Rituximab|rituximab|mesh-list
14584042|NCT00007865|Carboplatin|carboplatin|mesh-list
14584043|NCT00007865|Etoposide|etoposide|mesh-list
14584044|NCT00007865|Ifosfamide|ifosfamide|mesh-list
14584045|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14584046|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584047|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
14584048|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584049|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584050|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584051|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584052|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584053|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584054|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584055|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584056|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
14584057|NCT00007878|Leucovorin|leucovorin|mesh-list
14584058|NCT00007878|Fluorouracil|fluorouracil|mesh-list
14584059|NCT00007878|Bortezomib|bortezomib|mesh-list
14584060|NCT00007878|Calcium|calcium|mesh-list
14584061|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
14584062|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584063|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584064|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
14584065|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584066|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584067|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584068|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584069|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
14584070|NCT00007878|Antidotes|antidotes|mesh-ancestor
14584071|NCT00007878|Protective Agents|protective agents|mesh-ancestor
14584072|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
14584073|NCT00007878|Vitamins|vitamins|mesh-ancestor
14584074|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
15154525|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154526|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15154527|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
15154528|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14584075|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14584076|NCT00007891|Antibodies|antibodies|mesh-list
14584077|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
14584078|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14584079|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
14584080|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584081|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584082|NCT00007904|Tamoxifen|tamoxifen|mesh-list
14584083|NCT00007904|Paclitaxel|paclitaxel|mesh-list
14584084|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
14584085|NCT00007904|Doxorubicin|doxorubicin|mesh-list
14584086|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15154529|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
15154530|NCT04175990|Progestins|progestins|mesh-ancestor
15154531|NCT04175990|Hormones|hormones|mesh-ancestor
15154532|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154533|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154534|NCT04176328|Teicoplanin|teicoplanin|mesh-list
15154535|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15154536|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584087|NCT00007904|Lenograstim|lenograstim|mesh-list
14584088|NCT00007904|Sargramostim|sargramostim|mesh-list
15154537|NCT04176055|Haloperidol|haloperidol|mesh-list
15154538|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
15154539|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
14584089|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584090|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584091|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584092|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584093|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584094|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584095|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584096|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
14584097|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584098|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154540|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
15154541|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154542|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154543|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15154544|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15154545|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15154546|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154547|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14584099|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584100|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
14584101|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584102|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584103|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584104|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584105|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584106|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14584107|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14584108|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
14584109|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14584110|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14584111|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14584112|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14584113|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14584114|NCT00007917|Gemcitabine|gemcitabine|mesh-list
14584115|NCT00007917|Alvocidib|alvocidib|mesh-list
14584116|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584117|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
14584118|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584119|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584120|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
14584121|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584122|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584123|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584124|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
14584125|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584126|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
14584127|NCT00007917|Growth Substances|growth substances|mesh-ancestor
14584128|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14584129|NCT00007943|Gemcitabine|gemcitabine|mesh-list
14584130|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584131|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
14584132|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584133|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584134|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
14584135|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584136|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584137|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584138|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
14584139|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584140|NCT00007956|Antibodies|antibodies|mesh-list
14584141|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14584142|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
14584143|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293217|NCT00566813|Exenatide|exenatide|mesh-list
14293218|NCT00566813|Etanercept|etanercept|mesh-list
14293219|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14293220|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14293221|NCT00566813|Analgesics|analgesics|mesh-ancestor
14293222|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
14293223|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293224|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584144|NCT00007969|Verteporfin|verteporfin|mesh-list
14026053|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584145|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
14584146|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14584147|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584148|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14584149|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
14584150|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584151|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
14584152|NCT00007982|Thiotepa|thiotepa|mesh-list
14584153|NCT00007982|Carmustine|carmustine|mesh-list
14584154|NCT00007982|Etoposide|etoposide|mesh-list
14584155|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584156|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
14584157|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584158|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584159|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584160|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
14584161|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584162|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584163|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584164|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584165|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584166|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584167|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584168|NCT00007995|Interferons|interferons|mesh-list
14584169|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
14584170|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
14584171|NCT00007995|Melphalan|melphalan|mesh-list
14584172|NCT00007995|Busulfan|busulfan|mesh-list
14584173|NCT00007995|Sargramostim|sargramostim|mesh-list
14584174|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584175|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
14584176|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584177|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584178|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584179|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
14584180|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584181|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584182|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584183|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
14584184|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584185|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
14584186|NCT00008008|Thiotepa|thiotepa|mesh-list
14584187|NCT00008008|Sargramostim|sargramostim|mesh-list
14584188|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584189|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
14584190|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584191|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584192|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584193|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
14584194|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584195|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584196|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584197|NCT00008021|Cyclosporine|cyclosporine|mesh-list
14584198|NCT00008021|Paclitaxel|paclitaxel|mesh-list
14584199|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14584200|NCT00008021|Antibodies|antibodies|mesh-list
14584201|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
14584202|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14584203|NCT00008021|Cyclosporins|cyclosporins|mesh-list
14584204|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584205|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584206|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584207|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584208|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584209|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584210|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
14584211|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584212|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584213|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584214|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
14584215|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584216|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584217|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584218|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584219|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
14584220|NCT00008034|Capecitabine|capecitabine|mesh-list
14584221|NCT00008034|Epirubicin|epirubicin|mesh-list
14584222|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584223|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
14584224|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584225|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584226|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584227|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
14584228|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584229|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584230|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584231|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584232|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
14584233|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584234|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584235|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584236|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584237|NCT00008047|Paclitaxel|paclitaxel|mesh-list
14584238|NCT00008047|Fluorouracil|fluorouracil|mesh-list
14584239|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
14584240|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584241|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584242|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584243|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584244|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584245|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584246|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
14584247|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584248|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584249|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
14584250|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584251|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
14584252|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584253|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14584254|NCT00008060|Leucovorin|leucovorin|mesh-list
14584255|NCT00008060|Fluorouracil|fluorouracil|mesh-list
14584256|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
14584257|NCT00008060|Irinotecan|irinotecan|mesh-list
14584258|NCT00008060|Calcium|calcium|mesh-list
14584259|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
14584260|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584261|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584262|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
14584263|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584264|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15154548|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15154549|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
15154550|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154551|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154552|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15154553|NCT04176068|Calcium|calcium|mesh-list
15154554|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584265|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584266|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584267|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
15154555|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154556|NCT04175925|Famotidine|famotidine|mesh-list
15154557|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15154558|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15154559|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15154560|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
15154561|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
15154562|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154563|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154564|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180279|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
15180280|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180281|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584268|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15180282|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
14584269|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584270|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180283|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180284|NCT03941886|Aspirin|aspirin|mesh-list
14584271|NCT00008060|Antidotes|antidotes|mesh-ancestor
14584272|NCT00008060|Protective Agents|protective agents|mesh-ancestor
14584273|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
14584274|NCT00008060|Vitamins|vitamins|mesh-ancestor
14584275|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
14584276|NCT00008073|Doxorubicin|doxorubicin|mesh-list
14584277|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14584278|NCT00008073|Octreotide|octreotide|mesh-list
14584279|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584280|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584281|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584282|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584283|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584284|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584285|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14584286|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14584287|NCT00008086|Calcitriol|calcitriol|mesh-list
14584288|NCT00008086|Carboplatin|carboplatin|mesh-list
14584289|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584290|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584291|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584292|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14584293|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14584294|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154565|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15154566|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
15154567|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15154568|NCT04175522|Antibodies|antibodies|mesh-list
15154569|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
15154570|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
15154571|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154572|NCT04175587|Tretinoin|tretinoin|mesh-list
14584295|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14584296|NCT00008086|Vitamins|vitamins|mesh-ancestor
14584297|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
14584298|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14584299|NCT00008112|Cisplatin|cisplatin|mesh-list
14584300|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584301|NCT00008125|Gemcitabine|gemcitabine|mesh-list
14584302|NCT00008125|Carboplatin|carboplatin|mesh-list
14584303|NCT00008125|Docetaxel|docetaxel|mesh-list
14584304|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584305|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584306|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
14584307|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584308|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
14584309|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584310|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584311|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584312|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
14584313|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584314|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584315|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584316|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584317|NCT00008151|Cyclosporine|cyclosporine|mesh-list
14584318|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
14584319|NCT00008151|Methotrexate|methotrexate|mesh-list
14584320|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
14584321|NCT00008151|Fludarabine|fludarabine|mesh-list
14584322|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
14584323|NCT00008151|Cyclosporins|cyclosporins|mesh-list
14584324|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14584325|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
14584326|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15154573|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
15154574|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154575|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
15154576|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
15154577|NCT04175470|Tocotrienols|tocotrienols|mesh-list
15154578|NCT04175470|Vitamin E|vitamin e|mesh-list
15154579|NCT04175470|Tocopherols|tocopherols|mesh-list
15154580|NCT04175470|Bevacizumab|bevacizumab|mesh-list
15154581|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154582|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584327|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584328|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584329|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
14584330|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154583|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15154584|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15154585|NCT04175470|Growth Substances|growth substances|mesh-ancestor
14584331|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584332|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584333|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584334|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14584335|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584336|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
14584337|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584338|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14584339|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
14584340|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584341|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584342|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584343|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14584344|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
14584345|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14584346|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14584347|NCT00008177|Iodine|iodine|mesh-list
14584348|NCT00008177|Cyclosporine|cyclosporine|mesh-list
14584349|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
14584350|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14584351|NCT00008177|Fludarabine|fludarabine|mesh-list
14584352|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
14584353|NCT00008177|Antibodies|antibodies|mesh-list
14584354|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
14584355|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14584356|NCT00008177|Cyclosporins|cyclosporins|mesh-list
14584357|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
14584358|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584359|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584360|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584361|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
14584362|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584363|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584364|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584365|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
14584366|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584367|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584368|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584369|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584370|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584371|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14584372|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
14584373|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14584374|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14584375|NCT00008177|Trace Elements|trace elements|mesh-ancestor
14584376|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
14584377|NCT00008190|Aldesleukin|aldesleukin|mesh-list
14584378|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
14584379|NCT00008190|Melphalan|melphalan|mesh-list
14584380|NCT00008190|Busulfan|busulfan|mesh-list
14584381|NCT00008190|Etoposide|etoposide|mesh-list
15154586|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154587|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
15154588|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
15154589|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154590|NCT04175470|Protective Agents|protective agents|mesh-ancestor
15154591|NCT04175470|Vitamins|vitamins|mesh-ancestor
15154592|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
15154593|NCT04175171|Trastuzumab|trastuzumab|mesh-list
15154594|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154595|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154596|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
15154597|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154598|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154599|NCT04175158|Bevacizumab|bevacizumab|mesh-list
15154600|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
15154601|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154602|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154603|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15154604|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15154605|NCT04175158|Growth Substances|growth substances|mesh-ancestor
14584382|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584383|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
14584384|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584385|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584386|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584387|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
14584388|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584389|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584390|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584391|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584392|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584393|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584394|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584395|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584396|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584397|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
14584398|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584399|NCT00008203|Interferons|interferons|mesh-list
14584400|NCT00008203|Aldesleukin|aldesleukin|mesh-list
14584401|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
14584402|NCT00008203|Cyclosporine|cyclosporine|mesh-list
14584403|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
14584404|NCT00008203|Thiotepa|thiotepa|mesh-list
14584405|NCT00008203|Carboplatin|carboplatin|mesh-list
14584406|NCT00008203|Cyclosporins|cyclosporins|mesh-list
14584407|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584408|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
14584409|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584410|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584411|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584412|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
14584413|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584414|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584415|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584416|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
14584417|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584418|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584419|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
14584420|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584421|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584422|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584423|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584424|NCT00008229|Melphalan|melphalan|mesh-list
14584425|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
14584426|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584427|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584428|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
14584429|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584430|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584431|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584432|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584433|NCT00008242|Thalidomide|thalidomide|mesh-list
14584434|NCT00008242|Dexamethasone|dexamethasone|mesh-list
14584435|NCT00008242|Doxorubicin|doxorubicin|mesh-list
14584436|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14584437|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14584438|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
14584439|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
14584440|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584441|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584442|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14584443|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
14584444|NCT00008242|Hormones|hormones|mesh-ancestor
15154606|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154607|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
15154608|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15154609|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154610|NCT04175067|Antioxidants|antioxidants|mesh-list
15154611|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154612|NCT04175067|Protective Agents|protective agents|mesh-ancestor
14584445|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14584446|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14584447|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584448|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584449|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584450|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584451|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584452|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154613|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584453|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584454|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
14584455|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
14584456|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14584457|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584458|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14584459|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14584460|NCT00008242|Growth Substances|growth substances|mesh-ancestor
14584461|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14584462|NCT00008268|Melphalan|melphalan|mesh-list
14584463|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
14584464|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584465|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584466|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
14584467|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584468|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584469|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584470|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584471|NCT00008281|Leucovorin|leucovorin|mesh-list
14584472|NCT00008281|Fluorouracil|fluorouracil|mesh-list
14584473|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
14584474|NCT00008281|Calcium|calcium|mesh-list
14584475|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
14584476|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584477|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584478|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
14584479|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584480|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584481|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584482|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584483|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
14584484|NCT00008281|Antidotes|antidotes|mesh-ancestor
14584485|NCT00008281|Protective Agents|protective agents|mesh-ancestor
14584486|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
14584487|NCT00008281|Vitamins|vitamins|mesh-ancestor
14584488|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
14584489|NCT00008294|Leucovorin|leucovorin|mesh-list
14584490|NCT00008294|Dexamethasone|dexamethasone|mesh-list
14584491|NCT00008294|Fluorouracil|fluorouracil|mesh-list
14584492|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
14584493|NCT00008294|Floxuridine|floxuridine|mesh-list
14584494|NCT00008294|Calcium|calcium|mesh-list
14584495|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
14584496|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14584497|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
14584498|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
14584499|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584500|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584501|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14584502|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
14584503|NCT00008294|Hormones|hormones|mesh-ancestor
14584504|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14584505|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14584506|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584507|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584508|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
14584509|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584510|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584511|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584512|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
14584513|NCT00008294|Antidotes|antidotes|mesh-ancestor
14584514|NCT00008294|Protective Agents|protective agents|mesh-ancestor
14584515|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
14584516|NCT00008294|Vitamins|vitamins|mesh-ancestor
14584517|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
14584518|NCT00008307|Cyclosporine|cyclosporine|mesh-list
14584519|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
14584520|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
14584521|NCT00008307|Fludarabine|fludarabine|mesh-list
14584522|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
14584523|NCT00008307|Melphalan|melphalan|mesh-list
14584524|NCT00008307|Cyclosporins|cyclosporins|mesh-list
14584525|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14584526|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154614|NCT04175002|Progesterone|progesterone|mesh-list
14584527|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584528|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
14584529|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584530|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584531|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
15154615|NCT04175002|Progestins|progestins|mesh-ancestor
15154616|NCT04175002|Hormones|hormones|mesh-ancestor
14584532|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584533|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584534|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
14584535|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584536|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584537|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154617|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154618|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154619|NCT04174872|Midazolam|midazolam|mesh-list
15154620|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
15154621|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15154622|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14584538|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584539|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584540|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14584541|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
14584542|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14584543|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14584544|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
14584545|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
14584546|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584547|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14584548|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
14584549|NCT00008307|Hormones|hormones|mesh-ancestor
14584550|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14584551|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14584552|NCT00008307|Protective Agents|protective agents|mesh-ancestor
14584553|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14584554|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
14584555|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14584556|NCT00008333|Vinorelbine|vinorelbine|mesh-list
14584557|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584558|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584559|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584560|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584561|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584562|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584563|NCT00008359|Amphotericin B|amphotericin b|mesh-list
14584564|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14584565|NCT00008359|Caspofungin|caspofungin|mesh-list
14584566|NCT00008359|Amebicides|amebicides|mesh-ancestor
15154623|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154624|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15154625|NCT04174872|Analgesics|analgesics|mesh-ancestor
15154626|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
15154627|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584567|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14584568|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14584569|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584570|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14584571|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
14584572|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584573|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584574|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
14584575|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584576|NCT00008398|Sargramostim|sargramostim|mesh-list
14584577|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
14584578|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584579|NCT00008411|Docetaxel|docetaxel|mesh-list
14584580|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584581|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584582|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584583|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584584|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584585|NCT00008424|Irinotecan|irinotecan|mesh-list
14584586|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14584587|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584588|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584589|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584590|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154628|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14584591|NCT00008450|Cyclosporine|cyclosporine|mesh-list
14584592|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
14584593|NCT00008450|Cyclosporins|cyclosporins|mesh-list
14584594|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584595|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584596|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584597|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
14584598|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584599|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
14584600|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584601|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584602|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584603|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584604|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14584605|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584606|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14584607|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
14584608|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14584609|NCT00008463|Interferons|interferons|mesh-list
14584610|NCT00008463|Ribavirin|ribavirin|mesh-list
14584611|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
14584612|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
14584613|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14584614|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584615|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
14584616|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584617|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
14584618|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584619|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
14584620|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584621|NCT00008476|Capsaicin|capsaicin|mesh-list
14584622|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
14584623|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584624|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
14584625|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584626|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584627|NCT00008489|Didanosine|didanosine|mesh-list
14584628|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
14584629|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584630|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14584631|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14584632|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584633|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
14584634|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584635|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584636|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584637|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14584638|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15154629|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15154630|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15154631|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
15154632|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154633|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154634|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15154635|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15154636|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14584639|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
14584640|NCT00008515|Hormones|hormones|mesh-ancestor
14584641|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14584642|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584643|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
14584644|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14584645|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14584646|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584647|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584648|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584649|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
14584650|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584651|NCT00008554|Lamivudine|lamivudine|mesh-list
14584652|NCT00008554|Abacavir|abacavir|mesh-list
14584653|NCT00008554|Nelfinavir|nelfinavir|mesh-list
14584654|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
14584655|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14584656|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14584657|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584658|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584659|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
14584660|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584661|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584662|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584663|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14584664|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14584665|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
14584666|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
14584667|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584668|NCT00008736|Metoclopramide|metoclopramide|mesh-list
14584669|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
14584670|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
14584671|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584672|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584673|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14584674|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14584675|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14584676|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
14584677|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584678|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584679|NCT00008866|Didanosine|didanosine|mesh-list
14584680|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
14584681|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584682|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
15154637|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154638|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15154639|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
15154640|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
15154641|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
15154642|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
15154643|NCT04174339|Apatinib|apatinib|mesh-list
15154644|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154645|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15154646|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154647|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154648|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14584683|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584684|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584685|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15154649|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
15154650|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15154651|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
15154652|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15154653|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154654|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14026054|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
14584686|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
14584687|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14584688|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
14584689|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584690|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584691|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584692|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14584693|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
14584694|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
14584695|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584696|NCT00009048|Levodopa|levodopa|mesh-list
14584697|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14584698|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14584699|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
14584700|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584701|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584702|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584703|NCT00009061|Ritonavir|ritonavir|mesh-list
14584704|NCT00009061|Nelfinavir|nelfinavir|mesh-list
14584705|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
14584706|NCT00009061|Lamivudine|lamivudine|mesh-list
14584707|NCT00009061|Abacavir|abacavir|mesh-list
14584708|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14584709|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14584710|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
14584711|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584712|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584713|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584714|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584715|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
14584716|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584717|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15154655|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14584718|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15154656|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154657|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
15154658|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
15154659|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154660|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154661|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154662|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
15154663|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
15154664|NCT04174352|Tamoxifen|tamoxifen|mesh-list
15154665|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15154666|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
15154667|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154668|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154669|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15154670|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154671|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15154672|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15154673|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15154674|NCT04174261|Clopidogrel|clopidogrel|mesh-list
15154675|NCT04174261|Ticagrelor|ticagrelor|mesh-list
15154676|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15154677|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15154678|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15154679|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15154680|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
15154681|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154682|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584719|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14584720|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14584721|NCT00009178|Fluoxetine|fluoxetine|mesh-list
14584722|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14584723|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14584724|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14584725|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584726|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584727|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
14584728|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584729|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14584730|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
14584731|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14584732|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14584733|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14584734|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584735|NCT00009191|Sertraline|sertraline|mesh-list
14584736|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
14584737|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14584738|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15154683|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154684|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
15154685|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15154686|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15154687|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154688|NCT04173832|Amantadine|amantadine|mesh-list
15154689|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14584739|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14584740|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14584741|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584742|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584743|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
14584744|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584745|NCT00009204|Perphenazine|perphenazine|mesh-list
14584746|NCT00009204|Citalopram|citalopram|mesh-list
14584747|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15154690|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15154691|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
15154692|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154693|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
15154694|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154695|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154696|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154697|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14584748|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14584749|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14584750|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584751|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584752|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
14584753|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584754|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14584755|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
14584756|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14584757|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14584758|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14584759|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14584760|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14584761|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
14584762|NCT00009217|Haloperidol|haloperidol|mesh-list
14584763|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
14584764|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
14584765|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
14584766|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584767|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584768|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14584769|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14584770|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14584771|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14584772|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14584773|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14584774|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
14584775|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584776|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584777|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14584778|NCT00009230|Celecoxib|celecoxib|mesh-list
14584779|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14584780|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14584781|NCT00009230|Analgesics|analgesics|mesh-ancestor
14584782|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
14584783|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584784|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584785|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14584786|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584787|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14584788|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14584789|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584790|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584791|NCT00009555|Testosterone|testosterone|mesh-list
14584792|NCT00009555|Androgens|androgens|mesh-ancestor
14584793|NCT00009555|Hormones|hormones|mesh-ancestor
14584794|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14584795|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644401|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644402|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644403|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644404|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644405|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644406|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15154698|NCT04173832|Analgesics|analgesics|mesh-ancestor
15154699|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
15154700|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154701|NCT04174131|Lidocaine|lidocaine|mesh-list
15154702|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
14644407|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644408|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644409|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644410|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644411|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644412|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644413|NCT00191555|Haloperidol|haloperidol|mesh-list
14644414|NCT00191555|Olanzapine|olanzapine|mesh-list
14644415|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
14644416|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
14644417|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
14644418|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644419|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154703|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
15154704|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
14584796|NCT00009581|Acetylcholine|acetylcholine|mesh-list
14584797|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
14584798|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14584799|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
14584800|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584801|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584802|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584803|NCT00009620|Phenobarbital|phenobarbital|mesh-list
14584804|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
14584805|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14584806|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14584807|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584808|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14584809|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14584810|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584811|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584812|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
14584813|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
14584814|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14584815|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14584816|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14584817|NCT00009646|Indomethacin|indomethacin|mesh-list
14584818|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14584819|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14584820|NCT00009646|Analgesics|analgesics|mesh-ancestor
14584821|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
14584822|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584823|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584824|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14584825|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584826|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
14584827|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
14584828|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14584829|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14584830|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584831|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584832|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
14584833|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14584834|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
14584835|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14584836|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584837|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14584838|NCT00009672|Morphine|morphine|mesh-list
14584839|NCT00009672|Nortriptyline|nortriptyline|mesh-list
14584840|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14584841|NCT00009672|Narcotics|narcotics|mesh-ancestor
14584842|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14584843|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584844|NCT00009672|Analgesics|analgesics|mesh-ancestor
14584845|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
14584846|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584847|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14584848|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
14584849|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14584850|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14584851|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14584852|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14584853|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584854|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
14584855|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14584856|NCT00009698|Aldesleukin|aldesleukin|mesh-list
14584857|NCT00009698|Interleukin-2|interleukin-2|mesh-list
14584858|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584859|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14584860|NCT00009698|Analgesics|analgesics|mesh-ancestor
14584861|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
14584862|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584863|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584864|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14584865|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14584866|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
14584867|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584868|NCT00009750|Cyclosporine|cyclosporine|mesh-list
14584869|NCT00009750|Paclitaxel|paclitaxel|mesh-list
15154705|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154706|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154707|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
15154708|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154709|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15154710|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15154711|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15154712|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154713|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154714|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15154715|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
15154716|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
15154717|NCT04174131|Protective Agents|protective agents|mesh-ancestor
15154718|NCT04173858|Naloxegol|naloxegol|mesh-list
15154719|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15154720|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584870|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14584871|NCT00009750|Antibodies|antibodies|mesh-list
14584872|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
14584873|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14584874|NCT00009750|Cyclosporins|cyclosporins|mesh-list
14584875|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584876|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584877|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584878|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584879|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584880|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584881|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
14584882|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584883|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584884|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584885|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
14584886|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584887|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584888|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584889|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584890|NCT00009763|Cyclosporine|cyclosporine|mesh-list
14584891|NCT00009763|Paclitaxel|paclitaxel|mesh-list
14584892|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14584893|NCT00009763|Antibodies|antibodies|mesh-list
14584894|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
14584895|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15154721|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
15154722|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154723|NCT04173962|Midazolam|midazolam|mesh-list
15154724|NCT04173962|Ketamine|ketamine|mesh-list
15154725|NCT04173962|Analgesics|analgesics|mesh-ancestor
15154726|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
14584896|NCT00009763|Cyclosporins|cyclosporins|mesh-list
14584897|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584898|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584899|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584900|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
15154727|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154728|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154729|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15154730|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15154731|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
15154732|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
15154733|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154734|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15154735|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15154736|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154737|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154738|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15154739|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15154740|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15154741|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15154742|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154743|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
15154744|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
15180285|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15180286|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14584901|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584902|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154745|NCT04174170|Sertraline|sertraline|mesh-list
15154746|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
15154747|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
15154748|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154749|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15154750|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15154751|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15154752|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154753|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154754|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
15154755|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154756|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
15154757|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
15154758|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
15154759|NCT04173988|Fludarabine|fludarabine|mesh-list
15154760|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154761|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
15154762|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154763|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154764|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15154765|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
15154766|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154767|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154768|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15154769|NCT04173793|Ezetimibe|ezetimibe|mesh-list
15154770|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15154771|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15154772|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
15154773|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154774|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15154775|NCT04173780|Atropine|atropine|mesh-list
15154776|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15154777|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15154778|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15154779|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
15154780|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154781|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154782|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15154783|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
15154784|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
15154785|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
15154786|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15154787|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15154788|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
15154789|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154790|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154791|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
15154792|NCT04173416|Narcotics|narcotics|mesh-ancestor
15154793|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154794|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154795|NCT04173416|Analgesics|analgesics|mesh-ancestor
15154796|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
15154797|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14584903|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
14584904|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584905|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584906|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584907|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
14584908|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584909|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584910|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584911|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584912|NCT00009776|Cyclosporine|cyclosporine|mesh-list
14584913|NCT00009776|Paclitaxel|paclitaxel|mesh-list
14584914|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15154798|NCT04173403|Ezetimibe|ezetimibe|mesh-list
15154799|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15154800|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15154801|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
15154802|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154803|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15154804|NCT04173585|Bortezomib|bortezomib|mesh-list
14584915|NCT00009776|Antibodies|antibodies|mesh-list
15154805|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
15154806|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584916|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
14584917|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14584918|NCT00009776|Cyclosporins|cyclosporins|mesh-list
14584919|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584920|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584921|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584922|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584923|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584924|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584925|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
14584926|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584927|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584928|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14584929|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
14584930|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584931|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
14584932|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14584933|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14584934|NCT00009802|Calcitriol|calcitriol|mesh-list
14584935|NCT00009802|Paclitaxel|paclitaxel|mesh-list
15154807|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154808|NCT04173390|Pregabalin|pregabalin|mesh-list
15154809|NCT04173390|Analgesics|analgesics|mesh-ancestor
15154810|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
15154811|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154812|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154813|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
15154814|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14584936|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584937|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584938|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584939|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584940|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584941|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584942|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584943|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584944|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14584945|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14584946|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14584947|NCT00009802|Vitamins|vitamins|mesh-ancestor
14584948|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
14584949|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14584950|NCT00009815|Leucovorin|leucovorin|mesh-list
14584951|NCT00009815|Etoposide|etoposide|mesh-list
14584952|NCT00009815|Tegafur|tegafur|mesh-list
14584953|NCT00009815|Calcium|calcium|mesh-list
14584954|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
14584955|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584956|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584957|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584958|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584959|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14584960|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14584961|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14584962|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584963|NCT00009815|Antidotes|antidotes|mesh-ancestor
14584964|NCT00009815|Protective Agents|protective agents|mesh-ancestor
14584965|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
14584966|NCT00009815|Vitamins|vitamins|mesh-ancestor
14584967|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
14584968|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584969|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
14584970|NCT00009828|Leucovorin|leucovorin|mesh-list
14584971|NCT00009828|Paclitaxel|paclitaxel|mesh-list
14584972|NCT00009828|Tegafur|tegafur|mesh-list
14584973|NCT00009828|Calcium|calcium|mesh-list
14584974|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
14584975|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14584976|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14584977|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
14584978|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14584979|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584980|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584981|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14584982|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584983|NCT00009828|Antidotes|antidotes|mesh-ancestor
14584984|NCT00009828|Protective Agents|protective agents|mesh-ancestor
14584985|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
14584986|NCT00009828|Vitamins|vitamins|mesh-ancestor
14584987|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
14584988|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14584989|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
14584990|NCT00009841|Mitogens|mitogens|mesh-list
14584991|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
14584992|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14584993|NCT00009854|Ethanol|ethanol|mesh-list
14584994|NCT00009854|Carmustine|carmustine|mesh-list
14584995|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14584996|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14584997|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14584998|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14584999|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585000|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
14585001|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585002|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585003|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
14585004|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585005|NCT00009880|Paclitaxel|paclitaxel|mesh-list
14585006|NCT00009880|Fluorouracil|fluorouracil|mesh-list
14585007|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14585008|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585009|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585010|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585011|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585012|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585013|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
14585014|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585015|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585016|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
14585017|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585018|NCT00009893|Leucovorin|leucovorin|mesh-list
14585019|NCT00009893|Gemcitabine|gemcitabine|mesh-list
14585020|NCT00009893|Fluorouracil|fluorouracil|mesh-list
14585021|NCT00009893|Calcium|calcium|mesh-list
14585022|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
14585023|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585024|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
14585025|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585026|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585027|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
14585028|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585029|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585030|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585031|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
14585032|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585033|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14585034|NCT00009893|Antidotes|antidotes|mesh-ancestor
14585035|NCT00009893|Protective Agents|protective agents|mesh-ancestor
14585036|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
14585037|NCT00009893|Vitamins|vitamins|mesh-ancestor
14585038|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
14585039|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
14585040|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585041|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14585042|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585043|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585044|NCT00009919|Semaxinib|semaxinib|mesh-list
14585045|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14585046|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14585047|NCT00009919|Growth Substances|growth substances|mesh-ancestor
14585048|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585049|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
14585050|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585051|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14585052|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585053|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585054|NCT00009932|Paclitaxel|paclitaxel|mesh-list
14585055|NCT00009932|Fenretinide|fenretinide|mesh-list
14585056|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14585057|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585058|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
15154815|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14585059|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585060|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585061|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585062|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14585063|NCT00009932|Protective Agents|protective agents|mesh-ancestor
14585064|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585065|NCT00009958|Metronidazole|metronidazole|mesh-list
14585066|NCT00009958|Vaccines|vaccines|mesh-list
14585067|NCT00009958|Sargramostim|sargramostim|mesh-list
14585068|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
14585069|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585070|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585071|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585072|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14585073|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14585074|NCT00009971|Fenretinide|fenretinide|mesh-list
14585075|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585076|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14585077|NCT00009971|Protective Agents|protective agents|mesh-ancestor
14585078|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585079|NCT00009984|Thalidomide|thalidomide|mesh-list
14585080|NCT00009984|Fludarabine|fludarabine|mesh-list
14585081|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
14585082|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585083|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585084|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
14585085|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585086|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585087|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
14585088|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585089|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
14585090|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585091|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585092|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14585093|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14585094|NCT00009984|Growth Substances|growth substances|mesh-ancestor
14585095|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
14585096|NCT00009997|Tamoxifen|tamoxifen|mesh-list
14585097|NCT00009997|Paclitaxel|paclitaxel|mesh-list
14585098|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
14585099|NCT00009997|Doxorubicin|doxorubicin|mesh-list
14585100|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14585101|NCT00009997|Trastuzumab|trastuzumab|mesh-list
14585102|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14585103|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585104|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585105|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585106|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585107|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585108|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585109|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
14585110|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585111|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585112|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585113|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
14585114|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14585115|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585116|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14585117|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585118|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585119|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14585120|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14585121|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585122|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585123|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585124|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14585125|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14585126|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14585127|NCT00010010|Exemestane|exemestane|mesh-list
14585128|NCT00010010|Goserelin|goserelin|mesh-list
14585129|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585130|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14585131|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14585132|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585133|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154816|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585134|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15154817|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15154818|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15154819|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15154820|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154821|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154822|NCT04173507|Avelumab|avelumab|mesh-list
14585135|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585136|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585137|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585138|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585139|NCT00010023|Capecitabine|capecitabine|mesh-list
14585140|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585141|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585142|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
14585143|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585144|NCT00010036|Carboplatin|carboplatin|mesh-list
14585145|NCT00010036|Irinotecan|irinotecan|mesh-list
14585146|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585147|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14585148|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585149|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585150|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585151|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
14585152|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585153|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14585154|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585155|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585156|NCT00010062|Fluorouracil|fluorouracil|mesh-list
14585157|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
14585158|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585159|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585160|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585161|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585162|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
14585163|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585164|NCT00010075|Leucovorin|leucovorin|mesh-list
14585165|NCT00010075|Fluorouracil|fluorouracil|mesh-list
14585166|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
14585167|NCT00010075|Calcium|calcium|mesh-list
14585168|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
14585169|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14585170|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585171|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
14585172|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585173|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585174|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585175|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585176|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
14585177|NCT00010075|Antidotes|antidotes|mesh-ancestor
14585178|NCT00010075|Protective Agents|protective agents|mesh-ancestor
14585179|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
14585180|NCT00010075|Vitamins|vitamins|mesh-ancestor
14585181|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
14585182|NCT00010075|Analgesics|analgesics|mesh-ancestor
14585183|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
14585184|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585185|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14585186|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585187|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585188|NCT00010088|Leucovorin|leucovorin|mesh-list
14585189|NCT00010088|Gemcitabine|gemcitabine|mesh-list
14585190|NCT00010088|Fluorouracil|fluorouracil|mesh-list
14585191|NCT00010088|Calcium|calcium|mesh-list
14585192|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
14585193|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585194|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
14585195|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585196|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585197|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
14585198|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585199|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585200|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585201|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
14585202|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585203|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15154823|NCT04173507|Talazoparib|talazoparib|mesh-list
15154824|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15154825|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154826|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154827|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15154828|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154829|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154830|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
15154831|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154832|NCT04173611|Bupivacaine|bupivacaine|mesh-list
15154833|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
15154834|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
15154835|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154836|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585204|NCT00010088|Antidotes|antidotes|mesh-ancestor
14585205|NCT00010088|Protective Agents|protective agents|mesh-ancestor
14585206|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
14585207|NCT00010088|Vitamins|vitamins|mesh-ancestor
14585208|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
14585209|NCT00010140|Tamoxifen|tamoxifen|mesh-list
14585210|NCT00010140|Docetaxel|docetaxel|mesh-list
14585211|NCT00010140|Epirubicin|epirubicin|mesh-list
14585212|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585213|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585214|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585215|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585216|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585217|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585218|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14585219|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585220|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585221|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14585222|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585223|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585224|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585225|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585226|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14585227|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14585228|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14585229|NCT00010153|Fulvestrant|fulvestrant|mesh-list
14585230|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585231|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585232|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14585233|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14585234|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585235|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585236|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585237|NCT00010166|Gemcitabine|gemcitabine|mesh-list
14585238|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585239|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
14585240|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585241|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585242|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
14585243|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585244|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585245|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585246|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
14585247|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585248|NCT00010179|Lurtotecan|lurtotecan|mesh-list
14585249|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585250|NCT00010192|Aldesleukin|aldesleukin|mesh-list
14585251|NCT00010192|Rituximab|rituximab|mesh-list
14585252|NCT00010192|Interleukin-2|interleukin-2|mesh-list
14585253|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14585254|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585255|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
14585256|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585257|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585258|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14585259|NCT00010192|Analgesics|analgesics|mesh-ancestor
14585260|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
14585261|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585262|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14585263|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15154837|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
15154838|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585264|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
14585265|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585266|NCT00010231|Calcitriol|calcitriol|mesh-list
14585267|NCT00010231|Dexamethasone|dexamethasone|mesh-list
14585268|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585269|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
14585270|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
14585271|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585272|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585273|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14585274|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
15154839|NCT04173364|Ropivacaine|ropivacaine|mesh-list
15154840|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15154841|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
15154842|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
15154843|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154844|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154845|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
15154846|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154847|NCT04173325|Nivolumab|nivolumab|mesh-list
15154848|NCT04173325|Irinotecan|irinotecan|mesh-list
15154849|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14585275|NCT00010231|Hormones|hormones|mesh-ancestor
14585276|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585277|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585278|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585279|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14585280|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14585281|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14585282|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585283|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14585284|NCT00010231|Vitamins|vitamins|mesh-ancestor
14585285|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
14585286|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14585287|NCT00010270|Immunotoxins|immunotoxins|mesh-list
14585288|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
14585289|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585290|NCT00010283|Beclomethasone|beclomethasone|mesh-list
14585291|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585292|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
14585293|NCT00010283|Hormones|hormones|mesh-ancestor
14585294|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585295|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585296|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15154850|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154851|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14585297|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
14585298|NCT00010322|Toremifene|toremifene|mesh-list
14585299|NCT00010322|Atamestane|atamestane|mesh-list
14585300|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585301|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585302|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14585303|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14585304|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585305|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585306|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585307|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14585308|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585309|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585310|NCT00010361|Cyclosporine|cyclosporine|mesh-list
14585311|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
14585312|NCT00010361|Fludarabine|fludarabine|mesh-list
14585313|NCT00010361|Cyclosporins|cyclosporins|mesh-list
14585314|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585315|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585316|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585317|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
14585318|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585319|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154852|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154853|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15154854|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585320|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
15154855|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585321|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585322|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
14585323|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585324|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14585325|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585326|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14585327|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
14585328|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585329|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
14585330|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585331|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
14585332|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585333|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585334|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585335|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
14585336|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585337|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585338|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14585339|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
14585340|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585341|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
14585342|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585343|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585344|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585345|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
14585346|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585347|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585348|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14585349|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
14585350|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585351|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
14585352|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585353|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585354|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585355|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
14585356|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585357|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585358|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14585359|NCT00010426|Cysteamine|cysteamine|mesh-list
14585360|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14585361|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585362|NCT00010452|Picibanil|picibanil|mesh-list
14585363|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585364|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
14585365|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14585366|NCT00010686|Estrogens|estrogens|mesh-ancestor
14585367|NCT00010686|Hormones|hormones|mesh-ancestor
14585368|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585369|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585370|NCT00010699|Vitamin E|vitamin e|mesh-list
14585371|NCT00010699|Vitamins|vitamins|mesh-ancestor
14585372|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
14585373|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585374|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
14585375|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585376|NCT00010699|Protective Agents|protective agents|mesh-ancestor
14585377|NCT00010725|Vitamins|vitamins|mesh-list
14585378|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
14585379|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585380|NCT00010842|Vitamin E|vitamin e|mesh-list
14585381|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
14585382|NCT00010842|Selenium|selenium|mesh-list
14585383|NCT00010842|Vitamins|vitamins|mesh-ancestor
14585384|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
14585385|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585386|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
14585387|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585388|NCT00010842|Protective Agents|protective agents|mesh-ancestor
14585389|NCT00010842|Trace Elements|trace elements|mesh-ancestor
14585390|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
14585391|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14585392|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154856|NCT04173039|Antibodies|antibodies|mesh-list
14585393|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585394|NCT00010881|Antioxidants|antioxidants|mesh-list
15154857|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
14585395|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585396|NCT00010881|Protective Agents|protective agents|mesh-ancestor
14585397|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585398|NCT00011076|Pirfenidone|pirfenidone|mesh-list
14585399|NCT00011076|Analgesics|analgesics|mesh-ancestor
14585400|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
14585401|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585402|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154858|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154859|NCT04172961|Cyclosporine|cyclosporine|mesh-list
15154860|NCT04172961|Lifitegrast|lifitegrast|mesh-list
15154861|NCT04172961|Cyclosporins|cyclosporins|mesh-list
15154862|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154863|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154864|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154865|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
15154866|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585403|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14585404|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14585405|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585406|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585407|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585408|NCT00011089|Tenofovir|tenofovir|mesh-list
14585409|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
14585410|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585411|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14585412|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14585413|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585414|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585415|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15154867|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
15154868|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154869|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
15154870|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154871|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15154872|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15154873|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15154874|NCT04172987|Tirzepatide|tirzepatide|mesh-list
15154875|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14585416|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14644420|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14644421|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14644422|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14644423|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14644424|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644425|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14644426|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644427|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644428|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644429|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644430|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
14644431|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14644432|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
14644433|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14644434|NCT00191568|Gemcitabine|gemcitabine|mesh-list
14644435|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
14644436|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644437|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
14644438|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644439|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644440|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
14644441|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644442|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644443|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644444|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
14644445|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644446|NCT00191581|Insulin|insulin|mesh-list
14644447|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
14644448|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14644449|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
14644450|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14644451|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154876|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644452|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15154877|NCT04172987|Incretins|incretins|mesh-ancestor
15154878|NCT04172987|Hormones|hormones|mesh-ancestor
15154879|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154880|NCT04172922|Sirolimus|sirolimus|mesh-list
15154881|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585417|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14585418|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
14585419|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585420|NCT00011297|Gabapentin|gabapentin|mesh-list
14585421|NCT00011297|Lorazepam|lorazepam|mesh-list
14585422|NCT00011297|Analgesics|analgesics|mesh-ancestor
14585423|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
14585424|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585425|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585426|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
14585427|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14585428|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14585429|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14585430|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14585431|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14585432|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14585433|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14585434|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585435|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
14585436|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
14585437|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
14585438|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14585439|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14585440|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
14585441|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
14585442|NCT00011362|Dexamethasone|dexamethasone|mesh-list
14585443|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
14585444|NCT00011362|BB 1101|bb 1101|mesh-list
14585445|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585446|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
14585447|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
14585448|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585449|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585450|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14585451|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
14585452|NCT00011362|Hormones|hormones|mesh-ancestor
14585453|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15154882|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154883|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15154884|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154885|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
15154886|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154887|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
15154888|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154889|NCT04172727|Bupivacaine|bupivacaine|mesh-list
15154890|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
15154891|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
15154892|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154893|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154894|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
15154895|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154896|NCT04172844|Azacitidine|azacitidine|mesh-list
15154897|NCT04172844|Venetoclax|venetoclax|mesh-list
15154898|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15154899|NCT04172844|Pevonedistat|pevonedistat|mesh-list
15154900|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15154901|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
15154902|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154903|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154904|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
15154905|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15154906|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
15154907|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154908|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15154909|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154910|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15154911|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154912|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14021582|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585454|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585455|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585456|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
14585457|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585458|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585459|NCT00011375|Rolipram|rolipram|mesh-list
14585460|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
14585461|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14585462|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14585463|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14585464|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585465|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585466|NCT00011479|Abacavir|abacavir|mesh-list
14585467|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14585468|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14585469|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585470|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585471|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
14585472|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585473|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14585474|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14585475|NCT00011635|Silymarin|silymarin|mesh-list
14585476|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
14585477|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585478|NCT00011635|Protective Agents|protective agents|mesh-ancestor
14585479|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585480|NCT00011765|Fluoxetine|fluoxetine|mesh-list
14585481|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14585482|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14585483|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14585484|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585485|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14585486|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
14585487|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585488|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14585489|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
14585490|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14585491|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14585492|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14585493|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585494|NCT00011778|Bortezomib|bortezomib|mesh-list
14585495|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585496|NCT00011804|Topiramate|topiramate|mesh-list
14585497|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
14585498|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14585499|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585500|NCT00011895|Lamivudine|lamivudine|mesh-list
14585501|NCT00011895|Zidovudine|zidovudine|mesh-list
15154913|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154914|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15154915|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154916|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15154917|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154918|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154919|NCT04172740|Calcium|calcium|mesh-list
15154920|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15154921|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154922|NCT04172363|Octenidine|octenidine|mesh-list
14585502|NCT00011895|Efavirenz|efavirenz|mesh-list
14585503|NCT00011895|Abacavir|abacavir|mesh-list
14585504|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14585505|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14585506|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585507|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585508|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
14585509|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585510|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14585511|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14585512|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
14585513|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14585514|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14585515|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14585516|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15154923|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154924|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15154925|NCT04172311|Levetiracetam|levetiracetam|mesh-list
15154926|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
14585517|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14585518|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14585519|NCT00011908|Epratuzumab|epratuzumab|mesh-list
14585520|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14585521|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585522|NCT00011921|Paclitaxel|paclitaxel|mesh-list
14585523|NCT00011921|Etoposide|etoposide|mesh-list
14585524|NCT00011921|Carboplatin|carboplatin|mesh-list
14585525|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
15154927|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
15154928|NCT04172220|Midazolam|midazolam|mesh-list
15154929|NCT04172220|Anesthetics|anesthetics|mesh-list
15154930|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15154931|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154932|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15154933|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15154934|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15154935|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15154936|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15154937|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15154938|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
15154939|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
15154940|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
15154941|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154942|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154943|NCT04172064|Dobutamine|dobutamine|mesh-list
15154944|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14585526|NCT00011921|Epirubicin|epirubicin|mesh-list
14585527|NCT00011921|Ifosfamide|ifosfamide|mesh-list
14585528|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14585529|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585530|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585531|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585532|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585533|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585534|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14585535|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585536|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585537|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585538|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585539|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
14585540|NCT00011934|Interferons|interferons|mesh-list
14585541|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
14585542|NCT00011934|Sargramostim|sargramostim|mesh-list
14585543|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585544|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
14585545|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585546|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
14585547|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585548|NCT00011960|Paclitaxel|paclitaxel|mesh-list
14585549|NCT00011960|Cisplatin|cisplatin|mesh-list
14585550|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15154945|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
15154946|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
15154947|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15154948|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154949|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15154950|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15154951|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15154952|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
15154953|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15154954|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154955|NCT04172064|Protective Agents|protective agents|mesh-ancestor
14585551|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585552|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585553|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585554|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585555|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585556|NCT00011973|Fenretinide|fenretinide|mesh-list
14585557|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585558|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14585559|NCT00011973|Protective Agents|protective agents|mesh-ancestor
14585560|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585561|NCT00011999|Paclitaxel|paclitaxel|mesh-list
14585562|NCT00011999|Cisplatin|cisplatin|mesh-list
14585563|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15154956|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
15154957|NCT04172259|Docetaxel|docetaxel|mesh-list
14585564|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585565|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585566|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585567|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585568|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585569|NCT00012025|Fulvestrant|fulvestrant|mesh-list
14585570|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585571|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585572|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14585573|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14585574|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585575|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585576|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585577|NCT00012038|Irofulven|irofulven|mesh-list
14585578|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585579|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
14585580|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585581|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585582|NCT00012051|Cytarabine|cytarabine|mesh-list
14585583|NCT00012051|Dexamethasone|dexamethasone|mesh-list
14585584|NCT00012051|Rituximab|rituximab|mesh-list
15154958|NCT04172259|Doxorubicin|doxorubicin|mesh-list
15154959|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14585585|NCT00012051|Methotrexate|methotrexate|mesh-list
14585586|NCT00012051|Etoposide|etoposide|mesh-list
14585587|NCT00012051|Melphalan|melphalan|mesh-list
14585588|NCT00012051|Ifosfamide|ifosfamide|mesh-list
14585589|NCT00012051|Carmustine|carmustine|mesh-list
14585590|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585591|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585592|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
14585593|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
14585594|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585595|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585596|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14585597|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
14585598|NCT00012051|Hormones|hormones|mesh-ancestor
14585599|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585600|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585601|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14585602|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
14585603|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585604|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14585605|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
14585606|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14585607|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585608|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
14585609|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585610|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
14585611|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585612|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14585613|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585614|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14585615|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14585616|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14585617|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585618|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
14585619|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585620|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585621|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
14585622|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15154960|NCT04172259|Trastuzumab|trastuzumab|mesh-list
15154961|NCT04172259|Epirubicin|epirubicin|mesh-list
14585623|NCT00012090|Goserelin|goserelin|mesh-list
14585624|NCT00012090|Bicalutamide|bicalutamide|mesh-list
14585625|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585626|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585627|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
14585628|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585629|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585630|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585631|NCT00012116|Temozolomide|temozolomide|mesh-list
14585632|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585633|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
15154962|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15154963|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
15154964|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15154965|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15154966|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15154967|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
15154968|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154969|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154970|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15154971|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
15154972|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
15154973|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
15154974|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15154975|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15154976|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15154977|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154978|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15180287|NCT03941886|Analgesics|analgesics|mesh-ancestor
15180288|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
15180289|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180290|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180291|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585634|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585635|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585636|NCT00012129|Annamycin|annamycin|mesh-list
15180292|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15180293|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15180294|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14585637|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585638|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585639|NCT00012142|Sirolimus|sirolimus|mesh-list
14585640|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585641|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585642|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585643|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585644|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
14585645|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585646|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
14585647|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585648|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
15180295|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180296|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14021583|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
14021584|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14021585|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021586|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585649|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14585650|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180297|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15180298|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180299|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
15180300|NCT03942068|Paclitaxel|paclitaxel|mesh-list
15180301|NCT03942068|Apatinib|apatinib|mesh-list
15180302|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15180303|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180304|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180305|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
15180306|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585651|NCT00012181|Alvocidib|alvocidib|mesh-list
14585652|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585653|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
14585654|NCT00012181|Growth Substances|growth substances|mesh-ancestor
14585655|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585656|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14585657|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585658|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585659|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14585660|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585661|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14585662|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585663|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585664|NCT00012207|Aldesleukin|aldesleukin|mesh-list
14585665|NCT00012207|Prednisone|prednisone|mesh-list
14585666|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
14585667|NCT00012207|Vincristine|vincristine|mesh-list
14585668|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585669|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
14585670|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585671|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585672|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14585673|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
14585674|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585675|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585676|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14585677|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585678|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
14585679|NCT00012207|Hormones|hormones|mesh-ancestor
14585680|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585681|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14585682|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14585683|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585684|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585685|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585686|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14585687|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14585688|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
14585689|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585690|NCT00012220|Gemcitabine|gemcitabine|mesh-list
14585691|NCT00012220|Docetaxel|docetaxel|mesh-list
14585692|NCT00012220|Irinotecan|irinotecan|mesh-list
14585693|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585694|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585695|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
14585696|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585697|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
14585698|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585699|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585700|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585701|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
14585702|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585703|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585704|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585705|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585706|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14585707|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585708|NCT00012246|Sargramostim|sargramostim|mesh-list
14585709|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
14585710|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
14585711|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585712|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14585713|NCT00012259|Troxacitabine|troxacitabine|mesh-list
14585714|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585715|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15154979|NCT04171791|Venetoclax|venetoclax|mesh-list
15154980|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585716|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14585717|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
14585718|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585719|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
14585720|NCT00012311|Ifosfamide|ifosfamide|mesh-list
14585721|NCT00012311|Thiotepa|thiotepa|mesh-list
14585722|NCT00012311|Carboplatin|carboplatin|mesh-list
14585723|NCT00012311|Docetaxel|docetaxel|mesh-list
14585724|NCT00012311|Doxorubicin|doxorubicin|mesh-list
14585725|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14585726|NCT00012311|Fluorouracil|fluorouracil|mesh-list
14585727|NCT00012311|Methotrexate|methotrexate|mesh-list
14585728|NCT00012311|Etoposide|etoposide|mesh-list
14585729|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585730|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
14585731|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585732|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585733|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15180307|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
15180308|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180309|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180310|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180311|NCT03942458|Clopidogrel|clopidogrel|mesh-list
15180312|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14585734|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
14585735|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585736|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585737|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14585738|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14585739|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14585740|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14585741|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585742|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14585743|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585744|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585745|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
14585746|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585747|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14585748|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
14585749|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15154981|NCT04171726|Edoxaban|edoxaban|mesh-list
15154982|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15154983|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
15154984|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15154985|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
15154986|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154987|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154988|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
15154989|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
15154990|NCT04171622|Lenvatinib|lenvatinib|mesh-list
15154991|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15154992|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15154993|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15154994|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15154995|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15154996|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
15154997|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15154998|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15154999|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
15155000|NCT04171687|Clopidogrel|clopidogrel|mesh-list
15155001|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15155002|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15155003|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15155004|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15155005|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
15155006|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155007|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155008|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585750|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14585751|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14585752|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14585753|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14585754|NCT00012324|Doxorubicin|doxorubicin|mesh-list
14585755|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14585756|NCT00012324|Nolatrexed|nolatrexed|mesh-list
14585757|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14585758|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585759|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14585760|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585761|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585762|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585763|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15155009|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
15155010|NCT04171843|Fludarabine|fludarabine|mesh-list
15155011|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155012|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
15155013|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155014|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155015|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15155016|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
15155017|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155018|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155019|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15155020|NCT04171388|Micronutrients|micronutrients|mesh-list
15155021|NCT04171388|Trace Elements|trace elements|mesh-list
15155022|NCT04171388|Azithromycin|azithromycin|mesh-list
15155023|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155024|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155025|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155026|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
14585764|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
15155027|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
14585765|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14585766|NCT00012337|Gefitinib|gefitinib|mesh-list
15155028|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15155029|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585767|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585768|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14585769|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585770|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585771|NCT00012350|Tipifarnib|tipifarnib|mesh-list
14585772|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585773|NCT00012363|Gemcitabine|gemcitabine|mesh-list
14585774|NCT00012363|Irinotecan|irinotecan|mesh-list
14585775|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14585776|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
14585777|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585778|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585779|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
14585780|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585781|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585782|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585783|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
14585784|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585785|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14585786|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585787|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
14585788|NCT00012376|Sargramostim|sargramostim|mesh-list
14585789|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
14585790|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585791|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585792|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14585793|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
14585794|NCT00012389|Irinotecan|irinotecan|mesh-list
14585795|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585796|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15155030|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155031|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
15155032|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15155033|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155034|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155035|NCT04171739|Itraconazole|itraconazole|mesh-list
15155036|NCT04171739|Olorofim|olorofim|mesh-list
15155037|NCT04171739|Rifampin|rifampin|mesh-list
15155038|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
15155039|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155040|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15155041|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15155042|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155043|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155044|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15155045|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
15155046|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155047|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155048|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15155049|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15155050|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
15155051|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155052|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
15155053|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15155054|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15155055|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15155056|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15155057|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15155058|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15155059|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15155060|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
15155061|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
15155062|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585797|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14585798|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585799|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585800|NCT00012467|Interferons|interferons|mesh-list
14585801|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
14585802|NCT00012467|Itraconazole|itraconazole|mesh-list
14585803|NCT00012467|Fluconazole|fluconazole|mesh-list
14585804|NCT00012467|Amphotericin B|amphotericin b|mesh-list
15155063|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155064|NCT04171466|Metronidazole|metronidazole|mesh-list
14585805|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14585806|NCT00012467|Flucytosine|flucytosine|mesh-list
14585807|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585808|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
14585809|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585810|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
14585811|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14585812|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14585813|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585814|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585815|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14585816|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
14585817|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585818|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585819|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14585820|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14585821|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14585822|NCT00012467|Amebicides|amebicides|mesh-ancestor
14585823|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14585824|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14585825|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585826|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
14585827|NCT00012506|Etanercept|etanercept|mesh-list
14585828|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14585829|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14585830|NCT00012506|Analgesics|analgesics|mesh-ancestor
14585831|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
14585832|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585833|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585834|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14585835|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14585836|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14585837|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14585838|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
14585839|NCT00012519|Ritonavir|ritonavir|mesh-list
14585840|NCT00012519|Indinavir|indinavir|mesh-list
15155065|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
15155066|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021587|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021588|NCT02773017|Analgesics|analgesics|mesh-ancestor
14021589|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
14021590|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021591|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14021592|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14021593|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14021594|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14021595|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021596|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021597|NCT02773147|Pyridoxine|pyridoxine|mesh-list
14021598|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
14021599|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
14021600|NCT02773147|Hematinics|hematinics|mesh-ancestor
14021601|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
15155067|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155068|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15155069|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15155070|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15155071|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15155072|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155073|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155074|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155075|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15155076|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15155077|NCT04171180|Budesonide|budesonide|mesh-list
15155078|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
15155079|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155080|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15155081|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
15155082|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155083|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021602|NCT02773147|Vitamins|vitamins|mesh-ancestor
14021603|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
14021604|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585841|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14585842|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14585843|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
14585844|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585845|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585846|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14585847|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14585848|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
14585849|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585850|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14585851|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14585852|NCT00012558|Inositol|inositol|mesh-list
14585853|NCT00012558|Lamotrigine|lamotrigine|mesh-list
14585854|NCT00012558|Valproic Acid|valproic acid|mesh-list
14585855|NCT00012558|Risperidone|risperidone|mesh-list
14585856|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
14585857|NCT00012558|Bupropion|bupropion|mesh-list
14585858|NCT00012558|Paroxetine|paroxetine|mesh-list
14585859|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14585860|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
14585861|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14585862|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585863|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585864|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14585865|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14585866|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14585867|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14585868|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14585869|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
14585870|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14585871|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
14585872|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14585873|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14585874|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14585875|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14585876|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14585877|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585878|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
14585879|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14585880|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
14585881|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14585882|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14585883|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14585884|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
14585885|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
14585886|NCT00012558|Vitamins|vitamins|mesh-ancestor
14585887|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
14585888|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14585889|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14585890|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
14585891|NCT00012584|Methylphenidate|methylphenidate|mesh-list
14585892|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14585893|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585894|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14585895|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14585896|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14585897|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585898|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
14585899|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14585900|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14585901|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14585902|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14585903|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14585904|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14585905|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
14585906|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14585907|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14585908|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14585909|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14585910|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585911|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14585912|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
14585913|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14585914|NCT00012688|Doxycycline|doxycycline|mesh-list
14585915|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14585916|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585917|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
14585918|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
14585919|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14585920|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
14585921|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14585922|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14644453|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644454|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644455|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644456|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644457|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644458|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644459|NCT00191594|Analgesics|analgesics|mesh-ancestor
14644460|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
14644461|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644462|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644463|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644464|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
14644465|NCT00191607|Gemcitabine|gemcitabine|mesh-list
14644466|NCT00191607|Doxorubicin|doxorubicin|mesh-list
14644467|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14644468|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644469|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
14644470|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644471|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155084|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15155085|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
14644472|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
14644473|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644474|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644475|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644476|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
14644477|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644478|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14644479|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14644480|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14644481|NCT00191620|Gemcitabine|gemcitabine|mesh-list
14644482|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644483|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644484|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
14644485|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644486|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
14644487|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644488|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644489|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644490|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
14644491|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644492|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644493|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644494|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644495|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644496|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644497|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644498|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644499|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644500|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644501|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644502|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644503|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644504|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644505|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644506|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644507|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644508|NCT00191672|Gemcitabine|gemcitabine|mesh-list
15155086|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
15155087|NCT04171180|Hormones|hormones|mesh-ancestor
15155088|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155089|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15155090|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15155091|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14585923|NCT00012857|Acetaminophen|acetaminophen|mesh-list
14585924|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14585925|NCT00012857|Analgesics|analgesics|mesh-ancestor
14585926|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
14585927|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14585928|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585929|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
14585930|NCT00012909|Hormones|hormones|mesh-list
14585931|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14585932|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585933|NCT00013520|Lamivudine|lamivudine|mesh-list
14585934|NCT00013520|Zidovudine|zidovudine|mesh-list
14585935|NCT00013520|Efavirenz|efavirenz|mesh-list
14585936|NCT00013520|Nevirapine|nevirapine|mesh-list
14585937|NCT00013520|Abacavir|abacavir|mesh-list
14585938|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
14585939|NCT00013520|Stavudine|stavudine|mesh-list
14585940|NCT00013520|Didanosine|didanosine|mesh-list
14585941|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14585942|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14585943|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14585944|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14585945|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585946|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585947|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
14585948|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585949|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14585950|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14585951|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
14585952|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14585953|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14585954|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14585955|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15155092|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
15155093|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155094|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155095|NCT04171193|Isoflurane|isoflurane|mesh-list
15155096|NCT04171193|Sertraline|sertraline|mesh-list
15155097|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
15155098|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15155099|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15155100|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15155101|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155102|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155103|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155104|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
15155105|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155106|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15155107|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
15155108|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
15155109|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155110|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
15155111|NCT04171349|Carticaine|carticaine|mesh-list
15155112|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15155113|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155114|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155115|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14585956|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14585957|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14585958|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14585959|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14585960|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
14585961|NCT00013585|Selegiline|selegiline|mesh-list
15155116|NCT04171349|Analgesics|analgesics|mesh-ancestor
15155117|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
15155118|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155119|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15155120|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15155121|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15155122|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
15155123|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14585962|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
14585963|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14585964|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14585965|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14585966|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14585967|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585968|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585969|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14585970|NCT00013585|Protective Agents|protective agents|mesh-ancestor
14585971|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585972|NCT00013598|Pioglitazone|pioglitazone|mesh-list
14585973|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14585974|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585975|NCT00013624|Levodopa|levodopa|mesh-list
14585976|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14585977|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14585978|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
14585979|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14585980|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585981|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14585982|NCT00013663|Aldesleukin|aldesleukin|mesh-list
14585983|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14585984|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14585985|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14585986|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
14585987|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585988|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
14585989|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
14585990|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14585991|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
14585992|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14585993|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14585994|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14585995|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14585996|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14585997|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14585998|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14585999|NCT00013689|Renal Agents|renal agents|mesh-ancestor
14586000|NCT00013702|Adefovir|adefovir|mesh-list
14586001|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
15155124|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155125|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
14586002|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586003|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14586004|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14586005|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586006|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586007|NCT00013871|Vaccines|vaccines|mesh-list
14586008|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14586009|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
14586010|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586011|NCT00013962|Vitamin D|vitamin d|mesh-list
14586012|NCT00013962|Vitamins|vitamins|mesh-ancestor
15155126|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
15155127|NCT04171284|Docetaxel|docetaxel|mesh-list
15155128|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155129|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
15155130|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
15155131|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586013|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
14586014|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586015|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14586016|NCT00014001|Olanzapine|olanzapine|mesh-list
14586017|NCT00014001|Risperidone|risperidone|mesh-list
14586018|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14586019|NCT00014001|Ziprasidone|ziprasidone|mesh-list
14586020|NCT00014001|Clozapine|clozapine|mesh-list
14586021|NCT00014001|Perphenazine|perphenazine|mesh-list
14586022|NCT00014001|Fluphenazine|fluphenazine|mesh-list
14586023|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
14586024|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
15155132|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155133|NCT04171050|Anesthetics|anesthetics|mesh-list
15155134|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
15155135|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155136|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155137|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
14586025|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14586026|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
14586027|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586028|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586029|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586030|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15155138|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155139|NCT04170855|Furosemide|furosemide|mesh-list
15155140|NCT04170855|Diuretics|diuretics|mesh-ancestor
14586031|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14586032|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586033|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14586034|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14586035|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
14586036|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
14586037|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
14586038|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586039|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14586040|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14586041|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14586042|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586043|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
14586044|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
14586045|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
14586046|NCT00014014|Lamivudine|lamivudine|mesh-list
14586047|NCT00014014|Zidovudine|zidovudine|mesh-list
14586048|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14586049|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14586050|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14586051|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586052|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586053|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
14586054|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586055|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14586056|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14586057|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
14586058|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
14586059|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14021605|NCT02772822|Rituximab|rituximab|mesh-list
14021606|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14021607|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021608|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
14021609|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586060|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
14586061|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586062|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586063|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14586064|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
14586065|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14586066|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
14586067|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586068|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586069|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15155141|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
15155142|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155143|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15155144|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155145|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155146|NCT04170751|Vasopressins|vasopressins|mesh-list
15155147|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
15155148|NCT04170751|Norepinephrine|norepinephrine|mesh-list
15155149|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15155150|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15155151|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
15155152|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155153|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155154|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155155|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
15155156|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
15155157|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155158|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15155159|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
15155160|NCT04170751|Coagulants|coagulants|mesh-ancestor
15155161|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15155162|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
14586070|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
14586071|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
14586072|NCT00014040|Protective Agents|protective agents|mesh-ancestor
15155163|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
14586073|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14586074|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
14586075|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14586076|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
14586077|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586078|NCT00014092|Interferons|interferons|mesh-list
14586079|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
14586080|NCT00014092|Aldesleukin|aldesleukin|mesh-list
14586081|NCT00014092|Temozolomide|temozolomide|mesh-list
14586082|NCT00014092|Sargramostim|sargramostim|mesh-list
14586083|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586084|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
14586085|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586086|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586087|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
14586088|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586089|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
14586090|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586091|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14586092|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14586093|NCT00014105|Carboplatin|carboplatin|mesh-list
14586094|NCT00014105|Temozolomide|temozolomide|mesh-list
14586095|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586096|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586097|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
14586098|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586099|NCT00014118|Paclitaxel|paclitaxel|mesh-list
14586100|NCT00014118|Carboplatin|carboplatin|mesh-list
14586101|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586102|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586103|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586104|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586105|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586106|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155164|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155165|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155166|NCT04170959|Metformin|metformin|mesh-list
15155167|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15155168|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155169|NCT04170595|Trastuzumab|trastuzumab|mesh-list
15155170|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155171|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155172|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
15155173|NCT04170530|Irinotecan|irinotecan|mesh-list
15155174|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155175|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15155176|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15155177|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155178|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155179|NCT04170790|Saxagliptin|saxagliptin|mesh-list
15155180|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
15155181|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
15155182|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15155183|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15155184|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155185|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155186|NCT04170790|Urological Agents|urological agents|mesh-ancestor
15155187|NCT04170790|Incretins|incretins|mesh-ancestor
15155188|NCT04170790|Hormones|hormones|mesh-ancestor
15155189|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155190|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155191|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15155192|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
15155193|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15155194|NCT04170647|Plasminogen|plasminogen|mesh-list
15155195|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15155196|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15155197|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155198|NCT04170439|Chromium|chromium|mesh-list
15155199|NCT04170439|Metformin|metformin|mesh-list
15155200|NCT04170439|Citric Acid|citric acid|mesh-list
15155201|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
15155202|NCT04170439|Clomiphene|clomiphene|mesh-list
15155203|NCT04170439|Enclomiphene|enclomiphene|mesh-list
14586107|NCT00014144|Gefitinib|gefitinib|mesh-list
14586108|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586109|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14586110|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586111|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586112|NCT00014170|Gefitinib|gefitinib|mesh-list
14586113|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586114|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14586115|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586116|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586117|NCT00014183|Gefitinib|gefitinib|mesh-list
14586118|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586119|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14586120|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586121|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586122|NCT00014196|Docetaxel|docetaxel|mesh-list
14586123|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586124|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586125|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586126|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
15155204|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
15155205|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15155206|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155207|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
15155208|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15155209|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
15155210|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
15155211|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155212|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14586127|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586128|NCT00014209|Gemcitabine|gemcitabine|mesh-list
14586129|NCT00014209|Dexamethasone|dexamethasone|mesh-list
14586130|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586131|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14586132|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
14586133|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
15155213|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
15155214|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155215|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15155216|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
15155217|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15155218|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15155219|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15155220|NCT04170439|Trace Elements|trace elements|mesh-ancestor
15155221|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
15155222|NCT04170504|Methotrexate|methotrexate|mesh-list
15155223|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15155224|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
15155225|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15155226|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155227|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15155228|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
15155229|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155230|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155231|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
15155232|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155233|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15155234|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155235|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
15155236|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155237|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15155238|NCT04170270|Omeprazole|omeprazole|mesh-list
15155239|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15155240|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15155241|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15155242|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155243|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155244|NCT04170179|Lenvatinib|lenvatinib|mesh-list
15155245|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155246|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15155247|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155248|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155249|NCT04170465|Metformin|metformin|mesh-list
15155250|NCT04170465|Paclitaxel|paclitaxel|mesh-list
15155251|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
15155252|NCT04170465|Doxorubicin|doxorubicin|mesh-list
15155253|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14644509|NCT00191672|Paclitaxel|paclitaxel|mesh-list
14586134|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586135|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586136|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14586137|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
14586138|NCT00014209|Hormones|hormones|mesh-ancestor
14586139|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586140|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14586141|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586142|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
14586143|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586144|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
14586145|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586146|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586147|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586148|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
14586149|NCT00014235|Cyclosporine|cyclosporine|mesh-list
14586150|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
14586151|NCT00014235|Fludarabine|fludarabine|mesh-list
14586152|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
14586153|NCT00014235|Cyclosporins|cyclosporins|mesh-list
14586154|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586155|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586156|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
14586157|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586158|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586159|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
14586160|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586161|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586162|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
14586163|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586164|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
14586165|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586166|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14586167|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14586168|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14586169|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
14586170|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14586171|NCT00014248|Adenosine|adenosine|mesh-list
14586172|NCT00014248|Analgesics|analgesics|mesh-ancestor
14586173|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
14586174|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586175|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586176|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14586177|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
14586178|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14586179|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
14586180|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
14586181|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586182|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586183|NCT00014261|Interferons|interferons|mesh-list
14586184|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
14586185|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
15155254|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155255|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
15155256|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
15155257|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
15155258|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155259|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155260|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
15155261|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155262|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155263|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15155264|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
15155265|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15155266|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15155267|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15155268|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15155269|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15155270|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155271|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
15155272|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
15155273|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155274|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155275|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
14586186|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14586187|NCT00014261|Temozolomide|temozolomide|mesh-list
14586188|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586189|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
14586190|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586191|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586192|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
14586193|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586194|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
14586195|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586196|NCT00014274|Gemcitabine|gemcitabine|mesh-list
14586197|NCT00014274|Carboplatin|carboplatin|mesh-list
14586198|NCT00014274|Methotrexate|methotrexate|mesh-list
14586199|NCT00014274|Vinblastine|vinblastine|mesh-list
14586200|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586201|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586202|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
14586203|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586204|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
14586205|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586206|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586207|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586208|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
14586209|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586210|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14586211|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
14586212|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14586213|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
14586214|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14586215|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586216|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14586217|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586218|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586219|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586220|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586221|NCT00014287|Gemcitabine|gemcitabine|mesh-list
14586222|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586223|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
14586224|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586225|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586226|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
14586227|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586228|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586229|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586230|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
14586231|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586232|NCT00014313|Etoposide|etoposide|mesh-list
14586233|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586234|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586235|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14586236|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586237|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155276|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15155277|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15155278|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155279|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
15155280|NCT04170088|Coagulants|coagulants|mesh-ancestor
15155281|NCT04169945|Erythritol|erythritol|mesh-list
15155282|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
15155283|NCT04169867|Nivolumab|nivolumab|mesh-list
15155284|NCT04169867|Ipilimumab|ipilimumab|mesh-list
15155285|NCT04169867|Atezolizumab|atezolizumab|mesh-list
15155286|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155287|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155288|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15155289|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155290|NCT04169854|Lidocaine|lidocaine|mesh-list
15155291|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
15155292|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
15155293|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155294|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155295|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
15155296|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155297|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15155298|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14644510|NCT00191672|Docetaxel|docetaxel|mesh-list
15155299|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15155300|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155301|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180313|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15180314|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15180315|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15180316|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
15180317|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586238|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586239|NCT00014339|Prednisone|prednisone|mesh-list
14586240|NCT00014339|Melphalan|melphalan|mesh-list
14586241|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14586242|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
14586243|NCT00014339|Hormones|hormones|mesh-ancestor
14586244|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586245|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586246|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14586247|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586248|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586249|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
14586250|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586251|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14586252|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586253|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
14586254|NCT00014352|Ketoconazole|ketoconazole|mesh-list
14586255|NCT00014352|Docetaxel|docetaxel|mesh-list
14586256|NCT00014352|Doxorubicin|doxorubicin|mesh-list
14586257|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14586258|NCT00014352|Estramustine|estramustine|mesh-list
14586259|NCT00014352|Warfarin|warfarin|mesh-list
14586260|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586261|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586262|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586263|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586264|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586265|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15180318|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180319|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180320|NCT03941561|Tegafur|tegafur|mesh-list
15180321|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15180322|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
15180323|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180324|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180325|NCT03941795|Axitinib|axitinib|mesh-list
15180326|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180327|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180328|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180329|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180330|NCT03941587|Aflibercept|aflibercept|mesh-list
15180331|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15180332|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15180333|NCT03941587|Growth Substances|growth substances|mesh-ancestor
15180334|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180335|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
15180336|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586266|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14586267|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586268|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180337|NCT03941496|Azacitidine|azacitidine|mesh-list
15180338|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15180339|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
15180340|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180341|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180342|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180343|NCT03941535|Vitamin K|vitamin k|mesh-list
15180344|NCT03941535|Vitamins|vitamins|mesh-ancestor
15180345|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
15180346|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180347|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15180348|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15180349|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180350|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
15180351|NCT03941535|Coagulants|coagulants|mesh-ancestor
14586269|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
14586270|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
14586271|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586272|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14586273|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14586274|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14586275|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
14586276|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586277|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586278|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14586279|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586280|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
14586281|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14586282|NCT00014391|Ribavirin|ribavirin|mesh-list
14586283|NCT00014391|Palivizumab|palivizumab|mesh-list
14586284|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
14586285|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586286|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
14586287|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586288|NCT00014404|Celecoxib|celecoxib|mesh-list
14586289|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14586290|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14586291|NCT00014404|Analgesics|analgesics|mesh-ancestor
14586292|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
15155302|NCT04169841|Durvalumab|durvalumab|mesh-list
15155303|NCT04169841|Olaparib|olaparib|mesh-list
15155304|NCT04169841|Tremelimumab|tremelimumab|mesh-list
15155305|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155306|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155307|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15155308|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155309|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155310|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
15155311|NCT04169919|Povidone|povidone|mesh-list
15155312|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
15155313|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
15155314|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15155315|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155316|NCT04169763|Nelfinavir|nelfinavir|mesh-list
15155317|NCT04169763|Cisplatin|cisplatin|mesh-list
15155318|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155319|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15155320|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15155321|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
15155322|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155323|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155324|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15155325|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15155326|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
15155327|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155328|NCT04169256|Bupivacaine|bupivacaine|mesh-list
15155329|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
15155330|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
15155331|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155332|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155333|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
15155334|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155335|NCT04169347|Leucovorin|leucovorin|mesh-list
15155336|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
15155337|NCT04169347|Irinotecan|irinotecan|mesh-list
15155338|NCT04169347|Panitumumab|panitumumab|mesh-list
15155339|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155340|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15155341|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15155342|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155343|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155344|NCT04169347|Antidotes|antidotes|mesh-ancestor
15155345|NCT04169347|Protective Agents|protective agents|mesh-ancestor
15155346|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155347|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
15155348|NCT04169347|Vitamins|vitamins|mesh-ancestor
15155349|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
15155350|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155351|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
15155352|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
15155353|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155354|NCT04169230|Citalopram|citalopram|mesh-list
15155355|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15180352|NCT03941340|Aflutinib|aflutinib|mesh-list
14586293|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586294|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586295|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14586296|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586297|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14586298|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14586299|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586300|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586301|NCT00014430|Trastuzumab|trastuzumab|mesh-list
14586302|NCT00014430|Vinorelbine|vinorelbine|mesh-list
14586303|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14586304|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586305|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586306|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586307|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586308|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586309|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586310|NCT00014443|Thalidomide|thalidomide|mesh-list
14586311|NCT00014443|Topotecan|topotecan|mesh-list
14586312|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14586313|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586314|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586315|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586316|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586317|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586318|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
14586319|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586320|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
15155356|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15155357|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155358|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155359|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155360|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
15155361|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155362|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15155363|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
15155364|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15155365|NCT04169269|Enoxaparin|enoxaparin|mesh-list
15155366|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
15155367|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15155368|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
15155369|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15155370|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
15155371|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155372|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155373|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
15155374|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15155375|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15155376|NCT04168931|Trastuzumab|trastuzumab|mesh-list
15155377|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155378|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155379|NCT04168879|Bupivacaine|bupivacaine|mesh-list
15155380|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
15155381|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
15155382|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155383|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155384|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
15155385|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155386|NCT04168944|Lenvatinib|lenvatinib|mesh-list
15155387|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15155388|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155389|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15155390|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155391|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155392|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
15155393|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155394|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
15155395|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15155396|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155397|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155398|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14586321|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155399|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586322|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586323|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14586324|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14586325|NCT00014443|Growth Substances|growth substances|mesh-ancestor
14586326|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
14586327|NCT00014456|Gemcitabine|gemcitabine|mesh-list
14586328|NCT00014456|Docetaxel|docetaxel|mesh-list
14586329|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586330|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
14586331|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586332|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586333|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
14586334|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586335|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155400|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155401|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155402|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155403|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15155404|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
15155405|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15155406|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155407|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15155408|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15155409|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15155410|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15155411|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155412|NCT04168619|Methotrexate|methotrexate|mesh-list
15155413|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15155414|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
15155415|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15155416|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155417|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15155418|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
15155419|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155420|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155421|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
15155422|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155423|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14586336|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586337|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
14586338|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586339|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586340|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586341|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586342|NCT00014469|Methotrexate|methotrexate|mesh-list
14586343|NCT00014469|Melphalan|melphalan|mesh-list
14586344|NCT00014469|Busulfan|busulfan|mesh-list
15155424|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155425|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
15155426|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155427|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15155428|NCT04168203|Apixaban|apixaban|mesh-list
15155429|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15155430|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
15155431|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15155432|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
15155433|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155434|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155435|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
15155436|NCT04168294|Propofol|propofol|mesh-list
15155437|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15155438|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155439|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155440|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15155441|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
15155442|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
15155443|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15155444|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
15155445|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155446|NCT04168138|Cytarabine|cytarabine|mesh-list
15155447|NCT04168138|Decitabine|decitabine|mesh-list
15155448|NCT04168138|Aclarubicin|aclarubicin|mesh-list
15155449|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586345|NCT00014469|Tacrolimus|tacrolimus|mesh-list
14586346|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14586347|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
14586348|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14586349|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586350|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586351|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
14586352|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586353|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586354|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
14586355|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586356|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14586357|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586358|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
14586359|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586360|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14586361|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14586362|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586363|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
14586364|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14586365|NCT00014508|Cyclosporine|cyclosporine|mesh-list
14586366|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
14586367|NCT00014508|Melphalan|melphalan|mesh-list
14586368|NCT00014508|Fludarabine|fludarabine|mesh-list
14586369|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
14586370|NCT00014508|Cyclosporins|cyclosporins|mesh-list
14586371|NCT00014508|Sargramostim|sargramostim|mesh-list
14586372|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586373|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
14586374|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586375|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586376|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15155450|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
15155451|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155452|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155453|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
14586377|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
14586378|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586379|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586380|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14586381|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586382|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
14586383|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586384|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
14586385|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586386|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
14586387|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14586388|NCT00014534|Gemcitabine|gemcitabine|mesh-list
14586389|NCT00014534|Doxorubicin|doxorubicin|mesh-list
14586390|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14586391|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586392|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586393|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
14586394|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586395|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
14586396|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586397|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586398|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586399|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
14586400|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586401|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14586402|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14586403|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586404|NCT00014547|BBR 3464|bbr 3464|mesh-list
14586405|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586406|NCT00014573|Aldesleukin|aldesleukin|mesh-list
14586407|NCT00014573|Paclitaxel|paclitaxel|mesh-list
14586408|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
15155454|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155455|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155456|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
15155457|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155458|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155459|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15155460|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15155461|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586409|NCT00014573|Carmustine|carmustine|mesh-list
14586410|NCT00014573|Sargramostim|sargramostim|mesh-list
14586411|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15155462|NCT04168099|Cefotaxime|cefotaxime|mesh-list
14586412|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586413|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586414|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586415|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586416|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586417|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586418|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
14586419|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586420|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586421|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586422|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
14586423|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14586424|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14586425|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14586426|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
14586427|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586428|NCT00014586|Goserelin|goserelin|mesh-list
14586429|NCT00014586|Bicalutamide|bicalutamide|mesh-list
14586430|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14586431|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586432|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
14586433|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
14586434|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586435|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586436|NCT00014599|Paclitaxel|paclitaxel|mesh-list
14586437|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586438|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586439|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586440|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586441|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586442|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586443|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14586444|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586445|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14586446|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586447|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586448|NCT00014638|Letrozole|letrozole|mesh-list
14586449|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586450|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14586451|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14586452|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586453|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586454|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14586455|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
14586456|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586457|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586458|NCT00014651|Vapreotide|vapreotide|mesh-list
14586459|NCT00014651|Analgesics|analgesics|mesh-ancestor
14586460|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
15155463|NCT04168099|Cefoxitin|cefoxitin|mesh-list
15155464|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
15155465|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155466|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155467|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15155468|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15155469|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155470|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155471|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180353|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180354|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180355|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180356|NCT03941288|Cannabidiol|cannabidiol|mesh-list
15180357|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
15180358|NCT03940976|Afatinib|afatinib|mesh-list
15180359|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180360|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180361|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180362|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180363|NCT03940742|Tirzepatide|tirzepatide|mesh-list
15180364|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180365|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180366|NCT03940742|Incretins|incretins|mesh-ancestor
15180367|NCT03940742|Hormones|hormones|mesh-ancestor
15182150|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14586461|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586462|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586463|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586464|NCT00014677|Interleukin-4|interleukin-4|mesh-list
14586465|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14586466|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
14586467|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586468|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586469|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586470|NCT00014690|Topotecan|topotecan|mesh-list
14586471|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14586472|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586473|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586474|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586475|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586476|NCT00014729|Isotretinoin|isotretinoin|mesh-list
14586477|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
14586478|NCT00014755|Prednisone|prednisone|mesh-list
14586479|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
14586480|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14586481|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586482|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
14586483|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586484|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586485|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586486|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
14586487|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155472|NCT04167774|Paclitaxel|paclitaxel|mesh-list
15155473|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15155474|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15155475|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155476|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
15155477|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
15155478|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
15155479|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155480|NCT04167982|Isotretinoin|isotretinoin|mesh-list
15155481|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15155482|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
15155483|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15155484|NCT04167566|Artemisinins|artemisinins|mesh-list
15155485|NCT04167566|Artemisinin|artemisinin|mesh-list
15155486|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
15155487|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15155488|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15155489|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155490|NCT04167306|Bupropion|bupropion|mesh-list
15155491|NCT04167306|Varenicline|varenicline|mesh-list
15155492|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15155493|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
15155494|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15155495|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15155496|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15155497|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155498|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155499|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
15155500|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155501|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155502|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15155503|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15155504|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155505|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15155506|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15155507|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
15155508|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
15155509|NCT04167696|Fludarabine|fludarabine|mesh-list
15155510|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
15155511|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155512|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
15155513|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155514|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155515|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15155516|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
15155517|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155518|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586488|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155519|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15155520|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15155521|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
15155522|NCT04167592|Benzydamine|benzydamine|mesh-list
15155523|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155524|NCT04167137|Atezolizumab|atezolizumab|mesh-list
15155525|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155526|NCT04167228|Ceftazidime|ceftazidime|mesh-list
15155527|NCT04167228|Avibactam|avibactam|mesh-list
15155528|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
15155529|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155530|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155531|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15155532|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155533|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155534|NCT04167280|Ipratropium|ipratropium|mesh-list
15155535|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15155536|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
15155537|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155538|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155539|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15155540|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
15155541|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15155542|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
14291691|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291692|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291693|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15155543|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155544|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155545|NCT04167085|Doxycycline|doxycycline|mesh-list
15155546|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155547|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155548|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
15155549|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15155550|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15155551|NCT04167111|Vitamin D|vitamin d|mesh-list
15155552|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
15155553|NCT04167111|Vitamins|vitamins|mesh-ancestor
15155554|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
15155555|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155556|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15155557|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15155558|NCT04166721|Atezolizumab|atezolizumab|mesh-list
15155559|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155560|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
15155561|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155562|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155563|NCT04166890|Epinephrine|epinephrine|mesh-list
15155564|NCT04166890|Carticaine|carticaine|mesh-list
15155565|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15155566|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15155567|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
15155568|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155569|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155570|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155571|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15155572|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15155573|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
15155574|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155575|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15155576|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
15155577|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
15155578|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
15155579|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15155580|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
14291694|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14291695|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14291696|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14291697|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291698|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291699|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291700|NCT00555893|Oseltamivir|oseltamivir|mesh-list
14291701|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
14291702|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291703|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293225|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155581|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
15155582|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155583|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
15155584|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
15155585|NCT04166877|Analgesics|analgesics|mesh-ancestor
15155586|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
15155587|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155588|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155589|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
15155590|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155591|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15155592|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
14586489|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14586490|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14586491|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
14586492|NCT00014755|Hormones|hormones|mesh-ancestor
14586493|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586494|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14586495|NCT00014937|Ritonavir|ritonavir|mesh-list
14586496|NCT00014937|Lopinavir|lopinavir|mesh-list
14586497|NCT00014937|Lamivudine|lamivudine|mesh-list
14586498|NCT00014937|Zidovudine|zidovudine|mesh-list
14586499|NCT00014937|Stavudine|stavudine|mesh-list
14586500|NCT00014937|Didanosine|didanosine|mesh-list
15155593|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15155594|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155595|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155596|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15155597|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
15155598|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15155599|NCT04166604|Trifluridine|trifluridine|mesh-list
15155600|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
15155601|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155602|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
15155603|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155604|NCT04167007|Gemcitabine|gemcitabine|mesh-list
15155605|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15155606|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
15155607|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155608|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155609|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
15155610|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155611|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155612|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155613|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
15155614|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155615|NCT04166786|Ethanol|ethanol|mesh-list
15155616|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
15155617|NCT04166786|Petrolatum|petrolatum|mesh-list
15155618|NCT04166786|Testosterone|testosterone|mesh-list
15155619|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
15155620|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
15155621|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15155622|NCT04166786|Androgens|androgens|mesh-ancestor
15155623|NCT04166786|Hormones|hormones|mesh-ancestor
15155624|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155625|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155626|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15155627|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155628|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
15155629|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15155630|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155631|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155632|NCT04166786|Emollients|emollients|mesh-ancestor
15155633|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
15155634|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
15155635|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15155636|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
15155637|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155638|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155639|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15155640|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
15155641|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15155642|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
15182151|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14586501|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14586502|NCT00014937|Efavirenz|efavirenz|mesh-list
14586503|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14586504|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14586505|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
14586506|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586507|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155643|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155644|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155645|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15155646|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
15155647|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
15155648|NCT04166812|Protective Agents|protective agents|mesh-ancestor
15155649|NCT04166578|Lidocaine|lidocaine|mesh-list
15155650|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
15155651|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
15155652|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155653|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155654|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
15155655|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155656|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15155657|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15155658|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15155659|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155660|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155661|NCT04166396|Resveratrol|resveratrol|mesh-list
15155662|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
15155663|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155664|NCT04166396|Protective Agents|protective agents|mesh-ancestor
15155665|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155666|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155667|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15155668|NCT04166474|Dolutegravir|dolutegravir|mesh-list
15155669|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15155670|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15155671|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155672|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155673|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15155674|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15155675|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
15155676|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155677|NCT04166565|Dexamethasone|dexamethasone|mesh-list
15155678|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
15155679|NCT04166565|Bortezomib|bortezomib|mesh-list
15155680|NCT04166565|Daratumumab|daratumumab|mesh-list
15155681|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155682|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
15155683|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155684|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155685|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15155686|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
15155687|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155688|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155689|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15155690|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155691|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
15155692|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
14586508|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15155693|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155694|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15155695|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
15155696|NCT04166565|Hormones|hormones|mesh-ancestor
15155697|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155698|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15155699|NCT04166006|Interleukin-2|interleukin-2|mesh-list
15155700|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155701|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15155702|NCT04166006|Analgesics|analgesics|mesh-ancestor
15155703|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
15155704|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155705|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155706|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
15155707|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15155708|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15155709|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
15155710|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586509|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14586510|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
14586511|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586512|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14586513|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14586514|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14586515|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14586516|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
14586517|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14586518|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14586519|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14586520|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14586521|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14586522|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
14586523|NCT00014989|Analgesics|analgesics|mesh-ancestor
15155711|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155712|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155713|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
15155714|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
15155715|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155716|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
15155717|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15155718|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
15155719|NCT04166292|Lidocaine|lidocaine|mesh-list
15155720|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
14586524|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
14586525|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155721|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
15155722|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155723|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155724|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
15155725|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155726|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15155727|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15155728|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15155729|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155730|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155731|NCT04166253|Vitamin D|vitamin d|mesh-list
15155732|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
15155733|NCT04166253|Vitamins|vitamins|mesh-ancestor
15155734|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
15155735|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155736|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15180368|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180369|NCT03940664|Formaldehyde|formaldehyde|mesh-list
15180370|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
15180371|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180372|NCT03940807|Estradiol|estradiol|mesh-list
15180373|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15180374|NCT03940807|Estrogens|estrogens|mesh-ancestor
15180375|NCT03940807|Hormones|hormones|mesh-ancestor
15180376|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180377|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180378|NCT03940651|Anesthetics|anesthetics|mesh-list
15180379|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
15180380|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180381|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182152|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182153|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
15182154|NCT03923959|Coagulants|coagulants|mesh-ancestor
15182155|NCT03923803|Calcitonin|calcitonin|mesh-list
15182156|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
15182157|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14586526|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586527|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
14586528|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586529|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14586530|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
14586531|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14586532|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586533|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182158|NCT03923803|Katacalcin|katacalcin|mesh-list
14586534|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14586535|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
14586536|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14586537|NCT00015028|Buprenorphine|buprenorphine|mesh-list
14586538|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14586539|NCT00015028|Naloxone|naloxone|mesh-list
14586540|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14586541|NCT00015028|Narcotics|narcotics|mesh-ancestor
14586542|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586543|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586544|NCT00015028|Analgesics|analgesics|mesh-ancestor
14586545|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
14586546|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155737|NCT04165967|Nivolumab|nivolumab|mesh-list
15155738|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155739|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155740|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15155741|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155742|NCT04166318|Fluorouracil|fluorouracil|mesh-list
15155743|NCT04166318|Capecitabine|capecitabine|mesh-list
15155744|NCT04166318|Mitomycins|mitomycins|mesh-list
15155745|NCT04166318|Mitomycin|mitomycin|mesh-list
15155746|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
15155747|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155748|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15155749|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155750|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155751|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
15155752|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155753|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15155754|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
15155755|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15155756|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155757|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
15155758|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15155759|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
15155760|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155761|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
15155762|NCT04165902|Protective Agents|protective agents|mesh-ancestor
15155763|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
15155764|NCT04165850|Celecoxib|celecoxib|mesh-list
15155765|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15155766|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15155767|NCT04165850|Analgesics|analgesics|mesh-ancestor
15155768|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
15155769|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155770|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155771|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155772|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155773|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15155774|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15155775|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155776|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155777|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155778|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155779|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15155780|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15155781|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155782|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15155783|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15155784|NCT04165512|Triamcinolone|triamcinolone|mesh-list
15155785|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15155786|NCT04165512|Bupivacaine|bupivacaine|mesh-list
15155787|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
15155788|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
15155789|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155790|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155791|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
15155792|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155793|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155794|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
14586547|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15155795|NCT04165512|Hormones|hormones|mesh-ancestor
14586548|NCT00015041|Buprenorphine|buprenorphine|mesh-list
15155796|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586549|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14586550|NCT00015041|Narcotics|narcotics|mesh-ancestor
14586551|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586552|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586553|NCT00015041|Analgesics|analgesics|mesh-ancestor
14586554|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
14586555|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155797|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15155798|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
15155799|NCT04165629|Aspirin|aspirin|mesh-list
15155800|NCT04165629|Clopidogrel|clopidogrel|mesh-list
15155801|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15155802|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15155803|NCT04165629|Analgesics|analgesics|mesh-ancestor
15155804|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
15155805|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155806|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155807|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155808|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15155809|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15155810|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15155811|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155812|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15155813|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15155814|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155815|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
15155816|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15155817|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15155818|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15155819|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
15155820|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155821|NCT04165330|Nivolumab|nivolumab|mesh-list
15155822|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155823|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155824|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15155825|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155826|NCT04165174|Apatinib|apatinib|mesh-list
15155827|NCT04165174|Antibodies|antibodies|mesh-list
15155828|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15155829|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
15155830|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155831|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155832|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15155833|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155834|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155835|NCT04164823|Analgesics|analgesics|mesh-list
14021610|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021611|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15155836|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
15155837|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155838|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155839|NCT04164615|Capecitabine|capecitabine|mesh-list
15155840|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15155841|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
15155842|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155843|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155844|NCT04164524|Gentamicins|gentamicins|mesh-list
15155845|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15155846|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155847|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15155848|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155849|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155850|NCT04164797|Endostar protein|endostar protein|mesh-list
15155851|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15155852|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15155853|NCT04164797|Growth Substances|growth substances|mesh-ancestor
15155854|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155855|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
15155856|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155857|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
14021612|NCT02772640|Ezetimibe|ezetimibe|mesh-list
14293226|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293227|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293228|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293229|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
14586556|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14586557|NCT00015054|Methylphenidate|methylphenidate|mesh-list
14586558|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14586559|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155858|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15155859|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155860|NCT04164459|Latanoprost|latanoprost|mesh-list
15155861|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15155862|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15155863|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
15155864|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15155865|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
15155866|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15155867|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15155868|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155869|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15155870|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155871|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15155872|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155873|NCT04164693|Heparin|heparin|mesh-list
15155874|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15155875|NCT04164693|Tinzaparin|tinzaparin|mesh-list
15155876|NCT04164693|Dalteparin|dalteparin|mesh-list
15155877|NCT04164693|Warfarin|warfarin|mesh-list
15155878|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
15155879|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15155880|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15155881|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155882|NCT04164238|Paclitaxel|paclitaxel|mesh-list
15155883|NCT04164238|Carboplatin|carboplatin|mesh-list
15155884|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15155885|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155886|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
15155887|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
15155888|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
15155889|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155890|NCT04164212|Vaccines|vaccines|mesh-list
15155891|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
15155892|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155893|NCT04164355|Tadalafil|tadalafil|mesh-list
15155894|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
15155895|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15155896|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15155897|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155898|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155899|NCT04164355|Urological Agents|urological agents|mesh-ancestor
15155900|NCT04164368|Lenalidomide|lenalidomide|mesh-list
15155901|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
15155902|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155903|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15155904|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15155905|NCT04164368|Growth Substances|growth substances|mesh-ancestor
15155906|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
15155907|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155908|NCT04164329|Anesthetics|anesthetics|mesh-list
15155909|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
15155910|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155911|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155912|NCT04164264|Propofol|propofol|mesh-list
15155913|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15155914|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15155915|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155916|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15155917|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
15155918|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
15180382|NCT03940378|Levamisole|levamisole|mesh-list
15180383|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15180384|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
15180385|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180386|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
15180387|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
15180388|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14586560|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15180389|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180390|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15180391|NCT03940235|Androgens|androgens|mesh-list
15180392|NCT03940235|Hormones|hormones|mesh-ancestor
14586561|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14586562|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15155919|NCT04163978|Budesonide|budesonide|mesh-list
15155920|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
15155921|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155922|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15155923|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
15155924|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155925|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155926|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15155927|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
15155928|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
15155929|NCT04163978|Hormones|hormones|mesh-ancestor
15155930|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155931|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15155932|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
15155933|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155934|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15155935|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15155936|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
15155937|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
15155938|NCT04163978|Protective Agents|protective agents|mesh-ancestor
15155939|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
15155940|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155941|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15155942|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155943|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155944|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
15155945|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15155946|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15155947|NCT04163536|Prednisolone|prednisolone|mesh-list
15155948|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
15155949|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15155950|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
15155951|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15155952|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
15155953|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
15155954|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155955|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155956|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15155957|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
15155958|NCT04163536|Hormones|hormones|mesh-ancestor
15155959|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15155960|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15155961|NCT04163536|Protective Agents|protective agents|mesh-ancestor
15155962|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15155963|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155964|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
15155965|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15155966|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15155967|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15155968|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155969|NCT04163419|Tanezumab|tanezumab|mesh-list
15155970|NCT04163419|Analgesics|analgesics|mesh-ancestor
15155971|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
15155972|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15155973|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155974|NCT04163471|Hemostatics|hemostatics|mesh-list
15155975|NCT04163471|Coagulants|coagulants|mesh-ancestor
15155976|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15155977|NCT04163458|Menotropins|menotropins|mesh-list
15155978|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15155979|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
15155980|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15155981|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155982|NCT04163354|Listerine|listerine|mesh-list
15155983|NCT04163354|Fluorides|fluorides|mesh-list
15155984|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
15155985|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
15155986|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
15155987|NCT04163354|Protective Agents|protective agents|mesh-ancestor
14586563|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155988|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155989|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15155990|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15155991|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14586564|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
14586565|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586566|NCT00015067|Methylphenidate|methylphenidate|mesh-list
14586567|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14586568|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586569|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14586570|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14586571|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586572|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155992|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15155993|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15155994|NCT04163588|Metolazone|metolazone|mesh-list
15155995|NCT04163588|Diuretics|diuretics|mesh-list
14586573|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
14586574|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586575|NCT00015080|Naltrexone|naltrexone|mesh-list
14586576|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14586577|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15155996|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
15155997|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
15155998|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15155999|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156000|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156001|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15156002|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15156003|NCT04163237|Sorafenib|sorafenib|mesh-list
15156004|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156005|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15156006|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156007|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156008|NCT04162743|Trazodone|trazodone|mesh-list
15156009|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15156010|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15156011|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156012|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156013|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156014|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15156015|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15156016|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156017|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156018|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156019|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
15156020|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15156021|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
15156022|NCT04162834|Papaverine|papaverine|mesh-list
15156023|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15156024|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156025|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156026|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
15156027|NCT04162834|Urological Agents|urological agents|mesh-ancestor
15156028|NCT04162873|Celecoxib|celecoxib|mesh-list
15156029|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
15156030|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15156031|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15156032|NCT04162873|Analgesics|analgesics|mesh-ancestor
15156033|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
15156034|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156035|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156036|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156037|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156038|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15156039|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15156040|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156041|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156042|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15156043|NCT04162535|Lidocaine|lidocaine|mesh-list
15156044|NCT04162535|Propofol|propofol|mesh-list
15156045|NCT04162535|Sevoflurane|sevoflurane|mesh-list
15156046|NCT04162535|Anesthetics|anesthetics|mesh-list
15156047|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
15156048|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
15156049|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156050|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586578|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586579|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
14586580|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586581|NCT00015106|Lamotrigine|lamotrigine|mesh-list
14586582|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
14586583|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14586584|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586585|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586586|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14586587|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586588|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14586589|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14586590|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586591|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14586592|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14586593|NCT00015132|Sertraline|sertraline|mesh-list
14586594|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
14586595|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14586596|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14586597|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14586598|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586599|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586600|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586601|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
14586602|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586603|NCT00015171|Buprenorphine|buprenorphine|mesh-list
14586604|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14586605|NCT00015171|Naloxone|naloxone|mesh-list
14586606|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14586607|NCT00015171|Narcotics|narcotics|mesh-ancestor
14586608|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586609|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586610|NCT00015171|Analgesics|analgesics|mesh-ancestor
14586611|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
14586612|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586613|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14586614|NCT00015210|Nefazodone|nefazodone|mesh-list
14586615|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14586616|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14586617|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586618|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586619|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586620|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586621|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14586622|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
14586623|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14586624|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14586625|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14586626|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
14586627|NCT00015223|Methylphenidate|methylphenidate|mesh-list
14586628|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14586629|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586630|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14586631|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15156051|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
15156052|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156053|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15156054|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15156055|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15156056|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156057|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156058|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15156059|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
15156060|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14586632|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586633|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586634|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
14586635|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156061|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14021613|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15156062|NCT04162522|Citalopram|citalopram|mesh-list
15156063|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
15156064|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15156065|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15156066|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156067|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156068|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156069|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
15156070|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156071|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15156072|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
15156073|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156074|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
15156075|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
15180393|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586636|NCT00015236|Amantadine|amantadine|mesh-list
14586637|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14586638|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14586639|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
14586640|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586641|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
14586642|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586643|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586644|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586645|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14586646|NCT00015236|Analgesics|analgesics|mesh-ancestor
14586647|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
14586648|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180394|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180395|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
15180396|NCT03940391|Midazolam|midazolam|mesh-list
15180397|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15180398|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15180399|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180400|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180401|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15180402|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15180403|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15180404|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15180405|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
15180406|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
15180407|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
15180408|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
15180409|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180410|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586649|NCT00015249|Amantadine|amantadine|mesh-list
14586650|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14586651|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14586652|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
14586653|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586654|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
14586655|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586656|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586657|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586658|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14586659|NCT00015249|Analgesics|analgesics|mesh-ancestor
14586660|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
14586661|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586662|NCT00015275|Cocaine|cocaine|mesh-list
14586663|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
14586664|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
14586665|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586666|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586667|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
14586668|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586669|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14586670|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15180411|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
15180412|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
15180413|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15180414|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
15180415|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
15180416|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14021614|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14586671|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15156076|NCT04162028|Ketamine|ketamine|mesh-list
15156077|NCT04162028|Analgesics|analgesics|mesh-ancestor
15156078|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
15156079|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586672|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586673|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586674|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
14586675|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586676|NCT00015288|Buprenorphine|buprenorphine|mesh-list
14586677|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14586678|NCT00015288|Naloxone|naloxone|mesh-list
14586679|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14586680|NCT00015288|Narcotics|narcotics|mesh-ancestor
14586681|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586682|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586683|NCT00015288|Analgesics|analgesics|mesh-ancestor
14586684|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
14586685|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586686|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14586687|NCT00015301|Methylphenidate|methylphenidate|mesh-list
14586688|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14586689|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586690|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14586691|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14586692|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586693|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586694|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
14586695|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586696|NCT00015340|Buprenorphine|buprenorphine|mesh-list
14586697|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14586698|NCT00015340|Naloxone|naloxone|mesh-list
14586699|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14586700|NCT00015340|Narcotics|narcotics|mesh-ancestor
14586701|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586702|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586703|NCT00015340|Analgesics|analgesics|mesh-ancestor
14586704|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
14586705|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586706|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14586707|NCT00015548|Olanzapine|olanzapine|mesh-list
14586708|NCT00015548|Risperidone|risperidone|mesh-list
14586709|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14586710|NCT00015548|Citalopram|citalopram|mesh-list
14586711|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14586712|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
14586713|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14586714|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156080|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156081|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15156082|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15156083|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
15156084|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
15156085|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586715|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586716|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14586717|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14586718|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14586719|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14586720|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14586721|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
14586722|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
14586723|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
14586724|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586725|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14586726|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14586727|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14586728|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14586729|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
14586730|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14586731|NCT00015626|Metformin|metformin|mesh-list
14586732|NCT00015626|Pioglitazone|pioglitazone|mesh-list
14586733|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
14586734|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15156086|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14021615|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
14586735|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586736|NCT00015652|Ribavirin|ribavirin|mesh-list
14586737|NCT00015652|Aldesleukin|aldesleukin|mesh-list
14586738|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14586739|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
14586740|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586741|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
14586742|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586743|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586744|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14586745|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14586746|NCT00015665|Voriconazole|voriconazole|mesh-list
14586747|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
14586748|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586749|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14586750|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14586751|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586752|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586753|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14586754|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
14586755|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15156087|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14586756|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586757|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14586758|NCT00015691|Metformin|metformin|mesh-list
14586759|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
14586760|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14586761|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586762|NCT00015704|Aldesleukin|aldesleukin|mesh-list
14586763|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586764|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14586765|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14586766|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
14586767|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586768|NCT00015769|Levetiracetam|levetiracetam|mesh-list
14586769|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
14586770|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
14644511|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14644512|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644513|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644514|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
14644515|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644516|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644517|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644518|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
14644519|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
14644520|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644521|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644522|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644523|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
14644524|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644525|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644526|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644527|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644528|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644529|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644530|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644531|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644532|NCT00191685|Analgesics|analgesics|mesh-ancestor
14644533|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
14644534|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644535|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644536|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644537|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
14644538|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644539|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644540|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644541|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644542|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644543|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644544|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156088|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156089|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586771|NCT00015808|Idebenone|idebenone|mesh-list
14586772|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
14586773|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586774|NCT00015808|Protective Agents|protective agents|mesh-ancestor
14586775|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586776|NCT00015821|Thalidomide|thalidomide|mesh-list
14586777|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586778|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
14586779|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586780|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
14586781|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14586782|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586783|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14586784|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14586785|NCT00015821|Growth Substances|growth substances|mesh-ancestor
14586786|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
14586787|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586788|NCT00015834|Cytarabine|cytarabine|mesh-list
14586789|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
15156090|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
15156091|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15156092|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156093|NCT04161768|Norfloxacin|norfloxacin|mesh-list
15156094|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15156095|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156096|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15156097|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15156098|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156099|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156100|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156101|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15156102|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15156103|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15156104|NCT04161690|Ropivacaine|ropivacaine|mesh-list
15156105|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
14586790|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586791|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
14586792|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586793|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586794|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
14586795|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586796|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586797|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
14586798|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586799|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14586800|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586801|NCT00015860|Prednisone|prednisone|mesh-list
14586802|NCT00015860|Vincristine|vincristine|mesh-list
14586803|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
14586804|NCT00015860|Daunorubicin|daunorubicin|mesh-list
14586805|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14586806|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
14586807|NCT00015860|Hormones|hormones|mesh-ancestor
14586808|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586809|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586810|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14586811|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586812|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586813|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586814|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586815|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586816|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586817|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14586818|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586819|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14586820|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14586821|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586822|NCT00015873|Cytarabine|cytarabine|mesh-list
14586823|NCT00015873|Prednisolone|prednisolone|mesh-list
14586824|NCT00015873|Methotrexate|methotrexate|mesh-list
14586825|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
14586826|NCT00015873|Vincristine|vincristine|mesh-list
14586827|NCT00015873|Asparaginase|asparaginase|mesh-list
15156106|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
15180417|NCT03940430|Lactoferrin|lactoferrin|mesh-list
14586828|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14586829|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
14586830|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14586831|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586832|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586833|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
14586834|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586835|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586836|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
14586837|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586838|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14586839|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586840|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
14586841|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14586842|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14586843|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
14586844|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586845|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586846|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586847|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586848|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586849|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14586850|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
14586851|NCT00015873|Hormones|hormones|mesh-ancestor
14586852|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14586853|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14586854|NCT00015886|Docetaxel|docetaxel|mesh-list
14586855|NCT00015886|Fluorouracil|fluorouracil|mesh-list
14586856|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586857|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586858|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586859|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586860|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586861|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
14586862|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586863|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586864|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
14586865|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586866|NCT00015899|Lonafarnib|lonafarnib|mesh-list
14586867|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586868|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586869|NCT00015912|Interferons|interferons|mesh-list
14586870|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
14586871|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
14586872|NCT00015912|Thalidomide|thalidomide|mesh-list
14586873|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586874|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
14586875|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586876|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
14586877|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586878|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586879|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
14586880|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14586881|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14586882|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14586883|NCT00015912|Growth Substances|growth substances|mesh-ancestor
14586884|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
14586885|NCT00015925|Entinostat|entinostat|mesh-list
14586886|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586887|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14586888|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586889|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586890|NCT00015938|Docetaxel|docetaxel|mesh-list
14586891|NCT00015938|Vinorelbine|vinorelbine|mesh-list
14586892|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586893|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
14586894|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
14586895|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
14586896|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586897|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14586898|NCT00015951|Cytarabine|cytarabine|mesh-list
14586899|NCT00015951|Bevacizumab|bevacizumab|mesh-list
14586900|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
14586901|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14586902|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586903|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14586904|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14586905|NCT00015951|Growth Substances|growth substances|mesh-ancestor
14586906|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586907|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
14586908|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586909|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
14586910|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586911|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
14586912|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586913|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586914|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
14586915|NCT00015951|Analgesics|analgesics|mesh-ancestor
14586916|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
14586917|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14586918|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14021616|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021617|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14021618|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14021619|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021620|NCT02772744|Ribavirin|ribavirin|mesh-list
14021621|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
14021622|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
14021623|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021624|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
14021625|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586919|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586920|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586921|NCT00015964|Gefitinib|gefitinib|mesh-list
14586922|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586923|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14586924|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586925|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586926|NCT00015977|Interleukin-12|interleukin-12|mesh-list
14586927|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14586928|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
14586929|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586930|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14586931|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14586932|NCT00015977|Growth Substances|growth substances|mesh-ancestor
14586933|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
14586934|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586935|NCT00015990|Thalidomide|thalidomide|mesh-list
14586936|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586937|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
14586938|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586939|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
14586940|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14586941|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586942|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14586943|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14586944|NCT00015990|Growth Substances|growth substances|mesh-ancestor
14586945|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14586946|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156107|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156108|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156109|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
15156110|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156111|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15156112|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15156113|NCT04161690|Analgesics|analgesics|mesh-ancestor
14586947|NCT00016016|Cytarabine|cytarabine|mesh-list
14586948|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
14586949|NCT00016016|Alvocidib|alvocidib|mesh-list
14586950|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586951|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
14586952|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586953|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586954|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
14586955|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586956|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586957|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
14586958|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586959|NCT00016016|Analgesics|analgesics|mesh-ancestor
14586960|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
14586961|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021626|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14586962|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14586963|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14586964|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586965|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
14586966|NCT00016016|Growth Substances|growth substances|mesh-ancestor
14586967|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14586968|NCT00016042|Interferons|interferons|mesh-list
14586969|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
14586970|NCT00016042|Fluorouracil|fluorouracil|mesh-list
14586971|NCT00016042|Sargramostim|sargramostim|mesh-list
14586972|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
14586973|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586974|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14586975|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586976|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14586977|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
14586978|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14586979|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
14586980|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586981|NCT00016055|Temozolomide|temozolomide|mesh-list
14586982|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14586983|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
14586984|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586985|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14586986|NCT00016068|Valganciclovir|valganciclovir|mesh-list
14586987|NCT00016068|Ganciclovir|ganciclovir|mesh-list
14586988|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14586989|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
14586990|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586991|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14586992|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14586993|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586994|NCT00016081|Ribavirin|ribavirin|mesh-list
14586995|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
14586996|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14586997|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
14586998|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14586999|NCT00016094|Bevacizumab|bevacizumab|mesh-list
14587000|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15156114|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156115|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156116|NCT04161664|Paclitaxel|paclitaxel|mesh-list
15156117|NCT04161664|Carboplatin|carboplatin|mesh-list
15156118|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15156119|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156120|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
15156121|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156122|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156123|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156124|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
15156125|NCT04161729|Analgesics|analgesics|mesh-ancestor
15156126|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
14587001|NCT00016094|Antibodies|antibodies|mesh-list
14587002|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
14587003|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14587004|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587005|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14587006|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14587007|NCT00016094|Growth Substances|growth substances|mesh-ancestor
14587008|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587009|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587010|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
14587011|NCT00016107|Bevacizumab|bevacizumab|mesh-list
14587012|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14587013|NCT00016107|Docetaxel|docetaxel|mesh-list
14587014|NCT00016107|Estramustine|estramustine|mesh-list
14587015|NCT00016107|Antibodies|antibodies|mesh-list
14587016|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
14587017|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14587018|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587019|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14587020|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14587021|NCT00016107|Growth Substances|growth substances|mesh-ancestor
14587022|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587023|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587024|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
14587025|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587026|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587027|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587028|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587029|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587030|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
14587031|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587032|NCT00016133|Leucovorin|leucovorin|mesh-list
14587033|NCT00016133|Fluorouracil|fluorouracil|mesh-list
14587034|NCT00016133|Vaccines|vaccines|mesh-list
14587035|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
14587036|NCT00016133|Calcium|calcium|mesh-list
14587037|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
14587038|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
14587039|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587040|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14587041|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
14587042|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587043|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587044|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587045|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587046|NCT00016133|Antidotes|antidotes|mesh-ancestor
14587047|NCT00016133|Protective Agents|protective agents|mesh-ancestor
14587048|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
14587049|NCT00016133|Vitamins|vitamins|mesh-ancestor
14587050|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
14587051|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14587052|NCT00016159|Idarubicin|idarubicin|mesh-list
14587053|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
14587054|NCT00016159|Tretinoin|tretinoin|mesh-list
14587055|NCT00016159|Lintuzumab|lintuzumab|mesh-list
14587056|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587057|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587058|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587059|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587060|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587061|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587062|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
14587063|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14587064|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14587065|NCT00016172|Doxorubicin|doxorubicin|mesh-list
14587066|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14587067|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587068|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587069|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587070|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587071|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587072|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587073|NCT00016185|Docetaxel|docetaxel|mesh-list
14587074|NCT00016185|Alvocidib|alvocidib|mesh-list
14587075|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587076|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587077|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587078|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587079|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587080|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587081|NCT00016185|Growth Substances|growth substances|mesh-ancestor
14587082|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587083|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14587084|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587085|NCT00016198|Leucovorin|leucovorin|mesh-list
14587086|NCT00016198|Fluorouracil|fluorouracil|mesh-list
14587087|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
14587088|NCT00016198|Calcium|calcium|mesh-list
14587089|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
14587090|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14587091|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587092|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
14587093|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587094|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587095|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587096|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587097|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
14587098|NCT00016198|Antidotes|antidotes|mesh-ancestor
14587099|NCT00016198|Protective Agents|protective agents|mesh-ancestor
14587100|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
14587101|NCT00016198|Vitamins|vitamins|mesh-ancestor
14587102|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
14587103|NCT00016224|Thalidomide|thalidomide|mesh-list
15156127|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156128|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587104|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587105|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
14587106|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587107|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
14587108|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14587109|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587110|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14587111|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14587112|NCT00016224|Growth Substances|growth substances|mesh-ancestor
14587113|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587114|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587115|NCT00016263|Dacarbazine|dacarbazine|mesh-list
14587116|NCT00016263|Oblimersen|oblimersen|mesh-list
14587117|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587118|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
14587119|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587120|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587121|NCT00016276|Tamoxifen|tamoxifen|mesh-list
14587122|NCT00016276|Paclitaxel|paclitaxel|mesh-list
14587123|NCT00016276|Razoxane|razoxane|mesh-list
14587124|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
14587125|NCT00016276|Doxorubicin|doxorubicin|mesh-list
14587126|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14587127|NCT00016276|Trastuzumab|trastuzumab|mesh-list
14587128|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
14587129|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587130|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587131|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587132|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587133|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587134|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587135|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587136|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
14587137|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587138|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587139|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587140|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
14587141|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587142|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587143|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587144|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587145|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587146|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14587147|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14587148|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
14587149|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587150|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587151|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14587152|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14587153|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14587154|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14587155|NCT00016276|Protective Agents|protective agents|mesh-ancestor
14587156|NCT00016289|Interleukin-12|interleukin-12|mesh-list
14587157|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14587158|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
14587159|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587160|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14587161|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14587162|NCT00016289|Growth Substances|growth substances|mesh-ancestor
14587163|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587164|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587165|NCT00016302|Leucovorin|leucovorin|mesh-list
14587166|NCT00016302|Cytarabine|cytarabine|mesh-list
14587167|NCT00016302|Dexamethasone|dexamethasone|mesh-list
14587168|NCT00016302|Prednisone|prednisone|mesh-list
14587169|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
14587170|NCT00016302|Doxorubicin|doxorubicin|mesh-list
14587171|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14587172|NCT00016302|Methotrexate|methotrexate|mesh-list
14587173|NCT00016302|Vincristine|vincristine|mesh-list
14587174|NCT00016302|Daunorubicin|daunorubicin|mesh-list
14587175|NCT00016302|Asparaginase|asparaginase|mesh-list
14587176|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
14587177|NCT00016302|Pegaspargase|pegaspargase|mesh-list
14587178|NCT00016302|Thioguanine|thioguanine|mesh-list
14587179|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
15156129|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
15156130|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156131|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15156132|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
15156133|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15156134|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156135|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587180|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587181|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
14587182|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587183|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587184|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587185|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
14587186|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587187|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587188|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587189|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14587190|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
14587191|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
14587192|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587193|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14587194|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
14587195|NCT00016302|Hormones|hormones|mesh-ancestor
14587196|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587197|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587198|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587199|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587200|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587201|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587202|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14587203|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
14587204|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14587205|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587206|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
14587207|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
14587208|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14587209|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14587210|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
14587211|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587212|NCT00016302|Antidotes|antidotes|mesh-ancestor
14587213|NCT00016302|Protective Agents|protective agents|mesh-ancestor
14587214|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
14587215|NCT00016302|Vitamins|vitamins|mesh-ancestor
14587216|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
14587217|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587218|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587219|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587220|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587221|NCT00016315|Gemcitabine|gemcitabine|mesh-list
14587222|NCT00016315|Paclitaxel|paclitaxel|mesh-list
14587223|NCT00016315|Carboplatin|carboplatin|mesh-list
14587224|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587225|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587226|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587227|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587228|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587229|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587230|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587231|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
14587232|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
14587233|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587234|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587235|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587236|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
14587237|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587238|NCT00016328|Sirolimus|sirolimus|mesh-list
14587239|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14587240|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587241|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587242|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587243|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
14587244|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587245|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
14587246|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587247|NCT00016341|Tamoxifen|tamoxifen|mesh-list
14587248|NCT00016341|Paclitaxel|paclitaxel|mesh-list
15156136|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15156137|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
15156138|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15156139|NCT04161586|Prilocaine|prilocaine|mesh-list
15156140|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
15156141|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156142|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587249|NCT00016341|Doxorubicin|doxorubicin|mesh-list
15156143|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
15156144|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
15156145|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156146|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
15156147|NCT04161508|Neostigmine|neostigmine|mesh-list
15156148|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15156149|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156150|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156151|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
15156152|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156153|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156154|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15156155|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
15156156|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156157|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14587250|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14587251|NCT00016341|Megestrol|megestrol|mesh-list
14587252|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
14587253|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587254|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587255|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587256|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587257|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587258|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587259|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587260|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587261|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587262|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587263|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587264|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14587265|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
14587266|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587267|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587268|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14587269|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15156158|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15156159|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15156160|NCT04161560|Cetuximab|cetuximab|mesh-list
15156161|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15156162|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156163|NCT04161482|Furosemide|furosemide|mesh-list
15156164|NCT04161482|Diuretics|diuretics|mesh-ancestor
15156165|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
15156166|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156167|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15156168|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14587270|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14587271|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14587272|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14587273|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14587274|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
14587275|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14587276|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14587277|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14587278|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
14587279|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14587280|NCT00016367|Gemcitabine|gemcitabine|mesh-list
14587281|NCT00016367|Cisplatin|cisplatin|mesh-list
14587282|NCT00016367|Trastuzumab|trastuzumab|mesh-list
14587283|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587284|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587285|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
15156169|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156170|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
14587286|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587287|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
14587288|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587289|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587290|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156171|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
15156172|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15156173|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14587291|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
14587292|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587293|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14587294|NCT00016380|Dexamethasone|dexamethasone|mesh-list
14587295|NCT00016380|Ondansetron|ondansetron|mesh-list
14587296|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14587297|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
14587298|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
14587299|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587300|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587301|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14587302|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
14587303|NCT00016380|Hormones|hormones|mesh-ancestor
14587304|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587305|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587306|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587307|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
14587308|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
14587309|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14587310|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
14587311|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14587312|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587313|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14587314|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14587315|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14587316|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14587317|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14587318|NCT00016406|Paclitaxel|paclitaxel|mesh-list
14587319|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
14587320|NCT00016406|Doxorubicin|doxorubicin|mesh-list
14587321|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587322|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587323|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587324|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587325|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587326|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587327|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587328|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
14587329|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587330|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587331|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587332|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
14587333|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587334|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587335|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587336|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587337|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587338|NCT00016419|Cyclosporine|cyclosporine|mesh-list
14587339|NCT00016419|Cyclosporins|cyclosporins|mesh-list
14587340|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14587341|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587342|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587343|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587344|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
14587345|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587346|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
14587347|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587348|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
14587349|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587350|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14587351|NCT00016432|Exemestane|exemestane|mesh-list
14587352|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587353|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14587354|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14587355|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587356|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587357|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14587358|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
15156174|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156175|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156176|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156177|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156178|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
15156179|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14587359|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587360|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587361|NCT00016445|Hormones|hormones|mesh-list
14587362|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587363|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587364|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
14587365|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14587366|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587367|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
14587368|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587369|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587370|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587371|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
14587372|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587373|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587374|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587375|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
14587376|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14587377|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
14587378|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587379|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587380|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14587381|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
14587382|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14587383|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
14587384|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587385|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14587386|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14587387|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
14587388|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
14587389|NCT00016523|Protective Agents|protective agents|mesh-ancestor
14587390|NCT00016549|Bevacizumab|bevacizumab|mesh-list
14587391|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14587392|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587393|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14587394|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14587395|NCT00016549|Growth Substances|growth substances|mesh-ancestor
14587396|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587397|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
15156180|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156181|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15156182|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15156183|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156184|NCT04161430|Incretins|incretins|mesh-ancestor
15156185|NCT04161430|Hormones|hormones|mesh-ancestor
15156186|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15156187|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15156188|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
15156189|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156190|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587398|NCT00016588|Tenofovir|tenofovir|mesh-list
14587399|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
14587400|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587401|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14587402|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14587403|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587404|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156191|NCT04161404|Metformin|metformin|mesh-list
15156192|NCT04161404|Andrographolide|andrographolide|mesh-list
15156193|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15156194|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156195|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156196|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15156197|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15156198|NCT04161404|Analgesics|analgesics|mesh-ancestor
15156199|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
15156200|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156201|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156202|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15156203|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15156204|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156205|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
15156206|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15156207|NCT04161209|Citalopram|citalopram|mesh-list
14587405|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14587406|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14587407|NCT00016601|Ritonavir|ritonavir|mesh-list
14587408|NCT00016601|Nelfinavir|nelfinavir|mesh-list
14587409|NCT00016601|Indinavir|indinavir|mesh-list
14587410|NCT00016601|Nevirapine|nevirapine|mesh-list
14587411|NCT00016601|Efavirenz|efavirenz|mesh-list
14587412|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14587413|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
14587414|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14587415|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14587416|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
14587417|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587418|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587419|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15156208|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15156209|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15156210|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156211|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156212|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156213|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
14021627|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
14293230|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14587420|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15156214|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156215|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15156216|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
15156217|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156218|NCT04161014|Nintedanib|nintedanib|mesh-list
14587421|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
14587422|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587423|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14587424|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14587425|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15156219|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587426|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14587427|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14587428|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14587429|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14587430|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14587431|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14587432|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14587433|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14587434|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14587435|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
14587436|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14587437|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587438|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14587439|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14587440|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14587441|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587442|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587443|NCT00016666|Propranolol|propranolol|mesh-list
14587444|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14587445|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14587446|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
14587447|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14587448|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587449|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587450|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14587451|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14587452|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
14587453|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14587454|NCT00016744|Genistein|genistein|mesh-list
14587455|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587456|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15156220|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14587457|NCT00016744|Protective Agents|protective agents|mesh-ancestor
14587458|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587459|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14587460|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587461|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587462|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
14587463|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14587464|NCT00016744|Estrogens|estrogens|mesh-ancestor
14587465|NCT00016744|Hormones|hormones|mesh-ancestor
15156221|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156222|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156223|NCT04161053|Rifaximin|rifaximin|mesh-list
15156224|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
15156225|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15156226|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156227|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15156228|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15156229|NCT04161001|Amlodipine|amlodipine|mesh-list
15156230|NCT04161001|Olmesartan|olmesartan|mesh-list
15156231|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15156232|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
15156233|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15156234|NCT04161001|Ezetimibe|ezetimibe|mesh-list
14587466|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587467|NCT00016835|Metronidazole|metronidazole|mesh-list
14587468|NCT00016835|Doxycycline|doxycycline|mesh-list
14587469|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587470|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14587471|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14587472|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14587473|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
14587474|NCT00016861|Irinotecan|irinotecan|mesh-list
14587475|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14587476|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587477|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587478|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587479|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587480|NCT00016874|Paclitaxel|paclitaxel|mesh-list
14587481|NCT00016874|Cisplatin|cisplatin|mesh-list
14587482|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587483|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587484|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587485|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587486|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587487|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587488|NCT00016887|Interferons|interferons|mesh-list
14587489|NCT00016887|Cytarabine|cytarabine|mesh-list
14587490|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
14587491|NCT00016887|Dexamethasone|dexamethasone|mesh-list
15156235|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15156236|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15156237|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156238|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156239|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15156240|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156241|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
15156242|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15156243|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15156244|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
15156245|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15156246|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15156247|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156248|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15156249|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15156250|NCT04160936|Ropivacaine|ropivacaine|mesh-list
15156251|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
15156252|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
15156253|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156254|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156255|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
14587492|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
14587493|NCT00016887|Melphalan|melphalan|mesh-list
14587494|NCT00016887|Carmustine|carmustine|mesh-list
14587495|NCT00016887|Etoposide|etoposide|mesh-list
14587496|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587497|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
14587498|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587499|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587500|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587501|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
14587502|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587503|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587504|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587505|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14587506|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
14587507|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
14587508|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587509|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14587510|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
14587511|NCT00016887|Hormones|hormones|mesh-ancestor
14587512|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587513|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587514|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587515|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587516|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587517|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587518|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
14587519|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587520|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587521|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
14587522|NCT00016900|Paclitaxel|paclitaxel|mesh-list
14587523|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587524|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587525|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587526|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587527|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587528|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587529|NCT00016926|Capecitabine|capecitabine|mesh-list
14587530|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587531|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
14587532|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587533|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587534|NCT00016939|Alvocidib|alvocidib|mesh-list
14587535|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587536|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587537|NCT00016939|Growth Substances|growth substances|mesh-ancestor
14587538|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587539|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14587540|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587541|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587542|NCT00016952|Leucovorin|leucovorin|mesh-list
14587543|NCT00016952|Fluorouracil|fluorouracil|mesh-list
14587544|NCT00016952|Irinotecan|irinotecan|mesh-list
14587545|NCT00016952|Calcium|calcium|mesh-list
14587546|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
14587547|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14587548|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587549|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
14587550|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587551|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587552|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587553|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587554|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
14587555|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14587556|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587557|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587558|NCT00016952|Antidotes|antidotes|mesh-ancestor
14587559|NCT00016952|Protective Agents|protective agents|mesh-ancestor
14587560|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
14587561|NCT00016952|Vitamins|vitamins|mesh-ancestor
14587562|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
14587563|NCT00016978|Leucovorin|leucovorin|mesh-list
14587564|NCT00016978|Fluorouracil|fluorouracil|mesh-list
14587565|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
14587566|NCT00016978|Calcium|calcium|mesh-list
14587567|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
14587568|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14587569|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587570|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
14587571|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587572|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587573|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587574|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587575|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
14587576|NCT00016978|Antidotes|antidotes|mesh-ancestor
14587577|NCT00016978|Protective Agents|protective agents|mesh-ancestor
14587578|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
14587579|NCT00016978|Vitamins|vitamins|mesh-ancestor
14587580|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
14587581|NCT00016991|Gefitinib|gefitinib|mesh-list
14587582|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587583|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14587584|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587585|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587586|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
14587587|NCT00017004|Hematinics|hematinics|mesh-ancestor
14587588|NCT00017017|Paclitaxel|paclitaxel|mesh-list
14587589|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14587590|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587591|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587592|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587593|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587594|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587595|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587596|NCT00017030|Trabectedin|trabectedin|mesh-list
14587597|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587598|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
14587599|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587600|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587601|NCT00017069|Dexamethasone|dexamethasone|mesh-list
14587602|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
14587603|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14587604|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
14587605|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
14587606|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587607|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587608|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14587609|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
14587610|NCT00017069|Hormones|hormones|mesh-ancestor
14587611|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587612|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587613|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587614|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
14587615|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587616|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
14587617|NCT00017095|Docetaxel|docetaxel|mesh-list
14587618|NCT00017095|Fluorouracil|fluorouracil|mesh-list
14587619|NCT00017095|Epirubicin|epirubicin|mesh-list
14587620|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587621|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
14587622|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587623|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587624|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587625|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
14587626|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587627|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156256|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156257|NCT04161027|Pregabalin|pregabalin|mesh-list
15156258|NCT04161027|Analgesics|analgesics|mesh-ancestor
15156259|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
15156260|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156261|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156262|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
15156263|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14587628|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587629|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587630|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587631|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587632|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
14587633|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587634|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587635|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587636|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587637|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587638|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
15156264|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14587639|NCT00017108|Chlorambucil|chlorambucil|mesh-list
14587640|NCT00017108|Fludarabine|fludarabine|mesh-list
15156265|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156266|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15156267|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15156268|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15156269|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156270|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156271|NCT04160897|Tenofovir|tenofovir|mesh-list
15156272|NCT04160897|Entecavir|entecavir|mesh-list
15156273|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
15156274|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156275|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15156276|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15156277|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156278|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156279|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15156280|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15156281|NCT04160598|Fentanyl|fentanyl|mesh-list
15156282|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15156283|NCT04160598|Narcotics|narcotics|mesh-ancestor
15156284|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156285|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156286|NCT04160598|Analgesics|analgesics|mesh-ancestor
15156287|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
14587641|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
14587642|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587643|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
15156288|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156289|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15156290|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15156291|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
15156292|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
15156293|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
15156294|NCT04160676|Thiamine|thiamine|mesh-list
15156295|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
15156296|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156297|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
15156298|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156299|NCT04160676|Protective Agents|protective agents|mesh-ancestor
15156300|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156301|NCT04160676|Vitamins|vitamins|mesh-ancestor
15156302|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
15156303|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
14587644|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587645|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587646|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587647|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
14587648|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587649|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587650|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587651|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15156304|NCT04160416|Capecitabine|capecitabine|mesh-list
15156305|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
14587652|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
14587653|NCT00017121|Sargramostim|sargramostim|mesh-list
14587654|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
14587655|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587656|NCT00017134|Fenretinide|fenretinide|mesh-list
14587657|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587658|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14587659|NCT00017134|Protective Agents|protective agents|mesh-ancestor
14587660|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587661|NCT00017147|Carmustine|carmustine|mesh-list
14587662|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14587663|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587664|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
14587665|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587666|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587667|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156306|NCT04160416|Irinotecan|irinotecan|mesh-list
15156307|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15156308|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
15156309|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156310|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156311|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15156312|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15156313|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587668|NCT00017160|Doxorubicin|doxorubicin|mesh-list
14587669|NCT00017160|Ifosfamide|ifosfamide|mesh-list
14587670|NCT00017160|Sargramostim|sargramostim|mesh-list
14587671|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
14587672|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587673|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587674|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587675|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587676|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587677|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587678|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587679|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587680|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
14587681|NCT00017173|Cisplatin|cisplatin|mesh-list
14587682|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587683|NCT00017186|Gemcitabine|gemcitabine|mesh-list
14587684|NCT00017186|Epirubicin|epirubicin|mesh-list
14587685|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587686|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
14587687|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587688|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587689|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
14587690|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587691|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587692|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587693|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
14587694|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587695|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587696|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587697|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587698|NCT00017199|Bortezomib|bortezomib|mesh-list
15156314|NCT04160520|Morphine|morphine|mesh-list
15156315|NCT04160520|Pramipexole|pramipexole|mesh-list
14587699|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587700|NCT00017212|Exatecan|exatecan|mesh-list
14587701|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14587702|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587703|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587704|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587705|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587706|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
14587707|NCT00017225|Melphalan|melphalan|mesh-list
14587708|NCT00017225|Ifosfamide|ifosfamide|mesh-list
14587709|NCT00017225|Dacarbazine|dacarbazine|mesh-list
14587710|NCT00017225|Carboplatin|carboplatin|mesh-list
14587711|NCT00017225|Doxorubicin|doxorubicin|mesh-list
14587712|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14587713|NCT00017225|Etoposide|etoposide|mesh-list
14587714|NCT00017225|Vincristine|vincristine|mesh-list
14587715|NCT00017225|Tretinoin|tretinoin|mesh-list
14587716|NCT00017225|Vindesine|vindesine|mesh-list
14587717|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587718|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
14587719|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587720|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587721|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587722|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
14587723|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587724|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587725|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587726|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587727|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587728|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587729|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587730|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587731|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587732|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587733|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587734|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
14587735|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
14587736|NCT00017238|KRN 5500|krn 5500|mesh-list
14587737|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587738|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14587739|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156316|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14587740|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587741|NCT00017251|Carboplatin|carboplatin|mesh-list
15156317|NCT04160520|Narcotics|narcotics|mesh-ancestor
14587742|NCT00017251|Etoposide|etoposide|mesh-list
14587743|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
14587744|NCT00017251|Oblimersen|oblimersen|mesh-list
14587745|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587746|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587747|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587748|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587749|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587750|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587751|NCT00017264|Atrasentan|atrasentan|mesh-list
14587752|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587753|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14587754|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14587755|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587756|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
14587757|NCT00017277|Hematinics|hematinics|mesh-ancestor
14644545|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644546|NCT00191711|Gemcitabine|gemcitabine|mesh-list
14644547|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644548|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
14644549|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644550|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644551|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
14644552|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644553|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644554|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644555|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
14644556|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644557|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644558|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644559|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644560|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644561|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644562|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
15156318|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156319|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156320|NCT04160520|Analgesics|analgesics|mesh-ancestor
15156321|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
15156322|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156323|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
15156324|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156325|NCT04160520|Protective Agents|protective agents|mesh-ancestor
15156326|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15156327|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15156328|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
15156329|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
15156330|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156331|NCT04160611|Midazolam|midazolam|mesh-list
15156332|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15156333|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15156334|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021628|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644563|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644564|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644565|NCT00191750|Pemetrexed|pemetrexed|mesh-list
14644566|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156335|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156336|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14021629|NCT02772354|Metoprolol|metoprolol|mesh-list
14021630|NCT02772354|Verapamil|verapamil|mesh-list
14291704|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291705|NCT00555906|Dexamethasone|dexamethasone|mesh-list
14021631|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14291706|NCT00555906|Bortezomib|bortezomib|mesh-list
14291707|NCT00555906|Palbociclib|palbociclib|mesh-list
14291708|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291709|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
14291710|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
14291711|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291712|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291713|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14291714|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
14291715|NCT00555906|Hormones|hormones|mesh-ancestor
14291716|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587758|NCT00017290|Prednisone|prednisone|mesh-list
14587759|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
14587760|NCT00017290|Vincristine|vincristine|mesh-list
14587761|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
14587762|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14587763|NCT00017290|Antibodies|antibodies|mesh-list
14587764|NCT00017290|Sargramostim|sargramostim|mesh-list
14587765|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14587766|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14587767|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587768|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
14587769|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587770|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587771|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587772|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
14587773|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587774|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587775|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587776|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14587777|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
14587778|NCT00017290|Hormones|hormones|mesh-ancestor
14587779|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587780|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587781|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587782|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587783|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587784|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587785|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14587786|NCT00017303|Paclitaxel|paclitaxel|mesh-list
14587787|NCT00017303|Carboplatin|carboplatin|mesh-list
14587788|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587789|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587790|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587791|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587792|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587793|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587794|NCT00017316|Thalidomide|thalidomide|mesh-list
14587795|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587796|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
14587797|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587798|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
14587799|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14587800|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587801|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14587802|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14587803|NCT00017316|Growth Substances|growth substances|mesh-ancestor
14587804|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587805|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587806|NCT00017329|Bortezomib|bortezomib|mesh-list
14587807|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587808|NCT00017342|Cytarabine|cytarabine|mesh-list
14587809|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
15156337|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15156338|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156339|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15156340|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
15156341|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
15156342|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
15156343|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
15156344|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156345|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180418|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180419|NCT03940469|Dexamethasone|dexamethasone|mesh-list
15180420|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
15180421|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
15180422|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180423|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
15180424|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
15180425|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180426|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180427|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14587810|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587811|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
14587812|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587813|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180428|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
15180429|NCT03940469|Hormones|hormones|mesh-ancestor
14587814|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
14587815|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587816|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587817|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
14587818|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587819|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14587820|NCT00017355|Lenograstim|lenograstim|mesh-list
14587821|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14587822|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
14587823|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587824|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
14587825|NCT00017368|Melphalan|melphalan|mesh-list
14587826|NCT00017368|Ifosfamide|ifosfamide|mesh-list
14587827|NCT00017368|Thiotepa|thiotepa|mesh-list
14587828|NCT00017368|Carboplatin|carboplatin|mesh-list
14587829|NCT00017368|Doxorubicin|doxorubicin|mesh-list
14587830|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14587831|NCT00017368|Etoposide|etoposide|mesh-list
14587832|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
14587833|NCT00017368|Vincristine|vincristine|mesh-list
14587834|NCT00017368|Isotretinoin|isotretinoin|mesh-list
14587835|NCT00017368|Sargramostim|sargramostim|mesh-list
14587836|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587837|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
14587838|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587839|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587840|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587841|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
14587842|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587843|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587844|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587845|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14587846|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14587847|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14587848|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587849|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587850|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587851|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587852|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587853|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14587854|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
14587855|NCT00017381|Rituximab|rituximab|mesh-list
14587856|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14587857|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587858|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
14587859|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587860|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587861|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587862|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
14587863|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587864|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587865|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587866|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14587867|NCT00017394|Bevacizumab|bevacizumab|mesh-list
14587868|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14587869|NCT00017394|Vinorelbine|vinorelbine|mesh-list
14587870|NCT00017394|Antibodies|antibodies|mesh-list
14587871|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
14587872|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14587873|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587874|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14587875|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14587876|NCT00017394|Growth Substances|growth substances|mesh-ancestor
14587877|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587878|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
14587879|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
14587880|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587881|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587882|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587883|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587884|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587885|NCT00017407|Paclitaxel|paclitaxel|mesh-list
14587886|NCT00017407|Carboplatin|carboplatin|mesh-list
14587887|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587888|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587889|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587890|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587891|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156346|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
15156347|NCT04160195|Fludarabine|fludarabine|mesh-list
15156348|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156349|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
15156350|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587892|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587893|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
14587894|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587895|NCT00017459|Vinorelbine|vinorelbine|mesh-list
14587896|NCT00017459|Tirapazamine|tirapazamine|mesh-list
14587897|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587898|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14587899|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
14587900|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
14587901|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
14587902|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587903|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14587904|NCT00017472|Antibodies|antibodies|mesh-list
14587905|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
14587906|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14587907|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
14587908|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587909|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587910|NCT00017498|Gemcitabine|gemcitabine|mesh-list
14587911|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14587912|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
14587913|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156351|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156352|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15156353|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
15156354|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156355|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156356|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15156357|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
14587914|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587915|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
14587916|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14587917|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14587918|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587919|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
14587920|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587921|NCT00017511|Cevimeline|cevimeline|mesh-list
14587922|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14587923|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
14587924|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587925|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587926|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14587927|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14587928|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
14587929|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156358|NCT04160026|Piperaquine|piperaquine|mesh-list
15156359|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
15156360|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15156361|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
15156362|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15156363|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15156364|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156365|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14587930|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587931|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14587932|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
14587933|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587934|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587935|NCT00017576|Calcitriol|calcitriol|mesh-list
14587936|NCT00017576|Carboplatin|carboplatin|mesh-list
14587937|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587938|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14587939|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587940|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14587941|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14587942|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587943|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14587944|NCT00017576|Vitamins|vitamins|mesh-ancestor
15156366|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156367|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021632|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14021633|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
14021634|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
14021635|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021636|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021637|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14021638|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14021639|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14021640|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
14021641|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021642|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021643|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14021644|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14021645|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14021646|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
14021647|NCT02772419|Benralizumab|benralizumab|mesh-list
14021648|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14021649|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
14587945|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
14587946|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14587947|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
14587948|NCT00017589|Oblimersen|oblimersen|mesh-list
14587949|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14587950|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021650|NCT02772497|Aflibercept|aflibercept|mesh-list
14587951|NCT00017602|Dexamethasone|dexamethasone|mesh-list
14587952|NCT00017602|Oblimersen|oblimersen|mesh-list
14587953|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14587954|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
14587955|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
14587956|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587957|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587958|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14587959|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
14587960|NCT00017602|Hormones|hormones|mesh-ancestor
14587961|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587962|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14587963|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587964|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
14587965|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14587966|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14587967|NCT00017628|Prednisolone|prednisolone|mesh-list
14587968|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
14587969|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
14587970|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14587971|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
14587972|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587973|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
14587974|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587975|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587976|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587977|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
14587978|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14587979|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14587980|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14587981|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14587982|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
14587983|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
14587984|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14587985|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14587986|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
14587987|NCT00017628|Hormones|hormones|mesh-ancestor
14587988|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14587989|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14587990|NCT00017628|Protective Agents|protective agents|mesh-ancestor
14587991|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14021651|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14293231|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14293232|NCT00566813|Incretins|incretins|mesh-ancestor
14293233|NCT00566813|Hormones|hormones|mesh-ancestor
14293234|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293235|NCT00566852|Memantine|memantine|mesh-list
14293236|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14293237|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14293238|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
14587992|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
14587993|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14587994|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14587995|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
14587996|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14587997|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14587998|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14587999|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
14588000|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588001|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588002|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588003|NCT00017654|Cyclosporine|cyclosporine|mesh-list
14588004|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
14588005|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
14588006|NCT00017654|Cyclosporins|cyclosporins|mesh-list
14588007|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14588008|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588009|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
14588010|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588011|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14588012|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588013|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
14588014|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588015|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156368|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15156369|NCT04160026|Renal Agents|renal agents|mesh-ancestor
15156370|NCT04159870|Rifaximin|rifaximin|mesh-list
15156371|NCT04159870|Norfloxacin|norfloxacin|mesh-list
14021652|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14588016|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588017|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588018|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
14588019|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588020|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
14588021|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14588022|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14588023|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
14588024|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
14588025|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588026|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14588027|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
14588028|NCT00017654|Hormones|hormones|mesh-ancestor
14588029|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14588030|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14588031|NCT00017654|Protective Agents|protective agents|mesh-ancestor
14588032|NCT00017680|Melphalan|melphalan|mesh-list
14588033|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588034|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
14588035|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588036|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588037|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588038|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588039|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
14588040|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588041|NCT00017693|Interleukin-4|interleukin-4|mesh-list
14588042|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588043|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
14588044|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588045|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588046|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14588047|NCT00017719|Lamivudine|lamivudine|mesh-list
14588048|NCT00017719|Zidovudine|zidovudine|mesh-list
14588049|NCT00017719|Nevirapine|nevirapine|mesh-list
14588050|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14588051|NCT00017719|Nelfinavir|nelfinavir|mesh-list
14588052|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14588053|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588054|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588055|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156372|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14021653|NCT02772497|Growth Substances|growth substances|mesh-ancestor
14021654|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021655|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
14588056|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
14588057|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588058|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588059|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588060|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
14588061|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14588062|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14588063|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14588064|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14588065|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14588066|NCT00017758|Efavirenz|efavirenz|mesh-list
14588067|NCT00017758|Nelfinavir|nelfinavir|mesh-list
14588068|NCT00017758|Atorvastatin|atorvastatin|mesh-list
14588069|NCT00017758|Simvastatin|simvastatin|mesh-list
14588070|NCT00017758|Pravastatin|pravastatin|mesh-list
14588071|NCT00017758|Calcium|calcium|mesh-list
14588072|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14588073|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588074|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14588075|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14588076|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
14588077|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588078|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15156373|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156374|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15156375|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15156376|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15156377|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156378|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156379|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156380|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15156381|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15156382|NCT04160117|Colchicine|colchicine|mesh-list
15156383|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
15156384|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156385|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
15156386|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156387|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156388|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156389|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156390|NCT04159896|Nivolumab|nivolumab|mesh-list
15156391|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15156392|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156393|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15156394|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156395|NCT04159649|Letrozole|letrozole|mesh-list
15156396|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156397|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15156398|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15156399|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156400|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156401|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15156402|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
15156403|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15156404|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156405|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
15156406|NCT04159597|Upadacitinib|upadacitinib|mesh-list
15156407|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15156408|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15156409|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156410|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156411|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156412|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
15156413|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15156414|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15156415|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15156416|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
15156417|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156418|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156419|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156420|NCT04159181|Lactulose|lactulose|mesh-list
15156421|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
14588079|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14588080|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588081|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14588082|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588083|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
14588084|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588085|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14588086|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588087|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14588088|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14588089|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14588090|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14588091|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14588092|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14588093|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
14588094|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588095|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588096|NCT00017784|Valganciclovir|valganciclovir|mesh-list
14588097|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
14588098|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588099|NCT00017862|Reslizumab|reslizumab|mesh-list
14588100|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14588101|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14588102|NCT00017940|Mitogens|mitogens|mesh-list
14588103|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
14588104|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588105|NCT00017992|Ritonavir|ritonavir|mesh-list
14588106|NCT00017992|Lopinavir|lopinavir|mesh-list
14588107|NCT00017992|Emtricitabine|emtricitabine|mesh-list
14588108|NCT00017992|Stavudine|stavudine|mesh-list
14588109|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14588110|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14588111|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
14588112|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156422|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15156423|NCT04159181|Cathartics|cathartics|mesh-ancestor
15156424|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
15156425|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
15156426|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156427|NCT04159155|Paclitaxel|paclitaxel|mesh-list
15156428|NCT04159155|Carboplatin|carboplatin|mesh-list
15156429|NCT04159155|Niraparib|niraparib|mesh-list
15156430|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15156431|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156432|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
15156433|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156434|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156435|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588113|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588114|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588115|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588116|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
14588117|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588118|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14588119|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588120|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14588121|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588122|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
14588123|NCT00018018|Zidovudine|zidovudine|mesh-list
14588124|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
14588125|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588126|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14588127|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588128|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588129|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
14588130|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588131|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588132|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588133|NCT00018083|Efavirenz|efavirenz|mesh-list
14588134|NCT00018083|Isoniazid|isoniazid|mesh-list
14588135|NCT00018083|Rifabutin|rifabutin|mesh-list
14588136|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14588137|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588138|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588139|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156436|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15156437|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156438|NCT04159142|Paclitaxel|paclitaxel|mesh-list
15156439|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15156440|NCT04159142|Carboplatin|carboplatin|mesh-list
14588140|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
14588141|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588142|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14588143|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588144|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14588145|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14588146|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14588147|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14588148|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
14588149|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14588150|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14588151|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14588152|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
15156441|NCT04159142|Capecitabine|capecitabine|mesh-list
15156442|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15156443|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588153|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14588154|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14588155|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14588156|NCT00018135|Calcium|calcium|mesh-list
14588157|NCT00018135|Sevelamer|sevelamer|mesh-list
14588158|NCT00018135|Calcium acetate|calcium acetate|mesh-list
14588159|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14588160|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588161|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
14588162|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
14588163|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588164|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588165|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
14588166|NCT00018135|Antacids|antacids|mesh-ancestor
14588167|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14588168|NCT00018148|Nortriptyline|nortriptyline|mesh-list
14588169|NCT00018148|Nicotine|nicotine|mesh-list
14588170|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14588171|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
14588172|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588173|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588174|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14588175|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14588176|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
14588177|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588178|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588179|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14588180|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588181|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588182|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14588183|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588184|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588185|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
14588186|NCT00018161|Mecamylamine|mecamylamine|mesh-list
14588187|NCT00018161|Nicotine|nicotine|mesh-list
14588188|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14588189|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
14588190|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588191|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588192|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14588193|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14588194|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
14588195|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588196|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588197|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14588198|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14588199|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14588200|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14588201|NCT00018174|Fluoxetine|fluoxetine|mesh-list
14588202|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14588203|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588204|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588205|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588206|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588207|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
14588208|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588209|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14021656|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021657|NCT02772601|Metoprolol|metoprolol|mesh-list
15156444|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
15156445|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156446|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156447|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156448|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15156449|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
15156450|NCT04159077|Tamsulosin|tamsulosin|mesh-list
15156451|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15156452|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14588210|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
15156453|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15156454|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
15156455|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156456|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156457|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156458|NCT04159077|Urological Agents|urological agents|mesh-ancestor
15156459|NCT04158934|Factor VIII|factor viii|mesh-list
15156460|NCT04158934|BAX 855|bax 855|mesh-list
15156461|NCT04158934|Coagulants|coagulants|mesh-ancestor
14588211|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588212|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14588213|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588214|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588215|NCT00018187|Mecamylamine|mecamylamine|mesh-list
14588216|NCT00018187|Bupropion|bupropion|mesh-list
14588217|NCT00018187|Nicotine|nicotine|mesh-list
14588218|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14588219|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
14588220|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588221|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588222|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14588223|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14588224|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
14588225|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588226|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588227|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14588228|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588229|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588230|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14588231|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588232|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588233|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
14588234|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14588235|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588236|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588237|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14588238|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14588239|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14588240|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14588241|NCT00018200|Benztropine|benztropine|mesh-list
14588242|NCT00018200|Fluoxetine|fluoxetine|mesh-list
14588243|NCT00018200|Desipramine|desipramine|mesh-list
14588244|NCT00018200|Clomipramine|clomipramine|mesh-list
14588245|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14588246|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588247|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588248|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588249|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588250|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
14588251|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588252|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14588253|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588254|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588255|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14588256|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15156462|NCT04158947|Trastuzumab|trastuzumab|mesh-list
15156463|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15156464|NCT04158947|Afatinib|afatinib|mesh-list
15156465|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15156466|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156467|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15156468|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156469|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021658|NCT02772601|Midazolam|midazolam|mesh-list
14588257|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588258|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14588259|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14588260|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
14588261|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14588262|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14588263|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
14588264|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
14588265|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588266|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14588267|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14588268|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
14588269|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14588270|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
14588271|NCT00018213|Naltrexone|naltrexone|mesh-list
14588272|NCT00018213|Nicotine|nicotine|mesh-list
14588273|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14588274|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
14588275|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588276|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588277|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14588278|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14588279|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
14588280|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588281|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588282|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14588283|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14588284|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
14588285|NCT00018278|Donepezil|donepezil|mesh-list
14588286|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14588287|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588288|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588289|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
14588290|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588291|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588292|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
14588293|NCT00018291|Gabapentin|gabapentin|mesh-list
14588294|NCT00018291|Risperidone|risperidone|mesh-list
14588295|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14588296|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
14588297|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588298|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588299|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588300|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14588301|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14588302|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14588303|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588304|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14588305|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
14588306|NCT00018291|Analgesics|analgesics|mesh-ancestor
14588307|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
14588308|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588309|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
14588310|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14588311|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14588312|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14588313|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
14588314|NCT00018343|Estrogens|estrogens|mesh-list
14588315|NCT00018343|Hormones|hormones|mesh-ancestor
14588316|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14588317|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588318|NCT00018356|Testosterone|testosterone|mesh-list
14588319|NCT00018356|Androgens|androgens|mesh-ancestor
14588320|NCT00018356|Hormones|hormones|mesh-ancestor
14588321|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14588322|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588323|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
14588324|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14588325|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588326|NCT00018447|Fluorides|fluorides|mesh-list
14588327|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
14588328|NCT00018447|Protective Agents|protective agents|mesh-ancestor
14588329|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588330|NCT00018460|Vitamins|vitamins|mesh-list
14588331|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
14588332|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
14588333|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588334|NCT00018551|Folic Acid|folic acid|mesh-list
14588335|NCT00018551|Hematinics|hematinics|mesh-ancestor
14588336|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
14588337|NCT00018551|Vitamins|vitamins|mesh-ancestor
14588338|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
14588339|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588340|NCT00018603|Guanfacine|guanfacine|mesh-list
14588341|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14588342|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14588343|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14588344|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14588345|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
14588346|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588347|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588348|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588349|NCT00018642|Haloperidol|haloperidol|mesh-list
14588350|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14588351|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
14588352|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588353|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588354|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14588355|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14588356|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14588357|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588358|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
14588359|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
14588360|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588361|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14588362|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14588363|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
14588364|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588365|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588366|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14588367|NCT00018668|Olanzapine|olanzapine|mesh-list
14588368|NCT00018668|Risperidone|risperidone|mesh-list
14588369|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14588370|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14588371|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
14588372|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588373|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588374|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588375|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14588376|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14588377|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14588378|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588379|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14588380|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
14588381|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
14588382|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
14588383|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588384|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14588385|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14588386|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588387|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588388|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588389|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14588390|NCT00018694|Cathartics|cathartics|mesh-ancestor
14588391|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14588392|NCT00018733|Paroxetine|paroxetine|mesh-list
15156470|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
14588393|NCT00018733|Desipramine|desipramine|mesh-list
14588394|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14588395|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588396|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588397|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588398|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588399|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
14588400|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588401|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14588402|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588403|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588404|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14588405|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588406|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644567|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588407|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14588408|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14588409|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644568|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644569|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14644570|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644571|NCT00191763|Gemcitabine|gemcitabine|mesh-list
14644572|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644573|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644574|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
14644575|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644576|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
14644577|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644578|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644579|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644580|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
14644581|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644582|NCT00191802|Teriparatide|teriparatide|mesh-list
14644583|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14644584|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644585|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14644586|NCT00191828|Olanzapine|olanzapine|mesh-list
14644587|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
14644588|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
14644589|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644590|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644591|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14644592|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14644593|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14644594|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14644595|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644596|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14644597|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644598|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644599|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644600|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644601|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
14644602|NCT00191841|Gemcitabine|gemcitabine|mesh-list
15156471|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156472|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156473|NCT04158739|Cytarabine|cytarabine|mesh-list
15156474|NCT04158739|Antibodies|antibodies|mesh-list
15156475|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
15156476|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15156477|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
15156478|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156479|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644603|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644604|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644605|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
14644606|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644607|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
14644608|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644609|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644610|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644611|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
14644612|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644613|NCT00191867|Teriparatide|teriparatide|mesh-list
14644614|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14644615|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644616|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14644617|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14644618|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14644619|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644620|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644621|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644622|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
14644623|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644624|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644625|NCT00191893|Teriparatide|teriparatide|mesh-list
15156480|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
15156481|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156482|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588410|NCT00018759|Paroxetine|paroxetine|mesh-list
14588411|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14588412|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588413|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588414|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588415|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588416|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
14588417|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588418|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14588419|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588420|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588421|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14588422|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588423|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588424|NCT00018824|Naltrexone|naltrexone|mesh-list
14588425|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14588426|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14588427|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588428|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
14588429|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588430|NCT00018850|Haloperidol|haloperidol|mesh-list
14588431|NCT00018850|Ondansetron|ondansetron|mesh-list
14588432|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
14588433|NCT00018850|Nicotine|nicotine|mesh-list
14588434|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14588435|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
14588436|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588437|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588438|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14588439|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15156483|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
15156484|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156485|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156486|NCT04158674|Simendan|simendan|mesh-list
15156487|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15156488|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
14588440|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
14588441|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588442|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588443|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
14588444|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14588445|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
14588446|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
14588447|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14588448|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
14588449|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14588450|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14588451|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14588452|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588453|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14588454|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14588455|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
14588456|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14588457|NCT00018863|Methylphenidate|methylphenidate|mesh-list
14588458|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14588459|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588460|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14588461|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588462|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588463|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588464|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
14588465|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588466|NCT00018902|Fluoxetine|fluoxetine|mesh-list
14588467|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14588468|NCT00018902|Citalopram|citalopram|mesh-list
14588469|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14588470|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14588471|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588472|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588473|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14588474|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
15156489|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15156490|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15156491|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588475|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588476|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14588477|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
14588478|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14588479|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14588480|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588481|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588482|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14588483|NCT00018941|Aldesleukin|aldesleukin|mesh-list
14588484|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588485|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588486|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588487|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
14588488|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588489|NCT00018954|Cytarabine|cytarabine|mesh-list
14588490|NCT00018954|Prednisone|prednisone|mesh-list
14588491|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
14588492|NCT00018954|Ifosfamide|ifosfamide|mesh-list
14588493|NCT00018954|Doxorubicin|doxorubicin|mesh-list
14588494|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14588495|NCT00018954|Methotrexate|methotrexate|mesh-list
14588496|NCT00018954|Etoposide|etoposide|mesh-list
14588497|NCT00018954|Vincristine|vincristine|mesh-list
14588498|NCT00018954|Daunorubicin|daunorubicin|mesh-list
14588499|NCT00018954|Asparaginase|asparaginase|mesh-list
14588500|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
14588501|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588502|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
14588503|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588504|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14588505|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588506|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
14588507|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588508|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588509|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588510|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14588511|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14588512|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14588513|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588514|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14588515|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
14588516|NCT00018954|Hormones|hormones|mesh-ancestor
14588517|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14588518|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14588519|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14588520|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
14588521|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14588522|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588523|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
14588524|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
14588525|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14588526|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588527|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14588528|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
14588529|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588530|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
14588531|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14588532|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14588533|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
14588534|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588535|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
14588536|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588537|NCT00019019|Paclitaxel|paclitaxel|mesh-list
14588538|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
14588539|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14588540|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588541|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
14588542|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
14588543|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
14588544|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588545|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14588546|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588547|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14588548|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588549|NCT00019032|Antibodies|antibodies|mesh-list
14588550|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14588551|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
14588552|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156492|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156493|NCT04158674|Protective Agents|protective agents|mesh-ancestor
15156494|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588553|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
14588554|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
14588555|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588556|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
14588557|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588558|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588559|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588560|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14588561|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14588562|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14588563|NCT00019058|Protective Agents|protective agents|mesh-ancestor
14588564|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588565|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
14588566|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14588567|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
14588568|NCT00019071|Cladribine|cladribine|mesh-list
14588569|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588570|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588571|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
14588572|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588573|NCT00019084|Aldesleukin|aldesleukin|mesh-list
14588574|NCT00019084|Vaccines|vaccines|mesh-list
14588575|NCT00019084|Sargramostim|sargramostim|mesh-list
14588576|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
14588577|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588578|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588579|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588580|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588581|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
14588582|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588583|NCT00019097|Melphalan|melphalan|mesh-list
14588584|NCT00019097|Sargramostim|sargramostim|mesh-list
14588585|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14588586|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588587|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
14588588|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588589|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588590|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588591|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588592|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
14588593|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588594|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588595|NCT00019123|Thalidomide|thalidomide|mesh-list
14588596|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588597|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
14588598|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588599|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
14588600|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14588601|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588602|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14588603|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14588604|NCT00019123|Growth Substances|growth substances|mesh-ancestor
14588605|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
14588606|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588607|NCT00019136|Aldesleukin|aldesleukin|mesh-list
14588608|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588609|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588610|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588611|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
14588612|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588613|NCT00019175|Aldesleukin|aldesleukin|mesh-list
14588614|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588615|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588616|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588617|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
14588618|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588619|NCT00019188|Interleukin-12|interleukin-12|mesh-list
14588620|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588621|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
15156495|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14588622|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588623|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15156496|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
15156497|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588624|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14588625|NCT00019188|Growth Substances|growth substances|mesh-ancestor
14588626|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
14588627|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588628|NCT00019214|Aldesleukin|aldesleukin|mesh-list
14588629|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588630|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588631|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588632|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
14588633|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588634|NCT00019227|Calcium|calcium|mesh-list
14588635|NCT00019227|Daclizumab|daclizumab|mesh-list
14588636|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
14588637|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14588638|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588639|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588640|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
14588641|NCT00019227|Antidotes|antidotes|mesh-ancestor
14588642|NCT00019227|Protective Agents|protective agents|mesh-ancestor
14588643|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
14588644|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
14588645|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588646|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14588647|NCT00019240|Cidofovir|cidofovir|mesh-list
14588648|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
14588649|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588650|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588651|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588652|NCT00019318|Romidepsin|romidepsin|mesh-list
14588653|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15156498|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156499|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
15156500|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156501|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156502|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15156503|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15156504|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156505|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
15156506|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
15156507|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15156508|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156509|NCT04158713|Piperaquine|piperaquine|mesh-list
15156510|NCT04158713|Artenimol|artenimol|mesh-list
15156511|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
15156512|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15156513|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14588654|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588655|NCT00019331|Aldesleukin|aldesleukin|mesh-list
14588656|NCT00019331|Sargramostim|sargramostim|mesh-list
14588657|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
14588658|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588659|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588660|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588661|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588662|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
14588663|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588664|NCT00019344|Alvocidib|alvocidib|mesh-list
14588665|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588666|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
14588667|NCT00019344|Growth Substances|growth substances|mesh-ancestor
14588668|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588669|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14588670|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588671|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588672|NCT00019357|Aldesleukin|aldesleukin|mesh-list
14588673|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588674|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588675|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588676|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
14588677|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588678|NCT00019383|Aldesleukin|aldesleukin|mesh-list
15156514|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156515|NCT04158830|Aspirin|aspirin|mesh-list
14588679|NCT00019383|Sargramostim|sargramostim|mesh-list
14588680|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
14588681|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
15156516|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15156517|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15156518|NCT04158830|Analgesics|analgesics|mesh-ancestor
14588682|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588683|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588684|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588685|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588686|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
14588687|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588688|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588689|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
14588690|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588691|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
14588692|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588693|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14588694|NCT00019396|Protective Agents|protective agents|mesh-ancestor
14588695|NCT00019409|Cytarabine|cytarabine|mesh-list
14588696|NCT00019409|Prednisone|prednisone|mesh-list
14588697|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
14588698|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14588699|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14588700|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14588701|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
14588702|NCT00019409|Methotrexate|methotrexate|mesh-list
14588703|NCT00019409|Vincristine|vincristine|mesh-list
14588704|NCT00019409|Daunorubicin|daunorubicin|mesh-list
14588705|NCT00019409|Asparaginase|asparaginase|mesh-list
14588706|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
14588707|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588708|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
14588709|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588710|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14588711|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588712|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
14588713|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588714|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588715|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588716|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14588717|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
14588718|NCT00019409|Hormones|hormones|mesh-ancestor
14588719|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14588720|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14588721|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14588722|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
14588723|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14588724|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588725|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
14588726|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14588727|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588728|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14588729|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588730|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
14588731|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588732|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14588733|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
14588734|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
14588735|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
14588736|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14588737|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14588738|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14588739|NCT00019422|Carboplatin|carboplatin|mesh-list
14588740|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588741|NCT00019435|Immunotoxins|immunotoxins|mesh-list
14588742|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
14588743|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588744|NCT00019448|Interleukin-2|interleukin-2|mesh-list
14588745|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588746|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14588747|NCT00019448|Analgesics|analgesics|mesh-ancestor
14588748|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
14588749|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156519|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
15156520|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14588750|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588751|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
14588752|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588753|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14588754|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14588755|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588756|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14588757|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588758|NCT00019474|Interferons|interferons|mesh-list
14588759|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
14588760|NCT00019474|Fluorouracil|fluorouracil|mesh-list
14588761|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
14588762|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
14588763|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588764|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588765|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588766|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588767|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
14588768|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588769|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
14588770|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588771|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
14588772|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588773|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588774|NCT00019487|Aldesleukin|aldesleukin|mesh-list
14588775|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
14588776|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588777|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588778|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588779|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
14588780|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588781|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14588782|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
14588783|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156521|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156522|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156523|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156524|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15156525|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14588784|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14588785|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14588786|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
14588787|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14588788|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588789|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14588790|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14588791|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14588792|NCT00019513|Leucovorin|leucovorin|mesh-list
14588793|NCT00019513|Gemcitabine|gemcitabine|mesh-list
14588794|NCT00019513|Fluorouracil|fluorouracil|mesh-list
14588795|NCT00019513|Calcium|calcium|mesh-list
14588796|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
14588797|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588798|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
14588799|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588800|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588801|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
14588802|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588803|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588804|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588805|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
14588806|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588807|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14588808|NCT00019513|Antidotes|antidotes|mesh-ancestor
14588809|NCT00019513|Protective Agents|protective agents|mesh-ancestor
14588810|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
14588811|NCT00019513|Vitamins|vitamins|mesh-ancestor
14588812|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
14588813|NCT00019539|Thalidomide|thalidomide|mesh-list
14588814|NCT00019539|Bevacizumab|bevacizumab|mesh-list
14588815|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14588816|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588817|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14588818|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15156526|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588819|NCT00019539|Growth Substances|growth substances|mesh-ancestor
14588820|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588821|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
14588822|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588823|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
14588824|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
14588825|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14588826|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588827|NCT00019552|Irofulven|irofulven|mesh-list
14588828|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588829|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
14588830|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588831|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588832|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14588833|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14588834|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588835|NCT00019591|Aldesleukin|aldesleukin|mesh-list
14588836|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588837|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588838|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588839|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
14588840|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588841|NCT00019630|Doxorubicin|doxorubicin|mesh-list
14588842|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14588843|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14588844|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588845|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14588846|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14588847|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588848|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588849|NCT00019669|Aldesleukin|aldesleukin|mesh-list
14588850|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588851|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588852|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588853|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
14588854|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588855|NCT00019695|Alendronate|alendronate|mesh-list
14588856|NCT00019695|Ketoconazole|ketoconazole|mesh-list
14588857|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
14588858|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588859|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14588860|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14588861|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588862|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588863|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14588864|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
14588865|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14588866|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588867|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14588868|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14588869|NCT00019721|Aldesleukin|aldesleukin|mesh-list
14588870|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
14588871|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588872|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588873|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588874|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
14588875|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588876|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15156527|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15156528|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15156529|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156530|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
15156531|NCT04158856|Trastuzumab|trastuzumab|mesh-list
15156532|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15156533|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156534|NCT04158076|Amlodipine|amlodipine|mesh-list
15156535|NCT04158076|Telmisartan|telmisartan|mesh-list
15156536|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
15156537|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15156538|NCT04158076|Ezetimibe|ezetimibe|mesh-list
15156539|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15156540|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15156541|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156542|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156543|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15156544|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021659|NCT02772601|Caffeine|caffeine|mesh-list
15156545|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
14588877|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
14588878|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588879|NCT00019734|Aldesleukin|aldesleukin|mesh-list
14588880|NCT00019734|Vaccines|vaccines|mesh-list
14588881|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
14588882|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588883|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588884|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588885|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588886|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
14588887|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588888|NCT00019760|Leucovorin|leucovorin|mesh-list
14588889|NCT00019760|Melphalan|melphalan|mesh-list
14588890|NCT00019760|Floxuridine|floxuridine|mesh-list
14588891|NCT00019760|Calcium|calcium|mesh-list
14588892|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
14588893|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14588894|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588895|NCT00019760|Antidotes|antidotes|mesh-ancestor
14588896|NCT00019760|Protective Agents|protective agents|mesh-ancestor
14588897|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
14588898|NCT00019760|Vitamins|vitamins|mesh-ancestor
14588899|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
14588900|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588901|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
14588902|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588903|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588904|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588905|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588906|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
14588907|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588908|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
14588909|NCT00019773|Capecitabine|capecitabine|mesh-list
14588910|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
14588911|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588912|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
14588913|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588914|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588915|NCT00019786|Melphalan|melphalan|mesh-list
14588916|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588917|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
14588918|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588919|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588920|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14588921|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588922|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
14588923|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588924|NCT00019812|Paclitaxel|paclitaxel|mesh-list
14588925|NCT00019812|Trastuzumab|trastuzumab|mesh-list
14588926|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14588927|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588928|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14588929|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156546|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15156547|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15156548|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
15156549|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15156550|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15156551|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156552|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15156553|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15156554|NCT04158102|Bupivacaine|bupivacaine|mesh-list
15156555|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
15156556|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
15156557|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14588930|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14588931|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588932|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14588933|NCT00019825|Decitabine|decitabine|mesh-list
14588934|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588935|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
14588936|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588937|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588938|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588939|NCT00019838|Fludarabine|fludarabine|mesh-list
15156558|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588940|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
14588941|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14588942|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588943|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588944|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
14588945|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588946|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588947|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
14588948|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588949|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14588950|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588951|NCT00019864|Leucovorin|leucovorin|mesh-list
14588952|NCT00019864|Doxorubicin|doxorubicin|mesh-list
14588953|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14588954|NCT00019864|Methotrexate|methotrexate|mesh-list
14588955|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
14021660|NCT02772601|Omeprazole|omeprazole|mesh-list
14021661|NCT02772601|Warfarin|warfarin|mesh-list
14021662|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14021663|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14021664|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021665|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021666|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14021667|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14021668|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14021669|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14021670|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
14021671|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
14021672|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
14021673|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
14021674|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021675|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021676|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
14021677|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14021678|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021679|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14021680|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588956|NCT00019864|Razoxane|razoxane|mesh-list
14588957|NCT00019864|Calcium|calcium|mesh-list
14588958|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
14588959|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588960|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14588961|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14588962|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14588963|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14588964|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588965|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15156559|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
14588966|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588967|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14588968|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
14588969|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14588970|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14588971|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
14588972|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
14588973|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14588974|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14588975|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
14588976|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14588977|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14588978|NCT00019864|Antidotes|antidotes|mesh-ancestor
14588979|NCT00019864|Protective Agents|protective agents|mesh-ancestor
14588980|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
14588981|NCT00019864|Vitamins|vitamins|mesh-ancestor
14588982|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
14588983|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14588984|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
14588985|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
14588986|NCT00019890|Sargramostim|sargramostim|mesh-list
14588987|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
14588988|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14588989|NCT00019916|Aldesleukin|aldesleukin|mesh-list
14021681|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14021682|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14588990|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14588991|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14588992|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14588993|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
14291717|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14291718|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156560|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180430|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180431|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14291719|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180432|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180433|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15180434|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180435|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15180436|NCT03940469|Analgesics|analgesics|mesh-ancestor
15180437|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
15180438|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15180439|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15180440|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14291720|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291721|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588994|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14588995|NCT00019968|Melphalan|melphalan|mesh-list
15180441|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
15180442|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180443|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180444|NCT03939663|Misoprostol|misoprostol|mesh-list
15180445|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15180446|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
15180447|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15180448|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180449|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15180450|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180451|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
15180452|NCT03939884|Diclofenac|diclofenac|mesh-list
15180453|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15180454|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15180455|NCT03939884|Analgesics|analgesics|mesh-ancestor
15180456|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
15180457|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180458|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180459|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14588996|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14588997|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
14588998|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14588999|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589000|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14589001|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589002|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
14589003|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589004|NCT00019994|Aldesleukin|aldesleukin|mesh-list
14589005|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
14589006|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589007|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589008|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589009|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
14589010|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589011|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14589012|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
14589013|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589014|NCT00020007|Paclitaxel|paclitaxel|mesh-list
14589015|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589016|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589017|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589018|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589019|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589020|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589021|NCT00020046|Thalidomide|thalidomide|mesh-list
14589022|NCT00020046|Docetaxel|docetaxel|mesh-list
14589023|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589024|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589025|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589026|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14291722|NCT00555971|Omalizumab|omalizumab|mesh-list
14291723|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14291724|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14291725|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
14589027|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589028|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589029|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
14589030|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589031|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
14589032|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589033|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589034|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14589035|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14589036|NCT00020046|Growth Substances|growth substances|mesh-ancestor
14589037|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589038|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
14589039|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589040|NCT00020124|Doxorubicin|doxorubicin|mesh-list
14589041|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14589042|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15156561|NCT04158167|Oxytocin|oxytocin|mesh-list
15156562|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
15156563|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15156564|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156565|NCT04158362|Paclitaxel|paclitaxel|mesh-list
15156566|NCT04158362|Capecitabine|capecitabine|mesh-list
15156567|NCT04158362|Letrozole|letrozole|mesh-list
15156568|NCT04158362|Fulvestrant|fulvestrant|mesh-list
15156569|NCT04158362|Anastrozole|anastrozole|mesh-list
14589043|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589044|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589045|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589046|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589047|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589048|NCT00020150|Temozolomide|temozolomide|mesh-list
14589049|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14589050|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14589051|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
14589052|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589053|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589054|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589055|NCT00020176|Cyclosporine|cyclosporine|mesh-list
14589056|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
14589057|NCT00020176|Fludarabine|fludarabine|mesh-list
14589058|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
14589059|NCT00020176|Cyclosporins|cyclosporins|mesh-list
14589060|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589061|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
14589062|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589063|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589064|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14589065|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
14589066|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589067|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589068|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14589069|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589070|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
14589071|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589072|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
14589073|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589074|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
14589075|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14589076|NCT00020189|Aspirin|aspirin|mesh-list
14589077|NCT00020189|Alvocidib|alvocidib|mesh-list
14589078|NCT00020189|Clopidogrel|clopidogrel|mesh-list
14589079|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14589080|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14589081|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14589082|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14589083|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
14589084|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14589085|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589086|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589087|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14589088|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14589089|NCT00020189|Analgesics|analgesics|mesh-ancestor
14589090|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
15156570|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15156571|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156572|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589091|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589092|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14589093|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589094|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14589095|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14589096|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14589097|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589098|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
14589099|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589100|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589101|NCT00020189|Growth Substances|growth substances|mesh-ancestor
14589102|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14589103|NCT00020202|Romidepsin|romidepsin|mesh-list
14589104|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14589105|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589106|NCT00020254|Aldesleukin|aldesleukin|mesh-list
14589107|NCT00020254|Nilutamide|nilutamide|mesh-list
14589108|NCT00020254|Vaccines|vaccines|mesh-list
14589109|NCT00020254|Sargramostim|sargramostim|mesh-list
14589110|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
14589111|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589112|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589113|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589114|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589115|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
14589116|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589117|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
14589118|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
14589119|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14589120|NCT00020267|Interleukin-2|interleukin-2|mesh-list
14589121|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589122|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14589123|NCT00020267|Analgesics|analgesics|mesh-ancestor
14589124|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
14589125|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589126|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156573|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156574|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156575|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156576|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15156577|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
15156578|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15156579|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15156580|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156581|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15156582|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
15156583|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15156584|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156585|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15156586|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15156587|NCT04158050|Omalizumab|omalizumab|mesh-list
14589127|NCT00020332|Docetaxel|docetaxel|mesh-list
14589128|NCT00020332|Alvocidib|alvocidib|mesh-list
14589129|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589130|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589131|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589132|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589133|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589134|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589135|NCT00020332|Growth Substances|growth substances|mesh-ancestor
14589136|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589137|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14589138|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589139|NCT00020345|Gemcitabine|gemcitabine|mesh-list
14589140|NCT00020345|Fluorouracil|fluorouracil|mesh-list
14589141|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589142|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
14589143|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589144|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589145|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
14589146|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589147|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589148|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589149|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
14589150|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589151|NCT00020358|Aldesleukin|aldesleukin|mesh-list
14589152|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
14589153|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589154|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589155|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589156|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
14589157|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589158|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14589159|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
14589160|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589161|NCT00020371|Lenograstim|lenograstim|mesh-list
14589162|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14589163|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
14589164|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589165|NCT00020397|Aldesleukin|aldesleukin|mesh-list
14589166|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589167|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589168|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589169|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
14589170|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589171|NCT00020410|Antibodies|antibodies|mesh-list
14589172|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14589173|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
14589174|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589175|NCT00020449|Paclitaxel|paclitaxel|mesh-list
14589176|NCT00020449|Doxorubicin|doxorubicin|mesh-list
14589177|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14589178|NCT00020449|Interleukin-12|interleukin-12|mesh-list
14589179|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589180|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589181|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589182|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589183|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589184|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589185|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14589186|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589187|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589188|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589189|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14589190|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
14589191|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589192|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14589193|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14589194|NCT00020449|Growth Substances|growth substances|mesh-ancestor
14589195|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589196|NCT00020462|Aldesleukin|aldesleukin|mesh-list
14589197|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156588|NCT04158050|Antibodies|antibodies|mesh-list
15156589|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
14589198|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589199|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589200|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
14589201|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589202|NCT00020475|Interleukin-2|interleukin-2|mesh-list
14589203|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589204|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14589205|NCT00020475|Analgesics|analgesics|mesh-ancestor
14589206|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
14589207|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589208|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589209|NCT00020488|Leucovorin|leucovorin|mesh-list
14589210|NCT00020488|Fluorouracil|fluorouracil|mesh-list
14589211|NCT00020488|Irinotecan|irinotecan|mesh-list
14589212|NCT00020488|Calcium|calcium|mesh-list
14589213|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
14589214|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589215|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589216|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
14589217|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589218|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589219|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589220|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589221|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
14589222|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14589223|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589224|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589225|NCT00020488|Antidotes|antidotes|mesh-ancestor
15156590|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589226|NCT00020488|Protective Agents|protective agents|mesh-ancestor
14589227|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
14589228|NCT00020488|Vitamins|vitamins|mesh-ancestor
14589229|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
14589230|NCT00020501|Leucovorin|leucovorin|mesh-list
14589231|NCT00020501|Fluorouracil|fluorouracil|mesh-list
14589232|NCT00020501|Floxuridine|floxuridine|mesh-list
14589233|NCT00020501|Irinotecan|irinotecan|mesh-list
14589234|NCT00020501|Melphalan|melphalan|mesh-list
14589235|NCT00020501|Calcium|calcium|mesh-list
14589236|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
14589237|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589238|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589239|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
14589240|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589241|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589242|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589243|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589244|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
14589245|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14589246|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589247|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589248|NCT00020501|Antidotes|antidotes|mesh-ancestor
14589249|NCT00020501|Protective Agents|protective agents|mesh-ancestor
14589250|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
14589251|NCT00020501|Vitamins|vitamins|mesh-ancestor
14589252|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
14589253|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14589254|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
14589255|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14589256|NCT00020527|Caspofungin|caspofungin|mesh-list
14589257|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
14589258|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589259|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589260|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589261|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
14589262|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14589263|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
14589264|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589265|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14589266|NCT00020540|Protective Agents|protective agents|mesh-ancestor
14589267|NCT00020566|Dactinomycin|dactinomycin|mesh-list
14589268|NCT00020566|Doxorubicin|doxorubicin|mesh-list
14589269|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14589270|NCT00020566|Etoposide|etoposide|mesh-list
14589271|NCT00020566|Vincristine|vincristine|mesh-list
14589272|NCT00020566|Melphalan|melphalan|mesh-list
15156591|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15156592|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15156593|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
15156594|NCT04158388|Tryptophan|tryptophan|mesh-list
15156595|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15156596|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
15156597|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156598|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
15156599|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589273|NCT00020566|Busulfan|busulfan|mesh-list
14589274|NCT00020566|Ifosfamide|ifosfamide|mesh-list
14589275|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14589276|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589277|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589278|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589279|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589280|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589281|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589282|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589283|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589284|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589285|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14589286|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
14589287|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14589288|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156600|NCT04157803|Acetic Acid|acetic acid|mesh-list
15156601|NCT04157803|Retinol acetate|retinol acetate|mesh-list
14589289|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
14589290|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589291|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589292|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589293|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14589294|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15156602|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589295|NCT00020579|Entinostat|entinostat|mesh-list
14589296|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589297|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14589298|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589299|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644626|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14644627|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644628|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15156603|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156604|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15156605|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
15156606|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156607|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15156608|NCT04157803|Protective Agents|protective agents|mesh-ancestor
14644629|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644630|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644631|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644632|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644633|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644634|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644635|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644636|NCT00191919|Analgesics|analgesics|mesh-ancestor
14644637|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
14644638|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644639|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644640|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644641|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
14644642|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14644643|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14644644|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644645|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644646|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644647|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14644648|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644649|NCT00191932|Analgesics|analgesics|mesh-ancestor
14644650|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
14644651|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644652|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644653|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644654|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
14644655|NCT00191971|Gemcitabine|gemcitabine|mesh-list
15156609|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156610|NCT04157959|Febuxostat|febuxostat|mesh-list
15156611|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
15156612|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156613|NCT04157751|Empagliflozin|empagliflozin|mesh-list
15156614|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15156615|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156616|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15156617|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156618|NCT04157998|Metoclopramide|metoclopramide|mesh-list
15156619|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
15156620|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
15156621|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156622|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156623|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15156624|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14644656|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644657|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
14644658|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644659|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644660|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
14644661|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644662|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644663|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156625|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15156626|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
15156627|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156628|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156629|NCT04157491|Antibodies|antibodies|mesh-list
15156630|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
15156631|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589300|NCT00020605|Naloxone|naloxone|mesh-list
14589301|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14589302|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589303|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
14589304|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589305|NCT00020618|Morphine|morphine|mesh-list
14589306|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14589307|NCT00020618|Narcotics|narcotics|mesh-ancestor
14589308|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14589309|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589310|NCT00020618|Analgesics|analgesics|mesh-ancestor
14589311|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
14589312|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589313|NCT00020631|Pirfenidone|pirfenidone|mesh-list
14589314|NCT00020631|Analgesics|analgesics|mesh-ancestor
14589315|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
14589316|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589317|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589318|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14589319|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14589320|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14589321|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589322|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589323|NCT00020644|Gemcitabine|gemcitabine|mesh-list
14589324|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589325|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
15156632|NCT04157478|Temozolomide|temozolomide|mesh-list
15156633|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15156634|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
15156635|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156636|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156637|NCT04157699|Tenofovir|tenofovir|mesh-list
15156638|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
15156639|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156640|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14589326|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589327|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589328|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
14589329|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589330|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589331|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589332|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
14589333|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589334|NCT00020657|Ondansetron|ondansetron|mesh-list
14589335|NCT00020657|Granisetron|granisetron|mesh-list
14589336|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
14589337|NCT00020657|Dolasetron|dolasetron|mesh-list
14589338|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
14589339|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
14589340|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589341|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589342|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14589343|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
14589344|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
14589345|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14589346|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
14589347|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14589348|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589349|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14589350|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14589351|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14589352|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14589353|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14589354|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14589355|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
14589356|NCT00020670|Vaccines|vaccines|mesh-list
14589357|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
14589358|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589359|NCT00020696|Tirapazamine|tirapazamine|mesh-list
14589360|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589361|NCT00020709|Docetaxel|docetaxel|mesh-list
14589362|NCT00020709|Etoposide|etoposide|mesh-list
14589363|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
14589364|NCT00020709|Gefitinib|gefitinib|mesh-list
14589365|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589366|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589367|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589368|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589369|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589370|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15156641|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15156642|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156643|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156644|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15156645|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15156646|NCT04157257|Tenofovir|tenofovir|mesh-list
15156647|NCT04157257|Entecavir|entecavir|mesh-list
15156648|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
15156649|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156650|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15156651|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15156652|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589371|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589372|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589373|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589374|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14589375|NCT00020735|Toremifene|toremifene|mesh-list
14589376|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14589377|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589378|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14589379|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14589380|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
14589381|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14589382|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589383|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14589384|NCT00020748|Irinotecan|irinotecan|mesh-list
14589385|NCT00020748|Epirubicin|epirubicin|mesh-list
14589386|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15156653|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156654|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15156655|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15156656|NCT04156984|Golimumab|golimumab|mesh-list
15156657|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14589387|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589388|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589389|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589390|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589391|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14589392|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589393|NCT00020761|Paclitaxel|paclitaxel|mesh-list
14589394|NCT00020761|Irinotecan|irinotecan|mesh-list
14589395|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589396|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589397|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589398|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589399|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589400|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589401|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14589402|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589403|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589404|NCT00020774|Gemcitabine|gemcitabine|mesh-list
14589405|NCT00020774|Lonafarnib|lonafarnib|mesh-list
14589406|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589407|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
14589408|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589409|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589410|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
14589411|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589412|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589413|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589414|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
14589415|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589416|NCT00020787|Cisplatin|cisplatin|mesh-list
14589417|NCT00020787|Fluorouracil|fluorouracil|mesh-list
14589418|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589419|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
14589420|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589421|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589422|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589423|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
14589424|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180460|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589425|NCT00020800|Rituximab|rituximab|mesh-list
14589426|NCT00020800|Fludarabine|fludarabine|mesh-list
14589427|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
14589428|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14589429|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589430|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
14589431|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589432|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589433|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589434|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
14589435|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589436|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589437|NCT00020839|Temozolomide|temozolomide|mesh-list
15156658|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156659|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156660|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
15156661|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156662|NCT04157010|Methotrexate|methotrexate|mesh-list
15156663|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15156664|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
15156665|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15156666|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156667|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15156668|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
15156669|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156670|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156671|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
15156672|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156673|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15156674|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156675|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
15156676|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156677|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15156678|NCT04157036|Ibuprofen|ibuprofen|mesh-list
15156679|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
15156680|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15156681|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15156682|NCT04157036|Prednisolone|prednisolone|mesh-list
15156683|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
15156684|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15156685|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
14021683|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14021684|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14021685|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
14021686|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14021687|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14589438|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15156686|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15156687|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14589439|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
14589440|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589441|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589442|NCT00020865|Levofloxacin|levofloxacin|mesh-list
14589443|NCT00020865|Ofloxacin|ofloxacin|mesh-list
14589444|NCT00020865|Cefepime|cefepime|mesh-list
14589445|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14589446|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589447|NCT00020865|Renal Agents|renal agents|mesh-ancestor
14589448|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589449|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589450|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589451|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589452|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589453|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589454|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14589455|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14589456|NCT00020878|Celecoxib|celecoxib|mesh-list
14589457|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14589458|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14589459|NCT00020878|Analgesics|analgesics|mesh-ancestor
14589460|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
15156688|NCT04157036|Analgesics|analgesics|mesh-ancestor
15156689|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
14589461|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589462|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589463|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14589464|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589465|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14589466|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14589467|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589468|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589469|NCT00020917|Leucovorin|leucovorin|mesh-list
14589470|NCT00020917|Fluorouracil|fluorouracil|mesh-list
14589471|NCT00020917|Irinotecan|irinotecan|mesh-list
14589472|NCT00020917|Cetuximab|cetuximab|mesh-list
14589473|NCT00020917|Calcium|calcium|mesh-list
14589474|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
14589475|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589476|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589477|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
14589478|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589479|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589480|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589481|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589482|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
14589483|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14589484|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589485|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589486|NCT00020917|Antidotes|antidotes|mesh-ancestor
14589487|NCT00020917|Protective Agents|protective agents|mesh-ancestor
14589488|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
14589489|NCT00020917|Vitamins|vitamins|mesh-ancestor
14589490|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
14589491|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14589492|NCT00020930|Cetuximab|cetuximab|mesh-list
14589493|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14589494|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589495|NCT00020943|Leucovorin|leucovorin|mesh-list
14589496|NCT00020943|Cytarabine|cytarabine|mesh-list
14589497|NCT00020943|Prednisone|prednisone|mesh-list
14589498|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
14589499|NCT00020943|Carmustine|carmustine|mesh-list
14589500|NCT00020943|Rituximab|rituximab|mesh-list
15156690|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156691|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156692|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156693|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589501|NCT00020943|Doxorubicin|doxorubicin|mesh-list
14589502|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14589503|NCT00020943|Methotrexate|methotrexate|mesh-list
14589504|NCT00020943|Etoposide|etoposide|mesh-list
14589505|NCT00020943|Vincristine|vincristine|mesh-list
14589506|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
14589507|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589508|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
14589509|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589510|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589511|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14589512|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
14589513|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589514|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589515|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14589516|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14589517|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14589518|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589519|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589520|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589521|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14589522|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
14589523|NCT00020943|Hormones|hormones|mesh-ancestor
15156694|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15156695|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156696|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156697|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
15156698|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
15156699|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14589524|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15156700|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
15156701|NCT04157036|Hormones|hormones|mesh-ancestor
14589525|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14589526|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14589527|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
15156702|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15156703|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15156704|NCT04157036|Protective Agents|protective agents|mesh-ancestor
15156705|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15156706|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156707|NCT04156750|Metformin|metformin|mesh-list
15156708|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15156709|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156710|NCT04156555|Amoxicillin|amoxicillin|mesh-list
15156711|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
14589528|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14589529|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589530|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
14589531|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
14589532|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14589533|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14589534|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589535|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
14589536|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589537|NCT00020943|Antidotes|antidotes|mesh-ancestor
14589538|NCT00020943|Protective Agents|protective agents|mesh-ancestor
14589539|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
14589540|NCT00020943|Vitamins|vitamins|mesh-ancestor
14589541|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
14589542|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589543|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589544|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589545|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
14589546|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589547|NCT00021034|Taurolidine|taurolidine|mesh-list
14589548|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589549|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14589550|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589551|NCT00021047|Carboplatin|carboplatin|mesh-list
14589552|NCT00021047|Capecitabine|capecitabine|mesh-list
14589553|NCT00021047|Epirubicin|epirubicin|mesh-list
14589554|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589555|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589556|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
14589557|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589558|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14589559|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589560|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589561|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589562|NCT00021060|Paclitaxel|paclitaxel|mesh-list
14589563|NCT00021060|Bevacizumab|bevacizumab|mesh-list
14589564|NCT00021060|Carboplatin|carboplatin|mesh-list
14589565|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14589566|NCT00021060|Antibodies|antibodies|mesh-list
14589567|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
14589568|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14589569|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589570|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156712|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
15156713|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15156714|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589571|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589572|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589573|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589574|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589575|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14589576|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14589577|NCT00021060|Growth Substances|growth substances|mesh-ancestor
14589578|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589579|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589580|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
14589581|NCT00021073|Leucovorin|leucovorin|mesh-list
14589582|NCT00021073|Fluorouracil|fluorouracil|mesh-list
14589583|NCT00021073|Irinotecan|irinotecan|mesh-list
14589584|NCT00021073|Alvocidib|alvocidib|mesh-list
14589585|NCT00021073|Calcium|calcium|mesh-list
15156715|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156716|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14589586|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
14589587|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589588|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589589|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
14644664|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
14589590|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589591|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589592|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589593|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589594|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
14589595|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14589596|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589597|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589598|NCT00021073|Antidotes|antidotes|mesh-ancestor
14589599|NCT00021073|Protective Agents|protective agents|mesh-ancestor
14589600|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
14589601|NCT00021073|Vitamins|vitamins|mesh-ancestor
14589602|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
14589603|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589604|NCT00021073|Growth Substances|growth substances|mesh-ancestor
14589605|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14589606|NCT00021099|Epothilones|epothilones|mesh-list
14589607|NCT00021099|Epothilone B|epothilone b|mesh-list
14589608|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589609|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589610|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589611|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589612|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589613|NCT00021112|Etoposide|etoposide|mesh-list
14589614|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589615|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589616|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14589617|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589618|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589619|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589620|NCT00021138|Nicotine|nicotine|mesh-list
14589621|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14589622|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
14589623|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589624|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589625|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14589626|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14589627|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14589628|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14589629|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589630|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
14589631|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14589632|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589633|NCT00021164|Aldesleukin|aldesleukin|mesh-list
14589634|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
14589635|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589636|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589637|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589638|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
14589639|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589640|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14589641|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
14589642|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589643|NCT00021216|Bortezomib|bortezomib|mesh-list
14589644|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589645|NCT00021242|Docetaxel|docetaxel|mesh-list
14589646|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589647|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589648|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589649|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589650|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589651|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
14589652|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589653|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
15156717|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156718|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156719|NCT04156815|Isotretinoin|isotretinoin|mesh-list
15156720|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
15156721|NCT04156425|Golimumab|golimumab|mesh-list
15156722|NCT04156425|Dexetimide|dexetimide|mesh-list
15156723|NCT04156425|Citalopram|citalopram|mesh-list
15156724|NCT04156425|Calcium|calcium|mesh-list
14589654|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589655|NCT00021281|Leucovorin|leucovorin|mesh-list
14589656|NCT00021281|Fluorouracil|fluorouracil|mesh-list
15156725|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589657|NCT00021281|Irinotecan|irinotecan|mesh-list
14589658|NCT00021281|Calcium|calcium|mesh-list
14589659|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
14589660|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589661|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589662|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
14589663|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589664|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589665|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589666|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589667|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
14589668|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14589669|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14589670|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589671|NCT00021281|Antidotes|antidotes|mesh-ancestor
14589672|NCT00021281|Protective Agents|protective agents|mesh-ancestor
14589673|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
14589674|NCT00021281|Vitamins|vitamins|mesh-ancestor
14589675|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
14589676|NCT00021294|Eflornithine|eflornithine|mesh-list
14589677|NCT00021294|Triamcinolone|triamcinolone|mesh-list
14589678|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14589679|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
14589680|NCT00021294|Hormones|hormones|mesh-ancestor
14589681|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14589682|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589683|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589684|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589685|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589686|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14589687|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14589688|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14589689|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589690|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14589691|NCT00021307|Carboplatin|carboplatin|mesh-list
14589692|NCT00021307|Temozolomide|temozolomide|mesh-list
14589693|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589694|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14589695|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
14589696|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589697|NCT00021320|Paclitaxel|paclitaxel|mesh-list
14589698|NCT00021320|Fluorouracil|fluorouracil|mesh-list
14589699|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589700|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589701|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589702|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589703|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589704|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156726|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156727|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15156728|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14589705|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
14589706|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589707|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589708|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
14589709|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589710|NCT00021333|Paclitaxel|paclitaxel|mesh-list
14589711|NCT00021333|Cisplatin|cisplatin|mesh-list
14589712|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589713|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589714|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589715|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589716|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589717|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589718|NCT00021346|Gemcitabine|gemcitabine|mesh-list
14589719|NCT00021346|Carboplatin|carboplatin|mesh-list
14589720|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589721|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589722|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
14589723|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589724|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
14589725|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589726|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589727|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156729|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14021688|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
14589728|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
14589729|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589730|NCT00021359|Dexamethasone|dexamethasone|mesh-list
14589731|NCT00021359|Isotretinoin|isotretinoin|mesh-list
14589732|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14589733|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
14589734|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
15156730|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156731|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156732|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
14589735|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589736|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589737|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14589738|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
14589739|NCT00021359|Hormones|hormones|mesh-ancestor
14589740|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14589741|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14589742|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589743|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14589744|NCT00021372|Paclitaxel|paclitaxel|mesh-list
14589745|NCT00021372|Estramustine|estramustine|mesh-list
14589746|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14589747|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589748|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589749|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589750|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589751|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589752|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14589753|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
14589754|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14589755|NCT00021385|Squalamine|squalamine|mesh-list
14589756|NCT00021385|Carboplatin|carboplatin|mesh-list
14589757|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589758|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589759|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589760|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14589761|NCT00021385|Protective Agents|protective agents|mesh-ancestor
14589762|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589763|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14589764|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15156733|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15156734|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
15156735|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156736|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15156737|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15156738|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
15156739|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
15156740|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156741|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15156742|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15156743|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
15156744|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15156745|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156746|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589765|NCT00021385|Growth Substances|growth substances|mesh-ancestor
14589766|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589767|NCT00021398|Leucovorin|leucovorin|mesh-list
14589768|NCT00021398|Fluorouracil|fluorouracil|mesh-list
14589769|NCT00021398|Calcium|calcium|mesh-list
14589770|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
14589771|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589772|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589773|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
14589774|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589775|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589776|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589777|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589778|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
14589779|NCT00021398|Antidotes|antidotes|mesh-ancestor
14589780|NCT00021398|Protective Agents|protective agents|mesh-ancestor
14589781|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
14589782|NCT00021398|Vitamins|vitamins|mesh-ancestor
15156747|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
15156748|NCT04156451|Furosemide|furosemide|mesh-list
14589783|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
14589784|NCT00021450|Goserelin|goserelin|mesh-list
14589785|NCT00021450|Bicalutamide|bicalutamide|mesh-list
14589786|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14589787|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589788|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
14589789|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
14589790|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14589791|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589792|NCT00021463|Lamivudine|lamivudine|mesh-list
14589793|NCT00021463|Zidovudine|zidovudine|mesh-list
14589794|NCT00021463|Efavirenz|efavirenz|mesh-list
14589795|NCT00021463|Nevirapine|nevirapine|mesh-list
14589796|NCT00021463|Abacavir|abacavir|mesh-list
14589797|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
14589798|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14589799|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14589800|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156749|NCT04156451|Diuretics|diuretics|mesh-ancestor
15156750|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
15156751|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589801|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589802|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
14589803|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589804|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15156752|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14589805|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589806|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
14589807|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14589808|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14589809|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14589810|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14589811|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14589812|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14589813|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
14589814|NCT00021489|Abacavir|abacavir|mesh-list
14589815|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14589816|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589817|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14589818|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
14589819|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589820|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589821|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589822|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589823|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14589824|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14589825|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
14589826|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589827|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589828|NCT00021528|Mirtazapine|mirtazapine|mesh-list
14589829|NCT00021528|Buspirone|buspirone|mesh-list
14589830|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
14589831|NCT00021528|Sertraline|sertraline|mesh-list
14589832|NCT00021528|Citalopram|citalopram|mesh-list
14589833|NCT00021528|Nortriptyline|nortriptyline|mesh-list
14589834|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
14589835|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14589836|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14589837|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14589838|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14589839|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589840|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14589841|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
14589842|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589843|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589844|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14589845|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14589846|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14589847|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14589848|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
14589849|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
14589850|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14589851|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14589852|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14589853|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14589854|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
14589855|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14589856|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14589857|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14589858|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14589859|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14589860|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14589861|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14589862|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
14589863|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14589864|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14589865|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589866|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589867|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589868|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
14589869|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589870|NCT00021567|Interferons|interferons|mesh-list
14589871|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
14589872|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589873|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
14589874|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589875|NCT00021645|Vitamin E|vitamin e|mesh-list
14589876|NCT00021645|Vitamins|vitamins|mesh-ancestor
14589877|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
14589878|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589879|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
14589880|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589881|NCT00021645|Protective Agents|protective agents|mesh-ancestor
14589882|NCT00021671|Metronidazole|metronidazole|mesh-list
14589883|NCT00021671|Nevirapine|nevirapine|mesh-list
14589884|NCT00021671|Erythromycin|erythromycin|mesh-list
14589885|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
14589886|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14589887|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
14589888|NCT00021671|Ampicillin|ampicillin|mesh-list
15156753|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156754|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156755|NCT04156464|Lorazepam|lorazepam|mesh-list
15156756|NCT04156464|Phenobarbital|phenobarbital|mesh-list
15156757|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
15156758|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
15156759|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
15156760|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156761|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156762|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15156763|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14589889|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589890|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14589891|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14589892|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14589893|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14589894|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14589895|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589896|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589897|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
14589898|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14589899|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14589900|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14589901|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14589902|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14589903|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14589904|NCT00021736|Bevacizumab|bevacizumab|mesh-list
14589905|NCT00021736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14589906|NCT00021736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589907|NCT00021736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14589908|NCT00021736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14589909|NCT00021736|Growth Substances|growth substances|mesh-ancestor
14589910|NCT00021736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589911|NCT00021736|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589912|NCT00021814|Doxazosin|doxazosin|mesh-list
14589913|NCT00021814|Finasteride|finasteride|mesh-list
14589914|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14589915|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14589916|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589917|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589918|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
14589919|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14589920|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589921|NCT00021814|Urological Agents|urological agents|mesh-ancestor
14589922|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14589923|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14589924|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14589925|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14589926|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
14589927|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14589928|NCT00021827|Hormones|hormones|mesh-list
14589929|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
14589930|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14589931|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14589932|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589933|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589934|NCT00021983|Immunotoxins|immunotoxins|mesh-list
14589935|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
14589936|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589937|NCT00021996|Valdecoxib|valdecoxib|mesh-list
14589938|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14589939|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14589940|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589941|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589942|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15156764|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156765|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15156766|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15156767|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156768|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
14589943|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14589944|NCT00021996|Analgesics|analgesics|mesh-ancestor
14589945|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
14589946|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589947|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589948|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14589949|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14589950|NCT00022009|Gemcitabine|gemcitabine|mesh-list
14589951|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14589952|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
14589953|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589954|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589955|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
14589956|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14589957|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14589958|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14589959|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
14589960|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156769|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
15156770|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021689|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
14589961|NCT00022022|Docetaxel|docetaxel|mesh-list
14589962|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589963|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14589964|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14589965|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14589966|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589967|NCT00022048|Bevacizumab|bevacizumab|mesh-list
14589968|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14589969|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14589970|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14589971|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14589972|NCT00022048|Growth Substances|growth substances|mesh-ancestor
14589973|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589974|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
14589975|NCT00022074|Gabapentin|gabapentin|mesh-list
14589976|NCT00022074|Analgesics|analgesics|mesh-ancestor
14589977|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
14589978|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14589979|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589980|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
14589981|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14589982|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14589983|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14589984|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156771|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589985|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14589986|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14589987|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14589988|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14589989|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
14589990|NCT00022087|Vitamin D|vitamin d|mesh-list
14589991|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
14589992|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
14589993|NCT00022087|Calcium|calcium|mesh-list
14589994|NCT00022087|Vitamins|vitamins|mesh-ancestor
14589995|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
14589996|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14589997|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14589998|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14589999|NCT00022126|Cytarabine|cytarabine|mesh-list
14590000|NCT00022126|Cyclosporine|cyclosporine|mesh-list
15156772|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15156773|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15156774|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15156775|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15156776|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15156777|NCT04156204|Tacrolimus|tacrolimus|mesh-list
15156778|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156779|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
15156780|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590001|NCT00022126|Dexamethasone|dexamethasone|mesh-list
14590002|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
14590003|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
14590004|NCT00022126|Doxorubicin|doxorubicin|mesh-list
14590005|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14590006|NCT00022126|Methotrexate|methotrexate|mesh-list
14590007|NCT00022126|Vincristine|vincristine|mesh-list
14590008|NCT00022126|Daunorubicin|daunorubicin|mesh-list
14590009|NCT00022126|Asparaginase|asparaginase|mesh-list
15156781|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15156782|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156783|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590010|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
14590011|NCT00022126|Pegaspargase|pegaspargase|mesh-list
14590012|NCT00022126|Thioguanine|thioguanine|mesh-list
14590013|NCT00022126|Cyclosporins|cyclosporins|mesh-list
14590014|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590015|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
14590016|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590017|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590018|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14590019|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
14590020|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590021|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590022|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14590023|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590024|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
14590025|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
14590026|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590027|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14590028|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
14590029|NCT00022126|Hormones|hormones|mesh-ancestor
15180461|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15180462|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180463|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180464|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
15180465|NCT03939923|Rocuronium|rocuronium|mesh-list
14590030|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14590031|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14590032|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590033|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590034|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590035|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590036|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14590037|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
14590038|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14590039|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590040|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
14590041|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
14590042|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15180466|NCT03939923|Neostigmine|neostigmine|mesh-list
15180467|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14590043|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590044|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
14590045|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590046|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590047|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590048|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590049|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590050|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
14590051|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14590052|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14590053|NCT00022126|Protective Agents|protective agents|mesh-ancestor
14590054|NCT00022139|Paclitaxel|paclitaxel|mesh-list
14590055|NCT00022139|Carboplatin|carboplatin|mesh-list
14590056|NCT00022139|Fluorouracil|fluorouracil|mesh-list
14590057|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590058|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590059|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590060|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590061|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590062|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590063|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
14590064|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590065|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590066|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
14590067|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644665|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644666|NCT00191997|Olanzapine|olanzapine|mesh-list
14644667|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
14644668|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
14644669|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644670|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644671|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14644672|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14644673|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14644674|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14644675|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14021690|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644676|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14644677|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14644678|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14644679|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644680|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021691|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14644681|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
14644682|NCT00192049|Gemcitabine|gemcitabine|mesh-list
14644683|NCT00192049|Mitomycins|mitomycins|mesh-list
14644684|NCT00192049|Mitomycin|mitomycin|mesh-list
14644685|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644686|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
14644687|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644688|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644689|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
14644690|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644691|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644692|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644693|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
14644694|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644695|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14644696|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
14644697|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644698|NCT00192062|Gemcitabine|gemcitabine|mesh-list
14644699|NCT00192062|Vinorelbine|vinorelbine|mesh-list
14644700|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644701|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
14644702|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644703|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644704|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
14644705|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644706|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644707|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644708|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
14644709|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644710|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14644711|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644712|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590068|NCT00022152|Vinorelbine|vinorelbine|mesh-list
14590069|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590070|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590071|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590072|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
14021692|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14590073|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590074|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590075|NCT00022165|Selenium|selenium|mesh-list
14590076|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
14590077|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590078|NCT00022165|Protective Agents|protective agents|mesh-ancestor
14590079|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590080|NCT00022165|Trace Elements|trace elements|mesh-ancestor
14590081|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
14590082|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
14590083|NCT00022178|Doxorubicin|doxorubicin|mesh-list
14590084|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14590085|NCT00022178|Fluorouracil|fluorouracil|mesh-list
14590086|NCT00022178|Vincristine|vincristine|mesh-list
14590087|NCT00022178|Epirubicin|epirubicin|mesh-list
14590088|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590089|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
14590090|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590091|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590092|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14590093|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
14590094|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590095|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590096|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14590097|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590098|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590099|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590100|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590101|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
14590102|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590103|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590104|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590105|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590106|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590107|NCT00022191|Gemcitabine|gemcitabine|mesh-list
15156784|NCT04156347|Topotecan|topotecan|mesh-list
15156785|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14590108|NCT00022191|Paclitaxel|paclitaxel|mesh-list
14590109|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590110|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590111|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590112|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590113|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590114|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590115|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590116|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
14590117|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
14590118|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590119|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156786|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15156787|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156788|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156789|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156790|NCT04156035|Lamotrigine|lamotrigine|mesh-list
15156791|NCT04156035|Ketamine|ketamine|mesh-list
14590120|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156792|NCT04156035|Analgesics|analgesics|mesh-ancestor
14291726|NCT00555997|Ziprasidone|ziprasidone|mesh-list
14291727|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14291728|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
14291729|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291730|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291731|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291732|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14291733|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14291734|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291735|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14291736|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14291737|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
14291738|NCT00556049|Gemcitabine|gemcitabine|mesh-list
14590121|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
14590122|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590123|NCT00022204|Vitamin E|vitamin e|mesh-list
14590124|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
15156793|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
15156794|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156795|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156796|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15156797|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15156798|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
15156799|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
15156800|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156801|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15156802|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14590125|NCT00022204|Vitamins|vitamins|mesh-ancestor
14590126|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
14590127|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590128|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
14590129|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590130|NCT00022204|Protective Agents|protective agents|mesh-ancestor
14590131|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14590132|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590133|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14590134|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14590135|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
14590136|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14590137|NCT00022217|Paclitaxel|paclitaxel|mesh-list
14590138|NCT00022217|Carboplatin|carboplatin|mesh-list
14590139|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590140|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590141|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590142|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590143|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590144|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156803|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156804|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156805|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
15156806|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15156807|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14590145|NCT00022230|Aldesleukin|aldesleukin|mesh-list
14590146|NCT00022230|Paclitaxel|paclitaxel|mesh-list
14590147|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
14590148|NCT00022230|Doxorubicin|doxorubicin|mesh-list
14590149|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14590150|NCT00022230|Sargramostim|sargramostim|mesh-list
14590151|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590152|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590153|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590154|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590155|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590156|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156808|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15156809|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15156810|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15156811|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156812|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15156813|NCT04156074|Vitamin D|vitamin d|mesh-list
14590157|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590158|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
14590159|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590160|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590161|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14590162|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
14590163|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14590164|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590165|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590166|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590167|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590168|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14590169|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14590170|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
14590171|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590172|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
14590173|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590174|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14590175|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
15156814|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
15156815|NCT04156074|Vitamins|vitamins|mesh-list
15156816|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
15156817|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156818|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15156819|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15156820|NCT04156152|Listerine|listerine|mesh-list
15156821|NCT04156152|Fluorides|fluorides|mesh-list
15156822|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
15156823|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
15156824|NCT04156152|Protective Agents|protective agents|mesh-ancestor
15156825|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156826|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15156827|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156828|NCT04156087|Gemcitabine|gemcitabine|mesh-list
15156829|NCT04156087|Durvalumab|durvalumab|mesh-list
15156830|NCT04156087|Tremelimumab|tremelimumab|mesh-list
15156831|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15156832|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
14590176|NCT00022308|Irinotecan|irinotecan|mesh-list
14590177|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590178|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14590179|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590180|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590181|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590182|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
14590183|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14590184|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590185|NCT00022360|Taurolidine|taurolidine|mesh-list
15156833|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156834|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156835|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
15156836|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156837|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156838|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156839|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
15156840|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590186|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590187|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14590188|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590189|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
14590190|NCT00022386|Hematinics|hematinics|mesh-ancestor
14590191|NCT00022399|Celecoxib|celecoxib|mesh-list
14590192|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14590193|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14590194|NCT00022399|Analgesics|analgesics|mesh-ancestor
14590195|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
14590196|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590197|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590198|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590199|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590200|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14590201|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14590202|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590203|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590204|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14590205|NCT00022412|Vitamins|vitamins|mesh-ancestor
14590206|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
14590207|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590208|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15156841|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15156842|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15156843|NCT04155814|Hematinics|hematinics|mesh-ancestor
15156844|NCT04155879|Colchicine|colchicine|mesh-list
15156845|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
15156846|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590209|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
14590210|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590211|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590212|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590213|NCT00022438|Aldesleukin|aldesleukin|mesh-list
14590214|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
14590215|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156847|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
15156848|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
15156849|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156850|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590216|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14590217|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14590218|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
14590219|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590220|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14590221|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
14590222|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590223|NCT00022451|Tipifarnib|tipifarnib|mesh-list
14590224|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590225|NCT00022464|Sirolimus|sirolimus|mesh-list
14590226|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590227|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590228|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590229|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590230|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
14590231|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590232|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
14590233|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590234|NCT00022529|Trastuzumab|trastuzumab|mesh-list
14590235|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14590236|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590237|NCT00022542|Epothilones|epothilones|mesh-list
14590238|NCT00022542|Epothilone B|epothilone b|mesh-list
14590239|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590240|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590241|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590242|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590243|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590244|NCT00022555|Vincristine|vincristine|mesh-list
14590245|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
14590246|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590247|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590248|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590249|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590250|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590251|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590252|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15156851|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156852|NCT04155983|Ropivacaine|ropivacaine|mesh-list
15156853|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
15156854|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
15156855|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156856|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156857|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
15156858|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15156859|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
15156860|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15156861|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
15156862|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590253|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
14590254|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590255|NCT00022581|Thalidomide|thalidomide|mesh-list
14590256|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590257|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
14590258|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590259|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
14590260|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590261|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590262|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14590263|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14590264|NCT00022581|Growth Substances|growth substances|mesh-ancestor
14590265|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
14590266|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590267|NCT00022594|Lurtotecan|lurtotecan|mesh-list
14590268|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590269|NCT00022607|Thalidomide|thalidomide|mesh-list
14590270|NCT00022607|Bevacizumab|bevacizumab|mesh-list
14590271|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15156863|NCT04155632|Expectorants|expectorants|mesh-ancestor
15156864|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
15156865|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15156866|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
15156867|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156868|NCT04155632|Protective Agents|protective agents|mesh-ancestor
14590272|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590273|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14644713|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590274|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14590275|NCT00022607|Growth Substances|growth substances|mesh-ancestor
14590276|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590277|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
14590278|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590279|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
14590280|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
14590281|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590282|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590283|NCT00022620|Paclitaxel|paclitaxel|mesh-list
14590284|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590285|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590286|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590287|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590288|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590289|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590290|NCT00022646|Gemcitabine|gemcitabine|mesh-list
14590291|NCT00022646|Pemetrexed|pemetrexed|mesh-list
14590292|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590293|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
14590294|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590295|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590296|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
14590297|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590298|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590299|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590300|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
14590301|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590302|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14590303|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590304|NCT00022685|Epratuzumab|epratuzumab|mesh-list
14590305|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14590306|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590307|NCT00022711|Temozolomide|temozolomide|mesh-list
14590308|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14590309|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
14590310|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590311|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590312|NCT00022724|Sirolimus|sirolimus|mesh-list
14590313|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590314|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590315|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590316|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590317|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
14590318|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590319|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
14590320|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590321|NCT00022737|Leucovorin|leucovorin|mesh-list
14590322|NCT00022737|Cytarabine|cytarabine|mesh-list
14590323|NCT00022737|Cyclosporine|cyclosporine|mesh-list
15156869|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156870|NCT04155632|Antidotes|antidotes|mesh-ancestor
15156871|NCT04155658|Fluorides|fluorides|mesh-list
15156872|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
14590324|NCT00022737|Dexamethasone|dexamethasone|mesh-list
14590325|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
14590326|NCT00022737|Ifosfamide|ifosfamide|mesh-list
14590327|NCT00022737|Methotrexate|methotrexate|mesh-list
14590328|NCT00022737|Etoposide|etoposide|mesh-list
14590329|NCT00022737|Vincristine|vincristine|mesh-list
14590330|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
14590331|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
14590332|NCT00022737|Daunorubicin|daunorubicin|mesh-list
14590333|NCT00022737|Asparaginase|asparaginase|mesh-list
14590334|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
14590335|NCT00022737|Pegaspargase|pegaspargase|mesh-list
14590336|NCT00022737|Cyclosporins|cyclosporins|mesh-list
14590337|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
14590338|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590339|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
14590340|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590341|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590342|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15156873|NCT04155658|Protective Agents|protective agents|mesh-ancestor
14590343|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
14590344|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590345|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590346|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14590347|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590348|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
14590349|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
14590350|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590351|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14590352|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
14590353|NCT00022737|Hormones|hormones|mesh-ancestor
14590354|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14590355|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14590356|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14590357|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
14590358|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14590359|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590360|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
14590361|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
14590362|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590363|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14590364|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590365|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590366|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590367|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590368|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
14590369|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590370|NCT00022737|Antidotes|antidotes|mesh-ancestor
14590371|NCT00022737|Protective Agents|protective agents|mesh-ancestor
14590372|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
14590373|NCT00022737|Vitamins|vitamins|mesh-ancestor
14590374|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
14590375|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590376|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590377|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590378|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
14590379|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14590380|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14590381|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590382|NCT00022841|Pamidronate|pamidronate|mesh-list
14590383|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14590384|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590385|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
14590386|NCT00022880|Antibodies|antibodies|mesh-list
14590387|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
14590388|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590389|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590390|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
14590391|NCT00022893|Antibodies|antibodies|mesh-list
14590392|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
14590393|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590394|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590395|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
14590396|NCT00022906|Antibodies|antibodies|mesh-list
14590397|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
14590398|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156874|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156875|NCT04155918|Allopurinol|allopurinol|mesh-list
15156876|NCT04155918|Febuxostat|febuxostat|mesh-list
14590399|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590400|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
14590401|NCT00022932|Antibodies|antibodies|mesh-list
14590402|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
14590403|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590404|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590405|NCT00022945|Prednisone|prednisone|mesh-list
14590406|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
14590407|NCT00022945|Doxorubicin|doxorubicin|mesh-list
14590408|NCT00022945|Vincristine|vincristine|mesh-list
14590409|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
14590410|NCT00022945|Antibodies|antibodies|mesh-list
14590411|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590412|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
14590413|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590414|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590415|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15156877|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
15156878|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590416|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
14590417|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590418|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590419|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15156879|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156880|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
15156881|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590420|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590421|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590422|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590423|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590424|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590425|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
14590426|NCT00022945|Hormones|hormones|mesh-ancestor
14590427|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14590428|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14590429|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590430|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590431|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590432|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590433|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
14590434|NCT00022958|Antibodies|antibodies|mesh-list
14590435|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
14590436|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590437|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590438|NCT00022971|Rituximab|rituximab|mesh-list
14590439|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14590440|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590441|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
14590442|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590443|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590444|NCT00023153|Adefovir|adefovir|mesh-list
14590445|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14590446|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
14590447|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590448|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14590449|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590450|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590451|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590452|NCT00023166|Paclitaxel|paclitaxel|mesh-list
14590453|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590454|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590455|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590456|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590457|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590458|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590459|NCT00023218|Ritonavir|ritonavir|mesh-list
14590460|NCT00023218|Lopinavir|lopinavir|mesh-list
14590461|NCT00023218|Efavirenz|efavirenz|mesh-list
14590462|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14590463|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14590464|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
14590465|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590466|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590467|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14590468|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14590469|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
14590470|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590471|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14590472|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14590473|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14590474|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590475|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14590476|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14590477|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14590478|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14590479|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14590480|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
14590481|NCT00023231|Sirolimus|sirolimus|mesh-list
14590482|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14590483|NCT00023231|Ganciclovir|ganciclovir|mesh-list
14590484|NCT00023231|Prednisone|prednisone|mesh-list
14590485|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
14590486|NCT00023231|Atorvastatin|atorvastatin|mesh-list
14590487|NCT00023231|Daclizumab|daclizumab|mesh-list
14590488|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590489|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
14590490|NCT00023231|Hormones|hormones|mesh-ancestor
14644714|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
15156882|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14590491|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14590492|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590493|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14590494|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590495|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590496|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590497|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590498|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590499|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590500|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590501|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590502|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
14590503|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590504|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
14590505|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
14590506|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
14590507|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590508|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14590509|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14590510|NCT00023231|Protective Agents|protective agents|mesh-ancestor
14590511|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14590512|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14590513|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
14590514|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14590515|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14590516|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
14590517|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14590518|NCT00023231|Renal Agents|renal agents|mesh-ancestor
14590519|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
14590520|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14590521|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14590522|NCT00023244|Cyclosporine|cyclosporine|mesh-list
14590523|NCT00023244|Sirolimus|sirolimus|mesh-list
14590524|NCT00023244|Trimethoprim|trimethoprim|mesh-list
14590525|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
14590526|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14590527|NCT00023244|Prednisone|prednisone|mesh-list
14590528|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
14590529|NCT00023244|Tacrolimus|tacrolimus|mesh-list
14590530|NCT00023244|Cyclosporins|cyclosporins|mesh-list
14590531|NCT00023244|Basiliximab|basiliximab|mesh-list
14590532|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590533|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
14590534|NCT00023244|Hormones|hormones|mesh-ancestor
14590535|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14590536|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590537|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14590538|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590539|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590540|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
14590541|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14590542|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590543|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590544|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
14590545|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590546|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
14590547|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590548|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590549|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590550|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
14590551|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
14590552|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590553|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14590554|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14590555|NCT00023244|Protective Agents|protective agents|mesh-ancestor
14590556|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14590557|NCT00023244|Renal Agents|renal agents|mesh-ancestor
14590558|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
14590559|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14590560|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14590561|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14590562|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14590563|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14590564|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14590565|NCT00023283|Buprenorphine|buprenorphine|mesh-list
14590566|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14590567|NCT00023283|Narcotics|narcotics|mesh-ancestor
14590568|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14590569|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590570|NCT00023283|Analgesics|analgesics|mesh-ancestor
14590571|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
14590572|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590573|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14590574|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
14590575|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14590576|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
14590577|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590578|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590579|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14590580|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
14590581|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14590582|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
14590583|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590584|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14590585|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14590586|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
14590587|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
14590588|NCT00023296|Protective Agents|protective agents|mesh-ancestor
14590589|NCT00023335|Isoniazid|isoniazid|mesh-list
14590590|NCT00023335|Rifapentine|rifapentine|mesh-list
14590591|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590592|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590593|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156883|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
15156884|NCT04155918|Protective Agents|protective agents|mesh-ancestor
14590594|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14590595|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14590596|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
14590597|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590598|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14590599|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590600|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
14590601|NCT00023348|Isoniazid|isoniazid|mesh-list
14590602|NCT00023348|Rifabutin|rifabutin|mesh-list
14590603|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590604|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590605|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590606|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14590607|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14590608|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
14590609|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590610|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14590611|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590612|NCT00023361|Rifabutin|rifabutin|mesh-list
14590613|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590614|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590615|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590616|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590617|NCT00023374|Rifampin|rifampin|mesh-list
14590618|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
14590619|NCT00023374|Ethambutol|ethambutol|mesh-list
14590620|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590621|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590622|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590623|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590624|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
14590625|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590626|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590627|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590628|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14590629|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14590630|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14590631|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14590632|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14590633|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14590634|NCT00023387|Isoniazid|isoniazid|mesh-list
14590635|NCT00023387|Rifapentine|rifapentine|mesh-list
14590636|NCT00023387|Rifampin|rifampin|mesh-list
14590637|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590638|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590639|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156885|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590640|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14590641|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14590642|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
14590643|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590644|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14590645|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590646|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
15156886|NCT04155697|Ethanol|ethanol|mesh-list
15156887|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
15156888|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15156889|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156890|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156891|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156892|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
15156893|NCT04155554|Tenofovir|tenofovir|mesh-list
15156894|NCT04155554|Lamivudine|lamivudine|mesh-list
15156895|NCT04155554|Emtricitabine|emtricitabine|mesh-list
15156896|NCT04155554|Abacavir|abacavir|mesh-list
15156897|NCT04155554|Dolutegravir|dolutegravir|mesh-list
15156898|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15156899|NCT04155554|Triumeq|triumeq|mesh-list
15156900|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
15156901|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156902|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15156903|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15156904|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156905|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156906|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15156907|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15156908|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15156909|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15156910|NCT04155515|Ribavirin|ribavirin|mesh-list
15156911|NCT04155515|Yimitasvir|yimitasvir|mesh-list
15156912|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
15156913|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156914|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
15156915|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156916|NCT04155229|Acetaminophen|acetaminophen|mesh-list
15156917|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15156918|NCT04155229|Oxycodone|oxycodone|mesh-list
15156919|NCT04155229|Hydrocodone|hydrocodone|mesh-list
15156920|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14590647|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590648|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590649|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14590650|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14590651|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14590652|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14590653|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14590654|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14590655|NCT00023400|Nelfinavir|nelfinavir|mesh-list
14590656|NCT00023400|Rifabutin|rifabutin|mesh-list
14590657|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14590658|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14590659|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
14590660|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590661|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590662|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14590663|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14590664|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
14590665|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590666|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590667|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590668|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590669|NCT00023413|Efavirenz|efavirenz|mesh-list
14590670|NCT00023413|Rifabutin|rifabutin|mesh-list
14590671|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14590672|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590673|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590674|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590675|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
14590676|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590677|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15156921|NCT04155229|Analgesics|analgesics|mesh-ancestor
15156922|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
15156923|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590678|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14590679|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14590680|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14590681|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14590682|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14590683|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590684|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590685|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590686|NCT00023426|Rifapentine|rifapentine|mesh-list
14590687|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14590688|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
14590689|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590690|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590691|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
14590692|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14590693|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
14590694|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590695|NCT00023530|Thalidomide|thalidomide|mesh-list
14590696|NCT00023530|Fluconazole|fluconazole|mesh-list
14590697|NCT00023530|Voriconazole|voriconazole|mesh-list
14590698|NCT00023530|Dexamethasone|dexamethasone|mesh-list
14590699|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590700|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
14590701|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
14590702|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590703|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590704|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14590705|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
14590706|NCT00023530|Hormones|hormones|mesh-ancestor
14590707|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14590708|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14590709|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590710|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590711|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
14590712|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
14590713|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14590714|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590715|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14590716|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14590717|NCT00023530|Growth Substances|growth substances|mesh-ancestor
14590718|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
14590719|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
14590720|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15156924|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156925|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
15156926|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15156927|NCT04155229|Narcotics|narcotics|mesh-ancestor
15156928|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15156929|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
15156930|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
15156931|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15156932|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156933|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15156934|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
15156935|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15156936|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
15156937|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
15156938|NCT04154852|Folic Acid|folic acid|mesh-list
15156939|NCT04154852|Adalimumab|adalimumab|mesh-list
15156940|NCT04154852|Methotrexate|methotrexate|mesh-list
15156941|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15156942|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
15156943|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15156944|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156945|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15156946|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
15156947|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156948|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156949|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
15156950|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15156951|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15156952|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15156953|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
14590721|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15156954|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590722|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590723|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590724|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14590725|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
14590726|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14590727|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14590728|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14590729|NCT00023621|Celecoxib|celecoxib|mesh-list
14590730|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14590731|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14590732|NCT00023621|Analgesics|analgesics|mesh-ancestor
14590733|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
15156955|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15156956|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15156957|NCT04154852|Hematinics|hematinics|mesh-ancestor
15156958|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
14590734|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590735|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590736|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590737|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590738|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14590739|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15156959|NCT04154852|Vitamins|vitamins|mesh-ancestor
15156960|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
15156961|NCT04154813|Topiramate|topiramate|mesh-list
14590740|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590741|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590742|NCT00023634|Sargramostim|sargramostim|mesh-list
14590743|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
14590744|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590745|NCT00023660|Celecoxib|celecoxib|mesh-list
14590746|NCT00023660|Fluorouracil|fluorouracil|mesh-list
14590747|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590748|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
14590749|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590750|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590751|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590752|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
14590753|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590754|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14590755|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14590756|NCT00023660|Analgesics|analgesics|mesh-ancestor
15156962|NCT04154813|Fluoxetine|fluoxetine|mesh-list
15156963|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
14590757|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
14590758|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14590759|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14590760|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14590761|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14590762|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14590763|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590764|NCT00023699|Gefitinib|gefitinib|mesh-list
14590765|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590766|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14590767|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590768|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590769|NCT00023725|Semaxinib|semaxinib|mesh-list
14590770|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15156964|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15156965|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156966|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15156967|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15156968|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15156969|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156970|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15156971|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
14590771|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14590772|NCT00023725|Growth Substances|growth substances|mesh-ancestor
14590773|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590774|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
14590775|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590776|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14590777|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180468|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14590778|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590779|NCT00023738|Doxorubicin|doxorubicin|mesh-list
14590780|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14590781|NCT00023738|Ifosfamide|ifosfamide|mesh-list
14590782|NCT00023738|Dacarbazine|dacarbazine|mesh-list
14590783|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590784|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590785|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590786|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590787|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590788|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590789|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14590790|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
14590791|NCT00023751|Leucovorin|leucovorin|mesh-list
14590792|NCT00023751|Fluorouracil|fluorouracil|mesh-list
14590793|NCT00023751|Calcium|calcium|mesh-list
14590794|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
14590795|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14590796|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590797|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
14590798|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590799|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590800|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590801|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590802|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
14590803|NCT00023751|Antidotes|antidotes|mesh-ancestor
14590804|NCT00023751|Protective Agents|protective agents|mesh-ancestor
14590805|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
14590806|NCT00023751|Vitamins|vitamins|mesh-ancestor
14590807|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
14644715|NCT00192088|Pemetrexed|pemetrexed|mesh-list
14644716|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644717|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644718|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644719|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14644720|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644721|NCT00192101|Gemcitabine|gemcitabine|mesh-list
14644722|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644723|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644724|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
14644725|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644726|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
14644727|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644728|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644729|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644730|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
14644731|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644732|NCT00192413|Vaccines|vaccines|mesh-list
14644733|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
14644734|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644735|NCT00192569|Interferons|interferons|mesh-list
14644736|NCT00192569|Ribavirin|ribavirin|mesh-list
14644737|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
14644738|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
14644739|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14644740|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644741|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
14644742|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644743|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
14644744|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644745|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
14644746|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644747|NCT00192595|Tenofovir|tenofovir|mesh-list
14644748|NCT00192595|Lamivudine|lamivudine|mesh-list
14644749|NCT00192595|Zidovudine|zidovudine|mesh-list
14644750|NCT00192595|Efavirenz|efavirenz|mesh-list
14644751|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
14644752|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644753|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14644754|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644755|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644756|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180469|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14644757|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14644758|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14644759|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
14644760|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14590808|NCT00023777|Cytarabine|cytarabine|mesh-list
14590809|NCT00023777|Daunorubicin|daunorubicin|mesh-list
14590810|NCT00023777|Sargramostim|sargramostim|mesh-list
14590811|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590812|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
14590813|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590814|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590815|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
14590816|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590817|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590818|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
14590819|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590820|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590821|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590822|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590823|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590824|NCT00023790|Silicon|silicon|mesh-list
14590825|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
14590826|NCT00023790|Trace Elements|trace elements|mesh-ancestor
14590827|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
14590828|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590829|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
14590830|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14590831|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14590832|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590833|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
14590834|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14590835|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14590836|NCT00023816|Carbendazim|carbendazim|mesh-list
14590837|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
14590838|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
14590839|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14590840|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590841|NCT00023829|Bicalutamide|bicalutamide|mesh-list
14590842|NCT00023829|Flutamide|flutamide|mesh-list
14590843|NCT00023829|Hormones|hormones|mesh-list
14590844|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14590845|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590846|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
14590847|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
14590848|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590849|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14590850|NCT00023842|Mitomycins|mitomycins|mesh-list
14590851|NCT00023842|Mitomycin|mitomycin|mesh-list
14590852|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
14590853|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590854|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590855|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
14590856|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590857|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590858|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590859|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14590860|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
14590861|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590862|NCT00023855|Doxorubicin|doxorubicin|mesh-list
14590863|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14590864|NCT00023855|Bortezomib|bortezomib|mesh-list
14590865|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590866|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590867|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590868|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590869|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590870|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590871|NCT00023868|Leucovorin|leucovorin|mesh-list
14590872|NCT00023868|Doxorubicin|doxorubicin|mesh-list
14590873|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14590874|NCT00023868|Fluorouracil|fluorouracil|mesh-list
14590875|NCT00023868|Irinotecan|irinotecan|mesh-list
14590876|NCT00023868|Mitomycins|mitomycins|mesh-list
14590877|NCT00023868|Mitomycin|mitomycin|mesh-list
14590878|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
14590879|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590880|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590881|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590882|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590883|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590884|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590885|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590886|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
14590887|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590888|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590889|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
14590890|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14590891|NCT00023868|Antidotes|antidotes|mesh-ancestor
14590892|NCT00023868|Protective Agents|protective agents|mesh-ancestor
14590893|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
14590894|NCT00023868|Vitamins|vitamins|mesh-ancestor
14590895|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
14590896|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
14590897|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590898|NCT00023881|Bortezomib|bortezomib|mesh-list
14590899|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590900|NCT00023894|Alvocidib|alvocidib|mesh-list
14590901|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590902|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
14590903|NCT00023894|Growth Substances|growth substances|mesh-ancestor
14590904|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590905|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14590906|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590907|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590908|NCT00023907|Paclitaxel|paclitaxel|mesh-list
15156972|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15156973|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
15156974|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15156975|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15156976|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15156977|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590909|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14590910|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590911|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590912|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590913|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590914|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590915|NCT00023920|Cytarabine|cytarabine|mesh-list
14590916|NCT00023920|Bevacizumab|bevacizumab|mesh-list
14590917|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14590918|NCT00023920|Idarubicin|idarubicin|mesh-list
14590919|NCT00023920|Antibodies|antibodies|mesh-list
14590920|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
14590921|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14590922|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590923|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14590924|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14590925|NCT00023920|Growth Substances|growth substances|mesh-ancestor
14590926|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590927|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
14590928|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
14590929|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590930|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
14590931|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590932|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
14590933|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590934|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590935|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590936|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590937|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590938|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590939|NCT00023933|Antibodies|antibodies|mesh-list
14590940|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14590941|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
14590942|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590943|NCT00023946|Epothilones|epothilones|mesh-list
14590944|NCT00023946|Epothilone B|epothilone b|mesh-list
14590945|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
14590946|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
14590947|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
14590948|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590949|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590950|NCT00023959|Bevacizumab|bevacizumab|mesh-list
15156978|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
15156979|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14590951|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14590952|NCT00023959|Fluorouracil|fluorouracil|mesh-list
14590953|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
14590954|NCT00023959|Antibodies|antibodies|mesh-list
14590955|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
14590956|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14590957|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590958|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14590959|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14590960|NCT00023959|Growth Substances|growth substances|mesh-ancestor
14590961|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590962|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
14590963|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
14590964|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
14590965|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590966|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590967|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590968|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
14590969|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590970|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14590971|NCT00023972|Gemcitabine|gemcitabine|mesh-list
14590972|NCT00023972|Exatecan|exatecan|mesh-list
14590973|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14590974|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
14590975|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14590976|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590977|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
14590978|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14590979|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590980|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14590981|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
14590982|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14590983|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14590984|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590985|NCT00023998|Leucovorin|leucovorin|mesh-list
14590986|NCT00023998|Doxorubicin|doxorubicin|mesh-list
14590987|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14590988|NCT00023998|Methotrexate|methotrexate|mesh-list
14590989|NCT00023998|Trastuzumab|trastuzumab|mesh-list
14590990|NCT00023998|Etoposide|etoposide|mesh-list
14590991|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
14590992|NCT00023998|Ifosfamide|ifosfamide|mesh-list
14590993|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
14590994|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14590995|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14590996|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14590997|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14590998|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14590999|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591000|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591001|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14591002|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
14591003|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14591004|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591005|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
14591006|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
14591007|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14591008|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591009|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
14591010|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591011|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591012|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14591013|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591014|NCT00023998|Antidotes|antidotes|mesh-ancestor
14591015|NCT00023998|Protective Agents|protective agents|mesh-ancestor
14591016|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
14591017|NCT00023998|Vitamins|vitamins|mesh-ancestor
14591018|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
14591019|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591020|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
15156980|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
14291739|NCT00556049|Sunitinib|sunitinib|mesh-list
14291740|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14291741|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
14291742|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291743|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291744|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
14291745|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291746|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291747|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291748|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
15156981|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156982|NCT04154982|Expectorants|expectorants|mesh-ancestor
15156983|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
15156984|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15156985|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
15156986|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591021|NCT00024011|Bortezomib|bortezomib|mesh-list
14591022|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591023|NCT00024050|Cyclosporine|cyclosporine|mesh-list
14591024|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
14591025|NCT00024050|Busulfan|busulfan|mesh-list
14591026|NCT00024050|Methotrexate|methotrexate|mesh-list
14591027|NCT00024050|Cyclosporins|cyclosporins|mesh-list
14591028|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591029|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
14591030|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591031|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591032|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591033|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
14591034|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591035|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591036|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591037|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14591038|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
14591039|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14591040|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591041|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
14591042|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
14591043|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591044|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14591045|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591046|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
14591047|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591048|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14591049|NCT00024063|Orantinib|orantinib|mesh-list
14591050|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591051|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591052|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591053|NCT00024089|Gefitinib|gefitinib|mesh-list
14591054|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591055|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591056|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591057|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591058|NCT00024115|Antibodies|antibodies|mesh-list
14591059|NCT00024115|Immunotoxins|immunotoxins|mesh-list
14591060|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
14591061|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591062|NCT00024128|Cyclosporine|cyclosporine|mesh-list
14591063|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
14591064|NCT00024128|Cyclosporins|cyclosporins|mesh-list
14591065|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14591066|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591067|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
14591068|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591069|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591070|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591071|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
14591072|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591073|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591074|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591075|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591076|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
14591077|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591078|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
14591079|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14591080|NCT00024141|Fluorouracil|fluorouracil|mesh-list
14591081|NCT00024141|Irinotecan|irinotecan|mesh-list
14591082|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
14591083|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591084|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591085|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591086|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591087|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
14591088|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591089|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15156987|NCT04154982|Protective Agents|protective agents|mesh-ancestor
14591090|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591091|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591092|NCT00024154|Trastuzumab|trastuzumab|mesh-list
14591093|NCT00024154|Gefitinib|gefitinib|mesh-list
14591094|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14591095|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591096|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591097|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591098|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591099|NCT00024180|Romidepsin|romidepsin|mesh-list
14591100|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591101|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591102|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
14591103|NCT00024193|Melphalan|melphalan|mesh-list
14591104|NCT00024193|Busulfan|busulfan|mesh-list
14591105|NCT00024193|Doxorubicin|doxorubicin|mesh-list
14591106|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591107|NCT00024193|Etoposide|etoposide|mesh-list
14591108|NCT00024193|Vincristine|vincristine|mesh-list
14591109|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591110|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
14591111|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591112|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591113|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591114|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
14591115|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591116|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591117|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591118|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591119|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591120|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591121|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591122|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591123|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591124|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591125|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591126|NCT00024206|Orantinib|orantinib|mesh-list
14591127|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591128|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591129|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591130|NCT00024232|Antibodies|antibodies|mesh-list
14591131|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14591132|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
14591133|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591134|NCT00024245|Probenecid|probenecid|mesh-list
14591135|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
14591136|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
14591137|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591138|NCT00024245|Renal Agents|renal agents|mesh-ancestor
14591139|NCT00024271|Gemcitabine|gemcitabine|mesh-list
14591140|NCT00024271|Interferons|interferons|mesh-list
14591141|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
14591142|NCT00024271|Doxorubicin|doxorubicin|mesh-list
14591143|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591144|NCT00024271|Mitomycins|mitomycins|mesh-list
14591145|NCT00024271|Mitomycin|mitomycin|mesh-list
14591146|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591147|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591148|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
14591149|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591150|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
14591151|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591152|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591153|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591154|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
14591155|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591156|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591157|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591158|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591159|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
14591160|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591161|NCT00024284|Carboplatin|carboplatin|mesh-list
14591162|NCT00024284|Irinotecan|irinotecan|mesh-list
14591163|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591164|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14591165|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591166|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591167|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591168|NCT00024297|Warfarin|warfarin|mesh-list
14591169|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
14591170|NCT00024310|Folic Acid|folic acid|mesh-list
14591171|NCT00024310|Paclitaxel|paclitaxel|mesh-list
14591172|NCT00024310|Lometrexol|lometrexol|mesh-list
14591173|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591174|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591175|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591176|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591177|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591178|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591179|NCT00024310|Hematinics|hematinics|mesh-ancestor
14591180|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
14591181|NCT00024310|Vitamins|vitamins|mesh-ancestor
14591182|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
14591183|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591184|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591185|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
14591186|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14591187|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591188|NCT00024323|Cisplatin|cisplatin|mesh-list
14591189|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591190|NCT00024336|Tamoxifen|tamoxifen|mesh-list
14591191|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14591192|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
14591193|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14591194|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591195|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14591196|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591197|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14591198|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14591199|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14591200|NCT00024349|Fluorouracil|fluorouracil|mesh-list
14591201|NCT00024349|Mitomycins|mitomycins|mesh-list
14591202|NCT00024349|Mitomycin|mitomycin|mesh-list
14591203|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
14591204|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591205|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591206|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591207|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591208|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
14591209|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591210|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591211|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
14591212|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591213|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591214|NCT00024362|BBR 3464|bbr 3464|mesh-list
14591215|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591216|NCT00024375|Paclitaxel|paclitaxel|mesh-list
14591217|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591218|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591219|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591220|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591221|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591222|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591223|NCT00024388|Paclitaxel|paclitaxel|mesh-list
14591224|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591225|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591226|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591227|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591228|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591229|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591230|NCT00024401|Paclitaxel|paclitaxel|mesh-list
15156988|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15156989|NCT04154982|Antidotes|antidotes|mesh-ancestor
15156990|NCT04154748|Omeprazole|omeprazole|mesh-list
15156991|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15156992|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15156993|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15156994|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591231|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591232|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15156995|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15156996|NCT04155008|Dexamethasone|dexamethasone|mesh-list
14591233|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591234|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591235|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
15156997|NCT04155008|Dronabinol|dronabinol|mesh-list
14591236|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591237|NCT00024414|Paclitaxel|paclitaxel|mesh-list
14591238|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591239|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591240|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591241|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591242|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591243|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591244|NCT00024427|Gemcitabine|gemcitabine|mesh-list
14591245|NCT00024427|Fluorouracil|fluorouracil|mesh-list
14591246|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591247|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
14591248|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591249|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591250|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
14591251|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591252|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591253|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591254|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
14591255|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591256|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
14591257|NCT00024440|Fludarabine|fludarabine|mesh-list
14591258|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
14591259|NCT00024440|Oblimersen|oblimersen|mesh-list
14591260|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591261|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
14591262|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591263|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591264|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591265|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
14591266|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591267|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591268|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591269|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591270|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
14591271|NCT00024453|Teicoplanin|teicoplanin|mesh-list
14591272|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14591273|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15156998|NCT04155008|Mirtazapine|mirtazapine|mesh-list
15156999|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157000|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
15157001|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
15157002|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14591274|NCT00024466|Vaccines|vaccines|mesh-list
14591275|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
14591276|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591277|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
14591278|NCT00024492|Analgesics|analgesics|mesh-ancestor
14591279|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
14591280|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14591281|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591282|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591283|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591284|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591285|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591286|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157003|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157004|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157005|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
15157006|NCT04155008|Hormones|hormones|mesh-ancestor
15157007|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157008|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15157009|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157010|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
15157011|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15157012|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15157013|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
15157014|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
15157015|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157016|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157017|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14591287|NCT00024518|Interferons|interferons|mesh-list
14591288|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
14591289|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591290|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
14591291|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591292|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
14591293|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591294|NCT00024531|Atorvastatin|atorvastatin|mesh-list
14591295|NCT00024531|Calcium|calcium|mesh-list
14591296|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14591297|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591298|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14591299|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14591300|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
14591301|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591302|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14591303|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14591304|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591305|NCT00024544|Antibodies|antibodies|mesh-list
14591306|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14591307|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
14591308|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591309|NCT00024687|Immunotoxins|immunotoxins|mesh-list
14591310|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
14591311|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591312|NCT00024986|Tenofovir|tenofovir|mesh-list
14591313|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
14591314|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591315|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14591316|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591317|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591318|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591319|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14591320|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14591321|NCT00025012|Isotretinoin|isotretinoin|mesh-list
14591322|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
14591323|NCT00025038|Cytarabine|cytarabine|mesh-list
14591324|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
14591325|NCT00025038|Fludarabine|fludarabine|mesh-list
14591326|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
14591327|NCT00025038|Tipifarnib|tipifarnib|mesh-list
14591328|NCT00025038|Isotretinoin|isotretinoin|mesh-list
14591329|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
14591330|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14591331|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
14591332|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591333|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
14591334|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591335|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591336|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591337|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
14591338|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591339|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591340|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591341|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591342|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
14591343|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
14591344|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157018|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15157019|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157020|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14591345|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
14591346|NCT00025051|Celecoxib|celecoxib|mesh-list
14591347|NCT00025051|Mitogens|mitogens|mesh-list
14591348|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14591349|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14591350|NCT00025051|Analgesics|analgesics|mesh-ancestor
14591351|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
14591352|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14591353|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591354|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14591355|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591356|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14591357|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14591358|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591359|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591360|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591361|NCT00025064|Prednisolone|prednisolone|mesh-list
14591362|NCT00025064|Doxorubicin|doxorubicin|mesh-list
14591363|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15157021|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15157022|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15157023|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
15157024|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15157025|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14591364|NCT00025064|Etoposide|etoposide|mesh-list
14591365|NCT00025064|Vincristine|vincristine|mesh-list
14591366|NCT00025064|Melphalan|melphalan|mesh-list
14591367|NCT00025064|Ifosfamide|ifosfamide|mesh-list
14591368|NCT00025064|Dacarbazine|dacarbazine|mesh-list
14591369|NCT00025064|Bleomycin|bleomycin|mesh-list
14591370|NCT00025064|Vinblastine|vinblastine|mesh-list
14591371|NCT00025064|Procarbazine|procarbazine|mesh-list
14591372|NCT00025064|Chlorambucil|chlorambucil|mesh-list
14591373|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591374|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591375|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591376|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591377|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591378|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591379|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591380|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591381|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591382|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591383|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591384|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
14591385|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591386|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591387|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
14591388|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591389|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14591390|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
14591391|NCT00025064|Hormones|hormones|mesh-ancestor
14591392|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14591393|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14591394|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
14591395|NCT00025077|Thiotepa|thiotepa|mesh-list
14591396|NCT00025077|Carboplatin|carboplatin|mesh-list
14591397|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591398|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
14591399|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591400|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591401|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591402|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
14591403|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591404|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591405|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591406|NCT00025090|Fluorouracil|fluorouracil|mesh-list
14591407|NCT00025090|Mitomycins|mitomycins|mesh-list
14591408|NCT00025090|Mitomycin|mitomycin|mesh-list
14591409|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591410|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
14591411|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591412|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591413|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591414|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
14591415|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591416|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591417|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
14591418|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14021693|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14591419|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591420|NCT00025103|Dactinomycin|dactinomycin|mesh-list
14591421|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
14591422|NCT00025103|Melphalan|melphalan|mesh-list
14591423|NCT00025103|Carboplatin|carboplatin|mesh-list
14591424|NCT00025103|Doxorubicin|doxorubicin|mesh-list
14591425|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15157026|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
15157027|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15157028|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
14021694|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
14591426|NCT00025103|Etoposide|etoposide|mesh-list
14591427|NCT00025103|Vincristine|vincristine|mesh-list
14591428|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591429|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
14591430|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591431|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591432|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591433|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
14591434|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591435|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591436|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591437|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591438|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591439|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591440|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591441|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591442|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591443|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591444|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591445|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14591446|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591447|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14591448|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591449|NCT00025116|Gefitinib|gefitinib|mesh-list
14591450|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591451|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591452|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591453|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591454|NCT00025142|Leucovorin|leucovorin|mesh-list
14591455|NCT00025142|Fluorouracil|fluorouracil|mesh-list
14591456|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
14591457|NCT00025142|Gefitinib|gefitinib|mesh-list
14591458|NCT00025142|Calcium|calcium|mesh-list
14591459|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
14591460|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14591461|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591462|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
14591463|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591464|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591465|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591466|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591467|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
14591468|NCT00025142|Antidotes|antidotes|mesh-ancestor
14591469|NCT00025142|Protective Agents|protective agents|mesh-ancestor
14591470|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
14591471|NCT00025142|Vitamins|vitamins|mesh-ancestor
14591472|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
14591473|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591474|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591475|NCT00025168|Gemcitabine|gemcitabine|mesh-list
14591476|NCT00025168|Irinotecan|irinotecan|mesh-list
14591477|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591478|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
14591479|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591480|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591481|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
14591482|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591483|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591484|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591485|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
14591486|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591487|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14591488|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591489|NCT00025181|Ipilimumab|ipilimumab|mesh-list
14591490|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
14591491|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14591492|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591493|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14591494|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591495|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14591496|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
15157029|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15157030|NCT04155008|Analgesics|analgesics|mesh-ancestor
14591497|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591498|NCT00025194|Estramustine|estramustine|mesh-list
14591499|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591500|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
14591501|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591502|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591503|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15157031|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
15157032|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15157033|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15157034|NCT04154735|Rifaximin|rifaximin|mesh-list
15157035|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
15157036|NCT04154735|Fludarabine|fludarabine|mesh-list
15157037|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
15157038|NCT04154735|Tacrolimus|tacrolimus|mesh-list
15157039|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157040|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
15157041|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157042|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15157043|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15157044|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
15157045|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591504|NCT00025207|Gefitinib|gefitinib|mesh-list
14591505|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591506|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591507|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591508|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591509|NCT00025220|Thalidomide|thalidomide|mesh-list
14591510|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591511|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
14591512|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591513|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
14591514|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157046|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157047|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15157048|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15157049|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157050|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14591515|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591516|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14591517|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14591518|NCT00025220|Growth Substances|growth substances|mesh-ancestor
14591519|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
14591520|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591521|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
14591522|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591523|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591524|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591525|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591526|NCT00025272|Carboplatin|carboplatin|mesh-list
14591527|NCT00025272|Etoposide|etoposide|mesh-list
14591528|NCT00025272|Topotecan|topotecan|mesh-list
14591529|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591530|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591531|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591532|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591533|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591534|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591535|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14591536|NCT00025285|Thalidomide|thalidomide|mesh-list
14591537|NCT00025285|Carboplatin|carboplatin|mesh-list
14591538|NCT00025285|Irinotecan|irinotecan|mesh-list
14591539|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591540|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14591541|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591542|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591543|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591544|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591545|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
14591546|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591547|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
14591548|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14591549|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591550|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14591551|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14591552|NCT00025285|Growth Substances|growth substances|mesh-ancestor
14591553|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
14591554|NCT00025298|Paclitaxel|paclitaxel|mesh-list
14591555|NCT00025298|Carboplatin|carboplatin|mesh-list
14591556|NCT00025298|Amifostine|amifostine|mesh-list
15157051|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157052|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591557|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591558|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591559|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591560|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591561|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591562|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591563|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14591564|NCT00025298|Protective Agents|protective agents|mesh-ancestor
14591565|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591566|NCT00025311|Topotecan|topotecan|mesh-list
14591567|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14591568|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591569|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591570|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591571|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591572|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
14591573|NCT00025324|Thiotepa|thiotepa|mesh-list
14591574|NCT00025324|Carboplatin|carboplatin|mesh-list
14591575|NCT00025324|Etoposide|etoposide|mesh-list
14591576|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591577|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
14591578|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591579|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591580|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591581|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
14591582|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591583|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591584|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591585|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591586|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591587|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591588|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591589|NCT00025337|Leucovorin|leucovorin|mesh-list
14591590|NCT00025337|Bevacizumab|bevacizumab|mesh-list
14591591|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14591592|NCT00025337|Fluorouracil|fluorouracil|mesh-list
14591593|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
14591594|NCT00025337|Antibodies|antibodies|mesh-list
14591595|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
14591596|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14591597|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
14591598|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591599|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14591600|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14591601|NCT00025337|Growth Substances|growth substances|mesh-ancestor
14591602|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591603|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
14591604|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
14591605|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
14591606|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591607|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591608|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591609|NCT00025337|Antidotes|antidotes|mesh-ancestor
14591610|NCT00025337|Protective Agents|protective agents|mesh-ancestor
14591611|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
14591612|NCT00025337|Vitamins|vitamins|mesh-ancestor
14591613|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
14591614|NCT00025350|Gefitinib|gefitinib|mesh-list
14591615|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591616|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591617|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591618|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591619|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
14591620|NCT00025363|Ifosfamide|ifosfamide|mesh-list
14591621|NCT00025363|Doxorubicin|doxorubicin|mesh-list
14591622|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591623|NCT00025363|Irinotecan|irinotecan|mesh-list
14591624|NCT00025363|Etoposide|etoposide|mesh-list
14591625|NCT00025363|Vincristine|vincristine|mesh-list
14591626|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
14591627|NCT00025363|Tirapazamine|tirapazamine|mesh-list
14591628|NCT00025363|Sargramostim|sargramostim|mesh-list
14591629|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021695|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14591630|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
14591631|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591632|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591633|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591634|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
14591635|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591636|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591637|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591638|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591639|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591640|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591641|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157053|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157054|NCT04154722|Azithromycin|azithromycin|mesh-list
15157055|NCT04154722|Meropenem|meropenem|mesh-list
15157056|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157057|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157058|NCT04154449|Insulin|insulin|mesh-list
14591642|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14591643|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591644|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591645|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591646|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591647|NCT00025376|Bortezomib|bortezomib|mesh-list
14591648|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591649|NCT00025389|Paclitaxel|paclitaxel|mesh-list
14591650|NCT00025389|Bevacizumab|bevacizumab|mesh-list
14591651|NCT00025389|Carboplatin|carboplatin|mesh-list
14591652|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591653|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591654|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591655|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591656|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591657|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591658|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14591659|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14591660|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14591661|NCT00025389|Growth Substances|growth substances|mesh-ancestor
14591662|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591663|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
14591664|NCT00025402|Interferons|interferons|mesh-list
14591665|NCT00025402|Cytarabine|cytarabine|mesh-list
14591666|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
14591667|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
14591668|NCT00025402|Busulfan|busulfan|mesh-list
14591669|NCT00025402|Etoposide|etoposide|mesh-list
14591670|NCT00025402|Idarubicin|idarubicin|mesh-list
14591671|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
14591672|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591673|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
14591674|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591675|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591676|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591677|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
14591678|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591679|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591680|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591681|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591682|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591683|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591684|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591685|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
14591686|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591687|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591688|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
14591689|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591690|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
14591691|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644761|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14644762|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14644763|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14644764|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14644765|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14644766|NCT00192608|Saquinavir|saquinavir|mesh-list
14644767|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14644768|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14644769|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
14644770|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157059|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157060|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157061|NCT04154319|Vaccines|vaccines|mesh-list
14591692|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
14591693|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591694|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591695|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591696|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591697|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
14591698|NCT00025428|Carboplatin|carboplatin|mesh-list
14591699|NCT00025428|Doxorubicin|doxorubicin|mesh-list
14591700|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591701|NCT00025428|Etoposide|etoposide|mesh-list
14591702|NCT00025428|Vincristine|vincristine|mesh-list
14591703|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591704|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
14591705|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591706|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591707|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591708|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
14591709|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591710|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591711|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591712|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591713|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591714|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591715|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591716|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591717|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591718|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591719|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591720|NCT00025441|Dactinomycin|dactinomycin|mesh-list
14591721|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
14591722|NCT00025441|Ifosfamide|ifosfamide|mesh-list
14591723|NCT00025441|Carboplatin|carboplatin|mesh-list
14591724|NCT00025441|Doxorubicin|doxorubicin|mesh-list
14591725|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591726|NCT00025441|Etoposide|etoposide|mesh-list
14591727|NCT00025441|Vincristine|vincristine|mesh-list
14591728|NCT00025441|Epirubicin|epirubicin|mesh-list
14591729|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591730|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
14591731|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591732|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591733|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591734|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
14591735|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591736|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591737|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591738|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591739|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591740|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591741|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591742|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591743|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591744|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591745|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591746|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14591747|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591748|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14591749|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591750|NCT00025454|Tipifarnib|tipifarnib|mesh-list
14591751|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591752|NCT00025467|Thalidomide|thalidomide|mesh-list
14591753|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591754|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
14591755|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591756|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
14591757|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14591758|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591759|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14591760|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14591761|NCT00025467|Growth Substances|growth substances|mesh-ancestor
14591762|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
14591763|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591764|NCT00025480|Paclitaxel|paclitaxel|mesh-list
14591765|NCT00025480|Carboplatin|carboplatin|mesh-list
14591766|NCT00025480|Tipifarnib|tipifarnib|mesh-list
14591767|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591768|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591769|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
15157062|NCT04154319|Immunologic Factors|immunologic factors|mesh-ancestor
14591770|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591771|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591772|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591773|NCT00025493|Docetaxel|docetaxel|mesh-list
14591774|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591775|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591776|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591777|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591778|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591779|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
14591780|NCT00025519|Thalidomide|thalidomide|mesh-list
14591781|NCT00025519|Fludarabine|fludarabine|mesh-list
14591782|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
14591783|NCT00025519|Tacrolimus|tacrolimus|mesh-list
14591784|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591785|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591786|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
14591787|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591788|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591789|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
15157063|NCT04154319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180470|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180471|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180472|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15180473|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180474|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180475|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
14591790|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591791|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14591792|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591793|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591794|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14591795|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
14591796|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14591797|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591798|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
14591799|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14591800|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14591801|NCT00025519|Growth Substances|growth substances|mesh-ancestor
14591802|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
14591803|NCT00025532|Antibodies|antibodies|mesh-list
14591804|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14591805|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
14591806|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591807|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
14591808|NCT00025545|Methotrexate|methotrexate|mesh-list
14591809|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591810|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
14591811|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591812|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591813|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591814|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
14591815|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591816|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591817|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591818|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14591819|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
14591820|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14591821|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591822|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
14591823|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
14591824|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591825|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14591826|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591827|NCT00025558|Carboplatin|carboplatin|mesh-list
14591828|NCT00025558|Temozolomide|temozolomide|mesh-list
14591829|NCT00025558|Thiotepa|thiotepa|mesh-list
14591830|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591831|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
14591832|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180476|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180477|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15180478|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
15180479|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14591833|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591834|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
14591835|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591836|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591837|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591838|NCT00025584|Bortezomib|bortezomib|mesh-list
14591839|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591840|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
14591841|NCT00025597|Carboplatin|carboplatin|mesh-list
14591842|NCT00025597|Doxorubicin|doxorubicin|mesh-list
14591843|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591844|NCT00025597|Etoposide|etoposide|mesh-list
14591845|NCT00025597|Vincristine|vincristine|mesh-list
15157064|NCT04154293|Isotretinoin|isotretinoin|mesh-list
15157065|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
15157066|NCT04153968|Retinol acetate|retinol acetate|mesh-list
15157067|NCT04153968|Protective Agents|protective agents|mesh-ancestor
15157068|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157069|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15157070|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
15157071|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14591846|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591847|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
14591848|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591849|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591850|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591851|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
14591852|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591853|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591854|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591855|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591856|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591857|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591858|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591859|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591860|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591861|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591862|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591863|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
14591864|NCT00025610|Carboplatin|carboplatin|mesh-list
14591865|NCT00025610|Doxorubicin|doxorubicin|mesh-list
14591866|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591867|NCT00025610|Etoposide|etoposide|mesh-list
14591868|NCT00025610|Vincristine|vincristine|mesh-list
14591869|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591870|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
14591871|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591872|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591873|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591874|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
14591875|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591876|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591877|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591878|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591879|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591880|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591881|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591882|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591883|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591884|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591885|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591886|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
14591887|NCT00025623|Carboplatin|carboplatin|mesh-list
14591888|NCT00025623|Doxorubicin|doxorubicin|mesh-list
14591889|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591890|NCT00025623|Etoposide|etoposide|mesh-list
15157072|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157073|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
15157074|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157075|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157076|NCT04154033|Naltrexone|naltrexone|mesh-list
15157077|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15157078|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15157079|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157080|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
15157081|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14591891|NCT00025623|Vincristine|vincristine|mesh-list
14591892|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591893|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
14591894|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591895|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591896|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591897|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
14591898|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591899|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591900|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591901|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591902|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591903|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591904|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591905|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591906|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591907|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591908|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591909|NCT00025636|Cytarabine|cytarabine|mesh-list
14591910|NCT00025636|Dexamethasone|dexamethasone|mesh-list
14591911|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
14591912|NCT00025636|Melphalan|melphalan|mesh-list
14591913|NCT00025636|Carmustine|carmustine|mesh-list
14591914|NCT00025636|Methotrexate|methotrexate|mesh-list
14591915|NCT00025636|Etoposide|etoposide|mesh-list
14591916|NCT00025636|Vincristine|vincristine|mesh-list
14591917|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591918|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
14591919|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591920|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14591921|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14591922|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
14591923|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591924|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591925|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591926|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14591927|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
14591928|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
14591929|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14591930|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14591931|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
15157082|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
15157083|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15157084|NCT04153708|Antibodies|antibodies|mesh-list
15157085|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
15157086|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
14591932|NCT00025636|Hormones|hormones|mesh-ancestor
14591933|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14591934|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14591935|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14591936|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
14591937|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14591938|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14591939|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
14591940|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14591941|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591942|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14591943|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14591944|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591945|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591946|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591947|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
14591948|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14591949|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591950|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591951|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591952|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
15157087|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
15157088|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591953|NCT00025649|Melphalan|melphalan|mesh-list
14591954|NCT00025649|Busulfan|busulfan|mesh-list
14591955|NCT00025649|Carboplatin|carboplatin|mesh-list
14591956|NCT00025649|Doxorubicin|doxorubicin|mesh-list
14591957|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14591958|NCT00025649|Etoposide|etoposide|mesh-list
14591959|NCT00025649|Vincristine|vincristine|mesh-list
14591960|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14591961|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
14591962|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14591963|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15157089|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
15157090|NCT04153487|Vitamins|vitamins|mesh-ancestor
15157091|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
15157092|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157093|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
15157094|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591964|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15157095|NCT04153487|Protective Agents|protective agents|mesh-ancestor
15157096|NCT04153734|Paclitaxel|paclitaxel|mesh-list
15157097|NCT04153734|Carboplatin|carboplatin|mesh-list
15157098|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
15157099|NCT04153734|Pemetrexed|pemetrexed|mesh-list
15157100|NCT04153734|Cisplatin|cisplatin|mesh-list
15157101|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15157102|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157103|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
15157104|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
15157105|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157106|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157107|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15157108|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157109|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15157110|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15157111|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
15157112|NCT04153201|Antimalarials|antimalarials|mesh-list
14591965|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
14591966|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591967|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591968|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14591969|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14591970|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14591971|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14591972|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591973|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591974|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591975|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591976|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591977|NCT00025675|Gefitinib|gefitinib|mesh-list
14591978|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591979|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14591980|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591981|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591982|NCT00025688|Paclitaxel|paclitaxel|mesh-list
14591983|NCT00025688|Carboplatin|carboplatin|mesh-list
15157113|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15157114|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15157115|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157116|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157117|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591984|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14591985|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14591986|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
14591987|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
14591988|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
14591989|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591990|NCT00025727|Ritonavir|ritonavir|mesh-list
14591991|NCT00025727|Lopinavir|lopinavir|mesh-list
14591992|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
15157118|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15157119|NCT04153383|Milrinone|milrinone|mesh-list
15157120|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15157121|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15157122|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
15157123|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15157124|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14021696|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
14591993|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14591994|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14591995|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
14591996|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14591997|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14591998|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14591999|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14814025|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157125|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157126|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592000|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
14592001|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592002|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14592003|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14592004|NCT00025740|Clonazepam|clonazepam|mesh-list
14592005|NCT00025740|Paroxetine|paroxetine|mesh-list
14592006|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14592007|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14592008|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14592009|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592010|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592011|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
14592012|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592013|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14592014|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
14592015|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14592016|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14592017|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14592018|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592019|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
14592020|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
14592021|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
14592022|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
14592023|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14592024|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592025|NCT00025779|Guanfacine|guanfacine|mesh-list
14592026|NCT00025779|Methylphenidate|methylphenidate|mesh-list
14592027|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14592028|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592029|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14592030|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14592031|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14592032|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592033|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
14592034|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592035|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14592036|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14592037|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14592038|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14592039|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14592040|NCT00025792|Pramipexole|pramipexole|mesh-list
14592041|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
14592042|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592043|NCT00025792|Protective Agents|protective agents|mesh-ancestor
14592044|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592045|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14592046|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14592047|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
14592048|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
14592049|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592050|NCT00026039|Estrogens|estrogens|mesh-list
14592051|NCT00026039|Hormones|hormones|mesh-ancestor
14592052|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592053|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592054|NCT00026052|Riluzole|riluzole|mesh-list
14592055|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
14592056|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14592057|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14592058|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592059|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157127|NCT04153383|Protective Agents|protective agents|mesh-ancestor
15157128|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157129|NCT04153253|Aflibercept|aflibercept|mesh-list
15157130|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15157131|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15157132|NCT04153253|Growth Substances|growth substances|mesh-ancestor
15157133|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592060|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592061|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14592062|NCT00026052|Protective Agents|protective agents|mesh-ancestor
14592063|NCT00026078|Docetaxel|docetaxel|mesh-list
14592064|NCT00026078|Ifosfamide|ifosfamide|mesh-list
15157134|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
15157135|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592065|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592066|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14592067|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14592068|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14592069|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592070|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592071|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
14592072|NCT00026091|Fenretinide|fenretinide|mesh-list
14592073|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592074|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14592075|NCT00026091|Protective Agents|protective agents|mesh-ancestor
14592076|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592077|NCT00026104|Gemcitabine|gemcitabine|mesh-list
14592078|NCT00026104|Paclitaxel|paclitaxel|mesh-list
14592079|NCT00026104|Tipifarnib|tipifarnib|mesh-list
14592080|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14592081|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592082|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
14592083|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
14592084|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
14592085|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592086|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592087|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
14592088|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
14592089|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592090|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592091|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592092|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
14592093|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592094|NCT00026130|Gemcitabine|gemcitabine|mesh-list
14592095|NCT00026130|Fluorouracil|fluorouracil|mesh-list
14592096|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592097|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
14592098|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592099|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592100|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
14592101|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592102|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592103|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592104|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
14592105|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592106|NCT00026143|Interferons|interferons|mesh-list
14592107|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
14592108|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
14592109|NCT00026143|Interleukin-12|interleukin-12|mesh-list
14592110|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592111|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
14592112|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592113|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
14592114|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592115|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14592116|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592117|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592118|NCT00026143|Growth Substances|growth substances|mesh-ancestor
14592119|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592120|NCT00026156|Docetaxel|docetaxel|mesh-list
14592121|NCT00026156|Vinorelbine|vinorelbine|mesh-list
14592122|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592123|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
14592124|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
14592125|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
14592126|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592127|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14592128|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
14592129|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592130|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592131|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592132|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592133|NCT00026182|Rituximab|rituximab|mesh-list
14592134|NCT00026182|Interleukin-12|interleukin-12|mesh-list
14592135|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14592136|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157136|NCT04153123|Epinephrine|epinephrine|mesh-list
15157137|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15157138|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15157139|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
15157140|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592137|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
14592138|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592139|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592140|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14592141|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592142|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592143|NCT00026182|Growth Substances|growth substances|mesh-ancestor
14592144|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592145|NCT00026195|Irinotecan|irinotecan|mesh-list
14592146|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14592147|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592148|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592149|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592150|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592151|NCT00026234|Dexamethasone|dexamethasone|mesh-list
14592152|NCT00026234|Capecitabine|capecitabine|mesh-list
14592153|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
15157141|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157142|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157143|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15157144|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15157145|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
15157146|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157147|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15157148|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
15157149|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
15157150|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
15157151|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15157152|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
15157153|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15157154|NCT04153084|Cathartics|cathartics|mesh-ancestor
15157155|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157156|NCT04153084|Laxatives|laxatives|mesh-ancestor
15157157|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
15157158|NCT04152655|Idebenone|idebenone|mesh-list
14592154|NCT00026234|Floxuridine|floxuridine|mesh-list
14592155|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14592156|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
14592157|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
14592158|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592159|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592160|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14592161|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
14592162|NCT00026234|Hormones|hormones|mesh-ancestor
14592163|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592164|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14592165|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592166|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592167|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
14592168|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592169|NCT00026260|Semaxinib|semaxinib|mesh-list
14592170|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592171|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592172|NCT00026260|Growth Substances|growth substances|mesh-ancestor
14592173|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592174|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592175|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592176|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592177|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592178|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592179|NCT00026273|Leucovorin|leucovorin|mesh-list
14592180|NCT00026273|Fluorouracil|fluorouracil|mesh-list
14592181|NCT00026273|Irinotecan|irinotecan|mesh-list
14592182|NCT00026273|Calcium|calcium|mesh-list
14592183|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
14592184|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14592185|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157159|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
15157160|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157161|NCT04152655|Vitamins|vitamins|mesh-ancestor
15157162|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
14592186|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
14592187|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592188|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15157163|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157164|NCT04152655|Protective Agents|protective agents|mesh-ancestor
14592189|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592190|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592191|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
14592192|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14592193|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592194|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592195|NCT00026273|Antidotes|antidotes|mesh-ancestor
14592196|NCT00026273|Protective Agents|protective agents|mesh-ancestor
14592197|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
14592198|NCT00026273|Vitamins|vitamins|mesh-ancestor
14592199|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
14592200|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14592201|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
14592202|NCT00026286|Estrogens|estrogens|mesh-list
14592203|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14592204|NCT00026286|Hormones|hormones|mesh-ancestor
14592205|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592206|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592207|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14592208|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14592209|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14592210|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
14592211|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14592212|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14592213|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14592214|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14592215|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14592216|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592217|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
14592218|NCT00026299|Gefitinib|gefitinib|mesh-list
14592219|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592220|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592221|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592222|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592223|NCT00026338|Gemcitabine|gemcitabine|mesh-list
14592224|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15157165|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14592225|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592226|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
14592227|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592228|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592229|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
15157166|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157167|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157168|NCT04152681|Apatinib|apatinib|mesh-list
15157169|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157170|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15157171|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021697|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592230|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592231|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592232|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592233|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
14592234|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592235|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592236|NCT00026351|Rituximab|rituximab|mesh-list
14592237|NCT00026351|Pentostatin|pentostatin|mesh-list
14592238|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14592239|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592240|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
14592241|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592242|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592243|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14592244|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021698|NCT02772107|Temozolomide|temozolomide|mesh-list
14592245|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592246|NCT00026364|Leucovorin|leucovorin|mesh-list
14592247|NCT00026364|Fluorouracil|fluorouracil|mesh-list
14592248|NCT00026364|Irinotecan|irinotecan|mesh-list
14592249|NCT00026364|Gefitinib|gefitinib|mesh-list
14592250|NCT00026364|Calcium|calcium|mesh-list
14592251|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
14021699|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592252|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14592253|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592254|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
14592255|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592256|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15157172|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157173|NCT04152759|Golimumab|golimumab|mesh-list
15157174|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15157175|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157176|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592257|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592258|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592259|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
14592260|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14592261|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592262|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592263|NCT00026364|Antidotes|antidotes|mesh-ancestor
14592264|NCT00026364|Protective Agents|protective agents|mesh-ancestor
14592265|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
14592266|NCT00026364|Vitamins|vitamins|mesh-ancestor
14592267|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
14592268|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592269|NCT00026377|Leuprolide|leuprolide|mesh-list
14592270|NCT00026377|Goserelin|goserelin|mesh-list
14592271|NCT00026377|Flutamide|flutamide|mesh-list
14592272|NCT00026377|Bicalutamide|bicalutamide|mesh-list
14592273|NCT00026377|Semaxinib|semaxinib|mesh-list
14592274|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14592275|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
14592276|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14592277|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592278|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14592279|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592280|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
14592281|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
15157177|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
15157178|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157179|NCT04153032|Diltiazem|diltiazem|mesh-list
15157180|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15157181|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15157182|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15157183|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157184|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14592282|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592283|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592284|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592285|NCT00026377|Growth Substances|growth substances|mesh-ancestor
14592286|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592287|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592288|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592289|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592290|NCT00026403|Gemcitabine|gemcitabine|mesh-list
14592291|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592292|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592293|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
14592294|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592295|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
14592296|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592297|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157185|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592298|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592299|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
14592300|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592301|NCT00026416|Interferons|interferons|mesh-list
14592302|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
14592303|NCT00026416|Thalidomide|thalidomide|mesh-list
14592304|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592305|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
14592306|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592307|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
14592308|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592309|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592310|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
14592311|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592312|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592313|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592314|NCT00026416|Growth Substances|growth substances|mesh-ancestor
14592315|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592316|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
14592317|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592318|NCT00026442|Capecitabine|capecitabine|mesh-list
14592319|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592320|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
14592321|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592322|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592323|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
14592324|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592325|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14592326|NCT00026468|Protective Agents|protective agents|mesh-ancestor
14592327|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592328|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14592329|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592330|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592331|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14592332|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14592333|NCT00026468|Analgesics|analgesics|mesh-ancestor
14592334|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
14592335|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592336|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14592337|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592338|NCT00026520|Interferons|interferons|mesh-list
14592339|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
14592340|NCT00026520|Thalidomide|thalidomide|mesh-list
14592341|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592342|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
14592343|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592344|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
14592345|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592346|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592347|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
14592348|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592349|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592350|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592351|NCT00026520|Growth Substances|growth substances|mesh-ancestor
14592352|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592353|NCT00026533|Thalidomide|thalidomide|mesh-list
14592354|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592355|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
14592356|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592357|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
14592358|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592359|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592360|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592361|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592362|NCT00026533|Growth Substances|growth substances|mesh-ancestor
14592363|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592364|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592365|NCT00026585|Tamoxifen|tamoxifen|mesh-list
14592366|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14592367|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
14592368|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592369|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592370|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14592371|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592372|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14592373|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14592374|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14592375|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14592376|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14592377|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
14592378|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592379|NCT00026637|Sertraline|sertraline|mesh-list
14592380|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
14592381|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14592382|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14592383|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14592384|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14592385|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592386|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592387|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
14592388|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592389|NCT00026819|Rofecoxib|rofecoxib|mesh-list
14592390|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14592391|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14592392|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592393|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592394|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14021700|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
14021701|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592395|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14592396|NCT00026819|Analgesics|analgesics|mesh-ancestor
14592397|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
14592398|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592399|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592400|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14592401|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592402|NCT00026962|Estradiol|estradiol|mesh-list
14592403|NCT00026962|Progesterone|progesterone|mesh-list
14592404|NCT00026962|Estrogens|estrogens|mesh-ancestor
14592405|NCT00026962|Hormones|hormones|mesh-ancestor
14592406|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592407|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592408|NCT00026962|Progestins|progestins|mesh-ancestor
14592409|NCT00027014|Fentanyl|fentanyl|mesh-list
14592410|NCT00027014|Oxycodone|oxycodone|mesh-list
15157186|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
14592411|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14592412|NCT00027014|Narcotics|narcotics|mesh-ancestor
14592413|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14592414|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592415|NCT00027014|Analgesics|analgesics|mesh-ancestor
14592416|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
14592417|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592418|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14592419|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14592420|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
14592421|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
14592422|NCT00027040|Selegiline|selegiline|mesh-list
14592423|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
14592424|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14592425|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14592426|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14592427|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14592428|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592429|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592430|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15157187|NCT04152889|Docetaxel|docetaxel|mesh-list
15157188|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157189|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
15157190|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
14592431|NCT00027040|Protective Agents|protective agents|mesh-ancestor
14592432|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644771|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644772|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14644773|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14644774|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
14644775|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644776|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15157191|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157192|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644777|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14644778|NCT00192621|Lamivudine|lamivudine|mesh-list
14644779|NCT00192621|Zidovudine|zidovudine|mesh-list
14644780|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14644781|NCT00192621|Lopinavir|lopinavir|mesh-list
14644782|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14644783|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644784|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157193|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
15157194|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15157195|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157196|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157197|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15157198|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15157199|NCT04152980|Protective Agents|protective agents|mesh-ancestor
14021702|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157200|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157201|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
15157202|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15157203|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
15157204|NCT04152564|Bupivacaine|bupivacaine|mesh-list
15157205|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
15157206|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
15157207|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
15157208|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157209|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157210|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
15157211|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157212|NCT04152434|Erenumab|erenumab|mesh-list
15157213|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14592433|NCT00027053|Trazodone|trazodone|mesh-list
15157214|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592434|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14592435|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14592436|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14592437|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592438|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14592439|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14592440|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14592441|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14592442|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592443|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592444|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
14592445|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14592446|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
14592447|NCT00027066|Aspirin|aspirin|mesh-list
14592448|NCT00027066|Warfarin|warfarin|mesh-list
14592449|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14592450|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14592451|NCT00027066|Analgesics|analgesics|mesh-ancestor
14592452|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
14592453|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592454|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592455|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14592456|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592457|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14592458|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14592459|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592460|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14592461|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14592462|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592463|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
14592464|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
14592465|NCT00027079|Naltrexone|naltrexone|mesh-list
14592466|NCT00027079|Ondansetron|ondansetron|mesh-list
14592467|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14592468|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14592469|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592470|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
14592471|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592472|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
14592473|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
14592474|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157215|NCT04152434|Analgesics|analgesics|mesh-ancestor
15157216|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
15157217|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157218|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157219|NCT04152629|Methylphenidate|methylphenidate|mesh-list
15157220|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15157221|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15157222|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157223|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15157224|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15157225|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15157226|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157227|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
15157228|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592475|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
14592476|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
14592477|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14592478|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
14592479|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592480|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592481|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14592482|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14592483|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14592484|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14592485|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14592486|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
14592487|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592488|NCT00027287|Vitamin E|vitamin e|mesh-list
14592489|NCT00027287|Vitamins|vitamins|mesh-ancestor
14592490|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
14592491|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592492|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
14592493|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592494|NCT00027287|Protective Agents|protective agents|mesh-ancestor
14592495|NCT00027300|Natalizumab|natalizumab|mesh-list
14592496|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
14592497|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592498|NCT00027339|Ritonavir|ritonavir|mesh-list
14592499|NCT00027339|Lopinavir|lopinavir|mesh-list
14592500|NCT00027339|Indinavir|indinavir|mesh-list
14592501|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
14592502|NCT00027339|Tenofovir|tenofovir|mesh-list
14592503|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14592504|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14592505|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
14592506|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592507|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592508|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14592509|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14592510|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
14592511|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592512|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14592513|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14592514|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14592515|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14592516|NCT00027391|Albuterol|albuterol|mesh-list
14592517|NCT00027391|Oxandrolone|oxandrolone|mesh-list
14592518|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14592519|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
14592520|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592521|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021703|NCT02772237|Riboflavin|riboflavin|mesh-list
14021704|NCT02772237|Vitamins|vitamins|mesh-ancestor
14021705|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
14021706|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021707|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
14021708|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14021709|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
14021710|NCT02772211|Cycloserine|cycloserine|mesh-list
14021711|NCT02772211|Ketamine|ketamine|mesh-list
14021712|NCT02772211|Analgesics|analgesics|mesh-ancestor
14021713|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
14021714|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021715|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021716|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14021717|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14021718|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
14021719|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
14021720|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021721|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14021722|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14021723|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021724|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021725|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14592522|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14592523|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
14592524|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
14592525|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14592526|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14592527|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14592528|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14592529|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
14592530|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592531|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592532|NCT00027391|Androgens|androgens|mesh-ancestor
14592533|NCT00027391|Hormones|hormones|mesh-ancestor
14592534|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592535|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
14592536|NCT00027404|Fluoxetine|fluoxetine|mesh-list
14592537|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14592538|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14592539|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14592540|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592541|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592542|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
14592543|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592544|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14592545|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
14592546|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14592547|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14592548|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14592549|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592550|NCT00027443|Cyclosporine|cyclosporine|mesh-list
14592551|NCT00027443|Cyclosporins|cyclosporins|mesh-list
14592552|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
14592553|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592554|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592555|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157229|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
15157230|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15157231|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15157232|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
14021726|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021727|NCT02772211|Renal Agents|renal agents|mesh-ancestor
14021728|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14021729|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
14021730|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14021731|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
14592556|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
14592557|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592558|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
14592559|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157233|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15180480|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15180481|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15180482|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
15180483|NCT03939637|Antibodies|antibodies|mesh-list
15180484|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
15180485|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14021732|NCT02772120|Progesterone|progesterone|mesh-list
14592560|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
14592561|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592562|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14592563|NCT00027495|Curcumin|curcumin|mesh-list
14592564|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14592565|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14592566|NCT00027495|Analgesics|analgesics|mesh-ancestor
14592567|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
14592568|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592569|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592570|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14592571|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592572|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592573|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592574|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592575|NCT00027508|Trabectedin|trabectedin|mesh-list
14592576|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592577|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
14592578|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592579|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592580|NCT00027521|Bleomycin|bleomycin|mesh-list
15180486|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14021733|NCT02772120|Progestins|progestins|mesh-ancestor
14021734|NCT02772120|Hormones|hormones|mesh-ancestor
14021735|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021736|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157234|NCT04152317|Misoprostol|misoprostol|mesh-list
15157235|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15157236|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
14021737|NCT02772029|Apatinib|apatinib|mesh-list
14021738|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021739|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14021740|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592581|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15157237|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15157238|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592582|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592583|NCT00027534|Metronidazole|metronidazole|mesh-list
14592584|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592585|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592586|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14592587|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14592588|NCT00027547|Cytarabine|cytarabine|mesh-list
14592589|NCT00027547|Cyclosporine|cyclosporine|mesh-list
14592590|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
14592591|NCT00027547|Methotrexate|methotrexate|mesh-list
14592592|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
14592593|NCT00027547|Fludarabine|fludarabine|mesh-list
14592594|NCT00027547|Cyclosporins|cyclosporins|mesh-list
14592595|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14592596|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
14592597|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14592598|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592599|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592600|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
14592601|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592602|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592603|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
14592604|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592605|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14592606|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592607|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
14592608|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592609|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14592610|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
14592611|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592612|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
14592613|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14592614|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14592615|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14592616|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
14592617|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592618|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
14592619|NCT00027573|Methotrexate|methotrexate|mesh-list
14592620|NCT00027573|Fludarabine|fludarabine|mesh-list
14592621|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
14592622|NCT00027573|Tacrolimus|tacrolimus|mesh-list
14592623|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592624|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
14592625|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592626|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592627|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592628|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
14592629|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592630|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592631|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14592632|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14592633|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
14592634|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14592635|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592636|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
14592637|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
14592638|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157239|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15157240|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157241|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
15157242|NCT04152356|Sorafenib|sorafenib|mesh-list
15157243|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157244|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14021741|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592639|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15157245|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180487|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
14592640|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14592641|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14592642|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
14592643|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592644|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592645|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592646|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592647|NCT00027599|Bevacizumab|bevacizumab|mesh-list
14592648|NCT00027599|Sargramostim|sargramostim|mesh-list
14592649|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14592650|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592651|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592652|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592653|NCT00027599|Growth Substances|growth substances|mesh-ancestor
14592654|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592655|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592656|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
14592657|NCT00027612|Irinotecan|irinotecan|mesh-list
14592658|NCT00027612|Carmustine|carmustine|mesh-list
14592659|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14592660|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592661|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592662|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592663|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592664|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592665|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
14592666|NCT00027625|Temozolomide|temozolomide|mesh-list
14592667|NCT00027625|Gefitinib|gefitinib|mesh-list
14592668|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592669|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
14592670|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592671|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592672|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592673|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592674|NCT00027638|Thalidomide|thalidomide|mesh-list
14592675|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592676|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
14592677|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592678|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
14592679|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592680|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592681|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592682|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592683|NCT00027638|Growth Substances|growth substances|mesh-ancestor
14592684|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592685|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592686|NCT00027664|Interferons|interferons|mesh-list
14592687|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
14592688|NCT00027664|Thalidomide|thalidomide|mesh-list
14592689|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592690|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
14592691|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592692|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
14592693|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592694|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592695|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
14592696|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592697|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592698|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592699|NCT00027664|Growth Substances|growth substances|mesh-ancestor
14592700|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592701|NCT00027677|Halofuginone|halofuginone|mesh-list
14592702|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592703|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
14592704|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14592705|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14592706|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592707|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14592708|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592709|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592710|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592711|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592712|NCT00027677|Growth Substances|growth substances|mesh-ancestor
14592713|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157246|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157247|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
15157248|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15157249|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
15157250|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592714|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592715|NCT00027690|Gefitinib|gefitinib|mesh-list
14592716|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592717|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14592718|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592719|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592720|NCT00027703|Gemcitabine|gemcitabine|mesh-list
14592721|NCT00027703|Bevacizumab|bevacizumab|mesh-list
14592722|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14592723|NCT00027703|Antibodies|antibodies|mesh-list
14592724|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
14592725|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14592726|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592727|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592728|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592729|NCT00027703|Growth Substances|growth substances|mesh-ancestor
14592730|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592731|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592732|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
14592733|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592734|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
14592735|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592736|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
14592737|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592738|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592739|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592740|NCT00027716|Bortezomib|bortezomib|mesh-list
14592741|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592742|NCT00027742|Interferons|interferons|mesh-list
14592743|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
14592744|NCT00027742|Temozolomide|temozolomide|mesh-list
14021742|NCT02771925|Gabapentin|gabapentin|mesh-list
14021743|NCT02771925|Analgesics|analgesics|mesh-ancestor
14592745|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592746|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
14592747|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592748|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592749|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
15157251|NCT04152057|Paclitaxel|paclitaxel|mesh-list
15157252|NCT04152057|Trastuzumab|trastuzumab|mesh-list
15157253|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15157254|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157255|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14021744|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
14592750|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592751|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
14592752|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592753|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
14592754|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592755|NCT00027807|Aldesleukin|aldesleukin|mesh-list
14592756|NCT00027807|Molgramostim|molgramostim|mesh-list
14592757|NCT00027807|Sargramostim|sargramostim|mesh-list
14592758|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
14592759|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592760|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592761|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14592762|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14592763|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
14592764|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592765|NCT00027820|Cyclosporine|cyclosporine|mesh-list
14592766|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
14592767|NCT00027820|Fludarabine|fludarabine|mesh-list
14592768|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
14592769|NCT00027820|Cyclosporins|cyclosporins|mesh-list
14592770|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592771|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592772|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
14592773|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592774|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592775|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
14592776|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592777|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592778|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
14592779|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592780|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
14592781|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592782|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14592783|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14592784|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14592785|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
14592786|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592787|NCT00027833|Leucovorin|leucovorin|mesh-list
14592788|NCT00027833|Fluorouracil|fluorouracil|mesh-list
14592789|NCT00027833|Irinotecan|irinotecan|mesh-list
14592790|NCT00027833|Calcium|calcium|mesh-list
14592791|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
14592792|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14592793|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592794|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
15157256|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
15157257|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157258|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157259|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15157260|NCT04151823|Vitamin D|vitamin d|mesh-list
15157261|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
15157262|NCT04151823|Vitamins|vitamins|mesh-ancestor
15157263|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
15157264|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157265|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15157266|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15157267|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14592795|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592796|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592797|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592798|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592799|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
14592800|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14592801|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592802|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592803|NCT00027833|Antidotes|antidotes|mesh-ancestor
14592804|NCT00027833|Protective Agents|protective agents|mesh-ancestor
14592805|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
14592806|NCT00027833|Vitamins|vitamins|mesh-ancestor
14592807|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
14592808|NCT00027859|Ketoconazole|ketoconazole|mesh-list
14592809|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
14592810|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14592811|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14592812|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14592813|NCT00027859|Docetaxel|docetaxel|mesh-list
14592814|NCT00027859|Estramustine|estramustine|mesh-list
14592815|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592816|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
14592817|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
14592818|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
14592819|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592820|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14592821|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
14592822|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592823|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14592824|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14592825|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592826|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14592827|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
14592828|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14592829|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592830|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14592831|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592832|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
14592833|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14592834|NCT00027872|Tipifarnib|tipifarnib|mesh-list
14592835|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592836|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
14592837|NCT00027885|Bevacizumab|bevacizumab|mesh-list
14592838|NCT00027885|Docetaxel|docetaxel|mesh-list
15157268|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592839|NCT00027885|Doxorubicin|doxorubicin|mesh-list
14592840|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14592841|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592842|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
14592843|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592844|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592845|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592846|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
14592847|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592848|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592849|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14592850|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14592851|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14592852|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14592853|NCT00027885|Growth Substances|growth substances|mesh-ancestor
15157269|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157270|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157271|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
15157272|NCT04151680|Apixaban|apixaban|mesh-list
15157273|NCT04151680|Edoxaban|edoxaban|mesh-list
15157274|NCT04151680|Dabigatran|dabigatran|mesh-list
15157275|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15157276|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
15157277|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15157278|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
15157279|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157280|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157281|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
15157282|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
15157283|NCT04151706|Busulfan|busulfan|mesh-list
15157284|NCT04151706|Thiotepa|thiotepa|mesh-list
15157285|NCT04151706|Fludarabine|fludarabine|mesh-list
15157286|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157287|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
15157288|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157289|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15157290|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15157291|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
15157292|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157293|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157294|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15157295|NCT04151472|Ubiquinone|ubiquinone|mesh-list
15157296|NCT04151472|Idebenone|idebenone|mesh-list
15157297|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
15157298|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157299|NCT04151472|Protective Agents|protective agents|mesh-ancestor
15157300|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157301|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
15157302|NCT04151719|Bromides|bromides|mesh-list
15157303|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
15157304|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
15157305|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15157306|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157307|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
15157308|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157309|NCT04151459|Metformin|metformin|mesh-list
15157310|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157311|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157312|NCT04151355|Atorvastatin|atorvastatin|mesh-list
15157313|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15157314|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15157315|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
15157316|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157317|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15157318|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15157319|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592854|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
14592855|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14592856|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
14592857|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
14592858|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14592859|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14592860|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592861|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592862|NCT00027898|Carboplatin|carboplatin|mesh-list
14592863|NCT00027898|Etoposide|etoposide|mesh-list
14592864|NCT00027898|Bortezomib|bortezomib|mesh-list
15157320|NCT04151381|Aminophylline|aminophylline|mesh-list
15157321|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15157322|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
15157323|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592865|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
14592866|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592867|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14592868|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14592869|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592870|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592871|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592872|NCT00027911|Sargramostim|sargramostim|mesh-list
14592873|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
14592874|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592875|NCT00027924|Cyclosporine|cyclosporine|mesh-list
14592876|NCT00027924|Methotrexate|methotrexate|mesh-list
14592877|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
14592878|NCT00027924|Fludarabine|fludarabine|mesh-list
14592879|NCT00027924|Busulfan|busulfan|mesh-list
14592880|NCT00027924|Cyclosporins|cyclosporins|mesh-list
14592881|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14592882|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
14592883|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14592884|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592885|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592886|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
14592887|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592888|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592889|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14592890|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592891|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14592892|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592893|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
14592894|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592895|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14592896|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
14592897|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592898|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14592899|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
14592900|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592901|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14592902|NCT00027937|Aldesleukin|aldesleukin|mesh-list
14592903|NCT00027937|Paclitaxel|paclitaxel|mesh-list
14592904|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
14592905|NCT00027937|Melphalan|melphalan|mesh-list
14592906|NCT00027937|Busulfan|busulfan|mesh-list
14592907|NCT00027937|Thiotepa|thiotepa|mesh-list
14592908|NCT00027937|Sargramostim|sargramostim|mesh-list
14592909|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14592910|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592911|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14592912|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14592913|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14592914|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592915|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592916|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
14592917|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592918|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592919|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14592920|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
14592921|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14592922|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14592923|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14592924|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
14592925|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592926|NCT00027963|Gabapentin|gabapentin|mesh-list
14592927|NCT00027963|Analgesics|analgesics|mesh-ancestor
14592928|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
14592929|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592930|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592931|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
14592932|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14592933|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14592934|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14592935|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15157324|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157325|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14592936|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14592937|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14592938|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14592939|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592940|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
14592941|NCT00027976|Celecoxib|celecoxib|mesh-list
14592942|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14592943|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14592944|NCT00027976|Analgesics|analgesics|mesh-ancestor
14592945|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
14592946|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14592947|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592948|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14592949|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14592950|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14592951|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14592952|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592953|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592954|NCT00027989|Gemcitabine|gemcitabine|mesh-list
14592955|NCT00027989|Doxorubicin|doxorubicin|mesh-list
14592956|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14592957|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14592958|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
14592959|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592960|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592961|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
14592962|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592963|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592964|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592965|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
14592966|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592967|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14592968|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14592969|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14592970|NCT00028028|Sirolimus|sirolimus|mesh-list
14592971|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14592972|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592973|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14592974|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592975|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
14592976|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592977|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
14592978|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592979|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14592980|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14592981|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592982|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592983|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14592984|NCT00028132|Tenofovir|tenofovir|mesh-list
14592985|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
14592986|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14592987|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14592988|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14592989|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592990|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14592991|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14592992|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14592993|NCT00028171|Tacrolimus|tacrolimus|mesh-list
14592994|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14592995|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
14592996|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14592997|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14592998|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14592999|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593000|NCT00028275|Interferons|interferons|mesh-list
14593001|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
14593002|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593003|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
14593004|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593005|NCT00028288|Daclizumab|daclizumab|mesh-list
14593006|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593007|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
14593008|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593009|NCT00028314|Ritonavir|ritonavir|mesh-list
14593010|NCT00028314|Lopinavir|lopinavir|mesh-list
14593011|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14593012|NCT00028314|Nevirapine|nevirapine|mesh-list
14593013|NCT00028314|Abacavir|abacavir|mesh-list
14593014|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14593015|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14593016|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
14593017|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593018|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593019|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14593020|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14593021|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
14593022|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593023|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14593024|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14593025|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14593026|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593027|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14593028|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14593029|NCT00028327|Lamivudine|lamivudine|mesh-list
14593030|NCT00028327|Zidovudine|zidovudine|mesh-list
15157326|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
15157327|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14593031|NCT00028327|Efavirenz|efavirenz|mesh-list
14593032|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14593033|NCT00028327|Nelfinavir|nelfinavir|mesh-list
14593034|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14593035|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593036|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593037|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593038|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
14593039|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593040|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14593041|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14593042|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
14593043|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14593044|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14593045|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14593046|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14593047|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14593048|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14593049|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14593050|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14593051|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
14593052|NCT00028353|Toremifene|toremifene|mesh-list
14593053|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14593054|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593055|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14593056|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14593057|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
14593058|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593059|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593060|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14593061|NCT00028366|Ritonavir|ritonavir|mesh-list
14593062|NCT00028366|Lopinavir|lopinavir|mesh-list
14593063|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
14593064|NCT00028366|Tenofovir|tenofovir|mesh-list
14593065|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14593066|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14593067|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
14593068|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593069|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593070|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14593071|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14593072|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
14593073|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593074|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14593075|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14593076|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14593077|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593078|NCT00028405|Talaporfin|talaporfin|mesh-list
14593079|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593080|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14593081|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
14593082|NCT00028418|Clofarabine|clofarabine|mesh-list
14593083|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593084|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
15157328|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14593085|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593086|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593087|NCT00028431|Ipilimumab|ipilimumab|mesh-list
14593088|NCT00028431|Antibodies|antibodies|mesh-list
14593089|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
14593090|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593091|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14593092|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593093|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14593094|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593095|NCT00028483|Docetaxel|docetaxel|mesh-list
15157329|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157330|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157331|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15157332|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15157333|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
15157334|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157335|NCT04151381|Protective Agents|protective agents|mesh-ancestor
15157336|NCT04151147|Mitogens|mitogens|mesh-list
15157337|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593096|NCT00028483|Doxorubicin|doxorubicin|mesh-list
14593097|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
14593098|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593099|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593100|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593101|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593102|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593103|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593104|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593105|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593106|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593107|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
14593108|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593109|NCT00028496|Metronidazole|metronidazole|mesh-list
14593110|NCT00028496|Molgramostim|molgramostim|mesh-list
14593111|NCT00028496|Vaccines|vaccines|mesh-list
14593112|NCT00028496|Sargramostim|sargramostim|mesh-list
14593113|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
14593114|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593115|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593116|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593117|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14593118|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14593119|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14593120|NCT00028535|Paclitaxel|paclitaxel|mesh-list
14593121|NCT00028535|Trastuzumab|trastuzumab|mesh-list
14593122|NCT00028535|Interleukin-12|interleukin-12|mesh-list
14593123|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593124|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593125|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593126|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593127|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593128|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593129|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14593130|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14593131|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
14593132|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593133|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14593134|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14593135|NCT00028535|Growth Substances|growth substances|mesh-ancestor
14593136|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
14593137|NCT00028561|Carboplatin|carboplatin|mesh-list
14593138|NCT00028561|Epothilone B|epothilone b|mesh-list
14593139|NCT00028561|Epothilones|epothilones|mesh-list
14593140|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593141|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593142|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593143|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593144|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593145|NCT00028574|Gabapentin|gabapentin|mesh-list
14593146|NCT00028574|Analgesics|analgesics|mesh-ancestor
14593147|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
15157338|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593148|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593149|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593150|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
15157339|NCT04150965|Thalidomide|thalidomide|mesh-list
15157340|NCT04150965|Dexamethasone|dexamethasone|mesh-list
15157341|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
15157342|NCT04150965|Pomalidomide|pomalidomide|mesh-list
15157343|NCT04150965|Elotuzumab|elotuzumab|mesh-list
15157344|NCT04150965|BB 1101|bb 1101|mesh-list
15157345|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157346|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
15157347|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
15157348|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157349|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157350|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14593151|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14593152|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14593153|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14593154|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14593155|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14593156|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14593157|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157351|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
15157352|NCT04150965|Hormones|hormones|mesh-ancestor
15157353|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157354|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15157355|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157356|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
15157357|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157358|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157359|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
15157360|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15157361|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15157362|NCT04150965|Growth Substances|growth substances|mesh-ancestor
15157363|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
15157364|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593158|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593159|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
14593160|NCT00028587|Paclitaxel|paclitaxel|mesh-list
15157365|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
15157366|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157367|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593161|NCT00028587|Carboplatin|carboplatin|mesh-list
14593162|NCT00028587|Bortezomib|bortezomib|mesh-list
14593163|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593164|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593165|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593166|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593167|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593168|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593169|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
14593170|NCT00028600|Melphalan|melphalan|mesh-list
14593171|NCT00028600|Methotrexate|methotrexate|mesh-list
14593172|NCT00028600|Fludarabine|fludarabine|mesh-list
15157368|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15157369|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157370|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
15157371|NCT04150939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
15157372|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157373|NCT04150575|Paclitaxel|paclitaxel|mesh-list
15157374|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15157375|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15157376|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157377|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
15157378|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593173|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
14593174|NCT00028600|Tacrolimus|tacrolimus|mesh-list
14593175|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593176|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
14593177|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593178|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593179|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593180|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
14593181|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593182|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593183|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593184|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14021745|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157379|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593185|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
14593186|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14593187|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593188|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
14593189|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
14593190|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593191|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14593192|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593193|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14593194|NCT00028613|Antibodies|antibodies|mesh-list
14593195|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14593196|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
14593197|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593198|NCT00028652|Interleukin-12|interleukin-12|mesh-list
14593199|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14593200|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
14593201|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593202|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14593203|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14593204|NCT00028652|Growth Substances|growth substances|mesh-ancestor
14593205|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
14593206|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593207|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
14593208|NCT00028665|Carmustine|carmustine|mesh-list
14593209|NCT00028665|Rituximab|rituximab|mesh-list
14593210|NCT00028665|Etoposide|etoposide|mesh-list
14593211|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593212|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
14593213|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593214|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593215|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593216|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
14593217|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593218|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593219|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593220|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14593221|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593222|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593223|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593224|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644785|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644786|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
14644787|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644788|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14644789|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14644790|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
14644791|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14644792|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14644793|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
14644794|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14644795|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14644796|NCT00192634|Tenofovir|tenofovir|mesh-list
14644797|NCT00192634|Lamivudine|lamivudine|mesh-list
14644798|NCT00192634|Emtricitabine|emtricitabine|mesh-list
14644799|NCT00192634|Abacavir|abacavir|mesh-list
14644800|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
14644801|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644802|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14644803|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644804|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644805|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644806|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14644807|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14644808|NCT00192660|Ritonavir|ritonavir|mesh-list
14644809|NCT00192660|Nelfinavir|nelfinavir|mesh-list
14644810|NCT00192660|Indinavir|indinavir|mesh-list
14644811|NCT00192660|Saquinavir|saquinavir|mesh-list
14644812|NCT00192660|Amprenavir|amprenavir|mesh-list
14644813|NCT00192660|Tenofovir|tenofovir|mesh-list
14644814|NCT00192660|Lamivudine|lamivudine|mesh-list
14644815|NCT00192660|Zidovudine|zidovudine|mesh-list
14644816|NCT00192660|Nevirapine|nevirapine|mesh-list
14644817|NCT00192660|Abacavir|abacavir|mesh-list
14644818|NCT00192660|Stavudine|stavudine|mesh-list
14644819|NCT00192660|Didanosine|didanosine|mesh-list
14644820|NCT00192660|Tipranavir|tipranavir|mesh-list
14644821|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
14644822|NCT00192660|Efavirenz|efavirenz|mesh-list
14644823|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14644824|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14593225|NCT00028678|Dalteparin|dalteparin|mesh-list
14593226|NCT00028678|Tinzaparin|tinzaparin|mesh-list
14593227|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14593228|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
14593229|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14593230|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14593231|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593232|NCT00028691|Chlorambucil|chlorambucil|mesh-list
14593233|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593234|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
14593235|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593236|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593237|NCT00028717|Prednisone|prednisone|mesh-list
14593238|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
14593239|NCT00028717|Rituximab|rituximab|mesh-list
14593240|NCT00028717|Doxorubicin|doxorubicin|mesh-list
14593241|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14593242|NCT00028717|Vincristine|vincristine|mesh-list
14593243|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593244|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
14593245|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593246|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593247|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593248|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
14593249|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593250|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157380|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157381|NCT04150614|Dexamethasone|dexamethasone|mesh-list
15157382|NCT04150614|Ondansetron|ondansetron|mesh-list
15157383|NCT04150614|Granisetron|granisetron|mesh-list
15157384|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157385|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
15157386|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
14593251|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593252|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14593253|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593254|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593255|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593256|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593257|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14593258|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
15157387|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157388|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157389|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157390|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
15157391|NCT04150614|Hormones|hormones|mesh-ancestor
15157392|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157393|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15157394|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157395|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
15157396|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
15157397|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15157398|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
15157399|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157400|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157401|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15157402|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15157403|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157404|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14593259|NCT00028717|Hormones|hormones|mesh-ancestor
14593260|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593261|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14593262|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593263|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593264|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593265|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593266|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
14593267|NCT00028730|Thiotepa|thiotepa|mesh-list
14593268|NCT00028730|Fludarabine|fludarabine|mesh-list
14593269|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
14593270|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14593271|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157405|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14593272|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
14593273|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157406|NCT04150458|Choline|choline|mesh-list
14593274|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593275|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593276|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
14593277|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593278|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593279|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593280|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593281|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
14593282|NCT00028743|Paclitaxel|paclitaxel|mesh-list
14593283|NCT00028743|Carboplatin|carboplatin|mesh-list
14593284|NCT00028743|Topotecan|topotecan|mesh-list
14593285|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593286|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593287|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593288|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593289|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593290|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593291|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14593292|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593293|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593294|NCT00028756|Gemcitabine|gemcitabine|mesh-list
14593295|NCT00028756|Doxorubicin|doxorubicin|mesh-list
14593296|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14593297|NCT00028756|Methotrexate|methotrexate|mesh-list
14593298|NCT00028756|Vinblastine|vinblastine|mesh-list
15157407|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
15157408|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15157409|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
15157410|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593299|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593300|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593301|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
14593302|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593303|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
14593304|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593305|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593306|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593307|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
14593308|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593309|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593310|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593311|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15157411|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157412|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15157413|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
15157414|NCT04150640|Fluorouracil|fluorouracil|mesh-list
15157415|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
15157416|NCT04150640|Trastuzumab|trastuzumab|mesh-list
15157417|NCT04150640|Irinotecan|irinotecan|mesh-list
15157418|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
15157419|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157420|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593312|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14593313|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
14593314|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14593315|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14593316|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14593317|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593318|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593319|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593320|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593321|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593322|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593323|NCT00028782|Etanidazole|etanidazole|mesh-list
14593324|NCT00028782|Imidazole|imidazole|mesh-list
14593325|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593326|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593327|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593328|NCT00028795|Temozolomide|temozolomide|mesh-list
14593329|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593330|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
14593331|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593332|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593333|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
14814026|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593334|NCT00028821|Estradiol|estradiol|mesh-list
14593335|NCT00028821|Estrogens|estrogens|mesh-ancestor
14593336|NCT00028821|Hormones|hormones|mesh-ancestor
14593337|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593338|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593339|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593340|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593341|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593342|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593343|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593344|NCT00028834|Gemcitabine|gemcitabine|mesh-list
14593345|NCT00028834|Bevacizumab|bevacizumab|mesh-list
14593346|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14593347|NCT00028834|Antibodies|antibodies|mesh-list
14593348|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
14593349|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14593350|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593351|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14593352|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14593353|NCT00028834|Growth Substances|growth substances|mesh-ancestor
14593354|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593355|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
14593356|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
14593357|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593358|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
14593359|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593360|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
14593361|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157421|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157422|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157423|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
15157424|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157425|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15157426|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15157427|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15157428|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593362|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593363|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593364|NCT00028847|Cytarabine|cytarabine|mesh-list
14593365|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
14593366|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593367|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
14593368|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593369|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593370|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
14593371|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593372|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593373|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
14593374|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593375|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593376|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593377|NCT00028860|Gemcitabine|gemcitabine|mesh-list
14593378|NCT00028860|Paclitaxel|paclitaxel|mesh-list
14593379|NCT00028860|Carboplatin|carboplatin|mesh-list
14593380|NCT00028860|Ifosfamide|ifosfamide|mesh-list
14593381|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593382|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593383|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593384|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593385|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593386|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593387|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593388|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
14593389|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
14593390|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593391|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593392|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593393|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
14593394|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593395|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593396|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
14593397|NCT00028873|Paclitaxel|paclitaxel|mesh-list
14593398|NCT00028873|Docetaxel|docetaxel|mesh-list
14593399|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593400|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593401|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593402|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593403|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593404|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593405|NCT00028886|Interferons|interferons|mesh-list
14593406|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
14593407|NCT00028886|Thalidomide|thalidomide|mesh-list
14593408|NCT00028886|Dexamethasone|dexamethasone|mesh-list
14593409|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
14593410|NCT00028886|Melphalan|melphalan|mesh-list
14593411|NCT00028886|Doxorubicin|doxorubicin|mesh-list
14593412|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14593413|NCT00028886|Vincristine|vincristine|mesh-list
14593414|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593415|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
14593416|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593417|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593418|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593419|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
14593420|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593421|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593422|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593423|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14593424|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
14593425|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
14593426|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593427|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14593428|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
14593429|NCT00028886|Hormones|hormones|mesh-ancestor
14593430|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593431|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14593432|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593433|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593434|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593435|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593436|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
14593437|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593438|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593439|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593440|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593441|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593442|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
14021746|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021747|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
14021748|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14021749|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14021750|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021751|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14021752|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14021753|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14021754|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021755|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021756|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
14021757|NCT02771860|Denosumab|denosumab|mesh-list
14021758|NCT02771860|Calcium|calcium|mesh-list
14021759|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14021760|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021761|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14021762|NCT02771782|Vaccines|vaccines|mesh-list
14291749|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291750|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14291751|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14291752|NCT00556049|Growth Substances|growth substances|mesh-ancestor
14291753|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
14291754|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291755|NCT00556140|Aripiprazole|aripiprazole|mesh-list
14291756|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
14291757|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14291758|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14291759|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14291760|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291761|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291762|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
14291763|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
14291764|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291765|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593443|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14593444|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14593445|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14593446|NCT00028886|Growth Substances|growth substances|mesh-ancestor
14593447|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
14593448|NCT00028899|Cytarabine|cytarabine|mesh-list
14593449|NCT00028899|Asparaginase|asparaginase|mesh-list
14593450|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
14593451|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
14593452|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593453|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
14593454|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593455|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593456|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
14593457|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593458|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593459|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
14593460|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593461|NCT00028899|Analgesics|analgesics|mesh-ancestor
14593462|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
14593463|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593464|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593465|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593466|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593467|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14593468|NCT00028912|Carboplatin|carboplatin|mesh-list
14593469|NCT00028912|Bortezomib|bortezomib|mesh-list
14593470|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593471|NCT00028925|Carboplatin|carboplatin|mesh-list
14593472|NCT00028925|Topotecan|topotecan|mesh-list
14593473|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593474|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14593475|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593476|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593477|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593478|NCT00028938|Paclitaxel|paclitaxel|mesh-list
14593479|NCT00028938|Carboplatin|carboplatin|mesh-list
14593480|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
14593481|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593482|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593483|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593484|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593485|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593486|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593487|NCT00028938|Hematinics|hematinics|mesh-ancestor
14593488|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14593489|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
14593490|NCT00028951|Coagulants|coagulants|mesh-ancestor
14593491|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
14593492|NCT00028964|Doxorubicin|doxorubicin|mesh-list
14593493|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15157429|NCT04150562|Avelumab|avelumab|mesh-list
15157430|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15157431|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180488|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180489|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
15180490|NCT03939975|Nivolumab|nivolumab|mesh-list
15180491|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15180492|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180493|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15180494|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180495|NCT03939871|Vinorelbine|vinorelbine|mesh-list
15180496|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180497|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180498|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
15180499|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
15180500|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
15180501|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180502|NCT03940001|Paclitaxel|paclitaxel|mesh-list
15180503|NCT03940001|Carboplatin|carboplatin|mesh-list
15180504|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14021763|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
14593494|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593495|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
14593496|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593497|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593498|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593499|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
14593500|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593501|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593502|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593503|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593504|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593505|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593506|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593507|NCT00028990|Paclitaxel|paclitaxel|mesh-list
14593508|NCT00028990|Bevacizumab|bevacizumab|mesh-list
14593509|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593510|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593511|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593512|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
15157432|NCT04150536|Lidocaine|lidocaine|mesh-list
15157433|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
15157434|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
15157435|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157436|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157437|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
15157438|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157439|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15157440|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15157441|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15157442|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15157443|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157444|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15157445|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15157446|NCT04150731|Estradiol|estradiol|mesh-list
15157447|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15157448|NCT04150731|Estrogens|estrogens|mesh-ancestor
15157449|NCT04150731|Hormones|hormones|mesh-ancestor
14593513|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593514|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593515|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14593516|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14593517|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14593518|NCT00028990|Growth Substances|growth substances|mesh-ancestor
14593519|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593520|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14593521|NCT00029003|Gefitinib|gefitinib|mesh-list
14593522|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593523|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593524|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593525|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593526|NCT00029042|Infliximab|infliximab|mesh-list
14593527|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14593528|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14593529|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593530|NCT00029159|Estrogens|estrogens|mesh-list
14593531|NCT00029159|Androgens|androgens|mesh-list
14593532|NCT00029159|Hormones|hormones|mesh-ancestor
14593533|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593534|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593535|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
14593536|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14593537|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593538|NCT00029250|Allicin|allicin|mesh-list
14593539|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593540|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14593541|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
14593542|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593543|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15157450|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157451|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157452|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15157453|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
15157454|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15157455|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15157456|NCT04150757|Ketamine|ketamine|mesh-list
15157457|NCT04150757|Analgesics|analgesics|mesh-ancestor
15157458|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
14593544|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
14593545|NCT00029250|Protective Agents|protective agents|mesh-ancestor
14644825|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
15157459|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157460|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157461|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15157462|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15157463|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
15157464|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
15157465|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157466|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15157467|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14593546|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593547|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14593548|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14593549|NCT00029315|Plasminogen|plasminogen|mesh-list
14593550|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14593551|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14593552|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14593553|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593554|NCT00029328|Etanercept|etanercept|mesh-list
14593555|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14593556|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14593557|NCT00029328|Analgesics|analgesics|mesh-ancestor
14593558|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
14593559|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593560|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593561|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14593562|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593563|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14593564|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593565|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
14593566|NCT00029380|Cyclosporine|cyclosporine|mesh-list
14593567|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
14593568|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
14593569|NCT00029380|Busulfan|busulfan|mesh-list
14593570|NCT00029380|Cyclosporins|cyclosporins|mesh-list
14593571|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593572|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
14593573|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593574|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593575|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593576|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
14593577|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593578|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593579|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593580|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593581|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
14593582|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593583|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
14593584|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14593585|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593586|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15157468|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593587|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
14593588|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14593589|NCT00029458|Clozapine|clozapine|mesh-list
14593590|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14593591|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
14593592|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593593|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593594|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593595|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15157469|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157470|NCT04150289|Panobinostat|panobinostat|mesh-list
15157471|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157472|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15157473|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157474|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157475|NCT04150367|Rifampin|rifampin|mesh-list
15157476|NCT04150367|Isoniazid|isoniazid|mesh-list
15157477|NCT04150367|Ethambutol|ethambutol|mesh-list
15157478|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15157479|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15157480|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
14593596|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14593597|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14593598|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14593599|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
14593600|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
14593601|NCT00029497|Amitriptyline|amitriptyline|mesh-list
14593602|NCT00029497|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14593603|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14593604|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
14593605|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14593606|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14593607|NCT00029497|Analgesics|analgesics|mesh-ancestor
14593608|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
14593609|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593610|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593611|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14593612|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14593613|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14593614|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593615|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
14593616|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593617|NCT00029497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14593618|NCT00029497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14593619|NCT00029497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14593620|NCT00029523|Cytarabine|cytarabine|mesh-list
14593621|NCT00029523|Methotrexate|methotrexate|mesh-list
14593622|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14593623|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
14593624|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14593625|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593626|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593627|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
14593628|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593629|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593630|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14593631|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593632|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14593633|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593634|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
14593635|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593636|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593637|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
14593638|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593639|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14593640|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14593641|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14593642|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14593643|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593644|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14593645|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593646|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593647|NCT00029627|Yohimbine|yohimbine|mesh-list
14593648|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
14593649|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
14593650|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593651|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593652|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14593653|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14593654|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14593655|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
14593656|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593657|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593658|NCT00029627|Urological Agents|urological agents|mesh-ancestor
14593659|NCT00029679|Borage oil|borage oil|mesh-list
14593660|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021764|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
14021765|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021766|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14021767|NCT02771795|Trastuzumab|trastuzumab|mesh-list
14021768|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14021769|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021770|NCT02771834|Vitamin D|vitamin d|mesh-list
14021771|NCT02771834|Vitamins|vitamins|mesh-ancestor
14021772|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
14593661|NCT00029757|Estrogens|estrogens|mesh-list
14593662|NCT00029757|Hormones|hormones|mesh-ancestor
14021773|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593663|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593664|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593665|NCT00029770|Acetaminophen|acetaminophen|mesh-list
14593666|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14593667|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14593668|NCT00029770|Codeine|codeine|mesh-list
14593669|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14593670|NCT00029770|Analgesics|analgesics|mesh-ancestor
14593671|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
14593672|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593673|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593674|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
14593675|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14593676|NCT00029770|Narcotics|narcotics|mesh-ancestor
14593677|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14593678|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
14593679|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
14593680|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593681|NCT00029822|Alfuzosin|alfuzosin|mesh-list
14593682|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14593683|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14593684|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14593685|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
14593686|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157481|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157482|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157483|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
15157484|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593687|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593688|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593689|NCT00029822|Urological Agents|urological agents|mesh-ancestor
14593690|NCT00029835|Rimonabant|rimonabant|mesh-list
14593691|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14593692|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14593693|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14593694|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593695|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593696|NCT00029835|Hormones|hormones|mesh-ancestor
14593697|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593698|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593699|NCT00029848|Rimonabant|rimonabant|mesh-list
14593700|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14593701|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14593702|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14593703|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593704|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593705|NCT00029848|Hormones|hormones|mesh-ancestor
14593706|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593707|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593708|NCT00029861|Rimonabant|rimonabant|mesh-list
14593709|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14593710|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14593711|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14593712|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593713|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593714|NCT00029861|Hormones|hormones|mesh-ancestor
14593715|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593716|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593717|NCT00029874|Minocycline|minocycline|mesh-list
14593718|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14593719|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593720|NCT00030004|Midazolam|midazolam|mesh-list
14593721|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14593722|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14593723|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14593724|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593725|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14593726|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14593727|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14593728|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14593729|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
14593730|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
14593731|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
14593732|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
14593733|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14593734|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593735|NCT00030030|Silymarin|silymarin|mesh-list
15157485|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157486|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157487|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15157488|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14593736|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
14593737|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593738|NCT00030030|Protective Agents|protective agents|mesh-ancestor
14593739|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593740|NCT00030056|Molgramostim|molgramostim|mesh-list
14593741|NCT00030056|Sargramostim|sargramostim|mesh-list
14593742|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
14593743|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593744|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593745|NCT00030069|Calcitriol|calcitriol|mesh-list
14593746|NCT00030069|Dexamethasone|dexamethasone|mesh-list
14593747|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14593748|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
14593749|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
14593750|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593751|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593752|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14593753|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
14593754|NCT00030069|Hormones|hormones|mesh-ancestor
14593755|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14593756|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14593757|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593758|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14593759|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14593760|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14593761|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593762|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14593763|NCT00030069|Vitamins|vitamins|mesh-ancestor
15157489|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15157490|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15157491|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15157492|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15157493|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14593764|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
14593765|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14593766|NCT00030082|Melphalan|melphalan|mesh-list
14593767|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14593768|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
14593769|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593770|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593771|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14593772|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593773|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
14593774|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593775|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
14593776|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593777|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593778|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593779|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593780|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593781|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
14593782|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
14593783|NCT00030173|Epothilones|epothilones|mesh-list
14593784|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
14593785|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593786|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593787|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593788|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593789|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593790|NCT00030238|Calcium|calcium|mesh-list
14593791|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14593792|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644826|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647441|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14593793|NCT00030342|Interferons|interferons|mesh-list
14593794|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
14593795|NCT00030342|Fluorouracil|fluorouracil|mesh-list
14593796|NCT00030342|Sargramostim|sargramostim|mesh-list
14593797|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
14593798|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593799|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593800|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157494|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15157495|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
15157496|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15157497|NCT04150172|Rebamipide|rebamipide|mesh-list
15157498|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15157499|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157500|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
15157501|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593801|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593802|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
14593803|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593804|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
14593805|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593806|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
14593807|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593808|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593809|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14593810|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593811|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593812|NCT00030368|Paclitaxel|paclitaxel|mesh-list
14593813|NCT00030368|Bortezomib|bortezomib|mesh-list
14593814|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593815|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593816|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593817|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593818|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593819|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593820|NCT00030381|Esorubicin|esorubicin|mesh-list
14593821|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593822|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593823|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
14593824|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593825|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593826|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593827|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593828|NCT00030407|Celecoxib|celecoxib|mesh-list
14593829|NCT00030407|Docetaxel|docetaxel|mesh-list
14593830|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593831|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593832|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593833|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593834|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593835|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14593836|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14593837|NCT00030407|Analgesics|analgesics|mesh-ancestor
14593838|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
14593839|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593840|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593841|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14593842|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593843|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14593844|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14593845|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593846|NCT00030420|Celecoxib|celecoxib|mesh-list
14593847|NCT00030420|Docetaxel|docetaxel|mesh-list
14593848|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593849|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593850|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593851|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593852|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593853|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14593854|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14593855|NCT00030420|Analgesics|analgesics|mesh-ancestor
14593856|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
14593857|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157502|NCT04150172|Protective Agents|protective agents|mesh-ancestor
14593858|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157503|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157504|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157505|NCT04149938|Lidocaine|lidocaine|mesh-list
15157506|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
15157507|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
15157508|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157509|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157510|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
15157511|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14593859|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14593860|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14593861|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14593862|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14593863|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593864|NCT00030433|Gemcitabine|gemcitabine|mesh-list
14593865|NCT00030433|Irinotecan|irinotecan|mesh-list
14593866|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593867|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
14593868|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593869|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593870|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
14593871|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593872|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593873|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14593874|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
14593875|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593876|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14593877|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593878|NCT00030446|Carboplatin|carboplatin|mesh-list
14593879|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14593880|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593881|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593882|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593883|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593884|NCT00030459|Vinorelbine|vinorelbine|mesh-list
14021774|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14021775|NCT02771717|Budesonide|budesonide|mesh-list
15157512|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15157513|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15157514|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15157515|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15157516|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157517|NCT04150146|Rebamipide|rebamipide|mesh-list
14593885|NCT00030459|Mitomycins|mitomycins|mesh-list
14593886|NCT00030459|Mitomycin|mitomycin|mesh-list
14593887|NCT00030459|Vinblastine|vinblastine|mesh-list
14593888|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593889|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593890|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593891|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593892|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593893|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593894|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593895|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
14593896|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14593897|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593898|NCT00030472|Doxorubicin|doxorubicin|mesh-list
14593899|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14593900|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593901|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593902|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593903|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593904|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593905|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593906|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14593907|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593908|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593909|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593910|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593911|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14593912|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593913|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593914|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021776|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14593915|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593916|NCT00030511|Fluorouracil|fluorouracil|mesh-list
14593917|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
14593918|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593919|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593920|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593921|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021777|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14021778|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
14021779|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021780|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593922|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
14593923|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593924|NCT00030524|Gefitinib|gefitinib|mesh-list
14593925|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593926|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593927|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593928|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593929|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14593930|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593931|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593932|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593933|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593934|NCT00030550|Thalidomide|thalidomide|mesh-list
14593935|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021781|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14021782|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
14021783|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
14021784|NCT02771717|Hormones|hormones|mesh-ancestor
14021785|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14021786|NCT02771912|Propofol|propofol|mesh-list
14021787|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14021788|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14593936|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
14593937|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593938|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
14593939|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14593940|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14593941|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14593942|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14593943|NCT00030550|Growth Substances|growth substances|mesh-ancestor
14593944|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
14593945|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593946|NCT00030563|Irinotecan|irinotecan|mesh-list
14593947|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14593948|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593949|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593950|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593951|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593952|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14593953|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593954|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14593955|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593956|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593957|NCT00030589|Bexarotene|bexarotene|mesh-list
14593958|NCT00030589|Methoxsalen|methoxsalen|mesh-list
14593959|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593960|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14593961|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14593962|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
14593963|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14593964|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
14593965|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14593966|NCT00030615|Decitabine|decitabine|mesh-list
14593967|NCT00030615|Azacitidine|azacitidine|mesh-list
14593968|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14593969|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
14593970|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593971|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593972|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593973|NCT00030641|Docetaxel|docetaxel|mesh-list
14593974|NCT00030641|Oblimersen|oblimersen|mesh-list
15157518|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15157519|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14593975|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593976|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593977|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593978|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593979|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593980|NCT00030654|Ketoconazole|ketoconazole|mesh-list
14593981|NCT00030654|Vinblastine|vinblastine|mesh-list
14593982|NCT00030654|Docetaxel|docetaxel|mesh-list
14593983|NCT00030654|Doxorubicin|doxorubicin|mesh-list
14593984|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14593985|NCT00030654|Bicalutamide|bicalutamide|mesh-list
14593986|NCT00030654|Flutamide|flutamide|mesh-list
14593987|NCT00030654|Estramustine|estramustine|mesh-list
14593988|NCT00030654|Hormones|hormones|mesh-list
14593989|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14593990|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14593991|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
14593992|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
14593993|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
14593994|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14593995|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14593996|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14593997|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14593998|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14593999|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594000|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594001|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
14594002|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594003|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14594004|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14594005|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15157520|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
15157521|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157522|NCT04150146|Protective Agents|protective agents|mesh-ancestor
15157523|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157524|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157525|NCT04150107|Insulin|insulin|mesh-list
15157526|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157527|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157528|NCT04149483|Atorvastatin|atorvastatin|mesh-list
15157529|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15157530|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14594006|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
14594007|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14594008|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
14594009|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594010|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14594011|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
14594012|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
15157531|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
15157532|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157533|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14594013|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157534|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15157535|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594014|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14594015|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594016|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594017|NCT00030693|Metronidazole|metronidazole|mesh-list
15157536|NCT04149678|Cyclosporine|cyclosporine|mesh-list
15157537|NCT04149678|Cyclosporins|cyclosporins|mesh-list
15157538|NCT04149678|Ozanimod|ozanimod|mesh-list
15157539|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157540|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157541|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157542|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
15157543|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157544|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
15157545|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157546|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
15157547|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594018|NCT00030693|Vaccines|vaccines|mesh-list
14594019|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
14594020|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594021|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594022|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157548|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15157549|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15157550|NCT04149626|Midazolam|midazolam|mesh-list
15157551|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
15157552|NCT04149626|Remifentanil|remifentanil|mesh-list
15157553|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15157554|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157555|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594023|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14594024|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14594025|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
14594026|NCT00030719|Melphalan|melphalan|mesh-list
14594027|NCT00030719|Busulfan|busulfan|mesh-list
14594028|NCT00030719|Carboplatin|carboplatin|mesh-list
14594029|NCT00030719|Etoposide|etoposide|mesh-list
14594030|NCT00030719|Vincristine|vincristine|mesh-list
14594031|NCT00030719|Dinutuximab|dinutuximab|mesh-list
14594032|NCT00030719|Isotretinoin|isotretinoin|mesh-list
14594033|NCT00030719|Antibodies|antibodies|mesh-list
14594034|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14594035|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594036|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
14594037|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594038|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594039|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14594040|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
14594041|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594042|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594043|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14594044|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594045|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14594046|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594047|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594048|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594049|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594050|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594051|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594052|NCT00030732|Gemcitabine|gemcitabine|mesh-list
14594053|NCT00030732|Capecitabine|capecitabine|mesh-list
14594054|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594055|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
14594056|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594057|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594058|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
14594059|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594060|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594061|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594062|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
14594063|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594064|NCT00030745|Gemcitabine|gemcitabine|mesh-list
14594065|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594066|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594067|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
14594068|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594069|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
14594070|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594071|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594072|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594073|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
14594074|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594075|NCT00030758|Lenograstim|lenograstim|mesh-list
14594076|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14594077|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
14594078|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594079|NCT00030784|Doxorubicin|doxorubicin|mesh-list
14594080|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14594081|NCT00030784|Ifosfamide|ifosfamide|mesh-list
14594082|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14594083|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594084|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14594085|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15157556|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14594086|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594087|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594088|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14594089|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
14594090|NCT00030797|Irinotecan|irinotecan|mesh-list
15157557|NCT04149626|Analgesics|analgesics|mesh-ancestor
14594091|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14594092|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594093|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594094|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594095|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594096|NCT00030810|Docetaxel|docetaxel|mesh-list
14594097|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594098|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594099|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594100|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157558|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
15157559|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157560|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15157561|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15157562|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15157563|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
14594101|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594102|NCT00030849|Interferons|interferons|mesh-list
14594103|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
14594104|NCT00030849|Bexarotene|bexarotene|mesh-list
14594105|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594106|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
14594107|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594108|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
14594109|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594110|NCT00030862|Irinotecan|irinotecan|mesh-list
14594111|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594112|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14594113|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594114|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594115|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594116|NCT00030875|Bortezomib|bortezomib|mesh-list
14594117|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594118|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14594119|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594120|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14594121|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594122|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594123|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14594124|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14594125|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
14594126|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14594127|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14594128|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14594129|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594130|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594131|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594132|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14594133|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
14594134|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14594135|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14594136|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14594137|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14594138|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
14594139|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14594140|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14594141|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14594142|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14594143|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594144|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594145|NCT00030966|Natalizumab|natalizumab|mesh-list
14594146|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
14594147|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594148|NCT00030979|Donepezil|donepezil|mesh-list
14594149|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14594150|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594151|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594152|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
14594153|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594154|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594155|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
15157564|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594156|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
14594157|NCT00031018|Donepezil|donepezil|mesh-list
14594158|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15157565|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157566|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15157567|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14594159|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594160|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594161|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
14594162|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594163|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594164|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
14594165|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
14594166|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594167|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594168|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
14594169|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14021789|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594170|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14594171|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594172|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14594173|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14594174|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
14594175|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594176|NCT00031057|Riboflavin|riboflavin|mesh-list
14594177|NCT00031057|Thiamine|thiamine|mesh-list
14594178|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
14594179|NCT00031057|Vitamins|vitamins|mesh-ancestor
14594180|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
14594181|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594182|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14594183|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594184|NCT00031070|Cyclosporine|cyclosporine|mesh-list
14594185|NCT00031070|Lamivudine|lamivudine|mesh-list
14594186|NCT00031070|Zidovudine|zidovudine|mesh-list
14594187|NCT00031070|Efavirenz|efavirenz|mesh-list
14594188|NCT00031070|Abacavir|abacavir|mesh-list
14594189|NCT00031070|Vaccines|vaccines|mesh-list
14594190|NCT00031070|Cyclosporins|cyclosporins|mesh-list
14594191|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14594192|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
14594193|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594194|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594195|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594196|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594197|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
14594198|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594199|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594200|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594201|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14594202|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14594203|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14594204|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
14594205|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14594206|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14594207|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
14594208|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14594209|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14594210|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14594211|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14594212|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14594213|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15157568|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15157569|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15157570|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15157571|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
14594214|NCT00031083|Interferons|interferons|mesh-list
14594215|NCT00031083|Interferon-beta|interferon-beta|mesh-list
14594216|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594217|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
14594218|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594219|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
14594220|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594221|NCT00031096|Azelaic acid|azelaic acid|mesh-list
14594222|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594223|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594224|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14594225|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14594226|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
14594227|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594228|NCT00031109|Antacids|antacids|mesh-ancestor
14594229|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594230|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14594231|NCT00031135|Choline|choline|mesh-list
14594232|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
14594233|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14594234|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
14594235|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594236|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14594237|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14594238|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
14594239|NCT00031148|Mitogens|mitogens|mesh-list
14594240|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594241|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594242|NCT00031161|Nitisinone|nitisinone|mesh-list
14594243|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594244|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594245|NCT00031187|Docetaxel|docetaxel|mesh-list
14594246|NCT00031187|Doxorubicin|doxorubicin|mesh-list
14594247|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
14594248|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594249|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594250|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594251|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594252|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594253|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14594254|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14594255|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594256|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594257|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
14594258|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594259|NCT00031278|Trastuzumab|trastuzumab|mesh-list
14594260|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14594261|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594262|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
14594263|NCT00031291|Antibodies|antibodies|mesh-list
14594264|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
14594265|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14594266|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14594267|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
14594268|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594269|NCT00031317|Clozapine|clozapine|mesh-list
14594270|NCT00031317|Paroxetine|paroxetine|mesh-list
14594271|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14594272|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14594273|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14594274|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594275|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594276|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
14594277|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594278|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14594279|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
14594280|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14594281|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14594282|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14594283|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594284|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14594285|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14594286|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14594287|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594288|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
14594289|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
14594290|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14594291|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
14594292|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594293|NCT00031395|Clonidine|clonidine|mesh-list
14594294|NCT00031395|Methylphenidate|methylphenidate|mesh-list
14594295|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14594296|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594297|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14594298|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14594299|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14594300|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594301|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
14594302|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594303|NCT00031395|Analgesics|analgesics|mesh-ancestor
14594304|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
14594305|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594306|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14594307|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
14594308|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
14594309|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14594310|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15157572|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
14021790|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594311|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14594312|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
14594313|NCT00031434|Valganciclovir|valganciclovir|mesh-list
14594314|NCT00031434|Ganciclovir|ganciclovir|mesh-list
14594315|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14594316|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
14594317|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594318|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14594319|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594320|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594321|NCT00031473|Ribavirin|ribavirin|mesh-list
14594322|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
14594323|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157573|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
15157574|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
15157575|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15157576|NCT04149626|Narcotics|narcotics|mesh-ancestor
15157577|NCT04149470|Omeprazole|omeprazole|mesh-list
15157578|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15157579|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157580|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15157581|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157582|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157583|NCT04149444|Trifluridine|trifluridine|mesh-list
15157584|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
15157585|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157586|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
14594324|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
14594325|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594326|NCT00031499|Azithromycin|azithromycin|mesh-list
14594327|NCT00031499|Doxycycline|doxycycline|mesh-list
14594328|NCT00031499|Penicillins|penicillins|mesh-list
14594329|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14594330|NCT00031499|Penicillin G|penicillin g|mesh-list
14594331|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
14594332|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14594333|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594334|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
14594335|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14594336|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14594337|NCT00031564|Aldesleukin|aldesleukin|mesh-list
14594338|NCT00031564|Interleukin-2|interleukin-2|mesh-list
14594339|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021791|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14021792|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
14021793|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
14594340|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594341|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14594342|NCT00031564|Analgesics|analgesics|mesh-ancestor
15157587|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157588|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
14594343|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
14594344|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594345|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14594346|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14594347|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
14594348|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594349|NCT00031577|Paclitaxel|paclitaxel|mesh-list
14594350|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594351|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021794|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14594352|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594353|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594354|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157589|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157590|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594355|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594356|NCT00031616|Brivudine|brivudine|mesh-list
14594357|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
14594358|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
14594359|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594360|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594361|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594362|NCT00031629|Gemcitabine|gemcitabine|mesh-list
14594363|NCT00031629|Docetaxel|docetaxel|mesh-list
14594364|NCT00031629|Lenograstim|lenograstim|mesh-list
14594365|NCT00031629|Sargramostim|sargramostim|mesh-list
14594366|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594367|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
14594368|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594369|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594370|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
14594371|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594372|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594373|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594374|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
14594375|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594376|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594377|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594378|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594379|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14594380|NCT00031642|Rituximab|rituximab|mesh-list
14594381|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14594382|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594383|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
15157591|NCT04149275|Nivolumab|nivolumab|mesh-list
15157592|NCT04149275|Ipilimumab|ipilimumab|mesh-list
15157593|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15157594|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594384|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594385|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594386|NCT00031655|Cyclosporine|cyclosporine|mesh-list
14594387|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
14594388|NCT00031655|Fludarabine|fludarabine|mesh-list
15157595|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15157596|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157597|NCT04148963|Loxapine|loxapine|mesh-list
15157598|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15157599|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14594389|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
14594390|NCT00031655|Cyclosporins|cyclosporins|mesh-list
14594391|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594392|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594393|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
14594394|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594395|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594396|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
14594397|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594398|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594399|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
14594400|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594401|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594402|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594403|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14594404|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14594405|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14594406|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
14594407|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14594408|NCT00031681|Irinotecan|irinotecan|mesh-list
14594409|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14594410|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14594411|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594412|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594413|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594414|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594415|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14594416|NCT00031707|Megestrol|megestrol|mesh-list
14594417|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
15157600|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594418|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15157601|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594419|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14647442|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
14594420|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14594421|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
14594422|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14594423|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594424|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14594425|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14594426|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594427|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157602|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15157603|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15157604|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
15157605|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157606|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157607|NCT04149327|Amoxicillin|amoxicillin|mesh-list
15157608|NCT04149327|Metronidazole|metronidazole|mesh-list
14594428|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
14594429|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14594430|NCT00031720|Tamoxifen|tamoxifen|mesh-list
14594431|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14594432|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
14594433|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594434|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594435|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594436|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594437|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14594438|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14594439|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14594440|NCT00031733|Interleukin-12|interleukin-12|mesh-list
14594441|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14594442|NCT00031733|Sargramostim|sargramostim|mesh-list
14594443|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
14594444|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
14594445|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
14594446|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594447|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594448|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14594449|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14594450|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14594451|NCT00031733|Growth Substances|growth substances|mesh-ancestor
14594452|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
14594453|NCT00031733|Antacids|antacids|mesh-ancestor
14594454|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594455|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14594456|NCT00031746|Caseins|caseins|mesh-list
14594457|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
14594458|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
14594459|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594460|NCT00031759|Imiquimod|imiquimod|mesh-list
14594461|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15157609|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157610|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157611|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15157612|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14594462|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
14594463|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594464|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594465|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
14594466|NCT00031785|Megestrol|megestrol|mesh-list
14594467|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
14594468|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14594469|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14594470|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14594471|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
14594472|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14594473|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594474|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14594475|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14594476|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594477|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594478|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
14594479|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14594480|NCT00031798|Methylphenidate|methylphenidate|mesh-list
14594481|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14594482|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594483|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14594484|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14594485|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14594486|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157613|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15157614|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
14594487|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
14594488|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594489|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14594490|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14594491|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
14594492|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594493|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594494|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14594495|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14594496|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14594497|NCT00031824|Cyclosporine|cyclosporine|mesh-list
14594498|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
14594499|NCT00031824|Prednisone|prednisone|mesh-list
14594500|NCT00031824|Tacrolimus|tacrolimus|mesh-list
14594501|NCT00031824|Cyclosporins|cyclosporins|mesh-list
14594502|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14594503|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
14021795|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14021796|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14026055|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026056|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14026057|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026058|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14594504|NCT00031824|Hormones|hormones|mesh-ancestor
14594505|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594506|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594507|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594508|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594509|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594510|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
14594511|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14594512|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594513|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594514|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
14594515|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594516|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594517|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594518|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
14594519|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14594520|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14594521|NCT00031837|Gemcitabine|gemcitabine|mesh-list
14594522|NCT00031837|Dalteparin|dalteparin|mesh-list
14594523|NCT00031837|Tinzaparin|tinzaparin|mesh-list
14594524|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14594525|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594526|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
14026059|NCT02745691|Gefitinib|gefitinib|mesh-list
14026060|NCT02745691|Crizotinib|crizotinib|mesh-list
14026061|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026062|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14026063|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594527|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594528|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594529|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
14594530|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594531|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594532|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594533|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
14594534|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594535|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
14594536|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14594537|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14644827|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644828|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14644829|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14644830|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
14644831|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644832|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14026064|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594538|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14594539|NCT00031850|Goserelin|goserelin|mesh-list
14594540|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594541|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594542|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14594543|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
14021797|NCT02771457|Infliximab|infliximab|mesh-list
14021798|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14021799|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021800|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594544|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594545|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594546|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14594547|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14594548|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14594549|NCT00031863|Rofecoxib|rofecoxib|mesh-list
14594550|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14594551|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14594552|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594553|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021801|NCT02771392|Tetracaine|tetracaine|mesh-list
14021802|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15157615|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157616|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157617|NCT04149067|Incretins|incretins|mesh-ancestor
15157618|NCT04149067|Hormones|hormones|mesh-ancestor
15157619|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157620|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14021803|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
14021804|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
14021805|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021806|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021807|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
14594554|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15157621|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
15157622|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157623|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157624|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15157625|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
15157626|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
15157627|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15157628|NCT04149106|Amodiaquine|amodiaquine|mesh-list
15157629|NCT04149106|Artenimol|artenimol|mesh-list
15157630|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
15157631|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15157632|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14594555|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14594556|NCT00031863|Analgesics|analgesics|mesh-ancestor
14594557|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
14594558|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594559|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594560|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14594561|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594562|NCT00031876|Paclitaxel|paclitaxel|mesh-list
14594563|NCT00031876|Capecitabine|capecitabine|mesh-list
14594564|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594565|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594566|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594567|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594568|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594569|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594570|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594571|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
14594572|NCT00031889|Exemestane|exemestane|mesh-list
14594573|NCT00031889|Bicalutamide|bicalutamide|mesh-list
14594574|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594575|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14594576|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14594577|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594578|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594579|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14594580|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
14814027|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14021808|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594581|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594582|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594583|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
14594584|NCT00031902|Prednisolone|prednisolone|mesh-list
14594585|NCT00031902|Rituximab|rituximab|mesh-list
14594586|NCT00031902|Vincristine|vincristine|mesh-list
14594587|NCT00031902|Bleomycin|bleomycin|mesh-list
14594588|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14594589|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594590|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
14594591|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594592|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594593|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594594|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594595|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594596|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594597|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594598|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14594599|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
14594600|NCT00031902|Hormones|hormones|mesh-ancestor
14594601|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594602|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594603|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14594604|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
14594605|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594606|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14594607|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594608|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594609|NCT00031928|Mafosfamide|mafosfamide|mesh-list
14594610|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14594611|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
14594612|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594613|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594614|NCT00031941|Lenalidomide|lenalidomide|mesh-list
14594615|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
14594616|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594617|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14594618|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14594619|NCT00031941|Growth Substances|growth substances|mesh-ancestor
14594620|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
14594621|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594622|NCT00031954|Gemcitabine|gemcitabine|mesh-list
14594623|NCT00031954|Paclitaxel|paclitaxel|mesh-list
14594624|NCT00031954|Carboplatin|carboplatin|mesh-list
14594625|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594626|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594627|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594628|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594629|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594630|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594631|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594632|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
14594633|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
14594634|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594635|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594636|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594637|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
14594638|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594639|NCT00031967|Melatonin|melatonin|mesh-list
14594640|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
14594641|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594642|NCT00031967|Protective Agents|protective agents|mesh-ancestor
14594643|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594644|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594645|NCT00031980|Cyclosporine|cyclosporine|mesh-list
14594646|NCT00031980|Cyclosporins|cyclosporins|mesh-list
14594647|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594648|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594649|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594650|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
14594651|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594652|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
14594653|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594654|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594655|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594656|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14594657|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14594658|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594659|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14594660|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594661|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594662|NCT00032019|Prednisone|prednisone|mesh-list
14594663|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
14594664|NCT00032019|Rituximab|rituximab|mesh-list
14594665|NCT00032019|Doxorubicin|doxorubicin|mesh-list
14594666|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14594667|NCT00032019|Etoposide|etoposide|mesh-list
14594668|NCT00032019|Vincristine|vincristine|mesh-list
14594669|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594670|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
14594671|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594672|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594673|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14594674|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
14594675|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594676|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594677|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14594678|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14594679|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14594680|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14594681|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594682|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594683|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14594684|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
14594685|NCT00032019|Hormones|hormones|mesh-ancestor
14594686|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594687|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594688|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594689|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594690|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594691|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594692|NCT00032032|Paclitaxel|paclitaxel|mesh-list
14594693|NCT00032032|Carboplatin|carboplatin|mesh-list
14594694|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594695|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594696|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594697|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594698|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594699|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594700|NCT00032045|Ipilimumab|ipilimumab|mesh-list
14594701|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
14594702|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14594703|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594704|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15157633|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157634|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14594705|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157635|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157636|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594706|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14594707|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
14594708|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594709|NCT00032084|Bupropion|bupropion|mesh-list
14594710|NCT00032084|Nicotine|nicotine|mesh-list
14594711|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14594712|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
14594713|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594714|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594715|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14594716|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14594717|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
14594718|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594719|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594720|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15157637|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15157638|NCT04149106|Renal Agents|renal agents|mesh-ancestor
15157639|NCT04149015|Paclitaxel|paclitaxel|mesh-list
14594721|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
15157640|NCT04149015|Fluorouracil|fluorouracil|mesh-list
14594722|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14594723|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14594724|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14594725|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14594726|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
14594727|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14594728|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14594729|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594730|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
14594731|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594732|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14594733|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
14594734|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14594735|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157641|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
15157642|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15157643|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594736|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14594737|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594738|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594739|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14594740|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594741|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14594742|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594743|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594744|NCT00032136|Tamoxifen|tamoxifen|mesh-list
14594745|NCT00032136|Exemestane|exemestane|mesh-list
14594746|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594747|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14594748|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
14594749|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594750|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594751|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594752|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594753|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14594754|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14594755|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14594756|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14594757|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14594758|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594759|NCT00032149|Prednisolone|prednisolone|mesh-list
14594760|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
14594761|NCT00032149|Etoposide|etoposide|mesh-list
14594762|NCT00032149|Vincristine|vincristine|mesh-list
14594763|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
14594764|NCT00032149|Bleomycin|bleomycin|mesh-list
14594765|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594766|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
14594767|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594768|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594769|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14594770|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
14594771|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594772|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594773|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14594774|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14594775|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14594776|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594777|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594778|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594779|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594780|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594781|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14594782|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
14594783|NCT00032149|Hormones|hormones|mesh-ancestor
14594784|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594785|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14594786|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157644|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594787|NCT00032149|Analgesics|analgesics|mesh-ancestor
14594788|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
14594789|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14594790|NCT00032162|Carboplatin|carboplatin|mesh-list
14594791|NCT00032162|Doxorubicin|doxorubicin|mesh-list
15157645|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
15157646|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594792|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14594793|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594794|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14594795|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14594796|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14594797|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594798|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594799|NCT00032175|Gemcitabine|gemcitabine|mesh-list
14594800|NCT00032175|Capecitabine|capecitabine|mesh-list
14594801|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14594802|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
14594803|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594804|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594805|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
14594806|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594807|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594808|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14594809|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
14594810|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594811|NCT00032188|Aldesleukin|aldesleukin|mesh-list
14594812|NCT00032188|Interleukin-2|interleukin-2|mesh-list
14594813|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
14594814|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594815|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14594816|NCT00032188|Analgesics|analgesics|mesh-ancestor
14594817|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
14594818|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594819|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594820|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14594821|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14594822|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
14594823|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594824|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14594825|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
14594826|NCT00032279|Visilizumab|visilizumab|mesh-list
14594827|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
14594828|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594829|NCT00032292|Visilizumab|visilizumab|mesh-list
14594830|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
14594831|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594832|NCT00032305|Visilizumab|visilizumab|mesh-list
14594833|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
14594834|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594835|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14594836|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14594837|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
14594838|NCT00032396|Hormones|hormones|mesh-ancestor
14594839|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594840|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594841|NCT00032734|Satavaptan|satavaptan|mesh-list
14594842|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14594843|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594844|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
14594845|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157647|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157648|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
15157649|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15157650|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157651|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
15157652|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157653|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
14594846|NCT00032747|Vasopressins|vasopressins|mesh-list
14594847|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
14594848|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
14594849|NCT00032747|Coagulants|coagulants|mesh-ancestor
14594850|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14594851|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14594852|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
14594853|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594854|NCT00032773|Pentostatin|pentostatin|mesh-list
14594855|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157654|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14594856|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14594857|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594858|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594859|NCT00032786|Natalizumab|natalizumab|mesh-list
14594860|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
14594861|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594862|NCT00032799|Natalizumab|natalizumab|mesh-list
14594863|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
14594864|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594865|NCT00032812|Raclopride|raclopride|mesh-list
14594866|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14594867|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14594868|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594869|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594870|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14594871|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14594872|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
14594873|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594874|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594875|NCT00032825|Ketoconazole|ketoconazole|mesh-list
14594876|NCT00032825|Docetaxel|docetaxel|mesh-list
14594877|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594878|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14594879|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14594880|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14594881|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594882|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
14594883|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14594884|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14594885|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14594886|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594887|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14594888|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
14594889|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14594890|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594891|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14594892|NCT00032838|Yohimbine|yohimbine|mesh-list
14594893|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
14594894|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
14594895|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594896|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594897|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14594898|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14594899|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14594900|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
14594901|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594902|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594903|NCT00032838|Urological Agents|urological agents|mesh-ancestor
14594904|NCT00032890|Celecoxib|celecoxib|mesh-list
14594905|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14594906|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15157655|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15157656|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157657|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
15157658|NCT04149171|Coagulants|coagulants|mesh-ancestor
15157659|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
15157660|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15157661|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
15157662|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157663|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157664|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15157665|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
15157666|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15157667|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
15157668|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157669|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157670|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15157671|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
15157672|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
15157673|NCT04149132|Protective Agents|protective agents|mesh-ancestor
15157674|NCT04148898|Bevacizumab|bevacizumab|mesh-list
15157675|NCT04148898|Osimertinib|osimertinib|mesh-list
15157676|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15157677|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14594907|NCT00032890|Analgesics|analgesics|mesh-ancestor
14594908|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
14594909|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594910|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594911|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14594912|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14594913|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14594914|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14594915|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594916|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594917|NCT00032929|Selegiline|selegiline|mesh-list
14594918|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
14594919|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14594920|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14594921|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14594922|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14594923|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594924|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594925|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14594926|NCT00032929|Protective Agents|protective agents|mesh-ancestor
14594927|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594928|NCT00032942|Lofexidine|lofexidine|mesh-list
14594929|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14594930|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14594931|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594932|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
14594933|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594934|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14594935|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14594936|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14594937|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
14594938|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594939|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594940|NCT00032955|Buprenorphine|buprenorphine|mesh-list
15157678|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15157679|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15157680|NCT04148898|Growth Substances|growth substances|mesh-ancestor
15157681|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157682|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
14594941|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14594942|NCT00032955|Naloxone|naloxone|mesh-list
14594943|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14594944|NCT00032955|Narcotics|narcotics|mesh-ancestor
14594945|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594946|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594947|NCT00032955|Analgesics|analgesics|mesh-ancestor
14594948|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
14594949|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594950|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14594951|NCT00032968|Buprenorphine|buprenorphine|mesh-list
14594952|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14594953|NCT00032968|Naloxone|naloxone|mesh-list
14594954|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14594955|NCT00032968|Narcotics|narcotics|mesh-ancestor
14594956|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594957|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594958|NCT00032968|Analgesics|analgesics|mesh-ancestor
14594959|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
14594960|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14594961|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14594962|NCT00033033|Reserpine|reserpine|mesh-list
14594963|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14594964|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14594965|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14594966|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14594967|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594968|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14594969|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14594970|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14594971|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14594972|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594973|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
14594974|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14594975|NCT00033046|Modafinil|modafinil|mesh-list
14594976|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14594977|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594978|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14594979|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14594980|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14594981|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594982|NCT00033059|Tolcapone|tolcapone|mesh-list
14594983|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14594984|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14594985|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14594986|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594987|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594988|NCT00033072|Selegiline|selegiline|mesh-list
14594989|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
14594990|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14594991|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14594992|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14594993|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14594994|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14594995|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14594996|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14594997|NCT00033072|Protective Agents|protective agents|mesh-ancestor
14594998|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14594999|NCT00033085|Ondansetron|ondansetron|mesh-list
14595000|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
14595001|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
14595002|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595003|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595004|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595005|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
14595006|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
14595007|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595008|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
14595009|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595010|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595011|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595012|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595013|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595014|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595015|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14595016|NCT00033098|Metyrapone|metyrapone|mesh-list
14595017|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
14595018|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595019|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595020|NCT00033111|Cabergoline|cabergoline|mesh-list
14595021|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14595022|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14595023|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
14595024|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
14595025|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595026|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595027|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595028|NCT00033163|Tenofovir|tenofovir|mesh-list
14595029|NCT00033163|Adefovir|adefovir|mesh-list
14595030|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14595031|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
14595032|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595033|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14595034|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595035|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157683|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15157684|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157685|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157686|NCT04148885|Paclitaxel|paclitaxel|mesh-list
15157687|NCT04148885|Carboplatin|carboplatin|mesh-list
15157688|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15157689|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595036|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595037|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14595038|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14595039|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
14595040|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
14595041|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595042|NCT00033176|Protective Agents|protective agents|mesh-ancestor
14814028|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14595043|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595044|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
14595045|NCT00033176|Vitamins|vitamins|mesh-ancestor
14595046|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
14595047|NCT00033189|Ubiquinone|ubiquinone|mesh-list
14595048|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
14595049|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
14595050|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595051|NCT00033189|Vitamins|vitamins|mesh-ancestor
14595052|NCT00033215|S 3304|s 3304|mesh-list
14595053|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
14595054|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
14595055|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595056|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595057|NCT00033241|Gemcitabine|gemcitabine|mesh-list
14595058|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14595059|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595060|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
14595061|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595062|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595063|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
14595064|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595065|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595066|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595067|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
14595068|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595069|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14595070|NCT00033254|Thalidomide|thalidomide|mesh-list
14595071|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595072|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
15157690|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
15157691|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
15157692|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157693|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595073|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595074|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
14595075|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14595076|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595077|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14595078|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14595079|NCT00033254|Growth Substances|growth substances|mesh-ancestor
14595080|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
14595081|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595082|NCT00033267|Sirolimus|sirolimus|mesh-list
14595083|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14595084|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595085|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14595086|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595087|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
14595088|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595089|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
14595090|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595091|NCT00033280|Temozolomide|temozolomide|mesh-list
14595092|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14595093|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
14595094|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595095|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595096|NCT00033306|Irinotecan|irinotecan|mesh-list
14595097|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14595098|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14595099|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595100|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595101|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644833|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14644834|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14644835|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644836|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
14644837|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14644838|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14644839|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14644840|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14644841|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14644842|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15157694|NCT04148820|Aspirin|aspirin|mesh-list
15157695|NCT04148820|Perindopril|perindopril|mesh-list
15157696|NCT04148820|Atorvastatin|atorvastatin|mesh-list
15157697|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15157698|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14595102|NCT00033319|Aspirin|aspirin|mesh-list
14595103|NCT00033319|Folic Acid|folic acid|mesh-list
14595104|NCT00033319|Hematinics|hematinics|mesh-ancestor
14595105|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
14595106|NCT00033319|Vitamins|vitamins|mesh-ancestor
14595107|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
14595108|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595109|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14595110|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14595111|NCT00033319|Analgesics|analgesics|mesh-ancestor
14595112|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
14595113|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595114|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14595115|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14595116|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14595117|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14595118|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595119|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14595120|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14595121|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595122|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
14595123|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
14595124|NCT00033332|Pamidronate|pamidronate|mesh-list
14595125|NCT00033332|Thalidomide|thalidomide|mesh-list
14595126|NCT00033332|Dexamethasone|dexamethasone|mesh-list
14595127|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14595128|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
14595129|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
14595130|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595131|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595132|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595133|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
14595134|NCT00033332|Hormones|hormones|mesh-ancestor
14595135|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595136|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595137|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595138|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595139|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
14595140|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
14595141|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14595142|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595143|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15157699|NCT04148820|Analgesics|analgesics|mesh-ancestor
15157700|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
15157701|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157702|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157703|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14595144|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14595145|NCT00033332|Growth Substances|growth substances|mesh-ancestor
14595146|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14595147|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14595148|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
14595149|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14595150|NCT00033345|Protective Agents|protective agents|mesh-ancestor
14595151|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595152|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595153|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14595154|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14595155|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
14595156|NCT00033358|Norgestrel|norgestrel|mesh-list
14595157|NCT00033358|Estradiol|estradiol|mesh-list
14595158|NCT00033358|Estrogens|estrogens|mesh-ancestor
14595159|NCT00033358|Hormones|hormones|mesh-ancestor
14595160|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595161|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595162|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14595163|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
14595164|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14595165|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14595166|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14595167|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14595168|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14595169|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14595170|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595171|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595172|NCT00033410|Paclitaxel|paclitaxel|mesh-list
14595173|NCT00033410|Carboplatin|carboplatin|mesh-list
14595174|NCT00033410|Tirapazamine|tirapazamine|mesh-list
14595175|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595176|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595177|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595178|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595179|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595180|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595181|NCT00033423|Rituximab|rituximab|mesh-list
14595182|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14595183|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595184|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
14595185|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595186|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14595187|NCT00033436|Niacinamide|niacinamide|mesh-list
14595188|NCT00033436|Niacin|niacin|mesh-list
14595189|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
14595190|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
14595191|NCT00033436|Vitamins|vitamins|mesh-ancestor
14595192|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
14595193|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595194|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14595195|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
14595196|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595197|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14595198|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
14595199|NCT00033449|Gefitinib|gefitinib|mesh-list
14595200|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595201|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14595202|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595203|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595204|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14595205|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595206|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14595207|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595208|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595209|NCT00033553|Gemcitabine|gemcitabine|mesh-list
14595210|NCT00033553|Paclitaxel|paclitaxel|mesh-list
14595211|NCT00033553|Carboplatin|carboplatin|mesh-list
14595212|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595213|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595214|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595215|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595216|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595217|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595218|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595219|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
14595220|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
14595221|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595222|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595223|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595224|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
14595225|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595226|NCT00033566|S 3304|s 3304|mesh-list
14595227|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
15157704|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15157705|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15157706|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15157707|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157708|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15157709|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15157710|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595228|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
14595229|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595230|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595231|NCT00033592|Bupropion|bupropion|mesh-list
14595232|NCT00033592|Nicotine|nicotine|mesh-list
14595233|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14291766|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14595234|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
14595235|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595236|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595237|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14595238|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14595239|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
14595240|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595241|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595242|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14595243|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
14595244|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15157711|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
15157712|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15157713|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15157714|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
15157715|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14595245|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14595246|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14595247|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14595248|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
14595249|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14595250|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595251|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595252|NCT00033605|Octreotide|octreotide|mesh-list
14595253|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595254|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595255|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595256|NCT00033618|Epothilones|epothilones|mesh-list
14595257|NCT00033618|Epothilone B|epothilone b|mesh-list
14595258|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595259|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595260|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595261|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595262|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595263|NCT00033644|Doxorubicin|doxorubicin|mesh-list
14595264|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14595265|NCT00033644|Mitomycins|mitomycins|mesh-list
15157716|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15157717|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15157718|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
15157719|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15157720|NCT04148833|Paclitaxel|paclitaxel|mesh-list
14595266|NCT00033644|Mitomycin|mitomycin|mesh-list
14595267|NCT00033644|Dacarbazine|dacarbazine|mesh-list
14595268|NCT00033644|Sargramostim|sargramostim|mesh-list
14595269|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595270|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14595271|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14595272|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14595273|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595274|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595275|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
14291767|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14291768|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
14291769|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14595276|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595277|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
14595278|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595279|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14595280|NCT00033683|Tamoxifen|tamoxifen|mesh-list
14595281|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
14595282|NCT00033683|Docetaxel|docetaxel|mesh-list
14595283|NCT00033683|Fluorouracil|fluorouracil|mesh-list
14595284|NCT00033683|Methotrexate|methotrexate|mesh-list
14595285|NCT00033683|Epirubicin|epirubicin|mesh-list
14595286|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595287|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
14595288|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595289|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14595290|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14595291|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
14595292|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595293|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595294|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14595295|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595296|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595297|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157721|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595298|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
15157722|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595299|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595300|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14595301|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
14595302|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14595303|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
14595304|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595305|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14595306|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595307|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14595308|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14595309|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14595310|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14595311|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
14595312|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595313|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595314|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14595315|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14595316|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14595317|NCT00033696|Paclitaxel|paclitaxel|mesh-list
14595318|NCT00033696|Etoposide|etoposide|mesh-list
14595319|NCT00033696|Carboplatin|carboplatin|mesh-list
14595320|NCT00033696|Topotecan|topotecan|mesh-list
14595321|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595322|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595323|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595324|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595325|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595326|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021809|NCT02771509|Mitogens|mitogens|mesh-list
14021810|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
14021811|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021812|NCT02771379|Idebenone|idebenone|mesh-list
14021813|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
14021814|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595327|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14595328|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14595329|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021815|NCT02771379|Protective Agents|protective agents|mesh-ancestor
14021816|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021817|NCT02771587|Ethanol|ethanol|mesh-list
14021818|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14021819|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021820|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021821|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595330|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14595331|NCT00033709|Thalidomide|thalidomide|mesh-list
14595332|NCT00033709|Temozolomide|temozolomide|mesh-list
14595333|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14595334|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
14595335|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595336|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595337|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595338|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
14595339|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595340|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
14595341|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14595342|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595343|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14595344|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14595345|NCT00033709|Growth Substances|growth substances|mesh-ancestor
14021822|NCT02771704|Iodine|iodine|mesh-list
14021823|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
14021824|NCT02771704|Fluorides|fluorides|mesh-list
14021825|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
14021826|NCT02771704|Protective Agents|protective agents|mesh-ancestor
14595346|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
14595347|NCT00033722|Folic Acid|folic acid|mesh-list
14595348|NCT00033722|Lometrexol|lometrexol|mesh-list
14595349|NCT00033722|Hematinics|hematinics|mesh-ancestor
14595350|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
14595351|NCT00033722|Vitamins|vitamins|mesh-ancestor
14595352|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
14595353|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814029|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
14021827|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021828|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14595354|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595355|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
14595356|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595357|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595358|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15157723|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
15157724|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595359|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595360|NCT00033735|Fluorouracil|fluorouracil|mesh-list
14595361|NCT00033735|Irofulven|irofulven|mesh-list
14595362|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
14595363|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595364|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595365|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595366|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157725|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157726|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157727|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
15157728|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14595367|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
14595368|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595369|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14595370|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
14595371|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14595372|NCT00033748|Antibodies|antibodies|mesh-list
14595373|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
14595374|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14595375|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
14595376|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595377|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595378|NCT00033813|Oxatomide|oxatomide|mesh-list
14595379|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14595380|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
14595381|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
14595382|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595383|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595384|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595385|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14595386|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15157729|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15157730|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157731|NCT04148599|Lidocaine|lidocaine|mesh-list
15157732|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
15157733|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
14291770|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14291771|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15157734|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
15157735|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157736|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157737|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
15157738|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157739|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15157740|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15157741|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15157742|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15157743|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157744|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15157745|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15157746|NCT04148599|Analgesics|analgesics|mesh-ancestor
15157747|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15157748|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15157749|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15157750|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
15157751|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157752|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15157753|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15157754|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157755|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157756|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15157757|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15157758|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157759|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
14595387|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
14595388|NCT00033891|Infliximab|infliximab|mesh-list
14595389|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
14595390|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595391|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14595392|NCT00033982|Posaconazole|posaconazole|mesh-list
14595393|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
14595394|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595395|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14595396|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14595397|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14595398|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14595399|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595400|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595401|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595402|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14595403|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
14595404|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595405|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595406|NCT00034047|Nafarelin|nafarelin|mesh-list
14595407|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14595408|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
14595409|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14595410|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595411|NCT00034060|Etanercept|etanercept|mesh-list
14595412|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14595413|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14595414|NCT00034060|Analgesics|analgesics|mesh-ancestor
14595415|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
14595416|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595417|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595418|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14595419|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14595420|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595421|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595422|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
14595423|NCT00034086|Ritonavir|ritonavir|mesh-list
14595424|NCT00034086|Lopinavir|lopinavir|mesh-list
14595425|NCT00034086|Tenofovir|tenofovir|mesh-list
14595426|NCT00034086|Lamivudine|lamivudine|mesh-list
14595427|NCT00034086|Zidovudine|zidovudine|mesh-list
14595428|NCT00034086|Stavudine|stavudine|mesh-list
14595429|NCT00034086|Didanosine|didanosine|mesh-list
14595430|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14595431|NCT00034086|Vaccines|vaccines|mesh-list
14595432|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14595433|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
14595434|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595435|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14595436|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14595437|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
14595438|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595439|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595440|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14595441|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14595442|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
14595443|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595444|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14595445|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595446|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14595447|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595448|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
14595449|NCT00034125|Tamoxifen|tamoxifen|mesh-list
14595450|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15157760|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180505|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595451|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
14595452|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595453|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595454|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595455|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595456|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14595457|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15180506|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595458|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14595459|NCT00034138|Oregovomab|oregovomab|mesh-list
14595460|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14595461|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595462|NCT00034151|Paclitaxel|paclitaxel|mesh-list
14595463|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595464|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595465|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595466|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595467|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595468|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595469|NCT00034164|Paclitaxel|paclitaxel|mesh-list
14595470|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595471|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595472|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595473|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595474|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595475|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595476|NCT00034177|Paclitaxel|paclitaxel|mesh-list
14595477|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14595478|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595479|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595480|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595481|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595482|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595483|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595484|NCT00034190|Paclitaxel|paclitaxel|mesh-list
14595485|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595486|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595487|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595488|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595489|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595490|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595491|NCT00034229|Felbamate|felbamate|mesh-list
14595492|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
14595493|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14595494|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14595495|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595496|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595497|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595498|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
14595499|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14595500|NCT00034242|Antibodies|antibodies|mesh-list
14595501|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
14595502|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14595503|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
14595504|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595505|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
14595506|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14595507|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595508|NCT00034346|Paclitaxel|paclitaxel|mesh-list
14595509|NCT00034346|Carboplatin|carboplatin|mesh-list
14595510|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595511|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595512|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595513|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595514|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595515|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595516|NCT00034359|Lamivudine|lamivudine|mesh-list
14595517|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14595518|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595519|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595520|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595521|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
14595522|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595523|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14595524|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14595525|NCT00034372|Oregovomab|oregovomab|mesh-list
15157761|NCT04148846|Dexamethasone|dexamethasone|mesh-list
15157762|NCT04148846|Ketoprofen|ketoprofen|mesh-list
15157763|NCT04148846|Theophylline|theophylline|mesh-list
15157764|NCT04148846|Gabapentin|gabapentin|mesh-list
15157765|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157766|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
15157767|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
15157768|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157769|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595526|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14595527|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595528|NCT00034385|Valganciclovir|valganciclovir|mesh-list
14595529|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
14595530|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595531|NCT00034463|Folic Acid|folic acid|mesh-list
14595532|NCT00034463|Vitamins|vitamins|mesh-ancestor
14595533|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
14595534|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595535|NCT00034463|Hematinics|hematinics|mesh-ancestor
14595536|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
14595537|NCT00034489|Gemcitabine|gemcitabine|mesh-list
14595538|NCT00034489|Pemetrexed|pemetrexed|mesh-list
14595539|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595540|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
15157770|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157771|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
15157772|NCT04148846|Hormones|hormones|mesh-ancestor
15157773|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157774|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595541|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595542|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595543|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
14595544|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595545|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595546|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595547|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
15157775|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157776|NCT04148846|Analgesics|analgesics|mesh-ancestor
15157777|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
15157778|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
15157779|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15157780|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15157781|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595548|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595549|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14595550|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595551|NCT00034502|Irinotecan|irinotecan|mesh-list
14595552|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14595553|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14595554|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595555|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595556|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595557|NCT00034528|Prednisone|prednisone|mesh-list
14595558|NCT00034528|Fludarabine|fludarabine|mesh-list
14595559|NCT00034528|Busulfan|busulfan|mesh-list
14595560|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14595561|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
14595562|NCT00034528|Hormones|hormones|mesh-ancestor
14595563|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595564|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595565|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595566|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595567|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595568|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595569|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
14595570|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
14595571|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14595572|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14595573|NCT00034541|Paclitaxel|paclitaxel|mesh-list
14595574|NCT00034541|Carboplatin|carboplatin|mesh-list
14595575|NCT00034541|Cetuximab|cetuximab|mesh-list
14595576|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595577|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595578|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595579|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595580|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595581|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595582|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14595583|NCT00034580|Olanzapine|olanzapine|mesh-list
14595584|NCT00034580|Risperidone|risperidone|mesh-list
14595585|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595586|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
14595587|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595588|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595589|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595590|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595591|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595592|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595593|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595594|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14595595|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
14595596|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
14595597|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
14595598|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595599|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595600|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14595601|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14595602|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14595603|NCT00034593|Gemcitabine|gemcitabine|mesh-list
15157782|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15157783|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15157784|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14595604|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595605|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
14595606|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595607|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595608|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
14595609|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595610|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595611|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595612|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
14595613|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595614|NCT00034606|Gemcitabine|gemcitabine|mesh-list
14595615|NCT00034606|Pemetrexed|pemetrexed|mesh-list
14595616|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595617|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
14595618|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595619|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595620|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
14595621|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595622|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595623|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595624|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
14595625|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595626|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14595627|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595628|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
14595629|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595630|NCT00034632|Posaconazole|posaconazole|mesh-list
14595631|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
14595632|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595633|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14595634|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14595635|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14595636|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14595637|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595638|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595639|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595640|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14595641|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
14595642|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595643|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595644|NCT00034645|Posaconazole|posaconazole|mesh-list
14595645|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
14595646|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595647|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14595648|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14595649|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15157785|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157786|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157787|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
15157788|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15157789|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15157790|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15157791|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14595650|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14595651|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15157792|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157793|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15157794|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15157795|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
15157796|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15157797|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
15157798|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15157799|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15157800|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
15157801|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
15157802|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15157803|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15157804|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15157805|NCT04148261|Epinephrine|epinephrine|mesh-list
15157806|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15157807|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15157808|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
15157809|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157810|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157811|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157812|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15157813|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14595652|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595653|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595654|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14595655|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
14595656|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595657|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595658|NCT00034658|Posaconazole|posaconazole|mesh-list
14595659|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
14595660|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595661|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14595662|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14595663|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14595664|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14595665|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595666|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595667|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595668|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14595669|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
14595670|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14595671|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595672|NCT00034671|Posaconazole|posaconazole|mesh-list
14595673|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
14595674|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595675|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14595676|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14595677|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14595678|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14595679|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595680|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595681|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595682|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14595683|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
14595684|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157814|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
15157815|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157816|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15157817|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
15157818|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
15157819|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
15157820|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15157821|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157822|NCT04148183|Metformin|metformin|mesh-list
15157823|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
15157824|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15157825|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157826|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
15157827|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15157828|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
15157829|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157830|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157831|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14595685|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595686|NCT00034697|Temozolomide|temozolomide|mesh-list
14595687|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14595688|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
14595689|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595690|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595691|NCT00034710|Capsaicin|capsaicin|mesh-list
14595692|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
14595693|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
14595694|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
14595695|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595696|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595697|NCT00034736|Levofloxacin|levofloxacin|mesh-list
14595698|NCT00034736|Ofloxacin|ofloxacin|mesh-list
14595699|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14595700|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595701|NCT00034736|Renal Agents|renal agents|mesh-ancestor
14595702|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14595703|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14595704|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14595705|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595706|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595707|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595708|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14595709|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595710|NCT00034749|Risperidone|risperidone|mesh-list
14595711|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595712|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
14595713|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595714|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595715|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595716|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595717|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595718|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595719|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595720|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14595721|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
14595722|NCT00034762|Risperidone|risperidone|mesh-list
14595723|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595724|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
14595725|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595726|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595727|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157832|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
15157833|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
15157834|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15157835|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
15157836|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157837|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595728|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595729|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595730|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595731|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595732|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14595733|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
14595734|NCT00034775|Risperidone|risperidone|mesh-list
14595735|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595736|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
14595737|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595738|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595739|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595740|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595741|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595742|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595743|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595744|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14595745|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
14595746|NCT00034788|Becaplermin|becaplermin|mesh-list
14595747|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
15157838|NCT04147806|Dexamethasone|dexamethasone|mesh-list
15157839|NCT04147806|Tamsulosin|tamsulosin|mesh-list
15157840|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157841|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
14595748|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
15157842|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
14595749|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14595750|NCT00034788|Growth Substances|growth substances|mesh-ancestor
14595751|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595752|NCT00034801|Olanzapine|olanzapine|mesh-list
14595753|NCT00034801|Ziprasidone|ziprasidone|mesh-list
15157843|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157844|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157845|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15157846|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
15157847|NCT04147806|Hormones|hormones|mesh-ancestor
15157848|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157849|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14595754|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
14595755|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
14595756|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595757|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595758|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595759|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595760|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595761|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595762|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595763|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14595764|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14595765|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14595766|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595767|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595768|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
14595769|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595770|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14595771|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
14595772|NCT00034840|Valsartan|valsartan|mesh-list
14595773|NCT00034840|Telmisartan|telmisartan|mesh-list
14595774|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14595775|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14595776|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14595777|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644843|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14644844|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14644845|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
14644846|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14644847|NCT00192673|Asparaginase|asparaginase|mesh-list
14644848|NCT00192673|Pegaspargase|pegaspargase|mesh-list
14644849|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644850|NCT00192712|Gemcitabine|gemcitabine|mesh-list
14644851|NCT00192712|Irinotecan|irinotecan|mesh-list
14644852|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644853|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
14644854|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644855|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644856|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
14644857|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644858|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644859|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644860|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
14644861|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644862|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14644863|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14644864|NCT00192725|Tryptophan|tryptophan|mesh-list
14644865|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14644866|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
14644867|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14644868|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
14644869|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644870|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
14644871|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644872|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14644873|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14644874|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
14644875|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644876|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644877|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14644878|NCT00192777|Capecitabine|capecitabine|mesh-list
14644879|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15157850|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595778|NCT00034853|Naproxen|naproxen|mesh-list
14595779|NCT00034853|Meloxicam|meloxicam|mesh-list
14595780|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14595781|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14595782|NCT00034853|Analgesics|analgesics|mesh-ancestor
14595783|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
14595784|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595785|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595786|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14595787|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14595788|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
14595789|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14595790|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595791|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595792|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14595793|NCT00034866|Tipranavir|tipranavir|mesh-list
14595794|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14595795|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
14595796|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14595797|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14595798|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
14595799|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595800|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595801|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595802|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14595803|NCT00034879|Gefitinib|gefitinib|mesh-list
14595804|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595805|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14595806|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595807|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595808|NCT00034892|Olanzapine|olanzapine|mesh-list
14595809|NCT00034892|Risperidone|risperidone|mesh-list
14595810|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595811|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
14595812|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595813|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595814|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595815|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595816|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595817|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595818|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595819|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14595820|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
14595821|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
14595822|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
14595823|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595824|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595825|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14595826|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14595827|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14595828|NCT00034905|Risperidone|risperidone|mesh-list
14595829|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14595830|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14595831|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
14595832|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595833|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595834|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595835|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14595836|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14595837|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14595838|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595839|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14595840|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
14595841|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
14595842|NCT00034944|Aprepitant|aprepitant|mesh-list
14595843|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
14595844|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
14595845|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595846|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595847|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595848|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14595849|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595850|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595851|NCT00034983|Aprepitant|aprepitant|mesh-list
14595852|NCT00034983|Paroxetine|paroxetine|mesh-list
14595853|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14595854|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14595855|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14595856|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595857|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595858|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
14595859|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595860|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14595861|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
14595862|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595863|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14595864|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595865|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595866|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
14595867|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
14595868|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595869|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595870|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14595871|NCT00035009|Aprepitant|aprepitant|mesh-list
14595872|NCT00035009|Paroxetine|paroxetine|mesh-list
14595873|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14595874|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14595875|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14595876|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595877|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595878|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
14595879|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595880|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14595881|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
14595882|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14595883|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14595884|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14595885|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595886|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
14595887|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
14595888|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595889|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595890|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14595891|NCT00035035|Gemcitabine|gemcitabine|mesh-list
14595892|NCT00035035|Pemetrexed|pemetrexed|mesh-list
14595893|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595894|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
14595895|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595896|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595897|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
14595898|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14595899|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595900|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595901|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
14595902|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595903|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14595904|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595905|NCT00035048|Aprepitant|aprepitant|mesh-list
14595906|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
14595907|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
14595908|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14595909|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595910|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14595911|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14595912|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595913|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595914|NCT00035061|Pemetrexed|pemetrexed|mesh-list
14595915|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595916|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595917|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595918|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14595919|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595920|NCT00035074|Methotrexate|methotrexate|mesh-list
14595921|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14595922|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
14595923|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15180507|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595924|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595925|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14595926|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
14595927|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595928|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595929|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
14595930|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595931|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14595932|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14595933|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
14595934|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14595935|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14595936|NCT00035087|Epothilones|epothilones|mesh-list
14595937|NCT00035087|Epothilone B|epothilone b|mesh-list
14595938|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595939|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595940|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595941|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595942|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595943|NCT00035100|Epothilones|epothilones|mesh-list
14595944|NCT00035100|Epothilone B|epothilone b|mesh-list
14595945|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595946|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595947|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595948|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595949|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595950|NCT00035113|Epothilones|epothilones|mesh-list
14595951|NCT00035113|Epothilone B|epothilone b|mesh-list
14595952|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595953|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595954|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
15157851|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14595955|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595956|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595957|NCT00035126|Epothilones|epothilones|mesh-list
14595958|NCT00035126|Epothilone B|epothilone b|mesh-list
14595959|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595960|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595961|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595962|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595963|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595964|NCT00035139|Methylphenidate|methylphenidate|mesh-list
14595965|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14595966|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14595967|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15157852|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15157853|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15157854|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
15157855|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15157856|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021829|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021830|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
14021831|NCT02771704|Trace Elements|trace elements|mesh-ancestor
14021832|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
14595968|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14021833|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
14595969|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14595970|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157857|NCT04147806|Urological Agents|urological agents|mesh-ancestor
15157858|NCT04147754|Morphine|morphine|mesh-list
15157859|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157860|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157861|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15157862|NCT04147754|Narcotics|narcotics|mesh-ancestor
15157863|NCT04147754|Analgesics|analgesics|mesh-ancestor
15157864|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
15157865|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157866|NCT04147845|Triamcinolone|triamcinolone|mesh-list
15157867|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15157868|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15157869|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15157870|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157871|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
15157872|NCT04147845|Hormones|hormones|mesh-ancestor
14021834|NCT02771743|Ifosfamide|ifosfamide|mesh-list
15180508|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595971|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
14595972|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14595973|NCT00035152|Paclitaxel|paclitaxel|mesh-list
14595974|NCT00035152|Carboplatin|carboplatin|mesh-list
14595975|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14595976|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595977|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595978|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595979|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595980|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595981|NCT00035165|Epothilones|epothilones|mesh-list
14595982|NCT00035165|Epothilone B|epothilone b|mesh-list
14595983|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
14595984|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
14595985|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
14595986|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595987|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14595988|NCT00035178|Argatroban|argatroban|mesh-list
14595989|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
14595990|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14595991|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
14595992|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595993|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14595994|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
14595995|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14595996|NCT00035191|Galantamine|galantamine|mesh-list
14595997|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14595998|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14595999|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596000|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
14596001|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596002|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596003|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14596004|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
14596005|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596006|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
14596007|NCT00035204|Galantamine|galantamine|mesh-list
14596008|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14596009|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596010|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596011|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
14596012|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596013|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596014|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14596015|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
14596016|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596017|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
14596018|NCT00035230|Topiramate|topiramate|mesh-list
14596019|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
14596020|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14596021|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596022|NCT00035243|Epothilones|epothilones|mesh-list
14596023|NCT00035243|Epothilone B|epothilone b|mesh-list
14596024|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14596025|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14596026|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14596027|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596028|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596029|NCT00035256|Teriparatide|teriparatide|mesh-list
14596030|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14596031|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14596032|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596033|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14596034|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15157873|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157874|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157875|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157876|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
15157877|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157878|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157879|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
15157880|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15157881|NCT04147728|Growth Substances|growth substances|mesh-ancestor
14596035|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
15157882|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157883|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
15157884|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157885|NCT04147286|Atorvastatin|atorvastatin|mesh-list
15157886|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15157887|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14596036|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596037|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14596038|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14596039|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14596040|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596041|NCT00035282|Aprepitant|aprepitant|mesh-list
14596042|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
14596043|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
14596044|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596045|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596046|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596047|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14596048|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596049|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596050|NCT00035295|Aprepitant|aprepitant|mesh-list
14596051|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
14596052|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
14596053|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596054|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596055|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596056|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14596057|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596058|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596059|NCT00035308|Abetimus|abetimus|mesh-list
14596060|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596061|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
14596062|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596063|NCT00035321|Olanzapine|olanzapine|mesh-list
14596064|NCT00035321|Fluoxetine|fluoxetine|mesh-list
14596065|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
14596066|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
14596067|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596068|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596069|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596070|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596071|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596072|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596073|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596074|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14596075|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14596076|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596077|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596078|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596079|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
14596080|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15157888|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
15157889|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157890|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15157891|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15157892|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157893|NCT04147208|Ritonavir|ritonavir|mesh-list
15157894|NCT04147208|Entecavir|entecavir|mesh-list
15157895|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15157896|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14596081|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596082|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14596083|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14596084|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596085|NCT00035347|Azithromycin|azithromycin|mesh-list
14596086|NCT00035347|Levofloxacin|levofloxacin|mesh-list
14596087|NCT00035347|Ofloxacin|ofloxacin|mesh-list
14596088|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
14596089|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596090|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157897|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
15157898|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157899|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157900|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14596091|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14596092|NCT00035347|Renal Agents|renal agents|mesh-ancestor
14596093|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14596094|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14596095|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596096|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596097|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596098|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14596099|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14596100|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14596101|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
14596102|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596103|NCT00035425|Vancomycin|vancomycin|mesh-list
14596104|NCT00035425|Linezolid|linezolid|mesh-list
14596105|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596106|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596107|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14596108|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596109|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596110|NCT00035451|Sotalol|sotalol|mesh-list
14596111|NCT00035451|Azimilide|azimilide|mesh-list
14596112|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14596113|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14596114|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
14596115|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596116|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596117|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596118|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14596119|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
14596120|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
14596121|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596122|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14596123|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596124|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14596125|NCT00035464|Azimilide|azimilide|mesh-list
14596126|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14596127|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14596128|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596129|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596130|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14596131|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596132|NCT00035477|Azimilide|azimilide|mesh-list
14596133|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14596134|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14596135|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596136|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596137|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14596138|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596139|NCT00035490|Azimilide|azimilide|mesh-list
14596140|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14596141|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14596142|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596143|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596144|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14596145|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596146|NCT00035516|Epothilones|epothilones|mesh-list
14596147|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
14596148|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
14596149|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
14596150|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596151|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596152|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14596153|NCT00035581|Poly I-C|poly i-c|mesh-list
14596154|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
14596155|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596156|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
15157901|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15157902|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
15157903|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157904|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15157905|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15157906|NCT04147481|Anesthetics|anesthetics|mesh-list
15157907|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
15157908|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157909|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157910|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
15157911|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157912|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
15157913|NCT04147390|Tacrolimus|tacrolimus|mesh-list
15157914|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15157915|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
15157916|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157917|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14596157|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
14596158|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596159|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
14596160|NCT00035607|Hematinics|hematinics|mesh-ancestor
14596161|NCT00035620|Lenograstim|lenograstim|mesh-list
14596162|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14596163|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
15157918|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157919|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157920|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15157921|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157922|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15157923|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
15157924|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157925|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157926|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
14596164|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596165|NCT00035802|Topiramate|topiramate|mesh-list
14596166|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
14596167|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14596168|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596169|NCT00035854|Linezolid|linezolid|mesh-list
14596170|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596171|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596172|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14596173|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596174|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596175|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14596176|NCT00035893|Poly I-C|poly i-c|mesh-list
14596177|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
14596178|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596179|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
14596180|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
14596181|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596182|NCT00035958|Prednisone|prednisone|mesh-list
14596183|NCT00035958|Etanercept|etanercept|mesh-list
14596184|NCT00035958|Methotrexate|methotrexate|mesh-list
14596185|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14596186|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
14596187|NCT00035958|Hormones|hormones|mesh-ancestor
14596188|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596189|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596190|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14596191|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596192|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14596193|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
14596194|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14596195|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596196|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
14596197|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596198|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596199|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596200|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14596201|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596202|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
14596203|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596204|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596205|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14596206|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14596207|NCT00035958|Analgesics|analgesics|mesh-ancestor
14596208|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
14596209|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596210|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596211|NCT00035971|Alendronate|alendronate|mesh-list
15157927|NCT04147533|Dasatinib|dasatinib|mesh-list
14596212|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14596213|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14596214|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596215|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14596216|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
14596217|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596218|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14596219|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14596220|NCT00035984|Exenatide|exenatide|mesh-list
14596221|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14596222|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596223|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14596224|NCT00035984|Incretins|incretins|mesh-ancestor
14596225|NCT00035984|Hormones|hormones|mesh-ancestor
14596226|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596227|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
14596228|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14596229|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596230|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
14596231|NCT00036023|Hematinics|hematinics|mesh-ancestor
14596232|NCT00036062|Sivelestat|sivelestat|mesh-list
14596233|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14596234|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
14596235|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596236|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596237|NCT00036088|Olanzapine|olanzapine|mesh-list
14596238|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
14596239|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
14596240|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596241|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596242|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596243|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596244|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596245|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596246|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596247|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14596248|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14596249|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596250|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596251|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596252|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
14596253|NCT00036101|Aripiprazole|aripiprazole|mesh-list
14596254|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596255|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596256|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596257|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596258|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596259|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596260|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
14596261|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
14596262|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596263|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596264|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14596265|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14596266|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
14596267|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14596268|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14596269|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14596270|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14596271|NCT00036114|Aripiprazole|aripiprazole|mesh-list
14596272|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596273|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596274|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596275|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596276|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596277|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596278|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
14596279|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
14596280|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596281|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596282|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14596283|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14596284|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
14596285|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14596286|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14596287|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14596288|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14596289|NCT00036127|Aripiprazole|aripiprazole|mesh-list
14596290|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596291|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596292|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596293|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596294|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596295|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596296|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
14596297|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
14596298|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596299|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596300|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14596301|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14596302|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
14596303|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14596304|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14596305|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14596306|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14596307|NCT00036153|Methotrexate|methotrexate|mesh-list
14596308|NCT00036153|Tacrolimus|tacrolimus|mesh-list
14596309|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14596310|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
14596311|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14596312|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596313|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596314|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
14596315|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596316|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596317|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596318|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596319|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14596320|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596321|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
14596322|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596323|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596324|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14596325|NCT00036166|Micafungin|micafungin|mesh-list
14596326|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
14596327|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596328|NCT00036179|Micafungin|micafungin|mesh-list
14596329|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
14596330|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596331|NCT00036218|Ropinirole|ropinirole|mesh-list
14596332|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14596333|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14596334|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
14596335|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
14596336|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596337|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596338|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596339|NCT00036231|Secretin|secretin|mesh-list
14596340|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596341|NCT00036231|Hormones|hormones|mesh-ancestor
14596342|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596343|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596344|NCT00036244|Secretin|secretin|mesh-list
14596345|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596346|NCT00036244|Hormones|hormones|mesh-ancestor
14596347|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596348|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596349|NCT00036283|Celecoxib|celecoxib|mesh-list
14596350|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14596351|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14596352|NCT00036283|Analgesics|analgesics|mesh-ancestor
14596353|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
15157928|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157929|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15157930|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157931|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596354|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157932|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
15157933|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15157934|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157935|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15157936|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15157937|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157938|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157939|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157940|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15157941|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15157942|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15157943|NCT04146883|Cephalexin|cephalexin|mesh-list
15157944|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15157945|NCT04147416|Propofol|propofol|mesh-list
15157946|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15157947|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15157948|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157949|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15157950|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
15157951|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
15157952|NCT04146610|Antibodies|antibodies|mesh-list
15157953|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
15157954|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
15157955|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180509|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596355|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596356|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14596357|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596358|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14596359|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14596360|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596361|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596362|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14596363|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14596364|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14596365|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596366|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596367|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596368|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596369|NCT00036309|Analgesics|analgesics|mesh-ancestor
14596370|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
14596371|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596372|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596373|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596374|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
14596375|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14596376|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14596377|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14596378|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14596379|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596380|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596381|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596382|NCT00036335|Analgesics|analgesics|mesh-ancestor
14596383|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
14596384|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596385|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596386|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596387|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
14596388|NCT00036348|Aripiprazole|aripiprazole|mesh-list
14596389|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596390|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596391|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596392|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596393|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596394|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596395|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
14596396|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
14596397|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596398|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596399|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14596400|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14596401|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
14644880|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
14596402|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14596403|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14596404|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14596405|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14644881|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644882|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644883|NCT00192803|Candesartan|candesartan|mesh-list
14644884|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14644885|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14644886|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14644887|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644888|NCT00192842|Gemcitabine|gemcitabine|mesh-list
14644889|NCT00192842|Curcumin|curcumin|mesh-list
14644890|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644891|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
14644892|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644893|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021835|NCT02771743|Carboplatin|carboplatin|mesh-list
14644894|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
14644895|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021836|NCT02771743|Doxorubicin|doxorubicin|mesh-list
14021837|NCT02771743|Etoposide|etoposide|mesh-list
14021838|NCT02771743|Interleukin-2|interleukin-2|mesh-list
14644896|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644897|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644898|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
14644899|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644900|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14644901|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14644902|NCT00192842|Analgesics|analgesics|mesh-ancestor
14644903|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
14644904|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14644905|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14644906|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14644907|NCT00192855|Entacapone|entacapone|mesh-list
14644908|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14644909|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14644910|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14644911|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644912|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644913|NCT00192959|Propofol|propofol|mesh-list
14644914|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14644915|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14644916|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644917|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14644918|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
14644919|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
14647443|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647444|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647445|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647446|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14647447|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14647448|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647449|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14647450|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14647451|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
14647452|NCT00199953|Rabeprazole|rabeprazole|mesh-list
14647453|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14647454|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647455|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14647456|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647457|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647458|NCT00199966|Valproic Acid|valproic acid|mesh-list
14647459|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
14647460|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647461|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647462|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
14647463|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647464|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647465|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
14647466|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14647467|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021839|NCT02771743|Isotretinoin|isotretinoin|mesh-list
14021840|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596406|NCT00036361|Aripiprazole|aripiprazole|mesh-list
14596407|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596408|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596409|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596410|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596411|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596412|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596413|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
15157956|NCT04146220|Prednisolone|prednisolone|mesh-list
15157957|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157958|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
15157959|NCT04146220|Hormones|hormones|mesh-ancestor
15157960|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596414|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
14596415|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596416|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596417|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14596418|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14596419|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
14596420|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14596421|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14596422|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14596423|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14596424|NCT00036374|Infliximab|infliximab|mesh-list
14596425|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596426|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596427|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596428|NCT00036387|Infliximab|infliximab|mesh-list
14596429|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596430|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596431|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596432|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
14596433|NCT00036400|Hematinics|hematinics|mesh-ancestor
15157961|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157962|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15157963|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157964|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
15157965|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15157966|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15157967|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157968|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
15157969|NCT04146376|Coagulants|coagulants|mesh-ancestor
15157970|NCT04146207|Prednisone|prednisone|mesh-list
15157971|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157972|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
15157973|NCT04146207|Hormones|hormones|mesh-ancestor
15157974|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15157975|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157976|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15157977|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15157978|NCT04146493|Heparin|heparin|mesh-list
15157979|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
15157980|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15157981|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15157982|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157983|NCT04146532|Aspirin|aspirin|mesh-list
15157984|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15157985|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15157986|NCT04146532|Analgesics|analgesics|mesh-ancestor
15157987|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
15157988|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15157989|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15157990|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15157991|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15157992|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15157993|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15157994|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15157995|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15157996|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15157997|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15157998|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
15157999|NCT04146155|Liraglutide|liraglutide|mesh-list
15158000|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15158001|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596434|NCT00036439|Infliximab|infliximab|mesh-list
14596435|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596436|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596437|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596438|NCT00036452|Ritonavir|ritonavir|mesh-list
14596439|NCT00036452|Lopinavir|lopinavir|mesh-list
14596440|NCT00036452|Tenofovir|tenofovir|mesh-list
14596441|NCT00036452|Emtricitabine|emtricitabine|mesh-list
14596442|NCT00036452|Stavudine|stavudine|mesh-list
14596443|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14596444|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14596445|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
14596446|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596447|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596448|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14596449|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14596450|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
14596451|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596452|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14596453|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14596454|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14596455|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596456|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
14596457|NCT00036491|Rituximab|rituximab|mesh-list
14596458|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14596459|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596460|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
14596461|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596462|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596463|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
14596464|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14596465|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596466|NCT00036543|Atrasentan|atrasentan|mesh-list
14596467|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596468|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14596469|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14596470|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596471|NCT00036556|Atrasentan|atrasentan|mesh-list
14596472|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596473|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14596474|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14596475|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596476|NCT00036582|Clozapine|clozapine|mesh-list
14596477|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14596478|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
14596479|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596480|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596481|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596482|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14596483|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14596484|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596485|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596486|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
14596487|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
14596488|NCT00036634|Tenofovir|tenofovir|mesh-list
14596489|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
14596490|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596491|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14596492|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596493|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596494|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596495|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14596496|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14596497|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14596498|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596499|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14596500|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596501|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596502|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
14596503|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596504|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14596505|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596506|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596507|NCT00036764|Epothilones|epothilones|mesh-list
14596508|NCT00036764|Epothilone B|epothilone b|mesh-list
14596509|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
14596510|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
14596511|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
14596512|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596513|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596514|NCT00036777|Carboplatin|carboplatin|mesh-list
14596515|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14596516|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596517|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14596518|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596519|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596520|NCT00036790|Doxorubicin|doxorubicin|mesh-list
14596521|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14596522|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
14596523|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14596524|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596525|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14596526|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14596527|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596528|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596529|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14596530|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596531|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
14596532|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596533|NCT00036855|Rituximab|rituximab|mesh-list
14596534|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14596535|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14596536|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596537|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
14596538|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596539|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596540|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
14596541|NCT00036868|Fluorouracil|fluorouracil|mesh-list
14596542|NCT00036868|Methotrexate|methotrexate|mesh-list
14596543|NCT00036868|Trastuzumab|trastuzumab|mesh-list
14596544|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596545|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
14596546|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596547|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596548|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14596549|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
14596550|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596551|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596552|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14596553|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
14596554|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596555|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14596556|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
14596557|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14596558|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596559|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596560|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14596561|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596562|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14596563|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
14596564|NCT00036881|Astringents|astringents|mesh-ancestor
14596565|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596566|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
15158002|NCT04146155|Incretins|incretins|mesh-ancestor
15158003|NCT04146155|Hormones|hormones|mesh-ancestor
15158004|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158005|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
15158006|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
15158007|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
15158008|NCT04146259|Calcium|calcium|mesh-list
15158009|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15158010|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158011|NCT04146259|Antacids|antacids|mesh-ancestor
15158012|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158013|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15158014|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15158015|NCT04146259|Vitamins|vitamins|mesh-ancestor
15158016|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
15158017|NCT04145856|Simethicone|simethicone|mesh-list
15158018|NCT04145856|Alverine|alverine|mesh-list
15158019|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
14596567|NCT00036894|Lenalidomide|lenalidomide|mesh-list
15180510|NCT03939806|Oxytocin|oxytocin|mesh-list
15180511|NCT03939806|Carbetocin|carbetocin|mesh-list
15158020|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158021|NCT04145856|Emollients|emollients|mesh-ancestor
15158022|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
15158023|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
15158024|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
15158025|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158026|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158027|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
15158028|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
15158029|NCT04146038|Azacitidine|azacitidine|mesh-list
15158030|NCT04146038|Decitabine|decitabine|mesh-list
15158031|NCT04146038|Venetoclax|venetoclax|mesh-list
15158032|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15158033|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
15158034|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158035|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158036|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158037|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15158038|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158039|NCT04146038|Analgesics|analgesics|mesh-ancestor
15158040|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
15158041|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158042|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158043|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158044|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158045|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14596568|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
14596569|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596570|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14596571|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14596572|NCT00036894|Growth Substances|growth substances|mesh-ancestor
14596573|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
14596574|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596575|NCT00036946|Aflibercept|aflibercept|mesh-list
14596576|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14596577|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14596578|NCT00036946|Growth Substances|growth substances|mesh-ancestor
14596579|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596580|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
14596581|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596582|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
15158046|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
15158047|NCT04146116|Povidone|povidone|mesh-list
15158048|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
15158049|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
15158050|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15158051|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158052|NCT04145804|Insulin|insulin|mesh-list
15158053|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15158054|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158055|NCT04145583|Voriconazole|voriconazole|mesh-list
15158056|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
15158057|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158058|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15158059|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15158060|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158061|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158062|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15158063|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
15158064|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158065|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158066|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15158067|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15158068|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158069|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15158070|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158071|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158072|NCT04145492|Vitamin D|vitamin d|mesh-list
15158073|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
15158074|NCT04145492|Vitamins|vitamins|mesh-list
15158075|NCT04145492|Vitamin K|vitamin k|mesh-list
15158076|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
15158077|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
14596583|NCT00036985|Doxorubicin|doxorubicin|mesh-list
14596584|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15158078|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596585|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596586|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
14596587|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596588|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596589|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14596590|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
14596591|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596592|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596593|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14596594|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14596595|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14596596|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14596597|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596598|NCT00037011|Antibodies|antibodies|mesh-list
14596599|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14596600|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
14596601|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596602|NCT00037037|Sargramostim|sargramostim|mesh-list
14596603|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
14596604|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596605|NCT00037050|Vancomycin|vancomycin|mesh-list
14596606|NCT00037050|Linezolid|linezolid|mesh-list
14596607|NCT00037050|Oxacillin|oxacillin|mesh-list
14596608|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
14596609|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596610|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596611|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14596612|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596613|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596614|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
14596615|NCT00037063|Vitamin E|vitamin e|mesh-list
15158079|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15158080|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15158081|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15158082|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15158083|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158084|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
15158085|NCT04145492|Coagulants|coagulants|mesh-ancestor
15158086|NCT04145921|Tacrine|tacrine|mesh-list
15158087|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15158088|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158089|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158090|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
14596616|NCT00037063|Riboflavin|riboflavin|mesh-list
14596617|NCT00037063|Thiamine|thiamine|mesh-list
14596618|NCT00037063|Vitamins|vitamins|mesh-ancestor
14596619|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
14596620|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158091|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158092|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158093|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15158094|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
15158095|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158096|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
15158097|NCT04145687|Metformin|metformin|mesh-list
15158098|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15158099|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158100|NCT04145518|Naproxen|naproxen|mesh-list
15158101|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15158102|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158103|NCT04145518|Analgesics|analgesics|mesh-ancestor
15158104|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
15158105|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158106|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158107|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158108|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158109|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
15158110|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15158111|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158112|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158113|NCT04145193|Leucovorin|leucovorin|mesh-list
15158114|NCT04145193|Fluorouracil|fluorouracil|mesh-list
15158115|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
14596621|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
15158116|NCT04145193|Durvalumab|durvalumab|mesh-list
15158117|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14596622|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596623|NCT00037063|Protective Agents|protective agents|mesh-ancestor
14596624|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
14596625|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14596626|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596627|NCT00037089|Tegafur|tegafur|mesh-list
14596628|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596629|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
14596630|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596631|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596632|NCT00037102|Interferons|interferons|mesh-list
14596633|NCT00037102|Interferon-beta|interferon-beta|mesh-list
14596634|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
14596635|NCT00037102|Methotrexate|methotrexate|mesh-list
14596636|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14596637|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
14596638|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14596639|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596640|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596641|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
14596642|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596643|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596644|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596645|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596646|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14596647|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596648|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
14596649|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596650|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596651|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
14596652|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596653|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14596654|NCT00037115|Interferons|interferons|mesh-list
14596655|NCT00037115|Interferon-beta|interferon-beta|mesh-list
14596656|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
15158118|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
14596657|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
14596658|NCT00037115|Methotrexate|methotrexate|mesh-list
14596659|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14596660|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
14596661|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14596662|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596663|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596664|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
14596665|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596666|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596667|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
14596668|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596669|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14596670|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596671|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
14596672|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596673|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596674|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
14596675|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596676|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14596677|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
14596678|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
14596679|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596680|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596681|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
14596682|NCT00037115|Hormones|hormones|mesh-ancestor
14596683|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596684|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14596685|NCT00037115|Protective Agents|protective agents|mesh-ancestor
14596686|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14596687|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
14596688|NCT00037154|Urological Agents|urological agents|mesh-ancestor
14596689|NCT00037180|Leucovorin|leucovorin|mesh-list
14596690|NCT00037180|Celecoxib|celecoxib|mesh-list
14596691|NCT00037180|Fluorouracil|fluorouracil|mesh-list
14596692|NCT00037180|Irinotecan|irinotecan|mesh-list
14596693|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
14596694|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596695|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596696|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596697|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596698|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
14596699|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596700|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14596701|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14596702|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596703|NCT00037180|Antidotes|antidotes|mesh-ancestor
14596704|NCT00037180|Protective Agents|protective agents|mesh-ancestor
14596705|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
14596706|NCT00037180|Vitamins|vitamins|mesh-ancestor
14596707|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
14596708|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14596709|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14596710|NCT00037180|Analgesics|analgesics|mesh-ancestor
14596711|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
14596712|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596713|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14596714|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596715|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14596716|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14596717|NCT00037206|Anidulafungin|anidulafungin|mesh-list
14596718|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
14596719|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596720|NCT00037219|Anidulafungin|anidulafungin|mesh-list
14596721|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
14596722|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596723|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
14596724|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596725|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596726|NCT00037518|Cinacalcet|cinacalcet|mesh-list
14596727|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14596728|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596729|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14596730|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
14596731|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596732|NCT00037531|Sirolimus|sirolimus|mesh-list
14596733|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596734|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596735|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14596736|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596737|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
14596738|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596739|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
14596740|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596741|NCT00037544|Factor VIII|factor viii|mesh-list
15158119|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158120|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15158121|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158122|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15158123|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
15158124|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158125|NCT04145193|Antidotes|antidotes|mesh-ancestor
15158126|NCT04145193|Protective Agents|protective agents|mesh-ancestor
15158127|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
15158128|NCT04145193|Vitamins|vitamins|mesh-ancestor
15158129|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
15158130|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15158131|NCT04145258|Aspirin|aspirin|mesh-list
15158132|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15158133|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158134|NCT04145258|Analgesics|analgesics|mesh-ancestor
15158135|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
15158136|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158137|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158138|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158139|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158140|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15158141|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15158142|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158143|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15158144|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15158145|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158146|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
15158147|NCT04145440|Felzartamab|felzartamab|mesh-list
15158148|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158149|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
14021841|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
14596742|NCT00037544|Coagulants|coagulants|mesh-ancestor
14596743|NCT00037570|Pantoprazole|pantoprazole|mesh-list
14596744|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14596745|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596746|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14596747|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596748|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596749|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
14596750|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14596751|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596752|NCT00037596|Cytarabine|cytarabine|mesh-list
14596753|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
14596754|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596755|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
14596756|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596757|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596758|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
14596759|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596760|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596761|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
14596762|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596763|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14596764|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
14596765|NCT00037609|Capecitabine|capecitabine|mesh-list
14596766|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596767|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
14596768|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596769|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596770|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14596771|NCT00037609|Protective Agents|protective agents|mesh-ancestor
14596772|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596773|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14596774|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596775|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14596776|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14596777|NCT00037609|Analgesics|analgesics|mesh-ancestor
15158150|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158151|NCT04145102|Propolis|propolis|mesh-list
15158152|NCT04145102|Fluorides|fluorides|mesh-list
15158153|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
15158154|NCT04145102|Protective Agents|protective agents|mesh-ancestor
15158155|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158156|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158157|NCT04145336|Indomethacin|indomethacin|mesh-list
15158158|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15158159|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158160|NCT04145336|Analgesics|analgesics|mesh-ancestor
15158161|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
15158162|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158163|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158164|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158165|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158166|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
15158167|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
15158168|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15158169|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15158170|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158171|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158172|NCT04145232|Nivolumab|nivolumab|mesh-list
15158173|NCT04145232|Ipilimumab|ipilimumab|mesh-list
15158174|NCT04145232|Atezolizumab|atezolizumab|mesh-list
15158175|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15158176|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158177|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15158178|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158179|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
15158180|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15158181|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15158182|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
15158183|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158184|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158185|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158186|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
15158187|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
14596778|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
15158188|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596779|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596780|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14596781|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596782|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
14596783|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14596784|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596785|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596786|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596787|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
14596788|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596789|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14596790|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14596791|NCT00037635|Cinacalcet|cinacalcet|mesh-list
14596792|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14596793|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596794|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14596795|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
14596796|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596797|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14596798|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596799|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14596800|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14596801|NCT00037674|Topiramate|topiramate|mesh-list
14596802|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
14596803|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14596804|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596805|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14596806|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596807|NCT00037752|Sibutramine|sibutramine|mesh-list
14596808|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
14596809|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14596810|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
15158189|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
15158190|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15158191|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
15158192|NCT04144712|Caffeine|caffeine|mesh-list
15158193|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
15158194|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158195|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15158196|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158197|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15158198|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158199|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15158200|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15158201|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
15158202|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158203|NCT04144933|Acetaminophen|acetaminophen|mesh-list
15158204|NCT04144933|Dexamethasone|dexamethasone|mesh-list
15158205|NCT04144933|Lidocaine|lidocaine|mesh-list
15158206|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
15158207|NCT04144933|Sufentanil|sufentanil|mesh-list
15158208|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
15158209|NCT04144933|Ketamine|ketamine|mesh-list
15158210|NCT04144933|Gabapentin|gabapentin|mesh-list
15158211|NCT04144933|Dsuvia|dsuvia|mesh-list
15158212|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
15158213|NCT04144933|Ondansetron|ondansetron|mesh-list
15158214|NCT04144933|Sevoflurane|sevoflurane|mesh-list
15158215|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15158216|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158217|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
15158218|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
15158219|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158220|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158221|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15158222|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
15158223|NCT04144933|Hormones|hormones|mesh-ancestor
15158224|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158225|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15158226|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158227|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
15158228|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
14596811|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14644920|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
15158229|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158230|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
15158231|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14596812|NCT00037804|Irinotecan|irinotecan|mesh-list
14596813|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14596814|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14596815|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596816|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596817|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596818|NCT00037817|Celecoxib|celecoxib|mesh-list
14596819|NCT00037817|Decitabine|decitabine|mesh-list
14596820|NCT00037817|Romidepsin|romidepsin|mesh-list
14596821|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14596822|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14596823|NCT00037817|Analgesics|analgesics|mesh-ancestor
14596824|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
14596825|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596826|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596827|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14596828|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596829|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14596830|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14596831|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596832|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596833|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14596834|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
14596835|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596836|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14596837|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14596838|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596839|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596840|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596841|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14596842|NCT00037882|Interferons|interferons|mesh-list
14596843|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
14596844|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
14596845|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14596846|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158232|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15158233|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15158234|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158235|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158236|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15158237|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158238|NCT04144933|Analgesics|analgesics|mesh-ancestor
15158239|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15158240|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15158241|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15158242|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
15158243|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158244|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15158245|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15158246|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
15158247|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15158248|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15158249|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
15158250|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15158251|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15158252|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
15158253|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15158254|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15158255|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15158256|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
15158257|NCT04144933|Narcotics|narcotics|mesh-ancestor
15158258|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
15158259|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
15158260|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15158261|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
15158262|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15158263|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15158264|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15158265|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
15158266|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15158267|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15180512|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
15180513|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15180514|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180515|NCT03939182|Abexinostat|abexinostat|mesh-list
14596847|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
15158268|NCT04144439|Butyric Acid|butyric acid|mesh-list
15158269|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
15158270|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
15158271|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158272|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158273|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158274|NCT04144218|Lacosamide|lacosamide|mesh-list
15158275|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
15158276|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15158277|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15158278|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158279|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158280|NCT04144465|Phenylephrine|phenylephrine|mesh-list
15158281|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
15158282|NCT04144465|Norepinephrine|norepinephrine|mesh-list
15158283|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15158284|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
15158285|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
14596848|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596849|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
14596850|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596851|NCT00037999|Testosterone|testosterone|mesh-list
14596852|NCT00037999|Androgens|androgens|mesh-ancestor
14596853|NCT00037999|Hormones|hormones|mesh-ancestor
14596854|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596855|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596856|NCT00038012|Carboplatin|carboplatin|mesh-list
14596857|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596858|NCT00038025|Pentostatin|pentostatin|mesh-list
14596859|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596860|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14596861|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596862|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596863|NCT00038051|Lintuzumab|lintuzumab|mesh-list
14596864|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14596865|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596866|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
14596867|NCT00038064|Hematinics|hematinics|mesh-ancestor
14596868|NCT00038077|Metoprolol|metoprolol|mesh-list
14596869|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14596870|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14596871|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
14596872|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
14596873|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596874|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596875|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14596876|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14596877|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14596878|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
14596879|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596880|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596881|NCT00038090|Thalidomide|thalidomide|mesh-list
14596882|NCT00038090|Dexamethasone|dexamethasone|mesh-list
14596883|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14596884|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
14596885|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
14596886|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596887|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596888|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14596889|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
14596890|NCT00038090|Hormones|hormones|mesh-ancestor
14596891|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14596892|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14596893|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596894|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596895|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
14596896|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
14596897|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596898|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596899|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14596900|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15158286|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021842|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596901|NCT00038090|Growth Substances|growth substances|mesh-ancestor
14596902|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
14596903|NCT00038116|Dopamine|dopamine|mesh-list
14596904|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14596905|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
14596906|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
14596907|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596908|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596909|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
14596910|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14596911|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596912|NCT00038116|Protective Agents|protective agents|mesh-ancestor
14596913|NCT00038168|Paclitaxel|paclitaxel|mesh-list
14596914|NCT00038168|Estramustine|estramustine|mesh-list
14596915|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14596916|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596917|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
14596918|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
14596919|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
14596920|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596921|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14596922|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
14596923|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14596924|NCT00038181|Thalidomide|thalidomide|mesh-list
14596925|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596926|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
14596927|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596928|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
14596929|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596930|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596931|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14596932|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14596933|NCT00038181|Growth Substances|growth substances|mesh-ancestor
14596934|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
14596935|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596936|NCT00038194|Docetaxel|docetaxel|mesh-list
14596937|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
14596938|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596939|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
14596940|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
14596941|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
14596942|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596943|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14596944|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596945|NCT00038207|Vincristine|vincristine|mesh-list
14596946|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14596947|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596948|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
14596949|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
15158287|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158288|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
15158289|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14021843|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14596950|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
15158290|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
14021844|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14021845|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
14021846|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021847|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021848|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14021849|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14021850|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14021851|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14021852|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021853|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14021854|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021855|NCT02771743|Analgesics|analgesics|mesh-ancestor
14021856|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
14021857|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14596951|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158291|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
15158292|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15158293|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15158294|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15158295|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
14596952|NCT00038220|Ritonavir|ritonavir|mesh-list
14596953|NCT00038220|Lopinavir|lopinavir|mesh-list
14021858|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
14021859|NCT02771418|Anesthetics|anesthetics|mesh-list
14021860|NCT02771418|Propofol|propofol|mesh-list
14596954|NCT00038220|Tenofovir|tenofovir|mesh-list
14596955|NCT00038220|Lamivudine|lamivudine|mesh-list
15158296|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158297|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158298|NCT04144465|Protective Agents|protective agents|mesh-ancestor
15158299|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
15158300|NCT04144153|Anesthetics|anesthetics|mesh-list
15158301|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596956|NCT00038220|Efavirenz|efavirenz|mesh-list
14596957|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14596958|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14596959|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
14596960|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14596961|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596962|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14596963|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14596964|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
14596965|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596966|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14596967|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14596968|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14596969|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14596970|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14596971|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14596972|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14596973|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14596974|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14596975|NCT00038233|Thalidomide|thalidomide|mesh-list
14596976|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596977|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
14596978|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596979|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
15158302|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158303|NCT04144153|Narcotics|narcotics|mesh-ancestor
15158304|NCT04144153|Analgesics|analgesics|mesh-ancestor
15158305|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
15158306|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158307|NCT04144101|Etoricoxib|etoricoxib|mesh-list
14596980|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14596981|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14596982|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14596983|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14596984|NCT00038233|Growth Substances|growth substances|mesh-ancestor
14596985|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
15158308|NCT04144101|Aceclofenac|aceclofenac|mesh-list
15158309|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15158310|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158311|NCT04144101|Analgesics|analgesics|mesh-ancestor
15158312|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
15158313|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158314|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158315|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158316|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158317|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15158318|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15158319|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158320|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158321|NCT04143880|Progesterone|progesterone|mesh-list
15158322|NCT04143880|Progestins|progestins|mesh-ancestor
15158323|NCT04143880|Hormones|hormones|mesh-ancestor
15158324|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158325|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158326|NCT04143906|Gemcitabine|gemcitabine|mesh-list
15158327|NCT04143906|Carboplatin|carboplatin|mesh-list
15158328|NCT04143906|Vinorelbine|vinorelbine|mesh-list
15158329|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158330|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15158331|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
14021861|NCT02771418|Sevoflurane|sevoflurane|mesh-list
14021862|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14596986|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158332|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596987|NCT00038246|Thalidomide|thalidomide|mesh-list
14596988|NCT00038246|Paclitaxel|paclitaxel|mesh-list
14596989|NCT00038246|Estramustine|estramustine|mesh-list
14596990|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14596991|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14596992|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
14596993|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
14596994|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
14596995|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14596996|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14596997|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
14596998|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14596999|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
14597000|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14597001|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597002|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14597003|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14597004|NCT00038246|Growth Substances|growth substances|mesh-ancestor
14597005|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
14597006|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597007|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
14597008|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14597009|NCT00038259|Aldesleukin|aldesleukin|mesh-list
14597010|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597011|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597012|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597013|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
14597014|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597015|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
14597016|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597017|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597018|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14597019|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
14597020|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14597021|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597022|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597023|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597024|NCT00038376|Interferons|interferons|mesh-list
14597025|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
14597026|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
14597027|NCT00038376|Isotretinoin|isotretinoin|mesh-list
14597028|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597029|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
14597030|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597031|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
14597032|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597033|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14597034|NCT00038389|Rofecoxib|rofecoxib|mesh-list
14597035|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14597036|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14597037|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597038|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597039|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14597040|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158333|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
15158334|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158335|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158336|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15158337|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
15158338|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158339|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15158340|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
15158341|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
15158342|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
15158343|NCT04144192|Lidocaine|lidocaine|mesh-list
15158344|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
15158345|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
15158346|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158347|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158348|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
15158349|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158350|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15158351|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14597041|NCT00038389|Analgesics|analgesics|mesh-ancestor
14597042|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
15158352|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14597043|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14597044|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597045|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14597046|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597047|NCT00038402|Paclitaxel|paclitaxel|mesh-list
14597048|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
14597049|NCT00038402|Fluorouracil|fluorouracil|mesh-list
14597050|NCT00038402|Trastuzumab|trastuzumab|mesh-list
14597051|NCT00038402|Epirubicin|epirubicin|mesh-list
14597052|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597053|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597054|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597055|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597056|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
15158353|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158354|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158355|NCT04143802|Dulaglutide|dulaglutide|mesh-list
15158356|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15158357|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158358|NCT04143685|Misoprostol|misoprostol|mesh-list
15158359|NCT04143685|Oxytocin|oxytocin|mesh-list
15158360|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
15158361|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15158362|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158363|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15158364|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
15158365|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15158366|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15158367|NCT04143724|Luspatercept|luspatercept|mesh-list
15158368|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15158369|NCT04143724|Hematinics|hematinics|mesh-ancestor
15158370|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
15158371|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158372|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
14597057|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597058|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15158373|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15158374|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15158375|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15158376|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158377|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158378|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
15158379|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158380|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158381|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15158382|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158383|NCT04143581|Empagliflozin|empagliflozin|mesh-list
15158384|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15158385|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158386|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15158387|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158388|NCT04143607|Gefitinib|gefitinib|mesh-list
15158389|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158390|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15158391|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158392|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597059|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
14597060|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597061|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597062|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597063|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
14597064|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597065|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
14597066|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597067|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597068|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597069|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14597070|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597071|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597072|NCT00038480|Ritonavir|ritonavir|mesh-list
14597073|NCT00038480|Lopinavir|lopinavir|mesh-list
15158393|NCT04143451|Imiquimod|imiquimod|mesh-list
15158394|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15158395|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
14597074|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14597075|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14597076|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
15158396|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158397|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158398|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
15158399|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
15158400|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14597077|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597078|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597079|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597080|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597081|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
14597082|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597083|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14597084|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14597085|NCT00038493|Temozolomide|temozolomide|mesh-list
14597086|NCT00038493|Lonafarnib|lonafarnib|mesh-list
14597087|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597088|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
14597089|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597090|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597091|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597092|NCT00038506|Tenofovir|tenofovir|mesh-list
14597093|NCT00038506|Lamivudine|lamivudine|mesh-list
14597094|NCT00038506|Zidovudine|zidovudine|mesh-list
14597095|NCT00038506|Abacavir|abacavir|mesh-list
14597096|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14597097|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
14597098|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597099|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14597100|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14597101|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597102|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597103|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597104|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597105|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
14597106|NCT00038519|Ritonavir|ritonavir|mesh-list
14597107|NCT00038519|Saquinavir|saquinavir|mesh-list
14597108|NCT00038519|Amprenavir|amprenavir|mesh-list
14597109|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14597110|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14597111|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
14597112|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597113|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158401|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15158402|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15158403|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158404|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158405|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
15158406|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158407|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158408|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15158409|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158410|NCT04143321|Empagliflozin|empagliflozin|mesh-list
15158411|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15158412|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158413|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15158414|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158415|NCT04143165|Lidocaine|lidocaine|mesh-list
15158416|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
15158417|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
15158418|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158419|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158420|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
15158421|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158422|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15158423|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15158424|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15158425|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158426|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158427|NCT04143256|Menthol|menthol|mesh-list
15158428|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
15158429|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
14597114|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15158430|NCT04143412|Ramipril|ramipril|mesh-list
14597115|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597116|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
14597117|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597118|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14021863|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021864|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14021865|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14021866|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
14021867|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14021868|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14021869|NCT02771600|Anesthetics|anesthetics|mesh-list
14021870|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
14597119|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14597120|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14597121|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
14597122|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14597123|NCT00038532|Ritonavir|ritonavir|mesh-list
14597124|NCT00038532|Saquinavir|saquinavir|mesh-list
14597125|NCT00038532|Amprenavir|amprenavir|mesh-list
14597126|NCT00038532|Efavirenz|efavirenz|mesh-list
14597127|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14597128|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14597129|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
14597130|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597131|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597132|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15158431|NCT04143412|Eplerenone|eplerenone|mesh-list
15158432|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15158433|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
15158434|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158435|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158436|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15158437|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15158438|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
15158439|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158440|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158441|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15158442|NCT04143412|Diuretics|diuretics|mesh-ancestor
15158443|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
15158444|NCT04143191|Sorafenib|sorafenib|mesh-list
15158445|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158446|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15158447|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158448|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597133|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597134|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
14597135|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597136|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14597137|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14597138|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14597139|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14597140|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14597141|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14597142|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15180516|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15180517|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180518|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180519|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15180520|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
15180521|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180522|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180523|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180524|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180525|NCT03939273|Metronidazole|metronidazole|mesh-list
15180526|NCT03939273|Vancomycin|vancomycin|mesh-list
15180527|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
15180528|NCT03939273|Fluconazole|fluconazole|mesh-list
15180529|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180530|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15180531|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14597143|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14021871|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14597144|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14597145|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14597146|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
14597147|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14597148|NCT00038545|Paclitaxel|paclitaxel|mesh-list
14597149|NCT00038545|Topotecan|topotecan|mesh-list
14597150|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597151|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158449|NCT04142931|Nivolumab|nivolumab|mesh-list
15158450|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15158451|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158452|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15158453|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158454|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
15158455|NCT04142840|Propofol|propofol|mesh-list
15158456|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15158457|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158458|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158459|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15158460|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
15158461|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
15158462|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158463|NCT04142840|Analgesics|analgesics|mesh-ancestor
15158464|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
15158465|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158466|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15158467|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14597152|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597153|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597154|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597155|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597156|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14597157|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597158|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597159|NCT00038558|Doxorubicin|doxorubicin|mesh-list
14597160|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14597161|NCT00038558|Bleomycin|bleomycin|mesh-list
14597162|NCT00038558|Dacarbazine|dacarbazine|mesh-list
14597163|NCT00038558|Vinblastine|vinblastine|mesh-list
14597164|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597165|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597166|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15158468|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15158469|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
15158470|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158471|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158472|NCT04142762|Itraconazole|itraconazole|mesh-list
15158473|NCT04142762|Rifampin|rifampin|mesh-list
15158474|NCT04142762|Midazolam|midazolam|mesh-list
15158475|NCT04142762|Esomeprazole|esomeprazole|mesh-list
15158476|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
15158477|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15158478|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15158479|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
15158480|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
15158481|NCT04142762|Estradiol|estradiol|mesh-list
15158482|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15158483|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15158484|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158485|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158486|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15158487|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15158488|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15158489|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15158490|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
15158491|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
15158492|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
15158493|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
15158494|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158495|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158496|NCT04142762|Estrogens|estrogens|mesh-ancestor
14597167|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15158497|NCT04142762|Hormones|hormones|mesh-ancestor
15158498|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158499|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15158500|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15180532|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14597168|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597169|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597170|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597171|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
14597172|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597173|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597174|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597175|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597176|NCT00038571|Bortezomib|bortezomib|mesh-list
14597177|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597178|NCT00038584|Lonafarnib|lonafarnib|mesh-list
14597179|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158501|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15158502|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15158503|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15158504|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15158505|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158506|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
15158507|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158508|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15158509|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15158510|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15158511|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
15158512|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15158513|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15158514|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15158515|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
15158516|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15158517|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
15158518|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15158519|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15158520|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15158521|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15158522|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15158523|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15158524|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15158525|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15158526|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15158527|NCT04142749|Oltipraz|oltipraz|mesh-list
15158528|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
15158529|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158530|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
15158531|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15158532|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
15158533|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15158534|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15158535|NCT04142749|Protective Agents|protective agents|mesh-ancestor
15158536|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158537|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158538|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15158539|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15158540|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158541|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158542|NCT04142151|Aspirin|aspirin|mesh-list
15158543|NCT04142151|Clopidogrel|clopidogrel|mesh-list
15158544|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15158545|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158546|NCT04142151|Analgesics|analgesics|mesh-ancestor
15158547|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
15158548|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158549|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158550|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158551|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158552|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15158553|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14597180|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597181|NCT00038597|Lonafarnib|lonafarnib|mesh-list
14597182|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597183|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597184|NCT00038623|Rituximab|rituximab|mesh-list
14597185|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597186|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597187|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
14597188|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597189|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597190|NCT00038636|Ritonavir|ritonavir|mesh-list
14597191|NCT00038636|Lopinavir|lopinavir|mesh-list
14597192|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14597193|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14597194|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
14597195|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597196|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158554|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158555|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15158556|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15158557|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158558|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
15158559|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15158560|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15158561|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15158562|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
15158563|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158564|NCT04141995|Leucovorin|leucovorin|mesh-list
14597197|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597198|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597199|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
14597200|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597201|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14597202|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14597203|NCT00038662|Atrasentan|atrasentan|mesh-list
14597204|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597205|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14597206|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14597207|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597208|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
14597209|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597210|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597211|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14597212|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14597213|NCT00038701|Growth Substances|growth substances|mesh-ancestor
14597214|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597215|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
14597216|NCT00038766|Semapimod|semapimod|mesh-list
14597217|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14597218|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158565|NCT04141995|Fluorouracil|fluorouracil|mesh-list
15158566|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
15158567|NCT04141995|Irinotecan|irinotecan|mesh-list
15158568|NCT04141995|Camptothecin|camptothecin|mesh-list
15158569|NCT04141995|Digoxin|digoxin|mesh-list
15158570|NCT04141995|Calcium|calcium|mesh-list
15158571|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
15158572|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15158573|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158574|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
15158575|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158576|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15158577|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158578|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15158579|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
15158580|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15158581|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15158582|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158583|NCT04141995|Antidotes|antidotes|mesh-ancestor
15158584|NCT04141995|Protective Agents|protective agents|mesh-ancestor
15158585|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
15158586|NCT04141995|Vitamins|vitamins|mesh-ancestor
15158587|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
15158588|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15158589|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15158590|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15158591|NCT04142411|Insulin|insulin|mesh-list
15158592|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15158593|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
15158594|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14597219|NCT00038766|Analgesics|analgesics|mesh-ancestor
15158595|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158596|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15158597|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
15158598|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
15158599|NCT04142411|Protective Agents|protective agents|mesh-ancestor
15158600|NCT04141904|Tofacitinib|tofacitinib|mesh-list
14597220|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
14597221|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14597222|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597223|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14597224|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597225|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597226|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
14597227|NCT00038792|Mitogens|mitogens|mesh-list
14597228|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597229|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597230|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
14644921|NCT00193011|Docetaxel|docetaxel|mesh-list
15158601|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15158602|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158603|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158604|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15158605|NCT04141787|Cefazolin|cefazolin|mesh-list
15158606|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
15158607|NCT04141787|Daptomycin|daptomycin|mesh-list
15158608|NCT04141787|Cloxacillin|cloxacillin|mesh-list
15158609|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158610|NCT04141410|Simendan|simendan|mesh-list
15158611|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15158612|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
15158613|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15158614|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15158615|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158616|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158617|NCT04141410|Protective Agents|protective agents|mesh-ancestor
15158618|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158619|NCT04141501|Psilocybin|psilocybin|mesh-list
15158620|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
15158621|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158622|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15158623|NCT04141553|Diltiazem|diltiazem|mesh-list
15158624|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15158625|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15158626|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158627|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158628|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15158629|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158630|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
15158631|NCT04141319|Ketorolac|ketorolac|mesh-list
15158632|NCT04141319|Epinephrine|epinephrine|mesh-list
15158633|NCT04141319|Ropivacaine|ropivacaine|mesh-list
15158634|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
15158635|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
15158636|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158637|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158638|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
15158639|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158640|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15158641|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15158642|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
15158643|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158644|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158645|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15158646|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15158647|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
15158648|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15158649|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
15158650|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
15158651|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
15158652|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15158653|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15158654|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158655|NCT04141319|Analgesics|analgesics|mesh-ancestor
15158656|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15158657|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021872|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158658|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15158659|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158660|NCT04141163|Metformin|metformin|mesh-list
15158661|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14597231|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597232|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597233|NCT00038831|Vidarabine|vidarabine|mesh-list
14597234|NCT00038831|Fludarabine|fludarabine|mesh-list
14597235|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
14597236|NCT00038831|Melphalan|melphalan|mesh-list
14597237|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
14597238|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14597239|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
14597240|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597241|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597242|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
14597243|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158662|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158663|NCT04140786|Gentamicins|gentamicins|mesh-list
15158664|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15158665|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158666|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15158667|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158668|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158669|NCT04140578|Ertapenem|ertapenem|mesh-list
15158670|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15158671|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158672|NCT04140487|Azacitidine|azacitidine|mesh-list
15158673|NCT04140487|Venetoclax|venetoclax|mesh-list
15158674|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15158675|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
15158676|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158677|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158678|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158679|NCT04140448|Ranibizumab|ranibizumab|mesh-list
15158680|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15158681|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15158682|NCT04140448|Growth Substances|growth substances|mesh-ancestor
15158683|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158684|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
15158685|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158686|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
15158687|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15158688|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15158689|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158690|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
15158691|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
15158692|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180533|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15180534|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15180535|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180536|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180537|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180538|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15180539|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15180540|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
15180541|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15180542|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15180543|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
15180544|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180545|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180546|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15180547|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15180548|NCT03938740|Insulin|insulin|mesh-list
15180549|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15180550|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
15180551|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
15180552|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180553|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180554|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
15180555|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15180556|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
15180557|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180558|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
15180559|NCT03938883|Protective Agents|protective agents|mesh-ancestor
15180560|NCT03938662|Choline|choline|mesh-list
15180561|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
14597244|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597245|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
14597246|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597247|NCT00038831|Antiviral Agents|antiviral agents|mesh-ancestor
14597248|NCT00038831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597249|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597250|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
14597251|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597252|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597253|NCT00038844|Vidarabine|vidarabine|mesh-list
14597254|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
14597255|NCT00038844|Rituximab|rituximab|mesh-list
14597256|NCT00038844|Fludarabine|fludarabine|mesh-list
14597257|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
14597258|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
14597259|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597260|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
14597261|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597262|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597263|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597264|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
14597265|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597266|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597267|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597268|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597269|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597270|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
14597271|NCT00038844|Antiviral Agents|antiviral agents|mesh-ancestor
14597272|NCT00038844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597273|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
14597274|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15158693|NCT04140461|Amphotericin B|amphotericin b|mesh-list
15158694|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15158695|NCT04140461|Flucytosine|flucytosine|mesh-list
15158696|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158697|NCT04140461|Amebicides|amebicides|mesh-ancestor
15158698|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15158699|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15158700|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15158701|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
15158702|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
15158703|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158704|NCT04140591|Propranolol|propranolol|mesh-list
15158705|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15158706|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15158707|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15158708|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
15158709|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158710|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158711|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158712|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15158713|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15158714|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
15158715|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158716|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15158717|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15158718|NCT04140409|Octreotide|octreotide|mesh-list
15158719|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15158720|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15158721|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158722|NCT04140318|Paclitaxel|paclitaxel|mesh-list
15158723|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15158724|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158725|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
15158726|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
15158727|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
15158728|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158729|NCT04140006|Alendronate|alendronate|mesh-list
15158730|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15158731|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158732|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
15158733|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
15158734|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158735|NCT04139928|Cathartics|cathartics|mesh-ancestor
15158736|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14597275|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158737|NCT04139928|Antacids|antacids|mesh-ancestor
15158738|NCT04140292|Vitamin D|vitamin d|mesh-list
15158739|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
14597276|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14597277|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14597278|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14597279|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14597280|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597281|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597282|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597283|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14597284|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
14597285|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14597286|NCT00038922|Oprelvekin|oprelvekin|mesh-list
14597287|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597288|NCT00038935|Factor VIII|factor viii|mesh-list
14597289|NCT00038935|Coagulants|coagulants|mesh-ancestor
14597290|NCT00038961|PENTA|penta|mesh-list
14597291|NCT00038961|Fondaparinux|fondaparinux|mesh-list
14597292|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14597293|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
14597294|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14597295|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
14597296|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597297|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597298|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
14597299|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15158740|NCT04140292|Vitamins|vitamins|mesh-ancestor
15158741|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
14814030|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814031|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814032|NCT00861315|Amikacin|amikacin|mesh-list
14814033|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14597300|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14597301|NCT00038974|Ribavirin|ribavirin|mesh-list
15158742|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158743|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15158744|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15158745|NCT04139915|Dactolisib|dactolisib|mesh-list
14597302|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14597303|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
14597304|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597305|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
14597306|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597307|NCT00039013|Exenatide|exenatide|mesh-list
14597308|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14597309|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597310|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14597311|NCT00039013|Incretins|incretins|mesh-ancestor
14597312|NCT00039013|Hormones|hormones|mesh-ancestor
15158746|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158747|NCT04139941|Antibodies|antibodies|mesh-list
15158748|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
15158749|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
15158750|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158751|NCT04140058|Ondansetron|ondansetron|mesh-list
15158752|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
15158753|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
15158754|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158755|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158756|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15158757|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
15158758|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
15158759|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15158760|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
15158761|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158762|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158763|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15158764|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15158765|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158766|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15158767|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15158768|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
15158769|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15158770|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158771|NCT04140136|Tocotrienols|tocotrienols|mesh-list
15158772|NCT04140136|Vitamin E|vitamin e|mesh-list
14597313|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14597314|NCT00039026|Exenatide|exenatide|mesh-list
14597315|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14597316|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597317|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14597318|NCT00039026|Incretins|incretins|mesh-ancestor
14597319|NCT00039026|Hormones|hormones|mesh-ancestor
14597320|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14597321|NCT00039039|Paclitaxel|paclitaxel|mesh-list
14597322|NCT00039039|Carboplatin|carboplatin|mesh-list
14597323|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597324|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158773|NCT04140136|Tocopherols|tocopherols|mesh-list
15158774|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
15158775|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158776|NCT04140136|Protective Agents|protective agents|mesh-ancestor
15158777|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158778|NCT04140136|Vitamins|vitamins|mesh-ancestor
15158779|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
15158780|NCT04140201|Simvastatin|simvastatin|mesh-list
15158781|NCT04140201|Fenofibrate|fenofibrate|mesh-list
15158782|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15158783|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15158784|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
14597325|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597326|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597327|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597328|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597329|NCT00039052|Interleukin-4|interleukin-4|mesh-list
14597330|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14597331|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
14597332|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597333|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597334|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597335|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14597336|NCT00039091|Ipilimumab|ipilimumab|mesh-list
14597337|NCT00039091|Antibodies|antibodies|mesh-list
14597338|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
14597339|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14597340|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
14597341|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597342|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158785|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158786|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15158787|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15158788|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158789|NCT04139824|Naproxen|naproxen|mesh-list
15158790|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15158791|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15158792|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158793|NCT04139824|Analgesics|analgesics|mesh-ancestor
15158794|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
15158795|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158796|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158797|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158798|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
15158799|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15158800|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158801|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158802|NCT04139668|Naltrexone|naltrexone|mesh-list
15158803|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15158804|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15158805|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158806|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
15158807|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158808|NCT04139525|Heparin|heparin|mesh-list
15158809|NCT04139525|Calcium heparin|calcium heparin|mesh-list
15158810|NCT04139525|Citric Acid|citric acid|mesh-list
15158811|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
15158812|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
15158813|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15158814|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
15158815|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
15158816|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026065|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
14597343|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14644922|NCT00193011|Fluorouracil|fluorouracil|mesh-list
15158817|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15158818|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14597344|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597345|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
14597346|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14597347|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597348|NCT00039117|Cytarabine|cytarabine|mesh-list
15158819|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
15158820|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158821|NCT04139772|Docetaxel|docetaxel|mesh-list
15158822|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
15158823|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158824|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
15158825|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
15158826|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
15158827|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158828|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15158829|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158830|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
15158831|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158832|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158833|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15158834|NCT04139395|Citric Acid|citric acid|mesh-list
15158835|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
15158836|NCT04139395|Gallium citrate|gallium citrate|mesh-list
15158837|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
15158838|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15158839|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
15158840|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
15158841|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158842|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15158843|NCT04139629|Antibodies|antibodies|mesh-list
15158844|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
15158845|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158846|NCT04139681|Menthol|menthol|mesh-list
15158847|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
15158848|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
15158849|NCT04139213|Naltrexone|naltrexone|mesh-list
15158850|NCT04139213|Buprenorphine|buprenorphine|mesh-list
15158851|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15158852|NCT04139213|Naloxone|naloxone|mesh-list
15158853|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15158854|NCT04139213|Narcotics|narcotics|mesh-ancestor
15158855|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158856|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158857|NCT04139213|Analgesics|analgesics|mesh-ancestor
15158858|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
15158859|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158860|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15158861|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15158862|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
15158863|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15158864|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
15158865|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158866|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15158867|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15158868|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
15158869|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158870|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158871|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15158872|NCT04138992|Bevacizumab|bevacizumab|mesh-list
15158873|NCT04138992|Cisplatin|cisplatin|mesh-list
15158874|NCT04138992|Docetaxel|docetaxel|mesh-list
15158875|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15158876|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158877|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15158878|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15158879|NCT04138992|Growth Substances|growth substances|mesh-ancestor
15158880|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158881|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
15158882|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
15158883|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
15158884|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
15158885|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158886|NCT04139070|Bleomycin|bleomycin|mesh-list
15158887|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15158888|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158889|NCT04138901|Ropivacaine|ropivacaine|mesh-list
15158890|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
15158891|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
15158892|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158893|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158894|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
15158895|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158896|NCT04138628|Atezolizumab|atezolizumab|mesh-list
15158897|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180562|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15180563|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
15180564|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180565|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180566|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15180567|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
15182159|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15182160|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182161|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182162|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
15182163|NCT03923556|Neostigmine|neostigmine|mesh-list
15182164|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15182165|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182166|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182167|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
15182168|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182169|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182170|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15182171|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
15182172|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182173|NCT03923829|Zinc|zinc|mesh-list
15182174|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
15182175|NCT03923829|Trace Elements|trace elements|mesh-ancestor
15182176|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
15182177|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182178|NCT03923829|Astringents|astringents|mesh-ancestor
15182179|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
15182180|NCT03923751|Anesthetics|anesthetics|mesh-list
15182181|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182182|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182183|NCT03923114|Exenatide|exenatide|mesh-list
15182184|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15182185|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182186|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15182187|NCT03923114|Incretins|incretins|mesh-ancestor
15182188|NCT03923114|Hormones|hormones|mesh-ancestor
15182189|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182190|NCT03923166|Capecitabine|capecitabine|mesh-list
15182191|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15182192|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
15182193|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182194|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182195|NCT03923361|Propofol|propofol|mesh-list
15182196|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15182197|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182198|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182199|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15182200|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
15182201|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
15182202|NCT03923218|Vitamin D|vitamin d|mesh-list
15182203|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
15182204|NCT03923218|Vitamins|vitamins|mesh-ancestor
15182205|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
15182206|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182207|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182208|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15182209|NCT03923140|Tranilast|tranilast|mesh-list
15182210|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15182211|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182212|NCT03923140|Analgesics|analgesics|mesh-ancestor
15182213|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
15182214|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182215|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182216|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182217|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182218|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15182219|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14597349|NCT00039117|Daunorubicin|daunorubicin|mesh-list
14597350|NCT00039117|Oblimersen|oblimersen|mesh-list
14597351|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597352|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
15158898|NCT04138420|Bevacizumab|bevacizumab|mesh-list
15158899|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15158900|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158901|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15158902|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15158903|NCT04138420|Growth Substances|growth substances|mesh-ancestor
15158904|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158905|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
15158906|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
15158907|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158908|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15158909|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158910|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158911|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15158912|NCT04138888|Olmesartan|olmesartan|mesh-list
15158913|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15158914|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15158915|NCT04138888|Diuretics|diuretics|mesh-ancestor
15158916|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
15158917|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158918|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15158919|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158920|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158921|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15158922|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15158923|NCT04138836|Itraconazole|itraconazole|mesh-list
15158924|NCT04138836|Midazolam|midazolam|mesh-list
15158925|NCT04138836|Esomeprazole|esomeprazole|mesh-list
14021873|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
14021874|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158926|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15158927|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15158928|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158929|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158930|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15158931|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15158932|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15158933|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15158934|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
15158935|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
15158936|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
15158937|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
15158938|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15158939|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158940|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15158941|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15158942|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15158943|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158944|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
15158945|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158946|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15158947|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15158948|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15158949|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
15158950|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15158951|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15158952|NCT04138719|Paclitaxel|paclitaxel|mesh-list
15158953|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15158954|NCT04138719|Carboplatin|carboplatin|mesh-list
15158955|NCT04138719|Epirubicin|epirubicin|mesh-list
15158956|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15158957|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15158958|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
15158959|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
15158960|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
15158961|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158962|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15158963|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14021875|NCT02771405|Ribavirin|ribavirin|mesh-list
14597353|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597354|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597355|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
14597356|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597357|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597358|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
14597359|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597360|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597361|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14597362|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15158964|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15158965|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158966|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
15158967|NCT04138277|Miglustat|miglustat|mesh-list
15158968|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15158969|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158970|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15158971|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15158972|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
15158973|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15158974|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15158975|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15158976|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158977|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
15158978|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15158979|NCT04138472|Lidocaine|lidocaine|mesh-list
15158980|NCT04138472|Fentanyl|fentanyl|mesh-list
15158981|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
15158982|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
15158983|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
15158984|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15158985|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15158986|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
15158987|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15158988|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15158989|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15158990|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15158991|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15158992|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15158993|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15158994|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15158995|NCT04138472|Analgesics|analgesics|mesh-ancestor
15158996|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15158997|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15158998|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15158999|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
15159000|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159001|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15159002|NCT04138472|Narcotics|narcotics|mesh-ancestor
15159003|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15159004|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15159005|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
15159006|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
15159007|NCT04138264|Narcotics|narcotics|mesh-ancestor
15159008|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159009|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159010|NCT04138264|Analgesics|analgesics|mesh-ancestor
15159011|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
15159012|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159013|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
15159014|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
15159015|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159016|NCT04138251|Empagliflozin|empagliflozin|mesh-list
15159017|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15159018|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159019|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15159020|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159021|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
15159022|NCT04137978|Diuretics|diuretics|mesh-ancestor
15159023|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
15159024|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159025|NCT04137978|Expectorants|expectorants|mesh-ancestor
15159026|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
15159027|NCT04138004|Lubiprostone|lubiprostone|mesh-list
15159028|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15159029|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15180568|NCT03938389|Valsartan|valsartan|mesh-list
15159030|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159031|NCT04138238|Sirolimus|sirolimus|mesh-list
15159032|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15159033|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159034|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15159035|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159036|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
15159037|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159038|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
15159039|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159040|NCT04138212|Paclitaxel|paclitaxel|mesh-list
15159041|NCT04138212|Cisplatin|cisplatin|mesh-list
15159042|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15159043|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159044|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
15159045|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
15159046|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
15159047|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159048|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
15159049|NCT04137640|Docetaxel|docetaxel|mesh-list
15159050|NCT04137640|Letrozole|letrozole|mesh-list
15159051|NCT04137640|Epirubicin|epirubicin|mesh-list
15159052|NCT04137640|Palbociclib|palbociclib|mesh-list
15159053|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159054|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
15159055|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159056|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159057|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15159058|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
15159059|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159060|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159061|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15159062|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
15159063|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
15159064|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
15159065|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15159066|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15159067|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159068|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15159069|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
15159070|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159071|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15159072|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15159073|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15159074|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15159075|NCT04137536|Antibodies|antibodies|mesh-list
15159076|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15159077|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
15159078|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159079|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15159080|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
15159081|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159082|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159083|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15159084|NCT04137588|Growth Substances|growth substances|mesh-ancestor
15159085|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159086|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
15159087|NCT04137653|Paclitaxel|paclitaxel|mesh-list
15159088|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15159089|NCT04137653|Carboplatin|carboplatin|mesh-list
15159090|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15159091|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159092|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
15159093|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
15159094|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
15159095|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159096|NCT04137432|Oxytocin|oxytocin|mesh-list
15159097|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
15159098|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15159099|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159100|NCT04137198|Sufentanil|sufentanil|mesh-list
15159101|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15159102|NCT04137198|Narcotics|narcotics|mesh-ancestor
15159103|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159104|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159105|NCT04137198|Analgesics|analgesics|mesh-ancestor
14597363|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597364|NCT00039156|IDN 5109|idn 5109|mesh-list
14597365|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597366|NCT00039169|IDN 5109|idn 5109|mesh-list
14597367|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597368|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14597369|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597370|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597371|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597372|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597373|NCT00039208|Leucovorin|leucovorin|mesh-list
14597374|NCT00039208|Fluorouracil|fluorouracil|mesh-list
14597375|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
14597376|NCT00039208|Irinotecan|irinotecan|mesh-list
14597377|NCT00039208|Calcium|calcium|mesh-list
14597378|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
14597379|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14597380|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597381|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
14597382|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597383|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597384|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597385|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597386|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
14597387|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14597388|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597389|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597390|NCT00039208|Antidotes|antidotes|mesh-ancestor
14597391|NCT00039208|Protective Agents|protective agents|mesh-ancestor
14597392|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
14597393|NCT00039208|Vitamins|vitamins|mesh-ancestor
14597394|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
14597395|NCT00039234|Aldesleukin|aldesleukin|mesh-list
14597396|NCT00039234|Histamine|histamine|mesh-list
14597397|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
14597398|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597399|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597400|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14021876|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
14021877|NCT02771405|Simeprevir|simeprevir|mesh-list
14021878|NCT02771405|Ledipasvir|ledipasvir|mesh-list
14597401|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
14597402|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597403|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
14597404|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
14597405|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597406|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597407|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597408|NCT00039273|Panitumumab|panitumumab|mesh-list
14597409|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597410|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597411|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14597412|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14597413|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597414|NCT00039338|Cisplatin|cisplatin|mesh-list
14597415|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644923|NCT00193011|Methotrexate|methotrexate|mesh-list
15159106|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
14644924|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644925|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
14644926|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644927|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14644928|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14644929|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
14644930|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644931|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644932|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14644933|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644934|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14644935|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644936|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
14644937|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644938|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14021879|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
14644939|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
14644940|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14644941|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
14644942|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597416|NCT00039351|Prednisone|prednisone|mesh-list
14597417|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
14597418|NCT00039351|Vincristine|vincristine|mesh-list
14597419|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597420|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
14597421|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597422|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597423|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597424|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
14597425|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597426|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597427|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597428|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14597429|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
14597430|NCT00039351|Hormones|hormones|mesh-ancestor
14597431|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14597432|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15159107|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159108|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14597433|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597434|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597435|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597436|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597437|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
14597438|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597439|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597440|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597441|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159109|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15159110|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
15159111|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
14026066|NCT02745561|Endostatins|endostatins|mesh-list
14597442|NCT00039390|Capecitabine|capecitabine|mesh-list
14597443|NCT00039390|Gefitinib|gefitinib|mesh-list
14597444|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597445|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
14597446|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597447|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597448|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597449|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597450|NCT00039403|Gemcitabine|gemcitabine|mesh-list
14597451|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14597452|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597453|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
14597454|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597455|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597456|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
14597457|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597458|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597459|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597460|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
14597461|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597462|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597463|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
14597464|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597465|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597466|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597467|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597468|NCT00039429|Atrasentan|atrasentan|mesh-list
14597469|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597470|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14597471|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14597472|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597473|NCT00039442|Capecitabine|capecitabine|mesh-list
14597474|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597475|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
14597476|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597477|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597478|NCT00039455|Trastuzumab|trastuzumab|mesh-list
14597479|NCT00039455|Alvocidib|alvocidib|mesh-list
14597480|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597481|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597482|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
14597483|NCT00039455|Growth Substances|growth substances|mesh-ancestor
15159112|NCT04137185|Hormones|hormones|mesh-list
14597484|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597485|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597486|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597487|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597488|NCT00039468|Thalidomide|thalidomide|mesh-list
14597489|NCT00039468|Irinotecan|irinotecan|mesh-list
14597490|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14597491|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597492|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597493|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597494|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597495|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597496|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
14597497|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597498|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
14597499|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14597500|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597501|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14597502|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14597503|NCT00039468|Growth Substances|growth substances|mesh-ancestor
14597504|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
14597505|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
14597506|NCT00039481|Doxorubicin|doxorubicin|mesh-list
14597507|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14597508|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
14597509|NCT00039481|Razoxane|razoxane|mesh-list
14597510|NCT00039481|Oblimersen|oblimersen|mesh-list
14597511|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597512|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
14597513|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597514|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597515|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597516|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
14597517|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597518|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597519|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597520|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597521|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14597522|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597523|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597524|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14597525|NCT00039481|Protective Agents|protective agents|mesh-ancestor
14597526|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597527|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597528|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14597529|NCT00039494|Temozolomide|temozolomide|mesh-list
14597530|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597531|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597532|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597533|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597534|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597535|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
14597536|NCT00039520|Sulindac|sulindac|mesh-list
14597537|NCT00039520|Docetaxel|docetaxel|mesh-list
14597538|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597539|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597540|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597541|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597542|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597543|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14597544|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14597545|NCT00039520|Analgesics|analgesics|mesh-ancestor
14597546|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
14597547|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14597548|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597549|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14597550|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597551|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14597552|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159113|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159114|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159115|NCT04137328|Liraglutide|liraglutide|mesh-list
15159116|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14597553|NCT00039546|Gemcitabine|gemcitabine|mesh-list
14597554|NCT00039546|Paclitaxel|paclitaxel|mesh-list
15159117|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597555|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
14597556|NCT00039546|Epirubicin|epirubicin|mesh-list
14597557|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597558|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597559|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597560|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597561|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597562|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597563|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597564|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
14597565|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597566|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597567|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597568|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
14597569|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597570|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597571|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
14597572|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
14597573|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597574|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597575|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597576|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14597577|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597578|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
14597579|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597580|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597581|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597582|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597583|NCT00039611|Leucovorin|leucovorin|mesh-list
14597584|NCT00039611|Fluorouracil|fluorouracil|mesh-list
14597585|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
14597586|NCT00039611|Calcium|calcium|mesh-list
14597587|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
14597588|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14597589|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597590|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
14597591|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597592|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597593|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597594|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597595|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
14597596|NCT00039611|Antidotes|antidotes|mesh-ancestor
14597597|NCT00039611|Protective Agents|protective agents|mesh-ancestor
14597598|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
14597599|NCT00039611|Vitamins|vitamins|mesh-ancestor
14597600|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
15159118|NCT04137328|Incretins|incretins|mesh-ancestor
15159119|NCT04137328|Hormones|hormones|mesh-ancestor
14597601|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
14597602|NCT00039663|Pravastatin|pravastatin|mesh-list
14597603|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
14597604|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14597605|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597606|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14597607|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14597608|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
14597609|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597610|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14597611|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14597612|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597613|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14597614|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14597615|NCT00039767|Lepirudin|lepirudin|mesh-list
14597616|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
14597617|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14597618|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
14597619|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597620|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597621|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
14597622|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14597623|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14597624|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
15159120|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14597625|NCT00039780|Protective Agents|protective agents|mesh-ancestor
15159121|NCT04137276|Vitamins|vitamins|mesh-list
14597626|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597627|NCT00039832|Reteplase|reteplase|mesh-list
14597628|NCT00039832|Abciximab|abciximab|mesh-list
15159122|NCT04137276|Ascorbic Acid|ascorbic acid|mesh-list
15159123|NCT04137276|Thiamine|thiamine|mesh-list
15159124|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
15159125|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
15159126|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159127|NCT04137276|Antioxidants|antioxidants|mesh-ancestor
14597629|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
14597630|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14597631|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14597632|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14597633|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597634|NCT00039858|Argatroban|argatroban|mesh-list
14597635|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
14597636|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14597637|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
14597638|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597639|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597640|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
14597641|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14597642|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
14597643|NCT00039884|Hematinics|hematinics|mesh-ancestor
14597644|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14597645|NCT00039962|Thymalfasin|thymalfasin|mesh-list
14597646|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
14597647|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597648|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14597649|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
14597650|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597651|NCT00039975|Ritonavir|ritonavir|mesh-list
14597652|NCT00039975|Indinavir|indinavir|mesh-list
14597653|NCT00039975|Amlodipine|amlodipine|mesh-list
14597654|NCT00039975|Diltiazem|diltiazem|mesh-list
14597655|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14597656|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14597657|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
15159128|NCT04137276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159129|NCT04137276|Protective Agents|protective agents|mesh-ancestor
14597658|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597659|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597660|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597661|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597662|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
14597663|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597664|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14597665|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14597666|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14597667|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14597668|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14597669|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14597670|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597671|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
14597672|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
14597673|NCT00039988|Albuterol|albuterol|mesh-list
14597674|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
14597675|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14597676|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
14597677|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14597678|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597679|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14597680|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
14597681|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
14597682|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15159130|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
15159131|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159132|NCT04137380|Mirikizumab|mirikizumab|mesh-list
15159133|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15159134|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14597683|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14597684|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14597685|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14597686|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
14597687|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159135|NCT04137380|Analgesics|analgesics|mesh-ancestor
15159136|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
14597688|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597689|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14597690|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
14597691|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597692|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597693|NCT00040014|Exemestane|exemestane|mesh-list
14597694|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159137|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159138|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159139|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159140|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159141|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15159142|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15159143|NCT04137029|Bromides|bromides|mesh-list
15159144|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
15159145|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
15159146|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15159147|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
15159148|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159149|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159150|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15159151|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
15159152|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15159153|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15159154|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14597695|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14597696|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14597697|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597698|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597699|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14597700|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
14597701|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14597702|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597703|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14597704|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
14597705|NCT00040027|Thymalfasin|thymalfasin|mesh-list
14597706|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
14597707|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597708|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
14597709|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597710|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14597711|NCT00040040|Bupropion|bupropion|mesh-list
14597712|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14597713|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
15159155|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
15159156|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597714|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14597715|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14597716|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14597717|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159157|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159158|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
14597718|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597719|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
14597720|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597721|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597722|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14597723|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14597724|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597725|NCT00040053|Ondansetron|ondansetron|mesh-list
14597726|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
14597727|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
14597728|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159159|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15159160|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
15159161|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
15159162|NCT04136886|Cisplatin|cisplatin|mesh-list
15159163|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159164|NCT04136613|Copper|copper|mesh-list
15159165|NCT04136613|Trace Elements|trace elements|mesh-ancestor
15159166|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
15159167|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180569|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14597729|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159168|NCT04136743|Dexamethasone|dexamethasone|mesh-list
15159169|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159170|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
15159171|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
15159172|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159173|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159174|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15159175|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
14597730|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14597731|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
14597732|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
14597733|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14597734|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
14597735|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597736|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597737|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14597738|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14597739|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14597740|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14597741|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14597742|NCT00040066|Cocaine|cocaine|mesh-list
14597743|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
14597744|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
14597745|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14597746|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597747|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
14597748|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14597749|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14597750|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14597751|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15159176|NCT04136743|Hormones|hormones|mesh-ancestor
15159177|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159178|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15159179|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159180|NCT04136782|Paclitaxel|paclitaxel|mesh-list
15159181|NCT04136782|Docetaxel|docetaxel|mesh-list
14597752|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159182|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15159183|NCT04136782|Carboplatin|carboplatin|mesh-list
15159184|NCT04136782|Epirubicin|epirubicin|mesh-list
14597753|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597754|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
14597755|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597756|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
14597757|NCT00040105|Tipifarnib|tipifarnib|mesh-list
14597758|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597759|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597760|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597761|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597762|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
14597763|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14597764|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14597765|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597766|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597767|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
14597768|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597769|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597770|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597771|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
14597772|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14597773|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14597774|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597775|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597776|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
14597777|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597778|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597779|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597780|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14597781|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597782|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597783|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644943|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15159185|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15159186|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159187|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
15159188|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
15159189|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
15159190|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597784|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597785|NCT00040209|Levodopa|levodopa|mesh-list
14597786|NCT00040209|Apomorphine|apomorphine|mesh-list
14597787|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14597788|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14597789|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
14597790|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597791|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597792|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597793|NCT00040209|Emetics|emetics|mesh-ancestor
14597794|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
14597795|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14597796|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14597797|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
14597798|NCT00040248|Daclizumab|daclizumab|mesh-list
14597799|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597800|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
14597801|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597802|NCT00040261|Memantine|memantine|mesh-list
14597803|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14597804|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14597805|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
14597806|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14597807|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597808|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597809|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14597810|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14597811|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
14597812|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14597813|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14597814|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597815|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597816|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
14597817|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597818|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14597819|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14597820|NCT00040300|Racivir|racivir|mesh-list
14597821|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
14597822|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597823|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
14597824|NCT00040378|Vitamins|vitamins|mesh-list
14597825|NCT00040378|Vitamin E|vitamin e|mesh-list
14597826|NCT00040378|Tocopherols|tocopherols|mesh-list
14597827|NCT00040378|Tocotrienols|tocotrienols|mesh-list
14597828|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
14597829|NCT00040378|Selenium|selenium|mesh-list
14597830|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
14597831|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597832|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
14597833|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597834|NCT00040378|Protective Agents|protective agents|mesh-ancestor
14597835|NCT00040378|Trace Elements|trace elements|mesh-ancestor
14597836|NCT00040391|Leucovorin|leucovorin|mesh-list
15159191|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15159192|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15159193|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15159194|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597837|NCT00040391|Fluorouracil|fluorouracil|mesh-list
14597838|NCT00040391|Irinotecan|irinotecan|mesh-list
15159195|NCT04136535|Carboplatin|carboplatin|mesh-list
15159196|NCT04136535|Pemetrexed|pemetrexed|mesh-list
15159197|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597839|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
14597840|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597841|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597842|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597843|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597844|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
14597845|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597846|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15159198|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597847|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597848|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597849|NCT00040391|Antidotes|antidotes|mesh-ancestor
14597850|NCT00040391|Protective Agents|protective agents|mesh-ancestor
14597851|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
14597852|NCT00040391|Vitamins|vitamins|mesh-ancestor
14597853|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
14597854|NCT00040417|Fludarabine|fludarabine|mesh-list
14597855|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
14597856|NCT00040417|Sargramostim|sargramostim|mesh-list
14597857|NCT00040417|Lenograstim|lenograstim|mesh-list
14597858|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597859|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
14597860|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597861|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14597862|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597863|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
14597864|NCT00040469|Busulfan|busulfan|mesh-list
14597865|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
14597866|NCT00040469|Phenytoin|phenytoin|mesh-list
14597867|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597868|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
14597869|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597870|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597871|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597872|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
14597873|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597874|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597875|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597876|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597877|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
14597878|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14597879|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14597880|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14597881|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14597882|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14597883|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
14597884|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597885|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
14597886|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597887|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597888|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597889|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
14597890|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597891|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597892|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597893|NCT00040495|Pantoprazole|pantoprazole|mesh-list
14597894|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14597895|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14597896|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14597897|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597898|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597899|NCT00040508|Sirolimus|sirolimus|mesh-list
14597900|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14597901|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597902|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597903|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597904|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
14597905|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597906|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
14597907|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597908|NCT00040521|Oprelvekin|oprelvekin|mesh-list
14597909|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597910|NCT00040586|Interleukin-2|interleukin-2|mesh-list
14597911|NCT00040586|Antibodies|antibodies|mesh-list
14597912|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14597913|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
14597914|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597915|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597916|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14597917|NCT00040586|Analgesics|analgesics|mesh-ancestor
14597918|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
14597919|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14597920|NCT00040599|Labetuzumab|labetuzumab|mesh-list
14597921|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14597922|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597923|NCT00040625|Pemetrexed|pemetrexed|mesh-list
14814034|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597924|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597925|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597926|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597927|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14597928|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14597929|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
14597930|NCT00040651|Fludarabine|fludarabine|mesh-list
14597931|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
14597932|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597933|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
14597934|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597935|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597936|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597937|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
14597938|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597939|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597940|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597941|NCT00040690|Leucovorin|leucovorin|mesh-list
14597942|NCT00040690|Cytarabine|cytarabine|mesh-list
14597943|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
14597944|NCT00040690|Ifosfamide|ifosfamide|mesh-list
14597945|NCT00040690|Doxorubicin|doxorubicin|mesh-list
14597946|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14597947|NCT00040690|Methotrexate|methotrexate|mesh-list
14597948|NCT00040690|Etoposide|etoposide|mesh-list
14597949|NCT00040690|Vincristine|vincristine|mesh-list
14597950|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
14597951|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14597952|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
14597953|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14597954|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14597955|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14597956|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
14597957|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597958|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597959|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14597960|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14597961|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14597962|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14597963|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597964|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14597965|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
14597966|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14597967|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14597968|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
14597969|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
14597970|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14597971|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14597972|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597973|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
14597974|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14597975|NCT00040690|Antidotes|antidotes|mesh-ancestor
14597976|NCT00040690|Protective Agents|protective agents|mesh-ancestor
14597977|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
14597978|NCT00040690|Vitamins|vitamins|mesh-ancestor
14597979|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
14597980|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597981|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597982|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14597983|NCT00040768|Bortezomib|bortezomib|mesh-list
14597984|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597985|NCT00040781|Gefitinib|gefitinib|mesh-list
14597986|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597987|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14597988|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14597989|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597990|NCT00040794|Paclitaxel|paclitaxel|mesh-list
14597991|NCT00040794|Carboplatin|carboplatin|mesh-list
14597992|NCT00040794|Gefitinib|gefitinib|mesh-list
14597993|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14597994|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14597995|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
14597996|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
14597997|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
15159199|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597998|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14597999|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598000|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598001|NCT00040807|Docetaxel|docetaxel|mesh-list
14598002|NCT00040807|Irinotecan|irinotecan|mesh-list
14598003|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598004|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598005|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598006|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598007|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598008|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14598009|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598010|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598011|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
14598012|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598013|NCT00040859|Capecitabine|capecitabine|mesh-list
14598014|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
14598015|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598016|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
14598017|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598018|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598019|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
14598020|NCT00040872|Thiotepa|thiotepa|mesh-list
14598021|NCT00040872|Carboplatin|carboplatin|mesh-list
14598022|NCT00040872|Doxorubicin|doxorubicin|mesh-list
14598023|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14598024|NCT00040872|Etoposide|etoposide|mesh-list
14598025|NCT00040872|Vincristine|vincristine|mesh-list
14598026|NCT00040872|Topotecan|topotecan|mesh-list
14598027|NCT00040872|Isotretinoin|isotretinoin|mesh-list
14598028|NCT00040872|Antibodies|antibodies|mesh-list
14598029|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14598030|NCT00040872|Sargramostim|sargramostim|mesh-list
14598031|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598032|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
14598033|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598034|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598035|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14598036|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
14598037|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598038|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598039|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14598040|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598041|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598042|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598043|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598044|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598045|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598046|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598047|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598048|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14598049|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
14598050|NCT00040885|Docetaxel|docetaxel|mesh-list
14598051|NCT00040885|Infliximab|infliximab|mesh-list
14598052|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598053|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598054|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598055|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598056|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598057|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
14598058|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14598059|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598060|NCT00040950|Rituximab|rituximab|mesh-list
14598061|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14598062|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598063|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
14598064|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598065|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598066|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14598067|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598068|NCT00041015|Etoposide|etoposide|mesh-list
14598069|NCT00041015|Topotecan|topotecan|mesh-list
14598070|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159200|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14598071|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598072|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598073|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598074|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598075|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598076|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14598077|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
14598078|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598079|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598080|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598081|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644944|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14644945|NCT00193024|Docetaxel|docetaxel|mesh-list
14644946|NCT00193024|Epirubicin|epirubicin|mesh-list
14644947|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644948|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644949|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
14644950|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644951|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644952|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14644953|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14644954|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14644955|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644956|NCT00193076|Gemcitabine|gemcitabine|mesh-list
14644957|NCT00193076|Carboplatin|carboplatin|mesh-list
14644958|NCT00193076|Trastuzumab|trastuzumab|mesh-list
14644959|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159201|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15159202|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
15159203|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
15159204|NCT04136639|Fluorides|fluorides|mesh-list
15159205|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
15159206|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
15159207|NCT04136639|Protective Agents|protective agents|mesh-ancestor
15159208|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644960|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644961|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
14644962|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644963|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
14644964|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644965|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14644966|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14644967|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
14021880|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644968|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644969|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14644970|NCT00193089|Docetaxel|docetaxel|mesh-list
14644971|NCT00193089|Trastuzumab|trastuzumab|mesh-list
14644972|NCT00193089|Vinorelbine|vinorelbine|mesh-list
14644973|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644974|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
14644975|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14644976|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14644977|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644978|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14644979|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14644980|NCT00193102|Thalidomide|thalidomide|mesh-list
14644981|NCT00193102|Capecitabine|capecitabine|mesh-list
14644982|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14644983|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
14644984|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14644985|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14644986|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159209|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159210|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15159211|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159212|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
15159213|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159214|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14644987|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
14644988|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14644989|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
14644990|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14644991|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14644992|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14644993|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14644994|NCT00193102|Growth Substances|growth substances|mesh-ancestor
14644995|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14644996|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
14644997|NCT00193115|Docetaxel|docetaxel|mesh-list
14644998|NCT00193115|Doxorubicin|doxorubicin|mesh-list
14644999|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598082|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
14598083|NCT00041054|Carboplatin|carboplatin|mesh-list
14598084|NCT00041054|Etoposide|etoposide|mesh-list
14598085|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598086|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598087|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598088|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598089|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598090|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598091|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14598092|NCT00041054|Protective Agents|protective agents|mesh-ancestor
14598093|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598094|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14598095|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14598096|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14598097|NCT00041054|Analgesics|analgesics|mesh-ancestor
14598098|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
14598099|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598100|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598101|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598102|NCT00041093|Docetaxel|docetaxel|mesh-list
14598103|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598104|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598105|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598106|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598107|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598108|NCT00041106|Gemcitabine|gemcitabine|mesh-list
15159215|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15159216|NCT04136470|Nivolumab|nivolumab|mesh-list
15159217|NCT04136470|Ipilimumab|ipilimumab|mesh-list
14598109|NCT00041106|Gefitinib|gefitinib|mesh-list
14598110|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598111|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598112|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
14598113|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598114|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
14598115|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598116|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598117|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598118|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
14598119|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598120|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598121|NCT00041171|Docetaxel|docetaxel|mesh-list
14598122|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598123|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598124|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598125|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598126|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598127|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
14598128|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598129|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598130|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598131|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598132|NCT00041210|Prednisone|prednisone|mesh-list
14598133|NCT00041210|Doxorubicin|doxorubicin|mesh-list
14598134|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14598135|NCT00041210|Bleomycin|bleomycin|mesh-list
14598136|NCT00041210|Etoposide|etoposide|mesh-list
15159218|NCT04136470|Atezolizumab|atezolizumab|mesh-list
15159219|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15159220|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159221|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15159222|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159223|NCT04136600|Antibodies|antibodies|mesh-list
15159224|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
15159225|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159226|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15159227|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
15159228|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15159229|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159230|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15159231|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159232|NCT04135846|Doxazosin|doxazosin|mesh-list
14598137|NCT00041210|Vincristine|vincristine|mesh-list
14598138|NCT00041210|Dacarbazine|dacarbazine|mesh-list
15159233|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14598139|NCT00041210|Vinblastine|vinblastine|mesh-list
14598140|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
14598141|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598142|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598143|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598144|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598145|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598146|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598147|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598148|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
14598149|NCT00041210|Hormones|hormones|mesh-ancestor
14598150|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14598151|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598152|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14598153|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598154|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598155|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598156|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598157|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14598158|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
14598159|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
14598160|NCT00041223|Procyanidin|procyanidin|mesh-list
14598161|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
14598162|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598163|NCT00041223|Protective Agents|protective agents|mesh-ancestor
14598164|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598165|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14598166|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14598167|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598168|NCT00041236|Exatecan|exatecan|mesh-list
14598169|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14598170|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598171|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598172|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598173|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598174|NCT00041262|Fluorouracil|fluorouracil|mesh-list
14598175|NCT00041262|Epirubicin|epirubicin|mesh-list
14598176|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598177|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
14598178|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598179|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598180|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598181|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
14598182|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598183|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598184|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598185|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598186|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598187|NCT00041275|Megestrol|megestrol|mesh-list
14598188|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
14598189|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14598190|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14598191|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14598192|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
14598193|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14598194|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598195|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14598196|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14598197|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14598198|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598199|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
14598200|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14598201|NCT00041288|Cyclosporine|cyclosporine|mesh-list
14598202|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
14598203|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
14598204|NCT00041288|Methotrexate|methotrexate|mesh-list
14598205|NCT00041288|Fludarabine|fludarabine|mesh-list
14598206|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
14598207|NCT00041288|Tacrolimus|tacrolimus|mesh-list
14598208|NCT00041288|Cyclosporins|cyclosporins|mesh-list
14598209|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598210|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
14598211|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598212|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598213|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14598214|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
14598215|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598216|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598217|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14598218|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14598219|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
14598220|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14598221|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598222|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
14598223|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
14598224|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598225|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14598226|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14598227|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14598228|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
14598229|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598230|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598231|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14598232|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
14598233|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14598234|NCT00041314|Gemcitabine|gemcitabine|mesh-list
14598235|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
14598236|NCT00041314|Carboplatin|carboplatin|mesh-list
14598237|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598238|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598239|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
14598240|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598241|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
14598242|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598243|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598244|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598245|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
14598246|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598247|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14598248|NCT00041314|Protective Agents|protective agents|mesh-ancestor
14598249|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14598250|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14598251|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14598252|NCT00041314|Analgesics|analgesics|mesh-ancestor
14598253|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
14598254|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598255|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598256|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598257|NCT00041327|Interferons|interferons|mesh-list
14598258|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
14598259|NCT00041327|Lamivudine|lamivudine|mesh-list
14598260|NCT00041327|Zidovudine|zidovudine|mesh-list
14598261|NCT00041327|Prednisone|prednisone|mesh-list
14598262|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
14598263|NCT00041327|Doxorubicin|doxorubicin|mesh-list
14598264|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14598265|NCT00041327|Etoposide|etoposide|mesh-list
14598266|NCT00041327|Vincristine|vincristine|mesh-list
14598267|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598268|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
14598269|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598270|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598271|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14598272|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
14598273|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598274|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598275|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14598276|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598277|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598278|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598279|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598280|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159234|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15159235|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15159236|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14598281|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
14598282|NCT00041327|Hormones|hormones|mesh-ancestor
14598283|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14598284|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14598285|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598286|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
14598287|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598288|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598289|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598290|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598291|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14598292|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14598293|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14598294|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14598295|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
14598296|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
14598297|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598298|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598299|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159237|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
15159238|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159239|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159240|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159241|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15159242|NCT04136015|Dasatinib|dasatinib|mesh-list
15159243|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598300|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598301|NCT00041431|Hormones|hormones|mesh-list
14598302|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14598303|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598304|NCT00041483|Anecortave|anecortave|mesh-list
14598305|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14598306|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14598307|NCT00041483|Growth Substances|growth substances|mesh-ancestor
14598308|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598309|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
14598310|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598311|NCT00041535|Miglustat|miglustat|mesh-list
14598312|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598313|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598314|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14598315|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14598316|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
14598317|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598318|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14598319|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14598320|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598321|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
14598322|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14598323|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
14598324|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598325|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598326|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14598327|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
14598328|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14598329|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
14598330|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598331|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598332|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14598333|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
14598334|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
14598335|NCT00041548|Protective Agents|protective agents|mesh-ancestor
14598336|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
14598337|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14598338|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
14598339|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598340|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598341|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14598342|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
14598343|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15159244|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15159245|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159246|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159247|NCT04135898|Bevacizumab|bevacizumab|mesh-list
14598344|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
14598345|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598346|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598347|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14021881|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
14598348|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
14598349|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
14598350|NCT00041561|Protective Agents|protective agents|mesh-ancestor
14598351|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
14598352|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14598353|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
14598354|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598355|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598356|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14598357|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
14598358|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14598359|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
14598360|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598361|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598362|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14598363|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
14598364|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
14598365|NCT00041574|Protective Agents|protective agents|mesh-ancestor
14598366|NCT00041639|Labetuzumab|labetuzumab|mesh-list
14598367|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14598368|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598369|NCT00041652|Labetuzumab|labetuzumab|mesh-list
14598370|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15159248|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15159249|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159250|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14598371|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598372|NCT00041665|Mitogens|mitogens|mesh-list
14598373|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598374|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598375|NCT00041678|Aripiprazole|aripiprazole|mesh-list
14598376|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
14598377|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14598378|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14598379|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14598380|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14598381|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598382|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
14598383|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
14598384|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598385|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598386|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14598387|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14598388|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
14598389|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14598390|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14598391|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14598392|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14598393|NCT00041691|Labetuzumab|labetuzumab|mesh-list
14598394|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14598395|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598396|NCT00041704|Anidulafungin|anidulafungin|mesh-list
14598397|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
14598398|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598399|NCT00041782|Dalteparin|dalteparin|mesh-list
14598400|NCT00041782|Tinzaparin|tinzaparin|mesh-list
14598401|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14598402|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
14598403|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14598404|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14598405|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598406|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
14598407|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15159251|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15159252|NCT04135898|Growth Substances|growth substances|mesh-ancestor
15159253|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159254|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
15159255|NCT04135885|Folic Acid|folic acid|mesh-list
15159256|NCT04135885|Hematinics|hematinics|mesh-ancestor
15159257|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
14598408|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
14598409|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14598410|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598411|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15159258|NCT04135885|Vitamins|vitamins|mesh-ancestor
15159259|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
14598412|NCT00041977|Doxycycline|doxycycline|mesh-list
14598413|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14598414|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598415|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
14598416|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14598417|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14598418|NCT00041990|Decitabine|decitabine|mesh-list
14598419|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598420|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
14598421|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598422|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598423|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598424|NCT00042003|Decitabine|decitabine|mesh-list
14598425|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598426|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
14598427|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598428|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598429|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598430|NCT00042016|Decitabine|decitabine|mesh-list
14598431|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598432|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
14598433|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598434|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598435|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598436|NCT00042029|Aprepitant|aprepitant|mesh-list
14598437|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
14598438|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
14598439|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598440|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598441|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14598442|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14598443|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598444|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598445|NCT00042068|Meloxicam|meloxicam|mesh-list
14598446|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14598447|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14598448|NCT00042068|Analgesics|analgesics|mesh-ancestor
14598449|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
14598450|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598451|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598452|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598453|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598454|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14598455|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14598456|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598457|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598458|NCT00042146|Zolpidem|zolpidem|mesh-list
14598459|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14598460|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14598461|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14598462|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598463|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14598464|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
14598465|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
14598466|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598467|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598468|NCT00042172|Donepezil|donepezil|mesh-list
14598469|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14598470|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598471|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598472|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
14598473|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598474|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598475|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
14598476|NCT00042289|Ritonavir|ritonavir|mesh-list
14598477|NCT00042289|Lopinavir|lopinavir|mesh-list
14598478|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14598479|NCT00042289|Darunavir|darunavir|mesh-list
14598480|NCT00042289|Tenofovir|tenofovir|mesh-list
14598481|NCT00042289|Nevirapine|nevirapine|mesh-list
14598482|NCT00042289|Dolutegravir|dolutegravir|mesh-list
14598483|NCT00042289|Cobicistat|cobicistat|mesh-list
14598484|NCT00042289|Elvitegravir|elvitegravir|mesh-list
14598485|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
14598486|NCT00042289|Efavirenz|efavirenz|mesh-list
14598487|NCT00042289|Levofloxacin|levofloxacin|mesh-list
14598488|NCT00042289|Ofloxacin|ofloxacin|mesh-list
14598489|NCT00042289|Rifampin|rifampin|mesh-list
14598490|NCT00042289|Isoniazid|isoniazid|mesh-list
14598491|NCT00042289|Linezolid|linezolid|mesh-list
14598492|NCT00042289|Cycloserine|cycloserine|mesh-list
14598493|NCT00042289|Amikacin|amikacin|mesh-list
14598494|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
14598495|NCT00042289|Ethambutol|ethambutol|mesh-list
14598496|NCT00042289|Bedaquiline|bedaquiline|mesh-list
14598497|NCT00042289|Etravirine|etravirine|mesh-list
14598498|NCT00042289|Clofazimine|clofazimine|mesh-list
14598499|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14598500|NCT00042289|Kanamycin|kanamycin|mesh-list
14598501|NCT00042289|Ethionamide|ethionamide|mesh-list
14598502|NCT00042289|Prothionamide|prothionamide|mesh-list
14598503|NCT00042289|Capreomycin|capreomycin|mesh-list
14598504|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14598505|NCT00042289|Etonogestrel|etonogestrel|mesh-list
14598506|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-list
14598507|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-list
14598508|NCT00042289|Estradiol|estradiol|mesh-list
14598509|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14598510|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14598511|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
14598512|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598513|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598514|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14598515|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14598516|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
14598517|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598518|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14598519|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14598520|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14598521|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14598522|NCT00042289|Estrogens|estrogens|mesh-ancestor
14598523|NCT00042289|Hormones|hormones|mesh-ancestor
14598524|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14598525|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598526|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14598527|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14598528|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14598529|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14598530|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598531|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598532|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598533|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14598534|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14598535|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14598536|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14598537|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14598538|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14598539|NCT00042289|Renal Agents|renal agents|mesh-ancestor
14598540|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14598541|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14598542|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14598543|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
14598544|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
14598545|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14598546|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14598547|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14598548|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14598549|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14598550|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
14598551|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14598552|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14598553|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14598554|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14598555|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598556|NCT00042302|Paclitaxel|paclitaxel|mesh-list
14598557|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14598558|NCT00042302|Carboplatin|carboplatin|mesh-list
14598559|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598560|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598561|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598562|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598563|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598564|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598565|NCT00042315|Vinorelbine|vinorelbine|mesh-list
14645000|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
14598566|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598567|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598568|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598569|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598570|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598571|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598572|NCT00042328|Valacyclovir|valacyclovir|mesh-list
14598573|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
14598574|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598575|NCT00042341|Clofarabine|clofarabine|mesh-list
14598576|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598577|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
14598578|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598579|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598580|NCT00042354|Clofarabine|clofarabine|mesh-list
14598581|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598582|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
14598583|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598584|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598585|NCT00042367|Mafosfamide|mafosfamide|mesh-list
14598586|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
14598587|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14598588|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
14598589|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598590|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598591|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598592|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598593|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14598594|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
14598595|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598596|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14598597|NCT00042393|Adefovir|adefovir|mesh-list
14598598|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14598599|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
14598600|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598601|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14598602|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14598603|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598604|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598605|NCT00042406|Zanolimumab|zanolimumab|mesh-list
14598606|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14598607|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598608|NCT00042458|Pramlintide|pramlintide|mesh-list
14598609|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14598610|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598611|NCT00042471|Pramlintide|pramlintide|mesh-list
14598612|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14598613|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14598614|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598615|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
14598616|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14598617|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14598618|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598619|NCT00042536|Naltrexone|naltrexone|mesh-list
14598620|NCT00042536|Yohimbine|yohimbine|mesh-list
14598621|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14598622|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14598623|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598624|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
14598625|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598626|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
14598627|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
14598628|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14598629|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14598630|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14598631|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
14598632|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598633|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598634|NCT00042536|Urological Agents|urological agents|mesh-ancestor
14598635|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14598636|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14598637|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14598638|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14598639|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14598640|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14598641|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14598642|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598643|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598644|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598645|NCT00042562|Analgesics|analgesics|mesh-ancestor
14598646|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
14598647|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598648|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
14598649|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14598650|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
14598651|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14598652|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14598653|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14598654|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14598655|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598656|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14598657|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598658|NCT00042575|Analgesics|analgesics|mesh-ancestor
14598659|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
14598660|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598661|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
14598662|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14598663|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
14598664|NCT00042588|Antibodies|antibodies|mesh-list
14598665|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14598666|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
14598667|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645001|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645002|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645003|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14645004|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
14645005|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645006|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645007|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14645008|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645009|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645010|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645011|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14645012|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14645013|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645014|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645015|NCT00193141|Paclitaxel|paclitaxel|mesh-list
14645016|NCT00193141|Carboplatin|carboplatin|mesh-list
15159260|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159261|NCT04135833|Itraconazole|itraconazole|mesh-list
15159262|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15159263|NCT04135833|Rifampin|rifampin|mesh-list
15159264|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
15159265|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159266|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14645017|NCT00193141|Fluorouracil|fluorouracil|mesh-list
14645018|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645019|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645020|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645021|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645022|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645023|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645024|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
14645025|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645026|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645027|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
14645028|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645029|NCT00193154|Bevacizumab|bevacizumab|mesh-list
14645030|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14645031|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14645032|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645033|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14645034|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14645035|NCT00193154|Growth Substances|growth substances|mesh-ancestor
14645036|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645037|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
15159267|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14598668|NCT00042601|Pramlintide|pramlintide|mesh-list
14598669|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14598670|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598671|NCT00042653|Cinacalcet|cinacalcet|mesh-list
14598672|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15159268|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159269|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598673|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598674|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14598675|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
14598676|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14598677|NCT00042679|Gemcitabine|gemcitabine|mesh-list
14598678|NCT00042679|Carboplatin|carboplatin|mesh-list
14598679|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598680|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598681|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
14598682|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598683|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
14598684|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598685|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598686|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598687|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
14598688|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598689|NCT00042718|Amoxicillin|amoxicillin|mesh-list
14598690|NCT00042718|Azithromycin|azithromycin|mesh-list
14598691|NCT00042718|Levofloxacin|levofloxacin|mesh-list
14598692|NCT00042718|Ofloxacin|ofloxacin|mesh-list
14598693|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
14598694|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
14598695|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14598696|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14598697|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598698|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14598699|NCT00042718|Renal Agents|renal agents|mesh-ancestor
14598700|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598701|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598702|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598703|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598704|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598705|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14598706|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14598707|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14598708|NCT00042731|Lycopene|lycopene|mesh-list
14598709|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598710|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
14598711|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598712|NCT00042731|Protective Agents|protective agents|mesh-ancestor
14598713|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598714|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14598715|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14598716|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598717|NCT00042796|Decitabine|decitabine|mesh-list
14598718|NCT00042796|Azacitidine|azacitidine|mesh-list
14598719|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598720|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
14598721|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598722|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598723|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598724|NCT00042809|Paclitaxel|paclitaxel|mesh-list
14598725|NCT00042809|Trastuzumab|trastuzumab|mesh-list
14598726|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14598727|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598728|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598729|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598730|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598731|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598732|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598733|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14598734|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598735|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598736|NCT00042822|Romidepsin|romidepsin|mesh-list
14598737|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598738|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598739|NCT00042835|Paclitaxel|paclitaxel|mesh-list
14598740|NCT00042835|Etoposide|etoposide|mesh-list
14598741|NCT00042835|Docetaxel|docetaxel|mesh-list
14598742|NCT00042835|Carboplatin|carboplatin|mesh-list
14598743|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14598744|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
14598745|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598746|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598747|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
14598748|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
14598749|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
14598750|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598751|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598752|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598753|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598754|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598755|NCT00042848|Modafinil|modafinil|mesh-list
14598756|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14598757|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598758|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14598759|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14598760|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14598761|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598762|NCT00042861|Leucovorin|leucovorin|mesh-list
14598763|NCT00042861|Fluorouracil|fluorouracil|mesh-list
14598764|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14598765|NCT00042861|Calcium|calcium|mesh-list
14598766|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
14598767|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14598768|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598769|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
14598770|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598771|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598772|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598773|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598774|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
14598775|NCT00042861|Antidotes|antidotes|mesh-ancestor
14598776|NCT00042861|Protective Agents|protective agents|mesh-ancestor
14598777|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
14598778|NCT00042861|Vitamins|vitamins|mesh-ancestor
14598779|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
14598780|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598781|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598782|NCT00042874|Leucovorin|leucovorin|mesh-list
14598783|NCT00042874|Fluorouracil|fluorouracil|mesh-list
14598784|NCT00042874|Irinotecan|irinotecan|mesh-list
14598785|NCT00042874|Alvocidib|alvocidib|mesh-list
14598786|NCT00042874|Calcium|calcium|mesh-list
14598787|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
14598788|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14598789|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598790|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
14598791|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598792|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598793|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598794|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598795|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
14598796|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14598797|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598798|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598799|NCT00042874|Antidotes|antidotes|mesh-ancestor
14598800|NCT00042874|Protective Agents|protective agents|mesh-ancestor
14598801|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
14598802|NCT00042874|Vitamins|vitamins|mesh-ancestor
14598803|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
14598804|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
14598805|NCT00042874|Growth Substances|growth substances|mesh-ancestor
14598806|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598807|NCT00042887|Mitomycins|mitomycins|mesh-list
14598808|NCT00042887|Mitomycin|mitomycin|mesh-list
14598809|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598810|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598811|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
14598812|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598813|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14598814|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598815|NCT00042913|Epratuzumab|epratuzumab|mesh-list
14598816|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14598817|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598818|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14598819|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14598820|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598821|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
14598822|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598823|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14598824|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598825|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598826|NCT00042965|Gemcitabine|gemcitabine|mesh-list
14598827|NCT00042965|Capecitabine|capecitabine|mesh-list
14598828|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598829|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
14598830|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598831|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598832|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
14598833|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598834|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159270|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15159271|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
15159272|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14598835|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598836|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
14598837|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598838|NCT00042978|Carboplatin|carboplatin|mesh-list
14598839|NCT00042978|Etoposide|etoposide|mesh-list
14598840|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
14598841|NCT00042978|Oblimersen|oblimersen|mesh-list
14598842|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598843|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14598844|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598845|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598846|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598847|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159273|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159274|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15159275|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15159276|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
15159277|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15159278|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
15159279|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15159280|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15159281|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14598848|NCT00043004|Leucovorin|leucovorin|mesh-list
14598849|NCT00043004|Bevacizumab|bevacizumab|mesh-list
14598850|NCT00043004|Fluorouracil|fluorouracil|mesh-list
14598851|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
14598852|NCT00043004|Calcium|calcium|mesh-list
14598853|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
14598854|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14598855|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159282|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15159283|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15159284|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15159285|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15159286|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
15159287|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15159288|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
15159289|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15159290|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
15159291|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159292|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159293|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
15159294|NCT04135781|Paclitaxel|paclitaxel|mesh-list
14598856|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14598857|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14598858|NCT00043004|Growth Substances|growth substances|mesh-ancestor
14598859|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598860|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
14598861|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14598862|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
14598863|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598864|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598865|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598866|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
14598867|NCT00043004|Antidotes|antidotes|mesh-ancestor
14598868|NCT00043004|Protective Agents|protective agents|mesh-ancestor
14598869|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
14598870|NCT00043004|Vitamins|vitamins|mesh-ancestor
14598871|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
14598872|NCT00043043|Celecoxib|celecoxib|mesh-list
14598873|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14598874|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14598875|NCT00043043|Analgesics|analgesics|mesh-ancestor
14598876|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
14598877|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598878|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598879|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598880|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14598881|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14598882|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14598883|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598884|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598885|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
14598886|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
14598887|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
14598888|NCT00043069|Estrogens|estrogens|mesh-list
14598889|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
14598890|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
14598891|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14598892|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598893|NCT00043069|Vitamins|vitamins|mesh-ancestor
14598894|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
14598895|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14598896|NCT00043069|Hormones|hormones|mesh-ancestor
14598897|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14598898|NCT00043069|Antacids|antacids|mesh-ancestor
14598899|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598900|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14598901|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14598902|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14598903|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
14598904|NCT00043082|Carboplatin|carboplatin|mesh-list
14598905|NCT00043082|Doxorubicin|doxorubicin|mesh-list
14598906|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14598907|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598908|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14598909|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14598910|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14598911|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598912|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598913|NCT00043095|Gemcitabine|gemcitabine|mesh-list
14598914|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598915|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
14598916|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598917|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598918|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
14598919|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598920|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598921|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598922|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
14598923|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598924|NCT00043121|Leucovorin|leucovorin|mesh-list
14598925|NCT00043121|Fluorouracil|fluorouracil|mesh-list
14598926|NCT00043121|Capecitabine|capecitabine|mesh-list
14598927|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
14598928|NCT00043121|Calcium|calcium|mesh-list
14598929|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
14598930|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14598931|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598932|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
14598933|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598934|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598935|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598936|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14598937|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
14598938|NCT00043121|Antidotes|antidotes|mesh-ancestor
14598939|NCT00043121|Protective Agents|protective agents|mesh-ancestor
14814035|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
14598940|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
14598941|NCT00043121|Vitamins|vitamins|mesh-ancestor
14598942|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
14598943|NCT00043134|Decitabine|decitabine|mesh-list
15159295|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15159296|NCT04135781|Capecitabine|capecitabine|mesh-list
15159297|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
15159298|NCT04135781|Tegafur|tegafur|mesh-list
15159299|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15159300|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598944|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14598945|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
14598946|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598947|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598948|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598949|NCT00043147|Prednisone|prednisone|mesh-list
14598950|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
14598951|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14598952|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14598953|NCT00043147|Prednisolone|prednisolone|mesh-list
14598954|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
14598955|NCT00043147|Beclomethasone|beclomethasone|mesh-list
14598956|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14598957|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
14598958|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14598959|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
14598960|NCT00043147|Hormones|hormones|mesh-ancestor
14598961|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159301|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
15159302|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
15159303|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
15159304|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159305|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159306|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
14598962|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14598963|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14598964|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598965|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
14598966|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
14598967|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14598968|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14598969|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14598970|NCT00043147|Protective Agents|protective agents|mesh-ancestor
14598971|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14598972|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
14598973|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
14598974|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14598975|NCT00043264|Azithromycin|azithromycin|mesh-list
14598976|NCT00043264|Rifampin|rifampin|mesh-list
14598977|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14598978|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14598979|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14598980|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
14598981|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
14598982|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14598983|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14598984|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598985|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14598986|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14598987|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14598988|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14598989|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14598990|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14598991|NCT00043277|Bivalirudin|bivalirudin|mesh-list
14598992|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
14598993|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14598994|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
15159307|NCT04135508|Adalimumab|adalimumab|mesh-list
15159308|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159309|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159310|NCT04135313|Capecitabine|capecitabine|mesh-list
15159311|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
15159312|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159313|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
15159314|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598995|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645038|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15159315|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159316|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
14598996|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598997|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
14598998|NCT00043303|Interferons|interferons|mesh-list
15159317|NCT04135378|Vitamins|vitamins|mesh-ancestor
15159318|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
15159319|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159320|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
15159321|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14598999|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
14599000|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599001|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
14599002|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599003|NCT00043316|Interferons|interferons|mesh-list
14599004|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
14599005|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599006|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
14599007|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599008|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
15159322|NCT04135378|Protective Agents|protective agents|mesh-ancestor
15159323|NCT04135690|Sorafenib|sorafenib|mesh-list
15159324|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599009|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
14599010|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599011|NCT00043342|Interferons|interferons|mesh-list
14599012|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
14599013|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599014|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
14599015|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021882|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599016|NCT00043355|Interferons|interferons|mesh-list
14599017|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
14599018|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599019|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
14599020|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599021|NCT00043381|Decitabine|decitabine|mesh-list
14599022|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599023|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
14599024|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599025|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599026|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599027|NCT00043394|Trastuzumab|trastuzumab|mesh-list
14599028|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14599029|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599030|NCT00043537|Fluoxetine|fluoxetine|mesh-list
14599031|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14599032|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14599033|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599034|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599035|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599036|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
14599037|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599038|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14599039|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599040|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599041|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14599042|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599043|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599044|NCT00043576|Calcitriol|calcitriol|mesh-list
14599045|NCT00043576|Docetaxel|docetaxel|mesh-list
14599046|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599047|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
14599048|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
14599049|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14599050|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599051|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14599052|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599053|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14599054|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814036|NCT00861328|Irinotecan|irinotecan|mesh-list
14021883|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
14599055|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14599056|NCT00043576|Vitamins|vitamins|mesh-ancestor
14599057|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
14645039|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159325|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599058|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14599059|NCT00043589|Donepezil|donepezil|mesh-list
14599060|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14599061|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599062|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599063|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
14599064|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599065|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599066|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
14599067|NCT00043654|Mifepristone|mifepristone|mesh-list
15159326|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159327|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599068|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14599069|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
14599070|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14599071|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599072|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14599073|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14599074|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14599075|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
14599076|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14599077|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14599078|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
14599079|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599080|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
14599081|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14599082|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14599083|NCT00043667|Daclizumab|daclizumab|mesh-list
14599084|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599085|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
14599086|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599087|NCT00043680|Celecoxib|celecoxib|mesh-list
14599088|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14599089|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14599090|NCT00043680|Analgesics|analgesics|mesh-ancestor
14599091|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
14599092|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14599093|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599094|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14599095|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14599096|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14599097|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14599098|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599099|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599100|NCT00043706|Antibodies|antibodies|mesh-list
14599101|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14599102|NCT00043706|Mitogens|mitogens|mesh-list
14599103|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
14599104|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599105|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
14599106|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599107|NCT00043719|Vitamin D|vitamin d|mesh-list
14599108|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
14599109|NCT00043719|Calcium|calcium|mesh-list
14599110|NCT00043719|Vitamins|vitamins|mesh-ancestor
14599111|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
14599112|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599113|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14599114|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14599115|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
14599116|NCT00043758|Tolvaptan|tolvaptan|mesh-list
14599117|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14599118|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599119|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
14599120|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599121|NCT00043771|Tolvaptan|tolvaptan|mesh-list
14599122|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14599123|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599124|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
14599125|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599126|NCT00043784|Enoxaparin|enoxaparin|mesh-list
14599127|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
14599128|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15159328|NCT04135456|Mannitol|mannitol|mesh-list
15159329|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15159330|NCT04135456|Diuretics|diuretics|mesh-ancestor
15159331|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
15159332|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159333|NCT04134884|Talazoparib|talazoparib|mesh-list
15159334|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15159335|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159336|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159337|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599129|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14599130|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599131|NCT00043810|Vidarabine|vidarabine|mesh-list
14599132|NCT00043810|Fludarabine|fludarabine|mesh-list
14599133|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
14599134|NCT00043810|Busulfan|busulfan|mesh-list
14599135|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
14599136|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599137|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599138|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
14599139|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599140|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599141|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
14599142|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599143|NCT00043810|Antiviral Agents|antiviral agents|mesh-ancestor
14599144|NCT00043810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599145|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
14599146|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14599147|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14599148|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14599149|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14599150|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599151|NCT00043823|Bevacizumab|bevacizumab|mesh-list
14599152|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14599153|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14599154|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599155|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14599156|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14599157|NCT00043823|Growth Substances|growth substances|mesh-ancestor
14599158|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599159|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
15159338|NCT04134923|Corticosterone|corticosterone|mesh-list
15159339|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159340|NCT04134897|Capecitabine|capecitabine|mesh-list
15159341|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
15159342|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159343|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
15159344|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159345|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180570|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15180571|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15180572|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15180573|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180574|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
15180575|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180576|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
15180577|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15180578|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15180579|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180580|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
15180581|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180582|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180583|NCT03937843|Carboplatin|carboplatin|mesh-list
15180584|NCT03937843|Etoposide|etoposide|mesh-list
15180585|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599160|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599161|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599162|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599163|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14599164|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599165|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599166|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15180586|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14599167|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599168|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14599169|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599170|NCT00043862|Topotecan|topotecan|mesh-list
14599171|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14599172|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599173|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599174|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599175|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599176|NCT00043875|Lamotrigine|lamotrigine|mesh-list
14599177|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
14599178|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14599179|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599180|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599181|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14599182|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599183|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14599184|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599185|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14599186|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599187|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14599188|NCT00043888|Ritonavir|ritonavir|mesh-list
14599189|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
14599190|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14599191|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14599192|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14599193|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14599194|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599195|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599196|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14599197|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14599198|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
14599199|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599200|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14599201|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599202|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14599203|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14599204|NCT00043901|Lamotrigine|lamotrigine|mesh-list
14599205|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
14599206|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14599207|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599208|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599209|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14599210|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599211|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14599212|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599213|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14599214|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599215|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14599216|NCT00043914|Lamotrigine|lamotrigine|mesh-list
14599217|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
14599218|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14599219|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599220|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599221|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14599222|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599223|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14599224|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599225|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14599226|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599227|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14599228|NCT00043927|Cisplatin|cisplatin|mesh-list
14599229|NCT00043927|Etoposide|etoposide|mesh-list
14599230|NCT00043927|Topotecan|topotecan|mesh-list
14599231|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599232|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14599233|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14599234|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599235|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599236|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599237|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14599238|NCT00043940|Bivalirudin|bivalirudin|mesh-list
14599239|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
14599240|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14599241|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
14599242|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599243|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599244|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
14599245|NCT00043953|Ritonavir|ritonavir|mesh-list
14599246|NCT00043953|Lopinavir|lopinavir|mesh-list
14599247|NCT00043953|Saquinavir|saquinavir|mesh-list
14599248|NCT00043953|Lamivudine|lamivudine|mesh-list
14599249|NCT00043953|Zidovudine|zidovudine|mesh-list
14599250|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14599251|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14599252|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14599253|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
14599254|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599255|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291772|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14291773|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14291774|NCT00556322|Docetaxel|docetaxel|mesh-list
14291775|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291776|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291777|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291778|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291779|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
14291780|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
14291781|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
14291782|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
14599256|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14599257|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14599258|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
14599259|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599260|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14599261|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599262|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14599263|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14599264|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
14599265|NCT00043966|Ritonavir|ritonavir|mesh-list
14599266|NCT00043966|Lopinavir|lopinavir|mesh-list
14599267|NCT00043966|Tenofovir|tenofovir|mesh-list
14599268|NCT00043966|Emtricitabine|emtricitabine|mesh-list
14599269|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14599270|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14599271|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
14599272|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599273|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599274|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14599275|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14599276|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
14599277|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599278|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14599279|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599280|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14599281|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14599282|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14599283|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14599284|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14599285|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599286|NCT00044135|Clevudine|clevudine|mesh-list
14599287|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
14599288|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599289|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
14599290|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599291|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599292|NCT00044187|Sibutramine|sibutramine|mesh-list
14599293|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599294|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599295|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
14599296|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14645040|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645041|NCT00193167|Topotecan|topotecan|mesh-list
14645042|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645043|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645044|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291783|NCT00556374|Denosumab|denosumab|mesh-list
14645045|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599297|NCT00044265|Ramipril|ramipril|mesh-list
14599298|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14599299|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
14599300|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599301|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599302|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14599303|NCT00044278|Lamotrigine|lamotrigine|mesh-list
14599304|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
14599305|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14599306|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599307|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599308|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14599309|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599310|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14599311|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599312|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14599313|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599314|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14599315|NCT00044291|Toremifene|toremifene|mesh-list
14599316|NCT00044291|Letrozole|letrozole|mesh-list
14599317|NCT00044291|Hormones|hormones|mesh-list
14599318|NCT00044291|Atamestane|atamestane|mesh-list
14599319|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
14599320|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
14599321|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
14599322|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599323|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599324|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599325|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14599326|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14599327|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599328|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599329|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
14599330|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14599331|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14599332|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15159346|NCT04135014|Midazolam|midazolam|mesh-list
15159347|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
15159348|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15159349|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159350|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159351|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159352|NCT04135014|Analgesics|analgesics|mesh-ancestor
15159353|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
15159354|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159355|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15159356|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14599333|NCT00044343|Lapatinib|lapatinib|mesh-list
14599334|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599335|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599336|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599337|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599338|NCT00044382|Lenalidomide|lenalidomide|mesh-list
14599339|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
14599340|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599341|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14599342|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14599343|NCT00044382|Growth Substances|growth substances|mesh-ancestor
14599344|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
14599345|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599346|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
14599347|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599348|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599349|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
14599350|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599351|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599352|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
14599353|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599354|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599355|NCT00044434|Bupropion|bupropion|mesh-list
14599356|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14599357|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
15159357|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14599358|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599359|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14599360|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14599361|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599362|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599363|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
14599364|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599365|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159358|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
15159359|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159360|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159361|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15159362|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15159363|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599366|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14599367|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599368|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599369|NCT00044447|Glimepiride|glimepiride|mesh-list
14599370|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14599371|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14599372|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159364|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15159365|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15159366|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
15159367|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
15159368|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
15159369|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
15159370|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
15159371|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15159372|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
15159373|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159374|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
15159375|NCT04134611|Protective Agents|protective agents|mesh-ancestor
14599373|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599374|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
14599375|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
14599376|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14599377|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599378|NCT00044473|Levofloxacin|levofloxacin|mesh-list
14599379|NCT00044473|Ofloxacin|ofloxacin|mesh-list
14599380|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15159376|NCT04134650|Metformin|metformin|mesh-list
15159377|NCT04134650|Linagliptin|linagliptin|mesh-list
15159378|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15159379|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159380|NCT04134650|Incretins|incretins|mesh-ancestor
15159381|NCT04134650|Hormones|hormones|mesh-ancestor
15159382|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159383|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15159384|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
15159385|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159386|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599381|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599382|NCT00044473|Renal Agents|renal agents|mesh-ancestor
14599383|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14599384|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14599385|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599386|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291784|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14599387|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599388|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599389|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14599390|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599391|NCT00044486|Posaconazole|posaconazole|mesh-list
14599392|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
14599393|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599394|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14599395|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14599396|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15159387|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
15159388|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
15159389|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15159390|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159391|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15159392|NCT04134468|Gemcitabine|gemcitabine|mesh-list
15159393|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15159394|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159395|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
15159396|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159397|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159398|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
15159399|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159400|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159401|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159402|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
15159403|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599397|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14599398|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599399|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599400|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599401|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15159404|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
15159405|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15159406|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159407|NCT04134416|Donepezil|donepezil|mesh-list
15159408|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15159409|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159410|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159411|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
15159412|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159413|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159414|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
15159415|NCT04134182|Nivolumab|nivolumab|mesh-list
15159416|NCT04134182|Ipilimumab|ipilimumab|mesh-list
15159417|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15159418|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159419|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15159420|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159421|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
15159422|NCT04134130|Testosterone|testosterone|mesh-list
15159423|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
15159424|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
15159425|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14599402|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
14599403|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599404|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599405|NCT00044525|Taxane|taxane|mesh-list
14599406|NCT00044525|IDN 5109|idn 5109|mesh-list
14599407|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599408|NCT00044538|Taxane|taxane|mesh-list
14599409|NCT00044538|IDN 5109|idn 5109|mesh-list
14599410|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599411|NCT00044551|Taxane|taxane|mesh-list
14599412|NCT00044551|IDN 5109|idn 5109|mesh-list
14599413|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599414|NCT00044564|IDN 5109|idn 5109|mesh-list
14599415|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159426|NCT04134130|Androgens|androgens|mesh-ancestor
15159427|NCT04134130|Hormones|hormones|mesh-ancestor
15159428|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159429|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159430|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15159431|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159432|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
15159433|NCT04134273|Clindamycin|clindamycin|mesh-list
15159434|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
15159435|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
15159436|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15159437|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599416|NCT00044577|Tenofovir|tenofovir|mesh-list
14599417|NCT00044577|Lamivudine|lamivudine|mesh-list
14599418|NCT00044577|Abacavir|abacavir|mesh-list
14599419|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
14599420|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
14599421|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599422|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14599423|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14599424|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159438|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14599425|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159439|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599426|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14599427|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14599428|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
14599429|NCT00044616|Fluoxetine|fluoxetine|mesh-list
14599430|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14599431|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14599432|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599433|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599434|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599435|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
14599436|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599437|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14599438|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599439|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599440|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14599441|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599442|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599443|NCT00044629|Zolpidem|zolpidem|mesh-list
14599444|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14599445|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14599446|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14599447|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599448|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14599449|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
14599450|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
14599451|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599452|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599453|NCT00044642|Lorazepam|lorazepam|mesh-list
14599454|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
15159440|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159441|NCT04134598|Tamoxifen|tamoxifen|mesh-list
15159442|NCT04134598|Letrozole|letrozole|mesh-list
15159443|NCT04134598|Anastrozole|anastrozole|mesh-list
15159444|NCT04134598|Exemestane|exemestane|mesh-list
15159445|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159446|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15159447|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15159448|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159449|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159450|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15159451|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
15159452|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159453|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599455|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
14599456|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
14599457|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14599458|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599459|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14599460|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14599461|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14599462|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14599463|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599464|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599465|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
14599466|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
14599467|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599468|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599469|NCT00044668|Exenatide|exenatide|mesh-list
14599470|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14599471|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599472|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14599473|NCT00044668|Incretins|incretins|mesh-ancestor
14599474|NCT00044668|Hormones|hormones|mesh-ancestor
14599475|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599476|NCT00044681|Risperidone|risperidone|mesh-list
14599477|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14599478|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
14599479|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599480|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599481|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599482|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14599483|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14599484|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159454|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14599485|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599486|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14599487|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
14599488|NCT00044694|Exenatide|exenatide|mesh-list
14599489|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14599490|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599491|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14599492|NCT00044694|Incretins|incretins|mesh-ancestor
14599493|NCT00044694|Hormones|hormones|mesh-ancestor
14599494|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599495|NCT00044707|Pramlintide|pramlintide|mesh-list
14599496|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14599497|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599498|NCT00044720|Sirolimus|sirolimus|mesh-list
14599499|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14599500|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599501|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14599502|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159455|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15159456|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15159457|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15159458|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
15159459|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15159460|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
15159461|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159462|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159463|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15159464|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
15159465|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15159466|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
15159467|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599503|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
14599504|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599505|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
14599506|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599507|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
14599508|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14599509|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599510|NCT00044746|Tazobactam|tazobactam|mesh-list
14599511|NCT00044746|Piperacillin|piperacillin|mesh-list
14599512|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14599513|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14599514|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599515|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14599516|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599517|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599518|NCT00044759|Tazobactam|tazobactam|mesh-list
14599519|NCT00044759|Piperacillin|piperacillin|mesh-list
14599520|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14599521|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14599522|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599523|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14599524|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599525|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599526|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14599527|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14599528|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14599529|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599530|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599531|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599532|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599533|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14599534|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599535|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599536|NCT00044785|Leucovorin|leucovorin|mesh-list
14599537|NCT00044785|Fluorouracil|fluorouracil|mesh-list
14599538|NCT00044785|Irinotecan|irinotecan|mesh-list
14599539|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
14599540|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599541|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599542|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599543|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599544|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
14599545|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599546|NCT00044785|Antidotes|antidotes|mesh-ancestor
14599547|NCT00044785|Protective Agents|protective agents|mesh-ancestor
14599548|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
14599549|NCT00044785|Vitamins|vitamins|mesh-ancestor
14599550|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
14599551|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14599552|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599553|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599554|NCT00044798|Citalopram|citalopram|mesh-list
14599555|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14599556|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14599557|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599558|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599559|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599560|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
14599561|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599562|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14599563|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599564|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599565|NCT00044811|Fexofenadine|fexofenadine|mesh-list
14599566|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14599567|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14599568|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14599569|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
14599570|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
14599571|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599572|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599573|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599574|NCT00044824|Fexofenadine|fexofenadine|mesh-list
14599575|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14599576|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14599577|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14599578|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
14599579|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
14599580|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599581|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599582|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599583|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14599584|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
14599585|NCT00044837|Estradiol|estradiol|mesh-list
14599586|NCT00044837|Estrogens|estrogens|mesh-ancestor
14599587|NCT00044837|Hormones|hormones|mesh-ancestor
14599588|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599589|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599590|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14599591|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
14599592|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14599593|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14599594|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14599595|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14599596|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14599597|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14599598|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14599599|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599600|NCT00044863|Cetuximab|cetuximab|mesh-list
14599601|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14599602|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599603|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
14599604|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14599605|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
14599606|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14599607|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599608|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14599609|NCT00044889|Clofarabine|clofarabine|mesh-list
14599610|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599611|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
14599612|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599613|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599614|NCT00044902|Epratuzumab|epratuzumab|mesh-list
14599615|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14599616|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599617|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
14599618|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14599619|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14599620|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
14599621|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599622|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599623|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599624|NCT00044928|Tazobactam|tazobactam|mesh-list
14599625|NCT00044928|Piperacillin|piperacillin|mesh-list
14599626|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14599627|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14599628|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599629|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14599630|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599631|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599632|NCT00044954|Cyclosporine|cyclosporine|mesh-list
14599633|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
14599634|NCT00044954|Fludarabine|fludarabine|mesh-list
14599635|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
14599636|NCT00044954|Cyclosporins|cyclosporins|mesh-list
14599637|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599638|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599639|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
14599640|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599641|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599642|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
14599643|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599644|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599645|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
14599646|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599647|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
14599648|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14599649|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14599650|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14599651|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14599652|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
14599653|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14599654|NCT00044993|Docetaxel|docetaxel|mesh-list
14599655|NCT00044993|Doxorubicin|doxorubicin|mesh-list
14599656|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14599657|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599658|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14599659|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14599660|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14599661|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599662|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14599663|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14599664|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599665|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599666|NCT00045006|Vorinostat|vorinostat|mesh-list
14599667|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599668|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14599669|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599670|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599671|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14599672|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14599673|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599674|NCT00045136|Melphalan|melphalan|mesh-list
14599675|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14599676|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
14599677|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599678|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599679|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14599680|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599681|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
14599682|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599683|NCT00045149|Aldesleukin|aldesleukin|mesh-list
14599684|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599685|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14599686|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14599687|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
14599688|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599689|NCT00045175|Topotecan|topotecan|mesh-list
14599690|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14599691|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14599692|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599693|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599694|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599695|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599696|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599697|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
14599698|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599699|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599700|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599701|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599702|NCT00045227|Docetaxel|docetaxel|mesh-list
14599703|NCT00045227|Vaccines|vaccines|mesh-list
14599704|NCT00045227|Sargramostim|sargramostim|mesh-list
14599705|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
14599706|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599707|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599708|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14599709|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14599710|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14599711|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599712|NCT00045266|Aflibercept|aflibercept|mesh-list
14599713|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14599714|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14599715|NCT00045266|Growth Substances|growth substances|mesh-ancestor
14599716|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599717|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
14599718|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599719|NCT00045279|Interferons|interferons|mesh-list
14599720|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
14599721|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
14599722|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14599723|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599724|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
14599725|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599726|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
14599727|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599728|NCT00045292|Valacyclovir|valacyclovir|mesh-list
14599729|NCT00045292|Acyclovir|acyclovir|mesh-list
14599730|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
14599731|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599732|NCT00045318|Exatecan|exatecan|mesh-list
14599733|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14599734|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599735|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599736|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599737|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599738|NCT00045370|Interferons|interferons|mesh-list
14599739|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
14599740|NCT00045370|Sirolimus|sirolimus|mesh-list
14599741|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599742|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
14599743|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599744|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
14599745|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599746|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14599747|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14599748|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
14599749|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599750|NCT00045396|Tipifarnib|tipifarnib|mesh-list
14599751|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599752|NCT00045422|Interferons|interferons|mesh-list
14599753|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
14599754|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
14599755|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599756|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
14599757|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599758|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
14599759|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599760|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599761|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599762|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599763|NCT00045448|Docetaxel|docetaxel|mesh-list
14599764|NCT00045448|Alvocidib|alvocidib|mesh-list
14599765|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599766|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14599767|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14599768|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14599769|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599770|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
14599771|NCT00045448|Growth Substances|growth substances|mesh-ancestor
14599772|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599773|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599774|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599775|NCT00045461|Carboplatin|carboplatin|mesh-list
14599776|NCT00045461|Ifosfamide|ifosfamide|mesh-list
14599777|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599778|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14599779|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
14599780|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599781|NCT00045500|Prednisone|prednisone|mesh-list
14599782|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14599783|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14599784|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
14599785|NCT00045500|Hormones|hormones|mesh-ancestor
14599786|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599787|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159468|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159469|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15159470|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
15159471|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
15159472|NCT04134078|Protective Agents|protective agents|mesh-ancestor
15159473|NCT04134065|Vitamin D|vitamin d|mesh-list
15159474|NCT04134065|Vitamins|vitamins|mesh-ancestor
15159475|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
15159476|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159477|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15159478|NCT04134052|Midazolam|midazolam|mesh-list
15159479|NCT04134052|Ketamine|ketamine|mesh-list
14021884|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159480|NCT04134052|Analgesics|analgesics|mesh-ancestor
15159481|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
15159482|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14599788|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14599789|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599790|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599791|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599792|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599793|NCT00045513|Fludarabine|fludarabine|mesh-list
14599794|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
14599795|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14599796|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599797|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599798|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
14599799|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599800|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599801|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
14599802|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599803|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599804|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599805|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14599806|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599807|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599808|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599809|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599810|NCT00045539|Leucovorin|leucovorin|mesh-list
14599811|NCT00045539|Methotrexate|methotrexate|mesh-list
14599812|NCT00045539|Thiotepa|thiotepa|mesh-list
14599813|NCT00045539|Calcium|calcium|mesh-list
14599814|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
14599815|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14599816|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599817|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14599818|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
14599819|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14599820|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599821|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
14599822|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599823|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599824|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
14599825|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599826|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14599827|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159483|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021885|NCT02771314|Osimertinib|osimertinib|mesh-list
14599828|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
14599829|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14599830|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14599831|NCT00045539|Antidotes|antidotes|mesh-ancestor
14599832|NCT00045539|Protective Agents|protective agents|mesh-ancestor
14599833|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
14291785|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14291786|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291787|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14291788|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291789|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291790|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14291791|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
14291792|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599834|NCT00045539|Vitamins|vitamins|mesh-ancestor
14599835|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
14599836|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14599837|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
14599838|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14599839|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
14599840|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599841|NCT00045591|Celecoxib|celecoxib|mesh-list
14599842|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14599843|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14599844|NCT00045591|Analgesics|analgesics|mesh-ancestor
14599845|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
14599846|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14599847|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599848|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14599849|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14599850|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14599851|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14599852|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599853|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599854|NCT00045604|Irinotecan|irinotecan|mesh-list
14599855|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
14599856|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599857|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14599858|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599859|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599860|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599861|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599862|NCT00045617|Etoposide|etoposide|mesh-list
14599863|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14599864|NCT00045617|Vaccines|vaccines|mesh-list
14599865|NCT00045617|Antibodies|antibodies|mesh-list
14599866|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
14599867|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15159484|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15159485|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14599868|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14599869|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
14599870|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599871|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599872|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14599873|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14599874|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14599875|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599876|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599877|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
14599878|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599879|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14599880|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599881|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599882|NCT00045682|Paclitaxel|paclitaxel|mesh-list
14599883|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14599884|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14599885|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14599886|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599887|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14599888|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14599889|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14599890|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599891|NCT00045695|Bortezomib|bortezomib|mesh-list
14599892|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599893|NCT00045721|Carmustine|carmustine|mesh-list
14599894|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14599895|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14599896|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
14599897|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599898|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599899|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599900|NCT00045747|Fluorouracil|fluorouracil|mesh-list
14599901|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14599902|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
14599903|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599904|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14599905|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599906|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14599907|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
14599908|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599909|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14021886|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021887|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14021888|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021889|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021890|NCT02770950|Indomethacin|indomethacin|mesh-list
14021891|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14021892|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14021893|NCT02770950|Analgesics|analgesics|mesh-ancestor
14021894|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
14021895|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021896|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021897|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14021898|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021899|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
14021900|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
14021901|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14021902|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14021903|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026067|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599910|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599911|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14599912|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159486|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
15159487|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
15159488|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159489|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15159490|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15159491|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159492|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159493|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15159494|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14599913|NCT00045773|Sertraline|sertraline|mesh-list
14599914|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599915|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15159495|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15159496|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15159497|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15159498|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
15159499|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
14599916|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14599917|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14599918|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159500|NCT04133961|Phenylephrine|phenylephrine|mesh-list
15159501|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
15159502|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15159503|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
15159504|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
15159505|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14599919|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599920|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599921|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
14599922|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599923|NCT00045799|Omeprazole|omeprazole|mesh-list
14599924|NCT00045799|Cimetidine|cimetidine|mesh-list
14599925|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14599926|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15159506|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599927|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14599928|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14599929|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599930|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14599931|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
14599932|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
14599933|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599934|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599935|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14599936|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14599937|NCT00045812|Ezetimibe|ezetimibe|mesh-list
14599938|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14599939|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14599940|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
14599941|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14599942|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14599943|NCT00045864|Aldesleukin|aldesleukin|mesh-list
14599944|NCT00045864|Rituximab|rituximab|mesh-list
14599945|NCT00045864|Interleukin-2|interleukin-2|mesh-list
14599946|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14599947|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599948|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
14599949|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599950|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14599951|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14599952|NCT00045864|Analgesics|analgesics|mesh-ancestor
14599953|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
14599954|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14599955|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15159507|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
15159508|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15159509|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
14599956|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14599957|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
14599958|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599959|NCT00045877|Aldesleukin|aldesleukin|mesh-list
14599960|NCT00045877|Rituximab|rituximab|mesh-list
14599961|NCT00045877|Interleukin-2|interleukin-2|mesh-list
14599962|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14599963|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599964|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
14599965|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599966|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14599967|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14599968|NCT00045877|Analgesics|analgesics|mesh-ancestor
14599969|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
14599970|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14599971|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14599972|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14599973|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
14599974|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14599975|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14599976|NCT00045916|Nortriptyline|nortriptyline|mesh-list
14599977|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
14599978|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14599979|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159510|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
15159511|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15159512|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14599980|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14599981|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14599982|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14599983|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14599984|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14599985|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14599986|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14599987|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14599988|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
14599989|NCT00045955|Fexofenadine|fexofenadine|mesh-list
14599990|NCT00045955|Montelukast|montelukast|mesh-list
14599991|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14599992|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
14599993|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14599994|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
14645046|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14599995|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14599996|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159513|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15159514|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
15159515|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159516|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159517|NCT04133961|Protective Agents|protective agents|mesh-ancestor
15159518|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
15159519|NCT04134026|Hematinics|hematinics|mesh-ancestor
15159520|NCT04133974|Methadone|methadone|mesh-list
15159521|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14599997|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14599998|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14599999|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600000|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14600001|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14600002|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14600003|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
14600004|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
14600005|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645047|NCT00193193|Paclitaxel|paclitaxel|mesh-list
14645048|NCT00193193|Carboplatin|carboplatin|mesh-list
14645049|NCT00193193|Estramustine|estramustine|mesh-list
14645050|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645051|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645052|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645053|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645054|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645055|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645056|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14645057|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
14645058|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14645059|NCT00193232|Docetaxel|docetaxel|mesh-list
14645060|NCT00193232|Bortezomib|bortezomib|mesh-list
14645061|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645062|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645063|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645064|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645065|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645066|NCT00193245|Docetaxel|docetaxel|mesh-list
14645067|NCT00193245|Topotecan|topotecan|mesh-list
14645068|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645069|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645070|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645071|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645072|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645073|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645074|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645075|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645076|NCT00193271|Docetaxel|docetaxel|mesh-list
14645077|NCT00193271|Estramustine|estramustine|mesh-list
14645078|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645079|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645080|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645081|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645082|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645083|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14645084|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
14645085|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14645086|NCT00193284|Carboplatin|carboplatin|mesh-list
14645087|NCT00193284|Docetaxel|docetaxel|mesh-list
14645088|NCT00193284|Fluorouracil|fluorouracil|mesh-list
14645089|NCT00193284|Gefitinib|gefitinib|mesh-list
14645090|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645091|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645092|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645093|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645094|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645095|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
14645096|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645097|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645098|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
14645099|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645100|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14645101|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159522|NCT04133974|Narcotics|narcotics|mesh-ancestor
14600006|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14600007|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14600008|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600009|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600010|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600011|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600012|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600013|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14600014|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600015|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600016|NCT00046033|Ritonavir|ritonavir|mesh-list
14600017|NCT00046033|Lopinavir|lopinavir|mesh-list
14600018|NCT00046033|Saquinavir|saquinavir|mesh-list
14600019|NCT00046033|Amprenavir|amprenavir|mesh-list
14600020|NCT00046033|Tenofovir|tenofovir|mesh-list
14600021|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14600022|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14600023|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
15159523|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159524|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159525|NCT04133974|Analgesics|analgesics|mesh-ancestor
15159526|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
15159527|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159528|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
15159529|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
15159530|NCT04134637|Bupivacaine|bupivacaine|mesh-list
15159531|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
15159532|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
15159533|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159534|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159535|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
15159536|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159537|NCT04133571|Lidocaine|lidocaine|mesh-list
14600024|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600025|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600026|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14600027|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14600028|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
14600029|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600030|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14600031|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14600032|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14600033|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14600034|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14600035|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
14600036|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600037|NCT00046111|Topotecan|topotecan|mesh-list
14600038|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14600039|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600040|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600041|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600042|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600043|NCT00046137|Teriparatide|teriparatide|mesh-list
14600044|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15159538|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
15159539|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
15159540|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159541|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159542|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
15159543|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600045|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14600046|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600047|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14600048|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14600049|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
14600050|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14600051|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14600052|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15159544|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15159545|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15159546|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14600053|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
14600054|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14600055|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600056|NCT00046163|Midodrine|midodrine|mesh-list
14600057|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
14600058|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
14600059|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600060|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600061|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14600062|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14600063|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14600064|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14600065|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
14600066|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600067|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600068|NCT00046176|Lamivudine|lamivudine|mesh-list
14600069|NCT00046176|Abacavir|abacavir|mesh-list
14600070|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
14291793|NCT00556439|Abatacept|abatacept|mesh-list
14291794|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14291795|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291796|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291797|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291798|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
14291799|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600071|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14600072|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14600073|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600074|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600075|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
14600076|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600077|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14600078|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14600079|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
14600080|NCT00046241|Bupropion|bupropion|mesh-list
14600081|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14600082|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600083|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600084|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14600085|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600086|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600087|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600088|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
14600089|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600090|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600091|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14600092|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14600093|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600094|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
14600095|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14600096|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600097|NCT00046267|Niacin|niacin|mesh-list
15159547|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159548|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159549|NCT04133428|Valsartan|valsartan|mesh-list
14600098|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14600099|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
14600100|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600101|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14600102|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
14600103|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
14600104|NCT00046267|Vitamins|vitamins|mesh-ancestor
14600105|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
14600106|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600107|NCT00046293|Abciximab|abciximab|mesh-list
14600108|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
14600109|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14600110|NCT00046306|Antioxidants|antioxidants|mesh-list
14600111|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600112|NCT00046306|Protective Agents|protective agents|mesh-ancestor
14600113|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600114|NCT00046319|Ambrisentan|ambrisentan|mesh-list
14600115|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14600116|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14600117|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14600118|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14600119|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
14600120|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600121|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600122|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14600123|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14600124|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
14600125|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600126|NCT00046358|Ibuprofen|ibuprofen|mesh-list
14600127|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14600128|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14600129|NCT00046358|Analgesics|analgesics|mesh-ancestor
14600130|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
14600131|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600132|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600133|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14600134|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600135|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14600136|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600137|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600138|NCT00046384|Aripiprazole|aripiprazole|mesh-list
14600139|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600140|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600141|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14600142|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14600143|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14600144|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600145|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
14600146|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
14600147|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600148|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600149|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14600150|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14600151|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
14600152|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14600153|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14600154|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14600155|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14600156|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14600157|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600158|NCT00046462|Metformin|metformin|mesh-list
14600159|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
14600160|NCT00046462|Glyburide|glyburide|mesh-list
14600161|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14600162|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14600163|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600164|NCT00046501|Insulin|insulin|mesh-list
14600165|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
14600166|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14600167|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
14600168|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
14600169|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14600170|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600171|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14600172|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600173|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15159550|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15159551|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15159552|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15159553|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15159554|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159555|NCT04133155|Gemcitabine|gemcitabine|mesh-list
15159556|NCT04133155|Paclitaxel|paclitaxel|mesh-list
15159557|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15159558|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159559|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
15159560|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
15159561|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
15159562|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600174|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600175|NCT00046553|Mifepristone|mifepristone|mesh-list
14600176|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14600177|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
14600178|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14600179|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600180|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14600181|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14600182|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14600183|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
14600184|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14600185|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14600186|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
14600187|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14600188|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
14600189|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15159563|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159564|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
15159565|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
15159566|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159567|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159568|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159569|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
15159570|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600190|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14600191|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
14600192|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14600193|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600194|NCT00046735|Lenalidomide|lenalidomide|mesh-list
14600195|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
14600196|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600197|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14600198|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14600199|NCT00046735|Growth Substances|growth substances|mesh-ancestor
14600200|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600201|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600202|NCT00046748|Omalizumab|omalizumab|mesh-list
14600203|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14600204|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14600205|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14600206|NCT00046787|Lurtotecan|lurtotecan|mesh-list
14600207|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600208|NCT00046800|Lurtotecan|lurtotecan|mesh-list
14600209|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600210|NCT00046813|Nicotine|nicotine|mesh-list
14600211|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14600212|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
14600213|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600214|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600215|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14600216|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14600217|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
14600218|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600219|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600220|NCT00046826|Thalidomide|thalidomide|mesh-list
14600221|NCT00046826|Docetaxel|docetaxel|mesh-list
14600222|NCT00046826|Estramustine|estramustine|mesh-list
14600223|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600224|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14600225|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14600226|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600227|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600228|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600229|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
14600230|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600231|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
14600232|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600233|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600234|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14600235|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15159571|NCT04133311|Latanoprost|latanoprost|mesh-list
15159572|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15159573|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15159574|NCT04133337|Apatinib|apatinib|mesh-list
15159575|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159576|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15159577|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159578|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159579|NCT04133506|Aspirin|aspirin|mesh-list
15159580|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14600236|NCT00046826|Growth Substances|growth substances|mesh-ancestor
15159581|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159582|NCT04133506|Analgesics|analgesics|mesh-ancestor
14600237|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600238|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14600239|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
14600240|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14600241|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
14600242|NCT00046852|Melphalan|melphalan|mesh-list
14600243|NCT00046852|Carmustine|carmustine|mesh-list
14600244|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14600245|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600246|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
14600247|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600248|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600249|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14600250|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
14600251|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600252|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600253|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14600254|NCT00046878|Carmustine|carmustine|mesh-list
14600255|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14600256|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14600257|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
14600258|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600259|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600260|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600261|NCT00046904|Etanercept|etanercept|mesh-list
14600262|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14600263|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14600264|NCT00046904|Analgesics|analgesics|mesh-ancestor
14600265|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
14600266|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600267|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600268|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14600269|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600270|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600271|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600272|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
14600273|NCT00046917|Irinotecan|irinotecan|mesh-list
14600274|NCT00046917|Alvocidib|alvocidib|mesh-list
14600275|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600276|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14600277|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600278|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600279|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600280|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600281|NCT00046917|Growth Substances|growth substances|mesh-ancestor
14600282|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600283|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600284|NCT00046943|Atrasentan|atrasentan|mesh-list
14600285|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600286|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14600287|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14600288|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600289|NCT00046969|Cisplatin|cisplatin|mesh-list
14600290|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600291|NCT00046995|Leucovorin|leucovorin|mesh-list
14600292|NCT00046995|Carboplatin|carboplatin|mesh-list
14600293|NCT00046995|Fluorouracil|fluorouracil|mesh-list
14600294|NCT00046995|Calcium|calcium|mesh-list
14600295|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
14600296|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600297|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14600298|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600299|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
14600300|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600301|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600302|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600303|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
14600304|NCT00046995|Antidotes|antidotes|mesh-ancestor
14600305|NCT00046995|Protective Agents|protective agents|mesh-ancestor
14600306|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
14600307|NCT00046995|Vitamins|vitamins|mesh-ancestor
14600308|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
14600309|NCT00047021|Cytarabine|cytarabine|mesh-list
14600310|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
14814037|NCT00861328|Camptothecin|camptothecin|mesh-list
14600311|NCT00047021|Sargramostim|sargramostim|mesh-list
14600312|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600313|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
14600314|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600315|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600316|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
14600317|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600318|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600319|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
14600320|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600321|NCT00047021|Analgesics|analgesics|mesh-ancestor
14600322|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
14600323|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600324|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14600325|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600326|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600327|NCT00047047|Gemcitabine|gemcitabine|mesh-list
14600328|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600329|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600330|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
14600331|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600332|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
14600333|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600334|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600335|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600336|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
14600337|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600338|NCT00047073|Sirolimus|sirolimus|mesh-list
14600339|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600340|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600341|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14600342|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600343|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
14600344|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600345|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
14600346|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600347|NCT00047099|Tamoxifen|tamoxifen|mesh-list
14600348|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
14600349|NCT00047099|Docetaxel|docetaxel|mesh-list
14600350|NCT00047099|Fluorouracil|fluorouracil|mesh-list
14600351|NCT00047099|Epirubicin|epirubicin|mesh-list
14600352|NCT00047099|Goserelin|goserelin|mesh-list
14600353|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600354|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
14600355|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600356|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600357|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14600358|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
14600359|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600360|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159583|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
15159584|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159585|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159586|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159587|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600361|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14600362|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
14600363|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
14600364|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600365|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
14600366|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600367|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14600368|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14600369|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600370|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600371|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14600372|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
14600373|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14600374|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14600375|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14600376|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14600377|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14600378|NCT00047112|Fluorouracil|fluorouracil|mesh-list
14600379|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600380|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
14600381|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600382|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600383|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600384|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
14600385|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600386|NCT00047138|Dactinomycin|dactinomycin|mesh-list
14600387|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
14600388|NCT00047138|Carboplatin|carboplatin|mesh-list
14600389|NCT00047138|Doxorubicin|doxorubicin|mesh-list
14600390|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14600391|NCT00047138|Etoposide|etoposide|mesh-list
14600392|NCT00047138|Vincristine|vincristine|mesh-list
14600393|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600394|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
14600395|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600396|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600397|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14600398|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
14600399|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600400|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600401|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14600402|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14021904|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600403|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14600404|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600405|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600406|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14600407|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
14600408|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
14600409|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600410|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600411|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021905|NCT02771158|Midodrine|midodrine|mesh-list
14021906|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
14600412|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14600413|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14600414|NCT00047164|Ipilimumab|ipilimumab|mesh-list
14600415|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14600416|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600417|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14600418|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600419|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
14600420|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600421|NCT00047190|Tipifarnib|tipifarnib|mesh-list
14600422|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600423|NCT00047203|Alvocidib|alvocidib|mesh-list
14600424|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600425|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600426|NCT00047203|Growth Substances|growth substances|mesh-ancestor
14600427|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600428|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600429|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600430|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600431|NCT00047216|Tipifarnib|tipifarnib|mesh-list
14600432|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600433|NCT00047229|Doxorubicin|doxorubicin|mesh-list
14600434|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14600435|NCT00047229|Oblimersen|oblimersen|mesh-list
14600436|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14600437|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600438|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14600439|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600440|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600441|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600442|NCT00047242|Irinotecan|irinotecan|mesh-list
14600443|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14600444|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14600445|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15159588|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15159589|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15159590|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021907|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
14600446|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600447|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600448|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600449|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600450|NCT00047255|Carboplatin|carboplatin|mesh-list
14600451|NCT00047255|Docetaxel|docetaxel|mesh-list
14600452|NCT00047255|Trastuzumab|trastuzumab|mesh-list
15159591|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15159592|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15159593|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159594|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
15159595|NCT04133194|Mesalamine|mesalamine|mesh-list
15159596|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14600453|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600454|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
14600455|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
14600456|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600457|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600458|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14600459|NCT00047268|Cytarabine|cytarabine|mesh-list
14600460|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
14600461|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600462|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
14600463|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600464|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600465|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
14600466|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600467|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600468|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
14600469|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600470|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14600471|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600472|NCT00047281|Thalidomide|thalidomide|mesh-list
14600473|NCT00047281|Celecoxib|celecoxib|mesh-list
14600474|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
14600475|NCT00047281|Etoposide|etoposide|mesh-list
14600476|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600477|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
14600478|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600479|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600480|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14600481|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
14600482|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600483|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600484|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14600485|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14600486|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14600487|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600488|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600489|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14600490|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14600491|NCT00047281|Analgesics|analgesics|mesh-ancestor
14600492|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
14600493|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600494|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14600495|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14600496|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14600497|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
14600498|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600499|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159597|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159598|NCT04133194|Analgesics|analgesics|mesh-ancestor
15159599|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
15159600|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159601|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159602|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159603|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159604|NCT04133259|Tenofovir|tenofovir|mesh-list
15159605|NCT04133259|Entecavir|entecavir|mesh-list
15159606|NCT04133259|Antibodies|antibodies|mesh-list
15159607|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15159608|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
15159609|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159610|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
15159611|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159612|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15159613|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15159614|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600500|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15159615|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159616|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15159617|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15159618|NCT04133480|Cannabidiol|cannabidiol|mesh-list
15159619|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
15159620|NCT04132791|Aspirin|aspirin|mesh-list
15159621|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15159622|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159623|NCT04132791|Analgesics|analgesics|mesh-ancestor
15159624|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
15159625|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159626|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159627|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14600501|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15159628|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159629|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15159630|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15159631|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159632|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14600502|NCT00047281|Growth Substances|growth substances|mesh-ancestor
14600503|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600504|NCT00047294|Thalidomide|thalidomide|mesh-list
14600505|NCT00047294|Celecoxib|celecoxib|mesh-list
14600506|NCT00047294|Temozolomide|temozolomide|mesh-list
14600507|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14600508|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
14600509|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600510|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600511|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14600512|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159633|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15159634|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159635|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
15180587|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14600513|NCT00047294|Analgesics|analgesics|mesh-ancestor
14600514|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
14600515|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600516|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600517|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14600518|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600519|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14600520|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14600521|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600522|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600523|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
14600524|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
14600525|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600526|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600527|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14600528|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14600529|NCT00047294|Growth Substances|growth substances|mesh-ancestor
14600530|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600531|NCT00047307|Gemcitabine|gemcitabine|mesh-list
14600532|NCT00047307|Alvocidib|alvocidib|mesh-list
14600533|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600534|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
14600535|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600536|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600537|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
14600538|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600539|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180588|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15180589|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180590|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180591|NCT03938259|Fentanyl|fentanyl|mesh-list
15180592|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15180593|NCT03938259|Narcotics|narcotics|mesh-ancestor
15180594|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14600540|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600541|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
14600542|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600543|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600544|NCT00047307|Growth Substances|growth substances|mesh-ancestor
14600545|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600546|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14600547|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600548|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600549|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600550|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600551|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14600552|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600553|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600554|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600555|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600556|NCT00047450|Citalopram|citalopram|mesh-list
14600557|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14600558|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600559|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600560|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600561|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600562|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
14600563|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600564|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14600565|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600566|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600567|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14600568|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14600569|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600570|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14600571|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600572|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600573|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600574|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
14600575|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600576|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
14600577|NCT00047502|Lonafarnib|lonafarnib|mesh-list
14291800|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14291801|NCT00556452|Busulfan|busulfan|mesh-list
14291802|NCT00556452|Clofarabine|clofarabine|mesh-list
15159636|NCT04133051|Bupivacaine|bupivacaine|mesh-list
15159637|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
15159638|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
15159639|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159640|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159641|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
15159642|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159643|NCT04132583|Diclofenac|diclofenac|mesh-list
15159644|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15159645|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159646|NCT04132583|Analgesics|analgesics|mesh-ancestor
15159647|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
15159648|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291803|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
14291804|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291805|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291806|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
14291807|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291808|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14291809|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291810|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14291811|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600578|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600579|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600580|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159649|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159650|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159651|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159652|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15159653|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159654|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600581|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600582|NCT00047554|Travoprost|travoprost|mesh-list
14600583|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14600584|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14600585|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14600586|NCT00047567|Zonisamide|zonisamide|mesh-list
14021908|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600587|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
14600588|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14600589|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600590|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600591|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14600592|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600593|NCT00047580|Tizanidine|tizanidine|mesh-list
14600594|NCT00047580|Analgesics|analgesics|mesh-ancestor
14600595|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
14600596|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600597|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600598|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
14600599|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14600600|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14600601|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
14600602|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
14600603|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14600604|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14600605|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14600606|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
14600607|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600608|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645102|NCT00193297|Paclitaxel|paclitaxel|mesh-list
14645103|NCT00193297|Carboplatin|carboplatin|mesh-list
14645104|NCT00193297|Topotecan|topotecan|mesh-list
14645105|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645106|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159655|NCT04132479|Amoxicillin|amoxicillin|mesh-list
15159656|NCT04132479|Clarithromycin|clarithromycin|mesh-list
15159657|NCT04132479|Tinidazole|tinidazole|mesh-list
15159658|NCT04132479|Rabeprazole|rabeprazole|mesh-list
15159659|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15159660|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159661|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15159662|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159663|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159664|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15159665|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15159666|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15159667|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15159668|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15159669|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
15159670|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15159671|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15159672|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15159673|NCT04132674|Tenofovir|tenofovir|mesh-list
15159674|NCT04132674|Emtricitabine|emtricitabine|mesh-list
15159675|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15159676|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
15159677|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645107|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645108|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645109|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645110|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645111|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645112|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645113|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645114|NCT00193310|Paclitaxel|paclitaxel|mesh-list
14645115|NCT00193310|Carboplatin|carboplatin|mesh-list
14645116|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645117|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645118|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645119|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645120|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645121|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645122|NCT00193323|Gemcitabine|gemcitabine|mesh-list
14645123|NCT00193323|Docetaxel|docetaxel|mesh-list
14645124|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645125|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
14645126|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645127|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645128|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
15159678|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15159679|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14645129|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600609|NCT00047632|Interferons|interferons|mesh-list
14600610|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
14600611|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600612|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
14600613|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600614|NCT00047645|Interferons|interferons|mesh-list
14600615|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
14600616|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600617|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
14600618|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600619|NCT00047658|Interferons|interferons|mesh-list
14600620|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
14600621|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600622|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
14600623|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600624|NCT00047671|Citalopram|citalopram|mesh-list
14600625|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14600626|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600627|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600628|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600629|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600630|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
14600631|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600632|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14600633|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600634|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600635|NCT00047710|Bevacizumab|bevacizumab|mesh-list
14600636|NCT00047710|Capecitabine|capecitabine|mesh-list
14600637|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14600638|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600639|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14600640|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14600641|NCT00047710|Growth Substances|growth substances|mesh-ancestor
14600642|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600643|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600644|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600645|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
14600646|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600647|NCT00047723|Minocycline|minocycline|mesh-list
14600648|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600649|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600650|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14600651|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600652|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600653|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600654|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159680|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159681|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159682|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15159683|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15159684|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
14600655|NCT00047749|Ziconotide|ziconotide|mesh-list
15159685|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
15159686|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15159687|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15159688|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159689|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159690|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159691|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159692|NCT04132661|Bisacodyl|bisacodyl|mesh-list
15159693|NCT04132661|Cathartics|cathartics|mesh-ancestor
14600656|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14600657|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600658|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600659|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14600660|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600661|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14600662|NCT00047749|Protective Agents|protective agents|mesh-ancestor
14600663|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14600664|NCT00047749|Analgesics|analgesics|mesh-ancestor
14600665|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
14600666|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600667|NCT00047762|Bevacizumab|bevacizumab|mesh-list
14814038|NCT00861328|ON 01910|on 01910|mesh-list
14814039|NCT00861328|Glycine|glycine|mesh-list
15159694|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600668|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14600669|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14600670|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600671|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14600672|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14600673|NCT00047762|Growth Substances|growth substances|mesh-ancestor
14600674|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600675|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
14600676|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600677|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600678|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600679|NCT00047801|Docetaxel|docetaxel|mesh-list
14600680|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600681|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
14600682|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
14600683|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600684|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600685|NCT00047827|Amphotericin B|amphotericin b|mesh-list
14600686|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14600687|NCT00047827|Micafungin|micafungin|mesh-list
14600688|NCT00047827|Amebicides|amebicides|mesh-ancestor
14600689|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14600690|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14600691|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600692|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600693|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
14600694|NCT00047840|Docetaxel|docetaxel|mesh-list
14600695|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600696|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
14600697|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
14600698|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600699|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600700|NCT00048087|Docetaxel|docetaxel|mesh-list
14600701|NCT00048087|Gefitinib|gefitinib|mesh-list
14600702|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600703|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14600704|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14600705|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600706|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600707|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600708|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600709|NCT00048113|Alicaforsen|alicaforsen|mesh-list
14600710|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600711|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600712|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
14600713|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600714|NCT00048126|Capecitabine|capecitabine|mesh-list
14600715|NCT00048126|Irinotecan|irinotecan|mesh-list
14600716|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600717|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
14600718|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600719|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600720|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14600721|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600722|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600723|NCT00048139|Capecitabine|capecitabine|mesh-list
14600724|NCT00048139|Irinotecan|irinotecan|mesh-list
14600725|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600726|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
14600727|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600728|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600729|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14600730|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14600731|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600732|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
14600733|NCT00048152|Cyclosporine|cyclosporine|mesh-list
14600734|NCT00048152|Cyclosporins|cyclosporins|mesh-list
14600735|NCT00048152|Daclizumab|daclizumab|mesh-list
14600736|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14600737|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600738|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14600739|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
14600740|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600741|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600742|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600743|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600744|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
14600745|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14600746|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600747|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
14600748|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600749|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600750|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14600751|NCT00048204|Paroxetine|paroxetine|mesh-list
14600752|NCT00048204|Vestipitant|vestipitant|mesh-list
14600753|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14600754|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600755|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600756|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600757|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600758|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
14600759|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600760|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14291812|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
14291813|NCT00556478|Lidocaine|lidocaine|mesh-list
14291814|NCT00556478|Prilocaine|prilocaine|mesh-list
14291815|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14291816|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
14291817|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
14291818|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291819|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291820|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
14600761|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600762|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600763|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14600764|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14600765|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600766|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14600767|NCT00048230|Bortezomib|bortezomib|mesh-list
14600768|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600769|NCT00048295|Alicaforsen|alicaforsen|mesh-list
14600770|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600771|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600772|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
14600773|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600774|NCT00048334|Romidepsin|romidepsin|mesh-list
14600775|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14600776|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600777|NCT00048360|Bupropion|bupropion|mesh-list
14600778|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14600779|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600780|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600781|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14600782|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600783|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600784|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600785|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
14600786|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600787|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600788|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14600789|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14600790|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600791|NCT00048373|Etanercept|etanercept|mesh-list
14600792|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14600793|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14600794|NCT00048373|Analgesics|analgesics|mesh-ancestor
14600795|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
14600796|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600797|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600798|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14600799|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14600800|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600801|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14600802|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
14600803|NCT00048399|Fludarabine|fludarabine|mesh-list
14600804|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
14600805|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600806|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14600807|NCT00048412|Fludarabine|fludarabine|mesh-list
14291821|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600808|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
14600809|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159695|NCT04132661|Laxatives|laxatives|mesh-ancestor
15159696|NCT04132713|Capecitabine|capecitabine|mesh-list
15159697|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159698|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
15159699|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159700|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159701|NCT04132635|Mitogens|mitogens|mesh-list
15159702|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14600810|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14600811|NCT00048425|Simendan|simendan|mesh-list
14600812|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14600813|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
14600814|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14600815|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14600816|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600817|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600818|NCT00048425|Protective Agents|protective agents|mesh-ancestor
14600819|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600820|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14600821|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600822|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600823|NCT00048503|Tipifarnib|tipifarnib|mesh-list
14600824|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600825|NCT00048555|Galiximab|galiximab|mesh-list
14600826|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14600827|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600828|NCT00048594|Aprepitant|aprepitant|mesh-list
14600829|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
14600830|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
14600831|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600832|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600833|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600834|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14600835|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600836|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600837|NCT00048607|Aprepitant|aprepitant|mesh-list
14600838|NCT00048607|Paroxetine|paroxetine|mesh-list
14600839|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14600840|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600841|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600842|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600843|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600844|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
14600845|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600846|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14600847|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600848|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600849|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14600850|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14600851|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600852|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
14600853|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
14600854|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600855|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600856|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14600857|NCT00048646|Progesterone|progesterone|mesh-list
14600858|NCT00048646|Progestins|progestins|mesh-ancestor
14600859|NCT00048646|Hormones|hormones|mesh-ancestor
14600860|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14600861|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645130|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159703|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021909|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021910|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14021911|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14021912|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14021913|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14021914|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14021915|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14021916|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159704|NCT04132648|Curcumin|curcumin|mesh-list
14600862|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
14600863|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14600864|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600865|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
14600866|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600867|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600868|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600869|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600870|NCT00048750|Micafungin|micafungin|mesh-list
14600871|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
14600872|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600873|NCT00048763|Cilostazol|cilostazol|mesh-list
14600874|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14600875|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
14600876|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600877|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600878|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14600879|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
14600880|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14600881|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14600882|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600883|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14600884|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
14600885|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14600886|NCT00048763|Protective Agents|protective agents|mesh-ancestor
14600887|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14600888|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14600889|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600890|NCT00048776|Cilostazol|cilostazol|mesh-list
14600891|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14600892|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
14600893|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159705|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15159706|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159707|NCT04132648|Analgesics|analgesics|mesh-ancestor
15159708|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
15159709|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159710|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159711|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159712|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021917|NCT02770885|Dulaglutide|dulaglutide|mesh-list
14021918|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14600894|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600895|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14600896|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
14600897|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14600898|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14600899|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021919|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021920|NCT02770651|Everolimus|everolimus|mesh-list
14021921|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159713|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159714|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159715|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159716|NCT04132570|Budesonide|budesonide|mesh-list
15159717|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159718|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15159719|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
15159720|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159721|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021922|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14021923|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
14021924|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021925|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
14021926|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14021927|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14600900|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14600901|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14600902|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15159722|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15159723|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
14021928|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600903|NCT00048776|Protective Agents|protective agents|mesh-ancestor
14600904|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15159724|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
15159725|NCT04132570|Hormones|hormones|mesh-ancestor
15159726|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159727|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
15159728|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15159729|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
15159730|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15159731|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600905|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14600906|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600907|NCT00048802|Valproic Acid|valproic acid|mesh-list
14600908|NCT00048802|Olanzapine|olanzapine|mesh-list
14600909|NCT00048802|Risperidone|risperidone|mesh-list
14600910|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14600911|NCT00048802|Ziprasidone|ziprasidone|mesh-list
14600912|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14600913|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
14600914|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600915|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600916|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600917|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14600918|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14600919|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14600920|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600921|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14600922|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
14600923|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
14600924|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
14600925|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600926|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600927|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14600928|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600929|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600930|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600931|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600932|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
14600933|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
14600934|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
14600935|NCT00048828|Olanzapine|olanzapine|mesh-list
14600936|NCT00048828|Clozapine|clozapine|mesh-list
14600937|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
14600938|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
14600939|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14600940|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600941|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600942|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14600943|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14600944|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14600945|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600946|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14600947|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600948|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600949|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600950|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600951|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
14600952|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14600953|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
14600954|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
14600955|NCT00048841|Alendronate|alendronate|mesh-list
14600956|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14600957|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600958|NCT00048854|Sertraline|sertraline|mesh-list
14600959|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
14600960|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14600961|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14600962|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14600963|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14600964|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600965|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14600966|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
14600967|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159732|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14600968|NCT00048880|Antibodies|antibodies|mesh-list
14600969|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14600970|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
14600971|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600972|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14600973|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
14600974|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14600975|NCT00049023|Octreotide|octreotide|mesh-list
14600976|NCT00049023|Edotreotide|edotreotide|mesh-list
14600977|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14600978|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14600979|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600980|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14600981|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600982|NCT00049062|Gefitinib|gefitinib|mesh-list
14600983|NCT00049062|Anastrozole|anastrozole|mesh-list
14600984|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600985|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14600986|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14600987|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14600988|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14600989|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14600990|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14600991|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14600992|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
14600993|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14600994|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14600995|NCT00049075|Fludarabine|fludarabine|mesh-list
14600996|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
14600997|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14600998|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14600999|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
14601000|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601001|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601002|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
14601003|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601004|NCT00049088|Bevacizumab|bevacizumab|mesh-list
14601005|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14601006|NCT00049088|Docetaxel|docetaxel|mesh-list
14601007|NCT00049088|Antibodies|antibodies|mesh-list
14601008|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
14601009|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14601010|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601011|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14601012|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14601013|NCT00049088|Growth Substances|growth substances|mesh-ancestor
14601014|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601015|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
14601016|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
14601017|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601018|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601019|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601020|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601021|NCT00049101|Leucovorin|leucovorin|mesh-list
14601022|NCT00049101|Fluorouracil|fluorouracil|mesh-list
14601023|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
14601024|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14601025|NCT00049101|Calcium|calcium|mesh-list
14601026|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
15159733|NCT04132557|Methylphenidate|methylphenidate|mesh-list
15159734|NCT04132557|Amphetamine|amphetamine|mesh-list
15159735|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15159736|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
15159737|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15159738|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14601027|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14601028|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601029|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
14601030|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601031|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601032|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601033|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601034|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
14814040|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159739|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601035|NCT00049101|Antidotes|antidotes|mesh-ancestor
14601036|NCT00049101|Protective Agents|protective agents|mesh-ancestor
15159740|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15159741|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15159742|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159743|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159744|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
15159745|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159746|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15159747|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
15159748|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
15159749|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
15159750|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159751|NCT04132063|Levetiracetam|levetiracetam|mesh-list
15159752|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
15159753|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
15159754|NCT04132115|Vancomycin|vancomycin|mesh-list
15159755|NCT04132115|Gentamicins|gentamicins|mesh-list
15159756|NCT04132115|Meropenem|meropenem|mesh-list
15159757|NCT04132115|Tazobactam|tazobactam|mesh-list
14601037|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
14601038|NCT00049101|Vitamins|vitamins|mesh-ancestor
14601039|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
14601040|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14601041|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601042|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
14601043|NCT00049114|Doxorubicin|doxorubicin|mesh-list
14601044|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14601045|NCT00049114|Tipifarnib|tipifarnib|mesh-list
14601046|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601047|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
14601048|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601049|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601050|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601051|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
14601052|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601053|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601054|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14601055|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14601056|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14601057|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14601058|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601059|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14601060|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601061|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14601062|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601063|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601064|NCT00049179|Cytarabine|cytarabine|mesh-list
14601065|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
14601066|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601067|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
14601068|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601069|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601070|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
14601071|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601072|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601073|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
14601074|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601075|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14601076|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
15159758|NCT04132115|Linezolid|linezolid|mesh-list
15159759|NCT04132115|Piperacillin|piperacillin|mesh-list
15159760|NCT04132115|Daptomycin|daptomycin|mesh-list
14601077|NCT00049192|Oblimersen|oblimersen|mesh-list
14601078|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601079|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14601080|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601081|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601082|NCT00049218|Carboplatin|carboplatin|mesh-list
14601083|NCT00049218|Etoposide|etoposide|mesh-list
14601084|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159761|NCT04132115|Amikacin|amikacin|mesh-list
15159762|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15159763|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
15159764|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
15159765|NCT04132115|Acyclovir|acyclovir|mesh-list
14601085|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14601086|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14601087|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15159766|NCT04132115|Ganciclovir|ganciclovir|mesh-list
14601088|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601089|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601090|NCT00049244|Capecitabine|capecitabine|mesh-list
14601091|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601092|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
14601093|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601094|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159767|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15159768|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159769|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15159770|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159771|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159772|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15159773|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
15159774|NCT04132011|Morphine|morphine|mesh-list
15159775|NCT04132011|Oxycodone|oxycodone|mesh-list
15159776|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
15159777|NCT04132011|Hydromorphone|hydromorphone|mesh-list
14601095|NCT00049283|Docetaxel|docetaxel|mesh-list
14601096|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14601097|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601098|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601099|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601100|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601101|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601102|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14601103|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601104|NCT00049296|Thalidomide|thalidomide|mesh-list
14601105|NCT00049296|Docetaxel|docetaxel|mesh-list
14601106|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601107|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601108|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601109|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601110|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601111|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601112|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
14601113|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601114|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
14601115|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14601116|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601117|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14601118|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14601119|NCT00049296|Growth Substances|growth substances|mesh-ancestor
14601120|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
14601121|NCT00049335|Capecitabine|capecitabine|mesh-list
14601122|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601123|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
14601124|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601125|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601126|NCT00049348|Gemcitabine|gemcitabine|mesh-list
14601127|NCT00049348|Fluorouracil|fluorouracil|mesh-list
15159778|NCT04132011|Narcotics|narcotics|mesh-ancestor
14601128|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
14601129|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601130|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601131|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
14601132|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601133|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
14601134|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601135|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601136|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601137|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
14601138|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601139|NCT00049348|Hematinics|hematinics|mesh-ancestor
14601140|NCT00049361|Thalidomide|thalidomide|mesh-list
14601141|NCT00049361|Temozolomide|temozolomide|mesh-list
14601142|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601143|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
15159779|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159780|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601144|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601145|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601146|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601147|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
14601148|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159781|NCT04132011|Analgesics|analgesics|mesh-ancestor
14601149|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
14601150|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14601151|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601152|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14601153|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14601154|NCT00049361|Growth Substances|growth substances|mesh-ancestor
14601155|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
14645131|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645132|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
14645133|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645134|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645135|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645136|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645137|NCT00193336|Gefitinib|gefitinib|mesh-list
14645138|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645139|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14645140|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645141|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645142|NCT00193349|Carboplatin|carboplatin|mesh-list
15159782|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
15159783|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645143|NCT00193349|Irinotecan|irinotecan|mesh-list
14645144|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
14645145|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645146|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645147|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645148|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159784|NCT04132102|Afatinib|afatinib|mesh-list
15159785|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159786|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15159787|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159788|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159789|NCT04131829|Fluoxetine|fluoxetine|mesh-list
15159790|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15159791|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15159792|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159793|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159794|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645149|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645150|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14645151|NCT00193362|Gemcitabine|gemcitabine|mesh-list
14645152|NCT00193362|Paclitaxel|paclitaxel|mesh-list
14645153|NCT00193362|Vinorelbine|vinorelbine|mesh-list
14645154|NCT00193362|Carboplatin|carboplatin|mesh-list
14645155|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645156|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645157|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645158|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645159|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645160|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645161|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645162|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
14645163|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
14645164|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645165|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645166|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645167|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
14645168|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645169|NCT00193388|Topotecan|topotecan|mesh-list
14645170|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645171|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15159795|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
15159796|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159797|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15159798|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
15159799|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645172|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645173|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645174|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645175|NCT00193401|Topotecan|topotecan|mesh-list
14645176|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645177|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645178|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645179|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647468|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601156|NCT00049374|Thalidomide|thalidomide|mesh-list
14601157|NCT00049374|Dexamethasone|dexamethasone|mesh-list
14601158|NCT00049374|Oblimersen|oblimersen|mesh-list
14601159|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601160|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
14601161|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
14601162|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601163|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601164|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14601165|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
14601166|NCT00049374|Hormones|hormones|mesh-ancestor
14601167|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14601168|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14601169|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14021929|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14021930|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14021931|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021932|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021933|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601170|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601171|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
14601172|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
14601173|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14601174|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601175|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14601176|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14601177|NCT00049374|Growth Substances|growth substances|mesh-ancestor
14601178|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
14601179|NCT00049387|Temozolomide|temozolomide|mesh-list
14601180|NCT00049387|Tipifarnib|tipifarnib|mesh-list
14601181|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601182|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
14601183|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601184|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601185|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
14601186|NCT00049413|Rituximab|rituximab|mesh-list
14601187|NCT00049413|Pentostatin|pentostatin|mesh-list
14601188|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601189|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
14601190|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601191|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601192|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601193|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
14601194|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601195|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601196|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14601197|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14601198|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14601199|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601200|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
14601201|NCT00049439|Lomustine|lomustine|mesh-list
14601202|NCT00049439|Etoposide|etoposide|mesh-list
14601203|NCT00049439|Procarbazine|procarbazine|mesh-list
14601204|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601205|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
14601206|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601207|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601208|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15159800|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15159801|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15159802|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159803|NCT04131621|Nivolumab|nivolumab|mesh-list
15159804|NCT04131621|Ipilimumab|ipilimumab|mesh-list
15159805|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15159806|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159807|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15159808|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159809|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
15159810|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14021934|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14021935|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
14601209|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
14601210|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601211|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601212|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14601213|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14601214|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14601215|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14601216|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601217|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
14601218|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14601219|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601220|NCT00049556|Gefitinib|gefitinib|mesh-list
14601221|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601222|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14601223|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601224|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601225|NCT00049569|Leucovorin|leucovorin|mesh-list
14601226|NCT00049569|Cytarabine|cytarabine|mesh-list
14601227|NCT00049569|Prednisone|prednisone|mesh-list
14601228|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
14601229|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14601230|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14601231|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14601232|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
14601233|NCT00049569|Doxorubicin|doxorubicin|mesh-list
14601234|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14601235|NCT00049569|Methotrexate|methotrexate|mesh-list
14601236|NCT00049569|Etoposide|etoposide|mesh-list
14601237|NCT00049569|Vincristine|vincristine|mesh-list
14601238|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
14601239|NCT00049569|Asparaginase|asparaginase|mesh-list
14601240|NCT00049569|Pegaspargase|pegaspargase|mesh-list
14601241|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
14601242|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601243|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
14601244|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601245|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601246|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601247|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
14601248|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601249|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601250|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15159811|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15159812|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14601251|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14601252|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14601253|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14601254|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601255|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601256|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
14601257|NCT00049569|Hormones|hormones|mesh-ancestor
14601258|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14601259|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14601260|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14601261|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
14601262|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14601263|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601264|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
14601265|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
14601266|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14601267|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14601268|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14601269|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
14601270|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601271|NCT00049569|Antidotes|antidotes|mesh-ancestor
14601272|NCT00049569|Protective Agents|protective agents|mesh-ancestor
14601273|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
14601274|NCT00049569|Vitamins|vitamins|mesh-ancestor
14601275|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
14601276|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601277|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601278|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601279|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14601280|NCT00049582|Decitabine|decitabine|mesh-list
14601281|NCT00049582|Azacitidine|azacitidine|mesh-list
14601282|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601283|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
14601284|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601285|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601286|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601287|NCT00049595|Prednisone|prednisone|mesh-list
14601288|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
14601289|NCT00049595|Dacarbazine|dacarbazine|mesh-list
14601290|NCT00049595|Doxorubicin|doxorubicin|mesh-list
14601291|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14601292|NCT00049595|Etoposide|etoposide|mesh-list
14601293|NCT00049595|Vincristine|vincristine|mesh-list
14601294|NCT00049595|Bleomycin|bleomycin|mesh-list
15159813|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159814|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159815|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
15159816|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159817|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601295|NCT00049595|Vinblastine|vinblastine|mesh-list
14601296|NCT00049595|Procarbazine|procarbazine|mesh-list
14601297|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601298|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
14601299|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601300|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601301|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601302|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
14601303|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601304|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601305|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14601306|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14601307|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14601308|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14601309|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601310|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601311|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
14601312|NCT00049595|Hormones|hormones|mesh-ancestor
14601313|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14601314|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14601315|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14601316|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601317|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601318|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601319|NCT00049608|Gemcitabine|gemcitabine|mesh-list
14601320|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601321|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
14601322|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601323|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601324|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
14601325|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601326|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601327|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601328|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
14601329|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601330|NCT00049634|Cyclosporine|cyclosporine|mesh-list
14601331|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
14601332|NCT00049634|Busulfan|busulfan|mesh-list
14601333|NCT00049634|Methotrexate|methotrexate|mesh-list
14601334|NCT00049634|Cyclosporins|cyclosporins|mesh-list
14601335|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601336|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
14601337|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601338|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601339|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601340|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
14601341|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601342|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601343|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14601344|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15159818|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15159819|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159820|NCT04131582|Metformin|metformin|mesh-list
15159821|NCT04131582|Empagliflozin|empagliflozin|mesh-list
15159822|NCT04131582|Linagliptin|linagliptin|mesh-list
15159823|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15159824|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159825|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15159826|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159827|NCT04131582|Incretins|incretins|mesh-ancestor
15159828|NCT04131582|Hormones|hormones|mesh-ancestor
15159829|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14601345|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
14601346|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14601347|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601348|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
14601349|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
14601350|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601351|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14601352|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14601353|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
14601354|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601355|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14601356|NCT00049660|Capecitabine|capecitabine|mesh-list
14601357|NCT00049660|Vinorelbine|vinorelbine|mesh-list
14601358|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601359|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
14601360|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601361|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601362|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14601363|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601364|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601365|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601366|NCT00049725|Daclizumab|daclizumab|mesh-list
14601367|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601368|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
14601369|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601370|NCT00049751|Adalimumab|adalimumab|mesh-list
14601371|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601372|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601373|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14601374|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601375|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14601376|NCT00049777|Heparin|heparin|mesh-list
14601377|NCT00049777|Calcium heparin|calcium heparin|mesh-list
14601378|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14601379|NCT00049777|Tinzaparin|tinzaparin|mesh-list
14601380|NCT00049777|Dalteparin|dalteparin|mesh-list
14601381|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
14601382|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14601383|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14601384|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601385|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601386|NCT00049790|Paclitaxel|paclitaxel|mesh-list
14601387|NCT00049790|Carboplatin|carboplatin|mesh-list
14601388|NCT00049790|Angiostatins|angiostatins|mesh-list
14601389|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14601390|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601391|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601392|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601393|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601394|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601395|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14601396|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14601397|NCT00049790|Growth Substances|growth substances|mesh-ancestor
14601398|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601399|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
14601400|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
14601401|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14601402|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15159830|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14601403|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
14601404|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
14601405|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14601406|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601407|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
14601408|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14601409|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601410|NCT00049946|Risperidone|risperidone|mesh-list
14601411|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14601412|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
14601413|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601414|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601415|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601416|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14601417|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14601418|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14601419|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601420|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14601421|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
14601422|NCT00049972|Paroxetine|paroxetine|mesh-list
14601423|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14601424|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14601425|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14601426|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601427|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601428|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
14601429|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601430|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14601431|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
14601432|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601433|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14601434|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601435|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601436|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
14601437|NCT00049985|Hematinics|hematinics|mesh-ancestor
14601438|NCT00049998|Topotecan|topotecan|mesh-list
14601439|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14601440|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14601441|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601442|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601443|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601444|NCT00050063|Vaccines|vaccines|mesh-list
14601445|NCT00050063|Immunologic Factors|immunologic factors|mesh-ancestor
14601446|NCT00050063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601447|NCT00050141|Tipifarnib|tipifarnib|mesh-list
14601448|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601449|NCT00050154|Tipifarnib|tipifarnib|mesh-list
14601450|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601451|NCT00050180|Indinavir|indinavir|mesh-list
14601452|NCT00050180|Saquinavir|saquinavir|mesh-list
14601453|NCT00050180|Midazolam|midazolam|mesh-list
14601454|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14601455|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14601456|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14601457|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601458|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14601459|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14601460|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601461|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14601462|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
14601463|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
14601464|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
14601465|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
15159831|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
15159832|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159833|NCT04131283|Epinephrine|epinephrine|mesh-list
15159834|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15159835|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15159836|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
14601466|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159837|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159838|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159839|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159840|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15159841|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15159842|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
15159843|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601467|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601468|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14601469|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14601470|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
14601471|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601472|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14601473|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14601474|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
14601475|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601476|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14601477|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601478|NCT00050206|Olanzapine|olanzapine|mesh-list
14601479|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
15159844|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14601480|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
14601481|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601482|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159845|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
14601483|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14601484|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14601485|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14601486|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159846|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
15159847|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
15159848|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15159849|NCT04131309|Dexamethasone|dexamethasone|mesh-list
15159850|NCT04131309|Bortezomib|bortezomib|mesh-list
15159851|NCT04131309|Daratumumab|daratumumab|mesh-list
15159852|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159853|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
15159854|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
15159855|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601487|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601488|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14601489|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14601490|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159856|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159857|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15159858|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
15159859|NCT04131309|Hormones|hormones|mesh-ancestor
15159860|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159861|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15159862|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159863|NCT04131231|Aldesleukin|aldesleukin|mesh-list
15159864|NCT04131231|Methotrexate|methotrexate|mesh-list
15159865|NCT04131231|Interleukin-2|interleukin-2|mesh-list
15159866|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15159867|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
15159868|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15159869|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159870|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159871|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
14601491|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601492|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601493|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
14601494|NCT00050245|Rituximab|rituximab|mesh-list
14601495|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14601496|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601497|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
14601498|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601499|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601500|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
14601501|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
14601502|NCT00050271|Vitamins|vitamins|mesh-ancestor
14601503|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
14601504|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601505|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
14601506|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
14601507|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14601508|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601509|NCT00050336|Lonafarnib|lonafarnib|mesh-list
14601510|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601511|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601512|NCT00050349|Epothilones|epothilones|mesh-list
14601513|NCT00050349|Epothilone B|epothilone b|mesh-list
14601514|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601515|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601516|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601517|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601518|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601519|NCT00050362|Rofecoxib|rofecoxib|mesh-list
14601520|NCT00050362|Bupivacaine|bupivacaine|mesh-list
14601521|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
14601522|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
14601523|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14601524|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601525|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
14601526|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601527|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14601528|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14601529|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159872|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601530|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601531|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14601532|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14601533|NCT00050362|Analgesics|analgesics|mesh-ancestor
14601534|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601535|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601536|NCT00050375|Oregovomab|oregovomab|mesh-list
14601537|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14601538|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601539|NCT00050401|Vancomycin|vancomycin|mesh-list
14601540|NCT00050401|Tobramycin|tobramycin|mesh-list
14601541|NCT00050401|Meropenem|meropenem|mesh-list
14601542|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14601543|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601544|NCT00050414|Dexamethasone|dexamethasone|mesh-list
14601545|NCT00050414|Trabectedin|trabectedin|mesh-list
14601546|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601547|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
14601548|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
14601549|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601550|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601551|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14601552|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
14601553|NCT00050414|Hormones|hormones|mesh-ancestor
14601554|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14601555|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14601556|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601557|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601558|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
14601559|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601560|NCT00050427|Trabectedin|trabectedin|mesh-list
14601561|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601562|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
14601563|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601564|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601565|NCT00050440|Dexamethasone|dexamethasone|mesh-list
14601566|NCT00050440|Trabectedin|trabectedin|mesh-list
14601567|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601568|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
14601569|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
14601570|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601571|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601572|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14601573|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
15159873|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159874|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
15159875|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159876|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15159877|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159878|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
15159879|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159880|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15159881|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159882|NCT04131231|Analgesics|analgesics|mesh-ancestor
15159883|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
15159884|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159885|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15159886|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15159887|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
15159888|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15159889|NCT04131322|Adalimumab|adalimumab|mesh-list
15159890|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15159891|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159892|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159893|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15159894|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15159895|NCT04131192|Gemcitabine|gemcitabine|mesh-list
15159896|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15159897|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
15159898|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159899|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159900|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
15159901|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601574|NCT00050440|Hormones|hormones|mesh-ancestor
14601575|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159902|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601576|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14601577|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601578|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14601579|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
14601580|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601581|NCT00050479|Celecoxib|celecoxib|mesh-list
14601582|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14601583|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14601584|NCT00050479|Analgesics|analgesics|mesh-ancestor
14601585|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
14601586|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601587|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601588|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601589|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601590|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14601591|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14601592|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601593|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601594|NCT00050505|Vaccines|vaccines|mesh-list
14601595|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
14601596|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601597|NCT00050531|Interferons|interferons|mesh-list
14601598|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
14601599|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
14601600|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14601601|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14601602|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
14601603|NCT00050531|Molgramostim|molgramostim|mesh-list
14601604|NCT00050531|Sargramostim|sargramostim|mesh-list
14601605|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601606|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
14601607|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601608|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
14601609|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601610|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14601611|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601612|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601613|NCT00050596|Docetaxel|docetaxel|mesh-list
14601614|NCT00050596|Ipilimumab|ipilimumab|mesh-list
14601615|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601616|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601617|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601618|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601619|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601620|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14601621|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14601622|NCT00050609|Tadalafil|tadalafil|mesh-list
14601623|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
15159903|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15159904|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
15159905|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180595|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180596|NCT03938259|Analgesics|analgesics|mesh-ancestor
15180597|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
15180598|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180599|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15180600|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15180601|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
15180602|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
15180603|NCT03937869|Secnidazole|secnidazole|mesh-list
15180604|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14601624|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14601625|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14601626|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601627|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601628|NCT00050609|Urological Agents|urological agents|mesh-ancestor
14601629|NCT00050635|Octreotide|octreotide|mesh-list
14601630|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14601631|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14601632|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601633|NCT00050648|Cyclosporine|cyclosporine|mesh-list
14601634|NCT00050648|Cyclosporins|cyclosporins|mesh-list
14601635|NCT00050648|Daclizumab|daclizumab|mesh-list
14601636|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601637|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180605|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14601638|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601639|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
14601640|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601641|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
14601642|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601643|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
14601644|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601645|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14601646|NCT00050661|Daclizumab|daclizumab|mesh-list
14601647|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601648|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
14601649|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601650|NCT00050674|Lenograstim|lenograstim|mesh-list
14601651|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14601652|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
14601653|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601654|NCT00050713|Sirolimus|sirolimus|mesh-list
14601655|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14601656|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601657|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14601658|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601659|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
14601660|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601661|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
14601662|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601663|NCT00050726|Interleukin-2|interleukin-2|mesh-list
14601664|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601665|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159906|NCT04130698|Nicotine|nicotine|mesh-list
15159907|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15159908|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
15159909|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159910|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159911|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15159912|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15159913|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
15159914|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159915|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159916|NCT04130815|Furosemide|furosemide|mesh-list
15159917|NCT04130815|Diuretics|diuretics|mesh-ancestor
15159918|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
15159919|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601666|NCT00050726|Analgesics|analgesics|mesh-ancestor
14601667|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
14601668|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601669|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601670|NCT00050804|Sertraline|sertraline|mesh-list
14601671|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
14601672|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601673|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14601674|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14601675|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14601676|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601677|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601678|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
14601679|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601680|NCT00050817|Clopidogrel|clopidogrel|mesh-list
14601681|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14601682|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14601683|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14601684|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14601685|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
14601686|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814041|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14814042|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14814043|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814044|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814045|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14814046|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14814047|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
14814048|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814049|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159920|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14601687|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814050|NCT00861367|Aspirin|aspirin|mesh-list
14814051|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14601688|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601689|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
14601690|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
14601691|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
14601692|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14601693|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601694|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
14601695|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601696|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601697|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14601698|NCT00050830|Protective Agents|protective agents|mesh-ancestor
14601699|NCT00050843|Thalidomide|thalidomide|mesh-list
14601700|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601701|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
15159921|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159922|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159923|NCT04130672|Hemostatics|hemostatics|mesh-list
15159924|NCT04130672|Coagulants|coagulants|mesh-ancestor
15159925|NCT04130464|Ketorolac|ketorolac|mesh-list
15159926|NCT04130464|Ropivacaine|ropivacaine|mesh-list
15159927|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
15159928|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
15159929|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15159930|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159931|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
15159932|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159933|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15159934|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14601702|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601703|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
14601704|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14601705|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601706|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14601707|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14601708|NCT00050843|Growth Substances|growth substances|mesh-ancestor
14601709|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
14601710|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601711|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
14601712|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14601713|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14601714|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601715|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14601716|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14601717|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
14601718|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601719|NCT00050895|Ritonavir|ritonavir|mesh-list
14601720|NCT00050895|Lopinavir|lopinavir|mesh-list
14601721|NCT00050895|Tenofovir|tenofovir|mesh-list
14601722|NCT00050895|Lamivudine|lamivudine|mesh-list
14601723|NCT00050895|Zidovudine|zidovudine|mesh-list
14601724|NCT00050895|Stavudine|stavudine|mesh-list
14601725|NCT00050895|Efavirenz|efavirenz|mesh-list
14601726|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14601727|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14601728|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
15159935|NCT04130464|Analgesics|analgesics|mesh-ancestor
15159936|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15159937|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15159938|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15159939|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159940|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159941|NCT04130399|Folfirinox|folfirinox|mesh-list
15159942|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159943|NCT04130438|Nebivolol|nebivolol|mesh-list
15159944|NCT04130438|Diltiazem|diltiazem|mesh-list
14601729|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601730|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601731|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14601732|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14601733|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
14601734|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601735|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14647469|NCT00199979|Nevirapine|nevirapine|mesh-list
14814052|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15159945|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15159946|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
14601736|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601737|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14601738|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14291822|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14291823|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14291824|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14291825|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14021936|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14021937|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021938|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14021939|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14021940|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14021941|NCT02770794|Infliximab|infliximab|mesh-list
14021942|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291826|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159947|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15159948|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15159949|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15159950|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291827|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14291828|NCT00556491|Minocycline|minocycline|mesh-list
14291829|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14291830|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291831|NCT00556504|Ribavirin|ribavirin|mesh-list
14601739|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
14601740|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14601741|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14601742|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14601743|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14601744|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14601745|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14601746|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14601747|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
14601748|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601749|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
14601750|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
14601751|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14601752|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14601753|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14601754|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601755|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14601756|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14601757|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
14601758|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
14601759|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14601760|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14601761|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14601762|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601763|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14601764|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14601765|NCT00050973|Bexarotene|bexarotene|mesh-list
14814053|NCT00861367|Analgesics|analgesics|mesh-ancestor
15159951|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159952|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159953|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159954|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15159955|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15159956|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15159957|NCT04130477|Nickel|nickel|mesh-list
15159958|NCT04130477|Trace Elements|trace elements|mesh-ancestor
15159959|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
15159960|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159961|NCT04130230|Choline|choline|mesh-list
15159962|NCT04130230|Neostigmine|neostigmine|mesh-list
15159963|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15159964|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159965|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021943|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021944|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14021945|NCT02770690|Lidocaine|lidocaine|mesh-list
14021946|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
14021947|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
14601766|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645180|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645181|NCT00193440|Rituximab|rituximab|mesh-list
14645182|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14645183|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645184|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
14645185|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645186|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645187|NCT00193466|Rituximab|rituximab|mesh-list
14645188|NCT00193466|Fludarabine|fludarabine|mesh-list
14645189|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14645190|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645191|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
14645192|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645193|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645194|NCT00193505|Rituximab|rituximab|mesh-list
14645195|NCT00193505|Carboplatin|carboplatin|mesh-list
14645196|NCT00193505|Etoposide|etoposide|mesh-list
14645197|NCT00193505|Ifosfamide|ifosfamide|mesh-list
14645198|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14645199|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645200|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
14645201|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645202|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645203|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645204|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14645205|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645206|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645207|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645208|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14645209|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
14645210|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
14645211|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645212|NCT00193531|Paclitaxel|paclitaxel|mesh-list
14645213|NCT00193531|Etoposide|etoposide|mesh-list
14645214|NCT00193531|Carboplatin|carboplatin|mesh-list
15159966|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
15159967|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15159968|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159969|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15159970|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
15159971|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15159972|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
15159973|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15159974|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
15159975|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15159976|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15159977|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
15159978|NCT04130152|Letrozole|letrozole|mesh-list
15159979|NCT04130152|Palbociclib|palbociclib|mesh-list
15159980|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15159981|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15159982|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15159983|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159984|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159985|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15159986|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
15159987|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15159988|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15159989|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15159990|NCT04130087|Selegiline|selegiline|mesh-list
15159991|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
15159992|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15159993|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15159994|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15159995|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15159996|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15159997|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15159998|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15159999|NCT04130087|Protective Agents|protective agents|mesh-ancestor
15160000|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160001|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
15160002|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14645215|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645216|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601767|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
14601768|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
14601769|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
14601770|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14601771|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601772|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
14601773|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14601774|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601775|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14601776|NCT00051051|Protective Agents|protective agents|mesh-ancestor
14601777|NCT00051077|Ribavirin|ribavirin|mesh-list
14601778|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14601779|NCT00051077|Adefovir|adefovir|mesh-list
14601780|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14601781|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
14601782|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601783|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
14601784|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601785|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14601786|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14601787|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601788|NCT00051090|Lamivudine|lamivudine|mesh-list
14601789|NCT00051090|Efavirenz|efavirenz|mesh-list
14601790|NCT00051090|Abacavir|abacavir|mesh-list
14601791|NCT00051090|Didanosine|didanosine|mesh-list
14601792|NCT00051090|Telbivudine|telbivudine|mesh-list
14601793|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14601794|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14601795|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601796|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601797|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
14601798|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601799|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14601800|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14601801|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14601802|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601803|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14601804|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14601805|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14601806|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14601807|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
14601808|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
14601809|NCT00051116|Lenalidomide|lenalidomide|mesh-list
14601810|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
14601811|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601812|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14601813|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14601814|NCT00051116|Growth Substances|growth substances|mesh-ancestor
14601815|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
14601816|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601817|NCT00051142|Travoprost|travoprost|mesh-list
14601818|NCT00051142|Latanoprost|latanoprost|mesh-list
14601819|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14601820|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14601821|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14601822|NCT00051155|Timolol|timolol|mesh-list
14601823|NCT00051155|Travoprost|travoprost|mesh-list
14601824|NCT00051155|Latanoprost|latanoprost|mesh-list
14601825|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14601826|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14601827|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
14601828|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601829|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601830|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601831|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14601832|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15160003|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
15160004|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160005|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
15160006|NCT04130100|Protective Agents|protective agents|mesh-ancestor
15160007|NCT04129788|Bisacodyl|bisacodyl|mesh-list
15160008|NCT04129788|Cathartics|cathartics|mesh-ancestor
14291832|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14601833|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14601834|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14601835|NCT00051181|Travoprost|travoprost|mesh-list
14021948|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
14601836|NCT00051181|Latanoprost|latanoprost|mesh-list
14601837|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14601838|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14601839|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14601840|NCT00051259|Bupropion|bupropion|mesh-list
15160009|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160010|NCT04129788|Laxatives|laxatives|mesh-ancestor
15160011|NCT04129697|Dexamethasone|dexamethasone|mesh-list
15160012|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
15160013|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15160014|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15160015|NCT04129697|Prednisolone|prednisolone|mesh-list
15160016|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
15160017|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15160018|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
15160019|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160020|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
15160021|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
15160022|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160023|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160024|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160025|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
15160026|NCT04129697|Hormones|hormones|mesh-ancestor
15160027|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160028|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14601841|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14601842|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
15160029|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160030|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15160031|NCT04129697|Protective Agents|protective agents|mesh-ancestor
14601843|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601844|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14601845|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14601846|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14601847|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601848|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
14601849|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601850|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601851|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14601852|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601853|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601854|NCT00051272|Bupropion|bupropion|mesh-list
14601855|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14601856|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
14601857|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601858|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14601859|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14601860|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160032|NCT04129736|Teriflunomide|teriflunomide|mesh-list
15160033|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15160034|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15160035|NCT04129736|Analgesics|analgesics|mesh-ancestor
15160036|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
14601861|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601862|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
14601863|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601864|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601865|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14601866|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601867|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601868|NCT00051285|Enoximone|enoximone|mesh-list
14601869|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14601870|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
14601871|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14601872|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14601873|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601874|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601875|NCT00051285|Protective Agents|protective agents|mesh-ancestor
14601876|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601877|NCT00051298|Olanzapine|olanzapine|mesh-list
14601878|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
14601879|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
14601880|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160037|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160038|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601881|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601882|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14601883|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14601884|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14601885|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14601886|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14601887|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14601888|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14601889|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14601890|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601891|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14601892|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
14601893|NCT00051389|Fosinopril|fosinopril|mesh-list
14601894|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14601895|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
14601896|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601897|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601898|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14601899|NCT00051441|Benzydamine|benzydamine|mesh-list
14601900|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14601901|NCT00051493|Carboplatin|carboplatin|mesh-list
14601902|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601903|NCT00051506|Carboplatin|carboplatin|mesh-list
14601904|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601905|NCT00051532|Seocalcitol|seocalcitol|mesh-list
15160039|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160040|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160041|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160042|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
15160043|NCT04129710|Rituximab|rituximab|mesh-list
15160044|NCT04129710|Methotrexate|methotrexate|mesh-list
15160045|NCT04129710|Etoposide|etoposide|mesh-list
15160046|NCT04129710|Lenalidomide|lenalidomide|mesh-list
15160047|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160048|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160049|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
15160050|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160051|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160052|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15160053|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
15160054|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14601906|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601907|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601908|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
14601909|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601910|NCT00051545|Seocalcitol|seocalcitol|mesh-list
14601911|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601912|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160055|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160056|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
15160057|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601913|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
14601914|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601915|NCT00051571|Docetaxel|docetaxel|mesh-list
14601916|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601917|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
14601918|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14601919|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
14601920|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601921|NCT00051584|Gemcitabine|gemcitabine|mesh-list
14601922|NCT00051584|Doxorubicin|doxorubicin|mesh-list
14601923|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
15160058|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
15160059|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160060|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14601924|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14601925|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
14601926|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601927|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601928|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
14601929|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601930|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160061|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601931|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14601932|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
14601933|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601934|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14601935|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14601936|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14601937|NCT00051597|Antibodies|antibodies|mesh-list
14601938|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14601939|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
14601940|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14601941|NCT00051623|Infliximab|infliximab|mesh-list
14601942|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
14601943|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14601944|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14601945|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
14601946|NCT00051688|Tezacitabine|tezacitabine|mesh-list
14601947|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601948|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601949|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601950|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
14601951|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14601952|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160062|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15160063|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15160064|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15160065|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15160066|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15160067|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15160068|NCT04129710|Growth Substances|growth substances|mesh-ancestor
15160069|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
15160070|NCT04129424|Insulin|insulin|mesh-list
15160071|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15160072|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160073|NCT04129255|Octreotide|octreotide|mesh-list
15160074|NCT04129255|Somatostatin|somatostatin|mesh-list
15160075|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160076|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15160077|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160078|NCT04129255|Hormones|hormones|mesh-ancestor
15160079|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160080|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160081|NCT04129489|Cannabidiol|cannabidiol|mesh-list
14601953|NCT00051753|Amoxicillin|amoxicillin|mesh-list
14601954|NCT00051753|Levofloxacin|levofloxacin|mesh-list
14601955|NCT00051753|Ofloxacin|ofloxacin|mesh-list
14601956|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
14601957|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
14601958|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14601959|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14601960|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601961|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14601962|NCT00051753|Renal Agents|renal agents|mesh-ancestor
14601963|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14601964|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14601965|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601966|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601967|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14601968|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14601969|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601970|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14601971|NCT00051831|Ritonavir|ritonavir|mesh-list
14601972|NCT00051831|Saquinavir|saquinavir|mesh-list
14021949|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14021950|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021951|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
14021952|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14021953|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14021954|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14021955|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14021956|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14021957|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601973|NCT00051831|Tenofovir|tenofovir|mesh-list
14601974|NCT00051831|Emtricitabine|emtricitabine|mesh-list
14601975|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
15160082|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
15160083|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
14601976|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14601977|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14601978|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
14601979|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601980|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601981|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14601982|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14601983|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
14601984|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601985|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14601986|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14601987|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14601988|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14601989|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14601990|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14601991|NCT00051844|Capravirine|capravirine|mesh-list
14601992|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14601993|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14601994|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14601995|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14601996|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
14601997|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14601998|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14601999|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14602000|NCT00051896|Vanoxerine|vanoxerine|mesh-list
14602001|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14602002|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14602003|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14602004|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602005|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
14602006|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14602007|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602008|NCT00051974|Bortezomib|bortezomib|mesh-list
14602009|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602010|NCT00051987|Bortezomib|bortezomib|mesh-list
14602011|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602012|NCT00052000|Antibodies|antibodies|mesh-list
14602013|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14602014|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
14602015|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602016|NCT00052013|Vatalanib|vatalanib|mesh-list
14602017|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602018|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602019|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602020|NCT00052026|Carvedilol|carvedilol|mesh-list
14602021|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15160084|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160085|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602022|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14602023|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
14602024|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14602025|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602026|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602027|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14602028|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
14602029|NCT00052026|Protective Agents|protective agents|mesh-ancestor
14602030|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15160086|NCT04128891|Valsartan|valsartan|mesh-list
15160087|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15160088|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15160089|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15160090|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15160091|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160092|NCT04128787|Omeprazole|omeprazole|mesh-list
15160093|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15160094|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160095|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15160096|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160097|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160098|NCT04128800|Apatinib|apatinib|mesh-list
15160099|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160100|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602031|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14021958|NCT02770404|Nafithromycin|nafithromycin|mesh-list
14602032|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14602033|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
14602034|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14602035|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15160101|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160102|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602036|NCT00052039|Interferons|interferons|mesh-list
14602037|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
14602038|NCT00052039|Azathioprine|azathioprine|mesh-list
14602039|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602040|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
14602041|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602042|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
14602043|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602044|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602045|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602046|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
14602047|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602048|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602049|NCT00052052|Interferons|interferons|mesh-list
14602050|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
14602051|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602052|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
14602053|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602054|NCT00052117|Capravirine|capravirine|mesh-list
15180606|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180607|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
14602055|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602056|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602057|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14602058|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14602059|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
14602060|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602061|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14602062|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14602063|NCT00052169|Docetaxel|docetaxel|mesh-list
14602064|NCT00052169|Gefitinib|gefitinib|mesh-list
14602065|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602066|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602067|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602068|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602069|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602070|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602071|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180608|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15180609|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602072|NCT00052208|Gefitinib|gefitinib|mesh-list
14602073|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602074|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602075|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602076|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602077|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
14602078|NCT00052221|Hematinics|hematinics|mesh-ancestor
14602079|NCT00052273|Capecitabine|capecitabine|mesh-list
14602080|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602081|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
14602082|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602083|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602084|NCT00052286|Modafinil|modafinil|mesh-list
14602085|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14602086|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602087|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14602088|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14602089|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14602090|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602091|NCT00052299|Cytarabine|cytarabine|mesh-list
14602092|NCT00052299|Etoposide|etoposide|mesh-list
14602093|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
14602094|NCT00052299|Idarubicin|idarubicin|mesh-list
14602095|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
14602096|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180610|NCT03937687|Caffeine|caffeine|mesh-list
15180611|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14602097|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602098|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602099|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602100|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602101|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160103|NCT04129008|Aspirin|aspirin|mesh-list
15160104|NCT04129008|Indobufen|indobufen|mesh-list
15160105|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15160106|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15160107|NCT04129008|Analgesics|analgesics|mesh-ancestor
15160108|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
15160109|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160110|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160111|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160112|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160113|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15160114|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15160115|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160116|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15160117|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15160118|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160119|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
15160120|NCT04129112|Propofol|propofol|mesh-list
15160121|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
15160122|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160123|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602102|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602103|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
14602104|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
14602105|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602106|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602107|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
14602108|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602109|NCT00052299|Analgesics|analgesics|mesh-ancestor
14602110|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
14602111|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602112|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602113|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14602114|NCT00052312|Paclitaxel|paclitaxel|mesh-list
14602115|NCT00052312|Doxorubicin|doxorubicin|mesh-list
14602116|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14602117|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602118|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602119|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602120|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602121|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602122|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602123|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602124|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602125|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602126|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602127|NCT00052338|Gemcitabine|gemcitabine|mesh-list
14602128|NCT00052338|Carboplatin|carboplatin|mesh-list
14602129|NCT00052338|Bortezomib|bortezomib|mesh-list
14602130|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602131|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602132|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
14602133|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602134|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
14602135|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602136|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602137|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602138|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
14602139|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602140|NCT00052351|Metronidazole|metronidazole|mesh-list
14602141|NCT00052351|Paclitaxel|paclitaxel|mesh-list
14602142|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
14602143|NCT00052351|Doxorubicin|doxorubicin|mesh-list
14602144|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14602145|NCT00052351|Vaccines|vaccines|mesh-list
14602146|NCT00052351|Sargramostim|sargramostim|mesh-list
14602147|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
14602148|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602149|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602150|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814054|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
15160124|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14602151|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602152|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602153|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602154|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602155|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602156|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602157|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602158|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
14602159|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602160|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602161|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602162|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602163|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602164|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602165|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602166|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14602167|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14602168|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
15160125|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15160126|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
15160127|NCT04128878|Sotalol|sotalol|mesh-list
15160128|NCT04128878|Dofetilide|dofetilide|mesh-list
15160129|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14602169|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602170|NCT00052377|Aldesleukin|aldesleukin|mesh-list
14602171|NCT00052377|Interleukin-2|interleukin-2|mesh-list
14602172|NCT00052377|Interleukin-12|interleukin-12|mesh-list
14602173|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602174|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14602175|NCT00052377|Analgesics|analgesics|mesh-ancestor
14602176|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
14602177|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602178|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602179|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14602180|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14602181|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
14602182|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602183|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14602184|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
14602185|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602186|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602187|NCT00052377|Growth Substances|growth substances|mesh-ancestor
14602188|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602189|NCT00052390|Bevacizumab|bevacizumab|mesh-list
14602190|NCT00052390|Doxorubicin|doxorubicin|mesh-list
14602191|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14602192|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14602193|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602194|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602195|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602196|NCT00052390|Growth Substances|growth substances|mesh-ancestor
14602197|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602198|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602199|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602200|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602201|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602202|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602203|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602204|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14602205|NCT00052403|Antibodies|antibodies|mesh-list
14602206|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
14602207|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14602208|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
14602209|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
14602210|NCT00052403|Mitogens|mitogens|mesh-list
14602211|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602212|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602213|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602214|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602215|NCT00052416|Thalidomide|thalidomide|mesh-list
14602216|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602217|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
14814055|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602218|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602219|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
14602220|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602221|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602222|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602223|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602224|NCT00052416|Growth Substances|growth substances|mesh-ancestor
14602225|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602226|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602227|NCT00052455|Vincristine|vincristine|mesh-list
14602228|NCT00052455|Temozolomide|temozolomide|mesh-list
14602229|NCT00052455|Lomustine|lomustine|mesh-list
14602230|NCT00052455|Procarbazine|procarbazine|mesh-list
14602231|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602232|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602233|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602234|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602235|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602236|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602237|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602238|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
14602239|NCT00052468|Gemcitabine|gemcitabine|mesh-list
14602240|NCT00052468|Paclitaxel|paclitaxel|mesh-list
14602241|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14602242|NCT00052468|Carboplatin|carboplatin|mesh-list
14602243|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602244|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602245|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602246|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602247|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602248|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602249|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602250|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
14602251|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
14602252|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602253|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602254|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602255|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
14602256|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602257|NCT00052494|Irinotecan|irinotecan|mesh-list
14602258|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
14602259|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602260|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14602261|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602262|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602263|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602264|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602265|NCT00052507|Bortezomib|bortezomib|mesh-list
14602266|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602267|NCT00052559|Bevacizumab|bevacizumab|mesh-list
14602268|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14602269|NCT00052559|Fluorouracil|fluorouracil|mesh-list
14602270|NCT00052559|Antibodies|antibodies|mesh-list
14602271|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
14602272|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14814056|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291833|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14291834|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
14291835|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291836|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
14291837|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291838|NCT00556673|Fluticasone|fluticasone|mesh-list
14291839|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
14291840|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14291841|NCT00556673|Maleic acid|maleic acid|mesh-list
14291842|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291843|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14291844|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
14291845|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291846|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291847|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14291848|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
14291849|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291850|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14602273|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160130|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14602274|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602275|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602276|NCT00052559|Growth Substances|growth substances|mesh-ancestor
14602277|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602278|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602279|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
14602280|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
15160131|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
15160132|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14602281|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602282|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602283|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602284|NCT00052585|Leucovorin|leucovorin|mesh-list
14602285|NCT00052585|Fluorouracil|fluorouracil|mesh-list
14602286|NCT00052585|Irinotecan|irinotecan|mesh-list
15160133|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160134|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160135|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15160136|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
15160137|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
14602287|NCT00052585|Gefitinib|gefitinib|mesh-list
14602288|NCT00052585|Calcium|calcium|mesh-list
14602289|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
14602290|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14602291|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160138|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160139|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14602292|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
14602293|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602294|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602295|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602296|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602297|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
14602298|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14602299|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602300|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602301|NCT00052585|Antidotes|antidotes|mesh-ancestor
14602302|NCT00052585|Protective Agents|protective agents|mesh-ancestor
14602303|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
14602304|NCT00052585|Vitamins|vitamins|mesh-ancestor
14602305|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
14602306|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14645217|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
15160140|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160141|NCT04128748|Cytarabine|cytarabine|mesh-list
15160142|NCT04128748|Daunorubicin|daunorubicin|mesh-list
15160143|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160144|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
15160145|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645218|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645219|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645220|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645221|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14645222|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645223|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645224|NCT00193544|Thalidomide|thalidomide|mesh-list
14645225|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
14645226|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645227|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
14645228|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645229|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
14645230|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645231|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645232|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14645233|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14645234|NCT00193544|Growth Substances|growth substances|mesh-ancestor
14645235|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
14645236|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645237|NCT00193557|Bortezomib|bortezomib|mesh-list
14645238|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645239|NCT00193570|Docetaxel|docetaxel|mesh-list
14645240|NCT00193570|Topotecan|topotecan|mesh-list
14645241|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645242|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645243|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645244|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645245|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645246|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14814057|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160146|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645247|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645248|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602307|NCT00052611|Celecoxib|celecoxib|mesh-list
14602308|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14602309|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14602310|NCT00052611|Analgesics|analgesics|mesh-ancestor
14602311|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
14602312|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602313|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602314|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602315|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602316|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14602317|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15160147|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
15160148|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160149|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160150|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
15160151|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160152|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602318|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602319|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602320|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14602321|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14602322|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602323|NCT00052689|Gemcitabine|gemcitabine|mesh-list
14602324|NCT00052689|Bortezomib|bortezomib|mesh-list
14602325|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602326|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
14602327|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602328|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602329|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
14602330|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602331|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602332|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602333|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
14602334|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602335|NCT00052728|Tamoxifen|tamoxifen|mesh-list
14602336|NCT00052728|Tipifarnib|tipifarnib|mesh-list
14602337|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14602338|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
14602339|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602340|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602341|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602342|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602343|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14602344|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14602345|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14602346|NCT00052754|Gefitinib|gefitinib|mesh-list
14602347|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602348|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602349|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602350|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602351|NCT00052780|Temozolomide|temozolomide|mesh-list
14602352|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14602353|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602354|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
14602355|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602356|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602357|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602358|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14602359|NCT00052832|Vitamins|vitamins|mesh-ancestor
14602360|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
14602361|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160153|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15160154|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15160155|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160156|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
15160157|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160158|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
14602362|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14602363|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
14602364|NCT00052845|Docetaxel|docetaxel|mesh-list
15160159|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602365|NCT00052845|Estramustine|estramustine|mesh-list
14602366|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602367|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602368|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602369|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602370|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602371|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602372|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
14602373|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602374|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14602375|NCT00052845|Protective Agents|protective agents|mesh-ancestor
14602376|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602377|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14602378|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602379|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14602380|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14602381|NCT00052845|Analgesics|analgesics|mesh-ancestor
14602382|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
14602383|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602384|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291851|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14291852|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14291853|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14291854|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291855|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291856|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602385|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602386|NCT00052884|Melphalan|melphalan|mesh-list
14602387|NCT00052884|Amifostine|amifostine|mesh-list
14602388|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
14602389|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602390|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602391|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
14602392|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160160|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160161|NCT04128683|Bromocriptine|bromocriptine|mesh-list
15160162|NCT04128683|Amisulpride|amisulpride|mesh-list
15160163|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15160164|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15160165|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160166|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160167|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15160168|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15160169|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
15160170|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15160171|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160172|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15160173|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
15160174|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15160175|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15160176|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
15160177|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160178|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
15160179|NCT04128254|Apixaban|apixaban|mesh-list
15160180|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15160181|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
15160182|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15160183|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
15160184|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160185|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160186|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
15160187|NCT04128540|Fentanyl|fentanyl|mesh-list
15160188|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15160189|NCT04128540|Narcotics|narcotics|mesh-ancestor
15160190|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160191|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602393|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602394|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602395|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602396|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14602397|NCT00052884|Protective Agents|protective agents|mesh-ancestor
14602398|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
14602399|NCT00052923|Carmustine|carmustine|mesh-list
14602400|NCT00052923|Rituximab|rituximab|mesh-list
14602401|NCT00052923|Etoposide|etoposide|mesh-list
14602402|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160192|NCT04128540|Analgesics|analgesics|mesh-ancestor
14602403|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
14602404|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602405|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602406|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602407|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
14602408|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602409|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602410|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602411|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14602412|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602413|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602414|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602415|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602416|NCT00052936|Prednisone|prednisone|mesh-list
14602417|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
14602418|NCT00052936|Rituximab|rituximab|mesh-list
14602419|NCT00052936|Doxorubicin|doxorubicin|mesh-list
14602420|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14602421|NCT00052936|Vincristine|vincristine|mesh-list
14602422|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602423|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
14602424|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602425|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602426|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15160193|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
15160194|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160195|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15160196|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15160197|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
15160198|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
15160199|NCT04128501|Azacitidine|azacitidine|mesh-list
15160200|NCT04128501|Venetoclax|venetoclax|mesh-list
15160201|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160202|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
15160203|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160204|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160205|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160206|NCT04128176|Omalizumab|omalizumab|mesh-list
14602427|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
14602428|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602429|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602430|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602431|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160207|NCT04128176|Rituximab|rituximab|mesh-list
15160208|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160209|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160210|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
15160211|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160212|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160213|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15160214|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15160215|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
15160216|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
15160217|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160218|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
15160219|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160220|NCT04127747|Rituximab|rituximab|mesh-list
14602432|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602433|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602434|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602435|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602436|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602437|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
14602438|NCT00052936|Hormones|hormones|mesh-ancestor
14602439|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602440|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602441|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602442|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602443|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602444|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602445|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
14602446|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602447|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602448|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602449|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602450|NCT00053001|Thalidomide|thalidomide|mesh-list
14602451|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
14602452|NCT00053001|Hematinics|hematinics|mesh-ancestor
14602453|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602454|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
14602455|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602456|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
15160221|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160222|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602457|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602458|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602459|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602460|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602461|NCT00053001|Growth Substances|growth substances|mesh-ancestor
14602462|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602463|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602464|NCT00053027|Rituximab|rituximab|mesh-list
14602465|NCT00053027|Cladribine|cladribine|mesh-list
14602466|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14602467|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602468|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
14602469|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602470|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602471|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602472|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
14602473|NCT00053092|Rituximab|rituximab|mesh-list
14602474|NCT00053092|Fludarabine|fludarabine|mesh-list
14602475|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
14602476|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602477|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
14602478|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602479|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602480|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602481|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
14602482|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602483|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602484|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602485|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14602486|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602487|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
14602488|NCT00053105|Cytarabine|cytarabine|mesh-list
14602489|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
14602490|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14602491|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14602492|NCT00053105|Prednisolone|prednisolone|mesh-list
14602493|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
14602494|NCT00053105|Pixantrone|pixantrone|mesh-list
14602495|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14602496|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
14602497|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602498|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602499|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
14602500|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602501|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
15160223|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
15160224|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160225|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160226|NCT04127851|Cyclosporine|cyclosporine|mesh-list
15160227|NCT04127851|Cyclosporins|cyclosporins|mesh-list
15160228|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160229|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160230|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160231|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
15160232|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602502|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602503|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602504|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
14602505|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602506|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602507|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
15160233|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
14602508|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
14602509|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602510|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160234|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602511|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
14602512|NCT00053105|Hormones|hormones|mesh-ancestor
14602513|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602514|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14602515|NCT00053105|Protective Agents|protective agents|mesh-ancestor
14602516|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602517|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602518|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602519|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602520|NCT00053118|Carboplatin|carboplatin|mesh-list
14602521|NCT00053118|Etoposide|etoposide|mesh-list
14602522|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602523|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602524|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602525|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602526|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602527|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602528|NCT00053131|Cytarabine|cytarabine|mesh-list
14602529|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
14602530|NCT00053131|Sargramostim|sargramostim|mesh-list
14602531|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602532|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
14602533|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602534|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602535|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
14602536|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602537|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602538|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
14602539|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602540|NCT00053131|Analgesics|analgesics|mesh-ancestor
14602541|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
14602542|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602543|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602544|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602545|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602546|NCT00053144|Cytarabine|cytarabine|mesh-list
14602547|NCT00053144|Irinotecan|irinotecan|mesh-list
14602548|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14602549|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602550|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602551|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602552|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602553|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602554|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
14602555|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
14602556|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602557|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602558|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
14602559|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602560|NCT00053157|Sargramostim|sargramostim|mesh-list
14602561|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
14602562|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602563|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
14602564|NCT00053196|Methotrexate|methotrexate|mesh-list
14602565|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
14602566|NCT00053196|Fludarabine|fludarabine|mesh-list
14602567|NCT00053196|Busulfan|busulfan|mesh-list
14602568|NCT00053196|Allopurinol|allopurinol|mesh-list
14602569|NCT00053196|Tacrolimus|tacrolimus|mesh-list
15160235|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
15160236|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160237|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15160238|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15160239|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160240|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602570|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14602571|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14602572|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
14602573|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14602574|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602575|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602576|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
14602577|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602578|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602579|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
15160241|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
14602580|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602581|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14602582|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602583|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
14602584|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602585|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14602586|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14602587|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602588|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14602589|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
14602590|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602591|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602592|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
14602593|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602594|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602595|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
14602596|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14602597|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
14602598|NCT00053196|Protective Agents|protective agents|mesh-ancestor
14602599|NCT00053209|Gemcitabine|gemcitabine|mesh-list
14602600|NCT00053209|Pemetrexed|pemetrexed|mesh-list
14602601|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602602|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
14602603|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602604|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602605|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
14602606|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602607|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602608|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602609|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
14602610|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602611|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14602612|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14602613|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
14602614|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602615|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
14602616|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
14602617|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602618|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602619|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602620|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602621|NCT00053287|Thalidomide|thalidomide|mesh-list
14602622|NCT00053287|Carboplatin|carboplatin|mesh-list
14602623|NCT00053287|Fludarabine|fludarabine|mesh-list
14602624|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
14602625|NCT00053287|Topotecan|topotecan|mesh-list
14602626|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602627|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602628|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
14602629|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602630|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602631|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
14602632|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14021959|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602633|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14602634|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602635|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602636|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
14602637|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602638|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602639|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602640|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602641|NCT00053287|Growth Substances|growth substances|mesh-ancestor
14602642|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602643|NCT00053300|Thalidomide|thalidomide|mesh-list
14602644|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160242|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160243|NCT04128020|Nivolumab|nivolumab|mesh-list
15160244|NCT04128020|Azacitidine|azacitidine|mesh-list
15160245|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160246|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160247|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15160248|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160249|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14291857|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602645|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
14602646|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602647|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
14602648|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602649|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602650|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602651|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602652|NCT00053300|Growth Substances|growth substances|mesh-ancestor
14602653|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602654|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602655|NCT00053326|Fenretinide|fenretinide|mesh-list
15160250|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
15160251|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160252|NCT04127721|Methotrexate|methotrexate|mesh-list
15160253|NCT04127721|Fludarabine|fludarabine|mesh-list
14602656|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602657|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14602658|NCT00053326|Protective Agents|protective agents|mesh-ancestor
14602659|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602660|NCT00053339|Tamoxifen|tamoxifen|mesh-list
14602661|NCT00053339|Trastuzumab|trastuzumab|mesh-list
14602662|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14602663|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602664|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14602665|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
14602666|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602667|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602668|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602669|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14602670|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14602671|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14602672|NCT00053378|Calcium|calcium|mesh-list
14602673|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14602674|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602675|NCT00053430|Thalidomide|thalidomide|mesh-list
14602676|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602677|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
14602678|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602679|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
14602680|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602681|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602682|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602683|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602684|NCT00053430|Growth Substances|growth substances|mesh-ancestor
14602685|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602686|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602687|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14602688|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14602689|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
14602690|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602691|NCT00053599|Simvastatin|simvastatin|mesh-list
14602692|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14602693|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14602694|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
14602695|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602696|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14602697|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14602698|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602699|NCT00053612|Vitamin A|vitamin a|mesh-list
14602700|NCT00053612|Vitamins|vitamins|mesh-ancestor
14602701|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
14602702|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602703|NCT00053638|Tenofovir|tenofovir|mesh-list
14602704|NCT00053638|Lamivudine|lamivudine|mesh-list
14602705|NCT00053638|Efavirenz|efavirenz|mesh-list
14602706|NCT00053638|Abacavir|abacavir|mesh-list
14602707|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
14602708|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602709|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14602710|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14602711|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602712|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160254|NCT04127721|Busulfan|busulfan|mesh-list
14602713|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14602714|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14602715|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14602716|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15160255|NCT04127721|Tacrolimus|tacrolimus|mesh-list
14602717|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14602718|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14602719|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14602720|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14602721|NCT00053716|Alprostadil|alprostadil|mesh-list
14602722|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14602723|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
14602724|NCT00053716|Urological Agents|urological agents|mesh-ancestor
14602725|NCT00053768|Prednisone|prednisone|mesh-list
14602726|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
14602727|NCT00053768|Doxorubicin|doxorubicin|mesh-list
14602728|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14602729|NCT00053768|Etoposide|etoposide|mesh-list
14602730|NCT00053768|Vincristine|vincristine|mesh-list
14602731|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602732|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
14602733|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602734|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602735|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602736|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
14602737|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602738|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602739|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602740|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14814058|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814059|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14602741|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602742|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602743|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602744|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602745|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
14602746|NCT00053768|Hormones|hormones|mesh-ancestor
14602747|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602748|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602749|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602750|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602751|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602752|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602753|NCT00053807|Interferons|interferons|mesh-list
14602754|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
14602755|NCT00053807|Aldesleukin|aldesleukin|mesh-list
14602756|NCT00053807|Fluorouracil|fluorouracil|mesh-list
14602757|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
14602758|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602759|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602760|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602761|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602762|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
14602763|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602764|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
14602765|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602766|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14602767|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14602768|NCT00053820|Interferons|interferons|mesh-list
14602769|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
14602770|NCT00053820|Aldesleukin|aldesleukin|mesh-list
14602771|NCT00053820|Fluorouracil|fluorouracil|mesh-list
14602772|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
14602773|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602774|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602775|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602776|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602777|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
14602778|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602779|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
14602780|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602781|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14602782|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14602783|NCT00053833|Irinotecan|irinotecan|mesh-list
14602784|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14602785|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602786|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602787|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602788|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602789|NCT00053872|Vincristine|vincristine|mesh-list
14602790|NCT00053872|Lomustine|lomustine|mesh-list
14602791|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291858|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14291859|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291860|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14291861|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291862|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291863|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
15160256|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15160257|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
14291864|NCT00556933|Sirolimus|sirolimus|mesh-list
14291865|NCT00556933|Tacrolimus|tacrolimus|mesh-list
14291866|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
14291867|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14291868|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291869|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
14602792|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602793|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602794|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602795|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602796|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602797|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602798|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
14602799|NCT00053885|Vatalanib|vatalanib|mesh-list
14602800|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602801|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602802|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602803|NCT00053911|Tamoxifen|tamoxifen|mesh-list
14602804|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
14602805|NCT00053911|Docetaxel|docetaxel|mesh-list
14602806|NCT00053911|Fluorouracil|fluorouracil|mesh-list
14602807|NCT00053911|Epirubicin|epirubicin|mesh-list
14602808|NCT00053911|Anastrozole|anastrozole|mesh-list
14602809|NCT00053911|Goserelin|goserelin|mesh-list
14602810|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602811|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
14602812|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602813|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602814|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602815|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
14602816|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602817|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602818|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602819|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602820|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602821|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602822|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
14602823|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602824|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602825|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602826|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602827|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602828|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15160258|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15160259|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160260|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160261|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
14602829|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
14602830|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602831|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602832|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14602833|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14602834|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14602835|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14602836|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14602837|NCT00053937|Pirfenidone|pirfenidone|mesh-list
15160262|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160263|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160264|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
15160265|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160266|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15160267|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160268|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
15160269|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160270|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14291870|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602838|NCT00053937|Analgesics|analgesics|mesh-ancestor
14602839|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
14602840|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602841|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602842|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14602843|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14602844|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602845|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602846|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602847|NCT00053950|NSC 366140|nsc 366140|mesh-list
14602848|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602849|NCT00053963|Romidepsin|romidepsin|mesh-list
14602850|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602851|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602852|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
14602853|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14602854|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15160271|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15160272|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
15160273|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602855|NCT00053976|Prednisolone|prednisolone|mesh-list
14602856|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
14602857|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14602858|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
14602859|NCT00053976|Daclizumab|daclizumab|mesh-list
14602860|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602861|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
14602862|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
14602863|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602864|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602865|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14602866|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
14602867|NCT00053976|Hormones|hormones|mesh-ancestor
14602868|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602869|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14602870|NCT00053976|Protective Agents|protective agents|mesh-ancestor
14602871|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602872|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602873|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602874|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
14602875|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14602876|NCT00054002|Trioxsalen|trioxsalen|mesh-list
14602877|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602878|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
14602879|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14602880|NCT00054041|Vaccines|vaccines|mesh-list
14602881|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
14602882|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602883|NCT00054054|Docetaxel|docetaxel|mesh-list
14602884|NCT00054054|Fluorouracil|fluorouracil|mesh-list
14602885|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602886|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602887|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602888|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602889|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602890|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
14602891|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602892|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602893|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
14602894|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602895|NCT00054067|Cisplatin|cisplatin|mesh-list
15160274|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15160275|NCT04127396|Sorafenib|sorafenib|mesh-list
15160276|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
15160277|NCT04127396|Lenvatinib|lenvatinib|mesh-list
15160278|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602896|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602897|NCT00054106|Flutamide|flutamide|mesh-list
14602898|NCT00054106|Buserelin|buserelin|mesh-list
14602899|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
14602900|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
14602901|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602902|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602903|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602904|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602905|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14602906|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
15160279|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14602907|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14602908|NCT00054158|Thalidomide|thalidomide|mesh-list
14602909|NCT00054158|Dexamethasone|dexamethasone|mesh-list
14602910|NCT00054158|Doxorubicin|doxorubicin|mesh-list
14602911|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14602912|NCT00054158|Vincristine|vincristine|mesh-list
14602913|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602914|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
14602915|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
14602916|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14602917|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602918|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14602919|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
14602920|NCT00054158|Hormones|hormones|mesh-ancestor
14602921|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14602922|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14602923|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602924|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14602925|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14602926|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14602927|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602928|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602929|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602930|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602931|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602932|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602933|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602934|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
14602935|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
14602936|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14602937|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14602938|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14602939|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14602940|NCT00054158|Growth Substances|growth substances|mesh-ancestor
15160280|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160281|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160282|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15160283|NCT04127396|Estrogens|estrogens|mesh-ancestor
15160284|NCT04127396|Hormones|hormones|mesh-ancestor
14602941|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
14602942|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14602943|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14602944|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
14602945|NCT00054184|Paclitaxel|paclitaxel|mesh-list
14602946|NCT00054184|Docetaxel|docetaxel|mesh-list
14602947|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14602948|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602949|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602950|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602951|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602952|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602953|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602954|NCT00054197|Gemcitabine|gemcitabine|mesh-list
14602955|NCT00054197|Paclitaxel|paclitaxel|mesh-list
14602956|NCT00054197|Vinorelbine|vinorelbine|mesh-list
14602957|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14602958|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602959|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602960|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602961|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602962|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602963|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602964|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602965|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
15160285|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160286|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160287|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15160288|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
15160289|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15160290|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160291|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160292|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15160293|NCT04127500|Analgesics|analgesics|mesh-ancestor
14602966|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
14602967|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160294|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
15160295|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160296|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15160297|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15160298|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14602968|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14602969|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602970|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
14602971|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602972|NCT00054210|Paclitaxel|paclitaxel|mesh-list
14602973|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14602974|NCT00054210|Carboplatin|carboplatin|mesh-list
14602975|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14602976|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14602977|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602978|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
14602979|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
14602980|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
14602981|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602982|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
14602983|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
14602984|NCT00054236|Fludarabine|fludarabine|mesh-list
14602985|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
14602986|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14602987|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14602988|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
14602989|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14602990|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14602991|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14602992|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
14602993|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14602994|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14602995|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14602996|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14602997|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
14602998|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14602999|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
14603000|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
14603001|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603002|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14603003|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
14603004|NCT00054236|Hormones|hormones|mesh-ancestor
14603005|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603006|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14603007|NCT00054236|Protective Agents|protective agents|mesh-ancestor
14603008|NCT00054288|Gemcitabine|gemcitabine|mesh-list
14603009|NCT00054288|Irinotecan|irinotecan|mesh-list
14603010|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603011|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
14603012|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603013|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603014|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
14603015|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603016|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603017|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603018|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
14603019|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603020|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14603021|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14603022|NCT00054314|IDN 5109|idn 5109|mesh-list
14603023|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603024|NCT00054340|Cyclosporine|cyclosporine|mesh-list
14603025|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
14603026|NCT00054340|Busulfan|busulfan|mesh-list
14603027|NCT00054340|Methotrexate|methotrexate|mesh-list
14603028|NCT00054340|Cyclosporins|cyclosporins|mesh-list
14603029|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14603030|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603031|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
14603032|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603033|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603034|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14603035|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
14603036|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160299|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
14603037|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603038|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14603039|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14603040|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
14603041|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14603042|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603043|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
14603044|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603045|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603046|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14603047|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14603048|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
14603049|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603050|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14603051|NCT00054392|Gemcitabine|gemcitabine|mesh-list
14603052|NCT00054392|Paclitaxel|paclitaxel|mesh-list
14603053|NCT00054392|Carboplatin|carboplatin|mesh-list
14603054|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14603055|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603056|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603057|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603058|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603059|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603060|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603061|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
14603062|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
14603063|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603064|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603065|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603066|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
14603067|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603068|NCT00054405|Aldesleukin|aldesleukin|mesh-list
14603069|NCT00054405|Interleukin-2|interleukin-2|mesh-list
14603070|NCT00054405|Interleukin-12|interleukin-12|mesh-list
14603071|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603072|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14603073|NCT00054405|Analgesics|analgesics|mesh-ancestor
14603074|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
14603075|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603076|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603077|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14603078|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14603079|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
14603080|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603081|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14603082|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
14603083|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603084|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603085|NCT00054405|Growth Substances|growth substances|mesh-ancestor
14603086|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603087|NCT00054418|Vitamin D|vitamin d|mesh-list
14603088|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
14603089|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
14603090|NCT00054418|Calcium|calcium|mesh-list
14603091|NCT00054418|Vitamins|vitamins|mesh-ancestor
14603092|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
14603093|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603094|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603095|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14603096|NCT00054418|Antacids|antacids|mesh-ancestor
14603097|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603098|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14603099|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14603100|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603101|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
14603102|NCT00054431|Decitabine|decitabine|mesh-list
14603103|NCT00054431|Azacitidine|azacitidine|mesh-list
14603104|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603105|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603106|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603107|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603108|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603109|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
14603110|NCT00054444|Topotecan|topotecan|mesh-list
15160300|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14603111|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160301|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603112|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15160302|NCT04127357|Fluorides|fluorides|mesh-list
15160303|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
15160304|NCT04127357|Protective Agents|protective agents|mesh-ancestor
15160305|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160306|NCT04127084|Empagliflozin|empagliflozin|mesh-list
15160307|NCT04127084|Canagliflozin|canagliflozin|mesh-list
15160308|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15160309|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160310|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15160311|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160312|NCT04126941|Calcium|calcium|mesh-list
15160313|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15160314|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160315|NCT04127058|Iloperidone|iloperidone|mesh-list
14021960|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603113|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14603114|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603115|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603116|NCT00054457|Docetaxel|docetaxel|mesh-list
14603117|NCT00054457|Capecitabine|capecitabine|mesh-list
14603118|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603119|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603120|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603121|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603122|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603123|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603124|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
14603125|NCT00054470|Trastuzumab|trastuzumab|mesh-list
14603126|NCT00054470|Tipifarnib|tipifarnib|mesh-list
14603127|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603128|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603129|NCT00054483|Bortezomib|bortezomib|mesh-list
14603130|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645249|NCT00193583|Carboplatin|carboplatin|mesh-list
14021961|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14021962|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021963|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021964|NCT02770508|Ritonavir|ritonavir|mesh-list
14021965|NCT02770508|Darunavir|darunavir|mesh-list
14021966|NCT02770508|Tenofovir|tenofovir|mesh-list
14021967|NCT02770508|Lamivudine|lamivudine|mesh-list
14021968|NCT02770508|Emtricitabine|emtricitabine|mesh-list
14021969|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14021970|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14645250|NCT00193583|Topotecan|topotecan|mesh-list
14645251|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645252|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645253|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645254|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645255|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645256|NCT00193622|Bevacizumab|bevacizumab|mesh-list
14645257|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14645258|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14645259|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645260|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14645261|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14645262|NCT00193622|Growth Substances|growth substances|mesh-ancestor
14645263|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645264|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
14021971|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
14021972|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021973|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645265|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14645266|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645267|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645268|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
14645269|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15160316|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15160317|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15160318|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160319|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814060|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14814061|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021974|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14645270|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814062|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14814063|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14814064|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603131|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14603132|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603133|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603134|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814065|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
14814066|NCT00861406|Interferons|interferons|mesh-list
14814067|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
14814068|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
14814069|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14814070|NCT00861406|Vaccines|vaccines|mesh-list
14814071|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
14814072|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814073|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160320|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14603135|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603136|NCT00054522|Calcitriol|calcitriol|mesh-list
14603137|NCT00054522|Dexamethasone|dexamethasone|mesh-list
14603138|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603139|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
14603140|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
14603141|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160321|NCT04127019|Paclitaxel|paclitaxel|mesh-list
15160322|NCT04127019|Docetaxel|docetaxel|mesh-list
15160323|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
14603142|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160324|NCT04127019|Fluorouracil|fluorouracil|mesh-list
15160325|NCT04127019|Epirubicin|epirubicin|mesh-list
14603143|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160326|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15160327|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160328|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
15160329|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
15160330|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
15160331|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160332|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160333|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
14603144|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
14603145|NCT00054522|Hormones|hormones|mesh-ancestor
14603146|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603147|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14603148|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603149|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603150|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14603151|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603152|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603153|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14603154|NCT00054522|Vitamins|vitamins|mesh-ancestor
14603155|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
14603156|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14603157|NCT00054535|Aldesleukin|aldesleukin|mesh-list
14603158|NCT00054535|Vaccines|vaccines|mesh-list
14603159|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
14603160|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603161|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603162|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14603163|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14603164|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
14603165|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603166|NCT00054548|Paclitaxel|paclitaxel|mesh-list
14603167|NCT00054548|Oblimersen|oblimersen|mesh-list
14603168|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14603169|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603170|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603171|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603172|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603173|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603174|NCT00054561|Vitamin E|vitamin e|mesh-list
14603175|NCT00054561|Interferons|interferons|mesh-list
14603176|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
14603177|NCT00054561|Isotretinoin|isotretinoin|mesh-list
14814074|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
15160334|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160335|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603178|NCT00054561|Vitamins|vitamins|mesh-ancestor
14814075|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814076|NCT00861419|Niacinamide|niacinamide|mesh-list
14603179|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
14603180|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603181|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603182|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
14603183|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603184|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
14603185|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
14603186|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603187|NCT00054561|Protective Agents|protective agents|mesh-ancestor
14603188|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603189|NCT00054574|Panitumumab|panitumumab|mesh-list
14603190|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603191|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603192|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
14603193|NCT00054587|Docetaxel|docetaxel|mesh-list
14603194|NCT00054587|Fluorouracil|fluorouracil|mesh-list
14603195|NCT00054587|Trastuzumab|trastuzumab|mesh-list
14603196|NCT00054587|Epirubicin|epirubicin|mesh-list
14603197|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603198|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
14603199|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603200|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603201|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14603202|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
14603203|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603204|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603205|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14603206|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603207|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603208|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603209|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
14603210|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603211|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603212|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14603213|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15160336|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15160337|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
15160338|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15160339|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
15160340|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160341|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15160342|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15160343|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15160344|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180612|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180613|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15180614|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180615|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180616|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15180617|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14603214|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14603215|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603216|NCT00054600|Methoxsalen|methoxsalen|mesh-list
14603217|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14603218|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603219|NCT00054613|Methoxsalen|methoxsalen|mesh-list
14603220|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14603221|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603222|NCT00054626|Gemcitabine|gemcitabine|mesh-list
14603223|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603224|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603225|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
14603226|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603227|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
14603228|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603229|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603230|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603231|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
14603232|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603233|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
14603234|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603235|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14603236|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603237|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
14814077|NCT00861419|Bevacizumab|bevacizumab|mesh-list
14814078|NCT00861419|Sunitinib|sunitinib|mesh-list
14603238|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603239|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603240|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603241|NCT00054834|Epratuzumab|epratuzumab|mesh-list
14603242|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603243|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603244|NCT00054873|Fluorouracil|fluorouracil|mesh-list
14603245|NCT00054873|Tezacitabine|tezacitabine|mesh-list
14603246|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
14603247|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603248|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603249|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603250|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603251|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
14603252|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603253|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603254|NCT00054886|Sunitinib|sunitinib|mesh-list
14603255|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603256|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603257|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603258|NCT00054886|Growth Substances|growth substances|mesh-ancestor
14603259|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603260|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603261|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603262|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603263|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603264|NCT00054938|Aspirin|aspirin|mesh-list
14603265|NCT00054938|Ramipril|ramipril|mesh-list
14603266|NCT00054938|Pravastatin|pravastatin|mesh-list
14603267|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603268|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14603269|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14603270|NCT00054938|Analgesics|analgesics|mesh-ancestor
14603271|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
14603272|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603273|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603274|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603275|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14603276|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14603277|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603278|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14603279|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14603280|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603281|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
14603282|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14603283|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
14603284|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14603285|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14603286|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14603287|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
14603288|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14603289|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15160345|NCT04126993|Apatinib|apatinib|mesh-list
15160346|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160347|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15160348|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603290|NCT00054977|Fluorouracil|fluorouracil|mesh-list
14603291|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
14603292|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603293|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603294|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603295|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603296|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
14603297|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603298|NCT00055042|Vitamin E|vitamin e|mesh-list
14603299|NCT00055042|Vitamins|vitamins|mesh-ancestor
14603300|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
14603301|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603302|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
14603303|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603304|NCT00055042|Protective Agents|protective agents|mesh-ancestor
14603305|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
14603306|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14603307|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603308|NCT00055120|Ritonavir|ritonavir|mesh-list
14603309|NCT00055120|Lopinavir|lopinavir|mesh-list
14603310|NCT00055120|Tenofovir|tenofovir|mesh-list
14603311|NCT00055120|Emtricitabine|emtricitabine|mesh-list
14603312|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14603313|NCT00055120|Stavudine|stavudine|mesh-list
14603314|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14603315|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14603316|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
14603317|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603318|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603319|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14603320|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14603321|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
14603322|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603323|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14603324|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14603325|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14603326|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14603327|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
15160349|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160350|NCT04127227|Gemcitabine|gemcitabine|mesh-list
15160351|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
15160352|NCT04127227|Pegaspargase|pegaspargase|mesh-list
15160353|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160354|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
15160355|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603328|NCT00055133|Paclitaxel|paclitaxel|mesh-list
14603329|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14603330|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603331|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603332|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603333|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603334|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603335|NCT00055159|Plasminogen|plasminogen|mesh-list
14603336|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14603337|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14603338|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14603339|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603340|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
14603341|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
14603342|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603343|NCT00055198|Daptomycin|daptomycin|mesh-list
14603344|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14603345|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603346|NCT00055250|Gemcitabine|gemcitabine|mesh-list
14603347|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603348|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
14603349|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603350|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603351|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
14603352|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603353|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603354|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603355|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
14603356|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603357|NCT00055302|Anastrozole|anastrozole|mesh-list
14603358|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14603359|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603360|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15160356|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160357|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
15160358|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160359|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160360|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160361|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
15160362|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160363|NCT04126811|Apatinib|apatinib|mesh-list
15160364|NCT04126811|Ifosfamide|ifosfamide|mesh-list
15160365|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
15160366|NCT04126811|Pirarubicin|pirarubicin|mesh-list
14603361|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14603362|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645271|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15160367|NCT04126811|Doxorubicin|doxorubicin|mesh-list
14814079|NCT00861419|Trebananib|trebananib|mesh-list
15160368|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603363|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603364|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14603365|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
14603366|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603367|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603368|NCT00055341|Ribavirin|ribavirin|mesh-list
14603369|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14603370|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
14603371|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603372|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
14603373|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603374|NCT00055367|Natalizumab|natalizumab|mesh-list
14603375|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
14603376|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603377|NCT00055393|Bupropion|bupropion|mesh-list
14603378|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14603379|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
14603380|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14603381|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14603382|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14603383|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603384|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603385|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
14603386|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14603387|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603388|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14603389|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15160369|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15160370|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160371|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160372|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15160373|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
15160374|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14603390|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603391|NCT00055419|Cetuximab|cetuximab|mesh-list
14603392|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603393|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603394|NCT00055432|Gemcitabine|gemcitabine|mesh-list
14603395|NCT00055432|Pemetrexed|pemetrexed|mesh-list
14603396|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603397|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
14603398|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603399|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603400|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
14603401|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603402|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603403|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603404|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
14603405|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603406|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14603407|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14603408|NCT00055484|Zonisamide|zonisamide|mesh-list
14603409|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
14603410|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14603411|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603412|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603413|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603414|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603415|NCT00055523|Adalimumab|adalimumab|mesh-list
14603416|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603417|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603418|NCT00055536|Natalizumab|natalizumab|mesh-list
14603419|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
14603420|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603421|NCT00055549|Lorazepam|lorazepam|mesh-list
14603422|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
14603423|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
14603424|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
14603425|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14603426|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14603427|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14603428|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603429|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603430|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
14603431|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
14603432|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
14603433|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603434|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14603435|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15160375|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15160376|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15160377|NCT04126668|Vorolanib|vorolanib|mesh-list
15160378|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15160379|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160380|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160381|NCT04126681|Interferons|interferons|mesh-list
15160382|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
15160383|NCT04126681|Dasatinib|dasatinib|mesh-list
15160384|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
15160385|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
15160386|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160387|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
15160388|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160389|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15160390|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160391|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160392|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
15160393|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15160394|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15160395|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15160396|NCT04126330|Vitamin D|vitamin d|mesh-list
15160397|NCT04126330|Vitamins|vitamins|mesh-ancestor
15160398|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
15160399|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160400|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15160401|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15160402|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
15160403|NCT04126720|Vitamin E|vitamin e|mesh-list
15160404|NCT04126720|Vitamins|vitamins|mesh-ancestor
15160405|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
15160406|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160407|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
15160408|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160409|NCT04126720|Protective Agents|protective agents|mesh-ancestor
15160410|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15160411|NCT04126304|Azithromycin|azithromycin|mesh-list
14603436|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14603437|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14603438|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14603439|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14603440|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
14603441|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
14603442|NCT00055562|Lenalidomide|lenalidomide|mesh-list
14603443|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
14603444|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603445|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603446|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603447|NCT00055562|Growth Substances|growth substances|mesh-ancestor
14603448|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603449|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603450|NCT00055614|Topotecan|topotecan|mesh-list
14603451|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14603452|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14603453|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603454|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603455|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603456|NCT00055640|Prednisone|prednisone|mesh-list
14603457|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
14603458|NCT00055640|Rituximab|rituximab|mesh-list
14603459|NCT00055640|Doxorubicin|doxorubicin|mesh-list
14603460|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14603461|NCT00055640|Vincristine|vincristine|mesh-list
14603462|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14814080|NCT00861419|Sorafenib|sorafenib|mesh-list
15160412|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160413|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
14603463|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
14603464|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603465|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814081|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
15180618|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
14603466|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14603467|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
14603468|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603469|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603470|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14603471|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603472|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14603473|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14603474|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15160414|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160415|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
15160416|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15160417|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15160418|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160419|NCT04126252|Urological Agents|urological agents|mesh-ancestor
14603475|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603476|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603477|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
14603478|NCT00055640|Hormones|hormones|mesh-ancestor
14603479|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603480|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14603481|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14603482|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603483|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603484|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603485|NCT00055653|Cyclosporine|cyclosporine|mesh-list
14603486|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
14603487|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
14603488|NCT00055653|Melphalan|melphalan|mesh-list
14603489|NCT00055653|Busulfan|busulfan|mesh-list
14603490|NCT00055653|Fludarabine|fludarabine|mesh-list
14603491|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
14603492|NCT00055653|Cyclosporins|cyclosporins|mesh-list
14603493|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14603494|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603495|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
14603496|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603497|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603498|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14603499|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
14603500|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603501|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603502|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14603503|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603504|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
14603505|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603506|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
14603507|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603508|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603509|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14603510|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603511|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
14603512|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
14603513|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603514|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14603515|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
14603516|NCT00055653|Hormones|hormones|mesh-ancestor
14603517|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603518|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14603519|NCT00055653|Protective Agents|protective agents|mesh-ancestor
14603520|NCT00055666|Beclomethasone|beclomethasone|mesh-list
14603521|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603522|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
14603523|NCT00055666|Hormones|hormones|mesh-ancestor
14603524|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603525|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603526|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14603527|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
14603528|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
14603529|NCT00055679|Fluorouracil|fluorouracil|mesh-list
14603530|NCT00055679|Epirubicin|epirubicin|mesh-list
14603531|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603532|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
15160420|NCT04126044|Bevacizumab|bevacizumab|mesh-list
14603533|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603534|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603535|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14603536|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
14603537|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603538|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603539|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14603540|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
14603541|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603542|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14603543|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14603544|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14603545|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603546|NCT00055718|Silymarin|silymarin|mesh-list
14603547|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
14603548|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603549|NCT00055718|Protective Agents|protective agents|mesh-ancestor
14603550|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603551|NCT00055757|Gemcitabine|gemcitabine|mesh-list
14603552|NCT00055757|Tipifarnib|tipifarnib|mesh-list
14603553|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603554|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603555|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
14603556|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603557|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
14603558|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603559|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603560|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603561|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
14603562|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603563|NCT00055770|Docetaxel|docetaxel|mesh-list
14603564|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14603565|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603566|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603567|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603568|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603569|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603570|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603571|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603572|NCT00055809|Interferons|interferons|mesh-list
14603573|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
14603574|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
14603575|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14603576|NCT00055809|Bevacizumab|bevacizumab|mesh-list
14603577|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14603578|NCT00055809|Antibodies|antibodies|mesh-list
14603579|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
14603580|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14603581|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603582|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603583|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603584|NCT00055809|Growth Substances|growth substances|mesh-ancestor
14603585|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603586|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603587|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
14603588|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
14603589|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603590|NCT00055822|Leucovorin|leucovorin|mesh-list
14603591|NCT00055822|Fluorouracil|fluorouracil|mesh-list
14603592|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
14603593|NCT00055822|Oblimersen|oblimersen|mesh-list
14603594|NCT00055822|Calcium|calcium|mesh-list
14603595|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
14603596|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603597|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603598|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
14603599|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603600|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603601|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603602|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603603|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
14603604|NCT00055822|Antidotes|antidotes|mesh-ancestor
14603605|NCT00055822|Protective Agents|protective agents|mesh-ancestor
14603606|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
14603607|NCT00055822|Vitamins|vitamins|mesh-ancestor
14603608|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
15160421|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603609|NCT00055835|Gemcitabine|gemcitabine|mesh-list
14603610|NCT00055835|Paclitaxel|paclitaxel|mesh-list
14603611|NCT00055835|Carboplatin|carboplatin|mesh-list
14603612|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14603613|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603614|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603615|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603616|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603617|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603618|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603619|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
14603620|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
14603621|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603622|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603623|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603624|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
14603625|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603626|NCT00055861|Bevacizumab|bevacizumab|mesh-list
14603627|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14603628|NCT00055861|Docetaxel|docetaxel|mesh-list
14603629|NCT00055861|Antibodies|antibodies|mesh-list
14603630|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
14603631|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14603632|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603633|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603634|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603635|NCT00055861|Growth Substances|growth substances|mesh-ancestor
14603636|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603637|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603638|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
14603639|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603640|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603641|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603642|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603643|NCT00055874|Interferons|interferons|mesh-list
14603644|NCT00055874|Cytarabine|cytarabine|mesh-list
14603645|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
14603646|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
14603647|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
14603648|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603649|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
14603650|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603651|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603652|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
14603653|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603654|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603655|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
14603656|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603657|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603658|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603659|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
14603660|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14603661|NCT00055887|Gemcitabine|gemcitabine|mesh-list
14603662|NCT00055887|Paclitaxel|paclitaxel|mesh-list
14603663|NCT00055887|Vinorelbine|vinorelbine|mesh-list
14603664|NCT00055887|Carboplatin|carboplatin|mesh-list
14603665|NCT00055887|Efaproxiral|efaproxiral|mesh-list
14603666|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14603667|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603668|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
14603669|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
14603670|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603671|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603672|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603673|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
14603674|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
14603675|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603676|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603677|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603678|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
14603679|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603680|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
14603681|NCT00055913|Bevacizumab|bevacizumab|mesh-list
14603682|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14603683|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14603684|NCT00055913|Antibodies|antibodies|mesh-list
14603685|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
14603686|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14603687|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603688|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603689|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603690|NCT00055913|Growth Substances|growth substances|mesh-ancestor
14603691|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603692|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603693|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
14603694|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603695|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603696|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160422|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160423|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15160424|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15160425|NCT04126044|Growth Substances|growth substances|mesh-ancestor
15160426|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160427|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
15160428|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15160429|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15160430|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603697|NCT00055939|Exatecan|exatecan|mesh-list
14603698|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14603699|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14603700|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603701|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603702|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603703|NCT00055952|Exatecan|exatecan|mesh-list
14603704|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14603705|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14603706|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603707|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603708|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603709|NCT00055965|Gemcitabine|gemcitabine|mesh-list
14603710|NCT00055965|Carboplatin|carboplatin|mesh-list
14603711|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603712|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603713|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
14603714|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603715|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
14603716|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603717|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603718|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603719|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
14603720|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603721|NCT00055978|Celecoxib|celecoxib|mesh-list
15160431|NCT04125927|Cysteamine|cysteamine|mesh-list
15160432|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
15160433|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160434|NCT04125719|Nivolumab|nivolumab|mesh-list
15160435|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160436|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160437|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15160438|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160439|NCT04125563|Capsaicin|capsaicin|mesh-list
15160440|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
15160441|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
15160442|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
15160443|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160444|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160445|NCT04125706|Metronidazole|metronidazole|mesh-list
15160446|NCT04125706|Minocycline|minocycline|mesh-list
15160447|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160448|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15160449|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15160450|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15160451|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15160452|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15160453|NCT04125082|Insulin|insulin|mesh-list
15160454|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15160455|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15160456|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160457|NCT04124991|Durvalumab|durvalumab|mesh-list
15160458|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160459|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180619|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180620|NCT03937609|Infliximab|infliximab|mesh-list
15180621|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
15180622|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14603722|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14603723|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14603724|NCT00055978|Analgesics|analgesics|mesh-ancestor
14021975|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14021976|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
14021977|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14021978|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14021979|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14603725|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
14603726|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603727|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603728|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603729|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603730|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14603731|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14603732|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603733|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603734|NCT00055991|Bexarotene|bexarotene|mesh-list
14603735|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603736|NCT00056004|Zileuton|zileuton|mesh-list
14603737|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14603738|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14603739|NCT00056004|Analgesics|analgesics|mesh-ancestor
14603740|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
14603741|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603742|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603743|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160460|NCT04125121|Propofol|propofol|mesh-list
15160461|NCT04125121|Sevoflurane|sevoflurane|mesh-list
15160462|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15160463|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160464|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160465|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15160466|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
15160467|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
15160468|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14603744|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603745|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14603746|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603747|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603748|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14603749|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
14603750|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603751|NCT00056030|Leucovorin|leucovorin|mesh-list
14603752|NCT00056030|Fluorouracil|fluorouracil|mesh-list
14603753|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
14603754|NCT00056030|Cetuximab|cetuximab|mesh-list
14603755|NCT00056030|Calcium|calcium|mesh-list
15160469|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15160470|NCT04124614|Sertraline|sertraline|mesh-list
15160471|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
15160472|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
15160473|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15160474|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15160475|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15160476|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160477|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160478|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15160479|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
15160480|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603756|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
14603757|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603758|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603759|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
14603760|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603761|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160481|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
15160482|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
15160483|NCT04124822|Prednisolone|prednisolone|mesh-list
14603762|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603763|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603764|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
14603765|NCT00056030|Antidotes|antidotes|mesh-ancestor
14021980|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15160484|NCT04124822|Piroxicam|piroxicam|mesh-list
14603766|NCT00056030|Protective Agents|protective agents|mesh-ancestor
14603767|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
14603768|NCT00056030|Vitamins|vitamins|mesh-ancestor
14603769|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
14603770|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603771|NCT00056056|Bexarotene|bexarotene|mesh-list
14603772|NCT00056056|Methoxsalen|methoxsalen|mesh-list
14603773|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603774|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14603775|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603776|NCT00056082|Celecoxib|celecoxib|mesh-list
14603777|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14603778|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14603779|NCT00056082|Analgesics|analgesics|mesh-ancestor
14603780|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
14603781|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603782|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603783|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14603784|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603785|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14603786|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14603787|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603788|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603789|NCT00056095|Cyclosporine|cyclosporine|mesh-list
14603790|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
14603791|NCT00056095|Fludarabine|fludarabine|mesh-list
14603792|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
14603793|NCT00056095|Cyclosporins|cyclosporins|mesh-list
14603794|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603795|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
14603796|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603797|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603798|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14603799|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
14603800|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603801|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603802|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14603803|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14603804|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
14603805|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603806|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
15160485|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160486|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
14603807|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603808|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603809|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14603810|NCT00056225|Vitamins|vitamins|mesh-list
14603811|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
14603812|NCT00056225|Hydroxocobalamin|hydroxocobalamin|mesh-list
14603813|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
14603814|NCT00056225|Pyridoxal|pyridoxal|mesh-list
14603815|NCT00056225|Pyridoxine|pyridoxine|mesh-list
14603816|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
14603817|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
14603818|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603819|NCT00056225|Hematinics|hematinics|mesh-ancestor
14645272|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
14645273|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645274|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645275|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645276|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645277|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
14645278|NCT00193648|Adalimumab|adalimumab|mesh-list
14645279|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645280|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645281|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14645282|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645283|NCT00193661|Testosterone|testosterone|mesh-list
14645284|NCT00193661|Androgens|androgens|mesh-ancestor
14645285|NCT00193661|Hormones|hormones|mesh-ancestor
14645286|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645287|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645288|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
14645289|NCT00193674|Progestins|progestins|mesh-ancestor
15160487|NCT04124822|Hormones|hormones|mesh-ancestor
14645290|NCT00193674|Hormones|hormones|mesh-ancestor
14645291|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645292|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645293|NCT00193700|Testosterone|testosterone|mesh-list
14603820|NCT00056264|Infliximab|infliximab|mesh-list
14603821|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
14603822|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160488|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160489|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160490|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15160491|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160492|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603823|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603824|NCT00056277|Lamotrigine|lamotrigine|mesh-list
14603825|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
14603826|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14603827|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603828|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603829|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603830|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603831|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14603832|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14603833|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14603834|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14603835|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14603836|NCT00056329|Vitamin E|vitamin e|mesh-list
14603837|NCT00056329|Tocopherols|tocopherols|mesh-list
14603838|NCT00056329|Vitamins|vitamins|mesh-ancestor
14603839|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
14603840|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603841|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
14603842|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603843|NCT00056329|Protective Agents|protective agents|mesh-ancestor
14603844|NCT00056368|Fluconazole|fluconazole|mesh-list
14603845|NCT00056368|Anidulafungin|anidulafungin|mesh-list
15160493|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15160494|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15160495|NCT04124822|Analgesics|analgesics|mesh-ancestor
14603846|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
14603847|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603848|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14603849|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14603850|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603851|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603852|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14603853|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
15160496|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
15160497|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160498|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15160499|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603854|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14603855|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603856|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14603857|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14603858|NCT00056381|Anidulafungin|anidulafungin|mesh-list
15160500|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160501|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
15160502|NCT04124887|Listerine|listerine|mesh-list
15160503|NCT04124887|Calcium|calcium|mesh-list
15160504|NCT04124887|Fluorides|fluorides|mesh-list
15160505|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
15160506|NCT04124887|Caseins|caseins|mesh-list
15160507|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15160508|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160509|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15160510|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
15160511|NCT04124887|Protective Agents|protective agents|mesh-ancestor
15160512|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15160513|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160514|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
15160515|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
15160516|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160517|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15160518|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15160519|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15160520|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160521|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160522|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15160523|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160524|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160525|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
15160526|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15160527|NCT04124913|Progesterone|progesterone|mesh-list
15160528|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
15160529|NCT04124913|Progestins|progestins|mesh-ancestor
15160530|NCT04124913|Hormones|hormones|mesh-ancestor
15160531|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160532|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160533|NCT04124926|Lansoprazole|lansoprazole|mesh-list
15160534|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
15160535|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15160536|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160537|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15160538|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160539|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160540|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
15160541|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160542|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
15160543|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160544|NCT04124757|Rocuronium|rocuronium|mesh-list
15160545|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15160546|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15160547|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14603859|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
14603860|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603861|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
14603862|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
14603863|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
14603864|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14603865|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14603866|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603867|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603868|NCT00056433|Urological Agents|urological agents|mesh-ancestor
14603869|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603870|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
14603871|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14603872|NCT00056446|Vatalanib|vatalanib|mesh-list
14603873|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603874|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603875|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603876|NCT00056459|Vatalanib|vatalanib|mesh-list
14603877|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603878|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603879|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603880|NCT00056576|Zonisamide|zonisamide|mesh-list
14603881|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
14603882|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14603883|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603884|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603885|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603886|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603887|NCT00056641|Ritonavir|ritonavir|mesh-list
14603888|NCT00056641|Lopinavir|lopinavir|mesh-list
14603889|NCT00056641|Saquinavir|saquinavir|mesh-list
14603890|NCT00056641|Amprenavir|amprenavir|mesh-list
14603891|NCT00056641|Tipranavir|tipranavir|mesh-list
14603892|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14603893|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14603894|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
14603895|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603896|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603897|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14603898|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14603899|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
14603900|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603901|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14603902|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14603903|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14603904|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
14603905|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15160548|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603906|NCT00056654|Leuprolide|leuprolide|mesh-list
14603907|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14603908|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
14603909|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14603910|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603911|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14603912|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603913|NCT00056693|Sunitinib|sunitinib|mesh-list
14603914|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603915|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603916|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603917|NCT00056693|Growth Substances|growth substances|mesh-ancestor
14603918|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603919|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603920|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14603921|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603922|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603923|NCT00056758|Vaccines|vaccines|mesh-list
14603924|NCT00056758|Immunologic Factors|immunologic factors|mesh-ancestor
14603925|NCT00056758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603926|NCT00056797|Interleukin-2|interleukin-2|mesh-list
14603927|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603928|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14603929|NCT00056797|Analgesics|analgesics|mesh-ancestor
14603930|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
14603931|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14603932|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603933|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
14603934|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14603935|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603936|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603937|NCT00056823|Ranibizumab|ranibizumab|mesh-list
14603938|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603939|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603940|NCT00056823|Growth Substances|growth substances|mesh-ancestor
14603941|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603942|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603943|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603944|NCT00056836|Ranibizumab|ranibizumab|mesh-list
14603945|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14603946|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14603947|NCT00056836|Growth Substances|growth substances|mesh-ancestor
14603948|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603949|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
14603950|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603951|NCT00056875|Mitogens|mitogens|mesh-list
14603952|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14603953|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603954|NCT00056966|Fludarabine|fludarabine|mesh-list
14603955|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
14603956|NCT00056966|Tacrolimus|tacrolimus|mesh-list
14603957|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603958|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603959|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14603960|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
14603961|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603962|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14603963|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14603964|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603965|NCT00056979|Fludarabine|fludarabine|mesh-list
14603966|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
14603967|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603968|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603969|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
14603970|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
14603971|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160549|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160550|NCT04124198|Nimorazole|nimorazole|mesh-list
15160551|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15160552|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15160553|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15160554|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160555|NCT04124302|Insulin|insulin|mesh-list
15160556|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14603972|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
14603973|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160557|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
15160558|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
15160559|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
14603974|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14603975|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14603976|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
14603977|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603978|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14603979|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14603980|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14603981|NCT00057031|Calcitriol|calcitriol|mesh-list
14603982|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14603983|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14603984|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14603985|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14603986|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14603987|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14603988|NCT00057031|Vitamins|vitamins|mesh-ancestor
14603989|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
14603990|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14603991|NCT00057122|Rifampin|rifampin|mesh-list
14603992|NCT00057122|Rifapentine|rifapentine|mesh-list
14603993|NCT00057122|Isoniazid|isoniazid|mesh-list
14603994|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14603995|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
14603996|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14603997|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14603998|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
14603999|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14604000|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604001|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604002|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14604003|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14604004|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14604005|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14604006|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14604007|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14604008|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14604009|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14604010|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
14604011|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14604012|NCT00057265|Lamivudine|lamivudine|mesh-list
14604013|NCT00057265|Telbivudine|telbivudine|mesh-list
14604014|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14604015|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14604016|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604017|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604018|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
14604019|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604020|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14604021|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14604022|NCT00057278|Gabapentin|gabapentin|mesh-list
14604023|NCT00057278|Analgesics|analgesics|mesh-ancestor
14604024|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
14604025|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604026|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604027|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
14604028|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14604029|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15160560|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15160561|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160562|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
15160563|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15160564|NCT04124367|Protective Agents|protective agents|mesh-ancestor
15160565|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160566|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
15160567|NCT04124432|Nicotine|nicotine|mesh-list
15160568|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15160569|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
15160570|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160571|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160572|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15160573|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15160574|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
15160575|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180623|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160576|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160577|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15160578|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15160579|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15160580|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
15160581|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160582|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14604030|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14604031|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14604032|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14604033|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14604034|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604035|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604036|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
14604037|NCT00057304|Insulin|insulin|mesh-list
14604038|NCT00057304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14604039|NCT00057304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604040|NCT00057343|Rituximab|rituximab|mesh-list
14604041|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604042|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604043|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
14604044|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291871|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14291872|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291873|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291874|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14291875|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291876|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14604045|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604046|NCT00057356|Conivaptan|conivaptan|mesh-list
14604047|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14604048|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604049|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
14604050|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604051|NCT00057369|Dalbavancin|dalbavancin|mesh-list
14604052|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14604053|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604054|NCT00057382|Doxorubicin|doxorubicin|mesh-list
14604055|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14604056|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604057|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604058|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604059|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604060|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604061|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
14604062|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604063|NCT00057408|Olanzapine|olanzapine|mesh-list
14604064|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
14604065|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
14604066|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
14604067|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604068|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604069|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14604070|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14604071|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14604072|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15160583|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15160584|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160585|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
15160586|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15160587|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160588|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
15160589|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160590|NCT04124016|Protective Agents|protective agents|mesh-ancestor
15160591|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160592|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15160593|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14604073|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14604074|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14604075|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160594|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604076|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604077|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604078|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
14604079|NCT00057421|Prednisolone|prednisolone|mesh-list
14604080|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160595|NCT04124094|Fluticasone|fluticasone|mesh-list
15160596|NCT04124094|Xhance|xhance|mesh-list
15160597|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15160598|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15160599|NCT04124094|Charcoal|charcoal|mesh-list
15160600|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160601|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15160602|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
15160603|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160604|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160605|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15160606|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
15160607|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
14604081|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
14604082|NCT00057421|Hormones|hormones|mesh-ancestor
14604083|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14604084|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604085|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14604086|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604087|NCT00057447|Interferons|interferons|mesh-list
14604088|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
14604089|NCT00057447|Rituximab|rituximab|mesh-list
14604090|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604091|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604092|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
14604093|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604094|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604095|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
14604096|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604097|NCT00057512|Masoprocol|masoprocol|mesh-list
14604098|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
14604099|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604100|NCT00057512|Protective Agents|protective agents|mesh-ancestor
14604101|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604102|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14604103|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604104|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14604105|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14604106|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14604107|NCT00057512|Analgesics|analgesics|mesh-ancestor
14604108|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
14604109|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604110|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604111|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604112|NCT00057564|Thalidomide|thalidomide|mesh-list
14604113|NCT00057564|Dexamethasone|dexamethasone|mesh-list
14604114|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
14604115|NCT00057564|BB 1101|bb 1101|mesh-list
14604116|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160608|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15160609|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15160610|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15160611|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15160612|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
15160613|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15160614|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160615|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
15160616|NCT04124094|Hormones|hormones|mesh-ancestor
14604117|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
14604118|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
14604119|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604120|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604121|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14604122|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
14604123|NCT00057564|Hormones|hormones|mesh-ancestor
14604124|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14604125|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14604126|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604127|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
15160617|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160618|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
14604128|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604129|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604130|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604131|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
14604132|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
14604133|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14604134|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604135|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14604136|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14604137|NCT00057564|Growth Substances|growth substances|mesh-ancestor
14604138|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
14604139|NCT00057616|Lenalidomide|lenalidomide|mesh-list
14604140|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
14604141|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604142|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14604143|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14604144|NCT00057616|Growth Substances|growth substances|mesh-ancestor
14604145|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
14604146|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604147|NCT00057642|Sertraline|sertraline|mesh-list
14604148|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14604149|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
14604150|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14604151|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14604152|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14604153|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14604154|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604155|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604156|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
14604157|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604158|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14604159|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14604160|NCT00057707|Modafinil|modafinil|mesh-list
14604161|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14604162|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604163|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14604164|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14604165|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14604166|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604167|NCT00057720|Doxorubicin|doxorubicin|mesh-list
14604168|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14604169|NCT00057720|Topotecan|topotecan|mesh-list
14604170|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14604171|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160619|NCT04124094|Antidotes|antidotes|mesh-ancestor
15160620|NCT04124094|Protective Agents|protective agents|mesh-ancestor
15160621|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14604172|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604173|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604174|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604175|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604176|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14645294|NCT00193700|Androgens|androgens|mesh-ancestor
14645295|NCT00193700|Hormones|hormones|mesh-ancestor
14645296|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645297|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645298|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14645299|NCT00193726|Estradiol|estradiol|mesh-list
14645300|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14645301|NCT00193726|Estrogens|estrogens|mesh-ancestor
14645302|NCT00193726|Hormones|hormones|mesh-ancestor
14645303|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645304|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645305|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14645306|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
14645307|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14645308|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14645309|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14645310|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15160622|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15160623|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160624|NCT04124081|Entecavir|entecavir|mesh-list
15160625|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
14604177|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
14604178|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604179|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
14604180|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14604181|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14604182|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604183|NCT00057759|Urological Agents|urological agents|mesh-ancestor
14604184|NCT00057798|Gemcitabine|gemcitabine|mesh-list
14604185|NCT00057798|Vinorelbine|vinorelbine|mesh-list
14604186|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604187|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
14604188|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604189|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604190|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
14604191|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604192|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604193|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604194|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
15160626|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160627|NCT04123925|Nivolumab|nivolumab|mesh-list
15160628|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14021981|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14021982|NCT02770378|Ritonavir|ritonavir|mesh-list
14021983|NCT02770378|Itraconazole|itraconazole|mesh-list
14604195|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160629|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160630|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15160631|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160632|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15160633|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160634|NCT04123717|Acetaminophen|acetaminophen|mesh-list
15160635|NCT04123717|Ibuprofen|ibuprofen|mesh-list
15160636|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15160637|NCT04123717|Analgesics|analgesics|mesh-ancestor
15160638|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
15160639|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160640|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160641|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
14604196|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604197|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604198|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604199|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604200|NCT00057850|Cisplatin|cisplatin|mesh-list
14604201|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604202|NCT00057889|Ipilimumab|ipilimumab|mesh-list
14604203|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604204|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604205|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14604206|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604207|NCT00057928|Gemcitabine|gemcitabine|mesh-list
14604208|NCT00057928|Paclitaxel|paclitaxel|mesh-list
14604209|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604210|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604211|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604212|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604213|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604214|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604215|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604216|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
14604217|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
14604218|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604219|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604220|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604221|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
14604222|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604223|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
14604224|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604225|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604226|NCT00058006|Celecoxib|celecoxib|mesh-list
14604227|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14604228|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14604229|NCT00058006|Analgesics|analgesics|mesh-ancestor
15160642|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15160643|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604230|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
14604231|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604232|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604233|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604234|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604235|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14604236|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14604237|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604238|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604239|NCT00058045|Aldesleukin|aldesleukin|mesh-list
15160644|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160645|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15160646|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160647|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160648|NCT04123652|Lidocaine|lidocaine|mesh-list
15160649|NCT04123652|Ketamine|ketamine|mesh-list
15160650|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
14604240|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604241|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14604242|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15160651|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
14604243|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
14604244|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604245|NCT00058071|Amifostine|amifostine|mesh-list
14604246|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14604247|NCT00058071|Protective Agents|protective agents|mesh-ancestor
14604248|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604249|NCT00058084|Prednisone|prednisone|mesh-list
14604250|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
14604251|NCT00058084|Epothilone B|epothilone b|mesh-list
14604252|NCT00058084|Epothilones|epothilones|mesh-list
14604253|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604254|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
14604255|NCT00058084|Hormones|hormones|mesh-ancestor
14604256|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14604257|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604258|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14604259|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604260|NCT00058084|Analgesics|analgesics|mesh-ancestor
14604261|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
14604262|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604263|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604264|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604265|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604266|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604267|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604268|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604269|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604270|NCT00058097|Tipifarnib|tipifarnib|mesh-list
14604271|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604272|NCT00058149|Gemcitabine|gemcitabine|mesh-list
14604273|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
14604274|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604275|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
14604276|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604277|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604278|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
14604279|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604280|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604281|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604282|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
14604283|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604284|NCT00058201|Leucovorin|leucovorin|mesh-list
14604285|NCT00058201|Gemcitabine|gemcitabine|mesh-list
14604286|NCT00058201|Fluorouracil|fluorouracil|mesh-list
14604287|NCT00058201|Calcium|calcium|mesh-list
14604288|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
14604289|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604290|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
14604291|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604292|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604293|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
14604294|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604295|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604296|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604297|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
14604298|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645311|NCT00193739|Paclitaxel|paclitaxel|mesh-list
15180624|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
15160652|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160653|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604299|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14604300|NCT00058201|Antidotes|antidotes|mesh-ancestor
14604301|NCT00058201|Protective Agents|protective agents|mesh-ancestor
14604302|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
14604303|NCT00058201|Vitamins|vitamins|mesh-ancestor
14604304|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
14604305|NCT00058227|Rituximab|rituximab|mesh-list
14604306|NCT00058227|Fludarabine|fludarabine|mesh-list
14604307|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
14604308|NCT00058227|Alvocidib|alvocidib|mesh-list
14604309|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604310|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604311|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
14604312|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604313|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604314|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604315|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
14604316|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604317|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604318|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
14604319|NCT00058227|Growth Substances|growth substances|mesh-ancestor
14604320|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14604321|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604322|NCT00058253|Docetaxel|docetaxel|mesh-list
14604323|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604324|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604325|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604326|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604327|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604328|NCT00058279|Aldesleukin|aldesleukin|mesh-list
14604329|NCT00058279|Ipilimumab|ipilimumab|mesh-list
14604330|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604331|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160654|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
15160655|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160656|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15160657|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15160658|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15160659|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160660|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160661|NCT04123652|Analgesics|analgesics|mesh-ancestor
15160662|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15160663|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15160664|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
14604332|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14604333|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604334|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14604335|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14604336|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
14604337|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604338|NCT00058292|Cytarabine|cytarabine|mesh-list
14604339|NCT00058292|Rituximab|rituximab|mesh-list
14604340|NCT00058292|Etoposide|etoposide|mesh-list
14604341|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
14604342|NCT00058292|Melphalan|melphalan|mesh-list
14604343|NCT00058292|Carmustine|carmustine|mesh-list
14604344|NCT00058292|Lenograstim|lenograstim|mesh-list
14604345|NCT00058292|Sargramostim|sargramostim|mesh-list
14604346|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604347|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604348|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
14604349|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604350|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604351|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604352|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604353|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604354|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604355|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604356|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160665|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14604357|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
14604358|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
14604359|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604360|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604361|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14604362|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14604363|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
14604364|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14604365|NCT00058305|Vincristine|vincristine|mesh-list
14604366|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
14604367|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604368|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604369|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604370|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604371|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604372|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604373|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14604374|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
14604375|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604376|NCT00058318|Gemcitabine|gemcitabine|mesh-list
14604377|NCT00058318|Capecitabine|capecitabine|mesh-list
14604378|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604379|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
14604380|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604381|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604382|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
14604383|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604384|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604385|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604386|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
14604387|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604388|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
14604389|NCT00058331|Hematinics|hematinics|mesh-ancestor
14604390|NCT00058357|Lidocaine|lidocaine|mesh-list
14604391|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
14604392|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
14604393|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14604394|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604395|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
14604396|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604397|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14604398|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14604399|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14604400|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14604401|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604402|NCT00058435|Abagovomab|abagovomab|mesh-list
14604403|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604404|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604405|NCT00058448|Docetaxel|docetaxel|mesh-list
14604406|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604407|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604408|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604409|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604410|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604411|NCT00058461|Cytarabine|cytarabine|mesh-list
14604412|NCT00058461|Rituximab|rituximab|mesh-list
14604413|NCT00058461|Carboplatin|carboplatin|mesh-list
14604414|NCT00058461|Methotrexate|methotrexate|mesh-list
14604415|NCT00058461|Etoposide|etoposide|mesh-list
14604416|NCT00058461|Ifosfamide|ifosfamide|mesh-list
14604417|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604418|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604419|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
14604420|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604421|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604422|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14604423|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
14604424|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15160666|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15160667|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604425|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604426|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
14604427|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604428|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14604429|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604430|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14604431|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604432|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15160668|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
14645312|NCT00193739|Carboplatin|carboplatin|mesh-list
14604433|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604434|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604435|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604436|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
14604437|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604438|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14604439|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
14604440|NCT00058474|Fluorouracil|fluorouracil|mesh-list
14604441|NCT00058474|Capecitabine|capecitabine|mesh-list
14604442|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
15160669|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15160670|NCT04123743|Protective Agents|protective agents|mesh-ancestor
15160671|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160672|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
15160673|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
14604443|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
14604444|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604445|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604446|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604447|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604448|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
14604449|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604450|NCT00058487|Thalidomide|thalidomide|mesh-list
14604451|NCT00058487|Epirubicin|epirubicin|mesh-list
14604452|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14604453|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604454|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604455|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604456|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604457|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604458|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604459|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
14604460|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604461|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
15160674|NCT04123392|Busulfan|busulfan|mesh-list
15160675|NCT04123392|Decitabine|decitabine|mesh-list
15160676|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160677|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
15160678|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160679|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160680|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14604462|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14604463|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604464|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14604465|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14604466|NCT00058487|Growth Substances|growth substances|mesh-ancestor
14604467|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
14604468|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
14604469|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604470|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
14604471|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604472|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604473|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14604474|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
14604475|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604476|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604477|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14604478|NCT00058682|Anidulafungin|anidulafungin|mesh-list
14604479|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
14604480|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604481|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
14604482|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604483|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14604484|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604485|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604486|NCT00058890|Gabapentin|gabapentin|mesh-list
14604487|NCT00058890|Analgesics|analgesics|mesh-ancestor
14604488|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
14604489|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604490|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604491|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
14604492|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14604493|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14604494|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291877|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
14604495|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14604496|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14604497|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14604498|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604499|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604500|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
14604501|NCT00058903|Sertraline|sertraline|mesh-list
14604502|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
14604503|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14604504|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14604505|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14604506|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14604507|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604508|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604509|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
14604510|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604511|NCT00058929|Treprostinil|treprostinil|mesh-list
14814082|NCT00861419|Imetelstat|imetelstat|mesh-list
14814083|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14814084|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604512|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14604513|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
14604514|NCT00058955|Triazolam|triazolam|mesh-list
14604515|NCT00058955|Pentobarbital|pentobarbital|mesh-list
14604516|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14604517|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14604518|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
14604519|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
14604520|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14604521|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604522|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14604523|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14604524|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14604525|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
14604526|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
14604527|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604528|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604529|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14604530|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14604531|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14604532|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14604533|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14604534|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604535|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604536|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604537|NCT00058968|Analgesics|analgesics|mesh-ancestor
14604538|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
14604539|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604540|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
14604541|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14604542|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
14604543|NCT00058994|Anecortave|anecortave|mesh-list
14604544|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14604545|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14604546|NCT00058994|Growth Substances|growth substances|mesh-ancestor
14604547|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604548|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
14604549|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604550|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
14604551|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604552|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604553|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14604554|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14604555|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14604556|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604557|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604558|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
14604559|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604560|NCT00059306|Aspirin|aspirin|mesh-list
14604561|NCT00059306|Clopidogrel|clopidogrel|mesh-list
14604562|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14604563|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14604564|NCT00059306|Analgesics|analgesics|mesh-ancestor
14814085|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14604565|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
14604566|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604567|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604568|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604569|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604570|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14604571|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14604572|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604573|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14604574|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14604575|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604576|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
14604577|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14604578|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14604579|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14604580|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
14604581|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604582|NCT00059358|Interferons|interferons|mesh-list
14604583|NCT00059358|Ribavirin|ribavirin|mesh-list
14604584|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
14604585|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
14604586|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14604587|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604588|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
14604589|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604590|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
14604591|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604592|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
14604593|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604594|NCT00059462|Interleukin-2|interleukin-2|mesh-list
14604595|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604596|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14604597|NCT00059462|Analgesics|analgesics|mesh-ancestor
14604598|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
14604599|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604600|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604601|NCT00059592|Valacyclovir|valacyclovir|mesh-list
14604602|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
14604603|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604604|NCT00059618|Carboplatin|carboplatin|mesh-list
14604605|NCT00059618|Bortezomib|bortezomib|mesh-list
14604606|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604607|NCT00059631|Bortezomib|bortezomib|mesh-list
14604608|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
14604609|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604610|NCT00059631|Analgesics|analgesics|mesh-ancestor
14604611|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
14604612|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604613|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604614|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604615|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604616|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604617|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604618|NCT00059722|Gefitinib|gefitinib|mesh-list
14604619|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604620|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14604621|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604622|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604623|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14604624|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604625|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14604626|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604627|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645313|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645314|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645315|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645316|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645317|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645318|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645319|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
14645320|NCT00193856|Leuprolide|leuprolide|mesh-list
14645321|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15160681|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
14645322|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180625|NCT03937544|Fludarabine|fludarabine|mesh-list
15160682|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160683|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160684|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15160685|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15160686|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
15160687|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160688|NCT04123288|ACT-709478|act-709478|mesh-list
15160689|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15160690|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160691|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160692|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15160693|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160694|NCT04123210|Vitamin A|vitamin a|mesh-list
15160695|NCT04123210|Vitamins|vitamins|mesh-ancestor
15160696|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
15160697|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160698|NCT04123041|Nicotine|nicotine|mesh-list
15160699|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15160700|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
14604628|NCT00059761|Irinotecan|irinotecan|mesh-list
14604629|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604630|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14604631|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604632|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604633|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604634|NCT00059800|Boron|boron|mesh-list
14604635|NCT00059800|Trace Elements|trace elements|mesh-ancestor
14604636|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
14604637|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604638|NCT00059813|Interferons|interferons|mesh-list
14604639|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
14604640|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
14604641|NCT00059813|Oblimersen|oblimersen|mesh-list
14604642|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604643|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
14604644|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604645|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
14604646|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604647|NCT00059826|Interferons|interferons|mesh-list
14604648|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
14604649|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
14604650|NCT00059826|Fluorouracil|fluorouracil|mesh-list
14604651|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604652|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
14604653|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604654|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604655|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604656|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
14604657|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604658|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
14604659|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604660|NCT00059852|Gemcitabine|gemcitabine|mesh-list
14604661|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14604662|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604663|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
14604664|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604665|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604666|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
14604667|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604668|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604669|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604670|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
14604671|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604672|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14604673|NCT00059865|Gemcitabine|gemcitabine|mesh-list
14604674|NCT00059865|Pemetrexed|pemetrexed|mesh-list
14604675|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604676|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
14604677|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604678|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604679|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
14604680|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604681|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160701|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160702|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604682|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604683|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
14604684|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604685|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14604686|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14604687|NCT00059878|Interferons|interferons|mesh-list
14604688|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
14604689|NCT00059878|Voriconazole|voriconazole|mesh-list
14604690|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604691|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
14604692|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604693|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
14604694|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14604695|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14604696|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604697|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604698|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14604699|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
14604700|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14604701|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604702|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14604703|NCT00059904|Aldesleukin|aldesleukin|mesh-list
14604704|NCT00059904|Rituximab|rituximab|mesh-list
14604705|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604706|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604707|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
14604708|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604709|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604710|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14604711|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14604712|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
14604713|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604714|NCT00059917|Camptothecin|camptothecin|mesh-list
14604715|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604716|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604717|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14604718|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604719|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604720|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604721|NCT00059930|Leucovorin|leucovorin|mesh-list
14604722|NCT00059930|Dexamethasone|dexamethasone|mesh-list
14604723|NCT00059930|Fluorouracil|fluorouracil|mesh-list
14604724|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
14604725|NCT00059930|Floxuridine|floxuridine|mesh-list
15160703|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15160704|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15160705|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
15160706|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15160707|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160708|NCT04123249|Propofol|propofol|mesh-list
15160709|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
14604726|NCT00059930|Calcium|calcium|mesh-list
14604727|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
14604728|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604729|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
14604730|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
14604731|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604732|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604733|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14604734|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
14604735|NCT00059930|Hormones|hormones|mesh-ancestor
14604736|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14604737|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14604738|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604739|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14604740|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
14604741|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604742|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604743|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604744|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
14604745|NCT00059930|Antidotes|antidotes|mesh-ancestor
14604746|NCT00059930|Protective Agents|protective agents|mesh-ancestor
14604747|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
14604748|NCT00059930|Vitamins|vitamins|mesh-ancestor
14604749|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
14604750|NCT00059943|Docetaxel|docetaxel|mesh-list
14604751|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160710|NCT04123249|Sevoflurane|sevoflurane|mesh-list
14021984|NCT02770378|Minocycline|minocycline|mesh-list
14021985|NCT02770378|Celecoxib|celecoxib|mesh-list
14021986|NCT02770378|Temozolomide|temozolomide|mesh-list
14021987|NCT02770378|Auranofin|auranofin|mesh-list
14021988|NCT02770378|Captopril|captopril|mesh-list
14021989|NCT02770378|Disulfiram|disulfiram|mesh-list
14021990|NCT02770378|Aprepitant|aprepitant|mesh-list
14021991|NCT02770378|Sertraline|sertraline|mesh-list
14021992|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14604752|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604753|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604754|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604755|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604756|NCT00060112|Gemcitabine|gemcitabine|mesh-list
14604757|NCT00060112|Oblimersen|oblimersen|mesh-list
14604758|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604759|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
14604760|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604761|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604762|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
14604763|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604764|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604765|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604766|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
14604767|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604768|NCT00060125|Tipifarnib|tipifarnib|mesh-list
14604769|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604770|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
14604771|NCT00060138|Antibodies|antibodies|mesh-list
14604772|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14604773|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
14604774|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604775|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14604776|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
14604777|NCT00060242|Combretastatin|combretastatin|mesh-list
14604778|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604779|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604780|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604781|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604782|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604783|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604784|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
14604785|NCT00060255|Melphalan|melphalan|mesh-list
14604786|NCT00060255|Busulfan|busulfan|mesh-list
14604787|NCT00060255|Thiotepa|thiotepa|mesh-list
14604788|NCT00060255|Carmustine|carmustine|mesh-list
14604789|NCT00060255|Carboplatin|carboplatin|mesh-list
14604790|NCT00060255|Etoposide|etoposide|mesh-list
14604791|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604792|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
14604793|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604794|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604795|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14604796|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
14604797|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604798|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604799|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14604800|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604801|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604802|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604803|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604804|NCT00060294|Rituximab|rituximab|mesh-list
14604805|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14604806|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604807|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
14604808|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604809|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604810|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14604811|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604812|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14604813|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604814|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604815|NCT00060359|Paclitaxel|paclitaxel|mesh-list
14021993|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14604816|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14604817|NCT00060359|Carboplatin|carboplatin|mesh-list
14021994|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
14604818|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14604819|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604820|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604821|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604822|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604823|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604824|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160711|NCT04123249|Anesthetics|anesthetics|mesh-list
15160712|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15160713|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160714|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160715|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
15160716|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15160717|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15180626|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604825|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14604826|NCT00060372|Ipilimumab|ipilimumab|mesh-list
14604827|NCT00060372|Antibodies|antibodies|mesh-list
14604828|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
14604829|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14604830|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
14604831|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604832|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604833|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14604834|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604835|NCT00060385|Prednisone|prednisone|mesh-list
14604836|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
14604837|NCT00060385|Doxorubicin|doxorubicin|mesh-list
14604838|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14604839|NCT00060385|Etoposide|etoposide|mesh-list
14604840|NCT00060385|Vincristine|vincristine|mesh-list
14604841|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604842|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
14604843|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604844|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604845|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14604846|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
14604847|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604848|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604849|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14604850|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14604851|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14604852|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604853|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604854|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604855|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
14604856|NCT00060385|Hormones|hormones|mesh-ancestor
15180627|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
15180628|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180629|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15180630|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15180631|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
15180632|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180633|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180634|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15180635|NCT03937648|Lasmiditan|lasmiditan|mesh-list
15180636|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15180637|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
15180638|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180639|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180640|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180641|NCT03937401|Oxytocin|oxytocin|mesh-list
15180642|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
15180643|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15180644|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180645|NCT03937258|Probenecid|probenecid|mesh-list
15180646|NCT03937258|Abrocitinib|abrocitinib|mesh-list
14604857|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14604858|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14604859|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14604860|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
14604861|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
14604862|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
14604863|NCT00060398|Dexamethasone|dexamethasone|mesh-list
14604864|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
15180647|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
14604865|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180648|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
14604866|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
14604867|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
14604868|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604869|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604870|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14604871|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
14604872|NCT00060398|Hormones|hormones|mesh-ancestor
14604873|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14604874|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14604875|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604876|NCT00060398|Hematinics|hematinics|mesh-ancestor
14604877|NCT00060411|Leucovorin|leucovorin|mesh-list
14604878|NCT00060411|Bevacizumab|bevacizumab|mesh-list
14604879|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14604880|NCT00060411|Fluorouracil|fluorouracil|mesh-list
15160718|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
15160719|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160720|NCT04122911|Temozolomide|temozolomide|mesh-list
15160721|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15160722|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
15160723|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160724|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160725|NCT04122599|Melatonin|melatonin|mesh-list
15160726|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
15160727|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160728|NCT04122599|Protective Agents|protective agents|mesh-ancestor
15160729|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160730|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160731|NCT04122716|Liraglutide|liraglutide|mesh-list
15160732|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15160733|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160734|NCT04122716|Incretins|incretins|mesh-ancestor
14604881|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
14604882|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14604883|NCT00060411|Antibodies|antibodies|mesh-list
14604884|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
14604885|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15160735|NCT04122716|Hormones|hormones|mesh-ancestor
15160736|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160737|NCT04122560|Fluconazole|fluconazole|mesh-list
15160738|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
15160739|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604886|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
14604887|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604888|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14604889|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14604890|NCT00060411|Growth Substances|growth substances|mesh-ancestor
14604891|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604892|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
14604893|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
14604894|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
14604895|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604896|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604897|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604898|NCT00060411|Antidotes|antidotes|mesh-ancestor
14604899|NCT00060411|Protective Agents|protective agents|mesh-ancestor
14604900|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
14604901|NCT00060411|Vitamins|vitamins|mesh-ancestor
14604902|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
14604903|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14604904|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604905|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
14604906|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14604907|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
14604908|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604909|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604910|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14604911|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
14604912|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14604913|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
14604914|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604915|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14604916|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14604917|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
14604918|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
15160740|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15180649|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604919|NCT00060450|Protective Agents|protective agents|mesh-ancestor
14604920|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
14604921|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
14604922|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14604923|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604924|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14604925|NCT00060476|Rofecoxib|rofecoxib|mesh-list
14604926|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14604927|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14604928|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604929|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604930|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14604931|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14604932|NCT00060476|Analgesics|analgesics|mesh-ancestor
14604933|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
14604934|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14604935|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604936|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14604937|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604938|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14604939|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
14604940|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14604941|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14604942|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14604943|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14604944|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604945|NCT00060502|Gemcitabine|gemcitabine|mesh-list
14604946|NCT00060502|Infliximab|infliximab|mesh-list
14604947|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14604948|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
14604949|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604950|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604951|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
14604952|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604953|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604954|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604955|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
14604956|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604957|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
14604958|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14604959|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14604960|NCT00060554|Heparin|heparin|mesh-list
14604961|NCT00060554|PENTA|penta|mesh-list
14604962|NCT00060554|Fondaparinux|fondaparinux|mesh-list
14604963|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
14604964|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14604965|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14604966|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604967|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14604968|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
14604969|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14604970|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
14604971|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604972|NCT00060567|Irinotecan|irinotecan|mesh-list
14604973|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14604974|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14604975|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14604976|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14604977|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14604978|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604979|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14604980|NCT00060632|Sirolimus|sirolimus|mesh-list
14604981|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14604982|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604983|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14604984|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604985|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
14604986|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604987|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
14604988|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604989|NCT00060645|Sirolimus|sirolimus|mesh-list
14604990|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14604991|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14604992|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14604993|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14604994|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
14604995|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14604996|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
14604997|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14604998|NCT00060671|Rituximab|rituximab|mesh-list
14604999|NCT00060671|Pixantrone|pixantrone|mesh-list
14605000|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605001|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605002|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
14605003|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605004|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605005|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14605006|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605007|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605008|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605009|NCT00060684|Dexamethasone|dexamethasone|mesh-list
14605010|NCT00060684|Rituximab|rituximab|mesh-list
14605011|NCT00060684|Fludarabine|fludarabine|mesh-list
14605012|NCT00060684|Pixantrone|pixantrone|mesh-list
14605013|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14605014|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
14605015|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
14605016|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605017|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605018|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14021995|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14021996|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605019|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
14605020|NCT00060684|Hormones|hormones|mesh-ancestor
14605021|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14605022|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14605023|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605024|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605025|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
14605026|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605027|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605028|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14605029|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605030|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605031|NCT00060866|Propranolol|propranolol|mesh-list
14605032|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14605033|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14605034|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
14605035|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605036|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605037|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605038|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14605039|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14605040|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
14605041|NCT00060905|Valproic Acid|valproic acid|mesh-list
14605042|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
14605043|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160741|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15160742|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160743|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160744|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15160745|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
15160746|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160747|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160748|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15160749|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15160750|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
14605044|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605045|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
14605046|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605047|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605048|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
14605049|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14605050|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14605051|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14605052|NCT00060918|Metoprolol|metoprolol|mesh-list
14605053|NCT00060918|Carvedilol|carvedilol|mesh-list
14605054|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14605055|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14605056|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
14605057|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
14605058|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605059|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605060|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14605061|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14605062|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14605063|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
14605064|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605065|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605066|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
14605067|NCT00060918|Protective Agents|protective agents|mesh-ancestor
14605068|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14605069|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14605070|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14605071|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
14605072|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14605073|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14605074|NCT00060931|Metoprolol|metoprolol|mesh-list
14605075|NCT00060931|Carvedilol|carvedilol|mesh-list
14605076|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14605077|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14605078|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
14605079|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
14605080|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605081|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605082|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14605083|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14605084|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14605085|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
14605086|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605087|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605088|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
14605089|NCT00060931|Protective Agents|protective agents|mesh-ancestor
14605090|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14605091|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14605092|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14605093|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
14605094|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14605095|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14605096|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
14605097|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14605098|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14605099|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14605100|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14605101|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605102|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
14605103|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605104|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605105|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14605106|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605107|NCT00060996|Treprostinil|treprostinil|mesh-list
14605108|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14605109|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
14605110|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
14605111|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605112|NCT00061022|Protective Agents|protective agents|mesh-ancestor
14605113|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605114|NCT00061035|Vaccines|vaccines|mesh-list
14605115|NCT00061035|Immunologic Factors|immunologic factors|mesh-ancestor
14605116|NCT00061035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605117|NCT00061074|Nicotine|nicotine|mesh-list
14605118|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14605119|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
14605120|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605121|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605122|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14605123|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14605124|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
14605125|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605126|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605127|NCT00061087|Methylphenidate|methylphenidate|mesh-list
14605128|NCT00061087|Bupropion|bupropion|mesh-list
14605129|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14605130|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605131|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14605132|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14605133|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14605134|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605135|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
14605136|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605137|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14605138|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
14605139|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14605140|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14605141|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14605142|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605143|NCT00061113|Fluoxetine|fluoxetine|mesh-list
14605144|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14605145|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14605146|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14605147|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605148|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605149|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
14605150|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605151|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14605152|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
14605153|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14605154|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14605155|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14605156|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605157|NCT00061126|Panitumumab|panitumumab|mesh-list
14605158|NCT00061126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605159|NCT00061126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605160|NCT00061152|Capsaicin|capsaicin|mesh-list
14605161|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
14605162|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14605163|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
14605164|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605165|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605166|NCT00061178|Bevacizumab|bevacizumab|mesh-list
14605167|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605168|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605169|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14605170|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14605171|NCT00061178|Growth Substances|growth substances|mesh-ancestor
14605172|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605173|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
14605174|NCT00061243|Vaccines|vaccines|mesh-list
14605175|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
14605176|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605177|NCT00061256|Vitamin D|vitamin d|mesh-list
14605178|NCT00061256|Alendronate|alendronate|mesh-list
14605179|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
14605180|NCT00061256|Calcium|calcium|mesh-list
14605181|NCT00061256|Vitamins|vitamins|mesh-ancestor
14605182|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
14605183|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605184|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14605185|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14605186|NCT00061256|Antacids|antacids|mesh-ancestor
15160751|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
15160752|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160753|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
15160754|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
15160755|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14605187|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605188|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14605189|NCT00061282|Clotrimazole|clotrimazole|mesh-list
14605190|NCT00061282|Miconazole|miconazole|mesh-list
14605191|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14605192|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605193|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
14605194|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15160756|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14021997|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15160757|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605195|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14605196|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605197|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605198|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14605199|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
14605200|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14605201|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605202|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14605203|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14605204|NCT00061308|Gemcitabine|gemcitabine|mesh-list
14605205|NCT00061308|Topotecan|topotecan|mesh-list
14605206|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605207|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
14605208|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605209|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605210|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
14605211|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605212|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605213|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605214|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
14605215|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605216|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14605217|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605218|NCT00061321|Nevirapine|nevirapine|mesh-list
14605219|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14605220|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14605221|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605222|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605223|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
14605224|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605225|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14605226|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14605227|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14605228|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14605229|NCT00061360|Cyclosporine|cyclosporine|mesh-list
14605230|NCT00061360|Sirolimus|sirolimus|mesh-list
14605231|NCT00061360|Cyclosporins|cyclosporins|mesh-list
14605232|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605233|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605234|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605235|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
14605236|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605237|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
14605238|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605239|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
14605240|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605241|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14605242|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14605243|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14605244|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605245|NCT00061425|Epratuzumab|epratuzumab|mesh-list
14605246|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605247|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645323|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14645324|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
14645325|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14645326|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14645327|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645328|NCT00193869|Dexamethasone|dexamethasone|mesh-list
14645329|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645330|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
14645331|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
14645332|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645333|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645334|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14645335|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
14645336|NCT00193869|Hormones|hormones|mesh-ancestor
14645337|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645338|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14645339|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645340|NCT00193882|Cisplatin|cisplatin|mesh-list
14645341|NCT00193882|Fluorouracil|fluorouracil|mesh-list
14645342|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645343|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
14605248|NCT00061438|Meropenem|meropenem|mesh-list
14605249|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14605250|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160758|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160759|NCT04122105|Urological Agents|urological agents|mesh-ancestor
15160760|NCT04122222|Vaccines|vaccines|mesh-list
15160761|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
15160762|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160763|NCT04121975|Endostar protein|endostar protein|mesh-list
15160764|NCT04121975|Endostatins|endostatins|mesh-list
15160765|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160766|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15160767|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15160768|NCT04121975|Growth Substances|growth substances|mesh-ancestor
15160769|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160770|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
15160771|NCT04122040|Roxithromycin|roxithromycin|mesh-list
15160772|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15160773|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160774|NCT04121910|Itraconazole|itraconazole|mesh-list
15160775|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
15160776|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160777|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15160778|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15160779|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160780|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160781|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15160782|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
15160783|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14605251|NCT00061451|Gemcitabine|gemcitabine|mesh-list
14605252|NCT00061451|Pemetrexed|pemetrexed|mesh-list
14605253|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605254|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
14605255|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605256|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605257|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
14605258|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605259|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605260|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605261|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
14605262|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605263|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14605264|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14605265|NCT00061464|Gemcitabine|gemcitabine|mesh-list
14605266|NCT00061464|Pemetrexed|pemetrexed|mesh-list
14605267|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605268|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
14605269|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605270|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605271|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
14605272|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605273|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605274|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605275|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
14605276|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605277|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14605278|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14605279|NCT00061477|Gemcitabine|gemcitabine|mesh-list
14605280|NCT00061477|Pemetrexed|pemetrexed|mesh-list
14605281|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605282|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
14605283|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160784|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160785|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15160786|NCT04121767|Warfarin|warfarin|mesh-list
15160787|NCT04121767|Edoxaban|edoxaban|mesh-list
14605284|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605285|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
14605286|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605287|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605288|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605289|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
14605290|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160788|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
14605291|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14605292|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15160789|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15160790|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
15160791|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15160792|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
15160793|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160794|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160795|NCT04121689|Caseins|caseins|mesh-list
15160796|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
15160797|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
15160798|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160799|NCT04121611|Aspirin|aspirin|mesh-list
15160800|NCT04121611|Heparin|heparin|mesh-list
15160801|NCT04121611|Calcium heparin|calcium heparin|mesh-list
15160802|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
15160803|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15160804|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14605293|NCT00061503|Travoprost|travoprost|mesh-list
14605294|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14605295|NCT00061516|Brinzolamide|brinzolamide|mesh-list
14605296|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14605297|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605298|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605299|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14605300|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14605301|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14605302|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14605303|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14605304|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14605305|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14605306|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14605307|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605308|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605309|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605310|NCT00061542|Timolol|timolol|mesh-list
14605311|NCT00061542|Betaxolol|betaxolol|mesh-list
14605312|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14605313|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14605314|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
14605315|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605316|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605317|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605318|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14605319|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14605320|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
14605321|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
14605322|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605323|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14605324|NCT00061594|Ranibizumab|ranibizumab|mesh-list
14605325|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14605326|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14605327|NCT00061594|Growth Substances|growth substances|mesh-ancestor
15160805|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14021998|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14605328|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605329|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14605330|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605331|NCT00061620|Tezacitabine|tezacitabine|mesh-list
14605332|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605333|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605334|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605335|NCT00061646|Carboplatin|carboplatin|mesh-list
14605336|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605337|NCT00061711|Hormones|hormones|mesh-list
14605338|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
14605339|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14605340|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605341|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14605342|NCT00061711|Estrogens|estrogens|mesh-ancestor
14605343|NCT00061750|Deferasirox|deferasirox|mesh-list
14605344|NCT00061750|Deferoxamine|deferoxamine|mesh-list
14605345|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15160806|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14021999|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
14605346|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
14605347|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
14605348|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605349|NCT00061750|Siderophores|siderophores|mesh-ancestor
14605350|NCT00061763|Deferasirox|deferasirox|mesh-list
15160807|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15160808|NCT04121611|Analgesics|analgesics|mesh-ancestor
15160809|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
15160810|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160811|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160812|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160813|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605351|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14605352|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
14605353|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
14605354|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605355|NCT00061776|Capsaicin|capsaicin|mesh-list
14605356|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
14605357|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
15160814|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15160815|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15160816|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605358|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
14605359|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605360|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605361|NCT00061789|Acetylcholine|acetylcholine|mesh-list
14605362|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
14605363|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14605364|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
14605365|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605366|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605367|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605368|NCT00061802|Risperidone|risperidone|mesh-list
14605369|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14605370|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14605371|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
14605372|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605373|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605374|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605375|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14605376|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14605377|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14605378|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14605379|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14605380|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
14605381|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
14605382|NCT00061815|Leucovorin|leucovorin|mesh-list
14605383|NCT00061815|Fluorouracil|fluorouracil|mesh-list
14605384|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
14605385|NCT00061815|Cetuximab|cetuximab|mesh-list
14605386|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
14605387|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605388|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605389|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605390|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605391|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
14605392|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605393|NCT00061815|Antidotes|antidotes|mesh-ancestor
14605394|NCT00061815|Protective Agents|protective agents|mesh-ancestor
14605395|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
14605396|NCT00061815|Vitamins|vitamins|mesh-ancestor
14605397|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
14605398|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605399|NCT00061854|Soblidotin|soblidotin|mesh-list
14605400|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605401|NCT00061867|Doxorubicin|doxorubicin|mesh-list
14605402|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14605403|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14605404|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605405|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14605406|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605407|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605408|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160817|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
15160818|NCT04121819|Cytarabine|cytarabine|mesh-list
15160819|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605409|NCT00061906|Celecoxib|celecoxib|mesh-list
15160820|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
14605410|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14605411|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14605412|NCT00061906|Analgesics|analgesics|mesh-ancestor
14605413|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
14605414|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605415|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605416|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14605417|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605418|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14605419|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14605420|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605421|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605422|NCT00061919|Thalidomide|thalidomide|mesh-list
14605423|NCT00061919|Carboplatin|carboplatin|mesh-list
14605424|NCT00061919|Etoposide|etoposide|mesh-list
15160821|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160822|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160823|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
14605425|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
14605426|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605427|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14605428|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14605429|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605430|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605431|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605432|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605433|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
14605434|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605435|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
14605436|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14605437|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605438|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14605439|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14605440|NCT00061919|Growth Substances|growth substances|mesh-ancestor
14605441|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
14605442|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
14605443|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605444|NCT00061984|Doxorubicin|doxorubicin|mesh-list
14605445|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14605446|NCT00061984|Ifosfamide|ifosfamide|mesh-list
14605447|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14605448|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605449|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14605450|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605451|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605452|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605453|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14605454|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
14605455|NCT00061997|Inositol|inositol|mesh-list
14605456|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
14605457|NCT00061997|Vitamins|vitamins|mesh-ancestor
14605458|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
14605459|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605460|NCT00062023|Aspirin|aspirin|mesh-list
14605461|NCT00062023|Sulindac|sulindac|mesh-list
14605462|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14605463|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14605464|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14605465|NCT00062023|Analgesics|analgesics|mesh-ancestor
14605466|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
14605467|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605468|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605469|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14605470|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605471|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14605472|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14605473|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605474|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14605475|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14605476|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605477|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
14605478|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14605479|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14605480|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605481|NCT00062036|Aldesleukin|aldesleukin|mesh-list
14605482|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
14605483|NCT00062036|Fludarabine|fludarabine|mesh-list
14605484|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
14605485|NCT00062036|Interleukin-2|interleukin-2|mesh-list
14605486|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
14605487|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160824|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160825|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160826|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
15160827|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160828|NCT04121780|Hormones|hormones|mesh-list
15160829|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160830|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160831|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
15160832|NCT04121507|Thiotepa|thiotepa|mesh-list
15160833|NCT04121507|Fludarabine|fludarabine|mesh-list
15160834|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160835|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
15160836|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160837|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160838|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15160839|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
15160840|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160841|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160842|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15160843|NCT04121533|Vitamin D|vitamin d|mesh-list
15160844|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
15160845|NCT04121533|Vitamins|vitamins|mesh-ancestor
15160846|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
15160847|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605488|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
14605489|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605490|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605491|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14605492|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
14605493|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605494|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605495|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14605496|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605497|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
14605498|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14605499|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14605500|NCT00062036|Analgesics|analgesics|mesh-ancestor
14605501|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
14605502|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605503|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14605504|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14605505|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
14605506|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605507|NCT00062062|Paclitaxel|paclitaxel|mesh-list
14605508|NCT00062062|Carboplatin|carboplatin|mesh-list
14605509|NCT00062062|Gefitinib|gefitinib|mesh-list
14605510|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14605511|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160848|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15160849|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15160850|NCT04121416|Sufentanil|sufentanil|mesh-list
15160851|NCT04121416|Oxycodone|oxycodone|mesh-list
15160852|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15160853|NCT04121416|Narcotics|narcotics|mesh-ancestor
15160854|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160855|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160856|NCT04121416|Analgesics|analgesics|mesh-ancestor
15160857|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
15160858|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160859|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14605512|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14605513|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14605514|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14605515|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160860|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14605516|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14605517|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605518|NCT00062075|Romidepsin|romidepsin|mesh-list
15160861|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
14605519|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15160862|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
14605520|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605521|NCT00062101|Celecoxib|celecoxib|mesh-list
14605522|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14605523|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605524|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14605525|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605526|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605527|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14605528|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14605529|NCT00062101|Analgesics|analgesics|mesh-ancestor
14605530|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
14605531|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605532|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605533|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14605534|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605535|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14605536|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14605537|NCT00062114|Rituximab|rituximab|mesh-list
14605538|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605539|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605540|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
14605541|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605542|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605543|NCT00062127|Thalidomide|thalidomide|mesh-list
14605544|NCT00062127|Irinotecan|irinotecan|mesh-list
14605545|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14605546|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15160863|NCT04121039|Apatinib|apatinib|mesh-list
15160864|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605547|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605548|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605549|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605550|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605551|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
14605552|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605553|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
14605554|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14605555|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605556|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14605557|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14605558|NCT00062127|Growth Substances|growth substances|mesh-ancestor
14605559|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
14605560|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
14605561|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605562|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
14605563|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605564|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605565|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14605566|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
14605567|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605568|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605569|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14605570|NCT00062179|Celecoxib|celecoxib|mesh-list
14605571|NCT00062179|Paclitaxel|paclitaxel|mesh-list
14605572|NCT00062179|Carboplatin|carboplatin|mesh-list
14605573|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14605574|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605575|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
14605576|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
14605577|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
14605578|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605579|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14605580|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15180650|NCT03937258|Renal Agents|renal agents|mesh-ancestor
14605581|NCT00062179|Analgesics|analgesics|mesh-ancestor
14605582|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
14605583|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605584|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605585|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14605586|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605587|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14605588|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14605589|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605590|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
14605591|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605592|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14605593|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605594|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605595|NCT00062231|Amoxicillin|amoxicillin|mesh-list
14605596|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
14605597|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
14605598|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
14605599|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
14605600|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14605601|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14605602|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14605603|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605604|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14605605|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605606|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605607|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605608|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605609|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14605610|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
14605611|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14605612|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605613|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14605614|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14605615|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15160865|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15160866|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160867|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160868|NCT04121338|Bupivacaine|bupivacaine|mesh-list
15160869|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
14605616|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14605617|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14605618|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14605619|NCT00062244|Oblimersen|oblimersen|mesh-list
14605620|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605621|NCT00062257|Irofulven|irofulven|mesh-list
14605622|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14605623|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
14605624|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605625|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605626|NCT00062270|Gemcitabine|gemcitabine|mesh-list
14605627|NCT00062270|Docetaxel|docetaxel|mesh-list
14022000|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022001|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14022002|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14022003|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14022004|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
14022005|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022006|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14022007|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022008|NCT02770378|Analgesics|analgesics|mesh-ancestor
14605628|NCT00062270|Gefitinib|gefitinib|mesh-list
14605629|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605630|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605631|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
14605632|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605633|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
15160870|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
15160871|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15160872|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160873|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
15160874|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160875|NCT04121403|Rituximab|rituximab|mesh-list
15160876|NCT04121403|Cladribine|cladribine|mesh-list
14605634|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605635|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605636|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605637|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
14605638|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605639|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
14605640|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
14605641|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
14605642|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14605643|NCT00062283|Alanosine|alanosine|mesh-list
14605644|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14605645|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605646|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
14605647|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
14605648|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605649|NCT00062296|Rituximab|rituximab|mesh-list
14605650|NCT00062296|Epirubicin|epirubicin|mesh-list
14605651|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605652|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605653|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
14605654|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160877|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15160878|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160879|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
15160880|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160881|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160882|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160883|NCT04121091|Pramipexole|pramipexole|mesh-list
15160884|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
15160885|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160886|NCT04121091|Protective Agents|protective agents|mesh-ancestor
15160887|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160888|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15160889|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15160890|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
15160891|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
15160892|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180651|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180652|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180653|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180654|NCT03936907|Nabiximols|nabiximols|mesh-list
15180655|NCT03936907|Analgesics|analgesics|mesh-ancestor
15180656|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
15180657|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180658|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180659|NCT03936777|Fenfluramine|fenfluramine|mesh-list
15180660|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15180661|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15180662|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15180663|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022009|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
14022010|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605655|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605656|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14605657|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14605658|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605659|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605660|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605661|NCT00062322|Irinotecan|irinotecan|mesh-list
14605662|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605663|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14605664|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605665|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605666|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605667|NCT00062426|Leucovorin|leucovorin|mesh-list
14605668|NCT00062426|Bevacizumab|bevacizumab|mesh-list
14605669|NCT00062426|Fluorouracil|fluorouracil|mesh-list
14605670|NCT00062426|Capecitabine|capecitabine|mesh-list
14605671|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
14605672|NCT00062426|Calcium|calcium|mesh-list
14605673|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
14605674|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605675|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605676|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14605677|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14605678|NCT00062426|Growth Substances|growth substances|mesh-ancestor
14605679|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605680|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
14605681|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14605682|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
14605683|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605684|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605685|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605686|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
14605687|NCT00062426|Antidotes|antidotes|mesh-ancestor
14605688|NCT00062426|Protective Agents|protective agents|mesh-ancestor
14605689|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
14605690|NCT00062426|Vitamins|vitamins|mesh-ancestor
14605691|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
14605692|NCT00062478|Camptothecin|camptothecin|mesh-list
14605693|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14605694|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605695|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14605696|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605697|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605698|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645344|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645345|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645346|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645347|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
14645348|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645349|NCT00193895|Carboplatin|carboplatin|mesh-list
14645350|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645351|NCT00193921|Gemcitabine|gemcitabine|mesh-list
14645352|NCT00193921|Cisplatin|cisplatin|mesh-list
14645353|NCT00193921|Vinorelbine|vinorelbine|mesh-list
14645354|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160893|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
15160894|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
15160895|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15160896|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15160897|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160898|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160899|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160900|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645355|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645356|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
14645357|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645358|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
14645359|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645360|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645361|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645362|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
14645363|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645364|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645365|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645366|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645367|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645368|NCT00193973|Methotrexate|methotrexate|mesh-list
14645369|NCT00193973|Idarubicin|idarubicin|mesh-list
14645370|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14645371|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
14645372|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14645373|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645374|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645375|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
14645376|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645377|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645378|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
14645379|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645380|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14645381|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645382|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
14645383|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645384|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14645385|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14645386|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14645387|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645388|NCT00194038|Aripiprazole|aripiprazole|mesh-list
14645389|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
14645390|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645391|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14645392|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14645393|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645394|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645395|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
14645396|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
14645397|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645398|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605699|NCT00062556|Niacin|niacin|mesh-list
14605700|NCT00062556|Lovastatin|lovastatin|mesh-list
14605701|NCT00062556|L 647318|l 647318|mesh-list
14605702|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
14605703|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14605704|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
14605705|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605706|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14605707|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
14605708|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
14605709|NCT00062556|Vitamins|vitamins|mesh-ancestor
14605710|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
14605711|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605712|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14605713|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14605714|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605715|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
14605716|NCT00062595|Vitamin K|vitamin k|mesh-list
14605717|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14605718|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14605719|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605720|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
14605721|NCT00062595|Coagulants|coagulants|mesh-ancestor
14605722|NCT00062595|Vitamins|vitamins|mesh-ancestor
14605723|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
14605724|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605725|NCT00062660|Tipranavir|tipranavir|mesh-list
14605726|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14605727|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14605728|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
14605729|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605730|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14605731|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14605732|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14605733|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14605734|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605735|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605736|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605737|NCT00062673|Analgesics|analgesics|mesh-ancestor
14605738|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
14605739|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605740|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
14605741|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14605742|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
14605743|NCT00062686|Lapatinib|lapatinib|mesh-list
14605744|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605745|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14605746|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160901|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
15160902|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15160903|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15160904|NCT04120987|Lifitegrast|lifitegrast|mesh-list
15160905|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15160906|NCT04120753|Amlodipine|amlodipine|mesh-list
15160907|NCT04120753|Olmesartan|olmesartan|mesh-list
15160908|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15160909|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15160910|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160911|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160912|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15160913|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160914|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
15160915|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15160916|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15160917|NCT04120974|Insulin|insulin|mesh-list
15160918|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15160919|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160920|NCT04120805|Hemostatics|hemostatics|mesh-list
15160921|NCT04120805|Coagulants|coagulants|mesh-ancestor
15160922|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
15160923|NCT04120922|Calcium|calcium|mesh-list
15160924|NCT04120922|Sevelamer|sevelamer|mesh-list
15160925|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15160926|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605747|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605748|NCT00062699|Calcitriol|calcitriol|mesh-list
15160927|NCT04120922|Antacids|antacids|mesh-ancestor
15160928|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160929|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14605749|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14605750|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605751|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14605752|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15160930|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
15160931|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
15160932|NCT04120831|Abatacept|abatacept|mesh-list
15160933|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022011|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605753|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605754|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14605755|NCT00062699|Vitamins|vitamins|mesh-ancestor
14605756|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
14605757|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14605758|NCT00062712|Sirolimus|sirolimus|mesh-list
14605759|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14605760|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022012|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022013|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022014|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14022015|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14022016|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
14022017|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14022018|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14022019|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14022020|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14022021|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022022|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
14022023|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
14022024|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14022025|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14022026|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
14605761|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605762|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14605763|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605764|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
14605765|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605766|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
14605767|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605768|NCT00062790|Dutasteride|dutasteride|mesh-list
14605769|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14605770|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14605771|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605772|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605773|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
14605774|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14605775|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605776|NCT00062803|Heparin|heparin|mesh-list
14605777|NCT00062803|Warfarin|warfarin|mesh-list
14605778|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
14605779|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
14605780|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14605781|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14605782|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605783|NCT00062816|Ribavirin|ribavirin|mesh-list
14605784|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
14605785|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605786|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
14605787|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605788|NCT00062842|Irinotecan|irinotecan|mesh-list
14605789|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14605790|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605791|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605792|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605793|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605794|NCT00062881|Mafosfamide|mafosfamide|mesh-list
14605795|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14605796|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
14605797|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605798|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605799|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
14605800|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605801|NCT00062946|Fallypride|fallypride|mesh-list
14605802|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14605803|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14605804|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
14605805|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605806|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605807|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605808|NCT00062972|Donepezil|donepezil|mesh-list
14605809|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14605810|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605811|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605812|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
14605813|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605814|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605815|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
14605816|NCT00063011|Calcium|calcium|mesh-list
14605817|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14605818|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605819|NCT00063024|Calcium|calcium|mesh-list
14605820|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14605821|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645399|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14645400|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14645401|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
14645402|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14645403|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14645404|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14645405|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14645406|NCT00194064|Olanzapine|olanzapine|mesh-list
15160934|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
15160935|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160936|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160937|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15160938|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160939|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15160940|NCT04120961|Hirudins|hirudins|mesh-list
15160941|NCT04120961|Bivalirudin|bivalirudin|mesh-list
15160942|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
15160943|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15160944|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
15160945|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160946|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160947|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
15160948|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15160949|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15160950|NCT04120636|Celecoxib|celecoxib|mesh-list
14645407|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
14645408|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
14645409|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645410|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645411|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14645412|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14645413|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14645414|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645415|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645416|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14645417|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14645418|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14645419|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160951|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15160952|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15160953|NCT04120636|Analgesics|analgesics|mesh-ancestor
15160954|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
15160955|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160956|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160957|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160958|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15160959|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15160960|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14645420|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645421|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
14645422|NCT00194090|Celecoxib|celecoxib|mesh-list
15160961|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180664|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605822|NCT00063076|Bexarotene|bexarotene|mesh-list
14605823|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605824|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
14605825|NCT00063089|Antibodies|antibodies|mesh-list
14605826|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
14605827|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14605828|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14605829|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
14605830|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605831|NCT00063128|Insulin|insulin|mesh-list
14605832|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14605833|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14605834|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605835|NCT00063141|Irinotecan|irinotecan|mesh-list
14605836|NCT00063141|Cetuximab|cetuximab|mesh-list
14605837|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14605838|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605839|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605840|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605841|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605842|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605843|NCT00063193|Minocycline|minocycline|mesh-list
14605844|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14605845|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605846|NCT00063310|Leuprolide|leuprolide|mesh-list
14605847|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14605848|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
14605849|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14605850|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605851|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14605852|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605853|NCT00063323|Bupropion|bupropion|mesh-list
14605854|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14605855|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
14605856|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14605857|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14605858|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14605859|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14605860|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605861|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
14605862|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14605863|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605864|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14605865|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14605866|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605867|NCT00063388|Cetuximab|cetuximab|mesh-list
14605868|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605869|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605870|NCT00063401|Paclitaxel|paclitaxel|mesh-list
14605871|NCT00063401|Carboplatin|carboplatin|mesh-list
14605872|NCT00063401|Cetuximab|cetuximab|mesh-list
14605873|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14605874|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605875|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
14605876|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
14605877|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
14605878|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605879|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14605880|NCT00063414|Alicaforsen|alicaforsen|mesh-list
14605881|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14605882|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605883|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
14605884|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605885|NCT00063453|Vitamins|vitamins|mesh-list
14605886|NCT00063453|Vitamin E|vitamin e|mesh-list
14605887|NCT00063453|Tocopherols|tocopherols|mesh-list
14605888|NCT00063453|Tocotrienols|tocotrienols|mesh-list
14605889|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
14605890|NCT00063453|Selenium|selenium|mesh-list
14605891|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
14605892|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605893|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
14605894|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605895|NCT00063453|Protective Agents|protective agents|mesh-ancestor
14605896|NCT00063453|Trace Elements|trace elements|mesh-ancestor
14605897|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
14605898|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15160962|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160963|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
15160964|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
14605899|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605900|NCT00063583|Pirfenidone|pirfenidone|mesh-list
14605901|NCT00063583|Analgesics|analgesics|mesh-ancestor
14605902|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
14605903|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605904|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605905|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14605906|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14605907|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14605908|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605909|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605910|NCT00063596|Vitamin A|vitamin a|mesh-list
14605911|NCT00063596|Vitamins|vitamins|mesh-ancestor
14605912|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
14605913|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605914|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
14605915|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14605916|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605917|NCT00063687|Oxypurinol|oxypurinol|mesh-list
14605918|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605919|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605920|NCT00063713|Bortezomib|bortezomib|mesh-list
14605921|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605922|NCT00063726|Bortezomib|bortezomib|mesh-list
14605923|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605924|NCT00063791|Bortezomib|bortezomib|mesh-list
14605925|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605926|NCT00063804|Ritonavir|ritonavir|mesh-list
14605927|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14605928|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14605929|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
14605930|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605931|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605932|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14605933|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14605934|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
14605935|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605936|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14605937|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14605938|NCT00063830|Alicaforsen|alicaforsen|mesh-list
14605939|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14605940|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605941|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
14605942|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605943|NCT00063869|Etanercept|etanercept|mesh-list
14605944|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14605945|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14605946|NCT00063869|Analgesics|analgesics|mesh-ancestor
14605947|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
14605948|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14605949|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605950|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14605951|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14605952|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14605953|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605954|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
14605955|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14605956|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605957|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14605958|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605959|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605960|NCT00063947|Gemcitabine|gemcitabine|mesh-list
14605961|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14605962|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605963|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
14605964|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605965|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605966|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
14605967|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605968|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605969|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605970|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
15160965|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14605971|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14605972|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14605973|NCT00063960|Irinotecan|irinotecan|mesh-list
14605974|NCT00063960|Floxuridine|floxuridine|mesh-list
14605975|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14605976|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14605977|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14605978|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605979|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605980|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605981|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
14605982|NCT00064012|Docetaxel|docetaxel|mesh-list
14605983|NCT00064012|Bortezomib|bortezomib|mesh-list
14605984|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605985|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14605986|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14605987|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14605988|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605989|NCT00064051|Gemcitabine|gemcitabine|mesh-list
14605990|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14605991|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
14605992|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14605993|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14605994|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
14605995|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14605996|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160966|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160967|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15160968|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160969|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
15160970|NCT04120363|Testosterone|testosterone|mesh-list
15160971|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
15160972|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
15160973|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15160974|NCT04120363|Androgens|androgens|mesh-ancestor
15160975|NCT04120363|Hormones|hormones|mesh-ancestor
15160976|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160977|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160978|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15160979|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160980|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
15160981|NCT04120311|Dexamethasone|dexamethasone|mesh-list
14605997|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14605998|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
14605999|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606000|NCT00064064|Gemcitabine|gemcitabine|mesh-list
14606001|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606002|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
14606003|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606004|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606005|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
15160982|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
15160983|NCT04120311|BB 1101|bb 1101|mesh-list
15160984|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15160985|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
15160986|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
15160987|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15160988|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15160989|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15160990|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
15160991|NCT04120311|Hormones|hormones|mesh-ancestor
15160992|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15160993|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15160994|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15160995|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
15160996|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15160997|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15160998|NCT04120259|Metformin|metformin|mesh-list
15160999|NCT04120259|Acetic Acid|acetic acid|mesh-list
15161000|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15161001|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606006|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606007|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606008|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161002|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15161003|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161004|NCT04120350|Rituximab|rituximab|mesh-list
14606009|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
14606010|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606011|NCT00064090|Cytarabine|cytarabine|mesh-list
14606012|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606013|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
14606014|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606015|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606016|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
14606017|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606018|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606019|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
14606020|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606021|NCT00064116|Rituximab|rituximab|mesh-list
15161005|NCT04120350|Methotrexate|methotrexate|mesh-list
15161006|NCT04120350|Lenalidomide|lenalidomide|mesh-list
15161007|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15161008|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161009|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
15161010|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606022|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14606023|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606024|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
14606025|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606026|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606027|NCT00064129|Ipilimumab|ipilimumab|mesh-list
14606028|NCT00064129|Sargramostim|sargramostim|mesh-list
14606029|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14606030|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606031|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14606032|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606033|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
14606034|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606035|NCT00064142|Halofuginone|halofuginone|mesh-list
14606036|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606037|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
14606038|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14606039|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14606040|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606041|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14606042|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606043|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606044|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14606045|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14606046|NCT00064142|Growth Substances|growth substances|mesh-ancestor
14606047|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606048|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
14606049|NCT00064181|Leucovorin|leucovorin|mesh-list
14606050|NCT00064181|Celecoxib|celecoxib|mesh-list
14606051|NCT00064181|Fluorouracil|fluorouracil|mesh-list
14606052|NCT00064181|Capecitabine|capecitabine|mesh-list
14606053|NCT00064181|Irinotecan|irinotecan|mesh-list
14606054|NCT00064181|Calcium|calcium|mesh-list
14606055|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
14606056|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14606057|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161011|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161012|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15161013|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
15180665|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
14606058|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
14606059|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606060|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606061|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606062|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606063|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
14606064|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14606065|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14606066|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606067|NCT00064181|Antidotes|antidotes|mesh-ancestor
14606068|NCT00064181|Protective Agents|protective agents|mesh-ancestor
14606069|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
14606070|NCT00064181|Vitamins|vitamins|mesh-ancestor
14606071|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
14606072|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14606073|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14606074|NCT00064181|Analgesics|analgesics|mesh-ancestor
14606075|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
14606076|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606077|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14606078|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606079|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14606080|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14606081|NCT00064194|Vitamin E|vitamin e|mesh-list
14606082|NCT00064194|Selenium|selenium|mesh-list
14606083|NCT00064194|Vitamins|vitamins|mesh-ancestor
14606084|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
14606085|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606086|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
14606087|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606088|NCT00064194|Protective Agents|protective agents|mesh-ancestor
14606089|NCT00064194|Trace Elements|trace elements|mesh-ancestor
14606090|NCT00064207|Gemcitabine|gemcitabine|mesh-list
14606091|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606092|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
14606093|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606094|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606095|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
14606096|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606097|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606098|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606099|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
14606100|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606101|NCT00064220|Soblidotin|soblidotin|mesh-list
14606102|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606103|NCT00064233|Dasatinib|dasatinib|mesh-list
14606104|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606105|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14606106|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606107|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606108|NCT00064246|Rituximab|rituximab|mesh-list
14606109|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14606110|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14606111|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606112|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
14606113|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606114|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606115|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
14606116|NCT00064285|Alvocidib|alvocidib|mesh-list
14606117|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606118|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14606119|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606120|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606121|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
14606122|NCT00064285|Growth Substances|growth substances|mesh-ancestor
14606123|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606124|NCT00064389|Albuterol|albuterol|mesh-list
14606125|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14606126|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
14606127|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606128|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606129|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14606130|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
14606131|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
14606132|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14606133|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14606134|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14606135|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14606136|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
14606137|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606138|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606139|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14606140|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
14606141|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14606142|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14606143|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
14606144|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606145|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606146|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14606147|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
14814086|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14606148|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14606149|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14606150|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14606151|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14606152|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606153|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606154|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
14606155|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14606156|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14606157|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
14606158|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606159|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606160|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14606161|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
14606162|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14606163|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14606164|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14606165|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
14606166|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606167|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606168|NCT00064428|PENTA|penta|mesh-list
14606169|NCT00064428|Fondaparinux|fondaparinux|mesh-list
14606170|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14606171|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
14606172|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14606173|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
14606174|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606175|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606176|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
14606177|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14606178|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14606179|NCT00064467|Bupropion|bupropion|mesh-list
14606180|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14606181|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
14606182|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606183|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14606184|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14606185|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606186|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606187|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
14606188|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606189|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161014|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15161015|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15161016|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
15161017|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161018|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161019|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161020|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15161021|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161022|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14606190|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14606191|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14606192|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606193|NCT00064610|Bortezomib|bortezomib|mesh-list
14606194|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606195|NCT00064623|Capsaicin|capsaicin|mesh-list
14606196|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
14606197|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
14606198|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
14606199|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606200|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606201|NCT00064636|Bortezomib|bortezomib|mesh-list
14606202|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606203|NCT00064649|Finasteride|finasteride|mesh-list
14606204|NCT00064649|Alfuzosin|alfuzosin|mesh-list
14606205|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14606206|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14606207|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606208|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161023|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15161024|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15161025|NCT04120350|Growth Substances|growth substances|mesh-ancestor
14606209|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
14606210|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606211|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606212|NCT00064649|Urological Agents|urological agents|mesh-ancestor
14606213|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14606214|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14606215|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14606216|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14606217|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606218|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
14606219|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14606220|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606221|NCT00064766|Doxycycline|doxycycline|mesh-list
14606222|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14606223|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606224|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
14606225|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14606226|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14645423|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14645424|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14645425|NCT00194090|Analgesics|analgesics|mesh-ancestor
14645426|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
14645427|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645428|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645429|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645430|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645431|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14645432|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14645433|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645434|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645435|NCT00194272|Methotrexate|methotrexate|mesh-list
14645436|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14645437|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
14645438|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14645439|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645440|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645441|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
14645442|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645443|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645444|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
14645445|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645446|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14645447|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645448|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
14645449|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645450|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14645451|NCT00194324|Miconazole|miconazole|mesh-list
14645452|NCT00194324|Clotrimazole|clotrimazole|mesh-list
14645453|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
14645454|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645455|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14645456|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14645457|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645458|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645459|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14645460|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
14645461|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645462|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645463|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14645464|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14645465|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14645466|NCT00194402|Niacin|niacin|mesh-list
14645467|NCT00194402|Niacinamide|niacinamide|mesh-list
14645468|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
14645469|NCT00194402|Atorvastatin|atorvastatin|mesh-list
14645470|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14645471|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14645472|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
14645473|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645474|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14645475|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14645476|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606227|NCT00064857|Pycnogenols|pycnogenols|mesh-list
14606228|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14606229|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
14606230|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606231|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
14606232|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606233|NCT00064857|Protective Agents|protective agents|mesh-ancestor
14606234|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14606235|NCT00064974|Lenalidomide|lenalidomide|mesh-list
14606236|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
14606237|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606238|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14606239|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14606240|NCT00064974|Growth Substances|growth substances|mesh-ancestor
14606241|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
14606242|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606243|NCT00065117|Leucovorin|leucovorin|mesh-list
14606244|NCT00065117|Fluorouracil|fluorouracil|mesh-list
14606245|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
14606246|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
14606247|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606248|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606249|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606250|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606251|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
14606252|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606253|NCT00065117|Antidotes|antidotes|mesh-ancestor
14606254|NCT00065117|Protective Agents|protective agents|mesh-ancestor
14606255|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
14606256|NCT00065117|Vitamins|vitamins|mesh-ancestor
14606257|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
14606258|NCT00065130|Insulin|insulin|mesh-list
14606259|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14606260|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
14606261|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
14606262|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
14606263|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
14606264|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14606265|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606266|NCT00065143|Clofarabine|clofarabine|mesh-list
14606267|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606268|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
14606269|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606270|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606271|NCT00065169|Celecoxib|celecoxib|mesh-list
14606272|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14606273|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14606274|NCT00065169|Analgesics|analgesics|mesh-ancestor
14606275|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
14606276|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161026|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
15161027|NCT04120519|Thalidomide|thalidomide|mesh-list
14606277|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606278|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14606279|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606280|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14606281|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14606282|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606283|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606284|NCT00065273|Olanzapine|olanzapine|mesh-list
14606285|NCT00065273|Risperidone|risperidone|mesh-list
14606286|NCT00065273|Clozapine|clozapine|mesh-list
14606287|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14606288|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
14606289|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606290|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606291|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606292|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15161028|NCT04120519|Dexamethasone|dexamethasone|mesh-list
15161029|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
15161030|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161031|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
14606293|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14606294|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161032|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606295|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606296|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14606297|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
14606298|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
14606299|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
14606300|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606301|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14606302|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14606303|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14606304|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606305|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
14606306|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
14606307|NCT00065325|Fulvestrant|fulvestrant|mesh-list
14606308|NCT00065325|Exemestane|exemestane|mesh-list
14606309|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14606310|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606311|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14606312|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14606313|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
14606314|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606315|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606316|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14606317|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14606318|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606319|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606320|NCT00065351|Lenalidomide|lenalidomide|mesh-list
14606321|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
14606322|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606323|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14606324|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14606325|NCT00065351|Growth Substances|growth substances|mesh-ancestor
14606326|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
14606327|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606328|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
14606329|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
14606330|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14606331|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14606332|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606333|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14606334|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606335|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606336|NCT00065455|Vitamin A|vitamin a|mesh-list
14606337|NCT00065455|Vitamins|vitamins|mesh-ancestor
14606338|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
14606339|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606340|NCT00065533|Pemetrexed|pemetrexed|mesh-list
14606341|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606342|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606343|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606344|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14606345|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14606346|NCT00065546|Choline|choline|mesh-list
14606347|NCT00065546|Estrogens|estrogens|mesh-list
14606348|NCT00065546|Hormones|hormones|mesh-ancestor
14606349|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606350|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606351|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
14606352|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14606353|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
14606354|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606355|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14606356|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14606357|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
14606358|NCT00065559|Celecoxib|celecoxib|mesh-list
14606359|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14606360|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14606361|NCT00065559|Analgesics|analgesics|mesh-ancestor
14606362|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
14606363|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606364|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606365|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14606366|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606367|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14606368|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14606369|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606370|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606371|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
14606372|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
14606373|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606374|NCT00065624|Protective Agents|protective agents|mesh-ancestor
14606375|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606376|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
14606377|NCT00065624|Vitamins|vitamins|mesh-ancestor
14606378|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
14606379|NCT00065637|Teriparatide|teriparatide|mesh-list
14606380|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14606381|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606382|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14606383|NCT00065741|Silymarin|silymarin|mesh-list
14606384|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
14606385|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606386|NCT00065741|Protective Agents|protective agents|mesh-ancestor
14606387|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606388|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14606389|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14606390|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
14606391|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606392|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606393|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14606394|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14606395|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14606396|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
14606397|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14606398|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606399|NCT00065884|Valproic Acid|valproic acid|mesh-list
14606400|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
14606401|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606402|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606403|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
14606404|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606405|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606406|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
14606407|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14606408|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14606409|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606410|NCT00065923|Topiramate|topiramate|mesh-list
14606411|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
14606412|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14606413|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606414|NCT00065936|Naltrexone|naltrexone|mesh-list
14606415|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14606416|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14606417|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606418|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
14606419|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606420|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
14606421|NCT00065949|Analgesics|analgesics|mesh-ancestor
14606422|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
14606423|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606424|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606425|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
14606426|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14606427|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14606428|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
14606429|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14606430|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606431|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606432|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14606433|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
14606434|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14606435|NCT00065962|Secretin|secretin|mesh-list
14606436|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14606437|NCT00065962|Hormones|hormones|mesh-ancestor
14606438|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606439|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606440|NCT00066001|Metronidazole|metronidazole|mesh-list
14606441|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606442|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14606443|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14606444|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14606445|NCT00066027|Doxycycline|doxycycline|mesh-list
14606446|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14606447|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606448|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
14606449|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14606450|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14606451|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
14606452|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
14606453|NCT00066040|Fluorides|fluorides|mesh-list
14606454|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
14606455|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
14606456|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
14606457|NCT00066040|Protective Agents|protective agents|mesh-ancestor
14606458|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606459|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14291878|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14291879|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291880|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
14291881|NCT00556998|Voriconazole|voriconazole|mesh-list
14291882|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
14291883|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291884|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14291885|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14606460|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606461|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
14606462|NCT00066092|Lenograstim|lenograstim|mesh-list
14606463|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14606464|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
14606465|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606466|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14606467|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14606468|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14606469|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
14606470|NCT00066157|Estradiol|estradiol|mesh-list
14606471|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14606472|NCT00066157|Estrogens|estrogens|mesh-list
14606473|NCT00066157|Progesterone|progesterone|mesh-list
14606474|NCT00066157|Hormones|hormones|mesh-ancestor
14606475|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606476|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606477|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14606478|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
14606479|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14606480|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14606481|NCT00066157|Progestins|progestins|mesh-ancestor
14606482|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14606483|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14606484|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15161033|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161034|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15161035|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
15161036|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161037|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161038|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15161039|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161040|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
15161041|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
15161042|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161043|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161044|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
15161045|NCT04120519|Hormones|hormones|mesh-ancestor
15161046|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161047|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161048|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
15161049|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15161050|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161051|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15161052|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14026068|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14026069|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14026070|NCT02745561|Growth Substances|growth substances|mesh-ancestor
14026071|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026072|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
14026073|NCT02745522|Oxytocin|oxytocin|mesh-list
14026074|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
14026075|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14606485|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14606486|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14606487|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161053|NCT04120519|Growth Substances|growth substances|mesh-ancestor
15161054|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
15161055|NCT04120415|Vedolizumab|vedolizumab|mesh-list
15161056|NCT04120415|Vaccines|vaccines|mesh-list
14606488|NCT00066196|Dacarbazine|dacarbazine|mesh-list
14606489|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14606490|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
14606491|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606492|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606493|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
15161057|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
15161058|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161059|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161060|NCT04120337|Lidocaine|lidocaine|mesh-list
15161061|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
14606494|NCT00066248|Megestrol|megestrol|mesh-list
14606495|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
14606496|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14606497|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14606498|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14606499|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
14606500|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14606501|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606502|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14606503|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14606504|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14606505|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606506|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
14606507|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14606508|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
14606509|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14606510|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14606511|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14606512|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
14606513|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
14606514|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606515|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606516|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14606517|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
14606518|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14606519|NCT00066274|Leucovorin|leucovorin|mesh-list
14606520|NCT00066274|Fluorouracil|fluorouracil|mesh-list
14606521|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
14606522|NCT00066274|Irinotecan|irinotecan|mesh-list
14606523|NCT00066274|Calcium|calcium|mesh-list
14606524|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
14606525|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14606526|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606527|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
14606528|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606529|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606530|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606531|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606532|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
14606533|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14606534|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14606535|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606536|NCT00066274|Antidotes|antidotes|mesh-ancestor
14606537|NCT00066274|Protective Agents|protective agents|mesh-ancestor
14606538|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
14606539|NCT00066274|Vitamins|vitamins|mesh-ancestor
14606540|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
14606541|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
14606542|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606543|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14606544|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606545|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161062|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
15161063|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161064|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161065|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
14606546|NCT00066339|Gefitinib|gefitinib|mesh-list
14606547|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161066|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606548|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14606549|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606550|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606551|NCT00066352|Bortezomib|bortezomib|mesh-list
14606552|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606553|NCT00066378|Gefitinib|gefitinib|mesh-list
14606554|NCT00066378|Anastrozole|anastrozole|mesh-list
14606555|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606556|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14606557|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606558|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606559|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14606560|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14606561|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14606562|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14606563|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
14606564|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606565|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606566|NCT00066391|Irinotecan|irinotecan|mesh-list
14606567|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606568|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14606569|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14606570|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606571|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606572|NCT00066417|Cyclosporine|cyclosporine|mesh-list
14606573|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
14606574|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
14606575|NCT00066417|Thiotepa|thiotepa|mesh-list
14606576|NCT00066417|Fludarabine|fludarabine|mesh-list
14606577|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
14606578|NCT00066417|Cyclosporins|cyclosporins|mesh-list
14606579|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606580|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
14606581|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161067|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15161068|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15161069|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14606582|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606583|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14606584|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
14606585|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606586|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606587|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14606588|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606589|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
14606590|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606591|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
14606592|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606593|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
14606594|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14606595|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14606596|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
15161070|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15161071|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161072|NCT04119921|Ketorolac|ketorolac|mesh-list
15161073|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15161074|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
15161075|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161076|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161077|NCT04119921|Analgesics|analgesics|mesh-ancestor
15161078|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
15161079|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161080|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161081|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161082|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161083|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15161084|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161085|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606597|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
14606598|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606599|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14606600|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
14814087|NCT00861419|Growth Substances|growth substances|mesh-ancestor
14606601|NCT00066417|Hormones|hormones|mesh-ancestor
14645477|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
14606602|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606603|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14606604|NCT00066417|Protective Agents|protective agents|mesh-ancestor
14606605|NCT00066443|Docetaxel|docetaxel|mesh-list
14606606|NCT00066443|Epirubicin|epirubicin|mesh-list
14606607|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606608|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
14606609|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
14606610|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
14606611|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606612|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14606613|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14606614|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14606615|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606616|NCT00066456|Docetaxel|docetaxel|mesh-list
14606617|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606618|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14606619|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
14606620|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14606621|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606622|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
14606623|NCT00066482|Cisplatin|cisplatin|mesh-list
14606624|NCT00066482|Etoposide|etoposide|mesh-list
14606625|NCT00066482|Bleomycin|bleomycin|mesh-list
14606626|NCT00066482|Lenograstim|lenograstim|mesh-list
14606627|NCT00066482|Sargramostim|sargramostim|mesh-list
14606628|NCT00066482|Mesna|mesna|mesh-list
14606629|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606630|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
14606631|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606632|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606633|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14606634|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
14606635|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606636|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606637|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14606638|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14606639|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14606640|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14606641|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606642|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14606643|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14606644|NCT00066482|Protective Agents|protective agents|mesh-ancestor
14645478|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
14645479|NCT00194402|Vitamins|vitamins|mesh-ancestor
14645480|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
14645481|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645482|NCT00194467|Valganciclovir|valganciclovir|mesh-list
14645483|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
15161086|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15161087|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15161088|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
15161089|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15161090|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161091|NCT04120064|Vitamins|vitamins|mesh-ancestor
15161092|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
15161093|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15161094|NCT04119752|Curcumin|curcumin|mesh-list
15161095|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161096|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161097|NCT04119752|Analgesics|analgesics|mesh-ancestor
15161098|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
15161099|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161100|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161101|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161102|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645484|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161103|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161104|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161105|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161106|NCT04119622|Capecitabine|capecitabine|mesh-list
15161107|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
15161108|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15161109|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
14645485|NCT00194480|Interferons|interferons|mesh-list
14645486|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645487|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
14606645|NCT00066508|Bortezomib|bortezomib|mesh-list
14606646|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606647|NCT00066547|Antibodies|antibodies|mesh-list
14606648|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14606649|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
14606650|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606651|NCT00066586|Exemestane|exemestane|mesh-list
14606652|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606653|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14606654|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14606655|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606656|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606657|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14606658|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
14606659|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606660|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606661|NCT00066599|Voriconazole|voriconazole|mesh-list
14606662|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
14606663|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606664|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14606665|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14606666|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606667|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606668|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14606669|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
14606670|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606671|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606672|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14606673|NCT00066612|Irinotecan|irinotecan|mesh-list
14606674|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14606675|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14606676|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606677|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606678|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606679|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
14606680|NCT00066625|Bortezomib|bortezomib|mesh-list
14606681|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606682|NCT00066638|Romidepsin|romidepsin|mesh-list
14606683|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14606684|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606685|NCT00066651|Immunotoxins|immunotoxins|mesh-list
14606686|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
14606687|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606688|NCT00066716|Celecoxib|celecoxib|mesh-list
14606689|NCT00066716|Paclitaxel|paclitaxel|mesh-list
14606690|NCT00066716|Carboplatin|carboplatin|mesh-list
14606691|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14606692|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606693|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14606694|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14606695|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14606696|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606697|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14606698|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14606699|NCT00066716|Analgesics|analgesics|mesh-ancestor
14606700|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
14606701|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606702|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606703|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14606704|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606705|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14606706|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14606707|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606708|NCT00066768|Gemcitabine|gemcitabine|mesh-list
14606709|NCT00066768|Suramin|suramin|mesh-list
14606710|NCT00066768|Docetaxel|docetaxel|mesh-list
14606711|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606712|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
14606713|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606714|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606715|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
14606716|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606717|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606718|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606719|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
14606720|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606721|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
14606722|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
14606723|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
14606724|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
14606725|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
14606726|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14606727|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14606728|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14606729|NCT00066794|Cytarabine|cytarabine|mesh-list
14606730|NCT00066794|Cyclosporine|cyclosporine|mesh-list
14606731|NCT00066794|Daunorubicin|daunorubicin|mesh-list
14606732|NCT00066794|Cyclosporins|cyclosporins|mesh-list
14606733|NCT00066794|Sargramostim|sargramostim|mesh-list
14606734|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606735|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
14606736|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606737|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606738|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
14606739|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606740|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606741|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
14606742|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606743|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161110|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161111|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161112|NCT04119674|Temozolomide|temozolomide|mesh-list
15161113|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15161114|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
15161115|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161116|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161117|NCT04119297|Heparinoids|heparinoids|mesh-list
15161118|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161119|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
15161120|NCT04119739|Ibuprofen|ibuprofen|mesh-list
15161121|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161122|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161123|NCT04119739|Analgesics|analgesics|mesh-ancestor
15161124|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
15161125|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161126|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161127|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161128|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161129|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15161130|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161131|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161132|NCT04119180|Midazolam|midazolam|mesh-list
15161133|NCT04119180|Ketamine|ketamine|mesh-list
15161134|NCT04119180|Analgesics|analgesics|mesh-ancestor
15161135|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
15161136|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161137|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161138|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15161139|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15161140|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
15161141|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
14606744|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
14606745|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
14606746|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606747|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14606748|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14606749|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14606750|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14606751|NCT00066846|Leucovorin|leucovorin|mesh-list
14606752|NCT00066846|Bevacizumab|bevacizumab|mesh-list
14606753|NCT00066846|Fluorouracil|fluorouracil|mesh-list
14606754|NCT00066846|Calcium|calcium|mesh-list
14606755|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
15161142|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161143|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15161144|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15161145|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161146|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606756|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14606757|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606758|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15161147|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15161148|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15161149|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15161150|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15161151|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15161152|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
15161153|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
15161154|NCT04118920|Insulin|insulin|mesh-list
15161155|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15161156|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15161157|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180666|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180667|NCT03936517|Prednisolone|prednisolone|mesh-list
15180668|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
15180669|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180670|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
15180671|NCT03936517|Hormones|hormones|mesh-ancestor
14606759|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14606760|NCT00066846|Growth Substances|growth substances|mesh-ancestor
14606761|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606762|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
15180672|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180673|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180674|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15180675|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180676|NCT03936491|Methylphenidate|methylphenidate|mesh-list
15180677|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15180678|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15180679|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180680|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15180681|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14606763|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14606764|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
14606765|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606766|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606767|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14606768|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
14606769|NCT00066846|Antidotes|antidotes|mesh-ancestor
14606770|NCT00066846|Protective Agents|protective agents|mesh-ancestor
14606771|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
14606772|NCT00066846|Vitamins|vitamins|mesh-ancestor
14606773|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
14606774|NCT00066859|Sertraline|sertraline|mesh-list
14606775|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
14606776|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606777|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14606778|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14606779|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606780|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606781|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606782|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
14606783|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606784|NCT00066872|Imiquimod|imiquimod|mesh-list
14606785|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14606786|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
14606787|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606788|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606789|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
14606790|NCT00066885|Calcitriol|calcitriol|mesh-list
14606791|NCT00066885|Docetaxel|docetaxel|mesh-list
14606792|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606793|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14606794|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
14606795|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
14606796|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606797|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14606798|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606799|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14606800|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606801|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14606802|NCT00066885|Vitamins|vitamins|mesh-ancestor
14606803|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
14606804|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15180682|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182308|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14606805|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
14606806|NCT00066989|Antibodies|antibodies|mesh-list
14606807|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
14606808|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14606809|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14606810|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
14606811|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606812|NCT00067015|Goserelin|goserelin|mesh-list
14606813|NCT00067015|Bicalutamide|bicalutamide|mesh-list
14606814|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14606815|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606816|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
14606817|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
14606818|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606819|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606820|NCT00067041|Treprostinil|treprostinil|mesh-list
14606821|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14606822|NCT00067080|Deferasirox|deferasirox|mesh-list
14606823|NCT00067080|Deferoxamine|deferoxamine|mesh-list
14606824|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14606825|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
14606826|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
14606827|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606828|NCT00067080|Siderophores|siderophores|mesh-ancestor
15161158|NCT04119336|Dexamethasone|dexamethasone|mesh-list
15161159|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
15161160|NCT04119336|Nivolumab|nivolumab|mesh-list
15161161|NCT04119336|Ixazomib|ixazomib|mesh-list
15161162|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161163|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
15161164|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161165|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161166|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14606829|NCT00067093|Vitamin K|vitamin k|mesh-list
14606830|NCT00067093|Heparin|heparin|mesh-list
14606831|NCT00067093|Calcium heparin|calcium heparin|mesh-list
14606832|NCT00067093|Idraparinux|idraparinux|mesh-list
15161167|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
15161168|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161169|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161170|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14606833|NCT00067093|Vitamins|vitamins|mesh-ancestor
14606834|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
14606835|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606836|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
14606837|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14606838|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14606839|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606840|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14606841|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
14606842|NCT00067093|Coagulants|coagulants|mesh-ancestor
14606843|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14606844|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
14606845|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14606846|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
14606847|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606848|NCT00067119|Aspirin|aspirin|mesh-list
14606849|NCT00067119|Dipyridamole|dipyridamole|mesh-list
14606850|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
14606851|NCT00067119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14606852|NCT00067119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14606853|NCT00067119|Analgesics|analgesics|mesh-ancestor
14606854|NCT00067119|Sensory System Agents|sensory system agents|mesh-ancestor
14606855|NCT00067119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606856|NCT00067119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606857|NCT00067119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14606858|NCT00067119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14606859|NCT00067119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14606860|NCT00067119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14606861|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606862|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14606863|NCT00067119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14606864|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606865|NCT00067119|Antipyretics|antipyretics|mesh-ancestor
14606866|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14606867|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
14606868|NCT00067158|Nicotine|nicotine|mesh-list
14606869|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14606870|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
14606871|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606872|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606873|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14606874|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14606875|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
14606876|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606877|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606878|NCT00067262|Valproic Acid|valproic acid|mesh-list
14606879|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
14606880|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606881|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606882|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
14606883|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606884|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606885|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
14606886|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14606887|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14606888|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606889|NCT00067301|Citalopram|citalopram|mesh-list
14606890|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14606891|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14606892|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606893|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606894|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606895|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
14606896|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606897|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14606898|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
14606899|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606900|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
14606901|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14606902|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606903|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
14606904|NCT00067353|Fluorides|fluorides|mesh-list
14606905|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
14606906|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
14606907|NCT00067353|Protective Agents|protective agents|mesh-ancestor
14606908|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606909|NCT00067405|Micronutrients|micronutrients|mesh-list
14606910|NCT00067405|Trace Elements|trace elements|mesh-list
14606911|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606912|NCT00067431|Valproic Acid|valproic acid|mesh-list
14606913|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
14606914|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606915|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606916|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
14606917|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606918|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606919|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
14606920|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14606921|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14606922|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606923|NCT00067444|Paroxetine|paroxetine|mesh-list
14606924|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14606925|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14606926|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606927|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606928|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606929|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
14606930|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606931|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14606932|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
14606933|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14606934|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14606935|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14606936|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606937|NCT00067457|Alosetron|alosetron|mesh-list
14606938|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14606939|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14606940|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
14606941|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606942|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606943|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606944|NCT00067496|Modafinil|modafinil|mesh-list
14606945|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14606946|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606947|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14606948|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14606949|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14606950|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606951|NCT00067509|Progesterone|progesterone|mesh-list
14606952|NCT00067509|Estrogens|estrogens|mesh-list
14606953|NCT00067509|Progestins|progestins|mesh-ancestor
14606954|NCT00067509|Hormones|hormones|mesh-ancestor
14606955|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14606956|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606957|NCT00067535|Cocaine|cocaine|mesh-list
14606958|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
14606959|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
14606960|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14606961|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606962|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
14606963|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14606964|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14606965|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14606966|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14606967|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14606968|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606969|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
14606970|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606971|NCT00067548|EKB 569|ekb 569|mesh-list
14606972|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14606973|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14606974|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14606975|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606976|NCT00067561|Alosetron|alosetron|mesh-list
14606977|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14606978|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14606979|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
14606980|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14606981|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14606982|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606983|NCT00067600|Calcium|calcium|mesh-list
14606984|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14606985|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606986|NCT00067626|Chromium|chromium|mesh-list
14606987|NCT00067626|Trace Elements|trace elements|mesh-ancestor
14606988|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
14606989|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606990|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14606991|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14606992|NCT00067743|Lenalidomide|lenalidomide|mesh-list
14606993|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
14606994|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14606995|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14606996|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14606997|NCT00067743|Growth Substances|growth substances|mesh-ancestor
14606998|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
14606999|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607000|NCT00067756|Butyric Acid|butyric acid|mesh-list
14607001|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
14607002|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
14607003|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607004|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607005|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607006|NCT00067860|Hormones|hormones|mesh-list
14607007|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607008|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607009|NCT00067899|Vitamins|vitamins|mesh-list
14607010|NCT00067899|Ascorbic Acid|ascorbic acid|mesh-list
14607011|NCT00067899|Vitamin E|vitamin e|mesh-list
14607012|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
14607013|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607014|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
14607015|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607016|NCT00067899|Protective Agents|protective agents|mesh-ancestor
14607017|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14607018|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14607019|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14607020|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14607021|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14607022|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607023|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607024|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607025|NCT00067912|Analgesics|analgesics|mesh-ancestor
14607026|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
14607027|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814088|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814089|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
14607028|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
14607029|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14607030|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
14607031|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14607032|NCT00067925|Calcium|calcium|mesh-list
14607033|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14607034|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607035|NCT00067938|Lamotrigine|lamotrigine|mesh-list
14607036|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
14607037|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14607038|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14607039|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607040|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14607041|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607042|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14607043|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14607044|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14607045|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14607046|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14607047|NCT00067951|Metformin|metformin|mesh-list
14607048|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
14607049|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14607050|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607051|NCT00068029|Octreotide|octreotide|mesh-list
14607052|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14607053|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14607054|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607055|NCT00068042|Octreotide|octreotide|mesh-list
14607056|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14607057|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14607058|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607059|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
14607060|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14607061|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14607062|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
14607063|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607064|NCT00068068|Talaporfin|talaporfin|mesh-list
14607065|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607066|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14607067|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
14607068|NCT00068081|Capsaicin|capsaicin|mesh-list
14607069|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
14607070|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
14607071|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
14607072|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607073|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645488|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645489|NCT00194519|Acyclovir|acyclovir|mesh-list
14645490|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
14645491|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645492|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
14645493|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645494|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
14645495|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14645496|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14645497|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645498|NCT00194597|Urological Agents|urological agents|mesh-ancestor
14645499|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
14645500|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14645501|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14645502|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14645503|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14607074|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
14607075|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14607076|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607077|NCT00068276|Vitamins|vitamins|mesh-ancestor
14607078|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
14607079|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14607080|NCT00068289|Bortezomib|bortezomib|mesh-list
14607081|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607082|NCT00068302|Sirolimus|sirolimus|mesh-list
14607083|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14607084|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607085|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14607086|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607087|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
14607088|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607089|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
14607090|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607091|NCT00068315|Rituximab|rituximab|mesh-list
14607092|NCT00068315|Fludarabine|fludarabine|mesh-list
14607093|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
14607094|NCT00068315|Bortezomib|bortezomib|mesh-list
14607095|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607096|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607097|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
14607098|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607099|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607100|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607101|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
14607102|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607103|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607104|NCT00068432|Gemcitabine|gemcitabine|mesh-list
14607105|NCT00068432|Celecoxib|celecoxib|mesh-list
14607106|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607107|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
15161171|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161172|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
15161173|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
14607108|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607109|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607110|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
14607111|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607112|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607113|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607114|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
14607115|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607116|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14607117|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14607118|NCT00068432|Analgesics|analgesics|mesh-ancestor
14607119|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
14607120|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607121|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607122|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161174|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161175|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161176|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
15161177|NCT04119336|Hormones|hormones|mesh-ancestor
15161178|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161179|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161180|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15161181|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15161182|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
15161183|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161184|NCT04119037|Morphine|morphine|mesh-list
15161185|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14607123|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14607124|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14607125|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
14607126|NCT00068458|Calcium|calcium|mesh-list
14607127|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14607128|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607129|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14607130|NCT00068471|Anidulafungin|anidulafungin|mesh-list
14607131|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
14607132|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607133|NCT00068484|Bortezomib|bortezomib|mesh-list
14607134|NCT00068484|Topotecan|topotecan|mesh-list
15161186|NCT04119037|Narcotics|narcotics|mesh-ancestor
14607135|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607136|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14607137|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607138|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607139|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607140|NCT00068497|Gefitinib|gefitinib|mesh-list
14607141|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607142|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14607143|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607144|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607145|NCT00068523|Cyclosporine|cyclosporine|mesh-list
14607146|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
14607147|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
14607148|NCT00068523|Fludarabine|fludarabine|mesh-list
14607149|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
14607150|NCT00068523|Cyclosporins|cyclosporins|mesh-list
14607151|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14607152|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607153|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
14607154|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607155|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607156|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607157|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
14607158|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161187|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161188|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161189|NCT04119037|Analgesics|analgesics|mesh-ancestor
15161190|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
15161191|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161192|NCT04118855|Axitinib|axitinib|mesh-list
15161193|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161194|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161195|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161196|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161197|NCT04118842|Rifampin|rifampin|mesh-list
15161198|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15161199|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
14607159|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607160|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14607161|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607162|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
14607163|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607164|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
14607165|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607166|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14607167|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14607168|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161200|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15161201|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161202|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
15161203|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15161204|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161205|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161206|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15161207|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14607169|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
14607170|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
14607171|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607172|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14607173|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
14607174|NCT00068523|Hormones|hormones|mesh-ancestor
14607175|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607176|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14607177|NCT00068523|Protective Agents|protective agents|mesh-ancestor
14607178|NCT00068549|Gemcitabine|gemcitabine|mesh-list
14607179|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607180|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607181|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
14607182|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607183|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
14607184|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607185|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607186|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607187|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
14607188|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607189|NCT00068653|Celecoxib|celecoxib|mesh-list
14607190|NCT00068653|Gefitinib|gefitinib|mesh-list
14607191|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14607192|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14607193|NCT00068653|Analgesics|analgesics|mesh-ancestor
14607194|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
14607195|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607196|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607197|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607198|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607199|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14607200|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14607201|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607202|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607203|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607204|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14607205|NCT00068666|Temozolomide|temozolomide|mesh-list
14607206|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607207|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
14607208|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607209|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607210|NCT00068731|Lycopene|lycopene|mesh-list
14607211|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607212|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
14607213|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607214|NCT00068731|Protective Agents|protective agents|mesh-ancestor
14607215|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607216|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14607217|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14607218|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607219|NCT00068744|Fluorouracil|fluorouracil|mesh-list
14607220|NCT00068744|Mitomycins|mitomycins|mesh-list
14607221|NCT00068744|Mitomycin|mitomycin|mesh-list
14607222|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607223|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
14607224|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607225|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607226|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607227|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
14607228|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607229|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14607230|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
14607231|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14607232|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607233|NCT00068757|Paclitaxel|paclitaxel|mesh-list
14607234|NCT00068757|Trastuzumab|trastuzumab|mesh-list
14607235|NCT00068757|Lonafarnib|lonafarnib|mesh-list
14607236|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607237|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607238|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607239|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607240|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607241|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607242|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15161208|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15161209|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15161210|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15161211|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15161212|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
15161213|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15161214|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161215|NCT04118556|Sirolimus|sirolimus|mesh-list
15161216|NCT04118556|Etanercept|etanercept|mesh-list
15161217|NCT04118556|Everolimus|everolimus|mesh-list
15161218|NCT04118556|Infliximab|infliximab|mesh-list
15161219|NCT04118556|Vedolizumab|vedolizumab|mesh-list
15161220|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161221|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161222|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
15161223|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161224|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14607243|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161225|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607244|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
15161226|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15161227|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
14607245|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607246|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14607247|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607248|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607249|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14607250|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
14607251|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607252|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
14607253|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
14607254|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14607255|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607256|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14607257|NCT00068861|Metformin|metformin|mesh-list
14607258|NCT00068861|Clomiphene|clomiphene|mesh-list
14607259|NCT00068861|Enclomiphene|enclomiphene|mesh-list
14607260|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
14607261|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14607262|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607263|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14607264|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
14607265|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607266|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14607267|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
14607268|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14607269|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14607270|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14607271|NCT00068952|Temozolomide|temozolomide|mesh-list
15161228|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161229|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161230|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161231|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161232|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161233|NCT04118556|Analgesics|analgesics|mesh-ancestor
15161234|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
15161235|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161236|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161237|NCT04118699|Rifaximin|rifaximin|mesh-list
15161238|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15161239|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161240|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161241|NCT04118777|Ropivacaine|ropivacaine|mesh-list
15161242|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
15161243|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
15161244|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161245|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161246|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
15161247|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607272|NCT00068952|Carmustine|carmustine|mesh-list
14607273|NCT00068952|Lomustine|lomustine|mesh-list
14607274|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607275|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
14607276|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607277|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607278|NCT00069251|Bupropion|bupropion|mesh-list
14607279|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14607280|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
14607281|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14607282|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14607283|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14607284|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14607285|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607286|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
15161248|NCT04118153|Abatacept|abatacept|mesh-list
15161249|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15161250|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161251|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161252|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607287|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607288|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607289|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14607290|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14607291|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607292|NCT00069355|Propranolol|propranolol|mesh-list
14607293|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14607294|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14607295|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
14607296|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607297|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607298|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607299|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14607300|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14607301|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
14607302|NCT00069446|Bevacizumab|bevacizumab|mesh-list
14607303|NCT00069446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607304|NCT00069446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607305|NCT00069446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14607306|NCT00069446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14607307|NCT00069446|Growth Substances|growth substances|mesh-ancestor
14607308|NCT00069446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607309|NCT00069446|Growth Inhibitors|growth inhibitors|mesh-ancestor
14607310|NCT00069459|Bupropion|bupropion|mesh-list
14607311|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14607312|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
14607313|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14607314|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14607315|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14607316|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14607317|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607318|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
14607319|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607320|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607321|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14607322|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14607323|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607324|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14607325|NCT00069498|Mesalamine|mesalamine|mesh-list
14607326|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
14607327|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14607328|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607329|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14607330|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14607331|NCT00069498|Analgesics|analgesics|mesh-ancestor
14607332|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
14607333|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607334|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607335|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607336|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607337|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
14607338|NCT00069550|Donepezil|donepezil|mesh-list
14607339|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14607340|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607341|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607342|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
14607343|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607344|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607345|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
14607346|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
14607347|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
14607348|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14607349|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14607350|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14607351|NCT00069706|Latanoprost|latanoprost|mesh-list
14607352|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14607353|NCT00069836|Metformin|metformin|mesh-list
14607354|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
14607355|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14607356|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607357|NCT00069875|Gemcitabine|gemcitabine|mesh-list
14607358|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607359|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607360|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
14607361|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607362|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
15161253|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
15161254|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607363|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607364|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607365|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607366|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
14607367|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607368|NCT00069888|Docetaxel|docetaxel|mesh-list
14607369|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607370|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607371|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607372|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607373|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607374|NCT00069901|Paclitaxel|paclitaxel|mesh-list
14607375|NCT00069901|Carboplatin|carboplatin|mesh-list
14607376|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14607377|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607378|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161255|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161256|NCT04117919|Triamcinolone|triamcinolone|mesh-list
15161257|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15161258|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15161259|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
15161260|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15161261|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15161262|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15161263|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15161264|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161265|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
15161266|NCT04117919|Hormones|hormones|mesh-ancestor
15161267|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161268|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161269|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161270|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
15161271|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161272|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161273|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15161274|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
15161275|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14607379|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607380|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607381|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607382|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607383|NCT00069927|Methylphenidate|methylphenidate|mesh-list
14607384|NCT00069927|Amphetamine|amphetamine|mesh-list
14607385|NCT00069927|Adderall|adderall|mesh-list
14607386|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
14607387|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14607388|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607389|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14607390|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14607391|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14607392|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607393|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
14607394|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607395|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
14607396|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
14607397|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607398|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
14607399|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14607400|NCT00069940|Sargramostim|sargramostim|mesh-list
14607401|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
14607402|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607403|NCT00069966|Cytarabine|cytarabine|mesh-list
14607404|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
14607405|NCT00069966|Rituximab|rituximab|mesh-list
14607406|NCT00069966|Pixantrone|pixantrone|mesh-list
14607407|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607408|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607409|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
14607410|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607411|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607412|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607413|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
14607414|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607415|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
14607416|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607417|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607418|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607419|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
14607420|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
14607421|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607422|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14607423|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
14607424|NCT00069966|Hormones|hormones|mesh-ancestor
14607425|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607426|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14607427|NCT00069966|Protective Agents|protective agents|mesh-ancestor
14607428|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14607429|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607430|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607431|NCT00069992|Fludarabine|fludarabine|mesh-list
14607432|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
14607433|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607434|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607435|NCT00070057|Celecoxib|celecoxib|mesh-list
14607436|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14607437|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14607438|NCT00070057|Analgesics|analgesics|mesh-ancestor
14607439|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
14607440|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607441|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607442|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607443|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607444|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14607445|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14607446|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607447|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607448|NCT00070083|Prednisone|prednisone|mesh-list
14607449|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
14607450|NCT00070083|Rituximab|rituximab|mesh-list
14607451|NCT00070083|Doxorubicin|doxorubicin|mesh-list
15161276|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15161277|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15161278|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161279|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161280|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161281|NCT04117893|Analgesics|analgesics|mesh-ancestor
15161282|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
15161283|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161284|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
15161285|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15161286|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
15161287|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14607452|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14607453|NCT00070083|Vincristine|vincristine|mesh-list
14607454|NCT00070083|Oblimersen|oblimersen|mesh-list
14607455|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607456|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
14607457|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607458|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607459|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607460|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
14607461|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607462|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607463|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14607464|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607465|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14607466|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14607467|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607468|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607469|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607470|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
14607471|NCT00070083|Hormones|hormones|mesh-ancestor
14607472|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607473|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14607474|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607475|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607476|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
15161288|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
14607477|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607478|NCT00070122|Leucovorin|leucovorin|mesh-list
14607479|NCT00070122|Bevacizumab|bevacizumab|mesh-list
14607480|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14607481|NCT00070122|Fluorouracil|fluorouracil|mesh-list
14607482|NCT00070122|Capecitabine|capecitabine|mesh-list
14607483|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
15161289|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
15161290|NCT04117893|Protective Agents|protective agents|mesh-ancestor
15161291|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
15161292|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15161293|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15161294|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161295|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
15161296|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161297|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
15161298|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
15161299|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15161300|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161301|NCT04117750|Vitamins|vitamins|mesh-ancestor
15161302|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
15161303|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15161304|NCT04117750|Antacids|antacids|mesh-ancestor
15161305|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161306|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161307|NCT04117698|Ethambutol|ethambutol|mesh-list
15161308|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
15161309|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15161310|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161311|NCT04118322|Peppermint oil|peppermint oil|mesh-list
15161312|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
15161313|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
14607484|NCT00070122|Antibodies|antibodies|mesh-list
14607485|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
14607486|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14607487|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
14607488|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607489|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14607490|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14607491|NCT00070122|Growth Substances|growth substances|mesh-ancestor
14607492|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607493|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
14607494|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
14607495|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
14607496|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607497|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607498|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607499|NCT00070122|Antidotes|antidotes|mesh-ancestor
15161314|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161315|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161316|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161317|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
15161318|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
15161319|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14607500|NCT00070122|Protective Agents|protective agents|mesh-ancestor
14607501|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
14607502|NCT00070122|Vitamins|vitamins|mesh-ancestor
14607503|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
14607504|NCT00070148|Megestrol|megestrol|mesh-list
14607505|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
14607506|NCT00070148|Oxandrolone|oxandrolone|mesh-list
14607507|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14607508|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14607509|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14607510|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
14607511|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14607512|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607513|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14607514|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14607515|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14607516|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607517|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
14607518|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14607519|NCT00070148|Androgens|androgens|mesh-ancestor
14607520|NCT00070148|Hormones|hormones|mesh-ancestor
14607521|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161320|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607522|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
15161321|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161322|NCT04117451|Propolis|propolis|mesh-list
15182309|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
14607523|NCT00070161|Donepezil|donepezil|mesh-list
14607524|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14607525|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607526|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607527|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
14607528|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607529|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607530|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
14607531|NCT00070174|Cytarabine|cytarabine|mesh-list
14607532|NCT00070174|Cyclosporine|cyclosporine|mesh-list
14607533|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
14607534|NCT00070174|Busulfan|busulfan|mesh-list
14607535|NCT00070174|Methotrexate|methotrexate|mesh-list
14607536|NCT00070174|Etoposide|etoposide|mesh-list
14607537|NCT00070174|Daunorubicin|daunorubicin|mesh-list
14607538|NCT00070174|Asparaginase|asparaginase|mesh-list
14607539|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
14607540|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
15161323|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161324|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15161325|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15161326|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607541|NCT00070174|Cyclosporins|cyclosporins|mesh-list
14607542|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607543|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
14607544|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607545|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607546|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607547|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
14607548|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607549|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607550|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14607551|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14607552|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
14607553|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14607554|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607555|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
14607556|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
14607557|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607558|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14607559|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14607560|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607561|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14607562|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607563|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
14607564|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607565|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
14607566|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14607567|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14607568|NCT00070174|Analgesics|analgesics|mesh-ancestor
14607569|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
14607570|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607571|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14645504|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645505|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
14645506|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645507|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161327|NCT04117178|Memantine|memantine|mesh-list
15161328|NCT04117178|Donepezil|donepezil|mesh-list
15161329|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15161330|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161331|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161332|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
15161333|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161334|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161335|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
15161336|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15161337|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15161338|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
15161339|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15161340|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15161341|NCT04117009|Remifentanil|remifentanil|mesh-list
14645508|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14645509|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647470|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14647471|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14607572|NCT00070187|Interferons|interferons|mesh-list
14607573|NCT00070187|Cytarabine|cytarabine|mesh-list
14607574|NCT00070187|Aldesleukin|aldesleukin|mesh-list
14607575|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
14607576|NCT00070187|Cyclosporine|cyclosporine|mesh-list
14607577|NCT00070187|Etoposide|etoposide|mesh-list
14607578|NCT00070187|Melphalan|melphalan|mesh-list
14607579|NCT00070187|Interleukin-2|interleukin-2|mesh-list
14607580|NCT00070187|Carmustine|carmustine|mesh-list
14607581|NCT00070187|Cyclosporins|cyclosporins|mesh-list
14607582|NCT00070187|Lenograstim|lenograstim|mesh-list
14607583|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607584|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607585|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14607586|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607587|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607588|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607589|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
14607590|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607591|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607592|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
14607593|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607594|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
14607595|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607596|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14607597|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
15161342|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15161343|NCT04117009|Narcotics|narcotics|mesh-ancestor
15161344|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161345|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161346|NCT04117009|Analgesics|analgesics|mesh-ancestor
15161347|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
15161348|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161349|NCT04117243|Misoprostol|misoprostol|mesh-list
14607598|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161350|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
15161351|NCT04117243|Oxytocin|oxytocin|mesh-list
14022027|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607599|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607600|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14607601|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607602|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
14607603|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14607604|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14607605|NCT00070187|Analgesics|analgesics|mesh-ancestor
14607606|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
14607607|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607608|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14607609|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14607610|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
14607611|NCT00070200|Melphalan|melphalan|mesh-list
14607612|NCT00070200|Doxorubicin|doxorubicin|mesh-list
14607613|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14607614|NCT00070200|Etoposide|etoposide|mesh-list
14607615|NCT00070200|Vincristine|vincristine|mesh-list
14607616|NCT00070200|Topotecan|topotecan|mesh-list
14607617|NCT00070200|Isotretinoin|isotretinoin|mesh-list
14607618|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607619|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
14607620|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607621|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607622|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607623|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
14607624|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607625|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607626|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14607627|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14607628|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14607629|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607630|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161352|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
15161353|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14607631|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607632|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607633|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607634|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607635|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14607636|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
14607637|NCT00070213|Leucovorin|leucovorin|mesh-list
14607638|NCT00070213|Fluorouracil|fluorouracil|mesh-list
14607639|NCT00070213|Capecitabine|capecitabine|mesh-list
14607640|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
14607641|NCT00070213|Calcium|calcium|mesh-list
14607642|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
14607643|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14607644|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607645|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
14607646|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607647|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607648|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607649|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607650|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
14607651|NCT00070213|Antidotes|antidotes|mesh-ancestor
14607652|NCT00070213|Protective Agents|protective agents|mesh-ancestor
14607653|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
14607654|NCT00070213|Vitamins|vitamins|mesh-ancestor
14607655|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
14607656|NCT00070239|Alvocidib|alvocidib|mesh-list
14607657|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14607658|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14607659|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607660|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607661|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607662|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
14607663|NCT00070239|Growth Substances|growth substances|mesh-ancestor
14607664|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14607665|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607666|NCT00070252|Docetaxel|docetaxel|mesh-list
14607667|NCT00070252|Capecitabine|capecitabine|mesh-list
14607668|NCT00070252|Tipifarnib|tipifarnib|mesh-list
14607669|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607670|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607671|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607672|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607673|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607674|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607675|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
14607676|NCT00070265|Capecitabine|capecitabine|mesh-list
14607677|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
14607678|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607679|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
14607680|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607681|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607682|NCT00070278|Gemcitabine|gemcitabine|mesh-list
14607683|NCT00070278|Paclitaxel|paclitaxel|mesh-list
14607684|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
14607685|NCT00070278|Epirubicin|epirubicin|mesh-list
14607686|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607687|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607688|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607689|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607690|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607691|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607692|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607693|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
14607694|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607695|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607696|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607697|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
14607698|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14607699|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607700|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
14607701|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
14607702|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607703|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607704|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14607705|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14607706|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607707|NCT00070304|Gemcitabine|gemcitabine|mesh-list
14607708|NCT00070304|Vinorelbine|vinorelbine|mesh-list
14607709|NCT00070304|Lenograstim|lenograstim|mesh-list
14607710|NCT00070304|Sargramostim|sargramostim|mesh-list
14607711|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607712|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
14607713|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607714|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607715|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
14607716|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607717|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607718|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607719|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
14607720|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607721|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14607722|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607723|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607724|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607725|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607726|NCT00070343|Dacarbazine|dacarbazine|mesh-list
14607727|NCT00070343|Oblimersen|oblimersen|mesh-list
14607728|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607729|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
14607730|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607731|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607732|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
14607733|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
14607734|NCT00070382|Hematinics|hematinics|mesh-ancestor
14607735|NCT00070434|Leucovorin|leucovorin|mesh-list
14607736|NCT00070434|Pyridoxine|pyridoxine|mesh-list
14607737|NCT00070434|Fluorouracil|fluorouracil|mesh-list
14607738|NCT00070434|Capecitabine|capecitabine|mesh-list
14607739|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
14607740|NCT00070434|Irinotecan|irinotecan|mesh-list
14607741|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
14607742|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607743|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
14607744|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607745|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607746|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607747|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607748|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
14607749|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15161354|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161355|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15161356|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14607750|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14607751|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607752|NCT00070434|Antidotes|antidotes|mesh-ancestor
14607753|NCT00070434|Protective Agents|protective agents|mesh-ancestor
14607754|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
14607755|NCT00070434|Vitamins|vitamins|mesh-ancestor
14607756|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
14607757|NCT00070447|Prednisone|prednisone|mesh-list
14607758|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
14607759|NCT00070447|Rituximab|rituximab|mesh-list
14607760|NCT00070447|Doxorubicin|doxorubicin|mesh-list
14607761|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14607762|NCT00070447|Vincristine|vincristine|mesh-list
14607763|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607764|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
15161357|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161358|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
15161359|NCT04117243|Coagulants|coagulants|mesh-ancestor
15161360|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15161361|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
15161362|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15161363|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180683|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607765|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607766|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15180684|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
15180685|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180686|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14607767|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607768|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
15180687|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
15182220|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182221|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14607769|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607770|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607771|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14607772|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607773|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14607774|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14607775|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15161364|NCT04117074|Bupivacaine|bupivacaine|mesh-list
15161365|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
15161366|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
15161367|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161368|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161369|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
15161370|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161371|NCT04117191|Tryptophan|tryptophan|mesh-list
15161372|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15161373|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
14607776|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607777|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607778|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
14607779|NCT00070447|Hormones|hormones|mesh-ancestor
14607780|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607781|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14607782|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607783|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607784|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607785|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607786|NCT00070473|Pemetrexed|pemetrexed|mesh-list
14607787|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607788|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607789|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607790|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14607791|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14607792|NCT00070486|Gemcitabine|gemcitabine|mesh-list
14607793|NCT00070486|Celecoxib|celecoxib|mesh-list
14607794|NCT00070486|Zileuton|zileuton|mesh-list
14607795|NCT00070486|Carboplatin|carboplatin|mesh-list
14607796|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607797|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607798|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
14607799|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607800|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
14607801|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607802|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607803|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607804|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
14607805|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607806|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14607807|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14607808|NCT00070486|Analgesics|analgesics|mesh-ancestor
14607809|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
14607810|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607811|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607812|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14607813|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14607814|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14607815|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14607816|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14607817|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
14607818|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607819|NCT00070525|Tipifarnib|tipifarnib|mesh-list
14607820|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161374|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15161375|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
15161376|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15161377|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161378|NCT04116931|Clopidogrel|clopidogrel|mesh-list
15161379|NCT04116931|Ticagrelor|ticagrelor|mesh-list
15161380|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15161381|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15161382|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15161383|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14607821|NCT00070538|Cytarabine|cytarabine|mesh-list
14607822|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607823|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
14607824|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607825|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607826|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
14607827|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291886|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607828|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161384|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
14607829|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
14607830|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607831|NCT00070551|Cytarabine|cytarabine|mesh-list
14607832|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607833|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
14607834|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607835|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607836|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
14607837|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607838|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607839|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
14607840|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607841|NCT00070629|Paclitaxel|paclitaxel|mesh-list
14607842|NCT00070629|Docetaxel|docetaxel|mesh-list
14607843|NCT00070629|Cisplatin|cisplatin|mesh-list
15161385|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161386|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161387|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161388|NCT04116554|Bupivacaine|bupivacaine|mesh-list
14607844|NCT00070629|Carboplatin|carboplatin|mesh-list
14607845|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607846|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607847|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607848|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607849|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607850|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607851|NCT00070642|Dacarbazine|dacarbazine|mesh-list
14607852|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14607853|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
14607854|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607855|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607856|NCT00070655|Vitamin K|vitamin k|mesh-list
14607857|NCT00070655|Warfarin|warfarin|mesh-list
14607858|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
14607859|NCT00070655|Idraparinux|idraparinux|mesh-list
14607860|NCT00070655|Vitamins|vitamins|mesh-ancestor
14607861|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
14607862|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607863|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
15161389|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
15161390|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
15161391|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161392|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161393|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
15161394|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161395|NCT04116528|Ketamine|ketamine|mesh-list
15161396|NCT04116528|Buprenorphine|buprenorphine|mesh-list
14022028|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022029|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
15161397|NCT04116528|Analgesics|analgesics|mesh-ancestor
15161398|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
14022030|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
14607864|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14607865|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14607866|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607867|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
14607868|NCT00070655|Coagulants|coagulants|mesh-ancestor
14607869|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14607870|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
14607871|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14607872|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
14607873|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607874|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
14607875|NCT00070733|Testosterone|testosterone|mesh-list
14607876|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
14022031|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022032|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14022033|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14607877|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
14607878|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14607879|NCT00070733|Androgens|androgens|mesh-ancestor
14607880|NCT00070733|Hormones|hormones|mesh-ancestor
14607881|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607882|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161399|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607883|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161400|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607884|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161401|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15161402|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15161403|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
15161404|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
15161405|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14607885|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
14607886|NCT00070759|Daclizumab|daclizumab|mesh-list
14607887|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607888|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
14607889|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607890|NCT00070837|Antibodies|antibodies|mesh-list
14607891|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14607892|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
14607893|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607894|NCT00071071|Zanolimumab|zanolimumab|mesh-list
14607895|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607896|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607897|NCT00071084|Zanolimumab|zanolimumab|mesh-list
14607898|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14607899|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607900|NCT00071097|Darunavir|darunavir|mesh-list
14607901|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14607902|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14607903|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
14607904|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607905|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607906|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14607907|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14607908|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
14607909|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607910|NCT00071136|Gemcitabine|gemcitabine|mesh-list
14607911|NCT00071136|Pemetrexed|pemetrexed|mesh-list
14607912|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14607913|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
14607914|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607915|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607916|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
14607917|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607918|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607919|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607920|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
14607921|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607922|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14607923|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14607924|NCT00071188|Paclitaxel|paclitaxel|mesh-list
14607925|NCT00071188|Carboplatin|carboplatin|mesh-list
14607926|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14607927|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14607928|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
14607929|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
14607930|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
14607931|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607932|NCT00071201|Adefovir|adefovir|mesh-list
14607933|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14607934|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
14607935|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14607936|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15161406|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15161407|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15161408|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161409|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607937|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14607938|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161410|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15161411|NCT04116528|Narcotics|narcotics|mesh-ancestor
15161412|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15161413|NCT04116827|Tamoxifen|tamoxifen|mesh-list
15161414|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15161415|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
15161416|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607939|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607940|NCT00071227|Triamcinolone|triamcinolone|mesh-list
14607941|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14607942|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15180688|NCT03936426|Copper|copper|mesh-list
14607943|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14607944|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14607945|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
14607946|NCT00071227|Hormones|hormones|mesh-ancestor
14607947|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607948|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161417|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161418|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161419|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161420|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15161421|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15161422|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15161423|NCT04116411|Valganciclovir|valganciclovir|mesh-list
15161424|NCT04116411|Temozolomide|temozolomide|mesh-list
15161425|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15161426|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
15161427|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161428|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161429|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
15161430|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161431|NCT04116359|Cisplatin|cisplatin|mesh-list
15161432|NCT04116359|Etoposide|etoposide|mesh-list
15161433|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
15161434|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
15161435|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161436|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15161437|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15161438|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15161439|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161440|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161441|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
15161442|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161443|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
15161444|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
15161445|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
15161446|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
15161447|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14607949|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14607950|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
14607951|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607952|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607953|NCT00071240|Hormones|hormones|mesh-list
14607954|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14607955|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607956|NCT00071253|Valproic Acid|valproic acid|mesh-list
14607957|NCT00071253|Olanzapine|olanzapine|mesh-list
14607958|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
14607959|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
14607960|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14607961|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607962|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14607963|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14607964|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14607965|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14607966|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14607967|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14607968|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14607969|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14607970|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607971|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14607972|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
14607973|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
14607974|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607975|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
14607976|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
14607977|NCT00071266|Niacin|niacin|mesh-list
14607978|NCT00071266|Lovastatin|lovastatin|mesh-list
15161448|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161449|NCT04115982|Vitamins|vitamins|mesh-ancestor
15161450|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
15161451|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15161452|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
14607979|NCT00071266|L 647318|l 647318|mesh-list
15161453|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161454|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
14607980|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
15161455|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
15161456|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161457|NCT04115904|Ibuprofen|ibuprofen|mesh-list
15161458|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14607981|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14607982|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
14607983|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14607984|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14607985|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
14607986|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
14607987|NCT00071266|Vitamins|vitamins|mesh-ancestor
14607988|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
14607989|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14607990|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14607991|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14607992|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607993|NCT00071279|Idraparinux|idraparinux|mesh-list
14607994|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14607995|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
14607996|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14607997|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
14607998|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14607999|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608000|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
14608001|NCT00071331|Tolvaptan|tolvaptan|mesh-list
14608002|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14608003|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608004|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
14608005|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608006|NCT00071448|Insulin|insulin|mesh-list
14608007|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14608008|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
14608009|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
14608010|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14608011|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608012|NCT00071539|Immunotoxins|immunotoxins|mesh-list
14608013|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
14608014|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608015|NCT00071643|Citalopram|citalopram|mesh-list
14608016|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14608017|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14608018|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608019|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608020|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608021|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
14608022|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608023|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14608024|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
14608025|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608026|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14608027|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14608028|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14608029|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14608030|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608031|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608032|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608033|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608034|NCT00071695|Analgesics|analgesics|mesh-ancestor
14608035|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
14608036|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608037|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
14608038|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608039|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
14608040|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14608041|NCT00071747|Lamotrigine|lamotrigine|mesh-list
14608042|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
14608043|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14608044|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608045|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608046|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15161459|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022034|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15161460|NCT04115904|Analgesics|analgesics|mesh-ancestor
14608047|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608048|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14608049|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14608050|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14608051|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608052|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14608053|NCT00071838|Daclizumab|daclizumab|mesh-list
14608054|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608055|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
14608056|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608057|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
14608058|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608059|NCT00071942|Metronidazole|metronidazole|mesh-list
14608060|NCT00071942|Vaccines|vaccines|mesh-list
14608061|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
14608062|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608063|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608064|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14608065|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14608066|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14608067|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
14608068|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14608069|NCT00071955|Antibodies|antibodies|mesh-list
14608070|NCT00071955|Sargramostim|sargramostim|mesh-list
14608071|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14608072|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
14608073|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608074|NCT00071968|Sirolimus|sirolimus|mesh-list
14608075|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14608076|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608077|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14608078|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608079|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
14608080|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608081|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
14608082|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608083|NCT00071994|Gefitinib|gefitinib|mesh-list
14608084|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608085|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14608086|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608087|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645510|NCT00194649|Miglustat|miglustat|mesh-list
14645511|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645512|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645513|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14645514|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14645515|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
14645516|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645517|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14645518|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14645519|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645520|NCT00194714|Vaccines|vaccines|mesh-list
14645521|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
14645522|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645523|NCT00194727|Capecitabine|capecitabine|mesh-list
14645524|NCT00194727|Vinorelbine|vinorelbine|mesh-list
14645525|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645526|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
14645527|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645528|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645529|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645530|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645531|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645532|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645533|NCT00194740|Docetaxel|docetaxel|mesh-list
14645534|NCT00194740|Vinorelbine|vinorelbine|mesh-list
15161461|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
15161462|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161463|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161464|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022035|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14645535|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022036|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14645536|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645537|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645538|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647472|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161465|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161466|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15161467|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161468|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161469|NCT04116320|Imiquimod|imiquimod|mesh-list
15161470|NCT04116320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15161471|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
15161472|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161473|NCT04116320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161474|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
15161475|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
15161476|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
15161477|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161478|NCT04116203|Metformin|metformin|mesh-list
14608088|NCT00072007|Prednisone|prednisone|mesh-list
14608089|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
14608090|NCT00072007|Rituximab|rituximab|mesh-list
14608091|NCT00072007|Doxorubicin|doxorubicin|mesh-list
14608092|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14608093|NCT00072007|Vincristine|vincristine|mesh-list
14608094|NCT00072007|Cladribine|cladribine|mesh-list
14608095|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608096|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
14608097|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608098|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608099|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608100|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
14608101|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608102|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608103|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14608104|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14608105|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14608106|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14608107|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608108|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608109|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608110|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
14608111|NCT00072007|Hormones|hormones|mesh-ancestor
14608112|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14608113|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14608114|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14608115|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608116|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608117|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
15161479|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15161480|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161481|NCT04115878|Oxybutynin|oxybutynin|mesh-list
15161482|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15161483|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15161484|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15161485|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15161486|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161487|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
15161488|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161489|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161490|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
15161491|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
15161492|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161493|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15161494|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15161495|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
15161496|NCT04115878|Urological Agents|urological agents|mesh-ancestor
14022037|NCT02770261|Candesartan|candesartan|mesh-list
14608118|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
14608119|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14608120|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608121|NCT00072033|Docetaxel|docetaxel|mesh-list
14608122|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608123|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608124|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608125|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608126|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022038|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
14022039|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15161497|NCT04115748|Adalimumab|adalimumab|mesh-list
15161498|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608127|NCT00072046|Interferons|interferons|mesh-list
14608128|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
14608129|NCT00072046|Bevacizumab|bevacizumab|mesh-list
14608130|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14608131|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608132|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14608133|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14608134|NCT00072046|Growth Substances|growth substances|mesh-ancestor
14608135|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608136|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
14608137|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
14608138|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608139|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
14608140|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
14608141|NCT00072059|Hematinics|hematinics|mesh-ancestor
14608142|NCT00072072|Celecoxib|celecoxib|mesh-list
14608143|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14608144|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608145|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14608146|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608147|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608148|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14608149|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14608150|NCT00072072|Analgesics|analgesics|mesh-ancestor
14608151|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
14608152|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608153|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608154|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608155|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161499|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161500|NCT04115800|Sirolimus|sirolimus|mesh-list
15161501|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15161502|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161503|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15161504|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161505|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
15161506|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161507|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
15161508|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161509|NCT04115423|Adalimumab|adalimumab|mesh-list
15161510|NCT04115423|Etanercept|etanercept|mesh-list
15161511|NCT04115423|Golimumab|golimumab|mesh-list
15161512|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
15161513|NCT04115423|Infliximab|infliximab|mesh-list
15161514|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161515|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161516|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161517|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161518|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161519|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161520|NCT04115423|Analgesics|analgesics|mesh-ancestor
15161521|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
15161522|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161523|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161524|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161525|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
14608156|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14608157|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14608158|NCT00072085|Aldesleukin|aldesleukin|mesh-list
14608159|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
14608160|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608161|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14608162|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14608163|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
14608164|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608165|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14608166|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
14608167|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161526|NCT04115631|Cytarabine|cytarabine|mesh-list
15161527|NCT04115631|Rituximab|rituximab|mesh-list
15161528|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15161529|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15161530|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
15161531|NCT04115631|Antibodies|antibodies|mesh-list
14608168|NCT00072098|Interleukin-12|interleukin-12|mesh-list
14608169|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15161532|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
15161533|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14608170|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
14608171|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608172|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14608173|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14608174|NCT00072098|Growth Substances|growth substances|mesh-ancestor
14608175|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
14608176|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608177|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14022040|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14022041|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14022042|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
14022043|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022044|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14022045|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14022046|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022047|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14022048|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14022049|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14022050|NCT02770430|Infliximab|infliximab|mesh-list
14022051|NCT02770430|Basiliximab|basiliximab|mesh-list
14022052|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
14022053|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022054|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022055|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022056|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
14022057|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022058|NCT02770274|Aspirin|aspirin|mesh-list
14022059|NCT02770274|Cilostazol|cilostazol|mesh-list
14608178|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608179|NCT00072124|Dacarbazine|dacarbazine|mesh-list
14608180|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608181|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608182|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
14608183|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608184|NCT00072137|Metronidazole|metronidazole|mesh-list
14608185|NCT00072137|Molgramostim|molgramostim|mesh-list
14608186|NCT00072137|Vaccines|vaccines|mesh-list
14608187|NCT00072137|Sargramostim|sargramostim|mesh-list
14608188|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
14608189|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608190|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608191|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608192|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14608193|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14608194|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14608195|NCT00072150|Bortezomib|bortezomib|mesh-list
14608196|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608197|NCT00072163|Thalidomide|thalidomide|mesh-list
14608198|NCT00072163|Temozolomide|temozolomide|mesh-list
14608199|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608200|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
14608201|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608202|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608203|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608204|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
14608205|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608206|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
14608207|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14608208|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608209|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14608210|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14608211|NCT00072163|Growth Substances|growth substances|mesh-ancestor
14608212|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
14608213|NCT00072215|Paclitaxel|paclitaxel|mesh-list
14608214|NCT00072215|Vinblastine|vinblastine|mesh-list
14608215|NCT00072215|Ifosfamide|ifosfamide|mesh-list
14608216|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14608217|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608218|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608219|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608220|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
15161534|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
15161535|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022060|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161536|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608221|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161537|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161538|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608222|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608223|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
14608224|NCT00072228|Gemcitabine|gemcitabine|mesh-list
14608225|NCT00072228|Soblidotin|soblidotin|mesh-list
14608226|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608227|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
14608228|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608229|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608230|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
14608231|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608232|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608233|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608234|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
14608235|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161539|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
15161540|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161541|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
15161542|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161543|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161544|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15161545|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
15161546|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
15161547|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15161548|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161549|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161550|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161551|NCT04115449|Analgesics|analgesics|mesh-ancestor
15161552|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
15161553|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161554|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15161555|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15161556|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15161557|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
15161558|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161559|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161560|NCT04115410|Gemcitabine|gemcitabine|mesh-list
15161561|NCT04115410|Cisplatin|cisplatin|mesh-list
15161562|NCT04115410|Carboplatin|carboplatin|mesh-list
15161563|NCT04115410|Docetaxel|docetaxel|mesh-list
15161564|NCT04115410|Pemetrexed|pemetrexed|mesh-list
15161565|NCT04115410|Vinorelbine|vinorelbine|mesh-list
15161566|NCT04115410|Gefitinib|gefitinib|mesh-list
15161567|NCT04115410|Mitomycins|mitomycins|mesh-list
15161568|NCT04115410|Mitomycin|mitomycin|mesh-list
15161569|NCT04115410|Vinblastine|vinblastine|mesh-list
15161570|NCT04115410|Afatinib|afatinib|mesh-list
15161571|NCT04115410|Osimertinib|osimertinib|mesh-list
15161572|NCT04115410|Crizotinib|crizotinib|mesh-list
15161573|NCT04115410|Ceritinib|ceritinib|mesh-list
15161574|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
15161575|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15161576|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15161577|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
15161578|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161579|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
15161580|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161581|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608236|NCT00072267|Topotecan|topotecan|mesh-list
14608237|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14608238|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14608239|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608240|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608241|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608242|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608243|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14608244|NCT00072319|Paclitaxel|paclitaxel|mesh-list
14608245|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
14608246|NCT00072319|Epirubicin|epirubicin|mesh-list
14608247|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14608248|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608249|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608250|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608251|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608252|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161582|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161583|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
14608253|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608254|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
14608255|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608256|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608257|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608258|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
14608259|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14608260|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14608261|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14608262|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608263|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608264|NCT00072332|Cisplatin|cisplatin|mesh-list
14608265|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608266|NCT00072345|Thalidomide|thalidomide|mesh-list
14608267|NCT00072345|Temozolomide|temozolomide|mesh-list
14608268|NCT00072345|Lomustine|lomustine|mesh-list
14608269|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608270|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
14608271|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608272|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608273|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608274|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
14608275|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608276|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
14608277|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14608278|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608279|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14608280|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14608281|NCT00072345|Growth Substances|growth substances|mesh-ancestor
14608282|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
14608283|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
14608284|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14608285|NCT00072358|Irinotecan|irinotecan|mesh-list
14608286|NCT00072358|Temozolomide|temozolomide|mesh-list
14608287|NCT00072358|Molgramostim|molgramostim|mesh-list
14608288|NCT00072358|Isotretinoin|isotretinoin|mesh-list
14608289|NCT00072358|Antibodies|antibodies|mesh-list
14608290|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
14608291|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14608292|NCT00072358|Sargramostim|sargramostim|mesh-list
14608293|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
14608294|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
14608295|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608296|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608297|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14608298|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608299|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608300|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608301|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608302|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
14608303|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
14608304|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14608305|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608306|NCT00072436|Gemcitabine|gemcitabine|mesh-list
14608307|NCT00072436|Alvocidib|alvocidib|mesh-list
14608308|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608309|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
14608310|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608311|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608312|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
14608313|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608314|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608315|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608316|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
14608317|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608318|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
14608319|NCT00072436|Growth Substances|growth substances|mesh-ancestor
14608320|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14608321|NCT00072462|Tamoxifen|tamoxifen|mesh-list
14608322|NCT00072462|Anastrozole|anastrozole|mesh-list
14608323|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608324|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14608325|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
14608326|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14608327|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608328|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14608329|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608330|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14608331|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14608332|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14608333|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14608334|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14608335|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608336|NCT00072527|Carboplatin|carboplatin|mesh-list
14608337|NCT00072527|Irinotecan|irinotecan|mesh-list
14608338|NCT00072527|Etoposide|etoposide|mesh-list
14608339|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161584|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161585|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
15161586|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608340|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14608341|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608342|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608343|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608344|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14608345|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14608346|NCT00072540|Celecoxib|celecoxib|mesh-list
14608347|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14608348|NCT00072540|Mitogens|mitogens|mesh-list
14608349|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14608350|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14608351|NCT00072540|Analgesics|analgesics|mesh-ancestor
14608352|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
14608353|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608354|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608355|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608356|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608357|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14608358|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14608359|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608360|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608361|NCT00072553|Leucovorin|leucovorin|mesh-list
14608362|NCT00072553|Celecoxib|celecoxib|mesh-list
14608363|NCT00072553|Fluorouracil|fluorouracil|mesh-list
14608364|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
14608365|NCT00072553|Calcium|calcium|mesh-list
14608366|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
14608367|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14608368|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608369|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
14608370|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608371|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608372|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608373|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022061|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022062|NCT02770274|Analgesics|analgesics|mesh-ancestor
14022063|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
14022064|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022065|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022066|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022067|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608374|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
15161587|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
15161588|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15161589|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14608375|NCT00072553|Antidotes|antidotes|mesh-ancestor
14608376|NCT00072553|Protective Agents|protective agents|mesh-ancestor
14608377|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
14608378|NCT00072553|Vitamins|vitamins|mesh-ancestor
14608379|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
14608380|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14608381|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14608382|NCT00072553|Analgesics|analgesics|mesh-ancestor
14608383|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
14608384|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608385|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608386|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608387|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15161590|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14608388|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14608389|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608390|NCT00072579|Sargramostim|sargramostim|mesh-list
14608391|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
14608392|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608393|NCT00072592|Rituximab|rituximab|mesh-list
14608394|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14608395|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608396|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
14608397|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608398|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608399|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
14608400|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608401|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14608402|NCT00072618|Protective Agents|protective agents|mesh-ancestor
14608403|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608404|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14608405|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608406|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608407|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14608408|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14608409|NCT00072618|Analgesics|analgesics|mesh-ancestor
14608410|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
14608411|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608412|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608413|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608414|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14608415|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608416|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14608417|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608418|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022068|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14022069|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14022070|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022071|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14022072|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14022073|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022074|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
14022075|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14022076|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
14022077|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14608419|NCT00072670|Trabectedin|trabectedin|mesh-list
14608420|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15161591|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15161592|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14608421|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
14608422|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608423|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608424|NCT00072683|Tolvaptan|tolvaptan|mesh-list
14608425|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14608426|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608427|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
14608428|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608429|NCT00072722|Pomalidomide|pomalidomide|mesh-list
14608430|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
14608431|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608432|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14608433|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14608434|NCT00072722|Growth Substances|growth substances|mesh-ancestor
14608435|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
14608436|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608437|NCT00072748|EKB 569|ekb 569|mesh-list
14608438|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608439|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14608440|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608441|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608442|NCT00072787|Cisplatin|cisplatin|mesh-list
14608443|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608444|NCT00072826|Acetylcholine|acetylcholine|mesh-list
14608445|NCT00072826|Oxypurinol|oxypurinol|mesh-list
14608446|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
14608447|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14608448|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
14608449|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608450|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022078|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
14608451|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608452|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608453|NCT00072839|Teduglutide|teduglutide|mesh-list
14608454|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14608455|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14608456|NCT00072839|Protective Agents|protective agents|mesh-ancestor
14608457|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608458|NCT00072852|Irinotecan|irinotecan|mesh-list
14608459|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14608460|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608461|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608462|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161593|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
15161594|NCT04115462|Morphine|morphine|mesh-list
15161595|NCT04115462|Histamine|histamine|mesh-list
15161596|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
15161597|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15161598|NCT04115462|Narcotics|narcotics|mesh-ancestor
15161599|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161600|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161601|NCT04115462|Analgesics|analgesics|mesh-ancestor
15161602|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
15161603|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608463|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608464|NCT00072865|Carboplatin|carboplatin|mesh-list
14608465|NCT00072865|Pemetrexed|pemetrexed|mesh-list
14608466|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608467|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608468|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608469|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14608470|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14608471|NCT00072904|Repaglinide|repaglinide|mesh-list
14608472|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14608473|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608474|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
14608475|NCT00072930|Prednisone|prednisone|mesh-list
14608476|NCT00072930|Docetaxel|docetaxel|mesh-list
14608477|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608478|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608479|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608480|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608481|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608482|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608483|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
14608484|NCT00072930|Hormones|hormones|mesh-ancestor
14608485|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14608486|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608487|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14608488|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14608489|NCT00072943|Interferons|interferons|mesh-list
14608490|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
14608491|NCT00072943|Antibodies|antibodies|mesh-list
14608492|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14608493|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
14608494|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608495|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608496|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
14608497|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608498|NCT00072969|Daclizumab|daclizumab|mesh-list
14608499|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608500|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
14608501|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161604|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
15161605|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
15161606|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161607|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161608|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
14608502|NCT00072982|Borage oil|borage oil|mesh-list
14608503|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608504|NCT00073047|Daclizumab|daclizumab|mesh-list
15161609|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14022079|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
14022080|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14608505|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608506|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
14608507|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161610|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608508|NCT00073164|Valproic Acid|valproic acid|mesh-list
14608509|NCT00073164|Olanzapine|olanzapine|mesh-list
14608510|NCT00073164|Risperidone|risperidone|mesh-list
14608511|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14608512|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
14608513|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608514|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608515|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608516|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14608517|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14608518|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14608519|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608520|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14608521|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
14608522|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
14608523|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
14608524|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608525|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14608526|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14608527|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14608528|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608529|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
14608530|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608531|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
14608532|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
14608533|NCT00073203|Paroxetine|paroxetine|mesh-list
14608534|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14608535|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14608536|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608537|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608538|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608539|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
14608540|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608541|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14608542|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
14608543|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608544|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14608545|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14608546|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608547|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14608548|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14608549|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14608550|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14608551|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608552|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608553|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14608554|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14608555|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
14608556|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608557|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608558|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14608559|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14608560|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
15161611|NCT04115189|Sunitinib|sunitinib|mesh-list
15161612|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161613|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15161614|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14608561|NCT00073372|Abciximab|abciximab|mesh-list
14608562|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
14608563|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14608564|NCT00073385|Docetaxel|docetaxel|mesh-list
15161615|NCT04115189|Growth Substances|growth substances|mesh-ancestor
15161616|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161617|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14608565|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608566|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608567|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608568|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608569|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608570|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14608571|NCT00073411|Citalopram|citalopram|mesh-list
14608572|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14608573|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14608574|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15180689|NCT03936426|Trace Elements|trace elements|mesh-ancestor
14608575|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608576|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608577|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
14608578|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608579|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14608580|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
14608581|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608582|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608583|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14608584|NCT00073411|Analgesics|analgesics|mesh-ancestor
14608585|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
14608586|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
14608587|NCT00073437|Infliximab|infliximab|mesh-list
14608588|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14608589|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14608590|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608591|NCT00073580|Hirudins|hirudins|mesh-list
14608592|NCT00073580|Anticoagulants|anticoagulants|mesh-list
14608593|NCT00073580|Bivalirudin|bivalirudin|mesh-list
14608594|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
14608595|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14608596|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
14608597|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608598|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608599|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14608600|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14608601|NCT00073593|Heparin|heparin|mesh-list
14608602|NCT00073593|Bivalirudin|bivalirudin|mesh-list
14608603|NCT00073593|Protamines|protamines|mesh-list
14608604|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
14608605|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14608606|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14608607|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608608|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
14608609|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14608610|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
15161618|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161619|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161620|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608611|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608612|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
14608613|NCT00073593|Coagulants|coagulants|mesh-ancestor
14608614|NCT00073658|Risperidone|risperidone|mesh-list
14608615|NCT00073658|Citalopram|citalopram|mesh-list
14608616|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14608617|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
14608618|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608619|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608620|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608621|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14608622|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14608623|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14608624|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608625|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14608626|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
14608627|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14608628|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14608629|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608630|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14608631|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
14645539|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645540|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645541|NCT00194753|Paclitaxel|paclitaxel|mesh-list
14645542|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
14645543|NCT00194753|Doxorubicin|doxorubicin|mesh-list
14645544|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645545|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645546|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
14645547|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
14645548|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645549|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645550|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645551|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
14645552|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161621|NCT04115111|Durvalumab|durvalumab|mesh-list
14608632|NCT00073697|Dexetimide|dexetimide|mesh-list
14608633|NCT00073697|Citalopram|citalopram|mesh-list
14608634|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14608635|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14608636|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608637|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608638|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608639|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
14608640|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608641|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14608642|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
14608643|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608644|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14608645|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14608646|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
14608647|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
14608648|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608649|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14608650|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14608651|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
14608652|NCT00073710|Calcitriol|calcitriol|mesh-list
14608653|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14608654|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608655|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14608656|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608657|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608658|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14608659|NCT00073710|Vitamins|vitamins|mesh-ancestor
14608660|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
14608661|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14608662|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14608663|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608664|NCT00073736|Cytarabine|cytarabine|mesh-list
14608665|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608666|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
14608667|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608668|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608669|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
14608670|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608671|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608672|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
14608673|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608674|NCT00073814|Albuterol|albuterol|mesh-list
15180690|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
14608675|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14608676|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
14608677|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608678|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608679|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14608680|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
14608681|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
14608682|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14608683|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14608684|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14608685|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14608686|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
14608687|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608688|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608689|NCT00073827|Albuterol|albuterol|mesh-list
14608690|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14608691|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
14608692|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608693|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608694|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14608695|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
14608696|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
14608697|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14608698|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14608699|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14608700|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14608701|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
14608702|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608703|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608704|NCT00073840|Albuterol|albuterol|mesh-list
14608705|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14608706|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
14608707|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608708|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608709|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14608710|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14608711|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
14608712|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14608713|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14608714|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14608715|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14608716|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
14608717|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14608718|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608719|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
14608720|NCT00073879|Fludarabine|fludarabine|mesh-list
14608721|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
14608722|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
14608723|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608724|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
14608725|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608726|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608727|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608728|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
14608729|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608730|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608731|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14608732|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608733|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
14608734|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14608735|NCT00073905|Gemcitabine|gemcitabine|mesh-list
14608736|NCT00073905|Capecitabine|capecitabine|mesh-list
14608737|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608738|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
14608739|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608740|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608741|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
14608742|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608743|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608744|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608745|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
14608746|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608747|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
14608748|NCT00073931|Sargramostim|sargramostim|mesh-list
14608749|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
14608750|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608751|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608752|NCT00073970|Celecoxib|celecoxib|mesh-list
14608753|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14608754|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14608755|NCT00073970|Analgesics|analgesics|mesh-ancestor
14608756|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
14608757|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608758|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608759|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608760|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608761|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14608762|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14608763|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608764|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608765|NCT00074009|Bortezomib|bortezomib|mesh-list
14608766|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608767|NCT00074022|Docetaxel|docetaxel|mesh-list
14608768|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608769|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608770|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608771|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608772|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608773|NCT00074074|Infliximab|infliximab|mesh-list
14608774|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
14608775|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14608776|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608777|NCT00074087|Doxorubicin|doxorubicin|mesh-list
14608778|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14608779|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14608780|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608781|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14608782|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608783|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608784|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608785|NCT00074100|Amonafide|amonafide|mesh-list
14608786|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608787|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
14608788|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608789|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608790|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608791|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
14608792|NCT00074139|Docetaxel|docetaxel|mesh-list
14608793|NCT00074139|Doxorubicin|doxorubicin|mesh-list
14608794|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14608795|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608796|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
14608797|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608798|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608799|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608800|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
14608801|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608802|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608803|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14608804|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608805|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608806|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608807|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14608808|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14608809|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15161622|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14608810|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608811|NCT00074178|Cytarabine|cytarabine|mesh-list
14608812|NCT00074178|Dexamethasone|dexamethasone|mesh-list
14608813|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
14608814|NCT00074178|Methotrexate|methotrexate|mesh-list
14608815|NCT00074178|Etoposide|etoposide|mesh-list
14608816|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
14608817|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608818|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
14608819|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608820|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608821|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608822|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
14608823|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608824|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608825|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14608826|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608827|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
14608828|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
14608829|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608830|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14608831|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
14608832|NCT00074178|Hormones|hormones|mesh-ancestor
14608833|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14608834|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14608835|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14608836|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
14608837|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14608838|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608839|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
14608840|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14608841|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608842|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14608843|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14608844|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14608845|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14608846|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608847|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
14608848|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608849|NCT00074191|Cytarabine|cytarabine|mesh-list
14608850|NCT00074191|Dexamethasone|dexamethasone|mesh-list
14608851|NCT00074191|Methotrexate|methotrexate|mesh-list
15161623|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608852|NCT00074191|Lomustine|lomustine|mesh-list
14608853|NCT00074191|Procarbazine|procarbazine|mesh-list
14608854|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14608855|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
14608856|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
14608857|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14608858|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608859|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14608860|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
14608861|NCT00074191|Hormones|hormones|mesh-ancestor
14608862|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14608863|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14608864|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608865|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14608866|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
14608867|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14608868|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608869|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
14608870|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608871|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14608872|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608873|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14608874|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608875|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
14022081|NCT02770274|Protective Agents|protective agents|mesh-ancestor
14022082|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14022083|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14022084|NCT02770222|Rifampin|rifampin|mesh-list
14022085|NCT02770222|Selexipag|selexipag|mesh-list
14022086|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
14022087|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14022088|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
14022089|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022090|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022091|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
14608876|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608877|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14608878|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
14608879|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608880|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14608881|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
14608882|NCT00074204|Gemcitabine|gemcitabine|mesh-list
14608883|NCT00074204|Carboplatin|carboplatin|mesh-list
14608884|NCT00074204|Docetaxel|docetaxel|mesh-list
14608885|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608886|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608887|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
14608888|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608889|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
14608890|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608891|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608892|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608893|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
14608894|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608895|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608896|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
14608897|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
14608898|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
14608899|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14608900|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
14608901|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608902|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608903|NCT00074321|Capecitabine|capecitabine|mesh-list
14608904|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
14608905|NCT00074321|Irinotecan|irinotecan|mesh-list
14608906|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608907|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
14608908|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608909|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608910|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14608911|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608912|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608913|NCT00074334|Immunotoxins|immunotoxins|mesh-list
14608914|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
14608915|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022092|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14608916|NCT00074399|Nevirapine|nevirapine|mesh-list
14608917|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14608918|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14608919|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608920|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608921|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
14608922|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608923|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14608924|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14608925|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14608926|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14608927|NCT00074438|Rituximab|rituximab|mesh-list
14608928|NCT00074438|Methotrexate|methotrexate|mesh-list
14608929|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14608930|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608931|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
14608932|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608933|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14608934|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14608935|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
14608936|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14608937|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608938|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
14608939|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608940|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
14608941|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608942|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14608943|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608944|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14608945|NCT00074607|Gemcitabine|gemcitabine|mesh-list
14608946|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608947|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
14608948|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608949|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608950|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
15161624|NCT04115163|Gemcitabine|gemcitabine|mesh-list
15161625|NCT04115163|Paclitaxel|paclitaxel|mesh-list
15161626|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15161627|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15161628|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161629|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14608951|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608952|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608953|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608954|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
14608955|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608956|NCT00074620|Hirudins|hirudins|mesh-list
14608957|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
14608958|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14608959|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
14608960|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608961|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608962|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
14608963|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14608964|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14608965|NCT00074737|Cytarabine|cytarabine|mesh-list
14608966|NCT00074737|Idarubicin|idarubicin|mesh-list
14608967|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14608968|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
14608969|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608970|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608971|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
14608972|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14608973|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14608974|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
14608975|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608976|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14608977|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14608978|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14608979|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608980|NCT00074750|Molgramostim|molgramostim|mesh-list
14608981|NCT00074750|Sargramostim|sargramostim|mesh-list
14608982|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
14608983|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608984|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14608985|NCT00074776|Lamotrigine|lamotrigine|mesh-list
14022093|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14608986|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14608987|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14608988|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14608989|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14608990|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14608991|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
14608992|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14608993|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14608994|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14608995|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14608996|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14608997|NCT00074828|Enoxaparin|enoxaparin|mesh-list
14608998|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
14608999|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14609000|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14609001|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609002|NCT00074841|Azithromycin|azithromycin|mesh-list
14609003|NCT00074841|Chloroquine|chloroquine|mesh-list
14609004|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14609005|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
14609006|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
14609007|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14609008|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14609009|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609010|NCT00074841|Amebicides|amebicides|mesh-ancestor
14609011|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14609012|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15161630|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
15161631|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
15161632|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161633|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15161634|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
15161635|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
15161636|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161637|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161638|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161639|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
15161640|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161641|NCT04115020|Naltrexone|naltrexone|mesh-list
15161642|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15161643|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15161644|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161645|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
15161646|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180691|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180692|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15180693|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180694|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609013|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
14609014|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609015|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14609016|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14609017|NCT00074841|Analgesics|analgesics|mesh-ancestor
14609018|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
14609019|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609020|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609021|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180695|NCT03936062|Incretins|incretins|mesh-ancestor
15180696|NCT03936062|Hormones|hormones|mesh-ancestor
14609022|NCT00074841|Filaricides|filaricides|mesh-ancestor
14609023|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
14609024|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
14609025|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14609026|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609027|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609028|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14609029|NCT00074841|Renal Agents|renal agents|mesh-ancestor
14609030|NCT00075010|Decitabine|decitabine|mesh-list
14609031|NCT00075010|Valproic Acid|valproic acid|mesh-list
14609032|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609033|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
14609034|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609035|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180697|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180698|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14609036|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609037|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
14609038|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
14609039|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609040|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609041|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
14609042|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14609043|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609044|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14609045|NCT00075075|Infliximab|infliximab|mesh-list
14609046|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
14609047|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14609048|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609049|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14609050|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14609051|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609052|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609053|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
14609054|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609055|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609056|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14609057|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
14609058|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609059|NCT00075192|Leuprolide|leuprolide|mesh-list
14609060|NCT00075192|Bicalutamide|bicalutamide|mesh-list
14609061|NCT00075192|Tremelimumab|tremelimumab|mesh-list
14609062|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14609063|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
14609064|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14609065|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609066|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14609067|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609068|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
14609069|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
14609070|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14609071|NCT00075205|Rimonabant|rimonabant|mesh-list
14609072|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14609073|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14609074|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14609075|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609076|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609077|NCT00075205|Hormones|hormones|mesh-ancestor
14609078|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14609079|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609080|NCT00075231|Ritonavir|ritonavir|mesh-list
14609081|NCT00075231|Lopinavir|lopinavir|mesh-list
14609082|NCT00075231|Lamivudine|lamivudine|mesh-list
14609083|NCT00075231|Zidovudine|zidovudine|mesh-list
14609084|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14609085|NCT00075231|Efavirenz|efavirenz|mesh-list
14609086|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14609087|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14609088|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
14609089|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609090|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609091|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14609092|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14609093|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
14609094|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609095|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15161647|NCT04115072|Praziquantel|praziquantel|mesh-list
15161648|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
15161649|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15161650|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161651|NCT04114643|Thrombin|thrombin|mesh-list
14609096|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14609097|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14609098|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14609099|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
15161652|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
14022094|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022095|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14022096|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14609100|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15161653|NCT04114643|Coagulants|coagulants|mesh-ancestor
15161654|NCT04114630|Erenumab|erenumab|mesh-list
14609101|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14609102|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14609103|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14609104|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14609105|NCT00075374|Docetaxel|docetaxel|mesh-list
14609106|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609107|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609108|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609109|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609110|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609111|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
14609112|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
14609113|NCT00075387|Carboplatin|carboplatin|mesh-list
14609114|NCT00075387|Etoposide|etoposide|mesh-list
15161655|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15161656|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609115|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
14609116|NCT00075387|Antidotes|antidotes|mesh-list
14609117|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161657|NCT04114630|Analgesics|analgesics|mesh-ancestor
15161658|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
15161659|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161660|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161661|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
15161662|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161663|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15161664|NCT04114383|Protective Agents|protective agents|mesh-ancestor
15161665|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161666|NCT04114526|Nicotine|nicotine|mesh-list
14609118|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
14609119|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609120|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609121|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609122|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
14609123|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609124|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609125|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14609126|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609127|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14609128|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609129|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609130|NCT00075387|Protective Agents|protective agents|mesh-ancestor
14609131|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
14609132|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
14609133|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14609134|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609135|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
14609136|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
14609137|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
14609138|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609139|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
14609140|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609141|NCT00075439|Gefitinib|gefitinib|mesh-list
14609142|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609143|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161667|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15161668|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
14609144|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609145|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609146|NCT00075452|Gemcitabine|gemcitabine|mesh-list
14609147|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
14609148|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609149|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
14609150|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609151|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609152|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
14609153|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609154|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609155|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609156|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
14609157|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609158|NCT00075465|Docetaxel|docetaxel|mesh-list
14609159|NCT00075465|Epirubicin|epirubicin|mesh-list
15161669|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609160|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609161|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609162|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609163|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609164|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609165|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609166|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14609167|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609168|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609169|NCT00075491|Fenretinide|fenretinide|mesh-list
14609170|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609171|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14609172|NCT00075491|Protective Agents|protective agents|mesh-ancestor
14609173|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609174|NCT00075517|Gemcitabine|gemcitabine|mesh-list
14609175|NCT00075517|Docetaxel|docetaxel|mesh-list
14609176|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609177|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
14609178|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609179|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609180|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
14609181|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609182|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609183|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609184|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
14609185|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609186|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609187|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609188|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609189|NCT00075543|Docetaxel|docetaxel|mesh-list
14609190|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
14609191|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609192|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609193|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609194|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609195|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609196|NCT00075556|Capecitabine|capecitabine|mesh-list
14609197|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609198|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
14609199|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609200|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645553|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645554|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14645555|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
14645556|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14645557|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14645558|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14645559|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645560|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645561|NCT00194766|Temozolomide|temozolomide|mesh-list
14645562|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14645563|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
14645564|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645565|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645566|NCT00194818|Mesalamine|mesalamine|mesh-list
14645567|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14645568|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14645569|NCT00194818|Analgesics|analgesics|mesh-ancestor
14645570|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
14645571|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645572|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645573|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645574|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645575|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
14645576|NCT00194857|Hematinics|hematinics|mesh-ancestor
14645577|NCT00194883|Hormones|hormones|mesh-list
14645578|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645579|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645580|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
14645581|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
14645582|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14645583|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14645584|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645585|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645586|NCT00194909|Urological Agents|urological agents|mesh-ancestor
14645587|NCT00194935|Topotecan|topotecan|mesh-list
14645588|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14609201|NCT00075595|Leucovorin|leucovorin|mesh-list
14609202|NCT00075595|Fluorouracil|fluorouracil|mesh-list
14609203|NCT00075595|Irinotecan|irinotecan|mesh-list
14609204|NCT00075595|Calcium|calcium|mesh-list
14609205|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
14609206|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14609207|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609208|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
15161670|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161671|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14609209|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609210|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609211|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609212|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609213|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
14609214|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14609215|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609216|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609217|NCT00075595|Antidotes|antidotes|mesh-ancestor
14609218|NCT00075595|Protective Agents|protective agents|mesh-ancestor
14022097|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14022098|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14609219|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
14609220|NCT00075595|Vitamins|vitamins|mesh-ancestor
14609221|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
14609222|NCT00075621|Melphalan|melphalan|mesh-list
14609223|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
14609224|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609225|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609226|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
14609227|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609228|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609229|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14609230|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609231|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
14609232|NCT00075634|Doxorubicin|doxorubicin|mesh-list
14609233|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14609234|NCT00075634|Decitabine|decitabine|mesh-list
14609235|NCT00075634|Azacitidine|azacitidine|mesh-list
14609236|NCT00075634|Lenograstim|lenograstim|mesh-list
14609237|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609238|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
14609239|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609240|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609241|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609242|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
14609243|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609244|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609245|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14609246|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609247|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14609248|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609249|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609250|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14609251|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609252|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
14609253|NCT00075647|Sirolimus|sirolimus|mesh-list
14609254|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14609255|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609256|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609257|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609258|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
14609259|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161672|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15161673|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
15161674|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161675|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161676|NCT04114461|Tofacitinib|tofacitinib|mesh-list
15161677|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161678|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161679|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022099|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14609260|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
14609261|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609262|NCT00075673|Celecoxib|celecoxib|mesh-list
14609263|NCT00075673|Vinorelbine|vinorelbine|mesh-list
15161680|NCT04114396|Antibodies|antibodies|mesh-list
15161681|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
15161682|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161683|NCT04114188|Prednisolone|prednisolone|mesh-list
14609264|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14609265|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14609266|NCT00075673|Analgesics|analgesics|mesh-ancestor
14609267|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
14609268|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609269|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609270|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14609271|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609272|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14609273|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14609274|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609275|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609276|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609277|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609278|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609279|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609280|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609281|NCT00075686|Gemcitabine|gemcitabine|mesh-list
14609282|NCT00075686|Cetuximab|cetuximab|mesh-list
14609283|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609284|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
14609285|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609286|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609287|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
15161684|NCT04114188|Infliximab|infliximab|mesh-list
15161685|NCT04114188|Tacrolimus|tacrolimus|mesh-list
15161686|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
15161687|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15161688|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
15161689|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15161690|NCT04114188|Antibodies|antibodies|mesh-list
14609288|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609289|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609290|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609291|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
14609292|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609293|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14609294|NCT00075699|Vincristine|vincristine|mesh-list
14609295|NCT00075699|Vinorelbine|vinorelbine|mesh-list
14609296|NCT00075699|Mitomycins|mitomycins|mesh-list
14609297|NCT00075699|Mitomycin|mitomycin|mesh-list
14609298|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609299|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609300|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609301|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609302|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609303|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609304|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609305|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
14609306|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14609307|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609308|NCT00075712|Paclitaxel|paclitaxel|mesh-list
14609309|NCT00075712|Carboplatin|carboplatin|mesh-list
14609310|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609311|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609312|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609313|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609314|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609315|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609316|NCT00075738|Leucovorin|leucovorin|mesh-list
14609317|NCT00075738|Fluorouracil|fluorouracil|mesh-list
14609318|NCT00075738|Irinotecan|irinotecan|mesh-list
14609319|NCT00075738|Calcium|calcium|mesh-list
14609320|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
14609321|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609322|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14609323|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609324|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
15161691|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609325|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609326|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609327|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161692|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
15161693|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609328|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
14609329|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14609330|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609331|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609332|NCT00075738|Antidotes|antidotes|mesh-ancestor
14609333|NCT00075738|Protective Agents|protective agents|mesh-ancestor
14609334|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
14609335|NCT00075738|Vitamins|vitamins|mesh-ancestor
14609336|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
14609337|NCT00075751|Gemcitabine|gemcitabine|mesh-list
14609338|NCT00075751|Carboplatin|carboplatin|mesh-list
14609339|NCT00075751|Bortezomib|bortezomib|mesh-list
14609340|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609341|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609342|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
14609343|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609344|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
14609345|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609346|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609347|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609348|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
14609349|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609350|NCT00075777|Valproic Acid|valproic acid|mesh-list
14609351|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
14609352|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609353|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609354|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
14609355|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609356|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609357|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
14609358|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14609359|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609360|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14609361|NCT00075855|Testosterone|testosterone|mesh-list
14609362|NCT00075855|Androgens|androgens|mesh-ancestor
14609363|NCT00075855|Hormones|hormones|mesh-ancestor
14609364|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14609365|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609366|NCT00075868|Octreotide|octreotide|mesh-list
14609367|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14609368|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14609369|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609370|NCT00075894|Alanosine|alanosine|mesh-list
14609371|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609372|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609373|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
14609374|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
14609375|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609376|NCT00075907|Ritonavir|ritonavir|mesh-list
14609377|NCT00075907|Lopinavir|lopinavir|mesh-list
14609378|NCT00075907|Efavirenz|efavirenz|mesh-list
14609379|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14609380|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14609381|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14609382|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609383|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609384|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14609385|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14609386|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
14609387|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609388|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14609389|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14609390|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14609391|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14609392|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14609393|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14609394|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14609395|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14609396|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14609397|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
14609398|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609399|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14609400|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14609401|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609402|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161694|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15161695|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161696|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022100|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14022101|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14022102|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
14022103|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14022104|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14022105|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14022106|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14022107|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14609403|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
15161697|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161698|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
14609404|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
14609405|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
14609406|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609407|NCT00075959|Protective Agents|protective agents|mesh-ancestor
14609408|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609409|NCT00075972|Nicotine|nicotine|mesh-list
14609410|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14609411|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
14609412|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161699|NCT04114188|Hormones|hormones|mesh-ancestor
15161700|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161701|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161702|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609413|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609414|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14609415|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14609416|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
14609417|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609418|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609419|NCT00075998|Interferons|interferons|mesh-list
14609420|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
14609421|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609422|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
14609423|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609424|NCT00076115|Risperidone|risperidone|mesh-list
14609425|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14609426|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
14609427|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161703|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161704|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161705|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161706|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
15161707|NCT04114149|Narcotics|narcotics|mesh-ancestor
15161708|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609428|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609429|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609430|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14609431|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14609432|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609433|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14609434|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14609435|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
14609436|NCT00076206|Sirolimus|sirolimus|mesh-list
14609437|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14609438|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609439|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609440|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609441|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
14609442|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609443|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
14609444|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609445|NCT00076232|Acyclovir|acyclovir|mesh-list
14609446|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
14609447|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609448|NCT00076284|Aplaviroc|aplaviroc|mesh-list
14609449|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14609450|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14609451|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609452|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14609453|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14609454|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
14609455|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609456|NCT00076310|Cisplatin|cisplatin|mesh-list
14609457|NCT00076310|Docetaxel|docetaxel|mesh-list
14609458|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14609459|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609460|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609461|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609462|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609463|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609464|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14609465|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609466|NCT00076323|Primaquine|primaquine|mesh-list
14609467|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
14609468|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14609469|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14609470|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609471|NCT00076349|Rituximab|rituximab|mesh-list
14609472|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14609473|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14609474|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161709|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161710|NCT04114149|Analgesics|analgesics|mesh-ancestor
15161711|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
15161712|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161713|NCT04113772|Nitisinone|nitisinone|mesh-list
15161714|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161715|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161716|NCT04113863|Anastrozole|anastrozole|mesh-list
15161717|NCT04113863|Tretinoin|tretinoin|mesh-list
15161718|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161719|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161720|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15161721|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14609475|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
14609476|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609477|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609478|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609479|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
14609480|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609481|NCT00076362|Octreotide|octreotide|mesh-list
14609482|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14609483|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14609484|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609485|NCT00076388|Docetaxel|docetaxel|mesh-list
14609486|NCT00076388|Gefitinib|gefitinib|mesh-list
14609487|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609488|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609489|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609490|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609491|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609492|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161722|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161723|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161724|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15161725|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
14609493|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609494|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
14609495|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609496|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14609497|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
14609498|NCT00076414|Acetylcholine|acetylcholine|mesh-list
14609499|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
14609500|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14609501|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
14609502|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609503|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609504|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609505|NCT00076440|Leuprolide|leuprolide|mesh-list
14609506|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14609507|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
14609508|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15161726|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161727|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161728|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
14609509|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609510|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14609511|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609512|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
14609513|NCT00076492|Vitamins|vitamins|mesh-ancestor
14609514|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
14609515|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609516|NCT00076518|Fenofibrate|fenofibrate|mesh-list
14609517|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14609518|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
14609519|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609520|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14609521|NCT00076531|Leuprolide|leuprolide|mesh-list
14609522|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14609523|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
14609524|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14609525|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609526|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14609527|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609528|NCT00076544|Ziconotide|ziconotide|mesh-list
14609529|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14609530|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14609531|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609532|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14609533|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609534|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14609535|NCT00076544|Protective Agents|protective agents|mesh-ancestor
14609536|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14609537|NCT00076544|Analgesics|analgesics|mesh-ancestor
14609538|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
14609539|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609540|NCT00076609|Capecitabine|capecitabine|mesh-list
14609541|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609542|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
14609543|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609544|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609545|NCT00076635|Interferons|interferons|mesh-list
14609546|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
14609547|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609548|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
14609549|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609550|NCT00076674|Levodopa|levodopa|mesh-list
14609551|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14609552|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14609553|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
14609554|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609555|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609556|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609557|NCT00076726|Infliximab|infliximab|mesh-list
14609558|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
14022108|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14022109|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022110|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609559|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14609560|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609561|NCT00076791|Tenofovir|tenofovir|mesh-list
14609562|NCT00076791|Emtricitabine|emtricitabine|mesh-list
14609563|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14609564|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
14609565|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15161729|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161730|NCT04113954|Prilocaine|prilocaine|mesh-list
15161731|NCT04113954|Mepivacaine|mepivacaine|mesh-list
15161732|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
15161733|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
15161734|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161735|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161736|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
15161737|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161738|NCT04113915|Cyclosporine|cyclosporine|mesh-list
15161739|NCT04113915|Dexamethasone|dexamethasone|mesh-list
15161740|NCT04113915|Cyclosporins|cyclosporins|mesh-list
15161741|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161742|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
14609566|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15161743|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
15161744|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161745|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161746|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14609567|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14609568|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609569|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609570|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14609571|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14609572|NCT00076856|Temozolomide|temozolomide|mesh-list
14609573|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609574|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
14609575|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609576|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609577|NCT00076869|Amphotericin B|amphotericin b|mesh-list
14609578|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14609579|NCT00076869|Caspofungin|caspofungin|mesh-list
14609580|NCT00076869|Amebicides|amebicides|mesh-ancestor
14609581|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14609582|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14609583|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609584|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14609585|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
14609586|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609587|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609588|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14609589|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609590|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609591|NCT00076986|Carmustine|carmustine|mesh-list
15161747|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
15161748|NCT04113915|Hormones|hormones|mesh-ancestor
15161749|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14609592|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609593|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
14609594|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609595|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609596|NCT00077025|Gefitinib|gefitinib|mesh-list
14609597|NCT00077025|Anastrozole|anastrozole|mesh-list
14609598|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609599|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161750|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161751|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161752|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161753|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161754|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
15161755|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609600|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609601|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609602|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14609603|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14609604|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14609605|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14609606|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
14609607|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14609608|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609609|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
14609610|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
14609611|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609612|NCT00077077|Capecitabine|capecitabine|mesh-list
14609613|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609614|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
15161756|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161757|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
15161758|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609615|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609616|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609617|NCT00077103|Doxorubicin|doxorubicin|mesh-list
14609618|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14609619|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
14609620|NCT00077103|Combretastatin|combretastatin|mesh-list
14609621|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609622|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609623|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14609624|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609625|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161759|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
14609626|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609627|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609628|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609629|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609630|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609631|NCT00077116|Cytarabine|cytarabine|mesh-list
14609632|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
14609633|NCT00077116|Busulfan|busulfan|mesh-list
14609634|NCT00077116|Idarubicin|idarubicin|mesh-list
14609635|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
14609636|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609637|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
14609638|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609639|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609640|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609641|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
15161760|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15161761|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
15161762|NCT04113889|Metformin|metformin|mesh-list
15161763|NCT04113889|Pioglitazone|pioglitazone|mesh-list
15161764|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15161765|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161766|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
14609642|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609643|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609644|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14609645|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609646|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
14609647|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
14609648|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609649|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609650|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14609651|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609652|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161767|NCT04113889|Vitamins|vitamins|mesh-ancestor
15161768|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
15161769|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
15161770|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
15161771|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
15161772|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161773|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15161774|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161775|NCT04114097|Betamethasone|betamethasone|mesh-list
15161776|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
15161777|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15161778|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
15161779|NCT04114097|Tacrolimus|tacrolimus|mesh-list
15161780|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15161781|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161782|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
15161783|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161784|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15161785|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161786|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161787|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161788|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
15161789|NCT04114097|Hormones|hormones|mesh-ancestor
15161790|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161791|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15161792|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
15161793|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15161794|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15161795|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161796|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161797|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15161798|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15161799|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161800|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
15161801|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161802|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
15161803|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15161804|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14609653|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14609654|NCT00077129|Paclitaxel|paclitaxel|mesh-list
14609655|NCT00077129|Carboplatin|carboplatin|mesh-list
14609656|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609657|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609658|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609659|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609660|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609661|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609662|NCT00077168|Tamoxifen|tamoxifen|mesh-list
14609663|NCT00077168|Anastrozole|anastrozole|mesh-list
14609664|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609665|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14609666|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
14609667|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14609668|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609669|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14609670|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609671|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14609672|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14609673|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14609674|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14609675|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14609676|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609677|NCT00077181|Cytarabine|cytarabine|mesh-list
14609678|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15161805|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
15161806|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161807|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161808|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15161809|NCT04113668|Diflunisal|diflunisal|mesh-list
15161810|NCT04113668|BMS-986165|bms-986165|mesh-list
15161811|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161812|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161813|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161814|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161815|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161816|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161817|NCT04113668|Analgesics|analgesics|mesh-ancestor
15161818|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
15161819|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609679|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
14609680|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609681|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609682|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
14609683|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609684|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609685|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
15161820|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161821|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14609686|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609687|NCT00077194|Romidepsin|romidepsin|mesh-list
14609688|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609689|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609690|NCT00077220|Paclitaxel|paclitaxel|mesh-list
14609691|NCT00077220|Carboplatin|carboplatin|mesh-list
14609692|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609693|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609694|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609695|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609696|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609697|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609698|NCT00077233|Leucovorin|leucovorin|mesh-list
14609699|NCT00077233|Fluorouracil|fluorouracil|mesh-list
14609700|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
14609701|NCT00077233|Irinotecan|irinotecan|mesh-list
14609702|NCT00077233|Cetuximab|cetuximab|mesh-list
14609703|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609704|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
14609705|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609706|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609707|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609708|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609709|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
14609710|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14609711|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609712|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609713|NCT00077233|Antidotes|antidotes|mesh-ancestor
14609714|NCT00077233|Protective Agents|protective agents|mesh-ancestor
14609715|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
14609716|NCT00077233|Vitamins|vitamins|mesh-ancestor
14609717|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
14609718|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14609719|NCT00077246|Paclitaxel|paclitaxel|mesh-list
14609720|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14609721|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609722|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609723|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609724|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609725|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609726|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609727|NCT00077259|Epothilones|epothilones|mesh-list
14609728|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
14609729|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609730|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609731|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609732|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609733|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609734|NCT00077298|Bevacizumab|bevacizumab|mesh-list
14609735|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14609736|NCT00077298|Cetuximab|cetuximab|mesh-list
14609737|NCT00077298|Irinotecan|irinotecan|mesh-list
14609738|NCT00077298|Antibodies|antibodies|mesh-list
14609739|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
14609740|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14609741|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609742|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14609743|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14609744|NCT00077298|Growth Substances|growth substances|mesh-ancestor
14609745|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609746|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
14609747|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
14609748|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14609749|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609750|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609751|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609752|NCT00077311|Docetaxel|docetaxel|mesh-list
14609753|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
14609754|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
14609755|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609756|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609757|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14609758|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609759|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609760|NCT00077311|Hematinics|hematinics|mesh-ancestor
14609761|NCT00077311|Protective Agents|protective agents|mesh-ancestor
14609762|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609763|NCT00077337|Romidepsin|romidepsin|mesh-list
14609764|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609765|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609766|NCT00077350|Gemcitabine|gemcitabine|mesh-list
14609767|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609768|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
14609769|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609770|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609771|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
14609772|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609773|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609774|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609775|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
14609776|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609777|NCT00077363|Capecitabine|capecitabine|mesh-list
14609778|NCT00077363|Tipifarnib|tipifarnib|mesh-list
14609779|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609780|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
14609781|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609782|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609783|NCT00077389|Carboplatin|carboplatin|mesh-list
15161822|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609784|NCT00077389|Doxorubicin|doxorubicin|mesh-list
14609785|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14609786|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609787|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15161823|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14609788|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14609789|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15161824|NCT04113551|Guanfacine|guanfacine|mesh-list
15161825|NCT04113551|Methylphenidate|methylphenidate|mesh-list
15161826|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15161827|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15161828|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15161829|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15161830|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161831|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
15161832|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161833|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161834|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15180699|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
14609790|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609791|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609792|NCT00077402|Fenretinide|fenretinide|mesh-list
14609793|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609794|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14609795|NCT00077402|Protective Agents|protective agents|mesh-ancestor
14609796|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645589|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14645590|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645591|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645592|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645593|NCT00194948|Citalopram|citalopram|mesh-list
14645594|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14645595|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14645596|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14645597|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645598|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645599|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
14645600|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645601|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14645602|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
14645603|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645604|NCT00194961|Hormones|hormones|mesh-list
14645605|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645606|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645607|NCT00194974|Clonidine|clonidine|mesh-list
14645608|NCT00194974|Labetalol|labetalol|mesh-list
14645609|NCT00194974|Methyldopa|methyldopa|mesh-list
14645610|NCT00194974|Nifedipine|nifedipine|mesh-list
14645611|NCT00194974|Analgesics|analgesics|mesh-ancestor
14645612|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
14645613|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645614|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645615|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14645616|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
14645617|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
14645618|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14645619|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14645620|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14645621|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
14645622|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645623|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645624|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14645625|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14645626|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14645627|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
14645628|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
14645629|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14645630|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14645631|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14645632|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
14645633|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14645634|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14645635|NCT00195000|Cytarabine|cytarabine|mesh-list
14645636|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
14022111|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645637|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645638|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
15161835|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15161836|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
15161837|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15161838|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15161839|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15161840|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15161841|NCT04113538|Aflibercept|aflibercept|mesh-list
15161842|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15161843|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15161844|NCT04113538|Growth Substances|growth substances|mesh-ancestor
15161845|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161846|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
14609797|NCT00077415|Gemcitabine|gemcitabine|mesh-list
14609798|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609799|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
14609800|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609801|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609802|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
14609803|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14609804|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609805|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609806|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
15161847|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161848|NCT04113226|Rituximab|rituximab|mesh-list
15161849|NCT04113226|Lenalidomide|lenalidomide|mesh-list
15161850|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15161851|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609807|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609808|NCT00077428|Doxorubicin|doxorubicin|mesh-list
14609809|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14609810|NCT00077428|Bortezomib|bortezomib|mesh-list
14609811|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14609812|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609813|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14609814|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14609815|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609816|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609817|NCT00077441|Bortezomib|bortezomib|mesh-list
14609818|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609819|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14609820|NCT00077454|Temozolomide|temozolomide|mesh-list
14609821|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609822|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14609823|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609824|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609825|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14609826|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
14609827|NCT00077467|Bortezomib|bortezomib|mesh-list
14609828|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609829|NCT00077493|Antibodies|antibodies|mesh-list
14609830|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
14609831|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14609832|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
14609833|NCT00077493|Immunotoxins|immunotoxins|mesh-list
14609834|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
14609835|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609836|NCT00077519|Tipifarnib|tipifarnib|mesh-list
14609837|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609838|NCT00077532|Ipilimumab|ipilimumab|mesh-list
14609839|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
14609840|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14609841|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609842|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14609843|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609844|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14609845|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
14609846|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609847|NCT00077545|Cisplatin|cisplatin|mesh-list
14609848|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609849|NCT00077558|Fludarabine|fludarabine|mesh-list
14609850|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
15161852|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
15161853|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609851|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609852|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14609853|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
14647541|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14609854|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609855|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14609856|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
14609857|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609858|NCT00077584|Bosentan|bosentan|mesh-list
14609859|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14609860|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14609861|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609862|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
14609863|NCT00077597|Hematinics|hematinics|mesh-ancestor
14609864|NCT00077688|Paclitaxel|paclitaxel|mesh-list
14609865|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14609866|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609867|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
14609868|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
15161854|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161855|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15161856|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15161857|NCT04113226|Growth Substances|growth substances|mesh-ancestor
15161858|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
15161859|NCT04113109|Icatibant|icatibant|mesh-list
15161860|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15161861|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15161862|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161863|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161864|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161865|NCT04113109|Analgesics|analgesics|mesh-ancestor
15161866|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
15161867|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022112|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609869|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
14609870|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609871|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14609872|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14609873|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14609874|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609875|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609876|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14609877|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14609878|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15161868|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161869|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161870|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15161871|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
15161872|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
15161873|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15161874|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161875|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
14609879|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
14609880|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609881|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609882|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14609883|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14609884|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
14022113|NCT02770105|Caffeine|caffeine|mesh-list
14022114|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14022115|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022116|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14022117|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022118|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022119|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14022120|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14609885|NCT00077727|Galantamine|galantamine|mesh-list
14609886|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14609887|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609888|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609889|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
14609890|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609891|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609892|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14609893|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
14609894|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609895|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
14609896|NCT00077753|Enoxaparin|enoxaparin|mesh-list
14609897|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
14609898|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
15161876|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15161877|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
15161878|NCT04113005|Coagulants|coagulants|mesh-ancestor
15161879|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15161880|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
15161881|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609899|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14609900|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15180700|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180701|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180702|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15180703|NCT03936374|Omeprazole|omeprazole|mesh-list
15180704|NCT03936374|Linrodostat|linrodostat|mesh-list
15180705|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15180706|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180707|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15180708|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180709|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609901|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609902|NCT00077779|Adalimumab|adalimumab|mesh-list
14609903|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14609904|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14609905|NCT00077792|Enoxaparin|enoxaparin|mesh-list
14609906|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
14609907|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
14609908|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14609909|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14609910|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609911|NCT00077805|Enoxaparin|enoxaparin|mesh-list
14609912|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
14609913|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
14609914|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14609915|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14609916|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609917|NCT00077818|Enoxaparin|enoxaparin|mesh-list
14609918|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
14609919|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
14609920|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14609921|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14609922|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609923|NCT00077844|Enoxaparin|enoxaparin|mesh-list
14609924|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
14609925|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
14609926|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14609927|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14609928|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609929|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
14609930|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
14609931|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609932|NCT00077883|Cisplatin|cisplatin|mesh-list
14609933|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609934|NCT00077948|Metoprolol|metoprolol|mesh-list
14609935|NCT00077948|Enoximone|enoximone|mesh-list
14609936|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14609937|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14609938|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
14609939|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
14609940|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609941|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609942|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14609943|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14609944|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14609945|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
14609946|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609947|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609948|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14609949|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
15180710|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
15180711|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15180712|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609950|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14647542|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
14609951|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14609952|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609953|NCT00077948|Protective Agents|protective agents|mesh-ancestor
14609954|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
14609955|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14609956|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609957|NCT00077987|Sunitinib|sunitinib|mesh-list
14609958|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609959|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14609960|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14609961|NCT00077987|Growth Substances|growth substances|mesh-ancestor
14609962|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609963|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
14609964|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14609965|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609966|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609967|NCT00078000|Sunitinib|sunitinib|mesh-list
14609968|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14609969|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14609970|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14609971|NCT00078000|Growth Substances|growth substances|mesh-ancestor
14609972|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022121|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
14022122|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026076|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026077|NCT02745769|Ramucirumab|ramucirumab|mesh-list
14026078|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026079|NCT02745470|Lixisenatide|lixisenatide|mesh-list
14026080|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026081|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609973|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
14609974|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14609975|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14609976|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609977|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14609978|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14609979|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14609980|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609981|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14609982|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14609983|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14609984|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14609985|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
14609986|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14609987|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14609988|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14609989|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14609990|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
14609991|NCT00078117|Buprenorphine|buprenorphine|mesh-list
14609992|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14609993|NCT00078117|Narcotics|narcotics|mesh-ancestor
14609994|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14609995|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161882|NCT04112823|Dexamethasone|dexamethasone|mesh-list
15161883|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
15161884|NCT04112823|BB 1101|bb 1101|mesh-list
15161885|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161886|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
15161887|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
15161888|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161889|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161890|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161891|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
15161892|NCT04112823|Hormones|hormones|mesh-ancestor
15161893|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161894|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15161895|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161896|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
15161897|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161898|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161899|NCT04112550|Acetaminophen|acetaminophen|mesh-list
14609996|NCT00078117|Analgesics|analgesics|mesh-ancestor
14609997|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
14026082|NCT02745431|Oxytocin|oxytocin|mesh-list
14026083|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
14609998|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14609999|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14610000|NCT00078130|Buprenorphine|buprenorphine|mesh-list
14610001|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14610002|NCT00078130|Naloxone|naloxone|mesh-list
14610003|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14610004|NCT00078130|Narcotics|narcotics|mesh-ancestor
14610005|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610006|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610007|NCT00078130|Analgesics|analgesics|mesh-ancestor
14610008|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
14610009|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610010|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14610011|NCT00078182|Tenofovir|tenofovir|mesh-list
14610012|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
14610013|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610014|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14610015|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14610016|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610017|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610018|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14610019|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14610020|NCT00078195|Omalizumab|omalizumab|mesh-list
14610021|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
14610022|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
14610023|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14610024|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610025|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14610026|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14610027|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
14610028|NCT00078234|Rituximab|rituximab|mesh-list
14610029|NCT00078234|Fludarabine|fludarabine|mesh-list
14610030|NCT00078234|Oblimersen|oblimersen|mesh-list
14610031|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610032|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610033|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
14610034|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610035|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610036|NCT00078247|Lamivudine|lamivudine|mesh-list
14610037|NCT00078247|Zidovudine|zidovudine|mesh-list
14610038|NCT00078247|Abacavir|abacavir|mesh-list
14610039|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14610040|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14610041|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610042|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610043|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
14610044|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610045|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14610046|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14610047|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
14610048|NCT00078260|Pemetrexed|pemetrexed|mesh-list
14610049|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610050|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610051|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610052|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14610053|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14610054|NCT00078351|Hylan|hylan|mesh-list
14610055|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
14610056|NCT00078351|Protective Agents|protective agents|mesh-ancestor
14610057|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610058|NCT00078390|S 3304|s 3304|mesh-list
14610059|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
14610060|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
14610061|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161900|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15161901|NCT04112550|Oxycodone|oxycodone|mesh-list
15161902|NCT04112550|Methadone|methadone|mesh-list
15161903|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161904|NCT04112550|Analgesics|analgesics|mesh-ancestor
15161905|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
14610062|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610063|NCT00078442|Interferons|interferons|mesh-list
14610064|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
15161906|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161907|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610065|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
14610066|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14610067|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610068|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
14610069|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610070|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
14610071|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610072|NCT00078481|Idebenone|idebenone|mesh-list
14610073|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
14610074|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610075|NCT00078481|Protective Agents|protective agents|mesh-ancestor
14610076|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610077|NCT00078546|Antibodies|antibodies|mesh-list
14610078|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15161908|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
15161909|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15161910|NCT04112550|Narcotics|narcotics|mesh-ancestor
15161911|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161912|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
15161913|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
14610079|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
14610080|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610081|NCT00078572|Capecitabine|capecitabine|mesh-list
14610082|NCT00078572|Lapatinib|lapatinib|mesh-list
14610083|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610084|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
14610085|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610086|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610087|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610088|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610089|NCT00078598|Rituximab|rituximab|mesh-list
14610090|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
14610091|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610092|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610093|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
14610094|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610095|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610096|NCT00078611|Natalizumab|natalizumab|mesh-list
14610097|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
14610098|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610099|NCT00078689|Daclizumab|daclizumab|mesh-list
14610100|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15161914|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15161915|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14610101|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
14610102|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610103|NCT00078793|Etanercept|etanercept|mesh-list
14610104|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14610105|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14610106|NCT00078793|Analgesics|analgesics|mesh-ancestor
14610107|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
14610108|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610109|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610110|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14610111|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610112|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14610113|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610114|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
14610115|NCT00078806|Etanercept|etanercept|mesh-list
14610116|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14610117|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14610118|NCT00078806|Analgesics|analgesics|mesh-ancestor
14610119|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
14610120|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610121|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610122|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14610123|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610124|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14610125|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610126|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
14610127|NCT00078832|Anastrozole|anastrozole|mesh-list
14610128|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14610129|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610130|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14610131|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14610132|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161916|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610133|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161917|NCT04112212|Vedolizumab|vedolizumab|mesh-list
14610134|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14610135|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
14610136|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610137|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610138|NCT00078845|Amifostine|amifostine|mesh-list
14610139|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14610140|NCT00078845|Protective Agents|protective agents|mesh-ancestor
14610141|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161918|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15161919|NCT04112368|Estradiol|estradiol|mesh-list
15161920|NCT04112368|Progesterone|progesterone|mesh-list
15161921|NCT04112368|Estrogens|estrogens|mesh-ancestor
15161922|NCT04112368|Hormones|hormones|mesh-ancestor
14610142|NCT00078858|Cyclosporine|cyclosporine|mesh-list
14610143|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
14610144|NCT00078858|Fludarabine|fludarabine|mesh-list
14610145|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
14610146|NCT00078858|Cyclosporins|cyclosporins|mesh-list
14610147|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610148|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610149|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
14610150|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610151|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610152|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
14610153|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610154|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610155|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
14610156|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610157|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
14610158|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610159|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14610160|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610161|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14610162|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
14610163|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610164|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
14610165|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610166|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14610167|NCT00078910|Protective Agents|protective agents|mesh-ancestor
14610168|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610169|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14610170|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610171|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610172|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14610173|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14610174|NCT00078910|Analgesics|analgesics|mesh-ancestor
14610175|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
15161923|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15161924|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161925|NCT04112368|Progestins|progestins|mesh-ancestor
15161926|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15161927|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
15161928|NCT04112147|Ubiquinone|ubiquinone|mesh-list
15161929|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
15161930|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161931|NCT04112043|Niacinamide|niacinamide|mesh-list
15161932|NCT04112043|Niacin|niacin|mesh-list
15161933|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
15161934|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
15161935|NCT04112043|Vitamins|vitamins|mesh-ancestor
15161936|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
15161937|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161938|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15161939|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
15161940|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161941|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15161942|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
15161943|NCT04112498|Nivolumab|nivolumab|mesh-list
15161944|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15161945|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15161946|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15161947|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610176|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610177|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15161948|NCT04112394|Anesthetics|anesthetics|mesh-list
15161949|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
15161950|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15161951|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161952|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
15161953|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161954|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
15161955|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14610178|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610179|NCT00078962|Gemcitabine|gemcitabine|mesh-list
14610180|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610181|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
14610182|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610183|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610184|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
15161956|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15161957|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161958|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
15161959|NCT04111822|Coagulants|coagulants|mesh-ancestor
15161960|NCT04111614|Tofacitinib|tofacitinib|mesh-list
15161961|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15161962|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610185|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610186|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610187|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610188|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
15161963|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161964|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
15161965|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15161966|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15161967|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
15161968|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161969|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161970|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15161971|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
15161972|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15161973|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
15161974|NCT04111484|Protective Agents|protective agents|mesh-ancestor
14610189|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610190|NCT00078975|Gemcitabine|gemcitabine|mesh-list
14610191|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610192|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
14610193|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610194|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610195|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
14610196|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610197|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15161975|NCT04111432|Vaccines|vaccines|mesh-list
15161976|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
15161977|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15161978|NCT04111328|Sufentanil|sufentanil|mesh-list
14610198|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610199|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
14610200|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610201|NCT00078988|Carboplatin|carboplatin|mesh-list
14610202|NCT00078988|Etoposide|etoposide|mesh-list
14610203|NCT00078988|Thiotepa|thiotepa|mesh-list
14610204|NCT00078988|Isotretinoin|isotretinoin|mesh-list
14610205|NCT00078988|Lenograstim|lenograstim|mesh-list
14610206|NCT00078988|Sargramostim|sargramostim|mesh-list
15161979|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
15161980|NCT04111328|Dsuvia|dsuvia|mesh-list
15161981|NCT04111328|Hydromorphone|hydromorphone|mesh-list
15161982|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14610207|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610208|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14610209|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14610210|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610211|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610212|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610213|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14610214|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
14610215|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610216|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14610217|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
15161983|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610218|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15161984|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610219|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610220|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
14610221|NCT00079014|Doxorubicin|doxorubicin|mesh-list
14610222|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14610223|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610224|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610225|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14610226|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610227|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610228|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610229|NCT00079027|Doxorubicin|doxorubicin|mesh-list
14610230|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14610231|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610232|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610233|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14610234|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610235|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610236|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610237|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14610238|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610239|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610240|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610241|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610242|NCT00079066|Cetuximab|cetuximab|mesh-list
14610243|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610244|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610245|NCT00079079|Gemcitabine|gemcitabine|mesh-list
14610246|NCT00079079|Carboplatin|carboplatin|mesh-list
14610247|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610248|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610249|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
14610250|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610251|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
14610252|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610253|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610254|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610255|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
14610256|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610257|NCT00079092|Thalidomide|thalidomide|mesh-list
14610258|NCT00079092|Procarbazine|procarbazine|mesh-list
14610259|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610260|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
14610261|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610262|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
14610263|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610264|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610265|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14610266|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14610267|NCT00079092|Growth Substances|growth substances|mesh-ancestor
14610268|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
14610269|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610270|NCT00079105|Prednisolone|prednisolone|mesh-list
14610271|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
14610272|NCT00079105|Etoposide|etoposide|mesh-list
14610273|NCT00079105|Vincristine|vincristine|mesh-list
14610274|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
14610275|NCT00079105|Bleomycin|bleomycin|mesh-list
14610276|NCT00079105|Vinblastine|vinblastine|mesh-list
15161985|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15161986|NCT04111328|Analgesics|analgesics|mesh-ancestor
15161987|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
15161988|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15161989|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15161990|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15161991|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15161992|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
15161993|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15161994|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15161995|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15161996|NCT04111328|Narcotics|narcotics|mesh-ancestor
15161997|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15161998|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15161999|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
14610277|NCT00079105|Procarbazine|procarbazine|mesh-list
14610278|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
14610279|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610280|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
14610281|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610282|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610283|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14610284|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
14610285|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610286|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610287|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14610288|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14610289|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14610290|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610291|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610292|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610293|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610294|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610295|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14610296|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
14610297|NCT00079105|Hormones|hormones|mesh-ancestor
14610298|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610299|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14610300|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610301|NCT00079105|Analgesics|analgesics|mesh-ancestor
14610302|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
14610303|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610304|NCT00079118|Docetaxel|docetaxel|mesh-list
14610305|NCT00079118|Irinotecan|irinotecan|mesh-list
14610306|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610307|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610308|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610309|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610310|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162000|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
15162001|NCT04111159|Propofol|propofol|mesh-list
15162002|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15162003|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162004|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162005|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15162006|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
15162007|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
15162008|NCT04111315|Dipyrone|dipyrone|mesh-list
15162009|NCT04111315|Ibuprofen|ibuprofen|mesh-list
15162010|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15162011|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14610311|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14610312|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610313|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610314|NCT00079131|Oblimersen|oblimersen|mesh-list
14610315|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610316|NCT00079144|Aldesleukin|aldesleukin|mesh-list
14610317|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
14610318|NCT00079144|Fludarabine|fludarabine|mesh-list
14610319|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
14610320|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
14610321|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162012|NCT04111315|Analgesics|analgesics|mesh-ancestor
15162013|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
15162014|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162015|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610322|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
14610323|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610324|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610325|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14610326|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
14610327|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610328|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610329|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14610330|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610331|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
14610332|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14610333|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14610334|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14610335|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
14610336|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610337|NCT00079157|Sargramostim|sargramostim|mesh-list
14610338|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
14610339|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
15162016|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162017|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162018|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15162019|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162020|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162021|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
15162022|NCT04111302|Dezocine|dezocine|mesh-list
15162023|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15162024|NCT04111302|Narcotics|narcotics|mesh-ancestor
15162025|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162026|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162027|NCT04111302|Analgesics|analgesics|mesh-ancestor
15162028|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
15162029|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162030|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15162031|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15162032|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
15162033|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162034|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162035|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162036|NCT04111848|Ketamine|ketamine|mesh-list
15162037|NCT04111848|Analgesics|analgesics|mesh-ancestor
14610340|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610341|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14610342|NCT00079170|Docetaxel|docetaxel|mesh-list
14610343|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610344|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610345|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610346|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610347|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610348|NCT00079222|Itraconazole|itraconazole|mesh-list
14610349|NCT00079222|Voriconazole|voriconazole|mesh-list
14610350|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
14610351|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610352|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14610353|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14610354|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610355|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610356|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14610357|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
14610358|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610359|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610360|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14610361|NCT00079235|Sirolimus|sirolimus|mesh-list
14610362|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610363|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610364|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610365|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610366|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
14610367|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610368|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
15162038|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
15162039|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162040|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162041|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15162042|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15162043|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
14610369|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610370|NCT00079248|Progesterone|progesterone|mesh-list
14610371|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14610372|NCT00079248|Estrogens|estrogens|mesh-list
14610373|NCT00079248|Progestins|progestins|mesh-ancestor
14610374|NCT00079248|Hormones|hormones|mesh-ancestor
14610375|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610376|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610377|NCT00079261|Gemcitabine|gemcitabine|mesh-list
14610378|NCT00079261|Prednisone|prednisone|mesh-list
14610379|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
14610380|NCT00079261|Doxorubicin|doxorubicin|mesh-list
14610381|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14610382|NCT00079261|Vincristine|vincristine|mesh-list
14610383|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610384|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
14610385|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162044|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
15162045|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162046|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15162047|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15162048|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162049|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162050|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
15162051|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
15162052|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162053|NCT04111003|Anesthetics|anesthetics|mesh-list
15162054|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610386|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610387|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14610388|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
14610389|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610390|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610391|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14610392|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610393|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
14610394|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
14610395|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610396|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610397|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610398|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14610399|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610400|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14610401|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
14610402|NCT00079261|Hormones|hormones|mesh-ancestor
14610403|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610404|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14610405|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14610406|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610407|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610408|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645639|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645640|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645641|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
14645642|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645643|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645644|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
14645645|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645646|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14645647|NCT00195078|Gefitinib|gefitinib|mesh-list
14645648|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645649|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14645650|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645651|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645652|NCT00195104|Cytarabine|cytarabine|mesh-list
14645653|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
14645654|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645655|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
14645656|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645657|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645658|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
14645659|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645660|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645661|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
14645662|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645663|NCT00195156|Valproic Acid|valproic acid|mesh-list
14645664|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
14645665|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645666|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645667|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
14645668|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645669|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645670|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
14645671|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14645672|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645673|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645674|NCT00195195|Sirolimus|sirolimus|mesh-list
14645675|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645676|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645677|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14645678|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162055|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162056|NCT04110665|Acetaminophen|acetaminophen|mesh-list
14610409|NCT00079287|Gemcitabine|gemcitabine|mesh-list
14610410|NCT00079287|Paclitaxel|paclitaxel|mesh-list
14610411|NCT00079287|Vinorelbine|vinorelbine|mesh-list
14610412|NCT00079287|Docetaxel|docetaxel|mesh-list
14610413|NCT00079287|Carboplatin|carboplatin|mesh-list
14610414|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14610415|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610416|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610417|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610418|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610419|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610420|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610421|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
14610422|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
14610423|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610424|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610425|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610426|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
14610427|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610428|NCT00079300|Imiquimod|imiquimod|mesh-list
14610429|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14610430|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
14610431|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610432|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610433|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
14610434|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
14610435|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610436|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610437|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610438|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610439|NCT00079352|Gemcitabine|gemcitabine|mesh-list
14610440|NCT00079352|Irinotecan|irinotecan|mesh-list
14610441|NCT00079352|Alvocidib|alvocidib|mesh-list
15162057|NCT04110665|Morphine|morphine|mesh-list
15162058|NCT04110665|Oxycodone|oxycodone|mesh-list
15162059|NCT04110665|Tramadol|tramadol|mesh-list
15162060|NCT04110665|Nefopam|nefopam|mesh-list
15162061|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15162062|NCT04110665|Narcotics|narcotics|mesh-ancestor
15162063|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162064|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162065|NCT04110665|Analgesics|analgesics|mesh-ancestor
15162066|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
15162067|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162068|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15162069|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
15180713|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180714|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15180715|NCT03936205|Analgesics|analgesics|mesh-ancestor
15180716|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
15180717|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180718|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14610442|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610443|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
14610444|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610445|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610446|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
14610447|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610448|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610449|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610450|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
14610451|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610452|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14610453|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610454|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
14610455|NCT00079352|Growth Substances|growth substances|mesh-ancestor
14610456|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610457|NCT00079365|Gemcitabine|gemcitabine|mesh-list
14610458|NCT00079365|Fluorouracil|fluorouracil|mesh-list
14610459|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15180719|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15180720|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15180721|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
14610460|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
14610461|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180722|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645679|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
15182222|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14610462|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610463|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
14610464|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610465|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610466|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610467|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
14610468|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610469|NCT00079378|Decitabine|decitabine|mesh-list
14610470|NCT00079378|Azacitidine|azacitidine|mesh-list
14610471|NCT00079378|Valproic Acid|valproic acid|mesh-list
14610472|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610473|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
14610474|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610475|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610476|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610477|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
14610478|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
14610479|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610480|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610481|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
14610482|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14610483|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610484|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15162070|NCT04110873|Ubiquinone|ubiquinone|mesh-list
15162071|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
15162072|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610485|NCT00079430|Paclitaxel|paclitaxel|mesh-list
14610486|NCT00079430|Bevacizumab|bevacizumab|mesh-list
14610487|NCT00079430|Carboplatin|carboplatin|mesh-list
14610488|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14610489|NCT00079430|Antibodies|antibodies|mesh-list
14610490|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
14610491|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14610492|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14610493|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610494|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610495|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610496|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
15162073|NCT04110834|Itraconazole|itraconazole|mesh-list
15162074|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15162075|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
15162076|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610497|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610498|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14610499|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14610500|NCT00079430|Growth Substances|growth substances|mesh-ancestor
14610501|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610502|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
14610503|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
14610504|NCT00079443|Rituximab|rituximab|mesh-list
14610505|NCT00079443|Fludarabine|fludarabine|mesh-list
14610506|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
14610507|NCT00079443|Romidepsin|romidepsin|mesh-list
14610508|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610509|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610510|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
14610511|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610512|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610513|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610514|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
14610515|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610516|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162077|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15162078|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15162079|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162080|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162081|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15162082|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
15162083|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162084|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162085|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15162086|NCT04110860|Voriconazole|voriconazole|mesh-list
15162087|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
14610517|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610518|NCT00079456|Sirolimus|sirolimus|mesh-list
14610519|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610520|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610521|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610522|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610523|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
14610524|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610525|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
15162088|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162089|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15162090|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14610526|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610527|NCT00079469|Bupropion|bupropion|mesh-list
14610528|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14610529|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
14610530|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14610531|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14610532|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14610533|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14610534|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610535|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
14610536|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610537|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610538|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14610539|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14610540|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610541|NCT00079508|Bivalirudin|bivalirudin|mesh-list
14610542|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
14610543|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14610544|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
14610545|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610546|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610547|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
14610548|NCT00079560|Dronabinol|dronabinol|mesh-list
14610549|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
14610550|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610551|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14610552|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14610553|NCT00079560|Analgesics|analgesics|mesh-ancestor
14610554|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
14610555|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610556|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14610557|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14610558|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610559|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610560|NCT00079560|Hormones|hormones|mesh-ancestor
14610561|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162091|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182223|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
14610562|NCT00079586|Heparin|heparin|mesh-list
14610563|NCT00079586|Bivalirudin|bivalirudin|mesh-list
14610564|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
14610565|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14610566|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14610567|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610568|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
14610569|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14610570|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
14610571|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610572|NCT00079612|Sorafenib|sorafenib|mesh-list
14610573|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610574|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610575|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610576|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610577|NCT00079638|Niacin|niacin|mesh-list
14610578|NCT00079638|Atorvastatin|atorvastatin|mesh-list
14610579|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14610580|NCT00079638|Simvastatin|simvastatin|mesh-list
14610581|NCT00079638|Ezetimibe|ezetimibe|mesh-list
14610582|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14610583|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14610584|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
14610585|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610586|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14610587|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14610588|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610589|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
14610590|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
14610591|NCT00079638|Vitamins|vitamins|mesh-ancestor
14610592|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
14610593|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610594|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
14610595|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610596|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610597|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14610598|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610599|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610600|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
14610601|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610602|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610603|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
14610604|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
14610605|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162092|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162093|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15162094|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
15162095|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162096|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162097|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15162098|NCT04110808|Phentolamine|phentolamine|mesh-list
15162099|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
14610606|NCT00079807|Protective Agents|protective agents|mesh-ancestor
14610607|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610608|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
14610609|NCT00079807|Vitamins|vitamins|mesh-ancestor
14610610|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
14610611|NCT00079820|Vaccines|vaccines|mesh-list
14610612|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
14610613|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610614|NCT00079833|Esomeprazole|esomeprazole|mesh-list
14610615|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14610616|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14610617|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14610618|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610619|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610620|NCT00079872|Pemetrexed|pemetrexed|mesh-list
14610621|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610622|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610623|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610624|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14610625|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14610626|NCT00079885|Tigecycline|tigecycline|mesh-list
14610627|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610628|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610629|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14610630|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610631|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610632|NCT00079911|Valacyclovir|valacyclovir|mesh-list
14610633|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
14610634|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610635|NCT00079924|Teriparatide|teriparatide|mesh-list
14610636|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14610637|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14610638|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610639|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14610640|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14610641|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
14610642|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610643|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14610644|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14610645|NCT00079963|Vitamins|vitamins|mesh-list
14610646|NCT00079963|Ascorbic Acid|ascorbic acid|mesh-list
14610647|NCT00079963|Vitamin E|vitamin e|mesh-list
15162100|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
15162101|NCT04110808|Anesthetics|anesthetics|mesh-list
15162102|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162103|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162104|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
15162105|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15162106|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15162107|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
14610648|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
14610649|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610650|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
15162108|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162109|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162110|NCT04111380|Paclitaxel|paclitaxel|mesh-list
14610651|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610652|NCT00079963|Protective Agents|protective agents|mesh-ancestor
14610653|NCT00079976|Tigecycline|tigecycline|mesh-list
15162111|NCT04111380|Cisplatin|cisplatin|mesh-list
15162112|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15162113|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162114|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610654|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610655|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610656|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14610657|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610658|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610659|NCT00079989|Tigecycline|tigecycline|mesh-list
14610660|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610661|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610662|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14610663|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610664|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610665|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
14610666|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610667|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14610668|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
14610669|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
14610670|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610671|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14610672|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
14610673|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
14610674|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610675|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14610676|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
14610677|NCT00080080|Docetaxel|docetaxel|mesh-list
14610678|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610679|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610680|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610681|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610682|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610683|NCT00080145|Risperidone|risperidone|mesh-list
14610684|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14610685|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
14610686|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610687|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610688|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610689|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14610690|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14610691|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610692|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14610693|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14610694|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
14610695|NCT00080158|Mirtazapine|mirtazapine|mesh-list
14610696|NCT00080158|Citalopram|citalopram|mesh-list
14610697|NCT00080158|Bupropion|bupropion|mesh-list
14610698|NCT00080158|Fluoxetine|fluoxetine|mesh-list
14610699|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14610700|NCT00080158|Sertraline|sertraline|mesh-list
14610701|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14610702|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14610703|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14610704|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610705|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610706|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
14610707|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610708|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14610709|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
14610710|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14022123|NCT02769832|Gemcitabine|gemcitabine|mesh-list
14610711|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15162115|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
15162116|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
14022124|NCT02769832|Paclitaxel|paclitaxel|mesh-list
14610712|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
14610713|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14610714|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14610715|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610716|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14610717|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022125|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14022126|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14022127|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022128|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
14022129|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
14022130|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
14022131|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022132|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022133|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
14022134|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
14022135|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022136|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022137|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610718|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14610719|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14610720|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
14610721|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
14610722|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14610723|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14610724|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14610725|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14610726|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
15162117|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022138|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
14022139|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022140|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
14022141|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022142|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
14022143|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022144|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022145|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14022146|NCT02769936|Cycloserine|cycloserine|mesh-list
14022147|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14022148|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022149|NCT02769936|Renal Agents|renal agents|mesh-ancestor
14022150|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14022151|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
14022152|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022153|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
15162118|NCT04111289|Tirofiban|tirofiban|mesh-list
15162119|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15162120|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14022154|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022155|NCT02769910|Capsaicin|capsaicin|mesh-list
14022156|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
14022157|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
15162121|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162122|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15162123|NCT04110535|Midazolam|midazolam|mesh-list
15162124|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15162125|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15162126|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162127|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162128|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15162129|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15162130|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15162131|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15162132|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
15162133|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
15162134|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
15162135|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
15162136|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162137|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162138|NCT04110418|Terlipressin|terlipressin|mesh-list
15162139|NCT04110418|Methylene Blue|methylene blue|mesh-list
15162140|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022158|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
14022159|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162141|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162142|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15162143|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15162144|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15162145|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15162146|NCT04110587|Analgesics|analgesics|mesh-list
15162147|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
15162148|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162149|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14610727|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14610728|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14610729|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14610730|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14610731|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610732|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14610733|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610734|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610735|NCT00080275|Niacin|niacin|mesh-list
14610736|NCT00080275|Simvastatin|simvastatin|mesh-list
14610737|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14610738|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14610739|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
14610740|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610741|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14610742|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14610743|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610744|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
14610745|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
14610746|NCT00080275|Vitamins|vitamins|mesh-ancestor
14610747|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
14610748|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610749|NCT00080314|Aripiprazole|aripiprazole|mesh-list
14610750|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
14610751|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14610752|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14610753|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14610754|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610755|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610756|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
14610757|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
14610758|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610759|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610760|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14610761|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14610762|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
14610763|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14610764|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14610765|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15162150|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
15162151|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162152|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
15162153|NCT04110587|Protective Agents|protective agents|mesh-ancestor
15162154|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
14610766|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14610767|NCT00080327|Aripiprazole|aripiprazole|mesh-list
14610768|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
14610769|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14610770|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14610771|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14610772|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610773|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610774|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
15162155|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162156|NCT04110132|Bupivacaine|bupivacaine|mesh-list
15162157|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
15162158|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
15162159|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162160|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162161|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
15162162|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610775|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
14610776|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162163|NCT04110028|Niacinamide|niacinamide|mesh-list
15162164|NCT04110028|Niacin|niacin|mesh-list
15162165|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
14610777|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610778|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14610779|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14610780|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
15162166|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
15162167|NCT04110028|Vitamins|vitamins|mesh-ancestor
15162168|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
15162169|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162170|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15162171|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
15162172|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162173|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15162174|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
15162175|NCT04110210|Morphine|morphine|mesh-list
15162176|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15162177|NCT04110210|Narcotics|narcotics|mesh-ancestor
15162178|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162179|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162180|NCT04110210|Analgesics|analgesics|mesh-ancestor
15162181|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
15162182|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610781|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14610782|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14610783|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14610784|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14610785|NCT00080340|Gefitinib|gefitinib|mesh-list
14610786|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610787|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610788|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610789|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610790|NCT00080405|Bortezomib|bortezomib|mesh-list
14610791|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610792|NCT00080418|Paclitaxel|paclitaxel|mesh-list
14610793|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14610794|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610795|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610796|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610797|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610798|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610799|NCT00080431|Daclizumab|daclizumab|mesh-list
14610800|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610801|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
14610802|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610803|NCT00080444|Dexamethasone|dexamethasone|mesh-list
14610804|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
14610805|NCT00080444|Ondansetron|ondansetron|mesh-list
14610806|NCT00080444|Aprepitant|aprepitant|mesh-list
14610807|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
14610808|NCT00080444|BB 1101|bb 1101|mesh-list
14610809|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14610810|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
14610811|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
15162183|NCT04110301|Lenalidomide|lenalidomide|mesh-list
14610812|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610813|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610814|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14610815|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
14610816|NCT00080444|Hormones|hormones|mesh-ancestor
14610817|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610818|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15162184|NCT04110301|Antibodies|antibodies|mesh-list
15162185|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15162186|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
15162187|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162188|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15162189|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15162190|NCT04110301|Growth Substances|growth substances|mesh-ancestor
15162191|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
14610819|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610820|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
14610821|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610822|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610823|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
15162192|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162193|NCT04110288|Paclitaxel|paclitaxel|mesh-list
14610824|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
15162194|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14610825|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14610826|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
14610827|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610828|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14610829|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14610830|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14610831|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14610832|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14610833|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14610834|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
14610835|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14610836|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610837|NCT00080496|Imipenem|imipenem|mesh-list
14610838|NCT00080496|Tigecycline|tigecycline|mesh-list
14610839|NCT00080496|Cilastatin|cilastatin|mesh-list
14610840|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610841|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610842|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15162195|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162196|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610843|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610844|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610845|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
14610846|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
14610847|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610848|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610849|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610850|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610851|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610852|NCT00080522|Ritonavir|ritonavir|mesh-list
14610853|NCT00080522|Lopinavir|lopinavir|mesh-list
14610854|NCT00080522|Lamivudine|lamivudine|mesh-list
14610855|NCT00080522|Zidovudine|zidovudine|mesh-list
14610856|NCT00080522|Stavudine|stavudine|mesh-list
14610857|NCT00080522|Didanosine|didanosine|mesh-list
15162197|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610858|NCT00080522|Efavirenz|efavirenz|mesh-list
14610859|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14610860|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14610861|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
14610862|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610863|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162198|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
15162199|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162200|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
15162201|NCT04110340|Streptomycin|streptomycin|mesh-list
15162202|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14610864|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15162203|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162204|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15162205|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15162206|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162207|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610865|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14610866|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
14610867|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610868|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14610869|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14610870|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14610871|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14610872|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
14610873|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14610874|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14610875|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14610876|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14610877|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14610878|NCT00080613|Exemestane|exemestane|mesh-list
14610879|NCT00080613|Hormones|hormones|mesh-list
14610880|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610881|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610882|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610883|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14610884|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14610885|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645680|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610886|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610887|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14610888|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
14610889|NCT00080626|Docetaxel|docetaxel|mesh-list
14610890|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610891|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610892|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610893|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610894|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610895|NCT00080665|Docetaxel|docetaxel|mesh-list
14610896|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
14610897|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610898|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610899|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610900|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610901|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610902|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610903|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610904|NCT00080678|Docetaxel|docetaxel|mesh-list
14610905|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
14610906|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610907|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
14610908|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
14610909|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
14610910|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610911|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610912|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610913|NCT00080743|Tamoxifen|tamoxifen|mesh-list
14610914|NCT00080743|Gefitinib|gefitinib|mesh-list
14610915|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610916|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14610917|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
14610918|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14610919|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610920|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14610921|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610922|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14610923|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14610924|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14610925|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14610926|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610927|NCT00080782|Celecoxib|celecoxib|mesh-list
14610928|NCT00080782|Doxorubicin|doxorubicin|mesh-list
14610929|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14610930|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610931|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610932|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14610933|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610934|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610935|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610936|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14610937|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14610938|NCT00080782|Analgesics|analgesics|mesh-ancestor
14610939|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
14610940|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14610941|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610942|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14610943|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610944|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14610945|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14610946|NCT00080795|Gemcitabine|gemcitabine|mesh-list
15162208|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162209|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15162210|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15162211|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15162212|NCT04110275|Plasminogen|plasminogen|mesh-list
15162213|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15162214|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14610947|NCT00080795|Doxorubicin|doxorubicin|mesh-list
14610948|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14610949|NCT00080795|Ifosfamide|ifosfamide|mesh-list
14610950|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610951|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14610952|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
14610953|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610954|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
14610955|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14610956|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610957|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610958|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
15162215|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15162216|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162217|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14610959|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610960|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14610961|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14610962|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14610963|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14610964|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
14610965|NCT00080808|Phentolamine|phentolamine|mesh-list
14610966|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
14610967|NCT00080808|Alprostadil|alprostadil|mesh-list
14610968|NCT00080808|Papaverine|papaverine|mesh-list
14610969|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610970|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
14610971|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14610972|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14610973|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14610974|NCT00080808|Urological Agents|urological agents|mesh-ancestor
14610975|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14610976|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14610977|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
14610978|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14610979|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610980|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14610981|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14610982|NCT00080847|Prednisone|prednisone|mesh-list
14610983|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
14610984|NCT00080847|Rituximab|rituximab|mesh-list
14610985|NCT00080847|Doxorubicin|doxorubicin|mesh-list
14610986|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14610987|NCT00080847|Vincristine|vincristine|mesh-list
14610988|NCT00080847|Oblimersen|oblimersen|mesh-list
15162218|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162219|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162220|NCT04110119|Diclofenac|diclofenac|mesh-list
15162221|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15162222|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15162223|NCT04110119|Analgesics|analgesics|mesh-ancestor
15162224|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
15162225|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162226|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162227|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162228|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162229|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15162230|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162231|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162232|NCT04109872|Lenalidomide|lenalidomide|mesh-list
15162233|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
15162234|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162235|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15162236|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14610989|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14610990|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
14610991|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14610992|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14610993|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14610994|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
14610995|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14610996|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14610997|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14610998|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14610999|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14611000|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611001|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611002|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611003|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611004|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
14611005|NCT00080847|Hormones|hormones|mesh-ancestor
14611006|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611007|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14611008|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611009|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
14611010|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14611011|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611012|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14611013|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14611014|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611015|NCT00080886|Cytarabine|cytarabine|mesh-list
14611016|NCT00080886|Rituximab|rituximab|mesh-list
14611017|NCT00080886|Etoposide|etoposide|mesh-list
14611018|NCT00080886|Melphalan|melphalan|mesh-list
14611019|NCT00080886|Carmustine|carmustine|mesh-list
14611020|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611021|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611022|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
14611023|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611024|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162237|NCT04109872|Growth Substances|growth substances|mesh-ancestor
15162238|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
15162239|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162240|NCT04109742|Curcumin|curcumin|mesh-list
15162241|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15162242|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15162243|NCT04109742|Analgesics|analgesics|mesh-ancestor
15162244|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
15162245|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162246|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162247|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162248|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162249|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162250|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162251|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162252|NCT04109859|Methylene Blue|methylene blue|mesh-list
15162253|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162254|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162255|NCT04109924|Trifluridine|trifluridine|mesh-list
15162256|NCT04109924|Bevacizumab|bevacizumab|mesh-list
15162257|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15162258|NCT04109924|Irinotecan|irinotecan|mesh-list
15162259|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
15162260|NCT04109924|Antibodies|antibodies|mesh-list
15162261|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
14611025|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611026|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611027|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611028|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611029|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611030|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611031|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
14611032|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
14611033|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611034|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611035|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611036|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
14611037|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14611038|NCT00080925|Cytarabine|cytarabine|mesh-list
14611039|NCT00080925|Cyclosporine|cyclosporine|mesh-list
14611040|NCT00080925|Prednisone|prednisone|mesh-list
14611041|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
14611042|NCT00080925|Rituximab|rituximab|mesh-list
14611043|NCT00080925|Doxorubicin|doxorubicin|mesh-list
14611044|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14611045|NCT00080925|Fludarabine|fludarabine|mesh-list
14611046|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
14611047|NCT00080925|Etoposide|etoposide|mesh-list
14611048|NCT00080925|Vincristine|vincristine|mesh-list
14611049|NCT00080925|Cyclosporins|cyclosporins|mesh-list
14611050|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611051|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
15162262|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14611052|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611053|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611054|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15162263|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162264|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611055|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
14611056|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611057|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611058|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14611059|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611060|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14611061|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611062|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611063|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611064|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611065|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
14611066|NCT00080925|Hormones|hormones|mesh-ancestor
14611067|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611068|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15162265|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15162266|NCT04109924|Growth Substances|growth substances|mesh-ancestor
15162267|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162268|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
15162269|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
15162270|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14611069|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611070|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
14611071|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611072|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
14611073|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611074|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
15162271|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15162272|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162273|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162274|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
15162275|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
15162276|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162277|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15162278|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15162279|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162280|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
15162281|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15162282|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162283|NCT04109261|Palbociclib|palbociclib|mesh-list
14611075|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
14611076|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611077|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
14611078|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
14611079|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14611080|NCT00080951|Leucovorin|leucovorin|mesh-list
14611081|NCT00080951|Fluorouracil|fluorouracil|mesh-list
14611082|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
14611083|NCT00080951|Irinotecan|irinotecan|mesh-list
14611084|NCT00080951|Calcium|calcium|mesh-list
14611085|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
15162284|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162285|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15162286|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162287|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162288|NCT04109339|Oxytocin|oxytocin|mesh-list
15162289|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
15162290|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15162291|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162292|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
15162293|NCT04109534|Miotics|miotics|mesh-ancestor
15162294|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
15162295|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162296|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162297|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15162298|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15162299|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
15162300|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15162301|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15162302|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
15162303|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162304|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162305|NCT04108897|Doxycycline|doxycycline|mesh-list
14611086|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14645681|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
15162306|NCT04108897|Ivermectin|ivermectin|mesh-list
15162307|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15162308|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162309|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
15162310|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14611087|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611088|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
14611089|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611090|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611091|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611092|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611093|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
14611094|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14611095|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611096|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611097|NCT00080951|Antidotes|antidotes|mesh-ancestor
14611098|NCT00080951|Protective Agents|protective agents|mesh-ancestor
14611099|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
14611100|NCT00080951|Vitamins|vitamins|mesh-ancestor
14611101|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
14611102|NCT00080977|Aldesleukin|aldesleukin|mesh-list
14611103|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611104|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14611105|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14611106|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
14611107|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022160|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645682|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645683|NCT00195208|Pantoprazole|pantoprazole|mesh-list
14645684|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14645685|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14645686|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14645687|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645688|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645689|NCT00195286|Tazobactam|tazobactam|mesh-list
15162311|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15162312|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14645690|NCT00195286|Piperacillin|piperacillin|mesh-list
14645691|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14645692|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645693|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645694|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14645695|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645696|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645697|NCT00195299|Sirolimus|sirolimus|mesh-list
14645698|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645699|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645700|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14645701|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645702|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
14645703|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645704|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
14645705|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645706|NCT00195312|Bupivacaine|bupivacaine|mesh-list
14645707|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
14645708|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
14645709|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162313|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
15162314|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180723|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180724|NCT03936049|Liraglutide|liraglutide|mesh-list
15180725|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15180726|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180727|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180728|NCT03936049|Incretins|incretins|mesh-ancestor
15180729|NCT03936049|Hormones|hormones|mesh-ancestor
15180730|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180731|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
15180732|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180733|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180734|NCT03936153|Abexinostat|abexinostat|mesh-list
15180735|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15180736|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645710|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645711|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
14645712|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645713|NCT00195364|Etanercept|etanercept|mesh-list
14611108|NCT00080990|Leucovorin|leucovorin|mesh-list
14611109|NCT00080990|Fluorouracil|fluorouracil|mesh-list
14611110|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
14611111|NCT00080990|Alvocidib|alvocidib|mesh-list
14611112|NCT00080990|Calcium|calcium|mesh-list
14611113|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
14611114|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14611115|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611116|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
14611117|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611118|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611119|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611120|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611121|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
14611122|NCT00080990|Antidotes|antidotes|mesh-ancestor
14611123|NCT00080990|Protective Agents|protective agents|mesh-ancestor
14611124|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
15162315|NCT04108468|Golimumab|golimumab|mesh-list
15162316|NCT04108468|Methotrexate|methotrexate|mesh-list
15162317|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15162318|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
15162319|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15162320|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162321|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611125|NCT00080990|Vitamins|vitamins|mesh-ancestor
14611126|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
14611127|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611128|NCT00080990|Growth Substances|growth substances|mesh-ancestor
14611129|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14611130|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611131|NCT00081042|Paclitaxel|paclitaxel|mesh-list
14611132|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14611133|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611134|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611135|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14611136|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14611137|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611138|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611139|NCT00081055|Cyclosporine|cyclosporine|mesh-list
14611140|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
14611141|NCT00081055|Busulfan|busulfan|mesh-list
14611142|NCT00081055|Methotrexate|methotrexate|mesh-list
14611143|NCT00081055|Cyclosporins|cyclosporins|mesh-list
14611144|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611145|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
14611146|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611147|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611148|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611149|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
14611150|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611151|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611152|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14611153|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14611154|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
14611155|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14611156|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611157|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
14611158|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
14611159|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611160|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14611161|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14611162|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
14611163|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611164|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14611165|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
14611166|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611167|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611168|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14611169|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14611170|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611171|NCT00081107|Epothilones|epothilones|mesh-list
14611172|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
14611173|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
15162322|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
14611174|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
15162323|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611175|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611176|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611177|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611178|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
14611179|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
14611180|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611181|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14611182|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611183|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611184|NCT00081172|Antibodies|antibodies|mesh-list
14611185|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14611186|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
14611187|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611188|NCT00081224|Celecoxib|celecoxib|mesh-list
14611189|NCT00081224|Capecitabine|capecitabine|mesh-list
14611190|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611191|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
14611192|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611193|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611194|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14611195|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14611196|NCT00081224|Analgesics|analgesics|mesh-ancestor
14611197|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
14611198|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611199|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611200|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611201|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611202|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14611203|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15162324|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162325|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
15162326|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162327|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15162328|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162329|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
15162330|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162331|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15162332|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15162333|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162334|NCT04108676|Omeprazole|omeprazole|mesh-list
15162335|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15162336|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15162337|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15162338|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162339|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162340|NCT04108637|Penicillins|penicillins|mesh-list
15162341|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15162342|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162343|NCT04108234|Ketamine|ketamine|mesh-list
15162344|NCT04108234|Analgesics|analgesics|mesh-ancestor
14611204|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611205|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
14611206|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611207|NCT00081276|Cisplatin|cisplatin|mesh-list
14611208|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611209|NCT00081302|Paclitaxel|paclitaxel|mesh-list
14611210|NCT00081302|Carboplatin|carboplatin|mesh-list
14611211|NCT00081302|Cetuximab|cetuximab|mesh-list
14611212|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611213|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611214|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14611215|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
15162345|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
15162346|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162347|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162348|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15162349|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15162350|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
15162351|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
15162352|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162353|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15162354|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15162355|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162356|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162357|NCT04108013|Paclitaxel|paclitaxel|mesh-list
15162358|NCT04108013|Carboplatin|carboplatin|mesh-list
14611216|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
15162359|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15162360|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162361|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
15162362|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
15162363|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
15162364|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162365|NCT04107896|Tamsulosin|tamsulosin|mesh-list
15162366|NCT04107896|Silodosin|silodosin|mesh-list
15162367|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15162368|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15162369|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15162370|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
14611217|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611218|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611219|NCT00081315|Amifostine|amifostine|mesh-list
14611220|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14611221|NCT00081315|Protective Agents|protective agents|mesh-ancestor
14611222|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611223|NCT00081380|Valproic Acid|valproic acid|mesh-list
14611224|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14611225|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
14611226|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
14611227|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14611228|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14611229|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14611230|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611231|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611232|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162371|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162372|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162373|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162374|NCT04107896|Urological Agents|urological agents|mesh-ancestor
15162375|NCT04107805|Midazolam|midazolam|mesh-list
15162376|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15162377|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15162378|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162379|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162380|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15162381|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15162382|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15162383|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15162384|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
15162385|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
14022161|NCT02769884|Pancrelipase|pancrelipase|mesh-list
14022162|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14611233|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
14611234|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
14611235|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
14611236|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14611237|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
14611238|NCT00081471|Hematinics|hematinics|mesh-ancestor
14611239|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
14611240|NCT00081484|Hematinics|hematinics|mesh-ancestor
14611241|NCT00081536|Capecitabine|capecitabine|mesh-list
14611242|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611243|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
14611244|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611245|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611246|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
14611247|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611248|NCT00081575|Levofloxacin|levofloxacin|mesh-list
14611249|NCT00081575|Ofloxacin|ofloxacin|mesh-list
14611250|NCT00081575|Tigecycline|tigecycline|mesh-list
14611251|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14022163|NCT02769793|Levodopa|levodopa|mesh-list
14022164|NCT02769793|Benserazide|benserazide|mesh-list
14022165|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
14022166|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14022167|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14611252|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611253|NCT00081575|Renal Agents|renal agents|mesh-ancestor
14611254|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022168|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
14611255|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611256|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611257|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022169|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162386|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
14611258|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611259|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611260|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14611261|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14611262|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14611263|NCT00081588|Darunavir|darunavir|mesh-list
14611264|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14611265|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14611266|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
14611267|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611268|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611269|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14611270|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14611271|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
14611272|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611273|NCT00081614|Bevacizumab|bevacizumab|mesh-list
14611274|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14611275|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611276|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611277|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611278|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611279|NCT00081614|Growth Substances|growth substances|mesh-ancestor
14611280|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611281|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611282|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14611283|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611284|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611285|NCT00081744|Tigecycline|tigecycline|mesh-list
14611286|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611287|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611288|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14611289|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611290|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611291|NCT00081757|Thalidomide|thalidomide|mesh-list
14611292|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611293|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
14611294|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611295|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611296|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611297|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611298|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611299|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611300|NCT00081757|Growth Substances|growth substances|mesh-ancestor
14611301|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611302|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611303|NCT00081796|Capecitabine|capecitabine|mesh-list
15162387|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
15162388|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162389|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162390|NCT04107740|TA 0910|ta 0910|mesh-list
15162391|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
14611304|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611305|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
14611306|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611307|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611308|NCT00081822|Cytarabine|cytarabine|mesh-list
14611309|NCT00081822|Clofarabine|clofarabine|mesh-list
14611310|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611311|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
14611312|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611313|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611314|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
14611315|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611316|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611317|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
14611318|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611319|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
14611320|NCT00081835|Antibodies|antibodies|mesh-list
14611321|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
14611322|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15162392|NCT04107428|Somatostatin|somatostatin|mesh-list
15162393|NCT04107428|Hormones|hormones|mesh-ancestor
15182224|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
14611323|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14611324|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
14611325|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611326|NCT00081848|Metronidazole|metronidazole|mesh-list
14611327|NCT00081848|Celecoxib|celecoxib|mesh-list
14022170|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022171|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022172|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022173|NCT02769494|Riboflavin|riboflavin|mesh-list
14022174|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
14022175|NCT02769494|Mesalamine|mesalamine|mesh-list
14022176|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
14022177|NCT02769494|Vitamins|vitamins|mesh-ancestor
14022178|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
14611328|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14611329|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14611330|NCT00081848|Analgesics|analgesics|mesh-ancestor
14611331|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
14611332|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611333|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611334|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611335|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611336|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14611337|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14611338|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611339|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611340|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162394|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162395|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162396|NCT04107779|Menthol|menthol|mesh-list
14611341|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611342|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14611343|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14611344|NCT00081874|Everolimus|everolimus|mesh-list
14611345|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611346|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611347|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
14611348|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611349|NCT00081887|Clofarabine|clofarabine|mesh-list
14611350|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611351|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
14611352|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611353|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611354|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
14611355|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14611356|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611357|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
14611358|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611359|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14611360|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611361|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611362|NCT00081978|Etravirine|etravirine|mesh-list
14611363|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14611364|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14611365|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611366|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611367|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
14611368|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611369|NCT00082043|Dutasteride|dutasteride|mesh-list
14611370|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14611371|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14611372|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162397|NCT04107779|Nicotine|nicotine|mesh-list
15162398|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15162399|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
15162400|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162401|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162402|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15162403|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15162404|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
15162405|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022179|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162406|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162407|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
14611373|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611374|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
14611375|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611376|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611377|NCT00082082|Thymalfasin|thymalfasin|mesh-list
14611378|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14611379|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
14611380|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611381|NCT00082095|Doxorubicin|doxorubicin|mesh-list
14611382|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15162408|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
15162409|NCT04107480|Dopamine|dopamine|mesh-list
15162410|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
15162411|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15162412|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
14611383|NCT00082095|Capecitabine|capecitabine|mesh-list
14611384|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14611385|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611386|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15162413|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
15162414|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611387|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611388|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611389|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611390|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611391|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
14611392|NCT00082186|Bosentan|bosentan|mesh-list
14611393|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14611394|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14611395|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611396|NCT00082199|Aripiprazole|aripiprazole|mesh-list
14611397|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
14611398|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14611399|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14611400|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14611401|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14611402|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611403|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
14611404|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
14611405|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14611406|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611407|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14611408|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14611409|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
14611410|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14611411|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14611412|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14611413|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14611414|NCT00082212|Cetuximab|cetuximab|mesh-list
14611415|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611416|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611417|NCT00082225|Antibodies|antibodies|mesh-list
14611418|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
14611419|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611420|NCT00082251|Niacin|niacin|mesh-list
14611421|NCT00082251|Simvastatin|simvastatin|mesh-list
14611422|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14611423|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14611424|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
14611425|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611426|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14611427|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14611428|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611429|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
14611430|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
14611431|NCT00082251|Vitamins|vitamins|mesh-ancestor
14611432|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
15162415|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162416|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
15162417|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162418|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611433|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162419|NCT04107480|Protective Agents|protective agents|mesh-ancestor
15162420|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
14611434|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
14611435|NCT00082277|Anastrozole|anastrozole|mesh-list
14611436|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14611437|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611438|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14611439|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14611440|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611441|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611442|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14611443|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
14611444|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611445|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611446|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14611447|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14611448|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14611449|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14611450|NCT00082316|Capsaicin|capsaicin|mesh-list
14611451|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
14611452|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
14611453|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
14611454|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611455|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611456|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14611457|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14611458|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14611459|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14611460|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
14611461|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162421|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15162422|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162423|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162424|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14611462|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611463|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14611464|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14611465|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
14611466|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611467|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14611468|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14611469|NCT00082446|Vaccines|vaccines|mesh-list
14611470|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
14611471|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611472|NCT00082472|Docetaxel|docetaxel|mesh-list
14611473|NCT00082472|Doxorubicin|doxorubicin|mesh-list
14611474|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14611475|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611476|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14611477|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14611478|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611479|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611480|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14611481|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611482|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611483|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611484|NCT00082485|Baclofen|baclofen|mesh-list
14611485|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14611486|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611487|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14611488|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611489|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14611490|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
14611491|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
14611492|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14611493|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611494|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14611495|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14611496|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
14611497|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611498|NCT00082524|Caspofungin|caspofungin|mesh-list
14611499|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
14611500|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611501|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647543|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15162425|NCT04106999|Analgesics|analgesics|mesh-ancestor
14611502|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611503|NCT00082537|Caspofungin|caspofungin|mesh-list
14611504|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15162426|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
15162427|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162428|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15162429|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15162430|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15162431|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
15162432|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162433|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180737|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180738|NCT03936140|Iloprost|iloprost|mesh-list
15180739|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15180740|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
15180741|NCT03936036|Linagliptin|linagliptin|mesh-list
14611505|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
14611506|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611507|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611508|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611509|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14611510|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14611511|NCT00082563|Azithromycin|azithromycin|mesh-list
14611512|NCT00082563|Chloroquine|chloroquine|mesh-list
14611513|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14611514|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611515|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611516|NCT00082563|Amebicides|amebicides|mesh-ancestor
14611517|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14611518|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14611519|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
14611520|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611521|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14611522|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14611523|NCT00082563|Analgesics|analgesics|mesh-ancestor
14611524|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
14611525|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611526|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611527|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611528|NCT00082563|Filaricides|filaricides|mesh-ancestor
14611529|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
14611530|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
14611531|NCT00082576|Azithromycin|azithromycin|mesh-list
14611532|NCT00082576|Chloroquine|chloroquine|mesh-list
14611533|NCT00082576|Mefloquine|mefloquine|mesh-list
14611534|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611535|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611536|NCT00082576|Amebicides|amebicides|mesh-ancestor
14611537|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15180742|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180743|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180744|NCT03936036|Incretins|incretins|mesh-ancestor
15180745|NCT03936036|Hormones|hormones|mesh-ancestor
15180746|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180747|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15180748|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
15180749|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180750|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180751|NCT03936023|Saxagliptin|saxagliptin|mesh-list
15180752|NCT03936023|Incretins|incretins|mesh-ancestor
14611538|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14611539|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
14611540|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611541|NCT00082589|Eplerenone|eplerenone|mesh-list
14611542|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14611543|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
14611544|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611545|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611546|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14611547|NCT00082589|Diuretics|diuretics|mesh-ancestor
14611548|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
14611549|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14611550|NCT00082602|Galantamine|galantamine|mesh-list
15180753|NCT03936023|Hormones|hormones|mesh-ancestor
14611551|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14611552|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611553|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611554|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
14611555|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162434|NCT04107194|Amoxicillin|amoxicillin|mesh-list
15162435|NCT04107194|Metronidazole|metronidazole|mesh-list
15162436|NCT04107194|Clarithromycin|clarithromycin|mesh-list
15162437|NCT04107194|Levofloxacin|levofloxacin|mesh-list
15162438|NCT04107194|Tetracycline|tetracycline|mesh-list
15162439|NCT04107194|Rifabutin|rifabutin|mesh-list
15162440|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
15162441|NCT04107194|Pantoprazole|pantoprazole|mesh-list
15162442|NCT04107194|Bismuth|bismuth|mesh-list
15162443|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15162444|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162445|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15162446|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15162447|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15162448|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162449|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611556|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611557|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14611558|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
14611559|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611560|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
14611561|NCT00082667|Gefitinib|gefitinib|mesh-list
14611562|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611563|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14611564|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611565|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162450|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15162451|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15162452|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15162453|NCT04107194|Renal Agents|renal agents|mesh-ancestor
15162454|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15162455|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15162456|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162457|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15162458|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15162459|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15162460|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15162461|NCT04107194|Antacids|antacids|mesh-ancestor
15162462|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15162463|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
15162464|NCT04107220|Valsartan|valsartan|mesh-list
15162465|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15162466|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15162467|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15162468|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162469|NCT04107103|Nivolumab|nivolumab|mesh-list
15162470|NCT04107103|Pemetrexed|pemetrexed|mesh-list
15162471|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611585|NCT00082719|Interferons|interferons|mesh-list
14611586|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
14611587|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
15162472|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162473|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15162474|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162475|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162476|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14611588|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611589|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
14611590|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611591|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
14611592|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162477|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15162478|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
15162479|NCT04106830|Azathioprine|azathioprine|mesh-list
15162480|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162481|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
15162482|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162483|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162484|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14611593|NCT00082784|Bortezomib|bortezomib|mesh-list
14611594|NCT00082784|Alvocidib|alvocidib|mesh-list
14611595|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611596|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
15162485|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15162486|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
15162487|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611597|NCT00082784|Growth Substances|growth substances|mesh-ancestor
14611598|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611599|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14611600|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611601|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611602|NCT00082797|Leucovorin|leucovorin|mesh-list
14611603|NCT00082797|Methotrexate|methotrexate|mesh-list
14611604|NCT00082797|Calcium|calcium|mesh-list
14611605|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
14611606|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14611607|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611608|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14611609|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
14611610|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14611611|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15162488|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162489|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162490|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162491|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
15162492|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15162493|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162494|NCT04106752|Caffeine|caffeine|mesh-list
15162495|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15162496|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162497|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15162498|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162499|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162500|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15162501|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15162502|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
15162503|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162504|NCT04106700|Apixaban|apixaban|mesh-list
15162505|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14611612|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
14611613|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611614|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611615|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
14611616|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611617|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14611618|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611619|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
15162506|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
15162507|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15162508|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
15162509|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162510|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611620|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611621|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14611622|NCT00082797|Antidotes|antidotes|mesh-ancestor
14611623|NCT00082797|Protective Agents|protective agents|mesh-ancestor
14611624|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
14611625|NCT00082797|Vitamins|vitamins|mesh-ancestor
14611626|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
14611627|NCT00082823|Aflibercept|aflibercept|mesh-list
14611628|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611629|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611630|NCT00082823|Growth Substances|growth substances|mesh-ancestor
14611631|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611632|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611633|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645714|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14645715|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14645716|NCT00195364|Analgesics|analgesics|mesh-ancestor
14645717|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
14645718|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645719|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645720|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645721|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645722|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14645723|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162511|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
15162512|NCT04106804|Abatacept|abatacept|mesh-list
14611634|NCT00082836|Rituximab|rituximab|mesh-list
14611635|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611636|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611637|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
14611638|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611639|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162513|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15162514|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162515|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162516|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162517|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
14611640|NCT00082862|Gemcitabine|gemcitabine|mesh-list
14611641|NCT00082862|Interferons|interferons|mesh-list
14611642|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
14611643|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611644|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611645|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
14611646|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611647|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
14611648|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611649|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611650|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611651|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
14611652|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611653|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
14611654|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611655|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
14611656|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14611657|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611658|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
14611659|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611660|NCT00082966|Bortezomib|bortezomib|mesh-list
14611661|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611662|NCT00083005|Thalidomide|thalidomide|mesh-list
14611663|NCT00083005|Docetaxel|docetaxel|mesh-list
14611664|NCT00083005|Estramustine|estramustine|mesh-list
14611665|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611666|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14611667|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14611668|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611669|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611670|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611671|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
14611672|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611673|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
15162518|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162519|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611674|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611675|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611676|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611677|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611678|NCT00083005|Growth Substances|growth substances|mesh-ancestor
14611679|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611680|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611681|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
14611682|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14611683|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
14611684|NCT00083031|Bevacizumab|bevacizumab|mesh-list
14611685|NCT00083031|Methotrexate|methotrexate|mesh-list
14611686|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611687|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
14611688|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162520|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15162521|NCT04106557|Gaboxadol|gaboxadol|mesh-list
15162522|NCT04106557|Analgesics|analgesics|mesh-ancestor
15162523|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
15162524|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162525|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162526|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
15162527|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
15162528|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
15162529|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162530|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022180|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14611689|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611690|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611691|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
14611692|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611693|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611694|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14611695|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611696|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611697|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611698|NCT00083031|Growth Substances|growth substances|mesh-ancestor
14611699|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611700|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14611701|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
14611702|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14611703|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611704|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
14611705|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
14611706|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611707|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14611708|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14611709|NCT00083057|Paclitaxel|paclitaxel|mesh-list
14611710|NCT00083057|Gefitinib|gefitinib|mesh-list
14611711|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611712|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611713|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14611714|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14611715|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611716|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611717|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14611718|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611719|NCT00083070|Temozolomide|temozolomide|mesh-list
14611720|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611721|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
14611722|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611723|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611724|NCT00083083|Paclitaxel|paclitaxel|mesh-list
14611725|NCT00083083|Etoposide|etoposide|mesh-list
14611726|NCT00083083|Vinorelbine|vinorelbine|mesh-list
14611727|NCT00083083|Vinblastine|vinblastine|mesh-list
14611728|NCT00083083|Docetaxel|docetaxel|mesh-list
14611729|NCT00083083|Carboplatin|carboplatin|mesh-list
14611730|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14611731|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611732|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611733|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14611734|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14611735|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14611736|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611737|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611738|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611739|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611740|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14611741|NCT00083096|Temozolomide|temozolomide|mesh-list
14611742|NCT00083096|Lonafarnib|lonafarnib|mesh-list
14611743|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611744|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
14611745|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611746|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611747|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611748|NCT00083109|Suramin|suramin|mesh-list
14611749|NCT00083109|Fluorouracil|fluorouracil|mesh-list
14611750|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
14611751|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611752|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611753|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611754|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611755|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
15162531|NCT04106726|Ivermectin|ivermectin|mesh-list
15162532|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15162533|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162534|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15162535|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162536|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15162537|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
15162538|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
14611756|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611757|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
14611758|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
14611759|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14611760|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611761|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14611762|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14611763|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14611764|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611765|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611766|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611767|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14611768|NCT00083148|Capecitabine|capecitabine|mesh-list
14611769|NCT00083148|Irinotecan|irinotecan|mesh-list
14611770|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611771|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
14611772|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611773|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611774|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14611775|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611776|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611777|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
14611778|NCT00083161|Etoposide|etoposide|mesh-list
14611779|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611780|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
14611781|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611782|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611783|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611784|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
14611785|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611786|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611787|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14611788|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611789|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611790|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611791|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611792|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
14611793|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611794|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
14611795|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611796|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611797|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14611798|NCT00083213|Aflibercept|aflibercept|mesh-list
14611799|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15162539|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162540|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
15162541|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14611800|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611801|NCT00083213|Growth Substances|growth substances|mesh-ancestor
14611802|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611803|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611804|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611805|NCT00083252|Cisplatin|cisplatin|mesh-list
14611806|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611807|NCT00083278|Ipilimumab|ipilimumab|mesh-list
14611808|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14611809|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611810|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14611811|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611812|NCT00083304|Efaproxiral|efaproxiral|mesh-list
14611813|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
14611814|NCT00083343|Caspofungin|caspofungin|mesh-list
14611815|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
14611816|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611817|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611818|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611819|NCT00083408|Pamidronate|pamidronate|mesh-list
14611820|NCT00083408|Thalidomide|thalidomide|mesh-list
14611821|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611822|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
14611823|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611824|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611825|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611826|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611827|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611828|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611829|NCT00083408|Growth Substances|growth substances|mesh-ancestor
15162542|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611830|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611831|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611832|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14611833|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
14611834|NCT00083434|Hematinics|hematinics|mesh-ancestor
14611835|NCT00083460|Thalidomide|thalidomide|mesh-list
14611836|NCT00083460|Dexamethasone|dexamethasone|mesh-list
14611837|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611838|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
14611839|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
14611840|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611841|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611842|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14611843|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
14611844|NCT00083460|Hormones|hormones|mesh-ancestor
14611845|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611846|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14611847|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611848|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611849|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
14611850|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611851|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611852|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611853|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611854|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611855|NCT00083460|Growth Substances|growth substances|mesh-ancestor
14611856|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611857|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
14611858|NCT00083486|Hematinics|hematinics|mesh-ancestor
14611859|NCT00083525|Capecitabine|capecitabine|mesh-list
14611860|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14611861|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
14611862|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611863|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611864|NCT00083538|Thalidomide|thalidomide|mesh-list
14611865|NCT00083538|Dexamethasone|dexamethasone|mesh-list
14611866|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
14611867|NCT00083538|Etoposide|etoposide|mesh-list
14611868|NCT00083538|Doxorubicin|doxorubicin|mesh-list
15162543|NCT04106362|Cisplatin|cisplatin|mesh-list
15162544|NCT04106362|Cetuximab|cetuximab|mesh-list
15162545|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15162546|NCT04106362|Antibodies|antibodies|mesh-list
15162547|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
15162548|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15162549|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
15162550|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162551|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611869|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14611870|NCT00083538|Cisplatin|cisplatin|mesh-list
14611871|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611872|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
14611873|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611874|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162552|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
15162553|NCT04105985|Tetracaine|tetracaine|mesh-list
15162554|NCT04105985|Carticaine|carticaine|mesh-list
14611875|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611876|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
14611877|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162555|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
15162556|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
15162557|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162558|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162559|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
14611878|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611879|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14611880|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611881|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
14611882|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
14611883|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611884|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14611885|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
14611886|NCT00083538|Hormones|hormones|mesh-ancestor
14611887|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611888|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14611889|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15162560|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611890|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14611891|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611892|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611893|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14611894|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611895|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611896|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611897|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611898|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611899|NCT00083538|Growth Substances|growth substances|mesh-ancestor
14611900|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611901|NCT00083577|Thalidomide|thalidomide|mesh-list
14611902|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611903|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
14611904|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611905|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611906|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611907|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611908|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611909|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611910|NCT00083577|Growth Substances|growth substances|mesh-ancestor
14611911|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611912|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162561|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15162562|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15162563|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
15162564|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162565|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162566|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
15162567|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
15162568|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
15162569|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15162570|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
15162571|NCT04106011|Gabapentin|gabapentin|mesh-list
15162572|NCT04106011|Analgesics|analgesics|mesh-ancestor
15162573|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
15162574|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162575|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162576|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
15162577|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15162578|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15162579|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162580|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15162581|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14611913|NCT00083590|Huperzine A|huperzine a|mesh-list
14611914|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14611915|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611916|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611917|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
15162582|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15162583|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162584|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162585|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
15162586|NCT04106050|Lidocaine|lidocaine|mesh-list
15162587|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
15162588|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
15162589|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162590|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611918|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14611919|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611920|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14611921|NCT00083590|Protective Agents|protective agents|mesh-ancestor
14611922|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14611923|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14611924|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14611925|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14611926|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611927|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14611928|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14611929|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14611930|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
14611931|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14611932|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162591|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
14611933|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14611934|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14611935|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
14611936|NCT00083681|Thalidomide|thalidomide|mesh-list
14611937|NCT00083681|Dexamethasone|dexamethasone|mesh-list
14611938|NCT00083681|Etoposide|etoposide|mesh-list
14611939|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
14611940|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611941|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14611942|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
14611943|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
14611944|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14611945|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611946|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14611947|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
14611948|NCT00083681|Hormones|hormones|mesh-ancestor
14611949|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14611950|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14611951|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14611952|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15162592|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162593|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15162594|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15162595|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15162596|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14611953|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14611954|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14611955|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14611956|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611957|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
14611958|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14611959|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14611960|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
14611961|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14611962|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611963|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611964|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611965|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611966|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611967|NCT00083681|Growth Substances|growth substances|mesh-ancestor
14611968|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611969|NCT00083694|Thalidomide|thalidomide|mesh-list
14611970|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611971|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
14611972|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611973|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611974|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611975|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162597|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162598|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
15162599|NCT04105946|Remifentanil|remifentanil|mesh-list
15162600|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14611976|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611977|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611978|NCT00083694|Growth Substances|growth substances|mesh-ancestor
14611979|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611980|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611981|NCT00083707|Thalidomide|thalidomide|mesh-list
14611982|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14611983|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
14611984|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611985|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
14611986|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14611987|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14611988|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14611989|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14611990|NCT00083707|Growth Substances|growth substances|mesh-ancestor
14611991|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14611992|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611993|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14611994|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
14611995|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14611996|NCT00083785|Talaporfin|talaporfin|mesh-list
14611997|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14611998|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14611999|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14612000|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14612001|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
14612002|NCT00083824|Estrogens|estrogens|mesh-list
14612003|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14612004|NCT00083824|Hormones|hormones|mesh-ancestor
14612005|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612006|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162601|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162602|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162603|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15162604|NCT04105946|Analgesics|analgesics|mesh-ancestor
15162605|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
15162606|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612007|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14612008|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14612009|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14612010|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
14612011|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14612012|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14612013|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14612014|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14612015|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14612016|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612017|NCT00083876|Thalidomide|thalidomide|mesh-list
14612018|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612019|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
14612020|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612021|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
14612022|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612023|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612024|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14612025|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14612026|NCT00083876|Growth Substances|growth substances|mesh-ancestor
14612027|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
14612028|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612029|NCT00083902|Thalidomide|thalidomide|mesh-list
14612030|NCT00083902|Dexamethasone|dexamethasone|mesh-list
14612031|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612032|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
14612033|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
14612034|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612035|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612036|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14612037|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
14612038|NCT00083902|Hormones|hormones|mesh-ancestor
15162607|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15162608|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14612039|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612040|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14612041|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612042|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612043|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
14612044|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
14612045|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612046|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612047|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14612048|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14612049|NCT00083902|Growth Substances|growth substances|mesh-ancestor
14612050|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
14612051|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14612052|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
14612053|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612054|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14612055|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14612056|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612057|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612058|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14612059|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14612060|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14612061|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14612062|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162609|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14612063|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612064|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612065|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14612066|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
14612067|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612068|NCT00083993|Sirolimus|sirolimus|mesh-list
14612069|NCT00083993|Letrozole|letrozole|mesh-list
14612070|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612071|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14612072|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14612073|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612074|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612075|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14612076|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
14612077|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612078|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612079|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15162610|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
15162611|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162612|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162613|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15162614|NCT04105946|Narcotics|narcotics|mesh-ancestor
15162615|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15162616|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
15162617|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15162618|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
15162619|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162620|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
15162621|NCT04105920|Protective Agents|protective agents|mesh-ancestor
14612080|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612081|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14612082|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
14612083|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612084|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
14612085|NCT00084019|Ritonavir|ritonavir|mesh-list
14612086|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14612087|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14612088|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14612089|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
14612090|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612091|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612092|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14612093|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14612094|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
14612095|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612096|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14612097|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14612098|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14612099|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
14612100|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612101|NCT00084058|Ritonavir|ritonavir|mesh-list
14612102|NCT00084058|Lopinavir|lopinavir|mesh-list
14612103|NCT00084058|Saquinavir|saquinavir|mesh-list
14612104|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14612105|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14612106|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
14612107|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612108|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612109|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14612110|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14612111|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
14612112|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612113|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14612114|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14612115|NCT00084097|Omalizumab|omalizumab|mesh-list
14612116|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14612117|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14612118|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
14612119|NCT00084201|Amoxicillin|amoxicillin|mesh-list
14612120|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612121|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612122|NCT00084214|Paclitaxel|paclitaxel|mesh-list
14612123|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14612124|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162622|NCT04105764|Bromides|bromides|mesh-list
14612125|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612126|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612127|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612128|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612129|NCT00084227|Azithromycin|azithromycin|mesh-list
14612130|NCT00084227|Chloroquine|chloroquine|mesh-list
15162623|NCT04105764|Rocuronium|rocuronium|mesh-list
15162624|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15162625|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
15162626|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15162627|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15162628|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162629|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162630|NCT04105374|Flucytosine|flucytosine|mesh-list
15162631|NCT04105374|Temozolomide|temozolomide|mesh-list
15162632|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15162633|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
15162634|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162635|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162636|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
15162637|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162638|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
15162639|NCT04105426|Antioxidants|antioxidants|mesh-list
14612131|NCT00084227|Atovaquone|atovaquone|mesh-list
14612132|NCT00084227|Proguanil|proguanil|mesh-list
14612133|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14612134|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612135|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612136|NCT00084227|Amebicides|amebicides|mesh-ancestor
14612137|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14612138|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14612139|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
14612140|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612141|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612142|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612143|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
14612144|NCT00084240|Azithromycin|azithromycin|mesh-list
14612145|NCT00084240|Chloroquine|chloroquine|mesh-list
14612146|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14612147|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
14612148|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
14612149|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14612150|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612151|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612152|NCT00084240|Amebicides|amebicides|mesh-ancestor
14612153|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14612154|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14612155|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
14612156|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612157|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14612158|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612159|NCT00084240|Analgesics|analgesics|mesh-ancestor
14612160|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
14612161|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612162|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612163|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612164|NCT00084240|Filaricides|filaricides|mesh-ancestor
14612165|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
14612166|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
14612167|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14612168|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612169|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612170|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14612171|NCT00084240|Renal Agents|renal agents|mesh-ancestor
14612172|NCT00084279|Interferons|interferons|mesh-list
14612173|NCT00084279|Ribavirin|ribavirin|mesh-list
14612174|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
14612175|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
14612176|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
14612177|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612178|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
14612179|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612180|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
14612181|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612182|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
15162640|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612183|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612184|NCT00084370|Celecoxib|celecoxib|mesh-list
14645724|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
14612185|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14612186|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612187|NCT00084370|Analgesics|analgesics|mesh-ancestor
14612188|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
14612189|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612190|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612191|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612192|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612193|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14612194|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14612195|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612196|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612197|NCT00084396|Letrozole|letrozole|mesh-list
14612198|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612199|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14612200|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14612201|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612202|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612203|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14612204|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
14612205|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612206|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612207|NCT00084435|Docetaxel|docetaxel|mesh-list
14612208|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612209|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612210|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
15162641|NCT04105426|Protective Agents|protective agents|mesh-ancestor
15162642|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162643|NCT04105140|Oxytocin|oxytocin|mesh-list
15162644|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
15162645|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14612211|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612212|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612213|NCT00084448|Celecoxib|celecoxib|mesh-list
14612214|NCT00084448|Paclitaxel|paclitaxel|mesh-list
14612215|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14612216|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612217|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612218|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612219|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612220|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612221|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14612222|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612223|NCT00084448|Analgesics|analgesics|mesh-ancestor
14612224|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
14612225|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612226|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612227|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612228|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612229|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14612230|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15162646|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162647|NCT04105231|Cannabidiol|cannabidiol|mesh-list
15162648|NCT04105231|Risperidone|risperidone|mesh-list
14612231|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612232|NCT00084461|Romidepsin|romidepsin|mesh-list
14612233|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14612234|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612235|NCT00084513|Trastuzumab|trastuzumab|mesh-list
14612236|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
14612237|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612238|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612239|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612240|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612241|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612242|NCT00084565|Paclitaxel|paclitaxel|mesh-list
14612243|NCT00084565|Topotecan|topotecan|mesh-list
14612244|NCT00084565|Estramustine|estramustine|mesh-list
14612245|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14612246|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612247|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
15162649|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15162650|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
15162651|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182225|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612248|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612249|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612250|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612251|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14612252|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14612253|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612254|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14612255|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
14612256|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14612257|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
14612258|NCT00084578|Celecoxib|celecoxib|mesh-list
14612259|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14612260|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612261|NCT00084578|Analgesics|analgesics|mesh-ancestor
14612262|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
15162652|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162653|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162654|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15162655|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15162656|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612263|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612264|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612265|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612266|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612267|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14612268|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14612269|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612270|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612271|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14612272|NCT00084591|Capecitabine|capecitabine|mesh-list
14612273|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612274|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
14612275|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612276|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612277|NCT00084604|Bevacizumab|bevacizumab|mesh-list
14612278|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14612279|NCT00084604|Irinotecan|irinotecan|mesh-list
14612280|NCT00084604|Antibodies|antibodies|mesh-list
14612281|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
14612282|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14612283|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612284|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14612285|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14612286|NCT00084604|Growth Substances|growth substances|mesh-ancestor
14612287|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612288|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
14612289|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
14612290|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14612291|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14612292|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612293|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612294|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
14612295|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612296|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612297|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612298|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645725|NCT00195377|Etanercept|etanercept|mesh-list
15162657|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15162658|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15162659|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
15162660|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
15162661|NCT04105205|Apramycin|apramycin|mesh-list
15162662|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15162663|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162664|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
15162665|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15162666|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180754|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180755|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180756|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15180757|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
14645726|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15180758|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612299|NCT00084643|Capecitabine|capecitabine|mesh-list
14612300|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
14612301|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612302|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
14612303|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612304|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612305|NCT00084669|Zolpidem|zolpidem|mesh-list
14612306|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14612307|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14612308|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14612309|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14612310|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162667|NCT04105023|Genistein|genistein|mesh-list
15162668|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15162669|NCT04105023|Protective Agents|protective agents|mesh-ancestor
14612311|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612312|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612313|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14612314|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
14612315|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612316|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14612317|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14612318|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612319|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14612320|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
14612321|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
14612322|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
14612323|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
14612324|NCT00084695|Melphalan|melphalan|mesh-list
15162670|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162671|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162672|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612325|NCT00084695|Busulfan|busulfan|mesh-list
14612326|NCT00084695|Fludarabine|fludarabine|mesh-list
14612327|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
14612328|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14612329|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612330|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
14612331|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612332|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612333|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14612334|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
14612335|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612336|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612337|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14612338|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612339|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
14612340|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612341|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
14612342|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
14612343|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612344|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14612345|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
14612346|NCT00084695|Hormones|hormones|mesh-ancestor
15162673|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162674|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162675|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
15162676|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15162677|NCT04105023|Estrogens|estrogens|mesh-ancestor
15162678|NCT04105023|Hormones|hormones|mesh-ancestor
15162679|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162680|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
15162681|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15162682|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162683|NCT04104867|Domperidone|domperidone|mesh-list
15162684|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
15162685|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
15162686|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162687|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162688|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15162689|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15162690|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
15162691|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612347|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182226|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15162692|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162693|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
14612348|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14612349|NCT00084695|Protective Agents|protective agents|mesh-ancestor
14612350|NCT00084708|Calcitriol|calcitriol|mesh-list
14612351|NCT00084708|Dexamethasone|dexamethasone|mesh-list
14612352|NCT00084708|Gefitinib|gefitinib|mesh-list
14612353|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612354|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
14612355|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
14612356|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612357|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612358|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14612359|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
14612360|NCT00084708|Hormones|hormones|mesh-ancestor
14612361|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612362|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14612363|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612364|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612365|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612366|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612367|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14612368|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14612369|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14612370|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14612371|NCT00084708|Vitamins|vitamins|mesh-ancestor
14612372|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
14612373|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14612374|NCT00084721|Celecoxib|celecoxib|mesh-list
14612375|NCT00084721|Irinotecan|irinotecan|mesh-list
14612376|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15162694|NCT04104984|Progesterone|progesterone|mesh-list
15162695|NCT04104984|Progestins|progestins|mesh-ancestor
15162696|NCT04104984|Hormones|hormones|mesh-ancestor
15162697|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162698|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612377|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14612378|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612379|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612380|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612381|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14612382|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612383|NCT00084721|Analgesics|analgesics|mesh-ancestor
14612384|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
14612385|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612386|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612387|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612388|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612389|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14612390|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14612391|NCT00084734|Docetaxel|docetaxel|mesh-list
14612392|NCT00084734|Capecitabine|capecitabine|mesh-list
14612393|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612394|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612395|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612396|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612397|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612398|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612399|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
14612400|NCT00084773|Fluorouracil|fluorouracil|mesh-list
14612401|NCT00084773|Cetuximab|cetuximab|mesh-list
14612402|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
14612403|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612404|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612405|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612406|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612407|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
14612408|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612409|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612410|NCT00084786|Docetaxel|docetaxel|mesh-list
14612411|NCT00084786|Gefitinib|gefitinib|mesh-list
14612412|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612413|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182227|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14612414|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612415|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612416|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612417|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612418|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612419|NCT00084812|Safingol|safingol|mesh-list
14612420|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612421|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612422|NCT00084825|Docetaxel|docetaxel|mesh-list
14612423|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
14612424|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612425|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612426|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612427|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612428|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612429|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612430|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612431|NCT00084877|Irinotecan|irinotecan|mesh-list
14612432|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14612433|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15162699|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15162700|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
15162701|NCT04104789|Tetracaine|tetracaine|mesh-list
15162702|NCT04104789|Carticaine|carticaine|mesh-list
15162703|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
15162704|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
15162705|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162706|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162707|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
15162708|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162709|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14612434|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612435|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612436|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612437|NCT00084890|Carboplatin|carboplatin|mesh-list
14612438|NCT00084890|Docetaxel|docetaxel|mesh-list
14612439|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612440|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612441|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612442|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612443|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612444|NCT00084916|Sirolimus|sirolimus|mesh-list
14612445|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612446|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612447|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14612448|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612449|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
14612450|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612451|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
14612452|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612453|NCT00084942|Gemcitabine|gemcitabine|mesh-list
14612454|NCT00084942|Capecitabine|capecitabine|mesh-list
14612455|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612456|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
14612457|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612458|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612459|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
14612460|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612461|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612462|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612463|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
14612464|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612465|NCT00084981|Decitabine|decitabine|mesh-list
14612466|NCT00084981|Azacitidine|azacitidine|mesh-list
14612467|NCT00084981|Valproic Acid|valproic acid|mesh-list
14612468|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612469|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
14612470|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612471|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612472|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612473|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
14612474|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
14612475|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612476|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612477|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
14612478|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15162710|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15162711|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
14612479|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612480|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612481|NCT00085020|Trastuzumab|trastuzumab|mesh-list
14612482|NCT00085020|Lapatinib|lapatinib|mesh-list
14612483|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612484|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612485|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612486|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612487|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612488|NCT00085111|Bevacizumab|bevacizumab|mesh-list
14612489|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14612490|NCT00085111|Antibodies|antibodies|mesh-list
14612491|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
14612492|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14612493|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612494|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14612495|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14612496|NCT00085111|Growth Substances|growth substances|mesh-ancestor
15162712|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162713|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162714|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
15162715|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
15162716|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
15162717|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15162718|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
15162719|NCT04104204|Morphine|morphine|mesh-list
15162720|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14612497|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612498|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
14612499|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
14612500|NCT00085124|Cytarabine|cytarabine|mesh-list
14612501|NCT00085124|Daunorubicin|daunorubicin|mesh-list
14612502|NCT00085124|Oblimersen|oblimersen|mesh-list
14612503|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612504|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
14612505|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612506|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612507|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
14612508|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612509|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612510|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
14612511|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612512|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14612513|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14612514|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14612515|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612516|NCT00085150|Immunotoxins|immunotoxins|mesh-list
14612517|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
14612518|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612519|NCT00085163|Leucovorin|leucovorin|mesh-list
14612520|NCT00085163|Celecoxib|celecoxib|mesh-list
14612521|NCT00085163|Fluorouracil|fluorouracil|mesh-list
14612522|NCT00085163|Calcium|calcium|mesh-list
14612523|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
14612524|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14612525|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612526|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
14612527|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612528|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612529|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612530|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612531|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
14612532|NCT00085163|Antidotes|antidotes|mesh-ancestor
14612533|NCT00085163|Protective Agents|protective agents|mesh-ancestor
14612534|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
14612535|NCT00085163|Vitamins|vitamins|mesh-ancestor
14612536|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
14612537|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14612538|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612539|NCT00085163|Analgesics|analgesics|mesh-ancestor
14612540|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
14612541|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612542|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612543|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612544|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14612545|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14612546|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612547|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
15162721|NCT04104204|Narcotics|narcotics|mesh-ancestor
15162722|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162723|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162724|NCT04104204|Analgesics|analgesics|mesh-ancestor
15162725|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
15162726|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162727|NCT04104438|Everolimus|everolimus|mesh-list
15162728|NCT04104438|Basiliximab|basiliximab|mesh-list
15162729|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162730|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162731|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
15162732|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162733|NCT04104334|Remifentanil|remifentanil|mesh-list
14612548|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14612549|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
14612550|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612551|NCT00085228|Docetaxel|docetaxel|mesh-list
14612552|NCT00085228|Oblimersen|oblimersen|mesh-list
14612553|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612554|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612555|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612556|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612557|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612558|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14612559|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612560|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612561|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612562|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612563|NCT00085306|Interferons|interferons|mesh-list
14612564|NCT00085306|Interferon-beta|interferon-beta|mesh-list
14612565|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612566|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
14612567|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612568|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
14612569|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612570|NCT00085332|Docetaxel|docetaxel|mesh-list
14612571|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162734|NCT04104334|Desflurane|desflurane|mesh-list
15162735|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
14612572|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612573|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612574|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612575|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612576|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
14612577|NCT00085345|Melphalan|melphalan|mesh-list
14612578|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
14612579|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14612580|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
14612581|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612582|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612583|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14612584|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612585|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
14612586|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612587|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
14612588|NCT00085345|Protective Agents|protective agents|mesh-ancestor
14612589|NCT00085345|Vitamins|vitamins|mesh-ancestor
14612590|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
14612591|NCT00085358|Paclitaxel|paclitaxel|mesh-list
14612592|NCT00085358|Docetaxel|docetaxel|mesh-list
14612593|NCT00085358|Bevacizumab|bevacizumab|mesh-list
14612594|NCT00085358|Carboplatin|carboplatin|mesh-list
14612595|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15162736|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162737|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162738|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14612596|NCT00085358|Antibodies|antibodies|mesh-list
14612597|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
14612598|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14612599|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14612600|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612601|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612602|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612603|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612604|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162739|NCT04104334|Narcotics|narcotics|mesh-ancestor
14612605|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14612606|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14612607|NCT00085358|Growth Substances|growth substances|mesh-ancestor
14612608|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612609|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
14612610|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
14612611|NCT00085384|Interferons|interferons|mesh-list
14612612|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
14612613|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
14612614|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14612615|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612616|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
14612617|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612618|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
14612619|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612620|NCT00085449|Cyclosporine|cyclosporine|mesh-list
14612621|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
14612622|NCT00085449|Fludarabine|fludarabine|mesh-list
14612623|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
14612624|NCT00085449|Melphalan|melphalan|mesh-list
14612625|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
14612626|NCT00085449|Cyclosporins|cyclosporins|mesh-list
14612627|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612628|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612629|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
14612630|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612631|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612632|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
14612633|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612634|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612635|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
14612636|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612637|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
14612638|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612639|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14612640|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14612641|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14612642|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
14612643|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612644|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14612645|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
14612646|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14612647|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612648|NCT00085462|Aldesleukin|aldesleukin|mesh-list
14612649|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
14612650|NCT00085462|Fludarabine|fludarabine|mesh-list
14612651|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
14612652|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612653|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
14612654|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612655|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612656|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14612657|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
14612658|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612659|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612660|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14612661|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612662|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
14612663|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14612664|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14612665|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
14612666|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612667|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
14612668|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612669|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612670|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612671|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612672|NCT00085501|Paclitaxel|paclitaxel|mesh-list
14612673|NCT00085501|Carboplatin|carboplatin|mesh-list
14612674|NCT00085501|Cetuximab|cetuximab|mesh-list
14612675|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14612676|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612677|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612678|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612679|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612680|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612681|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612682|NCT00085527|Romidepsin|romidepsin|mesh-list
14612683|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14612684|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612685|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14612686|NCT00085553|Tipifarnib|tipifarnib|mesh-list
14612687|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612688|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14612689|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612690|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612691|NCT00085579|Aldesleukin|aldesleukin|mesh-list
14612692|NCT00085579|Sargramostim|sargramostim|mesh-list
14612693|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
14612694|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612695|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612696|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14612697|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14612698|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
14612699|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612700|NCT00085696|Rituximab|rituximab|mesh-list
14612701|NCT00085696|Bortezomib|bortezomib|mesh-list
14612702|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612703|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612704|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
14612705|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612706|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612707|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14612708|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14612709|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14612710|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612711|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612712|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612713|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14612714|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14612715|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
14612716|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612717|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612718|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14612719|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14612720|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
14612721|NCT00085761|Capsaicin|capsaicin|mesh-list
14612722|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
14612723|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14612724|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
14612725|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612726|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612727|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
14612728|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612729|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14612730|NCT00085826|Protective Agents|protective agents|mesh-ancestor
14612731|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612732|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14612733|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612734|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612735|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14612736|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612737|NCT00085826|Analgesics|analgesics|mesh-ancestor
14612738|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
14612739|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612740|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14612741|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612742|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14612743|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
14612744|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612745|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14612746|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14612747|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612748|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612749|NCT00085943|Ritonavir|ritonavir|mesh-list
14612750|NCT00085943|Lopinavir|lopinavir|mesh-list
14612751|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
14612752|NCT00085943|Lamivudine|lamivudine|mesh-list
14612753|NCT00085943|Abacavir|abacavir|mesh-list
14612754|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14612755|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14612756|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
14612757|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612758|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612759|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14612760|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14612761|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
14612762|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612763|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14612764|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14612765|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14612766|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14612767|NCT00085969|Exenatide|exenatide|mesh-list
14612768|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14612769|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612770|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14612771|NCT00085969|Incretins|incretins|mesh-ancestor
14612772|NCT00085969|Hormones|hormones|mesh-ancestor
14612773|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612774|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
14612775|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612776|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14612777|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14612778|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
14612779|NCT00086086|Hematinics|hematinics|mesh-ancestor
14612780|NCT00086099|Amifostine|amifostine|mesh-list
14612781|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14612782|NCT00086099|Protective Agents|protective agents|mesh-ancestor
14612783|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612784|NCT00086112|Risperidone|risperidone|mesh-list
14612785|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14612786|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
14612787|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612788|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612789|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612790|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14612791|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14612792|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612793|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612794|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14612795|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
14612796|NCT00086125|Sirolimus|sirolimus|mesh-list
14612797|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14612798|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612799|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14612800|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612801|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
14612802|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612803|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
14612804|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612805|NCT00086177|Progesterone|progesterone|mesh-list
14612806|NCT00086177|Progestins|progestins|mesh-ancestor
14612807|NCT00086177|Hormones|hormones|mesh-ancestor
14612808|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612809|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612810|NCT00086203|Rituximab|rituximab|mesh-list
14612811|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612812|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612813|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
14612814|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612815|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612816|NCT00086255|Tiagabine|tiagabine|mesh-list
14612817|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
14612818|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14612819|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14612820|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14612821|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612822|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
14612823|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612824|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612825|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
14612826|NCT00086268|Carboplatin|carboplatin|mesh-list
14612827|NCT00086268|Docetaxel|docetaxel|mesh-list
14612828|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612829|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612830|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612831|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612832|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612833|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14612834|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612835|NCT00086294|Levodopa|levodopa|mesh-list
14612836|NCT00086294|Pimavanserin|pimavanserin|mesh-list
14612837|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14612838|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14612839|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
14612840|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612841|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612842|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612843|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14612844|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14612845|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612846|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612847|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14612848|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14612849|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
14612850|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14612851|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14612852|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14612853|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612854|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612855|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612856|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14612857|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14612858|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
14612859|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612860|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612861|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14612862|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14612863|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
14612864|NCT00086333|Docetaxel|docetaxel|mesh-list
14612865|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612866|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14612867|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14612868|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14612869|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612870|NCT00086359|Ritonavir|ritonavir|mesh-list
14612871|NCT00086359|Lopinavir|lopinavir|mesh-list
14612872|NCT00086359|Lamivudine|lamivudine|mesh-list
14612873|NCT00086359|Zidovudine|zidovudine|mesh-list
14612874|NCT00086359|Abacavir|abacavir|mesh-list
14612875|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14612876|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14612877|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14612878|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
14612879|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612880|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612881|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14612882|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14612883|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
14612884|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612885|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14612886|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14612887|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15162740|NCT04104334|Analgesics|analgesics|mesh-ancestor
15162741|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
15162742|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162743|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15162744|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
15162745|NCT04103684|Dexamethasone|dexamethasone|mesh-list
15162746|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
15162747|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15162748|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15162749|NCT04103684|Prednisolone|prednisolone|mesh-list
15162750|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
15162751|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15162752|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
15162753|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162754|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
15162755|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
15162756|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162757|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162758|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15162759|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
15162760|NCT04103684|Hormones|hormones|mesh-ancestor
15162761|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162762|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14612888|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14612889|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
14612890|NCT00086463|Iloprost|iloprost|mesh-list
14612891|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14612892|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
14612893|NCT00086489|Tremelimumab|tremelimumab|mesh-list
14612894|NCT00086489|Ipilimumab|ipilimumab|mesh-list
14612895|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612896|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612897|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14612898|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612899|NCT00086528|XL647|xl647|mesh-list
14612900|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612901|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15162763|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162764|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15162765|NCT04103684|Protective Agents|protective agents|mesh-ancestor
15162766|NCT04103905|Antibodies|antibodies|mesh-list
15162767|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15162768|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
15162769|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162770|NCT04103697|Capecitabine|capecitabine|mesh-list
15162771|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
15162772|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15162773|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
15162774|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162775|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162776|NCT04103489|Eculizumab|eculizumab|mesh-list
14612902|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612903|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612904|NCT00086541|Interferons|interferons|mesh-list
14612905|NCT00086541|Ribavirin|ribavirin|mesh-list
14612906|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
14612907|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612908|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
14612909|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612910|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
14612911|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612912|NCT00086593|Lamotrigine|lamotrigine|mesh-list
14612913|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
15162777|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15162778|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162779|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
14612914|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14612915|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14612916|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612917|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14612918|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612919|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14612920|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14612921|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14612922|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612923|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14612924|NCT00086606|Omalizumab|omalizumab|mesh-list
14612925|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14612926|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14612927|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
14612928|NCT00086632|Oregovomab|oregovomab|mesh-list
14612929|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612930|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612931|NCT00086645|Dexetimide|dexetimide|mesh-list
14612932|NCT00086645|Citalopram|citalopram|mesh-list
15162780|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162781|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
15162782|NCT04103476|Estrogens|estrogens|mesh-list
15162783|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15162784|NCT04103476|Hormones|hormones|mesh-ancestor
15162785|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162786|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162787|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15162788|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15162789|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
15162790|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14612933|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15162791|NCT04103398|Sorafenib|sorafenib|mesh-list
15162792|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
14612934|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14612935|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14612936|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612937|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14612938|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
14612939|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612940|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14612941|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
15162793|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162794|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15162795|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162796|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612942|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14612943|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14612944|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14612945|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
14612946|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
14612947|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14612948|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14612949|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14612950|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
14612951|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
14612952|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14612953|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14612954|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612955|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14612956|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14612957|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
14612958|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612959|NCT00086736|Eflornithine|eflornithine|mesh-list
14612960|NCT00086736|Bicalutamide|bicalutamide|mesh-list
14612961|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
14612962|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
14612963|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14612964|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612965|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612966|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14612967|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14612968|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14612969|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612970|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14612971|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612972|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645727|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14645728|NCT00195377|Analgesics|analgesics|mesh-ancestor
14645729|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
14645730|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645731|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645732|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645733|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645734|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14645735|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645736|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
14645737|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14645738|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
14645739|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645740|NCT00195416|Etanercept|etanercept|mesh-list
14645741|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14645742|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14645743|NCT00195416|Analgesics|analgesics|mesh-ancestor
14645744|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
14645745|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645746|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645747|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645748|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645749|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14645750|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645751|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
14645752|NCT00195455|Estradiol|estradiol|mesh-list
14645753|NCT00195455|Estrogens|estrogens|mesh-ancestor
14022181|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
14022182|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14645754|NCT00195455|Hormones|hormones|mesh-ancestor
14022183|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14612973|NCT00086775|Rituximab|rituximab|mesh-list
14612974|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
14612975|NCT00086775|Fludarabine|fludarabine|mesh-list
14612976|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
14612977|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14612978|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612979|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
14612980|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14612981|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14612982|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612983|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
14612984|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612985|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612986|NCT00086801|Gemcitabine|gemcitabine|mesh-list
14612987|NCT00086801|Doxorubicin|doxorubicin|mesh-list
14612988|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14612989|NCT00086801|Vinblastine|vinblastine|mesh-list
14612990|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14612991|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14612992|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
14612993|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14612994|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14612995|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
14612996|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14612997|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14612998|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14612999|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
14613000|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613001|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613002|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14613003|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14613004|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14613005|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14613006|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613007|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613008|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613009|NCT00086827|Romidepsin|romidepsin|mesh-list
14613010|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613011|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613012|NCT00086840|Sirolimus|sirolimus|mesh-list
14613013|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613014|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613015|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613016|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613017|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
14613018|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613019|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
14613020|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613021|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14613022|NCT00086879|Temozolomide|temozolomide|mesh-list
14613023|NCT00086879|Carmustine|carmustine|mesh-list
14613024|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613025|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613026|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613027|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613028|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613029|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
14613030|NCT00086892|Carboplatin|carboplatin|mesh-list
14613031|NCT00086892|Cetuximab|cetuximab|mesh-list
14613032|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613033|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14613034|NCT00086931|Capecitabine|capecitabine|mesh-list
14613035|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
14613036|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613037|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
14613038|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613039|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613040|NCT00086944|Rituximab|rituximab|mesh-list
14613041|NCT00086944|Carboplatin|carboplatin|mesh-list
14613042|NCT00086944|Etoposide|etoposide|mesh-list
14613043|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
14613044|NCT00086944|Ifosfamide|ifosfamide|mesh-list
14613045|NCT00086944|Oblimersen|oblimersen|mesh-list
14613046|NCT00086944|Lenograstim|lenograstim|mesh-list
14613047|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14613048|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162797|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14613049|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
14613050|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613051|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613052|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14613053|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14613054|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14613055|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613056|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613057|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14613058|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613059|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
14613060|NCT00086970|Ifosfamide|ifosfamide|mesh-list
14613061|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14613062|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613063|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
14613064|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613065|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613066|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613067|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
14613068|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613069|NCT00087009|Rituximab|rituximab|mesh-list
14613070|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14613071|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613072|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
14613073|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613074|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613075|NCT00087035|Docetaxel|docetaxel|mesh-list
14613076|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14613077|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613078|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613079|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613080|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613081|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613082|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613083|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613084|NCT00087048|Topotecan|topotecan|mesh-list
14613085|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14613086|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14613087|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613088|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613089|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613090|NCT00087074|Sirolimus|sirolimus|mesh-list
14613091|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613092|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613093|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613094|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613095|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
14613096|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613097|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
14613098|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613099|NCT00087087|Pemetrexed|pemetrexed|mesh-list
14613100|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613101|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613102|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613103|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14613104|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14613105|NCT00087100|Pemetrexed|pemetrexed|mesh-list
14613106|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613107|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613108|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613109|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14613110|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14613111|NCT00087113|Pemetrexed|pemetrexed|mesh-list
14613112|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613113|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613114|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613115|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14613116|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14613117|NCT00087165|Prednisone|prednisone|mesh-list
14613118|NCT00087165|Docetaxel|docetaxel|mesh-list
14613119|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613120|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613121|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613122|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613123|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613124|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14613125|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
14613126|NCT00087165|Hormones|hormones|mesh-ancestor
14613127|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14613128|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613129|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613130|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
14613131|NCT00087178|Doxorubicin|doxorubicin|mesh-list
14613132|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14613133|NCT00087178|Fluorouracil|fluorouracil|mesh-list
14613134|NCT00087178|Epirubicin|epirubicin|mesh-list
14613135|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613136|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
14613137|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613138|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613139|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613140|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
14613141|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613142|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613143|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14613144|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613145|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14613146|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14613147|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613148|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
14613149|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613150|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
14613151|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14613152|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14613153|NCT00087217|Paclitaxel|paclitaxel|mesh-list
14613154|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14613155|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613156|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613157|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613158|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613159|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613160|NCT00087256|Celecoxib|celecoxib|mesh-list
14613161|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14613162|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14613163|NCT00087256|Analgesics|analgesics|mesh-ancestor
14613164|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
14613165|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162798|NCT04103398|Estrogens|estrogens|mesh-ancestor
15162799|NCT04103398|Hormones|hormones|mesh-ancestor
15162800|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162801|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162802|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613166|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613167|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14613168|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613169|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14613170|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14613171|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613172|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613173|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14613174|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613175|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613176|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613177|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613178|NCT00087282|Irinotecan|irinotecan|mesh-list
14613179|NCT00087282|Alvocidib|alvocidib|mesh-list
14613180|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14613181|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14613182|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613183|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613184|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613185|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
14613186|NCT00087282|Growth Substances|growth substances|mesh-ancestor
15162803|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
15162804|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15162805|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
15162806|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162807|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
15162808|NCT04103125|Protective Agents|protective agents|mesh-ancestor
15162809|NCT04102995|Pregnanolone|pregnanolone|mesh-list
15162810|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
15162811|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162812|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162813|NCT04102878|Anesthetics|anesthetics|mesh-list
15162814|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
14613187|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613188|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613189|NCT00087295|Romidepsin|romidepsin|mesh-list
14613190|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613191|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613192|NCT00087334|Capecitabine|capecitabine|mesh-list
14613193|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
14613194|NCT00087334|Gefitinib|gefitinib|mesh-list
14613195|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613196|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
14613197|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613198|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613199|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613200|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613201|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14613202|NCT00087347|Hematinics|hematinics|mesh-ancestor
14613203|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14613204|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14613205|NCT00087373|Metronidazole|metronidazole|mesh-list
14613206|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613207|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613208|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14613209|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14613210|NCT00087399|Gabapentin|gabapentin|mesh-list
14613211|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
14613212|NCT00087399|Analgesics|analgesics|mesh-ancestor
14613213|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
14613214|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613215|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613216|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
14613217|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14613218|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613219|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613220|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613221|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14613222|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14613223|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613224|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613225|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
14613226|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14613227|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613228|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613229|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613230|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613231|NCT00087425|Rituximab|rituximab|mesh-list
14613232|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
14613233|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14613234|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613235|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
14613236|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613237|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613238|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14613239|NCT00087451|Sirolimus|sirolimus|mesh-list
14613240|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613241|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613242|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613243|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613244|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
14613245|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613246|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
14613247|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613248|NCT00087464|Tenofovir|tenofovir|mesh-list
14613249|NCT00087464|Emtricitabine|emtricitabine|mesh-list
14613250|NCT00087464|Nevirapine|nevirapine|mesh-list
14613251|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
14613252|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162815|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613253|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14613254|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15162816|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182228|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
14613255|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613256|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613257|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14613258|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14613259|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14613260|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14613261|NCT00087542|Pimavanserin|pimavanserin|mesh-list
14613262|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14613263|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14613264|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613265|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613266|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613267|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613268|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15162817|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
15162818|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162819|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
15162820|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162821|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15162822|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
15162823|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
15162824|NCT04102670|Protective Agents|protective agents|mesh-ancestor
15162825|NCT04102800|Benralizumab|benralizumab|mesh-list
15162826|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15162827|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
15162828|NCT04102943|Tacrolimus|tacrolimus|mesh-list
14613269|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14613270|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14613271|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
14613272|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613273|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613274|NCT00087581|Cyclosporine|cyclosporine|mesh-list
14613275|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
14613276|NCT00087581|Tacrolimus|tacrolimus|mesh-list
14613277|NCT00087581|Cyclosporins|cyclosporins|mesh-list
14613278|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162829|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15162830|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
15162831|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162832|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15162833|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162834|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162835|NCT04102592|Permethrin|permethrin|mesh-list
15162836|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162837|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162838|NCT04102267|Epinephrine|epinephrine|mesh-list
15162839|NCT04102267|Bupivacaine|bupivacaine|mesh-list
15162840|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
15162841|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
14613279|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
14613280|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613281|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14613282|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613283|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613284|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
14613285|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613286|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
15162842|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162843|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162844|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
14022184|NCT02769494|Analgesics|analgesics|mesh-ancestor
15162845|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162846|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15162847|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15162848|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
15162849|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162850|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162851|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15162852|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15162853|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
15162854|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15162855|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
15162856|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
15162857|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
15162858|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14613287|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613288|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613289|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613290|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14613291|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
14613292|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613293|NCT00087620|Capecitabine|capecitabine|mesh-list
14613294|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613295|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
14613296|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613297|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613298|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
14613299|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14613300|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613301|NCT00087711|Gemcitabine|gemcitabine|mesh-list
14613302|NCT00087711|Pemetrexed|pemetrexed|mesh-list
14613303|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613304|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613305|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
14613306|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613307|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
14613308|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613309|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613310|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613311|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
14613312|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613313|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14613314|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14613315|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14613316|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14613317|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613318|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613319|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613320|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613321|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613322|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14613323|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
14613324|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613325|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14613326|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
14613327|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613328|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613329|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613330|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613331|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613332|NCT00087802|Gemcitabine|gemcitabine|mesh-list
14613333|NCT00087802|Paclitaxel|paclitaxel|mesh-list
14613334|NCT00087802|Carboplatin|carboplatin|mesh-list
14613335|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
14613336|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14613337|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613338|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613339|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613340|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613341|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613342|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613343|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
14613344|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
14613345|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613346|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613347|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613348|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
14613349|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613350|NCT00087815|Dexamethasone|dexamethasone|mesh-list
14613351|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14613352|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
14613353|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
14613354|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613355|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613356|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613357|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
14613358|NCT00087815|Hormones|hormones|mesh-ancestor
14613359|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14613360|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613361|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613362|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14613363|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613364|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613365|NCT00087854|Amonafide|amonafide|mesh-list
14613366|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613367|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
14613368|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613369|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613370|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613371|NCT00087867|Bortezomib|bortezomib|mesh-list
14613372|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613373|NCT00087880|Bupropion|bupropion|mesh-list
14613374|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14613375|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
14613376|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613377|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14613378|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613379|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613380|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613381|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
14613382|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613383|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613384|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14613385|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14613386|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613387|NCT00087945|Lamivudine|lamivudine|mesh-list
14613388|NCT00087945|Zidovudine|zidovudine|mesh-list
14613389|NCT00087945|Abacavir|abacavir|mesh-list
14613390|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
14613391|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14613392|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14613393|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613394|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613395|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
14613396|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613397|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14613398|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14613399|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
14613400|NCT00088036|Olanzapine|olanzapine|mesh-list
14613401|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
14613402|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
14613403|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613404|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613405|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613406|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613407|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613408|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613409|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613410|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14613411|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613412|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613413|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613414|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613415|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
14613416|NCT00088049|Olanzapine|olanzapine|mesh-list
14613417|NCT00088049|Aripiprazole|aripiprazole|mesh-list
14613418|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
14613419|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
14613420|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162859|NCT04102449|Apremilast|apremilast|mesh-list
15162860|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15162861|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15162862|NCT04102449|Analgesics|analgesics|mesh-ancestor
15162863|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
15162864|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162865|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162866|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162867|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162868|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14022185|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
14613421|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613422|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613423|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613424|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15162869|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15162870|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162871|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162872|NCT04102566|Ibuprofen|ibuprofen|mesh-list
15162873|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15162874|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15162875|NCT04102566|Analgesics|analgesics|mesh-ancestor
15162876|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
15162877|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162878|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162879|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162880|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162881|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15162882|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162883|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162884|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
15162885|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
15162886|NCT04102176|Protective Agents|protective agents|mesh-ancestor
15162887|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162888|NCT04101929|Irinotecan|irinotecan|mesh-list
15162889|NCT04101929|Apatinib|apatinib|mesh-list
15162890|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15162891|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15162892|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162893|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613425|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613426|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613427|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14613428|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613429|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613430|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613431|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613432|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
14613433|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
14613434|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
14613435|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
14613436|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14613437|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14613438|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14613439|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14613440|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14613441|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14613442|NCT00088075|Risperidone|risperidone|mesh-list
14613443|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14613444|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
14613445|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613446|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613447|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613448|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613449|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613450|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613451|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613452|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14613453|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
14613454|NCT00088088|Paclitaxel|paclitaxel|mesh-list
14613455|NCT00088088|Carboplatin|carboplatin|mesh-list
14613456|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14613457|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613458|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613459|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613460|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613461|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613462|NCT00088114|Paclitaxel|paclitaxel|mesh-list
14613463|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14613464|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613465|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613466|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
15162894|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162895|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15162896|NCT04102072|Dobutamine|dobutamine|mesh-list
15162897|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14613467|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
15162898|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
15162899|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
14613468|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613469|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
14613470|NCT00088231|Vatalanib|vatalanib|mesh-list
14613471|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613472|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613473|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613474|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613475|NCT00088270|Leucovorin|leucovorin|mesh-list
14613476|NCT00088270|Fluorouracil|fluorouracil|mesh-list
14613477|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
14613478|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613479|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613480|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613481|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613482|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
14613483|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613484|NCT00088270|Antidotes|antidotes|mesh-ancestor
14613485|NCT00088270|Protective Agents|protective agents|mesh-ancestor
14613486|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
14613487|NCT00088270|Vitamins|vitamins|mesh-ancestor
14613488|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
14613489|NCT00088387|Valproic Acid|valproic acid|mesh-list
14613490|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613491|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613492|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613493|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
14613494|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613495|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613496|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613497|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
14613498|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
14613499|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613500|NCT00088478|Olanzapine|olanzapine|mesh-list
14613501|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
14613502|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
14613503|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613504|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613505|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613506|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613507|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613508|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613509|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613510|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14613511|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613512|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613513|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613514|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613515|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
14613516|NCT00088491|Olanzapine|olanzapine|mesh-list
14613517|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
14613518|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
14613519|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613520|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613521|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613522|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613523|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613524|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613525|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613526|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14613527|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613528|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613529|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613530|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613531|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
14613532|NCT00088504|Interferons|interferons|mesh-list
14613533|NCT00088504|Ribavirin|ribavirin|mesh-list
14613534|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
15162900|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162901|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162902|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15162903|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15162904|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15162905|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022186|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613535|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
15162906|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162907|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162908|NCT04102072|Protective Agents|protective agents|mesh-ancestor
15162909|NCT04101838|Vaccines|vaccines|mesh-list
15162910|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
15162911|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162912|NCT04101812|Doxorubicin|doxorubicin|mesh-list
15162913|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15162914|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613536|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14613537|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613538|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
14613539|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613540|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
14613541|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613542|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
14613543|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613544|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
14613545|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14613546|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
14613547|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613548|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613549|NCT00088556|Paclitaxel|paclitaxel|mesh-list
14613550|NCT00088556|Carboplatin|carboplatin|mesh-list
14613551|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14613552|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613553|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613554|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613555|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613556|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613557|NCT00088582|Octreotide|octreotide|mesh-list
15162915|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162916|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14613558|NCT00088582|Pasireotide|pasireotide|mesh-list
14613559|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613560|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613561|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613562|NCT00088582|Hormones|hormones|mesh-ancestor
14613563|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14613564|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613565|NCT00088608|Pasireotide|pasireotide|mesh-list
14613566|NCT00088608|Hormones|hormones|mesh-ancestor
14613567|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14613568|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613569|NCT00088686|Capsaicin|capsaicin|mesh-list
14613570|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
14613571|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
14613572|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
14613573|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613574|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645755|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645756|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645757|NCT00195468|Cyclosporine|cyclosporine|mesh-list
14645758|NCT00195468|Cyclosporins|cyclosporins|mesh-list
14645759|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645760|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645761|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645762|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
14645763|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645764|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
14645765|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645766|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
14645767|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645768|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14645769|NCT00195481|Sirolimus|sirolimus|mesh-list
14645770|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645771|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645772|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14645773|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645774|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
15162917|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15162918|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162919|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162920|NCT04101500|Aminophylline|aminophylline|mesh-list
14645775|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613575|NCT00088816|Tegafur|tegafur|mesh-list
14613576|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613577|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613578|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
14613579|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613580|NCT00088855|Doxorubicin|doxorubicin|mesh-list
14613581|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14613582|NCT00088855|Bortezomib|bortezomib|mesh-list
14613583|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613584|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613585|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14613586|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14613587|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613588|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613589|NCT00088894|Gemcitabine|gemcitabine|mesh-list
14613590|NCT00088894|Bevacizumab|bevacizumab|mesh-list
14613591|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14613592|NCT00088894|Antibodies|antibodies|mesh-list
14613593|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
14613594|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14613595|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613596|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14613597|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14613598|NCT00088894|Growth Substances|growth substances|mesh-ancestor
14613599|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613600|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
14613601|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
14613602|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613603|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
14613604|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613605|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
14613606|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613607|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613608|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613609|NCT00088933|Metronidazole|metronidazole|mesh-list
14613610|NCT00088933|Docetaxel|docetaxel|mesh-list
14613611|NCT00088933|Vaccines|vaccines|mesh-list
14613612|NCT00088933|Sargramostim|sargramostim|mesh-list
14613613|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
14613614|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613615|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613616|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613617|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613618|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613619|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613620|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613621|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613622|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14613623|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14613624|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14613625|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613626|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613627|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613628|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613629|NCT00088959|Celecoxib|celecoxib|mesh-list
14613630|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14613631|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613632|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613633|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613634|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613635|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14613636|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14613637|NCT00088959|Analgesics|analgesics|mesh-ancestor
15162921|NCT04101500|Bromides|bromides|mesh-list
15162922|NCT04101500|Ipratropium|ipratropium|mesh-list
15162923|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
15162924|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15162925|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
15162926|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162927|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162928|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15162929|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
15162930|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15162931|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
15162932|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613638|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
15162933|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162934|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15162935|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15162936|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162937|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15162938|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15162939|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
15162940|NCT04101500|Protective Agents|protective agents|mesh-ancestor
14613639|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613640|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613641|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14613642|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613643|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14613644|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14613645|NCT00088998|Bevacizumab|bevacizumab|mesh-list
14613646|NCT00088998|Docetaxel|docetaxel|mesh-list
14613647|NCT00088998|Capecitabine|capecitabine|mesh-list
14613648|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14613649|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613650|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14613651|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14613652|NCT00088998|Growth Substances|growth substances|mesh-ancestor
14613653|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613654|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
14613655|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613656|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613657|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613658|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613659|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613660|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
14613661|NCT00089037|Sirolimus|sirolimus|mesh-list
14613662|NCT00089037|Methotrexate|methotrexate|mesh-list
14613663|NCT00089037|Tacrolimus|tacrolimus|mesh-list
14613664|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14613665|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
14613666|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14613667|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613668|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613669|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
14613670|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613671|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613672|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
14613673|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613674|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14613675|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613676|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
14613677|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162941|NCT04101474|Ketamine|ketamine|mesh-list
15162942|NCT04101474|Analgesics|analgesics|mesh-ancestor
15162943|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
14613678|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14613679|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14613680|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613681|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613682|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14613683|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
14613684|NCT00089050|Cyclosporine|cyclosporine|mesh-list
14613685|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
14613686|NCT00089050|Cyclosporins|cyclosporins|mesh-list
14613687|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613688|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613689|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613690|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
14613691|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613692|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
14613693|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613694|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
14613695|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613696|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14613697|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14613698|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613699|NCT00089063|Sargramostim|sargramostim|mesh-list
14613700|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
15162944|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613701|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
14645776|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
14613702|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613703|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14613704|NCT00089089|Decitabine|decitabine|mesh-list
14613705|NCT00089089|Azacitidine|azacitidine|mesh-list
14613706|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613707|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
14613708|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613709|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613710|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613711|NCT00089115|Rituximab|rituximab|mesh-list
14613712|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
14613713|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14613714|NCT00089115|Antibodies|antibodies|mesh-list
14613715|NCT00089115|Sargramostim|sargramostim|mesh-list
14613716|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14613717|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14613718|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613719|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
14613720|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613721|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613722|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14613723|NCT00089154|Antibodies|antibodies|mesh-list
14613724|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
14613725|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14613726|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
14613727|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613728|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613729|NCT00089167|Thalidomide|thalidomide|mesh-list
14613730|NCT00089167|Dexamethasone|dexamethasone|mesh-list
14613731|NCT00089167|Melphalan|melphalan|mesh-list
14613732|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14613733|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
14613734|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
14613735|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613736|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613737|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613738|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
14613739|NCT00089167|Hormones|hormones|mesh-ancestor
14613740|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14613741|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613742|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613743|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
14613744|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613745|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
14613746|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613747|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14613748|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613749|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
15162945|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022187|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022188|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022189|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
14022190|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14022191|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15162946|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14022192|NCT02769689|Prednisolone|prednisolone|mesh-list
15162947|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15162948|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
15162949|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
15162950|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162951|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15162952|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15162953|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15162954|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162955|NCT04101682|Bupivacaine|bupivacaine|mesh-list
15162956|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
15162957|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
15162958|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15162959|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162960|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
15162961|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15162962|NCT04101578|Cyclosporine|cyclosporine|mesh-list
15162963|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
14022193|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
14613750|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613751|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15162964|NCT04101578|Prednisone|prednisone|mesh-list
15162965|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
15162966|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
14613752|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14613753|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14613754|NCT00089167|Growth Substances|growth substances|mesh-ancestor
14613755|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14613756|NCT00089193|Sargramostim|sargramostim|mesh-list
14613757|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
14613758|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
14613759|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613760|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14613761|NCT00089206|Sargramostim|sargramostim|mesh-list
14613762|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
14613763|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
14613764|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613765|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14613766|NCT00089219|Sargramostim|sargramostim|mesh-list
14613767|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
14613768|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
14613769|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613770|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14613771|NCT00089258|Isotretinoin|isotretinoin|mesh-list
14613772|NCT00089258|Antibodies|antibodies|mesh-list
14613773|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14613774|NCT00089258|Sargramostim|sargramostim|mesh-list
14613775|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
14613776|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613777|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
14613778|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14613779|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
14613780|NCT00089349|Methotrexate|methotrexate|mesh-list
14613781|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
14613782|NCT00089349|Antibodies|antibodies|mesh-list
14613783|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
14613784|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14613785|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
14613786|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613787|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613788|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14613789|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
14613790|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14613791|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613792|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
14613793|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613794|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14613795|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613796|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14613797|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613798|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613799|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14613800|NCT00089401|Melphalan|melphalan|mesh-list
15162967|NCT04101578|Methotrexate|methotrexate|mesh-list
15162968|NCT04101578|Azathioprine|azathioprine|mesh-list
15162969|NCT04101578|Bromides|bromides|mesh-list
15162970|NCT04101578|Tacrolimus|tacrolimus|mesh-list
15162971|NCT04101578|Cyclosporins|cyclosporins|mesh-list
15162972|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15162973|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
15162974|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15162975|NCT04101578|Antibodies|antibodies|mesh-list
15162976|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
15162977|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15162978|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
15162979|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
15162980|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15162981|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15162982|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15162983|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
15162984|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15162985|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162986|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14613801|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613802|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
14613803|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613804|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15162987|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15162988|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
15162989|NCT04101578|Hormones|hormones|mesh-ancestor
15162990|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15162991|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613805|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14613806|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613807|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
14613808|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613809|NCT00089427|Temozolomide|temozolomide|mesh-list
14613810|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613811|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
14613812|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613813|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613814|NCT00089440|Aripiprazole|aripiprazole|mesh-list
15162992|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15162993|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
15162994|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15162995|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15162996|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
14022194|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14022195|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
14022196|NCT02769689|Natalizumab|natalizumab|mesh-list
14022197|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022198|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
14022199|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
14022200|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613815|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
14613816|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613817|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613818|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613819|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613820|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613821|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
14613822|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
14613823|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613824|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613825|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14613826|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14613827|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
14613828|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14613829|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14613830|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14613831|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14613832|NCT00089453|Dexamethasone|dexamethasone|mesh-list
14613833|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
14613834|NCT00089453|Melphalan|melphalan|mesh-list
14022201|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022202|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613835|NCT00089453|Fludarabine|fludarabine|mesh-list
14613836|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613837|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
14613838|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613839|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613840|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613841|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
14613842|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613843|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613844|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14613845|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14613846|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
15162997|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
15162998|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15162999|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15163000|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15163001|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15163002|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
15163003|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163004|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15163005|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15163006|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
15163007|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15163008|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
14022203|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
14022204|NCT02769689|Hormones|hormones|mesh-ancestor
14613847|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
14613848|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163009|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
15163010|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613849|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613850|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
14613851|NCT00089453|Hormones|hormones|mesh-ancestor
14613852|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14613853|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613854|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
14613855|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14613856|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14613857|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613858|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14613859|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14613860|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
14613861|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613862|NCT00089518|Valsartan|valsartan|mesh-list
14613863|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14613864|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14613865|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14613866|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613867|NCT00089557|Capsaicin|capsaicin|mesh-list
14613868|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
14613869|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
14613870|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
14613871|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613872|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613873|NCT00089570|Terlipressin|terlipressin|mesh-list
14613874|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14613875|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14613876|NCT00089622|Levodopa|levodopa|mesh-list
14613877|NCT00089622|Lisuride|lisuride|mesh-list
14613878|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14613879|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14613880|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
14613881|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613882|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613883|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613884|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14613885|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
14613886|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
14613887|NCT00089687|Vanoxerine|vanoxerine|mesh-list
14613888|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14613889|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613890|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613891|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613892|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
14613893|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613894|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613895|NCT00089700|Ibalizumab|ibalizumab|mesh-list
14613896|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14613897|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14613898|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
14613899|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613900|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
14613901|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613902|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
14613903|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613904|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14613905|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14613906|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
14613907|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613908|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613909|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14613910|NCT00089765|Ranibizumab|ranibizumab|mesh-list
14613911|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14613912|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14613913|NCT00089765|Growth Substances|growth substances|mesh-ancestor
14613914|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613915|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
14613916|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613917|NCT00089804|Abetimus|abetimus|mesh-list
14613918|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613919|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
14613920|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613921|NCT00089830|Squalamine|squalamine|mesh-list
15163011|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163012|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14613922|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14613923|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14613924|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14613925|NCT00089830|Protective Agents|protective agents|mesh-ancestor
14613926|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613927|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613928|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14613929|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14613930|NCT00089830|Growth Substances|growth substances|mesh-ancestor
14613931|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14613932|NCT00089856|Prednisone|prednisone|mesh-list
14613933|NCT00089856|Docetaxel|docetaxel|mesh-list
14613934|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14613935|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
14613936|NCT00089856|Hormones|hormones|mesh-ancestor
14613937|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14613938|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613939|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14613940|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613941|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
14613942|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
14613943|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
14613944|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613945|NCT00089869|Olanzapine|olanzapine|mesh-list
14613946|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14613947|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
14613948|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
14613949|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613950|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613951|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613952|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613953|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613954|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613955|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613956|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14613957|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613958|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613959|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613960|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613961|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
14613962|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14613963|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
14613964|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
15163013|NCT04101578|Protective Agents|protective agents|mesh-ancestor
15163014|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
15163015|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15163016|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
15163017|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613965|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15163018|NCT04101708|Amoxicillin|amoxicillin|mesh-list
15163019|NCT04101708|Clarithromycin|clarithromycin|mesh-list
15163020|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14613966|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
14613967|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613968|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613969|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
14613970|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14613971|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14613972|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613973|NCT00090012|Olanzapine|olanzapine|mesh-list
14613974|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14613975|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
14613976|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
14613977|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14613978|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14613979|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14613980|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14613981|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14613982|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14613983|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14613984|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15163021|NCT04101708|Lansoprazole|lansoprazole|mesh-list
15163022|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
15163023|NCT04101708|Bismuth|bismuth|mesh-list
14613985|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14613986|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14613987|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613988|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14613989|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
15163024|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15163025|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163026|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15163027|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163028|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022205|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022206|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14022207|NCT02769689|Protective Agents|protective agents|mesh-ancestor
14022208|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14022209|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022210|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
14613990|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
15163029|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15163030|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14613991|NCT00090025|Leucovorin|leucovorin|mesh-list
14613992|NCT00090025|Fluorouracil|fluorouracil|mesh-list
14613993|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
14613994|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14613995|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14613996|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14613997|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14613998|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
14613999|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614000|NCT00090025|Antidotes|antidotes|mesh-ancestor
14614001|NCT00090025|Protective Agents|protective agents|mesh-ancestor
14614002|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
14614003|NCT00090025|Vitamins|vitamins|mesh-ancestor
14614004|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
14614005|NCT00090038|Rituximab|rituximab|mesh-list
14614006|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14614007|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614008|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
14614009|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614010|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614011|NCT00090090|Elsamicin A|elsamicin a|mesh-list
14614012|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614013|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614014|NCT00090155|Ondansetron|ondansetron|mesh-list
14614015|NCT00090155|Aprepitant|aprepitant|mesh-list
14614016|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
14614017|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
14614018|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614019|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614020|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614021|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
14614022|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
14614023|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14614024|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
14614025|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614026|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614027|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14614028|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14614029|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614030|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614031|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14614032|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14614033|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
14614034|NCT00090194|Antibodies|antibodies|mesh-list
14614035|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
14614036|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14614037|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14614038|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
14614039|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614040|NCT00090207|Ondansetron|ondansetron|mesh-list
14614041|NCT00090207|Aprepitant|aprepitant|mesh-list
14614042|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
14614043|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
14614044|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614045|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614046|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614047|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
14614048|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
14614049|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14614050|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
14614051|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614052|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614053|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14614054|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14614055|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614056|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614057|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14614058|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14614059|NCT00090246|Ondansetron|ondansetron|mesh-list
14614060|NCT00090246|Aprepitant|aprepitant|mesh-list
14614061|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
14614062|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
14614063|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614064|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614065|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614066|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
14614067|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
14614068|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14614069|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
14614070|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614071|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163031|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15163032|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163033|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15163034|NCT04101708|Antacids|antacids|mesh-ancestor
15163035|NCT04101760|Sargramostim|sargramostim|mesh-list
15163036|NCT04101760|Lenograstim|lenograstim|mesh-list
15163037|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
15163038|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163039|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15163040|NCT04101370|Bosentan|bosentan|mesh-list
15163041|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15163042|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15163043|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163044|NCT04101227|Ondansetron|ondansetron|mesh-list
15163045|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
15163046|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
15163047|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163048|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163049|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163050|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
15163051|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
15163052|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15163053|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
15163054|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614072|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14614073|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14614074|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614075|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614076|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14614077|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14614078|NCT00090272|Ertapenem|ertapenem|mesh-list
14614079|NCT00090272|Cefotetan|cefotetan|mesh-list
14614080|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14614081|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614082|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14614083|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
14614084|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614085|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14614086|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14614087|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614088|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614089|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14614090|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
14614091|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614092|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14614093|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14614094|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614095|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614096|NCT00090428|Caseins|caseins|mesh-list
14614097|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
14614098|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
15163055|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022211|NCT02769572|Diclofenac|diclofenac|mesh-list
14022212|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14022213|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022214|NCT02769572|Analgesics|analgesics|mesh-ancestor
14022215|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
14022216|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022217|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022218|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022219|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022220|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14022221|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614099|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614100|NCT00090480|Vaccines|vaccines|mesh-list
14614101|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
14614102|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614103|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
14614104|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
14614105|NCT00090623|Ranibizumab|ranibizumab|mesh-list
14614106|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14614107|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14614108|NCT00090623|Growth Substances|growth substances|mesh-ancestor
14614109|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614110|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
14614111|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614112|NCT00090675|Gefitinib|gefitinib|mesh-list
14614113|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614114|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614115|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614116|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614117|NCT00090727|AQ4N|aq4n|mesh-list
14614118|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614119|NCT00090896|Ipilimumab|ipilimumab|mesh-list
14614120|NCT00090896|Antibodies|antibodies|mesh-list
14614121|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14614122|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
14614123|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614124|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14614125|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614126|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14614127|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614128|NCT00090909|Gemcitabine|gemcitabine|mesh-list
14614129|NCT00090909|Dexamethasone|dexamethasone|mesh-list
14614130|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614131|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614132|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
14614133|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
14614134|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614135|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614136|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614137|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
14614138|NCT00090909|Hormones|hormones|mesh-ancestor
14614139|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14614140|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14614141|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614142|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
14614143|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614144|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
14614145|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614146|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614147|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614148|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
14614149|NCT00091039|Metronidazole|metronidazole|mesh-list
14614150|NCT00091039|Paclitaxel|paclitaxel|mesh-list
14614151|NCT00091039|Carboplatin|carboplatin|mesh-list
14614152|NCT00091039|Vaccines|vaccines|mesh-list
14614153|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
14614154|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614155|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14614156|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614157|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
14614158|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
14614159|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
14022222|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022223|NCT02769325|Ketorolac|ketorolac|mesh-list
14614160|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614161|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614162|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14614163|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14614164|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14614165|NCT00091052|Sargramostim|sargramostim|mesh-list
14614166|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
14614167|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645777|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645778|NCT00195533|Tazobactam|tazobactam|mesh-list
14645779|NCT00195533|Piperacillin|piperacillin|mesh-list
14645780|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14645781|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645782|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645783|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14645784|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645785|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645786|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
14645787|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14645788|NCT00195559|Estradiol|estradiol|mesh-list
14645789|NCT00195559|Estrogens|estrogens|mesh-ancestor
14645790|NCT00195559|Hormones|hormones|mesh-ancestor
14645791|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645792|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645793|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14645794|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
14645795|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14645796|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14645797|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14645798|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14645799|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14645800|NCT00195572|Leucovorin|leucovorin|mesh-list
14645801|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
14645802|NCT00195572|Antidotes|antidotes|mesh-ancestor
14645803|NCT00195572|Protective Agents|protective agents|mesh-ancestor
14645804|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645805|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
14645806|NCT00195572|Vitamins|vitamins|mesh-ancestor
14645807|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
14645808|NCT00195585|Leucovorin|leucovorin|mesh-list
14645809|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
14645810|NCT00195585|Antidotes|antidotes|mesh-ancestor
14645811|NCT00195585|Protective Agents|protective agents|mesh-ancestor
14645812|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645813|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
14645814|NCT00195585|Vitamins|vitamins|mesh-ancestor
14645815|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
14645816|NCT00195598|Paroxetine|paroxetine|mesh-list
14645817|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14645818|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14645819|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14645820|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14645821|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645822|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645823|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
14645824|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645825|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14645826|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
14645827|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645828|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14645829|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14645830|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645831|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14645832|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14645833|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
14645834|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645835|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
14645836|NCT00195637|Antibodies|antibodies|mesh-list
14645837|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
14645838|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14645839|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14645840|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
14645841|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645842|NCT00195689|Adalimumab|adalimumab|mesh-list
14645843|NCT00195689|Antibodies|antibodies|mesh-list
14645844|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14645845|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
14645846|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645847|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614168|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
14614169|NCT00091078|Oblimersen|oblimersen|mesh-list
14614170|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614171|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614172|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614173|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614174|NCT00091104|Aldesleukin|aldesleukin|mesh-list
14614175|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
14614176|NCT00091104|Fludarabine|fludarabine|mesh-list
14614177|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
14614178|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
14614179|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614180|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
14614181|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614182|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614183|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14614184|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
14614185|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614186|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614187|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15163056|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15163057|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15163058|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163059|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15163060|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14614188|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614189|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
14614190|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14614191|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14614192|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14614193|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
14614194|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614195|NCT00091117|Bortezomib|bortezomib|mesh-list
14614196|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614197|NCT00091130|Vaccines|vaccines|mesh-list
14614198|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
14614199|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614200|NCT00091143|Fludarabine|fludarabine|mesh-list
15163061|NCT04101136|Atorvastatin|atorvastatin|mesh-list
15163062|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15163063|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14614201|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
14614202|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
14614203|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14614204|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614205|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614206|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
14614207|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614208|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614209|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
14614210|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614211|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14614212|NCT00091156|Gefitinib|gefitinib|mesh-list
14614213|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614214|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614215|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614216|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614217|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
14614218|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614219|NCT00091195|Romidepsin|romidepsin|mesh-list
14614220|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614221|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614222|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
14614223|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14614224|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614225|NCT00091247|Tetracycline|tetracycline|mesh-list
14614226|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14614227|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614228|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14614229|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614230|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614231|NCT00091299|Warfarin|warfarin|mesh-list
14614232|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
15163064|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
14614233|NCT00091312|Leucovorin|leucovorin|mesh-list
14614234|NCT00091312|Fluorouracil|fluorouracil|mesh-list
14614235|NCT00091312|Irinotecan|irinotecan|mesh-list
14614236|NCT00091312|Calcium|calcium|mesh-list
14614237|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
14614238|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14614239|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614240|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
14614241|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614242|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614243|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614244|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614245|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
14614246|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14614247|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14614248|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614249|NCT00091312|Antidotes|antidotes|mesh-ancestor
14614250|NCT00091312|Protective Agents|protective agents|mesh-ancestor
14614251|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
14614252|NCT00091312|Vitamins|vitamins|mesh-ancestor
14614253|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
14614254|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14614255|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
14614256|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614257|NCT00091325|Protective Agents|protective agents|mesh-ancestor
14614258|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614259|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14614260|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15163065|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163066|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15163067|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15163068|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180759|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180760|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180761|NCT03936010|Canagliflozin|canagliflozin|mesh-list
15180762|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14614261|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614262|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14614263|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
14614264|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14614265|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
14614266|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614267|NCT00091377|Paclitaxel|paclitaxel|mesh-list
14614268|NCT00091377|Cisplatin|cisplatin|mesh-list
14614269|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14614270|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614271|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14614272|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14614273|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14614274|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614275|NCT00091429|Ranolazine|ranolazine|mesh-list
14614276|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14614277|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14614278|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614279|NCT00091468|Nicotine|nicotine|mesh-list
14614280|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14614281|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
15180763|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15180764|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180765|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14614282|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614283|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614284|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14614285|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14614286|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
14614287|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614288|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614289|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14614290|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
14614291|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614292|NCT00091559|Vorinostat|vorinostat|mesh-list
14614293|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614294|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14614295|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614296|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614297|NCT00091598|Ambrisentan|ambrisentan|mesh-list
14614298|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14614299|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
14614300|NCT00091611|Fludarabine|fludarabine|mesh-list
14614301|NCT00091611|Interleukin-2|interleukin-2|mesh-list
14614302|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614303|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
14614304|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614305|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614306|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14614307|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
14614308|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614309|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614310|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14614311|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614312|NCT00091611|Analgesics|analgesics|mesh-ancestor
14614313|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
14614314|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614315|NCT00091624|Lenalidomide|lenalidomide|mesh-list
14614316|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
14614317|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614318|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14614319|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14614320|NCT00091624|Growth Substances|growth substances|mesh-ancestor
14614321|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
14614322|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614323|NCT00091650|Olanzapine|olanzapine|mesh-list
14614324|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
14614325|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
14614326|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614327|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614328|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614329|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14614330|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14614331|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614332|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614333|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14614334|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14614335|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14614336|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614337|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614338|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
14614339|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14614340|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614341|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614342|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614343|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614344|NCT00091702|Vaccines|vaccines|mesh-list
14614345|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
14614346|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614347|NCT00091715|Bosentan|bosentan|mesh-list
14614348|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14614349|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14614350|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614351|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14022224|NCT02769325|Atropine|atropine|mesh-list
14614352|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
14614353|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
14614354|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
14614355|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14614356|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14614357|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614358|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14614359|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14614360|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14614361|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14614362|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14614363|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14614364|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614365|NCT00091741|Etanercept|etanercept|mesh-list
14614366|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614367|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614368|NCT00091741|Analgesics|analgesics|mesh-ancestor
14614369|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
14614370|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614371|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614372|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614373|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614374|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614375|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614376|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
14614377|NCT00091806|Panitumumab|panitumumab|mesh-list
14614378|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14614379|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614380|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
14614381|NCT00091858|Hematinics|hematinics|mesh-ancestor
14614382|NCT00091897|Rituximab|rituximab|mesh-list
14614383|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14614384|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614385|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
14614386|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614387|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614388|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
14614389|NCT00091910|Hematinics|hematinics|mesh-ancestor
15163069|NCT04101019|Lidocaine|lidocaine|mesh-list
15163070|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
15163071|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
14614390|NCT00091936|Lamivudine|lamivudine|mesh-list
14614391|NCT00091936|Efavirenz|efavirenz|mesh-list
14614392|NCT00091936|Didanosine|didanosine|mesh-list
14614393|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14614394|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14614395|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614396|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614397|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
14614398|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614399|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14614400|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14614401|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14614402|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14614403|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14614404|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14614405|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14614406|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14614407|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
14614408|NCT00092001|Sunitinib|sunitinib|mesh-list
14614409|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614410|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14614411|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14614412|NCT00092001|Growth Substances|growth substances|mesh-ancestor
14614413|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614414|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
14614415|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614416|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614417|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614418|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
14614419|NCT00092079|Alendronate|alendronate|mesh-list
14614420|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14614421|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614422|NCT00092079|Vitamins|vitamins|mesh-ancestor
14614423|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
14614424|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14614425|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
14614426|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
14614427|NCT00092170|Ertapenem|ertapenem|mesh-list
14614428|NCT00092170|Ticarcillin|ticarcillin|mesh-list
14614429|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14614430|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614431|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614432|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14614433|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614434|NCT00092183|Ondansetron|ondansetron|mesh-list
14614435|NCT00092183|Aprepitant|aprepitant|mesh-list
14614436|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
14614437|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
14614438|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614439|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614440|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614441|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
14614442|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
14614443|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14614444|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
14614445|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614446|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614447|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14614448|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14614449|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614450|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614451|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14614452|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15163072|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163073|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163074|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
15163075|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614453|NCT00092196|Aprepitant|aprepitant|mesh-list
14614454|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
14614455|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
14614456|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614457|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614458|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614459|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14614460|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614461|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614462|NCT00092274|Ofatumumab|ofatumumab|mesh-list
14614463|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614464|NCT00092287|Lanreotide|lanreotide|mesh-list
14614465|NCT00092287|Octreotide|octreotide|mesh-list
14614466|NCT00092287|Somatostatin|somatostatin|mesh-list
15163076|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15163077|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15163078|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15163079|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163080|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163081|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
15163082|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
15163083|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15163084|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15163085|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163086|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614467|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614468|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614469|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14614470|NCT00092287|Hormones|hormones|mesh-ancestor
14614471|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14614472|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614473|NCT00092300|Valdecoxib|valdecoxib|mesh-list
14614474|NCT00092300|Rofecoxib|rofecoxib|mesh-list
14614475|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614476|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14614477|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614478|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614479|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614480|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614481|NCT00092300|Analgesics|analgesics|mesh-ancestor
14614482|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
14614483|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614484|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614485|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614486|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614487|NCT00092313|Acetaminophen|acetaminophen|mesh-list
15163087|NCT04100759|Urological Agents|urological agents|mesh-ancestor
15163088|NCT04100772|Vaccines|vaccines|mesh-list
15163089|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
15163090|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163091|NCT04100655|Molgramostim|molgramostim|mesh-list
15163092|NCT04100655|Estradiol|estradiol|mesh-list
15163093|NCT04100655|Sargramostim|sargramostim|mesh-list
14614488|NCT00092313|Rofecoxib|rofecoxib|mesh-list
14614489|NCT00092313|Oxycodone|oxycodone|mesh-list
14614490|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614491|NCT00092313|Analgesics|analgesics|mesh-ancestor
14614492|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
14614493|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163094|NCT04100655|Estrogens|estrogens|mesh-ancestor
15163095|NCT04100655|Hormones|hormones|mesh-ancestor
14614494|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614495|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
15180766|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614496|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14614497|NCT00092313|Narcotics|narcotics|mesh-ancestor
14614498|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614499|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614500|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14614501|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614502|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614503|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614504|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614505|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614506|NCT00092326|Acetaminophen|acetaminophen|mesh-list
14614507|NCT00092326|Rofecoxib|rofecoxib|mesh-list
14614508|NCT00092326|Oxycodone|oxycodone|mesh-list
14614509|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614510|NCT00092326|Analgesics|analgesics|mesh-ancestor
14614511|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
14614512|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614513|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163096|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163097|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163098|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
15163099|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163100|NCT04101383|Insulin|insulin|mesh-list
15163101|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15163102|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
15163103|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15163104|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163105|NCT04100824|Nimodipine|nimodipine|mesh-list
15163106|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15163107|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15163108|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163109|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614514|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
14614515|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14614516|NCT00092326|Narcotics|narcotics|mesh-ancestor
14614517|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14614518|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614519|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14614520|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614521|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614522|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614523|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614524|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614525|NCT00092339|Valdecoxib|valdecoxib|mesh-list
14614526|NCT00092339|Rofecoxib|rofecoxib|mesh-list
14614527|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614528|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14614529|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614530|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614531|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614532|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614533|NCT00092339|Analgesics|analgesics|mesh-ancestor
14614534|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
14614535|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614536|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614537|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614538|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614539|NCT00092352|Celecoxib|celecoxib|mesh-list
14614540|NCT00092352|Rofecoxib|rofecoxib|mesh-list
14614541|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614542|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614543|NCT00092352|Analgesics|analgesics|mesh-ancestor
14614544|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
14614545|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163110|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15163111|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163112|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
15163113|NCT04100330|Cytarabine|cytarabine|mesh-list
15163114|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614546|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614547|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614548|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614549|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614550|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14614551|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614552|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614553|NCT00092365|Celecoxib|celecoxib|mesh-list
14614554|NCT00092365|Rofecoxib|rofecoxib|mesh-list
14614555|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614556|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614557|NCT00092365|Analgesics|analgesics|mesh-ancestor
14614558|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
14614559|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614560|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163115|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
15163116|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163117|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163118|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
15163119|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163120|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614561|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614562|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614563|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614564|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14614565|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614566|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614567|NCT00092378|Diclofenac|diclofenac|mesh-list
14614568|NCT00092378|Rofecoxib|rofecoxib|mesh-list
14614569|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614570|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614571|NCT00092378|Analgesics|analgesics|mesh-ancestor
14614572|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
14614573|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614574|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614575|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614576|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614577|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14614578|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614579|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614580|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614581|NCT00092391|Vaccines|vaccines|mesh-list
14614582|NCT00092391|Immunoglobulins|immunoglobulins|mesh-list
15163121|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
14614583|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
14614584|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614585|NCT00092404|Vaccines|vaccines|mesh-list
14614586|NCT00092404|Immunoglobulins|immunoglobulins|mesh-list
14614587|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
14614588|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614589|NCT00092508|Mesalamine|mesalamine|mesh-list
14614590|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614591|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614592|NCT00092508|Analgesics|analgesics|mesh-ancestor
14614593|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
14614594|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614595|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614596|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614597|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614598|NCT00092846|Lovastatin|lovastatin|mesh-list
14614599|NCT00092846|L 647318|l 647318|mesh-list
14614600|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
14614601|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14614602|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14614603|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
14614604|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614605|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14614606|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14614607|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614608|NCT00092924|Mapatumumab|mapatumumab|mesh-list
14614609|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614610|NCT00092937|Busulfan|busulfan|mesh-list
14614611|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
14614612|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614613|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614614|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
14614615|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614616|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14614617|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163122|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614618|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14614619|NCT00092976|Factor VIII|factor viii|mesh-list
14614620|NCT00092976|Coagulants|coagulants|mesh-ancestor
14614621|NCT00093002|Fulvestrant|fulvestrant|mesh-list
14614622|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14614623|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614624|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14614625|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14614626|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
15163123|NCT04100473|Insulin|insulin|mesh-list
15163124|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15163125|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
14614627|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14614628|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614629|NCT00093028|Bortezomib|bortezomib|mesh-list
14614630|NCT00093028|Lenalidomide|lenalidomide|mesh-list
14614631|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163126|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15163127|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163128|NCT04100226|Vitamin D|vitamin d|mesh-list
15163129|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
15163130|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
15163131|NCT04100226|Vitamins|vitamins|mesh-ancestor
15163132|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
15163133|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163134|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15163135|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15163136|NCT04100226|Antacids|antacids|mesh-ancestor
15163137|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163138|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163139|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
14614632|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
14614633|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614634|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14614635|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14614636|NCT00093028|Growth Substances|growth substances|mesh-ancestor
14614637|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14614638|NCT00093067|Daptomycin|daptomycin|mesh-list
14614639|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14614640|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614641|NCT00093093|Interferons|interferons|mesh-list
14614642|NCT00093093|Ribavirin|ribavirin|mesh-list
14614643|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
14614644|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
14614645|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14614646|NCT00093093|Taribavirin|taribavirin|mesh-list
14614647|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163140|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15163141|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15163142|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163143|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
15163144|NCT04100447|Coagulants|coagulants|mesh-ancestor
15163145|NCT04100434|Evolocumab|evolocumab|mesh-list
15163146|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15163147|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15163148|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
15163149|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163150|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15163151|NCT04100083|Spironolactone|spironolactone|mesh-list
15163152|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15163153|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
15163154|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163155|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163156|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15163157|NCT04100083|Diuretics|diuretics|mesh-ancestor
15163158|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
15163159|NCT04099771|Ketamine|ketamine|mesh-list
15163160|NCT04099771|Analgesics|analgesics|mesh-ancestor
15163161|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
15163162|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163163|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163164|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14614648|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
15163165|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14614649|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614650|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
14645848|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15163166|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
15163167|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
14614651|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614652|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
14614653|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614654|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14614655|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614656|NCT00093158|Anticoagulants|anticoagulants|mesh-list
14614657|NCT00093158|Bivalirudin|bivalirudin|mesh-list
15163168|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163169|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15163170|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15163171|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163172|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163173|NCT04099563|Abrocitinib|abrocitinib|mesh-list
15163174|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15163175|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163176|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163177|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
15163178|NCT04099641|Bavituximab|bavituximab|mesh-list
15163179|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15163180|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163181|NCT04099732|Dabigatran|dabigatran|mesh-list
15163182|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15163183|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14022225|NCT02769325|Morphine|morphine|mesh-list
14022226|NCT02769325|Propofol|propofol|mesh-list
14022227|NCT02769325|Sevoflurane|sevoflurane|mesh-list
14022228|NCT02769325|Rocuronium|rocuronium|mesh-list
14022229|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14022230|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022231|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022232|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14022233|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
14022234|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
14022235|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14614658|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
14614659|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14614660|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
14614661|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614662|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614663|NCT00093184|Anticoagulants|anticoagulants|mesh-list
14614664|NCT00093184|Bivalirudin|bivalirudin|mesh-list
14614665|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
14614666|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14614667|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
14614668|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614669|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614670|NCT00093223|Paclitaxel|paclitaxel|mesh-list
14614671|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14614672|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14614673|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614674|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
14614675|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
14614676|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
14614677|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614678|NCT00093249|Clevidipine|clevidipine|mesh-list
14614679|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14614680|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14614681|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614682|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14614683|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614684|NCT00093262|Clevidipine|clevidipine|mesh-list
14614685|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14614686|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163184|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15163185|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
15163186|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163187|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15163188|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15163189|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163190|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
15163191|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15163192|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
14022236|NCT02769325|Narcotics|narcotics|mesh-ancestor
14022237|NCT02769325|Analgesics|analgesics|mesh-ancestor
14614687|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614688|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15163193|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
15163194|NCT04099407|Pirfenidone|pirfenidone|mesh-list
15163195|NCT04099407|Analgesics|analgesics|mesh-ancestor
15163196|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
15163197|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163198|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163199|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15163200|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15163201|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15163202|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15163203|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163204|NCT04099238|Warfarin|warfarin|mesh-list
15163205|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
15163206|NCT04099238|Dabigatran|dabigatran|mesh-list
15163207|NCT04099238|Apixaban|apixaban|mesh-list
15163208|NCT04099238|Edoxaban|edoxaban|mesh-list
15163209|NCT04099238|Anticoagulants|anticoagulants|mesh-list
15163210|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
15163211|NCT04099238|Phenindione|phenindione|mesh-list
15163212|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15163213|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
15163214|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15163215|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
15163216|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163217|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163218|NCT04099069|Anesthetics|anesthetics|mesh-list
15163219|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163220|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163221|NCT04099303|Vaccines|vaccines|mesh-list
15163222|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
15163223|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180767|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
15180768|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180769|NCT03935685|Mirtazapine|mirtazapine|mesh-list
15180770|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
15180771|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15180772|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15180773|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
15180774|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
15180775|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180776|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180777|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180778|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15180779|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15180780|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180781|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15180782|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15180783|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15180784|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
15180785|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15180786|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15180787|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
14614689|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614690|NCT00093288|Bupropion|bupropion|mesh-list
14614691|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14614692|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
14614693|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14614694|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14614695|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14614696|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14614697|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614698|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
14614699|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614700|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614701|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14614702|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14614703|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614704|NCT00093301|Simendan|simendan|mesh-list
14614705|NCT00093301|Dobutamine|dobutamine|mesh-list
14614706|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15180788|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15180789|NCT03935815|Ropivacaine|ropivacaine|mesh-list
15180790|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
15180791|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
14614707|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
14614708|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14614709|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14614710|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614711|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614712|NCT00093301|Protective Agents|protective agents|mesh-ancestor
14614713|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614714|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
14614715|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
14614716|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614717|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14614718|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14614719|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14614720|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
14614721|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614722|NCT00093314|Ofatumumab|ofatumumab|mesh-list
14614723|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645849|NCT00195728|Acetaminophen|acetaminophen|mesh-list
14645850|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14645851|NCT00195728|Hydrocodone|hydrocodone|mesh-list
14645852|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14645853|NCT00195728|Analgesics|analgesics|mesh-ancestor
14645854|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
14645855|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645856|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645857|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
14645858|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14645859|NCT00195728|Narcotics|narcotics|mesh-ancestor
14645860|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645861|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
14645862|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
14645863|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14645864|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645865|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645866|NCT00195741|Valproic Acid|valproic acid|mesh-list
14645867|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
14645868|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645869|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645870|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
14645871|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645872|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645873|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
14645874|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14645875|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645876|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645877|NCT00195754|Valproic Acid|valproic acid|mesh-list
14645878|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
14645879|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645880|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645881|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
14645882|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645883|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645884|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
14645885|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14645886|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163224|NCT04098861|Timolol|timolol|mesh-list
15163225|NCT04098861|Latanoprost|latanoprost|mesh-list
15163226|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15163227|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15163228|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
15163229|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163230|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163231|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163232|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15163233|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15163234|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15163235|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15163236|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
15163237|NCT04098653|Busulfan|busulfan|mesh-list
15163238|NCT04098653|Decitabine|decitabine|mesh-list
15163239|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15163240|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
15163241|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163242|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15163243|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15163244|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
15163245|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163246|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614724|NCT00093353|Cefixime|cefixime|mesh-list
14614725|NCT00093353|Irinotecan|irinotecan|mesh-list
14614726|NCT00093353|Temozolomide|temozolomide|mesh-list
14614727|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14614728|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14614729|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614730|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614731|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614732|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14614733|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
14614734|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14614735|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614736|NCT00093366|Etanercept|etanercept|mesh-list
14614737|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
14614738|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614739|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614740|NCT00093366|Analgesics|analgesics|mesh-ancestor
14614741|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
14614742|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614743|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614744|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614745|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614746|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14614747|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614748|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
14614749|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614750|NCT00093418|Tipifarnib|tipifarnib|mesh-list
14614751|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614752|NCT00093444|Doxorubicin|doxorubicin|mesh-list
14614753|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14614754|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614755|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614756|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14614757|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14614758|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614759|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614760|NCT00093457|Sorafenib|sorafenib|mesh-list
14614761|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614762|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614763|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614764|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614765|NCT00093483|Cytarabine|cytarabine|mesh-list
14614766|NCT00093483|Idarubicin|idarubicin|mesh-list
14614767|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
14614768|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614769|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
14614770|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614771|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614772|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
14614773|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614774|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614775|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
14614776|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614777|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614778|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14614779|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14614780|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163247|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14614781|NCT00093509|Doxorubicin|doxorubicin|mesh-list
14614782|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14614783|NCT00093509|Ifosfamide|ifosfamide|mesh-list
14614784|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
14614785|NCT00093509|Mesna|mesna|mesh-list
14614786|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614787|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163248|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15163249|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
15163250|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163251|NCT04098874|Bupropion|bupropion|mesh-list
14614788|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15163252|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14614789|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14614790|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163253|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
15163254|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15163255|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15163256|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15163257|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163258|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163259|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
15163260|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163261|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163262|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15163263|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15163264|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614791|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614792|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14614793|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
14614794|NCT00093509|Protective Agents|protective agents|mesh-ancestor
14614795|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614796|NCT00093522|Fludarabine|fludarabine|mesh-list
14614797|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
14614798|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14614799|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614800|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614801|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
14614802|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614803|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614804|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
14614805|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614806|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14614807|NCT00093548|Vaccines|vaccines|mesh-list
14614808|NCT00093548|Sargramostim|sargramostim|mesh-list
14614809|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
14614810|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614811|NCT00093561|Lycopene|lycopene|mesh-list
14614812|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614813|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
14614814|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614815|NCT00093561|Protective Agents|protective agents|mesh-ancestor
14614816|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614817|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14614818|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15163265|NCT04098718|Prednisolone|prednisolone|mesh-list
15163266|NCT04098718|Benralizumab|benralizumab|mesh-list
15163267|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15163268|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
15163269|NCT04098718|Hormones|hormones|mesh-ancestor
15163270|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163271|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163272|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15163273|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163274|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15163275|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
15163276|NCT04098796|Antibodies|antibodies|mesh-list
15163277|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
15163278|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163279|NCT04098432|Nivolumab|nivolumab|mesh-list
15163280|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15163281|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163282|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15163283|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163284|NCT04098302|Dutasteride|dutasteride|mesh-list
15163285|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15163286|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15163287|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163288|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163289|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
14614819|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614820|NCT00093587|Cyclosporine|cyclosporine|mesh-list
15163290|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163291|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614821|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
14614822|NCT00093587|Busulfan|busulfan|mesh-list
14614823|NCT00093587|Cyclosporins|cyclosporins|mesh-list
14614824|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14614825|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614826|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
14614827|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614828|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614829|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14614830|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
14614831|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614832|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614833|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14614834|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614835|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
14614836|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614837|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14614838|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14614839|NCT00093600|Cytarabine|cytarabine|mesh-list
14614840|NCT00093600|Daunorubicin|daunorubicin|mesh-list
14614841|NCT00093600|Midostaurin|midostaurin|mesh-list
14614842|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614843|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
14614844|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614845|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614846|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
14614847|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614848|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614849|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
14614850|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614851|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614852|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14614853|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14614854|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614855|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614856|NCT00093613|Sorafenib|sorafenib|mesh-list
14614857|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614858|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614859|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614860|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614861|NCT00093626|Sorafenib|sorafenib|mesh-list
14614862|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614863|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614864|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614865|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614866|NCT00093639|Everolimus|everolimus|mesh-list
14614867|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
14614868|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614869|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614870|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
14614871|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614872|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614873|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614874|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614875|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
14614876|NCT00093652|Gefitinib|gefitinib|mesh-list
14614877|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614878|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614879|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614880|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163292|NCT04098081|Gemcitabine|gemcitabine|mesh-list
15163293|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
15163294|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15163295|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
15163296|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163297|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614881|NCT00093665|Fluorouracil|fluorouracil|mesh-list
14614882|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614883|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
14614884|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614885|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614886|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614887|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
14614888|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614889|NCT00093678|Celecoxib|celecoxib|mesh-list
14614890|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14614891|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14614892|NCT00093678|Analgesics|analgesics|mesh-ancestor
14614893|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
14614894|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14614895|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614896|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14614897|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614898|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14614899|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15163298|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
15163299|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163300|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163301|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15163302|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
14614900|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614901|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614902|NCT00093704|Ganciclovir|ganciclovir|mesh-list
14614903|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14614904|NCT00093704|Bortezomib|bortezomib|mesh-list
14614905|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614906|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
14614907|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614908|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14614909|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614910|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614911|NCT00093743|Cyclosporine|cyclosporine|mesh-list
14614912|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
14614913|NCT00093743|Fludarabine|fludarabine|mesh-list
14614914|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
14614915|NCT00093743|Cyclosporins|cyclosporins|mesh-list
14614916|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614917|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14614918|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
14614919|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614920|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614921|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
14614922|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614923|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614924|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
14614925|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14614926|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
14614927|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614928|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14614929|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614930|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14614931|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
14614932|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14614933|NCT00093769|Rituximab|rituximab|mesh-list
14614934|NCT00093769|Bortezomib|bortezomib|mesh-list
14614935|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14614936|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614937|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
14614938|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614939|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614940|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
14614941|NCT00093834|Doxorubicin|doxorubicin|mesh-list
14614942|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14614943|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14614944|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
14614945|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614946|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14614947|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14614948|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
14614949|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614950|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14614951|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14614952|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14614953|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14614954|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14614955|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614956|NCT00093860|Propranolol|propranolol|mesh-list
14614957|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15163303|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163304|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15163305|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14614958|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14614959|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
14614960|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14614961|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614962|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614963|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14614964|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14614965|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
14614966|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
14614967|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14614968|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14614969|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614970|NCT00093886|Clevidipine|clevidipine|mesh-list
14614971|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
14614972|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
14614973|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14614974|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14614975|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614976|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14614977|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163306|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15163307|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
15163308|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163309|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14614978|NCT00093912|Nitroprusside|nitroprusside|mesh-list
14614979|NCT00093912|Clevidipine|clevidipine|mesh-list
14614980|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14614981|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
14614982|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15163310|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15163311|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163312|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
15163313|NCT04097847|Tocopherols|tocopherols|mesh-list
15163314|NCT04097847|Vitamin E|vitamin e|mesh-list
15163315|NCT04097847|Tocotrienols|tocotrienols|mesh-list
15163316|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
15163317|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
14614983|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614984|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14614985|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14614986|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14614987|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614988|NCT00093925|Nicardipine|nicardipine|mesh-list
14614989|NCT00093925|Clevidipine|clevidipine|mesh-list
14614990|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14614991|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14614992|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14614993|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14614994|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14614995|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14614996|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
14614997|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
14614998|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14614999|NCT00093951|Protective Agents|protective agents|mesh-ancestor
14615000|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615001|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
14615002|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
14615003|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615004|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615005|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
14615006|NCT00093977|Hematinics|hematinics|mesh-ancestor
14615007|NCT00093990|Tipifarnib|tipifarnib|mesh-list
14615008|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615009|NCT00094003|Poly I-C|poly i-c|mesh-list
14615010|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
14615011|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615012|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
14615013|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
14615014|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615015|NCT00094029|Sunitinib|sunitinib|mesh-list
14645887|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15163318|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15163319|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163320|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163321|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15163322|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15163323|NCT04097847|Protective Agents|protective agents|mesh-ancestor
14615016|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615017|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615018|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615019|NCT00094029|Growth Substances|growth substances|mesh-ancestor
14615020|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615021|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615022|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615023|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615024|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615025|NCT00094081|Tirapazamine|tirapazamine|mesh-list
14615026|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615027|NCT00094120|Squalamine|squalamine|mesh-list
14615028|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14615029|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615030|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14615031|NCT00094120|Protective Agents|protective agents|mesh-ancestor
14615032|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615033|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615034|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615035|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615036|NCT00094120|Growth Substances|growth substances|mesh-ancestor
14615037|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615038|NCT00094146|Octreotide|octreotide|mesh-list
14615039|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615040|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14615041|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615042|NCT00094289|Disulfiram|disulfiram|mesh-list
14615043|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14615044|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14615045|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615046|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615047|NCT00094315|Cocaine|cocaine|mesh-list
14615048|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
14615049|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
14615050|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615051|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615052|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
14615053|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615054|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14615055|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14615056|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14615057|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14615058|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615059|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
14615060|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615061|NCT00094341|Etanercept|etanercept|mesh-list
14615062|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14615063|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14615064|NCT00094341|Analgesics|analgesics|mesh-ancestor
15163324|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163325|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
15163326|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14615065|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
14615066|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615067|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615068|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14615069|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14615070|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615071|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615072|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
14615073|NCT00094367|Lamivudine|lamivudine|mesh-list
14615074|NCT00094367|Abacavir|abacavir|mesh-list
14615075|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14615076|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14615077|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615078|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615079|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
14615080|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615081|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14615082|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14615083|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
14615084|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615085|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
14615086|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615087|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15163327|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
15163328|NCT04097847|Vitamins|vitamins|mesh-ancestor
15163329|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
14615088|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14615089|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
14615090|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615091|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615092|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14615093|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
14615094|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
14615095|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615096|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
14615097|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615098|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615099|NCT00094432|Aripiprazole|aripiprazole|mesh-list
14615100|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
14615101|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615102|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615103|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615104|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615105|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615106|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615107|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
14615108|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615109|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615110|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15163330|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14615111|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615112|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
14615113|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615114|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615115|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615116|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615117|NCT00094484|Cinacalcet|cinacalcet|mesh-list
14615118|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14615119|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615120|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14615121|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
14615122|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14615123|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
14615124|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14615125|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14615126|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
14615127|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615128|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615129|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14615130|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14615131|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
14615132|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615133|NCT00094549|Valproic Acid|valproic acid|mesh-list
14615134|NCT00094549|Olanzapine|olanzapine|mesh-list
14615135|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
14615136|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
14615137|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615138|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615139|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615140|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615141|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615142|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615143|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615144|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14615145|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14615146|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14615147|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615148|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615149|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
14615150|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
14615151|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615152|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
14615153|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
14615154|NCT00094614|Atropine|atropine|mesh-list
14615155|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14615156|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15163331|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
14615157|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14615158|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
14615159|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615160|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615161|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14615162|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
14615163|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
14615164|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
14615165|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14615166|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14615167|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
14615168|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615169|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615170|NCT00094627|Gaboxadol|gaboxadol|mesh-list
14615171|NCT00094627|Analgesics|analgesics|mesh-ancestor
14615172|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
14615173|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615174|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615175|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
14615176|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
14615177|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
14615178|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615179|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615180|NCT00094640|Olanzapine|olanzapine|mesh-list
14615181|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
14615182|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
14615183|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615184|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615185|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615186|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615187|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615188|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615189|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615190|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14615191|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14615192|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14615193|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615194|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615195|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
14615196|NCT00094666|Gaboxadol|gaboxadol|mesh-list
14615197|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615198|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615199|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615200|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615201|NCT00094666|Analgesics|analgesics|mesh-ancestor
14615202|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
14615203|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
14615204|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
14615205|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
14615206|NCT00094692|Atropine|atropine|mesh-list
14615207|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14615208|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14615209|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14615210|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
14615211|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615212|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615213|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14615214|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
14615215|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
14615216|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
14615217|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14615218|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14615219|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
14615220|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615221|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615222|NCT00094848|Mapatumumab|mapatumumab|mesh-list
14615223|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615224|NCT00094926|Risperidone|risperidone|mesh-list
14615225|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615226|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
14615227|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615228|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615229|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615230|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615231|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615232|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615233|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615234|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615235|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
14615236|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
14615237|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615238|NCT00094978|Alvocidib|alvocidib|mesh-list
14615239|NCT00094978|Romidepsin|romidepsin|mesh-list
14615240|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615241|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615242|NCT00094978|Growth Substances|growth substances|mesh-ancestor
14615243|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615244|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615245|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615246|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615247|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14615248|NCT00095043|Gaboxadol|gaboxadol|mesh-list
14615249|NCT00095043|Analgesics|analgesics|mesh-ancestor
14615250|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
14615251|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615252|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615253|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
14615254|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
15163332|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15163333|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15163334|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
15163335|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163336|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15163337|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15163338|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163339|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163340|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14615255|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
14615256|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615257|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615258|NCT00095069|Gaboxadol|gaboxadol|mesh-list
14615259|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615260|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615261|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615262|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615263|NCT00095069|Analgesics|analgesics|mesh-ancestor
14615264|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
14615265|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
14615266|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
14615267|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
14615268|NCT00095082|Insulin|insulin|mesh-list
14615269|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14615270|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
14615271|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
14615272|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
14615273|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15163341|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15163342|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
15163343|NCT04097613|Budesonide|budesonide|mesh-list
15163344|NCT04097613|Povidone|povidone|mesh-list
15163345|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15163346|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15163347|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
15163348|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163349|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163350|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15163351|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
15163352|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
15163353|NCT04097613|Hormones|hormones|mesh-ancestor
14615274|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615275|NCT00095134|Risperidone|risperidone|mesh-list
14615276|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615277|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
14615278|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615279|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615280|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615281|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615282|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615283|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615284|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15163354|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14615285|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15163355|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
15163356|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
15163357|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15163358|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163359|NCT04097574|Menthol|menthol|mesh-list
15163360|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
15163361|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
15163362|NCT04097444|Leucovorin|leucovorin|mesh-list
15163363|NCT04097444|Bevacizumab|bevacizumab|mesh-list
15163364|NCT04097444|Fluorouracil|fluorouracil|mesh-list
15163365|NCT04097444|Capecitabine|capecitabine|mesh-list
15163366|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
15163367|NCT04097444|Irinotecan|irinotecan|mesh-list
15163368|NCT04097444|Calcium|calcium|mesh-list
15163369|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
14615286|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
14615287|NCT00095186|Lactoferrin|lactoferrin|mesh-list
14615288|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615289|NCT00095225|Bevacizumab|bevacizumab|mesh-list
14615290|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14615291|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615292|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615293|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615294|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615295|NCT00095225|Growth Substances|growth substances|mesh-ancestor
14615296|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615297|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615298|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615299|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615300|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615301|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
14615302|NCT00095251|Lorazepam|lorazepam|mesh-list
14615303|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14615304|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615305|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615306|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14615307|NCT00095251|Analgesics|analgesics|mesh-ancestor
14615308|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
14615309|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615310|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14615311|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14615312|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14615313|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
14615314|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615315|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615316|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
14615317|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
14615318|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
14615319|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615320|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14615321|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615322|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615323|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
14615324|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
14615325|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
14615326|NCT00095264|Hematinics|hematinics|mesh-ancestor
14615327|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
14615328|NCT00095277|Hematinics|hematinics|mesh-ancestor
14615329|NCT00095316|Caspofungin|caspofungin|mesh-list
14615330|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
14615331|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615332|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615333|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645888|NCT00195767|Valproic Acid|valproic acid|mesh-list
14645889|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
14645890|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645891|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645892|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
14645893|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645894|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645895|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
14645896|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15163370|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15163371|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645897|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645898|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15163372|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15163373|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15163374|NCT04097444|Growth Substances|growth substances|mesh-ancestor
15163375|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163376|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615334|NCT00095329|Sirolimus|sirolimus|mesh-list
14615335|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14615336|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615337|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14615338|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615339|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
14615340|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615341|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
14615342|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615343|NCT00095355|Valproic Acid|valproic acid|mesh-list
14615344|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615345|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615346|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615347|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
14615348|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615349|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615350|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615351|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
14615352|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
14615353|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615354|NCT00095368|Amoxicillin|amoxicillin|mesh-list
14615355|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14615356|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615357|NCT00095433|Ranibizumab|ranibizumab|mesh-list
14615358|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615359|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615360|NCT00095433|Growth Substances|growth substances|mesh-ancestor
14615361|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615362|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615363|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615364|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
14615365|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14615366|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615367|NCT00095459|Bevacizumab|bevacizumab|mesh-list
14615368|NCT00095459|Sorafenib|sorafenib|mesh-list
14615369|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615370|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615371|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615372|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615373|NCT00095459|Growth Substances|growth substances|mesh-ancestor
14615374|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615375|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615376|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615377|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615378|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615379|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14615380|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615381|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615382|NCT00095511|Aripiprazole|aripiprazole|mesh-list
14615383|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
14615384|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615385|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615386|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615387|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615388|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615389|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615390|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
14615391|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615392|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615393|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615394|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615395|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
14615396|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615397|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615398|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615399|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615400|NCT00095524|Aripiprazole|aripiprazole|mesh-list
14615401|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
14615402|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615403|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615404|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615405|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615406|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615407|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615408|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
14615409|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163377|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15163378|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
15163379|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163380|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15163381|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15163382|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
14615410|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615411|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615412|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615413|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
14615414|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615415|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615416|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615417|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615418|NCT00095641|Capecitabine|capecitabine|mesh-list
14615419|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14615420|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
14615421|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615422|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615423|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
14615424|NCT00095654|Ramipril|ramipril|mesh-list
14615425|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14615426|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615427|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14615428|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
14615429|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615430|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615431|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14615432|NCT00095667|Lapatinib|lapatinib|mesh-list
14615433|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615434|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615435|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615436|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615437|NCT00095680|Bortezomib|bortezomib|mesh-list
14615438|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615439|NCT00095693|Sorafenib|sorafenib|mesh-list
14615440|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14615441|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615442|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615443|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615444|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615445|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14615446|NCT00095706|Bevacizumab|bevacizumab|mesh-list
14615447|NCT00095706|Trastuzumab|trastuzumab|mesh-list
14615448|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615449|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615450|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615451|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615452|NCT00095706|Growth Substances|growth substances|mesh-ancestor
14615453|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615454|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615455|NCT00095719|Aripiprazole|aripiprazole|mesh-list
14615456|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
15163383|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15163384|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15163385|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163386|NCT04097444|Antidotes|antidotes|mesh-ancestor
15163387|NCT04097444|Protective Agents|protective agents|mesh-ancestor
15163388|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
15163389|NCT04097444|Vitamins|vitamins|mesh-ancestor
15163390|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
15163391|NCT04097288|Dexetimide|dexetimide|mesh-list
15163392|NCT04097288|Citalopram|citalopram|mesh-list
15163393|NCT04097288|Reboxetine|reboxetine|mesh-list
15163394|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15163395|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14615457|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615458|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15163396|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163397|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163398|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615459|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615460|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615461|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615462|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615463|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
14615464|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615465|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615466|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615467|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615468|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
14615469|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615470|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615471|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615472|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615473|NCT00095745|Aripiprazole|aripiprazole|mesh-list
14615474|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
14615475|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615476|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615477|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615478|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615479|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615480|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615481|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
14615482|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615483|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615484|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615485|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615486|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
14615487|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615488|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615489|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615490|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615491|NCT00095758|Aripiprazole|aripiprazole|mesh-list
14615492|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
14615493|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615494|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615495|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615496|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615497|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615498|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615499|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
14615500|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615501|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615502|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615503|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615504|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
14615505|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615506|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615507|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615508|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615509|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
14615510|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615511|NCT00095810|Aripiprazole|aripiprazole|mesh-list
15163399|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
15163400|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163401|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15163402|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
15163403|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15163404|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15163405|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15163406|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
15163407|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
14615512|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
14615513|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615514|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615515|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615516|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615517|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615518|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615519|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
14615520|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615521|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163408|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615522|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615523|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615524|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
14615525|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615526|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615527|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615528|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615529|NCT00095823|Aripiprazole|aripiprazole|mesh-list
14615530|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
14615531|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615532|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615533|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615534|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615535|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615536|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615537|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
14615538|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615539|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615540|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615541|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615542|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
14615543|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615544|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615545|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14615546|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615547|NCT00095862|Interferons|interferons|mesh-list
14615548|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
14615549|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
14615550|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615551|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
14615552|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615553|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14615554|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14615555|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
14615556|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615557|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615558|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14615559|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
14022238|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
14022239|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022240|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14615560|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615561|NCT00095888|Gemcitabine|gemcitabine|mesh-list
14615562|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14615563|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
14615564|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615565|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615566|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
14615567|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615568|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615569|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615570|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
14615571|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615572|NCT00095901|Capecitabine|capecitabine|mesh-list
14615573|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14615574|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
14615575|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615576|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615577|NCT00095914|Paclitaxel|paclitaxel|mesh-list
14615578|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14615579|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14615580|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615581|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14615582|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14615583|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14615584|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615585|NCT00095927|Paclitaxel|paclitaxel|mesh-list
14615586|NCT00095927|Carboplatin|carboplatin|mesh-list
14615587|NCT00095927|Amifostine|amifostine|mesh-list
14615588|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14615589|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615590|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
14615591|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
14615592|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
14615593|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615594|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14615595|NCT00095927|Protective Agents|protective agents|mesh-ancestor
14615596|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615597|NCT00095966|Gemcitabine|gemcitabine|mesh-list
14615598|NCT00095966|Sorafenib|sorafenib|mesh-list
14615599|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14615600|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
14615601|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615602|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615603|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
14615604|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615605|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615606|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615607|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
14615608|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615609|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615610|NCT00096005|Bortezomib|bortezomib|mesh-list
14615611|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615612|NCT00096057|Antibodies|antibodies|mesh-list
14615613|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14615614|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
14615615|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615616|NCT00096070|Gemcitabine|gemcitabine|mesh-list
14615617|NCT00096070|Fluorouracil|fluorouracil|mesh-list
14615618|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
14615619|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14615620|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
15163409|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15163410|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15163411|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
15163412|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15163413|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
15163414|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
14615621|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615622|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615623|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
14615624|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615625|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615626|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615627|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
14615628|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615629|NCT00096083|Melphalan|melphalan|mesh-list
14615630|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14615631|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
14615632|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615633|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615634|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14615635|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615636|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
14615637|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615638|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
14615639|NCT00096096|Tacrolimus|tacrolimus|mesh-list
14615640|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615641|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
14615642|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615643|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14615644|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615645|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615646|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14615647|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615648|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14615649|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
14615650|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14615651|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615652|NCT00096148|Cytarabine|cytarabine|mesh-list
14615653|NCT00096148|Bevacizumab|bevacizumab|mesh-list
14615654|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14615655|NCT00096148|Idarubicin|idarubicin|mesh-list
14615656|NCT00096148|Antibodies|antibodies|mesh-list
14615657|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
14615658|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14615659|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163415|NCT04096768|Ketamine|ketamine|mesh-list
15163416|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14615660|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615661|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615662|NCT00096148|Growth Substances|growth substances|mesh-ancestor
14615663|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615664|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615665|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
14615666|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14615667|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
14615668|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615669|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
14615670|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615671|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615672|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14615673|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14615674|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14615675|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615676|NCT00096187|Pemetrexed|pemetrexed|mesh-list
14615677|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615678|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615679|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615680|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14615681|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14615682|NCT00096291|Paclitaxel|paclitaxel|mesh-list
14615683|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14615684|NCT00096291|Doxorubicin|doxorubicin|mesh-list
14615685|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14615686|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14615687|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615688|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14615689|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14615690|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14615691|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615692|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14615693|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14615694|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14615695|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615696|NCT00096304|Docetaxel|docetaxel|mesh-list
14615697|NCT00096304|Epirubicin|epirubicin|mesh-list
14615698|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615699|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
14615700|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
14615701|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
14615702|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615703|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14615704|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14615705|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14615706|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615707|NCT00096317|Ketoconazole|ketoconazole|mesh-list
14615708|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
14615709|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615710|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14615711|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14615712|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615713|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615714|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14615715|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
14615716|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14615717|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615718|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14615719|NCT00096330|Folic Acid|folic acid|mesh-list
14615720|NCT00096330|Hematinics|hematinics|mesh-ancestor
14615721|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
14615722|NCT00096330|Vitamins|vitamins|mesh-ancestor
14615723|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
14615724|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615725|NCT00096343|Paclitaxel|paclitaxel|mesh-list
14615726|NCT00096343|Carboplatin|carboplatin|mesh-list
14615727|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14615728|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615729|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
14615730|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
14615731|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
14615732|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615733|NCT00096369|Tamoxifen|tamoxifen|mesh-list
14615734|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14615735|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
14615736|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14615737|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615738|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14615739|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615740|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14615741|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14615742|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14615743|NCT00096395|Gemcitabine|gemcitabine|mesh-list
14615744|NCT00096395|Sorafenib|sorafenib|mesh-list
14615745|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14615746|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
14615747|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615748|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615749|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
14615750|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615751|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615752|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14615753|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
14615754|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615755|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615756|NCT00096434|Sorafenib|sorafenib|mesh-list
14615757|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615758|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615759|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615760|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615761|NCT00096473|Donepezil|donepezil|mesh-list
14615762|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14615763|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615764|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615765|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
14615766|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615767|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615768|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
14615769|NCT00096512|Sorafenib|sorafenib|mesh-list
14615770|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615771|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14615772|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615773|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615774|NCT00096525|Lenalidomide|lenalidomide|mesh-list
14615775|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
14615776|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615777|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615778|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615779|NCT00096525|Growth Substances|growth substances|mesh-ancestor
14615780|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615781|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615782|NCT00096551|Metronidazole|metronidazole|mesh-list
14615783|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615784|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14615785|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14615786|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14615787|NCT00096616|Albuterol|albuterol|mesh-list
14615788|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14615789|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
15163417|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163418|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615790|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615791|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615792|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14615793|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
14615794|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
14615795|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14615796|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14615797|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14615798|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14615799|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
14615800|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615801|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615802|NCT00096629|Vaccines|vaccines|mesh-list
14615803|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
14615804|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615805|NCT00096655|Infliximab|infliximab|mesh-list
14615806|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
14615807|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615808|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14615809|NCT00096668|Paclitaxel|paclitaxel|mesh-list
14615810|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14615811|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615812|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
14615813|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
14615814|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
14615815|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163419|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15163420|NCT04096768|Analgesics|analgesics|mesh-ancestor
15163421|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
15163422|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615816|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
14615817|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14615818|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
14615819|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14615820|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615821|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14615822|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14615823|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14615824|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
14615825|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
15163423|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14615826|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615827|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
14615828|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615829|NCT00096720|Levodopa|levodopa|mesh-list
14615830|NCT00096720|Pramipexole|pramipexole|mesh-list
14615831|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14615832|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14615833|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
14615834|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615835|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615836|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163424|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15163425|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15163426|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
15163427|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163428|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163429|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15163430|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14615837|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
14615838|NCT00096720|Protective Agents|protective agents|mesh-ancestor
14615839|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615840|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14615841|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14615842|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14615843|NCT00096811|Entecavir|entecavir|mesh-list
14615844|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
14615845|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615846|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
14615847|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615848|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14615849|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
14615850|NCT00096850|Ritonavir|ritonavir|mesh-list
14615851|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14615852|NCT00096850|Rifampin|rifampin|mesh-list
14615853|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14615854|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14615855|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
14615856|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14615857|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615858|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14615859|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14615860|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
14615861|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615862|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14615863|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14615864|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14615865|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
14615866|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14615867|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
14615868|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14615869|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15163431|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
14615870|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15163432|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
15163433|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15163434|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15180792|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180793|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180794|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
15180795|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180796|NCT03935984|Calcitonin|calcitonin|mesh-list
15180797|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
15180798|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15180799|NCT03935984|Katacalcin|katacalcin|mesh-list
15180800|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15180801|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180802|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15180803|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
14615871|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14615872|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14615873|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14615874|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14615875|NCT00096863|Haloperidol|haloperidol|mesh-list
14615876|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
14615877|NCT00096863|Ziprasidone|ziprasidone|mesh-list
14615878|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
14615879|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
14615880|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14615881|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615882|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615883|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615884|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615885|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615886|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615887|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615888|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
14615889|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615890|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615891|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14615892|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615893|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
14615894|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
14615895|NCT00096915|Hematinics|hematinics|mesh-ancestor
14615896|NCT00096967|Bevacizumab|bevacizumab|mesh-list
14615897|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615898|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615899|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615900|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615901|NCT00096967|Growth Substances|growth substances|mesh-ancestor
14615902|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615903|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615904|NCT00097019|Bevacizumab|bevacizumab|mesh-list
14615905|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615906|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615907|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14615908|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14615909|NCT00097019|Growth Substances|growth substances|mesh-ancestor
15180804|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
15180805|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180806|NCT03935646|Adderall|adderall|mesh-list
15180807|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15180808|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180809|NCT03935451|Apixaban|apixaban|mesh-list
14615910|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615911|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
14615912|NCT00097032|Risperidone|risperidone|mesh-list
14615913|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14615914|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14615915|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
14615916|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615917|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615918|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615919|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615920|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615921|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615922|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615923|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14615924|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
14615925|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
14615926|NCT00097045|Interferons|interferons|mesh-list
14615927|NCT00097045|Ribavirin|ribavirin|mesh-list
14615928|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
14615929|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615930|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
14615931|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14615932|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
14615933|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615934|NCT00097071|Insulin|insulin|mesh-list
14615935|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14615936|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
14615937|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
15163435|NCT04097028|Trifluridine|trifluridine|mesh-list
15163436|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
15163437|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163438|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
15163439|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163440|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
15163441|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163442|NCT04096599|Fluorides|fluorides|mesh-list
15163443|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
15163444|NCT04096599|Protective Agents|protective agents|mesh-ancestor
15163445|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615938|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14615939|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615940|NCT00097084|Insulin|insulin|mesh-list
14615941|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14615942|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
14615943|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
14615944|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
14615945|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14615946|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615947|NCT00097110|Ascorbic Acid|ascorbic acid|mesh-list
14615948|NCT00097110|Vitamins|vitamins|mesh-ancestor
14615949|NCT00097110|Micronutrients|micronutrients|mesh-ancestor
14615950|NCT00097110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615951|NCT00097110|Antioxidants|antioxidants|mesh-ancestor
14615952|NCT00097110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615953|NCT00097110|Protective Agents|protective agents|mesh-ancestor
15163446|NCT04096742|Tretinoin|tretinoin|mesh-list
15163447|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163448|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
15163449|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
15163450|NCT04096638|Atezolizumab|atezolizumab|mesh-list
15163451|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163452|NCT04096690|Pegaspargase|pegaspargase|mesh-list
15163453|NCT04096690|Antibodies|antibodies|mesh-list
15163454|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15163455|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
15163456|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163457|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163458|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
15163459|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15163460|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
14615954|NCT00097123|Misoprostol|misoprostol|mesh-list
14615955|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14615956|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
14615957|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14615958|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615959|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14615960|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14615961|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
14645899|NCT00195780|Valproic Acid|valproic acid|mesh-list
14645900|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
14645901|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645902|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645903|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
14645904|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645905|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645906|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
15163461|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14645907|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14645908|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645909|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645910|NCT00195793|Atorvastatin|atorvastatin|mesh-list
14645911|NCT00195793|Ezetimibe|ezetimibe|mesh-list
15163462|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
14615962|NCT00097188|Rituximab|rituximab|mesh-list
14615963|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615964|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615965|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
14615966|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615967|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14615968|NCT00097214|Carboplatin|carboplatin|mesh-list
14615969|NCT00097214|Cetuximab|cetuximab|mesh-list
14615970|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615971|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615972|NCT00097227|Paclitaxel|paclitaxel|mesh-list
14615973|NCT00097227|Carboplatin|carboplatin|mesh-list
14615974|NCT00097227|Cetuximab|cetuximab|mesh-list
14615975|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14615976|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14615977|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14615978|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14615979|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14615980|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615981|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14615982|NCT00097266|Haloperidol|haloperidol|mesh-list
14615983|NCT00097266|Aripiprazole|aripiprazole|mesh-list
14615984|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
14615985|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
14615986|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14615987|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14615988|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14615989|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14615990|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14615991|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
14615992|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
14615993|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14615994|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14615995|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14615996|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14615997|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
14615998|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14615999|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14616000|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14616001|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14616002|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
14616003|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
14616004|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616005|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14616006|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14616007|NCT00097279|Metformin|metformin|mesh-list
14616008|NCT00097279|Pioglitazone|pioglitazone|mesh-list
14616009|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
14616010|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
14616011|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616012|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616013|NCT00097318|Interferons|interferons|mesh-list
14616014|NCT00097318|Interferon-beta|interferon-beta|mesh-list
14616015|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
14616016|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616017|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
14616018|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616019|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
14616020|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616021|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14616022|NCT00097344|Toremifene|toremifene|mesh-list
14616023|NCT00097344|Letrozole|letrozole|mesh-list
14616024|NCT00097344|Hormones|hormones|mesh-list
14616025|NCT00097344|Atamestane|atamestane|mesh-list
14616026|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
15163463|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163464|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163465|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
15163466|NCT04096391|Analgesics|analgesics|mesh-list
15163467|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
15163468|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616027|NCT00097344|Estrogens|estrogens|mesh-list
14616028|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
14616029|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
14616030|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616031|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616032|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616033|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14616034|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14616035|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616036|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616037|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
14616038|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14616039|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14616040|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616041|NCT00097383|Epirubicin|epirubicin|mesh-list
14616042|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14616043|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616044|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14616045|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14616046|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616047|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616048|NCT00097435|Ribavirin|ribavirin|mesh-list
14616049|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
14616050|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616051|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
14616052|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616053|NCT00097734|Ertapenem|ertapenem|mesh-list
14616054|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14616055|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616056|NCT00097760|Natalizumab|natalizumab|mesh-list
14616057|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
14616058|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616059|NCT00097799|Ritonavir|ritonavir|mesh-list
14616060|NCT00097799|Tipranavir|tipranavir|mesh-list
14616061|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14616062|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14616063|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616064|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616065|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616066|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14616067|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14616068|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
14616069|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616070|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14616071|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14616072|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
14616073|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616074|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616075|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
14616076|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616077|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616078|NCT00097851|Docetaxel|docetaxel|mesh-list
14616079|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163469|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163470|NCT04096157|Isavuconazole|isavuconazole|mesh-list
15163471|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
15163472|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616080|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
14616081|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
14616082|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
14616083|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616084|NCT00097877|Insulin|insulin|mesh-list
14616085|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14616086|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
14616087|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
14616088|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
14616089|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616090|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616091|NCT00097903|Camptothecin|camptothecin|mesh-list
14616092|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14616093|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616094|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14616095|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14616096|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616097|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616098|NCT00097916|Memantine|memantine|mesh-list
14616099|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14616100|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14616101|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
15163473|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15163474|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14616102|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616103|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616104|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022241|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14022242|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14022243|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022244|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022245|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022246|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14616105|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14616106|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14616107|NCT00097929|Vorinostat|vorinostat|mesh-list
14616108|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616109|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14616110|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616111|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616112|NCT00097942|Memantine|memantine|mesh-list
14616113|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14616114|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14616115|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
14616116|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616117|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616118|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616119|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14616120|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14616121|NCT00097968|Everolimus|everolimus|mesh-list
14616122|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616123|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616124|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
14616125|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616126|NCT00098007|Everolimus|everolimus|mesh-list
14616127|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616128|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616129|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
14616130|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616131|NCT00098033|Clofarabine|clofarabine|mesh-list
14616132|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14616133|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
14616134|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616135|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163475|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163476|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163477|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
15163478|NCT04095754|Anesthetics|anesthetics|mesh-list
15163479|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163480|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163481|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15163482|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15163483|NCT04095754|Analgesics|analgesics|mesh-ancestor
15163484|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
15163485|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163486|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15163487|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15163488|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14616136|NCT00098046|Famciclovir|famciclovir|mesh-list
14616137|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
14616138|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616139|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14616140|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616141|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616142|NCT00098111|Azathioprine|azathioprine|mesh-list
15163489|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
15163490|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163491|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163492|NCT04095715|Hemostatics|hemostatics|mesh-list
15163493|NCT04095715|Coagulants|coagulants|mesh-ancestor
14022247|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026084|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14616143|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
14616144|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616145|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14616146|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616147|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15163494|NCT04096027|Cabergoline|cabergoline|mesh-list
14616148|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
14616149|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163495|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15163496|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15163497|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
15163498|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
15163499|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163500|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163501|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163502|NCT04095832|Anesthetics|anesthetics|mesh-list
15163503|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14616150|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616151|NCT00098124|Milnacipran|milnacipran|mesh-list
14616152|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
14616153|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14616154|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14616155|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14616156|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616157|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616158|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616159|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14616160|NCT00098124|Analgesics|analgesics|mesh-ancestor
14616161|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
14616162|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616163|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
14616164|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14616165|NCT00098137|Olmesartan|olmesartan|mesh-list
14616166|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14616167|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14616168|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14616169|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616170|NCT00098241|Everolimus|everolimus|mesh-list
14616171|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616172|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616173|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
14616174|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616175|NCT00098280|Eculizumab|eculizumab|mesh-list
14616176|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14616177|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616178|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
14616179|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616180|NCT00098319|Folic Acid|folic acid|mesh-list
14616181|NCT00098319|Hematinics|hematinics|mesh-ancestor
14616182|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
14616183|NCT00098319|Vitamins|vitamins|mesh-ancestor
14616184|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
14616185|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616186|NCT00098358|Zileuton|zileuton|mesh-list
14616187|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14616188|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14616189|NCT00098358|Analgesics|analgesics|mesh-ancestor
14616190|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
14616191|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616192|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616193|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14616194|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616195|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14616196|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616197|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616198|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14616199|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
14616200|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616201|NCT00098384|Rifaximin|rifaximin|mesh-list
14616202|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14616203|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616204|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14616205|NCT00098397|Romidepsin|romidepsin|mesh-list
14616206|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14616207|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616208|NCT00098423|Cytarabine|cytarabine|mesh-list
14616209|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14616210|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
14616211|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163504|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616212|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616213|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
14616214|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616215|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616216|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
14616217|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616218|NCT00098436|Temozolomide|temozolomide|mesh-list
14616219|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14616220|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
14616221|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616222|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616223|NCT00098462|Sirolimus|sirolimus|mesh-list
14616224|NCT00098462|Gefitinib|gefitinib|mesh-list
14616225|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14616226|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616227|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14616228|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616229|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
15163505|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
15163506|NCT04095624|Narcotics|narcotics|mesh-ancestor
15163507|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163508|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163509|NCT04095624|Analgesics|analgesics|mesh-ancestor
15163510|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
15163511|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163512|NCT04095312|Pancrelipase|pancrelipase|mesh-list
15163513|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163514|NCT04095390|Capecitabine|capecitabine|mesh-list
15163515|NCT04095390|Letrozole|letrozole|mesh-list
15163516|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15163517|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
15163518|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163519|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163520|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15163521|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15163522|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163523|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15163524|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
15163525|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163526|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163527|NCT04095455|Ketamine|ketamine|mesh-list
15163528|NCT04095455|Analgesics|analgesics|mesh-ancestor
15163529|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
15163530|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163531|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163532|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15163533|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14616230|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15163534|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
15163535|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
15163536|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163537|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15163538|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15163539|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163540|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163541|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
15163542|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
15163543|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15163544|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15163545|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163546|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163547|NCT04095299|Capecitabine|capecitabine|mesh-list
14616231|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
14616232|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616233|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616234|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616235|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616236|NCT00098488|Rituximab|rituximab|mesh-list
14616237|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14616238|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616239|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
14616240|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163548|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15163549|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
14616241|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616242|NCT00098501|Sirolimus|sirolimus|mesh-list
14616243|NCT00098501|EKB 569|ekb 569|mesh-list
14616244|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14616245|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616246|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14616247|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616248|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
14616249|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616250|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
14616251|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616252|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616253|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163550|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163551|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163552|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
15163553|NCT04095169|Complement C3|complement c3|mesh-list
15163554|NCT04095169|Complement C3d|complement c3d|mesh-list
15163555|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
15163556|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163557|NCT04094948|Clenbuterol|clenbuterol|mesh-list
15163558|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15163559|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15163560|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
15163561|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163562|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163563|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163564|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15163565|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
14616254|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616255|NCT00098527|Romidepsin|romidepsin|mesh-list
14616256|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14616257|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616258|NCT00098540|Sorafenib|sorafenib|mesh-list
14616259|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616260|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616261|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616262|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616263|NCT00098553|Everolimus|everolimus|mesh-list
14616264|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616265|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616266|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
14616267|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616268|NCT00098579|Doxorubicin|doxorubicin|mesh-list
14616269|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14616270|NCT00098579|Alvocidib|alvocidib|mesh-list
14616271|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14616272|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616273|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14616274|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14616275|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616276|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616277|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
14616278|NCT00098579|Growth Substances|growth substances|mesh-ancestor
14616279|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616280|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616281|NCT00098605|Lapatinib|lapatinib|mesh-list
14616282|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616283|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616284|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616285|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616286|NCT00098618|Interferons|interferons|mesh-list
14616287|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
14616288|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
14616289|NCT00098618|Sorafenib|sorafenib|mesh-list
14616290|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616291|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
14616292|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616293|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616294|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616295|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616296|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
14616297|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616298|NCT00098631|Lapatinib|lapatinib|mesh-list
14616299|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163566|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616300|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616301|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616302|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616303|NCT00098683|Amifostine|amifostine|mesh-list
14616304|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14616305|NCT00098683|Protective Agents|protective agents|mesh-ancestor
14616306|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616307|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14616308|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14616309|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616310|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616311|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
14616312|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616313|NCT00098800|Fenretinide|fenretinide|mesh-list
14616314|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616315|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14616316|NCT00098800|Protective Agents|protective agents|mesh-ancestor
14616317|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616318|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
14616319|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616320|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616321|NCT00098878|Carboplatin|carboplatin|mesh-list
14616322|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616323|NCT00098891|Entinostat|entinostat|mesh-list
14616324|NCT00098891|Isotretinoin|isotretinoin|mesh-list
14616325|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14616326|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
14616327|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616328|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616329|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616330|NCT00098917|Vaccines|vaccines|mesh-list
14616331|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
14616332|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616333|NCT00098969|Resveratrol|resveratrol|mesh-list
14616334|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
14616335|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616336|NCT00098969|Protective Agents|protective agents|mesh-ancestor
14616337|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616338|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616339|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14616340|NCT00098982|Leucovorin|leucovorin|mesh-list
14616341|NCT00098982|Fluorouracil|fluorouracil|mesh-list
14616342|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
14616343|NCT00098982|Bortezomib|bortezomib|mesh-list
14616344|NCT00098982|Calcium|calcium|mesh-list
14616345|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
14616346|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14616347|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616348|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
14616349|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616350|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14616351|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616352|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616353|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
14616354|NCT00098982|Antidotes|antidotes|mesh-ancestor
14616355|NCT00098982|Protective Agents|protective agents|mesh-ancestor
14616356|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
14616357|NCT00098982|Vitamins|vitamins|mesh-ancestor
14616358|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
14616359|NCT00098995|Tirapazamine|tirapazamine|mesh-list
14616360|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616361|NCT00099008|Genistein|genistein|mesh-list
14616362|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14616363|NCT00099008|Protective Agents|protective agents|mesh-ancestor
14616364|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616365|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616366|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616367|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616368|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616369|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
14616370|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14616371|NCT00099008|Estrogens|estrogens|mesh-ancestor
14616372|NCT00099008|Hormones|hormones|mesh-ancestor
14616373|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616374|NCT00099060|Lapatinib|lapatinib|mesh-list
14616375|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616376|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616377|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616378|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616379|NCT00099125|Irinotecan|irinotecan|mesh-list
14616380|NCT00099125|Temozolomide|temozolomide|mesh-list
14616381|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14616382|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14616383|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616384|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616385|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616386|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14616387|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
14645912|NCT00195793|Fenofibrate|fenofibrate|mesh-list
14645913|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14645914|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14645915|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
14645916|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645917|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14645918|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14645919|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645920|NCT00195806|Valproic Acid|valproic acid|mesh-list
14645921|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
14645922|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645923|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645924|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
14645925|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645926|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645927|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
14645928|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14645929|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645930|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14645931|NCT00195845|Galantamine|galantamine|mesh-list
14645932|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14645933|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645934|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645935|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
14645936|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14645937|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645938|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14645939|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
14645940|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645941|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
14645942|NCT00195871|Cytarabine|cytarabine|mesh-list
14645943|NCT00195871|Prednisone|prednisone|mesh-list
14645944|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
14645945|NCT00195871|Methotrexate|methotrexate|mesh-list
14645946|NCT00195871|Etoposide|etoposide|mesh-list
14645947|NCT00195871|Vincristine|vincristine|mesh-list
14645948|NCT00195871|Daunorubicin|daunorubicin|mesh-list
14645949|NCT00195871|Asparaginase|asparaginase|mesh-list
14645950|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14645951|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
14645952|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645953|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14645954|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14645955|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
14645956|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645957|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14645958|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14645959|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14645960|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
14645961|NCT00195871|Hormones|hormones|mesh-ancestor
14645962|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14645963|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14645964|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14645965|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
14645966|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14645967|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14645968|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
14645969|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
14645970|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645971|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14645972|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14645973|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14645974|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14645975|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14616388|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14616389|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14616390|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14616391|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
14616392|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616393|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616394|NCT00099164|Progestins|progestins|mesh-ancestor
14616395|NCT00099164|Hormones|hormones|mesh-ancestor
14616396|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
14616397|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
14616398|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616399|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616400|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
14616401|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616402|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14616403|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14616404|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616405|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616406|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
14616407|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
14616408|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
14616409|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616410|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616411|NCT00099216|Rivastigmine|rivastigmine|mesh-list
14616412|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14616413|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616414|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616415|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
15163567|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15163568|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
15163569|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
15163570|NCT04095013|Fentanyl|fentanyl|mesh-list
15163571|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
15163572|NCT04095013|Bupivacaine|bupivacaine|mesh-list
15163573|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
15163574|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
15163575|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14616416|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616417|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616418|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14616419|NCT00099216|Protective Agents|protective agents|mesh-ancestor
14616420|NCT00099242|Rivastigmine|rivastigmine|mesh-list
14616421|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14616422|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616423|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616424|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
14616425|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616426|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616427|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14616428|NCT00099242|Protective Agents|protective agents|mesh-ancestor
14616429|NCT00099320|Exenatide|exenatide|mesh-list
14616430|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616431|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616432|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14616433|NCT00099320|Incretins|incretins|mesh-ancestor
14616434|NCT00099320|Hormones|hormones|mesh-ancestor
14616435|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616436|NCT00099333|Exenatide|exenatide|mesh-list
14616437|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616438|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616439|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14616440|NCT00099333|Incretins|incretins|mesh-ancestor
14616441|NCT00099333|Hormones|hormones|mesh-ancestor
14616442|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616443|NCT00099450|INS 50589|ins 50589|mesh-list
14616444|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14616445|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14616446|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
14616447|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616448|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616449|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616450|NCT00099489|Interferons|interferons|mesh-list
15163576|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163577|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
15163578|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616451|NCT00099489|Interferon-beta|interferon-beta|mesh-list
14616452|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
14616453|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616454|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
14616455|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616456|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
14616457|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616458|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14616459|NCT00099502|Interferons|interferons|mesh-list
14616460|NCT00099502|Interferon-beta|interferon-beta|mesh-list
14616461|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
14616462|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
14616463|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616464|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
14616465|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616466|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
14616467|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616468|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14616469|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616470|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616471|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
14616472|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616473|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616474|NCT00099554|Etanercept|etanercept|mesh-list
14616475|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14616476|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14616477|NCT00099554|Analgesics|analgesics|mesh-ancestor
14616478|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
14616479|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616480|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616481|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14616482|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616483|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14616484|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616485|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
14616486|NCT00099606|Dasatinib|dasatinib|mesh-list
14616487|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616488|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616489|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616490|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616491|NCT00099619|Insulin|insulin|mesh-list
14616492|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15163579|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15163580|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15163581|NCT04095013|Analgesics|analgesics|mesh-ancestor
15163582|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15163583|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15163584|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15163585|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
15163586|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163587|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163588|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15163589|NCT04095013|Narcotics|narcotics|mesh-ancestor
15163590|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15163591|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15163592|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
15163593|NCT04094805|Calcitriol|calcitriol|mesh-list
15163594|NCT04094805|Dexamethasone|dexamethasone|mesh-list
15163595|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14616493|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
14616494|NCT00099619|Exenatide|exenatide|mesh-list
14616495|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616496|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616497|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14616498|NCT00099619|Incretins|incretins|mesh-ancestor
14616499|NCT00099619|Hormones|hormones|mesh-ancestor
14616500|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616501|NCT00099645|Mifepristone|mifepristone|mesh-list
14616502|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14616503|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
14616504|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14616505|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616506|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15163596|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
15163597|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
14616507|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14616508|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14616509|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
15163598|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163599|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163600|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163601|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
15163602|NCT04094805|Hormones|hormones|mesh-ancestor
15163603|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163604|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14616510|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14616511|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14616512|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
15163605|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163606|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15163607|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15163608|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163609|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163610|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15163611|NCT04094805|Vitamins|vitamins|mesh-ancestor
15163612|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
15163613|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15163614|NCT04094909|Paclitaxel|paclitaxel|mesh-list
15163615|NCT04094909|Cisplatin|cisplatin|mesh-list
15163616|NCT04094909|Carboplatin|carboplatin|mesh-list
15163617|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
15163618|NCT04094909|Pemetrexed|pemetrexed|mesh-list
15163619|NCT04094909|Endostatins|endostatins|mesh-list
15163620|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15163621|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163622|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
15163623|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
15163624|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
15163625|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163626|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15163627|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163628|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15163629|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15163630|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14616513|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616514|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
14616515|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15163631|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15163632|NCT04094909|Growth Substances|growth substances|mesh-ancestor
15163633|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163634|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
14616516|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14616517|NCT00099684|Ezetimibe|ezetimibe|mesh-list
14616518|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14616519|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14616520|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
14616521|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616522|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14616523|NCT00099710|Curcumin|curcumin|mesh-list
15163635|NCT04094727|Lumefantrine|lumefantrine|mesh-list
15163636|NCT04094727|Artemether|artemether|mesh-list
15163637|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15163638|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
15163639|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15163640|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15163641|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180810|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15180811|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
15180812|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15180813|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
15180814|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180815|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180816|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
15180817|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
15180818|NCT03935152|Progestins|progestins|mesh-ancestor
14616524|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14616525|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14616526|NCT00099710|Analgesics|analgesics|mesh-ancestor
14616527|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
15180819|NCT03935152|Hormones|hormones|mesh-ancestor
15180820|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180821|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180822|NCT03935139|Glycerol|glycerol|mesh-list
14616528|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616529|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616530|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14616531|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616532|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616533|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616534|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163642|NCT04094584|Naltrexone|naltrexone|mesh-list
15163643|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15163644|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15163645|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163646|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
15163647|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163648|NCT04094597|Lactoferrin|lactoferrin|mesh-list
15163649|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163650|NCT04094532|Bupivacaine|bupivacaine|mesh-list
14616535|NCT00099736|Cyclosporine|cyclosporine|mesh-list
14616536|NCT00099736|Cyclosporins|cyclosporins|mesh-list
14616537|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14616538|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
14616539|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616540|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14616541|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616542|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616543|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616544|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
14616545|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616546|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616547|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14616548|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14616549|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14616550|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14616551|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616552|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616553|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
14616554|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616555|NCT00099775|Caspofungin|caspofungin|mesh-list
14616556|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
14616557|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616558|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616559|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616560|NCT00099788|Ranolazine|ranolazine|mesh-list
14616561|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14616562|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14616563|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616564|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14616565|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14616566|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616567|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616568|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
14616569|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616570|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14616571|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616572|NCT00099866|Metformin|metformin|mesh-list
14616573|NCT00099866|Vildagliptin|vildagliptin|mesh-list
15163651|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
15163652|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
15163653|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163654|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163655|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
15163656|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616574|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616575|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616576|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14616577|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616578|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616579|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616580|NCT00099892|Vildagliptin|vildagliptin|mesh-list
15163657|NCT04094467|Leuprolide|leuprolide|mesh-list
15163658|NCT04094467|Cetrorelix|cetrorelix|mesh-list
15163659|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15163660|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
15163661|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14616581|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616582|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616583|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14616584|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616585|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616586|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616587|NCT00099905|Vildagliptin|vildagliptin|mesh-list
14616588|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616589|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616590|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14616591|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616592|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616593|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616594|NCT00099918|Vildagliptin|vildagliptin|mesh-list
14616595|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616596|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616597|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14616598|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616599|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616600|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616601|NCT00099931|Vildagliptin|vildagliptin|mesh-list
14616602|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616603|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616604|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14616605|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616606|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616607|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616608|NCT00099944|Glimepiride|glimepiride|mesh-list
14616609|NCT00099944|Vildagliptin|vildagliptin|mesh-list
14616610|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14616611|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616612|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616613|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616614|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
14616615|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14616616|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616617|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616618|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616619|NCT00099957|Vildagliptin|vildagliptin|mesh-list
14616620|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14616621|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616622|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14616623|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616624|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616625|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616626|NCT00099970|Dacarbazine|dacarbazine|mesh-list
14616627|NCT00099970|Volociximab|volociximab|mesh-list
14616628|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14616629|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
15163662|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163663|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14616630|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616631|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616632|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14616633|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14616634|NCT00099970|Growth Substances|growth substances|mesh-ancestor
14616635|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616636|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
14616637|NCT00099996|Ezetimibe|ezetimibe|mesh-list
14616638|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14616639|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14616640|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
14616641|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616642|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14616643|NCT00100009|Triamcinolone|triamcinolone|mesh-list
14616644|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15163664|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163665|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
15163666|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163667|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
15163668|NCT04094701|Narcotics|narcotics|mesh-ancestor
15163669|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163670|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163671|NCT04094701|Analgesics|analgesics|mesh-ancestor
15163672|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
15163673|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163674|NCT04094090|Riboflavin|riboflavin|mesh-list
15163675|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
15163676|NCT04094090|Vitamins|vitamins|mesh-ancestor
14022248|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616645|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14616646|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15163677|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
15163678|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163679|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15163680|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
15163681|NCT04094142|Lenalidomide|lenalidomide|mesh-list
15163682|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
14616647|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14616648|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
14616649|NCT00100009|Hormones|hormones|mesh-ancestor
14616650|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616651|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616652|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14616653|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
14616654|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616655|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616656|NCT00100074|Lobeline|lobeline|mesh-list
14616657|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14616658|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
14616659|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616660|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616661|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14616662|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14616663|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
14616664|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616665|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616666|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
14616667|NCT00100100|Modafinil|modafinil|mesh-list
14616668|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14616669|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616670|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14616671|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14616672|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14616673|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616674|NCT00100113|Vanoxerine|vanoxerine|mesh-list
15163683|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163684|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
15163685|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163686|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15163687|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15163688|NCT04094142|Growth Substances|growth substances|mesh-ancestor
15163689|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
15163690|NCT04093895|Taurolidine|taurolidine|mesh-list
15163691|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163692|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15163693|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163694|NCT04093518|Estradiol|estradiol|mesh-list
15163695|NCT04093518|Estrogens|estrogens|mesh-ancestor
14616675|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14616676|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14616677|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14616678|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616679|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
14616680|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616681|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616682|NCT00100126|Amoxicillin|amoxicillin|mesh-list
14616683|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14616684|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616685|NCT00100139|Paclitaxel|paclitaxel|mesh-list
15163696|NCT04093518|Hormones|hormones|mesh-ancestor
15163697|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616686|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15163698|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163699|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
15163700|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14616687|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14616688|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616689|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
14616690|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14616691|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14616692|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616693|NCT00100243|Abarelix|abarelix|mesh-list
14616694|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
14616695|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616696|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616697|NCT00100269|Antioxidants|antioxidants|mesh-list
14616698|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616699|NCT00100269|Protective Agents|protective agents|mesh-ancestor
14616700|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616701|NCT00100308|Heparin|heparin|mesh-list
14616702|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
14616703|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14616704|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14616705|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616706|NCT00100412|Phenylephrine|phenylephrine|mesh-list
14616707|NCT00100412|Dobutamine|dobutamine|mesh-list
14616708|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
14616709|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14616710|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
14616711|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
14616712|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616713|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616714|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
14616715|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14616716|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
14616717|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
14616718|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14616719|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14616720|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14616721|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
14616722|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616723|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616724|NCT00100412|Protective Agents|protective agents|mesh-ancestor
14616725|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14616726|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14616727|NCT00100464|Paroxetine|paroxetine|mesh-list
14616728|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14616729|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14616730|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14616731|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616732|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616733|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
14616734|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616735|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14616736|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
14616737|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14616738|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14616739|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14616740|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616741|NCT00100477|Etoposide|etoposide|mesh-list
14616742|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
14616743|NCT00100477|Topotecan|topotecan|mesh-list
14616744|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14616745|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616746|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14616747|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14616748|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616749|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616750|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14616751|NCT00100477|Analgesics|analgesics|mesh-ancestor
14616752|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
14616753|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616754|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616755|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
14616756|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616757|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616758|NCT00100568|Lamivudine|lamivudine|mesh-list
15163701|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616759|NCT00100568|Zidovudine|zidovudine|mesh-list
14616760|NCT00100568|Efavirenz|efavirenz|mesh-list
14616761|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14616762|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14616763|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14616764|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616765|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616766|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
14616767|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616768|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14616769|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14616770|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
14616771|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14616772|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14616773|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14616774|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14616775|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14616776|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14616777|NCT00100581|Interferons|interferons|mesh-list
14616778|NCT00100581|Ritonavir|ritonavir|mesh-list
14616779|NCT00100581|Tenofovir|tenofovir|mesh-list
14616780|NCT00100581|Ribavirin|ribavirin|mesh-list
14616781|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
14616782|NCT00100581|Lamivudine|lamivudine|mesh-list
14616783|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
14616784|NCT00100581|Efavirenz|efavirenz|mesh-list
14616785|NCT00100581|Lopinavir|lopinavir|mesh-list
14616786|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14616787|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616788|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
14616789|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616790|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14616791|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14616792|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616793|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616794|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616795|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14616796|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14616797|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14616798|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14616799|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14616800|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14616801|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
14616802|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
14616803|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616804|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14616805|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14616806|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14616807|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14616808|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14616809|NCT00100594|Lamivudine|lamivudine|mesh-list
14616810|NCT00100594|Zidovudine|zidovudine|mesh-list
14616811|NCT00100594|Efavirenz|efavirenz|mesh-list
14616812|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14616813|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14616814|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14616815|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616816|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616817|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
14616818|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616819|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14616820|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14616821|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
14616822|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14616823|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14616824|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15163702|NCT04093531|Ustekinumab|ustekinumab|mesh-list
15163703|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
15163704|NCT04093713|Nordefrin|nordefrin|mesh-list
15163705|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14616825|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14616826|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14616827|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15163706|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
15163707|NCT04093648|Fludarabine|fludarabine|mesh-list
14616828|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
14616829|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14616830|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616831|NCT00100646|Ritonavir|ritonavir|mesh-list
14616832|NCT00100646|Lopinavir|lopinavir|mesh-list
14616833|NCT00100646|Lamivudine|lamivudine|mesh-list
14616834|NCT00100646|Stavudine|stavudine|mesh-list
15163708|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15163709|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
15163710|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163711|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15163712|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15163713|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
14616835|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14616836|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14616837|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
14616838|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616839|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616840|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14616841|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14616842|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
14616843|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616844|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14616845|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14616846|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14616847|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14616848|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
14616849|NCT00100685|Volociximab|volociximab|mesh-list
14616850|NCT00100685|Antibodies|antibodies|mesh-list
14616851|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14616852|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
14616853|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616854|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15163714|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163715|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163716|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15163717|NCT04093206|Vitamins|vitamins|mesh-list
15163718|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
15163719|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
15163720|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163721|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
15163722|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163723|NCT04093206|Protective Agents|protective agents|mesh-ancestor
15163724|NCT04093219|Acetaminophen|acetaminophen|mesh-list
15163725|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15163726|NCT04093219|Analgesics|analgesics|mesh-ancestor
14616855|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14616856|NCT00100685|Growth Substances|growth substances|mesh-ancestor
14616857|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
14616858|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616859|NCT00100737|Rituximab|rituximab|mesh-list
14616860|NCT00100737|Interleukin-2|interleukin-2|mesh-list
14616861|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14616862|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616863|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
14616864|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616865|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616866|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14616867|NCT00100737|Analgesics|analgesics|mesh-ancestor
14616868|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
14616869|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616870|NCT00100750|Gemcitabine|gemcitabine|mesh-list
14616871|NCT00100750|Tipifarnib|tipifarnib|mesh-list
14616872|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14616873|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
14616874|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616875|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616876|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
14616877|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616878|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616879|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15163727|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
15163728|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163729|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616880|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
14616881|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163730|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
14616882|NCT00100776|Olanzapine|olanzapine|mesh-list
14616883|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
14616884|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
14616885|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616886|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616887|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14616888|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14616889|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14616890|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14616891|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14616892|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14616893|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14616894|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14616895|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616896|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14616897|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
14616898|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14616899|NCT00100854|Fulvestrant|fulvestrant|mesh-list
14616900|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616901|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616902|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616903|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616904|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14616905|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14616906|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14616907|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
14616908|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616909|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616910|NCT00100880|Lenalidomide|lenalidomide|mesh-list
14616911|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
14616912|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616913|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14616914|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14616915|NCT00100880|Growth Substances|growth substances|mesh-ancestor
14616916|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
14616917|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616918|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
14616919|NCT00100893|Procyanidin|procyanidin|mesh-list
14616920|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
14616921|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616922|NCT00100893|Protective Agents|protective agents|mesh-ancestor
14616923|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616924|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14616925|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14616926|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616927|NCT00100906|Aldesleukin|aldesleukin|mesh-list
14616928|NCT00100906|Interleukin-2|interleukin-2|mesh-list
14616929|NCT00100906|Tretinoin|tretinoin|mesh-list
14616930|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616931|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14616932|NCT00100906|Analgesics|analgesics|mesh-ancestor
14616933|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
14616934|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616935|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616936|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14616937|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14616938|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
14616939|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616940|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
14616941|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14616942|NCT00100945|Gefitinib|gefitinib|mesh-list
14616943|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616944|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616945|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616946|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814090|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15163731|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
15163732|NCT04093271|Promethazine|promethazine|mesh-list
15163733|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15163734|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14814091|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814543|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14616947|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
14616948|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14616949|NCT00100958|Protective Agents|protective agents|mesh-ancestor
14616950|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616951|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616952|NCT00100971|Vaccines|vaccines|mesh-list
14616953|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
14616954|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616955|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
14616956|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14616957|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14616958|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616959|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14616960|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14616961|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
14616962|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616963|NCT00101062|Celecoxib|celecoxib|mesh-list
14616964|NCT00101062|Letrozole|letrozole|mesh-list
14616965|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616966|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14616967|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14616968|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616969|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616970|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14616971|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
14616972|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14616973|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14616974|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14616975|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14616976|NCT00101062|Analgesics|analgesics|mesh-ancestor
14616977|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
14616978|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14616979|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14616980|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14616981|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14616982|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14616983|NCT00101075|Capecitabine|capecitabine|mesh-list
14616984|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
14616985|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14616986|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
14616987|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616988|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616989|NCT00101088|Sirolimus|sirolimus|mesh-list
14616990|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
14616991|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14616992|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14616993|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14616994|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14616995|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14616996|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14616997|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14616998|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
14616999|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617000|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
14617001|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617002|NCT00101114|Interferons|interferons|mesh-list
14617003|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
14617004|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
14617005|NCT00101114|Sorafenib|sorafenib|mesh-list
14617006|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617007|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
14617008|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617009|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617010|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617011|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617012|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
14617013|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617014|NCT00101127|Gemcitabine|gemcitabine|mesh-list
14617015|NCT00101127|Docetaxel|docetaxel|mesh-list
15163735|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163736|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163737|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
15163738|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
15163739|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
14617016|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617017|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
14617018|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617019|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163740|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163741|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
15163742|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
15163743|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163744|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15163745|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
15163746|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
15163747|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163748|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163749|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15163750|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
15163751|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
15163752|NCT04093050|Vasopressins|vasopressins|mesh-list
15163753|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
15163754|NCT04093050|Coagulants|coagulants|mesh-ancestor
15163755|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15163756|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15163757|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
15163758|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163759|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
14617020|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
14617021|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617022|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617023|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617024|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
14617025|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617026|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
14617027|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
14617028|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
14617029|NCT00101140|Fludarabine|fludarabine|mesh-list
14617030|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
14617031|NCT00101140|Thiotepa|thiotepa|mesh-list
14617032|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14617033|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617034|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617035|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
14617036|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617037|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617038|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
14617039|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617040|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15163760|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
15163761|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163762|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
15163763|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
15163764|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617041|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
14617042|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14617043|NCT00101153|Cytarabine|cytarabine|mesh-list
14617044|NCT00101153|Daunorubicin|daunorubicin|mesh-list
14617045|NCT00101153|Tipifarnib|tipifarnib|mesh-list
14617046|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617047|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
15163765|NCT04092868|Protamines|protamines|mesh-list
15163766|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
15163767|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163768|NCT04092868|Coagulants|coagulants|mesh-ancestor
15163769|NCT04092621|Amiodarone|amiodarone|mesh-list
15163770|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15163771|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
15163772|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15163773|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163774|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163775|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15163776|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15163777|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15163778|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163779|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15163780|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15163781|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14617048|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617049|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814544|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15180823|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14617050|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
15180824|NCT03935139|Protective Agents|protective agents|mesh-ancestor
14617051|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617052|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617053|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
14617054|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617055|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14617056|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14617057|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14617058|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617059|NCT00101179|Azacitidine|azacitidine|mesh-list
14617060|NCT00101179|Entinostat|entinostat|mesh-list
14617061|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14617062|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617063|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
14617064|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617065|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617066|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617067|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
14617068|NCT00101205|Etoposide|etoposide|mesh-list
14617069|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
14617070|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617071|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14617072|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14617073|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14617074|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617075|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617076|NCT00101231|Alvocidib|alvocidib|mesh-list
14617077|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617078|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
14617079|NCT00101231|Growth Substances|growth substances|mesh-ancestor
14617080|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617081|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617082|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617083|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617084|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
14617085|NCT00101270|Irinotecan|irinotecan|mesh-list
14617086|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617087|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14617088|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14617089|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617090|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617091|NCT00101296|Tipifarnib|tipifarnib|mesh-list
14617092|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617093|NCT00101309|Aldesleukin|aldesleukin|mesh-list
14617094|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617095|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14617096|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14617097|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
14617098|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617099|NCT00101335|Celecoxib|celecoxib|mesh-list
14617100|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14617101|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14617102|NCT00101335|Analgesics|analgesics|mesh-ancestor
14617103|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
14617104|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617105|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617106|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14617107|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14617108|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14617109|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14617110|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617111|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617112|NCT00101348|Bevacizumab|bevacizumab|mesh-list
14617113|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14617114|NCT00101348|Cetuximab|cetuximab|mesh-list
14617115|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14814092|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814093|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
14814094|NCT00861419|Vitamins|vitamins|mesh-ancestor
14814095|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
14814096|NCT00861445|Lacosamide|lacosamide|mesh-list
14814097|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
14814098|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14617116|NCT00101348|Antibodies|antibodies|mesh-list
14617117|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
14617118|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14814099|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15163782|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15163783|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15163784|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15163785|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
15163786|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617119|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617120|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14617121|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14617122|NCT00101348|Growth Substances|growth substances|mesh-ancestor
14617123|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617124|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
14617125|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
14617126|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617127|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163787|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15163788|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15163789|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163790|NCT04092387|Nicotine|nicotine|mesh-list
15163791|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15163792|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
15163793|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163794|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163795|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15163796|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15163797|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
14617128|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617129|NCT00101374|Leflunomide|leflunomide|mesh-list
14617130|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617131|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617132|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617133|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
14617134|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617135|NCT00101426|Ranirestat|ranirestat|mesh-list
14617136|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617137|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617138|NCT00101569|Aripiprazole|aripiprazole|mesh-list
14617139|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
14617140|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14617141|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14617142|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14617143|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14617144|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617145|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
14617146|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
14617147|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617148|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617149|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14617150|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14617151|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
14617152|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14617153|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14617154|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14617155|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14617156|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14617157|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14617158|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14617159|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14617160|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617161|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14617162|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14617163|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14617164|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
14617165|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617166|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617167|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14617168|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14617169|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
14617170|NCT00101673|Vildagliptin|vildagliptin|mesh-list
14617171|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15163798|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163799|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14645976|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
15163800|NCT04092478|Anesthetics|anesthetics|mesh-list
14617172|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617173|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14617174|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617175|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617176|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617177|NCT00101712|Vildagliptin|vildagliptin|mesh-list
14617178|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14617179|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617180|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14617181|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617182|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617183|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617184|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
14617185|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14617186|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617187|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14617188|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
14617189|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15163801|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163802|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163803|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
15163804|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
15163805|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
15163806|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163807|NCT04092309|Valsartan|valsartan|mesh-list
15163808|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14617190|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617191|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617192|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617193|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
14617194|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
14617195|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14617196|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617197|NCT00101764|Triamcinolone|triamcinolone|mesh-list
14617198|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14617199|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14617200|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14617201|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14617202|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
14617203|NCT00101764|Hormones|hormones|mesh-ancestor
14617204|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617205|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617206|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617207|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
14617208|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617209|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617210|NCT00101790|Pamidronate|pamidronate|mesh-list
14617211|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14617212|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617213|NCT00101803|Vildagliptin|vildagliptin|mesh-list
14617214|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14617215|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617216|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14617217|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617218|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617219|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617220|NCT00101829|Rituximab|rituximab|mesh-list
14617221|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14617222|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617223|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
14617224|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617225|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14617226|NCT00101842|Gemcitabine|gemcitabine|mesh-list
14617227|NCT00101842|Pemetrexed|pemetrexed|mesh-list
14617228|NCT00101842|Cisplatin|cisplatin|mesh-list
14617229|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617230|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
14617231|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617232|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617233|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
14617234|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617235|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617236|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617237|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
14617238|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617239|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14617240|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14617241|NCT00101894|Panitumumab|panitumumab|mesh-list
14617242|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
14617243|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14617244|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617245|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617246|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617247|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617248|NCT00101920|Panitumumab|panitumumab|mesh-list
14617249|NCT00101920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14617250|NCT00101920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617251|NCT00101998|Alvimopan|alvimopan|mesh-list
14617252|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617253|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
14617254|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617255|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617256|NCT00102115|Talaporfin|talaporfin|mesh-list
14617257|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617258|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14617259|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
14617260|NCT00102141|Drospirenone|drospirenone|mesh-list
14617261|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14617262|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14617263|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14617264|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14617265|NCT00102141|Estradiol|estradiol|mesh-list
14617266|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14617267|NCT00102141|Estrogens|estrogens|mesh-ancestor
14617268|NCT00102141|Hormones|hormones|mesh-ancestor
14617269|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617270|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617271|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14617272|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
14617273|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14022249|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14617274|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14617275|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14617276|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
14617277|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14617278|NCT00102141|Diuretics|diuretics|mesh-ancestor
14617279|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
14617280|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14617281|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14617282|NCT00102154|Gaboxadol|gaboxadol|mesh-list
14617283|NCT00102154|Analgesics|analgesics|mesh-ancestor
14617284|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
15163809|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15163810|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15163811|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14617285|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617286|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617287|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
14617288|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
14617289|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
14617290|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617291|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617292|NCT00102167|Gaboxadol|gaboxadol|mesh-list
14617293|NCT00102167|Analgesics|analgesics|mesh-ancestor
14617294|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
14617295|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617296|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617297|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
14617298|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
14617299|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
14617300|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617301|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617302|NCT00102206|Ritonavir|ritonavir|mesh-list
14617303|NCT00102206|Lopinavir|lopinavir|mesh-list
14617304|NCT00102206|Saquinavir|saquinavir|mesh-list
15163812|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14617305|NCT00102206|Tenofovir|tenofovir|mesh-list
14617306|NCT00102206|Lamivudine|lamivudine|mesh-list
14617307|NCT00102206|Zidovudine|zidovudine|mesh-list
14617308|NCT00102206|Emtricitabine|emtricitabine|mesh-list
14617309|NCT00102206|Abacavir|abacavir|mesh-list
14617310|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14617311|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14617312|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617313|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617314|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617315|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14617316|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14617317|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
14617318|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617319|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14617320|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14617321|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14617322|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14617323|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
14617324|NCT00102219|Doxorubicin|doxorubicin|mesh-list
14617325|NCT00102219|Pemetrexed|pemetrexed|mesh-list
14617326|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14617327|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617328|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14617329|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14617330|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617331|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617332|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14617333|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14617334|NCT00102258|Hormones|hormones|mesh-list
14617335|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617336|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617337|NCT00102271|Oxypurinol|oxypurinol|mesh-list
14617338|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617339|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617340|NCT00102284|Levodopa|levodopa|mesh-list
14617341|NCT00102284|Modafinil|modafinil|mesh-list
14617342|NCT00102284|Rivastigmine|rivastigmine|mesh-list
14617343|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14617344|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14617345|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
14617346|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617347|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617348|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617349|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14617350|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14617351|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14617352|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14617353|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14617354|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617355|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
14617356|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14617357|NCT00102284|Protective Agents|protective agents|mesh-ancestor
14617358|NCT00102310|Z 338|z 338|mesh-list
14617359|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14617360|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617361|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617362|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
14617363|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617364|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617365|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617366|NCT00102375|Topotecan|topotecan|mesh-list
14617367|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14617368|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14617369|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617370|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617371|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617372|NCT00102388|Vildagliptin|vildagliptin|mesh-list
14617373|NCT00102388|Gliclazide|gliclazide|mesh-list
14617374|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14617375|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617376|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14617377|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617378|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180825|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617379|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617380|NCT00102414|Gemcitabine|gemcitabine|mesh-list
14617381|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617382|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
14617383|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617384|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617385|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
14617386|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617387|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617388|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617389|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
14617390|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617391|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
14617392|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14617393|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617394|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617395|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14617396|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14617397|NCT00102453|Protective Agents|protective agents|mesh-ancestor
14617398|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617399|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
14617400|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14617401|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
14617402|NCT00102479|Aripiprazole|aripiprazole|mesh-list
14617403|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
14617404|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14617405|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14617406|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14617407|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14617408|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163813|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163814|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
15163815|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163816|NCT04091971|Ketamine|ketamine|mesh-list
15163817|NCT04091971|Analgesics|analgesics|mesh-ancestor
15163818|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
15163819|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617409|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
14617410|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
14617411|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163820|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163821|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15163822|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15163823|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
15163824|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
15163825|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163826|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15163827|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15163828|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163829|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163830|NCT04092101|Nicotine|nicotine|mesh-list
15163831|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15163832|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
14617412|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617413|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14617414|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14617415|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
14617416|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14617417|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14617418|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14617419|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14617420|NCT00102492|Casopitant|casopitant|mesh-list
14617421|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
14617422|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
14617423|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617424|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617425|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617426|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14617427|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617428|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617429|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
14617430|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617431|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14617432|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
15180826|NCT03935217|Secnidazole|secnidazole|mesh-list
14617433|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
14617434|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
14617435|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14617436|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14617437|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617438|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617439|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617440|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14617441|NCT00102583|Cyclosporine|cyclosporine|mesh-list
14617442|NCT00102583|Cyclosporins|cyclosporins|mesh-list
14617443|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617444|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617445|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617446|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
14617447|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617448|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
14617449|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617450|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
14617451|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14617452|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14617453|NCT00102609|Dexamethasone|dexamethasone|mesh-list
14617454|NCT00102609|Doxorubicin|doxorubicin|mesh-list
14617455|NCT00102609|Trabectedin|trabectedin|mesh-list
14617456|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14617457|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
14617458|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
14617459|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617460|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617461|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617462|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
14617463|NCT00102609|Hormones|hormones|mesh-ancestor
14617464|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617465|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14617466|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617467|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14617468|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14617469|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14617470|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617471|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617472|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14617473|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
14617474|NCT00102622|Paclitaxel|paclitaxel|mesh-list
14617475|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14617476|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617477|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
14617478|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
14617479|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14617480|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617481|NCT00102635|Fenretinide|fenretinide|mesh-list
14617482|NCT00102635|Lonafarnib|lonafarnib|mesh-list
14617483|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617484|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14617485|NCT00102635|Protective Agents|protective agents|mesh-ancestor
14617486|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617487|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617488|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617489|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
14617490|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14617491|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617492|NCT00102674|Cangrelor|cangrelor|mesh-list
14617493|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14617494|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14617495|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14617496|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14617497|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
14617498|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617499|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617500|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617501|NCT00102700|Gemcitabine|gemcitabine|mesh-list
14617502|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
14617503|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617504|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
14617505|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617506|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617507|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
14617508|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617509|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617510|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617511|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
15163833|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163834|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163835|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15163836|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15163837|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
14617512|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617513|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14617514|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14617515|NCT00102713|Valproic Acid|valproic acid|mesh-list
14617516|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
14617517|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617518|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617519|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
14617520|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617521|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617522|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
14617523|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14617524|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14617525|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14617526|NCT00102752|Gemcitabine|gemcitabine|mesh-list
14617527|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617528|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
14617529|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617530|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617531|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
14617532|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617533|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617534|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617535|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
14617536|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617537|NCT00102765|Fluticasone|fluticasone|mesh-list
14617538|NCT00102765|Xhance|xhance|mesh-list
14617539|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14617540|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14617541|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14617542|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14617543|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
14617544|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617545|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617546|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14617547|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
14617548|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
14617549|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14617550|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14617551|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14617552|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14617553|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
14617554|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617555|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617556|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
14617557|NCT00102765|Hormones|hormones|mesh-ancestor
14617558|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617559|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
14617560|NCT00102778|Ritonavir|ritonavir|mesh-list
14617561|NCT00102778|Lopinavir|lopinavir|mesh-list
14617562|NCT00102778|Aplaviroc|aplaviroc|mesh-list
14617563|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14617564|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14617565|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617566|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617567|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163838|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163839|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163840|NCT04091880|Vaccines|vaccines|mesh-list
15163841|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
15163842|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163843|NCT04091815|Anesthetics|anesthetics|mesh-list
14617568|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14617569|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14617570|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
14617571|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617572|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14617573|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14617574|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14617575|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14617576|NCT00102830|Trebananib|trebananib|mesh-list
14617577|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14617578|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14617579|NCT00102830|Growth Substances|growth substances|mesh-ancestor
14617580|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617581|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14617582|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617583|NCT00102843|Folic Acid|folic acid|mesh-list
14617584|NCT00102843|Betaine|betaine|mesh-list
14617585|NCT00102843|Hematinics|hematinics|mesh-ancestor
14617586|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
14617587|NCT00102843|Vitamins|vitamins|mesh-ancestor
14617588|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
14617589|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617590|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617591|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
14617592|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14617593|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
14617594|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617595|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14617596|NCT00102856|Pramipexole|pramipexole|mesh-list
14617597|NCT00102856|Rivastigmine|rivastigmine|mesh-list
14617598|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
14617599|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617600|NCT00102856|Protective Agents|protective agents|mesh-ancestor
14617601|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617602|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14617603|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14617604|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
14617605|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
14617606|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617607|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14617608|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617609|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
14617610|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14617611|NCT00102869|Levodopa|levodopa|mesh-list
14617612|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14617613|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14617614|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
14617615|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617616|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617617|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163844|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163845|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163846|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
15163847|NCT04091698|Ubiquinone|ubiquinone|mesh-list
15163848|NCT04091698|Vitamins|vitamins|mesh-ancestor
15163849|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
15163850|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163851|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
15163852|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15163853|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15163854|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163855|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163856|NCT04091763|Polidocanol|polidocanol|mesh-list
15163857|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15163858|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15163859|NCT04091503|Temozolomide|temozolomide|mesh-list
15163860|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14617618|NCT00102882|Fluticasone|fluticasone|mesh-list
14617619|NCT00102882|Xhance|xhance|mesh-list
14617620|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14617621|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14617622|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14617623|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14617624|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
14617625|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617626|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617627|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14617628|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
15163861|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
15180827|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14617629|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
15163862|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617630|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14617631|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14617632|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14617633|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14617634|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14617635|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617636|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617637|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
14617638|NCT00102882|Hormones|hormones|mesh-ancestor
14617639|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617640|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
14617641|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
14617642|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14617643|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617644|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
14617645|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14617646|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14617647|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617648|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14617649|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14617650|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
14617651|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617652|NCT00102947|Daptomycin|daptomycin|mesh-list
14617653|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14617654|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617655|NCT00102973|Carboplatin|carboplatin|mesh-list
14617656|NCT00102973|Doxorubicin|doxorubicin|mesh-list
14617657|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14617658|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617659|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14617660|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14617661|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14617662|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617663|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617664|NCT00102986|Ritonavir|ritonavir|mesh-list
14617665|NCT00102986|Lopinavir|lopinavir|mesh-list
14617666|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14617667|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14617668|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617669|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617670|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617671|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14617672|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14617673|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
14617674|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617675|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14617676|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14617677|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14617678|NCT00103038|Hematinics|hematinics|mesh-ancestor
14617679|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14617680|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14617681|NCT00103051|Gemcitabine|gemcitabine|mesh-list
14617682|NCT00103051|Gefitinib|gefitinib|mesh-list
14617683|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617684|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617685|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
14617686|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617687|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
14617688|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617689|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617690|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617691|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
14617692|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617693|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617694|NCT00103103|Leucovorin|leucovorin|mesh-list
14617695|NCT00103103|Fluorouracil|fluorouracil|mesh-list
14617696|NCT00103103|Bortezomib|bortezomib|mesh-list
14617697|NCT00103103|Calcium|calcium|mesh-list
14617698|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
14617699|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14617700|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617701|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
14617702|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617703|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617704|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617705|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617706|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
14617707|NCT00103103|Antidotes|antidotes|mesh-ancestor
14617708|NCT00103103|Protective Agents|protective agents|mesh-ancestor
14617709|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
14617710|NCT00103103|Vitamins|vitamins|mesh-ancestor
14617711|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
14617712|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
14617713|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617714|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617715|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163863|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163864|NCT04091490|Nivolumab|nivolumab|mesh-list
15163865|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15163866|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163867|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15163868|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163869|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
15163870|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15163871|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15163872|NCT04091412|Protective Agents|protective agents|mesh-ancestor
15163873|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617716|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617717|NCT00103233|Trastuzumab|trastuzumab|mesh-list
15163874|NCT04091204|Olaparib|olaparib|mesh-list
15163875|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15163876|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163877|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163878|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163879|NCT04091074|Clopidogrel|clopidogrel|mesh-list
15163880|NCT04091074|Ticagrelor|ticagrelor|mesh-list
15163881|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15163882|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15180828|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14617718|NCT00103233|Vinorelbine|vinorelbine|mesh-list
14617719|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14617720|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617721|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14617722|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
14617723|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
14617724|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
14617725|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617726|NCT00103246|Silicon|silicon|mesh-list
14617727|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
14617728|NCT00103246|Trace Elements|trace elements|mesh-ancestor
14617729|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
14617730|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617731|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
14617732|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14617733|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14617734|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617735|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
14617736|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14617737|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
14617738|NCT00103272|Bortezomib|bortezomib|mesh-list
14617739|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617740|NCT00103298|Leucovorin|leucovorin|mesh-list
14617741|NCT00103298|Fluorouracil|fluorouracil|mesh-list
14617742|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
14617743|NCT00103298|Melphalan|melphalan|mesh-list
14617744|NCT00103298|Calcium|calcium|mesh-list
14617745|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
14617746|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14617747|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617748|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
14617749|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617750|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617751|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617752|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617753|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
14617754|NCT00103298|Antidotes|antidotes|mesh-ancestor
14814545|NCT00863733|Acetic Acid|acetic acid|mesh-list
14617755|NCT00103298|Protective Agents|protective agents|mesh-ancestor
14617756|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
14617757|NCT00103298|Vitamins|vitamins|mesh-ancestor
14617758|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
14617759|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14617760|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
14617761|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14617762|NCT00103324|Lapatinib|lapatinib|mesh-list
14617763|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617764|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617765|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617766|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617767|NCT00103389|Docetaxel|docetaxel|mesh-list
14617768|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617769|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
14617770|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14617771|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
14617772|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617773|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
14617774|NCT00103519|Hormones|hormones|mesh-ancestor
14617775|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617776|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617777|NCT00103545|Abagovomab|abagovomab|mesh-list
14617778|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14617779|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617780|NCT00103571|Olanzapine|olanzapine|mesh-list
14617781|NCT00103571|Aripiprazole|aripiprazole|mesh-list
14617782|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
14617783|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
14617784|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617785|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617786|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617787|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14617788|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14617789|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14617790|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14617791|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14617792|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14617793|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14617794|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617795|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617796|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
14617797|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14617798|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
14617799|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
14617800|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14617801|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14617802|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14617803|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14617804|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14617805|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14617806|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
14617807|NCT00103597|Domperidone|domperidone|mesh-list
14617808|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
14617809|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
14617810|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617811|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617812|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617813|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14617814|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
14617815|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617816|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617817|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14617818|NCT00103623|Abarelix|abarelix|mesh-list
14617819|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
14617820|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617821|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617822|NCT00103649|Xaliproden|xaliproden|mesh-list
14617823|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14617824|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14617825|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
14617826|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617827|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617828|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617829|NCT00103701|Dasatinib|dasatinib|mesh-list
14617830|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617831|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14617832|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163883|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15163884|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15163885|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
14617833|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617834|NCT00103727|Risperidone|risperidone|mesh-list
14617835|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14617836|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
14617837|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617838|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617839|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617840|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14617841|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14617842|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14617843|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14617844|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14617845|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
14617846|NCT00103753|Deferiprone|deferiprone|mesh-list
14617847|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14617848|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
14617849|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
14617850|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617851|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14617852|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14617853|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14617854|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617855|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
14617856|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14617857|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617858|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
14617859|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
15163886|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163887|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163888|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163889|NCT04091178|Vitamin D|vitamin d|mesh-list
15163890|NCT04091178|Vitamins|vitamins|mesh-ancestor
14617860|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14617861|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
14617862|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617863|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15163891|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
14617864|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14617865|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
14617866|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617867|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617868|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14617869|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14617870|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14617871|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
14617872|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14617873|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617874|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617875|NCT00103805|Levodopa|levodopa|mesh-list
14617876|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14617877|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14617878|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
14617879|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617880|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617881|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617882|NCT00103818|Gaboxadol|gaboxadol|mesh-list
14617883|NCT00103818|Analgesics|analgesics|mesh-ancestor
14617884|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
14617885|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617886|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617887|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
14617888|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
14617889|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
14617890|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617891|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617892|NCT00103922|Cilomilast|cilomilast|mesh-list
14617893|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14617894|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14617895|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14645977|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
14617896|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617897|NCT00103935|Exenatide|exenatide|mesh-list
14617898|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14617899|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617900|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14617901|NCT00103935|Incretins|incretins|mesh-ancestor
14617902|NCT00103935|Hormones|hormones|mesh-ancestor
14617903|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617904|NCT00103948|Donepezil|donepezil|mesh-list
14617905|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14617906|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617907|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617908|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
14617909|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617910|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617911|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
15163892|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163893|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15163894|NCT04091009|Buprenorphine|buprenorphine|mesh-list
15163895|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15163896|NCT04091009|Naloxone|naloxone|mesh-list
15163897|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15163898|NCT04091009|Narcotics|narcotics|mesh-ancestor
15163899|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163900|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163901|NCT04091009|Analgesics|analgesics|mesh-ancestor
15163902|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
15163903|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163904|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15163905|NCT04090879|Nicotine|nicotine|mesh-list
15163906|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15163907|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
15163908|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163909|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163910|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15163911|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15163912|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
15163913|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15163914|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163915|NCT04090697|Oxandrolone|oxandrolone|mesh-list
15163916|NCT04090697|Androgens|androgens|mesh-ancestor
15163917|NCT04090697|Hormones|hormones|mesh-ancestor
15163918|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163919|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163920|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
15163921|NCT04090736|Azacitidine|azacitidine|mesh-list
15163922|NCT04090736|Pevonedistat|pevonedistat|mesh-list
14022250|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14617912|NCT00104013|Xaliproden|xaliproden|mesh-list
14617913|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14617914|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14617915|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
14617916|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617917|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617918|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617919|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
14617920|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
14617921|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
14617922|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
14617923|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617924|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617925|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
14617926|NCT00104169|Hematinics|hematinics|mesh-ancestor
14617927|NCT00104182|Insulin|insulin|mesh-list
14617928|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14617929|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
14617930|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
14617931|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
14617932|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
14617933|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14617934|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617935|NCT00104260|Verapamil|verapamil|mesh-list
14617936|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14617937|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14617938|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163923|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14617939|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617940|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14617941|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617942|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
14645978|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
14645979|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
14645980|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645981|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14645982|NCT00195910|Morphine|morphine|mesh-list
14645983|NCT00195910|Hydromorphone|hydromorphone|mesh-list
14645984|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14645985|NCT00195910|Narcotics|narcotics|mesh-ancestor
14645986|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14645987|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14645988|NCT00195910|Analgesics|analgesics|mesh-ancestor
14645989|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
14645990|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14645991|NCT00195923|Clindamycin|clindamycin|mesh-list
14645992|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
14645993|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
14645994|NCT00195923|Gentamicins|gentamicins|mesh-list
14645995|NCT00195923|Ceftazidime|ceftazidime|mesh-list
14645996|NCT00195923|Ampicillin|ampicillin|mesh-list
14645997|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14645998|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14645999|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14646000|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646001|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646002|NCT00195936|Cinacalcet|cinacalcet|mesh-list
14646003|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14646004|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646005|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14646006|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
14646007|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646008|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
15163924|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
14646009|NCT00195988|Tacrolimus|tacrolimus|mesh-list
14646010|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646011|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
14646012|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646013|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14646014|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646015|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646016|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646017|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646018|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14646019|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
14646020|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14646021|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646022|NCT00196131|Morphine|morphine|mesh-list
14646023|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14646024|NCT00196131|Narcotics|narcotics|mesh-ancestor
14646025|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646026|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646027|NCT00196131|Analgesics|analgesics|mesh-ancestor
14646028|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
14646029|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647473|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647474|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
14647475|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647476|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14647477|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14647478|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14647479|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14647480|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14647481|NCT00200174|Exemestane|exemestane|mesh-list
14647482|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647483|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15163925|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163926|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163927|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163928|NCT04090801|Ethanol|ethanol|mesh-list
15163929|NCT04090801|Minoxidil|minoxidil|mesh-list
14647484|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14647485|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617943|NCT00104273|Rasagiline|rasagiline|mesh-list
14617944|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14617945|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617946|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617947|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14617948|NCT00104273|Protective Agents|protective agents|mesh-ancestor
14617949|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617950|NCT00104286|Troxacitabine|troxacitabine|mesh-list
14617951|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617952|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14617953|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14617954|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
14617955|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163930|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15163931|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15163932|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163933|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163934|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15163935|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
15180829|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180830|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15180831|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15180832|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15180833|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15180834|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180835|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
15180836|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180837|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180838|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15180839|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180840|NCT03935074|Melphalan|melphalan|mesh-list
15180841|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15180842|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
15180843|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180844|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180845|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15180846|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180847|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
14617956|NCT00104403|Dexamethasone|dexamethasone|mesh-list
14617957|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
14617958|NCT00104403|Ondansetron|ondansetron|mesh-list
14617959|NCT00104403|Casopitant|casopitant|mesh-list
14617960|NCT00104403|BB 1101|bb 1101|mesh-list
14617961|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14617962|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
14617963|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
14617964|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14617965|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14617966|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14617967|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
14617968|NCT00104403|Hormones|hormones|mesh-ancestor
14617969|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14617970|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14617971|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14617972|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
14617973|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14617974|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617975|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
14617976|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14617977|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14617978|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
14617979|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14617980|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14617981|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14617982|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14617983|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14617984|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14617985|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14617986|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14617987|NCT00104429|Aplaviroc|aplaviroc|mesh-list
14617988|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14617989|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14617990|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646030|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
14814546|NCT00863733|Vadimezan|vadimezan|mesh-list
14617991|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14617992|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
14617993|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14617994|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14617995|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14617996|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14617997|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14617998|NCT00104442|Rivastigmine|rivastigmine|mesh-list
14617999|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14618000|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618001|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618002|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
14618003|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618004|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618005|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14618006|NCT00104442|Protective Agents|protective agents|mesh-ancestor
14618007|NCT00104468|Troxacitabine|troxacitabine|mesh-list
14618008|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618009|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14618010|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14618011|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
14618012|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618013|NCT00104546|Vitamin K|vitamin k|mesh-list
14618014|NCT00104546|Vitamins|vitamins|mesh-ancestor
14618015|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
14618016|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618017|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14618018|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14618019|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618020|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
14618021|NCT00104546|Coagulants|coagulants|mesh-ancestor
14618022|NCT00104598|Bupropion|bupropion|mesh-list
14618023|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14618024|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
14618025|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618026|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14618027|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14618028|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618029|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618030|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
14618031|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618032|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618033|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14618034|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14618035|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618036|NCT00104624|Docetaxel|docetaxel|mesh-list
14618037|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618038|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
14618039|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
14618040|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
14618041|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618042|NCT00104663|Quinacrine|quinacrine|mesh-list
14618043|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
14618044|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14618045|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
14618046|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14618047|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618048|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
14618049|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14618050|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
14618051|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618052|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618053|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618054|NCT00104689|Capecitabine|capecitabine|mesh-list
14022251|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14022252|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14022253|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15163936|NCT04090112|Lidocaine|lidocaine|mesh-list
14022254|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14022255|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
14618055|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
14618056|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14814100|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618057|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
14618058|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814101|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814102|NCT00861510|ON 01910|on 01910|mesh-list
14814103|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814104|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15163937|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
15163938|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
15163939|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15163940|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163941|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
14618059|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618060|NCT00104715|Docetaxel|docetaxel|mesh-list
14618061|NCT00104715|Goserelin|goserelin|mesh-list
14618062|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
14618063|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618064|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
14618065|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
14618066|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
14618067|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618068|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14618069|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618070|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618071|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618072|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14618073|NCT00104741|Flutamide|flutamide|mesh-list
14618074|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
14618075|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14618076|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
14618077|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14618078|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618079|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14618080|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14618081|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618082|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
14618083|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618084|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618085|NCT00104767|Celecoxib|celecoxib|mesh-list
14618086|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14618087|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14618088|NCT00104767|Analgesics|analgesics|mesh-ancestor
14618089|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
14618090|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618091|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163942|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15163943|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15163944|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14618092|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14618093|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618094|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14618095|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14618096|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618097|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618098|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
14618099|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14618100|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
14618101|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618102|NCT00104793|Carboplatin|carboplatin|mesh-list
14618103|NCT00104793|Irinotecan|irinotecan|mesh-list
14618104|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618105|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14618106|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618107|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618108|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618109|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
14618110|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
14618111|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14618112|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618113|NCT00104806|Vitamins|vitamins|mesh-ancestor
14618114|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
14618115|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14618116|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618117|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
14618118|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14618119|NCT00104819|Antibodies|antibodies|mesh-list
14618120|NCT00104819|Sargramostim|sargramostim|mesh-list
14618121|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14618122|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
14618123|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618124|NCT00104845|Vaccines|vaccines|mesh-list
14618125|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
14618126|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618127|NCT00104910|Cetuximab|cetuximab|mesh-list
14618128|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618129|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14618130|NCT00104923|Fenretinide|fenretinide|mesh-list
14618131|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618132|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14618133|NCT00104923|Protective Agents|protective agents|mesh-ancestor
14618134|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618135|NCT00104949|Trastuzumab|trastuzumab|mesh-list
14618136|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14618137|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618138|NCT00104962|Lenalidomide|lenalidomide|mesh-list
14618139|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
14618140|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618141|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14618142|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14618143|NCT00104962|Growth Substances|growth substances|mesh-ancestor
14618144|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14618145|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618146|NCT00104975|Fludarabine|fludarabine|mesh-list
15163945|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15163946|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15163947|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163948|NCT04090047|Itraconazole|itraconazole|mesh-list
15163949|NCT04090047|PF-06700841|pf-06700841|mesh-list
14618147|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
14618148|NCT00104975|Melphalan|melphalan|mesh-list
14618149|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
14618150|NCT00104975|Thiotepa|thiotepa|mesh-list
14618151|NCT00104975|Tacrolimus|tacrolimus|mesh-list
14618152|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618153|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14618154|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
14618155|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618156|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618157|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
14618158|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618159|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14618160|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618161|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14618162|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
14618163|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14618164|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14618165|NCT00104988|Thalidomide|thalidomide|mesh-list
14618166|NCT00104988|Temozolomide|temozolomide|mesh-list
14618167|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14618168|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
14618169|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618170|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618171|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618172|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
14618173|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618174|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
14618175|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14618176|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618177|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14618178|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14618179|NCT00104988|Growth Substances|growth substances|mesh-ancestor
14618180|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
14618181|NCT00105040|Levetiracetam|levetiracetam|mesh-list
14618182|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
14618183|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
14618184|NCT00105105|Mifepristone|mifepristone|mesh-list
14618185|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15163950|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
15163951|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022256|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14618186|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
14618187|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14618188|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618189|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14618190|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14618191|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14618192|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
15163952|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15163953|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15163954|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163955|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163956|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15163957|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
15163958|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15163959|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15163960|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15163961|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14618193|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14618194|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14618195|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618196|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618197|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
14618198|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14618199|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14618200|NCT00105144|Caspofungin|caspofungin|mesh-list
14618201|NCT00105144|Micafungin|micafungin|mesh-list
14618202|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
14618203|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618204|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618205|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618206|NCT00105209|Aspirin|aspirin|mesh-list
14618207|NCT00105209|Clopidogrel|clopidogrel|mesh-list
14618208|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14618209|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14618210|NCT00105209|Analgesics|analgesics|mesh-ancestor
14618211|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
14618212|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618213|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618214|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14618215|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618216|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14618217|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14618218|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618219|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14618220|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14618221|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163962|NCT04090021|Amoxicillin|amoxicillin|mesh-list
15163963|NCT04090021|Metronidazole|metronidazole|mesh-list
15163964|NCT04090021|Clarithromycin|clarithromycin|mesh-list
15163965|NCT04090021|Levofloxacin|levofloxacin|mesh-list
15163966|NCT04090021|Ofloxacin|ofloxacin|mesh-list
15163967|NCT04090021|Rifabutin|rifabutin|mesh-list
15163968|NCT04090021|Esomeprazole|esomeprazole|mesh-list
14022257|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
14618222|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
14618223|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14618224|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14618225|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14618226|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
14618227|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618228|NCT00105287|Fentanyl|fentanyl|mesh-list
14618229|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14618230|NCT00105287|Narcotics|narcotics|mesh-ancestor
14618231|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618232|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618233|NCT00105287|Analgesics|analgesics|mesh-ancestor
14618234|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
14618235|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618236|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14618237|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14618238|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
15163969|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15163970|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618239|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
14618240|NCT00105300|Adalimumab|adalimumab|mesh-list
14618241|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022258|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
14618242|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618243|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14618244|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14618245|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14618246|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618247|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618248|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618249|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14618250|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14618251|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
14618252|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618253|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618254|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14618255|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14618256|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
14618257|NCT00105352|Glucagon|glucagon|mesh-list
14618258|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14618259|NCT00105352|Hormones|hormones|mesh-ancestor
14618260|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618261|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618262|NCT00105404|Triamcinolone|triamcinolone|mesh-list
14618263|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14618264|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14618265|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14618266|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14618267|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
14618268|NCT00105404|Hormones|hormones|mesh-ancestor
14618269|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618270|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618271|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618272|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
14618273|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618274|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618275|NCT00105495|Deferiprone|deferiprone|mesh-list
14618276|NCT00105495|Deferoxamine|deferoxamine|mesh-list
14618277|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14618278|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
14618279|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
14618280|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618281|NCT00105495|Siderophores|siderophores|mesh-ancestor
14618282|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
14618283|NCT00105547|Analgesics|analgesics|mesh-ancestor
14618284|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
14618285|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618286|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618287|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14618288|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14618289|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14618290|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618291|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14618292|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618293|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618294|NCT00105937|Fentanyl|fentanyl|mesh-list
14618295|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14618296|NCT00105937|Narcotics|narcotics|mesh-ancestor
14618297|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618298|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618299|NCT00105937|Analgesics|analgesics|mesh-ancestor
14618300|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
14618301|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618302|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14618303|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14618304|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
14618305|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
14618306|NCT00105950|Lapatinib|lapatinib|mesh-list
14618307|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618308|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14618309|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163971|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15163972|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15163973|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15163974|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14618310|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618311|NCT00106054|Leucovorin|leucovorin|mesh-list
14618312|NCT00106054|Bevacizumab|bevacizumab|mesh-list
14618313|NCT00106054|Irinotecan|irinotecan|mesh-list
15163975|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15163976|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163977|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163978|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15163979|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15163980|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15163981|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15163982|NCT04090021|Renal Agents|renal agents|mesh-ancestor
15163983|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14618314|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14618315|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618316|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14618317|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14618318|NCT00106054|Growth Substances|growth substances|mesh-ancestor
14618319|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618320|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
14618321|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14618322|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618323|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618324|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618325|NCT00106054|Antidotes|antidotes|mesh-ancestor
14618326|NCT00106054|Protective Agents|protective agents|mesh-ancestor
14618327|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
14618328|NCT00106054|Vitamins|vitamins|mesh-ancestor
14618329|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
14646031|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14646032|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
14646033|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14646034|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646035|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14646036|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14646037|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14646038|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
14646039|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14646040|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
14646041|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14646042|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646043|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14646044|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14646045|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14646046|NCT00196378|Estrogens|estrogens|mesh-list
14646047|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14646048|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
14646049|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
14646050|NCT00196378|Hormones|hormones|mesh-ancestor
14646051|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646052|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646053|NCT00196391|Progesterone|progesterone|mesh-list
14646054|NCT00196391|Progestins|progestins|mesh-ancestor
14646055|NCT00196391|Hormones|hormones|mesh-ancestor
14646056|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646057|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646058|NCT00196417|Heparin|heparin|mesh-list
14646059|NCT00196417|Certoparin|certoparin|mesh-list
15163984|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15163985|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163986|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15163987|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15163988|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
15163989|NCT04089657|Apatinib|apatinib|mesh-list
15163990|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15163991|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15163992|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15163993|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15163994|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
15163995|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15163996|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15163997|NCT04089813|Metformin|metformin|mesh-list
15163998|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14646060|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
14646061|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15163999|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164000|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
15164001|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14618330|NCT00106132|Triamcinolone|triamcinolone|mesh-list
14618331|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14618332|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14618333|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14618334|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14618335|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
14618336|NCT00106132|Hormones|hormones|mesh-ancestor
14618337|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618338|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618339|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618340|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
14618341|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618342|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618343|NCT00106158|Vaccines|vaccines|mesh-list
14618344|NCT00106158|Immunologic Factors|immunologic factors|mesh-ancestor
14618345|NCT00106158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618346|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14618347|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
14618348|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618349|NCT00106197|Bupropion|bupropion|mesh-list
14618350|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14618351|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
14618352|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618353|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14618354|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14618355|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164002|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
15164003|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
15164004|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164005|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164006|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14618356|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618357|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
14618358|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618359|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618360|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14618361|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14618362|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618363|NCT00106262|Irinotecan|irinotecan|mesh-list
14618364|NCT00106262|Bortezomib|bortezomib|mesh-list
14618365|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14618366|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618367|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618368|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618369|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618370|NCT00106288|Amphotericin B|amphotericin b|mesh-list
14618371|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14618372|NCT00106288|Micafungin|micafungin|mesh-list
14618373|NCT00106288|Amebicides|amebicides|mesh-ancestor
14618374|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14618375|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14618376|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618377|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14618378|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
14618379|NCT00106301|Romidepsin|romidepsin|mesh-list
14618380|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14618381|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618382|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14618383|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14618384|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
14618385|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618386|NCT00106366|Insulin|insulin|mesh-list
15164007|NCT04089852|Analgesics|analgesics|mesh-ancestor
15164008|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
15164009|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164010|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
15164011|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164012|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164013|NCT04089631|Capecitabine|capecitabine|mesh-list
15164014|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14618387|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14618388|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
14618389|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
14618390|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
14618391|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15164015|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
14618392|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618393|NCT00106379|Tenofovir|tenofovir|mesh-list
15164016|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618394|NCT00106379|Emtricitabine|emtricitabine|mesh-list
14618395|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14618396|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
14618397|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618398|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14618399|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14618400|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618401|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618402|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14618403|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14618404|NCT00106405|Memantine|memantine|mesh-list
14618405|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14618406|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14618407|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
14618408|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618409|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618410|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618411|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14618412|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14618413|NCT00106418|Romidepsin|romidepsin|mesh-list
14618414|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14618415|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618416|NCT00106496|Tacrolimus|tacrolimus|mesh-list
14618417|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618418|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
14618419|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618420|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14618421|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618422|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618423|NCT00106522|Methotrexate|methotrexate|mesh-list
14618424|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14618425|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
14618426|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14618427|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618428|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14618429|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
14618430|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618431|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618432|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
14618433|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618434|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14618435|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618436|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
14618437|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618438|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14618439|NCT00106548|Methotrexate|methotrexate|mesh-list
14618440|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14618441|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
14618442|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14618443|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618444|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14618445|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
14618446|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618447|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618448|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
14618449|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618450|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14618451|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618452|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
14618453|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618454|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14618455|NCT00106561|Irbesartan|irbesartan|mesh-list
14618456|NCT00106561|Spironolactone|spironolactone|mesh-list
14618457|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14618458|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618459|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618460|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618461|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14618462|NCT00106561|Diuretics|diuretics|mesh-ancestor
14618463|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
14618464|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14618465|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14618466|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14618467|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618468|NCT00106587|Paclitaxel|paclitaxel|mesh-list
14618469|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14618470|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618471|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14618472|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14618473|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14618474|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618475|NCT00106600|Pixantrone|pixantrone|mesh-list
14618476|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15164017|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164018|NCT04089605|Dexamethasone|dexamethasone|mesh-list
14618477|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618478|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618479|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618480|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618481|NCT00106613|Romidepsin|romidepsin|mesh-list
14618482|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14618483|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618484|NCT00106691|Toremifene|toremifene|mesh-list
14618485|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14618486|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618487|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14618488|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14618489|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618490|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618491|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618492|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14618493|NCT00106821|Bromides|bromides|mesh-list
14618494|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
14618495|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14618496|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
14618497|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618498|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618499|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14618500|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
14618501|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
14618502|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14618503|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
14618504|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618505|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618506|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
14618507|NCT00106834|Infliximab|infliximab|mesh-list
14618508|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14618509|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14618510|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618511|NCT00106847|Infliximab|infliximab|mesh-list
14618512|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14618513|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14618514|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618515|NCT00106886|Folic Acid|folic acid|mesh-list
14618516|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
14618517|NCT00106886|Pyridoxal|pyridoxal|mesh-list
14618518|NCT00106886|Pyridoxine|pyridoxine|mesh-list
14618519|NCT00106886|Vitamins|vitamins|mesh-ancestor
14618520|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
14618521|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618522|NCT00106886|Hematinics|hematinics|mesh-ancestor
14618523|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
15164019|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
15164020|NCT04089605|Ranibizumab|ranibizumab|mesh-list
15164021|NCT04089605|BB 1101|bb 1101|mesh-list
15164022|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164023|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
15164024|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
15164025|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164026|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618524|NCT00107003|Lapatinib|lapatinib|mesh-list
14618525|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618526|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14618527|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814105|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164027|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14618528|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618529|NCT00107016|Letrozole|letrozole|mesh-list
14618530|NCT00107016|Everolimus|everolimus|mesh-list
14618531|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618532|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14618533|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14618534|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618535|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618536|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14618537|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618538|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618539|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618540|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618541|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
14618542|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14618543|NCT00107081|Amoxicillin|amoxicillin|mesh-list
14618544|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
14618545|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618546|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14618547|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618548|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618549|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618550|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618551|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14618552|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14618553|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14618554|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618555|NCT00107107|Pramlintide|pramlintide|mesh-list
14618556|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14618557|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618558|NCT00107237|Everolimus|everolimus|mesh-list
14618559|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618560|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618561|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
14618562|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618563|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
14618564|NCT00107263|Letrozole|letrozole|mesh-list
14618565|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618566|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14618567|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14618568|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618569|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618570|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14618571|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618572|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618573|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618574|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14618575|NCT00107341|Paclitaxel|paclitaxel|mesh-list
14618576|NCT00107341|Carboplatin|carboplatin|mesh-list
14618577|NCT00107341|Bortezomib|bortezomib|mesh-list
14618578|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14618579|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618580|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
14618581|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
14618582|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
14618583|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618584|NCT00107354|Cytarabine|cytarabine|mesh-list
14618585|NCT00107354|Aldesleukin|aldesleukin|mesh-list
14618586|NCT00107354|Etoposide|etoposide|mesh-list
14618587|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
14618588|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14618589|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618590|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14618591|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618592|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618593|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618594|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022259|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
14022260|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14022261|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14022262|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
14022263|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022264|NCT02769390|Clonidine|clonidine|mesh-list
14618595|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
14022265|NCT02769390|Diazepam|diazepam|mesh-list
14618596|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
14618597|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618598|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618599|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
14618600|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618601|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14618602|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14618603|NCT00107354|Analgesics|analgesics|mesh-ancestor
14618604|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
14618605|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618606|NCT00107393|Capecitabine|capecitabine|mesh-list
14618607|NCT00107393|Trastuzumab|trastuzumab|mesh-list
14618608|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164028|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
15164029|NCT04089605|Hormones|hormones|mesh-ancestor
15164030|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164031|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15164032|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164033|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
15164034|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164035|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164036|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14618609|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
14618610|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618611|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618612|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14618613|NCT00107419|Pemetrexed|pemetrexed|mesh-list
14618614|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618615|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618616|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618617|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14618618|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14618619|NCT00107432|Sorafenib|sorafenib|mesh-list
14618620|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618621|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14618622|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618623|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618624|NCT00107458|Valproic Acid|valproic acid|mesh-list
14618625|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
14618626|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618627|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618628|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
14618629|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618630|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618631|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
14618632|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14618633|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618634|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618635|NCT00107471|Topotecan|topotecan|mesh-list
15164037|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15164038|NCT04089605|Growth Substances|growth substances|mesh-ancestor
15164039|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
15164040|NCT04089592|Fentanyl|fentanyl|mesh-list
15164041|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
15164042|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15164043|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164044|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164045|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15164046|NCT04089592|Analgesics|analgesics|mesh-ancestor
14618636|NCT00107471|Lenograstim|lenograstim|mesh-list
14618637|NCT00107471|Sargramostim|sargramostim|mesh-list
14618638|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14618639|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
14618640|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618641|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14618642|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618643|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618644|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618645|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618646|NCT00107510|Carboplatin|carboplatin|mesh-list
14618647|NCT00107510|Docetaxel|docetaxel|mesh-list
15164047|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
14618648|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618649|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
14618650|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
14618651|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
14618652|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618653|NCT00107523|Cytarabine|cytarabine|mesh-list
14618654|NCT00107523|Idarubicin|idarubicin|mesh-list
14618655|NCT00107523|Pravastatin|pravastatin|mesh-list
14618656|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14618657|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
14618658|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618659|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618660|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
14618661|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14618662|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14618663|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
14618664|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618665|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14618666|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14618667|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14618668|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618669|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14618670|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14618671|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14618672|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14618673|NCT00107601|Insulin|insulin|mesh-list
14618674|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14618675|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618676|NCT00107731|Valproic Acid|valproic acid|mesh-list
14618677|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15164048|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164049|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15164050|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15164051|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15164052|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164053|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164054|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164055|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15164056|NCT04089592|Narcotics|narcotics|mesh-ancestor
15164057|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15164058|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15164059|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
15164060|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
15164061|NCT04089345|Ustekinumab|ustekinumab|mesh-list
15164062|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
15164063|NCT04089163|Flucytosine|flucytosine|mesh-list
15164064|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
15164065|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164066|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
15164067|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164068|NCT04089072|Phenylephrine|phenylephrine|mesh-list
15164069|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
15164070|NCT04089072|Methylene Blue|methylene blue|mesh-list
15164071|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15164072|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
15164073|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
15164074|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164075|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164076|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
15164077|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15164078|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
15164079|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
14618678|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
14618679|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618680|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14618681|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14618682|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618683|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618684|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618685|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618686|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
14618687|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
14618688|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
14618689|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618690|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
15164080|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15164081|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15164082|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14618691|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14618692|NCT00107796|Modafinil|modafinil|mesh-list
14618693|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14618694|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618695|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14618696|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14618697|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14618698|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618699|NCT00107809|Modafinil|modafinil|mesh-list
14618700|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14618701|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618702|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15164083|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164084|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164085|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164086|NCT04089072|Protective Agents|protective agents|mesh-ancestor
15164087|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164088|NCT04089176|Oxytocin|oxytocin|mesh-list
15164089|NCT04089176|Carbetocin|carbetocin|mesh-list
15164090|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
15164091|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15164092|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164093|NCT04088851|Metformin|metformin|mesh-list
15164094|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15164095|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164096|NCT04088903|Daratumumab|daratumumab|mesh-list
15164097|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164098|NCT04088604|Fluorouracil|fluorouracil|mesh-list
14618703|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14618704|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14618705|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618706|NCT00107822|Lidocaine|lidocaine|mesh-list
14618707|NCT00107822|Tetracaine|tetracaine|mesh-list
14618708|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
14618709|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
14618710|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618711|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618712|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
14618713|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618714|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14618715|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14618716|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14618717|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618718|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618719|NCT00107835|Lidocaine|lidocaine|mesh-list
14618720|NCT00107835|Tetracaine|tetracaine|mesh-list
14618721|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
14618722|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
14618723|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164099|NCT04088604|Irinotecan|irinotecan|mesh-list
14618724|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618725|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
14618726|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618727|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14618728|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14618729|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14618730|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618731|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618732|NCT00107848|Modafinil|modafinil|mesh-list
14618733|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14618734|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618735|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14618736|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14618737|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14618738|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618739|NCT00107874|Misoprostol|misoprostol|mesh-list
14618740|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14618741|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
14618742|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14618743|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618744|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14618745|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15164100|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
15164101|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618746|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
14646062|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14646063|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646064|NCT00196469|Heparin|heparin|mesh-list
14646065|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
14646066|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14646067|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14646068|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646069|NCT00196534|Thrombin|thrombin|mesh-list
14646070|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
14646071|NCT00196534|Coagulants|coagulants|mesh-ancestor
14646072|NCT00196547|Montelukast|montelukast|mesh-list
14646073|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14022266|NCT02769390|Analgesics|analgesics|mesh-ancestor
14022267|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
14022268|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022269|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022270|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14646074|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
14646075|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14646076|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
14646077|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646078|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646079|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14646080|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14646081|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646082|NCT00196586|Interferons|interferons|mesh-list
14646083|NCT00196586|Ribavirin|ribavirin|mesh-list
14646084|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
14646085|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
14646086|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14646087|NCT00196586|Interleukin-2|interleukin-2|mesh-list
14646088|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646089|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
14646090|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646091|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
14646092|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646093|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
14646094|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646095|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14646096|NCT00196586|Analgesics|analgesics|mesh-ancestor
14646097|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
14646098|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646099|NCT00196599|Emtricitabine|emtricitabine|mesh-list
14646100|NCT00196599|Efavirenz|efavirenz|mesh-list
14646101|NCT00196599|Didanosine|didanosine|mesh-list
14646102|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
14646103|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646104|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14646105|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646106|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646107|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646108|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14646109|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14646110|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14646111|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14646112|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14646113|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14646114|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14646115|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14646116|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
14646117|NCT00196612|Emtricitabine|emtricitabine|mesh-list
14646118|NCT00196612|Efavirenz|efavirenz|mesh-list
14646119|NCT00196612|Didanosine|didanosine|mesh-list
14646120|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
14646121|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646122|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14646123|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646124|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646125|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646126|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14646127|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14646128|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14646129|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14618747|NCT00108004|Pramlintide|pramlintide|mesh-list
14618748|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14618749|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618750|NCT00108017|Timolol|timolol|mesh-list
14618751|NCT00108017|Dorzolamide|dorzolamide|mesh-list
14618752|NCT00108017|Maleic acid|maleic acid|mesh-list
14618753|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14618754|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14618755|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14618756|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618757|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618758|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618759|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14618760|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14618761|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618762|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14618763|NCT00108095|Ondansetron|ondansetron|mesh-list
14618764|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
14618765|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
14618766|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618767|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618768|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14618769|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
14618770|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
14618771|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14618772|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
14618773|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618774|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618775|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14618776|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14618777|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618778|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618779|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14618780|NCT00108186|Celecoxib|celecoxib|mesh-list
14618781|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14618782|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14618783|NCT00108186|Analgesics|analgesics|mesh-ancestor
14618784|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
14618785|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618786|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618787|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14618788|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14618789|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14618790|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14618791|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618792|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618793|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14618794|NCT00108238|Estradiol|estradiol|mesh-list
14618795|NCT00108238|Progesterone|progesterone|mesh-list
14618796|NCT00108238|Estrogens|estrogens|mesh-ancestor
14618797|NCT00108238|Hormones|hormones|mesh-ancestor
14618798|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618799|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618800|NCT00108238|Progestins|progestins|mesh-ancestor
14618801|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14618802|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618803|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14618804|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14618805|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14618806|NCT00108251|Eplerenone|eplerenone|mesh-list
14618807|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14618808|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
14618809|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618810|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618811|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14618812|NCT00108251|Diuretics|diuretics|mesh-ancestor
14618813|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
14618814|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14618815|NCT00108316|Fluoxetine|fluoxetine|mesh-list
14618816|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14618817|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14618818|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618819|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618820|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618821|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
14618822|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618823|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14618824|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
14618825|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15164102|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164103|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164104|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164105|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
15164106|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164107|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14618826|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14618827|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14618828|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618829|NCT00108368|Olanzapine|olanzapine|mesh-list
14618830|NCT00108368|Risperidone|risperidone|mesh-list
14618831|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14618832|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
14618833|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618834|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618835|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618836|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14618837|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14618838|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618839|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618840|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14618841|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
14618842|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
14618843|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
14618844|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618845|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14618846|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14618847|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14618848|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618849|NCT00108394|Pamidronate|pamidronate|mesh-list
14618850|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14618851|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618852|NCT00108420|Prazosin|prazosin|mesh-list
14618853|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14618854|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14618855|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14618856|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14618857|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
14618858|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618859|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618860|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618861|NCT00108446|Lidocaine|lidocaine|mesh-list
14618862|NCT00108446|Fentanyl|fentanyl|mesh-list
14618863|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
14618864|NCT00108446|Naloxone|naloxone|mesh-list
14618865|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
14618866|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
14618867|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618868|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618869|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
14618870|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618871|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14618872|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14618873|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14618874|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618875|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618876|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14618877|NCT00108446|Narcotics|narcotics|mesh-ancestor
14618878|NCT00108446|Analgesics|analgesics|mesh-ancestor
15164108|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15164109|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164110|NCT04088461|Metformin|metformin|mesh-list
15164111|NCT04088461|Linagliptin|linagliptin|mesh-list
15164112|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15164113|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164114|NCT04088461|Incretins|incretins|mesh-ancestor
15164115|NCT04088461|Hormones|hormones|mesh-ancestor
15164116|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14618879|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14618880|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14618881|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
14618882|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14618883|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
14618884|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
14618885|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14618886|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14618887|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618888|NCT00108498|Mirtazapine|mirtazapine|mesh-list
14618889|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
14618890|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618891|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14618892|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
14618893|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
14618894|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618895|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618896|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618897|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14618898|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14618899|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618900|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14618901|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14618902|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14618903|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
14618904|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14618905|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14618906|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
14618907|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14618908|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
14618909|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14618910|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
14618911|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618912|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14618913|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14618914|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14618915|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618916|NCT00108537|Bupropion|bupropion|mesh-list
14618917|NCT00108537|Nicotine|nicotine|mesh-list
14618918|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14618919|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
14618920|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618921|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618922|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14618923|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14618924|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
14618925|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618926|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618927|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14618928|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
14618929|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618930|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14618931|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14618932|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618933|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
14618934|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14618935|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15164117|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15164118|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
15164119|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164120|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164121|NCT04088448|Metformin|metformin|mesh-list
15164122|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14618936|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618937|NCT00108563|Citalopram|citalopram|mesh-list
14618938|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14618939|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14618940|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14618941|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618942|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618943|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
14618944|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164123|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618945|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14618946|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
14618947|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618948|NCT00108576|Valproic Acid|valproic acid|mesh-list
14618949|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
14618950|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14618951|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618952|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
14618953|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618954|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618955|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
14618956|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14618957|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618958|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14618959|NCT00108602|Acetazolamide|acetazolamide|mesh-list
14618960|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
14618961|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14618962|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164124|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15164125|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15164126|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15164127|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180848|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180849|NCT03935347|Vidarabine|vidarabine|mesh-list
15180850|NCT03935347|Aldesleukin|aldesleukin|mesh-list
15180851|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
15180852|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
15180853|NCT03935347|Fludarabine|fludarabine|mesh-list
15180854|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
15180855|NCT03935347|Interleukin-2|interleukin-2|mesh-list
15180856|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
14618963|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618964|NCT00108602|Diuretics|diuretics|mesh-ancestor
14618965|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
14618966|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618967|NCT00108615|Metformin|metformin|mesh-list
14618968|NCT00108615|Pioglitazone|pioglitazone|mesh-list
14618969|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14618970|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618971|NCT00108667|Levodopa|levodopa|mesh-list
14618972|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14618973|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14618974|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
14618975|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14618976|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618977|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618978|NCT00108706|Candesartan|candesartan|mesh-list
14618979|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14618980|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14618981|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14618982|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14618983|NCT00108771|Fentanyl|fentanyl|mesh-list
14618984|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14618985|NCT00108771|Narcotics|narcotics|mesh-ancestor
14618986|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14618987|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14618988|NCT00108771|Analgesics|analgesics|mesh-ancestor
14618989|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
14618990|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14618991|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14618992|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14618993|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
14618994|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
14618995|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14618996|NCT00108797|Coagulants|coagulants|mesh-ancestor
14618997|NCT00108849|Estradiol|estradiol|mesh-list
14618998|NCT00108849|Estrogens|estrogens|mesh-ancestor
14618999|NCT00108849|Hormones|hormones|mesh-ancestor
14619000|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619001|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619002|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
14619003|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14619004|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
15180857|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
14619005|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180858|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15180859|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
14619006|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619007|NCT00108979|Citalopram|citalopram|mesh-list
14619008|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14619009|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14619010|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164128|NCT04088266|Buprenorphine|buprenorphine|mesh-list
15164129|NCT04088266|Naloxone|naloxone|mesh-list
15164130|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15164131|NCT04088266|Narcotics|narcotics|mesh-ancestor
15164132|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164133|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164134|NCT04088266|Analgesics|analgesics|mesh-ancestor
15164135|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
15164136|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164137|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14619011|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619012|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619013|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
14619014|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619015|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14619016|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
14619017|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14619018|NCT00108992|Diclofenac|diclofenac|mesh-list
14619019|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619020|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619021|NCT00108992|Analgesics|analgesics|mesh-ancestor
14619022|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
14619023|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619024|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619025|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619026|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619027|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14619028|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619029|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619030|NCT00109044|Citalopram|citalopram|mesh-list
14619031|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14619032|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14619033|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14619034|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619035|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619036|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
14619037|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619038|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14619039|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
14619040|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14619041|NCT00109057|Bevacizumab|bevacizumab|mesh-list
14619042|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619043|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619044|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14619045|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14619046|NCT00109057|Growth Substances|growth substances|mesh-ancestor
14619047|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619048|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
14619049|NCT00109070|Bevacizumab|bevacizumab|mesh-list
14619050|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619051|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619052|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14619053|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14619054|NCT00109070|Growth Substances|growth substances|mesh-ancestor
14619055|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619056|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
14619057|NCT00109096|Pemetrexed|pemetrexed|mesh-list
14619058|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619059|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619060|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619061|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14619062|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619063|NCT00109109|Vorinostat|vorinostat|mesh-list
14619064|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619065|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14619066|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164138|NCT04088032|Durvalumab|durvalumab|mesh-list
15164139|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14619067|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619068|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14619069|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14619070|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14619071|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619072|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619073|NCT00109135|Hormones|hormones|mesh-ancestor
14619074|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619075|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619076|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14619077|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14619078|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14619079|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619080|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619081|NCT00109148|Hormones|hormones|mesh-ancestor
14619082|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619083|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619084|NCT00109161|Antibodies|antibodies|mesh-list
14619085|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14619086|NCT00109161|Daclizumab|daclizumab|mesh-list
14619087|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
15164140|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164141|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164142|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14619088|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619089|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619090|NCT00109187|Omalizumab|omalizumab|mesh-list
14619091|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14619092|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14619093|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
14619094|NCT00109200|Omalizumab|omalizumab|mesh-list
14619095|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14619096|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14619097|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
14619098|NCT00109226|Bevacizumab|bevacizumab|mesh-list
14619099|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619100|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619101|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14619102|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14619103|NCT00109226|Growth Substances|growth substances|mesh-ancestor
14619104|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619105|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
15164143|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164144|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164145|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14619106|NCT00109239|Bevacizumab|bevacizumab|mesh-list
14619107|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619108|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619109|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14619110|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14619111|NCT00109239|Growth Substances|growth substances|mesh-ancestor
14619112|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619113|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
14619114|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14619115|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619116|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14619117|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619118|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619119|NCT00109278|Vaccines|vaccines|mesh-list
14619120|NCT00109278|Immunoglobulins|immunoglobulins|mesh-list
15164146|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
15164147|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164148|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164149|NCT04088175|Menthol|menthol|mesh-list
15164150|NCT04088175|Nicotine|nicotine|mesh-list
15164151|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15164152|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
15164153|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164154|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619121|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
14619122|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619123|NCT00109356|AQ4N|aq4n|mesh-list
14619124|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619125|NCT00109382|Aspirin|aspirin|mesh-list
14619126|NCT00109382|Clopidogrel|clopidogrel|mesh-list
14619127|NCT00109382|Simvastatin|simvastatin|mesh-list
14619128|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619129|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619130|NCT00109382|Analgesics|analgesics|mesh-ancestor
14619131|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
14619132|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619133|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619134|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619135|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619136|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14619137|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14619138|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619139|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14619140|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14619141|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619142|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
14619143|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14619144|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14619145|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14619146|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
14619147|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619148|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14619149|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14619150|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
14619151|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14619152|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14619153|NCT00109395|Midazolam|midazolam|mesh-list
14619154|NCT00109395|Lorazepam|lorazepam|mesh-list
14619155|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14619156|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14619157|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619158|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619159|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14619160|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14619161|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14619162|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14619163|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
14619164|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
14619165|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
14619166|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
14619167|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619168|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619169|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
14619170|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
14619171|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
14619172|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619173|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619174|NCT00109408|Methotrexate|methotrexate|mesh-list
14619175|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14619176|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
14619177|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14619178|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619179|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14619180|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
14619181|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619182|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619183|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
14619184|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619185|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14619186|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619187|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
14619188|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619189|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619190|NCT00109551|Folic Acid|folic acid|mesh-list
14619191|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
14619192|NCT00109551|Hematinics|hematinics|mesh-ancestor
14619193|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
14619194|NCT00109551|Vitamins|vitamins|mesh-ancestor
14619195|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
14619196|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619197|NCT00109551|Astringents|astringents|mesh-ancestor
14619198|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
14619199|NCT00109564|Acetylcholine|acetylcholine|mesh-list
14619200|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
14619201|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
14619202|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14619203|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
14619204|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619205|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619206|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619207|NCT00109603|Tenofovir|tenofovir|mesh-list
14619208|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
14619209|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619210|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14619211|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619212|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619213|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619214|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14619215|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14619216|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
14619217|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14619218|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14619219|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14619220|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619221|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
14619222|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
14646130|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14646131|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14646132|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14646133|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14646134|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
14646135|NCT00196625|Ritonavir|ritonavir|mesh-list
14646136|NCT00196625|Amprenavir|amprenavir|mesh-list
14646137|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14646138|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14646139|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
14646140|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646141|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646142|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14646143|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14646144|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
14646145|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646146|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14646147|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14646148|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14646149|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
14646150|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14646151|NCT00196638|Interferons|interferons|mesh-list
14646152|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
14646153|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14646154|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646155|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
14646156|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646157|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
14646158|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646159|NCT00196664|Paroxetine|paroxetine|mesh-list
14646160|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14646161|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14646162|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14646163|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646164|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646165|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
14646166|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646167|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14646168|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
14646169|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14646170|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14646171|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14646172|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646173|NCT00196677|Vitamins|vitamins|mesh-list
14646174|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
14646175|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646176|NCT00196690|Donepezil|donepezil|mesh-list
14646177|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14646178|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647544|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14619223|NCT00109746|Chromium|chromium|mesh-list
14619224|NCT00109746|Picolinic acid|picolinic acid|mesh-list
15164155|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15164156|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15164157|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
15164158|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164159|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164160|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
15164161|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
15164162|NCT04087915|Evolocumab|evolocumab|mesh-list
15164163|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15164164|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15164165|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
15164166|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164167|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15164168|NCT04088084|Palmidrol|palmidrol|mesh-list
15164169|NCT04088084|Analgesics|analgesics|mesh-ancestor
15164170|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
15164171|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164172|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164173|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15164174|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15164175|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164176|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15164177|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
15164178|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164179|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15164180|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15164181|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164182|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164183|NCT04088084|Hormones|hormones|mesh-ancestor
15164184|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164185|NCT04088110|Trastuzumab|trastuzumab|mesh-list
15164186|NCT04088110|Letrozole|letrozole|mesh-list
15164187|NCT04088110|Anastrozole|anastrozole|mesh-list
15164188|NCT04088110|Exemestane|exemestane|mesh-list
15164189|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15164190|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619225|NCT00109746|Trace Elements|trace elements|mesh-ancestor
14619226|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
14619227|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619228|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14619229|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
14619230|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
14619231|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619232|NCT00109785|Idoxuridine|idoxuridine|mesh-list
15164191|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164192|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15164193|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619233|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14619234|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14619235|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619236|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
14619237|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619238|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619239|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619240|NCT00109798|Temozolomide|temozolomide|mesh-list
14619241|NCT00109798|Topotecan|topotecan|mesh-list
14619242|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14619243|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
14619244|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619245|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619246|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14619247|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14619248|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619249|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
14619250|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14619251|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
14619252|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619253|NCT00109824|Decitabine|decitabine|mesh-list
14619254|NCT00109824|Azacitidine|azacitidine|mesh-list
14619255|NCT00109824|Valproic Acid|valproic acid|mesh-list
14619256|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14619257|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
14619258|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647545|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14619259|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619260|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619261|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
14619262|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
14619263|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619264|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619265|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
14619266|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14619267|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619268|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14619269|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
14619270|NCT00109941|Mitogens|mitogens|mesh-list
14619271|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
14619272|NCT00109941|Narcotics|narcotics|mesh-ancestor
14619273|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619274|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619275|NCT00109941|Analgesics|analgesics|mesh-ancestor
14619276|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
14619277|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619278|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
14619279|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619280|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619281|NCT00109954|Cisplatin|cisplatin|mesh-list
14619282|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619283|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
14619284|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14619285|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14619286|NCT00109993|Prednisolone|prednisolone|mesh-list
14619287|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
14619288|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
14619289|NCT00109993|Tacrolimus|tacrolimus|mesh-list
14619290|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14619291|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
14619292|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619293|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
14619294|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619295|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14619296|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619297|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619298|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619299|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
14619300|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
14619301|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619302|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619303|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
14619304|NCT00109993|Hormones|hormones|mesh-ancestor
14619305|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619306|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14619307|NCT00109993|Protective Agents|protective agents|mesh-ancestor
14619308|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14619309|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619310|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619311|NCT00110006|Prednisone|prednisone|mesh-list
14619312|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
14619313|NCT00110006|Rituximab|rituximab|mesh-list
14619314|NCT00110006|Doxorubicin|doxorubicin|mesh-list
14619315|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14619316|NCT00110006|Vincristine|vincristine|mesh-list
14619317|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14619318|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619319|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
14619320|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619321|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619322|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14619323|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
14619324|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619325|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619326|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14619327|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619328|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14619329|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14619330|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14619331|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619332|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619333|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
14619334|NCT00110006|Hormones|hormones|mesh-ancestor
14647546|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14619335|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619336|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14619337|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14619338|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
14619339|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
14619340|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
14619341|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14619342|NCT00110032|Etanidazole|etanidazole|mesh-list
14619343|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619344|NCT00110045|Caspofungin|caspofungin|mesh-list
14619345|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
14619346|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619347|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619348|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619349|NCT00110058|Interferons|interferons|mesh-list
14619350|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
14619351|NCT00110058|Cyclosporine|cyclosporine|mesh-list
14619352|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
14619353|NCT00110058|Fludarabine|fludarabine|mesh-list
14619354|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
14619355|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
14619356|NCT00110058|Cyclosporins|cyclosporins|mesh-list
14619357|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619358|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14619359|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
14619360|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619361|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619362|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
14619363|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619364|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
14619365|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619366|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619367|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
14619368|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
14619369|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619370|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14619371|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14619372|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14619373|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
14619374|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14619375|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14619376|NCT00110071|Iodine|iodine|mesh-list
14619377|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
14619378|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14619379|NCT00110071|Fludarabine|fludarabine|mesh-list
14619380|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
14619381|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
14619382|NCT00110071|Antibodies|antibodies|mesh-list
14619383|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
14619384|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14619385|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
14619386|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619387|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619388|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14619389|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
14619390|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619391|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619392|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14619393|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619394|NCT00110071|Trace Elements|trace elements|mesh-ancestor
14619395|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
14619396|NCT00110110|Cyclosporine|cyclosporine|mesh-list
14619397|NCT00110110|Carboplatin|carboplatin|mesh-list
14619398|NCT00110110|Etoposide|etoposide|mesh-list
14619399|NCT00110110|Vincristine|vincristine|mesh-list
14619400|NCT00110110|Cyclosporins|cyclosporins|mesh-list
14619401|NCT00110110|Lenograstim|lenograstim|mesh-list
14619402|NCT00110110|Sargramostim|sargramostim|mesh-list
14619403|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619404|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14619405|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14619406|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14619407|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619408|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619409|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14619410|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
14619411|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619412|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14619413|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14619414|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14619415|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619416|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
14619417|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619418|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14619419|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619420|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14619421|NCT00110123|Fotemustine|fotemustine|mesh-list
14619422|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619423|NCT00110162|Hormones|hormones|mesh-list
14619424|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
14619425|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619426|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619427|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
14619428|NCT00110188|Sirolimus|sirolimus|mesh-list
15164194|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164195|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15164196|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
15164197|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164198|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164199|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15164200|NCT04087746|Ranibizumab|ranibizumab|mesh-list
15164201|NCT04087746|Aflibercept|aflibercept|mesh-list
15164202|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15164203|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14619429|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14619430|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619431|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14619432|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164204|NCT04087746|Growth Substances|growth substances|mesh-ancestor
15164205|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164206|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
15164207|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164208|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
15164209|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15164210|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
15164211|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164212|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
15164213|NCT04088006|Protective Agents|protective agents|mesh-ancestor
15164214|NCT04087967|Cytarabine|cytarabine|mesh-list
15164215|NCT04087967|Decitabine|decitabine|mesh-list
15164216|NCT04087967|Idarubicin|idarubicin|mesh-list
15164217|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164218|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
15164219|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164220|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164221|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
15164222|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164223|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164224|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
15164225|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164226|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164227|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15164228|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14619433|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
14619434|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619435|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
14619436|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619437|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14619438|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
14619439|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619440|NCT00110240|Vildagliptin|vildagliptin|mesh-list
14619441|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14619442|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619443|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14619444|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
14619445|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619446|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619447|NCT00110253|Lidocaine|lidocaine|mesh-list
14619448|NCT00110253|Tetracaine|tetracaine|mesh-list
14619449|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
14619450|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
14619451|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619452|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619453|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
14619454|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619455|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14619456|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14619457|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14619458|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14619459|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619460|NCT00110344|Sorafenib|sorafenib|mesh-list
14619461|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619462|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14619463|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619464|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619465|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
14619466|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14619467|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619468|NCT00110448|Aspirin|aspirin|mesh-list
14619469|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619470|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619471|NCT00110448|Analgesics|analgesics|mesh-ancestor
14619472|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
14619473|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619474|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619475|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619476|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619477|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14619478|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14619479|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619480|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14619481|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14619482|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619483|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
14619484|NCT00110474|Acetaminophen|acetaminophen|mesh-list
15164229|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15164230|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
15164231|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
15164232|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15164233|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
15164234|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164235|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164236|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15164237|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
15164238|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15164239|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15164240|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15164241|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164242|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164243|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164244|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15164245|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14619485|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619486|NCT00110474|Analgesics|analgesics|mesh-ancestor
14619487|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
14619488|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619489|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619490|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
14619491|NCT00110578|Aldesleukin|aldesleukin|mesh-list
14619492|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619493|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14619494|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14619495|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
14619496|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619497|NCT00110591|Leronlimab|leronlimab|mesh-list
14619498|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15164246|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15164247|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
15164248|NCT04087460|Vaccines|vaccines|mesh-list
15164249|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15164250|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
15164251|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164252|NCT04087668|Anesthetics|anesthetics|mesh-list
15164253|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164254|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619499|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15164255|NCT04087759|Bedaquiline|bedaquiline|mesh-list
15164256|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
15164257|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
15164258|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15164259|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164260|NCT04087408|Hormones|hormones|mesh-list
15164261|NCT04087408|Progesterone|progesterone|mesh-list
15164262|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164263|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164264|NCT04087408|Progestins|progestins|mesh-ancestor
15164265|NCT04087421|Glycerol|glycerol|mesh-list
15164266|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14619500|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619501|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14619502|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14619503|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
14619504|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619505|NCT00110604|Folic Acid|folic acid|mesh-list
14619506|NCT00110604|Hematinics|hematinics|mesh-ancestor
14619507|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
14619508|NCT00110604|Vitamins|vitamins|mesh-ancestor
14619509|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
14619510|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619511|NCT00110630|Nicotine|nicotine|mesh-list
14619512|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14619513|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
14619514|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619515|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619516|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14619517|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14619518|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
14619519|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619520|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619521|NCT00110669|Prednisone|prednisone|mesh-list
14619522|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619523|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
14619524|NCT00110669|Hormones|hormones|mesh-ancestor
14619525|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619526|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619527|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14619528|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619529|NCT00110682|Imiquimod|imiquimod|mesh-list
14619530|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14619531|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
14619532|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619533|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619534|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
14619535|NCT00110695|Paclitaxel|paclitaxel|mesh-list
14619536|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14619537|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14619538|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164267|NCT04087421|Protective Agents|protective agents|mesh-ancestor
15164268|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164269|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15164270|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
15164271|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164272|NCT04086940|Esmolol|esmolol|mesh-list
15164273|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15164274|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15164275|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15164276|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164277|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164278|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619539|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
14619540|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14619541|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
14619542|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619543|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
14619544|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14619545|NCT00110708|Antibodies|antibodies|mesh-list
14619546|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
14619547|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619548|NCT00110721|Fluorouracil|fluorouracil|mesh-list
15164279|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619549|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
14619550|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619551|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14619552|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619553|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619554|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
14619555|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619556|NCT00110734|Lidocaine|lidocaine|mesh-list
14619557|NCT00110734|Tetracaine|tetracaine|mesh-list
14619558|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
14619559|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
14619560|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619561|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619562|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
14619563|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619564|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14619565|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14619566|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14619567|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14619568|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619569|NCT00110747|Lidocaine|lidocaine|mesh-list
14619570|NCT00110747|Tetracaine|tetracaine|mesh-list
14619571|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
14619572|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
14619573|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619574|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619575|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
14619576|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619577|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14619578|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14619579|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14619580|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14619581|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619582|NCT00110760|Lidocaine|lidocaine|mesh-list
14619583|NCT00110760|Tetracaine|tetracaine|mesh-list
14619584|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
14619585|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
14619586|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619587|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619588|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
15164280|NCT04087317|Acetaminophen|acetaminophen|mesh-list
15164281|NCT04087317|Ibuprofen|ibuprofen|mesh-list
15164282|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15164283|NCT04087317|Analgesics|analgesics|mesh-ancestor
15164284|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
15164285|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164286|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164287|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
14619589|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619590|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14619591|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14619592|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14619593|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14619594|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619595|NCT00110773|Lidocaine|lidocaine|mesh-list
14619596|NCT00110773|Tetracaine|tetracaine|mesh-list
14619597|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
14619598|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
14619599|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619600|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619601|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
14619602|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619603|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14619604|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14619605|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14619606|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14619607|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619608|NCT00110851|Metformin|metformin|mesh-list
14619609|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
14619610|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14619611|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619612|NCT00110864|Insulin|insulin|mesh-list
14619613|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14619614|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619615|NCT00110877|Darunavir|darunavir|mesh-list
14619616|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15164288|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619617|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14619618|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
14619619|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619620|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619621|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14619622|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14619623|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
14619624|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619625|NCT00110903|Etanercept|etanercept|mesh-list
14619626|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619627|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619628|NCT00110903|Analgesics|analgesics|mesh-ancestor
14619629|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
14619630|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619631|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619632|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619633|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619634|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619635|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619636|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
14619637|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14619638|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619639|NCT00110929|Cinacalcet|cinacalcet|mesh-list
14619640|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14619641|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619642|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14619643|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
14619644|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619645|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
14619646|NCT00110955|Hematinics|hematinics|mesh-ancestor
14619647|NCT00110981|Etanercept|etanercept|mesh-list
14619648|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619649|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619650|NCT00110981|Analgesics|analgesics|mesh-ancestor
14619651|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
14619652|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619653|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619654|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619655|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619656|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619657|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619658|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
14619659|NCT00111020|Sorafenib|sorafenib|mesh-list
14619660|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619661|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15164289|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164290|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15164291|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15164292|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164293|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164294|NCT04086537|Hepcidins|hepcidins|mesh-list
15164295|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164296|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
15164297|NCT04086719|BMS-986165|bms-986165|mesh-list
15164298|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
15164299|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15164300|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15164301|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164302|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15164303|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164304|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164305|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
15164306|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180860|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180861|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619662|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619663|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619664|NCT00111046|Ibuprofen|ibuprofen|mesh-list
14619665|NCT00111046|Tramadol|tramadol|mesh-list
14619666|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619667|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619668|NCT00111046|Analgesics|analgesics|mesh-ancestor
14619669|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
14619670|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180862|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14619671|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619672|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619673|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619674|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15164307|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
15164308|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
15164309|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164310|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164311|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619675|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619676|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619677|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14619678|NCT00111046|Narcotics|narcotics|mesh-ancestor
14619679|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619680|NCT00111072|Dexamethasone|dexamethasone|mesh-list
14619681|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619682|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
14619683|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
14619684|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619685|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619686|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619687|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
14619688|NCT00111072|Hormones|hormones|mesh-ancestor
14619689|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619690|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14619691|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619692|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
14619693|NCT00111098|Hematinics|hematinics|mesh-ancestor
14619694|NCT00111111|Etanercept|etanercept|mesh-list
14619695|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619696|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619697|NCT00111111|Analgesics|analgesics|mesh-ancestor
14619698|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
14619699|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619700|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619701|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619702|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619703|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619704|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619705|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
14619706|NCT00111124|Etanercept|etanercept|mesh-list
14619707|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619708|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619709|NCT00111124|Analgesics|analgesics|mesh-ancestor
14619710|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
14619711|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619712|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619713|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619714|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619715|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619716|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619717|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
14619718|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
14619719|NCT00111137|Hematinics|hematinics|mesh-ancestor
14619720|NCT00111150|Tenofovir|tenofovir|mesh-list
14619721|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
14619722|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619723|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14619724|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619725|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619726|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619727|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14619728|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14619729|NCT00111163|Artesunate|artesunate|mesh-list
14619730|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
14619731|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
14619732|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14619733|NCT00111163|Amodiaquine|amodiaquine|mesh-list
14619734|NCT00111163|Dapsone|dapsone|mesh-list
14619735|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
14619736|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
14619737|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14619738|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14619739|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619740|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619741|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
14619742|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
14619743|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14619744|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
14619745|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14619746|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619747|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619748|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14619749|NCT00111163|Renal Agents|renal agents|mesh-ancestor
14619750|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
14619751|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14619752|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14619753|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14619754|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14619755|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619756|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619757|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14619758|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14619759|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14619760|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
14619761|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619762|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619763|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14619764|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14619765|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
14619766|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14619767|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
14619768|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14619769|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14619770|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164312|NCT04086290|Androgens|androgens|mesh-list
15164313|NCT04086290|Hormones|hormones|mesh-ancestor
15164314|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164315|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164316|NCT04086264|Azacitidine|azacitidine|mesh-list
15164317|NCT04086264|Decitabine|decitabine|mesh-list
15164318|NCT04086264|Venetoclax|venetoclax|mesh-list
15164319|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164320|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
15164321|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164322|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164323|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164324|NCT04086186|Bupivacaine|bupivacaine|mesh-list
15164325|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
15164326|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
15164327|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164328|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164329|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
15164330|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164331|NCT04086238|Decitabine|decitabine|mesh-list
15164332|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
15164333|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164334|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
15164335|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164336|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164337|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164338|NCT04085913|Lidocaine|lidocaine|mesh-list
15164339|NCT04085913|Epinephrine|epinephrine|mesh-list
15164340|NCT04085913|Racepinephrine|racepinephrine|mesh-list
14619771|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
15164341|NCT04085913|Bupivacaine|bupivacaine|mesh-list
15164342|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
15164343|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
14619772|NCT00111215|Coagulants|coagulants|mesh-ancestor
14619773|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14619774|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
14619775|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619776|NCT00111267|Vitamins|vitamins|mesh-list
14619777|NCT00111267|Folic Acid|folic acid|mesh-list
14619778|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
14619779|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
14619780|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
14619781|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
14619782|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164344|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
15164345|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14619783|NCT00111267|Hematinics|hematinics|mesh-ancestor
15164346|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619784|NCT00111280|Etravirine|etravirine|mesh-list
15180863|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
14619785|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14619786|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619787|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619788|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619789|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
14619790|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619791|NCT00111306|Epratuzumab|epratuzumab|mesh-list
14619792|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14619793|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619794|NCT00111319|Bortezomib|bortezomib|mesh-list
14619795|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619796|NCT00111345|Daunorubicin|daunorubicin|mesh-list
14619797|NCT00111345|Idarubicin|idarubicin|mesh-list
14619798|NCT00111345|Cladribine|cladribine|mesh-list
14619799|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14619800|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619801|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14619802|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14619803|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619804|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619805|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619806|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
14619807|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619808|NCT00111371|Levodopa|levodopa|mesh-list
14619809|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14619810|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14619811|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
14619812|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14619813|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619814|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619815|NCT00111397|Interferons|interferons|mesh-list
14619816|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
14619817|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619818|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
14619819|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619820|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14619821|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619822|NCT00111436|Etanercept|etanercept|mesh-list
14619823|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619824|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619825|NCT00111436|Analgesics|analgesics|mesh-ancestor
14619826|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
14619827|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619828|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619829|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619830|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619831|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619832|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619833|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
14646179|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646180|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
14646181|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646182|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646183|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
14646184|NCT00196703|Memantine|memantine|mesh-list
14646185|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14646186|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14646187|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
14646188|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646189|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646190|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646191|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14646192|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14646193|NCT00196755|Calcium|calcium|mesh-list
14646194|NCT00196755|Sevelamer|sevelamer|mesh-list
14646195|NCT00196755|Calcium acetate|calcium acetate|mesh-list
14646196|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14646197|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646198|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
14646199|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
14646200|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646201|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
14646202|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646203|NCT00196820|Capecitabine|capecitabine|mesh-list
14646204|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14619834|NCT00111449|Etanercept|etanercept|mesh-list
15164347|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
15164348|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619835|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619836|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619837|NCT00111449|Analgesics|analgesics|mesh-ancestor
14619838|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
14619839|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619840|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619841|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619842|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619843|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619844|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619845|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
14619846|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
14619847|NCT00111462|Hematinics|hematinics|mesh-ancestor
14619848|NCT00111540|Exenatide|exenatide|mesh-list
14619849|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14619850|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619851|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14619852|NCT00111540|Incretins|incretins|mesh-ancestor
14619853|NCT00111540|Hormones|hormones|mesh-ancestor
14619854|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619855|NCT00111566|Eptifibatide|eptifibatide|mesh-list
14619856|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14619857|NCT00111618|Vadimezan|vadimezan|mesh-list
14619858|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619859|NCT00111631|Metformin|metformin|mesh-list
14619860|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14619861|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14619862|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619863|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
14619864|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619865|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619866|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
14619867|NCT00111644|Lactams|lactams|mesh-list
14619868|NCT00111644|beta-Lactams|beta-lactams|mesh-list
14619869|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14619870|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619871|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14619872|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
14619873|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619874|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619875|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14619876|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619877|NCT00111748|Thalidomide|thalidomide|mesh-list
14619878|NCT00111748|Dexamethasone|dexamethasone|mesh-list
14619879|NCT00111748|Bortezomib|bortezomib|mesh-list
14619880|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619881|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
14619882|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
14619883|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619884|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619885|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619886|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
14619887|NCT00111748|Hormones|hormones|mesh-ancestor
14619888|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619889|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14619890|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619891|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619892|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
14619893|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
14619894|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14619895|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619896|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14619897|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14619898|NCT00111748|Growth Substances|growth substances|mesh-ancestor
14619899|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
14619900|NCT00111774|Panitumumab|panitumumab|mesh-list
14619901|NCT00111774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164349|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15164350|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14619902|NCT00111774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619903|NCT00111787|Paclitaxel|paclitaxel|mesh-list
14619904|NCT00111787|Lapatinib|lapatinib|mesh-list
14619905|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14619906|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619907|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
14619908|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
14619909|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
14619910|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619911|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14619912|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619913|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
14619914|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14619915|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14619916|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619917|NCT00111891|Niacin|niacin|mesh-list
14619918|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14619919|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
14619920|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619921|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14619922|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
14619923|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
15164351|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15164352|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164353|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164354|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15164355|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15164356|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164357|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164358|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15164359|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15164360|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
15164361|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15164362|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
15164363|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
15164364|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
15164365|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15164366|NCT04085562|Amlodipine|amlodipine|mesh-list
15164367|NCT04085562|Bisoprolol|bisoprolol|mesh-list
15164368|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14619924|NCT00111891|Vitamins|vitamins|mesh-ancestor
14619925|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
14619926|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619927|NCT00111904|Paclitaxel|paclitaxel|mesh-list
14619928|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14619929|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619930|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
14619931|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
14619932|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14619933|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619934|NCT00111943|Tenofovir|tenofovir|mesh-list
14619935|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
14619936|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14619937|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14619938|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619939|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619940|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619941|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14619942|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14619943|NCT00111956|Etanercept|etanercept|mesh-list
14619944|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14619945|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14619946|NCT00111956|Analgesics|analgesics|mesh-ancestor
14619947|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
14619948|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619949|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619950|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619951|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619952|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619953|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619954|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
14619955|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
14619956|NCT00111995|Hematinics|hematinics|mesh-ancestor
14619957|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
14619958|NCT00112008|Hematinics|hematinics|mesh-ancestor
14619959|NCT00112021|Pramlintide|pramlintide|mesh-list
14619960|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
15164369|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14619961|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15164370|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14619962|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619963|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
14619964|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14619965|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14619966|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619967|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
14619968|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14619969|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14619970|NCT00112034|Prednisolone|prednisolone|mesh-list
14619971|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
14619972|NCT00112034|Methotrexate|methotrexate|mesh-list
14619973|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14619974|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
14619975|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14619976|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
14619977|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14619978|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619979|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14619980|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
14619981|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14619982|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14619983|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14619984|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14619985|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14619986|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14619987|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
14619988|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14619989|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14619990|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14619991|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
14619992|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
14619993|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14619994|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14619995|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
14619996|NCT00112034|Hormones|hormones|mesh-ancestor
15164371|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164372|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15164373|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14619997|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14619998|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14619999|NCT00112034|Protective Agents|protective agents|mesh-ancestor
14620000|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14620001|NCT00112086|Paclitaxel|paclitaxel|mesh-list
14620002|NCT00112086|Carboplatin|carboplatin|mesh-list
14620003|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14620004|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620005|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
14620006|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620007|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620008|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620009|NCT00112138|Gabapentin|gabapentin|mesh-list
14620010|NCT00112138|Analgesics|analgesics|mesh-ancestor
14620011|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
14620012|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620013|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620014|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
14620015|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14620016|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14620017|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620018|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620019|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14620020|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14620021|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620022|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620023|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
15164374|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
15164375|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
15164376|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
15164377|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164378|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15164379|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15164380|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14620024|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
15164381|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164382|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164383|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
14022271|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
14022272|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
14022273|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14022274|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14022275|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14022276|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
14620025|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620026|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14620027|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620028|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620029|NCT00112346|Gemcitabine|gemcitabine|mesh-list
14620030|NCT00112346|Cetuximab|cetuximab|mesh-list
14620031|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620032|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
14620033|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620034|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620035|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
14620036|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620037|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620038|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620039|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
14620040|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620041|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620042|NCT00112372|Sirolimus|sirolimus|mesh-list
14620043|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14620044|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620045|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14620046|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620047|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
14620048|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620049|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
14620050|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620051|NCT00112476|Sirolimus|sirolimus|mesh-list
14620052|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
14620053|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14620054|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620055|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14620056|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620057|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
14620058|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620059|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
14620060|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620061|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14620062|NCT00112515|Modafinil|modafinil|mesh-list
14620063|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14620064|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620065|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14620066|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14620067|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14620068|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620069|NCT00112528|Gemcitabine|gemcitabine|mesh-list
14620070|NCT00112528|Bevacizumab|bevacizumab|mesh-list
14620071|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
14620072|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620073|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620074|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14620075|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14620076|NCT00112528|Growth Substances|growth substances|mesh-ancestor
14620077|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620078|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
14620079|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620080|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
14620081|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620082|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
14620083|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620084|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620085|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164384|NCT04085744|Lidocaine|lidocaine|mesh-list
15164385|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
14022277|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620086|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
14620087|NCT00112554|Cytarabine|cytarabine|mesh-list
15164386|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
14620088|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620089|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
14620090|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620091|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620092|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
14620093|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620094|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620095|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
14620096|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620097|NCT00112567|Fludarabine|fludarabine|mesh-list
15164387|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164388|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164389|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
15164390|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164391|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15164392|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15164393|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15164394|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164395|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164396|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164397|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
15164398|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15164399|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
15164400|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15164401|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
15164402|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14022278|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164403|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15164404|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164405|NCT04085770|Vitamins|vitamins|mesh-ancestor
15164406|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
15164407|NCT04085757|Dinoprostone|dinoprostone|mesh-list
15164408|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
15164409|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15164410|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164411|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
15164412|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15164413|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14022279|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14022280|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
15164414|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164415|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
15164416|NCT04085575|Coagulants|coagulants|mesh-ancestor
15164417|NCT04085627|Amlodipine|amlodipine|mesh-list
15164418|NCT04085627|Valsartan|valsartan|mesh-list
15164419|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
15164420|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15164421|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15164422|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164423|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164424|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15164425|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164426|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
15164427|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15164428|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15164429|NCT04085393|Granisetron|granisetron|mesh-list
15164430|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
15164431|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
15164432|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164433|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164434|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15164435|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15164436|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
15164437|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164438|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164439|NCT04085640|Ropivacaine|ropivacaine|mesh-list
15164440|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
14620098|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
14620099|NCT00112567|Thiotepa|thiotepa|mesh-list
14620100|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620101|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620102|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
14646205|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
15164441|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
14620103|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620104|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620105|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
14620106|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620107|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14022281|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
14022282|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620108|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
14620109|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14620110|NCT00112619|Topotecan|topotecan|mesh-list
14620111|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14620112|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14620113|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620114|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620115|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620116|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
14620117|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620118|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14620119|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620120|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620121|NCT00112645|Cyclosporine|cyclosporine|mesh-list
14620122|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
14620123|NCT00112645|Methotrexate|methotrexate|mesh-list
14620124|NCT00112645|Melphalan|melphalan|mesh-list
14620125|NCT00112645|Busulfan|busulfan|mesh-list
14620126|NCT00112645|Cyclosporins|cyclosporins|mesh-list
14620127|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14620128|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14620129|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
14620130|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14620131|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620132|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620133|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
15164442|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164443|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164444|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
14620134|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620135|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620136|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
14620137|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620138|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14620139|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620140|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
14620141|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14620142|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14620143|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
14620144|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620145|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14620146|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14620147|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
14620148|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
14620149|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620150|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620151|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
14620152|NCT00112645|Hormones|hormones|mesh-ancestor
14620153|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620154|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14620155|NCT00112645|Protective Agents|protective agents|mesh-ancestor
14620156|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14620157|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
14620158|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14620159|NCT00112658|Leucovorin|leucovorin|mesh-list
14620160|NCT00112658|Gemcitabine|gemcitabine|mesh-list
14620161|NCT00112658|Fluorouracil|fluorouracil|mesh-list
14620162|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
14620163|NCT00112658|Irinotecan|irinotecan|mesh-list
14620164|NCT00112658|Calcium|calcium|mesh-list
14620165|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
14620166|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620167|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
14620168|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620169|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620170|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
14620171|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620172|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620173|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620174|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
14620175|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620176|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14620177|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14620178|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14620179|NCT00112658|Antidotes|antidotes|mesh-ancestor
14620180|NCT00112658|Protective Agents|protective agents|mesh-ancestor
14620181|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
14620182|NCT00112658|Vitamins|vitamins|mesh-ancestor
14620183|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
14620184|NCT00112684|Alvocidib|alvocidib|mesh-list
14620185|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620186|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14620187|NCT00112684|Growth Substances|growth substances|mesh-ancestor
14620188|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620189|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14620190|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620191|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620192|NCT00112697|Docetaxel|docetaxel|mesh-list
14620193|NCT00112697|Fluorouracil|fluorouracil|mesh-list
14620194|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620195|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
14620196|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620197|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620198|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620199|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
14620200|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620201|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620202|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
14620203|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620204|NCT00112710|Gemcitabine|gemcitabine|mesh-list
14620205|NCT00112710|Carboplatin|carboplatin|mesh-list
14620206|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620207|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620208|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
14620209|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620210|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
14620211|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620212|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620213|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620214|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
14620215|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620216|NCT00112749|Infliximab|infliximab|mesh-list
14022283|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14022284|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022285|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14022286|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14620217|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14620218|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620219|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14620220|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
14620221|NCT00112775|Dasatinib|dasatinib|mesh-list
14620222|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620223|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14620224|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620225|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620226|NCT00112853|Etoposide|etoposide|mesh-list
14620227|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
14620228|NCT00112853|Tipifarnib|tipifarnib|mesh-list
14620229|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14620230|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620231|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14620232|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14620233|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620234|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620235|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
14620236|NCT00112879|Thalidomide|thalidomide|mesh-list
14620237|NCT00112879|Dexamethasone|dexamethasone|mesh-list
14620238|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
14022287|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14022288|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14022289|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620239|NCT00112879|Mitogens|mitogens|mesh-list
14620240|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14620241|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
14620242|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
14620243|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620244|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620245|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620246|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
14620247|NCT00112879|Hormones|hormones|mesh-ancestor
14620248|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620249|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14620250|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620251|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620252|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620253|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620254|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
14620255|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
14620256|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14620257|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620258|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14620259|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14620260|NCT00112879|Growth Substances|growth substances|mesh-ancestor
14620261|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
14620262|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
14620263|NCT00112879|Protective Agents|protective agents|mesh-ancestor
14620264|NCT00112879|Vitamins|vitamins|mesh-ancestor
14620265|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
14620266|NCT00112892|Selenium|selenium|mesh-list
14620267|NCT00112892|Irinotecan|irinotecan|mesh-list
14620268|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14620269|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14620270|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620271|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620272|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022290|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14022291|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
14022292|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
14022293|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
14620273|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
14620274|NCT00112892|Protective Agents|protective agents|mesh-ancestor
14620275|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620276|NCT00112892|Trace Elements|trace elements|mesh-ancestor
14620277|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
14620278|NCT00112931|Rituximab|rituximab|mesh-list
14620279|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620280|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620281|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
14620282|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620283|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14620284|NCT00112983|Eculizumab|eculizumab|mesh-list
14620285|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14620286|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620287|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
14620288|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620289|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
14620290|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
14620291|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620292|NCT00112996|Protective Agents|protective agents|mesh-ancestor
14620293|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620294|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
14620295|NCT00112996|Vitamins|vitamins|mesh-ancestor
14620296|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
14620297|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
14620298|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620299|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620300|NCT00113074|Nicotine|nicotine|mesh-list
14620301|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14620302|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
14620303|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620304|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620305|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14620306|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14620307|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
14620308|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620309|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620310|NCT00113100|Ethanol|ethanol|mesh-list
14620311|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14620312|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14620313|NCT00113100|Estradiol|estradiol|mesh-list
14620314|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14022294|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
14620315|NCT00113100|Estrogens|estrogens|mesh-ancestor
14620316|NCT00113100|Hormones|hormones|mesh-ancestor
14620317|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620318|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620319|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14620320|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
14620321|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14620322|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14620323|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14620324|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620325|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620326|NCT00113113|Rubitecan|rubitecan|mesh-list
14620327|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620328|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15164445|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164446|NCT04085094|Pilocarpine|pilocarpine|mesh-list
15164447|NCT04085094|Miotics|miotics|mesh-ancestor
15164448|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
15164449|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164450|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620329|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14620330|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620331|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620332|NCT00113165|Lamotrigine|lamotrigine|mesh-list
14620333|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
14620334|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14620335|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14620336|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620337|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14620338|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620339|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14620340|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14620341|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620342|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620343|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14620344|NCT00113256|Rubitecan|rubitecan|mesh-list
14620345|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620346|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14620347|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14620348|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620349|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620350|NCT00113282|Interleukin-2|interleukin-2|mesh-list
14620351|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620352|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14620353|NCT00113282|Analgesics|analgesics|mesh-ancestor
14620354|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
14620355|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620356|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620357|NCT00113347|Docetaxel|docetaxel|mesh-list
14620358|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14620359|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620360|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
14620361|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620362|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620363|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620364|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14620365|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620366|NCT00113503|Azathioprine|azathioprine|mesh-list
14620367|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
14620368|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620369|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620370|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620371|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620372|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
14620373|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620374|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646206|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646207|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646208|NCT00196846|Goserelin|goserelin|mesh-list
14646209|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14646210|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646211|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
14646212|NCT00196859|Capecitabine|capecitabine|mesh-list
14646213|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646214|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
14620375|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14620376|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
14620377|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
14620378|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620379|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620380|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14620381|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14620382|NCT00113542|Growth Substances|growth substances|mesh-ancestor
14620383|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620384|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
14620385|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620386|NCT00113594|Olanzapine|olanzapine|mesh-list
14620387|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
14620388|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
14620389|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620390|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620391|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620392|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14620393|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14620394|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620395|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620396|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14620397|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14620398|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14620399|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620400|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620401|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
14620402|NCT00113685|Dextrans|dextrans|mesh-list
15164451|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15164452|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15164453|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
15164454|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620403|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14620404|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
14620405|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
14620406|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
14620407|NCT00113698|Enalapril|enalapril|mesh-list
14620408|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14620409|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14620410|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620411|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620412|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14620413|NCT00113737|Fluoxetine|fluoxetine|mesh-list
14620414|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14620415|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14620416|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14620417|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620418|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620419|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
14620420|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620421|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14620422|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
14620423|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620424|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14620425|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14620426|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620427|NCT00113776|Panitumumab|panitumumab|mesh-list
14620428|NCT00113776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620429|NCT00113776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620430|NCT00113802|Epratuzumab|epratuzumab|mesh-list
14620431|NCT00113802|Antibodies|antibodies|mesh-list
14620432|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
14620433|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620434|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620435|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620436|NCT00113815|Topiramate|topiramate|mesh-list
14620437|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
14620438|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14620439|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620440|NCT00113828|Cyclosporine|cyclosporine|mesh-list
14620441|NCT00113828|Cyclosporins|cyclosporins|mesh-list
14620442|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620443|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164455|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620444|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620445|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
14620446|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620447|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
14022295|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
14620448|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620449|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
14620450|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14620451|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14620452|NCT00113854|Mannitol|mannitol|mesh-list
14620453|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14620454|NCT00113854|Diuretics|diuretics|mesh-ancestor
14620455|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
14620456|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620457|NCT00113906|Melatonin|melatonin|mesh-list
14620458|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
14620459|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620460|NCT00113906|Protective Agents|protective agents|mesh-ancestor
14620461|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620462|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620463|NCT00113945|Cinacalcet|cinacalcet|mesh-list
14620464|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14620465|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620466|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14620467|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
14620468|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620469|NCT00113958|Cinacalcet|cinacalcet|mesh-list
14620470|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14620471|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620472|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14620473|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
14620474|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620475|NCT00113971|Epratuzumab|epratuzumab|mesh-list
14620476|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620477|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620478|NCT00113984|Metronidazole|metronidazole|mesh-list
14620479|NCT00113984|Ipilimumab|ipilimumab|mesh-list
14620480|NCT00113984|Sargramostim|sargramostim|mesh-list
14620481|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
14620482|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620483|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620484|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620485|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14620486|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620487|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620488|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14620489|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14620490|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14620491|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14620492|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14620493|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
14620494|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620495|NCT00114010|Antacids|antacids|mesh-ancestor
14620496|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620497|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620498|NCT00114023|Imiquimod|imiquimod|mesh-list
14620499|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14620500|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
14620501|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620502|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620503|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
14620504|NCT00114153|Carboplatin|carboplatin|mesh-list
14620505|NCT00114153|Capecitabine|capecitabine|mesh-list
14620506|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620507|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620508|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
14620509|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620510|NCT00114179|Gemcitabine|gemcitabine|mesh-list
14620511|NCT00114179|Bevacizumab|bevacizumab|mesh-list
14620512|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14620513|NCT00114179|Capecitabine|capecitabine|mesh-list
14620514|NCT00114179|Antibodies|antibodies|mesh-list
14620515|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
15164456|NCT04085354|Vitamins|vitamins|mesh-list
14022296|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620516|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14620517|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620518|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14620519|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14620520|NCT00114179|Growth Substances|growth substances|mesh-ancestor
14620521|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620522|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
14620523|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
14620524|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620525|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
14620526|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620527|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
14620528|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620529|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620530|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620531|NCT00114192|Thalidomide|thalidomide|mesh-list
14620532|NCT00114192|Docetaxel|docetaxel|mesh-list
14620533|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620534|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
14620535|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620536|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620537|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620538|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620539|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
14620540|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620541|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
14620542|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14620543|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620544|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14620545|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14620546|NCT00114192|Growth Substances|growth substances|mesh-ancestor
15164457|NCT04085354|Folic Acid|folic acid|mesh-list
15164458|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
15164459|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
15164460|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
15164461|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164462|NCT04085354|Hematinics|hematinics|mesh-ancestor
15164463|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
15164464|NCT04085172|Guanfacine|guanfacine|mesh-list
15164465|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15164466|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15164467|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15164468|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14620547|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
14620548|NCT00114205|Docetaxel|docetaxel|mesh-list
14620549|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620550|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
15164469|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164470|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164471|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620551|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620552|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620553|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620554|NCT00114257|Decitabine|decitabine|mesh-list
14620555|NCT00114257|Romidepsin|romidepsin|mesh-list
14620556|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620557|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
14620558|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620559|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620560|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620561|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14620562|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
14620563|NCT00114270|Letrozole|letrozole|mesh-list
14620564|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620565|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14620566|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14620567|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620568|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620569|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14620570|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
14620571|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620572|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620573|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14620574|NCT00114283|Lapatinib|lapatinib|mesh-list
14620575|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620576|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14620577|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620578|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620579|NCT00114361|Ribavirin|ribavirin|mesh-list
14620580|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14620581|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
14620582|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620583|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
14620584|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620585|NCT00114374|Citalopram|citalopram|mesh-list
14620586|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14620587|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14620588|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14620589|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620590|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620591|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
14620592|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620593|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14620594|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
14620595|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620596|NCT00114387|Tocopherols|tocopherols|mesh-list
14620597|NCT00114387|Vitamin E|vitamin e|mesh-list
14620598|NCT00114387|Tocotrienols|tocotrienols|mesh-list
14620599|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
14620600|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
14620601|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620602|NCT00114387|Protective Agents|protective agents|mesh-ancestor
14620603|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620604|NCT00114387|Vitamins|vitamins|mesh-ancestor
14620605|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
14620606|NCT00114400|Vitamins|vitamins|mesh-list
14620607|NCT00114400|Folic Acid|folic acid|mesh-list
14620608|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
14620609|NCT00114400|Hydroxocobalamin|hydroxocobalamin|mesh-list
14620610|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
14620611|NCT00114400|Pyridoxal|pyridoxal|mesh-list
14620612|NCT00114400|Pyridoxine|pyridoxine|mesh-list
14620613|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
14620614|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
14620615|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620616|NCT00114400|Hematinics|hematinics|mesh-ancestor
14620617|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
14620618|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
14620619|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620620|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620621|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620622|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
14620623|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14620624|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620625|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620626|NCT00114478|Epinephrine|epinephrine|mesh-list
14620627|NCT00114478|Albuterol|albuterol|mesh-list
14620628|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14620629|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14620630|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
14620631|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620632|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620633|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620634|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14620635|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14620636|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
14620637|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620638|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14620639|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
14620640|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
14620641|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
14620642|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14620643|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
14620644|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14620645|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14620646|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14620647|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14620648|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14620649|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
14620650|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620651|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14620652|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14620653|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620654|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
14620655|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14620656|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620657|NCT00114569|Lorazepam|lorazepam|mesh-list
14620658|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
14620659|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
14620660|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
14620661|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620662|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620663|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620664|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14620665|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620666|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14620667|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14620668|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620669|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
14620670|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
14620671|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620672|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620673|NCT00114686|Valproic Acid|valproic acid|mesh-list
14620674|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14620675|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
14620676|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620677|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14620678|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14620679|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620680|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620681|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620682|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620683|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
14620684|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
14620685|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
14620686|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620687|NCT00114764|Lenograstim|lenograstim|mesh-list
14620688|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14620689|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
14620690|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620691|NCT00114803|Calcitonin|calcitonin|mesh-list
14620692|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
14620693|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14620694|NCT00114803|Katacalcin|katacalcin|mesh-list
14620695|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14620696|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620697|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14620698|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
14620699|NCT00114816|Docetaxel|docetaxel|mesh-list
14620700|NCT00114816|Capecitabine|capecitabine|mesh-list
14620701|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620702|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
15164472|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164473|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15164474|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15164475|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15164476|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15164477|NCT04085120|Dexamethasone|dexamethasone|mesh-list
15164478|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
15164479|NCT04085120|Lidocaine|lidocaine|mesh-list
15164480|NCT04085120|Ropivacaine|ropivacaine|mesh-list
15164481|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164482|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
15164483|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
14620703|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620704|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620705|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620706|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620707|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
14620708|NCT00114868|Vitamins|vitamins|mesh-list
14620709|NCT00114868|Vitamin A|vitamin a|mesh-list
14620710|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
14620711|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
14620712|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620713|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
14620714|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164484|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620715|NCT00114868|Protective Agents|protective agents|mesh-ancestor
14620716|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14620717|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620718|NCT00114933|Ritonavir|ritonavir|mesh-list
14620719|NCT00114933|Lopinavir|lopinavir|mesh-list
14620720|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14620721|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14620722|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
14620723|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620724|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620725|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14620726|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14620727|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
14620728|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620729|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14620730|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14620731|NCT00114946|Bevacizumab|bevacizumab|mesh-list
14620732|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620733|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620734|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14620735|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14620736|NCT00114946|Growth Substances|growth substances|mesh-ancestor
14620737|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620738|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
14620739|NCT00115011|Citalopram|citalopram|mesh-list
14620740|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14620741|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14620742|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14620743|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620744|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620745|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
14620746|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620747|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14620748|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
14620749|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620750|NCT00115024|Estradiol|estradiol|mesh-list
14620751|NCT00115024|Estrogens|estrogens|mesh-ancestor
14620752|NCT00115024|Hormones|hormones|mesh-ancestor
14620753|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620754|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620755|NCT00115089|Beclomethasone|beclomethasone|mesh-list
14620756|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14620757|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
14620758|NCT00115089|Hormones|hormones|mesh-ancestor
14620759|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620760|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620761|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14620762|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
14620763|NCT00115102|Fentanyl|fentanyl|mesh-list
14620764|NCT00115102|Ketamine|ketamine|mesh-list
14620765|NCT00115102|Esketamine|esketamine|mesh-list
14620766|NCT00115102|Analgesics|analgesics|mesh-ancestor
14620767|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
14620768|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620769|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620770|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14620771|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14620772|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
14620773|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
14620774|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164485|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164486|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15164487|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
15164488|NCT04085120|Hormones|hormones|mesh-ancestor
15164489|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164490|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15164491|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164492|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
15164493|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
15164494|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164495|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
15164496|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15164497|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15164498|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15164499|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164500|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620775|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15164501|NCT04085250|Nivolumab|nivolumab|mesh-list
14620776|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14620777|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620778|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620779|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14620780|NCT00115102|Narcotics|narcotics|mesh-ancestor
14620781|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14620782|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
14620783|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620784|NCT00115115|Dopamine|dopamine|mesh-list
14620785|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14620786|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
14620787|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
14620788|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620789|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620790|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
14620791|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620792|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620793|NCT00115115|Protective Agents|protective agents|mesh-ancestor
14620794|NCT00115128|Lenograstim|lenograstim|mesh-list
14620795|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14620796|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
14620797|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620798|NCT00115154|Imiquimod|imiquimod|mesh-list
14620799|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14620800|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
14620801|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620802|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620803|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
14620804|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
14620805|NCT00115167|Hematinics|hematinics|mesh-ancestor
14620806|NCT00115219|Etanercept|etanercept|mesh-list
14620807|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14620808|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14620809|NCT00115219|Analgesics|analgesics|mesh-ancestor
14620810|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
14620811|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620812|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620813|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14620814|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14620815|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14620816|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620817|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
14646215|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646216|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646217|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14646218|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646219|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
14646220|NCT00196872|Epirubicin|epirubicin|mesh-list
14646221|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646222|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
14646223|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646224|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646225|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14646226|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
14646227|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646228|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646229|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14646230|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646231|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14646232|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646233|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646234|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
14646235|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14646236|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
14646237|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646238|NCT00196885|Expectorants|expectorants|mesh-ancestor
14646239|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
14646240|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14646241|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
14646242|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646243|NCT00196885|Protective Agents|protective agents|mesh-ancestor
14646244|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646245|NCT00196885|Antidotes|antidotes|mesh-ancestor
14646246|NCT00196989|Pioglitazone|pioglitazone|mesh-list
14646247|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14620818|NCT00115245|Adefovir|adefovir|mesh-list
14620819|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14620820|NCT00115245|Telbivudine|telbivudine|mesh-list
14620821|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
14620822|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620823|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14620824|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14620825|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620826|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620827|NCT00115310|Capsaicin|capsaicin|mesh-list
14620828|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
14620829|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
14620830|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
15164502|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164503|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164504|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15164505|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164506|NCT04085315|Osimertinib|osimertinib|mesh-list
15164507|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164508|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14620831|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620832|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620833|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14620834|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14620835|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14620836|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14620837|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620838|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620839|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620840|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14620841|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
14620842|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14620843|NCT00115375|Clopidogrel|clopidogrel|mesh-list
14620844|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14620845|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14620846|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14620847|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14620848|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
14620849|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620850|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620851|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620852|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
14620853|NCT00115414|Docetaxel|docetaxel|mesh-list
14620854|NCT00115414|Doxorubicin|doxorubicin|mesh-list
14620855|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620856|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
14620857|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620858|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14620859|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14620860|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
14620861|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620862|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620863|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14620864|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
14620865|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620866|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620867|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14620868|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14620869|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14620870|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620871|NCT00115479|Benzocaine|benzocaine|mesh-list
14620872|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620873|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
14620874|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
14620875|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14620876|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
14620877|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620878|NCT00115492|Fluticasone|fluticasone|mesh-list
14620879|NCT00115492|Xhance|xhance|mesh-list
14620880|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14620881|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14620882|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14620883|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14620884|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
14620885|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620886|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620887|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14620888|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
14620889|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
14620890|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14620891|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14620892|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14620893|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14620894|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
14620895|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620896|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620897|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
14620898|NCT00115492|Hormones|hormones|mesh-ancestor
14620899|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14620900|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
14620901|NCT00115518|Cetuximab|cetuximab|mesh-list
14620902|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14620903|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620904|NCT00115531|Vaccines|vaccines|mesh-list
14620905|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
14620906|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620907|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14620908|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620909|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620910|NCT00115570|Insulin|insulin|mesh-list
14620911|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14620912|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
14620913|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
14620914|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
14022297|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022298|NCT02769286|Osimertinib|osimertinib|mesh-list
14022299|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022300|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14022301|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620915|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
15164509|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164510|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164511|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
15164512|NCT04085419|Denosumab|denosumab|mesh-list
14620916|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
14620917|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
14620918|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14620919|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620920|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14620921|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14620922|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14620923|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620924|NCT00115609|Tenofovir|tenofovir|mesh-list
14620925|NCT00115609|Emtricitabine|emtricitabine|mesh-list
14620926|NCT00115609|Efavirenz|efavirenz|mesh-list
14620927|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
14620928|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620929|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14620930|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14620931|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620932|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620933|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14620934|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14620935|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14620936|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14620937|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14620938|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14620939|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14620940|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14620941|NCT00115622|Fluticasone|fluticasone|mesh-list
14620942|NCT00115622|Xhance|xhance|mesh-list
14620943|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14620944|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14620945|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
14620946|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620947|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164513|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14620948|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14620949|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
14620950|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14620951|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15164514|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164515|NCT04085237|Ropivacaine|ropivacaine|mesh-list
15164516|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
15164517|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
15164518|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164519|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620952|NCT00115635|Gemcitabine|gemcitabine|mesh-list
14620953|NCT00115635|Docetaxel|docetaxel|mesh-list
14620954|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14620955|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
14620956|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620957|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14620958|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
14620959|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620960|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620961|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620962|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
14620963|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620964|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14620965|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14620966|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14620967|NCT00115648|Zidovudine|zidovudine|mesh-list
14620968|NCT00115648|Nevirapine|nevirapine|mesh-list
14620969|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
14620970|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620971|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14620972|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14620973|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14620974|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
14620975|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14620976|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14620977|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14620978|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14620979|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14620980|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
14620981|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14620982|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620983|NCT00115687|Nicotine|nicotine|mesh-list
14620984|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15164520|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
15164521|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164522|NCT04084977|Antibodies|antibodies|mesh-list
15164523|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
14620985|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
14620986|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14620987|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14620988|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14620989|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14620990|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
14620991|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14620992|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14620993|NCT00115700|Prednisolone|prednisolone|mesh-list
14620994|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
14620995|NCT00115700|Rituximab|rituximab|mesh-list
14620996|NCT00115700|Vincristine|vincristine|mesh-list
14620997|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14620998|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
14620999|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621000|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621001|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14621002|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
14621003|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621004|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621005|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14621006|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14621007|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14621008|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14621009|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14621010|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14621011|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621012|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
15164524|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621013|NCT00115700|Hormones|hormones|mesh-ancestor
15164525|NCT04084912|Dexamethasone|dexamethasone|mesh-list
15164526|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
15164527|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15164528|NCT04084912|BB 1101|bb 1101|mesh-list
15164529|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164530|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
15164531|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
15164532|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164533|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164534|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15164535|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
15164536|NCT04084912|Hormones|hormones|mesh-ancestor
15164537|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164538|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15164539|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164540|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
15164541|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164542|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621014|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621015|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14621016|NCT00115726|Furosemide|furosemide|mesh-list
14621017|NCT00115726|Diuretics|diuretics|mesh-ancestor
14621018|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
14621019|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621020|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14621021|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14621022|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621023|NCT00115752|Valdecoxib|valdecoxib|mesh-list
14621024|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
14621025|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14621026|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621027|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621028|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14621029|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14621030|NCT00115752|Analgesics|analgesics|mesh-ancestor
14621031|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
14621032|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621033|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621034|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621035|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621036|NCT00115817|Atorvastatin|atorvastatin|mesh-list
14621037|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14621038|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14621039|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
14621040|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621041|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14621042|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14621043|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621044|NCT00115830|Atorvastatin|atorvastatin|mesh-list
14621045|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14621046|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14621047|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14621048|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
14621049|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621050|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14621051|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14621052|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621053|NCT00115908|Ribavirin|ribavirin|mesh-list
14621054|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14621055|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
14621056|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621057|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
15164543|NCT04084496|Folfirinox|folfirinox|mesh-list
15164544|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164545|NCT04084158|Paclitaxel|paclitaxel|mesh-list
15164546|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15164547|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15164548|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164549|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
15164550|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
14026085|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164551|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
14621058|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621059|NCT00115921|Antimalarials|antimalarials|mesh-list
14022302|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022303|NCT02769130|Losartan|losartan|mesh-list
14022304|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14022305|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14022306|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14022307|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14022308|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022309|NCT02769104|Docetaxel|docetaxel|mesh-list
14621060|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15164552|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621061|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14621062|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621063|NCT00115947|Terlipressin|terlipressin|mesh-list
14621064|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14621065|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14621066|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
14621067|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14621068|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621069|NCT00116064|Lorazepam|lorazepam|mesh-list
14621070|NCT00116064|Paraldehyde|paraldehyde|mesh-list
14621071|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
14621072|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
14621073|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
14621074|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621075|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621076|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621077|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14621078|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14621079|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14621080|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14621081|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14621082|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
14621083|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
14621084|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621085|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621086|NCT00116103|Tacrolimus|tacrolimus|mesh-list
14621087|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621088|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
14621089|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621090|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14621091|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621092|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621093|NCT00116181|Etanercept|etanercept|mesh-list
14621094|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14621095|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14621096|NCT00116181|Analgesics|analgesics|mesh-ancestor
14621097|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
14621098|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180864|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180865|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180866|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15180867|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15180868|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621099|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621100|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621101|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621102|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621103|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621104|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
14621105|NCT00116259|Aripiprazole|aripiprazole|mesh-list
14621106|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
14621107|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14621108|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14621109|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14621110|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14621111|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621112|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
14621113|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
14621114|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621115|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621116|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14621117|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14621118|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
14621119|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14621120|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14621121|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14621122|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14621123|NCT00116324|Montelukast|montelukast|mesh-list
14621124|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14621125|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
14621126|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14621127|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
14621128|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621129|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621130|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14621131|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14621132|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621133|NCT00116350|Misoprostol|misoprostol|mesh-list
14621134|NCT00116350|Oxytocin|oxytocin|mesh-list
14621135|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
14621136|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14621137|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621138|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14621139|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
14621140|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14621141|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621142|NCT00116389|Gemcitabine|gemcitabine|mesh-list
14621143|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621144|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
14621145|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621146|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621147|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
14621148|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621149|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621150|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621151|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
14621152|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621153|NCT00116402|Fluticasone|fluticasone|mesh-list
14621154|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14621155|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164553|NCT04084106|Amoxicillin|amoxicillin|mesh-list
15164554|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
15164555|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
15164556|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15164557|NCT04084106|Penicillin V|penicillin v|mesh-list
15164558|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15164559|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164560|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164561|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164562|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15164563|NCT04084171|Insulin|insulin|mesh-list
15164564|NCT04084171|Pancrelipase|pancrelipase|mesh-list
14621156|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14621157|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
14621158|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621159|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621160|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14621161|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
14621162|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
14621163|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14621164|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14621165|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14621166|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14621167|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14621168|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621169|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621170|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
14621171|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621172|NCT00116467|Vaccines|vaccines|mesh-list
14621173|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
14621174|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621175|NCT00116480|Misoprostol|misoprostol|mesh-list
14621176|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14621177|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
14621178|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15164565|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15180869|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
15164566|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164567|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15164568|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15164569|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
14621179|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621180|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14621181|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621182|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
14621183|NCT00116493|Folic Acid|folic acid|mesh-list
14621184|NCT00116493|Mebendazole|mebendazole|mesh-list
14621185|NCT00116493|Piperazine|piperazine|mesh-list
14621186|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
14621187|NCT00116493|DMP 777|dmp 777|mesh-list
14621188|NCT00116493|Hematinics|hematinics|mesh-ancestor
14621189|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
14621190|NCT00116493|Vitamins|vitamins|mesh-ancestor
14621191|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
14621192|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621193|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
14621194|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
14621195|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14621196|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621197|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
14621198|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
14621199|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
14621200|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621201|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621202|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621203|NCT00116506|Bevacizumab|bevacizumab|mesh-list
14621204|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14621205|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14621206|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621207|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14621208|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14621209|NCT00116506|Growth Substances|growth substances|mesh-ancestor
14621210|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621211|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
14621212|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14621213|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621214|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621215|NCT00116532|Citalopram|citalopram|mesh-list
14621216|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14621217|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14621218|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14621219|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621220|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621221|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
14621222|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621223|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14621224|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
14621225|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14621226|NCT00116545|Troglitazone|troglitazone|mesh-list
14621227|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14621228|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621229|NCT00116597|Vaccines|vaccines|mesh-list
14621230|NCT00116597|Immunologic Factors|immunologic factors|mesh-ancestor
14621231|NCT00116597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621232|NCT00116623|Indomethacin|indomethacin|mesh-list
14621233|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
14621234|NCT00116623|Analgesics|analgesics|mesh-ancestor
14621235|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
14621236|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621237|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621238|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
14621239|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164570|NCT04083898|Prednisone|prednisone|mesh-list
15164571|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15164572|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164573|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
15164574|NCT04083898|Hormones|hormones|mesh-ancestor
15164575|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164576|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164577|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14621240|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14621241|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
14621242|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14621243|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14621244|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621245|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14621246|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
14621247|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14621248|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14621249|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14621250|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621251|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621252|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
14621253|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14621254|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621255|NCT00116636|Lopinavir|lopinavir|mesh-list
14621256|NCT00116636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14621257|NCT00116636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14621258|NCT00116636|Protease Inhibitors|protease inhibitors|mesh-ancestor
14621259|NCT00116636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621260|NCT00116636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621261|NCT00116636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14621262|NCT00116636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14621263|NCT00116636|Antiviral Agents|antiviral agents|mesh-ancestor
14621264|NCT00116636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621265|NCT00116636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14621266|NCT00116636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14621267|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621268|NCT00116701|Hematinics|hematinics|mesh-ancestor
14621269|NCT00116727|Etanercept|etanercept|mesh-list
14621270|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14621271|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14621272|NCT00116727|Analgesics|analgesics|mesh-ancestor
14621273|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
14621274|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621275|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621276|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621277|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621278|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621279|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621280|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
14621281|NCT00116870|Lovastatin|lovastatin|mesh-list
14621282|NCT00116870|L 647318|l 647318|mesh-list
14621283|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
14621284|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14621285|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14621286|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
14621287|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621288|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14621289|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14621290|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621291|NCT00116896|Cisplatin|cisplatin|mesh-list
14621292|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646248|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646249|NCT00197080|Ropinirole|ropinirole|mesh-list
14646250|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15164578|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164579|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15164580|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
15164581|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164582|NCT04083911|Cytarabine|cytarabine|mesh-list
15164583|NCT04083911|Decitabine|decitabine|mesh-list
15164584|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
15164585|NCT04083911|Aclarubicin|aclarubicin|mesh-list
14646251|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14646252|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
14646253|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
14646254|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646255|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646256|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646257|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
14646258|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14646259|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646260|NCT00197197|Aplaviroc|aplaviroc|mesh-list
14646261|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15164586|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164587|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
14646262|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15164588|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164589|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164590|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
15164591|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164592|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164593|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
14621293|NCT00116922|Metformin|metformin|mesh-list
14621294|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
14621295|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14621296|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621297|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
14621298|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621299|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14621300|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621301|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621302|NCT00116948|Cimetidine|cimetidine|mesh-list
14621303|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14621304|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621305|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14621306|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
15164594|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164595|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164596|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15164597|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15164598|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14621307|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
14621308|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621309|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621310|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621311|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14621312|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14621313|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621314|NCT00116961|Dexamethasone|dexamethasone|mesh-list
14621315|NCT00116961|Bortezomib|bortezomib|mesh-list
14621316|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621317|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
14621318|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
14621319|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621320|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621321|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621322|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
14621323|NCT00116961|Hormones|hormones|mesh-ancestor
14621324|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621325|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14621326|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621327|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
14621328|NCT00117000|Testosterone|testosterone|mesh-list
14621329|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
14621330|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
14621331|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14621332|NCT00117000|Androgens|androgens|mesh-ancestor
14621333|NCT00117000|Hormones|hormones|mesh-ancestor
14621334|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164599|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15164600|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15164601|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15164602|NCT04083807|Thrombin|thrombin|mesh-list
15164603|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
15164604|NCT04083807|Coagulants|coagulants|mesh-ancestor
15164605|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
15164606|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
15164607|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
14621335|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621336|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14621337|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621338|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
14621339|NCT00117013|Topotecan|topotecan|mesh-list
14621340|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14621341|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14621342|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164608|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164609|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164610|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
15164611|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621343|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621344|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621345|NCT00117026|Benphothiamine|benphothiamine|mesh-list
14621346|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14621347|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
15164612|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15164613|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164614|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164615|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
15164616|NCT04083755|Hematinics|hematinics|mesh-ancestor
15164617|NCT04083599|Gemcitabine|gemcitabine|mesh-list
15164618|NCT04083599|Paclitaxel|paclitaxel|mesh-list
15164619|NCT04083599|Carboplatin|carboplatin|mesh-list
15164620|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
15164621|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15164622|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164623|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
15164624|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
15164625|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
15164626|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164627|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164628|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
14621348|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621349|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
14621350|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
14621351|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621352|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621353|NCT00117039|Hematinics|hematinics|mesh-ancestor
14621354|NCT00117052|Cinacalcet|cinacalcet|mesh-list
14621355|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14621356|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621357|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14621358|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
14621359|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621360|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621361|NCT00117065|Hematinics|hematinics|mesh-ancestor
14621362|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621363|NCT00117078|Hematinics|hematinics|mesh-ancestor
14621364|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14621365|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621366|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621367|NCT00117104|Hematinics|hematinics|mesh-ancestor
14621368|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621369|NCT00117117|Hematinics|hematinics|mesh-ancestor
14621370|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621371|NCT00117130|Hematinics|hematinics|mesh-ancestor
14621372|NCT00117182|Budesonide|budesonide|mesh-list
14621373|NCT00117182|Mannitol|mannitol|mesh-list
14621374|NCT00117182|Bromides|bromides|mesh-list
14621375|NCT00117182|Albuterol|albuterol|mesh-list
14621376|NCT00117182|Ipratropium|ipratropium|mesh-list
14621377|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621378|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14621379|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
14621380|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621381|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621382|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14621383|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
14621384|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
14621385|NCT00117182|Hormones|hormones|mesh-ancestor
14621386|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621387|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
14621388|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
14621389|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14621390|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14621391|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14621392|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14621393|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
14621394|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621395|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621396|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14621397|NCT00117182|Diuretics|diuretics|mesh-ancestor
14621398|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
14621399|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15164629|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
15164630|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621400|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
14621401|NCT00117208|Mannitol|mannitol|mesh-list
14621402|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14621403|NCT00117208|Diuretics|diuretics|mesh-ancestor
14621404|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
14621405|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621406|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621407|NCT00117234|Hematinics|hematinics|mesh-ancestor
14621408|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621409|NCT00117247|Hematinics|hematinics|mesh-ancestor
15164631|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164632|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164633|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
15164634|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164635|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164636|NCT04083651|Bromides|bromides|mesh-list
15164637|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
15164638|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
15164639|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15164640|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164641|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
15164642|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164643|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15164644|NCT04083417|Penicillins|penicillins|mesh-list
15164645|NCT04083417|Penicillin V|penicillin v|mesh-list
15164646|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164647|NCT04083664|Hepcidins|hepcidins|mesh-list
15164648|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164649|NCT04083625|Carbetocin|carbetocin|mesh-list
14621410|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
15164650|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
15164651|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15164652|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164653|NCT04083144|Varenicline|varenicline|mesh-list
15164654|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15164655|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15164656|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
15164657|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621411|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14621412|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14621413|NCT00117260|Estradiol|estradiol|mesh-list
14621414|NCT00117260|Estrogens|estrogens|mesh-ancestor
14621415|NCT00117260|Hormones|hormones|mesh-ancestor
14621416|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621417|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621418|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14621419|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
14621420|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14621421|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14621422|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14621423|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14621424|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14621425|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14621426|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
14621427|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14621428|NCT00117273|Estradiol|estradiol|mesh-list
14621429|NCT00117273|Estrogens|estrogens|mesh-ancestor
14621430|NCT00117273|Hormones|hormones|mesh-ancestor
14621431|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621432|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621433|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14621434|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
14621435|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14621436|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14621437|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14621438|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14621439|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14621440|NCT00117299|Vatalanib|vatalanib|mesh-list
14621441|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14621442|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621443|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621444|NCT00117351|Bortezomib|bortezomib|mesh-list
14621445|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621446|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
14621447|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14621448|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14621449|NCT00117377|Analgesics|analgesics|mesh-ancestor
14621450|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
15164658|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164659|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164660|NCT04083105|Midazolam|midazolam|mesh-list
14621451|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621452|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621453|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621454|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621455|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
14621456|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621457|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
14621458|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14621459|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621460|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621461|NCT00117403|Vitamins|vitamins|mesh-list
14621462|NCT00117403|Vitamin E|vitamin e|mesh-list
14621463|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
14621464|NCT00117403|Ubiquinone|ubiquinone|mesh-list
14621465|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
14621466|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621467|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
14621468|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621469|NCT00117403|Protective Agents|protective agents|mesh-ancestor
14621470|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
14621471|NCT00117442|Paclitaxel|paclitaxel|mesh-list
14621472|NCT00117442|Carboplatin|carboplatin|mesh-list
14621473|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14621474|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621475|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14621476|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14621477|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14621478|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621479|NCT00117455|Lenograstim|lenograstim|mesh-list
14621480|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14621481|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
14621482|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621483|NCT00117468|Progesterone|progesterone|mesh-list
14621484|NCT00117468|Progestins|progestins|mesh-ancestor
14621485|NCT00117468|Hormones|hormones|mesh-ancestor
14621486|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621487|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621488|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14621489|NCT00117494|Pravastatin|pravastatin|mesh-list
14621490|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14621491|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14621492|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
14621493|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621494|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14621495|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14621496|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621497|NCT00117520|Caffeine|caffeine|mesh-list
14621498|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14621499|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621500|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14621501|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621502|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621503|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14621504|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14621505|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
14621506|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621507|NCT00117533|Ribavirin|ribavirin|mesh-list
14621508|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
14621509|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
14621510|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621511|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
14621512|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621513|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621514|NCT00117546|Methyldopa|methyldopa|mesh-list
14621515|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15164661|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
14621516|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
14621517|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
14621518|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621519|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621520|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14621521|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14621522|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15164662|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14621523|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164663|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14621524|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621525|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621526|NCT00117611|Omalizumab|omalizumab|mesh-list
14621527|NCT00117611|Antibodies|antibodies|mesh-list
14621528|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
14621529|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621530|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14621531|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14621532|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
14621533|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621534|NCT00117624|Hematinics|hematinics|mesh-ancestor
14621535|NCT00117663|Hormones|hormones|mesh-list
14621536|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621537|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621538|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
14621539|NCT00117689|Tacrolimus|tacrolimus|mesh-list
14621540|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
14621541|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14621542|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621543|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
14621544|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621545|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14621546|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621547|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621548|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14621549|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621550|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14621551|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
14621552|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14621553|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621554|NCT00117702|Everolimus|everolimus|mesh-list
14621555|NCT00117702|Tacrolimus|tacrolimus|mesh-list
15164664|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164665|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164666|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15164667|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15164668|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15164669|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15164670|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
15164671|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
15164672|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
15164673|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
15164674|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164675|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621556|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621557|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
14621558|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621559|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14621560|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621561|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164676|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15164677|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15164678|NCT04083105|Analgesics|analgesics|mesh-ancestor
15164679|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
15164680|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164681|NCT04083157|Imiquimod|imiquimod|mesh-list
15164682|NCT04083157|Vaccines|vaccines|mesh-list
15164683|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
15164684|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164685|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15164686|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164687|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
15164688|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
15164689|NCT04083209|Narcotics|narcotics|mesh-ancestor
15164690|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164691|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164692|NCT04083209|Analgesics|analgesics|mesh-ancestor
15164693|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
15164694|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164695|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
15164696|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
15164697|NCT04083560|Hematinics|hematinics|mesh-ancestor
14621562|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621563|NCT00117728|Nevirapine|nevirapine|mesh-list
15164698|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
15164699|NCT04083560|Vitamins|vitamins|mesh-ancestor
15164700|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
15180870|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
15164701|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164702|NCT04083066|Cytarabine|cytarabine|mesh-list
15164703|NCT04083066|Dexamethasone|dexamethasone|mesh-list
15164704|NCT04083066|Rituximab|rituximab|mesh-list
15164705|NCT04083066|Methotrexate|methotrexate|mesh-list
15164706|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164707|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
15164708|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
15164709|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164710|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164711|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15164712|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
15164713|NCT04083066|Hormones|hormones|mesh-ancestor
15164714|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164715|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15164716|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164717|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164718|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
14621564|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14621565|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14621566|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621567|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621568|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
14621569|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621570|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14621571|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14621572|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14621573|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14621574|NCT00117754|Terbinafine|terbinafine|mesh-list
14621575|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
14621576|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621577|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621578|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621579|NCT00117767|Terbinafine|terbinafine|mesh-list
14621580|NCT00117767|Griseofulvin|griseofulvin|mesh-list
14621581|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
14621582|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621583|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621584|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621585|NCT00117780|Insulin|insulin|mesh-list
14621586|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14621587|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
14621588|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
14621589|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14621590|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621591|NCT00117832|Azelastine|azelastine|mesh-list
14621592|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14621593|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
14621594|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621595|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621596|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15164719|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15164720|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15164721|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
15164722|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15164723|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164724|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
15164725|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164726|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
15164727|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164728|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15164729|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164730|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15164731|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
14621597|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
14621598|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14621599|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621600|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621601|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14621602|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14621603|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14621604|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
15164732|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621605|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
14621606|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621607|NCT00117897|Lenograstim|lenograstim|mesh-list
14621608|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14621609|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
14621610|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621611|NCT00117936|Mitogens|mitogens|mesh-list
14621612|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14621613|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621614|NCT00117975|Galiximab|galiximab|mesh-list
14621615|NCT00117975|Rituximab|rituximab|mesh-list
14621616|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14621617|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621618|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
14621619|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621620|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621621|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621622|NCT00118014|Sertraline|sertraline|mesh-list
14621623|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
14621624|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14621625|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14621626|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14621627|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14621628|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621629|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621630|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
14621631|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621632|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
14621633|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
14621634|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14621635|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
14621636|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14621637|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14621638|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621639|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14621640|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621641|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621642|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14621643|NCT00118027|Renal Agents|renal agents|mesh-ancestor
14621644|NCT00118066|Calcitriol|calcitriol|mesh-list
14621645|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14621646|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621647|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14621648|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14621649|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621650|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14621651|NCT00118066|Vitamins|vitamins|mesh-ancestor
14621652|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
14621653|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14621654|NCT00118105|Bevacizumab|bevacizumab|mesh-list
14621655|NCT00118105|Capecitabine|capecitabine|mesh-list
14621656|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
14621657|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14621658|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621659|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14621660|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14621661|NCT00118105|Growth Substances|growth substances|mesh-ancestor
14621662|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621663|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
14621664|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621665|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
14621666|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621667|NCT00118170|Sorafenib|sorafenib|mesh-list
14621668|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164733|NCT04083118|Listerine|listerine|mesh-list
15164734|NCT04083118|Fluorides|fluorides|mesh-list
15164735|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
15164736|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
15164737|NCT04083118|Protective Agents|protective agents|mesh-ancestor
15164738|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164739|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15164740|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621669|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14621670|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621671|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164741|NCT04083235|Leucovorin|leucovorin|mesh-list
15164742|NCT04083235|Gemcitabine|gemcitabine|mesh-list
14621672|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14621673|NCT00118183|Cetuximab|cetuximab|mesh-list
15164743|NCT04083235|Paclitaxel|paclitaxel|mesh-list
15164744|NCT04083235|Fluorouracil|fluorouracil|mesh-list
15164745|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
15164746|NCT04083235|Irinotecan|irinotecan|mesh-list
15164747|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15164748|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164749|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14621674|NCT00118183|Docetaxel|docetaxel|mesh-list
14621675|NCT00118183|Bortezomib|bortezomib|mesh-list
14621676|NCT00118183|Antibodies|antibodies|mesh-list
14621677|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
14621678|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14621679|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
14621680|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621681|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621682|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14621683|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14621684|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14621685|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621686|NCT00118196|Azacitidine|azacitidine|mesh-list
14621687|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
14621688|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621689|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
14621690|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621691|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621692|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621693|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14621694|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14621695|NCT00118222|Ether|ether|mesh-list
14621696|NCT00118222|Trioxsalen|trioxsalen|mesh-list
14621697|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621698|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
14621699|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14621700|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14621701|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
14621702|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
14621703|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14621704|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621705|NCT00118235|Bevacizumab|bevacizumab|mesh-list
14621706|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14621707|NCT00118235|Irinotecan|irinotecan|mesh-list
14621708|NCT00118235|Antibodies|antibodies|mesh-list
14621709|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
14621710|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14621711|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621712|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14621713|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14621714|NCT00118235|Growth Substances|growth substances|mesh-ancestor
14621715|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621716|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
14621717|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
14621718|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14621719|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14621720|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621721|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621722|NCT00118261|Leucovorin|leucovorin|mesh-list
14621723|NCT00118261|Bevacizumab|bevacizumab|mesh-list
14621724|NCT00118261|Fluorouracil|fluorouracil|mesh-list
14621725|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
14621726|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14621727|NCT00118261|Calcium|calcium|mesh-list
14621728|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
14621729|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14621730|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621731|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14621732|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14621733|NCT00118261|Growth Substances|growth substances|mesh-ancestor
14621734|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621735|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14621736|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14621737|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
15164750|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14621738|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621739|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621740|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621741|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
14621742|NCT00118261|Antidotes|antidotes|mesh-ancestor
14621743|NCT00118261|Protective Agents|protective agents|mesh-ancestor
14621744|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
14621745|NCT00118261|Vitamins|vitamins|mesh-ancestor
14621746|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
14621747|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14621748|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621749|NCT00118300|Capecitabine|capecitabine|mesh-list
14621750|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621751|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
14621752|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621753|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621754|NCT00118313|Imiquimod|imiquimod|mesh-list
14621755|NCT00118313|Sargramostim|sargramostim|mesh-list
14621756|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
14621757|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14621758|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
14621759|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621760|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621761|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15164751|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
15164752|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164753|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15164754|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
15164755|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
14022310|NCT02769104|Letrozole|letrozole|mesh-list
14022311|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14022312|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164756|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164757|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621762|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
14621763|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14621764|NCT00118313|Protective Agents|protective agents|mesh-ancestor
14621765|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14621766|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
14621767|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621768|NCT00118326|Lenograstim|lenograstim|mesh-list
14621769|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14621770|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
14621771|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621772|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
14621773|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14621774|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14621775|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621776|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14621777|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621778|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14621779|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
14621780|NCT00118638|Hematinics|hematinics|mesh-ancestor
14621781|NCT00118690|Fluticasone|fluticasone|mesh-list
14621782|NCT00118690|Xhance|xhance|mesh-list
14621783|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14621784|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621785|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14621786|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
14621787|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621788|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621789|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14621790|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
14621791|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
14621792|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14621793|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14621794|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14621795|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14621796|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
14621797|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621798|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621799|NCT00118768|Interferons|interferons|mesh-list
14621800|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
14621801|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022313|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
14022314|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
14022315|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
14026086|NCT02745054|Anticoagulants|anticoagulants|mesh-list
14621802|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
14621803|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621804|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
15164758|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022316|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621805|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621806|NCT00118794|Lumefantrine|lumefantrine|mesh-list
14621807|NCT00118794|Artemether|artemether|mesh-list
14621808|NCT00118794|Dapsone|dapsone|mesh-list
14621809|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
14621810|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14621811|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
14621812|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14621813|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14621814|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621815|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14621816|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621817|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621818|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
14621819|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14621820|NCT00118807|Artesunate|artesunate|mesh-list
14621821|NCT00118807|Chloroquine|chloroquine|mesh-list
14621822|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
14621823|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
14621824|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14621825|NCT00118807|Amodiaquine|amodiaquine|mesh-list
14022317|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14022318|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022319|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14022320|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
14022321|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164759|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
15164760|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164761|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15164762|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15164763|NCT04083235|Antidotes|antidotes|mesh-ancestor
14621826|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
14621827|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14621828|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14621829|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621830|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621831|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
14621832|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
14621833|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15164764|NCT04083235|Protective Agents|protective agents|mesh-ancestor
15164765|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
15164766|NCT04083235|Vitamins|vitamins|mesh-ancestor
15164767|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
15164768|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15164769|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
15164770|NCT04082949|Coagulants|coagulants|mesh-ancestor
15164771|NCT04082962|Dexamethasone|dexamethasone|mesh-list
14621834|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
14621835|NCT00118807|Amebicides|amebicides|mesh-ancestor
14621836|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621837|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14621838|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621839|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621840|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14621841|NCT00118807|Renal Agents|renal agents|mesh-ancestor
14621842|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14621843|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164772|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164773|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
15164774|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
15164775|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164776|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164777|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15164778|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
15164779|NCT04082962|Hormones|hormones|mesh-ancestor
15164780|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164781|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15164782|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164783|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14022322|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022323|NCT02769169|Ranibizumab|ranibizumab|mesh-list
14646263|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646264|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14646265|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15164784|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15164785|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164786|NCT04082897|Atezolizumab|atezolizumab|mesh-list
15164787|NCT04082897|Venetoclax|venetoclax|mesh-list
15164788|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
15164789|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164790|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164791|NCT04082650|Vitamin D|vitamin d|mesh-list
15164792|NCT04082650|Vitamins|vitamins|mesh-ancestor
15164793|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
15164794|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621844|NCT00118937|Metformin|metformin|mesh-list
14621845|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14621846|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621847|NCT00118950|Metformin|metformin|mesh-list
14621848|NCT00118950|Repaglinide|repaglinide|mesh-list
14621849|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14621850|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621851|NCT00118963|Metformin|metformin|mesh-list
14621852|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
14621853|NCT00118963|Repaglinide|repaglinide|mesh-list
15164795|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15164796|NCT04082715|Celecoxib|celecoxib|mesh-list
15164797|NCT04082715|Levodopa|levodopa|mesh-list
15164798|NCT04082715|Carbidopa|carbidopa|mesh-list
15164799|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15164800|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15164801|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15164802|NCT04082715|Analgesics|analgesics|mesh-ancestor
15164803|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
15164804|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164805|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164806|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621854|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14621855|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621856|NCT00118976|Lisinopril|lisinopril|mesh-list
14621857|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14621858|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
14621859|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621860|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621861|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14621862|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14621863|NCT00118976|Protective Agents|protective agents|mesh-ancestor
14621864|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621865|NCT00119002|Dexamethasone|dexamethasone|mesh-list
14621866|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14621867|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
14621868|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
14621869|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14621870|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621871|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14621872|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
14621873|NCT00119002|Hormones|hormones|mesh-ancestor
14621874|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14621875|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15164807|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15164808|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15164809|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15164810|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164811|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164812|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15164813|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15164814|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
15164815|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164816|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15164817|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15164818|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
14022324|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14022325|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14621876|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621877|NCT00119119|Tocopherols|tocopherols|mesh-list
14621878|NCT00119119|Vitamin E|vitamin e|mesh-list
14621879|NCT00119119|Tocotrienols|tocotrienols|mesh-list
14621880|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
14621881|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
14621882|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164819|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
15164820|NCT04082858|Midazolam|midazolam|mesh-list
15164821|NCT04082858|Ketamine|ketamine|mesh-list
15164822|NCT04082858|Analgesics|analgesics|mesh-ancestor
14621883|NCT00119119|Protective Agents|protective agents|mesh-ancestor
14621884|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621885|NCT00119119|Vitamins|vitamins|mesh-ancestor
14621886|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
14621887|NCT00119132|Artesunate|artesunate|mesh-list
15164823|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
15164824|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164825|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164826|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15164827|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15164828|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
14022326|NCT02769169|Growth Substances|growth substances|mesh-ancestor
14022327|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022328|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
14022329|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022330|NCT02768948|Losartan|losartan|mesh-list
15164829|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
15164830|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164831|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15164832|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15164833|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164834|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164835|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15164836|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15164837|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15164838|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15164839|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14621888|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
14621889|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
14621890|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14621891|NCT00119132|Amodiaquine|amodiaquine|mesh-list
14621892|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
14621893|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14621894|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14621895|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621896|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621897|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
14621898|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
14621899|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14621900|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
14621901|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14621902|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164840|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
15164841|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
15164842|NCT04082793|Diclofenac|diclofenac|mesh-list
14022331|NCT02768948|Telmisartan|telmisartan|mesh-list
14621903|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621904|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14621905|NCT00119132|Renal Agents|renal agents|mesh-ancestor
14621906|NCT00119145|Artesunate|artesunate|mesh-list
14621907|NCT00119145|Amodiaquine|amodiaquine|mesh-list
14621908|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14621909|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
14621910|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14621911|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14621912|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621913|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621914|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
15164843|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15164844|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15164845|NCT04082793|Analgesics|analgesics|mesh-ancestor
15164846|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
15164847|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164848|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164849|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15164850|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15164851|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15164852|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164853|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164854|NCT04082806|Trazodone|trazodone|mesh-list
15164855|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15164856|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14621915|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
14621916|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14621917|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
14621918|NCT00119171|Capecitabine|capecitabine|mesh-list
14621919|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621920|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
14621921|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621922|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621923|NCT00119184|Anesthetics|anesthetics|mesh-list
14621924|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14621925|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621926|NCT00119210|Bupropion|bupropion|mesh-list
14621927|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14022332|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14022333|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14022334|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14022335|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14022336|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022337|NCT02768727|Xenon|xenon|mesh-list
14022338|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14621928|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
14621929|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14621930|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14621931|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14621932|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14621933|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621934|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
14621935|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14621936|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621937|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14621938|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14621939|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621940|NCT00119236|Irinotecan|irinotecan|mesh-list
14621941|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14621942|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14621943|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621944|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621945|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621946|NCT00119249|Sorafenib|sorafenib|mesh-list
14621947|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621948|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14621949|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621950|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621951|NCT00119301|Leucovorin|leucovorin|mesh-list
14621952|NCT00119301|Trimetrexate|trimetrexate|mesh-list
14621953|NCT00119301|Methotrexate|methotrexate|mesh-list
14621954|NCT00119301|Calcium|calcium|mesh-list
14621955|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
14621956|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14621957|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621958|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14621959|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
14621960|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14621961|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621962|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
14621963|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14621964|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621965|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
14621966|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621967|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14621968|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621969|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
14621970|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14621971|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14621972|NCT00119301|Antidotes|antidotes|mesh-ancestor
14621973|NCT00119301|Protective Agents|protective agents|mesh-ancestor
14621974|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
14621975|NCT00119301|Vitamins|vitamins|mesh-ancestor
14621976|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
14621977|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
14621978|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621979|NCT00119314|Gemcitabine|gemcitabine|mesh-list
14621980|NCT00119314|Capecitabine|capecitabine|mesh-list
14621981|NCT00119314|Docetaxel|docetaxel|mesh-list
14621982|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14621983|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
15164857|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14621984|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164858|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621985|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14621986|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
14621987|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14621988|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14621989|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14621990|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
14621991|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14621992|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
14621993|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
14621994|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
14621995|NCT00119340|Cyclosporine|cyclosporine|mesh-list
14621996|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
14621997|NCT00119340|Fludarabine|fludarabine|mesh-list
14621998|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
14621999|NCT00119340|Cyclosporins|cyclosporins|mesh-list
14622000|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622001|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14622002|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
14622003|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622004|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622005|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
14622006|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622007|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622008|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
14622009|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622010|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622011|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622012|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14622013|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14622014|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14622015|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
14622016|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14622017|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
14622018|NCT00119483|Testosterone|testosterone|mesh-list
14622019|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
14622020|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
14622021|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14622022|NCT00119483|Androgens|androgens|mesh-ancestor
14622023|NCT00119483|Hormones|hormones|mesh-ancestor
14622024|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14622025|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622026|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14622027|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622028|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
14622029|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
14622030|NCT00119496|Beclomethasone|beclomethasone|mesh-list
14622031|NCT00119496|Theophylline|theophylline|mesh-list
14622032|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622033|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622034|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14622035|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622036|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622037|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
14622038|NCT00119496|Hormones|hormones|mesh-ancestor
14622039|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14622040|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14622041|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
14622042|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14622043|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
14622044|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622045|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14622046|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
14622047|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14622048|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14622049|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
14622050|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622051|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
14622052|NCT00119587|Hematinics|hematinics|mesh-ancestor
14622053|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
14622054|NCT00119613|Hematinics|hematinics|mesh-ancestor
14622055|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
14622056|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
14622057|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622058|NCT00119626|Protective Agents|protective agents|mesh-ancestor
14622059|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622060|NCT00119639|Sorafenib|sorafenib|mesh-list
14622061|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622062|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14622063|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622064|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164859|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15164860|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15164861|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14622065|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14622066|NCT00119652|Paroxetine|paroxetine|mesh-list
14622067|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
14622068|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622069|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14622070|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14622071|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622072|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622073|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14622074|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14622075|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622076|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622077|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622078|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
14622079|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14622080|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14622081|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622082|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622083|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14622084|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
14622085|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622086|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
14622087|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14622088|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14622089|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14622090|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622091|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622092|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
14622093|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622094|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622095|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14622096|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622097|NCT00119730|Rituximab|rituximab|mesh-list
14622098|NCT00119730|Fludarabine|fludarabine|mesh-list
14622099|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
14622100|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14622101|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622102|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
14622103|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622104|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622105|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622106|NCT00119730|Analgesics|analgesics|mesh-ancestor
14622107|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
15164862|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15164863|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164864|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164865|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
15164866|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15164867|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
15164868|NCT04082767|Midazolam|midazolam|mesh-list
15164869|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
15164870|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15164871|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164872|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164873|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622108|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622109|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14622110|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14622111|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622112|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15164874|NCT04082767|Analgesics|analgesics|mesh-ancestor
15164875|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
15164876|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164877|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15164878|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15164879|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15164880|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164881|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15164882|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164883|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15164884|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15164885|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15164886|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15164887|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15164888|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
15164889|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
15164890|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
15164891|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
14622113|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14622114|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14622115|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622116|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622117|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622118|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14622119|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14622120|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
14622121|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622122|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622123|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14622124|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14622125|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
14622126|NCT00119769|Hormones|hormones|mesh-list
14622127|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14622128|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622129|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
14622130|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14622131|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622132|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622133|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
14622134|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622135|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622136|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
14622137|NCT00119990|Icodextrin|icodextrin|mesh-list
14622138|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14622139|NCT00120003|Candesartan|candesartan|mesh-list
14622140|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
14622141|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14622142|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14622143|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14622144|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622145|NCT00120055|Atorvastatin|atorvastatin|mesh-list
14622146|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14622147|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14622148|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
14622149|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622150|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14622151|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14622152|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622153|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14622154|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14622155|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
14622156|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622157|NCT00120081|Antacids|antacids|mesh-ancestor
14622158|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622159|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622160|NCT00120120|Lenalidomide|lenalidomide|mesh-list
14622161|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
14622162|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622163|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14622164|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14622165|NCT00120120|Growth Substances|growth substances|mesh-ancestor
14622166|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
14622167|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622168|NCT00120133|Atorvastatin|atorvastatin|mesh-list
14622169|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14622170|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14622171|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
14622172|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164892|NCT04082598|Amoxicillin|amoxicillin|mesh-list
15164893|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
14622173|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14622174|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14622175|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622176|NCT00120172|Bevacizumab|bevacizumab|mesh-list
14622177|NCT00120172|Capecitabine|capecitabine|mesh-list
14622178|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
15164894|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
15164895|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15164896|NCT04082598|Lactoferrin|lactoferrin|mesh-list
15164897|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15164898|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164899|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15164900|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164901|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164902|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15164903|NCT04082559|Metronidazole|metronidazole|mesh-list
15164904|NCT04082559|Doxycycline|doxycycline|mesh-list
15164905|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
15164906|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15164907|NCT04082559|Complement Factor H|complement factor h|mesh-list
15164908|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15164909|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
15164910|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15164911|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14622179|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14622180|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622181|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14622182|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14622183|NCT00120172|Growth Substances|growth substances|mesh-ancestor
14622184|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622185|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
14622186|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14622187|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
14622188|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622189|NCT00120185|Interleukin-2|interleukin-2|mesh-list
14622190|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622191|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622192|NCT00120185|Analgesics|analgesics|mesh-ancestor
14622193|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
14622194|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622195|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622196|NCT00120198|Rituximab|rituximab|mesh-list
14622197|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14622198|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622199|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
14622200|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622201|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622202|NCT00120237|Misoprostol|misoprostol|mesh-list
14622203|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14622204|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
14622205|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14622206|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622207|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14622208|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622209|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
14622210|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
14622211|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14622212|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622213|NCT00120302|Analgesics|analgesics|mesh-ancestor
14622214|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
14622215|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622216|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622217|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622218|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622219|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622220|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164912|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
15164913|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15164914|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15164915|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15164916|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164917|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164918|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15164919|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15164920|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15164921|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15164922|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
15164923|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164924|NCT04082286|Antibodies|antibodies|mesh-list
15164925|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15164926|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
15164927|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180871|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180872|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15180873|NCT03935347|Analgesics|analgesics|mesh-ancestor
15180874|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
15180875|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180876|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15180877|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15180878|NCT03935256|Paclitaxel|paclitaxel|mesh-list
15180879|NCT03935256|Carboplatin|carboplatin|mesh-list
14622221|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
14622222|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14622223|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622224|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622225|NCT00120315|Esomeprazole|esomeprazole|mesh-list
14622226|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14622227|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622228|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14622229|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622230|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622231|NCT00120341|Analgesics|analgesics|mesh-list
14622232|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
14622233|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622234|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622235|NCT00120354|Lamivudine|lamivudine|mesh-list
14622236|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622237|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622238|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622239|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622240|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
14622241|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622242|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622243|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622244|NCT00120367|Tenofovir|tenofovir|mesh-list
14622245|NCT00120367|Emtricitabine|emtricitabine|mesh-list
14622246|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
15180880|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180881|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180882|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
15180883|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
15180884|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
15180885|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182229|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15182230|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182231|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182232|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182233|NCT03923075|Analgesics|analgesics|mesh-ancestor
15182234|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
15182235|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182236|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15182237|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15182238|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15182239|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
15182240|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182241|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182242|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15182243|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14622247|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
14622248|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622249|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15182244|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182245|NCT03923231|Ritonavir|ritonavir|mesh-list
15182246|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15182247|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15182248|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15182249|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
15182250|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182330|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164928|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
14622250|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622251|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622252|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622253|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622254|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622255|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14622256|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15164929|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15164930|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164931|NCT04082182|Vaccines|vaccines|mesh-list
15164932|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
15164933|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164934|NCT04081909|Fentanyl|fentanyl|mesh-list
15164935|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
15164936|NCT04081909|Ketamine|ketamine|mesh-list
15164937|NCT04081909|Remifentanil|remifentanil|mesh-list
15164938|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15164939|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164940|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164941|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15164942|NCT04081909|Analgesics|analgesics|mesh-ancestor
15164943|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
15164944|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622257|NCT00120380|Iloprost|iloprost|mesh-list
14622258|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14622259|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
14622260|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
14622261|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14622262|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164945|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15164946|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15164947|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15164948|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
15164949|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622263|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14622264|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
14622265|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14622266|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622267|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622268|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622269|NCT00120432|Phenylephrine|phenylephrine|mesh-list
14622270|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
14622271|NCT00120432|Tropicamide|tropicamide|mesh-list
14622272|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14622273|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
14622274|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
14622275|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622276|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622277|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
14622278|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14622279|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
14622280|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
14622281|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14622282|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14622283|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14622284|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
14622285|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622286|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622287|NCT00120432|Protective Agents|protective agents|mesh-ancestor
14622288|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14622289|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14622290|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
14622291|NCT00120471|Tenofovir|tenofovir|mesh-list
14622292|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
14622293|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622294|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622295|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622296|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622297|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622298|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622299|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15164950|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814547|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15164951|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14622300|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
14622301|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
14622302|NCT00120484|Vitamins|vitamins|mesh-ancestor
14622303|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
14622304|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622305|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
14622306|NCT00120484|Hematinics|hematinics|mesh-ancestor
14646266|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
14646267|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646268|NCT00197249|Vaccines|vaccines|mesh-list
14646269|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
14646270|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646271|NCT00197301|Vaccines|vaccines|mesh-list
14646272|NCT00197301|Immunologic Factors|immunologic factors|mesh-ancestor
14646273|NCT00197301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646274|NCT00197327|Bupivacaine|bupivacaine|mesh-list
14646275|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
14646276|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
14646277|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646278|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646279|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
15164952|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15164953|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
15164954|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
15164955|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15164956|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15164957|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15164958|NCT04081909|Narcotics|narcotics|mesh-ancestor
14646280|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646281|NCT00197340|Ropivacaine|ropivacaine|mesh-list
14646282|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
14646283|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
14646284|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646285|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646286|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
14646287|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646288|NCT00197353|Bupivacaine|bupivacaine|mesh-list
14646289|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
14646290|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
14646291|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646292|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646293|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
14646294|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646295|NCT00197379|Roxithromycin|roxithromycin|mesh-list
14646296|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14646297|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646298|NCT00197418|Amoxicillin|amoxicillin|mesh-list
14646299|NCT00197418|Metronidazole|metronidazole|mesh-list
14646300|NCT00197418|Clarithromycin|clarithromycin|mesh-list
14646301|NCT00197418|Rabeprazole|rabeprazole|mesh-list
14646302|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14646303|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646304|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14646305|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14646306|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14646307|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646308|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646309|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14646310|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14646311|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14646312|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14646313|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14646314|NCT00197444|Nedaplatin|nedaplatin|mesh-list
14646315|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646316|NCT00197483|Pergolide|pergolide|mesh-list
14646317|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
14646318|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
14646319|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646320|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646321|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646322|NCT00197548|Folic Acid|folic acid|mesh-list
15164959|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14646323|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
14646324|NCT00197548|Vitamins|vitamins|mesh-ancestor
15164960|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
14646325|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
14646326|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646327|NCT00197548|Hematinics|hematinics|mesh-ancestor
15164961|NCT04081545|Analgesics|analgesics|mesh-list
14622307|NCT00120497|Hormones|hormones|mesh-list
14622308|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14622309|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622310|NCT00120510|Lamivudine|lamivudine|mesh-list
14622311|NCT00120510|Zidovudine|zidovudine|mesh-list
14622312|NCT00120510|Efavirenz|efavirenz|mesh-list
14622313|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14622314|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622315|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622316|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622317|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622318|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
14622319|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622320|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622321|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622322|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
15164962|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
15164963|NCT04081545|Anesthetics|anesthetics|mesh-list
15164964|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15164965|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164966|NCT04081545|Narcotics|narcotics|mesh-ancestor
15164967|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
15164968|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15164969|NCT04081805|Estradiol|estradiol|mesh-list
15164970|NCT04081805|Estrogens|estrogens|mesh-ancestor
15164971|NCT04081805|Hormones|hormones|mesh-ancestor
15164972|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15164973|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022339|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
14622323|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14622324|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622325|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14622326|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14622327|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14622328|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14622329|NCT00120536|Vildagliptin|vildagliptin|mesh-list
14622330|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14622331|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622332|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14622333|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
14622334|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622335|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622336|NCT00120601|Naltrexone|naltrexone|mesh-list
14622337|NCT00120601|Acamprosate|acamprosate|mesh-list
14622338|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14622339|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14622340|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622341|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
14622342|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622343|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14622344|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14622345|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14622346|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
14022340|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
14022341|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022342|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022343|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
14022344|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14022345|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14022346|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14622347|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14622348|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622349|NCT00120640|Progestins|progestins|mesh-ancestor
14622350|NCT00120640|Hormones|hormones|mesh-ancestor
14622351|NCT00120653|Metoclopramide|metoclopramide|mesh-list
14622352|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
14622353|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
14622354|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622355|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622356|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622357|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14622358|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14622359|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
15164974|NCT04081688|Atezolizumab|atezolizumab|mesh-list
14622360|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622361|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164975|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15164976|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
15164977|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
14622362|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
14622363|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
14622364|NCT00120679|Hematinics|hematinics|mesh-ancestor
15164978|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164979|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
15164980|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15164981|NCT04081389|Interferons|interferons|mesh-list
15164982|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
15164983|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
15164984|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
15164985|NCT04081389|Celecoxib|celecoxib|mesh-list
15164986|NCT04081389|Paclitaxel|paclitaxel|mesh-list
15164987|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
15164988|NCT04081389|Doxorubicin|doxorubicin|mesh-list
15164989|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15164990|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15164991|NCT04081389|Daunorubicin|daunorubicin|mesh-list
15164992|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
15164993|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15164994|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15164995|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
15164996|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14622365|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
14622366|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
14622367|NCT00120692|Hematinics|hematinics|mesh-ancestor
14622368|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
14622369|NCT00120705|Hematinics|hematinics|mesh-ancestor
14622370|NCT00120718|Fasudil|fasudil|mesh-list
15164997|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
15164998|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15164999|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165000|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
14622371|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14622372|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622373|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622374|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14622375|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622376|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
14622377|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14622378|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622379|NCT00120731|Acetazolamide|acetazolamide|mesh-list
14622380|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
14622381|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622382|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
15165001|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165002|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15165003|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15165004|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
15165005|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15165006|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14622383|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14622384|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622385|NCT00120731|Diuretics|diuretics|mesh-ancestor
14622386|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
14622387|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622388|NCT00120731|Expectorants|expectorants|mesh-ancestor
14622389|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
14622390|NCT00120744|Ondansetron|ondansetron|mesh-list
14622391|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
14622392|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
15165007|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15165008|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15165009|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165010|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
15165011|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165012|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15165013|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622393|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622394|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165014|NCT04081389|Analgesics|analgesics|mesh-ancestor
15165015|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
15165016|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165017|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165018|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15165019|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15165020|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14622395|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622396|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
14622397|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
15165021|NCT04081376|Hydromorphone|hydromorphone|mesh-list
15165022|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15165023|NCT04081376|Narcotics|narcotics|mesh-ancestor
15165024|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622398|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14622399|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
14622400|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622401|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165025|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165026|NCT04081376|Analgesics|analgesics|mesh-ancestor
15165027|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
15165028|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165029|NCT04081480|Valacyclovir|valacyclovir|mesh-list
15165030|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
15165031|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165032|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
15165033|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15165034|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
15165035|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165036|NCT04081012|Expectorants|expectorants|mesh-ancestor
15165037|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
15165038|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15165039|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
15165040|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165041|NCT04081012|Protective Agents|protective agents|mesh-ancestor
15165042|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165043|NCT04081012|Antidotes|antidotes|mesh-ancestor
15165044|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
15165045|NCT04081077|Linezolid|linezolid|mesh-list
15165046|NCT04081077|Bedaquiline|bedaquiline|mesh-list
15165047|NCT04081077|Clofazimine|clofazimine|mesh-list
15165048|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165049|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165050|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15165051|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15165052|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165053|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165054|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165055|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15165056|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
15165057|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165058|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
15165059|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14622402|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14622403|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14622404|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622405|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622406|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14622407|NCT00120757|Alendronate|alendronate|mesh-list
14622408|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14622409|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622410|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
14622411|NCT00120783|Ritonavir|ritonavir|mesh-list
14622412|NCT00120783|Indinavir|indinavir|mesh-list
14622413|NCT00120783|Lamivudine|lamivudine|mesh-list
14622414|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14622415|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14622416|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14622417|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622418|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622419|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622420|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622421|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
14622422|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022347|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622423|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14622424|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622425|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15165060|NCT04080908|Hematinics|hematinics|mesh-ancestor
15165061|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15165062|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15165063|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
15165064|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14622426|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622427|NCT00120796|Lamivudine|lamivudine|mesh-list
14622428|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622429|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622430|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622431|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622432|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
14622433|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622434|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622435|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622436|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
14622437|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
14622438|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14622439|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
14622440|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14622441|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14622442|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622443|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14622444|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622445|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622446|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14622447|NCT00120809|Renal Agents|renal agents|mesh-ancestor
14622448|NCT00120822|Folic Acid|folic acid|mesh-list
14622449|NCT00120822|Hematinics|hematinics|mesh-ancestor
14622450|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
14622451|NCT00120822|Vitamins|vitamins|mesh-ancestor
14622452|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
14622453|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622454|NCT00120835|Interferons|interferons|mesh-list
14622455|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622456|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
14622457|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622458|NCT00120861|Interferons|interferons|mesh-list
14622459|NCT00120861|Ribavirin|ribavirin|mesh-list
14622460|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622461|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
14622462|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622463|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
14622464|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622465|NCT00120887|Atorvastatin|atorvastatin|mesh-list
14622466|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14622467|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14622468|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
14622469|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622470|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14622471|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14622472|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622473|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
14622474|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14622475|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14622476|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
14622477|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14622478|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622479|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
14622480|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622481|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14622482|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622483|NCT00120952|Cobalt|cobalt|mesh-list
14622484|NCT00120952|Chromium|chromium|mesh-list
14622485|NCT00120952|Trace Elements|trace elements|mesh-ancestor
14622486|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
15165065|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165066|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15165067|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165068|NCT04080726|Esomeprazole|esomeprazole|mesh-list
15165069|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15165070|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165071|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15165072|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165073|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165074|NCT04080739|Ropivacaine|ropivacaine|mesh-list
15165075|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
15165076|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
15180886|NCT03934710|Serotonin|serotonin|mesh-list
14622487|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165077|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165078|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165079|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
15165080|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165081|NCT04080375|Dinoprostone|dinoprostone|mesh-list
15165082|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
15165083|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15165084|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165085|NCT04080388|Diuretics|diuretics|mesh-list
15165086|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
15165087|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165088|NCT04080713|Budesonide|budesonide|mesh-list
15165089|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622488|NCT00120978|Fluticasone|fluticasone|mesh-list
14622489|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14622490|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
14622491|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622492|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622493|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14622494|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
14622495|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622496|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622497|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15165090|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15165091|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
15165092|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165093|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165094|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15165095|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
15165096|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
14622498|NCT00121017|Ritonavir|ritonavir|mesh-list
14622499|NCT00121017|Lopinavir|lopinavir|mesh-list
14622500|NCT00121017|Tenofovir|tenofovir|mesh-list
14622501|NCT00121017|Emtricitabine|emtricitabine|mesh-list
14622502|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14622503|NCT00121017|Efavirenz|efavirenz|mesh-list
14622504|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15165097|NCT04080713|Hormones|hormones|mesh-ancestor
15165098|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180887|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
15180888|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
15180889|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180890|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180891|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180892|NCT03934450|Primaquine|primaquine|mesh-list
15180893|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
15180894|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14622505|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14622506|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
14622507|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622508|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622509|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622510|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622511|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
14622512|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622513|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14622514|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622515|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622516|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622517|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15180895|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15180896|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180897|NCT03934411|Tramadol|tramadol|mesh-list
15180898|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15180899|NCT03934411|Narcotics|narcotics|mesh-ancestor
15180900|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180901|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180902|NCT03934411|Analgesics|analgesics|mesh-ancestor
15180903|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
15180904|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180905|NCT03934216|BMS-986165|bms-986165|mesh-list
15180906|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
15180907|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15180908|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180909|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622518|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15165099|NCT04080622|Selenium|selenium|mesh-list
15165100|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
15165101|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165102|NCT04080622|Protective Agents|protective agents|mesh-ancestor
15165103|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165104|NCT04080622|Trace Elements|trace elements|mesh-ancestor
14622519|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14622520|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15165105|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
15165106|NCT04080349|Misoprostol|misoprostol|mesh-list
15165107|NCT04080349|Dinoprostone|dinoprostone|mesh-list
15165108|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15165109|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
15165110|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15165111|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165112|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15165113|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165114|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
14622521|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14622522|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
14622523|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
14622524|NCT00121030|Hematinics|hematinics|mesh-ancestor
14622525|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14622526|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622527|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14622528|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622529|NCT00121069|Citalopram|citalopram|mesh-list
14622530|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15165115|NCT04080323|Dinoprostone|dinoprostone|mesh-list
15165116|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
15165117|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15165118|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165119|NCT04080336|Misoprostol|misoprostol|mesh-list
15165120|NCT04080336|Dinoprostone|dinoprostone|mesh-list
15165121|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15165122|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
15165123|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15165124|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165125|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15165126|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165127|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
15165128|NCT04080310|Ezetimibe|ezetimibe|mesh-list
15165129|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
15165130|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14622531|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14622532|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622533|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622534|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165131|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15165132|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
15165133|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165134|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14622535|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
14622536|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622537|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14622538|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
14622539|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622540|NCT00121095|Docetaxel|docetaxel|mesh-list
14622541|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14622542|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622543|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14622544|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14622545|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14622546|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622547|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622548|NCT00121095|Analgesics|analgesics|mesh-ancestor
14622549|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
14622550|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622551|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622552|NCT00121147|Travoprost|travoprost|mesh-list
15165135|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165136|NCT04080869|Vitamin A|vitamin a|mesh-list
15165137|NCT04080869|Tretinoin|tretinoin|mesh-list
15165138|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
14022348|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
14622553|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14622554|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14622555|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14622556|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14622557|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14622558|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
14622559|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622560|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622561|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622562|NCT00121264|Sorafenib|sorafenib|mesh-list
14622563|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622564|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14622565|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622566|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622567|NCT00121277|Capecitabine|capecitabine|mesh-list
14622568|NCT00121277|Vorinostat|vorinostat|mesh-list
14622569|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14622570|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
15165139|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165140|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
15165141|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
15165142|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
15165143|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165144|NCT04080869|Protective Agents|protective agents|mesh-ancestor
14622571|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622572|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622573|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14622574|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622575|NCT00121303|Cytarabine|cytarabine|mesh-list
14622576|NCT00121303|Daunorubicin|daunorubicin|mesh-list
14622577|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
14622578|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15165145|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165146|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15165147|NCT04080869|Vitamins|vitamins|mesh-ancestor
15165148|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
15165149|NCT04079933|Nicotine|nicotine|mesh-list
15165150|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15165151|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
14622579|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
14622580|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622581|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622582|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
14622583|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622584|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622585|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
14622586|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622587|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14622588|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14622589|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14622590|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622591|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14622592|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
14622593|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14622594|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622595|NCT00121316|Analgesics|analgesics|mesh-ancestor
14622596|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
14622597|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622598|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622599|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622600|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622601|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622602|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622603|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
14622604|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14622605|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622606|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622607|NCT00121329|Lidocaine|lidocaine|mesh-list
15165152|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165153|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165154|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15165155|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14622608|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
15165156|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
15165157|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165158|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165159|NCT04080076|Tacrolimus|tacrolimus|mesh-list
15165160|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165161|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
15165162|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165163|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15165164|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165165|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165166|NCT04079517|Tamoxifen|tamoxifen|mesh-list
15165167|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15165168|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
15165169|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165170|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165171|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15165172|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165173|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15165174|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15165175|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14622609|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
14622610|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622611|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622612|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
14622613|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622614|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14622615|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14622616|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14622617|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622618|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622619|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
14622620|NCT00121381|Tacrolimus|tacrolimus|mesh-list
14622621|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14622622|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622623|NCT00121381|Analgesics|analgesics|mesh-ancestor
14622624|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
15165176|NCT04079686|Cefazolin|cefazolin|mesh-list
15165177|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165178|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622625|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622626|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622627|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622628|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622629|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622630|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622631|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
14622632|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14622633|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622634|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165179|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
15165180|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15165181|NCT04079725|Mitomycins|mitomycins|mesh-list
15165182|NCT04079725|Mitomycin|mitomycin|mesh-list
15165183|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15165184|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165185|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
15165186|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165187|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15165188|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165189|NCT04079413|Insulin|insulin|mesh-list
15165190|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15165191|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
15165192|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
15165193|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15165194|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15165195|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165196|NCT04079192|Umirolimus|umirolimus|mesh-list
15165197|NCT04079192|Paclitaxel|paclitaxel|mesh-list
14622635|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
14622636|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15165198|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15165199|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165200|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
15165201|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
15165202|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
15180910|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
15165203|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622637|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622638|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
14622639|NCT00121407|Verteporfin|verteporfin|mesh-list
14622640|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14622641|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622642|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
14622643|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165204|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165205|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165206|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
15165207|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622644|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14622645|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
14622646|NCT00121446|Enoxaparin|enoxaparin|mesh-list
14622647|NCT00121446|Tenecteplase|tenecteplase|mesh-list
14622648|NCT00121446|Clopidogrel|clopidogrel|mesh-list
14622649|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14622650|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14622651|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14622652|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14622653|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
14622654|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622655|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622656|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622657|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
14622658|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14622659|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14622660|NCT00121459|Psyllium|psyllium|mesh-list
14622661|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
14622662|NCT00121459|Cathartics|cathartics|mesh-ancestor
14622663|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622664|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
14622665|NCT00121498|Lidocaine|lidocaine|mesh-list
14622666|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
14622667|NCT00121498|Anesthetics|anesthetics|mesh-list
14622668|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622669|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622670|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
14622671|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622672|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14622673|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14622674|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14622675|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622676|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622677|NCT00121511|Fluorouracil|fluorouracil|mesh-list
14622678|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
14622679|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622680|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14622681|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622682|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622683|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
14622684|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622685|NCT00121524|Atropine|atropine|mesh-list
14622686|NCT00121524|Amiodarone|amiodarone|mesh-list
14622687|NCT00121524|Epinephrine|epinephrine|mesh-list
14622688|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14622689|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14622690|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
14622691|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622692|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622693|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165208|NCT04079231|Aflibercept|aflibercept|mesh-list
15165209|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14622694|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14622695|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14622696|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
14622697|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622698|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14622699|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
14622700|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
14622701|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
14622702|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14622703|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15180911|NCT03934203|BI 409306|bi 409306|mesh-list
14622704|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14622705|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
14622706|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14622707|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14622708|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
14622709|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
14622710|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14622711|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622712|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14622713|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15165210|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15165211|NCT04079231|Growth Substances|growth substances|mesh-ancestor
15165212|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165213|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
15165214|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165215|NCT04079374|Etanercept|etanercept|mesh-list
15165216|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15165217|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165218|NCT04079374|Analgesics|analgesics|mesh-ancestor
15165219|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
15165220|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165221|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165222|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165223|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15165224|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165225|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165226|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
15165227|NCT04079257|Eculizumab|eculizumab|mesh-list
15165228|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15165229|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622714|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622715|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622716|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14622717|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14622718|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14622719|NCT00121550|Clarithromycin|clarithromycin|mesh-list
14622720|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14622721|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622722|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14622723|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622724|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622725|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14622726|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622727|NCT00121563|Thalidomide|thalidomide|mesh-list
14622728|NCT00121563|Ibuprofen|ibuprofen|mesh-list
14622729|NCT00121563|Diazepam|diazepam|mesh-list
14622730|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14622731|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622732|NCT00121563|Analgesics|analgesics|mesh-ancestor
14622733|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
14622734|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622735|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622736|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622737|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622738|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14622739|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622740|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622741|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622742|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
14622743|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
14622744|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14622745|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622746|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14622747|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14622748|NCT00121563|Growth Substances|growth substances|mesh-ancestor
14622749|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
14622750|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622751|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14622752|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
15165230|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
15165231|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165232|NCT04079088|Interferons|interferons|mesh-list
15165233|NCT04079088|Interferon-beta|interferon-beta|mesh-list
15165234|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
15165235|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
14622753|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
14622754|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
14622755|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622756|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14622757|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622758|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14622759|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14622760|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14622761|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14622762|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622763|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14622764|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
14622765|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
14622766|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
14622767|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
14622768|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622769|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
14622770|NCT00121602|Hematinics|hematinics|mesh-ancestor
14622771|NCT00121615|Etanercept|etanercept|mesh-list
14622772|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14622773|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622774|NCT00121615|Analgesics|analgesics|mesh-ancestor
14622775|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
14622776|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622777|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622778|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622779|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622780|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14622781|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622782|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
14622783|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
14622784|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14622785|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622786|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622787|NCT00121680|Lenvatinib|lenvatinib|mesh-list
14622788|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622789|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14622790|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622791|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622792|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
14622793|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14622794|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622795|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14622796|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
14622797|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14622798|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622799|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622800|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622801|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14622802|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622803|NCT00121875|Hormones|hormones|mesh-list
14622804|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14622805|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165236|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
15165237|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165238|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
15165239|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165240|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
15165241|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165242|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15165243|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165244|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15165245|NCT04079140|Dinoprostone|dinoprostone|mesh-list
15165246|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
15165247|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15165248|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622806|NCT00121888|Paroxetine|paroxetine|mesh-list
14622807|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14622808|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14622809|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622810|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622811|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622812|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
15165249|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
15182331|NCT03921684|Capecitabine|capecitabine|mesh-list
14646328|NCT00197561|Selenium|selenium|mesh-list
14622813|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622814|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14622815|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
14622816|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622817|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14622818|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622819|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622820|NCT00121914|Ethanol|ethanol|mesh-list
14622821|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14622822|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622823|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622824|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622825|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
14622826|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15165250|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15165251|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
15165252|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622827|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622828|NCT00121966|Insulin|insulin|mesh-list
14622829|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14622830|NCT00121966|Metformin|metformin|mesh-list
14622831|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
14622832|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
14622833|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
14622834|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
14622835|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
15165253|NCT04078711|Losartan|losartan|mesh-list
15165254|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15165255|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15165256|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15165257|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15165258|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165259|NCT04078659|Lidocaine|lidocaine|mesh-list
15165260|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
15165261|NCT04078659|Fentanyl|fentanyl|mesh-list
15165262|NCT04078659|Propofol|propofol|mesh-list
15165263|NCT04078659|Atracurium|atracurium|mesh-list
15165264|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
15165265|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
14622836|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14622837|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622838|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14622839|NCT00121979|Racivir|racivir|mesh-list
14622840|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622841|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622842|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622843|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
14622844|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622845|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
14622846|NCT00122018|Fenoldopam|fenoldopam|mesh-list
14622847|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14622848|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
14622849|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622850|NCT00122018|Expectorants|expectorants|mesh-ancestor
14622851|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
14622852|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14622853|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
14622854|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622855|NCT00122018|Protective Agents|protective agents|mesh-ancestor
14622856|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622857|NCT00122018|Antidotes|antidotes|mesh-ancestor
14622858|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14622859|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
14622860|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
14622861|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
14622862|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622863|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
14622864|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14622865|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14622866|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14622867|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14622868|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
14622869|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622870|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622871|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622872|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15165266|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622873|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622874|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14622875|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
14622876|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14622877|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14622878|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14622879|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14622880|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646329|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
14646330|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646331|NCT00197561|Protective Agents|protective agents|mesh-ancestor
14646332|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646333|NCT00197561|Trace Elements|trace elements|mesh-ancestor
14646334|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
14646335|NCT00197587|Nevirapine|nevirapine|mesh-list
14646336|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14646337|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646338|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646339|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646340|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
14646341|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646342|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14646343|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14646344|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14646345|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14646346|NCT00197613|Lamivudine|lamivudine|mesh-list
14646347|NCT00197613|Zidovudine|zidovudine|mesh-list
14646348|NCT00197613|Efavirenz|efavirenz|mesh-list
14646349|NCT00197613|Nevirapine|nevirapine|mesh-list
14646350|NCT00197613|Stavudine|stavudine|mesh-list
14646351|NCT00197613|Didanosine|didanosine|mesh-list
14646352|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14646353|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646354|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646355|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646356|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
14646357|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646358|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14026087|NCT02745093|Misoprostol|misoprostol|mesh-list
14646359|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14646360|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
14646361|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14646362|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14646363|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14646364|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14646365|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14646366|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14646367|NCT00197639|Ritonavir|ritonavir|mesh-list
14646368|NCT00197639|Indinavir|indinavir|mesh-list
14646369|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14646370|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14646371|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
14646372|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646373|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646374|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14646375|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14646376|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
14646377|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646378|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14646379|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14646380|NCT00197730|Folic Acid|folic acid|mesh-list
14646381|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
14646382|NCT00197730|Vitamins|vitamins|mesh-ancestor
14646383|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
14646384|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646385|NCT00197730|Hematinics|hematinics|mesh-ancestor
14646386|NCT00197743|Vitamin A|vitamin a|mesh-list
14646387|NCT00197743|Beta Carotene|beta carotene|mesh-list
14646388|NCT00197743|Carotenoids|carotenoids|mesh-list
14646389|NCT00197743|Vitamins|vitamins|mesh-ancestor
14646390|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
14646391|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646392|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
14646393|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646394|NCT00197743|Protective Agents|protective agents|mesh-ancestor
14646395|NCT00197743|Provitamins|provitamins|mesh-ancestor
14646396|NCT00197756|Vitamins|vitamins|mesh-list
14646397|NCT00197756|Vitamin A|vitamin a|mesh-list
14622881|NCT00122096|Valdecoxib|valdecoxib|mesh-list
14622882|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14622883|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14622884|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622885|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622886|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14622887|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14622888|NCT00122096|Analgesics|analgesics|mesh-ancestor
14622889|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
14622890|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622891|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622892|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14622893|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14622894|NCT00122226|Ritonavir|ritonavir|mesh-list
14622895|NCT00122226|Lopinavir|lopinavir|mesh-list
14622896|NCT00122226|Lamivudine|lamivudine|mesh-list
14622897|NCT00122226|Zidovudine|zidovudine|mesh-list
14622898|NCT00122226|Nevirapine|nevirapine|mesh-list
14622899|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14622900|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14622901|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
14622902|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622903|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622904|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622905|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622906|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
14622907|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622908|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14622909|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622910|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622911|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622912|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
14622913|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14622914|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14622915|NCT00122291|Capecitabine|capecitabine|mesh-list
14622916|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14622917|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
14622918|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622919|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622920|NCT00122304|Eculizumab|eculizumab|mesh-list
14622921|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14622922|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622923|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
15165267|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165268|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
15165269|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165270|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15165271|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15165272|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15165273|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14622924|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622925|NCT00122330|Eculizumab|eculizumab|mesh-list
14622926|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14622927|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622928|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
14622929|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622930|NCT00122343|Sirolimus|sirolimus|mesh-list
14622931|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14622932|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622933|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14622934|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622935|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
14622936|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14622937|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
14622938|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622939|NCT00122356|Alendronate|alendronate|mesh-list
14622940|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14622941|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622942|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
14622943|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14622944|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
14622945|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14622946|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14622947|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14622948|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
14622949|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
14622950|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14622951|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
14622952|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14622953|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622954|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
14622955|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14622956|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14622957|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622958|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622959|NCT00122486|Tenofovir|tenofovir|mesh-list
14622960|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
14622961|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622962|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622963|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622964|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622965|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622966|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622967|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622968|NCT00122499|Tadalafil|tadalafil|mesh-list
14622969|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
14622970|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14622971|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14622972|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622973|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622974|NCT00122499|Urological Agents|urological agents|mesh-ancestor
14622975|NCT00122512|Tenofovir|tenofovir|mesh-list
14622976|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
14622977|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165274|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165275|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15165276|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15165277|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
15165278|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14622978|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622979|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622980|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622981|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622982|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622983|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622984|NCT00122538|Lamivudine|lamivudine|mesh-list
14622985|NCT00122538|Efavirenz|efavirenz|mesh-list
14622986|NCT00122538|Didanosine|didanosine|mesh-list
14622987|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14622988|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14622989|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14622990|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14622991|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
14622992|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14622993|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14622994|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14622995|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14622996|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14622997|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14622998|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14622999|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14623000|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14623001|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
14623002|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14623003|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
14623004|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623005|NCT00122577|Ritonavir|ritonavir|mesh-list
14623006|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14623007|NCT00122577|Tenofovir|tenofovir|mesh-list
14623008|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14623009|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14623010|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
14623011|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623012|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623013|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14623014|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14623015|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
14623016|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623017|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14623018|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14623019|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14623020|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14623021|NCT00122590|Ritonavir|ritonavir|mesh-list
14623022|NCT00122590|Lopinavir|lopinavir|mesh-list
14623023|NCT00122590|Nelfinavir|nelfinavir|mesh-list
14623024|NCT00122590|Indinavir|indinavir|mesh-list
14623025|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14623026|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14623027|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14623028|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623029|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623030|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14623031|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14623032|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
14623033|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623034|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14623035|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14623036|NCT00122603|Saquinavir|saquinavir|mesh-list
14623037|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
14623038|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14623039|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14623040|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
14623041|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623042|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623043|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14623044|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14623045|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
14623046|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623047|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14623048|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14623049|NCT00122616|Ribavirin|ribavirin|mesh-list
14623050|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14623051|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14623052|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
14623053|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623054|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
14623055|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623056|NCT00122629|Interferons|interferons|mesh-list
14623057|NCT00122629|Ribavirin|ribavirin|mesh-list
14623058|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
14623059|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
14623060|NCT00122629|Amantadine|amantadine|mesh-list
14623061|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14623062|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623063|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
14623064|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623065|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
14623066|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623067|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
14623068|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623069|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14623070|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14623071|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
14623072|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623073|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14623074|NCT00122629|Analgesics|analgesics|mesh-ancestor
14623075|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
14623076|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623077|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14623078|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14623079|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
14623080|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14623081|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623082|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623083|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
14623084|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623085|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14623086|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14623087|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14623088|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14623089|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14623090|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
14623091|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14623092|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623093|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623094|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
14623095|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623096|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14623097|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14623098|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14623099|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
14623100|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
14623101|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623102|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
14623103|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623104|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623105|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
14623106|NCT00122720|Hematinics|hematinics|mesh-ancestor
14623107|NCT00122733|Loxapine|loxapine|mesh-list
14623108|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14623109|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14623110|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623111|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623112|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623113|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14623114|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
14623115|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623116|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623117|NCT00122746|Cisplatin|cisplatin|mesh-list
14623118|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623119|NCT00122759|Ketamine|ketamine|mesh-list
14623120|NCT00122759|Analgesics|analgesics|mesh-ancestor
14623121|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
14623122|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623123|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623124|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14623125|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14623126|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
14623127|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
14623128|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623129|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14623130|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14623131|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623132|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623133|NCT00122772|Cisplatin|cisplatin|mesh-list
14623134|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623135|NCT00122785|Dexamethasone|dexamethasone|mesh-list
14623136|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14623137|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
14623138|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
14623139|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623140|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623141|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14623142|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
14623143|NCT00122785|Hormones|hormones|mesh-ancestor
14623144|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623145|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14623146|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623147|NCT00122811|Perindopril|perindopril|mesh-list
14623148|NCT00122811|Indapamide|indapamide|mesh-list
14623149|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14623150|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
14623151|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623152|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623153|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14623154|NCT00122811|Diuretics|diuretics|mesh-ancestor
14623155|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
14623156|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623157|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14623158|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623159|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14623160|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14623161|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623162|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623163|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623164|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623165|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623166|NCT00122824|Analgesics|analgesics|mesh-ancestor
14623167|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
14623168|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623169|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
14623170|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623171|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
14623172|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14623173|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14623174|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14623175|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623176|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623177|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623178|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623179|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623180|NCT00122837|Analgesics|analgesics|mesh-ancestor
15165279|NCT04078659|Narcotics|narcotics|mesh-ancestor
15165280|NCT04078659|Analgesics|analgesics|mesh-ancestor
15165281|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14623181|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
14623182|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623183|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
14623184|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623185|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
14623186|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14623187|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15165282|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
14623188|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14623189|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14623190|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623191|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623192|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623193|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623194|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623195|NCT00122850|Analgesics|analgesics|mesh-ancestor
14623196|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
14623197|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623198|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
14623199|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623200|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
14623201|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14623202|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14623203|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14623204|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623205|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623206|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165283|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15165284|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15165285|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
15165286|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14022349|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14022350|NCT02768961|Ledipasvir|ledipasvir|mesh-list
15165287|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15165288|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15165289|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15165290|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15165291|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15165292|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
15165293|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165294|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
15165295|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
15165296|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165297|NCT04078880|Protective Agents|protective agents|mesh-ancestor
15165298|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165299|NCT04078880|Vitamins|vitamins|mesh-ancestor
15165300|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
15165301|NCT04078399|Interferons|interferons|mesh-list
15165302|NCT04078399|Azacitidine|azacitidine|mesh-list
15165303|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165304|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
15165305|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165306|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15165307|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
14623207|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623208|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623209|NCT00122863|Analgesics|analgesics|mesh-ancestor
14623210|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
14623211|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623212|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
14623213|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623214|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
14623215|NCT00122876|Talaporfin|talaporfin|mesh-list
14623216|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623217|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14623218|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
14623219|NCT00122889|Allicin|allicin|mesh-list
14623220|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
14623221|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
14623222|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623223|NCT00122889|Protective Agents|protective agents|mesh-ancestor
14623224|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623225|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14623226|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623227|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14623228|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623229|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623230|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14623231|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
14623232|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14623233|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15165308|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165309|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165310|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
15165311|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
15165312|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165313|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165314|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15165315|NCT04078425|Diuretics|diuretics|mesh-ancestor
14623234|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14623235|NCT00122941|Micronutrients|micronutrients|mesh-list
14623236|NCT00122941|Trace Elements|trace elements|mesh-list
14623237|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623238|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
14623239|NCT00123149|Hematinics|hematinics|mesh-ancestor
14623240|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14623241|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
14623242|NCT00123175|Progestins|progestins|mesh-list
14623243|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14623244|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14623245|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14623246|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
14623247|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14623248|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623249|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14623250|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14623251|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14623252|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14623253|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623254|NCT00123175|Hormones|hormones|mesh-ancestor
14623255|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623256|NCT00123201|Dronabinol|dronabinol|mesh-list
14623257|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
14623258|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623259|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623260|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14623261|NCT00123201|Analgesics|analgesics|mesh-ancestor
14623262|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
14623263|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623264|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14623265|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14623266|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623267|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623268|NCT00123201|Hormones|hormones|mesh-ancestor
14623269|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623270|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
14623271|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14623272|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623273|NCT00123253|Tesamorelin|tesamorelin|mesh-list
14623274|NCT00123253|Growth Substances|growth substances|mesh-ancestor
14623275|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623276|NCT00123266|Plasminogen|plasminogen|mesh-list
14623277|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14623278|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14623279|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623280|NCT00123279|Plasminogen|plasminogen|mesh-list
14623281|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14623282|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14623283|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623284|NCT00123292|Plasminogen|plasminogen|mesh-list
14623285|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
14623286|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14623287|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14623288|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623289|NCT00123305|Plasminogen|plasminogen|mesh-list
14623290|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
14623291|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14623292|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14623293|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623294|NCT00123318|Cisplatin|cisplatin|mesh-list
14623295|NCT00123318|Fluorouracil|fluorouracil|mesh-list
14623296|NCT00123318|Epirubicin|epirubicin|mesh-list
14623297|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623298|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
14623299|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623300|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623301|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623302|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
14623303|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623304|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623305|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15165316|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
15180912|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15180913|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180914|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15180915|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15180916|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180917|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180918|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180919|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15180920|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
15180921|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15180922|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14623306|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14623307|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623308|NCT00123331|Cyclosporine|cyclosporine|mesh-list
14623309|NCT00123331|Sirolimus|sirolimus|mesh-list
14623310|NCT00123331|Cyclosporins|cyclosporins|mesh-list
14623311|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623312|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623313|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623314|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
14623315|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623316|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
14623317|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623318|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
14623319|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14623320|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14623321|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14623322|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623323|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623324|NCT00123370|Modafinil|modafinil|mesh-list
14623325|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14623326|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623327|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14623328|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14623329|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14623330|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623331|NCT00123383|Modafinil|modafinil|mesh-list
15180923|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623332|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14623333|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623334|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14623335|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14623336|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14623337|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623338|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14623339|NCT00123461|Vitamins|vitamins|mesh-ancestor
14623340|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
14623341|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623342|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14623343|NCT00123539|Estrogens|estrogens|mesh-list
14623344|NCT00123539|Hormones|hormones|mesh-ancestor
14623345|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623346|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623347|NCT00123552|Artesunate|artesunate|mesh-list
14623348|NCT00123552|Lumefantrine|lumefantrine|mesh-list
14623349|NCT00123552|Artemether|artemether|mesh-list
14623350|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
14623351|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
14623352|NCT00123552|Amodiaquine|amodiaquine|mesh-list
14623353|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14623354|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
14623355|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14623356|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14623357|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623358|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623359|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
14623360|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
14623361|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14623362|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
14623363|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14623364|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623365|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623366|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14623367|NCT00123552|Renal Agents|renal agents|mesh-ancestor
14623368|NCT00123578|Pentobarbital|pentobarbital|mesh-list
14623369|NCT00123578|Lorazepam|lorazepam|mesh-list
14623370|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
14623371|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
14623372|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
14623373|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623374|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623375|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14623376|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14623377|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165317|NCT04078269|Vaccines|vaccines|mesh-list
15165318|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
15165319|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165320|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
15165321|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14623378|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14623379|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14623380|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623381|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
14623382|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
14623383|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623384|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623385|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14623386|NCT00123656|Fluticasone|fluticasone|mesh-list
14623387|NCT00123656|Esomeprazole|esomeprazole|mesh-list
14623388|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14623389|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14623390|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
14623391|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623392|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165322|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15165323|NCT04078204|Protective Agents|protective agents|mesh-ancestor
15165324|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165325|NCT04078048|Vitamins|vitamins|mesh-list
15165326|NCT04078048|Ascorbic Acid|ascorbic acid|mesh-list
15165327|NCT04078048|Vitamin E|vitamin e|mesh-list
15165328|NCT04078048|Antioxidants|antioxidants|mesh-list
15165329|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
15165330|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165331|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165332|NCT04078048|Protective Agents|protective agents|mesh-ancestor
14623393|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14623394|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
14623395|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
14623396|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14623397|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14623398|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14623399|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14623400|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623401|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623402|NCT00123669|Progesterone|progesterone|mesh-list
14623403|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14623404|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14623405|NCT00123669|Progestins|progestins|mesh-ancestor
14623406|NCT00123669|Hormones|hormones|mesh-ancestor
14623407|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623408|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165333|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
15165334|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
15165335|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15165336|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
15165337|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165338|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165339|NCT04077853|Progestins|progestins|mesh-ancestor
15165340|NCT04077853|Hormones|hormones|mesh-ancestor
15165341|NCT04077827|Propofol|propofol|mesh-list
15165342|NCT04077827|Desflurane|desflurane|mesh-list
15165343|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15165344|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165345|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165346|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15165347|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
15165348|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
15165349|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15165350|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
15165351|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
15165352|NCT04077957|Etanercept|etanercept|mesh-list
15165353|NCT04077957|Methotrexate|methotrexate|mesh-list
14623409|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14623410|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
14646398|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
14646399|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
14646400|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646401|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
14646402|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646403|NCT00197756|Protective Agents|protective agents|mesh-ancestor
14646404|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14646405|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646406|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14646407|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
14646408|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646409|NCT00197834|Valproic Acid|valproic acid|mesh-list
14646410|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
14646411|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646412|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646413|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
14646414|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646415|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646416|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
14646417|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14646418|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646419|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14646420|NCT00197886|Norepinephrine|norepinephrine|mesh-list
14646421|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14646422|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14646423|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14646424|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646425|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646426|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646427|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
14646428|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
14646429|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646430|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14646431|NCT00197912|Celecoxib|celecoxib|mesh-list
14646432|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
15165354|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14646433|NCT00197912|Interleukin-2|interleukin-2|mesh-list
14646434|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
15165355|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
14623411|NCT00123825|Gemcitabine|gemcitabine|mesh-list
14623412|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623413|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623414|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
14623415|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623416|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
14623417|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623418|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623419|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623420|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
15165356|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15165357|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165358|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15165359|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
15165360|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165361|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165362|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
14623421|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623422|NCT00123851|Capecitabine|capecitabine|mesh-list
14623423|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
14623424|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14623425|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623426|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
14623427|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165363|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165364|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15165365|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165366|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
15165367|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15165368|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14623428|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165369|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
15165370|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15165371|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14022351|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
14022352|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623429|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14623430|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623431|NCT00123877|Esorubicin|esorubicin|mesh-list
14623432|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623433|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623434|NCT00123890|Aplaviroc|aplaviroc|mesh-list
14623435|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14623436|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14623437|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623438|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14623439|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14623440|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
14623441|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623442|NCT00123903|Metoprolol|metoprolol|mesh-list
14623443|NCT00123903|Carvedilol|carvedilol|mesh-list
14623444|NCT00123903|Lisinopril|lisinopril|mesh-list
14623445|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14623446|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14623447|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
14623448|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
14623449|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623450|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623451|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14623452|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14623453|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14623454|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
14623455|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623456|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623457|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
14623458|NCT00123903|Protective Agents|protective agents|mesh-ancestor
14623459|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14623460|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623461|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14623462|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
14623463|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14623464|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14623465|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14623466|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
14623467|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623468|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14623469|NCT00123916|Benzonidazole|benzonidazole|mesh-list
14623470|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623471|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
14623472|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623473|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14623474|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14623475|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14623476|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623477|NCT00123929|Docetaxel|docetaxel|mesh-list
14623478|NCT00123929|Doxorubicin|doxorubicin|mesh-list
14623479|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623480|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14623481|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14623482|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14623483|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623484|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623485|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14623486|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15165372|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165373|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15165374|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165375|NCT04077957|Analgesics|analgesics|mesh-ancestor
15165376|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
15165377|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165378|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165379|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165380|NCT04077892|Budesonide|budesonide|mesh-list
15165381|NCT04077892|Montelukast|montelukast|mesh-list
15165382|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165383|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15165384|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
15165385|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165386|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165387|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15165388|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
15165389|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
15165390|NCT04077892|Hormones|hormones|mesh-ancestor
15165391|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623487|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623488|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14623489|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
14623490|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623491|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14623492|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14623493|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623494|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623495|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
14623496|NCT00124098|Hematinics|hematinics|mesh-ancestor
14623497|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
14623498|NCT00124111|Fluorouracil|fluorouracil|mesh-list
14623499|NCT00124111|Methotrexate|methotrexate|mesh-list
14623500|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623501|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
14623502|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623503|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14623504|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14623505|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
14623506|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623507|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623508|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14623509|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
14623510|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623511|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15165392|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15165393|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
15165394|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15165395|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15165396|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165397|NCT04077866|Temozolomide|temozolomide|mesh-list
15165398|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15165399|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
15165400|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623512|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
15165401|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165402|NCT04077983|Gemcitabine|gemcitabine|mesh-list
15165403|NCT04077983|Paclitaxel|paclitaxel|mesh-list
15165404|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15165405|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165406|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
15165407|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
15165408|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
15165409|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623513|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14623514|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
14623515|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623516|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14623517|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14623518|NCT00124137|Diuretics|diuretics|mesh-list
14623519|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
14623520|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623521|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
14623522|NCT00124150|Analgesics|analgesics|mesh-ancestor
14623523|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
14623524|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623525|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623526|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
14623527|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623528|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14623529|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
14623530|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14623531|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623532|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623533|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14623534|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
14623535|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14623536|NCT00124241|Lamivudine|lamivudine|mesh-list
14623537|NCT00124241|Telbivudine|telbivudine|mesh-list
14623538|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14623539|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14623540|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623541|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623542|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
14623543|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623544|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14623545|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14623546|NCT00124267|Quinine|quinine|mesh-list
14623547|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
14623548|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14623549|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14623550|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623551|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14623552|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623553|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14623554|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623555|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165410|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15165411|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
15165412|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
15165413|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165414|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165415|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165416|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
15165417|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165418|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
15165419|NCT04077905|Doxorubicin|doxorubicin|mesh-list
14623556|NCT00124267|Analgesics|analgesics|mesh-ancestor
14623557|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
14623558|NCT00124280|Everolimus|everolimus|mesh-list
14623559|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623560|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623561|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
14623562|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623563|NCT00124306|Amitriptyline|amitriptyline|mesh-list
14623564|NCT00124306|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14623565|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14623566|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
15165420|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15165421|NCT04077905|Etoposide|etoposide|mesh-list
15165422|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623567|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623568|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14623569|NCT00124306|Analgesics|analgesics|mesh-ancestor
14623570|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
14623571|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623572|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623573|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14623574|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623575|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623576|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623577|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14623578|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623579|NCT00124306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14623580|NCT00124306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14623581|NCT00124306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623582|NCT00124332|Rimonabant|rimonabant|mesh-list
14623583|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14623584|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14623585|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14623586|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623587|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623588|NCT00124332|Hormones|hormones|mesh-ancestor
14623589|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623590|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623591|NCT00124358|Buprenorphine|buprenorphine|mesh-list
14623592|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14623593|NCT00124358|Narcotics|narcotics|mesh-ancestor
14623594|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623595|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623596|NCT00124358|Analgesics|analgesics|mesh-ancestor
14623597|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
14623598|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623599|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14623600|NCT00124384|Modafinil|modafinil|mesh-list
15165423|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165424|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15165425|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15165426|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165427|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165428|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15165429|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165430|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
14623601|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14623602|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623603|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14623604|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14623605|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14623606|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623607|NCT00124397|Atorvastatin|atorvastatin|mesh-list
14623608|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14623609|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14623610|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
14623611|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623612|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14623613|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14623614|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623615|NCT00124436|Alitretinoin|alitretinoin|mesh-list
14623616|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623617|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
14623618|NCT00124475|Alitretinoin|alitretinoin|mesh-list
14623619|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623620|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14623621|NCT00124527|Capecitabine|capecitabine|mesh-list
15165431|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
15165432|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165433|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165434|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165435|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
15165436|NCT04077905|Hormones|hormones|mesh-ancestor
15165437|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165438|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15165439|NCT04077905|Protective Agents|protective agents|mesh-ancestor
14623622|NCT00124527|Irofulven|irofulven|mesh-list
14623623|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623624|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
14623625|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623626|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623627|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14623628|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
14623629|NCT00124540|Misoprostol|misoprostol|mesh-list
14623630|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14623631|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
14623632|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14623633|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623634|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14623635|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14623636|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
14623637|NCT00124566|Prednisone|prednisone|mesh-list
14623638|NCT00124566|Capecitabine|capecitabine|mesh-list
14623639|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
14623640|NCT00124566|Irofulven|irofulven|mesh-list
14623641|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14623642|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
14623643|NCT00124566|Hormones|hormones|mesh-ancestor
14623644|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623645|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623646|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14623647|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623648|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623649|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
14623650|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623651|NCT00124566|Analgesics|analgesics|mesh-ancestor
14623652|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
14623653|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623654|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14623655|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14623656|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623657|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14623658|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
14623659|NCT00124605|Pamidronate|pamidronate|mesh-list
14623660|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
15165440|NCT04077736|Aldesleukin|aldesleukin|mesh-list
14623661|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623662|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14623663|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623664|NCT00124644|Cytarabine|cytarabine|mesh-list
14623665|NCT00124644|Etoposide|etoposide|mesh-list
14623666|NCT00124644|Daunorubicin|daunorubicin|mesh-list
14623667|NCT00124644|Tipifarnib|tipifarnib|mesh-list
14623668|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14623669|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14623670|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623671|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14623672|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14623673|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623674|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623675|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
14623676|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
14623677|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623678|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623679|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
14623680|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623681|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623682|NCT00124683|Bupropion|bupropion|mesh-list
14623683|NCT00124683|Nicotine|nicotine|mesh-list
14623684|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14623685|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
14623686|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623687|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623688|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14623689|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14623690|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
14623691|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623692|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623693|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14623694|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
14623695|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623696|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15165441|NCT04077736|Interleukin-2|interleukin-2|mesh-list
14623697|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623698|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623699|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
14623700|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14623701|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14623702|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623703|NCT00124696|Cocaethylene|cocaethylene|mesh-list
14623704|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14623705|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623706|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623707|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623708|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
14623709|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623710|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623711|NCT00124722|Bromides|bromides|mesh-list
14623712|NCT00124722|Rocuronium|rocuronium|mesh-list
14623713|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
14623714|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14623715|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14623716|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14623717|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623718|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623719|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
14623720|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
14623721|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
14623722|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623723|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623724|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14623725|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14623726|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
14623727|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
14623728|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623729|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623730|NCT00124813|Thalidomide|thalidomide|mesh-list
14623731|NCT00124813|Idarubicin|idarubicin|mesh-list
14623732|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623733|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
14623734|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623735|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
14623736|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14623737|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165442|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165443|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165444|NCT04077736|Analgesics|analgesics|mesh-ancestor
15165445|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
15165446|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165447|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165448|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15165449|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15165450|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
15165451|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623738|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14623739|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14623740|NCT00124813|Growth Substances|growth substances|mesh-ancestor
14623741|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
14623742|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623743|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623744|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14623745|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14623746|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623747|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623748|NCT00124826|Insulin|insulin|mesh-list
14623749|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14623750|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623751|NCT00124839|Naltrexone|naltrexone|mesh-list
14623752|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14623753|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14623754|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623755|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
14623756|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623757|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14623758|NCT00124930|Olanzapine|olanzapine|mesh-list
14623759|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
15165452|NCT04077944|Trace Elements|trace elements|mesh-list
14623760|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
15165453|NCT04077944|Micronutrients|micronutrients|mesh-list
14623761|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623762|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623763|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14623764|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14623765|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14623766|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623767|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623768|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14623769|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14623770|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623771|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623772|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623773|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
14623774|NCT00124956|Doxorubicin|doxorubicin|mesh-list
14623775|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14623776|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623777|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14623778|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14623779|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623780|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623781|NCT00124969|Amlodipine|amlodipine|mesh-list
14623782|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14623783|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14623784|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623785|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623786|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14623787|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623788|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
14623789|NCT00124995|Terbutaline|terbutaline|mesh-list
14623790|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14623791|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
14623792|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623793|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623794|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14623795|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
14623796|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
14623797|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
15165454|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165455|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15165456|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
15165457|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
15165458|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14623798|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14623799|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14623800|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14623801|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14623802|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
14623803|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623804|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623805|NCT00125008|Vaccines|vaccines|mesh-list
14623806|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
14623807|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623808|NCT00125021|Capecitabine|capecitabine|mesh-list
14623809|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14623810|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14623811|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
14623812|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623813|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623814|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14623815|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623816|NCT00125047|Vaccines|vaccines|mesh-list
15165459|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
15165460|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165461|NCT04077515|Sirolimus|sirolimus|mesh-list
15165462|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165463|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165464|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15165465|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165466|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
15165467|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165468|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
15165469|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165470|NCT04077580|Methenamine|methenamine|mesh-list
14623817|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
14623818|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623819|NCT00125060|Simvastatin|simvastatin|mesh-list
14623820|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14623821|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14623822|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
14623823|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623824|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14623825|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14623826|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623827|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14623828|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
14623829|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14623830|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14623831|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14623832|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623833|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623834|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
14623835|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623836|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623837|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14623838|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165471|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
15165472|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
15165473|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15165474|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165475|NCT04077580|Renal Agents|renal agents|mesh-ancestor
15165476|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165477|NCT04077684|Interleukin-2|interleukin-2|mesh-list
14623839|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14623840|NCT00125229|Mannitol|mannitol|mesh-list
14623841|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14623842|NCT00125229|Diuretics|diuretics|mesh-ancestor
15165478|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165479|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165480|NCT04077684|Analgesics|analgesics|mesh-ancestor
15165481|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
14623843|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
14623844|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623845|NCT00125255|Lidocaine|lidocaine|mesh-list
14623846|NCT00125255|Tetracaine|tetracaine|mesh-list
14623847|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
14623848|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
14623849|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623850|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623851|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
14623852|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623853|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14623854|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14623855|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14623856|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14623857|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623858|NCT00125294|Methadone|methadone|mesh-list
14623859|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15165482|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165483|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165484|NCT04077398|Ropivacaine|ropivacaine|mesh-list
15165485|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
15165486|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
14623860|NCT00125294|Narcotics|narcotics|mesh-ancestor
14623861|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623862|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623863|NCT00125294|Analgesics|analgesics|mesh-ancestor
14623864|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
14623865|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623866|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
14623867|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
14623868|NCT00125307|Tacrolimus|tacrolimus|mesh-list
14623869|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14623870|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
14623871|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165487|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165488|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623872|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15165489|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
14623873|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623874|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623875|NCT00125346|Tobramycin|tobramycin|mesh-list
14623876|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14623877|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623878|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14623879|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
14623880|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646435|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646436|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646437|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646438|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14646439|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
14646440|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646441|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646442|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14646443|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14646444|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14646445|NCT00197912|Analgesics|analgesics|mesh-ancestor
14646446|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
14646447|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165490|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165491|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15165492|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15165493|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15165494|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646448|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646449|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14646450|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14646451|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647486|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647487|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14647488|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
14647489|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647490|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647491|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14647492|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14647493|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14647494|NCT00200187|Anesthetics|anesthetics|mesh-list
14647495|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647496|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647497|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
14647498|NCT00200226|Pyridoxal|pyridoxal|mesh-list
14647499|NCT00200226|Pyridoxine|pyridoxine|mesh-list
14647500|NCT00200226|Misoprostol|misoprostol|mesh-list
14647501|NCT00200226|Vitamins|vitamins|mesh-ancestor
14647502|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
14647503|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647504|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14647505|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
14647506|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14647507|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14647508|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647509|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
14647510|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
14647511|NCT00200252|Oxytocin|oxytocin|mesh-list
14647512|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
14647513|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14647514|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647515|NCT00200382|Bortezomib|bortezomib|mesh-list
14647516|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647517|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14647518|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647519|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14647520|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647521|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647522|NCT00200421|Atenolol|atenolol|mesh-list
14647523|NCT00200421|Nebivolol|nebivolol|mesh-list
14647524|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14647525|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14647526|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
14647527|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
14647528|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647529|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623881|NCT00125398|Fospropofol|fospropofol|mesh-list
14623882|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14623883|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623884|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623885|NCT00125411|Docetaxel|docetaxel|mesh-list
14623886|NCT00125411|Satraplatin|satraplatin|mesh-list
14623887|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623888|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
14623889|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
14623890|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
14623891|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623892|NCT00125424|Midazolam|midazolam|mesh-list
14623893|NCT00125424|Fospropofol|fospropofol|mesh-list
14623894|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14623895|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14623896|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165495|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
15165496|NCT04077190|Cortisone|cortisone|mesh-list
15165497|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165498|NCT04076865|Lidocaine|lidocaine|mesh-list
15165499|NCT04076865|Histamine|histamine|mesh-list
15165500|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
15165501|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
15165502|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623897|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623898|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14623899|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14623900|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14623901|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14623902|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
14623903|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
14623904|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
14623905|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
14623906|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623907|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623908|NCT00125437|Spironolactone|spironolactone|mesh-list
14623909|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14623910|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
14623911|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14623912|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623913|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14623914|NCT00125437|Diuretics|diuretics|mesh-ancestor
14623915|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
14623916|NCT00125463|Candesartan|candesartan|mesh-list
14623917|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
14623918|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14623919|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14623920|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14623921|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623922|NCT00125489|Chloroquine|chloroquine|mesh-list
14623923|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14623924|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
14623925|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
14623926|NCT00125489|Amebicides|amebicides|mesh-ancestor
14623927|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14623928|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14623929|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14623930|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
14623931|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14623932|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14623933|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14623934|NCT00125489|Analgesics|analgesics|mesh-ancestor
14623935|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
14623936|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623937|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623938|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14623939|NCT00125489|Filaricides|filaricides|mesh-ancestor
15165503|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165504|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
15165505|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165506|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15165507|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15165508|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14623940|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
15180924|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
14623941|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
14623942|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15165509|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15165510|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165511|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
15165512|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
15165513|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165514|NCT04077255|Paclitaxel|paclitaxel|mesh-list
15165515|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15165516|NCT04077255|Antibodies|antibodies|mesh-list
15165517|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14623943|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165518|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165519|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
15165520|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
15165521|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
15165522|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165523|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
14623944|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623945|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14623946|NCT00125489|Renal Agents|renal agents|mesh-ancestor
14623947|NCT00125554|Metyrapone|metyrapone|mesh-list
14623948|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
14623949|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623950|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623951|NCT00125567|Levodopa|levodopa|mesh-list
14623952|NCT00125567|Carbidopa|carbidopa|mesh-list
14623953|NCT00125567|Entacapone|entacapone|mesh-list
14623954|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14623955|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14623956|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
14623957|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14623958|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623959|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623960|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14623961|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14623962|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14623963|NCT00125645|Irbesartan|irbesartan|mesh-list
14623964|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14623965|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14623966|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14623967|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623968|NCT00125671|Warfarin|warfarin|mesh-list
14623969|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
14623970|NCT00125684|Morphine|morphine|mesh-list
14623971|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14623972|NCT00125684|Narcotics|narcotics|mesh-ancestor
14623973|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623974|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623975|NCT00125684|Analgesics|analgesics|mesh-ancestor
14623976|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
14623977|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623978|NCT00125736|Rabeprazole|rabeprazole|mesh-list
14623979|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14623980|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14623981|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14623982|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165524|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623983|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14623984|NCT00125749|Vaccines|vaccines|mesh-list
14623985|NCT00125749|Immunologic Factors|immunologic factors|mesh-ancestor
14623986|NCT00125749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623987|NCT00125801|Hydromorphone|hydromorphone|mesh-list
14623988|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14623989|NCT00125801|Narcotics|narcotics|mesh-ancestor
14623990|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14623991|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14623992|NCT00125801|Analgesics|analgesics|mesh-ancestor
14623993|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
14623994|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14623995|NCT00125814|Interferons|interferons|mesh-list
14623996|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
14623997|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
14623998|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14623999|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
14624000|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624001|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
14624002|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624003|NCT00125827|Clofarabine|clofarabine|mesh-list
14624004|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624005|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
14624006|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624007|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624008|NCT00125840|Clofarabine|clofarabine|mesh-list
14624009|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624010|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
14624011|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624012|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624013|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14624014|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14624015|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14624016|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14624017|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624018|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624019|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624020|NCT00125892|Analgesics|analgesics|mesh-ancestor
14624021|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
14624022|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624023|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
14624024|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14624025|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
14624026|NCT00125905|Bupropion|bupropion|mesh-list
14624027|NCT00125905|Nicotine|nicotine|mesh-list
14624028|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14624029|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
14624030|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624031|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624032|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14624033|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14624034|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
15165525|NCT04077125|Rifaximin|rifaximin|mesh-list
15165526|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624035|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624036|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624037|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14624038|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
14624039|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14624040|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14624041|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14624042|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14624043|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
14624044|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14624045|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14624046|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624047|NCT00125918|Tadalafil|tadalafil|mesh-list
14624048|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
14624049|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14624050|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14624051|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624052|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624053|NCT00125918|Urological Agents|urological agents|mesh-ancestor
14624054|NCT00125983|Ritonavir|ritonavir|mesh-list
14624055|NCT00125983|Lopinavir|lopinavir|mesh-list
14624056|NCT00125983|Norinyl|norinyl|mesh-list
14624057|NCT00125983|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14624058|NCT00125983|Ortho Evra|ortho evra|mesh-list
14624059|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14624060|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14624061|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
14624062|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624063|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624064|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14624065|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14624066|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
14624067|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624068|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14624069|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14624070|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14624071|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15165527|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165528|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14624072|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14624073|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
14624074|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14624075|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624076|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14624077|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14624078|NCT00125983|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14624079|NCT00125983|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14624080|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14624081|NCT00125996|Hematinics|hematinics|mesh-ancestor
14624082|NCT00126009|Amisulpride|amisulpride|mesh-list
14624083|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14624084|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14624085|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165529|NCT04076436|Fosfomycin|fosfomycin|mesh-list
15165530|NCT04076436|Lactams|lactams|mesh-list
15165531|NCT04076436|beta-Lactams|beta-lactams|mesh-list
15165532|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165533|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165534|NCT04076709|Anesthetics|anesthetics|mesh-list
15165535|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165536|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165537|NCT04076826|Midazolam|midazolam|mesh-list
14624086|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624087|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14624088|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14624089|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
14624090|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624091|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624092|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14624093|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
14624094|NCT00126022|Tedisamil|tedisamil|mesh-list
14624095|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14624096|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14624097|NCT00126022|Protective Agents|protective agents|mesh-ancestor
14624098|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624099|NCT00126048|Atorvastatin|atorvastatin|mesh-list
14624100|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14624101|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14624102|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
14624103|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624104|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14624105|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14624106|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624107|NCT00126061|Tedisamil|tedisamil|mesh-list
14624108|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14624109|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14624110|NCT00126061|Protective Agents|protective agents|mesh-ancestor
14624111|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624112|NCT00126074|Tedisamil|tedisamil|mesh-list
14624113|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14624114|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14624115|NCT00126074|Protective Agents|protective agents|mesh-ancestor
14624116|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624117|NCT00126087|Dopamine|dopamine|mesh-list
14624118|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14624119|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
14624120|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
14624121|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624122|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624123|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
14624124|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624125|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624126|NCT00126087|Protective Agents|protective agents|mesh-ancestor
14624127|NCT00126100|Sargramostim|sargramostim|mesh-list
14624128|NCT00126100|Lenograstim|lenograstim|mesh-list
15165538|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
15165539|NCT04076826|Propofol|propofol|mesh-list
15165540|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15165541|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165542|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022353|NCT02769013|Praziquantel|praziquantel|mesh-list
14624129|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
14624130|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165543|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15165544|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
15165545|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
14624131|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14624132|NCT00126139|Abciximab|abciximab|mesh-list
14624133|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
14624134|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14624135|NCT00126204|Doxycycline|doxycycline|mesh-list
14624136|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624137|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624138|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
14624139|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14624140|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14624141|NCT00126230|Docetaxel|docetaxel|mesh-list
14624142|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624143|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624144|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624145|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624146|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624147|NCT00126243|Rituximab|rituximab|mesh-list
15165546|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165547|NCT04076826|Analgesics|analgesics|mesh-ancestor
15165548|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
15165549|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165550|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15165551|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15165552|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15165553|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
15165554|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165555|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165556|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15165557|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15165558|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15165559|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15165560|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
15165561|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
15165562|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15165563|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15165564|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165565|NCT04076371|Olanzapine|olanzapine|mesh-list
15165566|NCT04076371|Risperidone|risperidone|mesh-list
15165567|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15165568|NCT04076371|Ziprasidone|ziprasidone|mesh-list
15165569|NCT04076371|Sertraline|sertraline|mesh-list
15165570|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15165571|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
15165572|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165573|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165574|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165575|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15165576|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15165577|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165578|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15165579|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15165580|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
15165581|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
15165582|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
14291887|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624148|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624149|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624150|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
14624151|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624152|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624153|NCT00126256|Leucovorin|leucovorin|mesh-list
14624154|NCT00126256|Fluorouracil|fluorouracil|mesh-list
14624155|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
14624156|NCT00126256|Irinotecan|irinotecan|mesh-list
14624157|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
14624158|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624159|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624160|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624161|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624162|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
14624163|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624164|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14624165|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14624166|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624167|NCT00126256|Antidotes|antidotes|mesh-ancestor
15165583|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165584|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180925|NCT03934047|Coagulants|coagulants|mesh-ancestor
14624168|NCT00126256|Protective Agents|protective agents|mesh-ancestor
14624169|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
14624170|NCT00126256|Vitamins|vitamins|mesh-ancestor
14624171|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
14624172|NCT00126269|Gemcitabine|gemcitabine|mesh-list
14624173|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624174|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624175|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
14624176|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624177|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
14624178|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624179|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624180|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624181|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
14624182|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624183|NCT00126282|Cycloserine|cycloserine|mesh-list
14624184|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14624185|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624186|NCT00126282|Renal Agents|renal agents|mesh-ancestor
14624187|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14624188|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
14624189|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624190|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
14624191|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624192|NCT00126308|Mannitol|mannitol|mesh-list
14624193|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14624194|NCT00126308|Diuretics|diuretics|mesh-ancestor
14624195|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
14624196|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624197|NCT00126321|Cladribine|cladribine|mesh-list
14624198|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624199|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624200|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
14624201|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624202|NCT00126347|Folic Acid|folic acid|mesh-list
14624203|NCT00126347|Betaine|betaine|mesh-list
14624204|NCT00126347|Hematinics|hematinics|mesh-ancestor
14291888|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14291889|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
14291890|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291891|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291892|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14291893|NCT00557245|Tenofovir|tenofovir|mesh-list
14291894|NCT00557245|Emtricitabine|emtricitabine|mesh-list
14291895|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14291896|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
15165585|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15165586|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14624205|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
14624206|NCT00126347|Vitamins|vitamins|mesh-ancestor
14624207|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
14624208|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624209|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14624210|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
14624211|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14624212|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
14624213|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624214|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14624215|NCT00126360|Anastrozole|anastrozole|mesh-list
14624216|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14624217|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624218|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14624219|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14624220|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624221|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624222|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14624223|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
14624224|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624225|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624226|NCT00126373|Bupropion|bupropion|mesh-list
14624227|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14624228|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
14624229|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14624230|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14624231|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14624232|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14624233|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624234|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
14624235|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624236|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624237|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14624238|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14624239|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624240|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
14624241|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14624242|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624243|NCT00126399|Doxycycline|doxycycline|mesh-list
14624244|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624245|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624246|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
14624247|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14624248|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14624249|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14624250|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624251|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624252|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624253|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14624254|NCT00126451|Vorinostat|vorinostat|mesh-list
14624255|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624256|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15165587|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15165588|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
15165589|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15165590|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15165591|NCT04076098|Minocycline|minocycline|mesh-list
15165592|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165593|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165594|NCT04076137|Decitabine|decitabine|mesh-list
15165595|NCT04076137|Antibodies|antibodies|mesh-list
15165596|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15165597|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
14624257|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624258|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624259|NCT00126464|Tamoxifen|tamoxifen|mesh-list
14624260|NCT00126464|Fulvestrant|fulvestrant|mesh-list
14624261|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14624262|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
14624263|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624264|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624265|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14624266|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624267|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14624268|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15165598|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165599|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15165600|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
15165601|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165602|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165603|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165604|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
15165605|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624269|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14624270|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14624271|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
14624272|NCT00126516|Giapreza|giapreza|mesh-list
14624273|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14624274|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
14624275|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14624276|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14624277|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624278|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15165606|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624279|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14624280|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
14624281|NCT00126542|Bevacizumab|bevacizumab|mesh-list
14624282|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15165607|NCT04075955|Olanzapine|olanzapine|mesh-list
15165608|NCT04075955|Aprepitant|aprepitant|mesh-list
15165609|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
14624283|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14624284|NCT00126542|Antibodies|antibodies|mesh-list
14624285|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
14624286|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14624287|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624288|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14624289|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14624290|NCT00126542|Growth Substances|growth substances|mesh-ancestor
14624291|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624292|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
14624293|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
14624294|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14624295|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624296|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624297|NCT00126607|Trastuzumab|trastuzumab|mesh-list
14624298|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624299|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624300|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14624301|NCT00126620|Sorafenib|sorafenib|mesh-list
14624302|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624303|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14624304|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624305|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624306|NCT00126633|Gemcitabine|gemcitabine|mesh-list
14624307|NCT00126633|Bevacizumab|bevacizumab|mesh-list
14624308|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624309|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624310|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14624311|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14624312|NCT00126633|Growth Substances|growth substances|mesh-ancestor
14624313|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624314|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
14624315|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624316|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
14624317|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624318|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
14624319|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624320|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624321|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624322|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
14624323|NCT00126646|Antibodies|antibodies|mesh-list
14624324|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
14624325|NCT00126646|Immunotoxins|immunotoxins|mesh-list
14624326|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
14624327|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624328|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
14624329|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14624330|NCT00126698|Trimethoprim|trimethoprim|mesh-list
14624331|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
14624332|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624333|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624334|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14624335|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14624336|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624337|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624338|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624339|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14624340|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14624341|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14624342|NCT00126698|Renal Agents|renal agents|mesh-ancestor
14624343|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
14624344|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14624345|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14624346|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14624347|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15165610|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
15165611|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165612|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165613|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165614|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14624348|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14624349|NCT00126763|Fentanyl|fentanyl|mesh-list
14624350|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14624351|NCT00126763|Narcotics|narcotics|mesh-ancestor
14624352|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14624353|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624354|NCT00126763|Analgesics|analgesics|mesh-ancestor
14624355|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
14624356|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624357|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14624358|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14624359|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
14624360|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
14624361|NCT00126789|Fentanyl|fentanyl|mesh-list
14624362|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14624363|NCT00126789|Narcotics|narcotics|mesh-ancestor
14624364|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14624365|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624366|NCT00126789|Analgesics|analgesics|mesh-ancestor
14624367|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
14624368|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624369|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14624370|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14624371|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
14624372|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
14624373|NCT00126880|Lamivudine|lamivudine|mesh-list
15165615|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15165616|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14291897|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291898|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14291899|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14291900|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291901|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291902|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14291903|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14291904|NCT00557284|Montelukast|montelukast|mesh-list
14291905|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14291906|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
14291907|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14291908|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
14624374|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15165617|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15165618|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15165619|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15165620|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14624375|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14624376|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624377|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624378|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
14624379|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624380|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14624381|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14624382|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
14624383|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
14624384|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
14624385|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14624386|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14624387|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624388|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14624389|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624390|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624391|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14624392|NCT00126906|Renal Agents|renal agents|mesh-ancestor
14624393|NCT00126971|Dapsone|dapsone|mesh-list
14624394|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
14624395|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624396|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
14624397|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14624398|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14624399|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14624400|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624401|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624402|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
14624403|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624404|NCT00127010|Vaccines|vaccines|mesh-list
14624405|NCT00127010|Immunoglobulins|immunoglobulins|mesh-list
14624406|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
14624407|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624408|NCT00127023|Vaccines|vaccines|mesh-list
14624409|NCT00127023|Immunoglobulins|immunoglobulins|mesh-list
15180926|NCT03934294|Metoclopramide|metoclopramide|mesh-list
14624410|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
14624411|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624412|NCT00127049|Gemcitabine|gemcitabine|mesh-list
14624413|NCT00127049|Ifosfamide|ifosfamide|mesh-list
14624414|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624415|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624416|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
14624417|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624418|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
14624419|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624420|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624421|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624422|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
14624423|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624424|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14624425|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
14624426|NCT00127075|Estradiol|estradiol|mesh-list
14624427|NCT00127075|Estrogens|estrogens|mesh-ancestor
14624428|NCT00127075|Hormones|hormones|mesh-ancestor
14624429|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624430|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624431|NCT00127088|Docetaxel|docetaxel|mesh-list
14624432|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624433|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624434|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624435|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624436|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624437|NCT00127114|Amantadine|amantadine|mesh-list
14624438|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14624439|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14624440|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
14624441|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624442|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
14624443|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624444|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624445|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624446|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14624447|NCT00127114|Analgesics|analgesics|mesh-ancestor
14624448|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
14624449|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646452|NCT00198055|Aripiprazole|aripiprazole|mesh-list
14646453|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
14646454|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14646455|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14646456|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14646457|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646458|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646459|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
14646460|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
14646461|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646462|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646463|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14646464|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14646465|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
14646466|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14646467|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15165621|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165622|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165623|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
15165624|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14646468|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14646469|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14646470|NCT00198094|Alprazolam|alprazolam|mesh-list
14646471|NCT00198094|Sertraline|sertraline|mesh-list
14646472|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
14646473|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14646474|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14646475|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14646476|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14646477|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646478|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646479|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
15165625|NCT04075721|Dexamethasone|dexamethasone|mesh-list
15165626|NCT04075721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646480|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624450|NCT00127127|Vorinostat|vorinostat|mesh-list
14624451|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624452|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14624453|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624454|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624455|NCT00127140|Vorinostat|vorinostat|mesh-list
14624456|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624457|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14624458|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624459|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624460|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14624461|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
14624462|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624463|NCT00127257|Diazepam|diazepam|mesh-list
14624464|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14624465|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
14624466|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
14624467|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
14624468|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624469|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624470|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14624471|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14624472|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14624473|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14624474|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14624475|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15165627|NCT04075721|Antiemetics|antiemetics|mesh-ancestor
15165628|NCT04075721|Autonomic Agents|autonomic agents|mesh-ancestor
15165629|NCT04075721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165630|NCT04075721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165631|NCT04075721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165632|NCT04075721|Glucocorticoids|glucocorticoids|mesh-ancestor
15165633|NCT04075721|Hormones|hormones|mesh-ancestor
14624476|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14624477|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14624478|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14624479|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
14624480|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
14624481|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
14624482|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
14624483|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624484|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624485|NCT00127270|Darifenacin|darifenacin|mesh-list
14624486|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14624487|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14624488|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
14624489|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624490|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165634|NCT04075721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165635|NCT04075721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15165636|NCT04075721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165637|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15165638|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15165639|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
15165640|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022354|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
14624491|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624492|NCT00127270|Urological Agents|urological agents|mesh-ancestor
14624493|NCT00127335|Atorvastatin|atorvastatin|mesh-list
14624494|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14624495|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14624496|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
14624497|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624498|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14624499|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14624500|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624501|NCT00127387|Etanercept|etanercept|mesh-list
14624502|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14624503|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14624504|NCT00127387|Analgesics|analgesics|mesh-ancestor
14624505|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
14624506|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624507|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624508|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14624509|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624510|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14624511|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624512|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
14624513|NCT00127478|Atrasentan|atrasentan|mesh-list
14624514|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624515|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14624516|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14624517|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624518|NCT00127504|Azithromycin|azithromycin|mesh-list
14624519|NCT00127504|Rifampin|rifampin|mesh-list
14624520|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624521|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624522|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14624523|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
14624524|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
14624525|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14624526|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624527|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624528|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14624529|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14624530|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14624531|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15165641|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165642|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165643|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15165644|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15165645|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15165646|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165647|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165648|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15165649|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15165650|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165651|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
15165652|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624532|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14624533|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14624534|NCT00127569|Rituximab|rituximab|mesh-list
14624535|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624536|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624537|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
15165653|NCT04075474|Listerine|listerine|mesh-list
15165654|NCT04075474|Fluorides|fluorides|mesh-list
15165655|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
15165656|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
15165657|NCT04075474|Protective Agents|protective agents|mesh-ancestor
15165658|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165659|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15165660|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165661|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15165662|NCT04075227|Dexamethasone|dexamethasone|mesh-list
14624538|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624539|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624540|NCT00127595|Gemcitabine|gemcitabine|mesh-list
14624541|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
14624542|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624543|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
14624544|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624545|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624546|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
14624547|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624548|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624549|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624550|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
14624551|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624552|NCT00127673|Sertraline|sertraline|mesh-list
14624553|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
14624554|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14624555|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14624556|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14624557|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15165663|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14624558|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624559|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624560|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
14624561|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624562|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
14624563|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
14624564|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
14624565|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14624566|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14624567|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624568|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624569|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624570|NCT00127764|Dexamethasone|dexamethasone|mesh-list
14624571|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14624572|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
14624573|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
14624574|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624575|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624576|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14624577|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
14624578|NCT00127764|Hormones|hormones|mesh-ancestor
14624579|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624580|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15165664|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
15165665|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
15165666|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165667|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165668|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165669|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
15165670|NCT04075227|Hormones|hormones|mesh-ancestor
15165671|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165672|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15165673|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165674|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15165675|NCT04075006|Ketamine|ketamine|mesh-list
15165676|NCT04075006|Analgesics|analgesics|mesh-ancestor
15165677|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
15165678|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165679|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624581|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624582|NCT00127777|Amantadine|amantadine|mesh-list
14624583|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14624584|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14624585|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
14624586|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624587|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
14624588|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624589|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624590|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624591|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14624592|NCT00127777|Analgesics|analgesics|mesh-ancestor
14624593|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
14624594|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624595|NCT00127829|Gefitinib|gefitinib|mesh-list
14624596|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624597|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14624598|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624599|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624600|NCT00127868|Selenium|selenium|mesh-list
14624601|NCT00127868|Ketoconazole|ketoconazole|mesh-list
14624602|NCT00127868|Ciclopirox|ciclopirox|mesh-list
14624603|NCT00127868|Griseofulvin|griseofulvin|mesh-list
14624604|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
14624605|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
14624606|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624607|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14624608|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14624609|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624610|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624611|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14624612|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
14624613|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165680|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14624614|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165681|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15165682|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
15165683|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
15165684|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165685|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15165686|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15165687|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165688|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165689|NCT04075149|Spironolactone|spironolactone|mesh-list
15165690|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15165691|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
15165692|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165693|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624615|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14624616|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
14624617|NCT00127868|Protective Agents|protective agents|mesh-ancestor
14624618|NCT00127868|Trace Elements|trace elements|mesh-ancestor
14624619|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
14624620|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
14624621|NCT00127881|Zanolimumab|zanolimumab|mesh-list
14624622|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624623|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624624|NCT00127907|Vasopressins|vasopressins|mesh-list
14624625|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
15165694|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15165695|NCT04075149|Diuretics|diuretics|mesh-ancestor
15165696|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
15165697|NCT04075240|Aspirin|aspirin|mesh-list
15165698|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
15165699|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15165700|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165701|NCT04075240|Analgesics|analgesics|mesh-ancestor
15165702|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
15165703|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165704|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165705|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14624626|NCT00127907|Epinephrine|epinephrine|mesh-list
14624627|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14624628|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14624629|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
14624630|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624631|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624632|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624633|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14624634|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14624635|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
14624636|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624637|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14624638|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
14624639|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
14624640|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
14624641|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14624642|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
14624643|NCT00127907|Coagulants|coagulants|mesh-ancestor
14624644|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14624645|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
14624646|NCT00127920|Bevacizumab|bevacizumab|mesh-list
14624647|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624648|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165706|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15165707|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15165708|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15165709|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165710|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15165711|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14624649|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14624650|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14624651|NCT00127920|Growth Substances|growth substances|mesh-ancestor
14624652|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624653|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
14624654|NCT00127959|Tenofovir|tenofovir|mesh-list
14624655|NCT00127959|Zidovudine|zidovudine|mesh-list
14624656|NCT00127959|Emtricitabine|emtricitabine|mesh-list
14624657|NCT00127959|Efavirenz|efavirenz|mesh-list
14022355|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14624658|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
14624659|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624660|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14624661|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14624662|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165712|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165713|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
15165714|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15165715|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
15165716|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15165717|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
15165718|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
15165719|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
15165720|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15165721|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165722|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
15165723|NCT04075188|Aflibercept|aflibercept|mesh-list
14624663|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624664|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14624665|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14624666|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
14624667|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14624668|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14624669|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14624670|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14624671|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14624672|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14624673|NCT00127972|Lamivudine|lamivudine|mesh-list
14624674|NCT00127972|Efavirenz|efavirenz|mesh-list
14624675|NCT00127972|Nevirapine|nevirapine|mesh-list
14624676|NCT00127972|Stavudine|stavudine|mesh-list
14022356|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165724|NCT04075188|Verteporfin|verteporfin|mesh-list
15165725|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15165726|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15165727|NCT04075188|Growth Substances|growth substances|mesh-ancestor
15165728|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165729|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
14624677|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14624678|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14624679|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624680|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624681|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
14624682|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624683|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14624684|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14624685|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14624686|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14624687|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14624688|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14624689|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14624690|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14624691|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
14624692|NCT00127985|Prednisolone|prednisolone|mesh-list
14624693|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14624694|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
14624695|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14624696|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
14624697|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14624698|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
14624699|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14624700|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
14624701|NCT00127985|Hormones|hormones|mesh-ancestor
15165730|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165731|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15165732|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
15165733|NCT04075604|Nivolumab|nivolumab|mesh-list
15165734|NCT04075604|Palbociclib|palbociclib|mesh-list
15165735|NCT04075604|Anastrozole|anastrozole|mesh-list
15165736|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15165737|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165738|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15165739|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165740|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15165741|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165742|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15165743|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14624702|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624703|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624704|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14624705|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624706|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
14624707|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
15165744|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15165745|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15165746|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
15165747|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165748|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165749|NCT04075201|Vaccines|vaccines|mesh-list
14624708|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624709|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14624710|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14624711|NCT00127985|Protective Agents|protective agents|mesh-ancestor
14624712|NCT00127998|Artesunate|artesunate|mesh-list
14624713|NCT00127998|Chloroquine|chloroquine|mesh-list
14624714|NCT00127998|Lumefantrine|lumefantrine|mesh-list
14624715|NCT00127998|Artemether|artemether|mesh-list
14624716|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
14624717|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
14624718|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14624719|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14624720|NCT00127998|Amodiaquine|amodiaquine|mesh-list
14624721|NCT00127998|Mefloquine|mefloquine|mesh-list
14624722|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
14624723|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14624724|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14624725|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624726|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624727|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
14624728|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
14624729|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14624730|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
14624731|NCT00127998|Amebicides|amebicides|mesh-ancestor
14624732|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624733|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14624734|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624735|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624736|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14624737|NCT00127998|Renal Agents|renal agents|mesh-ancestor
14624738|NCT00128037|Mitomycins|mitomycins|mesh-list
14624739|NCT00128037|Mitomycin|mitomycin|mesh-list
14624740|NCT00128037|Vindesine|vindesine|mesh-list
14624741|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624742|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14624743|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
14624744|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624745|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14624746|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624747|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14624748|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624749|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624750|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624751|NCT00128154|Chromium|chromium|mesh-list
14624752|NCT00128154|Picolinic acid|picolinic acid|mesh-list
14624753|NCT00128154|Trace Elements|trace elements|mesh-ancestor
14624754|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
15165750|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
15165751|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165752|NCT04074746|Vidarabine|vidarabine|mesh-list
15165753|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
15165754|NCT04074746|Fludarabine|fludarabine|mesh-list
15165755|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
15165756|NCT04074746|Antibodies|antibodies|mesh-list
15165757|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14624755|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624756|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14624757|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
14624758|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
15165758|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624759|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624760|NCT00128232|Octreotide|octreotide|mesh-list
14624761|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14624762|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14624763|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624764|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
14624765|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14624766|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14624767|NCT00128245|Analgesics|analgesics|mesh-ancestor
14624768|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
14624769|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624770|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624771|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14624772|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624773|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
14624774|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624775|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
14624776|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14624777|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624778|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624779|NCT00128271|Bavituximab|bavituximab|mesh-list
14624780|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14624781|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624782|NCT00128297|Pamidronate|pamidronate|mesh-list
14624783|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14624784|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624785|NCT00128310|Gemcitabine|gemcitabine|mesh-list
14624786|NCT00128310|Vinorelbine|vinorelbine|mesh-list
14624787|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624788|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
14624789|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022357|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
14022358|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14022359|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022360|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624790|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624791|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
14624792|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624793|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624794|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14624795|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
14624796|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624797|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14624798|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624799|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624800|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624801|NCT00128323|Nystatin|nystatin|mesh-list
14624802|NCT00128323|Gentian Violet|gentian violet|mesh-list
14624803|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14624804|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624805|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165759|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
15165760|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165761|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15165762|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15165763|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
15165764|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165765|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165766|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15165767|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15165768|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
15165769|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
15165770|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180927|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
15180928|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
15180929|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180930|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180931|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15180932|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15180933|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15180934|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
14022361|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15180935|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180936|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180937|NCT03933956|Empagliflozin|empagliflozin|mesh-list
15180938|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15182332|NCT03921684|Nivolumab|nivolumab|mesh-list
14624806|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
14022362|NCT02768688|Analgesics|analgesics|mesh-ancestor
14624807|NCT00128323|Ionophores|ionophores|mesh-ancestor
14624808|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15165771|NCT04074473|Propranolol|propranolol|mesh-list
15165772|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15165773|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15165774|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
15165775|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165776|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165777|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165778|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15165779|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15165780|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
15165781|NCT04074603|Insulin|insulin|mesh-list
14624809|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624810|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14624811|NCT00128414|Colchicine|colchicine|mesh-list
14624812|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
14624813|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624814|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624815|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624816|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624817|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624818|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624819|NCT00128427|Colchicine|colchicine|mesh-list
14624820|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
14624821|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624822|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624823|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624824|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624825|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624826|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624827|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
14624828|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14624829|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
14624830|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624831|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624832|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14624833|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
14624834|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
14624835|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14624836|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
14624837|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14624838|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624839|NCT00128453|Colchicine|colchicine|mesh-list
14624840|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
14624841|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14624842|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624843|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624844|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624845|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165782|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15165783|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165784|NCT04074564|Apatinib|apatinib|mesh-list
14624846|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165785|NCT04074564|Antibodies|antibodies|mesh-list
15165786|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
15165787|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165788|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624847|NCT00128466|Gentamicins|gentamicins|mesh-list
14624848|NCT00128466|Streptomycin|streptomycin|mesh-list
14624849|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14624850|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624851|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14624852|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624853|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624854|NCT00128479|Mifepristone|mifepristone|mesh-list
14624855|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14624856|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
14624857|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14624858|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624859|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14624860|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15165789|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15165790|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165791|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624861|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15165792|NCT04074460|Propofol|propofol|mesh-list
14624862|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
14624863|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14624864|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14624865|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
14624866|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624867|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
14624868|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14624869|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14624870|NCT00128505|Mifepristone|mifepristone|mesh-list
14624871|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14624872|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
14624873|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14624874|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624875|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14624876|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14624877|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14624878|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
14624879|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14624880|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14624881|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
14624882|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624883|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
14624884|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14624885|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14624886|NCT00128518|Perindopril|perindopril|mesh-list
14624887|NCT00128518|Indapamide|indapamide|mesh-list
14624888|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14624889|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
14624890|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624891|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624892|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14624893|NCT00128518|Diuretics|diuretics|mesh-ancestor
14624894|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
14624895|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624896|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14624897|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14624898|NCT00128531|Leuprolide|leuprolide|mesh-list
14624899|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14624900|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
14624901|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14624902|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624903|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14624904|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624905|NCT00128544|Telbivudine|telbivudine|mesh-list
14624906|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
14624907|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624908|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14624909|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624910|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624911|NCT00128557|Vitamin A|vitamin a|mesh-list
14624912|NCT00128557|Vitamins|vitamins|mesh-ancestor
14624913|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
14624914|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624915|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
14624916|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624917|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
15165793|NCT04074460|Sevoflurane|sevoflurane|mesh-list
15165794|NCT04074460|Desflurane|desflurane|mesh-list
15165795|NCT04074460|Isoflurane|isoflurane|mesh-list
15165796|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15165797|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165798|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165799|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15165800|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
14624918|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624919|NCT00128635|Antibodies|antibodies|mesh-list
14624920|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14624921|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
14624922|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624923|NCT00128700|Temozolomide|temozolomide|mesh-list
14624924|NCT00128700|Vatalanib|vatalanib|mesh-list
15165801|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
14624925|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15165802|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15165803|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15165804|NCT04074551|Losartan|losartan|mesh-list
15165805|NCT04074551|Amlodipine|amlodipine|mesh-list
15165806|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15165807|NCT04074551|Ezetimibe|ezetimibe|mesh-list
15165808|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15165809|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15165810|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15165811|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165812|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15165813|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165814|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
14624926|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
14624927|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624928|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624929|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14624930|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624931|NCT00128739|Budesonide|budesonide|mesh-list
14624932|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14624933|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14624934|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
14624935|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14624936|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624937|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14624938|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
14624939|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
14624940|NCT00128739|Hormones|hormones|mesh-ancestor
14624941|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624942|NCT00128752|Beta Carotene|beta carotene|mesh-list
14624943|NCT00128752|Carotenoids|carotenoids|mesh-list
14624944|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
14624945|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624946|NCT00128752|Protective Agents|protective agents|mesh-ancestor
14624947|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624948|NCT00128752|Provitamins|provitamins|mesh-ancestor
14624949|NCT00128752|Vitamins|vitamins|mesh-ancestor
14624950|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
14624951|NCT00128778|Doxorubicin|doxorubicin|mesh-list
14624952|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14624953|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14624954|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624955|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14624956|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14624957|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624958|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624959|NCT00128791|Nitroprusside|nitroprusside|mesh-list
14624960|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14624961|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
14624962|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14624963|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624964|NCT00128804|Beta Carotene|beta carotene|mesh-list
15165815|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15165816|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15165817|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
15165818|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15165819|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15165820|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165821|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14624965|NCT00128804|Carotenoids|carotenoids|mesh-list
14624966|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
14624967|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624968|NCT00128804|Protective Agents|protective agents|mesh-ancestor
14624969|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624970|NCT00128804|Provitamins|provitamins|mesh-ancestor
14624971|NCT00128804|Vitamins|vitamins|mesh-ancestor
14624972|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
14624973|NCT00128843|Anastrozole|anastrozole|mesh-list
14624974|NCT00128843|Exemestane|exemestane|mesh-list
14624975|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14624976|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624977|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14624978|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14624979|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624980|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165822|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14026088|NCT02745093|Mifepristone|mifepristone|mesh-list
14624981|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14624982|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
14624983|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14624984|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14624985|NCT00128856|Gemcitabine|gemcitabine|mesh-list
14624986|NCT00128856|Paclitaxel|paclitaxel|mesh-list
14624987|NCT00128856|Doxorubicin|doxorubicin|mesh-list
14624988|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14624989|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14624990|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
14624991|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
14624992|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
14624993|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14624994|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14624995|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
14624996|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
14624997|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14624998|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14624999|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625000|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
15165823|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15165824|NCT04074421|Rifaximin|rifaximin|mesh-list
15165825|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165826|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165827|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15165828|NCT04074213|Clozapine|clozapine|mesh-list
15165829|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14625001|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625002|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625003|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625004|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646481|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14646482|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646483|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14646484|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15165830|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
15165831|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165832|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165833|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165834|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15165835|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15165836|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022363|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
15165837|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15165838|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
15165839|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
15165840|NCT04073953|Primaquine|primaquine|mesh-list
15165841|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
15165842|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15165843|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14646485|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
14646486|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
14646487|NCT00198120|Cycloserine|cycloserine|mesh-list
14646488|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14646489|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646490|NCT00198120|Renal Agents|renal agents|mesh-ancestor
14646491|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14646492|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
14646493|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14646494|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
14646495|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646496|NCT00198146|Daclizumab|daclizumab|mesh-list
14646497|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646498|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
14646499|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646500|NCT00198159|Gefitinib|gefitinib|mesh-list
14646501|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646502|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14646503|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646504|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646505|NCT00198172|Epirubicin|epirubicin|mesh-list
14646506|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646507|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646508|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15165844|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15165845|NCT04074317|Insulin|insulin|mesh-list
15165846|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14625005|NCT00128895|Azathioprine|azathioprine|mesh-list
14625006|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
14625007|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625008|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625009|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165847|NCT04074317|Pramlintide|pramlintide|mesh-list
15165848|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15165849|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625010|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625011|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
14625012|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625013|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625014|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14625015|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
14625016|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625017|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
14625018|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14625019|NCT00128934|Estradiol|estradiol|mesh-list
14625020|NCT00128934|Estrogens|estrogens|mesh-ancestor
14625021|NCT00128934|Hormones|hormones|mesh-ancestor
14625022|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625023|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625024|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14625025|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
14625026|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14625027|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14625028|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14625029|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14625030|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14625031|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
14625032|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625033|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625034|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14625035|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
14625036|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14625037|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625038|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625039|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625040|NCT00129038|Aspirin|aspirin|mesh-list
14625041|NCT00129038|Dipyridamole|dipyridamole|mesh-list
15165850|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
15165851|NCT04073849|Hematinics|hematinics|mesh-ancestor
15165852|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
14625042|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14625043|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14625044|NCT00129038|Analgesics|analgesics|mesh-ancestor
14625045|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
14625046|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625047|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625048|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625049|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625050|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14625051|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14625052|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625053|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14625054|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14625055|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625056|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
14625057|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14625058|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
14625059|NCT00129090|Rituximab|rituximab|mesh-list
14625060|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14625061|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625062|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
14625063|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625064|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625065|NCT00129142|Toremifene|toremifene|mesh-list
14625066|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14625067|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625068|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14625069|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15165853|NCT04073758|Remifentanil|remifentanil|mesh-list
14625070|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
14625071|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15165854|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14625072|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625073|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14625074|NCT00129155|Treosulfan|treosulfan|mesh-list
14625075|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14625076|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
14625077|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625078|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625079|NCT00129168|Cytarabine|cytarabine|mesh-list
14625080|NCT00129168|Daunorubicin|daunorubicin|mesh-list
14625081|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625082|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
15165855|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165856|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165857|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165858|NCT04073758|Analgesics|analgesics|mesh-ancestor
15165859|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
15165860|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165861|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15165862|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15165863|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15165864|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
15165865|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165866|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165867|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15165868|NCT04073758|Narcotics|narcotics|mesh-ancestor
15165869|NCT04073797|Evolocumab|evolocumab|mesh-list
15165870|NCT04073797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15165871|NCT04073797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15165872|NCT04073797|Antimetabolites|antimetabolites|mesh-ancestor
15165873|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165874|NCT04073797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14625083|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625084|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625085|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
14625086|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625087|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165875|NCT04073550|Topotecan|topotecan|mesh-list
15165876|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15165877|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625088|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
15165878|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165879|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165880|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165881|NCT04073537|Paclitaxel|paclitaxel|mesh-list
15165882|NCT04073537|Carboplatin|carboplatin|mesh-list
15165883|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15165884|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165885|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625089|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165886|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
15165887|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
15165888|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165889|NCT04073719|Acetic Acid|acetic acid|mesh-list
14625090|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625091|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625092|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625093|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625094|NCT00129181|Levodopa|levodopa|mesh-list
14625095|NCT00129181|Carbidopa|carbidopa|mesh-list
14625096|NCT00129181|Cabergoline|cabergoline|mesh-list
14625097|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14625098|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14625099|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14625100|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
14625101|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165890|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15165891|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625102|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625103|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625104|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14625105|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625106|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
14625107|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14625108|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
14625109|NCT00129207|Bortezomib|bortezomib|mesh-list
14625110|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625111|NCT00129233|Amlodipine|amlodipine|mesh-list
15165892|NCT04073602|Trastuzumab|trastuzumab|mesh-list
15165893|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15165894|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022364|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625112|NCT00129233|Valsartan|valsartan|mesh-list
14625113|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14625114|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14625115|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14625116|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625117|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14625118|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625119|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
14625120|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14625121|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14625122|NCT00129298|Tiagabine|tiagabine|mesh-list
14625123|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
15165895|NCT04073680|Canagliflozin|canagliflozin|mesh-list
15165896|NCT04073680|Serabelisib|serabelisib|mesh-list
15165897|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15165898|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165899|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15165900|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165901|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625124|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14625125|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14625126|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14625127|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625128|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
14625129|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625130|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625131|NCT00129337|Bavituximab|bavituximab|mesh-list
14625132|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14625133|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625134|NCT00129363|Carvedilol|carvedilol|mesh-list
14625135|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14625136|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14625137|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
14625138|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625139|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625140|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625141|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14625142|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
14625143|NCT00129363|Protective Agents|protective agents|mesh-ancestor
14625144|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14625145|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14625146|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14625147|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
14625148|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14625149|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14625150|NCT00129506|Methotrexate|methotrexate|mesh-list
14625151|NCT00129506|Misoprostol|misoprostol|mesh-list
14625152|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14625153|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
14625154|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14625155|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625156|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625157|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
14625158|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625159|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625160|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625161|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625162|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625163|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625164|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
14625165|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625166|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14625167|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14625168|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625169|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
14625170|NCT00129519|Imiquimod|imiquimod|mesh-list
14625171|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14625172|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
14625173|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625174|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625175|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
14625176|NCT00129597|Ketamine|ketamine|mesh-list
14625177|NCT00129597|Analgesics|analgesics|mesh-ancestor
14625178|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
14625179|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625180|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625181|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14625182|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14625183|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
14625184|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
14625185|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14625186|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14625187|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14625188|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625189|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625190|NCT00129688|Amikacin|amikacin|mesh-list
14625191|NCT00129688|Cloxacillin|cloxacillin|mesh-list
14625192|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14625193|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625194|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
14625195|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14625196|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625197|NCT00129805|Aspirin|aspirin|mesh-list
14625198|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
15165902|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
15165903|NCT04073173|Analgesics|analgesics|mesh-list
15165904|NCT04073173|Narcotics|narcotics|mesh-ancestor
15165905|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165906|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165907|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
15165908|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165909|NCT04074265|Ketorolac|ketorolac|mesh-list
15165910|NCT04074265|Epinephrine|epinephrine|mesh-list
14291909|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291910|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291911|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14291912|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14291913|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291914|NCT00557310|Teriparatide|teriparatide|mesh-list
14291915|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14625199|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14625200|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022365|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14625201|NCT00129805|Analgesics|analgesics|mesh-ancestor
14625202|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
14625203|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022366|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14022367|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14022368|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022369|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022370|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022371|NCT02768805|Vaccines|vaccines|mesh-list
14022372|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
14022373|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022374|NCT02768649|Risperidone|risperidone|mesh-list
14022375|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14022376|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
14022377|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022378|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022379|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625204|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625205|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625206|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625207|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14625208|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14625209|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625210|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15165911|NCT04074265|Ropivacaine|ropivacaine|mesh-list
15165912|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
15165913|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
14625211|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14625212|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625213|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
14625214|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14625215|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
14625216|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625217|NCT00129818|Famciclovir|famciclovir|mesh-list
14625218|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
14625219|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625220|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14625221|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625222|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625223|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
14625224|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625225|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14625226|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625227|NCT00129857|HU 211|hu 211|mesh-list
14625228|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14625229|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
14625230|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
14625231|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625232|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625233|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625234|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14625235|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14625236|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625237|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625238|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14625239|NCT00129857|Protective Agents|protective agents|mesh-ancestor
14625240|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
14625241|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291916|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291917|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14291918|NCT00557349|Omeprazole|omeprazole|mesh-list
14291919|NCT00557349|Famotidine|famotidine|mesh-list
14291920|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15165914|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15165915|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165916|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
15165917|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165918|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15165919|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15165920|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
15165921|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165922|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625242|NCT00129896|Docetaxel|docetaxel|mesh-list
14625243|NCT00129896|Doxorubicin|doxorubicin|mesh-list
14625244|NCT00129896|Trastuzumab|trastuzumab|mesh-list
14625245|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625246|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625247|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625248|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625249|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625250|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625251|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625252|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625253|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625254|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14625255|NCT00129922|Paclitaxel|paclitaxel|mesh-list
14625256|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
14625257|NCT00129922|Fluorouracil|fluorouracil|mesh-list
14625258|NCT00129922|Epirubicin|epirubicin|mesh-list
14625259|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14625260|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625261|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625262|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625263|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625264|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625265|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15165923|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15165924|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15165925|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
15165926|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14625266|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
14625267|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165927|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
15165928|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
15165929|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
15165930|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15165931|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15165932|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15165933|NCT04074265|Analgesics|analgesics|mesh-ancestor
15165934|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15165935|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15165936|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15165937|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165938|NCT04073160|Durvalumab|durvalumab|mesh-list
15165939|NCT04073160|Tremelimumab|tremelimumab|mesh-list
15165940|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15165941|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15165942|NCT04073134|Evolocumab|evolocumab|mesh-list
15165943|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15165944|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15165945|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
15165946|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165947|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15165948|NCT04074122|Adenosine|adenosine|mesh-list
15165949|NCT04074122|Isoproterenol|isoproterenol|mesh-list
15165950|NCT04074122|Epinephrine|epinephrine|mesh-list
15165951|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15165952|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15165953|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
15165954|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165955|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165956|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165957|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15165958|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15165959|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
15165960|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15165961|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15165962|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
15165963|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
14625268|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625269|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14625270|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
14625271|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14625272|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
14625273|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625274|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625275|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625276|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625277|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022380|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14022381|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14022382|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022383|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14625278|NCT00129948|Troxacitabine|troxacitabine|mesh-list
14625279|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625280|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14625281|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14625282|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
15165964|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
15165965|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15165966|NCT04074122|Analgesics|analgesics|mesh-ancestor
15165967|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
15165968|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15165969|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
15165970|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15165971|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
15165972|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
15165973|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15165974|NCT04074122|Protective Agents|protective agents|mesh-ancestor
15165975|NCT04073927|Butyric Acid|butyric acid|mesh-list
15165976|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
15165977|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
15165978|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165979|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165980|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165981|NCT04073316|Warfarin|warfarin|mesh-list
14625283|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625284|NCT00130000|Eculizumab|eculizumab|mesh-list
15165982|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
15165983|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
15165984|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14625285|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14625286|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625287|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
14625288|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625289|NCT00130013|Amoxicillin|amoxicillin|mesh-list
14625290|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14625291|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625292|NCT00130026|Caffeine|caffeine|mesh-list
14625293|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14625294|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165985|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
15165986|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15165987|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
15165988|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165989|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625295|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14625296|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625297|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625298|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14625299|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14625300|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
14625301|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625302|NCT00130065|Folic Acid|folic acid|mesh-list
14625303|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
14625304|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
14625305|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14625306|NCT00130065|Hematinics|hematinics|mesh-ancestor
14625307|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
14625308|NCT00130065|Vitamins|vitamins|mesh-ancestor
14625309|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
14625310|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625311|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
14625312|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14625313|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14625314|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625315|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625316|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15165990|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
15165991|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15165992|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14625317|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625318|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14625319|NCT00130065|Renal Agents|renal agents|mesh-ancestor
14625320|NCT00130091|Clonidine|clonidine|mesh-list
14625321|NCT00130091|Analgesics|analgesics|mesh-ancestor
14625322|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
14625323|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625324|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625325|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14625326|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
14625327|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
14625328|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14625329|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14625330|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14625331|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
14625332|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625333|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625334|NCT00130143|Amifostine|amifostine|mesh-list
14625335|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14625336|NCT00130143|Protective Agents|protective agents|mesh-ancestor
14625337|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625338|NCT00130156|Doxazosin|doxazosin|mesh-list
14625339|NCT00130156|Bunazosin|bunazosin|mesh-list
14625340|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14625341|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14625342|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14625343|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14625344|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
14625345|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625346|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625347|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625348|NCT00130195|Cytarabine|cytarabine|mesh-list
14625349|NCT00130195|Dexamethasone|dexamethasone|mesh-list
14625350|NCT00130195|Prednisolone|prednisolone|mesh-list
14625351|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
14625352|NCT00130195|Methotrexate|methotrexate|mesh-list
14625353|NCT00130195|Vincristine|vincristine|mesh-list
14625354|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
14625355|NCT00130195|Daunorubicin|daunorubicin|mesh-list
14625356|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625357|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
14625358|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625359|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625360|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14625361|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
14625362|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625363|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625364|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14625365|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625366|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
14625367|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
14625368|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625369|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625370|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
14625371|NCT00130195|Hormones|hormones|mesh-ancestor
14625372|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625373|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14625374|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14625375|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
14625376|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14625377|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625378|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
14625379|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625380|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625381|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625382|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14625383|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
14625384|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625385|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14625386|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625387|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625388|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625389|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14625390|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625391|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625392|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625393|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
14625394|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14625395|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14625396|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625397|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
14625398|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625399|NCT00130234|Omalizumab|omalizumab|mesh-list
14625400|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14625401|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14625402|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
14625403|NCT00130325|Isoniazid|isoniazid|mesh-list
14625404|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
14625405|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14625406|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625407|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14625408|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14625409|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
14625410|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625411|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14625412|NCT00130338|Rivastigmine|rivastigmine|mesh-list
14625413|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14625414|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625415|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625416|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
14625417|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625418|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625419|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14625420|NCT00130338|Protective Agents|protective agents|mesh-ancestor
14625421|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
14625422|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14625423|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
14625424|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625425|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625426|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14625427|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
14625428|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14625429|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14625430|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14625431|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
14625432|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625433|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625434|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
14625435|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14625436|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14625437|NCT00130364|Analgesics|analgesics|mesh-ancestor
14625438|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
14625439|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625440|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625441|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625442|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625443|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625444|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625445|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
15165993|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15165994|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15165995|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15165996|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
15165997|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15165998|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15165999|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15166000|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166001|NCT04073056|Bupivacaine|bupivacaine|mesh-list
15166002|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
15166003|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
15166004|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166005|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166006|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
15166007|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166008|NCT04072640|Voriconazole|voriconazole|mesh-list
14625446|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14625447|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625448|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625449|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
14625450|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14625451|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625452|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
14625453|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14625454|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14625455|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625456|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14625457|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625458|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14625459|NCT00130455|Citalopram|citalopram|mesh-list
14625460|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15166009|NCT04072640|Amphotericin B|amphotericin b|mesh-list
15166010|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15166011|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
15166012|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
15166013|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
15166014|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166015|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15166016|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15166017|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166018|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166019|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15166020|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
15166021|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15166022|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166023|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15166024|NCT04072640|Amebicides|amebicides|mesh-ancestor
15166025|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15166026|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15166027|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166028|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15166029|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166030|NCT04072770|Caseins|caseins|mesh-list
15166031|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
15166032|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
15166033|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166034|NCT04072900|Imiquimod|imiquimod|mesh-list
15166035|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15166036|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
15166037|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166038|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166039|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
14625461|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14625462|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15180939|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180940|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14625463|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625464|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625465|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
14625466|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625467|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14625468|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
14625469|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14625470|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
14625471|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14625472|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
14625473|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625474|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
14625475|NCT00130468|Protective Agents|protective agents|mesh-ancestor
14625476|NCT00130481|Atorvastatin|atorvastatin|mesh-list
14625477|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14625478|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14625479|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
14625480|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625481|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14625482|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14625483|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625484|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
14625485|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14625486|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625487|NCT00130507|Capecitabine|capecitabine|mesh-list
14625488|NCT00130507|Trastuzumab|trastuzumab|mesh-list
14625489|NCT00130507|Vinorelbine|vinorelbine|mesh-list
14625490|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625491|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
14625492|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625493|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625494|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14625495|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14625496|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625497|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625498|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625499|NCT00130546|Sirolimus|sirolimus|mesh-list
14625500|NCT00130546|Paclitaxel|paclitaxel|mesh-list
14625501|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14625502|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625503|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625504|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625505|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625506|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625507|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14625508|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625509|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625510|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
14625511|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625512|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
14625513|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625514|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
14625515|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14625516|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14625517|NCT00130572|Analgesics|analgesics|mesh-ancestor
14625518|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
14625519|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625520|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625521|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625522|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15180941|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625523|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625524|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625525|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
14625526|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14625527|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625528|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625529|NCT00130585|Folic Acid|folic acid|mesh-list
14625530|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
15166040|NCT04072601|Atorvastatin|atorvastatin|mesh-list
15166041|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15166042|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15166043|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
15166044|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166045|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15166046|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15166047|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166048|NCT04072341|Propolis|propolis|mesh-list
14625531|NCT00130585|Hematinics|hematinics|mesh-ancestor
14625532|NCT00130585|Vitamins|vitamins|mesh-ancestor
14625533|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
14625534|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625535|NCT00130676|Mifepristone|mifepristone|mesh-list
14625536|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14625537|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
14625538|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14625539|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625540|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14625541|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14625542|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14625543|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
14625544|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14625545|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14625546|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
14625547|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625548|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
14625549|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14625550|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14625551|NCT00130702|Gefitinib|gefitinib|mesh-list
14625552|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625553|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15166049|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166050|NCT04072497|Vaccines|vaccines|mesh-list
15166051|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
15166052|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166053|NCT04072263|Interferons|interferons|mesh-list
15166054|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
15166055|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
15166056|NCT04072263|Paclitaxel|paclitaxel|mesh-list
15166057|NCT04072263|Carboplatin|carboplatin|mesh-list
15166058|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15166059|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166060|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
15166061|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
15166062|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
15166063|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166064|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
15166065|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166066|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
15166067|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166068|NCT04072471|Lesinurad|lesinurad|mesh-list
15166069|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
15166070|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15166071|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
15166072|NCT04072471|Renal Agents|renal agents|mesh-ancestor
15166073|NCT04072146|Varenicline|varenicline|mesh-list
15166074|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15166075|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14625554|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166076|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
15166077|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166078|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625555|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166079|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166080|NCT04072068|Edoxaban|edoxaban|mesh-list
15166081|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15166082|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
15180942|NCT03934333|Budesonide|budesonide|mesh-list
15166083|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15166084|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
15166085|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625556|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
14625557|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
14625558|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166086|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166087|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
15166088|NCT04072198|Leucovorin|leucovorin|mesh-list
15166089|NCT04072198|Bevacizumab|bevacizumab|mesh-list
15166090|NCT04072198|Nivolumab|nivolumab|mesh-list
15166091|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
15166092|NCT04072198|Irinotecan|irinotecan|mesh-list
15166093|NCT04072198|Fluorouracil|fluorouracil|mesh-list
15166094|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166095|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166096|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15166097|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15166098|NCT04072198|Growth Substances|growth substances|mesh-ancestor
14625559|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625560|NCT00130767|Finasteride|finasteride|mesh-list
14625561|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14625562|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14625563|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625564|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625565|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
14625566|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625567|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625568|NCT00130767|Urological Agents|urological agents|mesh-ancestor
14625569|NCT00130819|Buprenorphine|buprenorphine|mesh-list
14625570|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14625571|NCT00130819|Narcotics|narcotics|mesh-ancestor
14625572|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14625573|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625574|NCT00130819|Analgesics|analgesics|mesh-ancestor
14625575|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
14625576|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625577|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14625578|NCT00130845|Octreotide|octreotide|mesh-list
14625579|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625580|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15166099|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166100|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
15166101|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15166102|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166103|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15166104|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15166105|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166106|NCT04072198|Antidotes|antidotes|mesh-ancestor
15166107|NCT04072198|Protective Agents|protective agents|mesh-ancestor
15166108|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
15166109|NCT04072198|Vitamins|vitamins|mesh-ancestor
15166110|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
15166111|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
15166112|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15166113|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15166114|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
15166115|NCT04071756|Tazarotene|tazarotene|mesh-list
15166116|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
15166117|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
15166118|NCT04072328|Midazolam|midazolam|mesh-list
15166119|NCT04072328|Propofol|propofol|mesh-list
15166120|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15166121|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166122|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166123|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15166124|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
15166125|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
15166126|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15166127|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15166128|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15166129|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15166130|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
15166131|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
15166132|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166133|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166134|NCT04071769|Xenon|xenon|mesh-list
15166135|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15166136|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
15166137|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
15166138|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166139|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166140|NCT04071821|Cetirizine|cetirizine|mesh-list
15166141|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15166142|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15166143|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15166144|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
15166145|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
15166146|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166147|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166148|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166149|NCT04071639|Ubiquinone|ubiquinone|mesh-list
15166150|NCT04071639|Haloperidol|haloperidol|mesh-list
15166151|NCT04071639|Risperidone|risperidone|mesh-list
15166152|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
15166153|NCT04071639|Sertraline|sertraline|mesh-list
15166154|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
15166155|NCT04071639|Idebenone|idebenone|mesh-list
15166156|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15166157|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
15166158|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166159|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166160|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166161|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15166162|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15166163|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166164|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15166165|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15166166|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
15166167|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
15166168|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15166169|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15166170|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14625581|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625582|NCT00130858|Carboplatin|carboplatin|mesh-list
14625583|NCT00130858|Topotecan|topotecan|mesh-list
14625584|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625585|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14625586|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625587|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625588|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625589|NCT00130871|Simendan|simendan|mesh-list
14625590|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14625591|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
14625592|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14625593|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14625594|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166171|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
15166172|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
15166173|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166174|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166175|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15166176|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
15166177|NCT04071639|Protective Agents|protective agents|mesh-ancestor
15166178|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
15166179|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15166180|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
15166181|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15166182|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15166183|NCT04071574|Cetrorelix|cetrorelix|mesh-list
15166184|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15166185|NCT04071574|Hormones|hormones|mesh-ancestor
15166186|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15166187|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625595|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625596|NCT00130871|Protective Agents|protective agents|mesh-ancestor
14625597|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625598|NCT00130884|Simendan|simendan|mesh-list
14625599|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15166188|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
15166189|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15166190|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
15166191|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14022384|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14625600|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
14625601|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14625602|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14625603|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625604|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625605|NCT00130884|Protective Agents|protective agents|mesh-ancestor
14625606|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625607|NCT00130897|Sunitinib|sunitinib|mesh-list
14625608|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625609|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14625610|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14625611|NCT00130897|Growth Substances|growth substances|mesh-ancestor
14625612|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625613|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14625614|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14625615|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625616|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625617|NCT00130910|Albendazole|albendazole|mesh-list
14625618|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
14625619|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14625620|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625621|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
14625622|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14625623|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14625624|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625625|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625626|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625627|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625628|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625629|NCT00130936|Carboplatin|carboplatin|mesh-list
14625630|NCT00130936|Capecitabine|capecitabine|mesh-list
14625631|NCT00130936|Epirubicin|epirubicin|mesh-list
14625632|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625633|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625634|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
14625635|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625636|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625637|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625638|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15166192|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15166193|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15166194|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166195|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15166196|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
15166197|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
15166198|NCT04071262|Prednisolone|prednisolone|mesh-list
15166199|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
14625639|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625640|NCT00130975|Candesartan|candesartan|mesh-list
14625641|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14625642|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14625643|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14625644|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625645|NCT00131027|Cytarabine|cytarabine|mesh-list
14625646|NCT00131027|Dexamethasone|dexamethasone|mesh-list
14625647|NCT00131027|Prednisolone|prednisolone|mesh-list
14625648|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
14625649|NCT00131027|Doxorubicin|doxorubicin|mesh-list
14625650|NCT00131027|Methotrexate|methotrexate|mesh-list
14625651|NCT00131027|Etoposide|etoposide|mesh-list
14625652|NCT00131027|Vincristine|vincristine|mesh-list
14625653|NCT00131027|Daunorubicin|daunorubicin|mesh-list
14625654|NCT00131027|Asparaginase|asparaginase|mesh-list
14625655|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
14625656|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625657|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
14625658|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625659|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625660|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14625661|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
14625662|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625663|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166200|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625664|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14625665|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166201|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
15166202|NCT04071262|Hormones|hormones|mesh-ancestor
14625666|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
14625667|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
14625668|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625669|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625670|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
14625671|NCT00131027|Hormones|hormones|mesh-ancestor
14625672|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625673|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14625674|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625675|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625676|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625677|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625678|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14625679|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
14625680|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14625681|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625682|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
14625683|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625684|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625685|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14625686|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14625687|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
14625688|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625689|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625690|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
15166203|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15166204|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166205|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15166206|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166207|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15166208|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166209|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166210|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
15166211|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15166212|NCT04071353|Interferons|interferons|mesh-list
15166213|NCT04071353|Ribavirin|ribavirin|mesh-list
15166214|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166215|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
15166216|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166217|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
15166218|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625691|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625692|NCT00131040|Aprotinin|aprotinin|mesh-list
14625693|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
14625694|NCT00131040|Coagulants|coagulants|mesh-ancestor
14625695|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14625696|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14625697|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
15166219|NCT04071106|Betamethasone|betamethasone|mesh-list
15166220|NCT04071106|Calcipotriene|calcipotriene|mesh-list
14625698|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625699|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625700|NCT00131053|Cytarabine|cytarabine|mesh-list
14625701|NCT00131053|Dexamethasone|dexamethasone|mesh-list
14625702|NCT00131053|Prednisolone|prednisolone|mesh-list
14625703|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
14625704|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
14625705|NCT00131053|Methotrexate|methotrexate|mesh-list
14625706|NCT00131053|Vincristine|vincristine|mesh-list
14625707|NCT00131053|Asparaginase|asparaginase|mesh-list
14625708|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
14625709|NCT00131053|Pirarubicin|pirarubicin|mesh-list
14625710|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625711|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
15166221|NCT04071106|Petrolatum|petrolatum|mesh-list
15166222|NCT04071106|Turmeric extract|turmeric extract|mesh-list
15166223|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166224|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
15166225|NCT04071106|Hormones|hormones|mesh-ancestor
15166226|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15166227|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166228|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15166229|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
14625712|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625713|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625714|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14625715|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
15166230|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
15166231|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
15166232|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166233|NCT04071106|Protective Agents|protective agents|mesh-ancestor
15166234|NCT04071106|Emollients|emollients|mesh-ancestor
15166235|NCT04070742|Minocycline|minocycline|mesh-list
14625716|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625717|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625718|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14625719|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625720|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
14625721|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
14625722|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625723|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625724|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
14625725|NCT00131053|Hormones|hormones|mesh-ancestor
14625726|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625727|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14625728|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14625729|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
14625730|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14625731|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14625732|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
14625733|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
14625734|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166236|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166237|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166238|NCT04070755|Minocycline|minocycline|mesh-list
15166239|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166240|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166241|NCT04070794|Metformin|metformin|mesh-list
15166242|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15166243|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166244|NCT04070833|Vitamin D|vitamin d|mesh-list
15166245|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
15166246|NCT04070833|Vitamins|vitamins|mesh-list
15166247|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
15166248|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166249|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15166250|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15166251|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
14022385|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
14022386|NCT02768545|Ezetimibe|ezetimibe|mesh-list
14022387|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14022388|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14022389|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
14022390|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022391|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14022392|NCT02768532|Vedolizumab|vedolizumab|mesh-list
14022393|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022394|NCT02768519|OTS167|ots167|mesh-list
14022395|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14022396|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022397|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625735|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625736|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14625737|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
14625738|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625739|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14625740|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625741|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625742|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625743|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
14625744|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14625745|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625746|NCT00131144|Octreotide|octreotide|mesh-list
15166252|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15166253|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
15166254|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15166255|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
15166256|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166257|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
15166258|NCT04070729|Protective Agents|protective agents|mesh-ancestor
14022398|NCT02769078|Warfarin|warfarin|mesh-list
14022399|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
15180943|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022400|NCT02769078|Dabigatran|dabigatran|mesh-list
14625747|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625748|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14625749|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625750|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
14625751|NCT00131183|Androgens|androgens|mesh-ancestor
14625752|NCT00131183|Hormones|hormones|mesh-ancestor
14625753|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625754|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625755|NCT00131235|Azithromycin|azithromycin|mesh-list
14625756|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
14625757|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
14625758|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14625759|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166259|NCT04070495|Clarithromycin|clarithromycin|mesh-list
15166260|NCT04070495|Rifampin|rifampin|mesh-list
15166261|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166262|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166263|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14625760|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166264|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166265|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166266|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15166267|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15166268|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15166269|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
15166270|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
15166271|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15166272|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15166273|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15166274|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15166275|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15166276|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15166277|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15166278|NCT04070469|Amoxicillin|amoxicillin|mesh-list
15166279|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166280|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166281|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
15166282|NCT04070391|Pyridoxal|pyridoxal|mesh-list
15166283|NCT04070391|Pyridoxine|pyridoxine|mesh-list
15166284|NCT04070391|Vitamins|vitamins|mesh-ancestor
14625761|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
14625762|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14625763|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14625764|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625765|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625766|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022401|NCT02769078|Apixaban|apixaban|mesh-list
14625767|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14625768|NCT00131235|Renal Agents|renal agents|mesh-ancestor
14625769|NCT00131261|Dexamethasone|dexamethasone|mesh-list
14625770|NCT00131261|Belinostat|belinostat|mesh-list
14022402|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
14022403|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14022404|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
14022405|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14625771|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14625772|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
14625773|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
15166285|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
15166286|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166287|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
15166288|NCT04070482|Tenofovir|tenofovir|mesh-list
14022406|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
14022407|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022408|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022409|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
14022410|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14022411|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022412|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14022413|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14022414|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14625774|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625775|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166289|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
14625776|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625777|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
14022415|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022416|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
14022417|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625778|NCT00131261|Hormones|hormones|mesh-ancestor
14625779|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625780|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14625781|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166290|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166291|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15166292|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15166293|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166294|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166295|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15166296|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15166297|NCT04070079|Tenofovir|tenofovir|mesh-list
15166298|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
14625782|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14625783|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625784|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625785|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
14625786|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625787|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14625788|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625789|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625790|NCT00131300|Hylan|hylan|mesh-list
14625791|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
14625792|NCT00131300|Protective Agents|protective agents|mesh-ancestor
15166299|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166300|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15166301|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15166302|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166303|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166304|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14625793|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625794|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
14625795|NCT00131313|Rituximab|rituximab|mesh-list
14625796|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625797|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
14625798|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625799|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625800|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14625801|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
14625802|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625803|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166305|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15166306|NCT04070001|Ibuprofen|ibuprofen|mesh-list
15166307|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15166308|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15166309|NCT04070001|Analgesics|analgesics|mesh-ancestor
15166310|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
15166311|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166312|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625804|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15166313|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166314|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15166315|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15166316|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166317|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625805|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14625806|NCT00131326|Hylan|hylan|mesh-list
14625807|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
14625808|NCT00131326|Protective Agents|protective agents|mesh-ancestor
14625809|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625810|NCT00131339|Cycloserine|cycloserine|mesh-list
14625811|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14625812|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625813|NCT00131339|Renal Agents|renal agents|mesh-ancestor
15166318|NCT04069949|Sorafenib|sorafenib|mesh-list
15166319|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166320|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15166321|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022418|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
14625814|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15166322|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166323|NCT04069936|Nivolumab|nivolumab|mesh-list
15166324|NCT04069936|Tadalafil|tadalafil|mesh-list
15166325|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166326|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166327|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15166328|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166329|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
15166330|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15166331|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15166332|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625815|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
14625816|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14625817|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
14625818|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625819|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14625820|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14625821|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14625822|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625823|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625824|NCT00131391|Hormones|hormones|mesh-ancestor
14625825|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625826|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625827|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14625828|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14625829|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14625830|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625831|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625832|NCT00131404|Hormones|hormones|mesh-ancestor
14625833|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625834|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625835|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14625836|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14625837|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14625838|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166333|NCT04069936|Urological Agents|urological agents|mesh-ancestor
15166334|NCT04069845|Doxorubicin|doxorubicin|mesh-list
15166335|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15166336|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15166337|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166338|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15166339|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15166340|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166341|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166342|NCT04069858|Entecavir|entecavir|mesh-list
15166343|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
15166344|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166345|NCT04069234|Clopidogrel|clopidogrel|mesh-list
14625839|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625840|NCT00131430|Hormones|hormones|mesh-ancestor
14625841|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625842|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625843|NCT00131443|Topiramate|topiramate|mesh-list
14625844|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
14625845|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14625846|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625847|NCT00131482|Thrombin|thrombin|mesh-list
14625848|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
14625849|NCT00131482|Coagulants|coagulants|mesh-ancestor
14625850|NCT00131495|Testosterone|testosterone|mesh-list
14625851|NCT00131495|Androgens|androgens|mesh-ancestor
14625852|NCT00131495|Hormones|hormones|mesh-ancestor
14625853|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625854|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625855|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
15166346|NCT04069234|Ticagrelor|ticagrelor|mesh-list
15166347|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14625856|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
14625857|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625858|NCT00131521|Expectorants|expectorants|mesh-ancestor
14625859|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
15166348|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15166349|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15166350|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15166351|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
15166352|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625860|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14625861|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
14625862|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625863|NCT00131521|Protective Agents|protective agents|mesh-ancestor
14625864|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625865|NCT00131703|Chloroquine|chloroquine|mesh-list
14625866|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
14625867|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
14625868|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14625869|NCT00131703|Amodiaquine|amodiaquine|mesh-list
14625870|NCT00131703|Amebicides|amebicides|mesh-ancestor
14625871|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14625872|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14625873|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625874|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
14625875|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625876|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625877|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625878|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625879|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14625880|NCT00131703|Renal Agents|renal agents|mesh-ancestor
14625881|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
14625882|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
14625883|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15166353|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166354|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166355|NCT04069169|Lidocaine|lidocaine|mesh-list
15166356|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
15166357|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
15166358|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166359|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166360|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
15166361|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166362|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15166363|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15166364|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15166365|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15166366|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166367|NCT04069208|Cytarabine|cytarabine|mesh-list
15166368|NCT04069208|Idarubicin|idarubicin|mesh-list
15166369|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15166370|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
14625884|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
14625885|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14625886|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14625887|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625888|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14625889|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625890|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625891|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14625892|NCT00131716|Renal Agents|renal agents|mesh-ancestor
14625893|NCT00131742|Lamivudine|lamivudine|mesh-list
14625894|NCT00131742|Telbivudine|telbivudine|mesh-list
14625895|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14625896|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14625897|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625898|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625899|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
14625900|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625901|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14625902|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14625903|NCT00131755|Diazoxide|diazoxide|mesh-list
14625904|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14625905|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
14625906|NCT00131768|Hylan|hylan|mesh-list
14625907|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
14625908|NCT00131768|Protective Agents|protective agents|mesh-ancestor
15166371|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166372|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166373|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
15166374|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625909|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625910|NCT00131846|Diuretics|diuretics|mesh-list
14625911|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14625912|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
14625913|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625914|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14625915|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166375|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15166376|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
15166377|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625916|NCT00131963|Paclitaxel|paclitaxel|mesh-list
14625917|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
14625918|NCT00131963|Doxorubicin|doxorubicin|mesh-list
14625919|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14625920|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625921|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
14625922|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
14625923|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
14625924|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625925|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14625926|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
14625927|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625928|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14625929|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15166378|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15166379|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15166380|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625930|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
14625931|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14625932|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14625933|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14625934|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625935|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625936|NCT00131989|Sorafenib|sorafenib|mesh-list
14625937|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625938|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14625939|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625940|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625941|NCT00132054|Irinotecan|irinotecan|mesh-list
14625942|NCT00132054|Amrubicin|amrubicin|mesh-list
15166381|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166382|NCT04069325|Febuxostat|febuxostat|mesh-list
15166383|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
15166384|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15166385|NCT04069429|Heparin|heparin|mesh-list
14022419|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14022420|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022421|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022422|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14022423|NCT02768610|Analgesics|analgesics|mesh-ancestor
14625943|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14625944|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625945|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625946|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625947|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625948|NCT00132067|Vorinostat|vorinostat|mesh-list
14625949|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625950|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14625951|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625952|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022424|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
14022425|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625953|NCT00132093|Eplerenone|eplerenone|mesh-list
14625954|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14625955|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
15166386|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
15166387|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15166388|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15166389|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166390|NCT04069286|Amoxicillin|amoxicillin|mesh-list
14625956|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14625957|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625958|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14625959|NCT00132093|Diuretics|diuretics|mesh-ancestor
14625960|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
14625961|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15166391|NCT04069286|Omeprazole|omeprazole|mesh-list
15166392|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166393|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166394|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15166395|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166396|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15166397|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166398|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166399|NCT04069078|Scopolamine|scopolamine|mesh-list
15166400|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15166401|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15166402|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
15166403|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
15166404|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166405|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166406|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14625962|NCT00132106|Phentolamine|phentolamine|mesh-list
14625963|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14625964|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14625965|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
14625966|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625967|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625968|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625969|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14625970|NCT00132119|Nalmefene|nalmefene|mesh-list
14625971|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14625972|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625973|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
14625974|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625975|NCT00132158|Irinotecan|irinotecan|mesh-list
14625976|NCT00132158|Gefitinib|gefitinib|mesh-list
14625977|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14625978|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14625979|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14625980|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14625981|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625982|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14625983|NCT00132184|Vitamin D|vitamin d|mesh-list
15166407|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
15166408|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14625984|NCT00132184|Vitamins|vitamins|mesh-ancestor
14625985|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
14625986|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625987|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15166409|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
15166410|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166411|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166412|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15166413|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
15166414|NCT04069065|Tacrolimus|tacrolimus|mesh-list
15166415|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15166416|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
15166417|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166418|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15166419|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166420|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166421|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
15166422|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15166423|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
15166424|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166425|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166426|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15166427|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
15166428|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15166429|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
15166430|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166431|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14625988|NCT00132210|Interferons|interferons|mesh-list
14625989|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14625990|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
14625991|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14625992|NCT00132236|Nicotine|nicotine|mesh-list
14625993|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14625994|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
14625995|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14625996|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14625997|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14625998|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14625999|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
14626000|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626001|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626002|NCT00132275|Amoxicillin|amoxicillin|mesh-list
14626003|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
14626004|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
14626005|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626006|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626007|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14626008|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626009|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646509|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646510|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646511|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646512|NCT00198198|Aripiprazole|aripiprazole|mesh-list
14646513|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
14646514|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14646515|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14646516|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14646517|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646518|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646519|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
14646520|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
14646521|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646522|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646523|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14646524|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14646525|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
14646526|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14646527|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14646528|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14646529|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14646530|NCT00198237|Docetaxel|docetaxel|mesh-list
14646531|NCT00198237|Capecitabine|capecitabine|mesh-list
14646532|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646533|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646534|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646535|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646536|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646537|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646538|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
14646539|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14646540|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14646541|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14646542|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14646543|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646544|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646545|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646546|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14646547|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
14646548|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14646549|NCT00198354|Gemcitabine|gemcitabine|mesh-list
14646550|NCT00198354|Paclitaxel|paclitaxel|mesh-list
14646551|NCT00198354|Carboplatin|carboplatin|mesh-list
14646552|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14646553|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646554|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646555|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646556|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646557|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646558|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646559|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
14646560|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
14626010|NCT00132379|Docetaxel|docetaxel|mesh-list
14626011|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626012|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
14626013|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626014|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626015|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626016|NCT00132418|Etanercept|etanercept|mesh-list
14626017|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14626018|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14626019|NCT00132418|Analgesics|analgesics|mesh-ancestor
14626020|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
14626021|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626022|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626023|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626024|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626025|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626026|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626027|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
14626028|NCT00132431|Cinacalcet|cinacalcet|mesh-list
14626029|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14626030|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626031|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14626032|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
14626033|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626034|NCT00132444|UC-781|uc-781|mesh-list
14626035|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14626036|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
14626037|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626038|NCT00132535|Chloroquine|chloroquine|mesh-list
14626039|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
14626040|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
14626041|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14626042|NCT00132535|Amebicides|amebicides|mesh-ancestor
14626043|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14626044|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14626045|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626046|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
14626047|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626048|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14626049|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626050|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626051|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14626052|NCT00132535|Renal Agents|renal agents|mesh-ancestor
14626053|NCT00132548|Artesunate|artesunate|mesh-list
14626054|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
14626055|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
14626056|NCT00132548|Amodiaquine|amodiaquine|mesh-list
14626057|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14626058|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
15166432|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15166433|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
15166434|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
15166435|NCT04069052|Protective Agents|protective agents|mesh-ancestor
15166436|NCT04068766|Bupivacaine|bupivacaine|mesh-list
15166437|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
15166438|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
15166439|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166440|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166441|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
15166442|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166443|NCT04068974|Apatinib|apatinib|mesh-list
15166444|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166445|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15166446|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626059|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14626060|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14626061|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626062|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626063|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
14626064|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
14626065|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14626066|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
14626067|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14626068|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626069|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626070|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14626071|NCT00132548|Renal Agents|renal agents|mesh-ancestor
15166447|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166448|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
15166449|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14626072|NCT00132561|Artesunate|artesunate|mesh-list
14626073|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
14626074|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
14626075|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
14626076|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14626077|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14626078|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626079|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626080|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
14626081|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
14626082|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14626083|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
14626084|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14626085|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626086|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626087|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14626088|NCT00132561|Renal Agents|renal agents|mesh-ancestor
14626089|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14626090|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
14626091|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14626092|NCT00132587|Protective Agents|protective agents|mesh-ancestor
14626093|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626094|NCT00132600|Bacitracin|bacitracin|mesh-list
14626095|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15166450|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166451|NCT04068948|Midazolam|midazolam|mesh-list
15166452|NCT04068948|Meperidine|meperidine|mesh-list
15166453|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
15166454|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15166455|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15166456|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166457|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166458|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15166459|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15166460|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15166461|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15166462|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
15166463|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
15166464|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
15166465|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
15166466|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166467|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166468|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15166469|NCT04068948|Narcotics|narcotics|mesh-ancestor
15166470|NCT04068948|Analgesics|analgesics|mesh-ancestor
15166471|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
15166472|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166473|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
15166474|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
15166475|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15166476|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
15166477|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
15166478|NCT04068610|Leucovorin|leucovorin|mesh-list
15166479|NCT04068610|Bevacizumab|bevacizumab|mesh-list
15166480|NCT04068610|Durvalumab|durvalumab|mesh-list
15166481|NCT04068610|Fluorouracil|fluorouracil|mesh-list
15166482|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
15166483|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166484|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166485|NCT04068610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15166486|NCT04068610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15166487|NCT04068610|Growth Substances|growth substances|mesh-ancestor
14626096|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166488|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166489|NCT04068610|Growth Inhibitors|growth inhibitors|mesh-ancestor
15166490|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
15166491|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166492|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15166493|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15166494|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
15166495|NCT04068610|Antidotes|antidotes|mesh-ancestor
15166496|NCT04068610|Protective Agents|protective agents|mesh-ancestor
15166497|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
14626097|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166498|NCT04068610|Vitamins|vitamins|mesh-ancestor
15166499|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
15166500|NCT04068506|Gabapentin|gabapentin|mesh-list
15166501|NCT04068506|Analgesics|analgesics|mesh-ancestor
15166502|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
15166503|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166504|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166505|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
15166506|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15166507|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15166508|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166509|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15166510|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15166511|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15166512|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166513|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166514|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
15166515|NCT04068272|Bosentan|bosentan|mesh-list
15166516|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15166517|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15166518|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166519|NCT04068207|Minocycline|minocycline|mesh-list
15166520|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626098|NCT00132613|Bleomycin|bleomycin|mesh-list
14626099|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14626100|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626101|NCT00132639|Docetaxel|docetaxel|mesh-list
14626102|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626103|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
14626104|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626105|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
15166521|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166522|NCT04068246|Metformin|metformin|mesh-list
15166523|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15166524|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166525|NCT04067986|Apatinib|apatinib|mesh-list
15166526|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166527|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14626106|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626107|NCT00132652|Lamivudine|lamivudine|mesh-list
14626108|NCT00132652|Telbivudine|telbivudine|mesh-list
14626109|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14626110|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14626111|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626112|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626113|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
14626114|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626115|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14626116|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14022426|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14022427|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14022428|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14022429|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
14022430|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022431|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022432|NCT02768493|Ropivacaine|ropivacaine|mesh-list
14022433|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
14022434|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
14022435|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022436|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022437|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
14022438|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022439|NCT02768415|Apatinib|apatinib|mesh-list
14022440|NCT02768415|Vinorelbine|vinorelbine|mesh-list
14626117|NCT00132743|Cilostazol|cilostazol|mesh-list
14626118|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14626119|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
14626120|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626121|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626122|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14626123|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
14626124|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14626125|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14626126|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022441|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626127|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14626128|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
14626129|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14626130|NCT00132743|Protective Agents|protective agents|mesh-ancestor
15166528|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166529|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166530|NCT04067791|Melatonin|melatonin|mesh-list
15166531|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
14626131|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14626132|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14626133|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626134|NCT00132756|Estramustine|estramustine|mesh-list
14626135|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15166532|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166533|NCT04067791|Protective Agents|protective agents|mesh-ancestor
15166534|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166535|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14626136|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
14626137|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626138|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626139|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14626140|NCT00132821|Bupropion|bupropion|mesh-list
14626141|NCT00132821|Nicotine|nicotine|mesh-list
14626142|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14626143|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
14626144|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626145|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626146|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14626147|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14626148|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
14626149|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626150|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626151|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14626152|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
14626153|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15166536|NCT04067817|Phenylephrine|phenylephrine|mesh-list
15166537|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
15166538|NCT04067817|Norepinephrine|norepinephrine|mesh-list
15166539|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15166540|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15166541|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
15166542|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
15166543|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166544|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166545|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
15166546|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
15166547|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
15166548|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15166549|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15166550|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15166551|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
15166552|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166553|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166554|NCT04067817|Protective Agents|protective agents|mesh-ancestor
15166555|NCT04067856|Dexamethasone|dexamethasone|mesh-list
15166556|NCT04067856|Bevacizumab|bevacizumab|mesh-list
15166557|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166558|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166559|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15166560|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15166561|NCT04067856|Growth Substances|growth substances|mesh-ancestor
15166562|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166563|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
15166564|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166565|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
15166566|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
15166567|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166568|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166569|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
15166570|NCT04067856|Hormones|hormones|mesh-ancestor
15166571|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15166572|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15166573|NCT04067531|Clindamycin|clindamycin|mesh-list
15166574|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
15166575|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
15166576|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166577|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166578|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15166579|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166580|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166581|NCT04067518|Pegaspargase|pegaspargase|mesh-list
15166582|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166583|NCT04067115|Alovudine|alovudine|mesh-list
15166584|NCT04067115|Irinotecan|irinotecan|mesh-list
15166585|NCT04067115|Trabectedin|trabectedin|mesh-list
15166586|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15166587|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14626154|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14626155|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14626156|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626157|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
14626158|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14626159|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14626160|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626161|NCT00132860|Azithromycin|azithromycin|mesh-list
14626162|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626163|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626164|NCT00132886|Tolvaptan|tolvaptan|mesh-list
14626165|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14626166|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626167|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
14626168|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626169|NCT00132899|Methotrexate|methotrexate|mesh-list
14626170|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14626171|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
15166588|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166589|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166590|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166591|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15166592|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
15166593|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
15166594|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166595|NCT04067505|Nadroparin|nadroparin|mesh-list
15166596|NCT04067505|Warfarin|warfarin|mesh-list
14626172|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14626173|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626174|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14626175|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
14626176|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626177|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626178|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
14626179|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166597|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
15166598|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
15166599|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15166600|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
15166601|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14626180|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14626181|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626182|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
14626183|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626184|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14626185|NCT00132912|Vorapaxar|vorapaxar|mesh-list
14626186|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14626187|NCT00132925|Triamcinolone|triamcinolone|mesh-list
14626188|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626189|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
14626190|NCT00132925|Hormones|hormones|mesh-ancestor
14626191|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626192|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626193|NCT00132938|Telithromycin|telithromycin|mesh-list
14626194|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626195|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626196|NCT00132951|Azithromycin|azithromycin|mesh-list
14626197|NCT00132951|Telithromycin|telithromycin|mesh-list
14626198|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626199|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626200|NCT00133003|Abciximab|abciximab|mesh-list
14626201|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
15166602|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
14626202|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15166603|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15180944|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14626203|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14626204|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626205|NCT00133042|Omalizumab|omalizumab|mesh-list
14626206|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14626207|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14626208|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
14626209|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
14626210|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
14626211|NCT00133172|Prednisone|prednisone|mesh-list
14626212|NCT00133172|Tacrolimus|tacrolimus|mesh-list
14626213|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626214|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
14626215|NCT00133172|Hormones|hormones|mesh-ancestor
14626216|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626217|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626218|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14626219|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626220|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626221|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
14626222|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14626223|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626224|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626225|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14626226|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14626227|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
14626228|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626229|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626230|NCT00133185|Losartan|losartan|mesh-list
14626231|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14626232|NCT00133185|Telmisartan|telmisartan|mesh-list
14626233|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14626234|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14626235|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14626236|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14626237|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626238|NCT00133185|Diuretics|diuretics|mesh-ancestor
14626239|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
14626240|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626241|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14626242|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15166604|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166605|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15166606|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15166607|NCT04067492|Diclofenac|diclofenac|mesh-list
15166608|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15166609|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14626243|NCT00133198|Pramipexole|pramipexole|mesh-list
14626244|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
14626245|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626246|NCT00133198|Protective Agents|protective agents|mesh-ancestor
14626247|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626248|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14626249|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14626250|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
14626251|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
14626252|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626253|NCT00133224|Prednisone|prednisone|mesh-list
14626254|NCT00133224|Docetaxel|docetaxel|mesh-list
15166610|NCT04067492|Analgesics|analgesics|mesh-ancestor
15166611|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
15166612|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166613|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166614|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166615|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15166616|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15166617|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166618|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626255|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166619|NCT04067024|Anesthetics|anesthetics|mesh-list
15166620|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166621|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166622|NCT04067102|Paclitaxel|paclitaxel|mesh-list
15166623|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15166624|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
14626256|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
15166625|NCT04067102|Carboplatin|carboplatin|mesh-list
15166626|NCT04067102|Epirubicin|epirubicin|mesh-list
15166627|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15166628|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166629|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
15166630|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
15166631|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
15166632|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022442|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14626257|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626258|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626259|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626260|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626261|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
14626262|NCT00133224|Hormones|hormones|mesh-ancestor
14626263|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626264|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626265|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14626266|NCT00133237|Sirolimus|sirolimus|mesh-list
14626267|NCT00133237|Paclitaxel|paclitaxel|mesh-list
14626268|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14626269|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626270|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14626271|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626272|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626273|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626274|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626275|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626276|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14626277|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
14626278|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626279|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
14626280|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626281|NCT00133250|Heparin|heparin|mesh-list
14626282|NCT00133250|Calcium heparin|calcium heparin|mesh-list
14626283|NCT00133250|Abciximab|abciximab|mesh-list
14626284|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
14626285|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14626286|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14626287|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626288|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14626289|NCT00133276|Citalopram|citalopram|mesh-list
14626290|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14626291|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14626292|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626293|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626294|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626295|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
14626296|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022443|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022444|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022445|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14022446|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
14022447|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
14022448|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626297|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14626298|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
14626299|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14626300|NCT00133315|Adalimumab|adalimumab|mesh-list
14626301|NCT00133315|Etanercept|etanercept|mesh-list
14626302|NCT00133315|Infliximab|infliximab|mesh-list
14626303|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626304|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15166633|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15166634|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
15166635|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166636|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15166637|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15166638|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
15166639|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15166640|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15166641|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15166642|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15166643|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166644|NCT04067037|Vincristine|vincristine|mesh-list
15166645|NCT04067037|Epirubicin|epirubicin|mesh-list
15166646|NCT04067037|Dacarbazine|dacarbazine|mesh-list
15166647|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15166648|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166649|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
15166650|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
15166651|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
15166652|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022449|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14626305|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
14626306|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626307|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14626308|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14626309|NCT00133315|Analgesics|analgesics|mesh-ancestor
14626310|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
14626311|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626312|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626313|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626314|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
14626315|NCT00133328|Valsartan|valsartan|mesh-list
14626316|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14626317|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14626318|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14626319|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626320|NCT00133341|Parthenolide|parthenolide|mesh-list
14626321|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14626322|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14626323|NCT00133341|Analgesics|analgesics|mesh-ancestor
14626324|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
14626325|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626326|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626327|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626328|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626329|NCT00133354|Anastrozole|anastrozole|mesh-list
14626330|NCT00133354|Hormones|hormones|mesh-list
14626331|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626332|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626333|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14626334|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626335|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14626336|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14626337|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626338|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626339|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14626340|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
14626341|NCT00133367|Sirolimus|sirolimus|mesh-list
14626342|NCT00133367|Fludarabine|fludarabine|mesh-list
14626343|NCT00133367|Melphalan|melphalan|mesh-list
14626344|NCT00133367|Tacrolimus|tacrolimus|mesh-list
14626345|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
14626346|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14626347|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626348|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626349|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626350|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
14626351|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626352|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14626353|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626354|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626355|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626356|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14626357|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
14626358|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14626359|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
14626360|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14626361|NCT00133380|Atorvastatin|atorvastatin|mesh-list
14626362|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14626363|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14626364|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
14626365|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626366|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14626367|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14626368|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626369|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
14626370|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14626371|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626372|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626373|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14626374|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14626375|NCT00133393|Protective Agents|protective agents|mesh-ancestor
14626376|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626377|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
14626378|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14626379|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
14626380|NCT00133406|Vitamin A|vitamin a|mesh-list
14626381|NCT00133406|Glycine|glycine|mesh-list
14626382|NCT00133406|Vitamins|vitamins|mesh-ancestor
14626383|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
14626384|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626385|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166653|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15166654|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14626386|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
14626387|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626388|NCT00133419|Vitamins|vitamins|mesh-list
14626389|NCT00133419|Vitamin A|vitamin a|mesh-list
14626390|NCT00133419|Zinc|zinc|mesh-list
14626391|NCT00133419|Trace Elements|trace elements|mesh-list
14626392|NCT00133419|Micronutrients|micronutrients|mesh-list
14626393|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
14626394|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626395|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
14626396|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626397|NCT00133419|Protective Agents|protective agents|mesh-ancestor
14626398|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14626399|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626400|NCT00133445|Vaccines|vaccines|mesh-list
14626401|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
14626402|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626403|NCT00133458|Albendazole|albendazole|mesh-list
14626404|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
14626405|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14626406|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626407|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
14626408|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14626409|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14626410|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
14626411|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626412|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626413|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626414|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626415|NCT00133523|Vaccines|vaccines|mesh-list
14626416|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
14626417|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626418|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14626419|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
14626420|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626421|NCT00133562|Glycine|glycine|mesh-list
14626422|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
14626423|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626424|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626425|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626426|NCT00133627|Ketotifen|ketotifen|mesh-list
14626427|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
14626428|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
14626429|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14626430|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
14626431|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
15166655|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15166656|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166657|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15166658|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
15166659|NCT04066803|Folic Acid|folic acid|mesh-list
15166660|NCT04066803|Hematinics|hematinics|mesh-ancestor
15166661|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
15166662|NCT04066803|Vitamins|vitamins|mesh-ancestor
14626432|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626433|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626434|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626435|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15166663|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
15166664|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166665|NCT04066790|Paclitaxel|paclitaxel|mesh-list
15166666|NCT04066790|Trastuzumab|trastuzumab|mesh-list
15166667|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15166668|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166669|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
15166670|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
15166671|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626436|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
14626437|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14626438|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626439|NCT00133640|Vitamins|vitamins|mesh-ancestor
14626440|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
14626441|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14626442|NCT00133692|Atenolol|atenolol|mesh-list
14626443|NCT00133692|Verapamil|verapamil|mesh-list
14626444|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14626445|NCT00133692|Trandolapril|trandolapril|mesh-list
14626446|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15166672|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166673|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166674|NCT04066764|Nadroparin|nadroparin|mesh-list
15166675|NCT04066764|Warfarin|warfarin|mesh-list
15166676|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
15166677|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
15166678|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15166679|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
15166680|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15166681|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
15166682|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166683|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166684|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15166685|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15166686|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
15166687|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166688|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166689|NCT04066881|Vaccines|vaccines|mesh-list
15166690|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
15166691|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180945|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
15180946|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180947|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180948|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15180949|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
15180950|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
15180951|NCT03934333|Hormones|hormones|mesh-ancestor
15180952|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180953|NCT03933982|Vinorelbine|vinorelbine|mesh-list
15180954|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15180955|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15180956|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
15180957|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
15180958|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
15180959|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022450|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626447|NCT00133692|Diuretics|diuretics|mesh-ancestor
14626448|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
14626449|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626450|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15180960|NCT03933865|Ketamine|ketamine|mesh-list
14626451|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626452|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626453|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14626454|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
14626455|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
14626456|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626457|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14626458|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14626459|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14626460|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
14626461|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180961|NCT03933865|Hydromorphone|hydromorphone|mesh-list
14626462|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14626463|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15180962|NCT03933865|Analgesics|analgesics|mesh-ancestor
14626464|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
14626465|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14626466|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
14626467|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626468|NCT00133731|Heparin|heparin|mesh-list
15166692|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
15166693|NCT04066621|Sulbactam|sulbactam|mesh-list
15166694|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166695|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166696|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15166697|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626469|NCT00133731|Calcium heparin|calcium heparin|mesh-list
14626470|NCT00133731|Otamixaban|otamixaban|mesh-list
14626471|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
14626472|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14626473|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14626474|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626475|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14626476|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
15166698|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166699|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15166700|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15166701|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
14626477|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14626478|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
14626479|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626480|NCT00133744|Folic Acid|folic acid|mesh-list
14626481|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
14626482|NCT00133744|Vitamins|vitamins|mesh-ancestor
14626483|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
14626484|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626485|NCT00133744|Hematinics|hematinics|mesh-ancestor
14626486|NCT00133757|Bupropion|bupropion|mesh-list
14626487|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14626488|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
14626489|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14626490|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14626491|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14626492|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626493|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626494|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
14626495|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626496|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626497|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14626498|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14626499|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626500|NCT00133770|Pantoprazole|pantoprazole|mesh-list
14626501|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14626502|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626503|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14626504|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626505|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626506|NCT00133796|Trastuzumab|trastuzumab|mesh-list
14626507|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14626508|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626509|NCT00133822|Risperidone|risperidone|mesh-list
14626510|NCT00133822|Sertraline|sertraline|mesh-list
14626511|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14626512|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
14626513|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166702|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166703|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
15166704|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15166705|NCT04066452|Antibodies|antibodies|mesh-list
15166706|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
15166707|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166708|NCT04066179|Prednisolone|prednisolone|mesh-list
15166709|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166710|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
15166711|NCT04066179|Hormones|hormones|mesh-ancestor
14626514|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626515|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626516|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15166712|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15166713|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626517|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14626518|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14626519|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14626520|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14626521|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
14626522|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
14626523|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14626524|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14626525|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626526|NCT00133848|Retapamulin|retapamulin|mesh-list
14626527|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626528|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626529|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
14626530|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14626531|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626532|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626533|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
14626534|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626535|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626536|NCT00133874|Retapamulin|retapamulin|mesh-list
15166714|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15166715|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166716|NCT04066296|Bupivacaine|bupivacaine|mesh-list
15166717|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
14022451|NCT02768337|Afatinib|afatinib|mesh-list
14022452|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626537|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626538|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166718|NCT04066296|Anesthetics|anesthetics|mesh-list
14022453|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14022454|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022455|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646561|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646562|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646563|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646564|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
14646565|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646566|NCT00198367|Cisplatin|cisplatin|mesh-list
14646567|NCT00198367|Carboplatin|carboplatin|mesh-list
14646568|NCT00198367|Vinorelbine|vinorelbine|mesh-list
14646569|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646570|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646571|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14646572|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646573|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646574|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646575|NCT00198380|Gefitinib|gefitinib|mesh-list
14646576|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646577|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14646578|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646579|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646580|NCT00198393|Gemcitabine|gemcitabine|mesh-list
14646581|NCT00198393|Docetaxel|docetaxel|mesh-list
14646582|NCT00198393|Gefitinib|gefitinib|mesh-list
14646583|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646584|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
14646585|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646586|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646587|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
14646588|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646589|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646590|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646591|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
14646592|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646593|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646594|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
15166719|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166720|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166721|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
15166722|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166723|NCT04066257|Metronidazole|metronidazole|mesh-list
14026089|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14646595|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646596|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15166724|NCT04066257|Tetracycline|tetracycline|mesh-list
14626539|NCT00133887|Sirolimus|sirolimus|mesh-list
14626540|NCT00133887|Cyclosporine|cyclosporine|mesh-list
14626541|NCT00133887|Tacrolimus|tacrolimus|mesh-list
14626542|NCT00133887|Cyclosporins|cyclosporins|mesh-list
14626543|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626544|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
14626545|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626546|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14626547|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626548|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166725|NCT04066257|Bismuth|bismuth|mesh-list
14626549|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14626550|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626551|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14626552|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166726|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166727|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022456|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
14022457|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14022458|NCT02768571|Protective Agents|protective agents|mesh-ancestor
14022459|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626553|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
14626554|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
14626555|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626556|NCT00134030|Interferons|interferons|mesh-list
14626557|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
14626558|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
15166728|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15166729|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14626559|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14626560|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14626561|NCT00134030|Cisplatin|cisplatin|mesh-list
14626562|NCT00134030|Doxorubicin|doxorubicin|mesh-list
14626563|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14626564|NCT00134030|Methotrexate|methotrexate|mesh-list
14626565|NCT00134030|Etoposide|etoposide|mesh-list
14626566|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
14626567|NCT00134030|Ifosfamide|ifosfamide|mesh-list
14626568|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
14626569|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
14626570|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626571|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14626572|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15166730|NCT04066257|Antacids|antacids|mesh-ancestor
15166731|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166732|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166733|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15166734|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166735|NCT04066231|Erythromycin|erythromycin|mesh-list
15166736|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
15166737|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15166738|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
15166739|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
15166740|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166741|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166742|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166743|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15166744|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166745|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166746|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
15166747|NCT04066114|Prednisone|prednisone|mesh-list
15166748|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
15166749|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15166750|NCT04066114|Everolimus|everolimus|mesh-list
15166751|NCT04066114|Abatacept|abatacept|mesh-list
15166752|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
15166753|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15166754|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166755|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
15166756|NCT04066114|Hormones|hormones|mesh-ancestor
14626573|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14626574|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626575|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626576|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15166757|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15166758|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022460|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
14626577|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
14626578|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15166759|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15166760|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166761|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15166762|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
15166763|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15166764|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15166765|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
14626579|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626580|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14626581|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
14626582|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14626583|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14626584|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626585|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
14626586|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626587|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14626588|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15166766|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166767|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626589|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
15166768|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166769|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166770|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
15166771|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
15166772|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166773|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166774|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15166775|NCT04066114|Protective Agents|protective agents|mesh-ancestor
15166776|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15166777|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15166778|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
15166779|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
15166780|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166781|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166782|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166783|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
15166784|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
15166785|NCT04066660|Fucoidan|fucoidan|mesh-list
14626590|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626591|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14626592|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
14626593|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
14626594|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14626595|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626596|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626597|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14626598|NCT00134069|Cetuximab|cetuximab|mesh-list
14626599|NCT00134069|Irinotecan|irinotecan|mesh-list
14626600|NCT00134069|Sorafenib|sorafenib|mesh-list
14626601|NCT00134069|Antibodies|antibodies|mesh-list
14626602|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
14626603|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14626604|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
14626605|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626606|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626607|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14626608|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14626609|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626610|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626611|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14626612|NCT00134095|Irinotecan|irinotecan|mesh-list
14626613|NCT00134095|Tegafur|tegafur|mesh-list
14626614|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14626615|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14626616|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166786|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15166787|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166788|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
15166789|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166790|NCT04066088|Guanfacine|guanfacine|mesh-list
15166791|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15166792|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15166793|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14626617|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626618|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166794|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15166795|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
15166796|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166797|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166798|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166799|NCT04065906|Methylphenidate|methylphenidate|mesh-list
15166800|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15166801|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15166802|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166803|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15166804|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15166805|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15166806|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166807|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
15166808|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166809|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15166810|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
15166811|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
15166812|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15166813|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15166814|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
14626619|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15166815|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166816|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166817|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166818|NCT04065919|Epinephrine|epinephrine|mesh-list
15166819|NCT04065919|Bupivacaine|bupivacaine|mesh-list
15166820|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
15166821|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
15166822|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166823|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166824|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
14626620|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
14626621|NCT00134147|Insulin|insulin|mesh-list
14626622|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14626623|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626624|NCT00134160|Amlodipine|amlodipine|mesh-list
14626625|NCT00134160|Olmesartan|olmesartan|mesh-list
14626626|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14626627|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
14626628|NCT00134160|Calcium|calcium|mesh-list
14626629|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14626630|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626631|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14626632|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626633|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626634|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
14626635|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14626636|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14626637|NCT00134173|Atorvastatin|atorvastatin|mesh-list
14626638|NCT00134173|Torcetrapib|torcetrapib|mesh-list
14626639|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14626640|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14626641|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
15166825|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166826|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15166827|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15166828|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
15166829|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166830|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166831|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15166832|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15166833|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
15166834|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15166835|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
15166836|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
15166837|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
15166838|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15166839|NCT04065932|BMS-986165|bms-986165|mesh-list
15166840|NCT04065932|Famotidine|famotidine|mesh-list
15166841|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14626642|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626643|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14626644|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14626645|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626646|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
15166842|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15166843|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15166844|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
15166845|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
15166846|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166847|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166848|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626647|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626648|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14626649|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
14626650|NCT00134199|Sibutramine|sibutramine|mesh-list
14626651|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
14626652|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14626653|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
14626654|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14626655|NCT00134212|Epinephrine|epinephrine|mesh-list
14626656|NCT00134212|Norepinephrine|norepinephrine|mesh-list
14626657|NCT00134212|Dopexamine|dopexamine|mesh-list
14626658|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14626659|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14626660|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
14626661|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626662|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626663|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166849|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
15166850|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15166851|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166852|NCT04065529|Zinc|zinc|mesh-list
15166853|NCT04065529|Trace Elements|trace elements|mesh-ancestor
15166854|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
15166855|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166856|NCT04065451|Epinephrine|epinephrine|mesh-list
15166857|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14626664|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14626665|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14626666|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
14626667|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626668|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14626669|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
14626670|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
14626671|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
14626672|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14626673|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
14626674|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
14626675|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
14626676|NCT00134290|Metformin|metformin|mesh-list
15166858|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15166859|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
15166860|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166861|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626677|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14626678|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626679|NCT00134303|Metformin|metformin|mesh-list
14626680|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14626681|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626682|NCT00134355|Vatalanib|vatalanib|mesh-list
14626683|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14626684|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626685|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626686|NCT00134368|Etanercept|etanercept|mesh-list
14626687|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14626688|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15166862|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626689|NCT00134368|Analgesics|analgesics|mesh-ancestor
14626690|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
14626691|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626692|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626693|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626694|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626695|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626696|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626697|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
14626698|NCT00134394|Etanercept|etanercept|mesh-list
15166863|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15166864|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15166865|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
15166866|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166867|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14626699|NCT00134394|Tacrolimus|tacrolimus|mesh-list
14626700|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626701|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
14626702|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626703|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14626704|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626705|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626706|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14626707|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14626708|NCT00134394|Analgesics|analgesics|mesh-ancestor
14626709|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
14626710|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626711|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626712|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626713|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626714|NCT00134420|Clonidine|clonidine|mesh-list
14626715|NCT00134420|Mitogens|mitogens|mesh-list
14626716|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626717|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626718|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626719|NCT00134420|Analgesics|analgesics|mesh-ancestor
14626720|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
14626721|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626722|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14626723|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
14626724|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
14626725|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14626726|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14626727|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14626728|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
14626729|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626730|NCT00134485|Atorvastatin|atorvastatin|mesh-list
14626731|NCT00134485|Torcetrapib|torcetrapib|mesh-list
14626732|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14626733|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14626734|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
14626735|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626736|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14626737|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14626738|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626739|NCT00134498|Atorvastatin|atorvastatin|mesh-list
14626740|NCT00134498|Torcetrapib|torcetrapib|mesh-list
14626741|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14626742|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14626743|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
14626744|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626745|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14626746|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14626747|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626748|NCT00134511|Atorvastatin|atorvastatin|mesh-list
14626749|NCT00134511|Torcetrapib|torcetrapib|mesh-list
14626750|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14626751|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14626752|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
14626753|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626754|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14626755|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14626756|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626757|NCT00134550|Atorvastatin|atorvastatin|mesh-list
14626758|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14626759|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14626760|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
14626761|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626762|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14626763|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14626764|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626765|NCT00134641|Gemcitabine|gemcitabine|mesh-list
14626766|NCT00134641|Vinorelbine|vinorelbine|mesh-list
14626767|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14626768|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
14626769|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626770|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626771|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
14626772|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14626773|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626774|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14626775|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
14626776|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626777|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14626778|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
14626779|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626780|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626781|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14626782|NCT00134654|Estrogens|estrogens|mesh-ancestor
14626783|NCT00134654|Hormones|hormones|mesh-ancestor
14626784|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626785|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626786|NCT00134667|Verteporfin|verteporfin|mesh-list
14626787|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14626788|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
15166868|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
15166869|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
15166870|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
15166871|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15166872|NCT04065581|Metformin|metformin|mesh-list
15166873|NCT04065581|Acarbose|acarbose|mesh-list
15166874|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15166875|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166876|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15166877|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166878|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166879|NCT04065555|Cetuximab|cetuximab|mesh-list
15166880|NCT04065555|Avelumab|avelumab|mesh-list
15166881|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15166882|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166883|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166884|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
15166885|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166886|NCT04065230|Tenofovir|tenofovir|mesh-list
15166887|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
15166888|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166889|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15166890|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15166891|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166892|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166893|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15166894|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15166895|NCT04065399|Cobicistat|cobicistat|mesh-list
15166896|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14626789|NCT00134680|Trastuzumab|trastuzumab|mesh-list
15166897|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15166898|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
15166899|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166900|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15166901|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15166902|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166903|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626790|NCT00134680|Letrozole|letrozole|mesh-list
14626791|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14626792|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626793|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14626794|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14626795|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626796|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626797|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14626798|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
14626799|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626800|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626801|NCT00134693|Prednisolone|prednisolone|mesh-list
14626802|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14626803|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
15166904|NCT04065165|Lanreotide|lanreotide|mesh-list
15166905|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166906|NCT04065308|Daratumumab|daratumumab|mesh-list
14022461|NCT02768376|Fentanyl|fentanyl|mesh-list
14022462|NCT02768376|Bupivacaine|bupivacaine|mesh-list
14626804|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15166907|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166908|NCT04065282|Capecitabine|capecitabine|mesh-list
15166909|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
15166910|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14626805|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
14626806|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14626807|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
14626808|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626809|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
14626810|NCT00134693|Hormones|hormones|mesh-ancestor
14626811|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626812|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626813|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14626814|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626815|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
14626816|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
14626817|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626818|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626819|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14626820|NCT00134693|Protective Agents|protective agents|mesh-ancestor
14626821|NCT00134706|Carboplatin|carboplatin|mesh-list
14626822|NCT00134706|Docetaxel|docetaxel|mesh-list
14626823|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626824|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
14626825|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
14626826|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
14626827|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626828|NCT00134745|Estradiol|estradiol|mesh-list
15166911|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
15166912|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166913|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166914|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15166915|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166916|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166917|NCT04065269|Olaparib|olaparib|mesh-list
15166918|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15166919|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626829|NCT00134745|Estrogens|estrogens|mesh-ancestor
14626830|NCT00134745|Hormones|hormones|mesh-ancestor
14626831|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626832|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626833|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14626834|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14626835|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626836|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
14626837|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14626838|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14626839|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14626840|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14626841|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626842|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
14626843|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626844|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166920|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166921|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166922|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
15166923|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15166924|NCT04065035|Protective Agents|protective agents|mesh-ancestor
15166925|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166926|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
15166927|NCT04065009|Ropivacaine|ropivacaine|mesh-list
15166928|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
15166929|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
14626845|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14626846|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626847|NCT00134875|Buprenorphine|buprenorphine|mesh-list
14626848|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14626849|NCT00134875|Naloxone|naloxone|mesh-list
14626850|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14626851|NCT00134875|Narcotics|narcotics|mesh-ancestor
14626852|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14626853|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166930|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166931|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626854|NCT00134875|Analgesics|analgesics|mesh-ancestor
14626855|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
14626856|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626857|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14626858|NCT00134888|Buprenorphine|buprenorphine|mesh-list
14626859|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14626860|NCT00134888|Naloxone|naloxone|mesh-list
14626861|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14626862|NCT00134888|Narcotics|narcotics|mesh-ancestor
14626863|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14626864|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166932|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
15166933|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15166934|NCT04065113|Ethanol|ethanol|mesh-list
15166935|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15166936|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166937|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166938|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166939|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15166940|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
15166941|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15166942|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
14626865|NCT00134888|Analgesics|analgesics|mesh-ancestor
14626866|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
14626867|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626868|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14626869|NCT00134914|Buprenorphine|buprenorphine|mesh-list
14626870|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14626871|NCT00134914|Narcotics|narcotics|mesh-ancestor
14626872|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14626873|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626874|NCT00134914|Analgesics|analgesics|mesh-ancestor
14626875|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
14626876|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626877|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14626878|NCT00134953|Rivastigmine|rivastigmine|mesh-list
14626879|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14626880|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626881|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626882|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
14626883|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626884|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626885|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14626886|NCT00134953|Protective Agents|protective agents|mesh-ancestor
14626887|NCT00134966|Levodopa|levodopa|mesh-list
14626888|NCT00134966|Carbidopa|carbidopa|mesh-list
14626889|NCT00134966|Entacapone|entacapone|mesh-list
14626890|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14626891|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14626892|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
14626893|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626894|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626895|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626896|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14626897|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626898|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14626899|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
14626900|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14626901|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
15166943|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15166944|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166945|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14626902|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626903|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626904|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14626905|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
14626906|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14626907|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14626908|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15166946|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15166947|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166948|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
15166949|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14626909|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
14626910|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626911|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626912|NCT00134992|Prednisolone|prednisolone|mesh-list
14626913|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15166950|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15166951|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
15166952|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15166953|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166954|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166955|NCT04064619|Urological Agents|urological agents|mesh-ancestor
15166956|NCT04064632|Darunavir|darunavir|mesh-list
14626914|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
14626915|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14626916|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
14626917|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14626918|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
14626919|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626920|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
14626921|NCT00134992|Hormones|hormones|mesh-ancestor
14626922|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626923|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626924|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14626925|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626926|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
14626927|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
14626928|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626929|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626930|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14626931|NCT00134992|Protective Agents|protective agents|mesh-ancestor
14626932|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
14626933|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626934|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14626935|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626936|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626937|NCT00135018|Celecoxib|celecoxib|mesh-list
14626938|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14626939|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14626940|NCT00135018|Analgesics|analgesics|mesh-ancestor
14626941|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
14626942|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626943|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626944|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14626945|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14626946|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14626947|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14626948|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14626949|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14626950|NCT00135057|Insulin|insulin|mesh-list
14626951|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14626952|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
14626953|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
14626954|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14626955|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626956|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
14626957|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14626958|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626959|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
14626960|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14626961|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626962|NCT00135096|Insulin|insulin|mesh-list
14626963|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14626964|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
14626965|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
14626966|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14626967|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626968|NCT00135122|Prednisolone|prednisolone|mesh-list
14626969|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14626970|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
14626971|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14626972|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
14626973|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15166957|NCT04064632|Cobicistat|cobicistat|mesh-list
15166958|NCT04064632|Rilpivirine|rilpivirine|mesh-list
15166959|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14626974|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
15166960|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14626975|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15166961|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
15166962|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15166963|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15166964|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15166965|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15166966|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
15166967|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166968|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14626976|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
14626977|NCT00135122|Hormones|hormones|mesh-ancestor
14626978|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14626979|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14626980|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14626981|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626982|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
14626983|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
14626984|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14626985|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14626986|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14626987|NCT00135122|Protective Agents|protective agents|mesh-ancestor
14626988|NCT00135135|Carboplatin|carboplatin|mesh-list
14626989|NCT00135135|Doxorubicin|doxorubicin|mesh-list
14626990|NCT00135135|Irinotecan|irinotecan|mesh-list
14626991|NCT00135135|Etoposide|etoposide|mesh-list
14626992|NCT00135135|Melphalan|melphalan|mesh-list
14626993|NCT00135135|Topotecan|topotecan|mesh-list
14626994|NCT00135135|Gefitinib|gefitinib|mesh-list
15166969|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15166970|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15166971|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15180963|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
15180964|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180965|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180966|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15180967|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15180968|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
15180969|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
15180970|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15180971|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15180972|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15180973|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14626995|NCT00135135|Tretinoin|tretinoin|mesh-list
14626996|NCT00135135|Isotretinoin|isotretinoin|mesh-list
14626997|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14626998|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14626999|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14627000|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14627001|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627002|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627003|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14627004|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14627005|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14627006|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
14627007|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14627008|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627009|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
14627010|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627011|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14627012|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
14627013|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
14627014|NCT00135187|Dexamethasone|dexamethasone|mesh-list
14627015|NCT00135187|Bortezomib|bortezomib|mesh-list
14627016|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627017|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
14627018|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
14627019|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627020|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627021|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14627022|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
14627023|NCT00135187|Hormones|hormones|mesh-ancestor
14627024|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627025|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14627026|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627027|NCT00135304|Vitamin D|vitamin d|mesh-list
14627028|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14627029|NCT00135304|Cinacalcet|cinacalcet|mesh-list
14627030|NCT00135304|Vitamins|vitamins|mesh-ancestor
14627031|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
14627032|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627033|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15166972|NCT04064554|Vaccines|vaccines|mesh-list
15166973|NCT04064554|Immunologic Factors|immunologic factors|mesh-ancestor
15166974|NCT04064554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166975|NCT04064190|Durvalumab|durvalumab|mesh-list
15166976|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15166977|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15166978|NCT04064125|Minocycline|minocycline|mesh-list
15166979|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15166980|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166981|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
15166982|NCT04063839|Grazoprevir|grazoprevir|mesh-list
15166983|NCT04063839|Ledipasvir|ledipasvir|mesh-list
15166984|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
15166985|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15166986|NCT04064138|Anesthetics|anesthetics|mesh-list
15166987|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15166988|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166989|NCT04064073|Metformin|metformin|mesh-list
15166990|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15166991|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166992|NCT04063904|Misoprostol|misoprostol|mesh-list
15166993|NCT04063904|Mifepristone|mifepristone|mesh-list
15166994|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15166995|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
15166996|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15166997|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15166998|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15166999|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15167000|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
15167001|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15167002|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15167003|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15167004|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15167005|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
15167006|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15167007|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15167008|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
15167009|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167010|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
14627034|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14627035|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14627036|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
14627037|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627038|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
14627039|NCT00135317|Hematinics|hematinics|mesh-ancestor
14627040|NCT00135408|Budesonide|budesonide|mesh-list
14627041|NCT00135408|Ipilimumab|ipilimumab|mesh-list
14627042|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14627043|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167011|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15167012|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14627044|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14627045|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627046|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627047|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14627048|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
14627049|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627050|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627051|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14627052|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
14627053|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
14627054|NCT00135408|Hormones|hormones|mesh-ancestor
14627055|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627056|NCT00135434|Ritonavir|ritonavir|mesh-list
14627057|NCT00135434|Lopinavir|lopinavir|mesh-list
14627058|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14627059|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14627060|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14627061|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
15167013|NCT04064060|Luspatercept|luspatercept|mesh-list
15167014|NCT04064060|Hematinics|hematinics|mesh-ancestor
15167015|NCT04063865|Everolimus|everolimus|mesh-list
14627062|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627063|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627064|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14627065|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14627066|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
14627067|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627068|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14627069|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627070|NCT00135473|Insulin|insulin|mesh-list
15167016|NCT04063865|Tacrolimus|tacrolimus|mesh-list
15167017|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15167018|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
15167019|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167020|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15167021|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167022|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167023|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167024|NCT04063683|Paclitaxel|paclitaxel|mesh-list
15167025|NCT04063683|Cisplatin|cisplatin|mesh-list
15167026|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15167027|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167028|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
14627071|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14627072|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14627073|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14627074|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627075|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
14627076|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
14627077|NCT00135499|Prednisone|prednisone|mesh-list
14627078|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
14627079|NCT00135499|Rituximab|rituximab|mesh-list
14627080|NCT00135499|Doxorubicin|doxorubicin|mesh-list
14627081|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14627082|NCT00135499|Vincristine|vincristine|mesh-list
14627083|NCT00135499|Bleomycin|bleomycin|mesh-list
14627084|NCT00135499|Vindesine|vindesine|mesh-list
14627085|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627086|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
14627087|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627088|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627089|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14627090|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
14627091|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627092|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627093|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14627094|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14627095|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14627096|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14627097|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14627098|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627099|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627100|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
14627101|NCT00135499|Hormones|hormones|mesh-ancestor
14627102|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627103|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14627104|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14627105|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14627106|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14627107|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14627108|NCT00135525|Paroxetine|paroxetine|mesh-list
15167029|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
15167030|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167031|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167032|NCT04063527|Paclitaxel|paclitaxel|mesh-list
15167033|NCT04063527|Carboplatin|carboplatin|mesh-list
15167034|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15167035|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167036|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
15167037|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
15167038|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167039|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022463|NCT02768376|Anesthetics|anesthetics|mesh-list
14627109|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14627110|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14627111|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167040|NCT04063540|Amiloride|amiloride|mesh-list
15167041|NCT04063540|Diuretics|diuretics|mesh-ancestor
15167042|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
15167043|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167044|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15167045|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15167046|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167047|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167048|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15167049|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15167050|NCT04063267|Nicotine|nicotine|mesh-list
15167051|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15167052|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
15167053|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167054|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167055|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15167056|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15167057|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
15167058|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167059|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627112|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627113|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627114|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
14627115|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627116|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14627117|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
14627118|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627119|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14627120|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627121|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646597|NCT00198432|Paclitaxel|paclitaxel|mesh-list
14646598|NCT00198432|Vinorelbine|vinorelbine|mesh-list
14646599|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14646600|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646601|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646602|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646603|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646604|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167060|NCT04063449|Endostar protein|endostar protein|mesh-list
15167061|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15167062|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15167063|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15167064|NCT04063449|Growth Substances|growth substances|mesh-ancestor
15167065|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167066|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
15167067|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167068|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167069|NCT04063358|Ranibizumab|ranibizumab|mesh-list
15167070|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15167071|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15167072|NCT04063358|Growth Substances|growth substances|mesh-ancestor
15167073|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646605|NCT00198445|Bromfenac|bromfenac|mesh-list
14646606|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14646607|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14646608|NCT00198445|Analgesics|analgesics|mesh-ancestor
14646609|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
14646610|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646611|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646612|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646613|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646614|NCT00198523|Tobramycin|tobramycin|mesh-list
15167074|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
15167075|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167076|NCT04063189|Clarithromycin|clarithromycin|mesh-list
15167077|NCT04063189|Dexamethasone|dexamethasone|mesh-list
14646615|NCT00198523|Prednisolone|prednisolone|mesh-list
14646616|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14646617|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
14646618|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14646619|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
14646620|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14646621|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
15167078|NCT04063189|Lenalidomide|lenalidomide|mesh-list
15167079|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627122|NCT00135551|Benidipine|benidipine|mesh-list
14627123|NCT00135551|Diuretics|diuretics|mesh-list
14627124|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14627125|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14627126|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14627127|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
14627128|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627129|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627130|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627131|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14627132|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
14627133|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627134|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14627135|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14627136|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
15167080|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
15167081|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
15167082|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167083|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167084|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15167085|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
15167086|NCT04063189|Hormones|hormones|mesh-ancestor
15167087|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167088|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167089|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627137|NCT00135577|Alvimopan|alvimopan|mesh-list
14627138|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14627139|NCT00135603|Amoxicillin|amoxicillin|mesh-list
14627140|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
14627141|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
14627142|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14627143|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627144|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627145|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14627146|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627147|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627148|NCT00135668|Nitroprusside|nitroprusside|mesh-list
14627149|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14627150|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
14627151|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14627152|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627153|NCT00135681|Nedocromil|nedocromil|mesh-list
14627154|NCT00135681|Budesonide|budesonide|mesh-list
14627155|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627156|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14627157|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
14627158|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627159|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627160|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14627161|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
14627162|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
14627163|NCT00135681|Hormones|hormones|mesh-ancestor
14627164|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627165|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14627166|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
14627167|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15167090|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
15167091|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15167092|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15167093|NCT04063189|Growth Substances|growth substances|mesh-ancestor
15167094|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
15167095|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167096|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167097|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15167098|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167099|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167100|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15167101|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15167102|NCT04063163|Carboplatin|carboplatin|mesh-list
15167103|NCT04063163|Etoposide|etoposide|mesh-list
15167104|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167105|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15167106|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14627168|NCT00135720|Etanercept|etanercept|mesh-list
14627169|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14627170|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627171|NCT00135720|Analgesics|analgesics|mesh-ancestor
14627172|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
14627173|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627174|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627175|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627176|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627177|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14627178|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627179|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
14627180|NCT00135733|Alefacept|alefacept|mesh-list
14627181|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
14627182|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
14627183|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627184|NCT00135746|Nicotine|nicotine|mesh-list
14627185|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14627186|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
14627187|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627188|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627189|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14627190|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14627191|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
14627192|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627193|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627194|NCT00135759|Naltrexone|naltrexone|mesh-list
14627195|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14627196|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14627197|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627198|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
14627199|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627200|NCT00135785|Bupropion|bupropion|mesh-list
14627201|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15167107|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15167108|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167109|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167110|NCT04063046|Anesthetics|anesthetics|mesh-list
15167111|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167112|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167113|NCT04063124|Dasatinib|dasatinib|mesh-list
15167114|NCT04063124|Quercetin|quercetin|mesh-list
15167115|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167116|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15167117|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167118|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627202|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
14627203|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627204|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14627205|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15167119|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
15167120|NCT04063124|Protective Agents|protective agents|mesh-ancestor
15167121|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627206|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627207|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627208|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
14627209|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627210|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627211|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14627212|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627213|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627214|NCT00135811|Cyclosporine|cyclosporine|mesh-list
14627215|NCT00135811|Dexamethasone|dexamethasone|mesh-list
14627216|NCT00135811|Cyclosporins|cyclosporins|mesh-list
14627217|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627218|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
14627219|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
14627220|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627221|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167122|NCT04062760|Diuretics|diuretics|mesh-list
15167123|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
15167124|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167125|NCT04062890|Vigabatrin|vigabatrin|mesh-list
15167126|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
15167127|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627222|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14627223|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
14627224|NCT00135811|Hormones|hormones|mesh-ancestor
14627225|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627226|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14627227|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627228|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627229|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627230|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627231|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
14627232|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
14627233|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627234|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14627235|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627236|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14627237|NCT00135824|Povidone|povidone|mesh-list
15167128|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167129|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
14627238|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14627239|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14627240|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
14627241|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
14627242|NCT00135837|Verteporfin|verteporfin|mesh-list
14627243|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14627244|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
14627245|NCT00135863|Tinzaparin|tinzaparin|mesh-list
14627246|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14627247|NCT00135863|Dalteparin|dalteparin|mesh-list
14627248|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
15167130|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167131|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167132|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
15167133|NCT04063033|Hematinics|hematinics|mesh-ancestor
15180974|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180975|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15180976|NCT03933865|Narcotics|narcotics|mesh-ancestor
15180977|NCT03933631|Ofloxacin|ofloxacin|mesh-list
15180978|NCT03933631|Prednisolone|prednisolone|mesh-list
15180979|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
15180980|NCT03933631|Pilocarpine|pilocarpine|mesh-list
15180981|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15180982|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
15180983|NCT03933631|Hormones|hormones|mesh-ancestor
15180984|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15180985|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15180986|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15180987|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627249|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14627250|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15180988|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
15180989|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15180990|NCT03933631|Miotics|miotics|mesh-ancestor
15180991|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15180992|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15180993|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
15180994|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15180995|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15180996|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15180997|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15180998|NCT03933631|Renal Agents|renal agents|mesh-ancestor
15180999|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181000|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15181001|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15181002|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181003|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15181004|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15181005|NCT03933787|Saxagliptin|saxagliptin|mesh-list
15181006|NCT03933787|Incretins|incretins|mesh-ancestor
15181007|NCT03933787|Hormones|hormones|mesh-ancestor
15181008|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181009|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181010|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14627251|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627252|NCT00135876|Dalteparin|dalteparin|mesh-list
14627253|NCT00135876|Tinzaparin|tinzaparin|mesh-list
15181011|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
14627254|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14627255|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
14627256|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14627257|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14627258|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627259|NCT00135902|Progesterone|progesterone|mesh-list
14627260|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14627261|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14627262|NCT00135902|Progestins|progestins|mesh-ancestor
14627263|NCT00135902|Hormones|hormones|mesh-ancestor
14627264|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627265|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627266|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14627267|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
14627268|NCT00135928|Sargramostim|sargramostim|mesh-list
14627269|NCT00135928|Lenograstim|lenograstim|mesh-list
14627270|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
14627271|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627272|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14627273|NCT00135941|Insulin|insulin|mesh-list
14627274|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14627275|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
14627276|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
14627277|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14627278|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627279|NCT00135954|Prednisolone|prednisolone|mesh-list
14627280|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
14627281|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627282|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
14627283|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627284|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627285|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14627286|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
14627287|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627288|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167134|NCT04062695|Tofacitinib|tofacitinib|mesh-list
15167135|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15167136|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167137|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167138|NCT04062656|Leucovorin|leucovorin|mesh-list
14627289|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14627290|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627291|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
14627292|NCT00135954|Hormones|hormones|mesh-ancestor
14627293|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627294|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167139|NCT04062656|Folic Acid|folic acid|mesh-list
15167140|NCT04062656|Docetaxel|docetaxel|mesh-list
14627295|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
14627296|NCT00135967|Prednisone|prednisone|mesh-list
14627297|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
14627298|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14627299|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14627300|NCT00135967|Prednisolone|prednisolone|mesh-list
14627301|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
14627302|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14627303|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
14627304|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627305|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
14627306|NCT00135967|Hormones|hormones|mesh-ancestor
14627307|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627308|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627309|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14627310|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167141|NCT04062656|Fluorouracil|fluorouracil|mesh-list
15167142|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
15167143|NCT04062656|Nivolumab|nivolumab|mesh-list
15167144|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167145|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
15167146|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
15167147|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167148|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167149|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
15167150|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15167151|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627311|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15167152|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
15167153|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167154|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167155|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15167156|NCT04062656|Antidotes|antidotes|mesh-ancestor
15167157|NCT04062656|Protective Agents|protective agents|mesh-ancestor
15167158|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
15167159|NCT04062656|Vitamins|vitamins|mesh-ancestor
15167160|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
15167161|NCT04062656|Hematinics|hematinics|mesh-ancestor
15167162|NCT04062175|Azithromycin|azithromycin|mesh-list
15167163|NCT04062175|Cephalosporins|cephalosporins|mesh-list
15167164|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167165|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167166|NCT04062123|Fentanyl|fentanyl|mesh-list
15167167|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
15167168|NCT04062123|Propofol|propofol|mesh-list
15167169|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15167170|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167171|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167172|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15167173|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
15167174|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
15167175|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167176|NCT04062123|Analgesics|analgesics|mesh-ancestor
15167177|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
15167178|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167179|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15167180|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15167181|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15167182|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
15167183|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167184|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167185|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15167186|NCT04062123|Narcotics|narcotics|mesh-ancestor
15167187|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15167188|NCT04062591|Piroxicam|piroxicam|mesh-list
15167189|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167190|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627312|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14627313|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
14627314|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627315|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627316|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627317|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627318|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
14627319|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
14627320|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627321|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15167191|NCT04062591|Analgesics|analgesics|mesh-ancestor
15167192|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
15167193|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167194|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167195|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167196|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627322|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14627323|NCT00135967|Protective Agents|protective agents|mesh-ancestor
14627324|NCT00135993|Rotigotine|rotigotine|mesh-list
14627325|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
14627326|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
14627327|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627328|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627329|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627330|NCT00136045|Rotigotine|rotigotine|mesh-list
14627331|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
14627332|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
14627333|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627334|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627335|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627336|NCT00136058|Alendronate|alendronate|mesh-list
14627337|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
14627338|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14627339|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627340|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15167197|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15167198|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167199|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627341|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627342|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627343|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14627344|NCT00136110|Valproic Acid|valproic acid|mesh-list
14627345|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
14627346|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627347|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627348|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
14627349|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627350|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627351|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
14627352|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14627353|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627354|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627355|NCT00136175|Gemcitabine|gemcitabine|mesh-list
14627356|NCT00136175|Paclitaxel|paclitaxel|mesh-list
14627357|NCT00136175|Carboplatin|carboplatin|mesh-list
14627358|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14627359|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627360|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
14627361|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
14627362|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
14627363|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627364|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14627365|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
14627366|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
14627367|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627368|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627369|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627370|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
14627371|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627372|NCT00136188|Folic Acid|folic acid|mesh-list
14627373|NCT00136188|Hematinics|hematinics|mesh-ancestor
14627374|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
14627375|NCT00136188|Vitamins|vitamins|mesh-ancestor
14627376|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
14627377|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627378|NCT00136201|Tigecycline|tigecycline|mesh-list
14627379|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627380|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627381|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14627382|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627383|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627384|NCT00136266|Vitamin D|vitamin d|mesh-list
14627385|NCT00136266|Vitamins|vitamins|mesh-list
14627386|NCT00136266|Vitamin A|vitamin a|mesh-list
14627387|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
14627388|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
14627389|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627390|NCT00136266|Trace Elements|trace elements|mesh-ancestor
14627391|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14627392|NCT00136292|Daptomycin|daptomycin|mesh-list
14627393|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627394|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627395|NCT00136344|Levofloxacin|levofloxacin|mesh-list
14627396|NCT00136344|Ofloxacin|ofloxacin|mesh-list
14627397|NCT00136344|Cefuroxime|cefuroxime|mesh-list
14627398|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
14627399|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14627400|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627401|NCT00136344|Renal Agents|renal agents|mesh-ancestor
14627402|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627403|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14627404|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14627405|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627406|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627407|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627408|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14627409|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627410|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
14627411|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14627412|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627413|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
14627414|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14627415|NCT00136383|Paroxetine|paroxetine|mesh-list
14627416|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14627417|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14627418|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627419|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627420|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627421|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627422|NCT00136383|Analgesics|analgesics|mesh-ancestor
14627423|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
14627424|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627425|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
15167200|NCT04062565|Treprostinil|treprostinil|mesh-list
15167201|NCT04062565|Riociguat|riociguat|mesh-list
14627426|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627427|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
14627428|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14627429|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
14627430|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14627431|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14627432|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627433|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627434|NCT00136396|Rituximab|rituximab|mesh-list
14627435|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14627436|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627437|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
14627438|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627439|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627440|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
14627441|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627442|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14627443|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627444|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627445|NCT00136435|Leucovorin|leucovorin|mesh-list
14627446|NCT00136435|Cytarabine|cytarabine|mesh-list
14627447|NCT00136435|Dexamethasone|dexamethasone|mesh-list
14627448|NCT00136435|Prednisone|prednisone|mesh-list
14627449|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
14627450|NCT00136435|Doxorubicin|doxorubicin|mesh-list
14627451|NCT00136435|Methotrexate|methotrexate|mesh-list
14627452|NCT00136435|Vincristine|vincristine|mesh-list
14627453|NCT00136435|Asparaginase|asparaginase|mesh-list
14627454|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
14627455|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627456|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
14627457|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
15167202|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15167203|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
15167204|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167205|NCT04062201|Levofloxacin|levofloxacin|mesh-list
15167206|NCT04062201|Ofloxacin|ofloxacin|mesh-list
15167207|NCT04062201|Isoniazid|isoniazid|mesh-list
15167208|NCT04062201|Linezolid|linezolid|mesh-list
15167209|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
15167210|NCT04062201|Ethambutol|ethambutol|mesh-list
15167211|NCT04062201|Bedaquiline|bedaquiline|mesh-list
15167212|NCT04062201|Clofazimine|clofazimine|mesh-list
15167213|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14627458|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627459|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627460|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14627461|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
14627462|NCT00136435|Hormones|hormones|mesh-ancestor
14627463|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627464|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14627465|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627466|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14627467|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14627468|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14627469|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627470|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627471|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14627472|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
14627473|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15167214|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167215|NCT04062201|Renal Agents|renal agents|mesh-ancestor
15167216|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167217|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15167218|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15167219|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167220|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167221|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167222|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14627474|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14627475|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
14627476|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14627477|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14627478|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627479|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
14627480|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627481|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14627482|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
14627483|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627484|NCT00136435|Antidotes|antidotes|mesh-ancestor
14627485|NCT00136435|Protective Agents|protective agents|mesh-ancestor
14627486|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
14627487|NCT00136435|Vitamins|vitamins|mesh-ancestor
14627488|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
14627489|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14627490|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
14627491|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
14627492|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
14627493|NCT00136448|Cytarabine|cytarabine|mesh-list
14627494|NCT00136448|Interleukin-2|interleukin-2|mesh-list
14627495|NCT00136448|Daunorubicin|daunorubicin|mesh-list
14627496|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14627497|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
14627498|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627499|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627500|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
14627501|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627502|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627503|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
14627504|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627505|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627506|NCT00136448|Analgesics|analgesics|mesh-ancestor
14627507|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
14627508|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627509|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14627510|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14627511|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14627512|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627513|NCT00136461|Tretinoin|tretinoin|mesh-list
14627514|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
14627515|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627516|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
14627517|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14627518|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14627519|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
14627520|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627521|NCT00136474|Amifostine|amifostine|mesh-list
14627522|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14627523|NCT00136474|Protective Agents|protective agents|mesh-ancestor
14627524|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627525|NCT00136487|Celecoxib|celecoxib|mesh-list
14627526|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14627527|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167223|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15167224|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
15167225|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14627528|NCT00136487|Analgesics|analgesics|mesh-ancestor
14627529|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
14627530|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627531|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627532|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627533|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627534|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15167226|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15167227|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
15167228|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15167229|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15167230|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167231|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
15167232|NCT04062370|Ranibizumab|ranibizumab|mesh-list
15167233|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15167234|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14627535|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14627536|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167235|NCT04062370|Growth Substances|growth substances|mesh-ancestor
15167236|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167237|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
15167238|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167239|NCT04062357|Lidocaine|lidocaine|mesh-list
15167240|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
15167241|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
15167242|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167243|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167244|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
15167245|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167246|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15167247|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15167248|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15167249|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167250|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167251|NCT04061824|Olmesartan|olmesartan|mesh-list
15167252|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
15167253|NCT04061824|Giapreza|giapreza|mesh-list
15167254|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15167255|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
15167256|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15167257|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15167258|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15167259|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
15167260|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167261|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15167262|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15167263|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167264|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15167265|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15167266|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15167267|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15167268|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
15167269|NCT04061772|Prednisone|prednisone|mesh-list
15167270|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
15167271|NCT04061772|Etoposide|etoposide|mesh-list
15167272|NCT04061772|Bortezomib|bortezomib|mesh-list
15167273|NCT04061772|Epirubicin|epirubicin|mesh-list
15167274|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15167275|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
14627537|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627538|NCT00136526|Docetaxel|docetaxel|mesh-list
14627539|NCT00136526|Fosfestrol|fosfestrol|mesh-list
14627540|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
14627541|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167276|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627542|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
14627543|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
14627544|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
14627545|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627546|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14627547|NCT00136526|Estrogens|estrogens|mesh-ancestor
14627548|NCT00136526|Hormones|hormones|mesh-ancestor
14627549|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627550|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167277|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167278|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15167279|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
14627551|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14627552|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
14627553|NCT00136539|Doxorubicin|doxorubicin|mesh-list
14627554|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14627555|NCT00136539|Trastuzumab|trastuzumab|mesh-list
15167280|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167281|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627556|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627557|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
14627558|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627559|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627560|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14627561|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
15167282|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15167283|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167284|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
15167285|NCT04061772|Hormones|hormones|mesh-ancestor
14627562|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627563|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627564|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14627565|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14627566|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15167286|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167287|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167288|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15167289|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15167290|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15167291|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167292|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14627567|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14627568|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627569|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14627570|NCT00136552|Rituximab|rituximab|mesh-list
14627571|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14627572|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627573|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
14627574|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627575|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627576|NCT00136565|Prednisone|prednisone|mesh-list
14627577|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
14627578|NCT00136565|Doxorubicin|doxorubicin|mesh-list
14627579|NCT00136565|Bortezomib|bortezomib|mesh-list
14627580|NCT00136565|Bleomycin|bleomycin|mesh-list
14627581|NCT00136565|Vindesine|vindesine|mesh-list
14627582|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15167293|NCT04062019|Aldesleukin|aldesleukin|mesh-list
15167294|NCT04062019|Interleukin-2|interleukin-2|mesh-list
15167295|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167296|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627583|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
14627584|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627585|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627586|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14627587|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
14627588|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627589|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167297|NCT04062019|Analgesics|analgesics|mesh-ancestor
15167298|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
15167299|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627590|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14627591|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14627592|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14627593|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14627594|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627595|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627596|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
14627597|NCT00136565|Hormones|hormones|mesh-ancestor
14627598|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627599|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14627600|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14627601|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
14627602|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
14627603|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
14627604|NCT00136578|Carboplatin|carboplatin|mesh-list
14627605|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627606|NCT00136591|Bortezomib|bortezomib|mesh-list
14627607|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627608|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
14627609|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14627610|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14627611|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627612|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627613|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14627614|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14627615|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627616|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
14627617|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
14627618|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627619|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167300|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627620|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14627621|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14627622|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627623|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
14627624|NCT00136734|Methylphenidate|methylphenidate|mesh-list
14627625|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14627626|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627627|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14627628|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14627629|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627630|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627631|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
14627632|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627633|NCT00136747|Memantine|memantine|mesh-list
14627634|NCT00136747|Bupropion|bupropion|mesh-list
14627635|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14627636|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
14627637|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627638|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14627639|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14627640|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627641|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627642|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
14627643|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627644|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627645|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14627646|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627647|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627648|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14627649|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14627650|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14627651|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15167301|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15167302|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15167303|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
15167304|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167305|NCT04062045|Ropivacaine|ropivacaine|mesh-list
15167306|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
15167307|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
15167308|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167309|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167310|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
15167311|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167312|NCT04061798|Heparin|heparin|mesh-list
15167313|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
15167314|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15167315|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15167316|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167317|NCT04061863|Nivolumab|nivolumab|mesh-list
15167318|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167319|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167320|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15167321|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167322|NCT04062006|Aldesleukin|aldesleukin|mesh-list
15167323|NCT04062006|Interleukin-2|interleukin-2|mesh-list
15167324|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167325|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167326|NCT04062006|Analgesics|analgesics|mesh-ancestor
15167327|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
15167328|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022464|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
14022465|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14022466|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022467|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
14022468|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022469|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14022470|NCT02768376|Narcotics|narcotics|mesh-ancestor
14022471|NCT02768376|Analgesics|analgesics|mesh-ancestor
14022472|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14022473|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14022474|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
14022475|NCT02768363|Valacyclovir|valacyclovir|mesh-list
14022476|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
14627652|NCT00136773|Amlodipine|amlodipine|mesh-list
14627653|NCT00136773|Benazepril|benazepril|mesh-list
15181012|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022477|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627654|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14627655|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14627656|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627657|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627658|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14627659|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627660|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
14627661|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14627662|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
14627663|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627664|NCT00136786|Memantine|memantine|mesh-list
14627665|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14627666|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14627667|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
14627668|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167329|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627669|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167330|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15167331|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15167332|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
15167333|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167334|NCT04061512|Dexamethasone|dexamethasone|mesh-list
15167335|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
15167336|NCT04061512|Rituximab|rituximab|mesh-list
15167337|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15167338|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
15167339|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167340|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167341|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15167342|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
14627670|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627671|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14627672|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14627673|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
14627674|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14627675|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
14627676|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167343|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167344|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167345|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15167346|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167347|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
15167348|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
15167349|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167350|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14627677|NCT00136825|Expectorants|expectorants|mesh-ancestor
14627678|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
14627679|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14627680|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
14627681|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627682|NCT00136825|Protective Agents|protective agents|mesh-ancestor
14627683|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627684|NCT00136825|Antidotes|antidotes|mesh-ancestor
14627685|NCT00136851|Amlodipine|amlodipine|mesh-list
14627686|NCT00136851|Benazepril|benazepril|mesh-list
14627687|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14627688|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14627689|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627690|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627691|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15167351|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
15167352|NCT04061512|Hormones|hormones|mesh-ancestor
15167353|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167354|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167355|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167356|NCT04061655|Iron|iron|mesh-list
15167357|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15167358|NCT04061655|Trace Elements|trace elements|mesh-ancestor
15167359|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
15167360|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167361|NCT04061655|Hematinics|hematinics|mesh-ancestor
15167362|NCT04061447|Clarithromycin|clarithromycin|mesh-list
15167363|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167364|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167365|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14627692|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627693|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
14627694|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14627695|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
14627696|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627697|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14627698|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14627699|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627700|NCT00136942|Atorvastatin|atorvastatin|mesh-list
14627701|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14627702|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14627703|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
14627704|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627705|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14627706|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14627707|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627708|NCT00136968|Voriconazole|voriconazole|mesh-list
14627709|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
14627710|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627711|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14627712|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627713|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627714|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627715|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14627716|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
14627717|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14627718|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167366|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167367|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167368|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15167369|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15167370|NCT04061265|Lidocaine|lidocaine|mesh-list
15167371|NCT04061265|Epinephrine|epinephrine|mesh-list
15167372|NCT04061265|Carticaine|carticaine|mesh-list
15167373|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
15167374|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
15167375|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167376|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167377|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
15167378|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167379|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15167380|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15167381|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15167382|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167383|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167384|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15167385|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14022478|NCT02768077|Melatonin|melatonin|mesh-list
14627719|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14627720|NCT00136981|Atorvastatin|atorvastatin|mesh-list
14627721|NCT00136981|Torcetrapib|torcetrapib|mesh-list
14627722|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14627723|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14627724|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
14627725|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167386|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
15167387|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167388|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14627726|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14627727|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14627728|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627729|NCT00136994|Ziprasidone|ziprasidone|mesh-list
14627730|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14627731|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
15167389|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15167390|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
15167391|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15167392|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
15167393|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
15167394|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
15167395|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15167396|NCT04061538|Zinc|zinc|mesh-list
15167397|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
14627732|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627733|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627734|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627735|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14627736|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14627737|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627738|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627739|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15167398|NCT04061538|Trace Elements|trace elements|mesh-ancestor
15167399|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
15167400|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167401|NCT04061538|Astringents|astringents|mesh-ancestor
15167402|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
15167403|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15167404|NCT04061473|Empagliflozin|empagliflozin|mesh-list
15167405|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15167406|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167407|NCT04061473|Incretins|incretins|mesh-ancestor
15167408|NCT04061473|Hormones|hormones|mesh-ancestor
15167409|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167410|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15167411|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
15167412|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167413|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167414|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15167415|NCT04061200|Empagliflozin|empagliflozin|mesh-list
15167416|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15167417|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167418|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15167419|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167420|NCT04061161|Bromides|bromides|mesh-list
15167421|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
15167422|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15167423|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
15167424|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167425|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167426|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14627740|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
14627741|NCT00137007|Azithromycin|azithromycin|mesh-list
14627742|NCT00137007|Ampicillin|ampicillin|mesh-list
14627743|NCT00137007|Sulbactam|sulbactam|mesh-list
14627744|NCT00137007|Sultamicillin|sultamicillin|mesh-list
14627745|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627746|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627747|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14627748|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627749|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627750|NCT00137020|Ziprasidone|ziprasidone|mesh-list
14627751|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14627752|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
14627753|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627754|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627755|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627756|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14627757|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14627758|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627759|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627760|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14627761|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
14627762|NCT00137033|Celecoxib|celecoxib|mesh-list
14627763|NCT00137033|Naproxen|naproxen|mesh-list
14627764|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14627765|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627766|NCT00137033|Analgesics|analgesics|mesh-ancestor
14627767|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
14627768|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627769|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627770|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627771|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627772|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14627773|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14627774|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627775|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627776|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
14627777|NCT00137059|Acetaminophen|acetaminophen|mesh-list
14627778|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627779|NCT00137059|Analgesics|analgesics|mesh-ancestor
14627780|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
14627781|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627782|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627783|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
14646622|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646623|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
14646624|NCT00198523|Hormones|hormones|mesh-ancestor
14646625|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646626|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646627|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14646628|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646629|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
14646630|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
14646631|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646632|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15167427|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
15167428|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
15167429|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14022479|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
14022480|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646633|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15167430|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
15167431|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167432|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167433|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
15167434|NCT04060888|Ustekinumab|ustekinumab|mesh-list
15167435|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
15167436|NCT04061057|Lidocaine|lidocaine|mesh-list
15167437|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
15167438|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
15167439|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167440|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167441|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
15167442|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167443|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15167444|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15167445|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15167446|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167447|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167448|NCT04061239|Cytarabine|cytarabine|mesh-list
15167449|NCT04061239|Azacitidine|azacitidine|mesh-list
15167450|NCT04061239|Daunorubicin|daunorubicin|mesh-list
15167451|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15167452|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
15167453|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167454|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646634|NCT00198523|Protective Agents|protective agents|mesh-ancestor
14646635|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167455|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
15167456|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646636|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646637|NCT00198536|Ecabet|ecabet|mesh-list
14646638|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646639|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14646640|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14646641|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
14646642|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646643|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646644|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15167457|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15167458|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
15167459|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167460|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167461|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15167462|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15167463|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15167464|NCT04060914|Clopidogrel|clopidogrel|mesh-list
15167465|NCT04060914|Ticagrelor|ticagrelor|mesh-list
15167466|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14646645|NCT00198536|Protective Agents|protective agents|mesh-ancestor
14646646|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167467|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14627784|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
14627785|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627786|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
14627787|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14627788|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14627789|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627790|NCT00137072|Urological Agents|urological agents|mesh-ancestor
14627791|NCT00137085|Ketamine|ketamine|mesh-list
14627792|NCT00137085|Analgesics|analgesics|mesh-ancestor
14627793|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
14627794|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167468|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15167469|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15167470|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
15167471|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167472|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627795|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627796|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14627797|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14627798|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
14627799|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
14627800|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167473|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167474|NCT04060771|Dexamethasone|dexamethasone|mesh-list
15167475|NCT04060771|Palonosetron|palonosetron|mesh-list
15167476|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167477|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
15167478|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
15167479|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167480|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167481|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15167482|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
15167483|NCT04060771|Hormones|hormones|mesh-ancestor
15167484|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167485|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167486|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627801|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14627802|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14627803|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627804|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627805|NCT00137098|Caffeine|caffeine|mesh-list
14627806|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14627807|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627808|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14627809|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627810|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627811|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14627812|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14627813|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
15167487|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15167488|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15167489|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
15167490|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167491|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167492|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
15167493|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15167494|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181013|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181014|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15181015|NCT03933748|Teicoplanin|teicoplanin|mesh-list
15181016|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181017|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181018|NCT03933501|Amoxicillin|amoxicillin|mesh-list
15181019|NCT03933501|Metronidazole|metronidazole|mesh-list
14627814|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627815|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
14627816|NCT00137202|Promethazine|promethazine|mesh-list
14627817|NCT00137202|Ondansetron|ondansetron|mesh-list
14627818|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
14627819|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
14627820|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627821|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627822|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14627823|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
14627824|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14627825|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14627826|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
14627827|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627828|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627829|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14627830|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15167495|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
15167496|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15167497|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
15167498|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167499|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627831|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167500|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15167501|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
15167502|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15167503|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
15167504|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167505|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167506|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15167507|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
15167508|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
15167509|NCT04060979|Protective Agents|protective agents|mesh-ancestor
15167510|NCT04060836|Factor VIII|factor viii|mesh-list
15167511|NCT04060836|Coagulants|coagulants|mesh-ancestor
15167512|NCT04060719|Rifampin|rifampin|mesh-list
15167513|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15167514|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
15167515|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167516|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167517|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
15167518|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15167519|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167520|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167521|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15167522|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15167523|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15167524|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15167525|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15167526|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15167527|NCT04060381|Ibuprofen|ibuprofen|mesh-list
15167528|NCT04060381|Dopamine|dopamine|mesh-list
15167529|NCT04060381|Epinephrine|epinephrine|mesh-list
15167530|NCT04060381|Norepinephrine|norepinephrine|mesh-list
14627832|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627833|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14627834|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14627835|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14627836|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
14627837|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
15167531|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167532|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167533|NCT04060381|Analgesics|analgesics|mesh-ancestor
14627838|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
14627839|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14627840|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
14627841|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
14627842|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14627843|NCT00137254|Insulin|insulin|mesh-list
14627844|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14627845|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627846|NCT00137345|Sirolimus|sirolimus|mesh-list
14627847|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627848|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627849|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14627850|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627851|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
14627852|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14627853|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
15167534|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
14627854|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627855|NCT00137358|Amifostine|amifostine|mesh-list
14627856|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15167535|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167536|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627857|NCT00137358|Protective Agents|protective agents|mesh-ancestor
14627858|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627859|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14627860|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14627861|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14627862|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
14627863|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627864|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627865|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627866|NCT00137397|Urological Agents|urological agents|mesh-ancestor
14627867|NCT00137410|Celecoxib|celecoxib|mesh-list
14627868|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14627869|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627870|NCT00137410|Analgesics|analgesics|mesh-ancestor
14627871|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
14627872|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627873|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627874|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14627875|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14627876|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14627877|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14627878|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627879|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627880|NCT00137462|Atorvastatin|atorvastatin|mesh-list
14627881|NCT00137462|Torcetrapib|torcetrapib|mesh-list
14627882|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14627883|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14627884|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
14627885|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627886|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14627887|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14627888|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627889|NCT00137501|Nifedipine|nifedipine|mesh-list
14627890|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14627891|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627892|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627893|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14627894|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167537|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167538|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167539|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15167540|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167541|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167542|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15167543|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15167544|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
15167545|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167546|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15167547|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14627895|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
14627896|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
14627897|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14627898|NCT00137514|Chloroquine|chloroquine|mesh-list
14627899|NCT00137514|Amodiaquine|amodiaquine|mesh-list
14627900|NCT00137514|Amebicides|amebicides|mesh-ancestor
14627901|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14627902|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14627903|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627904|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
14627905|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167548|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
15167549|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14627906|NCT00137527|Anesthetics|anesthetics|mesh-list
14627907|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627908|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627909|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14627910|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
14627911|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
14627912|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14627913|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
14627914|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15167550|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
15167551|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
15167552|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
14627915|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14627916|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627917|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14627918|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627919|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627920|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14627921|NCT00137553|Renal Agents|renal agents|mesh-ancestor
14627922|NCT00137566|Acetaminophen|acetaminophen|mesh-list
14627923|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14627924|NCT00137566|Analgesics|analgesics|mesh-ancestor
14627925|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
14627926|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627927|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627928|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
14627929|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14627930|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
14627931|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627932|NCT00137657|Trimethoprim|trimethoprim|mesh-list
14627933|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14627934|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
14627935|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14627936|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14627937|NCT00137657|Renal Agents|renal agents|mesh-ancestor
14627938|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
14627939|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14627940|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14627941|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14627942|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627943|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627944|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14627945|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14627946|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14627947|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14627948|NCT00137696|Vaccines|vaccines|mesh-list
14627949|NCT00137696|Immunologic Factors|immunologic factors|mesh-ancestor
14627950|NCT00137696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627951|NCT00137709|Lamotrigine|lamotrigine|mesh-list
14627952|NCT00137709|Valproic Acid|valproic acid|mesh-list
14627953|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
14627954|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14627955|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14627956|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627957|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14627958|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627959|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14627960|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14627961|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627962|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627963|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14627964|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627965|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
14627966|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627967|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
14627968|NCT00137735|Gabapentin|gabapentin|mesh-list
14627969|NCT00137735|Analgesics|analgesics|mesh-ancestor
14627970|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
14627971|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14627972|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14627973|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
14627974|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14627975|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14627976|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627977|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14627978|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14627979|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14022481|NCT02768077|Protective Agents|protective agents|mesh-ancestor
14022482|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022483|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14627980|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14627981|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627982|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
14627983|NCT00137761|Docetaxel|docetaxel|mesh-list
14022484|NCT02768389|Bevacizumab|bevacizumab|mesh-list
14026090|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
14627984|NCT00137761|Gefitinib|gefitinib|mesh-list
14627985|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627986|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14627987|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14627988|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14627989|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14627990|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14627991|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14627992|NCT00137774|Bevacizumab|bevacizumab|mesh-list
14627993|NCT00137774|Temozolomide|temozolomide|mesh-list
14627994|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14627995|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14627996|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14627997|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14627998|NCT00137774|Growth Substances|growth substances|mesh-ancestor
14627999|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628000|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
14628001|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14628002|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
14628003|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628004|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
14628005|NCT00137787|Cefepime|cefepime|mesh-list
14628006|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628007|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628008|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14628009|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628010|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628011|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628012|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628013|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14628014|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14628015|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14628016|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628017|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14628018|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628019|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167553|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15167554|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15167555|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
15167556|NCT04060381|Protective Agents|protective agents|mesh-ancestor
15167557|NCT04060472|Paclitaxel|paclitaxel|mesh-list
15167558|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
15167559|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15167560|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15167561|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167562|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
15167563|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
15167564|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167565|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167566|NCT04060459|Paclitaxel|paclitaxel|mesh-list
15167567|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15167568|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628020|NCT00137813|Bevacizumab|bevacizumab|mesh-list
14628021|NCT00137813|Docetaxel|docetaxel|mesh-list
14628022|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14628023|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628024|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14628025|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14628026|NCT00137813|Growth Substances|growth substances|mesh-ancestor
14628027|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628028|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
14628029|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628030|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628031|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628032|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628033|NCT00137826|Bevacizumab|bevacizumab|mesh-list
15167569|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
15167570|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
15167571|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167572|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167573|NCT04060407|Nivolumab|nivolumab|mesh-list
15167574|NCT04060407|Ipilimumab|ipilimumab|mesh-list
15167575|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167576|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167577|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14628034|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14628035|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14628036|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628037|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15167578|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167579|NCT04060277|Acetic Acid|acetic acid|mesh-list
15167580|NCT04060277|Letermovir|letermovir|mesh-list
15167581|NCT04060277|Vaccines|vaccines|mesh-list
15167582|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
14628038|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14628039|NCT00137826|Growth Substances|growth substances|mesh-ancestor
14628040|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628041|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14628042|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14628043|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628044|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628045|NCT00137852|Celecoxib|celecoxib|mesh-list
14628046|NCT00137852|Irinotecan|irinotecan|mesh-list
14628047|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628048|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14628049|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628050|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628051|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628052|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14628053|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14628054|NCT00137852|Analgesics|analgesics|mesh-ancestor
14628055|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
15167583|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167584|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167585|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167586|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167587|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167588|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167589|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15167590|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
15167591|NCT04060264|Eculizumab|eculizumab|mesh-list
14628056|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628057|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167592|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15167593|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15167594|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
15167595|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167596|NCT04060550|Omalizumab|omalizumab|mesh-list
14628058|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14628059|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628060|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14628061|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14628062|NCT00137995|Cytarabine|cytarabine|mesh-list
14628063|NCT00137995|Dexamethasone|dexamethasone|mesh-list
14628064|NCT00137995|Rituximab|rituximab|mesh-list
14628065|NCT00137995|Etoposide|etoposide|mesh-list
14628066|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
14628067|NCT00137995|Melphalan|melphalan|mesh-list
14628068|NCT00137995|Ifosfamide|ifosfamide|mesh-list
14628069|NCT00137995|Carboplatin|carboplatin|mesh-list
14628070|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14628071|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
14628072|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
14628073|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628074|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628075|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14628076|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
14628077|NCT00137995|Hormones|hormones|mesh-ancestor
14628078|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14628079|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167597|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15167598|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15167599|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
15167600|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15167601|NCT04059770|Amphotericin B|amphotericin b|mesh-list
15167602|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
14628080|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628081|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167603|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628082|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
15167604|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14628083|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628084|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14628085|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14628086|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628087|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628088|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628089|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628090|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
14628091|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
14628092|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628093|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628094|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14628095|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
14628096|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14628097|NCT00138060|Fluorouracil|fluorouracil|mesh-list
14628098|NCT00138060|Irinotecan|irinotecan|mesh-list
14628099|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
14628100|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167605|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15167606|NCT04059770|Amebicides|amebicides|mesh-ancestor
15167607|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167608|NCT04060043|Goserelin|goserelin|mesh-list
15167609|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167610|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167611|NCT04060095|Anesthetics|anesthetics|mesh-list
15167612|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167613|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167614|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
15167615|NCT04060017|Leucovorin|leucovorin|mesh-list
15167616|NCT04060017|Calcium|calcium|mesh-list
15167617|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
15167618|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14628101|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628102|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628103|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628104|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
14628105|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628106|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14628107|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628108|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628109|NCT00138099|Dalteparin|dalteparin|mesh-list
14628110|NCT00138099|Tinzaparin|tinzaparin|mesh-list
14628111|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14628112|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
14628113|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14628114|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14628115|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628116|NCT00138112|Vancomycin|vancomycin|mesh-list
14628117|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628118|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628119|NCT00138138|Methylphenidate|methylphenidate|mesh-list
15167619|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167620|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15167621|NCT04060017|Antidotes|antidotes|mesh-ancestor
15167622|NCT04060017|Protective Agents|protective agents|mesh-ancestor
15167623|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
14628120|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14628121|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628122|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14628123|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14628124|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14628125|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628126|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
14628127|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167624|NCT04060017|Vitamins|vitamins|mesh-ancestor
15167625|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
15167626|NCT04059887|Atezolizumab|atezolizumab|mesh-list
15167627|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167628|NCT04059978|Remifentanil|remifentanil|mesh-list
15167629|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15167630|NCT04059978|Narcotics|narcotics|mesh-ancestor
15167631|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14628128|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
15167632|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167633|NCT04059978|Analgesics|analgesics|mesh-ancestor
15167634|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
14628129|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628130|NCT00138177|Leucovorin|leucovorin|mesh-list
14628131|NCT00138177|Fluorouracil|fluorouracil|mesh-list
14628132|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
14628133|NCT00138177|Vorinostat|vorinostat|mesh-list
14628134|NCT00138177|Calcium|calcium|mesh-list
14628135|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
14628136|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14628137|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628138|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
14628139|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628140|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628141|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628142|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628143|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
14628144|NCT00138177|Antidotes|antidotes|mesh-ancestor
15167635|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167636|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
15167637|NCT04060030|Leucovorin|leucovorin|mesh-list
15167638|NCT04060030|Calcium|calcium|mesh-list
15167639|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
15167640|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15167641|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167642|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15167643|NCT04060030|Antidotes|antidotes|mesh-ancestor
15167644|NCT04060030|Protective Agents|protective agents|mesh-ancestor
15167645|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
15167646|NCT04060030|Vitamins|vitamins|mesh-ancestor
15167647|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
15167648|NCT04059679|Aspirin|aspirin|mesh-list
15167649|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
15167650|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167651|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167652|NCT04059679|Analgesics|analgesics|mesh-ancestor
15167653|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
15167654|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167655|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167656|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167657|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167658|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15167659|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15167660|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167661|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15167662|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15167663|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167664|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
15167665|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15167666|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
15167667|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15167668|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
15167669|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
15167670|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
15167671|NCT04059445|Calcium|calcium|mesh-list
15167672|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15167673|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167674|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15167675|NCT04059536|Aspirin|aspirin|mesh-list
15167676|NCT04059536|Heparin|heparin|mesh-list
15167677|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167678|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167679|NCT04059536|Analgesics|analgesics|mesh-ancestor
15167680|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
15167681|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167682|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167683|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167684|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167685|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15167686|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15167687|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167688|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15167689|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15167690|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167691|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
14628145|NCT00138177|Protective Agents|protective agents|mesh-ancestor
14628146|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
14628147|NCT00138177|Vitamins|vitamins|mesh-ancestor
15167692|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
15167693|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
15167694|NCT04059458|Calcium|calcium|mesh-list
15167695|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15167696|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167697|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15167698|NCT04059523|Tretinoin|tretinoin|mesh-list
15167699|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167700|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
15167701|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
15167702|NCT04059224|Trametinib|trametinib|mesh-list
15167703|NCT04059224|Dabrafenib|dabrafenib|mesh-list
15167704|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167705|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15167706|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167707|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167708|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
15167709|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167710|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167711|NCT04059198|Tenofovir|tenofovir|mesh-list
15167712|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
15167713|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167714|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15167715|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15167716|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167717|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167718|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15167719|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15167720|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
15167721|NCT04058899|Nalbuphine|nalbuphine|mesh-list
15167722|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15167723|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167724|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167725|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167726|NCT04058899|Analgesics|analgesics|mesh-ancestor
15167727|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
15167728|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167729|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15167730|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15167731|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15167732|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
15167733|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167734|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167735|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15167736|NCT04058899|Narcotics|narcotics|mesh-ancestor
15167737|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
15167738|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167739|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167740|NCT04059172|Ibuprofen|ibuprofen|mesh-list
15167741|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167742|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167743|NCT04059172|Analgesics|analgesics|mesh-ancestor
14628148|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
15167744|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
15167745|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167746|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167747|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167748|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167749|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15167750|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167751|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181020|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181021|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181022|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14628149|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14628150|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628151|NCT00138216|Irinotecan|irinotecan|mesh-list
14628152|NCT00138216|Vincristine|vincristine|mesh-list
14628153|NCT00138216|Temozolomide|temozolomide|mesh-list
14628154|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14628155|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628156|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628157|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628158|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628159|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15181023|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15181024|NCT03933397|Morphine|morphine|mesh-list
14628160|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628161|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628162|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628163|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14628164|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
14628165|NCT00138229|Aldesleukin|aldesleukin|mesh-list
14628166|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
14628167|NCT00138229|Fludarabine|fludarabine|mesh-list
15167752|NCT04058522|Triamcinolone|triamcinolone|mesh-list
15167753|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167754|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
15167755|NCT04058522|Hormones|hormones|mesh-ancestor
15167756|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167757|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167758|NCT04058678|Danazol|danazol|mesh-list
15167759|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15167760|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
15167761|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167762|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167763|NCT04058717|Nicotine|nicotine|mesh-list
15167764|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15167765|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
15167766|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167767|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167768|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15167769|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15167770|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
15167771|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167772|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167773|NCT04058743|Cobalt|cobalt|mesh-list
15167774|NCT04058743|Chromium|chromium|mesh-list
15167775|NCT04058743|Nickel|nickel|mesh-list
15167776|NCT04058743|Trace Elements|trace elements|mesh-ancestor
15167777|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
15167778|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167779|NCT04058236|Polygeline|polygeline|mesh-list
15167780|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
15167781|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
15167782|NCT04058145|Plerixafor|plerixafor|mesh-list
15167783|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
15167784|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167785|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167786|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15167787|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15167788|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
15167789|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167790|NCT04058210|Ivacaftor|ivacaftor|mesh-list
15167791|NCT04058210|Elexacaftor|elexacaftor|mesh-list
15167792|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15167793|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167794|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167795|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
15167796|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167797|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
15167798|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15167799|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15167800|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167801|NCT04058132|Urological Agents|urological agents|mesh-ancestor
15167802|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
15167803|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15167804|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15167805|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15167806|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167807|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167808|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
15167809|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167810|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167811|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15167812|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167813|NCT04058054|Histamine|histamine|mesh-list
15167814|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
15167815|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
15167816|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167817|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167818|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167819|NCT04057989|Ketamine|ketamine|mesh-list
14628168|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
15167820|NCT04057989|Analgesics|analgesics|mesh-ancestor
15167821|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
15167822|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167823|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167824|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15167825|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15167826|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
15167827|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
15167828|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167829|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15167830|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14628169|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628170|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
14628171|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628172|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628173|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14628174|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
14628175|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628176|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628177|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15167831|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167832|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167833|NCT04057365|Nivolumab|nivolumab|mesh-list
15167834|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15167835|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167836|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15167837|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628178|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628179|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
14628180|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15167838|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15167839|NCT04057456|Nabilone|nabilone|mesh-list
15167840|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
15167841|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
15167842|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167843|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167844|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15167845|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15167846|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15167847|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15167848|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14628181|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14628182|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
14628183|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628184|NCT00138242|Carboplatin|carboplatin|mesh-list
14628185|NCT00138242|Docetaxel|docetaxel|mesh-list
14628186|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167849|NCT04057261|Liraglutide|liraglutide|mesh-list
15167850|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15167851|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167852|NCT04057261|Incretins|incretins|mesh-ancestor
14628187|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628188|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628189|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167853|NCT04057261|Hormones|hormones|mesh-ancestor
15167854|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167855|NCT04057300|Aspirin|aspirin|mesh-list
15167856|NCT04057300|Clopidogrel|clopidogrel|mesh-list
15167857|NCT04057300|Ticagrelor|ticagrelor|mesh-list
15167858|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167859|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167860|NCT04057300|Analgesics|analgesics|mesh-ancestor
15167861|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
15167862|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628190|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628191|NCT00138359|Niclosamide|niclosamide|mesh-list
14628192|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
14628193|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14628194|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
14628195|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14628196|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628197|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
15167863|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167864|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167865|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628198|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
14628199|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628200|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628201|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14628202|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628203|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628204|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628205|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628206|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14628207|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14628208|NCT00138515|Vildagliptin|vildagliptin|mesh-list
15167866|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15167867|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15167868|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167869|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15167870|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15167871|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167872|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
15167873|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15167874|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14628209|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628210|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628211|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628212|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628213|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628214|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628215|NCT00138541|Vildagliptin|vildagliptin|mesh-list
14628216|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628217|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628218|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628219|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628220|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628221|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628222|NCT00138554|Pioglitazone|pioglitazone|mesh-list
14628223|NCT00138554|Vildagliptin|vildagliptin|mesh-list
14628224|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628225|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628226|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628227|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
15167875|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15167876|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
15167877|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167878|NCT04057326|Pancreatin|pancreatin|mesh-list
15167879|NCT04057326|Pancrelipase|pancrelipase|mesh-list
14628228|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628229|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628230|NCT00138567|Vildagliptin|vildagliptin|mesh-list
14628231|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628232|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167880|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15167881|NCT04057482|Dequalinium|dequalinium|mesh-list
15167882|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15167883|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167884|NCT04056923|Methylene Blue|methylene blue|mesh-list
15167885|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167886|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167887|NCT04056949|Paclitaxel|paclitaxel|mesh-list
15167888|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15167889|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15167890|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167891|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
15167892|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
15167893|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167894|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167895|NCT04056897|Teriflunomide|teriflunomide|mesh-list
15167896|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167897|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167898|NCT04056897|Analgesics|analgesics|mesh-ancestor
15167899|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
15167900|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167901|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167902|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167903|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167904|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15167905|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
15167906|NCT04057014|Amoxicillin|amoxicillin|mesh-list
15167907|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167908|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167909|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15167910|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15167911|NCT04056975|Antibodies|antibodies|mesh-list
15167912|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
15167913|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167914|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
14628233|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628234|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628235|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628236|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628237|NCT00138580|Vildagliptin|vildagliptin|mesh-list
14628238|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15167915|NCT04056806|Terlipressin|terlipressin|mesh-list
15167916|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15167917|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167918|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15167919|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15181025|NCT03933397|Hydromorphone|hydromorphone|mesh-list
14628239|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628240|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628241|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628242|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628243|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628244|NCT00138593|Vildagliptin|vildagliptin|mesh-list
14628245|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628246|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628247|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628248|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628249|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628250|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646647|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646648|NCT00198562|Losartan|losartan|mesh-list
14646649|NCT00198562|Amlodipine|amlodipine|mesh-list
14646650|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
14646651|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14646652|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14646653|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646654|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14646655|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646656|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
14646657|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14646658|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14646659|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14646660|NCT00198588|Argatroban|argatroban|mesh-list
14646661|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
14646662|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14646663|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
14646664|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646665|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646666|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
14646667|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14646668|NCT00198601|Gentamicins|gentamicins|mesh-list
14646669|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181026|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15181027|NCT03933397|Narcotics|narcotics|mesh-ancestor
15181028|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181029|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181030|NCT03933397|Analgesics|analgesics|mesh-ancestor
15181031|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
15181032|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181033|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
15181034|NCT03933280|Nalbuphine|nalbuphine|mesh-list
15181035|NCT03933280|Propofol|propofol|mesh-list
15181036|NCT03933280|Benoxinate|benoxinate|mesh-list
15181037|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15181038|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
15181039|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181040|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181041|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15181042|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15167920|NCT04056845|Acetaminophen|acetaminophen|mesh-list
15167921|NCT04056845|Diclofenac|diclofenac|mesh-list
15167922|NCT04056845|Analgesics|analgesics|mesh-list
15167923|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15167924|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15167925|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
15167926|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15167927|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167928|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167929|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167930|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15167931|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167932|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167933|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
15167934|NCT04056650|Caffeine|caffeine|mesh-list
15167935|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14628251|NCT00138606|Vildagliptin|vildagliptin|mesh-list
14628252|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628253|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628254|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628255|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628256|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628257|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628258|NCT00138619|Vildagliptin|vildagliptin|mesh-list
14628259|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628260|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628261|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14628262|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628263|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628264|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628265|NCT00138632|Vatalanib|vatalanib|mesh-list
14628266|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14628267|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628268|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628269|NCT00138710|Letrozole|letrozole|mesh-list
14628270|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628271|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14628272|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14628273|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167936|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167937|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15167938|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167939|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167940|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15167941|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15167942|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
15167943|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15167944|NCT04056754|Prednisone|prednisone|mesh-list
14628274|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628275|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14628276|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
14628277|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14628278|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628279|NCT00138736|Lectins|lectins|mesh-list
14628280|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
14628281|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
14628282|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628283|NCT00138736|Coagulants|coagulants|mesh-ancestor
14628284|NCT00138801|Doxycycline|doxycycline|mesh-list
14628285|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
14628286|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628287|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628288|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
14628289|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15167945|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
15167946|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15167947|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
15167948|NCT04056754|Hormones|hormones|mesh-ancestor
15167949|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15167950|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167951|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15167952|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167953|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14628290|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15167954|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167955|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167956|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
15167957|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15167958|NCT04056442|Cannabidiol|cannabidiol|mesh-list
15167959|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
15167960|NCT04056325|Ivermectin|ivermectin|mesh-list
15167961|NCT04056325|Moxidectin|moxidectin|mesh-list
15167962|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15167963|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15167964|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
15167965|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
15167966|NCT04056702|Ivacaftor|ivacaftor|mesh-list
15167967|NCT04056702|Elexacaftor|elexacaftor|mesh-list
15167968|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15167969|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15167970|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167971|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14628291|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
15167972|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
15167973|NCT04056039|Colchicine|colchicine|mesh-list
15167974|NCT04056039|Atorvastatin|atorvastatin|mesh-list
15167975|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15167976|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14628292|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15167977|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
14628293|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14628294|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628295|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14628296|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628297|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14628298|NCT00138944|Eplerenone|eplerenone|mesh-list
14628299|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14628300|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
14628301|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14628302|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628303|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14628304|NCT00138944|Diuretics|diuretics|mesh-ancestor
14628305|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
14628306|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14628307|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
14628308|NCT00138970|Cyclosporine|cyclosporine|mesh-list
14628309|NCT00138970|Prednisolone|prednisolone|mesh-list
14628310|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14628311|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
14628312|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14628313|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
14628314|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14628315|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
14628316|NCT00138970|Daclizumab|daclizumab|mesh-list
14628317|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14628318|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
14628319|NCT00138970|Hormones|hormones|mesh-ancestor
14628320|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14628321|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628322|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14628323|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628324|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
14628325|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
14628326|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628327|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14628328|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14628329|NCT00138970|Protective Agents|protective agents|mesh-ancestor
14628330|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14628331|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14628332|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
14628333|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628334|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628335|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628336|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628337|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
15167978|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167979|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14628338|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
15181043|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
14022485|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14022486|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022487|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14022488|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14022489|NCT02768389|Growth Substances|growth substances|mesh-ancestor
14022490|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022491|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
14022492|NCT02768220|Empagliflozin|empagliflozin|mesh-list
14022493|NCT02768220|Linagliptin|linagliptin|mesh-list
14628339|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628340|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
14628341|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628342|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14628343|NCT00138983|Vitamin D|vitamin d|mesh-list
14628344|NCT00138983|Alendronate|alendronate|mesh-list
14628345|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
14628346|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14628347|NCT00138983|Vitamins|vitamins|mesh-ancestor
14628348|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
14628349|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15167980|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15167981|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167982|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
15167983|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15167984|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
15167985|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
15167986|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
15167987|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15167988|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
15167989|NCT04056143|Apixaban|apixaban|mesh-list
15167990|NCT04056143|Edoxaban|edoxaban|mesh-list
15167991|NCT04056143|Dabigatran|dabigatran|mesh-list
15167992|NCT04056143|Thromboplastin|thromboplastin|mesh-list
15167993|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15167994|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
15167995|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15167996|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
15167997|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15167998|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15167999|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
15168000|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
15168001|NCT04056143|Coagulants|coagulants|mesh-ancestor
15168002|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15168003|NCT04056169|Ezetimibe|ezetimibe|mesh-list
15168004|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15168005|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15168006|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
15168007|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168008|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15168009|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15168010|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168011|NCT04056000|Caffeine|caffeine|mesh-list
15168012|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15168013|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168014|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15168015|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168016|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168017|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15168018|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15168019|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
15168020|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168021|NCT04055480|Insulin|insulin|mesh-list
14022494|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15168022|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14628350|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14628351|NCT00139009|Cyclosporine|cyclosporine|mesh-list
14628352|NCT00139009|Cyclosporins|cyclosporins|mesh-list
14628353|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628354|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628355|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628356|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
14628357|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628358|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
14628359|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168023|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
15168024|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
15168025|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628360|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14628361|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628362|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14628363|NCT00139035|Cyclosporine|cyclosporine|mesh-list
14628364|NCT00139035|Cyclosporins|cyclosporins|mesh-list
14628365|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628366|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628367|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628368|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
14628369|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628370|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
14628371|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628372|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
14628373|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628374|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14628375|NCT00139061|Atorvastatin|atorvastatin|mesh-list
14628376|NCT00139061|Torcetrapib|torcetrapib|mesh-list
14628377|NCT00139061|Fenofibrate|fenofibrate|mesh-list
14628378|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14628379|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14628380|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
14628381|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628382|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14628383|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14628384|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628385|NCT00139074|Valproic Acid|valproic acid|mesh-list
15168026|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168027|NCT04055506|Ritonavir|ritonavir|mesh-list
15168028|NCT04055506|BMS-986165|bms-986165|mesh-list
15168029|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15168030|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15168031|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
15168032|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168033|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168034|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15168035|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15168036|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
15168037|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168038|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15168039|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15168040|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
14628386|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14628387|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
14628388|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15168041|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15168042|NCT04055623|Aldesleukin|aldesleukin|mesh-list
15168043|NCT04055623|Interleukin-2|interleukin-2|mesh-list
15168044|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168045|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168046|NCT04055623|Analgesics|analgesics|mesh-ancestor
15168047|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
15168048|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168049|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168050|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14628389|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14628390|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14628391|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168051|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15168052|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
15168053|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168054|NCT04055649|Paclitaxel|paclitaxel|mesh-list
15168055|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14628392|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628393|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
14628394|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628395|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628396|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
14628397|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628398|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
14628399|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
14628400|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14628401|NCT00139152|Omalizumab|omalizumab|mesh-list
15168056|NCT04055649|TIC10 compound|tic10 compound|mesh-list
14628402|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14628403|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15168057|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15168058|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628404|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
14628405|NCT00139165|Budesonide|budesonide|mesh-list
14628406|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14628407|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14628408|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
15168059|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
15168060|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
15168061|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
15168062|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168063|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
15168064|NCT04055415|Expectorants|expectorants|mesh-list
15168065|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
15168066|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168067|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168068|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15168069|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
15168070|NCT04054960|Levodopa|levodopa|mesh-list
15168071|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15168072|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15168073|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
15168074|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628409|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628410|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628411|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14628412|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
14628413|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
14628414|NCT00139165|Hormones|hormones|mesh-ancestor
14628415|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14628416|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
14628417|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14628418|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628419|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
14628420|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14628421|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
14628422|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628423|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628424|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14628425|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
14628426|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14628427|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
14628428|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628429|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628430|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14628431|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
14628432|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
14628433|NCT00139217|Protective Agents|protective agents|mesh-ancestor
14628434|NCT00139230|Leucovorin|leucovorin|mesh-list
14628435|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
14628436|NCT00139230|Fluorouracil|fluorouracil|mesh-list
14628437|NCT00139230|Docetaxel|docetaxel|mesh-list
14628438|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628439|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
14628440|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628441|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628442|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628443|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
14628444|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628445|NCT00139230|Antidotes|antidotes|mesh-ancestor
15168075|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168076|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168077|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
15168078|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15168079|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15168080|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168081|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
15168082|NCT04055194|Coagulants|coagulants|mesh-ancestor
15168083|NCT04055142|Cidofovir|cidofovir|mesh-list
15168084|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
15168085|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168086|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628446|NCT00139230|Protective Agents|protective agents|mesh-ancestor
14628447|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
15168087|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168088|NCT04055233|Biguanides|biguanides|mesh-list
14628448|NCT00139230|Vitamins|vitamins|mesh-ancestor
14628449|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
14628450|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628451|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628452|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628453|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628454|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628455|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14628456|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628457|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628458|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14628459|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14628460|NCT00139243|Leucovorin|leucovorin|mesh-list
14628461|NCT00139243|Fluorouracil|fluorouracil|mesh-list
14628462|NCT00139243|Docetaxel|docetaxel|mesh-list
14628463|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628464|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
14628465|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628466|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628467|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628468|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
14628469|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628470|NCT00139243|Antidotes|antidotes|mesh-ancestor
14628471|NCT00139243|Protective Agents|protective agents|mesh-ancestor
14628472|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
14628473|NCT00139243|Vitamins|vitamins|mesh-ancestor
14628474|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
15168089|NCT04055233|Polihexanide|polihexanide|mesh-list
15168090|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168091|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
15168092|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168093|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181044|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181045|NCT03933280|Analgesics|analgesics|mesh-ancestor
15181046|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
15181047|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181048|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15181049|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15181050|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15181051|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
15181052|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181053|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181054|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15181055|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15181056|NCT03933280|Narcotics|narcotics|mesh-ancestor
15181057|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
15181058|NCT03933605|Midazolam|midazolam|mesh-list
15181059|NCT03933605|Palonosetron|palonosetron|mesh-list
14628475|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628476|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628477|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628478|NCT00139256|Betamethasone|betamethasone|mesh-list
14628479|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14628480|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
14628481|NCT00139256|Hormones|hormones|mesh-ancestor
14628482|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181060|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15181061|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15181062|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181063|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181064|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15181065|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15181066|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15181067|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15181068|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
15181069|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
15181070|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
15181071|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
15181072|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181073|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181074|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
15181075|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
14628483|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628484|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15181076|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181077|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15181078|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14628485|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
15168094|NCT04054830|Diclofenac|diclofenac|mesh-list
14628486|NCT00139269|Docetaxel|docetaxel|mesh-list
14628487|NCT00139269|Fluorouracil|fluorouracil|mesh-list
14628488|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628489|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628490|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628491|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628492|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628493|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
14628494|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628495|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628496|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
14628497|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628498|NCT00139282|Squalamine|squalamine|mesh-list
14628499|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628500|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628501|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14628502|NCT00139282|Protective Agents|protective agents|mesh-ancestor
14628503|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628504|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628505|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14628506|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15168095|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14628507|NCT00139282|Growth Substances|growth substances|mesh-ancestor
14628508|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
14628509|NCT00139360|Bevacizumab|bevacizumab|mesh-list
14628510|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14628511|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628512|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14628513|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14628514|NCT00139360|Growth Substances|growth substances|mesh-ancestor
14628515|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628516|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
14628517|NCT00139373|Donepezil|donepezil|mesh-list
14628518|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14628519|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628520|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628521|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
14628522|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628523|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628524|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
14628525|NCT00139386|Candesartan|candesartan|mesh-list
14628526|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14628527|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14628528|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14628529|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628530|NCT00139516|Nicotine|nicotine|mesh-list
14628531|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14628532|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
14628533|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628534|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628535|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14628536|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14628537|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
14628538|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628539|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628540|NCT00139555|Amlodipine|amlodipine|mesh-list
14628541|NCT00139555|Benazepril|benazepril|mesh-list
14628542|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15168096|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168097|NCT04054830|Analgesics|analgesics|mesh-ancestor
14628543|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15168098|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
15168099|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168100|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168101|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168102|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15168103|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15168104|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168105|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168106|NCT04054531|Paclitaxel|paclitaxel|mesh-list
15168107|NCT04054531|Carboplatin|carboplatin|mesh-list
15168108|NCT04054531|Pemetrexed|pemetrexed|mesh-list
15168109|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14628544|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15168110|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168111|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
15168112|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
15168113|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
15168114|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168115|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168116|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15168117|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15168118|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
14628545|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628546|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14628547|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628548|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
14628549|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14628550|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628551|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168119|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15168120|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15168121|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168122|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
15168123|NCT04054687|Coagulants|coagulants|mesh-ancestor
15168124|NCT04054635|Fluorides|fluorides|mesh-list
15168125|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
15168126|NCT04054635|Protective Agents|protective agents|mesh-ancestor
14628552|NCT00139568|Tegaserod|tegaserod|mesh-list
14628553|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14628554|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
14628555|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168127|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168128|NCT04054518|Durvalumab|durvalumab|mesh-list
15168129|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14628556|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628557|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628558|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
14628559|NCT00139581|Tacrolimus|tacrolimus|mesh-list
15168130|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168131|NCT04054362|Gemcitabine|gemcitabine|mesh-list
14628560|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14628561|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14628562|NCT00139581|Analgesics|analgesics|mesh-ancestor
14628563|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
14628564|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628565|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628566|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14628567|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628568|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
14628569|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168132|NCT04054362|Paclitaxel|paclitaxel|mesh-list
15168133|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15168134|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15168135|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168136|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
15168137|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
15168138|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
15168139|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168140|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14628570|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
14628571|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14628572|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628573|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628574|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14628575|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628576|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14628577|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628578|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628579|NCT00139633|Carboplatin|carboplatin|mesh-list
14628580|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628581|NCT00139646|Diclofenac|diclofenac|mesh-list
14628582|NCT00139646|Parecoxib|parecoxib|mesh-list
14628583|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14628584|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14628585|NCT00139646|Analgesics|analgesics|mesh-ancestor
15168141|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
15168142|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
15168143|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628586|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
14628587|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628588|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628589|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14628590|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628591|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14628592|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628593|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628594|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15168144|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168145|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168146|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
15168147|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168148|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15168149|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168150|NCT04054206|Ibudilast|ibudilast|mesh-list
15168151|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15168152|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
15168153|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168154|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168155|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15168156|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
15168157|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15168158|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168159|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628595|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14628596|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
14628597|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
14628598|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14628599|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628600|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14628601|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14628602|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14628603|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14628604|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628605|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14628606|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14628607|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14628608|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15168160|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15168161|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
15168162|NCT04054024|Erenumab|erenumab|mesh-list
15168163|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15168164|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168165|NCT04054024|Analgesics|analgesics|mesh-ancestor
15168166|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
15168167|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168168|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168169|NCT04054089|Tenofovir|tenofovir|mesh-list
15168170|NCT04054089|Lamivudine|lamivudine|mesh-list
15168171|NCT04054089|Emtricitabine|emtricitabine|mesh-list
15168172|NCT04054089|Dolutegravir|dolutegravir|mesh-list
15168173|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
15168174|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168175|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14628609|NCT00139698|Olmesartan|olmesartan|mesh-list
14628610|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14628611|NCT00139698|Diuretics|diuretics|mesh-ancestor
14628612|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
14628613|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628614|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15168176|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15168177|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022495|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628615|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14628616|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628617|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14628618|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14628619|NCT00139711|Docetaxel|docetaxel|mesh-list
14628620|NCT00139711|Irinotecan|irinotecan|mesh-list
15168178|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168179|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14628621|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628622|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628623|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628624|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628625|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628626|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14628627|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628628|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628629|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14628630|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14628631|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14628632|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
14628633|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628634|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628635|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628636|NCT00139724|Urological Agents|urological agents|mesh-ancestor
14628637|NCT00139750|Varenicline|varenicline|mesh-list
14628638|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14628639|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14628640|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
14628641|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628642|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628643|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628644|NCT00139815|Enoxaparin|enoxaparin|mesh-list
14628645|NCT00139815|PENTA|penta|mesh-list
14628646|NCT00139815|Fondaparinux|fondaparinux|mesh-list
14628647|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
14628648|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14628649|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14628650|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628651|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14628652|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
14628653|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14628654|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628655|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628656|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14628657|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14628658|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
14628659|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628660|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628661|NCT00139854|Alprazolam|alprazolam|mesh-list
14628662|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14628663|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14628664|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628665|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14628666|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14628667|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14628668|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
14628669|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
14628670|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628671|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628672|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14628673|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14628674|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
14628675|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628676|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14628677|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14628678|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
14628679|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
14628680|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628681|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628682|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14628683|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14628684|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
14628685|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628686|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14628687|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14628688|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
14628689|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
14628690|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628691|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628692|NCT00139893|Metoclopramide|metoclopramide|mesh-list
14628693|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
14628694|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
14628695|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628696|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628697|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14628698|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14628699|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14628700|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
14628701|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628702|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628703|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
14628704|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14628705|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
14628706|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14628707|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628708|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14628709|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
14628710|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14628711|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14628712|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14628713|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
14628714|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628715|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628716|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
14628717|NCT00140010|Hematinics|hematinics|mesh-ancestor
14628718|NCT00140023|Azithromycin|azithromycin|mesh-list
14628719|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628720|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628721|NCT00140062|Latanoprost|latanoprost|mesh-list
14628722|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14628723|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14628724|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
14628725|NCT00140075|Epirubicin|epirubicin|mesh-list
14628726|NCT00140075|Taxane|taxane|mesh-list
14628727|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628728|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
14628729|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628730|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628731|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14628732|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
14628733|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168180|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15168181|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15168182|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14628734|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628735|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14628736|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14628737|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14628738|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628739|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646670|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646671|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14646672|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646673|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646674|NCT00198614|Metoprolol|metoprolol|mesh-list
14646675|NCT00198614|Carvedilol|carvedilol|mesh-list
14646676|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14646677|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15168183|NCT04054063|Etomidate|etomidate|mesh-list
15168184|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15168185|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168186|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168187|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168188|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
15168189|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
15168190|NCT04053959|Insulin|insulin|mesh-list
15168191|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15168192|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168193|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022496|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14646678|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
14646679|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
14646680|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646681|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646682|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14646683|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15168194|NCT04053972|Lenvatinib|lenvatinib|mesh-list
15168195|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628740|NCT00140101|Paclitaxel|paclitaxel|mesh-list
14628741|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14628742|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628743|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628744|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628745|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628746|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628747|NCT00140114|Misoprostol|misoprostol|mesh-list
14628748|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14628749|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
14628750|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14628751|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628752|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14628753|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14628754|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
14628755|NCT00140153|Testosterone|testosterone|mesh-list
14628756|NCT00140153|Androgens|androgens|mesh-ancestor
14628757|NCT00140153|Hormones|hormones|mesh-ancestor
14628758|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14628759|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628760|NCT00140166|Pyridoxine|pyridoxine|mesh-list
14628761|NCT00140166|Niacinamide|niacinamide|mesh-list
14628762|NCT00140166|Niacin|niacin|mesh-list
14628763|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
14628764|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
14628765|NCT00140166|Vitamins|vitamins|mesh-ancestor
14628766|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
14628767|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628768|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14628769|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
14628770|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628771|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14628772|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
14628773|NCT00140218|Pramipexole|pramipexole|mesh-list
14628774|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
14628775|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628776|NCT00140218|Protective Agents|protective agents|mesh-ancestor
14628777|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168196|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15168197|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168198|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168199|NCT04054115|Alprostadil|alprostadil|mesh-list
15168200|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14628778|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14628779|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14628780|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
14628781|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
14628782|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168201|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
15168202|NCT04054115|Urological Agents|urological agents|mesh-ancestor
15168203|NCT04054128|Heparin|heparin|mesh-list
15168204|NCT04054128|Calcium heparin|calcium heparin|mesh-list
14628783|NCT00140257|Citalopram|citalopram|mesh-list
14628784|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14628785|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14628786|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14628787|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628788|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628789|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
14628790|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628791|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14628792|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
14628793|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14628794|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
14628795|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14628796|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628797|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
14628798|NCT00140309|Rifampin|rifampin|mesh-list
14628799|NCT00140309|Isoniazid|isoniazid|mesh-list
14628800|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
14628801|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628802|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628803|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14628804|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628805|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168205|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
15168206|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14628806|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628807|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628808|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14628809|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
14628810|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
14628811|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14628812|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14628813|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14628814|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14628815|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14628816|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14628817|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14628818|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14628819|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14628820|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
14628821|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14628822|NCT00140361|Artesunate|artesunate|mesh-list
14628823|NCT00140361|Lumefantrine|lumefantrine|mesh-list
14628824|NCT00140361|Artemether|artemether|mesh-list
14628825|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
14628826|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
14628827|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14628828|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
14628829|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14628830|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14628831|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628832|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628833|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
14628834|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
14628835|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14628836|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
14628837|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14628838|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628839|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628840|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14628841|NCT00140361|Renal Agents|renal agents|mesh-ancestor
14628842|NCT00140452|Thalidomide|thalidomide|mesh-list
14628843|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628844|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
14628845|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628846|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
14628847|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628848|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628849|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14628850|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14628851|NCT00140452|Growth Substances|growth substances|mesh-ancestor
14628852|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
14628853|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628854|NCT00140465|Clopidogrel|clopidogrel|mesh-list
14628855|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14628856|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14628857|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14628858|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15168207|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15168208|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168209|NCT04053985|Lenvatinib|lenvatinib|mesh-list
15168210|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168211|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15168212|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168213|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168214|NCT04053712|Glucagon|glucagon|mesh-list
15168215|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15168216|NCT04053712|Hormones|hormones|mesh-ancestor
14628859|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
14628860|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628861|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628862|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628863|NCT00140478|Mifepristone|mifepristone|mesh-list
14628864|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14628865|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
14628866|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14628867|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628868|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15181079|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14628869|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14628870|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14628871|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
14628872|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14628873|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14628874|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
14628875|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14628876|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
14628877|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14628878|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14628879|NCT00140517|Chloroquine|chloroquine|mesh-list
14628880|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
14628881|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
14628882|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14628883|NCT00140517|Amebicides|amebicides|mesh-ancestor
14628884|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14628885|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14628886|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628887|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
14628888|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628889|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14628890|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628891|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628892|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14628893|NCT00140517|Renal Agents|renal agents|mesh-ancestor
14628894|NCT00140530|Sirolimus|sirolimus|mesh-list
14628895|NCT00140530|Paclitaxel|paclitaxel|mesh-list
14628896|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14628897|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628898|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
14628899|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
14628900|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
14628901|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628902|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628903|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628904|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14628905|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
14628906|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628907|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
14628908|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628909|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
14628910|NCT00140543|Sirolimus|sirolimus|mesh-list
14628911|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14628912|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628913|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14628914|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
14628915|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14628916|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628917|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628918|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628919|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
14628920|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628921|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
14628922|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628923|NCT00140569|Interferons|interferons|mesh-list
14628924|NCT00140569|Fludarabine|fludarabine|mesh-list
14628925|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628926|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
14628927|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14628928|NCT00140582|Rituximab|rituximab|mesh-list
14628929|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15168217|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168218|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168219|NCT04053699|Factor VIII|factor viii|mesh-list
15168220|NCT04053699|Coagulants|coagulants|mesh-ancestor
15168221|NCT04053621|Thiamine|thiamine|mesh-list
15168222|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
15168223|NCT04053621|Metformin|metformin|mesh-list
15168224|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168225|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168226|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
15168227|NCT04053621|Vitamins|vitamins|mesh-ancestor
14628930|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628931|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
14628932|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168228|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
15168229|NCT04053543|CXA-10|cxa-10|mesh-list
14628933|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628934|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
15168230|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168231|NCT04053400|Ketamine|ketamine|mesh-list
15168232|NCT04053400|Analgesics|analgesics|mesh-ancestor
15168233|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
15168234|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168235|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168236|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15168237|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168238|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
15168239|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
15168240|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168241|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15168242|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15168243|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168244|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168245|NCT04053491|Anesthetics|anesthetics|mesh-list
15168246|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168247|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168248|NCT04053140|Penicillins|penicillins|mesh-list
15168249|NCT04053140|Penicillin G|penicillin g|mesh-list
15168250|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
15168251|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
15168252|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15168253|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168254|NCT04052932|Allopurinol|allopurinol|mesh-list
15168255|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
15168256|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168257|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168258|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
15168259|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15168260|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14628935|NCT00140595|Rituximab|rituximab|mesh-list
14628936|NCT00140595|Doxorubicin|doxorubicin|mesh-list
14628937|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14628938|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
14628939|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628940|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628941|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14628942|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
14628943|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628944|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628945|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14628946|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14628947|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14628948|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14628949|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14628950|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628951|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
14628952|NCT00140647|Ramipril|ramipril|mesh-list
14628953|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14628954|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628955|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14628956|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628957|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628958|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628959|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14628960|NCT00140660|Rituximab|rituximab|mesh-list
14628961|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14628962|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628963|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
14628964|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628965|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14628966|NCT00140712|Ropinirole|ropinirole|mesh-list
14628967|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14628968|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14628969|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
14628970|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
14628971|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14628972|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628973|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628974|NCT00140725|Interferons|interferons|mesh-list
14628975|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
15168261|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
14628976|NCT00140725|Lamivudine|lamivudine|mesh-list
15168262|NCT04052932|Protective Agents|protective agents|mesh-ancestor
15168263|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181080|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
15181081|NCT03933293|Ezetimibe|ezetimibe|mesh-list
15181082|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14628977|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
14628978|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628979|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
14628980|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181083|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15181084|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
14628981|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
14628982|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14628983|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14628984|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14628985|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628986|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628987|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14628988|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15181085|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181086|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15181087|NCT03933345|Naloxone|naloxone|mesh-list
15181088|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15181089|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181090|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
15181091|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181092|NCT03933358|Hormones|hormones|mesh-list
15181093|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181094|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181095|NCT03933319|Doxorubicin|doxorubicin|mesh-list
15181096|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15181097|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15181098|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14628989|NCT00140751|Ritonavir|ritonavir|mesh-list
14628990|NCT00140751|Lopinavir|lopinavir|mesh-list
14628991|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14628992|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14628993|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
14628994|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14628995|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14628996|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14628997|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14628998|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
14628999|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629000|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14629001|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14629002|NCT00140764|Metronidazole|metronidazole|mesh-list
14629003|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629004|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14629005|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14629006|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14629007|NCT00140790|Valsartan|valsartan|mesh-list
14629008|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14629009|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14629010|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14629011|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629012|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14629013|NCT00140803|Verteporfin|verteporfin|mesh-list
14629014|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629015|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
14629016|NCT00140803|Hormones|hormones|mesh-ancestor
14629017|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629018|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629019|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15181099|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15181100|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14629020|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
14629021|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14629022|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
14629023|NCT00140868|Phenobarbital|phenobarbital|mesh-list
14629024|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
14629025|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14629026|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181101|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182333|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629027|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629028|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14629029|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14629030|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629031|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629032|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
15168264|NCT04052711|Minocycline|minocycline|mesh-list
15168265|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15168266|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629033|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
14629034|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14629035|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14629036|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14629037|NCT00140894|Rofecoxib|rofecoxib|mesh-list
14629038|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629039|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629040|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629041|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14629042|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14629043|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629044|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629045|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629046|NCT00140894|Analgesics|analgesics|mesh-ancestor
14629047|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
14629048|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629049|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629050|NCT00140920|Diclofenac|diclofenac|mesh-list
14629051|NCT00140920|Rofecoxib|rofecoxib|mesh-list
14629052|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629053|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629054|NCT00140920|Analgesics|analgesics|mesh-ancestor
14629055|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
14629056|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629057|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629058|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629059|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629060|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14629061|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629062|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629063|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14629064|NCT00140933|Diclofenac|diclofenac|mesh-list
14629065|NCT00140933|Rofecoxib|rofecoxib|mesh-list
14629066|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629067|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629068|NCT00140933|Analgesics|analgesics|mesh-ancestor
14629069|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
14629070|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629071|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629072|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629073|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629074|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14629075|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629076|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629077|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14629078|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14629079|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14629080|NCT00140998|Estradiol|estradiol|mesh-list
14629081|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14629082|NCT00140998|Estrogens|estrogens|mesh-ancestor
14629083|NCT00140998|Hormones|hormones|mesh-ancestor
14629084|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629085|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629086|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14629087|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
14629088|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14629089|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14629090|NCT00141011|Ancrod|ancrod|mesh-list
14629091|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
15168267|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
15168268|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629092|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14629093|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14646684|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15168269|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14629094|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629095|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14629096|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14629097|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629098|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14629099|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14629100|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629101|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629102|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
14629103|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629104|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14629105|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14629106|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629107|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14629108|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14629109|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629110|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629111|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
14629112|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629113|NCT00141089|Tegaserod|tegaserod|mesh-list
14629114|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15168270|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168271|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168272|NCT04052867|Lidocaine|lidocaine|mesh-list
15168273|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168274|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
15168275|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168276|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168277|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
15168278|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168279|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14629115|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
14629116|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629117|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629118|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629119|NCT00141141|Atorvastatin|atorvastatin|mesh-list
14629120|NCT00141141|Simvastatin|simvastatin|mesh-list
14629121|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14629122|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14629123|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
14629124|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629125|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14629126|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14629127|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629128|NCT00141154|Celecoxib|celecoxib|mesh-list
14629129|NCT00141154|Loxoprofen|loxoprofen|mesh-list
14629130|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629131|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629132|NCT00141154|Analgesics|analgesics|mesh-ancestor
14629133|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
14629134|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629135|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629136|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629137|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629138|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14629139|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14629140|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629141|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629142|NCT00141167|Varenicline|varenicline|mesh-list
14629143|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14629144|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14629145|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629146|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629147|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629148|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629149|NCT00141193|Celecoxib|celecoxib|mesh-list
14629150|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629151|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629152|NCT00141193|Analgesics|analgesics|mesh-ancestor
14629153|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
14629154|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629155|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629156|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629157|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629158|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14629159|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14629160|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629161|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629162|NCT00141206|Varenicline|varenicline|mesh-list
14629163|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14629164|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14629165|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629166|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629167|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629168|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629169|NCT00141232|Atorvastatin|atorvastatin|mesh-list
14629170|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14629171|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14629172|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
14629173|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629174|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14629175|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15168280|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15168281|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15168282|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15168283|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168284|NCT04053205|Paclitaxel|paclitaxel|mesh-list
15168285|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15168286|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168287|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
15168288|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
15168289|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
14629176|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629177|NCT00141245|Pregabalin|pregabalin|mesh-list
14629178|NCT00141245|Analgesics|analgesics|mesh-ancestor
14629179|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
14629180|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629181|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629182|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
14629183|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629184|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629185|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629186|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629187|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15168290|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168291|NCT04052776|Levodopa|levodopa|mesh-list
15168292|NCT04052776|Carbidopa|carbidopa|mesh-list
15168293|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15168294|NCT04052776|Buspirone|buspirone|mesh-list
15168295|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15168296|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14629188|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629189|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629190|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629191|NCT00141258|Pregabalin|pregabalin|mesh-list
14629192|NCT00141258|Analgesics|analgesics|mesh-ancestor
14629193|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
14629194|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629195|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629196|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
14629197|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629198|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629199|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629200|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629201|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629202|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629203|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629204|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629205|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
14629206|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168297|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
15168298|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168299|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168300|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168301|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15168302|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168303|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15168304|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15168305|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629207|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
14629208|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14629209|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15168306|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15168307|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15168308|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
15168309|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15168310|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
15168311|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
15168312|NCT04052659|Azacitidine|azacitidine|mesh-list
15168313|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15168314|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
15168315|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168316|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629210|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629211|NCT00141310|Urological Agents|urological agents|mesh-ancestor
14629212|NCT00141336|Pregabalin|pregabalin|mesh-list
14629213|NCT00141336|Analgesics|analgesics|mesh-ancestor
14629214|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
14629215|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629216|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629217|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
14629218|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629219|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629220|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629221|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15168317|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168318|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
15168319|NCT04052269|Tadalafil|tadalafil|mesh-list
14629222|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629223|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629224|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629225|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629226|NCT00141362|Pregabalin|pregabalin|mesh-list
14629227|NCT00141362|Analgesics|analgesics|mesh-ancestor
14629228|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
14629229|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629230|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629231|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
14629232|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629233|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629234|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629235|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629236|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629237|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629238|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629239|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629240|NCT00141375|Pregabalin|pregabalin|mesh-list
14629241|NCT00141375|Analgesics|analgesics|mesh-ancestor
14629242|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
14629243|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629244|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629245|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
14629246|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629247|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629248|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629249|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629250|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15168320|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
15168321|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15168322|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15168323|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168324|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168325|NCT04052269|Urological Agents|urological agents|mesh-ancestor
15168326|NCT04052178|Capsaicin|capsaicin|mesh-list
15168327|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
15168328|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
15168329|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
15168330|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168331|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168332|NCT04051723|Dexamethasone|dexamethasone|mesh-list
15168333|NCT04051723|Ropivacaine|ropivacaine|mesh-list
15168334|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168335|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
15168336|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
15168337|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168338|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168339|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15168340|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
15168341|NCT04051723|Hormones|hormones|mesh-ancestor
15168342|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168343|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14629251|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629252|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629253|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629254|NCT00141388|Pregabalin|pregabalin|mesh-list
15168344|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168345|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168346|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
15168347|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168348|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
14629255|NCT00141388|Analgesics|analgesics|mesh-ancestor
14629256|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
14629257|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629258|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629259|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
14629260|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629261|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629262|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629263|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629264|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629265|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629266|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629267|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629268|NCT00141401|Pregabalin|pregabalin|mesh-list
14629269|NCT00141401|Analgesics|analgesics|mesh-ancestor
14629270|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
15168349|NCT04051853|Sorafenib|sorafenib|mesh-list
15168350|NCT04051853|Midazolam|midazolam|mesh-list
15168351|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15168352|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15168353|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168354|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168355|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15168356|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629271|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629272|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629273|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
14629274|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629275|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629276|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629277|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629278|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629279|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629280|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629281|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629282|NCT00141414|Pregabalin|pregabalin|mesh-list
14629283|NCT00141414|Analgesics|analgesics|mesh-ancestor
14629284|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
14022497|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022498|NCT02768220|Incretins|incretins|mesh-ancestor
14022499|NCT02768220|Hormones|hormones|mesh-ancestor
14022500|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022501|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14022502|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
14022503|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022504|NCT02768168|Dezocine|dezocine|mesh-list
14629285|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168357|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15168358|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168359|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
15168360|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
14022505|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14022506|NCT02768168|Narcotics|narcotics|mesh-ancestor
14629286|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629287|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
14629288|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629289|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629290|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629291|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629292|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629293|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629294|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629295|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629296|NCT00141427|Pregabalin|pregabalin|mesh-list
14629297|NCT00141427|Analgesics|analgesics|mesh-ancestor
14629298|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
14629299|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629300|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629301|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
14629302|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629303|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629304|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629305|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15168361|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
15168362|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
15168363|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168364|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168365|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168366|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15168367|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168368|NCT04051827|Midazolam|midazolam|mesh-list
15168369|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15168370|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15168371|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168372|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168373|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15168374|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15168375|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629306|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629307|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629308|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629309|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629310|NCT00141492|Testosterone|testosterone|mesh-list
14629311|NCT00141492|Androgens|androgens|mesh-ancestor
14629312|NCT00141492|Hormones|hormones|mesh-ancestor
14629313|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629314|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629315|NCT00141531|Apaziquone|apaziquone|mesh-list
14629316|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629317|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
14629318|NCT00141544|Estrogens|estrogens|mesh-list
14629319|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
14629320|NCT00141544|Estrone|estrone|mesh-list
14629321|NCT00141544|Testosterone|testosterone|mesh-list
14629322|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
14629323|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
14629324|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14629325|NCT00141544|Hormones|hormones|mesh-ancestor
14629326|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629327|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629328|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14629329|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629330|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
14629331|NCT00141544|Androgens|androgens|mesh-ancestor
14629332|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
14629333|NCT00141557|Estrogens|estrogens|mesh-list
14629334|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
14629335|NCT00141557|Estrone|estrone|mesh-list
14629336|NCT00141557|Testosterone|testosterone|mesh-list
14629337|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
14629338|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
14629339|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14629340|NCT00141557|Hormones|hormones|mesh-ancestor
14629341|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629342|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629343|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14629344|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629345|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
14629346|NCT00141557|Androgens|androgens|mesh-ancestor
14629347|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
14629348|NCT00141570|Estrogens|estrogens|mesh-list
14629349|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
14629350|NCT00141570|Testosterone|testosterone|mesh-list
14629351|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
14629352|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
14629353|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14629354|NCT00141570|Hormones|hormones|mesh-ancestor
14629355|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629356|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629357|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14629358|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629359|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
14629360|NCT00141570|Androgens|androgens|mesh-ancestor
14629361|NCT00141583|Candesartan|candesartan|mesh-list
15168376|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168377|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
15168378|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
15168379|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
15168380|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
15168381|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168382|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168383|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15168384|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
15168385|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168386|NCT04051632|Insulin|insulin|mesh-list
15168387|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168388|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168389|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
15168390|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14629362|NCT00141583|Enalapril|enalapril|mesh-list
14629363|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14629364|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14629365|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14629366|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629367|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14629368|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
14629369|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629370|NCT00141596|Amiloride|amiloride|mesh-list
14629371|NCT00141596|Furosemide|furosemide|mesh-list
14629372|NCT00141596|Diuretics|diuretics|mesh-ancestor
14629373|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
14629374|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629375|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14629376|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629377|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629378|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14629379|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14629380|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14629381|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14629382|NCT00141648|Prednisolone|prednisolone|mesh-list
14629383|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
14629384|NCT00141648|Doxorubicin|doxorubicin|mesh-list
14629385|NCT00141648|Vincristine|vincristine|mesh-list
14629386|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629387|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
14629388|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629389|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629390|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14629391|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
14629392|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629393|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629394|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14629395|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14629396|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14629397|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14629398|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629399|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14629400|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
15168391|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14629401|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
14629402|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
15168392|NCT04051567|Aspirin|aspirin|mesh-list
14629403|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629404|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
14629405|NCT00141648|Hormones|hormones|mesh-ancestor
14629406|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629407|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14629408|NCT00141700|Rituximab|rituximab|mesh-list
14629409|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14629410|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629411|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
14629412|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629413|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629414|NCT00141713|Etanercept|etanercept|mesh-list
14629415|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629416|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629417|NCT00141713|Analgesics|analgesics|mesh-ancestor
14629418|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
14629419|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629420|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629421|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629422|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629423|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14629424|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629425|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
14629426|NCT00141791|Etanercept|etanercept|mesh-list
14629427|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629428|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629429|NCT00141791|Analgesics|analgesics|mesh-ancestor
14629430|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
14629431|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629432|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629433|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629434|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629435|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14629436|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629437|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
14646685|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14646686|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646687|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646688|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
14646689|NCT00198614|Protective Agents|protective agents|mesh-ancestor
14646690|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14646691|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14646692|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14646693|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
14646694|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14646695|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14646696|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14646697|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14646698|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646699|NCT00198627|Renal Agents|renal agents|mesh-ancestor
14646700|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14646701|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
14646702|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14646703|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14646704|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14646705|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646706|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
14646707|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14646708|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646709|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
14646710|NCT00198718|Vitamin A|vitamin a|mesh-list
14646711|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
14646712|NCT00198718|Vitamins|vitamins|mesh-ancestor
14646713|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
14646714|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646715|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
14646716|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646717|NCT00198718|Protective Agents|protective agents|mesh-ancestor
14646718|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14646719|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646720|NCT00198848|Folic Acid|folic acid|mesh-list
14646721|NCT00198848|Hematinics|hematinics|mesh-ancestor
14646722|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
14646723|NCT00198848|Vitamins|vitamins|mesh-ancestor
14646724|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
14646725|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629438|NCT00141804|Sirolimus|sirolimus|mesh-list
14629439|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14629440|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629441|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14629442|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168393|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15168394|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168395|NCT04051567|Analgesics|analgesics|mesh-ancestor
15168396|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
15168397|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168398|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168399|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168400|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15168401|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15168402|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15168403|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168404|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15168405|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15168406|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168407|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
15168408|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
15168409|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15168410|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15168411|NCT04051203|Prednisolone|prednisolone|mesh-list
15168412|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
14629443|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
14629444|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629445|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
14629446|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629447|NCT00141830|Methotrexate|methotrexate|mesh-list
14629448|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14629449|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
14629450|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14629451|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629452|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629453|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
14629454|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629455|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629456|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
14629457|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168413|NCT04051203|Lidocaine|lidocaine|mesh-list
15168414|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15168415|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
15168416|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168417|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
14629458|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14629459|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629460|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
14629461|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629462|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14629463|NCT00141843|Factor VIII|factor viii|mesh-list
14629464|NCT00141843|Coagulants|coagulants|mesh-ancestor
14629465|NCT00141882|Memantine|memantine|mesh-list
14629466|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14629467|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14629468|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
14629469|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629470|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629471|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629472|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15168418|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168419|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168420|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
15168421|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022507|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168422|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15168423|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15168424|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15168425|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14022508|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629473|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14629474|NCT00141895|Misoprostol|misoprostol|mesh-list
15182334|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
14629475|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14022509|NCT02768168|Analgesics|analgesics|mesh-ancestor
14022510|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
14022511|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629476|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
14629477|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14629478|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629479|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14629480|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14629481|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
15168426|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168427|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168428|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
15168429|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
15168430|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15168431|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
15168432|NCT04051203|Hormones|hormones|mesh-ancestor
15168433|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168434|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15168435|NCT04051203|Protective Agents|protective agents|mesh-ancestor
15168436|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15168437|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168438|NCT04051255|Metronidazole|metronidazole|mesh-list
15168439|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168440|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15168441|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15168442|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15168443|NCT04051047|Gemcitabine|gemcitabine|mesh-list
15168444|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15168445|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
15168446|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168447|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168448|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
15168449|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168450|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168451|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168452|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
15168453|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168454|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
15168455|NCT04051099|Bupivacaine|bupivacaine|mesh-list
15168456|NCT04051099|Propofol|propofol|mesh-list
15168457|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168458|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
15168459|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168460|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168461|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
15168462|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168463|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15168464|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168465|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
15168466|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168467|NCT04051099|Analgesics|analgesics|mesh-ancestor
15168468|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15168469|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15168470|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15168471|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
15168472|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022512|NCT02768207|Vemurafenib|vemurafenib|mesh-list
14629482|NCT00141908|Castor Oil|castor oil|mesh-list
15168473|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168474|NCT04050592|Estradiol|estradiol|mesh-list
15168475|NCT04050592|Estrogens|estrogens|mesh-ancestor
15168476|NCT04050592|Hormones|hormones|mesh-ancestor
15168477|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168478|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181102|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181103|NCT03932916|Donepezil|donepezil|mesh-list
15181104|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15181105|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629483|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
15181106|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181107|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
15181108|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181109|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181110|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
15181111|NCT03932864|Plerixafor|plerixafor|mesh-list
15181112|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14629484|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14629485|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14629486|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
14629487|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14629488|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629489|NCT00141908|Progestins|progestins|mesh-ancestor
15168479|NCT04050670|Tirzepatide|tirzepatide|mesh-list
15168480|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168481|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168482|NCT04050670|Incretins|incretins|mesh-ancestor
15168483|NCT04050670|Hormones|hormones|mesh-ancestor
15168484|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168485|NCT04050826|Lidocaine|lidocaine|mesh-list
15168486|NCT04050826|Prilocaine|prilocaine|mesh-list
15168487|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
14629490|NCT00141908|Hormones|hormones|mesh-ancestor
14629491|NCT00141908|Cathartics|cathartics|mesh-ancestor
14629492|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14629493|NCT00141947|Bexarotene|bexarotene|mesh-list
14629494|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629495|NCT00141960|Famotidine|famotidine|mesh-list
14629496|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14629497|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14629498|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14629499|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
14629500|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
14629501|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629502|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629503|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629504|NCT00141986|Vitamin D|vitamin d|mesh-list
14629505|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
14629506|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
14629507|NCT00141986|Vitamins|vitamins|mesh-list
14629508|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
14629509|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629510|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14629511|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629512|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
14629513|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
14629514|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14629515|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14629516|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629517|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629518|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14629519|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14629520|NCT00142038|Docetaxel|docetaxel|mesh-list
15168488|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
15168489|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168490|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168491|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
15168492|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168493|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15168494|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15168495|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15168496|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15168497|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168498|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
15168499|NCT04050488|Astringents|astringents|mesh-ancestor
15168500|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168501|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
15168502|NCT04050761|Nivolumab|nivolumab|mesh-list
15168503|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15168504|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168505|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14629521|NCT00142038|Capecitabine|capecitabine|mesh-list
14629522|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629523|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14629524|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14629525|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14629526|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629527|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629528|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
14629529|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
14629530|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14629531|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
15168506|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168507|NCT04050735|Ethanol|ethanol|mesh-list
15168508|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15168509|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168510|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168511|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168512|NCT04050215|Edetic Acid|edetic acid|mesh-list
14629532|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629533|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629534|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14629535|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14629536|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14629537|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
14629538|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629539|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629540|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14629541|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
14629542|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
14629543|NCT00142051|Protective Agents|protective agents|mesh-ancestor
14629544|NCT00142129|Bortezomib|bortezomib|mesh-list
14629545|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629546|NCT00142155|Rituximab|rituximab|mesh-list
14629547|NCT00142155|Antibodies|antibodies|mesh-list
14629548|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14629549|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
14629550|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629551|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14629552|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629553|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629554|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
14629555|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14629556|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629557|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
14629558|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
14629559|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14629560|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
14629561|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14629562|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14629563|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629564|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14629565|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629566|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629567|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14629568|NCT00142207|Renal Agents|renal agents|mesh-ancestor
14629569|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
14629570|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14629571|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14629572|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629573|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629574|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629575|NCT00142246|Amodiaquine|amodiaquine|mesh-list
14629576|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
14629577|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14629578|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14629579|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629580|NCT00142324|Donepezil|donepezil|mesh-list
14629581|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14629582|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629583|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629584|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629585|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629586|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629587|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
14629588|NCT00142337|Zidovudine|zidovudine|mesh-list
14629589|NCT00142337|Didanosine|didanosine|mesh-list
14629590|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
14629591|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629592|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14629593|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14629594|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629595|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
14629596|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629597|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14629598|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14629599|NCT00142350|Fluorouracil|fluorouracil|mesh-list
14629600|NCT00142350|Irinotecan|irinotecan|mesh-list
14629601|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629602|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
14629603|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629604|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629605|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629606|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
15168513|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15168514|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
15168515|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
15168516|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168517|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
15168518|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15168519|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14629607|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629608|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14629609|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14629610|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629611|NCT00142402|Modafinil|modafinil|mesh-list
14629612|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14629613|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629614|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14629615|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14629616|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14629617|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629618|NCT00142428|Cetuximab|cetuximab|mesh-list
14629619|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14629620|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629621|NCT00142467|Gemcitabine|gemcitabine|mesh-list
14629622|NCT00142467|Bevacizumab|bevacizumab|mesh-list
14629623|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
14629624|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14629625|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629626|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14629627|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15168520|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
15168521|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15168522|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
15168523|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
15168524|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168525|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168526|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168527|NCT04050267|Analgesics|analgesics|mesh-ancestor
14629628|NCT00142467|Growth Substances|growth substances|mesh-ancestor
14629629|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629630|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
14629631|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629632|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
14629633|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629634|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
14629635|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629636|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629637|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629638|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
14629639|NCT00142480|Bevacizumab|bevacizumab|mesh-list
14629640|NCT00142480|Capecitabine|capecitabine|mesh-list
14629641|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
14629642|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14629643|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629644|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14629645|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14629646|NCT00142480|Growth Substances|growth substances|mesh-ancestor
14629647|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629648|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
14629649|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629650|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
14629651|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629652|NCT00142493|Midazolam|midazolam|mesh-list
14629653|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
14629654|NCT00142493|Thiopental|thiopental|mesh-list
14629655|NCT00142493|Propofol|propofol|mesh-list
14629656|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14629657|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629658|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629659|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14629660|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
14629661|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
14629662|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629663|NCT00142493|Analgesics|analgesics|mesh-ancestor
15168528|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
15168529|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168530|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14629664|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
15168531|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168532|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168533|NCT04050059|Lidocaine|lidocaine|mesh-list
15168534|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15168535|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168536|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
15168537|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168538|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629665|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629666|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14629667|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14629668|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14629669|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14629670|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629671|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629672|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14629673|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629674|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629675|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629676|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
14629677|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
14629678|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
14629679|NCT00142545|Apomorphine|apomorphine|mesh-list
14629680|NCT00142545|Emetics|emetics|mesh-ancestor
14629681|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629682|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
14629683|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629684|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14629685|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
14629686|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
14629687|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629688|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629689|NCT00142571|Gemcitabine|gemcitabine|mesh-list
14629690|NCT00142571|Docetaxel|docetaxel|mesh-list
14629691|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629692|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
14629693|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629694|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629695|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
14629696|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629697|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629698|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14629699|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
14629700|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629701|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
14629702|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14629703|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
14629704|NCT00142610|Vitamins|vitamins|mesh-list
14629705|NCT00142610|Vitamin E|vitamin e|mesh-list
14629706|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
14629707|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629708|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
14629709|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629710|NCT00142610|Protective Agents|protective agents|mesh-ancestor
14629711|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
15168539|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
15168540|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168541|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15168542|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15168543|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15168544|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15168545|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168546|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14629712|NCT00142727|Methadone|methadone|mesh-list
14629713|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
14629714|NCT00142727|Narcotics|narcotics|mesh-ancestor
14629715|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14646726|NCT00198978|Cytarabine|cytarabine|mesh-list
14629716|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629717|NCT00142727|Analgesics|analgesics|mesh-ancestor
14629718|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
14629719|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629720|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
14629721|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
14629722|NCT00142779|Fluoxetine|fluoxetine|mesh-list
14629723|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14629724|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14629725|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629726|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629727|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629728|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
14629729|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629730|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14629731|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
14629732|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629733|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14629734|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14629735|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629736|NCT00142844|Naltrexone|naltrexone|mesh-list
14629737|NCT00142844|Disulfiram|disulfiram|mesh-list
15168547|NCT04049916|Artesunate|artesunate|mesh-list
15168548|NCT04049916|Piperaquine|piperaquine|mesh-list
14629738|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14629739|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14629740|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629741|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
14629742|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629743|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14629744|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629745|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629746|NCT00142870|Bupropion|bupropion|mesh-list
14629747|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14629748|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
14629749|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629750|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14629751|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14629752|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629753|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629754|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
14629755|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629756|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629757|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14629758|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14629759|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629760|NCT00142883|Pregabalin|pregabalin|mesh-list
14629761|NCT00142883|Analgesics|analgesics|mesh-ancestor
14629762|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
14629763|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629764|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629765|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
14629766|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629767|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629768|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629769|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629770|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629771|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629772|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629773|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629774|NCT00142896|Morphine|morphine|mesh-list
14629775|NCT00142896|Tramadol|tramadol|mesh-list
14629776|NCT00142896|Naloxone|naloxone|mesh-list
14629777|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14629778|NCT00142896|Narcotics|narcotics|mesh-ancestor
14629779|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629780|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629781|NCT00142896|Analgesics|analgesics|mesh-ancestor
14629782|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
14629783|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629784|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14629785|NCT00142948|Naltrexone|naltrexone|mesh-list
14629786|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14629787|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14629788|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629789|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
14629790|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629791|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14629792|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14629793|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14629794|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629795|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629796|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14629797|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629798|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629799|NCT00142974|Tegaserod|tegaserod|mesh-list
14629800|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14629801|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
14629802|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629803|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629804|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629805|NCT00142987|Tegaserod|tegaserod|mesh-list
14629806|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14629807|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
14629808|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629809|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629810|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629811|NCT00143000|Ribavirin|ribavirin|mesh-list
14629812|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14629813|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
14629814|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629815|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
14629816|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14629817|NCT00143026|Levodopa|levodopa|mesh-list
14629818|NCT00143026|Carbidopa|carbidopa|mesh-list
14629819|NCT00143026|Entacapone|entacapone|mesh-list
14629820|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14629821|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14629822|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
14629823|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629824|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629825|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629826|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14629827|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629828|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14629829|NCT00143065|Rituximab|rituximab|mesh-list
14629830|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
14629831|NCT00143065|Fludarabine|fludarabine|mesh-list
14629832|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14629833|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14629834|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
14629835|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629836|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629837|NCT00143091|Sertraline|sertraline|mesh-list
14629838|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
14629839|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629840|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14629841|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14629842|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629843|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629844|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629845|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
14629846|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629847|NCT00143104|Insulin|insulin|mesh-list
15168549|NCT04049916|Primaquine|primaquine|mesh-list
15168550|NCT04049916|Artenimol|artenimol|mesh-list
14629848|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14629849|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629850|NCT00143130|Pregabalin|pregabalin|mesh-list
14629851|NCT00143130|Analgesics|analgesics|mesh-ancestor
14629852|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
14629853|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629854|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629855|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
14629856|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629857|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629858|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168551|NCT04049916|Pyronaridine|pyronaridine|mesh-list
14629859|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629860|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629861|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629862|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629863|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629864|NCT00143143|Pregabalin|pregabalin|mesh-list
14629865|NCT00143143|Analgesics|analgesics|mesh-ancestor
14629866|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
14629867|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629868|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629869|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
14629870|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629871|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629872|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629873|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629874|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629875|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629876|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629877|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629878|NCT00143156|Pregabalin|pregabalin|mesh-list
14629879|NCT00143156|Analgesics|analgesics|mesh-ancestor
14629880|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
14629881|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629882|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629883|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
14629884|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15168552|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
15168553|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15168554|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15168555|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168556|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168557|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
15168558|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
15168559|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15168560|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
15168561|NCT04050098|Metformin|metformin|mesh-list
15168562|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168563|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629885|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629886|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629887|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629888|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14629889|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629890|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629891|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629892|NCT00143169|Parecoxib|parecoxib|mesh-list
14629893|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14629894|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14629895|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629896|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629897|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14629898|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14629899|NCT00143169|Analgesics|analgesics|mesh-ancestor
14629900|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
14629901|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14629902|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629903|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14629904|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14629905|NCT00143195|Amlodipine|amlodipine|mesh-list
14629906|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14629907|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629908|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629909|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629910|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629911|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629912|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
14629913|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
15168564|NCT04049747|Bicalutamide|bicalutamide|mesh-list
15168565|NCT04049747|Finasteride|finasteride|mesh-list
15168566|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
15168567|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
15168568|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168569|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168570|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168571|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15168572|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15168573|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168574|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168575|NCT04049747|Urological Agents|urological agents|mesh-ancestor
15168576|NCT04049409|Trastuzumab|trastuzumab|mesh-list
15168577|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15168578|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168579|NCT04049539|Cytarabine|cytarabine|mesh-list
15168580|NCT04049539|Daunorubicin|daunorubicin|mesh-list
15168581|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14629914|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
14629915|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14629916|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15168582|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
15168583|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629917|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629918|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629919|NCT00143221|Urological Agents|urological agents|mesh-ancestor
15168584|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168585|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
15168586|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168587|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168588|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
15168589|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168590|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15168591|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15168592|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15168593|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168594|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
15168595|NCT04049513|Fludarabine|fludarabine|mesh-list
15168596|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168597|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
15168598|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168599|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15168600|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15168601|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
15168602|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168603|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168604|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15168605|NCT04049266|Aflibercept|aflibercept|mesh-list
15168606|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15168607|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15168608|NCT04049266|Growth Substances|growth substances|mesh-ancestor
14629920|NCT00143234|Amlodipine|amlodipine|mesh-list
14629921|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
14629922|NCT00143234|Atorvastatin|atorvastatin|mesh-list
14629923|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14629924|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14629925|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
14629926|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629927|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14629928|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14629929|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629930|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15168609|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168610|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
15168611|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168612|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
15168613|NCT04049344|Decitabine|decitabine|mesh-list
15168614|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168615|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15168616|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
15168617|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168618|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168619|NCT04049201|Midazolam|midazolam|mesh-list
15168620|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15168621|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14629931|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14629932|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14629933|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14629934|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629935|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
14629936|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
14629937|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629938|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
14629939|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14629940|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14629941|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14629942|NCT00143260|Urological Agents|urological agents|mesh-ancestor
14629943|NCT00143286|Varenicline|varenicline|mesh-list
14629944|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14629945|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14629946|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629947|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629948|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629949|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629950|NCT00143299|Varenicline|varenicline|mesh-list
14629951|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14629952|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14629953|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629954|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629955|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629956|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629957|NCT00143325|Varenicline|varenicline|mesh-list
14629958|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14629959|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14629960|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629961|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629962|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629963|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629964|NCT00143338|Insulin|insulin|mesh-list
14629965|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14629966|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629967|NCT00143351|Ziprasidone|ziprasidone|mesh-list
14629968|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14629969|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
15168622|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168623|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168624|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15168625|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15168626|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15168627|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168628|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
15168629|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
15168630|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
15168631|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
15168632|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168633|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629970|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629971|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629972|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629973|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14629974|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14629975|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14629976|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14629977|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14629978|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
14629979|NCT00143364|Varenicline|varenicline|mesh-list
14629980|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14629981|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14629982|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629983|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629984|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629985|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629986|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14629987|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14629988|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14629989|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14629990|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14629991|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14629992|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14629993|NCT00143377|Urological Agents|urological agents|mesh-ancestor
14646727|NCT00198978|Dexamethasone|dexamethasone|mesh-list
14646728|NCT00198978|Prednisolone|prednisolone|mesh-list
14646729|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
14646730|NCT00198978|Rituximab|rituximab|mesh-list
14646731|NCT00198978|Methotrexate|methotrexate|mesh-list
14629994|NCT00143429|Latanoprost|latanoprost|mesh-list
14629995|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14629996|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14629997|NCT00143442|Reboxetine|reboxetine|mesh-list
14629998|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
14629999|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14630000|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14630001|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14630002|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14630003|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630004|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14630005|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168634|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15168635|NCT04048889|Ropivacaine|ropivacaine|mesh-list
15168636|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15168637|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168638|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
15168639|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168640|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168641|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
15168642|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168643|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
15168644|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15168645|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168646|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168647|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168648|NCT04049227|Letrozole|letrozole|mesh-list
15168649|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168650|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15168651|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15168652|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168653|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168654|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15168655|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
15168656|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168657|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630006|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630007|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14630008|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14630009|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14630010|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
14630011|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630012|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630013|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630014|NCT00143481|Urological Agents|urological agents|mesh-ancestor
14630015|NCT00143520|Pioglitazone|pioglitazone|mesh-list
14630016|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630017|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630018|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
14630019|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
14630020|NCT00143533|Irinotecan|irinotecan|mesh-list
14630021|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14630022|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630023|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630024|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630025|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630026|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14630027|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630028|NCT00143546|Defibrotide|defibrotide|mesh-list
14630029|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14630030|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14630031|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630032|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14630033|NCT00143559|Antibodies|antibodies|mesh-list
14630034|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
14630035|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630036|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
14630037|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630038|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
14630039|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630040|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630041|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630042|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
14630043|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630044|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630045|NCT00143676|Atorvastatin|atorvastatin|mesh-list
14630046|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14630047|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14630048|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
14630049|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630050|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14630051|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14630052|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630053|NCT00143689|Ritonavir|ritonavir|mesh-list
14630054|NCT00143689|Lopinavir|lopinavir|mesh-list
14630055|NCT00143689|Lamivudine|lamivudine|mesh-list
14630056|NCT00143689|Zidovudine|zidovudine|mesh-list
14630057|NCT00143689|Nevirapine|nevirapine|mesh-list
14630058|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14630059|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14630060|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630061|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630062|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630063|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630064|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630065|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
14630066|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630067|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14630068|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14630069|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630070|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630071|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
14630072|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630073|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630074|NCT00143702|Riboflavin|riboflavin|mesh-list
14630075|NCT00143702|Thiamine|thiamine|mesh-list
14630076|NCT00143702|Abacavir|abacavir|mesh-list
14630077|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630078|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630079|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630080|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630081|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
14630082|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630083|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630084|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630085|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
14630086|NCT00143702|Vitamins|vitamins|mesh-ancestor
14630087|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
15168658|NCT04049045|Empagliflozin|empagliflozin|mesh-list
15168659|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15168660|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168661|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168662|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181113|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15181114|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
15181115|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181116|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
15181117|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15181118|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
15181119|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
15181120|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181121|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181122|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15181123|NCT03932825|Analgesics|analgesics|mesh-ancestor
15181124|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
15181125|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181126|NCT03932981|Temozolomide|temozolomide|mesh-list
15181127|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15181128|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
15181129|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181130|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181131|NCT03933098|Vaccines|vaccines|mesh-list
15181132|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
15181133|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630088|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630089|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14630090|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
14630091|NCT00143715|Vitamin K|vitamin k|mesh-list
14630092|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
14630093|NCT00143715|Vitamins|vitamins|mesh-ancestor
14630094|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
14630095|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630096|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14630097|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14630098|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630099|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
14630100|NCT00143715|Coagulants|coagulants|mesh-ancestor
14630101|NCT00143728|Lamivudine|lamivudine|mesh-list
14630102|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630103|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630104|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630105|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630106|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
14630107|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630108|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630109|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630110|NCT00143741|Atorvastatin|atorvastatin|mesh-list
14630111|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14630112|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14630113|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
14630114|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630115|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14630116|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14630117|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630118|NCT00143780|Vaccines|vaccines|mesh-list
14630119|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
14630120|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630121|NCT00143806|Cyclosporine|cyclosporine|mesh-list
14630122|NCT00143806|Alefacept|alefacept|mesh-list
14630123|NCT00143806|Cyclosporins|cyclosporins|mesh-list
14630124|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630125|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630126|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630127|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
14630128|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630129|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
14630130|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630131|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
14630132|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14630133|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14630134|NCT00143871|Rituximab|rituximab|mesh-list
14630135|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14630136|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630137|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
14630138|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630139|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14630140|NCT00143949|Losartan|losartan|mesh-list
14630141|NCT00143949|Enalapril|enalapril|mesh-list
14630142|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14630143|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630144|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14630145|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14630146|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630147|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14630148|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630149|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630150|NCT00143975|Cytarabine|cytarabine|mesh-list
14630151|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
14630152|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
14630153|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14630154|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
14630155|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630156|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630157|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
14630158|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630159|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630160|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
14630161|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630162|NCT00143975|Analgesics|analgesics|mesh-ancestor
14630163|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
15168663|NCT04048863|Imidacloprid|imidacloprid|mesh-list
14630164|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630165|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630166|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630167|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168664|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
15168665|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168666|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168667|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168668|NCT04048811|Propofol|propofol|mesh-list
15168669|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15168670|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168671|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168672|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168673|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
15168674|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
15168675|NCT04048850|Grazoprevir|grazoprevir|mesh-list
15168676|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
15168677|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
15168678|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168679|NCT04048577|Natalizumab|natalizumab|mesh-list
15168680|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
15168681|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168682|NCT04048655|Neostigmine|neostigmine|mesh-list
15168683|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15168684|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168685|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168686|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
14630168|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14630169|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14630170|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14630171|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630172|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
14630173|NCT00144053|Paclitaxel|paclitaxel|mesh-list
14630174|NCT00144053|Vindesine|vindesine|mesh-list
14630175|NCT00144053|Carboplatin|carboplatin|mesh-list
14630176|NCT00144053|Irinotecan|irinotecan|mesh-list
14630177|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14630178|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630179|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
14630180|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
14630181|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14630182|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630183|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14630184|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630185|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630186|NCT00144066|Gefitinib|gefitinib|mesh-list
14630187|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168687|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168688|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168689|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15168690|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
15168691|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168692|NCT04048707|Octreotide|octreotide|mesh-list
15168693|NCT04048707|Midodrine|midodrine|mesh-list
15168694|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
15168695|NCT04048707|Giapreza|giapreza|mesh-list
15168696|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
15168697|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15168698|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15168699|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168700|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
15168701|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
15168702|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168703|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630188|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14630189|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630190|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630191|NCT00144118|Sevoflurane|sevoflurane|mesh-list
14630192|NCT00144118|Isoflurane|isoflurane|mesh-list
14630193|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14630194|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15168704|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15168705|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15168706|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15168707|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15168708|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
15168709|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168710|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168711|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15168712|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630195|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
14630196|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
14630197|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14630198|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630199|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
14630200|NCT00144131|Hematinics|hematinics|mesh-ancestor
14630201|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
14630202|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
14630203|NCT00144144|Giapreza|giapreza|mesh-list
14630204|NCT00144144|Calcium|calcium|mesh-list
14630205|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
14630206|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14630207|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14630208|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630209|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14630210|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14630211|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630212|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168713|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168714|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15168715|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
15168716|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168717|NCT04048317|Doxorubicin|doxorubicin|mesh-list
15168718|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15168719|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
15168720|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15168721|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168722|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15168723|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15168724|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168725|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630213|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630214|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14630215|NCT00144157|Zidovudine|zidovudine|mesh-list
14630216|NCT00144157|Nevirapine|nevirapine|mesh-list
14630217|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
14630218|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630219|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630220|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630221|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630222|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
14630223|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630224|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630225|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630226|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630227|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630228|NCT00144183|Zidovudine|zidovudine|mesh-list
14630229|NCT00144183|Nevirapine|nevirapine|mesh-list
14630230|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
14630231|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630232|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630233|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630234|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630235|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
14630236|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630237|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630238|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630239|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630240|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630241|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
14630242|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14630243|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
14630244|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630245|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630246|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14630247|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
14630248|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
14630249|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14630250|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
14630251|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630252|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630253|NCT00144209|Levodopa|levodopa|mesh-list
15168726|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
15168727|NCT04048226|Ketamine|ketamine|mesh-list
15168728|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
15168729|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14630254|NCT00144209|Pramipexole|pramipexole|mesh-list
14630255|NCT00144209|Benserazide|benserazide|mesh-list
14630256|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14630257|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14630258|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
14630259|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630260|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630261|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630262|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
14630263|NCT00144209|Protective Agents|protective agents|mesh-ancestor
14630264|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
14630265|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630266|NCT00144222|Telmisartan|telmisartan|mesh-list
15168730|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168731|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15168732|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168733|NCT04048226|Analgesics|analgesics|mesh-ancestor
15168734|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
14630267|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630268|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14630269|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14630270|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630271|NCT00144248|Nevirapine|nevirapine|mesh-list
14630272|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630273|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630274|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630275|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630276|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
14630277|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630278|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630279|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630280|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630281|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630282|NCT00144261|Nevirapine|nevirapine|mesh-list
14630283|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630284|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630285|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630286|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168735|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168736|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15168737|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15168738|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15168739|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
14630287|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
14630288|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630289|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630290|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630291|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630292|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630293|NCT00144274|Ambroxol|ambroxol|mesh-list
14630294|NCT00144274|Expectorants|expectorants|mesh-ancestor
14630295|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
15168740|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168741|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630296|NCT00144287|Ritonavir|ritonavir|mesh-list
15168742|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15168743|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14630297|NCT00144287|Tipranavir|tipranavir|mesh-list
14630298|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14630299|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14630300|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630301|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630302|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630303|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630304|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630305|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
14630306|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630307|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14630308|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14630309|NCT00144326|Bromides|bromides|mesh-list
14630310|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
14630311|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14630312|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
14630313|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630314|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630315|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14630316|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
14630317|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
14630318|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14630319|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
14630320|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630321|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630322|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
14630323|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
14630324|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
14630325|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14630326|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
14630327|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15168744|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
15168745|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15168746|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15168747|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15168748|NCT04048304|Vancomycin|vancomycin|mesh-list
15168749|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168750|NCT04048200|Fentanyl|fentanyl|mesh-list
15168751|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
15168752|NCT04048200|Ketamine|ketamine|mesh-list
15168753|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
15168754|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
15168755|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168756|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168757|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15168758|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168759|NCT04048200|Analgesics|analgesics|mesh-ancestor
14630328|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14630329|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630330|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14630331|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630332|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630333|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14630334|NCT00144352|Renal Agents|renal agents|mesh-ancestor
14630335|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14630336|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
14630337|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630338|NCT00144378|Irinotecan|irinotecan|mesh-list
14630339|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14630340|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630341|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630342|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630343|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630344|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
14630345|NCT00144417|Rifampin|rifampin|mesh-list
14630346|NCT00144417|Isoniazid|isoniazid|mesh-list
14630347|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
14630348|NCT00144417|Ethambutol|ethambutol|mesh-list
14630349|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14630350|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630351|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630352|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630353|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630354|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630355|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630356|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14630357|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
14630358|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
14630359|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630360|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14630361|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630362|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14630363|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14630364|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14630365|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630366|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14630367|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14630368|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
14630369|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15168760|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
15168761|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168762|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15181134|NCT03932578|Atropine|atropine|mesh-list
15168763|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15168764|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15168765|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
15168766|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168767|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168768|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15168769|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168770|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
15168771|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15168772|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15168773|NCT04048200|Narcotics|narcotics|mesh-ancestor
15168774|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15168775|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
15168776|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
14630370|NCT00144430|Pentostatin|pentostatin|mesh-list
14630371|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630372|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14630373|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630374|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630375|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
14630376|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14630377|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
14630378|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14630379|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630380|NCT00144456|Vitamins|vitamins|mesh-ancestor
14630381|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
14630382|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14630383|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
15168777|NCT04048070|Sufentanil|sufentanil|mesh-list
15168778|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15168779|NCT04048070|Narcotics|narcotics|mesh-ancestor
15168780|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168781|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168782|NCT04048070|Analgesics|analgesics|mesh-ancestor
15168783|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
15168784|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168785|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15168786|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15168787|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
14630384|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630385|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
15168788|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
15168789|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15168790|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15168791|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168792|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15168793|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15168794|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168795|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168796|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
15168797|NCT04048161|Tacrolimus|tacrolimus|mesh-list
15168798|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168799|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
15168800|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168801|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15168802|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168803|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168804|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15168805|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168806|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14630386|NCT00144482|Hematinics|hematinics|mesh-ancestor
15168807|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
15168808|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15168809|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168810|NCT04047654|Anticoagulants|anticoagulants|mesh-list
15168811|NCT04047706|Nivolumab|nivolumab|mesh-list
15168812|NCT04047706|Temozolomide|temozolomide|mesh-list
15168813|NCT04047706|Linrodostat|linrodostat|mesh-list
15168814|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15168815|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168816|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15168817|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168818|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15168819|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
14630387|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
14630388|NCT00144495|Hematinics|hematinics|mesh-ancestor
15168820|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168821|NCT04047940|Metformin|metformin|mesh-list
15168822|NCT04047940|Valsartan|valsartan|mesh-list
15168823|NCT04047940|Atorvastatin|atorvastatin|mesh-list
15168824|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15168825|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168826|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15168827|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15168828|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
15168829|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168830|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15168831|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14630389|NCT00144677|Sirolimus|sirolimus|mesh-list
14630390|NCT00144677|Tacrolimus|tacrolimus|mesh-list
14630391|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630392|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
14630393|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168832|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168833|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15168834|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14630394|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14630395|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630396|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630397|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14630398|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630399|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14630400|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630401|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
14630402|NCT00144703|Sirolimus|sirolimus|mesh-list
14630403|NCT00144703|Tacrolimus|tacrolimus|mesh-list
14630404|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630405|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
14630406|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630407|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14630408|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630409|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630410|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14630411|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630412|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14630413|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630414|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
14630415|NCT00144716|Insect Repellents|insect repellents|mesh-list
14630416|NCT00144716|Protective Agents|protective agents|mesh-ancestor
14630417|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630418|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
14630419|NCT00144755|Hematinics|hematinics|mesh-ancestor
14630420|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
14630421|NCT00144807|Rituximab|rituximab|mesh-list
14630422|NCT00144807|Doxorubicin|doxorubicin|mesh-list
14630423|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630424|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
15168835|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15168836|NCT04047758|Letrozole|letrozole|mesh-list
14630425|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630426|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14630427|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14630428|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
14630429|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630430|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630431|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14630432|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14630433|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14630434|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630435|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630436|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630437|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
15168837|NCT04047758|Palbociclib|palbociclib|mesh-list
15168838|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168839|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15168840|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15168841|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168842|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630438|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14630439|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
14646732|NCT00198978|Vincristine|vincristine|mesh-list
15168843|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14630440|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630441|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
14630442|NCT00144820|Protective Agents|protective agents|mesh-ancestor
14630443|NCT00144833|Ritonavir|ritonavir|mesh-list
14630444|NCT00144833|Lopinavir|lopinavir|mesh-list
14630445|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
14630446|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14630447|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14630448|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630449|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630450|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630451|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630452|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630453|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
14630454|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630455|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14630456|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14630457|NCT00144846|Albuterol|albuterol|mesh-list
14630458|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14630459|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
14630460|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630461|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630462|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14630463|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
14630464|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
14630465|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14630466|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14630467|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14630468|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14630469|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
14630470|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630471|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630472|NCT00144872|Lamotrigine|lamotrigine|mesh-list
14630473|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
14630474|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14630475|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14630476|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630477|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14630478|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630479|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14630480|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15168844|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
15168845|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168846|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168847|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14630481|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14630482|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14022513|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630483|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14630484|NCT00144911|Fluticasone|fluticasone|mesh-list
14630485|NCT00144911|Xhance|xhance|mesh-list
14630486|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14630487|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14630488|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14630489|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
14630490|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630491|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630492|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14630493|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
14630494|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
14630495|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14630496|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14630497|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14630498|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14630499|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
14630500|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630501|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646733|NCT00198978|Asparaginase|asparaginase|mesh-list
14646734|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
14646735|NCT00198978|Idarubicin|idarubicin|mesh-list
14646736|NCT00198978|Sargramostim|sargramostim|mesh-list
14646737|NCT00198978|Lenograstim|lenograstim|mesh-list
15168848|NCT04047641|Cytarabine|cytarabine|mesh-list
15168849|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
15168850|NCT04047641|Idarubicin|idarubicin|mesh-list
15168851|NCT04047641|Cladribine|cladribine|mesh-list
14630502|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14630503|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630504|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14630505|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630506|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630507|NCT00144989|Cisplatin|cisplatin|mesh-list
14630508|NCT00144989|Irinotecan|irinotecan|mesh-list
14630509|NCT00144989|Etoposide|etoposide|mesh-list
14630510|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630511|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14630512|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630513|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630514|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630515|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14630516|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630517|NCT00145002|Lenograstim|lenograstim|mesh-list
14630518|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14630519|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
14630520|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630521|NCT00145028|Carboplatin|carboplatin|mesh-list
14630522|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630523|NCT00145093|Chromium|chromium|mesh-list
14630524|NCT00145093|Trace Elements|trace elements|mesh-ancestor
14630525|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
14630526|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630527|NCT00145106|Minocycline|minocycline|mesh-list
14630528|NCT00145106|Tazarotene|tazarotene|mesh-list
14630529|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14630530|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630531|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14630532|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
14630533|NCT00145171|Apomorphine|apomorphine|mesh-list
14630534|NCT00145171|Emetics|emetics|mesh-ancestor
14630535|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630536|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
14630537|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630538|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14630539|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
14630540|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
14630541|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630542|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168852|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15168853|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
15168854|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168855|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168856|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
15168857|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168858|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168859|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
15168860|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168861|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15168862|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15168863|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15168864|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168865|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15168866|NCT04047849|Amoxicillin|amoxicillin|mesh-list
15168867|NCT04047849|Azithromycin|azithromycin|mesh-list
15168868|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168869|NCT04047914|Mupirocin|mupirocin|mesh-list
15168870|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15168871|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168872|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15168873|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168874|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168875|NCT04047875|Norethindrone|norethindrone|mesh-list
15168876|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
15168877|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15168878|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15168879|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15168880|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
15168881|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15168882|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630543|NCT00145184|Vitamins|vitamins|mesh-list
15168883|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15168884|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14630544|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
15168885|NCT04047745|Bupivacaine|bupivacaine|mesh-list
15168886|NCT04047745|Ropivacaine|ropivacaine|mesh-list
15168887|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168888|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
15168889|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168890|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168891|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
15168892|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168893|NCT04047680|Ritonavir|ritonavir|mesh-list
15168894|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
14630545|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
14630546|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630547|NCT00145210|Atenolol|atenolol|mesh-list
14630548|NCT00145210|Nebivolol|nebivolol|mesh-list
14630549|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14630550|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630551|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
14630552|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
15168895|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15168896|NCT04047680|Grazoprevir|grazoprevir|mesh-list
15168897|NCT04047680|Ledipasvir|ledipasvir|mesh-list
15168898|NCT04047680|Velpatasvir|velpatasvir|mesh-list
15168899|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15168900|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15168901|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
15168902|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168903|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168904|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15168905|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15168906|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
15168907|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168908|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15168909|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15168910|NCT04047576|Sirolimus|sirolimus|mesh-list
15168911|NCT04047576|Prednisone|prednisone|mesh-list
15168912|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168913|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
15168914|NCT04047576|Hormones|hormones|mesh-ancestor
15168915|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168916|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168917|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15168918|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168919|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15168920|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15168921|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15168922|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
15168923|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15168924|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
15168925|NCT04047797|Rituximab|rituximab|mesh-list
15168926|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15168927|NCT04047797|Ixazomib|ixazomib|mesh-list
15168928|NCT04047797|Antibodies|antibodies|mesh-list
15168929|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
15168930|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15168931|NCT04047797|Glycine|glycine|mesh-list
15168932|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
15168933|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168934|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168935|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15168936|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168937|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
15168938|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630553|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630554|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630555|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14630556|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14630557|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14630558|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
14630559|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630560|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630561|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
14630562|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14630563|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15168939|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
15168940|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630564|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15168941|NCT04047329|Anesthetics|anesthetics|mesh-list
15168942|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14630565|NCT00145236|Nebivolol|nebivolol|mesh-list
14630566|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630567|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
14630568|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14630569|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14630570|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14630571|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
14630572|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630573|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630574|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630575|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
14630576|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14630577|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630578|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
14630579|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14630580|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15168943|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168944|NCT04047394|Rasburicase|rasburicase|mesh-list
15168945|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
15168946|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15168947|NCT04047355|Propranolol|propranolol|mesh-list
15168948|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15168949|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15168950|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
14630581|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630582|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630583|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14630584|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14630585|NCT00145301|Analgesics|analgesics|mesh-ancestor
14630586|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
14630587|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630588|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630589|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14630590|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14630591|NCT00145314|Leucovorin|leucovorin|mesh-list
15168951|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15168952|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168953|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168954|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15168955|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15168956|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
15168957|NCT04047446|Dexamethasone|dexamethasone|mesh-list
14630592|NCT00145314|Folic Acid|folic acid|mesh-list
14630593|NCT00145314|Fluorouracil|fluorouracil|mesh-list
14630594|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
14630595|NCT00145314|Cetuximab|cetuximab|mesh-list
14630596|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
14630597|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
14630598|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630599|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14630600|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630601|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630602|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
14630603|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630604|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14630605|NCT00145314|Antidotes|antidotes|mesh-ancestor
14630606|NCT00145314|Protective Agents|protective agents|mesh-ancestor
14630607|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
14630608|NCT00145314|Vitamins|vitamins|mesh-ancestor
14630609|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
14630610|NCT00145314|Hematinics|hematinics|mesh-ancestor
14630611|NCT00145340|Pioglitazone|pioglitazone|mesh-list
14630612|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630613|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630614|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
14630615|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630616|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630617|NCT00145379|Metformin|metformin|mesh-list
15168958|NCT04047446|Bupivacaine|bupivacaine|mesh-list
15168959|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15168960|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
15168961|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
15168962|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168963|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630618|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630619|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168964|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15168965|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
15168966|NCT04047446|Hormones|hormones|mesh-ancestor
15168967|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15168968|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15168969|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168970|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
15168971|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
15168972|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168973|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
15168974|NCT04047017|Apatinib|apatinib|mesh-list
15168975|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15168976|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15168977|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630620|NCT00145405|Octreotide|octreotide|mesh-list
14630621|NCT00145405|Lanreotide|lanreotide|mesh-list
14630622|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14630623|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14630624|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630625|NCT00145444|Olanzapine|olanzapine|mesh-list
14630626|NCT00145444|Ziprasidone|ziprasidone|mesh-list
14630627|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
14630628|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
14630629|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630630|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630631|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14630632|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14630633|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14630634|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14630635|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14630636|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14630637|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14630638|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14630639|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630640|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630641|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
14630642|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14630643|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14630644|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
14630645|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
14630646|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
14630647|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14630648|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14630649|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15168978|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168979|NCT04046874|Analgesics|analgesics|mesh-list
15168980|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
15168981|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15168982|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168983|NCT04046744|Lidocaine|lidocaine|mesh-list
15168984|NCT04046744|Analgesics|analgesics|mesh-list
15168985|NCT04046744|Ropivacaine|ropivacaine|mesh-list
15168986|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
15168987|NCT04046744|Anesthetics|anesthetics|mesh-list
15168988|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15168989|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15168990|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
14630650|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630651|NCT00145483|Urological Agents|urological agents|mesh-ancestor
14630652|NCT00145522|Tibolone|tibolone|mesh-list
14630653|NCT00145522|Estradiol|estradiol|mesh-list
14630654|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
14630655|NCT00145522|Estrogens|estrogens|mesh-ancestor
14630656|NCT00145522|Hormones|hormones|mesh-ancestor
14630657|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14630658|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630659|NCT00145522|Progestins|progestins|mesh-ancestor
14630660|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
14630661|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
14630662|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630663|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14630664|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630665|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14630666|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
14630667|NCT00145561|Ritonavir|ritonavir|mesh-list
14630668|NCT00145561|Saquinavir|saquinavir|mesh-list
15168991|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630669|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14630670|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14630671|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630672|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630673|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630674|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630675|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630676|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
14630677|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630678|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14630679|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14630680|NCT00145613|Antibodies|antibodies|mesh-list
14630681|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
14630682|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630683|NCT00145639|Carboplatin|carboplatin|mesh-list
14630684|NCT00145639|Doxorubicin|doxorubicin|mesh-list
14630685|NCT00145639|Ifosfamide|ifosfamide|mesh-list
15168992|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15168993|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15168994|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15168995|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15168996|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15168997|NCT04047186|Nivolumab|nivolumab|mesh-list
15168998|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15168999|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169000|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15169001|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630686|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630687|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14630688|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630689|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630690|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169002|NCT04047004|Doxorubicin|doxorubicin|mesh-list
15169003|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169004|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15169005|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15169006|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15169007|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169008|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169009|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
15169010|NCT04046861|Vitamins|vitamins|mesh-ancestor
15169011|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
15169012|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169013|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
15169014|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169015|NCT04046861|Protective Agents|protective agents|mesh-ancestor
15181135|NCT03932578|Metoclopramide|metoclopramide|mesh-list
15181136|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15181137|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15181138|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14630691|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630692|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14630693|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
14630694|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14630695|NCT00145652|Hematinics|hematinics|mesh-ancestor
14630696|NCT00145665|Telbivudine|telbivudine|mesh-list
14630697|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
14630698|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630699|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630700|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181139|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
15181140|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630701|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630702|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
14630703|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
14630704|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14630705|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14630706|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14630707|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630708|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630709|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630710|NCT00145730|Ibuprofen|ibuprofen|mesh-list
15181141|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181142|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14630711|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14630712|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14630713|NCT00145730|Analgesics|analgesics|mesh-ancestor
14630714|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
14630715|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630716|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630717|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14630718|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14630719|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14630720|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169016|NCT04046822|Liraglutide|liraglutide|mesh-list
15169017|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15169018|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169019|NCT04046822|Incretins|incretins|mesh-ancestor
15169020|NCT04046822|Hormones|hormones|mesh-ancestor
15169021|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169022|NCT04046510|Oxytocin|oxytocin|mesh-list
15169023|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
15169024|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169025|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169026|NCT04046653|Sulforaphane|sulforaphane|mesh-list
15169027|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15169028|NCT04046653|Protective Agents|protective agents|mesh-ancestor
15169029|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169030|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169031|NCT04046679|Bleomycin|bleomycin|mesh-list
14630721|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630722|NCT00145847|Naltrexone|naltrexone|mesh-list
14630723|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14630724|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14630725|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630726|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
14630727|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630728|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14630729|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
14630730|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630731|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
14630732|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630733|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14630734|NCT00145925|Gliclazide|gliclazide|mesh-list
14630735|NCT00145925|Perindopril|perindopril|mesh-list
14630736|NCT00145925|Indapamide|indapamide|mesh-list
14630737|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
14630738|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14630739|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630740|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630741|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630742|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630743|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630744|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630745|NCT00145925|Diuretics|diuretics|mesh-ancestor
14630746|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
14630747|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14630748|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14630749|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
14630750|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
14630751|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15169032|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15169033|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169034|NCT04046029|Heparin|heparin|mesh-list
15169035|NCT04046029|Bivalirudin|bivalirudin|mesh-list
15169036|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
15169037|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15169038|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15169039|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169040|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
15169041|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15169042|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
15169043|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169044|NCT04046016|Paclitaxel|paclitaxel|mesh-list
15169045|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15169046|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169047|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
15169048|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
15169049|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
15169050|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169051|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
15169052|NCT04046094|Vitamins|vitamins|mesh-ancestor
15169053|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
15169054|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169055|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
15169056|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169057|NCT04046094|Protective Agents|protective agents|mesh-ancestor
15169058|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
15169059|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
15169060|NCT04046289|Calcium|calcium|mesh-list
15169061|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14630752|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14630753|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630754|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630755|NCT00145938|Urological Agents|urological agents|mesh-ancestor
14630756|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
14630757|NCT00145990|Miotics|miotics|mesh-ancestor
14630758|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
14630759|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630760|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630761|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14630762|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14630763|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
14630764|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15169062|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169063|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15169064|NCT04046289|Antacids|antacids|mesh-ancestor
15169065|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169066|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14630765|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14630766|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
14630767|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630768|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630769|NCT00146016|Amantadine|amantadine|mesh-list
14630770|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14630771|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14630772|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
15169067|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
15169068|NCT04046133|Capecitabine|capecitabine|mesh-list
15169069|NCT04046133|Mitomycins|mitomycins|mesh-list
15169070|NCT04046133|Mitomycin|mitomycin|mesh-list
15169071|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169072|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630773|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630774|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
14630775|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630776|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169073|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15169074|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
15169075|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169076|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15169077|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
15169078|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15169079|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169080|NCT04046302|Dinoprostone|dinoprostone|mesh-list
15169081|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
15169082|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169083|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169084|NCT04045678|Rotigotine|rotigotine|mesh-list
15169085|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
15169086|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
15169087|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169088|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169089|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169090|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
15169091|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169092|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169093|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15169094|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15169095|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169096|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169097|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630777|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630778|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169098|NCT04045730|Gemcitabine|gemcitabine|mesh-list
15169099|NCT04045730|Paclitaxel|paclitaxel|mesh-list
15169100|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
15169101|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15169102|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169103|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
15169104|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
15169105|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
15169106|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169107|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14630779|NCT00146016|Analgesics|analgesics|mesh-ancestor
14630780|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
14630781|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630782|NCT00146042|Erythromycin|erythromycin|mesh-list
14630783|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
14630784|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14630785|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
14630786|NCT00146042|Docetaxel|docetaxel|mesh-list
14630787|NCT00146042|Trastuzumab|trastuzumab|mesh-list
14630788|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630789|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14630790|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14630791|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14630792|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630793|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14630794|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14630795|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630796|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14630797|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14630798|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630799|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
14630800|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14630801|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
14630802|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630803|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630804|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
14630805|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169108|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
15169109|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
15169110|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169111|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169112|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15169113|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
15169114|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169115|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169116|NCT04045821|Plerixafor|plerixafor|mesh-list
15169117|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15169118|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15169119|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
15169120|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169121|NCT04045548|Dinoprostone|dinoprostone|mesh-list
15169122|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
15169123|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169124|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169125|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
15169126|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15169127|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169128|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15169129|NCT04046185|Progesterone|progesterone|mesh-list
15169130|NCT04046185|Progestins|progestins|mesh-ancestor
15169131|NCT04046185|Hormones|hormones|mesh-ancestor
15169132|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169133|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630806|NCT00146120|Etoposide|etoposide|mesh-list
14630807|NCT00146120|Idarubicin|idarubicin|mesh-list
14630808|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14630809|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630810|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630811|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630812|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630813|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630814|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14630815|NCT00146146|Letrozole|letrozole|mesh-list
14630816|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
14630817|NCT00146146|Dutasteride|dutasteride|mesh-list
15169134|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169135|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630818|NCT00146146|Testosterone|testosterone|mesh-list
14630819|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
14630820|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
14630821|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14630822|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630823|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14630824|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14630825|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630826|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630827|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14630828|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
14630829|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14630830|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630831|NCT00146146|Androgens|androgens|mesh-ancestor
14630832|NCT00146146|Hormones|hormones|mesh-ancestor
14630833|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14630834|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
14630835|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14630836|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
14630837|NCT00146159|Analgesics|analgesics|mesh-ancestor
15169136|NCT04046159|Tamoxifen|tamoxifen|mesh-list
15169137|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15169138|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
15169139|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169140|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169141|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15169142|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169143|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15169144|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15169145|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15169146|NCT04045431|Hylan|hylan|mesh-list
15169147|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
15169148|NCT04045431|Protective Agents|protective agents|mesh-ancestor
15169149|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169150|NCT04045093|Warfarin|warfarin|mesh-list
15169151|NCT04045093|Dabigatran|dabigatran|mesh-list
15169152|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
15169153|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
15169154|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15169155|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
15169156|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169157|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169158|NCT04044976|Caffeine|caffeine|mesh-list
15169159|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
15169160|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169161|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15169162|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169163|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15169164|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169165|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15169166|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15169167|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
15169168|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14630838|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
14630839|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630840|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169169|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
15169170|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15169171|NCT04044690|Antibodies|antibodies|mesh-list
15169172|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
15169173|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
15169174|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169175|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
15169176|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181143|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
15181144|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
15181145|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
15181146|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15181147|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15181148|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
14630841|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630842|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630843|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15181149|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181150|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169177|NCT04044651|Nivolumab|nivolumab|mesh-list
14630844|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630845|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630846|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14630847|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14630848|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14630849|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
14630850|NCT00146224|Hematinics|hematinics|mesh-ancestor
14630851|NCT00146237|Phenytoin|phenytoin|mesh-list
14630852|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
14630853|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14630854|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14022514|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14022515|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022516|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630855|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169178|NCT04044651|Lenvatinib|lenvatinib|mesh-list
15169179|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169180|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169181|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15169182|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169183|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15169184|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169185|NCT04044703|Vancomycin|vancomycin|mesh-list
15169186|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169187|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169188|NCT04044378|Ifosfamide|ifosfamide|mesh-list
15169189|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15169190|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
15169191|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169192|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169193|NCT04044430|Nivolumab|nivolumab|mesh-list
15169194|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169195|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169196|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15169197|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169198|NCT04044417|Curcumin|curcumin|mesh-list
15169199|NCT04044417|Simvastatin|simvastatin|mesh-list
15169200|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15169201|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15169202|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
15169203|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169204|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15169205|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15169206|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169207|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15169208|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169209|NCT04044417|Analgesics|analgesics|mesh-ancestor
15169210|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
14630856|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630857|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14630858|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630859|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
14630860|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14630861|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
14630862|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
14630863|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169211|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169212|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630864|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630865|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14630866|NCT00146250|Analgesics|analgesics|mesh-ancestor
14630867|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
14630868|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630869|NCT00146276|Gemcitabine|gemcitabine|mesh-list
14630870|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14630871|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
14630872|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630873|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630874|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
14630875|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169213|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14630876|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169214|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169215|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169216|NCT04044547|Rotigotine|rotigotine|mesh-list
15169217|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
15169218|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
15169219|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169220|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169221|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169222|NCT04044313|Lenvatinib|lenvatinib|mesh-list
15169223|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169224|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15169225|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169226|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169227|NCT04044287|Misoprostol|misoprostol|mesh-list
15169228|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15169229|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
15169230|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169231|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169232|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15169233|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169234|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
15169235|NCT04043897|Rifaximin|rifaximin|mesh-list
14630877|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630878|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
14630879|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630880|NCT00146289|Telmisartan|telmisartan|mesh-list
14630881|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630882|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14630883|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14630884|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630885|NCT00146341|Telmisartan|telmisartan|mesh-list
14630886|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14630887|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14630888|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15169236|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169237|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169238|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169239|NCT04043858|Midodrine|midodrine|mesh-list
15169240|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
15169241|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
15169242|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169243|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169244|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15169245|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15169246|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15169247|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15169248|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
15169249|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169250|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630889|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630890|NCT00146380|Lamivudine|lamivudine|mesh-list
14630891|NCT00146380|Zidovudine|zidovudine|mesh-list
14630892|NCT00146380|Nevirapine|nevirapine|mesh-list
14630893|NCT00146380|Nelfinavir|nelfinavir|mesh-list
15169251|NCT04044131|Sorbitol|sorbitol|mesh-list
15169252|NCT04044131|Cathartics|cathartics|mesh-ancestor
15169253|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169254|NCT04044079|Misoprostol|misoprostol|mesh-list
15169255|NCT04044079|Dinoprostone|dinoprostone|mesh-list
15169256|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15169257|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
15169258|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169259|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169260|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15169261|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169262|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
14630894|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14630895|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14630896|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169263|NCT04044222|Carboplatin|carboplatin|mesh-list
15169264|NCT04044222|Etoposide|etoposide|mesh-list
15169265|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
15169266|NCT04044222|Ifosfamide|ifosfamide|mesh-list
15169267|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
15169268|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169269|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15169270|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15169271|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15169272|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169273|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169274|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15169275|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
15169276|NCT04043676|Ponatinib|ponatinib|mesh-list
15169277|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169278|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15169279|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630897|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630898|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
14630899|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630900|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14630901|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14630902|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
14630903|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14630904|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14630905|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14630906|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14630907|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
14630908|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14630909|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14630910|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630911|NCT00146471|Levetiracetam|levetiracetam|mesh-list
14630912|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
14630913|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
14630914|NCT00146484|Insulin|insulin|mesh-list
14630915|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630916|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630917|NCT00146497|Budesonide|budesonide|mesh-list
14630918|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14630919|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14630920|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14630921|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
14630922|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14630923|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630924|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14630925|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
14630926|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
14022517|NCT02768116|Sirolimus|sirolimus|mesh-list
14630927|NCT00146497|Hormones|hormones|mesh-ancestor
14630928|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14630929|NCT00146523|Mifepristone|mifepristone|mesh-list
14630930|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14630931|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
14630932|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14630933|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630934|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15169280|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169281|NCT04043520|Estradiol|estradiol|mesh-list
15169282|NCT04043520|Estrogens|estrogens|mesh-list
15169283|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15169284|NCT04043520|Hormones|hormones|mesh-ancestor
15169285|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169286|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169287|NCT04043806|Ivacaftor|ivacaftor|mesh-list
15169288|NCT04043806|Elexacaftor|elexacaftor|mesh-list
15169289|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15169290|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169291|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169292|NCT04043702|Topiramate|topiramate|mesh-list
15169293|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
14630935|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14630936|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14630937|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
14630938|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14630939|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14630940|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
14630941|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14630942|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
14630943|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14630944|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15169294|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14630945|NCT00146549|Paclitaxel|paclitaxel|mesh-list
14630946|NCT00146549|Vinorelbine|vinorelbine|mesh-list
14630947|NCT00146549|Docetaxel|docetaxel|mesh-list
14630948|NCT00146549|Trastuzumab|trastuzumab|mesh-list
14630949|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14630950|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630951|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
14630952|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
14630953|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14630954|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630955|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14630956|NCT00146562|Paclitaxel|paclitaxel|mesh-list
14630957|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
14630958|NCT00146562|Doxorubicin|doxorubicin|mesh-list
14630959|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
14630960|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14630961|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630962|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14630963|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14630964|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14630965|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630966|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630967|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
14630968|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630969|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14630970|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14630971|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
14630972|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14630973|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14630974|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14630975|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14630976|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14630977|NCT00146562|Hematinics|hematinics|mesh-ancestor
14630978|NCT00146575|Sirolimus|sirolimus|mesh-list
14630979|NCT00146575|Paclitaxel|paclitaxel|mesh-list
14630980|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14630981|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14630982|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
14630983|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
14630984|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
14630985|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14630986|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14630987|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14630988|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14630989|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
14630990|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14630991|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
14630992|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630993|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
14630994|NCT00146588|Capecitabine|capecitabine|mesh-list
14630995|NCT00146588|Epirubicin|epirubicin|mesh-list
14630996|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15169295|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169296|NCT04043624|Lidocaine|lidocaine|mesh-list
15169297|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
15169298|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
15169299|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169300|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169301|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
15169302|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169303|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15169304|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15169305|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15169306|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169307|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169308|NCT04043494|Cytarabine|cytarabine|mesh-list
15169309|NCT04043494|Dexamethasone|dexamethasone|mesh-list
15169310|NCT04043494|Prednisone|prednisone|mesh-list
15169311|NCT04043494|Prednisolone|prednisolone|mesh-list
15169312|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
15169313|NCT04043494|Ifosfamide|ifosfamide|mesh-list
15169314|NCT04043494|Doxorubicin|doxorubicin|mesh-list
14630997|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
14630998|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14630999|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169315|NCT04043494|Methotrexate|methotrexate|mesh-list
15169316|NCT04043494|Vincristine|vincristine|mesh-list
15169317|NCT04043494|Daunorubicin|daunorubicin|mesh-list
14631000|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14631001|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
14631002|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631003|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631004|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14631005|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631006|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
14631007|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14631008|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14631009|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14631010|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631011|NCT00146601|Fulvestrant|fulvestrant|mesh-list
14631012|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14631013|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631014|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14631015|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14631016|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
14631017|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631018|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631019|NCT00146614|Sirolimus|sirolimus|mesh-list
14631020|NCT00146614|Methotrexate|methotrexate|mesh-list
14631021|NCT00146614|Tacrolimus|tacrolimus|mesh-list
14631022|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14631023|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
14631024|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14631025|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631026|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022518|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022519|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022520|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14022521|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022522|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
15169318|NCT04043494|Asparaginase|asparaginase|mesh-list
15169319|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
15169320|NCT04043494|Thioguanine|thioguanine|mesh-list
14631027|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
14631028|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631029|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631030|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
14631031|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631032|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14631033|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631034|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
14631035|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631036|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14631037|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14631038|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631039|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631040|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14631041|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
14631042|NCT00146627|Eflornithine|eflornithine|mesh-list
14631043|NCT00146627|Nifurtimox|nifurtimox|mesh-list
14631044|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631045|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14631046|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14631047|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14631048|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631049|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14631050|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631051|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631052|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
14631053|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
14631054|NCT00146718|Amodiaquine|amodiaquine|mesh-list
14631055|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
14631056|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14631057|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14631058|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631059|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14631060|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631061|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631062|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14631063|NCT00146718|Renal Agents|renal agents|mesh-ancestor
14631064|NCT00146731|Artesunate|artesunate|mesh-list
14631065|NCT00146731|Amodiaquine|amodiaquine|mesh-list
15169321|NCT04043494|Pegaspargase|pegaspargase|mesh-list
15169322|NCT04043494|Vindesine|vindesine|mesh-list
14631066|NCT00146731|Dapsone|dapsone|mesh-list
14631067|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
14631068|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
14631069|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14631070|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14631071|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631072|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631073|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
14631074|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
14631075|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14631076|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
14631077|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15169323|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15169324|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
15169325|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169326|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169327|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15169328|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
15169329|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169330|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169331|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15169332|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169333|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
15169334|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
15169335|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169336|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169337|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
15169338|NCT04043494|Hormones|hormones|mesh-ancestor
15169339|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169340|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15169341|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15169342|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15169343|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15169344|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169345|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14631078|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631079|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631080|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
15169346|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
15169347|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169348|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631081|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631082|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
14631083|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
14631084|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14631085|NCT00146783|Amodiaquine|amodiaquine|mesh-list
14631086|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
14631087|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14631088|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14631089|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631090|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14631091|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631092|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631093|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14631094|NCT00146783|Renal Agents|renal agents|mesh-ancestor
14631095|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14631096|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
14631097|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631098|NCT00146900|Citalopram|citalopram|mesh-list
14631099|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14631100|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14631101|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14631102|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631103|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631104|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
14631105|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631106|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14631107|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
14631108|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631109|NCT00146913|Interferons|interferons|mesh-list
14631110|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
15169349|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
15169350|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
15169351|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14631111|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169352|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15169353|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
15169354|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169355|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15169356|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
15169357|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
15169358|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
15169359|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
15169360|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169361|NCT04043325|Antibodies|antibodies|mesh-list
15169362|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
15169363|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169364|NCT04042948|Acetaminophen|acetaminophen|mesh-list
15169365|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169366|NCT04042948|Analgesics|analgesics|mesh-ancestor
15169367|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
15169368|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169369|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169370|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
15169371|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
15169372|NCT04043195|Nivolumab|nivolumab|mesh-list
15169373|NCT04043195|Ipilimumab|ipilimumab|mesh-list
15169374|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169375|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169376|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15169377|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169378|NCT04042974|Dinoprostone|dinoprostone|mesh-list
15169379|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
15169380|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169381|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169382|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
15169383|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15181151|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
15181152|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631112|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
14631113|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631114|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14631115|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631116|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631117|NCT00146926|Lidocaine|lidocaine|mesh-list
15181153|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15181154|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15181155|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
15181156|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
15181157|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15182251|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182252|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15182253|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15182254|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
15182255|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182256|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15182257|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14631118|NCT00146926|Ephedrine|ephedrine|mesh-list
14631119|NCT00146926|Ketamine|ketamine|mesh-list
14631120|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
14631121|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
14631122|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631123|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631124|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
14631125|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631126|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14631127|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14631128|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14631129|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14631130|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631131|NCT00146926|Analgesics|analgesics|mesh-ancestor
14631132|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14631133|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14631134|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
14631135|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14631136|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14631137|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182258|NCT03923179|Etoposide|etoposide|mesh-list
15182259|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15182260|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631138|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14631139|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
14631140|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
14631141|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14631142|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
14631143|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
14631144|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14631145|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14631146|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14631147|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631148|NCT00147121|Rituximab|rituximab|mesh-list
14631149|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14631150|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631151|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
14631152|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631153|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631154|NCT00147160|Temozolomide|temozolomide|mesh-list
14631155|NCT00147160|Cisplatin|cisplatin|mesh-list
14631156|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15169384|NCT04042805|Lenvatinib|lenvatinib|mesh-list
15169385|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169386|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15169387|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169388|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169389|NCT04042506|Nivolumab|nivolumab|mesh-list
15169390|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14631157|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
14631158|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631159|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169391|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169392|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15169393|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169394|NCT04042441|Insulin|insulin|mesh-list
15169395|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
15169396|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15169397|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169398|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
15169399|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15169400|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15169401|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169402|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
15169403|NCT04042688|Coagulants|coagulants|mesh-ancestor
15169404|NCT04042558|Bevacizumab|bevacizumab|mesh-list
14631160|NCT00147186|Hylan|hylan|mesh-list
14631161|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
14631162|NCT00147186|Protective Agents|protective agents|mesh-ancestor
14631163|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631164|NCT00147264|Telmisartan|telmisartan|mesh-list
14631165|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14631166|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14631167|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15169405|NCT04042558|Carboplatin|carboplatin|mesh-list
15169406|NCT04042558|Pemetrexed|pemetrexed|mesh-list
15169407|NCT04042558|Atezolizumab|atezolizumab|mesh-list
15169408|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15169409|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169410|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631168|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631169|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
14631170|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14631171|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14631172|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631173|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14631174|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14631175|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
14631176|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631177|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631178|NCT00147355|Acetaminophen|acetaminophen|mesh-list
14631179|NCT00147355|Ibuprofen|ibuprofen|mesh-list
14631180|NCT00147355|Codeine|codeine|mesh-list
14631181|NCT00147355|Ondansetron|ondansetron|mesh-list
15169411|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14631182|NCT00147355|Metoclopramide|metoclopramide|mesh-list
14631183|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14631184|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169412|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14631185|NCT00147355|Analgesics|analgesics|mesh-ancestor
14631186|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
14631187|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631188|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631189|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631190|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631191|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14631192|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631193|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631194|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
14631195|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
14631196|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
14631197|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631198|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
14631199|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
14631200|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14631201|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
14631202|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631203|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14631204|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14631205|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631206|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631207|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14631208|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14631209|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14631210|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
14631211|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14631212|NCT00147355|Narcotics|narcotics|mesh-ancestor
14631213|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
14631214|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
14631215|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
15169413|NCT04042558|Growth Substances|growth substances|mesh-ancestor
15169414|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169415|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
15169416|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631216|NCT00147381|Tacrolimus|tacrolimus|mesh-list
14631217|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631218|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
14631219|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631220|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14631221|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631222|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631223|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169417|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169418|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15169419|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15169420|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
15169421|NCT04042714|Trifluridine|trifluridine|mesh-list
15169422|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
14631224|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631225|NCT00147394|Risperidone|risperidone|mesh-list
14631226|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14631227|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
14631228|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631229|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631230|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631231|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14631232|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14631233|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631234|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631235|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14631236|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
14631237|NCT00147511|Linezolid|linezolid|mesh-list
14631238|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631239|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631240|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14631241|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631242|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631243|NCT00147524|Quinapril|quinapril|mesh-list
14631244|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14631245|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
14631246|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169423|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631247|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631248|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14631249|NCT00147563|Eplerenone|eplerenone|mesh-list
14631250|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14631251|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
14631252|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631253|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631254|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14631255|NCT00147563|Diuretics|diuretics|mesh-ancestor
14631256|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
15169424|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
15169425|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169426|NCT04042233|Vancomycin|vancomycin|mesh-list
14814106|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814107|NCT00861523|Thiamine|thiamine|mesh-list
15169427|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169428|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169429|NCT04041934|Tryptophan|tryptophan|mesh-list
15169430|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15169431|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
15169432|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631257|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14631258|NCT00147589|Eplerenone|eplerenone|mesh-list
14631259|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14631260|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
14631261|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631262|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631263|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14631264|NCT00147589|Diuretics|diuretics|mesh-ancestor
14631265|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
14631266|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14631267|NCT00147602|Atorvastatin|atorvastatin|mesh-list
14631268|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14631269|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14631270|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
14631271|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631272|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14631273|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14631274|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631275|NCT00147615|Eplerenone|eplerenone|mesh-list
14631276|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14631277|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
14631278|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631279|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631280|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14631281|NCT00147615|Diuretics|diuretics|mesh-ancestor
14631282|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
14631283|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14631284|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
14631285|NCT00147628|Citric Acid|citric acid|mesh-list
14631286|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
14631287|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
14631288|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14631289|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
14631290|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
14631291|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631292|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
14631293|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14631294|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14631295|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631296|NCT00147628|Urological Agents|urological agents|mesh-ancestor
14631297|NCT00147654|Tamsulosin|tamsulosin|mesh-list
14631298|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14631299|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14631300|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14631301|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14631302|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14631303|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631304|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631305|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814108|NCT00861523|Promethazine|promethazine|mesh-list
15169433|NCT04042051|Trastuzumab|trastuzumab|mesh-list
15169434|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15169435|NCT04042051|Maytansine|maytansine|mesh-list
15169436|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15169437|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631306|NCT00147654|Urological Agents|urological agents|mesh-ancestor
14631307|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14631308|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14631309|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
14631310|NCT00147667|Erythromycin|erythromycin|mesh-list
14631311|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
14631312|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14631313|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
14631314|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631315|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631316|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631317|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14631318|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631319|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631320|NCT00147680|Paclitaxel|paclitaxel|mesh-list
14631321|NCT00147680|Carboplatin|carboplatin|mesh-list
14631322|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14631323|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631324|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631325|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631326|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631327|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631328|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14631329|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14631330|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14631331|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
14631332|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631333|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14022523|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022524|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
14631334|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14631335|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14631336|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14631337|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
14631338|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631339|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14631340|NCT00147771|Imiquimod|imiquimod|mesh-list
14631341|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14631342|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
14631343|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631344|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169438|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15169439|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
15169440|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
15169441|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
15169442|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169443|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
15169444|NCT04042220|Hormones|hormones|mesh-ancestor
15169445|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169446|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169447|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
15169448|NCT04041856|Povidone|povidone|mesh-list
15169449|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
15169450|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
15169451|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15169452|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169453|NCT04042142|Glucagon|glucagon|mesh-list
15169454|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169455|NCT04042142|Hormones|hormones|mesh-ancestor
15169456|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022525|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169457|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169458|NCT04041843|Apixaban|apixaban|mesh-list
14631345|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
14631346|NCT00147784|Interferons|interferons|mesh-list
14631347|NCT00147784|Ribavirin|ribavirin|mesh-list
14631348|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631349|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
14631350|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631351|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
14631352|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631353|NCT00147836|Insulin|insulin|mesh-list
14022526|NCT02767999|Fluoxetine|fluoxetine|mesh-list
14631354|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14631355|NCT00147836|Metformin|metformin|mesh-list
14631356|NCT00147836|Gliclazide|gliclazide|mesh-list
15169459|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14631357|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
14631358|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
14631359|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
14631360|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14631361|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631362|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
14631363|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14631364|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14631365|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631366|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
14631367|NCT00147862|Coagulants|coagulants|mesh-ancestor
14631368|NCT00147875|Gemcitabine|gemcitabine|mesh-list
14631369|NCT00147875|Prednisone|prednisone|mesh-list
14631370|NCT00147875|Doxorubicin|doxorubicin|mesh-list
14631371|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14631372|NCT00147875|Vinblastine|vinblastine|mesh-list
14631373|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631374|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
14631375|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631376|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631377|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
14631378|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631379|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631380|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631381|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
14631382|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631383|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14631384|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14631385|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14631386|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631387|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
14631388|NCT00147875|Hormones|hormones|mesh-ancestor
14631389|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631390|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14631391|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14631392|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631393|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631394|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631395|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
14631396|NCT00147901|Fludarabine|fludarabine|mesh-list
14631397|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
14631398|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631399|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
14631400|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631401|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631402|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14631403|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
14631404|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631405|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631406|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14631407|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14631408|NCT00147914|Amoxicillin|amoxicillin|mesh-list
14631409|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
14631410|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
15169460|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
15169461|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15169462|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
15169463|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169464|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169465|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
15169466|NCT04041492|Vitamin D|vitamin d|mesh-list
15169467|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
15169468|NCT04041492|Vitamins|vitamins|mesh-ancestor
15169469|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
15169470|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169471|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15169472|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15169473|NCT04041791|Amoxicillin|amoxicillin|mesh-list
15169474|NCT04041791|Gentamicins|gentamicins|mesh-list
15169475|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
14631411|NCT00147914|Cefdinir|cefdinir|mesh-list
14631412|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14631413|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169476|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
14631414|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169477|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
15169478|NCT04041791|Penicillins|penicillins|mesh-list
15169479|NCT04041791|Ampicillin|ampicillin|mesh-list
14631415|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14631416|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631417|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631418|NCT00147953|Rituximab|rituximab|mesh-list
14631419|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14631420|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631421|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
14631422|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631423|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631424|NCT00147979|Heparin|heparin|mesh-list
14631425|NCT00147979|Calcium heparin|calcium heparin|mesh-list
14631426|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
14631427|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14631428|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14631429|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631430|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14631431|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
14631432|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631433|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631434|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631435|NCT00148018|Dexamethasone|dexamethasone|mesh-list
14631436|NCT00148018|Bortezomib|bortezomib|mesh-list
14631437|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631438|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
14631439|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
14631440|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631441|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631442|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631443|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
14631444|NCT00148018|Hormones|hormones|mesh-ancestor
14631445|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631446|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14631447|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631448|NCT00148031|Interferons|interferons|mesh-list
14631449|NCT00148031|Ribavirin|ribavirin|mesh-list
14631450|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631451|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
14631452|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631453|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
14631454|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631455|NCT00148070|Erythromycin|erythromycin|mesh-list
14631456|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
14631457|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14631458|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
14631459|NCT00148070|Docetaxel|docetaxel|mesh-list
14631460|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631461|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631462|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631463|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631464|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631465|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631466|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631467|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631468|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14631469|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631470|NCT00148083|Risperidone|risperidone|mesh-list
14631471|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14631472|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
14631473|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631474|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631475|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631476|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14631477|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14631478|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631479|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631480|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14631481|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
14631482|NCT00148135|Gemcitabine|gemcitabine|mesh-list
14631483|NCT00148135|Carboplatin|carboplatin|mesh-list
15169480|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15169481|NCT04041791|Penicillin G|penicillin g|mesh-list
15169482|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
15169483|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
14631484|NCT00148135|Capecitabine|capecitabine|mesh-list
14631485|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631486|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15169484|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169485|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169486|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15169487|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169488|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169489|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15169490|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15169491|NCT04041362|UB-421|ub-421|mesh-list
15169492|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
15169493|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169494|NCT04041349|Mitogens|mitogens|mesh-list
15169495|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
15169496|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169497|NCT04041427|Albendazole|albendazole|mesh-list
15169498|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
15169499|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15169500|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169501|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
15169502|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14631487|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
14631488|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631489|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
14631490|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631491|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631492|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631493|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
14631494|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631495|NCT00148148|Amphotericin B|amphotericin b|mesh-list
14631496|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14631497|NCT00148148|Caspofungin|caspofungin|mesh-list
14631498|NCT00148148|Amebicides|amebicides|mesh-ancestor
14631499|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14631500|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14631501|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631502|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631503|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
14631504|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631505|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646738|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646739|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
14646740|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646741|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646742|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14646743|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
14646744|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646745|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646746|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14646747|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169503|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15169504|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
15169505|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
15169506|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
15169507|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169508|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169509|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
15169510|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
15169511|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169512|NCT04041167|Protective Agents|protective agents|mesh-ancestor
15169513|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169514|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
15169515|NCT04041167|Vitamins|vitamins|mesh-ancestor
15169516|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
15169517|NCT04041128|Olaparib|olaparib|mesh-list
15169518|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15169519|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169520|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169521|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169522|NCT04041648|Treprostinil|treprostinil|mesh-list
15169523|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15169524|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15181158|NCT03932721|Evolocumab|evolocumab|mesh-list
15181159|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15181160|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15181161|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
14646748|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
15181162|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169525|NCT04040491|Gemcitabine|gemcitabine|mesh-list
15169526|NCT04040491|Lenalidomide|lenalidomide|mesh-list
15169527|NCT04040491|Antibodies|antibodies|mesh-list
15169528|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
15169529|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
15169530|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169531|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15169532|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
15169533|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169534|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169535|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
15169536|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169537|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169538|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15169539|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15169540|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15169541|NCT04040491|Growth Substances|growth substances|mesh-ancestor
15169542|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
14022527|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14631506|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
14631507|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14631508|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631509|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14631510|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
14631511|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631512|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631513|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631514|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631515|NCT00148265|Triamcinolone|triamcinolone|mesh-list
14631516|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631517|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
14631518|NCT00148265|Hormones|hormones|mesh-ancestor
14631519|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631520|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631521|NCT00148278|Dobutamine|dobutamine|mesh-list
14631522|NCT00148278|Epinephrine|epinephrine|mesh-list
14631523|NCT00148278|Norepinephrine|norepinephrine|mesh-list
14631524|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14631525|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14631526|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
14631527|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169543|NCT04040322|Iloprost|iloprost|mesh-list
15169544|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15169545|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
15169546|NCT04040465|Aspirin|aspirin|mesh-list
15169547|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15169548|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14631528|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631529|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631530|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14631531|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14631532|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
14631533|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631534|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14631535|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
14631536|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
14631537|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
14631538|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14631539|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14631540|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14631541|NCT00148278|Protective Agents|protective agents|mesh-ancestor
14631542|NCT00148291|Docetaxel|docetaxel|mesh-list
14631543|NCT00148291|Vinorelbine|vinorelbine|mesh-list
14631544|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631545|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631546|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631547|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631548|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631549|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14631550|NCT00148330|Triamcinolone|triamcinolone|mesh-list
14631551|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169549|NCT04040465|Analgesics|analgesics|mesh-ancestor
14631552|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
14631553|NCT00148330|Hormones|hormones|mesh-ancestor
14646749|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
15169550|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
15169551|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631554|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631555|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631556|NCT00148356|Paclitaxel|paclitaxel|mesh-list
14631557|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15169552|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169553|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169554|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169555|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15169556|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14631558|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631559|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631560|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631561|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631562|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631563|NCT00148382|Cetilistat|cetilistat|mesh-list
14631564|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631565|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631566|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14631567|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14631568|NCT00148395|Gemcitabine|gemcitabine|mesh-list
14631569|NCT00148395|Carboplatin|carboplatin|mesh-list
14631570|NCT00148395|Ifosfamide|ifosfamide|mesh-list
14631571|NCT00148395|Mitomycins|mitomycins|mesh-list
14631572|NCT00148395|Mitomycin|mitomycin|mesh-list
14631573|NCT00148395|Vinorelbine|vinorelbine|mesh-list
14631574|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631575|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631576|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
14631577|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631578|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
14631579|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631580|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631581|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631582|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
14631583|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631584|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14631585|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
14631586|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14631587|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14631588|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14631589|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631590|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631591|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631592|NCT00148408|Montelukast|montelukast|mesh-list
14631593|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14631594|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
14631595|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15169557|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169558|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15169559|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15169560|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169561|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
15169562|NCT04040452|Ketorolac|ketorolac|mesh-list
15169563|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15169564|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169565|NCT04040452|Analgesics|analgesics|mesh-ancestor
15169566|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
15169567|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169568|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169569|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169570|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169571|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15169572|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169573|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169574|NCT04040309|Lidocaine|lidocaine|mesh-list
15169575|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
15169576|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
15169577|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169578|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169579|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
15169580|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169581|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15169582|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15169583|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14631596|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
14631597|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631598|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631599|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14631600|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14631601|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631602|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
14631603|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
14631604|NCT00148421|Hematinics|hematinics|mesh-ancestor
14631605|NCT00148447|Citalopram|citalopram|mesh-list
14631606|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14631607|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14631608|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14631609|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169584|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169585|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631610|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631611|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
14631612|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631613|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14631614|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
14631615|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631616|NCT00148460|Tenecteplase|tenecteplase|mesh-list
14631617|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14631618|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14631619|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631620|NCT00148473|Misoprostol|misoprostol|mesh-list
14631621|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14631622|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
14631623|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14631624|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631625|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14631626|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631627|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
14631628|NCT00148499|Benzocaine|benzocaine|mesh-list
14631629|NCT00148499|Ambroxol|ambroxol|mesh-list
14631630|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
14631631|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
14631632|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631633|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631634|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
14631635|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631636|NCT00148499|Expectorants|expectorants|mesh-ancestor
14631637|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14631638|NCT00148551|Triamcinolone|triamcinolone|mesh-list
14631639|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14631640|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14631641|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14631642|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631643|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
14631644|NCT00148551|Hormones|hormones|mesh-ancestor
14631645|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631646|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631647|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631648|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
14631649|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631650|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631651|NCT00148564|Olanzapine|olanzapine|mesh-list
14631652|NCT00148564|Ziprasidone|ziprasidone|mesh-list
14631653|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
14631654|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
14631655|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631656|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631657|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631658|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14631659|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14631660|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631661|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631662|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15169586|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
15169587|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
15169588|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
14631663|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14631664|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14631665|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631666|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631667|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
14631668|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14631669|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14631670|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
14631671|NCT00148590|Memantine|memantine|mesh-list
14631672|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14631673|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14631674|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
14631675|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631676|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631677|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631678|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14631679|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14631680|NCT00148603|Montelukast|montelukast|mesh-list
14631681|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14631682|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
14631683|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14631684|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
14631685|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631686|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631687|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14631688|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14631689|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631690|NCT00148616|Memantine|memantine|mesh-list
14631691|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14631692|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14631693|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
14631694|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631695|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631696|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631697|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14631698|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14631699|NCT00148681|Paclitaxel|paclitaxel|mesh-list
14631700|NCT00148681|Vinorelbine|vinorelbine|mesh-list
14631701|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
14631702|NCT00148681|Doxorubicin|doxorubicin|mesh-list
14631703|NCT00148681|Trastuzumab|trastuzumab|mesh-list
14631704|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14631705|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631706|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631707|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631708|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631709|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631710|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631711|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
14631712|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631713|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631714|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14631715|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
14631716|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14631717|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14631718|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14631719|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14631720|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631721|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14631722|NCT00148694|Cisplatin|cisplatin|mesh-list
14631723|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631724|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14631725|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631726|NCT00148720|Capecitabine|capecitabine|mesh-list
14814109|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
15169589|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169590|NCT04039854|Propofol|propofol|mesh-list
15169591|NCT04039854|Sevoflurane|sevoflurane|mesh-list
15169592|NCT04039854|Desflurane|desflurane|mesh-list
15169593|NCT04039854|Isoflurane|isoflurane|mesh-list
15169594|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15169595|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169596|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169597|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15169598|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
14022528|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14631727|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631728|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
14631729|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631730|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631731|NCT00148746|Cyclosporine|cyclosporine|mesh-list
14631732|NCT00148746|Prednisolone|prednisolone|mesh-list
14631733|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
14631734|NCT00148746|Prednicarbate|prednicarbate|mesh-list
14631735|NCT00148746|Tacrolimus|tacrolimus|mesh-list
14631736|NCT00148746|Cyclosporins|cyclosporins|mesh-list
14631737|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631738|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
14631739|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631740|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14631741|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631742|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631743|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
14631744|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631745|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
14631746|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631747|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631748|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
14631749|NCT00148746|Hormones|hormones|mesh-ancestor
14631750|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631751|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14631752|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631753|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631754|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14631755|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14631756|NCT00148746|Analgesics|analgesics|mesh-ancestor
14631757|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
14631758|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14631759|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631760|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14631761|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631762|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631763|NCT00148785|Ritonavir|ritonavir|mesh-list
14631764|NCT00148785|Indinavir|indinavir|mesh-list
14631765|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
14631766|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14631767|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14631768|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
14631769|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631770|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631771|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14631772|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14631773|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
14631774|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631775|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14631776|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14631777|NCT00148824|Vaccines|vaccines|mesh-list
14631778|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14631779|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
14631780|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631781|NCT00148837|Interferons|interferons|mesh-list
14631782|NCT00148837|Ribavirin|ribavirin|mesh-list
14631783|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
14631784|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
14631785|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14631786|NCT00148837|Prazosin|prazosin|mesh-list
14631787|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631788|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
14631789|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631790|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
14631791|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631792|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
14631793|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631794|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14631795|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14631796|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14631797|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14631798|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
14631799|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631800|NCT00148850|Pioglitazone|pioglitazone|mesh-list
14631801|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14631802|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631803|NCT00148863|Interferons|interferons|mesh-list
14631804|NCT00148863|Ribavirin|ribavirin|mesh-list
14631805|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
14631806|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
14631807|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
14631808|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14631809|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631810|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
14631811|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631812|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
14631813|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631814|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
14631815|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631816|NCT00148876|Capecitabine|capecitabine|mesh-list
14631817|NCT00148876|Trastuzumab|trastuzumab|mesh-list
14631818|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631819|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
14631820|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631821|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631822|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14631823|NCT00148902|Docetaxel|docetaxel|mesh-list
14631824|NCT00148902|Lapatinib|lapatinib|mesh-list
14631825|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631826|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
14631827|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
14631828|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
14631829|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631830|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14631831|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631832|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
14631833|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14631834|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631835|NCT00149019|Antibodies|antibodies|mesh-list
14631836|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14631837|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
14631838|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631839|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
14631840|NCT00149058|Hematinics|hematinics|mesh-ancestor
14631841|NCT00149084|Amoxicillin|amoxicillin|mesh-list
14631842|NCT00149084|Clarithromycin|clarithromycin|mesh-list
14631843|NCT00149084|Lansoprazole|lansoprazole|mesh-list
14631844|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
14631845|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14631846|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631847|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14631848|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631849|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631850|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14631851|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14631852|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14631853|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631854|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14631855|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14631856|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14631857|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14631858|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14631859|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631860|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631861|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631862|NCT00149110|Analgesics|analgesics|mesh-ancestor
14631863|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
14631864|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631865|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
14631866|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631867|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
14631868|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
14631869|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631870|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
14631871|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631872|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14631873|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631874|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631875|NCT00149149|Polaprezinc|polaprezinc|mesh-list
14631876|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14631877|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631878|NCT00149162|Aldesleukin|aldesleukin|mesh-list
14631879|NCT00149162|Interleukin-2|interleukin-2|mesh-list
14631880|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631881|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14631882|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14631883|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
14631884|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631885|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14631886|NCT00149162|Analgesics|analgesics|mesh-ancestor
14631887|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
14631888|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631889|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631890|NCT00149188|Lanreotide|lanreotide|mesh-list
14631891|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631892|NCT00149201|Fluorouracil|fluorouracil|mesh-list
14631893|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
14631894|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631895|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631896|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631897|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631898|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
14631899|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631900|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
14631901|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15169599|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
15169600|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15169601|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15169602|NCT04039828|Zinc|zinc|mesh-list
15169603|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
15169604|NCT04039828|Trace Elements|trace elements|mesh-ancestor
15169605|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
15169606|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169607|NCT04039828|Astringents|astringents|mesh-ancestor
15169608|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
15169609|NCT04039880|Olorofim|olorofim|mesh-list
15169610|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
15169611|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169612|NCT04040023|Vitamins|vitamins|mesh-list
15169613|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
14631902|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14631903|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14631904|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14631905|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169614|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169615|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
15169616|NCT04039815|Thiamine|thiamine|mesh-list
15169617|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
15169618|NCT04039815|Vitamins|vitamins|mesh-ancestor
14631906|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
14631907|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631908|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169619|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
15169620|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169621|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169622|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
15169623|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
15169624|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169625|NCT04039815|Protective Agents|protective agents|mesh-ancestor
15169626|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
15169627|NCT04039698|Velpatasvir|velpatasvir|mesh-list
15169628|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
15169629|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169630|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15169631|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
15169632|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169633|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
14631909|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15169634|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15169635|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169636|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15169637|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
15169638|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169639|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022529|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169640|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631910|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169641|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169642|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14631911|NCT00149253|Etoricoxib|etoricoxib|mesh-list
14631912|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631913|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14631914|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14631915|NCT00149253|Analgesics|analgesics|mesh-ancestor
14631916|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
14631917|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631918|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14631919|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14631920|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14631921|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14631922|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631923|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631924|NCT00149292|Olanzapine|olanzapine|mesh-list
14631925|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
15169643|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15169644|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169645|NCT04039126|Iodine|iodine|mesh-list
15169646|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
14631926|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
14631927|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631928|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169647|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
15169648|NCT04039126|Tetracycline|tetracycline|mesh-list
15169649|NCT04039126|Povidone|povidone|mesh-list
15169650|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15169651|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631929|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14631930|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14631931|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14631932|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631933|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631934|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14631935|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14631936|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14631937|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631938|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631939|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
14631940|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
14631941|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14631942|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631943|NCT00149539|Buprenorphine|buprenorphine|mesh-list
14631944|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14631945|NCT00149539|Naloxone|naloxone|mesh-list
14631946|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14631947|NCT00149539|Narcotics|narcotics|mesh-ancestor
14631948|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631949|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631950|NCT00149539|Analgesics|analgesics|mesh-ancestor
14631951|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
14631952|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14631953|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14631954|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
14631955|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631956|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
14631957|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631958|NCT00149578|Leucovorin|leucovorin|mesh-list
14631959|NCT00149578|Gemcitabine|gemcitabine|mesh-list
14631960|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
14631961|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14631962|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
14631963|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631964|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14631965|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
14631966|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14631967|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14631968|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14631969|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
14631970|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631971|NCT00149578|Antidotes|antidotes|mesh-ancestor
14631972|NCT00149578|Protective Agents|protective agents|mesh-ancestor
14631973|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
14631974|NCT00149578|Vitamins|vitamins|mesh-ancestor
14631975|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
14631976|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15169652|NCT04039126|Trace Elements|trace elements|mesh-ancestor
14631977|NCT00149604|Estrogens|estrogens|mesh-list
15169653|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
14631978|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14631979|NCT00149604|Hormones|hormones|mesh-ancestor
14631980|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14631981|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631982|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14631983|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
14631984|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14631985|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14631986|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14631987|NCT00149617|Buspirone|buspirone|mesh-list
14631988|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15169654|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169655|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
15169656|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
14631989|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14631990|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14631991|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14631992|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14631993|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14631994|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
14631995|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14631996|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14631997|NCT00149656|Selenium|selenium|mesh-list
14631998|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
14631999|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632000|NCT00149656|Protective Agents|protective agents|mesh-ancestor
14632001|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632002|NCT00149656|Trace Elements|trace elements|mesh-ancestor
14632003|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
14632004|NCT00149708|Hormones|hormones|mesh-list
14632005|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632006|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646750|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646751|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14646752|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
14646753|NCT00198978|Hormones|hormones|mesh-ancestor
14646754|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646755|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14646756|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14646757|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14646758|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
14646759|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14646760|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646761|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
14646762|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
14646763|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646764|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14646765|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646766|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
14646767|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646768|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14646769|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646770|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646771|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646772|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14646773|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646774|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14646775|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646776|NCT00198991|Cytarabine|cytarabine|mesh-list
14646777|NCT00198991|Dexamethasone|dexamethasone|mesh-list
14646778|NCT00198991|Prednisolone|prednisolone|mesh-list
15169657|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169658|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15169659|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169660|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169661|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
15169662|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
15169663|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15169664|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15169665|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169666|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169667|NCT04039087|Urological Agents|urological agents|mesh-ancestor
14646779|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
14632007|NCT00149851|Tegaserod|tegaserod|mesh-list
14632008|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14632009|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
14632010|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632011|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632012|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632013|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
14632014|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632015|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632016|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632017|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632018|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632019|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632020|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632021|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632022|NCT00149877|Tegaserod|tegaserod|mesh-list
14632023|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14632024|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
14632025|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632026|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632027|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632028|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
14632029|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632030|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632031|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632032|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632033|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632034|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632035|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632036|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632037|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
14632038|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632039|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169668|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15169669|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169670|NCT04038970|Methotrexate|methotrexate|mesh-list
15169671|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15169672|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
15169673|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15169674|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169675|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15169676|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
15169677|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169678|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169679|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
15169680|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169681|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15169682|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15169683|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
15169684|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169685|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15169686|NCT04038853|Vitamin D|vitamin d|mesh-list
15169687|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
15169688|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
15169689|NCT04038853|Vitamins|vitamins|mesh-ancestor
15169690|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
15169691|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169692|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15169693|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15169694|NCT04038749|Cabergoline|cabergoline|mesh-list
15169695|NCT04038749|Bromocriptine|bromocriptine|mesh-list
15169696|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15169697|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15169698|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
15169699|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
15169700|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169701|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169702|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169703|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
15169704|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181163|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15181164|NCT03932292|Calcium|calcium|mesh-list
15181165|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15169705|NCT04038411|Etoposide|etoposide|mesh-list
15169706|NCT04038411|Lenalidomide|lenalidomide|mesh-list
15169707|NCT04038411|Antibodies|antibodies|mesh-list
15169708|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
15169709|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169710|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15169711|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169712|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15169713|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15169714|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169715|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169716|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15169717|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15169718|NCT04038411|Growth Substances|growth substances|mesh-ancestor
15169719|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
15169720|NCT04038437|Venetoclax|venetoclax|mesh-list
15169721|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169722|NCT04038619|Loperamide|loperamide|mesh-list
15169723|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
15169724|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169725|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
15169726|NCT04038320|Ledipasvir|ledipasvir|mesh-list
15169727|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
15169728|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169729|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
15169730|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15169731|NCT04038671|Charcoal|charcoal|mesh-list
15169732|NCT04038671|Antidotes|antidotes|mesh-ancestor
15169733|NCT04038671|Protective Agents|protective agents|mesh-ancestor
15169734|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169735|NCT04038307|Acetaminophen|acetaminophen|mesh-list
15169736|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169737|NCT04038307|Analgesics|analgesics|mesh-ancestor
15169738|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
15169739|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169740|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169741|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
15169742|NCT04038008|Fluconazole|fluconazole|mesh-list
15169743|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
15169744|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169745|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15169746|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15169747|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169748|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169749|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15169750|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
15169751|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169752|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169753|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15169754|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15169755|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
15169756|NCT04038034|Vitamins|vitamins|mesh-ancestor
15169757|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
14632040|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632041|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632042|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632043|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632044|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169758|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169759|NCT04037878|Tramadol|tramadol|mesh-list
15169760|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15169761|NCT04037878|Narcotics|narcotics|mesh-ancestor
15169762|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169763|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169764|NCT04037878|Analgesics|analgesics|mesh-ancestor
14632045|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632046|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
14632047|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632048|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632049|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632050|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632051|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169765|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
15169766|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169767|NCT04038125|Dexamethasone|dexamethasone|mesh-list
15169768|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169769|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
14632052|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632053|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169770|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
15169771|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169772|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169773|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15169774|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
15169775|NCT04038125|Hormones|hormones|mesh-ancestor
15169776|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632054|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632055|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
14632056|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632057|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632058|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632059|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632060|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632061|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632062|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632063|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632064|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
14632065|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632066|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632067|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632068|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632069|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632070|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632071|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632072|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632073|NCT00149981|Everolimus|everolimus|mesh-list
14632074|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632075|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632076|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
14632077|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632078|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
14632079|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632080|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632081|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632082|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632083|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632084|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169777|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15169778|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169779|NCT04038073|Antibodies|antibodies|mesh-list
15169780|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
15169781|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
15169782|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169783|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
15169784|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15169785|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169786|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169787|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169788|NCT04037774|Analgesics|analgesics|mesh-ancestor
15169789|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
15169790|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169791|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15169792|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15169793|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15169794|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
15169795|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169796|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169797|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
15169798|NCT04037566|Fludarabine|fludarabine|mesh-list
15169799|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15169800|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
15169801|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169802|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169803|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15169804|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
15169805|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169806|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169807|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15169808|NCT04037657|Propofol|propofol|mesh-list
14632085|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169809|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15169810|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169811|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169812|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15169813|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
15169814|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
14632086|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632087|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
14632088|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632089|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632090|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632091|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632092|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632093|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632094|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632095|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632096|NCT00150046|Everolimus|everolimus|mesh-list
14632097|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632098|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632099|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
14632100|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632101|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
14632102|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14632103|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14632104|NCT00150059|Analgesics|analgesics|mesh-ancestor
14632105|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
15169815|NCT04037176|Omalizumab|omalizumab|mesh-list
15169816|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15169817|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15169818|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
15169819|NCT04037514|Acetaminophen|acetaminophen|mesh-list
15169820|NCT04037514|Ibuprofen|ibuprofen|mesh-list
15169821|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15169822|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15169823|NCT04037514|Analgesics|analgesics|mesh-ancestor
15169824|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
15169825|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169826|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169827|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169828|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15169829|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15169830|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169831|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169832|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
15169833|NCT04037085|Ketamine|ketamine|mesh-list
15169834|NCT04037085|Analgesics|analgesics|mesh-ancestor
15169835|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
15169836|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022530|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632106|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632107|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632108|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14632109|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632110|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
14632111|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632112|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
14632113|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14632114|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632115|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632116|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
14632117|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632118|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14632119|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632120|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632121|NCT00150085|Cyclosporine|cyclosporine|mesh-list
14632122|NCT00150085|Cyclosporins|cyclosporins|mesh-list
14632123|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632124|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632125|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632126|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
14632127|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169837|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022531|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169838|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14632128|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
14632129|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632130|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
14632131|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632132|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14632133|NCT00150111|Rituximab|rituximab|mesh-list
14632134|NCT00150111|Vaccines|vaccines|mesh-list
14632135|NCT00150111|Methimazole|methimazole|mesh-list
14632136|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14632137|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632138|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
14632139|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632140|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632141|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
14632142|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
14632143|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632144|NCT00150124|Methimazole|methimazole|mesh-list
14632145|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
14632146|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14632147|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632148|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632149|NCT00150137|Methimazole|methimazole|mesh-list
14632150|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
14632151|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
14632152|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632153|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632154|NCT00150215|Olanzapine|olanzapine|mesh-list
14632155|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
14632156|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
14632157|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632158|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632159|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14632160|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14632161|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632162|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632163|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632164|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14632165|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632166|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632167|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632168|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632169|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
14632170|NCT00150228|Varenicline|varenicline|mesh-list
14632171|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14632172|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15169839|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15169840|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
15169841|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
15169842|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169843|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15169844|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15169845|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169846|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169847|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14632173|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
14632174|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632175|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632176|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632177|NCT00150241|Varenicline|varenicline|mesh-list
14632178|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14632179|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14632180|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
14632181|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632182|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814110|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
15181166|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181167|NCT03932409|Paclitaxel|paclitaxel|mesh-list
15181168|NCT03932409|Carboplatin|carboplatin|mesh-list
15181169|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
15181170|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15181171|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181172|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
15181173|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
14814111|NCT00861523|Vitamins|vitamins|mesh-ancestor
15169848|NCT04036721|Prednisone|prednisone|mesh-list
15169849|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15169850|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
14632183|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632184|NCT00150254|Varenicline|varenicline|mesh-list
14632185|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14632186|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14632187|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
14632188|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632189|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632190|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632191|NCT00150280|Ibuprofen|ibuprofen|mesh-list
14632192|NCT00150280|Celecoxib|celecoxib|mesh-list
14632193|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14632194|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14632195|NCT00150280|Analgesics|analgesics|mesh-ancestor
14632196|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
15169851|NCT04036721|Hormones|hormones|mesh-ancestor
15169852|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15169853|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169854|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15169855|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169856|NCT04036890|Minocycline|minocycline|mesh-list
14632197|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632198|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632199|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14632200|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632201|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14632202|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632203|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632204|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14632205|NCT00150293|Pregabalin|pregabalin|mesh-list
14632206|NCT00150293|Analgesics|analgesics|mesh-ancestor
14632207|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
14632208|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632209|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632210|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
14632211|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632212|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632213|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632214|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632215|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632216|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632217|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632218|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632219|NCT00150306|Sertraline|sertraline|mesh-list
14632220|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
14632221|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632222|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14632223|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632224|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632225|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632226|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632227|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
15169857|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169858|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169859|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
15169860|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15169861|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15169862|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15169863|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169864|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169865|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
15169866|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169867|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632228|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632229|NCT00150332|Linezolid|linezolid|mesh-list
14632230|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632231|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632232|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14632233|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632234|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169868|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14632235|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
14632236|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632237|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
14632238|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14632239|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14632240|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632241|NCT00150358|Urological Agents|urological agents|mesh-ancestor
14632242|NCT00150371|Atorvastatin|atorvastatin|mesh-list
14632243|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14632244|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14632245|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
14632246|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632247|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15169869|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169870|NCT04036487|Propofol|propofol|mesh-list
15169871|NCT04036487|Desflurane|desflurane|mesh-list
15169872|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15169873|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169874|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169875|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15169876|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
15169877|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
15169878|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15169879|NCT04036500|Estradiol|estradiol|mesh-list
15169880|NCT04036500|Estrogens|estrogens|mesh-ancestor
15169881|NCT04036500|Hormones|hormones|mesh-ancestor
15169882|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632248|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14632249|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632250|NCT00150384|Amlodipine|amlodipine|mesh-list
14632251|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
14632252|NCT00150384|Atorvastatin|atorvastatin|mesh-list
14632253|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14632254|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14632255|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
14632256|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632257|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14632258|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14632259|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632260|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14632261|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632262|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632263|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632264|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632265|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
14632266|NCT00150410|Insulin|insulin|mesh-list
14632267|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14632268|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632269|NCT00150423|Pregabalin|pregabalin|mesh-list
14632270|NCT00150423|Analgesics|analgesics|mesh-ancestor
14632271|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
14632272|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632273|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632274|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
14632275|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632276|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169883|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169884|NCT04036448|Lenalidomide|lenalidomide|mesh-list
15169885|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
15169886|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169887|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14632277|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632278|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632279|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632280|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632281|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632282|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632283|NCT00150436|Pregabalin|pregabalin|mesh-list
14632284|NCT00150436|Analgesics|analgesics|mesh-ancestor
14632285|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
14632286|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632287|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632288|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
14632289|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632290|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632291|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632292|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632293|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632294|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632295|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169888|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15169889|NCT04036448|Growth Substances|growth substances|mesh-ancestor
15169890|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
15169891|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169892|NCT04036526|Vaccines|vaccines|mesh-list
15169893|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
15169894|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169895|NCT04036305|Lidocaine|lidocaine|mesh-list
15169896|NCT04036305|Bupivacaine|bupivacaine|mesh-list
15169897|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
15169898|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
15169899|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169900|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169901|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
15169902|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169903|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15169904|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15169905|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14632296|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632297|NCT00150449|Pregabalin|pregabalin|mesh-list
14632298|NCT00150449|Analgesics|analgesics|mesh-ancestor
14632299|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
14632300|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632301|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632302|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
14632303|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632304|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632305|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632306|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632307|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632308|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632309|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632310|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632311|NCT00150527|Dexamethasone|dexamethasone|mesh-list
14632312|NCT00150527|Citalopram|citalopram|mesh-list
14632313|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14632314|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
14632315|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
14632316|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632317|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632318|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14632319|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
14632320|NCT00150527|Hormones|hormones|mesh-ancestor
14632321|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632322|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14632323|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632324|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14632325|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632326|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632327|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632328|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632329|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
14632330|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14632331|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
14632332|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632333|NCT00150553|Carbamazepine|carbamazepine|mesh-list
14632334|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
14632335|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
14632336|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632337|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632338|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632339|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632340|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14632341|NCT00150553|Analgesics|analgesics|mesh-ancestor
14632342|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
14632343|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181174|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
14022532|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
14632344|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14632345|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632346|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632347|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14632348|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14632349|NCT00150579|Amphetamine|amphetamine|mesh-list
14632350|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
14632351|NCT00150579|Adderall|adderall|mesh-list
14632352|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14632353|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169906|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169907|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169908|NCT04036201|Bupivacaine|bupivacaine|mesh-list
15169909|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
15169910|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
15169911|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
14632354|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
14632355|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
14632356|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632357|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
14632358|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632359|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632360|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
14632361|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14632362|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632363|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632364|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14632365|NCT00150605|Carbamazepine|carbamazepine|mesh-list
14632366|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
14632367|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
14632368|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632369|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632370|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632371|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632372|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14632373|NCT00150605|Analgesics|analgesics|mesh-ancestor
14632374|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
14632375|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632376|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14632377|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632378|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632379|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14632380|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14632381|NCT00150631|Candesartan|candesartan|mesh-list
14632382|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14632383|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14632384|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14632385|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632386|NCT00150657|Gemcitabine|gemcitabine|mesh-list
14632387|NCT00150657|Bevacizumab|bevacizumab|mesh-list
14632388|NCT00150657|Carboplatin|carboplatin|mesh-list
14632389|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14632390|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632391|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14632392|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14632393|NCT00150657|Growth Substances|growth substances|mesh-ancestor
14632394|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632395|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14632396|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14632397|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
14632398|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632399|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
14632400|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632401|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632402|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632403|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
14632404|NCT00150670|Cisplatin|cisplatin|mesh-list
14632405|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632406|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
14632407|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632408|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632409|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632410|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632411|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632412|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14632413|NCT00150709|Levetiracetam|levetiracetam|mesh-list
14632414|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
14632415|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
14632416|NCT00150722|Atorvastatin|atorvastatin|mesh-list
14632417|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14632418|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14632419|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
14632420|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632421|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14632422|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14632423|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632424|NCT00150735|Levetiracetam|levetiracetam|mesh-list
14632425|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
14632426|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
14632427|NCT00150748|Levetiracetam|levetiracetam|mesh-list
14632428|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
14632429|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
14632430|NCT00150761|Levocetirizine|levocetirizine|mesh-list
14632431|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14632432|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14632433|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
14632434|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
14632435|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632436|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169912|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169913|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169914|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
14632437|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632438|NCT00150774|Levetiracetam|levetiracetam|mesh-list
14632439|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
14632440|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
14632441|NCT00150787|Levetiracetam|levetiracetam|mesh-list
14632442|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
14632443|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
14632444|NCT00150826|Quinapril|quinapril|mesh-list
14632445|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14632446|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
14632447|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632448|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632449|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14632450|NCT00150839|Mirtazapine|mirtazapine|mesh-list
14632451|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14632452|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14632453|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632454|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632455|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632456|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632457|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632458|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14632459|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
14632460|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632461|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14632462|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
14632463|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
14632464|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632465|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632466|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632467|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14632468|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14632469|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14632470|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
14632471|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14632472|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14632473|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
14632474|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14632475|NCT00150852|Vancomycin|vancomycin|mesh-list
14632476|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632477|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632478|NCT00150865|Ropivacaine|ropivacaine|mesh-list
14632479|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
15169915|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632480|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
14632481|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632482|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632483|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
14632484|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632485|NCT00150891|Cyclosporine|cyclosporine|mesh-list
14632486|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
14632487|NCT00150891|Azathioprine|azathioprine|mesh-list
14632488|NCT00150891|Tacrolimus|tacrolimus|mesh-list
14632489|NCT00150891|Cyclosporins|cyclosporins|mesh-list
14632490|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632491|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
14632492|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632493|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14632494|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632495|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632496|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
14632497|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632498|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
14632499|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632500|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632501|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632502|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632503|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632504|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632505|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
14632506|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14632507|NCT00150982|Alefacept|alefacept|mesh-list
14632508|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
14632509|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
14632510|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632511|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14632512|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
14632513|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
14632514|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632515|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632516|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14632517|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14632518|NCT00150995|Growth Substances|growth substances|mesh-ancestor
14632519|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632520|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
14632521|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632522|NCT00151008|Bexarotene|bexarotene|mesh-list
14632523|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632524|NCT00151034|Gemcitabine|gemcitabine|mesh-list
14632525|NCT00151034|Paclitaxel|paclitaxel|mesh-list
14632526|NCT00151034|Carboplatin|carboplatin|mesh-list
14632527|NCT00151034|Trastuzumab|trastuzumab|mesh-list
14632528|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14632529|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632530|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
15169916|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15169917|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
15169918|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
15169919|NCT04036201|Protective Agents|protective agents|mesh-ancestor
15169920|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
15169921|NCT04036253|Hematinics|hematinics|mesh-ancestor
15169922|NCT04035850|Vortioxetine|vortioxetine|mesh-list
15169923|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
15169924|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15169925|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15169926|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15169927|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169928|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169929|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15169930|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632531|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
14632532|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
14632533|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632534|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14632535|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
14632536|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
14632537|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632538|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632539|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632540|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
14632541|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632542|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14632543|NCT00151047|Docetaxel|docetaxel|mesh-list
14632544|NCT00151047|Capecitabine|capecitabine|mesh-list
14632545|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632546|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
15169931|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15169932|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169933|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632547|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
14632548|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14632549|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632550|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14632551|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
14632552|NCT00151060|Paclitaxel|paclitaxel|mesh-list
14632553|NCT00151060|Etoposide|etoposide|mesh-list
14632554|NCT00151060|Estramustine|estramustine|mesh-list
14632555|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14632556|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632557|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
14632558|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
14632559|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
14632560|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632561|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14632562|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14632563|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632564|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14632565|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
14632566|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14632567|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
14632568|NCT00151073|Docetaxel|docetaxel|mesh-list
14632569|NCT00151073|Estramustine|estramustine|mesh-list
14632570|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632571|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
14632572|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
14632573|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
14632574|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632575|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14632576|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632577|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14632578|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
14632579|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14632580|NCT00151086|Vinorelbine|vinorelbine|mesh-list
14632581|NCT00151086|Estramustine|estramustine|mesh-list
14632582|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14632583|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632584|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
14632585|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
14632586|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14632587|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632588|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14632589|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
14632590|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14632591|NCT00151112|Anesthetics|anesthetics|mesh-list
14632592|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632593|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632594|NCT00151125|Oprelvekin|oprelvekin|mesh-list
14632595|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632596|NCT00151138|Atenolol|atenolol|mesh-list
14632597|NCT00151138|Lisinopril|lisinopril|mesh-list
14632598|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14632599|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
14632600|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632601|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632602|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14632603|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14632604|NCT00151138|Protective Agents|protective agents|mesh-ancestor
14632605|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632606|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14632607|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
14632608|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
14632609|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632610|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14632611|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14814112|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
14632612|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14632613|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14632614|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632615|NCT00151203|Clarithromycin|clarithromycin|mesh-list
14632616|NCT00151203|Dexamethasone|dexamethasone|mesh-list
14632617|NCT00151203|Lenalidomide|lenalidomide|mesh-list
14632618|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14632619|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
14632620|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
14632621|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632622|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632623|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14632624|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
14632625|NCT00151203|Hormones|hormones|mesh-ancestor
14632626|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14632627|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14632628|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169934|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
15169935|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15169936|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14632629|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
14632630|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14632631|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14632632|NCT00151203|Growth Substances|growth substances|mesh-ancestor
14632633|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
14632634|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632635|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632636|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14632637|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632638|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632639|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14632640|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14632641|NCT00151242|Cytarabine|cytarabine|mesh-list
14632642|NCT00151242|Etoposide|etoposide|mesh-list
14632643|NCT00151242|Idarubicin|idarubicin|mesh-list
14632644|NCT00151242|Tretinoin|tretinoin|mesh-list
14632645|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14632646|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632647|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14632648|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14632649|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632650|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632651|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14632652|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
14632653|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
14632654|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632655|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632656|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
14632657|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632658|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632659|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
14632660|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14632661|NCT00151255|Cytarabine|cytarabine|mesh-list
14632662|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
14632663|NCT00151255|Idarubicin|idarubicin|mesh-list
14632664|NCT00151255|Tretinoin|tretinoin|mesh-list
14632665|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14632666|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
14632667|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632668|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632669|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
14632670|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632671|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632672|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
14632673|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632674|NCT00151255|Analgesics|analgesics|mesh-ancestor
14632675|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
14632676|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632677|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14632678|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14632679|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632680|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632681|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
15169937|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14632682|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14646780|NCT00198991|Methotrexate|methotrexate|mesh-list
14632683|NCT00151294|Dexetimide|dexetimide|mesh-list
14632684|NCT00151294|Citalopram|citalopram|mesh-list
14632685|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
14632686|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14632687|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632688|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632689|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632690|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632691|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
14632692|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632693|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14632694|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632695|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14632696|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14632697|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
14632698|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
14632699|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632700|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14632701|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14632702|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
14632703|NCT00151346|Fentanyl|fentanyl|mesh-list
14632704|NCT00151346|Bupivacaine|bupivacaine|mesh-list
14632705|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
15169938|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15169939|NCT04035876|Apatinib|apatinib|mesh-list
15169940|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15169941|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15169942|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169943|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169944|NCT04035889|Melatonin|melatonin|mesh-list
15169945|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
15169946|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169947|NCT04035889|Protective Agents|protective agents|mesh-ancestor
15169948|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169949|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169950|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15169951|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169952|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15169953|NCT04035798|Memantine|memantine|mesh-list
15169954|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15169955|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15169956|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
15169957|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632706|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
14632707|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632708|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632709|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
14632710|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632711|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14632712|NCT00151346|Narcotics|narcotics|mesh-ancestor
14632713|NCT00151346|Analgesics|analgesics|mesh-ancestor
14632714|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14632715|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14632716|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
14632717|NCT00151450|Pregabalin|pregabalin|mesh-list
14632718|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14632719|NCT00151450|Analgesics|analgesics|mesh-ancestor
14632720|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
14632721|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632722|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632723|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
14632724|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632725|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632726|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632727|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632728|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632729|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632730|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632731|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632732|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14632733|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632734|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15169958|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632735|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14632736|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
14632737|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
14632738|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632739|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
14632740|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14632741|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14632742|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632743|NCT00151463|Urological Agents|urological agents|mesh-ancestor
14632744|NCT00151489|Pregabalin|pregabalin|mesh-list
14632745|NCT00151489|Analgesics|analgesics|mesh-ancestor
14632746|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
14632747|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632748|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632749|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
14632750|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632751|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632752|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632753|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632754|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632755|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632756|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15169959|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169960|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15169961|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15169962|NCT04035707|Rocuronium|rocuronium|mesh-list
15169963|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169964|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14632757|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632758|NCT00151502|Atorvastatin|atorvastatin|mesh-list
14632759|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14632760|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14632761|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
14632762|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632763|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14632764|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14632765|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632766|NCT00151515|Minoxidil|minoxidil|mesh-list
14632767|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14632768|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
14632769|NCT00151528|Pregabalin|pregabalin|mesh-list
14632770|NCT00151528|Analgesics|analgesics|mesh-ancestor
15169965|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14632771|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
14632772|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632773|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632774|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
14632775|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632776|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632777|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632778|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632779|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14632780|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14632781|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14632782|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14632783|NCT00151541|Dapsone|dapsone|mesh-list
15169966|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15169967|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15169968|NCT04035603|Cycloserine|cycloserine|mesh-list
15169969|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14632784|NCT00151541|Adapalene|adapalene|mesh-list
14632785|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14632786|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
14632787|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14632788|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14632789|NCT00151541|Analgesics|analgesics|mesh-ancestor
14632790|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
14632791|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632792|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632793|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14632794|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632795|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632796|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
14632797|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14632798|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14632799|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14632800|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632801|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632802|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
14632803|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632804|NCT00151567|Tamsulosin|tamsulosin|mesh-list
14632805|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14632806|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14632807|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15169970|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169971|NCT04035603|Renal Agents|renal agents|mesh-ancestor
15169972|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15169973|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
15169974|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15169975|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
15169976|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169977|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
15169978|NCT04035525|Ubiquinone|ubiquinone|mesh-list
15169979|NCT04035525|Vitamins|vitamins|mesh-ancestor
14632808|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14632809|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632810|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632811|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169980|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
15169981|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632812|NCT00151567|Urological Agents|urological agents|mesh-ancestor
14632813|NCT00151580|Ribavirin|ribavirin|mesh-list
14632814|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
14632815|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632816|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
14632817|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632818|NCT00151619|Amlodipine|amlodipine|mesh-list
14632819|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15169982|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
15169983|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15169984|NCT04035135|Antibodies|antibodies|mesh-list
15169985|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
15169986|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15169987|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
15169988|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15169989|NCT04035187|Itraconazole|itraconazole|mesh-list
15169990|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15169991|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15169992|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
15169993|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15169994|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15169995|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15169996|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15169997|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15169998|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15169999|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
15170000|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170001|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170002|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15170003|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
15170004|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15170005|NCT04035330|Eusol|eusol|mesh-list
15170006|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
15170007|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170008|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15170009|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170010|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
15170011|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
15170012|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632820|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14632821|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632822|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632823|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14632824|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632825|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
14632826|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
14632827|NCT00151632|Tacrolimus|tacrolimus|mesh-list
14632828|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15170013|NCT04035096|Protective Agents|protective agents|mesh-ancestor
14632829|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
14632830|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632831|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14632832|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632833|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632834|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14632835|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632836|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14632837|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
14632838|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14632839|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632840|NCT00151684|Diazoxide|diazoxide|mesh-list
14632841|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14632842|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
14632843|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
14632844|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14632845|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14632846|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632847|NCT00151710|Pioglitazone|pioglitazone|mesh-list
14632848|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14632849|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632850|NCT00151736|Etodolac|etodolac|mesh-list
14632851|NCT00151736|Chlorambucil|chlorambucil|mesh-list
14632852|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14632853|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
14632854|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632855|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632856|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14632857|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14632858|NCT00151736|Analgesics|analgesics|mesh-ancestor
14632859|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
14632860|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632861|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632862|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14632863|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632864|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14632865|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14632866|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632867|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14632868|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14632869|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14632870|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
14632871|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632872|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14632873|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14632874|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14632875|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14632876|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
14632877|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632878|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14632879|NCT00151801|Interferons|interferons|mesh-list
14632880|NCT00151801|Interferon-beta|interferon-beta|mesh-list
14632881|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
14632882|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632883|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
14632884|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632885|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
14632886|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632887|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14632888|NCT00151827|Losartan|losartan|mesh-list
14632889|NCT00151827|Olmesartan|olmesartan|mesh-list
14632890|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14632891|NCT00151827|Furosemide|furosemide|mesh-list
15170014|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170015|NCT04035096|Vitamins|vitamins|mesh-ancestor
15170016|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
15170017|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15170018|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170019|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
15170020|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
15170021|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182261|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14632892|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14632893|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14632894|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15170022|NCT04034823|Docetaxel|docetaxel|mesh-list
15170023|NCT04034823|Trastuzumab|trastuzumab|mesh-list
15170024|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170025|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
15170026|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
15170027|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
15170028|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170029|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170030|NCT04035070|Clindamycin|clindamycin|mesh-list
14632895|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14632896|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632897|NCT00151827|Diuretics|diuretics|mesh-ancestor
14632898|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
14632899|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632900|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14632901|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632902|NCT00151944|Mesalamine|mesalamine|mesh-list
14632903|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14632904|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14632905|NCT00151944|Analgesics|analgesics|mesh-ancestor
14632906|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
14632907|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632908|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632909|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14632910|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14632911|NCT00151957|Methylphenidate|methylphenidate|mesh-list
14632912|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15170031|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
15170032|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
15170033|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15170034|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15170035|NCT04035070|Eusol|eusol|mesh-list
15170036|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14022533|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632913|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632914|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14632915|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632916|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632917|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632918|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
14632919|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632920|NCT00151970|Methylphenidate|methylphenidate|mesh-list
14632921|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14632922|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632923|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14632924|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632925|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632926|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632927|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
14632928|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632929|NCT00151983|Methylphenidate|methylphenidate|mesh-list
14632930|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14632931|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632932|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14632933|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632934|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632935|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632936|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
14632937|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632938|NCT00152022|Amphetamine|amphetamine|mesh-list
14632939|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
14632940|NCT00152022|Adderall|adderall|mesh-list
14632941|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14632942|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632943|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
14632944|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
14632945|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632946|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
14632947|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632948|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170037|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632949|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
14632950|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14632951|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632952|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632953|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14632954|NCT00152035|Amphetamine|amphetamine|mesh-list
14632955|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
14632956|NCT00152035|Adderall|adderall|mesh-list
14632957|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14632958|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632959|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
14632960|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
14632961|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14632962|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
14632963|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14632964|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632965|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
14632966|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14632967|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14632968|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14632969|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14632970|NCT00152048|Eflornithine|eflornithine|mesh-list
14632971|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632972|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14632973|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14632974|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14632975|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14632976|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14632977|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14632978|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632979|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
14632980|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14632981|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632982|NCT00152126|Melphalan|melphalan|mesh-list
14632983|NCT00152126|Busulfan|busulfan|mesh-list
14632984|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14632985|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
14632986|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14632987|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14632988|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14632989|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14632990|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
14632991|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632992|NCT00152139|Antibodies|antibodies|mesh-list
14632993|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
14632994|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14632995|NCT00152178|Tamoxifen|tamoxifen|mesh-list
14632996|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
14632997|NCT00152178|Fluorouracil|fluorouracil|mesh-list
14632998|NCT00152178|Methotrexate|methotrexate|mesh-list
14632999|NCT00152178|Tegafur|tegafur|mesh-list
14633000|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633001|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
14633002|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633003|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633004|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14291921|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14291922|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14291923|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291924|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291925|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14291926|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
14291927|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
14291928|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291929|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633005|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
14633006|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633007|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633008|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14633009|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
14633010|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633011|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14022534|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14022535|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
14633012|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
14633013|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633014|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14633015|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633016|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14633017|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14633018|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14633019|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
14633020|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633021|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14633022|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14633023|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14633024|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14633025|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
14633026|NCT00152191|Fluorouracil|fluorouracil|mesh-list
14633027|NCT00152191|Methotrexate|methotrexate|mesh-list
14633028|NCT00152191|Tegafur|tegafur|mesh-list
14633029|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633030|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
14633031|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633032|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633033|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14633034|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
14633035|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633036|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633037|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14633038|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
14633039|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633040|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14633041|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
14633042|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633043|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14633044|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170038|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15170039|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170040|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170041|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
15170042|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15170043|NCT04034771|Propofol|propofol|mesh-list
15170044|NCT04034771|Melatonin|melatonin|mesh-list
15170045|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170046|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170047|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170048|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170049|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
15170050|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
15170051|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
15170052|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170053|NCT04034771|Protective Agents|protective agents|mesh-ancestor
15170054|NCT04034862|Lamivudine|lamivudine|mesh-list
15170055|NCT04034862|Dolutegravir|dolutegravir|mesh-list
15170056|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15170057|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15170058|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170059|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170060|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
15170061|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170062|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15170063|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15170064|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15170065|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15170066|NCT04034836|Parecoxib|parecoxib|mesh-list
15170067|NCT04034836|Ropivacaine|ropivacaine|mesh-list
15170068|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
15170069|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
15170070|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170071|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170072|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
15170073|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633045|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14633046|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14633047|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
15170074|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15170075|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15170076|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170077|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170078|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15170079|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170080|NCT04034836|Analgesics|analgesics|mesh-ancestor
15170081|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170082|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170083|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
15170084|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15170085|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170086|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15170087|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022536|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14633048|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
14633049|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14633050|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
14633051|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14633052|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14633053|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633054|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14633055|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633056|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633057|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14633058|NCT00152204|Renal Agents|renal agents|mesh-ancestor
14633059|NCT00152230|Tegafur|tegafur|mesh-list
14633060|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633061|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
14633062|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633063|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633064|NCT00152243|Tegafur|tegafur|mesh-list
14633065|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633066|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
14633067|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633068|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633069|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14633070|NCT00152282|Estrogens|estrogens|mesh-ancestor
14633071|NCT00152282|Hormones|hormones|mesh-ancestor
14633072|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633073|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633074|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14633075|NCT00152295|Estrogens|estrogens|mesh-ancestor
14633076|NCT00152295|Hormones|hormones|mesh-ancestor
14633077|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633078|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633079|NCT00152308|Sirolimus|sirolimus|mesh-list
14633080|NCT00152308|Ethanol|ethanol|mesh-list
14633081|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14633082|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633083|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14633084|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633085|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
14633086|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633087|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
14633088|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633089|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14633090|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14633091|NCT00152360|Orlistat|orlistat|mesh-list
14633092|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633093|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633094|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14633095|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14633096|NCT00152373|Levetiracetam|levetiracetam|mesh-list
14633097|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
14633098|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
14633099|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
14633100|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633101|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
14633102|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633103|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633104|NCT00152399|Somatostatin|somatostatin|mesh-list
14633105|NCT00152399|Hormones|hormones|mesh-ancestor
14633106|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633107|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633108|NCT00152412|Levocetirizine|levocetirizine|mesh-list
14633109|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14633110|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14633111|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
14633112|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
14633113|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633114|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633115|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633116|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
14633117|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633118|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
14633119|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633120|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633121|NCT00152438|Progesterone|progesterone|mesh-list
14633122|NCT00152438|Progestins|progestins|mesh-ancestor
14633123|NCT00152438|Hormones|hormones|mesh-ancestor
14633124|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633125|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633126|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
14633127|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633128|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
14633129|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633130|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633131|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
14633132|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14633133|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
14633134|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633135|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633136|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15170088|NCT04034524|Insulin|insulin|mesh-list
15170089|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15170090|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15170091|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170092|NCT04034589|Fulvestrant|fulvestrant|mesh-list
15170093|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14633137|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
14633138|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14633139|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
14633140|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633141|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633142|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14633143|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
14633144|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
14633145|NCT00152542|Protective Agents|protective agents|mesh-ancestor
14633146|NCT00152581|Interferons|interferons|mesh-list
14633147|NCT00152581|Ribavirin|ribavirin|mesh-list
14633148|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
14633149|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
14633150|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14633151|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633152|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
14633153|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633154|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
14633155|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633156|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
14633157|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170094|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170095|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15170096|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15170097|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
15170098|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170099|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170100|NCT04034485|Evolocumab|evolocumab|mesh-list
15170101|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15170102|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15170103|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
15170104|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170105|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15170106|NCT04034368|Tenofovir|tenofovir|mesh-list
15170107|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
15170108|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170109|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15170110|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15170111|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633158|NCT00152594|Voriconazole|voriconazole|mesh-list
14633159|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
14633160|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633161|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14633162|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14633163|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633164|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633165|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14633166|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
14633167|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633168|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170112|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170113|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15170114|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14022537|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14022538|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14022539|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022540|NCT02767661|Capecitabine|capecitabine|mesh-list
15170115|NCT04034173|Leucovorin|leucovorin|mesh-list
15170116|NCT04034173|Folic Acid|folic acid|mesh-list
15170117|NCT04034173|Irinotecan|irinotecan|mesh-list
15170118|NCT04034173|Panitumumab|panitumumab|mesh-list
15170119|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
14633169|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14633170|NCT00152620|Dexamethasone|dexamethasone|mesh-list
14633171|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
15170120|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15170121|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15170122|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170123|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170124|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170125|NCT04034173|Antidotes|antidotes|mesh-ancestor
15170126|NCT04034173|Protective Agents|protective agents|mesh-ancestor
15170127|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170128|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
15170129|NCT04034173|Vitamins|vitamins|mesh-ancestor
15170130|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
15170131|NCT04034173|Hematinics|hematinics|mesh-ancestor
15170132|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170133|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
15170134|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170135|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633172|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14633173|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14633174|NCT00152620|Prednisolone|prednisolone|mesh-list
14633175|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
14633176|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14633177|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
14633178|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633179|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
14633180|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
14633181|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633182|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633183|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14633184|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
14633185|NCT00152620|Hormones|hormones|mesh-ancestor
14633186|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633187|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14633188|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633189|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14633190|NCT00152620|Protective Agents|protective agents|mesh-ancestor
14633191|NCT00152633|Losartan|losartan|mesh-list
14633192|NCT00152633|Metoprolol|metoprolol|mesh-list
14633193|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14633194|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633195|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633196|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633197|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633198|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
14633199|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
14633200|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633201|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633202|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15170136|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
15170137|NCT04034199|Denosumab|denosumab|mesh-list
14022541|NCT02767661|Letrozole|letrozole|mesh-list
14022542|NCT02767661|Anastrozole|anastrozole|mesh-list
14633203|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14633204|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14633205|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
14633206|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633207|NCT00152646|Clopidogrel|clopidogrel|mesh-list
14633208|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14633209|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14633210|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14633211|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14633212|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
14633213|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633214|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633215|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633216|NCT00152698|Irbesartan|irbesartan|mesh-list
14633217|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633218|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633219|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633220|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633221|NCT00152724|Aspirin|aspirin|mesh-list
14633222|NCT00152724|Celecoxib|celecoxib|mesh-list
14633223|NCT00152724|Indomethacin|indomethacin|mesh-list
15170138|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15170139|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170140|NCT04033939|Propofol|propofol|mesh-list
15170141|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170142|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170143|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170144|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170145|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
15170146|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
15170147|NCT04033575|Listerine|listerine|mesh-list
14633224|NCT00152724|Nitroprusside|nitroprusside|mesh-list
14633225|NCT00152724|Acetylcholine|acetylcholine|mesh-list
14633226|NCT00152724|Capsaicin|capsaicin|mesh-list
14633227|NCT00152724|Clopidogrel|clopidogrel|mesh-list
14633228|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633229|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633230|NCT00152724|Analgesics|analgesics|mesh-ancestor
14633231|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
14633232|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633233|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633234|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633235|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633236|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14633237|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14633238|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633239|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14633240|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14633241|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633242|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
14633243|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14633244|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14633245|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14633246|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
15170148|NCT04033575|Fluorides|fluorides|mesh-list
15170149|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
15170150|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
14633247|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633248|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14633249|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
14633250|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
14633251|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
14633252|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
14633253|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633254|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633255|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
14633256|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14633257|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14633258|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
14633259|NCT00152750|Clonidine|clonidine|mesh-list
14633260|NCT00152750|Analgesics|analgesics|mesh-ancestor
14633261|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
15170151|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
15170152|NCT04033575|Protective Agents|protective agents|mesh-ancestor
15170153|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170154|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14022543|NCT02767661|Exemestane|exemestane|mesh-list
14633262|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633263|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633264|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633265|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
14633266|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
14633267|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14633268|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14633269|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14633270|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
14633271|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633272|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646781|NCT00198991|Fludarabine|fludarabine|mesh-list
14646782|NCT00198991|Vincristine|vincristine|mesh-list
14646783|NCT00198991|Doxorubicin|doxorubicin|mesh-list
14646784|NCT00198991|Daunorubicin|daunorubicin|mesh-list
14646785|NCT00198991|Asparaginase|asparaginase|mesh-list
14646786|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
14646787|NCT00198991|Idarubicin|idarubicin|mesh-list
14646788|NCT00198991|Thioguanine|thioguanine|mesh-list
14646789|NCT00198991|Cladribine|cladribine|mesh-list
14646790|NCT00198991|Vindesine|vindesine|mesh-list
14646791|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646792|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
14646793|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646794|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646795|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14646796|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
14646797|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646798|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646799|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14646800|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646801|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
14646802|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
14646803|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646804|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14646805|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
14646806|NCT00198991|Hormones|hormones|mesh-ancestor
14646807|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646808|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14646809|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14646810|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
14646811|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14646812|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15170155|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170156|NCT04033562|Lidocaine|lidocaine|mesh-list
15170157|NCT04033562|Bupivacaine|bupivacaine|mesh-list
15170158|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
15170159|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
15170160|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170161|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646813|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
14646814|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
14646815|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646816|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14646817|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646818|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
14646819|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646820|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14646821|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646822|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646823|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646824|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646825|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14646826|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646827|NCT00199004|Cytarabine|cytarabine|mesh-list
14646828|NCT00199004|Dexamethasone|dexamethasone|mesh-list
14646829|NCT00199004|Prednisolone|prednisolone|mesh-list
14646830|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
14646831|NCT00199004|Rituximab|rituximab|mesh-list
14646832|NCT00199004|Methotrexate|methotrexate|mesh-list
14646833|NCT00199004|Vincristine|vincristine|mesh-list
14646834|NCT00199004|Doxorubicin|doxorubicin|mesh-list
14646835|NCT00199004|Daunorubicin|daunorubicin|mesh-list
14646836|NCT00199004|Asparaginase|asparaginase|mesh-list
15170162|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
14646837|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
14646838|NCT00199004|Thioguanine|thioguanine|mesh-list
14646839|NCT00199004|Vindesine|vindesine|mesh-list
14646840|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633273|NCT00152802|Vaccines|vaccines|mesh-list
14633274|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
14633275|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633276|NCT00152815|Vitamin E|vitamin e|mesh-list
14633277|NCT00152815|Antioxidants|antioxidants|mesh-list
14633278|NCT00152815|Vitamins|vitamins|mesh-ancestor
14633279|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
14633280|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633281|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170163|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170164|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14633282|NCT00152815|Protective Agents|protective agents|mesh-ancestor
14633283|NCT00152828|Celecoxib|celecoxib|mesh-list
14633284|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633285|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633286|NCT00152828|Analgesics|analgesics|mesh-ancestor
14633287|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
14633288|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633289|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633290|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633291|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633292|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14633293|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14633294|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633295|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633296|NCT00152841|Vitamin E|vitamin e|mesh-list
14633297|NCT00152841|Vitamins|vitamins|mesh-ancestor
14633298|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
14633299|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633300|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
14633301|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633302|NCT00152841|Protective Agents|protective agents|mesh-ancestor
14633303|NCT00152854|Acetaminophen|acetaminophen|mesh-list
14633304|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633305|NCT00152854|Analgesics|analgesics|mesh-ancestor
14633306|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
14633307|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633308|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633309|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
14633310|NCT00152867|Dexamethasone|dexamethasone|mesh-list
14633311|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633312|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
14633313|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
14633314|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633315|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633316|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14633317|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
14633318|NCT00152867|Hormones|hormones|mesh-ancestor
14633319|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633320|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14633321|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633322|NCT00152893|Chromium|chromium|mesh-list
14633323|NCT00152893|Niacin|niacin|mesh-list
14633324|NCT00152893|Trace Elements|trace elements|mesh-ancestor
14633325|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
14633326|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633327|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14633328|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
14633329|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633330|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14633331|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
14633332|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
14633333|NCT00152893|Vitamins|vitamins|mesh-ancestor
14633334|NCT00152919|Meloxicam|meloxicam|mesh-list
14633335|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633336|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633337|NCT00152919|Analgesics|analgesics|mesh-ancestor
14633338|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
14633339|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633340|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633341|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170165|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15170166|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14022544|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14633342|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633343|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14633344|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14633345|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633346|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633347|NCT00152932|Dorzolamide|dorzolamide|mesh-list
15170167|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15170168|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170169|NCT04033471|Midazolam|midazolam|mesh-list
15170170|NCT04033471|Morphine|morphine|mesh-list
15170171|NCT04033471|Bupivacaine|bupivacaine|mesh-list
15170172|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
15170173|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
15170174|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170175|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170176|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
14633348|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633349|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14633350|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633351|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633352|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14633353|NCT00152945|Glycerol|glycerol|mesh-list
14633354|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14633355|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14633356|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14633357|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14633358|NCT00152945|Protective Agents|protective agents|mesh-ancestor
14633359|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633360|NCT00152958|Pramipexole|pramipexole|mesh-list
14633361|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
14633362|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633363|NCT00152958|Protective Agents|protective agents|mesh-ancestor
14633364|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633365|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14633366|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15170177|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170178|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15170179|NCT04033471|Narcotics|narcotics|mesh-ancestor
14633367|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
14633368|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
14633369|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633370|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
14633371|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14633372|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
14633373|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633374|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633375|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14633376|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
14633377|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
14633378|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14633379|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
14633380|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633381|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633382|NCT00152997|Pramipexole|pramipexole|mesh-list
14633383|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
14633384|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633385|NCT00152997|Protective Agents|protective agents|mesh-ancestor
14633386|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633387|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14633388|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14633389|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
14633390|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
14633391|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633392|NCT00153023|Valsartan|valsartan|mesh-list
14633393|NCT00153023|Telmisartan|telmisartan|mesh-list
14633394|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633395|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633396|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633397|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633398|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14633399|NCT00153049|Telmisartan|telmisartan|mesh-list
14633400|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
14633401|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633402|NCT00153049|Diuretics|diuretics|mesh-ancestor
14633403|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
15170180|NCT04033471|Analgesics|analgesics|mesh-ancestor
15170181|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15170182|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14633404|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633405|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14633406|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15170183|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15170184|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15170185|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15170186|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170187|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
15170188|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
15170189|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
15170190|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170191|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170192|NCT04033250|Bisacodyl|bisacodyl|mesh-list
15170193|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
14633407|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633408|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633409|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633410|NCT00153075|Fenoterol|fenoterol|mesh-list
14633411|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
14633412|NCT00153075|Ipratropium|ipratropium|mesh-list
14633413|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14633414|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
14633415|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633416|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633417|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14633418|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
14633419|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
14633420|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
14633421|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633422|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14633423|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14633424|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14633425|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
14633426|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633427|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633428|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14633429|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
14633430|NCT00153088|Telmisartan|telmisartan|mesh-list
15170194|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
15170195|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
15170196|NCT04033250|Citric Acid|citric acid|mesh-list
15170197|NCT04033250|Cathartics|cathartics|mesh-ancestor
15170198|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170199|NCT04033250|Laxatives|laxatives|mesh-ancestor
15170200|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
14633431|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633432|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633433|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633434|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633435|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14633436|NCT00153114|Laxatives|laxatives|mesh-ancestor
14633437|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14633438|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14633439|NCT00153127|Laxatives|laxatives|mesh-ancestor
14633440|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14633441|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14633442|NCT00153140|Laxatives|laxatives|mesh-ancestor
14633443|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14633444|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14633445|NCT00153153|Laxatives|laxatives|mesh-ancestor
14633446|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14633447|NCT00153192|Dronabinol|dronabinol|mesh-list
14633448|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
14633449|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633450|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14633451|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633452|NCT00153192|Analgesics|analgesics|mesh-ancestor
14633453|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
14633454|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633455|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14633456|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14633457|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14646841|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
15170201|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15170202|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
15170203|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
14633458|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633459|NCT00153192|Hormones|hormones|mesh-ancestor
14633460|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633461|NCT00153244|Lamotrigine|lamotrigine|mesh-list
14633462|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
14633463|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14633464|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14633465|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633466|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14633467|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633468|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14633469|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14633470|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14633471|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14633472|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14633473|NCT00153270|Valproic Acid|valproic acid|mesh-list
14633474|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
14633475|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633476|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633477|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
14633478|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633479|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633480|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
14633481|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14633482|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14633483|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14633484|NCT00153283|Gabapentin|gabapentin|mesh-list
14633485|NCT00153283|Analgesics|analgesics|mesh-ancestor
14633486|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
14633487|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633488|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633489|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
14633490|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15170204|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170205|NCT04033250|Antacids|antacids|mesh-ancestor
15170206|NCT04033172|Fulvestrant|fulvestrant|mesh-list
14633491|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14633492|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14633493|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14633494|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14633495|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14633496|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633497|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633498|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
14633499|NCT00153296|Carbamazepine|carbamazepine|mesh-list
14633500|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
14633501|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
14633502|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14633503|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14633504|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633505|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14633506|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633507|NCT00153296|Analgesics|analgesics|mesh-ancestor
14633508|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
14633509|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633510|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14633511|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14633512|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633513|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14633514|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14633515|NCT00153491|Lumefantrine|lumefantrine|mesh-list
15170207|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15170208|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633516|NCT00153491|Artemether|artemether|mesh-list
14633517|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14633518|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
14633519|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14633520|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14633521|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633522|NCT00153517|Metronidazole|metronidazole|mesh-list
14633523|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633524|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14633525|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14633526|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14633527|NCT00153530|Methotrexate|methotrexate|mesh-list
14633528|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14633529|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
14633530|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633531|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633532|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633533|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
14633534|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633535|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633536|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
14633537|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633538|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14633539|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633540|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
15170209|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15170210|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15170211|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
15170212|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170213|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170214|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15170215|NCT04033029|Tazobactam|tazobactam|mesh-list
15170216|NCT04033029|Piperacillin|piperacillin|mesh-list
15170217|NCT04033029|Daptomycin|daptomycin|mesh-list
15170218|NCT04033029|Ceftazidime|ceftazidime|mesh-list
15170219|NCT04033029|Cefepime|cefepime|mesh-list
15170220|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15170221|NCT04033029|Ceftolozane|ceftolozane|mesh-list
15170222|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170223|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15170224|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170225|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633541|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633542|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14633543|NCT00153543|Vaccines|vaccines|mesh-list
14633544|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14633545|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
14633546|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633547|NCT00153556|Vaccines|vaccines|mesh-list
14633548|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
14633549|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633550|NCT00153634|Azithromycin|azithromycin|mesh-list
14633551|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
14633552|NCT00153634|Meropenem|meropenem|mesh-list
14633553|NCT00153634|Tazobactam|tazobactam|mesh-list
14633554|NCT00153634|Piperacillin|piperacillin|mesh-list
14633555|NCT00153634|Tobramycin|tobramycin|mesh-list
14633556|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
15170226|NCT04033055|Ropivacaine|ropivacaine|mesh-list
15170227|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
15170228|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
15170229|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170230|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170231|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
15170232|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170233|NCT04033094|Morphine|morphine|mesh-list
15170234|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15170235|NCT04033094|Narcotics|narcotics|mesh-ancestor
15170236|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170237|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170238|NCT04033094|Analgesics|analgesics|mesh-ancestor
15170239|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
15170240|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181175|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181176|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15181177|NCT03932526|Apatinib|apatinib|mesh-list
15181178|NCT03932526|Vinorelbine|vinorelbine|mesh-list
15181179|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181180|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15181181|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181182|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633557|NCT00153634|Amikacin|amikacin|mesh-list
15181183|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15181184|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
14633558|NCT00153634|Ceftazidime|ceftazidime|mesh-list
14633559|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14022545|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022546|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
14633560|NCT00153634|Ticarcillin|ticarcillin|mesh-list
14633561|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
14633562|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14633563|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633564|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14633565|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14633566|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633567|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633568|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633569|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14633570|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14633571|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14633572|NCT00153660|Celecoxib|celecoxib|mesh-list
14633573|NCT00153660|Naproxen|naproxen|mesh-list
14633574|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633575|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633576|NCT00153660|Analgesics|analgesics|mesh-ancestor
14633577|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
14633578|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633579|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633580|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633581|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633582|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14633583|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14633584|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633585|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633586|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
14633587|NCT00153673|Celecoxib|celecoxib|mesh-list
14633588|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633589|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633590|NCT00153673|Analgesics|analgesics|mesh-ancestor
14633591|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
14633592|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633593|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633594|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633595|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633596|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14633597|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14633598|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633599|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633600|NCT00153699|Topiramate|topiramate|mesh-list
14633601|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
14633602|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14633603|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633604|NCT00153725|Aspirin|aspirin|mesh-list
14633605|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633606|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170241|NCT04033276|Rituximab|rituximab|mesh-list
15170242|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
15170243|NCT04033276|Antibodies|antibodies|mesh-list
15170244|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
15170245|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14633607|NCT00153725|Analgesics|analgesics|mesh-ancestor
14633608|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
14633609|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633610|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633611|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170246|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15170247|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170248|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170249|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
15170250|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170251|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170252|NCT04032691|Clonidine|clonidine|mesh-list
15170253|NCT04032691|Analgesics|analgesics|mesh-ancestor
15170254|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
15170255|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170256|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170257|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15170258|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
15170259|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
14291930|NCT00557362|Voriconazole|voriconazole|mesh-list
15170260|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15170261|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15170262|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170263|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
14633612|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633613|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14633614|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14633615|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633616|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14633617|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14633618|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633619|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
14633620|NCT00153764|Vitamins|vitamins|mesh-list
14633621|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
14633622|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633623|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
14633624|NCT00153868|Hematinics|hematinics|mesh-ancestor
14633625|NCT00153881|Carboplatin|carboplatin|mesh-list
14633626|NCT00153881|Docetaxel|docetaxel|mesh-list
14633627|NCT00153881|Capecitabine|capecitabine|mesh-list
14633628|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633629|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14633630|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14633631|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14633632|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633633|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633634|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
14633635|NCT00153907|Capecitabine|capecitabine|mesh-list
14633636|NCT00153907|Vinorelbine|vinorelbine|mesh-list
14633637|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633638|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
14633639|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633640|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633641|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14633642|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14633643|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14633644|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14633645|NCT00153933|Lenalidomide|lenalidomide|mesh-list
14633646|NCT00153933|Bortezomib|bortezomib|mesh-list
14633647|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
14633648|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633649|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14633650|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14633651|NCT00153933|Growth Substances|growth substances|mesh-ancestor
14633652|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
14633653|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633654|NCT00153946|Edaravone|edaravone|mesh-list
14633655|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14633656|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
14633657|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633658|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14633659|NCT00153946|Protective Agents|protective agents|mesh-ancestor
14633660|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633661|NCT00153972|Levodopa|levodopa|mesh-list
14633662|NCT00153972|Cabergoline|cabergoline|mesh-list
14633663|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14633664|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14633665|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
14633666|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633667|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633668|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633669|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
14633670|NCT00153998|Leucovorin|leucovorin|mesh-list
14633671|NCT00153998|Folic Acid|folic acid|mesh-list
14633672|NCT00153998|Fluorouracil|fluorouracil|mesh-list
14633673|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
14633674|NCT00153998|Irinotecan|irinotecan|mesh-list
14633675|NCT00153998|Cetuximab|cetuximab|mesh-list
14633676|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
14633677|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
14633678|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633679|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633680|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633681|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633682|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
14633683|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633684|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14633685|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14633686|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633687|NCT00153998|Antidotes|antidotes|mesh-ancestor
14633688|NCT00153998|Protective Agents|protective agents|mesh-ancestor
14633689|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
14633690|NCT00153998|Vitamins|vitamins|mesh-ancestor
14633691|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
14633692|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14633693|NCT00153998|Hematinics|hematinics|mesh-ancestor
14633694|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
14633695|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14633696|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633697|NCT00154024|Irbesartan|irbesartan|mesh-list
14633698|NCT00154024|Atorvastatin|atorvastatin|mesh-list
14633699|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14633700|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14633701|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
14633702|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633703|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14633704|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14633705|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633706|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14291931|NCT00557362|Natamycin|natamycin|mesh-list
14291932|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
14291933|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170264|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170265|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170266|NCT04032860|Tenofovir|tenofovir|mesh-list
15170267|NCT04032860|Entecavir|entecavir|mesh-list
15170268|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
14291934|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14291935|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14291936|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291937|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291938|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14291939|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
14291940|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291941|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633707|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633708|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633709|NCT00154037|Pioglitazone|pioglitazone|mesh-list
14633710|NCT00154037|Candesartan|candesartan|mesh-list
14633711|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14633712|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633713|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633714|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633715|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633716|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633717|NCT00154050|Candesartan|candesartan|mesh-list
14633718|NCT00154050|Quinapril|quinapril|mesh-list
14633719|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633720|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633721|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633722|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633723|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14633724|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
14633725|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633726|NCT00154076|Topiramate|topiramate|mesh-list
14633727|NCT00154076|Zonisamide|zonisamide|mesh-list
14633728|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
14633729|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14633730|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633731|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14633732|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14633733|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633734|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14633735|NCT00154089|Masoprocol|masoprocol|mesh-list
14633736|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
14633737|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633738|NCT00154089|Protective Agents|protective agents|mesh-ancestor
14633739|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633740|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14633741|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633742|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15170269|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633743|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633744|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633745|NCT00154089|Analgesics|analgesics|mesh-ancestor
14633746|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
14633747|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633748|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633749|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633750|NCT00154115|Simendan|simendan|mesh-list
14633751|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14633752|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
14633753|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14633754|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14633755|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633756|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633757|NCT00154115|Protective Agents|protective agents|mesh-ancestor
14633758|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633759|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
14633760|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633761|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
14633762|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
14633763|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
14633764|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14633765|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
14633766|NCT00154141|Coagulants|coagulants|mesh-ancestor
14633767|NCT00154167|Phentolamine|phentolamine|mesh-list
14633768|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14633769|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14633770|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
14633771|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170270|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15170271|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15170272|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170273|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170274|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15170275|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15170276|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
15170277|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15170278|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
15170279|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15170280|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
15170281|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170282|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170283|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
15170284|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
15170285|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170286|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170287|NCT04032834|Budesonide|budesonide|mesh-list
15170288|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170289|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15170290|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
14633772|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633773|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633774|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633775|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14633776|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14633777|NCT00154180|Estradiol|estradiol|mesh-list
15170291|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170292|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633778|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14633779|NCT00154180|Estrogens|estrogens|mesh-list
14633780|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14633781|NCT00154180|Progesterone|progesterone|mesh-list
14633782|NCT00154180|Hormones|hormones|mesh-ancestor
14633783|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633784|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633785|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14633786|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
14633787|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633788|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14633789|NCT00154180|Progestins|progestins|mesh-ancestor
14633790|NCT00154193|Cyclosporine|cyclosporine|mesh-list
14633791|NCT00154193|Cyclosporins|cyclosporins|mesh-list
14633792|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170293|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14633793|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170294|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
15170295|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
15170296|NCT04032834|Hormones|hormones|mesh-ancestor
15170297|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170298|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
15170299|NCT04032548|Propolis|propolis|mesh-list
15170300|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15170301|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170302|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
15170303|NCT04032236|Caffeine|caffeine|mesh-list
15170304|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15170305|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170306|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15170307|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170308|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170309|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15170310|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15170311|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
15170312|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170313|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
15170314|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14633794|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633795|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
14633796|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633797|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
14633798|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633799|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
14633800|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633801|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14633802|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
14633803|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14633804|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633805|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14633806|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
14633807|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14633808|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633809|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633810|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633811|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
14633812|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14633813|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14633814|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633815|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633816|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14633817|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14633818|NCT00154219|Analgesics|analgesics|mesh-ancestor
14633819|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
14633820|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633821|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633822|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14633823|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633824|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
14633825|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14633826|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633827|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14633828|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
14633829|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14633830|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633831|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633832|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633833|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
14633834|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14633835|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633836|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14633837|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
14633838|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14633839|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633840|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633841|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646842|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646843|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170315|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
15170316|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14633842|NCT00154258|Clozapine|clozapine|mesh-list
14633843|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14633844|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
14633845|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14633846|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633847|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633848|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14633849|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14633850|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14633851|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14633852|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
14633853|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
14633854|NCT00154271|Valsartan|valsartan|mesh-list
14633855|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14633856|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14633857|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14633858|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633859|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
14633860|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
14633861|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14633862|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14633863|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14633864|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633865|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14633866|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14633867|NCT00154336|Methotrexate|methotrexate|mesh-list
14633868|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
14633869|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14633870|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
14633871|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633872|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633873|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633874|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
14633875|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633876|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633877|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14633878|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633879|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14633880|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633881|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
14633882|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14633883|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14633884|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14633885|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
14633886|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633887|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14633888|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633889|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633890|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
14633891|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
14633892|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14633893|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14633894|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14633895|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170317|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170318|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14633896|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14633897|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14633898|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
14633899|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633900|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14633901|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633902|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633903|NCT00154401|Liraglutide|liraglutide|mesh-list
14633904|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14633905|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633906|NCT00154401|Incretins|incretins|mesh-ancestor
14633907|NCT00154401|Hormones|hormones|mesh-ancestor
14633908|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633909|NCT00154414|Liraglutide|liraglutide|mesh-list
14633910|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026091|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14633911|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633912|NCT00154414|Incretins|incretins|mesh-ancestor
14633913|NCT00154414|Hormones|hormones|mesh-ancestor
14633914|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14633915|NCT00154440|Amoxicillin|amoxicillin|mesh-list
14633916|NCT00154440|Metronidazole|metronidazole|mesh-list
14633917|NCT00154440|Clarithromycin|clarithromycin|mesh-list
14633918|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14633919|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14633920|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633921|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14633922|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14633923|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14633924|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633925|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633926|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14633927|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14633928|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
14633929|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14633930|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633931|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633932|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14633933|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14633934|NCT00154661|Protective Agents|protective agents|mesh-ancestor
14633935|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633936|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
14633937|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14633938|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
14633939|NCT00154687|Paclitaxel|paclitaxel|mesh-list
14633940|NCT00154687|Fluorouracil|fluorouracil|mesh-list
14633941|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14633942|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633943|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
14633944|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
14633945|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
14633946|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633947|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
14633948|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633949|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633950|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
14633951|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633952|NCT00154700|Folic Acid|folic acid|mesh-list
14633953|NCT00154700|Paclitaxel|paclitaxel|mesh-list
14633954|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14633955|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633956|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14633957|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14633958|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14633959|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633960|NCT00154700|Hematinics|hematinics|mesh-ancestor
14633961|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
14633962|NCT00154700|Vitamins|vitamins|mesh-ancestor
14633963|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
14633964|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633965|NCT00154726|Paclitaxel|paclitaxel|mesh-list
14633966|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14633967|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633968|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
14633969|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
14633970|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
14633971|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633972|NCT00154739|Gemcitabine|gemcitabine|mesh-list
14633973|NCT00154739|Epirubicin|epirubicin|mesh-list
14633974|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14633975|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633976|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
14633977|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633978|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
14633979|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14633980|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14633981|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14633982|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
15170319|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
14633983|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170320|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15170321|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
14633984|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14633985|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14633986|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14633987|NCT00154778|Leucovorin|leucovorin|mesh-list
14633988|NCT00154778|Antidotes|antidotes|mesh-ancestor
14633989|NCT00154778|Protective Agents|protective agents|mesh-ancestor
14633990|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14633991|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
14633992|NCT00154778|Vitamins|vitamins|mesh-ancestor
14633993|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
14633994|NCT00154791|Gemcitabine|gemcitabine|mesh-list
14633995|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
14633996|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14633997|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
14633998|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14633999|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634000|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
14634001|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634002|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634003|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14634004|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
14634005|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634006|NCT00154804|Paclitaxel|paclitaxel|mesh-list
14634007|NCT00154804|Cisplatin|cisplatin|mesh-list
14634008|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14634009|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634010|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
14634011|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
14634012|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
14634013|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634014|NCT00154843|Lycopene|lycopene|mesh-list
14634015|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14634016|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
14634017|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634018|NCT00154843|Protective Agents|protective agents|mesh-ancestor
14634019|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634020|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14634021|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14634022|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634023|NCT00154869|Ribavirin|ribavirin|mesh-list
14634024|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14634025|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
14634026|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634027|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
14634028|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634029|NCT00154882|Paclitaxel|paclitaxel|mesh-list
14634030|NCT00154882|Cisplatin|cisplatin|mesh-list
14634031|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14634032|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170322|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170323|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170324|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15170325|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
15170326|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
15170327|NCT04032366|Protective Agents|protective agents|mesh-ancestor
15170328|NCT04032132|Curcumin|curcumin|mesh-list
15170329|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15170330|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170331|NCT04032132|Analgesics|analgesics|mesh-ancestor
15170332|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
15170333|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634033|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
14634034|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
14634035|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
14634036|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634037|NCT00154895|Minocycline|minocycline|mesh-list
14634038|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14634039|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170334|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022547|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634040|NCT00155064|Losartan|losartan|mesh-list
14634041|NCT00155064|Captopril|captopril|mesh-list
14634042|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14634043|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14634044|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15170335|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170336|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14634045|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14634046|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634047|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14634048|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
14634049|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634050|NCT00155233|Morphine|morphine|mesh-list
14634051|NCT00155233|Nalbuphine|nalbuphine|mesh-list
14634052|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14634053|NCT00155233|Narcotics|narcotics|mesh-ancestor
14634054|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634055|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634056|NCT00155233|Analgesics|analgesics|mesh-ancestor
14634057|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
14634058|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634059|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
14634060|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14634061|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634062|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634063|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14634064|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14634065|NCT00155246|Protective Agents|protective agents|mesh-ancestor
14634066|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634067|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
14634068|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14634069|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
14634070|NCT00155259|Docetaxel|docetaxel|mesh-list
14634071|NCT00155259|Capecitabine|capecitabine|mesh-list
14634072|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634073|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
14634074|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
14634075|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
14634076|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634077|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14634078|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
14634079|NCT00155272|Thalidomide|thalidomide|mesh-list
14634080|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14634081|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
14634082|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634083|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
14634084|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14634085|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634086|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14634087|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14634088|NCT00155272|Growth Substances|growth substances|mesh-ancestor
14634089|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
14634090|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634091|NCT00155350|Pioglitazone|pioglitazone|mesh-list
14634092|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14634093|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634094|NCT00155376|Morphine|morphine|mesh-list
14634095|NCT00155376|Glucagon|glucagon|mesh-list
14634096|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15170337|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170338|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634097|NCT00155376|Narcotics|narcotics|mesh-ancestor
14634098|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634099|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634100|NCT00155376|Analgesics|analgesics|mesh-ancestor
15170339|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170340|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
15170341|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15170342|NCT04032184|Fluorides|fluorides|mesh-list
15170343|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
15170344|NCT04032184|Protective Agents|protective agents|mesh-ancestor
15170345|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170346|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15170347|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170348|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
15170349|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
15170350|NCT04032119|Epinephrine|epinephrine|mesh-list
14634101|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
14634102|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634103|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170351|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15170352|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170353|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
14634104|NCT00155376|Hormones|hormones|mesh-ancestor
14634105|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14634106|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14634107|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
14634108|NCT00155402|Coagulants|coagulants|mesh-ancestor
14634109|NCT00155558|Leucovorin|leucovorin|mesh-list
14634110|NCT00155558|Fluorouracil|fluorouracil|mesh-list
14634111|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
14634112|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634113|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14634114|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634115|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14634116|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
14634117|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634118|NCT00155558|Antidotes|antidotes|mesh-ancestor
14634119|NCT00155558|Protective Agents|protective agents|mesh-ancestor
14634120|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
14634121|NCT00155558|Vitamins|vitamins|mesh-ancestor
14634122|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
14646844|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14646845|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
14646846|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646847|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646848|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14646849|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646850|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
14646851|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
14646852|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646853|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14646854|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
14646855|NCT00199004|Hormones|hormones|mesh-ancestor
14646856|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646857|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14646858|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14646859|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14646860|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
14646861|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14646862|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646863|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
14646864|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
14646865|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646866|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14646867|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646868|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
14646869|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646870|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14646871|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646872|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646873|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646874|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646875|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14646876|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646877|NCT00199017|Cytarabine|cytarabine|mesh-list
14646878|NCT00199017|Dexamethasone|dexamethasone|mesh-list
14646879|NCT00199017|Prednisolone|prednisolone|mesh-list
14646880|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
14646881|NCT00199017|Methotrexate|methotrexate|mesh-list
14646882|NCT00199017|Vincristine|vincristine|mesh-list
15170354|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170355|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170356|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170357|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15170358|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15170359|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
15170360|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170361|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15170362|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
15170363|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
15170364|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
15170365|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14646883|NCT00199017|Doxorubicin|doxorubicin|mesh-list
14646884|NCT00199017|Daunorubicin|daunorubicin|mesh-list
15170366|NCT04032210|Zinc|zinc|mesh-list
14646885|NCT00199017|Asparaginase|asparaginase|mesh-list
14646886|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
14646887|NCT00199017|Thioguanine|thioguanine|mesh-list
15170367|NCT04032210|Fluorides|fluorides|mesh-list
15170368|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
15170369|NCT04032210|Protective Agents|protective agents|mesh-ancestor
15170370|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170371|NCT04032210|Trace Elements|trace elements|mesh-ancestor
14634123|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
14634124|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
14634125|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
14634126|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14634127|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634128|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634129|NCT00155714|Urological Agents|urological agents|mesh-ancestor
15170372|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
15170373|NCT04031859|Aspirin|aspirin|mesh-list
15170374|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14634130|NCT00155883|Leucovorin|leucovorin|mesh-list
14634131|NCT00155883|Fluorouracil|fluorouracil|mesh-list
14634132|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
14634133|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634134|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14634135|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634136|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15170375|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170376|NCT04031859|Analgesics|analgesics|mesh-ancestor
15170377|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
15170378|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170379|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170380|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170381|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170382|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15170383|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15170384|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170385|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15170386|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15170387|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170388|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
15170389|NCT04031872|Capecitabine|capecitabine|mesh-list
15170390|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14634137|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
14634138|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634139|NCT00155883|Antidotes|antidotes|mesh-ancestor
14634140|NCT00155883|Protective Agents|protective agents|mesh-ancestor
14634141|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
14634142|NCT00155883|Vitamins|vitamins|mesh-ancestor
14634143|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
14634144|NCT00156078|Pregabalin|pregabalin|mesh-list
14634145|NCT00156078|Analgesics|analgesics|mesh-ancestor
14634146|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
14634147|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634148|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634149|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
14634150|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14634151|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14634152|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634153|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14634154|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14634155|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634156|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634157|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15170391|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
15170392|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170393|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170394|NCT04031755|Minocycline|minocycline|mesh-list
15170395|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15170396|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170397|NCT04031703|Paclitaxel|paclitaxel|mesh-list
15170398|NCT04031703|Docetaxel|docetaxel|mesh-list
14022548|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634158|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
14634159|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634160|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14634161|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634162|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170399|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
15170400|NCT04031703|Carboplatin|carboplatin|mesh-list
15170401|NCT04031703|Fluorouracil|fluorouracil|mesh-list
15170402|NCT04031703|Epirubicin|epirubicin|mesh-list
14634163|NCT00156299|Dexamethasone|dexamethasone|mesh-list
14634164|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
14634165|NCT00156299|Choline|choline|mesh-list
14634166|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14634167|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
14634168|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
14634169|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634170|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634171|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14634172|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
14634173|NCT00156299|Hormones|hormones|mesh-ancestor
14634174|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14634175|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14634176|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634177|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
15170403|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15170404|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170405|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
15170406|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
15170407|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
15170408|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170409|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15170410|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
15170411|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170412|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170413|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15170414|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
15170415|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15170416|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
15170417|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14634178|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14634179|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
14634180|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634181|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14634182|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
14634183|NCT00156299|Analgesics|analgesics|mesh-ancestor
14634184|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
14634185|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14634186|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14634187|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14634188|NCT00156312|Docetaxel|docetaxel|mesh-list
14634189|NCT00156312|Capecitabine|capecitabine|mesh-list
15170418|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15170419|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15170420|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15170421|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170422|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
15170423|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15170424|NCT04031027|Apremilast|apremilast|mesh-list
15170425|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15170426|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170427|NCT04031027|Analgesics|analgesics|mesh-ancestor
15170428|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
15170429|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170430|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170431|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170432|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170433|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15170434|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15170435|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170436|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181185|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
15181186|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
15181187|NCT03932123|Vancomycin|vancomycin|mesh-list
15181188|NCT03932123|Meropenem|meropenem|mesh-list
15181189|NCT03932123|Tazobactam|tazobactam|mesh-list
15181190|NCT03932123|Piperacillin|piperacillin|mesh-list
15181191|NCT03932123|Cefotaxime|cefotaxime|mesh-list
15181192|NCT03932123|Cefoxitin|cefoxitin|mesh-list
15181193|NCT03932123|Azlocillin|azlocillin|mesh-list
15181194|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15181195|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634190|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634191|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
15181196|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14634192|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
14634193|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
15170437|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
15170438|NCT04030663|Papaverine|papaverine|mesh-list
15170439|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
15170440|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14634194|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634195|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14634196|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
14634197|NCT00156325|Citalopram|citalopram|mesh-list
14634198|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14634199|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14634200|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14634201|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634202|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634203|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
14634204|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634205|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14634206|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
14634207|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634208|NCT00156377|Mupirocin|mupirocin|mesh-list
14634209|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14634210|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634211|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14634212|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634213|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634214|NCT00156403|Amlodipine|amlodipine|mesh-list
14634215|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14634216|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14634217|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14634218|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634219|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14634220|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634221|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
14634222|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
14634223|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14634224|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14634225|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634226|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
14634227|NCT00156520|Coagulants|coagulants|mesh-ancestor
14634228|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14634229|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634230|NCT00156611|Abciximab|abciximab|mesh-list
14634231|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
14634232|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14634233|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14634234|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
14634235|NCT00156650|Testosterone|testosterone|mesh-list
14634236|NCT00156650|Acyline|acyline|mesh-list
14634237|NCT00156650|Androgens|androgens|mesh-ancestor
14634238|NCT00156650|Hormones|hormones|mesh-ancestor
14634239|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14634240|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634241|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14634242|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634243|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14634244|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14634245|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14634246|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
14634247|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14634248|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14634249|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14634250|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14634251|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
14634252|NCT00156689|Levetiracetam|levetiracetam|mesh-list
14634253|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
14634254|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
14634255|NCT00156858|Busulfan|busulfan|mesh-list
14634256|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
14634257|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634258|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14634259|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
15170441|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170442|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170443|NCT04030663|Urological Agents|urological agents|mesh-ancestor
15170444|NCT04030988|Dexamethasone|dexamethasone|mesh-list
14634260|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634261|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14634262|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170445|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170446|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
14634263|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14634264|NCT00156884|Cisplatin|cisplatin|mesh-list
14634265|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634266|NCT00156897|Orlistat|orlistat|mesh-list
14634267|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634268|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634269|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14634270|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14634271|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
14634272|NCT00156949|Hematinics|hematinics|mesh-ancestor
14634273|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
14634274|NCT00156962|Hematinics|hematinics|mesh-ancestor
14634275|NCT00156975|Capecitabine|capecitabine|mesh-list
14634276|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
14634277|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14634278|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
14634279|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634280|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634281|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
14634282|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14634283|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
14634284|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15170447|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
15170448|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170449|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170450|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14634285|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634286|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634287|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634288|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
14634289|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14634290|NCT00157040|Factor VIII|factor viii|mesh-list
14634291|NCT00157040|Coagulants|coagulants|mesh-ancestor
14634292|NCT00157053|Factor VIII|factor viii|mesh-list
14634293|NCT00157053|Coagulants|coagulants|mesh-ancestor
14634294|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
14634295|NCT00157066|Vitamin D|vitamin d|mesh-list
14634296|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14634297|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634298|NCT00157066|Vitamins|vitamins|mesh-ancestor
14634299|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
14634300|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14634301|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
14634302|NCT00157079|Antibodies|antibodies|mesh-list
14634303|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
14634304|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14634305|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14634306|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
14634307|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634308|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14634309|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
14634310|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14634311|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14634312|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
14634313|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634314|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634315|NCT00157105|Factor VIII|factor viii|mesh-list
14634316|NCT00157105|Coagulants|coagulants|mesh-ancestor
14634317|NCT00157118|Protein C|protein c|mesh-list
14634318|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
14634319|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14634320|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14634321|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634322|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14634323|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
14634324|NCT00157131|Coagulants|coagulants|mesh-ancestor
14646888|NCT00199017|Cladribine|cladribine|mesh-list
14646889|NCT00199017|Vindesine|vindesine|mesh-list
14646890|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646891|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
14646892|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646893|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646894|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14646895|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
15170451|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
14634325|NCT00157235|Bromides|bromides|mesh-list
14634326|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
14634327|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14634328|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
14634329|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634330|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634331|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14634332|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
14634333|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
14634334|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14634335|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
14634336|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634337|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634338|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
14634339|NCT00157261|Tenecteplase|tenecteplase|mesh-list
14634340|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14634341|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14634342|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634343|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
14634344|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14634345|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634346|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
14634347|NCT00157300|Hematinics|hematinics|mesh-ancestor
14634348|NCT00157326|Tadalafil|tadalafil|mesh-list
14634349|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
14634350|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14634351|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14634352|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634353|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634354|NCT00157326|Urological Agents|urological agents|mesh-ancestor
14634355|NCT00157378|Haloperidol|haloperidol|mesh-list
14634356|NCT00157378|Risperidone|risperidone|mesh-list
14634357|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
14634358|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14634359|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
14634360|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634361|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634362|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634363|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14634364|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634365|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634366|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634367|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14634368|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
14634369|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
14634370|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
14634371|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634372|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14634373|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15170452|NCT04030988|Hormones|hormones|mesh-ancestor
15170453|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170454|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15170455|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170456|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15170457|NCT04030715|Bismuth|bismuth|mesh-list
15170458|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170459|NCT04030715|Antacids|antacids|mesh-ancestor
15170460|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170461|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170462|NCT04030741|Metronidazole|metronidazole|mesh-list
15170463|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170464|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15170465|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15170466|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15170467|NCT04030442|Morphine|morphine|mesh-list
15170468|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15170469|NCT04030442|Narcotics|narcotics|mesh-ancestor
15170470|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170471|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170472|NCT04030442|Analgesics|analgesics|mesh-ancestor
15170473|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
15170474|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634374|NCT00157482|Simvastatin|simvastatin|mesh-list
14634375|NCT00157482|Ezetimibe|ezetimibe|mesh-list
14634376|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14634377|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14634378|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
15170475|NCT04030533|Ustekinumab|ustekinumab|mesh-list
14634379|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634380|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14634381|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14634382|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634383|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
14634384|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14634385|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14634386|NCT00157508|Analgesics|analgesics|mesh-ancestor
15170476|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15170477|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
15170478|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
15170479|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170480|NCT04030572|Clonidine|clonidine|mesh-list
15170481|NCT04030572|Analgesics|analgesics|mesh-ancestor
15170482|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
14634387|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
14634388|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634389|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634390|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14634391|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14634392|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14634393|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15170483|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170484|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170485|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15170486|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
15170487|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
15170488|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15170489|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15170490|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170491|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
15170492|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170493|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170494|NCT04030481|Anesthetics|anesthetics|mesh-list
15170495|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170496|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170497|NCT04030260|Nivolumab|nivolumab|mesh-list
14634394|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634395|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14634396|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14634397|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
14634398|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634399|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
15170498|NCT04030260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170499|NCT04030260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170500|NCT04030260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15170501|NCT04030260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170502|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
15170503|NCT04030195|Fludarabine|fludarabine|mesh-list
15170504|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14634400|NCT00157547|Citalopram|citalopram|mesh-list
14634401|NCT00157547|Fluoxetine|fluoxetine|mesh-list
14634402|NCT00157547|Paroxetine|paroxetine|mesh-list
14634403|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14634404|NCT00157547|Sertraline|sertraline|mesh-list
14634405|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14634406|NCT00157547|Serotonin|serotonin|mesh-list
14634407|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14634408|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15170505|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
14022549|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14634409|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634410|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634411|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
14634412|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634413|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14634414|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
14634415|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634416|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14634417|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15170506|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170507|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022550|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634418|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634419|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14634420|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14634421|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14634422|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634423|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634424|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14634425|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14634426|NCT00157586|Manidipine|manidipine|mesh-list
14634427|NCT00157586|Delapril|delapril|mesh-list
14634428|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14634429|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14634430|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14634431|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634432|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14634433|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634434|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14634435|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
14634436|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170508|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15170509|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
15170510|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634437|NCT00157651|Warfarin|warfarin|mesh-list
14634438|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
14634439|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
14634440|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14634441|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14634442|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634443|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
14634444|NCT00157677|Coagulants|coagulants|mesh-ancestor
14634445|NCT00157690|Alendronate|alendronate|mesh-list
14634446|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14634447|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634448|NCT00157716|Pyridoxal|pyridoxal|mesh-list
14634449|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
14634450|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
14634451|NCT00157716|Vitamins|vitamins|mesh-ancestor
14634452|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
14634453|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634454|NCT00157729|Pyridoxal|pyridoxal|mesh-list
14634455|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
14634456|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14634457|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14634458|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634459|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634460|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
14634461|NCT00157729|Vitamins|vitamins|mesh-ancestor
14634462|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
14634463|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634464|NCT00157859|Chloroquine|chloroquine|mesh-list
14634465|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
14634466|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
14634467|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14634468|NCT00157859|Amebicides|amebicides|mesh-ancestor
14634469|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634470|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634471|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634472|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
14634473|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14634474|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14634475|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634476|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634477|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14634478|NCT00157859|Renal Agents|renal agents|mesh-ancestor
14634479|NCT00157872|Naproxen|naproxen|mesh-list
14634480|NCT00157872|Rofecoxib|rofecoxib|mesh-list
14634481|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14634482|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14634483|NCT00157872|Analgesics|analgesics|mesh-ancestor
15170511|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170512|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15170513|NCT04030039|Interferons|interferons|mesh-list
14634484|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
14634485|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634486|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634487|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14634488|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14634489|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
14634490|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14634491|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634492|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634493|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14634494|NCT00157885|Artesunate|artesunate|mesh-list
14634495|NCT00157885|Amodiaquine|amodiaquine|mesh-list
14634496|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
14634497|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634498|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634499|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634500|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634501|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
14634502|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
14634503|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14634504|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
14634505|NCT00157898|Metronidazole|metronidazole|mesh-list
14634506|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
14634507|NCT00157898|Ertapenem|ertapenem|mesh-list
14634508|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634509|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14634510|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634511|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634512|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
14634513|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14634514|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
14634515|NCT00158002|Topiramate|topiramate|mesh-list
14634516|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
14634517|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14634518|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634519|NCT00158028|Risperidone|risperidone|mesh-list
14634520|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14634521|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
14634522|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634523|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634524|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634525|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14634526|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634527|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634528|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634529|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14634530|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
14634531|NCT00158041|Amifostine|amifostine|mesh-list
14634532|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14634533|NCT00158041|Protective Agents|protective agents|mesh-ancestor
14634534|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634535|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
14634536|NCT00158093|Atenolol|atenolol|mesh-list
14634537|NCT00158093|Nebivolol|nebivolol|mesh-list
14634538|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14634539|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634540|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14634541|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14634542|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634543|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634544|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634545|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634546|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14634547|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14634548|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
14634549|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
14634550|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634551|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14634552|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14634553|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14634554|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
14634555|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634556|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
14634557|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14634558|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14634559|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170514|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634560|NCT00158132|Amantadine|amantadine|mesh-list
14634561|NCT00158132|Propranolol|propranolol|mesh-list
14634562|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14634563|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14634564|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
14634565|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634566|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634567|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634568|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14634569|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14634570|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
14634571|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14634572|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14634573|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
14634574|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634575|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
14634576|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14634577|NCT00158132|Analgesics|analgesics|mesh-ancestor
14634578|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
14634579|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634580|NCT00158158|Nicotine|nicotine|mesh-list
14634581|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14634582|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
14634583|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634584|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634585|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14634586|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14634587|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
14634588|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634589|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634590|NCT00158171|Folic Acid|folic acid|mesh-list
14634591|NCT00158171|Nicotine|nicotine|mesh-list
14634592|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14634593|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
14634594|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634595|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634596|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14634597|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14634598|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
14634599|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634600|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634601|NCT00158171|Hematinics|hematinics|mesh-ancestor
14634602|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
14634603|NCT00158171|Vitamins|vitamins|mesh-ancestor
14634604|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
14634605|NCT00158210|Rivastigmine|rivastigmine|mesh-list
14634606|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14634607|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634608|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634609|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
14634610|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634611|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634612|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14634613|NCT00158210|Protective Agents|protective agents|mesh-ancestor
14634614|NCT00158236|Buprenorphine|buprenorphine|mesh-list
14634615|NCT00158236|Hydromorphone|hydromorphone|mesh-list
14634616|NCT00158236|Naloxone|naloxone|mesh-list
14634617|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14634618|NCT00158236|Narcotics|narcotics|mesh-ancestor
14634619|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634620|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634621|NCT00158236|Analgesics|analgesics|mesh-ancestor
14634622|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
14634623|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634624|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14634625|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
14634626|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634627|NCT00158301|Fluoxetine|fluoxetine|mesh-list
14634628|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14634629|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14634630|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14634631|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634632|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634633|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
14634634|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634635|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14634636|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
14634637|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634638|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15170515|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
14634639|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14634640|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634641|NCT00158405|Ritonavir|ritonavir|mesh-list
14634642|NCT00158405|Indinavir|indinavir|mesh-list
14634643|NCT00158405|Lamivudine|lamivudine|mesh-list
14634644|NCT00158405|Zidovudine|zidovudine|mesh-list
14634645|NCT00158405|Efavirenz|efavirenz|mesh-list
14634646|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14634647|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14634648|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
14634649|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634650|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634651|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14634652|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14634653|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
14634654|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634655|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14634656|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14634657|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14634658|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14634659|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
14634660|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14634661|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14634662|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14634663|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14634664|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14634665|NCT00158457|Tenofovir|tenofovir|mesh-list
14634666|NCT00158457|Emtricitabine|emtricitabine|mesh-list
14634667|NCT00158457|Efavirenz|efavirenz|mesh-list
14634668|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
14634669|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634670|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14634671|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14634672|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634673|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634674|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14634675|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14634676|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14634677|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14634678|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14634679|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14634680|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14634681|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14634682|NCT00158470|Lamivudine|lamivudine|mesh-list
14634683|NCT00158470|Efavirenz|efavirenz|mesh-list
14634684|NCT00158470|Didanosine|didanosine|mesh-list
14634685|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14634686|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15170516|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170517|NCT04030429|Crizotinib|crizotinib|mesh-list
15170518|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170519|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15170520|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170521|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170522|NCT04030455|Cisplatin|cisplatin|mesh-list
15170523|NCT04030455|Carboplatin|carboplatin|mesh-list
14634687|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634688|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634689|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
14634690|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634691|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14634692|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14634693|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14634694|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14634695|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14634696|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14634697|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14634698|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14634699|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
14634700|NCT00158483|Acyclovir|acyclovir|mesh-list
14634701|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
14634702|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634703|NCT00158496|Interferons|interferons|mesh-list
14634704|NCT00158496|Ribavirin|ribavirin|mesh-list
15170524|NCT04030455|Docetaxel|docetaxel|mesh-list
14634705|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
14634706|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
14634707|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14634708|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634709|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
14634710|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634711|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
14634712|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634713|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
14634714|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634715|NCT00158509|Valacyclovir|valacyclovir|mesh-list
14634716|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
14634717|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634718|NCT00158522|Interferons|interferons|mesh-list
14634719|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
15170525|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
14634720|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
14634721|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14634722|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634723|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
14634724|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634725|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
14634726|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634727|NCT00158548|Artesunate|artesunate|mesh-list
14634728|NCT00158548|Chloroquine|chloroquine|mesh-list
14634729|NCT00158548|Primaquine|primaquine|mesh-list
14634730|NCT00158548|Amodiaquine|amodiaquine|mesh-list
14634731|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
14634732|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634733|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634734|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634735|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634736|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
14634737|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
14634738|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14634739|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
14634740|NCT00158548|Amebicides|amebicides|mesh-ancestor
14634741|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14634742|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
14634743|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
14634744|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14634745|NCT00158561|Dapsone|dapsone|mesh-list
14634746|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
14634747|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
14634748|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634749|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634750|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634751|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14634752|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634753|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634754|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14634755|NCT00158561|Renal Agents|renal agents|mesh-ancestor
14634756|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
14634757|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14634758|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
14634759|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
14634760|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14634761|NCT00158574|Dapsone|dapsone|mesh-list
14634762|NCT00158574|Mefloquine|mefloquine|mesh-list
14634763|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
14634764|NCT00158574|Proguanil|proguanil|mesh-list
14634765|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
14634766|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634767|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15170526|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170527|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
15170528|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
15170529|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
15170530|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170531|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170532|NCT04030091|Insulin|insulin|mesh-list
15170533|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15170534|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
15170535|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14022551|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14634768|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634769|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14634770|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634771|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634772|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15181197|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634773|NCT00158574|Renal Agents|renal agents|mesh-ancestor
14634774|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
14634775|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14634776|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
14634777|NCT00158587|Primaquine|primaquine|mesh-list
14634778|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
14634779|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634780|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634781|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634782|NCT00158652|Carboplatin|carboplatin|mesh-list
14634783|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634784|NCT00158678|Cisplatin|cisplatin|mesh-list
14634785|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634786|NCT00158691|Amifostine|amifostine|mesh-list
14634787|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14634788|NCT00158691|Protective Agents|protective agents|mesh-ancestor
14634789|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634790|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14634791|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
14634792|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634793|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14634794|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15170536|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170537|NCT04029831|Ketamine|ketamine|mesh-list
15170538|NCT04029831|Propofol|propofol|mesh-list
15170539|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170540|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170541|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634795|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634796|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634797|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14634798|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
14634799|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634800|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14634801|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14634802|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634803|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634804|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14634805|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
14634806|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634807|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14634808|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14634809|NCT00158782|Lapatinib|lapatinib|mesh-list
14634810|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14634811|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14634812|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634813|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634814|NCT00158821|Tenofovir|tenofovir|mesh-list
14634815|NCT00158821|Lamivudine|lamivudine|mesh-list
14634816|NCT00158821|Efavirenz|efavirenz|mesh-list
14634817|NCT00158821|Stavudine|stavudine|mesh-list
14634818|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
14634819|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634820|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14634821|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14634822|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634823|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634824|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14634825|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14634826|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14634827|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14634828|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14634829|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14634830|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14634831|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14634832|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
14634833|NCT00158834|Fluticasone|fluticasone|mesh-list
14634834|NCT00158834|Xhance|xhance|mesh-list
14634835|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14634836|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14634837|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14634838|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
14634839|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634840|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634841|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14634842|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
14634843|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14634844|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14634845|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14634846|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14634847|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14634848|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14634849|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634850|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634851|NCT00158847|Fluticasone|fluticasone|mesh-list
14634852|NCT00158847|Xhance|xhance|mesh-list
14634853|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14634854|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14634855|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14634856|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
14634857|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634858|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634859|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14634860|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
14634861|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14634862|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14634863|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14634864|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14634865|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14634866|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
14634867|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634868|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634869|NCT00158873|Fentanyl|fentanyl|mesh-list
14634870|NCT00158873|Midazolam|midazolam|mesh-list
14634871|NCT00158873|Morphine|morphine|mesh-list
14634872|NCT00158873|Remifentanil|remifentanil|mesh-list
14634873|NCT00158873|Lorazepam|lorazepam|mesh-list
14634874|NCT00158873|Propofol|propofol|mesh-list
14634875|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14634876|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634877|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634878|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14634879|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
14634880|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
14634881|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14634882|NCT00158873|Narcotics|narcotics|mesh-ancestor
14634883|NCT00158873|Analgesics|analgesics|mesh-ancestor
14634884|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
14634885|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634886|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14634887|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14634888|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634889|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634890|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
14634891|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
14634892|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634893|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634894|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
14634895|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
14634896|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
14634897|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14634898|NCT00158886|Topotecan|topotecan|mesh-list
14634899|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14634900|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14634901|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634902|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634903|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646896|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646897|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646898|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14646899|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646900|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
14646901|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
14646902|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170542|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170543|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
15170544|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
14646903|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14646904|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
14646905|NCT00199017|Hormones|hormones|mesh-ancestor
14646906|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646907|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15170545|NCT04029831|Analgesics|analgesics|mesh-ancestor
15170546|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
15170547|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170548|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15170549|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15170550|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14634904|NCT00158990|Sertraline|sertraline|mesh-list
14634905|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
14634906|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634907|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14634908|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14634909|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14634910|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634911|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634912|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
15170551|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170552|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170553|NCT04029675|Ascorbic Acid|ascorbic acid|mesh-list
15170554|NCT04029675|Vitamins|vitamins|mesh-ancestor
14634913|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170555|NCT04029675|Micronutrients|micronutrients|mesh-ancestor
15170556|NCT04029675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170557|NCT04029675|Antioxidants|antioxidants|mesh-ancestor
15170558|NCT04029675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170559|NCT04029675|Protective Agents|protective agents|mesh-ancestor
15170560|NCT04029636|Xenon|xenon|mesh-list
15170561|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15170562|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
14634914|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
14634915|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170563|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
15170564|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170565|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170566|NCT04029428|Octreotide|octreotide|mesh-list
15170567|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15170568|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15170569|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170570|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170571|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14634916|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14634917|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170572|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170573|NCT04029350|Osimertinib|osimertinib|mesh-list
15170574|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170575|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15170576|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170577|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170578|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
15170579|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170580|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634918|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634919|NCT00159081|Haloperidol|haloperidol|mesh-list
14634920|NCT00159081|Risperidone|risperidone|mesh-list
14634921|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
14634922|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14634923|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
14634924|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634925|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634926|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634927|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14634928|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634929|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634930|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634931|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14634932|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
14634933|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
14634934|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
14634935|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634936|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14634937|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15170581|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634938|NCT00159094|Vinorelbine|vinorelbine|mesh-list
14634939|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14634940|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022552|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
14634941|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
15170582|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170583|NCT04029467|Analgesics|analgesics|mesh-ancestor
14634942|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
14634943|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
14634944|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634945|NCT00159107|Acamprosate|acamprosate|mesh-list
14634946|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14634947|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
14634948|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634949|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634950|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634951|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634952|NCT00159133|Lorazepam|lorazepam|mesh-list
14634953|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
14634954|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
14634955|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
14634956|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
14634957|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14634958|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634959|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14634960|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14634961|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14634962|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14634963|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14634964|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14634965|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
14634966|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
14634967|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634968|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634969|NCT00159146|Pindolol|pindolol|mesh-list
14634970|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14634971|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14634972|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
14634973|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14634974|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634975|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634976|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14634977|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14634978|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
14634979|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
14634980|NCT00159159|Cyclosporine|cyclosporine|mesh-list
14634981|NCT00159159|Cyclosporins|cyclosporins|mesh-list
14634982|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14634983|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14634984|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14634985|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
14634986|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634987|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
14634988|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14634989|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14634990|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14634991|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14634992|NCT00159211|Pioglitazone|pioglitazone|mesh-list
14634993|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14634994|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14634995|NCT00159224|Ritonavir|ritonavir|mesh-list
14634996|NCT00159224|Lopinavir|lopinavir|mesh-list
14634997|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14634998|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14634999|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
14635000|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635001|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635002|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14635003|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14635004|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
14635005|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635006|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14635007|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14635008|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
14635009|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14635010|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
14635011|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170584|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
14635012|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635013|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14635014|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
14635015|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14635016|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
14635017|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635018|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635019|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14635020|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635021|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
14635022|NCT00159302|Protective Agents|protective agents|mesh-ancestor
14635023|NCT00159380|Pimagedine|pimagedine|mesh-list
14635024|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635025|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635026|NCT00159445|Gemcitabine|gemcitabine|mesh-list
14635027|NCT00159445|Capecitabine|capecitabine|mesh-list
14635028|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14635029|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
14635030|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635031|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635032|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
14635033|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635034|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635035|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635036|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
14635037|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635038|NCT00159458|Gemcitabine|gemcitabine|mesh-list
14635039|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
14635040|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14635041|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
14635042|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635043|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635044|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
14635045|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635046|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635047|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635048|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
14635049|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635050|NCT00159471|Gemcitabine|gemcitabine|mesh-list
14635051|NCT00159471|Capecitabine|capecitabine|mesh-list
14635052|NCT00159471|Docetaxel|docetaxel|mesh-list
14635053|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14635054|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
14635055|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635056|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635057|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
14635058|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635059|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635060|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635061|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
14635062|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635063|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14635064|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14635065|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14635066|NCT00159484|Celecoxib|celecoxib|mesh-list
14635067|NCT00159484|Epothilone B|epothilone b|mesh-list
14635068|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14635069|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170585|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170586|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15170587|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15170588|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170589|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
15170590|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170591|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170592|NCT04029090|Edaravone|edaravone|mesh-list
14635070|NCT00159484|Analgesics|analgesics|mesh-ancestor
14635071|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
14635072|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635073|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635074|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14635075|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635076|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14635077|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14635078|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635079|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170593|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14635080|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170594|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
15170595|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170596|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15170597|NCT04029090|Protective Agents|protective agents|mesh-ancestor
15170598|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170599|NCT04029272|Metformin|metformin|mesh-list
15170600|NCT04029272|Exenatide|exenatide|mesh-list
15170601|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15170602|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170603|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15170604|NCT04029272|Incretins|incretins|mesh-ancestor
15170605|NCT04029272|Hormones|hormones|mesh-ancestor
15170606|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170607|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
15170608|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15170609|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
15170610|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15170611|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170612|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15170613|NCT04028778|Gefitinib|gefitinib|mesh-list
15170614|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170615|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14635081|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
14635082|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
14635083|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
14635084|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
14635085|NCT00159510|Methylene Blue|methylene blue|mesh-list
14635086|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14635087|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
14635088|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635089|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635090|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14635091|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
14635092|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14635093|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
14635094|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635095|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635096|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14635097|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635098|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
14635099|NCT00159510|Protective Agents|protective agents|mesh-ancestor
14635100|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635101|NCT00159536|Metformin|metformin|mesh-list
14635102|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14635103|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635104|NCT00159575|Metformin|metformin|mesh-list
14635105|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14635106|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635107|NCT00159614|Rolofylline|rolofylline|mesh-list
14635108|NCT00159614|Diuretics|diuretics|mesh-ancestor
14635109|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
14635110|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635111|NCT00159627|Rolofylline|rolofylline|mesh-list
14635112|NCT00159627|Diuretics|diuretics|mesh-ancestor
14635113|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
14635114|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635115|NCT00159653|Timolol|timolol|mesh-list
14635116|NCT00159653|Latanoprost|latanoprost|mesh-list
14635117|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14635118|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14635119|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
14635120|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635121|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635122|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635123|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14635124|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635125|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14635126|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15170616|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170617|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170618|NCT04028856|Interferons|interferons|mesh-list
14635127|NCT00159666|Pregabalin|pregabalin|mesh-list
14635128|NCT00159666|Analgesics|analgesics|mesh-ancestor
14635129|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
14635130|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635131|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170619|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170620|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
15170621|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170622|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15170623|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15170624|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170625|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
15170626|NCT04028765|Misoprostol|misoprostol|mesh-list
15170627|NCT04028765|Oxytocin|oxytocin|mesh-list
15170628|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
15170629|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15170630|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170631|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15170632|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
15170633|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15170634|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635132|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
14635133|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14635134|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635135|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635136|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635137|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14635138|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14635139|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14635140|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14635141|NCT00159679|Pregabalin|pregabalin|mesh-list
14635142|NCT00159679|Analgesics|analgesics|mesh-ancestor
14635143|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
14635144|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635145|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635146|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
14635147|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14635148|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635149|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635150|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635151|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14635152|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14635153|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14635154|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14635155|NCT00159692|Amlodipine|amlodipine|mesh-list
14635156|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15181198|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181199|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15181200|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181201|NCT03932266|Docetaxel|docetaxel|mesh-list
14635157|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14635158|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635159|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635160|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635161|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635162|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635163|NCT00159705|Pregabalin|pregabalin|mesh-list
14635164|NCT00159705|Analgesics|analgesics|mesh-ancestor
14635165|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
14635166|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635167|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635168|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
14635169|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14635170|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635171|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635172|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635173|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14635174|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14635175|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14635176|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14635177|NCT00159718|Amlodipine|amlodipine|mesh-list
14635178|NCT00159718|Atorvastatin|atorvastatin|mesh-list
14635179|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15181202|NCT03932266|Endostar protein|endostar protein|mesh-list
15181203|NCT03932266|Endostatins|endostatins|mesh-list
15181204|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181205|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
15181206|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
15181207|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
14635180|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14635181|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
14635182|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635183|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14635184|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14635185|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635186|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635187|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14635188|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635189|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635190|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635191|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635192|NCT00159731|Pregabalin|pregabalin|mesh-list
14635193|NCT00159731|Analgesics|analgesics|mesh-ancestor
14635194|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
14635195|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635196|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635197|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
14635198|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14635199|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635200|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635201|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635202|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14635203|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14635204|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14635205|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14635206|NCT00159757|Ziprasidone|ziprasidone|mesh-list
14635207|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14635208|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
14635209|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635210|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635211|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635212|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14635213|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14635214|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14635215|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14635216|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14635217|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
14635218|NCT00159770|Olanzapine|olanzapine|mesh-list
14635219|NCT00159770|Risperidone|risperidone|mesh-list
14635220|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14635221|NCT00159770|Ziprasidone|ziprasidone|mesh-list
14635222|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14635223|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
14635224|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635225|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635226|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635227|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14635228|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14635229|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14635230|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14635231|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14635232|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
14635233|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
14635234|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
14635235|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635236|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635237|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14635238|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14635239|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635240|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
14635241|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
14646908|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15170635|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
15170636|NCT04028804|Fluorides|fluorides|mesh-list
15170637|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
15170638|NCT04028804|Protective Agents|protective agents|mesh-ancestor
15170639|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170640|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
15170641|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170642|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
15170643|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170644|NCT04028739|Curcumin|curcumin|mesh-list
15170645|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15170646|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170647|NCT04028739|Analgesics|analgesics|mesh-ancestor
15170648|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
15170649|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170650|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170651|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170652|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170653|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170654|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170655|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170656|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
15170657|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170658|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
15170659|NCT04029038|Fludarabine|fludarabine|mesh-list
15170660|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15170661|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
15170662|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170663|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170664|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15170665|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
14635242|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635243|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635244|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14635245|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14635246|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635247|NCT00159809|Urological Agents|urological agents|mesh-ancestor
15170666|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170667|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170668|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15170669|NCT04028622|Anesthetics|anesthetics|mesh-list
15170670|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170671|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170672|NCT04028596|Acetaminophen|acetaminophen|mesh-list
15170673|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170674|NCT04028596|Analgesics|analgesics|mesh-ancestor
15170675|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
15170676|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170677|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170678|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
15170679|NCT04028505|Terlipressin|terlipressin|mesh-list
15170680|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15170681|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15170682|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15170683|NCT04028518|Plasminogen|plasminogen|mesh-list
15170684|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15170685|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15170686|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170687|NCT04028245|Spartalizumab|spartalizumab|mesh-list
15170688|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15170689|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170690|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170691|NCT04028323|Octreotide|octreotide|mesh-list
14635248|NCT00159835|Atorvastatin|atorvastatin|mesh-list
14635249|NCT00159835|Simvastatin|simvastatin|mesh-list
14635250|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14635251|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14635252|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
14635253|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635254|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14635255|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14635256|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635257|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
14635258|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635259|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635260|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14635261|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14635262|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635263|NCT00159887|Urological Agents|urological agents|mesh-ancestor
14635264|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
14635265|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635266|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
15170692|NCT04028323|Terlipressin|terlipressin|mesh-list
15170693|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170694|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14635267|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14635268|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14635269|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635270|NCT00159900|Urological Agents|urological agents|mesh-ancestor
14635271|NCT00159952|Insulin|insulin|mesh-list
14635272|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14635273|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635274|NCT00159978|Alovudine|alovudine|mesh-list
14635275|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
14635276|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635277|NCT00160030|Cisplatin|cisplatin|mesh-list
14635278|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635279|NCT00160043|Vatalanib|vatalanib|mesh-list
14635280|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14635281|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635282|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635283|NCT00160069|Sagopilone|sagopilone|mesh-list
14635284|NCT00160069|Epothilones|epothilones|mesh-list
14635285|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635286|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14635287|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14635288|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14635289|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635290|NCT00160160|Eprosartan|eprosartan|mesh-list
14635291|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635292|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14635293|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14635294|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635295|NCT00160173|Estradiol|estradiol|mesh-list
14635296|NCT00160173|Estrogens|estrogens|mesh-ancestor
14635297|NCT00160173|Hormones|hormones|mesh-ancestor
14635298|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635299|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635300|NCT00160186|Pancreatin|pancreatin|mesh-list
14635301|NCT00160186|Pancrelipase|pancrelipase|mesh-list
14635302|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635303|NCT00160238|Betahistine|betahistine|mesh-list
14635304|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635305|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
14635306|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
14635307|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635308|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635309|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635310|NCT00160264|Vitamin D|vitamin d|mesh-list
14635311|NCT00160264|Lactulose|lactulose|mesh-list
14635312|NCT00160264|Calcium|calcium|mesh-list
14635313|NCT00160264|Vitamins|vitamins|mesh-ancestor
14635314|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
14635315|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635316|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635317|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14635318|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635319|NCT00160277|Moxonidine|moxonidine|mesh-list
14635320|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635321|NCT00160290|Lactulose|lactulose|mesh-list
14635322|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635323|NCT00160316|Estradiol|estradiol|mesh-list
14635324|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
14635325|NCT00160316|Estrogens|estrogens|mesh-ancestor
14635326|NCT00160316|Hormones|hormones|mesh-ancestor
14635327|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635328|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635329|NCT00160316|Progestins|progestins|mesh-ancestor
14635330|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14635331|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14635332|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14635333|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
14635334|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635335|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635336|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14635337|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14635338|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
14814113|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814114|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
14814115|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14814116|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14814117|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
14814118|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
14635339|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635340|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
14635341|NCT00160342|Estrogens|estrogens|mesh-list
14635342|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
14635343|NCT00160342|Estrone|estrone|mesh-list
14635344|NCT00160342|Testosterone|testosterone|mesh-list
14635345|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
14635346|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
14635347|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14635348|NCT00160342|Hormones|hormones|mesh-ancestor
14635349|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635350|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635351|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14635352|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635353|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
14635354|NCT00160342|Androgens|androgens|mesh-ancestor
14635355|NCT00160355|Fludarabine|fludarabine|mesh-list
14635356|NCT00160355|Melphalan|melphalan|mesh-list
14635357|NCT00160355|Thiotepa|thiotepa|mesh-list
14635358|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635359|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635360|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635361|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
14635362|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635363|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14635364|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
14635365|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14635366|NCT00160394|Adapalene|adapalene|mesh-list
14635367|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14635368|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14635369|NCT00160394|Analgesics|analgesics|mesh-ancestor
14635370|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
14635371|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635372|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635373|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14635374|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635375|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
14635376|NCT00160407|Orlistat|orlistat|mesh-list
14635377|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635378|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635379|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14635380|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14646909|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
14646910|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14646911|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646912|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
14646913|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
14646914|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646915|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14646916|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646917|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
14646918|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646919|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14646920|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
14646921|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
14646922|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
14646923|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646924|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14646925|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646926|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
14646927|NCT00199030|Cladribine|cladribine|mesh-list
14646928|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14646929|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646930|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646931|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
14814119|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814120|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814121|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14814122|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14814123|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14814124|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814125|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
14814126|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
14814127|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
14814128|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635381|NCT00160485|Glyburide|glyburide|mesh-list
14635382|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14635383|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635384|NCT00160498|Lercanidipine|lercanidipine|mesh-list
14635385|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635386|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14635387|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635388|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635389|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14635390|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635391|NCT00160511|Levetiracetam|levetiracetam|mesh-list
14635392|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
14635393|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
14635394|NCT00160537|Levocetirizine|levocetirizine|mesh-list
14635395|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14635396|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14635397|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
14635398|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
14635399|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635400|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635401|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635402|NCT00160550|Levetiracetam|levetiracetam|mesh-list
14635403|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
14635404|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
14635405|NCT00160576|Levetiracetam|levetiracetam|mesh-list
14635406|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
14635407|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
14635408|NCT00160589|Levocetirizine|levocetirizine|mesh-list
14635409|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14635410|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14635411|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
14635412|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
14635413|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635414|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635415|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635416|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
14635417|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635418|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
14635419|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635420|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635421|NCT00160628|Levetiracetam|levetiracetam|mesh-list
14635422|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
14635423|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
14635424|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14635425|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14635426|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14635427|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
14635428|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635429|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14635430|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14635431|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635432|NCT00160849|Lopinavir|lopinavir|mesh-list
14635433|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14635434|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14635435|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
14635436|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635437|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635438|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14635439|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14635440|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
14635441|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635442|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14635443|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14635444|NCT00160875|Irinotecan|irinotecan|mesh-list
14635445|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635446|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14635447|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14635448|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635449|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635450|NCT00160888|Nitroprusside|nitroprusside|mesh-list
14635451|NCT00160888|Acetylcholine|acetylcholine|mesh-list
14635452|NCT00160888|Bradykinin|bradykinin|mesh-list
14635453|NCT00160888|Kininogens|kininogens|mesh-list
14635454|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635455|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635456|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14635457|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635458|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14635459|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
14635460|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635461|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635462|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14635463|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14635464|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635465|NCT00160927|Nitroprusside|nitroprusside|mesh-list
14635466|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15170695|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170696|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635467|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635468|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14635469|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635470|NCT00160966|Cyclosporine|cyclosporine|mesh-list
14635471|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
14635472|NCT00160966|Everolimus|everolimus|mesh-list
14635473|NCT00160966|Tacrolimus|tacrolimus|mesh-list
14635474|NCT00160966|Cyclosporins|cyclosporins|mesh-list
14635475|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635476|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
14635477|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635478|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14635479|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635480|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635481|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
14635482|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635483|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
14635484|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635485|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635486|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14635487|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14635488|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
14635489|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14635490|NCT00161018|Risperidone|risperidone|mesh-list
14635491|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14635492|NCT00161018|Fluphenazine|fluphenazine|mesh-list
14635493|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
14635494|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14635495|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14635496|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
14635497|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635498|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635499|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635500|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14635501|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14635502|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14635503|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14635504|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14635505|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
14635506|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
14635507|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14635508|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14635509|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14635510|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635511|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635512|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
14635513|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635514|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635515|NCT00161070|Aspirin|aspirin|mesh-list
14635516|NCT00161070|Dipyridamole|dipyridamole|mesh-list
14635517|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14635518|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14635519|NCT00161070|Analgesics|analgesics|mesh-ancestor
14635520|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
15170697|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15170698|NCT04028466|Omeprazole|omeprazole|mesh-list
15170699|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15170700|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170701|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15170702|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170703|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170704|NCT04028141|Ketamine|ketamine|mesh-list
14814129|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
15170705|NCT04028141|Propofol|propofol|mesh-list
14635521|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635522|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635523|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14635524|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635525|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14635526|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14635527|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635528|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14635529|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14635530|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635531|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
14635532|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14635533|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
14635534|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14635535|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14635536|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635537|NCT00161096|Pantoprazole|pantoprazole|mesh-list
14635538|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15170706|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170707|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170708|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635539|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635540|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14635541|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635542|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635543|NCT00161122|Vaccines|vaccines|mesh-list
14635544|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14635545|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
14635546|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635547|NCT00161200|Pantoprazole|pantoprazole|mesh-list
14635548|NCT00161200|Ranitidine|ranitidine|mesh-list
14635549|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14635550|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14635551|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635552|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14635553|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635554|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635555|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14635556|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
14635557|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
14635558|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635559|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635560|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
14635561|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14635562|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
14635563|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635564|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635565|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14635566|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14635567|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14635568|NCT00161239|Prednisone|prednisone|mesh-list
14635569|NCT00161239|Methotrexate|methotrexate|mesh-list
14635570|NCT00161239|Asparaginase|asparaginase|mesh-list
14635571|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14635572|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
14635573|NCT00161239|Hormones|hormones|mesh-ancestor
14635574|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635575|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635576|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14635577|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170709|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170710|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
15170711|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
15170712|NCT04028141|Analgesics|analgesics|mesh-ancestor
15170713|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
15170714|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170715|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15170716|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15170717|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15170718|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170719|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170720|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
14635578|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15170721|NCT04027972|Neostigmine|neostigmine|mesh-list
14635579|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
14635580|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635581|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14635582|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
14635583|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635584|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14635585|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635586|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14635587|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635588|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
14635589|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635590|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14635591|NCT00161278|Paclitaxel|paclitaxel|mesh-list
14635592|NCT00161278|Carboplatin|carboplatin|mesh-list
14635593|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14635594|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635595|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14635596|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14635597|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14635598|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635599|NCT00161291|Bevacizumab|bevacizumab|mesh-list
14635600|NCT00161291|Letrozole|letrozole|mesh-list
14635601|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14635602|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635603|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14635604|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14635605|NCT00161291|Growth Substances|growth substances|mesh-ancestor
14635606|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635607|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
14635608|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14635609|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14635610|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635611|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635612|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14635613|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
14635614|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635615|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
14635616|NCT00161304|Testosterone|testosterone|mesh-list
14635617|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
14635618|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
14635619|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14635620|NCT00161304|Androgens|androgens|mesh-ancestor
14635621|NCT00161304|Hormones|hormones|mesh-ancestor
14635622|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635623|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635624|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14635625|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635626|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
14635627|NCT00161330|Amoxicillin|amoxicillin|mesh-list
14635628|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
14635629|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
14635630|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
14635631|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14635632|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635633|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635634|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635635|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14635636|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14635637|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
14635638|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635639|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14635640|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14635641|NCT00161421|Leuprolide|leuprolide|mesh-list
14635642|NCT00161421|Testosterone|testosterone|mesh-list
14635643|NCT00161421|Dutasteride|dutasteride|mesh-list
14635644|NCT00161421|Androgens|androgens|mesh-ancestor
14635645|NCT00161421|Hormones|hormones|mesh-ancestor
14635646|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635647|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635648|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14635649|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635650|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14635651|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
14635652|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635653|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14635654|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14635655|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635656|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635657|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
14635658|NCT00161434|Valacyclovir|valacyclovir|mesh-list
14635659|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
14635660|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635661|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14635662|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
14635663|NCT00161447|Testosterone|testosterone|mesh-list
14635664|NCT00161447|Acyline|acyline|mesh-list
14635665|NCT00161447|Androgens|androgens|mesh-ancestor
15170722|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15170723|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170724|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170725|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
15170726|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170727|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170728|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15170729|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
14635666|NCT00161447|Hormones|hormones|mesh-ancestor
14635667|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635668|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635669|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14635670|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635671|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14635672|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14635673|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14635674|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
14635675|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635676|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14635677|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14635678|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14635679|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
14635680|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
14635681|NCT00161486|Testosterone|testosterone|mesh-list
14635682|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
14635683|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
14635684|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14635685|NCT00161486|Acyline|acyline|mesh-list
14635686|NCT00161486|Androgens|androgens|mesh-ancestor
14635687|NCT00161486|Hormones|hormones|mesh-ancestor
14635688|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635689|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635690|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15170730|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170731|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15170732|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14635691|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635692|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
14635693|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
14635694|NCT00161564|Rituximab|rituximab|mesh-list
14635695|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14635696|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635697|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
14635698|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635699|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635700|NCT00161577|Ketorolac|ketorolac|mesh-list
14635701|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15170733|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15170734|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
15170735|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170736|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170737|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170738|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170739|NCT04027829|Analgesics|analgesics|mesh-ancestor
15170740|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
15170741|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170742|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15170743|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15170744|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170745|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
15170746|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635702|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14635703|NCT00161577|Analgesics|analgesics|mesh-ancestor
14635704|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
14635705|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635706|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635707|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14635708|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635709|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14635710|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635711|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635712|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
14635713|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14635714|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635715|NCT00161655|Etanercept|etanercept|mesh-list
14635716|NCT00161655|Methotrexate|methotrexate|mesh-list
14635717|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14635718|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
14635719|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635720|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635721|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14635722|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
14635723|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635724|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635725|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
14635726|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635727|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14635728|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635729|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
14635730|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635731|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14635732|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14635733|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14635734|NCT00161655|Analgesics|analgesics|mesh-ancestor
14635735|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
14635736|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635737|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14635738|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14635739|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
14635740|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14635741|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635742|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
14635743|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14635744|NCT00161681|Estradiol|estradiol|mesh-list
14635745|NCT00161681|Estrogens|estrogens|mesh-ancestor
14635746|NCT00161681|Hormones|hormones|mesh-ancestor
14635747|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635748|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635749|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14635750|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
14635751|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635752|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14635753|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14635754|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14635755|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14635756|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14635757|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
14635758|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14635759|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14635760|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
14635761|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635762|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635763|NCT00161720|Protein C|protein c|mesh-list
14635764|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
14635765|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14635766|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14635767|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170747|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170748|NCT04027764|Paclitaxel|paclitaxel|mesh-list
15170749|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15170750|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170751|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
15170752|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
15170753|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
15170754|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635768|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14635769|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
14635770|NCT00161733|Coagulants|coagulants|mesh-ancestor
14635771|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14635772|NCT00161759|Thrombin|thrombin|mesh-list
14635773|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
14635774|NCT00161759|Coagulants|coagulants|mesh-ancestor
14635775|NCT00161811|Vaccines|vaccines|mesh-list
14635776|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
14635777|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635778|NCT00161837|Vaccines|vaccines|mesh-list
14635779|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
14635780|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635781|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14635782|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
14635783|NCT00161902|Coagulants|coagulants|mesh-ancestor
14635784|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14635785|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
14635786|NCT00161915|Coagulants|coagulants|mesh-ancestor
14646932|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646933|NCT00199043|Allopurinol|allopurinol|mesh-list
14646934|NCT00199043|Rasburicase|rasburicase|mesh-list
14646935|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
14646936|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646937|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646938|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
14646939|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646940|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14646941|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
14646942|NCT00199043|Protective Agents|protective agents|mesh-ancestor
14646943|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646944|NCT00199056|Cytarabine|cytarabine|mesh-list
14646945|NCT00199056|Dexamethasone|dexamethasone|mesh-list
14646946|NCT00199056|Prednisolone|prednisolone|mesh-list
14646947|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
14646948|NCT00199056|Ifosfamide|ifosfamide|mesh-list
14646949|NCT00199056|Methotrexate|methotrexate|mesh-list
14646950|NCT00199056|Fludarabine|fludarabine|mesh-list
14646951|NCT00199056|Vincristine|vincristine|mesh-list
14646952|NCT00199056|Doxorubicin|doxorubicin|mesh-list
14646953|NCT00199056|Daunorubicin|daunorubicin|mesh-list
14646954|NCT00199056|Asparaginase|asparaginase|mesh-list
14646955|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
14646956|NCT00199056|Idarubicin|idarubicin|mesh-list
14646957|NCT00199056|Thioguanine|thioguanine|mesh-list
14646958|NCT00199056|Vindesine|vindesine|mesh-list
14646959|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14646960|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
15170755|NCT04027751|Tropisetron|tropisetron|mesh-list
15170756|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
15170757|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
15170758|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170759|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170760|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170761|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14646961|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14646962|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14646963|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14646964|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
14646965|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14646966|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14646967|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14646968|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14646969|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
14646970|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
14646971|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14646972|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14646973|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
14646974|NCT00199056|Hormones|hormones|mesh-ancestor
14646975|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14646976|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14646977|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14646978|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
14646979|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14646980|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14646981|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
14646982|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14646983|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646984|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14646985|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14646986|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
14646987|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14646988|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14635787|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14635788|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
14635789|NCT00161980|Coagulants|coagulants|mesh-ancestor
14635790|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
14635791|NCT00161993|Antibodies|antibodies|mesh-list
14635792|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
14635793|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14635794|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14635795|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
14635796|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170762|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15170763|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
14635797|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
14635798|NCT00162006|Antibodies|antibodies|mesh-list
14635799|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
14635800|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14635801|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14635802|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
14635803|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635804|NCT00162019|Factor VIII|factor viii|mesh-list
14635805|NCT00162019|Coagulants|coagulants|mesh-ancestor
14635806|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14635807|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14635808|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635809|NCT00162110|Cetuximab|cetuximab|mesh-list
14635810|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14635811|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635812|NCT00162149|Ritonavir|ritonavir|mesh-list
14635813|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14635814|NCT00162149|Nevirapine|nevirapine|mesh-list
14635815|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14635816|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14635817|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
14635818|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635819|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635820|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14635821|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14635822|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
15170764|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170765|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170766|NCT04028024|Urinastatin|urinastatin|mesh-list
14635823|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635824|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14635825|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14635826|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14635827|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14635828|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14635829|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14635830|NCT00162188|Efavirenz|efavirenz|mesh-list
14635831|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14635832|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14635833|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635834|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635835|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
14635836|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635837|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14635838|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14635839|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14635840|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14635841|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14635842|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14635843|NCT00162201|Abatacept|abatacept|mesh-list
14635844|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14635845|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635846|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635847|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14635848|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
14635849|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635850|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14635851|NCT00162214|Ketoconazole|ketoconazole|mesh-list
14635852|NCT00162214|Dasatinib|dasatinib|mesh-list
15170767|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14635853|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635854|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14635855|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635856|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635857|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
14635858|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635859|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14635860|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14291942|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14291943|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14291944|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14291945|NCT00557440|Fluticasone|fluticasone|mesh-list
14291946|NCT00557440|Xhance|xhance|mesh-list
14291947|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
14291948|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15170768|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15170769|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
15170770|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170771|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170772|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
15170773|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
15170774|NCT04027959|Vitamins|vitamins|mesh-ancestor
15170775|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
15170776|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170777|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
15170778|NCT04027959|Hematinics|hematinics|mesh-ancestor
15170779|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
15170780|NCT04027517|Hematinics|hematinics|mesh-ancestor
15170781|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
15170782|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15170783|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291949|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14291950|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14291951|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14291952|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
14635861|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14635862|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
14635863|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14635864|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635865|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14635866|NCT00162227|Efavirenz|efavirenz|mesh-list
14635867|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14635868|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14635869|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635870|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635871|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
14635872|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635873|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14635874|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14635875|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14635876|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14635877|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14635878|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14635879|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
14635880|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14635881|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635882|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14635883|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635884|NCT00162318|Cetuximab|cetuximab|mesh-list
14635885|NCT00162318|Gefitinib|gefitinib|mesh-list
14635886|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14635887|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14635888|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14635889|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635890|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635891|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14635892|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15170784|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15170785|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170786|NCT04027322|Dexamethasone|dexamethasone|mesh-list
15170787|NCT04027322|Budesonide|budesonide|mesh-list
15170788|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170789|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
15170790|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
15170791|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170792|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170793|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170794|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
15170795|NCT04027322|Hormones|hormones|mesh-ancestor
15170796|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170797|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15170798|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170799|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15170800|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15170801|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
15170802|NCT04027192|Midazolam|midazolam|mesh-list
15170803|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14635893|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635894|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14635895|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14635896|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635897|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
15170804|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170805|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170806|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170807|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15170808|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15170809|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15170810|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170811|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
15170812|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
14635898|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14635899|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635900|NCT00162383|Dapsone|dapsone|mesh-list
14635901|NCT00162383|Debrisoquin|debrisoquin|mesh-list
14635902|NCT00162383|Mephenytoin|mephenytoin|mesh-list
14635903|NCT00162383|Caffeine|caffeine|mesh-list
14635904|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14635905|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635906|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14635907|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14635908|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635909|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14635910|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14635911|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
14635912|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635913|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635914|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
14635915|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14635916|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14635917|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14635918|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
14635919|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14635920|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14635921|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
14635922|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
14635923|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635924|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
14635925|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
14635926|NCT00162396|Albuterol|albuterol|mesh-list
14635927|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14635928|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
14635929|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635930|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635931|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14635932|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
14635933|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
14635934|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635935|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14635936|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14635937|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14635938|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
14635939|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635940|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635941|NCT00162409|Folic Acid|folic acid|mesh-list
14635942|NCT00162409|Hematinics|hematinics|mesh-ancestor
14635943|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
14635944|NCT00162409|Vitamins|vitamins|mesh-ancestor
14635945|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
14646989|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
14635946|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635947|NCT00162422|Albuterol|albuterol|mesh-list
15170813|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
15170814|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
15170815|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170816|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170817|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
15170818|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15170819|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15170820|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14635948|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14635949|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
14635950|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635951|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635952|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14635953|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14635954|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
14635955|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635956|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14635957|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14635958|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14635959|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
14635960|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635961|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635962|NCT00162435|Warfarin|warfarin|mesh-list
14635963|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
14635964|NCT00162461|Phenytoin|phenytoin|mesh-list
14635965|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
14635966|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14635967|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14635968|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635969|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635970|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14635971|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14635972|NCT00162474|Phenytoin|phenytoin|mesh-list
14635973|NCT00162474|Warfarin|warfarin|mesh-list
14635974|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
14635975|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
14635976|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14635977|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14635978|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14635979|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635980|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14635981|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14635982|NCT00162487|Albuterol|albuterol|mesh-list
14635983|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14635984|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
14635985|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14635986|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14635987|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14635988|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
14635989|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
14635990|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14635991|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14635992|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14635993|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14635994|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
14635995|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14635996|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14635997|NCT00162526|Tocopherols|tocopherols|mesh-list
14635998|NCT00162526|Vitamin E|vitamin e|mesh-list
14635999|NCT00162526|Tocotrienols|tocotrienols|mesh-list
15170821|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
15170822|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
15170823|NCT04026958|Clarithromycin|clarithromycin|mesh-list
15170824|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15170825|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15170826|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15170827|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170828|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170829|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15170830|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15170831|NCT04027166|Methadone|methadone|mesh-list
14636000|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
15170832|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14636001|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
14636002|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636003|NCT00162526|Protective Agents|protective agents|mesh-ancestor
14636004|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636005|NCT00162526|Vitamins|vitamins|mesh-ancestor
14636006|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
14636007|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
14636008|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14636009|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636010|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636011|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14636012|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14636013|NCT00162552|Protective Agents|protective agents|mesh-ancestor
14636014|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636015|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
14636016|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14636017|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
14636018|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14636019|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14636020|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
14636021|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636022|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636023|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636024|NCT00162591|Remifentanil|remifentanil|mesh-list
14636025|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14636026|NCT00162591|Narcotics|narcotics|mesh-ancestor
14636027|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14636028|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636029|NCT00162591|Analgesics|analgesics|mesh-ancestor
14636030|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
14636031|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636032|NCT00162604|Cefuroxime|cefuroxime|mesh-list
14636033|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
14636034|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636035|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636036|NCT00162643|Ritonavir|ritonavir|mesh-list
15170833|NCT04027166|Narcotics|narcotics|mesh-ancestor
15170834|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170835|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170836|NCT04027166|Analgesics|analgesics|mesh-ancestor
15170837|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
15170838|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170839|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
15170840|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
15181208|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636037|NCT00162643|Lopinavir|lopinavir|mesh-list
14636038|NCT00162643|Lamivudine|lamivudine|mesh-list
14636039|NCT00162643|Zidovudine|zidovudine|mesh-list
14636040|NCT00162643|Efavirenz|efavirenz|mesh-list
14636041|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14636042|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14636043|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
14636044|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181209|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15181210|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14636045|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636046|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14636047|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14636048|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
14636049|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636050|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14636051|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14636052|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15181211|NCT03932266|Growth Substances|growth substances|mesh-ancestor
15181212|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181213|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
15181214|NCT03931915|Leuprolide|leuprolide|mesh-list
15181215|NCT03931915|Relugolix|relugolix|mesh-list
15181216|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15181217|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
15181218|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15181219|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636053|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14636054|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
15181220|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15170841|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
15170842|NCT04026880|Testosterone|testosterone|mesh-list
15170843|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
15170844|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
15170845|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15170846|NCT04026880|Androgens|androgens|mesh-ancestor
15170847|NCT04026880|Hormones|hormones|mesh-ancestor
14636055|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14636056|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14636057|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14636058|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14636059|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14636060|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
14636061|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636062|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
14636063|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636064|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636065|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636066|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
14636067|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636068|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636069|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14636070|NCT00162669|Bevacizumab|bevacizumab|mesh-list
14636071|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14636072|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636073|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14636074|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15170848|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170849|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170850|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15170851|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170852|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
15170853|NCT04027283|Erythritol|erythritol|mesh-list
15170854|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
14636075|NCT00162669|Growth Substances|growth substances|mesh-ancestor
14636076|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636077|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
14636078|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14636079|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
14636080|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636081|NCT00162695|Etoposide|etoposide|mesh-list
14636082|NCT00162695|Vincristine|vincristine|mesh-list
14636083|NCT00162695|Epirubicin|epirubicin|mesh-list
14636084|NCT00162695|Ifosfamide|ifosfamide|mesh-list
14636085|NCT00162695|Carboplatin|carboplatin|mesh-list
14636086|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636087|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636088|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636089|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636090|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636091|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636092|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636093|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
14636094|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636095|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636096|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636097|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14636098|NCT00162721|Doxorubicin|doxorubicin|mesh-list
14636099|NCT00162721|Ifosfamide|ifosfamide|mesh-list
14636100|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636101|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14636102|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636103|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636104|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636105|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636106|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636107|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
14636108|NCT00162734|Interferons|interferons|mesh-list
14636109|NCT00162734|Ribavirin|ribavirin|mesh-list
14636110|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
14636111|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636112|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
14636113|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636114|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
14646990|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
15170855|NCT04026841|Antibodies|antibodies|mesh-list
14636115|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636116|NCT00162760|Thalidomide|thalidomide|mesh-list
14636117|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636118|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
14636119|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636120|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
14636121|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15170856|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
15170857|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170858|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
15170859|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15170860|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15170861|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170862|NCT04026776|Allopurinol|allopurinol|mesh-list
15170863|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
15170864|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170865|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636122|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636123|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14636124|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14636125|NCT00162760|Growth Substances|growth substances|mesh-ancestor
14636126|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
14636127|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636128|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
14636129|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
15170866|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
15170867|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170868|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14636130|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
14636131|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14636132|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
14636133|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
14636134|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636135|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636136|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636137|NCT00162799|Triflusal|triflusal|mesh-list
14636138|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14636139|NCT00162812|Epirubicin|epirubicin|mesh-list
14636140|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14636141|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636142|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636143|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15170869|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
15170870|NCT04026776|Protective Agents|protective agents|mesh-ancestor
15170871|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170872|NCT04026685|Phenylephrine|phenylephrine|mesh-list
15170873|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
15170874|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15170875|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
15170876|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
15170877|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170878|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170879|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
15170880|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15170881|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
15170882|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
15170883|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15170884|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15170885|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170886|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
14636144|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170887|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170888|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170889|NCT04026685|Protective Agents|protective agents|mesh-ancestor
15170890|NCT04026451|Propofol|propofol|mesh-list
15170891|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15170892|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170893|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170894|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170895|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
14636145|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636146|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
14636147|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15170896|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
15170897|NCT04026464|Acetaminophen|acetaminophen|mesh-list
14636148|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636149|NCT00162864|Montelukast|montelukast|mesh-list
14636150|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14636151|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
14636152|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14636153|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
14636154|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636155|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636156|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14636157|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14636158|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636159|NCT00162877|Esomeprazole|esomeprazole|mesh-list
14636160|NCT00162877|Rabeprazole|rabeprazole|mesh-list
14636161|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14636162|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636163|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14636164|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636165|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636166|NCT00162916|Citalopram|citalopram|mesh-list
14636167|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14636168|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14636169|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15170898|NCT04026464|Ibuprofen|ibuprofen|mesh-list
15170899|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15170900|NCT04026464|Analgesics|analgesics|mesh-ancestor
15170901|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
15170902|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170903|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170904|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
15170905|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15170906|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170907|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15170908|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14636170|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636171|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636172|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
14636173|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636174|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14636175|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
14636176|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14636177|NCT00162955|Valsartan|valsartan|mesh-list
14636178|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14636179|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14636180|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14636181|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636182|NCT00162968|Citalopram|citalopram|mesh-list
14636183|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14636184|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14636185|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14636186|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636187|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636188|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
14636189|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636190|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14636191|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
14636192|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14636193|NCT00163046|Gabapentin|gabapentin|mesh-list
14636194|NCT00163046|Analgesics|analgesics|mesh-ancestor
14636195|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
14636196|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636197|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170909|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170910|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170911|NCT04026074|Clonidine|clonidine|mesh-list
15170912|NCT04026074|Fentanyl|fentanyl|mesh-list
15170913|NCT04026074|Remifentanil|remifentanil|mesh-list
15170914|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14636198|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
14636199|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14636200|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14636201|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14636202|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14636203|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14636204|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14636205|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636206|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170915|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15170916|NCT04026074|Narcotics|narcotics|mesh-ancestor
15170917|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14636207|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
14636208|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
14636209|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14636210|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636211|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
14636212|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14636213|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636214|NCT00163111|Amphotericin B|amphotericin b|mesh-list
14636215|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14636216|NCT00163111|Fluconazole|fluconazole|mesh-list
14636217|NCT00163111|Amebicides|amebicides|mesh-ancestor
14636218|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14636219|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14636220|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636221|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636222|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
14636223|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14636224|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14636225|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636226|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636227|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14636228|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
14636229|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636230|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636231|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14636232|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14636233|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14636234|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14636235|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
14636236|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636237|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636238|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14636239|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14636240|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14636241|NCT00163150|Atorvastatin|atorvastatin|mesh-list
14636242|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14636243|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14636244|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
14636245|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636246|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14636247|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14636248|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636249|NCT00163202|Atorvastatin|atorvastatin|mesh-list
14636250|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15170918|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170919|NCT04026074|Analgesics|analgesics|mesh-ancestor
15170920|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
15170921|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170922|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15170923|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170924|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
15170925|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
14636251|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14636252|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
14636253|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636254|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14636255|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14636256|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636257|NCT00163241|Celecoxib|celecoxib|mesh-list
14636258|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14636259|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14636260|NCT00163241|Analgesics|analgesics|mesh-ancestor
14636261|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
15170926|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15170927|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
14636262|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636263|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170928|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
15170929|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15170930|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15170931|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15170932|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
15170933|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15170934|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170935|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
14636264|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14636265|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636266|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14636267|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14636268|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636269|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636270|NCT00163254|Abciximab|abciximab|mesh-list
14636271|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
14636272|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14636273|NCT00163267|Clopidogrel|clopidogrel|mesh-list
14636274|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14636275|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14636276|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14636277|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15170936|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15170937|NCT04026022|Fentanyl|fentanyl|mesh-list
15170938|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15170939|NCT04026022|Narcotics|narcotics|mesh-ancestor
15170940|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15170941|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170942|NCT04026022|Analgesics|analgesics|mesh-ancestor
15170943|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
15170944|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170945|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15170946|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15170947|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
15170948|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
15170949|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15170950|NCT04026282|Hormones|hormones|mesh-ancestor
15170951|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170952|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170953|NCT04026256|Denosumab|denosumab|mesh-list
15170954|NCT04026256|Teriparatide|teriparatide|mesh-list
15170955|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14636278|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
14636279|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636280|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636281|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636282|NCT00163306|Pantoprazole|pantoprazole|mesh-list
14636283|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14636284|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636285|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14636286|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636287|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636288|NCT00163319|Ciclesonide|ciclesonide|mesh-list
14636289|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
14636290|NCT00163319|Hormones|hormones|mesh-ancestor
14636291|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636292|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636293|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636294|NCT00163332|Ciclesonide|ciclesonide|mesh-list
14636295|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
14636296|NCT00163332|Hormones|hormones|mesh-ancestor
14636297|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636298|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636299|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636300|NCT00163345|Ciclesonide|ciclesonide|mesh-list
14636301|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
14636302|NCT00163345|Hormones|hormones|mesh-ancestor
14636303|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636304|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636305|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636306|NCT00163358|Ciclesonide|ciclesonide|mesh-list
15170956|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636307|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
14636308|NCT00163358|Hormones|hormones|mesh-ancestor
14636309|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636310|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636311|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636312|NCT00163371|Ciclesonide|ciclesonide|mesh-list
14636313|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
14636314|NCT00163371|Hormones|hormones|mesh-ancestor
14636315|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636316|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636317|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636318|NCT00163384|Ciclesonide|ciclesonide|mesh-list
14636319|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
14636320|NCT00163384|Hormones|hormones|mesh-ancestor
14636321|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636322|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636323|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636324|NCT00163397|Ciclesonide|ciclesonide|mesh-list
14636325|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
15170957|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15170958|NCT04026230|Atorvastatin|atorvastatin|mesh-list
15170959|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15170960|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15170961|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
15170962|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170963|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15170964|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15170965|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15170966|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
15170967|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15170968|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15170969|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15170970|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
15170971|NCT04025736|Coagulants|coagulants|mesh-ancestor
15170972|NCT04025671|Naloxone|naloxone|mesh-list
15170973|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15170974|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170975|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
15170976|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170977|NCT04025775|Insulin|insulin|mesh-list
15170978|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15170979|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170980|NCT04025840|Dexamethasone|dexamethasone|mesh-list
15170981|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
15170982|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15170983|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
15170984|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
15170985|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15170986|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15170987|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15170988|NCT04025840|Hormones|hormones|mesh-ancestor
15170989|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170990|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14636326|NCT00163397|Hormones|hormones|mesh-ancestor
14636327|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636328|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636329|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636330|NCT00163410|Ciclesonide|ciclesonide|mesh-list
14636331|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
14636332|NCT00163410|Hormones|hormones|mesh-ancestor
14636333|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636334|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636335|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636336|NCT00163423|Ciclesonide|ciclesonide|mesh-list
14636337|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
14636338|NCT00163423|Hormones|hormones|mesh-ancestor
14636339|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636340|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636341|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636342|NCT00163436|Ciclesonide|ciclesonide|mesh-list
14636343|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
14636344|NCT00163436|Hormones|hormones|mesh-ancestor
14636345|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15170991|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15170992|NCT04025918|Phenylephrine|phenylephrine|mesh-list
15170993|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
15170994|NCT04025918|Ephedrine|ephedrine|mesh-list
15170995|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15170996|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15170997|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
15170998|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
15170999|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171000|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171001|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
14636346|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636347|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636348|NCT00163449|Ciclesonide|ciclesonide|mesh-list
14636349|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
14636350|NCT00163449|Hormones|hormones|mesh-ancestor
14636351|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636352|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636353|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636354|NCT00163462|Ciclesonide|ciclesonide|mesh-list
14636355|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
14636356|NCT00163462|Hormones|hormones|mesh-ancestor
15171002|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
15171003|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
15171004|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15171005|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15171006|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15171007|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
15171008|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171009|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171010|NCT04025918|Protective Agents|protective agents|mesh-ancestor
15171011|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15171012|NCT04025567|Vancomycin|vancomycin|mesh-list
15171013|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171014|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171015|NCT04025593|Prednisone|prednisone|mesh-list
15171016|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
15171017|NCT04025593|Rituximab|rituximab|mesh-list
15171018|NCT04025593|Doxorubicin|doxorubicin|mesh-list
15171019|NCT04025593|Vincristine|vincristine|mesh-list
15171020|NCT04025593|Lenalidomide|lenalidomide|mesh-list
15171021|NCT04025593|Decitabine|decitabine|mesh-list
15171022|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171023|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
15171024|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171025|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171026|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15171027|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
15171028|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171029|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171030|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15171031|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171032|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15171033|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15171034|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15171035|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171036|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171037|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
15171038|NCT04025593|Hormones|hormones|mesh-ancestor
15171039|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171040|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15171041|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15171042|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636357|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636358|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636359|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636360|NCT00163488|Ciclesonide|ciclesonide|mesh-list
14636361|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
14636362|NCT00163488|Hormones|hormones|mesh-ancestor
14636363|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636364|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171043|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
15171044|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
15171045|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15171046|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14636365|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15171047|NCT04025593|Growth Substances|growth substances|mesh-ancestor
15171048|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
15171049|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15171050|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
15171051|NCT04025203|Ibuprofen|ibuprofen|mesh-list
15171052|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
15171053|NCT04025203|Gabapentin|gabapentin|mesh-list
15171054|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15171055|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171056|NCT04025203|Analgesics|analgesics|mesh-ancestor
15171057|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
15171058|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171059|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171060|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171061|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171062|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15171063|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171064|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171065|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
15171066|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15171067|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15171068|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171069|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15171070|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15171071|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15171072|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171073|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
15171074|NCT04025177|Indomethacin|indomethacin|mesh-list
15171075|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15171076|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171077|NCT04025177|Analgesics|analgesics|mesh-ancestor
15171078|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
15171079|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171080|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171081|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171082|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171083|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
15171084|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
14636366|NCT00163501|Ciclesonide|ciclesonide|mesh-list
14636367|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
14636368|NCT00163501|Hormones|hormones|mesh-ancestor
14636369|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636370|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171085|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15171086|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15171087|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171088|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171089|NCT04025489|Vitamin D|vitamin d|mesh-list
15171090|NCT04025489|Vitamins|vitamins|mesh-ancestor
15171091|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
15171092|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171093|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15171094|NCT04025060|Caffeine|caffeine|mesh-list
15171095|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15171096|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171097|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15171098|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171099|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171100|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15171101|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15171102|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
15171103|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181221|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181222|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
15181223|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
15181224|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181225|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
15181226|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15181227|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181228|NCT03931668|Maleic acid|maleic acid|mesh-list
15181229|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15181230|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181231|NCT03931863|Ondansetron|ondansetron|mesh-list
15181232|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
15181233|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
15181234|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171104|NCT04024683|Ropivacaine|ropivacaine|mesh-list
15171105|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
15171106|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
15171107|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171108|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171109|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
15171110|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171111|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
15171112|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171113|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171114|NCT04024696|Abexinostat|abexinostat|mesh-list
15171115|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15171116|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171117|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171118|NCT04024865|Domperidone|domperidone|mesh-list
15171119|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
15171120|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
15171121|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171122|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171123|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171124|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15171125|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
15171126|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171127|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171128|NCT04024813|Seladelpar|seladelpar|mesh-list
15171129|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15171130|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
15171131|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171132|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14636371|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636372|NCT00163514|Ciclesonide|ciclesonide|mesh-list
14636373|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
14636374|NCT00163514|Hormones|hormones|mesh-ancestor
14636375|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636376|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636377|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636378|NCT00163540|Formaldehyde|formaldehyde|mesh-list
14636379|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
14636380|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636381|NCT00163553|Meperidine|meperidine|mesh-list
14636382|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14636383|NCT00163553|Narcotics|narcotics|mesh-ancestor
14636384|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14636385|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636386|NCT00163553|Analgesics|analgesics|mesh-ancestor
14636387|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
14636388|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636389|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14636390|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
14636391|NCT00163566|Androgens|androgens|mesh-ancestor
14636392|NCT00163566|Hormones|hormones|mesh-ancestor
14636393|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636394|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636395|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15171133|NCT04024527|Amoxicillin|amoxicillin|mesh-list
15171134|NCT04024527|Metronidazole|metronidazole|mesh-list
15171135|NCT04024527|Esomeprazole|esomeprazole|mesh-list
14636396|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
14636397|NCT00163592|Coagulants|coagulants|mesh-ancestor
14636398|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14636399|NCT00163605|Thrombin|thrombin|mesh-list
14636400|NCT00163605|Calcium|calcium|mesh-list
14636401|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14636402|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636403|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
14636404|NCT00163605|Coagulants|coagulants|mesh-ancestor
14636405|NCT00163618|Formaldehyde|formaldehyde|mesh-list
14636406|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
14636407|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636408|NCT00163748|Gemcitabine|gemcitabine|mesh-list
14636409|NCT00163748|Vinorelbine|vinorelbine|mesh-list
15171136|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171137|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171138|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14636410|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14636411|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
14636412|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636413|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636414|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
14636415|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636416|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636417|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636418|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
14636419|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636420|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636421|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636422|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636423|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636424|NCT00163761|Gemcitabine|gemcitabine|mesh-list
14636425|NCT00163761|Vinorelbine|vinorelbine|mesh-list
14636426|NCT00163761|Ifosfamide|ifosfamide|mesh-list
14636427|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14636428|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
14636429|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636430|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171139|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15171140|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15171141|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171142|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15171143|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171144|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171145|NCT04024878|Nivolumab|nivolumab|mesh-list
15171146|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171147|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171148|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15171149|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171150|NCT04024891|Phentolamine|phentolamine|mesh-list
15171151|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15171152|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15171153|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15171154|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15171155|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
15171156|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171157|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171158|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171159|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15171160|NCT04024254|Folic Acid|folic acid|mesh-list
15171161|NCT04024254|Hematinics|hematinics|mesh-ancestor
15171162|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
15171163|NCT04024254|Vitamins|vitamins|mesh-ancestor
15171164|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
15171165|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171166|NCT04024384|Daratumumab|daratumumab|mesh-list
15171167|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171168|NCT04024241|Cytarabine|cytarabine|mesh-list
15171169|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
15171170|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15171171|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
15171172|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171173|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171174|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
15171175|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171176|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171177|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
15171178|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171179|NCT04024241|Analgesics|analgesics|mesh-ancestor
15171180|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
15171181|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171182|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15171183|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15171184|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171185|NCT04024163|Benzonidazole|benzonidazole|mesh-list
15171186|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171187|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
15171188|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171189|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15171190|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15171191|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15171192|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636431|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
14636432|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171193|NCT04024072|Brinzolamide|brinzolamide|mesh-list
15171194|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15171195|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171196|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171197|NCT04023760|Apixaban|apixaban|mesh-list
15171198|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15171199|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
15171200|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15171201|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
15171202|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171203|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171204|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
15171205|NCT04023565|Perindopril|perindopril|mesh-list
15171206|NCT04023565|Moxonidine|moxonidine|mesh-list
15171207|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15171208|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
15171209|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171210|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171211|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15171212|NCT04023617|Docetaxel|docetaxel|mesh-list
15171213|NCT04023617|Nivolumab|nivolumab|mesh-list
15171214|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171215|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
15171216|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
15171217|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
15171218|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171219|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171220|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15171221|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
15171222|NCT04023630|Clopidogrel|clopidogrel|mesh-list
15171223|NCT04023630|Ticagrelor|ticagrelor|mesh-list
15171224|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15171225|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15171226|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15171227|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15171228|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
14636433|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636434|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636435|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
14636436|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636437|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636438|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636439|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636440|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636441|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636442|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
14636443|NCT00163969|Ketamine|ketamine|mesh-list
14636444|NCT00163969|Analgesics|analgesics|mesh-ancestor
14636445|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
14636446|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636447|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636448|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14636449|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14636450|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
14636451|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
14291953|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291954|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291955|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14291956|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
14291957|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
14291958|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14636452|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171229|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171230|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171231|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171232|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15171233|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
15171234|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15171235|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
15171236|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171237|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
15171238|NCT04023149|Aldesleukin|aldesleukin|mesh-list
15171239|NCT04023149|Interleukin-2|interleukin-2|mesh-list
15171240|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171241|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171242|NCT04023149|Analgesics|analgesics|mesh-ancestor
15171243|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
15171244|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171245|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171246|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15171247|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15171248|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
15171249|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171250|NCT04023331|Copper|copper|mesh-list
15171251|NCT04023331|Trace Elements|trace elements|mesh-ancestor
15171252|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
15171253|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636453|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14636454|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14636455|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636456|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636457|NCT00163982|Norfloxacin|norfloxacin|mesh-list
14636458|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636459|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636460|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636461|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636462|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636463|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636464|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636465|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14636466|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14636467|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
14636468|NCT00164008|Pamidronate|pamidronate|mesh-list
14636469|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14636470|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636471|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
14636472|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14636473|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
14022553|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022554|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022555|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14022556|NCT02767635|Triamcinolone|triamcinolone|mesh-list
14022557|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14022558|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14022559|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14022560|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14022561|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14022562|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14022563|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022564|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022565|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14022566|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14022567|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022568|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
14636474|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
14636475|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14636476|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636477|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14636478|NCT00164047|Analgesics|analgesics|mesh-ancestor
14636479|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
14636480|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636481|NCT00164086|Atorvastatin|atorvastatin|mesh-list
14636482|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14636483|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14636484|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
14636485|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636486|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14636487|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14636488|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636489|NCT00164112|Azithromycin|azithromycin|mesh-list
14636490|NCT00164112|Levofloxacin|levofloxacin|mesh-list
14636491|NCT00164112|Ofloxacin|ofloxacin|mesh-list
14636492|NCT00164112|Telithromycin|telithromycin|mesh-list
14636493|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636494|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636495|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14636496|NCT00164112|Renal Agents|renal agents|mesh-ancestor
14636497|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636498|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636499|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14646991|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
15171254|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
14636500|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636501|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636502|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14636503|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14636504|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14636505|NCT00164125|Laxatives|laxatives|mesh-ancestor
14636506|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636507|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14636508|NCT00164164|Laxatives|laxatives|mesh-ancestor
14636509|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636510|NCT00164216|Artesunate|artesunate|mesh-list
14636511|NCT00164216|Mefloquine|mefloquine|mesh-list
14636512|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
14636513|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14636514|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14636515|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636516|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636517|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
14636518|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
14636519|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14636520|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
14636521|NCT00164242|Galantamine|galantamine|mesh-list
14636522|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14636523|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636524|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636525|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
14636526|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636527|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636528|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14636529|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
14636530|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636531|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
14636532|NCT00164255|Artesunate|artesunate|mesh-list
14636533|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
14636534|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
14636535|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
14636536|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14636537|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14636538|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636539|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636540|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
14636541|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
15171255|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15171256|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171257|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
15171258|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15171259|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
15171260|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171261|NCT04023266|Expectorants|expectorants|mesh-ancestor
15171262|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
15171263|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15171264|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
14636542|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14636543|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
14636544|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14636545|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636546|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636547|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14636548|NCT00164255|Renal Agents|renal agents|mesh-ancestor
14636549|NCT00164281|Isoniazid|isoniazid|mesh-list
14636550|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
14636551|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636552|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636553|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14636554|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14636555|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
14636556|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636557|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14636558|NCT00164359|Artesunate|artesunate|mesh-list
14636559|NCT00164359|Amodiaquine|amodiaquine|mesh-list
14636560|NCT00164359|Dapsone|dapsone|mesh-list
14636561|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
14636562|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
15171265|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171266|NCT04023266|Protective Agents|protective agents|mesh-ancestor
14636563|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14636564|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14636565|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636566|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636567|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
14636568|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
14636569|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14636570|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
14636571|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14636572|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636573|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636574|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
14636575|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636576|NCT00164411|Vaccines|vaccines|mesh-list
14636577|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14636578|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
14636579|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636580|NCT00164424|Acyclovir|acyclovir|mesh-list
14636581|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
14636582|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636583|NCT00164450|Isoniazid|isoniazid|mesh-list
14636584|NCT00164450|Rifapentine|rifapentine|mesh-list
14636585|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
14636586|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636587|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636588|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14636589|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14636590|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
14636591|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636592|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14636593|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14636594|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
14636595|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
14636596|NCT00164463|Isoniazid|isoniazid|mesh-list
14636597|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636598|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636599|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636600|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636601|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636602|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636603|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636604|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
14636605|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14636606|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14636607|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
14636608|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14636609|NCT00164710|Artesunate|artesunate|mesh-list
14636610|NCT00164710|Lumefantrine|lumefantrine|mesh-list
14636611|NCT00164710|Artemether|artemether|mesh-list
14636612|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
14636613|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
14636614|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14636615|NCT00164710|Amodiaquine|amodiaquine|mesh-list
14636616|NCT00164710|Dapsone|dapsone|mesh-list
14636617|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
14636618|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
14636619|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14636620|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14636621|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636622|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636623|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
14636624|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
14636625|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14636626|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
14636627|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14636628|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636629|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636630|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14636631|NCT00164710|Renal Agents|renal agents|mesh-ancestor
14636632|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
14636633|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636634|NCT00164736|Ritonavir|ritonavir|mesh-list
14636635|NCT00164736|Lopinavir|lopinavir|mesh-list
15171267|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171268|NCT04023266|Antidotes|antidotes|mesh-ancestor
15171269|NCT04023292|Tamoxifen|tamoxifen|mesh-list
15171270|NCT04023292|Letrozole|letrozole|mesh-list
14636636|NCT00164736|Lamivudine|lamivudine|mesh-list
14636637|NCT00164736|Zidovudine|zidovudine|mesh-list
14636638|NCT00164736|Nevirapine|nevirapine|mesh-list
14636639|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14636640|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14636641|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
14636642|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171271|NCT04023292|Exemestane|exemestane|mesh-list
15171272|NCT04023292|Anastrozole|anastrozole|mesh-list
14636643|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636644|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14636645|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14636646|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
14636647|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636648|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14636649|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14636650|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14636651|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14636652|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
14636653|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14636654|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14636655|NCT00164749|Curcumin|curcumin|mesh-list
14636656|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14636657|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14636658|NCT00164749|Analgesics|analgesics|mesh-ancestor
14636659|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
14636660|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636661|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636662|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14636663|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636664|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636665|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636666|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636667|NCT00164775|Imipramine|imipramine|mesh-list
14636668|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14636669|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
14636670|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14636671|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14636672|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14636673|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14636674|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636675|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14636676|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636677|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636678|NCT00164788|Esomeprazole|esomeprazole|mesh-list
14636679|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14291959|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14291960|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14291961|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14291962|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291963|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14291964|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291965|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
15171273|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171274|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15171275|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15171276|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14291966|NCT00557440|Hormones|hormones|mesh-ancestor
14291967|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14291968|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
14291969|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
14291970|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14636680|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636681|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14636682|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636683|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636684|NCT00164801|Diltiazem|diltiazem|mesh-list
14636685|NCT00164801|Baclofen|baclofen|mesh-list
14636686|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14636687|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636688|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14636689|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636690|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14636691|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
14636692|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
14636693|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636694|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636695|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15181235|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636696|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14814130|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
14636697|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14636698|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15171277|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171278|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14636699|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
14646992|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14646993|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14646994|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14646995|NCT00199069|Cytarabine|cytarabine|mesh-list
14646996|NCT00199069|Dexamethasone|dexamethasone|mesh-list
14646997|NCT00199069|Prednisolone|prednisolone|mesh-list
14646998|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
14646999|NCT00199069|Ifosfamide|ifosfamide|mesh-list
14647000|NCT00199069|Methotrexate|methotrexate|mesh-list
14647001|NCT00199069|Vincristine|vincristine|mesh-list
14647002|NCT00199069|Doxorubicin|doxorubicin|mesh-list
14647003|NCT00199069|Daunorubicin|daunorubicin|mesh-list
14647004|NCT00199069|Asparaginase|asparaginase|mesh-list
14647005|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
14647006|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
14647007|NCT00199069|Thioguanine|thioguanine|mesh-list
14647008|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647009|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
14647010|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647011|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647012|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14647013|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
14647014|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647015|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647016|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14647017|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647018|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
14647019|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
14647020|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647021|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647022|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
14647023|NCT00199069|Hormones|hormones|mesh-ancestor
14647024|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647025|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647026|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14647027|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
14647028|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14647029|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647030|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
14647031|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14647032|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647033|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14647034|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647035|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
14647036|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647037|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647038|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647039|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647040|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647041|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647042|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647043|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647044|NCT00199069|Analgesics|analgesics|mesh-ancestor
14647045|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
14647046|NCT00199082|Cytarabine|cytarabine|mesh-list
14647047|NCT00199082|Dexamethasone|dexamethasone|mesh-list
14647048|NCT00199082|Prednisolone|prednisolone|mesh-list
14647049|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
14647050|NCT00199082|Ifosfamide|ifosfamide|mesh-list
14647051|NCT00199082|Rituximab|rituximab|mesh-list
14647052|NCT00199082|Methotrexate|methotrexate|mesh-list
14647053|NCT00199082|Vincristine|vincristine|mesh-list
14647054|NCT00199082|Doxorubicin|doxorubicin|mesh-list
14647055|NCT00199082|Vindesine|vindesine|mesh-list
14647056|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647057|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
14647058|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647059|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647060|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14647061|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
14647062|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647063|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647064|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14636700|NCT00164840|Esomeprazole|esomeprazole|mesh-list
14636701|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14636702|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636703|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14636704|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636705|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636706|NCT00164866|Omeprazole|omeprazole|mesh-list
14636707|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14636708|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636709|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14636710|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636711|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636712|NCT00164892|Rofecoxib|rofecoxib|mesh-list
14636713|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14636714|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14636715|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636716|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636717|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14636718|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14636719|NCT00164892|Analgesics|analgesics|mesh-ancestor
14636720|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
14636721|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636722|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636723|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14636724|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636725|NCT00164931|Omeprazole|omeprazole|mesh-list
14636726|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14636727|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636728|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14636729|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636730|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636731|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
14636732|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
14636733|NCT00164970|Vitamins|vitamins|mesh-ancestor
14636734|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
14636735|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636736|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
14291971|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
14291972|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14291973|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291974|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14291975|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
14291976|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14291977|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14291978|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14291979|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
14291980|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293239|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636737|NCT00164970|Hematinics|hematinics|mesh-ancestor
14636738|NCT00164996|Anesthetics|anesthetics|mesh-list
14636739|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14636740|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636741|NCT00165035|Paclitaxel|paclitaxel|mesh-list
14636742|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14636743|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636744|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636745|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636746|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636747|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636748|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636749|NCT00165048|Rofecoxib|rofecoxib|mesh-list
14636750|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14636751|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14636752|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636753|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636754|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14636755|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14636756|NCT00165048|Analgesics|analgesics|mesh-ancestor
14636757|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
14636758|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636759|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636760|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14636761|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636762|NCT00165074|Calfactant|calfactant|mesh-list
14636763|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14636764|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
14636765|NCT00165087|Doxorubicin|doxorubicin|mesh-list
14636766|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
14636767|NCT00165087|Asparaginase|asparaginase|mesh-list
14636768|NCT00165087|Razoxane|razoxane|mesh-list
14636769|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14636770|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636771|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636772|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636773|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636774|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636775|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14636776|NCT00165087|Protective Agents|protective agents|mesh-ancestor
14636777|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636778|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636779|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636780|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
14636781|NCT00165139|Melphalan|melphalan|mesh-list
14636782|NCT00165139|Ifosfamide|ifosfamide|mesh-list
14636783|NCT00165139|Carboplatin|carboplatin|mesh-list
14636784|NCT00165139|Etoposide|etoposide|mesh-list
14636785|NCT00165139|Vincristine|vincristine|mesh-list
14636786|NCT00165139|Doxorubicin|doxorubicin|mesh-list
14636787|NCT00165139|Sargramostim|sargramostim|mesh-list
14636788|NCT00165139|Lenograstim|lenograstim|mesh-list
15171279|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
14636789|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636790|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
14636791|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636792|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636793|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636794|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
14636795|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636796|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636797|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14636798|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636799|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636800|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636801|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636802|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636803|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636804|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636805|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14636806|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14636807|NCT00165178|Leucovorin|leucovorin|mesh-list
14636808|NCT00165178|Cytarabine|cytarabine|mesh-list
14636809|NCT00165178|Dexamethasone|dexamethasone|mesh-list
14636810|NCT00165178|Prednisone|prednisone|mesh-list
14636811|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
14636812|NCT00165178|Doxorubicin|doxorubicin|mesh-list
14636813|NCT00165178|Methotrexate|methotrexate|mesh-list
14636814|NCT00165178|Vincristine|vincristine|mesh-list
14636815|NCT00165178|Asparaginase|asparaginase|mesh-list
15171280|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171281|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171282|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15171283|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15171284|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14636816|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
14636817|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14636818|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
14636819|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
14636820|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636821|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636822|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14636823|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
14636824|NCT00165178|Hormones|hormones|mesh-ancestor
14636825|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636826|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14636827|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636828|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14636829|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636830|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636831|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636832|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636833|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14636834|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
14636835|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14636836|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14636837|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
14636838|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14636839|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14636840|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636841|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
14636842|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636843|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14636844|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
14636845|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636846|NCT00165178|Antidotes|antidotes|mesh-ancestor
14636847|NCT00165178|Protective Agents|protective agents|mesh-ancestor
14636848|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
14636849|NCT00165178|Vitamins|vitamins|mesh-ancestor
14636850|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
14636851|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636852|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636853|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636854|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636855|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14636856|NCT00165191|Doxorubicin|doxorubicin|mesh-list
14636857|NCT00165191|Fluorouracil|fluorouracil|mesh-list
14636858|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636859|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14636860|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636861|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636862|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636863|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636864|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
14636865|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14636866|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636867|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
14636868|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636869|NCT00165204|Tibolone|tibolone|mesh-list
14636870|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
14636871|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
14636872|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636873|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636874|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14636875|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14636876|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636877|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14636878|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
14636879|NCT00165204|Hormones|hormones|mesh-ancestor
14636880|NCT00165217|Thalidomide|thalidomide|mesh-list
14636881|NCT00165217|Capecitabine|capecitabine|mesh-list
14636882|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14636883|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
14636884|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636885|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636886|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636887|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
14636888|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636889|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
14636890|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636891|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636892|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14636893|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14636894|NCT00165217|Growth Substances|growth substances|mesh-ancestor
14636895|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
14636896|NCT00165230|Thalidomide|thalidomide|mesh-list
14636897|NCT00165230|Temozolomide|temozolomide|mesh-list
14636898|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636899|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
14636900|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636901|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
14636902|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636903|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636904|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14636905|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14636906|NCT00165230|Growth Substances|growth substances|mesh-ancestor
14636907|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
14636908|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636909|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636910|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
14636911|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171285|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15171286|NCT04023305|Sevoflurane|sevoflurane|mesh-list
14636912|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
14636913|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636914|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
14636915|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14636916|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14636917|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636918|NCT00165295|Urological Agents|urological agents|mesh-ancestor
14636919|NCT00165308|Tamoxifen|tamoxifen|mesh-list
14636920|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14636921|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
14636922|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636923|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636924|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14636925|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636926|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14636927|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14636928|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14636929|NCT00165334|Cetuximab|cetuximab|mesh-list
14636930|NCT00165334|Vinorelbine|vinorelbine|mesh-list
14636931|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14636932|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636933|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636934|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636935|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636936|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636937|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636938|NCT00165347|Vatalanib|vatalanib|mesh-list
14636939|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14636940|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636941|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636942|NCT00165360|Temozolomide|temozolomide|mesh-list
14636943|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636944|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
14636945|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636946|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636947|NCT00165373|Endostatins|endostatins|mesh-list
14636948|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636949|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14636950|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14636951|NCT00165373|Growth Substances|growth substances|mesh-ancestor
14636952|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636953|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
14636954|NCT00165399|Docetaxel|docetaxel|mesh-list
14636955|NCT00165399|Goserelin|goserelin|mesh-list
14636956|NCT00165399|Bicalutamide|bicalutamide|mesh-list
14636957|NCT00165399|Estramustine|estramustine|mesh-list
14636958|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636959|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
14636960|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
14636961|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14636962|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14636963|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14636964|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
14636965|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
14636966|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14636967|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636968|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636969|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
14636970|NCT00165451|Thalidomide|thalidomide|mesh-list
14636971|NCT00165451|Celecoxib|celecoxib|mesh-list
14636972|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
14636973|NCT00165451|Etoposide|etoposide|mesh-list
14636974|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14636975|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
14636976|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14636977|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14636978|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14636979|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
14636980|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171287|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14636981|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14636982|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15171288|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15171289|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
15171290|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
15171291|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171292|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171293|NCT04023110|Carvedilol|carvedilol|mesh-list
15171294|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15171295|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14636983|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14636984|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14636985|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14636986|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14636987|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15171296|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
15171297|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171298|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171299|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171300|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15171301|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
15171302|NCT04023110|Protective Agents|protective agents|mesh-ancestor
15171303|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15171304|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15171305|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15171306|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
15171307|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15171308|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15181236|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15181237|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
15181238|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
15181239|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15181240|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
15181241|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14636988|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14636989|NCT00165451|Analgesics|analgesics|mesh-ancestor
14636990|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
14636991|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14636992|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14636993|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14636994|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14636995|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
14636996|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14636997|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14636998|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14636999|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14637000|NCT00165451|Growth Substances|growth substances|mesh-ancestor
14637001|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
14637002|NCT00165464|Irinotecan|irinotecan|mesh-list
15181242|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181243|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15181244|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15181245|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181246|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15181247|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15181248|NCT03931928|Tamoxifen|tamoxifen|mesh-list
15181249|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15181250|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
15181251|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181252|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181253|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15181254|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181255|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15181256|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15181257|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15181258|NCT03931889|Vitamin D|vitamin d|mesh-list
15181259|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
15181260|NCT03931889|Vitamins|vitamins|mesh-ancestor
15181261|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
15181262|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637003|NCT00165464|Docetaxel|docetaxel|mesh-list
15181263|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15181264|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15181265|NCT03931343|Epinephrine|epinephrine|mesh-list
15171309|NCT04022837|Pantoprazole|pantoprazole|mesh-list
15171310|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15171311|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171312|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15171313|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171314|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171315|NCT04023019|Thrombin|thrombin|mesh-list
15171316|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
15171317|NCT04023019|Coagulants|coagulants|mesh-ancestor
15171318|NCT04022811|Tobramycin|tobramycin|mesh-list
15171319|NCT04022811|Dexamethasone|dexamethasone|mesh-list
15171320|NCT04022811|Bromfenac|bromfenac|mesh-list
15171321|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
15171322|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171323|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
15171324|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
15171325|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171326|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171327|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171328|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
15171329|NCT04022811|Hormones|hormones|mesh-ancestor
15171330|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171331|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15171332|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171333|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171334|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171335|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15171336|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
14637004|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637005|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14637006|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14637007|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637008|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637009|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
14637010|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
14637011|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
14637012|NCT00165477|Lenalidomide|lenalidomide|mesh-list
14637013|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
14637014|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637015|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14637016|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14637017|NCT00165477|Growth Substances|growth substances|mesh-ancestor
14637018|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
14637019|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637020|NCT00165490|Irinotecan|irinotecan|mesh-list
14637021|NCT00165490|Cetuximab|cetuximab|mesh-list
14637022|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637023|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14637024|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14637025|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637026|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637027|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14637028|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
14637029|NCT00165516|Antidotes|antidotes|mesh-ancestor
14637030|NCT00165516|Protective Agents|protective agents|mesh-ancestor
14637031|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171337|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
15171338|NCT04022811|Protective Agents|protective agents|mesh-ancestor
15171339|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15171340|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171341|NCT04022811|Analgesics|analgesics|mesh-ancestor
15171342|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
15171343|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171344|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
15171345|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
15171346|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171347|NCT04022876|Carboplatin|carboplatin|mesh-list
15171348|NCT04022876|Pemetrexed|pemetrexed|mesh-list
14637032|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
14637033|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637034|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
15171349|NCT04022876|Topotecan|topotecan|mesh-list
15171350|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637035|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171351|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171352|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171353|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15181266|NCT03931343|Racepinephrine|racepinephrine|mesh-list
15171354|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15171355|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15171356|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15171357|NCT04022785|Azacitidine|azacitidine|mesh-list
15171358|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15171359|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
15171360|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171361|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171362|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171363|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
15171364|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15171365|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15171366|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022569|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637036|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637037|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
14637038|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
14637039|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
14637040|NCT00165555|Antidotes|antidotes|mesh-ancestor
14637041|NCT00165555|Protective Agents|protective agents|mesh-ancestor
14637042|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637043|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
14637044|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637045|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
14637046|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637047|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637048|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
14637049|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
14637050|NCT00165568|Bevacizumab|bevacizumab|mesh-list
14637051|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14637052|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637053|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14637054|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14637055|NCT00165568|Growth Substances|growth substances|mesh-ancestor
14637056|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637057|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
14637058|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14637059|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637060|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14637061|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637062|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637063|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
14637064|NCT00165633|Menatetrenone|menatetrenone|mesh-list
14637065|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
14637066|NCT00165633|Coagulants|coagulants|mesh-ancestor
14637067|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14637068|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14637069|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637070|NCT00165633|Vitamins|vitamins|mesh-ancestor
15171367|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
15171368|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15171369|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637071|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
14637072|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637073|NCT00165659|Donepezil|donepezil|mesh-list
14637074|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14637075|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637076|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637077|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637078|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637079|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637080|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
15171370|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15171371|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
15171372|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171373|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
15171374|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171375|NCT04022525|Leflunomide|leflunomide|mesh-list
15171376|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637081|NCT00165685|Sibutramine|sibutramine|mesh-list
14637082|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
14637083|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637084|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
14637085|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15171377|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171378|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171379|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
14637086|NCT00165737|Donepezil|donepezil|mesh-list
14637087|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14637088|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637089|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637090|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637091|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637092|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637093|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
14637094|NCT00165750|Donepezil|donepezil|mesh-list
14637095|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14637096|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637097|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637098|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637099|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637100|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637101|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
14637102|NCT00165763|Donepezil|donepezil|mesh-list
14637103|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14637104|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637105|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637106|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637107|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637108|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637109|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
14637110|NCT00165815|Donepezil|donepezil|mesh-list
14637111|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14637112|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637113|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637114|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637115|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637116|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637117|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
14637118|NCT00165828|Zonisamide|zonisamide|mesh-list
14637119|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
14637120|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14637121|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637122|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637123|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14637124|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637125|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14637126|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171380|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171381|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
15171382|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15171383|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
14637127|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14291981|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291982|NCT00557492|Gemcitabine|gemcitabine|mesh-list
14291983|NCT00557492|Bevacizumab|bevacizumab|mesh-list
14291984|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14291985|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637128|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637129|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637130|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14637131|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637132|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14637133|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637134|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637135|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
14637136|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637137|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14637138|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637139|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637140|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14637141|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
14637142|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637143|NCT00166127|Simendan|simendan|mesh-list
14637144|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15171384|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637145|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
14637146|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14637147|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14637148|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637149|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637150|NCT00166127|Protective Agents|protective agents|mesh-ancestor
14637151|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171385|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171386|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15171387|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
15171388|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15171389|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
15171390|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637152|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
14637153|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637154|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14291986|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14291987|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14291988|NCT00557492|Growth Substances|growth substances|mesh-ancestor
14291989|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14291990|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
14291991|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14291992|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
14291993|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14291994|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
14291995|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14291996|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637155|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14637156|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
14637157|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637158|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637159|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637160|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637161|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
14637162|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637163|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171391|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171392|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15171393|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
14637164|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14637165|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
14637166|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637167|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637168|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637169|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637170|NCT00166400|Metoprolol|metoprolol|mesh-list
14637171|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14637172|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14637173|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
14637174|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
14637175|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637176|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637177|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14637178|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14637179|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14637180|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
14637181|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637182|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637183|NCT00166413|Thalidomide|thalidomide|mesh-list
14637184|NCT00166413|Lenalidomide|lenalidomide|mesh-list
14637185|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637186|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
14637187|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637188|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
14637189|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637190|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637191|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14637192|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14637193|NCT00166413|Growth Substances|growth substances|mesh-ancestor
14291997|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14291998|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
14291999|NCT00557622|Paroxetine|paroxetine|mesh-list
14292000|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14292001|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15171394|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
15171395|NCT04022161|Protective Agents|protective agents|mesh-ancestor
15171396|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
15171397|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
15171398|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15171399|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15171400|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171401|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171402|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171403|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171404|NCT04022096|Lansoprazole|lansoprazole|mesh-list
15171405|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
15171406|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15171407|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171408|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15171409|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171410|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171411|NCT04022291|Insulin|insulin|mesh-list
15171412|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15171413|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15171414|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171415|NCT04022317|Insulin|insulin|mesh-list
15171416|NCT04022317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15171417|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15171418|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171419|NCT04022226|Ketamine|ketamine|mesh-list
15171420|NCT04022226|Methohexital|methohexital|mesh-list
15171421|NCT04022226|Analgesics|analgesics|mesh-ancestor
15171422|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
15171423|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171424|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171425|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15171426|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15171427|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
15171428|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
15171429|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171430|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14292002|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14292003|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292004|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292005|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
14637194|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
14637195|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647065|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647066|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
14647067|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
14647068|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647069|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647070|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
14647071|NCT00199082|Hormones|hormones|mesh-ancestor
14647072|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647073|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647074|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14647075|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14647076|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
14647077|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14647078|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647079|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
14647080|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
14647081|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647082|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14647083|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647084|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
14647085|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647086|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647087|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647088|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647089|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647090|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647091|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15171431|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15171432|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171433|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171434|NCT04022135|Folic Acid|folic acid|mesh-list
14637196|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
14637197|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637198|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14637199|NCT00166426|Protective Agents|protective agents|mesh-ancestor
14637200|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637201|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14637202|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637203|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171435|NCT04022135|Hematinics|hematinics|mesh-ancestor
15171436|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
15171437|NCT04022135|Vitamins|vitamins|mesh-ancestor
15171438|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
15171439|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171440|NCT04021992|Gemcitabine|gemcitabine|mesh-list
15171441|NCT04021992|Rituximab|rituximab|mesh-list
15171442|NCT04021992|Doxorubicin|doxorubicin|mesh-list
15171443|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14637204|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14637205|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14637206|NCT00166426|Analgesics|analgesics|mesh-ancestor
15171444|NCT04021992|Vinorelbine|vinorelbine|mesh-list
15171445|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171446|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637207|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
14637208|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637209|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14637210|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637211|NCT00166465|Leucovorin|leucovorin|mesh-list
14637212|NCT00166465|Fluorouracil|fluorouracil|mesh-list
14637213|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
14637214|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
14637215|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637216|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14637217|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637218|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637219|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
14637220|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637221|NCT00166465|Antidotes|antidotes|mesh-ancestor
14637222|NCT00166465|Protective Agents|protective agents|mesh-ancestor
14637223|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
14637224|NCT00166465|Vitamins|vitamins|mesh-ancestor
14637225|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
14637226|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
14637227|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637228|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14637229|NCT00166478|Protective Agents|protective agents|mesh-ancestor
14637230|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637231|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14637232|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637233|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637234|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14637235|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14637236|NCT00166478|Analgesics|analgesics|mesh-ancestor
14637237|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
14637238|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637239|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14637240|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637241|NCT00166491|Insulin|insulin|mesh-list
14637242|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14637243|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637244|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
14637245|NCT00166556|Tacrolimus|tacrolimus|mesh-list
14637246|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637247|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
14637248|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637249|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14637250|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637251|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637252|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14637253|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637254|NCT00166595|Risperidone|risperidone|mesh-list
14637255|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15171447|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
14637256|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
14637257|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171448|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171449|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637258|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637259|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637260|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14637261|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637262|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637263|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637264|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14637265|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
14637266|NCT00166621|Buspirone|buspirone|mesh-list
14637267|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14637268|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637269|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171450|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15171451|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
15171452|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171453|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
15171454|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171455|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171456|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171457|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637270|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637271|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637272|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14637273|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
14637274|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637275|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637276|NCT00166686|Clonidine|clonidine|mesh-list
14637277|NCT00166686|Analgesics|analgesics|mesh-ancestor
14637278|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
14637279|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637280|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637281|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14637282|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
14637283|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
14637284|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14637285|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14637286|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14637287|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
14637288|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637289|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637290|NCT00166725|Octreotide|octreotide|mesh-list
14637291|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14637292|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14637293|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637294|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
15171458|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15171459|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15171460|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15171461|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
15171462|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14637295|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14637296|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637297|NCT00166816|Cyclosporine|cyclosporine|mesh-list
14637298|NCT00166816|Sirolimus|sirolimus|mesh-list
14637299|NCT00166816|Tacrolimus|tacrolimus|mesh-list
15171463|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
15171464|NCT04022005|Gemcitabine|gemcitabine|mesh-list
15171465|NCT04022005|Rituximab|rituximab|mesh-list
15171466|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
15171467|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171468|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171469|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
15171470|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637300|NCT00166816|Cyclosporins|cyclosporins|mesh-list
14637301|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637302|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
14637303|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637304|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14637305|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637306|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637307|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
15171471|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637308|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637309|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
14637310|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15181267|NCT03931343|Bupivacaine|bupivacaine|mesh-list
14637311|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637312|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637313|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637314|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
14637315|NCT00166829|Sirolimus|sirolimus|mesh-list
14637316|NCT00166829|Tacrolimus|tacrolimus|mesh-list
14637317|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637318|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
14637319|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637320|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14637321|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637322|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637323|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637324|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637325|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14637326|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
14637327|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14292006|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292007|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14292008|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
14292009|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14292010|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14292011|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14292012|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637328|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637329|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
14637330|NCT00166842|Cyclosporine|cyclosporine|mesh-list
14637331|NCT00166842|Sirolimus|sirolimus|mesh-list
14637332|NCT00166842|Tacrolimus|tacrolimus|mesh-list
14637333|NCT00166842|Cyclosporins|cyclosporins|mesh-list
14637334|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637335|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
14637336|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637337|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14637338|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637339|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637340|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
14637341|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637342|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
14637343|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637344|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637345|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637346|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637347|NCT00166868|Neomycin|neomycin|mesh-list
14637348|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637349|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637350|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14637351|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637352|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637353|NCT00166881|Docetaxel|docetaxel|mesh-list
14637354|NCT00166881|Irinotecan|irinotecan|mesh-list
14637355|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637356|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14637357|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14637358|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14637359|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637360|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14637361|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14637362|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637363|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
14637364|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
14637365|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14637366|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637367|NCT00167154|Risperidone|risperidone|mesh-list
14637368|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14637369|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
14637370|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637371|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637372|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637373|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14637374|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637375|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637376|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637377|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14637378|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
14637379|NCT00167232|Naltrexone|naltrexone|mesh-list
14637380|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14637381|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14637382|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637383|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
14637384|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637385|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14637386|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14637387|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14637388|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637389|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637390|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
14637391|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637392|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637393|NCT00167375|Eszopiclone|eszopiclone|mesh-list
14637394|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14637395|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637396|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637397|NCT00167401|Docetaxel|docetaxel|mesh-list
14637398|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637399|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
14637400|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
14637401|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
14637402|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637403|NCT00167479|Risperidone|risperidone|mesh-list
14637404|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14637405|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
14637406|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637407|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637408|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637409|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14637410|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637411|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637412|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637413|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14637414|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
14637415|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
14637416|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637417|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637418|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14637419|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
14637420|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637421|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637422|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637423|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637424|NCT00167518|Triamcinolone|triamcinolone|mesh-list
14637425|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14637426|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
14637427|NCT00167518|Hormones|hormones|mesh-ancestor
14637428|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14637429|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637430|NCT00167557|Interferons|interferons|mesh-list
14637431|NCT00167557|Ribavirin|ribavirin|mesh-list
14637432|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637433|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
14637434|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637435|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
14637436|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637437|NCT00167583|Interferons|interferons|mesh-list
14637438|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
15171472|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15171473|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
15171474|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171475|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
15171476|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171477|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637439|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
14637440|NCT00167583|Cyclosporine|cyclosporine|mesh-list
14637441|NCT00167583|Cyclosporins|cyclosporins|mesh-list
14637442|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637443|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
14637444|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637445|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637446|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637447|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637448|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
14637449|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637450|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
14637451|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
14637452|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637453|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14637454|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14637455|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14637456|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
14637457|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637458|NCT00167648|Leuprolide|leuprolide|mesh-list
14637459|NCT00167648|Goserelin|goserelin|mesh-list
14637460|NCT00167648|Estradiol|estradiol|mesh-list
14637461|NCT00167648|Estrogens|estrogens|mesh-ancestor
14637462|NCT00167648|Hormones|hormones|mesh-ancestor
14637463|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14637464|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637465|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14637466|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14637467|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
14637468|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14637469|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637470|NCT00167674|Zidovudine|zidovudine|mesh-list
14637471|NCT00167674|Nevirapine|nevirapine|mesh-list
14637472|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
14637473|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637474|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14637475|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14637476|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637477|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
14637478|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637479|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14637480|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14637481|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14637482|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14637483|NCT00167687|Prazosin|prazosin|mesh-list
14637484|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14637485|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14637486|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14637487|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14637488|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
14637489|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637490|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637491|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637492|NCT00167713|Ibuprofen|ibuprofen|mesh-list
14637493|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14637494|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14637495|NCT00167713|Analgesics|analgesics|mesh-ancestor
14637496|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
14637497|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637498|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637499|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14637500|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637501|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14637502|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637503|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637504|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
14637505|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
14637506|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14637507|NCT00167739|Quinine|quinine|mesh-list
14637508|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
14637509|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14637510|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14637511|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637512|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14637513|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637514|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637515|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14637516|NCT00167739|Renal Agents|renal agents|mesh-ancestor
14637517|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14637518|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637519|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14637520|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637521|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14637522|NCT00167739|Analgesics|analgesics|mesh-ancestor
14637523|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
14637524|NCT00167765|Abciximab|abciximab|mesh-list
14637525|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
14637526|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14637527|NCT00167791|Rituximab|rituximab|mesh-list
14637528|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14637529|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637530|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
14637531|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637532|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637533|NCT00167817|Aripiprazole|aripiprazole|mesh-list
14637534|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
14637535|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637536|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14637537|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637538|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637539|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637540|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
14637541|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
14637542|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637543|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637544|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14637545|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14637546|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
14637547|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14637548|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14637549|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14637550|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14637551|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
14637552|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
14637553|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14637554|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
14637555|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14637556|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14637557|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637558|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14637559|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637560|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171478|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171479|NCT04022057|Ropivacaine|ropivacaine|mesh-list
15171480|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
15171481|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
15171482|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171483|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171484|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
15171485|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171486|NCT04021498|Simvastatin|simvastatin|mesh-list
15171487|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14637561|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14637562|NCT00167843|Renal Agents|renal agents|mesh-ancestor
14637563|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14637564|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14637565|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14637566|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637567|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637568|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637569|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637570|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14637571|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
14637572|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637573|NCT00167882|Mesalamine|mesalamine|mesh-list
14637574|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14637575|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14637576|NCT00167882|Analgesics|analgesics|mesh-ancestor
14637577|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
14637578|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637579|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637580|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14637581|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637582|NCT00167908|Amifostine|amifostine|mesh-list
14637583|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14637584|NCT00167908|Protective Agents|protective agents|mesh-ancestor
15171488|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15171489|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
14637585|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637586|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14637587|NCT00167921|Estrogens|estrogens|mesh-ancestor
14637588|NCT00167921|Hormones|hormones|mesh-ancestor
14637589|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14637590|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637591|NCT00167947|Cyclosporine|cyclosporine|mesh-list
14637592|NCT00167947|Sirolimus|sirolimus|mesh-list
14637593|NCT00167947|Cyclosporins|cyclosporins|mesh-list
14637594|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637595|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637596|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637597|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
14637598|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637599|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
14637600|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637601|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
14637602|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637603|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14637604|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637605|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14637606|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637607|NCT00167960|Tazobactam|tazobactam|mesh-list
14637608|NCT00167960|Piperacillin|piperacillin|mesh-list
14637609|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15171490|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171491|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15171492|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15171493|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171494|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
15171495|NCT04021550|Telmisartan|telmisartan|mesh-list
15171496|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15171497|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15171498|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15171499|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171500|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
15171501|NCT04021550|Protective Agents|protective agents|mesh-ancestor
15171502|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171503|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
15171504|NCT04021550|Vitamins|vitamins|mesh-ancestor
15171505|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
15171506|NCT04021433|Ketamine|ketamine|mesh-list
15171507|NCT04021433|Analgesics|analgesics|mesh-ancestor
14637610|NCT00167960|Lactams|lactams|mesh-list
14637611|NCT00167960|beta-Lactams|beta-lactams|mesh-list
14637612|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637613|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637614|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14637615|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637616|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647092|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647093|NCT00199095|Cytarabine|cytarabine|mesh-list
14647094|NCT00199095|Dexamethasone|dexamethasone|mesh-list
14647095|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
14647096|NCT00199095|Ifosfamide|ifosfamide|mesh-list
14647097|NCT00199095|Methotrexate|methotrexate|mesh-list
14647098|NCT00199095|Vincristine|vincristine|mesh-list
14647099|NCT00199095|Doxorubicin|doxorubicin|mesh-list
14647100|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
14647101|NCT00199095|Idarubicin|idarubicin|mesh-list
14647102|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647103|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
14647104|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647105|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647106|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14647107|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
14647108|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647109|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647110|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14647111|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647112|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
14647113|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
14647114|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647115|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647116|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
14647117|NCT00199095|Hormones|hormones|mesh-ancestor
15171508|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
15181268|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
14637617|NCT00167986|Vancomycin|vancomycin|mesh-list
14637618|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637619|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637620|NCT00167999|Tazobactam|tazobactam|mesh-list
14637621|NCT00167999|Piperacillin|piperacillin|mesh-list
14637622|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14637623|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637624|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637625|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14637626|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637627|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637628|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
14637629|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14637630|NCT00168012|Antibodies|antibodies|mesh-list
14637631|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
14637632|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637633|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
14637634|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14637635|NCT00168025|Antibodies|antibodies|mesh-list
14637636|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
14637637|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637638|NCT00168051|Factor VIII|factor viii|mesh-list
14637639|NCT00168051|Coagulants|coagulants|mesh-ancestor
14637640|NCT00168077|Thrombin|thrombin|mesh-list
14637641|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
14637642|NCT00168077|Coagulants|coagulants|mesh-ancestor
14637643|NCT00168090|Factor VIII|factor viii|mesh-list
14637644|NCT00168090|Coagulants|coagulants|mesh-ancestor
14637645|NCT00168168|Lenograstim|lenograstim|mesh-list
14637646|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14637647|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
14637648|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637649|NCT00168181|Pilocarpine|pilocarpine|mesh-list
14637650|NCT00168181|Miotics|miotics|mesh-ancestor
14637651|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
14637652|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637653|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637654|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14637655|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14637656|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637657|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637658|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637659|NCT00168350|Memantine|memantine|mesh-list
14637660|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14637661|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14637662|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
14637663|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637664|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637665|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637666|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14637667|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14637668|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14637669|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15171509|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171510|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171511|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15171512|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14637670|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14637671|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14637672|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14637673|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
14637674|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637675|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637676|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637677|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
14637678|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14637679|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14637680|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15171513|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
15171514|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
15171515|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637681|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15171516|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14637682|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637683|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637684|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637685|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637686|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14637687|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637688|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
14637689|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14637690|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14637691|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14637692|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637693|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637694|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637695|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171517|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15171518|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171519|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171520|NCT04021420|Nivolumab|nivolumab|mesh-list
15171521|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171522|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171523|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15171524|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171525|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15171526|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14637696|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637697|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14637698|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637699|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
14637700|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14637701|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14637702|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14637703|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637704|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637705|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637706|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637707|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637708|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14637709|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637710|NCT00168467|Ramipril|ramipril|mesh-list
14637711|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14637712|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
14637713|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637714|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637715|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14637716|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
14637717|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14637718|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14637719|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14637720|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637721|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637722|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
14637723|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637724|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637725|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14637726|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637727|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
14637728|NCT00168493|Serotonin|serotonin|mesh-list
14637729|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14637730|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637731|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14637732|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
14637733|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637734|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637735|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637736|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14637737|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637738|NCT00168519|Nitroprusside|nitroprusside|mesh-list
14637739|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14637740|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
14637741|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14637742|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637743|NCT00168532|Trimethoprim|trimethoprim|mesh-list
14637744|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14637745|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
14637746|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14637747|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637748|NCT00168532|Renal Agents|renal agents|mesh-ancestor
14637749|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
14637750|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14637751|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15171527|NCT04021264|Sufentanil|sufentanil|mesh-list
15171528|NCT04021264|Ropivacaine|ropivacaine|mesh-list
15171529|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
15171530|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
15171531|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171532|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171533|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
15171534|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637752|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14637753|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637754|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637755|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14637756|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14637757|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14637758|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14637759|NCT00168584|Vitamin A|vitamin a|mesh-list
14637760|NCT00168584|Vitamins|vitamins|mesh-ancestor
14637761|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
14637762|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637763|NCT00168597|Vitamin A|vitamin a|mesh-list
14637764|NCT00168597|Vitamins|vitamins|mesh-ancestor
14637765|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
14637766|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637767|NCT00168610|Vitamin A|vitamin a|mesh-list
14637768|NCT00168610|Vitamins|vitamins|mesh-ancestor
14637769|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
14637770|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637771|NCT00168623|Vitamin A|vitamin a|mesh-list
14637772|NCT00168623|Vitamins|vitamins|mesh-ancestor
14637773|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
14637774|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637775|NCT00168636|Vitamin A|vitamin a|mesh-list
14637776|NCT00168636|Vitamins|vitamins|mesh-ancestor
14637777|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
14637778|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637779|NCT00168649|Vitamin A|vitamin a|mesh-list
14637780|NCT00168649|Vitamins|vitamins|mesh-ancestor
14637781|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
14637782|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637783|NCT00168688|Micronutrients|micronutrients|mesh-list
14637784|NCT00168688|Trace Elements|trace elements|mesh-list
14637785|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637786|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14637787|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14637788|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637789|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
14637790|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637791|NCT00168714|Interferons|interferons|mesh-list
14637792|NCT00168714|Interferon-beta|interferon-beta|mesh-list
14637793|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
14637794|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637795|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
14637796|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637797|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
14637798|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637799|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14637800|NCT00168740|Rituximab|rituximab|mesh-list
14637801|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14637802|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637803|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
14637804|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637805|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637806|NCT00168753|Alefacept|alefacept|mesh-list
14637807|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
14637808|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
14637809|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637810|NCT00168766|Interferons|interferons|mesh-list
15171535|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14637811|NCT00168766|Interferon-beta|interferon-beta|mesh-list
14637812|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
14637813|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
14637814|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637815|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
14637816|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171536|NCT04021264|Narcotics|narcotics|mesh-ancestor
14637817|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14637818|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
14637819|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
14637820|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637821|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637822|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14637823|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
14637824|NCT00168766|Hormones|hormones|mesh-ancestor
14637825|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14637826|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14637827|NCT00168766|Protective Agents|protective agents|mesh-ancestor
14637828|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
14637829|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14637830|NCT00168779|Valsartan|valsartan|mesh-list
14637831|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14637832|NCT00168779|Telmisartan|telmisartan|mesh-list
14637833|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14637834|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14637835|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14637836|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637837|NCT00168779|Diuretics|diuretics|mesh-ancestor
15171537|NCT04021264|Analgesics|analgesics|mesh-ancestor
15171538|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15171539|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15171540|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
15171541|NCT04021108|Nivolumab|nivolumab|mesh-list
15171542|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171543|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171544|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15171545|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171546|NCT04021121|Linezolid|linezolid|mesh-list
15171547|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171548|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171549|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15171550|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637838|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
14637839|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637840|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14637841|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637842|NCT00168792|Tenecteplase|tenecteplase|mesh-list
14637843|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14637844|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14637845|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637846|NCT00168857|Losartan|losartan|mesh-list
14637847|NCT00168857|Telmisartan|telmisartan|mesh-list
14637848|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14637849|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14637850|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14637851|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14637852|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637853|NCT00168870|Gemcitabine|gemcitabine|mesh-list
14637854|NCT00168870|Treosulfan|treosulfan|mesh-list
14637855|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14637856|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
14637857|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637858|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637859|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
14637860|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637861|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637862|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14637863|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
14637864|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637865|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14637866|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
15171551|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181269|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
15181270|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
15181271|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181272|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181273|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
15181274|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181275|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14637867|NCT00168883|Paclitaxel|paclitaxel|mesh-list
14637868|NCT00168883|Vinorelbine|vinorelbine|mesh-list
15171552|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15171553|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15171554|NCT04021017|Estradiol|estradiol|mesh-list
15171555|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15171556|NCT04021017|Estrogens|estrogens|mesh-ancestor
15171557|NCT04021017|Hormones|hormones|mesh-ancestor
14637869|NCT00168883|Carboplatin|carboplatin|mesh-list
14637870|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14637871|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637872|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
14637873|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
14637874|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
14637875|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637876|NCT00168896|Carboplatin|carboplatin|mesh-list
14637877|NCT00168896|Irinotecan|irinotecan|mesh-list
14637878|NCT00168896|Etoposide|etoposide|mesh-list
14637879|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637880|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14637881|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14637882|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637883|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637884|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14637885|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14637886|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
14637887|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14637888|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14637889|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637890|NCT00168909|Vitamins|vitamins|mesh-ancestor
15171558|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171559|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171560|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14637891|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
14637892|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14637893|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14637894|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
14637895|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637896|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637897|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
14637898|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
14637899|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14637900|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14637901|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637902|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14637903|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14637904|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637905|NCT00169000|Docetaxel|docetaxel|mesh-list
14637906|NCT00169000|Capecitabine|capecitabine|mesh-list
15171561|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
14637907|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14637908|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
14637909|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
15171562|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15171563|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15171564|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
15171565|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14637910|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
14637911|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637912|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14637913|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
14637914|NCT00169013|Gabapentin|gabapentin|mesh-list
14637915|NCT00169013|Analgesics|analgesics|mesh-ancestor
14637916|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
14637917|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171566|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15171567|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171568|NCT04020666|Kallikreins|kallikreins|mesh-list
15171569|NCT04020666|Coagulants|coagulants|mesh-ancestor
15171570|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
15171571|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
15171572|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15171573|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171574|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
15171575|NCT04020653|Lumefantrine|lumefantrine|mesh-list
15171576|NCT04020653|Artemether|artemether|mesh-list
15171577|NCT04020653|Artemisinins|artemisinins|mesh-list
14637918|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171578|NCT04020653|Artemisinin|artemisinin|mesh-list
15171579|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15171580|NCT04020653|Citric Acid|citric acid|mesh-list
15171581|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
15171582|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
15171583|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15171584|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
15171585|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
15171586|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171587|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
15171588|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15171589|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15171590|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171591|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15171592|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
15171593|NCT04020653|Trace Elements|trace elements|mesh-ancestor
15171594|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
15171595|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171596|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15171597|NCT04021043|Nivolumab|nivolumab|mesh-list
15171598|NCT04021043|Ipilimumab|ipilimumab|mesh-list
15171599|NCT04021043|Antibodies|antibodies|mesh-list
14637919|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
14637920|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14637921|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637922|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637923|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637924|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14637925|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14637926|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637927|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637928|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
14637929|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
14637930|NCT00169026|Clozapine|clozapine|mesh-list
14637931|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637932|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637933|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637934|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637935|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14637936|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
14637937|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637938|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637939|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
14637940|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
14637941|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
14637942|NCT00169039|Clozapine|clozapine|mesh-list
14637943|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14637944|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
14637945|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637946|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637947|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171600|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
15171601|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15171602|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
15171603|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171604|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171605|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14637948|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14637949|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637950|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637951|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637952|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
14637953|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
14637954|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
14637955|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
14637956|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637957|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14637958|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14637959|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
14637960|NCT00169065|Olanzapine|olanzapine|mesh-list
14637961|NCT00169065|Clozapine|clozapine|mesh-list
15171606|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637962|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
14637963|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
15171607|NCT04020601|Ropivacaine|ropivacaine|mesh-list
15171608|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
14637964|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637965|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171609|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
14637966|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14637967|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14637968|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637969|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637970|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637971|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14637972|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14637973|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14637974|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14637975|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14637976|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
14637977|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14637978|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
14637979|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
14637980|NCT00169078|Chloroquine|chloroquine|mesh-list
14637981|NCT00169078|Amebicides|amebicides|mesh-ancestor
14637982|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14637983|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14637984|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14637985|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
14637986|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14637987|NCT00169091|Haloperidol|haloperidol|mesh-list
14637988|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
14637989|NCT00169091|Clozapine|clozapine|mesh-list
14637990|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
14637991|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
14637992|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14637993|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14637994|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14637995|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14637996|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14637997|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14637998|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14637999|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14638000|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
14638001|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638002|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638003|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14638004|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14638005|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
14638006|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
14638007|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
14638008|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
14638009|NCT00169130|Doxorubicin|doxorubicin|mesh-list
14638010|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638011|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
14638012|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171610|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171611|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638013|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638014|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14638015|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
14638016|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638017|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638018|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14638019|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14638020|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14638021|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14638022|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638023|NCT00169143|Rituximab|rituximab|mesh-list
14638024|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14638025|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638026|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
14638027|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638028|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638029|NCT00169156|Prednisone|prednisone|mesh-list
14638030|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
14638031|NCT00169156|Rituximab|rituximab|mesh-list
14638032|NCT00169156|Doxorubicin|doxorubicin|mesh-list
14638033|NCT00169156|Vincristine|vincristine|mesh-list
15171612|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
14638034|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638035|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
14638036|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638037|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638038|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14638039|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
14638040|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638041|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638042|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14638043|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14638044|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14638045|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14638046|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14638047|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638048|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638049|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
14638050|NCT00169156|Hormones|hormones|mesh-ancestor
14638051|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14638052|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638053|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14638054|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
14638055|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
14638056|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
14638057|NCT00169169|Rituximab|rituximab|mesh-list
14638058|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14638059|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638060|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
14638061|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638062|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638063|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
14638064|NCT00169182|Niacin|niacin|mesh-list
14638065|NCT00169182|Docetaxel|docetaxel|mesh-list
14638066|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638067|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
14638068|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
14638069|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
14638070|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638071|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
14638072|NCT00169182|Vitamins|vitamins|mesh-ancestor
14638073|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
14638074|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638075|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14638076|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
14638077|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14638078|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638079|NCT00169195|Gemcitabine|gemcitabine|mesh-list
14638080|NCT00169195|Rituximab|rituximab|mesh-list
14638081|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
14638082|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14638083|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638084|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
14638085|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638086|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638087|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14638088|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
14638089|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638090|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
14638091|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638092|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638093|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638094|NCT00169208|Rituximab|rituximab|mesh-list
14638095|NCT00169208|Fludarabine|fludarabine|mesh-list
15171613|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171614|NCT04020588|Minocycline|minocycline|mesh-list
15171615|NCT04020588|Celecoxib|celecoxib|mesh-list
15171616|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15171617|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171618|NCT04020588|Analgesics|analgesics|mesh-ancestor
15171619|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
15171620|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171621|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171622|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171623|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171624|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15171625|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15171626|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171627|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171628|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14638096|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
14638097|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14638098|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171629|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638099|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
14638100|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638101|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638102|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638103|NCT00169208|Analgesics|analgesics|mesh-ancestor
14638104|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
14638105|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638106|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14638107|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14638108|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638109|NCT00169221|Gefitinib|gefitinib|mesh-list
14638110|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638111|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14638112|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638113|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638114|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14638115|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
15171630|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15171631|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15171632|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15171633|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
15171634|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15171635|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171636|NCT04020380|Azithromycin|azithromycin|mesh-list
14638116|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638117|NCT00169247|Cetuximab|cetuximab|mesh-list
14638118|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638119|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14638120|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14638121|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
14638122|NCT00169299|Estrogens|estrogens|mesh-list
14638123|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14638124|NCT00169299|Hormones|hormones|mesh-ancestor
14638125|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14638126|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638127|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14638128|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14638129|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14638130|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
14638131|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14638132|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14638133|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14638134|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14638135|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638136|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638137|NCT00169416|Valacyclovir|valacyclovir|mesh-list
14638138|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
14638139|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638140|NCT00169468|Rituximab|rituximab|mesh-list
15171637|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171638|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171639|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15171640|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171641|NCT04020445|Insulin|insulin|mesh-list
15171642|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15171643|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171644|NCT04020328|Prednisone|prednisone|mesh-list
15171645|NCT04020328|Leflunomide|leflunomide|mesh-list
15171646|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022570|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638141|NCT00169468|Bortezomib|bortezomib|mesh-list
14638142|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14638143|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638144|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
14638145|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638146|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647118|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647119|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647120|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14647121|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
14647122|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14647123|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647124|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
15171647|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
15171648|NCT04020328|Hormones|hormones|mesh-ancestor
15171649|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171650|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171651|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638147|NCT00169520|Docetaxel|docetaxel|mesh-list
14638148|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638149|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
14638150|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
14638151|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
14638152|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638153|NCT00169533|Lapatinib|lapatinib|mesh-list
14638154|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638155|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14638156|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638157|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638158|NCT00169546|Fluticasone|fluticasone|mesh-list
14638159|NCT00169546|Xhance|xhance|mesh-list
14638160|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14638161|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638162|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14638163|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
14638164|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638165|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638166|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14638167|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
14638168|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
14638169|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14638170|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14638171|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14638172|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15171652|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171653|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171654|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171655|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638173|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
14638174|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638175|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638176|NCT00169559|Fenofibrate|fenofibrate|mesh-list
14638177|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14638178|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
14638179|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638180|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14638181|NCT00169572|Dexamethasone|dexamethasone|mesh-list
14638182|NCT00169572|Ondansetron|ondansetron|mesh-list
14638183|NCT00169572|Aprepitant|aprepitant|mesh-list
14638184|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
14638185|NCT00169572|Casopitant|casopitant|mesh-list
14638186|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638187|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
14638188|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
14638189|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638190|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638191|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638192|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
14638193|NCT00169572|Hormones|hormones|mesh-ancestor
14638194|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14638195|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638196|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638197|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
14638198|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14638199|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14638200|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
15171656|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
15171657|NCT04020263|Simendan|simendan|mesh-list
15171658|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15171659|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
15171660|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15171661|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15171662|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171663|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171664|NCT04020263|Protective Agents|protective agents|mesh-ancestor
15171665|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022571|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
14638201|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14022572|NCT02767635|Hormones|hormones|mesh-ancestor
14638202|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638203|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14638204|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14638205|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14638206|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14638207|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14638208|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14638209|NCT00169585|Levofloxacin|levofloxacin|mesh-list
14638210|NCT00169585|Ofloxacin|ofloxacin|mesh-list
14638211|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14638212|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638213|NCT00169585|Renal Agents|renal agents|mesh-ancestor
14638214|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14638215|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14638216|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14638217|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171666|NCT04020094|Atezolizumab|atezolizumab|mesh-list
15171667|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171668|NCT04020016|Nalbuphine|nalbuphine|mesh-list
15171669|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15171670|NCT04020016|Narcotics|narcotics|mesh-ancestor
15171671|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171672|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171673|NCT04020016|Analgesics|analgesics|mesh-ancestor
15171674|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
15171675|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171676|NCT04020003|Simendan|simendan|mesh-list
15171677|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15171678|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638218|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638219|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638220|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14638221|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14638222|NCT00169611|Methylphenidate|methylphenidate|mesh-list
14638223|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14638224|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638225|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14638226|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14638227|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638228|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638229|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
14638230|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638231|NCT00169624|Metformin|metformin|mesh-list
14638232|NCT00169624|Gliclazide|gliclazide|mesh-list
14638233|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14638234|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638235|NCT00169728|Vaccines|vaccines|mesh-list
14638236|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14638237|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
14638238|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638239|NCT00169819|Abciximab|abciximab|mesh-list
14638240|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
14638241|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14638242|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
14638243|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14638244|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638245|NCT00169845|Tocopherols|tocopherols|mesh-list
14638246|NCT00169845|Vitamin E|vitamin e|mesh-list
14638247|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
14638248|NCT00169845|Beta Carotene|beta carotene|mesh-list
14638249|NCT00169845|Carotenoids|carotenoids|mesh-list
14638250|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
14638251|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638252|NCT00169845|Protective Agents|protective agents|mesh-ancestor
14638253|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638254|NCT00169845|Vitamins|vitamins|mesh-ancestor
14638255|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
14638256|NCT00169845|Provitamins|provitamins|mesh-ancestor
14638257|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
14638258|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14638259|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638260|NCT00169949|Aripiprazole|aripiprazole|mesh-list
14638261|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
14638262|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15171679|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14638263|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14638264|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14638265|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14638266|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638267|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
14638268|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
14638269|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638270|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638271|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14638272|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14638273|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
14638274|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14638275|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14638276|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14638277|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14638278|NCT00169988|Risperidone|risperidone|mesh-list
14638279|NCT00169988|Sertraline|sertraline|mesh-list
14638280|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14638281|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
14638282|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638283|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638284|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638285|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14638286|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14638287|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14638288|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14638289|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14638290|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
14638291|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
14638292|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14638293|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14638294|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638295|NCT00170001|Esomeprazole|esomeprazole|mesh-list
14638296|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14638297|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638298|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14638299|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638300|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638301|NCT00170053|Sirolimus|sirolimus|mesh-list
14638302|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14638303|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638304|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14638305|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638306|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
14638307|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638308|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
14638309|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638310|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14638311|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
14638312|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638313|NCT00170196|Prednisone|prednisone|mesh-list
14638314|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638315|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
14638316|NCT00170196|Hormones|hormones|mesh-ancestor
14638317|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14638318|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638319|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638320|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638321|NCT00170209|Rifampin|rifampin|mesh-list
14638322|NCT00170209|Isoniazid|isoniazid|mesh-list
14638323|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14638324|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
14638325|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14638326|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638327|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
14638328|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14638329|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638330|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638331|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14647125|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
15171680|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15171681|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171682|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171683|NCT04020003|Protective Agents|protective agents|mesh-ancestor
15171684|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171685|NCT04020133|Epinephrine|epinephrine|mesh-list
15171686|NCT04020133|Bupivacaine|bupivacaine|mesh-list
14638332|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14638333|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14638334|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14638335|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14638336|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14638337|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14638338|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14638339|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
14638340|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14638341|NCT00170222|Doxycycline|doxycycline|mesh-list
14638342|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14638343|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638344|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
14638345|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14638346|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14638347|NCT00170378|Enoxaparin|enoxaparin|mesh-list
14638348|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
14638349|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14638350|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14638351|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638352|NCT00170404|Vitamins|vitamins|mesh-list
14638353|NCT00170404|Folic Acid|folic acid|mesh-list
14638354|NCT00170404|Vitamin A|vitamin a|mesh-list
14638355|NCT00170404|Thiamine|thiamine|mesh-list
14638356|NCT00170404|Selenium|selenium|mesh-list
14638357|NCT00170404|Micronutrients|micronutrients|mesh-list
14638358|NCT00170404|Trace Elements|trace elements|mesh-list
14638359|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638360|NCT00170404|Hematinics|hematinics|mesh-ancestor
14638361|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
14638362|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
14638363|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638364|NCT00170404|Protective Agents|protective agents|mesh-ancestor
14638365|NCT00170430|Fluconazole|fluconazole|mesh-list
14638366|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
14638367|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638368|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14638369|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14638370|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638371|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638372|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14638373|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
14638374|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14638375|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638376|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14638377|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14638378|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14638379|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14638380|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
14638381|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638382|NCT00170456|Antacids|antacids|mesh-ancestor
14638383|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638384|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638385|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14638386|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14638387|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
14638388|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638389|NCT00170469|Antacids|antacids|mesh-ancestor
14638390|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638391|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638392|NCT00170547|Vaccines|vaccines|mesh-list
14638393|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
14638394|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638395|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14638396|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14638397|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638398|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14638399|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
14638400|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638401|NCT00170664|Paclitaxel|paclitaxel|mesh-list
14638402|NCT00170664|Carboplatin|carboplatin|mesh-list
14638403|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14638404|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638405|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
14638406|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
14638407|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
14638408|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638409|NCT00170677|Topotecan|topotecan|mesh-list
14638410|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14638411|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14638412|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638413|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638414|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638415|NCT00170690|Treosulfan|treosulfan|mesh-list
14638416|NCT00170690|Busulfan|busulfan|mesh-list
14638417|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14638418|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
14638419|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638420|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638421|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638422|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
14638423|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638424|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15171687|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
15171688|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
15171689|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171690|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171691|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
15171692|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171693|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15171694|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15171695|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
15171696|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171697|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638425|NCT00170729|Prednisolone|prednisolone|mesh-list
14638426|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14638427|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
14638428|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14638429|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
14638430|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14638431|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
14638432|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638433|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
14638434|NCT00170729|Hormones|hormones|mesh-ancestor
14638435|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14638436|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638437|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638438|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638439|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
14638440|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
14638441|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171698|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15171699|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15171700|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
15171701|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15171702|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
14638442|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638443|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14638444|NCT00170729|Protective Agents|protective agents|mesh-ancestor
14638445|NCT00170742|Octreotide|octreotide|mesh-list
14638446|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638447|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638448|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638449|NCT00170755|Darifenacin|darifenacin|mesh-list
14638450|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14638451|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14638452|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
14638453|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638454|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171703|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
15171704|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
15171705|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15171706|NCT04019782|Hylan|hylan|mesh-list
15171707|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
15171708|NCT04019782|Protective Agents|protective agents|mesh-ancestor
15171709|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171710|NCT04019496|Calcitonin|calcitonin|mesh-list
14638455|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638456|NCT00170755|Urological Agents|urological agents|mesh-ancestor
14638457|NCT00170768|Oxybutynin|oxybutynin|mesh-list
15171711|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
14638458|NCT00170768|Darifenacin|darifenacin|mesh-list
14638459|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
14638460|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
14638461|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638462|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638463|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14638464|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14638465|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
14638466|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638467|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171712|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15171713|NCT04019496|Antibodies|antibodies|mesh-list
15171714|NCT04019496|Katacalcin|katacalcin|mesh-list
15171715|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
15171716|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171717|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15171718|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15171719|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638468|NCT00170768|Urological Agents|urological agents|mesh-ancestor
14638469|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
14638470|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14638471|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638472|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638473|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638474|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638475|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638476|NCT00170781|Analgesics|analgesics|mesh-ancestor
14638477|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
14638478|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638479|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638480|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638481|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638482|NCT00170794|Everolimus|everolimus|mesh-list
14638483|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638484|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638485|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
14638486|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638487|NCT00170820|Everolimus|everolimus|mesh-list
14638488|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638489|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638490|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
14638491|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638492|NCT00170833|Everolimus|everolimus|mesh-list
15171720|NCT04019548|Cisplatin|cisplatin|mesh-list
15171721|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171722|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15171723|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
15171724|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171725|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
15171726|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171727|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171728|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15171729|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15171730|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171731|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171732|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171733|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
15171734|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15171735|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171736|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171737|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14638493|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638494|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638495|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
14638496|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638497|NCT00170859|Everolimus|everolimus|mesh-list
14638498|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638499|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638500|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
14638501|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171738|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15171739|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638502|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
14638503|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15171740|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638504|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638505|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638506|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638507|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638508|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638509|NCT00170872|Analgesics|analgesics|mesh-ancestor
14638510|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
14638511|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638512|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638513|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638514|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638515|NCT00170885|Everolimus|everolimus|mesh-list
14638516|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638517|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638518|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
14638519|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638520|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
14638521|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14638522|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638523|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638524|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638525|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638526|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638527|NCT00170898|Analgesics|analgesics|mesh-ancestor
14638528|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
14638529|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638530|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171741|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638531|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638532|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638533|NCT00170924|Valsartan|valsartan|mesh-list
14638534|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638535|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638536|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638537|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647126|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647127|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14647128|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647129|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
14647130|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647131|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647132|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647133|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647134|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647135|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647136|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647137|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647138|NCT00199108|Dexamethasone|dexamethasone|mesh-list
14647139|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647140|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
14647141|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
15171742|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15171743|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
15171744|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15171745|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171746|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15171747|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14647142|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647143|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647144|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647145|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
14647146|NCT00199108|Hormones|hormones|mesh-ancestor
14647147|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647148|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647149|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647150|NCT00199121|Zidovudine|zidovudine|mesh-list
14647151|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
14647152|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647153|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15171748|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15181276|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15181277|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
15181278|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638538|NCT00170937|Valsartan|valsartan|mesh-list
14638539|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14638540|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638541|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638542|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638543|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638544|NCT00170937|Diuretics|diuretics|mesh-ancestor
14638545|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
14638546|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638547|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14638548|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638549|NCT00170963|Amlodipine|amlodipine|mesh-list
14638550|NCT00170963|Valsartan|valsartan|mesh-list
14638551|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638552|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14638553|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638554|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638555|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14638556|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638557|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638558|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638559|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638560|NCT00170976|Amlodipine|amlodipine|mesh-list
14638561|NCT00170976|Valsartan|valsartan|mesh-list
14638562|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638563|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14638564|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638565|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638566|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14638567|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638568|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638569|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638570|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638571|NCT00170989|Valsartan|valsartan|mesh-list
14638572|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14638573|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638574|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638575|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638576|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638577|NCT00170989|Diuretics|diuretics|mesh-ancestor
14638578|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
14638579|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638580|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14638581|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638582|NCT00171002|Amlodipine|amlodipine|mesh-list
14638583|NCT00171002|Valsartan|valsartan|mesh-list
14638584|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638585|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14638586|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638587|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638588|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14638589|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638590|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638591|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638592|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638593|NCT00171015|Valsartan|valsartan|mesh-list
14638594|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15171749|NCT04018937|Fludarabine|fludarabine|mesh-list
15171750|NCT04018937|Melphalan|melphalan|mesh-list
15171751|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
14638595|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638596|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638597|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638598|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638599|NCT00171015|Diuretics|diuretics|mesh-ancestor
14638600|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
14638601|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638602|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14638603|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638604|NCT00171028|Valsartan|valsartan|mesh-list
15171752|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638605|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638606|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638607|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638608|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638609|NCT00171041|Valsartan|valsartan|mesh-list
14638610|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638611|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638612|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638613|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638614|NCT00171067|Valsartan|valsartan|mesh-list
14638615|NCT00171067|Lisinopril|lisinopril|mesh-list
14638616|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638617|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638618|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638619|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638620|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14638621|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
14638622|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638623|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14638624|NCT00171067|Protective Agents|protective agents|mesh-ancestor
14638625|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171753|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171754|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171755|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
15171756|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638626|NCT00171080|Valsartan|valsartan|mesh-list
14638627|NCT00171080|Irbesartan|irbesartan|mesh-list
14638628|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638629|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638630|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638631|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638632|NCT00171093|Valsartan|valsartan|mesh-list
14638633|NCT00171093|Simvastatin|simvastatin|mesh-list
14292013|NCT00557830|Sorafenib|sorafenib|mesh-list
14292014|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14292015|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14638634|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14638635|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14638636|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
14638637|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638638|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14638639|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14638640|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638641|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638642|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638643|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638644|NCT00171106|Valsartan|valsartan|mesh-list
14638645|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638646|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638647|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638648|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638649|NCT00171119|Valsartan|valsartan|mesh-list
14638650|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638651|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638652|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638653|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171757|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15171758|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
15171759|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15171760|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171761|NCT04019093|Ethanol|ethanol|mesh-list
15171762|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15171763|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171764|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171765|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171766|NCT04019106|Budesonide|budesonide|mesh-list
15171767|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15171768|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171769|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15171770|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
14638654|NCT00171132|Atenolol|atenolol|mesh-list
14638655|NCT00171132|Valsartan|valsartan|mesh-list
14638656|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14638657|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638658|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638659|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638660|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638661|NCT00171132|Diuretics|diuretics|mesh-ancestor
14638662|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
14638663|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638664|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14638665|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638666|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14638667|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
14638668|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
14638669|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638670|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14638671|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14638672|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14638673|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
14638674|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638675|NCT00171145|Darifenacin|darifenacin|mesh-list
14638676|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14638677|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14638678|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
14638679|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638680|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638681|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638682|NCT00171145|Urological Agents|urological agents|mesh-ancestor
14638683|NCT00171171|Deferasirox|deferasirox|mesh-list
14638684|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14638685|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
14638686|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
14638687|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638688|NCT00171184|Darifenacin|darifenacin|mesh-list
14638689|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14638690|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14638691|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
14638692|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638693|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638694|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638695|NCT00171184|Urological Agents|urological agents|mesh-ancestor
14638696|NCT00171288|Ezetimibe|ezetimibe|mesh-list
14638697|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14638698|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14638699|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
14638700|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638701|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14638702|NCT00171327|Valsartan|valsartan|mesh-list
14638703|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15171771|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171772|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171773|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15171774|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
15171775|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
15171776|NCT04019106|Hormones|hormones|mesh-ancestor
15171777|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171778|NCT04018833|Ranibizumab|ranibizumab|mesh-list
15171779|NCT04018833|Aflibercept|aflibercept|mesh-list
15171780|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15171781|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15171782|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15171783|NCT04018833|Growth Substances|growth substances|mesh-ancestor
15171784|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171785|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
15171786|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171787|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
15171788|NCT04018482|Povidone|povidone|mesh-list
15171789|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
15171790|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
15171791|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15171792|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171793|NCT04018703|Midazolam|midazolam|mesh-list
15171794|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
15171795|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15171796|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14638704|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638705|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638706|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638707|NCT00171353|Valsartan|valsartan|mesh-list
14638708|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638709|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638710|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638711|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638712|NCT00171366|Amlodipine|amlodipine|mesh-list
14638713|NCT00171366|Benazepril|benazepril|mesh-list
14638714|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638715|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14638716|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638717|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638718|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14638719|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638720|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638721|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14638722|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
14638723|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638724|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
14638725|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14638726|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638727|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14638728|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
14638729|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14638730|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638731|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638732|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638733|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
14638734|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14638735|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638736|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14638737|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
14638738|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14638739|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638740|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638741|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638742|NCT00171418|Tegaserod|tegaserod|mesh-list
15171797|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171798|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171799|NCT04018703|Analgesics|analgesics|mesh-ancestor
15171800|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
15171801|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638743|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14638744|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
14638745|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638746|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638747|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638748|NCT00171431|Tegaserod|tegaserod|mesh-list
14638749|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14638750|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
14638751|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638752|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638753|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638754|NCT00171457|Tegaserod|tegaserod|mesh-list
14638755|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14638756|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
14638757|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638758|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638759|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638760|NCT00171470|Tegaserod|tegaserod|mesh-list
14638761|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14638762|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
14638763|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638764|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638765|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638766|NCT00171483|Tegaserod|tegaserod|mesh-list
14638767|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14638768|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
14638769|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638770|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638771|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638772|NCT00171496|Cyclosporine|cyclosporine|mesh-list
14638773|NCT00171496|Tacrolimus|tacrolimus|mesh-list
14638774|NCT00171496|Cyclosporins|cyclosporins|mesh-list
14638775|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638776|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
14638777|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638778|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14638779|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638780|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638781|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
14638782|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638783|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14638784|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638785|NCT00171509|Cyclosporine|cyclosporine|mesh-list
14638786|NCT00171509|Cyclosporins|cyclosporins|mesh-list
14638787|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638788|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638789|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638790|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
14638791|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638792|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
14638793|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638794|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
14638795|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638796|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14638797|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14638798|NCT00171522|Tegaserod|tegaserod|mesh-list
14638799|NCT00171522|Laxatives|laxatives|mesh-ancestor
14638800|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638801|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14638802|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
14638803|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638804|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638805|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638806|NCT00171535|Amlodipine|amlodipine|mesh-list
14638807|NCT00171535|Valsartan|valsartan|mesh-list
14638808|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638809|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15171802|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14638810|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638811|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638812|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14638813|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638814|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
14638815|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638816|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638817|NCT00171561|Valsartan|valsartan|mesh-list
14638818|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14638819|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638820|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638821|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638822|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638823|NCT00171561|Diuretics|diuretics|mesh-ancestor
14638824|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
14638825|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638826|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14638827|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638828|NCT00171574|Valsartan|valsartan|mesh-list
14638829|NCT00171574|Lisinopril|lisinopril|mesh-list
14638830|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638831|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638832|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638833|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638834|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14638835|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
14638836|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638837|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14638838|NCT00171574|Protective Agents|protective agents|mesh-ancestor
14638839|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638840|NCT00171587|Vatalanib|vatalanib|mesh-list
14638841|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14638842|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638843|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638844|NCT00171600|Valsartan|valsartan|mesh-list
14638845|NCT00171600|Lisinopril|lisinopril|mesh-list
14638846|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638847|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638848|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638849|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638850|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14638851|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
14638852|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638853|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14638854|NCT00171600|Protective Agents|protective agents|mesh-ancestor
14638855|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638856|NCT00171613|Octreotide|octreotide|mesh-list
14638857|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14638858|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14638859|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638860|NCT00171626|Diclofenac|diclofenac|mesh-list
14638861|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638862|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638863|NCT00171626|Analgesics|analgesics|mesh-ancestor
14638864|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
14638865|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638866|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638867|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638868|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638869|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638870|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638871|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638872|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
14638873|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14638874|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638875|NCT00171652|Diclofenac|diclofenac|mesh-list
14638876|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638877|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638878|NCT00171652|Analgesics|analgesics|mesh-ancestor
14638879|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
14638880|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638881|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171803|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15171804|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15171805|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
15171806|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171807|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638882|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638883|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638884|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638885|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638886|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638887|NCT00171665|Diclofenac|diclofenac|mesh-list
14638888|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638889|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638890|NCT00171665|Analgesics|analgesics|mesh-ancestor
14638891|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
15171808|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14638892|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638893|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638894|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638895|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638896|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638897|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638898|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638899|NCT00171678|Diclofenac|diclofenac|mesh-list
14638900|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638901|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638902|NCT00171678|Analgesics|analgesics|mesh-ancestor
14638903|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
14638904|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638905|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638906|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638907|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638908|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638909|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638910|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638911|NCT00171691|Diclofenac|diclofenac|mesh-list
14638912|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14638913|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14638914|NCT00171691|Analgesics|analgesics|mesh-ancestor
14638915|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
14638916|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638917|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638918|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14638919|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638920|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14638921|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638922|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638923|NCT00171717|Cyclosporine|cyclosporine|mesh-list
14638924|NCT00171717|Cyclosporins|cyclosporins|mesh-list
14638925|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638926|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638927|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638928|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
14638929|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638930|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
14638931|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638932|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14638933|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638934|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14638935|NCT00171743|Cyclosporine|cyclosporine|mesh-list
14638936|NCT00171743|Cyclosporins|cyclosporins|mesh-list
14638937|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638938|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638939|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14638940|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
14638941|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638942|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
14638943|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14638944|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
14638945|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14638946|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14638947|NCT00171756|Atenolol|atenolol|mesh-list
14638948|NCT00171756|Valsartan|valsartan|mesh-list
14638949|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638950|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638951|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638952|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638953|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14638954|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
14638955|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
14638956|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14638957|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638958|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14638959|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14638960|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14638961|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
14638962|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638963|NCT00171769|Certoparin|certoparin|mesh-list
14638964|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
14638965|NCT00171782|Valsartan|valsartan|mesh-list
14638966|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14638967|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14638968|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14638969|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14638970|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638971|NCT00171782|Diuretics|diuretics|mesh-ancestor
14638972|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
14638973|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638974|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14638975|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14638976|NCT00171795|Rivastigmine|rivastigmine|mesh-list
14638977|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14638978|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638979|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638980|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
14638981|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14638982|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638983|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14638984|NCT00171795|Protective Agents|protective agents|mesh-ancestor
14638985|NCT00171808|Letrozole|letrozole|mesh-list
14638986|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14638987|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14638988|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14638989|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14638990|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14638991|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14638992|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
14638993|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14638994|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14638995|NCT00171821|Deferasirox|deferasirox|mesh-list
14638996|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14638997|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
14638998|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
14638999|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639000|NCT00171847|Trastuzumab|trastuzumab|mesh-list
14639001|NCT00171847|Letrozole|letrozole|mesh-list
14639002|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14639003|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639004|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14639005|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14639006|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639007|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639008|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14639009|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
14639010|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639011|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639012|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
14639013|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639014|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14639015|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639016|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639017|NCT00171886|Octreotide|octreotide|mesh-list
14639018|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639019|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14639020|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639021|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
14639022|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639023|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14639024|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639025|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639026|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
14639027|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639028|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14639029|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171809|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14639030|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639031|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
14639032|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639033|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14639034|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639035|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639036|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
14639037|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14639038|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639039|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
14639040|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639041|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14639042|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639043|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639044|NCT00171990|Famciclovir|famciclovir|mesh-list
14639045|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
14639046|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639047|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14639048|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639049|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639050|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
14639051|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14639052|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639053|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
14639054|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14639055|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639056|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
14639057|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14639058|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639059|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
14639060|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14639061|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639062|NCT00172068|Vitamin D|vitamin d|mesh-list
14639063|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
14639064|NCT00172068|Calcium|calcium|mesh-list
14639065|NCT00172068|Vitamins|vitamins|mesh-ancestor
14639066|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
14639067|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639068|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14639069|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14639070|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
14639071|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14639072|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639073|NCT00172172|Calcium|calcium|mesh-list
14639074|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
14639075|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14639076|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639077|NCT00172302|Ascorbic Acid|ascorbic acid|mesh-list
14639078|NCT00172302|Vitamins|vitamins|mesh-ancestor
14639079|NCT00172302|Micronutrients|micronutrients|mesh-ancestor
14639080|NCT00172302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639081|NCT00172302|Antioxidants|antioxidants|mesh-ancestor
14639082|NCT00172302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639083|NCT00172302|Protective Agents|protective agents|mesh-ancestor
14639084|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
14639085|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171810|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15171811|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15171812|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15171813|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
15171814|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
14639086|NCT00172367|Lycopene|lycopene|mesh-list
14639087|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639088|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
14639089|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639090|NCT00172367|Protective Agents|protective agents|mesh-ancestor
14639091|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639092|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15171815|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
15171816|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
15171817|NCT04018690|Triamcinolone|triamcinolone|mesh-list
15171818|NCT04018690|Ropivacaine|ropivacaine|mesh-list
15171819|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
15171820|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
15171821|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171822|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171823|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
15171824|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171825|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171826|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
15171827|NCT04018690|Hormones|hormones|mesh-ancestor
15171828|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171829|NCT04018417|Amphotericin B|amphotericin b|mesh-list
15171830|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15171831|NCT04018417|Amebicides|amebicides|mesh-ancestor
15171832|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15171833|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15171834|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171835|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171836|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
15171837|NCT04018365|Empagliflozin|empagliflozin|mesh-list
15171838|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15171839|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639093|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15171840|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14639094|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639095|NCT00172380|Docetaxel|docetaxel|mesh-list
15171841|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171842|NCT04018768|Acetaminophen|acetaminophen|mesh-list
14639096|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639097|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639098|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639099|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639100|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639101|NCT00172419|Atorvastatin|atorvastatin|mesh-list
14639102|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14639103|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14639104|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
14639105|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639106|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14639107|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14639108|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647154|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647155|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647156|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
14647157|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647158|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14647159|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14647160|NCT00199134|Letrozole|letrozole|mesh-list
14647161|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647162|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14647163|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14647164|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647165|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647166|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14647167|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
14647168|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647169|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647170|NCT00199147|Cytarabine|cytarabine|mesh-list
14647171|NCT00199147|Fludarabine|fludarabine|mesh-list
14647172|NCT00199147|Etoposide|etoposide|mesh-list
14647173|NCT00199147|Idarubicin|idarubicin|mesh-list
14647174|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647175|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647176|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
15171843|NCT04018768|Ibuprofen|ibuprofen|mesh-list
15171844|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15171845|NCT04018768|Oxycodone|oxycodone|mesh-list
15171846|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171847|NCT04018768|Analgesics|analgesics|mesh-ancestor
15171848|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
15171849|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171850|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647177|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647178|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647179|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
14647180|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647181|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647182|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647183|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647184|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647185|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
14647186|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647187|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647188|NCT00199160|Sorafenib|sorafenib|mesh-list
14647189|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647190|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14647191|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647192|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647193|NCT00199186|Cytarabine|cytarabine|mesh-list
14647194|NCT00199186|Dexamethasone|dexamethasone|mesh-list
14647195|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
14647196|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
14647197|NCT00199186|Methotrexate|methotrexate|mesh-list
14647198|NCT00199186|Vincristine|vincristine|mesh-list
14647199|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
14647200|NCT00199186|Idarubicin|idarubicin|mesh-list
14647201|NCT00199186|BB 1101|bb 1101|mesh-list
15171851|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
15171852|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14647202|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647203|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
15171853|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647204|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647205|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171854|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171855|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15171856|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639109|NCT00172809|Interferons|interferons|mesh-list
14639110|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
14639111|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
14639112|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14639113|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639114|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
14639115|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639116|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
14639117|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639118|NCT00173667|Nifedipine|nifedipine|mesh-list
14639119|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14639120|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639121|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639122|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14639123|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639124|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639125|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
14639126|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14639127|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
14639128|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14639129|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14639130|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14639131|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639132|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639133|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
14639134|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639135|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639136|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14639137|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647206|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14647207|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
14647208|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647209|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647210|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14647211|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647212|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
14647213|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
14647214|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647215|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647216|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
14647217|NCT00199186|Hormones|hormones|mesh-ancestor
14647218|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647219|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647220|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
14647221|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647222|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14647223|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
14647224|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14647225|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647226|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
14647227|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
14647228|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14647229|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647230|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647231|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647232|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647233|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647234|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
14647235|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647236|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14647237|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647238|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647239|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647240|NCT00199212|Trastuzumab|trastuzumab|mesh-list
14647241|NCT00199212|Bortezomib|bortezomib|mesh-list
14647242|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14647243|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647244|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
14647245|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14647246|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171857|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639138|NCT00173862|Gemcitabine|gemcitabine|mesh-list
14639139|NCT00173862|Ifosfamide|ifosfamide|mesh-list
14639140|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14639141|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
14639142|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639143|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639144|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
14639145|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639146|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639147|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14639148|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
14639149|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639150|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14639151|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
14639152|NCT00173875|Gefitinib|gefitinib|mesh-list
14639153|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639154|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14639155|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639156|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639157|NCT00173888|Gemcitabine|gemcitabine|mesh-list
14639158|NCT00173888|Cisplatin|cisplatin|mesh-list
14639159|NCT00173888|Docetaxel|docetaxel|mesh-list
14639160|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639161|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14639162|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
14639163|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639164|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
14639165|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639166|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639167|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14639168|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
14639169|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639170|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639171|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639172|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639173|NCT00173901|Ceftazidime|ceftazidime|mesh-list
14639174|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14639175|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639176|NCT00174174|Modafinil|modafinil|mesh-list
14639177|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14639178|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639179|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14639180|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14639181|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14639182|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639183|NCT00174200|Risperidone|risperidone|mesh-list
14639184|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14639185|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
14639186|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639187|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639188|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639189|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14639190|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639191|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639192|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639193|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14639194|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
14639195|NCT00174226|Buspirone|buspirone|mesh-list
14639196|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14639197|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14639198|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14639199|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639200|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639201|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
14639202|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639203|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639204|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14639205|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639206|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639207|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639208|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14639209|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
14639210|NCT00174239|Levodopa|levodopa|mesh-list
14639211|NCT00174239|Carbidopa|carbidopa|mesh-list
14639212|NCT00174239|Cabergoline|cabergoline|mesh-list
14639213|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14639214|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14639215|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
14639216|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639217|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639218|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639219|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14639220|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639221|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
14639222|NCT00174304|Amlodipine|amlodipine|mesh-list
14639223|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
14639224|NCT00174304|Atorvastatin|atorvastatin|mesh-list
14639225|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14639226|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14639227|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
14639228|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639229|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14639230|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14022573|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022574|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022575|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
14022576|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022577|NCT02767596|Lixisenatide|lixisenatide|mesh-list
14022578|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14292016|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14292017|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292018|NCT00558012|Vitamin D|vitamin d|mesh-list
14292019|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
15171858|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15171859|NCT04018768|Narcotics|narcotics|mesh-ancestor
14292020|NCT00558012|Calcium|calcium|mesh-list
14292021|NCT00558012|Vitamins|vitamins|mesh-ancestor
14292022|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
14292023|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292024|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14639231|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639232|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14639233|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14639234|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639235|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14639236|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639237|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639238|NCT00174317|Celecoxib|celecoxib|mesh-list
14639239|NCT00174317|Diclofenac|diclofenac|mesh-list
14639240|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14639241|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14639242|NCT00174317|Analgesics|analgesics|mesh-ancestor
15171860|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171861|NCT04018378|Varenicline|varenicline|mesh-list
15171862|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15171863|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15171864|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
15171865|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171866|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171867|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171868|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
15171869|NCT04018157|Ketamine|ketamine|mesh-list
15171870|NCT04018157|Propofol|propofol|mesh-list
15171871|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15171872|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171873|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171874|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15171875|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
15171876|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
15171877|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171878|NCT04018157|Analgesics|analgesics|mesh-ancestor
15171879|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
15171880|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171881|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15171882|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15171883|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15171884|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14639243|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
15171885|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639244|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639245|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639246|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639247|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639248|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14639249|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14639250|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639251|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639252|NCT00174330|Amlodipine|amlodipine|mesh-list
14639253|NCT00174330|Atorvastatin|atorvastatin|mesh-list
14639254|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15171886|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171887|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15171888|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15171889|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15171890|NCT04018313|Omalizumab|omalizumab|mesh-list
14639255|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14639256|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
14639257|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639258|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14639259|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14639260|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639261|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14639262|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14639263|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639264|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14639265|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639266|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639267|NCT00174343|Exemestane|exemestane|mesh-list
14639268|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639269|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14639270|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14639271|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639272|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639273|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14639274|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
14639275|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639276|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639277|NCT00174356|Paclitaxel|paclitaxel|mesh-list
14639278|NCT00174356|Carboplatin|carboplatin|mesh-list
14639279|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14639280|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639281|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639282|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639283|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639284|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639285|NCT00174395|Eletriptan|eletriptan|mesh-list
14639286|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14639287|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
14639288|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639289|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639290|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639291|NCT00174434|Paclitaxel|paclitaxel|mesh-list
14639292|NCT00174434|Sunitinib|sunitinib|mesh-list
14639293|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14639294|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639295|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639296|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639297|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639298|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639299|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14639300|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14639301|NCT00174434|Growth Substances|growth substances|mesh-ancestor
14639302|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171891|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15171892|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15171893|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15171894|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
15171895|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
15171896|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171897|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
15171898|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15171899|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
14639303|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
14639304|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14639305|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639306|NCT00174473|Voriconazole|voriconazole|mesh-list
14639307|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
14639308|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639309|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14639310|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14639311|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639312|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639313|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14639314|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
14639315|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639316|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639317|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14639318|NCT00174486|Tadalafil|tadalafil|mesh-list
14639319|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
15171900|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
15171901|NCT04018274|Estradiol|estradiol|mesh-list
15171902|NCT04018274|Estrogens|estrogens|mesh-ancestor
15171903|NCT04018274|Hormones|hormones|mesh-ancestor
15171904|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171905|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171906|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15171907|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15171908|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15171909|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15171910|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15171911|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
15171912|NCT04017897|Nivolumab|nivolumab|mesh-list
15171913|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15171914|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171915|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14639320|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14639321|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14639322|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639323|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639324|NCT00174486|Urological Agents|urological agents|mesh-ancestor
14639325|NCT00174499|Nicotine|nicotine|mesh-list
14639326|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14639327|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
14639328|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639329|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639330|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14639331|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14639332|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14639333|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171916|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171917|NCT04018105|Metformin|metformin|mesh-list
15171918|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15171919|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171920|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
15171921|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15171922|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15171923|NCT04017741|Prednisolone|prednisolone|mesh-list
14022579|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022580|NCT02767752|Gemcitabine|gemcitabine|mesh-list
14022581|NCT02767752|Capecitabine|capecitabine|mesh-list
14022582|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022583|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
14022584|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022585|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022586|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
14022587|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022588|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022589|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022590|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
14022591|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639334|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639335|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
14639336|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171924|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
15171925|NCT04017741|Lidocaine|lidocaine|mesh-list
14022592|NCT02767882|Dexamethasone|dexamethasone|mesh-list
14639337|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639338|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14639339|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14639340|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639341|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639342|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639343|NCT00174538|Codeine|codeine|mesh-list
14639344|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14639345|NCT00174538|Narcotics|narcotics|mesh-ancestor
14639346|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639347|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639348|NCT00174538|Analgesics|analgesics|mesh-ancestor
14639349|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
14639350|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639351|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
14639352|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
14639353|NCT00174551|Prazosin|prazosin|mesh-list
14639354|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14639355|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14639356|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14639357|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14639358|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
14639359|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639360|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639361|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639362|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
14639363|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639364|NCT00174577|Risperidone|risperidone|mesh-list
14639365|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15171926|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15171927|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
15171928|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
15171929|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
15171930|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171931|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171932|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
15171933|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171934|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14639366|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
14639367|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639368|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639369|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639370|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14639371|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639372|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639373|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639374|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14639375|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
14639376|NCT00174590|Risperidone|risperidone|mesh-list
14639377|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14639378|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
14639379|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639380|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639381|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639382|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14639383|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639384|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639385|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639386|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14639387|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
14639388|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14639389|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
14639390|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639391|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14639392|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639393|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639394|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639395|NCT00174616|Capecitabine|capecitabine|mesh-list
14639396|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
14639397|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14639398|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
14639399|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639400|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639401|NCT00174629|Gemcitabine|gemcitabine|mesh-list
14639402|NCT00174629|Docetaxel|docetaxel|mesh-list
14639403|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14639404|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
14639405|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639406|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639407|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
14639408|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639409|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639410|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14639411|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
14639412|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639413|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639414|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639415|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639416|NCT00174642|Insulin|insulin|mesh-list
14639417|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14639418|NCT00174642|Metformin|metformin|mesh-list
14639419|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
14639420|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
14639421|NCT00174642|Secretagogues|secretagogues|mesh-list
14639422|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14639423|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639424|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
14639425|NCT00174655|Docetaxel|docetaxel|mesh-list
14639426|NCT00174655|Doxorubicin|doxorubicin|mesh-list
14639427|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14639428|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14639429|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
14639430|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639431|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639432|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14639433|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
14639434|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639435|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639436|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14639437|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639438|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639439|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639440|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14639441|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14639442|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14639443|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639444|NCT00174668|Insulin|insulin|mesh-list
14639445|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14639446|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
14639447|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
14639448|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14639449|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639450|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
14639451|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14639452|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639453|NCT00174694|Telithromycin|telithromycin|mesh-list
14639454|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15171935|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15171936|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15171937|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15171938|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171939|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171940|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
15171941|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
15171942|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171943|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
15171944|NCT04017741|Hormones|hormones|mesh-ancestor
15171945|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15171946|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15171947|NCT04017741|Protective Agents|protective agents|mesh-ancestor
15171948|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15171949|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15171950|NCT04018131|Cimetidine|cimetidine|mesh-list
15171951|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15171952|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171953|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15171954|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
14639455|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639456|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
14639457|NCT00174707|Docetaxel|docetaxel|mesh-list
14639458|NCT00174707|Methotrexate|methotrexate|mesh-list
14639459|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15171955|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
15171956|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15171957|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171958|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171959|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15171960|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15171961|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15171962|NCT04017845|Tribenoside|tribenoside|mesh-list
15171963|NCT04017845|Lidocaine|lidocaine|mesh-list
15171964|NCT04017845|Diltiazem|diltiazem|mesh-list
15171965|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
15171966|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
15171967|NCT04017845|Bisacodyl|bisacodyl|mesh-list
15171968|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
15171969|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
15171970|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171971|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171972|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
15171973|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15171974|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15171975|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14639460|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
14639461|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639462|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639463|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14639464|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
14639465|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639466|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639467|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14022593|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022594|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
14639468|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
15171976|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15171977|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15171978|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15171979|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15171980|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639469|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639470|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639471|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14639472|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
14639473|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14639474|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14639475|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
14639476|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14639477|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639478|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14639479|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14639480|NCT00174720|Ciclesonide|ciclesonide|mesh-list
14639481|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
14639482|NCT00174720|Hormones|hormones|mesh-ancestor
14639483|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639484|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171981|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15171982|NCT04017845|Cathartics|cathartics|mesh-ancestor
15171983|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15171984|NCT04017845|Laxatives|laxatives|mesh-ancestor
14639485|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14639486|NCT00174733|Ciclesonide|ciclesonide|mesh-list
14639487|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
14639488|NCT00174733|Hormones|hormones|mesh-ancestor
14639489|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639490|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639491|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14639492|NCT00174759|Clopidogrel|clopidogrel|mesh-list
14639493|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14639494|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14639495|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14639496|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14639497|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
14639498|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639499|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022595|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
14639500|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639501|NCT00174772|Cisplatin|cisplatin|mesh-list
14639502|NCT00174772|Docetaxel|docetaxel|mesh-list
14639503|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639504|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639505|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639506|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639507|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639508|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14639509|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14639510|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14639511|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
14639512|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639513|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639514|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171985|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15171986|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15171987|NCT04017845|Analgesics|analgesics|mesh-ancestor
15171988|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15171989|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15171990|NCT04017988|Ethanol|ethanol|mesh-list
15171991|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15171992|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15171993|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15171994|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15171995|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15171996|NCT04017650|Nivolumab|nivolumab|mesh-list
15171997|NCT04017650|Cetuximab|cetuximab|mesh-list
15171998|NCT04017650|Antibodies|antibodies|mesh-list
15171999|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
14639515|NCT00174798|Urological Agents|urological agents|mesh-ancestor
14639516|NCT00174811|Telithromycin|telithromycin|mesh-list
14639517|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14639518|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639519|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
14639520|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14639521|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639522|NCT00174863|SR 31747|sr 31747|mesh-list
14639523|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639524|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639525|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14639526|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
14639527|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639528|NCT00174876|Aripiprazole|aripiprazole|mesh-list
14639529|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
14639530|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639531|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15172000|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15172001|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
14292025|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14292026|NCT00558025|Pramipexole|pramipexole|mesh-list
14292027|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
14292028|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292029|NCT00558025|Protective Agents|protective agents|mesh-ancestor
14292030|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14292031|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14292032|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14292033|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
14292034|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
14292035|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172002|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172003|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172004|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15172005|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172006|NCT04017624|Nicotine|nicotine|mesh-list
15172007|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15172008|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
15172009|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172010|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172011|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15172012|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15172013|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
15172014|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14292036|NCT00558064|Amlodipine|amlodipine|mesh-list
14639532|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639533|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639534|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639535|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
14639536|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
14639537|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639538|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639539|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14639540|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14639541|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
14639542|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14639543|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14639544|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14639545|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14639546|NCT00174902|Aspirin|aspirin|mesh-list
14639547|NCT00174902|Propranolol|propranolol|mesh-list
14639548|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14639549|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14639550|NCT00174902|Analgesics|analgesics|mesh-ancestor
14639551|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
14639552|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639553|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639554|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639555|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639556|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14639557|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14639558|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639559|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14639560|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14639561|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639562|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
14639563|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14639564|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14639565|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
14639566|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639567|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14639568|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14639569|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639570|NCT00174928|Lansoprazole|lansoprazole|mesh-list
14639571|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
14639572|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14639573|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639574|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14639575|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639576|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639577|NCT00174993|Pioglitazone|pioglitazone|mesh-list
14639578|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14639579|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639580|NCT00175032|Aspirin|aspirin|mesh-list
14639581|NCT00175032|Celecoxib|celecoxib|mesh-list
14639582|NCT00175032|Naproxen|naproxen|mesh-list
14639583|NCT00175032|Lansoprazole|lansoprazole|mesh-list
14639584|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
14639585|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14639586|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14639587|NCT00175032|Analgesics|analgesics|mesh-ancestor
14639588|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
14639589|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639590|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639591|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639592|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639593|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14639594|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14639595|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639596|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14639597|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14639598|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639599|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
14639600|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14639601|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
14639602|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14639603|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639604|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14639605|NCT00175045|Lansoprazole|lansoprazole|mesh-list
14639606|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
14639607|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14639608|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639609|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14639610|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639611|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639612|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14639613|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14639614|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14639615|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639616|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639617|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14639618|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639619|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639620|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
14639621|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639622|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14639623|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639624|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14639625|NCT00175162|Protective Agents|protective agents|mesh-ancestor
14639626|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639627|NCT00175227|Furosemide|furosemide|mesh-list
14639628|NCT00175227|Mannitol|mannitol|mesh-list
14639629|NCT00175227|Diuretics|diuretics|mesh-ancestor
14639630|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
14639631|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639632|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14639633|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639634|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639635|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15172015|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172016|NCT04017377|Paclitaxel|paclitaxel|mesh-list
15172017|NCT04017377|Cisplatin|cisplatin|mesh-list
15172018|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15172019|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172020|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
15172021|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
15172022|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
15172023|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172024|NCT04017598|Iron|iron|mesh-list
15172025|NCT04017598|Trace Elements|trace elements|mesh-ancestor
15172026|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
15172027|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172028|NCT04017455|Bevacizumab|bevacizumab|mesh-list
15172029|NCT04017455|Atezolizumab|atezolizumab|mesh-list
14639636|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
14639637|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14639638|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647247|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647248|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647249|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647250|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647251|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647252|NCT00199264|Albaconazole|albaconazole|mesh-list
14647253|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
14647254|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647255|NCT00199277|Iron|iron|mesh-list
14647256|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14647257|NCT00199277|Trace Elements|trace elements|mesh-ancestor
14647258|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
14647259|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647260|NCT00199277|Hematinics|hematinics|mesh-ancestor
14647261|NCT00199316|Morphine|morphine|mesh-list
14647262|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14647263|NCT00199316|Narcotics|narcotics|mesh-ancestor
14647264|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647265|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647266|NCT00199316|Analgesics|analgesics|mesh-ancestor
14647267|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
14647268|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647269|NCT00199329|Ondansetron|ondansetron|mesh-list
14647270|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
14647271|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
14647272|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647273|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647274|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15172030|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14647275|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
14647276|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
15172031|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639639|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
14639640|NCT00175266|Infliximab|infliximab|mesh-list
14639641|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
14639642|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639643|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639644|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14639645|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639646|NCT00175305|Octreotide|octreotide|mesh-list
14639647|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639648|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14639649|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639650|NCT00175357|Methadone|methadone|mesh-list
14639651|NCT00175357|Heroin|heroin|mesh-list
14639652|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14639653|NCT00175357|Narcotics|narcotics|mesh-ancestor
14639654|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639655|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639656|NCT00175357|Analgesics|analgesics|mesh-ancestor
14639657|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
14639658|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639659|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
14639660|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14639661|NCT00175370|Vancomycin|vancomycin|mesh-list
14639662|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14639663|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639664|NCT00175383|Hormones|hormones|mesh-list
14639665|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14639666|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639667|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639668|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
14639669|NCT00175396|Leuprolide|leuprolide|mesh-list
14639670|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
14639671|NCT00175396|Flutamide|flutamide|mesh-list
14639672|NCT00175396|Bicalutamide|bicalutamide|mesh-list
14639673|NCT00175396|Nilutamide|nilutamide|mesh-list
14639674|NCT00175396|Buserelin|buserelin|mesh-list
14639675|NCT00175396|Androgens|androgens|mesh-list
14639676|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14639677|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14639678|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
14639679|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14639680|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639681|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14639682|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172032|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15172033|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15172034|NCT04017455|Growth Substances|growth substances|mesh-ancestor
15172035|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172036|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
15181279|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181280|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15181281|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15181282|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
15181283|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15181284|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
15181285|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
14639683|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
14639684|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
14639685|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639686|NCT00175396|Hormones|hormones|mesh-ancestor
14639687|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
14639688|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639689|NCT00175396|Protective Agents|protective agents|mesh-ancestor
14639690|NCT00175396|Vitamins|vitamins|mesh-ancestor
14639691|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
14639692|NCT00175396|Estrogens|estrogens|mesh-ancestor
14639693|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
14639694|NCT00175435|Vaccines|vaccines|mesh-list
14639695|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
14639696|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639697|NCT00175513|Valacyclovir|valacyclovir|mesh-list
14639698|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
14639699|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15181286|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
14639700|NCT00175565|Fluticasone|fluticasone|mesh-list
14639701|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639702|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14639703|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
14639704|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172037|NCT04017338|Ezetimibe|ezetimibe|mesh-list
15172038|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15172039|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15172040|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
15172041|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172042|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15172043|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15172044|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
15172045|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172046|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172047|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14639705|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639706|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14639707|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
14639708|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14639709|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14639710|NCT00175591|Bupivacaine|bupivacaine|mesh-list
14639711|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
14639712|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
14639713|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639714|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639715|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
14639716|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639717|NCT00175617|Minoxidil|minoxidil|mesh-list
14639718|NCT00175617|Spironolactone|spironolactone|mesh-list
14639719|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14639720|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
14639721|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639722|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639723|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14639724|NCT00175617|Diuretics|diuretics|mesh-ancestor
14639725|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
14639726|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14639727|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
15172048|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172049|NCT04017013|Lidocaine|lidocaine|mesh-list
15172050|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
15172051|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
14639728|NCT00175630|Bupivacaine|bupivacaine|mesh-list
14639729|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
14639730|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
14639731|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639732|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639733|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
14639734|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639735|NCT00175643|Imiquimod|imiquimod|mesh-list
14639736|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14639737|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
14639738|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639739|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639740|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
14639741|NCT00175682|Prazosin|prazosin|mesh-list
14639742|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14639743|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14639744|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14639745|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14639746|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
14639747|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639748|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639749|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639750|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14639751|NCT00175695|Protein C|protein c|mesh-list
14639752|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
14639753|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14639754|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14639755|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172052|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172053|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172054|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
15172055|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172056|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15172057|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14639756|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639757|NCT00175747|Budesonide|budesonide|mesh-list
14639758|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639759|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14639760|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
14639761|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639762|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639763|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14639764|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
14639765|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
14639766|NCT00175747|Hormones|hormones|mesh-ancestor
14639767|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639768|NCT00175812|Tretinoin|tretinoin|mesh-list
14639769|NCT00175812|Theophylline|theophylline|mesh-list
14639770|NCT00175812|Valproic Acid|valproic acid|mesh-list
14639771|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639772|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
14639773|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
14639774|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
14639775|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639776|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639777|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
14639778|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639779|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639780|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
14639781|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639782|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639783|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639784|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14639785|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
14639786|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639787|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14639788|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14639789|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14639790|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639791|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14639792|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14639793|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
14639794|NCT00175838|Aspirin|aspirin|mesh-list
14639795|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
14639796|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14639797|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14639798|NCT00175838|Analgesics|analgesics|mesh-ancestor
14639799|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
14639800|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639801|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639802|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639803|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639804|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14639805|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14639806|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172058|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15172059|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639807|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14639808|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14639809|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639810|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
14639811|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639812|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
14639813|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14639814|NCT00175890|Levetiracetam|levetiracetam|mesh-list
14639815|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
14639816|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
14639817|NCT00175903|Carbamazepine|carbamazepine|mesh-list
14639818|NCT00175903|Levetiracetam|levetiracetam|mesh-list
15172060|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172061|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15172062|NCT04016922|Hematinics|hematinics|mesh-ancestor
15172063|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15172064|NCT04017104|Edotreotide|edotreotide|mesh-list
15172065|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15172066|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172067|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
15172068|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15172069|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14639819|NCT00175903|Valproic Acid|valproic acid|mesh-list
14639820|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
14639821|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
14639822|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639823|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172070|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15172071|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
15172072|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15172073|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172074|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15172075|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15172076|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
15172077|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15172078|NCT04016389|Paclitaxel|paclitaxel|mesh-list
15172079|NCT04016389|Carboplatin|carboplatin|mesh-list
15172080|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15172081|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172082|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
14022596|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022597|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022598|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14022599|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
14022600|NCT02767882|Hormones|hormones|mesh-ancestor
14022601|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022602|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14022603|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022604|NCT02767713|Dexamethasone|dexamethasone|mesh-list
14022605|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639824|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
15172083|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
15172084|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
15172085|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172086|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
15172087|NCT04016740|Ketamine|ketamine|mesh-list
15172088|NCT04016740|Remifentanil|remifentanil|mesh-list
15172089|NCT04016740|Propofol|propofol|mesh-list
15172090|NCT04016740|Ropivacaine|ropivacaine|mesh-list
15172091|NCT04016740|Sevoflurane|sevoflurane|mesh-list
15172092|NCT04016740|Rocuronium|rocuronium|mesh-list
14639825|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172093|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15172094|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172095|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172096|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15172097|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
15172098|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
15172099|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172100|NCT04016740|Analgesics|analgesics|mesh-ancestor
15172101|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
15172102|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639826|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639827|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
14639828|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639829|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639830|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639831|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14639832|NCT00175903|Analgesics|analgesics|mesh-ancestor
14639833|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
14639834|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639835|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14639836|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639837|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14639838|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14639839|NCT00175929|Brivaracetam|brivaracetam|mesh-list
14639840|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
14639841|NCT00175955|Levetiracetam|levetiracetam|mesh-list
14639842|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
14639843|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
14639844|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
14639845|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
14639846|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639847|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14639848|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15172103|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15172104|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14639849|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639850|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172105|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14639851|NCT00175981|Urological Agents|urological agents|mesh-ancestor
14639852|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14639853|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14639854|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639855|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639856|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639857|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15172106|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
15172107|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172108|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022606|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
14639858|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14639859|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639860|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639861|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
14639862|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14639863|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
14639864|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14639865|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14639866|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14639867|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
14639868|NCT00176020|Niacin|niacin|mesh-list
14639869|NCT00176020|Niacinamide|niacinamide|mesh-list
14639870|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
14639871|NCT00176020|Vitamins|vitamins|mesh-ancestor
14639872|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
14639873|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639874|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14639875|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
14639876|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639877|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14639878|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
14639879|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
14639880|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639881|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14639882|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15172109|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15172110|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15172111|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15172112|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
15172113|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15172114|NCT04016740|Narcotics|narcotics|mesh-ancestor
15172115|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15172116|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15172117|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14639883|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
14639884|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639885|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
14639886|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14639887|NCT00176059|Antibodies|antibodies|mesh-list
14639888|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
14639889|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14639890|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
14639891|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639892|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14639893|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14639894|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639895|NCT00176241|Gemcitabine|gemcitabine|mesh-list
14639896|NCT00176241|Paclitaxel|paclitaxel|mesh-list
14639897|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14022607|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
14022608|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14022609|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022610|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639898|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639899|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639900|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639901|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639902|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639903|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14639904|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
14639905|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
14639906|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639907|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022611|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
14639908|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14639909|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
14639910|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639911|NCT00176267|Paclitaxel|paclitaxel|mesh-list
14639912|NCT00176267|Carboplatin|carboplatin|mesh-list
14639913|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14639914|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639915|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639916|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639917|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639918|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639919|NCT00176280|Dexamethasone|dexamethasone|mesh-list
14639920|NCT00176280|Sargramostim|sargramostim|mesh-list
14639921|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639922|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
14639923|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
14639924|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639925|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639926|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639927|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
14639928|NCT00176280|Hormones|hormones|mesh-ancestor
14639929|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639930|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15172118|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15172119|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15172120|NCT04016246|Propofol|propofol|mesh-list
15172121|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15172122|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172123|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172124|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15172125|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
15172126|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
14639931|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639932|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
14639933|NCT00176293|Dexamethasone|dexamethasone|mesh-list
14639934|NCT00176293|Doxorubicin|doxorubicin|mesh-list
14639935|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14639936|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
14639937|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
14639938|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14639939|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639940|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14639941|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
14639942|NCT00176293|Hormones|hormones|mesh-ancestor
14639943|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14639944|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14639945|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639946|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14639947|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14639948|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14639949|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639950|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639951|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14639952|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14639953|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14639954|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
14639955|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639956|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14639957|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14639958|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639959|NCT00176449|Bupropion|bupropion|mesh-list
14639960|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14639961|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
14639962|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14639963|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14639964|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15172127|NCT04016233|Tenofovir|tenofovir|mesh-list
15172128|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
15172129|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639965|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14639966|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172130|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15172131|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15172132|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14639967|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
14639968|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14639969|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639970|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14639971|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14639972|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172133|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172134|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15172135|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14022612|NCT02767713|Hormones|hormones|mesh-ancestor
14022613|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14292037|NCT00558064|Telmisartan|telmisartan|mesh-list
14639973|NCT00176475|Rituximab|rituximab|mesh-list
14639974|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14639975|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639976|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
14639977|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639978|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14639979|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
14639980|NCT00176527|Interferons|interferons|mesh-list
14639981|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
14639982|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
14639983|NCT00176527|Docetaxel|docetaxel|mesh-list
14639984|NCT00176527|Estramustine|estramustine|mesh-list
14639985|NCT00176527|Isotretinoin|isotretinoin|mesh-list
14639986|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14639987|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
14639988|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
14639989|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
14639990|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14639991|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
14639992|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14639993|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
14639994|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14639995|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
14639996|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14639997|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
14639998|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14639999|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
14640000|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
14640001|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640002|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14640003|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14640004|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640005|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640006|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640007|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
14640008|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
15172136|NCT04016051|Clarithromycin|clarithromycin|mesh-list
15172137|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15172138|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172139|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15172140|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640009|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640010|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14640011|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14640012|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640013|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640014|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640015|NCT00176618|Curcumin|curcumin|mesh-list
14640016|NCT00176618|Sulindac|sulindac|mesh-list
14640017|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14640018|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14640019|NCT00176618|Analgesics|analgesics|mesh-ancestor
14640020|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
14640021|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640022|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640023|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640024|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640025|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181287|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14640026|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640027|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640028|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14640029|NCT00176670|Midazolam|midazolam|mesh-list
14640030|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14640031|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14640032|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640033|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640034|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14640035|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640036|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640037|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14640038|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
14640039|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
14640040|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
14640041|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
14640042|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640043|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640044|NCT00176696|Anesthetics|anesthetics|mesh-list
14640045|NCT00176696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640046|NCT00176696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640047|NCT00176735|Capecitabine|capecitabine|mesh-list
14640048|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640049|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
14640050|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292038|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14640051|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640052|NCT00176761|Interleukin-2|interleukin-2|mesh-list
14640053|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640054|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14640055|NCT00176761|Analgesics|analgesics|mesh-ancestor
14640056|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
14640057|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172141|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172142|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15172143|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15172144|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
15172145|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15172146|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172147|NCT04016090|Folic Acid|folic acid|mesh-list
15172148|NCT04016090|Hematinics|hematinics|mesh-ancestor
15172149|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
15172150|NCT04016090|Vitamins|vitamins|mesh-ancestor
15172151|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
15172152|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172153|NCT04016220|Budesonide|budesonide|mesh-list
15172154|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172155|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15172156|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
15172157|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172158|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172159|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15172160|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
15172161|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
15172162|NCT04016220|Hormones|hormones|mesh-ancestor
15172163|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172164|NCT04015908|Acetaminophen|acetaminophen|mesh-list
15172165|NCT04015908|Celecoxib|celecoxib|mesh-list
15172166|NCT04015908|Pregabalin|pregabalin|mesh-list
14640058|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640059|NCT00176774|Leucovorin|leucovorin|mesh-list
14640060|NCT00176774|Fluorouracil|fluorouracil|mesh-list
14640061|NCT00176774|Irinotecan|irinotecan|mesh-list
14640062|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14640063|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
14640064|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640065|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640066|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172167|NCT04015908|Oxycodone|oxycodone|mesh-list
15172168|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172169|NCT04015908|Analgesics|analgesics|mesh-ancestor
15172170|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
15172171|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172172|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640067|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640068|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
14640069|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172173|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
15172174|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
15172175|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14640070|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14640071|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640072|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640073|NCT00176774|Antidotes|antidotes|mesh-ancestor
14640074|NCT00176774|Protective Agents|protective agents|mesh-ancestor
14640075|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
14640076|NCT00176774|Vitamins|vitamins|mesh-ancestor
14640077|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
14640078|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
14640079|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
14640080|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640081|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640082|NCT00176774|Growth Substances|growth substances|mesh-ancestor
14640083|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640084|NCT00176787|Capecitabine|capecitabine|mesh-list
14640085|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640086|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
14640087|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640088|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647277|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14647278|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
14647279|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647280|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647281|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14647282|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14647283|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647284|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14647285|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14647286|NCT00199342|Ecromeximab|ecromeximab|mesh-list
14647287|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15172176|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14647288|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647289|NCT00199355|Istradefylline|istradefylline|mesh-list
14647290|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14647291|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14647292|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14647293|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
14647294|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647295|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647296|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647297|NCT00199368|Istradefylline|istradefylline|mesh-list
14647298|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14647299|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15172177|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172178|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15172179|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15172180|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15172181|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172182|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15172183|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15172184|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172185|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172186|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15172187|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15172188|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172189|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15172190|NCT04015908|Narcotics|narcotics|mesh-ancestor
15172191|NCT04016207|Guanfacine|guanfacine|mesh-list
15172192|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15172193|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15172194|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15172195|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15172196|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
15172197|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172198|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172199|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172200|NCT04015869|Pregnanolone|pregnanolone|mesh-list
15172201|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
15172202|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172203|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172204|NCT04015596|Naproxen|naproxen|mesh-list
15172205|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14647300|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14640089|NCT00176813|Gemcitabine|gemcitabine|mesh-list
14640090|NCT00176813|Celecoxib|celecoxib|mesh-list
14640091|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640092|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640093|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
14640094|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640095|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
14640096|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640097|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172206|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172207|NCT04015596|Analgesics|analgesics|mesh-ancestor
15172208|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
14640098|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640099|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
14640100|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640101|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14640102|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14640103|NCT00176813|Analgesics|analgesics|mesh-ancestor
14640104|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
14640105|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640106|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640107|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640108|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14640109|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14640110|NCT00176943|Imiquimod|imiquimod|mesh-list
14640111|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14640112|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
14640113|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640114|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640115|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
14640116|NCT00176969|Capsaicin|capsaicin|mesh-list
14640117|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
14640118|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14640119|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
14640120|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640121|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640122|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
14640123|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
14640124|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14640125|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14640126|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640127|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640128|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640129|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640130|NCT00176995|Eflornithine|eflornithine|mesh-list
14640131|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640132|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14640133|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15172209|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172210|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172211|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172212|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172213|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
14640134|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14640135|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640136|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14640137|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640138|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640139|NCT00177008|Aripiprazole|aripiprazole|mesh-list
14640140|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640141|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640142|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14640143|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640144|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640145|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640146|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
14640147|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
14640148|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172214|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15172215|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172216|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172217|NCT04015414|Varenicline|varenicline|mesh-list
15172218|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14640149|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172219|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14640150|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14640151|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14640152|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
14640153|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14640154|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14640155|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14640156|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15172220|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
15172221|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172222|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172223|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172224|NCT04015700|Coal Tar|coal tar|mesh-list
15172225|NCT04015700|Vaccines|vaccines|mesh-list
15172226|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
15172227|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172228|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
15172229|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
15172230|NCT04015557|Acetaminophen|acetaminophen|mesh-list
15172231|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
15172232|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15172233|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172234|NCT04015557|Analgesics|analgesics|mesh-ancestor
15172235|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
15172236|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172237|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172238|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
15172239|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
15172240|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172241|NCT04015557|Expectorants|expectorants|mesh-ancestor
15172242|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640157|NCT00177021|Imiquimod|imiquimod|mesh-list
14640158|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14640159|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
14640160|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640161|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640162|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
14640163|NCT00177060|Hydromorphone|hydromorphone|mesh-list
14640164|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14640165|NCT00177060|Narcotics|narcotics|mesh-ancestor
14640166|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640167|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640168|NCT00177060|Analgesics|analgesics|mesh-ancestor
14640169|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
14640170|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640171|NCT00177086|Alfuzosin|alfuzosin|mesh-list
14640172|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14640173|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14640174|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14640175|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
14640176|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640177|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640178|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640179|NCT00177086|Urological Agents|urological agents|mesh-ancestor
14640180|NCT00177099|Tacrolimus|tacrolimus|mesh-list
14640181|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640182|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
14640183|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640184|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14640185|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640186|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640187|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
14640188|NCT00177138|Tacrolimus|tacrolimus|mesh-list
14640189|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640190|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
14640191|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640192|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15172243|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15172244|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
15172245|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172246|NCT04015557|Protective Agents|protective agents|mesh-ancestor
15172247|NCT04015557|Antidotes|antidotes|mesh-ancestor
15172248|NCT04015492|Factor VIII|factor viii|mesh-list
15172249|NCT04015492|BAX 855|bax 855|mesh-list
15172250|NCT04015492|Coagulants|coagulants|mesh-ancestor
15172251|NCT04015687|Lamotrigine|lamotrigine|mesh-list
15172252|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
15172253|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15172254|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15172255|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172256|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14640193|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640194|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640195|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14640196|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640197|NCT00177242|Gefitinib|gefitinib|mesh-list
14640198|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640199|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14640200|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640201|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640202|NCT00177281|Belotecan|belotecan|mesh-list
14640203|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14640204|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640205|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640206|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640207|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640208|NCT00177333|Doxycycline|doxycycline|mesh-list
14640209|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14640210|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640211|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
14640212|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14640213|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14640214|NCT00177372|Misoprostol|misoprostol|mesh-list
14640215|NCT00177372|Mifepristone|mifepristone|mesh-list
15172257|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172258|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15172259|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640216|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14640217|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
14640218|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14640219|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640220|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14640221|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14640222|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
14640223|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14640224|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14640225|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14640226|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14640227|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
14640228|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14640229|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14640230|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
14640231|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14640232|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
14640233|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14640234|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14640235|NCT00177398|Insulin|insulin|mesh-list
15172260|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172261|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15172262|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15181288|NCT03931239|Vaccines|vaccines|mesh-list
15181289|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
15181290|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181291|NCT03931317|Timolol|timolol|mesh-list
15181292|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15181293|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15181294|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
15181295|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181296|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181297|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181298|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15181299|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15181300|NCT03931135|Dexamethasone|dexamethasone|mesh-list
15181301|NCT03931135|Morphine|morphine|mesh-list
15181302|NCT03931135|Cyclizine|cyclizine|mesh-list
15181303|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15181304|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
15181305|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
15181306|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15181307|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640236|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15172263|NCT04015778|Paclitaxel|paclitaxel|mesh-list
15172264|NCT04015778|Carboplatin|carboplatin|mesh-list
15172265|NCT04015778|Nivolumab|nivolumab|mesh-list
15172266|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15172267|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172268|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
15172269|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
15172270|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
15172271|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172272|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15172273|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15172274|NCT04015661|Paclitaxel|paclitaxel|mesh-list
15172275|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14640237|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
14640238|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14640239|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640240|NCT00177411|Hormones|hormones|mesh-list
14640241|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
14640242|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14640243|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14640244|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640245|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14640246|NCT00177424|Sertraline|sertraline|mesh-list
14640247|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640248|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640249|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640250|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640251|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640252|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640253|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640254|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
14640255|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640256|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14640257|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14640258|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640259|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640260|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640261|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640262|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640263|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640264|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
15172276|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15172277|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172278|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
15172279|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
15172280|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
15172281|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172282|NCT04015375|Dapsone|dapsone|mesh-list
15172283|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172284|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
15172285|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15172286|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15172287|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15172288|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172289|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640265|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640266|NCT00177567|Lamotrigine|lamotrigine|mesh-list
14640267|NCT00177567|Valproic Acid|valproic acid|mesh-list
14640268|NCT00177567|Olanzapine|olanzapine|mesh-list
14640269|NCT00177567|Risperidone|risperidone|mesh-list
14640270|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
14640271|NCT00177567|Mirtazapine|mirtazapine|mesh-list
14640272|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
14640273|NCT00177567|Bupropion|bupropion|mesh-list
14640274|NCT00177567|Paroxetine|paroxetine|mesh-list
14640275|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14640276|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14640277|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
14640278|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640279|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640280|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640281|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14022614|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15172290|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
14640282|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640283|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640284|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640285|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14640286|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
14640287|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
14640288|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
14640289|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640290|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14640291|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640292|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640293|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15172291|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15172292|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15172293|NCT04015219|Lifitegrast|lifitegrast|mesh-list
15172294|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15172295|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
14640294|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640295|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640296|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14640297|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14640298|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640299|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640300|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
14640301|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14640302|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
14640303|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14640304|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14640305|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14640306|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14640307|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
14640308|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
14640309|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14640310|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14640311|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14640312|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14640313|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14640314|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14640315|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14640316|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
14640317|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14640318|NCT00177580|Pravastatin|pravastatin|mesh-list
14640319|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15172296|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15172297|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15172298|NCT04014634|Prednisolone|prednisolone|mesh-list
15172299|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
15172300|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15172301|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
14022615|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022616|NCT02767674|Gemcitabine|gemcitabine|mesh-list
14022617|NCT02767674|Prednisone|prednisone|mesh-list
14022618|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
14022619|NCT02767674|Rituximab|rituximab|mesh-list
14640320|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14640321|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
14640322|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172302|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172303|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
15172304|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
15172305|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172306|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172307|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15172308|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
15172309|NCT04014634|Hormones|hormones|mesh-ancestor
15172310|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172311|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15172312|NCT04014634|Protective Agents|protective agents|mesh-ancestor
15172313|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15172314|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172315|NCT04014790|KRN 7000|krn 7000|mesh-list
15172316|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15172317|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
15172318|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172319|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172320|NCT04014855|Lactoferrin|lactoferrin|mesh-list
15172321|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172322|NCT04014556|Aflibercept|aflibercept|mesh-list
15172323|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15172324|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15172325|NCT04014556|Growth Substances|growth substances|mesh-ancestor
15172326|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172327|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
15172328|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172329|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
14640323|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14640324|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14640325|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640326|NCT00177619|Alendronate|alendronate|mesh-list
14640327|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15172330|NCT04014192|Empagliflozin|empagliflozin|mesh-list
15172331|NCT04014192|Canagliflozin|canagliflozin|mesh-list
15172332|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15172333|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640328|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640329|NCT00177684|Amphotericin B|amphotericin b|mesh-list
14640330|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14640331|NCT00177684|Amebicides|amebicides|mesh-ancestor
14640332|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14640333|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14640334|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640335|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14640336|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
14640337|NCT00177710|Amphotericin B|amphotericin b|mesh-list
14640338|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14640339|NCT00177710|Amebicides|amebicides|mesh-ancestor
14640340|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14640341|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14640342|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640343|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14640344|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
14640345|NCT00177749|Posaconazole|posaconazole|mesh-list
14640346|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
14640347|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640348|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14640349|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14640350|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14640351|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14640352|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640353|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640354|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640355|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14640356|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
14640357|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14640358|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640359|NCT00177853|Celecoxib|celecoxib|mesh-list
14640360|NCT00177853|Irinotecan|irinotecan|mesh-list
14640361|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14640362|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640363|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640364|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640365|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640366|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14640367|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14640368|NCT00177853|Analgesics|analgesics|mesh-ancestor
14640369|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
14640370|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640371|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640372|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640373|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640374|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14640375|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14640376|NCT00177996|Sertraline|sertraline|mesh-list
14640377|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640378|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640379|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640380|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15172334|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15172335|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640381|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640382|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640383|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640384|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
14640385|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640386|NCT00178035|Paroxetine|paroxetine|mesh-list
14640387|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640388|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640389|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15172336|NCT04014101|Apatinib|apatinib|mesh-list
15172337|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172338|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15172339|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172340|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172341|NCT04014244|Triamcinolone|triamcinolone|mesh-list
15172342|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15172343|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15172344|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14640390|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640391|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640392|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
14640393|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640394|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640395|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640396|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640397|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14640398|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640399|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640400|NCT00178048|Paroxetine|paroxetine|mesh-list
14640401|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640402|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640403|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640404|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640405|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640406|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
14640407|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640408|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640409|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640410|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640411|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14640412|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640413|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640414|NCT00178100|Paroxetine|paroxetine|mesh-list
14640415|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640416|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640417|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640418|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640419|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640420|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
14640421|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640422|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640423|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
15172345|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172346|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
15172347|NCT04014244|Hormones|hormones|mesh-ancestor
15172348|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172349|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172350|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15172351|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
15172352|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172353|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172354|NCT04014361|Itraconazole|itraconazole|mesh-list
15172355|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
15172356|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172357|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15172358|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640424|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640425|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14647301|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
15172359|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172360|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640426|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640427|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640428|NCT00178113|Lycopene|lycopene|mesh-list
14640429|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640430|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
14640431|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640432|NCT00178113|Protective Agents|protective agents|mesh-ancestor
14640433|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640434|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14640435|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14640436|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640437|NCT00178269|Docetaxel|docetaxel|mesh-list
14640438|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640439|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
14640440|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
14640441|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
14640442|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640443|NCT00178373|Modafinil|modafinil|mesh-list
14640444|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14640445|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640446|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14640447|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14640448|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14640449|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640450|NCT00178451|Abciximab|abciximab|mesh-list
14640451|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
14640452|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14647302|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647303|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647304|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647305|NCT00199394|Istradefylline|istradefylline|mesh-list
14647306|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14647307|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14647308|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14647309|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
14647310|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647311|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647312|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647313|NCT00199407|Istradefylline|istradefylline|mesh-list
14647314|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14647315|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14647316|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14647317|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
14647318|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647319|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647320|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647321|NCT00199420|Istradefylline|istradefylline|mesh-list
14647322|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14647323|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14647324|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14647325|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
14647326|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647327|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647328|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647530|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14647531|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14647532|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14647533|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
14647534|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647535|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647536|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
14647537|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14647538|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15172361|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15172362|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
15172363|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172364|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172365|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15172366|NCT04014283|Selenium|selenium|mesh-list
15172367|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
14640453|NCT00178620|Reteplase|reteplase|mesh-list
14640454|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14640455|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14640456|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640457|NCT00178698|Gemcitabine|gemcitabine|mesh-list
14640458|NCT00178698|Interferons|interferons|mesh-list
14640459|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640460|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640461|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
14640462|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640463|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
14640464|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640465|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640466|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640467|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
14640468|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640469|NCT00178763|Gemcitabine|gemcitabine|mesh-list
14640470|NCT00178763|Interferons|interferons|mesh-list
14640471|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
14640472|NCT00178763|Cisplatin|cisplatin|mesh-list
14640473|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640474|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640475|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
14640476|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640477|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
14640478|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172368|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172369|NCT04014283|Protective Agents|protective agents|mesh-ancestor
15172370|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172371|NCT04014283|Trace Elements|trace elements|mesh-ancestor
15172372|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
15172373|NCT04013815|Ropivacaine|ropivacaine|mesh-list
15172374|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
14640479|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640480|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640481|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
14640482|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172375|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
15172376|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172377|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172378|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
15172379|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172380|NCT04013581|Empagliflozin|empagliflozin|mesh-list
15172381|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14640483|NCT00178802|Interferons|interferons|mesh-list
14640484|NCT00178802|Doxorubicin|doxorubicin|mesh-list
14640485|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14640486|NCT00178802|Fluorouracil|fluorouracil|mesh-list
14640487|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14640488|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640489|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14640490|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640491|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640492|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640493|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
14640494|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640495|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640496|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
14640497|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640498|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
14640499|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640500|NCT00178828|Bupropion|bupropion|mesh-list
14640501|NCT00178828|Sertraline|sertraline|mesh-list
14640502|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640503|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640504|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640505|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14640506|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640507|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640508|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640509|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
14640510|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640511|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640512|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15181308|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14640513|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640514|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640515|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640516|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
14640517|NCT00178854|Risperidone|risperidone|mesh-list
15172382|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172383|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14640518|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14640519|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
14640520|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172384|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172385|NCT04013919|Insulin|insulin|mesh-list
15172386|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15172387|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15172388|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172389|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
14640521|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640522|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640523|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14640524|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640525|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640526|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640527|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14640528|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
14640529|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
14640530|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14640531|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14640532|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14640533|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640534|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640535|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
14640536|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640537|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640538|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14640539|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640540|NCT00178971|Buspirone|buspirone|mesh-list
14640541|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14640542|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640543|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640544|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640545|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640546|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14640547|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
14640548|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640549|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640550|NCT00179023|Trimethaphan|trimethaphan|mesh-list
14640551|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
14640552|NCT00179023|Ephedrine|ephedrine|mesh-list
14640553|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
14640554|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14640555|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
14640556|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640557|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640558|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14640559|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640560|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
14640561|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14640562|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14640563|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
14640564|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14640565|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640566|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640567|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14640568|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14640569|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14640570|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15172390|NCT04013646|Hematinics|hematinics|mesh-ancestor
15172391|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15172392|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15172393|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172394|NCT04013620|Abatacept|abatacept|mesh-list
15172395|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14022620|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
14640571|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15172396|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640572|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
14640573|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
14640574|NCT00179062|Olanzapine|olanzapine|mesh-list
14640575|NCT00179062|Risperidone|risperidone|mesh-list
14640576|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14640577|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
14640578|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640579|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640580|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640581|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14640582|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640583|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640584|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640585|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14640586|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
14640587|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
14640588|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
14640589|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640590|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14640591|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640592|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640593|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640594|NCT00179114|Baclofen|baclofen|mesh-list
14640595|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
14640596|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14640597|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14640598|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14640599|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640600|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640601|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
14640602|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640603|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172397|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172398|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15172399|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
15172400|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640604|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14640605|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640606|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14640607|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14640608|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
14640609|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
14640610|NCT00179231|Olanzapine|olanzapine|mesh-list
14640611|NCT00179231|Clozapine|clozapine|mesh-list
14640612|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
14640613|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
14640614|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640615|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640616|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14640617|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14640618|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640619|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640620|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640621|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640622|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640623|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640624|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640625|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640626|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
14640627|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14640628|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
14640629|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
14640630|NCT00179244|Bupropion|bupropion|mesh-list
14640631|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640632|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640633|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640634|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14640635|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640636|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640637|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640638|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
14640639|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640640|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640641|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14640642|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14640643|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640644|NCT00179257|Sertraline|sertraline|mesh-list
14640645|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640646|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640647|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640648|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640649|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640650|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640651|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640652|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
14640653|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640654|NCT00179283|Sertraline|sertraline|mesh-list
14640655|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14640656|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
14640657|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640658|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14640659|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640660|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640661|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640662|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640663|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
14640664|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640665|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14640666|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14640667|NCT00179465|Tiagabine|tiagabine|mesh-list
14640668|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
14640669|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14640670|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14640671|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640672|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640673|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
14640674|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14640675|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14640676|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14640677|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640678|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
14640679|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640680|NCT00179608|Lenalidomide|lenalidomide|mesh-list
14640681|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
14640682|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640683|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640684|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640685|NCT00179608|Growth Substances|growth substances|mesh-ancestor
14640686|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640687|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640688|NCT00179686|Lenalidomide|lenalidomide|mesh-list
14640689|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
14640690|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640691|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640692|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640693|NCT00179686|Growth Substances|growth substances|mesh-ancestor
14640694|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640695|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640696|NCT00179699|Pemetrexed|pemetrexed|mesh-list
14640697|NCT00179699|Lenalidomide|lenalidomide|mesh-list
14640698|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640699|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640700|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640701|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14640702|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14640703|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
14640704|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640705|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640706|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640707|NCT00179699|Growth Substances|growth substances|mesh-ancestor
14640708|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640709|NCT00179712|Topotecan|topotecan|mesh-list
14640710|NCT00179712|Lenalidomide|lenalidomide|mesh-list
14640711|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14640712|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640713|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647329|NCT00199433|Istradefylline|istradefylline|mesh-list
14022621|NCT02767674|Epirubicin|epirubicin|mesh-list
14640714|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640715|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640716|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
14640717|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640718|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640719|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640720|NCT00179712|Growth Substances|growth substances|mesh-ancestor
14640721|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640722|NCT00179725|Doxorubicin|doxorubicin|mesh-list
14640723|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14640724|NCT00179725|Lenalidomide|lenalidomide|mesh-list
14640725|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14640726|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640727|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14640728|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640729|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640730|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640731|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
14640732|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640733|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640734|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640735|NCT00179725|Growth Substances|growth substances|mesh-ancestor
14640736|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640737|NCT00179738|Lenalidomide|lenalidomide|mesh-list
14640738|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
14640739|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640740|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640741|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640742|NCT00179738|Growth Substances|growth substances|mesh-ancestor
14640743|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640744|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640745|NCT00179751|Gemcitabine|gemcitabine|mesh-list
14640746|NCT00179751|Lenalidomide|lenalidomide|mesh-list
14640747|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640748|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
14640749|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640750|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640751|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
14640752|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640753|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640754|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640755|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
14640756|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640757|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640758|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640759|NCT00179751|Growth Substances|growth substances|mesh-ancestor
14640760|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640761|NCT00179764|Busulfan|busulfan|mesh-list
14640762|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
14640763|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640764|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640765|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
14640766|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640767|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14640768|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640769|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14640770|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
14640771|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640772|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
14640773|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640774|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640775|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14640776|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
14640777|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640778|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640779|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14640780|NCT00179881|Thalidomide|thalidomide|mesh-list
14640781|NCT00179881|Carboplatin|carboplatin|mesh-list
14640782|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640783|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640784|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
14640785|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640786|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
14640787|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14640788|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640789|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14640790|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14640791|NCT00179881|Growth Substances|growth substances|mesh-ancestor
14640792|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
14640793|NCT00179920|Carboplatin|carboplatin|mesh-list
14640794|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640795|NCT00180011|Omalizumab|omalizumab|mesh-list
14640796|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14640797|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14640798|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
15172401|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172402|NCT04013958|Ketamine|ketamine|mesh-list
15172403|NCT04013958|Analgesics|analgesics|mesh-ancestor
15172404|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
15172405|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172406|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172407|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15172408|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14640799|NCT00180024|Irbesartan|irbesartan|mesh-list
14640800|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14640801|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14640802|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14640803|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172409|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
15172410|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
15172411|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172412|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15172413|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15172414|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172415|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172416|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
15172417|NCT04013672|Sargramostim|sargramostim|mesh-list
15172418|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15172419|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172420|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
15172421|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172422|NCT04013880|Decitabine|decitabine|mesh-list
15172423|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15172424|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
15172425|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172426|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172427|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640804|NCT00180037|Ubiquinone|ubiquinone|mesh-list
14640805|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
14640806|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
14640807|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640808|NCT00180037|Vitamins|vitamins|mesh-ancestor
14640809|NCT00180050|Budesonide|budesonide|mesh-list
14640810|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640811|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14640812|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
14640813|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640814|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640815|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14640816|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640817|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
14640818|NCT00180050|Hormones|hormones|mesh-ancestor
14640819|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14640820|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14640821|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640822|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640823|NCT00180076|Budesonide|budesonide|mesh-list
15181309|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
15181310|NCT03931135|Hormones|hormones|mesh-ancestor
15181311|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15181312|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15181313|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15181314|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15181315|NCT03931135|Narcotics|narcotics|mesh-ancestor
15181316|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15181317|NCT03931135|Analgesics|analgesics|mesh-ancestor
15181318|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
14640824|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640825|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15172428|NCT04013542|Nivolumab|nivolumab|mesh-list
15172429|NCT04013542|Ipilimumab|ipilimumab|mesh-list
15172430|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15172431|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172432|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15172433|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640826|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
14640827|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640828|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640829|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14640830|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640831|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
14640832|NCT00180076|Hormones|hormones|mesh-ancestor
14640833|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14640834|NCT00180089|Budesonide|budesonide|mesh-list
14640835|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640836|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14640837|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
14640838|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640839|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640840|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14640841|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640842|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
14640843|NCT00180089|Hormones|hormones|mesh-ancestor
14640844|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14640845|NCT00180102|Cytarabine|cytarabine|mesh-list
14640846|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
14640847|NCT00180102|Amsacrine|amsacrine|mesh-list
14640848|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640849|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
14640850|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640851|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640852|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
14640853|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640854|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640855|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
14640856|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172434|NCT04013386|Dexamethasone|dexamethasone|mesh-list
15172435|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
15172436|NCT04013386|Aprepitant|aprepitant|mesh-list
15172437|NCT04013386|Mirtazapine|mirtazapine|mesh-list
15172438|NCT04013386|BB 1101|bb 1101|mesh-list
15172439|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172440|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
15172441|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
15172442|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172443|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172444|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15172445|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
14022622|NCT02767674|Vindesine|vindesine|mesh-list
14640857|NCT00180102|Analgesics|analgesics|mesh-ancestor
14640858|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
14640859|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640860|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14640861|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640862|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640863|NCT00180115|Cytarabine|cytarabine|mesh-list
14640864|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640865|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
14640866|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640867|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640868|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
14640869|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640870|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640871|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
14640872|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647330|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14647331|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14647332|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14647333|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
14647334|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647335|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647336|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647337|NCT00199446|Istradefylline|istradefylline|mesh-list
15172446|NCT04013386|Hormones|hormones|mesh-ancestor
15181319|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14640873|NCT00180128|Cytarabine|cytarabine|mesh-list
14640874|NCT00180128|Daunorubicin|daunorubicin|mesh-list
14640875|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
14640876|NCT00180128|Idarubicin|idarubicin|mesh-list
14640877|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14640878|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
14640879|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640880|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640881|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
14640882|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14640883|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640884|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
14640885|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640886|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14640887|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14640888|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15172447|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172448|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15172449|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172450|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
15172451|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172452|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172453|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15172454|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640889|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640890|NCT00180128|Analgesics|analgesics|mesh-ancestor
14640891|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
14640892|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640893|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
14640894|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15172455|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
15172456|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14640895|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14640896|NCT00180141|Analgesics|analgesics|mesh-ancestor
14640897|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
14640898|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640899|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640900|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14640901|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640902|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
14640903|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640904|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
14640905|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14640906|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640907|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640908|NCT00180310|Paclitaxel|paclitaxel|mesh-list
14640909|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14640910|NCT00180310|Everolimus|everolimus|mesh-list
14640911|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14640912|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640913|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14640914|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14640915|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14640916|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640917|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15172457|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14640918|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
14640919|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172458|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
15172459|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
15172460|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15172461|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15172462|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172463|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15172464|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15172465|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15172466|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
15172467|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15172468|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15172469|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
15172470|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15172471|NCT04013334|Nivolumab|nivolumab|mesh-list
14640920|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
15172472|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14640921|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
14640922|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14640923|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
14640924|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640925|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640926|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14640927|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640928|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14640929|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
14640930|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640931|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640932|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14640933|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
14640934|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
14640935|NCT00180622|Protective Agents|protective agents|mesh-ancestor
14640936|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
14640937|NCT00180635|Pimagedine|pimagedine|mesh-list
14640938|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640939|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640940|NCT00180791|Carboplatin|carboplatin|mesh-list
14640941|NCT00180791|Etoposide|etoposide|mesh-list
14640942|NCT00180791|Melphalan|melphalan|mesh-list
14640943|NCT00180791|Thiotepa|thiotepa|mesh-list
14640944|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640945|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14640946|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14640947|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14640948|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640949|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640950|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14640951|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
14640952|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14640953|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14640954|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
14640955|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640956|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
14640957|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172473|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172474|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15172475|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172476|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15172477|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15172478|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
15172479|NCT04013438|Estradiol|estradiol|mesh-list
15172480|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15172481|NCT04013438|Estrogens|estrogens|mesh-ancestor
15172482|NCT04013438|Hormones|hormones|mesh-ancestor
15172483|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172484|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640958|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14640959|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14640960|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640961|NCT00180843|Bromides|bromides|mesh-list
14640962|NCT00180843|Albuterol|albuterol|mesh-list
14640963|NCT00180843|Ipratropium|ipratropium|mesh-list
14640964|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
14640965|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14640966|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
14640967|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14640968|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640969|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14640970|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14640971|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
14640972|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15172485|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15172486|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
15172487|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15172488|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15172489|NCT04013438|Urological Agents|urological agents|mesh-ancestor
15172490|NCT04013477|Donepezil|donepezil|mesh-list
15172491|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15172492|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172493|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14292039|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14647539|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14640973|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14640974|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14640975|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14640976|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
14640977|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14640978|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14640979|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14640980|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
14640981|NCT00180882|Rituximab|rituximab|mesh-list
14640982|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14640983|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640984|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
14640985|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640986|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640987|NCT00180895|Rituximab|rituximab|mesh-list
14640988|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14640989|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640990|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
14640991|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14640992|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14640993|NCT00180908|Doxorubicin|doxorubicin|mesh-list
14640994|NCT00180908|Etoposide|etoposide|mesh-list
14640995|NCT00180908|Methotrexate|methotrexate|mesh-list
14640996|NCT00180908|Ifosfamide|ifosfamide|mesh-list
14640997|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14640998|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14640999|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14641000|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641001|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641002|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641003|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14641004|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
14641005|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14641006|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641007|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15172494|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
14641008|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
14641009|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
14641010|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14641011|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641012|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
14641013|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641014|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14641015|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14641016|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14641017|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
14641018|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
14641019|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641020|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14641021|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641022|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641023|NCT00180947|Vinorelbine|vinorelbine|mesh-list
14641024|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14641025|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641026|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
14641027|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
14641028|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
14641029|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641030|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
14641031|NCT00180960|Irinotecan|irinotecan|mesh-list
14641032|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641033|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14641034|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641035|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641036|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641037|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
14641038|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641039|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
14641040|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641041|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641042|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14641043|NCT00181012|Lidocaine|lidocaine|mesh-list
14641044|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
15172495|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641045|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
14641046|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641047|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641048|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
14641049|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641050|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14641051|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14641052|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14641053|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641054|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641055|NCT00181025|Melphalan|melphalan|mesh-list
14641056|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14641057|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
14641058|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641059|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641060|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14641061|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641062|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
14641063|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641064|NCT00181116|Levetiracetam|levetiracetam|mesh-list
14641065|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
14641066|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
14641067|NCT00181142|Daclizumab|daclizumab|mesh-list
14641068|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641069|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
14641070|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641071|NCT00181181|Atorvastatin|atorvastatin|mesh-list
14641072|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14641073|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14641074|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
14641075|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641076|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14641077|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14641078|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641079|NCT00181220|Valproic Acid|valproic acid|mesh-list
14641080|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
14641081|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641082|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641083|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
14641084|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641085|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641086|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
14641087|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15172496|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172497|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
15172498|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
15172499|NCT04013243|Analgesics|analgesics|mesh-ancestor
15172500|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
15172501|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172502|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172503|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
15172504|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172505|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15172506|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
15172507|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15172508|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15172509|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172510|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15172511|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
15172512|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15172513|NCT04013464|Citalopram|citalopram|mesh-list
15172514|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15172515|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15172516|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15172517|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172518|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172519|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
15172520|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172521|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15172522|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
15172523|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15172524|NCT04012918|Capecitabine|capecitabine|mesh-list
15172525|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15172526|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15172527|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
14641088|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172528|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172529|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172530|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15172531|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172532|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15172533|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
15172534|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172535|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172536|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15172537|NCT04012619|Cisplatin|cisplatin|mesh-list
15172538|NCT04012619|Carboplatin|carboplatin|mesh-list
15172539|NCT04012619|Pemetrexed|pemetrexed|mesh-list
14641089|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641090|NCT00181246|Fentanyl|fentanyl|mesh-list
14641091|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14641092|NCT00181246|Narcotics|narcotics|mesh-ancestor
14641093|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641094|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641095|NCT00181246|Analgesics|analgesics|mesh-ancestor
14641096|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
14641097|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641098|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14641099|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14641100|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
14641101|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
14641102|NCT00181272|Azithromycin|azithromycin|mesh-list
14641103|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14641104|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14641105|NCT00181298|Memantine|memantine|mesh-list
14641106|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14641107|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14641108|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
14641109|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641110|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641111|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641112|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14641113|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14641114|NCT00181532|Celecoxib|celecoxib|mesh-list
14641115|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15172540|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172541|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172542|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641116|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14641117|NCT00181532|Analgesics|analgesics|mesh-ancestor
14641118|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
14641119|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641120|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641121|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641122|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641123|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14641124|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14641125|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641126|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641127|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
14641128|NCT00181558|Atrasentan|atrasentan|mesh-list
14641129|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14641130|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641131|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641132|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14641133|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14641134|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641135|NCT00181571|Methylphenidate|methylphenidate|mesh-list
14641136|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14641137|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641138|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14641139|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641140|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641141|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172543|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14641142|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
14641143|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641144|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
14641145|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14641146|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641147|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
14641148|NCT00181597|Trilostane|trilostane|mesh-list
14641149|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641150|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14641151|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
14641152|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14641153|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641154|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641155|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641156|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641157|NCT00181636|Galantamine|galantamine|mesh-list
14641158|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14641159|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641160|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641161|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14641162|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641163|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641164|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14641165|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
14641166|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641167|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
14641168|NCT00181662|Curcumin|curcumin|mesh-list
14641169|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14641170|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14641171|NCT00181662|Analgesics|analgesics|mesh-ancestor
14641172|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
14641173|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641174|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641175|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641176|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641177|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641178|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641179|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641180|NCT00181675|Galantamine|galantamine|mesh-list
14641181|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14641182|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641183|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641184|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
14641185|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641186|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641187|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14641188|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
14641189|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641190|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
14641191|NCT00181688|Anastrozole|anastrozole|mesh-list
14641192|NCT00181688|Gefitinib|gefitinib|mesh-list
14641193|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14641194|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641195|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14641196|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14641197|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172544|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15172545|NCT04012775|Insulin|insulin|mesh-list
14641198|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641199|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14641200|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
14641201|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641202|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641203|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14641204|NCT00181727|Valproic Acid|valproic acid|mesh-list
14641205|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
14641206|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641207|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641208|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
14641209|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641210|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641211|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
14641212|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15172546|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14641213|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641214|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641215|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14641216|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14641217|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641218|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641219|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641220|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
14641221|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641222|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641223|NCT00181779|Aripiprazole|aripiprazole|mesh-list
14641224|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641225|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641226|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641227|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641228|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641229|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641230|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
14641231|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
14641232|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641233|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641234|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14641235|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14641236|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
14641237|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14641238|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14641239|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14641240|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14641241|NCT00181818|Bupropion|bupropion|mesh-list
14641242|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14641243|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641244|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641245|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14641246|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641247|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641248|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641249|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
14641250|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641251|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641252|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14641253|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14641254|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641255|NCT00181870|Carbamazepine|carbamazepine|mesh-list
14641256|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
14641257|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
14641258|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641259|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641260|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641261|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641262|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14641263|NCT00181870|Analgesics|analgesics|mesh-ancestor
14641264|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
14641265|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641266|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14641267|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641268|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172547|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15172548|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172549|NCT04012606|Carboplatin|carboplatin|mesh-list
15172550|NCT04012606|Etoposide|etoposide|mesh-list
14641269|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14641270|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14647338|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14647339|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14647340|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14647341|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
14647342|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647343|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647344|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647345|NCT00199472|Diuretics|diuretics|mesh-list
14647346|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
14641271|NCT00181896|Bupropion|bupropion|mesh-list
15172551|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172552|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15172553|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15172554|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15172555|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022623|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022624|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
14641272|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14641273|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641274|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641275|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14641276|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641277|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641278|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641279|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
14641280|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641281|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641282|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14641283|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14641284|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641285|NCT00181922|Ziprasidone|ziprasidone|mesh-list
14641286|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14641287|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
14641288|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641289|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641290|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641291|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641292|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641293|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641294|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641295|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14641296|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
14641297|NCT00181935|Olanzapine|olanzapine|mesh-list
14641298|NCT00181935|Risperidone|risperidone|mesh-list
14641299|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14641300|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
14641301|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641302|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641303|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641304|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641305|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641306|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641307|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641308|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14641309|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
14641310|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
14641311|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
14641312|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641313|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641314|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14641315|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641316|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641317|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14641318|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14641319|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641320|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641321|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641322|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
14641323|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641324|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641325|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14641326|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
14641327|NCT00181974|Coagulants|coagulants|mesh-ancestor
14641328|NCT00181987|Methylphenidate|methylphenidate|mesh-list
14641329|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14641330|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641331|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14641332|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641333|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641334|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172556|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641335|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
14641336|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172557|NCT04012450|Anesthetics|anesthetics|mesh-list
15172558|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172559|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641337|NCT00182013|Olanzapine|olanzapine|mesh-list
14641338|NCT00182013|Risperidone|risperidone|mesh-list
14641339|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14641340|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14641341|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
14641342|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641343|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641344|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641345|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641346|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641347|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641348|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641349|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14641350|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
14641351|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
14641352|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
14641353|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641354|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641355|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14641356|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641357|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641358|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641359|NCT00182039|Metoprolol|metoprolol|mesh-list
14641360|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14641361|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14641362|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
14641363|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
14641364|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641365|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641366|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14641367|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14641368|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14641369|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
14641370|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641371|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641372|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
14641373|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14641374|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641375|NCT00182104|Warfarin|warfarin|mesh-list
14641376|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
14641377|NCT00182143|Heparin|heparin|mesh-list
14641378|NCT00182143|Calcium heparin|calcium heparin|mesh-list
14641379|NCT00182143|Dalteparin|dalteparin|mesh-list
14641380|NCT00182143|Tinzaparin|tinzaparin|mesh-list
14641381|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14641382|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
14641383|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14641384|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14641385|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641386|NCT00182169|Hormones|hormones|mesh-list
14641387|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641388|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641389|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
14641390|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14641391|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14641392|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641393|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
14641394|NCT00182221|Coagulants|coagulants|mesh-ancestor
14641395|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14641396|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641397|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172560|NCT04012424|Curcumin|curcumin|mesh-list
15172561|NCT04012424|Analgesics|analgesics|mesh-list
15172562|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15172563|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172564|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
15172565|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172566|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172567|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172568|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641398|NCT00182312|Caffeine|caffeine|mesh-list
14641399|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
14641400|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641401|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14641402|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641403|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14641404|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641405|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14641406|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14641407|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
14641408|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641409|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
14641410|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14641411|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14641412|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641413|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
14641414|NCT00182351|Coagulants|coagulants|mesh-ancestor
14641415|NCT00182364|Heparin|heparin|mesh-list
14641416|NCT00182364|Calcium heparin|calcium heparin|mesh-list
14641417|NCT00182364|Dalteparin|dalteparin|mesh-list
14641418|NCT00182364|Tinzaparin|tinzaparin|mesh-list
14641419|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14641420|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
14641421|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14641422|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14641423|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641424|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14641425|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
14641426|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
14641427|NCT00182429|Metronidazole|metronidazole|mesh-list
14641428|NCT00182429|Rifampin|rifampin|mesh-list
14641429|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14641430|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14641431|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14641432|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14641433|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14641434|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
14641435|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
14641436|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14641437|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641438|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641439|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14641440|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14641441|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14641442|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14641443|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14641444|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14641445|NCT00182442|Olanzapine|olanzapine|mesh-list
14641446|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14641447|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
14641448|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
14641449|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641450|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641451|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641452|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641453|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641454|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641455|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641456|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14641457|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641458|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641459|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641460|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641461|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
14641462|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641463|NCT00182455|Topiramate|topiramate|mesh-list
14641464|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
14641465|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14641466|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172569|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172570|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172571|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172572|NCT04012307|Candesartan|candesartan|mesh-list
15172573|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
15172574|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15172575|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15172576|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15172577|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172578|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15172579|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15172580|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172581|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172582|NCT04012268|Aspirin|aspirin|mesh-list
15172583|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15172584|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172585|NCT04012268|Analgesics|analgesics|mesh-ancestor
15172586|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
15172587|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172588|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172589|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172590|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641467|NCT00182494|Metformin|metformin|mesh-list
14641468|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14641469|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641470|NCT00182507|Olanzapine|olanzapine|mesh-list
14641471|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
14641472|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
14641473|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641474|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641475|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641476|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641477|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641478|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641479|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641480|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14641481|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641482|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641483|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641484|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641485|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
14641486|NCT00182520|Topiramate|topiramate|mesh-list
14641487|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
14641488|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14641489|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641490|NCT00182533|Sertraline|sertraline|mesh-list
14641491|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641492|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641493|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14641494|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641495|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641496|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172591|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15172592|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15172593|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172594|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15172595|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15172596|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641497|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641498|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
14641499|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641500|NCT00182559|Cyclosporine|cyclosporine|mesh-list
14641501|NCT00182559|Tacrolimus|tacrolimus|mesh-list
14641502|NCT00182559|Cyclosporins|cyclosporins|mesh-list
14641503|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641504|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
14641505|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641506|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14641507|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641508|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641509|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
14641510|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14641511|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
14641512|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641513|NCT00182572|Naltrexone|naltrexone|mesh-list
15172597|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
15172598|NCT04012047|Cromakalim|cromakalim|mesh-list
14641514|NCT00182572|Buprenorphine|buprenorphine|mesh-list
14641515|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14641516|NCT00182572|Narcotics|narcotics|mesh-ancestor
14647540|NCT00200434|Nebivolol|nebivolol|mesh-list
14641517|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641518|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641519|NCT00182572|Analgesics|analgesics|mesh-ancestor
14641520|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
14641521|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641522|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14641523|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14641524|NCT00182611|Tegafur|tegafur|mesh-list
14641525|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641526|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641527|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
14641528|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641529|NCT00182650|Aldesleukin|aldesleukin|mesh-list
14641530|NCT00182650|Rituximab|rituximab|mesh-list
14641531|NCT00182650|Fludarabine|fludarabine|mesh-list
14641532|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
14641533|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14641534|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641535|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
14641536|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641537|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641538|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641539|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
14641540|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641541|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641542|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14641543|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14641544|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
14641545|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172599|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14641546|NCT00182663|Thalidomide|thalidomide|mesh-list
14641547|NCT00182663|Clarithromycin|clarithromycin|mesh-list
14641548|NCT00182663|Dexamethasone|dexamethasone|mesh-list
14641549|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641550|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
15172600|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15172601|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
15172602|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172603|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172604|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15172605|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
15172606|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
15172607|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
15172608|NCT04012294|Allopurinol|allopurinol|mesh-list
15172609|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
15172610|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641551|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
14641552|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641553|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641554|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641555|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
14641556|NCT00182663|Hormones|hormones|mesh-ancestor
14641557|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641558|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14641559|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641560|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641561|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
14641562|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
14641563|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14641564|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172611|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172612|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
15172613|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172614|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15172615|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
14641565|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14641566|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14641567|NCT00182663|Growth Substances|growth substances|mesh-ancestor
14641568|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14641569|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14641570|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641571|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172616|NCT04012294|Protective Agents|protective agents|mesh-ancestor
14641572|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14022625|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641573|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14641574|NCT00182702|Epothilones|epothilones|mesh-list
14641575|NCT00182702|Epothilone B|epothilone b|mesh-list
14641576|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
14641577|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14641578|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14641579|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641580|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641581|NCT00182715|Leucovorin|leucovorin|mesh-list
15172617|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172618|NCT04011930|Vitamin D|vitamin d|mesh-list
15172619|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
15172620|NCT04011930|Calcitriol|calcitriol|mesh-list
15172621|NCT04011930|Vitamins|vitamins|mesh-ancestor
15172622|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
15172623|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172624|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15172625|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15172626|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14641582|NCT00182715|Fluorouracil|fluorouracil|mesh-list
14641583|NCT00182715|Capecitabine|capecitabine|mesh-list
14641584|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
14641585|NCT00182715|Cetuximab|cetuximab|mesh-list
14641586|NCT00182715|Calcium|calcium|mesh-list
14641587|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
14641588|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14641589|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641590|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
14641591|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641592|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641593|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641594|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641595|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
14641596|NCT00182715|Antidotes|antidotes|mesh-ancestor
14641597|NCT00182715|Protective Agents|protective agents|mesh-ancestor
14641598|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
14641599|NCT00182715|Vitamins|vitamins|mesh-ancestor
15172627|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15172628|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172629|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15172630|NCT04011813|Antioxidants|antioxidants|mesh-list
15172631|NCT04011813|Hypotaurine|hypotaurine|mesh-list
15172632|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172633|NCT04011813|Protective Agents|protective agents|mesh-ancestor
15172634|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15181320|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
15181321|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
15181322|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15181323|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181324|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
15181325|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14641600|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
14641601|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14641602|NCT00182741|Calcitriol|calcitriol|mesh-list
14641603|NCT00182741|Prednisone|prednisone|mesh-list
14641604|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
14641605|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641606|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
14641607|NCT00182741|Hormones|hormones|mesh-ancestor
14641608|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641609|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641610|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14641611|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641612|NCT00182741|Analgesics|analgesics|mesh-ancestor
14641613|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
14641614|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641615|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14641616|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641617|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641618|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641619|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14641620|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14641621|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641622|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14641623|NCT00182741|Vitamins|vitamins|mesh-ancestor
15181326|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641624|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
14641625|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14641626|NCT00182806|Gemcitabine|gemcitabine|mesh-list
14641627|NCT00182806|Irinotecan|irinotecan|mesh-list
14641628|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641629|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
14641630|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641631|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641632|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
15172635|NCT04011670|Caffeine|caffeine|mesh-list
15172636|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14641633|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14641634|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641635|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641636|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
14641637|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641638|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14641639|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641640|NCT00182819|Temozolomide|temozolomide|mesh-list
14641641|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14641642|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
14641643|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641644|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641645|NCT00182845|Donepezil|donepezil|mesh-list
14641646|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14641647|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641648|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641649|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
14641650|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641651|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641652|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
14641653|NCT00182871|Testosterone|testosterone|mesh-list
14641654|NCT00182871|Androgens|androgens|mesh-ancestor
14641655|NCT00182871|Hormones|hormones|mesh-ancestor
14641656|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641657|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641658|NCT00182884|Donepezil|donepezil|mesh-list
14641659|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14641660|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641661|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641662|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
14641663|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641664|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641665|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
14641666|NCT00183001|Vitamin K|vitamin k|mesh-list
14641667|NCT00183001|Vitamins|vitamins|mesh-ancestor
14641668|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
14641669|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641670|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14641671|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14641672|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641673|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
14641674|NCT00183001|Coagulants|coagulants|mesh-ancestor
14641675|NCT00183040|Hormones|hormones|mesh-list
14641676|NCT00183040|Testosterone|testosterone|mesh-list
14641677|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641678|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641679|NCT00183040|Androgens|androgens|mesh-ancestor
14641680|NCT00183222|Naltrexone|naltrexone|mesh-list
14641681|NCT00183222|Ondansetron|ondansetron|mesh-list
14641682|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14641683|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14641684|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641685|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
14641686|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641687|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
14641688|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
14641689|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641690|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
14641691|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
14641692|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14641693|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
14641694|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641695|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172637|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641696|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641697|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641698|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641699|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641700|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14641701|NCT00183235|Aripiprazole|aripiprazole|mesh-list
14641702|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641703|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641704|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641705|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641706|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641707|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641708|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
14641709|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
14641710|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641711|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641712|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14641713|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14641714|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
14641715|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14641716|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14641717|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14641718|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14641719|NCT00183404|Olanzapine|olanzapine|mesh-list
14641720|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
14641721|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
14641722|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641723|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641724|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641725|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641726|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14641727|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641728|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641729|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14641730|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641731|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641732|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641733|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641734|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
14647347|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647348|NCT00199511|Mannitol|mannitol|mesh-list
14647349|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14647350|NCT00199511|Diuretics|diuretics|mesh-ancestor
14647351|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
14647352|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647353|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
14647354|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
15172638|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15172639|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172640|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172641|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15172642|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15172643|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
14647355|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14647356|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14647357|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647358|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647359|NCT00199563|Urological Agents|urological agents|mesh-ancestor
14647360|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
14647361|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14647362|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14647363|NCT00199576|Prednisolone|prednisolone|mesh-list
14647364|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
14647365|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14647366|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
14647367|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647368|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
14647369|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
14647370|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647371|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647372|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647373|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
14647374|NCT00199576|Hormones|hormones|mesh-ancestor
14647375|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172644|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641735|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
14641736|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641737|NCT00183612|Olanzapine|olanzapine|mesh-list
14641738|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
14641739|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
15172645|NCT04011748|Minoxidil|minoxidil|mesh-list
15172646|NCT04011748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15172647|NCT04011748|Vasodilator Agents|vasodilator agents|mesh-ancestor
15172648|NCT04011878|Mitomycins|mitomycins|mesh-list
15172649|NCT04011878|Mitomycin|mitomycin|mesh-list
15172650|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15172651|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172652|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
15172653|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172654|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15172655|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172656|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
15172657|NCT04011475|Olodaterol|olodaterol|mesh-list
15172658|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15172659|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
15172660|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172661|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172662|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15172663|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
15172664|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
15172665|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15172666|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
15172667|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172668|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172669|NCT04011345|Folic Acid|folic acid|mesh-list
15172670|NCT04011345|Hematinics|hematinics|mesh-ancestor
15172671|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
15172672|NCT04011345|Vitamins|vitamins|mesh-ancestor
15172673|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
15172674|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172675|NCT04011280|Varenicline|varenicline|mesh-list
15172676|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15172677|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15172678|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
15172679|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172680|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172681|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172682|NCT04011124|Rifampin|rifampin|mesh-list
15172683|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15172684|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
15172685|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15172686|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172687|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
15172688|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15172689|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641740|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641741|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641742|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641743|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14641744|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15172690|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641745|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641746|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641747|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15172691|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14641748|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641749|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641750|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641751|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641752|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
14641753|NCT00183742|Docetaxel|docetaxel|mesh-list
14641754|NCT00183742|Doxorubicin|doxorubicin|mesh-list
14641755|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14641756|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641757|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
14641758|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
14641759|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
15172692|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15172693|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14641760|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15181327|NCT03931369|Tolvaptan|tolvaptan|mesh-list
14641761|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14641762|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14641763|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641764|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641765|NCT00183807|Celecoxib|celecoxib|mesh-list
14641766|NCT00183807|Irinotecan|irinotecan|mesh-list
14641767|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641768|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14641769|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641770|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641771|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641772|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14641773|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14641774|NCT00183807|Analgesics|analgesics|mesh-ancestor
14641775|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
14641776|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641777|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641778|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641779|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641780|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14641781|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14641782|NCT00183820|Gemcitabine|gemcitabine|mesh-list
14641783|NCT00183820|Paclitaxel|paclitaxel|mesh-list
14641784|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
14641785|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14641786|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641787|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
14641788|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
14641789|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
14641790|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641791|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641792|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
14641793|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
14641794|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14641795|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641796|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641797|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
14641798|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641799|NCT00183833|Capecitabine|capecitabine|mesh-list
14641800|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
15172694|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15172695|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15172696|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15172697|NCT04010955|Edoxaban|edoxaban|mesh-list
15172698|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15172699|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
15172700|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14641801|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641802|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
14641803|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641804|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641805|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14641806|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641807|NCT00183846|Irinotecan|irinotecan|mesh-list
14641808|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14641809|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641810|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641811|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641812|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641813|NCT00183859|Irinotecan|irinotecan|mesh-list
14641814|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14641815|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641816|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172701|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
15172702|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172703|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172704|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
15172705|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
15172706|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
15172707|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14641817|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641818|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172708|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14641819|NCT00183885|Mitomycins|mitomycins|mesh-list
14641820|NCT00183885|Mitomycin|mitomycin|mesh-list
15172709|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14641821|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641822|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14641823|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
14641824|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641825|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14641826|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641827|NCT00183898|Capecitabine|capecitabine|mesh-list
14641828|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
14641829|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641830|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
14641831|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641832|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641833|NCT00183911|Leucovorin|leucovorin|mesh-list
14641834|NCT00183911|Fluorouracil|fluorouracil|mesh-list
14641835|NCT00183911|Floxuridine|floxuridine|mesh-list
14641836|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
14641837|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641838|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641839|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641840|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641841|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
14641842|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641843|NCT00183911|Antidotes|antidotes|mesh-ancestor
14641844|NCT00183911|Protective Agents|protective agents|mesh-ancestor
14641845|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
14641846|NCT00183911|Vitamins|vitamins|mesh-ancestor
14641847|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
14641848|NCT00183924|Carboplatin|carboplatin|mesh-list
14641849|NCT00183924|Docetaxel|docetaxel|mesh-list
14641850|NCT00183924|Estramustine|estramustine|mesh-list
14641851|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641852|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
14641853|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
14641854|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
14641855|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641856|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14641857|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
14641858|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14641859|NCT00183937|Docetaxel|docetaxel|mesh-list
14641860|NCT00183937|Bortezomib|bortezomib|mesh-list
14641861|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641862|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14641863|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14641864|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14641865|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641866|NCT00183950|Noscapine|noscapine|mesh-list
14641867|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
14641868|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
14641869|NCT00183976|Rituximab|rituximab|mesh-list
14641870|NCT00183976|Doxorubicin|doxorubicin|mesh-list
14641871|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14641872|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14641873|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641874|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
14641875|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641876|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172710|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172711|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172712|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172713|NCT04011241|Itraconazole|itraconazole|mesh-list
14641877|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14641878|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14641879|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641880|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641881|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641882|NCT00183989|Rituximab|rituximab|mesh-list
14641883|NCT00183989|Fludarabine|fludarabine|mesh-list
14641884|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
14641885|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14641886|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172714|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
15172715|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172716|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14641887|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
14641888|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641889|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647376|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14641890|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641891|NCT00183989|Analgesics|analgesics|mesh-ancestor
14641892|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
14641893|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641894|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14641895|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641896|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641897|NCT00184015|Bevacizumab|bevacizumab|mesh-list
14641898|NCT00184015|Bortezomib|bortezomib|mesh-list
14641899|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14641900|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641901|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14641902|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14641903|NCT00184015|Growth Substances|growth substances|mesh-ancestor
14641904|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641905|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
14641906|NCT00184041|Cytarabine|cytarabine|mesh-list
14641907|NCT00184041|Prednisone|prednisone|mesh-list
14641908|NCT00184041|Methotrexate|methotrexate|mesh-list
14641909|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
14641910|NCT00184041|Vincristine|vincristine|mesh-list
14641911|NCT00184041|Daunorubicin|daunorubicin|mesh-list
14641912|NCT00184041|Asparaginase|asparaginase|mesh-list
14641913|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
14641914|NCT00184041|Thioguanine|thioguanine|mesh-list
14641915|NCT00184041|Pegaspargase|pegaspargase|mesh-list
14641916|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641917|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
14641918|NCT00184041|Hormones|hormones|mesh-ancestor
14641919|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641920|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641921|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14641922|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14641923|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14641924|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
14641925|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14641926|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14641927|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
14641928|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641929|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
14641930|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641931|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14641932|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14641933|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
14641934|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14641935|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14641936|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14641937|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
14641938|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14641939|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14641940|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14641941|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14641942|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14641943|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
14641944|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14641945|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14641946|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14641947|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14641948|NCT00184106|Paroxetine|paroxetine|mesh-list
14641949|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14641950|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14641951|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641952|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641953|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641954|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
14641955|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641956|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14641957|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
14641958|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14641959|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14641960|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14641961|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641962|NCT00184171|Budesonide|budesonide|mesh-list
14641963|NCT00184171|Bismuth|bismuth|mesh-list
14641964|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14641965|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14641966|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
14641967|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641968|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641969|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14641970|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
14641971|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
14641972|NCT00184171|Hormones|hormones|mesh-ancestor
14641973|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14641974|NCT00184171|Antacids|antacids|mesh-ancestor
14641975|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641976|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14641977|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
14641978|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14641979|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14641980|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14641981|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
14641982|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14641983|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641984|NCT00184496|Methadone|methadone|mesh-list
14641985|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14641986|NCT00184496|Narcotics|narcotics|mesh-ancestor
14641987|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14641988|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14641989|NCT00184496|Analgesics|analgesics|mesh-ancestor
14641990|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
14641991|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14641992|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
14641993|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
14641994|NCT00184522|Esomeprazole|esomeprazole|mesh-list
14641995|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14641996|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15172717|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15172718|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172719|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172720|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15172721|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
14641997|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15172722|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172723|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172724|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15172725|NCT04011098|Fentanyl|fentanyl|mesh-list
15172726|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15172727|NCT04011098|Narcotics|narcotics|mesh-ancestor
15172728|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172729|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172730|NCT04011098|Analgesics|analgesics|mesh-ancestor
15172731|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
15172732|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172733|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14641998|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14641999|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642000|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
14642001|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
14642002|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642003|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642004|NCT00184574|Metformin|metformin|mesh-list
14642005|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
14642006|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
14642007|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642008|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642009|NCT00184587|Candesartan|candesartan|mesh-list
14642010|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
14642011|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
14642012|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14642013|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642014|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642015|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642016|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14642017|NCT00184613|Insulin|insulin|mesh-list
14642018|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14642019|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
14642020|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
14642021|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642022|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642023|NCT00184626|Insulin|insulin|mesh-list
14642024|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14642025|NCT00184626|Metformin|metformin|mesh-list
14642026|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
14642027|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
14642028|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
14642029|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642030|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642031|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
14642032|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642033|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642034|NCT00184665|Insulin|insulin|mesh-list
14642035|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14642036|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
14642037|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
14642038|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
14642039|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
14642040|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
14642041|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642042|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642043|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14642044|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14642045|NCT00184795|Norethindrone|norethindrone|mesh-list
14642046|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
14642047|NCT00184795|Estradiol|estradiol|mesh-list
14642048|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14642049|NCT00184795|Estrogens|estrogens|mesh-ancestor
14642050|NCT00184795|Hormones|hormones|mesh-ancestor
14642051|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642052|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642053|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14642054|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
14642055|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642056|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14642057|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14642058|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14642059|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14642060|NCT00184821|Glyburide|glyburide|mesh-list
14642061|NCT00184821|Adenosine|adenosine|mesh-list
14642062|NCT00184821|Diazoxide|diazoxide|mesh-list
14642063|NCT00184821|Annexin A5|annexin a5|mesh-list
14642064|NCT00184821|Analgesics|analgesics|mesh-ancestor
14642065|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
14642066|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642067|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642068|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14642069|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
14642070|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14642071|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
14642072|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
14642073|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642074|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642075|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642076|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642077|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642078|NCT00184847|Adenosine|adenosine|mesh-list
14642079|NCT00184847|Acetylcholine|acetylcholine|mesh-list
14642080|NCT00184847|Caffeine|caffeine|mesh-list
14642081|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14642082|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642083|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14642084|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642085|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642086|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14642087|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14642088|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
14642089|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172734|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15172735|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
15172736|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
15172737|NCT04010968|Venetoclax|venetoclax|mesh-list
15172738|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172739|NCT04011163|Morphine|morphine|mesh-list
14642090|NCT00184847|Analgesics|analgesics|mesh-ancestor
14642091|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
14642092|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172740|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15172741|NCT04011163|Narcotics|narcotics|mesh-ancestor
14642093|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14642094|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
14642095|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14642096|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
14642097|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14642098|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
14642099|NCT00184886|Methotrexate|methotrexate|mesh-list
14642100|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14642101|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
14642102|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642103|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642104|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642105|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
14642106|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642107|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642108|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642109|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642110|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642111|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642112|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
14642113|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642114|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642115|NCT00184899|Heparin|heparin|mesh-list
14642116|NCT00184899|Calcium heparin|calcium heparin|mesh-list
14642117|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14642118|NCT00184899|Glycerol|glycerol|mesh-list
14642119|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
14642120|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14642121|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14642122|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642123|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14642124|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14642125|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14642126|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14642127|NCT00184899|Protective Agents|protective agents|mesh-ancestor
14642128|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642129|NCT00184912|Caffeine|caffeine|mesh-list
14642130|NCT00184912|Annexin A5|annexin a5|mesh-list
14642131|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14642132|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642133|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14642134|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642135|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642136|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14642137|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15172742|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172743|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172744|NCT04011163|Analgesics|analgesics|mesh-ancestor
15172745|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
15172746|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172747|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
15172748|NCT04011033|Interleukin-2|interleukin-2|mesh-list
15172749|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15172750|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
15172751|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172752|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172753|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15172754|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
14642138|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
14642139|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642140|NCT00184938|Morphine|morphine|mesh-list
14642141|NCT00184938|Naloxone|naloxone|mesh-list
14642142|NCT00184938|Annexin A5|annexin a5|mesh-list
14642143|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14642144|NCT00184938|Narcotics|narcotics|mesh-ancestor
14642145|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14642146|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642147|NCT00184938|Analgesics|analgesics|mesh-ancestor
14642148|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
14642149|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642150|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14642151|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642152|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642153|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14642154|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14642155|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14642156|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
14642157|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642158|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14642159|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14642160|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642161|NCT00184977|Fluticasone|fluticasone|mesh-list
14642162|NCT00184977|Xhance|xhance|mesh-list
14642163|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
14642164|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14642165|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15172755|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172756|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172757|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15172758|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172759|NCT04011033|Analgesics|analgesics|mesh-ancestor
15172760|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
15172761|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172762|NCT04010929|Pemetrexed|pemetrexed|mesh-list
15172763|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172764|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172765|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172766|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15172767|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642166|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14642167|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
14642168|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642169|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642170|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14642171|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
14642172|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642173|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14642174|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
14642175|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642176|NCT00184977|Expectorants|expectorants|mesh-ancestor
14642177|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14642178|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
14642179|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642180|NCT00184977|Protective Agents|protective agents|mesh-ancestor
14642181|NCT00184977|Antidotes|antidotes|mesh-ancestor
14642182|NCT00184990|Pimagedine|pimagedine|mesh-list
14642183|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642184|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642185|NCT00185003|Tolbutamide|tolbutamide|mesh-list
14642186|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
14642187|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642188|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642189|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642190|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14647377|NCT00199576|Protective Agents|protective agents|mesh-ancestor
14647378|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647379|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647380|NCT00199602|Heparin|heparin|mesh-list
14647381|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
14647382|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14647383|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14647384|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647385|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
14647386|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647387|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647388|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14647389|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
14647390|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14647391|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647392|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647393|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647394|NCT00199719|Ribavirin|ribavirin|mesh-list
14647395|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
14647396|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647397|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
14647398|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647399|NCT00199745|Atorvastatin|atorvastatin|mesh-list
14647400|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14647401|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15172768|NCT04010942|Metformin|metformin|mesh-list
14642191|NCT00185055|Valsartan|valsartan|mesh-list
14642192|NCT00185055|Olmesartan|olmesartan|mesh-list
14642193|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14642194|NCT00185055|Irbesartan|irbesartan|mesh-list
14642195|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642196|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642197|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642198|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642199|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14642200|NCT00185068|Olmesartan|olmesartan|mesh-list
14642201|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14642202|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642203|NCT00185068|Diuretics|diuretics|mesh-ancestor
14642204|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
14642205|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642206|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14642207|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642208|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642209|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642210|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642211|NCT00185094|Losartan|losartan|mesh-list
14642212|NCT00185094|Atenolol|atenolol|mesh-list
14642213|NCT00185094|Olmesartan|olmesartan|mesh-list
14642214|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14642215|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14642216|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642217|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642218|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642219|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642220|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
14642221|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
14642222|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642223|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642224|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14642225|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14642226|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14642227|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14642228|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642229|NCT00185107|Simvastatin|simvastatin|mesh-list
14642230|NCT00185107|Ezetimibe|ezetimibe|mesh-list
14642231|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14642232|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14642233|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14642234|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
14642235|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642236|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14642237|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14642238|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642239|NCT00185120|Amlodipine|amlodipine|mesh-list
14642240|NCT00185120|Olmesartan|olmesartan|mesh-list
14642241|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14642242|NCT00185120|Benazepril|benazepril|mesh-list
14642243|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642244|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14642245|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642246|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642247|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14642248|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642249|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
14642250|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642251|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642252|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14642253|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
14642254|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642255|NCT00185133|Amlodipine|amlodipine|mesh-list
14642256|NCT00185133|Olmesartan|olmesartan|mesh-list
14642257|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14642258|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642259|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14642260|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642261|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642262|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14642263|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642264|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
14642265|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642266|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642267|NCT00185159|Olmesartan|olmesartan|mesh-list
14642268|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14642269|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642270|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642271|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642272|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642273|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14642274|NCT00185172|Olmesartan|olmesartan|mesh-list
14642275|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14642276|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642277|NCT00185172|Diuretics|diuretics|mesh-ancestor
14642278|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
14642279|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642280|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14642281|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642282|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642283|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642284|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642285|NCT00185185|Atenolol|atenolol|mesh-list
14642286|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14642287|NCT00185185|Olmesartan|olmesartan|mesh-list
14642288|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15172769|NCT04010942|Clomiphene|clomiphene|mesh-list
15172770|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14022626|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022627|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642289|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14642290|NCT00185185|Diuretics|diuretics|mesh-ancestor
14642291|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
14642292|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642293|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14642294|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642295|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642296|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642297|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14642298|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14642299|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
14642300|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
14642301|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642302|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14642303|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14642304|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14642305|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
14642306|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642307|NCT00185198|Testosterone|testosterone|mesh-list
14642308|NCT00185198|Androgens|androgens|mesh-ancestor
14642309|NCT00185198|Hormones|hormones|mesh-ancestor
14642310|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642311|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642312|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14642313|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14642314|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14642315|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14642316|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
14642317|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642318|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642319|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14642320|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14642321|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14642322|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14642323|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14642324|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14642325|NCT00185237|Estradiol|estradiol|mesh-list
14642326|NCT00185237|Estrogens|estrogens|mesh-ancestor
14642327|NCT00185237|Hormones|hormones|mesh-ancestor
14642328|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647402|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
14022628|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
15172771|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022629|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022630|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022631|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14022632|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14022633|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022634|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
14022635|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
14022636|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14022637|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022638|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022639|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
14022640|NCT02767674|Hormones|hormones|mesh-ancestor
14022641|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14022642|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14022643|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14642329|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642330|NCT00185250|Interferons|interferons|mesh-list
14642331|NCT00185250|Interferon-beta|interferon-beta|mesh-list
14642332|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
14642333|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642334|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
14642335|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642336|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
14642337|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642338|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14642339|NCT00185302|Entinostat|entinostat|mesh-list
14642340|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14642341|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642342|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642343|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642344|NCT00185315|Iloprost|iloprost|mesh-list
14642345|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14642346|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
14642347|NCT00185328|Estradiol|estradiol|mesh-list
14642348|NCT00185328|Estrogens|estrogens|mesh-ancestor
14642349|NCT00185328|Hormones|hormones|mesh-ancestor
14642350|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642351|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642352|NCT00185419|Desogestrel|desogestrel|mesh-list
14642353|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642354|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642355|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14642356|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14642357|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14642358|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
14642359|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14642360|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14642361|NCT00185419|Progestins|progestins|mesh-ancestor
14642362|NCT00185419|Hormones|hormones|mesh-ancestor
14642363|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642364|NCT00185445|Fludarabine|fludarabine|mesh-list
14642365|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
14642366|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642367|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642368|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
14642369|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642370|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642371|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
14642372|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642373|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
14642374|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14642375|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14642376|NCT00185510|Prednisolone|prednisolone|mesh-list
14642377|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
14642378|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
14642379|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14642380|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
14642381|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642382|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
14642383|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
14642384|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642385|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642386|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14642387|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
14642388|NCT00185510|Hormones|hormones|mesh-ancestor
14642389|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642390|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14642391|NCT00185510|Protective Agents|protective agents|mesh-ancestor
14642392|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14642393|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022644|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14022645|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14022646|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14022647|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14022648|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14022649|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14022650|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
14022651|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14022652|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14022653|NCT02767245|Thiamine|thiamine|mesh-list
14022654|NCT02767245|Vitamins|vitamins|mesh-ancestor
14022655|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
14022656|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022657|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
14022658|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14022659|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14022660|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14022661|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
14022662|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022663|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14022664|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14642394|NCT00185562|Adalimumab|adalimumab|mesh-list
14642395|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642396|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642397|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15172772|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15172773|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
15172774|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642398|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14642399|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14642400|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642401|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642402|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642403|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642404|NCT00185575|Analgesics|analgesics|mesh-ancestor
14642405|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
14642406|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642407|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
14642408|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14642409|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
14642410|NCT00185705|Telmisartan|telmisartan|mesh-list
14642411|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14022665|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022666|NCT02767375|Fluorouracil|fluorouracil|mesh-list
14022667|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
14022668|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
14022669|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022670|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14022671|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14022672|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14022673|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
14022674|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022675|NCT02767362|Atorvastatin|atorvastatin|mesh-list
14022676|NCT02767362|Ezetimibe|ezetimibe|mesh-list
14022677|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14022678|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14022679|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
14022680|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022681|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14022682|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14022683|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14022684|NCT02767401|Aspirin|aspirin|mesh-list
14022685|NCT02767401|Metoprolol|metoprolol|mesh-list
14642412|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14642413|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15172775|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15172776|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
14022686|NCT02767401|Clopidogrel|clopidogrel|mesh-list
14022687|NCT02767401|Ticagrelor|ticagrelor|mesh-list
14642414|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642415|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
14642416|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642417|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14642418|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
14642419|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642420|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642421|NCT00185835|Gefitinib|gefitinib|mesh-list
14642422|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642423|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14642424|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642425|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642426|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
14642427|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642428|NCT00185887|Terbutaline|terbutaline|mesh-list
14642429|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14642430|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
14642431|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642432|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642433|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14642434|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
14642435|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
14642436|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
14642437|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642438|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14642439|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14642440|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14642441|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
14642442|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642443|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172777|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15172778|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15172779|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15172780|NCT04010903|Insulin|insulin|mesh-list
15172781|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15172782|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172783|NCT04010669|Somatostatin|somatostatin|mesh-list
15172784|NCT04010669|Hormones|hormones|mesh-ancestor
15172785|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172786|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172787|NCT04010578|Vitamin D|vitamin d|mesh-list
15172788|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
15172789|NCT04010578|Vitamins|vitamins|mesh-ancestor
15172790|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
15172791|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642444|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14642445|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14642446|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642447|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14642448|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172792|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15172793|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15172794|NCT04010318|Anesthetics|anesthetics|mesh-list
15172795|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172796|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172797|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
14642449|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642450|NCT00185952|Nifedipine|nifedipine|mesh-list
14642451|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14642452|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642453|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642454|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14642455|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642456|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
14642457|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
14642458|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642459|NCT00185991|Gentamicins|gentamicins|mesh-list
14642460|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14642461|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642462|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14642463|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642464|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642465|NCT00186082|Cefoxitin|cefoxitin|mesh-list
14642466|NCT00186082|Cefotetan|cefotetan|mesh-list
14642467|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14642468|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642469|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
14642470|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14642471|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642472|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14642473|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14642474|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14642475|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642476|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14642477|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642478|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14642479|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
14642480|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14642481|NCT00186277|Docetaxel|docetaxel|mesh-list
14642482|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
14642483|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642484|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642485|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642486|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642487|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642488|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14642489|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
14642490|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642491|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14642492|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
14642493|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642494|NCT00186420|Docetaxel|docetaxel|mesh-list
14642495|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642496|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642497|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642498|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642499|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642500|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14642501|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
14642502|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642503|NCT00186706|Selenium|selenium|mesh-list
14642504|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
14642505|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642506|NCT00186706|Protective Agents|protective agents|mesh-ancestor
14642507|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642508|NCT00186706|Trace Elements|trace elements|mesh-ancestor
14642509|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
14642510|NCT00186745|Tinzaparin|tinzaparin|mesh-list
15172798|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15172799|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172800|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172801|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172802|NCT04010305|Analgesics|analgesics|mesh-ancestor
15172803|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
15172804|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172805|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15172806|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15172807|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15172808|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
15172809|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172810|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172811|NCT04010071|Axitinib|axitinib|mesh-list
15172812|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172813|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15172814|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642511|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14642512|NCT00186745|Dalteparin|dalteparin|mesh-list
14642513|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
14642514|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14642515|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14642516|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647403|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647404|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14647405|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14647406|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172815|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642517|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
14642518|NCT00186797|Fludarabine|fludarabine|mesh-list
14642519|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642520|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
14642521|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642522|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642523|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642524|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
14642525|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642526|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642527|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15172816|NCT04009759|Ketamine|ketamine|mesh-list
15172817|NCT04009759|Morphine|morphine|mesh-list
15172818|NCT04009759|Analgesics|analgesics|mesh-ancestor
15172819|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
15172820|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172821|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172822|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15172823|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15172824|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
15172825|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
15172826|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172827|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15172828|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15172829|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15172830|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172831|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15172832|NCT04009759|Narcotics|narcotics|mesh-ancestor
15172833|NCT04009772|Metronidazole|metronidazole|mesh-list
15172834|NCT04009772|Cefepime|cefepime|mesh-list
14642528|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
14642529|NCT00186810|Busulfan|busulfan|mesh-list
14642530|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642531|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
14642532|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172835|NCT04009772|Cefuroxime|cefuroxime|mesh-list
15172836|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
15172837|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642533|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642534|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642535|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
14642536|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642537|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642538|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642539|NCT00186823|Antibodies|antibodies|mesh-list
14642540|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
14642541|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642542|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
14642543|NCT00186849|Ifosfamide|ifosfamide|mesh-list
14642544|NCT00186849|Carboplatin|carboplatin|mesh-list
14642545|NCT00186849|Doxorubicin|doxorubicin|mesh-list
14642546|NCT00186849|Etoposide|etoposide|mesh-list
14642547|NCT00186849|Topotecan|topotecan|mesh-list
14642548|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642549|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
14642550|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642551|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642552|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642553|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
14642554|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642555|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642556|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642557|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14642558|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14642559|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642560|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642561|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642562|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14642563|NCT00186862|Interleukin-2|interleukin-2|mesh-list
14642564|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642565|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14642566|NCT00186862|Analgesics|analgesics|mesh-ancestor
15172838|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15172839|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15172840|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14642567|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
14642568|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642569|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642570|NCT00186940|Rasburicase|rasburicase|mesh-list
14642571|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
14642572|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642573|NCT00186966|Cytarabine|cytarabine|mesh-list
14642574|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
14642575|NCT00186966|Melphalan|melphalan|mesh-list
14642576|NCT00186966|Busulfan|busulfan|mesh-list
14642577|NCT00186966|Fludarabine|fludarabine|mesh-list
14642578|NCT00186966|Etoposide|etoposide|mesh-list
14642579|NCT00186966|Daunorubicin|daunorubicin|mesh-list
14642580|NCT00186966|Thioguanine|thioguanine|mesh-list
14642581|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642582|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
14642583|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642584|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642585|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642586|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
14642587|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642588|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642589|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642590|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642591|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
14642592|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642593|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15172841|NCT04009889|Silicon|silicon|mesh-list
15172842|NCT04009889|Trace Elements|trace elements|mesh-ancestor
15172843|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
15172844|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172845|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
15172846|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15172847|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172848|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
15172849|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
15172850|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172851|NCT04009603|Metformin|metformin|mesh-list
15172852|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14642594|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642595|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642596|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
14642597|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642598|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15172853|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172854|NCT04009525|Cyclosporine|cyclosporine|mesh-list
15172855|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
15172856|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
14642599|NCT00186979|Cefixime|cefixime|mesh-list
15172857|NCT04009525|Busulfan|busulfan|mesh-list
14642600|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
14642601|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
14642602|NCT00186979|Irinotecan|irinotecan|mesh-list
14642603|NCT00186979|Vincristine|vincristine|mesh-list
15172858|NCT04009525|Methotrexate|methotrexate|mesh-list
15172859|NCT04009525|Fludarabine|fludarabine|mesh-list
15172860|NCT04009525|Tacrolimus|tacrolimus|mesh-list
15172861|NCT04009525|Cyclosporins|cyclosporins|mesh-list
15172862|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
15172863|NCT04009525|Basiliximab|basiliximab|mesh-list
15172864|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15172865|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
15172866|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172867|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172868|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15172869|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
15172870|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172871|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172872|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15172873|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15172874|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
15172875|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15172876|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15172877|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
15172878|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
15172879|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172880|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642604|NCT00186979|Gefitinib|gefitinib|mesh-list
14642605|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14642606|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15172881|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15172882|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15172883|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
15172884|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172885|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15172886|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14642607|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642608|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642609|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642610|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642611|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642612|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642613|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642614|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14642615|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15172887|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
15172888|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15172889|NCT04009317|Crizotinib|crizotinib|mesh-list
15172890|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172891|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14642616|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642617|NCT00187005|Cytarabine|cytarabine|mesh-list
14642618|NCT00187005|Dexamethasone|dexamethasone|mesh-list
14642619|NCT00187005|Prednisone|prednisone|mesh-list
14642620|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
14642621|NCT00187005|Methotrexate|methotrexate|mesh-list
14642622|NCT00187005|Etoposide|etoposide|mesh-list
14642623|NCT00187005|Vincristine|vincristine|mesh-list
14642624|NCT00187005|Daunorubicin|daunorubicin|mesh-list
14642625|NCT00187005|Asparaginase|asparaginase|mesh-list
14642626|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
14642627|NCT00187005|Idarubicin|idarubicin|mesh-list
14642628|NCT00187005|Pegaspargase|pegaspargase|mesh-list
14642629|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642630|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
14642631|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642632|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642633|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642634|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
14642635|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642636|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642637|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642638|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642639|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
14642640|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
14642641|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642642|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14642643|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
14642644|NCT00187005|Hormones|hormones|mesh-ancestor
14642645|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642646|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14642647|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14642648|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
14642649|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642650|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642651|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
14642652|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642653|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642654|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642655|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642656|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642657|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14642658|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642659|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
14642660|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642661|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642662|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642663|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642664|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14642665|NCT00187031|Topotecan|topotecan|mesh-list
14642666|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14642667|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642668|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642669|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642670|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172892|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172893|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642671|NCT00187057|Cytarabine|cytarabine|mesh-list
14642672|NCT00187057|Dexamethasone|dexamethasone|mesh-list
14642673|NCT00187057|Prednisone|prednisone|mesh-list
14642674|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
14642675|NCT00187057|Doxorubicin|doxorubicin|mesh-list
14642676|NCT00187057|Methotrexate|methotrexate|mesh-list
14642677|NCT00187057|Etoposide|etoposide|mesh-list
14642678|NCT00187057|Vincristine|vincristine|mesh-list
14642679|NCT00187057|Daunorubicin|daunorubicin|mesh-list
14642680|NCT00187057|Asparaginase|asparaginase|mesh-list
14642681|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
14642682|NCT00187057|Vinblastine|vinblastine|mesh-list
14642683|NCT00187057|Procarbazine|procarbazine|mesh-list
14642684|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642685|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
14642686|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642687|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642688|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642689|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
14642690|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642691|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642692|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642693|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642694|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
14642695|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
14642696|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642697|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14642698|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
14642699|NCT00187057|Hormones|hormones|mesh-ancestor
14642700|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172894|NCT04009343|Lumefantrine|lumefantrine|mesh-list
15172895|NCT04009343|Artemether|artemether|mesh-list
15172896|NCT04009343|Piperaquine|piperaquine|mesh-list
15172897|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15172898|NCT04009343|Artenimol|artenimol|mesh-list
15172899|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
15172900|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14642701|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14642702|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14642703|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14642704|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642705|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642706|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14642707|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
14642708|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642709|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642710|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
14642711|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642712|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642713|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14022688|NCT02767401|Atorvastatin|atorvastatin|mesh-list
14022689|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14022690|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14022691|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172901|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15172902|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172903|NCT04008979|Aspirin|aspirin|mesh-list
15172904|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15172905|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15172906|NCT04008979|Analgesics|analgesics|mesh-ancestor
15172907|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
15172908|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172909|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14022692|NCT02767401|Analgesics|analgesics|mesh-ancestor
14022693|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
14642714|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642715|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
14642716|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14642717|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642718|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14642719|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14642720|NCT00187070|Cytarabine|cytarabine|mesh-list
15172910|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022694|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14642721|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14642722|NCT00187070|Dexamethasone|dexamethasone|mesh-list
14642723|NCT00187070|Prednisone|prednisone|mesh-list
14642724|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
14022695|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642725|NCT00187070|Ifosfamide|ifosfamide|mesh-list
14642726|NCT00187070|Carboplatin|carboplatin|mesh-list
14642727|NCT00187070|Doxorubicin|doxorubicin|mesh-list
14642728|NCT00187070|Methotrexate|methotrexate|mesh-list
14642729|NCT00187070|Etoposide|etoposide|mesh-list
14642730|NCT00187070|Vincristine|vincristine|mesh-list
14642731|NCT00187070|Vinblastine|vinblastine|mesh-list
14642732|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14642733|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
14642734|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14642735|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14642736|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14642737|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
14642738|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14642739|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14642740|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14642741|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14642742|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
14642743|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
14642744|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15172911|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15172912|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15172913|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15172914|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15172915|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14642745|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14642746|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
14642747|NCT00187070|Hormones|hormones|mesh-ancestor
14642748|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14642749|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14642750|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14642751|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14642752|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14642753|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14642754|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14642755|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
14642756|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14642757|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14642758|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
14022696|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14022697|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14022698|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14022699|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14022700|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14022701|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14642759|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
14642760|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14642761|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14642762|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14642763|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
14642764|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15172916|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15172917|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15172918|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
15172919|NCT04009018|Anesthetics|anesthetics|mesh-list
15172920|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15172921|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172922|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
15172923|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
15172924|NCT04009044|Tamoxifen|tamoxifen|mesh-list
15172925|NCT04009044|Afimoxifene|afimoxifene|mesh-list
15172926|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15172927|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
15172928|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15172929|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15172930|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15172931|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15172932|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15172933|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15172934|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14642765|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
14642766|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
15172935|NCT04008784|Triamcinolone|triamcinolone|mesh-list
15172936|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14642767|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647407|NCT00199758|Gemcitabine|gemcitabine|mesh-list
14647547|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647548|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647549|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647550|NCT00200447|Carbidopa|carbidopa|mesh-list
14647551|NCT00200447|Levodopa|levodopa|mesh-list
14647552|NCT00200447|Entacapone|entacapone|mesh-list
14647553|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14647554|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14647555|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15182335|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182336|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182337|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14647556|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
14647557|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647558|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647559|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647560|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14647561|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647562|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14647563|NCT00200460|Nebivolol|nebivolol|mesh-list
14647564|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14647565|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
14647566|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14647567|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14647568|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14647569|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
14647570|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647571|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647572|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647573|NCT00200473|Nebivolol|nebivolol|mesh-list
14647574|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14647575|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
14647576|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14647577|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14647578|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14647579|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14647580|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647581|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647582|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647583|NCT00200499|Nebivolol|nebivolol|mesh-list
14647584|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14647585|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
14647586|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14647587|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14647588|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14647589|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
14647590|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647591|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647592|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647593|NCT00200512|Apomorphine|apomorphine|mesh-list
14647594|NCT00200512|Emetics|emetics|mesh-ancestor
14647595|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647596|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
14647597|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647598|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647599|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
14647600|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
14647601|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647602|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647603|NCT00200525|Apomorphine|apomorphine|mesh-list
14647604|NCT00200525|Emetics|emetics|mesh-ancestor
14647605|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647606|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
14647607|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647608|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647609|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
14647610|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
14647611|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647612|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647613|NCT00200538|Memantine|memantine|mesh-list
14647614|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14647615|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14647616|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
15182338|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14647617|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647618|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647619|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647620|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14647621|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14647622|NCT00200551|Cyclosporine|cyclosporine|mesh-list
14647623|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
14647624|NCT00200551|Cyclosporins|cyclosporins|mesh-list
14647625|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14647626|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647627|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647628|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647629|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
14647630|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647631|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
14647632|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647633|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
14647634|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647635|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14647636|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647637|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647638|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14647639|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
14647640|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14647641|NCT00200564|Ketamine|ketamine|mesh-list
14647642|NCT00200564|Analgesics|analgesics|mesh-ancestor
14647643|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
14647644|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647645|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647646|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14647647|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14647648|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
14647649|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
14647650|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647651|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14647652|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14647653|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647654|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647655|NCT00200590|Acetaminophen|acetaminophen|mesh-list
14647656|NCT00200590|Morphine|morphine|mesh-list
14647657|NCT00200590|Nalbuphine|nalbuphine|mesh-list
14647658|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14647659|NCT00200590|Narcotics|narcotics|mesh-ancestor
14647660|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647661|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647662|NCT00200590|Analgesics|analgesics|mesh-ancestor
14647663|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
14647664|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647665|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14647666|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
14647667|NCT00200603|Calcium|calcium|mesh-list
14647668|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14647669|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647670|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
14647671|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14647672|NCT00200629|Adenosine|adenosine|mesh-list
14647673|NCT00200629|Analgesics|analgesics|mesh-ancestor
14647674|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
14647675|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647676|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647677|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14647678|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14647679|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14647680|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
14647681|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
14647682|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647683|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647684|NCT00200655|Pravastatin|pravastatin|mesh-list
14647685|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14647686|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14647687|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
14647688|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647689|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14647690|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14647691|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647692|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14647693|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14647694|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647695|NCT00200681|Bortezomib|bortezomib|mesh-list
14647696|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647697|NCT00200694|Valsartan|valsartan|mesh-list
14647698|NCT00200694|Ramipril|ramipril|mesh-list
14647699|NCT00200694|Furosemide|furosemide|mesh-list
14647700|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14647701|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14647702|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14647703|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647704|NCT00200694|Diuretics|diuretics|mesh-ancestor
14647705|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
14647706|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647707|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14647708|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14647709|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14647710|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14647711|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647712|NCT00200941|Topiramate|topiramate|mesh-list
14647713|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
14647714|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14647715|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725167|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15182339|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15182340|NCT03921736|Perindopril|perindopril|mesh-list
15182341|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15182342|NCT03921736|Diuretics|diuretics|mesh-ancestor
14293240|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293241|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293242|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14293243|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15182343|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
15182344|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182345|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15182346|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182347|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182348|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15182349|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
15182350|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182351|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15182352|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182353|NCT03921671|Paclitaxel|paclitaxel|mesh-list
15182354|NCT03921671|Carboplatin|carboplatin|mesh-list
15182355|NCT03921671|Ramucirumab|ramucirumab|mesh-list
15182356|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15182357|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182358|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182359|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
15182360|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
15182361|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182362|NCT03921593|Pancrelipase|pancrelipase|mesh-list
15182363|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15182364|NCT03921567|Lidocaine|lidocaine|mesh-list
15182365|NCT03921567|Ketamine|ketamine|mesh-list
15182366|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
15182367|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
15182368|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182369|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182370|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
15182371|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182372|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15182373|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15182374|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15182375|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182376|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182377|NCT03921567|Analgesics|analgesics|mesh-ancestor
15182378|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15182379|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14293244|NCT00566969|Carvedilol|carvedilol|mesh-list
14725168|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182380|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
15182381|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15182382|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15182383|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182384|NCT03921775|Propofol|propofol|mesh-list
15182385|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15182386|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647716|NCT00201305|Leucovorin|leucovorin|mesh-list
14647717|NCT00201305|Gemcitabine|gemcitabine|mesh-list
14647718|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647719|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
14647720|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647721|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647722|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
14647723|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647724|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647725|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647726|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
14647727|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647728|NCT00201305|Antidotes|antidotes|mesh-ancestor
14647729|NCT00201305|Protective Agents|protective agents|mesh-ancestor
14647730|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
14647731|NCT00201305|Vitamins|vitamins|mesh-ancestor
14647732|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
14647733|NCT00201318|Lamivudine|lamivudine|mesh-list
14647734|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
14647735|NCT00201318|Doxorubicin|doxorubicin|mesh-list
14647736|NCT00201318|Vincristine|vincristine|mesh-list
14647737|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647738|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
14647739|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647740|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647741|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14647742|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
14647743|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647744|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647745|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14647746|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647747|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647748|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647749|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647750|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647751|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647752|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647753|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647754|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14647755|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647756|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
14647757|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647758|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14647759|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14647760|NCT00201331|Leucovorin|leucovorin|mesh-list
14647761|NCT00201331|Antidotes|antidotes|mesh-ancestor
14647762|NCT00201331|Protective Agents|protective agents|mesh-ancestor
14647763|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647764|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
14647765|NCT00201331|Vitamins|vitamins|mesh-ancestor
14647766|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
14647767|NCT00201344|Leucovorin|leucovorin|mesh-list
14647768|NCT00201344|Antidotes|antidotes|mesh-ancestor
14647769|NCT00201344|Protective Agents|protective agents|mesh-ancestor
14647770|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182387|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182388|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15182389|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
15182390|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
15182391|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
15182392|NCT03921177|Micronutrients|micronutrients|mesh-list
15182393|NCT03921177|Trace Elements|trace elements|mesh-list
15182394|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182395|NCT03921034|Ropivacaine|ropivacaine|mesh-list
15182396|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
15182397|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
15182398|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182399|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647771|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
14647772|NCT00201344|Vitamins|vitamins|mesh-ancestor
14647773|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
14647774|NCT00201357|Thalidomide|thalidomide|mesh-list
14647775|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182400|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
15182401|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647776|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
14647777|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647778|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
14647779|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14647780|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647781|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14647782|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14647783|NCT00201357|Growth Substances|growth substances|mesh-ancestor
14647784|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
14647785|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647786|NCT00201383|Cisplatin|cisplatin|mesh-list
14647787|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647788|NCT00201396|Leucovorin|leucovorin|mesh-list
14647789|NCT00201396|Fluorouracil|fluorouracil|mesh-list
14647790|NCT00201396|Epirubicin|epirubicin|mesh-list
14647791|NCT00201396|Mitomycins|mitomycins|mesh-list
14647792|NCT00201396|Mitomycin|mitomycin|mesh-list
14647793|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647794|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
14647795|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647796|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647797|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647798|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
14647799|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647800|NCT00201396|Antidotes|antidotes|mesh-ancestor
14647801|NCT00201396|Protective Agents|protective agents|mesh-ancestor
14647802|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
14647803|NCT00201396|Vitamins|vitamins|mesh-ancestor
14647804|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
14647805|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647806|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647807|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647808|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647809|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
14647810|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647811|NCT00201422|Amoxicillin|amoxicillin|mesh-list
14647812|NCT00201422|Clarithromycin|clarithromycin|mesh-list
14647813|NCT00201422|Omeprazole|omeprazole|mesh-list
14647814|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14647815|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14647816|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14647817|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647818|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14647819|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647820|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647821|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14647822|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14647823|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14647824|NCT00201435|Paclitaxel|paclitaxel|mesh-list
14647825|NCT00201435|Docetaxel|docetaxel|mesh-list
14647826|NCT00201435|Capecitabine|capecitabine|mesh-list
14647827|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647828|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647829|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647830|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647831|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647832|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647833|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647834|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
14647835|NCT00201539|Morphine|morphine|mesh-list
14647836|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14647837|NCT00201539|Narcotics|narcotics|mesh-ancestor
14647838|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14647839|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647840|NCT00201539|Analgesics|analgesics|mesh-ancestor
14647841|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
14647842|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647843|NCT00201630|Alfuzosin|alfuzosin|mesh-list
14647844|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14647845|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14647846|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14647847|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
14647848|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647849|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647850|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647851|NCT00201630|Urological Agents|urological agents|mesh-ancestor
14647852|NCT00201669|Clofarabine|clofarabine|mesh-list
14647853|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14647854|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
14647855|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647856|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647857|NCT00201682|Etanercept|etanercept|mesh-list
14647858|NCT00201682|Rituximab|rituximab|mesh-list
14647859|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14647860|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647861|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
14647862|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647863|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647864|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14647865|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14647866|NCT00201682|Analgesics|analgesics|mesh-ancestor
14647867|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
14647868|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647869|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647870|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647871|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647872|NCT00201695|Dexamethasone|dexamethasone|mesh-list
14647873|NCT00201695|Doxorubicin|doxorubicin|mesh-list
14647874|NCT00201695|Vincristine|vincristine|mesh-list
14647875|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
14647876|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647877|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
14647878|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
14647879|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647880|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647881|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647882|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
14647883|NCT00201695|Hormones|hormones|mesh-ancestor
14647884|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182402|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
15182403|NCT03921099|Vitamins|vitamins|mesh-ancestor
15182404|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
14647885|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647886|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647887|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647888|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647889|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647890|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647891|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647892|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14647893|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647894|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647895|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647896|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
14647897|NCT00201708|Docetaxel|docetaxel|mesh-list
14647898|NCT00201708|Doxorubicin|doxorubicin|mesh-list
14647899|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647900|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
14647901|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647902|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647903|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14647904|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
14647905|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647906|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647907|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14647908|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647909|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647910|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647911|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647912|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14647913|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14647914|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647915|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
14647916|NCT00201721|Rituximab|rituximab|mesh-list
14647917|NCT00201721|Pentostatin|pentostatin|mesh-list
14647918|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647919|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
14647920|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647921|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725169|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
15182405|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647922|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14647923|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
14647924|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647925|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647926|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14647927|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14647928|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14647929|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647930|NCT00201747|Mitomycins|mitomycins|mesh-list
14647931|NCT00201747|Mitomycin|mitomycin|mesh-list
14647932|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14647933|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647934|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
14647935|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647936|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14647937|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647938|NCT00201786|Pentostatin|pentostatin|mesh-list
15182406|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
15182407|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182408|NCT03921099|Protective Agents|protective agents|mesh-ancestor
15182409|NCT03920657|Deferasirox|deferasirox|mesh-list
15182410|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15182411|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
15182412|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
15182413|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182414|NCT03920631|Nivolumab|nivolumab|mesh-list
14647939|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647940|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14647941|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647942|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647943|NCT00201799|Infliximab|infliximab|mesh-list
14647944|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14647945|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647946|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647947|NCT00201812|Dexamethasone|dexamethasone|mesh-list
14647948|NCT00201812|Etanercept|etanercept|mesh-list
14647949|NCT00201812|Docetaxel|docetaxel|mesh-list
14647950|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
14647951|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14647952|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
14647953|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
14647954|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14647955|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647956|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647957|NCT00201812|Hormones|hormones|mesh-ancestor
14647958|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14647959|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14647960|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14647961|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14647962|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14647963|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14647964|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647965|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14647966|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14647967|NCT00201812|Analgesics|analgesics|mesh-ancestor
14647968|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
14647969|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14647970|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14647971|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
14647972|NCT00201955|Rebamipide|rebamipide|mesh-list
14647973|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14647974|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647975|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
14647976|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647977|NCT00201955|Protective Agents|protective agents|mesh-ancestor
14647978|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647979|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647980|NCT00201981|Rebamipide|rebamipide|mesh-list
14647981|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14647982|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14647983|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
14647984|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647985|NCT00201981|Protective Agents|protective agents|mesh-ancestor
14293245|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14647986|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647987|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14647988|NCT00201994|Tolvaptan|tolvaptan|mesh-list
14293246|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14293247|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
14293248|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293249|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182415|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14647989|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14647990|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647991|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
14647992|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14647993|NCT00202007|Risperidone|risperidone|mesh-list
14647994|NCT00202007|Aripiprazole|aripiprazole|mesh-list
14647995|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14647996|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
14647997|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14647998|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14647999|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648000|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648001|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648002|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648003|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648004|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648005|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
14648006|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
14648007|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
14648008|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14648009|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14648010|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14648011|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14648012|NCT00202020|Aspirin|aspirin|mesh-list
14648013|NCT00202020|Cilostazol|cilostazol|mesh-list
14648014|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14648015|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14648016|NCT00202020|Analgesics|analgesics|mesh-ancestor
14648017|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
14648018|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648019|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648020|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648021|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648022|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14648023|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14648024|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648025|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14648026|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14648027|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648028|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
14648029|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14648030|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
14648031|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14648032|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
14648033|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
14648034|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15182416|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182417|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15182418|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223499|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
15223500|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
15223501|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
15223502|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223503|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15223504|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15223505|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15223506|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223507|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15223508|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15223509|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15223510|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
15223511|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223512|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648035|NCT00202020|Protective Agents|protective agents|mesh-ancestor
14729248|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
14648036|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14648037|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14648038|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
14648039|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14648040|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648041|NCT00202124|Tryptophan|tryptophan|mesh-list
14648042|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14648043|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
14648044|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648045|NCT00202163|Testosterone|testosterone|mesh-list
14648046|NCT00202163|Androgens|androgens|mesh-ancestor
14648047|NCT00202163|Hormones|hormones|mesh-ancestor
14648048|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648049|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648050|NCT00202176|Bromides|bromides|mesh-list
14648051|NCT00202176|Ipratropium|ipratropium|mesh-list
14648052|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
14648053|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14648054|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
14648055|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648056|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648057|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14648058|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
14648059|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14648060|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
14648061|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648062|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648063|NCT00202189|Budesonide|budesonide|mesh-list
14648064|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648065|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14648066|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
14648067|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648068|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182419|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
15182420|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
15182421|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182422|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15182423|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648069|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14648070|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
14648071|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
14648072|NCT00202189|Hormones|hormones|mesh-ancestor
14648073|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648074|NCT00202228|Riboflavin|riboflavin|mesh-list
14648075|NCT00202228|Thiamine|thiamine|mesh-list
14648076|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
14648077|NCT00202228|Vitamins|vitamins|mesh-ancestor
14648078|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
14648079|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648080|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14648081|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
14648082|NCT00202241|Testosterone|testosterone|mesh-list
14648083|NCT00202241|Androgens|androgens|mesh-ancestor
14648084|NCT00202241|Hormones|hormones|mesh-ancestor
14648085|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648086|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648087|NCT00202280|Folic Acid|folic acid|mesh-list
14648088|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
14648089|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
14648090|NCT00202280|Vitamins|vitamins|mesh-ancestor
14648091|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
14648092|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648093|NCT00202280|Hematinics|hematinics|mesh-ancestor
14648094|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
14648095|NCT00202293|Olanzapine|olanzapine|mesh-list
14648096|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
14648097|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
14648098|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
14648099|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648100|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648101|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15182424|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182425|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
14648102|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648103|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648104|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648105|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648106|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14648107|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14648108|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14648109|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648110|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648111|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
14648112|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648113|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
14648114|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
14648115|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
14648116|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648117|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648118|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648119|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
14648120|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648121|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648122|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648123|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14648124|NCT00202345|Hematinics|hematinics|mesh-ancestor
14648125|NCT00202358|Atenolol|atenolol|mesh-list
14648126|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14648127|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15182426|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182427|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15182428|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182429|NCT03921008|Paclitaxel|paclitaxel|mesh-list
15182430|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15182431|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182432|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182433|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
15182434|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
15182435|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182436|NCT03920878|Aflibercept|aflibercept|mesh-list
15182437|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15182438|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15182439|NCT03920878|Growth Substances|growth substances|mesh-ancestor
15182440|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182441|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
14648128|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
14648129|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
14648130|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648131|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648132|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14648133|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14648134|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14648135|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
14648136|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648137|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648138|NCT00202397|Riluzole|riluzole|mesh-list
14648139|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
14648140|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15182442|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182443|NCT03920618|Tenofovir|tenofovir|mesh-list
14648141|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14648142|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648143|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648144|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648145|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14648146|NCT00202397|Protective Agents|protective agents|mesh-ancestor
14648147|NCT00202423|Nabiximols|nabiximols|mesh-list
14648148|NCT00202423|Analgesics|analgesics|mesh-ancestor
14648149|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
14648150|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648151|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648152|NCT00202462|Testosterone|testosterone|mesh-list
14648153|NCT00202462|Androgens|androgens|mesh-ancestor
14648154|NCT00202462|Hormones|hormones|mesh-ancestor
14648155|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648156|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648157|NCT00202514|Valproic Acid|valproic acid|mesh-list
14648158|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
14648159|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729249|NCT00522210|Insulin|insulin|mesh-list
15182444|NCT03920618|Entecavir|entecavir|mesh-list
15182445|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
14648160|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648161|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
14648162|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648163|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648164|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
14648165|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648166|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648167|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648168|NCT00202553|Perindopril|perindopril|mesh-list
14648169|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14648170|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
14648171|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648172|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648173|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14648174|NCT00202592|Perindopril|perindopril|mesh-list
14648175|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15182446|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182447|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15182448|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15182449|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182450|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182451|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15182452|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15182453|NCT03920839|Gemcitabine|gemcitabine|mesh-list
15182454|NCT03920839|Paclitaxel|paclitaxel|mesh-list
15182455|NCT03920839|Carboplatin|carboplatin|mesh-list
15182456|NCT03920839|Pemetrexed|pemetrexed|mesh-list
14648176|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
14648177|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648178|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648179|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14725170|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14725171|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725172|NCT00502762|Topotecan|topotecan|mesh-list
14725173|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14725174|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725175|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725176|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725177|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725178|NCT00502788|Ribavirin|ribavirin|mesh-list
14725179|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14725180|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
14725181|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725182|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
14725183|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725184|NCT00502879|Etanercept|etanercept|mesh-list
15182457|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15182458|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182459|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182460|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
15182461|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
15182462|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182463|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15182464|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
15182465|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
15182466|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182467|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182468|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182469|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
15182470|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182471|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15182472|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15182473|NCT03920644|Scopolamine|scopolamine|mesh-list
14725185|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14725186|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725187|NCT00502879|Analgesics|analgesics|mesh-ancestor
14725188|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
14725189|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725190|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725191|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725192|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182474|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15182475|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15182476|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
15182477|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
14293250|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648180|NCT00202605|Amphetamine|amphetamine|mesh-list
14648181|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
14648182|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14648183|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648184|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
14648185|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
14648186|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648187|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
14648188|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648189|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648190|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14648191|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14648192|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14648193|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182478|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182479|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182480|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14648194|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14648195|NCT00202618|Amlodipine|amlodipine|mesh-list
14648196|NCT00202618|Valsartan|valsartan|mesh-list
14648197|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14648198|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14648199|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14648200|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648201|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14648202|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648203|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
14648204|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14648205|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14648206|NCT00202696|Nalmefene|nalmefene|mesh-list
14648207|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14648208|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648209|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
14648210|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648211|NCT00202774|Fluorouracil|fluorouracil|mesh-list
14648212|NCT00202774|Capecitabine|capecitabine|mesh-list
14648213|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
14648214|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
14648215|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648216|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14648217|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648218|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648219|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
14648220|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648221|NCT00202787|Leucovorin|leucovorin|mesh-list
14648222|NCT00202787|Cetuximab|cetuximab|mesh-list
14648223|NCT00202787|Fluorouracil|fluorouracil|mesh-list
14648224|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
14648225|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14648226|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648227|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
14648228|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648229|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14648230|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648231|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
14648232|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648233|NCT00202787|Antidotes|antidotes|mesh-ancestor
14648234|NCT00202787|Protective Agents|protective agents|mesh-ancestor
14648235|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
14648236|NCT00202787|Vitamins|vitamins|mesh-ancestor
14648237|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
14648238|NCT00202800|Gemcitabine|gemcitabine|mesh-list
14648239|NCT00202800|Etoposide|etoposide|mesh-list
14648240|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15182481|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
15182482|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15182483|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
15182484|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182485|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182486|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14648241|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
14648242|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648243|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648244|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
14648245|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648246|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648247|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648248|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
14648249|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648250|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14648251|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14648252|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14648253|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
14648254|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14648255|NCT00202852|Infliximab|infliximab|mesh-list
14648256|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14648257|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14648258|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648259|NCT00202865|Infliximab|infliximab|mesh-list
14648260|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
14648261|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14648262|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648263|NCT00202891|Sisomicin|sisomicin|mesh-list
14648264|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648265|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648266|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14648267|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648268|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648269|NCT00202917|Fludarabine|fludarabine|mesh-list
14648270|NCT00202917|Melphalan|melphalan|mesh-list
14648271|NCT00202917|Thiotepa|thiotepa|mesh-list
14648272|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648273|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648274|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648275|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
14648276|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648277|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14648278|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
14648279|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14648280|NCT00202969|Cisplatin|cisplatin|mesh-list
14648281|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648282|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
14648283|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
14648284|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14648285|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
14648286|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648287|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648288|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648289|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
14648290|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
14648291|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
14648292|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14648293|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
14648294|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648295|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648296|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648297|NCT00203034|Rasagiline|rasagiline|mesh-list
14648298|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14648299|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648300|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648301|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14648302|NCT00203034|Protective Agents|protective agents|mesh-ancestor
14648303|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648304|NCT00203060|Rasagiline|rasagiline|mesh-list
15182487|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
14648305|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14648306|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648307|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182488|NCT03920605|Tenofovir|tenofovir|mesh-list
15182489|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15182490|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15182491|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
15182492|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182493|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15182494|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15182495|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648308|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14648309|NCT00203060|Protective Agents|protective agents|mesh-ancestor
15182496|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648310|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648311|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
14648312|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
14648313|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
14648314|NCT00203073|Analgesics|analgesics|mesh-ancestor
14648315|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
14648316|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648317|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648318|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648319|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14648320|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14648321|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648322|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648323|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14648324|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
14648325|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648326|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648327|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
14648328|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
14648329|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14648330|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
14648331|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
14648332|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648333|NCT00203099|Expectorants|expectorants|mesh-ancestor
14648334|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
14648335|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14648336|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
14648337|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648338|NCT00203099|Protective Agents|protective agents|mesh-ancestor
14648339|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648340|NCT00203099|Antidotes|antidotes|mesh-ancestor
15182497|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15182498|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15182499|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
15182500|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15182501|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
15182502|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182503|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
14648341|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14648342|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
14648343|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648344|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648345|NCT00203112|Minocycline|minocycline|mesh-list
14648346|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
14648347|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
14648348|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648349|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648350|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14648351|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
14648352|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648353|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648354|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648355|NCT00203125|Rasagiline|rasagiline|mesh-list
14648356|NCT00203125|Tyramine|tyramine|mesh-list
14648357|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14648358|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648359|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648360|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14648361|NCT00203125|Protective Agents|protective agents|mesh-ancestor
14648362|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648363|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
14648364|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
14648365|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648366|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14648367|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14648368|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14648369|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14648370|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648371|NCT00203138|Rasagiline|rasagiline|mesh-list
14648372|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14648373|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648374|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648375|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14648376|NCT00203138|Protective Agents|protective agents|mesh-ancestor
14648377|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327518|NCT00802685|Analgesics|analgesics|mesh-ancestor
14648378|NCT00203164|Rasagiline|rasagiline|mesh-list
15182504|NCT03920553|Protective Agents|protective agents|mesh-ancestor
14648379|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14648380|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648381|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293251|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14293252|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
14293253|NCT00566969|Protective Agents|protective agents|mesh-ancestor
14293254|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14293255|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14648382|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15182505|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15182506|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15182507|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182508|NCT03920150|Vitamin D|vitamin d|mesh-list
15182509|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
14293256|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14648383|NCT00203164|Protective Agents|protective agents|mesh-ancestor
14648384|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648385|NCT00203177|Rasagiline|rasagiline|mesh-list
14648386|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15182510|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
15182511|NCT03920150|Vitamins|vitamins|mesh-list
15182512|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
15182513|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182514|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182515|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15182516|NCT03920137|Nicotine|nicotine|mesh-list
15182517|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15182518|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
15182519|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182520|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182521|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15182522|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15182523|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
15182524|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648387|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648388|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648389|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14648390|NCT00203177|Protective Agents|protective agents|mesh-ancestor
14648391|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293257|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
14293258|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14293259|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14648392|NCT00203190|Topiramate|topiramate|mesh-list
14648393|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
14648394|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14648395|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648396|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
14648397|NCT00203281|Tacrolimus|tacrolimus|mesh-list
14648398|NCT00203281|Daclizumab|daclizumab|mesh-list
14648399|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
14648400|NCT00203281|Antibodies|antibodies|mesh-list
14648401|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
14648402|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14648403|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14648404|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648405|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
14648406|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648407|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14648408|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648409|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648410|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14648411|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648412|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14648413|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
14648414|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648415|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648416|NCT00203320|Etanercept|etanercept|mesh-list
14648417|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14648418|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14648419|NCT00203320|Analgesics|analgesics|mesh-ancestor
14648420|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
15182525|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182526|NCT03920475|Sertraline|sertraline|mesh-list
14648421|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648422|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648423|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648424|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648425|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14648426|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182527|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15182528|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
15182529|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15182530|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15182531|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15182532|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182533|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182534|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182535|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
15182536|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182537|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15182538|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15182539|NCT03920319|Bupropion|bupropion|mesh-list
15182540|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15182541|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
15182542|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15182543|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15182544|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14648427|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
14648428|NCT00203359|Etanercept|etanercept|mesh-list
14648429|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14648430|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182545|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182546|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182547|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
15182548|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182549|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182550|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14648431|NCT00203359|Analgesics|analgesics|mesh-ancestor
14648432|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
15182551|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14648433|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648434|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648435|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648436|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648437|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14648438|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648439|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
14648440|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
14648441|NCT00203372|Bevacizumab|bevacizumab|mesh-list
14648442|NCT00203372|Docetaxel|docetaxel|mesh-list
14648443|NCT00203372|Doxorubicin|doxorubicin|mesh-list
14648444|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648445|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
14648446|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648447|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648448|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14648449|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
14648450|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648451|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648452|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14648453|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14648454|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14648455|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14648456|NCT00203372|Growth Substances|growth substances|mesh-ancestor
14648457|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
14648458|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14648459|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14648460|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14648461|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14648462|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14648463|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14648464|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648465|NCT00203385|Valproic Acid|valproic acid|mesh-list
14648466|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
14648467|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648468|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648469|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
14648470|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648471|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648472|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
15182552|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182553|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
15182554|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15182555|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182556|NCT03920397|Vitamins|vitamins|mesh-ancestor
15182557|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
15182558|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182559|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
15182560|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15182561|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182562|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182563|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
15182564|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182565|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182566|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
14648473|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648474|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648475|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648476|NCT00203450|Zonisamide|zonisamide|mesh-list
14648477|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
14648478|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14648479|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14648480|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648481|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14648482|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648483|NCT00203463|Topiramate|topiramate|mesh-list
14648484|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
14648485|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14648486|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648487|NCT00203528|Valproic Acid|valproic acid|mesh-list
14648488|NCT00203528|Risperidone|risperidone|mesh-list
14648489|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14648490|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
14648491|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648492|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648493|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648494|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648495|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648496|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648497|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648498|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648499|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
14648500|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
14648501|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648502|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
14648503|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
14648504|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14648505|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
14648506|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14648507|NCT00203554|Protective Agents|protective agents|mesh-ancestor
14648508|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648509|NCT00203567|Carbamazepine|carbamazepine|mesh-list
14648510|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
14648511|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
14648512|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648513|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648514|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648515|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648516|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14648517|NCT00203567|Analgesics|analgesics|mesh-ancestor
14648518|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
14648519|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648520|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14648521|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14648522|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648523|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14648524|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14648525|NCT00203580|Tinzaparin|tinzaparin|mesh-list
14648526|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14648527|NCT00203580|Dalteparin|dalteparin|mesh-list
15182567|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14293260|NCT00567008|Varenicline|varenicline|mesh-list
14648528|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
14648529|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14648530|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14648531|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648532|NCT00203606|Interferons|interferons|mesh-list
14648533|NCT00203606|Ribavirin|ribavirin|mesh-list
14648534|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
14648535|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
14648536|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14648537|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648538|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
14648539|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648540|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
14648541|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648542|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
14648543|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648544|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
14648545|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14648546|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648547|NCT00203658|Tinzaparin|tinzaparin|mesh-list
14648548|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14648549|NCT00203658|Dalteparin|dalteparin|mesh-list
14648550|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
14648551|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14648552|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14648553|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648554|NCT00203684|Flunisolide|flunisolide|mesh-list
14648555|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648556|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14648557|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
14648558|NCT00203697|Minocycline|minocycline|mesh-list
14648559|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648560|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648561|NCT00203723|Risperidone|risperidone|mesh-list
14648562|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15182568|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182569|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15182570|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
15182571|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648563|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
14648564|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648565|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182572|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182573|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182574|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182575|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15182576|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182577|NCT03919786|Anesthetics|anesthetics|mesh-list
15182578|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182579|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182580|NCT03919955|Oxybutynin|oxybutynin|mesh-list
15182581|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15182582|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15182583|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14648566|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648567|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648568|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648569|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648570|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648571|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648572|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
14648573|NCT00203736|Artesunate|artesunate|mesh-list
15182584|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182585|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648574|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
14648575|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
14648576|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14648577|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
14648578|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14648579|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14648580|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648581|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648582|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
14648583|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
15182586|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
14648584|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14648585|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
14648586|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14648587|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648588|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648589|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14648590|NCT00203736|Renal Agents|renal agents|mesh-ancestor
14648591|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14648592|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
14648593|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648594|NCT00203775|Risperidone|risperidone|mesh-list
14648595|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14648596|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
14648597|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648598|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648599|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648600|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648601|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648602|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648603|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648604|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648605|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
14648606|NCT00203788|Risperidone|risperidone|mesh-list
14648607|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14648608|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
14648609|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648610|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648611|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648612|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648613|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648614|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182587|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182588|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648615|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648616|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648617|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
14648618|NCT00203801|Artesunate|artesunate|mesh-list
14648619|NCT00203801|Lumefantrine|lumefantrine|mesh-list
14648620|NCT00203801|Artemether|artemether|mesh-list
14648621|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
14648622|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
14648623|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14648624|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14648625|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
14648626|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14648627|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14648628|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648629|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648630|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
14648631|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
14648632|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14648633|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
14648634|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14648635|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648636|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648637|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14648638|NCT00203801|Renal Agents|renal agents|mesh-ancestor
14648639|NCT00203814|Artesunate|artesunate|mesh-list
14648640|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
14648641|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
14648642|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14648643|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
14648644|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14648645|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14648646|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648647|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648648|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
14648649|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
14648650|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14648651|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
14648652|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14648653|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648654|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648655|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14648656|NCT00203814|Renal Agents|renal agents|mesh-ancestor
14648657|NCT00203905|Bevacizumab|bevacizumab|mesh-list
15182589|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
14648658|NCT00203905|Fluorouracil|fluorouracil|mesh-list
14648659|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
14648660|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14648661|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182590|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
15182591|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182592|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15182593|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15182594|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
14648662|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14648663|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14648664|NCT00203905|Growth Substances|growth substances|mesh-ancestor
14648665|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648666|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
14648667|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
14648668|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648669|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14648670|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648671|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
14648672|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
14648673|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648674|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14648675|NCT00203957|Istradefylline|istradefylline|mesh-list
15182595|NCT03919955|Urological Agents|urological agents|mesh-ancestor
15182596|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
15182597|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15182598|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182599|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
15182600|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
15182601|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15182602|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182603|NCT03919812|Vitamins|vitamins|mesh-ancestor
15182604|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
14648676|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14648677|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14648678|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14648679|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
14648680|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182605|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15182606|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
15182607|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15182608|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182609|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15182610|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182611|NCT03919552|Cisplatin|cisplatin|mesh-list
15182612|NCT03919552|Carboplatin|carboplatin|mesh-list
15182613|NCT03919552|Docetaxel|docetaxel|mesh-list
15182614|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648681|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648682|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648683|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
14648684|NCT00204022|Azathioprine|azathioprine|mesh-list
14648685|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14648686|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648687|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14648688|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
14648689|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648690|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648691|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648692|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648693|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
14648694|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14648695|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648696|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
14648697|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648698|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648699|NCT00204061|Amisulpride|amisulpride|mesh-list
14648700|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648701|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648702|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648703|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648704|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648705|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648706|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
14648707|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182615|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182616|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
14648708|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648709|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14648710|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
14648711|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14648712|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14648713|NCT00204074|Estradiol|estradiol|mesh-list
14648714|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14648715|NCT00204074|Estrogens|estrogens|mesh-ancestor
14648716|NCT00204074|Hormones|hormones|mesh-ancestor
14648717|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648718|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648719|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14648720|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
14648721|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14648722|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14648723|NCT00204152|Vaccines|vaccines|mesh-list
14648724|NCT00204152|Immunologic Factors|immunologic factors|mesh-ancestor
14648725|NCT00204152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648726|NCT00204191|Tacrolimus|tacrolimus|mesh-list
14648727|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648728|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
14648729|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648730|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14648731|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648732|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648733|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
14648734|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14648735|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648736|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14648737|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
14648738|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648739|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648740|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648741|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648742|NCT00204243|Naltrexone|naltrexone|mesh-list
14648743|NCT00204243|Methadone|methadone|mesh-list
14648744|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14648745|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14648746|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648747|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
14648748|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648749|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15182617|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
15182618|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182619|NCT03919565|Tenofovir|tenofovir|mesh-list
15182620|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15182621|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15182622|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
15182623|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182624|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14648750|NCT00204243|Narcotics|narcotics|mesh-ancestor
14648751|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648752|NCT00204243|Analgesics|analgesics|mesh-ancestor
14648753|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
14648754|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
14725193|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725194|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725195|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
14725196|NCT00502892|Carboplatin|carboplatin|mesh-list
14725197|NCT00502892|Topotecan|topotecan|mesh-list
14725198|NCT00502892|Ifosfamide|ifosfamide|mesh-list
14725199|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725200|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14725201|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725202|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725203|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725204|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14725205|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
14725206|NCT00502970|Interferons|interferons|mesh-list
14725207|NCT00502970|Ribavirin|ribavirin|mesh-list
14725208|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
14725209|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725210|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
14725211|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725212|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
15182625|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14648755|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14648756|NCT00204256|Hematinics|hematinics|mesh-ancestor
14648757|NCT00204269|Testosterone|testosterone|mesh-list
14648758|NCT00204269|Androgens|androgens|mesh-ancestor
14648759|NCT00204269|Hormones|hormones|mesh-ancestor
14648760|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648761|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648762|NCT00204308|Tenofovir|tenofovir|mesh-list
14648763|NCT00204308|Emtricitabine|emtricitabine|mesh-list
14648764|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
14648765|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648766|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14648767|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14293261|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14293262|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14293263|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293264|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293265|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648768|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182626|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182627|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182628|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15182629|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15182630|NCT03919253|Paclitaxel|paclitaxel|mesh-list
14648769|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648770|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14648771|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14648772|NCT00204321|Sirolimus|sirolimus|mesh-list
14648773|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14648774|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648775|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14648776|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648777|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
14648778|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648779|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
14648780|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648781|NCT00204347|Risperidone|risperidone|mesh-list
14648782|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14648783|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
14648784|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182631|NCT03919253|Maleic acid|maleic acid|mesh-list
15182632|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15182633|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182634|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182635|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
15182636|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
15182637|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182638|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182639|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
15182640|NCT03919526|Fludarabine|fludarabine|mesh-list
15182641|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182642|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
15182643|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182644|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182645|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15182646|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
15182647|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182648|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648785|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648786|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648787|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14648788|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648789|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648790|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648791|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14648792|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
14648793|NCT00204386|Topiramate|topiramate|mesh-list
14648794|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
14648795|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14648796|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648797|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14648798|NCT00204438|Desogestrel|desogestrel|mesh-list
14648799|NCT00204438|Estradiol|estradiol|mesh-list
15182649|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14648800|NCT00204438|Estrogens|estrogens|mesh-ancestor
15182650|NCT03919383|Lenvatinib|lenvatinib|mesh-list
14648801|NCT00204438|Hormones|hormones|mesh-ancestor
14648802|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648803|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648804|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14648805|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
14648806|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14648807|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14648808|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14648809|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14648810|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14648811|NCT00204438|Progestins|progestins|mesh-ancestor
14648812|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
14648813|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14648814|NCT00204451|Estradiol|estradiol|mesh-list
14648815|NCT00204451|Estrogens|estrogens|mesh-ancestor
14648816|NCT00204451|Hormones|hormones|mesh-ancestor
14648817|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648818|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648819|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14648820|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
14648821|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14648822|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14648823|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14648824|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14648825|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15182651|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182652|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15182653|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182654|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182655|NCT03919448|Bevacizumab|bevacizumab|mesh-list
15182656|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182657|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182658|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14293266|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648826|NCT00204503|Valproic Acid|valproic acid|mesh-list
14648827|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
14648828|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648829|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648830|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
14648831|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648832|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648833|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
14648834|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14648835|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14648836|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14648837|NCT00204529|Interferons|interferons|mesh-list
14648838|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
14648839|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
14648840|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14648841|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648842|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
14648843|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648844|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
14648845|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648846|NCT00204542|Diclofenac|diclofenac|mesh-list
14648847|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14648848|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14648849|NCT00204542|Analgesics|analgesics|mesh-ancestor
14648850|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
14648851|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648852|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648853|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648854|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648855|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14648856|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648857|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648858|NCT00204555|Imiquimod|imiquimod|mesh-list
14648859|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14648860|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
14648861|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648862|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648863|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
14648864|NCT00204568|Doxorubicin|doxorubicin|mesh-list
14648865|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14293267|NCT00567164|Drospirenone|drospirenone|mesh-list
14648866|NCT00204568|Trofosfamide|trofosfamide|mesh-list
14648867|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14648868|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648869|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14648870|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14648871|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648872|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648873|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648874|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
14648875|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648876|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14648877|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
14648878|NCT00204581|Aldesleukin|aldesleukin|mesh-list
14648879|NCT00204581|Interleukin-2|interleukin-2|mesh-list
14648880|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648881|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14648882|NCT00204581|Analgesics|analgesics|mesh-ancestor
14648883|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
14648884|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648885|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648886|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14648887|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14648888|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
14648889|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648890|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14648891|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14648892|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
14648893|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648894|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648895|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
14648896|NCT00204633|Hematinics|hematinics|mesh-ancestor
14648897|NCT00204646|Carboplatin|carboplatin|mesh-list
14648898|NCT00204646|Etoposide|etoposide|mesh-list
14648899|NCT00204646|Doxorubicin|doxorubicin|mesh-list
14648900|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14648901|NCT00204646|Ifosfamide|ifosfamide|mesh-list
14648902|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648903|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14648904|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14648905|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14648906|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648907|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648908|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14648909|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14648910|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
14648911|NCT00204659|Rituximab|rituximab|mesh-list
14648912|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14648913|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648914|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
14648915|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648916|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648917|NCT00204698|Rabeprazole|rabeprazole|mesh-list
14648918|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14648919|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14648920|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14648921|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648922|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648923|NCT00204737|Prednisone|prednisone|mesh-list
14648924|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648925|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
14648926|NCT00204737|Hormones|hormones|mesh-ancestor
14648927|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14648928|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648929|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14648930|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648931|NCT00204776|Capecitabine|capecitabine|mesh-list
14648932|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
14648933|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14648934|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
14648935|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648936|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648937|NCT00204789|Eflornithine|eflornithine|mesh-list
14648938|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14648939|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15182659|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15182660|NCT03919448|Growth Substances|growth substances|mesh-ancestor
14648940|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14648941|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14648942|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14648943|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14648944|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648945|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648946|NCT00204893|Calcium|calcium|mesh-list
14648947|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14648948|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648949|NCT00204906|Vitamin D|vitamin d|mesh-list
14648950|NCT00204906|Vitamins|vitamins|mesh-ancestor
14648951|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
14648952|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648953|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14648954|NCT00204919|Vitamin D|vitamin d|mesh-list
15182661|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182662|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
15182663|NCT03919084|Nicotine|nicotine|mesh-list
14648955|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
14648956|NCT00204919|Vitamins|vitamins|mesh-ancestor
14648957|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
14648958|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648959|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14648960|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14648961|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14648962|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
14648963|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648964|NCT00204984|Hydralazine|hydralazine|mesh-list
14648965|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14648966|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
14648967|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648968|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14648969|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
14648970|NCT00205166|Caffeine|caffeine|mesh-list
14648971|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14648972|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648973|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14648974|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648975|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648976|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14648977|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14648978|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
14648979|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14648980|NCT00205231|Etanercept|etanercept|mesh-list
14648981|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14648982|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14648983|NCT00205231|Analgesics|analgesics|mesh-ancestor
14648984|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
14648985|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14648986|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14648987|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14648988|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14648989|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14648990|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14648991|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
14648992|NCT00205283|Nelfinavir|nelfinavir|mesh-list
15182664|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15182665|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
15182666|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182667|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182668|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15182669|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15182670|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
15182671|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182672|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648993|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14648994|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14648995|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
14648996|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14648997|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14648998|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14648999|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14649000|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
14649001|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649002|NCT00205322|Leucovorin|leucovorin|mesh-list
14649003|NCT00205322|Capecitabine|capecitabine|mesh-list
14649004|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
14649005|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14649006|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
14649007|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649008|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649009|NCT00205322|Antidotes|antidotes|mesh-ancestor
15182673|NCT03919461|Etodolac|etodolac|mesh-list
15182674|NCT03919461|Propranolol|propranolol|mesh-list
15182675|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14649010|NCT00205322|Protective Agents|protective agents|mesh-ancestor
14649011|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649012|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
14649013|NCT00205322|Vitamins|vitamins|mesh-ancestor
14649014|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
14649015|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14649016|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
14649017|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649018|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14649019|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14649020|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649021|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182676|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15182677|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
15182678|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182679|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182680|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182681|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15182682|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14649022|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649023|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649024|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649025|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14649026|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649027|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649028|NCT00205634|Clarithromycin|clarithromycin|mesh-list
14649029|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14649030|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649031|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14649032|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649033|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649034|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14649035|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14649036|NCT00205725|Olanzapine|olanzapine|mesh-list
14649037|NCT00205725|Ziprasidone|ziprasidone|mesh-list
14293268|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14293269|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
14293270|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649038|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
14649039|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
14649040|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649041|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649042|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649043|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649044|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649045|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649046|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649047|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14649048|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649049|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649050|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649051|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649052|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
14649053|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649054|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649055|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
14725213|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725214|NCT00502970|Hematinics|hematinics|mesh-ancestor
14725215|NCT00503126|Bivalirudin|bivalirudin|mesh-list
14725216|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
15182683|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
14293271|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182684|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15182685|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182686|NCT03919461|Analgesics|analgesics|mesh-ancestor
15182687|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
15182688|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182689|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182690|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182691|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15182692|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15182693|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182694|NCT03919175|Rituximab|rituximab|mesh-list
15182695|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182696|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182697|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
15182698|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182699|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182700|NCT03918993|Tadalafil|tadalafil|mesh-list
15182701|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
15182702|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14649056|NCT00205738|Olanzapine|olanzapine|mesh-list
14649057|NCT00205738|Risperidone|risperidone|mesh-list
14649058|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649059|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
14649060|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649061|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649062|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649063|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649064|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649065|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649066|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649067|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649068|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
14649069|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
14649070|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
14649071|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649072|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649073|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14649074|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649075|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649076|NCT00205751|Thalidomide|thalidomide|mesh-list
15182703|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15182704|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182705|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649077|NCT00205751|Dexamethasone|dexamethasone|mesh-list
14649078|NCT00205751|Prednisone|prednisone|mesh-list
14649079|NCT00205751|Melphalan|melphalan|mesh-list
14649080|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14649081|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
14649082|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
14649083|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649084|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649085|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649086|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
14649087|NCT00205751|Hormones|hormones|mesh-ancestor
14649088|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649089|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14649090|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649091|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14649092|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
14649093|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649094|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14649095|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14649096|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
14649097|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
14649098|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14649099|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182706|NCT03918993|Urological Agents|urological agents|mesh-ancestor
15182707|NCT03918616|Dopamine|dopamine|mesh-list
15182708|NCT03918616|Memantine|memantine|mesh-list
15182709|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
15182710|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15182711|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14649100|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15182712|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
15182713|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182714|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649101|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14649102|NCT00205751|Growth Substances|growth substances|mesh-ancestor
14649103|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
14649104|NCT00205764|Melphalan|melphalan|mesh-list
14649105|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14649106|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
14649107|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649108|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649109|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14649110|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14649111|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
14649112|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649113|NCT00205816|Tigecycline|tigecycline|mesh-list
14649114|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14649115|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649116|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14649117|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649118|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649119|NCT00205842|Alvimopan|alvimopan|mesh-list
14649120|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649121|NCT00205946|Bupropion|bupropion|mesh-list
14649122|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14649123|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649124|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649125|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14649126|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649127|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649128|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649129|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
14649130|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649131|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649132|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14649133|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14649134|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649135|NCT00206024|Esomeprazole|esomeprazole|mesh-list
14649136|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14649137|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649138|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14649139|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649140|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649141|NCT00206050|Esomeprazole|esomeprazole|mesh-list
15182715|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182716|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15182717|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15182718|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15182719|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
15182720|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
15182721|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182722|NCT03918616|Protective Agents|protective agents|mesh-ancestor
15182723|NCT03918590|Nepafenac|nepafenac|mesh-list
15182724|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15182725|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15182726|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182727|NCT03918590|Analgesics|analgesics|mesh-ancestor
15182728|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
15182729|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649142|NCT00206050|Pantoprazole|pantoprazole|mesh-list
14649143|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14649144|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649145|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14649146|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649147|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649148|NCT00206063|Ximelagatran|ximelagatran|mesh-list
14649149|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
14649150|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14649151|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
14649152|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649153|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649154|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
14649155|NCT00206089|Ximelagatran|ximelagatran|mesh-list
14649156|NCT00206089|Melagatran|melagatran|mesh-list
14649157|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
14649158|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14649159|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
14649160|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649161|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649162|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
14649163|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14649164|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649165|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649166|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649167|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649168|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649169|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649170|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15182730|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182731|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182732|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649171|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649172|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649173|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649174|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649175|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649176|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649177|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14649178|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649179|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649180|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649181|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649182|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649183|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649184|NCT00206154|Budesonide|budesonide|mesh-list
14649185|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
14649186|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14649187|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14649188|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
14649189|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649190|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649191|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14649192|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
14649193|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
14649194|NCT00206154|Hormones|hormones|mesh-ancestor
14649195|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649196|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14649197|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14649198|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14649199|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
14649200|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649201|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649202|NCT00206167|Budesonide|budesonide|mesh-list
14649203|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
14649204|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14649205|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14649206|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
14649207|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649208|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649209|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14649210|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
14649211|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
14649212|NCT00206167|Hormones|hormones|mesh-ancestor
15182733|NCT03918590|Laxatives|laxatives|mesh-ancestor
15182734|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223513|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14649213|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649214|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14649215|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14649216|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14649217|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
14649218|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649219|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649220|NCT00206180|Esomeprazole|esomeprazole|mesh-list
15223514|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223515|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15223516|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15223517|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15223518|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223519|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15182735|NCT03918694|Ascorbic Acid|ascorbic acid|mesh-list
15182736|NCT03918694|Vitamins|vitamins|mesh-ancestor
15182737|NCT03918694|Micronutrients|micronutrients|mesh-ancestor
14649221|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14649222|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649223|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14649224|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649225|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649226|NCT00206193|Misoprostol|misoprostol|mesh-list
14649227|NCT00206193|Sulprostone|sulprostone|mesh-list
14649228|NCT00206193|Mifepristone|mifepristone|mesh-list
14649229|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14649230|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
14649231|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14649232|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649233|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14649234|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649235|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
14649236|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14649237|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14649238|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14649239|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14649240|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
14649241|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14649242|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14649243|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649244|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649245|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
14649246|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14649247|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14649248|NCT00206219|Methotrexate|methotrexate|mesh-list
14649249|NCT00206219|Gefitinib|gefitinib|mesh-list
14649250|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14649251|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
14649252|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14649253|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649254|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14649255|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
14649256|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649257|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649258|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
14649259|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649260|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14649261|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14649262|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
14649263|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649264|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14649265|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14649266|NCT00206232|Spironolactone|spironolactone|mesh-list
14649267|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14649268|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649269|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649270|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649271|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14649272|NCT00206232|Diuretics|diuretics|mesh-ancestor
14649273|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
14649274|NCT00206258|Pramlintide|pramlintide|mesh-list
14649275|NCT00206258|Glucagon|glucagon|mesh-list
14649276|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649277|NCT00206258|Hormones|hormones|mesh-ancestor
14649278|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649279|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649280|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14649281|NCT00206297|Pramlintide|pramlintide|mesh-list
14649282|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14649283|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649284|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14649285|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14649286|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15182738|NCT03918694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182739|NCT03918694|Antioxidants|antioxidants|mesh-ancestor
15182740|NCT03918694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182741|NCT03918694|Protective Agents|protective agents|mesh-ancestor
14649287|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
14649288|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649289|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14649290|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14649291|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649292|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
14649293|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14649294|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
14649295|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649296|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649297|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14649298|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
14649299|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649300|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649301|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14649302|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
14649303|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14649304|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649305|NCT00206414|Gefitinib|gefitinib|mesh-list
14649306|NCT00206414|Fulvestrant|fulvestrant|mesh-list
14649307|NCT00206414|Anastrozole|anastrozole|mesh-list
14649308|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649309|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14649310|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649311|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649312|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14649313|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14649314|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14649315|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649316|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649317|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649318|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14649319|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14649320|NCT00206453|Docetaxel|docetaxel|mesh-list
14649321|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649322|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
14649323|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
14649324|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
14649325|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649326|NCT00206466|Docetaxel|docetaxel|mesh-list
14649327|NCT00206466|Doxorubicin|doxorubicin|mesh-list
14649328|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
14649329|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14649330|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649331|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
14649332|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
14649333|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
14649334|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649335|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14649336|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14649337|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14649338|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649339|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14649340|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
14649341|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649342|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649343|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14649344|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
14649345|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14649346|NCT00206492|Tamoxifen|tamoxifen|mesh-list
14649347|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14649348|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649349|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649350|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649351|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14649352|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649353|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14649354|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14649355|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14649356|NCT00206505|Docetaxel|docetaxel|mesh-list
14649357|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649358|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
14649359|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
14649360|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
14649361|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649362|NCT00206544|Tamoxifen|tamoxifen|mesh-list
14649363|NCT00206544|Progesterone|progesterone|mesh-list
14649364|NCT00206544|Progestins|progestins|mesh-ancestor
14649365|NCT00206544|Hormones|hormones|mesh-ancestor
14649366|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649367|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649368|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14649369|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649370|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14649371|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649372|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14649373|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14649374|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14649375|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14649376|NCT00206557|Estradiol|estradiol|mesh-list
14649377|NCT00206557|Estrogens|estrogens|mesh-ancestor
14649378|NCT00206557|Hormones|hormones|mesh-ancestor
14649379|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649380|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649381|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14649382|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649383|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14649384|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14649385|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14649386|NCT00206570|Estradiol|estradiol|mesh-list
14649387|NCT00206570|Estrogens|estrogens|mesh-ancestor
14649388|NCT00206570|Hormones|hormones|mesh-ancestor
14649389|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649390|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649391|NCT00206596|Sargramostim|sargramostim|mesh-list
14649392|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
14649393|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649394|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14649395|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14649396|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
14649397|NCT00206622|Estradiol|estradiol|mesh-list
14649398|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14649399|NCT00206622|Estrogens|estrogens|mesh-ancestor
14649400|NCT00206622|Hormones|hormones|mesh-ancestor
14649401|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649402|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649403|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14649404|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
14649405|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14649406|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14649407|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14649408|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14649409|NCT00206635|Interferons|interferons|mesh-list
14649410|NCT00206635|Interferon-beta|interferon-beta|mesh-list
14649411|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
14649412|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649413|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
14649414|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293272|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14293273|NCT00567164|Diuretics|diuretics|mesh-ancestor
14293274|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
14293275|NCT00567190|Docetaxel|docetaxel|mesh-list
14293276|NCT00567190|Trastuzumab|trastuzumab|mesh-list
14293277|NCT00567190|Pertuzumab|pertuzumab|mesh-list
14293278|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293279|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
14293280|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
14293281|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
14293282|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293283|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293284|NCT00567229|Rituximab|rituximab|mesh-list
14649415|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
14649416|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649417|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14649418|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
14293285|NCT00567229|Lenalidomide|lenalidomide|mesh-list
14649419|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14649420|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
14293286|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293287|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649421|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649422|NCT00206661|Molgramostim|molgramostim|mesh-list
14649423|NCT00206661|Sargramostim|sargramostim|mesh-list
14649424|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
14649425|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649426|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649427|NCT00206674|Sargramostim|sargramostim|mesh-list
14649428|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
14649429|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649430|NCT00206700|Sargramostim|sargramostim|mesh-list
14649431|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
14293288|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
14293289|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293290|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293291|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14293292|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14293293|NCT00567229|Growth Substances|growth substances|mesh-ancestor
14649432|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649433|NCT00206713|Sargramostim|sargramostim|mesh-list
14649434|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
14649435|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649436|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
14649437|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
14649438|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
14649439|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14649440|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14649441|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649442|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14649443|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649444|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649445|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14649446|NCT00206739|Renal Agents|renal agents|mesh-ancestor
14649447|NCT00206765|Risperidone|risperidone|mesh-list
14649448|NCT00206765|Paroxetine|paroxetine|mesh-list
14649449|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649450|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
14649451|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649452|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649453|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649454|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649455|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649456|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649457|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649458|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649459|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
14649460|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14649461|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649462|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649463|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14649464|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649465|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14649466|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14649467|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649468|NCT00206778|Lamotrigine|lamotrigine|mesh-list
14649469|NCT00206778|Valproic Acid|valproic acid|mesh-list
14649470|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
14649471|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14649472|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649473|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649474|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14649475|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649476|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649477|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649478|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649479|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649480|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14649481|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649482|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
14649483|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649484|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
14649485|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14649486|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
14649487|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649488|NCT00206934|Dexetimide|dexetimide|mesh-list
14293294|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14649489|NCT00206934|Citalopram|citalopram|mesh-list
14649490|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14649491|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649492|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649493|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649494|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649495|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
14649496|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649497|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14649498|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649499|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649500|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14649501|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14649502|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
14649503|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
14649504|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649505|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14649506|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14649507|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
14649508|NCT00206947|Ziprasidone|ziprasidone|mesh-list
14649509|NCT00206947|Donepezil|donepezil|mesh-list
14649510|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14649511|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649512|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649513|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
14649514|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649515|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649516|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
14649517|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649518|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
14649519|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15182742|NCT03918889|Midazolam|midazolam|mesh-list
15182743|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
15182744|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15182745|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649520|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649521|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649522|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649523|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649524|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
14649525|NCT00206960|Risperidone|risperidone|mesh-list
14649526|NCT00206960|Clopenthixol|clopenthixol|mesh-list
14649527|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649528|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
14649529|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649530|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649531|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649532|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649533|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649534|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649535|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649536|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649537|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
14649538|NCT00206973|Mannitol|mannitol|mesh-list
14649539|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14649540|NCT00206973|Diuretics|diuretics|mesh-ancestor
14649541|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
14649542|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649543|NCT00206986|Clonidine|clonidine|mesh-list
14649544|NCT00206986|Analgesics|analgesics|mesh-ancestor
14649545|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
14649546|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649547|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649548|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14649549|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
14649550|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
14649551|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15182746|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182747|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182748|NCT03918889|Analgesics|analgesics|mesh-ancestor
15182749|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
15182750|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182751|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14649552|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14649553|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14649554|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
15182752|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14649555|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649556|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649557|NCT00206999|Imipramine|imipramine|mesh-list
14649558|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14649559|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649560|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649561|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14649562|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649563|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649564|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649565|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
14649566|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649567|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649568|NCT00207051|Cetuximab|cetuximab|mesh-list
14649569|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14649570|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649571|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14649572|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649573|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649574|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649575|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649576|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649577|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649578|NCT00207077|Cetuximab|cetuximab|mesh-list
14649579|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14649580|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14649581|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649582|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14649583|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182753|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15182754|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
15182755|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649584|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649585|NCT00207116|Cetuximab|cetuximab|mesh-list
14649586|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14649587|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649588|NCT00207129|Capecitabine|capecitabine|mesh-list
15182756|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182757|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15182758|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15182759|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15182760|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15182761|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14649589|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14649590|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
14649591|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649592|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649593|NCT00207155|Cetuximab|cetuximab|mesh-list
14649594|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14649595|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649596|NCT00207311|Interferons|interferons|mesh-list
14649597|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
15182762|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
15182763|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
15182764|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
15182765|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
15182766|NCT03918551|Febuxostat|febuxostat|mesh-list
15182767|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
15182768|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182769|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
15182770|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
15182771|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182772|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
15182773|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182774|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182775|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15182776|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
14649598|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
14649599|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14649600|NCT00207311|Orlistat|orlistat|mesh-list
14649601|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649602|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
14649603|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649604|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
15182777|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649605|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182778|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182779|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15182780|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182781|NCT03918265|Tacrolimus|tacrolimus|mesh-list
14649606|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649607|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649608|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14649609|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14725217|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14725218|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
14725219|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725220|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725221|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
14725222|NCT00503152|Valsartan|valsartan|mesh-list
14725223|NCT00503152|Benazepril|benazepril|mesh-list
14725224|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14725225|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14725226|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14725227|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725228|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14725229|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
14725230|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725231|NCT00503204|Cediranib|cediranib|mesh-list
14725232|NCT00503204|Lomustine|lomustine|mesh-list
14725233|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725234|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725235|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725236|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725237|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14725238|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
14725239|NCT00503243|Mesalamine|mesalamine|mesh-list
14725240|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14725241|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725242|NCT00503243|Analgesics|analgesics|mesh-ancestor
14725243|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
14725244|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725245|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725246|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725247|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725248|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
14725249|NCT00503321|Tegafur|tegafur|mesh-list
14725250|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725251|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
14725252|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725253|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725254|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14725255|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
14725256|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725257|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14725258|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
14725259|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725260|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
14725261|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14725262|NCT00503321|Protective Agents|protective agents|mesh-ancestor
14725263|NCT00503347|Bavituximab|bavituximab|mesh-list
14725264|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14725265|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725266|NCT00503386|Palonosetron|palonosetron|mesh-list
14725267|NCT00503386|Granisetron|granisetron|mesh-list
14725268|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
14725269|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
14725270|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725271|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725272|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15182782|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293295|NCT00567255|Naltrexone|naltrexone|mesh-list
14293296|NCT00567255|Bupropion|bupropion|mesh-list
14293297|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14293298|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14293299|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293300|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
14293301|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293302|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14725273|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14649610|NCT00207363|Interferons|interferons|mesh-list
14649611|NCT00207363|Ribavirin|ribavirin|mesh-list
14649612|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
14649613|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
14649614|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14649615|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649616|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
14649617|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649618|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
14649619|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649620|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
14649621|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649622|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
14649623|NCT00207402|Interferons|interferons|mesh-list
14649624|NCT00207402|Ribavirin|ribavirin|mesh-list
14649625|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
14649626|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649627|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
14649628|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649629|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
14649630|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649631|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14649632|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649633|NCT00207428|Carbamazepine|carbamazepine|mesh-list
14649634|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
14649635|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
14649636|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649637|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649638|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649639|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649640|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14649641|NCT00207428|Analgesics|analgesics|mesh-ancestor
14649642|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
14649643|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649644|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14649645|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649646|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649647|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14649648|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14649649|NCT00207532|Folic Acid|folic acid|mesh-list
14649650|NCT00207532|Hematinics|hematinics|mesh-ancestor
14649651|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
14649652|NCT00207532|Vitamins|vitamins|mesh-ancestor
14649653|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
14649654|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649655|NCT00207558|Folic Acid|folic acid|mesh-list
14649656|NCT00207558|Hematinics|hematinics|mesh-ancestor
14649657|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
14649658|NCT00207558|Vitamins|vitamins|mesh-ancestor
14649659|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
14649660|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649661|NCT00207584|Doxycycline|doxycycline|mesh-list
14649662|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14649663|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649664|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
14649665|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14649666|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14649667|NCT00207662|Infliximab|infliximab|mesh-list
14649668|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
15182783|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
15182784|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182785|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15182786|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182787|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182788|NCT03918252|Nivolumab|nivolumab|mesh-list
15182789|NCT03918252|Ipilimumab|ipilimumab|mesh-list
15182790|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182791|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182792|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15182793|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182794|NCT03918187|Midazolam|midazolam|mesh-list
15182795|NCT03918187|Nalbuphine|nalbuphine|mesh-list
14649669|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649670|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649671|NCT00207675|Infliximab|infliximab|mesh-list
14649672|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
15182796|NCT03918187|Bupivacaine|bupivacaine|mesh-list
14649673|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649674|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182797|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
15182798|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
15182799|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182800|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182801|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
15182802|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182803|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15182804|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15182805|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15182806|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15182807|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15182808|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15182809|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
14649675|NCT00207688|Infliximab|infliximab|mesh-list
14649676|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
14649677|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649678|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649679|NCT00207701|Infliximab|infliximab|mesh-list
14649680|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14649681|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649682|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649683|NCT00207753|Ivermectin|ivermectin|mesh-list
14649684|NCT00207753|Albendazole|albendazole|mesh-list
14649685|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14649686|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649687|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
14649688|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
14649689|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14649690|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14649691|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
14649692|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
14649693|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
14649694|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649695|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649696|NCT00207766|Infliximab|infliximab|mesh-list
14649697|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
14649698|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14649699|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182810|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
15182811|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
15182812|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15182813|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182814|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15182815|NCT03918187|Narcotics|narcotics|mesh-ancestor
15182816|NCT03918187|Analgesics|analgesics|mesh-ancestor
15182817|NCT03917914|Bisoprolol|bisoprolol|mesh-list
15182818|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15182819|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
15182820|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
15182821|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182822|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182823|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15182824|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15182825|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15182826|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
15182827|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649700|NCT00207779|Heparin|heparin|mesh-list
14649701|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
14649702|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15182828|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649703|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15182829|NCT03918135|Acetaminophen|acetaminophen|mesh-list
15182830|NCT03918135|Ibuprofen|ibuprofen|mesh-list
15182831|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15182832|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182833|NCT03918135|Analgesics|analgesics|mesh-ancestor
15182834|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
14649704|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649705|NCT00207792|Lenograstim|lenograstim|mesh-list
14649706|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14649707|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
14649708|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649709|NCT00207831|Tegafur|tegafur|mesh-list
14649710|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14649711|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
14649712|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649713|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649714|NCT00207844|Selenium|selenium|mesh-list
14649715|NCT00207844|Selenious Acid|selenious acid|mesh-list
14649716|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
14649717|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
14649718|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649719|NCT00207844|Protective Agents|protective agents|mesh-ancestor
14649720|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649721|NCT00207844|Trace Elements|trace elements|mesh-ancestor
14649722|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
14649723|NCT00207948|Ritonavir|ritonavir|mesh-list
14649724|NCT00207948|Lopinavir|lopinavir|mesh-list
14649725|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14649726|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14649727|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
14649728|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649729|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649730|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14649731|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14649732|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
14649733|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14649734|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14649735|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14649736|NCT00208039|Calfactant|calfactant|mesh-list
14649737|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14649738|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14649739|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
14649740|NCT00208065|Ephedrine|ephedrine|mesh-list
14649741|NCT00208065|Almotriptan|almotriptan|mesh-list
14649742|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14649743|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
14649744|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649745|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649746|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14649747|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
14649748|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
14649749|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14649750|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14649751|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
14649752|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14649753|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649754|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649755|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14649756|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
14649757|NCT00208117|Sertraline|sertraline|mesh-list
14649758|NCT00208117|Simvastatin|simvastatin|mesh-list
14649759|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14649760|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14649761|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
14649762|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649763|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14649764|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14649765|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182835|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649766|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649767|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649768|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14649769|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14649770|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15182836|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223520|NCT02101788|Protective Agents|protective agents|mesh-ancestor
15182837|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182838|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14649771|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649772|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
14649773|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649774|NCT00208130|Topiramate|topiramate|mesh-list
14649775|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
14649776|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14649777|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649778|NCT00208143|Risperidone|risperidone|mesh-list
14649779|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14649780|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15182839|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15182840|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182841|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182842|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
15182843|NCT03917940|Glimepiride|glimepiride|mesh-list
15182844|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15182845|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15182846|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182847|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182848|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
15182849|NCT03917784|Curcumin|curcumin|mesh-list
15182850|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15182851|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182852|NCT03917784|Analgesics|analgesics|mesh-ancestor
15182853|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
15182854|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649781|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
14649782|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649783|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649784|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649785|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15182855|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182856|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182857|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182858|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182859|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182860|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182861|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
15182862|NCT03917758|Empagliflozin|empagliflozin|mesh-list
15182863|NCT03917758|Canagliflozin|canagliflozin|mesh-list
15182864|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15182865|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182866|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15182867|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649786|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649787|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649788|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649789|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649790|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
14649791|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649792|NCT00208156|Mifepristone|mifepristone|mesh-list
14649793|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14649794|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
14649795|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14649796|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649797|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14649798|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14649799|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14649800|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
14649801|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14649802|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14649803|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649804|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649805|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
14649806|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14649807|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14649808|NCT00208169|Aripiprazole|aripiprazole|mesh-list
14649809|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649810|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649811|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649812|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649813|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649814|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649815|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
14649816|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
14649817|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649818|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649819|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14649820|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14649821|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
14649822|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14649823|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649824|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14649825|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649826|NCT00208182|Risperidone|risperidone|mesh-list
14649827|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649828|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
14649829|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649830|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649831|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649832|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649833|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649834|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649835|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649836|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649837|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
14649838|NCT00208195|Valproic Acid|valproic acid|mesh-list
14649839|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
14649840|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649841|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649842|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
14649843|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649844|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649845|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
14649846|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649847|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649848|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649849|NCT00208208|Ziprasidone|ziprasidone|mesh-list
15182868|NCT03917459|Enalapril|enalapril|mesh-list
14649850|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649851|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
14649852|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649853|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649854|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649855|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649856|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649857|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649858|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649859|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649860|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
14649861|NCT00208221|Telmisartan|telmisartan|mesh-list
14649862|NCT00208221|Ramipril|ramipril|mesh-list
14649863|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14649864|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14649865|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14649866|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649867|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14649868|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
14649869|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649870|NCT00208234|Omalizumab|omalizumab|mesh-list
14649871|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14649872|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14649873|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14649874|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
14649875|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
15182869|NCT03917459|Enalaprilat|enalaprilat|mesh-list
15182870|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15182871|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15182872|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
15182873|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182874|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182875|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14649876|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649877|NCT00208260|Leucovorin|leucovorin|mesh-list
14649878|NCT00208260|Fluorouracil|fluorouracil|mesh-list
14649879|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
14649880|NCT00208260|Folfirinox|folfirinox|mesh-list
14649881|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
14649882|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649883|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14649884|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649885|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14649886|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
14649887|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649888|NCT00208260|Antidotes|antidotes|mesh-ancestor
14649889|NCT00208260|Protective Agents|protective agents|mesh-ancestor
14649890|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
14649891|NCT00208260|Vitamins|vitamins|mesh-ancestor
14649892|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
14649893|NCT00208273|Letrozole|letrozole|mesh-list
14649894|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649895|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14649896|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14649897|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14649898|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649899|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14649900|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
14649901|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14649902|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649903|NCT00208299|Adenosine|adenosine|mesh-list
14649904|NCT00208299|Regadenoson|regadenoson|mesh-list
14649905|NCT00208299|Analgesics|analgesics|mesh-ancestor
14649906|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
14649907|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649908|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649909|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14649910|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
14649911|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14649912|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
14649913|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
14649914|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649915|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649916|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14649917|NCT00208312|Adenosine|adenosine|mesh-list
14649918|NCT00208312|Regadenoson|regadenoson|mesh-list
14649919|NCT00208312|Analgesics|analgesics|mesh-ancestor
14649920|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
14649921|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649922|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649923|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14649924|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
14649925|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14649926|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
14649927|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
14649928|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649929|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649930|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14649931|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14649932|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
14649933|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14649934|NCT00208403|Protective Agents|protective agents|mesh-ancestor
14649935|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649936|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
14649937|NCT00208442|Diuretics|diuretics|mesh-ancestor
14649938|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
14649939|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649940|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14649941|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649942|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649943|NCT00208520|Lamotrigine|lamotrigine|mesh-list
14649944|NCT00208520|Carbamazepine|carbamazepine|mesh-list
14649945|NCT00208520|Levetiracetam|levetiracetam|mesh-list
14649946|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
14649947|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
14649948|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14649949|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14649950|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649951|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14649952|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649953|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649954|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649955|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649956|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649957|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14649958|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
14649959|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14649960|NCT00208520|Analgesics|analgesics|mesh-ancestor
14649961|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
14649962|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14649963|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14649964|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14649965|NCT00208533|Aripiprazole|aripiprazole|mesh-list
14649966|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
14649967|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14649968|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14649969|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14649970|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14649971|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649972|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
14649973|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
14649974|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14649975|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649976|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14649977|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14649978|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
14649979|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14649980|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649981|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14649982|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14649983|NCT00208546|Bevacizumab|bevacizumab|mesh-list
14649984|NCT00208546|Cetuximab|cetuximab|mesh-list
14649985|NCT00208546|Capecitabine|capecitabine|mesh-list
14649986|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
14649987|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14649988|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14649989|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14649990|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14649991|NCT00208546|Growth Substances|growth substances|mesh-ancestor
14649992|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14649993|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
14649994|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14649995|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
14649996|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14649997|NCT00208559|Ziprasidone|ziprasidone|mesh-list
14649998|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14649999|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
14650000|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650001|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650002|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650003|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14650004|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650005|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650006|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650007|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14650008|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
14650009|NCT00208572|Citalopram|citalopram|mesh-list
14650010|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14650011|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650012|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650013|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650014|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650015|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
14650016|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650017|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14650018|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650019|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650020|NCT00208585|Sertraline|sertraline|mesh-list
14650021|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650022|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650023|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14650024|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650025|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650026|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182876|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15182877|NCT03917446|Propofol|propofol|mesh-list
14650027|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650028|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
14650029|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650030|NCT00208611|Vitamins|vitamins|mesh-list
14650031|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
14650032|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
14650033|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
14650034|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
14650035|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650036|NCT00208611|Hematinics|hematinics|mesh-ancestor
14650037|NCT00208702|Sertraline|sertraline|mesh-list
14650038|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650039|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650040|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14650041|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650042|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650043|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650044|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650045|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
14650046|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650047|NCT00208715|Modafinil|modafinil|mesh-list
14650048|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15182878|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15182879|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182880|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182881|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15182882|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
15182883|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
15182884|NCT03917537|Nivolumab|nivolumab|mesh-list
15182885|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15182886|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182887|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15182888|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182889|NCT03917628|Adalimumab|adalimumab|mesh-list
15182890|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182891|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182892|NCT03917420|Tenofovir|tenofovir|mesh-list
15182893|NCT03917420|Emtricitabine|emtricitabine|mesh-list
15182894|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15182895|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
15182896|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182897|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15182898|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15182899|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182900|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650049|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650050|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14650051|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14650052|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14650053|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650054|NCT00208741|Tiagabine|tiagabine|mesh-list
14650055|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
15182901|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15182902|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15182903|NCT03917303|Adalimumab|adalimumab|mesh-list
15182904|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182905|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182906|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
15182907|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
15182908|NCT03917095|Mesalamine|mesalamine|mesh-list
15182909|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15182910|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15182911|NCT03917095|Analgesics|analgesics|mesh-ancestor
15182912|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
15182913|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15182914|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182915|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15182916|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182917|NCT03916926|Fluorides|fluorides|mesh-list
15182918|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
14650056|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14650057|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15182919|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
15182920|NCT03916926|Protective Agents|protective agents|mesh-ancestor
15182921|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182922|NCT03917134|Metronidazole|metronidazole|mesh-list
15182923|NCT03917134|Cephalosporins|cephalosporins|mesh-list
15182924|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182925|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650058|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650059|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650060|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
14650061|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650062|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725274|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14725275|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
14725276|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725277|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725278|NCT00503412|Cediranib|cediranib|mesh-list
14725279|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725280|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725281|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725282|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725283|NCT00503451|Panobinostat|panobinostat|mesh-list
14725284|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725285|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14725286|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725287|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725288|NCT00503477|Cediranib|cediranib|mesh-list
14725289|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725290|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725291|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725292|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725293|NCT00503490|Levofloxacin|levofloxacin|mesh-list
14725294|NCT00503490|Ofloxacin|ofloxacin|mesh-list
14725295|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14725296|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725297|NCT00503490|Renal Agents|renal agents|mesh-ancestor
14725298|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14725299|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14725300|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725301|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725302|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725303|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725304|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14725305|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14725306|NCT00503503|Etanercept|etanercept|mesh-list
14725307|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14725308|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725309|NCT00503503|Analgesics|analgesics|mesh-ancestor
14725310|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
14725311|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725312|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725313|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725314|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725315|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725316|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725317|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
14725318|NCT00503516|Megestrol|megestrol|mesh-list
14725319|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
14725320|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14725321|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14725322|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14725323|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
14725324|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725325|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725326|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14725327|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14725328|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14725329|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725330|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
14725331|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14725332|NCT00503542|Metronidazole|metronidazole|mesh-list
14725333|NCT00503542|Clindamycin|clindamycin|mesh-list
14725334|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
14725335|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
15182926|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15182927|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14650063|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
14650064|NCT00208793|Vitamin D|vitamin d|mesh-list
14650065|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
14650066|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
14650067|NCT00208793|Vitamins|vitamins|mesh-list
14650068|NCT00208793|Calcium|calcium|mesh-list
14650069|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
14650070|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650071|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14650072|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14650073|NCT00208819|Valproic Acid|valproic acid|mesh-list
14650074|NCT00208819|Olanzapine|olanzapine|mesh-list
14650075|NCT00208819|Risperidone|risperidone|mesh-list
14650076|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14650077|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14650078|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
14650079|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650080|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182928|NCT03917082|Tamoxifen|tamoxifen|mesh-list
15182929|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15182930|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182931|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15182932|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
15182933|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182934|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182935|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15182936|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182937|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15182938|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15182939|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14650081|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650082|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14650083|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650084|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650085|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650086|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14650087|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
14650088|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
14650089|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
14650090|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650091|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14650092|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14650093|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650094|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650095|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650096|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
14650097|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650098|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
14650099|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
14650100|NCT00208858|Topiramate|topiramate|mesh-list
14650101|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
14650102|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650103|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650104|NCT00208897|Fluoxetine|fluoxetine|mesh-list
14650105|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14650106|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650107|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650108|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650109|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650110|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
14650111|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650112|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14650113|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650114|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650115|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15182940|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15182941|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650116|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15182942|NCT03917394|Iron|iron|mesh-list
15182943|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15182944|NCT03917394|Trace Elements|trace elements|mesh-ancestor
15182945|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
15182946|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650117|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650118|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
14650119|NCT00208923|Busulfan|busulfan|mesh-list
14650120|NCT00208923|Fludarabine|fludarabine|mesh-list
14650121|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650122|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
14650123|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650124|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650125|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14650126|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
14650127|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650128|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650129|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14650130|NCT00208936|Fluorouracil|fluorouracil|mesh-list
14650131|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650132|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
14650133|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650134|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650135|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650136|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
14650137|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650138|NCT00209014|Thalidomide|thalidomide|mesh-list
14650139|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650140|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
14650141|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650142|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
14650143|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650144|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650145|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15182947|NCT03917394|Hematinics|hematinics|mesh-ancestor
15223521|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15223522|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
15223523|NCT02081378|Niacinamide|niacinamide|mesh-list
15223524|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
15223525|NCT02081378|Dasatinib|dasatinib|mesh-list
15223526|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223527|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223528|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223529|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223530|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
14650146|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14650147|NCT00209014|Growth Substances|growth substances|mesh-ancestor
14650148|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
14650149|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650150|NCT00209079|Docetaxel|docetaxel|mesh-list
14650151|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
14650152|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650153|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
14650154|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
14650155|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
14650156|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650157|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14650158|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650159|NCT00209118|Paroxetine|paroxetine|mesh-list
14650160|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14650161|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650162|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650163|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650164|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650165|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
14650166|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650167|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14650168|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650169|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650170|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14650171|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14650172|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650173|NCT00209144|Insulin|insulin|mesh-list
14650174|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650175|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650176|NCT00209209|Interferons|interferons|mesh-list
14650177|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
14650178|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
14650179|NCT00209209|Prednisone|prednisone|mesh-list
14650180|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
15223531|NCT02081378|Vitamins|vitamins|mesh-ancestor
15223532|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
14650181|NCT00209209|Rituximab|rituximab|mesh-list
14650182|NCT00209209|Doxorubicin|doxorubicin|mesh-list
14650183|NCT00209209|Fludarabine|fludarabine|mesh-list
14650184|NCT00209209|Vincristine|vincristine|mesh-list
14650185|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650186|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
14650187|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650188|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650189|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14650190|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
14650191|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650192|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650193|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14650194|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14650195|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14650196|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14650197|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650198|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650199|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14650200|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
14650201|NCT00209209|Hormones|hormones|mesh-ancestor
14650202|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14650203|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14650204|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
14650205|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182948|NCT03917186|Sevoflurane|sevoflurane|mesh-list
15182949|NCT03917186|Desflurane|desflurane|mesh-list
15182950|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15182951|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15182952|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
15182953|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
15182954|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15182955|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182956|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
15182957|NCT03916679|Fludarabine|fludarabine|mesh-list
14650206|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14650207|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
15182958|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182959|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
15182960|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182961|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15182962|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15182963|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
15182964|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182965|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182966|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15182967|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
14650208|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14650209|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14650210|NCT00209222|Cytarabine|cytarabine|mesh-list
14650211|NCT00209222|Dexamethasone|dexamethasone|mesh-list
14650212|NCT00209222|Prednisone|prednisone|mesh-list
14650213|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
14650214|NCT00209222|Melphalan|melphalan|mesh-list
14650215|NCT00209222|Rituximab|rituximab|mesh-list
14650216|NCT00209222|Doxorubicin|doxorubicin|mesh-list
14650217|NCT00209222|Etoposide|etoposide|mesh-list
14650218|NCT00209222|Vincristine|vincristine|mesh-list
14650219|NCT00209222|Cisplatin|cisplatin|mesh-list
14650220|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650221|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
14650222|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650223|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650224|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14650225|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
14650226|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650227|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650228|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14650229|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14650230|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
14650231|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
14650232|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650233|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14650234|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
14650235|NCT00209222|Hormones|hormones|mesh-ancestor
14650236|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15182968|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15182969|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650237|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14650238|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14650239|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14650240|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14650241|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650242|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182970|NCT03916250|Petrolatum|petrolatum|mesh-list
15182971|NCT03916250|PF-06700841|pf-06700841|mesh-list
15182972|NCT03916250|Emollients|emollients|mesh-ancestor
15182973|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
15182974|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15182975|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182976|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182977|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14650243|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14650244|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
14650245|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
14650246|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
14650247|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650248|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
14650249|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
15182978|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14650250|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650251|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14650252|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
14650253|NCT00209261|Coagulants|coagulants|mesh-ancestor
14650254|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14650255|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
14650256|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650257|NCT00209300|Mesalamine|mesalamine|mesh-list
14650258|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14650259|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14650260|NCT00209300|Analgesics|analgesics|mesh-ancestor
14650261|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
14650262|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650263|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650264|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14650265|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650266|NCT00209313|Acyclovir|acyclovir|mesh-list
14650267|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
14650268|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650269|NCT00209352|Acyclovir|acyclovir|mesh-list
14650270|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
14650271|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650272|NCT00209469|Alendronate|alendronate|mesh-list
14650273|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14650274|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650275|NCT00209482|Metformin|metformin|mesh-list
14650276|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650277|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650278|NCT00209495|Dexamethasone|dexamethasone|mesh-list
14650279|NCT00209495|Pregabalin|pregabalin|mesh-list
14650280|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14650281|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
14650282|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
14650283|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650284|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650285|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14650286|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
14650287|NCT00209495|Hormones|hormones|mesh-ancestor
14650288|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14650289|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14650290|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650291|NCT00209495|Analgesics|analgesics|mesh-ancestor
14650292|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
14650293|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
14650294|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14650295|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650296|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650297|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14650298|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14650299|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650300|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650301|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650302|NCT00209521|Propofol|propofol|mesh-list
14650303|NCT00209521|Fospropofol|fospropofol|mesh-list
15182979|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
14650304|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14650305|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650306|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650307|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14650308|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
14650309|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
14650310|NCT00209534|Fospropofol|fospropofol|mesh-list
14650311|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14650312|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650313|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650314|NCT00209547|Fospropofol|fospropofol|mesh-list
14650315|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14650316|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650317|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650318|NCT00209573|Fospropofol|fospropofol|mesh-list
14650319|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14650320|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650321|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650322|NCT00209586|Fospropofol|fospropofol|mesh-list
14650323|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14650324|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650325|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650326|NCT00209599|Fospropofol|fospropofol|mesh-list
14650327|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14650328|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650329|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650330|NCT00209612|Paclitaxel|paclitaxel|mesh-list
14650331|NCT00209612|Irinotecan|irinotecan|mesh-list
14650332|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14650333|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650334|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14650335|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
14650336|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
14650337|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650338|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14650339|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650340|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650341|NCT00209625|Leucovorin|leucovorin|mesh-list
14650342|NCT00209625|Fluorouracil|fluorouracil|mesh-list
14650343|NCT00209625|Irinotecan|irinotecan|mesh-list
14650344|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
14650345|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650346|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650347|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650348|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650349|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
14650350|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650351|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14650352|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650353|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15182980|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15182981|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15182982|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15182983|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15182984|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15182985|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182986|NCT03916510|Capecitabine|capecitabine|mesh-list
15182987|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15182988|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
15182989|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15182990|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182991|NCT03916432|Sirolimus|sirolimus|mesh-list
14650354|NCT00209625|Antidotes|antidotes|mesh-ancestor
14650355|NCT00209625|Protective Agents|protective agents|mesh-ancestor
14650356|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
14650357|NCT00209625|Vitamins|vitamins|mesh-ancestor
14650358|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
14650359|NCT00209638|Irinotecan|irinotecan|mesh-list
14650360|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15182992|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650361|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650362|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650363|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650364|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650365|NCT00209651|Irinotecan|irinotecan|mesh-list
14650366|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14650367|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650368|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650369|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650370|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650371|NCT00209664|Irinotecan|irinotecan|mesh-list
14650372|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14650373|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650374|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650375|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650376|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650377|NCT00209677|Gemcitabine|gemcitabine|mesh-list
14650378|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650379|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
14650380|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650381|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650382|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
14650383|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650384|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650385|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650386|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
14650387|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650388|NCT00209690|Cisplatin|cisplatin|mesh-list
14650389|NCT00209690|Docetaxel|docetaxel|mesh-list
14650390|NCT00209690|Fluorouracil|fluorouracil|mesh-list
14650391|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650392|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14650393|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14650394|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14650395|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650396|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
14650397|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650398|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650399|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
14650400|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650401|NCT00209703|Leucovorin|leucovorin|mesh-list
14650402|NCT00209703|Fluorouracil|fluorouracil|mesh-list
14650403|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
14650404|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
14650405|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
14650406|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650407|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650408|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650409|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650410|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
14650411|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650412|NCT00209703|Antidotes|antidotes|mesh-ancestor
14650413|NCT00209703|Protective Agents|protective agents|mesh-ancestor
14650414|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
14650415|NCT00209703|Vitamins|vitamins|mesh-ancestor
14650416|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
14650417|NCT00209716|Cisplatin|cisplatin|mesh-list
14650418|NCT00209716|Docetaxel|docetaxel|mesh-list
14650419|NCT00209716|Fluorouracil|fluorouracil|mesh-list
14650420|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650421|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14650422|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14650423|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14650424|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650425|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
14650426|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650427|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650428|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
14650429|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650430|NCT00209729|Docetaxel|docetaxel|mesh-list
14650431|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650432|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
14650433|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
14650434|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
14650435|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650436|NCT00209742|Leucovorin|leucovorin|mesh-list
14650437|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
14650438|NCT00209742|Tegafur|tegafur|mesh-list
14650439|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
14650440|NCT00209742|Antidotes|antidotes|mesh-ancestor
14650441|NCT00209742|Protective Agents|protective agents|mesh-ancestor
14650442|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650443|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
14650444|NCT00209742|Vitamins|vitamins|mesh-ancestor
14650445|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
14650446|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650447|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
14650448|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650449|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650450|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14650451|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
14650452|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14650453|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
14650454|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650455|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
14650456|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14650457|NCT00209755|Ribavirin|ribavirin|mesh-list
14650458|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
14650459|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650460|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
14650461|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650462|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
14650463|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
15182993|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15182994|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15182995|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15182996|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
15182997|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15182998|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
15182999|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183000|NCT03916406|Midazolam|midazolam|mesh-list
15183001|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15183002|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15183003|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183004|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183005|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15183006|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15183007|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650464|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14650465|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
14650466|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14650467|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14650468|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650469|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14650470|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650471|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650472|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14650473|NCT00209781|Renal Agents|renal agents|mesh-ancestor
14650474|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
14650475|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
14650476|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14650477|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
14650478|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14650479|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14650480|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650481|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14650482|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650483|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183008|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15183009|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
15183010|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
15183011|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
15183012|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
15183013|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183014|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183015|NCT03916068|Vitamin E|vitamin e|mesh-list
15183016|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
15183017|NCT03916068|Vitamins|vitamins|mesh-ancestor
15183018|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
15183019|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183020|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
15183021|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183022|NCT03916068|Protective Agents|protective agents|mesh-ancestor
15183023|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15183024|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183025|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15183026|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14650484|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14650485|NCT00209794|Renal Agents|renal agents|mesh-ancestor
15183027|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
14650486|NCT00209807|Citalopram|citalopram|mesh-list
14650487|NCT00209807|Reboxetine|reboxetine|mesh-list
14650488|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14650489|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650490|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650491|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650492|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650493|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
14650494|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650495|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14650496|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650497|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650498|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14650499|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
14650500|NCT00209833|Cytarabine|cytarabine|mesh-list
14650501|NCT00209833|Fludarabine|fludarabine|mesh-list
14650502|NCT00209833|Etoposide|etoposide|mesh-list
14650503|NCT00209833|Idarubicin|idarubicin|mesh-list
14650504|NCT00209833|Daunorubicin|daunorubicin|mesh-list
14650505|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650506|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650507|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
14650508|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650509|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650510|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
14650511|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650512|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14650513|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14650514|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650515|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650516|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
14650517|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650518|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14650519|NCT00209846|Gaboxadol|gaboxadol|mesh-list
14650520|NCT00209846|Analgesics|analgesics|mesh-ancestor
14650521|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
14650522|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650523|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650524|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
14650525|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
14650526|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
14650527|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650528|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650529|NCT00209859|Cyclosporine|cyclosporine|mesh-list
14650530|NCT00209859|Betamethasone|betamethasone|mesh-list
14650531|NCT00209859|Methotrexate|methotrexate|mesh-list
14650532|NCT00209859|Cyclosporins|cyclosporins|mesh-list
14650533|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14650534|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
14650535|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14650536|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650537|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650538|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
14650539|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650540|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650541|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
14650542|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650543|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14650544|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650545|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
15183028|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15183029|NCT03915964|Adalimumab|adalimumab|mesh-list
15183030|NCT03915964|Etanercept|etanercept|mesh-list
15183031|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
15183032|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15183033|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183034|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15183035|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183036|NCT03915964|Analgesics|analgesics|mesh-ancestor
15183037|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
15183038|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183039|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183040|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14650546|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650547|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15183041|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650548|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
14650549|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650550|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14650551|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14650552|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
14650553|NCT00209859|Hormones|hormones|mesh-ancestor
14650554|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14650555|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14650556|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
14650557|NCT00209872|Lidocaine|lidocaine|mesh-list
14650558|NCT00209872|Ketamine|ketamine|mesh-list
14650559|NCT00209872|Gabapentin|gabapentin|mesh-list
14650560|NCT00209872|Esketamine|esketamine|mesh-list
14650561|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
15183042|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
14650562|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
14650563|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183043|NCT03915938|Ketamine|ketamine|mesh-list
15183044|NCT03915938|Analgesics|analgesics|mesh-ancestor
15183045|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
15183046|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183047|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183048|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15183049|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15183050|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
14650564|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650565|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
14650566|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650567|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14650568|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14650569|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14650570|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650571|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650572|NCT00209872|Analgesics|analgesics|mesh-ancestor
14650573|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14650574|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14650575|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
14650576|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14650577|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14650578|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650579|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
14650580|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14650581|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650582|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650583|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
14650584|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650585|NCT00209885|Lidocaine|lidocaine|mesh-list
15183051|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
15183052|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183053|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15183054|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15183055|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183056|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183057|NCT03916094|Trastuzumab|trastuzumab|mesh-list
15183058|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183059|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183060|NCT03915366|Valganciclovir|valganciclovir|mesh-list
15183061|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
15183062|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
14650586|NCT00209885|Droperidol|droperidol|mesh-list
14650587|NCT00209885|Ketamine|ketamine|mesh-list
14650588|NCT00209885|Gabapentin|gabapentin|mesh-list
14650589|NCT00209885|Esketamine|esketamine|mesh-list
14650590|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
14650591|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
14650592|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650593|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650594|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
14650595|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650596|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14650597|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14650598|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14650599|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650600|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183063|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650601|NCT00209885|Analgesics|analgesics|mesh-ancestor
14650602|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14650603|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14650604|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
14650605|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14650606|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14650607|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650608|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
14650609|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14650610|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650611|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650612|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
14650613|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
14650614|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14650615|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
14650616|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
14650617|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14650618|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14650619|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14650620|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14650621|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
14650622|NCT00209924|Gaboxadol|gaboxadol|mesh-list
14650623|NCT00209924|Analgesics|analgesics|mesh-ancestor
14650624|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
14650625|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650626|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650627|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
14650628|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
15183064|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15183065|NCT03915444|Gemcitabine|gemcitabine|mesh-list
15183066|NCT03915444|Paclitaxel|paclitaxel|mesh-list
15183067|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15183068|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183069|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183070|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
15183071|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183072|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183073|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15183074|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
15183075|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
15183076|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183077|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183078|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183079|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
15183080|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183081|NCT03915561|Parecoxib|parecoxib|mesh-list
15183082|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15183083|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15183084|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183085|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183086|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15183087|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183088|NCT03915561|Analgesics|analgesics|mesh-ancestor
15183089|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
15183090|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183091|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183092|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15183093|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183094|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
15183095|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15183096|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183097|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
15183098|NCT03915340|Propafenone|propafenone|mesh-list
15183099|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14650629|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
14650630|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650631|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650632|NCT00209937|Gaboxadol|gaboxadol|mesh-list
14650633|NCT00209937|Analgesics|analgesics|mesh-ancestor
14650634|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
14650635|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650636|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183100|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14650637|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
14650638|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
14650639|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
14650640|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650641|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650642|NCT00209950|Gaboxadol|gaboxadol|mesh-list
14650643|NCT00209950|Analgesics|analgesics|mesh-ancestor
14650644|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
14650645|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650646|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650647|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
14650648|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
14650649|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
14650650|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650651|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650652|NCT00209963|Gaboxadol|gaboxadol|mesh-list
14650653|NCT00209963|Analgesics|analgesics|mesh-ancestor
14650654|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
14650655|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650656|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650657|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
14650658|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
14650659|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
14650660|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650661|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650662|NCT00209989|Tipifarnib|tipifarnib|mesh-list
14650663|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650664|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
14650665|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14650666|NCT00210002|Hematinics|hematinics|mesh-ancestor
14650667|NCT00210028|Tamoxifen|tamoxifen|mesh-list
14650668|NCT00210028|Tipifarnib|tipifarnib|mesh-list
14650669|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14650670|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
14650671|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14650672|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650673|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14650674|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650675|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14650676|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14293303|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
14293304|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650677|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14650678|NCT00210041|Gemcitabine|gemcitabine|mesh-list
14293305|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14293306|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14650679|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650680|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650681|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
14650682|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650683|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
14650684|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650685|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650686|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650687|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
14650688|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650689|NCT00210132|Ropivacaine|ropivacaine|mesh-list
14650690|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
14650691|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
15183101|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15183102|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183103|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183104|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15183105|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
15183106|NCT03914963|Coagulants|coagulants|mesh-ancestor
15223533|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650692|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650693|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650694|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
14650695|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650696|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
14650697|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14650698|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
14650699|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
14650700|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223534|NCT01970410|Teriflunomide|teriflunomide|mesh-list
14293307|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15225663|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
14650701|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183107|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
15183108|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183109|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183110|NCT03914755|Tucatinib|tucatinib|mesh-list
15183111|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183112|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14650702|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14650703|NCT00210158|Analgesics|analgesics|mesh-ancestor
14650704|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
14650705|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650706|NCT00210210|Ketamine|ketamine|mesh-list
14650707|NCT00210210|Analgesics|analgesics|mesh-ancestor
14650708|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
14650709|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650710|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650711|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14650712|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14650713|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
14650714|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
14650715|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650716|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14650717|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14650718|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650719|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650720|NCT00210301|Modafinil|modafinil|mesh-list
14650721|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14650722|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650723|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14650724|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14650725|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14650726|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725336|NCT00503542|Fluconazole|fluconazole|mesh-list
14725337|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725338|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14725339|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14725340|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14725341|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14725342|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725343|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725344|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
14725345|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14725346|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14725347|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14725348|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
14725349|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725350|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725351|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14725352|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14725353|NCT00503568|Vaccines|vaccines|mesh-list
14725354|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
14725355|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725356|NCT00503594|Cytarabine|cytarabine|mesh-list
14725357|NCT00503594|Methotrexate|methotrexate|mesh-list
14725358|NCT00503594|Vincristine|vincristine|mesh-list
14725359|NCT00503594|Temozolomide|temozolomide|mesh-list
14725360|NCT00503594|Procarbazine|procarbazine|mesh-list
14725361|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14725362|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
14725363|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725364|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725365|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725366|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
14725367|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725368|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725369|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
14725370|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725371|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14725372|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725373|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
14725374|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725375|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14725376|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
14650727|NCT00210314|Cytarabine|cytarabine|mesh-list
14650728|NCT00210314|Methotrexate|methotrexate|mesh-list
14650729|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14650730|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
14650731|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14650732|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650733|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650734|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
14650735|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650736|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650737|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
14650738|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650739|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14650740|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650741|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
14650742|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650743|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14650744|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
14650745|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650746|NCT00210327|Bortezomib|bortezomib|mesh-list
14650747|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650748|NCT00210340|Rituximab|rituximab|mesh-list
14650749|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14650750|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650751|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
14293308|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293309|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
14293310|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293311|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14293312|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15183113|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183114|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183115|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
15183116|NCT03914690|Hematinics|hematinics|mesh-ancestor
14293313|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650752|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650753|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650754|NCT00210366|Idarubicin|idarubicin|mesh-list
14650755|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14650756|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650757|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14650758|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650759|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650760|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650761|NCT00210379|Rituximab|rituximab|mesh-list
14650762|NCT00210379|Methotrexate|methotrexate|mesh-list
14650763|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14650764|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650765|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
14650766|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650767|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14650768|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14650769|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
14650770|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14650771|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14650772|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
14650773|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650774|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
14650775|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650776|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14650777|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14650778|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14650779|NCT00210392|Bortezomib|bortezomib|mesh-list
14650780|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650781|NCT00210405|Micronutrients|micronutrients|mesh-list
14650782|NCT00210405|Trace Elements|trace elements|mesh-list
14650783|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650784|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
14650785|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14650786|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14650787|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14650788|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650789|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650790|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183117|NCT03914638|Albuterol|albuterol|mesh-list
14650791|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650792|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650793|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14650794|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650795|NCT00210457|Lanreotide|lanreotide|mesh-list
14650796|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650797|NCT00210483|Almotriptan|almotriptan|mesh-list
14650798|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14650799|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
14650800|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650801|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650802|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650803|NCT00210496|Topiramate|topiramate|mesh-list
14650804|NCT00210496|Almotriptan|almotriptan|mesh-list
14650805|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
14650806|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650807|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650808|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14650809|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
14650810|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650811|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650812|NCT00210509|Almotriptan|almotriptan|mesh-list
14650813|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15183118|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15183119|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
15183120|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650814|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
14650815|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650816|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183121|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183122|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15183123|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
15183124|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
15183125|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15183126|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15183127|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15183128|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15183129|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
14650817|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650818|NCT00210535|Topiramate|topiramate|mesh-list
14650819|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
14650820|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650821|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650822|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14650823|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14650824|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650825|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650826|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650827|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650828|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14650829|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14650830|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
14650831|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650832|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650833|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14650834|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14650835|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
14650836|NCT00210561|Acetaminophen|acetaminophen|mesh-list
14650837|NCT00210561|Tramadol|tramadol|mesh-list
14650838|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14650839|NCT00210561|Analgesics|analgesics|mesh-ancestor
14650840|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
14650841|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650842|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650843|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
14650844|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14650845|NCT00210561|Narcotics|narcotics|mesh-ancestor
14650846|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650847|NCT00210574|Topiramate|topiramate|mesh-list
14650848|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
14650849|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15183130|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293314|NCT00567268|Gabapentin|gabapentin|mesh-list
14650850|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183131|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650851|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
14650852|NCT00210587|Hematinics|hematinics|mesh-ancestor
14650853|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
14650854|NCT00210600|Hematinics|hematinics|mesh-ancestor
14650855|NCT00210665|Trabectedin|trabectedin|mesh-list
14650856|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14650857|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
14650858|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650859|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650860|NCT00210691|Risperidone|risperidone|mesh-list
14650861|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14650862|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
14650863|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650864|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650865|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650866|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14650867|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650868|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650869|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650870|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14650871|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
14650872|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14650873|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14650874|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650875|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650876|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650877|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650878|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14650879|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14650880|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
14650881|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650882|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650883|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14650884|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14650885|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
14650886|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
14650887|NCT00210730|Hematinics|hematinics|mesh-ancestor
14650888|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
14650889|NCT00210743|Hematinics|hematinics|mesh-ancestor
14650890|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
14650891|NCT00210756|Hematinics|hematinics|mesh-ancestor
14650892|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14650893|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14650894|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650895|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183132|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
15183133|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
15183134|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650896|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650897|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14650898|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14650899|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14650900|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
14650901|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650902|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650903|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14650904|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14650905|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
14650906|NCT00210782|Topiramate|topiramate|mesh-list
14650907|NCT00210782|Phenytoin|phenytoin|mesh-list
14650908|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
14650909|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650910|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650911|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14650912|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14650913|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14650914|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650915|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14650916|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14650917|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
14650918|NCT00210795|Hematinics|hematinics|mesh-ancestor
14650919|NCT00210808|Topiramate|topiramate|mesh-list
15183135|NCT03914404|Protective Agents|protective agents|mesh-ancestor
15183136|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183137|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
14650920|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
14650921|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650922|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650923|NCT00210821|Topiramate|topiramate|mesh-list
14650924|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
14650925|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650926|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650927|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
14650928|NCT00210834|Hematinics|hematinics|mesh-ancestor
14650929|NCT00210847|Acetaminophen|acetaminophen|mesh-list
14650930|NCT00210847|Tramadol|tramadol|mesh-list
14650931|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14650932|NCT00210847|Analgesics|analgesics|mesh-ancestor
14650933|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
14650934|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14650935|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650936|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
14650937|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14650938|NCT00210847|Narcotics|narcotics|mesh-ancestor
14650939|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14650940|NCT00210860|Topiramate|topiramate|mesh-list
14650941|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
14650942|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650943|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650944|NCT00210873|Topiramate|topiramate|mesh-list
14650945|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
14650946|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650947|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650948|NCT00210886|Levofloxacin|levofloxacin|mesh-list
14650949|NCT00210886|Ofloxacin|ofloxacin|mesh-list
14650950|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14650951|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650952|NCT00210886|Renal Agents|renal agents|mesh-ancestor
14650953|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650954|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14650955|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14650956|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14650957|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14650958|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650959|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14650960|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14650961|NCT00210899|Vancomycin|vancomycin|mesh-list
14650962|NCT00210899|Ceftazidime|ceftazidime|mesh-list
14650963|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
14650964|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14650965|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650966|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650967|NCT00210912|Topiramate|topiramate|mesh-list
14650968|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
15183138|NCT03914404|Vitamins|vitamins|mesh-ancestor
15183139|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
15183140|NCT03914677|Mecamylamine|mecamylamine|mesh-list
14293315|NCT00567268|Analgesics|analgesics|mesh-ancestor
15183141|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15183142|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
15183143|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
15183144|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183145|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183146|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15183147|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15183148|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183149|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293316|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
14293317|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293318|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183150|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183151|NCT03914534|Valproic Acid|valproic acid|mesh-list
15183152|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
15183153|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183154|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183155|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
15183156|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14650969|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14650970|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183157|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183158|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
15183159|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14650971|NCT00210925|Topiramate|topiramate|mesh-list
14650972|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
14650973|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15183160|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183161|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15183162|NCT03914352|Antibodies|antibodies|mesh-list
15183163|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
15183164|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183165|NCT03914118|Modafinil|modafinil|mesh-list
15183166|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15183167|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183168|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15183169|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15183170|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14650974|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14650975|NCT00210938|Doripenem|doripenem|mesh-list
14650976|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650977|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650978|NCT00210990|Doripenem|doripenem|mesh-list
14650979|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650980|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650981|NCT00211003|Doripenem|doripenem|mesh-list
14650982|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14650983|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650984|NCT00211016|Doripenem|doripenem|mesh-list
14650985|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15183171|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183172|NCT03914092|Triamcinolone|triamcinolone|mesh-list
15183173|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15183174|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15183175|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15183176|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15183177|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
14650986|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14650987|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
14650988|NCT00211120|Hematinics|hematinics|mesh-ancestor
14650989|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
14650990|NCT00211133|Hematinics|hematinics|mesh-ancestor
14650991|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
14650992|NCT00211146|Hematinics|hematinics|mesh-ancestor
14650993|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
14650994|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14650995|NCT00211224|Riluzole|riluzole|mesh-list
14650996|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
14650997|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14650998|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14650999|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651000|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651001|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651002|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14651003|NCT00211224|Protective Agents|protective agents|mesh-ancestor
14651004|NCT00211250|Valproic Acid|valproic acid|mesh-list
14651005|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
14651006|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651007|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651008|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
14651009|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651010|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651011|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
14651012|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14651013|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651014|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14651015|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
14651016|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651017|NCT00211302|Aripiprazole|aripiprazole|mesh-list
14651018|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
14651019|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14651020|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14651021|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14651022|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651023|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651024|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
14651025|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
14651026|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183178|NCT03914092|Hormones|hormones|mesh-ancestor
15183179|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651027|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651028|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14651029|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14651030|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
14651031|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14651032|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14651033|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14651034|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14651035|NCT00211315|Anecortave|anecortave|mesh-list
14651036|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651037|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651038|NCT00211315|Growth Substances|growth substances|mesh-ancestor
14651039|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651040|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651041|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651042|NCT00211328|Anecortave|anecortave|mesh-list
14651043|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651044|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651045|NCT00211328|Growth Substances|growth substances|mesh-ancestor
14651046|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651047|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651048|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651049|NCT00211341|Vitamin A|vitamin a|mesh-list
14651050|NCT00211341|Vitamins|vitamins|mesh-ancestor
14651051|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
14651052|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651053|NCT00211354|Anecortave|anecortave|mesh-list
15183180|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183181|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183182|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
15183183|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183184|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183185|NCT03913884|Mitogens|mitogens|mesh-list
15183186|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183187|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183188|NCT03914235|Lidocaine|lidocaine|mesh-list
15183189|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
15183190|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
15183191|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651054|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651055|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651056|NCT00211354|Growth Substances|growth substances|mesh-ancestor
14651057|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651058|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651059|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651060|NCT00211367|Anecortave|anecortave|mesh-list
14651061|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651062|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15183192|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183193|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
15183194|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183195|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15183196|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15183197|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15183198|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183199|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183200|NCT03913858|Anesthetics|anesthetics|mesh-list
15183201|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183202|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183203|NCT03913650|Bupivacaine|bupivacaine|mesh-list
15183204|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
15183205|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
15183206|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183207|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183208|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
14651063|NCT00211367|Growth Substances|growth substances|mesh-ancestor
14651064|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651065|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651066|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651067|NCT00211380|Aripiprazole|aripiprazole|mesh-list
14651068|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
14651069|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14651070|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14651071|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14651072|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651073|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651074|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
15183209|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651075|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
14651076|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651077|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651078|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14651079|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14651080|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
14651081|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14651082|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14651083|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14651084|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14651085|NCT00211393|Ketoconazole|ketoconazole|mesh-list
14651086|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
14651087|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651088|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14651089|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14651090|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651091|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651092|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14651093|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
14651094|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651095|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651096|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14651097|NCT00211406|Anecortave|anecortave|mesh-list
14651098|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651099|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651100|NCT00211406|Growth Substances|growth substances|mesh-ancestor
14651101|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651102|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651103|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651104|NCT00211419|Triamcinolone|triamcinolone|mesh-list
14651105|NCT00211419|Anecortave|anecortave|mesh-list
14651106|NCT00211419|Verteporfin|verteporfin|mesh-list
14651107|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14651108|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
14651109|NCT00211419|Hormones|hormones|mesh-ancestor
14651110|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651111|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651112|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14651113|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
14651114|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651115|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651116|NCT00211419|Growth Substances|growth substances|mesh-ancestor
14651117|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651118|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651119|NCT00211432|Anecortave|anecortave|mesh-list
14651120|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651121|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651122|NCT00211432|Growth Substances|growth substances|mesh-ancestor
14651123|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651124|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651125|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651126|NCT00211445|Verteporfin|verteporfin|mesh-list
14651127|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14651128|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
15183210|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
15183211|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15183212|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15183213|NCT03913702|Prednisolone|prednisolone|mesh-list
15183214|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
15183215|NCT03913702|Ketorolac|ketorolac|mesh-list
15183216|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15183217|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15183218|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
15183219|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15183220|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
15183221|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
15183222|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183223|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293319|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
14651129|NCT00211458|Anecortave|anecortave|mesh-list
14651130|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651131|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651132|NCT00211458|Growth Substances|growth substances|mesh-ancestor
15183224|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15183225|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
15183226|NCT03913702|Hormones|hormones|mesh-ancestor
14651133|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183227|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15183228|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15183229|NCT03913702|Protective Agents|protective agents|mesh-ancestor
15183230|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15183231|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183232|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15183233|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183234|NCT03913702|Analgesics|analgesics|mesh-ancestor
15183235|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
15183236|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183237|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15183238|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183239|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183240|NCT03913806|Bevacizumab|bevacizumab|mesh-list
15183241|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183242|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183243|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15183244|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15183245|NCT03913806|Growth Substances|growth substances|mesh-ancestor
15183246|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183247|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
15183248|NCT03913455|Carboplatin|carboplatin|mesh-list
15183249|NCT03913455|Guadecitabine|guadecitabine|mesh-list
15183250|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183251|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
15183252|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
15183253|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183254|NCT03913468|Protective Agents|protective agents|mesh-ancestor
14293320|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14651134|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651135|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651136|NCT00211471|Anecortave|anecortave|mesh-list
14651137|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651138|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651139|NCT00211471|Growth Substances|growth substances|mesh-ancestor
14651140|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651141|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
14651142|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651143|NCT00211484|Anecortave|anecortave|mesh-list
14651144|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14651145|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14651146|NCT00211484|Growth Substances|growth substances|mesh-ancestor
14651147|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651148|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
14293321|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15183255|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183256|NCT03913468|Vitamins|vitamins|mesh-ancestor
15183257|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
15183258|NCT03913234|Trastuzumab|trastuzumab|mesh-list
15183259|NCT03913234|Letrozole|letrozole|mesh-list
15183260|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183261|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183262|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15183263|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15183264|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183265|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183266|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15183267|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
15183268|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15183269|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183270|NCT03913221|Caffeine|caffeine|mesh-list
15183271|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
15183272|NCT03913221|Citric Acid|citric acid|mesh-list
15183273|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
15183274|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
15183275|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15183276|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
15183277|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
15183278|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651149|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651150|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
14293322|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183279|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15225664|NCT04057469|Tulobuterol|tulobuterol|mesh-list
14651151|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651152|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
14651153|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651154|NCT00211562|Vitamin E|vitamin e|mesh-list
14651155|NCT00211562|Olanzapine|olanzapine|mesh-list
14651156|NCT00211562|Vitamins|vitamins|mesh-ancestor
14651157|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
14651158|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651159|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
14651160|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
14651161|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651162|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14651163|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14651164|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14651165|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183280|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183281|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15183282|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183283|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15183284|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15183285|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
14651166|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14651167|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14651168|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14651169|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14651170|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651171|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651172|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
14651173|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
14651174|NCT00211562|Protective Agents|protective agents|mesh-ancestor
14651175|NCT00211588|Galantamine|galantamine|mesh-list
14651176|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14651177|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651178|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651179|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
14651180|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651181|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651182|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14651183|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
14651184|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651185|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
14651186|NCT00211614|Lansoprazole|lansoprazole|mesh-list
14651187|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
14651188|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14651189|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14651190|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14651191|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651192|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651193|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
14651194|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14651195|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
14651196|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651197|NCT00211653|Expectorants|expectorants|mesh-ancestor
14651198|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
14651199|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14651200|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
14651201|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651202|NCT00211653|Protective Agents|protective agents|mesh-ancestor
14651203|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651204|NCT00211653|Antidotes|antidotes|mesh-ancestor
14651205|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
14651206|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14651207|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14651208|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14651209|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14651210|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651211|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
14651212|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651213|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651214|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14651215|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651216|NCT00211705|Pravastatin|pravastatin|mesh-list
14651217|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14651218|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14651219|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
14725377|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651220|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651221|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14651222|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14651223|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651224|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
14651225|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14651226|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14651227|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14651228|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14651229|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651230|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
14651231|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651232|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183286|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183287|NCT03912974|Citalopram|citalopram|mesh-list
15183288|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15183289|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14651233|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14651234|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651235|NCT00211744|Topiramate|topiramate|mesh-list
14651236|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
14651237|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651238|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651239|NCT00211796|Valproic Acid|valproic acid|mesh-list
14651240|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
14651241|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651242|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651243|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
14651244|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651245|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651246|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
14651247|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14651248|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651249|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14725378|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14725379|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
14725380|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
14725381|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
14725382|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14725383|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
14725384|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14725385|NCT00503607|Laxatives|laxatives|mesh-ancestor
14725386|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725387|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
14725388|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14725389|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14725390|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14725391|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14725392|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725393|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
14725394|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725395|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725396|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14725397|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725398|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
14725399|NCT00503659|Miotics|miotics|mesh-ancestor
14725400|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
14725401|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725402|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725403|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14725404|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14725405|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
14725406|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14725407|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14725408|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14725409|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725410|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725411|NCT00503763|Simvastatin|simvastatin|mesh-list
14725412|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14725413|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14725414|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
14725415|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725416|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14651250|NCT00211848|Interferons|interferons|mesh-list
14651251|NCT00211848|Ribavirin|ribavirin|mesh-list
14651252|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293323|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14293324|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14651253|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
14651254|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651255|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
14651256|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651257|NCT00211939|Atorvastatin|atorvastatin|mesh-list
14651258|NCT00211939|Calcium|calcium|mesh-list
14651259|NCT00211939|Sevelamer|sevelamer|mesh-list
14651260|NCT00211939|Calcium acetate|calcium acetate|mesh-list
14651261|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14651262|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651263|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14651264|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14651265|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
14651266|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651267|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14651268|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14651269|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651270|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
14651271|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
14651272|NCT00211952|Celecoxib|celecoxib|mesh-list
14651273|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14651274|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14651275|NCT00211952|Analgesics|analgesics|mesh-ancestor
14651276|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
14651277|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651278|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651279|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14651280|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651281|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14651282|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14651283|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651284|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651285|NCT00211978|Calcium|calcium|mesh-list
14651286|NCT00211978|Calcium acetate|calcium acetate|mesh-list
14651287|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14651288|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651289|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
14651290|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
14651291|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651292|NCT00212004|Pioglitazone|pioglitazone|mesh-list
15183290|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183291|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183292|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183293|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
15183294|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651293|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651294|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293325|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14651295|NCT00212017|Voglibose|voglibose|mesh-list
14651296|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651297|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651298|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14651299|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651300|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651301|NCT00212030|Nicorandil|nicorandil|mesh-list
14651302|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14651303|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14651304|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
14651305|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
14651306|NCT00212030|Vitamins|vitamins|mesh-ancestor
14651307|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
14651308|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651309|NCT00212043|Gemcitabine|gemcitabine|mesh-list
14651310|NCT00212043|Carboplatin|carboplatin|mesh-list
14651311|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814589|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
14814590|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814591|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14651312|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15183295|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15183296|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
15183297|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15183298|NCT03912857|Apatinib|apatinib|mesh-list
15183299|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183300|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15183301|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183302|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183303|NCT03912909|Empagliflozin|empagliflozin|mesh-list
15183304|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14651313|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
14651314|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651315|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
14651316|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651317|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651318|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14651319|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
14651320|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651321|NCT00212069|Gemcitabine|gemcitabine|mesh-list
14651322|NCT00212069|Carboplatin|carboplatin|mesh-list
14651323|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651324|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14651325|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
14651326|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651327|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
14651328|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651329|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651330|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14651331|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
14651332|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651333|NCT00212082|Docetaxel|docetaxel|mesh-list
14651334|NCT00212082|Doxorubicin|doxorubicin|mesh-list
14651335|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651336|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
14651337|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
15183305|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183306|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15183307|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183308|NCT03913182|Apatinib|apatinib|mesh-list
15183309|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183310|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293326|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293327|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293328|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
14293329|NCT00567320|Varenicline|varenicline|mesh-list
14293330|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14293331|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14293332|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293333|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293334|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293335|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293336|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14293337|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293338|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293339|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293340|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293341|NCT00567398|Icodextrin|icodextrin|mesh-list
14293342|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
14293343|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14651338|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183311|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183312|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223535|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15223536|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14651339|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651340|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14651341|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14651342|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14651343|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651344|NCT00212095|Ketoconazole|ketoconazole|mesh-list
14293344|NCT00567476|Omalizumab|omalizumab|mesh-list
14651345|NCT00212095|Docetaxel|docetaxel|mesh-list
14651346|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651347|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183313|NCT03913052|Viscosupplements|viscosupplements|mesh-list
15183314|NCT03913052|Protective Agents|protective agents|mesh-ancestor
15183315|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183316|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
14651348|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14651349|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14651350|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651351|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
14651352|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651353|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14651354|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14651355|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651356|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14651357|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
14651358|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651359|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651360|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14651361|NCT00212108|Celecoxib|celecoxib|mesh-list
14651362|NCT00212108|Gefitinib|gefitinib|mesh-list
14651363|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14651364|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14651365|NCT00212108|Analgesics|analgesics|mesh-ancestor
14651366|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
14651367|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651368|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651369|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14651370|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651371|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14651372|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14651373|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651374|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651375|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651376|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14651377|NCT00212147|Anesthetics|anesthetics|mesh-list
14651378|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651379|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651380|NCT00212173|Sibutramine|sibutramine|mesh-list
14651381|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
14651382|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14651383|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
14651384|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14651385|NCT00212186|Selenium|selenium|mesh-list
14651386|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
14651387|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651388|NCT00212186|Protective Agents|protective agents|mesh-ancestor
14651389|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651390|NCT00212186|Trace Elements|trace elements|mesh-ancestor
14651391|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
15183317|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
15183318|NCT03912766|Coagulants|coagulants|mesh-ancestor
15183319|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14651392|NCT00212199|Orlistat|orlistat|mesh-list
14651393|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651394|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651395|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14651396|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14651397|NCT00212212|Selenium|selenium|mesh-list
14651398|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
14651399|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651400|NCT00212212|Protective Agents|protective agents|mesh-ancestor
14651401|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651402|NCT00212212|Trace Elements|trace elements|mesh-ancestor
14651403|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
14651404|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14651405|NCT00212277|Norethindrone|norethindrone|mesh-list
14651406|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
14651407|NCT00212277|Estradiol|estradiol|mesh-list
14651408|NCT00212277|Estrogens|estrogens|mesh-ancestor
14651409|NCT00212277|Hormones|hormones|mesh-ancestor
14651410|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651411|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651412|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14651413|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
14651414|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651415|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14651416|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14651417|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14651418|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14651419|NCT00212290|Pioglitazone|pioglitazone|mesh-list
14651420|NCT00212290|Nateglinide|nateglinide|mesh-list
14651421|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651422|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651423|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14651424|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651425|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14651426|NCT00212342|Norethindrone|norethindrone|mesh-list
14651427|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
14651428|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14651429|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14651430|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14651431|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
14651432|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651433|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651434|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14651435|NCT00212342|Estrogens|estrogens|mesh-ancestor
14651436|NCT00212342|Hormones|hormones|mesh-ancestor
14651437|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651438|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14651439|NCT00212472|Factor VIII|factor viii|mesh-list
14651440|NCT00212472|Coagulants|coagulants|mesh-ancestor
14651441|NCT00212589|Leucovorin|leucovorin|mesh-list
14651442|NCT00212589|Folic Acid|folic acid|mesh-list
14651443|NCT00212589|Fluorouracil|fluorouracil|mesh-list
14651444|NCT00212589|Capecitabine|capecitabine|mesh-list
14651445|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
14651446|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
14651447|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651448|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14651449|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651450|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14651451|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
14651452|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651453|NCT00212589|Antidotes|antidotes|mesh-ancestor
14651454|NCT00212589|Protective Agents|protective agents|mesh-ancestor
15183320|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15183321|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
15183322|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183323|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
15183324|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
15183325|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183326|NCT03912727|Protective Agents|protective agents|mesh-ancestor
15183327|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183328|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
15183329|NCT03912727|Vitamins|vitamins|mesh-ancestor
15183330|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
14651455|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
14651456|NCT00212589|Vitamins|vitamins|mesh-ancestor
14651457|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
14651458|NCT00212589|Hematinics|hematinics|mesh-ancestor
14651459|NCT00212602|Aprepitant|aprepitant|mesh-list
14651460|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
14651461|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
14651462|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
14651463|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651464|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651465|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14651466|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14651467|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651468|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651469|NCT00212615|Capecitabine|capecitabine|mesh-list
14651470|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
14651471|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14651472|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
14651473|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651474|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651475|NCT00212654|Landiolol|landiolol|mesh-list
15183331|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
14651476|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14651477|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14651478|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14651479|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183332|NCT03912740|Remifentanil|remifentanil|mesh-list
14651480|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651481|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651482|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14651483|NCT00212680|Landiolol|landiolol|mesh-list
14651484|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14651485|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14651486|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
14651487|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651488|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651489|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651490|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14651491|NCT00212810|Topiramate|topiramate|mesh-list
14651492|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
14651493|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15183333|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15183334|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183335|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183336|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183337|NCT03912740|Analgesics|analgesics|mesh-ancestor
15183338|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
15183339|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183340|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15183341|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15183342|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14651494|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651495|NCT00212823|Almotriptan|almotriptan|mesh-list
14651496|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14651497|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
14651498|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651499|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651500|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651501|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
14651502|NCT00212875|Hematinics|hematinics|mesh-ancestor
14651503|NCT00213070|Miglitol|miglitol|mesh-list
14651504|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651505|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651506|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651507|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651508|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14651509|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14651510|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14651511|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
14651512|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14651513|NCT00213096|ST 1435|st 1435|mesh-list
14651514|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
14651515|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
14651516|NCT00213096|Estradiol|estradiol|mesh-list
14651517|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14651518|NCT00213096|Estrogens|estrogens|mesh-ancestor
15183343|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
15183344|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183345|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183346|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15183347|NCT03912740|Narcotics|narcotics|mesh-ancestor
15183348|NCT03912402|Paclitaxel|paclitaxel|mesh-list
14651519|NCT00213096|Hormones|hormones|mesh-ancestor
14651520|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651521|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651522|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14651523|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651524|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14651525|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14651526|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14651527|NCT00213109|Miglitol|miglitol|mesh-list
14651528|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651529|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651530|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651531|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651532|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14651533|NCT00213122|Miglitol|miglitol|mesh-list
14651534|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651535|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183349|NCT03912402|Bevacizumab|bevacizumab|mesh-list
15183350|NCT03912402|Carboplatin|carboplatin|mesh-list
14651536|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651537|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651538|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14651539|NCT00213200|Morphine|morphine|mesh-list
14651540|NCT00213200|Tetracaine|tetracaine|mesh-list
14651541|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14651542|NCT00213200|Narcotics|narcotics|mesh-ancestor
14651543|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651544|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651545|NCT00213200|Analgesics|analgesics|mesh-ancestor
14651546|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
14651547|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651548|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
14651549|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
14651550|NCT00213226|Dexamethasone|dexamethasone|mesh-list
14651551|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14651552|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
14651553|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
14651554|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651555|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651556|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14651557|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
14651558|NCT00213226|Hormones|hormones|mesh-ancestor
14651559|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651560|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14651561|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651562|NCT00213252|Prednisolone|prednisolone|mesh-list
14651563|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14651564|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
14651565|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14651566|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
14651567|NCT00213252|Montelukast|montelukast|mesh-list
14651568|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14651569|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
14651570|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14651571|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
14651572|NCT00213252|Hormones|hormones|mesh-ancestor
14651573|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651574|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651575|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14651576|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651577|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
14651578|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
14651579|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651580|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14651581|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14651582|NCT00213252|Protective Agents|protective agents|mesh-ancestor
14651583|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14651584|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
14651585|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14651586|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
14651587|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14651588|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14651589|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651590|NCT00213265|Vaccines|vaccines|mesh-list
14651591|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14651592|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
14651593|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651594|NCT00213278|Vinblastine|vinblastine|mesh-list
14651595|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14651596|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651597|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14651598|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14651599|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14651600|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651601|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
14651602|NCT00213291|Hematinics|hematinics|mesh-ancestor
14725417|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15183351|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15183352|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183353|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183354|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
14725418|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725419|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14725420|NCT00503815|Laxatives|laxatives|mesh-ancestor
14651603|NCT00213486|Irinotecan|irinotecan|mesh-list
14651604|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15183355|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183356|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183357|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183358|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14293345|NCT00567476|Terbutaline|terbutaline|mesh-list
14293346|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
14293347|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
14293348|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14293349|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
14651605|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14651606|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651607|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651608|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651609|NCT00213512|Rituximab|rituximab|mesh-list
14651610|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14651611|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651612|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
14651613|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651614|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651615|NCT00213538|Methotrexate|methotrexate|mesh-list
14651616|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14651617|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14651618|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
14651619|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651620|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651621|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14651622|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
14651623|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651624|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651625|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14651626|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651627|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14651628|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14651629|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
14651630|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651631|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14651632|NCT00213551|Antioxidants|antioxidants|mesh-list
14651633|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651634|NCT00213551|Protective Agents|protective agents|mesh-ancestor
14651635|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651636|NCT00213564|Methotrexate|methotrexate|mesh-list
14651637|NCT00213564|Infliximab|infliximab|mesh-list
14651638|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14651639|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
14651640|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651641|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651642|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14651643|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
14651644|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651645|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651646|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
14651647|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651648|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14651649|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14651650|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
14651651|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651652|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14651653|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14651654|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
14651655|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14651656|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14651657|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651658|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183359|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15183360|NCT03912402|Growth Substances|growth substances|mesh-ancestor
15183361|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183362|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
15183363|NCT03912389|Carboplatin|carboplatin|mesh-list
15183364|NCT03912389|Pemetrexed|pemetrexed|mesh-list
15183365|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293350|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651659|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651660|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651661|NCT00213590|Cyclosporine|cyclosporine|mesh-list
14651662|NCT00213590|Cyclosporins|cyclosporins|mesh-list
14651663|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651664|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183366|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651665|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14651666|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
14651667|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651668|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
14651669|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651670|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
14651671|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183367|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183368|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14651672|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14651673|NCT00213694|Celecoxib|celecoxib|mesh-list
14651674|NCT00213694|Docetaxel|docetaxel|mesh-list
14651675|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651676|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
14651677|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
14651678|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
14651679|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651680|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14651681|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14651682|NCT00213694|Analgesics|analgesics|mesh-ancestor
14651683|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
14651684|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651685|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651686|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14651687|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651688|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14651689|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14651690|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651691|NCT00213759|Lenograstim|lenograstim|mesh-list
14651692|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14651693|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
14651694|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651695|NCT00214032|Pycnogenols|pycnogenols|mesh-list
14651696|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14651697|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
14651698|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651699|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
14651700|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651701|NCT00214032|Protective Agents|protective agents|mesh-ancestor
14651702|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14651703|NCT00214058|Carboplatin|carboplatin|mesh-list
14651704|NCT00214058|Docetaxel|docetaxel|mesh-list
14651705|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651706|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
14651707|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
14651708|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
14651709|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651710|NCT00214084|Allopurinol|allopurinol|mesh-list
14651711|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
14651712|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651713|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651714|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
14651715|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651716|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14651717|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
14651718|NCT00214084|Protective Agents|protective agents|mesh-ancestor
14651719|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651720|NCT00214110|Tamoxifen|tamoxifen|mesh-list
15183369|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15183370|NCT03912220|Niacinamide|niacinamide|mesh-list
15183371|NCT03912220|Niacin|niacin|mesh-list
15183372|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
15183373|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
15183374|NCT03912220|Vitamins|vitamins|mesh-ancestor
15183375|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
15183376|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183377|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15183378|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
14651721|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14651722|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
15183379|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183380|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15183381|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
14651723|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651724|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651725|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14651726|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651727|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14651728|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14651729|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14651730|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
14651731|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14651732|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651733|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
14651734|NCT00214240|Antibodies|antibodies|mesh-list
14651735|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
14651736|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14651737|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14651738|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
14651739|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651740|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14651741|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14651742|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651743|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
14651744|NCT00214266|Rituximab|rituximab|mesh-list
14651745|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
14651746|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14651747|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651748|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
14651749|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651750|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651751|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14651752|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14651753|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
14651754|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14651755|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651756|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651757|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651758|NCT00214318|Metoprolol|metoprolol|mesh-list
14651759|NCT00214318|Carvedilol|carvedilol|mesh-list
14651760|NCT00214318|Terbutaline|terbutaline|mesh-list
14651761|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14651762|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14651763|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
14651764|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
14651765|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651766|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651767|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14651768|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14651769|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14651770|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
14651771|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651772|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651773|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
14651774|NCT00214318|Protective Agents|protective agents|mesh-ancestor
14651775|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14651776|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14651777|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14651778|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
14651779|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14651780|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14651781|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14651782|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14651783|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
14651784|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
14651785|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
14651786|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651787|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14651788|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14651789|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15183382|NCT03912415|Paclitaxel|paclitaxel|mesh-list
14651790|NCT00214331|Azithromycin|azithromycin|mesh-list
14651791|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
14651792|NCT00214331|Gentamicins|gentamicins|mesh-list
15183383|NCT03912415|Bevacizumab|bevacizumab|mesh-list
15183384|NCT03912415|Carboplatin|carboplatin|mesh-list
15183385|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15183386|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183387|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183388|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
15183389|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183390|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183391|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183392|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15183393|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15183394|NCT03912415|Growth Substances|growth substances|mesh-ancestor
15183395|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183396|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
15183397|NCT03912285|Losartan|losartan|mesh-list
15183398|NCT03912285|Amlodipine|amlodipine|mesh-list
15183399|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15183400|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15183401|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183402|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183403|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15183404|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183405|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
15183406|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15183407|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15183408|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15183409|NCT03911817|Midodrine|midodrine|mesh-list
15183410|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
15183411|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
15183412|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651793|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14651794|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651795|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14651796|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14651797|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651798|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651799|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651800|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14651801|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14651802|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14651803|NCT00214370|Fentanyl|fentanyl|mesh-list
14651804|NCT00214370|Propofol|propofol|mesh-list
14651805|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14651806|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651807|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651808|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14651809|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
14651810|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
14651811|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14651812|NCT00214370|Narcotics|narcotics|mesh-ancestor
14651813|NCT00214370|Analgesics|analgesics|mesh-ancestor
14651814|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
14651815|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651816|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14651817|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14651818|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
14651819|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651820|NCT00214552|Rabeprazole|rabeprazole|mesh-list
14651821|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14651822|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14651823|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14651824|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651825|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651826|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14651827|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
14651828|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14651829|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14651830|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14651831|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651832|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651833|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14651834|NCT00214604|Pravastatin|pravastatin|mesh-list
14651835|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14651836|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15183413|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651837|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
14651838|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651839|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14651840|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14651841|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651842|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14651843|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14651844|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14651845|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
14651846|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651847|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14651848|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14651849|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651850|NCT00214630|Atorvastatin|atorvastatin|mesh-list
14651851|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14651852|NCT00214630|Calcium|calcium|mesh-list
14651853|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14651854|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651855|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14651856|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14651857|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
14651858|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651859|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14651860|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14651861|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651862|NCT00214643|Clindamycin|clindamycin|mesh-list
14651863|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
14651864|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
14651865|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
14651866|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14651867|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651868|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14651869|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651870|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651871|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
14651872|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
14651873|NCT00214682|Vitamins|vitamins|mesh-ancestor
14651874|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
14651875|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651876|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
14651877|NCT00214682|Hematinics|hematinics|mesh-ancestor
14651878|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
14651879|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14651880|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
14651881|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14651882|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14651883|NCT00214825|Eplerenone|eplerenone|mesh-list
14651884|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14651885|NCT00214825|Diuretics|diuretics|mesh-ancestor
14651886|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
14651887|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651888|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14651889|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14651890|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651891|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14651892|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
14651893|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14651894|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14651895|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14651896|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651897|NCT00214864|Docetaxel|docetaxel|mesh-list
14651898|NCT00214864|Capecitabine|capecitabine|mesh-list
14651899|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651900|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
14651901|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
14651902|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
14651903|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651904|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14651905|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
14651906|NCT00214877|Methylene Blue|methylene blue|mesh-list
14651907|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651908|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725421|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725422|NCT00503828|Naproxen|naproxen|mesh-list
14651909|NCT00214942|Fentanyl|fentanyl|mesh-list
14651910|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14651911|NCT00214942|Narcotics|narcotics|mesh-ancestor
14651912|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651913|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651914|NCT00214942|Analgesics|analgesics|mesh-ancestor
14651915|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
14651916|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651917|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14651918|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14651919|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
14651920|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
14651921|NCT00214955|Fentanyl|fentanyl|mesh-list
14651922|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14651923|NCT00214955|Narcotics|narcotics|mesh-ancestor
14651924|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14651925|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651926|NCT00214955|Analgesics|analgesics|mesh-ancestor
14651927|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
14651928|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14651929|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14651930|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14651931|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
14651932|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
14651933|NCT00214981|Modafinil|modafinil|mesh-list
14651934|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14651935|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183414|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15183415|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15183416|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15183417|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15183418|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
15183419|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183420|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183421|NCT03911648|Lidocaine|lidocaine|mesh-list
15183422|NCT03911648|Bupivacaine|bupivacaine|mesh-list
15183423|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
15183424|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
14651936|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14651937|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14651938|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14651939|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651940|NCT00214994|Tiagabine|tiagabine|mesh-list
14651941|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
14651942|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14651943|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14651944|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14651945|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651946|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
14651947|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651948|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651949|NCT00215007|Levofloxacin|levofloxacin|mesh-list
14651950|NCT00215007|Ofloxacin|ofloxacin|mesh-list
15183425|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183426|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183427|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
14293351|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293352|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14293353|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293354|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
14651951|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14651952|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14651953|NCT00215007|Renal Agents|renal agents|mesh-ancestor
14651954|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14651955|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14651956|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14651957|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651958|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651959|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651960|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14651961|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15183428|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293355|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651962|NCT00215046|Methotrexate|methotrexate|mesh-list
14651963|NCT00215046|Vinblastine|vinblastine|mesh-list
15183429|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15183430|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15183431|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15183432|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183433|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183434|NCT03911440|Azithromycin|azithromycin|mesh-list
15183435|NCT03911440|Doxycycline|doxycycline|mesh-list
15183436|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15183437|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183438|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
15183439|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15183440|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15183441|NCT03911336|Acetaminophen|acetaminophen|mesh-list
15183442|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15183443|NCT03911336|Ketoprofen|ketoprofen|mesh-list
14651964|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14651965|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
14651966|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14651967|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651968|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14651969|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
14651970|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651971|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14651972|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
14651973|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14651974|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14651975|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14651976|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
14651977|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14651978|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14651979|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14651980|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14651981|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14651982|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14651983|NCT00215124|Lenograstim|lenograstim|mesh-list
14651984|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14651985|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
14651986|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651987|NCT00215163|Paroxetine|paroxetine|mesh-list
14651988|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14651989|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14651990|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183444|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183445|NCT03911336|Analgesics|analgesics|mesh-ancestor
15183446|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
14651991|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14651992|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14651993|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
14651994|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14651995|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14651996|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
14651997|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14651998|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15183447|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183448|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183449|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
15183450|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15183451|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183452|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15183453|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183454|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183455|NCT03911570|Acetaminophen|acetaminophen|mesh-list
15183456|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15183457|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15183458|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183459|NCT03911570|Analgesics|analgesics|mesh-ancestor
15183460|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
15183461|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183462|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183463|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
14651999|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15183464|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183465|NCT03911557|Durvalumab|durvalumab|mesh-list
14652000|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652001|NCT00215176|Modafinil|modafinil|mesh-list
14652002|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14652003|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652004|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14652005|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14652006|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14652007|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652008|NCT00215202|Gefitinib|gefitinib|mesh-list
14652009|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652010|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14652011|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652012|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652013|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14652014|NCT00215228|Citalopram|citalopram|mesh-list
14652015|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14652016|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14652017|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652018|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652019|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652020|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
14652021|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652022|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14652023|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
14652024|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15183466|NCT03911557|Tremelimumab|tremelimumab|mesh-list
15183467|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183468|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183469|NCT03911414|Inositol|inositol|mesh-list
14652025|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652026|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14652027|NCT00215228|Analgesics|analgesics|mesh-ancestor
14652028|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
14652029|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
14652030|NCT00215241|Risperidone|risperidone|mesh-list
14652031|NCT00215241|Sertraline|sertraline|mesh-list
14652032|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14652033|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
14652034|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652035|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652036|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652037|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652038|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652039|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652040|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652041|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14652042|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
14652043|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
14652044|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14652045|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14652046|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652047|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14652048|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
14652049|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652050|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652051|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652052|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652053|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652054|NCT00215267|Praziquantel|praziquantel|mesh-list
14652055|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
14652056|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14652057|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652058|NCT00215280|Ivermectin|ivermectin|mesh-list
14652059|NCT00215280|Albendazole|albendazole|mesh-list
14652060|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14652061|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652062|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
14652063|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
14652064|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14652065|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14652066|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652067|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652068|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652069|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652070|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652071|NCT00215345|Celecoxib|celecoxib|mesh-list
14652072|NCT00215345|Docetaxel|docetaxel|mesh-list
14652073|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652074|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652075|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652076|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652077|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652078|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14652079|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14652080|NCT00215345|Analgesics|analgesics|mesh-ancestor
14652081|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
14652082|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652083|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652084|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652085|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652086|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14652087|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14652088|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652089|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
14652090|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652091|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
14652092|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652093|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652094|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652095|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652096|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14652097|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652098|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652099|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652100|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652101|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652102|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
14652103|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652104|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
15183470|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
15183471|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15183472|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
15183473|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183474|NCT03911414|Expectorants|expectorants|mesh-ancestor
15183475|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
15183476|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15183477|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
15183478|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183479|NCT03911414|Protective Agents|protective agents|mesh-ancestor
15183480|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183481|NCT03911414|Antidotes|antidotes|mesh-ancestor
15183482|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
15183483|NCT03911414|Vitamins|vitamins|mesh-ancestor
15183484|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
15183485|NCT03911271|Atropine|atropine|mesh-list
15183486|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15183487|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15183488|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15183489|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
15183490|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183491|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183492|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15183493|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
15183494|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
15183495|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
15183496|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15183497|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15183498|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183499|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183500|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183501|NCT03910803|Brodalumab|brodalumab|mesh-list
15183502|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
15183503|NCT03910647|Pantoprazole|pantoprazole|mesh-list
15183504|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15183505|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15183506|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15183507|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183508|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223537|NCT01970410|Analgesics|analgesics|mesh-ancestor
15223538|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
15183509|NCT03910634|Carboplatin|carboplatin|mesh-list
15183510|NCT03910634|Fluorouracil|fluorouracil|mesh-list
15183511|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183512|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
15183513|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183514|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15183515|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293356|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14293357|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652105|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652106|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652107|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652108|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652109|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14652110|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652111|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652112|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652113|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652114|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652115|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
14652116|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652117|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
14652118|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652119|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652120|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652121|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652122|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14652123|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652124|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652125|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652126|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652127|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652128|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
14652129|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652130|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
14652131|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652132|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652133|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652134|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652135|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14652136|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652137|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652138|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652139|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652140|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652141|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
14652142|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652143|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
14652144|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652145|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652146|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652147|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652148|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14652149|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652150|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652151|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652152|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652153|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183516|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
15183517|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183518|NCT03910712|Trastuzumab|trastuzumab|mesh-list
15183519|NCT03910712|Letrozole|letrozole|mesh-list
15183520|NCT03910712|Anastrozole|anastrozole|mesh-list
15183521|NCT03910712|Exemestane|exemestane|mesh-list
15183522|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15183523|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183524|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183525|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15183526|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183527|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183528|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15183529|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
14652154|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
14652155|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652156|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
14652157|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652158|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652159|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652160|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652161|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14652162|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652163|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652164|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652165|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652166|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652167|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
14652168|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652169|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
14652170|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652171|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652172|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652173|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652174|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15183530|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15183531|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183532|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15183533|NCT03910556|Propofol|propofol|mesh-list
15183534|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15183535|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183536|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183537|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15183538|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
15183539|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
15183540|NCT03910543|Tofacitinib|tofacitinib|mesh-list
15183541|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14652175|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652176|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652177|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652178|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652179|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652180|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
14652181|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14652182|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
14652183|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652184|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652185|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652186|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652187|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14652188|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14652189|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652190|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652191|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652192|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652193|NCT00215462|Vinorelbine|vinorelbine|mesh-list
14652194|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14652195|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652196|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652197|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652198|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183542|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183543|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183544|NCT03910361|Pioglitazone|pioglitazone|mesh-list
15183545|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15183546|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183547|NCT03910504|Rocuronium|rocuronium|mesh-list
15183548|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15183549|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15183550|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15183551|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183552|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183553|NCT03910231|Tolvaptan|tolvaptan|mesh-list
15183554|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14652199|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652200|NCT00215501|Fluorouracil|fluorouracil|mesh-list
14652201|NCT00215501|Capecitabine|capecitabine|mesh-list
14652202|NCT00215501|Irinotecan|irinotecan|mesh-list
14652203|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652204|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
14652205|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652206|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652207|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652208|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
14652209|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652210|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14652211|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652212|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652213|NCT00215514|Fluorouracil|fluorouracil|mesh-list
14652214|NCT00215514|Epirubicin|epirubicin|mesh-list
14652215|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652216|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
14652217|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652218|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652219|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652220|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
14652221|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652222|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14652223|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14652224|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652225|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652226|NCT00215579|Risperidone|risperidone|mesh-list
14652227|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14652228|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
14652229|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652230|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652231|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652232|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652233|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652234|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652235|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652236|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14652237|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
14652238|NCT00215592|Zonisamide|zonisamide|mesh-list
14652239|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
14652240|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14652241|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652242|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652243|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14652244|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652245|NCT00215631|Tadalafil|tadalafil|mesh-list
14652246|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
14652247|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14652248|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14652249|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652250|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652251|NCT00215631|Urological Agents|urological agents|mesh-ancestor
14652252|NCT00215709|Docetaxel|docetaxel|mesh-list
14652253|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652254|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652255|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652256|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652257|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652258|NCT00215722|Cetuximab|cetuximab|mesh-list
14652259|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14652260|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652261|NCT00215748|Dexamethasone|dexamethasone|mesh-list
14652262|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652263|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
14652264|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
14652265|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652266|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652267|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652268|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
14652269|NCT00215748|Hormones|hormones|mesh-ancestor
14652270|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14652271|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14652272|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652273|NCT00215774|Flecainide|flecainide|mesh-list
14652274|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14652275|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14652276|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14652277|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652278|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652279|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14652280|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
14652281|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652282|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
14652283|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
14652284|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652285|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
14652286|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652287|NCT00215839|Ribavirin|ribavirin|mesh-list
14652288|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
14652289|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652290|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
14652291|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652292|NCT00215865|Ribavirin|ribavirin|mesh-list
14652293|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14652294|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
14652295|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652296|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
14652297|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652298|NCT00215891|Interferons|interferons|mesh-list
14652299|NCT00215891|Ribavirin|ribavirin|mesh-list
14652300|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652301|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
14652302|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652303|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
14652304|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652305|NCT00215956|Topotecan|topotecan|mesh-list
15183555|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183556|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
15183557|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183558|NCT03910088|Acetaminophen|acetaminophen|mesh-list
15183559|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
15183560|NCT03910088|Diclofenac|diclofenac|mesh-list
15183561|NCT03910088|Pregabalin|pregabalin|mesh-list
15183562|NCT03910088|Caffeine|caffeine|mesh-list
14652306|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14652307|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652308|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652309|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652310|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652311|NCT00215982|Capecitabine|capecitabine|mesh-list
14652312|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
14652313|NCT00215982|Irinotecan|irinotecan|mesh-list
14652314|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652315|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
14652316|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652317|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652318|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14652319|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652320|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652321|NCT00215995|Cisplatin|cisplatin|mesh-list
14652322|NCT00215995|Irinotecan|irinotecan|mesh-list
14652323|NCT00215995|Gefitinib|gefitinib|mesh-list
14652324|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652325|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15183563|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183564|NCT03910088|Analgesics|analgesics|mesh-ancestor
15183565|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
15183566|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183567|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183568|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
15183569|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
15183570|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15183571|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183572|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183573|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15183574|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14652326|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652327|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652328|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183575|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652329|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14652330|NCT00216008|Docetaxel|docetaxel|mesh-list
15183576|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183577|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15183578|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652331|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652332|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652333|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652334|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652335|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652336|NCT00216021|Capecitabine|capecitabine|mesh-list
14652337|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
14652338|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652339|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
14652340|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652341|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183579|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15183580|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183581|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15183582|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183583|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15183584|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15183585|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14652342|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
14652343|NCT00216034|Tegafur|tegafur|mesh-list
14652344|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652345|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
14652346|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652347|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652348|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14652349|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
14652350|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652351|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14652352|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
14652353|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652354|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
14652355|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14652356|NCT00216034|Protective Agents|protective agents|mesh-ancestor
14652357|NCT00216047|Trastuzumab|trastuzumab|mesh-list
14652358|NCT00216047|Vatalanib|vatalanib|mesh-list
14652359|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14652360|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652361|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14652362|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652363|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652364|NCT00216073|Capecitabine|capecitabine|mesh-list
14652365|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
14652366|NCT00216073|Trastuzumab|trastuzumab|mesh-list
14652367|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652368|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
15183586|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15183587|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
15183588|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183589|NCT03909776|Cisplatin|cisplatin|mesh-list
15183590|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183591|NCT03909594|Ketamine|ketamine|mesh-list
15183592|NCT03909594|Bupivacaine|bupivacaine|mesh-list
15183593|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
15183594|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
15183595|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183596|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652369|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652370|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652371|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14652372|NCT00216112|Docetaxel|docetaxel|mesh-list
14652373|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
14652374|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652375|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652376|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652377|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652378|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652379|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14652380|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183597|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
15183598|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183599|NCT03909594|Analgesics|analgesics|mesh-ancestor
15183600|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14652381|NCT00216138|Docetaxel|docetaxel|mesh-list
14652382|NCT00216138|Capecitabine|capecitabine|mesh-list
14652383|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652384|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652385|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652386|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652387|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652388|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652389|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
14652390|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
14652391|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14652392|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652393|NCT00216164|Gemcitabine|gemcitabine|mesh-list
14652394|NCT00216164|Rituximab|rituximab|mesh-list
14652395|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14652396|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652397|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
14652398|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652399|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652400|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652401|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
14652402|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183601|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15183602|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
15183603|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15183604|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15183605|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183606|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183607|NCT03909477|Xenon|xenon|mesh-list
15183608|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15183609|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
15183610|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
15183611|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183612|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183613|NCT03909724|Sunitinib|sunitinib|mesh-list
15183614|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183615|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15183616|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15183617|NCT03909724|Growth Substances|growth substances|mesh-ancestor
15183618|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183619|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
15183620|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15183621|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183622|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183623|NCT03909737|Azithromycin|azithromycin|mesh-list
15183624|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15183625|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183626|NCT03909529|Digoxin|digoxin|mesh-list
15183627|NCT03909529|Spironolactone|spironolactone|mesh-list
15183628|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15183629|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
15183630|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15183631|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183632|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15183633|NCT03909529|Diuretics|diuretics|mesh-ancestor
15183634|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
15183635|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14652403|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
14652404|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652405|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652406|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652407|NCT00216177|Adalimumab|adalimumab|mesh-list
14652408|NCT00216177|Infliximab|infliximab|mesh-list
14652409|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652410|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652411|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652412|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652413|NCT00216190|Midazolam|midazolam|mesh-list
14652414|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
15183636|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15183637|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183638|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183639|NCT03909529|Protective Agents|protective agents|mesh-ancestor
15183640|NCT03909607|Ketamine|ketamine|mesh-list
14652415|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14652416|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183641|NCT03909607|Analgesics|analgesics|mesh-ancestor
15183642|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
14293358|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293359|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293360|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14293361|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
14652417|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652418|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14652419|NCT00216190|Analgesics|analgesics|mesh-ancestor
14652420|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
14652421|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652422|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14652423|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14652424|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14652425|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652426|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652427|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652428|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14652429|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14652430|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652431|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652432|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14652433|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
14652434|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
14652435|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
14652436|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
14652437|NCT00216216|Pemetrexed|pemetrexed|mesh-list
14652438|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652439|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652440|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652441|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14652442|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14652443|NCT00216268|Ribavirin|ribavirin|mesh-list
14652444|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
14652445|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652446|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
14652447|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652448|NCT00216281|Clozapine|clozapine|mesh-list
14652449|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14652450|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14652451|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14652452|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652453|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652454|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652455|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652456|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652457|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14652458|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
14652459|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652460|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652461|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652462|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652463|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
14652464|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
14652465|NCT00216294|Secretin|secretin|mesh-list
14652466|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652467|NCT00216294|Hormones|hormones|mesh-ancestor
14652468|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14652469|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652470|NCT00216346|Amphotericin B|amphotericin b|mesh-list
14652471|NCT00216346|Paromomycin|paromomycin|mesh-list
14652472|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14652473|NCT00216346|Amebicides|amebicides|mesh-ancestor
14652474|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14652475|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14652476|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652477|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14652478|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
14652479|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14652480|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
14652481|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
14652482|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293362|NCT00567489|Icodextrin|icodextrin|mesh-list
14293363|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
14652483|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14652484|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14652485|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652486|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14652487|NCT00216372|Lanreotide|lanreotide|mesh-list
14652488|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652489|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
14652490|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14652491|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652492|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14652493|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14652494|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14652495|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652496|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652497|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652498|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652499|NCT00216398|Lanreotide|lanreotide|mesh-list
14652500|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652501|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
14652502|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14652503|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14652504|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14652505|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652506|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652507|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
14652508|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652509|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652510|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14652511|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652512|NCT00216424|Capecitabine|capecitabine|mesh-list
14652513|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652514|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
14652515|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652516|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652517|NCT00216437|Capecitabine|capecitabine|mesh-list
15183643|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183644|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183645|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15183646|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15183647|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
15183648|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
15183649|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183650|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15183651|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15183652|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183653|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183654|NCT03909412|Dexamethasone|dexamethasone|mesh-list
15183655|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
15183656|NCT03909412|Sargramostim|sargramostim|mesh-list
14652518|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652519|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
14652520|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652521|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652522|NCT00216450|Rabeprazole|rabeprazole|mesh-list
14652523|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14652524|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652525|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14652526|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652527|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652528|NCT00216463|Mipomersen|mipomersen|mesh-list
14652529|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14652530|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14652531|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
14652532|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652533|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15183657|NCT03909412|Lenograstim|lenograstim|mesh-list
15183658|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183659|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
14652534|NCT00216489|Rabeprazole|rabeprazole|mesh-list
14652535|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14652536|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652537|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14652538|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652539|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183660|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183661|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652540|NCT00216502|Galantamine|galantamine|mesh-list
14652541|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14652542|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652543|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652544|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
14652545|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652546|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652547|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14652548|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
14652549|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652550|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
14652551|NCT00216515|Galantamine|galantamine|mesh-list
14652552|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14652553|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652554|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652555|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
14652556|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652557|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652558|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14652559|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
14652560|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652561|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
14652562|NCT00216528|Risperidone|risperidone|mesh-list
14652563|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14652564|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
14652565|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652566|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652567|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652568|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652569|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652570|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652571|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652572|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14652573|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
14725423|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14725424|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725425|NCT00503828|Analgesics|analgesics|mesh-ancestor
14725426|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
14725427|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725428|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725429|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725430|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725431|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
14725432|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14725433|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725434|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725435|NCT00503932|Capecitabine|capecitabine|mesh-list
14725436|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725437|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
14725438|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725439|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725440|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14725441|NCT00503971|Vorinostat|vorinostat|mesh-list
14725442|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725443|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725444|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725445|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725446|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14729250|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
14729251|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729252|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729253|NCT00522249|Interferons|interferons|mesh-list
14729254|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14729255|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
14729256|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14729257|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14729258|NCT00522249|Sunitinib|sunitinib|mesh-list
14729259|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729260|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
14729261|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729262|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14729263|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729264|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729265|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14652574|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
14652575|NCT00216541|Hematinics|hematinics|mesh-ancestor
14652576|NCT00216554|Risperidone|risperidone|mesh-list
14652577|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14652578|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
14652579|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652580|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652581|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652582|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652583|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652584|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652585|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652586|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14652587|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
14652588|NCT00216567|Topiramate|topiramate|mesh-list
14652589|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
14652590|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14652591|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652592|NCT00216580|Risperidone|risperidone|mesh-list
14652593|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14652594|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
14652595|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652596|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652597|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652598|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652599|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652600|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652601|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652602|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14652603|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
14652604|NCT00216606|Topiramate|topiramate|mesh-list
14652605|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
14652606|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14652607|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652608|NCT00216619|Topiramate|topiramate|mesh-list
14652609|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
14652610|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14652611|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652612|NCT00216632|Risperidone|risperidone|mesh-list
14652613|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14652614|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
14652615|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652616|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652617|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652618|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652619|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652620|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652621|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652622|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14652623|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
14652624|NCT00216645|Doxorubicin|doxorubicin|mesh-list
14652625|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14652626|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14652627|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652628|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14652629|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652630|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652631|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652632|NCT00216658|Fentanyl|fentanyl|mesh-list
14652633|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14652634|NCT00216658|Narcotics|narcotics|mesh-ancestor
14652635|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652636|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652637|NCT00216658|Analgesics|analgesics|mesh-ancestor
14652638|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
14652639|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652640|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14652641|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14652642|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
14652643|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
14652644|NCT00216684|Fentanyl|fentanyl|mesh-list
14652645|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14652646|NCT00216684|Narcotics|narcotics|mesh-ancestor
14652647|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652648|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652649|NCT00216684|Analgesics|analgesics|mesh-ancestor
14652650|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
14652651|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652652|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14652653|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14652654|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
14652655|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
14652656|NCT00216697|Bortezomib|bortezomib|mesh-list
14652657|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652658|NCT00216723|Aripiprazole|aripiprazole|mesh-list
14652659|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
14652660|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14652661|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14652662|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14652663|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652664|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652665|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
14652666|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
14652667|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652668|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652669|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14652670|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14652671|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
14652672|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14652673|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15183662|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15183663|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
15183664|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183665|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183666|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15183667|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15183668|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
15183669|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
15183670|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183671|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652674|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14652675|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14652676|NCT00216762|Rituximab|rituximab|mesh-list
14652677|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14652678|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652679|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
14652680|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652681|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652682|NCT00216775|Interferons|interferons|mesh-list
14652683|NCT00216775|Ribavirin|ribavirin|mesh-list
14652684|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
14652685|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
14652686|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652687|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
14652688|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652689|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
14652690|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652691|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
15183672|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
15183673|NCT03909412|Hormones|hormones|mesh-ancestor
15183674|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293364|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14293365|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
14293366|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293367|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293368|NCT00567879|Trastuzumab|trastuzumab|mesh-list
14293369|NCT00567879|Panobinostat|panobinostat|mesh-list
14293370|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293371|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652692|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652693|NCT00216788|Esomeprazole|esomeprazole|mesh-list
14652694|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14652695|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652696|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14652697|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652698|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652699|NCT00216827|Betamethasone|betamethasone|mesh-list
14652700|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
14652701|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15183675|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14293372|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14652702|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
14652703|NCT00216827|Calcipotriene|calcipotriene|mesh-list
14652704|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14652705|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652706|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
14652707|NCT00216827|Hormones|hormones|mesh-ancestor
14652708|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14652709|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652710|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652711|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652712|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652713|NCT00216840|Betamethasone|betamethasone|mesh-list
14652714|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
14652715|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14652716|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
14652717|NCT00216840|Calcipotriene|calcipotriene|mesh-list
14652718|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14652719|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652720|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
14652721|NCT00216840|Hormones|hormones|mesh-ancestor
14652722|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14652723|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652724|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652725|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652726|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652727|NCT00216866|Dalteparin|dalteparin|mesh-list
14652728|NCT00216866|Tinzaparin|tinzaparin|mesh-list
14652729|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14652730|NCT00216866|Warfarin|warfarin|mesh-list
14652731|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
14652732|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14652733|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14652734|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652735|NCT00216879|Betamethasone|betamethasone|mesh-list
14652736|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
14652737|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14652738|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
14652739|NCT00216879|Calcipotriene|calcipotriene|mesh-list
14652740|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14652741|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652742|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
14652743|NCT00216879|Hormones|hormones|mesh-ancestor
14652744|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14652745|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652746|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652747|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652748|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652749|NCT00216892|Betamethasone|betamethasone|mesh-list
14652750|NCT00216892|Calcipotriene|calcipotriene|mesh-list
14652751|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652752|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
14652753|NCT00216892|Hormones|hormones|mesh-ancestor
14652754|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14652755|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652756|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14652757|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
14652758|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652759|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14652760|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14652761|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14652762|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652763|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652764|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652765|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652766|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652767|NCT00216931|Iloprost|iloprost|mesh-list
14652768|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15183676|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15183677|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
15183678|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
15183679|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183680|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
15183681|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183682|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183683|NCT03909646|Fluorouracil|fluorouracil|mesh-list
15183684|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15183685|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
15183686|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
14652769|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
14652770|NCT00217009|Furocoumarins|furocoumarins|mesh-list
14652771|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652772|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14652773|NCT00217048|Yohimbine|yohimbine|mesh-list
14652774|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
14652775|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
14652776|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652777|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183687|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183688|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652778|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14652779|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14652780|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14652781|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14652782|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14652783|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652784|NCT00217048|Urological Agents|urological agents|mesh-ancestor
14652785|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
14652786|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14652787|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652788|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14652789|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
14652790|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14652791|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652792|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652793|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652794|NCT00217178|Folic Acid|folic acid|mesh-list
14652795|NCT00217178|Vitamins|vitamins|mesh-ancestor
14652796|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
14652797|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652798|NCT00217178|Hematinics|hematinics|mesh-ancestor
14652799|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
14652800|NCT00217191|Ibuprofen|ibuprofen|mesh-list
14652801|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14652802|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14652803|NCT00217191|Analgesics|analgesics|mesh-ancestor
14652804|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
14652805|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652806|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652807|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652808|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652809|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14652810|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652811|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652812|NCT00217204|Pancrelipase|pancrelipase|mesh-list
14652813|NCT00217204|Pancreatin|pancreatin|mesh-list
14652814|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652815|NCT00217243|Lidocaine|lidocaine|mesh-list
14652816|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
14652817|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
14652818|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14652819|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652820|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
14652821|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652822|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14652823|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14652824|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14652825|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14652826|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652827|NCT00217282|Gemcitabine|gemcitabine|mesh-list
14652828|NCT00217282|Bevacizumab|bevacizumab|mesh-list
14652829|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
14652830|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14652831|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652832|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14652833|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14652834|NCT00217282|Growth Substances|growth substances|mesh-ancestor
15183689|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183690|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183691|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
15183692|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652835|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652836|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
14652837|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652838|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
14652839|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652840|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
14652841|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652842|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652843|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652844|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
14652845|NCT00217295|Topiramate|topiramate|mesh-list
14652846|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
14652847|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14652848|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652849|NCT00217373|Interferons|interferons|mesh-list
14652850|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
14652851|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
14652852|NCT00217373|Metronidazole|metronidazole|mesh-list
14652853|NCT00217373|Vaccines|vaccines|mesh-list
14652854|NCT00217373|Sargramostim|sargramostim|mesh-list
14652855|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
14652856|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652857|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652858|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
14652859|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652860|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14652861|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14652862|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14652863|NCT00217386|Etanercept|etanercept|mesh-list
14652864|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14652865|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14652866|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14652867|NCT00217386|Analgesics|analgesics|mesh-ancestor
14652868|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
14652869|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14652870|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652871|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14652872|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652873|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14652874|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652875|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
14652876|NCT00217412|Vorinostat|vorinostat|mesh-list
14652877|NCT00217412|Isotretinoin|isotretinoin|mesh-list
14652878|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183693|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15183694|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652879|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14652880|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652881|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652882|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14652883|NCT00217451|Clindamycin|clindamycin|mesh-list
14652884|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
14652885|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
14652886|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
14652887|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14652888|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652889|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14652890|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652891|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183695|NCT03909152|Anastrozole|anastrozole|mesh-list
15183696|NCT03909152|Onapristone|onapristone|mesh-list
15183697|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15183698|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183699|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15183700|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15183701|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183702|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183703|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15183704|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
15183705|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293373|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652892|NCT00217477|Gemcitabine|gemcitabine|mesh-list
14652893|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652894|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
14652895|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652896|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652897|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
14652898|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652899|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652900|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652901|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
14652902|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652903|NCT00217503|Zidovudine|zidovudine|mesh-list
14652904|NCT00217503|Valganciclovir|valganciclovir|mesh-list
14652905|NCT00217503|Ganciclovir|ganciclovir|mesh-list
14652906|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
14652907|NCT00217503|Bevacizumab|bevacizumab|mesh-list
14652908|NCT00217503|Doxorubicin|doxorubicin|mesh-list
14652909|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14652910|NCT00217503|Etoposide|etoposide|mesh-list
14652911|NCT00217503|Bortezomib|bortezomib|mesh-list
14652912|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652913|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
14652914|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652915|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14652916|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14652917|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
14652918|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652919|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652920|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14652921|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14652922|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14652923|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14652924|NCT00217503|Growth Substances|growth substances|mesh-ancestor
14652925|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
14652926|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14652927|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14652928|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652929|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652930|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14652931|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
14652932|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14652933|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14652934|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
14652935|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652936|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14652937|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14652938|NCT00217516|Selenium|selenium|mesh-list
14652939|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
14652940|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652941|NCT00217516|Protective Agents|protective agents|mesh-ancestor
14652942|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652943|NCT00217516|Trace Elements|trace elements|mesh-ancestor
14652944|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
14652945|NCT00217529|Carboplatin|carboplatin|mesh-list
14652946|NCT00217529|Docetaxel|docetaxel|mesh-list
14652947|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14652948|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652949|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652950|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652951|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652952|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652953|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14652954|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652955|NCT00217542|Interferons|interferons|mesh-list
14652956|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
14652957|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
14652958|NCT00217542|Azacitidine|azacitidine|mesh-list
14652959|NCT00217542|Amifostine|amifostine|mesh-list
14652960|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652961|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
14652962|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652963|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652964|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
14652965|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652966|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652967|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
14652968|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652969|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14652970|NCT00217542|Protective Agents|protective agents|mesh-ancestor
14652971|NCT00217555|Gemcitabine|gemcitabine|mesh-list
14652972|NCT00217555|Topotecan|topotecan|mesh-list
14652973|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14652974|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
14652975|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652976|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652977|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
14652978|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14652979|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14652980|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14652981|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
14652982|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14652983|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14652984|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14652985|NCT00217568|Carboplatin|carboplatin|mesh-list
14652986|NCT00217568|Docetaxel|docetaxel|mesh-list
14652987|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652988|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652989|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652990|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652991|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652992|NCT00217607|Paclitaxel|paclitaxel|mesh-list
14652993|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15183706|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183707|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15183708|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
15183709|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15183710|NCT03909074|Vaccines|vaccines|mesh-list
15183711|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
15183712|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183713|NCT03908892|Tetracycline|tetracycline|mesh-list
15183714|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15183715|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183716|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15183717|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183718|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183719|NCT03908944|Methadone|methadone|mesh-list
15183720|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15183721|NCT03908944|Narcotics|narcotics|mesh-ancestor
14652994|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14652995|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
14652996|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
14652997|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
14652998|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14652999|NCT00217646|Sorafenib|sorafenib|mesh-list
14653000|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653001|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14653002|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653003|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653004|NCT00217659|Anastrozole|anastrozole|mesh-list
14653005|NCT00217659|Goserelin|goserelin|mesh-list
14653006|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14653007|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653008|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14653009|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14653010|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653011|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653012|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14653013|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
14653014|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14653015|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653016|NCT00217698|Gemcitabine|gemcitabine|mesh-list
14653017|NCT00217698|Gefitinib|gefitinib|mesh-list
14653018|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653019|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653020|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
14653021|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653022|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
14653023|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653024|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183722|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183723|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183724|NCT03908944|Analgesics|analgesics|mesh-ancestor
15183725|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
15183726|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183727|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
15183728|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
15183729|NCT03908619|Esomeprazole|esomeprazole|mesh-list
14653025|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653026|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
14653027|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653028|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14653029|NCT00217711|Capecitabine|capecitabine|mesh-list
14653030|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
14653031|NCT00217711|Irinotecan|irinotecan|mesh-list
14653032|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653033|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
14653034|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653035|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653036|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14653037|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653038|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653039|NCT00217815|Efungumab|efungumab|mesh-list
14653040|NCT00217815|Docetaxel|docetaxel|mesh-list
14653041|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653042|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14653043|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14653044|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14653045|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653046|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
14653047|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183730|NCT03908619|Omeprazole|omeprazole|mesh-list
15183731|NCT03908619|Rabeprazole|rabeprazole|mesh-list
15183732|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15183733|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15183734|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15183735|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183736|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183737|NCT03908736|Picolinic acid|picolinic acid|mesh-list
15183738|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15183739|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
15183740|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
15183741|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223539|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223540|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653048|NCT00217828|Citalopram|citalopram|mesh-list
14653049|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14653050|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653051|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653052|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653053|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653054|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
14653055|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653056|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14653057|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
14653058|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653059|NCT00217932|Valproic Acid|valproic acid|mesh-list
14653060|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
14653061|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653062|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653063|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
14653064|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653065|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653066|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
14653067|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14653068|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653069|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653070|NCT00218049|Vanoxerine|vanoxerine|mesh-list
14653071|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14653072|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653073|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653074|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653075|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
14653076|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653077|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653078|NCT00218075|Levodopa|levodopa|mesh-list
14653079|NCT00218075|Carbidopa|carbidopa|mesh-list
14653080|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14653081|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14653082|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
14653083|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223541|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223542|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725447|NCT00504062|Fluticasone|fluticasone|mesh-list
14653084|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653085|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653086|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14653087|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653088|NCT00218101|Buprenorphine|buprenorphine|mesh-list
14653089|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14653090|NCT00218101|Narcotics|narcotics|mesh-ancestor
14653091|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653092|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653093|NCT00218101|Analgesics|analgesics|mesh-ancestor
14653094|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
14653095|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653096|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14653097|NCT00218114|Valproic Acid|valproic acid|mesh-list
14653098|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
14653099|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653100|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653101|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
14653102|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653103|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653104|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
14653105|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14653106|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653107|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653108|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
14653109|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14653110|NCT00218127|Narcotics|narcotics|mesh-ancestor
14653111|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653112|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653113|NCT00218127|Analgesics|analgesics|mesh-ancestor
14653114|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
14653115|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653116|NCT00218140|Nicotine|nicotine|mesh-list
14653117|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14653118|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
14653119|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653120|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653121|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14653122|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14653123|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653124|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653125|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725448|NCT00504062|Budesonide|budesonide|mesh-list
14725449|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725450|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14725451|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
15183742|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15183743|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15183744|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183745|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183746|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15183747|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183748|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725452|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725453|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725454|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14725455|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
14725456|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
14725457|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14725458|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
14725459|NCT00504062|Hormones|hormones|mesh-ancestor
14725460|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725461|NCT00504101|Bortezomib|bortezomib|mesh-list
14725462|NCT00504101|Melphalan|melphalan|mesh-list
14725463|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
14725464|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725465|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14725466|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
14725467|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725468|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14725469|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725470|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
14725471|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725472|NCT00504127|Naproxen|naproxen|mesh-list
14653126|NCT00218153|Naltrexone|naltrexone|mesh-list
14653127|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14653128|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14653129|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653130|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
14653131|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653132|NCT00218166|Triazolam|triazolam|mesh-list
14653133|NCT00218166|Tiagabine|tiagabine|mesh-list
14653134|NCT00218166|Baclofen|baclofen|mesh-list
14653135|NCT00218166|GABA Agonists|gaba agonists|mesh-list
14653136|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14653137|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653138|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14653139|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653140|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14653141|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
14653142|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653143|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653144|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14653145|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14653146|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14653147|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653148|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653149|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
14653150|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
14653151|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14653152|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653153|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653154|NCT00218205|Celecoxib|celecoxib|mesh-list
14653155|NCT00218205|Epirubicin|epirubicin|mesh-list
14653156|NCT00218205|Estramustine|estramustine|mesh-list
14653157|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14653158|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14653159|NCT00218205|Analgesics|analgesics|mesh-ancestor
14653160|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
14653161|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653162|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183749|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183750|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183751|NCT03908593|Pantoprazole|pantoprazole|mesh-list
15183752|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14653163|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14653164|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14653165|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14653166|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14653167|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653168|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653169|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14653170|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653171|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14653172|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653173|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14653174|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
14653175|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14653176|NCT00218218|Nicotine|nicotine|mesh-list
14653177|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14653178|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
14653179|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183753|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15183754|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15183755|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183756|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183757|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
15183758|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
15183759|NCT03908528|Doxorubicin|doxorubicin|mesh-list
14653180|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653181|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14653182|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14653183|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653184|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653185|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653186|NCT00218231|Bupropion|bupropion|mesh-list
14653187|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14653188|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
14653189|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15183760|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14653190|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14653191|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653192|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653193|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653194|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
14653195|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653196|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653197|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14653198|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14653199|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653200|NCT00218244|Lobeline|lobeline|mesh-list
14653201|NCT00218244|Nicotine|nicotine|mesh-list
14653202|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14653203|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
14653204|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653205|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653206|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14653207|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14653208|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653209|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653210|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653211|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
14653212|NCT00218283|Nicotine|nicotine|mesh-list
14653213|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14653214|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
14653215|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653216|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653217|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14653218|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14653219|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653220|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653221|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653222|NCT00218309|Hydromorphone|hydromorphone|mesh-list
14653223|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14653224|NCT00218309|Narcotics|narcotics|mesh-ancestor
14653225|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653226|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653227|NCT00218309|Analgesics|analgesics|mesh-ancestor
14653228|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
14653229|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653230|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14653231|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14653232|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653233|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653234|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653235|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
14653236|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653237|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653238|NCT00218348|Amphetamine|amphetamine|mesh-list
14653239|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
14653240|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14653241|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653242|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
14653243|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
14653244|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653245|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
14653246|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653247|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653248|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
14653249|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14653250|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653251|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183761|NCT03908528|Paclitaxel|paclitaxel|mesh-list
15183762|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15183763|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183764|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
15183765|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183766|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183767|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15183768|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
15183769|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183770|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653252|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14653253|NCT00218361|Hydromorphone|hydromorphone|mesh-list
14653254|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14653255|NCT00218361|Narcotics|narcotics|mesh-ancestor
14293374|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293375|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14653256|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653257|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653258|NCT00218361|Analgesics|analgesics|mesh-ancestor
14653259|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
14653260|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653261|NCT00218374|Gabapentin|gabapentin|mesh-list
14653262|NCT00218374|Analgesics|analgesics|mesh-ancestor
14653263|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
14653264|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653265|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653266|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
14653267|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14653268|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14653269|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183771|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15183772|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15183773|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14653270|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653271|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14653272|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14653273|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653274|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653275|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
14653276|NCT00218413|Vaccines|vaccines|mesh-list
14653277|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
14653278|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653279|NCT00218504|Dronabinol|dronabinol|mesh-list
14653280|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
14653281|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653282|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653283|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14653284|NCT00218504|Analgesics|analgesics|mesh-ancestor
14653285|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
14653286|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653287|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14653288|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14653289|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653290|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653291|NCT00218504|Hormones|hormones|mesh-ancestor
14653292|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14653293|NCT00218517|Selegiline|selegiline|mesh-list
14653294|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
14653295|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653296|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14653297|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14653298|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14653299|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653300|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653301|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14653302|NCT00218517|Protective Agents|protective agents|mesh-ancestor
14653303|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653304|NCT00218530|Lofexidine|lofexidine|mesh-list
14653305|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14653306|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14653307|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653308|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
14653309|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653310|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14653311|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14653312|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14653313|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
14653314|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653315|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653316|NCT00218569|Naltrexone|naltrexone|mesh-list
14653317|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14653318|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14653319|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653320|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
14653321|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183774|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15183775|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183776|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15183777|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183778|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
15183779|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
14653322|NCT00218608|Disulfiram|disulfiram|mesh-list
14653323|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14653324|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14653325|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653326|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653327|NCT00218621|Buprenorphine|buprenorphine|mesh-list
14653328|NCT00218621|Methadone|methadone|mesh-list
14653329|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14653330|NCT00218621|Narcotics|narcotics|mesh-ancestor
14653331|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653332|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653333|NCT00218621|Analgesics|analgesics|mesh-ancestor
14653334|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
14653335|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653336|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14653337|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
14653338|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
15183780|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
15183781|NCT03908528|Protective Agents|protective agents|mesh-ancestor
15183782|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
15183783|NCT03908528|Vitamins|vitamins|mesh-ancestor
15183784|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
15183785|NCT03908814|Antibodies|antibodies|mesh-list
15183786|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
15183787|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653339|NCT00218660|Naltrexone|naltrexone|mesh-list
14653340|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14653341|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14653342|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653343|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
14653344|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653345|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
14653346|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14653347|NCT00218855|Thalidomide|thalidomide|mesh-list
14653348|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653349|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
14653350|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653351|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
14653352|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14653353|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653354|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14653355|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14653356|NCT00218855|Growth Substances|growth substances|mesh-ancestor
14653357|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
14653358|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653359|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
14653360|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14653361|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653362|NCT00219232|Rivastigmine|rivastigmine|mesh-list
14653363|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14653364|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653365|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653366|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653367|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653368|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653369|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14653370|NCT00219232|Protective Agents|protective agents|mesh-ancestor
14653371|NCT00219245|Rivastigmine|rivastigmine|mesh-list
14653372|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14653373|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653374|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653375|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183788|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
15183789|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
14814592|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15183790|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653376|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183791|NCT03908489|Protective Agents|protective agents|mesh-ancestor
14653377|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653378|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14653379|NCT00219245|Protective Agents|protective agents|mesh-ancestor
14653380|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
14653381|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14653382|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653383|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
14653384|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14653385|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653386|NCT00219310|Famciclovir|famciclovir|mesh-list
14653387|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
14653388|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653389|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14653390|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653391|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653392|NCT00219323|Omalizumab|omalizumab|mesh-list
14653393|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14653394|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14653395|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14653396|NCT00219375|Sivelestat|sivelestat|mesh-list
14653397|NCT00219375|Glycine|glycine|mesh-list
14653398|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14653399|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
14653400|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653401|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653402|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
14653403|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653404|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653405|NCT00219388|Simendan|simendan|mesh-list
15183792|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183793|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15183794|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183795|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15183796|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183797|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
15183798|NCT03908333|Gemcitabine|gemcitabine|mesh-list
15183799|NCT03908333|Paclitaxel|paclitaxel|mesh-list
15183800|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15183801|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15183802|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183803|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183804|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
15183805|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14653406|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14653407|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
14653408|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14653409|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14653410|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653411|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653412|NCT00219388|Protective Agents|protective agents|mesh-ancestor
14653413|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653414|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14653415|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
14653416|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653417|NCT00219440|Metformin|metformin|mesh-list
14653418|NCT00219440|Pioglitazone|pioglitazone|mesh-list
14653419|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14653420|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653421|NCT00219466|Zinc|zinc|mesh-list
14653422|NCT00219466|Tocopherols|tocopherols|mesh-list
14653423|NCT00219466|Vitamin E|vitamin e|mesh-list
14653424|NCT00219466|Tocotrienols|tocotrienols|mesh-list
14653425|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
14653426|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
14653427|NCT00219466|Trace Elements|trace elements|mesh-ancestor
14653428|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
14653429|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653430|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
14653431|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653432|NCT00219466|Protective Agents|protective agents|mesh-ancestor
14653433|NCT00219466|Vitamins|vitamins|mesh-ancestor
14653434|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
15183806|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653435|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
14653436|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14653437|NCT00219479|Phenytoin|phenytoin|mesh-list
14653438|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
15183807|NCT03908333|Vitamins|vitamins|mesh-ancestor
14653439|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14653440|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14653441|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653442|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653443|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14653444|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14653445|NCT00219570|Clindamycin|clindamycin|mesh-list
14653446|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
14653447|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
14653448|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
14653449|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14653450|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653451|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14653452|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653453|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653454|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14653455|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653456|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653457|NCT00219596|Timolol|timolol|mesh-list
15183808|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
14653458|NCT00219596|Latanoprost|latanoprost|mesh-list
14653459|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14653460|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14653461|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14653462|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653463|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653464|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653465|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14653466|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14653467|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14653468|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14653469|NCT00219700|Ibuprofen|ibuprofen|mesh-list
14653470|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14653471|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14653472|NCT00219700|Analgesics|analgesics|mesh-ancestor
14653473|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
14653474|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653475|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653476|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14653477|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14653478|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14653479|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653480|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653481|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
14653482|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14653483|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
14653484|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
14653485|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653486|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653487|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14653488|NCT00219713|Analgesics|analgesics|mesh-ancestor
14653489|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
14653490|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725473|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14725474|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14725475|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725476|NCT00504127|Analgesics|analgesics|mesh-ancestor
14725477|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
14725478|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725479|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725480|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725481|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725482|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
14725483|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14725484|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183809|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183810|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15183811|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
15183812|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
14725485|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725486|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14725487|NCT00504140|Interferons|interferons|mesh-list
15183813|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653491|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
14653492|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653493|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14653494|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653495|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653496|NCT00219739|Interferons|interferons|mesh-list
14653497|NCT00219739|Cytarabine|cytarabine|mesh-list
14653498|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
14653499|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653500|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
14653501|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653502|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653503|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
14653504|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653505|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653506|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
14653507|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653508|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14653509|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653510|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
14653511|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653512|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14653513|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653514|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653515|NCT00219765|Cytarabine|cytarabine|mesh-list
14653516|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
14653517|NCT00219765|Daunorubicin|daunorubicin|mesh-list
14653518|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653519|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
15183814|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183815|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183816|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
14653520|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653521|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653522|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
14653523|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653524|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653525|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
14653526|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653527|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14653528|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653529|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14653530|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14653531|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653532|NCT00219778|Mifepristone|mifepristone|mesh-list
14653533|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14653534|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
14653535|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14653536|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653537|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14653538|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15183817|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
15183818|NCT03908333|Protective Agents|protective agents|mesh-ancestor
15183819|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
15183820|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183821|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183822|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183823|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15183824|NCT03908060|Morphine|morphine|mesh-list
15183825|NCT03908060|Methadone|methadone|mesh-list
15183826|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14653539|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14653540|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
15183827|NCT03908060|Narcotics|narcotics|mesh-ancestor
15183828|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183829|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183830|NCT03908060|Analgesics|analgesics|mesh-ancestor
15183831|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
15183832|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183833|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
15183834|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
14653541|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14653542|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15183835|NCT03908372|Docetaxel|docetaxel|mesh-list
15183836|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653543|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
14653544|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14653545|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
14653546|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14653547|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14653548|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
14653549|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14653550|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653551|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653552|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653553|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
15183837|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183838|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
15183839|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183840|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183841|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
15183842|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15183843|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15183844|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15183845|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183846|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653554|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653555|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653556|NCT00219856|Propofol|propofol|mesh-list
15183847|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183848|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183849|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183850|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15183851|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183852|NCT03907800|Paclitaxel|paclitaxel|mesh-list
15183853|NCT03907800|Carboplatin|carboplatin|mesh-list
15183854|NCT03907800|Trastuzumab|trastuzumab|mesh-list
15183855|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15183856|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183857|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
15183858|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
15183859|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
15183860|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183861|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15183862|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
15183863|NCT03907852|Fludarabine|fludarabine|mesh-list
15183864|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183865|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
15183866|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183867|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15183868|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15183869|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
15183870|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183871|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183872|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15183873|NCT03907813|Bupivacaine|bupivacaine|mesh-list
15183874|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
15183875|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
15183876|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653557|NCT00219856|Desflurane|desflurane|mesh-list
14653558|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14653559|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653560|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653561|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14653562|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
14653563|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
14653564|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14653565|NCT00219869|Galantamine|galantamine|mesh-list
14653566|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14653567|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653568|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653569|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653570|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653571|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653572|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14653573|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
14653574|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653575|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
14653576|NCT00219882|Turmeric extract|turmeric extract|mesh-list
14653577|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
14653578|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653579|NCT00219882|Protective Agents|protective agents|mesh-ancestor
14653580|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653581|NCT00219895|Ibuprofen|ibuprofen|mesh-list
14653582|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14653583|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14653584|NCT00219895|Analgesics|analgesics|mesh-ancestor
14653585|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
14653586|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653587|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653588|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14653589|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14653590|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14653591|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653592|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653593|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
14653594|NCT00219908|Analgesics|analgesics|mesh-ancestor
14653595|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
14653596|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653597|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653598|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653599|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14653600|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653601|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653602|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653603|NCT00219921|Morphine|morphine|mesh-list
14653604|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14653605|NCT00219921|Narcotics|narcotics|mesh-ancestor
14653606|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653607|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653608|NCT00219921|Analgesics|analgesics|mesh-ancestor
14653609|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
14653610|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653611|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14653612|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
14653613|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653614|NCT00219973|Bemiparin|bemiparin|mesh-list
14653615|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
14653616|NCT00220051|Capecitabine|capecitabine|mesh-list
14653617|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
14653618|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653619|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
14653620|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653621|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653622|NCT00220064|Leucovorin|leucovorin|mesh-list
14653623|NCT00220064|Fluorouracil|fluorouracil|mesh-list
14653624|NCT00220064|Irinotecan|irinotecan|mesh-list
14653625|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
14653626|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653627|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653628|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653629|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653630|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
14653631|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653632|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14653633|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653634|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653635|NCT00220064|Antidotes|antidotes|mesh-ancestor
14653636|NCT00220064|Protective Agents|protective agents|mesh-ancestor
14653637|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
14653638|NCT00220064|Vitamins|vitamins|mesh-ancestor
14653639|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
14653640|NCT00220103|Capecitabine|capecitabine|mesh-list
15183877|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183878|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
15183879|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183880|NCT03907423|Metformin|metformin|mesh-list
15183881|NCT03907423|Glimepiride|glimepiride|mesh-list
14653641|NCT00220103|Epirubicin|epirubicin|mesh-list
15183882|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15183883|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14653642|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653643|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653644|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
15183884|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653645|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653646|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14653647|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14653648|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653649|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653650|NCT00220116|Capecitabine|capecitabine|mesh-list
14653651|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
14653652|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653653|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
14653654|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653655|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653656|NCT00220129|Capecitabine|capecitabine|mesh-list
14653657|NCT00220129|Epirubicin|epirubicin|mesh-list
14653658|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653659|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653660|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
14653661|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653662|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14653663|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14653664|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653665|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653666|NCT00220155|Gemcitabine|gemcitabine|mesh-list
14653667|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653668|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
14653669|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653670|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653671|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
14653672|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653673|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653674|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653675|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
14653676|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653677|NCT00220168|Capecitabine|capecitabine|mesh-list
14653678|NCT00220168|Irinotecan|irinotecan|mesh-list
14653679|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653680|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
14653681|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653682|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653683|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14653684|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653685|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653686|NCT00220194|Leuprolide|leuprolide|mesh-list
14653687|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14653688|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
14653689|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14653690|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653691|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14653692|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653693|NCT00220220|Amlodipine|amlodipine|mesh-list
14653694|NCT00220220|Olmesartan|olmesartan|mesh-list
14653695|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14653696|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14653697|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14653698|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653699|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653700|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14653701|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653702|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
14653703|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14653704|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14653705|NCT00220233|Amlodipine|amlodipine|mesh-list
14653706|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14653707|NCT00220233|Olmesartan|olmesartan|mesh-list
14653708|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14653709|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14653710|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14653711|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653712|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653713|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14653714|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653715|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
15183885|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14653716|NCT00220233|Diuretics|diuretics|mesh-ancestor
14653717|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
15183886|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15183887|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
15183888|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183889|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15183890|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15183891|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183892|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14653718|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14653719|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14653720|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14653721|NCT00220259|Fluticasone|fluticasone|mesh-list
14653722|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14653723|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14653724|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
14653725|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653726|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653727|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14653728|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
14653729|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
14653730|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14653731|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14653732|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
14653733|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653734|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
14653735|NCT00220298|Testosterone|testosterone|mesh-list
14653736|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
14653737|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
14653738|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14653739|NCT00220298|Androgens|androgens|mesh-ancestor
14653740|NCT00220298|Hormones|hormones|mesh-ancestor
14653741|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14653742|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653743|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14653744|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653745|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
14653746|NCT00220311|Fludarabine|fludarabine|mesh-list
14653747|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
14653748|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653749|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653750|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
14653751|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653752|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653753|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
14653754|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653755|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14653756|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14653757|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14653758|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14653759|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
14653760|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14653761|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653762|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14653763|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14653764|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14653765|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14653766|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14653767|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14653768|NCT00220337|Lacosamide|lacosamide|mesh-list
14653769|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
14653770|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14653771|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14653772|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653773|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653774|NCT00220350|Leuprolide|leuprolide|mesh-list
14653775|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14653776|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
14653777|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14653778|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183893|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15183894|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
15183895|NCT03907371|Donepezil|donepezil|mesh-list
15183896|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15183897|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183898|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653779|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14653780|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653781|NCT00220428|Vaccines|vaccines|mesh-list
14653782|NCT00220428|Immunologic Factors|immunologic factors|mesh-ancestor
14653783|NCT00220428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653784|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
14653785|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14653786|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14653787|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14653788|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14653789|NCT00220480|Citalopram|citalopram|mesh-list
14653790|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14653791|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653792|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653793|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653794|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653795|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
14653796|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653797|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14653798|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
14653799|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653800|NCT00220493|Methylphenidate|methylphenidate|mesh-list
14653801|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14653802|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653803|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14653804|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653805|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653806|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653807|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
14653808|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653809|NCT00220506|Modafinil|modafinil|mesh-list
14653810|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14653811|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653812|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14653813|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14653814|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14653815|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653816|NCT00220532|Folic Acid|folic acid|mesh-list
14653817|NCT00220532|Riboflavin|riboflavin|mesh-list
14653818|NCT00220532|Hematinics|hematinics|mesh-ancestor
14653819|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
14653820|NCT00220532|Vitamins|vitamins|mesh-ancestor
14653821|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
14653822|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653823|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14653824|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
14653825|NCT00220584|Donepezil|donepezil|mesh-list
14653826|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14653827|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653828|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653829|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653830|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814593|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15183899|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
15183900|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183901|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183902|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
15183903|NCT03907098|Endostar protein|endostar protein|mesh-list
15183904|NCT03907098|Endostatins|endostatins|mesh-list
15183905|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15183906|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15183907|NCT03907098|Growth Substances|growth substances|mesh-ancestor
15183908|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183909|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
15183910|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183911|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
15183912|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15183913|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
14293376|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14293377|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
14293378|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293379|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293380|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14293381|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293382|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15183914|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183915|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
14653831|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653832|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
14653833|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
14653834|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653835|NCT00220649|Leucovorin|leucovorin|mesh-list
14653836|NCT00220649|Gemcitabine|gemcitabine|mesh-list
14653837|NCT00220649|Fluorouracil|fluorouracil|mesh-list
14653838|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
14653839|NCT00220649|Irinotecan|irinotecan|mesh-list
14653840|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14653841|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
14653842|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653843|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653844|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
14653845|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653846|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653847|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14653848|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
14653849|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653850|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14653851|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14653852|NCT00220649|Antidotes|antidotes|mesh-ancestor
14653853|NCT00220649|Protective Agents|protective agents|mesh-ancestor
14653854|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
15183916|NCT03906877|Protective Agents|protective agents|mesh-ancestor
15183917|NCT03906916|Micafungin|micafungin|mesh-list
15183918|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
15183919|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15183920|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
15183921|NCT03907215|Citalopram|citalopram|mesh-list
15183922|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15183923|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15183924|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15183925|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183926|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183927|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
15183928|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183929|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15183930|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
15183931|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653855|NCT00220649|Vitamins|vitamins|mesh-ancestor
14653856|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
14653857|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
14653858|NCT00220675|Hematinics|hematinics|mesh-ancestor
14653859|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
14653860|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14653861|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653862|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653863|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653864|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
14653865|NCT00220766|Antibodies|antibodies|mesh-list
14653866|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
14653867|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14653868|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14653869|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
14653870|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
14653871|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653872|NCT00220818|Lansoprazole|lansoprazole|mesh-list
14653873|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
14653874|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14653875|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14653876|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14653877|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653878|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653879|NCT00220831|Vitamin E|vitamin e|mesh-list
14653880|NCT00220831|Vitamins|vitamins|mesh-ancestor
15183932|NCT03907163|Dronabinol|dronabinol|mesh-list
15183933|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
14653881|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
14653882|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653883|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
14653884|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653885|NCT00220831|Protective Agents|protective agents|mesh-ancestor
14653886|NCT00220844|Amitriptyline|amitriptyline|mesh-list
14653887|NCT00220844|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15183934|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183935|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15183936|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15183937|NCT03907163|Analgesics|analgesics|mesh-ancestor
15183938|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
15183939|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183940|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15183941|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15183942|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15183943|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653888|NCT00220844|Desipramine|desipramine|mesh-list
14653889|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14653890|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
14653891|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14653892|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14653893|NCT00220844|Analgesics|analgesics|mesh-ancestor
14653894|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
14653895|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653896|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653897|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14653898|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14653899|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14653900|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653901|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
14653902|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653903|NCT00220844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14653904|NCT00220844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14653905|NCT00220844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653906|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653907|NCT00220857|Rabeprazole|rabeprazole|mesh-list
14653908|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14653909|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14653910|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14653911|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653912|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653913|NCT00220896|Donepezil|donepezil|mesh-list
14653914|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14653915|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653916|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653917|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14653918|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14653919|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653920|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
14653921|NCT00220909|Lansoprazole|lansoprazole|mesh-list
14653922|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
15183944|NCT03907163|Hormones|hormones|mesh-ancestor
15183945|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15183946|NCT03907111|Chitosan|chitosan|mesh-list
15183947|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15183948|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15183949|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
15183950|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183951|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15183952|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
15183953|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
15183954|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
15183955|NCT03907111|Coagulants|coagulants|mesh-ancestor
15183956|NCT03906721|Oxycodone|oxycodone|mesh-list
15183957|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15183958|NCT03906721|Narcotics|narcotics|mesh-ancestor
15183959|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183960|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183961|NCT03906721|Analgesics|analgesics|mesh-ancestor
15183962|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
15183963|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223543|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223544|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
15223545|NCT01963728|Insulin|insulin|mesh-list
14653923|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14653924|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725488|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
14653925|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14653926|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653927|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653928|NCT00220922|Ethanol|ethanol|mesh-list
14653929|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14653930|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653931|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653932|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653933|NCT00220987|Insulin|insulin|mesh-list
14653934|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14653935|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14653936|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653937|NCT00221000|Methoxsalen|methoxsalen|mesh-list
14653938|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14653939|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
14653940|NCT00221026|Methoxsalen|methoxsalen|mesh-list
14653941|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14653942|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14653943|NCT00221039|Methoxsalen|methoxsalen|mesh-list
14653944|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14653945|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
14653946|NCT00221052|Diclofenac|diclofenac|mesh-list
14653947|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14653948|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14653949|NCT00221052|Analgesics|analgesics|mesh-ancestor
14653950|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
14653951|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14653952|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653953|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14653954|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14653955|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14653956|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653957|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725489|NCT00504140|Etoposide|etoposide|mesh-list
14725490|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14725491|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725492|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14725493|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725494|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725495|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183964|NCT03906838|Ropivacaine|ropivacaine|mesh-list
15183965|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
15183966|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
14725496|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
14725497|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725498|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
14725499|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725500|NCT00504192|Gemcitabine|gemcitabine|mesh-list
14725501|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
14725502|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725503|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
14725504|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725505|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725506|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
14725507|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725508|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725509|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725510|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
14725511|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725512|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
14725513|NCT00504244|Azathioprine|azathioprine|mesh-list
14725514|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
14725515|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725516|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725517|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183967|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183968|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183969|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
15183970|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183971|NCT03906669|Tamoxifen|tamoxifen|mesh-list
15183972|NCT03906669|Letrozole|letrozole|mesh-list
15183973|NCT03906669|Progesterone|progesterone|mesh-list
14725518|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725519|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
15183974|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15183975|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14653958|NCT00221156|Acarbose|acarbose|mesh-list
14653959|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14653960|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653961|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653962|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14653963|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653964|NCT00221260|Anesthetics|anesthetics|mesh-list
14653965|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14653966|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653967|NCT00221286|Interferons|interferons|mesh-list
14653968|NCT00221286|Tenofovir|tenofovir|mesh-list
14653969|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
14653970|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
14653971|NCT00221286|Emtricitabine|emtricitabine|mesh-list
14653972|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14653973|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653974|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
14653975|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653976|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14653977|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14653978|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14653979|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14653980|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14653981|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14653982|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
14653983|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653984|NCT00221312|Alendronate|alendronate|mesh-list
14653985|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14653986|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653987|NCT00221325|Rituximab|rituximab|mesh-list
14653988|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14653989|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14653990|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
14653991|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14653992|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14653993|NCT00221364|Azithromycin|azithromycin|mesh-list
14653994|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14653995|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14653996|NCT00221390|Ropinirole|ropinirole|mesh-list
14653997|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14653998|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14653999|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
14654000|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
14654001|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654002|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654003|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654004|NCT00221416|Aripiprazole|aripiprazole|mesh-list
14654005|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654006|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654007|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654008|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654009|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654010|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654011|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
14654012|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
14654013|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654014|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654015|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14654016|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14654017|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
14654018|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14654019|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14654020|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14654021|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14654022|NCT00221429|Valproic Acid|valproic acid|mesh-list
14654023|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654024|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654025|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654026|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
14654027|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654028|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654029|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654030|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
14654031|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
14654032|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654033|NCT00221442|Zonisamide|zonisamide|mesh-list
14654034|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
14654035|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14654036|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654037|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654038|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654039|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654040|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15183976|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15183977|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15183978|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15183979|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15183980|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
15183981|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15183982|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183983|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15183984|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15183985|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15183986|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14654041|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654042|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654043|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654044|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654045|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654046|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654047|NCT00221481|Valproic Acid|valproic acid|mesh-list
14654048|NCT00221481|Olanzapine|olanzapine|mesh-list
14654049|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
14654050|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
14654051|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654052|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654053|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14654054|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654055|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654056|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654057|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654058|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14654059|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654060|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654061|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654062|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654063|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
14654064|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
14654065|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654066|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
14654067|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
14654068|NCT00221494|Pindolol|pindolol|mesh-list
14654069|NCT00221494|Citalopram|citalopram|mesh-list
14654070|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14654071|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654072|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654073|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654074|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654075|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
14654076|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654077|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14654078|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654079|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654080|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14654081|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14654082|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
14654083|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14654084|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14654085|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
14654086|NCT00221520|Midazolam|midazolam|mesh-list
14654087|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14654088|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14654089|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654090|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654091|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14654092|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654093|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654094|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14654095|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
14654096|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
14654097|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
14654098|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
14654099|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654100|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654101|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
14654102|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14654103|NCT00221611|Baclofen|baclofen|mesh-list
14654104|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14654105|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654106|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14654107|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654108|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14654109|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
14654110|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
14654111|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654112|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654113|NCT00221624|Ribavirin|ribavirin|mesh-list
14654114|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14654115|NCT00221624|Amantadine|amantadine|mesh-list
15183987|NCT03906669|Progestins|progestins|mesh-ancestor
15183988|NCT03906669|Hormones|hormones|mesh-ancestor
15183989|NCT03905798|Lorazepam|lorazepam|mesh-list
15183990|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
15183991|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
15183992|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
14654116|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
14654117|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654118|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
14654119|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654120|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14654121|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15183993|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15183994|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15183995|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15183996|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15183997|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15183998|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15183999|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15184000|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184001|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
15184002|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
15184003|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184004|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184005|NCT03905837|Lidocaine|lidocaine|mesh-list
15184006|NCT03905837|Piperidine|piperidine|mesh-list
15184007|NCT03905837|Remifentanil|remifentanil|mesh-list
15184008|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
15184009|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
15184010|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184011|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184012|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
15184013|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184014|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15184015|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15184016|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15184017|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184018|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184019|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15184020|NCT03905837|Narcotics|narcotics|mesh-ancestor
15184021|NCT03905837|Analgesics|analgesics|mesh-ancestor
15184022|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15184023|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15184024|NCT03905941|Metformin|metformin|mesh-list
15184025|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
15184026|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15184027|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184028|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184029|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
15184030|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15184031|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14654122|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
14654123|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184032|NCT03906123|Protective Agents|protective agents|mesh-ancestor
15184033|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184034|NCT03905967|Lenvatinib|lenvatinib|mesh-list
15223546|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15184035|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184036|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15184037|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184038|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184039|NCT03905759|Colchicine|colchicine|mesh-list
15184040|NCT03905759|Amiodarone|amiodarone|mesh-list
15184041|NCT03905759|Dronedarone|dronedarone|mesh-list
15184042|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
15184043|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15184044|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
15184045|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
15184046|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
15184047|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184048|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184049|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15184050|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
15184051|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15184052|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184053|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15184054|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14293383|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14293384|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14293385|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14293386|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293387|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293388|NCT00568022|Capecitabine|capecitabine|mesh-list
14293389|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293390|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
14293391|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293392|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654124|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654125|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654126|NCT00221624|Analgesics|analgesics|mesh-ancestor
14654127|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
14654128|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654129|NCT00221637|Valproic Acid|valproic acid|mesh-list
14654130|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
14654131|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654132|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654133|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
14654134|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654135|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654136|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
14654137|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654138|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654139|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654140|NCT00221650|Ribavirin|ribavirin|mesh-list
14654141|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14654142|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
14654143|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654144|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
14654145|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654146|NCT00221689|Baclofen|baclofen|mesh-list
14654147|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14654148|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654149|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14654150|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654151|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14654152|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
14654153|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
14654154|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654155|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654156|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14654157|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
14654158|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654159|NCT00221754|Pravastatin|pravastatin|mesh-list
14654160|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14654161|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14654162|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
14654163|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654164|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15184055|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14654165|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14654166|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654167|NCT00221845|Telmisartan|telmisartan|mesh-list
14654168|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14654169|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14654170|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14654171|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654172|NCT00221871|Ketamine|ketamine|mesh-list
14654173|NCT00221871|Analgesics|analgesics|mesh-ancestor
14654174|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
14293393|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
14654175|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654176|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654177|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14654178|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14654179|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
14654180|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
14654181|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654182|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14654183|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14654184|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654185|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654186|NCT00221962|Aripiprazole|aripiprazole|mesh-list
14654187|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654188|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654189|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654190|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654191|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654192|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654193|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
14654194|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
14654195|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654196|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654197|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14654198|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14654199|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
15184056|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184057|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14293394|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14293395|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
15184058|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15184059|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15184060|NCT03905603|Cosyntropin|cosyntropin|mesh-list
15184061|NCT03905603|Hormones|hormones|mesh-ancestor
15184062|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184063|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184064|NCT03905317|Bevacizumab|bevacizumab|mesh-list
15184065|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184066|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184067|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15184068|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15184069|NCT03905317|Growth Substances|growth substances|mesh-ancestor
15184070|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184071|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
15184072|NCT03905486|Pregabalin|pregabalin|mesh-list
15184073|NCT03905486|Analgesics|analgesics|mesh-ancestor
15184074|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
15184075|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184076|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184077|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
14293396|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293397|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293398|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14293399|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293400|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14293401|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
14293402|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184078|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15184079|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184080|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184081|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15184082|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15184083|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14293403|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654200|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14654201|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14654202|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14654203|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14654204|NCT00221975|Lamotrigine|lamotrigine|mesh-list
14654205|NCT00221975|Valproic Acid|valproic acid|mesh-list
14654206|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654207|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654208|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654209|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
14654210|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654211|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654212|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654213|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
14654214|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14654215|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654216|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654217|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654218|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14654219|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
14654220|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654221|NCT00221988|Levetiracetam|levetiracetam|mesh-list
14654222|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
14654223|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
14654224|NCT00222053|Thalidomide|thalidomide|mesh-list
15184084|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184085|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184086|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
15184087|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15184088|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184089|NCT03905564|Pyridoxine|pyridoxine|mesh-list
15184090|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
15184091|NCT03905564|Doxylamine|doxylamine|mesh-list
14654225|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14654226|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
14654227|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654228|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
14654229|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14654230|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654231|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15184092|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
15184093|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
15184094|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
15184095|NCT03905564|Vitamins|vitamins|mesh-ancestor
15184096|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
15184097|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184098|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
15184099|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
15184100|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184101|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184102|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15184103|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
15184104|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
15184105|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184106|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184107|NCT03904849|Cannabidiol|cannabidiol|mesh-list
15184108|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
15184109|NCT03905018|Tadalafil|tadalafil|mesh-list
15184110|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
15184111|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15184112|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15184113|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184114|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184115|NCT03905018|Urological Agents|urological agents|mesh-ancestor
15184116|NCT03904836|Tobramycin|tobramycin|mesh-list
15184117|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15184118|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184119|NCT03904888|Anesthetics|anesthetics|mesh-list
15184120|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
15184121|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184122|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184123|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
14814594|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184124|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223547|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
15223548|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
15184125|NCT03904680|Vitamin D|vitamin d|mesh-list
15184126|NCT03904680|Methotrexate|methotrexate|mesh-list
15184127|NCT03904680|Vitamins|vitamins|mesh-ancestor
15184128|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
15184129|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184130|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15184131|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15184132|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
15184133|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184134|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15184135|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
15184136|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184137|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184138|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
15184139|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184140|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15184141|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184142|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
15184143|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15184144|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15184145|NCT03904719|Vorolanib|vorolanib|mesh-list
14654232|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14654233|NCT00222053|Growth Substances|growth substances|mesh-ancestor
14654234|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
14654235|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654236|NCT00222079|Esomeprazole|esomeprazole|mesh-list
14654237|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15184146|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14654238|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14654239|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14654240|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654241|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654242|NCT00222144|Docetaxel|docetaxel|mesh-list
14654243|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
14654244|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184147|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184148|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654245|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
14654246|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
14654247|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
14654248|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654249|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14654250|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654251|NCT00222170|Rabeprazole|rabeprazole|mesh-list
14654252|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14654253|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14654254|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14654255|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654256|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654257|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
14654258|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14654259|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654260|NCT00222183|Analgesics|analgesics|mesh-ancestor
14654261|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
14654262|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654263|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654264|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654265|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654266|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
14654267|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14654268|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
14654269|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14654270|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654271|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654272|NCT00222235|Cycloserine|cycloserine|mesh-list
14654273|NCT00222235|Glycine|glycine|mesh-list
14654274|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14654275|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654276|NCT00222235|Renal Agents|renal agents|mesh-ancestor
14654277|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14654278|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
14654279|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14654280|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
14654281|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654282|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
14654283|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654284|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654285|NCT00222261|Aspirin|aspirin|mesh-list
14654286|NCT00222261|Clopidogrel|clopidogrel|mesh-list
14654287|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14654288|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654289|NCT00222261|Analgesics|analgesics|mesh-ancestor
14654290|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
14654291|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654292|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654293|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654294|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654295|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14654296|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14654297|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654298|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14654299|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14654300|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654301|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
14654302|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14654303|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14654304|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14654305|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
14654306|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654307|NCT00222443|Irinotecan|irinotecan|mesh-list
14654308|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14654309|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14654310|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654311|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654312|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654313|NCT00222469|Gemcitabine|gemcitabine|mesh-list
14654314|NCT00222469|Bevacizumab|bevacizumab|mesh-list
14654315|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
14654316|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14654317|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654318|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14654319|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14654320|NCT00222469|Growth Substances|growth substances|mesh-ancestor
14654321|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654322|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
14654323|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14654324|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
14654325|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654326|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
14654327|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654328|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654329|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14654330|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
14654331|NCT00222482|Valproic Acid|valproic acid|mesh-list
14654332|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
14654333|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654334|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654335|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
14654336|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654337|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654338|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
14654339|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654340|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654341|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654342|NCT00222495|Olanzapine|olanzapine|mesh-list
14654343|NCT00222495|Risperidone|risperidone|mesh-list
14654344|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14654345|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14654346|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
14654347|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654348|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654349|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654350|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654351|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654352|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654353|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654354|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14654355|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
14654356|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
14654357|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
14654358|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184149|NCT03904446|Methylergonovine|methylergonovine|mesh-list
15184150|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
15184151|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184152|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184153|NCT03904745|Atosiban|atosiban|mesh-list
15184154|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
15184155|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184156|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184157|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
15184158|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184159|NCT03904563|Bevacizumab|bevacizumab|mesh-list
15184160|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184161|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293404|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14654359|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14654360|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14654361|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654362|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654363|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654364|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
14654365|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14654366|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654367|NCT00222534|Acetazolamide|acetazolamide|mesh-list
14654368|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
14654369|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14654370|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654371|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654372|NCT00222534|Diuretics|diuretics|mesh-ancestor
14654373|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
14654374|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654375|NCT00222547|Vitamin A|vitamin a|mesh-list
14654376|NCT00222547|Albendazole|albendazole|mesh-list
14654377|NCT00222547|Vitamins|vitamins|mesh-ancestor
14654378|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
14654379|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654380|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654381|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654382|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
14654383|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14654384|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654385|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
14654386|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14654387|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14654388|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
14654389|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
14654390|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
14725520|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725521|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725522|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14725523|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14725524|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
14725525|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14725526|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725527|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725528|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14725529|NCT00504283|Morphine|morphine|mesh-list
14725530|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14725531|NCT00504283|Narcotics|narcotics|mesh-ancestor
14725532|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14725533|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725534|NCT00504283|Analgesics|analgesics|mesh-ancestor
14725535|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
14725536|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725537|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14725538|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725539|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725540|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725541|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14725542|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725543|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725544|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14725545|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184162|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14293405|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
14654391|NCT00222573|Metoprolol|metoprolol|mesh-list
14654392|NCT00222573|Clopidogrel|clopidogrel|mesh-list
14654393|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14654394|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14654395|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14654396|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14654397|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
14654398|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654399|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654400|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184163|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15184164|NCT03904563|Growth Substances|growth substances|mesh-ancestor
15184165|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184166|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
15184167|NCT03904732|Aspirin|aspirin|mesh-list
15184168|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15184169|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15184170|NCT03904732|Analgesics|analgesics|mesh-ancestor
15184171|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
15184172|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184173|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184174|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184175|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15184176|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15184177|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15184178|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184179|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15184180|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15184181|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184182|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
15184183|NCT03904537|Antibodies|antibodies|mesh-list
15184184|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
15184185|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184186|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15184187|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184188|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184189|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15184190|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184191|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184192|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
15184193|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
14654401|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14654402|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14654403|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
14654404|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
14654405|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654406|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14654407|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14654408|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14654409|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
14654410|NCT00222638|Vaccines|vaccines|mesh-list
14654411|NCT00222638|Immunologic Factors|immunologic factors|mesh-ancestor
15184194|NCT03903952|Vitamins|vitamins|mesh-ancestor
15184195|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
15184196|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184197|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
15184198|NCT03903952|Hematinics|hematinics|mesh-ancestor
15184199|NCT03904108|Ramucirumab|ramucirumab|mesh-list
15184200|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184201|NCT03904251|Cytarabine|cytarabine|mesh-list
15184202|NCT03904251|Daunorubicin|daunorubicin|mesh-list
15184203|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
15184204|NCT03904251|Calicheamicins|calicheamicins|mesh-list
15184205|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15184206|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
15184207|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184208|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184209|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
15184210|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184211|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184212|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
14654412|NCT00222638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654413|NCT00222651|Tenecteplase|tenecteplase|mesh-list
15184213|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184214|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15184215|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15184216|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15184217|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184218|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184219|NCT03904225|Tegafur|tegafur|mesh-list
15184220|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15184221|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
15184222|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184223|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184224|NCT03903835|Prednisone|prednisone|mesh-list
15184225|NCT03903835|Carboplatin|carboplatin|mesh-list
15184226|NCT03903835|Docetaxel|docetaxel|mesh-list
15184227|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
15184228|NCT03903835|Niraparib|niraparib|mesh-list
15184229|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15184230|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15184231|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184232|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
15184233|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
15184234|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
15184235|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184236|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184237|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
15184238|NCT03903835|Hormones|hormones|mesh-ancestor
15184239|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184240|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184241|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184242|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15184243|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654414|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14654415|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14654416|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654417|NCT00222677|Aspirin|aspirin|mesh-list
14654418|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14654419|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654420|NCT00222677|Analgesics|analgesics|mesh-ancestor
14654421|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
14654422|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654423|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654424|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654425|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654426|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14654427|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14654428|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654429|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14654430|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14654431|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654432|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
14654433|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14654434|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14654435|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654436|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654437|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654438|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14654439|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654440|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654441|NCT00222820|Citalopram|citalopram|mesh-list
14654442|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14654443|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654444|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654445|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654446|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654447|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
14654448|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654449|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14654450|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654451|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654452|NCT00222833|Aripiprazole|aripiprazole|mesh-list
14654453|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654454|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654455|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654456|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15184244|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
15184245|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14654457|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654458|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654459|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
14654460|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
14654461|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654462|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654463|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14654464|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14654465|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
14654466|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14654467|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14654468|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14654469|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14654470|NCT00222872|Hormones|hormones|mesh-list
14654471|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
14654472|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14654473|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293406|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
14654474|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654475|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654476|NCT00222976|Naproxen|naproxen|mesh-list
14654477|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14654478|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654479|NCT00222976|Analgesics|analgesics|mesh-ancestor
14654480|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
14654481|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654482|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654483|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654484|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654485|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
14654486|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15184246|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15184247|NCT03904056|Ranibizumab|ranibizumab|mesh-list
15184248|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15184249|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15184250|NCT03904056|Growth Substances|growth substances|mesh-ancestor
15184251|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184252|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
14654487|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654488|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654489|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
14654490|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14654491|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654492|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
14654493|NCT00223015|Tacrolimus|tacrolimus|mesh-list
14654494|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14654495|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
14654496|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654497|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14654498|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654499|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654500|NCT00223028|Sirolimus|sirolimus|mesh-list
14654501|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14654502|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654503|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14654504|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654505|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
14654506|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14654507|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
14654508|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654509|NCT00223054|Cyclosporine|cyclosporine|mesh-list
14654510|NCT00223054|Sirolimus|sirolimus|mesh-list
14654511|NCT00223054|Everolimus|everolimus|mesh-list
15184253|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184254|NCT03903887|Antibodies|antibodies|mesh-list
15184255|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
15184256|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184257|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
15184258|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15184259|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184260|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654512|NCT00223054|Tacrolimus|tacrolimus|mesh-list
14654513|NCT00223054|Cyclosporins|cyclosporins|mesh-list
14654514|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184261|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
15184262|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184263|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184264|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
14654515|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
14654516|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654517|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14654518|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654519|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654520|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
14654521|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654522|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
14654523|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654524|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654525|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14654526|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14654527|NCT00223145|Goserelin|goserelin|mesh-list
14654528|NCT00223145|Bicalutamide|bicalutamide|mesh-list
14654529|NCT00223145|Androgens|androgens|mesh-list
14654530|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14654531|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654532|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
14654533|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
14654534|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14654535|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654536|NCT00223145|Hormones|hormones|mesh-ancestor
14654537|NCT00223171|Androgens|androgens|mesh-list
14654538|NCT00223171|Hormones|hormones|mesh-ancestor
14654539|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14654540|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654541|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14654542|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654543|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654544|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654545|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654546|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654547|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654548|NCT00223223|Levetiracetam|levetiracetam|mesh-list
14654549|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
14654550|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
14654551|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14654552|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
15184265|NCT03903809|Hematinics|hematinics|mesh-ancestor
15184266|NCT03903718|Oseltamivir|oseltamivir|mesh-list
15184267|NCT03903718|MEDI8852|medi8852|mesh-list
15184268|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
15184269|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184270|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184271|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184272|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
15184273|NCT03903783|Cefotaxime|cefotaxime|mesh-list
15184274|NCT03903783|Cefoxitin|cefoxitin|mesh-list
14654553|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654554|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654555|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654556|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654557|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654558|NCT00223275|Naltrexone|naltrexone|mesh-list
14654559|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14654560|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14654561|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654562|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
14654563|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654564|NCT00223288|Citalopram|citalopram|mesh-list
14654565|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14654566|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654567|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654568|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654569|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654570|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
14654571|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654572|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14654573|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
15184275|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15184276|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293407|NCT00568061|Protective Agents|protective agents|mesh-ancestor
14654574|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654575|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
14654576|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14654577|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654578|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14654579|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
14654580|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14654581|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654582|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654583|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654584|NCT00223418|Aripiprazole|aripiprazole|mesh-list
14654585|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654586|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654587|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654588|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654589|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654590|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654591|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
14654592|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
14654593|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654594|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654595|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14654596|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14654597|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
14654598|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14654599|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14654600|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14654601|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14654602|NCT00223509|Lamotrigine|lamotrigine|mesh-list
14654603|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
14654604|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15184277|NCT03903640|Nivolumab|nivolumab|mesh-list
15184278|NCT03903640|Ipilimumab|ipilimumab|mesh-list
15184279|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184280|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184281|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15184282|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654605|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654606|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654607|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654608|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654609|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654610|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654611|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654612|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654613|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14654614|NCT00223548|Mesna|mesna|mesh-list
14654615|NCT00223548|Protective Agents|protective agents|mesh-ancestor
15184283|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15184284|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15184285|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184286|NCT03903367|Fentanyl|fentanyl|mesh-list
15184287|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14654616|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654617|NCT00223561|Methylphenidate|methylphenidate|mesh-list
14654618|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14654619|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654620|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14654621|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654622|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654623|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654624|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
14654625|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654626|NCT00223613|Insulin|insulin|mesh-list
14293408|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
15184288|NCT03903367|Narcotics|narcotics|mesh-ancestor
15184289|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184290|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184291|NCT03903367|Analgesics|analgesics|mesh-ancestor
15184292|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
15184293|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184294|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15184295|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14654627|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14654628|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654629|NCT00223626|Topiramate|topiramate|mesh-list
14654630|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
14654631|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14654632|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654633|NCT00223639|Topiramate|topiramate|mesh-list
14654634|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
14654635|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14654636|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654637|NCT00223691|Acarbose|acarbose|mesh-list
14654638|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
14654639|NCT00223691|Promethazine|promethazine|mesh-list
14654640|NCT00223691|Ibuprofen|ibuprofen|mesh-list
14654641|NCT00223691|Celecoxib|celecoxib|mesh-list
14654642|NCT00223691|Indomethacin|indomethacin|mesh-list
14654643|NCT00223691|Octreotide|octreotide|mesh-list
14654644|NCT00223691|Phenylephrine|phenylephrine|mesh-list
14654645|NCT00223691|Acetazolamide|acetazolamide|mesh-list
14654646|NCT00223691|Midodrine|midodrine|mesh-list
14654647|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
14654648|NCT00223691|Ephedrine|ephedrine|mesh-list
14654649|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
14654650|NCT00223691|Ergotamine|ergotamine|mesh-list
14654651|NCT00223691|Bromides|bromides|mesh-list
14654652|NCT00223691|Levodopa|levodopa|mesh-list
14654653|NCT00223691|Carbidopa|carbidopa|mesh-list
14654654|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14654655|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
14654656|NCT00223691|Methylphenidate|methylphenidate|mesh-list
14654657|NCT00223691|Caffeine|caffeine|mesh-list
14654658|NCT00223691|Modafinil|modafinil|mesh-list
14654659|NCT00223691|Rivastigmine|rivastigmine|mesh-list
14654660|NCT00223691|Ranitidine|ranitidine|mesh-list
14654661|NCT00223691|Yohimbine|yohimbine|mesh-list
14654662|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14654663|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14654664|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14654665|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654666|NCT00223691|Analgesics|analgesics|mesh-ancestor
14654667|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
14654668|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654669|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654670|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654671|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654672|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14654673|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654674|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654675|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14654676|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14654677|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14654678|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654679|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654680|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
14654681|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654682|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14654683|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14654684|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14654685|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
14654686|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
14654687|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14654688|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14654689|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14654690|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14654691|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654692|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14654693|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14654694|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
14654695|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14654696|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14654697|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654698|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
14654699|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
14654700|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
14654701|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
14654702|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14654703|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
14654704|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
14654705|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14654706|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
14654707|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14654708|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14654709|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14654710|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14654711|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
14654712|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
14654713|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14654714|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14654715|NCT00223691|Diuretics|diuretics|mesh-ancestor
14654716|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
14654717|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14654718|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14654719|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14654720|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
14654721|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14654722|NCT00223691|Protective Agents|protective agents|mesh-ancestor
14654723|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
14654724|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14654725|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14654726|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14654727|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14654728|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14654729|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
14654730|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
14654731|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14654732|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14654733|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
14654734|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
14654735|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14654736|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
14654737|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14654738|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14654739|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14654740|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14654741|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14654742|NCT00223691|Urological Agents|urological agents|mesh-ancestor
14654743|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654744|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654745|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14654746|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14654747|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654748|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
14654749|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14654750|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
14654751|NCT00223717|Aspirin|aspirin|mesh-list
14654752|NCT00223717|Losartan|losartan|mesh-list
14654753|NCT00223717|Metoprolol|metoprolol|mesh-list
14654754|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14654755|NCT00223717|Clonidine|clonidine|mesh-list
14654756|NCT00223717|Eplerenone|eplerenone|mesh-list
14654757|NCT00223717|Nebivolol|nebivolol|mesh-list
14654758|NCT00223717|Bosentan|bosentan|mesh-list
14293409|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14293410|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
14293411|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293412|NCT00568087|Expectorants|expectorants|mesh-ancestor
14293413|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14654759|NCT00223717|Diltiazem|diltiazem|mesh-list
14654760|NCT00223717|Guanfacine|guanfacine|mesh-list
14654761|NCT00223717|Prazosin|prazosin|mesh-list
14654762|NCT00223717|Hydralazine|hydralazine|mesh-list
14654763|NCT00223717|Captopril|captopril|mesh-list
14654764|NCT00223717|Nifedipine|nifedipine|mesh-list
14654765|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14654766|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
14654767|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
14654768|NCT00223717|Dipyridamole|dipyridamole|mesh-list
14654769|NCT00223717|Carbidopa|carbidopa|mesh-list
14654770|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
14654771|NCT00223717|Tamsulosin|tamsulosin|mesh-list
14654772|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14654773|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654774|NCT00223717|Analgesics|analgesics|mesh-ancestor
14654775|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
14654776|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293414|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14654777|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654778|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654779|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654780|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14654781|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15184296|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
14654782|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654783|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14654784|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14654785|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654786|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
14654787|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14654788|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14654789|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14654790|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14654791|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
14654792|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14654793|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14654794|NCT00223717|Urological Agents|urological agents|mesh-ancestor
14654795|NCT00223717|Diuretics|diuretics|mesh-ancestor
14654796|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
14654797|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14654798|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654799|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
14654800|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
15184297|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
15184298|NCT03903458|Nivolumab|nivolumab|mesh-list
15184299|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184300|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184301|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15184302|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184303|NCT03903302|Valproic Acid|valproic acid|mesh-list
15184304|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
15184305|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184306|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184307|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
15184308|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184309|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184310|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
15184311|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654801|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14654802|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14654803|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14654804|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
14654805|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654806|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14654807|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14654808|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14654809|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14654810|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15184312|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184313|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184314|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
15184315|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15184316|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15184317|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15184318|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184319|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184320|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
15184321|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184322|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184323|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15184324|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184325|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
15184326|NCT03903185|Ledipasvir|ledipasvir|mesh-list
15184327|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15184328|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
15184329|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654811|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14654812|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14654813|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
14654814|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14654815|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14654816|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654817|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
15184330|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15184331|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15184332|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15184333|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
15184334|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184335|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15184336|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15184337|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654818|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14654819|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14654820|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
14654821|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14654822|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14654823|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14654824|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14654825|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14654826|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
14654827|NCT00223717|Coagulants|coagulants|mesh-ancestor
14654828|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15184338|NCT03903133|Vitamin E|vitamin e|mesh-list
15184339|NCT03903133|Antioxidants|antioxidants|mesh-list
15184340|NCT03903133|Vitamins|vitamins|mesh-ancestor
15184341|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
15184342|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184343|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184344|NCT03903133|Protective Agents|protective agents|mesh-ancestor
15184345|NCT03902912|Prednisolone|prednisolone|mesh-list
15184346|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184347|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
15184348|NCT03902912|Hormones|hormones|mesh-ancestor
15184349|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184350|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184351|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184352|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184353|NCT03902925|Lidocaine|lidocaine|mesh-list
15184354|NCT03902925|Ropivacaine|ropivacaine|mesh-list
14654829|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14654830|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
14654831|NCT00223743|Zonisamide|zonisamide|mesh-list
14654832|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
14654833|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14654834|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654835|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654836|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654837|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654838|NCT00223769|Oxandrolone|oxandrolone|mesh-list
14654839|NCT00223769|Androgens|androgens|mesh-ancestor
14654840|NCT00223769|Hormones|hormones|mesh-ancestor
14654841|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14654842|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654843|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
14654844|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14654845|NCT00223860|Hormones|hormones|mesh-list
14654846|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14654847|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14654848|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184355|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
15184356|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
15184357|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184358|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184359|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
15184360|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293415|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
14293416|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654849|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14654850|NCT00223925|Maribavir|maribavir|mesh-list
15184361|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15184362|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15184363|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14293417|NCT00568087|Protective Agents|protective agents|mesh-ancestor
14293418|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293419|NCT00568087|Antidotes|antidotes|mesh-ancestor
14293420|NCT00568321|Tanezumab|tanezumab|mesh-list
14293421|NCT00568321|Analgesics|analgesics|mesh-ancestor
14293422|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
14293423|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184364|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654851|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
14654852|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654853|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
14654854|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
14654855|NCT00223938|Hematinics|hematinics|mesh-ancestor
14654856|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
14654857|NCT00223964|Hematinics|hematinics|mesh-ancestor
14654858|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
14654859|NCT00224068|Hematinics|hematinics|mesh-ancestor
14654860|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
14654861|NCT00224081|Hematinics|hematinics|mesh-ancestor
14654862|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14654863|NCT00224094|Estrogens|estrogens|mesh-ancestor
14654864|NCT00224094|Hormones|hormones|mesh-ancestor
14654865|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14654866|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654867|NCT00224146|Oxybutynin|oxybutynin|mesh-list
14654868|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
14654869|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
14654870|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654871|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654872|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14654873|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15184365|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223549|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
15223550|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
15223551|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15223552|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223553|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
15223554|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15223555|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223556|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14654874|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
14654875|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654876|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654877|NCT00224146|Urological Agents|urological agents|mesh-ancestor
14725546|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725547|NCT00504400|Ranibizumab|ranibizumab|mesh-list
14725548|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14725549|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14725550|NCT00504400|Growth Substances|growth substances|mesh-ancestor
14725551|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725552|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
14725553|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725554|NCT00504413|Digoxin|digoxin|mesh-list
14725555|NCT00504413|Midazolam|midazolam|mesh-list
14725556|NCT00504413|Methadone|methadone|mesh-list
14725557|NCT00504413|Bupropion|bupropion|mesh-list
14725558|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14725559|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14725560|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14725561|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223557|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15223558|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223559|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223560|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223561|NCT01880567|Rituximab|rituximab|mesh-list
15223562|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15223563|NCT01880567|Antibodies|antibodies|mesh-list
15223564|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
15223565|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15223566|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
15223567|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223568|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725562|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14725563|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14725564|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14725565|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14725566|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
14725567|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
14725568|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
14725569|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
15223569|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725570|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725571|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725572|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14725573|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654878|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14654879|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14654880|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14654881|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654882|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654883|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654884|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654885|NCT00224302|Analgesics|analgesics|mesh-ancestor
14654886|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
14654887|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654888|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
14654889|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654890|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
14654891|NCT00224315|Risperidone|risperidone|mesh-list
14654892|NCT00224315|Ziprasidone|ziprasidone|mesh-list
14654893|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14654894|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
14654895|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654896|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654897|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654898|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654899|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14654900|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654901|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654902|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14654903|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
14654904|NCT00224354|Interleukin-2|interleukin-2|mesh-list
14654905|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
14654906|NCT00224354|Immunotoxins|immunotoxins|mesh-list
14654907|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14654908|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654909|NCT00224354|Analgesics|analgesics|mesh-ancestor
14654910|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
14654911|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654912|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654913|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
14654914|NCT00224393|Etanercept|etanercept|mesh-list
14654915|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14654916|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14654917|NCT00224393|Analgesics|analgesics|mesh-ancestor
14654918|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
14654919|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654920|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654921|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654922|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14654923|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14654924|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14654925|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
14654926|NCT00224419|Nicotine|nicotine|mesh-list
14654927|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14654928|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
14654929|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14654930|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654931|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14654932|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14654933|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
15184366|NCT03902782|Dexamethasone|dexamethasone|mesh-list
15184367|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
15184368|NCT03902782|Epinephrine|epinephrine|mesh-list
15184369|NCT03902782|Bupivacaine|bupivacaine|mesh-list
15184370|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654934|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14654935|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654936|NCT00224445|Ritonavir|ritonavir|mesh-list
14654937|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14654938|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14654939|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14654940|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14654941|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
14654942|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654943|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654944|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14654945|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15184371|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
15184372|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
14654946|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
14654947|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654948|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14654949|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14654950|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14654951|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14654952|NCT00224458|Efavirenz|efavirenz|mesh-list
14654953|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14654954|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14654955|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14654956|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14654957|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654958|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
14654959|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14654960|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14654961|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14654962|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14654963|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14654964|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14654965|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14654966|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14654967|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14654968|NCT00224471|Vaccines|vaccines|mesh-list
14654969|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
14654970|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654971|NCT00224510|Lamotrigine|lamotrigine|mesh-list
14654972|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
14654973|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14654974|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654975|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654976|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654977|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654978|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14654979|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14293424|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293425|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14293426|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
14293427|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14293428|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
14293429|NCT00568399|Antidotes|antidotes|mesh-ancestor
14293430|NCT00568399|Protective Agents|protective agents|mesh-ancestor
14293431|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293432|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
14293433|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293434|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
14293435|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293436|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293437|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
14293438|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
14293439|NCT00568451|Paclitaxel|paclitaxel|mesh-list
14654980|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14654981|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14654982|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14654983|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
14654984|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14654985|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14654986|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14654987|NCT00224549|Amlodipine|amlodipine|mesh-list
14654988|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14654989|NCT00224549|Irbesartan|irbesartan|mesh-list
14654990|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14654991|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14654992|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14654993|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14654994|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14654995|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14654996|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
14654997|NCT00224549|Diuretics|diuretics|mesh-ancestor
14654998|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
14654999|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14655000|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15223570|NCT01842282|Amlexanox|amlexanox|mesh-list
14293440|NCT00568451|Carboplatin|carboplatin|mesh-list
14655001|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14655002|NCT00224588|Ketamine|ketamine|mesh-list
14655003|NCT00224588|Analgesics|analgesics|mesh-ancestor
14655004|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
14655005|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655006|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655007|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14655008|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14655009|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
14655010|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
14655011|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655012|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14655013|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14655014|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655015|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655016|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
14655017|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
14655018|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
14655019|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655020|NCT00224679|Aspirin|aspirin|mesh-list
14655021|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14655022|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655023|NCT00224679|Analgesics|analgesics|mesh-ancestor
14655024|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
14655025|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655026|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655027|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655028|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655029|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14655030|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14655031|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655032|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15184373|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184374|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184375|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184376|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
15184377|NCT03902782|Hormones|hormones|mesh-ancestor
15184378|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655033|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14655034|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655035|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
14655036|NCT00224692|Ketamine|ketamine|mesh-list
14655037|NCT00224692|Analgesics|analgesics|mesh-ancestor
14655038|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
14655039|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655040|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655041|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14655042|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14655043|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
14655044|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
14655045|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655046|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14655047|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14655048|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655049|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655050|NCT00224809|Aspirin|aspirin|mesh-list
14655051|NCT00224809|Spironolactone|spironolactone|mesh-list
15184379|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184380|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184381|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
15184382|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
15184383|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184384|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
15184385|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15184386|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15184387|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
15184388|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184389|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184390|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15184391|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15184392|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15184393|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
15184394|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
15184395|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
15184396|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15184397|NCT03902418|Tenofovir|tenofovir|mesh-list
15184398|NCT03902418|Emtricitabine|emtricitabine|mesh-list
14655052|NCT00224809|Clopidogrel|clopidogrel|mesh-list
14655053|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14655054|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14655055|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14655056|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14655057|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655058|NCT00224809|Analgesics|analgesics|mesh-ancestor
14655059|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
14655060|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655061|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655062|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655063|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655064|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14655065|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14655066|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655067|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14655068|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14655069|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
14655070|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14655071|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14655072|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14655073|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
15184399|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
15184400|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184401|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15184402|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15184403|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655074|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655075|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14655076|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
14655077|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655078|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14655079|NCT00224809|Diuretics|diuretics|mesh-ancestor
14655080|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
14655081|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
14655082|NCT00224822|Aripiprazole|aripiprazole|mesh-list
14655083|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655084|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655085|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14655086|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14655087|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655088|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655089|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
15184404|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184405|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15184406|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15184407|NCT03902522|Leronlimab|leronlimab|mesh-list
15184408|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15184409|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15184410|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184411|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15184412|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15184413|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
15184414|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184415|NCT03902106|Albuterol|albuterol|mesh-list
15184416|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15184417|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
14655090|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
14655091|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655092|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655093|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14655094|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14655095|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
14655096|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14655097|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14655098|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15184418|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184419|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184420|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14655099|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14655100|NCT00224978|Chloroquine|chloroquine|mesh-list
14655101|NCT00224978|Amebicides|amebicides|mesh-ancestor
14655102|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14655103|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14655104|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655105|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
14655106|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655107|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
14655108|NCT00225043|Phenylephrine|phenylephrine|mesh-list
14293441|NCT00568451|Temozolomide|temozolomide|mesh-list
14293442|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14293443|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293444|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
14293445|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
14293446|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
14293447|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293448|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14655109|NCT00225043|Epinephrine|epinephrine|mesh-list
14655110|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
14655111|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14655112|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14655113|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14655114|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655115|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655116|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655117|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14655118|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14655119|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
14655120|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655121|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14655122|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
14655123|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
14655124|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
14655125|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14655126|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14655127|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
14655128|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14655129|NCT00225043|Protective Agents|protective agents|mesh-ancestor
14655130|NCT00225056|Docetaxel|docetaxel|mesh-list
14655131|NCT00225056|Capecitabine|capecitabine|mesh-list
14655132|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655133|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
14655134|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
14655135|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655136|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655137|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655138|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
14655139|NCT00225108|Tinzaparin|tinzaparin|mesh-list
14655140|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14655141|NCT00225108|Dalteparin|dalteparin|mesh-list
14655142|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
14655143|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14655144|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14655145|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655146|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
14655147|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
14655148|NCT00225160|Vitamins|vitamins|mesh-ancestor
14655149|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
14655150|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655151|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
14655152|NCT00225173|Gemcitabine|gemcitabine|mesh-list
14655153|NCT00225173|Prednisone|prednisone|mesh-list
14655154|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
14655155|NCT00225173|Doxorubicin|doxorubicin|mesh-list
14655156|NCT00225173|Etoposide|etoposide|mesh-list
14655157|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
14655158|NCT00225173|Vincristine|vincristine|mesh-list
14655159|NCT00225173|Vinorelbine|vinorelbine|mesh-list
14655160|NCT00225173|Bleomycin|bleomycin|mesh-list
14655161|NCT00225173|Vinblastine|vinblastine|mesh-list
14655162|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655163|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
14655164|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655165|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655166|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14655167|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
14655168|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655169|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655170|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14655171|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655172|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
14655173|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
14655174|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184421|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
15184422|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
15184423|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184424|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15184425|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15184426|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15184427|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
15184428|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184429|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184430|NCT03902340|Analgesics|analgesics|mesh-list
15184431|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
15184432|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184433|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184434|NCT03902249|Dexamethasone|dexamethasone|mesh-list
15184435|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184436|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
15184437|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
15184438|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184439|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184440|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184441|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
14293449|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
14655175|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655176|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14655177|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14655178|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14655179|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655180|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
14655181|NCT00225173|Hormones|hormones|mesh-ancestor
14655182|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655183|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14655184|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14655185|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
14655186|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
14655187|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655188|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
14655189|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14655190|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655191|NCT00225238|Esomeprazole|esomeprazole|mesh-list
14655192|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14655193|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14655194|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14655195|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655196|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655197|NCT00225264|Pioglitazone|pioglitazone|mesh-list
14655198|NCT00225264|Glimepiride|glimepiride|mesh-list
14655199|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14655200|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655201|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14655202|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655203|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
14655204|NCT00225290|Thalidomide|thalidomide|mesh-list
14655205|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655206|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
14655207|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655208|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
14655209|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14655210|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655211|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14293450|NCT00568555|Naltrexone|naltrexone|mesh-list
14293451|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14293452|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14293453|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293454|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
14293455|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293456|NCT00568633|Cyclosporine|cyclosporine|mesh-list
14655212|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14655213|NCT00225290|Growth Substances|growth substances|mesh-ancestor
15184442|NCT03902249|Hormones|hormones|mesh-ancestor
14293457|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
14655214|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
14293458|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
14293459|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14293460|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14293461|NCT00568633|Prednisolone|prednisolone|mesh-list
14293462|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
14655215|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655216|NCT00225303|Etravirine|etravirine|mesh-list
15184443|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184444|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14655217|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14655218|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14655219|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655220|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655221|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
14655222|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655223|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
14655224|NCT00225342|Gliclazide|gliclazide|mesh-list
14655225|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14655226|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655227|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
14655228|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14655229|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655230|NCT00225381|Anesthetics|anesthetics|mesh-list
14655231|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655232|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655233|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14655234|NCT00225433|Ganirelix|ganirelix|mesh-list
14655235|NCT00225433|Hormones|hormones|mesh-ancestor
14655236|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655237|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655238|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
14655239|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14655240|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14655241|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14655242|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655243|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655244|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655245|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655246|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14655247|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655248|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655249|NCT00225511|Milnacipran|milnacipran|mesh-list
14655250|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14655251|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
14655252|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14655253|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14655254|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655255|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655256|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655257|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655258|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14655259|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655260|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655261|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655262|NCT00225511|Analgesics|analgesics|mesh-ancestor
14655263|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
14655264|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655265|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14655266|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14655267|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14655268|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655269|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655270|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655271|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655272|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14655273|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655274|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655275|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14655276|NCT00225589|Calcium|calcium|mesh-list
15184445|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293463|NCT00568633|Cyclosporins|cyclosporins|mesh-list
14655277|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14655278|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655279|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14655280|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14655281|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
14655282|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655283|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14655284|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14655285|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655286|NCT00225615|Verapamil|verapamil|mesh-list
14655287|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14655288|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14655289|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655290|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655291|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14655292|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655293|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
14655294|NCT00225667|Irbesartan|irbesartan|mesh-list
14655295|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14655296|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14655297|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14655298|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725574|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14725575|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14725576|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14725577|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
14725578|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14725579|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14725580|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725581|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14725582|NCT00504413|Narcotics|narcotics|mesh-ancestor
14725583|NCT00504413|Analgesics|analgesics|mesh-ancestor
14725584|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
14725585|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725586|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
14725587|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
14725588|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14725589|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14725590|NCT00504413|Protective Agents|protective agents|mesh-ancestor
14725591|NCT00504439|Simvastatin|simvastatin|mesh-list
14725592|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14725593|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15184446|NCT03901716|Fentanyl|fentanyl|mesh-list
15184447|NCT03901716|Midazolam|midazolam|mesh-list
15184448|NCT03901716|Sufentanil|sufentanil|mesh-list
15184449|NCT03901716|Remifentanil|remifentanil|mesh-list
15184450|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15184451|NCT03901716|Narcotics|narcotics|mesh-ancestor
15184452|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184453|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184454|NCT03901716|Analgesics|analgesics|mesh-ancestor
15184455|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
15184456|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293464|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
14293465|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14293466|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14293467|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
14293468|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725594|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
14725595|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725596|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14725597|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14725598|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725599|NCT00504465|Dinoprostone|dinoprostone|mesh-list
14725600|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
14725601|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725602|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725603|NCT00504491|Rituximab|rituximab|mesh-list
14725604|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
14725605|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14725606|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725607|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
15184457|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14293469|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655299|NCT00225706|Ibuprofen|ibuprofen|mesh-list
14655300|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14655301|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655302|NCT00225706|Analgesics|analgesics|mesh-ancestor
14655303|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
14655304|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655305|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184458|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15184459|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
15184460|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
15184461|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15184462|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14655306|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655307|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655308|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14655309|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655310|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655311|NCT00225797|Oxymorphone|oxymorphone|mesh-list
14655312|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14655313|NCT00225797|Narcotics|narcotics|mesh-ancestor
14655314|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655315|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655316|NCT00225797|Analgesics|analgesics|mesh-ancestor
14655317|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
14655318|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655319|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14655320|NCT00225849|Aspirin|aspirin|mesh-list
14655321|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14655322|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655323|NCT00225849|Analgesics|analgesics|mesh-ancestor
14655324|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
14655325|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655326|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655327|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655328|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655329|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14655330|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14655331|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655332|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14655333|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14655334|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655335|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
14655336|NCT00225862|Ropinirole|ropinirole|mesh-list
14655337|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14655338|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14655339|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
14655340|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
14655341|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655342|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655343|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655344|NCT00225875|Rituximab|rituximab|mesh-list
14655345|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14655346|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655347|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
14655348|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655349|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655350|NCT00225901|Mitogens|mitogens|mesh-list
14655351|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655352|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655353|NCT00225914|Paroxetine|paroxetine|mesh-list
14655354|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14655355|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14655356|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655357|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655358|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655359|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
14655360|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655361|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14655362|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655363|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655364|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14655365|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14655366|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184463|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14655367|NCT00225979|Octreotide|octreotide|mesh-list
14655368|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14655369|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14655370|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655371|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
14655372|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655373|NCT00226005|Vatalanib|vatalanib|mesh-list
14655374|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14655375|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655376|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655377|NCT00226044|Omeprazole|omeprazole|mesh-list
14655378|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14655379|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14655380|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14655381|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655382|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655383|NCT00226096|Metoprolol|metoprolol|mesh-list
14655384|NCT00226096|Clonidine|clonidine|mesh-list
14655385|NCT00226096|Nitroprusside|nitroprusside|mesh-list
14655386|NCT00226096|Hydralazine|hydralazine|mesh-list
14655387|NCT00226096|Labetalol|labetalol|mesh-list
14655388|NCT00226096|Nicardipine|nicardipine|mesh-list
14655389|NCT00226096|Phentolamine|phentolamine|mesh-list
14293470|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293471|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
14293472|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293473|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
14293474|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293475|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
14293476|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293477|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14293478|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14293479|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655390|NCT00226096|Urapidil|urapidil|mesh-list
14655391|NCT00226096|Enalaprilat|enalaprilat|mesh-list
14655392|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
14655393|NCT00226096|Esmolol|esmolol|mesh-list
14655394|NCT00226096|Glycerol|glycerol|mesh-list
14655395|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14655396|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14655397|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
14655398|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
14655399|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655400|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655401|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14655402|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14655403|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14655404|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
14655405|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655406|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655407|NCT00226096|Analgesics|analgesics|mesh-ancestor
14655408|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
14655409|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14655410|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14655411|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14655412|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
14655413|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14655414|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14655415|NCT00226096|Protective Agents|protective agents|mesh-ancestor
14655416|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
14655417|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14655418|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14655419|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14655420|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655421|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14655422|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14655423|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
14655424|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14655425|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
14655426|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655427|NCT00226109|Spironolactone|spironolactone|mesh-list
14293480|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14655428|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14293481|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
14655429|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
14655430|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184464|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655431|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655432|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15184465|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
15184466|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
15184467|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184468|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184469|NCT03901612|Ropivacaine|ropivacaine|mesh-list
15184470|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
15184471|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
15184472|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184473|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184474|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
15184475|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184476|NCT03901768|Dexamethasone|dexamethasone|mesh-list
15184477|NCT03901768|Triamcinolone|triamcinolone|mesh-list
14655433|NCT00226109|Diuretics|diuretics|mesh-ancestor
14655434|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
14655435|NCT00226122|Indomethacin|indomethacin|mesh-list
14655436|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14655437|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655438|NCT00226122|Analgesics|analgesics|mesh-ancestor
14655439|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
14655440|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655441|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655442|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655443|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655444|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
14655445|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
14655446|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14655447|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14655448|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655449|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655450|NCT00226135|Lamotrigine|lamotrigine|mesh-list
14655451|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655452|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655453|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14655454|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655455|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655456|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
14655457|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14655458|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655459|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14655460|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14655461|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14655462|NCT00226200|Omalizumab|omalizumab|mesh-list
14655463|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14655464|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14655465|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
14655466|NCT00226317|Aripiprazole|aripiprazole|mesh-list
14655467|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655468|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184478|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184479|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
15184480|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
15184481|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184482|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184483|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184484|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
15184485|NCT03901768|Hormones|hormones|mesh-ancestor
15184486|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184487|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184488|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184489|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
15184490|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15184491|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
15184492|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
15184493|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184494|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184495|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184496|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15184497|NCT03901482|Analgesics|analgesics|mesh-ancestor
14655469|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15184498|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
15184499|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655470|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15184500|NCT03901690|Imiquimod|imiquimod|mesh-list
15184501|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15184502|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
15184503|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184504|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184505|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
15184506|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
14293482|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293483|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293484|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
14293485|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
14293486|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655471|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655472|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655473|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
14655474|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
14655475|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655476|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655477|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14655478|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14655479|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
14655480|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14655481|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14655482|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14655483|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14655484|NCT00226330|Pioglitazone|pioglitazone|mesh-list
14655485|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14655486|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655487|NCT00226343|Valproic Acid|valproic acid|mesh-list
14655488|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
14655489|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655490|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655491|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
14655492|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655493|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655494|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
14655495|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14655496|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655497|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655498|NCT00226356|Betaine|betaine|mesh-list
14655499|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14655500|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
14655501|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14655502|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
14655503|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655504|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14655505|NCT00226382|Interferons|interferons|mesh-list
14655506|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
14655507|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
14655508|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14655509|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655510|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
14655511|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655512|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
14655513|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655514|NCT00226395|Oxymorphone|oxymorphone|mesh-list
14655515|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14655516|NCT00226395|Narcotics|narcotics|mesh-ancestor
14655517|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655518|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655519|NCT00226395|Analgesics|analgesics|mesh-ancestor
14655520|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
14655521|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655522|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14655523|NCT00226408|Interferons|interferons|mesh-list
14655524|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
14655525|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
14655526|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655527|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
14655528|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655529|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
14655530|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655531|NCT00226421|Oxymorphone|oxymorphone|mesh-list
14655532|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14655533|NCT00226421|Narcotics|narcotics|mesh-ancestor
14655534|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184507|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14655535|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655536|NCT00226421|Analgesics|analgesics|mesh-ancestor
14655537|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
14655538|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655539|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14655540|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14655541|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
14655542|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655543|NCT00226447|Interferons|interferons|mesh-list
14655544|NCT00226447|Lamivudine|lamivudine|mesh-list
14293487|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293488|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
14293489|NCT00568633|Hormones|hormones|mesh-ancestor
14655545|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655546|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
14655547|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655548|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14655549|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14655550|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655551|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655552|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14655553|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14655554|NCT00226473|Dacarbazine|dacarbazine|mesh-list
14655555|NCT00226473|Vindesine|vindesine|mesh-list
14655556|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655557|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14655558|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
14655559|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655560|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14655561|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
14655562|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
14655563|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655564|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
14655565|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14655566|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655567|NCT00226538|Fluconazole|fluconazole|mesh-list
14655568|NCT00226538|Rifampin|rifampin|mesh-list
14655569|NCT00226538|Diclofenac|diclofenac|mesh-list
14655570|NCT00226538|Phenytoin|phenytoin|mesh-list
14655571|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14655572|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655573|NCT00226538|Analgesics|analgesics|mesh-ancestor
14655574|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
14655575|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655576|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655577|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655578|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655579|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14655580|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655581|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655582|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
14655583|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655584|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14655585|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14655586|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14655587|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
14655588|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655589|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14655590|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14655591|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14655592|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
14655593|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14655594|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
15184508|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223571|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15223572|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
14293490|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293491|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15223573|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
15223574|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223575|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223576|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15223577|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
15223578|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655595|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14655596|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14655597|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14655598|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14655599|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14655600|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14655601|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14655602|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
14655603|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14655604|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14655605|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655606|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14655607|NCT00226551|Isoproterenol|isoproterenol|mesh-list
14655608|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14655609|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14655610|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
14655611|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655612|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655613|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655614|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14655615|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
14655616|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655617|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14655618|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
15184509|NCT03901118|Paclitaxel|paclitaxel|mesh-list
15184510|NCT03901118|Etoposide|etoposide|mesh-list
15184511|NCT03901118|Chiauranib|chiauranib|mesh-list
14655619|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14655620|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
14655621|NCT00226551|Protective Agents|protective agents|mesh-ancestor
14655622|NCT00226564|Alfentanil|alfentanil|mesh-list
14655623|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14655624|NCT00226564|Narcotics|narcotics|mesh-ancestor
14655625|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655626|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655627|NCT00226564|Analgesics|analgesics|mesh-ancestor
14655628|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
14655629|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655630|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14655631|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
14655632|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
14655633|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14655634|NCT00226668|Hormones|hormones|mesh-ancestor
14655635|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655636|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655637|NCT00226694|Citalopram|citalopram|mesh-list
14655638|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14655639|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14655640|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655641|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655642|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655643|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
14655644|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655645|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14655646|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655647|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655648|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
14655649|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14655650|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655651|NCT00226707|Analgesics|analgesics|mesh-ancestor
14814595|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184512|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15184513|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184514|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
15184515|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
15184516|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
15184517|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184518|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15184519|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15184520|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184521|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15184522|NCT03901170|Letrozole|letrozole|mesh-list
15223579|NCT01622335|Analgesics|analgesics|mesh-ancestor
14655652|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
14655653|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655654|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655655|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655656|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655657|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14655658|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655659|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
14655660|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14655661|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655662|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655663|NCT00226746|Gemcitabine|gemcitabine|mesh-list
14655664|NCT00226746|Paclitaxel|paclitaxel|mesh-list
14655665|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14655666|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184523|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184524|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15184525|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14655667|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
14655668|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
14655669|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655670|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655671|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655672|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
14655673|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
14655674|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655675|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655676|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655677|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
14655678|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655679|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
14655680|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14655681|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655682|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655683|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655684|NCT00226785|Analgesics|analgesics|mesh-ancestor
14655685|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
14655686|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655687|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14655688|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14655689|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14655690|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
14655691|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655692|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655693|NCT00226798|Capecitabine|capecitabine|mesh-list
14655694|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655695|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
14655696|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655697|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655698|NCT00226824|Galantamine|galantamine|mesh-list
14655699|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14655700|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655701|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655702|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
14655703|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655704|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655705|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14655706|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
14655707|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655708|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
14655709|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
15184526|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184527|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184528|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15184529|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
15184530|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655710|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14655711|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
14655712|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
14655713|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655714|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655715|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14655716|NCT00226837|Analgesics|analgesics|mesh-ancestor
14655717|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
14655718|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655719|NCT00226889|Bosentan|bosentan|mesh-list
14655720|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14655721|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14655722|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655723|NCT00226915|Paclitaxel|paclitaxel|mesh-list
14655724|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14655725|NCT00226915|Carboplatin|carboplatin|mesh-list
14655726|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14655727|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655728|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
14655729|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
14655730|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655731|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655732|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
14655733|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14655734|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655735|NCT00226967|Octreotide|octreotide|mesh-list
14655736|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14655737|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14655738|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655739|NCT00226980|Thalidomide|thalidomide|mesh-list
14655740|NCT00226980|Capecitabine|capecitabine|mesh-list
14655741|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655742|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
14655743|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655744|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655745|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655746|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
14655747|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655748|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
14655749|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14655750|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655751|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14655752|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14655753|NCT00226980|Growth Substances|growth substances|mesh-ancestor
14655754|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
14655755|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14655756|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655757|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14655758|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655759|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655760|NCT00227084|Hemostatics|hemostatics|mesh-list
14655761|NCT00227084|Coagulants|coagulants|mesh-ancestor
14655762|NCT00227097|Anticoagulants|anticoagulants|mesh-list
14655763|NCT00227110|Pioglitazone|pioglitazone|mesh-list
14655764|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14655765|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655766|NCT00227123|Risperidone|risperidone|mesh-list
14655767|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14655768|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14655769|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
14655770|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655771|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655772|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655773|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14655774|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14655775|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655776|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184531|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184532|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
14293492|NCT00568633|Protective Agents|protective agents|mesh-ancestor
14655777|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14655778|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
14655779|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655780|NCT00227136|Serotonin|serotonin|mesh-list
15184533|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15184534|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
15184535|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184536|NCT03900988|Expectorants|expectorants|mesh-ancestor
15184537|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
15184538|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14655781|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14655782|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
14655783|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184539|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
15184540|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184541|NCT03900988|Protective Agents|protective agents|mesh-ancestor
14655784|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655785|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655786|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14655787|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
14655788|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725608|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725609|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725610|NCT00504543|Everolimus|everolimus|mesh-list
14725611|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725612|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
14725613|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725614|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725615|NCT00504634|Bortezomib|bortezomib|mesh-list
14725616|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725617|NCT00504673|Insulin|insulin|mesh-list
14725618|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14725619|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
14725620|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
14725621|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
14725622|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
14725623|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
14725624|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14725625|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725626|NCT00504712|Testosterone|testosterone|mesh-list
14725627|NCT00504712|Androgens|androgens|mesh-ancestor
14725628|NCT00504712|Hormones|hormones|mesh-ancestor
14725629|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725630|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725631|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
14725632|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184542|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184543|NCT03900988|Antidotes|antidotes|mesh-ancestor
15184544|NCT03901001|Sirolimus|sirolimus|mesh-list
15184545|NCT03901001|Oseltamivir|oseltamivir|mesh-list
15184546|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15184547|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184548|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15184549|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184550|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
15184551|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184552|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
15184553|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184554|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
15184555|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184556|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184557|NCT03900949|Cytarabine|cytarabine|mesh-list
15184558|NCT03900949|Daunorubicin|daunorubicin|mesh-list
14725633|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14725634|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14725635|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14725636|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14725637|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
14725638|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725639|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725640|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14725641|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14725642|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14725643|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14725644|NCT00504855|Calpastatin|calpastatin|mesh-list
14725645|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14725646|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14725647|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725648|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725649|NCT00504933|Cetirizine|cetirizine|mesh-list
14725650|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14725651|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14725652|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15184559|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
15184560|NCT03900949|Midostaurin|midostaurin|mesh-list
14655789|NCT00227253|Hormones|hormones|mesh-list
14655790|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655791|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655792|NCT00227292|Citalopram|citalopram|mesh-list
14655793|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14655794|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14655795|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655796|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655797|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655798|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
14655799|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655800|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14655801|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655802|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655803|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
14655804|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14655805|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14655806|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14655807|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655808|NCT00227331|Amoxicillin|amoxicillin|mesh-list
14655809|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14655810|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655811|NCT00227357|Buprenorphine|buprenorphine|mesh-list
14655812|NCT00227357|Methadone|methadone|mesh-list
14655813|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14655814|NCT00227357|Naloxone|naloxone|mesh-list
14655815|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14655816|NCT00227357|Narcotics|narcotics|mesh-ancestor
14655817|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14655818|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655819|NCT00227357|Analgesics|analgesics|mesh-ancestor
14655820|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
14655821|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655822|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14655823|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
14655824|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14655825|NCT00227409|Edetic Acid|edetic acid|mesh-list
14655826|NCT00227409|Calcium|calcium|mesh-list
14655827|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
14655828|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14655829|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655830|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
14655831|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14655832|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
14655833|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
14655834|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655835|NCT00227409|Antidotes|antidotes|mesh-ancestor
14655836|NCT00227409|Protective Agents|protective agents|mesh-ancestor
14655837|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14655838|NCT00227448|Phenylephrine|phenylephrine|mesh-list
14655839|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
14655840|NCT00227448|Midodrine|midodrine|mesh-list
14655841|NCT00227448|Norepinephrine|norepinephrine|mesh-list
14655842|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14655843|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
14655844|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
14655845|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184561|NCT03900949|Calicheamicins|calicheamicins|mesh-list
15184562|NCT03900949|Staurosporine|staurosporine|mesh-list
15184563|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15184564|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
15184565|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184566|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184567|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
15184568|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184569|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655846|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655847|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
14655848|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14655849|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
14655850|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
15184570|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
15184571|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184572|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14655851|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14655852|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14655853|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14655854|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
14655855|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655856|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655857|NCT00227448|Protective Agents|protective agents|mesh-ancestor
14655858|NCT00227461|Levetiracetam|levetiracetam|mesh-list
14655859|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
14655860|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
14655861|NCT00227474|Vaccines|vaccines|mesh-list
14655862|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
14655863|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655864|NCT00227500|Pravastatin|pravastatin|mesh-list
14655865|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14655866|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14655867|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
14655868|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655869|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14655870|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14655871|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655872|NCT00227513|Bortezomib|bortezomib|mesh-list
14655873|NCT00227513|Vorinostat|vorinostat|mesh-list
14655874|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655875|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14655876|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655877|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655878|NCT00227565|Carboplatin|carboplatin|mesh-list
14655879|NCT00227565|Pemetrexed|pemetrexed|mesh-list
14655880|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655881|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655882|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655883|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14655884|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14655885|NCT00227630|Pemetrexed|pemetrexed|mesh-list
14655886|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655887|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655888|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655889|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14655890|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14655891|NCT00227656|Interferons|interferons|mesh-list
14655892|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
14655893|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
14655894|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14655895|NCT00227656|Capecitabine|capecitabine|mesh-list
14655896|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655897|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
14655898|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655899|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655900|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
15184573|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15184574|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15184575|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184576|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184577|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15184578|NCT03900871|Aspirin|aspirin|mesh-list
15184579|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15184580|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15184581|NCT03900871|Analgesics|analgesics|mesh-ancestor
15184582|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
15184583|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184584|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184585|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655901|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655902|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
14655903|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655904|NCT00227669|Gemcitabine|gemcitabine|mesh-list
14655905|NCT00227669|Docetaxel|docetaxel|mesh-list
14655906|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655907|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
14655908|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655909|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184586|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15184587|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15184588|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15184589|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184590|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14655910|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
14655911|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655912|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655913|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655914|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
14655915|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655916|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14655917|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14655918|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655919|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
14655920|NCT00227682|Thalidomide|thalidomide|mesh-list
14655921|NCT00227682|Dexamethasone|dexamethasone|mesh-list
14655922|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
14655923|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14655924|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
14655925|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
14655926|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14655927|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655928|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14655929|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
14655930|NCT00227682|Hormones|hormones|mesh-ancestor
14655931|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655932|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14655933|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655934|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14655935|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
14655936|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
14655937|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14655938|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14655939|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14655940|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14655941|NCT00227682|Growth Substances|growth substances|mesh-ancestor
14655942|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
14655943|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
14655944|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655945|NCT00227682|Protective Agents|protective agents|mesh-ancestor
14655946|NCT00227682|Vitamins|vitamins|mesh-ancestor
14655947|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
14655948|NCT00227695|Rituximab|rituximab|mesh-list
14655949|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293493|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14655950|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655951|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
15184591|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15184592|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184593|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
14655952|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184594|NCT03900858|Isoniazid|isoniazid|mesh-list
15184595|NCT03900858|Rifapentine|rifapentine|mesh-list
15184596|NCT03900858|Rifampin|rifampin|mesh-list
14655953|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14655954|NCT00227708|Docetaxel|docetaxel|mesh-list
14655955|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655956|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14655957|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14655958|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655959|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655960|NCT00227734|Capecitabine|capecitabine|mesh-list
14655961|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
14655962|NCT00227734|Cetuximab|cetuximab|mesh-list
14655963|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655964|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
14655965|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655966|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655967|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14655968|NCT00227747|Capecitabine|capecitabine|mesh-list
14655969|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
14655970|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14655971|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
14655972|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655973|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655974|NCT00227773|Octreotide|octreotide|mesh-list
14655975|NCT00227773|Hormones|hormones|mesh-list
14655976|NCT00227773|Somatostatin|somatostatin|mesh-list
14655977|NCT00227773|Mitogens|mitogens|mesh-list
14655978|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14655979|NCT00227773|Vatalanib|vatalanib|mesh-list
14655980|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14655981|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655982|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
14655983|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14655984|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14655985|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14655986|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14655987|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14655988|NCT00227812|Bupropion|bupropion|mesh-list
14655989|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14655990|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
14655991|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14655992|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14655993|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14655994|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14655995|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184597|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
15184598|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15184599|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184600|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15184601|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15184602|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
15184603|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184604|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15184605|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15184606|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
15184607|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15184608|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14655996|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
14655997|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14655998|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14655999|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14656000|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14656001|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656002|NCT00227942|Zolpidem|zolpidem|mesh-list
14656003|NCT00227942|Estrogens|estrogens|mesh-list
14656004|NCT00227942|Hormones|hormones|mesh-ancestor
14656005|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656006|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656007|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14656008|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14656009|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656010|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14656011|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
14656012|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
14656013|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184609|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14656014|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656015|NCT00227955|Imipramine|imipramine|mesh-list
14656016|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14656017|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656018|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656019|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14656020|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656021|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656022|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184610|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15184611|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15184612|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15184613|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15184614|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14656023|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
14656024|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656025|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656026|NCT00227981|Fluoxetine|fluoxetine|mesh-list
14656027|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14656028|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656029|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656030|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656031|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656032|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
14656033|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656034|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14656035|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656036|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184615|NCT03900624|Dexamethasone|dexamethasone|mesh-list
15184616|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184617|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
15184618|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
15184619|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656037|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14656038|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14656039|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656040|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
14656041|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656042|NCT00228020|Cyclosporine|cyclosporine|mesh-list
14656043|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
14656044|NCT00228020|Prednisone|prednisone|mesh-list
14656045|NCT00228020|Cyclosporins|cyclosporins|mesh-list
14656046|NCT00228020|Basiliximab|basiliximab|mesh-list
14656047|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656048|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
14656049|NCT00228020|Hormones|hormones|mesh-ancestor
14656050|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656051|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656052|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14656053|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656054|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656055|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656056|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656057|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
14656058|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
14656059|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656060|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
14656061|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656062|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14656063|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14656064|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14656065|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
14656066|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656067|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
14656068|NCT00228033|Calcium|calcium|mesh-list
14656069|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14656070|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656071|NCT00228033|Antacids|antacids|mesh-ancestor
14656072|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656073|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184620|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656074|NCT00228046|Valproic Acid|valproic acid|mesh-list
14656075|NCT00228046|Methylphenidate|methylphenidate|mesh-list
14656076|NCT00228046|Amphetamine|amphetamine|mesh-list
14656077|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
14656078|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14656079|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656080|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14656081|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656082|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656083|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656084|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
14656085|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656086|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
14656087|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
14656088|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656089|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
14656090|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14656091|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
14656092|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656093|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
14656094|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
14656095|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14656096|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656097|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656098|NCT00228163|Teriflunomide|teriflunomide|mesh-list
14656099|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14656100|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14656101|NCT00228163|Analgesics|analgesics|mesh-ancestor
14656102|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
14656103|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656104|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656105|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656106|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656107|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656108|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
14656109|NCT00228228|Vaccines|vaccines|mesh-list
14656110|NCT00228228|Immunologic Factors|immunologic factors|mesh-ancestor
14656111|NCT00228228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656112|NCT00228254|Vitamin A|vitamin a|mesh-list
14656113|NCT00228254|Vitamins|vitamins|mesh-ancestor
14656114|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
14656115|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656116|NCT00228267|Propofol|propofol|mesh-list
14656117|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14656118|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656119|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656120|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14656121|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
14656122|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
14656123|NCT00228319|Vitamins|vitamins|mesh-list
14656124|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
14656125|NCT00228319|Vitamin E|vitamin e|mesh-list
14656126|NCT00228319|Vitamin A|vitamin a|mesh-list
14656127|NCT00228319|Carboplatin|carboplatin|mesh-list
14656128|NCT00228319|Carotenoids|carotenoids|mesh-list
14656129|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656130|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656131|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
14656132|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656133|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
14656134|NCT00228319|Protective Agents|protective agents|mesh-ancestor
14656135|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
14656136|NCT00228358|Interleukin-2|interleukin-2|mesh-list
14656137|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
14656138|NCT00228358|Immunotoxins|immunotoxins|mesh-list
14656139|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656140|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
14656141|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656142|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656143|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14656144|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
14656145|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656146|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656147|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14656148|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15184621|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184622|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
15184623|NCT03900624|Hormones|hormones|mesh-ancestor
15184624|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184625|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14656149|NCT00228358|Analgesics|analgesics|mesh-ancestor
14656150|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
14656151|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656152|NCT00228397|Sirolimus|sirolimus|mesh-list
14656153|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656154|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656155|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14656156|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656157|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
14656158|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656159|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
14656160|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656161|NCT00228410|Vancomycin|vancomycin|mesh-list
14656162|NCT00228410|Tigecycline|tigecycline|mesh-list
14656163|NCT00228410|Aztreonam|aztreonam|mesh-list
14656164|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656165|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656166|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14656167|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656168|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656169|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14656170|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656171|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656172|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14656173|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14656174|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656175|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656176|NCT00228475|Budesonide|budesonide|mesh-list
14656177|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656178|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14656179|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
14656180|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656181|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656182|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14656183|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
14656184|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
14656185|NCT00228475|Hormones|hormones|mesh-ancestor
14656186|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656187|NCT00228488|Gefitinib|gefitinib|mesh-list
14656188|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656189|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14656190|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656191|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656192|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14656193|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14656194|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14656195|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
14656196|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656197|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14656198|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14656199|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656200|NCT00228527|Esomeprazole|esomeprazole|mesh-list
14656201|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14656202|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14656203|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14656204|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656205|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656206|NCT00228540|Modafinil|modafinil|mesh-list
14656207|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14656208|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656209|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14656210|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15184626|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184627|NCT03900637|Letrozole|letrozole|mesh-list
15184628|NCT03900637|Leuprolide|leuprolide|mesh-list
15184629|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184630|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14656211|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14656212|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656213|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
14656214|NCT00228592|Antibodies|antibodies|mesh-list
14656215|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
14656216|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14656217|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14656218|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
14656219|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656220|NCT00228605|Fentanyl|fentanyl|mesh-list
14656221|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14656222|NCT00228605|Narcotics|narcotics|mesh-ancestor
14656223|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656224|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656225|NCT00228605|Analgesics|analgesics|mesh-ancestor
14656226|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
14656227|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656228|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14656229|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14656230|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
14656231|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
14656232|NCT00228839|Infliximab|infliximab|mesh-list
14656233|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14656234|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14656235|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656236|NCT00228852|Fludarabine|fludarabine|mesh-list
14656237|NCT00228852|Busulfan|busulfan|mesh-list
14656238|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656239|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656240|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656241|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
14656242|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656243|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
14656244|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14656245|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14656246|NCT00228865|Insulin|insulin|mesh-list
14656247|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14656248|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
14656249|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656250|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656251|NCT00228878|Insulin|insulin|mesh-list
14656252|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
14656253|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656254|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656255|NCT00228891|Insulin|insulin|mesh-list
14656256|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14656257|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656258|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656259|NCT00228904|Insulin|insulin|mesh-list
14656260|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
14656261|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
14656262|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15184631|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14656263|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656264|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656265|NCT00228930|Tamoxifen|tamoxifen|mesh-list
15184632|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184633|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184634|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14656266|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14656267|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
14656268|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656269|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656270|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14656271|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656272|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14656273|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14656274|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15184635|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
15184636|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184637|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184638|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15184639|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
15184640|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725653|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
14725654|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
15184641|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184642|NCT03900377|Rituximab|rituximab|mesh-list
14656275|NCT00228982|Vancomycin|vancomycin|mesh-list
14656276|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
14656277|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14656278|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656279|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656280|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
14656281|NCT00228995|Hematinics|hematinics|mesh-ancestor
14656282|NCT00229060|Doripenem|doripenem|mesh-list
14656283|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656284|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656285|NCT00229112|Tazobactam|tazobactam|mesh-list
14656286|NCT00229112|Piperacillin|piperacillin|mesh-list
14656287|NCT00229112|Ertapenem|ertapenem|mesh-list
14656288|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14656289|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656290|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656291|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656292|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14656293|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656294|NCT00229125|Gabapentin|gabapentin|mesh-list
14656295|NCT00229125|Lorazepam|lorazepam|mesh-list
14656296|NCT00229125|Analgesics|analgesics|mesh-ancestor
14656297|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
14656298|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656299|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656300|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
14656301|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14656302|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14656303|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656304|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656305|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14656306|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14656307|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656308|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656309|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
14656310|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
14656311|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
14656312|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14656313|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14656314|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
14656315|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
14656316|NCT00229138|Tacrolimus|tacrolimus|mesh-list
14656317|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656318|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
14656319|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656320|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14656321|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656322|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656323|NCT00229216|Tinidazole|tinidazole|mesh-list
15184643|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184644|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184645|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
15184646|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184647|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15184648|NCT03900026|Evolocumab|evolocumab|mesh-list
15184649|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15184650|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15184651|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
15184652|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184653|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15184654|NCT03899675|Caffeine|caffeine|mesh-list
15184655|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15184656|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656324|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
14656325|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656326|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656327|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656328|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14656329|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14656330|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14656331|NCT00229242|Diuretics|diuretics|mesh-list
14656332|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
14656333|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656334|NCT00229333|Citalopram|citalopram|mesh-list
14656335|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14656336|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656337|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656338|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656339|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656340|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
14656341|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656342|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14656343|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656344|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656345|NCT00229385|Ziprasidone|ziprasidone|mesh-list
14656346|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14656347|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
14656348|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656349|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656350|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656351|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14656352|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14656353|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656354|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656355|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14656356|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
14656357|NCT00229424|Famotidine|famotidine|mesh-list
14656358|NCT00229424|Lafutidine|lafutidine|mesh-list
14656359|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14656360|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14656361|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14656362|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
14656363|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
14656364|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656365|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656366|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656367|NCT00229450|Estrogens|estrogens|mesh-list
14656368|NCT00229450|Hormones|hormones|mesh-ancestor
14656369|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656370|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656371|NCT00229476|Sertraline|sertraline|mesh-list
14656372|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656373|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184657|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15184658|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184659|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184660|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15184661|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15184662|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
15184663|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656374|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14656375|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656376|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656377|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656378|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656379|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
14656380|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656381|NCT00229515|Sirolimus|sirolimus|mesh-list
14656382|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
14656383|NCT00229515|Tirofiban|tirofiban|mesh-list
14656384|NCT00229515|Abciximab|abciximab|mesh-list
14656385|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656386|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656387|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14656388|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656389|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
14656390|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656391|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
14656392|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656393|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
14656394|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14656395|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14656396|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14656397|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656398|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14656399|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
14656400|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
14656401|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14656402|NCT00229515|Protective Agents|protective agents|mesh-ancestor
14656403|NCT00229528|Paroxetine|paroxetine|mesh-list
14656404|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14656405|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656406|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656407|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656408|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656409|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
14656410|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656411|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14656412|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656413|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656414|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14656415|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14656416|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656417|NCT00229567|Lidocaine|lidocaine|mesh-list
14656418|NCT00229567|Ketamine|ketamine|mesh-list
14656419|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
14656420|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
14656421|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656422|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656423|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
14656424|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656425|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14656426|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14656427|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14656428|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656429|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656430|NCT00229567|Analgesics|analgesics|mesh-ancestor
14656431|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14656432|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14656433|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
14656434|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14656435|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14656436|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656437|NCT00229593|ST 1435|st 1435|mesh-list
14656438|NCT00229593|Testosterone|testosterone|mesh-list
14656439|NCT00229593|Androgens|androgens|mesh-ancestor
14656440|NCT00229593|Hormones|hormones|mesh-ancestor
14656441|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656442|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656443|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14656444|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
14656445|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14656446|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14656447|NCT00229632|Idebenone|idebenone|mesh-list
14656448|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
14656449|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656450|NCT00229632|Protective Agents|protective agents|mesh-ancestor
14656451|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656452|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15184664|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
15184665|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184666|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184667|NCT03899961|Oxytocin|oxytocin|mesh-list
15184668|NCT03899961|Carbetocin|carbetocin|mesh-list
15184669|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
15184670|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184671|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184672|NCT03899610|Durvalumab|durvalumab|mesh-list
15184673|NCT03899610|Tremelimumab|tremelimumab|mesh-list
15184674|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184675|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184676|NCT03899506|Midazolam|midazolam|mesh-list
15184677|NCT03899506|Olanzapine|olanzapine|mesh-list
15184678|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15184679|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15184680|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184681|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184682|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15184683|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15184684|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184685|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15184686|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
15184687|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
15184688|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
15184689|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
15184690|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184691|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184692|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
15184693|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
14656453|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656454|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656455|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15184694|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184695|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184696|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15184697|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15184698|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656456|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14656457|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656458|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656459|NCT00229684|Pioglitazone|pioglitazone|mesh-list
14656460|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656461|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656462|NCT00229697|Tamoxifen|tamoxifen|mesh-list
15184699|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184700|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
15184701|NCT03899337|Prednisolone|prednisolone|mesh-list
15184702|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
15184703|NCT03899337|Rituximab|rituximab|mesh-list
15184704|NCT03899337|Doxorubicin|doxorubicin|mesh-list
14656463|NCT00229697|Gefitinib|gefitinib|mesh-list
14656464|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14656465|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
14656466|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656467|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656468|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14656469|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656470|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14656471|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14656472|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14656473|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14656474|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656475|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656476|NCT00229775|Chloroquine|chloroquine|mesh-list
14656477|NCT00229775|Artemether|artemether|mesh-list
14656478|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
14656479|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
14656480|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14656481|NCT00229775|Amebicides|amebicides|mesh-ancestor
14656482|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14656483|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14656484|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656485|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
14656486|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656487|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14656488|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656489|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184705|NCT03899337|Vincristine|vincristine|mesh-list
15184706|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
15184707|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184708|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
15184709|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184710|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656490|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14656491|NCT00229775|Renal Agents|renal agents|mesh-ancestor
14814596|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184711|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15184712|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
15184713|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184714|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184715|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15184716|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15184717|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14656492|NCT00229918|Triamcinolone|triamcinolone|mesh-list
14656493|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14656494|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14656495|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14656496|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656497|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
14656498|NCT00229918|Hormones|hormones|mesh-ancestor
14656499|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656500|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656501|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656502|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
14656503|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656504|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656505|NCT00229944|Azithromycin|azithromycin|mesh-list
14656506|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656507|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656508|NCT00229996|Leuprolide|leuprolide|mesh-list
14656509|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
14656510|NCT00229996|Norethindrone|norethindrone|mesh-list
14656511|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
14656512|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
14656513|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14656514|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656515|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14656516|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
14656517|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14656518|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656519|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14656520|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14656521|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14656522|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14656523|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
14656524|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
14656525|NCT00230035|Rituximab|rituximab|mesh-list
14656526|NCT00230035|Methotrexate|methotrexate|mesh-list
14656527|NCT00230035|Azathioprine|azathioprine|mesh-list
14656528|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
14656529|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14656530|NCT00230035|Antibodies|antibodies|mesh-list
14656531|NCT00230035|Sargramostim|sargramostim|mesh-list
14656532|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14656533|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
14656534|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14656535|NCT00230035|Leflunomide|leflunomide|mesh-list
14656536|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
14656537|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14656538|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14656539|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656540|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
14656541|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656542|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656543|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14656544|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
14656545|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14656546|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14656547|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
14656548|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656549|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
14656550|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656551|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14656552|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14656553|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14656554|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14656555|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
14656556|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656557|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656558|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656559|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
14656560|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
14656561|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656562|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14656563|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
14656564|NCT00230035|Hormones|hormones|mesh-ancestor
14656565|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656566|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14656567|NCT00230035|Protective Agents|protective agents|mesh-ancestor
14656568|NCT00230204|Antibodies|antibodies|mesh-list
14656569|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
14293494|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14293495|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14293496|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14293497|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14293498|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293499|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
14293500|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293501|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293502|NCT00568776|Inositol|inositol|mesh-list
14293503|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
14293504|NCT00568776|Vitamins|vitamins|mesh-ancestor
14293505|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
14293506|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656570|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656571|NCT00230217|Rasburicase|rasburicase|mesh-list
14656572|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
14656573|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656574|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
14656575|NCT00230321|Hematinics|hematinics|mesh-ancestor
14656576|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
14656577|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656578|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14656579|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656580|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656581|NCT00230373|Imiquimod|imiquimod|mesh-list
14656582|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14656583|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
14656584|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656585|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656586|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
14656587|NCT00230399|Celecoxib|celecoxib|mesh-list
14656588|NCT00230399|Capecitabine|capecitabine|mesh-list
14656589|NCT00230399|Irinotecan|irinotecan|mesh-list
14656590|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14656591|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
14656592|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656593|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656594|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14656595|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14656596|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656597|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14656598|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14656599|NCT00230399|Analgesics|analgesics|mesh-ancestor
14656600|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
14656601|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656602|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656603|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656604|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656605|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14656606|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14656607|NCT00230451|Paclitaxel|paclitaxel|mesh-list
14656608|NCT00230451|Fluorouracil|fluorouracil|mesh-list
14656609|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14656610|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656611|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
14656612|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
14656613|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
14656614|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656615|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
14656616|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14656617|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656618|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
14656619|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656620|NCT00230464|Vildagliptin|vildagliptin|mesh-list
14656621|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656622|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656623|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14293507|NCT00568958|Naltrexone|naltrexone|mesh-list
14656624|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
14656625|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656626|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656627|NCT00230477|Lamivudine|lamivudine|mesh-list
14656628|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14656629|NCT00230477|Adefovir|adefovir|mesh-list
14656630|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14656631|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14656632|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656633|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656634|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
14656635|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656636|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14656637|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14656638|NCT00230490|Adefovir|adefovir|mesh-list
14656639|NCT00230490|Pradefovir|pradefovir|mesh-list
14656640|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
14656641|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656642|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14656643|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14656644|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656645|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656646|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14725655|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725656|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725657|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725658|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
14725659|NCT00504946|Prednisone|prednisone|mesh-list
14725660|NCT00504946|Budesonide|budesonide|mesh-list
14725661|NCT00504946|Montelukast|montelukast|mesh-list
14725662|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725663|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
14725664|NCT00504946|Hormones|hormones|mesh-ancestor
14725665|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725666|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725667|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14725668|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725669|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14725670|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14725671|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14725672|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
14725673|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14725674|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14725675|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725676|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14725677|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
14725678|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725679|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14725680|NCT00504946|Vitamins|vitamins|mesh-ancestor
14725681|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
14725682|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14725683|NCT00504959|Ranibizumab|ranibizumab|mesh-list
14725684|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14725685|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14725686|NCT00504959|Growth Substances|growth substances|mesh-ancestor
14725687|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725688|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
14725689|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725690|NCT00505037|Sevelamer|sevelamer|mesh-list
14725691|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
14725692|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
14725693|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725694|NCT00505063|Vaccines|vaccines|mesh-list
14725695|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14725696|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
14725697|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725698|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14725699|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
14725700|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725701|NCT00505102|Everolimus|everolimus|mesh-list
14725702|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184718|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15184719|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15184720|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184721|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15184722|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
15184723|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
15184724|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
14656647|NCT00230503|Adefovir|adefovir|mesh-list
15184725|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184726|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
15184727|NCT03899337|Hormones|hormones|mesh-ancestor
15184728|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184729|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184730|NCT03899246|Capsaicin|capsaicin|mesh-list
15184731|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
15184732|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
15184733|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
15184734|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184735|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184736|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
15184737|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15184738|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656648|NCT00230503|Pradefovir|pradefovir|mesh-list
14656649|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
14656650|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656651|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14656652|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14656653|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656654|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656655|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14656656|NCT00230516|Lansoprazole|lansoprazole|mesh-list
14656657|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14656658|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14656659|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14656660|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656661|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656662|NCT00230529|Infliximab|infliximab|mesh-list
14656663|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
14656664|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14656665|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656666|NCT00230542|Carboplatin|carboplatin|mesh-list
14656667|NCT00230542|Pemetrexed|pemetrexed|mesh-list
14656668|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656669|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656670|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656671|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14656672|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14656673|NCT00230568|Donepezil|donepezil|mesh-list
14656674|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14656675|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814597|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
14656676|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656677|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
14656678|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656679|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656680|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
14656681|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14656682|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
15184739|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223580|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
14656683|NCT00230594|Coagulants|coagulants|mesh-ancestor
14656684|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14656685|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
14656686|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656687|NCT00230698|Topiramate|topiramate|mesh-list
14656688|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
14656689|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656690|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656691|NCT00230763|Timolol|timolol|mesh-list
14656692|NCT00230763|Latanoprost|latanoprost|mesh-list
14656693|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14656694|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14656695|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
14656696|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656697|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656698|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656699|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14656700|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14656701|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14656702|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14656703|NCT00230776|Pregabalin|pregabalin|mesh-list
14656704|NCT00230776|Analgesics|analgesics|mesh-ancestor
14656705|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
14656706|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656707|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656708|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
14656709|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15223581|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223582|NCT01509339|Vancomycin|vancomycin|mesh-list
15223583|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15223584|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223585|NCT01362374|Leucovorin|leucovorin|mesh-list
15223586|NCT01362374|Paclitaxel|paclitaxel|mesh-list
15223587|NCT01362374|Docetaxel|docetaxel|mesh-list
15223588|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
15223589|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15223590|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223591|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
15223592|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
15223593|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
15223594|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223595|NCT01362374|Antidotes|antidotes|mesh-ancestor
15223596|NCT01362374|Protective Agents|protective agents|mesh-ancestor
14656710|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656711|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656712|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14656713|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14656714|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14656715|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656716|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656717|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14656718|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14656719|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14656720|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
14656721|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656722|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656723|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656724|NCT00230789|Urological Agents|urological agents|mesh-ancestor
14656725|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14656726|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14656727|NCT00230815|Hormones|hormones|mesh-ancestor
14656728|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656729|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223597|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293508|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14814598|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
14656730|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14656731|NCT00230867|Acyclovir|acyclovir|mesh-list
14656732|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
14656733|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656734|NCT00230958|Interferons|interferons|mesh-list
14656735|NCT00230958|Ribavirin|ribavirin|mesh-list
14656736|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
14656737|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
14656738|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14656739|NCT00230958|Taribavirin|taribavirin|mesh-list
14656740|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656741|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
14656742|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656743|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
14656744|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656745|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
14656746|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656747|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
14656748|NCT00230984|Testosterone|testosterone|mesh-list
14656749|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
14656750|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
14656751|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14656752|NCT00230984|Androgens|androgens|mesh-ancestor
14656753|NCT00230984|Hormones|hormones|mesh-ancestor
14656754|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656755|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656756|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14656757|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656758|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
14656759|NCT00230997|Galantamine|galantamine|mesh-list
14656760|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14656761|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656762|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656763|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
14656764|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656765|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656766|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14656767|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
14656768|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656769|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
14656770|NCT00231023|Triamcinolone|triamcinolone|mesh-list
14656771|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14656772|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14656773|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14656774|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656775|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
14656776|NCT00231023|Hormones|hormones|mesh-ancestor
14656777|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14656778|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656779|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656780|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
14656781|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656782|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656783|NCT00231075|Paclitaxel|paclitaxel|mesh-list
14656784|NCT00231075|Carboplatin|carboplatin|mesh-list
14656785|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14656786|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656787|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
14656788|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
14656789|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
14656790|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656791|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14656792|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656793|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656794|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14656795|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14656796|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656797|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656798|NCT00231140|Thalidomide|thalidomide|mesh-list
14656799|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656800|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
14656801|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656802|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
14656803|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656804|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656805|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14656806|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14656807|NCT00231140|Growth Substances|growth substances|mesh-ancestor
14656808|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
14656809|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656810|NCT00231192|Repaglinide|repaglinide|mesh-list
14656811|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656812|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656813|NCT00231218|Ascorbic Acid|ascorbic acid|mesh-list
14656814|NCT00231218|Propolis|propolis|mesh-list
14656815|NCT00231218|Vitamins|vitamins|mesh-ancestor
14656816|NCT00231218|Micronutrients|micronutrients|mesh-ancestor
14656817|NCT00231218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656818|NCT00231218|Antioxidants|antioxidants|mesh-ancestor
14656819|NCT00231218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656820|NCT00231218|Protective Agents|protective agents|mesh-ancestor
15184740|NCT03899571|Oseltamivir|oseltamivir|mesh-list
15184741|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
15184742|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184743|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184744|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184745|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
15184746|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656821|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656822|NCT00231244|Sirolimus|sirolimus|mesh-list
14656823|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14656824|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656825|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14656826|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656827|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
14656828|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656829|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
14656830|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656831|NCT00231322|Praziquantel|praziquantel|mesh-list
14656832|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
14656833|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14656834|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656835|NCT00231335|Citalopram|citalopram|mesh-list
14656836|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14656837|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656838|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656839|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656840|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656841|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
14656842|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656843|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14656844|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656845|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656846|NCT00231348|Nefazodone|nefazodone|mesh-list
14656847|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14656848|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14656849|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656850|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656851|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656852|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656853|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14656854|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656855|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14656856|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14656857|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14656858|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
14656859|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
14656860|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656861|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656862|NCT00231452|Artesunate|artesunate|mesh-list
14656863|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
15184747|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184748|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15184749|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184750|NCT03899597|Oxytocin|oxytocin|mesh-list
15184751|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
15184752|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184753|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184754|NCT03899324|Bumetanide|bumetanide|mesh-list
14656864|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
14656865|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14656866|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
14656867|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14656868|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14656869|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14656870|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656871|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
14656872|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
14656873|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14656874|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
14656875|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14656876|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656877|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656878|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14656879|NCT00231452|Renal Agents|renal agents|mesh-ancestor
14656880|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
14656881|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14656882|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14656883|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14656884|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656885|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656886|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
14656887|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14656888|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656889|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14656890|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656891|NCT00231517|Morphine|morphine|mesh-list
14656892|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14656893|NCT00231517|Narcotics|narcotics|mesh-ancestor
14656894|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14656895|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293509|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14656896|NCT00231517|Analgesics|analgesics|mesh-ancestor
14656897|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
14656898|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656899|NCT00231530|Topiramate|topiramate|mesh-list
14656900|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
14656901|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656902|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656903|NCT00231556|Topiramate|topiramate|mesh-list
14656904|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
14656905|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656906|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656907|NCT00231569|Mipomersen|mipomersen|mesh-list
14656908|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14656909|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14656910|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
14656911|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656912|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14656913|NCT00231582|Paclitaxel|paclitaxel|mesh-list
14656914|NCT00231582|Etoposide|etoposide|mesh-list
14656915|NCT00231582|Carboplatin|carboplatin|mesh-list
14656916|NCT00231582|Epirubicin|epirubicin|mesh-list
14656917|NCT00231582|Ifosfamide|ifosfamide|mesh-list
14656918|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14656919|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656920|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14656921|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14656922|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14656923|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656924|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14656925|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15184755|NCT03899324|Diuretics|diuretics|mesh-ancestor
15184756|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
15184757|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184758|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15184759|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14656926|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656927|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14656928|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14656929|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
14656930|NCT00231595|Topiramate|topiramate|mesh-list
14656931|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
14656932|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656933|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656934|NCT00231608|Topiramate|topiramate|mesh-list
14656935|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
14656936|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656937|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656938|NCT00231621|Topiramate|topiramate|mesh-list
14656939|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
14656940|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656941|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656942|NCT00231634|Topiramate|topiramate|mesh-list
14656943|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
14656944|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656945|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656946|NCT00231647|Topiramate|topiramate|mesh-list
14656947|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
14656948|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656949|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656950|NCT00231660|Topiramate|topiramate|mesh-list
14656951|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
14656952|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656953|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656954|NCT00231673|Topiramate|topiramate|mesh-list
14656955|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
14656956|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656957|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656958|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
14656959|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14656960|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656961|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14656962|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14656963|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14656964|NCT00231764|Daclizumab|daclizumab|mesh-list
14656965|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14656966|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
14656967|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656968|NCT00231829|Celecoxib|celecoxib|mesh-list
14656969|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14656970|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14656971|NCT00231829|Analgesics|analgesics|mesh-ancestor
14656972|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
14656973|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14656974|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656975|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14656976|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14656977|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15184760|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184761|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
15184762|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15184763|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15184764|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184765|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
15184766|NCT03899233|Coagulants|coagulants|mesh-ancestor
15184767|NCT03899194|Citalopram|citalopram|mesh-list
15184768|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15223598|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
14656978|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14656979|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656980|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656981|NCT00231855|Docetaxel|docetaxel|mesh-list
14656982|NCT00231855|Topotecan|topotecan|mesh-list
14656983|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14656984|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
14656985|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
14656986|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
14656987|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656988|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14656989|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14656990|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14656991|NCT00231959|Pramipexole|pramipexole|mesh-list
14656992|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
14656993|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14656994|NCT00231959|Protective Agents|protective agents|mesh-ancestor
14656995|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14656996|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15184769|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15184770|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184771|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184772|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184773|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
15184774|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184775|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15184776|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
14656997|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14656998|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
14656999|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
14657000|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657001|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
14657002|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14657003|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14657004|NCT00231998|Analgesics|analgesics|mesh-ancestor
14657005|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
14657006|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657007|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657008|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657009|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657010|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657011|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657012|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
14657013|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14657014|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657015|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657016|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
14657017|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14657018|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14657019|NCT00232011|Analgesics|analgesics|mesh-ancestor
14657020|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
14657021|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657022|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657023|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657024|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657025|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657026|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657027|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
14657028|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14657029|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657030|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657031|NCT00232024|Tegaserod|tegaserod|mesh-list
14657032|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14657033|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
14657034|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657035|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657036|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657037|NCT00232037|Tegaserod|tegaserod|mesh-list
14657038|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14657039|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
14657040|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657041|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657042|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657043|NCT00232050|Omalizumab|omalizumab|mesh-list
15184777|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657044|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14657045|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14657046|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657047|NCT00232063|Cyclosporine|cyclosporine|mesh-list
14657048|NCT00232063|Cyclosporins|cyclosporins|mesh-list
14657049|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657050|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657051|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657052|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
14657053|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657054|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
14657055|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657056|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657057|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657058|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14657059|NCT00232076|Cyclosporine|cyclosporine|mesh-list
14657060|NCT00232076|Cyclosporins|cyclosporins|mesh-list
14657061|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657062|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657063|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657064|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
14657065|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657066|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
14657067|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657068|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657069|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657070|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14725703|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725704|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
14725705|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725706|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14725707|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14725708|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14725709|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
14725710|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725711|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14725712|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14725713|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725714|NCT00505167|Memantine|memantine|mesh-list
14725715|NCT00505167|Donepezil|donepezil|mesh-list
14725716|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14725717|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725718|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725719|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14725720|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725721|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725722|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
14725723|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14725724|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14725725|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
15184778|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
15184779|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15184780|NCT03899142|Antibodies|antibodies|mesh-list
15184781|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
15184782|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184783|NCT03898986|Vaccines|vaccines|mesh-list
15184784|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
14725726|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14725727|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14725728|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14725729|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
14725730|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725731|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
14725732|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14725733|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14725734|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184785|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657071|NCT00232089|Tegaserod|tegaserod|mesh-list
14657072|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14657073|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
14657074|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657075|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657076|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657077|NCT00232102|Tegaserod|tegaserod|mesh-list
14657078|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14657079|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
14657080|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657081|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657082|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657083|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
14657084|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14657085|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14657086|NCT00232115|Analgesics|analgesics|mesh-ancestor
14657087|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
14657088|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657089|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657090|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657091|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657092|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657093|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657094|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
14657095|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14657096|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657097|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657098|NCT00232154|Azithromycin|azithromycin|mesh-list
14657099|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657100|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657101|NCT00232167|Indiplon|indiplon|mesh-list
14657102|NCT00232167|Sertraline|sertraline|mesh-list
14657103|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657104|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657105|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14657106|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14657107|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657108|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657109|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657110|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
14657111|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657112|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14657113|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657114|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
14657115|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
14657116|NCT00232206|Docetaxel|docetaxel|mesh-list
14657117|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657118|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14657119|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14657120|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14657121|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657122|NCT00232271|Enoxaparin|enoxaparin|mesh-list
14657123|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
14657124|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14657125|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14657126|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657127|NCT00232284|Sertraline|sertraline|mesh-list
14657128|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
15184786|NCT03899077|Goserelin|goserelin|mesh-list
15184787|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15184788|NCT03899077|Leuprolide|leuprolide|mesh-list
15184789|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184790|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184791|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
15184792|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15184793|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
15184794|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184795|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657129|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657130|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14657131|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15184796|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15184797|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14657132|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14725735|NCT00505336|Eplerenone|eplerenone|mesh-list
14657133|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657134|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657135|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
14657136|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657137|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14657138|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657139|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657140|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14657141|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14657142|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657143|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657144|NCT00232349|Galantamine|galantamine|mesh-list
14657145|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14657146|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657147|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657148|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
14657149|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657150|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657151|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14657152|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
14657153|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657154|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
14657155|NCT00232362|Pioglitazone|pioglitazone|mesh-list
14657156|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
14657157|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14657158|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657159|NCT00232375|Insulin|insulin|mesh-list
14657160|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14657161|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657162|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14657163|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657164|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657165|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14657166|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14657167|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657168|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657169|NCT00232492|Ketamine|ketamine|mesh-list
14657170|NCT00232492|Analgesics|analgesics|mesh-ancestor
14657171|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
14657172|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657173|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657174|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14657175|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14657176|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
14657177|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
14657178|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657179|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14657180|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14657181|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657182|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657183|NCT00232531|Niacin|niacin|mesh-list
14657184|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
14657185|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14657186|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
14657187|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657188|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14657189|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
14657190|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
14657191|NCT00232531|Vitamins|vitamins|mesh-ancestor
14657192|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
14657193|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657194|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14657195|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657196|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657197|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14657198|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14657199|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657200|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657201|NCT00232622|Streptokinase|streptokinase|mesh-list
14657202|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14657203|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14657204|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657205|NCT00232648|Budesonide|budesonide|mesh-list
14657206|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657207|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14657208|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
14657209|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657210|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657211|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14657212|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657213|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
14657214|NCT00232648|Hormones|hormones|mesh-ancestor
14657215|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657216|NCT00232661|Tamoxifen|tamoxifen|mesh-list
14657217|NCT00232661|Anastrozole|anastrozole|mesh-list
14657218|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14657219|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
14657220|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657221|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657222|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14657223|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657224|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14657225|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14657226|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14657227|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14657228|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14657229|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657230|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657231|NCT00232674|Budesonide|budesonide|mesh-list
14657232|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657233|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14657234|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
14657235|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657236|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657237|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14657238|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657239|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
14657240|NCT00232674|Hormones|hormones|mesh-ancestor
14657241|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657242|NCT00232687|Aripiprazole|aripiprazole|mesh-list
14657243|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657244|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657245|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14657246|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14657247|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657248|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657249|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
14657250|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
14657251|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657252|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657253|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14657254|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14657255|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
14657256|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14657257|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14657258|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14657259|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14657260|NCT00232700|Citalopram|citalopram|mesh-list
14657261|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14657262|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14657263|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657264|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657265|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657266|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
14657267|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657268|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14657269|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657270|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657271|NCT00232765|Sirolimus|sirolimus|mesh-list
14657272|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657273|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657274|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14657275|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657276|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
14657277|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657278|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
14657279|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657280|NCT00232817|Nicotine|nicotine|mesh-list
14657281|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14657282|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
14657283|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657284|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657285|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14657286|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14657287|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
14657288|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657289|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657290|NCT00232856|Sirolimus|sirolimus|mesh-list
14657291|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657292|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657293|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15184798|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
15184799|NCT03899038|Anesthetics|anesthetics|mesh-list
15184800|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184801|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184802|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
15184803|NCT03898752|Vitamins|vitamins|mesh-ancestor
14657294|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657295|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
14657296|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657297|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
14657298|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657299|NCT00232882|Atenolol|atenolol|mesh-list
14657300|NCT00232882|Candesartan|candesartan|mesh-list
14657301|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
14657302|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14657303|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14657304|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14657305|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14657306|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657307|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14657308|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
14657309|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
14657310|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657311|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657312|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14657313|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14657314|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14657315|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14657316|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657317|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657318|NCT00232882|Diuretics|diuretics|mesh-ancestor
14657319|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
14657320|NCT00232895|Propofol|propofol|mesh-list
14657321|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14657322|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657323|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657324|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14657325|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
14657326|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
14657327|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
14657328|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14657329|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14657330|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657331|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14657332|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14657333|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
14657334|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657335|NCT00232934|Thalidomide|thalidomide|mesh-list
14657336|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657337|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
15184804|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
15184805|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184806|NCT03899285|Citalopram|citalopram|mesh-list
15184807|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15184808|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15184809|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14725736|NCT00505336|Atorvastatin|atorvastatin|mesh-list
15223599|NCT01362374|Vitamins|vitamins|mesh-ancestor
14657338|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657339|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
14657340|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657341|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657342|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14657343|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14657344|NCT00232934|Growth Substances|growth substances|mesh-ancestor
14657345|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
14657346|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657347|NCT00232947|Vaccines|vaccines|mesh-list
14657348|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
14657349|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657350|NCT00233012|Topiramate|topiramate|mesh-list
14657351|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
14657352|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14657353|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657354|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14657355|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14657356|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14657357|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657358|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657359|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657360|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657361|NCT00233025|Analgesics|analgesics|mesh-ancestor
14657362|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
14657363|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184810|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657364|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657365|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657366|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
14657367|NCT00233038|Ethanol|ethanol|mesh-list
14657368|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14657369|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184811|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184812|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
15184813|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184814|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14657370|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14657371|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657372|NCT00233051|Fluticasone|fluticasone|mesh-list
14657373|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14657374|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657375|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14657376|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
14657377|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657378|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657379|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14657380|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657381|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657382|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14657383|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14657384|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14657385|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14657386|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
14657387|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184815|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
15184816|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15184817|NCT03898882|Oxytocin|oxytocin|mesh-list
15184818|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
15184819|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15184820|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184821|NCT03898635|Linezolid|linezolid|mesh-list
15184822|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15184823|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184824|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15184825|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184826|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657388|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657389|NCT00233155|Capsaicin|capsaicin|mesh-list
14657390|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
15184827|NCT03898583|Calcitriol|calcitriol|mesh-list
14657391|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657392|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
14657393|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657394|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657395|NCT00233337|Artemether|artemether|mesh-list
14657396|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14657397|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
14657398|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14657399|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14657400|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657401|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14657402|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14657403|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657404|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
14657405|NCT00233532|Verapamil|verapamil|mesh-list
14657406|NCT00233532|Trandolapril|trandolapril|mesh-list
14657407|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14657408|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15184828|NCT03898583|Betamethasone|betamethasone|mesh-list
14657409|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657410|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657411|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14657412|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657413|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
14657414|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15184829|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
15184830|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15184831|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
15184832|NCT03898583|Calcipotriene|calcipotriene|mesh-list
15184833|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15184834|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184835|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
14657415|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657416|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657417|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14657418|NCT00233545|Miltefosine|miltefosine|mesh-list
14657419|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
14657420|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657421|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657422|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14657423|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14657424|NCT00233558|Adalimumab|adalimumab|mesh-list
14657425|NCT00233558|Methotrexate|methotrexate|mesh-list
14657426|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14657427|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
14657428|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14657429|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657430|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657431|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
14657432|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657433|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657434|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657435|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657436|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14657437|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657438|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
14657439|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657440|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14657441|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657442|NCT00233571|Adalimumab|adalimumab|mesh-list
14657443|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657444|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657445|NCT00233584|Budesonide|budesonide|mesh-list
15184836|NCT03898583|Hormones|hormones|mesh-ancestor
15184837|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184838|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184839|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15184840|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657446|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657447|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15184841|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
15184842|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14657448|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
14657449|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657450|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657451|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14657452|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657453|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
14657454|NCT00233584|Hormones|hormones|mesh-ancestor
14657455|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657456|NCT00233610|Tamoxifen|tamoxifen|mesh-list
14657457|NCT00233610|Bicalutamide|bicalutamide|mesh-list
14657458|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14657459|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
14657460|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657461|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657462|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14657463|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657464|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14657465|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14657466|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15184843|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15184844|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184845|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184846|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15184847|NCT03898583|Vitamins|vitamins|mesh-ancestor
15184848|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
15184849|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15184850|NCT03898193|Montelukast|montelukast|mesh-list
15184851|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15184852|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
15184853|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14657467|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
14657468|NCT00233623|Leucovorin|leucovorin|mesh-list
14657469|NCT00233623|Fluorouracil|fluorouracil|mesh-list
14657470|NCT00233623|Irinotecan|irinotecan|mesh-list
14657471|NCT00233623|Gefitinib|gefitinib|mesh-list
14657472|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
14657473|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657474|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657475|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657476|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657477|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
14657478|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657479|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14657480|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14657481|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657482|NCT00233623|Antidotes|antidotes|mesh-ancestor
15184854|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
15184855|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184856|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184857|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15184858|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15184859|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184860|NCT03898466|Fluticasone|fluticasone|mesh-list
15184861|NCT03898466|Xhance|xhance|mesh-list
15184862|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184863|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15184864|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
14657483|NCT00233623|Protective Agents|protective agents|mesh-ancestor
14657484|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
15184865|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184866|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657485|NCT00233623|Vitamins|vitamins|mesh-ancestor
14657486|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
14657487|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14657488|NCT00233636|Gefitinib|gefitinib|mesh-list
14657489|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657490|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14657491|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657492|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657493|NCT00233662|Alefacept|alefacept|mesh-list
14657494|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657495|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
14657496|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657497|NCT00233675|Tiagabine|tiagabine|mesh-list
14657498|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
14657499|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14657500|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14657501|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657502|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657503|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
14657504|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657505|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725737|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14725738|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14725739|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
14725740|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725741|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14725742|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14725743|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725744|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14725745|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
14725746|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725747|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725748|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14725749|NCT00505336|Diuretics|diuretics|mesh-ancestor
14725750|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
14725751|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14725752|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
14725753|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
14725754|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725755|NCT00505427|Protective Agents|protective agents|mesh-ancestor
14725756|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725757|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
14725758|NCT00505427|Vitamins|vitamins|mesh-ancestor
14725759|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
14725760|NCT00505492|Paclitaxel|paclitaxel|mesh-list
14725761|NCT00505492|Cisplatin|cisplatin|mesh-list
14725762|NCT00505492|Carboplatin|carboplatin|mesh-list
14725763|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14725764|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725765|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
14725766|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
14725767|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
14725768|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725769|NCT00505505|Insulin|insulin|mesh-list
14725770|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14725771|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14725772|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725773|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
14725774|NCT00505531|Tramadol|tramadol|mesh-list
14725775|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14725776|NCT00505531|Narcotics|narcotics|mesh-ancestor
14725777|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14725778|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725779|NCT00505531|Analgesics|analgesics|mesh-ancestor
14725780|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
14725781|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725782|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14725783|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15184867|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15184868|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
15184869|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
15184870|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15184871|NCT03898011|Lamotrigine|lamotrigine|mesh-list
14657506|NCT00233714|Sirolimus|sirolimus|mesh-list
14657507|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657508|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657509|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14657510|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657511|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
14657512|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657513|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
14657514|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657515|NCT00233766|Sirolimus|sirolimus|mesh-list
14657516|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657517|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657518|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14657519|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657520|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
14657521|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657522|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
14657523|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657524|NCT00233779|Sirolimus|sirolimus|mesh-list
14657525|NCT00233779|Heparin|heparin|mesh-list
14657526|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657527|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657528|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14657529|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657530|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
14657531|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657532|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
14657533|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657534|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
14657535|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14657536|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14657537|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657538|NCT00233792|Sirolimus|sirolimus|mesh-list
14657539|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657540|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657541|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15184872|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
15184873|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15184874|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184875|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184876|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15184877|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657542|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657543|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
14657544|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657545|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
14657546|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184878|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15184879|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15184880|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184881|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657547|NCT00233805|Sirolimus|sirolimus|mesh-list
14657548|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293510|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293511|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
14293512|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657549|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657550|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14657551|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657552|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
14657553|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657554|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
14657555|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657556|NCT00233818|Sirolimus|sirolimus|mesh-list
14293513|NCT00569010|Cytarabine|cytarabine|mesh-list
14657557|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657558|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657559|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14657560|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657561|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
14657562|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657563|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
14657564|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657565|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
14657566|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14657567|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14657568|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657569|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14657570|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14657571|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
14657572|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657573|NCT00233896|Beclomethasone|beclomethasone|mesh-list
14657574|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657575|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
14657576|NCT00233896|Hormones|hormones|mesh-ancestor
14657577|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657578|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657579|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14657580|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657581|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
14657582|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14657583|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657584|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14657585|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
14657586|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657587|NCT00233935|Protective Agents|protective agents|mesh-ancestor
14657588|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657589|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14657590|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14657591|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657592|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14657593|NCT00233961|Lenograstim|lenograstim|mesh-list
14657594|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14657595|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
14657596|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657597|NCT00234000|Azacitidine|azacitidine|mesh-list
14657598|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
14657599|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657600|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
14657601|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657602|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657603|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657604|NCT00234026|Gemcitabine|gemcitabine|mesh-list
14657605|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657606|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
14657607|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657608|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657609|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
14657610|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657611|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657612|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657613|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
14657614|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657615|NCT00234091|Ritonavir|ritonavir|mesh-list
14657616|NCT00234091|Lopinavir|lopinavir|mesh-list
14657617|NCT00234091|Nelfinavir|nelfinavir|mesh-list
14657618|NCT00234091|Lamivudine|lamivudine|mesh-list
14657619|NCT00234091|Zidovudine|zidovudine|mesh-list
14657620|NCT00234091|Nevirapine|nevirapine|mesh-list
14657621|NCT00234091|Abacavir|abacavir|mesh-list
14657622|NCT00234091|Efavirenz|efavirenz|mesh-list
14657623|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14657624|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14657625|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657626|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657627|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657628|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14657629|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14657630|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
14657631|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657632|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14657633|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14657634|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14657635|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14657636|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
14657637|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14657638|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14657639|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14657640|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14657641|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14657642|NCT00234117|Rabeprazole|rabeprazole|mesh-list
14657643|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14657644|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14657645|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14657646|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657647|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657648|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
14657649|NCT00234143|Hematinics|hematinics|mesh-ancestor
14657650|NCT00234182|Interferons|interferons|mesh-list
14657651|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
14657652|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
14657653|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657654|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
14657655|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657656|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
15184882|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15184883|NCT03898128|Immunotoxins|immunotoxins|mesh-list
15184884|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
15184885|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184886|NCT03898336|Micronutrients|micronutrients|mesh-list
15184887|NCT03898336|Trace Elements|trace elements|mesh-list
15184888|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184889|NCT03897660|Vitamins|vitamins|mesh-list
15184890|NCT03897660|Vitamin K|vitamin k|mesh-list
15184891|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
15184892|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
15184893|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184894|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15184895|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15184896|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184897|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
14657657|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657658|NCT00234195|Bupropion|bupropion|mesh-list
14657659|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14657660|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657661|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657662|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14657663|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14657664|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657665|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657666|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
14657667|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657668|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657669|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14657670|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14657671|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184898|NCT03897660|Coagulants|coagulants|mesh-ancestor
15184899|NCT03897868|Losartan|losartan|mesh-list
14657672|NCT00234234|Adalimumab|adalimumab|mesh-list
14657673|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184900|NCT03897868|Amlodipine|amlodipine|mesh-list
15184901|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15184902|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15184903|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15184904|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184905|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15184906|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657674|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657675|NCT00234299|Aspirin|aspirin|mesh-list
14657676|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14657677|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14657678|NCT00234299|Analgesics|analgesics|mesh-ancestor
14657679|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
14657680|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657681|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657682|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657683|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657684|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14657685|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14657686|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657687|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14657688|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14657689|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657690|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
14657691|NCT00234312|Citalopram|citalopram|mesh-list
14657692|NCT00234312|Sertraline|sertraline|mesh-list
14657693|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14657694|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14657695|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657696|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657697|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657698|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
14657699|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657700|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14657701|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657702|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657703|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14657704|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657705|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657706|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14657707|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14657708|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184907|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
15184908|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14657709|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657710|NCT00234390|Budesonide|budesonide|mesh-list
14657711|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657712|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14657713|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
14657714|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657715|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657716|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14657717|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
14657718|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
14657719|NCT00234390|Hormones|hormones|mesh-ancestor
14657720|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657721|NCT00234403|Fulvestrant|fulvestrant|mesh-list
14657722|NCT00234403|Gefitinib|gefitinib|mesh-list
14657723|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14657724|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657725|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14657726|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14657727|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
14657728|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657729|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657730|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14657731|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657732|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657733|NCT00234416|Gemcitabine|gemcitabine|mesh-list
14657734|NCT00234416|Gefitinib|gefitinib|mesh-list
14657735|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657736|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
14657737|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657738|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657739|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
14657740|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657741|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657742|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657743|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
14657744|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657745|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14657746|NCT00234429|Gefitinib|gefitinib|mesh-list
14657747|NCT00234429|Raltitrexed|raltitrexed|mesh-list
14657748|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657749|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14657750|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657751|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657752|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657753|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
14657754|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14657755|NCT00234442|Gefitinib|gefitinib|mesh-list
14657756|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657757|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14657758|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657759|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657760|NCT00234455|Sirolimus|sirolimus|mesh-list
14657761|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657762|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657763|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14657764|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657765|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
14657766|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184909|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15184910|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15184911|NCT03897309|Vaccines|vaccines|mesh-list
15184912|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
15184913|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223600|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
15223601|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15223602|NCT01248247|Sorafenib|sorafenib|mesh-list
15223603|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223604|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223605|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223606|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223607|NCT01164228|Gemcitabine|gemcitabine|mesh-list
15223608|NCT01164228|Sunitinib|sunitinib|mesh-list
15223609|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223610|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
14657767|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
14657768|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657769|NCT00234468|Gefitinib|gefitinib|mesh-list
14657770|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657771|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14657772|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657773|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657774|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
14657775|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14657776|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14657777|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14657778|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657779|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657780|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
14657781|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657782|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657783|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14657784|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657785|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
14657786|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14657787|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14657788|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14657789|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657790|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657791|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
14657792|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657793|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657794|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14657795|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657796|NCT00234572|Lanreotide|lanreotide|mesh-list
14657797|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657798|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
14657799|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14657800|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14657801|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657802|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
14657803|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657804|NCT00234637|Memantine|memantine|mesh-list
14657805|NCT00234637|Rivastigmine|rivastigmine|mesh-list
14657806|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14657807|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14657808|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
14657809|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14657810|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657811|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657812|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14657813|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14657814|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14657815|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657816|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
14657817|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14657818|NCT00234637|Protective Agents|protective agents|mesh-ancestor
14657819|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14657820|NCT00234676|Estrogens|estrogens|mesh-ancestor
14657821|NCT00234676|Hormones|hormones|mesh-ancestor
14657822|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657823|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657824|NCT00234689|Naltrexone|naltrexone|mesh-list
14657825|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14657826|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14657827|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657828|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
14657829|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14657830|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
14657831|NCT00234819|Estrogens|estrogens|mesh-list
14657832|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14657833|NCT00234819|Hormones|hormones|mesh-ancestor
14657834|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14657835|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657836|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14657837|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14657838|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
14657839|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14657840|NCT00234845|Adalimumab|adalimumab|mesh-list
14657841|NCT00234845|Methotrexate|methotrexate|mesh-list
14657842|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14657843|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
14657844|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14657845|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657846|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657847|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
14657848|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657849|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657850|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657851|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657852|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14657853|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657854|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
14657855|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657856|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14657857|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657858|NCT00234858|Losartan|losartan|mesh-list
14657859|NCT00234858|Verapamil|verapamil|mesh-list
14657860|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15184914|NCT03897413|Antacids|antacids|mesh-list
15184915|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
15184916|NCT03897413|Calcium|calcium|mesh-list
15184917|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15184918|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184919|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184920|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184921|NCT03897452|Fentanyl|fentanyl|mesh-list
15184922|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15184923|NCT03897452|Narcotics|narcotics|mesh-ancestor
15184924|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184925|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184926|NCT03897452|Analgesics|analgesics|mesh-ancestor
15184927|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
15184928|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184929|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15184930|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14657861|NCT00234858|Trandolapril|trandolapril|mesh-list
14657862|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14657863|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14657864|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14657865|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14657866|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657867|NCT00234858|Diuretics|diuretics|mesh-ancestor
14657868|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
14657869|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657870|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14657871|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657872|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14657873|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14657874|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
14657875|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14657876|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657877|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657878|NCT00234871|Verapamil|verapamil|mesh-list
14657879|NCT00234871|Amlodipine|amlodipine|mesh-list
14657880|NCT00234871|Benazepril|benazepril|mesh-list
14657881|NCT00234871|Trandolapril|trandolapril|mesh-list
14657882|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14657883|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14657884|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657885|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657886|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14657887|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657888|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
14657889|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14657890|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14657891|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657892|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657893|NCT00234897|Adalimumab|adalimumab|mesh-list
14657894|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657895|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657896|NCT00234910|Ritonavir|ritonavir|mesh-list
14657897|NCT00234910|Lopinavir|lopinavir|mesh-list
14657898|NCT00234910|Tenofovir|tenofovir|mesh-list
14657899|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14657900|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14657901|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657902|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657903|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657904|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14657905|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14657906|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
14657907|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657908|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14657909|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14657910|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14657911|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14657912|NCT00234923|Ritonavir|ritonavir|mesh-list
14657913|NCT00234923|Lopinavir|lopinavir|mesh-list
14657914|NCT00234923|Lamivudine|lamivudine|mesh-list
14657915|NCT00234923|Zidovudine|zidovudine|mesh-list
14657916|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14657917|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15184931|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
15184932|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
15184933|NCT03896971|Cyclosporine|cyclosporine|mesh-list
15184934|NCT03896971|Cyclosporins|cyclosporins|mesh-list
15184935|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184936|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184937|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184938|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
15184939|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184940|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
15184941|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184942|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
15184943|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15184944|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15184945|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
15184946|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15184947|NCT03896932|Antibodies|antibodies|mesh-list
15184948|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
15184949|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15184950|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
15184951|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184952|NCT03897062|Suvorexant|suvorexant|mesh-list
15184953|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14657918|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14657919|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657920|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657921|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657922|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14657923|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14657924|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
14657925|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657926|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14657927|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14657928|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14657929|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14657930|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
14657931|NCT00234936|Adalimumab|adalimumab|mesh-list
14657932|NCT00234936|Methotrexate|methotrexate|mesh-list
14657933|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14657934|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
14657935|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14657936|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657937|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14657938|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
14657939|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657940|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14657941|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
14657942|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657943|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14657944|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14657945|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
14657946|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14657947|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14657948|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14657949|NCT00234949|Cephalexin|cephalexin|mesh-list
14657950|NCT00234949|Cefdinir|cefdinir|mesh-list
14657951|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14657952|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657953|NCT00234962|Ritonavir|ritonavir|mesh-list
14657954|NCT00234962|Lopinavir|lopinavir|mesh-list
14657955|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14657956|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14657957|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657958|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657959|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657960|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14657961|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14657962|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
14657963|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657964|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14657965|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14657966|NCT00234975|Ritonavir|ritonavir|mesh-list
14657967|NCT00234975|Lopinavir|lopinavir|mesh-list
14657968|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14657969|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14657970|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657971|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657972|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657973|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14657974|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14657975|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
14657976|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14657977|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14657978|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14657979|NCT00234988|Sibutramine|sibutramine|mesh-list
14657980|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
14657981|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14657982|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
14657983|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14657984|NCT00235001|Verapamil|verapamil|mesh-list
14657985|NCT00235001|Trandolapril|trandolapril|mesh-list
14657986|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14657987|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14657988|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14657989|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14657990|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14657991|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14657992|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
14657993|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14657994|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
14657995|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14657996|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14657997|NCT00235014|Verapamil|verapamil|mesh-list
14657998|NCT00235014|Trandolapril|trandolapril|mesh-list
14657999|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14658000|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14658001|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658002|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658003|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14658004|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658005|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
14658006|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14658007|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
14658008|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658009|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14658010|NCT00235053|Fluticasone|fluticasone|mesh-list
14658011|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14658012|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14658013|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658014|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14658015|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
14658016|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658017|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658018|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14658019|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
14658020|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
14658021|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14658022|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14658023|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14658024|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14658025|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
14658026|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658027|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658028|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
14658029|NCT00235053|Hormones|hormones|mesh-ancestor
14658030|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658031|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
14658032|NCT00235079|Colchicine|colchicine|mesh-list
14658033|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
14658034|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658035|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
14658036|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
14658037|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
14658038|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658039|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658040|NCT00235092|Sirolimus|sirolimus|mesh-list
14658041|NCT00235092|Paclitaxel|paclitaxel|mesh-list
14658042|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14658043|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658044|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
14658045|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
14658046|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
14658047|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658048|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658049|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658050|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14658051|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
14658052|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658053|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
14658054|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658055|NCT00235105|Adalimumab|adalimumab|mesh-list
14658056|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658057|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658058|NCT00235144|Sirolimus|sirolimus|mesh-list
14658059|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658060|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658061|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14658062|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658063|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
14658064|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658065|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
14658066|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658067|NCT00235157|Sirolimus|sirolimus|mesh-list
14658068|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658069|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658070|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14658071|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658072|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
14658073|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658074|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
14658075|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725784|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
14725785|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
14725786|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
14725787|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
14725788|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725789|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14725790|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
14725791|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
14725792|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725793|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725794|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14725795|NCT00505700|Cytarabine|cytarabine|mesh-list
14725796|NCT00505700|Bortezomib|bortezomib|mesh-list
14725797|NCT00505700|Idarubicin|idarubicin|mesh-list
14725798|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725799|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
14725800|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725801|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725802|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
14725803|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725804|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725805|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
14725806|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725807|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14725808|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14725809|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725810|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725811|NCT00505739|Mifepristone|mifepristone|mesh-list
14725812|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14725813|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
14725814|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725815|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725816|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14725817|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14725818|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14725819|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
14725820|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14725821|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14725822|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
14725823|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725824|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
14725825|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14725826|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14725827|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14725828|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
14725829|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725830|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
14725831|NCT00505804|Haloperidol|haloperidol|mesh-list
14725832|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
14725833|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14725834|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14725835|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725836|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725837|NCT00505804|Analgesics|analgesics|mesh-ancestor
14725838|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
14725839|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725840|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14725841|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14725842|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14725843|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
14725844|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725845|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725846|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
14725847|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
14725848|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725849|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14725850|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14725851|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14725852|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658076|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
14658077|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14658078|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
14658079|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14658080|NCT00235222|Stavudine|stavudine|mesh-list
14658081|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
14658082|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658083|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14658084|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14658085|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658086|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
14658087|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658088|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14658089|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14658090|NCT00235235|Gemcitabine|gemcitabine|mesh-list
14658091|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
14658092|NCT00235235|Doxorubicin|doxorubicin|mesh-list
14658093|NCT00235235|Capecitabine|capecitabine|mesh-list
14658094|NCT00235235|Vinorelbine|vinorelbine|mesh-list
14658095|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658096|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
14658097|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658098|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658099|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14658100|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
14658101|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658102|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658103|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14658104|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14658105|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
14658106|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
14658107|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658108|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658109|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14658110|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15184954|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15184955|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15184956|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658111|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14658112|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14658113|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14658114|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14658115|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14658116|NCT00235248|Aspirin|aspirin|mesh-list
14658117|NCT00235248|Warfarin|warfarin|mesh-list
14658118|NCT00235248|Clopidogrel|clopidogrel|mesh-list
14658119|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14658120|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14658121|NCT00235248|Analgesics|analgesics|mesh-ancestor
14658122|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
14658123|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658124|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658125|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658126|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658127|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14658128|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14658129|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658130|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14658131|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14658132|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658133|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
14658134|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14658135|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14658136|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14658137|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
14658138|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658139|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
14658140|NCT00235261|Dexamethasone|dexamethasone|mesh-list
14658141|NCT00235261|Pregabalin|pregabalin|mesh-list
14658142|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658143|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
14658144|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
14658145|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658146|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658147|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14658148|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
14658149|NCT00235261|Hormones|hormones|mesh-ancestor
14658150|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658151|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14658152|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658153|NCT00235261|Analgesics|analgesics|mesh-ancestor
14658154|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
14658155|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
14658156|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14658157|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658158|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658159|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14658160|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14658161|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658162|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658163|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658164|NCT00235274|Secretin|secretin|mesh-list
14658165|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14658166|NCT00235274|Hormones|hormones|mesh-ancestor
14658167|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658168|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658169|NCT00235287|Candesartan|candesartan|mesh-list
14658170|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
14658171|NCT00235287|Enalapril|enalapril|mesh-list
14658172|NCT00235287|Enalaprilat|enalaprilat|mesh-list
14658173|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14658174|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14658175|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14658176|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658177|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14658178|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
14658179|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658180|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
14658181|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14658182|NCT00235300|Basiliximab|basiliximab|mesh-list
14658183|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
14658184|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658185|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658186|NCT00235313|Nicotine|nicotine|mesh-list
14658187|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15184957|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15184958|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15184959|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184960|NCT03896893|Emollients|emollients|mesh-list
15184961|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
15184962|NCT03896737|Thalidomide|thalidomide|mesh-list
15184963|NCT03896737|Dexamethasone|dexamethasone|mesh-list
15184964|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
15184965|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
15184966|NCT03896737|Bortezomib|bortezomib|mesh-list
15184967|NCT03896737|Daratumumab|daratumumab|mesh-list
15184968|NCT03896737|BB 1101|bb 1101|mesh-list
15184969|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15184970|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
15184971|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184972|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15184973|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14658188|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
14658189|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658190|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658191|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14658192|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14658193|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
14658194|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658195|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658196|NCT00235508|Eszopiclone|eszopiclone|mesh-list
14658197|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14658198|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658199|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658200|NCT00235521|Iloprost|iloprost|mesh-list
14658201|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14658202|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
14658203|NCT00235560|Sirolimus|sirolimus|mesh-list
14658204|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658205|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184974|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
14658206|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14658207|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658208|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
14658209|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658210|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
14658211|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658212|NCT00235651|Amphotericin B|amphotericin b|mesh-list
14658213|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14658214|NCT00235651|Amebicides|amebicides|mesh-ancestor
14658215|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14658216|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14658217|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658218|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658219|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
14658220|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
14658221|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14658222|NCT00235729|Lofexidine|lofexidine|mesh-list
14658223|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14658224|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14658225|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658226|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
14658227|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658228|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14658229|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14658230|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14658231|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14658232|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658233|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658234|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
14658235|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
14658236|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658237|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658238|NCT00235794|Sirolimus|sirolimus|mesh-list
14658239|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658240|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658241|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14658242|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658243|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
14658244|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658245|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
14658246|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658247|NCT00235820|Adalimumab|adalimumab|mesh-list
14658248|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658249|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658250|NCT00235859|Adalimumab|adalimumab|mesh-list
14658251|NCT00235859|Methotrexate|methotrexate|mesh-list
14658252|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14658253|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
14658254|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14658255|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15184975|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15184976|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15184977|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15184978|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15184979|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
15184980|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
15184981|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15184982|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15184983|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
15184984|NCT03896737|Hormones|hormones|mesh-ancestor
15184985|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15184986|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15184987|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
15184988|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725853|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
14658256|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14658257|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
14658258|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658259|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658260|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
14658261|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658262|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14658263|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658264|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
14658265|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658266|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14658267|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658268|NCT00235885|Adalimumab|adalimumab|mesh-list
14658269|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658270|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658271|NCT00235898|Leucovorin|leucovorin|mesh-list
14658272|NCT00235898|Fluorouracil|fluorouracil|mesh-list
14658273|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
14658274|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658275|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14658276|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658277|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658278|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
14658279|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658280|NCT00235898|Antidotes|antidotes|mesh-ancestor
14658281|NCT00235898|Protective Agents|protective agents|mesh-ancestor
14658282|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
15184989|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
15184990|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15184991|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15184992|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15184993|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15184994|NCT03896737|Growth Substances|growth substances|mesh-ancestor
15184995|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
14658283|NCT00235898|Vitamins|vitamins|mesh-ancestor
14658284|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
14658285|NCT00235911|Budesonide|budesonide|mesh-list
14658286|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
14658287|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658288|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14658289|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
14658290|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658291|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658292|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14658293|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
14658294|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
14658295|NCT00235911|Hormones|hormones|mesh-ancestor
14658296|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658297|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14658298|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14658299|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14658300|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
14658301|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658302|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658303|NCT00235937|Anastrozole|anastrozole|mesh-list
14658304|NCT00235937|Goserelin|goserelin|mesh-list
14658305|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14658306|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658307|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14658308|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14658309|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15184996|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
15184997|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
15184998|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
15184999|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185000|NCT03896321|Anticoagulants|anticoagulants|mesh-list
15185001|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15185002|NCT03896256|Ketamine|ketamine|mesh-list
15185003|NCT03896256|Analgesics|analgesics|mesh-ancestor
14658310|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658311|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14658312|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
14658313|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658314|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658315|NCT00235950|Clopidogrel|clopidogrel|mesh-list
14658316|NCT00235950|Atorvastatin|atorvastatin|mesh-list
14658317|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14658318|NCT00235950|Simvastatin|simvastatin|mesh-list
14658319|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14658320|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14658321|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
14658322|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658323|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14658324|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14658325|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658326|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14658327|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14658328|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14658329|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14658330|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
14658331|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658332|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658333|NCT00235963|Simvastatin|simvastatin|mesh-list
14658334|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14658335|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14658336|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
14658337|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658338|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14658339|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14658340|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658341|NCT00236002|Alendronate|alendronate|mesh-list
14658342|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14658343|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658344|NCT00236015|Tiagabine|tiagabine|mesh-list
14658345|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
14658346|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14658347|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14658348|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658349|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658350|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
14658351|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658352|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658353|NCT00236028|Infliximab|infliximab|mesh-list
14658354|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
14658355|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14658356|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14658357|NCT00236054|Tiagabine|tiagabine|mesh-list
14658358|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
14658359|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14658360|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14658361|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658362|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658363|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
14658364|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658365|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658366|NCT00236067|Tiagabine|tiagabine|mesh-list
14658367|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
14658368|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14658369|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14658370|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658371|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185004|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
15185005|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185006|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185007|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15185008|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15185009|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
14658372|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
14658373|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658374|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658375|NCT00236093|Fentanyl|fentanyl|mesh-list
14658376|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14658377|NCT00236093|Narcotics|narcotics|mesh-ancestor
14658378|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658379|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658380|NCT00236093|Analgesics|analgesics|mesh-ancestor
14658381|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
14658382|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658383|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14658384|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14658385|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
14658386|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
14658387|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
14658388|NCT00236106|Tacrolimus|tacrolimus|mesh-list
14658389|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658390|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
14658391|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658392|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14658393|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658394|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658395|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658396|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14658397|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14658398|NCT00236145|Fentanyl|fentanyl|mesh-list
14658399|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14658400|NCT00236145|Narcotics|narcotics|mesh-ancestor
14658401|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658402|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658403|NCT00236145|Analgesics|analgesics|mesh-ancestor
14658404|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
14658405|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658406|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14658407|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14658408|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
14658409|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
14658410|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
15185010|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
15185011|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185012|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15185013|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15185014|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658411|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658412|NCT00236223|Dexamethasone|dexamethasone|mesh-list
14658413|NCT00236223|Ketamine|ketamine|mesh-list
14658414|NCT00236223|Gabapentin|gabapentin|mesh-list
14658415|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658416|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
14658417|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
14658418|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658419|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658420|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14658421|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
14658422|NCT00236223|Hormones|hormones|mesh-ancestor
14658423|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658424|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14658425|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658426|NCT00236223|Analgesics|analgesics|mesh-ancestor
14658427|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
14658428|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14658429|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14658430|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
14658431|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
14658432|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658433|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14658434|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14658435|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658436|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658437|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
14658438|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14658439|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15185015|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185016|NCT03896113|Celecoxib|celecoxib|mesh-list
15185017|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14658440|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658441|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
14658442|NCT00236249|Lidocaine|lidocaine|mesh-list
14658443|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
14658444|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
14658445|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658446|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658447|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
14658448|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658449|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14658450|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14658451|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14658452|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658453|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658454|NCT00236275|Telbivudine|telbivudine|mesh-list
14658455|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
14658456|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658457|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14658458|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658459|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658460|NCT00236288|Bupropion|bupropion|mesh-list
14658461|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14658462|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
14658463|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658464|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14658465|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14658466|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658467|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658468|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
14658469|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658470|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658471|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14658472|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14658473|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658474|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15185018|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15185019|NCT03896113|Analgesics|analgesics|mesh-ancestor
15185020|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
15185021|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185022|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185023|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15185024|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15185025|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15185026|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15185027|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185028|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185029|NCT03896074|Bevacizumab|bevacizumab|mesh-list
15185030|NCT03896074|Atezolizumab|atezolizumab|mesh-list
14658475|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14658476|NCT00236301|Estradiol|estradiol|mesh-list
14658477|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14658478|NCT00236301|Estrogens|estrogens|mesh-ancestor
14658479|NCT00236301|Hormones|hormones|mesh-ancestor
14658480|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658481|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658482|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14658483|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
14658484|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14658485|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14658486|NCT00236327|Fentanyl|fentanyl|mesh-list
14658487|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14658488|NCT00236327|Narcotics|narcotics|mesh-ancestor
14658489|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658490|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658491|NCT00236327|Analgesics|analgesics|mesh-ancestor
14658492|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
14658493|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185031|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185032|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185033|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15185034|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15185035|NCT03896074|Growth Substances|growth substances|mesh-ancestor
15185036|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185037|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
15185038|NCT03896269|Cytarabine|cytarabine|mesh-list
14658494|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14658495|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15185039|NCT03896269|Daunorubicin|daunorubicin|mesh-list
15185040|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293514|NCT00569010|Azacitidine|azacitidine|mesh-list
14658496|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
14658497|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
14658498|NCT00236353|Risperidone|risperidone|mesh-list
14658499|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14658500|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
14658501|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658502|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658503|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658504|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14658505|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658506|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658507|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15185041|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
15185042|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185043|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185044|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
15185045|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185046|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185047|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
15185048|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185049|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15185050|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15185051|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15185052|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185053|NCT03895892|Caffeine|caffeine|mesh-list
15185054|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15185055|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185056|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14658508|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658509|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
14658510|NCT00236366|Fentanyl|fentanyl|mesh-list
14658511|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14658512|NCT00236366|Narcotics|narcotics|mesh-ancestor
14658513|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658514|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658515|NCT00236366|Analgesics|analgesics|mesh-ancestor
14658516|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
14658517|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658518|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14658519|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14658520|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
14658521|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
14658522|NCT00236379|Olanzapine|olanzapine|mesh-list
14658523|NCT00236379|Risperidone|risperidone|mesh-list
14658524|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14658525|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
14658526|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658527|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658528|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658529|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14658530|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658531|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658532|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658533|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658534|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
14658535|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
14658536|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
14658537|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658538|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14658539|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14658540|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14658541|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658542|NCT00236392|Rabeprazole|rabeprazole|mesh-list
14658543|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14658544|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14658545|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14658546|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658547|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658548|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
14658549|NCT00236405|Hematinics|hematinics|mesh-ancestor
14658550|NCT00236418|Topiramate|topiramate|mesh-list
14658551|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
14658552|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658553|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658554|NCT00236431|Galantamine|galantamine|mesh-list
14658555|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14658556|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658557|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658558|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
14658559|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658560|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658561|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14658562|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
14658563|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658564|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
14658565|NCT00236444|Risperidone|risperidone|mesh-list
14658566|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14658567|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
14658568|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658569|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658570|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658571|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14658572|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658573|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658574|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658575|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658576|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
14658577|NCT00236457|Risperidone|risperidone|mesh-list
14658578|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14658579|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
14658580|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658581|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658582|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658583|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14658584|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658585|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658586|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658587|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658588|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
15185057|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185058|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185059|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15185060|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15185061|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
15185062|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185063|NCT03896217|Simvastatin|simvastatin|mesh-list
15185064|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15185065|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15185066|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
15185067|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185068|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15185069|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15185070|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185071|NCT03895788|Niraparib|niraparib|mesh-list
15185072|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15185073|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185074|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185075|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185076|NCT03895801|Prednisone|prednisone|mesh-list
15185077|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
15185078|NCT03895801|Vilobelimab|vilobelimab|mesh-list
15185079|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15185080|NCT03895801|Hormones|hormones|mesh-ancestor
15185081|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185082|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185083|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15185084|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185085|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15185086|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185087|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
15185088|NCT03895671|Azacitidine|azacitidine|mesh-list
15185089|NCT03895671|Ponatinib|ponatinib|mesh-list
15185090|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15185091|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
15185092|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185093|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185094|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185095|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15185096|NCT03895528|Lonafarnib|lonafarnib|mesh-list
15185097|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185098|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185099|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
15185100|NCT03895970|Lenvatinib|lenvatinib|mesh-list
15185101|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185102|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185103|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14658589|NCT00236470|Risperidone|risperidone|mesh-list
14658590|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14658591|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
14658592|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658593|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658594|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185104|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185105|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185106|NCT03895502|Edoxaban|edoxaban|mesh-list
15185107|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15185108|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
15185109|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14658595|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14658596|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658597|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658598|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658599|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658600|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
14658601|NCT00236483|Acetaminophen|acetaminophen|mesh-list
14658602|NCT00236483|Tramadol|tramadol|mesh-list
14658603|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14658604|NCT00236483|Analgesics|analgesics|mesh-ancestor
14658605|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
14658606|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658607|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658608|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
14658609|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14658610|NCT00236483|Narcotics|narcotics|mesh-ancestor
14658611|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658612|NCT00236496|Topiramate|topiramate|mesh-list
14658613|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
14658614|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658615|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658616|NCT00236509|Topiramate|topiramate|mesh-list
14658617|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
14658618|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658619|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658620|NCT00236522|Levofloxacin|levofloxacin|mesh-list
14658621|NCT00236522|Ofloxacin|ofloxacin|mesh-list
14658622|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14658623|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658624|NCT00236522|Renal Agents|renal agents|mesh-ancestor
14658625|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658626|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14658627|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14658628|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658629|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658630|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658631|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14658632|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14658633|NCT00236535|Acetaminophen|acetaminophen|mesh-list
14658634|NCT00236535|Tramadol|tramadol|mesh-list
14658635|NCT00236535|Hydrocodone|hydrocodone|mesh-list
14658636|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14658637|NCT00236535|Analgesics|analgesics|mesh-ancestor
14658638|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
14658639|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658640|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658641|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
14658642|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14658643|NCT00236535|Narcotics|narcotics|mesh-ancestor
14658644|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185110|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14658645|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
14658646|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
14658647|NCT00236548|Risperidone|risperidone|mesh-list
14658648|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14658649|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
14658650|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658651|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185111|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185112|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185113|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
14658652|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658653|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14658654|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658655|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658656|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658657|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658658|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
14658659|NCT00236561|Topiramate|topiramate|mesh-list
14658660|NCT00236561|Propranolol|propranolol|mesh-list
14658661|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14658662|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14658663|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
14658664|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658665|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658666|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658667|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14658668|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14658669|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
14658670|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
14658671|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658672|NCT00236574|Galantamine|galantamine|mesh-list
14658673|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14658674|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658675|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658676|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
14658677|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658678|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658679|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14658680|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
14658681|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658682|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
14658683|NCT00236587|Risperidone|risperidone|mesh-list
14658684|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14658685|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
14658686|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658687|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658688|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658689|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14658690|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658691|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658692|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658693|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14658694|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
14658695|NCT00236600|Topiramate|topiramate|mesh-list
14658696|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
14658697|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658698|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658699|NCT00236613|Topiramate|topiramate|mesh-list
14658700|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
14658701|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15185114|NCT03895229|Empagliflozin|empagliflozin|mesh-list
15185115|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15185116|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185117|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15185118|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185119|NCT03895411|Sotalol|sotalol|mesh-list
14658702|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658703|NCT00236626|Topiramate|topiramate|mesh-list
14658704|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
14658705|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658706|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658707|NCT00236639|Topiramate|topiramate|mesh-list
14658708|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
14658709|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658710|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658711|NCT00236652|Levofloxacin|levofloxacin|mesh-list
14658712|NCT00236652|Ofloxacin|ofloxacin|mesh-list
14658713|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14658714|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658715|NCT00236652|Renal Agents|renal agents|mesh-ancestor
14658716|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658717|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14658718|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14658719|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658720|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658721|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658722|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14658723|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14658724|NCT00236665|Topiramate|topiramate|mesh-list
14658725|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
14658726|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658727|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658728|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
14658729|NCT00236678|Hematinics|hematinics|mesh-ancestor
14658730|NCT00236691|Topiramate|topiramate|mesh-list
14658731|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
14658732|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658733|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658734|NCT00236704|Topiramate|topiramate|mesh-list
14658735|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
14658736|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658737|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658738|NCT00236717|Topiramate|topiramate|mesh-list
14658739|NCT00236717|Carbamazepine|carbamazepine|mesh-list
14658740|NCT00236717|Valproic Acid|valproic acid|mesh-list
14658741|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
14658742|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658743|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658744|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658745|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658746|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
14658747|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658748|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
14658749|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14658750|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658751|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14658752|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14658753|NCT00236717|Analgesics|analgesics|mesh-ancestor
14658754|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
14658755|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14658756|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14658757|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14658758|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14658759|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14658760|NCT00236730|Topiramate|topiramate|mesh-list
14658761|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
14658762|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658763|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658764|NCT00236743|Topiramate|topiramate|mesh-list
14658765|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
14658766|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658767|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725854|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14725855|NCT00505817|Leuprolide|leuprolide|mesh-list
14725856|NCT00505817|Cetrorelix|cetrorelix|mesh-list
15185120|NCT03895411|Propafenone|propafenone|mesh-list
15185121|NCT03895411|Metoprolol|metoprolol|mesh-list
15185122|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15185123|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14725857|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14725858|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
14725859|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725860|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725861|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14725862|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725863|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
14658768|NCT00236756|Topiramate|topiramate|mesh-list
14658769|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
14658770|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658771|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658772|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14658773|NCT00236769|Norelgestromin|norelgestromin|mesh-list
14658774|NCT00236769|Estradiol|estradiol|mesh-list
14658775|NCT00236769|Estrogens|estrogens|mesh-ancestor
14658776|NCT00236769|Hormones|hormones|mesh-ancestor
14658777|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658778|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658779|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14658780|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
14658781|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14658782|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14658783|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14658784|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14658785|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14658786|NCT00236782|Norelgestromin|norelgestromin|mesh-list
14658787|NCT00236782|Estradiol|estradiol|mesh-list
14658788|NCT00236782|Estrogens|estrogens|mesh-ancestor
14658789|NCT00236782|Hormones|hormones|mesh-ancestor
14658790|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658791|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658792|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14658793|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
14658794|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14658795|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14658796|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14658797|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14658798|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14658799|NCT00236795|Norelgestromin|norelgestromin|mesh-list
14658800|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14658801|NCT00236795|Estradiol|estradiol|mesh-list
14658802|NCT00236795|Estrogens|estrogens|mesh-ancestor
14658803|NCT00236795|Hormones|hormones|mesh-ancestor
14658804|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658805|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658806|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14658807|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
14658808|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14658809|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14658810|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14658811|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14658812|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14658813|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14658814|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14658815|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14658816|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14658817|NCT00236808|Levofloxacin|levofloxacin|mesh-list
14658818|NCT00236808|Ofloxacin|ofloxacin|mesh-list
14658819|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14658820|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658821|NCT00236808|Renal Agents|renal agents|mesh-ancestor
14658822|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658823|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14658824|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14658825|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658826|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658827|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658828|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14658829|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14658830|NCT00236821|Levofloxacin|levofloxacin|mesh-list
14658831|NCT00236821|Ofloxacin|ofloxacin|mesh-list
15185124|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185125|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185126|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185127|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185128|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15185129|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
15185130|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
14658832|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14658833|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185131|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185132|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15185133|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15185134|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15185135|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15185136|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15223611|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223612|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223613|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
15223614|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223615|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223616|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223617|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
15223618|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223619|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15223620|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15223621|NCT01164228|Growth Substances|growth substances|mesh-ancestor
15223622|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
15223623|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223624|NCT01012167|Galantamine|galantamine|mesh-list
15223625|NCT01012167|Oxytocin|oxytocin|mesh-list
15223626|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
15223627|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15223628|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223629|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15223630|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223631|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223632|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
15223633|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223634|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15223635|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
15223636|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223637|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
15223638|NCT00924326|Vidarabine|vidarabine|mesh-list
15223639|NCT00924326|Aldesleukin|aldesleukin|mesh-list
15223640|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
15223641|NCT00924326|Fludarabine|fludarabine|mesh-list
15223642|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
15223643|NCT00924326|Interleukin-2|interleukin-2|mesh-list
15223644|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223645|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
15223646|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223647|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15223648|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15223649|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
14658834|NCT00236821|Renal Agents|renal agents|mesh-ancestor
14658835|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658836|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14658837|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14658838|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658839|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658840|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658841|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14658842|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14658843|NCT00236834|Levofloxacin|levofloxacin|mesh-list
14658844|NCT00236834|Ofloxacin|ofloxacin|mesh-list
14658845|NCT00236834|Imipenem|imipenem|mesh-list
14658846|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14658847|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658848|NCT00236834|Renal Agents|renal agents|mesh-ancestor
14658849|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658850|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14658851|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14658852|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658853|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223650|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223651|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658854|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658855|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14658856|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14658857|NCT00236847|Topiramate|topiramate|mesh-list
14658858|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
14658859|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658860|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658861|NCT00236860|Topiramate|topiramate|mesh-list
14658862|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
14658863|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658864|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658865|NCT00236873|Topiramate|topiramate|mesh-list
14658866|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
14658867|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658868|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658869|NCT00236886|Topiramate|topiramate|mesh-list
14658870|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
14658871|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658872|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658873|NCT00236912|Metronidazole|metronidazole|mesh-list
14658874|NCT00236912|Levofloxacin|levofloxacin|mesh-list
14658875|NCT00236912|Ofloxacin|ofloxacin|mesh-list
14658876|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658877|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658878|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14658879|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14658880|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14658881|NCT00236912|Renal Agents|renal agents|mesh-ancestor
14658882|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14658883|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14658884|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658885|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185137|NCT03894904|Heparin|heparin|mesh-list
15185138|NCT03894904|Papaverine|papaverine|mesh-list
15185139|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
15185140|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15185141|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14658886|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658887|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14658888|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14658889|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
14658890|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14658891|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
14658892|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14658893|NCT00236964|Hematinics|hematinics|mesh-ancestor
14658894|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
14658895|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
14658896|NCT00237016|Doxycycline|doxycycline|mesh-list
14658897|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14658898|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658899|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
15185142|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658900|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15185143|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15185144|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185145|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
15185146|NCT03894904|Urological Agents|urological agents|mesh-ancestor
15185147|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
15185148|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15185149|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15185150|NCT03894839|Glutaral|glutaral|mesh-list
15185151|NCT03894839|Eusol|eusol|mesh-list
15185152|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15185153|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658901|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14658902|NCT00237068|Lansoprazole|lansoprazole|mesh-list
15185154|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
15185155|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14658903|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
14658904|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14658905|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14658906|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14658907|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658908|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658909|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
14658910|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658911|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14658912|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658913|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658914|NCT00237133|Letrozole|letrozole|mesh-list
14658915|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658916|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14658917|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14658918|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658919|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658920|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14658921|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
14658922|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658923|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658924|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
14658925|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14658926|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658927|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
14658928|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14658929|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658930|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
14658931|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658932|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14658933|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658934|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658935|NCT00237198|Letrozole|letrozole|mesh-list
14658936|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658937|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14658938|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14658939|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658940|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658941|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14658942|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
14658943|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658944|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658945|NCT00237211|Letrozole|letrozole|mesh-list
14658946|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658947|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14658948|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14658949|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658950|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658951|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14658952|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
14658953|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658954|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658955|NCT00237224|Letrozole|letrozole|mesh-list
14658956|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14658957|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14658958|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14658959|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185156|NCT03894826|Vorinostat|vorinostat|mesh-list
15185157|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185158|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15185159|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185160|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185161|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
15185162|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15185163|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14658960|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658961|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14658962|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
14658963|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14658964|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658965|NCT00237237|Vildagliptin|vildagliptin|mesh-list
14658966|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658967|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658968|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14658969|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
14658970|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658971|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658972|NCT00237250|Vildagliptin|vildagliptin|mesh-list
14658973|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658974|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658975|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14658976|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
14658977|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185164|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
15185165|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15185166|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15185167|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15185168|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15185169|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185170|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
15185171|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14658978|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658979|NCT00237263|Entacapone|entacapone|mesh-list
14658980|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14658981|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14293515|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293516|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
14293517|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293518|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293519|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
14293520|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293521|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14658982|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14658983|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14658984|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658985|NCT00237289|Topiramate|topiramate|mesh-list
14658986|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
14658987|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658988|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658989|NCT00237302|Topiramate|topiramate|mesh-list
14658990|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
14658991|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14658992|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14658993|NCT00237328|Heparin|heparin|mesh-list
15185172|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185173|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15185174|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185175|NCT03894800|Fentanyl|fentanyl|mesh-list
15185176|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
15185177|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15185178|NCT03894800|Narcotics|narcotics|mesh-ancestor
15185179|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14658994|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
14658995|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14658996|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14658997|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14658998|NCT00237341|Fentanyl|fentanyl|mesh-list
14658999|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14659000|NCT00237341|Narcotics|narcotics|mesh-ancestor
14659001|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659002|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659003|NCT00237341|Analgesics|analgesics|mesh-ancestor
14659004|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
14659005|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659006|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14659007|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14293522|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
14659008|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
14659009|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
14659010|NCT00237367|Rabeprazole|rabeprazole|mesh-list
14659011|NCT00237367|Pantoprazole|pantoprazole|mesh-list
14659012|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14659013|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659014|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14659015|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659016|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659017|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14659018|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
14659019|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14659020|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14659021|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14659022|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659023|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659024|NCT00237419|Infliximab|infliximab|mesh-list
14659025|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
14659026|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659027|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659028|NCT00237445|Azithromycin|azithromycin|mesh-list
15185180|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185181|NCT03894800|Analgesics|analgesics|mesh-ancestor
15185182|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
15185183|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185184|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14659029|NCT00237445|Telithromycin|telithromycin|mesh-list
14659030|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659031|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659032|NCT00237471|Insulin|insulin|mesh-list
14659033|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14659034|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659035|NCT00237484|Interferons|interferons|mesh-list
14659036|NCT00237484|Ribavirin|ribavirin|mesh-list
14659037|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
14659038|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
14659039|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14659040|NCT00237484|Infliximab|infliximab|mesh-list
14659041|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659042|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
14659043|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659044|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
14659045|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659046|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
14659047|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659048|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14659049|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659050|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659051|NCT00237497|Zopiclone|zopiclone|mesh-list
14659052|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14659053|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659054|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659055|NCT00237510|Terazosin|terazosin|mesh-list
14659056|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14659057|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14659058|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14659059|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
14659060|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659061|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659062|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185185|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15185186|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
15185187|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
15185188|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15185189|NCT03894683|Melatonin|melatonin|mesh-list
15185190|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
14659063|NCT00237510|Urological Agents|urological agents|mesh-ancestor
14659064|NCT00237523|Iodine|iodine|mesh-list
14659065|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
14659066|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14659067|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659068|NCT00237523|Trace Elements|trace elements|mesh-ancestor
14659069|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
15185191|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293523|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659070|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659071|NCT00237536|Lonidamine|lonidamine|mesh-list
14659072|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659073|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15185192|NCT03894683|Protective Agents|protective agents|mesh-ancestor
14659074|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659075|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14659076|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
14659077|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14659078|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14659079|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14659080|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14659081|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659082|NCT00237575|Gemcitabine|gemcitabine|mesh-list
14659083|NCT00237575|Sargramostim|sargramostim|mesh-list
14659084|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659085|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14659086|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
14659087|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659088|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
14659089|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659090|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659091|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14659092|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
14659093|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659094|NCT00237588|Losartan|losartan|mesh-list
14659095|NCT00237588|Amlodipine|amlodipine|mesh-list
14659096|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14659097|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14659098|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659099|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659100|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14659101|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659102|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
14659103|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14659104|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14659105|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14659106|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
14659107|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14659108|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
14659109|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659110|NCT00237614|Expectorants|expectorants|mesh-ancestor
14659111|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659112|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14659113|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
14659114|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659115|NCT00237614|Protective Agents|protective agents|mesh-ancestor
14659116|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659117|NCT00237614|Antidotes|antidotes|mesh-ancestor
14659118|NCT00237627|Doxorubicin|doxorubicin|mesh-list
14659119|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14659120|NCT00237627|Bortezomib|bortezomib|mesh-list
14659121|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659122|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659123|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14659124|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14659125|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659126|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659127|NCT00237653|Valganciclovir|valganciclovir|mesh-list
14659128|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
14659129|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659130|NCT00237705|Metoclopramide|metoclopramide|mesh-list
14659131|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
14659132|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
14659133|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659134|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659135|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659136|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14659137|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14659138|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
14659139|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659140|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659141|NCT00237731|Morphine|morphine|mesh-list
14659142|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14659143|NCT00237731|Narcotics|narcotics|mesh-ancestor
14659144|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659145|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659146|NCT00237731|Analgesics|analgesics|mesh-ancestor
14659147|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
14659148|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185193|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185194|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185195|NCT03894189|Theophylline|theophylline|mesh-list
15185196|NCT03894189|Doxapram|doxapram|mesh-list
15185197|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659149|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
14659150|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14659151|NCT00237861|Olanzapine|olanzapine|mesh-list
14659152|NCT00237861|Risperidone|risperidone|mesh-list
14659153|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14659154|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14659155|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
14659156|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659157|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659158|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659159|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14659160|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14659161|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659162|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14659163|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14659164|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
14659165|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
14659166|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
14659167|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659168|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659169|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14659170|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14659171|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659172|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
14659173|NCT00237874|Aripiprazole|aripiprazole|mesh-list
14659174|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
14659175|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14659176|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14659177|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14659178|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659179|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659180|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
14659181|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
14659182|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659183|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659184|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14659185|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14659186|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
14659187|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14659188|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14659189|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14659190|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14659191|NCT00237887|Adalimumab|adalimumab|mesh-list
14659192|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659193|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659194|NCT00237900|Leucovorin|leucovorin|mesh-list
14659195|NCT00237900|Fluorouracil|fluorouracil|mesh-list
14659196|NCT00237900|Gefitinib|gefitinib|mesh-list
14659197|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
14659198|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659199|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14659200|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659201|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14659202|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
14659203|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659204|NCT00237900|Antidotes|antidotes|mesh-ancestor
14659205|NCT00237900|Protective Agents|protective agents|mesh-ancestor
14659206|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
14659207|NCT00237900|Vitamins|vitamins|mesh-ancestor
14659208|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
14659209|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659210|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659211|NCT00237913|Olanzapine|olanzapine|mesh-list
14659212|NCT00237913|Risperidone|risperidone|mesh-list
14659213|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14659214|NCT00237913|Aripiprazole|aripiprazole|mesh-list
14659215|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15185198|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
14659216|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
14659217|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659218|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185199|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659219|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659220|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14659221|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14659222|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659223|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14659224|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14659225|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
14659226|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
14659227|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
14659228|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659229|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659230|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14659231|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14659232|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659233|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
14659234|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
14659235|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14659236|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14659237|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14659238|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14659239|NCT00237939|Aripiprazole|aripiprazole|mesh-list
14659240|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
14659241|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14659242|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14659243|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14659244|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659245|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659246|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
14659247|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
14659248|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659249|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659250|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14659251|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14659252|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
14659253|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14659254|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14659255|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14659256|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14659257|NCT00237952|Chelating Agents|chelating agents|mesh-list
14659258|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
14659259|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659260|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
14659261|NCT00238004|Niacin|niacin|mesh-list
14659262|NCT00238004|Niacinamide|niacinamide|mesh-list
14659263|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
14659264|NCT00238004|Vitamins|vitamins|mesh-ancestor
14659265|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
14659266|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659267|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14659268|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
14659269|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659270|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14659271|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
14659272|NCT00238017|Artesunate|artesunate|mesh-list
14659273|NCT00238017|Amodiaquine|amodiaquine|mesh-list
14659274|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
14659275|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14659276|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14659277|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659278|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659279|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
14659280|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
14659281|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14659282|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
14659283|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
14659284|NCT00238043|Hematinics|hematinics|mesh-ancestor
14659285|NCT00238056|Domperidone|domperidone|mesh-list
14659286|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
14659287|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
14659288|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659289|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185200|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659290|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659291|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14659292|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
14659293|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185201|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659294|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659295|NCT00238082|Beclomethasone|beclomethasone|mesh-list
14659296|NCT00238082|Norflurane|norflurane|mesh-list
14659297|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15185202|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
15185203|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15185204|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185205|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185206|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
15185207|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15185208|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15185209|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
15185210|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185211|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15185212|NCT03894085|Paroxetine|paroxetine|mesh-list
14659298|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
14659299|NCT00238082|Hormones|hormones|mesh-ancestor
14659300|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659301|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659302|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659303|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659304|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
14659305|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659306|NCT00238147|Carboplatin|carboplatin|mesh-list
14659307|NCT00238147|Docetaxel|docetaxel|mesh-list
14659308|NCT00238147|Capecitabine|capecitabine|mesh-list
14659309|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659310|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
14659311|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
14659312|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
14659313|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659314|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14659315|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
14659316|NCT00238160|Fluorouracil|fluorouracil|mesh-list
14659317|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659318|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
14659319|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659320|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14659321|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14659322|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
14659323|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659324|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
14659325|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
14659326|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
14659327|NCT00238173|Carboplatin|carboplatin|mesh-list
14659328|NCT00238173|Etoposide|etoposide|mesh-list
14659329|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
14659330|NCT00238173|Mannitol|mannitol|mesh-list
14659331|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14659332|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14659333|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
14659334|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659335|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659336|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14659337|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
14659338|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659339|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659340|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14659341|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14659342|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14659343|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14659344|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659345|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
14659346|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659347|NCT00238173|Expectorants|expectorants|mesh-ancestor
14659348|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659349|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14659350|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
14659351|NCT00238173|Protective Agents|protective agents|mesh-ancestor
14659352|NCT00238173|Antidotes|antidotes|mesh-ancestor
14659353|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14659354|NCT00238173|Diuretics|diuretics|mesh-ancestor
15185213|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14659355|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
14659356|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659357|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659358|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
14659359|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
14659360|NCT00238199|Calcitriol|calcitriol|mesh-list
14659361|NCT00238199|Docetaxel|docetaxel|mesh-list
14659362|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659363|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14659364|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14659365|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14659366|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659367|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14659368|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659369|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14659370|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659371|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14659372|NCT00238199|Vitamins|vitamins|mesh-ancestor
14659373|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
14659374|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14659375|NCT00238212|Sorafenib|sorafenib|mesh-list
14659376|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659377|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659378|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659379|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659380|NCT00238225|Calcitriol|calcitriol|mesh-list
14659381|NCT00238225|Ketoconazole|ketoconazole|mesh-list
14659382|NCT00238225|Dexamethasone|dexamethasone|mesh-list
14659383|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659384|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
14659385|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
14659386|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659387|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659388|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659389|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
14659390|NCT00238225|Hormones|hormones|mesh-ancestor
14659391|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659392|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14659393|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659394|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
14659395|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659396|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14659397|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14659398|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659399|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659400|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14659401|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
14659402|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14659403|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14659404|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14659405|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659406|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14659407|NCT00238225|Vitamins|vitamins|mesh-ancestor
14659408|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
14659409|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14659410|NCT00238251|Temozolomide|temozolomide|mesh-list
14659411|NCT00238251|Gefitinib|gefitinib|mesh-list
14659412|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14659413|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
14659414|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659415|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659416|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659417|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659418|NCT00238277|Temozolomide|temozolomide|mesh-list
14659419|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14659420|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
15185214|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15185215|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15185216|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185217|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185218|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
15185219|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185220|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15185221|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
15185222|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15185223|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14659421|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659422|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659423|NCT00238290|Trastuzumab|trastuzumab|mesh-list
14659424|NCT00238290|Letrozole|letrozole|mesh-list
14659425|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14659426|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659427|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14659428|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14659429|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659430|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659431|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14659432|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
14659433|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659434|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659435|NCT00238316|Letrozole|letrozole|mesh-list
14659436|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659437|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14659438|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14659439|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185224|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15185225|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185226|NCT03894345|Prazosin|prazosin|mesh-list
15185227|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14659440|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659441|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14659442|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
14659443|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185228|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15185229|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15185230|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14659444|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659445|NCT00238329|Interferons|interferons|mesh-list
14659446|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
14659447|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
14659448|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14659449|NCT00238329|Thalidomide|thalidomide|mesh-list
14659450|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659451|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
14659452|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659453|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
14659454|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659455|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14659456|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
14659457|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659458|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14659459|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14659460|NCT00238329|Growth Substances|growth substances|mesh-ancestor
14659461|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
14659462|NCT00238368|Cytarabine|cytarabine|mesh-list
14659463|NCT00238368|Prednisone|prednisone|mesh-list
14659464|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
14659465|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
14659466|NCT00238368|Busulfan|busulfan|mesh-list
14659467|NCT00238368|Rituximab|rituximab|mesh-list
14659468|NCT00238368|Doxorubicin|doxorubicin|mesh-list
14659469|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14659470|NCT00238368|Etoposide|etoposide|mesh-list
14659471|NCT00238368|Vincristine|vincristine|mesh-list
14659472|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14659473|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14659474|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
14659475|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659476|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659477|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14659478|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
14659479|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659480|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659481|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14659482|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14659483|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659484|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14659485|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14659486|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659487|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659488|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
14659489|NCT00238368|Hormones|hormones|mesh-ancestor
14659490|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659491|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14659492|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14659493|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14659494|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
14659495|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
14659496|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185231|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185232|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185233|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185234|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185235|NCT03894280|Fluticasone|fluticasone|mesh-list
15185236|NCT03894280|Xhance|xhance|mesh-list
15185237|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15185238|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15185239|NCT03894280|Charcoal|charcoal|mesh-list
15185240|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15185241|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15185242|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
15185243|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185244|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185245|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15185246|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
15185247|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
14659497|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14659498|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
15185248|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14659499|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14659500|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
14659501|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
15185249|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14659502|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659503|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659504|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14659505|NCT00238368|Protective Agents|protective agents|mesh-ancestor
14659506|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14725864|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725865|NCT00505843|Levodopa|levodopa|mesh-list
14725866|NCT00505843|Carbidopa|carbidopa|mesh-list
14725867|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14725868|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14725869|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
14725870|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725871|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725872|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725873|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14725874|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729266|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14729267|NCT00522249|Growth Substances|growth substances|mesh-ancestor
14729268|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729269|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
14729270|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
14729433|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729434|NCT00523289|Bupivacaine|bupivacaine|mesh-list
14729435|NCT00523289|Ropivacaine|ropivacaine|mesh-list
14729436|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
14729437|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
14729438|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729439|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729440|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
14729441|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729442|NCT00523354|Infliximab|infliximab|mesh-list
14729443|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
14729444|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729445|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729446|NCT00523380|Doxorubicin|doxorubicin|mesh-list
14729447|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14729448|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14729449|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729450|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14729451|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14729452|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729453|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729454|NCT00523393|Insulin|insulin|mesh-list
14729455|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14729456|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729457|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729458|NCT00523406|Triamcinolone|triamcinolone|mesh-list
14729459|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729460|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
14729461|NCT00523406|Hormones|hormones|mesh-ancestor
14729462|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729463|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729464|NCT00523432|Sirolimus|sirolimus|mesh-list
14729465|NCT00523432|Topotecan|topotecan|mesh-list
14729466|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14729467|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14729468|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729469|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729470|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729471|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14729472|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729473|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14729474|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
14729475|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729476|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
14729477|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729478|NCT00523445|Varenicline|varenicline|mesh-list
14729479|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14729480|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14729481|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293524|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659507|NCT00238394|Cediranib|cediranib|mesh-list
14659508|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659509|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659510|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659511|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659512|NCT00238407|Docetaxel|docetaxel|mesh-list
14659513|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659514|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
14659515|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
14659516|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
14659517|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659518|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14659519|NCT00238459|Vaccines|vaccines|mesh-list
14659520|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
14659521|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659522|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
14659523|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659524|NCT00238472|Nateglinide|nateglinide|mesh-list
14659525|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14659526|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659527|NCT00238498|Vildagliptin|vildagliptin|mesh-list
14659528|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14659529|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659530|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14659531|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
14659532|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659533|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659534|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14659535|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14659536|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14659537|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659538|NCT00238563|Triamcinolone|triamcinolone|mesh-list
14659539|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659540|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
14659541|NCT00238563|Hormones|hormones|mesh-ancestor
14659542|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659543|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659544|NCT00238628|Bexarotene|bexarotene|mesh-list
14659545|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659546|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14659547|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
14659548|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14659549|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14659550|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14659551|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659552|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659553|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
14659554|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659555|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659556|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14659557|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659558|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14659559|NCT00238667|Aspirin|aspirin|mesh-list
14659560|NCT00238667|Heparin|heparin|mesh-list
14659561|NCT00238667|Calcium heparin|calcium heparin|mesh-list
14659562|NCT00238667|Dipyridamole|dipyridamole|mesh-list
14659563|NCT00238667|Warfarin|warfarin|mesh-list
14659564|NCT00238667|Anticoagulants|anticoagulants|mesh-list
14659565|NCT00238667|Clopidogrel|clopidogrel|mesh-list
14659566|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14659567|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14659568|NCT00238667|Analgesics|analgesics|mesh-ancestor
14659569|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
14659570|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659571|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659572|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659573|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659574|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14659575|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14725875|NCT00505882|Pramlintide|pramlintide|mesh-list
14659576|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659577|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15185250|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15185251|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15185252|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185253|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185254|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185255|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
15185256|NCT03894280|Hormones|hormones|mesh-ancestor
15185257|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659578|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14659579|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659580|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
14659581|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14659582|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14659583|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14659584|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
14659585|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659586|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14659587|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
14659588|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14659589|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14659590|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14659591|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659592|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659593|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659594|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659595|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14659596|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
14659597|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14659598|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
14659599|NCT00238732|Estrogens|estrogens|mesh-list
14659600|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14659601|NCT00238732|Hormones|hormones|mesh-ancestor
14659602|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659603|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659604|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14659605|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14659606|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
14659607|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14659608|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
14659609|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14659610|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14659611|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
14659612|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659613|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659614|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14659615|NCT00238784|Budesonide|budesonide|mesh-list
14659616|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
14659617|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659618|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659619|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
14725876|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15185258|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
14659620|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659621|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659622|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659623|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659624|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
14659625|NCT00238784|Hormones|hormones|mesh-ancestor
14659626|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659627|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14659628|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14659629|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14659630|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
14659631|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659632|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659633|NCT00238797|Gefitinib|gefitinib|mesh-list
14659634|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659635|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659636|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659637|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659638|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
14659639|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659640|NCT00238901|Basiliximab|basiliximab|mesh-list
14659641|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14659642|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
14659643|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659644|NCT00238914|Naltrexone|naltrexone|mesh-list
14293525|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14293526|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
14293527|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293528|NCT00569374|Modafinil|modafinil|mesh-list
14293529|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14293530|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293531|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14293532|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14293533|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14293534|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659645|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14659646|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14659647|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659648|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
14659649|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659650|NCT00238927|Fluticasone|fluticasone|mesh-list
14659651|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659652|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659653|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
14659654|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659655|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659656|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659657|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659658|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
14659659|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14659660|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
14659661|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659662|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659663|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659664|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659665|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659666|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659667|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659668|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659669|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
14659670|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659671|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659672|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659673|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659674|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659675|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659676|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659677|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659678|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
15185259|NCT03894280|Antidotes|antidotes|mesh-ancestor
15185260|NCT03894280|Protective Agents|protective agents|mesh-ancestor
15185261|NCT03894046|Imipenem|imipenem|mesh-list
15185262|NCT03894046|Colistin|colistin|mesh-list
15185263|NCT03894046|Sulbactam|sulbactam|mesh-list
14659679|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659680|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659681|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659682|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659683|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659684|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659685|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659686|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659687|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
14659688|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659689|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659690|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659691|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659692|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659693|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659694|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293535|NCT00569530|Calfactant|calfactant|mesh-list
14293536|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14293537|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293538|NCT00569582|Mifepristone|mifepristone|mesh-list
14293539|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14293540|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
14293541|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14659695|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659696|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
14659697|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659698|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659699|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659700|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659701|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659702|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659703|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659704|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659705|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
14659706|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659707|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659708|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14729271|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
14293542|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185264|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15185265|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185266|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15185267|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185268|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185269|NCT03894007|Maytansine|maytansine|mesh-list
15185270|NCT03894007|Docetaxel|docetaxel|mesh-list
14659709|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659710|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659711|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659712|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659713|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659714|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
14659715|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659716|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659717|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15185271|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15185272|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
15185273|NCT03894007|Carboplatin|carboplatin|mesh-list
14659718|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659719|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659720|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659721|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659722|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659723|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
14659724|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659725|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659726|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659727|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659728|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659729|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659730|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659731|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659732|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
14659733|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15185274|NCT03894007|Trastuzumab|trastuzumab|mesh-list
15185275|NCT03894007|Atezolizumab|atezolizumab|mesh-list
15185276|NCT03894007|Epirubicin|epirubicin|mesh-list
15185277|NCT03894007|Pertuzumab|pertuzumab|mesh-list
15185278|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15185279|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185280|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
15185281|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
15185282|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
15185283|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185284|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185285|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
15185286|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185287|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659734|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659735|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659736|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659737|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659738|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659739|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659740|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659741|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
14659742|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659743|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659744|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659745|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659746|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659747|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659748|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659749|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659750|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
14659751|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14659752|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659753|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14659754|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
14659755|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659756|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659757|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659758|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659759|NCT00239096|Losartan|losartan|mesh-list
14659760|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14659761|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14659762|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14659763|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14659764|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659765|NCT00239109|Olanzapine|olanzapine|mesh-list
14659766|NCT00239109|Ziprasidone|ziprasidone|mesh-list
14659767|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
14659768|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
14659769|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185288|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15185289|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
15185290|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15185291|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185292|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15185293|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14659770|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659771|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14659772|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14659773|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14659774|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14659775|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14659776|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14659777|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14659778|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659779|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659780|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659781|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
14659782|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14659783|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14659784|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
14659785|NCT00239161|Levofloxacin|levofloxacin|mesh-list
14659786|NCT00239161|Ofloxacin|ofloxacin|mesh-list
14659787|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14659788|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659789|NCT00239161|Renal Agents|renal agents|mesh-ancestor
14659790|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14659791|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14659792|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14659793|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659794|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659795|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659796|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14659797|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14659798|NCT00239174|Surinabant|surinabant|mesh-list
14659799|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14659800|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14659801|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659802|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659803|NCT00239174|Hormones|hormones|mesh-ancestor
14659804|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14659805|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659806|NCT00239200|Lapatinib|lapatinib|mesh-list
14659807|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659808|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659809|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659810|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659811|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
14659812|NCT00239239|Hematinics|hematinics|mesh-ancestor
14659813|NCT00239252|Interferons|interferons|mesh-list
14659814|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
14659815|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659816|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
14659817|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14659818|NCT00239278|Prednisolone|prednisolone|mesh-list
14659819|NCT00239278|Budesonide|budesonide|mesh-list
14659820|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
14659821|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659822|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
14659823|NCT00239278|Hormones|hormones|mesh-ancestor
14659824|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185294|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15185295|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185296|NCT03893695|Nivolumab|nivolumab|mesh-list
15185297|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185298|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185299|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15185300|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185301|NCT03893734|Methadone|methadone|mesh-list
15185302|NCT03893734|Hydromorphone|hydromorphone|mesh-list
15185303|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15185304|NCT03893734|Narcotics|narcotics|mesh-ancestor
15185305|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185306|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185307|NCT03893734|Analgesics|analgesics|mesh-ancestor
14659825|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659826|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14659827|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659828|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
14659829|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659830|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659831|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659832|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659833|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14659834|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14659835|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14659836|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185308|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
15185309|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185310|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
14659837|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185311|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659838|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659839|NCT00239291|Gefitinib|gefitinib|mesh-list
14659840|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185312|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14659841|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659842|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659843|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659844|NCT00239304|Gefitinib|gefitinib|mesh-list
14659845|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659846|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659847|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659848|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659849|NCT00239330|Atorvastatin|atorvastatin|mesh-list
14659850|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14659851|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14659852|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14659853|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
14659854|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659855|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14659856|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14659857|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659858|NCT00239343|Gefitinib|gefitinib|mesh-list
14659859|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14659860|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14659861|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659862|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659863|NCT00239369|Telmisartan|telmisartan|mesh-list
14659864|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14659865|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14659866|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14659867|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14659868|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659869|NCT00239369|Diuretics|diuretics|mesh-ancestor
14659870|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
14659871|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659872|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14659873|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14659874|NCT00239382|Meloxicam|meloxicam|mesh-list
14659875|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14659876|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14659877|NCT00239382|Analgesics|analgesics|mesh-ancestor
14659878|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
14659879|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659880|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659881|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659882|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659883|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14659884|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14659885|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659886|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659887|NCT00239395|Meloxicam|meloxicam|mesh-list
14659888|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14659889|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14659890|NCT00239395|Analgesics|analgesics|mesh-ancestor
14659891|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
14659892|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659893|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659894|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659895|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14659896|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14659897|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14659898|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14659899|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659900|NCT00239408|Bromides|bromides|mesh-list
14659901|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
14659902|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659903|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
14659904|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659905|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659906|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659907|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659908|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
14659909|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14659910|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
14659911|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659912|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659913|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
14659914|NCT00239421|Fluticasone|fluticasone|mesh-list
14659915|NCT00239421|Xhance|xhance|mesh-list
14659916|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
14659917|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
14659918|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14659919|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14659920|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659921|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
14659922|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659923|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659924|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659925|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659926|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
14659927|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14659928|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14659929|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14659930|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14659931|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
14659932|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659933|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659934|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
14659935|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14659936|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
14659937|NCT00239434|Bromides|bromides|mesh-list
14659938|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
14659939|NCT00239434|Ipratropium|ipratropium|mesh-list
15185313|NCT03893591|Dalteparin|dalteparin|mesh-list
15185314|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
15185315|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14659940|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659941|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
14659942|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659943|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659944|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659945|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659946|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
14659947|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14659948|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
14659949|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659950|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659951|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
14659952|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
14659953|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659954|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
14659955|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659956|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659957|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659958|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659959|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
14659960|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14659961|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
14659962|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659963|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659964|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
14659965|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659966|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
14659967|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659968|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659969|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659970|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659971|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
14659972|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15185316|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15185317|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185318|NCT03893864|Ubiquinone|ubiquinone|mesh-list
15185319|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
15185320|NCT03893864|Antioxidants|antioxidants|mesh-list
15185321|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185322|NCT03893864|Protective Agents|protective agents|mesh-ancestor
15185323|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659973|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
14659974|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659975|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659976|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14659977|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
14659978|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14659979|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
14659980|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14659981|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659982|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14659983|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
14659984|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
14659985|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14659986|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
14659987|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659988|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659989|NCT00239486|Pramipexole|pramipexole|mesh-list
14659990|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
14659991|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14659992|NCT00239486|Protective Agents|protective agents|mesh-ancestor
14659993|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14659994|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14659995|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14659996|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
14659997|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
14659998|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14659999|NCT00239499|Fluticasone|fluticasone|mesh-list
14660000|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
14660001|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14660002|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660003|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14660004|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
14660005|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660006|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660007|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14660008|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14660009|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14660010|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14660011|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
14660012|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14660013|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14660014|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660015|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660016|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14660017|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14660018|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14660019|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
14660020|NCT00239512|Ibuprofen|ibuprofen|mesh-list
14660021|NCT00239512|Indomethacin|indomethacin|mesh-list
14660022|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14660023|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660024|NCT00239512|Analgesics|analgesics|mesh-ancestor
14660025|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
14660026|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660027|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660028|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660029|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660030|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660031|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660032|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660033|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
14660034|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
14660035|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14660036|NCT00239538|Valsartan|valsartan|mesh-list
14660037|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14660038|NCT00239538|Telmisartan|telmisartan|mesh-list
14660039|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660040|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660041|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660042|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660043|NCT00239538|Diuretics|diuretics|mesh-ancestor
14660044|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
14660045|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660046|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14660047|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660048|NCT00239551|Lansoprazole|lansoprazole|mesh-list
14660049|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14660050|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660051|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14660052|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660053|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660054|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14660055|NCT00239616|Hematinics|hematinics|mesh-ancestor
14660056|NCT00239629|Teriparatide|teriparatide|mesh-list
14660057|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
14660058|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14660059|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660060|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14660061|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14660062|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660063|NCT00239707|Incretins|incretins|mesh-ancestor
14660064|NCT00239707|Hormones|hormones|mesh-ancestor
14660065|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660066|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660067|NCT00239746|Ibuprofen|ibuprofen|mesh-list
14660068|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14660069|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660070|NCT00239746|Analgesics|analgesics|mesh-ancestor
14660071|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
14660072|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660073|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660074|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660075|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660076|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660077|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660078|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660079|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14660080|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14660081|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660082|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660083|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
14660084|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660085|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14660086|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14660087|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660088|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660089|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
14660090|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660091|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14660092|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14660093|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660094|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660095|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
14660096|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660097|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15185324|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
15185325|NCT03893864|Vitamins|vitamins|mesh-ancestor
15185326|NCT03893630|Aspirin|aspirin|mesh-list
15185327|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15185328|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660098|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14660099|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660100|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660101|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
14660102|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660103|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14660104|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14660105|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185329|NCT03893630|Analgesics|analgesics|mesh-ancestor
15185330|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
15185331|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660106|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660107|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
14660108|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660109|NCT00239889|Calcitonin|calcitonin|mesh-list
14660110|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
14660111|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14660112|NCT00239889|Katacalcin|katacalcin|mesh-list
14660113|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14660114|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660115|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14660116|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
14725877|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725878|NCT00505947|Infliximab|infliximab|mesh-list
14725879|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
14725880|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725881|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725882|NCT00506051|Pemetrexed|pemetrexed|mesh-list
14725883|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725884|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725885|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725886|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14725887|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14725888|NCT00506168|Capecitabine|capecitabine|mesh-list
14725889|NCT00506168|Irinotecan|irinotecan|mesh-list
14725890|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725891|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
14725892|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725893|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725894|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14725895|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725896|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725897|NCT00506194|Gliclazide|gliclazide|mesh-list
14725898|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14725899|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725900|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
14725901|NCT00506207|Irinotecan|irinotecan|mesh-list
14725902|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725903|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14725904|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725905|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725906|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725907|NCT00506246|Propofol|propofol|mesh-list
14725908|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14725909|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14725910|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725911|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14725912|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
14725913|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
14725914|NCT00506259|Melatonin|melatonin|mesh-list
14725915|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
14725916|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725917|NCT00506259|Protective Agents|protective agents|mesh-ancestor
14725918|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725919|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14725920|NCT00506272|Insulin|insulin|mesh-list
14660117|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14660118|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14660119|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660120|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660121|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
14660122|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660123|NCT00239954|Citalopram|citalopram|mesh-list
14660124|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14660125|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14660126|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660127|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660128|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660129|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
14660130|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660131|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14660132|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
14660133|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14660134|NCT00239967|Rimonabant|rimonabant|mesh-list
14660135|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14660136|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14660137|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14660138|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660139|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660140|NCT00239967|Hormones|hormones|mesh-ancestor
14660141|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660142|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660143|NCT00239980|Dalteparin|dalteparin|mesh-list
14660144|NCT00239980|Tinzaparin|tinzaparin|mesh-list
14660145|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14660146|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
14660147|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14660148|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14660149|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660150|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
14660151|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
14660152|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14660153|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
14660154|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660155|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660156|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660157|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14660158|NCT00240019|Furosemide|furosemide|mesh-list
14660159|NCT00240019|Diuretics|diuretics|mesh-ancestor
14660160|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
14660161|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660162|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14660163|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660164|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660165|NCT00240032|Cetirizine|cetirizine|mesh-list
14660166|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
14660167|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
14660168|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14660169|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14660170|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14660171|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
14660172|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
14660173|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660174|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660175|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660176|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14660177|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
14660178|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660179|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660180|NCT00240045|Octreotide|octreotide|mesh-list
14660181|NCT00240045|Midodrine|midodrine|mesh-list
14660182|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660183|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14660184|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660185|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
14660186|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
14660187|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660188|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660189|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14660190|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14660191|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14660192|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14660193|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
14660194|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660195|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660196|NCT00240058|Phenylephrine|phenylephrine|mesh-list
14660197|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
14660198|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
14660199|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14660200|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
14660201|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
14660202|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660203|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660204|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
14660205|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14660206|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
14660207|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
14660208|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14660209|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15185332|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185333|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660210|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14660211|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
14660212|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660213|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185334|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15185335|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15185336|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15185337|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185338|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15185339|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15185340|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660214|NCT00240058|Protective Agents|protective agents|mesh-ancestor
14660215|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14660216|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14660217|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14660218|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
14660219|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14660220|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
14660221|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
14660222|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14660223|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
14660224|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660225|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
15185341|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
15185342|NCT03893747|Vaccines|vaccines|mesh-list
15185343|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
15185344|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185345|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15185346|NCT03893526|Valsartan|valsartan|mesh-list
15185347|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14660226|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15185348|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15185349|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660227|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14660228|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14660229|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660230|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
14660231|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
14660232|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
14660233|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660234|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
14660235|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
14660236|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660237|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14660238|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
14660239|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
14660240|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660241|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660242|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14660243|NCT00240149|Insulin|insulin|mesh-list
14660244|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14660245|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660246|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660247|NCT00240214|Sirolimus|sirolimus|mesh-list
14660248|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14660249|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660250|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14660251|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185350|NCT03893526|Incretins|incretins|mesh-ancestor
15185351|NCT03893526|Hormones|hormones|mesh-ancestor
14660252|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
14660253|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660254|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
14660255|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660256|NCT00240253|Pramlintide|pramlintide|mesh-list
14660257|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660258|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660259|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15185352|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185353|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15185354|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
15185355|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185356|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185357|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660260|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14660261|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14660262|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
14660263|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660264|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14660265|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14660266|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660267|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14660268|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14660269|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14660270|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
14660271|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185358|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15185359|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15185360|NCT03893435|Valsartan|valsartan|mesh-list
15185361|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15185362|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15185363|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15185364|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660272|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14660273|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14660274|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660275|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14660276|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14660277|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14660278|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
14660279|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660280|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14660281|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14660282|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660283|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14660284|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14660285|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14660286|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
14660287|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660288|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14660289|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14660290|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660291|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14660292|NCT00240318|Calcium|calcium|mesh-list
14660293|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14660294|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660295|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14660296|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14660297|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
14660298|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660299|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14660300|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14660301|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660302|NCT00240396|Narcotics|narcotics|mesh-list
14660303|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14660304|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660305|NCT00240396|Analgesics|analgesics|mesh-ancestor
14660306|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
14660307|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660308|NCT00240409|Pramipexole|pramipexole|mesh-list
14660309|NCT00240409|Bromocriptine|bromocriptine|mesh-list
14660310|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
14660311|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660312|NCT00240409|Protective Agents|protective agents|mesh-ancestor
14660313|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660314|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14660315|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14660316|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
14660317|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
14660318|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660319|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
14725921|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660320|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660321|NCT00240422|Telmisartan|telmisartan|mesh-list
14660322|NCT00240422|Ramipril|ramipril|mesh-list
14660323|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660324|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660325|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660326|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660327|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14660328|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
14660329|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660330|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14660331|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
14660332|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14660333|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
14660334|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660335|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660336|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14660337|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
14660338|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
14660339|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14660340|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
14660341|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185365|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185366|NCT03893097|Artesunate|artesunate|mesh-list
15185367|NCT03893097|Mefloquine|mefloquine|mesh-list
15185368|NCT03893097|Praziquantel|praziquantel|mesh-list
15185369|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
15185370|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15185371|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15185372|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185373|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185374|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
15185375|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
15185376|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15185377|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
15185378|NCT03893032|Modafinil|modafinil|mesh-list
15185379|NCT03893032|Amphetamine|amphetamine|mesh-list
15185380|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15185381|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185382|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15185383|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15185384|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15185385|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185386|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
15185387|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
15185388|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185389|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
14660342|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660343|NCT00240448|Valsartan|valsartan|mesh-list
14660344|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14660345|NCT00240448|Telmisartan|telmisartan|mesh-list
14660346|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660347|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660348|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660349|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660350|NCT00240448|Diuretics|diuretics|mesh-ancestor
14660351|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
14660352|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660353|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14660354|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660355|NCT00240474|Amlodipine|amlodipine|mesh-list
14660356|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14660357|NCT00240474|Telmisartan|telmisartan|mesh-list
14660358|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660359|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14660360|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660361|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660362|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14660363|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660364|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
14660365|NCT00240474|Diuretics|diuretics|mesh-ancestor
14660366|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
15185390|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185391|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
14660367|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14660368|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660369|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660370|NCT00240513|Minocycline|minocycline|mesh-list
14660371|NCT00240513|Tretinoin|tretinoin|mesh-list
14660372|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14660373|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660374|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660375|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
14660376|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
14660377|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
14660378|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14660379|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14660380|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
14660381|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660382|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660383|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14660384|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14660385|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
14660386|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660387|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
14660388|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660389|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660390|NCT00240617|Naproxen|naproxen|mesh-list
14660391|NCT00240617|Sumatriptan|sumatriptan|mesh-list
14660392|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14660393|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660394|NCT00240617|Analgesics|analgesics|mesh-ancestor
14660395|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
14660396|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660397|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660398|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660399|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660400|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
14660401|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660402|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660403|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660404|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14660405|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14660406|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14660407|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
14660408|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660409|NCT00240630|Naproxen|naproxen|mesh-list
14660410|NCT00240630|Sumatriptan|sumatriptan|mesh-list
14660411|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14660412|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660413|NCT00240630|Analgesics|analgesics|mesh-ancestor
14660414|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
14660415|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660416|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660417|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660418|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660419|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
14660420|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660421|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660422|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660423|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14660424|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14660425|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14660426|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
14660427|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660428|NCT00240656|Carvedilol|carvedilol|mesh-list
14660429|NCT00240656|Captopril|captopril|mesh-list
14660430|NCT00240656|Spironolactone|spironolactone|mesh-list
14660431|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14660432|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
14660433|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660434|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660435|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14660436|NCT00240656|Diuretics|diuretics|mesh-ancestor
14660437|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
15185392|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15185393|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15185394|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660438|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14660439|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14660440|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
14660441|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660442|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660443|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660444|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
14660445|NCT00240656|Protective Agents|protective agents|mesh-ancestor
14660446|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15185395|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15185396|NCT03893136|Leflunomide|leflunomide|mesh-list
15185397|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185398|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185399|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185400|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
15185401|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185402|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15185403|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15185404|NCT03893045|Hematinics|hematinics|mesh-ancestor
15185405|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15185406|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15223652|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15223653|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223654|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
15223655|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
15223656|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660447|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15223657|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15223658|NCT00924326|Analgesics|analgesics|mesh-ancestor
15223659|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
15223660|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223661|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15223662|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15223663|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
15223664|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15223665|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223666|NCT00321100|Bevacizumab|bevacizumab|mesh-list
15223667|NCT00321100|Cetuximab|cetuximab|mesh-list
15223668|NCT00321100|Capecitabine|capecitabine|mesh-list
15223669|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
14660448|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14660449|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
14660450|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14660451|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14660452|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14660453|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
14660454|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660455|NCT00240682|Cetuximab|cetuximab|mesh-list
14660456|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14660457|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660458|NCT00240695|Galantamine|galantamine|mesh-list
14660459|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14660460|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660461|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660462|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
14660463|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660464|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660465|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14660466|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
15223670|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223671|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223672|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14660467|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660468|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
14660469|NCT00240708|Risperidone|risperidone|mesh-list
14660470|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14660471|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
14660472|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660473|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660474|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660475|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14660476|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14660477|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14660478|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14660479|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14660480|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
14660481|NCT00240721|Topiramate|topiramate|mesh-list
14660482|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
14660483|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660484|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660485|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
14660486|NCT00240734|Hematinics|hematinics|mesh-ancestor
14660487|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
14660488|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14660489|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660490|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14660491|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660492|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660493|NCT00240760|Memantine|memantine|mesh-list
14660494|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14660495|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14660496|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
14660497|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660498|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660499|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660500|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14660501|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14660502|NCT00240773|Acetaminophen|acetaminophen|mesh-list
14660503|NCT00240773|Naproxen|naproxen|mesh-list
14660504|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660505|NCT00240773|Analgesics|analgesics|mesh-ancestor
14660506|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
14660507|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660508|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660509|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
14660510|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14660511|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660512|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660513|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
14660514|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660515|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660516|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660517|NCT00240786|Acetaminophen|acetaminophen|mesh-list
14660518|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660519|NCT00240786|Analgesics|analgesics|mesh-ancestor
14660520|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
14660521|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660522|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660523|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
14660524|NCT00240799|Acetaminophen|acetaminophen|mesh-list
14660525|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15185407|NCT03893240|Antibodies|antibodies|mesh-list
15185408|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
15185409|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
15185410|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185411|NCT03892902|Zopiclone|zopiclone|mesh-list
15185412|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15185413|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185414|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185415|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
15185416|NCT03892668|Oxytocin|oxytocin|mesh-list
15185417|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
15185418|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15185419|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185420|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14660526|NCT00240799|Analgesics|analgesics|mesh-ancestor
14660527|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
14660528|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660529|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660530|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
14660531|NCT00240812|Ibuprofen|ibuprofen|mesh-list
14660532|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
14660533|NCT00240812|Ephedrine|ephedrine|mesh-list
14660534|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14660535|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660536|NCT00240812|Analgesics|analgesics|mesh-ancestor
15185421|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15185422|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185423|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
15185424|NCT03892668|Coagulants|coagulants|mesh-ancestor
15185425|NCT03892525|Atezolizumab|atezolizumab|mesh-list
15185426|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660537|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
14660538|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660539|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660540|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660541|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660542|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660543|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660544|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660545|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14660546|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
14660547|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14660548|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14660549|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
14660550|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14660551|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14660552|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
14660553|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
14660554|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660555|NCT00240825|Acetaminophen|acetaminophen|mesh-list
14660556|NCT00240825|Ibuprofen|ibuprofen|mesh-list
14660557|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660558|NCT00240825|Analgesics|analgesics|mesh-ancestor
14660559|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
14660560|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660561|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660562|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
14660563|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15185427|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
15185428|NCT03892928|Propofol|propofol|mesh-list
15185429|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15185430|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185431|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185432|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15185433|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
15185434|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
14660564|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660565|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660566|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660567|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660568|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660569|NCT00240838|Acetaminophen|acetaminophen|mesh-list
14660570|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660571|NCT00240838|Analgesics|analgesics|mesh-ancestor
14660572|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
14660573|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660574|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660575|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
14660576|NCT00240851|Acetaminophen|acetaminophen|mesh-list
14660577|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660578|NCT00240851|Analgesics|analgesics|mesh-ancestor
14660579|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
14660580|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660581|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660582|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
14660583|NCT00240864|Acetaminophen|acetaminophen|mesh-list
14660584|NCT00240864|Ibuprofen|ibuprofen|mesh-list
14660585|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14660586|NCT00240864|Analgesics|analgesics|mesh-ancestor
14660587|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
14660588|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660589|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660590|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
14660591|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14660592|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660593|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660594|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14660595|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185435|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15185436|NCT03892928|Analgesics|analgesics|mesh-ancestor
15185437|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
15185438|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185439|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15185440|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15185441|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15185442|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185443|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185444|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185445|NCT03892499|Itraconazole|itraconazole|mesh-list
15185446|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
15185447|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660596|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660597|NCT00240916|Vaccines|vaccines|mesh-list
14660598|NCT00240916|Immunoglobulins|immunoglobulins|mesh-list
14660599|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
14660600|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660601|NCT00240929|Palivizumab|palivizumab|mesh-list
14293543|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14293544|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14293545|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14293546|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
14293547|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14293548|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14293549|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
14293550|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293551|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
14293552|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14293553|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14293554|NCT00569660|Azacitidine|azacitidine|mesh-list
14293555|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293556|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
14660602|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
14660603|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660604|NCT00240942|Letrozole|letrozole|mesh-list
14660605|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660606|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14660607|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14660608|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725922|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660609|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660610|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14293557|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293558|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293559|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660611|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
14660612|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660613|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185448|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15185449|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15185450|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185451|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185452|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14293560|NCT00569673|Docetaxel|docetaxel|mesh-list
15185453|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
15185454|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660614|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
14660615|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14660616|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660617|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14660618|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
14660619|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14660620|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660621|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660622|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660623|NCT00241007|Valsartan|valsartan|mesh-list
14660624|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14660625|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660626|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660627|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660628|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660629|NCT00241007|Diuretics|diuretics|mesh-ancestor
14660630|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
14660631|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660632|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14660633|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660634|NCT00241020|Octreotide|octreotide|mesh-list
14660635|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660636|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14660637|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660638|NCT00241046|Letrozole|letrozole|mesh-list
14660639|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660640|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14660641|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14660642|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660643|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660644|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14660645|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
14660646|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660647|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660648|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
14660649|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14660650|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660651|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14660652|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
14660653|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14660654|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660655|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660656|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660657|NCT00241072|Valsartan|valsartan|mesh-list
14660658|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660659|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660660|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660661|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660662|NCT00241085|Valsartan|valsartan|mesh-list
14660663|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660664|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660665|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660666|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660667|NCT00241098|Valsartan|valsartan|mesh-list
14660668|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660669|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660670|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660671|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660672|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
14660673|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14660674|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660675|NCT00241124|Valsartan|valsartan|mesh-list
14660676|NCT00241124|Lisinopril|lisinopril|mesh-list
14660677|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660678|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660679|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660680|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660681|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14660682|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
14660683|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660684|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14660685|NCT00241124|Protective Agents|protective agents|mesh-ancestor
14660686|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660687|NCT00241137|Valsartan|valsartan|mesh-list
14660688|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660689|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660690|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660691|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660692|NCT00241150|Valsartan|valsartan|mesh-list
14660693|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660694|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14660695|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660696|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660697|NCT00241163|Thrombin|thrombin|mesh-list
14660698|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
14660699|NCT00241163|Coagulants|coagulants|mesh-ancestor
14660700|NCT00241189|Sirolimus|sirolimus|mesh-list
14660701|NCT00241189|Methotrexate|methotrexate|mesh-list
14660702|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14660703|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
14660704|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14660705|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660706|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14660707|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
14660708|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660709|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660710|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14660711|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660712|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14660713|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660714|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
14660715|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660716|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14660717|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14660718|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660719|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14660720|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
14660721|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
14660722|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14660723|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14660724|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660725|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
14660726|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660727|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660728|NCT00241241|Interferons|interferons|mesh-list
14660729|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
14660730|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
14660731|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14660732|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660733|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
14660734|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660735|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
14660736|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660737|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
14660738|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14660739|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14660740|NCT00241254|Prednisolone|prednisolone|mesh-list
14660741|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
14660742|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
14660743|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14660744|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
14660745|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660746|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
14660747|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660748|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14660749|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14660750|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
14660751|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660752|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660753|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14660754|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660755|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
14660756|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
14660757|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660758|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660759|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
14660760|NCT00241254|Hormones|hormones|mesh-ancestor
14660761|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660762|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14660763|NCT00241254|Protective Agents|protective agents|mesh-ancestor
14660764|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15185455|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660765|NCT00241332|Fentanyl|fentanyl|mesh-list
14660766|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14660767|NCT00241332|Narcotics|narcotics|mesh-ancestor
14660768|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14660769|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660770|NCT00241332|Analgesics|analgesics|mesh-ancestor
14660771|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
14660772|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660773|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14660774|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14660775|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
14660776|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
14660777|NCT00241345|Valganciclovir|valganciclovir|mesh-list
14660778|NCT00241345|Ganciclovir|ganciclovir|mesh-list
14660779|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14660780|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
14660781|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660782|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14660783|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660784|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660785|NCT00241371|Clofarabine|clofarabine|mesh-list
14660786|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14660787|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
14660788|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660789|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660790|NCT00241423|Exenatide|exenatide|mesh-list
14660791|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660792|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660793|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14660794|NCT00241423|Incretins|incretins|mesh-ancestor
14660795|NCT00241423|Hormones|hormones|mesh-ancestor
14660796|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660797|NCT00241436|Anastrozole|anastrozole|mesh-list
14660798|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14660799|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660800|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14660801|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14660802|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660803|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660804|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14660805|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
14660806|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660807|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660808|NCT00241449|Tamoxifen|tamoxifen|mesh-list
14660809|NCT00241449|Fulvestrant|fulvestrant|mesh-list
14660810|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14660811|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
14660812|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660813|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660814|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14660815|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660816|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14660817|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14660818|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14660819|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14660820|NCT00241475|Gefitinib|gefitinib|mesh-list
14660821|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660822|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14660823|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660824|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660825|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14660826|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14660827|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14660828|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
15185456|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15185457|NCT03892447|Ferulic acid|ferulic acid|mesh-list
15185458|NCT03892447|Dopamine|dopamine|mesh-list
15185459|NCT03892447|Alprostadil|alprostadil|mesh-list
15185460|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15185461|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
15185462|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
15185463|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660829|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660830|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14660831|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14660832|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725923|NCT00506298|Diflunisal|diflunisal|mesh-list
14725924|NCT00506298|Bezafibrate|bezafibrate|mesh-list
14725925|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14725926|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
15185464|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725927|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725928|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14725929|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14725930|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725931|NCT00506298|Analgesics|analgesics|mesh-ancestor
14725932|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
15185465|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
15185466|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660833|NCT00241501|Esomeprazole|esomeprazole|mesh-list
14660834|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14660835|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660836|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14660837|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660838|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660839|NCT00241514|Esomeprazole|esomeprazole|mesh-list
14660840|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15185467|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185468|NCT03892447|Protective Agents|protective agents|mesh-ancestor
15185469|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15185470|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
15185471|NCT03892447|Urological Agents|urological agents|mesh-ancestor
15185472|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15185473|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15185474|NCT03892447|Analgesics|analgesics|mesh-ancestor
15185475|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
15185476|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660841|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660842|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14660843|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660844|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660845|NCT00241527|Esomeprazole|esomeprazole|mesh-list
14660846|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14660847|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660848|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14660849|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660850|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660851|NCT00241540|Esomeprazole|esomeprazole|mesh-list
14660852|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14660853|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660854|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14660855|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660856|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660857|NCT00241553|Esomeprazole|esomeprazole|mesh-list
14660858|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14660859|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660860|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14660861|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660862|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660863|NCT00241605|Metformin|metformin|mesh-list
14660864|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
14660865|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660866|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660867|NCT00241618|Interferons|interferons|mesh-list
14660868|NCT00241618|Ribavirin|ribavirin|mesh-list
14660869|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
14660870|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
14660871|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660872|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
14660873|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660874|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
14660875|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660876|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
14660877|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660878|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14660879|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14660880|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14660881|NCT00241722|Alvimopan|alvimopan|mesh-list
14660882|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660883|NCT00241982|Prednisolone|prednisolone|mesh-list
14660884|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660885|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
14660886|NCT00241982|Hormones|hormones|mesh-ancestor
14660887|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660888|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660889|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14660890|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185477|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15185478|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
15185479|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15185480|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14660891|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
14660892|NCT00242008|Rotigotine|rotigotine|mesh-list
15185481|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15185482|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15185483|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
15185484|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
15185485|NCT03892512|Esmolol|esmolol|mesh-list
15185486|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15185487|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185488|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185489|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15185490|NCT03892512|Analgesics|analgesics|mesh-ancestor
15185491|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
15185492|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185493|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14660893|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
14660894|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
14660895|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660896|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660897|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660898|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
14660899|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14660900|NCT00242177|Pioglitazone|pioglitazone|mesh-list
14660901|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660902|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660903|NCT00242190|Gemcitabine|gemcitabine|mesh-list
14660904|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
14660905|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14660906|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
14660907|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660908|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660909|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
14660910|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14660911|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660912|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14660913|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
14660914|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660915|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
14660916|NCT00242203|Docetaxel|docetaxel|mesh-list
14660917|NCT00242203|Trastuzumab|trastuzumab|mesh-list
14660918|NCT00242203|Epirubicin|epirubicin|mesh-list
14660919|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660920|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
14660921|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
14660922|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
14660923|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660924|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14660925|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14660926|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14660927|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14660928|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660929|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14660930|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660931|NCT00242268|Simvastatin|simvastatin|mesh-list
14660932|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14660933|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14660934|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
14660935|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660936|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14660937|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14660938|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14660939|NCT00242346|Candesartan|candesartan|mesh-list
14660940|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
14660941|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14660942|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15185494|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15185495|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14660943|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14660944|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660945|NCT00242359|Omalizumab|omalizumab|mesh-list
14660946|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14660947|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14660948|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
14660949|NCT00242372|Insulin|insulin|mesh-list
14660950|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14660951|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660952|NCT00242411|Budesonide|budesonide|mesh-list
14660953|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
14660954|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14660955|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14660956|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
14660957|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660958|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660959|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14660960|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
14660961|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
14660962|NCT00242411|Hormones|hormones|mesh-ancestor
14660963|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185496|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185497|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185498|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185499|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15185500|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15185501|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15185502|NCT03892434|Dexamethasone|dexamethasone|mesh-list
15185503|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
15185504|NCT03892434|Bevacizumab|bevacizumab|mesh-list
15185505|NCT03892434|BB 1101|bb 1101|mesh-list
15185506|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185507|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14660964|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14660965|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14660966|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14660967|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
14660968|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660969|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660970|NCT00242437|Thrombin|thrombin|mesh-list
14660971|NCT00242437|Hemostatics|hemostatics|mesh-list
14660972|NCT00242437|Coagulants|coagulants|mesh-ancestor
14660973|NCT00242450|Metoclopramide|metoclopramide|mesh-list
14660974|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
14660975|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
14660976|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14660977|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660978|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660979|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14660980|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14660981|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
14660982|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14660983|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14660984|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
14660985|NCT00242463|Nandrolone|nandrolone|mesh-list
14660986|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
14660987|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
14660988|NCT00242463|Androgens|androgens|mesh-ancestor
14660989|NCT00242463|Hormones|hormones|mesh-ancestor
14660990|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14660991|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660992|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
14660993|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14660994|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
14660995|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14660996|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14660997|NCT00242541|Octreotide|octreotide|mesh-list
14660998|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14660999|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661000|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661001|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
14661002|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14661003|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661004|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
15185508|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14661005|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14661006|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661007|NCT00242606|Lamotrigine|lamotrigine|mesh-list
14661008|NCT00242606|Levetiracetam|levetiracetam|mesh-list
14661009|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
14661010|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
14661011|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14661012|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14661013|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661014|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14661015|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661016|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14661017|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14661018|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661019|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661020|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14661021|NCT00242697|Anesthetics|anesthetics|mesh-list
14661022|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661023|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661024|NCT00242736|Esomeprazole|esomeprazole|mesh-list
14661025|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14661026|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661027|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14661028|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661029|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661030|NCT00242749|Gefitinib|gefitinib|mesh-list
14661031|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661032|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661033|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661034|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661035|NCT00242762|Docetaxel|docetaxel|mesh-list
14661036|NCT00242762|Gefitinib|gefitinib|mesh-list
14661037|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661038|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661039|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661040|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661041|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661042|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661043|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661044|NCT00242775|Fluticasone|fluticasone|mesh-list
14661045|NCT00242775|Budesonide|budesonide|mesh-list
14661046|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
14661047|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14661048|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661049|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14661050|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
14661051|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661052|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661053|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14661054|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14661055|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
14661056|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14661057|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
14661058|NCT00242775|Hormones|hormones|mesh-ancestor
14661059|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661060|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14661061|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14661062|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14661063|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14661064|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661065|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661066|NCT00242788|Capecitabine|capecitabine|mesh-list
14661067|NCT00242788|Gefitinib|gefitinib|mesh-list
14661068|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661069|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
14661070|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661071|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293561|NCT00569673|Trabectedin|trabectedin|mesh-list
14661072|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661073|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661074|NCT00242801|Gefitinib|gefitinib|mesh-list
14661075|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661076|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661077|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661078|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661079|NCT00242814|Amlodipine|amlodipine|mesh-list
14661080|NCT00242814|Telmisartan|telmisartan|mesh-list
14661081|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14661082|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15185509|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15185510|NCT03892434|Growth Substances|growth substances|mesh-ancestor
15185511|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185512|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
15185513|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661083|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14661084|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661085|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14661086|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661087|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
14661088|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14661089|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14661090|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
14661091|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14661092|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
14661093|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661094|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661095|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14661096|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
14661097|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14661098|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
14661099|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661100|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661101|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14661102|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
14661103|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
14661104|NCT00242853|Protective Agents|protective agents|mesh-ancestor
14661105|NCT00242879|Ritonavir|ritonavir|mesh-list
14661106|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14661107|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14661108|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
14661109|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661110|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661111|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14661112|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14661113|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
14661114|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661115|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14661116|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14661117|NCT00242918|Docetaxel|docetaxel|mesh-list
14661118|NCT00242918|Gefitinib|gefitinib|mesh-list
14661119|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661120|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661121|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661122|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661123|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661124|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661125|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661126|NCT00242944|Atorvastatin|atorvastatin|mesh-list
14661127|NCT00242944|Pitavastatin|pitavastatin|mesh-list
14661128|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15185514|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
15185515|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
15185516|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185517|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15185518|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
15185519|NCT03892434|Hormones|hormones|mesh-ancestor
15185520|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185521|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15185522|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
15185523|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185524|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661129|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15185525|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
14661130|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
14661131|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661132|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14661133|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14661134|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661135|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
14661136|NCT00242996|Carmustine|carmustine|mesh-list
14661137|NCT00242996|Rituximab|rituximab|mesh-list
14661138|NCT00242996|Etoposide|etoposide|mesh-list
14661139|NCT00242996|Sargramostim|sargramostim|mesh-list
14661140|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661141|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
14661142|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661143|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661144|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661145|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
14661146|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661147|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661148|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14661149|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14661150|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14661151|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14661152|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14661153|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661154|NCT00243009|Cyclosporine|cyclosporine|mesh-list
14661155|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
14661156|NCT00243009|Fludarabine|fludarabine|mesh-list
14661157|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
14661158|NCT00243009|Cyclosporins|cyclosporins|mesh-list
14661159|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661160|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661161|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
14661162|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661163|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661164|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
14661165|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661166|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661167|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
14661168|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661169|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14661170|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661171|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14661172|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14661173|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14661174|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
14661175|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661176|NCT00243035|Bortezomib|bortezomib|mesh-list
14661177|NCT00243035|Tipifarnib|tipifarnib|mesh-list
14661178|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725933|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725934|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725935|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725936|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725937|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14725938|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725939|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14725940|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
14725941|NCT00506311|Coagulants|coagulants|mesh-ancestor
14725942|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
14725943|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14725944|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
14725945|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725946|NCT00506506|Expectorants|expectorants|mesh-ancestor
14725947|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
14725948|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14725949|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
14725950|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725951|NCT00506506|Protective Agents|protective agents|mesh-ancestor
14725952|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725953|NCT00506506|Antidotes|antidotes|mesh-ancestor
14725954|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14725955|NCT00506532|Calfactant|calfactant|mesh-list
14725956|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
14725957|NCT00506545|Rolapitant|rolapitant|mesh-list
14725958|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14661179|NCT00243100|Gemcitabine|gemcitabine|mesh-list
14661180|NCT00243100|Vorinostat|vorinostat|mesh-list
14661181|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661182|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
14661183|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661184|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661185|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
14661186|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661187|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661188|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661189|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
14661190|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661191|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14661192|NCT00243113|Docetaxel|docetaxel|mesh-list
14661193|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661194|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661195|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661196|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661197|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661198|NCT00243178|Clopidogrel|clopidogrel|mesh-list
14661199|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14661200|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14661201|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14661202|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14661203|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
14661204|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661205|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661206|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661207|NCT00243204|Docetaxel|docetaxel|mesh-list
14661208|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661209|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661210|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
15185526|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
15185527|NCT03892330|Doxorubicin|doxorubicin|mesh-list
15185528|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15185529|NCT03892330|Vincristine|vincristine|mesh-list
15185530|NCT03892330|Pirarubicin|pirarubicin|mesh-list
15185531|NCT03892330|Epirubicin|epirubicin|mesh-list
15185532|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185533|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
14661211|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661212|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661213|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
14661214|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14661215|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661216|NCT00243256|Vitamins|vitamins|mesh-ancestor
14661217|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
14661218|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14661219|NCT00243399|Oxandrolone|oxandrolone|mesh-list
14661220|NCT00243399|Androgens|androgens|mesh-ancestor
14661221|NCT00243399|Hormones|hormones|mesh-ancestor
14661222|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661223|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661224|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
14661225|NCT00243464|Betamethasone|betamethasone|mesh-list
14661226|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
14661227|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14661228|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
14661229|NCT00243464|Calcipotriene|calcipotriene|mesh-list
14661230|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14661231|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661232|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
14661233|NCT00243464|Hormones|hormones|mesh-ancestor
14661234|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661235|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661236|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14661237|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14661238|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
14661239|NCT00243477|Citalopram|citalopram|mesh-list
14661240|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14661241|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14661242|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729272|NCT00522444|Analgesics|analgesics|mesh-ancestor
15185534|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185535|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15185536|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661243|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661244|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661245|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
14661246|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661247|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14661248|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
14293562|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293563|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
14293564|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661249|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661250|NCT00243646|Bicalutamide|bicalutamide|mesh-list
14661251|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661252|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661253|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
14661254|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14661255|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661256|NCT00243672|Atorvastatin|atorvastatin|mesh-list
14661257|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
14661258|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14661259|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14661260|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
14661261|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661262|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14661263|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14661264|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661265|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14661266|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14661267|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14661268|NCT00243711|Glycerol|glycerol|mesh-list
14661269|NCT00243711|Laxatives|laxatives|mesh-ancestor
14661270|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661271|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14661272|NCT00243711|Protective Agents|protective agents|mesh-ancestor
14661273|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661274|NCT00243724|Esomeprazole|esomeprazole|mesh-list
14661275|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14661276|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661277|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14661278|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661279|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661280|NCT00243737|Artesunate|artesunate|mesh-list
14661281|NCT00243737|Mefloquine|mefloquine|mesh-list
14661282|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
14661283|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14661284|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14661285|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661286|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661287|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
14661288|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
14661289|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14661290|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
14661291|NCT00243750|Methotrexate|methotrexate|mesh-list
14661292|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14661293|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
14661294|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14661295|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661296|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661297|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
14661298|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661299|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661300|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14661301|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661302|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14661303|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661304|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
14661305|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661306|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14661307|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
14661308|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14661309|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661310|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661311|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14661312|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14661313|NCT00243789|Protective Agents|protective agents|mesh-ancestor
14661314|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185537|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
15185538|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185539|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185540|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15185541|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15185542|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15185543|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15185544|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185545|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15185546|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
15185547|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
15185548|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
15185549|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15185550|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185551|NCT03892785|Prednisone|prednisone|mesh-list
15185552|NCT03892785|Methotrexate|methotrexate|mesh-list
15185553|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15185554|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
15185555|NCT03892785|Hormones|hormones|mesh-ancestor
14661315|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
14661316|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14661317|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
14661318|NCT00243815|Ibuprofen|ibuprofen|mesh-list
14661319|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14661320|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14661321|NCT00243815|Analgesics|analgesics|mesh-ancestor
14661322|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
15185556|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661323|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661324|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661325|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661326|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661327|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14661328|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661329|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661330|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14661331|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661332|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661333|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661334|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661335|NCT00243880|Lovastatin|lovastatin|mesh-list
14661336|NCT00243880|L 647318|l 647318|mesh-list
14661337|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
14661338|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14661339|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14661340|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
14661341|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661342|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14661343|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14661344|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661345|NCT00243893|Doxycycline|doxycycline|mesh-list
14661346|NCT00243893|Minocycline|minocycline|mesh-list
14661347|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661348|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661349|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
14661350|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14661351|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14661352|NCT00243945|Rotigotine|rotigotine|mesh-list
14661353|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
14661354|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
14661355|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661356|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661357|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661358|NCT00243984|Topiramate|topiramate|mesh-list
14661359|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
14661360|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14661361|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661362|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
14661363|NCT00244023|Testosterone|testosterone|mesh-list
14661364|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
14661365|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
14661366|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14661367|NCT00244023|Androgens|androgens|mesh-ancestor
14661368|NCT00244023|Hormones|hormones|mesh-ancestor
14661369|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661370|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661371|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661372|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661373|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
14661374|NCT00244075|Hormones|hormones|mesh-list
14661375|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661376|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661377|NCT00244127|Prednisone|prednisone|mesh-list
14661378|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
14661379|NCT00244127|Rituximab|rituximab|mesh-list
14661380|NCT00244127|Vincristine|vincristine|mesh-list
15185557|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185558|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15185559|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185560|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15185561|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
15185562|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15185563|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15185564|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
15185565|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661381|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661382|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
14661383|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661384|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661385|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661386|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
15185566|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
15185567|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185568|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15185569|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185570|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
15185571|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661387|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661388|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661389|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14661390|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14661391|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661392|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
14661393|NCT00244127|Hormones|hormones|mesh-ancestor
14661394|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661395|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661396|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14661397|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661398|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661399|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661400|NCT00244153|Dexamethasone|dexamethasone|mesh-list
14661401|NCT00244153|Morphine|morphine|mesh-list
14661402|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661403|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
14661404|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
14661405|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661406|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661407|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661408|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
14661409|NCT00244153|Hormones|hormones|mesh-ancestor
14661410|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661411|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661412|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661413|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14293565|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
14293566|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293567|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14293568|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
14293569|NCT00569777|Ketotifen|ketotifen|mesh-list
14293570|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
14293571|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14293572|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14661414|NCT00244153|Narcotics|narcotics|mesh-ancestor
14661415|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661416|NCT00244153|Analgesics|analgesics|mesh-ancestor
14661417|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
14661418|NCT00244166|Prednisolone|prednisolone|mesh-list
14661419|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661420|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
14661421|NCT00244166|Hormones|hormones|mesh-ancestor
14661422|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661423|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661424|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661425|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661426|NCT00244179|Interferons|interferons|mesh-list
14661427|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
14661428|NCT00244179|Infliximab|infliximab|mesh-list
14661429|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661430|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
14661431|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661432|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
14661433|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661434|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661435|NCT00244192|Infliximab|infliximab|mesh-list
14661436|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
14661437|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661438|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661439|NCT00244283|Sevoflurane|sevoflurane|mesh-list
14661440|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14661441|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14661442|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
14661443|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
14661444|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661445|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661446|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14661447|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14661448|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14661449|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14661450|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661451|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661452|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661453|NCT00244296|Analgesics|analgesics|mesh-ancestor
14661454|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
14661455|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661456|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
14661457|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661458|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
14661459|NCT00244309|Tamsulosin|tamsulosin|mesh-list
14661460|NCT00244309|Dutasteride|dutasteride|mesh-list
14661461|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14661462|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14661463|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14661464|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
14661465|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661466|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661467|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661468|NCT00244309|Urological Agents|urological agents|mesh-ancestor
14661469|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14661470|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14661471|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661472|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
14661473|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661474|NCT00244348|Fluorouracil|fluorouracil|mesh-list
14661475|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
14661476|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
14293573|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
14661477|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661478|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661479|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661480|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661481|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
14661482|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661483|NCT00244361|Rituximab|rituximab|mesh-list
14661484|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14661485|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661486|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
14661487|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661488|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661489|NCT00244426|Aspirin|aspirin|mesh-list
14661490|NCT00244426|Indobufen|indobufen|mesh-list
14661491|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14661492|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14661493|NCT00244426|Analgesics|analgesics|mesh-ancestor
14661494|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
14661495|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661496|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661497|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661498|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661499|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14661500|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14661501|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661502|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14661503|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14661504|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661505|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
14661506|NCT00244439|Permethrin|permethrin|mesh-list
14661507|NCT00244439|Malathion|malathion|mesh-list
14661508|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661509|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661510|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14661511|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14661512|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661513|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661514|NCT00244452|Cetrorelix|cetrorelix|mesh-list
14661515|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14661516|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
14661517|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14661518|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661519|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
14661520|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661521|NCT00244504|Moxonidine|moxonidine|mesh-list
14661522|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14661523|NCT00244517|Remifentanil|remifentanil|mesh-list
14661524|NCT00244517|Sevoflurane|sevoflurane|mesh-list
14661525|NCT00244517|Desflurane|desflurane|mesh-list
14661526|NCT00244517|Isoflurane|isoflurane|mesh-list
14661527|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
14661528|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661529|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661530|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14661531|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14661532|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
14661533|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14661534|NCT00244517|Narcotics|narcotics|mesh-ancestor
14661535|NCT00244517|Analgesics|analgesics|mesh-ancestor
14661536|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
14661537|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661538|NCT00244530|Nifedipine|nifedipine|mesh-list
14661539|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14661540|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14661541|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661542|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14661543|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661544|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
14661545|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
14661546|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14661547|NCT00244556|Etanercept|etanercept|mesh-list
14661548|NCT00244556|Methotrexate|methotrexate|mesh-list
14661549|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14661550|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
14661551|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14661552|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661553|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661554|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
14661555|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661556|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185572|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15185573|NCT03892421|Cytarabine|cytarabine|mesh-list
15185574|NCT03892421|Dexamethasone|dexamethasone|mesh-list
15185575|NCT03892421|Rituximab|rituximab|mesh-list
15185576|NCT03892421|Carboplatin|carboplatin|mesh-list
15185577|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15185578|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
15185579|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
15185580|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185581|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185582|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15185583|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
15185584|NCT03892421|Hormones|hormones|mesh-ancestor
15185585|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185586|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15185587|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185588|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185589|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
15185590|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15185591|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15185592|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
15185593|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185594|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
14293574|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
14661557|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
15185595|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185596|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661558|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661559|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14661560|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661561|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
14661562|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661563|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15185597|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
15185598|NCT03892122|Propofol|propofol|mesh-list
15185599|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15185600|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185601|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185602|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15185603|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
15185604|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
15185605|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15185606|NCT03892122|Analgesics|analgesics|mesh-ancestor
14293575|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293576|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185607|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
15185608|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185609|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14661564|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14661565|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14661566|NCT00244556|Analgesics|analgesics|mesh-ancestor
15185610|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15185611|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15185612|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185613|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185614|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185615|NCT03892395|Vitamin D|vitamin d|mesh-list
15185616|NCT03892395|Ergocalciferols|ergocalciferols|mesh-list
15185617|NCT03892395|Vitamins|vitamins|mesh-list
15185618|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
15185619|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
15185620|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185621|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15185622|NCT03892395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15185623|NCT03892213|Benzonidazole|benzonidazole|mesh-list
15185624|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185625|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
15185626|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185627|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15185628|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15185629|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14661567|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
14661568|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661569|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661570|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661571|NCT00244608|Budesonide|budesonide|mesh-list
14661572|NCT00244608|Terbutaline|terbutaline|mesh-list
14661573|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
14661574|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661575|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14661576|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
14661577|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661578|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661579|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14661580|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
14661581|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
14661582|NCT00244608|Hormones|hormones|mesh-ancestor
14661583|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661584|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14661585|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14661586|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14661587|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
14661588|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661589|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661590|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
14661591|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
14661592|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725959|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185630|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185631|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15185632|NCT03892148|Furosemide|furosemide|mesh-list
14661593|NCT00244738|Castor Oil|castor oil|mesh-list
14661594|NCT00244738|Cathartics|cathartics|mesh-ancestor
14661595|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661596|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
14661597|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661598|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661599|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661600|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661601|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
14661602|NCT00244907|Genistein|genistein|mesh-list
14661603|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14661604|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14661605|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661606|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14661607|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661608|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14661609|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14661610|NCT00244907|Protective Agents|protective agents|mesh-ancestor
14661611|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661612|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661613|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661614|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
14661615|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14293577|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293578|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14293579|NCT00569803|Abatacept|abatacept|mesh-list
14293580|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14293581|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661616|NCT00244907|Estrogens|estrogens|mesh-ancestor
14661617|NCT00244907|Hormones|hormones|mesh-ancestor
14661618|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661619|NCT00244920|Squalamine|squalamine|mesh-list
14661620|NCT00244920|Leuprolide|leuprolide|mesh-list
14661621|NCT00244920|Bicalutamide|bicalutamide|mesh-list
14661622|NCT00244920|Hormones|hormones|mesh-list
14661623|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
14661624|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661625|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661626|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14661627|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
14661628|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14661629|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661630|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661631|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
14661632|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661633|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661634|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15185633|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15185634|NCT03892148|Diuretics|diuretics|mesh-ancestor
15185635|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
15185636|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185637|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15185638|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15185639|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185640|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15185641|NCT03892044|Nivolumab|nivolumab|mesh-list
14661635|NCT00244920|Protective Agents|protective agents|mesh-ancestor
14661636|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14661637|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14661638|NCT00244920|Growth Substances|growth substances|mesh-ancestor
14661639|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
14661640|NCT00244946|Cytarabine|cytarabine|mesh-list
14661641|NCT00244946|Etoposide|etoposide|mesh-list
14661642|NCT00244946|Melphalan|melphalan|mesh-list
14661643|NCT00244946|Carmustine|carmustine|mesh-list
14661644|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14661645|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661646|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14661647|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14661648|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661649|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661650|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661651|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
14661652|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
14661653|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661654|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661655|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
14661656|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661657|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661658|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
14661659|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14661660|NCT00244959|Anastrozole|anastrozole|mesh-list
14661661|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661662|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661663|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14661664|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14661665|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661666|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661667|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14661668|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
14661669|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661670|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661671|NCT00244972|Sorafenib|sorafenib|mesh-list
14661672|NCT00244972|Tipifarnib|tipifarnib|mesh-list
14661673|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661674|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661675|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661676|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661677|NCT00244998|Fulvestrant|fulvestrant|mesh-list
14661678|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14661679|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661680|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14661681|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14661682|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
14661683|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661684|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661685|NCT00245024|Sulindac|sulindac|mesh-list
14661686|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14661687|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14661688|NCT00245024|Analgesics|analgesics|mesh-ancestor
14661689|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
14661690|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661691|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661692|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661693|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661694|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661695|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14661696|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661697|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661698|NCT00245089|Dactinomycin|dactinomycin|mesh-list
14661699|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
15185642|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185643|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185644|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15185645|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185646|NCT03891979|Metronidazole|metronidazole|mesh-list
15185647|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
15185648|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
15185649|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185650|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185651|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185652|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15185653|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15185654|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14661700|NCT00245089|Vincristine|vincristine|mesh-list
14661701|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661702|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
14661703|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661704|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661705|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661706|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
14661707|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661708|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661709|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14661710|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14661711|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661712|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661713|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661714|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661715|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661716|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14661717|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14661718|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185655|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15185656|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15185657|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185658|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185659|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15185660|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15185661|NCT03892070|Mannitol|mannitol|mesh-list
15185662|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15185663|NCT03892070|Diuretics|diuretics|mesh-ancestor
15185664|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
15185665|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185666|NCT03892161|Ritonavir|ritonavir|mesh-list
15185667|NCT03892161|Darunavir|darunavir|mesh-list
15185668|NCT03892161|Rifampin|rifampin|mesh-list
14661719|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14661720|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
14661721|NCT00245115|Busulfan|busulfan|mesh-list
15185669|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15185670|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15185671|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
15185672|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185673|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185674|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15185675|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15185676|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
15185677|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185678|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15185679|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15185680|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15185681|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
15185682|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15185683|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
15185684|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15185685|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15185686|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14661722|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661723|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
14661724|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661725|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661726|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661727|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
14661728|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661729|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661730|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14661731|NCT00245141|Dactinomycin|dactinomycin|mesh-list
14661732|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
14661733|NCT00245141|Vincristine|vincristine|mesh-list
14661734|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185687|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14661735|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
14661736|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661737|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661738|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661739|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
14661740|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661741|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661742|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14661743|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14661744|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661745|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661746|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661747|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661748|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661749|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14661750|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14661751|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661752|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14661753|NCT00245154|Paclitaxel|paclitaxel|mesh-list
14661754|NCT00245154|Carboplatin|carboplatin|mesh-list
14661755|NCT00245154|Cediranib|cediranib|mesh-list
14661756|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14661757|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661758|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
14661759|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
14661760|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
14661761|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661762|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661763|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14661764|NCT00245206|Olanzapine|olanzapine|mesh-list
14661765|NCT00245206|Risperidone|risperidone|mesh-list
14661766|NCT00245206|Aripiprazole|aripiprazole|mesh-list
14661767|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14661768|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
14661769|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661770|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661771|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661772|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14661773|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14661774|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661775|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661776|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14661777|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
14661778|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
14661779|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
14661780|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661781|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661782|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14661783|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14661784|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14661785|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
14661786|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
14661787|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14661788|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14661789|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14661790|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14661791|NCT00245245|Factor VIII|factor viii|mesh-list
14661792|NCT00245245|Coagulants|coagulants|mesh-ancestor
14661793|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
14661794|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661795|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
14661796|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14661797|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14661798|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661799|NCT00245258|Urological Agents|urological agents|mesh-ancestor
14661800|NCT00245297|Factor VIII|factor viii|mesh-list
14661801|NCT00245297|Coagulants|coagulants|mesh-ancestor
14661802|NCT00245336|Thrombin|thrombin|mesh-list
14661803|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
14661804|NCT00245336|Coagulants|coagulants|mesh-ancestor
14661805|NCT00245375|Acetaminophen|acetaminophen|mesh-list
14661806|NCT00245375|Ibuprofen|ibuprofen|mesh-list
14661807|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14661808|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14661809|NCT00245375|Analgesics|analgesics|mesh-ancestor
14661810|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
14661811|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661812|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661813|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661814|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661815|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14661816|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661817|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661818|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
14661819|NCT00245401|Sirolimus|sirolimus|mesh-list
14661820|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661821|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661822|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14661823|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661824|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
14661825|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661826|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
14661827|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661828|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14661829|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
14661830|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
14661831|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661832|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
14661833|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661834|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14661835|NCT00245427|Lactams|lactams|mesh-list
14661836|NCT00245427|beta-Lactams|beta-lactams|mesh-list
14661837|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14661838|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661839|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
14661840|NCT00245440|Azithromycin|azithromycin|mesh-list
14661841|NCT00245440|Telithromycin|telithromycin|mesh-list
14661842|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661843|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661844|NCT00245453|Azithromycin|azithromycin|mesh-list
14661845|NCT00245453|Clarithromycin|clarithromycin|mesh-list
14661846|NCT00245453|Telithromycin|telithromycin|mesh-list
14661847|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661848|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661849|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14661850|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661851|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661852|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14661853|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14661854|NCT00245505|Mesalamine|mesalamine|mesh-list
14661855|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14661856|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14661857|NCT00245505|Analgesics|analgesics|mesh-ancestor
14661858|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
14661859|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661860|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661861|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661862|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661863|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
14661864|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
14661865|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15185688|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15185689|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15185690|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15185691|NCT03891667|Disulfiram|disulfiram|mesh-list
15185692|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15185693|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15185694|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185695|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185696|NCT03891615|Niraparib|niraparib|mesh-list
15185697|NCT03891615|Osimertinib|osimertinib|mesh-list
15185698|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15185699|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185700|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185701|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661866|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14661867|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661868|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661869|NCT00245596|Urological Agents|urological agents|mesh-ancestor
14661870|NCT00245609|Pregabalin|pregabalin|mesh-list
14661871|NCT00245609|Alprazolam|alprazolam|mesh-list
14661872|NCT00245609|Analgesics|analgesics|mesh-ancestor
14661873|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
14661874|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661875|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661876|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
14661877|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14661878|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14661879|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661880|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14661881|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14661882|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14661883|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661884|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661885|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14661886|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
14661887|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
14661888|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661889|NCT00245661|Temazepam|temazepam|mesh-list
14661890|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14661891|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661892|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661893|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14661894|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14661895|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661896|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
14661897|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
14661898|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661899|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661900|NCT00245674|Amisulpride|amisulpride|mesh-list
14661901|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14661902|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14661903|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661904|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661905|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661906|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14661907|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
14661908|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661909|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661910|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14661911|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
14661912|NCT00245713|Levetiracetam|levetiracetam|mesh-list
14661913|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
14661914|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
14661915|NCT00245739|Darunavir|darunavir|mesh-list
14661916|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14661917|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14661918|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
14661919|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661920|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661921|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14661922|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14661923|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
14661924|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661925|NCT00245791|Levofloxacin|levofloxacin|mesh-list
14661926|NCT00245791|Ofloxacin|ofloxacin|mesh-list
14661927|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14661928|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661929|NCT00245791|Renal Agents|renal agents|mesh-ancestor
14661930|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661931|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14661932|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14661933|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661934|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661935|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661936|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14661937|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14661938|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
14661939|NCT00245895|Hematinics|hematinics|mesh-ancestor
14661940|NCT00245908|Azithromycin|azithromycin|mesh-list
14661941|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14661942|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14661943|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
14661944|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14661945|NCT00245921|Estradiol|estradiol|mesh-list
14661946|NCT00245921|Estrogens|estrogens|mesh-ancestor
14661947|NCT00245921|Hormones|hormones|mesh-ancestor
14661948|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14661949|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661950|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14661951|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
14661952|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14661953|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14661954|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14661955|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14661956|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14661957|NCT00245934|Etanercept|etanercept|mesh-list
14661958|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14661959|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14661960|NCT00245934|Analgesics|analgesics|mesh-ancestor
14661961|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
14661962|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14661963|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661964|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14661965|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661966|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661967|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661968|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
14661969|NCT00246064|Infliximab|infliximab|mesh-list
14661970|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
14661971|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14661972|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661973|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
14661974|NCT00246103|Fluorouracil|fluorouracil|mesh-list
14661975|NCT00246103|Epirubicin|epirubicin|mesh-list
14661976|NCT00246103|Valproic Acid|valproic acid|mesh-list
14661977|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14661978|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
14661979|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14661980|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14661981|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14661982|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
14661983|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14661984|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14661985|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14661986|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
14661987|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14661988|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14661989|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14661990|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14661991|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14661992|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
14661993|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
14661994|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14661995|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
14661996|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14661997|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14661998|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14661999|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
14662000|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14662001|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14662002|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14662003|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662004|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662005|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
14662006|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662007|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662008|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14662009|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662010|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
14662011|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14662012|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14662013|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14662014|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662015|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662016|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14662017|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662018|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662019|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14662020|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662021|NCT00246168|Acetaminophen|acetaminophen|mesh-list
14662022|NCT00246168|Tramadol|tramadol|mesh-list
14662023|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14662024|NCT00246168|Analgesics|analgesics|mesh-ancestor
14662025|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
14662026|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662027|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662028|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
14662029|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14662030|NCT00246168|Narcotics|narcotics|mesh-ancestor
14662031|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662032|NCT00246194|Risperidone|risperidone|mesh-list
14662033|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662034|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
14662035|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662036|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662037|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662038|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662039|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662040|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662041|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662042|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662043|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
14662044|NCT00246207|Methylphenidate|methylphenidate|mesh-list
14662045|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14662046|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662047|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662048|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662049|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662050|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662051|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
14662052|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662053|NCT00246220|Methylphenidate|methylphenidate|mesh-list
14662054|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14662055|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662056|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662057|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662058|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662059|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662060|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
14662061|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662062|NCT00246233|Methylphenidate|methylphenidate|mesh-list
14662063|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14662064|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662065|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662066|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662067|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662068|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662069|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
14662070|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662071|NCT00246246|Risperidone|risperidone|mesh-list
14662072|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662073|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
14662074|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662075|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662076|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662077|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662078|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662079|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662080|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662081|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662082|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
14662083|NCT00246272|Risperidone|risperidone|mesh-list
14662084|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662085|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
14662086|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662087|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662088|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662089|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662090|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662091|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662092|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662093|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662094|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
14662095|NCT00246285|Risperidone|risperidone|mesh-list
14662096|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662097|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
14662098|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662099|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662100|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662101|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662102|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662103|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662104|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662105|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662106|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
14662107|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
14662108|NCT00246298|Hematinics|hematinics|mesh-ancestor
14662109|NCT00246363|Silymarin|silymarin|mesh-list
14662110|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
14662111|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662112|NCT00246363|Protective Agents|protective agents|mesh-ancestor
14662113|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662114|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
14662115|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14662116|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662117|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662118|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14662119|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662120|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14662121|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662122|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662123|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662124|NCT00246402|Acipimox|acipimox|mesh-list
14662125|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14662126|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
14662127|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662128|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15185702|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15185703|NCT03891472|Fluorouracil|fluorouracil|mesh-list
15185704|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
15185705|NCT03891472|Irinotecan|irinotecan|mesh-list
15185706|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
15185707|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185708|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15185709|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185710|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185711|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
15185712|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185713|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15185714|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662129|NCT00246415|Memantine|memantine|mesh-list
14662130|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14662131|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14662132|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
14662133|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662134|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662135|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662136|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14662137|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14725960|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725961|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725962|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
14725963|NCT00506571|Irinotecan|irinotecan|mesh-list
14725964|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725965|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14725966|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725967|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725968|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725969|NCT00506623|Capecitabine|capecitabine|mesh-list
14725970|NCT00506623|Irinotecan|irinotecan|mesh-list
14725971|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725972|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
14725973|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725974|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725975|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14725976|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725977|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725978|NCT00506701|Tadalafil|tadalafil|mesh-list
14725979|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
14725980|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14725981|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14725982|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725983|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725984|NCT00506701|Urological Agents|urological agents|mesh-ancestor
14725985|NCT00506727|Amphetamine|amphetamine|mesh-list
14725986|NCT00506727|Adderall|adderall|mesh-list
14725987|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14725988|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14725989|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14725990|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14725991|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725992|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
14725993|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725994|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725995|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14725996|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
14725997|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
14725998|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725999|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
14726000|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14726001|NCT00506844|Capecitabine|capecitabine|mesh-list
14726002|NCT00506844|Irinotecan|irinotecan|mesh-list
14726003|NCT00506844|Cetuximab|cetuximab|mesh-list
15185715|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185716|NCT03891524|Enoxaparin|enoxaparin|mesh-list
15185717|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
15185718|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15185719|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15185720|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185721|NCT03891420|Galidesivir|galidesivir|mesh-list
15185722|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
15185723|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185724|NCT03891433|Meropenem|meropenem|mesh-list
15185725|NCT03891433|Tazobactam|tazobactam|mesh-list
15185726|NCT03891433|Piperacillin|piperacillin|mesh-list
15185727|NCT03891433|Ertapenem|ertapenem|mesh-list
15185728|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15185729|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185730|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15185731|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185732|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185733|NCT03891576|Niraparib|niraparib|mesh-list
15185734|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15185735|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185736|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185737|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185738|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15185739|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
15185740|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185741|NCT03891316|Sevoflurane|sevoflurane|mesh-list
15185742|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14662138|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14662139|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14662140|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
14662141|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662142|NCT00246467|Antacids|antacids|mesh-ancestor
14662143|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662144|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662145|NCT00246532|Morphine|morphine|mesh-list
14662146|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14662147|NCT00246532|Narcotics|narcotics|mesh-ancestor
14662148|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662149|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662150|NCT00246532|Analgesics|analgesics|mesh-ancestor
14662151|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
14662152|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662153|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
14662154|NCT00246597|Hematinics|hematinics|mesh-ancestor
14662155|NCT00246610|Nelfinavir|nelfinavir|mesh-list
14662156|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14662157|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14662158|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
14662159|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662160|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662161|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14662162|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14662163|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
14662164|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662165|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14662166|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662167|NCT00246636|Fenofibrate|fenofibrate|mesh-list
14662168|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14662169|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
14662170|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662171|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14662172|NCT00246675|Furosemide|furosemide|mesh-list
14662173|NCT00246675|Diuretics|diuretics|mesh-ancestor
14662174|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
14662175|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662176|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14662177|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662178|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662179|NCT00246688|Sagopilone|sagopilone|mesh-list
15185743|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15185744|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
15185745|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
15185746|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185747|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185748|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
15185749|NCT03891277|Hematinics|hematinics|mesh-ancestor
15185750|NCT03891095|Oxytocin|oxytocin|mesh-list
14662180|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662181|NCT00246701|Simvastatin|simvastatin|mesh-list
14662182|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14662183|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14662184|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
14662185|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662186|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14662187|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14662188|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662189|NCT00246909|Pantoprazole|pantoprazole|mesh-list
14662190|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14662191|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662192|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14662193|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662194|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662195|NCT00246974|Gemcitabine|gemcitabine|mesh-list
14662196|NCT00246974|Gefitinib|gefitinib|mesh-list
14662197|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662198|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14662199|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
14662200|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662201|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
14662202|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662203|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662204|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14662205|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
14662206|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662207|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14662208|NCT00247026|Ubiquinone|ubiquinone|mesh-list
14662209|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
14662210|NCT00247026|Curcumin|curcumin|mesh-list
14662211|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14662212|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14662213|NCT00247026|Analgesics|analgesics|mesh-ancestor
14662214|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
14662215|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662216|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662217|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14662218|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14662219|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662220|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662221|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662222|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
14662223|NCT00247026|Vitamins|vitamins|mesh-ancestor
14662224|NCT00247052|Diclofenac|diclofenac|mesh-list
14662225|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14662226|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14662227|NCT00247052|Analgesics|analgesics|mesh-ancestor
14662228|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
14662229|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662230|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293582|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662231|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14662232|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14662233|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14662234|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662235|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662236|NCT00247078|Antivenins|antivenins|mesh-list
14662237|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
14662238|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293583|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14662239|NCT00247117|Metformin|metformin|mesh-list
14662240|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14662241|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662242|NCT00247130|Omeprazole|omeprazole|mesh-list
14662243|NCT00247130|Ranitidine|ranitidine|mesh-list
14662244|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14662245|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14662246|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662247|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14662248|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662249|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662250|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14662251|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
14662252|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
14662253|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662254|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662255|NCT00247143|Lopinavir|lopinavir|mesh-list
14662256|NCT00247143|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14662257|NCT00247143|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14662258|NCT00247143|Protease Inhibitors|protease inhibitors|mesh-ancestor
14662259|NCT00247143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662260|NCT00247143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662261|NCT00247143|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14662262|NCT00247143|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14662263|NCT00247143|Antiviral Agents|antiviral agents|mesh-ancestor
14662264|NCT00247143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662265|NCT00247143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14662266|NCT00247143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14662267|NCT00247169|Progesterone|progesterone|mesh-list
14662268|NCT00247169|Progestins|progestins|mesh-ancestor
14662269|NCT00247169|Hormones|hormones|mesh-ancestor
14662270|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14662271|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662272|NCT00247208|Paclitaxel|paclitaxel|mesh-list
14662273|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14662274|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662275|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
14662276|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
14662277|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
14662278|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662279|NCT00247247|Entacapone|entacapone|mesh-list
14662280|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14662281|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14662282|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14662283|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662284|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662285|NCT00247364|Levetiracetam|levetiracetam|mesh-list
14662286|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
14662287|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
14662288|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
14662289|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
14662290|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662291|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
14662292|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662293|NCT00247481|Docetaxel|docetaxel|mesh-list
15185751|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
15185752|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15185753|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662294|NCT00247481|Gefitinib|gefitinib|mesh-list
14662295|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662296|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
14662297|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
14662298|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
14662299|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662300|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14662301|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662302|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
14662303|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14662304|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662305|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14662306|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
14662307|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14662308|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662309|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662310|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662311|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
14662312|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14662313|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
14662314|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662315|NCT00247507|Expectorants|expectorants|mesh-ancestor
14662316|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
14662317|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14662318|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
14662319|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662320|NCT00247507|Protective Agents|protective agents|mesh-ancestor
14662321|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662322|NCT00247507|Antidotes|antidotes|mesh-ancestor
14662323|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
14662324|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14662325|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14662326|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14662327|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662328|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662329|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
15223673|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15223674|NCT00321100|Growth Substances|growth substances|mesh-ancestor
14662330|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662331|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223675|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662332|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14662333|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662334|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14662335|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14662336|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662337|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662338|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662339|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662340|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662341|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
14662342|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662343|NCT00247585|Ethanol|ethanol|mesh-list
14662344|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14662345|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662346|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662347|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185754|NCT03891238|Avelumab|avelumab|mesh-list
15185755|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14662348|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
14662349|NCT00247650|Letrozole|letrozole|mesh-list
14662350|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662351|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14662352|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14662353|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662354|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662355|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14662356|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
14662357|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14662358|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662359|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14662360|NCT00247663|Letrozole|letrozole|mesh-list
14662361|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662362|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14662363|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14662364|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662365|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662366|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14662367|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
14662368|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14662369|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662370|NCT00247702|Warfarin|warfarin|mesh-list
14662371|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
14662372|NCT00247715|Pantoprazole|pantoprazole|mesh-list
14662373|NCT00247715|Ranitidine|ranitidine|mesh-list
14662374|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14662375|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
14662376|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14662377|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14662378|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662379|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14662380|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662381|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662382|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14662383|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
14662384|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
14662385|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662386|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662387|NCT00247715|Antacids|antacids|mesh-ancestor
14662388|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14662389|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
14662390|NCT00247741|Lidocaine|lidocaine|mesh-list
14662391|NCT00247741|Carticaine|carticaine|mesh-list
14662392|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
14662393|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
14662394|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662395|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662396|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
14662397|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662398|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14662399|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14662400|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14662401|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662402|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662403|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14662404|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14662405|NCT00247910|Diuretics|diuretics|mesh-ancestor
14662406|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
14662407|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662408|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14662409|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662410|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726004|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14726005|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
14726006|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726007|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726008|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14726009|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726010|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726011|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726012|NCT00506935|Vigabatrin|vigabatrin|mesh-list
14726013|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
14726014|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726015|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726016|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
14726017|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726018|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726019|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14726020|NCT00506961|Simvastatin|simvastatin|mesh-list
14726021|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14726022|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14726023|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
14726024|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726025|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14726026|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14726027|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726028|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
14726029|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14726030|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14726031|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
14726032|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
14726033|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726034|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726035|NCT00507000|Vitamin D|vitamin d|mesh-list
14726036|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
14726037|NCT00507000|Vitamins|vitamins|mesh-ancestor
14726038|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
14726039|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726040|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14726041|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14726042|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
14726043|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14726044|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
14726045|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726046|NCT00507052|Expectorants|expectorants|mesh-ancestor
14726047|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14726048|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14726049|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
14726050|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726051|NCT00507052|Protective Agents|protective agents|mesh-ancestor
14726052|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726053|NCT00507052|Antidotes|antidotes|mesh-ancestor
14726054|NCT00507065|Amphetamine|amphetamine|mesh-list
14726055|NCT00507065|Adderall|adderall|mesh-list
14726056|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14726057|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726058|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
14726059|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
14726060|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726061|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
14726062|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726063|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726064|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14726065|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14726066|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814599|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15185756|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726067|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662411|NCT00247988|Carboplatin|carboplatin|mesh-list
14662412|NCT00247988|Docetaxel|docetaxel|mesh-list
15185757|NCT03890952|Bevacizumab|bevacizumab|mesh-list
15185758|NCT03890952|Nivolumab|nivolumab|mesh-list
15185759|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
15185760|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185761|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185762|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15185763|NCT03890952|Growth Substances|growth substances|mesh-ancestor
15185764|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185765|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
14662413|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662414|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
14662415|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
14662416|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
14662417|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662418|NCT00248053|Curcumin|curcumin|mesh-list
14662419|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14662420|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14662421|NCT00248053|Analgesics|analgesics|mesh-ancestor
14662422|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
14662423|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662424|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662425|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14662426|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14662427|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662428|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662429|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662430|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14662431|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14662432|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662433|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662434|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662435|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662436|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662437|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
14662438|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662439|NCT00248118|Bupropion|bupropion|mesh-list
14662440|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14662441|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662442|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662443|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662444|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662445|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662446|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662447|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
14662448|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662449|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662450|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15185766|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15185767|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185768|NCT03891173|Vinorelbine|vinorelbine|mesh-list
15185769|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185770|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15185771|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
15185772|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
15185773|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
15185774|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662451|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14662452|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662453|NCT00248131|Octreotide|octreotide|mesh-list
14662454|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662455|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14662456|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662457|NCT00248144|Famciclovir|famciclovir|mesh-list
14662458|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
14662459|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662460|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14662461|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662462|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662463|NCT00248157|Octreotide|octreotide|mesh-list
14662464|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662465|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14662466|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662467|NCT00248183|Naluzotan|naluzotan|mesh-list
14662468|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14662469|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14662470|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
14662471|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662472|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662473|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662474|NCT00248209|Bupropion|bupropion|mesh-list
14662475|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14662476|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662477|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662478|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662479|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662480|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662481|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662482|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
14662483|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662484|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662485|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14662486|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14662487|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662488|NCT00248248|Doxorubicin|doxorubicin|mesh-list
14662489|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14662490|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14662491|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662492|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14662493|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662494|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662495|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662496|NCT00248261|Ziprasidone|ziprasidone|mesh-list
14662497|NCT00248261|Sertraline|sertraline|mesh-list
14662498|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662499|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662500|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14662501|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662502|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662503|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662504|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662505|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
14662506|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662507|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662508|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662509|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662510|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662511|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662512|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
14662513|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
14662514|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14662515|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662516|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
14662517|NCT00248313|Sirolimus|sirolimus|mesh-list
14662518|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14662519|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662520|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14662521|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662522|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
14662523|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14662524|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
14662525|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662526|NCT00248339|Ribavirin|ribavirin|mesh-list
14662527|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15185775|NCT03890809|BMS-986165|bms-986165|mesh-list
15185776|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
15185777|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15185778|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185779|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185780|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
15185781|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15185782|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15185783|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15185784|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15185785|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185786|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
15185787|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185788|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662528|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
14662529|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
14662530|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662531|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
14662532|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662533|NCT00248339|Hematinics|hematinics|mesh-ancestor
14662534|NCT00248430|Aldesleukin|aldesleukin|mesh-list
14662535|NCT00248430|Melphalan|melphalan|mesh-list
14662536|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14662537|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
14662538|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662539|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662540|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14662541|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14662542|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
14662543|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662544|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14662545|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14662546|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
14662547|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662548|NCT00248456|Betamethasone|betamethasone|mesh-list
14662549|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
14662550|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14662551|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
14662552|NCT00248456|Calcipotriene|calcipotriene|mesh-list
14662553|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14662554|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14662555|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
14662556|NCT00248456|Hormones|hormones|mesh-ancestor
14662557|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14662558|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662559|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14662560|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
14662561|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
14662562|NCT00248482|Cisplatin|cisplatin|mesh-list
14662563|NCT00248482|Irinotecan|irinotecan|mesh-list
14662564|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
14662565|NCT00248482|Camptothecin|camptothecin|mesh-list
14662566|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662567|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14662568|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662569|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662570|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662571|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15185789|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15185790|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185791|NCT03891043|Selenium|selenium|mesh-list
15185792|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
15185793|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185794|NCT03891043|Protective Agents|protective agents|mesh-ancestor
14662572|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14662573|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
14662574|NCT00248716|Hematinics|hematinics|mesh-ancestor
14662575|NCT00248729|Midazolam|midazolam|mesh-list
14662576|NCT00248729|Etomidate|etomidate|mesh-list
14662577|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14662578|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14662579|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662580|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662581|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14662582|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662583|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662584|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14662585|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
14662586|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
14662587|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
14662588|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
14662589|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662590|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662591|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
14662592|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14662593|NCT00248963|Estradiol|estradiol|mesh-list
14662594|NCT00248963|Estrogens|estrogens|mesh-ancestor
14662595|NCT00248963|Hormones|hormones|mesh-ancestor
14662596|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14662597|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662598|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14662599|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
14662600|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14662601|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14662602|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14662603|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14662604|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14662605|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14662606|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14662607|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
14662608|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662609|NCT00249041|Etanercept|etanercept|mesh-list
14662610|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14662611|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14662612|NCT00249041|Analgesics|analgesics|mesh-ancestor
14662613|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
14662614|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662615|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662616|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14662617|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14662618|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662619|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14662620|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
14662621|NCT00249106|Vaccines|vaccines|mesh-list
14662622|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
14662623|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662624|NCT00249119|Risperidone|risperidone|mesh-list
14662625|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662626|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
14662627|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662628|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662629|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662630|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662631|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662632|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662633|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662634|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662635|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
14662636|NCT00249132|Risperidone|risperidone|mesh-list
14662637|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662638|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
14662639|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662640|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662641|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662642|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662643|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662644|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662645|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662646|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662647|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
14662648|NCT00249145|Risperidone|risperidone|mesh-list
14662649|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662650|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
14662651|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662652|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662653|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662654|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662655|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662656|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662657|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662658|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662659|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
15185795|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185796|NCT03891043|Trace Elements|trace elements|mesh-ancestor
15185797|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
15185798|NCT03890770|BMS-986165|bms-986165|mesh-list
15185799|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
15185800|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15185801|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185802|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185803|NCT03890341|Drospirenone|drospirenone|mesh-list
15185804|NCT03890341|Midazolam|midazolam|mesh-list
15185805|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15185806|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15185807|NCT03890341|Betadex|betadex|mesh-list
15185808|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15185809|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15185810|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662660|NCT00249158|Risperidone|risperidone|mesh-list
14662661|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662662|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
14662663|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662664|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662665|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662666|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662667|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662668|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662669|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662670|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662671|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
14662672|NCT00249171|Risperidone|risperidone|mesh-list
14662673|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662674|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
14662675|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662676|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662677|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662678|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662679|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662680|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662681|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662682|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662683|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
14662684|NCT00249197|Levofloxacin|levofloxacin|mesh-list
14662685|NCT00249197|Ofloxacin|ofloxacin|mesh-list
14662686|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14662687|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662688|NCT00249197|Renal Agents|renal agents|mesh-ancestor
14662689|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14662690|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14662691|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662692|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662693|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662694|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662695|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14662696|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14662697|NCT00249210|Levofloxacin|levofloxacin|mesh-list
14662698|NCT00249210|Ofloxacin|ofloxacin|mesh-list
14662699|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14662700|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662701|NCT00249210|Renal Agents|renal agents|mesh-ancestor
14662702|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14662703|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14662704|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662705|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185811|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185812|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15185813|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662706|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662707|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662708|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14662709|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14662710|NCT00249223|Risperidone|risperidone|mesh-list
14662711|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662712|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
14662713|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662714|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662715|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662716|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662717|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662718|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662719|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662720|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662721|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
14662722|NCT00249236|Risperidone|risperidone|mesh-list
14662723|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662724|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
14662725|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662726|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662727|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662728|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14662729|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662730|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662731|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662732|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14662733|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
14662734|NCT00249353|Methylphenidate|methylphenidate|mesh-list
14662735|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14662736|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662737|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662738|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662739|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662740|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662741|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
14662742|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662743|NCT00249366|Lorazepam|lorazepam|mesh-list
14662744|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
14662745|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
14662746|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
14662747|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662748|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662749|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14662750|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14662751|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662752|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14662753|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14662754|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662755|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
14662756|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
14662757|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662758|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662759|NCT00249405|Citalopram|citalopram|mesh-list
14662760|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14662761|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662762|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662763|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293584|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
14293585|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293586|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293587|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
14293588|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14293589|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14293590|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
14293591|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293592|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293593|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293594|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14293595|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
14293596|NCT00569946|Axitinib|axitinib|mesh-list
14293597|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293598|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14662764|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662765|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
14662766|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662767|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14662768|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662769|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662770|NCT00249431|Sertraline|sertraline|mesh-list
14662771|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662772|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662773|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14662774|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14293599|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662775|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662776|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662777|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662778|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
14662779|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662780|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15185814|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15185815|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15185816|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
15185817|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
15185818|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
15185819|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
14662781|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14662782|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662783|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662784|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662785|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662786|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662787|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14662788|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662789|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662790|NCT00249509|Bupropion|bupropion|mesh-list
14293600|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293601|NCT00570089|Ranolazine|ranolazine|mesh-list
14293602|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14293603|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662791|NCT00249509|Nefazodone|nefazodone|mesh-list
14662792|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14662793|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662794|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662795|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14662796|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662797|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662798|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662799|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
14662800|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662801|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662802|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14662803|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14662804|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662805|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14662806|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14662807|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14662808|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
14662809|NCT00249574|Buprenorphine|buprenorphine|mesh-list
14662810|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14662811|NCT00249574|Naloxone|naloxone|mesh-list
14662812|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14662813|NCT00249574|Narcotics|narcotics|mesh-ancestor
14662814|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185820|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185821|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185822|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15185823|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15185824|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15185825|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
15223676|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
14662815|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662816|NCT00249574|Analgesics|analgesics|mesh-ancestor
14662817|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
14662818|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662819|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14662820|NCT00249587|Methadone|methadone|mesh-list
14662821|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14662822|NCT00249587|Narcotics|narcotics|mesh-ancestor
15185826|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15185827|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15185828|NCT03890341|Estrogens|estrogens|mesh-ancestor
15185829|NCT03890341|Hormones|hormones|mesh-ancestor
15185830|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14662823|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14662824|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662825|NCT00249587|Analgesics|analgesics|mesh-ancestor
14662826|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
14662827|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14662828|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
14662829|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
14726068|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14726069|NCT00507091|Leucovorin|leucovorin|mesh-list
14726070|NCT00507091|Fluorouracil|fluorouracil|mesh-list
14726071|NCT00507091|Irinotecan|irinotecan|mesh-list
14726072|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
14726073|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726074|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14726075|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726076|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726077|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
14726078|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726079|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14726080|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726081|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726082|NCT00507091|Antidotes|antidotes|mesh-ancestor
14726083|NCT00507091|Protective Agents|protective agents|mesh-ancestor
14726084|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
14726085|NCT00507091|Vitamins|vitamins|mesh-ancestor
14726086|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
14726087|NCT00507117|Eszopiclone|eszopiclone|mesh-list
14726088|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14726089|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726090|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726091|NCT00507143|Irinotecan|irinotecan|mesh-list
14726092|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14726093|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726094|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726095|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726096|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726097|NCT00507195|Midazolam|midazolam|mesh-list
14726098|NCT00507195|Propofol|propofol|mesh-list
14726099|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14726100|NCT00507195|Sevoflurane|sevoflurane|mesh-list
15185831|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15185832|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
15185833|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15185834|NCT03890341|Diuretics|diuretics|mesh-ancestor
15185835|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
15185836|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
15185837|NCT03890406|Rocuronium|rocuronium|mesh-list
14726101|NCT00507195|Desflurane|desflurane|mesh-list
14662830|NCT00249691|Topiramate|topiramate|mesh-list
14662831|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
14662832|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14662833|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662834|NCT00249704|Vitamin D|vitamin d|mesh-list
14662835|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
14662836|NCT00249704|Vitamins|vitamins|mesh-list
14662837|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
14662838|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662839|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14662840|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14662841|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
14662842|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
14662843|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14662844|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14662845|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662846|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662847|NCT00249730|Urological Agents|urological agents|mesh-ancestor
14662848|NCT00249782|Metronidazole|metronidazole|mesh-list
14662849|NCT00249782|Dapsone|dapsone|mesh-list
14662850|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662851|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14662852|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14662853|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14662854|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
14662855|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14662856|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662857|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662858|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
14662859|NCT00249847|Paroxetine|paroxetine|mesh-list
14662860|NCT00249847|Estrogens|estrogens|mesh-list
14662861|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14662862|NCT00249847|Hormones|hormones|mesh-ancestor
14662863|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14662864|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662865|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14662866|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662867|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662868|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662869|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662870|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
14662871|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14662872|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662873|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14662874|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14662875|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14662876|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662877|NCT00249860|Interferons|interferons|mesh-list
14662878|NCT00249860|Ribavirin|ribavirin|mesh-list
14662879|NCT00249860|Interferon-beta|interferon-beta|mesh-list
14662880|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
14662881|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662882|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
14662883|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14662884|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
14662885|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662886|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
14662887|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662888|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14662889|NCT00249886|Citalopram|citalopram|mesh-list
14662890|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14662891|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14662892|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662893|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662894|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662895|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
14662896|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662897|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14662898|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662899|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15185838|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15185839|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14662900|NCT00249899|Atorvastatin|atorvastatin|mesh-list
14662901|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14662902|NCT00249899|Simvastatin|simvastatin|mesh-list
14662903|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14662904|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14662905|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14662906|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
14662907|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662908|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14662909|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662910|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14662911|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14662912|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14662913|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
14662914|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662915|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14662916|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14662917|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662918|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14662919|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14662920|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14662921|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
14662922|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662923|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14662924|NCT00249964|Paclitaxel|paclitaxel|mesh-list
14662925|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14662926|NCT00249964|Carboplatin|carboplatin|mesh-list
15185840|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15185841|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185842|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185843|NCT03890510|Anesthetics|anesthetics|mesh-list
14662927|NCT00249964|Temozolomide|temozolomide|mesh-list
14662928|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14662929|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662930|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
14662931|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
14662932|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
14662933|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662934|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14662935|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
14662936|NCT00249977|Capecitabine|capecitabine|mesh-list
14662937|NCT00249977|Irinotecan|irinotecan|mesh-list
14662938|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662939|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14662940|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
14662941|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662942|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14662943|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662944|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662945|NCT00250029|Capecitabine|capecitabine|mesh-list
14662946|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
14662947|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14662948|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
15185844|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185845|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185846|NCT03890094|Sufentanil|sufentanil|mesh-list
14662949|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662950|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662951|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
14662952|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
14662953|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185847|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15185848|NCT03890094|Narcotics|narcotics|mesh-ancestor
14662954|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14662955|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662956|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662957|NCT00250068|Rubitecan|rubitecan|mesh-list
14662958|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662959|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14662960|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662961|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662962|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662963|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
14662964|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14662965|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14662966|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662967|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14662968|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662969|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662970|NCT00250094|Topotecan|topotecan|mesh-list
14662971|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14662972|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662973|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662974|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662975|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662976|NCT00250120|Camptothecin|camptothecin|mesh-list
14662977|NCT00250120|Rubitecan|rubitecan|mesh-list
14662978|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14662979|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14662980|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14662981|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14662982|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662983|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662984|NCT00250172|Rolipram|rolipram|mesh-list
14662985|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
14662986|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15185849|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15185850|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185851|NCT03890094|Analgesics|analgesics|mesh-ancestor
15185852|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
15185853|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185854|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15185855|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15185856|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
15185857|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
15185858|NCT03889717|Vitamin D|vitamin d|mesh-list
15185859|NCT03889717|Vitamins|vitamins|mesh-ancestor
15185860|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
15185861|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185862|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15185863|NCT03889808|Antitoxins|antitoxins|mesh-list
15185864|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
15185865|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185866|NCT03890042|Dienogest|dienogest|mesh-list
15185867|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15185868|NCT03890042|Gestodene|gestodene|mesh-list
15185869|NCT03890042|Femovan|femovan|mesh-list
15185870|NCT03890042|Estradiol|estradiol|mesh-list
15185871|NCT03890042|Estrogens|estrogens|mesh-ancestor
15185872|NCT03890042|Hormones|hormones|mesh-ancestor
15185873|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15185874|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185875|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15185876|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
15185877|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15185878|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15185879|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15185880|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15185881|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15185882|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
15185883|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15185884|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185885|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15185886|NCT03890042|Progestins|progestins|mesh-ancestor
15185887|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15185888|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15185889|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15185890|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
15185891|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14662987|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14662988|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14662989|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14662990|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662991|NCT00250185|Acetylcholine|acetylcholine|mesh-list
14662992|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
14662993|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14662994|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
14662995|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14662996|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14662997|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14662998|NCT00250237|Haloperidol|haloperidol|mesh-list
14662999|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
14663000|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
14663001|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
14663002|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663003|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663004|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663005|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663006|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663007|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663008|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663009|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663010|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
14663011|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663012|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663013|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14663014|NCT00250315|Dobutamine|dobutamine|mesh-list
14663015|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14663016|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
14663017|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
14663018|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663019|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663020|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14663021|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14663022|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14663023|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663024|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663025|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663026|NCT00250315|Protective Agents|protective agents|mesh-ancestor
14663027|NCT00250354|Risperidone|risperidone|mesh-list
14663028|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14663029|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
14663030|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663031|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185892|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185893|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
14663032|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663033|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663034|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663035|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663036|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663037|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663038|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
14663039|NCT00250367|Risperidone|risperidone|mesh-list
14663040|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14663041|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
14663042|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663043|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663044|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663045|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663046|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663047|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663048|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663049|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663050|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
14663051|NCT00250393|Istradefylline|istradefylline|mesh-list
14663052|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14663053|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14663054|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14663055|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
14663056|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663057|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663058|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663059|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
14663060|NCT00250536|Nandrolone|nandrolone|mesh-list
14663061|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
14663062|NCT00250536|Androgens|androgens|mesh-ancestor
14663063|NCT00250536|Hormones|hormones|mesh-ancestor
14663064|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663065|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663066|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
14663067|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14663068|NCT00250562|Valsartan|valsartan|mesh-list
14663069|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14663070|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14663071|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14663072|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14663073|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663074|NCT00250562|Diuretics|diuretics|mesh-ancestor
14663075|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
14663076|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663077|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14663078|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14663079|NCT00250575|Clozapine|clozapine|mesh-list
14663080|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14663081|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
14663082|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663083|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663084|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663085|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663086|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663087|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663088|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663089|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
14663090|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
14663091|NCT00250640|Iloprost|iloprost|mesh-list
14663092|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14663093|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
14663094|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
14663095|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14663096|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
15185894|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
15185895|NCT03889288|Analgesics|analgesics|mesh-list
15185896|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
15185897|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185898|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185899|NCT03889379|Albuterol|albuterol|mesh-list
15185900|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15185901|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
15185902|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185903|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185904|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14663097|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
15185905|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
15185906|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
15185907|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15185908|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15185909|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15185910|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15185911|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
15185912|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185913|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185914|NCT03889626|Capecitabine|capecitabine|mesh-list
15185915|NCT03889626|Apatinib|apatinib|mesh-list
15185916|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15185917|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
15185918|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185919|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185920|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15185921|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663098|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663099|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663100|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14663101|NCT00250692|Analgesics|analgesics|mesh-ancestor
14663102|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
14663103|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185922|NCT03889366|Aprepitant|aprepitant|mesh-list
15185923|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
15185924|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
15185925|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15185926|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185927|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15185928|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15185929|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185930|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185931|NCT03888924|Vaccines|vaccines|mesh-list
15185932|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
15185933|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
15185934|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185935|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14293604|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293605|NCT00570128|Donepezil|donepezil|mesh-list
14663104|NCT00250744|Gabapentin|gabapentin|mesh-list
14663105|NCT00250744|Aprepitant|aprepitant|mesh-list
14663106|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
14663107|NCT00250744|Analgesics|analgesics|mesh-ancestor
14663108|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
14663109|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663110|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663111|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
14663112|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14663113|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663114|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663115|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663116|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14663117|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14663118|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663119|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663120|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
14663121|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
14663122|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
14663123|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663124|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14663125|NCT00250796|Interferons|interferons|mesh-list
14663126|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
14663127|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14663128|NCT00250796|Thalidomide|thalidomide|mesh-list
14663129|NCT00250796|Octreotide|octreotide|mesh-list
14663130|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663131|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
14663132|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663133|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14663134|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
14663135|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663136|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
14663137|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14663138|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15185936|NCT03888846|Colchicine|colchicine|mesh-list
15185937|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
15185938|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
14663139|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14663140|NCT00250796|Growth Substances|growth substances|mesh-ancestor
14663141|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
14663142|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663143|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14663144|NCT00250861|Aldesleukin|aldesleukin|mesh-list
14663145|NCT00250861|Rituximab|rituximab|mesh-list
14663146|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663147|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663148|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
14663149|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663150|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14663151|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14663152|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14663153|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
14663154|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663155|NCT00250874|Docetaxel|docetaxel|mesh-list
14663156|NCT00250874|Doxorubicin|doxorubicin|mesh-list
14663157|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14663158|NCT00250874|Trastuzumab|trastuzumab|mesh-list
14663159|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663160|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663161|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663162|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663163|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663164|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14663165|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14663166|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14663167|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663168|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663169|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14663170|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14663171|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14663172|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663173|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663174|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14663175|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14663176|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663177|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663178|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663179|NCT00250978|Bevacizumab|bevacizumab|mesh-list
14663180|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663181|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663182|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14663183|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14663184|NCT00250978|Growth Substances|growth substances|mesh-ancestor
14663185|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663186|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14663187|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14663188|NCT00250991|Eptifibatide|eptifibatide|mesh-list
14663189|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14663190|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14663191|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663192|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14663193|NCT00251017|Vancomycin|vancomycin|mesh-list
14663194|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14663195|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663196|NCT00251030|Nelfinavir|nelfinavir|mesh-list
14663197|NCT00251030|Omeprazole|omeprazole|mesh-list
14663198|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14663199|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663200|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14663201|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663202|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663203|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14663204|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14663205|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
14663206|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14663207|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14663208|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
14663209|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663210|NCT00251056|Mannitol|mannitol|mesh-list
14663211|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14663212|NCT00251056|Diuretics|diuretics|mesh-ancestor
14663213|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
14663214|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663215|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14663216|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14663217|NCT00251082|Estradiol|estradiol|mesh-list
14663218|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14663219|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
14663220|NCT00251082|Estrogens|estrogens|mesh-ancestor
14663221|NCT00251082|Hormones|hormones|mesh-ancestor
14663222|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663223|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663224|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14663225|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
14663226|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14663227|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14663228|NCT00251082|Progestins|progestins|mesh-ancestor
14663229|NCT00251095|Paclitaxel|paclitaxel|mesh-list
14663230|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14663231|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663232|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663233|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663234|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663235|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663236|NCT00251186|Capecitabine|capecitabine|mesh-list
14663237|NCT00251186|Cetuximab|cetuximab|mesh-list
14663238|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14663239|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
14663240|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663241|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663242|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663243|NCT00251277|Rituximab|rituximab|mesh-list
14663244|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663245|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663246|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
14663247|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663248|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726102|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726103|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726104|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14726105|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
14726106|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
14726107|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14726108|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14726109|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14726110|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14726111|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
14726112|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
14726113|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726114|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726115|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14726116|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14726117|NCT00507221|Albendazole|albendazole|mesh-list
14726118|NCT00507221|Praziquantel|praziquantel|mesh-list
14726119|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
14726120|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14726121|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726122|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
14726123|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14726124|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14726125|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
14726126|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
14726127|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
14726128|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726129|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726130|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
14726131|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14726132|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
14726133|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726134|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726135|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14726136|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
14726137|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14726138|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14726139|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14726140|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663249|NCT00251355|Gemcitabine|gemcitabine|mesh-list
14663250|NCT00251355|Fluorouracil|fluorouracil|mesh-list
14663251|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14663252|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
14663253|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663254|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663255|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
14663256|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663257|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663258|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14663259|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
14663260|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663261|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
14663262|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663263|NCT00251381|Cetuximab|cetuximab|mesh-list
14663264|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663265|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663266|NCT00251394|Rituximab|rituximab|mesh-list
14663267|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663268|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663269|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
14663270|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663271|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14663272|NCT00251407|Docetaxel|docetaxel|mesh-list
14663273|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663274|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663275|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663276|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663277|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663278|NCT00251433|Docetaxel|docetaxel|mesh-list
14663279|NCT00251433|Trastuzumab|trastuzumab|mesh-list
14663280|NCT00251433|Lapatinib|lapatinib|mesh-list
14663281|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663282|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663283|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663284|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663285|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663286|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663287|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14663288|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663289|NCT00251459|Ranibizumab|ranibizumab|mesh-list
14663290|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14663291|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14663292|NCT00251459|Growth Substances|growth substances|mesh-ancestor
14663293|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663294|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
14663295|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663296|NCT00251472|Paclitaxel|paclitaxel|mesh-list
14663297|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14663298|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663299|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663300|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663301|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663302|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663303|NCT00251485|Cetuximab|cetuximab|mesh-list
14663304|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663305|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663306|NCT00251498|Cetuximab|cetuximab|mesh-list
14663307|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293606|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14293607|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293608|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293609|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293610|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293611|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293612|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
14663308|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663309|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
14663310|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663311|NCT00251524|Bevacizumab|bevacizumab|mesh-list
14663312|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
14663313|NCT00251524|Pemetrexed|pemetrexed|mesh-list
14663314|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15185939|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14663315|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663316|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14663317|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14663318|NCT00251524|Growth Substances|growth substances|mesh-ancestor
14663319|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663320|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
14663321|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663322|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663323|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14663324|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14663325|NCT00251550|Pemetrexed|pemetrexed|mesh-list
14663326|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663327|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663328|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663329|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14663330|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14663331|NCT00251602|Propranolol|propranolol|mesh-list
14663332|NCT00251602|Atropine|atropine|mesh-list
14663333|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14663334|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14663335|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663336|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663337|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663338|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663339|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14663340|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14663341|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
14663342|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14663343|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14663344|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
14663345|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663346|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14663347|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
14663348|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
14663349|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
14663350|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14663351|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14663352|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663353|NCT00251654|Anesthetics|anesthetics|mesh-list
14663354|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663355|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663356|NCT00251680|Atorvastatin|atorvastatin|mesh-list
14663357|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14663358|NCT00251680|Simvastatin|simvastatin|mesh-list
14663359|NCT00251680|Fenofibrate|fenofibrate|mesh-list
14663360|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14663361|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14663362|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
14663363|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663364|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14663365|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14663366|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663367|NCT00251706|Amiodarone|amiodarone|mesh-list
14663368|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14663369|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
14663370|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14663371|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14663372|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663373|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14663374|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14663375|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14663376|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663377|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14663378|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14663379|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14663380|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
14663381|NCT00251732|Nortriptyline|nortriptyline|mesh-list
14663382|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14663383|NCT00251732|Rabeprazole|rabeprazole|mesh-list
14663384|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14663385|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663386|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14663387|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663388|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663389|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663390|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14663391|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14663392|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14663393|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663394|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663395|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663396|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
14663397|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
14663398|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14663399|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14663400|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663401|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663402|NCT00251784|Urological Agents|urological agents|mesh-ancestor
14663403|NCT00251797|Thalidomide|thalidomide|mesh-list
14663404|NCT00251797|Irinotecan|irinotecan|mesh-list
14663405|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15185940|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
15185941|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
15185942|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
15185943|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185944|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185945|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14663406|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14663407|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663408|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663409|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663410|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14663411|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
14663412|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663413|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
14663414|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14663415|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663416|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14663417|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14663418|NCT00251797|Growth Substances|growth substances|mesh-ancestor
14663419|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
14663420|NCT00251823|Eptifibatide|eptifibatide|mesh-list
14663421|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15185946|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185947|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15185948|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15185949|NCT03888846|Protective Agents|protective agents|mesh-ancestor
15185950|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185951|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
15185952|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15185953|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
15223677|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223678|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
15223679|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663422|NCT00251849|KRM 1648|krm 1648|mesh-list
14663423|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14663424|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
14663425|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14663426|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663427|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
14663428|NCT00251888|Irinotecan|irinotecan|mesh-list
14663429|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663430|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14663431|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14663432|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663433|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663434|NCT00251901|Esomeprazole|esomeprazole|mesh-list
14663435|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14663436|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663437|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14663438|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663439|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663440|NCT00251914|Esomeprazole|esomeprazole|mesh-list
14663441|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14663442|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663443|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14663444|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663445|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223680|NCT05191784|Bevacizumab|bevacizumab|mesh-list
14663446|NCT00251940|Glyburide|glyburide|mesh-list
14663447|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14663448|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663449|NCT00251953|Metformin|metformin|mesh-list
14663450|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14663451|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663452|NCT00251966|Esomeprazole|esomeprazole|mesh-list
14663453|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14663454|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663455|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14663456|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663457|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663458|NCT00251992|Esomeprazole|esomeprazole|mesh-list
14663459|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14663460|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663461|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14663462|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663463|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663464|NCT00252044|Pergolide|pergolide|mesh-list
14663465|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
14663466|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
14663467|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663468|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663469|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663470|NCT00252122|Ketamine|ketamine|mesh-list
14663471|NCT00252122|Analgesics|analgesics|mesh-ancestor
14663472|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
14663473|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663474|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663475|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14663476|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14663477|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
14663478|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
14663479|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663480|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14663481|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14663482|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663483|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663484|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14663485|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
14663486|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663487|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14663488|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
14663489|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663490|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663491|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663492|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663493|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663494|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14663495|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14663496|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14663497|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14663498|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663499|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663500|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663501|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663502|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
14663503|NCT00252291|Miotics|miotics|mesh-ancestor
14663504|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
14663505|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663506|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663507|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14663508|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14663509|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
14663510|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14663511|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14663512|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663513|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663514|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663515|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
14663516|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663517|NCT00252304|Astringents|astringents|mesh-ancestor
15185954|NCT03889145|Amlodipine|amlodipine|mesh-list
15185955|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15185956|NCT03889145|Telmisartan|telmisartan|mesh-list
14663518|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
14663519|NCT00252317|Captopril|captopril|mesh-list
14663520|NCT00252317|Trandolapril|trandolapril|mesh-list
14663521|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14663522|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
14663523|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663524|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663525|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14663526|NCT00252330|Amibegron|amibegron|mesh-list
14663527|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14663528|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14663529|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663530|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185957|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15185958|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15185959|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15185960|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185961|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15185962|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185963|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
15185964|NCT03889145|Diuretics|diuretics|mesh-ancestor
15185965|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
15185966|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15185967|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14663531|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663532|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663533|NCT00252343|Amibegron|amibegron|mesh-list
14663534|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14663535|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14663536|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663537|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663538|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663539|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663540|NCT00252356|Amibegron|amibegron|mesh-list
14663541|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14663542|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14663543|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663544|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663545|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663546|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663547|NCT00252369|Infliximab|infliximab|mesh-list
14663548|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14663549|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
14663550|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663551|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14663552|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
14663553|NCT00252369|Coagulants|coagulants|mesh-ancestor
14663554|NCT00252408|Hormones|hormones|mesh-list
14663555|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663556|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663557|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
14663558|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
14663559|NCT00252434|Methamphetamine|methamphetamine|mesh-list
14663560|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14663561|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663562|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
14663563|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
14663564|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663565|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
14663566|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15185968|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15185969|NCT03889106|Ribavirin|ribavirin|mesh-list
15185970|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
14663567|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663568|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663569|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14663570|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14663571|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14663572|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14663573|NCT00252603|Galantamine|galantamine|mesh-list
14663574|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14663575|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663576|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663577|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663578|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663579|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663580|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14663581|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
14663582|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663583|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
14663584|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14663585|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
14663586|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185971|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185972|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
15185973|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185974|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
15185975|NCT03888677|Epirubicin|epirubicin|mesh-list
14663587|NCT00252655|Sirolimus|sirolimus|mesh-list
14663588|NCT00252655|Tacrolimus|tacrolimus|mesh-list
14663589|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14663590|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
14663591|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663592|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14663593|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663594|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663595|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14663596|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663597|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14663598|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663599|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
14663600|NCT00252668|Etanercept|etanercept|mesh-list
14663601|NCT00252668|Methotrexate|methotrexate|mesh-list
14663602|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14663603|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
14663604|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14663605|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663606|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14663607|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
15185976|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15185977|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
15185978|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15185979|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15185980|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14663608|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663609|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663610|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
14663611|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663612|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14663613|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14663614|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
14663615|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15185981|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
15185982|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663616|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14663617|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14663618|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14663619|NCT00252668|Analgesics|analgesics|mesh-ancestor
14663620|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
14663621|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663622|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14663623|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663624|NCT00252707|Docetaxel|docetaxel|mesh-list
14663625|NCT00252707|Gefitinib|gefitinib|mesh-list
14663626|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663627|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663628|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663629|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663630|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15185983|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185984|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15185985|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15185986|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15185987|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15185988|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185989|NCT03888664|Interferons|interferons|mesh-list
15185990|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
15185991|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15185992|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
14663631|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14663632|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663633|NCT00252785|Budesonide|budesonide|mesh-list
14663634|NCT00252785|Theophylline|theophylline|mesh-list
14663635|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
15185993|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15185994|NCT03888729|Velpatasvir|velpatasvir|mesh-list
15185995|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
15185996|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663636|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14663637|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14663638|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
14663639|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663640|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663641|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14663642|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
14663643|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
14663644|NCT00252785|Hormones|hormones|mesh-ancestor
14663645|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663646|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14663647|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14663648|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14663649|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663650|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663651|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663652|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14663653|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15185997|NCT03888534|Ixazomib|ixazomib|mesh-list
15185998|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663654|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
14663655|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14663656|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14663657|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
14663658|NCT00252798|Paclitaxel|paclitaxel|mesh-list
14663659|NCT00252798|Carboplatin|carboplatin|mesh-list
14663660|NCT00252798|Gefitinib|gefitinib|mesh-list
14663661|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14663662|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663663|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663664|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663665|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663666|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663667|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14663668|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663669|NCT00252811|Gefitinib|gefitinib|mesh-list
14663670|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663671|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14663672|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663673|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663674|NCT00252824|Budesonide|budesonide|mesh-list
14663675|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
14663676|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14663677|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14663678|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
14663679|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663680|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663681|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14663682|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
14663683|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
14663684|NCT00252824|Hormones|hormones|mesh-ancestor
14663685|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663686|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14663687|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14663688|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14663689|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663690|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663691|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663692|NCT00252863|Fluticasone|fluticasone|mesh-list
14663693|NCT00252863|Xhance|xhance|mesh-list
14663694|NCT00252863|Budesonide|budesonide|mesh-list
14663695|NCT00252863|Theophylline|theophylline|mesh-list
14663696|NCT00252863|Albuterol|albuterol|mesh-list
14663697|NCT00252863|Terbutaline|terbutaline|mesh-list
14663698|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
14663699|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14663700|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14663701|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14663702|NCT00252863|Montelukast|montelukast|mesh-list
14663703|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14663704|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14663705|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
14663706|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663707|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663708|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14663709|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
14663710|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
14663711|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14663712|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
14663713|NCT00252863|Hormones|hormones|mesh-ancestor
14663714|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663715|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14663716|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14663717|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14663718|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
14663719|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663720|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663721|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
14663722|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14663723|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14663724|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
14663725|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14663726|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14663727|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14663728|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663729|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
14293613|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14663730|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14663731|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14663732|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
14663733|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
14663734|NCT00252889|Doxorubicin|doxorubicin|mesh-list
14663735|NCT00252889|Topotecan|topotecan|mesh-list
14663736|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
14663737|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14663738|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663739|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14663740|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14663741|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663742|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663743|NCT00252928|Troclosene|troclosene|mesh-list
14663744|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
14663745|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663746|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
14663747|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
14663748|NCT00252954|Levetiracetam|levetiracetam|mesh-list
14663749|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
14663750|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
14726141|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726142|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726143|NCT00507247|Daptomycin|daptomycin|mesh-list
14726144|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14726145|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726146|NCT00507286|Alprostadil|alprostadil|mesh-list
14726147|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14726148|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14726149|NCT00507286|Urological Agents|urological agents|mesh-ancestor
14726150|NCT00507403|Infliximab|infliximab|mesh-list
14726151|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14726152|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14726153|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726154|NCT00507494|Pioglitazone|pioglitazone|mesh-list
14726155|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14726156|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726157|NCT00507585|Leucovorin|leucovorin|mesh-list
14726158|NCT00507585|Bevacizumab|bevacizumab|mesh-list
14726159|NCT00507585|Fluorouracil|fluorouracil|mesh-list
14726160|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
15185999|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
15186000|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726161|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726162|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726163|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14726164|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14726165|NCT00507585|Growth Substances|growth substances|mesh-ancestor
14726166|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726167|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
14726168|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
14726169|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726170|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15186001|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186002|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
15186003|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15186004|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15186005|NCT03888157|Liraglutide|liraglutide|mesh-list
15186006|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293614|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293615|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293616|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293617|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293618|NCT00570310|Pregabalin|pregabalin|mesh-list
14293619|NCT00570310|Analgesics|analgesics|mesh-ancestor
14726171|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14814600|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
14726172|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
14726173|NCT00507585|Antidotes|antidotes|mesh-ancestor
15186007|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186008|NCT03888157|Incretins|incretins|mesh-ancestor
15186009|NCT03888157|Hormones|hormones|mesh-ancestor
15186010|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15186011|NCT03888144|Ketorolac|ketorolac|mesh-list
15186012|NCT03888144|Oxycodone|oxycodone|mesh-list
15186013|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15186014|NCT03888144|Narcotics|narcotics|mesh-ancestor
14663751|NCT00253058|Cetirizine|cetirizine|mesh-list
14663752|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14663753|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14663754|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14663755|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
14663756|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
14663757|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663758|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663759|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663760|NCT00253110|Haloperidol|haloperidol|mesh-list
14663761|NCT00253110|Risperidone|risperidone|mesh-list
14663762|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
14663763|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14663764|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
14663765|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663766|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663767|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663768|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663769|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663770|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663771|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663772|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663773|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
14663774|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
14663775|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
14663776|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663777|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663778|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14663779|NCT00253123|Risperidone|risperidone|mesh-list
14663780|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14663781|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
14663782|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663783|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663784|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663785|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663786|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663787|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663788|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663789|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663790|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
14663791|NCT00253136|Risperidone|risperidone|mesh-list
14663792|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14663793|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
14663794|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663795|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663796|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663797|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663798|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663799|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663800|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663801|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663802|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
14663803|NCT00253149|Risperidone|risperidone|mesh-list
14663804|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14663805|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
14663806|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663807|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663808|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663809|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663810|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663811|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663812|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663813|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663814|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
14663815|NCT00253162|Risperidone|risperidone|mesh-list
14663816|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15186015|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663817|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
14663818|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663819|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663820|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663821|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663822|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663823|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663824|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663825|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14663826|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
14663827|NCT00253175|Topiramate|topiramate|mesh-list
14663828|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
14663829|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14663830|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663831|NCT00253188|Galantamine|galantamine|mesh-list
14663832|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14663833|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663834|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663835|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663836|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663837|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663838|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14663839|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
14663840|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663841|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
14663842|NCT00253201|Galantamine|galantamine|mesh-list
14663843|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15186016|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186017|NCT03888144|Analgesics|analgesics|mesh-ancestor
15186018|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
15186019|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186020|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186021|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186022|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186023|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186024|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15186025|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186026|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186027|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14663844|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663845|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663846|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663847|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663848|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663849|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14663850|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
14663851|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663852|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
14663853|NCT00253214|Galantamine|galantamine|mesh-list
14663854|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14663855|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663856|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663857|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663858|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663859|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663860|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14663861|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
14663862|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663863|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
14663864|NCT00253227|Galantamine|galantamine|mesh-list
14663865|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14663866|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663867|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663868|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
14663869|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663870|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663871|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14663872|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
14663873|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663874|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
14663875|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14663876|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14663877|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
14663878|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14663879|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14663880|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14663881|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14663882|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663883|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14663884|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14663885|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14663886|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663887|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14663888|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14663889|NCT00253305|Terbinafine|terbinafine|mesh-list
14663890|NCT00253305|Naftifine|naftifine|mesh-list
14663891|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
15186028|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14663892|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14663893|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663894|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663895|NCT00253318|Dexamethasone|dexamethasone|mesh-list
14663896|NCT00253318|Docetaxel|docetaxel|mesh-list
14663897|NCT00253318|Everolimus|everolimus|mesh-list
14663898|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14663899|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
14663900|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
14663901|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14663902|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663903|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14663904|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
14663905|NCT00253318|Hormones|hormones|mesh-ancestor
14663906|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663907|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14663908|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663909|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663910|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663911|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663912|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663913|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14663914|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
14663915|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
14663916|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
14663917|NCT00253344|Docetaxel|docetaxel|mesh-list
14663918|NCT00253344|Lenalidomide|lenalidomide|mesh-list
14663919|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663920|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
14663921|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
14663922|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
14663923|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663924|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
14663925|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663926|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14663927|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14663928|NCT00253344|Growth Substances|growth substances|mesh-ancestor
14663929|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
14663930|NCT00253396|Heparin|heparin|mesh-list
14663931|NCT00253396|Enoxaparin|enoxaparin|mesh-list
14663932|NCT00253396|Calcium heparin|calcium heparin|mesh-list
14663933|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
14663934|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14663935|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14663936|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663937|NCT00253422|Fulvestrant|fulvestrant|mesh-list
14663938|NCT00253422|Anastrozole|anastrozole|mesh-list
14663939|NCT00253422|Exemestane|exemestane|mesh-list
14663940|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14663941|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663942|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14663943|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14663944|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
14663945|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14663946|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663947|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14663948|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14663949|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663950|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663951|NCT00253461|Topotecan|topotecan|mesh-list
14663952|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14663953|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14663954|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14663955|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663956|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663957|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663958|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14663959|NCT00253474|Interferons|interferons|mesh-list
14663960|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
14663961|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
14663962|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14663963|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663964|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
14663965|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186029|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
15186030|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15186031|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15186032|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
15186033|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663966|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
14663967|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663968|NCT00253487|Temozolomide|temozolomide|mesh-list
14663969|NCT00253487|Busulfan|busulfan|mesh-list
14663970|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14663971|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14663972|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
14663973|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663974|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663975|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14663976|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
14663977|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663978|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14663979|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663980|NCT00253500|Epirubicin|epirubicin|mesh-list
14663981|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14663982|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663983|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14663984|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14663985|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14663986|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14663987|NCT00253526|Gemcitabine|gemcitabine|mesh-list
14663988|NCT00253526|Bevacizumab|bevacizumab|mesh-list
14663989|NCT00253526|Antibodies|antibodies|mesh-list
14663990|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
14663991|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14663992|NCT00253526|Mitogens|mitogens|mesh-list
14663993|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14663994|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14663995|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14663996|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14663997|NCT00253526|Growth Substances|growth substances|mesh-ancestor
14663998|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14663999|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
14664000|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
14664001|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664002|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
14664003|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664004|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
14664005|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186034|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15186035|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15186036|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
15186037|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
15186038|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186039|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186040|NCT03887650|Dexamethasone|dexamethasone|mesh-list
15186041|NCT03887650|Epinephrine|epinephrine|mesh-list
15186042|NCT03887650|Bupivacaine|bupivacaine|mesh-list
15186043|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186044|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
15186045|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
15186046|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186047|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186048|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664006|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664007|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186049|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
14664008|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
14664009|NCT00253539|Tamoxifen|tamoxifen|mesh-list
14664010|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14664011|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
14664012|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664013|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664014|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14664015|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664016|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14664017|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14664018|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14664019|NCT00253552|Cyclosporine|cyclosporine|mesh-list
14664020|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
14664021|NCT00253552|Busulfan|busulfan|mesh-list
14664022|NCT00253552|Methotrexate|methotrexate|mesh-list
14664023|NCT00253552|Etoposide|etoposide|mesh-list
14664024|NCT00253552|Cyclosporins|cyclosporins|mesh-list
14664025|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14664026|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
14664027|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293620|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
14293621|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293622|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664028|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14664029|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14664030|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
14664031|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664032|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664033|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14664034|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14664035|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
14664036|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14664037|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664038|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
14664039|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
14664040|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664041|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14664042|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14664043|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14664044|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14664045|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14664046|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
14664047|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664048|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14664049|NCT00253565|Capecitabine|capecitabine|mesh-list
14664050|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
14664051|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664052|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
14664053|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664054|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664055|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664056|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664057|NCT00253578|Sorafenib|sorafenib|mesh-list
14664058|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664059|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664060|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664061|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664062|NCT00253591|Vinorelbine|vinorelbine|mesh-list
14664063|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664064|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14664065|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
14664066|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
14664067|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
14664068|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664069|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14664070|NCT00253617|Trioxsalen|trioxsalen|mesh-list
14664071|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664072|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
14664073|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14293623|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
14664074|NCT00253721|Melphalan|melphalan|mesh-list
14664075|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14664076|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
14664077|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664078|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664079|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14664080|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14664081|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
14664082|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664083|NCT00253773|Acetaminophen|acetaminophen|mesh-list
14664084|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14664085|NCT00253773|Analgesics|analgesics|mesh-ancestor
14664086|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
14664087|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664088|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664089|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
14664090|NCT00253799|Hylan|hylan|mesh-list
14664091|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
14664092|NCT00253799|Protective Agents|protective agents|mesh-ancestor
14664093|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664094|NCT00253851|Heparin|heparin|mesh-list
14664095|NCT00253851|Calcium heparin|calcium heparin|mesh-list
14664096|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
14664097|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14664098|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14664099|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664100|NCT00253903|SR 46349B|sr 46349b|mesh-list
14664101|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14664102|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14664103|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664104|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14664105|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14664106|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
14664107|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664108|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664109|NCT00253929|Adenosine|adenosine|mesh-list
14664110|NCT00253929|Nitroprusside|nitroprusside|mesh-list
14664111|NCT00253929|Acetylcholine|acetylcholine|mesh-list
14664112|NCT00253929|Caffeine|caffeine|mesh-list
14664113|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14664114|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664115|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14664116|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664117|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664118|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14664119|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14664120|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
14664121|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664122|NCT00253929|Analgesics|analgesics|mesh-ancestor
14664123|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
14664124|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664125|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14664126|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
14726174|NCT00507585|Protective Agents|protective agents|mesh-ancestor
15186050|NCT03887650|Hormones|hormones|mesh-ancestor
15186051|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15186052|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15186053|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186054|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186055|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
15186056|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
15186057|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186058|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
15186059|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15186060|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15186061|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186062|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186063|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15186064|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15186065|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14664127|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14664128|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
14664129|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14664130|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14664131|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14664132|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
14664133|NCT00253955|Levofloxacin|levofloxacin|mesh-list
14664134|NCT00253955|Ofloxacin|ofloxacin|mesh-list
14664135|NCT00253955|Tazobactam|tazobactam|mesh-list
14664136|NCT00253955|Piperacillin|piperacillin|mesh-list
14664137|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14664138|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14664139|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664140|NCT00253955|Renal Agents|renal agents|mesh-ancestor
14664141|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664142|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14664143|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14664144|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664145|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664146|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664147|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14664148|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14664149|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14664150|NCT00254007|Citalopram|citalopram|mesh-list
14664151|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14664152|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14664153|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664154|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664155|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664156|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
15186066|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
15186067|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
15186068|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
15186069|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15186070|NCT03887754|Risperidone|risperidone|mesh-list
15186071|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15186072|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
15186073|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186074|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664157|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664158|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14664159|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664160|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664161|NCT00254020|Citalopram|citalopram|mesh-list
14664162|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14664163|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14664164|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664165|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664166|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664167|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
14664168|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664169|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14664170|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664171|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664172|NCT00254033|Methylphenidate|methylphenidate|mesh-list
14664173|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
14664174|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14664175|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664176|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14664177|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14664178|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664179|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664180|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
14664181|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664182|NCT00254046|Etravirine|etravirine|mesh-list
14664183|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14664184|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14664185|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664186|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664187|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
14664188|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664189|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
14664190|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14664191|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664192|NCT00254137|Capecitabine|capecitabine|mesh-list
14664193|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
14664194|NCT00254137|Irinotecan|irinotecan|mesh-list
14664195|NCT00254137|Cetuximab|cetuximab|mesh-list
14664196|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664197|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
14664198|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664199|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664200|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14664201|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14664202|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664203|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14664204|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
14726175|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
15186075|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186076|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664205|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14664206|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14664207|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
14664208|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14664209|NCT00254189|Estradiol|estradiol|mesh-list
14664210|NCT00254189|Estrogens|estrogens|mesh-ancestor
14664211|NCT00254189|Hormones|hormones|mesh-ancestor
14664212|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664213|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664214|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14664215|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
14664216|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14664217|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14664218|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14664219|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14664220|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14664221|NCT00254202|Iloperidone|iloperidone|mesh-list
14664222|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664223|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664224|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664225|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664226|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664227|NCT00254241|Risperidone|risperidone|mesh-list
14664228|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14664229|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14664230|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
14664231|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664232|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664233|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664234|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664235|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664236|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664237|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664238|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14664239|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
15186077|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15186078|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186079|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15186080|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15186081|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
15186082|NCT03887871|Tamsulosin|tamsulosin|mesh-list
15186083|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15186084|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15186085|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15186086|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186087|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186088|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186089|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186090|NCT03887871|Urological Agents|urological agents|mesh-ancestor
15186091|NCT03887858|Tamsulosin|tamsulosin|mesh-list
14664240|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664241|NCT00254254|Exenatide|exenatide|mesh-list
14664242|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14664243|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664244|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14664245|NCT00254254|Incretins|incretins|mesh-ancestor
14664246|NCT00254254|Hormones|hormones|mesh-ancestor
14664247|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664248|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
14664249|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664250|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664251|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664252|NCT00254319|Bevacizumab|bevacizumab|mesh-list
14664253|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14664254|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664255|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14664256|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15186092|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15186093|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15186094|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15186095|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186096|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664257|NCT00254319|Growth Substances|growth substances|mesh-ancestor
14726176|NCT00507585|Vitamins|vitamins|mesh-ancestor
14664258|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664259|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
14664260|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14664261|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
14664262|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14664263|NCT00254345|Protective Agents|protective agents|mesh-ancestor
14664264|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664265|NCT00254371|Androgens|androgens|mesh-list
14664266|NCT00254371|Hormones|hormones|mesh-ancestor
14664267|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664268|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664269|NCT00254384|Cisplatin|cisplatin|mesh-list
14664270|NCT00254384|Docetaxel|docetaxel|mesh-list
14664271|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14664272|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664273|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
14664274|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
14664275|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
14664276|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664277|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664278|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664279|NCT00254423|Dasatinib|dasatinib|mesh-list
14664280|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664281|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664282|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664283|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664284|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
14664285|NCT00254436|Hematinics|hematinics|mesh-ancestor
14664286|NCT00254449|Capsaicin|capsaicin|mesh-list
14664287|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
14664288|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
14664289|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
14664290|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664291|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664292|NCT00254475|Valsartan|valsartan|mesh-list
14664293|NCT00254475|Simvastatin|simvastatin|mesh-list
14664294|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14664295|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14664296|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
14664297|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664298|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14664299|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14664300|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664301|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14664302|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14664303|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14664304|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
14664305|NCT00254553|Testosterone|testosterone|mesh-list
14664306|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
14664307|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
14664308|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14664309|NCT00254553|Androgens|androgens|mesh-ancestor
14664310|NCT00254553|Hormones|hormones|mesh-ancestor
14664311|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664312|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664313|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14664314|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664315|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
14664316|NCT00254618|Mesalamine|mesalamine|mesh-list
14664317|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14664318|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14664319|NCT00254618|Analgesics|analgesics|mesh-ancestor
14664320|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
14664321|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664322|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664323|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14664324|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14664325|NCT00254631|Oxycodone|oxycodone|mesh-list
14664326|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14664327|NCT00254631|Narcotics|narcotics|mesh-ancestor
14664328|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664329|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664330|NCT00254631|Analgesics|analgesics|mesh-ancestor
14664331|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
14664332|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664333|NCT00254657|Levetiracetam|levetiracetam|mesh-list
14664334|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
14664335|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
14726177|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
14726178|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
14726179|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14726180|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14726181|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14726182|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14726183|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726184|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726185|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
14726186|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726187|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726188|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14726189|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726190|NCT00507663|Atenolol|atenolol|mesh-list
14726191|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14726192|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14726193|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
14726194|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
14726195|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726196|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726197|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14726198|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14726199|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14726200|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
14726201|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726202|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729273|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
14729274|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729275|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729276|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
14729277|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729278|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14729279|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
14729280|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14729281|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729282|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729283|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14729284|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
14729285|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14729286|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
14729287|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729288|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729289|NCT00522509|Floxuridine|floxuridine|mesh-list
14729290|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664336|NCT00254670|Naltrexone|naltrexone|mesh-list
14664337|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14664338|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14664339|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664340|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
14664341|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664342|NCT00254709|Sirolimus|sirolimus|mesh-list
14664343|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664344|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664345|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14664346|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664347|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
14664348|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14664349|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
14664350|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664351|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14664352|NCT00254735|Clomipramine|clomipramine|mesh-list
14664353|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664354|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664355|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664356|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664357|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664358|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664359|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14664360|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14664361|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14664362|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664363|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664364|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664365|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
14664366|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14664367|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664368|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664369|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664370|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664371|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664372|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664373|NCT00254774|Valproic Acid|valproic acid|mesh-list
14664374|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15186097|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293624|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14664375|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664376|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664377|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664378|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664379|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664380|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664381|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
14664382|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664383|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664384|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
14664385|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664386|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
14664387|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14664388|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664389|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664390|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664391|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664392|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664393|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293625|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14293626|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293627|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14293628|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14293629|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14293630|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14293631|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14293632|NCT00570323|Fulvestrant|fulvestrant|mesh-list
14293633|NCT00570323|Anastrozole|anastrozole|mesh-list
14293634|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14293635|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293636|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14293637|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14664394|NCT00254800|Exenatide|exenatide|mesh-list
14664395|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14664396|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14664397|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
14664398|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14664399|NCT00254800|Estradiol|estradiol|mesh-list
14664400|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14664401|NCT00254800|Estrogens|estrogens|mesh-ancestor
14664402|NCT00254800|Hormones|hormones|mesh-ancestor
14664403|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664404|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664405|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14664406|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
14664407|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14664408|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14664409|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14664410|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14664411|NCT00254800|Incretins|incretins|mesh-ancestor
14664412|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14664413|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14664414|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14664415|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14664416|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664417|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664418|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664419|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664420|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664421|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664422|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14664423|NCT00254865|Norelgestromin|norelgestromin|mesh-list
14664424|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
14664425|NCT00254865|Estradiol|estradiol|mesh-list
14664426|NCT00254865|Estrogens|estrogens|mesh-ancestor
14664427|NCT00254865|Hormones|hormones|mesh-ancestor
14664428|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664429|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664430|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14664431|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14664432|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14664433|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14664434|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14664435|NCT00254878|Methylphenidate|methylphenidate|mesh-list
15186098|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186099|NCT03887858|Urological Agents|urological agents|mesh-ancestor
15186100|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
15186101|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15186102|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186103|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15186104|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664436|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14664437|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664438|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14664439|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14664440|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664441|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664442|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
14664443|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664444|NCT00254917|Vaccines|vaccines|mesh-list
14664445|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
14664446|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664447|NCT00254930|Risperidone|risperidone|mesh-list
14664448|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14664449|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
14664450|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664451|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664452|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664453|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664454|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15186105|NCT03887260|Fentanyl|fentanyl|mesh-list
14726203|NCT00507793|Cyclosporine|cyclosporine|mesh-list
15186106|NCT03887260|Morphine|morphine|mesh-list
14664455|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664456|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664457|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14664458|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
14293638|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
14664459|NCT00254956|Ciclesonide|ciclesonide|mesh-list
14664460|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
14664461|NCT00254956|Hormones|hormones|mesh-ancestor
14664462|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664463|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664464|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14664465|NCT00255073|Baclofen|baclofen|mesh-list
14664466|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14664467|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664468|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14664469|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664470|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14664471|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
14664472|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
14664473|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664474|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664475|NCT00255242|Simvastatin|simvastatin|mesh-list
14664476|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14664477|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14664478|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
14664479|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664480|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14664481|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14664482|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664483|NCT00255255|Budesonide|budesonide|mesh-list
14664484|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
14664485|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14664486|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14664487|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
14664488|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664489|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664490|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14664491|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
14664492|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
14664493|NCT00255255|Hormones|hormones|mesh-ancestor
14664494|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664495|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14664496|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14664497|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14664498|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
14664499|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664500|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664501|NCT00255268|Goserelin|goserelin|mesh-list
14664502|NCT00255268|Bicalutamide|bicalutamide|mesh-list
14664503|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14664504|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664505|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
14664506|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
14664507|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664508|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664509|NCT00255372|Lactulose|lactulose|mesh-list
14664510|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664511|NCT00255385|Micronutrients|micronutrients|mesh-list
14664512|NCT00255385|Trace Elements|trace elements|mesh-list
14664513|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664514|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14664515|NCT00255424|Hematinics|hematinics|mesh-ancestor
14664516|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14664517|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14664518|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14664519|NCT00255437|Hematinics|hematinics|mesh-ancestor
14664520|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15186107|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15186108|NCT03887260|Narcotics|narcotics|mesh-ancestor
15186109|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186110|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186111|NCT03887260|Analgesics|analgesics|mesh-ancestor
15186112|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
15186113|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186114|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14664521|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14664522|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14664523|NCT00255450|Hematinics|hematinics|mesh-ancestor
14664524|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14664525|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14664526|NCT00255463|Gefitinib|gefitinib|mesh-list
14664527|NCT00255463|Anastrozole|anastrozole|mesh-list
14664528|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664529|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664530|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664531|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664532|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14664533|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14664534|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14664535|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14664536|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
14664537|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664538|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664539|NCT00255476|Gefitinib|gefitinib|mesh-list
14664540|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664541|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664542|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664543|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664544|NCT00255489|Gefitinib|gefitinib|mesh-list
14664545|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664546|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293639|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293640|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293641|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14293642|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14293643|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293644|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293645|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
14293646|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14293647|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
14293648|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293649|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293650|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14293651|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293652|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14293653|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
14293654|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293655|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293656|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14293657|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
14293658|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
14293659|NCT00570349|Protective Agents|protective agents|mesh-ancestor
14664547|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664548|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664549|NCT00255502|Metoprolol|metoprolol|mesh-list
14664550|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14664551|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14664552|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
14664553|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
14664554|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664555|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664556|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14664557|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14664558|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14664559|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
14664560|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186115|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15186116|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
15186117|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
15186118|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
15186119|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
15186120|NCT03887169|Vitamins|vitamins|mesh-ancestor
15186121|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
15186122|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186123|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
15186124|NCT03887169|Hematinics|hematinics|mesh-ancestor
15186125|NCT03887130|Gemcitabine|gemcitabine|mesh-list
15186126|NCT03887130|Paclitaxel|paclitaxel|mesh-list
15186127|NCT03887130|Vinorelbine|vinorelbine|mesh-list
15186128|NCT03887130|Docetaxel|docetaxel|mesh-list
15186129|NCT03887130|Capecitabine|capecitabine|mesh-list
15186130|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15186131|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186132|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
15186133|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
15186134|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
15186135|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186136|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15186137|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
15186138|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
15186139|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186140|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814601|NCT00863889|Hormones|hormones|mesh-ancestor
14814602|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814603|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14814604|NCT00863889|Protective Agents|protective agents|mesh-ancestor
14814605|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14814606|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814607|NCT00863902|Cetirizine|cetirizine|mesh-list
15186141|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186142|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
15186143|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223681|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223682|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223683|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15223684|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15223685|NCT05191784|Growth Substances|growth substances|mesh-ancestor
15223686|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664561|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664562|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14664563|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664564|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664565|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664566|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664567|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664568|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664569|NCT00255528|Metoprolol|metoprolol|mesh-list
14664570|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14664571|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14664572|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
14664573|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
14664574|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664575|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664576|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14664577|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14664578|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14664579|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
14664580|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664581|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664582|NCT00255541|Glyburide|glyburide|mesh-list
14664583|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14664584|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664585|NCT00255554|Citalopram|citalopram|mesh-list
14664586|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14664587|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14664588|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664589|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664590|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664591|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
14664592|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664593|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14664594|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664595|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664596|NCT00255567|Paromomycin|paromomycin|mesh-list
14664597|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14664598|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664599|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814608|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14814609|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14814610|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15223687|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
15223688|NCT05191706|Dexamethasone|dexamethasone|mesh-list
14664600|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14664601|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14664602|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
14664603|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14664604|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
14664605|NCT00255593|Rituximab|rituximab|mesh-list
14664606|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14664607|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664608|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
14664609|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664610|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14664611|NCT00255606|Prednisone|prednisone|mesh-list
14664612|NCT00255606|Docetaxel|docetaxel|mesh-list
14664613|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664614|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
14664615|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
14664616|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
14664617|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664618|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14664619|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
14664620|NCT00255606|Hormones|hormones|mesh-ancestor
14664621|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664622|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664623|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14664624|NCT00255658|Sirolimus|sirolimus|mesh-list
14664625|NCT00255658|Sorafenib|sorafenib|mesh-list
14293660|NCT00570401|Dasatinib|dasatinib|mesh-list
14664626|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664627|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293661|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293662|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293663|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664628|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664629|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664630|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664631|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664632|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14664633|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
14664634|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14664635|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
14664636|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664637|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
14664638|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
14664639|NCT00255710|Fludarabine|fludarabine|mesh-list
14664640|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
14664641|NCT00255710|Tacrolimus|tacrolimus|mesh-list
14664642|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14664643|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
14664644|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664645|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14664646|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14664647|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
14664648|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664649|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664650|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14664651|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664652|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
14664653|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14664654|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664655|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14664656|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14664657|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
14664658|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664659|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664660|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
14664661|NCT00255749|Hematinics|hematinics|mesh-ancestor
14293664|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664662|NCT00255762|Paclitaxel|paclitaxel|mesh-list
14664663|NCT00255762|Bevacizumab|bevacizumab|mesh-list
14664664|NCT00255762|Carboplatin|carboplatin|mesh-list
14664665|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14664666|NCT00255762|Antibodies|antibodies|mesh-list
14664667|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
14664668|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14664669|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14664670|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664671|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14664672|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14664673|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14664674|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664675|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14664676|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14664677|NCT00255762|Growth Substances|growth substances|mesh-ancestor
14664678|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664679|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
14664680|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
14664681|NCT00255788|Everolimus|everolimus|mesh-list
14664682|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664683|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14664684|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
14664685|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664686|NCT00255879|Olanzapine|olanzapine|mesh-list
14664687|NCT00255879|Risperidone|risperidone|mesh-list
14664688|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14664689|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14664690|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
14664691|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664692|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664693|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664694|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664695|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664696|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186144|NCT03886896|Lidocaine|lidocaine|mesh-list
15186145|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
15186146|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
14664697|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664698|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14664699|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
14664700|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
14664701|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
14664702|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664703|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664704|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14664705|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14664706|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664707|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
14664708|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
14664709|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14664710|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14664711|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
14664712|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664713|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664714|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664715|NCT00255996|Linezolid|linezolid|mesh-list
14664716|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664717|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664718|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14664719|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664720|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664721|NCT00256009|Misoprostol|misoprostol|mesh-list
14664722|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14664723|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
14664724|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14664725|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664726|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14664727|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664728|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
14664729|NCT00256100|PENTA|penta|mesh-list
14664730|NCT00256100|Fondaparinux|fondaparinux|mesh-list
14664731|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14664732|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
14664733|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14664734|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
14664735|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664736|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664737|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
14664738|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14664739|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14664740|NCT00256178|Simvastatin|simvastatin|mesh-list
14664741|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14664742|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14664743|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
14664744|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664745|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14664746|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14664747|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664748|NCT00256230|Disulfiram|disulfiram|mesh-list
14664749|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14664750|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14664751|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664752|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664753|NCT00256256|Glucagon|glucagon|mesh-list
14664754|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14664755|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664756|NCT00256256|Hormones|hormones|mesh-ancestor
14664757|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664758|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664759|NCT00256256|Incretins|incretins|mesh-ancestor
14664760|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
14664761|NCT00256269|Irinotecan|irinotecan|mesh-list
14664762|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664763|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14664764|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14664765|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664766|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186147|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186148|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186149|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
15186150|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186151|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14664767|NCT00256321|Celecoxib|celecoxib|mesh-list
14664768|NCT00256321|Capecitabine|capecitabine|mesh-list
14664769|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
14664770|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664771|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
14664772|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664773|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664774|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14664775|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14664776|NCT00256321|Analgesics|analgesics|mesh-ancestor
14664777|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
14664778|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664779|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664780|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14664781|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14664782|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14664783|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14664784|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664785|NCT00256334|Resveratrol|resveratrol|mesh-list
14664786|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
14664787|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664788|NCT00256334|Protective Agents|protective agents|mesh-ancestor
14664789|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664790|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664791|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14664792|NCT00256347|Morphine|morphine|mesh-list
14664793|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14664794|NCT00256347|Narcotics|narcotics|mesh-ancestor
14664795|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664796|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664797|NCT00256347|Analgesics|analgesics|mesh-ancestor
14664798|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
14664799|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664800|NCT00256399|Alfuzosin|alfuzosin|mesh-list
14664801|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14664802|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14664803|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14664804|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
14664805|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664806|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664807|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664808|NCT00256399|Urological Agents|urological agents|mesh-ancestor
14726204|NCT00507793|Sirolimus|sirolimus|mesh-list
14726205|NCT00507793|Cyclosporins|cyclosporins|mesh-list
14726206|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726207|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726208|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726209|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
14726210|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186152|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15186153|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15186154|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15186155|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186156|NCT03886779|Nepafenac|nepafenac|mesh-list
14726211|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
14726212|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726213|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
14726214|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14664809|NCT00256542|Lidocaine|lidocaine|mesh-list
14664810|NCT00256542|Heparin|heparin|mesh-list
14664811|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14664812|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
14664813|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664814|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186157|NCT03886779|Bromfenac|bromfenac|mesh-list
15186158|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186159|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186160|NCT03886779|Analgesics|analgesics|mesh-ancestor
15186161|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
14664815|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
14664816|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664817|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14664818|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14664819|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14664820|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14664821|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664822|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
14664823|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14664824|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14664825|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
14664826|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14664827|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664828|NCT00256711|Vinorelbine|vinorelbine|mesh-list
14664829|NCT00256711|Gefitinib|gefitinib|mesh-list
14664830|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14664831|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664832|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14664833|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14664834|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
15186162|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186163|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186164|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186165|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186166|NCT03886948|Mirikizumab|mirikizumab|mesh-list
15186167|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186168|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186169|NCT03886948|Analgesics|analgesics|mesh-ancestor
15186170|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
15186171|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186172|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186173|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293665|NCT00570492|Fluticasone|fluticasone|mesh-list
14664835|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664836|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14664837|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664838|NCT00256737|Omeprazole|omeprazole|mesh-list
14664839|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14664840|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664841|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14664842|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664843|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664844|NCT00256828|Lamivudine|lamivudine|mesh-list
14664845|NCT00256828|Efavirenz|efavirenz|mesh-list
14664846|NCT00256828|Didanosine|didanosine|mesh-list
14664847|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14664848|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14664849|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664850|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664851|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
14664852|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664853|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14664854|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15186174|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186175|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15186176|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664855|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14664856|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14664857|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14664858|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14664859|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14664860|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14664861|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
14664862|NCT00256893|Ropinirole|ropinirole|mesh-list
14664863|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14664864|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14664865|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
14664866|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
14664867|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664868|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664869|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664870|NCT00256932|Alvimopan|alvimopan|mesh-list
14664871|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14664872|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14664873|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664874|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664875|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664876|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664877|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664878|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14664879|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14664880|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
14664881|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664882|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664883|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14664884|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14664885|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
14664886|NCT00257036|Levofloxacin|levofloxacin|mesh-list
14664887|NCT00257036|Ofloxacin|ofloxacin|mesh-list
14664888|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14664889|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664890|NCT00257036|Renal Agents|renal agents|mesh-ancestor
14664891|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664892|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15186177|NCT03886922|Cromakalim|cromakalim|mesh-list
15186178|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15186179|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15186180|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
15186181|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186182|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186183|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15186184|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
15186185|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
15186186|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
15186187|NCT03887013|Trimetazidine|trimetazidine|mesh-list
15186188|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
15186189|NCT03886766|Efavirenz|efavirenz|mesh-list
14664893|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14664894|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664895|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664896|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664897|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14664898|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14664899|NCT00257049|Levofloxacin|levofloxacin|mesh-list
14664900|NCT00257049|Ofloxacin|ofloxacin|mesh-list
14664901|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14664902|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664903|NCT00257049|Renal Agents|renal agents|mesh-ancestor
14664904|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664905|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14664906|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14664907|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664908|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664909|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664910|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14664911|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14664912|NCT00257062|Levofloxacin|levofloxacin|mesh-list
14664913|NCT00257062|Ofloxacin|ofloxacin|mesh-list
14664914|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14664915|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664916|NCT00257062|Renal Agents|renal agents|mesh-ancestor
14664917|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664918|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14664919|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14664920|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14664921|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664922|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664923|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14664924|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14664925|NCT00257075|Risperidone|risperidone|mesh-list
14664926|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14664927|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
14664928|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664929|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664930|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664931|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14664932|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664933|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664934|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664935|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14664936|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
14664937|NCT00257114|Bortezomib|bortezomib|mesh-list
14664938|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664939|NCT00257127|Vaccines|vaccines|mesh-list
14664940|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14664941|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
14664942|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664943|NCT00257140|Levofloxacin|levofloxacin|mesh-list
14664944|NCT00257140|Ofloxacin|ofloxacin|mesh-list
14664945|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14664946|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664947|NCT00257140|Renal Agents|renal agents|mesh-ancestor
14664948|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664949|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14664950|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15186190|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15186191|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15186192|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186193|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186194|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
15186195|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186196|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15186197|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14664951|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186198|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14664952|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664953|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664954|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14664955|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15186199|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15186200|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15186201|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15186202|NCT03886441|Beclomethasone|beclomethasone|mesh-list
15186203|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186204|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
15186205|NCT03886441|Hormones|hormones|mesh-ancestor
15186206|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15186207|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186208|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15186209|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
14664956|NCT00257257|Rimonabant|rimonabant|mesh-list
14664957|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14664958|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14664959|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14664960|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664961|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664962|NCT00257257|Hormones|hormones|mesh-ancestor
14664963|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14664964|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664965|NCT00257270|Gabapentin|gabapentin|mesh-list
14664966|NCT00257270|Analgesics|analgesics|mesh-ancestor
14664967|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
14664968|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14664969|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14664970|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
14664971|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14664972|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14664973|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14664974|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14664975|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14664976|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14664977|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14664978|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664979|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
14664980|NCT00257348|Docetaxel|docetaxel|mesh-list
14664981|NCT00257348|Capecitabine|capecitabine|mesh-list
14664982|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14664983|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
14664984|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
14664985|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
14664986|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664987|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14664988|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
14664989|NCT00257361|Cycloserine|cycloserine|mesh-list
14664990|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14664991|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14664992|NCT00257361|Renal Agents|renal agents|mesh-ancestor
14664993|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14664994|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
14664995|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14664996|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
14664997|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14664998|NCT00257387|Cyclosporine|cyclosporine|mesh-list
14664999|NCT00257387|Cyclosporins|cyclosporins|mesh-list
14665000|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665001|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665002|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665003|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
14665004|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665005|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
14665006|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665007|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
14665008|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665009|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14665010|NCT00257426|Octreotide|octreotide|mesh-list
14665011|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665012|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14665013|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665014|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
14665015|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
14665016|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665017|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665018|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14665019|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14665020|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665021|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665022|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665023|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665024|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14665025|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
14665026|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665027|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14665028|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
14665029|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
14665030|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14665031|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
15186210|NCT03886662|LB100|lb100|mesh-list
15186211|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186212|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186213|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186214|NCT03886311|Nivolumab|nivolumab|mesh-list
15186215|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15186216|NCT03886311|Trabectedin|trabectedin|mesh-list
15186217|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15186218|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186219|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15186220|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186221|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14665032|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665033|NCT00257465|Vaccines|vaccines|mesh-list
14665034|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
14665035|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665036|NCT00257491|Telmisartan|telmisartan|mesh-list
14665037|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14665038|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14665039|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14665040|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665041|NCT00257530|Imiquimod|imiquimod|mesh-list
14665042|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14293666|NCT00570492|Xhance|xhance|mesh-list
14665043|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
14665044|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665045|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665046|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
14665047|NCT00257569|Cetirizine|cetirizine|mesh-list
14665048|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14665049|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14665050|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14665051|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
14665052|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
14665053|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186222|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
15186223|NCT03885947|Fludarabine|fludarabine|mesh-list
15186224|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
14665054|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665055|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665056|NCT00257582|Cetirizine|cetirizine|mesh-list
14665057|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14665058|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14665059|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14665060|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
14665061|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
14665062|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665063|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665064|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665065|NCT00257595|Cetirizine|cetirizine|mesh-list
14665066|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14665067|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14665068|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14665069|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
14665070|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
14665071|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665072|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665073|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665074|NCT00257621|Ritonavir|ritonavir|mesh-list
14665075|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14665076|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14665077|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
14665078|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665079|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665080|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14665081|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14665082|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
14665083|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665084|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14665085|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14665086|NCT00257634|Dexamethasone|dexamethasone|mesh-list
14665087|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665088|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
14665089|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
14665090|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665091|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665092|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665093|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
14665094|NCT00257634|Hormones|hormones|mesh-ancestor
14665095|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665096|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14665097|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665098|NCT00257699|Metronidazole|metronidazole|mesh-list
14665099|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
14665100|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665101|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665102|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14665103|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14665104|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14665105|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14665106|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665107|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665108|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665109|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14665110|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14665111|NCT00257712|Hormones|hormones|mesh-list
14665112|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14665113|NCT00257712|Tesamorelin|tesamorelin|mesh-list
14665114|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665115|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665116|NCT00257712|Growth Substances|growth substances|mesh-ancestor
14665117|NCT00257790|Tobramycin|tobramycin|mesh-list
14665118|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665119|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665120|NCT00257803|Oxytocin|oxytocin|mesh-list
14665121|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
14665122|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14665123|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665124|NCT00257816|Topotecan|topotecan|mesh-list
14665125|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665126|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14665127|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14665128|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665129|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665130|NCT00257829|Methazolamide|methazolamide|mesh-list
14665131|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14665132|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665133|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665134|NCT00257829|Diuretics|diuretics|mesh-ancestor
14665135|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
14665136|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665137|NCT00257855|Lamotrigine|lamotrigine|mesh-list
14293667|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293668|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14293669|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
14665138|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
14665139|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14665140|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665141|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665142|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14665143|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665144|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14665145|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14665146|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665147|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665148|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14665149|NCT00257868|Rivastigmine|rivastigmine|mesh-list
14665150|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14665151|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665152|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665153|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
14665154|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665155|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665156|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14665157|NCT00257868|Protective Agents|protective agents|mesh-ancestor
14665158|NCT00257959|Amiodarone|amiodarone|mesh-list
14665159|NCT00257959|Sotalol|sotalol|mesh-list
14665160|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14665161|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14665162|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
14665163|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14665164|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665165|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665166|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14665167|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14665168|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14665169|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665170|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14729291|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
15186225|NCT03885947|Thiotepa|thiotepa|mesh-list
15186226|NCT03885947|Valproic Acid|valproic acid|mesh-list
15186227|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186228|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186229|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186230|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
15186231|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186232|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186233|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15186234|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
14665171|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14665172|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14665173|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14665174|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14665175|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665176|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665177|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
14665178|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
14665179|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665180|NCT00257972|Aripiprazole|aripiprazole|mesh-list
14665181|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
14665182|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665183|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14665184|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14665185|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665186|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665187|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
14665188|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
14665189|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665190|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665191|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14665192|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14665193|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
14665194|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14665195|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14665196|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14665197|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14726215|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14726216|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14726217|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14726218|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726219|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
14726220|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14726221|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14726222|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14726223|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
14726224|NCT00507832|Tacrolimus|tacrolimus|mesh-list
14726225|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14726226|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14726227|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14726228|NCT00507832|Analgesics|analgesics|mesh-ancestor
14726229|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
14293670|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293671|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293672|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14293673|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
14726230|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726231|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726232|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726233|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
14726234|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726235|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
14726236|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14726237|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726238|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726239|NCT00507845|Felodipine|felodipine|mesh-list
14726240|NCT00507845|Ramipril|ramipril|mesh-list
14726241|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14726242|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
14726243|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726244|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726245|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14726246|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14726247|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14726248|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14293674|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
14726249|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14726250|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726251|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
14726252|NCT00507858|Dexamethasone|dexamethasone|mesh-list
14726253|NCT00507858|Pemetrexed|pemetrexed|mesh-list
14726254|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14726255|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
14726256|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
14665198|NCT00258050|Lapatinib|lapatinib|mesh-list
14665199|NCT00258050|Midazolam|midazolam|mesh-list
14665200|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14665201|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14665202|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665203|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665204|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14665205|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14665206|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665207|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14665208|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
14665209|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
14665210|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
14665211|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
14665212|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665213|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665214|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665215|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665216|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665217|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14665218|NCT00258063|Norelgestromin|norelgestromin|mesh-list
14665219|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
14665220|NCT00258063|Estradiol|estradiol|mesh-list
14665221|NCT00258063|Estrogens|estrogens|mesh-ancestor
14293675|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14293676|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14293677|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14293678|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293679|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293680|NCT00570674|Paclitaxel|paclitaxel|mesh-list
14665222|NCT00258063|Hormones|hormones|mesh-ancestor
14665223|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665224|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665225|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14665226|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14665227|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14665228|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14665229|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14665230|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
14665231|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14665232|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665233|NCT00258089|Levofloxacin|levofloxacin|mesh-list
14665234|NCT00258089|Ofloxacin|ofloxacin|mesh-list
14665235|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14665236|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665237|NCT00258089|Renal Agents|renal agents|mesh-ancestor
14665238|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665239|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14665240|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14665241|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665242|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665243|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665244|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14665245|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14665246|NCT00258102|Levofloxacin|levofloxacin|mesh-list
14665247|NCT00258102|Ofloxacin|ofloxacin|mesh-list
14665248|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14665249|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665250|NCT00258102|Renal Agents|renal agents|mesh-ancestor
14665251|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665252|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14665253|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14665254|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665255|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665256|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665257|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15186235|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15186236|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
15186237|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186238|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
14665258|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14665259|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14293681|NCT00570674|Carboplatin|carboplatin|mesh-list
14665260|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14665261|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15223689|NCT05191706|Prednisolone|prednisolone|mesh-list
14665262|NCT00258115|Analgesics|analgesics|mesh-ancestor
14665263|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
14665264|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665265|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665266|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665267|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665268|NCT00258193|Linaclotide|linaclotide|mesh-list
14665269|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14665270|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
14665271|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665272|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665273|NCT00258232|Celecoxib|celecoxib|mesh-list
14665274|NCT00258232|Capecitabine|capecitabine|mesh-list
14665275|NCT00258232|Irinotecan|irinotecan|mesh-list
14665276|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293682|NCT00570674|Cetuximab|cetuximab|mesh-list
14665277|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
14665278|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665279|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665280|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14665281|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14665282|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186239|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186240|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
15186241|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15186242|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186243|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665283|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14665284|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14665285|NCT00258232|Analgesics|analgesics|mesh-ancestor
14665286|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
14665287|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665288|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665289|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186244|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
15186245|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14293683|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14665290|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665291|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14665292|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14665293|NCT00258245|Aspirin|aspirin|mesh-list
14665294|NCT00258245|Vitamins|vitamins|mesh-list
14665295|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
14665296|NCT00258245|Thalidomide|thalidomide|mesh-list
14665297|NCT00258245|Dexamethasone|dexamethasone|mesh-list
14665298|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
14665299|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
14665300|NCT00258245|Bortezomib|bortezomib|mesh-list
14665301|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
14665302|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14665303|NCT00258245|BB 1101|bb 1101|mesh-list
14665304|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
14665305|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665306|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665307|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
14665308|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
14665309|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665310|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665311|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
14665312|NCT00258245|Hormones|hormones|mesh-ancestor
14665313|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293684|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14293685|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665314|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14665315|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665316|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
15186246|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15186247|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186248|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
15186249|NCT03885895|Coagulants|coagulants|mesh-ancestor
15186250|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14665317|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665318|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665319|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14665320|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14665321|NCT00258245|Analgesics|analgesics|mesh-ancestor
14665322|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
14665323|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665324|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14665325|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14665326|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14665327|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14665328|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
14665329|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
14665330|NCT00258245|Protective Agents|protective agents|mesh-ancestor
14665331|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665332|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
14665333|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
14665334|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15186251|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
14665335|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665336|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14665337|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14665338|NCT00258245|Growth Substances|growth substances|mesh-ancestor
14665339|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
14665340|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
14665341|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14665342|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665343|NCT00258271|Cytarabine|cytarabine|mesh-list
14665344|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
14665345|NCT00258271|Cladribine|cladribine|mesh-list
14665346|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14665347|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
14665348|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665349|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665350|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
14665351|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665352|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665353|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
14665354|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665355|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665356|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665357|NCT00258284|Docetaxel|docetaxel|mesh-list
14665358|NCT00258284|Capecitabine|capecitabine|mesh-list
14665359|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665360|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
14665361|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665362|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
14665363|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665364|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14665365|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
14665366|NCT00258297|Gefitinib|gefitinib|mesh-list
14665367|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14665368|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665369|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665370|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665371|NCT00258323|Fluorouracil|fluorouracil|mesh-list
14665372|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665373|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
14665374|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665375|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14665376|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665377|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
14665378|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665379|NCT00258336|Rituximab|rituximab|mesh-list
14665380|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
14665381|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14665382|NCT00258336|Antibodies|antibodies|mesh-list
14665383|NCT00258336|Sargramostim|sargramostim|mesh-list
14665384|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14665385|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14665386|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665387|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
14665388|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665389|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186252|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665390|NCT00258375|Docetaxel|docetaxel|mesh-list
14665391|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665392|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
14665393|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665394|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
14665395|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665396|NCT00258388|Prednisone|prednisone|mesh-list
14665397|NCT00258388|Docetaxel|docetaxel|mesh-list
14665398|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665399|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
14665400|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665401|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
14665402|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665403|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665404|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
14665405|NCT00258388|Hormones|hormones|mesh-ancestor
14665406|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665407|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665408|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14665409|NCT00258479|Modafinil|modafinil|mesh-list
14665410|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14665411|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665412|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14665413|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14665414|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14665415|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665416|NCT00258557|Darunavir|darunavir|mesh-list
14665417|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14665418|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14665419|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
14665420|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665421|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665422|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14665423|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14665424|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
14665425|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665426|NCT00258596|Sirolimus|sirolimus|mesh-list
14665427|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665428|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665429|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14665430|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665431|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
14665432|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665433|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
14665434|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665435|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
14665436|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14665437|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14665438|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14665439|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665440|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665441|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
14665442|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665443|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665444|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14665445|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665446|NCT00258622|Lidocaine|lidocaine|mesh-list
14665447|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
14665448|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
14665449|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665450|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665451|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
14665452|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665453|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14665454|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14665455|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14665456|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665457|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665458|NCT00258739|Gemcitabine|gemcitabine|mesh-list
14665459|NCT00258739|Carboplatin|carboplatin|mesh-list
14665460|NCT00258739|Docetaxel|docetaxel|mesh-list
14665461|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665462|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14665463|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
14665464|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665465|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
14665466|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665467|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186253|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
15186254|NCT03885830|Dasatinib|dasatinib|mesh-list
15186255|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186256|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665468|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665469|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
14665470|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665471|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
14665472|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665473|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
14665474|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
14665475|NCT00258765|Docetaxel|docetaxel|mesh-list
14665476|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293686|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14293687|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14293688|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14293689|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665477|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
14665478|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665479|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
14665480|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665481|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14665482|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665483|NCT00258791|Ibuprofen|ibuprofen|mesh-list
14665484|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14665485|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14665486|NCT00258791|Analgesics|analgesics|mesh-ancestor
14665487|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
14665488|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665489|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665490|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665491|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665492|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14665493|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665494|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665495|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
14665496|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14665497|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665498|NCT00258843|Vaccines|vaccines|mesh-list
14665499|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
14665500|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186257|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186258|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186259|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
14665501|NCT00259051|Omeprazole|omeprazole|mesh-list
14665502|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14665503|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293690|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293691|NCT00570687|Insulin|insulin|mesh-list
14293692|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293693|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293694|NCT00570700|Dasatinib|dasatinib|mesh-list
14293695|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665504|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14665505|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186260|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15186261|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186262|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186263|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186264|NCT03885804|Analgesics|analgesics|mesh-ancestor
15186265|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
15186266|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186267|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14665506|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665507|NCT00259064|Gefitinib|gefitinib|mesh-list
14665508|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665509|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665510|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665511|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665512|NCT00259077|Omeprazole|omeprazole|mesh-list
14665513|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14665514|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665515|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14665516|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665517|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665518|NCT00259116|Methocarbamol|methocarbamol|mesh-list
14665519|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14665520|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665521|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14665522|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665523|NCT00259129|Sorafenib|sorafenib|mesh-list
14665524|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665525|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665526|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665527|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665528|NCT00259142|Chloroquine|chloroquine|mesh-list
14665529|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
14665530|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
14665531|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14665532|NCT00259142|Amebicides|amebicides|mesh-ancestor
14665533|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14665534|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14665535|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665536|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
14665537|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665538|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14665539|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665540|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665541|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15186268|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15186269|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15186270|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186271|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186272|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186273|NCT03885258|Melatonin|melatonin|mesh-list
15186274|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
15186275|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186276|NCT03885258|Protective Agents|protective agents|mesh-ancestor
15186277|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186278|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186279|NCT03885427|Ketamine|ketamine|mesh-list
15186280|NCT03885427|Analgesics|analgesics|mesh-ancestor
15186281|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
15186282|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186283|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665542|NCT00259142|Renal Agents|renal agents|mesh-ancestor
14665543|NCT00259155|Rifaximin|rifaximin|mesh-list
14665544|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665545|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665546|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293696|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293697|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293698|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293699|NCT00570713|Gemcitabine|gemcitabine|mesh-list
14293700|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293701|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
14665547|NCT00259168|Nateglinide|nateglinide|mesh-list
14665548|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14665549|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665550|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
14665551|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14665552|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14665553|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14665554|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665555|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
15186284|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14327519|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
14665556|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14665557|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
14665558|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14665559|NCT00259181|Protective Agents|protective agents|mesh-ancestor
14665560|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665561|NCT00259220|Erythromycin|erythromycin|mesh-list
14665562|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
14665563|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14665564|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
14665565|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665566|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665567|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665568|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14665569|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665570|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665571|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
14665572|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665573|NCT00259376|Dronedarone|dronedarone|mesh-list
14665574|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14665575|NCT00259402|Fluorouracil|fluorouracil|mesh-list
14665576|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
14665577|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665578|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
14665579|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665580|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14665581|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665582|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
14665583|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665584|NCT00259428|Dronedarone|dronedarone|mesh-list
14665585|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14665586|NCT00259441|Simvastatin|simvastatin|mesh-list
14665587|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14665588|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14665589|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
14665590|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665591|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14665592|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14665593|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665594|NCT00259636|Zonisamide|zonisamide|mesh-list
14665595|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
14665596|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14665597|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665598|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665599|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14665600|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665601|NCT00259662|Atorvastatin|atorvastatin|mesh-list
14665602|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14665603|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14665604|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
14665605|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665606|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14665607|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14665608|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665609|NCT00259675|Gemcitabine|gemcitabine|mesh-list
14665610|NCT00259675|Carboplatin|carboplatin|mesh-list
14665611|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665612|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14665613|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
14665614|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665615|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
14665616|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665617|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665618|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665619|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
14665620|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726257|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726258|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726259|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14726260|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
14726261|NCT00507858|Hormones|hormones|mesh-ancestor
14726262|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14726263|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14726264|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726265|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726266|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726267|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14665621|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
14665622|NCT00259701|Acetylcholine|acetylcholine|mesh-list
14665623|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
15186285|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15186286|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
15186287|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
14665624|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14665625|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
14665626|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665627|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665628|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665629|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
14665630|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14665631|NCT00259766|Budesonide|budesonide|mesh-list
14665632|NCT00259766|Terbutaline|terbutaline|mesh-list
14665633|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
14665634|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665635|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14665636|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
14665637|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665638|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665639|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14665640|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
14665641|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
14665642|NCT00259766|Hormones|hormones|mesh-ancestor
14665643|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665644|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14665645|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14665646|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14665647|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
14665648|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186288|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186289|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15186290|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15186291|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665649|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665650|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
14665651|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
14665652|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14665653|NCT00259779|Prednisolone|prednisolone|mesh-list
14665654|NCT00259779|Budesonide|budesonide|mesh-list
14665655|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
14665656|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665657|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
14665658|NCT00259779|Hormones|hormones|mesh-ancestor
14665659|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665660|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665661|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14665662|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665663|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
14665664|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665665|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14665666|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14665667|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
14665668|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14665669|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14665670|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14665671|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14665672|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665673|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665674|NCT00259792|Budesonide|budesonide|mesh-list
14665675|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
14665676|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186292|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186293|NCT03885219|Paclitaxel|paclitaxel|mesh-list
15186294|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14665677|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14665678|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
14665679|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665680|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665681|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14665682|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
14665683|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
14665684|NCT00259792|Hormones|hormones|mesh-ancestor
14665685|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665686|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14665687|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14665688|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14665689|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
14665690|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665691|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665692|NCT00259805|Rituximab|rituximab|mesh-list
14665693|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14665694|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665695|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
14665696|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665697|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665698|NCT00259870|Olanzapine|olanzapine|mesh-list
14665699|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
14665700|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
14665701|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665702|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665703|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665704|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14665705|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14665706|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665707|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665708|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14665709|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14665710|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665711|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665712|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665713|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
14665714|NCT00259883|Paroxetine|paroxetine|mesh-list
14665715|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14665716|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14665717|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665718|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665719|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665720|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
14665721|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665722|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14665723|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
14665724|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665725|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14665726|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14665727|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665728|NCT00259896|Exenatide|exenatide|mesh-list
14665729|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14665730|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665731|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14665732|NCT00259896|Incretins|incretins|mesh-ancestor
14665733|NCT00259896|Hormones|hormones|mesh-ancestor
15186295|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186296|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
15186297|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665734|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665735|NCT00259922|Alvimopan|alvimopan|mesh-list
14665736|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665737|NCT00259935|Topotecan|topotecan|mesh-list
14665738|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14665739|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14665740|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665741|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665742|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665743|NCT00259974|Rituximab|rituximab|mesh-list
14665744|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14665745|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665746|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
14665747|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665748|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665749|NCT00259987|Lapatinib|lapatinib|mesh-list
14665750|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665751|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665752|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665753|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665754|NCT00260026|Docetaxel|docetaxel|mesh-list
14665755|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665756|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
14665757|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665758|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
14665759|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665760|NCT00260039|Vaccines|vaccines|mesh-list
14665761|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
14665762|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665763|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
15186298|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
15186299|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223690|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15223691|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
15223692|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15223693|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
15223694|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15223695|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
15223696|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223697|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
15223698|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
14665764|NCT00260052|Hematinics|hematinics|mesh-ancestor
15223699|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223700|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223701|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223702|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
15223703|NCT05191706|Hormones|hormones|mesh-ancestor
15223704|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223705|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223706|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223707|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15223708|NCT05191706|Protective Agents|protective agents|mesh-ancestor
15223709|NCT05191394|Antibodies|antibodies|mesh-list
15223710|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
15223711|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225665|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15225666|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15225667|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
15225668|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665765|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
14665766|NCT00260143|Testosterone|testosterone|mesh-list
14665767|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
14665768|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
14665769|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14665770|NCT00260143|Androgens|androgens|mesh-ancestor
14665771|NCT00260143|Hormones|hormones|mesh-ancestor
14665772|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665773|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665774|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14665775|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665776|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
14665777|NCT00260247|Carbamazepine|carbamazepine|mesh-list
14665778|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
14665779|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
15225730|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665780|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
14665781|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14665782|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665783|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665784|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665785|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14665786|NCT00260247|Analgesics|analgesics|mesh-ancestor
14665787|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
14665788|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665789|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14665790|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665791|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665792|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14665793|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14665794|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14665795|NCT00260260|Oxycodone|oxycodone|mesh-list
14665796|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14665797|NCT00260260|Narcotics|narcotics|mesh-ancestor
14665798|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665799|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665800|NCT00260260|Analgesics|analgesics|mesh-ancestor
14665801|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
14665802|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665803|NCT00260325|Valdecoxib|valdecoxib|mesh-list
14665804|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14665805|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14665806|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665807|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665808|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14665809|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14665810|NCT00260325|Analgesics|analgesics|mesh-ancestor
14665811|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
14665812|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665813|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665814|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14665815|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665816|NCT00260351|Vaccines|vaccines|mesh-list
14665817|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
14665818|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665819|NCT00260364|Gemcitabine|gemcitabine|mesh-list
14665820|NCT00260364|Bevacizumab|bevacizumab|mesh-list
14665821|NCT00260364|Capecitabine|capecitabine|mesh-list
14665822|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14665823|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14665824|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665825|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14665826|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14665827|NCT00260364|Growth Substances|growth substances|mesh-ancestor
14665828|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665829|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
14665830|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14665831|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
14665832|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665833|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
14665834|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665835|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186300|NCT03885180|Warfarin|warfarin|mesh-list
15186301|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
15186302|NCT03885388|Dactinomycin|dactinomycin|mesh-list
15186303|NCT03885388|Methotrexate|methotrexate|mesh-list
15186304|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15186305|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
15186306|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15186307|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186308|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15186309|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
15186310|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186311|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186312|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
15186313|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665836|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665837|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
14665838|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14665839|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
14665840|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14665841|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665842|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
14665843|NCT00260390|Hormones|hormones|mesh-ancestor
14665844|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665845|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665846|NCT00260416|Abciximab|abciximab|mesh-list
14665847|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
14665848|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15186314|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15186315|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186316|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
15186317|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186318|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15186319|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15186320|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186321|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15186322|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15186323|NCT03885297|Liraglutide|liraglutide|mesh-list
15186324|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15186325|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186326|NCT03885297|Incretins|incretins|mesh-ancestor
15186327|NCT03885297|Hormones|hormones|mesh-ancestor
15186328|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15186329|NCT03884881|Meropenem|meropenem|mesh-list
15186330|NCT03884881|Imipenem|imipenem|mesh-list
15186331|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15186332|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186333|NCT03885141|Zolpidem|zolpidem|mesh-list
14665849|NCT00260520|Dalteparin|dalteparin|mesh-list
14665850|NCT00260520|Tinzaparin|tinzaparin|mesh-list
14665851|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14665852|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
14665853|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14665854|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14665855|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665856|NCT00260611|Docetaxel|docetaxel|mesh-list
14665857|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
14665858|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665859|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
14665860|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
14665861|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
14665862|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665863|NCT00260624|Citalopram|citalopram|mesh-list
14665864|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14665865|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14665866|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665867|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665868|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665869|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
14665870|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665871|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14665872|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
14665873|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665874|NCT00260702|Omalizumab|omalizumab|mesh-list
14665875|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14665876|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14665877|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
14665878|NCT00260793|Ropinirole|ropinirole|mesh-list
14665879|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14665880|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14665881|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
14665882|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
14665883|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186334|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15186335|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14665884|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665885|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665886|NCT00260819|Bosentan|bosentan|mesh-list
14665887|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14665888|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14665889|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665890|NCT00260988|Dalteparin|dalteparin|mesh-list
14665891|NCT00260988|Tinzaparin|tinzaparin|mesh-list
14665892|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14665893|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
14665894|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14665895|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15186336|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186337|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186338|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15186339|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
15186340|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
15186341|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186342|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186343|NCT03884972|Venetoclax|venetoclax|mesh-list
14665896|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665897|NCT00261027|Exemestane|exemestane|mesh-list
14665898|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665899|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14665900|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14665901|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665902|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665903|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14665904|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
14665905|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665906|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665907|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14665908|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14665909|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14665910|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
14665911|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665912|NCT00261079|Fexofenadine|fexofenadine|mesh-list
14665913|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14665914|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14665915|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14665916|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
14665917|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
14665918|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665919|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665920|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665921|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
14665922|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665923|NCT00261105|Telithromycin|telithromycin|mesh-list
14665924|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14665925|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14665926|NCT00261118|Rituximab|rituximab|mesh-list
14665927|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14665928|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665929|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
14665930|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665931|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14665932|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
14665933|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14665934|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14665935|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14665936|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665937|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665938|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
14665939|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665940|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665941|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14665942|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14665943|NCT00261170|Bupropion|bupropion|mesh-list
14665944|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14665945|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
14665946|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665947|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14665948|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14665949|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14665950|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665951|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
14665952|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665953|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665954|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14665955|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14665956|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665957|NCT00261183|Melatonin|melatonin|mesh-list
14665958|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
14665959|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665960|NCT00261183|Protective Agents|protective agents|mesh-ancestor
14665961|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665962|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665963|NCT00261222|Amodiaquine|amodiaquine|mesh-list
14665964|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
14665965|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14665966|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14665967|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726268|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14726269|NCT00507949|Megestrol|megestrol|mesh-list
14726270|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
14726271|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14726272|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14726273|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14726274|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
14726275|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14726276|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726277|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14726278|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14726279|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14726280|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726281|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
14726282|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14726283|NCT00507962|Cisplatin|cisplatin|mesh-list
14726284|NCT00507962|Doxorubicin|doxorubicin|mesh-list
14726285|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14726286|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726287|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14726288|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14726289|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726290|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726291|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726292|NCT00507975|Nicotine|nicotine|mesh-list
14726293|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14726294|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
14726295|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726296|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726297|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14726298|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14726299|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
14726300|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726301|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726302|NCT00508040|Interferons|interferons|mesh-list
14726303|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
14726304|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
14726305|NCT00508040|Prednisone|prednisone|mesh-list
14726306|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14726307|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
14726308|NCT00508040|Hormones|hormones|mesh-ancestor
14726309|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14726310|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726311|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14814611|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
15186344|NCT03884972|Trabectedin|trabectedin|mesh-list
15186345|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186346|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15186347|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
15186348|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186349|NCT03884491|Vortioxetine|vortioxetine|mesh-list
15186350|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
15186351|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15186352|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15186353|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15186354|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186355|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726312|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726313|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
14665968|NCT00261248|Vaccines|vaccines|mesh-list
14665969|NCT00261248|Immunologic Factors|immunologic factors|mesh-ancestor
14665970|NCT00261248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665971|NCT00261261|Midazolam|midazolam|mesh-list
14665972|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14665973|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14665974|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14665975|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665976|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14665977|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14293702|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293703|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14665978|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14665979|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14665980|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
14665981|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
14665982|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
14665983|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
14665984|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14665985|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665986|NCT00261287|Ciclesonide|ciclesonide|mesh-list
14665987|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
14665988|NCT00261287|Hormones|hormones|mesh-ancestor
14665989|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14665990|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14665991|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14665992|NCT00261300|Pantoprazole|pantoprazole|mesh-list
14665993|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14665994|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14665995|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14665996|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14665997|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14665998|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
14665999|NCT00261313|Hematinics|hematinics|mesh-ancestor
14666000|NCT00261326|Simvastatin|simvastatin|mesh-list
14666001|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14666002|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14666003|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
14666004|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666005|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14666006|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14666007|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666008|NCT00261339|Pantoprazole|pantoprazole|mesh-list
14666009|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14666010|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666011|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14666012|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666013|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666014|NCT00261352|Metformin|metformin|mesh-list
15186356|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15186357|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15186358|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15186359|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186360|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186361|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
15186362|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15186363|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15223712|NCT05190952|Dexamethasone|dexamethasone|mesh-list
14666015|NCT00261352|Fenofibrate|fenofibrate|mesh-list
14666016|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14666017|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666018|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14666019|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
14666020|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666021|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14666022|NCT00261365|Ipilimumab|ipilimumab|mesh-list
14666023|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14666024|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666025|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14666026|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666027|NCT00261378|Doxorubicin|doxorubicin|mesh-list
14666028|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14666029|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14666030|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666031|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14666032|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14666033|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666034|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666035|NCT00261391|Marimastat|marimastat|mesh-list
14666036|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666037|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666038|NCT00261469|Topiramate|topiramate|mesh-list
14666039|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
14666040|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14666041|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666042|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14666043|NCT00261482|Norelgestromin|norelgestromin|mesh-list
14666044|NCT00261482|Estradiol|estradiol|mesh-list
14666045|NCT00261482|Estrogens|estrogens|mesh-ancestor
14666046|NCT00261482|Hormones|hormones|mesh-ancestor
14666047|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666048|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186364|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15186365|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14666049|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14666050|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
14666051|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14666052|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14666053|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14666054|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14666055|NCT00261508|Risperidone|risperidone|mesh-list
14666056|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14666057|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
14666058|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666059|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666060|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666061|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14666062|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14666063|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666064|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666065|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14666066|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
14666067|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
14666068|NCT00261521|Hematinics|hematinics|mesh-ancestor
14666069|NCT00261547|Rituximab|rituximab|mesh-list
14666070|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14666071|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666072|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
14666073|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186366|NCT03884348|Amoxicillin|amoxicillin|mesh-list
15186367|NCT03884348|Metronidazole|metronidazole|mesh-list
15186368|NCT03884348|Clarithromycin|clarithromycin|mesh-list
15186369|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15186370|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15186371|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666074|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666075|NCT00261560|Acetaminophen|acetaminophen|mesh-list
14666076|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14666077|NCT00261560|Analgesics|analgesics|mesh-ancestor
14666078|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
14666079|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666080|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666081|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
14666082|NCT00261573|Galantamine|galantamine|mesh-list
15186372|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14666083|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14666084|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666085|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666086|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
14666087|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186373|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14666088|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666089|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14666090|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
14666091|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666092|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
14666093|NCT00261586|Aspirin|aspirin|mesh-list
14666094|NCT00261586|Acetaminophen|acetaminophen|mesh-list
14666095|NCT00261586|Ibuprofen|ibuprofen|mesh-list
14666096|NCT00261586|Celecoxib|celecoxib|mesh-list
14666097|NCT00261586|Naproxen|naproxen|mesh-list
14666098|NCT00261586|Rofecoxib|rofecoxib|mesh-list
14666099|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14666100|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14666101|NCT00261586|Analgesics|analgesics|mesh-ancestor
14666102|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
14666103|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666104|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666105|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666106|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666107|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14666108|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14666109|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666110|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14666111|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14666112|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666113|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
15186374|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15186375|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666114|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14666115|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
14666116|NCT00261599|Midazolam|midazolam|mesh-list
14666117|NCT00261599|Fospropofol|fospropofol|mesh-list
14666118|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14666119|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14666120|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666121|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666122|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14666123|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14666124|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666125|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14666126|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
14666127|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
14666128|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
14666129|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
14666130|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666131|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666132|NCT00261612|Dexamethasone|dexamethasone|mesh-list
14666133|NCT00261612|Rituximab|rituximab|mesh-list
14666134|NCT00261612|Bortezomib|bortezomib|mesh-list
14666135|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666136|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
14666137|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
14666138|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666139|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666140|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666141|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
14666142|NCT00261612|Hormones|hormones|mesh-ancestor
14666143|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666144|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14666145|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666146|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14666147|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
15186376|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186377|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15186378|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15186379|NCT03884465|Treprostinil|treprostinil|mesh-list
15186380|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14666148|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666149|NCT00261625|Alendronate|alendronate|mesh-list
14666150|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14666151|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666152|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
14666153|NCT00261677|Hematinics|hematinics|mesh-ancestor
14666154|NCT00261703|Cisplatin|cisplatin|mesh-list
14666155|NCT00261703|Docetaxel|docetaxel|mesh-list
14666156|NCT00261703|Fluorouracil|fluorouracil|mesh-list
14666157|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666158|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
14666159|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
14666160|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
14666161|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666162|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
14666163|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14666164|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666165|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
14666166|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666167|NCT00261729|Prazosin|prazosin|mesh-list
15186381|NCT03884530|Aspirin|aspirin|mesh-list
15186382|NCT03884530|Ticagrelor|ticagrelor|mesh-list
15186383|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14666168|NCT00261729|Paroxetine|paroxetine|mesh-list
14666169|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14666170|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15186384|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186385|NCT03884530|Analgesics|analgesics|mesh-ancestor
15186386|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
15186387|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186388|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186389|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186390|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186391|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15186392|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15186393|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666171|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666172|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666173|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666174|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
14666175|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666176|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14666177|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
14666178|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666179|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14666180|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14666181|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666182|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14666183|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14666184|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14666185|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14666186|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14666187|NCT00261742|Penicillins|penicillins|mesh-list
14666188|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14666189|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666190|NCT00261755|Analgesics|analgesics|mesh-list
14666191|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
14666192|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666193|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814612|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
14814613|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814614|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814615|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814616|NCT00863915|Ramipril|ramipril|mesh-list
14814617|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14814618|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
14814619|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814620|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814621|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814622|NCT00863941|Bupropion|bupropion|mesh-list
14814623|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14814624|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
14666194|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
14666195|NCT00261820|Sirolimus|sirolimus|mesh-list
14666196|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
14666197|NCT00261820|Prednisolone|prednisolone|mesh-list
14666198|NCT00261820|Tacrolimus|tacrolimus|mesh-list
14666199|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666200|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
14666201|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666202|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14666203|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666204|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666205|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14666206|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666207|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14666208|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
14666209|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14666210|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666211|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
14666212|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666213|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
14666214|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
14666215|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666216|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666217|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
14666218|NCT00261820|Hormones|hormones|mesh-ancestor
14666219|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666220|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14666221|NCT00261820|Protective Agents|protective agents|mesh-ancestor
14666222|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14666223|NCT00261872|Methylphenidate|methylphenidate|mesh-list
14666224|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14666225|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666226|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14666227|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14666228|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666229|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666230|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
14666231|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666232|NCT00261911|Sibutramine|sibutramine|mesh-list
14666233|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
14666234|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666235|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
14666236|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14666237|NCT00261937|Furosemide|furosemide|mesh-list
14666238|NCT00261937|Diuretics|diuretics|mesh-ancestor
14666239|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666240|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666241|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14666242|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666243|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666244|NCT00261976|Infliximab|infliximab|mesh-list
14666245|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
14666246|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666247|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666248|NCT00262015|Vaccines|vaccines|mesh-list
14666249|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
14666250|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666251|NCT00262054|Heparin|heparin|mesh-list
14293704|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
14293705|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293706|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293707|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293708|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
14293709|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293710|NCT00570739|Metformin|metformin|mesh-list
14293711|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14293712|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293713|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666252|NCT00262054|Calcium heparin|calcium heparin|mesh-list
14666253|NCT00262054|Bivalirudin|bivalirudin|mesh-list
14666254|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
14666255|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14666256|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14814625|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814626|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14814627|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814628|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726314|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666257|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666258|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
14666259|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14666260|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
14666261|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666262|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
14666263|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14666264|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666265|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14666266|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
14666267|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14666268|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666269|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666270|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666271|NCT00262210|Prednisolone|prednisolone|mesh-list
14666272|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
14666273|NCT00262210|Etoposide|etoposide|mesh-list
14666274|NCT00262210|Epirubicin|epirubicin|mesh-list
14666275|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666276|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
14666277|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666278|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666279|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14666280|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
14666281|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186394|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15186395|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15186396|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186397|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
15186398|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15186399|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15186400|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14666282|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666283|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14666284|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14666285|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14666286|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14666287|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666288|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666289|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
14666290|NCT00262210|Hormones|hormones|mesh-ancestor
14666291|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666292|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14666293|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14666294|NCT00262262|Levetiracetam|levetiracetam|mesh-list
14666295|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
14666296|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
14666297|NCT00262275|Aspirin|aspirin|mesh-list
14666298|NCT00262275|Clopidogrel|clopidogrel|mesh-list
14666299|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14666300|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14666301|NCT00262275|Analgesics|analgesics|mesh-ancestor
14666302|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
14666303|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666304|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666305|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666306|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666307|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14666308|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14666309|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666310|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14666311|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14666312|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666313|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
15186401|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
15186402|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186403|NCT03884127|Orlistat|orlistat|mesh-list
15186404|NCT03884127|Ezetimibe|ezetimibe|mesh-list
15186405|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15186406|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15186407|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
14666314|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14666315|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15223713|NCT05190952|Ketamine|ketamine|mesh-list
14666316|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15186408|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186409|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15186410|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186411|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14666317|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
14666318|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666319|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14666320|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14666321|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666322|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
14666323|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666324|NCT00262327|Endostatins|endostatins|mesh-list
14666325|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666326|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14666327|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14666328|NCT00262327|Growth Substances|growth substances|mesh-ancestor
14666329|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666330|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
14666331|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
14666332|NCT00262379|Hematinics|hematinics|mesh-ancestor
14666333|NCT00262392|Pamidronate|pamidronate|mesh-list
14666334|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14666335|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666336|NCT00262405|Prednisone|prednisone|mesh-list
14666337|NCT00262405|Zileuton|zileuton|mesh-list
14666338|NCT00262405|Azathioprine|azathioprine|mesh-list
14666339|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666340|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
14666341|NCT00262405|Hormones|hormones|mesh-ancestor
14666342|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666343|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666344|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14666345|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666346|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
14666347|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666348|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14666349|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666350|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
14666351|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666352|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14666353|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14666354|NCT00262405|Analgesics|analgesics|mesh-ancestor
14666355|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
14666356|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666357|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14666358|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666359|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14666360|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
14666361|NCT00262418|Ivermectin|ivermectin|mesh-list
14666362|NCT00262418|Permethrin|permethrin|mesh-list
14666363|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14666364|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666365|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666366|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666367|NCT00262470|Indomethacin|indomethacin|mesh-list
14666368|NCT00262470|Octreotide|octreotide|mesh-list
14666369|NCT00262470|Propranolol|propranolol|mesh-list
14666370|NCT00262470|Clonidine|clonidine|mesh-list
14666371|NCT00262470|Mecamylamine|mecamylamine|mesh-list
14666372|NCT00262470|Acetazolamide|acetazolamide|mesh-list
14666373|NCT00262470|Isosorbide|isosorbide|mesh-list
14666374|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15186412|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15186413|NCT03883841|Hematinics|hematinics|mesh-ancestor
15186414|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15186415|NCT03883880|Capsaicin|capsaicin|mesh-list
15186416|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
14666375|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15186417|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
14666376|NCT00262470|Midodrine|midodrine|mesh-list
14666377|NCT00262470|Memantine|memantine|mesh-list
15186418|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
14666378|NCT00262470|Entacapone|entacapone|mesh-list
14666379|NCT00262470|Melatonin|melatonin|mesh-list
14666380|NCT00262470|Modafinil|modafinil|mesh-list
14666381|NCT00262470|Sertraline|sertraline|mesh-list
14666382|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14666383|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
14666384|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666385|NCT00262470|Protective Agents|protective agents|mesh-ancestor
14666386|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666387|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666388|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
14666389|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666390|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14666391|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14666392|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666393|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666394|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
15186419|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186420|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186421|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
15186422|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186423|NCT03883880|Protective Agents|protective agents|mesh-ancestor
15186424|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15186425|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15186426|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186427|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15186428|NCT03883919|Vitamin D|vitamin d|mesh-list
15186429|NCT03883919|Leucovorin|leucovorin|mesh-list
15186430|NCT03883919|Fluorouracil|fluorouracil|mesh-list
15186431|NCT03883919|Irinotecan|irinotecan|mesh-list
15186432|NCT03883919|Vitamins|vitamins|mesh-ancestor
15186433|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
15186434|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186435|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15186436|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
15186437|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186438|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15186439|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186440|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186441|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
14666395|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14666396|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14666397|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14666398|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14666399|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14666400|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
14666401|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14666402|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14666403|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
14666404|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14666405|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14666406|NCT00262470|Analgesics|analgesics|mesh-ancestor
14666407|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
14666408|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666409|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
14666410|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
14666411|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14666412|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14666413|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14666414|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15186442|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14666415|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14666416|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666417|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15186443|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14666418|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14666419|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14666420|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14666421|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14666422|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14666423|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186444|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186445|NCT03883919|Antidotes|antidotes|mesh-ancestor
15186446|NCT03883919|Protective Agents|protective agents|mesh-ancestor
15186447|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
15186448|NCT03884101|Paclitaxel|paclitaxel|mesh-list
15186449|NCT03884101|Carboplatin|carboplatin|mesh-list
15186450|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
15186451|NCT03884101|Lenvatinib|lenvatinib|mesh-list
15186452|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15186453|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186454|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
15186455|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
15186456|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
15186457|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186458|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15186459|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15186460|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186461|NCT03884036|Vitamin D|vitamin d|mesh-list
15186462|NCT03884036|Vitamins|vitamins|mesh-ancestor
15186463|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
15186464|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186465|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15186466|NCT03883984|Cysteamine|cysteamine|mesh-list
15186467|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
15186468|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666424|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666425|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666426|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
14666427|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
14666428|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14666429|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14666430|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666431|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
14666432|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14666433|NCT00262470|Diuretics|diuretics|mesh-ancestor
14666434|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666435|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
14666436|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14666437|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14666438|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14666439|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14666440|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14666441|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14666442|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14666443|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14666444|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
14666445|NCT00262483|Ribavirin|ribavirin|mesh-list
14666446|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14666447|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
14666448|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666449|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
14666450|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666451|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14666452|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14666453|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14666454|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
14666455|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666456|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15186469|NCT03883776|Octreotide|octreotide|mesh-list
15186470|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15186471|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15186472|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186473|NCT03883763|Bupivacaine|bupivacaine|mesh-list
14726315|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
15186474|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
15186475|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
15186476|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186477|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186478|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
14666457|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14666458|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666459|NCT00262561|Aspirin|aspirin|mesh-list
14666460|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14666461|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14666462|NCT00262561|Analgesics|analgesics|mesh-ancestor
14666463|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
14666464|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666465|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666466|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666467|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666468|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14666469|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14666470|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666471|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14666472|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14666473|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666474|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
14666475|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14666476|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666477|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666478|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14666479|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14666480|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
14666481|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666482|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666483|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14666484|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
14666485|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
14666486|NCT00262587|Hormones|hormones|mesh-ancestor
14666487|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666488|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
14666489|NCT00262769|Gemcitabine|gemcitabine|mesh-list
14666490|NCT00262769|Cisplatin|cisplatin|mesh-list
14666491|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666492|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14666493|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
14666494|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666495|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
14666496|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666497|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666498|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666499|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
14666500|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666501|NCT00262782|Fludarabine|fludarabine|mesh-list
14666502|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666503|NCT00262795|Fludarabine|fludarabine|mesh-list
14666504|NCT00262795|Chlorambucil|chlorambucil|mesh-list
14666505|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186479|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186480|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
15186481|NCT03883347|Remifentanil|remifentanil|mesh-list
15186482|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15186483|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186484|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186485|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186486|NCT03883347|Analgesics|analgesics|mesh-ancestor
15186487|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
15186488|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186489|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15186490|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15186491|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15186492|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186493|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186494|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186495|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15186496|NCT03883347|Narcotics|narcotics|mesh-ancestor
15223714|NCT05190952|Bupivacaine|bupivacaine|mesh-list
15223715|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223716|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
15223717|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
14666506|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666507|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14666508|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
14666509|NCT00262808|Leucovorin|leucovorin|mesh-list
14666510|NCT00262808|Fluorouracil|fluorouracil|mesh-list
15186497|NCT03883360|Cannabidiol|cannabidiol|mesh-list
15186498|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
15186499|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
15186500|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
15186501|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186502|NCT03883269|Ethanol|ethanol|mesh-list
15186503|NCT03883269|Clindamycin|clindamycin|mesh-list
15186504|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
15186505|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
15186506|NCT03883269|Erythromycin|erythromycin|mesh-list
15186507|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
15186508|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15186509|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
15186510|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15186511|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186512|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186513|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186514|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15186515|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15186516|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186517|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186518|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15186519|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
14666511|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
14666512|NCT00262808|Calcium|calcium|mesh-list
14666513|NCT00262808|Sargramostim|sargramostim|mesh-list
14666514|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
14666515|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14666516|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666517|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
14666518|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666519|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14666520|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666521|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666522|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
14666523|NCT00262808|Antidotes|antidotes|mesh-ancestor
14666524|NCT00262808|Protective Agents|protective agents|mesh-ancestor
14666525|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
14666526|NCT00262808|Vitamins|vitamins|mesh-ancestor
14666527|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
14666528|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
14666529|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
14666530|NCT00262886|Fludarabine|fludarabine|mesh-list
14666531|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
14666532|NCT00262886|Tacrolimus|tacrolimus|mesh-list
14666533|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14666534|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666535|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
14666536|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666537|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666538|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14666539|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
14666540|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666541|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666542|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14666543|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14666544|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
14666545|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14666546|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666547|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15186520|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15186521|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
15186522|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186523|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
15186524|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666548|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14666549|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
14666550|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14666551|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666552|NCT00262977|Aspirin|aspirin|mesh-list
14666553|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186525|NCT03883022|Vancomycin|vancomycin|mesh-list
14666554|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14666555|NCT00262977|Analgesics|analgesics|mesh-ancestor
14666556|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
14666557|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666558|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666559|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666560|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666561|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14666562|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14666563|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666564|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14666565|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14666566|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666567|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
14666568|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14666569|NCT00263003|Irbesartan|irbesartan|mesh-list
14666570|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14666571|NCT00263003|Diuretics|diuretics|mesh-ancestor
14666572|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666573|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666574|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14666575|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666576|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666577|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14666578|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14666579|NCT00263016|Docetaxel|docetaxel|mesh-list
14666580|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666581|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
14666582|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
14666583|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
14666584|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666585|NCT00263029|Capecitabine|capecitabine|mesh-list
14666586|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
14666587|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14666588|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
14666589|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666590|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726316|NCT00508092|Anesthetics|anesthetics|mesh-list
14726317|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
14726318|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726319|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726320|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
14726321|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726322|NCT00508209|Bortezomib|bortezomib|mesh-list
14726323|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726324|NCT00508222|Lopinavir|lopinavir|mesh-list
14726325|NCT00508222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15186526|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15186527|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186528|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
15186529|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
15186530|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15186531|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
15186532|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186533|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
15186534|NCT03883074|Protective Agents|protective agents|mesh-ancestor
15186535|NCT03883074|Antacids|antacids|mesh-ancestor
15186536|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186537|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15186538|NCT03883204|Risperidone|risperidone|mesh-list
15186539|NCT03883204|Aripiprazole|aripiprazole|mesh-list
15186540|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15186541|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
15186542|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186543|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186544|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186545|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15186546|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15186547|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666591|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
14666592|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666593|NCT00263068|Rotigotine|rotigotine|mesh-list
14666594|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
14666595|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
14666596|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666597|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666598|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666599|NCT00263094|Rofecoxib|rofecoxib|mesh-list
15186548|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15186549|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15186550|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
15186551|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
15186552|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
15186553|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15186554|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15186555|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15186556|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15186557|NCT03882463|Insulin|insulin|mesh-list
15186558|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15186559|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186560|NCT03882710|Metoprolol|metoprolol|mesh-list
15186561|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15186562|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15186563|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
15186564|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
15186565|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186566|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186567|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15186568|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14293714|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14293715|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14666600|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14666601|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14666602|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666603|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666604|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14666605|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14666606|NCT00263094|Analgesics|analgesics|mesh-ancestor
14666607|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
14666608|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666609|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666610|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666611|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666612|NCT00263133|Sertraline|sertraline|mesh-list
14666613|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
14666614|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666615|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14666616|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14666617|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666618|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666619|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666620|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
14666621|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666622|NCT00263185|Vitamin D|vitamin d|mesh-list
14666623|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
14666624|NCT00263185|Vitamins|vitamins|mesh-list
14666625|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
14666626|NCT00263185|Calcium|calcium|mesh-list
14666627|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
14666628|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666629|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14666630|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14666631|NCT00263185|Antacids|antacids|mesh-ancestor
14666632|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666633|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666634|NCT00263198|Letrozole|letrozole|mesh-list
14666635|NCT00263198|Vatalanib|vatalanib|mesh-list
14666636|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666637|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15186569|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14666638|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14666639|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666640|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186570|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
14666641|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14666642|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
15186571|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186572|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186573|NCT03882814|Meperidine|meperidine|mesh-list
15186574|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15186575|NCT03882814|Narcotics|narcotics|mesh-ancestor
15186576|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666643|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666644|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666645|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14666646|NCT00263263|Sirolimus|sirolimus|mesh-list
14666647|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14666648|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666649|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14666650|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666651|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
14666652|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666653|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
14666654|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666655|NCT00263276|Metformin|metformin|mesh-list
14666656|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
14666657|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14666658|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666659|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14666660|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666661|NCT00263302|Dexamethasone|dexamethasone|mesh-list
14666662|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666663|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
14666664|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
14666665|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666666|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666667|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666668|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
14666669|NCT00263302|Hormones|hormones|mesh-ancestor
14666670|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666671|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14666672|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666673|NCT00263315|Amphotericin B|amphotericin b|mesh-list
14666674|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14666675|NCT00263315|Amebicides|amebicides|mesh-ancestor
14666676|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14666677|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14666678|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666679|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14666680|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
14666681|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
14666682|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666683|NCT00263393|Atenolol|atenolol|mesh-list
14666684|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14666685|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14666686|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14666687|NCT00263393|Diuretics|diuretics|mesh-ancestor
14666688|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666689|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666690|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14666691|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666692|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666693|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14666694|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
14666695|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
14666696|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666697|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14666698|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14666699|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14666700|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
14666701|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666702|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
14666703|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186577|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186578|NCT03882814|Analgesics|analgesics|mesh-ancestor
14666704|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14666705|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
14666706|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666707|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666708|NCT00263458|Buprenorphine|buprenorphine|mesh-list
14666709|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14666710|NCT00263458|Narcotics|narcotics|mesh-ancestor
14666711|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666712|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666713|NCT00263458|Analgesics|analgesics|mesh-ancestor
14666714|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
14666715|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666716|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14666717|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
14666718|NCT00263484|Thalidomide|thalidomide|mesh-list
14666719|NCT00263484|Dexamethasone|dexamethasone|mesh-list
14666720|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
14666721|NCT00263484|BB 1101|bb 1101|mesh-list
14666722|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666723|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
14666724|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
14666725|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666726|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666727|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666728|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
14666729|NCT00263484|Hormones|hormones|mesh-ancestor
14666730|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666731|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14666732|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666733|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
14666734|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666735|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666736|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666737|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
14666738|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
14666739|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14666740|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666741|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14666742|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14666743|NCT00263484|Growth Substances|growth substances|mesh-ancestor
14666744|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
14666745|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14666746|NCT00263705|Capecitabine|capecitabine|mesh-list
14666747|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14666748|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
14666749|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186579|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
15186580|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666750|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666751|NCT00263718|Betamethasone|betamethasone|mesh-list
14666752|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
14666753|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14666754|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
15186581|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15186582|NCT03882775|Heparin|heparin|mesh-list
15186583|NCT03882775|Bivalirudin|bivalirudin|mesh-list
15186584|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
15186585|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15186586|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15186587|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186588|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
14666755|NCT00263718|Calcipotriene|calcipotriene|mesh-list
14666756|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14666757|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14666758|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
15186589|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15186590|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
15186591|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186592|NCT03882788|Fentanyl|fentanyl|mesh-list
15186593|NCT03882788|Isoflurane|isoflurane|mesh-list
15186594|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15186595|NCT03882788|Narcotics|narcotics|mesh-ancestor
14666759|NCT00263718|Hormones|hormones|mesh-ancestor
14726326|NCT00508222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15186596|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666760|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666761|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666762|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14666763|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
14666764|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
14666765|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14666766|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14666767|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
14666768|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666769|NCT00263744|Antacids|antacids|mesh-ancestor
14666770|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666771|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666772|NCT00263796|Oxytocin|oxytocin|mesh-list
14666773|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
14666774|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14666775|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666776|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14666777|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666778|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14666779|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666780|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666781|NCT00263965|Metformin|metformin|mesh-list
14666782|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14666783|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666784|NCT00263978|Defibrotide|defibrotide|mesh-list
14666785|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14666786|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14666787|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666788|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14666789|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
14666790|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
14666791|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666792|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14666793|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666794|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666795|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
14666796|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14666797|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666798|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
14666799|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
14666800|NCT00264108|Hematinics|hematinics|mesh-ancestor
14666801|NCT00264134|Carboplatin|carboplatin|mesh-list
14666802|NCT00264134|Docetaxel|docetaxel|mesh-list
14666803|NCT00264134|Irinotecan|irinotecan|mesh-list
14666804|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14666805|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
14666806|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
14666807|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
14666808|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666809|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14666810|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14666811|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666812|NCT00264173|Valproic Acid|valproic acid|mesh-list
14666813|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
14666814|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666815|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666816|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
14666817|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666818|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666819|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
14666820|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14666821|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666822|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666823|NCT00264186|Norepinephrine|norepinephrine|mesh-list
14666824|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
14666825|NCT00264186|Acetylcholine|acetylcholine|mesh-list
14666826|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14666827|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14666828|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
14666829|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666830|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666831|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666832|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
14666833|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
14666834|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666835|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14666836|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
14666837|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14666838|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
14666839|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14666840|NCT00264212|Irbesartan|irbesartan|mesh-list
14666841|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14666842|NCT00264212|Diuretics|diuretics|mesh-ancestor
14666843|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666844|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666845|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14666846|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666847|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666848|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14666849|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14666850|NCT00264225|Codeine|codeine|mesh-list
14666851|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14666852|NCT00264225|Narcotics|narcotics|mesh-ancestor
14666853|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666854|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666855|NCT00264225|Analgesics|analgesics|mesh-ancestor
14666856|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
14666857|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666858|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
14666859|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
14666860|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
14666861|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14666862|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666863|NCT00264277|Vitamin K|vitamin k|mesh-list
14666864|NCT00264277|Anticoagulants|anticoagulants|mesh-list
14666865|NCT00264277|Vitamins|vitamins|mesh-ancestor
14666866|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
14666867|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666868|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14666869|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14666870|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666871|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
14666872|NCT00264277|Coagulants|coagulants|mesh-ancestor
14666873|NCT00264355|Cyclosporine|cyclosporine|mesh-list
14666874|NCT00264355|Cyclosporins|cyclosporins|mesh-list
14666875|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666876|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666877|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14666878|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
14666879|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666880|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
14666881|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666882|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
14666883|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14666884|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14666885|NCT00264368|Ganciclovir|ganciclovir|mesh-list
14666886|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14666887|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
14726327|NCT00508222|Protease Inhibitors|protease inhibitors|mesh-ancestor
14666888|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14666889|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14666890|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666891|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666892|NCT00264407|Hormones|hormones|mesh-list
14666893|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14666894|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666895|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
14666896|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14666897|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666898|NCT00264446|Eniluracil|eniluracil|mesh-list
14666899|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666900|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666901|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
14666902|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666903|NCT00264472|Eniluracil|eniluracil|mesh-list
14666904|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666905|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666906|NCT00264485|Fentanyl|fentanyl|mesh-list
15186597|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186598|NCT03882788|Analgesics|analgesics|mesh-ancestor
15186599|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
15186600|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186601|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15186602|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15186603|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
15186604|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
15186605|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15186606|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
15186607|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
15186608|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
15186609|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186610|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666907|NCT00264485|Morphine|morphine|mesh-list
14666908|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14666909|NCT00264485|Narcotics|narcotics|mesh-ancestor
14666910|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666911|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666912|NCT00264485|Analgesics|analgesics|mesh-ancestor
14666913|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
14666914|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666915|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14666916|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14666917|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
14666918|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
14666919|NCT00264615|Lamotrigine|lamotrigine|mesh-list
14666920|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
14666921|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14666922|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666923|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666924|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14666925|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666926|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14666927|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14666928|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666929|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666930|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14666931|NCT00264628|Casopitant|casopitant|mesh-list
14293716|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
14293717|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666932|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
15186611|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
15186612|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666933|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
14666934|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666935|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666936|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666937|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14666938|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666939|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666940|NCT00264654|Paroxetine|paroxetine|mesh-list
14666941|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14666942|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14666943|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666944|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186613|NCT03882541|Midazolam|midazolam|mesh-list
15186614|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15186615|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15186616|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186617|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186618|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15186619|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15186620|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666945|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666946|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
14666947|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666948|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14666949|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
14666950|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666951|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14666952|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14666953|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726328|NCT00508222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726329|NCT00508222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726330|NCT00508222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14726331|NCT00508222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14726332|NCT00508222|Antiviral Agents|antiviral agents|mesh-ancestor
14726333|NCT00508222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726334|NCT00508222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14726335|NCT00508222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14726336|NCT00508287|Exenatide|exenatide|mesh-list
14293718|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14293719|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14293720|NCT00570765|Cathartics|cathartics|mesh-ancestor
14293721|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293722|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
14293723|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14293724|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14293725|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14293726|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293727|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293728|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293729|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293730|NCT00570908|Capecitabine|capecitabine|mesh-list
14293731|NCT00570908|Sunitinib|sunitinib|mesh-list
14293732|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293733|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
14293734|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293735|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293736|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14293737|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14293738|NCT00570908|Growth Substances|growth substances|mesh-ancestor
14726337|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14726338|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726339|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14726340|NCT00508287|Incretins|incretins|mesh-ancestor
14726341|NCT00508287|Hormones|hormones|mesh-ancestor
14726342|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14726343|NCT00508326|Paclitaxel|paclitaxel|mesh-list
14726344|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14726345|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726346|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
15186621|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15186622|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
15186623|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
14293739|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666954|NCT00264680|Lamotrigine|lamotrigine|mesh-list
14666955|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
14666956|NCT00264680|Valproic Acid|valproic acid|mesh-list
14666957|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14666958|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14666959|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666960|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14666961|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666962|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14666963|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14666964|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14666965|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14666966|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14666967|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14666968|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
14666969|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666970|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
14666971|NCT00264719|Metoclopramide|metoclopramide|mesh-list
14666972|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
14666973|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
14666974|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14666975|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666976|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14666977|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14666978|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14666979|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
14666980|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14666981|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666982|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
14666983|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14666984|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666985|NCT00264914|Satavaptan|satavaptan|mesh-list
14666986|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14666987|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666988|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666989|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666990|NCT00264927|Satavaptan|satavaptan|mesh-list
14666991|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14666992|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14666993|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
14666994|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14666995|NCT00264953|Prednisone|prednisone|mesh-list
14666996|NCT00264953|Etoposide|etoposide|mesh-list
15186624|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
15186625|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
15186626|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186627|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186628|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
15186629|NCT03882099|Vitamin D|vitamin d|mesh-list
15186630|NCT03882099|Vitamins|vitamins|mesh-ancestor
15186631|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
15186632|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186633|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14666997|NCT00264953|Vincristine|vincristine|mesh-list
14666998|NCT00264953|Doxorubicin|doxorubicin|mesh-list
14666999|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14667000|NCT00264953|Bleomycin|bleomycin|mesh-list
14667001|NCT00264953|Vinblastine|vinblastine|mesh-list
14667002|NCT00264953|Procarbazine|procarbazine|mesh-list
14667003|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667004|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
14667005|NCT00264953|Hormones|hormones|mesh-ancestor
14667006|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667007|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667008|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667009|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667010|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14667011|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14667012|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14667013|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667014|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667015|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667016|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
15186634|NCT03882164|Tacrolimus|tacrolimus|mesh-list
14667017|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667018|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14667019|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14667020|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14667021|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14667022|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667023|NCT00265018|Doxorubicin|doxorubicin|mesh-list
14667024|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14667025|NCT00265018|Bleomycin|bleomycin|mesh-list
14667026|NCT00265018|Vinblastine|vinblastine|mesh-list
14667027|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14667028|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667029|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14667030|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14667031|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667032|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667033|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14667034|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667035|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667036|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667037|NCT00265031|Prednisone|prednisone|mesh-list
14667038|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
14667039|NCT00265031|Etoposide|etoposide|mesh-list
14667040|NCT00265031|Vincristine|vincristine|mesh-list
14667041|NCT00265031|Doxorubicin|doxorubicin|mesh-list
14667042|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14667043|NCT00265031|Bleomycin|bleomycin|mesh-list
14667044|NCT00265031|Procarbazine|procarbazine|mesh-list
14667045|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667046|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
14667047|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667048|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667049|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14667050|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
14667051|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667052|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667053|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14667054|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667055|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
14667056|NCT00265031|Hormones|hormones|mesh-ancestor
14667057|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667058|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667059|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14667060|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14667061|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14667062|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667063|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
15186635|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186636|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
14293740|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
14667064|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667065|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667066|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14667067|NCT00265070|Gefitinib|gefitinib|mesh-list
14667068|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667069|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14667070|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667071|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667072|NCT00265135|Siltuximab|siltuximab|mesh-list
14667073|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293741|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14293742|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293743|NCT00570921|Everolimus|everolimus|mesh-list
14667074|NCT00265252|Alendronate|alendronate|mesh-list
14667075|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14667076|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667077|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14667078|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14667079|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14667080|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667081|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667082|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667083|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667084|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186637|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667085|NCT00265278|Modafinil|modafinil|mesh-list
14667086|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14667087|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667088|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14667089|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14667090|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14667091|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667092|NCT00265291|Fluoxetine|fluoxetine|mesh-list
14667093|NCT00265291|Desipramine|desipramine|mesh-list
14667094|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14667095|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14667096|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667097|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667098|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667099|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
14667100|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667101|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14667102|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
14293744|NCT00570921|Fulvestrant|fulvestrant|mesh-list
14293745|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293746|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293747|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
14293748|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293749|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14293750|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14293751|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15186638|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15186639|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186640|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186641|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
15186642|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
14293752|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
14667103|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14667104|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14667105|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14667106|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667107|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14667108|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14667109|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667110|NCT00265304|Ketoprofen|ketoprofen|mesh-list
14667111|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186643|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186644|NCT03882255|Propranolol|propranolol|mesh-list
15186645|NCT03882255|Ponesimod|ponesimod|mesh-list
15186646|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15186647|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15186648|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186649|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186650|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186651|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186652|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14667112|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14667113|NCT00265304|Analgesics|analgesics|mesh-ancestor
14667114|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
14667115|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667116|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667117|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667118|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667119|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14667120|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667121|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667122|NCT00265408|Aspirin|aspirin|mesh-list
14667123|NCT00265408|Warfarin|warfarin|mesh-list
14667124|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14667125|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14667126|NCT00265408|Analgesics|analgesics|mesh-ancestor
14667127|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
14667128|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667129|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667130|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667131|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667132|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14667133|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14667134|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667135|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14667136|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14667137|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667138|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
14667139|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
14667140|NCT00265460|Lobeline|lobeline|mesh-list
14667141|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14667142|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
14667143|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667144|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667145|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14667146|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14667147|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
14667148|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667149|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667150|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
14667151|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
14667152|NCT00265486|Hematinics|hematinics|mesh-ancestor
14667153|NCT00265551|Olanzapine|olanzapine|mesh-list
14667154|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
14667155|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
14667156|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186653|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14667157|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667158|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14667159|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14667160|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14667161|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14667162|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14667163|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14667164|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14667165|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667166|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667167|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667168|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
14667169|NCT00265642|Irbesartan|irbesartan|mesh-list
14667170|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14726347|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
15186654|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
15186655|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15186656|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186657|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
15186658|NCT03882008|Abatacept|abatacept|mesh-list
15186659|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15186660|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186661|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186662|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186663|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
15186664|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667171|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14667172|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14667173|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667174|NCT00265694|Gemcitabine|gemcitabine|mesh-list
14667175|NCT00265694|Carboplatin|carboplatin|mesh-list
14667176|NCT00265694|Vinorelbine|vinorelbine|mesh-list
14293753|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293754|NCT00570960|Dextrans|dextrans|mesh-list
14293755|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
14667177|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667178|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667179|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
14667180|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667181|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
14667182|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667183|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667184|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667185|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
14667186|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667187|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14667188|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667189|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667190|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667191|NCT00265733|Paclitaxel|paclitaxel|mesh-list
14667192|NCT00265733|Capecitabine|capecitabine|mesh-list
15186665|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186666|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
15186667|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15186668|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186669|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
15186670|NCT03882060|Hematinics|hematinics|mesh-ancestor
15186671|NCT03881943|Aspirin|aspirin|mesh-list
15186672|NCT03881943|Ticagrelor|ticagrelor|mesh-list
15186673|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186674|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186675|NCT03881943|Analgesics|analgesics|mesh-ancestor
15186676|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
15186677|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186678|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186679|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186680|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186681|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15186682|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14667193|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14667194|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14667195|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667196|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667197|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667198|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667199|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667200|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667201|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
14667202|NCT00265746|Metformin|metformin|mesh-list
14667203|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15186683|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186684|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15186685|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14667204|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667205|NCT00265772|Prednisolone|prednisolone|mesh-list
14667206|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667207|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
14667208|NCT00265772|Hormones|hormones|mesh-ancestor
14667209|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667210|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667211|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667212|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667213|NCT00265811|Cetuximab|cetuximab|mesh-list
14667214|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14667215|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667216|NCT00265824|Bevacizumab|bevacizumab|mesh-list
14667217|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14667218|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14667219|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667220|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14667221|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14667222|NCT00265824|Growth Substances|growth substances|mesh-ancestor
14667223|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667224|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
14667225|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14667226|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667227|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667228|NCT00265863|Mitomycins|mitomycins|mesh-list
14667229|NCT00265863|Mitomycin|mitomycin|mesh-list
14667230|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14667231|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667232|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
14667233|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667234|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14667235|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667236|NCT00265876|Gemcitabine|gemcitabine|mesh-list
14667237|NCT00265876|Saracatinib|saracatinib|mesh-list
14667238|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667239|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
14667240|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667241|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667242|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
14667243|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667244|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667245|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667246|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
14667247|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667248|NCT00265915|Rituximab|rituximab|mesh-list
14667249|NCT00265915|Sargramostim|sargramostim|mesh-list
14667250|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14667251|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667252|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
14667253|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667254|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667255|NCT00265928|Rituximab|rituximab|mesh-list
14667256|NCT00265928|Bortezomib|bortezomib|mesh-list
14667257|NCT00265928|Antibodies|antibodies|mesh-list
14667258|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
14667259|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14667260|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14667261|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
14667262|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667263|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14667264|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293756|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
14667265|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667266|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667267|NCT00265967|Irbesartan|irbesartan|mesh-list
14667268|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14667269|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14667270|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14667271|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667272|NCT00265993|Enoxaparin|enoxaparin|mesh-list
14667273|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
14667274|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14667275|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14667276|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667277|NCT00266058|Ritonavir|ritonavir|mesh-list
14667278|NCT00266058|Lopinavir|lopinavir|mesh-list
14667279|NCT00266058|Efavirenz|efavirenz|mesh-list
14667280|NCT00266058|Lumefantrine|lumefantrine|mesh-list
14667281|NCT00266058|Artemether|artemether|mesh-list
14667282|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14667283|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14667284|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14667285|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
14667286|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667287|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667288|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14667289|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14667290|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
15186686|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186687|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
14667291|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667292|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14667293|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14667294|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14667295|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14667296|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14667297|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14667298|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14667299|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14667300|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14667301|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
14667302|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14667303|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14667304|NCT00266097|Gemcitabine|gemcitabine|mesh-list
14667305|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
14667306|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14667307|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667308|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
14667309|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667310|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667311|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
14667312|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667313|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667314|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667315|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
14667316|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667317|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14667318|NCT00266123|Sirolimus|sirolimus|mesh-list
15186688|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15186689|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15186690|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15186691|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
15186692|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186693|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15186694|NCT03881904|Gestodene|gestodene|mesh-list
15186695|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15186696|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15186697|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15186698|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
14667319|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14667320|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667321|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14667322|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667323|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
14667324|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667325|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
14667326|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667327|NCT00266136|Cytarabine|cytarabine|mesh-list
14667328|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
14667329|NCT00266136|Daunorubicin|daunorubicin|mesh-list
14667330|NCT00266136|Thioguanine|thioguanine|mesh-list
14667331|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667332|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
14667333|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667334|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667335|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14667336|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
14667337|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667338|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667339|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14667340|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667341|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
14667342|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
14667343|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667344|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14667345|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14667346|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14667347|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667348|NCT00266149|Lamotrigine|lamotrigine|mesh-list
14667349|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
14667350|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14667351|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667352|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667353|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14667354|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667355|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14667356|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14667357|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14667358|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14667359|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14667360|NCT00266162|Bosentan|bosentan|mesh-list
14667361|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14667362|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14667363|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667364|NCT00266214|Lidocaine|lidocaine|mesh-list
14667365|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
14667366|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
14667367|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14667368|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667369|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
14667370|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667371|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14667372|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14667373|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14667374|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667375|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667376|NCT00266253|Metformin|metformin|mesh-list
14667377|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14667378|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667379|NCT00266318|Interferons|interferons|mesh-list
14667380|NCT00266318|Ribavirin|ribavirin|mesh-list
14667381|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
14667382|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667383|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
14667384|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667385|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
14726348|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667386|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667387|NCT00266344|Gaboxadol|gaboxadol|mesh-list
14667388|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667389|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667390|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667391|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293757|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
14293758|NCT00571064|Donepezil|donepezil|mesh-list
14667392|NCT00266344|Analgesics|analgesics|mesh-ancestor
14667393|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
14667394|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
14667395|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
14667396|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
14667397|NCT00266357|Gaboxadol|gaboxadol|mesh-list
14293759|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14293760|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667398|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667399|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667400|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667401|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667402|NCT00266357|Analgesics|analgesics|mesh-ancestor
14667403|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
14667404|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
14667405|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
14667406|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
14667407|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
14667408|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14667409|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667410|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
14726349|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726350|NCT00508365|Carvedilol|carvedilol|mesh-list
14726351|NCT00508365|Lisinopril|lisinopril|mesh-list
14726352|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14726353|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14726354|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
14726355|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726356|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726357|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726358|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14726359|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
14726360|NCT00508365|Protective Agents|protective agents|mesh-ancestor
14726361|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14726362|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726363|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14726364|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
14726365|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14726366|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14726367|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14726368|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
14726369|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726370|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14726371|NCT00508456|Temozolomide|temozolomide|mesh-list
14726372|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15186699|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15186700|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186701|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15186702|NCT03881904|Estrogens|estrogens|mesh-ancestor
15186703|NCT03881904|Hormones|hormones|mesh-ancestor
15186704|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14726373|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
14726374|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726375|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726376|NCT00508495|Acetaminophen|acetaminophen|mesh-list
14726377|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14726378|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14726379|NCT00508495|Analgesics|analgesics|mesh-ancestor
14726380|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
14726381|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726382|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726383|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
14726384|NCT00508664|Docetaxel|docetaxel|mesh-list
14726385|NCT00508664|Fluorouracil|fluorouracil|mesh-list
14726386|NCT00508664|Cetuximab|cetuximab|mesh-list
14293761|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726387|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667411|NCT00266487|Vitamins|vitamins|mesh-list
14667412|NCT00266487|Folic Acid|folic acid|mesh-list
14667413|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
14667414|NCT00266487|Hydroxocobalamin|hydroxocobalamin|mesh-list
14667415|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
14667416|NCT00266487|Pyridoxal|pyridoxal|mesh-list
14667417|NCT00266487|Pyridoxine|pyridoxine|mesh-list
14667418|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
14667419|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
14667420|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667421|NCT00266487|Hematinics|hematinics|mesh-ancestor
14667422|NCT00266539|Fentanyl|fentanyl|mesh-list
14667423|NCT00266539|Morphine|morphine|mesh-list
14667424|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14667425|NCT00266539|Narcotics|narcotics|mesh-ancestor
14667426|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14667427|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667428|NCT00266539|Analgesics|analgesics|mesh-ancestor
14667429|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
14667430|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667431|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14667432|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14667433|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
14667434|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
14667435|NCT00266552|Risperidone|risperidone|mesh-list
14667436|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14667437|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
14667438|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667439|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667440|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293762|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
14667441|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14667442|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14667443|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14667444|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14667445|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14293763|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293764|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293765|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
14667446|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
14667447|NCT00266578|Fluticasone|fluticasone|mesh-list
15186705|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15186706|NCT03881904|Progestins|progestins|mesh-ancestor
14667448|NCT00266578|Xhance|xhance|mesh-list
14667449|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667450|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14667451|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
14667452|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667453|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667454|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14667455|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
14667456|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
14667457|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14667458|NCT00266591|Topiramate|topiramate|mesh-list
14667459|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
14667460|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14667461|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667462|NCT00266604|Topiramate|topiramate|mesh-list
14667463|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
14667464|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14667465|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667466|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
14667467|NCT00266617|Hematinics|hematinics|mesh-ancestor
14667468|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14667469|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14667470|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14667471|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667472|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667473|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667474|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186707|NCT03881644|Sumatriptan|sumatriptan|mesh-list
15186708|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
14667475|NCT00266643|Analgesics|analgesics|mesh-ancestor
15186709|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14667476|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
14667477|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667478|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
14667479|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14667480|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
14293766|NCT00571103|Acamprosate|acamprosate|mesh-list
14293767|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14293768|NCT00571259|Gentamicins|gentamicins|mesh-list
14293769|NCT00571259|Heparin|heparin|mesh-list
14293770|NCT00571259|Citric Acid|citric acid|mesh-list
14667481|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
14667482|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
14667483|NCT00266721|Pancrelipase|pancrelipase|mesh-list
14667484|NCT00266721|Pancreatin|pancreatin|mesh-list
14667485|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14667486|NCT00266747|Amibegron|amibegron|mesh-list
14667487|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14667488|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14667489|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667490|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667491|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667492|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667493|NCT00266786|Ketorolac|ketorolac|mesh-list
14667494|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14667495|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14667496|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14667497|NCT00266786|Analgesics|analgesics|mesh-ancestor
14667498|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
14667499|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667500|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667501|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667502|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667503|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14667504|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667505|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667506|NCT00266838|Dexamethasone|dexamethasone|mesh-list
14667507|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667508|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
14667509|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
14667510|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667511|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667512|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14667513|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
14667514|NCT00266838|Hormones|hormones|mesh-ancestor
14667515|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667516|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667517|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667518|NCT00267163|Donepezil|donepezil|mesh-list
14667519|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14667520|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667521|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667522|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
15186710|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15186711|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15186712|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
14667523|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667524|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667525|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
14667526|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
14667527|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14667528|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14667529|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667530|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667531|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14667532|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186713|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186714|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186715|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186716|NCT03881644|Growth Substances|growth substances|mesh-ancestor
15186717|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
15186718|NCT03881696|Omalizumab|omalizumab|mesh-list
15186719|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
15186720|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15186721|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186722|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15186723|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15186724|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293771|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
14293772|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
14667533|NCT00267176|Analgesics|analgesics|mesh-ancestor
14667534|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
14667535|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667536|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667537|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667538|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667539|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
14667540|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14667541|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14667542|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667543|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667544|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14667545|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14667546|NCT00267215|Analgesics|analgesics|mesh-ancestor
14667547|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
14667548|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667549|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667550|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667551|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667552|NCT00267254|Atorvastatin|atorvastatin|mesh-list
14667553|NCT00267254|Simvastatin|simvastatin|mesh-list
14667554|NCT00267254|Torcetrapib|torcetrapib|mesh-list
14667555|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14667556|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14667557|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
14667558|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667559|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14667560|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14667561|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667562|NCT00267267|Atorvastatin|atorvastatin|mesh-list
14667563|NCT00267267|Simvastatin|simvastatin|mesh-list
14667564|NCT00267267|Ezetimibe|ezetimibe|mesh-list
14667565|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14667566|NCT00267267|Torcetrapib|torcetrapib|mesh-list
14667567|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14667568|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14667569|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
14667570|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667571|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14667572|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14667573|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667574|NCT00267306|Visilizumab|visilizumab|mesh-list
14667575|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
14667576|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667577|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
14667578|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
14667579|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14667580|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
14667581|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667582|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667583|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667584|NCT00267332|Modafinil|modafinil|mesh-list
14667585|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14667586|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667587|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14667588|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14667589|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14667590|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667591|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
14667592|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14667593|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
14667594|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667595|NCT00267384|Expectorants|expectorants|mesh-ancestor
14667596|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
14667597|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14667598|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
14667599|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667600|NCT00267384|Protective Agents|protective agents|mesh-ancestor
14667601|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667602|NCT00267384|Antidotes|antidotes|mesh-ancestor
14667603|NCT00267514|Sevelamer|sevelamer|mesh-list
14667604|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
14667605|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
14667606|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667607|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
14667608|NCT00267540|Vitamins|vitamins|mesh-ancestor
14667609|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
14667610|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667611|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14667612|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14667613|NCT00267553|Toremifene|toremifene|mesh-list
14667614|NCT00267553|Letrozole|letrozole|mesh-list
14667615|NCT00267553|Atamestane|atamestane|mesh-list
14667616|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667617|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14667618|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14667619|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667620|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667621|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14667622|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
14667623|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667624|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667625|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667626|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14667627|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14667628|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14667629|NCT00267657|Reserpine|reserpine|mesh-list
14667630|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14667631|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14667632|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14667633|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14667634|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667635|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14667636|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14667637|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14667638|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667639|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667640|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667641|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667642|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
14667643|NCT00267683|Glyburide|glyburide|mesh-list
14667644|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14667645|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667646|NCT00267709|Visilizumab|visilizumab|mesh-list
14667647|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
14667648|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667649|NCT00267722|Visilizumab|visilizumab|mesh-list
14667650|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
14667651|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667652|NCT00267813|Bupropion|bupropion|mesh-list
14667653|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14667654|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
14667655|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14667656|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14667657|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14667658|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667659|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667660|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
14667661|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667662|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667663|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14667664|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14667665|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667666|NCT00267826|Rituximab|rituximab|mesh-list
14667667|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14667668|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667669|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
14667670|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667671|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667672|NCT00267917|Fenoterol|fenoterol|mesh-list
14667673|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
14667674|NCT00267917|Ipratropium|ipratropium|mesh-list
14667675|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14667676|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
14667677|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667678|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667679|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14667680|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
14667681|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
14667682|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
14667683|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14667684|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14667685|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14667686|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14667687|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667688|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667689|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667690|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14667691|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
14667692|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14667693|NCT00267943|Telmisartan|telmisartan|mesh-list
14667694|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14667695|NCT00267943|Diuretics|diuretics|mesh-ancestor
14667696|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
14667697|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667698|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14667699|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667700|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667701|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14667702|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14667703|NCT00268138|Fluorides|fluorides|mesh-list
14667704|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
14667705|NCT00268138|Protective Agents|protective agents|mesh-ancestor
14667706|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667707|NCT00268151|Capecitabine|capecitabine|mesh-list
14667708|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
14667709|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667710|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
14667711|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667712|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667713|NCT00268177|Fluticasone|fluticasone|mesh-list
14667714|NCT00268177|Xhance|xhance|mesh-list
14667715|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14667716|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667717|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14667718|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
14667719|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667720|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667721|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14667722|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
14667723|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
14667724|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14667725|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14667726|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14667727|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14667728|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667729|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667730|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667731|NCT00268216|Fluticasone|fluticasone|mesh-list
14667732|NCT00268216|Xhance|xhance|mesh-list
14667733|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14667734|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667735|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14667736|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
14667737|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667738|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667739|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14667740|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
14667741|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
14667742|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14667743|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14667744|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14667745|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14667746|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667747|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667748|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667749|NCT00268229|Cytarabine|cytarabine|mesh-list
14667750|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
14667751|NCT00268229|Daunorubicin|daunorubicin|mesh-list
14667752|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667753|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
14667754|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667755|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667756|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
14667757|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667758|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667759|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
14667760|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667761|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14667762|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667763|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14667764|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14667765|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14293773|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14293774|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
14293775|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
14667766|NCT00268255|Gefitinib|gefitinib|mesh-list
14667767|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14667768|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667769|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14667770|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293776|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293777|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14293778|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14293779|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293780|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293781|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14293782|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293783|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14293784|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
14293785|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14293786|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
14726388|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
14726389|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
14726390|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
14726391|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726392|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
14726393|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14726394|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726395|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
14726396|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726397|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726398|NCT00508690|Metronidazole|metronidazole|mesh-list
14726399|NCT00508690|Kanamycin|kanamycin|mesh-list
14726400|NCT00508690|Cefmetazole|cefmetazole|mesh-list
14726401|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726402|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14667771|NCT00268333|Leucovorin|leucovorin|mesh-list
14667772|NCT00268333|Fluorouracil|fluorouracil|mesh-list
14667773|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
14667774|NCT00268333|Calcium|calcium|mesh-list
14667775|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
14667776|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14667777|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667778|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
14667779|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667780|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667781|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667782|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667783|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
14667784|NCT00268333|Antidotes|antidotes|mesh-ancestor
14667785|NCT00268333|Protective Agents|protective agents|mesh-ancestor
14667786|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
14667787|NCT00268333|Vitamins|vitamins|mesh-ancestor
14667788|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
14667789|NCT00268359|Bevacizumab|bevacizumab|mesh-list
15186725|NCT03881787|Cetuximab|cetuximab|mesh-list
15186726|NCT03881787|Antibodies|antibodies|mesh-list
15186727|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15186728|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
15186729|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186730|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15186731|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223718|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223719|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223720|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223721|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
15223722|NCT05190952|Hormones|hormones|mesh-ancestor
15223723|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223724|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223725|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223726|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
15223727|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
15223728|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223729|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
15223730|NCT05190952|Analgesics|analgesics|mesh-ancestor
15223731|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15223732|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14667790|NCT00268359|Irinotecan|irinotecan|mesh-list
14667791|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14667792|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667793|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14667794|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14667795|NCT00268359|Growth Substances|growth substances|mesh-ancestor
14667796|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667797|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
14667798|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14667799|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14667800|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667801|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667802|NCT00268372|Docetaxel|docetaxel|mesh-list
14667803|NCT00268372|Fluorouracil|fluorouracil|mesh-list
14667804|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667805|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667806|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667807|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14910537|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667808|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667809|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
14667810|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667811|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667812|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
14667813|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667814|NCT00268398|Leucovorin|leucovorin|mesh-list
14667815|NCT00268398|Folic Acid|folic acid|mesh-list
14667816|NCT00268398|Fluorouracil|fluorouracil|mesh-list
14667817|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
14667818|NCT00268398|Irinotecan|irinotecan|mesh-list
14667819|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
14667820|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
14667821|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667822|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667823|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667824|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667825|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
14667826|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667827|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14667828|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14667829|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186732|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
15186733|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186734|NCT03881423|Bromides|bromides|mesh-list
15186735|NCT03881423|Rocuronium|rocuronium|mesh-list
15186736|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15186737|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
15186738|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15186739|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15186740|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186741|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186742|NCT03881293|Lidocaine|lidocaine|mesh-list
15186743|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
15186744|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
15186745|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186746|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186747|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
15186748|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186749|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15186750|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15186751|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14667830|NCT00268398|Antidotes|antidotes|mesh-ancestor
14667831|NCT00268398|Protective Agents|protective agents|mesh-ancestor
14667832|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
14667833|NCT00268398|Vitamins|vitamins|mesh-ancestor
14667834|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
14667835|NCT00268398|Hematinics|hematinics|mesh-ancestor
14667836|NCT00268411|Gemcitabine|gemcitabine|mesh-list
14667837|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
14667838|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667839|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
14667840|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667841|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667842|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
14667843|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667844|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667845|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667846|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
15186752|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667847|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667848|NCT00268489|Bevacizumab|bevacizumab|mesh-list
14667849|NCT00268489|Pemetrexed|pemetrexed|mesh-list
15223733|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
14667850|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14667851|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667852|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14667853|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14667854|NCT00268489|Growth Substances|growth substances|mesh-ancestor
14667855|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667856|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
14667857|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667858|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667859|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14667860|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14667861|NCT00268515|Cyclosporine|cyclosporine|mesh-list
14667862|NCT00268515|Prednisone|prednisone|mesh-list
14667863|NCT00268515|Azathioprine|azathioprine|mesh-list
14667864|NCT00268515|Tacrolimus|tacrolimus|mesh-list
14667865|NCT00268515|Cyclosporins|cyclosporins|mesh-list
14667866|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667867|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
14667868|NCT00268515|Hormones|hormones|mesh-ancestor
14667869|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667870|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667871|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667872|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667873|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667874|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
14667875|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14667876|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667877|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667878|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
14667879|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14667880|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
14667881|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667882|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
14667883|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667884|NCT00268528|Methotrexate|methotrexate|mesh-list
14667885|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
14667886|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14667887|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
14667888|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14667889|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667890|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14667891|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
14667892|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667893|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667894|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
14667895|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667896|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14667897|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667898|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
14667899|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14667900|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14667901|NCT00268554|Dipyridamole|dipyridamole|mesh-list
14667902|NCT00268554|Caffeine|caffeine|mesh-list
14667903|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14667904|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667905|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14667906|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667907|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667908|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14667909|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14667910|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
14667911|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667912|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14667913|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
14667914|NCT00268567|Prednisone|prednisone|mesh-list
14667915|NCT00268567|Leflunomide|leflunomide|mesh-list
14667916|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667917|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
14667918|NCT00268567|Hormones|hormones|mesh-ancestor
14667919|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667920|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667921|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667922|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667923|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667924|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667925|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14667926|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
14667927|NCT00268593|Prednisone|prednisone|mesh-list
14667928|NCT00268593|Docetaxel|docetaxel|mesh-list
14667929|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667930|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667931|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667932|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667933|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667934|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14667935|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
14667936|NCT00268593|Hormones|hormones|mesh-ancestor
14667937|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14667938|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667939|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14667940|NCT00268619|Ramipril|ramipril|mesh-list
14667941|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14667942|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
14667943|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667944|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667945|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14667946|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
14667947|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14667948|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14667949|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667950|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14667951|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667952|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14667953|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
14667954|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14667955|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667956|NCT00268671|Docetaxel|docetaxel|mesh-list
14667957|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667958|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667959|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667960|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667961|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667962|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14667963|NCT00268684|Temozolomide|temozolomide|mesh-list
14667964|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667965|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14667966|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14667967|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667968|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14667969|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
14667970|NCT00268697|Ezetimibe|ezetimibe|mesh-list
14667971|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14667972|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14667973|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
14667974|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667975|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14667976|NCT00268710|Docetaxel|docetaxel|mesh-list
14667977|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14667978|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
14667979|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
14667980|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
14667981|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667982|NCT00268723|Albuterol|albuterol|mesh-list
14667983|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14667984|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
14667985|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14667986|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14667987|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14667988|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
14667989|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
14667990|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14667991|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14667992|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14667993|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14667994|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
14667995|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14667996|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14667997|NCT00268749|Glycine|glycine|mesh-list
14667998|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
14667999|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668000|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668001|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668002|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
14668003|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14668004|NCT00268788|Antibodies|antibodies|mesh-list
14668005|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
14668006|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14668007|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
14668008|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668009|NCT00268814|Methadone|methadone|mesh-list
14668010|NCT00268814|Heroin|heroin|mesh-list
14668011|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668012|NCT00268814|Narcotics|narcotics|mesh-ancestor
14668013|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668014|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668015|NCT00268814|Analgesics|analgesics|mesh-ancestor
14668016|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
14668017|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668018|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
14668019|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
14668020|NCT00268827|Lopinavir|lopinavir|mesh-list
14668021|NCT00268827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14668022|NCT00268827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14668023|NCT00268827|Protease Inhibitors|protease inhibitors|mesh-ancestor
14668024|NCT00268827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668025|NCT00268827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668026|NCT00268827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14668027|NCT00268827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14668028|NCT00268827|Antiviral Agents|antiviral agents|mesh-ancestor
14668029|NCT00268827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668030|NCT00268827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14668031|NCT00268827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14668032|NCT00268840|Gemcitabine|gemcitabine|mesh-list
14668033|NCT00268840|Docetaxel|docetaxel|mesh-list
14668034|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14668035|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
14668036|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668037|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668038|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
14668039|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668040|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668041|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14668042|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
14668043|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668044|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668045|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668046|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668047|NCT00268879|Renzapride|renzapride|mesh-list
14668048|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14668049|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
14668050|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668051|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668052|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668053|NCT00268918|Docetaxel|docetaxel|mesh-list
14668054|NCT00268918|Vatalanib|vatalanib|mesh-list
14668055|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668056|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668057|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668058|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668059|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668060|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14668061|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668062|NCT00268957|Sevelamer|sevelamer|mesh-list
14668063|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
14668064|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
14668065|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668066|NCT00268970|Paclitaxel|paclitaxel|mesh-list
14668067|NCT00268970|Satraplatin|satraplatin|mesh-list
14668068|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14668069|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668070|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668071|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668072|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668073|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668074|NCT00269035|Risperidone|risperidone|mesh-list
14668075|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14668076|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
14668077|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668078|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668079|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668080|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14668081|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14668082|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668083|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668084|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14668085|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
14668086|NCT00269061|Pioglitazone|pioglitazone|mesh-list
14668087|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14668088|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668089|NCT00269126|Fluticasone|fluticasone|mesh-list
14668090|NCT00269126|Xhance|xhance|mesh-list
14668091|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14668092|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14668093|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14668094|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14668095|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
14668096|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668097|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668098|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14668099|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
14668100|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
14668101|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14668102|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14668103|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14668104|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14668105|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
14668106|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668107|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668108|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
14668109|NCT00269126|Hormones|hormones|mesh-ancestor
14668110|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668111|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
14668112|NCT00269204|Niacin|niacin|mesh-list
14668113|NCT00269204|Niacinamide|niacinamide|mesh-list
14668114|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
14668115|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14668116|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
15186753|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186754|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
14668117|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668118|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14668119|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
14668120|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
14668121|NCT00269204|Vitamins|vitamins|mesh-ancestor
14668122|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
14668123|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668124|NCT00269217|Niacin|niacin|mesh-list
14668125|NCT00269217|Niacinamide|niacinamide|mesh-list
14668126|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
14668127|NCT00269217|Simvastatin|simvastatin|mesh-list
14668128|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14668129|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14668130|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
14668131|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668132|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14668133|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14668134|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668135|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
14668136|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
14668137|NCT00269217|Vitamins|vitamins|mesh-ancestor
14668138|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
14668139|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668140|NCT00269243|Quinapril|quinapril|mesh-list
14668141|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14668142|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
14668143|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668144|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668145|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14668146|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
14668147|NCT00269334|Paroxetine|paroxetine|mesh-list
14668148|NCT00269334|Citalopram|citalopram|mesh-list
14668149|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14668150|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14668151|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14668152|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668153|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668154|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
14668155|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668156|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14668157|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
14668158|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668159|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14668160|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14668161|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668162|NCT00269386|Clarithromycin|clarithromycin|mesh-list
14668163|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14668164|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668165|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14668166|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668167|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668168|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14668169|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14668170|NCT00269412|Rifaximin|rifaximin|mesh-list
14668171|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14668172|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668173|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668174|NCT00269542|Iron|iron|mesh-list
14668175|NCT00269542|Folic Acid|folic acid|mesh-list
14668176|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
14668177|NCT00269542|Trace Elements|trace elements|mesh-ancestor
14668178|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
14668179|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668180|NCT00269542|Hematinics|hematinics|mesh-ancestor
14668181|NCT00269542|Vitamins|vitamins|mesh-ancestor
14668182|NCT00269555|Genistein|genistein|mesh-list
14668183|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14668184|NCT00269555|Protective Agents|protective agents|mesh-ancestor
15186755|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186756|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15186757|NCT03881449|Aripiprazole|aripiprazole|mesh-list
15186758|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
15186759|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668185|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668186|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668187|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14668188|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668189|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668190|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
14668191|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14668192|NCT00269555|Estrogens|estrogens|mesh-ancestor
14668193|NCT00269555|Hormones|hormones|mesh-ancestor
14668194|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668195|NCT00269568|Misoprostol|misoprostol|mesh-list
14668196|NCT00269568|Mifepristone|mifepristone|mesh-list
14668197|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14668198|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
14668199|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14668200|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668201|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14668202|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15186760|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15186761|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15186762|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186763|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186764|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
15186765|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
15186766|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186767|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186768|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15186769|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15186770|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
15186771|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15186772|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15186773|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15186774|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15186775|NCT03881345|Anticoagulants|anticoagulants|mesh-list
15186776|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
15186777|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
14668203|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
14668204|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14668205|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14668206|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14668207|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14668208|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
14668209|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14668210|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14668211|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
14668212|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668213|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
14668214|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14668215|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14668216|NCT00269594|Lamotrigine|lamotrigine|mesh-list
14668217|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
14668218|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14668219|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14668220|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668221|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14668222|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668223|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14668224|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14668225|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668226|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668227|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14668228|NCT00269607|Naltrexone|naltrexone|mesh-list
14668229|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14668230|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14668231|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668232|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
14668233|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668234|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14668235|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14668236|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14668237|NCT00269620|Etonogestrel|etonogestrel|mesh-list
15186778|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14668238|NCT00269620|NuvaRing|nuvaring|mesh-list
14668239|NCT00269620|Norelgestromin|norelgestromin|mesh-list
14668240|NCT00269620|Ortho Evra|ortho evra|mesh-list
14668241|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
14668242|NCT00269620|Estradiol|estradiol|mesh-list
14668243|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14668244|NCT00269620|Estrogens|estrogens|mesh-ancestor
14668245|NCT00269620|Hormones|hormones|mesh-ancestor
14668246|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668247|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668248|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14668249|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14668250|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14668251|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14668252|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14668253|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14668254|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
14668255|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668256|NCT00269685|Vasopressins|vasopressins|mesh-list
14668257|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
14668258|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
14668259|NCT00269685|Coagulants|coagulants|mesh-ancestor
14668260|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14668261|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14668262|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
14668263|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668264|NCT00269724|Oxybutynin|oxybutynin|mesh-list
14668265|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
14668266|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
14668267|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668268|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668269|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14668270|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14668271|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
14668272|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668273|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668274|NCT00269724|Urological Agents|urological agents|mesh-ancestor
14668275|NCT00269737|Fentanyl|fentanyl|mesh-list
14668276|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668277|NCT00269737|Narcotics|narcotics|mesh-ancestor
14668278|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668279|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668280|NCT00269737|Analgesics|analgesics|mesh-ancestor
14668281|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
14668282|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293787|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293788|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293789|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14668283|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14668284|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14668285|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
14668286|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
14668287|NCT00269750|Oxybutynin|oxybutynin|mesh-list
14668288|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
14668289|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
14668290|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668291|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668292|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14668293|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14668294|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
14668295|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668296|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668297|NCT00269750|Urological Agents|urological agents|mesh-ancestor
14668298|NCT00269763|Fentanyl|fentanyl|mesh-list
14668299|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668300|NCT00269763|Narcotics|narcotics|mesh-ancestor
15186779|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186780|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15186781|NCT03880981|Acetaminophen|acetaminophen|mesh-list
15186782|NCT03880981|Ibuprofen|ibuprofen|mesh-list
15186783|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186784|NCT03880981|Analgesics|analgesics|mesh-ancestor
14668301|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668302|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668303|NCT00269763|Analgesics|analgesics|mesh-ancestor
15186785|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
14668304|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
14668305|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668306|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14668307|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14668308|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
14668309|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
14668310|NCT00269776|Methylphenidate|methylphenidate|mesh-list
14668311|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14668312|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668313|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14668314|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14668315|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14668316|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668317|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
14668318|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186786|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186787|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186788|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
15186789|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186790|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186791|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186792|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15186793|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186794|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186795|NCT03880903|Albuterol|albuterol|mesh-list
15186796|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15186797|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
14293790|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
14668319|NCT00269789|Methylphenidate|methylphenidate|mesh-list
14668320|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14668321|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668322|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14668323|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14668324|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14668325|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668326|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
14668327|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668328|NCT00269802|Methylphenidate|methylphenidate|mesh-list
14668329|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14668330|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668331|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14668332|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14668333|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14668334|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668335|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
14668336|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668337|NCT00269815|Methylphenidate|methylphenidate|mesh-list
14668338|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14668339|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668340|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14668341|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14668342|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14668343|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668344|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
14668345|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668346|NCT00269828|Paclitaxel|paclitaxel|mesh-list
14293791|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14293792|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14293793|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14293794|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
14293795|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293796|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668347|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14668348|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14668349|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15186798|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293797|NCT00571493|Cytarabine|cytarabine|mesh-list
14293798|NCT00571493|Etoposide|etoposide|mesh-list
14293799|NCT00571493|Bortezomib|bortezomib|mesh-list
14293800|NCT00571493|Melphalan|melphalan|mesh-list
14293801|NCT00571493|Carmustine|carmustine|mesh-list
14668350|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668351|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668352|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668353|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668354|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668355|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14668356|NCT00269841|Infliximab|infliximab|mesh-list
14668357|NCT00269841|Antibodies|antibodies|mesh-list
14668358|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
14668359|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14668360|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
14668361|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668362|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668363|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
14668364|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668365|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14668366|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14668367|NCT00269854|Infliximab|infliximab|mesh-list
14668368|NCT00269854|Antibodies|antibodies|mesh-list
14668369|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
14668370|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14668371|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
14668372|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668373|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668374|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
14668375|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668376|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14668377|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14668378|NCT00269867|Infliximab|infliximab|mesh-list
14668379|NCT00269867|Antibodies|antibodies|mesh-list
14668380|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
14668381|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14668382|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
14668383|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668384|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668385|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
14668386|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668387|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14668388|NCT00269880|Heparin|heparin|mesh-list
14668389|NCT00269880|Abciximab|abciximab|mesh-list
14668390|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
14668391|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14668392|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14668393|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668394|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14668395|NCT00269893|Abciximab|abciximab|mesh-list
14668396|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
14668397|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14668398|NCT00269906|Abciximab|abciximab|mesh-list
14668399|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
14668400|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14668401|NCT00269932|Levofloxacin|levofloxacin|mesh-list
14668402|NCT00269932|Ofloxacin|ofloxacin|mesh-list
14293802|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14668403|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14668404|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668405|NCT00269932|Renal Agents|renal agents|mesh-ancestor
14668406|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14668407|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14668408|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14668409|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668410|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668411|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668412|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14668413|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14726403|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14726404|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14726405|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14726406|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726407|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726408|NCT00508859|Sertraline|sertraline|mesh-list
14726409|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
14726410|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668414|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
14668415|NCT00269945|Hematinics|hematinics|mesh-ancestor
14668416|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
14668417|NCT00269958|Hematinics|hematinics|mesh-ancestor
14668418|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
14668419|NCT00269971|Hematinics|hematinics|mesh-ancestor
14668420|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
14293803|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293804|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14293805|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14668421|NCT00269984|Hematinics|hematinics|mesh-ancestor
14668422|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
14668423|NCT00269997|Hematinics|hematinics|mesh-ancestor
14668424|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
14668425|NCT00270010|Hematinics|hematinics|mesh-ancestor
14668426|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
14668427|NCT00270023|Hematinics|hematinics|mesh-ancestor
15186799|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186800|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15186801|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
15186802|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
15186803|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15186804|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15186805|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15186806|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15186807|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186808|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668428|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
14668429|NCT00270036|Hematinics|hematinics|mesh-ancestor
14668430|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
14668431|NCT00270049|Hematinics|hematinics|mesh-ancestor
14668432|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
14668433|NCT00270062|Hematinics|hematinics|mesh-ancestor
14668434|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
14668435|NCT00270075|Hematinics|hematinics|mesh-ancestor
14668436|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
14668437|NCT00270088|Hematinics|hematinics|mesh-ancestor
14668438|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
14668439|NCT00270101|Hematinics|hematinics|mesh-ancestor
14668440|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
14668441|NCT00270114|Hematinics|hematinics|mesh-ancestor
14668442|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
14668443|NCT00270127|Hematinics|hematinics|mesh-ancestor
14668444|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
14668445|NCT00270140|Hematinics|hematinics|mesh-ancestor
14668446|NCT00270153|Enalapril|enalapril|mesh-list
14668447|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14668448|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
14668449|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668450|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668451|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14668452|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
14668453|NCT00270166|Hematinics|hematinics|mesh-ancestor
14668454|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
14668455|NCT00270179|Hematinics|hematinics|mesh-ancestor
14668456|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
14668457|NCT00270270|Hematinics|hematinics|mesh-ancestor
14668458|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
14668459|NCT00270283|Hematinics|hematinics|mesh-ancestor
14668460|NCT00270322|Fentanyl|fentanyl|mesh-list
14668461|NCT00270322|Morphine|morphine|mesh-list
14668462|NCT00270322|Bupivacaine|bupivacaine|mesh-list
14668463|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668464|NCT00270322|Narcotics|narcotics|mesh-ancestor
14668465|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668466|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668467|NCT00270322|Analgesics|analgesics|mesh-ancestor
14668468|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
14668469|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186809|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186810|NCT03880968|Etanercept|etanercept|mesh-list
14668470|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14668471|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14668472|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
14668473|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
14668474|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
14668475|NCT00270335|Propofol|propofol|mesh-list
14668476|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14668477|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668478|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668479|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14668480|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
14668481|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
14668482|NCT00270348|Ciclesonide|ciclesonide|mesh-list
14668483|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
14668484|NCT00270348|Hormones|hormones|mesh-ancestor
14668485|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668486|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668487|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14668488|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14668489|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
14668490|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668491|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14668492|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
14668493|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668494|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14668495|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
14668496|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668497|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14668498|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
14668499|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668500|NCT00270413|Sunitinib|sunitinib|mesh-list
14668501|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668502|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14668503|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14668504|NCT00270413|Growth Substances|growth substances|mesh-ancestor
14668505|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668506|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
14668507|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14668508|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668509|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668510|NCT00270426|Benazepril|benazepril|mesh-list
14668511|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14668512|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
14668513|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668514|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668515|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14668516|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
14668517|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
14668518|NCT00270478|Hematinics|hematinics|mesh-ancestor
14668519|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668520|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
14668521|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668522|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668523|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14668524|NCT00270491|Paclitaxel|paclitaxel|mesh-list
14668525|NCT00270491|Capecitabine|capecitabine|mesh-list
14668526|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14668527|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668528|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668529|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668530|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668531|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668532|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14668533|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
14668534|NCT00270517|Telithromycin|telithromycin|mesh-list
14668535|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14668536|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668537|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
14668538|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
14668539|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14668540|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
14668541|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14668542|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14668543|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668544|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14668545|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668546|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668547|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14668548|NCT00270530|Renal Agents|renal agents|mesh-ancestor
14668549|NCT00270543|Leucovorin|leucovorin|mesh-list
14668550|NCT00270543|Fluorouracil|fluorouracil|mesh-list
14668551|NCT00270543|Docetaxel|docetaxel|mesh-list
14668552|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
14668553|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668554|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14668555|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668556|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14668557|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
14668558|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668559|NCT00270543|Antidotes|antidotes|mesh-ancestor
14668560|NCT00270543|Protective Agents|protective agents|mesh-ancestor
14668561|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
14668562|NCT00270543|Vitamins|vitamins|mesh-ancestor
14668563|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
14668564|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668565|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668566|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668567|NCT00270556|Tenofovir|tenofovir|mesh-list
14668568|NCT00270556|Abacavir|abacavir|mesh-list
14668569|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
14668570|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668571|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14668572|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14668573|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668574|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668575|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14668576|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14668577|NCT00270569|Cisplatin|cisplatin|mesh-list
14668578|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668579|NCT00270582|Gemcitabine|gemcitabine|mesh-list
14668580|NCT00270582|Docetaxel|docetaxel|mesh-list
14668581|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668582|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14668583|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
14668584|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668585|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
14668586|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668587|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668588|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14668589|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
14668590|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668591|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668592|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668593|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668594|NCT00270647|Vitamins|vitamins|mesh-list
14668595|NCT00270647|Ascorbic Acid|ascorbic acid|mesh-list
14668596|NCT00270647|Vitamin E|vitamin e|mesh-list
14668597|NCT00270647|Beta Carotene|beta carotene|mesh-list
14668598|NCT00270647|Carotenoids|carotenoids|mesh-list
14668599|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
14668600|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668601|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
14668602|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668603|NCT00270647|Protective Agents|protective agents|mesh-ancestor
15186811|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15186812|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15186813|NCT03880968|Analgesics|analgesics|mesh-ancestor
15186814|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
15186815|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186816|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186817|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186818|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15186819|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15186820|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15186821|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
15186822|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15186823|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15186824|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15186825|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15186826|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186827|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186828|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186829|NCT03880916|Analgesics|analgesics|mesh-ancestor
15186830|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
15186831|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186832|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
15186833|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668604|NCT00270647|Provitamins|provitamins|mesh-ancestor
14668605|NCT00270751|Minocycline|minocycline|mesh-list
14668606|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14668607|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668608|NCT00270777|Promethazine|promethazine|mesh-list
14668609|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
14668610|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
14668611|NCT00270777|Epinephrine|epinephrine|mesh-list
14668612|NCT00270777|Racepinephrine|racepinephrine|mesh-list
14668613|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
14668614|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14668615|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14668616|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14668617|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
14668618|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668619|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668620|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668621|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14668622|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14668623|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
14668624|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668625|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14668626|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
14668627|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
14668628|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
14668629|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14668630|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
14668631|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14668632|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14668633|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
14668634|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
14668635|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14668636|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14668637|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14668638|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186834|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
15186835|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
15186836|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15186837|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186838|NCT03880734|Vitamins|vitamins|mesh-ancestor
15186839|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
15186840|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15186841|NCT03880877|Leucovorin|leucovorin|mesh-list
15186842|NCT03880877|Antidotes|antidotes|mesh-ancestor
15186843|NCT03880877|Protective Agents|protective agents|mesh-ancestor
14668639|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
14668640|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
14668641|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
14668642|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
14668643|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668644|NCT00270816|Interferons|interferons|mesh-list
14668645|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668646|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
14668647|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186844|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186845|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
15186846|NCT03880877|Vitamins|vitamins|mesh-ancestor
15186847|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
15186848|NCT03880695|Doxorubicin|doxorubicin|mesh-list
15186849|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15186850|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15186851|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186852|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15186853|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15186854|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186855|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186856|NCT03880448|Metronidazole|metronidazole|mesh-list
15186857|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15186858|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15186859|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15186860|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15186861|NCT03880539|Vancomycin|vancomycin|mesh-list
14668648|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14668649|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
14668650|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668651|NCT00270881|Cytarabine|cytarabine|mesh-list
14668652|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
14668653|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14668654|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
14668655|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668656|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14668657|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14668658|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
14668659|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668660|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668661|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14668662|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14668663|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
14668664|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
14668665|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668666|NCT00270907|Gemcitabine|gemcitabine|mesh-list
14668667|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14668668|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14668669|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
14668670|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668671|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668672|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
14668673|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668674|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668675|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14668676|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
14668677|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668678|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14668679|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
14668680|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668681|NCT00271063|Annamycin|annamycin|mesh-list
14668682|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14668683|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668684|NCT00271206|Progesterone|progesterone|mesh-list
14668685|NCT00271206|Progestins|progestins|mesh-ancestor
14668686|NCT00271206|Hormones|hormones|mesh-ancestor
14668687|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668688|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668689|NCT00271245|Selenium|selenium|mesh-list
14668690|NCT00271245|Selenic Acid|selenic acid|mesh-list
14668691|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
14668692|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668693|NCT00271245|Protective Agents|protective agents|mesh-ancestor
14668694|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668695|NCT00271245|Trace Elements|trace elements|mesh-ancestor
14668696|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
14668697|NCT00271271|Gemcitabine|gemcitabine|mesh-list
14668698|NCT00271271|Vinorelbine|vinorelbine|mesh-list
14668699|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
14668700|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14668701|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
14668702|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668703|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668704|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
14668705|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668706|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668707|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14668708|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
14668709|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668710|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14668711|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668712|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668713|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668714|NCT00271284|Insulin|insulin|mesh-list
14668715|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14668716|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
14668717|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
14668718|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
15186862|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14668719|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14668720|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668721|NCT00271323|Docetaxel|docetaxel|mesh-list
14668722|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668723|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
14668724|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
14668725|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
14668726|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668727|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
14668728|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14668729|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668730|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668731|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14668732|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14668733|NCT00271336|Protective Agents|protective agents|mesh-ancestor
14668734|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668735|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
14668736|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14668737|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
14668738|NCT00271349|Budesonide|budesonide|mesh-list
14668739|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14668740|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14668741|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
14668742|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186863|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293806|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186864|NCT03880487|Oxycodone|oxycodone|mesh-list
15186865|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15186866|NCT03880487|Narcotics|narcotics|mesh-ancestor
15186867|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186868|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186869|NCT03880487|Analgesics|analgesics|mesh-ancestor
15186870|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
15186871|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186872|NCT03880825|Metformin|metformin|mesh-list
15186873|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15186874|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186875|NCT03880357|Betamethasone|betamethasone|mesh-list
15186876|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
15186877|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15186878|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
15186879|NCT03880357|Calcipotriene|calcipotriene|mesh-list
15186880|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15186881|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186882|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
15186883|NCT03880357|Hormones|hormones|mesh-ancestor
15186884|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15186885|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186886|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15186887|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
15186888|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
15186889|NCT03880396|Cisplatin|cisplatin|mesh-list
15186890|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186891|NCT03880409|Lidocaine|lidocaine|mesh-list
15186892|NCT03880409|Epinephrine|epinephrine|mesh-list
14668743|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668744|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14668745|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
14668746|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
14668747|NCT00271349|Hormones|hormones|mesh-ancestor
14668748|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668749|NCT00271401|Heparin|heparin|mesh-list
14668750|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
14668751|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14668752|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15186893|NCT03880409|Racepinephrine|racepinephrine|mesh-list
15186894|NCT03880409|Carticaine|carticaine|mesh-list
15186895|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
15186896|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
15186897|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
15186898|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186899|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186900|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
15186901|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186902|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15186903|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14668753|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668754|NCT00271414|Fentanyl|fentanyl|mesh-list
15225731|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
15186904|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15186905|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15186906|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186907|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15186908|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15186909|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
15186910|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186911|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15186912|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15186913|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
15186914|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15186915|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
15186916|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
15186917|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
15186918|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15186919|NCT03880045|Vasopressins|vasopressins|mesh-list
15186920|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
15186921|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
15186922|NCT03880045|Coagulants|coagulants|mesh-ancestor
15186923|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15186924|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15186925|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
15186926|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186927|NCT03879889|Nicotine|nicotine|mesh-list
15186928|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15186929|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
15186930|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668755|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668756|NCT00271414|Narcotics|narcotics|mesh-ancestor
14668757|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668758|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668759|NCT00271414|Analgesics|analgesics|mesh-ancestor
14668760|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
14668761|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668762|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14668763|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14668764|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
14668765|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
14668766|NCT00271427|Selenium|selenium|mesh-list
15186931|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186932|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15186933|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15186934|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
15186935|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668767|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
14668768|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668769|NCT00271427|Protective Agents|protective agents|mesh-ancestor
14668770|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668771|NCT00271427|Trace Elements|trace elements|mesh-ancestor
14668772|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
14668773|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
14668774|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14668775|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668776|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
14668777|NCT00271453|Fentanyl|fentanyl|mesh-list
14668778|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668779|NCT00271453|Narcotics|narcotics|mesh-ancestor
14668780|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186936|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186937|NCT03880123|Ixazomib|ixazomib|mesh-list
15186938|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186939|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
15186940|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186941|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186942|NCT03879837|Fluticasone|fluticasone|mesh-list
15186943|NCT03879837|Xhance|xhance|mesh-list
15186944|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186945|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15186946|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
15186947|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186948|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186949|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15186950|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
15186951|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
15186952|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15186953|NCT03879811|Nivolumab|nivolumab|mesh-list
15186954|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15186955|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186956|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15186957|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186958|NCT03879707|Melatonin|melatonin|mesh-list
15186959|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
15186960|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186961|NCT03879707|Protective Agents|protective agents|mesh-ancestor
15186962|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668781|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668782|NCT00271453|Analgesics|analgesics|mesh-ancestor
14668783|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
14668784|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668785|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14668786|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14668787|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
14668788|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
14668789|NCT00271466|Fentanyl|fentanyl|mesh-list
14668790|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668791|NCT00271466|Narcotics|narcotics|mesh-ancestor
14668792|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668793|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668794|NCT00271466|Analgesics|analgesics|mesh-ancestor
14668795|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
14668796|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668797|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14668798|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14668799|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
14668800|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
14726411|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14726412|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14726413|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726414|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726415|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726416|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
14726417|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726418|NCT00508885|Niacinamide|niacinamide|mesh-list
14726419|NCT00508885|Niacin|niacin|mesh-list
14726420|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
14726421|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
14726422|NCT00508885|Vitamins|vitamins|mesh-ancestor
14726423|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
14726424|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726425|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14668801|NCT00271492|Atrasentan|atrasentan|mesh-list
14668802|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668803|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14668804|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14668805|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668806|NCT00271518|Hormones|hormones|mesh-list
14668807|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668808|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668809|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14668810|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
14668811|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668812|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
14668813|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14668814|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
14668815|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14668816|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668817|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14668818|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14668819|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14668820|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
14668821|NCT00271635|Vitamins|vitamins|mesh-ancestor
14668822|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
14668823|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668824|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
14668825|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668826|NCT00271635|Protective Agents|protective agents|mesh-ancestor
14668827|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
14668828|NCT00271713|Vitamin D|vitamin d|mesh-list
14668829|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
14668830|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
14668831|NCT00271713|Vitamins|vitamins|mesh-list
14668832|NCT00271713|Calcium|calcium|mesh-list
14668833|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
14668834|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668835|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14668836|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14668837|NCT00271791|Prednisone|prednisone|mesh-list
14668838|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14668839|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
14668840|NCT00271791|Hormones|hormones|mesh-ancestor
14668841|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14668842|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668843|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14668844|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668845|NCT00271804|Bortezomib|bortezomib|mesh-list
14668846|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668847|NCT00271973|Oxycodone|oxycodone|mesh-list
14668848|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14668849|NCT00271973|Narcotics|narcotics|mesh-ancestor
14668850|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668851|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668852|NCT00271973|Analgesics|analgesics|mesh-ancestor
14668853|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
14668854|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668855|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
14668856|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14668857|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668858|NCT00272025|Citalopram|citalopram|mesh-list
14668859|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14668860|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14668861|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14668862|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668863|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668864|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
14668865|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668866|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14668867|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
14668868|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668869|NCT00272051|Xaliproden|xaliproden|mesh-list
14668870|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14668871|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14668872|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
14668873|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668874|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668875|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668876|NCT00272064|Insulin|insulin|mesh-list
14668877|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14668878|NCT00272064|Metformin|metformin|mesh-list
14668879|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
14668880|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
14668881|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14668882|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668883|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
14668884|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14668885|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668886|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
14668887|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14668888|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668889|NCT00272116|Vitamins|vitamins|mesh-list
14668890|NCT00272116|Vitamin A|vitamin a|mesh-list
14668891|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
14668892|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
14668893|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668894|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
14668895|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186963|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15186964|NCT03879694|Octreotide|octreotide|mesh-list
14668896|NCT00272116|Protective Agents|protective agents|mesh-ancestor
14668897|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14668898|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668899|NCT00272207|Nabilone|nabilone|mesh-list
14668900|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
14668901|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
14668902|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668903|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668904|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668905|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14668906|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14668907|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14668908|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14668909|NCT00272285|Granisetron|granisetron|mesh-list
14668910|NCT00272285|Ramosetron|ramosetron|mesh-list
14668911|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
15186965|NCT03879694|Sargramostim|sargramostim|mesh-list
15186966|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
15186967|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
15186968|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186969|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15186970|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15186971|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15186972|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15186973|NCT03879746|Paroxetine|paroxetine|mesh-list
15186974|NCT03879746|Tamsulosin|tamsulosin|mesh-list
14668912|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
14668913|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668914|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668915|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668916|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14668917|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
15186975|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15186976|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15186977|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15186978|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15186979|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15186980|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
15186981|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15186982|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15186983|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
15186984|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15186985|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14668918|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14668919|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668920|NCT00272324|Aspirin|aspirin|mesh-list
14668921|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14668922|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14668923|NCT00272324|Analgesics|analgesics|mesh-ancestor
14668924|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
14668925|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186986|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15186987|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15186988|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15186989|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15186990|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15186991|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
14668926|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668927|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14668928|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14668929|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14668930|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14668931|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668932|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14668933|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14668934|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668935|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
14668936|NCT00272415|Temozolomide|temozolomide|mesh-list
14668937|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14668938|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
14668939|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668940|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14668941|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
14668942|NCT00272428|Vitamin E|vitamin e|mesh-list
14668943|NCT00272428|Beta Carotene|beta carotene|mesh-list
14668944|NCT00272428|Selenium|selenium|mesh-list
14668945|NCT00272428|Carotenoids|carotenoids|mesh-list
14668946|NCT00272428|Vitamins|vitamins|mesh-ancestor
14668947|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
14668948|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668949|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
14668950|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668951|NCT00272428|Protective Agents|protective agents|mesh-ancestor
14668952|NCT00272428|Trace Elements|trace elements|mesh-ancestor
14668953|NCT00272428|Provitamins|provitamins|mesh-ancestor
14668954|NCT00272454|Aspirin|aspirin|mesh-list
15186992|NCT03879746|Urological Agents|urological agents|mesh-ancestor
15223734|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15223735|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15223736|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223737|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223738|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
15223739|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223740|NCT05190562|Astringents|astringents|mesh-ancestor
15223741|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
15223742|NCT05190432|Taxifolin|taxifolin|mesh-list
15223743|NCT05190432|Ergothioneine|ergothioneine|mesh-list
15223744|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
15223745|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668955|NCT00272454|Cilostazol|cilostazol|mesh-list
14668956|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14668957|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14668958|NCT00272454|Analgesics|analgesics|mesh-ancestor
14668959|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
14668960|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14668961|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668962|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14668963|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14668964|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14668965|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14668966|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668967|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14668968|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14668969|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668970|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
14668971|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14668972|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
14668973|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14668974|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
14668975|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
14668976|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14668977|NCT00272454|Protective Agents|protective agents|mesh-ancestor
14668978|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14668979|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14668980|NCT00272467|Omeprazole|omeprazole|mesh-list
14668981|NCT00272467|Rebamipide|rebamipide|mesh-list
14668982|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14668983|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14668984|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14668985|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668986|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668987|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
14668988|NCT00272467|Protective Agents|protective agents|mesh-ancestor
14668989|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14668990|NCT00272480|Lamivudine|lamivudine|mesh-list
14668991|NCT00272480|Zidovudine|zidovudine|mesh-list
14668992|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14668993|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14668994|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14668995|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14668996|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
14668997|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14668998|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14668999|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15186993|NCT03879590|Budesonide|budesonide|mesh-list
15186994|NCT03879590|Doxofylline|doxofylline|mesh-list
15186995|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15186996|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15186997|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
15186998|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15186999|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187000|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15187001|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
15187002|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
15187003|NCT03879590|Hormones|hormones|mesh-ancestor
15187004|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187005|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
15187006|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15187007|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187008|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187009|NCT03879460|Naltrexone|naltrexone|mesh-list
15187010|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15187011|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15187012|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187013|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
15187014|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187015|NCT03879564|Ketamine|ketamine|mesh-list
15187016|NCT03879564|Analgesics|analgesics|mesh-ancestor
15187017|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
15187018|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187019|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187020|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14669000|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
14669001|NCT00272493|Vaccines|vaccines|mesh-list
14669002|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
14669003|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669004|NCT00272558|Carboplatin|carboplatin|mesh-list
14669005|NCT00272558|Vinorelbine|vinorelbine|mesh-list
14669006|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669007|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14669008|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
15187021|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15187022|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
15187023|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
15187024|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187025|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15187026|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15187027|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187028|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187029|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
15187030|NCT03879486|Formaldehyde|formaldehyde|mesh-list
15187031|NCT03879486|Povidone|povidone|mesh-list
15187032|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
14669009|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
14669010|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
14669011|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187033|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
15187034|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14669012|NCT00272584|Risperidone|risperidone|mesh-list
14669013|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14669014|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
14669015|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187035|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187036|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
15187037|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
15187038|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15187039|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
15187040|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187041|NCT03879356|Expectorants|expectorants|mesh-ancestor
15187042|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
15187043|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15187044|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
15187045|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187046|NCT03879356|Protective Agents|protective agents|mesh-ancestor
14669016|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669017|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293807|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669018|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15187047|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187048|NCT03879356|Antidotes|antidotes|mesh-ancestor
15187049|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
15187050|NCT03879382|Fludarabine|fludarabine|mesh-list
15187051|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187052|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
15187053|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187054|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187055|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15187056|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
15187057|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187058|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187059|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15187060|NCT03879174|Tamoxifen|tamoxifen|mesh-list
15187061|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
15187062|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187063|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187064|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15187065|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
15187066|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187067|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187068|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15187069|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15187070|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15187071|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15187072|NCT03879122|Docetaxel|docetaxel|mesh-list
15187073|NCT03879122|Nivolumab|nivolumab|mesh-list
15187074|NCT03879122|Ipilimumab|ipilimumab|mesh-list
15187075|NCT03879122|Androgens|androgens|mesh-list
15187076|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187077|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
15187078|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
15187079|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187080|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187081|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187082|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15187083|NCT03879122|Hormones|hormones|mesh-ancestor
15187084|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187085|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187086|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
15187087|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
15187088|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
15187089|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187090|NCT03879057|Antibodies|antibodies|mesh-list
15187091|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15187092|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
15187093|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187094|NCT03878888|Bupivacaine|bupivacaine|mesh-list
15187095|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187096|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
15187097|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187098|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187099|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
15187100|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187101|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
15187102|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15187103|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187104|NCT03878771|Clobetasol|clobetasol|mesh-list
15187105|NCT03878771|Benzocaine|benzocaine|mesh-list
15187106|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187107|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
15187108|NCT03878771|Hormones|hormones|mesh-ancestor
15187109|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187110|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187111|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187112|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
15187113|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187114|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
15187115|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187116|NCT03878784|Sumatriptan|sumatriptan|mesh-list
15187117|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15187118|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15187119|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15187120|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
15187121|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187122|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187123|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187124|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
15187125|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
15187126|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187127|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14669019|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14669020|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14669021|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14669022|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14669023|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
14669024|NCT00272597|Risperidone|risperidone|mesh-list
14669025|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14669026|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
14669027|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669028|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669029|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669030|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14669031|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14669032|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14669033|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14669034|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14669035|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
14669036|NCT00272610|Vitamin A|vitamin a|mesh-list
15187128|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187129|NCT03878693|Fomepizole|fomepizole|mesh-list
15187130|NCT03878693|Antidotes|antidotes|mesh-ancestor
15187131|NCT03878693|Protective Agents|protective agents|mesh-ancestor
15187132|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187133|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187134|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187135|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
15187136|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
15187137|NCT03878667|Calcium|calcium|mesh-list
15187138|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15187139|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187140|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15187141|NCT03878667|Antacids|antacids|mesh-ancestor
15187142|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187143|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187144|NCT03878368|Sulforaphane|sulforaphane|mesh-list
15187145|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15187146|NCT03878368|Protective Agents|protective agents|mesh-ancestor
15187147|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187148|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187149|NCT03878264|Cortisone|cortisone|mesh-list
15187150|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187151|NCT03878069|Elapegademase|elapegademase|mesh-list
15187152|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
15187153|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187154|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669037|NCT00272610|Vitamins|vitamins|mesh-ancestor
15187155|NCT03878082|Acetaminophen|acetaminophen|mesh-list
14669038|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
15187156|NCT03878082|Propacetamol|propacetamol|mesh-list
15187157|NCT03878082|Analgesics|analgesics|mesh-ancestor
15187158|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
15187159|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187160|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187161|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15187162|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15187163|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187164|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187165|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
15187166|NCT03877705|Listerine|listerine|mesh-list
15187167|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
15187168|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15187169|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187170|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
15187171|NCT03877705|Protective Agents|protective agents|mesh-ancestor
15187172|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187173|NCT03877718|Promethazine|promethazine|mesh-list
15187174|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
14669039|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669040|NCT00272636|Amiodarone|amiodarone|mesh-list
15187175|NCT03877718|Sumatriptan|sumatriptan|mesh-list
15187176|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15187177|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15187178|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15187179|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
15187180|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187181|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187182|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187183|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
15187184|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
15187185|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15187186|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
15187187|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
15187188|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15187189|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15187190|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15187191|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187192|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187193|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
15187194|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
15187195|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187196|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
15187197|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
15187198|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187199|NCT03877965|Digoxin|digoxin|mesh-list
15187200|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15187201|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15187202|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187203|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187204|NCT03877965|Protective Agents|protective agents|mesh-ancestor
15187205|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187206|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15187207|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15187208|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15187209|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
15187210|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187211|NCT03877549|Dexamethasone|dexamethasone|mesh-list
15187212|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187213|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
15187214|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
15187215|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187216|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187217|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187218|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
15187219|NCT03877549|Hormones|hormones|mesh-ancestor
15187220|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187221|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15187222|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187223|NCT03877809|Sirolimus|sirolimus|mesh-list
14669041|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14669042|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
14669043|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14669044|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669045|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669046|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14669047|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14669048|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14669049|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669050|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14669051|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14669052|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14669053|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
14669054|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14669055|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14669056|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669057|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
15187224|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15187225|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187226|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15187227|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187228|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
15187229|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187230|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
15187231|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187232|NCT03877874|Terbutaline|terbutaline|mesh-list
15187233|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15187234|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
15187235|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187236|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187237|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15187238|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
15187239|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
15187240|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
15187241|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15187242|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669058|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
14669059|NCT00272688|Levodopa|levodopa|mesh-list
14669060|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14669061|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14669062|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
14669063|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187243|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15187244|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15187245|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
15187246|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187247|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187248|NCT03877692|Labetalol|labetalol|mesh-list
15187249|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15187250|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15187251|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
15187252|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187253|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187254|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669064|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669065|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669066|NCT00272701|Esomeprazole|esomeprazole|mesh-list
14669067|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14669068|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669069|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14669070|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669071|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669072|NCT00272714|Afimoxifene|afimoxifene|mesh-list
14669073|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669074|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14669075|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
14669076|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669077|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669078|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14669079|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15187255|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15187256|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
14293808|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293809|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
14293810|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
14293811|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293812|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293813|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
14293814|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669080|NCT00272740|Fulvestrant|fulvestrant|mesh-list
14669081|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14669082|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669083|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14669084|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14669085|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
14669086|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669087|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669088|NCT00272753|Budesonide|budesonide|mesh-list
14669089|NCT00272753|Albuterol|albuterol|mesh-list
14669090|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
14669091|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669092|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669093|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
14669094|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669095|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669096|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669097|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669098|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
14669099|NCT00272753|Hormones|hormones|mesh-ancestor
14669100|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669101|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669102|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14669103|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14669104|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669105|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669106|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669107|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
14669108|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14669109|NCT00272805|Carvedilol|carvedilol|mesh-list
14669110|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14669111|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14669112|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
15187257|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
15187258|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187259|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15187260|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15187261|NCT03877679|Triamcinolone|triamcinolone|mesh-list
15187262|NCT03877679|Curcumin|curcumin|mesh-list
15187263|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187264|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
15187265|NCT03877679|Hormones|hormones|mesh-ancestor
15187266|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187267|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187268|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187269|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187270|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15187271|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15187272|NCT03877679|Analgesics|analgesics|mesh-ancestor
15187273|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
15187274|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187275|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187276|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187277|NCT03877562|Olanzapine|olanzapine|mesh-list
15187278|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
15187279|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
15187280|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187281|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187282|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187283|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15187284|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15187285|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187286|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15187287|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15187288|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15187289|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15187290|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187291|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187292|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
15187293|NCT03877601|Bevacizumab|bevacizumab|mesh-list
14669113|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669114|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187294|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187295|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187296|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15187297|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15187298|NCT03877601|Growth Substances|growth substances|mesh-ancestor
15187299|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669115|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669116|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669117|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
14669118|NCT00272805|Protective Agents|protective agents|mesh-ancestor
14669119|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14669120|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669121|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15187300|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
15223746|NCT05190432|Protective Agents|protective agents|mesh-ancestor
15223747|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223748|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15223749|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15223750|NCT05190432|Analgesics|analgesics|mesh-ancestor
15223751|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
15223752|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293815|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14293816|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
14669122|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
15223753|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223754|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15223755|NCT05190341|Ibuprofen|ibuprofen|mesh-list
15223756|NCT05190341|Ketorolac|ketorolac|mesh-list
15223757|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15223758|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15223759|NCT05190341|Analgesics|analgesics|mesh-ancestor
15223760|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
15223761|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223762|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223763|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223764|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15223765|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15223766|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223767|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223768|NCT05190120|Ropivacaine|ropivacaine|mesh-list
15223769|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
15223770|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
15223771|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223772|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223773|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
15223774|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223775|NCT05190094|Letrozole|letrozole|mesh-list
15223776|NCT05190094|Palbociclib|palbociclib|mesh-list
15223777|NCT05190094|Anastrozole|anastrozole|mesh-list
15223778|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15223779|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223780|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15223781|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223782|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223783|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15223784|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
14669123|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14669124|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14669125|NCT00272831|Cilostazol|cilostazol|mesh-list
14669126|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669127|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
14669128|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669129|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669130|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669131|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669132|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14669133|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14669134|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669135|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14669136|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
14669137|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14669138|NCT00272831|Protective Agents|protective agents|mesh-ancestor
15223785|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293817|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15187301|NCT03877315|Cimetidine|cimetidine|mesh-list
15187302|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15187303|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187304|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15187305|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
15187306|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
15187307|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669139|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14669140|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14669141|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669142|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14669143|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669144|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187308|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187309|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187310|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15187311|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15187312|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187313|NCT03877406|Empagliflozin|empagliflozin|mesh-list
15187314|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15187315|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15187316|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187317|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187318|NCT03877120|Diazepam|diazepam|mesh-list
15187319|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
15187320|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15187321|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187322|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187323|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15187324|NCT03877120|Analgesics|analgesics|mesh-ancestor
15187325|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
15187326|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187327|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15187328|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15187329|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15187330|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
15187331|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187332|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187333|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15187334|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
15187335|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
15187336|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
15187337|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187338|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15187339|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15187340|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15187341|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15187342|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15187343|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15187344|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
15187345|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
15187346|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
15187347|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
15187348|NCT03877003|Choline|choline|mesh-list
15187349|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
15187350|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15187351|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
15187352|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187353|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187354|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15187355|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
15187356|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
15187357|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15187358|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15187359|NCT03876899|Analgesics|analgesics|mesh-ancestor
15187360|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
15187361|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669145|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669146|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
14669147|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669148|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
14669149|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15187362|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187363|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187364|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187365|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15187366|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
15187367|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187368|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15187369|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
15187370|NCT03876704|Vitamins|vitamins|mesh-list
15187371|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
15187372|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187373|NCT03876938|Olanzapine|olanzapine|mesh-list
15187374|NCT03876938|Aprepitant|aprepitant|mesh-list
14669150|NCT00272896|Protective Agents|protective agents|mesh-ancestor
14669151|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669152|NCT00272909|Piclozotan|piclozotan|mesh-list
14669153|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14669154|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14669155|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
14669156|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669157|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669158|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669159|NCT00272935|Estrogens|estrogens|mesh-list
14669160|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14669161|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
14669162|NCT00272935|Hormones|hormones|mesh-ancestor
14669163|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669164|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669165|NCT00272948|Defibrotide|defibrotide|mesh-list
14669166|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14669167|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14669168|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669169|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14669170|NCT00273013|Montelukast|montelukast|mesh-list
14669171|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669172|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669173|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14669174|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
15187375|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
15187376|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
15187377|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187378|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187379|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187380|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15187381|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15187382|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187383|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15187384|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15187385|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15187386|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15187387|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187388|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187389|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
15187390|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15187391|NCT03876886|Paclitaxel|paclitaxel|mesh-list
15187392|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15187393|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
15187394|NCT03876886|Carboplatin|carboplatin|mesh-list
15187395|NCT03876886|Epirubicin|epirubicin|mesh-list
15187396|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15187397|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187398|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
15187399|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
15187400|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187401|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187402|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187403|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
15187404|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187405|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187406|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15187407|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
15187408|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15187409|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15187410|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15187411|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726426|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
14910538|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15187412|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187413|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
15187414|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15187415|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15187416|NCT03876444|Prednisolone|prednisolone|mesh-list
15187417|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
15187418|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15187419|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
15187420|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187421|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
15187422|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
15187423|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669175|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669176|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669177|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14669178|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14669179|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669180|NCT00273026|Fluticasone|fluticasone|mesh-list
14669181|NCT00273026|Xhance|xhance|mesh-list
14669182|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14669183|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669184|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669185|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
14669186|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669187|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669188|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669189|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669190|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14669191|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14669192|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669193|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14669194|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15187424|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187425|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187426|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
15187427|NCT03876444|Hormones|hormones|mesh-ancestor
15187428|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187429|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15187430|NCT03876444|Protective Agents|protective agents|mesh-ancestor
15187431|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15187432|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187433|NCT03876548|Iodine|iodine|mesh-list
15187434|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
15187435|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15187436|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187437|NCT03876548|Trace Elements|trace elements|mesh-ancestor
15187438|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
15187439|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187440|NCT03876587|Docetaxel|docetaxel|mesh-list
15187441|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187442|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
15187443|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
15187444|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187445|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187446|NCT03876574|Gemcitabine|gemcitabine|mesh-list
15187447|NCT03876574|Dexamethasone|dexamethasone|mesh-list
15187448|NCT03876574|Floxuridine|floxuridine|mesh-list
15187449|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187450|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
15187451|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
15187452|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187453|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187454|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187455|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
15187456|NCT03876574|Hormones|hormones|mesh-ancestor
15187457|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187458|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15187459|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187460|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15187461|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
15187462|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187463|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
14293818|NCT00571519|Metformin|metformin|mesh-list
15187464|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293819|NCT00571519|Pioglitazone|pioglitazone|mesh-list
14293820|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293821|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293822|NCT00571649|Enoxaparin|enoxaparin|mesh-list
14293823|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
14293824|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
14293825|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14293826|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
14293827|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14293828|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
14293829|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293830|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187465|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187466|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187467|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
15187468|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
15187469|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15187470|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
15187471|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15187472|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
15187473|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187474|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15187475|NCT03876119|Plasminogen|plasminogen|mesh-list
15187476|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15187477|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15187478|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187479|NCT03876041|Dexamethasone|dexamethasone|mesh-list
15187480|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
15187481|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
15187482|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15187483|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15187484|NCT03876041|BB 1101|bb 1101|mesh-list
15187485|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187486|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
15187487|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
15187488|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187489|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187490|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187491|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
15187492|NCT03876041|Hormones|hormones|mesh-ancestor
15187493|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187494|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15187495|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187496|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
15187497|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187498|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187499|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15187500|NCT03876041|Protective Agents|protective agents|mesh-ancestor
15187501|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15187502|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187503|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
15187504|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15187505|NCT03875911|Mitomycins|mitomycins|mesh-list
15187506|NCT03875911|Mitomycin|mitomycin|mesh-list
15187507|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15187508|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187509|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
15187510|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187511|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15187512|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187513|NCT03875872|Propofol|propofol|mesh-list
15187514|NCT03875872|Anesthetics|anesthetics|mesh-list
15187515|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
15187516|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15187517|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187518|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187519|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15187520|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
15187521|NCT03875755|Inositol|inositol|mesh-list
15187522|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
15187523|NCT03875755|Vitamins|vitamins|mesh-ancestor
15187524|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
15187525|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293831|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
14293832|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15187526|NCT03875391|Oxytocin|oxytocin|mesh-list
15187527|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
15187528|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15187529|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293833|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14293834|NCT00571662|Cyclosporine|cyclosporine|mesh-list
14669195|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669196|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669197|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669198|NCT00273039|Paroxetine|paroxetine|mesh-list
14669199|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14669200|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14669201|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669202|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669203|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669204|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
14669205|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669206|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14669207|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
14669208|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14669209|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14669210|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14669211|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669212|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
14669213|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14669214|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14669215|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669216|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726427|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726428|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14726429|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
15187530|NCT03875274|Morphine|morphine|mesh-list
15187531|NCT03875274|Ropivacaine|ropivacaine|mesh-list
14726430|NCT00508898|Calcitriol|calcitriol|mesh-list
14726431|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14726432|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726433|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14726434|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726435|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726436|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14726437|NCT00508898|Vitamins|vitamins|mesh-ancestor
14726438|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
14726439|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14726440|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
14726441|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
14726442|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14726443|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726444|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14726445|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14726446|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14726447|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14726448|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726449|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
14726450|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14726451|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
14726452|NCT00508976|Lidocaine|lidocaine|mesh-list
14726453|NCT00508976|Bupivacaine|bupivacaine|mesh-list
14726454|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
14726455|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
14726456|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726457|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726458|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
14726459|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726460|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14726461|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14726462|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14726463|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726464|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726465|NCT00509015|Artesunate|artesunate|mesh-list
14726466|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
14726467|NCT00509015|Primaquine|primaquine|mesh-list
14726468|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
14726469|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14726470|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
15187532|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15187533|NCT03875274|Narcotics|narcotics|mesh-ancestor
14669217|NCT00273247|Interferons|interferons|mesh-list
14669218|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
14669219|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
14669220|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669221|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
14669222|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669223|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
14669224|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669225|NCT00273299|Valsartan|valsartan|mesh-list
14669226|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14669227|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14293835|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
14293836|NCT00571662|Pentostatin|pentostatin|mesh-list
14293837|NCT00571662|Cyclosporins|cyclosporins|mesh-list
14669228|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14669229|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14669230|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669231|NCT00273299|Diuretics|diuretics|mesh-ancestor
14669232|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
14669233|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669234|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14669235|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669236|NCT00273312|Epothilone B|epothilone b|mesh-list
14669237|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669238|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
14669239|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
14669240|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
14669241|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669242|NCT00273338|Calcitriol|calcitriol|mesh-list
14669243|NCT00273338|Docetaxel|docetaxel|mesh-list
14669244|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669245|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
14669246|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
14669247|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187534|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187535|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187536|NCT03875274|Analgesics|analgesics|mesh-ancestor
15187537|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
15187538|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187539|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187540|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
15223786|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223787|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223788|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223789|NCT05189977|Propranolol|propranolol|mesh-list
15223790|NCT05189977|Prazosin|prazosin|mesh-list
15223791|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15223792|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15223793|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
15223794|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223795|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223796|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669248|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669249|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14669250|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669251|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14669252|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669253|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14293838|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223797|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14669254|NCT00273338|Vitamins|vitamins|mesh-ancestor
14669255|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
14669256|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14669257|NCT00273377|Dexamethasone|dexamethasone|mesh-list
14669258|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669259|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
14669260|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
14669261|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669262|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669263|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187541|NCT03874975|Vitamin D|vitamin d|mesh-list
15187542|NCT03874975|Vitamins|vitamins|mesh-ancestor
15187543|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
15187544|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187545|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14293839|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293840|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293841|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
14293842|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293843|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
15187546|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
14669264|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
14669265|NCT00273377|Hormones|hormones|mesh-ancestor
14669266|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669267|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14669268|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187547|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15187548|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
15187549|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
15187550|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187551|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187552|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187553|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15187554|NCT03874832|Analgesics|analgesics|mesh-ancestor
15187555|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
14669269|NCT00273390|Infliximab|infliximab|mesh-list
14669270|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
14669271|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669272|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14669273|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
14669274|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
14669275|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14669276|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14669277|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669278|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669279|NCT00273416|Urological Agents|urological agents|mesh-ancestor
14669280|NCT00273429|Timolol|timolol|mesh-list
14669281|NCT00273429|Dorzolamide|dorzolamide|mesh-list
14669282|NCT00273429|Latanoprost|latanoprost|mesh-list
14669283|NCT00273429|Maleic acid|maleic acid|mesh-list
14669284|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14669285|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14669286|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669287|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669288|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669289|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669290|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14669291|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669292|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669293|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14669294|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14669295|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14669296|NCT00273442|Timolol|timolol|mesh-list
14669297|NCT00273442|Dorzolamide|dorzolamide|mesh-list
15187556|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669298|NCT00273442|Maleic acid|maleic acid|mesh-list
14669299|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14669300|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14669301|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669302|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669303|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669304|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669305|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14669306|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669307|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187557|NCT03874936|Dexamethasone|dexamethasone|mesh-list
15187558|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14669308|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14669309|NCT00273455|Timolol|timolol|mesh-list
14669310|NCT00273455|Bimatoprost|bimatoprost|mesh-list
14669311|NCT00273455|Dorzolamide|dorzolamide|mesh-list
14669312|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14669313|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14669314|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669315|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669316|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669317|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669318|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14669319|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669320|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669321|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14669322|NCT00273468|Granisetron|granisetron|mesh-list
14669323|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
14669324|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
14669325|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669326|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669327|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669328|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14669329|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
15187559|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187560|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
15187561|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
15187562|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187563|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187564|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187565|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
15187566|NCT03874936|Hormones|hormones|mesh-ancestor
15187567|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187568|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15187569|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187570|NCT03874884|Olaparib|olaparib|mesh-list
15187571|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15187572|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187573|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669330|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669331|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669332|NCT00273481|Timolol|timolol|mesh-list
14669333|NCT00273481|Dorzolamide|dorzolamide|mesh-list
14669334|NCT00273481|Latanoprost|latanoprost|mesh-list
14669335|NCT00273481|Maleic acid|maleic acid|mesh-list
14669336|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14669337|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14669338|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669339|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669340|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669341|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669342|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14669343|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669344|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187574|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187575|NCT03874806|Ropivacaine|ropivacaine|mesh-list
15187576|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15187577|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187578|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
15187579|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187580|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187581|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
15187582|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187583|NCT03874741|Cetuximab|cetuximab|mesh-list
15187584|NCT03874741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187585|NCT03874741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187586|NCT03874585|Nicotine|nicotine|mesh-list
15187587|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15187588|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
15187589|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187590|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187591|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15187592|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14814629|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814630|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
14814631|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814632|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187593|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
15187594|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187595|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187596|NCT03874364|Lidocaine|lidocaine|mesh-list
15187597|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187598|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
15187599|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187600|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187601|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
15187602|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187603|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15187604|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15187605|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15187606|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15187607|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187608|NCT03874338|Colchicine|colchicine|mesh-list
15187609|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
15187610|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187611|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
15187612|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
15187613|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187614|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187615|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187616|NCT03874273|Crizotinib|crizotinib|mesh-list
15187617|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187618|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15187619|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187620|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187621|NCT03874286|Liver Extracts|liver extracts|mesh-list
15187622|NCT03874286|Hematinics|hematinics|mesh-ancestor
15187623|NCT03874130|Scopolamine|scopolamine|mesh-list
15187624|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15187625|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15187626|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
15187627|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
15187628|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187629|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187630|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187631|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
15187632|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15187633|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
15187634|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187635|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187636|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15187637|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
15187638|NCT03874260|Fenofibrate|fenofibrate|mesh-list
15187639|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15187640|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
15187641|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187642|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15187643|NCT03874000|Metformin|metformin|mesh-list
15187644|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15187645|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187646|NCT03874026|Cetuximab|cetuximab|mesh-list
15187647|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187648|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187649|NCT03874156|Atorvastatin|atorvastatin|mesh-list
15187650|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15187651|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15187652|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
15187653|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187654|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15187655|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14669345|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14669346|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14669347|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14669348|NCT00273507|Paclitaxel|paclitaxel|mesh-list
14669349|NCT00273507|Carboplatin|carboplatin|mesh-list
14669350|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14669351|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669352|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
14669353|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
14669354|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187656|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187657|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
15187658|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
15187659|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
15187660|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187661|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
15187662|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14293844|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669355|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669356|NCT00273520|Telithromycin|telithromycin|mesh-list
14669357|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14669358|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669359|NCT00273533|Ramipril|ramipril|mesh-list
14669360|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14669361|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
14669362|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669363|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669364|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669365|NCT00273546|Docetaxel|docetaxel|mesh-list
15187663|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187664|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
15187665|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
15187666|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187667|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
15187668|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669366|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669367|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
14669368|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
14669369|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
14669370|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669371|NCT00273559|Prednisone|prednisone|mesh-list
14669372|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669373|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
14669374|NCT00273559|Hormones|hormones|mesh-ancestor
14669375|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669376|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669377|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14669378|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669379|NCT00273611|Vitamin D|vitamin d|mesh-list
14669380|NCT00273611|Vitamins|vitamins|mesh-ancestor
14669381|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
14669382|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669383|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14669384|NCT00273624|Olanzapine|olanzapine|mesh-list
14669385|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
14669386|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
14669387|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669388|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669389|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293845|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14293846|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293847|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14669390|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14669391|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15187669|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
14669392|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14669393|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14669394|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14669395|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14669396|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669397|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669398|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669399|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
14669400|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15187670|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187671|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187672|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15187673|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
15187674|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15187675|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
15187676|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187677|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187678|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15187679|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
15187680|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
15187681|NCT03873298|Protective Agents|protective agents|mesh-ancestor
15187682|NCT03873337|Nicotine|nicotine|mesh-list
15187683|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15187684|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
15187685|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187686|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187687|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15187688|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15187689|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
15187690|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187691|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187692|NCT03873740|Vaccines|vaccines|mesh-list
15187693|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
15187694|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223798|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15223799|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
15223800|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15223801|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15223802|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
15223803|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15223804|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
14669401|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14669402|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669403|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
14669404|NCT00273689|Albuterol|albuterol|mesh-list
14669405|NCT00273689|Montelukast|montelukast|mesh-list
14669406|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669407|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669408|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14669409|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
15223805|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15223806|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223807|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15223808|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15223809|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15223810|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
15223811|NCT05189704|Narcotics|narcotics|mesh-ancestor
14669410|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669411|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669412|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14669413|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14669414|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669415|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669416|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
14669417|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669418|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
14669419|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14669420|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669421|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14669422|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14669423|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
15223812|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14669424|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669425|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
14669426|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14669427|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
14669428|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669429|NCT00273702|Expectorants|expectorants|mesh-ancestor
14669430|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669431|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14669432|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
14669433|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669434|NCT00273702|Protective Agents|protective agents|mesh-ancestor
14669435|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669436|NCT00273702|Antidotes|antidotes|mesh-ancestor
14669437|NCT00273741|Methylphenidate|methylphenidate|mesh-list
14669438|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14669439|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669440|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14669441|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14669442|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669443|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669444|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
14669445|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669446|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
14669447|NCT00273767|Hematinics|hematinics|mesh-ancestor
14669448|NCT00273871|Cyclosporine|cyclosporine|mesh-list
14669449|NCT00273871|Tacrolimus|tacrolimus|mesh-list
14669450|NCT00273871|Cyclosporins|cyclosporins|mesh-list
14669451|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14669452|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
14669453|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669454|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14669455|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669456|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669457|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
14669458|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669459|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
14669460|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14669461|NCT00273884|Cytarabine|cytarabine|mesh-list
14669462|NCT00273884|Amonafide|amonafide|mesh-list
14669463|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14669464|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
14669465|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669466|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293848|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14293849|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293850|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14293851|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
14293852|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14293853|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14669467|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
14669468|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669469|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14669470|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
14669471|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669472|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669473|NCT00273949|Lactulose|lactulose|mesh-list
14669474|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669475|NCT00273962|Albuterol|albuterol|mesh-list
15187695|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
15187696|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187697|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187698|NCT03872661|Bevacizumab|bevacizumab|mesh-list
15187699|NCT03872661|Carboplatin|carboplatin|mesh-list
15187700|NCT03872661|Pemetrexed|pemetrexed|mesh-list
15187701|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187702|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187703|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15187704|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14293854|NCT00571688|Risperidone|risperidone|mesh-list
14669476|NCT00273962|Ipratropium|ipratropium|mesh-list
14669477|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669478|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
14669479|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669480|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669481|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669482|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
15187705|NCT03872661|Growth Substances|growth substances|mesh-ancestor
14669483|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
14669484|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14669485|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669486|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14669487|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14669488|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669489|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669490|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669491|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669492|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669493|NCT00273975|Lamivudine|lamivudine|mesh-list
14669494|NCT00273975|Zidovudine|zidovudine|mesh-list
14669495|NCT00273975|Nevirapine|nevirapine|mesh-list
14669496|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14669497|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14669498|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669499|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669500|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
14669501|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669502|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15187706|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187707|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
14669503|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14669504|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
14669505|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15187708|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187709|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187710|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15187711|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15187712|NCT03872700|Fentanyl|fentanyl|mesh-list
15187713|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15187714|NCT03872700|Narcotics|narcotics|mesh-ancestor
15187715|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187716|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187717|NCT03872700|Analgesics|analgesics|mesh-ancestor
15187718|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
15187719|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187720|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14669506|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14669507|NCT00273988|Nevirapine|nevirapine|mesh-list
14669508|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15187721|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15187722|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
15187723|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
15187724|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
15187725|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15187726|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15187727|NCT03872830|Analgesics|analgesics|mesh-ancestor
15187728|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
15187729|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187730|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187731|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187732|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187733|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15187734|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
15187735|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15187736|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15187737|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15187738|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187739|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187740|NCT03872570|Phenylephrine|phenylephrine|mesh-list
15187741|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
15187742|NCT03872570|Norepinephrine|norepinephrine|mesh-list
15187743|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15187744|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
15187745|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
14669509|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14669510|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669511|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669512|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
14669513|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669514|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14669515|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15187746|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669516|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15187747|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187748|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
15187749|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15187750|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
15187751|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
15187752|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15187753|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15187754|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15187755|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
15187756|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187757|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187758|NCT03872570|Protective Agents|protective agents|mesh-ancestor
15187759|NCT03872505|Paclitaxel|paclitaxel|mesh-list
15187760|NCT03872505|Carboplatin|carboplatin|mesh-list
15187761|NCT03872505|Durvalumab|durvalumab|mesh-list
15187762|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15187763|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187764|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
15187765|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
15187766|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187767|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187768|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187769|NCT03872336|Labetalol|labetalol|mesh-list
15187770|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15187771|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15187772|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
15187773|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187774|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187775|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187776|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15187777|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
15187778|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
15187779|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669517|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14669518|NCT00274001|Nevirapine|nevirapine|mesh-list
14669519|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14669520|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14669521|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669522|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187780|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15187781|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15187782|NCT03873415|BMS-986165|bms-986165|mesh-list
15187783|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
15187784|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15187785|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187786|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187787|NCT03873532|Capecitabine|capecitabine|mesh-list
15187788|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15187789|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
15187790|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187791|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187792|NCT03872232|Telmisartan|telmisartan|mesh-list
15187793|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15187794|NCT03872232|Ezetimibe|ezetimibe|mesh-list
15187795|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15187796|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15187797|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
15187798|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187799|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15187800|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15187801|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187802|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15187803|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15187804|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15187805|NCT03871972|Sirolimus|sirolimus|mesh-list
14669523|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
14669524|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669525|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14669526|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14669527|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14669528|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15187806|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15187807|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669529|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
14669530|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669531|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
14669532|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669533|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669534|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669535|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669536|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
14669537|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669538|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669539|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669540|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669541|NCT00274027|Bromides|bromides|mesh-list
15187808|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15187809|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187810|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
15187811|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187812|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
15187813|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187814|NCT03872011|Vitamins|vitamins|mesh-list
15187815|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
15187816|NCT03872011|Thiamine|thiamine|mesh-list
15187817|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
15187818|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
15187819|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187820|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187821|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
15187822|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187823|NCT03872011|Protective Agents|protective agents|mesh-ancestor
15187824|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
15187825|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
15187826|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15187827|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187828|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
15187829|NCT03871621|Metformin|metformin|mesh-list
15187830|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
15187831|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
15187832|NCT03871621|Meglitinide|meglitinide|mesh-list
15187833|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15187834|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187835|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14669542|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
14669543|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669544|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
14669545|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669546|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669547|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669548|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669549|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
14669550|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669551|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669552|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669553|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669554|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
14669555|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
14669556|NCT00274040|Ipratropium|ipratropium|mesh-list
14669557|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669558|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
14669559|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669560|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669561|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669562|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669563|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
14669564|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669565|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
15187836|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187837|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15187838|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15187839|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
15187840|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187841|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187842|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187843|NCT03871517|Aspirin|aspirin|mesh-list
15187844|NCT03871517|Indobufen|indobufen|mesh-list
15187845|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15187846|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15187847|NCT03871517|Analgesics|analgesics|mesh-ancestor
15187848|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
15187849|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187850|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187851|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187852|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187853|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15187854|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15187855|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187856|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15187857|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15187858|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187859|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
15187860|NCT03871361|Abatacept|abatacept|mesh-list
15187861|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15187862|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187863|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187864|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187865|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
15187866|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187867|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15187868|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
15187869|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15187870|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
14669566|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669567|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669568|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
14669569|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669570|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
14669571|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669572|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669573|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669574|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669575|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
14669576|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669577|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669578|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669579|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669580|NCT00274066|Fenoterol|fenoterol|mesh-list
14669581|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
14669582|NCT00274066|Ipratropium|ipratropium|mesh-list
14669583|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669584|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
14669585|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669586|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669587|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669588|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669589|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
14669590|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669591|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669592|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669593|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669594|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
14669595|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
15187871|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187872|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
14669596|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14726471|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15187873|NCT03871218|Protective Agents|protective agents|mesh-ancestor
15187874|NCT03871322|Vitamin D|vitamin d|mesh-list
15187875|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
15187876|NCT03871322|Vitamins|vitamins|mesh-list
15187877|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
15187878|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187879|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15187880|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15187881|NCT03871478|Lidocaine|lidocaine|mesh-list
15187882|NCT03871478|Bupivacaine|bupivacaine|mesh-list
15187883|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187884|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
15187885|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187886|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187887|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
14669597|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669598|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14669599|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14669600|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669601|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
14669602|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669603|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
14669604|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669605|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669606|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669607|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
14293855|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14293856|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
14293857|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293858|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669608|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
14669609|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669610|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669611|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669612|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669613|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
14669614|NCT00274092|Ipratropium|ipratropium|mesh-list
14669615|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669616|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
14669617|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669618|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669619|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669620|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669621|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
14669622|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669623|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669624|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669625|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669626|NCT00274105|Telmisartan|telmisartan|mesh-list
14669627|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669628|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14669629|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14669630|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669631|NCT00274118|Telmisartan|telmisartan|mesh-list
14669632|NCT00274118|Enalapril|enalapril|mesh-list
14669633|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669634|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15187888|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187889|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15187890|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15187891|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14669635|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14669636|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669637|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14669638|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
15187892|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15187893|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187894|NCT03871036|Paclitaxel|paclitaxel|mesh-list
14293859|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669639|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187895|NCT03871036|Durvalumab|durvalumab|mesh-list
15187896|NCT03871036|Tremelimumab|tremelimumab|mesh-list
15187897|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15187898|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187899|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
15187900|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
15187901|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
15187902|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187903|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187904|NCT03871062|Anesthetics|anesthetics|mesh-list
15187905|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187906|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187907|NCT03871114|Triamcinolone|triamcinolone|mesh-list
15187908|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15187909|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15187910|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15187911|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15187912|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
15187913|NCT03871114|Hormones|hormones|mesh-ancestor
15187914|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187915|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187916|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187917|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
15187918|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15187919|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223813|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223814|NCT05189704|Analgesics|analgesics|mesh-ancestor
15223815|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
15223816|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223817|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
15223818|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15223819|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223820|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
15223821|NCT05167084|Metyrapone|metyrapone|mesh-list
15223822|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223823|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
15223824|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223825|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223826|NCT05165992|Fentanyl|fentanyl|mesh-list
15223827|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14293860|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14293861|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14293862|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223828|NCT05165992|Narcotics|narcotics|mesh-ancestor
14669640|NCT00274131|Pramipexole|pramipexole|mesh-list
14669641|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
14669642|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669643|NCT00274131|Protective Agents|protective agents|mesh-ancestor
14669644|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669645|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14669646|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14669647|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
14669648|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
14669649|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669650|NCT00274144|Telmisartan|telmisartan|mesh-list
14669651|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669652|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14669653|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14669654|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669655|NCT00274170|Octreotide|octreotide|mesh-list
14669656|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669657|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14669658|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669659|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
14669660|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
14669661|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14669662|NCT00274235|Mefloquine|mefloquine|mesh-list
14669663|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
14669664|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14669665|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14669666|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669667|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14669668|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726472|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14293863|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14293864|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14669669|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669670|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14669671|NCT00274235|Renal Agents|renal agents|mesh-ancestor
14669672|NCT00274274|Insulin|insulin|mesh-list
14669673|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14669674|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
14669675|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
14669676|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14669677|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187920|NCT03871153|Paclitaxel|paclitaxel|mesh-list
14293865|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
14293866|NCT00571701|Celecoxib|celecoxib|mesh-list
14293867|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14669678|NCT00274326|Satavaptan|satavaptan|mesh-list
14669679|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14669680|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669681|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
14669682|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669683|NCT00274339|Lansoprazole|lansoprazole|mesh-list
14669684|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14669685|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669686|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14669687|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669688|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669689|NCT00274352|Adalimumab|adalimumab|mesh-list
14669690|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669691|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14669692|NCT00274391|Amiloride|amiloride|mesh-list
15187921|NCT03871153|Carboplatin|carboplatin|mesh-list
15187922|NCT03871153|Durvalumab|durvalumab|mesh-list
15187923|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15187924|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187925|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
14669693|NCT00274391|Diuretics|diuretics|mesh-ancestor
14669694|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
14669695|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669696|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14669697|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14669698|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669699|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669700|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14669701|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14669702|NCT00274404|Valacyclovir|valacyclovir|mesh-list
14669703|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
14669704|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669705|NCT00274417|Dutasteride|dutasteride|mesh-list
14669706|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14669707|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14669708|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669709|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669710|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
14669711|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669712|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669713|NCT00274430|Dexamethasone|dexamethasone|mesh-list
14669714|NCT00274430|Tadalafil|tadalafil|mesh-list
14669715|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669716|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
14669717|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
14669718|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669719|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669720|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669721|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
14669722|NCT00274430|Hormones|hormones|mesh-ancestor
14669723|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669724|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14669725|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669726|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
14669727|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15187926|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
15187927|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
14293868|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14669728|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15223829|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14669729|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669730|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669731|NCT00274430|Urological Agents|urological agents|mesh-ancestor
14669732|NCT00274443|Carboplatin|carboplatin|mesh-list
14669733|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14669734|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669735|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
14669736|NCT00274495|Ribavirin|ribavirin|mesh-list
14669737|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14669738|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
14669739|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669740|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
15187928|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187929|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15187930|NCT03870581|Warfarin|warfarin|mesh-list
15187931|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
15187932|NCT03870711|Lidocaine|lidocaine|mesh-list
15187933|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
15187934|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
15187935|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15187936|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187937|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
14669741|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669742|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14669743|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669744|NCT00274508|Bromides|bromides|mesh-list
14669745|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
14293869|NCT00571701|Analgesics|analgesics|mesh-ancestor
14293870|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
14293871|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293872|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187938|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15187939|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15187940|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15187941|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15187942|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15187943|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187944|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
15187945|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15187946|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
15187947|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669746|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669747|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
14669748|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669749|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669750|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669751|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669752|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
14669753|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669754|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669755|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669756|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669757|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
14669758|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
14669759|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669760|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
14669761|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669762|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669763|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669764|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669765|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
14669766|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669767|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669768|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669769|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669770|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
14669771|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14669772|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669773|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
14669774|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669775|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669776|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15187948|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
14669777|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
15187949|NCT03870646|Protective Agents|protective agents|mesh-ancestor
15187950|NCT03870503|Misoprostol|misoprostol|mesh-list
15187951|NCT03870503|Oxytocin|oxytocin|mesh-list
15187952|NCT03870503|Carbetocin|carbetocin|mesh-list
15187953|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
15187954|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15187955|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187956|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15187957|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
15187958|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15187959|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187960|NCT03870490|Cefepime|cefepime|mesh-list
15187961|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15187962|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187963|NCT03870256|Misoprostol|misoprostol|mesh-list
15187964|NCT03870256|Carbetocin|carbetocin|mesh-list
15187965|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15187966|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
15187967|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15187968|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187969|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15187970|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15187971|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
15187972|NCT03870399|Tamoxifen|tamoxifen|mesh-list
15187973|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15187974|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
15187975|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15187976|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187977|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15187978|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187979|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15187980|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15187981|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15187982|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
15187983|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
15187984|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187985|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
15187986|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15187987|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15187988|NCT03869996|Cytarabine|cytarabine|mesh-list
15187989|NCT03869996|Methotrexate|methotrexate|mesh-list
15187990|NCT03869996|Etoposide|etoposide|mesh-list
15187991|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15187992|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
15187993|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15187994|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15187995|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
15187996|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15187997|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15187998|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
15187999|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188000|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14669778|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
14669779|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669780|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669781|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669782|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669783|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669784|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14669785|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14669786|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669787|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
14669788|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669789|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
14669790|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669791|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669792|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669793|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669794|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
14669795|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669796|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669797|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188001|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15188002|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15188003|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669798|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188004|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15188005|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
15188006|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15188007|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
15188008|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15188009|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188010|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15188011|NCT03869931|Fenofibrate|fenofibrate|mesh-list
15188012|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15188013|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
15188014|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188015|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15188016|NCT03869762|Denosumab|denosumab|mesh-list
15188017|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14669799|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
14669800|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14669801|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669802|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
14669803|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669804|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669805|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669806|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669807|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
15188018|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188019|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
15188020|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15188021|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
15188022|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
15188023|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188024|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188025|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188026|NCT03869736|Analgesics|analgesics|mesh-ancestor
15188027|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
15188028|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188029|NCT03869528|Lidocaine|lidocaine|mesh-list
15188030|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188031|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
15188032|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188033|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188034|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
15188035|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188036|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15188037|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15188038|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15188039|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669808|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669809|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669810|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669811|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669812|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14669813|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14669814|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14669815|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
14669816|NCT00274573|Bromides|bromides|mesh-list
14669817|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
14669818|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14669819|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
14669820|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669821|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669822|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14669823|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
14669824|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
14669825|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14669826|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
14669827|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669828|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669829|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
14726473|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726474|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726475|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
14726476|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
14726477|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15188040|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669830|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
14669831|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14669832|NCT00274599|Telmisartan|telmisartan|mesh-list
14669833|NCT00274599|Ramipril|ramipril|mesh-list
14669834|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669835|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14669836|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14669837|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669838|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14669839|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
14669840|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669841|NCT00274612|Telmisartan|telmisartan|mesh-list
14669842|NCT00274612|Ramipril|ramipril|mesh-list
14669843|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669844|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14669845|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14669846|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669847|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14669848|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
15188041|NCT03869281|Pancrelipase|pancrelipase|mesh-list
15188042|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188043|NCT03869398|Calcitriol|calcitriol|mesh-list
15188044|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15188045|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188046|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15188047|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15188048|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669849|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669850|NCT00274638|Losartan|losartan|mesh-list
14669851|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14669852|NCT00274638|Telmisartan|telmisartan|mesh-list
14669853|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14669854|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14669855|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14669856|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14669857|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669858|NCT00274638|Diuretics|diuretics|mesh-ancestor
14669859|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
14669860|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669861|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14669862|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669863|NCT00274677|Lamotrigine|lamotrigine|mesh-list
14669864|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
14669865|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14669866|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14669867|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669868|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14669869|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669870|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14669871|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14669872|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188049|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15188050|NCT03869398|Vitamins|vitamins|mesh-ancestor
15188051|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
15188052|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15188053|NCT03869268|Aspirin|aspirin|mesh-list
15188054|NCT03869268|Ticagrelor|ticagrelor|mesh-list
15188055|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15188056|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188057|NCT03869268|Analgesics|analgesics|mesh-ancestor
15188058|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
14293873|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293874|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14293875|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14669873|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14293876|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14293877|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293878|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293879|NCT00571961|Ritonavir|ritonavir|mesh-list
14293880|NCT00571961|Lopinavir|lopinavir|mesh-list
14293881|NCT00571961|Buprenorphine|buprenorphine|mesh-list
14293882|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14293883|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14293884|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
15188059|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188060|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188061|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188062|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188063|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15188064|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15188065|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188066|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15188067|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15188068|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188069|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
15188070|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15188071|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15188072|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15188073|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
15188074|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188075|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
14669874|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14669875|NCT00274690|Casopitant|casopitant|mesh-list
14669876|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
14669877|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
14669878|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669879|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669880|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669881|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14669882|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14669883|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669884|NCT00274794|Rituximab|rituximab|mesh-list
14669885|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14669886|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669887|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
14669888|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293885|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669889|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14669890|NCT00274807|Cytarabine|cytarabine|mesh-list
14327520|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669891|NCT00274807|Etoposide|etoposide|mesh-list
14669892|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
14669893|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15188076|NCT03869047|Bupivacaine|bupivacaine|mesh-list
15188077|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188078|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
15188079|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188080|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188081|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
15188082|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188083|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15188084|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188085|NCT03869047|Analgesics|analgesics|mesh-ancestor
15188086|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15188087|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15188088|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15188089|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
15188090|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188091|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223830|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223831|NCT05165992|Analgesics|analgesics|mesh-ancestor
15223832|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
15223833|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223834|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15223835|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15223836|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
15223837|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
15223838|NCT05154968|Mannitol|mannitol|mesh-list
15223839|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15223840|NCT05154968|Diuretics|diuretics|mesh-ancestor
15223841|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
15223842|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223843|NCT05118256|Pirfenidone|pirfenidone|mesh-list
15223844|NCT05118256|Analgesics|analgesics|mesh-ancestor
15223845|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
15223846|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669894|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669895|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14669896|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14669897|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223847|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223848|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15223849|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15223850|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223851|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15223852|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223853|NCT05106335|Docetaxel|docetaxel|mesh-list
15223854|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223855|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
15223856|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
15223857|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
15223858|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223859|NCT05096845|Vaccines|vaccines|mesh-list
15223860|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
15223861|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223862|NCT05096832|Vaccines|vaccines|mesh-list
15223863|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
15223864|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223865|NCT05060965|Nicotine|nicotine|mesh-list
15223866|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15223867|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
15223868|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223869|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223870|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15223871|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15223872|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
15223873|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223874|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669898|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669899|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14669900|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
14669901|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
14669902|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669903|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223875|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15223876|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15188092|NCT03868852|Apatinib|apatinib|mesh-list
15188093|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188094|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15188095|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188096|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188097|NCT03869073|Evolocumab|evolocumab|mesh-list
15188098|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15188099|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15188100|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
15188101|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188102|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15188103|NCT03868969|Fosfomycin|fosfomycin|mesh-list
15188104|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15188105|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188106|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
15188107|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15188108|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
15188109|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
15188110|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188111|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188112|NCT03868722|Venetoclax|venetoclax|mesh-list
15188113|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
15188114|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669904|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
14669905|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669906|NCT00274807|Analgesics|analgesics|mesh-ancestor
14669907|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
14669908|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669909|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
14669910|NCT00274820|Thalidomide|thalidomide|mesh-list
14669911|NCT00274820|Dexamethasone|dexamethasone|mesh-list
14327521|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669912|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
14669913|NCT00274820|Vitamins|vitamins|mesh-ancestor
14669914|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
14669915|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669916|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669917|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
14669918|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
14669919|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669920|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14669921|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
14669922|NCT00274820|Hormones|hormones|mesh-ancestor
14669923|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14669924|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14669925|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669926|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
14669927|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669928|NCT00274820|Protective Agents|protective agents|mesh-ancestor
14669929|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14669930|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
14669931|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
14669932|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14669933|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669934|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14669935|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14669936|NCT00274820|Growth Substances|growth substances|mesh-ancestor
14669937|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14669938|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14669939|NCT00274833|Temozolomide|temozolomide|mesh-list
14669940|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188115|NCT03868072|Tofacitinib|tofacitinib|mesh-list
15188116|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14669941|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14669942|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669943|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669944|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15188117|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188118|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188119|NCT03868124|Travoprost|travoprost|mesh-list
15188120|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15188121|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15188122|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15188123|NCT03868137|Ibuprofen|ibuprofen|mesh-list
15188124|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15188125|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188126|NCT03868137|Analgesics|analgesics|mesh-ancestor
15188127|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
14669945|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
14669946|NCT00274859|Gemcitabine|gemcitabine|mesh-list
15188128|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188129|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188130|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188131|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188132|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15188133|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188134|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188135|NCT03868111|Sufentanil|sufentanil|mesh-list
15188136|NCT03868111|Remifentanil|remifentanil|mesh-list
14669947|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
14669948|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14669949|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
14669950|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669951|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669952|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
14669953|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14669954|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669955|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14669956|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
14669957|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669958|NCT00274872|Leucovorin|leucovorin|mesh-list
14669959|NCT00274872|Fluorouracil|fluorouracil|mesh-list
14669960|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
14669961|NCT00274872|Calcium|calcium|mesh-list
14669962|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
14669963|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14669964|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669965|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
14669966|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669967|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14669968|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669969|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14669970|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
14669971|NCT00274872|Antidotes|antidotes|mesh-ancestor
14669972|NCT00274872|Protective Agents|protective agents|mesh-ancestor
14669973|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
14669974|NCT00274872|Vitamins|vitamins|mesh-ancestor
14669975|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
14669976|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
14669977|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669978|NCT00274898|Celecoxib|celecoxib|mesh-list
14669979|NCT00274898|Docetaxel|docetaxel|mesh-list
14669980|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669981|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14669982|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14669983|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14669984|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14669985|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14669986|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14669987|NCT00274898|Analgesics|analgesics|mesh-ancestor
14669988|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
14669989|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14669990|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14669991|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14669992|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14669993|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14726478|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
14669994|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14669995|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14669996|NCT00274911|Vincristine|vincristine|mesh-list
14669997|NCT00274911|Lomustine|lomustine|mesh-list
14669998|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14669999|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670000|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670001|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670002|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670003|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670004|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670005|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
14670006|NCT00274950|Carboplatin|carboplatin|mesh-list
15188137|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15188138|NCT03868111|Narcotics|narcotics|mesh-ancestor
15188139|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188140|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188141|NCT03868111|Analgesics|analgesics|mesh-ancestor
15188142|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
15188143|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188144|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15188145|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15188146|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
15188147|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
15188148|NCT03868202|Estradiol|estradiol|mesh-list
15188149|NCT03868202|Progesterone|progesterone|mesh-list
15188150|NCT03868202|Estrogens|estrogens|mesh-ancestor
15188151|NCT03868202|Hormones|hormones|mesh-ancestor
15188152|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15188153|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188154|NCT03868202|Progestins|progestins|mesh-ancestor
15188155|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
15188156|NCT03868033|Denosumab|denosumab|mesh-list
15188157|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15188158|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188159|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15188160|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188161|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188162|NCT03867929|Vitamin D|vitamin d|mesh-list
15188163|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
15188164|NCT03867929|Calcifediol|calcifediol|mesh-list
15188165|NCT03867929|Vitamins|vitamins|mesh-ancestor
15188166|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
15188167|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188168|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15188169|NCT03867994|Carvedilol|carvedilol|mesh-list
14293886|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293887|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14293888|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14293889|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
14293890|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14293891|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14293892|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15188170|NCT03867994|Atorvastatin|atorvastatin|mesh-list
15188171|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15188172|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15188173|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
15188174|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188175|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15188176|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15188177|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188178|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15188179|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15188180|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
15188181|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188182|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188183|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15188184|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
15188185|NCT03867994|Protective Agents|protective agents|mesh-ancestor
15188186|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15188187|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15188188|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15188189|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
14670007|NCT00274950|Etoposide|etoposide|mesh-list
14670008|NCT00274950|Ifosfamide|ifosfamide|mesh-list
15188190|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15188191|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15188192|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15188193|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
15188194|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188195|NCT03867695|Ropivacaine|ropivacaine|mesh-list
15188196|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188197|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
15188198|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188199|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188200|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
15188201|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670009|NCT00274950|Bleomycin|bleomycin|mesh-list
14670010|NCT00274950|Vinblastine|vinblastine|mesh-list
14670011|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670012|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670013|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670014|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670015|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670016|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670017|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670018|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
14670019|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670020|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670021|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670022|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670023|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14670024|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
14670025|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670026|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
14670027|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670028|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670029|NCT00274963|Analgesics|analgesics|mesh-ancestor
14670030|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
14670031|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670032|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670033|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670034|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670035|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670036|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
14670037|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670038|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670039|NCT00274989|Rituximab|rituximab|mesh-list
14670040|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14670041|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670042|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670043|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
14670044|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670045|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670046|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670047|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
14670048|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670049|NCT00275015|Cytarabine|cytarabine|mesh-list
14670050|NCT00275015|Dexamethasone|dexamethasone|mesh-list
14670051|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
14670052|NCT00275015|Melphalan|melphalan|mesh-list
14670053|NCT00275015|Carmustine|carmustine|mesh-list
14670054|NCT00275015|Fludarabine|fludarabine|mesh-list
14670055|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
14670056|NCT00275015|Etoposide|etoposide|mesh-list
14670057|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670058|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
14670059|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670060|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670061|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670062|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
15188202|NCT03867799|Nivolumab|nivolumab|mesh-list
14670063|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670064|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670065|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14670066|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14670067|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
14670068|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
14670069|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670070|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14670071|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
14670072|NCT00275015|Hormones|hormones|mesh-ancestor
14670073|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670074|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14670075|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670076|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
14670077|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670078|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670079|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670080|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670081|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
14670082|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670083|NCT00275041|Irinotecan|irinotecan|mesh-list
14670084|NCT00275041|Cetuximab|cetuximab|mesh-list
14670085|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14670086|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670087|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670088|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670089|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670090|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670091|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
15188203|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15188204|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188205|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15188206|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188207|NCT03867851|Heparin|heparin|mesh-list
14670092|NCT00275054|Rituximab|rituximab|mesh-list
14670093|NCT00275054|Fludarabine|fludarabine|mesh-list
14670094|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670095|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
14670096|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188208|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
15188209|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15188210|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15188211|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188212|NCT03867097|Iloprost|iloprost|mesh-list
15188213|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15188214|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
15188215|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
15188216|NCT03867071|Hematinics|hematinics|mesh-ancestor
15188217|NCT03867370|Lenvatinib|lenvatinib|mesh-list
15188218|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188219|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15188220|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188221|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188222|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
15188223|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15188224|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188225|NCT03867214|Tranexamic Acid|tranexamic acid|mesh-list
15188226|NCT03867214|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15188227|NCT03867214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15188228|NCT03867214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188229|NCT03867214|Hemostatics|hemostatics|mesh-ancestor
15188230|NCT03867214|Coagulants|coagulants|mesh-ancestor
15188231|NCT03867123|Temozolomide|temozolomide|mesh-list
15188232|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15188233|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
15188234|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188235|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223877|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
15223878|NCT05042947|Hormones|hormones|mesh-ancestor
15223879|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223880|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223881|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670097|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188236|NCT03867240|Gabapentin|gabapentin|mesh-list
15188237|NCT03867240|Analgesics|analgesics|mesh-ancestor
15188238|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
15188239|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188240|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188241|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
15188242|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15188243|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15188244|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188245|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15188246|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15188247|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15188248|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188249|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188250|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
15188251|NCT03866980|Carboplatin|carboplatin|mesh-list
15188252|NCT03866980|Pemetrexed|pemetrexed|mesh-list
15188253|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188254|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188255|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188256|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15188257|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14670098|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670099|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
14670100|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670101|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670102|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14670103|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670104|NCT00275067|Temozolomide|temozolomide|mesh-list
14670105|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
14670106|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670107|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
14670108|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670109|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670110|NCT00275080|Decitabine|decitabine|mesh-list
14670111|NCT00275080|Azacitidine|azacitidine|mesh-list
14670112|NCT00275080|Vorinostat|vorinostat|mesh-list
14670113|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670114|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
14670115|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670116|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670117|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670118|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14670119|NCT00275093|Sirolimus|sirolimus|mesh-list
14670120|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14670121|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670122|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670123|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670124|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
14670125|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670126|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
14670127|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670128|NCT00275106|Leucovorin|leucovorin|mesh-list
14670129|NCT00275106|Cytarabine|cytarabine|mesh-list
14670130|NCT00275106|Dexamethasone|dexamethasone|mesh-list
14670131|NCT00275106|Prednisolone|prednisolone|mesh-list
14670132|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
14670133|NCT00275106|Doxorubicin|doxorubicin|mesh-list
14670134|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14670135|NCT00275106|Methotrexate|methotrexate|mesh-list
14670136|NCT00275106|Vincristine|vincristine|mesh-list
14670137|NCT00275106|Daunorubicin|daunorubicin|mesh-list
14670138|NCT00275106|Asparaginase|asparaginase|mesh-list
14670139|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
14670140|NCT00275106|Thioguanine|thioguanine|mesh-list
14670141|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
14670142|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670143|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
14670144|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670145|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670146|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670147|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
15188258|NCT03866993|Paclitaxel|paclitaxel|mesh-list
14670148|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670149|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670150|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14670151|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14670152|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
14670153|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
14670154|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670155|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14670156|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
15188259|NCT03866993|Carboplatin|carboplatin|mesh-list
15188260|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15188261|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188262|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
15188263|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
15188264|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
15188265|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670157|NCT00275106|Hormones|hormones|mesh-ancestor
14670158|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670159|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14670160|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670161|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670162|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670163|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670164|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14670165|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
14670166|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14670167|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670168|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
14670169|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14670170|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14670171|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14670172|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
14670173|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670174|NCT00275106|Antidotes|antidotes|mesh-ancestor
14670175|NCT00275106|Protective Agents|protective agents|mesh-ancestor
14670176|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
14670177|NCT00275106|Vitamins|vitamins|mesh-ancestor
14670178|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
14670179|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670180|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670181|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670182|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670183|NCT00275119|Gemcitabine|gemcitabine|mesh-list
14670184|NCT00275119|Fluorouracil|fluorouracil|mesh-list
14670185|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
14670186|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670187|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
14670188|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670189|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670190|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
14670191|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188266|NCT03866928|Stiripentol|stiripentol|mesh-list
15188267|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
15188268|NCT03866746|Aflibercept|aflibercept|mesh-list
15188269|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14670192|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670193|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670194|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
14670195|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188270|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15188271|NCT03866746|Growth Substances|growth substances|mesh-ancestor
15188272|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188273|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
15188274|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188275|NCT03866837|Micronutrients|micronutrients|mesh-list
15188276|NCT03866837|Trace Elements|trace elements|mesh-list
15188277|NCT03866837|Lactoferrin|lactoferrin|mesh-list
15188278|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188279|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188280|NCT03866681|Sirolimus|sirolimus|mesh-list
15188281|NCT03866681|Warfarin|warfarin|mesh-list
15188282|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15188283|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188284|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670196|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14670197|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670198|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14670199|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670200|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670201|NCT00275184|Metoclopramide|metoclopramide|mesh-list
15188285|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188286|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
15188287|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15188288|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
15188289|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188290|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
15188291|NCT03866629|Lifitegrast|lifitegrast|mesh-list
15188292|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15188293|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15188294|NCT03866733|Narcotics|narcotics|mesh-list
15188295|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188296|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188297|NCT03866733|Analgesics|analgesics|mesh-ancestor
15188298|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
15188299|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188300|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
15188301|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15188302|NCT03866577|Antibodies|antibodies|mesh-list
15188303|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
15188304|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15188305|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
15188306|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188307|NCT03866772|Misoprostol|misoprostol|mesh-list
15188308|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15188309|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
15188310|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15188311|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670202|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
14670203|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
14670204|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670205|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670206|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14670207|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14670208|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14670209|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
15188312|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15188313|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188314|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
15188315|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
15188316|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15188317|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670210|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670211|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670212|NCT00275197|Sertraline|sertraline|mesh-list
14670213|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
14670214|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670215|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14670216|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15188318|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15188319|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15188320|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188321|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188322|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670217|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670218|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670219|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670220|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
14670221|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670222|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
14670223|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670224|NCT00275236|Rotigotine|rotigotine|mesh-list
15188323|NCT03866525|Irinotecan|irinotecan|mesh-list
15188324|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15188325|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15188326|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188327|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670225|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
14670226|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
14670227|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670228|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670229|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670230|NCT00275249|Levorphanol|levorphanol|mesh-list
14670231|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14670232|NCT00275249|Narcotics|narcotics|mesh-ancestor
14670233|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14670234|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670235|NCT00275249|Analgesics|analgesics|mesh-ancestor
14670236|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
14670237|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670238|NCT00275314|Valganciclovir|valganciclovir|mesh-list
14670239|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
14670240|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670241|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
14670242|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
14670243|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670244|NCT00275405|Protective Agents|protective agents|mesh-ancestor
14670245|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670246|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14670247|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670248|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14670249|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670250|NCT00275418|Beta Carotene|beta carotene|mesh-list
14670251|NCT00275418|Carotenoids|carotenoids|mesh-list
14670252|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
14670253|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670254|NCT00275418|Protective Agents|protective agents|mesh-ancestor
14670255|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670256|NCT00275418|Provitamins|provitamins|mesh-ancestor
14670257|NCT00275418|Vitamins|vitamins|mesh-ancestor
14670258|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
14670259|NCT00275444|Tipranavir|tipranavir|mesh-list
14670260|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14670261|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14670262|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
14670263|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670264|NCT00275457|Pramipexole|pramipexole|mesh-list
14670265|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
14670266|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670267|NCT00275457|Protective Agents|protective agents|mesh-ancestor
14670268|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188328|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188329|NCT03866421|Liver Extracts|liver extracts|mesh-list
15188330|NCT03866421|Hematinics|hematinics|mesh-ancestor
15188331|NCT03866408|Pioglitazone|pioglitazone|mesh-list
15188332|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15188333|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188334|NCT03866447|Vitamin D|vitamin d|mesh-list
15188335|NCT03866447|Adapalene|adapalene|mesh-list
15188336|NCT03866447|Vitamins|vitamins|mesh-ancestor
15188337|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
15188338|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188339|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15188340|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14670269|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14670270|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14670271|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
14670272|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
14670273|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670274|NCT00275522|Sirolimus|sirolimus|mesh-list
14670275|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14670276|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670277|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670278|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670279|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
14670280|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670281|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
14670282|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670283|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
14670284|NCT00275535|Sirolimus|sirolimus|mesh-list
14670285|NCT00275535|Prednisone|prednisone|mesh-list
14670286|NCT00275535|Tacrolimus|tacrolimus|mesh-list
14670287|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
14670288|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14670289|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14670290|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
14670291|NCT00275535|Hormones|hormones|mesh-ancestor
14670292|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670293|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670294|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14670295|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670296|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670297|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
14670298|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14670299|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670300|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670301|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670302|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14670303|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
14670304|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14670305|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670306|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
14670307|NCT00275548|Ribavirin|ribavirin|mesh-list
14670308|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14670309|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
14670310|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670311|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
14670312|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670313|NCT00275600|Vitamin E|vitamin e|mesh-list
14670314|NCT00275600|Vitamins|vitamins|mesh-ancestor
14670315|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
14670316|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670317|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
14670318|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670319|NCT00275600|Protective Agents|protective agents|mesh-ancestor
14670320|NCT00275613|Rituximab|rituximab|mesh-list
14670321|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670322|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188341|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188342|NCT03866447|Analgesics|analgesics|mesh-ancestor
15188343|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
15188344|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188345|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188346|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188347|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
15188348|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15188349|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
15188350|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188351|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15188352|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15188353|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
15188354|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188355|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188356|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15188357|NCT03865992|Curcumin|curcumin|mesh-list
15188358|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15188359|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188360|NCT03865992|Analgesics|analgesics|mesh-ancestor
15188361|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
15188362|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188363|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188364|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188365|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188366|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188367|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188368|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188369|NCT03865888|Cyclosporine|cyclosporine|mesh-list
14670323|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
14670324|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670325|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670326|NCT00275639|Losartan|losartan|mesh-list
14670327|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14670328|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14670329|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14670330|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14670331|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670332|NCT00275652|Lamivudine|lamivudine|mesh-list
14670333|NCT00275652|Telbivudine|telbivudine|mesh-list
14670334|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14670335|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14670336|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670337|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670338|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
14670339|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670340|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14670341|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14670342|NCT00275665|Valganciclovir|valganciclovir|mesh-list
14670343|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
14670344|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670345|NCT00275730|Indomethacin|indomethacin|mesh-list
14670346|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14670347|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14670348|NCT00275730|Analgesics|analgesics|mesh-ancestor
14670349|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
14670350|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670351|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670352|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14670353|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670354|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
14670355|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
14670356|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14670357|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14670358|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670359|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670360|NCT00275756|Timolol|timolol|mesh-list
14670361|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14670362|NCT00275756|Dorzolamide|dorzolamide|mesh-list
14670363|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14670364|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14670365|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
14670366|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188370|NCT03865888|Tacrolimus|tacrolimus|mesh-list
14670367|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188371|NCT03865888|Cyclosporins|cyclosporins|mesh-list
15188372|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15188373|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
15188374|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188375|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15188376|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188377|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188378|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
15188379|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188380|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
15188381|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188382|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15188383|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15188384|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188385|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
15188386|NCT03865615|Oxytocin|oxytocin|mesh-list
15188387|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
15188388|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15188389|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188390|NCT03865550|Ketamine|ketamine|mesh-list
15188391|NCT03865550|Analgesics|analgesics|mesh-ancestor
15188392|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
15188393|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188394|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188395|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15188396|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15188397|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
15188398|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
14670368|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670369|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14670370|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14670371|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14670372|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14670373|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14670374|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14670375|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670376|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
14670377|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
14670378|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14670379|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14670380|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670381|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670382|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14670383|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14670384|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
14670385|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
14670386|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14670387|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14670388|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670389|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670390|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14670391|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14670392|NCT00275938|Interferons|interferons|mesh-list
14670393|NCT00275938|Ribavirin|ribavirin|mesh-list
14670394|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
14670395|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
14670396|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670397|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
14670398|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670399|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
14670400|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670401|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
14670402|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670403|NCT00275951|Cetuximab|cetuximab|mesh-list
14670404|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15188399|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188400|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15188401|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15188402|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188403|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188404|NCT03865563|Gemcitabine|gemcitabine|mesh-list
15188405|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
15188406|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15188407|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
15188408|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188409|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188410|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
15188411|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188412|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188413|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15188414|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
15188415|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670405|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670406|NCT00276003|Gemcitabine|gemcitabine|mesh-list
14670407|NCT00276003|Irinotecan|irinotecan|mesh-list
14670408|NCT00276003|Allopurinol|allopurinol|mesh-list
14670409|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670410|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
14670411|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670412|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670413|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
14670414|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670415|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670416|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670417|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
14670418|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670419|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14670420|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670421|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
14670422|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670423|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14670424|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
14670425|NCT00276003|Protective Agents|protective agents|mesh-ancestor
14670426|NCT00276029|Etanercept|etanercept|mesh-list
14670427|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14670428|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14670429|NCT00276029|Analgesics|analgesics|mesh-ancestor
14670430|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
14670431|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670432|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670433|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14670434|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670435|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14670436|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670437|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
14670438|NCT00276055|Gemcitabine|gemcitabine|mesh-list
14670439|NCT00276055|Bevacizumab|bevacizumab|mesh-list
14670440|NCT00276055|Docetaxel|docetaxel|mesh-list
14670441|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670442|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670443|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14670444|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14670445|NCT00276055|Growth Substances|growth substances|mesh-ancestor
14670446|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188416|NCT03865680|Fluorides|fluorides|mesh-list
14670447|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
14670448|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670449|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
14910539|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
14293893|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14293894|NCT00571961|Narcotics|narcotics|mesh-ancestor
14293895|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14293896|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293897|NCT00571961|Analgesics|analgesics|mesh-ancestor
14293898|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
14293899|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293900|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14293901|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14670450|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670451|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
14670452|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670453|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670454|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670455|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
14670456|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670457|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670458|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670459|NCT00276068|Lidocaine|lidocaine|mesh-list
14670460|NCT00276068|Desipramine|desipramine|mesh-list
14670461|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
14293902|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14670462|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
14670463|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14670464|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670465|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
14670466|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670467|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14670468|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14670469|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14670470|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670471|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670472|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14670473|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
14670474|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670475|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188417|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
15188418|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
15188419|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
15188420|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188421|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
15188422|NCT03865680|Protective Agents|protective agents|mesh-ancestor
15188423|NCT03865732|Pregnanolone|pregnanolone|mesh-list
15188424|NCT03865732|Ganaxolone|ganaxolone|mesh-list
15188425|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
15188426|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188427|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670476|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14670477|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14670478|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
14670479|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670480|NCT00276081|Gabapentin|gabapentin|mesh-list
14670481|NCT00276081|Estrogens|estrogens|mesh-list
14670482|NCT00276081|Analgesics|analgesics|mesh-ancestor
14670483|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
14670484|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670485|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670486|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
14670487|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14670488|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14670489|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14670490|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670491|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14670492|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14670493|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670494|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670495|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
14670496|NCT00276081|Hormones|hormones|mesh-ancestor
14670497|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670498|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14670499|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
14670500|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670501|NCT00276133|Atorvastatin|atorvastatin|mesh-list
14670502|NCT00276133|Probucol|probucol|mesh-list
14670503|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14670504|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14670505|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
14670506|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670507|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14670508|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14670509|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670510|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
14670511|NCT00276133|Protective Agents|protective agents|mesh-ancestor
14670512|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670513|NCT00276146|Dipyridamole|dipyridamole|mesh-list
14670514|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14670515|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670516|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670517|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14670518|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
14670519|NCT00276172|Natalizumab|natalizumab|mesh-list
14670520|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
14670521|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670522|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
14670523|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14670524|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670525|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670526|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
14670527|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670528|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670529|NCT00276198|Vitamin D|vitamin d|mesh-list
14670530|NCT00276198|Vitamin A|vitamin a|mesh-list
14670531|NCT00276198|Vitamins|vitamins|mesh-ancestor
14670532|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
14670533|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670534|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14670535|NCT00276276|Topotecan|topotecan|mesh-list
14670536|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14670537|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670538|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670539|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670540|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670541|NCT00276289|Spironolactone|spironolactone|mesh-list
14670542|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14670543|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
14670544|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670545|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670546|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14670547|NCT00276289|Diuretics|diuretics|mesh-ancestor
14670548|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
14726479|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14726480|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726481|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726482|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14726483|NCT00509015|Renal Agents|renal agents|mesh-ancestor
14726484|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14726485|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14726486|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
14726487|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726488|NCT00509158|Antacids|antacids|mesh-ancestor
14726489|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726490|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14726491|NCT00509184|Rituximab|rituximab|mesh-list
14726492|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726493|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726494|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
14726495|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726496|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726497|NCT00509327|Bisacodyl|bisacodyl|mesh-list
14726498|NCT00509327|Cathartics|cathartics|mesh-ancestor
14726499|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14726500|NCT00509327|Laxatives|laxatives|mesh-ancestor
14726501|NCT00509353|Irinotecan|irinotecan|mesh-list
14726502|NCT00509353|Vincristine|vincristine|mesh-list
14726503|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14726504|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14726505|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726506|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726507|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726508|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726509|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14726510|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
14726511|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
14726512|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
14726513|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14726514|NCT00509379|Rituximab|rituximab|mesh-list
14726515|NCT00509379|Bortezomib|bortezomib|mesh-list
14726516|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726517|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726518|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
14726519|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726520|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726521|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
14726522|NCT00509405|Diuretics|diuretics|mesh-ancestor
14726523|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
14726524|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726525|NCT00509405|Expectorants|expectorants|mesh-ancestor
14726526|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
14726527|NCT00509431|Sirolimus|sirolimus|mesh-list
14726528|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14726529|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726530|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726531|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726532|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726533|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14726534|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726535|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14726536|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
14726537|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726538|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
14726539|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726540|NCT00509470|Amlodipine|amlodipine|mesh-list
14670549|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
14670550|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15188428|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188429|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
15188430|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
15188431|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
15188432|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188433|NCT03865511|Osimertinib|osimertinib|mesh-list
15188434|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188435|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15188436|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188437|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188438|NCT03865290|Ondansetron|ondansetron|mesh-list
15188439|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
15188440|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
15188441|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188442|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188443|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188444|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
15188445|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
15188446|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15188447|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
15188448|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188449|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188450|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15188451|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15188452|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188453|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15188454|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15188455|NCT03865160|Atropine|atropine|mesh-list
15188456|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15188457|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15188458|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15188459|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15188460|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15188461|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
15188462|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188463|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188464|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15188465|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
15188466|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
15188467|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
15188468|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15188469|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15188470|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
15188471|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188472|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223882|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225669|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225670|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225671|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15225672|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
15225673|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293903|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
14293904|NCT00572117|Topiramate|topiramate|mesh-list
14293905|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
14293906|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293907|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293908|NCT00572156|Mecasermin|mecasermin|mesh-list
14293909|NCT00572156|Growth Substances|growth substances|mesh-ancestor
14670551|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15225674|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15225675|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
15225676|NCT04020809|Atezolizumab|atezolizumab|mesh-list
15225677|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225678|NCT04005209|Ketamine|ketamine|mesh-list
15225679|NCT04005209|Analgesics|analgesics|mesh-ancestor
15225680|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
15225681|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225682|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225683|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15225684|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15225685|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
14293910|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293911|NCT00572234|Bupropion|bupropion|mesh-list
14726541|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15188473|NCT03865004|Acetaminophen|acetaminophen|mesh-list
15188474|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15188475|NCT03865004|Morphine|morphine|mesh-list
15188476|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15188477|NCT03865004|Narcotics|narcotics|mesh-ancestor
15188478|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188479|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188480|NCT03865004|Analgesics|analgesics|mesh-ancestor
15188481|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
15188482|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188483|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14670552|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14670553|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670554|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670555|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
14670556|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670557|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670558|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14670559|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670560|NCT00276393|Insulin|insulin|mesh-list
14670561|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14670562|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670563|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
14670564|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14670565|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
14670566|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670567|NCT00276497|Pioglitazone|pioglitazone|mesh-list
14670568|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14670569|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670570|NCT00276523|Interferons|interferons|mesh-list
14670571|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
14670572|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
14670573|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14670574|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670575|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
14670576|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670577|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
14670578|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670579|NCT00276536|Interferons|interferons|mesh-list
14670580|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
14670581|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14670582|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670583|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
14670584|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670585|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
14670586|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670587|NCT00276575|Bevacizumab|bevacizumab|mesh-list
14670588|NCT00276575|Everolimus|everolimus|mesh-list
14670589|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14670590|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670591|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670592|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14670593|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14670594|NCT00276575|Growth Substances|growth substances|mesh-ancestor
14670595|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188484|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
15188485|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14670596|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
14670597|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15188486|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188487|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188488|NCT03864913|Testosterone|testosterone|mesh-list
15188489|NCT03864913|Androgens|androgens|mesh-ancestor
15188490|NCT03864913|Hormones|hormones|mesh-ancestor
15188491|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15188492|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188493|NCT03865147|Acetaminophen|acetaminophen|mesh-list
15188494|NCT03865147|Cetrimonium|cetrimonium|mesh-list
15188495|NCT03865147|Ibuprofen|ibuprofen|mesh-list
15188496|NCT03865147|Lidocaine|lidocaine|mesh-list
15188497|NCT03865147|Epinephrine|epinephrine|mesh-list
15188498|NCT03865147|Racepinephrine|racepinephrine|mesh-list
15188499|NCT03865147|Bupivacaine|bupivacaine|mesh-list
15188500|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15188501|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
15188502|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188503|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
15188504|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188505|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188506|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
15188507|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188508|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15188509|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15188510|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15188511|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15188512|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188513|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15188514|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188515|NCT03865147|Analgesics|analgesics|mesh-ancestor
15188516|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188517|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188518|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15188519|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188520|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
15188521|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15188522|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14670598|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
14670599|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14670600|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670601|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670602|NCT00276588|Gemcitabine|gemcitabine|mesh-list
14670603|NCT00276588|Paclitaxel|paclitaxel|mesh-list
14670604|NCT00276588|Carboplatin|carboplatin|mesh-list
14670605|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670606|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670607|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670608|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670609|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670610|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670611|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670612|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
14670613|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
14670614|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670615|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670616|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670617|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
14670618|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670619|NCT00276601|Cytarabine|cytarabine|mesh-list
14670620|NCT00276601|Methotrexate|methotrexate|mesh-list
14670621|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
14670622|NCT00276601|Daunorubicin|daunorubicin|mesh-list
14670623|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
14670624|NCT00276601|Tretinoin|tretinoin|mesh-list
14670625|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14670626|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
14670627|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14670628|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670629|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670630|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
15188523|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
15188524|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670631|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670632|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670633|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
14670634|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670635|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14670636|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670637|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
14670638|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670639|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14670640|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
14670641|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670642|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670643|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670644|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670645|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
14670646|NCT00276640|Carboplatin|carboplatin|mesh-list
14670647|NCT00276640|Etoposide|etoposide|mesh-list
14670648|NCT00276640|Vincristine|vincristine|mesh-list
14670649|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670650|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670651|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670652|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670653|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670654|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670655|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670656|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670657|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670658|NCT00276666|Vincristine|vincristine|mesh-list
14670659|NCT00276666|Lomustine|lomustine|mesh-list
14670660|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670661|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670662|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670663|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670664|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670665|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670666|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670667|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
14670668|NCT00276679|Temozolomide|temozolomide|mesh-list
14670669|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670670|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
14670671|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670672|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670673|NCT00276692|Irinotecan|irinotecan|mesh-list
14670674|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14670675|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670676|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670677|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670678|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670679|NCT00276705|Thalidomide|thalidomide|mesh-list
14670680|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
14670681|NCT00276705|Doxorubicin|doxorubicin|mesh-list
14670682|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14670683|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670684|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
14670685|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670686|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670687|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670688|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
14670689|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670690|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670691|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14670692|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670693|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670694|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670695|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670696|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
14670697|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14670698|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670699|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14670700|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14670701|NCT00276705|Growth Substances|growth substances|mesh-ancestor
14670702|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
14670703|NCT00276718|Carboplatin|carboplatin|mesh-list
14670704|NCT00276718|Etoposide|etoposide|mesh-list
14670705|NCT00276718|Bleomycin|bleomycin|mesh-list
14670706|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670707|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670708|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14726542|NCT00509470|Telmisartan|telmisartan|mesh-list
14670709|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670710|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670711|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670712|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14670713|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
14670714|NCT00276731|Carboplatin|carboplatin|mesh-list
14670715|NCT00276731|Etoposide|etoposide|mesh-list
14670716|NCT00276731|Vincristine|vincristine|mesh-list
14670717|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670718|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
14670719|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670720|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670721|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670722|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
14670723|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670724|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670725|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14670726|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670727|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670728|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670729|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670730|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670731|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670732|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670733|NCT00276757|Leucovorin|leucovorin|mesh-list
14670734|NCT00276757|Prednisolone|prednisolone|mesh-list
14670735|NCT00276757|Methotrexate|methotrexate|mesh-list
14670736|NCT00276757|Vinblastine|vinblastine|mesh-list
14670737|NCT00276757|Calcium|calcium|mesh-list
14670738|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
14670739|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14670740|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670741|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14670742|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
14670743|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14670744|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670745|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
14670746|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670747|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670748|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
14670749|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670750|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14670751|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670752|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
14670753|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670754|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14670755|NCT00276757|Antidotes|antidotes|mesh-ancestor
14670756|NCT00276757|Protective Agents|protective agents|mesh-ancestor
14670757|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
14670758|NCT00276757|Vitamins|vitamins|mesh-ancestor
14670759|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
14670760|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14670761|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
14670762|NCT00276757|Hormones|hormones|mesh-ancestor
14670763|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670764|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14670765|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670766|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670767|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670768|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670769|NCT00276770|Fluorides|fluorides|mesh-list
14670770|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
14670771|NCT00276770|Protective Agents|protective agents|mesh-ancestor
14670772|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670773|NCT00276783|Pemetrexed|pemetrexed|mesh-list
14670774|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670775|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670776|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670777|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14670778|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14670779|NCT00276796|Paclitaxel|paclitaxel|mesh-list
14670780|NCT00276796|Topotecan|topotecan|mesh-list
14670781|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670782|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670783|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670784|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670785|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670786|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670787|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14670788|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670789|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670790|NCT00276809|Cytarabine|cytarabine|mesh-list
14670791|NCT00276809|Dexamethasone|dexamethasone|mesh-list
14670792|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
14670793|NCT00276809|Melphalan|melphalan|mesh-list
14670794|NCT00276809|Carmustine|carmustine|mesh-list
14670795|NCT00276809|Fludarabine|fludarabine|mesh-list
14670796|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
14670797|NCT00276809|Etoposide|etoposide|mesh-list
14670798|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
14670799|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670800|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
14670801|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670802|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670803|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670804|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
14670805|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670806|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670807|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14670808|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14670809|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
14670810|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
14670811|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670812|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14670813|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
14670814|NCT00276809|Hormones|hormones|mesh-ancestor
14670815|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670816|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14670817|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670818|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
14670819|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670820|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14670821|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670822|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670823|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
14670824|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670825|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14670826|NCT00276835|Aldesleukin|aldesleukin|mesh-list
14670827|NCT00276835|Interleukin-2|interleukin-2|mesh-list
14670828|NCT00276835|Genistein|genistein|mesh-list
14670829|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670830|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14670831|NCT00276835|Analgesics|analgesics|mesh-ancestor
14670832|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
14670833|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14670834|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670835|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14670836|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14670837|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
14670838|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670839|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14670840|NCT00276835|Protective Agents|protective agents|mesh-ancestor
14670841|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14670842|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670843|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670844|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
14670845|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14670846|NCT00276835|Estrogens|estrogens|mesh-ancestor
14670847|NCT00276835|Hormones|hormones|mesh-ancestor
14670848|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14670849|NCT00276848|Vidarabine|vidarabine|mesh-list
14670850|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
14670851|NCT00276848|Fludarabine|fludarabine|mesh-list
14670852|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
14670853|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670854|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
14670855|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670856|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670857|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14670858|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
14670859|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670860|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670861|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14670862|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670863|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
14670864|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
14670865|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670866|NCT00276874|Aripiprazole|aripiprazole|mesh-list
14670867|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
14670868|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670869|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14670870|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14670871|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14670872|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670873|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
14670874|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
14670875|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670876|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670877|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14670878|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14670879|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
14670880|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14670881|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14670882|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14670883|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14670884|NCT00276900|Sertraline|sertraline|mesh-list
14670885|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
14670886|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670887|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14670888|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14670889|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670890|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670891|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670892|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
14670893|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670894|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
14670895|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670896|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14670897|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670898|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670899|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
14670900|NCT00276965|Sertraline|sertraline|mesh-list
14670901|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
14670902|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670903|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14670904|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14670905|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670906|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670907|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670908|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
14670909|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670910|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670911|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
14670912|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14670913|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14670914|NCT00276978|Aripiprazole|aripiprazole|mesh-list
14670915|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
14670916|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670917|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14670918|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14670919|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14670920|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670921|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
14670922|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
14670923|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670924|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670925|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14670926|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14670927|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
14670928|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14670929|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14670930|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14670931|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15188525|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15188526|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15188527|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
15188528|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15188529|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
15188530|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
14670932|NCT00277017|Interferons|interferons|mesh-list
14670933|NCT00277017|Thalidomide|thalidomide|mesh-list
14670934|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670935|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
14670936|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14670937|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670938|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
14670939|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670940|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
14670941|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14670942|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14670943|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14670944|NCT00277017|Growth Substances|growth substances|mesh-ancestor
14670945|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
14670946|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14670947|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
14670948|NCT00277043|Paclitaxel|paclitaxel|mesh-list
14670949|NCT00277043|Docetaxel|docetaxel|mesh-list
14670950|NCT00277043|Taxane|taxane|mesh-list
14670951|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670952|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670953|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670954|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670955|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670956|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670957|NCT00277069|Carboplatin|carboplatin|mesh-list
14670958|NCT00277069|Capecitabine|capecitabine|mesh-list
14670959|NCT00277069|Vinorelbine|vinorelbine|mesh-list
14670960|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670961|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14670962|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
14670963|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670964|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14670965|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14670966|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14670967|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14670968|NCT00277082|Camptothecin|camptothecin|mesh-list
14670969|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15188531|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
15188532|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15188533|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15188534|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15188535|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188536|NCT03865121|Nicotine|nicotine|mesh-list
14670970|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670971|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14670972|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14670973|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14670974|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670975|NCT00277108|Citalopram|citalopram|mesh-list
14670976|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14670977|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14670978|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14670979|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670980|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670981|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
14670982|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670983|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14670984|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
15188537|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15188538|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
15188539|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188540|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188541|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15188542|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15188543|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
15188544|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14670985|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14670986|NCT00277199|Abatacept|abatacept|mesh-list
14670987|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14670988|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670989|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670990|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670991|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
14670992|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14670993|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14670994|NCT00277225|Abatacept|abatacept|mesh-list
14670995|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14670996|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14670997|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14670998|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14670999|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
14671000|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671001|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671002|NCT00277251|Alendronate|alendronate|mesh-list
14671003|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14671004|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671005|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
14671006|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14671007|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
14671008|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671009|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671010|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14671011|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671012|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
14671013|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14671014|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
14671015|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671016|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671017|NCT00277342|Insulin|insulin|mesh-list
14671018|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14671019|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671020|NCT00277472|Valsartan|valsartan|mesh-list
14671021|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14671022|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14671023|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14671024|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14671025|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671026|NCT00277472|Diuretics|diuretics|mesh-ancestor
15188545|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671027|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
14671028|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671029|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14671030|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14671031|NCT00277498|Timolol|timolol|mesh-list
14671032|NCT00277498|Latanoprost|latanoprost|mesh-list
14671033|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14671034|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14671035|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
14671036|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671037|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671038|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671039|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14671040|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14671041|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14671042|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14671043|NCT00277511|Levofloxacin|levofloxacin|mesh-list
14671044|NCT00277511|Ofloxacin|ofloxacin|mesh-list
14671045|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14671046|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671047|NCT00277511|Renal Agents|renal agents|mesh-ancestor
14671048|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14671049|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14671050|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671051|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671052|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671053|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671054|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14671055|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14671056|NCT00277537|Mannitol|mannitol|mesh-list
14671057|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14671058|NCT00277537|Diuretics|diuretics|mesh-ancestor
14671059|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
14671060|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671061|NCT00277550|Tegaserod|tegaserod|mesh-list
14671062|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14671063|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
14671064|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671065|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671066|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671067|NCT00277589|Iodine|iodine|mesh-list
14671068|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14671069|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671070|NCT00277589|Trace Elements|trace elements|mesh-ancestor
14671071|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
14671072|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671073|NCT00277602|Riluzole|riluzole|mesh-list
14671074|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
14671075|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14671076|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14671077|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671078|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671079|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671080|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14671081|NCT00277602|Protective Agents|protective agents|mesh-ancestor
14671082|NCT00277641|Lamotrigine|lamotrigine|mesh-list
14671083|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
14671084|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14671085|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14671086|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671087|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14671088|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671089|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14671090|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14671091|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671092|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14671093|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14671094|NCT00277654|Risperidone|risperidone|mesh-list
14671095|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14671096|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
14671097|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671098|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671099|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671100|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14671101|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14671102|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671103|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14671104|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14671105|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
14671106|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14671107|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
14671108|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14671109|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14671110|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14671111|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671112|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671113|NCT00277693|Spironolactone|spironolactone|mesh-list
14671114|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14671115|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
14671116|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671117|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671118|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14671119|NCT00277693|Diuretics|diuretics|mesh-ancestor
14671120|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
14671121|NCT00277706|Vitamin D|vitamin d|mesh-list
14671122|NCT00277706|Calcium|calcium|mesh-list
14671123|NCT00277706|Vitamins|vitamins|mesh-ancestor
14671124|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
14671125|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188546|NCT03864978|Rifaximin|rifaximin|mesh-list
15188547|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14671126|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14671127|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14671128|NCT00277758|Interferons|interferons|mesh-list
14671129|NCT00277758|Ribavirin|ribavirin|mesh-list
14671130|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
14671131|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14671132|NCT00277758|Interleukin-2|interleukin-2|mesh-list
14671133|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671134|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
14671135|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671136|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
14671137|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671138|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
14671139|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671140|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14671141|NCT00277758|Analgesics|analgesics|mesh-ancestor
14671142|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
14671143|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671144|NCT00277862|Ribavirin|ribavirin|mesh-list
15188548|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188549|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188550|NCT03864783|Curcumin|curcumin|mesh-list
15188551|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15188552|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188553|NCT03864783|Analgesics|analgesics|mesh-ancestor
15188554|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
15188555|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671145|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
14671146|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
14671147|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14671148|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14671149|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
14671150|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671151|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
14671152|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671153|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
14671154|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671155|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726543|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14726544|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14726545|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726546|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726547|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14726548|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726549|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
14726550|NCT00509470|Diuretics|diuretics|mesh-ancestor
14726551|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
14726552|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14726553|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14726554|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14726555|NCT00509561|Capecitabine|capecitabine|mesh-list
14726556|NCT00509561|Cetuximab|cetuximab|mesh-list
14726557|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726558|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14726559|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
14726560|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726561|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726562|NCT00509613|Sirolimus|sirolimus|mesh-list
14726563|NCT00509613|Sorafenib|sorafenib|mesh-list
14726564|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726565|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726566|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726567|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188556|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188557|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188558|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726568|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14726569|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188559|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188560|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726570|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14726571|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
14726572|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726573|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
14726574|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726575|NCT00509639|Metronidazole|metronidazole|mesh-list
14726576|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726577|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14726578|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14726579|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14726580|NCT00509678|Rituximab|rituximab|mesh-list
14726581|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726582|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726583|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
14726584|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726585|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726586|NCT00509743|Diclofenac|diclofenac|mesh-list
14726587|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14726588|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14726589|NCT00509743|Analgesics|analgesics|mesh-ancestor
14726590|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
14726591|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726592|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726593|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14726594|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726595|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14726596|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726597|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729292|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729293|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729294|NCT00522587|Remifentanil|remifentanil|mesh-list
14729295|NCT00522587|Sevoflurane|sevoflurane|mesh-list
14729296|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15188561|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729297|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14671156|NCT00278070|Vinorelbine|vinorelbine|mesh-list
14671157|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671158|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671159|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671160|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671161|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671162|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671163|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
14671164|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14671165|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
14671166|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671167|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671168|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14671169|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671170|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14671171|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
14671172|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671173|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671174|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14671175|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
14671176|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
14671177|NCT00278083|Protective Agents|protective agents|mesh-ancestor
14671178|NCT00278122|Paclitaxel|paclitaxel|mesh-list
14671179|NCT00278122|Sargramostim|sargramostim|mesh-list
14671180|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671181|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671182|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671183|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671184|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671185|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293912|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14293913|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
14671186|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
14671187|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671188|NCT00278174|Interferons|interferons|mesh-list
14671189|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
14671190|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14671191|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671192|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
14671193|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671194|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
14671195|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671196|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14671197|NCT00278187|Volociximab|volociximab|mesh-list
14671198|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671199|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14671200|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671201|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671202|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14671203|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14671204|NCT00278187|Growth Substances|growth substances|mesh-ancestor
14671205|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671206|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
14671207|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
14671208|NCT00278213|Fludarabine|fludarabine|mesh-list
14671209|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
14671210|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
14671211|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
14671212|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671213|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
14671214|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671215|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671216|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14671217|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
14671218|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671219|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671220|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14671221|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14293914|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14293915|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14293916|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14293917|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14293918|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293919|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
14671222|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
14671223|NCT00278213|Analgesics|analgesics|mesh-ancestor
14293920|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293921|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671224|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
14671225|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671226|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14671227|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671228|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671229|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14671230|NCT00278252|Etoposide|etoposide|mesh-list
14671231|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671232|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671233|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14671234|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671235|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671236|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671237|NCT00278265|Vidarabine|vidarabine|mesh-list
14671238|NCT00278265|Methotrexate|methotrexate|mesh-list
14671239|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
14671240|NCT00278265|Fludarabine|fludarabine|mesh-list
14671241|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14671242|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
14671243|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14671244|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671245|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14671246|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
14671247|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671248|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671249|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
14671250|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671251|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14671252|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671253|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
14671254|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671255|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14671256|NCT00278265|Antiviral Agents|antiviral agents|mesh-ancestor
14671257|NCT00278265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671258|NCT00278278|Prednisone|prednisone|mesh-list
14671259|NCT00278278|Methotrexate|methotrexate|mesh-list
14671260|NCT00278278|Etoposide|etoposide|mesh-list
14671261|NCT00278278|Vincristine|vincristine|mesh-list
14671262|NCT00278278|Ifosfamide|ifosfamide|mesh-list
14671263|NCT00278278|Lomustine|lomustine|mesh-list
14671264|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188562|NCT03864666|Cilostazol|cilostazol|mesh-list
14671265|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14671266|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
15188563|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15188564|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
15188565|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188566|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188567|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15188568|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
15188569|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15188570|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15188571|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188572|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15188573|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
15188574|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15188575|NCT03864666|Protective Agents|protective agents|mesh-ancestor
15188576|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15188577|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15188578|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188579|NCT03864705|Metformin|metformin|mesh-list
15188580|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15188581|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188582|NCT03864250|Prednisone|prednisone|mesh-list
15188583|NCT03864250|Tacrolimus|tacrolimus|mesh-list
15188584|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188585|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
15188586|NCT03864250|Hormones|hormones|mesh-ancestor
15188587|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15188588|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188589|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15188590|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188591|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671267|NCT00278278|Hormones|hormones|mesh-ancestor
14671268|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671269|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671270|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14671271|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14671272|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
14671273|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14671274|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14671275|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
14671276|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671277|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
14671278|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671279|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14671280|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671281|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
14671282|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671283|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14671284|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671285|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14671286|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671287|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671288|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671289|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671290|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14671291|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
14671292|NCT00278330|Vorinostat|vorinostat|mesh-list
14671293|NCT00278330|Alvocidib|alvocidib|mesh-list
14671294|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671295|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14671296|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671297|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671298|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14671299|NCT00278330|Growth Substances|growth substances|mesh-ancestor
14671300|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671301|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14671302|NCT00278343|Cediranib|cediranib|mesh-list
14671303|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671304|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671305|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671306|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14671307|NCT00278369|Aldesleukin|aldesleukin|mesh-list
14671308|NCT00278369|Interleukin-2|interleukin-2|mesh-list
14671309|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
14671310|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671311|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14671312|NCT00278369|Analgesics|analgesics|mesh-ancestor
14671313|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
15188592|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
14671314|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671315|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671316|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14671317|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14671318|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
14671319|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671320|NCT00278382|Sorafenib|sorafenib|mesh-list
14671321|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671322|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14671323|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671324|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671325|NCT00278408|Prednisone|prednisone|mesh-list
14671326|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
14671327|NCT00278408|Rituximab|rituximab|mesh-list
14671328|NCT00278408|Doxorubicin|doxorubicin|mesh-list
14671329|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14671330|NCT00278408|Vincristine|vincristine|mesh-list
14671331|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671332|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
14671333|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671334|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671335|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14671336|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
14671337|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671338|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671339|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14671340|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14671341|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14671342|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14671343|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671344|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671345|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14671346|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
14671347|NCT00278408|Hormones|hormones|mesh-ancestor
14671348|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671349|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14671350|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671351|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671352|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671353|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671354|NCT00278421|Prednisone|prednisone|mesh-list
14671355|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
14671356|NCT00278421|Rituximab|rituximab|mesh-list
14671357|NCT00278421|Doxorubicin|doxorubicin|mesh-list
14671358|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14671359|NCT00278421|Vincristine|vincristine|mesh-list
14671360|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671361|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
14671362|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671363|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671364|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14671365|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
14671366|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671367|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671368|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14671369|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14671370|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14671371|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14671372|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671373|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671374|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14671375|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
14671376|NCT00278421|Hormones|hormones|mesh-ancestor
14671377|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671378|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14671379|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671380|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671381|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671382|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671383|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
14671384|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14671385|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671386|NCT00278460|Gemcitabine|gemcitabine|mesh-list
14671387|NCT00278460|Docetaxel|docetaxel|mesh-list
14671388|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14671389|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
14671390|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671391|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671392|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
14671393|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671394|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671395|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671396|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
14671397|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671398|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671399|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671400|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671401|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
14671402|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671403|NCT00278772|Valproic Acid|valproic acid|mesh-list
14671404|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
14671405|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671406|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671407|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
14671408|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671409|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671410|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
14671411|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14671412|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671413|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14671414|NCT00278824|Fentanyl|fentanyl|mesh-list
14671415|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14671416|NCT00278824|Narcotics|narcotics|mesh-ancestor
14671417|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671418|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671419|NCT00278824|Analgesics|analgesics|mesh-ancestor
14671420|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
14671421|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671422|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14671423|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14671424|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
14671425|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
14671426|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14671427|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14671428|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14671429|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14671430|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14671431|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
14671432|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14671433|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15188593|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15188594|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188595|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671434|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14671435|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188596|NCT03864523|Pioglitazone|pioglitazone|mesh-list
15188597|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15188598|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188599|NCT03864588|Ropivacaine|ropivacaine|mesh-list
15188600|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188601|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
15188602|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188603|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188604|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
15188605|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188606|NCT03864575|Celecoxib|celecoxib|mesh-list
15188607|NCT03864575|Nivolumab|nivolumab|mesh-list
15188608|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15188609|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188610|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15188611|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188612|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15188613|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188614|NCT03864575|Analgesics|analgesics|mesh-ancestor
15188615|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
15188616|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188617|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671436|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671437|NCT00278967|Bisacodyl|bisacodyl|mesh-list
14671438|NCT00278967|Cathartics|cathartics|mesh-ancestor
14671439|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188618|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188619|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188620|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14671440|NCT00278967|Laxatives|laxatives|mesh-ancestor
14671441|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
15188621|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15188622|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188623|NCT03864185|Rituximab|rituximab|mesh-list
14671442|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14671443|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
14671444|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671445|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188624|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15188625|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671446|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14671447|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671448|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
14671449|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14671450|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
14671451|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671452|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671453|NCT00279045|Metformin|metformin|mesh-list
14671454|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
14671455|NCT00279045|Glyburide|glyburide|mesh-list
14671456|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14671457|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671458|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
14671459|NCT00279084|Hematinics|hematinics|mesh-ancestor
14671460|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14671461|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
14671462|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671463|NCT00279123|Pantoprazole|pantoprazole|mesh-list
14671464|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14671465|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14671466|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14671467|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671468|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671469|NCT00279162|Betamethasone|betamethasone|mesh-list
14671470|NCT00279162|Calcipotriene|calcipotriene|mesh-list
14671471|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14671472|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
14671473|NCT00279162|Hormones|hormones|mesh-ancestor
14671474|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671475|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671476|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14671477|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671478|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14671479|NCT00279240|Metformin|metformin|mesh-list
14671480|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14671481|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671482|NCT00279253|Clonidine|clonidine|mesh-list
14671483|NCT00279253|Analgesics|analgesics|mesh-ancestor
14671484|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
14671485|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671486|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671487|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14671488|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
14671489|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
14671490|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14671491|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14671492|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14671493|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
14671494|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671495|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671496|NCT00279266|Thiamine|thiamine|mesh-list
14671497|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
14671498|NCT00279266|Vitamins|vitamins|mesh-ancestor
14671499|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
14671500|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671501|NCT00279344|Fentanyl|fentanyl|mesh-list
14671502|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14671503|NCT00279344|Narcotics|narcotics|mesh-ancestor
14671504|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671505|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671506|NCT00279344|Analgesics|analgesics|mesh-ancestor
14671507|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
15188626|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
15188627|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188628|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188629|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
15188630|NCT03864172|Calcium|calcium|mesh-list
15188631|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14671508|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671509|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14671510|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14671511|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
14671512|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
14671513|NCT00279383|Thrombin|thrombin|mesh-list
14671514|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
14671515|NCT00279383|Coagulants|coagulants|mesh-ancestor
14671516|NCT00279422|Visilizumab|visilizumab|mesh-list
14671517|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
14671518|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671519|NCT00279435|Visilizumab|visilizumab|mesh-list
14671520|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
14671521|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671522|NCT00279448|Tamoxifen|tamoxifen|mesh-list
14671523|NCT00279448|Exemestane|exemestane|mesh-list
14671524|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14671525|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
14671526|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671527|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671528|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14671529|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671530|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14671531|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14671532|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14671533|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14671534|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15188632|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188633|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15188634|NCT03864068|Inositol|inositol|mesh-list
15188635|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
15188636|NCT03864068|Vitamins|vitamins|mesh-ancestor
15188637|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
15188638|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188639|NCT03863925|Propofol|propofol|mesh-list
15188640|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15188641|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188642|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188643|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15188644|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
14671535|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726598|NCT00509834|Lactoferrin|lactoferrin|mesh-list
15188645|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
15188646|NCT03863977|Dexamethasone|dexamethasone|mesh-list
15188647|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
14671536|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671537|NCT00279461|Vitamin D|vitamin d|mesh-list
14671538|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
14671539|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
14671540|NCT00279461|Vitamins|vitamins|mesh-list
14671541|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
14671542|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671543|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14671544|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14671545|NCT00279487|Gabapentin|gabapentin|mesh-list
14671546|NCT00279487|Analgesics|analgesics|mesh-ancestor
14671547|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
14671548|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671549|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671550|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
14671551|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14671552|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15188648|NCT03863977|Bupivacaine|bupivacaine|mesh-list
15188649|NCT03863977|BB 1101|bb 1101|mesh-list
15188650|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188651|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
15188652|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
15188653|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188654|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188655|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14671553|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671554|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14671555|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15188656|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
15188657|NCT03863977|Hormones|hormones|mesh-ancestor
15188658|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15188659|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15188660|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188661|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
15188662|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188663|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188664|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188665|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
15188666|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188667|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
15188668|NCT03864016|Sufentanil|sufentanil|mesh-list
15188669|NCT03864016|Dsuvia|dsuvia|mesh-list
15188670|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
15188671|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14293922|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15188672|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188673|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15188674|NCT03864016|Narcotics|narcotics|mesh-ancestor
15188675|NCT03864016|Analgesics|analgesics|mesh-ancestor
15188676|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
15188677|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188678|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15188679|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15188680|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
15188681|NCT03863899|Anesthetics|anesthetics|mesh-list
15188682|NCT03863899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188683|NCT03863899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188684|NCT03863691|Amisulpride|amisulpride|mesh-list
15188685|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15188686|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15188687|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188688|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188689|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15188690|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15188691|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
15188692|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188693|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188694|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15188695|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
15188696|NCT03863405|Metformin|metformin|mesh-list
15188697|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293923|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15188698|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188699|NCT03863587|Ramucirumab|ramucirumab|mesh-list
15188700|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188701|NCT03863392|Misoprostol|misoprostol|mesh-list
15188702|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15188703|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
15188704|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15188705|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188706|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15188707|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188708|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
14671556|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14671557|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671558|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671559|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
14671560|NCT00279539|Mitogens|mitogens|mesh-list
15188709|NCT03863626|Furosemide|furosemide|mesh-list
15188710|NCT03863626|Diuretics|diuretics|mesh-ancestor
15188711|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
15188712|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188713|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15188714|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15188715|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188716|NCT03863613|Progesterone|progesterone|mesh-list
15188717|NCT03863613|Progestins|progestins|mesh-ancestor
15188718|NCT03863613|Hormones|hormones|mesh-ancestor
15188719|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671561|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
14671562|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671563|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671564|NCT00279539|Growth Substances|growth substances|mesh-ancestor
14671565|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671566|NCT00279565|Interferons|interferons|mesh-list
14671567|NCT00279565|Ribavirin|ribavirin|mesh-list
14671568|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
14671569|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
14671570|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14671571|NCT00279565|Buprenorphine|buprenorphine|mesh-list
14671572|NCT00279565|Methadone|methadone|mesh-list
14671573|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671574|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
14671575|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671576|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
14671577|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671578|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
14671579|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671580|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14671581|NCT00279565|Narcotics|narcotics|mesh-ancestor
14671582|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671583|NCT00279565|Analgesics|analgesics|mesh-ancestor
14671584|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
14671585|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671586|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14671587|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
14671588|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671589|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
14671590|NCT00279578|Factor VIII|factor viii|mesh-list
14671591|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14671592|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14671593|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671594|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
14671595|NCT00279578|Coagulants|coagulants|mesh-ancestor
14726599|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726600|NCT00509847|Lactoferrin|lactoferrin|mesh-list
14726601|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726602|NCT00509860|Irinotecan|irinotecan|mesh-list
14726603|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14293924|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726604|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726605|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188720|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188721|NCT03863366|Prucalopride|prucalopride|mesh-list
15188722|NCT03863366|Laxatives|laxatives|mesh-ancestor
15188723|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188724|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15188725|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15188726|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
15188727|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188728|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188729|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188730|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15188731|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223883|NCT05033847|Vaccines|vaccines|mesh-list
15223884|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
15223885|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671596|NCT00279617|Levetiracetam|levetiracetam|mesh-list
14671597|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
14671598|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
14671599|NCT00279734|Abatacept|abatacept|mesh-list
14671600|NCT00279734|Vaccines|vaccines|mesh-list
14671601|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
14671602|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671603|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14671604|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671605|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223886|NCT05019560|Sevoflurane|sevoflurane|mesh-list
15223887|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15223888|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15223889|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
14671606|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671607|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671608|NCT00279747|Naproxen|naproxen|mesh-list
14671609|NCT00279747|Meloxicam|meloxicam|mesh-list
14671610|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14671611|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14671612|NCT00279747|Analgesics|analgesics|mesh-ancestor
14671613|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
14671614|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671615|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671616|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14671617|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671618|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
14671619|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14671620|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671621|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671622|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14671623|NCT00279760|Abatacept|abatacept|mesh-list
14671624|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14671625|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671626|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671627|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671628|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
14671629|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671630|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671631|NCT00279825|Levodopa|levodopa|mesh-list
14671632|NCT00279825|Carbidopa|carbidopa|mesh-list
14671633|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14671634|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14671635|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14671636|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
14671637|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671638|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671639|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671640|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14671641|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671642|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14671643|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
14671644|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
14671645|NCT00279903|Cortisone|cortisone|mesh-list
14671646|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
14671647|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14671648|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14671649|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14671650|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14671651|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671652|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
14671653|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671654|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671655|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14671656|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671657|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14671658|NCT00280007|Bevacizumab|bevacizumab|mesh-list
14671659|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14671660|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671661|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14671662|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14671663|NCT00280007|Growth Substances|growth substances|mesh-ancestor
14671664|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671665|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
14671666|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14671667|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14671668|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
14671669|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671670|NCT00280033|Antacids|antacids|mesh-ancestor
14671671|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671672|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14671673|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
14671674|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
14671675|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14671676|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671677|NCT00280098|Docetaxel|docetaxel|mesh-list
14671678|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671679|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671680|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671681|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671682|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671683|NCT00280176|Fluorouracil|fluorouracil|mesh-list
14671684|NCT00280176|Bortezomib|bortezomib|mesh-list
14671685|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
14671686|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671687|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14671688|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671689|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671690|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
14671691|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671692|NCT00280215|Losartan|losartan|mesh-list
14671693|NCT00280215|Lisinopril|lisinopril|mesh-list
14671694|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14671695|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14671696|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14671697|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14671698|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14671699|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14671700|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671701|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
14671702|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14671703|NCT00280215|Protective Agents|protective agents|mesh-ancestor
14671704|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671705|NCT00280267|Testosterone|testosterone|mesh-list
14671706|NCT00280267|Androgens|androgens|mesh-ancestor
14671707|NCT00280267|Hormones|hormones|mesh-ancestor
14671708|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15188732|NCT03863223|Docetaxel|docetaxel|mesh-list
15188733|NCT03863223|Trastuzumab|trastuzumab|mesh-list
15188734|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188735|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
15188736|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
15188737|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671709|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671710|NCT00280280|Baclofen|baclofen|mesh-list
14671711|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14671712|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671713|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14671714|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671715|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14671716|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
14671717|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
14671718|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671719|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671720|NCT00280358|Fluticasone|fluticasone|mesh-list
14671721|NCT00280358|Xhance|xhance|mesh-list
14671722|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
14671723|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14671724|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14671725|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
14671726|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671727|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671728|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14671729|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671730|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
14671731|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14671732|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14671733|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14671734|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14671735|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
14671736|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671737|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671738|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
14671739|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14671740|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
14671741|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671742|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671743|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14671744|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671745|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14671746|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14671747|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14671748|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14671749|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671750|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671751|NCT00280423|Casopitant|casopitant|mesh-list
14671752|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
14671753|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
14671754|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671755|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671756|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14671757|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14671758|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188738|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223890|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
14671759|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671760|NCT00280436|Casopitant|casopitant|mesh-list
14671761|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
14671762|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
14671763|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671764|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671765|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14671766|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14671767|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671768|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671769|NCT00280462|Nifedipine|nifedipine|mesh-list
14671770|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14671771|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14671772|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671773|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14671774|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671775|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
14671776|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
14671777|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14671778|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14671779|NCT00280501|Sulpiride|sulpiride|mesh-list
14671780|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
14671781|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14671782|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14671783|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14671784|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671785|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671786|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14671787|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
14671788|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671789|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671790|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14671791|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
14671792|NCT00280514|Cefpirome|cefpirome|mesh-list
14671793|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14671794|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671795|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14671796|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671797|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671798|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671799|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671800|NCT00280540|Valsartan|valsartan|mesh-list
14671801|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14671802|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14671803|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14671804|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14671805|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671806|NCT00280540|Diuretics|diuretics|mesh-ancestor
14671807|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
14671808|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671809|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14671810|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14671811|NCT00280553|Bupivacaine|bupivacaine|mesh-list
14671812|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
14671813|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
14671814|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671815|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671816|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
14671817|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671818|NCT00280605|Alfuzosin|alfuzosin|mesh-list
14671819|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15188739|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15188740|NCT03862950|Metformin|metformin|mesh-list
15188741|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15188742|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188743|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
15188744|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15188745|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188746|NCT03862768|Sunitinib|sunitinib|mesh-list
14671820|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14671821|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14671822|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14671823|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671824|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671825|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671826|NCT00280605|Urological Agents|urological agents|mesh-ancestor
15188747|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
15188748|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188749|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15188750|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15188751|NCT03862768|Growth Substances|growth substances|mesh-ancestor
15188752|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188753|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
15188754|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15188755|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188756|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188757|NCT03862456|Azithromycin|azithromycin|mesh-list
15188758|NCT03862456|Metronidazole|metronidazole|mesh-list
14671827|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
14671828|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671829|NCT00280644|Leflunomide|leflunomide|mesh-list
14671830|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671831|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671832|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671833|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
14671834|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671835|NCT00280696|Levetiracetam|levetiracetam|mesh-list
14671836|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
14671837|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
14671838|NCT00280774|Memantine|memantine|mesh-list
14671839|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14671840|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14671841|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
14671842|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671843|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671844|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671845|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14671846|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14671847|NCT00280787|Paclitaxel|paclitaxel|mesh-list
14671848|NCT00280787|Carboplatin|carboplatin|mesh-list
14671849|NCT00280787|Irinotecan|irinotecan|mesh-list
14671850|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671851|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188759|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15188760|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188761|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15188762|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15188763|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
15188764|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15188765|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
15188766|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188767|NCT03862586|Expectorants|expectorants|mesh-ancestor
15188768|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
15188769|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15188770|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
15188771|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188772|NCT03862586|Protective Agents|protective agents|mesh-ancestor
15188773|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188774|NCT03862586|Antidotes|antidotes|mesh-ancestor
15188775|NCT03862651|Cangrelor|cangrelor|mesh-list
15188776|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15188777|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15188778|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15188779|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15188780|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
15188781|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188782|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188783|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188784|NCT03862612|Anesthetics|anesthetics|mesh-list
15188785|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188786|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188787|NCT03862404|Epinephrine|epinephrine|mesh-list
15188788|NCT03862404|Bupivacaine|bupivacaine|mesh-list
15188789|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188790|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
15188791|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188792|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188793|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
14671852|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671853|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671854|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671855|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671856|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14671857|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14671858|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671859|NCT00280839|Topiramate|topiramate|mesh-list
14671860|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
14671861|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14671862|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671863|NCT00280865|Pioglitazone|pioglitazone|mesh-list
14671864|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14671865|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671866|NCT00280878|Gemcitabine|gemcitabine|mesh-list
14671867|NCT00280878|Rituximab|rituximab|mesh-list
14671868|NCT00280878|Vinorelbine|vinorelbine|mesh-list
14671869|NCT00280878|Ifosfamide|ifosfamide|mesh-list
14671870|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14671871|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671872|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
14671873|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671874|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671875|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14671876|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
14671877|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671878|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
14671879|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671880|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671881|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14671882|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14671883|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
14671884|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
14671885|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
14671886|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14671887|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
14671888|NCT00280930|Letrozole|letrozole|mesh-list
14671889|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188794|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188795|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15188796|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15188797|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
15188798|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188799|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188800|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15188801|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15188802|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
15188803|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15188804|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671890|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14671891|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14671892|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671893|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671894|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14671895|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
14671896|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14671897|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671898|NCT00280956|Natalizumab|natalizumab|mesh-list
14671899|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
14671900|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671901|NCT00280969|Efavirenz|efavirenz|mesh-list
14671902|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14671903|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14671904|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14671905|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671906|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671907|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
14671908|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671909|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14671910|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14671911|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14671912|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14671913|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14671914|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14671915|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14671916|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14671917|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
14671918|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14671919|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14671920|NCT00280995|Mipomersen|mipomersen|mesh-list
14671921|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14671922|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14671923|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
14671924|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671925|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14671926|NCT00281008|Mipomersen|mipomersen|mesh-list
14671927|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14671928|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14671929|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
14671930|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671931|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14671932|NCT00281125|Pemetrexed|pemetrexed|mesh-list
14671933|NCT00281125|Vatalanib|vatalanib|mesh-list
14671934|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14671935|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671936|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671937|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14671938|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14671939|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726606|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726607|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726608|NCT00509938|Lactoferrin|lactoferrin|mesh-list
14726609|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726610|NCT00509964|Irinotecan|irinotecan|mesh-list
14726611|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14726612|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726613|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729298|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
14671940|NCT00281255|Allopurinol|allopurinol|mesh-list
14671941|NCT00281255|Dobutamine|dobutamine|mesh-list
14671942|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
14671943|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671944|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671945|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
14671946|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14671947|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14671948|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
14671949|NCT00281255|Protective Agents|protective agents|mesh-ancestor
14671950|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671951|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15188805|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
14671952|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
14671953|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
14671954|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188806|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
15188807|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15188808|NCT03862391|Analgesics|analgesics|mesh-list
15188809|NCT03862391|Antiemetics|antiemetics|mesh-list
15188810|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
15188811|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188812|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188813|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
15188814|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14671955|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14671956|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14671957|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14671958|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
14671959|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14671960|NCT00281281|Vancomycin|vancomycin|mesh-list
14671961|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14671962|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671963|NCT00281307|Tocopherols|tocopherols|mesh-list
14671964|NCT00281307|Vitamin E|vitamin e|mesh-list
14671965|NCT00281307|Tocotrienols|tocotrienols|mesh-list
14671966|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
14671967|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
14671968|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671969|NCT00281307|Protective Agents|protective agents|mesh-ancestor
14671970|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671971|NCT00281307|Vitamins|vitamins|mesh-ancestor
14671972|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
14671973|NCT00281476|Simvastatin|simvastatin|mesh-list
14671974|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14671975|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14671976|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
14671977|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671978|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14671979|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14671980|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671981|NCT00281489|Anesthetics|anesthetics|mesh-list
14671982|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14671983|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671984|NCT00281502|Rifaximin|rifaximin|mesh-list
14671985|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14671986|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14671987|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14671988|NCT00281515|Lonafarnib|lonafarnib|mesh-list
14671989|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14671990|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14671991|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
14671992|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15188815|NCT03861988|Ketamine|ketamine|mesh-list
14671993|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
15188816|NCT03861988|Analgesics|analgesics|mesh-ancestor
14671994|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14671995|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14671996|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14671997|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
14671998|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
14671999|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14672000|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
14672001|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672002|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672003|NCT00281593|Telmisartan|telmisartan|mesh-list
14672004|NCT00281593|Ramipril|ramipril|mesh-list
14672005|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14672006|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14672007|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14672008|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672009|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14672010|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
14672011|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672012|NCT00281606|Ritonavir|ritonavir|mesh-list
14293925|NCT00572455|Latanoprost|latanoprost|mesh-list
14293926|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14672013|NCT00281606|Lopinavir|lopinavir|mesh-list
14293927|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15188817|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
15188818|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188819|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188820|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15188821|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15188822|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
15188823|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
15188824|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188825|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15188826|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15188827|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188828|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188829|NCT03862287|Lidocaine|lidocaine|mesh-list
15188830|NCT03862287|Bupivacaine|bupivacaine|mesh-list
14293928|NCT00572468|Simvastatin|simvastatin|mesh-list
14672014|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14672015|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14672016|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
14672017|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672018|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672019|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14672020|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14672021|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
14672022|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672023|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14672024|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14672025|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
14672026|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14672027|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672028|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14672029|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
14672030|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14672031|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672032|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672033|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672034|NCT00281645|Analgesics|analgesics|mesh-list
15188831|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188832|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
15225686|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
14293929|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14672035|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
14672036|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672037|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672038|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
14672039|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14672040|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14672041|NCT00281710|Prednisolone|prednisolone|mesh-list
14672042|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
14672043|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14672044|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
14672045|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672046|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
14672047|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
14672048|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672049|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672050|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672051|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
14672052|NCT00281710|Hormones|hormones|mesh-ancestor
14672053|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14672054|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14672055|NCT00281710|Protective Agents|protective agents|mesh-ancestor
14672056|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14672057|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672058|NCT00281788|Paclitaxel|paclitaxel|mesh-list
14672059|NCT00281788|Carboplatin|carboplatin|mesh-list
14672060|NCT00281788|Capecitabine|capecitabine|mesh-list
14672061|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14672062|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672063|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672064|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672065|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672066|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672067|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672068|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
14672069|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14672070|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672071|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14672072|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672073|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672074|NCT00281892|Vidarabine|vidarabine|mesh-list
14672075|NCT00281892|Fludarabine|fludarabine|mesh-list
14672076|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
14672077|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672078|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672079|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
14672080|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672081|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672082|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
14672083|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672084|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
14672085|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672086|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
14672087|NCT00281905|Carboplatin|carboplatin|mesh-list
14672088|NCT00281905|Methotrexate|methotrexate|mesh-list
15188833|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188834|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188835|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
15188836|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188837|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15188838|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15188839|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15188840|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15188841|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672089|NCT00281905|Vincristine|vincristine|mesh-list
15188842|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15188843|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15188844|NCT03862079|Tazobactam|tazobactam|mesh-list
15188845|NCT03862079|Piperacillin|piperacillin|mesh-list
15188846|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15188847|NCT03862079|Nystatin|nystatin|mesh-list
15188848|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15188849|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15188850|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15188851|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672090|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672091|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
14672092|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672093|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672094|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672095|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
14672096|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672097|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672098|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14672099|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14672100|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
14672101|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14672102|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672103|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
14672104|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672105|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672106|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14672107|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14672108|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14672109|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672110|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672111|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672112|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
14672113|NCT00281931|Rituximab|rituximab|mesh-list
14672114|NCT00281931|Fludarabine|fludarabine|mesh-list
14672115|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
14672116|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672117|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
14672118|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672119|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672120|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672121|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
14672122|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188852|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672123|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672124|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14672125|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14672126|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672127|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
14672128|NCT00281944|Leucovorin|leucovorin|mesh-list
14672129|NCT00281944|Fluorouracil|fluorouracil|mesh-list
14672130|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
14672131|NCT00281944|Calcium|calcium|mesh-list
14672132|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
14672133|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14672134|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672135|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
14672136|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672137|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672138|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672139|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672140|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
14672141|NCT00281944|Antidotes|antidotes|mesh-ancestor
14672142|NCT00281944|Protective Agents|protective agents|mesh-ancestor
14672143|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
14672144|NCT00281944|Vitamins|vitamins|mesh-ancestor
14672145|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
14672146|NCT00281970|Docetaxel|docetaxel|mesh-list
14672147|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672148|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672149|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672150|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672151|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672152|NCT00281983|Cyclosporine|cyclosporine|mesh-list
14672153|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
14672154|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
14672155|NCT00281983|Busulfan|busulfan|mesh-list
14672156|NCT00281983|Rituximab|rituximab|mesh-list
14672157|NCT00281983|Methotrexate|methotrexate|mesh-list
14672158|NCT00281983|Fludarabine|fludarabine|mesh-list
14672159|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
14672160|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
14672161|NCT00281983|Cyclosporins|cyclosporins|mesh-list
14672162|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14672163|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672164|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
14672165|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672166|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672167|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672168|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
14672169|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672170|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672171|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14672172|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14672173|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14672174|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
14672175|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14672176|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672177|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
14672178|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672179|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672180|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14672181|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14672182|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
14672183|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672184|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14672185|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15188853|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
15188854|NCT03862079|Ionophores|ionophores|mesh-ancestor
15188855|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15188856|NCT03862144|Palonosetron|palonosetron|mesh-list
15188857|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
15188858|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
15188859|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188860|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188861|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15188862|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14672186|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14672187|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
14672188|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14672189|NCT00281996|Gemcitabine|gemcitabine|mesh-list
14672190|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
14672191|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672192|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
14672193|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672194|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672195|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
14672196|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672197|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672198|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672199|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
14672200|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672201|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14672202|NCT00282061|Melatonin|melatonin|mesh-list
14672203|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
14672204|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672205|NCT00282061|Protective Agents|protective agents|mesh-ancestor
14672206|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672207|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672208|NCT00282100|Gefitinib|gefitinib|mesh-list
14672209|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672210|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14672211|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672212|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672213|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
14672214|NCT00282126|Diuretics|diuretics|mesh-ancestor
14672215|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
14672216|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672217|NCT00282126|Expectorants|expectorants|mesh-ancestor
14672218|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
14672219|NCT00282139|Aripiprazole|aripiprazole|mesh-list
14672220|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
14672221|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672222|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14672223|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14672224|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672225|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672226|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
14672227|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
14672228|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672229|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672230|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14672231|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14672232|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
14672233|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14672234|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14672235|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14672236|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14672237|NCT00282165|Naratriptan|naratriptan|mesh-list
14672238|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14672239|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14672240|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14672241|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
14672242|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672243|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672244|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672245|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14672246|NCT00282178|Candesartan|candesartan|mesh-list
15188863|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15188864|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
15188865|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188866|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188867|NCT03861767|Metformin|metformin|mesh-list
15188868|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15188869|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188870|NCT03861598|Carvedilol|carvedilol|mesh-list
15188871|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15188872|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15188873|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
15188874|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188875|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188876|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188877|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14672247|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15188878|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
14293930|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14293931|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
14293932|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293933|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14293934|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14293935|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293936|NCT00572572|Aprepitant|aprepitant|mesh-list
14293937|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
14672248|NCT00282178|Diuretics|diuretics|mesh-ancestor
14672249|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
14672250|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672251|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14672252|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672253|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672254|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14672255|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14672256|NCT00282217|Sirolimus|sirolimus|mesh-list
14672257|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14672258|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672259|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14672260|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14293938|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
14293939|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293940|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672261|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
14672262|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672263|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
14672264|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672265|NCT00282360|Trimetazidine|trimetazidine|mesh-list
15188879|NCT03861598|Protective Agents|protective agents|mesh-ancestor
15188880|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15188881|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15188882|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15188883|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
15188884|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15188885|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14672266|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
14672267|NCT00282386|Rofecoxib|rofecoxib|mesh-list
14672268|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672269|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672270|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672271|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14672272|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14672273|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672274|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14672275|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14672276|NCT00282386|Analgesics|analgesics|mesh-ancestor
14672277|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
14672278|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672279|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672280|NCT00282399|Decitabine|decitabine|mesh-list
14672281|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672282|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
14672283|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672284|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188886|NCT03861611|Ibuprofen|ibuprofen|mesh-list
15188887|NCT03861611|Diclofenac|diclofenac|mesh-list
15188888|NCT03861611|Ketorolac|ketorolac|mesh-list
15188889|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15188890|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15188891|NCT03861611|Analgesics|analgesics|mesh-ancestor
15188892|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
15188893|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188894|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188895|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15188896|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188897|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15188898|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15188899|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188900|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
14293941|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672285|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672286|NCT00282451|Insulin|insulin|mesh-list
14672287|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14672288|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
14672289|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
14672290|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14672291|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
14672292|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672293|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672294|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
14672295|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14672296|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14672297|NCT00282503|Prednisolone|prednisolone|mesh-list
14672298|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
14672299|NCT00282503|Methoxsalen|methoxsalen|mesh-list
14672300|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14672301|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
14672302|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672303|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
14672304|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
14672305|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672306|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672307|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672308|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
14672309|NCT00282503|Hormones|hormones|mesh-ancestor
14672310|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14672311|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14672312|NCT00282503|Protective Agents|protective agents|mesh-ancestor
14672313|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14672314|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672315|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14672316|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672317|NCT00282594|Insulin|insulin|mesh-list
14672318|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672319|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672320|NCT00282607|Udenafil|udenafil|mesh-list
14672321|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14672322|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14672323|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672324|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672325|NCT00282698|Insulin|insulin|mesh-list
14672326|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672327|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672328|NCT00282724|Liarozole|liarozole|mesh-list
14672329|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
14672330|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
14672331|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14672332|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672333|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672334|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672335|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672336|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14672337|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672338|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14672339|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14672340|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14672341|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
14293942|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14293943|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293944|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293945|NCT00572728|Alovudine|alovudine|mesh-list
14293946|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
14672342|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729299|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
14672343|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672344|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672345|NCT00282932|Urological Agents|urological agents|mesh-ancestor
14672346|NCT00282945|Metformin|metformin|mesh-list
14672347|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
14672348|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672349|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672350|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
14672351|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14672352|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14672353|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14672354|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672355|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672356|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
14672357|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672358|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672359|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14672360|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672361|NCT00282997|Pregabalin|pregabalin|mesh-list
14672362|NCT00282997|Analgesics|analgesics|mesh-ancestor
14672363|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
14672364|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672365|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672366|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
14672367|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14672368|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672369|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672370|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14672371|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14672372|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14672373|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672374|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14726614|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726615|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726616|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
14726617|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14726618|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14726619|NCT00509990|Analgesics|analgesics|mesh-ancestor
14726620|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
14726621|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726622|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726623|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14726624|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726625|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
14726626|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726627|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
14726628|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14726629|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726630|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726631|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
14726632|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14726633|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14726634|NCT00510003|Analgesics|analgesics|mesh-ancestor
14726635|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
14726636|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726637|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726638|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14726639|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726640|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672375|NCT00283036|Irbesartan|irbesartan|mesh-list
14672376|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14672377|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14672378|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14672379|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672380|NCT00283088|Plasminogen|plasminogen|mesh-list
14672381|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14672382|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14672383|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14672384|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672385|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
14672386|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14672387|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672388|NCT00283114|Lintuzumab|lintuzumab|mesh-list
14672389|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14672390|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672391|NCT00283179|Risperidone|risperidone|mesh-list
14672392|NCT00283179|Aripiprazole|aripiprazole|mesh-list
14672393|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14672394|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
14672395|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672396|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672397|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672398|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14672399|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14672400|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672401|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672402|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14672403|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
14672404|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
14672405|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
14672406|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14672407|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14672408|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14672409|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14672410|NCT00283192|Sertraline|sertraline|mesh-list
14672411|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
14672412|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672413|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14672414|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14672415|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672416|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672417|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672418|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
14672419|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672420|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
14672421|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14672422|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672423|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672424|NCT00283309|Riluzole|riluzole|mesh-list
14672425|NCT00283309|Memantine|memantine|mesh-list
14672426|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14672427|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14672428|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
14672429|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672430|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672431|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672432|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14672433|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14672434|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
14672435|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14672436|NCT00283309|Protective Agents|protective agents|mesh-ancestor
14672437|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
14672438|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14672439|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
14672440|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672441|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14672442|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14672443|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14672444|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672445|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
14672446|NCT00283465|Hematinics|hematinics|mesh-ancestor
15188901|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672447|NCT00283478|Gemcitabine|gemcitabine|mesh-list
14672448|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672449|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
14672450|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672451|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672452|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
14672453|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672454|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672455|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672456|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
14672457|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672458|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
14672459|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14672460|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672461|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672462|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672463|NCT00283543|Temozolomide|temozolomide|mesh-list
14672464|NCT00283543|Carmustine|carmustine|mesh-list
14672465|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672466|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
14672467|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672468|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672469|NCT00283556|Irinotecan|irinotecan|mesh-list
14672470|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14672471|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14672472|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672473|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672474|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672475|NCT00283621|Doxorubicin|doxorubicin|mesh-list
14672476|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14672477|NCT00283621|Ifosfamide|ifosfamide|mesh-list
14672478|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
14672479|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14672480|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672481|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14672482|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14672483|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672484|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672485|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672486|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
14672487|NCT00283621|Hematinics|hematinics|mesh-ancestor
14672488|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14672489|NCT00283634|Bortezomib|bortezomib|mesh-list
14672490|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672491|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14672492|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672493|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672494|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
14672495|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672496|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
14672497|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14672498|NCT00283660|Protective Agents|protective agents|mesh-ancestor
14672499|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672500|NCT00283699|Albendazole|albendazole|mesh-list
14672501|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
14672502|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14672503|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672504|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
14672505|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14672506|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14672507|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672508|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672509|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672510|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672511|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672512|NCT00283751|Insulin|insulin|mesh-list
14672513|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14672514|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
14672515|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
14672516|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672517|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672518|NCT00283764|Latanoprost|latanoprost|mesh-list
14672519|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14672520|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14672521|NCT00283777|Chromium|chromium|mesh-list
14672522|NCT00283777|Picolinic acid|picolinic acid|mesh-list
14672523|NCT00283777|Trace Elements|trace elements|mesh-ancestor
14672524|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
14672525|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672526|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14672527|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
14672528|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
14672529|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672530|NCT00283790|Zolpidem|zolpidem|mesh-list
14672531|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14672532|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14672533|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672534|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672535|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14672536|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
14672537|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
14672538|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672539|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672540|NCT00283829|Docetaxel|docetaxel|mesh-list
14672541|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672542|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672543|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672544|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672545|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672546|NCT00283946|Zolpidem|zolpidem|mesh-list
14672547|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14672548|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14672549|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672550|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672551|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14672552|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
14672553|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
14672554|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672555|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672556|NCT00283985|Dexamethasone|dexamethasone|mesh-list
14672557|NCT00283985|Methotrexate|methotrexate|mesh-list
14672558|NCT00283985|Asparaginase|asparaginase|mesh-list
14672559|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672560|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
14672561|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
14672562|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672563|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672564|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672565|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
14672566|NCT00283985|Hormones|hormones|mesh-ancestor
14672567|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14672568|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14672569|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672570|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14672571|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
14672572|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14672573|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14672574|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
14672575|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672576|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672577|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672578|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14672579|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672580|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
14672581|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672582|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14672583|NCT00284024|Domperidone|domperidone|mesh-list
15188902|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
15188903|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188904|NCT03861299|Anesthetics|anesthetics|mesh-list
15188905|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188906|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188907|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
15188908|NCT03861403|Avelumab|avelumab|mesh-list
15188909|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15188910|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
15188911|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188912|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672584|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
14672585|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
14672586|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672587|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672588|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14293947|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
14672589|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14672590|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
14672591|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672592|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672593|NCT00284193|Thrombin|thrombin|mesh-list
14672594|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14672595|NCT00284193|Factor VIII|factor viii|mesh-list
14672596|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
14672597|NCT00284193|Coagulants|coagulants|mesh-ancestor
14672598|NCT00284206|Risperidone|risperidone|mesh-list
14672599|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14672600|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
14672601|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672602|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672603|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672604|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14672605|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14672606|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672607|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672608|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14672609|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
14672610|NCT00284232|Insulin|insulin|mesh-list
14672611|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672612|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672613|NCT00284258|Irinotecan|irinotecan|mesh-list
14672614|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14672615|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14672616|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672617|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672618|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672619|NCT00284271|Prednisone|prednisone|mesh-list
14672620|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
14672621|NCT00284271|Vincristine|vincristine|mesh-list
14672622|NCT00284271|Bleomycin|bleomycin|mesh-list
14672623|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
14672624|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672625|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
14672626|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188913|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15188914|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
15188915|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188916|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188917|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15188918|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15188919|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14672627|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15188920|NCT03861364|Propofol|propofol|mesh-list
15188921|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15188922|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188923|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188924|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15188925|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
15188926|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
15188927|NCT03860870|Clenbuterol|clenbuterol|mesh-list
15188928|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15188929|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15188930|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
15188931|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188932|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672628|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672629|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
14672630|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672631|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672632|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14672633|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672634|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
15188933|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188934|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15188935|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
15188936|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188937|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15188938|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
15188939|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
15188940|NCT03860597|Memantine|memantine|mesh-list
15188941|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15188942|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14672635|NCT00284271|Hormones|hormones|mesh-ancestor
14672636|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14672637|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14672638|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14672639|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672640|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
15188943|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
15188944|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188945|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672641|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672642|NCT00284271|Hematinics|hematinics|mesh-ancestor
14672643|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14672644|NCT00284323|Adenosine|adenosine|mesh-list
14672645|NCT00284323|Analgesics|analgesics|mesh-ancestor
14672646|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
14672647|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672648|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672649|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14672650|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
14672651|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14672652|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
14672653|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
14672654|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188946|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188947|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15188948|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15188949|NCT03860831|Midazolam|midazolam|mesh-list
15188950|NCT03860831|Ketamine|ketamine|mesh-list
15188951|NCT03860831|Analgesics|analgesics|mesh-ancestor
15188952|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
15188953|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188954|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188955|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15188956|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15188957|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
15188958|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
15188959|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188960|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15188961|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15188962|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188963|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188964|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15188965|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14672655|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672656|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
14672657|NCT00284336|Doxorubicin|doxorubicin|mesh-list
14672658|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14672659|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672660|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
14672661|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672662|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672663|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672664|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
14672665|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672666|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672667|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14672668|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14672669|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14672670|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14672671|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672672|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
14672673|NCT00284427|Vitamins|vitamins|mesh-ancestor
14672674|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
14672675|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672676|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
14672677|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672678|NCT00284427|Protective Agents|protective agents|mesh-ancestor
14672679|NCT00284505|Thalidomide|thalidomide|mesh-list
14672680|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672681|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
14672682|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672683|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
14672684|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14672685|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672686|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14672687|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14672688|NCT00284505|Growth Substances|growth substances|mesh-ancestor
14672689|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
14672690|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672691|NCT00284531|Daclizumab|daclizumab|mesh-list
14672692|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672693|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
14672694|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672695|NCT00284583|Lidocaine|lidocaine|mesh-list
14672696|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
14672697|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
14672698|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672699|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672700|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
14672701|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672702|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14672703|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14672704|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14672705|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672706|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672707|NCT00284687|Artesunate|artesunate|mesh-list
14672708|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
14672709|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14672710|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15188966|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15188967|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15188968|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15188969|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
15188970|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
15188971|NCT03860662|Baclofen|baclofen|mesh-list
15188972|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15188973|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188974|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15188975|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15188976|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15188977|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
15188978|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
15188979|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15188980|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15188981|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15188982|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15188983|NCT03860636|Estradiol|estradiol|mesh-list
15188984|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14672711|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672712|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15188985|NCT03860636|Progesterone|progesterone|mesh-list
14672713|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
14672714|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
14672715|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14672716|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
14726641|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726642|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
14726643|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14726644|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726645|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726646|NCT00510016|Clonidine|clonidine|mesh-list
14726647|NCT00510016|Analgesics|analgesics|mesh-ancestor
14726648|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
14726649|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726650|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726651|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14726652|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
14726653|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
14726654|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14726655|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14726656|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14726657|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14726658|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726659|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726660|NCT00510081|Calcium|calcium|mesh-list
14726661|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14726662|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726663|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
14726664|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726665|NCT00510159|Artesunate|artesunate|mesh-list
14726666|NCT00510159|Sulfalene|sulfalene|mesh-list
14726667|NCT00510159|Praziquantel|praziquantel|mesh-list
15188986|NCT03860636|Estrogens|estrogens|mesh-ancestor
15188987|NCT03860636|Hormones|hormones|mesh-ancestor
15188988|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15188989|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15188990|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15188991|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
15188992|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15188993|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15188994|NCT03860636|Progestins|progestins|mesh-ancestor
15188995|NCT03860480|Bupivacaine|bupivacaine|mesh-list
15188996|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
15188997|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
15188998|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15188999|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189000|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
14726668|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
14726669|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14726670|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14726671|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726672|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726673|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
14726674|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
14726675|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14726676|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
14726677|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14726678|NCT00510159|Renal Agents|renal agents|mesh-ancestor
14726679|NCT00510172|Epoprostenol|epoprostenol|mesh-list
15189001|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726680|NCT00510172|Tezosentan|tezosentan|mesh-list
14726681|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14672717|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14672718|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672719|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14672720|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14672721|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14672722|NCT00284765|Analgesics|analgesics|mesh-ancestor
14672723|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
14672724|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672725|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672726|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672727|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672728|NCT00284778|Docetaxel|docetaxel|mesh-list
14672729|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672730|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672731|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672732|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672733|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672734|NCT00284791|Lamotrigine|lamotrigine|mesh-list
14672735|NCT00284791|Sertraline|sertraline|mesh-list
14672736|NCT00284791|Fluoxetine|fluoxetine|mesh-list
14672737|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
15189002|NCT03860012|Folic Acid|folic acid|mesh-list
15189003|NCT03860012|Hematinics|hematinics|mesh-ancestor
15189004|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
15189005|NCT03860012|Vitamins|vitamins|mesh-ancestor
15189006|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
15189007|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189008|NCT03860129|Sevoflurane|sevoflurane|mesh-list
15189009|NCT03860129|Desflurane|desflurane|mesh-list
15189010|NCT03860129|Isoflurane|isoflurane|mesh-list
15189011|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15189012|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15189013|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
15189014|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
14672738|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672739|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14672740|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14672741|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672742|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672743|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672744|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
14672745|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672746|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14672747|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14672748|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14672749|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672750|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
14672751|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14672752|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14672753|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14672754|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14672755|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672756|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14672757|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
14672758|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14672759|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672760|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14672761|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
14672762|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14672763|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672764|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672765|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672766|NCT00284947|Prednisone|prednisone|mesh-list
14672767|NCT00284947|Prednisolone|prednisolone|mesh-list
14672768|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
14672769|NCT00284947|Basiliximab|basiliximab|mesh-list
14672770|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672771|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
14672772|NCT00284947|Hormones|hormones|mesh-ancestor
14672773|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14672774|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672775|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15189015|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189016|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672776|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672777|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
14672778|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
14672779|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672780|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672781|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14672782|NCT00284947|Protective Agents|protective agents|mesh-ancestor
14672783|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672784|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
14672785|NCT00285051|Ondansetron|ondansetron|mesh-list
14672786|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
14672787|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
14672788|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672789|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672790|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672791|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
14672792|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
14672793|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14672794|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
14672795|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672796|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672797|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14672798|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14672799|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672800|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672801|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14672802|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
14672803|NCT00285090|Vitamin D|vitamin d|mesh-list
14672804|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
14672805|NCT00285090|Vitamins|vitamins|mesh-list
14672806|NCT00285090|Calcium|calcium|mesh-list
14672807|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
14672808|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672809|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14672810|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14672811|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
14672812|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672813|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672814|NCT00285155|Bupropion|bupropion|mesh-list
14672815|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14672816|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
14672817|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672818|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14672819|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14672820|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672821|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672822|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
14672823|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672824|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672825|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14672826|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14672827|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672828|NCT00285181|Simvastatin|simvastatin|mesh-list
14672829|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14672830|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14672831|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
14672832|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672833|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14672834|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15189017|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
15189018|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15189019|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15189020|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
15189021|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189022|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15189023|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15189024|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15189025|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189026|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15189027|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189028|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14672835|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672836|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
14672837|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14672838|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189029|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189030|NCT03860207|Antibodies|antibodies|mesh-list
14672839|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672840|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14672841|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14672842|NCT00285298|Protective Agents|protective agents|mesh-ancestor
14672843|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672844|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
14672845|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14672846|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
14672847|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
14672848|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14672849|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672850|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14672851|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
14672852|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14672853|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672854|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672855|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672856|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14672857|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
14672858|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672859|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14672860|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14672861|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672862|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672863|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672864|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
14672865|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672866|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14672867|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14672868|NCT00285389|Dexamethasone|dexamethasone|mesh-list
14672869|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
14672870|NCT00285389|Melphalan|melphalan|mesh-list
14672871|NCT00285389|Chlorambucil|chlorambucil|mesh-list
14672872|NCT00285389|Rituximab|rituximab|mesh-list
14672873|NCT00285389|Vincristine|vincristine|mesh-list
14672874|NCT00285389|Doxorubicin|doxorubicin|mesh-list
14672875|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14672876|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
14672877|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672878|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14672879|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14672880|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
14672881|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672882|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672883|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14672884|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14672885|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
14672886|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
14672887|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14672888|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672889|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
14672890|NCT00285389|Hormones|hormones|mesh-ancestor
14672891|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14672892|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14672893|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14672894|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14672895|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
14672896|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672897|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672898|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15189031|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
15189032|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15189033|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
15189034|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189035|NCT03859934|Melatonin|melatonin|mesh-list
15189036|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
15189037|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189038|NCT03859934|Protective Agents|protective agents|mesh-ancestor
15189039|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189040|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14672899|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14672900|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14672901|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672902|NCT00285415|Carboplatin|carboplatin|mesh-list
14672903|NCT00285415|Docetaxel|docetaxel|mesh-list
14672904|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672905|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
14293948|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672906|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
14672907|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
14672908|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672909|NCT00285428|Veltuzumab|veltuzumab|mesh-list
14672910|NCT00285428|Antibodies|antibodies|mesh-list
14672911|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
14672912|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672913|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672914|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14672915|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672916|NCT00285519|Doxazosin|doxazosin|mesh-list
14672917|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14672918|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14672919|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14672920|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14672921|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
14672922|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672923|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672924|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672925|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14672926|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14672927|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14672928|NCT00285623|Thrombin|thrombin|mesh-list
14672929|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
14672930|NCT00285623|Coagulants|coagulants|mesh-ancestor
14672931|NCT00285662|Artesunate|artesunate|mesh-list
14672932|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
14672933|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
14672934|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14672935|NCT00285662|Amodiaquine|amodiaquine|mesh-list
14672936|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
14672937|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14672938|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14672939|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14672940|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14672941|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
14672942|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
14672943|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14672944|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
14672945|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14672946|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672947|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672948|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14672949|NCT00285662|Renal Agents|renal agents|mesh-ancestor
14672950|NCT00285675|Calcitriol|calcitriol|mesh-list
14672951|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14672952|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189041|NCT03859908|Ethanol|ethanol|mesh-list
15189042|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
15189043|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15189044|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15189045|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189046|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189047|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189048|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
15189049|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189050|NCT03860077|Nicotine|nicotine|mesh-list
14293949|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
14672953|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14672954|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672955|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672956|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14672957|NCT00285675|Vitamins|vitamins|mesh-ancestor
14672958|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
14672959|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14672960|NCT00285727|Ropinirole|ropinirole|mesh-list
15189051|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14672961|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14672962|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14672963|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
14672964|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
14672965|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14672966|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672967|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672968|NCT00285766|Selegiline|selegiline|mesh-list
14672969|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
14672970|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14672971|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14672972|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14672973|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14672974|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14672975|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672976|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14672977|NCT00285766|Protective Agents|protective agents|mesh-ancestor
14672978|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672979|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
14672980|NCT00285805|Amiloride|amiloride|mesh-list
14672981|NCT00285805|Furosemide|furosemide|mesh-list
14672982|NCT00285805|Diuretics|diuretics|mesh-ancestor
14672983|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
14672984|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672985|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14672986|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14672987|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14672988|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672989|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14672990|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14672991|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14672992|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14672993|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14672994|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14672995|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14672996|NCT00285883|Saquinavir|saquinavir|mesh-list
14672997|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14672998|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14672999|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
14673000|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673001|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673002|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14673003|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14673004|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
14673005|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673006|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14673007|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14673008|NCT00285896|Glucagon|glucagon|mesh-list
14673009|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14673010|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14673011|NCT00285896|Hormones|hormones|mesh-ancestor
14673012|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673013|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673014|NCT00285896|Incretins|incretins|mesh-ancestor
14673015|NCT00286013|Gemcitabine|gemcitabine|mesh-list
14673016|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
14673017|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14673018|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
14673019|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673020|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673021|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
14673022|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673023|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673024|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673025|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
14673026|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673027|NCT00286026|Azithromycin|azithromycin|mesh-list
14673028|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14673029|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673030|NCT00286052|Naloxone|naloxone|mesh-list
14673031|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14673032|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673033|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
15189052|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
15189053|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673034|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673035|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14673036|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673037|NCT00286117|Tamoxifen|tamoxifen|mesh-list
14673038|NCT00286117|Anastrozole|anastrozole|mesh-list
14673039|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14673040|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
14673041|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673042|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673043|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14673044|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673045|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14673046|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14673047|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14673048|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14673049|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14673050|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673051|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673052|NCT00286130|Leucovorin|leucovorin|mesh-list
14673053|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
14673054|NCT00286130|Irinotecan|irinotecan|mesh-list
14673055|NCT00286130|Cetuximab|cetuximab|mesh-list
14673056|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673057|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14673058|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673059|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673060|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673061|NCT00286130|Antidotes|antidotes|mesh-ancestor
14673062|NCT00286130|Protective Agents|protective agents|mesh-ancestor
14673063|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293950|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293951|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14293952|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14673064|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
14673065|NCT00286130|Vitamins|vitamins|mesh-ancestor
15189054|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189055|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15189056|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14673066|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
14673067|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14673068|NCT00286143|Fentanyl|fentanyl|mesh-list
14673069|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14673070|NCT00286143|Narcotics|narcotics|mesh-ancestor
14673071|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673072|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673073|NCT00286143|Analgesics|analgesics|mesh-ancestor
14673074|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
14673075|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673076|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14673077|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14673078|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
14673079|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
14673080|NCT00286208|Misoprostol|misoprostol|mesh-list
14673081|NCT00286208|Mifepristone|mifepristone|mesh-list
14673082|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14673083|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
14673084|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14673085|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673086|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14673087|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14673088|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
14673089|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15189057|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
15189058|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189059|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673090|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14673091|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14673092|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14673093|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
15189060|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
15189061|NCT03859921|Progestins|progestins|mesh-ancestor
15189062|NCT03859921|Hormones|hormones|mesh-ancestor
15189063|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673094|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14673095|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14673096|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
14673097|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673098|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
14673099|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14673100|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14673101|NCT00286260|Levetiracetam|levetiracetam|mesh-list
14673102|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
14673103|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
14673104|NCT00286273|Heparin|heparin|mesh-list
14673105|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14673106|NCT00286273|Tinzaparin|tinzaparin|mesh-list
14673107|NCT00286273|Dalteparin|dalteparin|mesh-list
14673108|NCT00286273|Nadroparin|nadroparin|mesh-list
14673109|NCT00286273|Citric Acid|citric acid|mesh-list
14673110|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
14673111|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
14673112|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14673113|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
14673114|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
14673115|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673116|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14673117|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14673118|NCT00286312|Atorvastatin|atorvastatin|mesh-list
14673119|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14673120|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14673121|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
14673122|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673123|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14673124|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14673125|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673126|NCT00286351|Goserelin|goserelin|mesh-list
14673127|NCT00286351|Anastrozole|anastrozole|mesh-list
14673128|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14673129|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673130|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14673131|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14673132|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673133|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673134|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15189064|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189065|NCT03859856|Hormones|hormones|mesh-list
15189066|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189067|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189068|NCT03859583|Capsaicin|capsaicin|mesh-list
15189069|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
15189070|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189071|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
15189072|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189073|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189074|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
15189075|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15189076|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189077|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189078|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15189079|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15189080|NCT03859570|Protective Agents|protective agents|mesh-ancestor
15189081|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189082|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189083|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15189084|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
14673135|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
14673136|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189085|NCT03859687|Vitamins|vitamins|mesh-list
15189086|NCT03859687|Vitamin A|vitamin a|mesh-list
15189087|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
15189088|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
15189089|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189090|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
15189091|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673137|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673138|NCT00286364|Androgens|androgens|mesh-list
14673139|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14673140|NCT00286364|Hormones|hormones|mesh-ancestor
14673141|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673142|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673143|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14673144|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673145|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673146|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14673147|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
14673148|NCT00286403|Fenoldopam|fenoldopam|mesh-list
14673149|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673150|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673151|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
14673152|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
14673153|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
14673154|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673155|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673156|NCT00286416|Omalizumab|omalizumab|mesh-list
14673157|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14673158|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14673159|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
14673160|NCT00286481|Simvastatin|simvastatin|mesh-list
14673161|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14673162|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14673163|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
14673164|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673165|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14673166|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14673167|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673168|NCT00286585|Propofol|propofol|mesh-list
14673169|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
14673170|NCT00286585|Anesthetics|anesthetics|mesh-list
14673171|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14673172|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673173|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673174|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
14673175|NCT00286611|Amifostine|amifostine|mesh-list
14673176|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14673177|NCT00286611|Protective Agents|protective agents|mesh-ancestor
14673178|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673179|NCT00286624|Cyclosporine|cyclosporine|mesh-list
14673180|NCT00286624|Everolimus|everolimus|mesh-list
14673181|NCT00286624|Cyclosporins|cyclosporins|mesh-list
14673182|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14673183|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673184|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673185|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673186|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
14673187|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673188|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
14673189|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673190|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
14673191|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14673192|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14673193|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673194|NCT00286689|Hormones|hormones|mesh-list
14673195|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673196|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189092|NCT03859687|Protective Agents|protective agents|mesh-ancestor
15189093|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15189094|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189095|NCT03859635|Bupivacaine|bupivacaine|mesh-list
15189096|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
15189097|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
15189098|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189099|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189100|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
14673197|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
14673198|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14673199|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673200|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14673201|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
14673202|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15189101|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673203|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673204|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14673205|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14673206|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14673207|NCT00286871|Tacrolimus|tacrolimus|mesh-list
14673208|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673209|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
14673210|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673211|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14673212|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673213|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673214|NCT00286923|Topiramate|topiramate|mesh-list
14673215|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
14673216|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14673217|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673218|NCT00286936|Zolpidem|zolpidem|mesh-list
14673219|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14673220|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14673221|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673222|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673223|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14673224|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
14673225|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
14673226|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189102|NCT03859362|Ertapenem|ertapenem|mesh-list
15189103|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15189104|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189105|NCT03859375|Disinfectants|disinfectants|mesh-list
15189106|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189107|NCT03859141|Vaccines|vaccines|mesh-list
15189108|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
15189109|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673227|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673228|NCT00286962|Insulin|insulin|mesh-list
14673229|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14673230|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14673231|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673232|NCT00286988|Topiramate|topiramate|mesh-list
14673233|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
14673234|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14673235|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673236|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
14673237|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673238|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14673239|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673240|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673241|NCT00287066|Insulin|insulin|mesh-list
14673242|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14673243|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14673244|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673245|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
14673246|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673247|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14673248|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673249|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673250|NCT00287157|Tizanidine|tizanidine|mesh-list
15223891|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223892|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223893|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15223894|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15223895|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15223896|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14673251|NCT00287157|Analgesics|analgesics|mesh-ancestor
14673252|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
14673253|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673254|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673255|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
14673256|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14673257|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14673258|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
14673259|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
14673260|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14673261|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14673262|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14673263|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673264|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673265|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673266|NCT00287170|Calcitriol|calcitriol|mesh-list
15189110|NCT03859102|Acetaminophen|acetaminophen|mesh-list
15189111|NCT03859102|Dexamethasone|dexamethasone|mesh-list
15189112|NCT03859102|Gabapentin|gabapentin|mesh-list
14673267|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
14673268|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14673269|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673270|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14673271|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14673272|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673273|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14673274|NCT00287170|Vitamins|vitamins|mesh-ancestor
14673275|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
14673276|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14673277|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
14673278|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189113|NCT03859102|Ondansetron|ondansetron|mesh-list
15189114|NCT03859102|Anesthetics|anesthetics|mesh-list
15189115|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
15189116|NCT03859102|Lansoprazole|lansoprazole|mesh-list
15189117|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
15189118|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189119|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
14673279|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673280|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673281|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
14673282|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15189120|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
15189121|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189122|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189123|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15189124|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
14673283|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673284|NCT00287209|Amiodarone|amiodarone|mesh-list
14673285|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14673286|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
14673287|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14673288|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14673289|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673290|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14673291|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14673292|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14673293|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673294|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14673295|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14673296|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14673297|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
14673298|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14673299|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673300|NCT00287300|Azithromycin|azithromycin|mesh-list
14673301|NCT00287300|Artesunate|artesunate|mesh-list
14673302|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
14673303|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
14673304|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14673305|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14673306|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673307|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
14673308|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15189125|NCT03859102|Hormones|hormones|mesh-ancestor
15189126|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223897|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673309|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14673310|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673311|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
14673312|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
14673313|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14673314|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
14673315|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14673316|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673317|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673318|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14673319|NCT00287300|Renal Agents|renal agents|mesh-ancestor
14673320|NCT00287313|Vitamin K|vitamin k|mesh-list
14673321|NCT00287313|Vitamins|vitamins|mesh-ancestor
14673322|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
14673323|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673324|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14673325|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14673326|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673327|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
14673328|NCT00287313|Coagulants|coagulants|mesh-ancestor
14673329|NCT00287326|Clonidine|clonidine|mesh-list
14673330|NCT00287326|Morphine|morphine|mesh-list
14673331|NCT00287326|Bupivacaine|bupivacaine|mesh-list
14673332|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
14673333|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
14673334|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673335|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673336|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
14673337|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673338|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14673339|NCT00287326|Narcotics|narcotics|mesh-ancestor
14673340|NCT00287326|Analgesics|analgesics|mesh-ancestor
14673341|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673342|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
14673343|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
14673344|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14673345|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14673346|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14673347|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673348|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673349|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673350|NCT00287352|Amantadine|amantadine|mesh-list
14673351|NCT00287352|Olanzapine|olanzapine|mesh-list
14673352|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
14673353|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
14673354|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673355|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673356|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14673357|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14673358|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14673359|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673360|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673361|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14293953|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293954|NCT00572832|Vaccines|vaccines|mesh-list
14293955|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
14293956|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293957|NCT00572897|Fludarabine|fludarabine|mesh-list
14673362|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14673363|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14673364|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673365|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673366|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
14673367|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14673368|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14673369|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
14293958|NCT00572897|Melphalan|melphalan|mesh-list
14293959|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673370|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673371|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
14673372|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14673373|NCT00287352|Analgesics|analgesics|mesh-ancestor
14673374|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
14673375|NCT00287378|Omalizumab|omalizumab|mesh-list
14673376|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14673377|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14673378|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
14673379|NCT00287391|Rabeprazole|rabeprazole|mesh-list
14673380|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14673381|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14673382|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14673383|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673384|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673385|NCT00287430|Hormones|hormones|mesh-list
14673386|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673387|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673388|NCT00287443|Hormones|hormones|mesh-list
14673389|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673390|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673391|NCT00287456|Insulin|insulin|mesh-list
14673392|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14673393|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14673394|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673395|NCT00287495|Sorafenib|sorafenib|mesh-list
14673396|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673397|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14673398|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673399|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673400|NCT00287521|Timolol|timolol|mesh-list
14673401|NCT00287521|Latanoprost|latanoprost|mesh-list
14673402|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14673403|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14673404|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673405|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673406|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673407|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673408|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14673409|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673410|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14673411|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14673412|NCT00287534|Tamoxifen|tamoxifen|mesh-list
14673413|NCT00287534|Anastrozole|anastrozole|mesh-list
14673414|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14673415|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
14673416|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673417|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673418|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14673419|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673420|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14673421|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14673422|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14673423|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14673424|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14673425|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673426|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673427|NCT00287560|Propofol|propofol|mesh-list
14673428|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14673429|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673430|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673431|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15189127|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15189128|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189129|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15189130|NCT03859102|Analgesics|analgesics|mesh-ancestor
15189131|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
15189132|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
15189133|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189134|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
14673432|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
14673433|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
14673434|NCT00287651|Insulin|insulin|mesh-list
14673435|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14673436|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14673437|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673438|NCT00287664|Terlipressin|terlipressin|mesh-list
14673439|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673440|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14673441|NCT00287677|Hormones|hormones|mesh-list
14673442|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673443|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673444|NCT00287742|Risperidone|risperidone|mesh-list
14673445|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14673446|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
14673447|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673448|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673449|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673450|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14673451|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14673452|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673453|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673454|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14673455|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
14673456|NCT00287768|Docetaxel|docetaxel|mesh-list
14673457|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673458|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673459|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673460|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673461|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673462|NCT00287781|Lidocaine|lidocaine|mesh-list
14673463|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
14673464|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
14673465|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673466|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673467|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
14673468|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673469|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14673470|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14673471|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14673472|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14673473|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673474|NCT00287794|Diazepam|diazepam|mesh-list
14673475|NCT00287794|Melatonin|melatonin|mesh-list
14673476|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
14673477|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673478|NCT00287794|Protective Agents|protective agents|mesh-ancestor
14673479|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673480|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673481|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14673482|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
14293960|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293961|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14293962|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
14293963|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293964|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14293965|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
14293966|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14293967|NCT00572936|Timolol|timolol|mesh-list
14293968|NCT00572936|Dorzolamide|dorzolamide|mesh-list
14293969|NCT00572936|Latanoprost|latanoprost|mesh-list
14293970|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14293971|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15189135|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14673483|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
14673484|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
14673485|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673486|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14673487|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14673488|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14673489|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14673490|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14673491|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14673492|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673493|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14673494|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
14673495|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
14673496|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
14673497|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
14673498|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673499|NCT00287820|Olanzapine|olanzapine|mesh-list
14673500|NCT00287820|Risperidone|risperidone|mesh-list
14673501|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14673502|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
14673503|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673504|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673505|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673506|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14673507|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14673508|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673509|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673510|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14673511|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
14673512|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
14673513|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
14673514|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673515|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14673516|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14673517|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14673518|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14673519|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
14673520|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673521|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14673522|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673523|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673524|NCT00287859|Topotecan|topotecan|mesh-list
14673525|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14673526|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673527|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673528|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673529|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673530|NCT00287885|Docetaxel|docetaxel|mesh-list
14673531|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673532|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673533|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673534|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673535|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673536|NCT00287911|Topotecan|topotecan|mesh-list
14673537|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673538|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14673539|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673540|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673541|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673542|NCT00287924|Methotrexate|methotrexate|mesh-list
14673543|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14673544|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
14673545|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14673546|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673547|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14673548|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
14673549|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673550|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673551|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14673552|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673553|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14673554|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673555|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
14673556|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14673557|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14673558|NCT00287937|Paclitaxel|paclitaxel|mesh-list
14673559|NCT00287937|Carboplatin|carboplatin|mesh-list
14673560|NCT00287937|Vorinostat|vorinostat|mesh-list
14673561|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14673562|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673563|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673564|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673565|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673566|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673567|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14673568|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673569|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
14673570|NCT00287950|Carboplatin|carboplatin|mesh-list
14673571|NCT00287950|Etoposide|etoposide|mesh-list
14673572|NCT00287950|Vincristine|vincristine|mesh-list
14673573|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673574|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
14673575|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673576|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14673577|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14673578|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
14673579|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673580|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673581|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14673582|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14673583|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14673584|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673585|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673586|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673587|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673588|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673589|NCT00287963|Topotecan|topotecan|mesh-list
14673590|NCT00287963|Vinorelbine|vinorelbine|mesh-list
14673591|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14673592|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673593|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673594|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673595|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673596|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14673597|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673598|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673599|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673600|NCT00287976|Irinotecan|irinotecan|mesh-list
14673601|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14673602|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673603|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673604|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673605|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673606|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
14673607|NCT00288002|Docetaxel|docetaxel|mesh-list
14673608|NCT00288002|Capecitabine|capecitabine|mesh-list
14673609|NCT00288002|Trastuzumab|trastuzumab|mesh-list
14673610|NCT00288002|Epirubicin|epirubicin|mesh-list
14673611|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673612|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
14673613|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673614|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14673615|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14673616|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
14673617|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673618|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673619|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14673620|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673621|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673622|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673623|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14673624|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
14673625|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14673626|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14673627|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14673628|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673629|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726682|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14726683|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
14726684|NCT00510211|Olanzapine|olanzapine|mesh-list
14726685|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
14726686|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
14726687|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726688|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726689|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14726690|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14726691|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14726692|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726693|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14726694|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14726695|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14726696|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14726697|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189136|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15189137|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15189138|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15189139|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15189140|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189141|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189142|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
15189143|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
14726698|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726699|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
14726700|NCT00510250|Sorafenib|sorafenib|mesh-list
14726701|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726702|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726703|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726704|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726705|NCT00510263|Valacyclovir|valacyclovir|mesh-list
14726706|NCT00510263|Prednisolone|prednisolone|mesh-list
14726707|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14726708|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
14726709|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14726710|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
14726711|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14726712|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
14726713|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14726714|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
14726715|NCT00510263|Hormones|hormones|mesh-ancestor
15189144|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189145|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15189146|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
15189147|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15189148|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15189149|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15189150|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189151|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
15189152|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726716|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14726717|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189153|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
14673630|NCT00288028|Bortezomib|bortezomib|mesh-list
14673631|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673632|NCT00288041|Paclitaxel|paclitaxel|mesh-list
14673633|NCT00288041|Carboplatin|carboplatin|mesh-list
14673634|NCT00288041|Bortezomib|bortezomib|mesh-list
14673635|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14673636|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673637|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673638|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673639|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673640|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673641|NCT00288158|Allopurinol|allopurinol|mesh-list
14673642|NCT00288158|Probenecid|probenecid|mesh-list
15189154|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189155|NCT03858972|Capecitabine|capecitabine|mesh-list
14673643|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
14673644|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673645|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673646|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
14673647|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14673648|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14673649|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
14673650|NCT00288158|Protective Agents|protective agents|mesh-ancestor
14673651|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673652|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
14673653|NCT00288158|Renal Agents|renal agents|mesh-ancestor
14673654|NCT00288171|Allopurinol|allopurinol|mesh-list
14673655|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
14673656|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673657|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673658|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
14673659|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14673660|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14673661|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
14673662|NCT00288171|Protective Agents|protective agents|mesh-ancestor
14673663|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673664|NCT00288184|Allopurinol|allopurinol|mesh-list
14673665|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
14673666|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814633|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14814634|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14814635|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814636|NCT00863980|Telmisartan|telmisartan|mesh-list
14814637|NCT00863980|Candesartan|candesartan|mesh-list
14814638|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
14814639|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814640|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14814641|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14814642|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814643|NCT00864006|Valproic Acid|valproic acid|mesh-list
14814644|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
14814645|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814646|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814647|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
14814648|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814649|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814650|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
14814651|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14814652|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814653|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814654|NCT00864019|Sertraline|sertraline|mesh-list
14814655|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
14814656|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814657|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14814658|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814659|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814660|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814661|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814662|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
14814663|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814664|NCT00864045|Olanzapine|olanzapine|mesh-list
14814665|NCT00864045|Sertindole|sertindole|mesh-list
14293972|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673667|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673668|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
14673669|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15189156|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189157|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
15189158|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189159|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673670|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14673671|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
14673672|NCT00288184|Protective Agents|protective agents|mesh-ancestor
14673673|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673674|NCT00288197|Voriconazole|voriconazole|mesh-list
14673675|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
14673676|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673677|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14673678|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14673679|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673680|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673681|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14673682|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
14673683|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673684|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673685|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14673686|NCT00288223|Telithromycin|telithromycin|mesh-list
14673687|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14673688|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673689|NCT00288236|Rimonabant|rimonabant|mesh-list
14673690|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14673691|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14673692|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14673693|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673694|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673695|NCT00288236|Hormones|hormones|mesh-ancestor
14673696|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673697|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673698|NCT00288249|Sagopilone|sagopilone|mesh-list
14673699|NCT00288249|Epothilones|epothilones|mesh-list
14673700|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673701|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673702|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673703|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673704|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673705|NCT00288262|Melatonin|melatonin|mesh-list
14673706|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
14673707|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673708|NCT00288262|Protective Agents|protective agents|mesh-ancestor
14673709|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673710|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673711|NCT00288353|Aripiprazole|aripiprazole|mesh-list
14673712|NCT00288353|Ziprasidone|ziprasidone|mesh-list
14673713|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14673714|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673715|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14673716|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14673717|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189160|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
15189161|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15189162|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189163|NCT03858465|Phenylephrine|phenylephrine|mesh-list
15189164|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
15189165|NCT03858465|Ephedrine|ephedrine|mesh-list
15189166|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14673718|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673719|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
14673720|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
15189167|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
15189168|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
15189169|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189170|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189171|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
15189172|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15189173|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
14673721|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673722|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673723|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14673724|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14673725|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
14673726|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14673727|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14673728|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14673729|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14673730|NCT00288379|Budesonide|budesonide|mesh-list
14673731|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
14673732|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14673733|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14673734|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
14673735|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673736|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673737|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14673738|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
14673739|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
14673740|NCT00288379|Hormones|hormones|mesh-ancestor
14673741|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14673742|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14673743|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14673744|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14673745|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673746|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673747|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673748|NCT00288431|Sirolimus|sirolimus|mesh-list
14673749|NCT00288431|Doxorubicin|doxorubicin|mesh-list
14673750|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14673751|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673752|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14673753|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14673754|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673755|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673756|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14673757|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673758|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
14673759|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673760|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
14673761|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673762|NCT00288444|Docetaxel|docetaxel|mesh-list
14673763|NCT00288444|Lonafarnib|lonafarnib|mesh-list
14673764|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673765|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673766|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673767|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673768|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673769|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673770|NCT00288470|Hylan|hylan|mesh-list
14673771|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
14673772|NCT00288470|Protective Agents|protective agents|mesh-ancestor
14673773|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673774|NCT00288483|Policosanol|policosanol|mesh-list
14673775|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14673776|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14673777|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
14673778|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673779|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14673780|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14673781|NCT00288522|Lanreotide|lanreotide|mesh-list
14673782|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673783|NCT00288535|Sirolimus|sirolimus|mesh-list
14673784|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14673785|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673786|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14673787|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189174|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
15189175|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14673788|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
14673789|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14673790|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
14673791|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673792|NCT00288548|Metoprolol|metoprolol|mesh-list
14673793|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14673794|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673795|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
14673796|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
14673797|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673798|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673799|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14673800|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14673801|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14673802|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673803|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673804|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673805|NCT00288561|Ranibizumab|ranibizumab|mesh-list
14673806|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14673807|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14673808|NCT00288561|Growth Substances|growth substances|mesh-ancestor
14673809|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673810|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
14673811|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673812|NCT00288652|Reboxetine|reboxetine|mesh-list
14673813|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
14673814|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673815|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14673816|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14673817|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14673818|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673819|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673820|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673821|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673822|NCT00288717|Telmisartan|telmisartan|mesh-list
14673823|NCT00288717|Candesartan|candesartan|mesh-list
14673824|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673825|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14673826|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14673827|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673828|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14673829|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
14673830|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673831|NCT00288743|Insulin|insulin|mesh-list
14673832|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14673833|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673834|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
14673835|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
14673836|NCT00288769|Vitamins|vitamins|mesh-ancestor
14673837|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
14673838|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673839|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
14673840|NCT00288769|Hematinics|hematinics|mesh-ancestor
14673841|NCT00288782|Mirtazapine|mirtazapine|mesh-list
14673842|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
15189176|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15189177|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15189178|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
15189179|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189180|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673843|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14673844|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14673845|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
14673846|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
14673847|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673848|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673849|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673850|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14673851|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15189181|NCT03858465|Protective Agents|protective agents|mesh-ancestor
15189182|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15189183|NCT03858491|Cobicistat|cobicistat|mesh-list
15189184|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15189185|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15189186|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
14673852|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673853|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14673854|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14673855|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14673856|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673857|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14673858|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14673859|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
14673860|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14673861|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
14673862|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
14673863|NCT00288873|Vitamin D|vitamin d|mesh-list
14673864|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14673865|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673866|NCT00288873|Vitamins|vitamins|mesh-ancestor
14673867|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
14673868|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14673869|NCT00288951|Travoprost|travoprost|mesh-list
15189187|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189188|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14673870|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673871|NCT00289042|Enoxaparin|enoxaparin|mesh-list
14673872|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
14673873|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14673874|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14673875|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673876|NCT00289250|Artesunate|artesunate|mesh-list
14673877|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
14673878|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
14673879|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14673880|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
14673881|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14673882|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14673883|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673884|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673885|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
14673886|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
14673887|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14673888|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
14673889|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14673890|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673891|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673892|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14673893|NCT00289250|Renal Agents|renal agents|mesh-ancestor
14673894|NCT00289263|Paclitaxel|paclitaxel|mesh-list
14673895|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14673896|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673897|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673898|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
14673899|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
14673900|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673901|NCT00289354|Chromium|chromium|mesh-list
14673902|NCT00289354|Biotin|biotin|mesh-list
14673903|NCT00289354|Picolinic acid|picolinic acid|mesh-list
14673904|NCT00289354|Trace Elements|trace elements|mesh-ancestor
14673905|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
14673906|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673907|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
14673908|NCT00289354|Vitamins|vitamins|mesh-ancestor
14673909|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14673910|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
14673911|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
14673912|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673913|NCT00289406|Amlodipine|amlodipine|mesh-list
14673914|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14673915|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14673916|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14673917|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673918|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14673919|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673920|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
14673921|NCT00289419|Ketorolac|ketorolac|mesh-list
14673922|NCT00289419|Epinephrine|epinephrine|mesh-list
14673923|NCT00289419|Racepinephrine|racepinephrine|mesh-list
14673924|NCT00289419|Morphine|morphine|mesh-list
14673925|NCT00289419|Ropivacaine|ropivacaine|mesh-list
14673926|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
14673927|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14673928|NCT00289419|Narcotics|narcotics|mesh-ancestor
14673929|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14673930|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673931|NCT00289419|Analgesics|analgesics|mesh-ancestor
14673932|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
14673933|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14673934|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
14673935|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
14673936|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14673937|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14673938|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14673939|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14673940|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14673941|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673942|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673943|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14673944|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14673945|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
14673946|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14673947|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14673948|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14673949|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
14673950|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14673951|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
14673952|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
14673953|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
14673954|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14673955|NCT00289445|Leucovorin|leucovorin|mesh-list
14673956|NCT00289445|Folic Acid|folic acid|mesh-list
14673957|NCT00289445|Mitomycins|mitomycins|mesh-list
14673958|NCT00289445|Mitomycin|mitomycin|mesh-list
14673959|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
14673960|NCT00289445|Antidotes|antidotes|mesh-ancestor
14673961|NCT00289445|Protective Agents|protective agents|mesh-ancestor
14673962|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673963|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
14673964|NCT00289445|Vitamins|vitamins|mesh-ancestor
14673965|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
14673966|NCT00289445|Hematinics|hematinics|mesh-ancestor
14673967|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14673968|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673969|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
14673970|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673971|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14673972|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673973|NCT00289510|Vaccines|vaccines|mesh-list
14673974|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
14673975|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14673976|NCT00289588|Mupirocin|mupirocin|mesh-list
14673977|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14673978|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14673979|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14673980|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14673981|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673982|NCT00289601|Eptifibatide|eptifibatide|mesh-list
14673983|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14673984|NCT00289627|Ipilimumab|ipilimumab|mesh-list
14673985|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14673986|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673987|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14673988|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673989|NCT00289809|Ifosfamide|ifosfamide|mesh-list
14673990|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14673991|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
14673992|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14673993|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726718|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14726719|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726720|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
14726721|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
15189189|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15189190|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189191|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189192|NCT03858387|Meropenem|meropenem|mesh-list
15189193|NCT03858387|Imipenem|imipenem|mesh-list
15189194|NCT03858387|Cilastatin|cilastatin|mesh-list
15189195|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15189196|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189197|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
15189198|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726722|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726723|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14726724|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14726725|NCT00510263|Protective Agents|protective agents|mesh-ancestor
14726726|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
14726727|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726728|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
14726729|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726730|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726731|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726732|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726733|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
14726734|NCT00510367|Doxorubicin|doxorubicin|mesh-list
14726735|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14726736|NCT00510367|Fluorouracil|fluorouracil|mesh-list
14726737|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726738|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
14726739|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726740|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726741|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14726742|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
14726743|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726744|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726745|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14726746|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14726747|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14726748|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726749|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726750|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
14726751|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14726752|NCT00510393|Everolimus|everolimus|mesh-list
14726753|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189199|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189200|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15189201|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189202|NCT03858270|Memantine|memantine|mesh-list
15189203|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15189204|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15189205|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
15189206|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189207|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726754|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726755|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
14726756|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726757|NCT00510406|Tamsulosin|tamsulosin|mesh-list
14726758|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
14726759|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14726760|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14726761|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14726762|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
14726763|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726764|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726765|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726766|NCT00510406|Urological Agents|urological agents|mesh-ancestor
14726767|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14726768|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15189208|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189209|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14673994|NCT00289835|Paclitaxel|paclitaxel|mesh-list
14673995|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14673996|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14673997|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14673998|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
14673999|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674000|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674001|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674002|NCT00289861|Risperidone|risperidone|mesh-list
14674003|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14674004|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
14674005|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674006|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674007|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674008|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14674009|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14674010|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674011|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674012|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14674013|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
14674014|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14674015|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15189210|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15189211|NCT03858062|Insulin|insulin|mesh-list
15189212|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15189213|NCT03858062|Pancrelipase|pancrelipase|mesh-list
14674016|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
14674017|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674018|NCT00289952|Valproic Acid|valproic acid|mesh-list
14674019|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
14674020|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674021|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674022|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
14674023|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674024|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674025|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
14674026|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14674027|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674028|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674029|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
14674030|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674031|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15189214|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15189215|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674032|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
14674033|NCT00290017|Pemetrexed|pemetrexed|mesh-list
14674034|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674035|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674036|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674037|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14674038|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14674039|NCT00290030|Alfuzosin|alfuzosin|mesh-list
14674040|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14674041|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14674042|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14674043|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
14674044|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674045|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674046|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674047|NCT00290030|Urological Agents|urological agents|mesh-ancestor
14674048|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
14674049|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14674050|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674051|NCT00290069|Sirolimus|sirolimus|mesh-list
14674052|NCT00290069|Tacrolimus|tacrolimus|mesh-list
14674053|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14674054|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
14674055|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674056|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14674057|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674058|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674059|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14674060|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674061|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15189216|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14674062|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674063|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
14674064|NCT00290082|Midazolam|midazolam|mesh-list
14674065|NCT00290082|Loxapine|loxapine|mesh-list
14674066|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14674067|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14674068|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674069|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674070|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14674071|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15189217|NCT03857854|Pirfenidone|pirfenidone|mesh-list
15189218|NCT03857854|Analgesics|analgesics|mesh-ancestor
15189219|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
15189220|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189221|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189222|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15189223|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15189224|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189225|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15189226|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189227|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15189228|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189229|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189230|NCT03857399|Caspofungin|caspofungin|mesh-list
15189231|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
15189232|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189233|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674072|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674073|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14674074|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
14674075|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
14674076|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
14674077|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
14674078|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674079|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674080|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14674081|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14674082|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
15189234|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189235|NCT03857711|Amiodarone|amiodarone|mesh-list
15189236|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15189237|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189238|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15189239|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189240|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189241|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15189242|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15189243|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15189244|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189245|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14674083|NCT00290108|Propofol|propofol|mesh-list
14674084|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14674085|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674086|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674087|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14674088|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
14674089|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
14674090|NCT00290121|Olanzapine|olanzapine|mesh-list
14674091|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
14674092|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
14674093|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674094|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674095|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14674096|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14674097|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14674098|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674099|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674100|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14674101|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14674102|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14674103|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674104|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674105|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
14674106|NCT00290173|Ritodrine|ritodrine|mesh-list
14674107|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
14674108|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
14674109|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674110|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674111|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
14674112|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14674113|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14674114|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14674115|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14674116|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14674117|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674118|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674119|NCT00290264|Budesonide|budesonide|mesh-list
14674120|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
14674121|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674122|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14674123|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
14674124|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674125|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674126|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14674127|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
14674128|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
14674129|NCT00290264|Hormones|hormones|mesh-ancestor
14674130|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674131|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14674132|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14674133|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14674134|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
14674135|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674136|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674137|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
14674138|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14674139|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674140|NCT00290420|Chloroquine|chloroquine|mesh-list
14674141|NCT00290420|Amebicides|amebicides|mesh-ancestor
14674142|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14674143|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14674144|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674145|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
15189246|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15189247|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15189248|NCT03857763|Paclitaxel|paclitaxel|mesh-list
15189249|NCT03857763|Apatinib|apatinib|mesh-list
15189250|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15189251|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189252|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674146|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674147|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
14674148|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674149|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14674150|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674151|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674152|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
14674153|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14674154|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14674155|NCT00290602|Prednisolone|prednisolone|mesh-list
15189253|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
15189254|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674156|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
14674157|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14674158|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
14674159|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674160|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
14674161|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
14674162|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674163|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674164|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14674165|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
14674166|NCT00290602|Hormones|hormones|mesh-ancestor
14674167|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14293973|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293974|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674168|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14674169|NCT00290602|Protective Agents|protective agents|mesh-ancestor
14674170|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14674171|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674172|NCT00290628|Cyclosporine|cyclosporine|mesh-list
14674173|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
14674174|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
14674175|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
14674176|NCT00290628|Melphalan|melphalan|mesh-list
14674177|NCT00290628|Busulfan|busulfan|mesh-list
14674178|NCT00290628|Cyclosporins|cyclosporins|mesh-list
14674179|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14674180|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15189255|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189256|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15189257|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189258|NCT03857386|Anesthetics|anesthetics|mesh-list
15189259|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189260|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189261|NCT03857815|Antibodies|antibodies|mesh-list
15189262|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
15189263|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189264|NCT03857581|Olanzapine|olanzapine|mesh-list
15189265|NCT03857581|Clozapine|clozapine|mesh-list
15189266|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
15189267|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
15189268|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189269|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189270|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15189271|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14674181|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
14674182|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674183|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674184|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14674185|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
14674186|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674187|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674188|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14674189|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674190|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
14674191|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674192|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
14674193|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14674194|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14674195|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14674196|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
14674197|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14674198|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674199|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
14674200|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
14674201|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674202|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14674203|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
14674204|NCT00290628|Hormones|hormones|mesh-ancestor
14674205|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674206|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14674207|NCT00290628|Protective Agents|protective agents|mesh-ancestor
15189272|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15189273|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674208|NCT00290641|Cyclosporine|cyclosporine|mesh-list
14674209|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
15189274|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674210|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
14674211|NCT00290641|Fludarabine|fludarabine|mesh-list
14674212|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
14674213|NCT00290641|Cyclosporins|cyclosporins|mesh-list
14674214|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14674215|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
14674216|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674217|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674218|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14674219|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
14674220|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674221|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189275|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15189276|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15189277|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189278|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293975|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674222|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14674223|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14674224|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
14674225|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674226|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
14674227|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674228|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14674229|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14674230|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14674231|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14674232|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
14674233|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14674234|NCT00290667|Prednisone|prednisone|mesh-list
14674235|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
14674236|NCT00290667|Rituximab|rituximab|mesh-list
14674237|NCT00290667|Doxorubicin|doxorubicin|mesh-list
14674238|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14674239|NCT00290667|Vincristine|vincristine|mesh-list
14674240|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15189279|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189280|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
15189281|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15189282|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
15189283|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
14293976|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14293977|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14293978|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14293979|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14293980|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14293981|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14293982|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
14293983|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14674241|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
15223898|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223899|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
15223900|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223901|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15223902|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15223903|NCT04990323|Vidarabine|vidarabine|mesh-list
14674242|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674243|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674244|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14674245|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
14674246|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674247|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223904|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
15223905|NCT04990323|Busulfan|busulfan|mesh-list
15223906|NCT04990323|Thiotepa|thiotepa|mesh-list
15223907|NCT04990323|Fludarabine|fludarabine|mesh-list
15223908|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
15223909|NCT04990323|Clofarabine|clofarabine|mesh-list
15223910|NCT04990323|Tacrolimus|tacrolimus|mesh-list
15223911|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223912|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
15223913|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223914|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674248|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15223915|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15223916|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
14293984|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674249|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14674250|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15189284|NCT03857334|Cortivazol|cortivazol|mesh-list
15189285|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189286|NCT03857139|Nicotine|nicotine|mesh-list
15189287|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15189288|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
15189289|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189290|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189291|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15189292|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15189293|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
15189294|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189295|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189296|NCT03856853|Pirfenidone|pirfenidone|mesh-list
14674251|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14674252|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14674253|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189297|NCT03856853|Analgesics|analgesics|mesh-ancestor
15189298|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
15189299|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674254|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674255|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
14674256|NCT00290667|Hormones|hormones|mesh-ancestor
14674257|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674258|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14674259|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14674260|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674261|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674262|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674263|NCT00290680|Celecoxib|celecoxib|mesh-list
14674264|NCT00290680|Bortezomib|bortezomib|mesh-list
14674265|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674266|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14674267|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674268|NCT00290680|Analgesics|analgesics|mesh-ancestor
14674269|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
14674270|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674271|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674272|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674273|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674274|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14674275|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674276|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674277|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674278|NCT00290719|Irinotecan|irinotecan|mesh-list
14674279|NCT00290719|Gefitinib|gefitinib|mesh-list
14674280|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674281|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14674282|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14674283|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674284|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674285|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14674286|NCT00290758|Genistein|genistein|mesh-list
14674287|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14674288|NCT00290758|Protective Agents|protective agents|mesh-ancestor
14674289|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674290|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674291|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14674292|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674293|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674294|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
14674295|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14674296|NCT00290758|Estrogens|estrogens|mesh-ancestor
14674297|NCT00290758|Hormones|hormones|mesh-ancestor
14674298|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674299|NCT00290823|Albendazole|albendazole|mesh-list
14674300|NCT00290823|Dexamethasone|dexamethasone|mesh-list
14674301|NCT00290823|Omeprazole|omeprazole|mesh-list
14674302|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674303|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
14674304|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
15189300|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189301|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14674305|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674306|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674307|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14674308|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
14674309|NCT00290823|Hormones|hormones|mesh-ancestor
14674310|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674311|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14674312|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674313|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14674314|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14674315|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674316|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674317|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
14674318|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14674319|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674320|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
14674321|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14674322|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14674323|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674324|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674325|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674326|NCT00290836|Thrombin|thrombin|mesh-list
14674327|NCT00290836|Aprotinin|aprotinin|mesh-list
14674328|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
14674329|NCT00290836|Coagulants|coagulants|mesh-ancestor
14674330|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14674331|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14674332|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
14674333|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674334|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674335|NCT00290849|Bivalirudin|bivalirudin|mesh-list
14674336|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
14674337|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14674338|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
14674339|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674340|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674341|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
14674342|NCT00290901|Celecoxib|celecoxib|mesh-list
15189302|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15189303|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189304|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15189305|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189306|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
15189307|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
15189308|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15189309|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15189310|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674343|NCT00290901|Tramadol|tramadol|mesh-list
14674344|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14674345|NCT00290901|Narcotics|narcotics|mesh-ancestor
14674346|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674347|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674348|NCT00290901|Analgesics|analgesics|mesh-ancestor
14674349|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
14674350|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674351|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14674352|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674353|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674354|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674355|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14674356|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674357|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674358|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674359|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14674360|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
14674361|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674362|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14674363|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15189311|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674364|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14674365|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674366|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674367|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
14674368|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674369|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14674370|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14674371|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
14674372|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14674373|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674374|NCT00290940|Metformin|metformin|mesh-list
14674375|NCT00290940|Pioglitazone|pioglitazone|mesh-list
14674376|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14674377|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674378|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
14674379|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14674380|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674381|NCT00290992|Rasburicase|rasburicase|mesh-list
14674382|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
14674383|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674384|NCT00291005|Docetaxel|docetaxel|mesh-list
14674385|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674386|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674387|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674388|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674389|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674390|NCT00291109|Letrozole|letrozole|mesh-list
14674391|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674392|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14674393|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14674394|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674395|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674396|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14674397|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
14674398|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674399|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674400|NCT00291122|Celecoxib|celecoxib|mesh-list
14674401|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14674402|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674403|NCT00291122|Analgesics|analgesics|mesh-ancestor
14674404|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
14674405|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674406|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674407|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674408|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674409|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14674410|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674411|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674412|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674413|NCT00291148|Pregabalin|pregabalin|mesh-list
14674414|NCT00291148|Paroxetine|paroxetine|mesh-list
14674415|NCT00291148|Analgesics|analgesics|mesh-ancestor
14674416|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
14674417|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674418|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674419|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
14674420|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14674421|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14674422|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674423|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14674424|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14674425|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14674426|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674427|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674428|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14674429|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14674430|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674431|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
14674432|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15189312|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189313|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15189314|NCT03856970|Glyburide|glyburide|mesh-list
15189315|NCT03856970|Digoxin|digoxin|mesh-list
15189316|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14674433|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
14674434|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14674435|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14674436|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674437|NCT00291213|Levetiracetam|levetiracetam|mesh-list
14674438|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
14674439|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
14726769|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
14726770|NCT00510419|Sumatriptan|sumatriptan|mesh-list
14726771|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14726772|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14726773|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14726774|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
14726775|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726776|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726777|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726778|NCT00510445|Imetelstat|imetelstat|mesh-list
14726779|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
14726780|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726781|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726782|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726783|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
14726784|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14726785|NCT00510471|Antibodies|antibodies|mesh-list
14726786|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14726787|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
14726788|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726789|NCT00510536|Acetaminophen|acetaminophen|mesh-list
14726790|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14726791|NCT00510536|Analgesics|analgesics|mesh-ancestor
14726792|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
14726793|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726794|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726795|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
14726796|NCT00510588|Metformin|metformin|mesh-list
14726797|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14726798|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726799|NCT00510614|Tinidazole|tinidazole|mesh-list
14726800|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
14726801|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726802|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14726803|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726804|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14726805|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14726806|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14726807|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
14726808|NCT00510627|Irinotecan|irinotecan|mesh-list
14726809|NCT00510627|Cetuximab|cetuximab|mesh-list
15189317|NCT03856970|Norethindrone|norethindrone|mesh-list
15189318|NCT03856970|Estradiol|estradiol|mesh-list
15189319|NCT03856970|Estrogens|estrogens|mesh-ancestor
15189320|NCT03856970|Hormones|hormones|mesh-ancestor
15189321|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189322|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726810|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726811|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14726812|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14726813|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726814|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726815|NCT00510627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14726816|NCT00510640|Sunitinib|sunitinib|mesh-list
14726817|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726818|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14726819|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14726820|NCT00510640|Growth Substances|growth substances|mesh-ancestor
14726821|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726822|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
14726823|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726824|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726825|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726826|NCT00510666|Tramadol|tramadol|mesh-list
14726827|NCT00510666|Butorphanol|butorphanol|mesh-list
15189323|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14726828|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14726829|NCT00510666|Narcotics|narcotics|mesh-ancestor
14726830|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674440|NCT00291369|Interferons|interferons|mesh-list
14674441|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
14674442|NCT00291369|Interleukin-2|interleukin-2|mesh-list
14674443|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14674444|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
14674445|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674446|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
14674447|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674448|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
14674449|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674450|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674451|NCT00291369|Analgesics|analgesics|mesh-ancestor
15189324|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
15189325|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15189326|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15189327|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15189328|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15189329|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15189330|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15189331|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189332|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189333|NCT03856970|Protective Agents|protective agents|mesh-ancestor
15189334|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15189335|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15189336|NCT03856658|Floxuridine|floxuridine|mesh-list
15189337|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189338|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
14674452|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
14674453|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674454|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14674455|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14674456|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14674457|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
14674458|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14674459|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14674460|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14674461|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14674462|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14674463|NCT00291382|Fluticasone|fluticasone|mesh-list
14674464|NCT00291382|Xhance|xhance|mesh-list
14674465|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14674466|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674467|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14674468|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
14674469|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674470|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674471|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14674472|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
14674473|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14674474|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14674475|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14674476|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14674477|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14674478|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
14674479|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674480|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674481|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
14674482|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14674483|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
14674484|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674485|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674486|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15189339|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674487|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
14674488|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14674489|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
14674490|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14293985|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293986|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14293987|NCT00573066|Analgesics|analgesics|mesh-ancestor
14674491|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674492|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14674493|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
14674494|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
14674495|NCT00291408|Protective Agents|protective agents|mesh-ancestor
14674496|NCT00291538|Bortezomib|bortezomib|mesh-list
14674497|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674498|NCT00291616|Interferons|interferons|mesh-list
14674499|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
14674500|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
14674501|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14674502|NCT00291616|Thymalfasin|thymalfasin|mesh-list
14674503|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674504|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
14674505|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674506|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
14674507|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674508|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14674509|NCT00291707|Pemetrexed|pemetrexed|mesh-list
14674510|NCT00291707|Cetuximab|cetuximab|mesh-list
14674511|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674512|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674513|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674514|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14674515|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14674516|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14674517|NCT00291720|Spironolactone|spironolactone|mesh-list
14674518|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14674519|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
14674520|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674521|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14293988|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
14293989|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14293990|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14293991|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14293992|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14674522|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14674523|NCT00291720|Diuretics|diuretics|mesh-ancestor
14674524|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
14674525|NCT00291733|Levetiracetam|levetiracetam|mesh-list
14674526|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
14674527|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
14674528|NCT00291746|Esomeprazole|esomeprazole|mesh-list
14674529|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14674530|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14674531|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14674532|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674533|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674534|NCT00291759|Tamoxifen|tamoxifen|mesh-list
14674535|NCT00291759|Anastrozole|anastrozole|mesh-list
14674536|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14674537|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
14674538|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674539|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674540|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14674541|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674542|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14674543|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14674544|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14674545|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14674546|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14674547|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674548|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674549|NCT00291772|Pramlintide|pramlintide|mesh-list
14674550|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14293993|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14674551|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674552|NCT00291785|Leucovorin|leucovorin|mesh-list
14293994|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14293995|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327522|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327523|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327524|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674553|NCT00291785|Folic Acid|folic acid|mesh-list
14674554|NCT00291785|Fluorouracil|fluorouracil|mesh-list
14674555|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
14674556|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
14674557|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674558|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14674559|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674560|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14674561|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
14674562|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674563|NCT00291785|Antidotes|antidotes|mesh-ancestor
14674564|NCT00291785|Protective Agents|protective agents|mesh-ancestor
14674565|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
14674566|NCT00291785|Vitamins|vitamins|mesh-ancestor
14674567|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
14674568|NCT00291785|Hematinics|hematinics|mesh-ancestor
14674569|NCT00291811|Plerixafor|plerixafor|mesh-list
14674570|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14674571|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14674572|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
15189340|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189341|NCT03856671|Metronidazole|metronidazole|mesh-list
15189342|NCT03856671|Neomycin|neomycin|mesh-list
15189343|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189344|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15189345|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15189346|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15189347|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15189348|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189349|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189350|NCT03856632|Liraglutide|liraglutide|mesh-list
15189351|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
15189352|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15189353|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189354|NCT03856632|Incretins|incretins|mesh-ancestor
15189355|NCT03856632|Hormones|hormones|mesh-ancestor
15189356|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674573|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726831|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726832|NCT00510666|Analgesics|analgesics|mesh-ancestor
14726833|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
15189357|NCT03856697|Gefitinib|gefitinib|mesh-list
15189358|NCT03856697|Maleic acid|maleic acid|mesh-list
14726834|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14726835|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
14726836|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
14726837|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14726838|NCT00510705|Metformin|metformin|mesh-list
14726839|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14726840|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726841|NCT00510913|Tacrolimus|tacrolimus|mesh-list
14726842|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14726843|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
14726844|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726845|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14726846|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726847|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726848|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
14726849|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189359|NCT03856697|Abivertinib|abivertinib|mesh-list
15189360|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674574|NCT00291850|Paclitaxel|paclitaxel|mesh-list
14674575|NCT00291850|Cisplatin|cisplatin|mesh-list
14674576|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14674577|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674578|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674579|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674580|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674581|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674582|NCT00291863|Simvastatin|simvastatin|mesh-list
14674583|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14674584|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14674585|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
14674586|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674587|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14674588|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14674589|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674590|NCT00291915|Adalimumab|adalimumab|mesh-list
14674591|NCT00291915|Methotrexate|methotrexate|mesh-list
14674592|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14674593|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
14674594|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14674595|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674596|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14674597|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
14674598|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674599|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674600|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
14674601|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674602|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14674603|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14674604|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
14674605|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674606|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14674607|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674608|NCT00291980|Vaccines|vaccines|mesh-list
14674609|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
14674610|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674611|NCT00292071|Caspofungin|caspofungin|mesh-list
14674612|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
15189361|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189362|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674613|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674614|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674615|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189363|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15189364|NCT03856502|Dexamethasone|dexamethasone|mesh-list
15189365|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
15189366|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
14293996|NCT00573131|Paclitaxel|paclitaxel|mesh-list
14674616|NCT00292110|Methadone|methadone|mesh-list
14674617|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14674618|NCT00292110|Narcotics|narcotics|mesh-ancestor
14674619|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674620|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674621|NCT00292110|Analgesics|analgesics|mesh-ancestor
14674622|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
14674623|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674624|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
14674625|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14674626|NCT00292123|Methadone|methadone|mesh-list
14674627|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14674628|NCT00292123|Narcotics|narcotics|mesh-ancestor
14674629|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189367|NCT03856502|BB 1101|bb 1101|mesh-list
15189368|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14293997|NCT00573131|Cisplatin|cisplatin|mesh-list
14293998|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14293999|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294000|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
14294001|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
14294002|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
14327525|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674630|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674631|NCT00292123|Analgesics|analgesics|mesh-ancestor
14674632|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
14674633|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294003|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294004|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14294005|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
14294006|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294007|NCT00573248|Nicotine|nicotine|mesh-list
14674634|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
14674635|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
14674636|NCT00292201|Atorvastatin|atorvastatin|mesh-list
14674637|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14674638|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14674639|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
14674640|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674641|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14674642|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14674643|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674644|NCT00292214|Acetaminophen|acetaminophen|mesh-list
14674645|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674646|NCT00292214|Analgesics|analgesics|mesh-ancestor
14674647|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
14674648|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189369|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
15189370|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
15189371|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189372|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189373|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14294008|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14294009|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
14674649|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674650|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
14674651|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
14674652|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15189374|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
15189375|NCT03856502|Hormones|hormones|mesh-ancestor
15189376|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189377|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15189378|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189379|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
15189380|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189381|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189382|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
15189383|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
15189384|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189385|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
15189386|NCT03856242|Tamsulosin|tamsulosin|mesh-list
15189387|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14674653|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
14674654|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674655|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674656|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
14674657|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674658|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
14674659|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14674660|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
14674661|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674662|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674663|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
14674664|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674665|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14674666|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14674667|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14674668|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14674669|NCT00292344|Rifaximin|rifaximin|mesh-list
14674670|NCT00292344|Loperamide|loperamide|mesh-list
14674671|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
14674672|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14674673|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674674|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14674675|NCT00292409|Aripiprazole|aripiprazole|mesh-list
14674676|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
14674677|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14674678|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14674679|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14674680|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674681|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674682|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
14674683|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
14674684|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674685|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674686|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14674687|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14674688|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
14674689|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14674690|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14674691|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14674692|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14674693|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
14674694|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14674695|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
14674696|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814666|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
14674697|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674698|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14674699|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
14674700|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
14674701|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14674702|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
14674703|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674704|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674705|NCT00292526|Enalapril|enalapril|mesh-list
14674706|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14674707|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
14674708|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674709|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674710|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14674711|NCT00292695|Ifosfamide|ifosfamide|mesh-list
14674712|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674713|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14674714|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
14674715|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674716|NCT00292708|Cefmetazole|cefmetazole|mesh-list
14674717|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14674718|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674719|NCT00292721|Celecoxib|celecoxib|mesh-list
14674720|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14674721|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674722|NCT00292721|Analgesics|analgesics|mesh-ancestor
14674723|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
14674724|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674725|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674726|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674727|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674728|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14674729|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674730|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674731|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674732|NCT00292734|Zolpidem|zolpidem|mesh-list
14674733|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14674734|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14674735|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14674736|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674737|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14674738|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
14674739|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
14674740|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674741|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674742|NCT00292747|Ibuprofen|ibuprofen|mesh-list
14674743|NCT00292747|Drotaverin|drotaverin|mesh-list
14674744|NCT00292747|Papaverine|papaverine|mesh-list
14674745|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14674746|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15189388|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15189389|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15189390|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
15189391|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189392|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189393|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189394|NCT03856242|Urological Agents|urological agents|mesh-ancestor
15189395|NCT03856112|Dexamethasone|dexamethasone|mesh-list
15189396|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
15189397|NCT03856112|Venetoclax|venetoclax|mesh-list
15189398|NCT03856112|Ixazomib|ixazomib|mesh-list
15189399|NCT03856112|Ichthammol|ichthammol|mesh-list
15189400|NCT03856112|BB 1101|bb 1101|mesh-list
15189401|NCT03856112|Glycine|glycine|mesh-list
15189402|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189403|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
15189404|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
15189405|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189406|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674747|NCT00292747|Analgesics|analgesics|mesh-ancestor
14674748|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
14674749|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674750|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674751|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674752|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674753|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674754|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674755|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674756|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
14674757|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
14674758|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
14674759|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14674760|NCT00292747|Urological Agents|urological agents|mesh-ancestor
14674761|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
14674762|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14674763|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674764|NCT00292799|Metformin|metformin|mesh-list
14674765|NCT00292799|Orlistat|orlistat|mesh-list
14674766|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14674767|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674768|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674769|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674770|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14674771|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14674772|NCT00292838|Fluticasone|fluticasone|mesh-list
14674773|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674774|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14674775|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
14674776|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674777|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674778|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14674779|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
15189407|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15189408|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
15189409|NCT03856112|Hormones|hormones|mesh-ancestor
15189410|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189411|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15189412|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189413|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674780|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14674781|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14674782|NCT00292890|Insulin|insulin|mesh-list
14674783|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14674784|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674785|NCT00292929|Artesunate|artesunate|mesh-list
14674786|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
14674787|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15189414|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
15189415|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189416|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
15189417|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189418|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189419|NCT03855865|Vortioxetine|vortioxetine|mesh-list
15189420|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
15189421|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15189422|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15189423|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15189424|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189425|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189426|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15189427|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15189428|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189429|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189430|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189431|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
15189432|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15189433|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15189434|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15189435|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14674788|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14674789|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674790|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674791|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
14674792|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
14674793|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14674794|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
14674795|NCT00292955|Cetuximab|cetuximab|mesh-list
14674796|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14674797|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674798|NCT00293072|Rituximab|rituximab|mesh-list
14674799|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14674800|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674801|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
14674802|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674803|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674804|NCT00293085|Docetaxel|docetaxel|mesh-list
14674805|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674806|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674807|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674808|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674809|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674810|NCT00293098|Deferiprone|deferiprone|mesh-list
14674811|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14674812|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
14674813|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
14674814|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674815|NCT00293111|Etodolac|etodolac|mesh-list
14674816|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14674817|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674818|NCT00293111|Analgesics|analgesics|mesh-ancestor
14674819|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
14674820|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674821|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674822|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674823|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674824|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14674825|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674826|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674827|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674828|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
14674829|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674830|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15189436|NCT03855826|Amiodarone|amiodarone|mesh-list
15189437|NCT03855826|Nifekalant|nifekalant|mesh-list
14674831|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674832|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674833|NCT00293150|Eplerenone|eplerenone|mesh-list
14726850|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14674834|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14674835|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
14674836|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674837|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674838|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14674839|NCT00293150|Diuretics|diuretics|mesh-ancestor
14674840|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
14674841|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14674842|NCT00293163|Hylan|hylan|mesh-list
14674843|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
14674844|NCT00293163|Protective Agents|protective agents|mesh-ancestor
15189438|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15189439|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189440|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15189441|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189442|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674845|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674846|NCT00293176|Donepezil|donepezil|mesh-list
14674847|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14674848|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674849|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674850|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
14674851|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14674852|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674853|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
14674854|NCT00293228|Isoniazid|isoniazid|mesh-list
14674855|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
14674856|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14674857|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674858|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14674859|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14674860|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
14674861|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674862|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15189443|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15189444|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15189445|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15189446|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189447|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15189448|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15189449|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14674863|NCT00293280|Lomustine|lomustine|mesh-list
14674864|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14674865|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
14674866|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674867|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674868|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14674869|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674870|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674871|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674872|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15189450|NCT03855501|Calcium|calcium|mesh-list
15189451|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15189452|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189453|NCT03855579|Simendan|simendan|mesh-list
15189454|NCT03855579|Milrinone|milrinone|mesh-list
15189455|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15189456|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189457|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15189458|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14674873|NCT00293332|Bevacizumab|bevacizumab|mesh-list
14674874|NCT00293332|Carboplatin|carboplatin|mesh-list
14674875|NCT00293332|Docetaxel|docetaxel|mesh-list
14674876|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14674877|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674878|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14674879|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14674880|NCT00293332|Growth Substances|growth substances|mesh-ancestor
14674881|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674882|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14674883|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674884|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674885|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674886|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674887|NCT00293345|Gemcitabine|gemcitabine|mesh-list
14674888|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14674889|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
14674890|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674891|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674892|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
14674893|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674894|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674895|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14674896|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
14674897|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674898|NCT00293358|Carboplatin|carboplatin|mesh-list
14674899|NCT00293358|Etoposide|etoposide|mesh-list
14674900|NCT00293358|Ifosfamide|ifosfamide|mesh-list
14674901|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
14674902|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674903|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14674904|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14674905|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14674906|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674907|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674908|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14674909|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
14674910|NCT00293371|Prednisone|prednisone|mesh-list
14674911|NCT00293371|Docetaxel|docetaxel|mesh-list
14674912|NCT00293371|Vatalanib|vatalanib|mesh-list
14674913|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674914|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
14674915|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
14674916|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
14674917|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674918|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674919|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
14674920|NCT00293371|Hormones|hormones|mesh-ancestor
14674921|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14674922|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674923|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14674924|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14674925|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674926|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
14674927|NCT00293410|Clofarabine|clofarabine|mesh-list
14674928|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14674929|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
14674930|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674931|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674932|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14674933|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
14674934|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674935|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674936|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14674937|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14674938|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
14674939|NCT00293436|Celecoxib|celecoxib|mesh-list
14674940|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14674941|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674942|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14674943|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674944|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674945|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14726851|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814667|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
14814668|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674946|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14674947|NCT00293436|Analgesics|analgesics|mesh-ancestor
14674948|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
14674949|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14674950|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674951|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14674952|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674953|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14674954|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14674955|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
14674956|NCT00293475|Rituximab|rituximab|mesh-list
14674957|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14674958|NCT00293475|Carboplatin|carboplatin|mesh-list
14674959|NCT00293475|Methotrexate|methotrexate|mesh-list
14674960|NCT00293475|Mannitol|mannitol|mesh-list
14674961|NCT00293475|Antibodies|antibodies|mesh-list
14674962|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
14674963|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14674964|NCT00293475|Antidotes|antidotes|mesh-list
14674965|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
14674966|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14674967|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14674968|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14674969|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14674970|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
14674971|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14674972|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14674973|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
14674974|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674975|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14674976|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14674977|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14674978|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14674979|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14674980|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14674981|NCT00293475|Diuretics|diuretics|mesh-ancestor
15189459|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189460|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189461|NCT03855579|Protective Agents|protective agents|mesh-ancestor
15189462|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189463|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15189464|NCT03855423|Tocotrienols|tocotrienols|mesh-list
15189465|NCT03855423|Vitamin E|vitamin e|mesh-list
15189466|NCT03855423|Tocopherols|tocopherols|mesh-list
15189467|NCT03855423|Tocovid|tocovid|mesh-list
15189468|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
15189469|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189470|NCT03855423|Protective Agents|protective agents|mesh-ancestor
15189471|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189472|NCT03855423|Vitamins|vitamins|mesh-ancestor
15189473|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
15189474|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
15189475|NCT03855527|Fluorides|fluorides|mesh-list
15189476|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
15189477|NCT03855527|Protective Agents|protective agents|mesh-ancestor
15189478|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189479|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15189480|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189481|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
15223917|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223918|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223919|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15223920|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223921|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
14674982|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
14674983|NCT00293475|Protective Agents|protective agents|mesh-ancestor
14674984|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
14674985|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
14674986|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14674987|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14674988|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
15223922|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
14674989|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
14674990|NCT00293501|Tinzaparin|tinzaparin|mesh-list
14674991|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14674992|NCT00293501|Dalteparin|dalteparin|mesh-list
14674993|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
14674994|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14674995|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14674996|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14674997|NCT00293514|Thrombin|thrombin|mesh-list
14674998|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
14674999|NCT00293514|Coagulants|coagulants|mesh-ancestor
14675000|NCT00293527|Interferons|interferons|mesh-list
14675001|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
14675002|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
14675003|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675004|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
14675005|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675006|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
14675007|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675008|NCT00293592|Dexamethasone|dexamethasone|mesh-list
14675009|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14675010|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
14675011|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
14675012|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675013|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675014|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14675015|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
14675016|NCT00293592|Hormones|hormones|mesh-ancestor
14675017|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675018|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14675019|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675020|NCT00293631|Ketorolac|ketorolac|mesh-list
14675021|NCT00293631|Lornoxicam|lornoxicam|mesh-list
14675022|NCT00293631|Piroxicam|piroxicam|mesh-list
14675023|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14675024|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14675025|NCT00293631|Analgesics|analgesics|mesh-ancestor
14675026|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
14675027|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675028|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675029|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14675030|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675031|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14675032|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675033|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675034|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
14675035|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
14675036|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
14675037|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675038|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675039|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14675040|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14675041|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
14675042|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
14675043|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675044|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675045|NCT00293657|Lornoxicam|lornoxicam|mesh-list
14675046|NCT00293657|Piroxicam|piroxicam|mesh-list
14675047|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14675048|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14675049|NCT00293657|Analgesics|analgesics|mesh-ancestor
14675050|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
14675051|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675052|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675053|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14675054|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675055|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14675056|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189482|NCT03855306|Glyburide|glyburide|mesh-list
15189483|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15189484|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189485|NCT03855384|Cisplatin|cisplatin|mesh-list
15189486|NCT03855384|Carboplatin|carboplatin|mesh-list
15189487|NCT03855384|Fluorouracil|fluorouracil|mesh-list
15189488|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189489|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
14675057|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729300|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675058|NCT00293670|Goserelin|goserelin|mesh-list
14675059|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14675060|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675061|NCT00293696|Goserelin|goserelin|mesh-list
14675062|NCT00293696|Bicalutamide|bicalutamide|mesh-list
14675063|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14675064|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675065|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
15189490|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189491|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189492|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15189493|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
15189494|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189495|NCT03855332|Cilostazol|cilostazol|mesh-list
15189496|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
15189497|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189498|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14294010|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294011|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675066|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
15189499|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15189500|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189501|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189502|NCT03855332|Urological Agents|urological agents|mesh-ancestor
15189503|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14294012|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14675067|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675068|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675069|NCT00293735|Labetalol|labetalol|mesh-list
14675070|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14675071|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14675072|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675073|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675074|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675075|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675076|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675077|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
14675078|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
14675079|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675080|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14675081|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14675082|NCT00293761|Travoprost|travoprost|mesh-list
14675083|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675084|NCT00293787|Timolol|timolol|mesh-list
14675085|NCT00293787|Travoprost|travoprost|mesh-list
14675086|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14675087|NCT00293787|Latanoprost|latanoprost|mesh-list
14675088|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14675089|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14675090|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14675091|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675092|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675093|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675094|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675095|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14675096|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675097|NCT00293800|Timolol|timolol|mesh-list
14675098|NCT00293800|Travoprost|travoprost|mesh-list
14675099|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14675100|NCT00293800|Latanoprost|latanoprost|mesh-list
14675101|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14675102|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14675103|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14675104|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675105|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189504|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
14675106|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675107|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675108|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14675109|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675110|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14675111|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
14675112|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675113|NCT00293839|Oxybutynin|oxybutynin|mesh-list
14675114|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
14675115|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
14675116|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675117|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675118|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14675119|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14675120|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
14675121|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675122|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675123|NCT00293839|Urological Agents|urological agents|mesh-ancestor
14675124|NCT00293891|Tacrolimus|tacrolimus|mesh-list
14675125|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675126|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
14675127|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675128|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675129|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675130|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294013|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14294014|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
14675131|NCT00293917|Tacrolimus|tacrolimus|mesh-list
14675132|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675133|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
14675134|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675135|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675136|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675137|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675138|NCT00293930|Tacrolimus|tacrolimus|mesh-list
14675139|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675140|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
14675141|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675142|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675143|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675144|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675145|NCT00293969|Morphine|morphine|mesh-list
14675146|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14675147|NCT00293969|Narcotics|narcotics|mesh-ancestor
14675148|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675149|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675150|NCT00293969|Analgesics|analgesics|mesh-ancestor
14675151|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
14675152|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675153|NCT00294008|Risperidone|risperidone|mesh-list
14675154|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14675155|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
14675156|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675157|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675158|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675159|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14675160|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14675161|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675162|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14675163|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14675164|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
14675165|NCT00294086|Valsartan|valsartan|mesh-list
14675166|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675167|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14675168|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14675169|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675170|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14675171|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14675172|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
14675173|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675174|NCT00294099|Antacids|antacids|mesh-ancestor
14675175|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675176|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14675177|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
14675178|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189505|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675179|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
14675180|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675181|NCT00294164|Hormones|hormones|mesh-list
14675182|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675183|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675184|NCT00294190|Topotecan|topotecan|mesh-list
14675185|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14675186|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14675187|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675188|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189506|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189507|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15189508|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
15189509|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14675189|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675190|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
14675191|NCT00294203|Hematinics|hematinics|mesh-ancestor
14675192|NCT00294255|Risperidone|risperidone|mesh-list
14675193|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14675194|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
14675195|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675196|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675197|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675198|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14675199|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14675200|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675201|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14675202|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14675203|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
14675204|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14675205|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
14675206|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675207|NCT00294359|Bevacizumab|bevacizumab|mesh-list
14675208|NCT00294359|Capecitabine|capecitabine|mesh-list
14675209|NCT00294359|Mitomycins|mitomycins|mesh-list
14675210|NCT00294359|Mitomycin|mitomycin|mesh-list
14675211|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14675212|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675213|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14675214|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14675215|NCT00294359|Growth Substances|growth substances|mesh-ancestor
14675216|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675217|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
14675218|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675219|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
14675220|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675221|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14675222|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
14675223|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14675224|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189510|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15189511|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15189512|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15189513|NCT03855332|Protective Agents|protective agents|mesh-ancestor
15189514|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15189515|NCT03855267|Propofol|propofol|mesh-list
14675225|NCT00294385|Gemcitabine|gemcitabine|mesh-list
14675226|NCT00294385|Docetaxel|docetaxel|mesh-list
14675227|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675228|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
14675229|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675230|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675231|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
14675232|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675233|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675234|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675235|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
15189516|NCT03855267|Etomidate|etomidate|mesh-list
15189517|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15189518|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189519|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189520|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15189521|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
15189522|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
15189523|NCT03855371|Decitabine|decitabine|mesh-list
14294015|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675236|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675237|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
14675238|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
14675239|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
14675240|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
14675241|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14675242|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189524|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
15189525|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189526|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
15189527|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189528|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189529|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189530|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
14675243|NCT00294463|Tibolone|tibolone|mesh-list
14675244|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14675245|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14675246|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14675247|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
14675248|NCT00294463|Estradiol|estradiol|mesh-list
14675249|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14675250|NCT00294463|Progesterone|progesterone|mesh-list
14675251|NCT00294463|Estrogens|estrogens|mesh-ancestor
14675252|NCT00294463|Hormones|hormones|mesh-ancestor
14675253|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675254|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675255|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14675256|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
14675257|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14675258|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15189531|NCT03855007|Prednisone|prednisone|mesh-list
14675259|NCT00294463|Progestins|progestins|mesh-ancestor
14675260|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
14675261|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
14675262|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15189532|NCT03855007|Methotrexate|methotrexate|mesh-list
14675263|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14675264|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675265|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14675266|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
14675267|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14675268|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14675269|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15189533|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189534|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
15189535|NCT03855007|Hormones|hormones|mesh-ancestor
15189536|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189537|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189538|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15189539|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189540|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15189541|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
15189542|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15189543|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189544|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
15189545|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189546|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
14675270|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14675271|NCT00294502|Minocycline|minocycline|mesh-list
14675272|NCT00294502|Gentamicins|gentamicins|mesh-list
14675273|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675274|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14675275|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675276|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14675277|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675278|NCT00294567|Amlodipine|amlodipine|mesh-list
14675279|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
14675280|NCT00294567|Calcium|calcium|mesh-list
14675281|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14675282|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675283|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675284|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14675285|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675286|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
14675287|NCT00294580|Maloprim|maloprim|mesh-list
14675288|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
14675289|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14675290|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14675291|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675292|NCT00294593|Leucovorin|leucovorin|mesh-list
14675293|NCT00294593|Folic Acid|folic acid|mesh-list
14675294|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
14675295|NCT00294593|Antidotes|antidotes|mesh-ancestor
14675296|NCT00294593|Protective Agents|protective agents|mesh-ancestor
14675297|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675298|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
14675299|NCT00294593|Vitamins|vitamins|mesh-ancestor
14675300|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
14675301|NCT00294593|Hematinics|hematinics|mesh-ancestor
14675302|NCT00294606|Phenylephrine|phenylephrine|mesh-list
14675303|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
14675304|NCT00294606|Norepinephrine|norepinephrine|mesh-list
14675305|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14675306|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
14675307|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
14675308|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675309|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675310|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
14675311|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14675312|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
14675313|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
14675314|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14675315|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14675316|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14675317|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675318|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675319|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189547|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189548|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14675320|NCT00294606|Protective Agents|protective agents|mesh-ancestor
14675321|NCT00294619|Hormones|hormones|mesh-list
15189549|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675322|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675323|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189550|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
15189551|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15189552|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15189553|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
15189554|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15189555|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15189556|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675324|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14675325|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675326|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14675327|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675328|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675329|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
14675330|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14675331|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675332|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14675333|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14675334|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675335|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675336|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675337|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14675338|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14675339|NCT00294775|Candesartan|candesartan|mesh-list
14675340|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675341|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14675342|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14675343|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675344|NCT00294853|Calcium|calcium|mesh-list
14675345|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14675346|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675347|NCT00294892|Nevirapine|nevirapine|mesh-list
14675348|NCT00294892|Carbamazepine|carbamazepine|mesh-list
14675349|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14675350|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14675351|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675352|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675353|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
14675354|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675355|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14675356|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14675357|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14675358|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14675359|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
14675360|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
14675361|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14675362|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675363|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675364|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14675365|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14675366|NCT00294892|Analgesics|analgesics|mesh-ancestor
14675367|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
14675368|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675369|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15189557|NCT03854799|Capecitabine|capecitabine|mesh-list
15189558|NCT03854799|Avelumab|avelumab|mesh-list
15189559|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675370|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14675371|NCT00294918|Hormones|hormones|mesh-list
14675372|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675373|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675374|NCT00294931|Bevacizumab|bevacizumab|mesh-list
14675375|NCT00294931|Carboplatin|carboplatin|mesh-list
14675376|NCT00294931|Irinotecan|irinotecan|mesh-list
14675377|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14675378|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675379|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14675380|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14675381|NCT00294931|Growth Substances|growth substances|mesh-ancestor
14675382|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675383|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
14675384|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14675385|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14675386|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675387|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675388|NCT00294944|Idazoxan|idazoxan|mesh-list
14675389|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14675390|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14675391|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14675392|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675393|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675394|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675395|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675396|NCT00294996|Doxorubicin|doxorubicin|mesh-list
14675397|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14675398|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675399|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14675400|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14675401|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675402|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675403|NCT00295035|Celecoxib|celecoxib|mesh-list
14675404|NCT00295035|Curcumin|curcumin|mesh-list
14675405|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14675406|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14675407|NCT00295035|Analgesics|analgesics|mesh-ancestor
14675408|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
14675409|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675410|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675411|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14675412|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675413|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14675414|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14675415|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675416|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675417|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675418|NCT00295100|Tamoxifen|tamoxifen|mesh-list
14675419|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14675420|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
14675421|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675422|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675423|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14675424|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675425|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14675426|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14675427|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14675428|NCT00295165|Sargramostim|sargramostim|mesh-list
14675429|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
14675430|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675431|NCT00295178|Vancomycin|vancomycin|mesh-list
14675432|NCT00295178|Daptomycin|daptomycin|mesh-list
14675433|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14675434|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675435|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
14675436|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14675437|NCT00295243|Topotecan|topotecan|mesh-list
14675438|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14675439|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14675440|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675441|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675442|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726852|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726853|NCT00510939|Bortezomib|bortezomib|mesh-list
14726854|NCT00510939|Tipifarnib|tipifarnib|mesh-list
14726855|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726856|NCT00510965|Ranibizumab|ranibizumab|mesh-list
14726857|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14726858|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14726859|NCT00510965|Growth Substances|growth substances|mesh-ancestor
14726860|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726861|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
14726862|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726863|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14726864|NCT00511017|Vitamins|vitamins|mesh-ancestor
14726865|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
14726866|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726867|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14726868|NCT00511069|Bortezomib|bortezomib|mesh-list
14726869|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726870|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14726871|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
15189560|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
15189561|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189562|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189563|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15189564|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
14726872|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726873|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726874|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726875|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726876|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
14726877|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726878|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
14726879|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14726880|NCT00511212|Antibodies|antibodies|mesh-list
14726881|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
14726882|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14726883|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
14726884|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726885|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
14726886|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14726887|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726888|NCT00511225|Vitamins|vitamins|mesh-ancestor
14726889|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
14726890|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14726891|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14726892|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
14726893|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14726894|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14726895|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14726896|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726897|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726898|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
14726899|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726900|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14726901|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189565|NCT03854812|Fentanyl|fentanyl|mesh-list
15189566|NCT03854812|Propofol|propofol|mesh-list
15189567|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15189568|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189569|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189570|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14726902|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726903|NCT00511316|Montelukast|montelukast|mesh-list
14726904|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15189571|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
15189572|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
15189573|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14726905|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
14726906|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14726907|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
15189574|NCT03854812|Narcotics|narcotics|mesh-ancestor
15189575|NCT03854812|Analgesics|analgesics|mesh-ancestor
14675443|NCT00295282|Antibodies|antibodies|mesh-list
14675444|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14675445|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
14675446|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675447|NCT00295308|Clonidine|clonidine|mesh-list
14675448|NCT00295308|Analgesics|analgesics|mesh-ancestor
14675449|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
14675450|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675451|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675452|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675453|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
14675454|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
15189576|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
15189577|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189578|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15189579|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15189580|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
14675455|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14675456|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15189581|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15189582|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189583|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189584|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14675457|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14675458|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675459|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675460|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675461|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
14675462|NCT00295347|Spironolactone|spironolactone|mesh-list
14675463|NCT00295347|Citalopram|citalopram|mesh-list
14675464|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14675465|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14675466|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189585|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
14675467|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675468|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675469|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
14675470|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189586|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15189587|NCT03854942|Naltrexone|naltrexone|mesh-list
14675471|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14675472|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
14675473|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14675474|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14675475|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
14675476|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675477|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14675478|NCT00295347|Diuretics|diuretics|mesh-ancestor
14675479|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
14675480|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14675481|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14675482|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14675483|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14675484|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
14675485|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675486|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14675487|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14675488|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675489|NCT00295386|Zopiclone|zopiclone|mesh-list
14675490|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14675491|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675492|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675493|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14675494|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
14675495|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14675496|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14675497|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14675498|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675499|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675500|NCT00295425|Cyclosporine|cyclosporine|mesh-list
14675501|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
14675502|NCT00295425|Cyclosporins|cyclosporins|mesh-list
14675503|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675504|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675505|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675506|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
14675507|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675508|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
14675509|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675510|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
14675511|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675512|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675513|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14675514|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675515|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14675516|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
14675517|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14675518|NCT00295464|Betamethasone|betamethasone|mesh-list
14675519|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14675520|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
14675521|NCT00295464|Hormones|hormones|mesh-ancestor
14675522|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675523|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675524|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14675525|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14675526|NCT00295542|Atenolol|atenolol|mesh-list
14675527|NCT00295542|Valsartan|valsartan|mesh-list
14675528|NCT00295542|Telmisartan|telmisartan|mesh-list
14675529|NCT00295542|Carvedilol|carvedilol|mesh-list
14675530|NCT00295542|Olmesartan|olmesartan|mesh-list
14675531|NCT00295542|Enalapril|enalapril|mesh-list
14675532|NCT00295542|Lisinopril|lisinopril|mesh-list
14675533|NCT00295542|Nebivolol|nebivolol|mesh-list
14675534|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
14675535|NCT00295542|Doxazosin|doxazosin|mesh-list
14675536|NCT00295542|Indapamide|indapamide|mesh-list
14294016|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675537|NCT00295542|Quinapril|quinapril|mesh-list
14675538|NCT00295542|Torsemide|torsemide|mesh-list
14675539|NCT00295542|Spirapril|spirapril|mesh-list
15189588|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14294017|NCT00573261|Pregabalin|pregabalin|mesh-list
14294018|NCT00573261|Analgesics|analgesics|mesh-ancestor
14294019|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
14675540|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14675541|NCT00295542|Diuretics|diuretics|mesh-list
14675542|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14675543|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14675544|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675545|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14675546|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675547|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675548|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675549|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
14675550|NCT00295542|Protective Agents|protective agents|mesh-ancestor
14675551|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14675552|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14675553|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14675554|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
14675555|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14675556|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14675557|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14675558|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
14675559|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675560|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14675561|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
14675562|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14675563|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
14675564|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
14675565|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675566|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14675567|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14675568|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14675569|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14675570|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14675571|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14675572|NCT00295555|Doxazosin|doxazosin|mesh-list
14675573|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675574|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14675575|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14675576|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14675577|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675578|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675579|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675580|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675581|NCT00295594|Tacrolimus|tacrolimus|mesh-list
14675582|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675583|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
14675584|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675585|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675586|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675587|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675588|NCT00295607|Antibodies|antibodies|mesh-list
14675589|NCT00295607|Tacrolimus|tacrolimus|mesh-list
14675590|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
14675591|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675592|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675593|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675594|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675595|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675596|NCT00295646|Tamoxifen|tamoxifen|mesh-list
14675597|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
14675598|NCT00295646|Anastrozole|anastrozole|mesh-list
14675599|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14294020|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675600|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14675601|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675602|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675603|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14675604|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675605|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14675606|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14675607|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14675608|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14675609|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14675610|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675611|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675612|NCT00295672|Vinorelbine|vinorelbine|mesh-list
14675613|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14675614|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675615|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
14675616|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
14675617|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
14675618|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675619|NCT00295685|Antacids|antacids|mesh-list
14675620|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675621|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14675622|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
14675623|NCT00295698|Filaricides|filaricides|mesh-ancestor
14675624|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
14675625|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
14675626|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14675627|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675628|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14675629|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675630|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675631|NCT00295776|Lamotrigine|lamotrigine|mesh-list
14675632|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
14675633|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14675634|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14675635|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675636|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14675637|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675638|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14675639|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14675640|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675641|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14675642|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14675643|NCT00295789|Paclitaxel|paclitaxel|mesh-list
14675644|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14675645|NCT00295789|Carboplatin|carboplatin|mesh-list
14675646|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14675647|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675648|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
14675649|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
14675650|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
14675651|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675652|NCT00295815|Lomustine|lomustine|mesh-list
14675653|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14675654|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
14675655|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675656|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675657|NCT00295841|Cytarabine|cytarabine|mesh-list
14675658|NCT00295841|Clofarabine|clofarabine|mesh-list
14675659|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675660|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
14814669|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814670|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14814671|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14814672|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14814673|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814674|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814675|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14814676|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814677|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814678|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814679|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675661|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675662|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675663|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
14675664|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675665|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675666|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
14675667|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675668|NCT00295893|Paclitaxel|paclitaxel|mesh-list
14675669|NCT00295893|Docetaxel|docetaxel|mesh-list
14675670|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
14675671|NCT00295893|Carboplatin|carboplatin|mesh-list
14675672|NCT00295893|Doxorubicin|doxorubicin|mesh-list
14675673|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14675674|NCT00295893|Trastuzumab|trastuzumab|mesh-list
14675675|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14675676|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675677|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
14675678|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
14675679|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
14675680|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675681|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675682|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
14675683|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675684|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675685|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14675686|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
14675687|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14675688|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14675689|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14675690|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14675691|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675692|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14675693|NCT00295919|Ketoconazole|ketoconazole|mesh-list
14675694|NCT00295919|Fenretinide|fenretinide|mesh-list
14675695|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
14675696|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675697|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14675698|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14675699|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675700|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675701|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14675702|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
14675703|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675704|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675705|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14675706|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675707|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14675708|NCT00295919|Protective Agents|protective agents|mesh-ancestor
14675709|NCT00295945|Fentanyl|fentanyl|mesh-list
14675710|NCT00295945|Hydromorphone|hydromorphone|mesh-list
14675711|NCT00295945|Ropivacaine|ropivacaine|mesh-list
14675712|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
14675713|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
14675714|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675715|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675716|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
14675717|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675718|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14675719|NCT00295945|Narcotics|narcotics|mesh-ancestor
14675720|NCT00295945|Analgesics|analgesics|mesh-ancestor
14675721|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14675722|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14675723|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
14675724|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
14675725|NCT00295958|Immunotoxins|immunotoxins|mesh-list
14675726|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14675727|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
14675728|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675729|NCT00295971|Fludarabine|fludarabine|mesh-list
14675730|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
14675731|NCT00295971|Thiotepa|thiotepa|mesh-list
14675732|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14814680|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
14675733|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675734|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675735|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
14814681|NCT00864058|Gabapentin|gabapentin|mesh-list
14675736|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675737|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675738|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
14675739|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675740|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14675741|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
14675742|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14675743|NCT00295984|Nicotine|nicotine|mesh-list
14675744|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14675745|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
14675746|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675747|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675748|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14675749|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14675750|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
14675751|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675752|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675753|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
14675754|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
14675755|NCT00295997|Busulfan|busulfan|mesh-list
14675756|NCT00295997|Methotrexate|methotrexate|mesh-list
14675757|NCT00295997|Fludarabine|fludarabine|mesh-list
14675758|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
14675759|NCT00295997|Tacrolimus|tacrolimus|mesh-list
14675760|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14675761|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15189589|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15189590|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189591|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
15189592|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189593|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
15189594|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15189595|NCT03854708|Hormones|hormones|mesh-ancestor
15189596|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189597|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189598|NCT03854383|Isosorbide|isosorbide|mesh-list
15189599|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15189600|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15189601|NCT03854383|Misoprostol|misoprostol|mesh-list
15189602|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15189603|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
14675762|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
14675763|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675764|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675765|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14675766|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
14675767|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675768|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675769|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14675770|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14675771|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
14675772|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14675773|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675774|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
14675775|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
14675776|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675777|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14675778|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14675779|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675780|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14675781|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14675782|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
14675783|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14675784|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675785|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
14675786|NCT00296010|Doxorubicin|doxorubicin|mesh-list
14675787|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14675788|NCT00296010|Methotrexate|methotrexate|mesh-list
14675789|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675790|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
14675791|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675792|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675793|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14675794|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
14675795|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675796|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675797|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14675798|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14675799|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14675800|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14294021|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294022|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
14294023|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14294024|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294025|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294026|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14294027|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14294028|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14294029|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294030|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14294031|NCT00573287|Risperidone|risperidone|mesh-list
14675801|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675802|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14675803|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
14675804|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14675805|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675806|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
14675807|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
14675808|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14675809|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14675810|NCT00296023|Methotrexate|methotrexate|mesh-list
14675811|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
14675812|NCT00296023|Fludarabine|fludarabine|mesh-list
14675813|NCT00296023|Busulfan|busulfan|mesh-list
14675814|NCT00296023|Tacrolimus|tacrolimus|mesh-list
14675815|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14675816|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14675817|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
15189604|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15189605|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189606|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15189607|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14675818|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14675819|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675820|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675821|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
14675822|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189608|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
15189609|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15189610|NCT03854383|Diuretics|diuretics|mesh-ancestor
14675823|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675824|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
14675825|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675826|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14675827|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675828|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
14675829|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675830|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14675831|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675832|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
14675833|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14675834|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14675835|NCT00296049|Vancomycin|vancomycin|mesh-list
14675836|NCT00296049|Daptomycin|daptomycin|mesh-list
14675837|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294032|NCT00573287|Clozapine|clozapine|mesh-list
14675838|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675839|NCT00296062|Bevacizumab|bevacizumab|mesh-list
14675840|NCT00296062|Capecitabine|capecitabine|mesh-list
15189611|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
14675841|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
14675842|NCT00296062|Irinotecan|irinotecan|mesh-list
14675843|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14675844|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675845|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14675846|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14675847|NCT00296062|Growth Substances|growth substances|mesh-ancestor
14675848|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675849|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
14675850|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675851|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
14675852|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294033|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14294034|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
14294035|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675853|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14675854|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14675855|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675856|NCT00296127|Celecoxib|celecoxib|mesh-list
14675857|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14675858|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14675859|NCT00296127|Analgesics|analgesics|mesh-ancestor
14675860|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
14675861|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189612|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189613|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15189614|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189615|NCT03854617|Vinorelbine|vinorelbine|mesh-list
15189616|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15189617|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189618|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
15189619|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
15189620|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
15189621|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189622|NCT03854409|Aripiprazole|aripiprazole|mesh-list
15189623|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
15189624|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15189625|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15189626|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15189627|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189628|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189629|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
15189630|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
15189631|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189632|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189633|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15189634|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15189635|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
15189636|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15189637|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14675862|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675863|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189638|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15189639|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15189640|NCT03854344|Lidocaine|lidocaine|mesh-list
15189641|NCT03854344|Bupivacaine|bupivacaine|mesh-list
15189642|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
15189643|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
14675864|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675865|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14675866|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14675867|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675868|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675869|NCT00296179|Zolpidem|zolpidem|mesh-list
14675870|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14675871|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14675872|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675873|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675874|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14675875|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
14675876|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
14675877|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729301|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189644|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14675878|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675879|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
14675880|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675881|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
14675882|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675883|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14675884|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14675885|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
14675886|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675887|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675888|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14675889|NCT00296218|Irbesartan|irbesartan|mesh-list
14675890|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14675891|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14675892|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14675893|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675894|NCT00296257|Rimacalib|rimacalib|mesh-list
14675895|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14675896|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675897|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675898|NCT00296309|Tacrolimus|tacrolimus|mesh-list
14675899|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675900|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
14675901|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675902|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675903|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675904|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675905|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
14675906|NCT00296348|Tacrolimus|tacrolimus|mesh-list
14675907|NCT00296348|Daclizumab|daclizumab|mesh-list
14675908|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675909|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
14675910|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189645|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189646|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
15189647|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675911|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675912|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675913|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675914|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14675915|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14675916|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14675917|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
14675918|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14675919|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14675920|NCT00296361|Tacrolimus|tacrolimus|mesh-list
14675921|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14675922|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
14675923|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675924|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14675925|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675926|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675927|NCT00296387|Atorvastatin|atorvastatin|mesh-list
14675928|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14675929|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14675930|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14675931|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
14675932|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675933|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14675934|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14675935|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14675936|NCT00296465|Citric Acid|citric acid|mesh-list
14675937|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
14675938|NCT00296465|Clomiphene|clomiphene|mesh-list
14675939|NCT00296465|Enclomiphene|enclomiphene|mesh-list
14675940|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
14675941|NCT00296465|Hormones|hormones|mesh-list
14675942|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14675943|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
15189648|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15189649|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15189650|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15189651|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14675944|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14675945|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
14675946|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
14675947|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675948|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675949|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675950|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14675951|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
14675952|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14675953|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
14675954|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14675955|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14675956|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14675957|NCT00296478|Progesterone|progesterone|mesh-list
14675958|NCT00296478|Progestins|progestins|mesh-ancestor
14675959|NCT00296478|Hormones|hormones|mesh-ancestor
14675960|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675961|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675962|NCT00296530|Fluticasone|fluticasone|mesh-list
14675963|NCT00296530|Xhance|xhance|mesh-list
14675964|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14675965|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14675966|NCT00296530|Montelukast|montelukast|mesh-list
14675967|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14675968|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14675969|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
14675970|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14675971|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675972|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14675973|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
14675974|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
14675975|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14675976|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14675977|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14675978|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14675979|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
14675980|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14675981|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675982|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14675983|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
14675984|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14675985|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14675986|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14675987|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
14675988|NCT00296530|Hormones|hormones|mesh-ancestor
14675989|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
14675990|NCT00296608|Leucovorin|leucovorin|mesh-list
14675991|NCT00296608|Fluorouracil|fluorouracil|mesh-list
14675992|NCT00296608|Calcium|calcium|mesh-list
14675993|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
14675994|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14675995|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14675996|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
14675997|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14675998|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14675999|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676000|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14676001|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
14676002|NCT00296608|Antidotes|antidotes|mesh-ancestor
14676003|NCT00296608|Protective Agents|protective agents|mesh-ancestor
14814682|NCT00864058|Analgesics|analgesics|mesh-ancestor
14676004|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
14676005|NCT00296608|Vitamins|vitamins|mesh-ancestor
14676006|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
14676007|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14676008|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14676009|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
14676010|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676011|NCT00296634|Antacids|antacids|mesh-ancestor
14676012|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676013|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14676014|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
14676015|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
14676016|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14676017|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676018|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14676019|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676020|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676021|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676022|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
14676023|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676024|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
14676025|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676026|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14676027|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189652|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189653|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15189654|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15189655|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
15189656|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676028|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14676029|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14676030|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676031|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14676032|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14676033|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676034|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676035|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676036|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676037|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676038|NCT00296699|Analgesics|analgesics|mesh-ancestor
14676039|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
14676040|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676041|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
15189657|NCT03854266|Heparin|heparin|mesh-list
15189658|NCT03854266|Calcium heparin|calcium heparin|mesh-list
15189659|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14676042|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676043|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
14676044|NCT00296712|Dexetimide|dexetimide|mesh-list
14676045|NCT00296712|Citalopram|citalopram|mesh-list
14676046|NCT00296712|Bupropion|bupropion|mesh-list
14676047|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14676048|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676049|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676050|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676051|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676052|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
14676053|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676054|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14676055|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
14676056|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676057|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14676058|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14676059|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
14676060|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
14676061|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729302|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15189660|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
15189661|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15189662|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15189663|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676062|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14676063|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14676064|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
14676065|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14676066|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
14676067|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14676068|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14676069|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676070|NCT00296751|Fentanyl|fentanyl|mesh-list
14676071|NCT00296751|Meperidine|meperidine|mesh-list
14676072|NCT00296751|Bupivacaine|bupivacaine|mesh-list
14676073|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
14676074|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
14676075|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676076|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676077|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
14676078|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676079|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14676080|NCT00296751|Narcotics|narcotics|mesh-ancestor
14676081|NCT00296751|Analgesics|analgesics|mesh-ancestor
14676082|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14676083|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14676084|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
14676085|NCT00296777|Citalopram|citalopram|mesh-list
14676086|NCT00296777|Bupropion|bupropion|mesh-list
14676087|NCT00296777|Imipramine|imipramine|mesh-list
14676088|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14676089|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676090|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676091|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676092|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676093|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
14676094|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676095|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14676096|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
14676097|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676098|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14676099|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
14676100|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14676101|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14676102|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676103|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14676104|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14676105|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
14676106|NCT00296790|Zolpidem|zolpidem|mesh-list
14676107|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14676108|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14676109|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676110|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676111|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14676112|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
14676113|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
14676114|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676115|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676116|NCT00296803|Clopidogrel|clopidogrel|mesh-list
14676117|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14676118|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14676119|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14676120|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14676121|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
14676122|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729303|NCT00522587|Narcotics|narcotics|mesh-ancestor
14676123|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676124|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676125|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
14676126|NCT00296868|Vitamins|vitamins|mesh-ancestor
14676127|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
14676128|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676129|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
14676130|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676131|NCT00296868|Protective Agents|protective agents|mesh-ancestor
14676132|NCT00296894|Adalimumab|adalimumab|mesh-list
14676133|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676134|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14726908|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14726909|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726910|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14726911|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14726912|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726913|NCT00511446|Docetaxel|docetaxel|mesh-list
14726914|NCT00511446|Capecitabine|capecitabine|mesh-list
14726915|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
14726916|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726917|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
14726918|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
14726919|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
14726920|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294036|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294037|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294038|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14726921|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14726922|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
14726923|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
14726924|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
14726925|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14726926|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14726927|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726928|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726929|NCT00511498|Urological Agents|urological agents|mesh-ancestor
14726930|NCT00511576|Docetaxel|docetaxel|mesh-list
14726931|NCT00511576|Mocetinostat|mocetinostat|mesh-list
14726932|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14726933|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
14726934|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
14726935|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14726936|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726937|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14726938|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14726939|NCT00511602|Insulin|insulin|mesh-list
14726940|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14294039|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14294040|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726941|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726942|NCT00511628|Risperidone|risperidone|mesh-list
14676135|NCT00296933|Citalopram|citalopram|mesh-list
14676136|NCT00296933|Bupropion|bupropion|mesh-list
14676137|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14676138|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676139|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676140|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676141|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676142|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
14676143|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676144|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14676145|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
14676146|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676147|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14676148|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
14676149|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14676150|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14676151|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676152|NCT00296946|Bromides|bromides|mesh-list
15189664|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
15189665|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15189666|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15189667|NCT03854175|Estradiol|estradiol|mesh-list
15189668|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14676153|NCT00296946|Ipratropium|ipratropium|mesh-list
14676154|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
14676155|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14676156|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
14676157|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676158|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676159|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14676160|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676161|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14676162|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
14676163|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676164|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676165|NCT00296959|Topiramate|topiramate|mesh-list
14676166|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
14676167|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14676168|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676169|NCT00296972|Interferons|interferons|mesh-list
14676170|NCT00296972|Ribavirin|ribavirin|mesh-list
14676171|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676172|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
14676173|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676174|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
14676175|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676176|NCT00297011|Valacyclovir|valacyclovir|mesh-list
14676177|NCT00297011|Clobetasol|clobetasol|mesh-list
14676178|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
14676179|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676180|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676181|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
14676182|NCT00297011|Hormones|hormones|mesh-ancestor
14676183|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676184|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676185|NCT00297050|Peramivir|peramivir|mesh-list
14676186|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
15189669|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189670|NCT03854175|Estrogens|estrogens|mesh-ancestor
15189671|NCT03854175|Hormones|hormones|mesh-ancestor
14676187|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676188|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294041|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14294042|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14294043|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
14294044|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
14294045|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
14294046|NCT00573430|Candesartan|candesartan|mesh-list
14294047|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
14294048|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14294049|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14294050|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14294051|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676189|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676190|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
14676191|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14676192|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676193|NCT00297076|Aplaviroc|aplaviroc|mesh-list
14676194|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14676195|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14676196|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676197|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14676198|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14676199|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
14676200|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676201|NCT00297128|Capecitabine|capecitabine|mesh-list
14676202|NCT00297128|Cetuximab|cetuximab|mesh-list
14676203|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14676204|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
14676205|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676206|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676207|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14676208|NCT00297141|Capecitabine|capecitabine|mesh-list
14676209|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
14676210|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14676211|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
14676212|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676213|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676214|NCT00297206|Valacyclovir|valacyclovir|mesh-list
14676215|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
14676216|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676217|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
14676218|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
14676219|NCT00297219|Calcium|calcium|mesh-list
14294052|NCT00573443|Quinidine|quinidine|mesh-list
14294053|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
14676220|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14676221|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676222|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14676223|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14676224|NCT00297284|Modafinil|modafinil|mesh-list
14676225|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14676226|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676227|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14676228|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14676229|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14676230|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676231|NCT00297323|Topiramate|topiramate|mesh-list
14676232|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
14676233|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14676234|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676235|NCT00297336|Topiramate|topiramate|mesh-list
14676236|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
14676237|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729304|NCT00522587|Analgesics|analgesics|mesh-ancestor
15189672|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189673|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189674|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15189675|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
15189676|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15189677|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15189678|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189679|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15189680|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15189681|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676238|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676239|NCT00297349|Topiramate|topiramate|mesh-list
14676240|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
14676241|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14676242|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676243|NCT00297362|Galantamine|galantamine|mesh-list
14676244|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14676245|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676246|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676247|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
14676248|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676249|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676250|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14676251|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
14676252|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676253|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
14676254|NCT00297375|Acetaminophen|acetaminophen|mesh-list
14676255|NCT00297375|Tramadol|tramadol|mesh-list
14676256|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14676257|NCT00297375|Analgesics|analgesics|mesh-ancestor
14676258|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
14676259|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676260|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676261|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
14676262|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14676263|NCT00297375|Narcotics|narcotics|mesh-ancestor
14676264|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676265|NCT00297388|Risperidone|risperidone|mesh-list
14676266|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14676267|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
14676268|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294054|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
14294055|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
14294056|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676269|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676270|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676271|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14676272|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14676273|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676274|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676275|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14676276|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
14676277|NCT00297466|Nicotine|nicotine|mesh-list
14676278|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14676279|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
14676280|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676281|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676282|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15189682|NCT03854175|Urological Agents|urological agents|mesh-ancestor
15189683|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
15189684|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15189685|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
15189686|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
14294057|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14676283|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14676284|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
14676285|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676286|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676287|NCT00297505|Citalopram|citalopram|mesh-list
14676288|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14676289|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676290|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676291|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676292|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676293|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
14676294|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676295|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14676296|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
14676297|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676298|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
14676299|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189687|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189688|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189689|NCT03853993|Vaccines|vaccines|mesh-list
15189690|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
15189691|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676300|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14676301|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14676302|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676303|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676304|NCT00297544|Urological Agents|urological agents|mesh-ancestor
14676305|NCT00297570|Interferons|interferons|mesh-list
14676306|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
14676307|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676308|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
14676309|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676310|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14676311|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676312|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676313|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
14676314|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14676315|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676316|NCT00297661|Sirolimus|sirolimus|mesh-list
14676317|NCT00297661|Paclitaxel|paclitaxel|mesh-list
14676318|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14676319|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676320|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
14676321|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
14676322|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
14676323|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676324|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15189692|NCT03853785|Podophyllin|podophyllin|mesh-list
15189693|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15189694|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189695|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
15189696|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189697|NCT03853707|Paclitaxel|paclitaxel|mesh-list
15189698|NCT03853707|Carboplatin|carboplatin|mesh-list
15189699|NCT03853707|Capecitabine|capecitabine|mesh-list
15189700|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15189701|NCT03853707|Atezolizumab|atezolizumab|mesh-list
15189702|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15189703|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15189704|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189705|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
15189706|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
15189707|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
15189708|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676325|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676326|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14294058|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14294059|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294060|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676327|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
14676328|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15189709|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189710|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
15189711|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
14676329|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
14676330|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676331|NCT00297674|Clarithromycin|clarithromycin|mesh-list
14676332|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676333|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676334|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14676335|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676336|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676337|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14676338|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14676339|NCT00297739|Risperidone|risperidone|mesh-list
14676340|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15189712|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189713|NCT03853525|Petrolatum|petrolatum|mesh-list
15189714|NCT03853525|Emollients|emollients|mesh-ancestor
14676341|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
14676342|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676343|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676344|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676345|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14676346|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14676347|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676348|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676349|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14676350|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
14676351|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14676352|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14676353|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676354|NCT00297765|Tacrolimus|tacrolimus|mesh-list
14676355|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14676356|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
14676357|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676358|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14676359|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676360|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676361|NCT00297804|Paclitaxel|paclitaxel|mesh-list
14676362|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14676363|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676364|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
14676365|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
14676366|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
14676367|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676368|NCT00297817|Vaccines|vaccines|mesh-list
14676369|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
14676370|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676371|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14676372|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
14676373|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676374|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14676375|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14676376|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676377|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676378|NCT00297960|Olanzapine|olanzapine|mesh-list
14676379|NCT00297960|Ziprasidone|ziprasidone|mesh-list
14676380|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
14676381|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
14676382|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676383|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676384|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14676385|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14676386|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14676387|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676388|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676389|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14676390|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676391|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676392|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676393|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676394|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
14676395|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14676396|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14676397|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
14676398|NCT00298012|Methotrexate|methotrexate|mesh-list
14676399|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14676400|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
14676401|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14676402|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676403|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14676404|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
14676405|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676406|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676407|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
14676408|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676409|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14676410|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14676411|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
14676412|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14676413|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14676414|NCT00298025|Cetrorelix|cetrorelix|mesh-list
14676415|NCT00298025|Menotropins|menotropins|mesh-list
14676416|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14676417|NCT00298025|Hormones|hormones|mesh-list
14676418|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14676419|NCT00298025|Ganirelix|ganirelix|mesh-list
14676420|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676421|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676422|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
14676423|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14676424|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
15189715|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189716|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
15189717|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
15189718|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189719|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
15189720|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15189721|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
15189722|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189723|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189724|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15189725|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
15189726|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15189727|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
15189728|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189729|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189730|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15189731|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189732|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
15189733|NCT03853642|Protective Agents|protective agents|mesh-ancestor
14676425|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14676426|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
14676427|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14676428|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
14676429|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676430|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14676431|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676432|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
14676433|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676434|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
14676435|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14676436|NCT00298168|Protective Agents|protective agents|mesh-ancestor
14676437|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
14676438|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14676439|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
14676440|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676441|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14676442|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676443|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
14676444|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676445|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
14676446|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14676447|NCT00298181|Protective Agents|protective agents|mesh-ancestor
14676448|NCT00298194|Z 338|z 338|mesh-list
14676449|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14676450|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676451|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676452|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
14676453|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676454|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676455|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14676456|NCT00298285|Enoxaparin|enoxaparin|mesh-list
14676457|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
14676458|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14676459|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15189734|NCT03853538|Petrolatum|petrolatum|mesh-list
15189735|NCT03853538|Emollients|emollients|mesh-ancestor
15189736|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
15223923|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676460|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676461|NCT00298324|Cyclosporine|cyclosporine|mesh-list
14676462|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
14676463|NCT00298324|Prednisone|prednisone|mesh-list
15223924|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15223925|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223926|NCT04989829|Omeprazole|omeprazole|mesh-list
14676464|NCT00298324|Cyclosporins|cyclosporins|mesh-list
14676465|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223927|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14676466|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
14676467|NCT00298324|Hormones|hormones|mesh-ancestor
14676468|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676469|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676470|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14676471|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676472|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676473|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676474|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14676475|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
14676476|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
14676477|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676478|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
14676479|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14676480|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14676481|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14676482|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14676483|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
14676484|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676485|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
14676486|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
14676487|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676488|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676489|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14676490|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14676491|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
14676492|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676493|NCT00298415|Gemcitabine|gemcitabine|mesh-list
14676494|NCT00298415|Paclitaxel|paclitaxel|mesh-list
14676495|NCT00298415|Vinorelbine|vinorelbine|mesh-list
14676496|NCT00298415|Carboplatin|carboplatin|mesh-list
14676497|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14676498|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14676499|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676500|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
14676501|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
14676502|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
14676503|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676504|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14676505|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
14676506|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
14676507|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676508|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676509|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14676510|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
14676511|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676512|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14676513|NCT00298454|Furosemide|furosemide|mesh-list
14676514|NCT00298454|Diuretics|diuretics|mesh-ancestor
14676515|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
14676516|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676517|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14676518|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676519|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676520|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
14676521|NCT00298506|Tacrolimus|tacrolimus|mesh-list
14676522|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14676523|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
14676524|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676525|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14676526|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676527|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676528|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14676529|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676530|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14676531|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
14676532|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676533|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676534|NCT00298545|Calcitriol|calcitriol|mesh-list
14676535|NCT00298545|Calcium|calcium|mesh-list
14676536|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14676537|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676538|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14676539|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676540|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676541|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14676542|NCT00298545|Vitamins|vitamins|mesh-ancestor
14676543|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
14676544|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14676545|NCT00298571|Epinephrine|epinephrine|mesh-list
14676546|NCT00298571|Bupivacaine|bupivacaine|mesh-list
14676547|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
14676548|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
14676549|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676550|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676551|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
14676552|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676553|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14676554|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14676555|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
14676556|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676557|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676558|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14676559|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14676560|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
14676561|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14676562|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676563|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
14676564|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
14676565|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14726943|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14726944|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
14726945|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726946|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726947|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726948|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14726949|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14726950|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726951|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14726952|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14726953|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
14729305|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
14729306|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729307|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
14729308|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
14729309|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729310|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
14729311|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729312|NCT00522665|Irinotecan|irinotecan|mesh-list
14729313|NCT00522665|Cetuximab|cetuximab|mesh-list
14729314|NCT00522665|Everolimus|everolimus|mesh-list
14729315|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14676566|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
14294061|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676567|NCT00298597|Sargramostim|sargramostim|mesh-list
14676568|NCT00298597|Immunologic Factors|immunologic factors|mesh-ancestor
14676569|NCT00298597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676570|NCT00298597|Hematinics|hematinics|mesh-ancestor
14676571|NCT00298636|Adenosine|adenosine|mesh-list
14676572|NCT00298636|Analgesics|analgesics|mesh-ancestor
14676573|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
14676574|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676575|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676576|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14676577|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
14676578|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14676579|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
14676580|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
14676581|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676582|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676583|NCT00298662|Interferons|interferons|mesh-list
14676584|NCT00298662|Interferon-beta|interferon-beta|mesh-list
14676585|NCT00298662|Tacrolimus|tacrolimus|mesh-list
14676586|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
14676587|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676588|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
14676589|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676590|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14676591|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
14676592|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676593|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14676594|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676595|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676596|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14676597|NCT00298675|Irinotecan|irinotecan|mesh-list
14676598|NCT00298675|Iniparib|iniparib|mesh-list
14676599|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14676600|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14676601|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676602|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676603|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676604|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14676605|NCT00298688|Gefitinib|gefitinib|mesh-list
14676606|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676607|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14676608|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676609|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676610|NCT00298714|Losartan|losartan|mesh-list
14676611|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14676612|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14676613|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14676614|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14676615|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676616|NCT00298779|Bortezomib|bortezomib|mesh-list
14676617|NCT00298779|Omeprazole|omeprazole|mesh-list
14676618|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676619|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14676620|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14676621|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14676622|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676623|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676624|NCT00298857|Valproic Acid|valproic acid|mesh-list
14676625|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
14676626|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676627|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676628|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
14676629|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676630|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676631|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
14676632|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14676633|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676634|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676635|NCT00298870|Isoniazid|isoniazid|mesh-list
14676636|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
14676637|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676638|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676639|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14676640|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14676641|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
14676642|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676643|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14676644|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
14676645|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14676646|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676647|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14676648|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
14676649|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676650|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189737|NCT03853694|Morphine|morphine|mesh-list
15189738|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15189739|NCT03853694|Narcotics|narcotics|mesh-ancestor
14676651|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676652|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676653|NCT00298909|Niacin|niacin|mesh-list
14676654|NCT00298909|Niacinamide|niacinamide|mesh-list
14676655|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
14676656|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14676657|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
14676658|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676659|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14676660|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
14676661|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
14676662|NCT00298909|Vitamins|vitamins|mesh-ancestor
14676663|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
14676664|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676665|NCT00298922|Azithromycin|azithromycin|mesh-list
14676666|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676667|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676668|NCT00298974|Acetaminophen|acetaminophen|mesh-list
14676669|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14676670|NCT00298974|Hydrocodone|hydrocodone|mesh-list
14676671|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14676672|NCT00298974|Analgesics|analgesics|mesh-ancestor
14676673|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
14676674|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676675|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676676|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
14676677|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14676678|NCT00298974|Narcotics|narcotics|mesh-ancestor
14676679|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676680|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
14676681|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676682|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14676683|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676684|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14676685|NCT00299013|Prednisolone|prednisolone|mesh-list
14676686|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14676687|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
14676688|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14676689|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
14676690|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14676691|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
14676692|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676693|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
14676694|NCT00299013|Hormones|hormones|mesh-ancestor
14676695|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676696|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676697|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14676698|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676699|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
14676700|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
14676701|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676702|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14676703|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14676704|NCT00299013|Protective Agents|protective agents|mesh-ancestor
14676705|NCT00299026|Paclitaxel|paclitaxel|mesh-list
14676706|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14676707|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676708|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
14676709|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
14676710|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
14676711|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676712|NCT00299039|Acetaminophen|acetaminophen|mesh-list
14676713|NCT00299039|Ibuprofen|ibuprofen|mesh-list
14676714|NCT00299039|Codeine|codeine|mesh-list
14676715|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14676716|NCT00299039|Analgesics|analgesics|mesh-ancestor
14676717|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
14676718|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676719|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676720|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
14676721|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14676722|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676723|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14676724|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14676725|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676726|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676727|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14676728|NCT00299039|Narcotics|narcotics|mesh-ancestor
14676729|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676730|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
14676731|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676732|NCT00299065|Zileuton|zileuton|mesh-list
14676733|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14676734|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14676735|NCT00299065|Analgesics|analgesics|mesh-ancestor
14676736|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
14676737|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676738|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676739|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676740|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14676741|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14676742|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676743|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676744|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14676745|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
14676746|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676747|NCT00299091|Efavirenz|efavirenz|mesh-list
14676748|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14676749|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14676750|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676751|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676752|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
14676753|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676754|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14676755|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14676756|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14676757|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14676758|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14676759|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14676760|NCT00299208|Azithromycin|azithromycin|mesh-list
14676761|NCT00299208|Artesunate|artesunate|mesh-list
14676762|NCT00299208|Quinine|quinine|mesh-list
14676763|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676764|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676765|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
14676766|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14676767|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14676768|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676769|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
14676770|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
14676771|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14676772|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
14814683|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
14814684|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814685|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814686|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
14814687|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14814688|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14814689|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814690|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814691|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14814692|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14814693|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814694|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676773|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14676774|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676775|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14676776|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676777|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14676778|NCT00299208|Analgesics|analgesics|mesh-ancestor
14676779|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
14676780|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14676781|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14676782|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676783|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676784|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676785|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14676786|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676787|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676788|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
14676789|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
14676790|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
14676791|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14676792|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14676793|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676794|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14676795|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676796|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676797|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14676798|NCT00299247|Renal Agents|renal agents|mesh-ancestor
14676799|NCT00299286|Lapatinib|lapatinib|mesh-list
14676800|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676801|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14676802|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676803|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676804|NCT00299351|Romidepsin|romidepsin|mesh-list
14676805|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14676806|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676807|NCT00299364|Tibolone|tibolone|mesh-list
14676808|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
14676809|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
14676810|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676811|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676812|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14676813|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14676814|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676815|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14676816|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
14676817|NCT00299364|Hormones|hormones|mesh-ancestor
14676818|NCT00299377|Abciximab|abciximab|mesh-list
14676819|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
14676820|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14676821|NCT00299390|Sagopilone|sagopilone|mesh-list
14676822|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676823|NCT00299455|Amoxicillin|amoxicillin|mesh-list
14676824|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
14676825|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
14676826|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14676827|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676828|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676829|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14676830|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676831|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676832|NCT00299520|Linezolid|linezolid|mesh-list
14676833|NCT00299520|Iclaprim|iclaprim|mesh-list
14676834|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14676835|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676836|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14676837|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676838|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676839|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14676840|NCT00299559|Camphor|camphor|mesh-list
14676841|NCT00299559|Menthol|menthol|mesh-list
14676842|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
14676843|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
14676844|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14676845|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676846|NCT00299572|Alendronate|alendronate|mesh-list
14676847|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14676848|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676849|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14676850|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676851|NCT00299611|Levetiracetam|levetiracetam|mesh-list
14676852|NCT00299611|Sertraline|sertraline|mesh-list
14676853|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
14676854|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14676855|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14676856|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14676857|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14676858|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676859|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676860|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
14676861|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676862|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
14676863|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
14676864|NCT00299650|Cisatracurium|cisatracurium|mesh-list
14676865|NCT00299650|Atracurium|atracurium|mesh-list
14676866|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14676867|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14676868|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676869|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676870|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14676871|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14676872|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14676873|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
14676874|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676875|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676876|NCT00299676|Galantamine|galantamine|mesh-list
14676877|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14676878|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676879|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189740|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189741|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189742|NCT03853694|Analgesics|analgesics|mesh-ancestor
15189743|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
15189744|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189745|NCT03853304|Folic Acid|folic acid|mesh-list
15189746|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
15189747|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
15189748|NCT03853304|Vitamins|vitamins|mesh-ancestor
15189749|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
15189750|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189751|NCT03853304|Hematinics|hematinics|mesh-ancestor
15189752|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
15189753|NCT03853512|Petrolatum|petrolatum|mesh-list
15189754|NCT03853512|Emollients|emollients|mesh-ancestor
15189755|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189756|NCT03853369|Nifekalant|nifekalant|mesh-list
15189757|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15189758|NCT03853395|Antibodies|antibodies|mesh-list
15189759|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
15189760|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189761|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
15189762|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15189763|NCT03853200|Acetic Acid|acetic acid|mesh-list
15189764|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
15189765|NCT03853200|Edetic Acid|edetic acid|mesh-list
15189766|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
15189767|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15189768|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189769|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
15189770|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189771|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
15189772|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15189773|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
14676880|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
14676881|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676882|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676883|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14676884|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
14676885|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189774|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
15189775|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189776|NCT03853200|Antidotes|antidotes|mesh-ancestor
14676886|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
14676887|NCT00299754|Misoprostol|misoprostol|mesh-list
14676888|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14676889|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
14676890|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14676891|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676892|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14676893|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14676894|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
14676895|NCT00299819|Sifalimumab|sifalimumab|mesh-list
14676896|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14676897|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
14676898|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676899|NCT00299845|Lansoprazole|lansoprazole|mesh-list
14676900|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
14676901|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14676902|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15189777|NCT03853200|Protective Agents|protective agents|mesh-ancestor
15189778|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189779|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15189780|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15189781|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
15189782|NCT03853096|Cefazolin|cefazolin|mesh-list
15189783|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15189784|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189785|NCT03852979|Paclitaxel|paclitaxel|mesh-list
15189786|NCT03852979|Carboplatin|carboplatin|mesh-list
15189787|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15189788|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189789|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
15189790|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
15189791|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
15189792|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189793|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
15189794|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15189795|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
15189796|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189797|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
15189798|NCT03852914|Protective Agents|protective agents|mesh-ancestor
15189799|NCT03852797|Ketamine|ketamine|mesh-list
15189800|NCT03852797|Propofol|propofol|mesh-list
15189801|NCT03852797|Etomidate|etomidate|mesh-list
15189802|NCT03852797|Oxytocin|oxytocin|mesh-list
15189803|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15189804|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14676903|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14676904|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676905|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676906|NCT00299858|Theophylline|theophylline|mesh-list
14676907|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14676908|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
14676909|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676910|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676911|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14676912|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676913|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14676914|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676915|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676916|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
14676917|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14676918|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14676919|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
14676920|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676921|NCT00299871|Lixisenatide|lixisenatide|mesh-list
14676922|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14676923|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676924|NCT00299884|Atorvastatin|atorvastatin|mesh-list
14676925|NCT00299884|Ezetimibe|ezetimibe|mesh-list
14676926|NCT00299884|Fenofibrate|fenofibrate|mesh-list
14676927|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14676928|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14676929|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
14676930|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676931|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15189805|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189806|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14676932|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14676933|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189807|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
15189808|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
15189809|NCT03852797|Analgesics|analgesics|mesh-ancestor
15189810|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
15189811|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189812|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15189813|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15189814|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15189815|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189816|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189817|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
14676934|NCT00299910|Montelukast|montelukast|mesh-list
14676935|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14676936|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676937|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14676938|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
14676939|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676940|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676941|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14676942|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14676943|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676944|NCT00299923|Ribavirin|ribavirin|mesh-list
14676945|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14676946|NCT00299923|Amantadine|amantadine|mesh-list
14676947|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
14676948|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676949|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
14676950|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676951|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14676952|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14676953|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
14676954|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14676955|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676956|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14676957|NCT00299923|Analgesics|analgesics|mesh-ancestor
14676958|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
14676959|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676960|NCT00299936|Ribavirin|ribavirin|mesh-list
14676961|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14676962|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
14676963|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676964|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
14676965|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676966|NCT00299962|Interferons|interferons|mesh-list
14676967|NCT00299962|Interferon-beta|interferon-beta|mesh-list
14676968|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14676969|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
14676970|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14676971|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
14676972|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676973|NCT00300014|Triamcinolone|triamcinolone|mesh-list
14676974|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676975|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
14676976|NCT00300014|Hormones|hormones|mesh-ancestor
14676977|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676978|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676979|NCT00300040|HBOC 201|hboc 201|mesh-list
14676980|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
14676981|NCT00300079|Brinzolamide|brinzolamide|mesh-list
14676982|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14676983|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14676984|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14676985|NCT00300118|Budesonide|budesonide|mesh-list
14676986|NCT00300118|Mesalamine|mesalamine|mesh-list
14676987|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14676988|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14676989|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
14676990|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14676991|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14676992|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14676993|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
14676994|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
15189818|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14676995|NCT00300118|Hormones|hormones|mesh-ancestor
14676996|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14676997|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14676998|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14676999|NCT00300118|Analgesics|analgesics|mesh-ancestor
14677000|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
14677001|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677002|NCT00300131|Everolimus|everolimus|mesh-list
14677003|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677004|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677005|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
14677006|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677007|NCT00300196|Ancrod|ancrod|mesh-list
14677008|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
14677009|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14677010|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14677011|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677012|NCT00300222|Capsaicin|capsaicin|mesh-list
14677013|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
14677014|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
14677015|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
14677016|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677017|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677018|NCT00300287|Vildagliptin|vildagliptin|mesh-list
14677019|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14677020|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677021|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14677022|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
14677023|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677024|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726954|NCT00511654|Midazolam|midazolam|mesh-list
14726955|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14726956|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14726957|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14726958|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726959|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14726960|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14726961|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14726962|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14726963|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
14726964|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
14726965|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
14726966|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
14726967|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726968|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726969|NCT00511719|Insulin|insulin|mesh-list
14726970|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14726971|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14726972|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726973|NCT00511732|Insulin|insulin|mesh-list
14726974|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14726975|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726976|NCT00511771|Tegaserod|tegaserod|mesh-list
14726977|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14726978|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
14726979|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14726980|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14726981|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726982|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
14726983|NCT00511823|Granisetron|granisetron|mesh-list
14726984|NCT00511823|Casopitant|casopitant|mesh-list
14726985|NCT00511823|Dolasetron|dolasetron|mesh-list
14726986|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14726987|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14726988|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
14726989|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
14726990|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677025|NCT00300313|Citalopram|citalopram|mesh-list
14677026|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14677027|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677028|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677029|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677030|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677031|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
14677032|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677033|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14677034|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
14677035|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14677036|NCT00300339|Clopidogrel|clopidogrel|mesh-list
14677037|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14677038|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14677039|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14677040|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14677041|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
14677042|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677043|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677044|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677045|NCT00300352|Folic Acid|folic acid|mesh-list
14677046|NCT00300352|Hematinics|hematinics|mesh-ancestor
14677047|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
14677048|NCT00300352|Vitamins|vitamins|mesh-ancestor
14677049|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
14677050|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677051|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14677052|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14677053|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677054|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677055|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677056|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677057|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677058|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
14677059|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14677060|NCT00300404|Leucovorin|leucovorin|mesh-list
14677061|NCT00300404|Folic Acid|folic acid|mesh-list
14677062|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
14677063|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
14677064|NCT00300404|Antidotes|antidotes|mesh-ancestor
14677065|NCT00300404|Protective Agents|protective agents|mesh-ancestor
14677066|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677067|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
14677068|NCT00300404|Vitamins|vitamins|mesh-ancestor
14677069|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
14677070|NCT00300404|Hematinics|hematinics|mesh-ancestor
14677071|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
14677072|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14677073|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14677074|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677075|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14677076|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677077|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677078|NCT00300443|Bimatoprost|bimatoprost|mesh-list
14677079|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14677080|NCT00300508|Anastrozole|anastrozole|mesh-list
14677081|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14677082|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677083|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14677084|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14677085|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677086|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677087|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14677088|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
14677089|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14677090|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677091|NCT00300560|Colistin|colistin|mesh-list
14677092|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677093|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677094|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
14677095|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14677096|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14677097|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677098|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677099|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
14677100|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677101|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14677102|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14677103|NCT00300586|Gemcitabine|gemcitabine|mesh-list
14677104|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14677105|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677106|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
14677107|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677108|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677109|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
14677110|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677111|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677112|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677113|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
15189819|NCT03852628|Naltrexone|naltrexone|mesh-list
15189820|NCT03852628|Buprenorphine|buprenorphine|mesh-list
15189821|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15189822|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15189823|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189824|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
15189825|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189826|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15189827|NCT03852628|Narcotics|narcotics|mesh-ancestor
15189828|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189829|NCT03852628|Analgesics|analgesics|mesh-ancestor
15189830|NCT03852303|Ivermectin|ivermectin|mesh-list
15189831|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
15189832|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15189833|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189834|NCT03852602|Analgesics|analgesics|mesh-list
15189835|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
15189836|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189837|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189838|NCT03852446|Tryptophan|tryptophan|mesh-list
15189839|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15189840|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
15189841|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14294062|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14294063|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14294064|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
14677114|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677115|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14677116|NCT00300664|Hormones|hormones|mesh-list
14677117|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14677118|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677119|NCT00300716|Memantine|memantine|mesh-list
14677120|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14677121|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14677122|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
14677123|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677124|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677125|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677126|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14677127|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14677128|NCT00300729|Celecoxib|celecoxib|mesh-list
14677129|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14677130|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14677131|NCT00300729|Analgesics|analgesics|mesh-ancestor
14677132|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
14677133|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677134|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677135|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14677136|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677137|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14677138|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14677139|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677140|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677141|NCT00300768|Ivermectin|ivermectin|mesh-list
15189842|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
14677142|NCT00300768|Moxidectin|moxidectin|mesh-list
14677143|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14677144|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189843|NCT03852407|Melphalan|melphalan|mesh-list
15189844|NCT03852407|Fludarabine|fludarabine|mesh-list
14677145|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
14677146|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
14677147|NCT00300794|Ketamine|ketamine|mesh-list
14677148|NCT00300794|Analgesics|analgesics|mesh-ancestor
14677149|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
14677150|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677151|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677152|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14677153|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14677154|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
14677155|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
14677156|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14677157|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14677158|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14677159|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677160|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677161|NCT00300833|Tirofiban|tirofiban|mesh-list
14677162|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14677163|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14677164|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677165|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14677166|NCT00300846|Aripiprazole|aripiprazole|mesh-list
14677167|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
14677168|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14677169|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14677170|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14677171|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14677172|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677173|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
14677174|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
14677175|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677176|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677177|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14677178|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14677179|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
14677180|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14677181|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14677182|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14677183|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14677184|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
14677185|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14677186|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677187|NCT00300924|Acetaminophen|acetaminophen|mesh-list
14677188|NCT00300924|Rizatriptan|rizatriptan|mesh-list
14677189|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14677190|NCT00300924|Analgesics|analgesics|mesh-ancestor
14677191|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
14677192|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677193|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677194|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
14677195|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14677196|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
14677197|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677198|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677199|NCT00300937|Ubiquinone|ubiquinone|mesh-list
14677200|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
14677201|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
14677202|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677203|NCT00300937|Vitamins|vitamins|mesh-ancestor
14677204|NCT00300950|Gemcitabine|gemcitabine|mesh-list
14677205|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677206|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
14677207|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677208|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677209|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
14677210|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677211|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677212|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677213|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
14677214|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677215|NCT00301002|Alefacept|alefacept|mesh-list
14677216|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189845|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
15189846|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15189847|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
15189848|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189849|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15189850|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15189851|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
15189852|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189853|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189854|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15189855|NCT03852563|Petrolatum|petrolatum|mesh-list
15189856|NCT03852563|Emollients|emollients|mesh-ancestor
15189857|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
15189858|NCT03852251|Capecitabine|capecitabine|mesh-list
14677217|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
14677218|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677219|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
14677220|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
14677221|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14677222|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
14677223|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14677224|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14677225|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677226|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14677227|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677228|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677229|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14677230|NCT00301054|Renal Agents|renal agents|mesh-ancestor
14677231|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
14677232|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677233|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14677234|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677235|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677236|NCT00301106|Interleukin-12|interleukin-12|mesh-list
14677237|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14677238|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
14677239|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677240|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14677241|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14677242|NCT00301106|Growth Substances|growth substances|mesh-ancestor
14677243|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
14677244|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677245|NCT00301145|Varenicline|varenicline|mesh-list
14677246|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14677247|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14677248|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
15189859|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
15189860|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15189861|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
15189862|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677249|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677250|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677251|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677252|NCT00301171|Fluticasone|fluticasone|mesh-list
14677253|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14677254|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14677255|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
14677256|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677257|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677258|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14677259|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
14677260|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
14677261|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14677262|NCT00301210|Tramadol|tramadol|mesh-list
14677263|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14677264|NCT00301210|Narcotics|narcotics|mesh-ancestor
14677265|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189863|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677266|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189864|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14677267|NCT00301210|Analgesics|analgesics|mesh-ancestor
14677268|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
14677269|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677270|NCT00301223|Pregabalin|pregabalin|mesh-list
14677271|NCT00301223|Analgesics|analgesics|mesh-ancestor
14677272|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
14677273|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677274|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677275|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
14677276|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14677277|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677278|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677279|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14677280|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14677281|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14677282|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14677283|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14677284|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14677285|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14677286|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677287|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14677288|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677289|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677290|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677291|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
14677292|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677293|NCT00301301|Gemcitabine|gemcitabine|mesh-list
14677294|NCT00301301|Rituximab|rituximab|mesh-list
14677295|NCT00301301|Cisplatin|cisplatin|mesh-list
14677296|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14677297|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677298|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
14677299|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677300|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677301|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677302|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
14677303|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677304|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
14677305|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677306|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677307|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677308|NCT00301392|Pitavastatin|pitavastatin|mesh-list
14677309|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14677310|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14677311|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14677312|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
14677313|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677314|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677315|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14677316|NCT00301405|Thalidomide|thalidomide|mesh-list
14677317|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15189865|NCT03852160|Mirtazapine|mirtazapine|mesh-list
15189866|NCT03852160|Trazodone|trazodone|mesh-list
15189867|NCT03852160|S 20098|s 20098|mesh-list
14677318|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
14677319|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677320|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
14677321|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677322|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677323|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14677324|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14677325|NCT00301405|Growth Substances|growth substances|mesh-ancestor
14677326|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14677327|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677328|NCT00301457|Anastrozole|anastrozole|mesh-list
14677329|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14677330|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677331|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14677332|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14677333|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677334|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677335|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15189868|NCT03852160|Citalopram|citalopram|mesh-list
15189869|NCT03852160|Bupropion|bupropion|mesh-list
15189870|NCT03852160|Sertraline|sertraline|mesh-list
14677336|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
14677337|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14677338|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677339|NCT00301483|HBOC 201|hboc 201|mesh-list
14677340|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
14677341|NCT00301509|Ribavirin|ribavirin|mesh-list
14677342|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
14677343|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677344|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
14677345|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677346|NCT00301522|Paclitaxel|paclitaxel|mesh-list
14677347|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14677348|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677349|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
14677350|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
14677351|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
14677352|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677353|NCT00301535|HBOC 201|hboc 201|mesh-list
14677354|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
14677355|NCT00301574|Galantamine|galantamine|mesh-list
14677356|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14677357|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677358|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677359|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
14677360|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677361|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677362|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14677363|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
14677364|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677365|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
14677366|NCT00301587|Folic Acid|folic acid|mesh-list
14677367|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
14677368|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14677369|NCT00301587|Norgestimate|norgestimate|mesh-list
14677370|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14677371|NCT00301587|Estradiol|estradiol|mesh-list
14677372|NCT00301587|Estrogens|estrogens|mesh-ancestor
14677373|NCT00301587|Hormones|hormones|mesh-ancestor
14677374|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14677375|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677376|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14677377|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
14677378|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14677379|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14677380|NCT00301587|Hematinics|hematinics|mesh-ancestor
14677381|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
14677382|NCT00301587|Vitamins|vitamins|mesh-ancestor
14677383|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
14677384|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14677385|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14677386|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14677387|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677388|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677389|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14677390|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14677391|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677392|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677393|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677394|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14677395|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
14677396|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14677397|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677398|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14677399|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
14677400|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677401|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677402|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677403|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677404|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
14677405|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14677406|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677407|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14814695|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
14677408|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
14677409|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677410|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677411|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677412|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677413|NCT00301639|Methylphenidate|methylphenidate|mesh-list
14677414|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14677415|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677416|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14677417|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677418|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677419|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677420|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
15189871|NCT03852160|Esketamine|esketamine|mesh-list
15189872|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15189873|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15189874|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15189875|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189876|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189877|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
15189878|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189879|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15189880|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
15189881|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15189882|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189883|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15189884|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
14677421|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677422|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
14677423|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14677424|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15189885|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15189886|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15189887|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189888|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15189889|NCT03852160|Analgesics|analgesics|mesh-ancestor
15189890|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
14677425|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14677426|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
14677427|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677428|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677429|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677430|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677431|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
14677432|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14677433|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14677434|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14677435|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677436|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677437|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
14677438|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677439|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677440|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14677441|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677442|NCT00301730|Aldesleukin|aldesleukin|mesh-list
14677443|NCT00301730|Paclitaxel|paclitaxel|mesh-list
14677444|NCT00301730|Trastuzumab|trastuzumab|mesh-list
14677445|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14677446|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677447|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
14677448|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
14677449|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
14677450|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677451|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14677452|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14677453|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14677454|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
14677455|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677456|NCT00301782|Carboplatin|carboplatin|mesh-list
14677457|NCT00301782|Etoposide|etoposide|mesh-list
14677458|NCT00301782|Vincristine|vincristine|mesh-list
14677459|NCT00301782|Bleomycin|bleomycin|mesh-list
14677460|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
14677461|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677462|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14677463|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14677464|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14677465|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677466|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677467|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
14677468|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
14677469|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
14677470|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14677471|NCT00301795|Rituximab|rituximab|mesh-list
14677472|NCT00301795|Oblimersen|oblimersen|mesh-list
14677473|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14677474|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677475|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
14677476|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677477|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677478|NCT00301847|Sorafenib|sorafenib|mesh-list
14677479|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677480|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14677481|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677482|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677483|NCT00301860|Cyclosporine|cyclosporine|mesh-list
14677484|NCT00301860|Methotrexate|methotrexate|mesh-list
14677485|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
14677486|NCT00301860|Fludarabine|fludarabine|mesh-list
14677487|NCT00301860|Melphalan|melphalan|mesh-list
14677488|NCT00301860|Cyclosporins|cyclosporins|mesh-list
14677489|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14677490|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14677491|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
14677492|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14677493|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677494|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677495|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
14677496|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677497|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677498|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
14677499|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677500|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14677501|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677502|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
14677503|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677504|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14677505|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
14814696|NCT00864071|Griseofulvin|griseofulvin|mesh-list
15189891|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15189892|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
15189893|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
15189894|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15189895|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15189896|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189897|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15189898|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15189899|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15189900|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
15189901|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15189902|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14677506|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677507|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14677508|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14677509|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
14677510|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14677511|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
14677512|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
14677513|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14677514|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677515|NCT00301899|Trastuzumab|trastuzumab|mesh-list
14677516|NCT00301899|Pertuzumab|pertuzumab|mesh-list
14677517|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14677518|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677519|NCT00301912|Methotrexate|methotrexate|mesh-list
14677520|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
14677521|NCT00301912|Fludarabine|fludarabine|mesh-list
14677522|NCT00301912|Busulfan|busulfan|mesh-list
14677523|NCT00301912|Tacrolimus|tacrolimus|mesh-list
14677524|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14677525|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
14677526|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14677527|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677528|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677529|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
15189903|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15189904|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15189905|NCT03852056|Fluorides|fluorides|mesh-list
15189906|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
15189907|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
15189908|NCT03852056|Protective Agents|protective agents|mesh-ancestor
15189909|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189910|NCT03851835|Ondansetron|ondansetron|mesh-list
15189911|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
15189912|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
15189913|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189914|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189915|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15189916|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
15189917|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
14677530|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677531|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677532|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14677533|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677534|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14677535|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677536|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
14677537|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677538|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14677539|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14677540|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
14677541|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14677542|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14677543|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
14677544|NCT00301925|Fluorouracil|fluorouracil|mesh-list
14677545|NCT00301925|Capecitabine|capecitabine|mesh-list
14677546|NCT00301925|Methotrexate|methotrexate|mesh-list
14677547|NCT00301925|Epirubicin|epirubicin|mesh-list
14677548|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677549|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
14677550|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677551|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814697|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
15189918|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15189919|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
14677552|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14677553|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
14677554|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677555|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677556|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14677557|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
14677558|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677559|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14677560|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
14677561|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14677562|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
14677563|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677564|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14677565|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14677566|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14677567|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15189920|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189921|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189922|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15189923|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14677568|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14677569|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14677570|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677571|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14677572|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677573|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677574|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
14677575|NCT00301951|Fludarabine|fludarabine|mesh-list
14677576|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
14677577|NCT00301951|Busulfan|busulfan|mesh-list
14677578|NCT00301951|Tacrolimus|tacrolimus|mesh-list
14677579|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14677580|NCT00301951|Sargramostim|sargramostim|mesh-list
14677581|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677582|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677583|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
14677584|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677585|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677586|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
14677587|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677588|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14677589|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677590|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14677591|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14677592|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
14677593|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677594|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677595|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
14677596|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14677597|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14677598|NCT00301990|Aldesleukin|aldesleukin|mesh-list
14677599|NCT00301990|Bevacizumab|bevacizumab|mesh-list
14677600|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14677601|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677602|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14677603|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14677604|NCT00301990|Growth Substances|growth substances|mesh-ancestor
14677605|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189924|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15189925|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15189926|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15189927|NCT03851731|Naltrexone|naltrexone|mesh-list
15189928|NCT03851731|Naloxone|naloxone|mesh-list
14677606|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14677607|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14677608|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14677609|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
14677610|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14726991|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14726992|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14726993|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
14726994|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189929|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14726995|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189930|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14677611|NCT00302224|Ketoconazole|ketoconazole|mesh-list
14677612|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
14677613|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677614|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14677615|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14677616|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677617|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677618|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14677619|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
14677620|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14677621|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677622|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14677623|NCT00302289|Caffeine|caffeine|mesh-list
14677624|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14677625|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677626|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14677627|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677628|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677629|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14677630|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14677631|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
14677632|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677633|NCT00302341|Trimethoprim|trimethoprim|mesh-list
14677634|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14677635|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
14677636|NCT00302341|Pafuramidine|pafuramidine|mesh-list
14677637|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677638|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677639|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14677640|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677641|NCT00302341|Renal Agents|renal agents|mesh-ancestor
14677642|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
14677643|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14677644|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14677645|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14677646|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14677647|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14677648|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14677649|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677650|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14677651|NCT00302354|Methylphenidate|methylphenidate|mesh-list
14677652|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14677653|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677654|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14677655|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677656|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677657|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677658|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
14677659|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677660|NCT00302367|Methylphenidate|methylphenidate|mesh-list
14677661|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14677662|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677663|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15189931|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189932|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
15189933|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223928|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223929|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15223930|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223931|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223932|NCT04947332|Vaccines|vaccines|mesh-list
14677664|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677665|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677666|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677667|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
14677668|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677669|NCT00302393|Methylphenidate|methylphenidate|mesh-list
14677670|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15189934|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15189935|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
15189936|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189937|NCT03851432|Metformin|metformin|mesh-list
15189938|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15189939|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189940|NCT03851562|Alprostadil|alprostadil|mesh-list
14294065|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14294066|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
14294067|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14294068|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14294069|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294070|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677671|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677672|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14677673|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677674|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677675|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677676|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
14677677|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677678|NCT00302406|Methylphenidate|methylphenidate|mesh-list
14677679|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14677680|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677681|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14677682|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14677683|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14677684|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677685|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
14677686|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677687|NCT00302419|Streptokinase|streptokinase|mesh-list
15189941|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15189942|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
15189943|NCT03851562|Urological Agents|urological agents|mesh-ancestor
15189944|NCT03851289|Calcium|calcium|mesh-list
15189945|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15189946|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189947|NCT03851341|Metformin|metformin|mesh-list
15189948|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15189949|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14677688|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14677689|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14677690|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677691|NCT00302432|Menthol|menthol|mesh-list
14677692|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
14677693|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
14677694|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
14677695|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14677696|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677697|NCT00302497|Basiliximab|basiliximab|mesh-list
14677698|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677699|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
14677700|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677701|NCT00302523|Tacrolimus|tacrolimus|mesh-list
15189950|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189951|NCT03851341|Incretins|incretins|mesh-ancestor
15189952|NCT03851341|Hormones|hormones|mesh-ancestor
14294071|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14294072|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14677702|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677703|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
14677704|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677705|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14677706|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677707|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677708|NCT00302536|Tacrolimus|tacrolimus|mesh-list
14677709|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677710|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
14677711|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677712|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14677713|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677714|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677715|NCT00302549|Tacrolimus|tacrolimus|mesh-list
14677716|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677717|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
14677718|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677719|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14677720|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677721|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677722|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
14677723|NCT00302627|Vitamin D|vitamin d|mesh-list
14677724|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
14677725|NCT00302627|Pamidronate|pamidronate|mesh-list
14677726|NCT00302627|Vitamins|vitamins|mesh-list
14677727|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
14677728|NCT00302627|Calcium|calcium|mesh-list
14677729|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
14677730|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677731|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14677732|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14677733|NCT00302627|Antacids|antacids|mesh-ancestor
14677734|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677735|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14677736|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
14677737|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14677738|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677739|NCT00302653|Rasburicase|rasburicase|mesh-list
14677740|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
14677741|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677742|NCT00302666|Dienogest|dienogest|mesh-list
14677743|NCT00302666|Nandrolone|nandrolone|mesh-list
14677744|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14677745|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
14677746|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14677747|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677748|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14677749|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14677750|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14677751|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14677752|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
14677753|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14677754|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14677755|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677756|NCT00302666|Androgens|androgens|mesh-ancestor
14677757|NCT00302666|Hormones|hormones|mesh-ancestor
14677758|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
14677759|NCT00302692|Metoprolol|metoprolol|mesh-list
14677760|NCT00302692|Esmolol|esmolol|mesh-list
14677761|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14677762|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14677763|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
14677764|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
14677765|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677766|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677767|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14677768|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14677769|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14294073|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
14677770|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
14677771|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677772|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189953|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15189954|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15189955|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
15189956|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189957|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189958|NCT03851172|Ketorolac|ketorolac|mesh-list
15189959|NCT03851172|Nepafenac|nepafenac|mesh-list
15189960|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
15189961|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15189962|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15189963|NCT03851172|Analgesics|analgesics|mesh-ancestor
15189964|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
15189965|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15189966|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189967|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15189968|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15189969|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15189970|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15189971|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189972|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
15189973|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
15189974|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
15189975|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15189976|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15189977|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
15189978|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15189979|NCT03851393|Citric Acid|citric acid|mesh-list
15189980|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
15189981|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
15189982|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15189983|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
15189984|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
15189985|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189986|NCT03851159|Mannitol|mannitol|mesh-list
15189987|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15189988|NCT03851159|Diuretics|diuretics|mesh-ancestor
15189989|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
15189990|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15189991|NCT03851263|Evolocumab|evolocumab|mesh-list
15189992|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15189993|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15189994|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
14677773|NCT00302705|Valsartan|valsartan|mesh-list
14677774|NCT00302705|Enalapril|enalapril|mesh-list
14677775|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14677776|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14677777|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14677778|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677779|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14677780|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
14677781|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677782|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14677783|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
14677784|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14677785|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14677786|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14677787|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14677788|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677789|NCT00302822|Tenofovir|tenofovir|mesh-list
14677790|NCT00302822|Emtricitabine|emtricitabine|mesh-list
15189995|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15189996|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15189997|NCT03850886|Niacinamide|niacinamide|mesh-list
14677791|NCT00302822|Efavirenz|efavirenz|mesh-list
14677792|NCT00302822|Lopinavir|lopinavir|mesh-list
14814698|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15189998|NCT03850886|Niacin|niacin|mesh-list
14677793|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
14677794|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
14677795|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677796|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14677797|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14677798|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677799|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677800|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14677801|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14677802|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14677803|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14677804|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14677805|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14677806|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14677807|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14677808|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14677809|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14677810|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14677811|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14677812|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14677813|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14677814|NCT00302835|Analgesics|analgesics|mesh-list
14677815|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
14677816|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677817|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677818|NCT00302913|Clopidogrel|clopidogrel|mesh-list
15189999|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
15190000|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15190001|NCT03850886|Vitamins|vitamins|mesh-ancestor
15190002|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
15190003|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190004|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
15190005|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15190006|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
15190007|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190008|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14677819|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14677820|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14677821|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14677822|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14677823|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
14677824|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677825|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677826|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677827|NCT00303004|Bosentan|bosentan|mesh-list
14677828|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
14677829|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
14677830|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14677831|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14677832|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677833|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677834|NCT00303004|Urological Agents|urological agents|mesh-ancestor
14677835|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14677836|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14677837|NCT00303017|Naproxen|naproxen|mesh-list
14677838|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14677839|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14677840|NCT00303017|Analgesics|analgesics|mesh-ancestor
14677841|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
14677842|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677843|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677844|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14677845|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677846|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
14677847|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14677848|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677849|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677850|NCT00303056|Icatibant|icatibant|mesh-list
14677851|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14677852|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190009|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
15190010|NCT03850769|Paclitaxel|paclitaxel|mesh-list
14294074|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14677853|NCT00303056|Analgesics|analgesics|mesh-ancestor
14677854|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
14677855|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14677856|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677857|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14677858|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677859|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14677860|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14677861|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677862|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14677863|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677864|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
14677865|NCT00303160|Ascorbic Acid|ascorbic acid|mesh-list
14677866|NCT00303160|Vitamins|vitamins|mesh-ancestor
14677867|NCT00303160|Micronutrients|micronutrients|mesh-ancestor
14677868|NCT00303160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677869|NCT00303160|Antioxidants|antioxidants|mesh-ancestor
14677870|NCT00303160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677871|NCT00303160|Protective Agents|protective agents|mesh-ancestor
14677872|NCT00303264|Esomeprazole|esomeprazole|mesh-list
14677873|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14677874|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14677875|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14677876|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677877|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677878|NCT00303277|Simvastatin|simvastatin|mesh-list
14677879|NCT00303277|Pravastatin|pravastatin|mesh-list
14677880|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14677881|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14677882|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
14677883|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677884|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14677885|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14677886|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677887|NCT00303290|Interferons|interferons|mesh-list
14677888|NCT00303290|Cytarabine|cytarabine|mesh-list
14814699|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
14814700|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14814701|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14814702|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814703|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
14814704|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
14814705|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814706|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
14814707|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14814708|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
14814709|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14814710|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677889|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
14814711|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14814712|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14814713|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14814714|NCT00864149|Carvedilol|carvedilol|mesh-list
14814715|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14814716|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14814717|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814718|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814719|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814720|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677890|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
14677891|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14677892|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677893|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
14677894|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677895|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677896|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
14677897|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677898|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677899|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
14677900|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677901|NCT00303381|Interferons|interferons|mesh-list
14677902|NCT00303381|Interferon-beta|interferon-beta|mesh-list
14677903|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
14677904|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677905|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
14677906|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677907|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
14677908|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677909|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14677910|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14677911|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14677912|NCT00303407|Nadroparin|nadroparin|mesh-list
14677913|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
14677914|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14677915|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14677916|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677917|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14677918|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14677919|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14677920|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677921|NCT00303433|Memantine|memantine|mesh-list
14677922|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14677923|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14677924|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
14677925|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14677926|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677927|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677928|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14677929|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14677930|NCT00303524|Goserelin|goserelin|mesh-list
14677931|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14677932|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677933|NCT00303537|Metformin|metformin|mesh-list
14677934|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14677935|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677936|NCT00303550|Linezolid|linezolid|mesh-list
14677937|NCT00303550|Iclaprim|iclaprim|mesh-list
14677938|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677939|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677940|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14677941|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677942|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677943|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14677944|NCT00303576|Dapivirine|dapivirine|mesh-list
14677945|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14677946|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14677947|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
14677948|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677949|NCT00303589|Lactams|lactams|mesh-list
14677950|NCT00303589|beta-Lactams|beta-lactams|mesh-list
14677951|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14677952|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677953|NCT00303615|Anastrozole|anastrozole|mesh-list
14677954|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
14677955|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14677956|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677957|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14677958|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14677959|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677960|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677961|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14677962|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
14677963|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14677964|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677965|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
14677966|NCT00303615|Hormones|hormones|mesh-ancestor
14677967|NCT00303732|Everolimus|everolimus|mesh-list
14677968|NCT00303732|Vatalanib|vatalanib|mesh-list
14677969|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677970|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677971|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
14677972|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14677973|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14677974|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677975|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677976|NCT00303745|Capecitabine|capecitabine|mesh-list
14677977|NCT00303745|Irinotecan|irinotecan|mesh-list
14677978|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677979|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
14677980|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677981|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677982|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14677983|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14677984|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677985|NCT00303758|Leucovorin|leucovorin|mesh-list
14677986|NCT00303758|Gemcitabine|gemcitabine|mesh-list
14677987|NCT00303758|Fluorouracil|fluorouracil|mesh-list
14677988|NCT00303758|Calcium|calcium|mesh-list
14677989|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
14677990|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14677991|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14677992|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
14677993|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14677994|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
14677995|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14677996|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14677997|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14677998|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
14677999|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678000|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14678001|NCT00303758|Antidotes|antidotes|mesh-ancestor
14678002|NCT00303758|Protective Agents|protective agents|mesh-ancestor
14678003|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
14678004|NCT00303758|Vitamins|vitamins|mesh-ancestor
14678005|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
14726996|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14726997|NCT00511849|Paclitaxel|paclitaxel|mesh-list
15190011|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15190012|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190013|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
15190014|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
14726998|NCT00511849|Carboplatin|carboplatin|mesh-list
14726999|NCT00511849|Sunitinib|sunitinib|mesh-list
14727000|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727001|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727002|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
14727003|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727004|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
14727005|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727006|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14727007|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14727008|NCT00511849|Growth Substances|growth substances|mesh-ancestor
14727009|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727010|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
14727011|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14727012|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727013|NCT00511940|Acamprosate|acamprosate|mesh-list
14727014|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14727015|NCT00511953|Gabapentin|gabapentin|mesh-list
14727016|NCT00511953|Analgesics|analgesics|mesh-ancestor
14727017|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
15190015|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
15190016|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190017|NCT03850561|Ubiquinone|ubiquinone|mesh-list
15190018|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
15190019|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
15190020|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190021|NCT03850561|Vitamins|vitamins|mesh-ancestor
15190022|NCT03850652|Iron|iron|mesh-list
15190023|NCT03850652|Trace Elements|trace elements|mesh-ancestor
15190024|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
15190025|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190026|NCT03850483|PF-06700841|pf-06700841|mesh-list
14727018|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727019|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727020|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
14727021|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14727022|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15190027|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14678006|NCT00303771|Leucovorin|leucovorin|mesh-list
14678007|NCT00303771|Fluorouracil|fluorouracil|mesh-list
14678008|NCT00303771|Irinotecan|irinotecan|mesh-list
14678009|NCT00303771|Calcium|calcium|mesh-list
14678010|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
14678011|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14678012|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678013|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
14678014|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678015|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678016|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678017|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678018|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
14678019|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14678020|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14678021|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678022|NCT00303771|Antidotes|antidotes|mesh-ancestor
14678023|NCT00303771|Protective Agents|protective agents|mesh-ancestor
14678024|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
14678025|NCT00303771|Vitamins|vitamins|mesh-ancestor
14678026|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
14678027|NCT00303784|Goserelin|goserelin|mesh-list
14678028|NCT00303784|Estradiol|estradiol|mesh-list
14678029|NCT00303784|Estrogens|estrogens|mesh-ancestor
14678030|NCT00303784|Hormones|hormones|mesh-ancestor
14678031|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678032|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678033|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14678034|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678035|NCT00303797|Bortezomib|bortezomib|mesh-list
14678036|NCT00303797|Sorafenib|sorafenib|mesh-list
14678037|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678038|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14678039|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678040|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678041|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
14678042|NCT00303810|Thiotepa|thiotepa|mesh-list
14678043|NCT00303810|Lomustine|lomustine|mesh-list
14678044|NCT00303810|Carboplatin|carboplatin|mesh-list
14678045|NCT00303810|Methotrexate|methotrexate|mesh-list
14678046|NCT00303810|Etoposide|etoposide|mesh-list
14678047|NCT00303810|Vincristine|vincristine|mesh-list
14678048|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
14678049|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678050|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
14678051|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678052|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14678053|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14678054|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
14678055|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678056|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678057|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14678058|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14678059|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
14678060|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14678061|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678062|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
14678063|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
14678064|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678065|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15190028|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190029|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190030|NCT03850587|Celecoxib|celecoxib|mesh-list
15190031|NCT03850587|Tramadol|tramadol|mesh-list
15190032|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15190033|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190034|NCT03850587|Analgesics|analgesics|mesh-ancestor
15190035|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
15190036|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190037|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190038|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190039|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14678066|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14678067|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14678068|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14678069|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15190040|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14678070|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14678071|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14678072|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14678073|NCT00303836|Aldesleukin|aldesleukin|mesh-list
14678074|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
14678075|NCT00303836|Fludarabine|fludarabine|mesh-list
14678076|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
14678077|NCT00303836|Interleukin-2|interleukin-2|mesh-list
14678078|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
14678079|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678080|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
14678081|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678082|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14678083|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14678084|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
14678085|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678086|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678087|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14678088|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678089|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
14678090|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14678091|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14678092|NCT00303836|Analgesics|analgesics|mesh-ancestor
14678093|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
14678094|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678095|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14678096|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14678097|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
14678098|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678099|NCT00303888|Docetaxel|docetaxel|mesh-list
14678100|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678101|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14678102|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14678103|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14678104|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190041|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15190042|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190043|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190044|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15190045|NCT03850587|Narcotics|narcotics|mesh-ancestor
15190046|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190047|NCT03850535|Cytarabine|cytarabine|mesh-list
15190048|NCT03850535|Daunorubicin|daunorubicin|mesh-list
15190049|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15190050|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
15190051|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190052|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190053|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
15190054|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190055|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678105|NCT00303927|Capecitabine|capecitabine|mesh-list
14678106|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678107|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
15190056|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
14678108|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678109|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678110|NCT00303940|Carboplatin|carboplatin|mesh-list
14678111|NCT00303940|Temozolomide|temozolomide|mesh-list
14678112|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678113|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14678114|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
14678115|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678116|NCT00303992|Trastuzumab|trastuzumab|mesh-list
14678117|NCT00303992|Irinotecan|irinotecan|mesh-list
14678118|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14678119|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678120|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14678121|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14678122|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678123|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678124|NCT00304018|Prednisone|prednisone|mesh-list
14678125|NCT00304018|Fludarabine|fludarabine|mesh-list
14678126|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
14678127|NCT00304018|Etoposide|etoposide|mesh-list
14678128|NCT00304018|Busulfan|busulfan|mesh-list
14678129|NCT00304018|Tacrolimus|tacrolimus|mesh-list
14678130|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14678131|NCT00304018|Sargramostim|sargramostim|mesh-list
14678132|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14678133|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
14678134|NCT00304018|Hormones|hormones|mesh-ancestor
14678135|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678136|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678137|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14678138|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678139|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678140|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
14678141|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190057|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190058|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15190059|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15190060|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15190061|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190062|NCT03850314|Glycine|glycine|mesh-list
15190063|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
15190064|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190065|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190066|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190067|NCT03850301|Etifoxine|etifoxine|mesh-list
15190068|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15190069|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15190070|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190071|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190072|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15190073|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15190074|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190075|NCT03850028|Atezolizumab|atezolizumab|mesh-list
15190076|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190077|NCT03849833|Vitamin D|vitamin d|mesh-list
15190078|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
15190079|NCT03849833|Vitamins|vitamins|mesh-ancestor
15190080|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
15190081|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678142|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678143|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
14678144|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14678145|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14678146|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14678147|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678148|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14678149|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
14678150|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14678151|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14678152|NCT00304135|Gemcitabine|gemcitabine|mesh-list
14678153|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
14678154|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678155|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678156|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
15190082|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14678157|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678158|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
14678159|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678160|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678161|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678162|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
14678163|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678164|NCT00304200|Temozolomide|temozolomide|mesh-list
14678165|NCT00304200|Sunitinib|sunitinib|mesh-list
14678166|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14678167|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
14678168|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678169|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678170|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14678171|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14678172|NCT00304200|Growth Substances|growth substances|mesh-ancestor
14678173|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678174|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
14678175|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14678176|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678177|NCT00304213|Testosterone|testosterone|mesh-list
14678178|NCT00304213|Androgens|androgens|mesh-ancestor
14678179|NCT00304213|Hormones|hormones|mesh-ancestor
14678180|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678181|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678182|NCT00304226|Amlodipine|amlodipine|mesh-list
14678183|NCT00304226|Valsartan|valsartan|mesh-list
14678184|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14678185|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14678186|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14678187|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678188|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14678189|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678190|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
14678191|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14678192|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14678193|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14678194|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14678195|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14678196|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14678197|NCT00304252|Interferons|interferons|mesh-list
14678198|NCT00304252|Interferon-beta|interferon-beta|mesh-list
14678199|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
14678200|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678201|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
14678202|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678203|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
14678204|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678205|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14678206|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
14678207|NCT00304291|Analgesics|analgesics|mesh-ancestor
14678208|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
14678209|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190083|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15190084|NCT03849508|Phenylephrine|phenylephrine|mesh-list
15190085|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
15190086|NCT03849508|Norepinephrine|norepinephrine|mesh-list
15190087|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15190088|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
15190089|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
15190090|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190091|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190092|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
15190093|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15190094|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
15190095|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
14678210|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678211|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678212|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14678213|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14678214|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678215|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678216|NCT00304317|Celecoxib|celecoxib|mesh-list
14678217|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14678218|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14678219|NCT00304317|Analgesics|analgesics|mesh-ancestor
14678220|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
14678221|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678222|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678223|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14678224|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14678225|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14678226|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14678227|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678228|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678229|NCT00304369|Metronidazole|metronidazole|mesh-list
14678230|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678231|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14678232|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14678233|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14678234|NCT00304382|Vaccines|vaccines|mesh-list
14678235|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14678236|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
14678237|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678238|NCT00304421|Rabeprazole|rabeprazole|mesh-list
14678239|NCT00304421|Pantoprazole|pantoprazole|mesh-list
14678240|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14678241|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14678242|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14678243|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190096|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15190097|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15190098|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15190099|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
15190100|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190101|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190102|NCT03849508|Protective Agents|protective agents|mesh-ancestor
15190103|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
15190104|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15190105|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190106|NCT03849664|Riboflavin|riboflavin|mesh-list
15190107|NCT03849664|Niacinamide|niacinamide|mesh-list
15190108|NCT03849664|Niacin|niacin|mesh-list
15190109|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
15190110|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
15190111|NCT03849664|Povidone|povidone|mesh-list
15190112|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15190113|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190114|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
15190115|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
14814721|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15190116|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
14814722|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
15190117|NCT03849664|Vitamins|vitamins|mesh-ancestor
15190118|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
15190119|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15190120|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190121|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15190122|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
15190123|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190124|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14678244|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678245|NCT00304434|Oseltamivir|oseltamivir|mesh-list
14678246|NCT00304434|Probenecid|probenecid|mesh-list
14678247|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
14678248|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678249|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678250|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678251|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
14678252|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
14678253|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14678254|NCT00304434|Renal Agents|renal agents|mesh-ancestor
14678255|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
14678256|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14678257|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678258|NCT00304460|Aldesleukin|aldesleukin|mesh-list
14678259|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678260|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14678261|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14678262|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
14678263|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678264|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14678265|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678266|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678267|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14678268|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678269|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678270|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678271|NCT00304499|Oxybutynin|oxybutynin|mesh-list
14678272|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
14678273|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
14678274|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678275|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678276|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14678277|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14678278|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14678279|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678280|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678281|NCT00304499|Urological Agents|urological agents|mesh-ancestor
14678282|NCT00304538|Glucagon|glucagon|mesh-list
14678283|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14678284|NCT00304538|Hormones|hormones|mesh-ancestor
14678285|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678286|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678287|NCT00304551|Ribavirin|ribavirin|mesh-list
14678288|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14678289|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
14678290|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
14678291|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678292|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
14678293|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678294|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
14678295|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678296|NCT00304616|Olanzapine|olanzapine|mesh-list
14678297|NCT00304616|Risperidone|risperidone|mesh-list
14678298|NCT00304616|Aripiprazole|aripiprazole|mesh-list
14678299|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14678300|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15190125|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
15190126|NCT03849729|Phentermine|phentermine|mesh-list
15190127|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15190128|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190129|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
15190130|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15190131|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
15190132|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
14678301|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
15190133|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678302|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727023|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678303|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678304|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678305|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14678306|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678307|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678308|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15190134|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
15190135|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190136|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223933|NCT04947332|Immunologic Factors|immunologic factors|mesh-ancestor
15223934|NCT04947332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678309|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14678310|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
14678311|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
14678312|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
14678313|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678314|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14678315|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14678316|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14678317|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14678318|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678319|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
14678320|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14678321|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14678322|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14678323|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14678324|NCT00304629|Galantamine|galantamine|mesh-list
14678325|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14678326|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678327|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678328|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
14678329|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678330|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678331|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14678332|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
14678333|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678334|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
14678335|NCT00304642|Dapivirine|dapivirine|mesh-list
14678336|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14678337|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14678338|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
14678339|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678340|NCT00304655|Aripiprazole|aripiprazole|mesh-list
14678341|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678342|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678343|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14678344|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678345|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678346|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678347|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
14678348|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
14678349|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678350|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678351|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14678352|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14678353|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
14678354|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14678355|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14678356|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14678357|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14678358|NCT00304668|Dapivirine|dapivirine|mesh-list
14678359|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14678360|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14678361|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
14678362|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678363|NCT00304681|Methylphenidate|methylphenidate|mesh-list
14678364|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15223935|NCT04945720|Durvalumab|durvalumab|mesh-list
15223936|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15223937|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223938|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223939|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
14727024|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678365|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678366|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14678367|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14678368|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14678369|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678370|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
14678371|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678372|NCT00304720|Tacrolimus|tacrolimus|mesh-list
14678373|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678374|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
14678375|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678376|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14678377|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678378|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678379|NCT00304772|Fluconazole|fluconazole|mesh-list
14678380|NCT00304772|Micafungin|micafungin|mesh-list
14678381|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
14678382|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678383|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14678384|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14678385|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678386|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678387|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14678388|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
14678389|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678390|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678391|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14678392|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14678393|NCT00304785|Latanoprost|latanoprost|mesh-list
14678394|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14678395|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14678396|NCT00304811|Vancomycin|vancomycin|mesh-list
14678397|NCT00304811|Rifampin|rifampin|mesh-list
14678398|NCT00304811|Gentamicins|gentamicins|mesh-list
14678399|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14678400|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678401|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14678402|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
14678403|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
14678404|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14678405|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678406|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678407|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14678408|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14678409|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14678410|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15190137|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
15190138|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190139|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
15190140|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
15190141|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
14678411|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14678412|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14678413|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14678414|NCT00304850|Ketamine|ketamine|mesh-list
14678415|NCT00304850|Analgesics|analgesics|mesh-ancestor
14678416|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
14678417|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678418|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190142|NCT03849404|Adalimumab|adalimumab|mesh-list
15190143|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190144|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15190145|NCT03849209|Pancrelipase|pancrelipase|mesh-list
15190146|NCT03849209|Pancreatin|pancreatin|mesh-list
15190147|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15190148|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
14678419|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14678420|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14678421|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
14678422|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
14678423|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678424|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14678425|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14678426|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678427|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678428|NCT00304980|Lumefantrine|lumefantrine|mesh-list
14678429|NCT00304980|Artemether|artemether|mesh-list
14678430|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
14678431|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
14678432|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14678433|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14678434|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
14678435|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14678436|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14678437|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678438|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14678439|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678440|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678441|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15190149|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
15190150|NCT03849235|Glucagon|glucagon|mesh-list
15190151|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15190152|NCT03849235|Hormones|hormones|mesh-ancestor
15190153|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190154|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190155|NCT03849313|Adalimumab|adalimumab|mesh-list
15190156|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190157|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15190158|NCT03849196|Bisacodyl|bisacodyl|mesh-list
15190159|NCT03849196|Cathartics|cathartics|mesh-ancestor
15190160|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15190161|NCT03849196|Laxatives|laxatives|mesh-ancestor
15190162|NCT03849170|Vaccines|vaccines|mesh-list
15190163|NCT03849170|Immunologic Factors|immunologic factors|mesh-ancestor
15190164|NCT03849170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190165|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
15190166|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15190167|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
14678442|NCT00304980|Renal Agents|renal agents|mesh-ancestor
14678443|NCT00304993|Niacin|niacin|mesh-list
14678444|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
14678445|NCT00304993|Fenofibrate|fenofibrate|mesh-list
14678446|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14678447|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678448|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15190168|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
15190169|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190170|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190171|NCT03848611|Vorolanib|vorolanib|mesh-list
15190172|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15190173|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190174|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190175|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
15190176|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15190177|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190178|NCT03848806|Calcitriol|calcitriol|mesh-list
15190179|NCT03848806|Calcipotriene|calcipotriene|mesh-list
15190180|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190181|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15190182|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190183|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15190184|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190185|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190186|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15190187|NCT03848806|Vitamins|vitamins|mesh-ancestor
15190188|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
14294075|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14678449|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
14678450|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678451|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15190189|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15190190|NCT03848533|Metformin|metformin|mesh-list
15190191|NCT03848533|Melatonin|melatonin|mesh-list
14678452|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
14678453|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
14678454|NCT00304993|Vitamins|vitamins|mesh-ancestor
14678455|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
14678456|NCT00305019|Clevudine|clevudine|mesh-list
14678457|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
14678458|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678459|NCT00305201|Pravastatin|pravastatin|mesh-list
14678460|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14678461|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14678462|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
14678463|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678464|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14678465|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14678466|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678467|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
14678468|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
15190192|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15190193|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190194|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
15190195|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190196|NCT03848533|Protective Agents|protective agents|mesh-ancestor
15190197|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190198|NCT03848182|Gemcitabine|gemcitabine|mesh-list
15190199|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15190200|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
15190201|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190202|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190203|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
15190204|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190205|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190206|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15190207|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
15190208|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190209|NCT03848780|Desflurane|desflurane|mesh-list
15190210|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15190211|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
15190212|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
15190213|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190214|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190215|NCT03848234|Estradiol|estradiol|mesh-list
15190216|NCT03848234|Estrogens|estrogens|mesh-ancestor
15190217|NCT03848234|Hormones|hormones|mesh-ancestor
15190218|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190219|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190220|NCT03848104|Cefoxitin|cefoxitin|mesh-list
15190221|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15190222|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190223|NCT03848065|Vaccines|vaccines|mesh-list
15190224|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
15190225|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190226|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15190227|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190228|NCT03848039|Vaccines|vaccines|mesh-list
15190229|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
15190230|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190231|NCT03847818|Carboplatin|carboplatin|mesh-list
15190232|NCT03847818|Docetaxel|docetaxel|mesh-list
15190233|NCT03847818|Trastuzumab|trastuzumab|mesh-list
15190234|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190235|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
15190236|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
15190237|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
15190238|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190239|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190240|NCT03847792|Dexamethasone|dexamethasone|mesh-list
15190241|NCT03847792|Fentanyl|fentanyl|mesh-list
15190242|NCT03847792|Bupivacaine|bupivacaine|mesh-list
15190243|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190244|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
15190245|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
14678469|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678470|NCT00305292|Modafinil|modafinil|mesh-list
14678471|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15190246|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190247|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190248|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15190249|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
14678472|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678473|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14678474|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14678475|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14678476|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678477|NCT00305331|Domperidone|domperidone|mesh-list
14678478|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
14678479|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
14678480|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678481|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678482|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14678483|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14678484|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
14678485|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678486|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678487|NCT00305370|Aripiprazole|aripiprazole|mesh-list
14678488|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678489|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678490|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14678491|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678492|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678493|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678494|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
14678495|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
14678496|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678497|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678498|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14678499|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14678500|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
14678501|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14678502|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15190250|NCT03847792|Hormones|hormones|mesh-ancestor
15190251|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190252|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15190253|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678503|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14678504|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14678505|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14678506|NCT00305383|Taribavirin|taribavirin|mesh-list
15190254|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190255|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
15190256|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190257|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
15190258|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15190259|NCT03847792|Narcotics|narcotics|mesh-ancestor
15190260|NCT03847792|Analgesics|analgesics|mesh-ancestor
15190261|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15190262|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15190263|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
15223940|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223941|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15223942|NCT04944290|Brinzolamide|brinzolamide|mesh-list
15223943|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15223944|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15223945|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14678507|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
14678508|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678509|NCT00305396|Sirolimus|sirolimus|mesh-list
14678510|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14678511|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678512|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14678513|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678514|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
14678515|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678516|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
15223946|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15223947|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
15223948|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223949|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223950|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223951|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15223952|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223953|NCT04939090|Megestrol|megestrol|mesh-list
14678517|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678518|NCT00305409|Sulfalene|sulfalene|mesh-list
14678519|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678520|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14678521|NCT00305409|Renal Agents|renal agents|mesh-ancestor
14678522|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
14678523|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14678524|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14678525|NCT00305422|Risperidone|risperidone|mesh-list
14678526|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14678527|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14678528|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
14678529|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678530|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678531|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678532|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14678533|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678534|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678535|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678536|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14678537|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
14678538|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678539|NCT00305461|Ciclesonide|ciclesonide|mesh-list
14678540|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
14678541|NCT00305461|Hormones|hormones|mesh-ancestor
14678542|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678543|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678544|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14678545|NCT00305474|Risperidone|risperidone|mesh-list
14678546|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14678547|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
14678548|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678549|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678550|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678551|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14678552|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678553|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678554|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678555|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14678556|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
14678557|NCT00305487|Ciclesonide|ciclesonide|mesh-list
14678558|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
14678559|NCT00305487|Hormones|hormones|mesh-ancestor
14678560|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678561|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678562|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14678563|NCT00305500|Citalopram|citalopram|mesh-list
14678564|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14678565|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14678566|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14678567|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814723|NCT00864149|Protective Agents|protective agents|mesh-ancestor
15190264|NCT03847571|Acetazolamide|acetazolamide|mesh-list
15190265|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
15190266|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15190267|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190268|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190269|NCT03847571|Diuretics|diuretics|mesh-ancestor
15190270|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
15190271|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190272|NCT03847922|Lidocaine|lidocaine|mesh-list
15190273|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
15190274|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190275|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
15190276|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190277|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190278|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
15190279|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190280|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15190281|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15190282|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15190283|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190284|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678568|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678569|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
14678570|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678571|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14678572|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678573|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678574|NCT00305513|Caffeine|caffeine|mesh-list
14678575|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14678576|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678577|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14678578|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678579|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678580|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14678581|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14678582|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
14678583|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678584|NCT00305539|Adalimumab|adalimumab|mesh-list
14678585|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14678586|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14678587|NCT00305552|Thalidomide|thalidomide|mesh-list
14678588|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678589|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
14678590|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678591|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
14678592|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14678593|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678594|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14678595|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14678596|NCT00305552|Growth Substances|growth substances|mesh-ancestor
14678597|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
14678598|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678599|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
14678600|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14678601|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14678602|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678603|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678604|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678605|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
14727025|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14727026|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14727027|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727028|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727029|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
14727030|NCT00511966|Rabeprazole|rabeprazole|mesh-list
14727031|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14727032|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727033|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14727034|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727035|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727036|NCT00511979|Insulin|insulin|mesh-list
15190285|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15190286|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
15190287|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190288|NCT03847922|Analgesics|analgesics|mesh-ancestor
15190289|NCT03847896|Budesonide|budesonide|mesh-list
15190290|NCT03847896|Albuterol|albuterol|mesh-list
15190291|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190292|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15190293|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
15190294|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190295|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190296|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15190297|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
15190298|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
15190299|NCT03847896|Hormones|hormones|mesh-ancestor
15190300|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190301|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
15190302|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190303|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15190304|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15190305|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15190306|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
15190307|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727037|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15190308|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678606|NCT00305630|Triamcinolone|triamcinolone|mesh-list
14678607|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14678608|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14678609|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14678610|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14678611|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
14678612|NCT00305630|Hormones|hormones|mesh-ancestor
14678613|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678614|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678615|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678616|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
14678617|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678618|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678619|NCT00305669|Sargramostim|sargramostim|mesh-list
14678620|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
14678621|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678622|NCT00305708|Fludarabine|fludarabine|mesh-list
14678623|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
14678624|NCT00305708|Busulfan|busulfan|mesh-list
14678625|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14678626|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678627|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678628|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
14678629|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678630|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678631|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
14678632|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678633|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
14678634|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14678635|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14678636|NCT00305734|Gemcitabine|gemcitabine|mesh-list
14678637|NCT00305734|Bortezomib|bortezomib|mesh-list
14678638|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678639|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
14678640|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678641|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678642|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
14678643|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678644|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678645|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678646|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
14678647|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678648|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14678649|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14678650|NCT00305747|Protective Agents|protective agents|mesh-ancestor
14678651|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678652|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678653|NCT00305786|Gemcitabine|gemcitabine|mesh-list
14678654|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
14678655|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14678656|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
14678657|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678658|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678659|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
14678660|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190309|NCT03847506|Amlodipine|amlodipine|mesh-list
15190310|NCT03847506|Candesartan|candesartan|mesh-list
15190311|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
14678661|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678662|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678663|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
14678664|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678665|NCT00305812|Dexamethasone|dexamethasone|mesh-list
14678666|NCT00305812|Lenalidomide|lenalidomide|mesh-list
15190312|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15190313|NCT03847506|Ezetimibe|ezetimibe|mesh-list
15190314|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15190315|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15190316|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190317|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678667|NCT00305812|Melphalan|melphalan|mesh-list
14678668|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14678669|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
14678670|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
15190318|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14678671|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678672|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678673|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14678674|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
14678675|NCT00305812|Hormones|hormones|mesh-ancestor
14678676|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678677|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15190319|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190320|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
15190321|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14678678|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678679|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
14678680|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14678681|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14678682|NCT00305812|Growth Substances|growth substances|mesh-ancestor
14678683|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
14678684|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14678685|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
14678686|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678687|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14678688|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678689|NCT00305825|Bevacizumab|bevacizumab|mesh-list
14678690|NCT00305825|Letrozole|letrozole|mesh-list
14678691|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14678692|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678693|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14678694|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15190322|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15190323|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
15190324|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15190325|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15190326|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190327|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15190328|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15190329|NCT03847623|Curcumin|curcumin|mesh-list
15190330|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15190331|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190332|NCT03847623|Analgesics|analgesics|mesh-ancestor
15190333|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
15190334|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190335|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190336|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190337|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15190338|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190339|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190340|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190341|NCT03847558|Hormones|hormones|mesh-list
15190342|NCT03847558|Testosterone|testosterone|mesh-list
15190343|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15190344|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190345|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190346|NCT03847558|Androgens|androgens|mesh-ancestor
15190347|NCT03847363|Anesthetics|anesthetics|mesh-list
15190348|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190349|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190350|NCT03847207|Pasireotide|pasireotide|mesh-list
15190351|NCT03847207|Hormones|hormones|mesh-ancestor
15190352|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190353|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190354|NCT03847246|Entecavir|entecavir|mesh-list
15190355|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
15190356|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190357|NCT03847155|Nicotine|nicotine|mesh-list
15190358|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15190359|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
15190360|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190361|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190362|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15190363|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15190364|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14678695|NCT00305825|Growth Substances|growth substances|mesh-ancestor
14678696|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678697|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
14678698|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14678699|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14678700|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678701|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678702|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14678703|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
14678704|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678705|NCT00305838|Tamoxifen|tamoxifen|mesh-list
14678706|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14678707|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
14678708|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678709|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678710|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14678711|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678712|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14678713|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14678714|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14678715|NCT00305903|Memantine|memantine|mesh-list
14678716|NCT00305903|Rivastigmine|rivastigmine|mesh-list
14678717|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14678718|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14678719|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
14678720|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678721|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678722|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678723|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14678724|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14678725|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14678726|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678727|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
14678728|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14678729|NCT00305903|Protective Agents|protective agents|mesh-ancestor
14678730|NCT00306020|Morphine|morphine|mesh-list
15190365|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190366|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190367|NCT03847272|Prednisone|prednisone|mesh-list
15190368|NCT03847272|Ustekinumab|ustekinumab|mesh-list
15190369|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190370|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
15190371|NCT03847272|Hormones|hormones|mesh-ancestor
15190372|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190373|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190374|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15190375|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190376|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190377|NCT03847441|Vitamin D|vitamin d|mesh-list
15190378|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
15190379|NCT03847441|Calcipotriene|calcipotriene|mesh-list
15190380|NCT03847441|Vitamins|vitamins|mesh-ancestor
15190381|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
15190382|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190383|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15190384|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15190385|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190386|NCT03847376|Rilpivirine|rilpivirine|mesh-list
15190387|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15190388|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15190389|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190390|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190391|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
15190392|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190393|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15190394|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15190395|NCT03846739|Oxytocin|oxytocin|mesh-list
15190396|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
15190397|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190398|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190399|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
15190400|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15190401|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14678731|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14678732|NCT00306020|Narcotics|narcotics|mesh-ancestor
14678733|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678734|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678735|NCT00306020|Analgesics|analgesics|mesh-ancestor
14678736|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
14678737|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678738|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14678739|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
14678740|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14678741|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
14678742|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
14678743|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678744|NCT00306046|Diphosphonates|diphosphonates|mesh-list
15190402|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190403|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
14678745|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14678746|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678747|NCT00306124|Levodopa|levodopa|mesh-list
14678748|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14678749|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14678750|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
14678751|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678752|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678753|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678754|NCT00306137|Aprotinin|aprotinin|mesh-list
14678755|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
15190404|NCT03846973|Coagulants|coagulants|mesh-ancestor
15190405|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
14678756|NCT00306137|Coagulants|coagulants|mesh-ancestor
14678757|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14678758|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14678759|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
14678760|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678761|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678762|NCT00306150|Aprotinin|aprotinin|mesh-list
14678763|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
14678764|NCT00306150|Coagulants|coagulants|mesh-ancestor
14678765|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14678766|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15190406|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15190407|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15190408|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
15190409|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190410|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190411|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15190412|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
15190413|NCT03846765|Phenylephrine|phenylephrine|mesh-list
15190414|NCT03846765|Dobutamine|dobutamine|mesh-list
15190415|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
15190416|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15190417|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
15190418|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
15190419|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190420|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190421|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
15190422|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15190423|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
15190424|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
15190425|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15190426|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15190427|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15190428|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
14678767|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
14678768|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678769|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678770|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
14678771|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14678772|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678773|NCT00306254|Enoxaparin|enoxaparin|mesh-list
14678774|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
14678775|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
14678776|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14678777|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15190429|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223954|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
14678778|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678779|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14678780|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
14678781|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14678782|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
14678783|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678784|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
15190430|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190431|NCT03846765|Protective Agents|protective agents|mesh-ancestor
15190432|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15190433|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14678785|NCT00306267|Hematinics|hematinics|mesh-ancestor
14678786|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
14678787|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14678788|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678789|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14678790|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14678791|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678792|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678793|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678794|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
14678795|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
14678796|NCT00306358|Vitamins|vitamins|mesh-ancestor
14678797|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
14678798|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678799|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
14678800|NCT00306358|Hematinics|hematinics|mesh-ancestor
14678801|NCT00306397|Sirolimus|sirolimus|mesh-list
14678802|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14678803|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678804|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14678805|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678806|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
14678807|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678808|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
14678809|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678810|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
14678811|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14678812|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678813|NCT00306410|Vitamins|vitamins|mesh-ancestor
14678814|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
14678815|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14678816|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
14678817|NCT00306462|Nifedipine|nifedipine|mesh-list
14678818|NCT00306462|Analgesics|analgesics|mesh-ancestor
14678819|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
15190434|NCT03846271|Oxytocin|oxytocin|mesh-list
15190435|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
15190436|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190437|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190438|NCT03846388|Hormones|hormones|mesh-list
14678820|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678821|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678822|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
14678823|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678824|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14678825|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
14678826|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14678827|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190439|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14678828|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678829|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14678830|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
14678831|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190440|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190441|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190442|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15190443|NCT03846583|Trastuzumab|trastuzumab|mesh-list
15190444|NCT03846583|Tucatinib|tucatinib|mesh-list
15190445|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15190446|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190447|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190448|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15190449|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190450|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190451|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14294076|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294077|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14294078|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14294079|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
14294080|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14294081|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14294082|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14294083|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294084|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294085|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678832|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
14678833|NCT00306475|Valproic Acid|valproic acid|mesh-list
14678834|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
14678835|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678836|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678837|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
14678838|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678839|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678840|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
14678841|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678842|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678843|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678844|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14678845|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678846|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678847|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14678848|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14678849|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678850|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678851|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
14678852|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678853|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
15190452|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
15190453|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190454|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190455|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15190456|NCT03846180|Octreotide|octreotide|mesh-list
15190457|NCT03846180|Terlipressin|terlipressin|mesh-list
14678854|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
14678855|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
14678856|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678857|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
14678858|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14678859|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678860|NCT00306683|Diazoxide|diazoxide|mesh-list
14678861|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14678862|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
14678863|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
14678864|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14678865|NCT00306696|Spironolactone|spironolactone|mesh-list
14678866|NCT00306696|Furosemide|furosemide|mesh-list
14678867|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14678868|NCT00306696|Diuretics|diuretics|mesh-ancestor
14678869|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
14678870|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678871|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14678872|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14678873|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678874|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14678875|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
14678876|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14678877|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14678878|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14678879|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14678880|NCT00306722|Fospropofol|fospropofol|mesh-list
14678881|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14678882|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14678883|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678884|NCT00306735|Palonosetron|palonosetron|mesh-list
15190458|NCT03846180|Somatostatin|somatostatin|mesh-list
15190459|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15190460|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15190461|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190462|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15190463|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15190464|NCT03846180|Hormones|hormones|mesh-ancestor
15190465|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190466|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190467|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
15190468|NCT03846284|Bupivacaine|bupivacaine|mesh-list
15190469|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
15190470|NCT03846284|Anesthetics|anesthetics|mesh-list
15190471|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
15190472|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190473|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190474|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
15190475|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190476|NCT03846284|Analgesics|analgesics|mesh-ancestor
15190477|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15190478|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
15190479|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15190480|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190481|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190482|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15190483|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
15190484|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190485|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
15190486|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15190487|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190488|NCT03846102|Acetaminophen|acetaminophen|mesh-list
15190489|NCT03846102|Morphine|morphine|mesh-list
15190490|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
14678885|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
14678886|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
14678887|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190491|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15190492|NCT03846102|Narcotics|narcotics|mesh-ancestor
15190493|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190494|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294086|NCT00573508|Urological Agents|urological agents|mesh-ancestor
14294087|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15190495|NCT03846102|Analgesics|analgesics|mesh-ancestor
14678888|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678889|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14678890|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14678891|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14678892|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
14678893|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678894|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678895|NCT00306748|Linaclotide|linaclotide|mesh-list
14678896|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14678897|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
14678898|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678899|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14678900|NCT00306774|Vitamin D|vitamin d|mesh-list
14678901|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
14678902|NCT00306774|Vitamins|vitamins|mesh-ancestor
14678903|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
14678904|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678905|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14678906|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14678907|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15190496|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
15190497|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190498|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190499|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
15190500|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190501|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
15190502|NCT03845699|Fentanyl|fentanyl|mesh-list
15190503|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15190504|NCT03845699|Narcotics|narcotics|mesh-ancestor
15190505|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190506|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190507|NCT03845699|Analgesics|analgesics|mesh-ancestor
15190508|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
15190509|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190510|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15190511|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15190512|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
15190513|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
15190514|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
15190515|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190516|NCT03845881|Oxycodone|oxycodone|mesh-list
15190517|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15190518|NCT03845881|Narcotics|narcotics|mesh-ancestor
15190519|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190520|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190521|NCT03845881|Analgesics|analgesics|mesh-ancestor
15190522|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
15190523|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190524|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
14678908|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14678909|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14678910|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
14294088|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14294089|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294090|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14294091|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14678911|NCT00306813|Lenalidomide|lenalidomide|mesh-list
15190525|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190526|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
15190527|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
14678912|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
14678913|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678914|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14678915|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15190528|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190529|NCT03845673|Psyllium|psyllium|mesh-list
15190530|NCT03845673|Cathartics|cathartics|mesh-ancestor
15190531|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223955|NCT04939090|Olanzapine|olanzapine|mesh-list
15223956|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
15223957|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
15223958|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223959|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223960|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223961|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15223962|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15223963|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223964|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15223965|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15190532|NCT03845387|Pramipexole|pramipexole|mesh-list
15190533|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
14678916|NCT00306813|Growth Substances|growth substances|mesh-ancestor
14678917|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
14678918|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678919|NCT00306826|Pioglitazone|pioglitazone|mesh-list
14678920|NCT00306826|Simvastatin|simvastatin|mesh-list
14678921|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14678922|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14678923|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
14678924|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678925|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14678926|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14678927|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678928|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14678929|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678930|NCT00306878|Abatacept|abatacept|mesh-list
14678931|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14678932|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190534|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190535|NCT03845387|Protective Agents|protective agents|mesh-ancestor
15190536|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190537|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15190538|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15190539|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
15190540|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
15190541|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190542|NCT03845348|Ketoconazole|ketoconazole|mesh-list
15190543|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
15190544|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190545|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15190546|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15190547|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294092|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294093|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294094|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
14294095|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294096|NCT00573755|Sorafenib|sorafenib|mesh-list
14294097|NCT00573755|Letrozole|letrozole|mesh-list
14294098|NCT00573755|Anastrozole|anastrozole|mesh-list
15190548|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190549|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15190550|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
15190551|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190552|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190553|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15190554|NCT03845322|Curcumin|curcumin|mesh-list
15190555|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15190556|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190557|NCT03845322|Analgesics|analgesics|mesh-ancestor
15190558|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
15190559|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190560|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190561|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190562|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15190563|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190564|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190565|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190566|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15190567|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15190568|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15190569|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190570|NCT03845179|Incretins|incretins|mesh-ancestor
15190571|NCT03845179|Hormones|hormones|mesh-ancestor
15223966|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14294099|NCT00573755|Exemestane|exemestane|mesh-list
14294100|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678933|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294101|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14678934|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14678935|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
14678936|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678937|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14678938|NCT00306969|Bexarotene|bexarotene|mesh-list
14678939|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678940|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14678941|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
14678942|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190572|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190573|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
15190574|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190575|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190576|NCT03845153|Metformin|metformin|mesh-list
14294102|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294103|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294104|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14294105|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14294106|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14294107|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14294108|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14294109|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294110|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14294111|NCT00573768|Diclofenac|diclofenac|mesh-list
14294112|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14294113|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14294114|NCT00573768|Analgesics|analgesics|mesh-ancestor
14294115|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
14294116|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294117|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294118|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294119|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294120|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14294121|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294122|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294123|NCT00573794|Adalimumab|adalimumab|mesh-list
14294124|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294125|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294126|NCT00573859|Methylphenidate|methylphenidate|mesh-list
14294127|NCT00573859|Amphetamine|amphetamine|mesh-list
14294128|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14678943|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14678944|NCT00307099|Meropenem|meropenem|mesh-list
14678945|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678946|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14678947|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
14678948|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
14678949|NCT00307177|Vaccines|vaccines|mesh-list
14678950|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
14678951|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678952|NCT00307203|Bupropion|bupropion|mesh-list
14678953|NCT00307203|Nicotine|nicotine|mesh-list
14678954|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14678955|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
14678956|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14678957|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14678958|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14678959|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14678960|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
14678961|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14678962|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678963|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14678964|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
14678965|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14678966|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14678967|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14678968|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14678969|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
14678970|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14678971|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14678972|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678973|NCT00307255|Gemcitabine|gemcitabine|mesh-list
14678974|NCT00307255|Paclitaxel|paclitaxel|mesh-list
14678975|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15190577|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15190578|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190579|NCT03845010|Verapamil|verapamil|mesh-list
15190580|NCT03845010|Sotalol|sotalol|mesh-list
15190581|NCT03845010|Flecainide|flecainide|mesh-list
15190582|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15190583|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15190584|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190585|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190586|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15190587|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190588|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
15190589|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14678976|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14678977|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14678978|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
14678979|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
14678980|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
14678981|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678982|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15190590|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15190591|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
15190592|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190593|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
15190594|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
15190595|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190596|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15190597|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15190598|NCT03845049|Aflibercept|aflibercept|mesh-list
15190599|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15190600|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15190601|NCT03845049|Growth Substances|growth substances|mesh-ancestor
15190602|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190603|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
15190604|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190605|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
15190606|NCT03844841|Propofol|propofol|mesh-list
15190607|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15190608|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190609|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190610|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15190611|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
15190612|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
15190613|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190614|NCT03844841|Analgesics|analgesics|mesh-ancestor
15190615|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
15190616|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190617|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15190618|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15190619|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15190620|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
15190621|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190622|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190623|NCT03844984|Lidocaine|lidocaine|mesh-list
15190624|NCT03844984|Midazolam|midazolam|mesh-list
15190625|NCT03844984|Ketamine|ketamine|mesh-list
15190626|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190627|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
15190628|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190629|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190630|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
15190631|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190632|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15190633|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15190634|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15190635|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190636|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190637|NCT03844984|Analgesics|analgesics|mesh-ancestor
15190638|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15190639|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15190640|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
14678983|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
14678984|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
14678985|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14678986|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678987|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15190641|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14678988|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
14678989|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190642|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15190643|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190644|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15190645|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15190646|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15190647|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15190648|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15190649|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
15190650|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
15190651|NCT03844932|Cyclosporine|cyclosporine|mesh-list
15190652|NCT03844932|Cyclosporins|cyclosporins|mesh-list
15190653|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190654|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190655|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15190656|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
15190657|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190658|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
15190659|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190660|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190661|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15190662|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15190663|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
15190664|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190665|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
15190666|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
15190667|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190668|NCT03844815|Decitabine|decitabine|mesh-list
15190669|NCT03844815|Venetoclax|venetoclax|mesh-list
15190670|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15190671|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
15190672|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678990|NCT00307307|Niacin|niacin|mesh-list
14678991|NCT00307307|Simvastatin|simvastatin|mesh-list
14678992|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14678993|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14678994|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
14678995|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14678996|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14678997|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14678998|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14678999|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
14679000|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
14679001|NCT00307307|Vitamins|vitamins|mesh-ancestor
14679002|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
14679003|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679004|NCT00307411|Hormones|hormones|mesh-list
14679005|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679006|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727038|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14727039|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727040|NCT00512044|Anesthetics|anesthetics|mesh-list
14727041|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727042|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727043|NCT00512057|Allopurinol|allopurinol|mesh-list
14727044|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
14727045|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727046|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727047|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
14727048|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727049|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14727050|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
14727051|NCT00512057|Protective Agents|protective agents|mesh-ancestor
14727052|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727053|NCT00512070|Olanzapine|olanzapine|mesh-list
14727054|NCT00512070|Melatonin|melatonin|mesh-list
14727055|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
14727056|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727057|NCT00512070|Protective Agents|protective agents|mesh-ancestor
14727058|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727059|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190673|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190674|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190675|NCT03844581|Propiverine|propiverine|mesh-list
15190676|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
15190677|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
15190678|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190679|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190680|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15190681|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15190682|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
15190683|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190684|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190685|NCT03844581|Urological Agents|urological agents|mesh-ancestor
15190686|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15190687|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
15190688|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15190689|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
15190690|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190691|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190692|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15190693|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15190694|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15190695|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190696|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15190697|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15190698|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15190699|NCT03844451|Epinephrine|epinephrine|mesh-list
15190700|NCT03844451|Bupivacaine|bupivacaine|mesh-list
15190701|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190702|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
15190703|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190704|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190705|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
15190706|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190707|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15190708|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15190709|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
14679007|NCT00307450|Levetiracetam|levetiracetam|mesh-list
14679008|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
14679009|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
14679010|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
14679011|NCT00307502|Ritonavir|ritonavir|mesh-list
14679012|NCT00307502|Lopinavir|lopinavir|mesh-list
14294129|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
14294130|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14679013|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14679014|NCT00307502|Darunavir|darunavir|mesh-list
14679015|NCT00307502|Nelfinavir|nelfinavir|mesh-list
14679016|NCT00307502|Indinavir|indinavir|mesh-list
14679017|NCT00307502|Saquinavir|saquinavir|mesh-list
14679018|NCT00307502|Amprenavir|amprenavir|mesh-list
14679019|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
15190710|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190711|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190712|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14679020|NCT00307502|Nevirapine|nevirapine|mesh-list
14679021|NCT00307502|Tipranavir|tipranavir|mesh-list
14679022|NCT00307502|Efavirenz|efavirenz|mesh-list
14679023|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14679024|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14679025|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14679026|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679027|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679028|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14679029|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14679030|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
14679031|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679032|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14679033|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14814724|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14814725|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814726|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14814727|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814728|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14814729|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14814730|NCT00864162|Ramipril|ramipril|mesh-list
14814731|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14814732|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
14814733|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814734|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814735|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814736|NCT00864188|Beta Carotene|beta carotene|mesh-list
14814737|NCT00864188|Carotenoids|carotenoids|mesh-list
14814738|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
14814739|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814740|NCT00864188|Protective Agents|protective agents|mesh-ancestor
14814741|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814742|NCT00864188|Provitamins|provitamins|mesh-ancestor
14814743|NCT00864188|Vitamins|vitamins|mesh-ancestor
14814744|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
14814745|NCT00864201|Bosentan|bosentan|mesh-list
14814746|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814747|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14814748|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814749|NCT00864214|Hormones|hormones|mesh-list
14814750|NCT00864214|Estradiol|estradiol|mesh-list
14814751|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814752|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814753|NCT00864214|Estrogens|estrogens|mesh-ancestor
14814754|NCT00864240|Clobetasol|clobetasol|mesh-list
14294131|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14679034|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14679035|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14679036|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14679037|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14679038|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14679039|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14679040|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14679041|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14679042|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
14679043|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14679044|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14679045|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
14679046|NCT00307515|Coagulants|coagulants|mesh-ancestor
14679047|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14679048|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
14679049|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679050|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14679051|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14679052|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14679053|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679054|NCT00307593|Rituximab|rituximab|mesh-list
14679055|NCT00307593|Infliximab|infliximab|mesh-list
14679056|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190713|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15190714|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
15190715|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15190716|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
15190717|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
15190718|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
15190719|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15190720|NCT03844776|Acetaminophen|acetaminophen|mesh-list
15190721|NCT03844776|Amoxicillin|amoxicillin|mesh-list
15190722|NCT03844776|Metronidazole|metronidazole|mesh-list
15190723|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15190724|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
15190725|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15190726|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190727|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190728|NCT03844776|Analgesics|analgesics|mesh-ancestor
15190729|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
15190730|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190731|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190732|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
15190733|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15190734|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
15190735|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15190736|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15190737|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15190738|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190739|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190740|NCT03844620|Trifluridine|trifluridine|mesh-list
15190741|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
15190742|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190743|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
15190744|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190745|NCT03844529|Lidocaine|lidocaine|mesh-list
15190746|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190747|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
15190748|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190749|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190750|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
15190751|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190752|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15190753|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15190754|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15190755|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190756|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190757|NCT03844594|Eptifibatide|eptifibatide|mesh-list
15190758|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15190759|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
15190760|NCT03844763|Avelumab|avelumab|mesh-list
15190761|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15190762|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
15190763|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190764|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15190765|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15190766|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
15223967|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190767|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190768|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679057|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679058|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
14679059|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679060|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679061|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
14679062|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679063|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
14679064|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14679065|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14679066|NCT00307606|Prednisolone|prednisolone|mesh-list
14679067|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
14679068|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14679069|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
14679070|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679071|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
14679072|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
14679073|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679074|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679075|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15190769|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15190770|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190771|NCT03844139|Glycerol|glycerol|mesh-list
15190772|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15190773|NCT03844139|Protective Agents|protective agents|mesh-ancestor
15190774|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190775|NCT03844256|Capecitabine|capecitabine|mesh-list
15190776|NCT03844256|Nivolumab|nivolumab|mesh-list
15190777|NCT03844256|Ipilimumab|ipilimumab|mesh-list
15190778|NCT03844256|Mitomycins|mitomycins|mesh-list
15190779|NCT03844256|Mitomycin|mitomycin|mesh-list
15190780|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15190781|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
15190782|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190783|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190784|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190785|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15190786|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15190787|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
15190788|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15190789|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190790|NCT03844217|Tryptophan|tryptophan|mesh-list
15190791|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15190792|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
15190793|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15190794|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
15190795|NCT03844360|Bortezomib|bortezomib|mesh-list
15190796|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
15190797|NCT03844360|Dasatinib|dasatinib|mesh-list
15190798|NCT03844360|Pegaspargase|pegaspargase|mesh-list
15190799|NCT03844360|Sargramostim|sargramostim|mesh-list
15190800|NCT03844360|Lenograstim|lenograstim|mesh-list
15190801|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190802|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15190803|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190804|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190805|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
15190806|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190807|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15190808|NCT03844243|Mitogens|mitogens|mesh-list
15190809|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
15190810|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190811|NCT03843749|Trastuzumab|trastuzumab|mesh-list
15190812|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190813|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190814|NCT03844178|Tetracaine|tetracaine|mesh-list
15190815|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190816|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
15190817|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190818|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190819|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
14679076|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
15190820|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679077|NCT00307606|Hormones|hormones|mesh-ancestor
14727060|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
15190821|NCT03843853|Bevacizumab|bevacizumab|mesh-list
15190822|NCT03843853|Pemetrexed|pemetrexed|mesh-list
14679078|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679079|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14679080|NCT00307606|Protective Agents|protective agents|mesh-ancestor
14679081|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679082|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679083|NCT00307619|Topiramate|topiramate|mesh-list
14679084|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
14679085|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14679086|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679087|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14679088|NCT00307632|Estradiol|estradiol|mesh-list
14679089|NCT00307632|Estrogens|estrogens|mesh-ancestor
15190823|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190824|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190825|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15190826|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14679090|NCT00307632|Hormones|hormones|mesh-ancestor
14679091|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679092|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679093|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14679094|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
14679095|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190827|NCT03843853|Growth Substances|growth substances|mesh-ancestor
15190828|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190829|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
15190830|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190831|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190832|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15190833|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15190834|NCT03843879|Lidocaine|lidocaine|mesh-list
15190835|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
15190836|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
15190837|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190838|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190839|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
15190840|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190841|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15190842|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15190843|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15190844|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15190845|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223968|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223969|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223970|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
15223971|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15223972|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15223973|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15223974|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
15223975|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15223976|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15223977|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15223978|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223979|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223980|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
15223981|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15223982|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
15223983|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223984|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
15223985|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
15223986|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223987|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
15223988|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223989|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223990|NCT04865497|Vaccines|vaccines|mesh-list
15223991|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
15223992|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223993|NCT04823247|Interleukin-23|interleukin-23|mesh-list
15223994|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15223995|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15223996|NCT04823247|Growth Substances|growth substances|mesh-ancestor
15223997|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679096|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14679097|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14679098|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14679099|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
14679100|NCT00307645|Prednisone|prednisone|mesh-list
14679101|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
14679102|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
14679103|NCT00307645|Azathioprine|azathioprine|mesh-list
14679104|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679105|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
14679106|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679107|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679108|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679109|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
14679110|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679111|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190846|NCT03843736|Drospirenone|drospirenone|mesh-list
15190847|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
15190848|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15190849|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
15190850|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15190851|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15190852|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190853|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15190854|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15190855|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15190856|NCT03843736|Estrogens|estrogens|mesh-ancestor
15190857|NCT03843736|Hormones|hormones|mesh-ancestor
15190858|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190859|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15190860|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
15190861|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15190862|NCT03843736|Diuretics|diuretics|mesh-ancestor
15190863|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
15190864|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
15190865|NCT03843541|Ambroxol|ambroxol|mesh-list
15190866|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15190867|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
15190868|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190869|NCT03843541|Expectorants|expectorants|mesh-ancestor
15190870|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
15190871|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15190872|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
15190873|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190874|NCT03843541|Protective Agents|protective agents|mesh-ancestor
15190875|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190876|NCT03843541|Antidotes|antidotes|mesh-ancestor
15190877|NCT03843528|Azacitidine|azacitidine|mesh-list
15190878|NCT03843528|Vorinostat|vorinostat|mesh-list
15190879|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15190880|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
15190881|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190882|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190883|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190884|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15190885|NCT03843281|Acetaminophen|acetaminophen|mesh-list
15190886|NCT03843281|Morphine|morphine|mesh-list
15190887|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15190888|NCT03843281|Narcotics|narcotics|mesh-ancestor
15190889|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190890|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190891|NCT03843281|Analgesics|analgesics|mesh-ancestor
15190892|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
15190893|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190894|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15190895|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
15190896|NCT03843294|Nivolumab|nivolumab|mesh-list
15190897|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190898|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190899|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15190900|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190901|NCT03843229|Bufanolides|bufanolides|mesh-list
15190902|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15190903|NCT03843229|Protective Agents|protective agents|mesh-ancestor
14679112|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15223998|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
14679113|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15190904|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190905|NCT03843515|Nivolumab|nivolumab|mesh-list
15190906|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190907|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190908|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15190909|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679114|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
14679115|NCT00307645|Hormones|hormones|mesh-ancestor
14679116|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679117|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679118|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679119|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14679120|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
14679121|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14679122|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679123|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679124|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
14679125|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
15190910|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
15190911|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190912|NCT03843060|Itraconazole|itraconazole|mesh-list
15190913|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
15190914|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190915|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15190916|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15190917|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190918|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190919|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15190920|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
15190921|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15190922|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190923|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15190924|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
15190925|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15190926|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15190927|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15190928|NCT03843047|Nicotine|nicotine|mesh-list
15190929|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15190930|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
15190931|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190932|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190933|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15190934|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15190935|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
15190936|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190937|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190938|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
15190939|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15190940|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
15190941|NCT03842800|Ketamine|ketamine|mesh-list
15190942|NCT03842800|Analgesics|analgesics|mesh-ancestor
14679126|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679127|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679128|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14679129|NCT00307645|Protective Agents|protective agents|mesh-ancestor
14679130|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
14679131|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679132|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
14679133|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14679134|NCT00307658|Antibodies|antibodies|mesh-list
14679135|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
14679136|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
14679137|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14679138|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
14679139|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679140|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
14679141|NCT00307671|Prednisone|prednisone|mesh-list
14679142|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
14679143|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14679144|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14679145|NCT00307671|Prednisolone|prednisolone|mesh-list
14679146|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
14679147|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
15190943|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
15190944|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190945|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190946|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15190947|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15190948|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
15190949|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
15190950|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190951|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15190952|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15190953|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190954|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190955|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
15190956|NCT03842839|Olodaterol|olodaterol|mesh-list
15190957|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15190958|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
15190959|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15190960|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190961|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15190962|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
15190963|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
15190964|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15190965|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
15190966|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190967|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190968|NCT03842631|Timolol|timolol|mesh-list
15190969|NCT03842631|Maleic acid|maleic acid|mesh-list
15190970|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15190971|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15190972|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
15190973|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15190974|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190975|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190976|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15190977|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15190978|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190979|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
15190980|NCT03842488|Darunavir|darunavir|mesh-list
15190981|NCT03842488|Cobicistat|cobicistat|mesh-list
15190982|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15190983|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15190984|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
15190985|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15190986|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15190987|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15190988|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15190989|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15190990|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15190991|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15190992|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
15190993|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14679148|NCT00307671|Methotrexate|methotrexate|mesh-list
15190994|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14679149|NCT00307671|Azathioprine|azathioprine|mesh-list
14679150|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14679151|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
14294132|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679152|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679153|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
14679154|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679155|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679156|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679157|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
15190995|NCT03842423|Anesthetics|anesthetics|mesh-list
15190996|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15190997|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15190998|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
15190999|NCT03842254|Hematinics|hematinics|mesh-ancestor
15191000|NCT03842046|Phenylephrine|phenylephrine|mesh-list
15191001|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
15191002|NCT03842046|Norepinephrine|norepinephrine|mesh-list
15191003|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15191004|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
15191005|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
15191006|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191007|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191008|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
15191009|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15191010|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
15191011|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191012|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15191013|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15191014|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15191015|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
15191016|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191017|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191018|NCT03842046|Protective Agents|protective agents|mesh-ancestor
15191019|NCT03842020|Amiodarone|amiodarone|mesh-list
15191020|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15191021|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
15191022|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15191023|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191024|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191025|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15191026|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15191027|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15191028|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191029|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15191030|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15191031|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15191032|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
15191033|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15191034|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
15191035|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15191036|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15191037|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679158|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679159|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679160|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14679161|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679162|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
15191038|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15191039|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191040|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15191041|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191042|NCT03841890|Tolnaftate|tolnaftate|mesh-list
15191043|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
15191044|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191045|NCT03841721|Linezolid|linezolid|mesh-list
15191046|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15191047|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191048|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15191049|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191050|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223999|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224000|NCT04817787|Metformin|metformin|mesh-list
15224001|NCT04817787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15224002|NCT04817787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294133|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15224003|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
14679163|NCT00307671|Hormones|hormones|mesh-ancestor
14679164|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679165|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679166|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14679167|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
14679168|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14679169|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679170|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
14679171|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
14679172|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679173|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14679174|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14679175|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679176|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15191051|NCT03841747|Paclitaxel|paclitaxel|mesh-list
15191052|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
15191053|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15191054|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191055|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
15191056|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
15191057|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
15191058|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191059|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191060|NCT03841526|Glucagon|glucagon|mesh-list
15191061|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15191062|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191063|NCT03841526|Hormones|hormones|mesh-ancestor
15191064|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191065|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191066|NCT03841526|Incretins|incretins|mesh-ancestor
15191067|NCT03841812|Propofol|propofol|mesh-list
15191068|NCT03841812|Sevoflurane|sevoflurane|mesh-list
15191069|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15191070|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191071|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191072|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15191073|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
15191074|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
15191075|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15191076|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15191077|NCT03841591|Metformin|metformin|mesh-list
15191078|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15191079|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191080|NCT03841383|Dipyridamole|dipyridamole|mesh-list
15191081|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15191082|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191083|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191084|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15191085|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
15191086|NCT03841305|Liver Extracts|liver extracts|mesh-list
15191087|NCT03841305|Hematinics|hematinics|mesh-ancestor
15191088|NCT03841357|Abatacept|abatacept|mesh-list
15191089|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15191090|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191091|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191092|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15191093|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
15191094|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191095|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15191096|NCT03841474|Citalopram|citalopram|mesh-list
15191097|NCT03841474|Sertraline|sertraline|mesh-list
15191098|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15191099|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15191100|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191101|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191102|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191103|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
15191104|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191105|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15191106|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
15191107|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15191108|NCT03841136|Etoposide|etoposide|mesh-list
15191109|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14679177|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
14679178|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14679179|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679180|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
14679181|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
14679182|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679183|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679184|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14679185|NCT00307671|Protective Agents|protective agents|mesh-ancestor
14679186|NCT00307723|Gemcitabine|gemcitabine|mesh-list
14679187|NCT00307723|Bevacizumab|bevacizumab|mesh-list
14679188|NCT00307723|Fluorouracil|fluorouracil|mesh-list
14679189|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
14679190|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679191|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679192|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14679193|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14679194|NCT00307723|Growth Substances|growth substances|mesh-ancestor
14679195|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679196|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14679197|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679198|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
14679199|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679200|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
14679201|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679202|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679203|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679204|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
14679205|NCT00307775|Estradiol|estradiol|mesh-list
14679206|NCT00307775|Estrogens|estrogens|mesh-ancestor
14679207|NCT00307775|Hormones|hormones|mesh-ancestor
14679208|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679209|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679210|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
14679211|NCT00307814|Hematinics|hematinics|mesh-ancestor
14679212|NCT00307827|Visilizumab|visilizumab|mesh-list
14679213|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
14679214|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679215|NCT00307944|Pantoprazole|pantoprazole|mesh-list
14679216|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14679217|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679218|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14679219|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679220|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679221|NCT00307996|Ubiquinone|ubiquinone|mesh-list
14679222|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
14679223|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
14679224|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679225|NCT00307996|Vitamins|vitamins|mesh-ancestor
14679226|NCT00308048|Interferons|interferons|mesh-list
14679227|NCT00308048|Ribavirin|ribavirin|mesh-list
15191110|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191111|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15191112|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15191113|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191114|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679228|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
14679229|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
14679230|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14679231|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679232|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
14679233|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679234|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
14679235|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679236|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
14679237|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679238|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14679239|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
14679240|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
14679241|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14679242|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
14679243|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
15191115|NCT03840421|Gemcitabine|gemcitabine|mesh-list
15191116|NCT03840421|Cisplatin|cisplatin|mesh-list
14679244|NCT00308165|Topotecan|topotecan|mesh-list
15191117|NCT03840421|Fluorouracil|fluorouracil|mesh-list
14679245|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14679246|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14679247|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679248|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679249|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679250|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14679251|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679252|NCT00308191|Bromides|bromides|mesh-list
14679253|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
14679254|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
14679255|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15191118|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191119|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15191120|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
15191121|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191122|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
15191123|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679256|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
14679257|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679258|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679259|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14679260|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
14679261|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14679262|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14679263|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14679264|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
14679265|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679266|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679267|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
14679268|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14679269|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
14679270|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
14679271|NCT00308269|Folic Acid|folic acid|mesh-list
14679272|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
14679273|NCT00308269|Hematinics|hematinics|mesh-ancestor
14679274|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
14679275|NCT00308269|Vitamins|vitamins|mesh-ancestor
14679276|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
14679277|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679278|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679279|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679280|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
14814755|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814756|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
14814757|NCT00864240|Hormones|hormones|mesh-ancestor
14814758|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814759|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814760|NCT00864279|Cetirizine|cetirizine|mesh-list
14814761|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14814762|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14814763|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14679281|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
14679282|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679283|NCT00308321|Prednisolone|prednisolone|mesh-list
14814764|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
14814765|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
14814766|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814767|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191124|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191125|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15191126|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
15191127|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191128|NCT03840122|Anesthetics|anesthetics|mesh-list
15191129|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
15191130|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191131|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191132|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
15191133|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191134|NCT03839888|Atropine|atropine|mesh-list
15191135|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15191136|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15191137|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15191138|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
15224004|NCT04816162|Ketamine|ketamine|mesh-list
14679284|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14679285|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
14679286|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14679287|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
14679288|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14679289|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
14679290|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679291|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
14679292|NCT00308321|Hormones|hormones|mesh-ancestor
14679293|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679294|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679295|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679296|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679297|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
14679298|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
15191139|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191140|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191141|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15191142|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191143|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
15191144|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
14679299|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679300|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679301|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14679302|NCT00308321|Protective Agents|protective agents|mesh-ancestor
14679303|NCT00308334|Domperidone|domperidone|mesh-list
14679304|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
14679305|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
14679306|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679307|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679308|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679309|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14679310|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
14679311|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679312|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679313|NCT00308360|Valproic Acid|valproic acid|mesh-list
14679314|NCT00308360|Risperidone|risperidone|mesh-list
14679315|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14679316|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
14679317|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679318|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679319|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679320|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14679321|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14679322|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14679323|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14679324|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14679325|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
14679326|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
14679327|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679328|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
14679329|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
14679330|NCT00308373|Metformin|metformin|mesh-list
14679331|NCT00308373|Pioglitazone|pioglitazone|mesh-list
14679332|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14679333|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14679334|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679335|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
14679336|NCT00308425|Valsartan|valsartan|mesh-list
14679337|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679338|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679339|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14679340|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
14679341|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14679342|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679343|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679344|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679345|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14679346|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14679347|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15191145|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15191146|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15191147|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
14679348|NCT00308438|Teduglutide|teduglutide|mesh-list
14679349|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679350|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14679351|NCT00308438|Protective Agents|protective agents|mesh-ancestor
14679352|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679353|NCT00308451|Chromium|chromium|mesh-list
14679354|NCT00308451|Biotin|biotin|mesh-list
14679355|NCT00308451|Picolinic acid|picolinic acid|mesh-list
14679356|NCT00308451|Trace Elements|trace elements|mesh-ancestor
14679357|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
14294134|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14294135|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14679358|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679359|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
14679360|NCT00308451|Vitamins|vitamins|mesh-ancestor
14679361|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14679362|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
14679363|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
14679364|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679365|NCT00308477|Dexamethasone|dexamethasone|mesh-list
14679366|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679367|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
14679368|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
14679369|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679370|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679371|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679372|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
14679373|NCT00308477|Hormones|hormones|mesh-ancestor
14679374|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679375|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679376|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679377|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14679378|NCT00308490|Hematinics|hematinics|mesh-ancestor
14679379|NCT00308503|SR 46349B|sr 46349b|mesh-list
14679380|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14679381|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14679382|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679383|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14679384|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14679385|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
14679386|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679387|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679388|NCT00308529|Bevacizumab|bevacizumab|mesh-list
14679389|NCT00308529|Carboplatin|carboplatin|mesh-list
14679390|NCT00308529|Irinotecan|irinotecan|mesh-list
14679391|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679392|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679393|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14679394|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14679395|NCT00308529|Growth Substances|growth substances|mesh-ancestor
14679396|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679397|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
14679398|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14294136|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294137|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
14679399|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14679400|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679401|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679402|NCT00308542|Dexamethasone|dexamethasone|mesh-list
14679403|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191148|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191149|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191150|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
15191151|NCT03840226|Antacids|antacids|mesh-ancestor
15191152|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191153|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191154|NCT03840057|Azithromycin|azithromycin|mesh-list
15191155|NCT03840057|Metoclopramide|metoclopramide|mesh-list
15191156|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15191157|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191158|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
15191159|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
15191160|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191161|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191162|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191163|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15191164|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14679404|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
14679405|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
14679406|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679407|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679408|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679409|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
14679410|NCT00308542|Hormones|hormones|mesh-ancestor
14679411|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679412|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679413|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679414|NCT00308594|Dexamethasone|dexamethasone|mesh-list
14679415|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679416|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
14679417|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
14679418|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679419|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679420|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679421|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
14679422|NCT00308594|Hormones|hormones|mesh-ancestor
14679423|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679424|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679425|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679426|NCT00308607|Interferons|interferons|mesh-list
14679427|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
14679428|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
14679429|NCT00308607|Bevacizumab|bevacizumab|mesh-list
14679430|NCT00308607|Dacarbazine|dacarbazine|mesh-list
14679431|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679432|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679433|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14679434|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14679435|NCT00308607|Growth Substances|growth substances|mesh-ancestor
14679436|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679437|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
14679438|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
14679439|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679440|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
14679441|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679442|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
14679443|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679444|NCT00308763|Bupropion|bupropion|mesh-list
14679445|NCT00308763|Nicotine|nicotine|mesh-list
14679446|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14679447|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
14679448|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679449|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679450|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14679451|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14679452|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
14679453|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191165|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
15191166|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191167|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191168|NCT03839914|Vancomycin|vancomycin|mesh-list
15191169|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14679454|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679455|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14679456|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
14679457|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14679458|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14679459|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14679460|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14679461|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
14679462|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14679463|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14679464|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679465|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
14679466|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14679467|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679468|NCT00308841|Lidocaine|lidocaine|mesh-list
14679469|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
14679470|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
14679471|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14679472|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679473|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
14679474|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679475|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14679476|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14679477|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14679478|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14679479|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679480|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
14679481|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14679482|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14679483|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679484|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
14679485|NCT00308880|Coagulants|coagulants|mesh-ancestor
14679486|NCT00308945|Travoprost|travoprost|mesh-list
14679487|NCT00308945|Latanoprost|latanoprost|mesh-list
14679488|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14679489|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14679490|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14679491|NCT00308971|Vitamin E|vitamin e|mesh-list
14679492|NCT00308971|Tocopherols|tocopherols|mesh-list
14679493|NCT00308971|Tocotrienols|tocotrienols|mesh-list
14679494|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
14679495|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
14679496|NCT00308971|Vitamins|vitamins|mesh-ancestor
14679497|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
14679498|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679499|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
14679500|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679501|NCT00308971|Protective Agents|protective agents|mesh-ancestor
14679502|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
14679503|NCT00309049|Epothilones|epothilones|mesh-list
14679504|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679505|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
14679506|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
15191170|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191171|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
15191172|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15191173|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
15191174|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191175|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
14679507|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679508|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727061|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
14727062|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727063|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727064|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14727065|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14727066|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14727067|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14727068|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14727069|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14727070|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727071|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
14727072|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
14727073|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14727074|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
14727075|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727076|NCT00512265|Expectorants|expectorants|mesh-ancestor
14727077|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
14727078|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14727079|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
14727080|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727081|NCT00512265|Protective Agents|protective agents|mesh-ancestor
14727082|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727083|NCT00512265|Antidotes|antidotes|mesh-ancestor
14727084|NCT00512291|Olanzapine|olanzapine|mesh-list
14727085|NCT00512291|Fluoxetine|fluoxetine|mesh-list
14727086|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
14727087|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
14727088|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727089|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727090|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727091|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14727092|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14727093|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727094|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14727095|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14727096|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14727097|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14727098|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727099|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727100|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
14727101|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14727102|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
14727103|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14727104|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14727105|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727106|NCT00512395|Fentanyl|fentanyl|mesh-list
14727107|NCT00512395|Ropivacaine|ropivacaine|mesh-list
14727108|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14727109|NCT00512395|Narcotics|narcotics|mesh-ancestor
14727110|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727111|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727112|NCT00512395|Analgesics|analgesics|mesh-ancestor
14727113|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
14727114|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727115|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14727116|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14727117|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
14679509|NCT00309088|Tacrolimus|tacrolimus|mesh-list
14679510|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679511|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
14679512|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679513|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14679514|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679515|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679516|NCT00309101|Tacrolimus|tacrolimus|mesh-list
14679517|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679518|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
14679519|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679520|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14679521|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679522|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679523|NCT00309192|Triamcinolone|triamcinolone|mesh-list
14679524|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14679525|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14679526|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14679527|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679528|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
14679529|NCT00309192|Hormones|hormones|mesh-ancestor
14679530|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679531|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679532|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679533|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
14679534|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679535|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679536|NCT00309205|Dapivirine|dapivirine|mesh-list
14679537|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14679538|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14679539|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
14679540|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679541|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
14679542|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14679543|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14679544|NCT00309218|Prednisolone|prednisolone|mesh-list
14679545|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
14679546|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14679547|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
14679548|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679549|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
14679550|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
14679551|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679552|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679553|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679554|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
14679555|NCT00309218|Hormones|hormones|mesh-ancestor
14679556|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679557|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14679558|NCT00309218|Protective Agents|protective agents|mesh-ancestor
14679559|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679560|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679561|NCT00309257|Valsartan|valsartan|mesh-list
14679562|NCT00309257|Benazepril|benazepril|mesh-list
14679563|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14679564|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14679565|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14679566|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679567|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14679568|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
14679569|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679570|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
14679571|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679572|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679573|NCT00309283|Somatostatin|somatostatin|mesh-list
14679574|NCT00309283|Hormones|hormones|mesh-ancestor
14679575|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679576|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679577|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
14679578|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14679579|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679580|NCT00309322|Phentolamine|phentolamine|mesh-list
14679581|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14679582|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14679583|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
14679584|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679585|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679586|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679587|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14679588|NCT00309335|Phentolamine|phentolamine|mesh-list
14679589|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14679590|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14679591|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
14679592|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679593|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679594|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679595|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14679596|NCT00309361|Phentolamine|phentolamine|mesh-list
14679597|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14679598|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14679599|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
14679600|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679601|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679602|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679603|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14679604|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14679605|NCT00309374|Simvastatin|simvastatin|mesh-list
14679606|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14679607|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14679608|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
14679609|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679610|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14679611|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14679612|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679613|NCT00309413|Cannabidiol|cannabidiol|mesh-list
14679614|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
14679615|NCT00309478|Tamoxifen|tamoxifen|mesh-list
14679616|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
14679617|NCT00309478|Fluorouracil|fluorouracil|mesh-list
14679618|NCT00309478|Methotrexate|methotrexate|mesh-list
14679619|NCT00309478|Goserelin|goserelin|mesh-list
14679620|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679621|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
14679622|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679623|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679624|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679625|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
14679626|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679627|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679628|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14679629|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
14679630|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679631|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14294138|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294139|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14679632|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
15191176|NCT03840070|Protective Agents|protective agents|mesh-ancestor
15224005|NCT04816162|Propofol|propofol|mesh-list
15224006|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15224007|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224008|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224009|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15224010|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
15224011|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
15224012|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15224013|NCT04816162|Analgesics|analgesics|mesh-ancestor
14679633|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14679634|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14679635|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679636|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14679637|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14679638|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14679639|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
14679640|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679641|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679642|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14679643|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14679644|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14679645|NCT00309491|Tamoxifen|tamoxifen|mesh-list
14294140|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
14679646|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
14679647|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14679648|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
14679649|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679650|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679651|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679652|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679653|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14679654|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14679655|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14679656|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14679657|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14679658|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679659|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679660|NCT00309517|Leucovorin|leucovorin|mesh-list
14679661|NCT00309517|Edrecolomab|edrecolomab|mesh-list
14679662|NCT00309517|Antidotes|antidotes|mesh-ancestor
14679663|NCT00309517|Protective Agents|protective agents|mesh-ancestor
14679664|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679665|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
14679666|NCT00309517|Vitamins|vitamins|mesh-ancestor
14679667|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
14679668|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14679669|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
14679670|NCT00309530|Interferons|interferons|mesh-list
14679671|NCT00309530|Fluorouracil|fluorouracil|mesh-list
14679672|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
14679673|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679674|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679675|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679676|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679677|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
14679678|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679679|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
14679680|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679681|NCT00309543|Leucovorin|leucovorin|mesh-list
14679682|NCT00309543|Fluorouracil|fluorouracil|mesh-list
14679683|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
15224014|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
14679684|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679685|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679686|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679687|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679688|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
14679689|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679690|NCT00309543|Antidotes|antidotes|mesh-ancestor
14679691|NCT00309543|Protective Agents|protective agents|mesh-ancestor
14679692|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
14679693|NCT00309543|Vitamins|vitamins|mesh-ancestor
14679694|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
14679695|NCT00309556|Docetaxel|docetaxel|mesh-list
14679696|NCT00309556|Capecitabine|capecitabine|mesh-list
15191177|NCT03839771|Ivosidenib|ivosidenib|mesh-list
15191178|NCT03839771|Glycine|glycine|mesh-list
15191179|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679697|NCT00309556|Trastuzumab|trastuzumab|mesh-list
14679698|NCT00309556|Epirubicin|epirubicin|mesh-list
14679699|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679700|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679701|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14679702|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14679703|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679704|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679705|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
14679706|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679707|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679708|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15191180|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191181|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191182|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
15191183|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191184|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191185|NCT03839940|Dexamethasone|dexamethasone|mesh-list
15191186|NCT03839940|Everolimus|everolimus|mesh-list
15191187|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191188|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
14294141|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
14294142|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
14294143|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294144|NCT00573989|Pemetrexed|pemetrexed|mesh-list
14294145|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14294146|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294147|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294148|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294149|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14294150|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14294151|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14294152|NCT00574067|Buprenorphine|buprenorphine|mesh-list
14294153|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14294154|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14294155|NCT00574067|Narcotics|narcotics|mesh-ancestor
14294156|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294157|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294158|NCT00574067|Analgesics|analgesics|mesh-ancestor
14294159|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
14294160|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294161|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14294162|NCT00574119|Spironolactone|spironolactone|mesh-list
14294163|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14294164|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
14294165|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679709|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15191189|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
15191190|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191191|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191192|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191193|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
15191194|NCT03839940|Hormones|hormones|mesh-ancestor
15191195|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191196|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679710|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679711|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
14679712|NCT00309569|Fluorouracil|fluorouracil|mesh-list
14679713|NCT00309569|Methotrexate|methotrexate|mesh-list
14679714|NCT00309569|Epirubicin|epirubicin|mesh-list
14679715|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679716|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
14679717|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679718|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679719|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679720|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
14294166|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294167|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14294168|NCT00574119|Diuretics|diuretics|mesh-ancestor
14679721|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679722|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294169|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
14294170|NCT00574171|Capecitabine|capecitabine|mesh-list
14294171|NCT00574171|Lapatinib|lapatinib|mesh-list
14294172|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679723|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14679724|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
14679725|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679726|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14679727|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
14679728|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14679729|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
14679730|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679731|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14679732|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14679733|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679734|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14679735|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14679736|NCT00309621|Alitretinoin|alitretinoin|mesh-list
14679737|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679738|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
14679739|NCT00309634|Vaccines|vaccines|mesh-list
14679740|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
14679741|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679742|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
14679743|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14679744|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679745|NCT00309673|Lidocaine|lidocaine|mesh-list
14679746|NCT00309673|Prilocaine|prilocaine|mesh-list
14679747|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14679748|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
14679749|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
14679750|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14679751|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679752|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
14679753|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679754|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14679755|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15191197|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191198|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294173|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
14294174|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294175|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679756|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14294176|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14679757|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14679758|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679759|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14679760|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14679761|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14679762|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14679763|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14679764|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679765|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14679766|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14679767|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14679768|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
14679769|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679770|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679771|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14679772|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14679773|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
14679774|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14679775|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14679776|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
14679777|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14679778|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14679779|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14679780|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14679781|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679782|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14679783|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14679784|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
14679785|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679786|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679787|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14679788|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15191199|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
15191200|NCT03839550|Apatinib|apatinib|mesh-list
15191201|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191202|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15191203|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191204|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191205|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
15191206|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
15191207|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15191208|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
15191209|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294177|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294178|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
14294179|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14294180|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294181|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14294182|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
14294183|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294184|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294185|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294186|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294187|NCT00574236|Doxorubicin|doxorubicin|mesh-list
14294188|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679789|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
14679790|NCT00309712|Simvastatin|simvastatin|mesh-list
14679791|NCT00309712|Fenofibrate|fenofibrate|mesh-list
14679792|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14679793|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14679794|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
14679795|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679796|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14679797|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14679798|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679799|NCT00309725|Galantamine|galantamine|mesh-list
14679800|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14679801|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679802|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679803|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
14679804|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679805|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191210|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191211|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14679806|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14679807|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
14679808|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679809|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
14679810|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
14679811|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
14679812|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14679813|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14679814|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679815|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679816|NCT00309790|Urological Agents|urological agents|mesh-ancestor
14679817|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
14679818|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
14679819|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14679820|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14679821|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191212|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191213|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15191214|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
15191215|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191216|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191217|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15191218|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
14679822|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679823|NCT00309816|Urological Agents|urological agents|mesh-ancestor
14679824|NCT00309855|Anastrozole|anastrozole|mesh-list
14679825|NCT00309855|Testosterone|testosterone|mesh-list
14679826|NCT00309855|Dutasteride|dutasteride|mesh-list
14679827|NCT00309855|Androgens|androgens|mesh-ancestor
14679828|NCT00309855|Hormones|hormones|mesh-ancestor
14679829|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679830|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191219|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
15191220|NCT03839537|Protective Agents|protective agents|mesh-ancestor
15191221|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
15191222|NCT03839498|Axitinib|axitinib|mesh-list
14679831|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679832|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679833|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14679834|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14679835|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679836|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679837|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
14679838|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14679839|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14679840|NCT00309881|Prednisone|prednisone|mesh-list
14679841|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
14679842|NCT00309881|Rituximab|rituximab|mesh-list
14679843|NCT00309881|Doxorubicin|doxorubicin|mesh-list
14679844|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14679845|NCT00309881|Vincristine|vincristine|mesh-list
14679846|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679847|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
14679848|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679849|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679850|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679851|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
14679852|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679853|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679854|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14679855|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679856|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679857|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15191223|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191224|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14679858|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14679859|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679860|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679861|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
14679862|NCT00309881|Hormones|hormones|mesh-ancestor
14679863|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679864|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14679865|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14679866|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679867|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14679868|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14679869|NCT00309894|Ketoconazole|ketoconazole|mesh-list
14679870|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
14679871|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14679872|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14679873|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14679874|NCT00309894|Sargramostim|sargramostim|mesh-list
14679875|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679876|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
14679877|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679878|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
14679879|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679880|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14679881|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14679882|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679883|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679884|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14679885|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
14679886|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14679887|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14679888|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
14679889|NCT00309920|Docetaxel|docetaxel|mesh-list
14679890|NCT00309920|Doxorubicin|doxorubicin|mesh-list
14679891|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14679892|NCT00309920|Fluorouracil|fluorouracil|mesh-list
14679893|NCT00309920|Epirubicin|epirubicin|mesh-list
14679894|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
14679895|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679896|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
14679897|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679898|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679899|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679900|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
14679901|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679902|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679903|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14679904|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679905|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
14679906|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
14679907|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679908|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14679909|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14679910|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679911|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
14679912|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679913|NCT00309920|Hematinics|hematinics|mesh-ancestor
14679914|NCT00309998|Bevacizumab|bevacizumab|mesh-list
14679915|NCT00309998|Vinorelbine|vinorelbine|mesh-list
15191225|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679916|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679917|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679918|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14679919|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14679920|NCT00309998|Growth Substances|growth substances|mesh-ancestor
14679921|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679922|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
14679923|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14679924|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679925|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
14679926|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
14679927|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679928|NCT00310011|Gemcitabine|gemcitabine|mesh-list
14679929|NCT00310011|Paclitaxel|paclitaxel|mesh-list
14679930|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14679931|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679932|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679933|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14679934|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14679935|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679936|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679937|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
14679938|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
14679939|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679940|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679941|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679942|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
14679943|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679944|NCT00310024|Bortezomib|bortezomib|mesh-list
14679945|NCT00310024|Vorinostat|vorinostat|mesh-list
14679946|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679947|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14679948|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679949|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679950|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
14679951|NCT00310089|Docetaxel|docetaxel|mesh-list
14679952|NCT00310089|Doxorubicin|doxorubicin|mesh-list
14679953|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14679954|NCT00310089|Cediranib|cediranib|mesh-list
14679955|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679956|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
14679957|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679958|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679959|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14679960|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
14679961|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679962|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679963|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14679964|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
14679965|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14679966|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14679967|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14679968|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14679969|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14679970|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679971|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14679972|NCT00310128|Cytarabine|cytarabine|mesh-list
14679973|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
14679974|NCT00310128|Rituximab|rituximab|mesh-list
14679975|NCT00310128|Etoposide|etoposide|mesh-list
15191226|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191227|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15191228|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15191229|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191230|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
15191231|NCT03839251|Aripiprazole|aripiprazole|mesh-list
15191232|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
15191233|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15191234|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15191235|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15191236|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191237|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191238|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
15191239|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
15191240|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14679976|NCT00310128|Antibodies|antibodies|mesh-list
14679977|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
14679978|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14679979|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
14679980|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14679981|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14679982|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14679983|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14679984|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14679985|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14679986|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14679987|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14679988|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14679989|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14679990|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
14679991|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
14679992|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14679993|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14679994|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14679995|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
14679996|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
14679997|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14679998|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14679999|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
14680000|NCT00310128|Hormones|hormones|mesh-ancestor
14680001|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680002|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14680003|NCT00310128|Protective Agents|protective agents|mesh-ancestor
14680004|NCT00310141|Nicotine|nicotine|mesh-list
14680005|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14680006|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
14680007|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680008|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680009|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14680010|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14680011|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
14680012|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680013|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680014|NCT00310154|Docetaxel|docetaxel|mesh-list
14680015|NCT00310154|Gefitinib|gefitinib|mesh-list
14680016|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680017|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
14680018|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
14680019|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
14680020|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680021|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14680022|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680023|NCT00310206|Vaccines|vaccines|mesh-list
14680024|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
14680025|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680026|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
14680027|NCT00310232|Hematinics|hematinics|mesh-ancestor
14680028|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
14680029|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680030|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680031|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
14680032|NCT00310323|Caffeine|caffeine|mesh-list
14680033|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14680034|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680035|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14680036|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680037|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680038|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14680039|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14680040|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
14680041|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680042|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
14680043|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14680044|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14680045|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14680046|NCT00310336|Interferons|interferons|mesh-list
14680047|NCT00310336|Ribavirin|ribavirin|mesh-list
14680048|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
14680049|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
14680050|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14680051|NCT00310336|Betaine|betaine|mesh-list
14680052|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680053|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
14680054|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680055|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
14680056|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680057|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
14680058|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680059|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14680060|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
14680061|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14680062|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14680063|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14680064|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
14680065|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680066|NCT00310388|Ezogabine|ezogabine|mesh-list
14680067|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
14680068|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680069|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191241|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191242|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15191243|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15191244|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
15191245|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15191246|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15191247|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15191248|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15191249|NCT03839459|Denosumab|denosumab|mesh-list
15191250|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15191251|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191252|NCT03839160|Morphine|morphine|mesh-list
15191253|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15191254|NCT03839160|Narcotics|narcotics|mesh-ancestor
15191255|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191256|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191257|NCT03839160|Analgesics|analgesics|mesh-ancestor
15191258|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
14680070|NCT00310505|Amphotericin B|amphotericin b|mesh-list
14680071|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14680072|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14680073|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
14680074|NCT00310505|Amebicides|amebicides|mesh-ancestor
14680075|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14680076|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14680077|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680078|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14680079|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
14680080|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14680081|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14680082|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
14680083|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680084|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14680085|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14680086|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680087|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680088|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
14680089|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14680090|NCT00310531|Estradiol|estradiol|mesh-list
14680091|NCT00310531|Estrogens|estrogens|mesh-ancestor
14680092|NCT00310531|Hormones|hormones|mesh-ancestor
14680093|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680094|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680095|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14680096|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
14680097|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14680098|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14680099|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14680100|NCT00310583|Pregabalin|pregabalin|mesh-list
14680101|NCT00310583|Analgesics|analgesics|mesh-ancestor
14680102|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
14680103|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680104|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680105|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
14680106|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14680107|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680108|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680109|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14680110|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14680111|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14680112|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191259|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680113|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14680114|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
14680115|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14680116|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14680117|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680118|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14680119|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14680120|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680121|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680122|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680123|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14680124|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
14680125|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14680126|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680127|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14680128|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14680129|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14727118|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
14727119|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
14727120|NCT00512408|Testosterone|testosterone|mesh-list
14727121|NCT00512408|Androgens|androgens|mesh-ancestor
14727122|NCT00512408|Hormones|hormones|mesh-ancestor
14727123|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727124|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727125|NCT00512473|Hormones|hormones|mesh-list
14727126|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727127|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727128|NCT00512486|Benralizumab|benralizumab|mesh-list
14727129|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14727130|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
14727131|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
14727132|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14727133|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727134|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14727135|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14727136|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15191260|NCT03839134|Lidocaine|lidocaine|mesh-list
15191261|NCT03839134|Epinephrine|epinephrine|mesh-list
15191262|NCT03839134|Racepinephrine|racepinephrine|mesh-list
15191263|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
15191264|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
15191265|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
15191266|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191267|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727137|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14727138|NCT00512668|Sirolimus|sirolimus|mesh-list
14727139|NCT00512668|Leuprolide|leuprolide|mesh-list
14727140|NCT00512668|Goserelin|goserelin|mesh-list
14727141|NCT00512668|Flutamide|flutamide|mesh-list
14727142|NCT00512668|Bicalutamide|bicalutamide|mesh-list
14727143|NCT00512668|Nilutamide|nilutamide|mesh-list
14727144|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14727145|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
14727146|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14727147|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727148|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14727149|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727150|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14727151|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727152|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14727153|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
14727154|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727155|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
14727156|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
14727157|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
14727158|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727159|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
14727160|NCT00512681|Irinotecan|irinotecan|mesh-list
14727161|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191268|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
14727162|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14727163|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727164|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727165|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727166|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
14727167|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
14680130|NCT00310765|Pregabalin|pregabalin|mesh-list
14680131|NCT00310765|Gabapentin|gabapentin|mesh-list
14680132|NCT00310765|Analgesics|analgesics|mesh-ancestor
14680133|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
14680134|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680135|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680136|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
14680137|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14680138|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680139|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680140|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14680141|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14680142|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14680143|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680144|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14680145|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14680146|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14680147|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680148|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
14680149|NCT00310778|Atenolol|atenolol|mesh-list
14680150|NCT00310778|Valsartan|valsartan|mesh-list
14680151|NCT00310778|Candesartan|candesartan|mesh-list
14680152|NCT00310778|Ramipril|ramipril|mesh-list
14680153|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680154|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14680155|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14680156|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680157|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14680158|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
14680159|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680160|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14680161|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
14680162|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
14680163|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680164|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680165|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14680166|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14680167|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14680168|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
14680169|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680170|NCT00310843|Nevirapine|nevirapine|mesh-list
14680171|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14680172|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14680173|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680174|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680175|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
14680176|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680177|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14680178|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14680179|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14680180|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14680181|NCT00310895|Imetelstat|imetelstat|mesh-list
14680182|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
14680183|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680184|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680185|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14680186|NCT00310908|Tramadol|tramadol|mesh-list
14680187|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14680188|NCT00310908|Narcotics|narcotics|mesh-ancestor
14680189|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680190|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680191|NCT00310908|Analgesics|analgesics|mesh-ancestor
14680192|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
14680193|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680194|NCT00310921|Misoprostol|misoprostol|mesh-list
14680195|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14680196|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
14680197|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14680198|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680199|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14680200|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14680201|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
14680202|NCT00310934|Buprenorphine|buprenorphine|mesh-list
14680203|NCT00310934|Methadone|methadone|mesh-list
14680204|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14680205|NCT00310934|Narcotics|narcotics|mesh-ancestor
14680206|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680207|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680208|NCT00310934|Analgesics|analgesics|mesh-ancestor
14680209|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
14680210|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680211|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14680212|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
14680213|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
14680214|NCT00311038|Landiolol|landiolol|mesh-list
14680215|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14680216|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14680217|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
14680218|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680219|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680220|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680221|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14680222|NCT00311051|Ramatroban|ramatroban|mesh-list
14680223|NCT00311051|Montelukast|montelukast|mesh-list
14680224|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14680225|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14680226|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14680227|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
15191269|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191270|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15191271|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15191272|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15191273|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191274|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191275|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15191276|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15191277|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
15191278|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191279|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15191280|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15191281|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
14680228|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680229|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680230|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14680231|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14680232|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680233|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14680234|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
14680235|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680236|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680237|NCT00311116|Vitamin E|vitamin e|mesh-list
14680238|NCT00311116|Vitamins|vitamins|mesh-ancestor
14680239|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
14680240|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680241|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
14680242|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680243|NCT00311116|Protective Agents|protective agents|mesh-ancestor
14680244|NCT00311129|Rituximab|rituximab|mesh-list
14680245|NCT00311129|Fludarabine|fludarabine|mesh-list
14680246|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
14680247|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14680248|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680249|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
14680250|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680251|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14680252|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680253|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
14680254|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680255|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680256|NCT00311259|Melatonin|melatonin|mesh-list
14680257|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
14680258|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680259|NCT00311259|Protective Agents|protective agents|mesh-ancestor
14680260|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680261|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680262|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
14680263|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680264|NCT00311337|Bortezomib|bortezomib|mesh-list
14680265|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680266|NCT00311389|Timolol|timolol|mesh-list
14680267|NCT00311389|Travoprost|travoprost|mesh-list
14680268|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14680269|NCT00311389|Latanoprost|latanoprost|mesh-list
14680270|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14680271|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14680272|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14680273|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
14680274|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680275|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680276|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680277|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14680278|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680279|NCT00311467|Interferons|interferons|mesh-list
14680280|NCT00311467|Capecitabine|capecitabine|mesh-list
14680281|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680282|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
14680283|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680284|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680285|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
14680286|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680287|NCT00311545|Siltuximab|siltuximab|mesh-list
14680288|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680289|NCT00311558|Interferons|interferons|mesh-list
14680290|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
14680291|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
14680292|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14680293|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680294|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
15191282|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14680295|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680296|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
14680297|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191283|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191284|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
15191285|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
15191286|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15191287|NCT03839433|Ciclesonide|ciclesonide|mesh-list
15191288|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
15191289|NCT03839433|Hormones|hormones|mesh-ancestor
15224015|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680298|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14680299|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14680300|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
14680301|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14680302|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
14680303|NCT00311636|Paclitaxel|paclitaxel|mesh-list
14680304|NCT00311636|Docetaxel|docetaxel|mesh-list
14680305|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
14680306|NCT00311636|Doxorubicin|doxorubicin|mesh-list
14680307|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14680308|NCT00311636|Fluorouracil|fluorouracil|mesh-list
14680309|NCT00311636|Methotrexate|methotrexate|mesh-list
14680310|NCT00311636|Epirubicin|epirubicin|mesh-list
14680311|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14680312|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14680313|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680314|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
14680315|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
14680316|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
14680317|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680318|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680319|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
14680320|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680321|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14680322|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14680323|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
14680324|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14680325|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14680326|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15191290|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191291|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191292|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15191293|NCT03838926|Trichostatin A|trichostatin a|mesh-list
15191294|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
15191295|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191296|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15191297|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191298|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191299|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15191300|NCT03838783|Insulin|insulin|mesh-list
15191301|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15191302|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191303|NCT03838796|Lenvatinib|lenvatinib|mesh-list
14680327|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14680328|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680329|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
14680330|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680331|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14680332|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
14680333|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14680334|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14680335|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14680336|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14680337|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
14680338|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14680339|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
14680340|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14680341|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14680342|NCT00311688|Interleukin-2|interleukin-2|mesh-list
14680343|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680344|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191304|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191305|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15191306|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191307|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191308|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15191309|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
15191310|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191311|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
14680345|NCT00311688|Analgesics|analgesics|mesh-ancestor
14680346|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
14680347|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680348|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680349|NCT00311740|Valsartan|valsartan|mesh-list
14680350|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14680351|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680352|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14680353|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14680354|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680355|NCT00311740|Diuretics|diuretics|mesh-ancestor
14680356|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
14680357|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680358|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14680359|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680360|NCT00311753|Heparin|heparin|mesh-list
14680361|NCT00311753|Certoparin|certoparin|mesh-list
14680362|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
14680363|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14680364|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14680365|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680366|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
14680367|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680368|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680369|NCT00311857|Cetuximab|cetuximab|mesh-list
14680370|NCT00311857|Temozolomide|temozolomide|mesh-list
14680371|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14680372|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680373|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14814768|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814769|NCT00864305|Gabapentin|gabapentin|mesh-list
14814770|NCT00864305|Analgesics|analgesics|mesh-ancestor
14814771|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
14814772|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814773|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814774|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
14814775|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14814776|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14814777|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814778|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814779|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14814780|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14814781|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814782|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814783|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
14814784|NCT00864318|Paclitaxel|paclitaxel|mesh-list
14814785|NCT00864318|Etoposide|etoposide|mesh-list
14814786|NCT00864318|Ifosfamide|ifosfamide|mesh-list
14814787|NCT00864318|Carboplatin|carboplatin|mesh-list
14814788|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14814789|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814790|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14814791|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
14814792|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14814793|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814794|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14814795|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14814796|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814797|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14814798|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
14814799|NCT00864344|Sertraline|sertraline|mesh-list
14814800|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
14814801|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814802|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14814803|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814804|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814805|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814806|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814807|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
14814808|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814809|NCT00864357|Ibuprofen|ibuprofen|mesh-list
14814810|NCT00864357|Oxycodone|oxycodone|mesh-list
14814811|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14814812|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14680374|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
14680375|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680376|NCT00311870|Lisinopril|lisinopril|mesh-list
14680377|NCT00311870|Nisoldipine|nisoldipine|mesh-list
14680378|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14680379|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
14680380|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680381|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680382|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680383|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14680384|NCT00311870|Protective Agents|protective agents|mesh-ancestor
14680385|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680386|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14680387|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680388|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14680389|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
14680390|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
14680391|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
14680392|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14680393|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14680394|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680395|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680396|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680397|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14680398|NCT00311896|Bemiparin|bemiparin|mesh-list
14680399|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
14680400|NCT00311961|Prednisolone|prednisolone|mesh-list
14680401|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14680402|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
14680403|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14680404|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
14680405|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14680406|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
14680407|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680408|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
14680409|NCT00311961|Hormones|hormones|mesh-ancestor
14680410|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680411|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680412|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14680413|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680414|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
14680415|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
14680416|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680417|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14680418|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14680419|NCT00311961|Protective Agents|protective agents|mesh-ancestor
14680420|NCT00311974|Dihydralazine|dihydralazine|mesh-list
14680421|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680422|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
14680423|NCT00311987|Hormones|hormones|mesh-ancestor
14680424|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680425|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680426|NCT00312000|Capecitabine|capecitabine|mesh-list
14680427|NCT00312000|Irinotecan|irinotecan|mesh-list
14680428|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680429|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
14680430|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680431|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680432|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14680433|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14680434|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680435|NCT00312013|Nadroparin|nadroparin|mesh-list
14680436|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
14680437|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14680438|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14680439|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680440|NCT00312039|Lamivudine|lamivudine|mesh-list
14680441|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
14680442|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14680443|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14680444|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680445|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680446|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
14680447|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680448|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14680449|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14680450|NCT00312104|Insulin|insulin|mesh-list
14680451|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14680452|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
14680453|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
14680454|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
14680455|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680456|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680457|NCT00312130|Vildagliptin|vildagliptin|mesh-list
14680458|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15191312|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15191313|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15191314|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191315|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
15191316|NCT03838328|Coagulants|coagulants|mesh-ancestor
15191317|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
15191318|NCT03838575|Gentamicins|gentamicins|mesh-list
15191319|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
15191320|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15191321|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15191322|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
15191323|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15191324|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191325|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191326|NCT03838068|Anesthetics|anesthetics|mesh-list
15191327|NCT03838068|Procaine|procaine|mesh-list
15191328|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
14680459|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680460|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14680461|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
14680462|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680463|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680464|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
14680465|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14680466|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680467|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14680468|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
14680469|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14680470|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680471|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680472|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680473|NCT00312156|Insulin|insulin|mesh-list
14680474|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14680475|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
14680476|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
14680477|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
14680478|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
14680479|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
14680480|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680481|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680482|NCT00312182|Nelfinavir|nelfinavir|mesh-list
14680483|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14680484|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14680485|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
14680486|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680487|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680488|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14680489|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14680490|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
14680491|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680492|NCT00312260|Gabapentin|gabapentin|mesh-list
14680493|NCT00312260|Amitriptyline|amitriptyline|mesh-list
14680494|NCT00312260|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14680495|NCT00312260|Analgesics|analgesics|mesh-ancestor
14680496|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
14680497|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680498|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680499|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
14680500|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15191329|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191330|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680501|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14680502|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680503|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14680504|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14680505|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14680506|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680507|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680508|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
14680509|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14680510|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
14680511|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14680512|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14680513|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14680514|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680515|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
14680516|NCT00312260|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14680517|NCT00312273|Aminophylline|aminophylline|mesh-list
14680518|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14680519|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
14680520|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680521|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680522|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14680523|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
14680524|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14680525|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14680526|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680527|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680528|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15191331|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
15191332|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191333|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
15191334|NCT03837886|Calcium|calcium|mesh-list
15191335|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15191336|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191337|NCT03837886|Antacids|antacids|mesh-ancestor
15191338|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191339|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191340|NCT03838094|Calcium|calcium|mesh-list
15191341|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15191342|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191343|NCT03838133|Bupivacaine|bupivacaine|mesh-list
15191344|NCT03838133|Ropivacaine|ropivacaine|mesh-list
15191345|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
15191346|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
15191347|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191348|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191349|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
15191350|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224016|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15224017|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15224018|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15224019|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
15224020|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224021|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224022|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14680529|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14680530|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
14680531|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680532|NCT00312273|Protective Agents|protective agents|mesh-ancestor
14680533|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14680534|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
14680535|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14680536|NCT00312299|Protective Agents|protective agents|mesh-ancestor
14680537|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680538|NCT00312325|Prednisolone|prednisolone|mesh-list
14680539|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680540|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
14680541|NCT00312325|Hormones|hormones|mesh-ancestor
14680542|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680543|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680544|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14680545|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727168|NCT00512811|Furosemide|furosemide|mesh-list
14727169|NCT00512811|Diuretics|diuretics|mesh-ancestor
14727170|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
14727171|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727172|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14727173|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14727174|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727175|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
14727176|NCT00512824|Calcium|calcium|mesh-list
14727177|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14727178|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727179|NCT00512824|Antacids|antacids|mesh-ancestor
14727180|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727181|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727182|NCT00512850|Folic Acid|folic acid|mesh-list
14727183|NCT00512850|Hematinics|hematinics|mesh-ancestor
14727184|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
14727185|NCT00512850|Vitamins|vitamins|mesh-ancestor
14727186|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
14727187|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727188|NCT00512863|Adalimumab|adalimumab|mesh-list
14727189|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727190|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727191|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
14727192|NCT00512928|Vitamin K|vitamin k|mesh-list
14727193|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
14727194|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
14727195|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14727196|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14727197|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727198|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
14727199|NCT00512928|Coagulants|coagulants|mesh-ancestor
14727200|NCT00512928|Vitamins|vitamins|mesh-ancestor
14727201|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
14727202|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727203|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
14727204|NCT00512980|Gemcitabine|gemcitabine|mesh-list
14727205|NCT00512980|Prednisone|prednisone|mesh-list
14727206|NCT00512980|Doxorubicin|doxorubicin|mesh-list
14727207|NCT00512980|Vinblastine|vinblastine|mesh-list
14727208|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727209|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
14727210|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727211|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727212|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
14727213|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727214|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191351|NCT03838029|Etodolac|etodolac|mesh-list
15191352|NCT03838029|Propranolol|propranolol|mesh-list
15191353|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15191354|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15191355|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
15191356|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191357|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191358|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191359|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15191360|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15191361|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
15191362|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15191363|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14727215|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727216|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
14727217|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727218|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14727219|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14727220|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727221|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680546|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14680547|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680548|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14680549|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14680550|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14680551|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
14680552|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680553|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680554|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680555|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
14680556|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
14680557|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
14680558|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14680559|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680560|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
14680561|NCT00312481|Protective Agents|protective agents|mesh-ancestor
14680562|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680563|NCT00312481|Vitamins|vitamins|mesh-ancestor
14680564|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
14680565|NCT00312481|Cathartics|cathartics|mesh-ancestor
14680566|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14680567|NCT00312481|Laxatives|laxatives|mesh-ancestor
14680568|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14680569|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
14680570|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
14680571|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14680572|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14680573|NCT00312520|Prednisolone|prednisolone|mesh-list
14680574|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
14680575|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14680576|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
14680577|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680578|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
14680579|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
14680580|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680581|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680582|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14680583|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
15191364|NCT03838029|Analgesics|analgesics|mesh-ancestor
15191365|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
15191366|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191367|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191368|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15191369|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15191370|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15191371|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191372|NCT03837938|Dipropizine|dipropizine|mesh-list
15191373|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
15191374|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191375|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
15191376|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191377|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191378|NCT03837509|Daratumumab|daratumumab|mesh-list
15191379|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680584|NCT00312520|Hormones|hormones|mesh-ancestor
14680585|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680586|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14680587|NCT00312520|Protective Agents|protective agents|mesh-ancestor
14680588|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14680589|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680590|NCT00312533|Hylan|hylan|mesh-list
14680591|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
14680592|NCT00312533|Protective Agents|protective agents|mesh-ancestor
14680593|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680594|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
14680595|NCT00312546|Valproic Acid|valproic acid|mesh-list
14680596|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
14680597|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680598|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680599|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
14680600|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680601|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680602|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
14680603|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14680604|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680605|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14680606|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14680607|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14680608|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14680609|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14680610|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
14680611|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680612|NCT00312598|Aripiprazole|aripiprazole|mesh-list
14680613|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
14680614|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14680615|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14680616|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14680617|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680618|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680619|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
14680620|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
14680621|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680622|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680623|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14680624|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14680625|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
14680626|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14680627|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14680628|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14680629|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14680630|NCT00312650|Gemcitabine|gemcitabine|mesh-list
14680631|NCT00312650|Doxorubicin|doxorubicin|mesh-list
14680632|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14680633|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680634|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
14680635|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680636|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680637|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
14680638|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680639|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680640|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680641|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
14680642|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680643|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14680644|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14680645|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14680646|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14680647|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14680648|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14680649|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
14680650|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680651|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680652|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14680653|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14680654|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
14680655|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680656|NCT00312806|Pantoprazole|pantoprazole|mesh-list
14680657|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14680658|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14680659|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14680660|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680661|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680662|NCT00312819|Disulfiram|disulfiram|mesh-list
14680663|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14680664|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14680665|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680666|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680667|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
14680668|NCT00312871|Hematinics|hematinics|mesh-ancestor
14680669|NCT00312988|Gemcitabine|gemcitabine|mesh-list
14680670|NCT00312988|Topotecan|topotecan|mesh-list
14680671|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680672|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
14680673|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680674|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680675|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
14680676|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680677|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680678|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680679|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
14680680|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680681|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14680682|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14680683|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
14680684|NCT00313001|Exenatide|exenatide|mesh-list
14680685|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
14680686|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680687|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680688|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14680689|NCT00313001|Incretins|incretins|mesh-ancestor
14680690|NCT00313001|Hormones|hormones|mesh-ancestor
14680691|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680692|NCT00313053|Vincristine|vincristine|mesh-list
14680693|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14680694|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680695|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
15191380|NCT03837626|Amiloride|amiloride|mesh-list
15191381|NCT03837626|Diuretics|diuretics|mesh-ancestor
15191382|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
15191383|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191384|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15191385|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15191386|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191387|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191388|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15191389|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14680696|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
14680697|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14680698|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680699|NCT00313079|Vincristine|vincristine|mesh-list
14680700|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14680701|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680702|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
14680703|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
14680704|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
14680705|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680706|NCT00313105|Lobeline|lobeline|mesh-list
14680707|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14680708|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
14680709|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680710|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680711|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14680712|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14680713|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
14680714|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680715|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680716|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
14680717|NCT00313131|Metronidazole|metronidazole|mesh-list
14680718|NCT00313131|Fluconazole|fluconazole|mesh-list
14680719|NCT00313131|Clotrimazole|clotrimazole|mesh-list
14680720|NCT00313131|Miconazole|miconazole|mesh-list
15191390|NCT03837470|Furosemide|furosemide|mesh-list
14680721|NCT00313131|Tinidazole|tinidazole|mesh-list
14680722|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680723|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14680724|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14680725|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14680726|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
14680727|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14680728|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14680729|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680730|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680731|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14680732|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
14680733|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680734|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680735|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14680736|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14680737|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14680738|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14680739|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
14680740|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14680741|NCT00313157|Metoprolol|metoprolol|mesh-list
14680742|NCT00313157|Verapamil|verapamil|mesh-list
14680743|NCT00313157|Carvedilol|carvedilol|mesh-list
14680744|NCT00313157|Diltiazem|diltiazem|mesh-list
14680745|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14680746|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680747|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
14680748|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
14680749|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680750|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680751|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14680752|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14680753|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14680754|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14680755|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680756|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680757|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
14680758|NCT00313157|Protective Agents|protective agents|mesh-ancestor
14680759|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14680760|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680761|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14680762|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
14680763|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14680764|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14680765|NCT00313183|Pramlintide|pramlintide|mesh-list
14680766|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680767|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680768|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
14680769|NCT00313235|Vaccines|vaccines|mesh-list
14680770|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
14680771|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680772|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680773|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14680774|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14680775|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
14680776|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680777|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680778|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14680779|NCT00313261|Clevudine|clevudine|mesh-list
14680780|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
14680781|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680782|NCT00313274|Clevudine|clevudine|mesh-list
14680783|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
14680784|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680785|NCT00313287|Clevudine|clevudine|mesh-list
14680786|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
14680787|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680788|NCT00313391|Risperidone|risperidone|mesh-list
14680789|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14680790|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
14680791|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680792|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680793|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680794|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14680795|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14680796|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680797|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14680798|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14680799|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
14680800|NCT00313456|Satraplatin|satraplatin|mesh-list
14680801|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680802|NCT00313482|Prednisone|prednisone|mesh-list
14680803|NCT00313482|Docetaxel|docetaxel|mesh-list
14294189|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294190|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14294191|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14294192|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294193|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680804|NCT00313482|Sargramostim|sargramostim|mesh-list
14680805|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680806|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
14680807|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
14680808|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
14680809|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680810|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680811|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
14680812|NCT00313482|Hormones|hormones|mesh-ancestor
14680813|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14680814|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680815|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14680816|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
14680817|NCT00313508|Vidarabine|vidarabine|mesh-list
14680818|NCT00313508|Fludarabine|fludarabine|mesh-list
14680819|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
14680820|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680821|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680822|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
14680823|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680824|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680825|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
14680826|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680827|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
14680828|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680829|NCT00313521|Thiotepa|thiotepa|mesh-list
14680830|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14680831|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
14680832|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680833|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680834|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14680835|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680836|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
14680837|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680838|NCT00313534|Masoprocol|masoprocol|mesh-list
14680839|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
14680840|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680841|NCT00313534|Protective Agents|protective agents|mesh-ancestor
14680842|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680843|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14680844|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680845|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14680846|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14680847|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14680848|NCT00313534|Analgesics|analgesics|mesh-ancestor
14680849|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
14680850|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680851|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680852|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14680853|NCT00313547|Amlodipine|amlodipine|mesh-list
14680854|NCT00313547|Quinapril|quinapril|mesh-list
14680855|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14680856|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14680857|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680858|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680859|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14294194|NCT00574249|Adalimumab|adalimumab|mesh-list
14680860|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680861|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
14294195|NCT00574249|Betamethasone|betamethasone|mesh-list
14294196|NCT00574249|Calcipotriene|calcipotriene|mesh-list
14294197|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14680862|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14680863|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
14680864|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680865|NCT00313599|Paclitaxel|paclitaxel|mesh-list
14680866|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14680867|NCT00313599|Lapatinib|lapatinib|mesh-list
14680868|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14680869|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680870|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
14680871|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
14680872|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
14680873|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680874|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14680875|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680876|NCT00313625|Methotrexate|methotrexate|mesh-list
14680877|NCT00313625|Melphalan|melphalan|mesh-list
14680878|NCT00313625|Busulfan|busulfan|mesh-list
14680879|NCT00313625|Tacrolimus|tacrolimus|mesh-list
14680880|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14680881|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
14680882|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15191391|NCT03837470|Diuretics|diuretics|mesh-ancestor
15191392|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
15191393|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191394|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15191395|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294198|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14680883|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680884|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14680885|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
14680886|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680887|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680888|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
14680889|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680890|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14680891|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14680892|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
14680893|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14680894|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14680895|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14680896|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14680897|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
14680898|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14680899|NCT00313690|Docetaxel|docetaxel|mesh-list
14680900|NCT00313690|Bortezomib|bortezomib|mesh-list
14680901|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680902|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14680903|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14680904|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14680905|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680906|NCT00313742|Insulin|insulin|mesh-list
14680907|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14680908|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
14680909|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
14680910|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
14680911|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
14680912|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
14680913|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680914|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680915|NCT00313833|Buprenorphine|buprenorphine|mesh-list
14680916|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14680917|NCT00313833|Narcotics|narcotics|mesh-ancestor
14680918|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680919|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680920|NCT00313833|Analgesics|analgesics|mesh-ancestor
14680921|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
14680922|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680923|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15191396|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191397|NCT03836807|Ketoprofen|ketoprofen|mesh-list
15191398|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
14680924|NCT00313859|Simvastatin|simvastatin|mesh-list
14680925|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14680926|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14680927|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
14680928|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680929|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14680930|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14680931|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680932|NCT00313885|SR 46349B|sr 46349b|mesh-list
14680933|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14680934|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14680935|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680936|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14680937|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14680938|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
14680939|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680940|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680941|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
14680942|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
14680943|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14680944|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14680945|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14680946|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680947|NCT00313898|Urological Agents|urological agents|mesh-ancestor
14680948|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14680949|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14680950|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14680951|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
14680952|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680953|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680954|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680955|NCT00313924|Urological Agents|urological agents|mesh-ancestor
14680956|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
14680957|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14680958|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680959|NCT00313950|Vaccines|vaccines|mesh-list
14680960|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
14680961|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680962|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
14680963|NCT00313963|Analgesics|analgesics|mesh-ancestor
14680964|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
14680965|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14680966|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680967|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
14680968|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14680969|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14680970|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
14680971|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14680972|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14680973|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680974|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14680975|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
14680976|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14680977|NCT00313976|Interferons|interferons|mesh-list
14680978|NCT00313976|Interferon-beta|interferon-beta|mesh-list
14680979|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
14680980|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14680981|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
14680982|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14680983|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
14680984|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14680985|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14680986|NCT00314080|Antitoxins|antitoxins|mesh-list
14680987|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
14680988|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
14680989|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294199|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
14680990|NCT00314158|Timolol|timolol|mesh-list
14680991|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14680992|NCT00314158|Brinzolamide|brinzolamide|mesh-list
14680993|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14680994|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14680995|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14680996|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14680997|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14680998|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14680999|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681000|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14681001|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14681002|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14681003|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681004|NCT00314171|Timolol|timolol|mesh-list
14681005|NCT00314171|Dorzolamide|dorzolamide|mesh-list
14681006|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14681007|NCT00314171|Brinzolamide|brinzolamide|mesh-list
14681008|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14681009|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14681010|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14681011|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
14681012|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681013|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681014|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681015|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14681016|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14681017|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14681018|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681019|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14681020|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
14681021|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681022|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14681023|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14681024|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681025|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681026|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14294200|NCT00574249|Hormones|hormones|mesh-ancestor
14294201|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681027|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
14681028|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681029|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14681030|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14681031|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681032|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727222|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
14727223|NCT00512980|Hormones|hormones|mesh-ancestor
14727224|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727225|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14727226|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727227|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
14727228|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727229|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
14727230|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
14727231|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14727232|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727233|NCT00513032|Methylene Blue|methylene blue|mesh-list
14727234|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727235|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727236|NCT00513058|Vinorelbine|vinorelbine|mesh-list
14727237|NCT00513058|Lapatinib|lapatinib|mesh-list
14727238|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727239|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727240|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
14814813|NCT00864357|Analgesics|analgesics|mesh-ancestor
14727241|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727242|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681033|NCT00314314|Insulin|insulin|mesh-list
14681034|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14681035|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681036|NCT00314379|Vitamin E|vitamin e|mesh-list
14681037|NCT00314379|Vitamins|vitamins|mesh-ancestor
14681038|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
14681039|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681040|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
14681041|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681042|NCT00314379|Protective Agents|protective agents|mesh-ancestor
14681043|NCT00314405|Methylene Blue|methylene blue|mesh-list
14681044|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681045|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681046|NCT00314457|Bupivacaine|bupivacaine|mesh-list
14681047|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
14681048|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
14681049|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681050|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681051|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
14681052|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681053|NCT00314509|Ciclesonide|ciclesonide|mesh-list
14681054|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
14681055|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14681056|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
14681057|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681058|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681059|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14294202|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681060|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
14681061|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14681062|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14681063|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14681064|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
14681065|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681066|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681067|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
14681068|NCT00314509|Hormones|hormones|mesh-ancestor
14681069|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681070|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14681071|NCT00314548|Epoprostenol|epoprostenol|mesh-list
14681072|NCT00314548|Alprostadil|alprostadil|mesh-list
14681073|NCT00314548|Tezosentan|tezosentan|mesh-list
14681074|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14681075|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
14681076|NCT00314548|Urological Agents|urological agents|mesh-ancestor
14681077|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14681078|NCT00314561|Pioglitazone|pioglitazone|mesh-list
14681079|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
14681080|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14681081|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681082|NCT00314613|Risperidone|risperidone|mesh-list
14681083|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
14681084|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14681085|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
14681086|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681087|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681088|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681089|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14681090|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681091|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681092|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14681093|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
14681094|NCT00314626|Lamivudine|lamivudine|mesh-list
14681095|NCT00314626|Efavirenz|efavirenz|mesh-list
14681096|NCT00314626|Abacavir|abacavir|mesh-list
14681097|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14681098|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14681099|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681100|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681101|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
14681102|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681103|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14681104|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14681105|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14681106|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14681107|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14681108|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14681109|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14681110|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14681111|NCT00314639|Modafinil|modafinil|mesh-list
14681112|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14681113|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681114|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14681115|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14681116|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14681117|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681118|NCT00314652|Buprenorphine|buprenorphine|mesh-list
14681119|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14681120|NCT00314652|Narcotics|narcotics|mesh-ancestor
14681121|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681122|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681123|NCT00314652|Analgesics|analgesics|mesh-ancestor
14681124|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
14681125|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681126|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14681127|NCT00314665|Thalidomide|thalidomide|mesh-list
14681128|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681129|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
14681130|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681131|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
14681132|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14681133|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681134|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14681135|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14681136|NCT00314665|Growth Substances|growth substances|mesh-ancestor
14681137|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
14681138|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681139|NCT00314678|Paclitaxel|paclitaxel|mesh-list
14681140|NCT00314678|Topotecan|topotecan|mesh-list
14681141|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14681142|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681143|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
14681144|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
14681145|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681146|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681147|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14681148|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14681149|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681150|NCT00314704|Dopamine|dopamine|mesh-list
14681151|NCT00314704|Norepinephrine|norepinephrine|mesh-list
14681152|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14681153|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14681154|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
14681155|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681156|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681157|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681158|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
14681159|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
14681160|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681161|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14681162|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14681163|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
14681164|NCT00314704|Protective Agents|protective agents|mesh-ancestor
14681165|NCT00314743|Dexamethasone|dexamethasone|mesh-list
14681166|NCT00314743|Ondansetron|ondansetron|mesh-list
14681167|NCT00314743|Aprepitant|aprepitant|mesh-list
14681168|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191399|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15191400|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191401|NCT03836807|Analgesics|analgesics|mesh-ancestor
15191402|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
14681169|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
14681170|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
14681171|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681172|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681173|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14681174|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
14681175|NCT00314743|Hormones|hormones|mesh-ancestor
14681176|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681177|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14681178|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681179|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
14681180|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
14681181|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14814814|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
14814815|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814816|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814817|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814818|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814819|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14814820|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814821|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814822|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14294203|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14294204|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
14294205|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
14294206|NCT00574275|Gemcitabine|gemcitabine|mesh-list
14681182|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
14681183|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681184|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294207|NCT00574275|Aflibercept|aflibercept|mesh-list
14294208|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14681185|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14681186|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14681187|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681188|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814823|NCT00864357|Narcotics|narcotics|mesh-ancestor
14814824|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814825|NCT00864396|Lansoprazole|lansoprazole|mesh-list
14814826|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14814827|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14814828|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14814829|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814830|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814831|NCT00864409|Ropivacaine|ropivacaine|mesh-list
14814832|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
14814833|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
14814834|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814835|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814836|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
14814837|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294209|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
14328609|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14681189|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14681190|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14681191|NCT00314756|Imiquimod|imiquimod|mesh-list
14681192|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14681193|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
14681194|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681195|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681196|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
14681197|NCT00314782|Docetaxel|docetaxel|mesh-list
14681198|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681199|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
14681200|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
14681201|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681202|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681203|NCT00314821|Ropinirole|ropinirole|mesh-list
14681204|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14681205|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14681206|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
14681207|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
14681208|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681209|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681210|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681211|NCT00314860|Ropinirole|ropinirole|mesh-list
14681212|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14681213|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14681214|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
14681215|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
14681216|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681217|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681218|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681219|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
14681220|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681221|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14681222|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681223|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681224|NCT00314912|Tramiprosate|tramiprosate|mesh-list
14681225|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
14681226|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
14681227|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
14681228|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681229|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681230|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681231|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
14681232|NCT00314977|Docetaxel|docetaxel|mesh-list
14681233|NCT00314977|Doxorubicin|doxorubicin|mesh-list
14681234|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14681235|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681236|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
14681237|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681238|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681239|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14681240|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
14681241|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681242|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681243|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14681244|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
14681245|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
14681246|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681247|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14681248|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14681249|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14681250|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681251|NCT00314990|Folic Acid|folic acid|mesh-list
14681252|NCT00314990|Pyridoxine|pyridoxine|mesh-list
14681253|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
15191403|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191404|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191405|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191406|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15191407|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15191408|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328610|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
14681254|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
14681255|NCT00314990|Hematinics|hematinics|mesh-ancestor
14681256|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
14814838|NCT00864435|Carvedilol|carvedilol|mesh-list
14681257|NCT00314990|Vitamins|vitamins|mesh-ancestor
14814839|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14681258|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
14681259|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681260|NCT00315003|Azithromycin|azithromycin|mesh-list
14681261|NCT00315003|Telithromycin|telithromycin|mesh-list
14681262|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14681263|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681264|NCT00315016|Eplerenone|eplerenone|mesh-list
14681265|NCT00315016|Fosinopril|fosinopril|mesh-list
14681266|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14681267|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
14681268|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681269|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681270|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14681271|NCT00315016|Diuretics|diuretics|mesh-ancestor
14681272|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
14681273|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14681274|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14681275|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
14681276|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681277|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681278|NCT00315042|Penicillins|penicillins|mesh-list
14681279|NCT00315042|Telithromycin|telithromycin|mesh-list
14681280|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14681281|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681282|NCT00315081|Bromocriptine|bromocriptine|mesh-list
14681283|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14681284|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14681285|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14681286|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681287|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681288|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
14681289|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
14681290|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681291|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681292|NCT00315185|Cetuximab|cetuximab|mesh-list
14681293|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14681294|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681295|NCT00315211|Docetaxel|docetaxel|mesh-list
14681296|NCT00315211|Topotecan|topotecan|mesh-list
14681297|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681298|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
14681299|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
14681300|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681301|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681302|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14681303|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14681304|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681305|NCT00315276|Modafinil|modafinil|mesh-list
14681306|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14681307|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681308|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14681309|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14681310|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14681311|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681312|NCT00315367|Donepezil|donepezil|mesh-list
14681313|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14681314|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681315|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681316|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
14681317|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681318|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681319|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
14681320|NCT00315432|Interferons|interferons|mesh-list
14681321|NCT00315432|Ribavirin|ribavirin|mesh-list
14681322|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681323|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
14681324|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681325|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
14681326|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681327|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
14681328|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
14681329|NCT00315484|Hematinics|hematinics|mesh-ancestor
14681330|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14681331|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14681332|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14681333|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
14681334|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681335|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14681336|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14681337|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681338|NCT00315523|Levocetirizine|levocetirizine|mesh-list
14681339|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14681340|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14681341|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
14681342|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
14681343|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681344|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681345|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681346|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
14681347|NCT00315536|Remifentanil|remifentanil|mesh-list
14681348|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14681349|NCT00315536|Narcotics|narcotics|mesh-ancestor
14681350|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681351|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681352|NCT00315536|Analgesics|analgesics|mesh-ancestor
14681353|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
14681354|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681355|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14681356|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14681357|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14681358|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
14681359|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681360|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681361|NCT00315549|Penicillins|penicillins|mesh-list
14681362|NCT00315549|Telithromycin|telithromycin|mesh-list
14681363|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14681364|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681365|NCT00315601|Azithromycin|azithromycin|mesh-list
14681366|NCT00315601|Telithromycin|telithromycin|mesh-list
14681367|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14681368|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681369|NCT00315666|Memantine|memantine|mesh-list
14681370|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14681371|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14681372|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
14681373|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681374|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681375|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681376|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14681377|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14681378|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
14681379|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14681380|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681381|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681382|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14681383|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14681384|NCT00315679|Protective Agents|protective agents|mesh-ancestor
14681385|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681386|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
14681387|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14681388|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
14681389|NCT00315744|Fluticasone|fluticasone|mesh-list
14681390|NCT00315744|Xhance|xhance|mesh-list
14681391|NCT00315744|Albuterol|albuterol|mesh-list
14681392|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14681393|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14681394|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14681395|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
14681396|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681397|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681398|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14681399|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
14681400|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14681401|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14681402|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14681403|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14681404|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14681405|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
14681406|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681407|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681408|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
14681409|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14681410|NCT00315835|Buprenorphine|buprenorphine|mesh-list
14681411|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14681412|NCT00315835|Narcotics|narcotics|mesh-ancestor
14681413|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681414|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681415|NCT00315835|Analgesics|analgesics|mesh-ancestor
14681416|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
14681417|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681418|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14681419|NCT00315848|Buprenorphine|buprenorphine|mesh-list
14681420|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14681421|NCT00315848|Narcotics|narcotics|mesh-ancestor
14681422|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681423|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681424|NCT00315848|Analgesics|analgesics|mesh-ancestor
14681425|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
14681426|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681427|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14681428|NCT00315861|Pemetrexed|pemetrexed|mesh-list
14681429|NCT00315861|Topotecan|topotecan|mesh-list
14681430|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681431|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681432|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681433|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14681434|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14681435|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14681436|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14681437|NCT00315874|Buprenorphine|buprenorphine|mesh-list
14681438|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14681439|NCT00315874|Narcotics|narcotics|mesh-ancestor
14681440|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681441|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681442|NCT00315874|Analgesics|analgesics|mesh-ancestor
14681443|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
14681444|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681445|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14681446|NCT00315887|Buprenorphine|buprenorphine|mesh-list
14681447|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14681448|NCT00315887|Narcotics|narcotics|mesh-ancestor
14681449|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681450|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681451|NCT00315887|Analgesics|analgesics|mesh-ancestor
14681452|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
14681453|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681454|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14681455|NCT00315900|Valproic Acid|valproic acid|mesh-list
14681456|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14681457|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
14681458|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681459|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14681460|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14681461|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681462|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191409|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191410|NCT03836703|Iron|iron|mesh-list
14681463|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
14681464|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681465|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681466|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
15191411|NCT03836703|Trace Elements|trace elements|mesh-ancestor
15191412|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
15191413|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191414|NCT03836885|Apremilast|apremilast|mesh-list
15191415|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15191416|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191417|NCT03836885|Analgesics|analgesics|mesh-ancestor
15191418|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
15191419|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681467|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681468|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
14681469|NCT00315913|Propranolol|propranolol|mesh-list
14681470|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14681471|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14681472|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
14681473|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681474|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681475|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681476|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14681477|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14681478|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
14727243|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727244|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14727245|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727246|NCT00513110|Caffeine|caffeine|mesh-list
14727247|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14727248|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727249|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14727250|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727251|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727252|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14727253|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14727254|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
14727255|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727256|NCT00513149|Clopidogrel|clopidogrel|mesh-list
14727257|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14727258|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14727259|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14727260|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14727261|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
14727262|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727263|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727264|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727265|NCT00513162|Etoposide|etoposide|mesh-list
14727266|NCT00513162|Valproic Acid|valproic acid|mesh-list
14727267|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727268|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727269|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14727270|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727271|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727272|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727273|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
14727274|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
14727275|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727276|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727277|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
14727278|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14727279|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727280|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14727281|NCT00513188|Leucovorin|leucovorin|mesh-list
14727282|NCT00513188|Cytarabine|cytarabine|mesh-list
14727283|NCT00513188|Prednisone|prednisone|mesh-list
14727284|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
14727285|NCT00513188|Doxorubicin|doxorubicin|mesh-list
14727286|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14727287|NCT00513188|Methotrexate|methotrexate|mesh-list
14294210|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294211|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294212|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
14294213|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294214|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294215|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294216|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
14294217|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727288|NCT00513188|Vincristine|vincristine|mesh-list
14727289|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
14727290|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
14727291|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727292|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
14681479|NCT00315926|Melatonin|melatonin|mesh-list
14681480|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
14681481|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681482|NCT00315926|Protective Agents|protective agents|mesh-ancestor
14681483|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681484|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681485|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
14681486|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
14681487|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14681488|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
14681489|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681490|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681491|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14681492|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
14681493|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14681494|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
14681495|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681496|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681497|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14681498|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
14681499|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
14681500|NCT00315965|Protective Agents|protective agents|mesh-ancestor
14681501|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
14681502|NCT00316030|Bexarotene|bexarotene|mesh-list
14681503|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681504|NCT00316095|Telmisartan|telmisartan|mesh-list
14681505|NCT00316095|Simvastatin|simvastatin|mesh-list
14681506|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14681507|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14681508|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
14681509|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681510|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14681511|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14681512|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681513|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14681514|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14681515|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14681516|NCT00316160|Bupropion|bupropion|mesh-list
15191420|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191421|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191422|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15191423|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15191424|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15191425|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681517|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14681518|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14681519|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
14681520|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681521|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14681522|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14681523|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14681524|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681525|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
14681526|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681527|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681528|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14681529|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15191426|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191427|NCT03836833|Lamivudine|lamivudine|mesh-list
15191428|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15191429|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15191430|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191431|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191432|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
15191433|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191434|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15191435|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15191436|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
15191437|NCT03836781|Ketorolac|ketorolac|mesh-list
15191438|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15191439|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681530|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681531|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14681532|NCT00316212|INS 50589|ins 50589|mesh-list
14681533|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14681534|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14681535|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
14681536|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681537|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681538|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681539|NCT00316238|Olanzapine|olanzapine|mesh-list
14681540|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
14681541|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
14681542|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681543|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681544|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14681545|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14681546|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14681547|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14681548|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681549|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14681550|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14681551|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14681552|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681553|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681554|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
14681555|NCT00316329|Artesunate|artesunate|mesh-list
14681556|NCT00316329|Amodiaquine|amodiaquine|mesh-list
14681557|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
14681558|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14681559|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14681560|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681561|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681562|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
14681563|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
14681564|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14681565|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
14681566|NCT00316407|Paclitaxel|paclitaxel|mesh-list
14681567|NCT00316407|Carboplatin|carboplatin|mesh-list
14681568|NCT00316407|Lapatinib|lapatinib|mesh-list
14681569|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14681570|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191440|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
15191441|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15191442|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14681571|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
14681572|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
14681573|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681574|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681575|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14681576|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681577|NCT00316420|Gemcitabine|gemcitabine|mesh-list
14681578|NCT00316420|Capecitabine|capecitabine|mesh-list
14681579|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14681580|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
14681581|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681582|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681583|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
14681584|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681585|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681586|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681587|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
14681588|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681589|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
14681590|NCT00316433|Irinotecan|irinotecan|mesh-list
14681591|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191443|NCT03836781|Analgesics|analgesics|mesh-ancestor
15191444|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
14681592|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14681593|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14681594|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681595|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681596|NCT00316472|Niacinamide|niacinamide|mesh-list
14681597|NCT00316472|Niacin|niacin|mesh-list
14681598|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
14681599|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
14681600|NCT00316472|Vitamins|vitamins|mesh-ancestor
15191445|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681601|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
14681602|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681603|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14681604|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
14681605|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681606|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14681607|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
14681608|NCT00316498|Miglustat|miglustat|mesh-list
14681609|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681610|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681611|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14294218|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14294219|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14294220|NCT00574275|Growth Substances|growth substances|mesh-ancestor
14294221|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
14294222|NCT00574288|Dexamethasone|dexamethasone|mesh-list
14681612|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14681613|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
14681614|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681615|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14681616|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14681617|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681618|NCT00316563|Dronabinol|dronabinol|mesh-list
14681619|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
14681620|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681621|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681622|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14681623|NCT00316563|Analgesics|analgesics|mesh-ancestor
14681624|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
14681625|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191446|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191447|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191448|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681626|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14681627|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14681628|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681629|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681630|NCT00316563|Hormones|hormones|mesh-ancestor
14681631|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681632|NCT00316680|Vaccines|vaccines|mesh-list
14681633|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
14681634|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681635|NCT00316745|Leucovorin|leucovorin|mesh-list
14681636|NCT00316745|Fluorouracil|fluorouracil|mesh-list
14681637|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
14681638|NCT00316745|Irinotecan|irinotecan|mesh-list
14681639|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
14681640|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681641|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14681642|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681643|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681644|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
14681645|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681646|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14681647|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15191449|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15191450|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191451|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191452|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
15191453|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15191454|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191455|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191456|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
14294223|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
14294224|NCT00574288|Daratumumab|daratumumab|mesh-list
14681648|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681649|NCT00316745|Antidotes|antidotes|mesh-ancestor
14681650|NCT00316745|Protective Agents|protective agents|mesh-ancestor
14681651|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
14681652|NCT00316745|Vitamins|vitamins|mesh-ancestor
14681653|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
14681654|NCT00316758|Metformin|metformin|mesh-list
14681655|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14681656|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681657|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
14681658|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
15191457|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191458|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191459|NCT03836599|Allopurinol|allopurinol|mesh-list
15191460|NCT03836599|Verinurad|verinurad|mesh-list
15191461|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
15191462|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191463|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294225|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14294226|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294227|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
14294228|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
14681659|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14681660|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681661|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
14681662|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681663|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681664|NCT00316849|Sirolimus|sirolimus|mesh-list
14681665|NCT00316849|Temozolomide|temozolomide|mesh-list
14681666|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14681667|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
14681668|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681669|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681670|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14681671|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681672|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14681673|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
14681674|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681675|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
14681676|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681677|NCT00316875|Doxorubicin|doxorubicin|mesh-list
14681678|NCT00316875|Lapatinib|lapatinib|mesh-list
14681679|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14681680|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681681|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14681682|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14681683|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681684|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681685|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14681686|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14681687|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14681688|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681689|NCT00316927|Aspirin|aspirin|mesh-list
14681690|NCT00316927|Dexamethasone|dexamethasone|mesh-list
14681691|NCT00316927|Fosfestrol|fosfestrol|mesh-list
14681692|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
14681693|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14681694|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
14681695|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
14681696|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681697|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681698|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14681699|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
14681700|NCT00316927|Hormones|hormones|mesh-ancestor
14681701|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681702|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14681703|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681704|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14681705|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14681706|NCT00316927|Analgesics|analgesics|mesh-ancestor
14681707|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
14681708|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15191464|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
15191465|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294229|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681709|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14681710|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14681711|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681712|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14681713|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14681714|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681715|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
14681716|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14681717|NCT00316927|Estrogens|estrogens|mesh-ancestor
14681718|NCT00316940|Bortezomib|bortezomib|mesh-list
14681719|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14681720|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681721|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14681722|NCT00316940|Analgesics|analgesics|mesh-ancestor
14681723|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
15191466|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15191467|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
15191468|NCT03836599|Protective Agents|protective agents|mesh-ancestor
14681724|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681725|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681726|NCT00316953|Dasatinib|dasatinib|mesh-list
14681727|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681728|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14681729|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681730|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681731|NCT00317031|Naltrexone|naltrexone|mesh-list
14681732|NCT00317031|Acamprosate|acamprosate|mesh-list
14681733|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14681734|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14681735|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681736|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
14681737|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681738|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14681739|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14681740|NCT00317070|Protective Agents|protective agents|mesh-ancestor
14681741|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681742|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14681743|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
14681744|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681745|NCT00317096|Rituximab|rituximab|mesh-list
14681746|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14681747|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681748|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
14681749|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681750|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681751|NCT00317135|Vaccines|vaccines|mesh-list
14681752|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
14681753|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681754|NCT00317187|Vaccines|vaccines|mesh-list
14681755|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
14681756|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681757|NCT00317200|Paclitaxel|paclitaxel|mesh-list
14681758|NCT00317200|Bevacizumab|bevacizumab|mesh-list
14681759|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15191469|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191470|NCT03836560|Nicotine|nicotine|mesh-list
15191471|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15191472|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
15191473|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681760|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681761|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14681762|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14681763|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681764|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681765|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14681766|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14681767|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14681768|NCT00317200|Growth Substances|growth substances|mesh-ancestor
14681769|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681770|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
14681771|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14681772|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
14681773|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681774|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681775|NCT00317330|Rifampin|rifampin|mesh-list
14681776|NCT00317330|Isoniazid|isoniazid|mesh-list
15191474|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681777|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
14681778|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14681779|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
14681780|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14681781|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681782|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
14681783|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14681784|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681785|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681786|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14681787|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14681788|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14681789|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14681790|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14681791|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14681792|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14681793|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14681794|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
14681795|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14681796|NCT00317343|Anticoagulants|anticoagulants|mesh-list
14681797|NCT00317343|Bivalirudin|bivalirudin|mesh-list
14681798|NCT00317343|Thrombin|thrombin|mesh-list
14681799|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
14681800|NCT00317343|Coagulants|coagulants|mesh-ancestor
14681801|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
14681802|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14681803|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
14681804|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681805|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681806|NCT00317408|Leucovorin|leucovorin|mesh-list
14681807|NCT00317408|Cytarabine|cytarabine|mesh-list
14681808|NCT00317408|Cyclosporine|cyclosporine|mesh-list
15191475|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15191476|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15191477|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
15191478|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191479|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191480|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
15191481|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15191482|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191483|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191484|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15191485|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15191486|NCT03836222|Protective Agents|protective agents|mesh-ancestor
14681809|NCT00317408|Dexamethasone|dexamethasone|mesh-list
14681810|NCT00317408|Prednisolone|prednisolone|mesh-list
14681811|NCT00317408|Carboplatin|carboplatin|mesh-list
14681812|NCT00317408|Methotrexate|methotrexate|mesh-list
14681813|NCT00317408|Etoposide|etoposide|mesh-list
14681814|NCT00317408|Melphalan|melphalan|mesh-list
14681815|NCT00317408|Busulfan|busulfan|mesh-list
14681816|NCT00317408|Ifosfamide|ifosfamide|mesh-list
14681817|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
14681818|NCT00317408|Idarubicin|idarubicin|mesh-list
14681819|NCT00317408|Thiotepa|thiotepa|mesh-list
14681820|NCT00317408|Carmustine|carmustine|mesh-list
14681821|NCT00317408|Vinblastine|vinblastine|mesh-list
14681822|NCT00317408|Lomustine|lomustine|mesh-list
14681823|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
14681824|NCT00317408|Vindesine|vindesine|mesh-list
14681825|NCT00317408|Cyclosporins|cyclosporins|mesh-list
14681826|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14681827|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
14681828|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191487|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681829|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
15191488|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
14681830|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
14681831|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681832|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681833|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14681834|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
14681835|NCT00317408|Hormones|hormones|mesh-ancestor
14681836|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681837|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14681838|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681839|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14681840|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
14681841|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14681842|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14681843|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
14681844|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681845|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
14681846|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681847|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14681848|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681849|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
14681850|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681851|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14681852|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14681853|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14681854|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14681855|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
14681856|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681857|NCT00317408|Antidotes|antidotes|mesh-ancestor
14681858|NCT00317408|Protective Agents|protective agents|mesh-ancestor
14681859|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
14681860|NCT00317408|Vitamins|vitamins|mesh-ancestor
14681861|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
14681862|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
14681863|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14681864|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14681865|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
14681866|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14681867|NCT00317408|Analgesics|analgesics|mesh-ancestor
14681868|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
14681869|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14681870|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14681871|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14681872|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14681873|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
14681874|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681875|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
14681876|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14681877|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14681878|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681879|NCT00317421|Urological Agents|urological agents|mesh-ancestor
14681880|NCT00317434|Lapatinib|lapatinib|mesh-list
14681881|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681882|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14681883|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681884|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681885|NCT00317447|Prednisone|prednisone|mesh-list
14681886|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14681887|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
14681888|NCT00317447|Hormones|hormones|mesh-ancestor
14681889|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681890|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681891|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14681892|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681893|NCT00317499|Etanercept|etanercept|mesh-list
14681894|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14681895|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14681896|NCT00317499|Analgesics|analgesics|mesh-ancestor
14681897|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
14681898|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681899|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681900|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14681901|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681902|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14294230|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294231|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14294232|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
14814840|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14294233|NCT00574288|Hormones|hormones|mesh-ancestor
15191489|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15191490|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
15191491|NCT03836157|Bevacizumab|bevacizumab|mesh-list
15191492|NCT03836157|Maytansine|maytansine|mesh-list
15191493|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191494|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191495|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15191496|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14681903|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681904|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
14681905|NCT00317512|HBOC 201|hboc 201|mesh-list
15191497|NCT03836157|Growth Substances|growth substances|mesh-ancestor
15191498|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191499|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
14681906|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
14681907|NCT00317538|Etanercept|etanercept|mesh-list
14681908|NCT00317538|Infliximab|infliximab|mesh-list
14681909|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14681910|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14681911|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681912|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14681913|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14681914|NCT00317538|Analgesics|analgesics|mesh-ancestor
14681915|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
14681916|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681917|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681918|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14681919|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681920|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
14681921|NCT00317577|Timolol|timolol|mesh-list
14681922|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14681923|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14681924|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14681925|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
14681926|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681927|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681928|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681929|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14681930|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14681931|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14681932|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14681933|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14681934|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14681935|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
14681936|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14681937|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
14681938|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681939|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681940|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14681941|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
14681942|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14681943|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
14681944|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681945|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681946|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14681947|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14681948|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
14681949|NCT00317629|Protective Agents|protective agents|mesh-ancestor
14681950|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14681951|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14681952|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14681953|NCT00317655|Ibuprofen|ibuprofen|mesh-list
14681954|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14681955|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191500|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15191501|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
15191502|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
15191503|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
15224023|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14327526|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681956|NCT00317655|Analgesics|analgesics|mesh-ancestor
14294234|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14681957|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
14681958|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681959|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681960|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14681961|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681962|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14681963|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681964|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727293|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727294|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727295|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14727296|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
14727297|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727298|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727299|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14727300|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14727301|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14727302|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727303|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727304|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727305|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
14727306|NCT00513188|Hormones|hormones|mesh-ancestor
14727307|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727308|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14727309|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14727310|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
14727311|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14727312|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727313|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
14727314|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727315|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14727316|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14727317|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
14727318|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727319|NCT00513188|Antidotes|antidotes|mesh-ancestor
14727320|NCT00513188|Protective Agents|protective agents|mesh-ancestor
14727321|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
14727322|NCT00513188|Vitamins|vitamins|mesh-ancestor
14727323|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
14727324|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727325|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
14727326|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727327|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
14727328|NCT00513201|Insulin|insulin|mesh-list
14727329|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14727330|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14727331|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727332|NCT00513253|Lapatinib|lapatinib|mesh-list
14727333|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727334|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14727335|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727336|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727337|NCT00513266|Leucovorin|leucovorin|mesh-list
15191504|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191505|NCT03836001|Serlopitant|serlopitant|mesh-list
15191506|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15191507|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191508|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191509|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191510|NCT03836014|Dexamethasone|dexamethasone|mesh-list
15191511|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
15191512|NCT03836014|Lenalidomide|lenalidomide|mesh-list
15191513|NCT03836014|Daratumumab|daratumumab|mesh-list
15191514|NCT03836014|BB 1101|bb 1101|mesh-list
15191515|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15191516|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191517|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
15191518|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
15191519|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191520|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191521|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191522|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
14681965|NCT00317681|Tacrolimus|tacrolimus|mesh-list
14681966|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14681967|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
14681968|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681969|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14681970|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681971|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681972|NCT00317733|Ketoprofen|ketoprofen|mesh-list
14681973|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14681974|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14681975|NCT00317733|Analgesics|analgesics|mesh-ancestor
14681976|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
14681977|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14681978|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681979|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14681980|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14681981|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14681982|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14681983|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681984|NCT00317746|Citalopram|citalopram|mesh-list
14681985|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14681986|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14681987|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14681988|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14681989|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14681990|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
14681991|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14681992|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14681993|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
14681994|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14681995|NCT00317759|Fludarabine|fludarabine|mesh-list
14681996|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
14681997|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14681998|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14681999|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
14682000|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682001|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682002|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
14682003|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682004|NCT00317785|Cyclosporine|cyclosporine|mesh-list
14682005|NCT00317785|Sirolimus|sirolimus|mesh-list
14682006|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
14682007|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
14682008|NCT00317785|Methotrexate|methotrexate|mesh-list
14682009|NCT00317785|Tacrolimus|tacrolimus|mesh-list
14682010|NCT00317785|Cyclosporins|cyclosporins|mesh-list
14682011|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682012|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
14682013|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682014|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14682015|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14682016|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
14682017|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682018|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682019|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14682020|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14682021|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
14682022|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14682023|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14682024|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
14682025|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14682026|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682027|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14682028|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14682029|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14682030|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
15191523|NCT03836014|Hormones|hormones|mesh-ancestor
14682031|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682032|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14682033|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14682034|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
14682035|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682036|NCT00317798|Sirolimus|sirolimus|mesh-list
14682037|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14682038|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682039|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682040|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14682041|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682042|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
14682043|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682044|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
14682045|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682046|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
15191524|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191525|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15191526|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682047|NCT00317811|Bortezomib|bortezomib|mesh-list
14682048|NCT00317811|Melphalan|melphalan|mesh-list
14682049|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682050|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14682051|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
14682052|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682053|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14682054|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682055|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
14682056|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682057|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
14682058|NCT00317811|Protective Agents|protective agents|mesh-ancestor
14682059|NCT00317811|Vitamins|vitamins|mesh-ancestor
14682060|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
14682061|NCT00317850|Gabapentin|gabapentin|mesh-list
14682062|NCT00317850|Analgesics|analgesics|mesh-ancestor
14682063|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
14682064|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682065|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682066|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
14682067|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14682068|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14682069|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682070|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682071|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14682072|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14682073|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191527|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
15191528|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191529|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191530|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
15191531|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14682074|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682075|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
14682076|NCT00317876|Cyclosporine|cyclosporine|mesh-list
14682077|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
14682078|NCT00317876|Methotrexate|methotrexate|mesh-list
14682079|NCT00317876|Cyclosporins|cyclosporins|mesh-list
14682080|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682081|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
14682082|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682083|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14682084|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14682085|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
14682086|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682087|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294235|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14294236|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294237|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14294238|NCT00574288|Protective Agents|protective agents|mesh-ancestor
14294239|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
14294240|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14294241|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682088|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14682089|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14682090|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
14682091|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14294242|NCT00574405|Insulin|insulin|mesh-list
14294243|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14294244|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
14294245|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
14294246|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
14294247|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
14294248|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
14682092|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14682093|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
14682094|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
14682095|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682096|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14682097|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14682098|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
14682099|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682100|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14682101|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
14682102|NCT00317902|Hematinics|hematinics|mesh-ancestor
14682103|NCT00317915|Irbesartan|irbesartan|mesh-list
14682104|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682105|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14682106|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14682107|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682108|NCT00317928|Metformin|metformin|mesh-list
14682109|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682110|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682111|NCT00317954|Spironolactone|spironolactone|mesh-list
14682112|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14682113|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
14682114|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191532|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15191533|NCT03836014|Growth Substances|growth substances|mesh-ancestor
15191534|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
15224024|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15224025|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
15224026|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15224027|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224028|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
15224029|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
15224030|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15224031|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224032|NCT04787965|Opicapone|opicapone|mesh-list
15224033|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14294249|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682115|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727338|NCT00513266|Bevacizumab|bevacizumab|mesh-list
15224034|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682116|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14682117|NCT00317954|Diuretics|diuretics|mesh-ancestor
14682118|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
14682119|NCT00317967|Atorvastatin|atorvastatin|mesh-list
14682120|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14682121|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14682122|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
14682123|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682124|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14682125|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14682126|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682127|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14682128|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14682129|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14682130|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682131|NCT00317993|Simvastatin|simvastatin|mesh-list
14682132|NCT00317993|Ezetimibe|ezetimibe|mesh-list
14682133|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14682134|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14682135|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
14682136|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682137|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14682138|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14682139|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682140|NCT00318084|Esomeprazole|esomeprazole|mesh-list
14682141|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14682142|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682143|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14682144|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682145|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682146|NCT00318162|Naltrexone|naltrexone|mesh-list
14682147|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14682148|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14682149|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682150|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
14682151|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682152|NCT00318175|Bosentan|bosentan|mesh-list
14682153|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682154|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14682155|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682156|NCT00318201|Erythromycin|erythromycin|mesh-list
14682157|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
14682158|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14682159|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
14682160|NCT00318201|Diltiazem|diltiazem|mesh-list
14682161|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682162|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14682163|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682164|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682165|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14682166|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682167|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
14682168|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682169|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682170|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682171|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14682172|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682173|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14682174|NCT00318318|Estrogens|estrogens|mesh-ancestor
14682175|NCT00318318|Hormones|hormones|mesh-ancestor
14682176|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682177|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682178|NCT00318383|Vaccines|vaccines|mesh-list
14682179|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
14682180|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682181|NCT00318422|Liraglutide|liraglutide|mesh-list
14682182|NCT00318422|Glimepiride|glimepiride|mesh-list
14682183|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
14682184|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682185|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682186|NCT00318422|Incretins|incretins|mesh-ancestor
14682187|NCT00318422|Hormones|hormones|mesh-ancestor
14682188|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682189|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14682190|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682191|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
14682192|NCT00318448|Zolpidem|zolpidem|mesh-list
14682193|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14682194|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14682195|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682196|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682197|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14682198|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
14682199|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
14682200|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682201|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682202|NCT00318513|Bevacizumab|bevacizumab|mesh-list
14682203|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14682204|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294250|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294251|NCT00574548|Vaccines|vaccines|mesh-list
14682205|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14682206|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14682207|NCT00318513|Growth Substances|growth substances|mesh-ancestor
15191535|NCT03835676|Treprostinil|treprostinil|mesh-list
15191536|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15191537|NCT03835715|Vortioxetine|vortioxetine|mesh-list
15191538|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682208|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682209|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
14682210|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14682211|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682212|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682213|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14682214|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14682215|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682216|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682217|NCT00318552|Meropenem|meropenem|mesh-list
14682218|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682219|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682220|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
14682221|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682222|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682223|NCT00318669|Paroxetine|paroxetine|mesh-list
14682224|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14682225|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14682226|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682227|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682228|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682229|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
14682230|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682231|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14682232|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682233|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682234|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14682235|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14682236|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191539|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15191540|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15191541|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15191542|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191543|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191544|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15191545|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15191546|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191547|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191548|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191549|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
15191550|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15191551|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14682237|NCT00318760|Clonidine|clonidine|mesh-list
14682238|NCT00318760|Analgesics|analgesics|mesh-ancestor
14682239|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
14682240|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682241|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682242|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682243|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
14682244|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
14682245|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14682246|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14682247|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14682248|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682249|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682250|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682251|NCT00318773|Sertraline|sertraline|mesh-list
14682252|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682253|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682254|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14682255|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14682256|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682257|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682258|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682259|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
14682260|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682261|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
14682262|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
14682263|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682264|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682265|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
14682266|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14682267|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
14682268|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
14682269|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682270|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682271|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14682272|NCT00318825|Analgesics|analgesics|mesh-ancestor
14682273|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
14682274|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682275|NCT00318838|Azimilide|azimilide|mesh-list
14682276|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14682277|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14682278|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682279|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682280|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14682281|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682282|NCT00318890|Docetaxel|docetaxel|mesh-list
14682283|NCT00318890|Amifostine|amifostine|mesh-list
14682284|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682285|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14682286|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14682287|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14682288|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682289|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14682290|NCT00318890|Protective Agents|protective agents|mesh-ancestor
14682291|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682292|NCT00318903|Docetaxel|docetaxel|mesh-list
14682293|NCT00318903|Irinotecan|irinotecan|mesh-list
14682294|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682295|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
14682296|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
14682297|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
14682298|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682299|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14682300|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14682301|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682302|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
14682303|NCT00318955|Propofol|propofol|mesh-list
14682304|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14682305|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682306|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682307|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14682308|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
14682309|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
14682310|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14682311|NCT00318955|Analgesics|analgesics|mesh-ancestor
14682312|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
14682313|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682314|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14682315|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14682316|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14682317|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682318|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682319|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682320|NCT00318968|Esomeprazole|esomeprazole|mesh-list
14682321|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14682322|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682323|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14682324|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682325|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682326|NCT00318981|Methylphenidate|methylphenidate|mesh-list
14682327|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14682328|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682329|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14682330|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14682331|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682332|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682333|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
14682334|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682335|NCT00318994|Meropenem|meropenem|mesh-list
14682336|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682337|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682338|NCT00319007|Sulindac|sulindac|mesh-list
14294252|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14294253|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
14682339|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14682340|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14682341|NCT00319007|Analgesics|analgesics|mesh-ancestor
14682342|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
14682343|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682344|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682345|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14682346|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14682347|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682348|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14682349|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682350|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682351|NCT00319033|Bosentan|bosentan|mesh-list
14682352|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682353|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14682354|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682355|NCT00319059|Annexin A5|annexin a5|mesh-list
14682356|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682357|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682358|NCT00319072|Hormones|hormones|mesh-list
15191552|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15191553|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15191554|NCT03835442|Baclofen|baclofen|mesh-list
14682359|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682360|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682361|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
14682362|NCT00319150|Hematinics|hematinics|mesh-ancestor
14682363|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
14682364|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14682365|NCT00319163|Estradiol|estradiol|mesh-list
14682366|NCT00319163|Estrogens|estrogens|mesh-ancestor
14682367|NCT00319163|Hormones|hormones|mesh-ancestor
14682368|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191555|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15191556|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191557|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15191558|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191559|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14682369|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682370|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14682371|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
14682372|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14682373|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14682374|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14682375|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14682376|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14682377|NCT00319189|Nateglinide|nateglinide|mesh-list
14682378|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682379|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682380|NCT00319202|Candesartan|candesartan|mesh-list
14682381|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682382|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14682383|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14682384|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682385|NCT00319215|Zopiclone|zopiclone|mesh-list
14682386|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14682387|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682388|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682389|NCT00319267|Bosentan|bosentan|mesh-list
14682390|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682391|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14682392|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682393|NCT00319293|Metformin|metformin|mesh-list
14682394|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682395|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682396|NCT00319306|Budesonide|budesonide|mesh-list
14682397|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
14682398|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14682399|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14682400|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14682401|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
14682402|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682403|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682404|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14682405|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
14682406|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
14682407|NCT00319306|Hormones|hormones|mesh-ancestor
14682408|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682409|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14682410|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14294254|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294255|NCT00574587|Paclitaxel|paclitaxel|mesh-list
14294256|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
14294257|NCT00574587|Doxorubicin|doxorubicin|mesh-list
14682411|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14682412|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682413|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682414|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682415|NCT00319319|Mecamylamine|mecamylamine|mesh-list
14682416|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682417|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14682418|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
14682419|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682420|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682421|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14682422|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14682423|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
14682424|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682425|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682426|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
14682427|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727339|NCT00513266|Cetuximab|cetuximab|mesh-list
14727340|NCT00513266|Fluorouracil|fluorouracil|mesh-list
14727341|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
14727342|NCT00513266|Irinotecan|irinotecan|mesh-list
14727343|NCT00513266|Calcium|calcium|mesh-list
14727344|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
14727345|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14727346|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727347|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14727348|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14294258|NCT00574587|Trastuzumab|trastuzumab|mesh-list
14294259|NCT00574587|Vorinostat|vorinostat|mesh-list
14682428|NCT00319345|Mannitol|mannitol|mesh-list
14682429|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14682430|NCT00319345|Diuretics|diuretics|mesh-ancestor
14682431|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
14682432|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682433|NCT00319358|Antioxidants|antioxidants|mesh-list
14682434|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682435|NCT00319358|Protective Agents|protective agents|mesh-ancestor
14682436|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682437|NCT00319488|Budesonide|budesonide|mesh-list
14682438|NCT00319488|Albuterol|albuterol|mesh-list
14682439|NCT00319488|Montelukast|montelukast|mesh-list
14682440|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14682441|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14682442|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14682443|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
14682444|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682445|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682446|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14682447|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
14682448|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
14682449|NCT00319488|Hormones|hormones|mesh-ancestor
14682450|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682451|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
14682452|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14682453|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14682454|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682455|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
14682456|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14682457|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14682458|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14682459|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14682460|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682461|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682462|NCT00319514|Docetaxel|docetaxel|mesh-list
14682463|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682464|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
14682465|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
14682466|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
14682467|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682468|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14682469|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
14682470|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14682471|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14682472|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14682473|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14682474|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
14682475|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14682476|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682477|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14682478|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14682479|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14682480|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14682481|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682482|NCT00319566|Estrogens|estrogens|mesh-ancestor
14682483|NCT00319566|Hormones|hormones|mesh-ancestor
14682484|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682485|NCT00319605|Levetiracetam|levetiracetam|mesh-list
14682486|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
14682487|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
14682488|NCT00319618|Docetaxel|docetaxel|mesh-list
14682489|NCT00319618|Gefitinib|gefitinib|mesh-list
14682490|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682491|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
14682492|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
14682493|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
14682494|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682495|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14682496|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682497|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14682498|NCT00319670|Laxatives|laxatives|mesh-ancestor
14682499|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682500|NCT00319683|Eniluracil|eniluracil|mesh-list
14682501|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682502|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682503|NCT00319709|Amibegron|amibegron|mesh-list
14682504|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14682505|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14682506|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682507|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682508|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682509|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682510|NCT00319761|Calcitriol|calcitriol|mesh-list
14682511|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14682512|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682513|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14682514|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682515|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682516|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14682517|NCT00319761|Vitamins|vitamins|mesh-ancestor
14682518|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
14682519|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14682520|NCT00319787|Gefitinib|gefitinib|mesh-list
14682521|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682522|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14682523|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682524|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682525|NCT00319800|Irinotecan|irinotecan|mesh-list
14682526|NCT00319800|Gefitinib|gefitinib|mesh-list
14682527|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14682528|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14682529|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682530|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682531|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682532|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14682533|NCT00319852|Vaccines|vaccines|mesh-list
14682534|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
14682535|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682536|NCT00319865|Thalidomide|thalidomide|mesh-list
14682537|NCT00319865|Dexamethasone|dexamethasone|mesh-list
14682538|NCT00319865|Doxorubicin|doxorubicin|mesh-list
14682539|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14682540|NCT00319865|Bortezomib|bortezomib|mesh-list
14682541|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14682542|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
14682543|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
14682544|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682545|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682546|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682547|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
14682548|NCT00319865|Hormones|hormones|mesh-ancestor
14682549|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682550|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14682551|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682552|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14682553|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14682554|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14682555|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682556|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682557|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682558|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
14682559|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
14682560|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682561|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682562|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14682563|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14682564|NCT00319865|Growth Substances|growth substances|mesh-ancestor
14682565|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
14682566|NCT00319878|Cyclosporine|cyclosporine|mesh-list
14682567|NCT00319878|Sirolimus|sirolimus|mesh-list
14682568|NCT00319878|Cyclosporins|cyclosporins|mesh-list
14682569|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682570|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682571|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682572|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
14682573|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682574|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
14327527|NCT00802737|Ofatumumab|ofatumumab|mesh-list
14682575|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682576|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
14682577|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14682578|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14682579|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682580|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14682581|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682582|NCT00319917|Tacrolimus|tacrolimus|mesh-list
14682583|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682584|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
14682585|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682586|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14682587|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682588|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682589|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
15191560|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
15191561|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
15191562|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191563|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191564|NCT03835871|Beclomethasone|beclomethasone|mesh-list
14682590|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
14682591|NCT00320021|Vitamins|vitamins|mesh-ancestor
14682592|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
14682593|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682594|NCT00320034|Albuterol|albuterol|mesh-list
14682595|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14682596|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
14682597|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682598|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682599|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14682600|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
14682601|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
14682602|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14682603|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14682604|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14682605|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14682606|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682607|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682608|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682609|NCT00320047|Baclofen|baclofen|mesh-list
14682610|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14682611|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682612|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14682613|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682614|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14682615|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
14682616|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
14682617|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682618|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682619|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
14682620|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
14682621|NCT00320060|Vitamins|vitamins|mesh-ancestor
14682622|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
14682623|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682624|NCT00320073|Pemetrexed|pemetrexed|mesh-list
14682625|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14682626|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682627|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682628|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682629|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14682630|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15191565|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191566|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
15191567|NCT03835871|Hormones|hormones|mesh-ancestor
14682631|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14682632|NCT00320099|Insulin|insulin|mesh-list
14682633|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14682634|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
14682635|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14682636|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14682637|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14682638|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
14682639|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14682640|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682641|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14682642|NCT00320125|Calcium|calcium|mesh-list
14727349|NCT00513266|Growth Substances|growth substances|mesh-ancestor
15191568|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682643|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14682644|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682645|NCT00320229|Abciximab|abciximab|mesh-list
14682646|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
14682647|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14682648|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14682649|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682650|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682651|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14682652|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14682653|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682654|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682655|NCT00320294|Irinotecan|irinotecan|mesh-list
14682656|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682657|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14682658|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14682659|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682660|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682661|NCT00320307|Abacavir|abacavir|mesh-list
14682662|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14682663|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14682664|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682665|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682666|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
14682667|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682668|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14682669|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14682670|NCT00320320|Irinotecan|irinotecan|mesh-list
14682671|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14682672|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14682673|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682674|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682675|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682676|NCT00320359|Cisplatin|cisplatin|mesh-list
14682677|NCT00320359|Etoposide|etoposide|mesh-list
14682678|NCT00320359|Topotecan|topotecan|mesh-list
14682679|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682680|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14682681|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14682682|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14682683|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682684|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682685|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14682686|NCT00320476|Bortezomib|bortezomib|mesh-list
14682687|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682688|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14682689|NCT00320567|Norgestimate|norgestimate|mesh-list
14682690|NCT00320567|Estradiol|estradiol|mesh-list
14682691|NCT00320567|Estrogens|estrogens|mesh-ancestor
14682692|NCT00320567|Hormones|hormones|mesh-ancestor
14682693|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682694|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682695|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14682696|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
14682697|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14682698|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14682699|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14682700|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14682701|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14682702|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14682703|NCT00320580|Norelgestromin|norelgestromin|mesh-list
14682704|NCT00320580|Estradiol|estradiol|mesh-list
14682705|NCT00320580|Estrogens|estrogens|mesh-ancestor
14682706|NCT00320580|Hormones|hormones|mesh-ancestor
14682707|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14682708|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682709|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14682710|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
14682711|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14682712|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14682713|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14682714|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14682715|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
14682716|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14682717|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14682718|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682719|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
14682720|NCT00320619|Coagulants|coagulants|mesh-ancestor
14682721|NCT00320632|Desipramine|desipramine|mesh-list
14682722|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14682723|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682724|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682725|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682726|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682727|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14682728|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14682729|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682730|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682731|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682732|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682733|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14682734|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14682735|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
14682736|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682737|NCT00320658|Antacids|antacids|mesh-ancestor
14682738|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682739|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682740|NCT00320697|Bupropion|bupropion|mesh-list
14682741|NCT00320697|Nicotine|nicotine|mesh-list
14682742|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14682743|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
14682744|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682745|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682746|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14682747|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14682748|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
14682749|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682750|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682751|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14682752|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682753|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682754|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14682755|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14682756|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682757|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
14294260|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14294261|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682758|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14682759|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14682760|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682761|NCT00320723|Bupropion|bupropion|mesh-list
14682762|NCT00320723|Nicotine|nicotine|mesh-list
14682763|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14682764|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
14682765|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682766|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682767|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14682768|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14682769|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
14682770|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682771|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682772|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14682773|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682774|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682775|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14682776|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14682777|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682778|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
14682779|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14682780|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14682781|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682782|NCT00320736|Galantamine|galantamine|mesh-list
14682783|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14682784|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682785|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682786|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
14682787|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682788|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682789|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14682790|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
14682791|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682792|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
14682793|NCT00320775|Aflibercept|aflibercept|mesh-list
14682794|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14682795|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14682796|NCT00320775|Growth Substances|growth substances|mesh-ancestor
14682797|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682798|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
14682799|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682800|NCT00320814|Aflibercept|aflibercept|mesh-list
14682801|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14682802|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14682803|NCT00320814|Growth Substances|growth substances|mesh-ancestor
14682804|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682805|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
14682806|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682807|NCT00320827|Antibodies|antibodies|mesh-list
14682808|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
14682809|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682810|NCT00320853|Vitamin D|vitamin d|mesh-list
14682811|NCT00320853|Vitamins|vitamins|mesh-ancestor
14682812|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
14682813|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682814|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14682815|NCT00320879|Irbesartan|irbesartan|mesh-list
14682816|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682817|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14682818|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14682819|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682820|NCT00320892|Atropine|atropine|mesh-list
14682821|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14682822|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14682823|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14682824|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14682825|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
14682826|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682827|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682828|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14682829|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
14682830|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
15191569|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191570|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15191571|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
14682831|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
14682832|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14682833|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14682834|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
14682835|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682836|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682837|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14682838|NCT00320970|Candesartan|candesartan|mesh-list
14682839|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14682840|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14682841|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14682842|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682843|NCT00320983|Topotecan|topotecan|mesh-list
14682844|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682845|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14682846|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14682847|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682848|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682849|NCT00321009|Enoxaparin|enoxaparin|mesh-list
14682850|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
14682851|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14682852|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14682853|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682854|NCT00321074|Tacrolimus|tacrolimus|mesh-list
14682855|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682856|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
14294262|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14682857|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682858|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14682859|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682860|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682861|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
14682862|NCT00321113|Tacrolimus|tacrolimus|mesh-list
14682863|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14682864|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
14682865|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682866|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14682867|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682868|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682869|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14682870|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682871|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14682872|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
14682873|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682874|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682875|NCT00321126|Zinc|zinc|mesh-list
15191572|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
15191573|NCT03835507|Hematinics|hematinics|mesh-ancestor
15191574|NCT03835533|Nivolumab|nivolumab|mesh-list
15191575|NCT03835533|Poly ICLC|poly iclc|mesh-list
15191576|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191577|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191578|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14682876|NCT00321126|Trace Elements|trace elements|mesh-ancestor
14682877|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
14682878|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682879|NCT00321165|Taurolidine|taurolidine|mesh-list
14682880|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14682881|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14682882|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682883|NCT00321178|Clarithromycin|clarithromycin|mesh-list
14682884|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14682885|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191579|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191580|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
15191581|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
15191582|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682886|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14682887|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682888|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682889|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14682890|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14682891|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
14682892|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14682893|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
14682894|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
14682895|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682896|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682897|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14682898|NCT00321191|Analgesics|analgesics|mesh-ancestor
14682899|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
14682900|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727350|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727351|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
14727352|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14727353|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
14727354|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727355|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727356|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727357|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
14727358|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14727359|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727360|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727361|NCT00513266|Antidotes|antidotes|mesh-ancestor
14727362|NCT00513266|Protective Agents|protective agents|mesh-ancestor
14727363|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
14727364|NCT00513266|Vitamins|vitamins|mesh-ancestor
14727365|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
14729316|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14729317|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729318|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729319|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729320|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14729321|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729322|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
14729323|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729324|NCT00522743|Hormones|hormones|mesh-list
14729325|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729326|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729327|NCT00522782|Budesonide|budesonide|mesh-list
14729328|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
14729329|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729330|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14729331|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
14729332|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729333|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729334|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14729335|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
14729336|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
14729337|NCT00522782|Hormones|hormones|mesh-ancestor
14729338|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729339|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14729340|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
14729341|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191583|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
15191584|NCT03835286|Vitamins|vitamins|mesh-ancestor
14729342|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191585|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
15191586|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191587|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
15191588|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191589|NCT03835286|Protective Agents|protective agents|mesh-ancestor
15191590|NCT03834766|Amphetamine|amphetamine|mesh-list
15191591|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15191592|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191593|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
15191594|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
15191595|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191596|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
15191597|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191598|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294263|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14294264|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14294265|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294266|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294267|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
14294268|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294269|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294270|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14682901|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
14682902|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14682903|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
14682904|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682905|NCT00321230|Protective Agents|protective agents|mesh-ancestor
14682906|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682907|NCT00321230|Vitamins|vitamins|mesh-ancestor
14682908|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
14682909|NCT00321230|Laxatives|laxatives|mesh-ancestor
14682910|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682911|NCT00321347|Lidocaine|lidocaine|mesh-list
14682912|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
14682913|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
14682914|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682915|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682916|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
14682917|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682918|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14682919|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14294271|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
14294272|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14682920|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14682921|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682922|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682923|NCT00321360|Propofol|propofol|mesh-list
14682924|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14682925|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294273|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14294274|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14294275|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14294276|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682926|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682927|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14682928|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
14682929|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
15191599|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
14682930|NCT00321477|Casopitant|casopitant|mesh-list
14682931|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
14682932|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
14682933|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682934|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682935|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14682936|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14682937|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814841|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814842|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814843|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814844|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814845|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814846|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
14814847|NCT00864435|Protective Agents|protective agents|mesh-ancestor
14814848|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14814849|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814850|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14814851|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814852|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14814853|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14814854|NCT00864448|Ramipril|ramipril|mesh-list
14814855|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14814856|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
14814857|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814858|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814859|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814860|NCT00864474|Maraviroc|maraviroc|mesh-list
14814861|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14814862|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14814863|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814864|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14814865|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14814866|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
14814867|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814868|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14814869|NCT00864500|Clobetasol|clobetasol|mesh-list
14814870|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814871|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
14814872|NCT00864500|Hormones|hormones|mesh-ancestor
15191600|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15191601|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15191602|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814873|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14814874|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814875|NCT00864526|Ibuprofen|ibuprofen|mesh-list
14814876|NCT00864526|Oxycodone|oxycodone|mesh-list
14814877|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14814878|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14814879|NCT00864526|Analgesics|analgesics|mesh-ancestor
14814880|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
14814881|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814882|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814883|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814884|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814885|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14814886|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814887|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814888|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14814889|NCT00864526|Narcotics|narcotics|mesh-ancestor
14682938|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682939|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14682940|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14682941|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682942|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682943|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14682944|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14682945|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682946|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682947|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14682948|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14814890|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682949|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14682950|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682951|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682952|NCT00321490|Analgesics|analgesics|mesh-ancestor
14682953|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
14682954|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682955|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
14682956|NCT00321516|Aripiprazole|aripiprazole|mesh-list
14682957|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
14682958|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14682959|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14682960|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14682961|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14682962|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682963|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
14682964|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
14682965|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14682966|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682967|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14682968|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14682969|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
14682970|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14682971|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14682972|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14682973|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14682974|NCT00321581|Cediranib|cediranib|mesh-list
14682975|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682976|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14682977|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682978|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682979|NCT00321633|Carboplatin|carboplatin|mesh-list
14682980|NCT00321633|Docetaxel|docetaxel|mesh-list
14682981|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682982|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
14682983|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
14682984|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
14682985|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682986|NCT00321724|Cediranib|cediranib|mesh-list
14682987|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14682988|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14682989|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14682990|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14682991|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
14682992|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14682993|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14682994|NCT00321750|Analgesics|analgesics|mesh-ancestor
14682995|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
14682996|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14682997|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14682998|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14682999|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683000|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14683001|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683002|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
14683003|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14683004|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683005|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683006|NCT00321802|Simvastatin|simvastatin|mesh-list
14683007|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14683008|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14683009|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
14683010|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683011|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14683012|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14683013|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683014|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14683015|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14683016|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
14683017|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683018|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683019|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
15191603|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15191604|NCT03834831|Selenium|selenium|mesh-list
14683020|NCT00322036|Analgesics|analgesics|mesh-ancestor
14683021|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
14683022|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683023|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683024|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14683025|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14683026|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14683027|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683028|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14683029|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683030|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683031|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
14683032|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14683033|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
14683034|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683035|NCT00322062|Protective Agents|protective agents|mesh-ancestor
14683036|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683037|NCT00322062|Vitamins|vitamins|mesh-ancestor
14683038|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
14683039|NCT00322062|Laxatives|laxatives|mesh-ancestor
14683040|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683041|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
14683042|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14683043|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683044|NCT00322114|Lycopene|lycopene|mesh-list
14683045|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14683046|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
14683047|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683048|NCT00322114|Protective Agents|protective agents|mesh-ancestor
14683049|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683050|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14683051|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14683052|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683053|NCT00322127|Plerixafor|plerixafor|mesh-list
14683054|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14683055|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14683056|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
14683057|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683058|NCT00322166|Calcium|calcium|mesh-list
14683059|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683060|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683061|NCT00322296|Bexarotene|bexarotene|mesh-list
14683062|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683063|NCT00322400|Paclitaxel|paclitaxel|mesh-list
14683064|NCT00322400|Docetaxel|docetaxel|mesh-list
14683065|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
14683066|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14683067|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683068|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
14683069|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
14683070|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
14294277|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294278|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14294279|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14294280|NCT00574834|Ramipril|ramipril|mesh-list
14294281|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14294282|NCT00574834|Diuretics|diuretics|mesh-ancestor
14683071|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683072|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14683073|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294283|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
14683074|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
14683075|NCT00322413|Hematinics|hematinics|mesh-ancestor
14683076|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
14727366|NCT00513383|Paclitaxel|paclitaxel|mesh-list
15191605|NCT03834831|Ubiquinone|ubiquinone|mesh-list
15191606|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
15191607|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
15191608|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683077|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14683078|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14683079|NCT00322543|Analgesics|analgesics|mesh-ancestor
14683080|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
14683081|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683082|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683083|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14683084|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683085|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
14683086|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683087|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
14683088|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14683089|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683090|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683091|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
14683092|NCT00322569|Paclitaxel|paclitaxel|mesh-list
14683093|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14683094|NCT00322569|Tacrolimus|tacrolimus|mesh-list
14683095|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14683096|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683097|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
14683098|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
14683099|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
14683100|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683101|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14683102|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14683103|NCT00322569|Analgesics|analgesics|mesh-ancestor
14683104|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
14683105|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683106|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683107|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14683108|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683109|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
14683110|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683111|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
14683112|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14683113|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683114|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14683115|NCT00322595|Paroxetine|paroxetine|mesh-list
14683116|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
14683117|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14683118|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14683119|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683120|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683121|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683122|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14683123|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14683124|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683125|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683126|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683127|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
14683128|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14683129|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15191609|NCT03834831|Protective Agents|protective agents|mesh-ancestor
15191610|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191611|NCT03834831|Trace Elements|trace elements|mesh-ancestor
14683130|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15191612|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
15191613|NCT03834831|Vitamins|vitamins|mesh-ancestor
15191614|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
15191615|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15191616|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191617|NCT03834935|Analgesics|analgesics|mesh-ancestor
15191618|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
15191619|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191620|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191621|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191622|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683131|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683132|NCT00322660|Epinephrine|epinephrine|mesh-list
14683133|NCT00322660|Racepinephrine|racepinephrine|mesh-list
14683134|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
14683135|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14683136|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14683137|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
14683138|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683139|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683140|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683141|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14683142|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14683143|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
14683144|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683145|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14683146|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
14683147|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
14683148|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
14683149|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14683150|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14683151|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14683152|NCT00322699|Trioxsalen|trioxsalen|mesh-list
14683153|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683154|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
14683155|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14683156|NCT00322751|Topotecan|topotecan|mesh-list
14683157|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14683158|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683159|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683160|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683161|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683162|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
14683163|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
14683164|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14683165|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683166|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683167|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683168|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14683169|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14683170|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
14683171|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
14683172|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683173|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683174|NCT00322907|Mefloquine|mefloquine|mesh-list
14683175|NCT00322907|Quinine|quinine|mesh-list
14683176|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
14683177|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14683178|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14683179|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683180|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14683181|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683182|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14683183|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683184|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14683185|NCT00322907|Analgesics|analgesics|mesh-ancestor
14683186|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
14683187|NCT00322920|Topotecan|topotecan|mesh-list
14683188|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683189|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14683190|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683191|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683192|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683193|NCT00322972|Azithromycin|azithromycin|mesh-list
14683194|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683195|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683196|NCT00322985|Lenalidomide|lenalidomide|mesh-list
14683197|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
14683198|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683199|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14683200|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14683201|NCT00322985|Growth Substances|growth substances|mesh-ancestor
14683202|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
14683203|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683204|NCT00323011|Leucovorin|leucovorin|mesh-list
14683205|NCT00323011|Folic Acid|folic acid|mesh-list
14683206|NCT00323011|Bevacizumab|bevacizumab|mesh-list
14683207|NCT00323011|Fluorouracil|fluorouracil|mesh-list
14683208|NCT00323011|Irinotecan|irinotecan|mesh-list
14683209|NCT00323011|Dalteparin|dalteparin|mesh-list
14683210|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
14683211|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14683212|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683213|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14683214|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14683215|NCT00323011|Growth Substances|growth substances|mesh-ancestor
14683216|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683217|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
14683218|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
14683219|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683220|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14683221|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683222|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
14683223|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14683224|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683225|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683226|NCT00323011|Antidotes|antidotes|mesh-ancestor
14683227|NCT00323011|Protective Agents|protective agents|mesh-ancestor
14683228|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
14683229|NCT00323011|Vitamins|vitamins|mesh-ancestor
14683230|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
14683231|NCT00323011|Hematinics|hematinics|mesh-ancestor
14683232|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
14683233|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14683234|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14683235|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14683236|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14683237|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683238|NCT00323154|Nalbuphine|nalbuphine|mesh-list
14683239|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14683240|NCT00323154|Narcotics|narcotics|mesh-ancestor
14683241|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683242|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683243|NCT00323154|Analgesics|analgesics|mesh-ancestor
14683244|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
14683245|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683246|NCT00323206|Interleukin-12|interleukin-12|mesh-list
14683247|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14683248|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
14683249|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683250|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14683251|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14683252|NCT00323206|Growth Substances|growth substances|mesh-ancestor
14683253|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
14683254|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683255|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
14683256|NCT00323219|Cefazolin|cefazolin|mesh-list
14683257|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683258|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683259|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15191623|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
15191624|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683260|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683261|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683262|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191625|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
15191626|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15191627|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191628|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191629|NCT03834883|Ibutilide|ibutilide|mesh-list
15191630|NCT03834883|Progesterone|progesterone|mesh-list
15191631|NCT03834883|Progestins|progestins|mesh-ancestor
15191632|NCT03834883|Hormones|hormones|mesh-ancestor
15191633|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683263|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683264|NCT00323323|Prednisone|prednisone|mesh-list
14683265|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
14683266|NCT00323323|Doxorubicin|doxorubicin|mesh-list
14683267|NCT00323323|Vincristine|vincristine|mesh-list
14683268|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
14683269|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683270|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
15191634|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191635|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15191636|NCT03835065|Calpastatin|calpastatin|mesh-list
15191637|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14683271|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683272|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683273|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14683274|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
14683275|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683276|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683277|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14683278|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14683279|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14683280|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683281|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683282|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14683283|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
14683284|NCT00323323|Hormones|hormones|mesh-ancestor
14683285|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683286|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14683287|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14683288|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
14683289|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
14683290|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
14683291|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14683292|NCT00323375|Chloroquine|chloroquine|mesh-list
14683293|NCT00323375|Amebicides|amebicides|mesh-ancestor
14683294|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14683295|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14683296|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683297|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
14683298|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727367|NCT00513383|Docetaxel|docetaxel|mesh-list
15191638|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
15191639|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191640|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191641|NCT03834610|Tadalafil|tadalafil|mesh-list
15191642|NCT03834610|Testosterone|testosterone|mesh-list
15191643|NCT03834610|Androgens|androgens|mesh-ancestor
15191644|NCT03834610|Hormones|hormones|mesh-ancestor
15191645|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191646|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191647|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
15191648|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15191649|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15191650|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191651|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191652|NCT03834610|Urological Agents|urological agents|mesh-ancestor
15191653|NCT03834623|Nivolumab|nivolumab|mesh-list
15191654|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191655|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191656|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15191657|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191658|NCT03834454|Bupivacaine|bupivacaine|mesh-list
15191659|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
15191660|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
14727368|NCT00513383|Carboplatin|carboplatin|mesh-list
14727369|NCT00513383|Fluorouracil|fluorouracil|mesh-list
14727370|NCT00513383|Panitumumab|panitumumab|mesh-list
14727371|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727372|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727373|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
14727374|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727375|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
15191661|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191662|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191663|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
15191664|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191665|NCT03834506|Dexamethasone|dexamethasone|mesh-list
15191666|NCT03834506|Prednisone|prednisone|mesh-list
15191667|NCT03834506|Docetaxel|docetaxel|mesh-list
15191668|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
15191669|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727376|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727377|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
15191670|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
14683299|NCT00323505|Interferons|interferons|mesh-list
14683300|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
14683301|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
14683302|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683303|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
14683304|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683305|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
14683306|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683307|NCT00323544|Tenofovir|tenofovir|mesh-list
14683308|NCT00323544|Lamivudine|lamivudine|mesh-list
14683309|NCT00323544|Zidovudine|zidovudine|mesh-list
14683310|NCT00323544|Emtricitabine|emtricitabine|mesh-list
14683311|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14683312|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
14683313|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683314|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14683315|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14683316|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683317|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683318|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14683319|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14683320|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
14683321|NCT00323583|Leucovorin|leucovorin|mesh-list
14683322|NCT00323583|Paclitaxel|paclitaxel|mesh-list
14683323|NCT00323583|Fluorouracil|fluorouracil|mesh-list
14683324|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
14683325|NCT00323583|Calcium|calcium|mesh-list
14683326|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14683327|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683328|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
14683329|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
14683330|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
14683331|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683332|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683333|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683334|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
14683335|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14683336|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683337|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
14683338|NCT00323583|Antidotes|antidotes|mesh-ancestor
14683339|NCT00323583|Protective Agents|protective agents|mesh-ancestor
14683340|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
14683341|NCT00323583|Vitamins|vitamins|mesh-ancestor
14683342|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
14683343|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14683344|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683345|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14683346|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14683347|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14683348|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683349|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683350|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
14683351|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683352|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14683353|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14683354|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
14683355|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14683356|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
14683357|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683358|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
14683359|NCT00323778|Protective Agents|protective agents|mesh-ancestor
14683360|NCT00323791|Gemcitabine|gemcitabine|mesh-list
14683361|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
14683362|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14683363|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
14683364|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683365|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683366|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
14683367|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683368|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683369|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683370|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
14683371|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683372|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14683373|NCT00323804|Ribavirin|ribavirin|mesh-list
14683374|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14683375|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
14683376|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683377|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
14683378|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683379|NCT00323817|Z 338|z 338|mesh-list
14683380|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14683381|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683382|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683383|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
14683384|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683385|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683386|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683387|NCT00323830|Capecitabine|capecitabine|mesh-list
14683388|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683389|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14683390|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
14683391|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683392|NCT00323843|Isoproterenol|isoproterenol|mesh-list
14683393|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14683394|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14683395|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
14683396|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683397|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683398|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683399|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14683400|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
14683401|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683402|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14683403|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14683404|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14683405|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
14683406|NCT00323843|Protective Agents|protective agents|mesh-ancestor
14683407|NCT00323856|Factor VIII|factor viii|mesh-list
14683408|NCT00323856|Coagulants|coagulants|mesh-ancestor
14683409|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
14683410|NCT00323934|Mocetinostat|mocetinostat|mesh-list
14683411|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14683412|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191671|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
15191672|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191673|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191674|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683413|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683414|NCT00323947|Methylphenidate|methylphenidate|mesh-list
14683415|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14683416|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683417|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14683418|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15191675|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
15191676|NCT03834506|Hormones|hormones|mesh-ancestor
15191677|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191678|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15191679|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191680|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
15191681|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
15191682|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
15191683|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191684|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191685|NCT03834571|Paclitaxel|paclitaxel|mesh-list
15191686|NCT03834571|Cisplatin|cisplatin|mesh-list
15191687|NCT03834571|Carboplatin|carboplatin|mesh-list
15191688|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15191689|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15191690|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191691|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
15191692|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
15191693|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
15191694|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191695|NCT03834233|Nivolumab|nivolumab|mesh-list
15191696|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191697|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191698|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15191699|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191700|NCT03833999|Ondansetron|ondansetron|mesh-list
15191701|NCT03833999|Lactulose|lactulose|mesh-list
15191702|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
14294284|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683419|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683420|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683421|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
14683422|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683423|NCT00323973|Bisoprolol|bisoprolol|mesh-list
14683424|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14683425|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
14683426|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
14683427|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683428|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683429|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14683430|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14683431|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14683432|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
14683433|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683434|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683435|NCT00323986|Azithromycin|azithromycin|mesh-list
14683436|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683437|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683438|NCT00324012|Docetaxel|docetaxel|mesh-list
14683439|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683440|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14683441|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14683442|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14683443|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683444|NCT00324025|Efungumab|efungumab|mesh-list
14683445|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
14683446|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683447|NCT00324051|Olanzapine|olanzapine|mesh-list
14683448|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
14683449|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
14683450|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683451|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683452|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683453|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14683454|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683455|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683456|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14683457|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14683458|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14683459|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683460|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683461|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683462|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
14683463|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
14683464|NCT00324077|Dasatinib|dasatinib|mesh-list
14683465|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683466|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14683467|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683468|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683469|NCT00324129|Mocetinostat|mocetinostat|mesh-list
14683470|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14683471|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683472|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683473|NCT00324142|Tinidazole|tinidazole|mesh-list
14683474|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
14683475|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683476|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683477|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683478|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14294285|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14294286|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327528|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683479|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14683480|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14683481|NCT00324194|Mocetinostat|mocetinostat|mesh-list
14683482|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14683483|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814891|NCT00864552|Factor VIII|factor viii|mesh-list
15191703|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
15191704|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191705|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191706|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191707|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
15191708|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
15191709|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15191710|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
15191711|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191712|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191713|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15191714|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683484|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683485|NCT00324298|Etoposide|etoposide|mesh-list
14683486|NCT00324298|Bleomycin|bleomycin|mesh-list
14683487|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683488|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14683489|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14683490|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683491|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683492|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683493|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14683494|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
14683495|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14683496|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683497|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683498|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14683499|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683500|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683501|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683502|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683503|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14683504|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
14683505|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14683506|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683507|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14683508|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14683509|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14683510|NCT00324363|Exenatide|exenatide|mesh-list
14683511|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14814892|NCT00864552|Coagulants|coagulants|mesh-ancestor
14814893|NCT00864565|Fentanyl|fentanyl|mesh-list
14814894|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14814895|NCT00864565|Narcotics|narcotics|mesh-ancestor
14814896|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683512|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683513|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14683514|NCT00324363|Incretins|incretins|mesh-ancestor
14683515|NCT00324363|Hormones|hormones|mesh-ancestor
14683516|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683517|NCT00324376|Sevelamer|sevelamer|mesh-list
14683518|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
14683519|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
14814897|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814898|NCT00864565|Analgesics|analgesics|mesh-ancestor
14814899|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
14814900|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727378|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14814901|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14683520|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683521|NCT00324389|Interferons|interferons|mesh-list
14683522|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
14683523|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683524|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
14683525|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683526|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
14683527|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683528|NCT00324454|Levetiracetam|levetiracetam|mesh-list
14683529|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
14683530|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
14683531|NCT00324467|Acetaminophen|acetaminophen|mesh-list
14683532|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
14683533|NCT00324467|Promethazine|promethazine|mesh-list
14683534|NCT00324467|Dexamethasone|dexamethasone|mesh-list
14683535|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
14683536|NCT00324467|Prednisone|prednisone|mesh-list
14683537|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
14683538|NCT00324467|Ifosfamide|ifosfamide|mesh-list
14294287|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294288|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14294289|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
14294290|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294291|NCT00574847|Citalopram|citalopram|mesh-list
14294292|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14294293|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14683539|NCT00324467|Rituximab|rituximab|mesh-list
14683540|NCT00324467|Carboplatin|carboplatin|mesh-list
14683541|NCT00324467|Doxorubicin|doxorubicin|mesh-list
14683542|NCT00324467|Etoposide|etoposide|mesh-list
14683543|NCT00324467|Vincristine|vincristine|mesh-list
14683544|NCT00324467|Ondansetron|ondansetron|mesh-list
14683545|NCT00324467|BB 1101|bb 1101|mesh-list
14683546|NCT00324467|Mesna|mesna|mesh-list
14683547|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683548|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
14683549|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683550|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683551|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14683552|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
14683553|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683554|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683555|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14683556|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14683557|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
14683558|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
14683559|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683560|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683561|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
14683562|NCT00324467|Hormones|hormones|mesh-ancestor
14683563|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683564|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14683565|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
14683566|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683567|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14683568|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14683569|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14683570|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683571|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14683572|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
14683573|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
14683574|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
14683575|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14683576|NCT00324467|Analgesics|analgesics|mesh-ancestor
14683577|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
14683578|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
14683579|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
14683580|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
14683581|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14683582|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
14683583|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683584|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14683585|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683586|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683587|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14683588|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14683589|NCT00324467|Protective Agents|protective agents|mesh-ancestor
14683590|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14683591|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14683592|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
14683593|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
14683594|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14683595|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
14683596|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
14683597|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14683598|NCT00324480|Vorinostat|vorinostat|mesh-list
14683599|NCT00324480|Alvocidib|alvocidib|mesh-list
14683600|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683601|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14683602|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683603|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683604|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
14683605|NCT00324480|Growth Substances|growth substances|mesh-ancestor
14683606|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683607|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14683608|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
14683609|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14683610|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683611|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14683612|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
14683613|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683614|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683615|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683616|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683617|NCT00324519|Misoprostol|misoprostol|mesh-list
14683618|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14683619|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
14683620|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14683621|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683622|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14683623|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683624|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
14683625|NCT00324558|Bemiparin|bemiparin|mesh-list
14683626|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
14683627|NCT00324571|Calcium|calcium|mesh-list
14683628|NCT00324571|Sevelamer|sevelamer|mesh-list
14683629|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683630|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683631|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
14683632|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
14683633|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683634|NCT00324597|Gemcitabine|gemcitabine|mesh-list
14683635|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
14683636|NCT00324597|Imetelstat|imetelstat|mesh-list
14683637|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14683638|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
14683639|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683640|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683641|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
14683642|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683643|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683644|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683645|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
14683646|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683647|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14683648|NCT00324610|Capecitabine|capecitabine|mesh-list
14683649|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14683650|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
14683651|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683652|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683653|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
14683654|NCT00324623|Fludarabine|fludarabine|mesh-list
14683655|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
14683656|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683657|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
14683658|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683659|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683660|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14683661|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
14683662|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683663|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683664|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14683665|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14683666|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
14683667|NCT00324688|Tenofovir|tenofovir|mesh-list
14683668|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
14683669|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683670|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14683671|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14683672|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683673|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683674|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14683675|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14683676|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
14683677|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14683678|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683679|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683680|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683681|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683682|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14683683|NCT00324727|Melphalan|melphalan|mesh-list
14683684|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14683685|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
14683686|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191715|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191716|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15191717|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15191718|NCT03834012|Beclomethasone|beclomethasone|mesh-list
15191719|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191720|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
15191721|NCT03834012|Hormones|hormones|mesh-ancestor
15191722|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683687|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683688|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14683689|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683690|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
14683691|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683692|NCT00324766|Simendan|simendan|mesh-list
14683693|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15191723|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191724|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15191725|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191726|NCT03833921|Prednisone|prednisone|mesh-list
14683694|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
14683695|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14683696|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14683697|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683698|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683699|NCT00324766|Protective Agents|protective agents|mesh-ancestor
14683700|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683701|NCT00324779|Rituximab|rituximab|mesh-list
14683702|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14683703|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683704|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
14683705|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683706|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683707|NCT00324792|Insulin|insulin|mesh-list
14683708|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14683709|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683710|NCT00324818|Azithromycin|azithromycin|mesh-list
14683711|NCT00324818|Metronidazole|metronidazole|mesh-list
14683712|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683713|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683714|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14683715|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14683716|NCT00324831|Prednisone|prednisone|mesh-list
14683717|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
14683718|NCT00324831|Rituximab|rituximab|mesh-list
14683719|NCT00324831|Doxorubicin|doxorubicin|mesh-list
14683720|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14683721|NCT00324831|Vincristine|vincristine|mesh-list
14683722|NCT00324831|Vaccines|vaccines|mesh-list
14683723|NCT00324831|Antibodies|antibodies|mesh-list
14683724|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
14683725|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14683726|NCT00324831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14683727|NCT00324831|Sargramostim|sargramostim|mesh-list
14683728|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14683729|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
14683730|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683731|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683732|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14683733|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14683734|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
14683735|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683736|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683737|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14683738|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14683739|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14683740|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14683741|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14683742|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683743|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14683744|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
14683745|NCT00324831|Hormones|hormones|mesh-ancestor
14683746|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683747|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14683748|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14683749|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
14683750|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
14683751|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
14683752|NCT00324922|Vancomycin|vancomycin|mesh-list
14683753|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14683754|NCT00324922|Trimethoprim|trimethoprim|mesh-list
14683755|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
14683756|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14683757|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14683758|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14683759|NCT00324922|Renal Agents|renal agents|mesh-ancestor
14683760|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
14683761|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14683762|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14683763|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14683764|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683765|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683766|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14683767|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14683768|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14683769|NCT00324948|Alprostadil|alprostadil|mesh-list
14683770|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14683771|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
14683772|NCT00324948|Urological Agents|urological agents|mesh-ancestor
14683773|NCT00324974|Lansoprazole|lansoprazole|mesh-list
14683774|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
14683775|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14683776|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683777|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15191727|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
15191728|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191729|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
15191730|NCT03833921|Hormones|hormones|mesh-ancestor
15191731|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191732|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191733|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14683778|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683779|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683780|NCT00325000|Amitriptyline|amitriptyline|mesh-list
14683781|NCT00325000|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14683782|NCT00325000|Sertraline|sertraline|mesh-list
14683783|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
14683784|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14683785|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14683786|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14683787|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683788|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683789|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683790|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
14683791|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683792|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14683793|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14683794|NCT00325000|Analgesics|analgesics|mesh-ancestor
14683795|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
14683796|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683797|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14683798|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
14683799|NCT00325000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14683800|NCT00325000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683801|NCT00325000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683802|NCT00325026|Misoprostol|misoprostol|mesh-list
14683803|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14683804|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
14683805|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14683806|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683807|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15191734|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191735|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15191736|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191737|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191738|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
15191739|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15191740|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
15191741|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15191742|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191743|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191744|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191745|NCT03834129|Analgesics|analgesics|mesh-ancestor
15191746|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
15191747|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191748|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15191749|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15191750|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15191751|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
15191752|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191753|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683808|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683809|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
14683810|NCT00325104|Calcium|calcium|mesh-list
14683811|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
14683812|NCT00325104|Hormones|hormones|mesh-list
14683813|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683814|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683815|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683816|NCT00325117|Vildagliptin|vildagliptin|mesh-list
14683817|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14683818|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683819|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14683820|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
14683821|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683822|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683823|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
14683824|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14683825|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14683826|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
14683827|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683828|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683829|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14683830|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
14683831|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
14683832|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14683833|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
14683834|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683835|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683836|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
14683837|NCT00325169|Hormones|hormones|mesh-ancestor
14683838|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683839|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
14683840|NCT00325182|Levetiracetam|levetiracetam|mesh-list
14683841|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
14683842|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
14327529|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
14683843|NCT00325286|Carbamazepine|carbamazepine|mesh-list
14683844|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14683845|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683846|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
14683847|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683848|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683849|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683850|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
14683851|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14683852|NCT00325286|Analgesics|analgesics|mesh-ancestor
14683853|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
14683854|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683855|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14683856|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683857|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14683858|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14727379|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727380|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
14727381|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727382|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14727383|NCT00513396|Isoniazid|isoniazid|mesh-list
14727384|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
14727385|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14727386|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727387|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14727388|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14727389|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
14727390|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727391|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14727392|NCT00513487|Fluticasone|fluticasone|mesh-list
14727393|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
14727394|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727395|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14727396|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
14727397|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727398|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727399|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14727400|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
14727401|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727402|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14727403|NCT00513487|Miotics|miotics|mesh-ancestor
14727404|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14727405|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14727406|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14727407|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14727408|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
14727409|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727410|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727411|NCT00513513|Ritonavir|ritonavir|mesh-list
14727412|NCT00513513|Darunavir|darunavir|mesh-list
14727413|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14727414|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14727415|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
14727416|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727417|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727418|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14727419|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15191754|NCT03833895|Phenylephrine|phenylephrine|mesh-list
15191755|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
15191756|NCT03833895|Norepinephrine|norepinephrine|mesh-list
15191757|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15191758|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
15191759|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
15191760|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191761|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191762|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
15191763|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15191764|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
15191765|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191766|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15191767|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14727420|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
14727421|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727422|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15191768|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14683859|NCT00325325|Everolimus|everolimus|mesh-list
14683860|NCT00325325|Tacrolimus|tacrolimus|mesh-list
14683861|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14683862|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
14683863|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683864|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14683865|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683866|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683867|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683868|NCT00325351|Carboplatin|carboplatin|mesh-list
14683869|NCT00325351|Sagopilone|sagopilone|mesh-list
14683870|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14683871|NCT00325390|Clopidogrel|clopidogrel|mesh-list
14683872|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14683873|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14683874|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14683875|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14683876|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
14683877|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683878|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683879|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683880|NCT00325429|Vildagliptin|vildagliptin|mesh-list
14683881|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14683882|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683883|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14683884|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
14683885|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683886|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683887|NCT00325455|Anacetrapib|anacetrapib|mesh-list
14683888|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14683889|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14683890|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
14683891|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683892|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14683893|NCT00325546|Rimonabant|rimonabant|mesh-list
14683894|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14683895|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14683896|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14683897|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683898|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683899|NCT00325546|Hormones|hormones|mesh-ancestor
14683900|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14683901|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683902|NCT00325637|Losartan|losartan|mesh-list
14683903|NCT00325637|Cilnidipine|cilnidipine|mesh-list
14683904|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14683905|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14683906|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14683907|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14683908|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683909|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14683910|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683911|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683912|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683913|NCT00325676|Pantoprazole|pantoprazole|mesh-list
14683914|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14683915|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683916|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14683917|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683918|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683919|NCT00325689|Risperidone|risperidone|mesh-list
14814902|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14814903|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
14814904|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
14814905|NCT00864591|Adenosine|adenosine|mesh-list
14814906|NCT00864591|Analgesics|analgesics|mesh-ancestor
14814907|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
14814908|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814909|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814910|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14814911|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814912|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14814913|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
14683920|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14683921|NCT00325689|Aripiprazole|aripiprazole|mesh-list
14683922|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14683923|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
14683924|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683925|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683926|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683927|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14683928|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14683929|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683930|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14683931|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14683932|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
14683933|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
14683934|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
14683935|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14683936|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14683937|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14683938|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14683939|NCT00325715|Esomeprazole|esomeprazole|mesh-list
14683940|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14683941|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14683942|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14683943|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683944|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683945|NCT00325767|Albuterol|albuterol|mesh-list
15191769|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
15191770|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191771|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191772|NCT03833895|Protective Agents|protective agents|mesh-ancestor
15191773|NCT03833947|Dexamethasone|dexamethasone|mesh-list
15191774|NCT03833947|Lidocaine|lidocaine|mesh-list
15191775|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191776|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
14683946|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14683947|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
14683948|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683949|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683950|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14683951|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
15191777|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
15191778|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191779|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191780|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15191781|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
15191782|NCT03833947|Hormones|hormones|mesh-ancestor
15191783|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191784|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15191785|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191786|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
15191787|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
15191788|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191789|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
15191790|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15191791|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15191792|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15191793|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191794|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224035|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224036|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15224037|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15224038|NCT04770272|Paclitaxel|paclitaxel|mesh-list
14683952|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
14683953|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14683954|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14683955|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14683956|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14683957|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
14683958|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14683959|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683960|NCT00325793|Nicardipine|nicardipine|mesh-list
14683961|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15224039|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
15191795|NCT03833596|Prednisone|prednisone|mesh-list
15191796|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191797|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
15191798|NCT03833596|Hormones|hormones|mesh-ancestor
15191799|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191800|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191801|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15191802|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191803|NCT03833466|Metformin|metformin|mesh-list
15191804|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15191805|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191806|NCT03833570|Melatonin|melatonin|mesh-list
15191807|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
15191808|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191809|NCT03833570|Protective Agents|protective agents|mesh-ancestor
15191810|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191811|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14683962|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14683963|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683964|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683965|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683966|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683967|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
14683968|NCT00325806|Ramipril|ramipril|mesh-list
14683969|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14683970|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
14683971|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191812|NCT03833362|Interferons|interferons|mesh-list
15191813|NCT03833362|Ritonavir|ritonavir|mesh-list
15191814|NCT03833362|Ribavirin|ribavirin|mesh-list
15191815|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
15191816|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
15191817|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15191818|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15191819|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191820|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
15191821|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191822|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15191823|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15191824|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
15191825|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14683972|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683973|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14683974|NCT00325845|Hylan|hylan|mesh-list
14683975|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
15191826|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191827|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14683976|NCT00325845|Protective Agents|protective agents|mesh-ancestor
14683977|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683978|NCT00325858|Tramadol|tramadol|mesh-list
14683979|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14683980|NCT00325858|Narcotics|narcotics|mesh-ancestor
14683981|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294294|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294295|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191828|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15191829|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14683982|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683983|NCT00325858|Analgesics|analgesics|mesh-ancestor
14683984|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
14294296|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294297|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
14294298|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683985|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14683986|NCT00325910|Metformin|metformin|mesh-list
14683987|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14683988|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683989|NCT00325936|Cilnidipine|cilnidipine|mesh-list
14683990|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14683991|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14683992|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14683993|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14683994|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14683995|NCT00325949|Acetaminophen|acetaminophen|mesh-list
14683996|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14683997|NCT00325949|Hydrocodone|hydrocodone|mesh-list
14683998|NCT00325949|Oxycodone|oxycodone|mesh-list
14683999|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684000|NCT00325949|Analgesics|analgesics|mesh-ancestor
14684001|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
14684002|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684003|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684004|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
14684005|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14684006|NCT00325949|Narcotics|narcotics|mesh-ancestor
14684007|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684008|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
14684009|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
14684010|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14684011|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684012|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14684013|NCT00325962|Verapamil|verapamil|mesh-list
14684014|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14684015|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14684016|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294299|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15191830|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15191831|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
15191832|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
14294300|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684017|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684018|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14684019|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684020|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
14684021|NCT00326027|Pantoprazole|pantoprazole|mesh-list
14684022|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14684023|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14684024|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14684025|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684026|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684027|NCT00326053|Budesonide|budesonide|mesh-list
14684028|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
14684029|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191833|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191834|NCT03833440|Docetaxel|docetaxel|mesh-list
15191835|NCT03833440|Durvalumab|durvalumab|mesh-list
15191836|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191837|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
15191838|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
14684030|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15191839|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
14684031|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
14684032|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684033|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684034|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14684035|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
14684036|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
14684037|NCT00326053|Hormones|hormones|mesh-ancestor
14684038|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684039|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14684040|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14684041|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14684042|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
14684043|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684044|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684045|NCT00326092|Timolol|timolol|mesh-list
14684046|NCT00326092|Brinzolamide|brinzolamide|mesh-list
14684047|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14684048|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14684049|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
14684050|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684051|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684052|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684053|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14684054|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14684055|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14684056|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684057|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14684058|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684059|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684060|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684061|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684062|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684063|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684064|NCT00326131|Taxane|taxane|mesh-list
14684065|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684066|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14684067|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684068|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684069|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684070|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684071|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684072|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684073|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14684074|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
14684075|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684076|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14684077|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14684078|NCT00326235|Buspirone|buspirone|mesh-list
14684079|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14684080|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684081|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684082|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684083|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684084|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14684085|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
14684086|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684087|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684088|NCT00326248|Casopitant|casopitant|mesh-list
14684089|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
14684090|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
14684091|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684092|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684093|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14684094|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14684095|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684096|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684097|NCT00326300|Methylphenidate|methylphenidate|mesh-list
15191840|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191841|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191842|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15191843|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15191844|NCT03832972|Estrogens|estrogens|mesh-list
15191845|NCT03832972|Hormones|hormones|mesh-ancestor
15224040|NCT04770272|Carboplatin|carboplatin|mesh-list
14684098|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14684099|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684100|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14684101|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14684102|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684103|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684104|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
14684105|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684106|NCT00326352|Remifentanil|remifentanil|mesh-list
14684107|NCT00326352|Propofol|propofol|mesh-list
14684108|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14684109|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684110|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684111|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14684112|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
14684113|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
14684114|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14684115|NCT00326352|Narcotics|narcotics|mesh-ancestor
14684116|NCT00326352|Analgesics|analgesics|mesh-ancestor
14684117|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
14684118|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684119|NCT00326378|Docetaxel|docetaxel|mesh-list
14684120|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684121|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14684122|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14684123|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
14684124|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684125|NCT00326391|Methylphenidate|methylphenidate|mesh-list
14684126|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14684127|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684128|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14684129|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14684130|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684131|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684132|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
14684133|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684134|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14684135|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14684136|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14684137|NCT00326404|Desogestrel|desogestrel|mesh-list
14684138|NCT00326404|Estradiol|estradiol|mesh-list
14684139|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14684140|NCT00326404|Estrogens|estrogens|mesh-ancestor
15191846|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191847|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684141|NCT00326404|Hormones|hormones|mesh-ancestor
14684142|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684143|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684144|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14684145|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
14684146|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14684147|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14684148|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14684149|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14684150|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14684151|NCT00326404|Progestins|progestins|mesh-ancestor
14684152|NCT00326456|Paclitaxel|paclitaxel|mesh-list
14684153|NCT00326456|Carboplatin|carboplatin|mesh-list
14684154|NCT00326456|Doxorubicin|doxorubicin|mesh-list
14684155|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14684156|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14684157|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684158|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14684159|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
14684160|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14684161|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684162|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14684163|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14684164|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14684165|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684166|NCT00326469|Lanreotide|lanreotide|mesh-list
14684167|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684168|NCT00326508|Daclizumab|daclizumab|mesh-list
14684169|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14684170|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
14684171|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191848|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
15191849|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15191850|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15191851|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15191852|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15191853|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684172|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
14684173|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
14684174|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
14684175|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684176|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684177|NCT00326664|Cediranib|cediranib|mesh-list
14684178|NCT00326664|Maleic acid|maleic acid|mesh-list
14684179|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684180|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684181|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191854|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
15191855|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15191856|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191857|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15191858|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191859|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15191860|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15191861|NCT03832894|Estradiol|estradiol|mesh-list
14684182|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14684183|NCT00326768|Telmisartan|telmisartan|mesh-list
15191862|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15191863|NCT03832894|Progesterone|progesterone|mesh-list
15191864|NCT03832894|Estrogens|estrogens|mesh-ancestor
15191865|NCT03832894|Hormones|hormones|mesh-ancestor
15191866|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191867|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191868|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15191869|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
15191870|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15191871|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15191872|NCT03832894|Progestins|progestins|mesh-ancestor
15191873|NCT03832660|Valsartan|valsartan|mesh-list
15191874|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15191875|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15191876|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15191877|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191878|NCT03832816|Dronabinol|dronabinol|mesh-list
14684184|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14684185|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14684186|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14684187|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14684188|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684189|NCT00326768|Diuretics|diuretics|mesh-ancestor
14684190|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
14684191|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684192|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14684193|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684194|NCT00326807|Naltrexone|naltrexone|mesh-list
14684195|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14684196|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14684197|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684198|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
14684199|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684200|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
14684201|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
14684202|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14684203|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684204|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
14684205|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
14684206|NCT00326833|Vitamins|vitamins|mesh-ancestor
14684207|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
14684208|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684209|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
15191879|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
15191880|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191881|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15191882|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191883|NCT03832816|Analgesics|analgesics|mesh-ancestor
15191884|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
15191885|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191886|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15191887|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15191888|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684210|NCT00326833|Hematinics|hematinics|mesh-ancestor
14684211|NCT00326859|Remifentanil|remifentanil|mesh-list
14684212|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14684213|NCT00326859|Narcotics|narcotics|mesh-ancestor
14684214|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684215|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684216|NCT00326859|Analgesics|analgesics|mesh-ancestor
14684217|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
14684218|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684219|NCT00327080|Acetylcholine|acetylcholine|mesh-list
14684220|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
14684221|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14684222|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
14684223|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684224|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684225|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684226|NCT00327093|Bevacizumab|bevacizumab|mesh-list
14684227|NCT00327093|Cetuximab|cetuximab|mesh-list
14684228|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14684229|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684230|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14684231|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14684232|NCT00327093|Growth Substances|growth substances|mesh-ancestor
15191889|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191890|NCT03832816|Hormones|hormones|mesh-ancestor
15191891|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191892|NCT03832621|Nivolumab|nivolumab|mesh-list
15191893|NCT03832621|Ipilimumab|ipilimumab|mesh-list
15191894|NCT03832621|Temozolomide|temozolomide|mesh-list
15191895|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191896|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191897|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15191898|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191899|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15191900|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
15191901|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
14684233|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191902|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191903|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191904|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
15191905|NCT03832699|Progesterone|progesterone|mesh-list
15191906|NCT03832699|Progestins|progestins|mesh-ancestor
15191907|NCT03832699|Hormones|hormones|mesh-ancestor
15191908|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191909|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191910|NCT03832465|Levofloxacin|levofloxacin|mesh-list
15191911|NCT03832465|Ofloxacin|ofloxacin|mesh-list
15191912|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15191913|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15191914|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191915|NCT03832465|Renal Agents|renal agents|mesh-ancestor
15191916|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15191917|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15191918|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15191919|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684234|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
14684235|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
14684236|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14684237|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14684238|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684239|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
14684240|NCT00327106|Coagulants|coagulants|mesh-ancestor
14684241|NCT00327119|Panitumumab|panitumumab|mesh-list
14684242|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15191920|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684243|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727423|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14684244|NCT00327132|Amoxicillin|amoxicillin|mesh-list
14684245|NCT00327132|Clarithromycin|clarithromycin|mesh-list
15191921|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191922|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15191923|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15191924|NCT03832361|Maytansine|maytansine|mesh-list
15191925|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14684246|NCT00327132|Omeprazole|omeprazole|mesh-list
14684247|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14684248|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684249|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14684250|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14684251|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14684252|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191926|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191927|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
14684253|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684254|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14684255|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14684256|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14684257|NCT00327145|Amlodipine|amlodipine|mesh-list
14684258|NCT00327145|Valsartan|valsartan|mesh-list
14684259|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14684260|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14684261|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14684262|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684263|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684264|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14684265|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684266|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
14684267|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14684268|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14684269|NCT00327145|Diuretics|diuretics|mesh-ancestor
14684270|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
14684271|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14684272|NCT00327184|PENTA|penta|mesh-list
14684273|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
14684274|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14684275|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14684276|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684277|NCT00327197|Prednisolone|prednisolone|mesh-list
14684278|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684279|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
14684280|NCT00327197|Hormones|hormones|mesh-ancestor
14684281|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684282|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684283|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14684284|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684285|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
14684286|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684287|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14684288|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684289|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684290|NCT00327288|Docetaxel|docetaxel|mesh-list
14684291|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684292|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
14294301|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684293|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
14684294|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
14684295|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684296|NCT00327327|Gemcitabine|gemcitabine|mesh-list
14684297|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14684298|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
14684299|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684300|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684301|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
14684302|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684303|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684304|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14684305|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
14684306|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684307|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
15191928|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
15191929|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
15191930|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191931|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
15191932|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
15191933|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15191934|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191935|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15191936|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15191937|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191938|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191939|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15191940|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
15191941|NCT03832426|Ritonavir|ritonavir|mesh-list
15191942|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15191943|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15191944|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
15191945|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191946|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191947|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15191948|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15191949|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
15191950|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191951|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15191952|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15191953|NCT03831984|Bromfenac|bromfenac|mesh-list
15191954|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
15191955|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15191956|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
15191957|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684308|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14684309|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14684310|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
14684311|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684312|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684313|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14684314|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
14684315|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14684316|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14684317|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14684318|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
14684319|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684320|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684321|NCT00327379|Aprotinin|aprotinin|mesh-list
14684322|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
14684323|NCT00327379|Coagulants|coagulants|mesh-ancestor
14684324|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14684325|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14684326|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
14684327|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684328|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684329|NCT00327418|Atorvastatin|atorvastatin|mesh-list
14684330|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14684331|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14684332|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
14684333|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684334|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14684335|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14684336|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684337|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14684338|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
14684339|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684340|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
14684341|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
14684342|NCT00327535|Hematinics|hematinics|mesh-ancestor
14684343|NCT00327587|Amlodipine|amlodipine|mesh-list
14684344|NCT00327587|Valsartan|valsartan|mesh-list
14684345|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14684346|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14684347|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14684348|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684349|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684350|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15191958|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
15191959|NCT03831984|Protective Agents|protective agents|mesh-ancestor
14684351|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684352|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
14684353|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14684354|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14684355|NCT00327587|Diuretics|diuretics|mesh-ancestor
14684356|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
14684357|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14684358|NCT00327665|Vaccines|vaccines|mesh-list
14684359|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14684360|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
14684361|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684362|NCT00327678|Rituximab|rituximab|mesh-list
14684363|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
14684364|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14684365|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684366|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
15191960|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15191961|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191962|NCT03831984|Analgesics|analgesics|mesh-ancestor
14684367|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684368|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14684369|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14684370|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684371|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684372|NCT00327691|Atorvastatin|atorvastatin|mesh-list
14684373|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14684374|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14684375|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
14684376|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684377|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14684378|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14684379|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684380|NCT00327730|Eperisone|eperisone|mesh-list
14684381|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
14684382|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14684383|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684384|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684385|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14684386|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684387|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14684388|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14684389|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684390|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
14684391|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
14684392|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
14684393|NCT00327756|Ubiquinone|ubiquinone|mesh-list
14684394|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
14684395|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
14684396|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684397|NCT00327756|Vitamins|vitamins|mesh-ancestor
14684398|NCT00327769|Fulvestrant|fulvestrant|mesh-list
14684399|NCT00327769|Anastrozole|anastrozole|mesh-list
14684400|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15191963|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
15191964|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191965|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191966|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15191967|NCT03831815|Rocuronium|rocuronium|mesh-list
15191968|NCT03831815|Cisatracurium|cisatracurium|mesh-list
15191969|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15191970|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15191971|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15191972|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191973|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224041|NCT04770272|Atezolizumab|atezolizumab|mesh-list
15224042|NCT04770272|Epirubicin|epirubicin|mesh-list
15224043|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15224044|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15224045|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224046|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
15224047|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
14684401|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684402|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14684403|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14684404|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
14684405|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684406|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191974|NCT03831334|Minoxidil|minoxidil|mesh-list
15191975|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15191976|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
15191977|NCT03831321|Diclofenac|diclofenac|mesh-list
15191978|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15191979|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15191980|NCT03831321|Analgesics|analgesics|mesh-ancestor
14684407|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14684408|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14684409|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684410|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684411|NCT00327808|Budesonide|budesonide|mesh-list
14684412|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684413|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14684414|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
14684415|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684416|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684417|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14684418|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
14684419|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
14684420|NCT00327808|Hormones|hormones|mesh-ancestor
14684421|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684422|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14684423|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14684424|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14684425|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684426|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684427|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14684428|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684429|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684430|NCT00327847|Vitamin D|vitamin d|mesh-list
14684431|NCT00327847|Vitamins|vitamins|mesh-ancestor
14684432|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
14684433|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684434|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14684435|NCT00327925|Antibodies|antibodies|mesh-list
14684436|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
14684437|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684438|NCT00327990|Alendronate|alendronate|mesh-list
14684439|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
14684440|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14684441|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684442|NCT00328029|Busulfan|busulfan|mesh-list
14684443|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
14684444|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684445|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14684446|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
14684447|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684448|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14684449|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684450|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14684451|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
14684452|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
14684453|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
14684454|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684455|NCT00328120|Fulvestrant|fulvestrant|mesh-list
14684456|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14684457|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684458|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14684459|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14684460|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
14684461|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684462|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684463|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
14684464|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14684465|NCT00328302|Candesartan|candesartan|mesh-list
14684466|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14684467|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14684468|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15191981|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
14684469|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684470|NCT00328367|Aripiprazole|aripiprazole|mesh-list
14684471|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684472|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684473|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684474|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684475|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684476|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684477|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
14684478|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
14684479|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684480|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684481|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14684482|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14684483|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
14684484|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14684485|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14684486|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14684487|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14684488|NCT00328380|Rifaximin|rifaximin|mesh-list
14684489|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14684490|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684491|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14684492|NCT00328393|Pioglitazone|pioglitazone|mesh-list
14684493|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14684494|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684495|NCT00328432|Celecoxib|celecoxib|mesh-list
14684496|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14684497|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684498|NCT00328432|Analgesics|analgesics|mesh-ancestor
14684499|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
14684500|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684501|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684502|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684503|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14684504|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14684505|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14684506|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684507|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684508|NCT00328458|Epothilones|epothilones|mesh-list
14684509|NCT00328458|Epothilone B|epothilone b|mesh-list
14684510|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
14684511|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
14684512|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
14684513|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684514|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684515|NCT00328497|Bevacizumab|bevacizumab|mesh-list
14684516|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
14684517|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14684518|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684519|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14684520|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14684521|NCT00328497|Growth Substances|growth substances|mesh-ancestor
14684522|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684523|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
14684524|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
14684525|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
14684526|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
14684527|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684528|NCT00328549|Interferons|interferons|mesh-list
14684529|NCT00328549|Ribavirin|ribavirin|mesh-list
14684530|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684531|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
14684532|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684533|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
14684534|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684535|NCT00328692|Rolofylline|rolofylline|mesh-list
14684536|NCT00328692|Diuretics|diuretics|mesh-ancestor
14684537|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
14684538|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684539|NCT00328718|Fluticasone|fluticasone|mesh-list
14684540|NCT00328718|Xhance|xhance|mesh-list
14684541|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14684542|NCT00328718|Montelukast|montelukast|mesh-list
14684543|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684544|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14684545|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
14684546|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684547|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684548|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14684549|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
14684550|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
14684551|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14684552|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14684553|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14684554|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14684555|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
14684556|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684557|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684558|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14684559|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
14684560|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15191982|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15191983|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191984|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15191985|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15191986|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15191987|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15191988|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15191989|NCT03831464|Metformin|metformin|mesh-list
15191990|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15191991|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15191992|NCT03831269|Azithromycin|azithromycin|mesh-list
15191993|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15191994|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15191995|NCT03831113|Buprenorphine|buprenorphine|mesh-list
15191996|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15191997|NCT03831113|Narcotics|narcotics|mesh-ancestor
15191998|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15191999|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192000|NCT03831113|Analgesics|analgesics|mesh-ancestor
15192001|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
14684561|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14684562|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14727424|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14727425|NCT00513539|Trioxsalen|trioxsalen|mesh-list
14727426|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727427|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727428|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14727429|NCT00513552|Clarithromycin|clarithromycin|mesh-list
14727430|NCT00513552|Rifabutin|rifabutin|mesh-list
14727431|NCT00513552|Clofazimine|clofazimine|mesh-list
14727432|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14727433|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727434|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14727435|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727436|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727437|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14727438|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14727439|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14727440|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
14727441|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727442|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
14727443|NCT00513578|Sargramostim|sargramostim|mesh-list
14727444|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
14727445|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
14727446|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727447|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14727448|NCT00513630|Metformin|metformin|mesh-list
14727449|NCT00513630|Glipizide|glipizide|mesh-list
15192002|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192003|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15192004|NCT03831126|Betamethasone|betamethasone|mesh-list
15192005|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
14727450|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14727451|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727452|NCT00513643|Insulin|insulin|mesh-list
14727453|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14814914|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
14294302|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
14814915|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224048|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
14684563|NCT00328796|Lidocaine|lidocaine|mesh-list
14684564|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
14684565|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
14684566|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684567|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684568|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
14684569|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684570|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14684571|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14684572|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14684573|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684574|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684575|NCT00328809|Spironolactone|spironolactone|mesh-list
14684576|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14684577|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
14684578|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684579|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684580|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14684581|NCT00328809|Diuretics|diuretics|mesh-ancestor
14684582|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
14684583|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14684584|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684585|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684586|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684587|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684588|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684589|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684590|NCT00328874|Ubiquinone|ubiquinone|mesh-list
14684591|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
14684592|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
14684593|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684594|NCT00328874|Vitamins|vitamins|mesh-ancestor
14684595|NCT00328900|Atropine|atropine|mesh-list
14684596|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14684597|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14684598|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14684599|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
14684600|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684601|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684602|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14684603|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
14684604|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
14684605|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
14684606|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14684607|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14684608|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
14684609|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684610|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684611|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
14684612|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14684613|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684614|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684615|NCT00328939|Enoxaparin|enoxaparin|mesh-list
14684616|NCT00328939|PENTA|penta|mesh-list
14684617|NCT00328939|Fondaparinux|fondaparinux|mesh-list
14684618|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
14684619|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14684620|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14684621|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684622|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14684623|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
14684624|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14684625|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14684626|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684627|NCT00328965|Lacidipine|lacidipine|mesh-list
14684628|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14684629|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14684630|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684631|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684632|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14684633|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684634|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14684635|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684636|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684637|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684638|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684639|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684640|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684641|NCT00329069|Atorvastatin|atorvastatin|mesh-list
14684642|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14684643|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14684644|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
14684645|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684646|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14684647|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14684648|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684649|NCT00329095|Bimatoprost|bimatoprost|mesh-list
14684650|NCT00329095|Travoprost|travoprost|mesh-list
14684651|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
14684652|NCT00329095|Latanoprost|latanoprost|mesh-list
14684653|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14684654|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14684655|NCT00329134|Quinine|quinine|mesh-list
14684656|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
14684657|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14684658|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14684659|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684660|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14684661|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684662|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14684663|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684664|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684665|NCT00329134|Analgesics|analgesics|mesh-ancestor
14684666|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
14684667|NCT00329147|Paroxetine|paroxetine|mesh-list
14684668|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14684669|NCT00329147|Desipramine|desipramine|mesh-list
14684670|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14684671|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14684672|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684673|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684674|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684675|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
14684676|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684677|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14684678|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684679|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684680|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14684681|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14684682|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684683|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14684684|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14684685|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14684686|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
14684687|NCT00329173|Atorvastatin|atorvastatin|mesh-list
14684688|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14684689|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14684690|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14684691|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
14684692|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684693|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14684694|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14684695|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684696|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14684697|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14684698|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14684699|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14684700|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684701|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684702|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684703|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684704|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14684705|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684706|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684707|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
14684708|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14684709|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684710|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14684711|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684712|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684713|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684714|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684715|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294303|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294304|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14294305|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294306|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294307|NCT00574912|Insulin|insulin|mesh-list
14684716|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684717|NCT00329316|Progesterone|progesterone|mesh-list
14684718|NCT00329316|Progestins|progestins|mesh-ancestor
14684719|NCT00329316|Hormones|hormones|mesh-ancestor
14684720|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684721|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684722|NCT00329329|Capecitabine|capecitabine|mesh-list
14684723|NCT00329329|Satraplatin|satraplatin|mesh-list
14684724|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14684725|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
14684726|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684727|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684728|NCT00329355|Naproxen|naproxen|mesh-list
14684729|NCT00329355|Sumatriptan|sumatriptan|mesh-list
14684730|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192006|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15192007|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
14294308|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14294309|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
14294310|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14294311|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294312|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
14294313|NCT00574951|Imetelstat|imetelstat|mesh-list
15192008|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15192009|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
15192010|NCT03831126|Hormones|hormones|mesh-ancestor
15192011|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192012|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684731|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684732|NCT00329355|Analgesics|analgesics|mesh-ancestor
14684733|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
14684734|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684735|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684736|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684737|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15192013|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294314|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14684738|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
14684739|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14684740|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684741|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684742|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14684743|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14684744|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14684745|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
14684746|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684747|NCT00329368|Folic Acid|folic acid|mesh-list
14684748|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
14294315|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684749|NCT00329368|Interferons|interferons|mesh-list
14684750|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
14684751|NCT00329368|Interleukin-2|interleukin-2|mesh-list
14684752|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14684753|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684754|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
14684755|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684756|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
14684757|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684758|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684759|NCT00329368|Analgesics|analgesics|mesh-ancestor
14684760|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
14684761|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684762|NCT00329368|Hematinics|hematinics|mesh-ancestor
14684763|NCT00329368|Vitamins|vitamins|mesh-ancestor
14684764|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
14684765|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14684766|NCT00329381|Omalizumab|omalizumab|mesh-list
14684767|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14684768|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14684769|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14684770|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
14684771|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
14684772|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684773|NCT00329394|Ketamine|ketamine|mesh-list
14684774|NCT00329394|Analgesics|analgesics|mesh-ancestor
14684775|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
14684776|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684777|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684778|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15192014|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15192015|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
15192016|NCT03831425|Ubiquinone|ubiquinone|mesh-list
15192017|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
15192018|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
15192019|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192020|NCT03831425|Vitamins|vitamins|mesh-ancestor
15192021|NCT03831295|Antibodies|antibodies|mesh-list
14684779|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14684780|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
14684781|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
14684782|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684783|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14684784|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14684785|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684786|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684787|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14684788|NCT00329446|Citalopram|citalopram|mesh-list
14684789|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14684790|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14684791|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192022|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
15192023|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192024|NCT03830827|Vortioxetine|vortioxetine|mesh-list
15192025|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684792|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684793|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684794|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
14684795|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684796|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14684797|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684798|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684799|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684800|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684801|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684802|NCT00329459|Naproxen|naproxen|mesh-list
14684803|NCT00329459|Sumatriptan|sumatriptan|mesh-list
14684804|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14684805|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684806|NCT00329459|Analgesics|analgesics|mesh-ancestor
14684807|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
14684808|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684809|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684810|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684811|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14684812|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
14727454|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
14684813|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14684814|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684815|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684816|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14684817|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14684818|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14684819|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
14684820|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684821|NCT00329472|Gemcitabine|gemcitabine|mesh-list
14684822|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684823|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14684824|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
14684825|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684826|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
14684827|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684828|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684829|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14684830|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
14684831|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684832|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
14684833|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
14684834|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684835|NCT00329498|Protective Agents|protective agents|mesh-ancestor
14684836|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684837|NCT00329498|Vitamins|vitamins|mesh-ancestor
14684838|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
14684839|NCT00329511|Clonidine|clonidine|mesh-list
14684840|NCT00329511|Methyldopa|methyldopa|mesh-list
14684841|NCT00329511|Analgesics|analgesics|mesh-ancestor
14684842|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
14684843|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684844|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684845|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14684846|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
14684847|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
14684848|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14684849|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14684850|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14684851|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
14684852|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684853|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684854|NCT00329537|Sargramostim|sargramostim|mesh-list
14684855|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
14684856|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684857|NCT00329589|Bortezomib|bortezomib|mesh-list
14684858|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684859|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
14684860|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
14684861|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
14684862|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14684863|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684864|NCT00329628|Enoxaparin|enoxaparin|mesh-list
14684865|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
14684866|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14684867|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
14684868|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14684869|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
14684870|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684871|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684872|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
14684873|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14684874|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14684875|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
14684876|NCT00329680|Antioxidants|antioxidants|mesh-list
14684877|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684878|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684879|NCT00329680|Protective Agents|protective agents|mesh-ancestor
14684880|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14684881|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684882|NCT00329680|Analgesics|analgesics|mesh-ancestor
14684883|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
14684884|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684885|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684886|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14684887|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14684888|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
14684889|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14684890|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14684891|NCT00329693|Quinagolide|quinagolide|mesh-list
14684892|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
14684893|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
14684894|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684895|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684896|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684897|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14684898|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14684899|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14684900|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
14684901|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684902|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14684903|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14294316|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294317|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
14294318|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14294319|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14294320|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15192026|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192027|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15192028|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15192029|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684904|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684905|NCT00329810|Aripiprazole|aripiprazole|mesh-list
14684906|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684907|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684908|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14684909|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14684910|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14684911|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684912|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
14684913|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
14684914|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684915|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684916|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14684917|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14684918|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
14684919|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14684920|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14684921|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14684922|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14684923|NCT00329823|Etanercept|etanercept|mesh-list
14684924|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14684925|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14684926|NCT00329823|Analgesics|analgesics|mesh-ancestor
14684927|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
14684928|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14684929|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684930|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14684931|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14684932|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14684933|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14684934|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
14684935|NCT00329914|Progesterone|progesterone|mesh-list
14684936|NCT00329914|Progestins|progestins|mesh-ancestor
14684937|NCT00329914|Hormones|hormones|mesh-ancestor
14684938|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684939|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684940|NCT00329940|Letrozole|letrozole|mesh-list
14684941|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684942|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14684943|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14684944|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684945|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684946|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14684947|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
14684948|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14684949|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684950|NCT00330018|Valganciclovir|valganciclovir|mesh-list
14684951|NCT00330018|Acyclovir|acyclovir|mesh-list
15192030|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684952|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
14684953|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684954|NCT00330044|Carboplatin|carboplatin|mesh-list
14684955|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684956|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
14684957|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14684958|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
14684959|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684960|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
14684961|NCT00330135|Protective Agents|protective agents|mesh-ancestor
14684962|NCT00330148|Eflornithine|eflornithine|mesh-list
14684963|NCT00330148|Nifurtimox|nifurtimox|mesh-list
14684964|NCT00330148|Melarsoprol|melarsoprol|mesh-list
14684965|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684966|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14684967|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14684968|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14684969|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684970|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14684971|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684972|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684973|NCT00330239|Paroxetine|paroxetine|mesh-list
14684974|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14684975|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14684976|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294321|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14684977|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14684978|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14684979|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
14684980|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684981|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14684982|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
14684983|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14684984|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15192031|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14294322|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294323|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
14294324|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294325|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294326|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14294327|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294328|NCT00575029|Megestrol|megestrol|mesh-list
15192032|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15192033|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192034|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192035|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192036|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
15192037|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15192038|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14294329|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
14294330|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14294331|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14294332|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14294333|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
14294334|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14294335|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684985|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14684986|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14684987|NCT00330252|Rituximab|rituximab|mesh-list
14684988|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
14684989|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14684990|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14684991|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
14684992|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14684993|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14684994|NCT00330278|Cefazolin|cefazolin|mesh-list
14684995|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14684996|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14684997|NCT00330304|Isoniazid|isoniazid|mesh-list
14684998|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14684999|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
14685000|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14685001|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685002|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14685003|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14685004|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
14685005|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685006|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14685007|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14685008|NCT00330304|Renal Agents|renal agents|mesh-ancestor
14685009|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
14685010|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14685011|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14685012|NCT00330317|Letrozole|letrozole|mesh-list
14685013|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685014|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14685015|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14685016|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685017|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685018|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14685019|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
14685020|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685021|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685022|NCT00330395|Caspofungin|caspofungin|mesh-list
14685023|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
14685024|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685025|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685026|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685027|NCT00330486|Acamprosate|acamprosate|mesh-list
14685028|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14685029|NCT00330499|Cisplatin|cisplatin|mesh-list
14685030|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685031|NCT00330525|Sibutramine|sibutramine|mesh-list
14685032|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
14685033|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14685034|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
14685035|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14685036|NCT00330577|Timolol|timolol|mesh-list
14685037|NCT00330577|Latanoprost|latanoprost|mesh-list
14685038|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
14685039|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685040|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685041|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685042|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685043|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685044|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685045|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685046|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685047|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14685048|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14727455|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14727456|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727457|NCT00513656|Oxycodone|oxycodone|mesh-list
14727458|NCT00513656|Naloxone|naloxone|mesh-list
14727459|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14727460|NCT00513656|Narcotics|narcotics|mesh-ancestor
14685049|NCT00330655|Memantine|memantine|mesh-list
15192039|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15192040|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15192041|NCT03830957|Metoprolol|metoprolol|mesh-list
15192042|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15192043|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15192044|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
15192045|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
15192046|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294336|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14294337|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14294338|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14294339|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294340|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
14685050|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14685051|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14685052|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
14685053|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685054|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685055|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685056|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14685057|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14685058|NCT00330707|Interferons|interferons|mesh-list
14685059|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
14685060|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
14685061|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685062|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
14685063|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685064|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
14685065|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685066|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14685067|NCT00330746|Gemcitabine|gemcitabine|mesh-list
14685068|NCT00330746|Cetuximab|cetuximab|mesh-list
14685069|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192047|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192048|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15192049|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15192050|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15192051|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
15192052|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192053|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192054|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
15192055|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
15192056|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192057|NCT03830489|Protective Agents|protective agents|mesh-ancestor
15192058|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192059|NCT03830489|Vitamins|vitamins|mesh-ancestor
15192060|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
15192061|NCT03830684|Baicalein|baicalein|mesh-list
15192062|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
14685070|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
14685071|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685072|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685073|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
14685074|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685075|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685076|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14685077|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
14685078|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685079|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14685080|NCT00330772|Aspirin|aspirin|mesh-list
14685081|NCT00330772|Clopidogrel|clopidogrel|mesh-list
14685082|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14685083|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685084|NCT00330772|Analgesics|analgesics|mesh-ancestor
14685085|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
14685086|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685087|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685088|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685089|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685090|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14685091|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14685092|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192063|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685093|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14685094|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14685095|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685096|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
14685097|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14685098|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14685099|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14685100|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
14685101|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685102|NCT00330785|Amlodipine|amlodipine|mesh-list
14685103|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
14685104|NCT00330785|Atorvastatin|atorvastatin|mesh-list
14685105|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14685106|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14685107|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
14685108|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685109|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14685110|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15192064|NCT03830684|Protective Agents|protective agents|mesh-ancestor
15192065|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192066|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192067|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
15192068|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
15192069|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192070|NCT03830606|Paclitaxel|paclitaxel|mesh-list
15192071|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15192072|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192073|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
15192074|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
15192075|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
14685111|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685112|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685113|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14685114|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14685115|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14685116|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685117|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
14685118|NCT00330798|Ketorolac|ketorolac|mesh-list
14685119|NCT00330798|Nepafenac|nepafenac|mesh-list
14685120|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14685121|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685122|NCT00330798|Analgesics|analgesics|mesh-ancestor
14685123|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
14685124|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685125|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685126|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685127|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685128|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14685129|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685130|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685131|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14685132|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
14685133|NCT00330824|Dexamethasone|dexamethasone|mesh-list
14685134|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
14685135|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14685136|NCT00330824|BB 1101|bb 1101|mesh-list
14685137|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685138|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
14685139|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
14685140|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685141|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685142|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685143|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
14685144|NCT00330824|Hormones|hormones|mesh-ancestor
14685145|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685146|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14685147|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685148|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
14685149|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685150|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685151|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14814916|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225687|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14685152|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14685153|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14685154|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14685155|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
14685156|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685157|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14685158|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14685159|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14685160|NCT00330902|Artesunate|artesunate|mesh-list
14685161|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
14685162|NCT00330902|Primaquine|primaquine|mesh-list
14685163|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
14685164|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14685165|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
14685166|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14685167|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14685168|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192076|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192077|NCT03830398|Acetaminophen|acetaminophen|mesh-list
15192078|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192079|NCT03830398|Analgesics|analgesics|mesh-ancestor
15192080|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
15192081|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192082|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685169|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685170|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
14685171|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
14685172|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14685173|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
14685174|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14685175|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685176|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685177|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14685178|NCT00330902|Renal Agents|renal agents|mesh-ancestor
14685179|NCT00330941|Lidocaine|lidocaine|mesh-list
14685180|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14685181|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
14685182|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14685183|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685184|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
14685185|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685186|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685187|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14685188|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14685189|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14685190|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685191|NCT00330980|Simvastatin|simvastatin|mesh-list
14685192|NCT00330980|Pravastatin|pravastatin|mesh-list
14685193|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14685194|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14685195|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
14685196|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685197|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14685198|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14685199|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685200|NCT00330993|Misoprostol|misoprostol|mesh-list
14685201|NCT00330993|Mifepristone|mifepristone|mesh-list
14685202|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14685203|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
14685204|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685205|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685206|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14685207|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685208|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
14685209|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14685210|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14685211|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14685212|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14685213|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
14685214|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14685215|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15192083|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
14685216|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
14814917|NCT00864604|Nabumetone|nabumetone|mesh-list
15192084|NCT03830164|Vitamins|vitamins|mesh-list
14685217|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192085|NCT03830164|Vitamin E|vitamin e|mesh-list
15192086|NCT03830164|Tocopherols|tocopherols|mesh-list
15192087|NCT03830164|Tocotrienols|tocotrienols|mesh-list
15192088|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
15192089|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
15192090|NCT03830164|Atorvastatin|atorvastatin|mesh-list
15192091|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
14685218|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
14685219|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14685220|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14685221|NCT00331045|Alvimopan|alvimopan|mesh-list
14685222|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685223|NCT00331058|Prednisolone|prednisolone|mesh-list
14685224|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685225|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
14685226|NCT00331058|Hormones|hormones|mesh-ancestor
14685227|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685228|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685229|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14685230|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685231|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
14685232|NCT00331071|Ortho Evra|ortho evra|mesh-list
14685233|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
14685234|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685235|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685236|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14685237|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14685238|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14685239|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
14685240|NCT00331084|Dexamethasone|dexamethasone|mesh-list
14685241|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
14685242|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14685243|NCT00331084|BB 1101|bb 1101|mesh-list
14685244|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685245|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
14685246|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
14685247|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685248|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685249|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192092|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192093|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15192094|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15192095|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
15192096|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192097|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15192098|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15192099|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192100|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
15192101|NCT03830164|Protective Agents|protective agents|mesh-ancestor
14685250|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
14685251|NCT00331084|Hormones|hormones|mesh-ancestor
15192102|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14685252|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685253|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14685254|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685255|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
14685256|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685257|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685258|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685259|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15192103|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14685260|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15192104|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15192105|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
14685261|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14685262|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
14685263|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685264|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14685265|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14685266|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14685267|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
14685268|NCT00331097|Docetaxel|docetaxel|mesh-list
14685269|NCT00331097|Fluorouracil|fluorouracil|mesh-list
14685270|NCT00331097|Methotrexate|methotrexate|mesh-list
14685271|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14685272|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
14685273|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685274|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685275|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14685276|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
14685277|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685278|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685279|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14685280|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
14685281|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
14685282|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
14685283|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
14685284|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14685285|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14685286|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
14685287|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685288|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
14685289|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685290|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14685291|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14685292|NCT00331123|Testosterone|testosterone|mesh-list
14685293|NCT00331123|Androgens|androgens|mesh-ancestor
14685294|NCT00331123|Hormones|hormones|mesh-ancestor
14685295|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685296|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685297|NCT00331149|Ropinirole|ropinirole|mesh-list
14685298|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14685299|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14685300|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
14685301|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
14685302|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685303|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685304|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685305|NCT00331188|Vapreotide|vapreotide|mesh-list
14685306|NCT00331188|Analgesics|analgesics|mesh-ancestor
14685307|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
14685308|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685309|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685310|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685311|NCT00331214|Testosterone|testosterone|mesh-list
14685312|NCT00331214|Androgens|androgens|mesh-ancestor
14685313|NCT00331214|Hormones|hormones|mesh-ancestor
14685314|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685315|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685316|NCT00331240|Timolol|timolol|mesh-list
14685317|NCT00331240|Travoprost|travoprost|mesh-list
14685318|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
15192106|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15192107|NCT03830385|Carboplatin|carboplatin|mesh-list
15192108|NCT03830385|Bleomycin|bleomycin|mesh-list
15192109|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192110|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15192111|NCT03830086|Midazolam|midazolam|mesh-list
15192112|NCT03830086|Sufentanil|sufentanil|mesh-list
15192113|NCT03830086|Bupivacaine|bupivacaine|mesh-list
15192114|NCT03830086|Propofol|propofol|mesh-list
15192115|NCT03830086|Sevoflurane|sevoflurane|mesh-list
15192116|NCT03830086|Rocuronium|rocuronium|mesh-list
15192117|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
15192118|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
15192119|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14685319|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15192120|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685320|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685321|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685322|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685323|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685324|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685325|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685326|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685327|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14685328|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14685329|NCT00331305|Sertraline|sertraline|mesh-list
14685330|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
14685331|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14685332|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14685333|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14685334|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192121|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
14685335|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685336|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685337|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
14685338|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685339|NCT00331435|Verteporfin|verteporfin|mesh-list
14685340|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14685341|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14685342|NCT00331487|Pioglitazone|pioglitazone|mesh-list
14685343|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
14685344|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14685345|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685346|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14685347|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14685348|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14685349|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14685350|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685351|NCT00331500|Analgesics|analgesics|mesh-ancestor
14685352|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
14685353|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685354|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685355|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685356|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685357|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14685358|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14685359|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14685360|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
14685361|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
14685362|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685363|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685364|NCT00331513|Vorinostat|vorinostat|mesh-list
15192122|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192123|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15192124|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15192125|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
15192126|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15192127|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15192128|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15192129|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192130|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
15192131|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
15192132|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192133|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192134|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15192135|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15192136|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15192137|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15192138|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14685365|NCT00331513|Idarubicin|idarubicin|mesh-list
14685366|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685367|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14685368|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685369|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685370|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14685371|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14685372|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14685373|NCT00331526|Aldesleukin|aldesleukin|mesh-list
14685374|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685375|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14685376|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14685377|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
14685378|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685379|NCT00331604|Insulin|insulin|mesh-list
14685380|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14685381|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
14685382|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
14685383|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14685384|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
14685385|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14685386|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685387|NCT00331643|Epothilones|epothilones|mesh-list
14294341|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14294342|NCT00575042|Fenofibrate|fenofibrate|mesh-list
14294343|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14685388|NCT00331643|Epothilone B|epothilone b|mesh-list
14685389|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
14685390|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
14685391|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
14685392|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685393|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685394|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14685395|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14685396|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14685397|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
14685398|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685399|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685400|NCT00331695|Progestins|progestins|mesh-ancestor
14685401|NCT00331695|Hormones|hormones|mesh-ancestor
14685402|NCT00331708|Artesunate|artesunate|mesh-list
14685403|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
14685404|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
14685405|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14685406|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
14685407|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14685408|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14685409|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685410|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685411|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
14685412|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
14685413|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14685414|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
14685415|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14685416|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685417|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685418|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14685419|NCT00331708|Renal Agents|renal agents|mesh-ancestor
14685420|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
14685421|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
14685422|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14685423|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
14685424|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685425|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14685426|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685427|NCT00331786|Aspirin|aspirin|mesh-list
14685428|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
14685429|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
14685430|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14685431|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685432|NCT00331786|Analgesics|analgesics|mesh-ancestor
14685433|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
14685434|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685435|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685436|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685437|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685438|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14685439|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14685440|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685441|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14685442|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14685443|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685444|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
14685445|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14685446|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
14294344|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
14685447|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15192139|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14685448|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
14685449|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14685450|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
14685451|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685452|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14685453|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
14685454|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
14685455|NCT00331786|Protective Agents|protective agents|mesh-ancestor
14685456|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14685457|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
14685458|NCT00331825|Olanzapine|olanzapine|mesh-list
14685459|NCT00331825|Risperidone|risperidone|mesh-list
14685460|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14685461|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
14685462|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685463|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685464|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192140|NCT03830086|Narcotics|narcotics|mesh-ancestor
15192141|NCT03830086|Analgesics|analgesics|mesh-ancestor
15192142|NCT03830216|Insulin|insulin|mesh-list
15192143|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15192144|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15192145|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192146|NCT03830034|Iron|iron|mesh-list
15192147|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
15192148|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
15192149|NCT03830034|Trace Elements|trace elements|mesh-ancestor
15192150|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
15192151|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192152|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
15192153|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
15192154|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192155|NCT03829696|Misoprostol|misoprostol|mesh-list
15192156|NCT03829696|Mifepristone|mifepristone|mesh-list
15192157|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
15192158|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15192159|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
15192160|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15192161|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192162|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15192163|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192164|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
15192165|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15192166|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15192167|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15192168|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15192169|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
15192170|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15192171|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15192172|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
15192173|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192174|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
15192175|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15192176|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15192177|NCT03829839|Lorazepam|lorazepam|mesh-list
14685465|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15192178|NCT03829839|Oxytocin|oxytocin|mesh-list
15192179|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
15192180|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685466|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14685467|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14685468|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14685469|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14685470|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
14685471|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
14685472|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
14685473|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685474|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685475|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14685476|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14685477|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14685478|NCT00331838|Enoxaparin|enoxaparin|mesh-list
14685479|NCT00331838|Semuloparin|semuloparin|mesh-list
14685480|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14685481|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
14685482|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
14685483|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14685484|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14685485|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685486|NCT00331851|Metformin|metformin|mesh-list
14685487|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
14685488|NCT00331851|Liraglutide|liraglutide|mesh-list
14685489|NCT00331851|Glimepiride|glimepiride|mesh-list
14685490|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14685491|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685492|NCT00331851|Incretins|incretins|mesh-ancestor
14685493|NCT00331851|Hormones|hormones|mesh-ancestor
14685494|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685495|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685496|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14685497|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
14685498|NCT00331890|Choline|choline|mesh-list
14685499|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14685500|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
14685501|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14685502|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
14685503|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685504|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685505|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14685506|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
14685507|NCT00331955|Doxorubicin|doxorubicin|mesh-list
14685508|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14685509|NCT00331955|Vorinostat|vorinostat|mesh-list
14685510|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14685511|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685512|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14685513|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14685514|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685515|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685516|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14685517|NCT00331981|Amisulpride|amisulpride|mesh-list
14685518|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14685519|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14685520|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14685521|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685522|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14685523|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14685524|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
14685525|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192181|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192182|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
14685526|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685527|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14685528|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
14685529|NCT00331994|Metronidazole|metronidazole|mesh-list
14685530|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685531|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14685532|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14685533|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14685534|NCT00332020|Enoxaparin|enoxaparin|mesh-list
14685535|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
14685536|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14685537|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
14685538|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14685539|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
14685540|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685541|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685542|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
14685543|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14685544|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14685545|NCT00332033|Pirfenidone|pirfenidone|mesh-list
14685546|NCT00332033|Analgesics|analgesics|mesh-ancestor
14685547|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
14685548|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685549|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685550|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14685551|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685552|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685553|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685554|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192183|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
15192184|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
15192185|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192186|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192187|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14685555|NCT00332046|Casopitant|casopitant|mesh-list
14685556|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
14685557|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
14685558|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685559|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685560|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685561|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14685562|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685563|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685564|NCT00332059|Timolol|timolol|mesh-list
14685565|NCT00332059|Bimatoprost|bimatoprost|mesh-list
14685566|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685567|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685568|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685569|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685570|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685571|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685572|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685573|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685574|NCT00332072|Timolol|timolol|mesh-list
14685575|NCT00332072|Bimatoprost|bimatoprost|mesh-list
15192188|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192189|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15192190|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15192191|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192192|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
15192193|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
15192194|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192195|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192196|NCT03829943|Vitamin D|vitamin d|mesh-list
14685576|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685577|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685578|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685579|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685580|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685581|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685582|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685583|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685584|NCT00332085|Chromium|chromium|mesh-list
14685585|NCT00332085|Picolinic acid|picolinic acid|mesh-list
14685586|NCT00332085|Trace Elements|trace elements|mesh-ancestor
14685587|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
14685588|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685589|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14685590|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
14685591|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
14685592|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685593|NCT00332124|Choline|choline|mesh-list
14685594|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
14685595|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14685596|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
14685597|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685598|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685599|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14685600|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
14685601|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
15192197|NCT03829943|Vitamins|vitamins|mesh-ancestor
15192198|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
14685602|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14685603|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14685604|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
14685605|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685606|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685607|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685608|NCT00332137|Urological Agents|urological agents|mesh-ancestor
14685609|NCT00332176|Ribavirin|ribavirin|mesh-list
14685610|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14685611|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
14685612|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685613|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
14685614|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685615|NCT00332228|Naltrexone|naltrexone|mesh-list
14685616|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15192199|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192200|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15192201|NCT03829774|Acetaminophen|acetaminophen|mesh-list
14685617|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14685618|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685619|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
14685620|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685621|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14685622|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685623|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
14685624|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14685625|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14685626|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14685627|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14685628|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685629|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14685630|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14685631|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685632|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685633|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685634|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14685635|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
14685636|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685637|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685638|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14685639|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14685640|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14685641|NCT00332306|Lamivudine|lamivudine|mesh-list
14685642|NCT00332306|Efavirenz|efavirenz|mesh-list
14685643|NCT00332306|Nevirapine|nevirapine|mesh-list
14685644|NCT00332306|Didanosine|didanosine|mesh-list
14685645|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14685646|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14685647|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685648|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685649|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
14685650|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685651|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14685652|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14685653|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14685654|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14685655|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14685656|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14685657|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14685658|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14685659|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
14685660|NCT00332319|Casopitant|casopitant|mesh-list
14685661|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
14685662|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
15192202|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685663|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685664|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685665|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685666|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15192203|NCT03829774|Analgesics|analgesics|mesh-ancestor
15192204|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
15192205|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685667|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685668|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685669|NCT00332345|Timolol|timolol|mesh-list
14685670|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14685671|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685672|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685673|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685674|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192206|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192207|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
15192208|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
15192209|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224049|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224050|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224051|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
15224052|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224053|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224054|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14685675|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685676|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685677|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685678|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685679|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14685680|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15224055|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
15224056|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15224057|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15224058|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15224059|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15224060|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224061|NCT04716946|Durvalumab|durvalumab|mesh-list
15224062|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224063|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224064|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
15224065|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224066|NCT04713358|Nalmefene|nalmefene|mesh-list
14685681|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14685682|NCT00332384|Timolol|timolol|mesh-list
14685683|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14685684|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685685|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685686|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685687|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685688|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685689|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685690|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685691|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685692|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14685693|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14685694|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14685695|NCT00332397|Sirolimus|sirolimus|mesh-list
14685696|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14685697|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685698|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14685699|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685700|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
14685701|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14685702|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
14685703|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224067|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15224068|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224069|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
15224070|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224071|NCT04696952|Zopiclone|zopiclone|mesh-list
15224072|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15224073|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727461|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727462|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727463|NCT00513656|Analgesics|analgesics|mesh-ancestor
15224074|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727464|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
14727465|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224075|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
15224076|NCT04676802|Narcotics|narcotics|mesh-ancestor
14685704|NCT00332436|Timolol|timolol|mesh-list
14685705|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14685706|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685707|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685708|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685709|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685710|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685711|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685712|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685713|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685714|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14685715|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14685716|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14685717|NCT00332540|Timolol|timolol|mesh-list
14685718|NCT00332540|Bimatoprost|bimatoprost|mesh-list
14685719|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685720|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685721|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685722|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685723|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685724|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685725|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685726|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685727|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14685728|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14685729|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14685730|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14685731|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
14685732|NCT00332553|Estradiol|estradiol|mesh-list
14685733|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14685734|NCT00332553|Estrogens|estrogens|mesh-list
14685735|NCT00332553|Hormones|hormones|mesh-ancestor
14685736|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685737|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685738|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14685739|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
14685740|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14685741|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14685742|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14685743|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14685744|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14685745|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14685746|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14685747|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685748|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14685749|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
14685750|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14685751|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14685752|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14685753|NCT00332618|Glycerol|glycerol|mesh-list
14685754|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14685755|NCT00332618|Protective Agents|protective agents|mesh-ancestor
14685756|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685757|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
14685758|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14685759|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
14685760|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685761|NCT00332631|Expectorants|expectorants|mesh-ancestor
14685762|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
14685763|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14685764|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
14685765|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685766|NCT00332631|Protective Agents|protective agents|mesh-ancestor
14685767|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685768|NCT00332631|Antidotes|antidotes|mesh-ancestor
14685769|NCT00332735|Bupivacaine|bupivacaine|mesh-list
14685770|NCT00332735|Carticaine|carticaine|mesh-list
14685771|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
14685772|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
14685773|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14685774|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685775|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
14685776|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685777|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
14685778|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14685779|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14685780|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
14685781|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685782|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14685783|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685784|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14685785|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14685786|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14685787|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685788|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14685789|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685790|NCT00332774|Ketorolac|ketorolac|mesh-list
14685791|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14685792|NCT00332774|Nepafenac|nepafenac|mesh-list
14685793|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14685794|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14685795|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14685796|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685797|NCT00332774|Analgesics|analgesics|mesh-ancestor
14685798|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
14685799|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685800|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685801|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685802|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685803|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14685804|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685805|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685806|NCT00332787|Fluoxetine|fluoxetine|mesh-list
14685807|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14685808|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14685809|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14685810|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685811|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685812|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
14685813|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685814|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14685815|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
14685816|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14685817|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14685818|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14685819|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685820|NCT00332826|Insulin|insulin|mesh-list
14685821|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14685822|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685823|NCT00332852|Letrozole|letrozole|mesh-list
14685824|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685825|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14685826|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14685827|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685828|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192210|NCT03829917|Paromomycin|paromomycin|mesh-list
15192211|NCT03829917|Miltefosine|miltefosine|mesh-list
15192212|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15192213|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192214|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15192215|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15192216|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
14685829|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14685830|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
14685831|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685832|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685833|NCT00332891|Amibegron|amibegron|mesh-list
14685834|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14685835|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14685836|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685837|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685838|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685839|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685840|NCT00332904|Propranolol|propranolol|mesh-list
14685841|NCT00332904|Spironolactone|spironolactone|mesh-list
14685842|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15192217|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685843|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685844|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685845|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685846|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685847|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685848|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685849|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685850|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
14685851|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14685852|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
14685853|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685854|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14685855|NCT00332904|Diuretics|diuretics|mesh-ancestor
14685856|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
14685857|NCT00332930|Interferons|interferons|mesh-list
15192218|NCT03829930|Entinostat|entinostat|mesh-list
15192219|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192220|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15192221|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192222|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192223|NCT03829371|Dexamethasone|dexamethasone|mesh-list
14685858|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
14685859|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192224|NCT03829371|Prednisone|prednisone|mesh-list
15192225|NCT03829371|Lenalidomide|lenalidomide|mesh-list
15192226|NCT03829371|Melphalan|melphalan|mesh-list
15192227|NCT03829371|Bortezomib|bortezomib|mesh-list
15192228|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192229|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
15192230|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
15192231|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685860|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
14685861|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685862|NCT00332969|Octreotide|octreotide|mesh-list
14685863|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685864|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14685865|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685866|NCT00332995|Dapivirine|dapivirine|mesh-list
15192232|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192233|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192234|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
15192235|NCT03829371|Hormones|hormones|mesh-ancestor
15192236|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192237|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15192238|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192239|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
15192240|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15192241|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15192242|NCT03829371|Growth Substances|growth substances|mesh-ancestor
15192243|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
14294345|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685867|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14685868|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14685869|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
14685870|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14685871|NCT00333008|Prednisone|prednisone|mesh-list
14685872|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
14685873|NCT00333008|Rituximab|rituximab|mesh-list
14685874|NCT00333008|Vincristine|vincristine|mesh-list
14685875|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14685876|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
14685877|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685878|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685879|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14685880|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
14685881|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685882|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685883|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14685884|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14685885|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685886|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
14685887|NCT00333008|Hormones|hormones|mesh-ancestor
14685888|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685889|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15192244|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14685890|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14685891|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14685892|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14685893|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14685894|NCT00333021|PENTA|penta|mesh-list
14685895|NCT00333021|Fondaparinux|fondaparinux|mesh-list
14685896|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15192245|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
15192246|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192247|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15192248|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192249|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
15192250|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15192251|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14685897|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
14685898|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14685899|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
14685900|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685901|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685902|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
14685903|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14685904|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14685905|NCT00333034|Etanercept|etanercept|mesh-list
14685906|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14685907|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14685908|NCT00333034|Analgesics|analgesics|mesh-ancestor
15192252|NCT03829566|Prednisolone|prednisolone|mesh-list
15192253|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
15192254|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
15192255|NCT03829566|Rituximab|rituximab|mesh-list
15192256|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
15192257|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15192258|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15192259|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
15192260|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192261|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
14685909|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
14685910|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685911|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294346|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14294347|NCT00575094|Tigecycline|tigecycline|mesh-list
14294348|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14685912|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14685913|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14685914|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14685915|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14685916|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
14685917|NCT00333047|Letrozole|letrozole|mesh-list
14685918|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685919|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14685920|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14685921|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192262|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192263|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15192264|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15192265|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
15192266|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192267|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192268|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15192269|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192270|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192271|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
15192272|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
15192273|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192274|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192275|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
15192276|NCT03829566|Hormones|hormones|mesh-ancestor
15192277|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14294349|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294350|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14294351|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685922|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192278|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14685923|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14685924|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
15192279|NCT03829566|Protective Agents|protective agents|mesh-ancestor
14685925|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685926|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685927|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14685928|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14685929|NCT00333086|Letrozole|letrozole|mesh-list
14685930|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14685931|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14685932|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14685933|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685934|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685935|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14685936|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
14685937|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685938|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685939|NCT00333112|Tamsulosin|tamsulosin|mesh-list
14685940|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
14685941|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14685942|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14685943|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685944|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685945|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685946|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685947|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685948|NCT00333112|Urological Agents|urological agents|mesh-ancestor
14685949|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14685950|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14685951|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
14685952|NCT00333125|Timolol|timolol|mesh-list
14685953|NCT00333125|Travoprost|travoprost|mesh-list
14685954|NCT00333125|Dorzolamide|dorzolamide|mesh-list
14685955|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14685956|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14685957|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14685958|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14685959|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14685960|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685961|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685962|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685963|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14685964|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14685965|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14685966|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685967|NCT00333151|Metformin|metformin|mesh-list
14685968|NCT00333151|Liraglutide|liraglutide|mesh-list
14685969|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
14685970|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14685971|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685972|NCT00333151|Incretins|incretins|mesh-ancestor
14685973|NCT00333151|Hormones|hormones|mesh-ancestor
14685974|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14685975|NCT00333164|Cilostazol|cilostazol|mesh-list
14685976|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14685977|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
14685978|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14685979|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14685980|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14685981|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
14685982|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14685983|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14685984|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192280|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14685985|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14685986|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
14685987|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14685988|NCT00333164|Protective Agents|protective agents|mesh-ancestor
14685989|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14685990|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14685991|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14685992|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
14685993|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
14685994|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
14685995|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15192281|NCT03829592|Misoprostol|misoprostol|mesh-list
14685996|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14685997|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14685998|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14685999|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686000|NCT00333255|Nepafenac|nepafenac|mesh-list
14686001|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14686002|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14686003|NCT00333255|Analgesics|analgesics|mesh-ancestor
14686004|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
14686005|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686006|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686007|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686008|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686009|NCT00333281|Tadalafil|tadalafil|mesh-list
14686010|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
15192282|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15192283|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
15192284|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14686011|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14686012|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14686013|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686014|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686015|NCT00333281|Urological Agents|urological agents|mesh-ancestor
14686016|NCT00333294|Vinorelbine|vinorelbine|mesh-list
14686017|NCT00333294|Gefitinib|gefitinib|mesh-list
14686018|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686019|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14686020|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
14686021|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
14686022|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
14686023|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686024|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14686025|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686026|NCT00333307|Methocarbamol|methocarbamol|mesh-list
14686027|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14686028|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686029|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14686030|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686031|NCT00333346|Tramadol|tramadol|mesh-list
14686032|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14686033|NCT00333346|Narcotics|narcotics|mesh-ancestor
14686034|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686035|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686036|NCT00333346|Analgesics|analgesics|mesh-ancestor
14686037|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
14686038|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686039|NCT00333372|Z 338|z 338|mesh-list
14686040|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14686041|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686042|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686043|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
14686044|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686045|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686046|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686047|NCT00333385|Ceftazidime|ceftazidime|mesh-list
14686048|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686049|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686050|NCT00333398|Vaccines|vaccines|mesh-list
14686051|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
14686052|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686053|NCT00333424|Vaccines|vaccines|mesh-list
14686054|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
14686055|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686056|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14686057|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
14686058|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686059|NCT00333476|Squalamine|squalamine|mesh-list
14686060|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686061|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686062|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14686063|NCT00333476|Protective Agents|protective agents|mesh-ancestor
14686064|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686065|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686066|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14294352|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294353|NCT00575367|Azithromycin|azithromycin|mesh-list
14294354|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
14294355|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14294356|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14294357|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14294358|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294359|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294360|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14294361|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14294362|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294363|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686067|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14686068|NCT00333476|Growth Substances|growth substances|mesh-ancestor
14686069|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
14686070|NCT00333489|Valsartan|valsartan|mesh-list
14686071|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14686072|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14686073|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14686074|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686075|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
14686076|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14686077|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14686078|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686079|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686080|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14686081|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14686082|NCT00333567|Analgesics|analgesics|mesh-ancestor
14686083|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
14686084|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686085|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686086|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686087|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686088|NCT00333632|Fentanyl|fentanyl|mesh-list
14686089|NCT00333632|Midazolam|midazolam|mesh-list
14686090|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
14686091|NCT00333632|Propofol|propofol|mesh-list
14686092|NCT00333632|Isoflurane|isoflurane|mesh-list
14686093|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14686094|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686095|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686096|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14686097|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
14686098|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
14686099|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14686100|NCT00333632|Analgesics|analgesics|mesh-ancestor
14686101|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
14686102|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686103|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14686104|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14686105|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14686106|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
14686107|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686108|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686109|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14686110|NCT00333632|Narcotics|narcotics|mesh-ancestor
14686111|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14686112|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14686113|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686114|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686115|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
14686116|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
14686117|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14686118|NCT00333645|Caspofungin|caspofungin|mesh-list
14686119|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
14686120|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686121|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686122|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686123|NCT00333671|Glycerol|glycerol|mesh-list
14686124|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14686125|NCT00333671|Protective Agents|protective agents|mesh-ancestor
14686126|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686127|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
14686128|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14686129|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686130|NCT00333918|Bromfenac|bromfenac|mesh-list
14686131|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14686132|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14686133|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14686134|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14686135|NCT00333918|Analgesics|analgesics|mesh-ancestor
14686136|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
14686137|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686138|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686139|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686140|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686141|NCT00333931|Phenytoin|phenytoin|mesh-list
14686142|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
14686143|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15192285|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192286|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15192287|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192288|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
15192289|NCT03829345|Olaparib|olaparib|mesh-list
15192290|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15192291|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192292|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192293|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192294|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
15192295|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
15192296|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192297|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686144|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14686145|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14686146|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686147|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14686148|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14686149|NCT00333944|Pralidoxime|pralidoxime|mesh-list
14686150|NCT00333944|Antidotes|antidotes|mesh-ancestor
14686151|NCT00333944|Protective Agents|protective agents|mesh-ancestor
14686152|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686153|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
14686154|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
14294364|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686155|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686156|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14686157|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686158|NCT00333996|Dexamethasone|dexamethasone|mesh-list
14686159|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686160|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
14686161|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
14686162|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686163|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686164|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686165|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
14686166|NCT00333996|Hormones|hormones|mesh-ancestor
14686167|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686168|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14686169|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686170|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
14686171|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14686172|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14686173|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686174|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14686175|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14686176|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
14686177|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686178|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14686179|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
15192298|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192299|NCT03829319|Carboplatin|carboplatin|mesh-list
15192300|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
14294365|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14294366|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
14294367|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14294368|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686180|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686181|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15192301|NCT03829319|Pemetrexed|pemetrexed|mesh-list
15192302|NCT03829319|Lenvatinib|lenvatinib|mesh-list
14686182|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686183|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686184|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686185|NCT00334048|Ropinirole|ropinirole|mesh-list
14686186|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14686187|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14686188|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
14686189|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
14686190|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686191|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686192|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686193|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14686194|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14686195|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
14686196|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686197|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14686198|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686199|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686200|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686201|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14686202|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14686203|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
14686204|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686205|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686206|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14686207|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14686208|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
14686209|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
14686210|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14686211|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686212|NCT00334152|Casopitant|casopitant|mesh-list
14686213|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
14686214|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
14686215|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686216|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686217|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686218|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14686219|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686220|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727466|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14727467|NCT00513786|Paclitaxel|paclitaxel|mesh-list
14727468|NCT00513786|Bevacizumab|bevacizumab|mesh-list
14727469|NCT00513786|Carboplatin|carboplatin|mesh-list
14727470|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727471|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727472|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
14727473|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727474|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
14727475|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727476|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14727477|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14727478|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15192303|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192304|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192305|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192306|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192307|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15192308|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15192309|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15192310|NCT03829436|Nivolumab|nivolumab|mesh-list
15192311|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192312|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192313|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15192314|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727479|NCT00513786|Growth Substances|growth substances|mesh-ancestor
14727480|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727481|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14727482|NCT00513864|Morphine|morphine|mesh-list
14727483|NCT00513864|Codeine|codeine|mesh-list
14727484|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
14727485|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14727486|NCT00513864|Narcotics|narcotics|mesh-ancestor
14727487|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686221|NCT00334256|Tenofovir|tenofovir|mesh-list
14686222|NCT00334256|Emtricitabine|emtricitabine|mesh-list
14686223|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
14686224|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686225|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14686226|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14686227|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686228|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686229|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14686230|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14686231|NCT00334308|Caseins|caseins|mesh-list
14686232|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
14686233|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
14686234|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686235|NCT00334321|Paclitaxel|paclitaxel|mesh-list
14686236|NCT00334321|Carboplatin|carboplatin|mesh-list
14686237|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14686238|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686239|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
14686240|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
14686241|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
14686242|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686243|NCT00334347|Valproic Acid|valproic acid|mesh-list
14686244|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
14686245|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686246|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686247|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
14686248|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686249|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686250|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
14686251|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686252|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686253|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686254|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
14686255|NCT00334360|Buspirone|buspirone|mesh-list
14686256|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14686257|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686258|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686259|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14686260|NCT00334360|Analgesics|analgesics|mesh-ancestor
14686261|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
14686262|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686263|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14686264|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14686265|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14686266|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
14686267|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686268|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686269|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14686270|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686271|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686272|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14686273|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
14686274|NCT00334386|Torsemide|torsemide|mesh-list
14686275|NCT00334386|Diuretics|diuretics|mesh-list
14686276|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14686277|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
14686278|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686279|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14686280|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686281|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14686282|NCT00334399|Miglitol|miglitol|mesh-list
14686283|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686284|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686285|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14686286|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686287|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14686288|NCT00334412|Caspofungin|caspofungin|mesh-list
14686289|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14686290|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
14686291|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686292|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686293|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686294|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14686295|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14686296|NCT00334425|Menotropins|menotropins|mesh-list
14686297|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14686298|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
14686299|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14686300|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686301|NCT00334438|Rituximab|rituximab|mesh-list
14686302|NCT00334438|Bortezomib|bortezomib|mesh-list
14686303|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14686304|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14686305|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686306|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
14686307|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686308|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686309|NCT00334464|Warfarin|warfarin|mesh-list
14686310|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
14686311|NCT00334477|Tadalafil|tadalafil|mesh-list
14686312|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
14686313|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14686314|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14686315|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686316|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686317|NCT00334477|Urological Agents|urological agents|mesh-ancestor
14686318|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
14686319|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
14686320|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14686321|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14686322|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686323|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686324|NCT00334490|Urological Agents|urological agents|mesh-ancestor
14686325|NCT00334503|Miglitol|miglitol|mesh-list
14686326|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686327|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686328|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14686329|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686330|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14686331|NCT00334529|Oseltamivir|oseltamivir|mesh-list
14686332|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
14686333|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686334|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686335|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686336|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
14686337|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14686338|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686339|NCT00334581|Irbesartan|irbesartan|mesh-list
14686340|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14686341|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14686342|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14686343|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294369|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14294370|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14294371|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14294372|NCT00575380|Azithromycin|azithromycin|mesh-list
14294373|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
14686344|NCT00334594|Pemetrexed|pemetrexed|mesh-list
14686345|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686346|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686347|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686348|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14686349|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14686350|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
14686351|NCT00334646|Casopitant|casopitant|mesh-list
14686352|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686353|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
14686354|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686355|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686356|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14686357|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
14686358|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686359|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686360|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14686361|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
14686362|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
14294374|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14686363|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686364|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686365|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14686366|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686367|NCT00334672|Cyclosporine|cyclosporine|mesh-list
14686368|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
14686369|NCT00334672|Dexamethasone|dexamethasone|mesh-list
14686370|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
14686371|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14686372|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14686373|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14686374|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
14686375|NCT00334672|Busulfan|busulfan|mesh-list
14686376|NCT00334672|Methotrexate|methotrexate|mesh-list
14686377|NCT00334672|Etoposide|etoposide|mesh-list
14686378|NCT00334672|Cyclosporins|cyclosporins|mesh-list
14686379|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14686380|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686381|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
14686382|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192315|NCT03829124|Ketamine|ketamine|mesh-list
15192316|NCT03829124|Propofol|propofol|mesh-list
15192317|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15192318|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192319|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686383|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686384|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14686385|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
14686386|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686387|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686388|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14686389|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686390|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
14686391|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
14686392|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686393|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686394|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
14686395|NCT00334672|Hormones|hormones|mesh-ancestor
14686396|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686397|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14686398|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14686399|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
14686400|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14686401|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14686402|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
14686403|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14686404|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686405|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14686406|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14686407|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14686408|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14686409|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14686410|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
14686411|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686412|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14686413|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14686414|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14686415|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
14686416|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686417|NCT00334685|Pregabalin|pregabalin|mesh-list
14686418|NCT00334685|Reboxetine|reboxetine|mesh-list
14686419|NCT00334685|Analgesics|analgesics|mesh-ancestor
14686420|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
14686421|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686422|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192320|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15192321|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
15192322|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
15192323|NCT03829124|Analgesics|analgesics|mesh-ancestor
15192324|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
15192325|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192326|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15192327|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15192328|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15192329|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192330|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294375|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14686423|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
14686424|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14686425|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14686426|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686427|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14686428|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14686429|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686430|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686431|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686432|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
14686433|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14686434|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14686435|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
14686436|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192331|NCT03829150|Amoxicillin|amoxicillin|mesh-list
15192332|NCT03829150|Metronidazole|metronidazole|mesh-list
15192333|NCT03829150|Clarithromycin|clarithromycin|mesh-list
15192334|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
15192335|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15192336|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192337|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14686437|NCT00334698|Cetirizine|cetirizine|mesh-list
14686438|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
14686439|NCT00334698|Ephedrine|ephedrine|mesh-list
14686440|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14686441|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14686442|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14686443|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
14686444|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
14686445|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686446|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686447|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686448|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14686449|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
14686450|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686451|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14686452|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
14686453|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
14686454|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14686455|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14686456|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
14686457|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14686458|NCT00334763|Paclitaxel|paclitaxel|mesh-list
14686459|NCT00334763|Bevacizumab|bevacizumab|mesh-list
14686460|NCT00334763|Carboplatin|carboplatin|mesh-list
14686461|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14686462|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686463|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
14686464|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
14686465|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
14686466|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686467|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14686468|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14686469|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14686470|NCT00334763|Growth Substances|growth substances|mesh-ancestor
14686471|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686472|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
15192338|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15192339|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15192340|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192341|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192342|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15192343|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15192344|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14686473|NCT00334789|Vitamin A|vitamin a|mesh-list
14686474|NCT00334789|Tretinoin|tretinoin|mesh-list
14686475|NCT00334789|Belinostat|belinostat|mesh-list
14686476|NCT00334789|Isotretinoin|isotretinoin|mesh-list
14686477|NCT00334789|Vitamins|vitamins|mesh-ancestor
14686478|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
14686479|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192345|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192346|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14686480|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686481|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686482|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
14686483|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
14686484|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14686485|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686486|NCT00334854|Doxorubicin|doxorubicin|mesh-list
14686487|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14686488|NCT00334854|Ifosfamide|ifosfamide|mesh-list
14686489|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14686490|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686491|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14686492|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14686493|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686494|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686495|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14686496|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
15192347|NCT03829020|Metformin|metformin|mesh-list
15192348|NCT03829020|Nelfinavir|nelfinavir|mesh-list
15192349|NCT03829020|Bortezomib|bortezomib|mesh-list
15192350|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15192351|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192352|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192353|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14686497|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
14686498|NCT00334867|Ifosfamide|ifosfamide|mesh-list
14686499|NCT00334867|Doxorubicin|doxorubicin|mesh-list
14686500|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14686501|NCT00334867|Etoposide|etoposide|mesh-list
14686502|NCT00334867|Vincristine|vincristine|mesh-list
14686503|NCT00334867|Topotecan|topotecan|mesh-list
14686504|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
14686505|NCT00334867|Razoxane|razoxane|mesh-list
14686506|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686507|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
14686508|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686509|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686510|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14686511|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
14686512|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686513|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686514|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14686515|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14686516|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14686517|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14686518|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686519|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14686520|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
14686521|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
14686522|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
14686523|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14686524|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14686525|NCT00334867|Protective Agents|protective agents|mesh-ancestor
14686526|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14686527|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14686528|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686529|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14686530|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15192354|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15192355|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
15192356|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192357|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192358|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15192359|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14686531|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14686532|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686533|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
14686534|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686535|NCT00334906|Memantine|memantine|mesh-list
14686536|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14686537|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14686538|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
14686539|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686540|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686541|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686542|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14686543|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15192360|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
15192361|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686544|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14686545|NCT00334932|Doxorubicin|doxorubicin|mesh-list
14686546|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14686547|NCT00334932|Bortezomib|bortezomib|mesh-list
14686548|NCT00334932|Melphalan|melphalan|mesh-list
14686549|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14686550|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686551|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14686552|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14686553|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686554|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686555|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14686556|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
14686557|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14686558|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686559|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
14686560|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686561|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
14686562|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
14686563|NCT00335075|Temozolomide|temozolomide|mesh-list
14686564|NCT00335075|Semustine|semustine|mesh-list
14686565|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14686566|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
14686567|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686568|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686569|NCT00335088|Iodine|iodine|mesh-list
14686570|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
14686571|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
14686572|NCT00335088|Povidone|povidone|mesh-list
14686573|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686574|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686575|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14686576|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14686577|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686578|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686579|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686580|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686581|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14686582|NCT00335088|Trace Elements|trace elements|mesh-ancestor
15192362|NCT03829111|Nivolumab|nivolumab|mesh-list
15192363|NCT03829111|Ipilimumab|ipilimumab|mesh-list
14686583|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
14686584|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
14686585|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
14686586|NCT00335114|Cyclosporine|cyclosporine|mesh-list
14686587|NCT00335114|Cyclosporins|cyclosporins|mesh-list
14686588|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686589|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686590|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686591|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
14686592|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686593|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
14686594|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686595|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
14686596|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686597|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14686598|NCT00335166|Pramipexole|pramipexole|mesh-list
14686599|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
14686600|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686601|NCT00335166|Protective Agents|protective agents|mesh-ancestor
14686602|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686603|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14686604|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14686605|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
14686606|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
14686607|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686608|NCT00335179|Imiquimod|imiquimod|mesh-list
14686609|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14686610|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
15192364|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192365|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192366|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14686611|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224077|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686612|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686613|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
14686614|NCT00335192|Tenofovir|tenofovir|mesh-list
14686615|NCT00335192|Lamivudine|lamivudine|mesh-list
14686616|NCT00335192|Lopinavir|lopinavir|mesh-list
14686617|NCT00335192|Abacavir|abacavir|mesh-list
14686618|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
14686619|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686620|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14686621|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14686622|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686623|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686624|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14686625|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14686626|NCT00335192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14686627|NCT00335192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14686628|NCT00335192|Protease Inhibitors|protease inhibitors|mesh-ancestor
14686629|NCT00335192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14686630|NCT00335192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14686631|NCT00335205|Ropinirole|ropinirole|mesh-list
14686632|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14686633|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14686634|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
14686635|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
14686636|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686637|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686638|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686639|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
14686640|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686641|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686642|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14686643|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14686644|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14686645|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14686646|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686647|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686648|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686649|NCT00335270|Ritonavir|ritonavir|mesh-list
14686650|NCT00335270|Amprenavir|amprenavir|mesh-list
14686651|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
14686652|NCT00335270|Lamivudine|lamivudine|mesh-list
14686653|NCT00335270|Abacavir|abacavir|mesh-list
14686654|NCT00335270|Calcium|calcium|mesh-list
14686655|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14686656|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686657|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14686658|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14686659|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
14686660|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686661|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686662|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14686663|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14686664|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
14686665|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686666|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14686667|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14686668|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14686669|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14686670|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14686671|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
14686672|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686673|NCT00335309|Amoxicillin|amoxicillin|mesh-list
14686674|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
15192367|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192368|NCT03828929|Ascorbic Acid|ascorbic acid|mesh-list
15192369|NCT03828929|Thiamine|thiamine|mesh-list
14686675|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
14686676|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686677|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686678|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14686679|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686680|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192370|NCT03828929|Vitamins|vitamins|mesh-ancestor
15192371|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
15192372|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192373|NCT03828929|Antioxidants|antioxidants|mesh-ancestor
15192374|NCT03828929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192375|NCT03828929|Protective Agents|protective agents|mesh-ancestor
14686681|NCT00335348|Dexamethasone|dexamethasone|mesh-list
14686682|NCT00335348|Bortezomib|bortezomib|mesh-list
14686683|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686684|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
14686685|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
14686686|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686687|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686688|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686689|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
14686690|NCT00335348|Hormones|hormones|mesh-ancestor
14686691|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686692|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14686693|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686694|NCT00335400|Anesthetics|anesthetics|mesh-list
14686695|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686696|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686697|NCT00335413|Spironolactone|spironolactone|mesh-list
14686698|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14686699|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
14686700|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686701|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686702|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14686703|NCT00335413|Diuretics|diuretics|mesh-ancestor
14686704|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
14686705|NCT00335439|Ketorolac|ketorolac|mesh-list
14686706|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14686707|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14686708|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14686709|NCT00335439|Analgesics|analgesics|mesh-ancestor
14686710|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
14686711|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686712|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686713|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686714|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686715|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14686716|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686717|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686718|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
14686719|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14686720|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686721|NCT00335543|Gemcitabine|gemcitabine|mesh-list
14686722|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686723|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14686724|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
14686725|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686726|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
14686727|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686728|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686729|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686730|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
14686731|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686732|NCT00335582|Clonidine|clonidine|mesh-list
14686733|NCT00335582|Analgesics|analgesics|mesh-ancestor
14686734|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
14686735|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686736|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686737|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14686738|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
14686739|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
14686740|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14686741|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14686742|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14686743|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
14686744|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686745|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686746|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
14686747|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14686748|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
14686749|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686750|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686751|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14686752|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
14686753|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
14686754|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14686755|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
14686756|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686757|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686758|NCT00335647|Fluphenazine|fluphenazine|mesh-list
14686759|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
14686760|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14686761|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14686762|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686763|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686764|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686765|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686766|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14686767|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
14686768|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686769|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686770|NCT00335673|Irbesartan|irbesartan|mesh-list
14686771|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14686772|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14686773|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14686774|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686775|NCT00335686|Lopinavir|lopinavir|mesh-list
14686776|NCT00335686|Nevirapine|nevirapine|mesh-list
14686777|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14686778|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14686779|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
14686780|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686781|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686782|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14686783|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14686784|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
14686785|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686786|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14686787|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14686788|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14686789|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14686790|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14686791|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14686792|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14686793|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14686794|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14686795|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
14686796|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686797|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14686798|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14686799|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686800|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15192376|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
15192377|NCT03829046|Evolocumab|evolocumab|mesh-list
15192378|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15192379|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15192380|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
15192381|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192382|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15192383|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
15192384|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15192385|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192386|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15192387|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
15192388|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192389|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
15192390|NCT03828682|Prednisone|prednisone|mesh-list
15192391|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
15192392|NCT03828682|Tacrolimus|tacrolimus|mesh-list
15192393|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
15192394|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15192395|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192396|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
15192397|NCT03828682|Hormones|hormones|mesh-ancestor
14686801|NCT00335920|Dexamethasone|dexamethasone|mesh-list
14686802|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686803|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
14686804|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
15192398|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192399|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686805|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686806|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686807|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686808|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
14686809|NCT00335920|Hormones|hormones|mesh-ancestor
14686810|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686811|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14686812|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686813|NCT00335933|Gabapentin|gabapentin|mesh-list
14686814|NCT00335933|Analgesics|analgesics|mesh-ancestor
14686815|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
14686816|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14686817|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686818|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
14686819|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14686820|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14686821|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686822|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14686823|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14686824|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14686825|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686826|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686827|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
14727488|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727489|NCT00513864|Analgesics|analgesics|mesh-ancestor
14727490|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
14727491|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727492|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
14727493|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
14727494|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14727495|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14727496|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727497|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727498|NCT00513877|Bortezomib|bortezomib|mesh-list
14727499|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727500|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
14727501|NCT00513929|Astringents|astringents|mesh-ancestor
14727502|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727503|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727504|NCT00513955|Prednisolone|prednisolone|mesh-list
14727505|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
15192400|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15192401|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192402|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192403|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
14727506|NCT00513955|Doxorubicin|doxorubicin|mesh-list
14727507|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14727508|NCT00513955|Vincristine|vincristine|mesh-list
14727509|NCT00513955|Bortezomib|bortezomib|mesh-list
14727510|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727511|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
14727512|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727513|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727514|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14727515|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
14727516|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727517|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727518|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14727519|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14727520|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14727521|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727522|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727523|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727524|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
14727525|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727526|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
14727527|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727528|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
14727529|NCT00513955|Hormones|hormones|mesh-ancestor
14727530|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727531|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14727532|NCT00513968|Adefovir|adefovir|mesh-list
14727533|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
14727534|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727535|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14686828|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
14686829|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14686830|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
14686831|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14686832|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
14686833|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686834|NCT00335998|Cisplatin|cisplatin|mesh-list
14686835|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686836|NCT00336141|Vorinostat|vorinostat|mesh-list
14686837|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686838|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14686839|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686840|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686841|NCT00336154|Tetracycline|tetracycline|mesh-list
14686842|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14686843|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686844|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14686845|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686846|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686847|NCT00336167|Bezafibrate|bezafibrate|mesh-list
14686848|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14686849|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
14686850|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686851|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14686852|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
14686853|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14686854|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686855|NCT00336219|Pantoprazole|pantoprazole|mesh-list
14686856|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14686857|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14686858|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14686859|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686860|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686861|NCT00336245|Copper|copper|mesh-list
14686862|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
14686863|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14686864|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686865|NCT00336245|Trace Elements|trace elements|mesh-ancestor
14686866|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
14686867|NCT00336310|Repaglinide|repaglinide|mesh-list
14686868|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14686869|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686870|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14686871|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14686872|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14686873|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
14686874|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686875|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14686876|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14686877|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686878|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
14686879|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14686880|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14686881|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14686882|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14686883|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686884|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
14686885|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14686886|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686887|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14686888|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192404|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15192405|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192406|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192407|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15192408|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15192409|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
15192410|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15192411|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192412|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
15192413|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
15192414|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192415|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192416|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15192417|NCT03828682|Protective Agents|protective agents|mesh-ancestor
15192418|NCT03828773|Fluconazole|fluconazole|mesh-list
15192419|NCT03828773|Posaconazole|posaconazole|mesh-list
15192420|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
15192421|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192422|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15192423|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15192424|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192425|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192426|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15192427|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14686889|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
14686890|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686891|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
14686892|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686893|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686894|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14686895|NCT00336375|Lumefantrine|lumefantrine|mesh-list
14686896|NCT00336375|Artemether|artemether|mesh-list
14686897|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14686898|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
14686899|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14686900|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14686901|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686902|NCT00336401|Propofol|propofol|mesh-list
14686903|NCT00336401|Sevoflurane|sevoflurane|mesh-list
14686904|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14686905|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14686906|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686907|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14686908|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
14686909|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
14686910|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14686911|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14686912|NCT00336414|Prednisone|prednisone|mesh-list
14686913|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
14686914|NCT00336414|Azathioprine|azathioprine|mesh-list
14686915|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686916|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
14686917|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686918|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14686919|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14686920|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
14686921|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686922|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686923|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14686924|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14686925|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
14686926|NCT00336414|Hormones|hormones|mesh-ancestor
14686927|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686928|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14686929|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
14686930|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192428|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192429|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192430|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15192431|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15192432|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14686931|NCT00336453|Vaccines|vaccines|mesh-list
14686932|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
14686933|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
14686934|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686935|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
14686936|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
14686937|NCT00336466|Hematinics|hematinics|mesh-ancestor
14686938|NCT00336518|Ribavirin|ribavirin|mesh-list
14686939|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14686940|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
14686941|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686942|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
14686943|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686944|NCT00336531|Itraconazole|itraconazole|mesh-list
14686945|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
14686946|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686947|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14686948|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14686949|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686950|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686951|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14686952|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
14686953|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686954|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686955|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14686956|NCT00336648|Gemcitabine|gemcitabine|mesh-list
15192433|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15192434|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15192435|NCT03828474|Acetazolamide|acetazolamide|mesh-list
15192436|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
15192437|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14686957|NCT00336648|Bevacizumab|bevacizumab|mesh-list
14686958|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14686959|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686960|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14686961|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14686962|NCT00336648|Growth Substances|growth substances|mesh-ancestor
15192438|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192439|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192440|NCT03828474|Diuretics|diuretics|mesh-ancestor
15192441|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
15192442|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192443|NCT03828175|Anesthetics|anesthetics|mesh-list
15192444|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192445|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192446|NCT03828227|Bevacizumab|bevacizumab|mesh-list
15192447|NCT03828227|Capecitabine|capecitabine|mesh-list
15192448|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192449|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192450|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15192451|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15192452|NCT03828227|Growth Substances|growth substances|mesh-ancestor
14686963|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686964|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
14686965|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14686966|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
14686967|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686968|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
14686969|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14686970|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686971|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14686972|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
14686973|NCT00336674|Insulin|insulin|mesh-list
14686974|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14686975|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686976|NCT00336739|Cinacalcet|cinacalcet|mesh-list
14686977|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14686978|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14686979|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14686980|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
14686981|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14686982|NCT00336765|XL647|xl647|mesh-list
14686983|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686984|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14686985|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14686986|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686987|NCT00336791|Paclitaxel|paclitaxel|mesh-list
14686988|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
14686989|NCT00336791|Doxorubicin|doxorubicin|mesh-list
14686990|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14686991|NCT00336791|Fluorouracil|fluorouracil|mesh-list
14686992|NCT00336791|Epirubicin|epirubicin|mesh-list
14686993|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14686994|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14686995|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
14686996|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
14686997|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
14686998|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14686999|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687000|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
14687001|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687002|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687003|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14687004|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
14687005|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14687006|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14687007|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14687008|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14687009|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687010|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
14687011|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687012|NCT00336882|Midazolam|midazolam|mesh-list
14687013|NCT00336882|Propofol|propofol|mesh-list
14687014|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14687015|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687016|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687017|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14687018|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
14687019|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
14687020|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14687021|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14687022|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14687023|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687024|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
14687025|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
14687026|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687027|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687028|NCT00336921|Alfuzosin|alfuzosin|mesh-list
14687029|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14687030|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14687031|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14687032|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
14687033|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687034|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814918|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14814919|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14814920|NCT00864604|Analgesics|analgesics|mesh-ancestor
14814921|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
14814922|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814923|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814924|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814925|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814926|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14814927|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14814928|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814929|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814930|NCT00864617|Nifedipine|nifedipine|mesh-list
15192453|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192454|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
15192455|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192456|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
15192457|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192458|NCT03828006|Red yeast rice|red yeast rice|mesh-list
15192459|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15192460|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15192461|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15192462|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
15192463|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687035|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687036|NCT00336921|Urological Agents|urological agents|mesh-ancestor
14687037|NCT00336947|Tegafur|tegafur|mesh-list
14687038|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687039|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
14687040|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687041|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687042|NCT00336960|Celecoxib|celecoxib|mesh-list
14687043|NCT00336960|Fluorouracil|fluorouracil|mesh-list
14687044|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
14687045|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687046|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687047|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687048|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687049|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
14687050|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687051|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14687052|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14687053|NCT00336960|Analgesics|analgesics|mesh-ancestor
14687054|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
14687055|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687056|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687057|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687058|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14687059|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14687060|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687061|NCT00337051|Propofol|propofol|mesh-list
14687062|NCT00337051|Sevoflurane|sevoflurane|mesh-list
14687063|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14687064|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687065|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687066|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14687067|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
14687068|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
14687069|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14687070|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14687071|NCT00337090|Mirabegron|mirabegron|mesh-list
15192464|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192465|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15192466|NCT03828032|Mannitol|mannitol|mesh-list
15192467|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15192468|NCT03828032|Diuretics|diuretics|mesh-ancestor
14687072|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14687073|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14687074|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14687075|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
14687076|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687077|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687078|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687079|NCT00337090|Urological Agents|urological agents|mesh-ancestor
14687080|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14687081|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687082|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
14687083|NCT00337246|Rituximab|rituximab|mesh-list
14687084|NCT00337246|Fludarabine|fludarabine|mesh-list
14687085|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
14687086|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
14687087|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687088|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
14687089|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687090|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687091|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14687092|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
14687093|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687094|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687095|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14687096|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14687097|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687098|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
14687099|NCT00337246|Analgesics|analgesics|mesh-ancestor
14687100|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
15192469|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
15192470|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687101|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687102|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15192471|NCT03828019|Cyclosporine|cyclosporine|mesh-list
15192472|NCT03828019|Adalimumab|adalimumab|mesh-list
14687103|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14687104|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687105|NCT00337259|Gemcitabine|gemcitabine|mesh-list
14687106|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687107|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
14687108|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687109|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687110|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
14687111|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687112|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687113|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687114|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
14687115|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687116|NCT00337298|Amlodipine|amlodipine|mesh-list
14687117|NCT00337298|Lisinopril|lisinopril|mesh-list
15192473|NCT03828019|Methotrexate|methotrexate|mesh-list
15192474|NCT03828019|Azathioprine|azathioprine|mesh-list
15192475|NCT03828019|Tacrolimus|tacrolimus|mesh-list
15192476|NCT03828019|Cyclosporins|cyclosporins|mesh-list
15192477|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15192478|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
15192479|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15192480|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192481|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192482|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
14687118|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14687119|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14687120|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687121|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687122|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14687123|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192483|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192484|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192485|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
15192486|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687124|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
14687125|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14687126|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
14687127|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687128|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14687129|NCT00337298|Protective Agents|protective agents|mesh-ancestor
14687130|NCT00337376|Sirolimus|sirolimus|mesh-list
14687131|NCT00337376|Paclitaxel|paclitaxel|mesh-list
14687132|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14687133|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14687134|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687135|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
14687136|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
14687137|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
14687138|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687139|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687140|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687141|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14687142|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
14687143|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687144|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
14687145|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687146|NCT00337389|Leucovorin|leucovorin|mesh-list
14687147|NCT00337389|Bevacizumab|bevacizumab|mesh-list
15192487|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14687148|NCT00337389|Fluorouracil|fluorouracil|mesh-list
14687149|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14687150|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687151|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14687152|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14687153|NCT00337389|Growth Substances|growth substances|mesh-ancestor
14687154|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687155|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
14687156|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
14687157|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687158|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687159|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687160|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
14687161|NCT00337389|Antidotes|antidotes|mesh-ancestor
14687162|NCT00337389|Protective Agents|protective agents|mesh-ancestor
14687163|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
14687164|NCT00337389|Vitamins|vitamins|mesh-ancestor
14687165|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
14687166|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
14687167|NCT00337441|Hematinics|hematinics|mesh-ancestor
14687168|NCT00337493|Cyclosporine|cyclosporine|mesh-list
15192488|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192489|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
15192490|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15192491|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15192492|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15192493|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
15192494|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192495|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192496|NCT03827876|Calcitriol|calcitriol|mesh-list
15192497|NCT03827876|Betamethasone|betamethasone|mesh-list
14687169|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
14687170|NCT00337493|Tacrolimus|tacrolimus|mesh-list
14687171|NCT00337493|Cyclosporins|cyclosporins|mesh-list
14687172|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687173|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
14687174|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192498|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14687175|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14687176|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687177|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687178|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
14687179|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687180|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
14687181|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687182|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14687183|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687184|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14687185|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
14687186|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687187|NCT00337506|Dexamethasone|dexamethasone|mesh-list
14687188|NCT00337506|Bortezomib|bortezomib|mesh-list
14687189|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687190|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
14687191|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
14687192|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687193|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687194|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687195|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
14687196|NCT00337506|Hormones|hormones|mesh-ancestor
14687197|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14687198|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14687199|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687200|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
14687201|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14687202|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687203|NCT00337545|Everolimus|everolimus|mesh-list
14687204|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687205|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687206|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
14687207|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687208|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
14687209|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14687210|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14687211|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
14687212|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192499|NCT03827876|Calcipotriene|calcipotriene|mesh-list
14687213|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687214|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687215|NCT00337558|Urological Agents|urological agents|mesh-ancestor
14687216|NCT00337623|Prednisolone|prednisolone|mesh-list
14687217|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687218|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
14687219|NCT00337623|Hormones|hormones|mesh-ancestor
14687220|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14687221|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687222|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15192500|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192501|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
15192502|NCT03827876|Hormones|hormones|mesh-ancestor
15192503|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192504|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192505|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15192506|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
15192507|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15192508|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15192509|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192510|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192511|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15192512|NCT03827876|Vitamins|vitamins|mesh-ancestor
15192513|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
15192514|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15192515|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
15192516|NCT03828084|Decitabine|decitabine|mesh-list
15192517|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
15192518|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192519|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
15192520|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192521|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192522|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192523|NCT03828058|Tacrolimus|tacrolimus|mesh-list
15192524|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192525|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
15192526|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192527|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15192528|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192529|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192530|NCT03827889|Fluorides|fluorides|mesh-list
15192531|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
15192532|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
15192533|NCT03827889|Protective Agents|protective agents|mesh-ancestor
15192534|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224078|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224079|NCT04676802|Analgesics|analgesics|mesh-ancestor
14687223|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687224|NCT00337649|Trastuzumab|trastuzumab|mesh-list
14687225|NCT00337649|Epothilones|epothilones|mesh-list
14687226|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
14687227|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14687228|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687229|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
14687230|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
14687231|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
14687232|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687233|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
14687234|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14687235|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14687236|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687237|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15224080|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
15224081|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687238|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14687239|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
14687240|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687241|NCT00337740|Propranolol|propranolol|mesh-list
14687242|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14687243|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14687244|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
14687245|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687246|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687247|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687248|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14687249|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14687250|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
14687251|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14687252|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
14687253|NCT00337766|Coagulants|coagulants|mesh-ancestor
14687254|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14687255|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
14687256|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687257|NCT00337792|Fentanyl|fentanyl|mesh-list
14687258|NCT00337792|Midazolam|midazolam|mesh-list
14687259|NCT00337792|Oxycodone|oxycodone|mesh-list
14687260|NCT00337792|Lorazepam|lorazepam|mesh-list
14687261|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14687262|NCT00337792|Narcotics|narcotics|mesh-ancestor
14687263|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687264|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192535|NCT03827642|Naloxone|naloxone|mesh-list
15192536|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15192537|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687265|NCT00337792|Analgesics|analgesics|mesh-ancestor
14687266|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
14687267|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687268|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14687269|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14687270|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
14687271|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
14687272|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14687273|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14687274|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14687275|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687276|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
14687277|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
14687278|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687279|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687280|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
14687281|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
14687282|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
14687283|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687284|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14687285|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
14687286|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
14687287|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14687288|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687289|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14687290|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687291|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727536|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14727537|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727538|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727539|NCT00513981|Leucovorin|leucovorin|mesh-list
15192538|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
15192539|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192540|NCT03827629|Naloxone|naloxone|mesh-list
15192541|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15192542|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727540|NCT00513981|Methotrexate|methotrexate|mesh-list
14727541|NCT00513981|Calcium|calcium|mesh-list
14727542|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
14727543|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14727544|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192543|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
14727545|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14727546|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
14727547|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14727548|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15224082|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
14687292|NCT00337922|Lamivudine|lamivudine|mesh-list
14687293|NCT00337922|Abacavir|abacavir|mesh-list
14687294|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14687295|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14687296|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687297|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687298|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
14687299|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687300|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14687301|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14687302|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
14687303|NCT00337948|Hematinics|hematinics|mesh-ancestor
14687304|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
14687305|NCT00338000|Hematinics|hematinics|mesh-ancestor
15192544|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192545|NCT03827408|Midazolam|midazolam|mesh-list
15192546|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
15192547|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15192548|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192549|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192550|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192551|NCT03827408|Analgesics|analgesics|mesh-ancestor
15192552|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
15192553|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192554|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15192555|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15192556|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15192557|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
15192558|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192559|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192560|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15192561|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15192562|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15192563|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192564|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15192565|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
15192566|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
15192567|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
15192568|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
15192569|NCT03827070|Afatinib|afatinib|mesh-list
15192570|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192571|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15192572|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192573|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192574|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15192575|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15192576|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15192577|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192578|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192579|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15192580|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192581|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192582|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
15192583|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687306|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14687307|NCT00338052|Norethindrone|norethindrone|mesh-list
14687308|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
14687309|NCT00338052|Estradiol|estradiol|mesh-list
14687310|NCT00338052|Estrogens|estrogens|mesh-ancestor
14687311|NCT00338052|Hormones|hormones|mesh-ancestor
14687312|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14687313|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687314|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14687315|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
14687316|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14687317|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14687318|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14687319|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14687320|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14687321|NCT00338091|Losartan|losartan|mesh-list
14687322|NCT00338091|Benazepril|benazepril|mesh-list
14687323|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15192584|NCT03827044|Avelumab|avelumab|mesh-list
14687324|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15224083|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14687325|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14687326|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14687327|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687328|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14687329|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14687330|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687331|NCT00338117|Galantamine|galantamine|mesh-list
14687332|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14294376|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14294377|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294378|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294379|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14687333|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687334|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687335|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
14687336|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687337|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687338|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14687339|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
14687340|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687341|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
14687342|NCT00338130|Temozolomide|temozolomide|mesh-list
14687343|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14687344|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
14294380|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14294381|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687345|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687346|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687347|NCT00338195|Caffeine|caffeine|mesh-list
14687348|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14687349|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687350|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14687351|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687352|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687353|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14687354|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14687355|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
14687356|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687357|NCT00338221|Glycine|glycine|mesh-list
14687358|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
14687359|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687360|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687361|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687362|NCT00338247|Capecitabine|capecitabine|mesh-list
14687363|NCT00338247|Lapatinib|lapatinib|mesh-list
14687364|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687365|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
14687366|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687367|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687368|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14687369|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687370|NCT00338273|Aripiprazole|aripiprazole|mesh-list
14687371|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
14687372|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687373|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14687374|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14687375|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687376|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687377|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
14687378|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
14687379|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687380|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814931|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14814932|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14814933|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814934|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14814935|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814936|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814937|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
14814938|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14814939|NCT00864643|Atorvastatin|atorvastatin|mesh-list
14687381|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14687382|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14687383|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
14687384|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14687385|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14687386|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14687387|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14687388|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
14687389|NCT00338299|Hematinics|hematinics|mesh-ancestor
14687390|NCT00338312|Testosterone|testosterone|mesh-list
14687391|NCT00338312|Androgens|androgens|mesh-ancestor
14687392|NCT00338312|Hormones|hormones|mesh-ancestor
14687393|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14687394|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687395|NCT00338338|Amlodipine|amlodipine|mesh-list
14687396|NCT00338338|Lacidipine|lacidipine|mesh-list
14687397|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14687398|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14687399|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192585|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192586|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192587|NCT03827200|Ambrisentan|ambrisentan|mesh-list
15192588|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15192589|NCT03827278|Itraconazole|itraconazole|mesh-list
15192590|NCT03827278|Voriconazole|voriconazole|mesh-list
15192591|NCT03827278|Amphotericin B|amphotericin b|mesh-list
15192592|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
14687400|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687401|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14687402|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687403|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
14294382|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294383|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294384|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14294385|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
14294386|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14294387|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294388|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14294389|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14294390|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14294391|NCT00575588|Metformin|metformin|mesh-list
14294392|NCT00575588|Saxagliptin|saxagliptin|mesh-list
14294393|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14294394|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294395|NCT00575588|Incretins|incretins|mesh-ancestor
14687404|NCT00338377|Vidarabine|vidarabine|mesh-list
14687405|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
14687406|NCT00338377|Fludarabine|fludarabine|mesh-list
14687407|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
14687408|NCT00338377|Interleukin-2|interleukin-2|mesh-list
14687409|NCT00338377|Vaccines|vaccines|mesh-list
14687410|NCT00338377|Mesna|mesna|mesh-list
14687411|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687412|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
15192593|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192594|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15192595|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15192596|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192597|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192598|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15192599|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
15192600|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192601|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192602|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15192603|NCT03827278|Amebicides|amebicides|mesh-ancestor
15192604|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15192605|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15192606|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15192607|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
15192608|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15192609|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
15192610|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
15192611|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687413|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687414|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727549|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
14687415|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14687416|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
14687417|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687418|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687419|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14687420|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687421|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
14687422|NCT00338377|Antiviral Agents|antiviral agents|mesh-ancestor
14687423|NCT00338377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687424|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14687425|NCT00338377|Analgesics|analgesics|mesh-ancestor
14687426|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
14687427|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687428|NCT00338377|Protective Agents|protective agents|mesh-ancestor
14687429|NCT00338390|Lamivudine|lamivudine|mesh-list
15192612|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192613|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192614|NCT03826693|Analgesics|analgesics|mesh-ancestor
15192615|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
15192616|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687430|NCT00338390|Abacavir|abacavir|mesh-list
14687431|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
14687432|NCT00338390|Didanosine|didanosine|mesh-list
14687433|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14687434|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14687435|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687436|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687437|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
14687438|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687439|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14687440|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14687441|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
14687442|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
14687443|NCT00338416|Hematinics|hematinics|mesh-ancestor
14687444|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
14687445|NCT00338468|Hematinics|hematinics|mesh-ancestor
14687446|NCT00338481|Morphine|morphine|mesh-list
14687447|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15192617|NCT03826940|Lovastatin|lovastatin|mesh-list
15192618|NCT03826940|L 647318|l 647318|mesh-list
15192619|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
15192620|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15192621|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15192622|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
15192623|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192624|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15192625|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15192626|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687448|NCT00338481|Narcotics|narcotics|mesh-ancestor
14687449|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687450|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687451|NCT00338481|Analgesics|analgesics|mesh-ancestor
14687452|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
14687453|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687454|NCT00338494|Clofarabine|clofarabine|mesh-list
14687455|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687456|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
14687457|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687458|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687459|NCT00338507|Erdosteine|erdosteine|mesh-list
14687460|NCT00338507|Expectorants|expectorants|mesh-ancestor
14687461|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
14687462|NCT00338546|Cocaine|cocaine|mesh-list
14687463|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
14687464|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14687465|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687466|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687467|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14687468|NCT00338546|Analgesics|analgesics|mesh-ancestor
14687469|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
15192627|NCT03826875|Fluoxetine|fluoxetine|mesh-list
15192628|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14687470|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687471|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14687472|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14687473|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14687474|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
14687475|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687476|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687477|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
14687478|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
14687479|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14687480|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14687481|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14687482|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687483|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
14687484|NCT00338624|Oxybutynin|oxybutynin|mesh-list
14687485|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
14687486|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
14687487|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687488|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687489|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14687490|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14687491|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
14687492|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687493|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687494|NCT00338624|Urological Agents|urological agents|mesh-ancestor
14687495|NCT00338650|Adalimumab|adalimumab|mesh-list
14687496|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687497|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687498|NCT00338754|Adalimumab|adalimumab|mesh-list
14687499|NCT00338754|Antibodies|antibodies|mesh-list
14687500|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14687501|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
14687502|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687503|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687504|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687505|NCT00338767|Fluoxetine|fluoxetine|mesh-list
14687506|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14687507|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14687508|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687509|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687510|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687511|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
14687512|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687513|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14687514|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
14687515|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687516|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14687517|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14687518|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687519|NCT00338780|Lamivudine|lamivudine|mesh-list
14687520|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14687521|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14687522|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687523|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687524|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
14687525|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687526|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14687527|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14687528|NCT00338793|Prednisolone|prednisolone|mesh-list
14687529|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687530|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
14687531|NCT00338793|Hormones|hormones|mesh-ancestor
14687532|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14687533|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224084|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14687534|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14687535|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687536|NCT00338910|Metronidazole|metronidazole|mesh-list
14687537|NCT00338910|Budesonide|budesonide|mesh-list
14687538|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687539|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14687540|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
14687541|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687542|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687543|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14687544|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
14687545|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
14687546|NCT00338910|Hormones|hormones|mesh-ancestor
14687547|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192629|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15192630|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192631|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192632|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192633|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
15192634|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192635|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15192636|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
15192637|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192638|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15192639|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14294396|NCT00575588|Hormones|hormones|mesh-ancestor
14687548|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687549|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687550|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14687551|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14687552|NCT00338936|Valsartan|valsartan|mesh-list
14687553|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14687554|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14687555|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14687556|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14687557|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687558|NCT00338936|Diuretics|diuretics|mesh-ancestor
14687559|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
14687560|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687561|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14687562|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687563|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
14687564|NCT00339001|Hematinics|hematinics|mesh-ancestor
14687565|NCT00339014|Zonisamide|zonisamide|mesh-list
14687566|NCT00339014|Bupropion|bupropion|mesh-list
14687567|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14687568|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
14687569|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687570|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14687571|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14687572|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687573|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687574|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
14687575|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687576|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687577|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14687578|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14687579|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687580|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
14687581|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14687582|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14687583|NCT00339066|Sertraline|sertraline|mesh-list
14687584|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
14687585|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687586|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14687587|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14687588|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687589|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687590|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687591|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
14687592|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687593|NCT00339118|Doxorubicin|doxorubicin|mesh-list
14687594|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
14687595|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14687596|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687597|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14687598|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14687599|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687600|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687601|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687602|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
14687603|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687604|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687605|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14687606|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
14687607|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14687608|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14687609|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687610|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687611|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687612|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14687613|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14687614|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687615|NCT00339196|Azacitidine|azacitidine|mesh-list
14687616|NCT00339196|Tretinoin|tretinoin|mesh-list
14687617|NCT00339196|Valproic Acid|valproic acid|mesh-list
14687618|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687619|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
14687620|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687621|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687622|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192640|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192641|NCT03826589|Avelumab|avelumab|mesh-list
15192642|NCT03826589|Axitinib|axitinib|mesh-list
15192643|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192644|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192645|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15192646|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192647|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687623|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
14687624|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14687625|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
14687626|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
14687627|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687628|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687629|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
14687630|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14687631|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687632|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687633|NCT00339417|Ivermectin|ivermectin|mesh-list
14687634|NCT00339417|Albendazole|albendazole|mesh-list
14687635|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14687636|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687637|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
14687638|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
14687639|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14687640|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14687641|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14687642|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14687643|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14687644|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687645|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727550|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727551|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727552|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727553|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727554|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14727555|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727556|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
14727557|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727558|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14727559|NCT00513981|Antidotes|antidotes|mesh-ancestor
14727560|NCT00513981|Protective Agents|protective agents|mesh-ancestor
14727561|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
14727562|NCT00513981|Vitamins|vitamins|mesh-ancestor
14727563|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
14727564|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
14727565|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
14727566|NCT00514072|Vaccines|vaccines|mesh-list
14727567|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
14727568|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
14727569|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727570|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14727571|NCT00514111|Interferons|interferons|mesh-list
14727572|NCT00514111|Ribavirin|ribavirin|mesh-list
14727573|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727574|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
15192648|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
14727575|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727576|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
14727577|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727578|NCT00514163|Gemcitabine|gemcitabine|mesh-list
14687646|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15192649|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
15192650|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
15192651|NCT03826615|Gabapentin|gabapentin|mesh-list
15192652|NCT03826615|Analgesics|analgesics|mesh-ancestor
14687647|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687648|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14687649|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687650|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687651|NCT00339768|Amoxicillin|amoxicillin|mesh-list
14687652|NCT00339768|Omeprazole|omeprazole|mesh-list
14687653|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687654|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687655|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14687656|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687657|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14687658|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687659|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687660|NCT00340080|Abacavir|abacavir|mesh-list
14687661|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14687662|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14687663|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687664|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687665|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
14687666|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687667|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14687668|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14687669|NCT00340184|Paclitaxel|paclitaxel|mesh-list
14687670|NCT00340184|Carboplatin|carboplatin|mesh-list
14687671|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14687672|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687673|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
14687674|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
15192653|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
15192654|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192655|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687675|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
14687676|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687677|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14687678|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14687679|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14687680|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
14687681|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687682|NCT00340574|Antacids|antacids|mesh-ancestor
14687683|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687684|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687685|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
14687686|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14687687|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687688|NCT00340691|Doxycycline|doxycycline|mesh-list
14687689|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687690|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687691|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
14687692|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14687693|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14687694|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
14687695|NCT00341055|Hematinics|hematinics|mesh-ancestor
14727579|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727580|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
14727581|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727582|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727583|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
14727584|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727585|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727586|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727587|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
14727588|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727589|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
14727590|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14727591|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727592|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14727593|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14727594|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192656|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
14687696|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14687697|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14687698|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
14687699|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687700|NCT00341250|Antacids|antacids|mesh-ancestor
14687701|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687702|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687703|NCT00341432|Nicotine|nicotine|mesh-list
14687704|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14687705|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
14687706|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687707|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687708|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14687709|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14687710|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
14687711|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687712|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687713|NCT00342381|Amifampridine|amifampridine|mesh-list
14687714|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14687715|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687716|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687717|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14687718|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687719|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727595|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727596|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
14727597|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727598|NCT00514228|Sunitinib|sunitinib|mesh-list
14727599|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727600|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14727601|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14727602|NCT00514228|Growth Substances|growth substances|mesh-ancestor
14727603|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727604|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
14727605|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14727606|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727607|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727608|NCT00514293|Carboplatin|carboplatin|mesh-list
14727609|NCT00514293|Docetaxel|docetaxel|mesh-list
14727610|NCT00514293|Capecitabine|capecitabine|mesh-list
14727611|NCT00514293|Tretinoin|tretinoin|mesh-list
14727612|NCT00514293|Bexarotene|bexarotene|mesh-list
14727613|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727614|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
14727615|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
14727616|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
14727617|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727618|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727619|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
14727620|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
14727621|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727622|NCT00514397|Temozolomide|temozolomide|mesh-list
14727623|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
14727624|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14727625|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
14727626|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727627|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727628|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14727629|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727630|NCT00514410|Folic Acid|folic acid|mesh-list
14727631|NCT00514410|Hematinics|hematinics|mesh-ancestor
14727632|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
14727633|NCT00514410|Vitamins|vitamins|mesh-ancestor
14727634|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
14727635|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727636|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14727637|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
14727638|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727639|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
14727640|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14814940|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14814941|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14814942|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
14814943|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727641|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15192657|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14687720|NCT00342849|Succimer|succimer|mesh-list
14687721|NCT00342849|Antidotes|antidotes|mesh-ancestor
14687722|NCT00342849|Protective Agents|protective agents|mesh-ancestor
14687723|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687724|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
14687725|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
14687726|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687727|NCT00342862|Alefacept|alefacept|mesh-list
14687728|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
14687729|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
14687730|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687731|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14687732|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14687733|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
14687734|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687735|NCT00343005|Antacids|antacids|mesh-ancestor
14687736|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687737|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687738|NCT00343070|Citalopram|citalopram|mesh-list
14687739|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14687740|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14687741|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687742|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687743|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687744|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
14687745|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687746|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14687747|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
14687748|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687749|NCT00343096|Lorazepam|lorazepam|mesh-list
14687750|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
14687751|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
14687752|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
14687753|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687754|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687755|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687756|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15192658|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15192659|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192660|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192661|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15192662|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15192663|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192664|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192665|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
15192666|NCT03826602|Metformin|metformin|mesh-list
15192667|NCT03826602|Tucatinib|tucatinib|mesh-list
15192668|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15192669|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192670|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192671|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15192672|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192673|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192674|NCT03826550|Diclofenac|diclofenac|mesh-list
15192675|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192676|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192677|NCT03826550|Analgesics|analgesics|mesh-ancestor
15192678|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
15192679|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192680|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192681|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687757|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687758|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14687759|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14687760|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14687761|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
14687762|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
14687763|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687764|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687765|NCT00343135|Amoxicillin|amoxicillin|mesh-list
14687766|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
14687767|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
14727642|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192682|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687768|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14687769|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687770|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687771|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14687772|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687773|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687774|NCT00343161|Esomeprazole|esomeprazole|mesh-list
14687775|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14687776|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
14687777|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14687778|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687779|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14687780|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687781|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687782|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14687783|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
15192683|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15192684|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687784|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687785|NCT00343161|Antacids|antacids|mesh-ancestor
14687786|NCT00343174|Ancrod|ancrod|mesh-list
14687787|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
14687788|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14687789|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14687790|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687791|NCT00343187|Dapsone|dapsone|mesh-list
14687792|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687793|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
14687794|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14687795|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14687796|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14687797|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687798|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687799|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
14687800|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687801|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
14687802|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687803|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
15192685|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192686|NCT03826485|Pranlukast|pranlukast|mesh-list
15192687|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15192688|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
15192689|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15192690|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
15192691|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192692|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687804|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14687805|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14687806|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687807|NCT00343200|Urological Agents|urological agents|mesh-ancestor
14687808|NCT00343226|Basiliximab|basiliximab|mesh-list
14687809|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687810|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
14687811|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687812|NCT00343239|Docetaxel|docetaxel|mesh-list
14687813|NCT00343239|Fluorouracil|fluorouracil|mesh-list
14687814|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687815|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
15192693|NCT03826524|Epinephrine|epinephrine|mesh-list
14687816|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
14687817|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
14687818|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687819|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
14687820|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687821|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687822|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
14687823|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687824|NCT00343265|Progesterone|progesterone|mesh-list
14687825|NCT00343265|Progestins|progestins|mesh-ancestor
14687826|NCT00343265|Hormones|hormones|mesh-ancestor
14687827|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14687828|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687829|NCT00343278|Valacyclovir|valacyclovir|mesh-list
14687830|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
14687831|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687832|NCT00343317|Cefoxitin|cefoxitin|mesh-list
14687833|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14687834|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687835|NCT00343369|Cytarabine|cytarabine|mesh-list
14687836|NCT00343369|Dexamethasone|dexamethasone|mesh-list
14687837|NCT00343369|Prednisolone|prednisolone|mesh-list
14687838|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
14687839|NCT00343369|Doxorubicin|doxorubicin|mesh-list
14687840|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14687841|NCT00343369|Methotrexate|methotrexate|mesh-list
14687842|NCT00343369|Vincristine|vincristine|mesh-list
14687843|NCT00343369|Daunorubicin|daunorubicin|mesh-list
14687844|NCT00343369|Asparaginase|asparaginase|mesh-list
14687845|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
14687846|NCT00343369|Pegaspargase|pegaspargase|mesh-list
14687847|NCT00343369|Thioguanine|thioguanine|mesh-list
14687848|NCT00343369|Teniposide|teniposide|mesh-list
14687849|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687850|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
14687851|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687852|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687853|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14687854|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
14687855|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687856|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687857|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14687858|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687859|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
14687860|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
14687861|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687862|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14687863|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
14687864|NCT00343369|Hormones|hormones|mesh-ancestor
14687865|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14687866|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14687867|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14687868|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14687869|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14687870|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687871|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14687872|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
14687873|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14687874|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14687875|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
14687876|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
14687877|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14687878|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14687879|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
14687880|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687881|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14687882|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
14687883|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
14687884|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
14687885|NCT00343408|Leucovorin|leucovorin|mesh-list
14687886|NCT00343408|Gemcitabine|gemcitabine|mesh-list
14687887|NCT00343408|Fluorouracil|fluorouracil|mesh-list
14687888|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
15192694|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15192695|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15192696|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
15192697|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192698|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192699|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192700|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14687889|NCT00343408|Cediranib|cediranib|mesh-list
14687890|NCT00343408|Calcium|calcium|mesh-list
14687891|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
14687892|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687893|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192701|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15192702|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
14687894|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
14687895|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687896|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
14687897|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14687898|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687899|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192703|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687900|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
14687901|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687902|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14687903|NCT00343408|Antidotes|antidotes|mesh-ancestor
14687904|NCT00343408|Protective Agents|protective agents|mesh-ancestor
14687905|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
14687906|NCT00343408|Vitamins|vitamins|mesh-ancestor
14687907|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
14687908|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14687909|NCT00343421|Vaccines|vaccines|mesh-list
14687910|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14687911|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
14687912|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687913|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
14687914|NCT00343447|Rituximab|rituximab|mesh-list
14687915|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14687916|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
14687917|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687918|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687919|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14687920|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
14687921|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687922|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687923|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14687924|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14687925|NCT00343486|Solabegron|solabegron|mesh-list
14687926|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14687927|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14687928|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14687929|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
14687930|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687931|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687932|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687933|NCT00343499|Valsartan|valsartan|mesh-list
14687934|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14687935|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14687936|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14687937|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687938|NCT00343525|Bavituximab|bavituximab|mesh-list
14687939|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14687940|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687941|NCT00343629|Sulindac|sulindac|mesh-list
15192704|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15192705|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
15192706|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
15192707|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
15192708|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15192709|NCT03826368|Cannabidiol|cannabidiol|mesh-list
15192710|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
14687942|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14687943|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14687944|NCT00343629|Analgesics|analgesics|mesh-ancestor
14687945|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
14687946|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687947|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687948|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14687949|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14687950|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687951|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15192711|NCT03826316|Nalbuphine|nalbuphine|mesh-list
15192712|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15192713|NCT03826316|Narcotics|narcotics|mesh-ancestor
15192714|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192715|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192716|NCT03826316|Analgesics|analgesics|mesh-ancestor
15192717|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
15192718|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192719|NCT03825965|Cannabidiol|cannabidiol|mesh-list
15192720|NCT03825965|Anticonvulsants|anticonvulsants|mesh-ancestor
15192721|NCT03825887|Morphine|morphine|mesh-list
15192722|NCT03825887|Nalbuphine|nalbuphine|mesh-list
15192723|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15192724|NCT03825887|Narcotics|narcotics|mesh-ancestor
15192725|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687952|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192726|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687953|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687954|NCT00343655|Atorvastatin|atorvastatin|mesh-list
14687955|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14687956|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14687957|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
14687958|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687959|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14687960|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14687961|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687962|NCT00343668|Irinotecan|irinotecan|mesh-list
14687963|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14687964|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14687965|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687966|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687967|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687968|NCT00343707|Paroxetine|paroxetine|mesh-list
14687969|NCT00343707|Vestipitant|vestipitant|mesh-list
14687970|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14687971|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14687972|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14687973|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14687974|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14687975|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
14687976|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687977|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14687978|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
14687979|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192727|NCT03825887|Analgesics|analgesics|mesh-ancestor
15192728|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
15192729|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192730|NCT03826004|Clemastine|clemastine|mesh-list
15192731|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
15192732|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
14687980|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14687981|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14687982|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14687983|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14687984|NCT00343720|Bortezomib|bortezomib|mesh-list
14687985|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14687986|NCT00343733|Fentanyl|fentanyl|mesh-list
14687987|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14687988|NCT00343733|Narcotics|narcotics|mesh-ancestor
14687989|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14687990|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14687991|NCT00343733|Analgesics|analgesics|mesh-ancestor
14687992|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
14687993|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14687994|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14687995|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14687996|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
14687997|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
14687998|NCT00343759|Lapatinib|lapatinib|mesh-list
14687999|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688000|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14688001|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688002|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688003|NCT00343798|Cyclosporine|cyclosporine|mesh-list
15192733|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15192734|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
15192735|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
15192736|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192737|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192738|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192739|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15192740|NCT03825861|Folfirinox|folfirinox|mesh-list
15192741|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224085|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224086|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224087|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224088|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15224089|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15224090|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14688004|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
14688005|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
15192742|NCT03825809|Acetaminophen|acetaminophen|mesh-list
15192743|NCT03825809|Celecoxib|celecoxib|mesh-list
15192744|NCT03825809|Ketorolac|ketorolac|mesh-list
15192745|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14688006|NCT00343798|Fludarabine|fludarabine|mesh-list
14688007|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
14688008|NCT00343798|Cyclosporins|cyclosporins|mesh-list
14688009|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688010|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
14688011|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688012|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688013|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14688014|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
14688015|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688016|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688017|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14688018|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688019|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
14688020|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688021|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
14688022|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688023|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14688024|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14688025|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14688026|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14688027|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
14688028|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14688029|NCT00343811|Modafinil|modafinil|mesh-list
14688030|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14688031|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688032|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14688033|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14688034|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14688035|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688036|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15192746|NCT03825809|Diazepam|diazepam|mesh-list
15192747|NCT03825809|Gabapentin|gabapentin|mesh-list
15192748|NCT03825809|Hydrocodone|hydrocodone|mesh-list
15192749|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192750|NCT03825809|Analgesics|analgesics|mesh-ancestor
15192751|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
15192752|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192753|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192754|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
15192755|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192756|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192757|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15192758|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15192759|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15192760|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192761|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192762|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
15192763|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15192764|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14294397|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688037|NCT00343824|Laxatives|laxatives|mesh-ancestor
14688038|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688039|NCT00343850|Mesalamine|mesalamine|mesh-list
14688040|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14688041|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14688042|NCT00343850|Analgesics|analgesics|mesh-ancestor
14688043|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
14688044|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688045|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688046|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688047|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688048|NCT00343876|Aspirin|aspirin|mesh-list
14688049|NCT00343876|Clopidogrel|clopidogrel|mesh-list
14688050|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192765|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192766|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14688051|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14688052|NCT00343876|Analgesics|analgesics|mesh-ancestor
14688053|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
14688054|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688055|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688056|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688057|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688058|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14688059|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14688060|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688061|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14688062|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14688063|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688064|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
14688065|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14688066|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14688067|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14688068|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
14688069|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688070|NCT00343980|Insulin|insulin|mesh-list
14688071|NCT00343980|Glimepiride|glimepiride|mesh-list
15192767|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15192768|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15192769|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688072|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
14688073|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14688074|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14688075|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688076|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14688077|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688078|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
14688079|NCT00344006|Artesunate|artesunate|mesh-list
14688080|NCT00344006|Lumefantrine|lumefantrine|mesh-list
14688081|NCT00344006|Artemether|artemether|mesh-list
14688082|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14688083|NCT00344006|Dapsone|dapsone|mesh-list
14688084|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
14688085|NCT00344006|Proguanil|proguanil|mesh-list
14688086|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
14688087|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14688088|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14688089|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688090|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688091|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
14688092|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
14688093|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14688094|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
14688095|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14688096|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688097|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688098|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
14688099|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14688100|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
14688101|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
14688102|NCT00344058|Analgesics|analgesics|mesh-ancestor
14688103|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
14688104|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688105|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688106|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
14688107|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688108|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14688109|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
14688110|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14688111|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14688112|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688113|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14688114|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
14688115|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14688116|NCT00344123|Ritonavir|ritonavir|mesh-list
15192770|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
15192771|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15192772|NCT03825809|Narcotics|narcotics|mesh-ancestor
15192773|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
15192774|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
15192775|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14688117|NCT00344123|Tipranavir|tipranavir|mesh-list
14688118|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15192776|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
15192777|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
15192778|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192779|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15192780|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15192781|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15192782|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14688119|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14688120|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14688121|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
14688122|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688123|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688124|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14688125|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14688126|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
14688127|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688128|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14688129|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14688130|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14688131|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14688132|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
14688133|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14688134|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14814944|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14814945|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14688135|NCT00344149|Rituximab|rituximab|mesh-list
14688136|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688137|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688138|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
14688139|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688140|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14814946|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14814947|NCT00864669|Metformin|metformin|mesh-list
14814948|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14814949|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814950|NCT00864734|Metformin|metformin|mesh-list
14814951|NCT00864734|Glyburide|glyburide|mesh-list
14814952|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14814953|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814954|NCT00864747|Propranolol|propranolol|mesh-list
14814955|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14814956|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14814957|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
14814958|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814959|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814960|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814961|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14814962|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14814963|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
14814964|NCT00864760|Gabapentin|gabapentin|mesh-list
14814965|NCT00864760|Analgesics|analgesics|mesh-ancestor
15192783|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
15192784|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
15192785|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
15192786|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
15192787|NCT03825601|Flumazenil|flumazenil|mesh-list
15192788|NCT03825601|Antidotes|antidotes|mesh-ancestor
15192789|NCT03825601|Protective Agents|protective agents|mesh-ancestor
14814966|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
14814967|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688141|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14688142|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
14688143|NCT00344201|Coagulants|coagulants|mesh-ancestor
14688144|NCT00344227|Ranibizumab|ranibizumab|mesh-list
14688145|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688146|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688147|NCT00344227|Growth Substances|growth substances|mesh-ancestor
14688148|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688149|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688150|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688151|NCT00344253|Interferons|interferons|mesh-list
14688152|NCT00344253|Interferon-beta|interferon-beta|mesh-list
14688153|NCT00344253|Methotrexate|methotrexate|mesh-list
14688154|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14688155|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
14688156|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14688157|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688158|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688159|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
14688160|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688161|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688162|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
14688163|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688164|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14688165|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192790|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192791|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
15192792|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
15192793|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192794|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192795|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
15192796|NCT03825471|Anesthetics|anesthetics|mesh-list
15192797|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192798|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192799|NCT03825471|Narcotics|narcotics|mesh-ancestor
15192800|NCT03825471|Analgesics|analgesics|mesh-ancestor
15192801|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
15192802|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192803|NCT03825757|Aspirin|aspirin|mesh-list
15192804|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
15192805|NCT03825757|Salicylates|salicylates|mesh-list
15192806|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192807|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
15192808|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
14688166|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
14688167|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688168|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14688169|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
14688170|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688171|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14688172|NCT00344383|Norgestimate|norgestimate|mesh-list
14688173|NCT00344383|Estradiol|estradiol|mesh-list
14688174|NCT00344383|Estrogens|estrogens|mesh-ancestor
14688175|NCT00344383|Hormones|hormones|mesh-ancestor
14688176|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688177|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688178|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14688179|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
14688180|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14688181|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14688182|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14688183|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15192809|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
15192810|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192811|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192812|NCT03825757|Analgesics|analgesics|mesh-ancestor
14688184|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14688185|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
14688186|NCT00344409|Hematinics|hematinics|mesh-ancestor
14688187|NCT00344422|Dexamethasone|dexamethasone|mesh-list
14688188|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
14688189|NCT00344422|Doxorubicin|doxorubicin|mesh-list
14688190|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14688191|NCT00344422|Vincristine|vincristine|mesh-list
14688192|NCT00344422|BB 1101|bb 1101|mesh-list
14688193|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688194|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
14688195|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
14688196|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688197|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688198|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688199|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
14688200|NCT00344422|Hormones|hormones|mesh-ancestor
14688201|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688202|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14688203|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688204|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
14688205|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688206|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688207|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14688208|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14688209|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15192813|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
15192814|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192815|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192816|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192817|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688210|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14688211|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
14688212|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
14688213|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
14688214|NCT00344513|Carvedilol|carvedilol|mesh-list
14688215|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14688216|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14688217|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14688218|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
14688219|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688220|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688221|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688222|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14688223|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
14688224|NCT00344513|Protective Agents|protective agents|mesh-ancestor
14688225|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14688226|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14688227|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14688228|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
14688229|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14688230|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14688231|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
14688232|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688233|NCT00344526|Dexamethasone|dexamethasone|mesh-list
14688234|NCT00344526|Melphalan|melphalan|mesh-list
14688235|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688236|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
14688237|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
14688238|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688239|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688240|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688241|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
14688242|NCT00344526|Hormones|hormones|mesh-ancestor
14688243|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688244|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14688245|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688246|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15192818|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15192819|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192820|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192821|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15192822|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15192823|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14688247|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
14688248|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688249|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14688250|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688251|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
14688252|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14688253|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14688254|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
14688255|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688256|NCT00344539|Antacids|antacids|mesh-ancestor
14688257|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688258|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688259|NCT00344552|Paclitaxel|paclitaxel|mesh-list
14688260|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14688261|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688262|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
14688263|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
14688264|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
14688265|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688266|NCT00344565|Modafinil|modafinil|mesh-list
14688267|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14688268|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688269|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14688270|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14688271|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14688272|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688273|NCT00344617|Bevacizumab|bevacizumab|mesh-list
14688274|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688275|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688276|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688277|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688278|NCT00344617|Growth Substances|growth substances|mesh-ancestor
14688279|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688280|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
14727643|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727644|NCT00514527|Oritavancin|oritavancin|mesh-list
14727645|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14727646|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727647|NCT00514605|Antibodies|antibodies|mesh-list
14727648|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
15192824|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
15192825|NCT03825380|Bimatoprost|bimatoprost|mesh-list
15192826|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15192827|NCT03825250|Valproic Acid|valproic acid|mesh-list
15192828|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
15192829|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192830|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192831|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
15192832|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192833|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192834|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
15192835|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15192836|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192837|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15192838|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14727649|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
14727650|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727651|NCT00514618|Misoprostol|misoprostol|mesh-list
14727652|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14727653|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
14727654|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14727655|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727656|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14727657|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727658|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
14727659|NCT00514657|Mitogens|mitogens|mesh-list
14727660|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14727661|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727662|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
14727663|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14727664|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727665|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
14727666|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
15192839|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14688281|NCT00344669|Albendazole|albendazole|mesh-list
14688282|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
14688283|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14688284|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688285|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
14688286|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14688287|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14688288|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14688289|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14688290|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14688291|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688292|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688293|NCT00344695|Bupropion|bupropion|mesh-list
14688294|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14688295|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
14688296|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14688297|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14688298|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14688299|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14688300|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688301|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
14688302|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688303|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688304|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14688305|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14688306|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688307|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14688308|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688309|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688310|NCT00344760|Tenofovir|tenofovir|mesh-list
14688311|NCT00344760|Lamivudine|lamivudine|mesh-list
14688312|NCT00344760|Efavirenz|efavirenz|mesh-list
14688313|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
14688314|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
14688315|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688316|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14688317|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14688318|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688319|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688320|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14688321|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14688322|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14688323|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14688324|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14688325|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14688326|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14688327|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14688328|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14688329|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14688330|NCT00344812|Buprenorphine|buprenorphine|mesh-list
14688331|NCT00344812|Methadone|methadone|mesh-list
14688332|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14688333|NCT00344812|Narcotics|narcotics|mesh-ancestor
14688334|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688335|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688336|NCT00344812|Analgesics|analgesics|mesh-ancestor
14688337|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
14688338|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688339|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14688340|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
14688341|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14688342|NCT00344825|Fludarabine|fludarabine|mesh-list
14688343|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
14688344|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
14688345|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688346|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688347|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
15192840|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192841|NCT03825198|Dexamethasone|dexamethasone|mesh-list
15192842|NCT03825198|Ketorolac|ketorolac|mesh-list
15192843|NCT03825198|Sufentanil|sufentanil|mesh-list
15192844|NCT03825198|Morphine|morphine|mesh-list
15192845|NCT03825198|Bromides|bromides|mesh-list
15192846|NCT03825198|Propofol|propofol|mesh-list
15192847|NCT03825198|Sevoflurane|sevoflurane|mesh-list
15192848|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
15192849|NCT03825198|Rocuronium|rocuronium|mesh-list
14688348|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688349|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688350|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
14688351|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688352|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688353|NCT00344851|Metformin|metformin|mesh-list
14688354|NCT00344851|Exenatide|exenatide|mesh-list
14688355|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14688356|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688357|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14688358|NCT00344851|Incretins|incretins|mesh-ancestor
14688359|NCT00344851|Hormones|hormones|mesh-ancestor
14688360|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688361|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14688362|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688363|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688364|NCT00344942|Triamcinolone|triamcinolone|mesh-list
14688365|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14688366|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14688367|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14688368|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688369|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
14688370|NCT00344942|Hormones|hormones|mesh-ancestor
14688371|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688372|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688373|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688374|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
14688375|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688376|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688377|NCT00344955|Atorvastatin|atorvastatin|mesh-list
14688378|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14688379|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14688380|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
14688381|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688382|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14688383|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14688384|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688385|NCT00344981|Tenofovir|tenofovir|mesh-list
14688386|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
14688387|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
14688388|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688389|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14688390|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14688391|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688392|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688393|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14688394|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14688395|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688396|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
14688397|NCT00344994|Pramipexole|pramipexole|mesh-list
14688398|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
14688399|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688400|NCT00344994|Protective Agents|protective agents|mesh-ancestor
14688401|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688402|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14688403|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14688404|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
14688405|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
14688406|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688407|NCT00345059|Gemcitabine|gemcitabine|mesh-list
14688408|NCT00345059|Capecitabine|capecitabine|mesh-list
15192850|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192851|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
15192852|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
15192853|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192854|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192855|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15192856|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
15192857|NCT03825198|Hormones|hormones|mesh-ancestor
15192858|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15192859|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15192860|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192861|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
15192862|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688409|NCT00345059|Docetaxel|docetaxel|mesh-list
14688410|NCT00345059|Vinorelbine|vinorelbine|mesh-list
14688411|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688412|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
14688413|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688414|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688415|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
14688416|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688417|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688418|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688419|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
14688420|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688421|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14688422|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14688423|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14688424|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14688425|NCT00345098|Amibegron|amibegron|mesh-list
14688426|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14688427|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14688428|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14688429|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688430|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688431|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688432|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14688433|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688434|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688435|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14688436|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688437|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688438|NCT00345163|Bevacizumab|bevacizumab|mesh-list
14688439|NCT00345163|Irinotecan|irinotecan|mesh-list
15192863|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15192864|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15192865|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
15192866|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14688440|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688441|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688442|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688443|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688444|NCT00345163|Growth Substances|growth substances|mesh-ancestor
14688445|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688446|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688447|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14688448|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14688449|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688450|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688451|NCT00345202|Atorvastatin|atorvastatin|mesh-list
14688452|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14688453|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14688454|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
14688455|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688456|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14688457|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14688458|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688459|NCT00345306|Progesterone|progesterone|mesh-list
14688460|NCT00345306|Progestins|progestins|mesh-ancestor
14688461|NCT00345306|Hormones|hormones|mesh-ancestor
14688462|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688463|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688464|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14688465|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
14688466|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688467|NCT00345501|Iloprost|iloprost|mesh-list
14688468|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14688469|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
14688470|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
14688471|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
14688472|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14688473|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14688474|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192867|NCT03825198|Narcotics|narcotics|mesh-ancestor
14688475|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15192868|NCT03825198|Analgesics|analgesics|mesh-ancestor
15192869|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
14688476|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688477|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14688478|NCT00345657|Niacin|niacin|mesh-list
14688479|NCT00345657|Lovastatin|lovastatin|mesh-list
14688480|NCT00345657|L 647318|l 647318|mesh-list
14688481|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
14688482|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14688483|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
14688484|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688485|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14688486|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
14688487|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
14688488|NCT00345657|Vitamins|vitamins|mesh-ancestor
14688489|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
14688490|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688491|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14688492|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14688493|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688494|NCT00345696|Bevacizumab|bevacizumab|mesh-list
14688495|NCT00345696|Capecitabine|capecitabine|mesh-list
14688496|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
14688497|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688498|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688499|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688500|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688501|NCT00345696|Growth Substances|growth substances|mesh-ancestor
14688502|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688503|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688504|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688505|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
14688506|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688507|NCT00345735|Fentanyl|fentanyl|mesh-list
14688508|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14688509|NCT00345735|Narcotics|narcotics|mesh-ancestor
14688510|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688511|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688512|NCT00345735|Analgesics|analgesics|mesh-ancestor
14688513|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
14688514|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688515|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14688516|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14688517|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
14688518|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
14688519|NCT00345761|Bevacizumab|bevacizumab|mesh-list
14688520|NCT00345761|Capecitabine|capecitabine|mesh-list
14688521|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
14688522|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688523|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688524|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688525|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688526|NCT00345761|Growth Substances|growth substances|mesh-ancestor
14688527|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688528|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688529|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688530|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
14688531|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688532|NCT00345787|Buprenorphine|buprenorphine|mesh-list
14688533|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14688534|NCT00345787|Narcotics|narcotics|mesh-ancestor
14688535|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688536|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688537|NCT00345787|Analgesics|analgesics|mesh-ancestor
14688538|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
14688539|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688540|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14688541|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
14688542|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14688543|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14688544|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
14688545|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
14688546|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688547|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688548|NCT00345826|Dasatinib|dasatinib|mesh-list
14688549|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688550|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14688551|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688552|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688553|NCT00345982|Sertindole|sertindole|mesh-list
15192870|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192871|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15192872|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15192873|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192874|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15192875|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15192876|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688554|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14688555|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14688556|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688557|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688558|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14688559|NCT00346047|Buprenorphine|buprenorphine|mesh-list
14688560|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14688561|NCT00346047|Narcotics|narcotics|mesh-ancestor
14688562|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688563|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688564|NCT00346047|Analgesics|analgesics|mesh-ancestor
14688565|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
15192877|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192878|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
15192879|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15192880|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15192881|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15192882|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
15192883|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15192884|NCT03825367|Nivolumab|nivolumab|mesh-list
15192885|NCT03825367|Azacitidine|azacitidine|mesh-list
14688566|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688567|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14688568|NCT00346099|Capecitabine|capecitabine|mesh-list
14688569|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
14688570|NCT00346099|Panitumumab|panitumumab|mesh-list
14688571|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688572|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
14688573|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688574|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688575|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688576|NCT00346190|Alendronate|alendronate|mesh-list
14688577|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14688578|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688579|NCT00346229|Doxorubicin|doxorubicin|mesh-list
14688580|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14688581|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14688582|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688583|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14688584|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14688585|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688586|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688587|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
14688588|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14688589|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688590|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
14688591|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688592|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688593|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14688594|NCT00346294|Etanercept|etanercept|mesh-list
14688595|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192886|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15192887|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192888|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15192889|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192890|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192891|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
15192892|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294398|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14294399|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
14294400|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688596|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14688597|NCT00346294|Analgesics|analgesics|mesh-ancestor
14688598|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
14688599|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688600|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688601|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688602|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688603|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688604|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688605|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
14688606|NCT00346359|Methotrexate|methotrexate|mesh-list
14688607|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
14688608|NCT00346359|Fludarabine|fludarabine|mesh-list
14688609|NCT00346359|Busulfan|busulfan|mesh-list
14688610|NCT00346359|Tacrolimus|tacrolimus|mesh-list
14688611|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14688612|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14688613|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
14688614|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14688615|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688616|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688617|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
14688618|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688619|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688620|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14688621|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688622|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14688623|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688624|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
14688625|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688626|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14688627|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14688628|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
14688629|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14688630|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14688631|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
14688632|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688633|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688634|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14688635|NCT00346463|Allopurinol|allopurinol|mesh-list
14688636|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
14688637|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688638|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294401|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294402|NCT00575666|Insulin|insulin|mesh-list
14294403|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14294404|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294405|NCT00575887|Temozolomide|temozolomide|mesh-list
14688639|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
14688640|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688641|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14688642|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
14688643|NCT00346463|Protective Agents|protective agents|mesh-ancestor
14688644|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727667|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14727668|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14727669|NCT00514748|Analgesics|analgesics|mesh-ancestor
14727670|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
14727671|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294406|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15192893|NCT03825328|Gemcitabine|gemcitabine|mesh-list
15192894|NCT03825328|Paclitaxel|paclitaxel|mesh-list
15192895|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
15192896|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14688645|NCT00346489|Fluorouracil|fluorouracil|mesh-list
14688646|NCT00346489|Mitomycins|mitomycins|mesh-list
14688647|NCT00346489|Mitomycin|mitomycin|mesh-list
14688648|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
14688649|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688650|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14688651|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688652|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688653|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
14688654|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688655|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14688656|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
14688657|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14688658|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688659|NCT00346502|Betulinic acid|betulinic acid|mesh-list
14688660|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14688661|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14688662|NCT00346502|Analgesics|analgesics|mesh-ancestor
14688663|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
14688664|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688665|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688666|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688667|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688668|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
14688669|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14688670|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14688671|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688672|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14688673|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688674|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
14688675|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
14688676|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14688677|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14688678|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14688679|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
14688680|NCT00346567|Tenofovir|tenofovir|mesh-list
14688681|NCT00346567|Lamivudine|lamivudine|mesh-list
14688682|NCT00346567|Zidovudine|zidovudine|mesh-list
14688683|NCT00346567|Emtricitabine|emtricitabine|mesh-list
14688684|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14688685|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14688686|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
14688687|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688688|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14688689|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14688690|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688691|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688692|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14688693|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15192897|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15192898|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192899|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
15192900|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
15192901|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
15192902|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192903|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15192904|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
15192905|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
14688694|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
14688695|NCT00346580|Nelfinavir|nelfinavir|mesh-list
14688696|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14688697|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14688698|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
14688699|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688700|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688701|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14688702|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14688703|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
14688704|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688705|NCT00346619|Nelfinavir|nelfinavir|mesh-list
14688706|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14688707|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14688708|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
14688709|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688710|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688711|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14688712|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14688713|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
14688714|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688715|NCT00346645|Bortezomib|bortezomib|mesh-list
14688716|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688717|NCT00346684|Rituximab|rituximab|mesh-list
14688718|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688719|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688720|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
15192906|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192907|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192908|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15192909|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
15192910|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688721|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688722|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688723|NCT00346749|Fluticasone|fluticasone|mesh-list
14688724|NCT00346749|Xhance|xhance|mesh-list
14688725|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14688726|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688727|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14688728|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
14688729|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688730|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688731|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14688732|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
14688733|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14688734|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14688735|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14688736|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14688737|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14688738|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
14688739|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688740|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688741|NCT00346801|Celecoxib|celecoxib|mesh-list
14688742|NCT00346801|Cisplatin|cisplatin|mesh-list
14688743|NCT00346801|Irinotecan|irinotecan|mesh-list
14688744|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688745|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14688746|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14688747|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688748|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688749|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14688750|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14688751|NCT00346801|Analgesics|analgesics|mesh-ancestor
14688752|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
14688753|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688754|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688755|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688756|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14688757|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14688758|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15192911|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
15192912|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15192913|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
15192914|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688759|NCT00346827|Apomorphine|apomorphine|mesh-list
14688760|NCT00346827|Emetics|emetics|mesh-ancestor
14688761|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688762|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
14688763|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688764|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688765|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
14688766|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
14688767|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688768|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688769|NCT00346840|Misoprostol|misoprostol|mesh-list
15192915|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
14688770|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14688771|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
15192916|NCT03825133|Protective Agents|protective agents|mesh-ancestor
14688772|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14688773|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688774|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14688775|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688776|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
14688777|NCT00346853|Fomepizole|fomepizole|mesh-list
14688778|NCT00346853|Antidotes|antidotes|mesh-ancestor
14688779|NCT00346853|Protective Agents|protective agents|mesh-ancestor
14688780|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688781|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688782|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688783|NCT00346866|Anecortave|anecortave|mesh-list
14688784|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688785|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688786|NCT00346866|Growth Substances|growth substances|mesh-ancestor
14688787|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688788|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688789|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688790|NCT00346879|PENTA|penta|mesh-list
14688791|NCT00346879|Fondaparinux|fondaparinux|mesh-list
14688792|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14688793|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
14688794|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14688795|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
14688796|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688797|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688798|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
14688799|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14688800|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14688801|NCT00346918|Sirolimus|sirolimus|mesh-list
14688802|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14688803|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688804|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14688805|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688806|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
14688807|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688808|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
14688809|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688810|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
14688811|NCT00346957|Anecortave|anecortave|mesh-list
14688812|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688813|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688814|NCT00346957|Growth Substances|growth substances|mesh-ancestor
14688815|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688816|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688817|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688818|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688819|NCT00346970|Niacin|niacin|mesh-list
14688820|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14688821|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
14688822|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688823|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14688824|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
14688825|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
14688826|NCT00346970|Vitamins|vitamins|mesh-ancestor
14688827|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
14688828|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688829|NCT00346996|Insulin|insulin|mesh-list
14688830|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14688831|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
14688832|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
14688833|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
14688834|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
14688835|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14688836|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688837|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14688838|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14688839|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14688840|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14688841|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14688842|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
14688843|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688844|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688845|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688846|NCT00347048|Tacrolimus|tacrolimus|mesh-list
14688847|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14688848|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
15192917|NCT03824847|Clarithromycin|clarithromycin|mesh-list
14688849|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688850|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14688851|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688852|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688853|NCT00347087|Irbesartan|irbesartan|mesh-list
14688854|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14688855|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14688856|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14688857|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688858|NCT00347100|Metformin|metformin|mesh-list
14688859|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
14688860|NCT00347100|Glyburide|glyburide|mesh-list
14688861|NCT00347100|Glipizide|glipizide|mesh-list
14688862|NCT00347100|Gliclazide|gliclazide|mesh-list
14688863|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14688864|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688865|NCT00347113|Albendazole|albendazole|mesh-list
14688866|NCT00347113|Praziquantel|praziquantel|mesh-list
14688867|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
14688868|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14688869|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14688870|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
14688871|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14688872|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14688873|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
14688874|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
14688875|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
14688876|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688877|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15192918|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15192919|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15192920|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15192921|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192922|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192923|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14688878|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14688879|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14688880|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
14688881|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688882|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688883|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14688884|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
14688885|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14688886|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14688887|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14688888|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
14688889|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688890|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688891|NCT00347152|Valproic Acid|valproic acid|mesh-list
14688892|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
14688893|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688894|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688895|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
14688896|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688897|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688898|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
14688899|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14688900|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688901|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14688902|NCT00347165|Bevacizumab|bevacizumab|mesh-list
14688903|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688904|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688905|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688906|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15192924|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15192925|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
15192926|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15192927|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15192928|NCT03824925|Zinc|zinc|mesh-list
15192929|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
15192930|NCT03824925|Trace Elements|trace elements|mesh-ancestor
14688907|NCT00347165|Growth Substances|growth substances|mesh-ancestor
14688908|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688909|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688910|NCT00347204|Ketorolac|ketorolac|mesh-list
14688911|NCT00347204|Nepafenac|nepafenac|mesh-list
14688912|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14688913|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14688914|NCT00347204|Analgesics|analgesics|mesh-ancestor
14688915|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
14688916|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688917|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688918|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14688919|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15192931|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
15192932|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192933|NCT03824925|Astringents|astringents|mesh-ancestor
15192934|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
15192935|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15192936|NCT03825081|Pilocarpine|pilocarpine|mesh-list
15192937|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15192938|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15192939|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15192940|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15192941|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
15192942|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15192943|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192944|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192945|NCT03825081|Miotics|miotics|mesh-ancestor
15192946|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
15192947|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192948|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14688920|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14688921|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14688922|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688923|NCT00347256|Cisplatin|cisplatin|mesh-list
14688924|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688925|NCT00347295|Estazolam|estazolam|mesh-list
14688926|NCT00347295|Brotizolam|brotizolam|mesh-list
14688927|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15192949|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15192950|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
15192951|NCT03825068|Anesthetics|anesthetics|mesh-list
15192952|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
15192953|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192954|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192955|NCT03824665|Fentanyl|fentanyl|mesh-list
15192956|NCT03824665|Nalbuphine|nalbuphine|mesh-list
15192957|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15192958|NCT03824665|Narcotics|narcotics|mesh-ancestor
15192959|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192960|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192961|NCT03824665|Analgesics|analgesics|mesh-ancestor
15192962|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
15192963|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192964|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15192965|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15192966|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
15192967|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
15192968|NCT03825016|Diclofenac|diclofenac|mesh-list
14688928|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688929|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688930|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
14688931|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14688932|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14688933|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14688934|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
14688935|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
14688936|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688937|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688938|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
14688939|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688940|NCT00347386|Astringents|astringents|mesh-ancestor
14688941|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
14688942|NCT00347399|Bevacizumab|bevacizumab|mesh-list
14688943|NCT00347399|Verteporfin|verteporfin|mesh-list
14688944|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688945|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688946|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14688947|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14688948|NCT00347399|Growth Substances|growth substances|mesh-ancestor
15192969|NCT03825016|Lidocaine|lidocaine|mesh-list
15192970|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
15192971|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
14688949|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688950|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
14688951|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15192972|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192973|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192974|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
15192975|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192976|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15192977|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15192978|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15192979|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15192980|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15192981|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15192982|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15192983|NCT03825016|Analgesics|analgesics|mesh-ancestor
14688952|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
14688953|NCT00347412|Paclitaxel|paclitaxel|mesh-list
14688954|NCT00347412|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14688955|NCT00347412|Carboplatin|carboplatin|mesh-list
14688956|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14688957|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14688958|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
14688959|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
14688960|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
14688961|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688962|NCT00347425|Olanzapine|olanzapine|mesh-list
14688963|NCT00347425|Risperidone|risperidone|mesh-list
14688964|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14688965|NCT00347425|Aripiprazole|aripiprazole|mesh-list
14688966|NCT00347425|Ziprasidone|ziprasidone|mesh-list
14688967|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14688968|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
14688969|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14688970|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688971|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14688972|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14688973|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14688974|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14688975|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14688976|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14688977|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
14688978|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
14688979|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
14688980|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14688981|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14688982|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14688983|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14688984|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14688985|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
14688986|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
14688987|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15192984|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15192985|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15192986|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15192987|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15192988|NCT03824717|Ropivacaine|ropivacaine|mesh-list
15192989|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
15192990|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
15192991|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192992|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15192993|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
15192994|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15192995|NCT03824834|Morphine|morphine|mesh-list
15192996|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15192997|NCT03824834|Narcotics|narcotics|mesh-ancestor
15192998|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15192999|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193000|NCT03824834|Analgesics|analgesics|mesh-ancestor
15193001|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
15193002|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193003|NCT03824691|Durvalumab|durvalumab|mesh-list
15193004|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14688988|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14688989|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14688990|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14688991|NCT00347490|Enoxaparin|enoxaparin|mesh-list
14688992|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
14688993|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14688994|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14688995|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14688996|NCT00347503|Ketorolac|ketorolac|mesh-list
14688997|NCT00347503|Bromfenac|bromfenac|mesh-list
14688998|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14688999|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689000|NCT00347503|Analgesics|analgesics|mesh-ancestor
15193005|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193006|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15193007|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
15193008|NCT03824379|Cathartics|cathartics|mesh-ancestor
14689001|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
14689002|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689003|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689004|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689005|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193009|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193010|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193011|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
15193012|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15193013|NCT03824535|Fluorides|fluorides|mesh-list
15193014|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15193015|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689006|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689007|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689008|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689009|NCT00347542|Vitamin D|vitamin d|mesh-list
14689010|NCT00347542|Vitamins|vitamins|mesh-ancestor
14689011|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
14689012|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689013|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14689014|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
14689015|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14689016|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
14689017|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689018|NCT00347555|Antacids|antacids|mesh-ancestor
14689019|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689020|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14689021|NCT00347581|Methamphetamine|methamphetamine|mesh-list
14689022|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14689023|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689024|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
14689025|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
14689026|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689027|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
14689028|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689029|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689030|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14689031|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14689032|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14689033|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689034|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14689035|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
14689036|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14689037|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14689038|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689039|NCT00347685|Tramadol|tramadol|mesh-list
14814968|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814969|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
14814970|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14814971|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14814972|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14814973|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814974|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14814975|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15193016|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
14689040|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14814976|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14814977|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14814978|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
14689041|NCT00347685|Narcotics|narcotics|mesh-ancestor
14689042|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689043|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689044|NCT00347685|Analgesics|analgesics|mesh-ancestor
14689045|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
14689046|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689047|NCT00347698|Bevacizumab|bevacizumab|mesh-list
14689048|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14689049|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689050|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14689051|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14689052|NCT00347698|Growth Substances|growth substances|mesh-ancestor
14689053|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689054|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
14689055|NCT00347724|Tramadol|tramadol|mesh-list
14689056|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14689057|NCT00347724|Narcotics|narcotics|mesh-ancestor
14689058|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689059|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689060|NCT00347724|Analgesics|analgesics|mesh-ancestor
14689061|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
14689062|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689063|NCT00347737|Teriparatide|teriparatide|mesh-list
14689064|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14689065|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689066|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14689067|NCT00347750|Lopinavir|lopinavir|mesh-list
14689068|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14689069|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14689070|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
14689071|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689072|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689073|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14689074|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14689075|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
14689076|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689077|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14689078|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14689079|NCT00347763|Permethrin|permethrin|mesh-list
14689080|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689081|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689082|NCT00347802|Bimatoprost|bimatoprost|mesh-list
14689083|NCT00347802|Travoprost|travoprost|mesh-list
14689084|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689085|NCT00347815|Buprenorphine|buprenorphine|mesh-list
14689086|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14689087|NCT00347815|Narcotics|narcotics|mesh-ancestor
14689088|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689089|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689090|NCT00347815|Analgesics|analgesics|mesh-ancestor
14689091|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
14689092|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689093|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14294407|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
14689094|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
14689095|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
14689096|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14689097|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14689098|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14689099|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689100|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14689101|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14689102|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689103|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689104|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689105|NCT00347841|Bimatoprost|bimatoprost|mesh-list
14689106|NCT00347841|Latanoprost|latanoprost|mesh-list
14689107|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14689108|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15193017|NCT03824535|Protective Agents|protective agents|mesh-ancestor
15193018|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193019|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
15193020|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
15193021|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193022|NCT03824327|Papaverine|papaverine|mesh-list
15193023|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15193024|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193025|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193026|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
15193027|NCT03824327|Urological Agents|urological agents|mesh-ancestor
15193028|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
15193029|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15193030|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15193031|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193032|NCT03824171|Vitamins|vitamins|mesh-ancestor
15193033|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
15193034|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14689109|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689110|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15193035|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15193036|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
15193037|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193038|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15193039|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15193040|NCT03824314|Fentanyl|fentanyl|mesh-list
15193041|NCT03824314|Midazolam|midazolam|mesh-list
14689111|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14689112|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
14689113|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14689114|NCT00347854|Laxatives|laxatives|mesh-ancestor
14689115|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14689116|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
14689117|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
14689118|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14689119|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14689120|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689121|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689122|NCT00347867|Urological Agents|urological agents|mesh-ancestor
14689123|NCT00347971|Rituximab|rituximab|mesh-list
14689124|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14689125|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689126|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
14689127|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689128|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727672|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727673|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727674|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727675|NCT00514761|Capecitabine|capecitabine|mesh-list
14727676|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727677|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
14727678|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727679|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727680|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14727681|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15193042|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15193043|NCT03824314|Narcotics|narcotics|mesh-ancestor
15193044|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193045|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193046|NCT03824314|Analgesics|analgesics|mesh-ancestor
15193047|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
15193048|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193049|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15193050|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15193051|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
15193052|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
14727682|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727683|NCT00514891|Vitamin A|vitamin a|mesh-list
14727684|NCT00514891|Vitamins|vitamins|mesh-ancestor
14727685|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
14727686|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727687|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
14727688|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193053|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14727689|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14727690|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193054|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14689129|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14689130|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
14689131|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14689132|NCT00348010|Tramadol|tramadol|mesh-list
14689133|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14689134|NCT00348010|Narcotics|narcotics|mesh-ancestor
14689135|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689136|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689137|NCT00348010|Analgesics|analgesics|mesh-ancestor
14689138|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
14689139|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689140|NCT00348023|Timolol|timolol|mesh-list
14294408|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294409|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294410|NCT00575965|Simvastatin|simvastatin|mesh-list
14294411|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14294412|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14689141|NCT00348023|Bimatoprost|bimatoprost|mesh-list
14689142|NCT00348023|Travoprost|travoprost|mesh-list
14689143|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14689144|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14689145|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14689146|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689147|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689148|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689149|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14689150|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689151|NCT00348062|Bimatoprost|bimatoprost|mesh-list
14689152|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689153|NCT00348101|Enoximone|enoximone|mesh-list
14689154|NCT00348101|Esmolol|esmolol|mesh-list
14689155|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14689156|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14689157|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14689158|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
14689159|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689160|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689161|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689162|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14689163|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
14689164|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14689165|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14689166|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689167|NCT00348101|Protective Agents|protective agents|mesh-ancestor
14689168|NCT00348153|Adalimumab|adalimumab|mesh-list
14689169|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689170|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689171|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
14689172|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
14689173|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
14689174|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689175|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689176|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
14689177|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14689178|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14689179|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
14689180|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689181|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689182|NCT00348192|Donepezil|donepezil|mesh-list
14689183|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14689184|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689185|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689186|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
14689187|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689188|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689189|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
14689190|NCT00348231|Insulin|insulin|mesh-list
14689191|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689192|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689193|NCT00348244|Prednisolone|prednisolone|mesh-list
14689194|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14689195|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
15193055|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14689196|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14689197|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
14689198|NCT00348244|Ketorolac|ketorolac|mesh-list
14689199|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14689200|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
14689201|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689202|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
14689203|NCT00348244|Hormones|hormones|mesh-ancestor
14689204|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14689205|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689206|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14689207|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689208|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
15193056|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15193057|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
14689209|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
14689210|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689211|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14689212|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14689213|NCT00348244|Protective Agents|protective agents|mesh-ancestor
14689214|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689215|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689216|NCT00348244|Analgesics|analgesics|mesh-ancestor
14689217|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
14689218|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689219|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689220|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689221|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689222|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
14689223|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14689224|NCT00348296|Antibodies|antibodies|mesh-list
14689225|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
14689226|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14689227|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
14689228|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689229|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14689230|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
14689231|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14689232|NCT00348335|Cyclosporine|cyclosporine|mesh-list
14689233|NCT00348335|Cyclosporins|cyclosporins|mesh-list
14689234|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689235|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689236|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689237|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
14689238|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689239|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
14689240|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689241|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
14689242|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689243|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14689244|NCT00348361|Fluticasone|fluticasone|mesh-list
14689245|NCT00348361|Xhance|xhance|mesh-list
14689246|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689247|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14689248|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
14689249|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689250|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689251|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14689252|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
14689253|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
14689254|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14689255|NCT00348387|Vaccines|vaccines|mesh-list
14689256|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
14689257|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689258|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14689259|NCT00348400|Dorzolamide|dorzolamide|mesh-list
14689260|NCT00348400|Latanoprost|latanoprost|mesh-list
14689261|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14689262|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14689263|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689264|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14689265|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14689266|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14689267|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
14689268|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689269|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689270|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689271|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14689272|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689273|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
14689274|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14689275|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14689276|NCT00348413|Prednisolone|prednisolone|mesh-list
14689277|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
14689278|NCT00348413|Methotrexate|methotrexate|mesh-list
14689279|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14689280|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
14689281|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14689282|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
14689283|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14689284|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689285|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14689286|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
14689287|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689288|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689289|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
14689290|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689291|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14689292|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689293|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
14689294|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689295|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14689296|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689297|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
14689298|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
14689299|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689300|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14689301|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
14689302|NCT00348413|Hormones|hormones|mesh-ancestor
14689303|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14689304|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14689305|NCT00348413|Protective Agents|protective agents|mesh-ancestor
14689306|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14689307|NCT00348426|Antitoxins|antitoxins|mesh-list
14689308|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
14689309|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
14689310|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689311|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
14689312|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14689313|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14689314|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689315|NCT00348452|Celecoxib|celecoxib|mesh-list
14689316|NCT00348452|Tramadol|tramadol|mesh-list
14689317|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689318|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689319|NCT00348452|Analgesics|analgesics|mesh-ancestor
14689320|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
14689321|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689322|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689323|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689324|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689325|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14689326|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689327|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689328|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689329|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15193058|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
15193059|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193060|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193061|NCT03824119|Ibuprofen|ibuprofen|mesh-list
15193062|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193063|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15193064|NCT03824119|Analgesics|analgesics|mesh-ancestor
15193065|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
14689330|NCT00348452|Narcotics|narcotics|mesh-ancestor
14689331|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689332|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
14689333|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14689334|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689335|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689336|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689337|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689338|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689339|NCT00348491|Analgesics|analgesics|mesh-ancestor
14689340|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
14689341|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689342|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689343|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689344|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689345|NCT00348504|Simendan|simendan|mesh-list
14689346|NCT00348504|Dobutamine|dobutamine|mesh-list
14689347|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14689348|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
14689349|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14689350|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14689351|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689352|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689353|NCT00348504|Protective Agents|protective agents|mesh-ancestor
14689354|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689355|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
14689356|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
14689357|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689358|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14689359|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14689360|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14689361|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
14689362|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689363|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14689364|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14689365|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
14689366|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14689367|NCT00348517|Laxatives|laxatives|mesh-ancestor
14689368|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14689369|NCT00348530|Verapamil|verapamil|mesh-list
14689370|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14689371|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14689372|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689373|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689374|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14689375|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689376|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
14689377|NCT00348582|Ketorolac|ketorolac|mesh-list
14689378|NCT00348582|Nepafenac|nepafenac|mesh-list
14689379|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689380|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689381|NCT00348582|Analgesics|analgesics|mesh-ancestor
14689382|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
14689383|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689384|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689385|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689386|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689387|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689388|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689389|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689390|NCT00348634|Tegaserod|tegaserod|mesh-list
14689391|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14689392|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
14689393|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193066|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193067|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193068|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689394|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689395|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689396|NCT00348712|Insulin|insulin|mesh-list
14689397|NCT00348712|Metformin|metformin|mesh-list
14689398|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
14689399|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14689400|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689401|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689402|NCT00348725|Metformin|metformin|mesh-list
15193069|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193070|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193071|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193072|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193073|NCT03824340|Doxycycline|doxycycline|mesh-list
15193074|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193075|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193076|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
15193077|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15193078|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14689403|NCT00348725|Fenofibrate|fenofibrate|mesh-list
14689404|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689405|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689406|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14689407|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
14689408|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689409|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14689410|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
14689411|NCT00348738|Hematinics|hematinics|mesh-ancestor
14689412|NCT00348764|Polidocanol|polidocanol|mesh-list
14689413|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14689414|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14689415|NCT00348894|Reboxetine|reboxetine|mesh-list
14689416|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
14689417|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15193079|NCT03824002|Insulin|insulin|mesh-list
15193080|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15193081|NCT03824002|Metformin|metformin|mesh-list
15193082|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
15193083|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
15193084|NCT03824002|Dulaglutide|dulaglutide|mesh-list
15193085|NCT03824002|Repaglinide|repaglinide|mesh-list
15193086|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
15193087|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15193088|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15193089|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193090|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
15193091|NCT03823911|Grazoprevir|grazoprevir|mesh-list
15193092|NCT03823911|Ledipasvir|ledipasvir|mesh-list
15193093|NCT03823911|Velpatasvir|velpatasvir|mesh-list
15193094|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
15193095|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15193096|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
15193097|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193098|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
15193099|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
15193100|NCT03823846|Parecoxib|parecoxib|mesh-list
14689418|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14689419|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14689420|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689421|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689422|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
15193101|NCT03823846|Dezocine|dezocine|mesh-list
15193102|NCT03823846|Analgesics|analgesics|mesh-ancestor
15193103|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
15193104|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689423|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193105|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193106|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193107|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15193108|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193109|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193110|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193111|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689424|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689425|NCT00348920|Bupivacaine|bupivacaine|mesh-list
14689426|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
14689427|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
14689428|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689429|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689430|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
14689431|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689432|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
14689433|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689434|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689435|NCT00348985|Bortezomib|bortezomib|mesh-list
14689436|NCT00348985|Belinostat|belinostat|mesh-list
14689437|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689438|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14689439|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689440|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689441|NCT00348998|Bevacizumab|bevacizumab|mesh-list
14689442|NCT00348998|Goserelin|goserelin|mesh-list
14689443|NCT00348998|Bicalutamide|bicalutamide|mesh-list
14689444|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14689445|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689446|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14689447|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14689448|NCT00348998|Growth Substances|growth substances|mesh-ancestor
14689449|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193112|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193113|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15193114|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15193115|NCT03823846|Narcotics|narcotics|mesh-ancestor
15193116|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689450|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
14689451|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14689452|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
14689453|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
14689454|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14689455|NCT00349024|Povidone|povidone|mesh-list
14689456|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
14689457|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14689458|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
14689459|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689460|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
14689461|NCT00349024|Protective Agents|protective agents|mesh-ancestor
14689462|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
14689463|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
14689464|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
15193117|NCT03823703|Cortisone|cortisone|mesh-list
15193118|NCT03823703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193119|NCT03823976|Anesthetics|anesthetics|mesh-list
15193120|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193121|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224091|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689465|NCT00349076|Fluorouracil|fluorouracil|mesh-list
14689466|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689467|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
14689468|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689469|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14689470|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689471|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
14689472|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689473|NCT00349089|Pemetrexed|pemetrexed|mesh-list
14689474|NCT00349089|Vinorelbine|vinorelbine|mesh-list
14689475|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689476|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689477|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689478|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14689479|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14689480|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14689481|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
14689482|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14689483|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14689484|NCT00349115|Thalidomide|thalidomide|mesh-list
14689485|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689486|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
14689487|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689488|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
14689489|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14689490|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689491|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14689492|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14689493|NCT00349115|Growth Substances|growth substances|mesh-ancestor
14689494|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
14689495|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689496|NCT00349128|Metformin|metformin|mesh-list
14689497|NCT00349128|Fenofibrate|fenofibrate|mesh-list
14689498|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689499|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689500|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14689501|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
14689502|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689503|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14689504|NCT00349180|Enoxaparin|enoxaparin|mesh-list
14689505|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
14689506|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
14689507|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14689508|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14689509|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689510|NCT00349206|Sirolimus|sirolimus|mesh-list
14689511|NCT00349206|Sorafenib|sorafenib|mesh-list
14689512|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689513|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14689514|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689515|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689516|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14689517|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689518|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14689519|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
14689520|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689521|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
15193122|NCT03823950|Sargramostim|sargramostim|mesh-list
15193123|NCT03823950|Lenograstim|lenograstim|mesh-list
14689522|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689523|NCT00349219|Gemcitabine|gemcitabine|mesh-list
14689524|NCT00349219|Cisplatin|cisplatin|mesh-list
14689525|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14689526|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689527|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14689528|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
14689529|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689530|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
14689531|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689532|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689533|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689534|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
14689535|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689536|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14689537|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
14689538|NCT00349245|Remifentanil|remifentanil|mesh-list
14689539|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14689540|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689541|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689542|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689543|NCT00349245|Analgesics|analgesics|mesh-ancestor
14689544|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
14689545|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689546|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14689547|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14689548|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14689549|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
14689550|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729482|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193124|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
15193125|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193126|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14689551|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689552|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14689553|NCT00349245|Narcotics|narcotics|mesh-ancestor
14689554|NCT00349258|Leuprolide|leuprolide|mesh-list
14689555|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14689556|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
14689557|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14689558|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689559|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14689560|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689561|NCT00349284|Ezetimibe|ezetimibe|mesh-list
14689562|NCT00349284|Fenofibrate|fenofibrate|mesh-list
14689563|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14689564|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14689565|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
14689566|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689567|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14689568|NCT00349310|Pramipexole|pramipexole|mesh-list
14689569|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
14689570|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689571|NCT00349310|Protective Agents|protective agents|mesh-ancestor
14689572|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689573|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14689574|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14689575|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
14689576|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
14689577|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689578|NCT00349362|Testosterone|testosterone|mesh-list
14689579|NCT00349362|Androgens|androgens|mesh-ancestor
14689580|NCT00349362|Hormones|hormones|mesh-ancestor
14689581|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14689582|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814979|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
15193127|NCT03823612|Calcium|calcium|mesh-list
15193128|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15193129|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193130|NCT03823638|Mannitol|mannitol|mesh-list
15193131|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15193132|NCT03823638|Diuretics|diuretics|mesh-ancestor
15193133|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
15193134|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193135|NCT03823625|Nivolumab|nivolumab|mesh-list
15193136|NCT03823625|Ipilimumab|ipilimumab|mesh-list
14689583|NCT00349375|Simvastatin|simvastatin|mesh-list
15193137|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15193138|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193139|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15193140|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193141|NCT03823781|Milrinone|milrinone|mesh-list
15193142|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15193143|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15193144|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
15193145|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15193146|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15193147|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193148|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193149|NCT03823781|Protective Agents|protective agents|mesh-ancestor
15193150|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193151|NCT03823339|Liraglutide|liraglutide|mesh-list
15193152|NCT03823339|Xultophy|xultophy|mesh-list
14689584|NCT00349375|Fenofibrate|fenofibrate|mesh-list
14814980|NCT00864773|Growth Substances|growth substances|mesh-ancestor
14814981|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14814982|NCT00864799|Misoprostol|misoprostol|mesh-list
14814983|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14814984|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
14814985|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14814986|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193153|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689585|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14689586|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14689587|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
14689588|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689589|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14689590|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14689591|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689592|NCT00349401|Ketorolac|ketorolac|mesh-list
14689593|NCT00349401|Morphine|morphine|mesh-list
14689594|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14689595|NCT00349401|Narcotics|narcotics|mesh-ancestor
14689596|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689597|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689598|NCT00349401|Analgesics|analgesics|mesh-ancestor
14689599|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
14689600|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689601|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689602|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689603|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689604|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689605|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689606|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689607|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689608|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
14689609|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689610|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193154|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193155|NCT03823339|Incretins|incretins|mesh-ancestor
15193156|NCT03823339|Hormones|hormones|mesh-ancestor
15193157|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193158|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
15193159|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15193160|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14689611|NCT00349440|Cyclosporine|cyclosporine|mesh-list
14689612|NCT00349440|Cyclosporins|cyclosporins|mesh-list
14689613|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689614|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689615|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689616|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
14689617|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689618|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
14689619|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689620|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
14689621|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689622|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14689623|NCT00349453|Deferiprone|deferiprone|mesh-list
14689624|NCT00349453|Deferoxamine|deferoxamine|mesh-list
14689625|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14689626|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
14689627|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
14689628|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689629|NCT00349453|Siderophores|siderophores|mesh-ancestor
14689630|NCT00349492|Cisplatin|cisplatin|mesh-list
14689631|NCT00349492|Irinotecan|irinotecan|mesh-list
14689632|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689633|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14689634|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14689635|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689636|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689637|NCT00349518|Dasatinib|dasatinib|mesh-list
14689638|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689639|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14689640|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689641|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689642|NCT00349531|Pramipexole|pramipexole|mesh-list
14689643|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
14689644|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224092|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294413|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
14689645|NCT00349531|Protective Agents|protective agents|mesh-ancestor
14689646|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689647|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14689648|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14689649|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
14689650|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
14689651|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727691|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727692|NCT00514982|Adalimumab|adalimumab|mesh-list
14727693|NCT00514982|Mesalamine|mesalamine|mesh-list
14727694|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
14727695|NCT00514982|Infliximab|infliximab|mesh-list
14727696|NCT00514982|Tacrolimus|tacrolimus|mesh-list
14727697|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727698|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
14727699|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727700|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14727701|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727702|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727703|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727704|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727705|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727706|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727707|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
14727708|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727709|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727710|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14727711|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14727712|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14727713|NCT00514982|Analgesics|analgesics|mesh-ancestor
14727714|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
14727715|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727716|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
14727717|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14727718|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14727719|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
14727720|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
14727721|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727722|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727723|NCT00515138|Rituximab|rituximab|mesh-list
14727724|NCT00515138|Carboplatin|carboplatin|mesh-list
14727725|NCT00515138|Etoposide|etoposide|mesh-list
14727726|NCT00515138|Bortezomib|bortezomib|mesh-list
14727727|NCT00515138|Ifosfamide|ifosfamide|mesh-list
14727728|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14727729|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727730|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
14727731|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727732|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727733|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14727734|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14727735|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727736|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727737|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727738|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14727739|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
14727740|NCT00515151|Ethanol|ethanol|mesh-list
14727741|NCT00515151|Octenidine|octenidine|mesh-list
14727742|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14727743|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727744|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727745|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727746|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
14727747|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727748|NCT00515229|Amitriptyline|amitriptyline|mesh-list
14814987|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14689652|NCT00349557|Bevacizumab|bevacizumab|mesh-list
14689653|NCT00349557|Goserelin|goserelin|mesh-list
14689654|NCT00349557|Bicalutamide|bicalutamide|mesh-list
14689655|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14689656|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689657|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14689658|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14689659|NCT00349557|Growth Substances|growth substances|mesh-ancestor
14689660|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689661|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
14689662|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14689663|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
14689664|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
14689665|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14689666|NCT00349583|Cyclosporine|cyclosporine|mesh-list
14689667|NCT00349583|Cyclosporins|cyclosporins|mesh-list
14689668|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689669|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689670|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689671|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
14689672|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689673|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
14689674|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689675|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
14689676|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689677|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14689678|NCT00349596|Decitabine|decitabine|mesh-list
14689679|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14689680|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
14689681|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689682|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689683|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689684|NCT00349635|Metformin|metformin|mesh-list
14689685|NCT00349635|Fenofibrate|fenofibrate|mesh-list
14689686|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689687|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689688|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14689689|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
14689690|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689691|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14689692|NCT00349674|Methotrexate|methotrexate|mesh-list
14689693|NCT00349674|Azathioprine|azathioprine|mesh-list
14689694|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14689695|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
14689696|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14689697|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193161|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193162|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
15193163|NCT03823417|Coagulants|coagulants|mesh-ancestor
14689698|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15193164|NCT03823079|Irinotecan|irinotecan|mesh-list
15193165|NCT03823079|Raltitrexed|raltitrexed|mesh-list
15193166|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15193167|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15193168|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193169|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193170|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689699|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
14689700|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689701|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689702|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
14689703|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689704|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14689705|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689706|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
14689707|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689708|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14689709|NCT00349726|Inositol|inositol|mesh-list
14689710|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
14689711|NCT00349726|Vitamins|vitamins|mesh-ancestor
14689712|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
14689713|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689714|NCT00349739|Anecortave|anecortave|mesh-list
14689715|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14689716|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15193171|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14689717|NCT00349739|Growth Substances|growth substances|mesh-ancestor
14689718|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689719|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
14689720|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689721|NCT00349791|Testosterone|testosterone|mesh-list
14689722|NCT00349791|Androgens|androgens|mesh-ancestor
14689723|NCT00349791|Hormones|hormones|mesh-ancestor
14689724|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14689725|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689726|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
14689727|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14689728|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689729|NCT00350038|Irbesartan|irbesartan|mesh-list
14689730|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
14689731|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689732|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14689733|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14689734|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689735|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14689736|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
14689737|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14689738|NCT00350051|Prednisone|prednisone|mesh-list
14689739|NCT00350051|Sagopilone|sagopilone|mesh-list
14689740|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689741|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
14689742|NCT00350051|Hormones|hormones|mesh-ancestor
14689743|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14689744|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689745|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14689746|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689747|NCT00350077|Vitamins|vitamins|mesh-list
14689748|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
14689749|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
14689750|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689751|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
14689752|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689753|NCT00350077|Protective Agents|protective agents|mesh-ancestor
14689754|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
14294414|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294415|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14689755|NCT00350090|Hematinics|hematinics|mesh-ancestor
14689756|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
14689757|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
14294416|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14294417|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689758|NCT00350116|Vitamins|vitamins|mesh-ancestor
14689759|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
14689760|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689761|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
14689762|NCT00350116|Hematinics|hematinics|mesh-ancestor
14689763|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
15193172|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
15193173|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15193174|NCT03823274|Aspirin|aspirin|mesh-list
15193175|NCT03823274|Clopidogrel|clopidogrel|mesh-list
14689764|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14689765|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689766|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689767|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689768|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689769|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689770|NCT00350155|Analgesics|analgesics|mesh-ancestor
14689771|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
15193176|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193177|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15193178|NCT03823274|Analgesics|analgesics|mesh-ancestor
15193179|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
15193180|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193181|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193182|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193183|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193184|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15193185|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14689772|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193186|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689773|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689774|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689775|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689776|NCT00350168|Amlodipine|amlodipine|mesh-list
14689777|NCT00350168|Valsartan|valsartan|mesh-list
14689778|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689779|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14689780|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689781|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689782|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14689783|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294418|NCT00576056|Sorafenib|sorafenib|mesh-list
14294419|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294420|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14294421|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294422|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294423|NCT00576199|Bevacizumab|bevacizumab|mesh-list
14294424|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294425|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294426|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14294427|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14294428|NCT00576199|Growth Substances|growth substances|mesh-ancestor
14294429|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294430|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
14294431|NCT00576251|Tobramycin|tobramycin|mesh-list
14294432|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14294433|NCT00576251|Dexamethasone|dexamethasone|mesh-list
14294434|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294435|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
14294436|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
14294437|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689784|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
14689785|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14689786|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14689787|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
14689788|NCT00350181|Sirolimus|sirolimus|mesh-list
14689789|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
15193187|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15193188|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193189|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193190|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
15193191|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15193192|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15193193|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15193194|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
15193195|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193196|NCT03823482|Lidocaine|lidocaine|mesh-list
15193197|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
15193198|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
15193199|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193200|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689790|NCT00350181|Busulfan|busulfan|mesh-list
14689791|NCT00350181|Carmustine|carmustine|mesh-list
14689792|NCT00350181|Etoposide|etoposide|mesh-list
14689793|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689794|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
14689795|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689796|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689797|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14689798|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
14689799|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689800|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689801|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14689802|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14689803|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14689804|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14689805|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689806|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14689807|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14689808|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
14689809|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14689810|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294438|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193201|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
14294439|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14689811|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
14689812|NCT00350311|Nicotine|nicotine|mesh-list
14689813|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14689814|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
14689815|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689816|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689817|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14689818|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14689819|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14689820|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689821|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689822|NCT00350415|Mesalamine|mesalamine|mesh-list
14689823|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689824|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689825|NCT00350415|Analgesics|analgesics|mesh-ancestor
14689826|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
14689827|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689828|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689829|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689830|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689831|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
14689832|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689833|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
14689834|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14689835|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14689836|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689837|NCT00350441|Urological Agents|urological agents|mesh-ancestor
14689838|NCT00350454|Sirolimus|sirolimus|mesh-list
14689839|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14689840|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689841|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14689842|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689843|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
14689844|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689845|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
14689846|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689847|NCT00350467|Olanzapine|olanzapine|mesh-list
14689848|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14689849|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
14689850|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
14689851|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689852|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689853|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14689854|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14689855|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14689856|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689857|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14689858|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14689859|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14689860|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689861|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689862|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14689863|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
14689864|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14689865|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14689866|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14689867|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14689868|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
14689869|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14689870|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
14689871|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14689872|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14689873|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
14689874|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14689875|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689876|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14689877|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14689878|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14689879|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689880|NCT00350597|Molgramostim|molgramostim|mesh-list
14689881|NCT00350597|Sargramostim|sargramostim|mesh-list
14689882|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
14689883|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193202|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689884|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689885|NCT00350662|Deferiprone|deferiprone|mesh-list
14689886|NCT00350662|Deferoxamine|deferoxamine|mesh-list
14689887|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14689888|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
14689889|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
14689890|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689891|NCT00350662|Siderophores|siderophores|mesh-ancestor
14689892|NCT00350753|Bevacizumab|bevacizumab|mesh-list
14689893|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14689894|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14689895|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689896|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14689897|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14689898|NCT00350753|Growth Substances|growth substances|mesh-ancestor
14689899|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689900|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
14689901|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14689902|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689903|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689904|NCT00350818|Azacitidine|azacitidine|mesh-list
14689905|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14689906|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
14689907|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689908|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689909|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689910|NCT00350857|Carbamazepine|carbamazepine|mesh-list
14689911|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
14689912|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
14689913|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14689914|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689915|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689916|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14689917|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689918|NCT00350857|Analgesics|analgesics|mesh-ancestor
14689919|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
14689920|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689921|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14689922|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689923|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689924|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14689925|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14689926|NCT00350948|Doxorubicin|doxorubicin|mesh-list
14689927|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14689928|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14689929|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689930|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14689931|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14689932|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689933|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689934|NCT00350961|Gemcitabine|gemcitabine|mesh-list
14689935|NCT00350961|Capecitabine|capecitabine|mesh-list
14689936|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
14689937|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14689938|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
14689939|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689940|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14689941|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
14689942|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14689943|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689944|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689945|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
14689946|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689947|NCT00351026|Methadone|methadone|mesh-list
14689948|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14689949|NCT00351026|Narcotics|narcotics|mesh-ancestor
14689950|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14689951|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689952|NCT00351026|Analgesics|analgesics|mesh-ancestor
14689953|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
14689954|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689955|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
14689956|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
14689957|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
15224093|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
14689958|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689959|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689960|NCT00351052|Analgesics|analgesics|mesh-ancestor
14689961|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
14689962|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689963|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689964|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689965|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689966|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
14689967|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14689968|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
14689969|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14689970|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689971|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689972|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
14689973|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14689974|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689975|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689976|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14689977|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689978|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15193203|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15193204|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15193205|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15193206|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689979|NCT00351104|Ketoprofen|ketoprofen|mesh-list
14689980|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14689981|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14689982|NCT00351104|Analgesics|analgesics|mesh-ancestor
14689983|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
14689984|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14689985|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689986|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14689987|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14689988|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14689989|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14689990|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689991|NCT00351130|Amlodipine|amlodipine|mesh-list
14689992|NCT00351130|Valsartan|valsartan|mesh-list
14689993|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14689994|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14689995|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14689996|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14689997|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14689998|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14689999|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
14690000|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14690001|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14690002|NCT00351143|Fluticasone|fluticasone|mesh-list
14690003|NCT00351143|Xhance|xhance|mesh-list
14690004|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14690005|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14690006|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14690007|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
14690008|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690009|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690010|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14690011|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690012|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14690013|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14690014|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14690015|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15193207|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193208|NCT03823040|Oxiconazole|oxiconazole|mesh-list
15193209|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
15193210|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193211|NCT03823248|Folic Acid|folic acid|mesh-list
15193212|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
15193213|NCT03823248|Hematinics|hematinics|mesh-ancestor
14690016|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14690017|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
14690018|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690019|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690020|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14690021|NCT00351169|Citalopram|citalopram|mesh-list
14690022|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14690023|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14690024|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690025|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690026|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690027|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
14690028|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690029|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14690030|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690031|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690032|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14690033|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14690034|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690035|NCT00351182|Doxycycline|doxycycline|mesh-list
14690036|NCT00351182|Telithromycin|telithromycin|mesh-list
14690037|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14690038|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690039|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
14690040|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14690041|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14690042|NCT00351195|Capecitabine|capecitabine|mesh-list
14690043|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
15193214|NCT03823248|Vitamins|vitamins|mesh-ancestor
15193215|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
15193216|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690044|NCT00351195|Etoposide|etoposide|mesh-list
14690045|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690046|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
14690047|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690048|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690049|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14690050|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14690051|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14690052|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690053|NCT00351221|Mecasermin|mecasermin|mesh-list
14690054|NCT00351221|Growth Substances|growth substances|mesh-ancestor
14690055|NCT00351221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690056|NCT00351286|Simvastatin|simvastatin|mesh-list
14690057|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14690058|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14690059|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
14690060|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690061|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14690062|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14690063|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727749|NCT00515229|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14727750|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14727751|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
14814988|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14814989|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
15193217|NCT03822975|Heparin|heparin|mesh-list
15193218|NCT03822975|Calcium heparin|calcium heparin|mesh-list
15193219|NCT03822975|Bivalirudin|bivalirudin|mesh-list
15193220|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
15193221|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15193222|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15193223|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193224|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
15193225|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15193226|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
15193227|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193228|NCT03822936|Fluorouracil|fluorouracil|mesh-list
15193229|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
15193230|NCT03822936|Irinotecan|irinotecan|mesh-list
15193231|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
15193232|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193233|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15193234|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193235|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15193236|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
14690064|NCT00351364|Montelukast|montelukast|mesh-list
15193237|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193238|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15193239|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15193240|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193241|NCT03822962|Acetaminophen|acetaminophen|mesh-list
15193242|NCT03822962|Ibuprofen|ibuprofen|mesh-list
15193243|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193244|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15193245|NCT03822962|Analgesics|analgesics|mesh-ancestor
15193246|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
15193247|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690065|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14690066|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690067|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14690068|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
14690069|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690070|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690071|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14690072|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14690073|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690074|NCT00351403|Ribavirin|ribavirin|mesh-list
14690075|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14690076|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
14690077|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690078|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
14690079|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690080|NCT00351507|Vildagliptin|vildagliptin|mesh-list
14690081|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690082|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690083|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14690084|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
14690085|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690086|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690087|NCT00351546|Vildagliptin|vildagliptin|mesh-list
14690088|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690089|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690090|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14690091|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
14690092|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690093|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690094|NCT00351585|Vildagliptin|vildagliptin|mesh-list
14690095|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690096|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690097|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14690098|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
14690099|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193248|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193249|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193250|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193251|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14690100|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690101|NCT00351637|Methadone|methadone|mesh-list
14690102|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14690103|NCT00351637|Narcotics|narcotics|mesh-ancestor
14690104|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690105|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690106|NCT00351637|Analgesics|analgesics|mesh-ancestor
14690107|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
14690108|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690109|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
15193252|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690110|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690111|NCT00351663|Enoxaparin|enoxaparin|mesh-list
14690112|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
14690113|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14690114|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14690115|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690116|NCT00351702|Isoniazid|isoniazid|mesh-list
14690117|NCT00351702|Ethambutol|ethambutol|mesh-list
14690118|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
14690119|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14690120|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690121|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14690122|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14690123|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
14690124|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690125|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14690126|NCT00351715|Methadone|methadone|mesh-list
14690127|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14690128|NCT00351715|Narcotics|narcotics|mesh-ancestor
14690129|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690130|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690131|NCT00351715|Analgesics|analgesics|mesh-ancestor
14690132|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
14690133|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690134|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
14690135|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690136|NCT00351832|Vildagliptin|vildagliptin|mesh-list
14690137|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690138|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690139|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14690140|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
14690141|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690142|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690143|NCT00351871|Ribavirin|ribavirin|mesh-list
14690144|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14690145|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
14690146|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690147|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
14690148|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690149|NCT00351884|Vildagliptin|vildagliptin|mesh-list
14690150|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690151|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690152|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14690153|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
14690154|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690155|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690156|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14690157|NCT00351910|Amitriptyline|amitriptyline|mesh-list
14690158|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14690159|NCT00351910|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14690160|NCT00351910|Citalopram|citalopram|mesh-list
14690161|NCT00351910|Bupropion|bupropion|mesh-list
14690162|NCT00351910|Fluoxetine|fluoxetine|mesh-list
14690163|NCT00351910|Paroxetine|paroxetine|mesh-list
14690164|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14690165|NCT00351910|Sertraline|sertraline|mesh-list
14690166|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14690167|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14690168|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690169|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690170|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690171|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
14690172|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690173|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14690174|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690175|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690176|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690177|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14690178|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
14690179|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14690180|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14690181|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690182|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14690183|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15193253|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193254|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
15193255|NCT03822754|Vaccines|vaccines|mesh-list
15193256|NCT03822754|Immunologic Factors|immunologic factors|mesh-ancestor
15193257|NCT03822754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193258|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15193259|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15193260|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193261|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193262|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15193263|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
15193264|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193265|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294440|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
14294441|NCT00576251|Hormones|hormones|mesh-ancestor
14690184|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690185|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14690186|NCT00351910|Analgesics|analgesics|mesh-ancestor
14690187|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
14690188|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14690189|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14690190|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14690191|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
14690192|NCT00351975|Azacitidine|azacitidine|mesh-list
14690193|NCT00351975|Belinostat|belinostat|mesh-list
14690194|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690195|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
14690196|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690197|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690198|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690199|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14690200|NCT00352079|Gefitinib|gefitinib|mesh-list
14690201|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
14690202|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690203|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14690204|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690205|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690206|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14690207|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
14690208|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690209|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
14690210|NCT00352092|Sirolimus|sirolimus|mesh-list
14690211|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14690212|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14690213|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690214|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14690215|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
14690216|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14690217|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690218|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690219|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690220|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
14690221|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690222|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
14727752|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14814990|NCT00864812|Fluticasone|fluticasone|mesh-list
14814991|NCT00864812|Xhance|xhance|mesh-list
14814992|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
14814993|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14814994|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14814995|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14814996|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14814997|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
14814998|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14814999|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815000|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14815001|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14815002|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
14815003|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14815004|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
14815005|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14815006|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815007|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193266|NCT03822663|Caffeine|caffeine|mesh-list
14690223|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690224|NCT00352144|Eszopiclone|eszopiclone|mesh-list
14690225|NCT00352144|Zopiclone|zopiclone|mesh-list
14690226|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14690227|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690228|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690229|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
14690230|NCT00352170|Vitamin D|vitamin d|mesh-list
14690231|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
14690232|NCT00352170|Calcium|calcium|mesh-list
14690233|NCT00352170|Vitamins|vitamins|mesh-ancestor
14690234|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
14690235|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690236|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14690237|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14690238|NCT00352183|Simvastatin|simvastatin|mesh-list
14690239|NCT00352183|Fenofibrate|fenofibrate|mesh-list
14690240|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14690241|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14690242|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
14690243|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690244|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14690245|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14690246|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690247|NCT00352196|Risperidone|risperidone|mesh-list
14690248|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14690249|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
14690250|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690251|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690252|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690253|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14690254|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14690255|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690256|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690257|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14690258|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
14690259|NCT00352235|KRN 7000|krn 7000|mesh-list
14690260|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14690261|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
14690262|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690263|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690264|NCT00352261|Esomeprazole|esomeprazole|mesh-list
14690265|NCT00352261|Lansoprazole|lansoprazole|mesh-list
14690266|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
14690267|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14690268|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14690269|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14690270|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690271|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690272|NCT00352287|Pioglitazone|pioglitazone|mesh-list
14690273|NCT00352287|Hormones|hormones|mesh-list
14690274|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690275|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690276|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690277|NCT00352300|Paclitaxel|paclitaxel|mesh-list
14690278|NCT00352300|Carboplatin|carboplatin|mesh-list
14690279|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14690280|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690281|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
14690282|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
14690283|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
14690284|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690285|NCT00352313|Carboplatin|carboplatin|mesh-list
14690286|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690287|NCT00352339|Aripiprazole|aripiprazole|mesh-list
14690288|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690289|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690290|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14690291|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14690292|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690293|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690294|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
14690295|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
14690296|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690297|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193267|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14690298|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14690299|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14690300|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
14690301|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14690302|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14690303|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14690304|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14690305|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
14690306|NCT00352378|Docetaxel|docetaxel|mesh-list
14690307|NCT00352378|Doxorubicin|doxorubicin|mesh-list
14690308|NCT00352378|Capecitabine|capecitabine|mesh-list
14690309|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690310|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
14690311|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690312|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14690313|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14690314|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
14690315|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690316|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193268|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193269|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15193270|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193271|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193272|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15193273|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15193274|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
15193275|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690317|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14690318|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14690319|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14690320|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
15193276|NCT03822767|Vaccines|vaccines|mesh-list
15193277|NCT03822767|Immunologic Factors|immunologic factors|mesh-ancestor
15193278|NCT03822767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193279|NCT03822559|Timolol|timolol|mesh-list
14690321|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14690322|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14690323|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14690324|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690325|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690326|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
14690327|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
14690328|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14690329|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
14690330|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690331|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690332|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14690333|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690334|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14690335|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
14690336|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690337|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690338|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14690339|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
14690340|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
14690341|NCT00352430|Protective Agents|protective agents|mesh-ancestor
14690342|NCT00352443|Everolimus|everolimus|mesh-list
14690343|NCT00352443|Lapatinib|lapatinib|mesh-list
14690344|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690345|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690346|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
14690347|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690348|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14690349|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690350|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690351|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14690352|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690353|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690354|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14690355|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14690356|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690357|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690358|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
14690359|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
14690360|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14690361|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14690362|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690363|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690364|NCT00352482|Urological Agents|urological agents|mesh-ancestor
14690365|NCT00352495|Carboplatin|carboplatin|mesh-list
15193280|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15193281|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15193282|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15193283|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15193284|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
15193285|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193286|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193287|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193288|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15193289|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15193290|NCT03822845|Edetic Acid|edetic acid|mesh-list
15193291|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
15193292|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
14690366|NCT00352495|Vinblastine|vinblastine|mesh-list
14690367|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690368|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14690369|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
14690370|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
14690371|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
14690372|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690373|NCT00352521|Bevacizumab|bevacizumab|mesh-list
14690374|NCT00352521|Irinotecan|irinotecan|mesh-list
14690375|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14690376|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690377|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14690378|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14690379|NCT00352521|Growth Substances|growth substances|mesh-ancestor
14690380|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690381|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
14690382|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14690383|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14690384|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690385|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690386|NCT00352599|Lovastatin|lovastatin|mesh-list
14690387|NCT00352599|L 647318|l 647318|mesh-list
14690388|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
14690389|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14690390|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14690391|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
14690392|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690393|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14690394|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14690395|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690396|NCT00352625|Ketoprofen|ketoprofen|mesh-list
14690397|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14690398|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14690399|NCT00352625|Analgesics|analgesics|mesh-ancestor
14690400|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
14690401|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690402|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690403|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14690404|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14690405|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14690406|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690407|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690408|NCT00352651|Pregabalin|pregabalin|mesh-list
14690409|NCT00352651|Analgesics|analgesics|mesh-ancestor
14690410|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
14690411|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690412|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690413|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
14690414|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14690415|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690416|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690417|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14690418|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14690419|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14690420|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690421|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690422|NCT00352677|Bafetinib|bafetinib|mesh-list
14690423|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14690424|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690425|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690426|NCT00352742|Bortezomib|bortezomib|mesh-list
14690427|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14690428|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690429|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
14690430|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
14690431|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690432|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690433|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14690434|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14690435|NCT00352742|Growth Substances|growth substances|mesh-ancestor
14690436|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690437|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
14690438|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
14690439|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690440|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690441|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14690442|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14690443|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690444|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690445|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690446|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14690447|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14690448|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690449|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690450|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
14690451|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14690452|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690453|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14690454|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14690455|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14690456|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14690457|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14690458|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14690459|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14690460|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14690461|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
14690462|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690463|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690464|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690465|NCT00352833|Catumaxomab|catumaxomab|mesh-list
14690466|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14690467|NCT00352859|Gemcitabine|gemcitabine|mesh-list
14690468|NCT00352859|Interferons|interferons|mesh-list
14690469|NCT00352859|Sorafenib|sorafenib|mesh-list
14690470|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690471|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
15193293|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193294|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
15193295|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15193296|NCT03822546|Nicotine|nicotine|mesh-list
15193297|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15193298|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
14690472|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690473|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690474|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
14690475|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690476|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690477|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690478|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
14690479|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690480|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14690481|NCT00352950|Panitumumab|panitumumab|mesh-list
14690482|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14690483|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690484|NCT00353002|Lidocaine|lidocaine|mesh-list
14690485|NCT00353002|Tetracaine|tetracaine|mesh-list
15193299|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294442|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690486|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
14690487|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
14690488|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690489|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690490|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
14690491|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690492|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14690493|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14690494|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14690495|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690496|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690497|NCT00353015|Cisplatin|cisplatin|mesh-list
14690498|NCT00353015|Irinotecan|irinotecan|mesh-list
14690499|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690500|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14690501|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14690502|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690503|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690504|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
14690505|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690506|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690507|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14690508|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14690509|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690510|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690511|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690512|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14690513|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14690514|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690515|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690516|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
14690517|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14690518|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690519|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14690520|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14690521|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14690522|NCT00353041|Lidocaine|lidocaine|mesh-list
14690523|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
14690524|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
14690525|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14690526|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690527|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
14690528|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690529|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14690530|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14690531|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14690532|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690533|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690534|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
14690535|NCT00353054|Antacids|antacids|mesh-ancestor
14690536|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690537|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727753|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14727754|NCT00515229|Analgesics|analgesics|mesh-ancestor
14727755|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
14727756|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727757|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727758|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14727759|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14727760|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14727761|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727762|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
14727763|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727764|NCT00515229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14727765|NCT00515229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14727766|NCT00515229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727767|NCT00515255|Minocycline|minocycline|mesh-list
14727768|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14727769|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729343|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14729344|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
14690538|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
14690539|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14690540|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14690541|NCT00353067|Analgesics|analgesics|mesh-ancestor
14690542|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
14690543|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690544|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690545|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14690546|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14690547|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14690548|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690549|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690550|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
14690551|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14690552|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690553|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690554|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14690555|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690556|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14690557|NCT00353145|Gemcitabine|gemcitabine|mesh-list
14690558|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
15193300|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193301|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15193302|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15193303|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
15193304|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193305|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690559|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690560|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
14690561|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690562|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690563|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
15193306|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
15193307|NCT03822520|Celecoxib|celecoxib|mesh-list
15193308|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193309|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193310|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15193311|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15193312|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193313|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193314|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193315|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193316|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193317|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14690564|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690565|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690566|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690567|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
14690568|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690569|NCT00353184|Montelukast|montelukast|mesh-list
14690570|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14690571|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690572|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14690573|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
14690574|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690575|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690576|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14690577|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14690578|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690579|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
14690580|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14690581|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
14690582|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690583|NCT00353340|Expectorants|expectorants|mesh-ancestor
14690584|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690585|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14690586|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
14690587|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690588|NCT00353340|Protective Agents|protective agents|mesh-ancestor
15193318|NCT03822520|Analgesics|analgesics|mesh-ancestor
15193319|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
14690589|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690590|NCT00353340|Antidotes|antidotes|mesh-ancestor
14690591|NCT00353379|Guanfacine|guanfacine|mesh-list
14690592|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14690593|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14690594|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14690595|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15193320|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193321|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193322|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193323|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15193324|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193325|NCT03822091|Terlipressin|terlipressin|mesh-list
15193326|NCT03822091|Norepinephrine|norepinephrine|mesh-list
15193327|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15193328|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15193329|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15193330|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15193331|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
15193332|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193333|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193334|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193335|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
15193336|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
15193337|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193338|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15193339|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14690596|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
14690597|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690598|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690599|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690600|NCT00353561|Fluconazole|fluconazole|mesh-list
14690601|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
14690602|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690603|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14690604|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14690605|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690606|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690607|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14690608|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
14690609|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690610|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690611|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15193340|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15193341|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15193342|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193343|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193344|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193345|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
15193346|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15193347|NCT03822312|Tobramycin|tobramycin|mesh-list
15193348|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193349|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193350|NCT03822169|Choline|choline|mesh-list
15193351|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
15193352|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15193353|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
15193354|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193355|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193356|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15193357|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
15224094|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14690612|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15193358|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
15193359|NCT03821987|Busulfan|busulfan|mesh-list
15193360|NCT03821987|Fludarabine|fludarabine|mesh-list
15193361|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
15193362|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15193363|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
15193364|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193365|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193366|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14690613|NCT00353665|Riluzole|riluzole|mesh-list
14690614|NCT00353665|Memantine|memantine|mesh-list
14690615|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14690616|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14690617|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
14690618|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690619|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690620|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690621|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14690622|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14690623|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
14690624|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14690625|NCT00353665|Protective Agents|protective agents|mesh-ancestor
14690626|NCT00353678|Darexaban|darexaban|mesh-list
14690627|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14690628|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
15193367|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
15193368|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193369|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193370|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15193371|NCT03821792|Prednisone|prednisone|mesh-list
15193372|NCT03821792|Cortisone|cortisone|mesh-list
15193373|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
15193374|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193375|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
15193376|NCT03821792|Hormones|hormones|mesh-ancestor
15193377|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193378|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193379|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15193380|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690629|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14690630|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
14690631|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690632|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690633|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
14690634|NCT00353691|Metformin|metformin|mesh-list
14690635|NCT00353691|Glimepiride|glimepiride|mesh-list
14690636|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690637|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690638|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14690639|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690640|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
14690641|NCT00353717|Paclitaxel|paclitaxel|mesh-list
14690642|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14690643|NCT00353717|Cetuximab|cetuximab|mesh-list
14690644|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14690645|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690646|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14690647|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14690648|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14690649|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690650|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14690651|NCT00353743|Metronidazole|metronidazole|mesh-list
14690652|NCT00353743|Doxycycline|doxycycline|mesh-list
14690653|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690654|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193381|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14690655|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14690656|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15193382|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193383|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193384|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
15193385|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15193386|NCT03821649|Naloxone|naloxone|mesh-list
14690657|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
14690658|NCT00353808|Reboxetine|reboxetine|mesh-list
14690659|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690660|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690661|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14690662|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14690663|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690664|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690665|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
14690666|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690667|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690668|NCT00353912|Amlodipine|amlodipine|mesh-list
14690669|NCT00353912|Valsartan|valsartan|mesh-list
14690670|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14690671|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14690672|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690673|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690674|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14690675|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690676|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
14690677|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14690678|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14690679|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
14690680|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690681|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690682|NCT00354068|Temozolomide|temozolomide|mesh-list
14690683|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
14690684|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14690685|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
14690686|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690687|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193387|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15193388|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193389|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
15193390|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690688|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14690689|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690690|NCT00354081|Vitamins|vitamins|mesh-list
14690691|NCT00354081|Folic Acid|folic acid|mesh-list
14690692|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
14690693|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
14690694|NCT00354081|Pyridoxine|pyridoxine|mesh-list
14690695|NCT00354081|Pyridoxal|pyridoxal|mesh-list
14690696|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
14690697|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
14690698|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
14690699|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690700|NCT00354081|Hematinics|hematinics|mesh-ancestor
14690701|NCT00354094|Reboxetine|reboxetine|mesh-list
14690702|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
14690703|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14690704|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14690705|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14690706|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690707|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690708|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14690709|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690710|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193391|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15193392|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15193393|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193394|NCT03821623|Niacinamide|niacinamide|mesh-list
15193395|NCT03821623|Niacin|niacin|mesh-list
15193396|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
15193397|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
14690711|NCT00354146|Tipifarnib|tipifarnib|mesh-list
14690712|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690713|NCT00354185|Belinostat|belinostat|mesh-list
14690714|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690715|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14690716|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690717|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690718|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14690719|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
14690720|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14690721|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690722|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690723|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14690724|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14690725|NCT00354198|Protective Agents|protective agents|mesh-ancestor
15193398|NCT03821623|Vitamins|vitamins|mesh-ancestor
15193399|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
15193400|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193401|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15193402|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
15193403|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193404|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15193405|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
15193406|NCT03821714|Vitamins|vitamins|mesh-list
15193407|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
15193408|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15193409|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15193410|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15193411|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
14690726|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690727|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
14690728|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14690729|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
14690730|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14690731|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
14690732|NCT00354198|Hormones|hormones|mesh-ancestor
14690733|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690734|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14690735|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14690736|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193412|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
15193413|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193414|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14690737|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14690738|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690739|NCT00354276|Cytarabine|cytarabine|mesh-list
14690740|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690741|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
14690742|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690743|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690744|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
14690745|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690746|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690747|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
14690748|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193415|NCT03821714|Hormones|hormones|mesh-ancestor
14690749|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
14690750|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
14690751|NCT00354302|Alendronate|alendronate|mesh-list
14690752|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
14690753|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
14690754|NCT00354302|Calcium|calcium|mesh-list
14690755|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14690756|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690757|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14690758|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690759|NCT00354302|Vitamins|vitamins|mesh-ancestor
14690760|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
14690761|NCT00354302|Antacids|antacids|mesh-ancestor
14690762|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14690763|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14690764|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690765|NCT00354354|Ipratropium|ipratropium|mesh-list
14690766|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14690767|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
14690768|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690769|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690770|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14690771|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690772|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690773|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690774|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14690775|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
14690776|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
14690777|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690778|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
14690779|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690780|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14690781|NCT00354380|Artesunate|artesunate|mesh-list
14690782|NCT00354380|Amodiaquine|amodiaquine|mesh-list
14690783|NCT00354380|Methylene Blue|methylene blue|mesh-list
14690784|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
14690785|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14690786|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14690787|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690788|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690789|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
14690790|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
14690791|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14690792|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
14690793|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690794|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690795|NCT00354393|Methotrexate|methotrexate|mesh-list
14690796|NCT00354393|Vinorelbine|vinorelbine|mesh-list
14690797|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690798|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14690799|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
14690800|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14690801|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690802|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690803|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
14690804|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690805|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14690806|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690807|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14690808|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690809|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
14690810|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14690811|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14690812|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14690813|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
14690814|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
14690815|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
14690816|NCT00354406|Abciximab|abciximab|mesh-list
14690817|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
14690818|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14690819|NCT00354419|Cyclosporine|cyclosporine|mesh-list
14690820|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
14690821|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
14690822|NCT00354419|Cyclosporins|cyclosporins|mesh-list
14690823|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
14690824|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14690825|NCT00354419|Lenograstim|lenograstim|mesh-list
14690826|NCT00354419|Sargramostim|sargramostim|mesh-list
14690827|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
14690828|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690829|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
14690830|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690831|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14690832|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14690833|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
14690834|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690835|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690836|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14690837|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14690838|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690839|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
15193416|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193417|NCT03821480|Fluconazole|fluconazole|mesh-list
15193418|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
15193419|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193420|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15193421|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14690840|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690841|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
14690842|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14690843|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14690844|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14690845|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
14690846|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14690847|NCT00354458|Rolofylline|rolofylline|mesh-list
14690848|NCT00354458|Diuretics|diuretics|mesh-ancestor
14690849|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
14690850|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690851|NCT00354523|Capecitabine|capecitabine|mesh-list
14690852|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
14690853|NCT00354523|Dacarbazine|dacarbazine|mesh-list
14690854|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690855|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
14690856|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690857|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690858|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14690859|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193422|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193423|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193424|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15193425|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
14690860|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14690861|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
14690862|NCT00354549|Gemcitabine|gemcitabine|mesh-list
14690863|NCT00354549|Bevacizumab|bevacizumab|mesh-list
14690864|NCT00354549|Carboplatin|carboplatin|mesh-list
14690865|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14690866|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14690867|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690868|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14690869|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14690870|NCT00354549|Growth Substances|growth substances|mesh-ancestor
14690871|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690872|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
14690873|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14690874|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
14690875|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690876|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
14690877|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690878|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690879|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14690880|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
14690881|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14690882|NCT00354562|Docetaxel|docetaxel|mesh-list
15193426|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690883|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14690884|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14690885|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14690886|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14690887|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690888|NCT00354627|Etravirine|etravirine|mesh-list
14690889|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14690890|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14690891|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690892|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690893|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
14690894|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690895|NCT00354653|Lamivudine|lamivudine|mesh-list
14690896|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14690897|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14690898|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193427|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193428|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14690899|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690900|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
14690901|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690902|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14690903|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14690904|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14690905|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
14690906|NCT00354692|Hematinics|hematinics|mesh-ancestor
14690907|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
14690908|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14690909|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690910|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690911|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14690912|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14690913|NCT00354731|Protective Agents|protective agents|mesh-ancestor
14690914|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690915|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
14690916|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14690917|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
14690918|NCT00354757|Rabeprazole|rabeprazole|mesh-list
14690919|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14690920|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14690921|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14690922|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690923|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690924|NCT00354809|Casopitant|casopitant|mesh-list
14690925|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
14690926|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
14690927|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690928|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690929|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14690930|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14690931|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690932|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690933|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
14690934|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14690935|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
14690936|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690937|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14690938|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15193429|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15193430|NCT03821415|Estradiol|estradiol|mesh-list
15193431|NCT03821415|Estrogens|estrogens|mesh-ancestor
15193432|NCT03821415|Hormones|hormones|mesh-ancestor
15193433|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193434|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193435|NCT03821454|Capecitabine|capecitabine|mesh-list
15193436|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15193437|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
15193438|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193439|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193440|NCT03821493|Itraconazole|itraconazole|mesh-list
15193441|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15193442|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
14690939|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
14690940|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14690941|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690942|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14690943|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
14690944|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14690945|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14690946|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14690947|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14690948|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14690949|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690950|NCT00354900|Aprotinin|aprotinin|mesh-list
14690951|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
14690952|NCT00354900|Coagulants|coagulants|mesh-ancestor
14690953|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14690954|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14690955|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
14690956|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690957|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690958|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
14690959|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14690960|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690961|NCT00354952|Azithromycin|azithromycin|mesh-list
14690962|NCT00354952|Clarithromycin|clarithromycin|mesh-list
15193443|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294443|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14294444|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294445|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294446|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294447|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14294448|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14294449|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
14294450|NCT00576303|Hematinics|hematinics|mesh-ancestor
14294451|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14690963|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14690964|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690965|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14690966|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690967|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690968|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14690969|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14727770|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
14727771|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14727772|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14727773|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727774|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729345|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
14729346|NCT00522782|Protective Agents|protective agents|mesh-ancestor
14729347|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14729348|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
14729349|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14729350|NCT00522821|Antibodies|antibodies|mesh-list
14729351|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
14729352|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14729353|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729354|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
14729355|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729356|NCT00522886|Cetuximab|cetuximab|mesh-list
14729357|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14729358|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729359|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14729360|NCT00522938|Tosedostat|tosedostat|mesh-list
14729361|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729362|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14729363|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729364|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729365|NCT00523055|Lidocaine|lidocaine|mesh-list
14729366|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
14729367|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
14729368|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729369|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729370|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
14729371|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294452|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14690970|NCT00354965|Amoxicillin|amoxicillin|mesh-list
14690971|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
14690972|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
14690973|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14690974|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193444|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15193445|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15193446|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193447|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193448|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15193449|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
15193450|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14690975|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14690976|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14690977|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14690978|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690979|NCT00354991|Losartan|losartan|mesh-list
14690980|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14690981|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14690982|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14690983|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14690984|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14690985|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14690986|NCT00354991|Diuretics|diuretics|mesh-ancestor
14690987|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
14690988|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690989|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14690990|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14690991|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
14690992|NCT00355043|Astringents|astringents|mesh-ancestor
14690993|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14690994|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
14690995|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
14690996|NCT00355095|Hematinics|hematinics|mesh-ancestor
14690997|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
14690998|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14690999|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14691000|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691001|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
14691002|NCT00355108|Coagulants|coagulants|mesh-ancestor
14691003|NCT00355251|Atorvastatin|atorvastatin|mesh-list
14691004|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14691005|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14691006|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
14691007|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691008|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14691009|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15193451|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193452|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15193453|NCT03821168|Bevacizumab|bevacizumab|mesh-list
15193454|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
14691010|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691011|NCT00355277|Amitriptyline|amitriptyline|mesh-list
14691012|NCT00355277|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14691013|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14691014|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
14691015|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14691016|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691017|NCT00355277|Analgesics|analgesics|mesh-ancestor
14691018|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
14691019|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691020|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691021|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14691022|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14691023|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14691024|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691025|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
14691026|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193455|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15193456|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193457|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14691027|NCT00355277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14691028|NCT00355277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14691029|NCT00355277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691030|NCT00355290|Vitamin K|vitamin k|mesh-list
14691031|NCT00355290|Vitamins|vitamins|mesh-ancestor
14691032|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
14691033|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691034|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14691035|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14691036|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691037|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
14691038|NCT00355290|Coagulants|coagulants|mesh-ancestor
14691039|NCT00355303|Misoprostol|misoprostol|mesh-list
14691040|NCT00355303|Dinoprostone|dinoprostone|mesh-list
14691041|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14691042|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
14691043|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14691044|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691045|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14691046|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691047|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
14691048|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
14691049|NCT00355407|Hematinics|hematinics|mesh-ancestor
14691050|NCT00355446|Bimatoprost|bimatoprost|mesh-list
14691051|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14691052|NCT00355459|Doxycycline|doxycycline|mesh-list
14691053|NCT00355459|Tetracycline|tetracycline|mesh-list
14691054|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691055|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691056|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
14691057|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14691058|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14691059|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14691060|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691061|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691062|NCT00355524|Ritonavir|ritonavir|mesh-list
14691063|NCT00355524|Darunavir|darunavir|mesh-list
14691064|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14691065|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14691066|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691067|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691068|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691069|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691070|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14691071|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
14691072|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691073|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14691074|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14691075|NCT00355537|Testosterone|testosterone|mesh-list
14691076|NCT00355537|Androgens|androgens|mesh-ancestor
14691077|NCT00355537|Hormones|hormones|mesh-ancestor
14691078|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691079|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691080|NCT00355576|Minocycline|minocycline|mesh-list
14691081|NCT00355576|Celecoxib|celecoxib|mesh-list
14691082|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14691083|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691084|NCT00355576|Analgesics|analgesics|mesh-ancestor
14691085|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
14691086|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691087|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691088|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691089|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14691090|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14691091|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14691092|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691093|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691094|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691095|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691096|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14691097|NCT00355589|Ramipril|ramipril|mesh-list
14691098|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15193458|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15193459|NCT03821168|Growth Substances|growth substances|mesh-ancestor
15193460|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193461|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
14691099|NCT00355589|Diuretics|diuretics|mesh-ancestor
14691100|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
14691101|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691102|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14691103|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14691104|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691105|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14691106|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691107|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691108|NCT00355602|Metronidazole|metronidazole|mesh-list
14691109|NCT00355602|Vancomycin|vancomycin|mesh-list
14691110|NCT00355602|Clarithromycin|clarithromycin|mesh-list
14691111|NCT00355602|Doxycycline|doxycycline|mesh-list
14691112|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
14691113|NCT00355602|Rifaximin|rifaximin|mesh-list
14691114|NCT00355602|Cefuroxime|cefuroxime|mesh-list
14691115|NCT00355602|Neomycin|neomycin|mesh-list
14691116|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14691117|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14691118|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691119|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691120|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14691121|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14691122|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14691123|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691124|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691125|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14691126|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14691127|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
14691128|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14691129|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14691130|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691131|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14691132|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691133|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14691134|NCT00355602|Renal Agents|renal agents|mesh-ancestor
14691135|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14691136|NCT00355628|Fentanyl|fentanyl|mesh-list
14691137|NCT00355628|Citric Acid|citric acid|mesh-list
14691138|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
14691139|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14691140|NCT00355628|Narcotics|narcotics|mesh-ancestor
14691141|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691142|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691143|NCT00355628|Analgesics|analgesics|mesh-ancestor
14691144|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
15193462|NCT03821168|Hematinics|hematinics|mesh-ancestor
15193463|NCT03820830|Palbociclib|palbociclib|mesh-list
15193464|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691145|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691146|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14691147|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14691148|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
14691149|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
14691150|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
14691151|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14691152|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
14691153|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
14691154|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691155|NCT00355641|Ropinirole|ropinirole|mesh-list
14691156|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14691157|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14691158|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
14691159|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
14691160|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691161|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691162|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193465|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14691163|NCT00355667|Furosemide|furosemide|mesh-list
14691164|NCT00355667|Azosemide|azosemide|mesh-list
15193466|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691165|NCT00355667|Diuretics|diuretics|mesh-ancestor
14691166|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
14691167|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691168|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14691169|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14691170|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691171|NCT00355693|Propofol|propofol|mesh-list
14691172|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14691173|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691174|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691175|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14691176|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
14691177|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
14691178|NCT00355719|Ritonavir|ritonavir|mesh-list
14691179|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14691180|NCT00355719|Nevirapine|nevirapine|mesh-list
14691181|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14691182|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14691183|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691184|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691185|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691186|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691187|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14691188|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
14691189|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691190|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14691191|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14691192|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14691193|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14691194|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14691195|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15193467|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193468|NCT03820622|Paclitaxel|paclitaxel|mesh-list
15193469|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15193470|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15193471|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193472|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
15193473|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
15193474|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
15193475|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193476|NCT03820531|Pancrelipase|pancrelipase|mesh-list
15193477|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193478|NCT03820518|Calcitriol|calcitriol|mesh-list
15193479|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15193480|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193481|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15193482|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15193483|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193484|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15193485|NCT03820518|Vitamins|vitamins|mesh-ancestor
15193486|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
15193487|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15193488|NCT03820466|Aspirin|aspirin|mesh-list
14691196|NCT00355771|Levocetirizine|levocetirizine|mesh-list
14691197|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14691198|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14691199|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
14691200|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
14691201|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691202|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691203|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691204|NCT00355862|Cyclosporine|cyclosporine|mesh-list
14691205|NCT00355862|Sirolimus|sirolimus|mesh-list
14691206|NCT00355862|Prednisolone|prednisolone|mesh-list
14691207|NCT00355862|Azathioprine|azathioprine|mesh-list
14691208|NCT00355862|Tacrolimus|tacrolimus|mesh-list
14691209|NCT00355862|Cyclosporins|cyclosporins|mesh-list
14691210|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691211|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
14691212|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691213|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14691214|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691215|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691216|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
14691217|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691218|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
14691219|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14691220|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691221|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14691222|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691223|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691224|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
14691225|NCT00355862|Hormones|hormones|mesh-ancestor
14691226|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691227|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14691228|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
14691229|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691230|NCT00355901|Visilizumab|visilizumab|mesh-list
15193489|NCT03820466|Atorvastatin|atorvastatin|mesh-list
15193490|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193491|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15193492|NCT03820466|Analgesics|analgesics|mesh-ancestor
15193493|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
14691231|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
14691232|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691233|NCT00355927|Propofol|propofol|mesh-list
14691234|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14691235|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691236|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691237|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14691238|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
14691239|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
14691240|NCT00355953|Genistein|genistein|mesh-list
15193494|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193495|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691241|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14691242|NCT00355953|Protective Agents|protective agents|mesh-ancestor
14691243|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691244|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691245|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14691246|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691247|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691248|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
14691249|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14691250|NCT00355953|Estrogens|estrogens|mesh-ancestor
14691251|NCT00355953|Hormones|hormones|mesh-ancestor
14691252|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691253|NCT00355966|Misoprostol|misoprostol|mesh-list
14691254|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14691255|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
14691256|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14691257|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691258|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14691259|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691260|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
14691261|NCT00356005|Azithromycin|azithromycin|mesh-list
14691262|NCT00356005|Artesunate|artesunate|mesh-list
14691263|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193496|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193497|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193498|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15193499|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15193500|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193501|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15193502|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14691264|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691265|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
14691266|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14691267|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14691268|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691269|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
14691270|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
14691271|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14691272|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
14691273|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14691274|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14691275|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15193503|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193504|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
15193505|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15193506|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15193507|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
15193508|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15193509|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14691276|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14691277|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691278|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
14691279|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691280|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691281|NCT00356083|Methadone|methadone|mesh-list
14691282|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14691283|NCT00356083|Narcotics|narcotics|mesh-ancestor
14691284|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691285|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691286|NCT00356083|Analgesics|analgesics|mesh-ancestor
14691287|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
14691288|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691289|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
14691290|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
14691291|NCT00356096|Pramipexole|pramipexole|mesh-list
14691292|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
14691293|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691294|NCT00356096|Protective Agents|protective agents|mesh-ancestor
14691295|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691296|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14691297|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14691298|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
14691299|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
14691300|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691301|NCT00356226|Clonidine|clonidine|mesh-list
14691302|NCT00356226|Analgesics|analgesics|mesh-ancestor
14691303|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
14691304|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691305|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691306|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14691307|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
14691308|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
14691309|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14691310|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14691311|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14691312|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
14691313|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691314|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691315|NCT00356252|Carotenoids|carotenoids|mesh-list
14691316|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
14691317|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691318|NCT00356252|Protective Agents|protective agents|mesh-ancestor
14691319|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691320|NCT00356356|Etanercept|etanercept|mesh-list
14691321|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14691322|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691323|NCT00356356|Analgesics|analgesics|mesh-ancestor
14691324|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
14691325|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691326|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691327|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691328|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14691329|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691330|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15193510|NCT03820245|Lycopene|lycopene|mesh-list
15193511|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193512|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
15193513|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193514|NCT03820245|Protective Agents|protective agents|mesh-ancestor
15193515|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193516|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15193517|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15193518|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193519|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
14691331|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
14691332|NCT00356395|Candesartan|candesartan|mesh-list
14691333|NCT00356395|Ramipril|ramipril|mesh-list
14691334|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14691335|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14691336|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14691337|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691338|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14691339|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691340|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691341|NCT00356447|Estradiol|estradiol|mesh-list
14691342|NCT00356447|Estrogens|estrogens|mesh-ancestor
14691343|NCT00356447|Hormones|hormones|mesh-ancestor
14691344|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691345|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691346|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14691347|NCT00356460|Antibodies|antibodies|mesh-list
14691348|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
14691349|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14691350|NCT00356460|Mitogens|mitogens|mesh-list
14691351|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
14691352|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691353|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691354|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
14691355|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691356|NCT00356473|Atorvastatin|atorvastatin|mesh-list
14691357|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14691358|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14691359|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
14691360|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691361|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14691362|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14691363|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691364|NCT00356486|Ribavirin|ribavirin|mesh-list
14691365|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14691366|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
14691367|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
14691368|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691369|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
14691370|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691371|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
14691372|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691373|NCT00356616|Tenofovir|tenofovir|mesh-list
14691374|NCT00356616|Abacavir|abacavir|mesh-list
15193520|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15193521|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15193522|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193523|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
15193524|NCT03820206|Coagulants|coagulants|mesh-ancestor
15193525|NCT03820193|Acetaminophen|acetaminophen|mesh-list
15193526|NCT03820193|Celecoxib|celecoxib|mesh-list
15193527|NCT03820193|Ketorolac|ketorolac|mesh-list
15193528|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15193529|NCT03820193|Diazepam|diazepam|mesh-list
15193530|NCT03820193|Gabapentin|gabapentin|mesh-list
15193531|NCT03820193|Hydrocodone|hydrocodone|mesh-list
15193532|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691375|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
14691376|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691377|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14691378|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14691379|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691380|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691381|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691382|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15193533|NCT03820193|Analgesics|analgesics|mesh-ancestor
14691383|NCT00356720|Azithromycin|azithromycin|mesh-list
14691384|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193534|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
14691385|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691386|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
14691387|NCT00356733|Hematinics|hematinics|mesh-ancestor
14691388|NCT00356772|Azithromycin|azithromycin|mesh-list
14691389|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691390|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691391|NCT00356824|Artesunate|artesunate|mesh-list
14691392|NCT00356824|Amodiaquine|amodiaquine|mesh-list
14691393|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
14691394|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14691395|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14691396|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691397|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691398|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
14691399|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
14691400|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14691401|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
14691402|NCT00356850|Azithromycin|azithromycin|mesh-list
14691403|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691404|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727775|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
14727776|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14727777|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
14727778|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727779|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727780|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14727781|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
14727782|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14727783|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
14727784|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727785|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727786|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14727787|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
14727788|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
14727789|NCT00515281|Protective Agents|protective agents|mesh-ancestor
14727790|NCT00515320|Fluoxetine|fluoxetine|mesh-list
14727791|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14727792|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14727793|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14727794|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727795|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727796|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
14727797|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727798|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15193535|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193536|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193537|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
14727799|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
14727800|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14727801|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14727802|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14727803|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727804|NCT00515359|Propofol|propofol|mesh-list
14727805|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14727806|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727807|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727808|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14727809|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
14727810|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
14727811|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
14727812|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14727813|NCT00515450|Antibodies|antibodies|mesh-list
14727814|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
14727815|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14727816|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
14727817|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727818|NCT00515489|Risperidone|risperidone|mesh-list
14727819|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14727820|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
15193538|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193539|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193540|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193541|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14727821|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727822|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193542|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193543|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193544|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691405|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
14691406|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691407|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
14691408|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691409|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14691410|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14691411|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
14691412|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691413|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691414|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14691415|NCT00356941|Docetaxel|docetaxel|mesh-list
14691416|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
14691417|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691418|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
14691419|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
14691420|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
14691421|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691422|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
14691423|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
14691424|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691425|NCT00356954|Protective Agents|protective agents|mesh-ancestor
14691426|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691427|NCT00356954|Vitamins|vitamins|mesh-ancestor
14691428|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
14691429|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
14691430|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14691431|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
14691432|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691433|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691434|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14691435|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
14691436|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14691437|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
14691438|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
14691439|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691440|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691441|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14691442|NCT00357019|Protective Agents|protective agents|mesh-ancestor
14691443|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14691444|NCT00357045|Paroxetine|paroxetine|mesh-list
14691445|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14691446|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14691447|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14691448|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691449|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691450|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
14691451|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691452|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14691453|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
14691454|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14691455|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14691456|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14691457|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691458|NCT00357084|Prednisone|prednisone|mesh-list
14691459|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
14691460|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14691461|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14691462|NCT00357084|Prednisolone|prednisolone|mesh-list
14691463|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
15193545|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
15193546|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15193547|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15193548|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193549|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15193550|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15193551|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15193552|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193553|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
15193554|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14294453|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
14691464|NCT00357084|Methotrexate|methotrexate|mesh-list
14691465|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15193555|NCT03820193|Narcotics|narcotics|mesh-ancestor
14691466|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
14691467|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691468|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
14691469|NCT00357084|Hormones|hormones|mesh-ancestor
14691470|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691471|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691472|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14691473|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691474|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14691475|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
14691476|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14691477|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691478|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
14691479|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691480|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
14691481|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691482|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14691483|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691484|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
14691485|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14691486|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14691487|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
14691488|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
14691489|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691490|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691491|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14691492|NCT00357084|Protective Agents|protective agents|mesh-ancestor
14691493|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14691494|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14691495|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15193556|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
15193557|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
15193558|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15193559|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
15193560|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
15193561|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193562|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15193563|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15193564|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15193565|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15193566|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
15193567|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
15193568|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
14691496|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
14691497|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691498|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14691499|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14691500|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691501|NCT00357149|Cisplatin|cisplatin|mesh-list
14691502|NCT00357149|Docetaxel|docetaxel|mesh-list
14691503|NCT00357149|Fluorouracil|fluorouracil|mesh-list
14691504|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691505|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
14691506|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
14691507|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
14691508|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691509|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
14691510|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691511|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691512|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
14691513|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691514|NCT00357188|Ritonavir|ritonavir|mesh-list
14691515|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14691516|NCT00357188|Efavirenz|efavirenz|mesh-list
14691517|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14691518|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14691519|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691520|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691521|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691522|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691523|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14691524|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
14691525|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193569|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
15193570|NCT03820141|Trastuzumab|trastuzumab|mesh-list
15193571|NCT03820141|Durvalumab|durvalumab|mesh-list
15193572|NCT03820141|Pertuzumab|pertuzumab|mesh-list
14691526|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14691527|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14691528|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14691529|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14691530|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14691531|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14691532|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14691533|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14691534|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14691535|NCT00357240|Ritonavir|ritonavir|mesh-list
14691536|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14691537|NCT00357240|Omeprazole|omeprazole|mesh-list
14691538|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14691539|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14691540|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691541|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691542|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691543|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691544|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14691545|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
14691546|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691547|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14691548|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14691549|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14691550|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691551|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14691552|NCT00357253|Capecitabine|capecitabine|mesh-list
14691553|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691554|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
14691555|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691556|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691557|NCT00357292|Azithromycin|azithromycin|mesh-list
14691558|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691559|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691560|NCT00357305|Cytarabine|cytarabine|mesh-list
14691561|NCT00357305|Etoposide|etoposide|mesh-list
14691562|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
14691563|NCT00357305|Vorinostat|vorinostat|mesh-list
14691564|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14691565|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691566|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14691567|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14691568|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691569|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691570|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691571|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
14691572|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
14691573|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691574|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691575|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
14691576|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691577|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14691578|NCT00357318|Bevacizumab|bevacizumab|mesh-list
14691579|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14691580|NCT00357318|Sunitinib|sunitinib|mesh-list
14691581|NCT00357318|Antibodies|antibodies|mesh-list
14691582|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
14691583|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14691584|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691585|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14691586|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14691587|NCT00357318|Growth Substances|growth substances|mesh-ancestor
14691588|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193573|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15193574|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193575|NCT03820180|Fluticasone|fluticasone|mesh-list
15193576|NCT03820180|Xhance|xhance|mesh-list
15193577|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15193578|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15193579|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193580|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15193581|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
14691589|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
14691590|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
14691591|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14691592|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691593|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691594|NCT00357383|Azithromycin|azithromycin|mesh-list
14691595|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691596|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691597|NCT00357422|Ethanol|ethanol|mesh-list
14691598|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14691599|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691600|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691601|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691602|NCT00357448|Interleukin-2|interleukin-2|mesh-list
14691603|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
14691604|NCT00357448|Immunotoxins|immunotoxins|mesh-list
14691605|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691606|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691607|NCT00357448|Analgesics|analgesics|mesh-ancestor
14691608|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
14691609|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691610|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691611|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
14691612|NCT00357461|Ipilimumab|ipilimumab|mesh-list
14691613|NCT00357461|Vaccines|vaccines|mesh-list
14691614|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
14691615|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
14691616|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691617|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14691618|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691619|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15193582|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193583|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193584|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15193585|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
15193586|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
15193587|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14691620|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691621|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14691622|NCT00357474|Ethanol|ethanol|mesh-list
14691623|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14691624|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691625|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691626|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691627|NCT00357539|Azithromycin|azithromycin|mesh-list
14691628|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691629|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691630|NCT00357604|Ritonavir|ritonavir|mesh-list
14691631|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14691632|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
14691633|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14691634|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14691635|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14691636|NCT00357604|Norgestimate|norgestimate|mesh-list
14691637|NCT00357604|Norgestrel|norgestrel|mesh-list
14691638|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14691639|NCT00357604|Estradiol|estradiol|mesh-list
14691640|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14691641|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14691642|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14691643|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691644|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691645|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691646|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691647|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14294454|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
14294455|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14294456|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294457|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294458|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14294459|NCT00576381|Analgesics|analgesics|mesh-ancestor
14294460|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
14294461|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294462|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14294463|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14691648|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
14691649|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294464|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14294465|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
14294466|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294467|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294468|NCT00576472|Methylphenidate|methylphenidate|mesh-list
14294469|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14691650|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14691651|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14691652|NCT00357604|Estrogens|estrogens|mesh-ancestor
14691653|NCT00357604|Hormones|hormones|mesh-ancestor
14691654|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691655|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691656|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14691657|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
14691658|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14691659|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14691660|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14691661|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14691662|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14691663|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14691664|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691665|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14691666|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14691667|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691668|NCT00357617|Celecoxib|celecoxib|mesh-list
14691669|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14691670|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691671|NCT00357617|Analgesics|analgesics|mesh-ancestor
14691672|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
15193588|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14691673|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691674|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691675|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691676|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14691677|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14691678|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14691679|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691680|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691681|NCT00357630|Gemcitabine|gemcitabine|mesh-list
14691682|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691683|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
14691684|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691685|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691686|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
14691687|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691688|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691689|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691690|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
14691691|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691692|NCT00357643|Vitamin D|vitamin d|mesh-list
14691693|NCT00357643|Calcium|calcium|mesh-list
14691694|NCT00357643|Vitamins|vitamins|mesh-ancestor
14691695|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
14691696|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691697|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14691698|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14691699|NCT00357669|Brivaracetam|brivaracetam|mesh-list
14691700|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
14691701|NCT00357682|Aspirin|aspirin|mesh-list
14691702|NCT00357682|Esomeprazole|esomeprazole|mesh-list
14691703|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14691704|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691705|NCT00357682|Analgesics|analgesics|mesh-ancestor
14691706|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
14691707|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691708|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691709|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691710|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193589|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15193590|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15193591|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
15193592|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691711|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14691712|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14691713|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691714|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14691715|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14691716|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691717|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
14691718|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14691719|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691720|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14691721|NCT00357708|Decitabine|decitabine|mesh-list
14691722|NCT00357708|Azacitidine|azacitidine|mesh-list
14691723|NCT00357708|Vorinostat|vorinostat|mesh-list
14691724|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691725|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
14691726|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691727|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691728|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691729|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14691730|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14691731|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14691732|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14691733|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691734|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691735|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691736|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691737|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14691738|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
14691739|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691740|NCT00357747|Docetaxel|docetaxel|mesh-list
14691741|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193593|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193594|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
15193595|NCT03820180|Hormones|hormones|mesh-ancestor
14691742|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
14691743|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
14691744|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
14691745|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193596|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193597|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
15193598|NCT03820037|Opicapone|opicapone|mesh-list
15193599|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15193600|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193601|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193602|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14691746|NCT00357773|Azithromycin|azithromycin|mesh-list
14691747|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691748|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691749|NCT00357825|Reboxetine|reboxetine|mesh-list
14691750|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
14691751|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14691752|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14691753|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14691754|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14691755|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691756|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
14691757|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691758|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691759|NCT00357851|Aprotinin|aprotinin|mesh-list
14691760|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
14691761|NCT00357851|Coagulants|coagulants|mesh-ancestor
14691762|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14691763|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14691764|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
14691765|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691766|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691767|NCT00357864|Carbachol|carbachol|mesh-list
14691768|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14691769|NCT00357864|Miotics|miotics|mesh-ancestor
14691770|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
14691771|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691772|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691773|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15193603|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15193604|NCT03819790|Insulin|insulin|mesh-list
14691774|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
14691775|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193605|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14691776|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691777|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14691778|NCT00357864|Analgesics|analgesics|mesh-ancestor
14691779|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
14691780|NCT00357864|Protective Agents|protective agents|mesh-ancestor
14691781|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
14691782|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14691783|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691784|NCT00357942|Morphine|morphine|mesh-list
14691785|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14691786|NCT00357942|Narcotics|narcotics|mesh-ancestor
14691787|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691788|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691789|NCT00357942|Analgesics|analgesics|mesh-ancestor
14691790|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
14691791|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691792|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
14691793|NCT00357981|Ortho Evra|ortho evra|mesh-list
14691794|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14691795|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691796|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14691797|NCT00358020|Thalidomide|thalidomide|mesh-list
14691798|NCT00358020|Bortezomib|bortezomib|mesh-list
14691799|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691800|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691801|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
14691802|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691803|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
14691804|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691805|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691806|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14691807|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14691808|NCT00358020|Growth Substances|growth substances|mesh-ancestor
15193606|NCT03819790|Metformin|metformin|mesh-list
15193607|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
14691809|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
14691810|NCT00358124|Metformin|metformin|mesh-list
14691811|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
14691812|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
14691813|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14691814|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691825|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
14691826|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14691827|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14691828|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691829|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14691830|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691831|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14691832|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
14691833|NCT00358202|Cefepime|cefepime|mesh-list
14691834|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691835|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193608|NCT03819790|Lixisenatide|lixisenatide|mesh-list
15193609|NCT03819790|Gliclazide|gliclazide|mesh-list
15193610|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15193611|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224095|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
15224096|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15224097|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15224098|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224099|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15224100|NCT04641871|Irinotecan|irinotecan|mesh-list
15224101|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14691836|NCT00358228|Rimonabant|rimonabant|mesh-list
14691837|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14691838|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
15224102|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15193612|NCT03819647|Stiripentol|stiripentol|mesh-list
15193613|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
15193614|NCT03819556|Caseins|caseins|mesh-list
15193615|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
15193616|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
14691839|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14691840|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691841|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691842|NCT00358228|Hormones|hormones|mesh-ancestor
14691843|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691844|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691845|NCT00358280|Bupivacaine|bupivacaine|mesh-list
14691846|NCT00358280|Ropivacaine|ropivacaine|mesh-list
14691847|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
14691848|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
14691849|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691850|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691851|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
14691852|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691853|NCT00358293|Tizanidine|tizanidine|mesh-list
14691854|NCT00358293|Analgesics|analgesics|mesh-ancestor
14691855|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
14691856|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691857|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691858|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
14691859|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14691860|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14691861|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
14691862|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
14691863|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14691864|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14691865|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14691866|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
14691867|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691868|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691869|NCT00358319|Valproic Acid|valproic acid|mesh-list
14691870|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
14691871|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691872|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691873|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
14691874|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193617|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193618|NCT03821545|Lidocaine|lidocaine|mesh-list
15193619|NCT03821545|Ketamine|ketamine|mesh-list
15193620|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
15193621|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
15193622|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193623|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193624|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
15193625|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193626|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15193627|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15193628|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15193629|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15193630|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193631|NCT03821545|Analgesics|analgesics|mesh-ancestor
14691875|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691876|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
14691877|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14691878|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691879|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14691880|NCT00358358|Fluticasone|fluticasone|mesh-list
14691881|NCT00358358|Xhance|xhance|mesh-list
14691882|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14691883|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14691884|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691885|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14691886|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
14691887|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691888|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691889|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14691890|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
14691891|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
14691892|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14691893|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14691894|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14691895|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14691896|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
14691897|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691898|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691899|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
14691900|NCT00358358|Hormones|hormones|mesh-ancestor
14691901|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691902|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
14691903|NCT00358371|Floxacillin|floxacillin|mesh-list
15193632|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15193633|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15193634|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
15193635|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15193636|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15193637|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193638|NCT03819530|Micronutrients|micronutrients|mesh-list
15193639|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193640|NCT03819517|Resveratrol|resveratrol|mesh-list
15193641|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
14691904|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14691905|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691906|NCT00358384|Betamethasone|betamethasone|mesh-list
14691907|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
14691908|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14691909|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
14691910|NCT00358384|Calcipotriene|calcipotriene|mesh-list
14691911|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14691912|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691913|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
14691914|NCT00358384|Hormones|hormones|mesh-ancestor
14691915|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14691916|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691917|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14691918|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
14691919|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
14691920|NCT00358410|Casopitant|casopitant|mesh-list
14691921|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
14691922|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
14691923|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691924|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691925|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691926|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14691927|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691928|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691929|NCT00358488|Albuterol|albuterol|mesh-list
14691930|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14691931|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14691932|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
14691933|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691934|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691935|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14691936|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
14691937|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14691938|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14691939|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15193642|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193643|NCT03819517|Protective Agents|protective agents|mesh-ancestor
15193644|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193645|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193646|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15193647|NCT03819296|Prednisone|prednisone|mesh-list
14691940|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
14691941|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691942|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691943|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
14691944|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14691945|NCT00358553|Insulin|insulin|mesh-list
14691946|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14691947|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193648|NCT03819296|Cortisone|cortisone|mesh-list
15193649|NCT03819296|Infliximab|infliximab|mesh-list
15193650|NCT03819296|Vedolizumab|vedolizumab|mesh-list
15193651|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
15193652|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
15193653|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691948|NCT00358566|Gemcitabine|gemcitabine|mesh-list
14691949|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14691950|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
14691951|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691952|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691953|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
14691954|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691955|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691956|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691957|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
14691958|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691959|NCT00358618|Propofol|propofol|mesh-list
14691960|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14691961|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14691962|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691963|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14691964|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
14691965|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
14691966|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
14691967|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14691968|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
14691969|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691970|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727823|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727824|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14727825|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14727826|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727827|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14727828|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14727829|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
14727830|NCT00515554|Rituximab|rituximab|mesh-list
14727831|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14727832|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727833|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
14727834|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727835|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727836|NCT00515593|Hormones|hormones|mesh-list
14727837|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
14727838|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727839|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727840|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14727841|NCT00515684|Bevacizumab|bevacizumab|mesh-list
14727842|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14727843|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727844|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14727845|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14727846|NCT00515684|Growth Substances|growth substances|mesh-ancestor
14727847|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727848|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14727849|NCT00515736|Vitamins|vitamins|mesh-list
14727850|NCT00515736|Vitamin E|vitamin e|mesh-list
14727851|NCT00515736|Thiamine|thiamine|mesh-list
14727852|NCT00515736|Zinc|zinc|mesh-list
14727853|NCT00515736|Selenium|selenium|mesh-list
14727854|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
14727855|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727856|NCT00515736|Trace Elements|trace elements|mesh-ancestor
14727857|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
14727858|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727859|NCT00515736|Protective Agents|protective agents|mesh-ancestor
14727860|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
15193654|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
15193655|NCT03819296|Hormones|hormones|mesh-ancestor
15193656|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193657|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193658|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14727861|NCT00515788|Cytarabine|cytarabine|mesh-list
14727862|NCT00515788|Temozolomide|temozolomide|mesh-list
14727863|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727864|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
15193659|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14691971|NCT00358696|Tenofovir|tenofovir|mesh-list
14691972|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
14691973|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691974|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14691975|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14691976|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691977|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691978|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14691979|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14691980|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
14691981|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14691982|NCT00358813|Casopitant|casopitant|mesh-list
14691983|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
14691984|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
14691985|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14691986|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14691987|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14691988|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14691989|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14691990|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691991|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
14691992|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14691993|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14691994|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14691995|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14691996|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14691997|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
14691998|NCT00358969|Guanfacine|guanfacine|mesh-list
14691999|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692000|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14692001|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14692002|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14692003|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
14692004|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692005|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692006|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692007|NCT00359112|Metformin|metformin|mesh-list
14692008|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692009|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193660|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
15193661|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
15193662|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193663|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193664|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
15193665|NCT03819348|Clotrimazole|clotrimazole|mesh-list
14692010|NCT00359125|Mifepristone|mifepristone|mesh-list
14692011|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14692012|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
14692013|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14692014|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692015|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14692016|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14692017|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14692018|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
14692019|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14692020|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14692021|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
14692022|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692023|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
14692024|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14692025|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14692026|NCT00359151|Celecoxib|celecoxib|mesh-list
14692027|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14692028|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14692029|NCT00359151|Analgesics|analgesics|mesh-ancestor
14692030|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
14692031|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692032|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692033|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193666|NCT03819348|Miconazole|miconazole|mesh-list
15193667|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193668|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15193669|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15224103|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692034|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692035|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14692036|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14692037|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692038|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692039|NCT00359164|Bevacizumab|bevacizumab|mesh-list
14692040|NCT00359164|Verteporfin|verteporfin|mesh-list
14692041|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14692042|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692043|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14692044|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14692045|NCT00359164|Growth Substances|growth substances|mesh-ancestor
14692046|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692047|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
14692048|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14692049|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
14692050|NCT00359177|Casopitant|casopitant|mesh-list
14692051|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
14692052|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
14692053|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692054|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692055|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14692056|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14692057|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692058|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692059|NCT00359190|Lapatinib|lapatinib|mesh-list
14692060|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692061|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14692062|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692063|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692064|NCT00359229|Zolpidem|zolpidem|mesh-list
14692065|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14692066|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14692067|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692068|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692069|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14692070|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
14692071|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
14692072|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692073|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193670|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15193671|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193672|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193673|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15193674|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
15193675|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193676|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193677|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15193678|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15193679|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
15193680|NCT03820986|Lenvatinib|lenvatinib|mesh-list
15193681|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15193682|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193683|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15193684|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193685|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193686|NCT03819231|Oxytocin|oxytocin|mesh-list
15193687|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
15193688|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14692074|NCT00359333|Gemcitabine|gemcitabine|mesh-list
14692075|NCT00359333|Docetaxel|docetaxel|mesh-list
14692076|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14692077|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
14692078|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692079|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692080|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
14692081|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692082|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193689|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294470|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294471|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14692083|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15193690|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
14692084|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
14692085|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692086|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14692087|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14692088|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14692089|NCT00359359|Sagopilone|sagopilone|mesh-list
15193691|NCT03819322|Velpatasvir|velpatasvir|mesh-list
15193692|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
15193693|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193694|NCT03820908|Bisantrene|bisantrene|mesh-list
14692090|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692091|NCT00359385|Alendronate|alendronate|mesh-list
14692092|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14692093|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692094|NCT00359567|Palonosetron|palonosetron|mesh-list
14692095|NCT00359567|Granisetron|granisetron|mesh-list
14692096|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
14692097|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
14692098|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692099|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692100|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14692101|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14692102|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14692103|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
14692104|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692105|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692106|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
14692107|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
14692108|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692109|NCT00359658|Cyclosporine|cyclosporine|mesh-list
14692110|NCT00359658|Prednisolone|prednisolone|mesh-list
14692111|NCT00359658|Cyclosporins|cyclosporins|mesh-list
14692112|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692113|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692114|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14692115|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
14692116|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692117|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
14692118|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692119|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
14692120|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692121|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14692122|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692123|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
14692124|NCT00359658|Hormones|hormones|mesh-ancestor
14692125|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692126|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14692127|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692128|NCT00359671|Docetaxel|docetaxel|mesh-list
14815008|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815009|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14815010|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14815011|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14815012|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815013|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
14815014|NCT00864812|Hormones|hormones|mesh-ancestor
14815015|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815016|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
14815017|NCT00864825|Allopurinol|allopurinol|mesh-list
14815018|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
14815019|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815020|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815021|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
14815022|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14815023|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14815024|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
14815025|NCT00864825|Protective Agents|protective agents|mesh-ancestor
14815026|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815027|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14815028|NCT00864838|Acetazolamide|acetazolamide|mesh-list
14815029|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14815030|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14815031|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14692129|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692130|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
15193695|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14692131|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
14692132|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
14692133|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692134|NCT00359697|Mannitol|mannitol|mesh-list
14692135|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14692136|NCT00359697|Diuretics|diuretics|mesh-ancestor
14692137|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
14692138|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692139|NCT00359723|Methylphenidate|methylphenidate|mesh-list
14692140|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14692141|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692142|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14692143|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14692144|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14692145|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692146|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
14692147|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692148|NCT00359814|Cyclosporine|cyclosporine|mesh-list
14692149|NCT00359814|Cyclosporins|cyclosporins|mesh-list
14692150|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692151|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692152|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14692153|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
14692154|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692155|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
14692156|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692157|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
14692158|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692159|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14692160|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
14692161|NCT00359840|Hematinics|hematinics|mesh-ancestor
14692162|NCT00359853|Norfloxacin|norfloxacin|mesh-list
14692163|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692164|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692165|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14692166|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692167|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692168|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692169|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692170|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14692171|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14692172|NCT00359879|Exenatide|exenatide|mesh-list
14692173|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692174|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692175|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14692176|NCT00359879|Incretins|incretins|mesh-ancestor
14692177|NCT00359879|Hormones|hormones|mesh-ancestor
14692178|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692179|NCT00359892|Obatoclax|obatoclax|mesh-list
14692180|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692181|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692182|NCT00359905|Tamsulosin|tamsulosin|mesh-list
14692183|NCT00359905|Silodosin|silodosin|mesh-list
14692184|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14692185|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14692186|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14692187|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
14692188|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692189|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692190|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692191|NCT00359905|Urological Agents|urological agents|mesh-ancestor
14692192|NCT00359970|Azithromycin|azithromycin|mesh-list
14692193|NCT00359970|Loperamide|loperamide|mesh-list
14692194|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
14692195|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692196|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692197|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14692198|NCT00360048|Oxytocin|oxytocin|mesh-list
14692199|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
14692200|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14692201|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692202|NCT00360087|Bosentan|bosentan|mesh-list
14294472|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14692203|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692204|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15193696|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193697|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14692205|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692206|NCT00360178|Amlodipine|amlodipine|mesh-list
14692207|NCT00360178|Valsartan|valsartan|mesh-list
14692208|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14692209|NCT00360178|Candesartan|candesartan|mesh-list
14692210|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692211|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14692212|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14692213|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692214|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14692215|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692216|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
14692217|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14692218|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14294473|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294474|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294475|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
14294476|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294477|NCT00576576|Atorvastatin|atorvastatin|mesh-list
15193698|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15193699|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193700|NCT03819101|Aspirin|aspirin|mesh-list
15193701|NCT03819101|Atorvastatin|atorvastatin|mesh-list
15193702|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15193703|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15193704|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
15193705|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294478|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14692219|NCT00360178|Diuretics|diuretics|mesh-ancestor
14692220|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
14692221|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14692222|NCT00360191|Buspirone|buspirone|mesh-list
14692223|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14692224|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14692225|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692226|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692227|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14692228|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14692229|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
14692230|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692231|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692232|NCT00360295|Azithromycin|azithromycin|mesh-list
15193706|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15193707|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15193708|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193709|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193710|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15193711|NCT03819101|Analgesics|analgesics|mesh-ancestor
14692233|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692234|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692235|NCT00360386|Clopidogrel|clopidogrel|mesh-list
14692236|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14692237|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14692238|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14692239|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14692240|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
14692241|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692242|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692243|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692244|NCT00360438|Rasburicase|rasburicase|mesh-list
14692245|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
14692246|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692247|NCT00360464|Azithromycin|azithromycin|mesh-list
14692248|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692249|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692250|NCT00360594|Acamprosate|acamprosate|mesh-list
14692251|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14692252|NCT00360607|Metronidazole|metronidazole|mesh-list
14692253|NCT00360607|Amikacin|amikacin|mesh-list
14692254|NCT00360607|Ceftazidime|ceftazidime|mesh-list
14692255|NCT00360607|Sulbactam|sulbactam|mesh-list
14692256|NCT00360607|Cefoperazone|cefoperazone|mesh-list
14692257|NCT00360607|Sulperazone|sulperazone|mesh-list
14692258|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692259|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692260|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14692261|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14692262|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14692263|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692264|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692265|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14692266|NCT00360607|Renal Agents|renal agents|mesh-ancestor
14692267|NCT00360737|Antitoxins|antitoxins|mesh-list
14692268|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
14692269|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
14692270|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692271|NCT00360750|Cytarabine|cytarabine|mesh-list
14692272|NCT00360750|Carboplatin|carboplatin|mesh-list
14692273|NCT00360750|Etoposide|etoposide|mesh-list
14692274|NCT00360750|Vincristine|vincristine|mesh-list
14692275|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692276|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15193712|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
15193713|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193714|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692277|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14692278|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692279|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692280|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692281|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14692282|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
14692283|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
14692284|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692285|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14692286|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
14692287|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692288|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14692289|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14692290|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14692291|NCT00360763|Candesartan|candesartan|mesh-list
14692292|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
14692293|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692294|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14692295|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14692296|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727865|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727866|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727867|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
14727868|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727869|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727870|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
14727871|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727872|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15193715|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193716|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193717|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15193718|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15193719|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15193720|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193721|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
14692297|NCT00360776|Tipifarnib|tipifarnib|mesh-list
14692298|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692299|NCT00360815|Insulin|insulin|mesh-list
14692300|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692301|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692302|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14692303|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692304|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14692305|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692306|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692307|NCT00360945|Temozolomide|temozolomide|mesh-list
14692308|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692309|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14692310|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
14692311|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692312|NCT00360984|Insulin|insulin|mesh-list
14692313|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14692314|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
14692315|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692316|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692317|NCT00361010|Levetiracetam|levetiracetam|mesh-list
14692318|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
14692319|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
14692320|NCT00361023|Losartan|losartan|mesh-list
14692321|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14692322|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692323|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14692324|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14692325|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692326|NCT00361075|Estradiol|estradiol|mesh-list
14692327|NCT00361075|Estrogens|estrogens|mesh-list
14692328|NCT00361075|Progesterone|progesterone|mesh-list
14692329|NCT00361075|Hormones|hormones|mesh-ancestor
14692330|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692331|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692332|NCT00361075|Progestins|progestins|mesh-ancestor
14692333|NCT00361088|Bortezomib|bortezomib|mesh-list
14692334|NCT00361088|Tipifarnib|tipifarnib|mesh-list
14692335|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692336|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
14692337|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
14692338|NCT00361114|Dapsone|dapsone|mesh-list
14692339|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14692340|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
14692341|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
14692342|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14692343|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14692344|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692345|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14692346|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692347|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692348|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14692349|NCT00361114|Renal Agents|renal agents|mesh-ancestor
14692350|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
14692351|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692352|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14692353|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14692354|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15193722|NCT03819127|Metformin|metformin|mesh-list
15193723|NCT03819127|Vildagliptin|vildagliptin|mesh-list
15193724|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15193725|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193726|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15193727|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
15193728|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692355|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
14692356|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193729|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692357|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14692358|NCT00361166|Pimavanserin|pimavanserin|mesh-list
15193730|NCT03819010|Letrozole|letrozole|mesh-list
15193731|NCT03819010|Palbociclib|palbociclib|mesh-list
14692359|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14692360|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14692361|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14692362|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14692363|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692364|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692365|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14692366|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14692367|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14692368|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
14692369|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692370|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692371|NCT00361244|Irinotecan|irinotecan|mesh-list
14692372|NCT00361244|Cetuximab|cetuximab|mesh-list
14692373|NCT00361244|Sunitinib|sunitinib|mesh-list
14692374|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14692375|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692376|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692377|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692378|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692379|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14692380|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14692381|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14692382|NCT00361244|Growth Substances|growth substances|mesh-ancestor
14692383|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692384|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
14692385|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14692386|NCT00361309|Sunitinib|sunitinib|mesh-list
14692387|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692388|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14692389|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14692390|NCT00361309|Growth Substances|growth substances|mesh-ancestor
14692391|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692392|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
14692393|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14692394|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692395|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692396|NCT00361322|Clindamycin|clindamycin|mesh-list
14692397|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
14692398|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
14692399|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
14692400|NCT00361322|Salicylates|salicylates|mesh-list
14692401|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692402|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692403|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15193732|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193733|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15193734|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14692404|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692405|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692406|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
14692407|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
14692408|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
14692409|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14692410|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14692411|NCT00361322|Analgesics|analgesics|mesh-ancestor
14692412|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
14692413|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692414|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692415|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692416|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692417|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193735|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193736|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193737|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15193738|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
15193739|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193740|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193741|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15193742|NCT03818997|Paclitaxel|paclitaxel|mesh-list
15193743|NCT03818997|Atezolizumab|atezolizumab|mesh-list
14692418|NCT00361348|Heparin|heparin|mesh-list
14692419|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
14692420|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14692421|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14692422|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692423|NCT00361387|Methylphenidate|methylphenidate|mesh-list
14692424|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14692425|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692426|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14692427|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14692428|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14692429|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692430|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
14692431|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692432|NCT00361413|Alefacept|alefacept|mesh-list
14692433|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
14692434|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
14692435|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692436|NCT00361452|Epinephrine|epinephrine|mesh-list
14692437|NCT00361452|Albuterol|albuterol|mesh-list
14692438|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14692439|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14692440|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
14692441|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692442|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692443|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692444|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14692445|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14692446|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
14692447|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692448|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14692449|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
14692450|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
14692451|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
14692452|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14692453|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
14692454|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14692455|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14692456|NCT00361517|Amphotericin B|amphotericin b|mesh-list
14692457|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14692458|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14692459|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
14692460|NCT00361517|Amebicides|amebicides|mesh-ancestor
14692461|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14692462|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14692463|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692464|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692465|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
14692466|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14692467|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14692468|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14692469|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14692470|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
14692471|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692472|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692473|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14692474|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14692475|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14692476|NCT00361621|Prednisone|prednisone|mesh-list
14692477|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
14692478|NCT00361621|Rituximab|rituximab|mesh-list
14692479|NCT00361621|Doxorubicin|doxorubicin|mesh-list
14692480|NCT00361621|Vincristine|vincristine|mesh-list
14692481|NCT00361621|Bortezomib|bortezomib|mesh-list
14692482|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14692483|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
14692484|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692485|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692486|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14692487|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
14727873|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
14692488|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692489|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692490|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14692491|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14692492|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14692493|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14692494|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692495|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692496|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692497|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
14692498|NCT00361621|Hormones|hormones|mesh-ancestor
14692499|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692500|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14692501|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14692502|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
14692503|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
14692504|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
14692505|NCT00361686|Tramadol|tramadol|mesh-list
14692506|NCT00361686|Remifentanil|remifentanil|mesh-list
14692507|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14692508|NCT00361686|Narcotics|narcotics|mesh-ancestor
14692509|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692510|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692511|NCT00361686|Analgesics|analgesics|mesh-ancestor
14692512|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
14692513|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692514|NCT00361751|Fenofibrate|fenofibrate|mesh-list
14692515|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14692516|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
14692517|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692518|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14692519|NCT00361790|Aripiprazole|aripiprazole|mesh-list
14692520|NCT00361790|Citalopram|citalopram|mesh-list
14692521|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14692522|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14692523|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14692524|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193744|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15193745|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193746|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
15193747|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
15193748|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
15193749|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193750|NCT03818945|Listerine|listerine|mesh-list
15193751|NCT03818945|Fluorides|fluorides|mesh-list
14692525|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692526|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
14692527|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193752|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
15193753|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
15193754|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
15193755|NCT03818945|Protective Agents|protective agents|mesh-ancestor
15193756|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193757|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15193758|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193759|NCT03818932|Acetaminophen|acetaminophen|mesh-list
15193760|NCT03818932|Celecoxib|celecoxib|mesh-list
15193761|NCT03818932|Ketorolac|ketorolac|mesh-list
15193762|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15193763|NCT03818932|Diazepam|diazepam|mesh-list
15193764|NCT03818932|Gabapentin|gabapentin|mesh-list
15193765|NCT03818932|Hydrocodone|hydrocodone|mesh-list
15193766|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15193767|NCT03818932|Analgesics|analgesics|mesh-ancestor
15193768|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
15193769|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193770|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193771|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
15193772|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193773|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193774|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193775|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15193776|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193777|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692528|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14692529|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
14692530|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14692531|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14692532|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14692533|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692534|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
14692535|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
14692536|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14692537|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14692538|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14692539|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14692540|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14692541|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14692542|NCT00361803|Topotecan|topotecan|mesh-list
14692543|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14692544|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692545|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692546|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692547|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692548|NCT00361868|Metformin|metformin|mesh-list
14692549|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
14692550|NCT00361868|Fenofibrate|fenofibrate|mesh-list
14692551|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692552|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692553|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14692554|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
15193778|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193779|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
15193780|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15193781|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15193782|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193783|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15193784|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15193785|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15193786|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193787|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
15193788|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15193789|NCT03818932|Narcotics|narcotics|mesh-ancestor
14692555|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692556|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14692557|NCT00361881|Acyclovir|acyclovir|mesh-list
14692558|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
14692559|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
14692560|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692561|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692562|NCT00361894|Enoxaparin|enoxaparin|mesh-list
14692563|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
14692564|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14692565|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
14692566|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14692567|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
14692568|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692569|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692570|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
14692571|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14692572|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14692573|NCT00361907|Insulin|insulin|mesh-list
14692574|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14692575|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692576|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692577|NCT00361920|Prednisone|prednisone|mesh-list
14692578|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692579|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
14692580|NCT00361920|Hormones|hormones|mesh-ancestor
14692581|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15193790|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
14692582|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692583|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14692584|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692585|NCT00361933|Valganciclovir|valganciclovir|mesh-list
14692586|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
14692587|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692588|NCT00361959|Fluticasone|fluticasone|mesh-list
14692589|NCT00361959|Xhance|xhance|mesh-list
14692590|NCT00361959|Bromides|bromides|mesh-list
14692591|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
14692592|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14692593|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692594|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14692595|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
14692596|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692597|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692598|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14692599|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
14692600|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
14692601|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14692602|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
14692603|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14692604|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
14692605|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692606|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692607|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14692608|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14692609|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14692610|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14692611|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
14692612|NCT00361985|Esomeprazole|esomeprazole|mesh-list
14692613|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14692614|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193791|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
15193792|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15193793|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
15193794|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
15193795|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193796|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15193797|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15193798|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15193799|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15193800|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
14692615|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14692616|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692617|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692618|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
14692619|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14692620|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692621|NCT00361998|Renal Agents|renal agents|mesh-ancestor
14692622|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692623|NCT00362037|Irbesartan|irbesartan|mesh-list
14692624|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692625|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14692626|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14692627|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692628|NCT00362063|Hormones|hormones|mesh-list
14692629|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692630|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692631|NCT00362089|Dronabinol|dronabinol|mesh-list
14692632|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
14692633|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692634|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14692635|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14692636|NCT00362089|Analgesics|analgesics|mesh-ancestor
14692637|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
14692638|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692639|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14692640|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14692641|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692642|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692643|NCT00362089|Hormones|hormones|mesh-ancestor
14692644|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692645|NCT00362102|Cetuximab|cetuximab|mesh-list
14692646|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14692647|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692648|NCT00362141|Levetiracetam|levetiracetam|mesh-list
15193801|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
14692649|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
14692650|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
14692651|NCT00362206|Simvastatin|simvastatin|mesh-list
14692652|NCT00362206|Pravastatin|pravastatin|mesh-list
14692653|NCT00362206|Fenofibrate|fenofibrate|mesh-list
14692654|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14692655|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14692656|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
14692657|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692658|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14692659|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14692660|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692661|NCT00362219|Morphine|morphine|mesh-list
14692662|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14692663|NCT00362219|Narcotics|narcotics|mesh-ancestor
14692664|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692665|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692666|NCT00362219|Analgesics|analgesics|mesh-ancestor
14692667|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
14692668|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692669|NCT00362245|Amikacin|amikacin|mesh-list
14692670|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692671|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692672|NCT00362258|Irbesartan|irbesartan|mesh-list
14692673|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692674|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14692675|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14692676|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692677|NCT00362271|Aripiprazole|aripiprazole|mesh-list
14692678|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14692679|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
14692680|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14692681|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15193802|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
15193803|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
15193804|NCT03818919|Acetaminophen|acetaminophen|mesh-list
15193805|NCT03818919|Celecoxib|celecoxib|mesh-list
14692682|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14692683|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692684|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692685|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
14692686|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
15193806|NCT03818919|Ketorolac|ketorolac|mesh-list
15193807|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15193808|NCT03818919|Diazepam|diazepam|mesh-list
14692687|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692688|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193809|NCT03818919|Gabapentin|gabapentin|mesh-list
15193810|NCT03818919|Hydrocodone|hydrocodone|mesh-list
15193811|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14294479|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14294480|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
14294481|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294482|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14294483|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14294484|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692689|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14692690|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14294485|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
14692691|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
14692692|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14692693|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14692694|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14692695|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14692696|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14692697|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14692698|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14692699|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14692700|NCT00362310|Indinavir|indinavir|mesh-list
14692701|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14692702|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14692703|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
15193812|NCT03818919|Analgesics|analgesics|mesh-ancestor
15193813|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
14294486|NCT00576628|Hematinics|hematinics|mesh-ancestor
14294487|NCT00576680|Temozolomide|temozolomide|mesh-list
14294488|NCT00576680|Everolimus|everolimus|mesh-list
14294489|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14294490|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
14294491|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294492|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294493|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294494|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
14294495|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294496|NCT00576732|Risperidone|risperidone|mesh-list
14692704|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692705|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692706|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14692707|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14692708|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
14692709|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692710|NCT00362323|Metformin|metformin|mesh-list
14692711|NCT00362323|Fenofibrate|fenofibrate|mesh-list
14692712|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692713|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692714|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14692715|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
14692716|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692717|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14692718|NCT00362505|Clevudine|clevudine|mesh-list
14692719|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
14692720|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692721|NCT00362531|Prednisone|prednisone|mesh-list
15193814|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193815|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193816|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
15193817|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15193818|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15193819|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193820|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15193821|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15193822|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193823|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193824|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
15193825|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15193826|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15193827|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193828|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14692722|NCT00362531|Tacrolimus|tacrolimus|mesh-list
14692723|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692724|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
14692725|NCT00362531|Hormones|hormones|mesh-ancestor
14692726|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692727|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692728|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14692729|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692730|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14692731|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
14692732|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15193829|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15193830|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15193831|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193832|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
15193833|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15193834|NCT03818919|Narcotics|narcotics|mesh-ancestor
15193835|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
15193836|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
15193837|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15193838|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
15193839|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
15193840|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193841|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15193842|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15193843|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14294497|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14692733|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692734|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692735|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15193844|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14692736|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
14692737|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692738|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14692739|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14727874|NCT00515801|Glyburide|glyburide|mesh-list
14727875|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14727876|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727877|NCT00515866|Gemcitabine|gemcitabine|mesh-list
14727878|NCT00515866|Olaparib|olaparib|mesh-list
14727879|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14727880|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14727881|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
14727882|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727883|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727884|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
14727885|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14727886|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727887|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727888|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
14727889|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727890|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
14727891|NCT00515892|Antibodies|antibodies|mesh-list
14727892|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
14727893|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14727894|NCT00515892|Immunotoxins|immunotoxins|mesh-list
14727895|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
14727896|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727897|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727898|NCT00515905|Propofol|propofol|mesh-list
14727899|NCT00515905|Sevoflurane|sevoflurane|mesh-list
14727900|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14727901|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14727902|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727903|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14727904|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
14727905|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
14727906|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14727907|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14727908|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
14727909|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14727910|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14727911|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14727912|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14727913|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727914|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14727915|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727916|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727917|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14727918|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727919|NCT00515957|Antibodies|antibodies|mesh-list
14727920|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
14727921|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727922|NCT00516009|Dexamethasone|dexamethasone|mesh-list
14727923|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14727924|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
14727925|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
14727926|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14727927|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727928|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14727929|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
14727930|NCT00516009|Hormones|hormones|mesh-ancestor
14727931|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14727932|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14727933|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727934|NCT00516100|Pemetrexed|pemetrexed|mesh-list
14727935|NCT00516100|Bortezomib|bortezomib|mesh-list
14727936|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727937|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727938|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727939|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14727940|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14727941|NCT00516113|Paroxetine|paroxetine|mesh-list
14727942|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14727943|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14727944|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14727945|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692740|NCT00362570|Temozolomide|temozolomide|mesh-list
14692741|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14692742|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
14692743|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692744|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692745|NCT00362583|Fentanyl|fentanyl|mesh-list
14692746|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14692747|NCT00362583|Narcotics|narcotics|mesh-ancestor
14692748|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692749|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692750|NCT00362583|Analgesics|analgesics|mesh-ancestor
14692751|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
14692752|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692753|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14692754|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14692755|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
14692756|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
14692757|NCT00362596|Acyclovir|acyclovir|mesh-list
14692758|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
14692759|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692760|NCT00362635|Clevudine|clevudine|mesh-list
14692761|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
14692762|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692763|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
14692764|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14692765|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14692766|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14692767|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692768|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14692769|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14692770|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14692771|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692772|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692773|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
14692774|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692775|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14692776|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14692777|NCT00362700|Clevudine|clevudine|mesh-list
14692778|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
14692779|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692780|NCT00362713|Ipilimumab|ipilimumab|mesh-list
14692781|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14692782|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692783|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14692784|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692785|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
14692786|NCT00362726|Ritonavir|ritonavir|mesh-list
14692787|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14692788|NCT00362726|Maleic acid|maleic acid|mesh-list
14692789|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14692790|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14692791|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
14692792|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692793|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692794|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14692795|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14692796|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
14692797|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193845|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
15193846|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
15193847|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
15193848|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
15193849|NCT03818685|Capecitabine|capecitabine|mesh-list
15193850|NCT03818685|Nivolumab|nivolumab|mesh-list
15193851|NCT03818685|Ipilimumab|ipilimumab|mesh-list
15193852|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15193853|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
14294498|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
14692798|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14692799|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14692800|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692801|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692802|NCT00362752|Norfloxacin|norfloxacin|mesh-list
14692803|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692804|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193854|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294499|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692805|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14692806|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692807|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692808|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692809|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692810|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14692811|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14692812|NCT00362765|Metformin|metformin|mesh-list
14692813|NCT00362765|Fenofibrate|fenofibrate|mesh-list
14692814|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692815|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692816|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14692817|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
14692818|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692819|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14692820|NCT00362778|Insulin|insulin|mesh-list
14692821|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14692822|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193855|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193856|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15193857|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15193858|NCT03818581|Suvorexant|suvorexant|mesh-list
14692823|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
14692824|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14692825|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14692826|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14692827|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692828|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
14692829|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692830|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692831|NCT00362869|Levofloxacin|levofloxacin|mesh-list
14692832|NCT00362869|Ofloxacin|ofloxacin|mesh-list
14692833|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14692834|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692835|NCT00362869|Renal Agents|renal agents|mesh-ancestor
14692836|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692837|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14692838|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692839|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692840|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692841|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692842|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14692843|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14692844|NCT00362895|Tobramycin|tobramycin|mesh-list
14692845|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14692846|NCT00362895|Dexamethasone|dexamethasone|mesh-list
14692847|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
14692848|NCT00362895|BB 1101|bb 1101|mesh-list
14692849|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692850|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
14692851|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
14692852|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692853|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692854|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14692855|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
14692856|NCT00362895|Hormones|hormones|mesh-ancestor
14692857|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692858|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14692859|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692860|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
14692861|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692862|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692863|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692864|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692865|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14692866|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14692867|NCT00362921|Carmustine|carmustine|mesh-list
14692868|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14692869|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14692870|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
14692871|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692872|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692873|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692874|NCT00362934|Atorvastatin|atorvastatin|mesh-list
15193859|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15193860|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15193861|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193862|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193863|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15193864|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193865|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193866|NCT03818672|Rifaximin|rifaximin|mesh-list
15193867|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14692875|NCT00362934|Simvastatin|simvastatin|mesh-list
14692876|NCT00362934|Fenofibrate|fenofibrate|mesh-list
14692877|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14692878|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14692879|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
14692880|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692881|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14692882|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14692883|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692884|NCT00362947|Parnaparin|parnaparin|mesh-list
14692885|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
14692886|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14692887|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14692888|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692889|NCT00362960|Losartan|losartan|mesh-list
14692890|NCT00362960|Olmesartan|olmesartan|mesh-list
14692891|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14692892|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14692893|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14692894|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14692895|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14692896|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692897|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14692898|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14692899|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692900|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
14692901|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14692902|NCT00362986|Protective Agents|protective agents|mesh-ancestor
14692903|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193868|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193869|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193870|NCT03818282|Paclitaxel|paclitaxel|mesh-list
15193871|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15193872|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193873|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
15193874|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
14692904|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
15193875|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
15193876|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193877|NCT03818191|Acamprosate|acamprosate|mesh-list
15193878|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15193879|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
15193880|NCT03818308|Velpatasvir|velpatasvir|mesh-list
15193881|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
15193882|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193883|NCT03817970|Ondansetron|ondansetron|mesh-list
15193884|NCT03817970|Palonosetron|palonosetron|mesh-list
15193885|NCT03817970|Granisetron|granisetron|mesh-list
15193886|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
15193887|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
15193888|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15193889|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193890|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15193891|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
15193892|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
15193893|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15193894|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
15193895|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193896|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193897|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15193898|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15193899|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193900|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15193901|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15193902|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14692905|NCT00363025|Daunorubicin|daunorubicin|mesh-list
15193903|NCT03818295|Praliciguat|praliciguat|mesh-list
14692906|NCT00363025|Idarubicin|idarubicin|mesh-list
14692907|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14692908|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692909|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14692910|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692911|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692912|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692913|NCT00363090|Prednisone|prednisone|mesh-list
14692914|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
14692915|NCT00363090|Doxorubicin|doxorubicin|mesh-list
14692916|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14692917|NCT00363090|Vincristine|vincristine|mesh-list
14692918|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
14692919|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14692920|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
14692921|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692922|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692923|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14692924|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
14692925|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692926|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692927|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14692928|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15193904|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15193905|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
15193906|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193907|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224104|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224105|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224106|NCT04631471|Ibudilast|ibudilast|mesh-list
15224107|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15224108|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
15224109|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224110|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224111|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15224112|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
15224113|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15224114|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224115|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692929|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14692930|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14692931|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14692932|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14692933|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
14692934|NCT00363090|Hormones|hormones|mesh-ancestor
14692935|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692936|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224116|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15224117|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
15224118|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
15224119|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224120|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15224121|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224122|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224123|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
15224124|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15224125|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224126|NCT04558502|Amoxicillin|amoxicillin|mesh-list
15224127|NCT04558502|Clarithromycin|clarithromycin|mesh-list
14692937|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14692938|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
14692939|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
14692940|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
14692941|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14692942|NCT00363116|Daclizumab|daclizumab|mesh-list
14692943|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14692944|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
14692945|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692946|NCT00363155|KRN 7000|krn 7000|mesh-list
14692947|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14692948|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
14692949|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692950|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224128|NCT04558502|Minocycline|minocycline|mesh-list
14692951|NCT00363259|Ribavirin|ribavirin|mesh-list
14692952|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14692953|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
14692954|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692955|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
14692956|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14692957|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
14692958|NCT00363285|Hormones|hormones|mesh-list
14692959|NCT00363285|Cyproterone|cyproterone|mesh-list
14692960|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14692961|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692962|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
14692963|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
14692964|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692965|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14692966|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
14692967|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14692968|NCT00363337|Aripiprazole|aripiprazole|mesh-list
14692969|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
14692970|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14692971|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14692972|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14692973|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14692974|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692975|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
14692976|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
14692977|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14692978|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14692979|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14692980|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14692981|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
14692982|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14692983|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14692984|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14692985|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14692986|NCT00363350|Rituximab|rituximab|mesh-list
14692987|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14692988|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14692989|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
14692990|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692991|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14692992|NCT00363376|Zonisamide|zonisamide|mesh-list
14692993|NCT00363376|Olanzapine|olanzapine|mesh-list
14692994|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
14692995|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
14692996|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14692997|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14692998|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14692999|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14693000|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14693001|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693002|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693003|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14693004|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14693005|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14693006|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693007|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693008|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
14693009|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
14693010|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14693011|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14693012|NCT00363389|Misoprostol|misoprostol|mesh-list
14693013|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14693014|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
14693015|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14693016|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693017|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14693018|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693019|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
15193908|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
15193909|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15193910|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
15193911|NCT03817931|Mirabegron|mirabegron|mesh-list
15193912|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14693020|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14693021|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15193913|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
15193914|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
14693022|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693023|NCT00363519|Incretins|incretins|mesh-ancestor
14693024|NCT00363519|Hormones|hormones|mesh-ancestor
14693025|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693026|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14693027|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693028|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693029|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693030|NCT00363532|Calcitonin|calcitonin|mesh-list
14693031|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
14693032|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14693033|NCT00363532|Katacalcin|katacalcin|mesh-list
14693034|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14693035|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693036|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14693037|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
14693038|NCT00363571|Acetazolamide|acetazolamide|mesh-list
14693039|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
14693040|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14693041|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693042|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693043|NCT00363571|Diuretics|diuretics|mesh-ancestor
14693044|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
14693045|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693046|NCT00363584|Capecitabine|capecitabine|mesh-list
14693047|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14693048|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
14693049|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693050|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693051|NCT00363610|Pegaspargase|pegaspargase|mesh-list
14693052|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693053|NCT00363688|Penicillins|penicillins|mesh-list
14693054|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693055|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693056|NCT00363701|Esomeprazole|esomeprazole|mesh-list
14693057|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14693058|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693059|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14693060|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15193915|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
14693061|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693062|NCT00363727|Ropinirole|ropinirole|mesh-list
14693063|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15193916|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15193917|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
15193918|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193919|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193920|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193921|NCT03817931|Urological Agents|urological agents|mesh-ancestor
15193922|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15193923|NCT03818061|Bevacizumab|bevacizumab|mesh-list
15193924|NCT03818061|Atezolizumab|atezolizumab|mesh-list
15193925|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15193926|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193927|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15193928|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15193929|NCT03818061|Growth Substances|growth substances|mesh-ancestor
15224129|NCT04558502|Esomeprazole|esomeprazole|mesh-list
14693064|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14693065|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
14693066|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
14693067|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693068|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693069|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693070|NCT00363753|Aspirin|aspirin|mesh-list
14693071|NCT00363753|Clopidogrel|clopidogrel|mesh-list
14693072|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693073|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693074|NCT00363753|Analgesics|analgesics|mesh-ancestor
14693075|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
14693076|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693077|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693078|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693079|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693080|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14693081|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14693082|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693083|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14693084|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14693085|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693086|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
14693087|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14693088|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14693089|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14693090|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
14693091|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693092|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
14693093|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
14693094|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
14693095|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693096|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14693097|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14693098|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693099|NCT00363844|Incretins|incretins|mesh-ancestor
14693100|NCT00363844|Hormones|hormones|mesh-ancestor
14693101|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693102|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14693103|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693104|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693105|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693106|NCT00363857|Ropinirole|ropinirole|mesh-list
14693107|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14693108|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14693109|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
14693110|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
14693111|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693112|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693113|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693114|NCT00363909|Dexetimide|dexetimide|mesh-list
14693115|NCT00363909|Citalopram|citalopram|mesh-list
14693116|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14693117|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14693118|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14693119|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693120|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693121|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
14693122|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693123|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14693124|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
14693125|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693126|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14693127|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14693128|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
14693129|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
14693130|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693131|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14693132|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14693133|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815032|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14815033|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
14693134|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
14815034|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15193930|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193931|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
15193932|NCT03818048|Propofol|propofol|mesh-list
14693135|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14693136|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693137|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693138|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693139|NCT00363935|Analgesics|analgesics|mesh-ancestor
14693140|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
14693141|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693142|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14693143|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14693144|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14693145|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
14693146|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693147|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693148|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14693149|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14693150|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693151|NCT00363948|Incretins|incretins|mesh-ancestor
14693152|NCT00363948|Hormones|hormones|mesh-ancestor
14693153|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693154|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14693155|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693156|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693157|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693158|NCT00364000|Calcium|calcium|mesh-list
14693159|NCT00364000|Sevelamer|sevelamer|mesh-list
14693160|NCT00364000|Calcium acetate|calcium acetate|mesh-list
14693161|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14693162|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693163|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
14693164|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
14693165|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693166|NCT00364026|Darusentan|darusentan|mesh-list
14693167|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14693168|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693169|NCT00364052|Valganciclovir|valganciclovir|mesh-list
14693170|NCT00364052|Ganciclovir|ganciclovir|mesh-list
14693171|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14693172|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
14693173|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693174|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14693175|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693176|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693177|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14693178|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14693179|NCT00364143|Irinotecan|irinotecan|mesh-list
14693180|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14693181|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14693182|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693183|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693184|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693185|NCT00364195|Tesmilifene|tesmilifene|mesh-list
14693186|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
14693187|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
14693188|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693189|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693190|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693191|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14693192|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
14693193|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14693194|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693195|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
14693196|NCT00364260|Hematinics|hematinics|mesh-ancestor
14693197|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14693198|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14693199|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
14693200|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693201|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693202|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15193933|NCT03818048|Sevoflurane|sevoflurane|mesh-list
15193934|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15193935|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693203|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
14693204|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14693205|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14693206|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14693207|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
14693208|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693209|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727946|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14727947|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
14727948|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727949|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14727950|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
14727951|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14727952|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14727953|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14727954|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727955|NCT00516152|Methotrexate|methotrexate|mesh-list
14727956|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
14727957|NCT00516152|Fludarabine|fludarabine|mesh-list
14727958|NCT00516152|Busulfan|busulfan|mesh-list
14727959|NCT00516152|Tacrolimus|tacrolimus|mesh-list
14727960|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14727961|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
14727962|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14727963|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727964|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15193936|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193937|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15193938|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
15193939|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
15193940|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15193941|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15193942|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
14727965|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
14727966|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727967|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727968|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14727969|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727970|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14727971|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727972|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
14727973|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14727974|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14727975|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14727976|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
14727977|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14727978|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14727979|NCT00516191|Doxorubicin|doxorubicin|mesh-list
14727980|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14727981|NCT00516191|Bortezomib|bortezomib|mesh-list
14727982|NCT00516191|Melphalan|melphalan|mesh-list
14727983|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14727984|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14727985|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14727986|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14727987|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14727988|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727989|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14727990|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
14727991|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14727992|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14727993|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
14727994|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14727995|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14727996|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
14727997|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14727998|NCT00516243|Protective Agents|protective agents|mesh-ancestor
14727999|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728000|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14728001|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15193943|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
15193944|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15193945|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
15193946|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693210|NCT00364429|Lorazepam|lorazepam|mesh-list
14693211|NCT00364429|Risperidone|risperidone|mesh-list
14693212|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14693213|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
15193947|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15193948|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14693214|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693215|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693216|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693217|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14693218|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14693219|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693220|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693221|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14693222|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
14693223|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
14693224|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
14693225|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
14693226|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693227|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693228|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14693229|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14693230|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
14693231|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
14693232|NCT00364442|Fluticasone|fluticasone|mesh-list
14693233|NCT00364442|Xhance|xhance|mesh-list
14693234|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14693235|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693236|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14693237|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
14693238|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693239|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693240|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14693241|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14693242|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
14693243|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14693244|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14693245|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14693246|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14693247|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14693248|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693249|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693250|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
14693251|NCT00364455|Hematinics|hematinics|mesh-ancestor
14693252|NCT00364481|Omeprazole|omeprazole|mesh-list
14693253|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14693254|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693255|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14693256|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693257|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693258|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14693259|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14693260|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14693261|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
14693262|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693263|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14693264|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14693265|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693266|NCT00364572|Etanercept|etanercept|mesh-list
14693267|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693268|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693269|NCT00364572|Analgesics|analgesics|mesh-ancestor
14693270|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
14693271|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693272|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693273|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693274|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693275|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693276|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693277|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
14693278|NCT00364702|Methylphenidate|methylphenidate|mesh-list
14693279|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14693280|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693281|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14693282|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14917594|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693283|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14693284|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693285|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
14693286|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693287|NCT00364754|Tesmilifene|tesmilifene|mesh-list
14693288|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
14693289|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
14693290|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693291|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693292|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693293|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15193949|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
15193950|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294500|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294501|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693294|NCT00364806|Metoclopramide|metoclopramide|mesh-list
14693295|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
14693296|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
14693297|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
14693298|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693299|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693300|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693301|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14693302|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14693303|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
14693304|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693305|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693306|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14693307|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14693308|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693309|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693310|NCT00364871|Naltrexone|naltrexone|mesh-list
14693311|NCT00364871|Bupropion|bupropion|mesh-list
14693312|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14693313|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14693314|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693315|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
14693316|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693317|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14693318|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
14693319|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693320|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14693321|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14693322|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14693323|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693324|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
14693325|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693326|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14693327|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14693328|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693329|NCT00364988|Pioglitazone|pioglitazone|mesh-list
14693330|NCT00364988|Losartan|losartan|mesh-list
14693331|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14693332|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693333|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15193951|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193952|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15193953|NCT03818321|Methenamine|methenamine|mesh-list
15193954|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
15193955|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
15193956|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15193957|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193958|NCT03818321|Renal Agents|renal agents|mesh-ancestor
15193959|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15193960|NCT03817541|Propofol|propofol|mesh-list
14693334|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14693335|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14693336|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14693337|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693338|NCT00365001|Methotrexate|methotrexate|mesh-list
14294502|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14693339|NCT00365001|Simvastatin|simvastatin|mesh-list
14917595|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
14693340|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14693341|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
14693342|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14693343|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693344|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14693345|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
14693346|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693347|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693348|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
14693349|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693350|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14693351|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693352|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
14693353|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693354|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14693355|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14693356|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14693357|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14693358|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14693359|NCT00365040|Mitomycins|mitomycins|mesh-list
14693360|NCT00365040|Mitomycin|mitomycin|mesh-list
14693361|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14693362|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693363|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
14693364|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693365|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14693366|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693367|NCT00365170|Insulin|insulin|mesh-list
14693368|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14693369|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
14693370|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14693371|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693372|NCT00365183|Pemetrexed|pemetrexed|mesh-list
14693373|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
14693374|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693375|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693376|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693377|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14693378|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14693379|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14693380|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
14693381|NCT00365222|Temozolomide|temozolomide|mesh-list
14693382|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14693383|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
14693384|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693385|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693386|NCT00365287|Cyclosporine|cyclosporine|mesh-list
14693387|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
14693388|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
14693389|NCT00365287|Fludarabine|fludarabine|mesh-list
14693390|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
14693391|NCT00365287|Cyclosporins|cyclosporins|mesh-list
14693392|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14693393|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693394|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
14693395|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693396|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693397|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14693398|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
14693399|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693400|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693401|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14693402|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14693403|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
14693404|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693405|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
14693406|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693407|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
14693408|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14693409|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14693410|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14693411|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
14693412|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693413|NCT00365313|Celecoxib|celecoxib|mesh-list
14693414|NCT00365313|Esomeprazole|esomeprazole|mesh-list
14693415|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693416|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693417|NCT00365313|Analgesics|analgesics|mesh-ancestor
14693418|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
14693419|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693420|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693421|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693422|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693423|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14693424|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14693425|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693426|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693427|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14693428|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693429|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14693430|NCT00365339|Ritonavir|ritonavir|mesh-list
14693431|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14693432|NCT00365339|Tenofovir|tenofovir|mesh-list
14693433|NCT00365339|Aripiprazole|aripiprazole|mesh-list
14693434|NCT00365339|Famotidine|famotidine|mesh-list
14693435|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14693436|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14693437|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693438|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693439|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693440|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14693441|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14693442|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
14693443|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693444|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14693445|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14693446|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14693447|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14693448|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
14693449|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693450|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14693451|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14693452|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693453|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693454|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
14693455|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
14693456|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693457|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14693458|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14693459|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
14693460|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14693461|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14693462|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14693463|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14693464|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14693465|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693466|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14693467|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
14693468|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
14693469|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
14693470|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14693471|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
14693472|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693473|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693474|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14693475|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
14693476|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
14693477|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14693478|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
14693479|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693480|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693481|NCT00365586|Ketoprofen|ketoprofen|mesh-list
14693482|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14294503|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14294504|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294505|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14294506|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14693483|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693484|NCT00365586|Analgesics|analgesics|mesh-ancestor
15193961|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15193962|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193963|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193964|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15193965|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
15193966|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
15193967|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
15193968|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
15193969|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15193970|NCT03817567|Cetuximab|cetuximab|mesh-list
14693485|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
14693486|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693487|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693488|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693489|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693490|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14693491|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693492|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693493|NCT00365612|Tenofovir|tenofovir|mesh-list
14693494|NCT00365612|Emtricitabine|emtricitabine|mesh-list
14693495|NCT00365612|Efavirenz|efavirenz|mesh-list
14693496|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
14693497|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693498|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14693499|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14693500|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693501|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693502|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14693503|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14693504|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14693505|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14693506|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14693507|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14693508|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14693509|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14693510|NCT00365638|Simvastatin|simvastatin|mesh-list
14693511|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14693512|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14693513|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
14693514|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693515|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14693516|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14693517|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693518|NCT00365742|Simvastatin|simvastatin|mesh-list
14693519|NCT00365742|Red yeast rice|red yeast rice|mesh-list
14693520|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14693521|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14693522|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
14693523|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193971|NCT03817567|Antibodies|antibodies|mesh-list
15193972|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15193973|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
15193974|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193975|NCT03817567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15193976|NCT03817567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193977|NCT03817411|Capecitabine|capecitabine|mesh-list
15193978|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
15193979|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15193980|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
15193981|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193982|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693524|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14693525|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14693526|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693527|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
14693528|NCT00365755|Melphalan|melphalan|mesh-list
14693529|NCT00365755|Carboplatin|carboplatin|mesh-list
14693530|NCT00365755|Etoposide|etoposide|mesh-list
14693531|NCT00365755|Vincristine|vincristine|mesh-list
14815035|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15193983|NCT03817476|BI 425809|bi 425809|mesh-list
15193984|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
15193985|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15193986|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693532|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693533|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
14693534|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693535|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693536|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14693537|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
15193987|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15193988|NCT03817359|Remifentanil|remifentanil|mesh-list
15193989|NCT03817359|Propofol|propofol|mesh-list
15193990|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15193991|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15193992|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193993|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15193994|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
15193995|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
14693538|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693539|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693540|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14693541|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14693542|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14693543|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14693544|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693545|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
14693546|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
14693547|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
14693548|NCT00365820|Tegaserod|tegaserod|mesh-list
14693549|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14693550|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
14693551|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693552|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693553|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693554|NCT00365898|Hydromorphone|hydromorphone|mesh-list
14693555|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14693556|NCT00365898|Narcotics|narcotics|mesh-ancestor
14693557|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693558|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693559|NCT00365898|Analgesics|analgesics|mesh-ancestor
14693560|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
14693561|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693562|NCT00365924|Teriparatide|teriparatide|mesh-list
14693563|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14693564|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693565|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14693566|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14693567|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
14693568|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693569|NCT00365950|Warfarin|warfarin|mesh-list
14693570|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
14693571|NCT00366002|Darifenacin|darifenacin|mesh-list
14693572|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14693573|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14693574|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
14693575|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693576|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693577|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15193996|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15193997|NCT03817359|Narcotics|narcotics|mesh-ancestor
15193998|NCT03817359|Analgesics|analgesics|mesh-ancestor
15193999|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
15194000|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194001|NCT03816982|Bupivacaine|bupivacaine|mesh-list
15194002|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
15194003|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
15194004|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194005|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194006|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
15194007|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194008|NCT03817320|Dexamethasone|dexamethasone|mesh-list
15194009|NCT03817320|Doxorubicin|doxorubicin|mesh-list
15194010|NCT03817320|Vincristine|vincristine|mesh-list
15194011|NCT03817320|Asparaginase|asparaginase|mesh-list
15194012|NCT03817320|Ixazomib|ixazomib|mesh-list
15194013|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15194014|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
15194015|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
15194016|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194017|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194018|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194019|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
15194020|NCT03817320|Hormones|hormones|mesh-ancestor
15194021|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15194022|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15194023|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693578|NCT00366002|Urological Agents|urological agents|mesh-ancestor
14693579|NCT00366067|Phenytoin|phenytoin|mesh-list
14693580|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
14693581|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14693582|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14693583|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14693584|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693585|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14693586|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14693587|NCT00366093|Eszopiclone|eszopiclone|mesh-list
14693588|NCT00366093|Zopiclone|zopiclone|mesh-list
14693589|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14693590|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693591|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693592|NCT00366119|Ramipril|ramipril|mesh-list
14693593|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15194024|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14693594|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693595|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693596|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693597|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14693598|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
14693599|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14693600|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693601|NCT00366262|Naproxen|naproxen|mesh-list
14693602|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693603|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693604|NCT00366262|Analgesics|analgesics|mesh-ancestor
14693605|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
14693606|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693607|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693608|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693609|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693610|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
14693611|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14693612|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693613|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728002|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728003|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14728004|NCT00516282|Temozolomide|temozolomide|mesh-list
14728005|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14728006|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
15194025|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15194026|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14693614|NCT00366418|Rituximab|rituximab|mesh-list
14693615|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14693616|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693617|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
14693618|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693619|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693620|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
14693621|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14693622|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693623|NCT00366470|Vitamins|vitamins|mesh-ancestor
14693624|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
14693625|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14693626|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14693627|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14693628|NCT00366652|Desipramine|desipramine|mesh-list
14693629|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14693630|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14693631|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14693632|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693633|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693634|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693635|NCT00366652|Analgesics|analgesics|mesh-ancestor
14693636|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
14693637|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693638|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
14693639|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693640|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
14693641|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14693642|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693643|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14693644|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
14693645|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14693646|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14693647|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
14693648|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14693649|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693650|NCT00366834|Dexamethasone|dexamethasone|mesh-list
14693651|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
14693652|NCT00366834|Ondansetron|ondansetron|mesh-list
14693653|NCT00366834|Casopitant|casopitant|mesh-list
14693654|NCT00366834|BB 1101|bb 1101|mesh-list
14693655|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693656|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
14693657|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
14693658|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693659|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693660|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693661|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
14693662|NCT00366834|Hormones|hormones|mesh-ancestor
14693663|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693664|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14693665|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693666|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693667|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693668|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693669|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
14693670|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14693671|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14693672|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
14693673|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194027|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194028|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194029|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15194030|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
15194031|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
15194032|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
15194033|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
15194034|NCT03817268|Capecitabine|capecitabine|mesh-list
15194035|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15194036|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
15194037|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693674|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14693675|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14693676|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693677|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693678|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14693679|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14693680|NCT00366873|Calcium|calcium|mesh-list
14693681|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14693682|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693683|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
14693684|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14693685|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14693686|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693687|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693688|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693689|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693690|NCT00366938|Analgesics|analgesics|mesh-ancestor
14693691|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
14693692|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693693|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693694|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693695|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693696|NCT00367068|Baclofen|baclofen|mesh-list
14693697|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14693698|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693699|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14693700|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693701|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14693702|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
14693703|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
14693704|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693705|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693706|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
14693707|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14693708|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
14693709|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
14693710|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14693711|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14693712|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693713|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14693714|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693715|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693716|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14693717|NCT00367081|Renal Agents|renal agents|mesh-ancestor
14693718|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693719|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
14693720|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14693721|NCT00367094|Benazepril|benazepril|mesh-list
14693722|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14693723|NCT00367094|Diuretics|diuretics|mesh-ancestor
14693724|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
14693725|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194038|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194039|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
15194040|NCT03817112|Propofol|propofol|mesh-list
15194041|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15194042|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194043|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194044|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14693726|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15194045|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
14693727|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14693728|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693729|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14693730|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693731|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693732|NCT00367120|Amoxicillin|amoxicillin|mesh-list
14693733|NCT00367120|Azithromycin|azithromycin|mesh-list
14693734|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
14693735|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
14693736|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14693737|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693738|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693739|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14693740|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693741|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693742|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14693743|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
14693744|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693745|NCT00367185|Thalidomide|thalidomide|mesh-list
14693746|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693747|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
14693748|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693749|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
14693750|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693751|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693752|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14693753|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14693754|NCT00367185|Growth Substances|growth substances|mesh-ancestor
14693755|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
14693756|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693757|NCT00367211|Naproxen|naproxen|mesh-list
14693758|NCT00367211|Omeprazole|omeprazole|mesh-list
14693759|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14693760|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693761|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14693762|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194046|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
15194047|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15194048|NCT03817112|Analgesics|analgesics|mesh-ancestor
15194049|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
15194050|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194051|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15194052|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15194053|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15194054|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
15194055|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194056|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194057|NCT03816774|Simethicone|simethicone|mesh-list
15194058|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
15194059|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194060|NCT03816774|Emollients|emollients|mesh-ancestor
15194061|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
15194062|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
15194063|NCT03816592|Anesthetics|anesthetics|mesh-list
15194064|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194065|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194066|NCT03816592|Narcotics|narcotics|mesh-ancestor
14693763|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194067|NCT03816592|Analgesics|analgesics|mesh-ancestor
15194068|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
15194069|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194070|NCT03816488|Metformin|metformin|mesh-list
15194071|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
15194072|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15194073|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194074|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15194075|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15194076|NCT03816488|Analgesics|analgesics|mesh-ancestor
15194077|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
15194078|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194079|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15194080|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15194081|NCT03816553|Apatinib|apatinib|mesh-list
15194082|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194083|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15194084|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194085|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194086|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
15194087|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15194088|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194089|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15194090|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194091|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194092|NCT03816267|Albuterol|albuterol|mesh-list
15194093|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15194094|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
15194095|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194096|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194097|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14693764|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693765|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693766|NCT00367211|Analgesics|analgesics|mesh-ancestor
14693767|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
14693768|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693769|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693770|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693771|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693772|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
14693773|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14693774|NCT00367250|Trastuzumab|trastuzumab|mesh-list
14693775|NCT00367250|Cetuximab|cetuximab|mesh-list
14693776|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14693777|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693778|NCT00367263|Ciclesonide|ciclesonide|mesh-list
14693779|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
14693780|NCT00367263|Hormones|hormones|mesh-ancestor
14693781|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693782|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693783|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14693784|NCT00367276|Drospirenone|drospirenone|mesh-list
15194098|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
15194099|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
15194100|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15194101|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15194102|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15194103|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15194104|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
15194105|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693785|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14693786|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
14693787|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693788|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693789|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14693790|NCT00367276|Diuretics|diuretics|mesh-ancestor
14693791|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
14693792|NCT00367302|Buprenorphine|buprenorphine|mesh-list
14693793|NCT00367302|Methadone|methadone|mesh-list
14693794|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14693795|NCT00367302|Narcotics|narcotics|mesh-ancestor
14693796|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693797|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693798|NCT00367302|Analgesics|analgesics|mesh-ancestor
14693799|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
15224130|NCT04558502|Bismuth|bismuth|mesh-list
14693800|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693801|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14693802|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
14693803|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
14693804|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
14693805|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14294507|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
14294508|NCT00576758|Rituximab|rituximab|mesh-list
14294509|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
14294510|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14693806|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14693807|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693808|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693809|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693810|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693811|NCT00367315|Analgesics|analgesics|mesh-ancestor
14693812|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
14693813|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693814|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693815|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693816|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693817|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
14693818|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14693819|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14693820|NCT00367393|Analgesics|analgesics|mesh-ancestor
14693821|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
14693822|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693823|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693824|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693825|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693826|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14693827|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693828|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
14693829|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14693830|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294511|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294512|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
14294513|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294514|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294515|NCT00576823|Alfuzosin|alfuzosin|mesh-list
14294516|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14693831|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693832|NCT00367419|Erythromycin|erythromycin|mesh-list
14693833|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
14693834|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14693835|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
14693836|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693837|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693838|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693839|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14693840|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693841|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693842|NCT00367445|Insulin|insulin|mesh-list
14693843|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14693844|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
14693845|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14693846|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693847|NCT00367471|Paclitaxel|paclitaxel|mesh-list
14693848|NCT00367471|Carboplatin|carboplatin|mesh-list
14693849|NCT00367471|Trastuzumab|trastuzumab|mesh-list
14693850|NCT00367471|Lapatinib|lapatinib|mesh-list
14693851|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14693852|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693853|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14693854|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14693855|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14693856|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693857|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14693858|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14693859|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693860|NCT00367497|Cytarabine|cytarabine|mesh-list
14693861|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
14693862|NCT00367497|Rituximab|rituximab|mesh-list
14693863|NCT00367497|Etoposide|etoposide|mesh-list
14693864|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294517|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15194106|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693865|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14693866|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
14693867|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693868|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693869|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14693870|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14693871|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14693872|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693873|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693874|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14693875|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
14693876|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
14693877|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693878|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14693879|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14693880|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
14693881|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
14693882|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693883|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693884|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
14693885|NCT00367497|Hormones|hormones|mesh-ancestor
14693886|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693887|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14693888|NCT00367497|Protective Agents|protective agents|mesh-ancestor
14693889|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
14693890|NCT00367536|Estrogens|estrogens|mesh-list
14693891|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14693892|NCT00367536|Hormones|hormones|mesh-ancestor
14693893|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14693894|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693895|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14693896|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14693897|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
14693898|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14693899|NCT00367562|Valsartan|valsartan|mesh-list
14693900|NCT00367562|Enalapril|enalapril|mesh-list
14693901|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14693902|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14693903|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14693904|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693905|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14693906|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
14693907|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693908|NCT00367614|Pantoprazole|pantoprazole|mesh-list
14693909|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14693910|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14693911|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14693912|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693913|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693914|NCT00367627|Albendazole|albendazole|mesh-list
14693915|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
14693916|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14693917|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693918|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
14693919|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14693920|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14693921|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
14693922|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
14693923|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
14693924|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693925|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693926|NCT00367653|Azithromycin|azithromycin|mesh-list
14693927|NCT00367653|Chloroquine|chloroquine|mesh-list
14693928|NCT00367653|Mefloquine|mefloquine|mesh-list
14693929|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693930|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693931|NCT00367653|Amebicides|amebicides|mesh-ancestor
14693932|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14693933|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14693934|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
14693935|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14693936|NCT00367718|Bortezomib|bortezomib|mesh-list
14693937|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693938|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14693939|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
14693940|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693941|NCT00367822|Ropinirole|ropinirole|mesh-list
14693942|NCT00367822|Lisuride|lisuride|mesh-list
14693943|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14693944|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14693945|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
14693946|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
14693947|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693948|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693949|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194107|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14693950|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14693951|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
14693952|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
14693953|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693954|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14693955|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693956|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693957|NCT00367874|Buprenorphine|buprenorphine|mesh-list
14693958|NCT00367874|Valproic Acid|valproic acid|mesh-list
14693959|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14693960|NCT00367874|Narcotics|narcotics|mesh-ancestor
14693961|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14693962|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14693963|NCT00367874|Analgesics|analgesics|mesh-ancestor
14693964|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
14693965|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14693966|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14693967|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
14693968|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693969|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693970|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
14693971|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14693972|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
14693973|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14693974|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14693975|NCT00367913|Clarithromycin|clarithromycin|mesh-list
14693976|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
14693977|NCT00367913|Rifampin|rifampin|mesh-list
14693978|NCT00367913|Ethambutol|ethambutol|mesh-list
14693979|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14693980|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14693981|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14693982|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14693983|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14693984|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14693985|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14693986|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14693987|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14693988|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14693989|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14693990|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14693991|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
15194108|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15194109|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224131|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15224132|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224133|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15224134|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224135|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15224136|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224137|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224138|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14693992|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
15194110|NCT03816020|Niacinamide|niacinamide|mesh-list
15194111|NCT03816020|Niacin|niacin|mesh-list
15194112|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
15194113|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
15194114|NCT03816020|Vitamins|vitamins|mesh-ancestor
15194115|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
15194116|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194117|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15194118|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
15194119|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194120|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15194121|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
15194122|NCT03816072|Phenylephrine|phenylephrine|mesh-list
15194123|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
15194124|NCT03816072|Propofol|propofol|mesh-list
15194125|NCT03816072|Sevoflurane|sevoflurane|mesh-list
15194126|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14693993|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14693994|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14693995|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14693996|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14693997|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14693998|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14693999|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14694000|NCT00367939|Amlodipine|amlodipine|mesh-list
14694001|NCT00367939|Valsartan|valsartan|mesh-list
14694002|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14694003|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14694004|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694005|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694006|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14694007|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694008|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
14694009|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14694010|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14694011|NCT00367965|Eszopiclone|eszopiclone|mesh-list
14694012|NCT00367965|Zopiclone|zopiclone|mesh-list
14694013|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14694014|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694015|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694016|NCT00367978|Amlodipine|amlodipine|mesh-list
14694017|NCT00367978|Benazepril|benazepril|mesh-list
14694018|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14694019|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14694020|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694021|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694022|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14694023|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694024|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
14694025|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14694026|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
14694027|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694028|NCT00368017|Pioglitazone|pioglitazone|mesh-list
14694029|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694030|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694031|NCT00368030|Eszopiclone|eszopiclone|mesh-list
14694032|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14694033|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694034|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728007|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728008|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728009|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
14728010|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14728011|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728012|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
14728013|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
14728014|NCT00516399|Natamycin|natamycin|mesh-list
14728015|NCT00516399|Povidone|povidone|mesh-list
14728016|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15194127|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728017|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15194128|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194129|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14728018|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
15194130|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
14694035|NCT00368056|Eszopiclone|eszopiclone|mesh-list
14694036|NCT00368056|Zopiclone|zopiclone|mesh-list
15194131|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
15194132|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15194133|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15194134|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15194135|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
15194136|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
15194137|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194138|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
15194139|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15194140|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
15194141|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
15194142|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15194143|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15194144|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15194145|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
15194146|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194147|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194148|NCT03816072|Protective Agents|protective agents|mesh-ancestor
15194149|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
14694037|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14694038|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694039|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694040|NCT00368121|Dexamethasone|dexamethasone|mesh-list
14694041|NCT00368121|Cetuximab|cetuximab|mesh-list
14694042|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694043|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
14694044|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
14694045|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694046|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694047|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14694048|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
14694049|NCT00368121|Hormones|hormones|mesh-ancestor
14694050|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694051|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14694052|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694053|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694054|NCT00368134|Vildagliptin|vildagliptin|mesh-list
14694055|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694056|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694057|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14694058|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
14694059|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694060|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694061|NCT00368160|Eszopiclone|eszopiclone|mesh-list
14694062|NCT00368160|Zopiclone|zopiclone|mesh-list
14694063|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14694064|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694065|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694066|NCT00368238|Aspirin|aspirin|mesh-list
14694067|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
14694068|NCT00368238|Clopidogrel|clopidogrel|mesh-list
14694069|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14694070|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14694071|NCT00368238|Analgesics|analgesics|mesh-ancestor
14694072|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
14694073|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694074|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694075|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694076|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14694077|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14694078|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14694079|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694080|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14694081|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14694082|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694083|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
14694084|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14694085|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14694086|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14694087|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
14694088|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694089|NCT00368238|Hematinics|hematinics|mesh-ancestor
15194150|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15194151|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15194152|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14694090|NCT00368264|Infliximab|infliximab|mesh-list
14694091|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
15194153|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15194154|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694092|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14694093|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14694094|NCT00368303|Paroxetine|paroxetine|mesh-list
14694095|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14694096|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14694097|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694098|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194155|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
15194156|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194157|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194158|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15194159|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194160|NCT03815864|Antibodies|antibodies|mesh-list
15194161|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
15194162|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
15194163|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194164|NCT03815942|Nivolumab|nivolumab|mesh-list
15194165|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694099|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694100|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
14694101|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694102|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14694103|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
14694104|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694105|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14694106|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14694107|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694108|NCT00368329|Carboplatin|carboplatin|mesh-list
14694109|NCT00368329|Fluorouracil|fluorouracil|mesh-list
14694110|NCT00368329|Capecitabine|capecitabine|mesh-list
14694111|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14694112|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694113|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
14694114|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694115|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14694116|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694117|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
14694118|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694119|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14694120|NCT00368342|Azithromycin|azithromycin|mesh-list
14694121|NCT00368342|Clarithromycin|clarithromycin|mesh-list
14694122|NCT00368342|Erythromycin|erythromycin|mesh-list
14694123|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
14694124|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14694125|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
14694126|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14694127|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694128|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14694129|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694130|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694131|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14694132|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14694133|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14694134|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
14694135|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15194166|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194167|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15194168|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194169|NCT03815838|Fallypride|fallypride|mesh-list
15194170|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15194171|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14694136|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
14694137|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694138|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694139|NCT00368498|Teicoplanin|teicoplanin|mesh-list
14694140|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14694141|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694142|NCT00368589|Atorvastatin|atorvastatin|mesh-list
14694143|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14694144|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14694145|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
14694146|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694147|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14694148|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14694149|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694150|NCT00368602|Timolol|timolol|mesh-list
14694151|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14694152|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14694153|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
14694154|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694155|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194172|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
15194173|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194174|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694156|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694157|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14694158|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14694159|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
14694160|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14694161|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14694162|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14694163|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
14694164|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694165|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694166|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694167|NCT00368706|Urological Agents|urological agents|mesh-ancestor
14694168|NCT00368719|Tacrolimus|tacrolimus|mesh-list
14694169|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694170|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
14694171|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694172|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14694173|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694174|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694175|NCT00368862|Memantine|memantine|mesh-list
14694176|NCT00368862|Citalopram|citalopram|mesh-list
14694177|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15194175|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194176|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
15194177|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14694178|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14694179|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694180|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694181|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694182|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
14694183|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694184|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14694185|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
14694186|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694187|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14694188|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14694189|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
14694190|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14694191|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14694192|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
14694193|NCT00368901|Hematinics|hematinics|mesh-ancestor
14694194|NCT00368914|Sirolimus|sirolimus|mesh-list
14694195|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14694196|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694197|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14694198|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694199|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
14694200|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694201|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
14694202|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694203|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14694204|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14694205|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14694206|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
14694207|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
14694208|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14694209|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
15194178|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
15194179|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194180|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
15194181|NCT03815539|Protective Agents|protective agents|mesh-ancestor
15194182|NCT03815487|Insulin|insulin|mesh-list
15194183|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15194184|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15194185|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194186|NCT03815474|Epirubicin|epirubicin|mesh-list
15194187|NCT03815474|Ifosfamide|ifosfamide|mesh-list
15194188|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15194189|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194190|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15194191|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15194192|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694210|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694211|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14694212|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694213|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
14694214|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694215|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
15194193|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194194|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14694216|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14694217|NCT00369031|Protective Agents|protective agents|mesh-ancestor
14694218|NCT00369044|Prednisone|prednisone|mesh-list
14694219|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694220|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
14694221|NCT00369044|Hormones|hormones|mesh-ancestor
14694222|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694223|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694224|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14815036|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194195|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
15194196|NCT03815461|Paclitaxel|paclitaxel|mesh-list
15194197|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15194198|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194199|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
15194200|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
15194201|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
15194202|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194203|NCT03815448|Methotrexate|methotrexate|mesh-list
14694225|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694226|NCT00369096|Bemiparin|bemiparin|mesh-list
14694227|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
14694228|NCT00369148|Nateglinide|nateglinide|mesh-list
14694229|NCT00369148|Mitiglinide|mitiglinide|mesh-list
14694230|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815037|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
15194204|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15194205|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
14694231|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694232|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
14694233|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15194206|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15194207|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294518|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14294519|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
14294520|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294521|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194208|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15194209|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
15194210|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194211|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194212|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
15194213|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194214|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15194215|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15194216|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
15194217|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15194218|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15194219|NCT03815344|Misoprostol|misoprostol|mesh-list
14294522|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294523|NCT00576823|Urological Agents|urological agents|mesh-ancestor
14294524|NCT00576901|Bevacizumab|bevacizumab|mesh-list
14294525|NCT00576901|Docetaxel|docetaxel|mesh-list
14294526|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294527|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294528|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14294529|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14294530|NCT00576901|Growth Substances|growth substances|mesh-ancestor
14294531|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294532|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
14294533|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14694234|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694235|NCT00369239|Risperidone|risperidone|mesh-list
14694236|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14694237|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
14694238|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694239|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694240|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694241|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14694242|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14694243|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694244|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694245|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14694246|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
14694247|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
14694248|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694249|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694250|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14694251|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14694252|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
14694253|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694254|NCT00369356|Prednisone|prednisone|mesh-list
14694255|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694256|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
15194220|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14294534|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14294535|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14694257|NCT00369356|Hormones|hormones|mesh-ancestor
15194221|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
15194222|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15194223|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694258|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694259|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694260|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14694261|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694262|NCT00369395|Volociximab|volociximab|mesh-list
14694263|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694264|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694265|NCT00369395|Growth Substances|growth substances|mesh-ancestor
14694266|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694267|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694268|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694269|NCT00369408|Naltrexone|naltrexone|mesh-list
14694270|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14694271|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14694272|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694273|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
14694274|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694275|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14694276|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14694277|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14694278|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694279|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694280|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694281|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694282|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
14694283|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694284|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
14694285|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694286|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694287|NCT00369538|Losartan|losartan|mesh-list
14694288|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14694289|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14694290|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14694291|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14694292|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14694293|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694294|NCT00369538|Diuretics|diuretics|mesh-ancestor
14694295|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
14694296|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694297|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14694298|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694299|NCT00369551|Paclitaxel|paclitaxel|mesh-list
15194224|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15194225|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194226|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
15194227|NCT03815305|Petrolatum|petrolatum|mesh-list
15194228|NCT03815305|Emollients|emollients|mesh-ancestor
15194229|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14694300|NCT00369551|Bevacizumab|bevacizumab|mesh-list
14694301|NCT00369551|Carboplatin|carboplatin|mesh-list
14694302|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14694303|NCT00369551|Antibodies|antibodies|mesh-list
14694304|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
14694305|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14694306|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14694307|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694308|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
14694309|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
14694310|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
14694311|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694312|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694313|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694314|NCT00369551|Growth Substances|growth substances|mesh-ancestor
14694315|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694316|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694317|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
14694318|NCT00369603|Donepezil|donepezil|mesh-list
14694319|NCT00369603|Galantamine|galantamine|mesh-list
14694320|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14694321|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694322|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815038|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15194230|NCT03815435|Anesthetics|anesthetics|mesh-list
15194231|NCT03815435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194232|NCT03815435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694323|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
14694324|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694325|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694326|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
14694327|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14694328|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
14694329|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694330|NCT00369694|Terlipressin|terlipressin|mesh-list
14694331|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14694332|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14694333|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
14694334|NCT00369733|Hematinics|hematinics|mesh-ancestor
14694335|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
14694336|NCT00369772|Hematinics|hematinics|mesh-ancestor
14694337|NCT00369798|Rolipram|rolipram|mesh-list
14694338|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
14694339|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694340|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14694341|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14694342|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694343|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694344|NCT00369811|Fentanyl|fentanyl|mesh-list
14694345|NCT00369811|Oxycodone|oxycodone|mesh-list
14694346|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14694347|NCT00369811|Narcotics|narcotics|mesh-ancestor
14694348|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694349|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694350|NCT00369811|Analgesics|analgesics|mesh-ancestor
14694351|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
14694352|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694353|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14694354|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14694355|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
14694356|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
14694357|NCT00369837|Clevidipine|clevidipine|mesh-list
14694358|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14694359|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694360|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694361|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14694362|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194233|NCT03815279|Dexamethasone|dexamethasone|mesh-list
15194234|NCT03815279|Lenalidomide|lenalidomide|mesh-list
15194235|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15194236|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
15194237|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
15194238|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194239|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194240|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194241|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
14327530|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694363|NCT00369863|Triamcinolone|triamcinolone|mesh-list
14694364|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14694365|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14694366|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14694367|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694368|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
14694369|NCT00369863|Hormones|hormones|mesh-ancestor
14694370|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694371|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694372|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694373|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
14694374|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694375|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694376|NCT00369889|Bevacizumab|bevacizumab|mesh-list
14694377|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14694378|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694379|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694380|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694381|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15194242|NCT03815279|Hormones|hormones|mesh-ancestor
15194243|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15194244|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15194245|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694382|NCT00369889|Growth Substances|growth substances|mesh-ancestor
14728019|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
15194246|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
14694383|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694384|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694385|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14694386|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694387|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694388|NCT00369954|Gemcitabine|gemcitabine|mesh-list
14694389|NCT00369954|Carboplatin|carboplatin|mesh-list
15194247|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15194248|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15194249|NCT03815279|Growth Substances|growth substances|mesh-ancestor
15194250|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
15194251|NCT03814954|Epinephrine|epinephrine|mesh-list
14694390|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694391|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14694392|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
15194252|NCT03814954|Albuterol|albuterol|mesh-list
15194253|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14694393|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694394|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
14694395|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694396|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694397|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694398|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
14694399|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694400|NCT00369993|Fluticasone|fluticasone|mesh-list
14694401|NCT00369993|Xhance|xhance|mesh-list
14694402|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14694403|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694404|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14694405|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
14694406|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694407|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694408|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14694409|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
14694410|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
15194254|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15194255|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
15194256|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194257|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194258|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194259|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15194260|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15194261|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
15194262|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194263|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15194264|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
15194265|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
15194266|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
15194267|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15194268|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
15194269|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15194270|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15194271|NCT03814941|Anesthetics|anesthetics|mesh-list
15194272|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194273|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194274|NCT03814733|Ketamine|ketamine|mesh-list
15194275|NCT03814733|Alprazolam|alprazolam|mesh-list
15194276|NCT03814733|Analgesics|analgesics|mesh-ancestor
15194277|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
15194278|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194279|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194280|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15194281|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15194282|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
15194283|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
15194284|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194285|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15194286|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14694411|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14815039|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194287|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694412|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14694413|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14694414|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14694415|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
14694416|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694417|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694418|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14694419|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
14694420|NCT00370019|Estradiol|estradiol|mesh-list
14694421|NCT00370019|Estrogens|estrogens|mesh-ancestor
14694422|NCT00370019|Hormones|hormones|mesh-ancestor
14694423|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694424|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694425|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14694426|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
14694427|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14694428|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14694429|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14694430|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14694431|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14694432|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14694433|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14694434|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694435|NCT00370045|Bivalirudin|bivalirudin|mesh-list
14694436|NCT00370045|Eptifibatide|eptifibatide|mesh-list
14694437|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
14694438|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14694439|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
14694440|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694441|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694442|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
14694443|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14728020|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14728021|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728022|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728023|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
14728024|NCT00516412|Everolimus|everolimus|mesh-list
14728025|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728026|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728027|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
14728028|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728029|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
14728030|NCT00516425|Doxorubicin|doxorubicin|mesh-list
14728031|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14728032|NCT00516425|Epirubicin|epirubicin|mesh-list
14728033|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728034|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
14728035|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728036|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728037|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14728038|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
14728039|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728040|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327531|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14728041|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14728042|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14728043|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14294536|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294537|NCT00577005|Levetiracetam|levetiracetam|mesh-list
14294538|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
14294539|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
14294540|NCT00577031|Bevacizumab|bevacizumab|mesh-list
14294541|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
14294542|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294543|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294544|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14294545|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14294546|NCT00577031|Growth Substances|growth substances|mesh-ancestor
14694444|NCT00370097|Fluticasone|fluticasone|mesh-list
14694445|NCT00370097|Xhance|xhance|mesh-list
14694446|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694447|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14694448|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
14694449|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694450|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694451|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14694452|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
14694453|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
14694454|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14694455|NCT00370188|Topiramate|topiramate|mesh-list
15194288|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194289|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15194290|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15194291|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14694456|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
14694457|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694458|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694459|NCT00370201|Colchicine|colchicine|mesh-list
14694460|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
15194292|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694461|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14694462|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
14694463|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
14694464|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
14694465|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694466|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694467|NCT00370240|Ropivacaine|ropivacaine|mesh-list
14694468|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
14694469|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
14694470|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694471|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694472|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
14694473|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694474|NCT00370253|Terlipressin|terlipressin|mesh-list
14694475|NCT00370253|Norepinephrine|norepinephrine|mesh-list
14694476|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14694477|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14694478|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14694479|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14694480|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
14694481|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694482|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694483|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694484|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
14694485|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
14694486|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694487|NCT00370266|Triamcinolone|triamcinolone|mesh-list
14694488|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694489|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
14694490|NCT00370266|Hormones|hormones|mesh-ancestor
14694491|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694492|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694493|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
15194293|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
15194294|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
15194295|NCT03814759|Cisplatin|cisplatin|mesh-list
15194296|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194297|NCT03814577|Antioxidants|antioxidants|mesh-list
15194298|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194299|NCT03814577|Protective Agents|protective agents|mesh-ancestor
15194300|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194301|NCT03814629|Vitamins|vitamins|mesh-list
14694494|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815040|NCT00864838|Diuretics|diuretics|mesh-ancestor
14694495|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694496|NCT00370318|Acetaminophen|acetaminophen|mesh-list
14694497|NCT00370318|Vaccines|vaccines|mesh-list
14694498|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14694499|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
14694500|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694501|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14694502|NCT00370318|Analgesics|analgesics|mesh-ancestor
14694503|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
14694504|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694505|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
14694506|NCT00370370|Triamcinolone|triamcinolone|mesh-list
14694507|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14694508|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14694509|NCT00370370|Bevacizumab|bevacizumab|mesh-list
14694510|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14694511|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694512|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694513|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694514|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694515|NCT00370370|Growth Substances|growth substances|mesh-ancestor
14694516|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694517|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694518|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694519|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
14694520|NCT00370370|Hormones|hormones|mesh-ancestor
14694521|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694522|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694523|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
14694524|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694525|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694526|NCT00370422|Triamcinolone|triamcinolone|mesh-list
14694527|NCT00370422|Bevacizumab|bevacizumab|mesh-list
14694528|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694529|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694530|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694531|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694532|NCT00370422|Growth Substances|growth substances|mesh-ancestor
14694533|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694534|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694535|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694536|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
14694537|NCT00370422|Hormones|hormones|mesh-ancestor
14694538|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694539|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14694540|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
14694541|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694542|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14694543|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14694544|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694545|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694546|NCT00370539|Triamcinolone|triamcinolone|mesh-list
14694547|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14694548|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15194302|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
15194303|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694549|NCT00370539|Bevacizumab|bevacizumab|mesh-list
14694550|NCT00370539|Verteporfin|verteporfin|mesh-list
14694551|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14694552|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694553|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694554|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694555|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694556|NCT00370539|Growth Substances|growth substances|mesh-ancestor
14694557|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694558|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694559|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694560|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
14694561|NCT00370539|Hormones|hormones|mesh-ancestor
14694562|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694563|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694564|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
14694565|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815041|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
14728044|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14694566|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694567|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14694568|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
14694569|NCT00370565|Insulin|insulin|mesh-list
15194304|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
15194305|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15194306|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
15194307|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194308|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
15194309|NCT03814707|Protective Agents|protective agents|mesh-ancestor
15194310|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
15194311|NCT03814447|Fludarabine|fludarabine|mesh-list
15194312|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694570|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14694571|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694572|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694573|NCT00370591|Fluticasone|fluticasone|mesh-list
14694574|NCT00370591|Xhance|xhance|mesh-list
14694575|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14694576|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694577|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14694578|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
14694579|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694580|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694581|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14694582|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
14694583|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
14694584|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14694585|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14694586|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14694587|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14694588|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
14694589|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694590|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694591|NCT00370617|Metformin|metformin|mesh-list
14694592|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694593|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694594|NCT00370630|Triamcinolone|triamcinolone|mesh-list
14694595|NCT00370630|Bevacizumab|bevacizumab|mesh-list
14694596|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694597|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694598|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694599|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694600|NCT00370630|Growth Substances|growth substances|mesh-ancestor
14694601|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694602|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694603|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694604|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
14694605|NCT00370630|Hormones|hormones|mesh-ancestor
14694606|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694607|NCT00370643|Insulin|insulin|mesh-list
14694608|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14694609|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694610|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694611|NCT00370656|Pregabalin|pregabalin|mesh-list
14694612|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14694613|NCT00370656|Amitriptyline|amitriptyline|mesh-list
14694614|NCT00370656|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14694615|NCT00370656|Analgesics|analgesics|mesh-ancestor
15194313|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
15194314|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194315|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15194316|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15194317|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
15194318|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194319|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194320|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15194321|NCT03814616|Artesunate|artesunate|mesh-list
15194322|NCT03814616|Pyronaridine|pyronaridine|mesh-list
14294547|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294548|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694616|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
14694617|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694618|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694619|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
15194323|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
15194324|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14694620|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14694621|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694622|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694623|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14694624|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14694625|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14694626|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694627|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694628|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14694629|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14694630|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694631|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
14694632|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
14694633|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14694634|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14694635|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14694636|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
14694637|NCT00370656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14694638|NCT00370669|Triamcinolone|triamcinolone|mesh-list
14694639|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14694640|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14694641|NCT00370669|Bevacizumab|bevacizumab|mesh-list
14694642|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14694643|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694644|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694645|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694646|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694647|NCT00370669|Growth Substances|growth substances|mesh-ancestor
14694648|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694649|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694650|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694651|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
14694652|NCT00370669|Hormones|hormones|mesh-ancestor
14694653|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694654|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694655|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
14694656|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694657|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694658|NCT00370721|Bevacizumab|bevacizumab|mesh-list
14694659|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694660|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694661|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694662|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694663|NCT00370721|Growth Substances|growth substances|mesh-ancestor
14694664|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694665|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694666|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
14694667|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14694668|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14694669|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14694670|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694671|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694672|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
14694673|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694674|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694675|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14694676|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694677|NCT00370747|Ecabet|ecabet|mesh-list
14694678|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694679|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14694680|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14694681|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
14694682|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694683|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694684|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14694685|NCT00370747|Protective Agents|protective agents|mesh-ancestor
14694686|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694687|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694688|NCT00370760|Dexamethasone|dexamethasone|mesh-list
14694689|NCT00370760|Colchicine|colchicine|mesh-list
14694690|NCT00370760|Heparin|heparin|mesh-list
14694691|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14694692|NCT00370760|Tinzaparin|tinzaparin|mesh-list
14694693|NCT00370760|Dalteparin|dalteparin|mesh-list
14694694|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694695|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
14694696|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
14694697|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694698|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694699|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14694700|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
14694701|NCT00370760|Hormones|hormones|mesh-ancestor
14694702|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694703|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14694704|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694705|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
14694706|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14694707|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14694708|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694709|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
14694710|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14694711|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
14694712|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
14694713|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
14694714|NCT00370786|Bevacizumab|bevacizumab|mesh-list
14694715|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694716|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694717|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694718|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694719|NCT00370786|Growth Substances|growth substances|mesh-ancestor
14694720|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694721|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694722|NCT00370799|Betamethasone|betamethasone|mesh-list
14694723|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
14694724|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14694725|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
14694726|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14694727|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14694728|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694729|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
14694730|NCT00370799|Hormones|hormones|mesh-ancestor
14694731|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694732|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694733|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14694734|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14694735|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14694736|NCT00370825|Miltefosine|miltefosine|mesh-list
14694737|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
14694738|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694739|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14694740|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14694741|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694742|NCT00370851|Bevacizumab|bevacizumab|mesh-list
14694743|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694744|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694745|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694746|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694747|NCT00370851|Growth Substances|growth substances|mesh-ancestor
14694748|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694749|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694750|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
15194325|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15194326|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194327|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194328|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
15194329|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
15194330|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15194331|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
15194332|NCT03814642|Esomeprazole|esomeprazole|mesh-list
15194333|NCT03814642|Clopidogrel|clopidogrel|mesh-list
15194334|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15194335|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14694751|NCT00370968|Astringents|astringents|mesh-ancestor
14694752|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194336|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14294549|NCT00577096|Thalidomide|thalidomide|mesh-list
14694753|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
14694754|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14294550|NCT00577096|Dexamethasone|dexamethasone|mesh-list
14694755|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694756|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694757|NCT00371007|Incretins|incretins|mesh-ancestor
14694758|NCT00371007|Hormones|hormones|mesh-ancestor
14694759|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694760|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14694761|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14694762|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694763|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694764|NCT00371020|Heparin|heparin|mesh-list
14694765|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14694766|NCT00371020|Tinzaparin|tinzaparin|mesh-list
14694767|NCT00371020|Dalteparin|dalteparin|mesh-list
14694768|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
14694769|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14694770|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14694771|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694772|NCT00371033|Pregabalin|pregabalin|mesh-list
14694773|NCT00371033|Analgesics|analgesics|mesh-ancestor
14694774|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
14694775|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694776|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694777|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
14694778|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14694779|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14694780|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694781|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14694782|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14694783|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14694784|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14694785|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14694786|NCT00371072|Mitomycins|mitomycins|mesh-list
14694787|NCT00371072|Mitomycin|mitomycin|mesh-list
15194337|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15194338|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
15194339|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194340|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194341|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194342|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14694788|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14694789|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694790|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
14694791|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694792|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14694793|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694794|NCT00371098|Vaccines|vaccines|mesh-list
14694795|NCT00371098|Immunologic Factors|immunologic factors|mesh-ancestor
14694796|NCT00371098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694797|NCT00371111|Triamcinolone|triamcinolone|mesh-list
14694798|NCT00371111|Bevacizumab|bevacizumab|mesh-list
14694799|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694800|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694801|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694802|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694803|NCT00371111|Growth Substances|growth substances|mesh-ancestor
14694804|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694805|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694806|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694807|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
14694808|NCT00371111|Hormones|hormones|mesh-ancestor
14694809|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694810|NCT00371124|Atropine|atropine|mesh-list
14694811|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14694812|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14694813|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194343|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194344|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15194345|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194346|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15194347|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
15194348|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194349|NCT03814343|Amphotericin B|amphotericin b|mesh-list
15194350|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15194351|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14694814|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15194352|NCT03814343|Amebicides|amebicides|mesh-ancestor
15194353|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14694815|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14694816|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
14694817|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694818|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694819|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14694820|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
14694821|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
14694822|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
14694823|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14694824|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14694825|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
14694826|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694827|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694828|NCT00371306|Metformin|metformin|mesh-list
14694829|NCT00371306|Glyburide|glyburide|mesh-list
14694830|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694831|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694832|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
14694833|NCT00371319|Tacrolimus|tacrolimus|mesh-list
14694834|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694835|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
14694836|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694837|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14694838|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694839|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694840|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14694841|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694842|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14694843|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
14694844|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14694845|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694846|NCT00371332|Minocycline|minocycline|mesh-list
14694847|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14694848|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694849|NCT00371410|Triamcinolone|triamcinolone|mesh-list
14694850|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14694851|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14694852|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15194354|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15194355|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194356|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15194357|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
15194358|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15194359|NCT03814343|Protective Agents|protective agents|mesh-ancestor
15194360|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194361|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15194362|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
14694853|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694854|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
14694855|NCT00371410|Hormones|hormones|mesh-ancestor
14694856|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694857|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694858|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14694859|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
14694860|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694861|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694862|NCT00371488|Lapatinib|lapatinib|mesh-list
14694863|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694864|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14694865|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694866|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194363|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224139|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15224140|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15224141|NCT04558502|Antacids|antacids|mesh-ancestor
15224142|NCT04550455|Cladribine|cladribine|mesh-list
15224143|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224144|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224145|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
15224146|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694867|NCT00371501|Aspirin|aspirin|mesh-list
14694868|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14815042|NCT00864864|Sunitinib|sunitinib|mesh-list
15224147|NCT04505735|Corticosterone|corticosterone|mesh-list
15194364|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
15194365|NCT03814226|Growth Substances|growth substances|mesh-ancestor
15194366|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194367|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
14694869|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14694870|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14694871|NCT00371501|Analgesics|analgesics|mesh-ancestor
14694872|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
14694873|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694874|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694875|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694876|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14694877|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14694878|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14694879|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694880|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14694881|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14694882|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694883|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
14694884|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14694885|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14694886|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
14694887|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14694888|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14694889|NCT00371527|Ipratropium|ipratropium|mesh-list
14694890|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14694891|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
14694892|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694893|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694894|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14694895|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
14694896|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14694897|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
14694898|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694899|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694900|NCT00371553|Sunitinib|sunitinib|mesh-list
14694901|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694902|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14694903|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14694904|NCT00371553|Growth Substances|growth substances|mesh-ancestor
14694905|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694906|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
14694907|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14694908|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694909|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694910|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14694911|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14694912|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14694913|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
14694914|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694915|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14694916|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14694917|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694918|NCT00371592|Acyclovir|acyclovir|mesh-list
14694919|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
14694920|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694921|NCT00371696|Acetaminophen|acetaminophen|mesh-list
14694922|NCT00371696|Diclofenac|diclofenac|mesh-list
14694923|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14694924|NCT00371696|Analgesics|analgesics|mesh-ancestor
14694925|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
14694926|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14694927|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694928|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
14694929|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14694930|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14694931|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14694932|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14694933|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194368|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694934|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694935|NCT00371735|Artesunate|artesunate|mesh-list
14694936|NCT00371735|Dapsone|dapsone|mesh-list
14694937|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
14694938|NCT00371735|Proguanil|proguanil|mesh-list
14694939|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
14694940|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14694941|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14694942|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694943|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694944|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
14694945|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
14694946|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14694947|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
14694948|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14694949|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14694950|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694951|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
14694952|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14694953|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
14694954|NCT00371813|Varenicline|varenicline|mesh-list
14694955|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14694956|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14694957|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
14694958|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14694959|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14694960|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728045|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728046|NCT00516438|Topotecan|topotecan|mesh-list
14728047|NCT00516438|Olaparib|olaparib|mesh-list
14728048|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14728049|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14728050|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14728051|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194369|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194370|NCT03813875|Fentanyl|fentanyl|mesh-list
15194371|NCT03813875|Midazolam|midazolam|mesh-list
15194372|NCT03813875|Alfentanil|alfentanil|mesh-list
15194373|NCT03813875|Propofol|propofol|mesh-list
15194374|NCT03813875|Sevoflurane|sevoflurane|mesh-list
15194375|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15194376|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194377|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194378|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15194379|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
15194380|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
15194381|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194382|NCT03813875|Narcotics|narcotics|mesh-ancestor
15194383|NCT03813875|Analgesics|analgesics|mesh-ancestor
15194384|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
15194385|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728052|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728053|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194386|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194387|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15194388|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15194389|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728054|NCT00516464|Ranibizumab|ranibizumab|mesh-list
14728055|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14728056|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14728057|NCT00516464|Growth Substances|growth substances|mesh-ancestor
14728058|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728059|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
14728060|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728061|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14728062|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
14728063|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14728064|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
15194390|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
15194391|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
15194392|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194393|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194394|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15194395|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15194396|NCT03813784|Capecitabine|capecitabine|mesh-list
15194397|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
15194398|NCT03813784|Apatinib|apatinib|mesh-list
14728065|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14728066|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194399|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14694961|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14694962|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
14694963|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694964|NCT00371904|Rituximab|rituximab|mesh-list
14694965|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14694966|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694967|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
14694968|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694969|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14694970|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14694971|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14694972|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
14694973|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694974|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694975|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14694976|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14694977|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14694978|NCT00371995|Amphotericin B|amphotericin b|mesh-list
14694979|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14694980|NCT00371995|Miltefosine|miltefosine|mesh-list
14694981|NCT00371995|Amebicides|amebicides|mesh-ancestor
14694982|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14694983|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14694984|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14694985|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14694986|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
14694987|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14694988|NCT00372008|Testosterone|testosterone|mesh-list
14694989|NCT00372008|Androgens|androgens|mesh-ancestor
14694990|NCT00372008|Hormones|hormones|mesh-ancestor
14694991|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14694992|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694993|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
14694994|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14694995|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14694996|NCT00372099|Calcitonin|calcitonin|mesh-list
14694997|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
14694998|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14694999|NCT00372099|Katacalcin|katacalcin|mesh-list
14695000|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14695001|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695002|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14695003|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
14695004|NCT00372138|Thrombin|thrombin|mesh-list
14695005|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
14695006|NCT00372138|Coagulants|coagulants|mesh-ancestor
14695007|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
14695008|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
14695009|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695010|NCT00372216|Clopidogrel|clopidogrel|mesh-list
14695011|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14695012|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14695013|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14695014|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14695015|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
14695016|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695017|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695018|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695019|NCT00372229|Valganciclovir|valganciclovir|mesh-list
14695020|NCT00372229|Ganciclovir|ganciclovir|mesh-list
14695021|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14695022|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
14695023|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695024|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14695025|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695026|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695027|NCT00372294|Clindamycin|clindamycin|mesh-list
14695028|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
14695029|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
14695030|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
14695031|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
14695032|NCT00372294|Dexamethasone|dexamethasone|mesh-list
14695033|NCT00372294|Prednisolone|prednisolone|mesh-list
14695034|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14695035|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
14695036|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
14695037|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695038|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695039|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695040|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
14695041|NCT00372294|Hormones|hormones|mesh-ancestor
14695042|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14695043|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14695044|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695045|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15194400|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
15194401|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194402|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194403|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15194404|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194405|NCT03813979|Dolutegravir|dolutegravir|mesh-list
15194406|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14695046|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695047|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14695048|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695049|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695050|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
14695051|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695052|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695053|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14695054|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
14695055|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
14695056|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14695057|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14695058|NCT00372307|Analgesics|analgesics|mesh-ancestor
14695059|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
14695060|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695061|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695062|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14695063|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695064|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
14695065|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695066|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
14695067|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14695068|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695069|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695070|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
14695071|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14695072|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695073|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695074|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14695075|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695076|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14695077|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
14695078|NCT00372476|Vinorelbine|vinorelbine|mesh-list
14695079|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695080|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14695081|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695082|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695083|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14695084|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
14695085|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
14695086|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
14695087|NCT00372515|Gefitinib|gefitinib|mesh-list
14695088|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695089|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14695090|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695091|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695092|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
14695093|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14695094|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695095|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
14695096|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
14695097|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14695098|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
14695099|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695100|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695101|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194407|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15194408|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695102|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14695103|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695104|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695105|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14695106|NCT00372632|Renal Agents|renal agents|mesh-ancestor
14695107|NCT00372645|Folic Acid|folic acid|mesh-list
14695108|NCT00372645|Hematinics|hematinics|mesh-ancestor
14695109|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
14695110|NCT00372645|Vitamins|vitamins|mesh-ancestor
14695111|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
14695112|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695113|NCT00372658|Lidocaine|lidocaine|mesh-list
14695114|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
14695115|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
14695116|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695117|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695118|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
14695119|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695120|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14695121|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14695122|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14695123|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695124|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695125|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
14695126|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14695127|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695128|NCT00372723|Infliximab|infliximab|mesh-list
14695129|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
14695130|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695131|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695132|NCT00372736|Docetaxel|docetaxel|mesh-list
14695133|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695134|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
14695135|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
14695136|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
14695137|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695138|NCT00372762|Furosemide|furosemide|mesh-list
14695139|NCT00372762|Bumetanide|bumetanide|mesh-list
14695140|NCT00372762|Diuretics|diuretics|mesh-ancestor
14695141|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
14695142|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695143|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15194409|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695144|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695145|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695146|NCT00372788|Pemetrexed|pemetrexed|mesh-list
14695147|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695148|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695149|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695150|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14695151|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14695152|NCT00372801|Ibuprofen|ibuprofen|mesh-list
14695153|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14695154|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14695155|NCT00372801|Analgesics|analgesics|mesh-ancestor
14695156|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
14695157|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695158|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695159|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14695160|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695161|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14695162|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695163|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695164|NCT00372827|Travoprost|travoprost|mesh-list
14695165|NCT00372827|Brinzolamide|brinzolamide|mesh-list
14695166|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14695167|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14695168|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695169|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695170|NCT00372853|Tremelimumab|tremelimumab|mesh-list
14695171|NCT00372853|Ipilimumab|ipilimumab|mesh-list
14695172|NCT00372853|Sunitinib|sunitinib|mesh-list
14695173|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695174|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15194410|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15194411|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15194412|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
15194413|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194414|NCT03814148|Indapamide|indapamide|mesh-list
15194415|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14695175|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14695176|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695177|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14695178|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15194416|NCT03814148|Diuretics|diuretics|mesh-ancestor
15194417|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
15194418|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194419|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15194420|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15194421|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194422|NCT03814109|Niacin|niacin|mesh-list
15194423|NCT03814109|Indapamide|indapamide|mesh-list
15194424|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15194425|NCT03814109|Diuretics|diuretics|mesh-ancestor
15194426|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
15194427|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194428|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15194429|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695179|NCT00372853|Growth Substances|growth substances|mesh-ancestor
14695180|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695181|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
14695182|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14695183|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695184|NCT00372879|Vitamin E|vitamin e|mesh-list
14695185|NCT00372879|Vitamins|vitamins|mesh-ancestor
14695186|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
14695187|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695188|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
14695189|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695190|NCT00372879|Protective Agents|protective agents|mesh-ancestor
14695191|NCT00372892|Rituximab|rituximab|mesh-list
14695192|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14695193|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695194|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
14695195|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695196|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695197|NCT00373048|Mefloquine|mefloquine|mesh-list
14695198|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
14695199|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695200|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695201|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194430|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194431|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15194432|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
15194433|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15194434|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
15194435|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
15194436|NCT03814109|Vitamins|vitamins|mesh-ancestor
15194437|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
15194438|NCT03813927|Vitamin D|vitamin d|mesh-list
14695202|NCT00373061|Omalizumab|omalizumab|mesh-list
14695203|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14695204|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14695205|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
14695206|NCT00373087|Entacapone|entacapone|mesh-list
14695207|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14695208|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14695209|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194439|NCT03813927|Vitamins|vitamins|mesh-ancestor
15194440|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
15194441|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194442|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15194443|NCT03813940|Vaccines|vaccines|mesh-list
15194444|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
14695210|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14695211|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695212|NCT00373126|Nicotine|nicotine|mesh-list
14695213|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15194445|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194446|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
15194447|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
15194448|NCT03813771|Etanercept|etanercept|mesh-list
14695214|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
14695215|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695216|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695217|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14695218|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14695219|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
14695220|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695221|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695222|NCT00373165|Ganciclovir|ganciclovir|mesh-list
14695223|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14695224|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
14695225|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695226|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14695227|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695228|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695229|NCT00373178|Metformin|metformin|mesh-list
14695230|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
14695231|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14695232|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695233|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
14695234|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695235|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14695236|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
14695237|NCT00373217|Paclitaxel|paclitaxel|mesh-list
14695238|NCT00373217|Carboplatin|carboplatin|mesh-list
14695239|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14695240|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695241|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14695242|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14695243|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14695244|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695245|NCT00373282|Triamcinolone|triamcinolone|mesh-list
14695246|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14695247|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14695248|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14695249|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14695250|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
14695251|NCT00373282|Hormones|hormones|mesh-ancestor
14695252|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14695253|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695254|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695255|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
14695256|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695257|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695258|NCT00373373|Sorafenib|sorafenib|mesh-list
14695259|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695260|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14695261|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695262|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695263|NCT00373412|Vaccines|vaccines|mesh-list
14695264|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
14695265|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695266|NCT00373451|Heparin|heparin|mesh-list
14695267|NCT00373451|Calcium heparin|calcium heparin|mesh-list
15194449|NCT03813771|Methotrexate|methotrexate|mesh-list
15194450|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14294551|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
14294552|NCT00577096|Melphalan|melphalan|mesh-list
14294553|NCT00577096|Cisplatin|cisplatin|mesh-list
14294554|NCT00577096|Doxorubicin|doxorubicin|mesh-list
15194451|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
15194452|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15194453|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194454|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15194455|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
15194456|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194457|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194458|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
15194459|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194460|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15194461|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15194462|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
15194463|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294555|NCT00577096|Etoposide|etoposide|mesh-list
14294556|NCT00577096|Vincristine|vincristine|mesh-list
14695268|NCT00373451|Bivalirudin|bivalirudin|mesh-list
14695269|NCT00373451|Abciximab|abciximab|mesh-list
15194464|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15194465|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
15194466|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14294557|NCT00577096|Heparin|heparin|mesh-list
14294558|NCT00577096|Calcium heparin|calcium heparin|mesh-list
14294559|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14294560|NCT00577096|Tinzaparin|tinzaparin|mesh-list
15194467|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15194468|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194469|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15194470|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15194471|NCT03813771|Analgesics|analgesics|mesh-ancestor
15194472|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
15194473|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194474|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15194475|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194476|NCT03813641|Capecitabine|capecitabine|mesh-list
15194477|NCT03813641|Raltitrexed|raltitrexed|mesh-list
15194478|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14294561|NCT00577096|Dalteparin|dalteparin|mesh-list
14294562|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
14294563|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294564|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
14294565|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294566|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695270|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
15194479|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
15194480|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194481|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194482|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15194483|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194484|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
14695271|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14695272|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14695273|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695274|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
14695275|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14695276|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
14695277|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695278|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15194485|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15194486|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15194487|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194488|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
15194489|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
15194490|NCT03813394|Bevacizumab|bevacizumab|mesh-list
15194491|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
15194492|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15194493|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194494|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15194495|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15194496|NCT03813394|Growth Substances|growth substances|mesh-ancestor
15194497|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194498|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
15194499|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
14695279|NCT00373464|Etoricoxib|etoricoxib|mesh-list
14695280|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14695281|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14695282|NCT00373464|Analgesics|analgesics|mesh-ancestor
14695283|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
14695284|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695285|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695286|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14695287|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695288|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14695289|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14695290|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695291|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695292|NCT00373503|Lofexidine|lofexidine|mesh-list
14695293|NCT00373503|Dronabinol|dronabinol|mesh-list
14695294|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
15194500|NCT03813329|Calcium|calcium|mesh-list
15194501|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15194502|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294567|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14695295|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194503|NCT03813329|Antacids|antacids|mesh-ancestor
14695296|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695297|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14695298|NCT00373503|Analgesics|analgesics|mesh-ancestor
14695299|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
14695300|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695301|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14695302|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14695303|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695304|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695305|NCT00373503|Hormones|hormones|mesh-ancestor
14695306|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14695307|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14695308|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14695309|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14695310|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14695311|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14695312|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14695313|NCT00373542|Ropinirole|ropinirole|mesh-list
14695314|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14695315|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15194504|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194505|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194506|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
15194507|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15194508|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194509|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194510|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14695316|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
14695317|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
15194511|NCT03813277|Analgesics|analgesics|mesh-ancestor
15194512|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
15194513|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695318|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695319|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695320|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695321|NCT00373568|Miltefosine|miltefosine|mesh-list
14695322|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
14695323|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695324|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695325|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695326|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695327|NCT00373581|Cocaine|cocaine|mesh-list
15194514|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15194515|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15194516|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15194517|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
15194518|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194519|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194520|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15194521|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
15194522|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15194523|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15194524|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14695328|NCT00373581|Vigabatrin|vigabatrin|mesh-list
14695329|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
14695330|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
14695331|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695332|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695333|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
14695334|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695335|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14695336|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14695337|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14695338|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695339|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695340|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
14695341|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695342|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
14695343|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695344|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
14695345|NCT00373594|Rituximab|rituximab|mesh-list
14695346|NCT00373594|Fludarabine|fludarabine|mesh-list
14695347|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14695348|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695349|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
14695350|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695351|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695352|NCT00373607|Artesunate|artesunate|mesh-list
14695353|NCT00373607|Piperaquine|piperaquine|mesh-list
14695354|NCT00373607|Mefloquine|mefloquine|mesh-list
14695355|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
14695356|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695357|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695358|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695359|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695360|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
14695361|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
15194525|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194526|NCT03813316|Incretins|incretins|mesh-ancestor
15194527|NCT03813316|Hormones|hormones|mesh-ancestor
15194528|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15194529|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
14695362|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14695363|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
14695364|NCT00373620|Paclitaxel|paclitaxel|mesh-list
15194530|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194531|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194532|NCT03813303|Fentanyl|fentanyl|mesh-list
15194533|NCT03813303|Midazolam|midazolam|mesh-list
15194534|NCT03813303|Propofol|propofol|mesh-list
15194535|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15194536|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194537|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194538|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15194539|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
15194540|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
15194541|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194542|NCT03813303|Narcotics|narcotics|mesh-ancestor
15194543|NCT03813303|Analgesics|analgesics|mesh-ancestor
15194544|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
15194545|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194546|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194547|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15194548|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15194549|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15194550|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
15194551|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
15194552|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194553|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194554|NCT03813043|Midazolam|midazolam|mesh-list
15194555|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194556|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15194557|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194558|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194559|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15194560|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15194561|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15194562|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15194563|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
15194564|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
15194565|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
15194566|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
15194567|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194568|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194569|NCT03813069|Permethrin|permethrin|mesh-list
15194570|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194571|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194572|NCT03813108|Lumefantrine|lumefantrine|mesh-list
15194573|NCT03813108|Mefloquine|mefloquine|mesh-list
14294568|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
14294569|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695365|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14695366|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695367|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
14695368|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
14695369|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
15194574|NCT03813108|Atovaquone|atovaquone|mesh-list
15194575|NCT03813108|Proguanil|proguanil|mesh-list
15194576|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14695370|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695371|NCT00373646|Thalidomide|thalidomide|mesh-list
15194577|NCT03813108|Vaccines|vaccines|mesh-list
15194578|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
15194579|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15194580|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15194581|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695372|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695373|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
14695374|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695375|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
14695376|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14695377|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695378|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14695379|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14695380|NCT00373646|Growth Substances|growth substances|mesh-ancestor
14695381|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
14695382|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728067|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14728068|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14728069|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728070|NCT00516542|Letrozole|letrozole|mesh-list
14728071|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728072|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14728073|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14728074|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728075|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728076|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14728077|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
14728078|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14728079|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728080|NCT00516607|Temozolomide|temozolomide|mesh-list
14728081|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14728082|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
14728083|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728084|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728085|NCT00516672|Lapatinib|lapatinib|mesh-list
14728086|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728087|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14728088|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728089|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728090|NCT00516711|Sevoflurane|sevoflurane|mesh-list
14728091|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14728092|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14728093|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
14728094|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
14728095|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728096|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728097|NCT00516750|Doxorubicin|doxorubicin|mesh-list
14728098|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14728099|NCT00516750|Methotrexate|methotrexate|mesh-list
14728100|NCT00516750|Vinblastine|vinblastine|mesh-list
14728101|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728102|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14728103|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14728104|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14728105|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728106|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728107|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14728108|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
14728109|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14728110|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728111|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14728112|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
14728113|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728114|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14728115|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728116|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
14728117|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728118|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14728119|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14728120|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14728121|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14728122|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14728123|NCT00516802|Olaparib|olaparib|mesh-list
14728124|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15194582|NCT03813108|Immunologic Factors|immunologic factors|mesh-ancestor
14695383|NCT00373659|Ranibizumab|ranibizumab|mesh-list
14695384|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14695385|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14695386|NCT00373659|Growth Substances|growth substances|mesh-ancestor
14695387|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695388|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
14695389|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695390|NCT00373672|Modafinil|modafinil|mesh-list
14695391|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14695392|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695393|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14695394|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14695395|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14695396|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695397|NCT00373711|Iodine|iodine|mesh-list
14695398|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
14695399|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14695400|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14695401|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695402|NCT00373711|Trace Elements|trace elements|mesh-ancestor
14695403|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
14695404|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695405|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14695406|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695407|NCT00373776|Miltefosine|miltefosine|mesh-list
14695408|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
14695409|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695410|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695411|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695412|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695413|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
14695414|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14695415|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15194583|NCT03813108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194584|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194585|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194586|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
15194587|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15194588|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
15194589|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15194590|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
14695416|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14695417|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695418|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695419|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
14695420|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695421|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294570|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294571|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294572|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294573|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
14294574|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
14294575|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294576|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14294577|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
14294578|NCT00577096|Hormones|hormones|mesh-ancestor
14294579|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14294580|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14294581|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695422|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14695423|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695424|NCT00373802|Phenylephrine|phenylephrine|mesh-list
14695425|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
14695426|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14695427|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
14695428|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
14695429|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695430|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695431|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
14695432|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14695433|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
14695434|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
15194591|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14695435|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14695436|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14695437|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14695438|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
14695439|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695440|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695441|NCT00373802|Protective Agents|protective agents|mesh-ancestor
14695442|NCT00373815|Everolimus|everolimus|mesh-list
14695443|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695444|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695445|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
14695446|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695447|NCT00373893|Lidocaine|lidocaine|mesh-list
14695448|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
14695449|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
14695450|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695451|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695452|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
14695453|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194592|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14695454|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14695455|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14695456|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14695457|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695458|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695459|NCT00373906|Bortezomib|bortezomib|mesh-list
14695460|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695461|NCT00373919|Erythromycin|erythromycin|mesh-list
14695462|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
14695463|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14695464|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
14695465|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14695466|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695467|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695468|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14695469|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695470|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695471|NCT00374023|Vitamin A|vitamin a|mesh-list
14695472|NCT00374023|Vitamins|vitamins|mesh-ancestor
14695473|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
14695474|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695475|NCT00374075|Valproic Acid|valproic acid|mesh-list
14695476|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
14695477|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695478|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695479|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
14695480|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695481|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695482|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
14695483|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14695484|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695485|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695486|NCT00374101|Omeprazole|omeprazole|mesh-list
14695487|NCT00374101|Pantoprazole|pantoprazole|mesh-list
14695488|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14695489|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695490|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14695491|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695492|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695493|NCT00374192|Eszopiclone|eszopiclone|mesh-list
14695494|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14695495|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695496|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695497|NCT00374205|Artesunate|artesunate|mesh-list
14695498|NCT00374205|Lumefantrine|lumefantrine|mesh-list
14695499|NCT00374205|Artemether|artemether|mesh-list
14695500|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14695501|NCT00374205|Amodiaquine|amodiaquine|mesh-list
14695502|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
14695503|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695504|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695505|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695506|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695507|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
14695508|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
14695509|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14695510|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
14695511|NCT00374348|Aripiprazole|aripiprazole|mesh-list
14695512|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14695513|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695514|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14695515|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14695516|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695517|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695518|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
14695519|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
15194593|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15194594|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15194595|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194596|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
15194597|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194598|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194599|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15194600|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194601|NCT03813186|Decitabine|decitabine|mesh-list
14695520|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695521|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695522|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14695523|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14695524|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
14695525|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14695526|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14695527|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14695528|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14695529|NCT00374387|NuvaRing|nuvaring|mesh-list
14695530|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14695531|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
14695532|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14695533|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695534|NCT00374426|Sertraline|sertraline|mesh-list
14695535|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
14695536|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15194602|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15194603|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
15194604|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194605|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695537|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14695538|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14695539|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695540|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695541|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695542|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
14695543|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695544|NCT00374465|Verapamil|verapamil|mesh-list
14695545|NCT00374465|Carvedilol|carvedilol|mesh-list
14695546|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14695547|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14695548|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
14695549|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695550|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695551|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695552|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14695553|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
14695554|NCT00374465|Protective Agents|protective agents|mesh-ancestor
14695555|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14695556|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695557|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14695558|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
14695559|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15194606|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194607|NCT03812939|Octreotide|octreotide|mesh-list
15194608|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194609|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15194610|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194611|NCT03813030|Lidocaine|lidocaine|mesh-list
14695560|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14695561|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14695562|NCT00374478|Scopolamine|scopolamine|mesh-list
14695563|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15194612|NCT03813030|Prilocaine|prilocaine|mesh-list
15194613|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
14695564|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14695565|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
14695566|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
14695567|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695568|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695569|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695570|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
14695571|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14695572|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
14695573|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695574|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695575|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14695576|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
14695577|NCT00374621|Isosorbide|isosorbide|mesh-list
14695578|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14695579|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14695580|NCT00374621|Misoprostol|misoprostol|mesh-list
14695581|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14695582|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
14695583|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14695584|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695585|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14695586|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695587|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
14695588|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14695589|NCT00374621|Diuretics|diuretics|mesh-ancestor
14695590|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
14695591|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
14695592|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14695593|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695594|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
14695595|NCT00374647|Sirolimus|sirolimus|mesh-list
14695596|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14695597|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695598|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14695599|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
14695600|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14695601|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695602|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695603|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194614|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
15194615|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194616|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194617|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
15194618|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695604|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
14695605|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695606|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
14695607|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695608|NCT00374686|Valganciclovir|valganciclovir|mesh-list
15194619|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15194620|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15194621|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15194622|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15194623|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194624|NCT03812783|Sorafenib|sorafenib|mesh-list
15194625|NCT03812783|Folfirinox|folfirinox|mesh-list
15194626|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194627|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15194628|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194629|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194630|NCT03812796|Avelumab|avelumab|mesh-list
15194631|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15194632|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695609|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
14695610|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695611|NCT00374699|Bortezomib|bortezomib|mesh-list
15194633|NCT03812731|Fentanyl|fentanyl|mesh-list
15194634|NCT03812731|Ropivacaine|ropivacaine|mesh-list
15194635|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
15194636|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
15194637|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194638|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194639|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
15194640|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194641|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194642|NCT03812731|Narcotics|narcotics|mesh-ancestor
15194643|NCT03812731|Analgesics|analgesics|mesh-ancestor
15194644|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194645|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15194646|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
15194647|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
15194648|NCT03812380|Cathartics|cathartics|mesh-ancestor
15194649|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194650|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15194651|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15194652|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15194653|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15194654|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194655|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194656|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194657|NCT03812523|Analgesics|analgesics|mesh-ancestor
15194658|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
15194659|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695612|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695613|NCT00374764|Risperidone|risperidone|mesh-list
14695614|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14695615|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
14695616|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695617|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695618|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695619|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14695620|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14695621|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695622|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695623|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14695624|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
14695625|NCT00374777|Nitrazepam|nitrazepam|mesh-list
14695626|NCT00374777|Zolpidem|zolpidem|mesh-list
14695627|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14695628|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14695629|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695630|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695631|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14695632|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
14695633|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
14695634|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695635|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695636|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
14695637|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14695638|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14695639|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695640|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
14695641|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14695642|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14695643|NCT00374855|Diuretics|diuretics|mesh-ancestor
14695644|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
14695645|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695646|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14695647|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695648|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695649|NCT00374881|Phenylephrine|phenylephrine|mesh-list
14695650|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
14695651|NCT00374881|Morphine|morphine|mesh-list
15194660|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
15194661|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695652|NCT00374881|Sorbitol|sorbitol|mesh-list
15194662|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
14294582|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14695653|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14695654|NCT00374881|Narcotics|narcotics|mesh-ancestor
14695655|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695656|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695657|NCT00374881|Analgesics|analgesics|mesh-ancestor
14695658|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
14695659|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695660|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14695661|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
14695662|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
14695663|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
14695664|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14695665|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
14695666|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
14695667|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14695668|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14695669|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14695670|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
14695671|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695672|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695673|NCT00374881|Protective Agents|protective agents|mesh-ancestor
14695674|NCT00374881|Cathartics|cathartics|mesh-ancestor
14695675|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695676|NCT00374894|Succimer|succimer|mesh-list
14695677|NCT00374894|Antidotes|antidotes|mesh-ancestor
14695678|NCT00374894|Protective Agents|protective agents|mesh-ancestor
14695679|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695680|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
14695681|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
14695682|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695683|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
14695684|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14695685|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695686|NCT00374985|Docetaxel|docetaxel|mesh-list
15194663|NCT03812562|Nivolumab|nivolumab|mesh-list
15194664|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294583|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14294584|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14294585|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14294586|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
14294587|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
14294588|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
14294589|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
14294590|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14294591|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14294592|NCT00577096|Hematinics|hematinics|mesh-ancestor
14294593|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
14294594|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294595|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294596|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14294597|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14294598|NCT00577096|Growth Substances|growth substances|mesh-ancestor
14294599|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
14695687|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
15194665|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695688|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695689|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14695690|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14695691|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
14695692|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695693|NCT00375050|Riluzole|riluzole|mesh-list
14695694|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
14695695|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14695696|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14695697|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695698|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695699|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695700|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14695701|NCT00375050|Protective Agents|protective agents|mesh-ancestor
14695702|NCT00375076|Enoxaparin|enoxaparin|mesh-list
14695703|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
15194666|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15194667|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695704|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14695705|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14695706|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695707|NCT00375232|Montelukast|montelukast|mesh-list
14695708|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14695709|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
14695710|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14695711|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
14695712|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14695713|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695714|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14695715|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14695716|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695717|NCT00375245|Sirolimus|sirolimus|mesh-list
14695718|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14695719|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695720|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14695721|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695722|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
14695723|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695724|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
14695725|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695726|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
14695727|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14695728|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14695729|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695730|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
14695731|NCT00375258|Coagulants|coagulants|mesh-ancestor
14695732|NCT00375284|Pramipexole|pramipexole|mesh-list
14695733|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
14695734|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695735|NCT00375284|Protective Agents|protective agents|mesh-ancestor
14695736|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695737|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14695738|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14695739|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
14695740|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
15194668|NCT03812419|Esomeprazole|esomeprazole|mesh-list
14695741|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815043|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815044|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14815045|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14815046|NCT00864864|Growth Substances|growth substances|mesh-ancestor
14815047|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815048|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
14815049|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14815050|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815051|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815052|NCT00864890|Dexetimide|dexetimide|mesh-list
14815053|NCT00864890|Citalopram|citalopram|mesh-list
14815054|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14815055|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815056|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815057|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815058|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815059|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
14815060|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815061|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815062|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815063|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815064|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14815065|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14815066|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
14815067|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
14815068|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815069|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14815070|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14815071|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815072|NCT00864942|Lenalidomide|lenalidomide|mesh-list
14815073|NCT00864942|Rituximab|rituximab|mesh-list
14815074|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14815075|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
14815076|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815077|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14815078|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15194669|NCT03812419|Pantoprazole|pantoprazole|mesh-list
14695742|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
14695743|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
14695744|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14695745|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14695746|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695747|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695748|NCT00375297|Urological Agents|urological agents|mesh-ancestor
14695749|NCT00375310|Gemcitabine|gemcitabine|mesh-list
14695750|NCT00375310|Sorafenib|sorafenib|mesh-list
14695751|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14695752|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
14695753|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695754|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695755|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
14695756|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695757|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695758|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695759|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
14695760|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695761|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14695762|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
14695763|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
14695764|NCT00375375|Lactulose|lactulose|mesh-list
14695765|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695766|NCT00375388|Metformin|metformin|mesh-list
14695767|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14695768|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695769|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
14695770|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15194670|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15194671|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194672|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15194673|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194674|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224148|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224149|NCT04485104|Cannabidiol|cannabidiol|mesh-list
15224150|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
15224151|NCT04479267|Prednisone|prednisone|mesh-list
15224152|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
15224153|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15224154|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15224155|NCT04479267|Prednisolone|prednisolone|mesh-list
15224156|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
15224157|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
15224158|NCT04479267|Cortisone|cortisone|mesh-list
15224159|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
14695771|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14695772|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695773|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
14695774|NCT00375440|Coagulants|coagulants|mesh-ancestor
14695775|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
14695776|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14695777|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14695778|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695779|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
14695780|NCT00375466|Coagulants|coagulants|mesh-ancestor
14695781|NCT00375557|Valproic Acid|valproic acid|mesh-list
14695782|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14695783|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
14695784|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695785|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14695786|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14695787|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14695788|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695789|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
14695790|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695791|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695792|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
14695793|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695794|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
14695795|NCT00375583|Albendazole|albendazole|mesh-list
14695796|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
14695797|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695798|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695799|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
14695800|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15224160|NCT04479267|Rituximab|rituximab|mesh-list
15224161|NCT04479267|Doxorubicin|doxorubicin|mesh-list
15224162|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15194675|NCT03812770|Leucovorin|leucovorin|mesh-list
14695801|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695802|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
14695803|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
14695804|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
14695805|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695806|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695807|NCT00375596|Ketotifen|ketotifen|mesh-list
14695808|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14695809|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
14695810|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
14695811|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14695812|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
14695813|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
14695814|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695815|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695816|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695817|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14695818|NCT00375622|Tamoxifen|tamoxifen|mesh-list
14695819|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15194676|NCT03812770|Fluorouracil|fluorouracil|mesh-list
15194677|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
15194678|NCT03812770|Sorafenib|sorafenib|mesh-list
14695820|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
14695821|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14695822|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695823|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14695824|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695825|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14695826|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15194679|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
15194680|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194681|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15194682|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194683|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15194684|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
15194685|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194686|NCT03812770|Antidotes|antidotes|mesh-ancestor
15194687|NCT03812770|Protective Agents|protective agents|mesh-ancestor
15194688|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
14294600|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
14695827|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14695828|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
14695829|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14695830|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695831|NCT00375661|Interferons|interferons|mesh-list
14695832|NCT00375661|Ribavirin|ribavirin|mesh-list
14695833|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
14695834|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
14695835|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695836|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
14695837|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695838|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
14695839|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695840|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
14695841|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695842|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14695843|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
14695844|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14695845|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
14695846|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14695847|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695848|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14695849|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14695850|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695851|NCT00375765|Dutasteride|dutasteride|mesh-list
14695852|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14695853|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14695854|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695855|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294601|NCT00577122|Methotrexate|methotrexate|mesh-list
14695856|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
14695857|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15194689|NCT03812770|Vitamins|vitamins|mesh-ancestor
15194690|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
15194691|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15194692|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194693|NCT03812354|Nicotine|nicotine|mesh-list
14695858|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695859|NCT00375778|Memantine|memantine|mesh-list
14695860|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14695861|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14695862|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
14695863|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695864|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695865|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695866|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14695867|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14695868|NCT00375843|Citalopram|citalopram|mesh-list
14695869|NCT00375843|Sertraline|sertraline|mesh-list
15194694|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15194695|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
15194696|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695870|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14695871|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14695872|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695873|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695874|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695875|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
14695876|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695877|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14695878|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
15194697|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194698|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15194699|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15194700|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
15194701|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194702|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695879|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695880|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
14695881|NCT00375869|Hematinics|hematinics|mesh-ancestor
14695882|NCT00375895|Cyclosporine|cyclosporine|mesh-list
14695883|NCT00375895|Cyclosporins|cyclosporins|mesh-list
14695884|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695885|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695886|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14695887|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
14695888|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695889|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
14695890|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695891|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
14695892|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695893|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14695894|NCT00376012|Rifampin|rifampin|mesh-list
14695895|NCT00376012|Isoniazid|isoniazid|mesh-list
14695896|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
14695897|NCT00376012|Ethambutol|ethambutol|mesh-list
14695898|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14695899|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
14695900|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14695901|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695902|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
14695903|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14695904|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695905|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695906|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14695907|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14695908|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14695909|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14695910|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14695911|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14695912|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14815079|NCT00864942|Growth Substances|growth substances|mesh-ancestor
15194703|NCT03812315|Propolis|propolis|mesh-list
15194704|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194705|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15194706|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
15194707|NCT03812120|Coagulants|coagulants|mesh-ancestor
14695913|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14695914|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
14695915|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14695916|NCT00376025|Antioxidants|antioxidants|mesh-list
14695917|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695918|NCT00376025|Protective Agents|protective agents|mesh-ancestor
14695919|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695920|NCT00376038|Metformin|metformin|mesh-list
14695921|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14695922|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695923|NCT00376051|Citalopram|citalopram|mesh-list
14695924|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14695925|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14695926|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14695927|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695928|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695929|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
14815080|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
14815081|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815082|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14815083|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14695930|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695931|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14695932|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
14695933|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14695934|NCT00376064|Octreotide|octreotide|mesh-list
14695935|NCT00376064|Cabergoline|cabergoline|mesh-list
14695936|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695937|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14695938|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695939|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14695940|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14695941|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
14695942|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
14695943|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14695944|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695945|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695946|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
14695947|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14815084|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14815085|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
14815086|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815087|NCT00864968|Nabumetone|nabumetone|mesh-list
14815088|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14815089|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14815090|NCT00864968|Analgesics|analgesics|mesh-ancestor
14815091|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
14815092|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815093|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815094|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14815095|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14815096|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14815097|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14815098|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815099|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194708|NCT03812003|Remifentanil|remifentanil|mesh-list
15194709|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194710|NCT03812003|Narcotics|narcotics|mesh-ancestor
15194711|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194712|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194713|NCT03812003|Analgesics|analgesics|mesh-ancestor
15194714|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
15194715|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695948|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15194716|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
14695949|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
14695950|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14695951|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14695952|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
14695953|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
14695954|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14695955|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695956|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14695957|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
14695958|NCT00376077|Hormones|hormones|mesh-ancestor
14695959|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14695960|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14695961|NCT00376077|Protective Agents|protective agents|mesh-ancestor
14695962|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14695963|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695964|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
14695965|NCT00376103|Temozolomide|temozolomide|mesh-list
14695966|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14695967|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
14695968|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695969|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14695970|NCT00376129|Alefacept|alefacept|mesh-list
14695971|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14695972|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
14695973|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695974|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
14695975|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
14695976|NCT00376155|Amodiaquine|amodiaquine|mesh-list
14695977|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
14695978|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14695979|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14695980|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14695981|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14695982|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14695983|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695984|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14695985|NCT00376155|Renal Agents|renal agents|mesh-ancestor
14695986|NCT00376181|Pioglitazone|pioglitazone|mesh-list
14695987|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14695988|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14695989|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14695990|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14695991|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15194717|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
15194718|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15194719|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194720|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194721|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
15194722|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14294602|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14695992|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695993|NCT00376272|Valsartan|valsartan|mesh-list
14695994|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14695995|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14695996|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14695997|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14695998|NCT00376285|Fenofibrate|fenofibrate|mesh-list
14695999|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14696000|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
14696001|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696002|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14696003|NCT00376311|Calcitonin|calcitonin|mesh-list
14696004|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
14696005|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14294603|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
14294604|NCT00577122|Progesterone|progesterone|mesh-list
14696006|NCT00376311|Katacalcin|katacalcin|mesh-list
14696007|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14696008|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696009|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14696010|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14696011|NCT00376324|Tigecycline|tigecycline|mesh-list
14696012|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15194723|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696013|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696014|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14696015|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696016|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696017|NCT00376337|Micafungin|micafungin|mesh-list
14696018|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
14696019|NCT00376337|Clotrimazole|clotrimazole|mesh-list
14696020|NCT00376337|Miconazole|miconazole|mesh-list
14696021|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696022|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14696023|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14696024|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14696025|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696026|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696027|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14696028|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
14696029|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696030|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696031|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14696032|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14696033|NCT00376376|Levofloxacin|levofloxacin|mesh-list
14696034|NCT00376376|Ofloxacin|ofloxacin|mesh-list
14696035|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14696036|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696037|NCT00376376|Renal Agents|renal agents|mesh-ancestor
14696038|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14696039|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14696040|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14696041|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696042|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696043|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696044|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14696045|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14696046|NCT00376428|Gentamicins|gentamicins|mesh-list
14696047|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14696048|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696049|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14696050|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696051|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696052|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
14696053|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696054|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14696055|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696056|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696057|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
14696058|NCT00376480|Fludarabine|fludarabine|mesh-list
14696059|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
14696060|NCT00376480|Thiotepa|thiotepa|mesh-list
14696061|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14696062|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696063|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696064|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
14696065|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696066|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696067|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
14696068|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194724|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327532|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696069|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696070|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
14696071|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
14696072|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696073|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14696074|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
14696075|NCT00376480|Hormones|hormones|mesh-ancestor
14696076|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696077|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14696078|NCT00376480|Protective Agents|protective agents|mesh-ancestor
14696079|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14696080|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
14696081|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14696082|NCT00376493|Metronidazole|metronidazole|mesh-list
14696083|NCT00376493|Doxycycline|doxycycline|mesh-list
14696084|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696085|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14696086|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14696087|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14696088|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
14696089|NCT00376519|Cyclosporine|cyclosporine|mesh-list
14696090|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
14696091|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
14696092|NCT00376519|Fludarabine|fludarabine|mesh-list
14696093|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
14696094|NCT00376519|Cyclosporins|cyclosporins|mesh-list
14696095|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696096|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
14696097|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696098|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14696099|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14696100|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
14696101|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696102|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696103|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14696104|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696105|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
14696106|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696107|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
14696108|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696109|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
14696110|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14696111|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696112|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14696113|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
14696114|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14696115|NCT00376584|Niacin|niacin|mesh-list
14696116|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14696117|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
14696118|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696119|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14696120|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
14696121|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
15194725|NCT03811418|Docetaxel|docetaxel|mesh-list
15194726|NCT03811418|Trastuzumab|trastuzumab|mesh-list
15194727|NCT03811418|Vinorelbine|vinorelbine|mesh-list
14696122|NCT00376584|Vitamins|vitamins|mesh-ancestor
14696123|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
14696124|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696125|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
14696126|NCT00376662|Hormones|hormones|mesh-list
14696127|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696128|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696129|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14696130|NCT00376701|Bevacizumab|bevacizumab|mesh-list
14696131|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14696132|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696133|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14696134|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14696135|NCT00376701|Growth Substances|growth substances|mesh-ancestor
14696136|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696137|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
14696138|NCT00376727|Cetuximab|cetuximab|mesh-list
14696139|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14696140|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696141|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
14696142|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14696143|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696144|NCT00376766|Levetiracetam|levetiracetam|mesh-list
14696145|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
14696146|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
14696147|NCT00376792|Docetaxel|docetaxel|mesh-list
14696148|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696149|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696150|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696151|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696152|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696153|NCT00376818|Hormones|hormones|mesh-list
14696154|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696155|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696156|NCT00376831|Fentanyl|fentanyl|mesh-list
14696157|NCT00376831|Midazolam|midazolam|mesh-list
15194728|NCT03811418|Pertuzumab|pertuzumab|mesh-list
14696158|NCT00376831|Ketamine|ketamine|mesh-list
14696159|NCT00376831|Analgesics|analgesics|mesh-ancestor
14696160|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
14696161|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696162|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696163|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14696164|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14696165|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
14696166|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
14696167|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696168|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14696169|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14696170|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696171|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696172|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14696173|NCT00376831|Narcotics|narcotics|mesh-ancestor
14696174|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14696175|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14696176|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14696177|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14696178|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14696179|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
14696180|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
14696181|NCT00376870|Pioglitazone|pioglitazone|mesh-list
14815100|NCT00864981|Bupropion|bupropion|mesh-list
14815101|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815102|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815103|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815104|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14815105|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815106|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815107|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815108|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
14815109|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815110|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815111|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14815112|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815113|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815114|NCT00865007|Ritonavir|ritonavir|mesh-list
14815115|NCT00865007|Lopinavir|lopinavir|mesh-list
14815116|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14815117|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14815118|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14815119|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815120|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815121|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14815122|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14815123|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
14815124|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815125|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14815126|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815127|NCT00865033|Metformin|metformin|mesh-list
14815128|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815129|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815130|NCT00865059|Gabapentin|gabapentin|mesh-list
14815131|NCT00865059|Analgesics|analgesics|mesh-ancestor
14815132|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
14815133|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815134|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815135|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
14815136|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14815137|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815138|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815139|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815140|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14815141|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15194729|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194730|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
15194731|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
15194732|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
15194733|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194734|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15194735|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14696182|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14696183|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696184|NCT00376883|Pamidronate|pamidronate|mesh-list
14696185|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14696186|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696187|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
14696188|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
15194736|NCT03811509|Denosumab|denosumab|mesh-list
15194737|NCT03811509|Diphosphonates|diphosphonates|mesh-list
15194738|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15194739|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194740|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
15194741|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
15194742|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
15194743|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194744|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194745|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
14696189|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
14696190|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14696191|NCT00376987|Protective Agents|protective agents|mesh-ancestor
14696192|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696193|NCT00377000|Clindamycin|clindamycin|mesh-list
14696194|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
14696195|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
14696196|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14696197|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15194746|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194747|NCT03810872|Paclitaxel|paclitaxel|mesh-list
15194748|NCT03810872|Afatinib|afatinib|mesh-list
15194749|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15194750|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194751|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
15194752|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696198|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696199|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14696200|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696201|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696202|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728125|NCT00516802|Dacarbazine|dacarbazine|mesh-list
14728126|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728127|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728128|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728129|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14728130|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
14728131|NCT00516828|Cytarabine|cytarabine|mesh-list
15194753|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
15194754|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194755|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14728132|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14728133|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
14728134|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728135|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728136|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
14728137|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728138|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728139|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
14728140|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728141|NCT00516841|Volociximab|volociximab|mesh-list
14728142|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15194756|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194757|NCT03811223|Evolocumab|evolocumab|mesh-list
15194758|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15194759|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15194760|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
15194761|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194762|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15194763|NCT03811054|Apatinib|apatinib|mesh-list
14728143|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15194764|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194765|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15194766|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194767|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194768|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14728144|NCT00516841|Growth Substances|growth substances|mesh-ancestor
15194769|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728145|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696203|NCT00377052|Gemcitabine|gemcitabine|mesh-list
14696204|NCT00377052|Bortezomib|bortezomib|mesh-list
14696205|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696206|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
14696207|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696208|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696209|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
14696210|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696211|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696212|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696213|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
14696214|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696215|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
14696216|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14696217|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14696218|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
15194770|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194771|NCT03810976|Gemcitabine|gemcitabine|mesh-list
15194772|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15194773|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
15194774|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194775|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194776|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
15194777|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194778|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194779|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15194780|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
15194781|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194782|NCT03810703|Amphetamine|amphetamine|mesh-list
15194783|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
15194784|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15194785|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194786|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
15194787|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
15194788|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194789|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
15194790|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696219|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696220|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14696221|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14696222|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696223|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696224|NCT00377078|Lactoferrin|lactoferrin|mesh-list
14696225|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194791|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194792|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
15194793|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15194794|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15194795|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15194796|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15194797|NCT03810742|Irinotecan|irinotecan|mesh-list
14696226|NCT00377091|PENTA|penta|mesh-list
14696227|NCT00377091|Fondaparinux|fondaparinux|mesh-list
14696228|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14696229|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
14696230|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15194798|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15194799|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15194800|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194801|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194802|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696231|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14696232|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696233|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696234|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
14696235|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14696236|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15194803|NCT03810547|Ketamine|ketamine|mesh-list
14696237|NCT00377104|Alvocidib|alvocidib|mesh-list
14696238|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696239|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
14696240|NCT00377104|Growth Substances|growth substances|mesh-ancestor
14696241|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696242|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14696243|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728146|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
14696244|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696245|NCT00377143|Warfarin|warfarin|mesh-list
14696246|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
14696247|NCT00377273|Fluorouracil|fluorouracil|mesh-list
14696248|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
14696249|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696250|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696251|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696252|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696253|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
14696254|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696255|NCT00377325|Cyclosporine|cyclosporine|mesh-list
14696256|NCT00377325|Cyclosporins|cyclosporins|mesh-list
14696257|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696258|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696259|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696260|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
14696261|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696262|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
14696263|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194804|NCT03810547|Propofol|propofol|mesh-list
15194805|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14696264|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
14696265|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14696266|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14696267|NCT00377390|Omalizumab|omalizumab|mesh-list
14696268|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14696269|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14696270|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
14696271|NCT00377442|Simvastatin|simvastatin|mesh-list
14696272|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14696273|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14696274|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
14696275|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696276|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14696277|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14696278|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696279|NCT00377468|Dronabinol|dronabinol|mesh-list
14696280|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
14696281|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696282|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14696283|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14696284|NCT00377468|Analgesics|analgesics|mesh-ancestor
14696285|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
14696286|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696287|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14696288|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14696289|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696290|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696291|NCT00377468|Hormones|hormones|mesh-ancestor
14696292|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696293|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
14696294|NCT00377481|Hematinics|hematinics|mesh-ancestor
14696295|NCT00377494|Vaccines|vaccines|mesh-list
14696296|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
14696297|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696298|NCT00377546|Ketorolac|ketorolac|mesh-list
14696299|NCT00377546|Nepafenac|nepafenac|mesh-list
14696300|NCT00377546|Bromfenac|bromfenac|mesh-list
14696301|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14696302|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14696303|NCT00377546|Analgesics|analgesics|mesh-ancestor
14696304|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
14696305|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696306|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696307|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696308|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14696309|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14696310|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696311|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696312|NCT00377559|Docetaxel|docetaxel|mesh-list
14696313|NCT00377559|Doxorubicin|doxorubicin|mesh-list
14696314|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15194806|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696315|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696316|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696317|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696318|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696319|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696320|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696321|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14696322|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14696323|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194807|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194808|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15194809|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
15194810|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
15194811|NCT03810547|Analgesics|analgesics|mesh-ancestor
15194812|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
15194813|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194814|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15194815|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15194816|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15194817|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194818|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194819|NCT03810287|Domperidone|domperidone|mesh-list
15194820|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
14696324|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
14696325|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14696326|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
14696327|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696328|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
14696329|NCT00377624|Protective Agents|protective agents|mesh-ancestor
14696330|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
14696331|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14696332|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14696333|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194821|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
15194822|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696334|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696335|NCT00377780|Docetaxel|docetaxel|mesh-list
14696336|NCT00377780|Doxorubicin|doxorubicin|mesh-list
14696337|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14696338|NCT00377780|Trastuzumab|trastuzumab|mesh-list
14696339|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696340|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696341|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696342|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696343|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696344|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696345|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14696346|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14696347|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696348|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14696349|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14696350|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
14696351|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14696352|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14696353|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696354|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696355|NCT00377793|Urological Agents|urological agents|mesh-ancestor
14696356|NCT00377806|Diclofenac|diclofenac|mesh-list
14696357|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14696358|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14696359|NCT00377806|Analgesics|analgesics|mesh-ancestor
14696360|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
14696361|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696362|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696363|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696364|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15194823|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696365|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14696366|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696367|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696368|NCT00377910|Lidocaine|lidocaine|mesh-list
14696369|NCT00377910|Polidocanol|polidocanol|mesh-list
14696370|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
14696371|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
14696372|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696373|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696374|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
14696375|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696376|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14696377|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14696378|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14696379|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14696380|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696381|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14696382|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14696383|NCT00377923|Progesterone|progesterone|mesh-list
14696384|NCT00377923|Progestins|progestins|mesh-ancestor
14696385|NCT00377923|Hormones|hormones|mesh-ancestor
14696386|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696387|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696388|NCT00377936|Gemcitabine|gemcitabine|mesh-list
14696389|NCT00377936|Paclitaxel|paclitaxel|mesh-list
14696390|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696391|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
14696392|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696393|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696394|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
14696395|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696396|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696397|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696398|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
14696399|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696400|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14696401|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696402|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696403|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696404|NCT00377975|Pioglitazone|pioglitazone|mesh-list
14696405|NCT00377975|Ephedrine|ephedrine|mesh-list
14696406|NCT00377975|Caffeine|caffeine|mesh-list
14696407|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14696408|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696409|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14696410|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14696411|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696412|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696413|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14696414|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14696415|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
14696416|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696417|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
14696418|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
14696419|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696420|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14696421|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14696422|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
14696423|NCT00377988|Norgestimate|norgestimate|mesh-list
14696424|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
14696425|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14696426|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696427|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14696428|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14696429|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14696430|NCT00378027|PENTA|penta|mesh-list
14696431|NCT00378027|Fondaparinux|fondaparinux|mesh-list
14696432|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14696433|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
14696434|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14696435|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
14696436|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696437|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696438|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
14696439|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14696440|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14696441|NCT00378066|Bevacizumab|bevacizumab|mesh-list
14696442|NCT00378066|Capecitabine|capecitabine|mesh-list
14696443|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
14696444|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14696445|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696446|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14696447|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14696448|NCT00378066|Growth Substances|growth substances|mesh-ancestor
15194824|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194825|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15194826|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
15194827|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194828|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696449|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696450|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
14696451|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696452|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
14696453|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696454|NCT00378092|Risperidone|risperidone|mesh-list
14696455|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14696456|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
14696457|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696458|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696459|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696460|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14696461|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14696462|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696463|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14696464|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14696465|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
14696466|NCT00378118|Antibodies|antibodies|mesh-list
14696467|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
14696468|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
14696469|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
14696470|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696471|NCT00378144|Acetaminophen|acetaminophen|mesh-list
14696472|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
14696473|NCT00378144|Ephedrine|ephedrine|mesh-list
14696474|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14696475|NCT00378144|Analgesics|analgesics|mesh-ancestor
14696476|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
14696477|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696478|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696479|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
14696480|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14696481|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
14696482|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14696483|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
14696484|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
14696485|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14696486|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14696487|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
14696488|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
14696489|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696490|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696491|NCT00378183|Risperidone|risperidone|mesh-list
14696492|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15224163|NCT04479267|Antibodies|antibodies|mesh-list
15224164|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
15224165|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14696493|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
14696494|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696495|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696496|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696497|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14696498|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14696499|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696500|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14696501|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14696502|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
14696503|NCT00378196|Ranibizumab|ranibizumab|mesh-list
14696504|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14696505|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14815142|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815143|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815144|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
14815145|NCT00865072|Metformin|metformin|mesh-list
14815146|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815147|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815148|NCT00865085|Dexetimide|dexetimide|mesh-list
14815149|NCT00865085|Citalopram|citalopram|mesh-list
15194829|NCT03810391|Butorphanol|butorphanol|mesh-list
15194830|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194831|NCT03810391|Narcotics|narcotics|mesh-ancestor
15194832|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194833|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194834|NCT03810391|Analgesics|analgesics|mesh-ancestor
15194835|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
14815150|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14815151|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815152|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815153|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815154|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815155|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
14815156|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815157|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815158|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815159|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815160|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14815161|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14815162|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
14815163|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
14815164|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815165|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14815166|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14815167|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815168|NCT00865111|Bupropion|bupropion|mesh-list
14815169|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815170|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815171|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815172|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14815173|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815174|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815175|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815176|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
14815177|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815178|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815179|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14815180|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815181|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815182|NCT00865137|Tacrolimus|tacrolimus|mesh-list
14815183|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14815184|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
14815185|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815186|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14815187|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815188|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815189|NCT00865176|Eplerenone|eplerenone|mesh-list
15194836|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194837|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
15194838|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
15194839|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15194840|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
14696506|NCT00378196|Growth Substances|growth substances|mesh-ancestor
14696507|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696508|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
14696509|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696510|NCT00378287|Rabeprazole|rabeprazole|mesh-list
14696511|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14696512|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14696513|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14696514|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696515|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696516|NCT00378313|Gemcitabine|gemcitabine|mesh-list
14696517|NCT00378313|Paclitaxel|paclitaxel|mesh-list
14696518|NCT00378313|Epirubicin|epirubicin|mesh-list
14696519|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14696520|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696521|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696522|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696523|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696524|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696525|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696526|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
14696527|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
14696528|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696529|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696530|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696531|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
15194841|NCT03810209|Analgesics|analgesics|mesh-ancestor
15194842|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
15194843|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194844|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194845|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
15194846|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194847|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15194848|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
15194849|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15194850|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14696532|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696533|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696534|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14696535|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14696536|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
14696537|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696538|NCT00378404|Docetaxel|docetaxel|mesh-list
14696539|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696540|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696541|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696542|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696543|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696544|NCT00378417|Vaccines|vaccines|mesh-list
14696545|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
14696546|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696547|NCT00378443|Prednisone|prednisone|mesh-list
14696548|NCT00378443|Losartan|losartan|mesh-list
14696549|NCT00378443|Cilazapril|cilazapril|mesh-list
14696550|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696551|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
14696552|NCT00378443|Hormones|hormones|mesh-ancestor
14696553|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696554|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696555|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14696556|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696557|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14696558|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14696559|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14696560|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14696561|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696562|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14696563|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
14696564|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696565|NCT00378456|Vitamins|vitamins|mesh-list
14696566|NCT00378456|Leucovorin|leucovorin|mesh-list
14696567|NCT00378456|Folic Acid|folic acid|mesh-list
14696568|NCT00378456|Vitamin A|vitamin a|mesh-list
14696569|NCT00378456|Zinc|zinc|mesh-list
14696570|NCT00378456|Selenium|selenium|mesh-list
14696571|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
14696572|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
14696573|NCT00378456|Antioxidants|antioxidants|mesh-list
14696574|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
14696575|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696576|NCT00378456|Trace Elements|trace elements|mesh-ancestor
14696577|NCT00378456|Antidotes|antidotes|mesh-ancestor
14696578|NCT00378456|Protective Agents|protective agents|mesh-ancestor
14696579|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
15194851|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194852|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15194853|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
15194854|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15194855|NCT03810066|Osimertinib|osimertinib|mesh-list
15194856|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194857|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14696580|NCT00378456|Hematinics|hematinics|mesh-ancestor
14696581|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696582|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14696583|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696584|NCT00378495|Miltefosine|miltefosine|mesh-list
14696585|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
14696586|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696587|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696588|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14696589|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14696590|NCT00378547|Acetaminophen|acetaminophen|mesh-list
14696591|NCT00378547|Dexamethasone|dexamethasone|mesh-list
14696592|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
14696593|NCT00378547|Pregabalin|pregabalin|mesh-list
14696594|NCT00378547|BB 1101|bb 1101|mesh-list
14696595|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696596|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
14696597|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
14696598|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696599|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696600|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14696601|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
14696602|NCT00378547|Hormones|hormones|mesh-ancestor
14696603|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696604|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14696605|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696606|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
15194858|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194859|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194860|NCT03809949|Fentanyl|fentanyl|mesh-list
14696607|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696608|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696609|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14696610|NCT00378547|Analgesics|analgesics|mesh-ancestor
14696611|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
14696612|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
14696613|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
14696614|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14696615|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14696616|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14696617|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14696618|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14696619|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696620|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14696621|NCT00378612|Sirolimus|sirolimus|mesh-list
14696622|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14696623|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696624|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696625|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696626|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
14696627|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696628|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
14696629|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696630|NCT00378625|Artesunate|artesunate|mesh-list
14696631|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
15194861|NCT03809949|Anesthetics|anesthetics|mesh-list
15194862|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194863|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194864|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194865|NCT03809949|Narcotics|narcotics|mesh-ancestor
15194866|NCT03809949|Analgesics|analgesics|mesh-ancestor
15194867|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
14696632|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14696633|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14696634|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696635|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696636|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
14696637|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
14696638|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14696639|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
15194868|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194869|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194870|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15194871|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
15194872|NCT03809793|Acipimox|acipimox|mesh-list
15194873|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15194874|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
15194875|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194876|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15194877|NCT03809702|Pregabalin|pregabalin|mesh-list
15194878|NCT03809702|Analgesics|analgesics|mesh-ancestor
15194879|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
15194880|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194881|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194882|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
14696640|NCT00378638|Bevacizumab|bevacizumab|mesh-list
14696641|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14696642|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696643|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14696644|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14696645|NCT00378638|Growth Substances|growth substances|mesh-ancestor
14696646|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696647|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
14696648|NCT00378677|Cyclosporine|cyclosporine|mesh-list
14696649|NCT00378677|Cyclosporins|cyclosporins|mesh-list
14696650|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696651|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696652|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696653|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
14696654|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696655|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
14696656|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696657|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
14696658|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14696659|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14696660|NCT00378690|Leuprolide|leuprolide|mesh-list
14696661|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14696662|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
14696663|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14696664|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696665|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14696666|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696667|NCT00378716|Leucovorin|leucovorin|mesh-list
14696668|NCT00378716|Fluorouracil|fluorouracil|mesh-list
14696669|NCT00378716|Tegafur|tegafur|mesh-list
14696670|NCT00378716|Calcium|calcium|mesh-list
14696671|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
14696672|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14696673|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696674|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
14696675|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696676|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696677|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194883|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15194884|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14696678|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696679|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
14696680|NCT00378716|Antidotes|antidotes|mesh-ancestor
14696681|NCT00378716|Protective Agents|protective agents|mesh-ancestor
14696682|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
14696683|NCT00378716|Vitamins|vitamins|mesh-ancestor
14696684|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
14696685|NCT00378729|Metformin|metformin|mesh-list
14696686|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14696687|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696688|NCT00378755|Bortezomib|bortezomib|mesh-list
14696689|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696690|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14696691|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
14696692|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696693|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696694|NCT00378781|Minocycline|minocycline|mesh-list
14696695|NCT00378781|Heparin|heparin|mesh-list
14696696|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
14696697|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14696698|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14696699|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696700|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14696701|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728147|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728148|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
14728149|NCT00516854|Clidinium|clidinium|mesh-list
14728150|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14728151|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14728152|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728153|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728154|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14728155|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14728156|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728157|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
14728158|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
14728159|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728160|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728161|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
14728162|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
14728163|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728164|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
14728165|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14728166|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728167|NCT00516945|Lamivudine|lamivudine|mesh-list
14728168|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14728169|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14728170|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728171|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728172|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
14728173|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728174|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14728175|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14728176|NCT00516958|Levofloxacin|levofloxacin|mesh-list
14728177|NCT00516958|Ofloxacin|ofloxacin|mesh-list
14728178|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14728179|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14728180|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728181|NCT00516958|Renal Agents|renal agents|mesh-ancestor
14728182|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728183|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14728184|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14728185|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728186|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728187|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728188|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14728189|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14728190|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
14728191|NCT00516971|Esomeprazole|esomeprazole|mesh-list
14728192|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14728193|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14728194|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14728195|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728196|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728197|NCT00517062|Hormones|hormones|mesh-list
14728198|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14728199|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728200|NCT00517114|Rabeprazole|rabeprazole|mesh-list
14728201|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14696702|NCT00378820|Caseins|caseins|mesh-list
14696703|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
14696704|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
14696705|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696706|NCT00378833|Niacin|niacin|mesh-list
14696707|NCT00378833|Niacinamide|niacinamide|mesh-list
14696708|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
14696709|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14696710|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
14696711|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696712|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14696713|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
14696714|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
15194885|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194886|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15194887|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15194888|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15194889|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194890|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15194891|NCT03810261|Vitamin D|vitamin d|mesh-list
14696715|NCT00378833|Vitamins|vitamins|mesh-ancestor
14696716|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
14696717|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696718|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
14696719|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14696720|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14696721|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696722|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
14696723|NCT00378872|Coagulants|coagulants|mesh-ancestor
14696724|NCT00378911|Sunitinib|sunitinib|mesh-list
14696725|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696726|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14696727|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14696728|NCT00378911|Growth Substances|growth substances|mesh-ancestor
14696729|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696730|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14696731|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14696732|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696733|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696734|NCT00378937|Acetaminophen|acetaminophen|mesh-list
14696735|NCT00378937|Morphine|morphine|mesh-list
14696736|NCT00378937|Oxycodone|oxycodone|mesh-list
14696737|NCT00378937|Codeine|codeine|mesh-list
14696738|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
14696739|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
14696740|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14696741|NCT00378937|Narcotics|narcotics|mesh-ancestor
14696742|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14696743|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696744|NCT00378937|Analgesics|analgesics|mesh-ancestor
14696745|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
14696746|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696747|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14696748|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
14696749|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
14696750|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14696751|NCT00378976|Valacyclovir|valacyclovir|mesh-list
14696752|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
14696753|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696754|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
14696755|NCT00379015|Docetaxel|docetaxel|mesh-list
14815190|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14815191|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815192|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815193|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815194|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14815195|NCT00865176|Diuretics|diuretics|mesh-ancestor
14815196|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
14815197|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15194892|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
15194893|NCT03810261|Vitamins|vitamins|mesh-list
15194894|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
14696756|NCT00379015|Trastuzumab|trastuzumab|mesh-list
14696757|NCT00379015|Epirubicin|epirubicin|mesh-list
14696758|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696759|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
14696760|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696761|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14696762|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14696763|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
14696764|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696765|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696766|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14696767|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696768|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696769|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696770|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14696771|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696772|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14696773|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14696774|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696775|NCT00379028|Fluticasone|fluticasone|mesh-list
14696776|NCT00379028|Budesonide|budesonide|mesh-list
14696777|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
14696778|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14696779|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696780|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14696781|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
14696782|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696783|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696784|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14696785|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
14696786|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
14696787|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14696788|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
14696789|NCT00379028|Hormones|hormones|mesh-ancestor
14696790|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696791|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14696792|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14696793|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14696794|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
14696795|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696796|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696797|NCT00379041|Prednisone|prednisone|mesh-list
14696798|NCT00379041|Doxorubicin|doxorubicin|mesh-list
15194895|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194896|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15194897|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14696799|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14696800|NCT00379041|Bleomycin|bleomycin|mesh-list
14696801|NCT00379041|Vincristine|vincristine|mesh-list
14696802|NCT00379041|Vinblastine|vinblastine|mesh-list
14696803|NCT00379041|Procarbazine|procarbazine|mesh-list
14696804|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
14696805|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696806|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696807|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14696808|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14696809|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696810|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696811|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696812|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
14696813|NCT00379041|Hormones|hormones|mesh-ancestor
14696814|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696815|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696816|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14696817|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14696818|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696819|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696820|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696821|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
14696822|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14696823|NCT00379067|Tamsulosin|tamsulosin|mesh-list
15194898|NCT03809897|Nicotine|nicotine|mesh-list
15194899|NCT03809897|Varenicline|varenicline|mesh-list
15194900|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15194901|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
15194902|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194903|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194904|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15194905|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14696824|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14696825|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14696826|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14696827|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
14696828|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696829|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696830|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696831|NCT00379067|Urological Agents|urological agents|mesh-ancestor
14696832|NCT00379158|Micronutrients|micronutrients|mesh-list
14696833|NCT00379158|Trace Elements|trace elements|mesh-list
14696834|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696835|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14696836|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14696837|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14696838|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
14696839|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696840|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14696841|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14696842|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696843|NCT00379262|Fluorouracil|fluorouracil|mesh-list
14696844|NCT00379262|Capecitabine|capecitabine|mesh-list
15194906|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
15194907|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194908|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194909|NCT03809637|Pemetrexed|pemetrexed|mesh-list
15194910|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194911|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194912|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194913|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15194914|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15194915|NCT03809650|Macitentan|macitentan|mesh-list
15194916|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15194917|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15194918|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194919|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14696845|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
14696846|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696847|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14696848|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696849|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696850|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
14696851|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696852|NCT00379405|Ritonavir|ritonavir|mesh-list
14696853|NCT00379405|Saquinavir|saquinavir|mesh-list
14696854|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14696855|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14696856|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
14696857|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696858|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696859|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14696860|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15194920|NCT03809546|Dronabinol|dronabinol|mesh-list
15194921|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
15194922|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194923|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15194924|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15194925|NCT03809546|Analgesics|analgesics|mesh-ancestor
15194926|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
15194927|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194928|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15194929|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14696861|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
14696862|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696863|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14696864|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14696865|NCT00379418|Abciximab|abciximab|mesh-list
14696866|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
14696867|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14696868|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
14696869|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14696870|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14696871|NCT00379431|Prednisolone|prednisolone|mesh-list
14696872|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
14696873|NCT00379431|Rituximab|rituximab|mesh-list
14696874|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14696875|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
14696876|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14696877|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696878|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
14696879|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696880|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14696881|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696882|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
14696883|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
14696884|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696885|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14696886|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
14696887|NCT00379431|Hormones|hormones|mesh-ancestor
14696888|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696889|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14696890|NCT00379431|Protective Agents|protective agents|mesh-ancestor
14696891|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14696892|NCT00379457|Dactinomycin|dactinomycin|mesh-list
14696893|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
14696894|NCT00379457|Ifosfamide|ifosfamide|mesh-list
14696895|NCT00379457|Carboplatin|carboplatin|mesh-list
14696896|NCT00379457|Doxorubicin|doxorubicin|mesh-list
14696897|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14696898|NCT00379457|Etoposide|etoposide|mesh-list
14696899|NCT00379457|Vincristine|vincristine|mesh-list
14696900|NCT00379457|Topotecan|topotecan|mesh-list
14696901|NCT00379457|Vinorelbine|vinorelbine|mesh-list
14696902|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14696903|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
14696904|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696905|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14696906|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14696907|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
14696908|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696909|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696910|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14696911|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14696912|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14696913|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14696914|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696915|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14696916|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696917|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696918|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696919|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14696920|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14696921|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14696922|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14696923|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14696924|NCT00379483|Deferasirox|deferasirox|mesh-list
14696925|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14696926|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
14696927|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
14696928|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696929|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
14696930|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14696931|NCT00379509|Lapatinib|lapatinib|mesh-list
14696932|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696933|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14696934|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696935|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696936|NCT00379522|Vasopressins|vasopressins|mesh-list
14696937|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
14696938|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
14696939|NCT00379522|Coagulants|coagulants|mesh-ancestor
14696940|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14696941|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14696942|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
14696943|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696944|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
14696945|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14696946|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696947|NCT00379626|Hormones|hormones|mesh-list
14696948|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696949|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696950|NCT00379665|Cisplatin|cisplatin|mesh-list
14696951|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696952|NCT00379691|Phenylephrine|phenylephrine|mesh-list
14696953|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
14294605|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294606|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
15194930|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224166|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
14696954|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14696955|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
14696956|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
14696957|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14696958|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696959|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
14696960|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14696961|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
14696962|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
14696963|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14696964|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14696965|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14696966|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
14696967|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14696968|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696969|NCT00379691|Protective Agents|protective agents|mesh-ancestor
14696970|NCT00379717|Docetaxel|docetaxel|mesh-list
14696971|NCT00379717|Cisplatin|cisplatin|mesh-list
14696972|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696973|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14696974|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14696975|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14696976|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696977|NCT00379730|Prednisolone|prednisolone|mesh-list
14696978|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14696979|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
14696980|NCT00379730|Hormones|hormones|mesh-ancestor
14696981|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14696982|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696983|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14696984|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14696985|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14696986|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
14696987|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14696988|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14696989|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14696990|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696991|NCT00379756|Urological Agents|urological agents|mesh-ancestor
14696992|NCT00379847|Conivaptan|conivaptan|mesh-list
14696993|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14696994|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14696995|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
14696996|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14696997|NCT00379886|Thiopental|thiopental|mesh-list
14696998|NCT00379886|Propofol|propofol|mesh-list
14696999|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14697000|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697001|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697002|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14697003|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
14697004|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
14697005|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
14697006|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
14697007|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
14697008|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697009|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697010|NCT00379951|Ertapenem|ertapenem|mesh-list
14697011|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14697012|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697013|NCT00379964|Caspofungin|caspofungin|mesh-list
14697014|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
14697015|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697016|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697017|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697018|NCT00379977|Vaccines|vaccines|mesh-list
14697019|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
14697020|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294607|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697021|NCT00380120|Warfarin|warfarin|mesh-list
14697022|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
14697023|NCT00380133|Prednisolone|prednisolone|mesh-list
14697024|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14697025|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
14697026|NCT00380133|Hormones|hormones|mesh-ancestor
14697027|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697028|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697029|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14697030|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697031|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
14697032|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
14697033|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14697034|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
14697035|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14697036|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14697037|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697038|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14697039|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697040|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697041|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14697042|NCT00380146|Renal Agents|renal agents|mesh-ancestor
14697043|NCT00380224|Olanzapine|olanzapine|mesh-list
14815198|NCT00865215|Propranolol|propranolol|mesh-list
14815199|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14815200|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14815201|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815202|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815203|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815204|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815205|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14815206|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14815207|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
14815208|NCT00865241|Metformin|metformin|mesh-list
14815209|NCT00865241|Glyburide|glyburide|mesh-list
14815210|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815211|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815212|NCT00865267|Halobetasol|halobetasol|mesh-list
14815213|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14815214|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
14815215|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14815216|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14815217|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815218|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
14815219|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
14815220|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815221|NCT00865371|Bupropion|bupropion|mesh-list
14815222|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815223|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
15194931|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815224|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815225|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14815226|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815227|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815228|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815229|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
14815230|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815231|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815232|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14815233|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815234|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815235|NCT00865384|Mirtazapine|mirtazapine|mesh-list
14815236|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
15194932|NCT03809546|Hormones|hormones|mesh-ancestor
15194933|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15194934|NCT03809312|Amoxicillin|amoxicillin|mesh-list
15194935|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
15194936|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
15194937|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15194938|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194939|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15194940|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697044|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
14697045|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
14697046|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194941|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15194942|NCT03809442|Dexamethasone|dexamethasone|mesh-list
15194943|NCT03809442|Midazolam|midazolam|mesh-list
15194944|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
15194945|NCT03809442|Ketamine|ketamine|mesh-list
15194946|NCT03809442|Tramadol|tramadol|mesh-list
15194947|NCT03809442|Ropivacaine|ropivacaine|mesh-list
15194948|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15194949|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
15194950|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
15194951|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194952|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194953|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15194954|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
15194955|NCT03809442|Hormones|hormones|mesh-ancestor
15194956|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15194957|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15194958|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15194959|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15194960|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194961|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14697047|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697048|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697049|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14697050|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697051|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697052|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697053|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14697054|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14697055|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697056|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697057|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697058|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
14697059|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
14697060|NCT00380263|Growth Substances|growth substances|mesh-ancestor
14697061|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697062|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
14697063|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697064|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697065|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14697066|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14697067|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
14697068|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697069|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697070|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697071|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
14697072|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14697073|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14697074|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697075|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697076|NCT00380380|Vildagliptin|vildagliptin|mesh-list
14697077|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14697078|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697079|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14697080|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
15194962|NCT03809442|Analgesics|analgesics|mesh-ancestor
15194963|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
15194964|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15194965|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15194966|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15194967|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
15194968|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15194969|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194970|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15194971|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14697081|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697082|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697083|NCT00380406|Leuprolide|leuprolide|mesh-list
14697084|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14697085|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
14697086|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14697087|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697088|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14697089|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697090|NCT00380445|Vildagliptin|vildagliptin|mesh-list
14697091|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14697092|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697093|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14697094|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
14697095|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697096|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697097|NCT00380484|Budesonide|budesonide|mesh-list
14697098|NCT00380484|Montelukast|montelukast|mesh-list
14697099|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14697100|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14697101|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
14697102|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697103|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697104|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14697105|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
14697106|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
14697107|NCT00380484|Hormones|hormones|mesh-ancestor
14697108|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697109|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14697110|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
14697111|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14697112|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14697113|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728202|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14728203|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14728204|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728205|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729372|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14729373|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14729374|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14729375|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729376|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729377|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14729378|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14729379|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14729380|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
14729381|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729382|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729383|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729384|NCT00523068|Urological Agents|urological agents|mesh-ancestor
14729385|NCT00523120|Diclofenac|diclofenac|mesh-list
14729386|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14729387|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14729388|NCT00523120|Analgesics|analgesics|mesh-ancestor
14729389|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
14729390|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729391|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729392|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729393|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729394|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14729395|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729396|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729397|NCT00523133|Naltrexone|naltrexone|mesh-list
14729398|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14729399|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14729400|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729401|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
14729402|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729403|NCT00523159|Sargramostim|sargramostim|mesh-list
14729404|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
14697114|NCT00380575|Conivaptan|conivaptan|mesh-list
14697115|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14697116|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697117|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
14697118|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697119|NCT00380614|Lamivudine|lamivudine|mesh-list
14697120|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14697121|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14697122|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697123|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194972|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
14697124|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
14697125|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697126|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14697127|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14697128|NCT00380640|Trimethoprim|trimethoprim|mesh-list
14697129|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14697130|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697131|NCT00380640|Renal Agents|renal agents|mesh-ancestor
14697132|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
14697133|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14697134|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14697135|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14697136|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697137|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697138|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14697139|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14697140|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14697141|NCT00380679|Vaccines|vaccines|mesh-list
14697142|NCT00380679|Immunologic Factors|immunologic factors|mesh-ancestor
14697143|NCT00380679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697144|NCT00380770|Lamivudine|lamivudine|mesh-list
14697145|NCT00380770|Stavudine|stavudine|mesh-list
14697146|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
14294608|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294609|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14294610|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
14294611|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294612|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294613|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294614|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14294615|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
14294616|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14294617|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14294618|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
14294619|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
14294620|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294621|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14294622|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14294623|NCT00577122|Progestins|progestins|mesh-ancestor
14294624|NCT00577122|Hormones|hormones|mesh-ancestor
14294625|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14294626|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14294627|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14294628|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14294629|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
14697147|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15194973|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
15194974|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15194975|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15194976|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
15194977|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194978|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15194979|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697148|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14697149|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697150|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697151|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
14697152|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697153|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14697154|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14697155|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
15194980|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15194981|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
14697156|NCT00380822|Miglitol|miglitol|mesh-list
14697157|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697158|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697159|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14697160|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697161|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14697162|NCT00380835|Amrubicin|amrubicin|mesh-list
14697163|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697164|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14697165|NCT00380887|Estrogens|estrogens|mesh-ancestor
14697166|NCT00380887|Hormones|hormones|mesh-ancestor
14697167|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697168|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697169|NCT00380913|Nabilone|nabilone|mesh-list
14697170|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
14697171|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
14697172|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815237|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815238|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14815239|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
14815240|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
14815241|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815242|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815243|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815244|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14815245|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815246|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815247|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14815248|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14815249|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14815250|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815251|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14815252|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14815253|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
14815254|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14815255|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
14815256|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815257|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815258|NCT00865410|Bupropion|bupropion|mesh-list
14815259|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815260|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815261|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815262|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14815263|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815264|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815265|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815266|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
14815267|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815268|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815269|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14815270|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815271|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815272|NCT00865423|Gabapentin|gabapentin|mesh-list
14815273|NCT00865423|Analgesics|analgesics|mesh-ancestor
14815274|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
14815275|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815276|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815277|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
14815278|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14815279|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815280|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815281|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815282|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14815283|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14815284|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815285|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15194982|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
15194983|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194984|NCT03809442|Narcotics|narcotics|mesh-ancestor
15194985|NCT03809455|Fentanyl|fentanyl|mesh-list
15194986|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15194987|NCT03809455|Narcotics|narcotics|mesh-ancestor
14697173|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697174|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697175|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14697176|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697177|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194988|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15194989|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15194990|NCT03809455|Analgesics|analgesics|mesh-ancestor
15194991|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
15194992|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194993|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15194994|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14697178|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697179|NCT00380939|Atorvastatin|atorvastatin|mesh-list
14697180|NCT00380939|Pravastatin|pravastatin|mesh-list
14697181|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14697182|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14697183|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
14697184|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697185|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14697186|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14697187|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697188|NCT00380965|Nabilone|nabilone|mesh-list
14697189|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
14697190|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
14697191|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697192|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697193|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697194|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14697195|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697196|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697197|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697198|NCT00381017|Interferons|interferons|mesh-list
14697199|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
14697200|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
14697201|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14697202|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697203|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
14697204|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697205|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
14697206|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697207|NCT00381030|Carvedilol|carvedilol|mesh-list
14697208|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14697209|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14697210|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
14697211|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697212|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697213|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697214|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14697215|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
14697216|NCT00381030|Protective Agents|protective agents|mesh-ancestor
14697217|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14697218|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697219|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14697220|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
14697221|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14697222|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14697223|NCT00381134|Losartan|losartan|mesh-list
14697224|NCT00381134|Spironolactone|spironolactone|mesh-list
14697225|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14697226|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14697227|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14697228|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14697229|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697230|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14697231|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
14697232|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697233|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697234|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14697235|NCT00381134|Diuretics|diuretics|mesh-ancestor
14697236|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
14697237|NCT00381147|Clarithromycin|clarithromycin|mesh-list
14697238|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14697239|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15194995|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
14697240|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14697241|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697242|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697243|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14697244|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14697245|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
14697246|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14697247|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
14697248|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697249|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14697250|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14697251|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
14697252|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697253|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697254|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14697255|NCT00381199|Amitriptyline|amitriptyline|mesh-list
14697256|NCT00381199|Nabilone|nabilone|mesh-list
14697257|NCT00381199|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14697258|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14697259|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
14697260|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697261|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14697262|NCT00381199|Analgesics|analgesics|mesh-ancestor
14697263|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
14697264|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697265|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697266|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14697267|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14697268|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697269|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697270|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
14697271|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697272|NCT00381199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14697273|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697274|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697275|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
14697276|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
14697277|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697278|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14697279|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14697280|NCT00381251|Estrogens|estrogens|mesh-ancestor
14697281|NCT00381251|Hormones|hormones|mesh-ancestor
14697282|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697283|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697284|NCT00381264|Nabilone|nabilone|mesh-list
14697285|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
14697286|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
14697287|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697288|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697289|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697290|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14697291|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697292|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697293|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697294|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
14697295|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14697296|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697297|NCT00381342|Exenatide|exenatide|mesh-list
14697298|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14697299|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697300|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14697301|NCT00381342|Incretins|incretins|mesh-ancestor
14697302|NCT00381342|Hormones|hormones|mesh-ancestor
14697303|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697304|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
14697305|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14697306|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697307|NCT00381472|Ropinirole|ropinirole|mesh-list
14697308|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14697309|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14697310|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
14697311|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
14697312|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815286|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
14697313|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697314|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697315|NCT00381511|Heparin|heparin|mesh-list
14697316|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14697317|NCT00381511|Tinzaparin|tinzaparin|mesh-list
14697318|NCT00381511|Dalteparin|dalteparin|mesh-list
14697319|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
14697320|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14697321|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14697322|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697323|NCT00381537|Carbamazepine|carbamazepine|mesh-list
14697324|NCT00381537|Phenobarbital|phenobarbital|mesh-list
14697325|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
14697326|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
14697327|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697328|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697329|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697330|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697331|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14697332|NCT00381537|Analgesics|analgesics|mesh-ancestor
14697333|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
14697334|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15194996|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
15194997|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15194998|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14697335|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14697336|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697337|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697338|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14697339|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14697340|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14697341|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14697342|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14697343|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697344|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
14697345|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
14697346|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14697347|NCT00381589|Bromides|bromides|mesh-list
14697348|NCT00381589|Ipratropium|ipratropium|mesh-list
14697349|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
14697350|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14697351|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
14697352|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697353|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697354|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14697355|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
14697356|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14697357|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
14697358|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697359|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697360|NCT00381654|MP 412|mp 412|mesh-list
14697361|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697362|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14697363|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697364|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697365|NCT00381732|Tadalafil|tadalafil|mesh-list
14697366|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
14697367|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14697368|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14697369|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697370|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697371|NCT00381732|Urological Agents|urological agents|mesh-ancestor
14815287|NCT00865436|Metformin|metformin|mesh-list
14815288|NCT00865436|Glyburide|glyburide|mesh-list
14815289|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815290|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815291|NCT00865449|Spironolactone|spironolactone|mesh-list
15194999|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15195000|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195001|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195002|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15195003|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14697372|NCT00381758|Methylphenidate|methylphenidate|mesh-list
14815292|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15195004|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15195005|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
15195006|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195007|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195008|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15195009|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15195010|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
15195011|NCT03809260|Metformin|metformin|mesh-list
15195012|NCT03809260|Vancomycin|vancomycin|mesh-list
15195013|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15195014|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195015|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15195016|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697373|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14697374|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697375|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14697376|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14697377|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697378|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697379|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
14697380|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697381|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
14697382|NCT00381836|Hematinics|hematinics|mesh-ancestor
14697383|NCT00381875|Sargramostim|sargramostim|mesh-list
14697384|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
14697385|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
14697386|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697387|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14697388|NCT00381901|Trastuzumab|trastuzumab|mesh-list
14697389|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14697390|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697391|NCT00381914|Vitamin D|vitamin d|mesh-list
14697392|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
14697393|NCT00381914|Vitamins|vitamins|mesh-list
14697394|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
14697395|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697396|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14697397|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14697398|NCT00381953|Interferons|interferons|mesh-list
14697399|NCT00381953|Ribavirin|ribavirin|mesh-list
14697400|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
14697401|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
14697402|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14697403|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697404|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
14697405|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697406|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
14697407|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697408|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
14697409|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697410|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
14697411|NCT00382044|Hematinics|hematinics|mesh-ancestor
14697412|NCT00382057|Anastrozole|anastrozole|mesh-list
14697413|NCT00382057|Goserelin|goserelin|mesh-list
14697414|NCT00382057|Testosterone|testosterone|mesh-list
14697415|NCT00382057|Androgens|androgens|mesh-ancestor
14697416|NCT00382057|Hormones|hormones|mesh-ancestor
14697417|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697418|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697419|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14697420|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697421|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14697422|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14697423|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697424|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697425|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14697426|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
14697427|NCT00382083|Acetaminophen|acetaminophen|mesh-list
14697428|NCT00382083|Ibuprofen|ibuprofen|mesh-list
14697429|NCT00382083|Lidocaine|lidocaine|mesh-list
14697430|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195017|NCT03809273|Trimetazidine|trimetazidine|mesh-list
14697431|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
14697432|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697433|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697434|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
14697435|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195018|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
15195019|NCT03809065|Labetalol|labetalol|mesh-list
14697436|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14697437|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14697438|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14697439|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697440|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697441|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14697442|NCT00382083|Analgesics|analgesics|mesh-ancestor
14697443|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
14697444|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14697445|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14697446|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14697447|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14697448|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697449|NCT00382135|Tadalafil|tadalafil|mesh-list
14697450|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
14697451|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14697452|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14697453|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697454|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697455|NCT00382135|Urological Agents|urological agents|mesh-ancestor
14697456|NCT00382200|Decitabine|decitabine|mesh-list
14697457|NCT00382200|Tretinoin|tretinoin|mesh-list
14697458|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14697459|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
14697460|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697461|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697462|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697463|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
14697464|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
15195020|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
15195021|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
15195022|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15195023|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15195024|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
15195025|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195026|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195027|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195028|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15195029|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
15195030|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
15195031|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195032|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15195033|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15195034|NCT03809143|Buprenorphine|buprenorphine|mesh-list
14294630|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14294631|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15195035|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195036|NCT03809143|Narcotics|narcotics|mesh-ancestor
14697465|NCT00382213|Olmesartan|olmesartan|mesh-list
14697466|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14697467|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14697468|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14697469|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14697470|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697471|NCT00382239|Exenatide|exenatide|mesh-list
14697472|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14294632|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14294633|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14294634|NCT00577135|Furosemide|furosemide|mesh-list
14697473|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697474|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14697475|NCT00382239|Incretins|incretins|mesh-ancestor
14697476|NCT00382239|Hormones|hormones|mesh-ancestor
14697477|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697478|NCT00382330|Ciclopirox|ciclopirox|mesh-list
14697479|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
14697480|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697481|NCT00382343|Trimethoprim|trimethoprim|mesh-list
14697482|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14697483|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
14697484|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14697485|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697486|NCT00382343|Renal Agents|renal agents|mesh-ancestor
15195037|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697487|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
14697488|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14697489|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14697490|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14697491|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697492|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697493|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14697494|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14697495|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14697496|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14697497|NCT00382356|Dutasteride|dutasteride|mesh-list
14697498|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14697499|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14697500|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697501|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697502|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
14697503|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697504|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697505|NCT00382421|Aspirin|aspirin|mesh-list
14697506|NCT00382421|Amlodipine|amlodipine|mesh-list
14697507|NCT00382421|Bisoprolol|bisoprolol|mesh-list
14697508|NCT00382421|Molsidomine|molsidomine|mesh-list
14697509|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14697510|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14697511|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697512|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697513|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14697514|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697515|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
14697516|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14697517|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14697518|NCT00382421|Analgesics|analgesics|mesh-ancestor
14697519|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
14697520|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697521|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14697522|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14697523|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14697524|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14697525|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14697526|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14697527|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195038|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195039|NCT03809143|Analgesics|analgesics|mesh-ancestor
15195040|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
15195041|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195042|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15195043|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15195044|NCT03809221|Hormones|hormones|mesh-list
15195045|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15195046|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697528|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
14697529|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
14697530|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
14697531|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15195047|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195048|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
15195049|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15195050|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
15195051|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15195052|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15195053|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15195054|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195055|NCT03809156|Ambrisentan|ambrisentan|mesh-list
15195056|NCT03809156|Riociguat|riociguat|mesh-list
15195057|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
15195058|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195059|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15195060|NCT03808844|Propofol|propofol|mesh-list
15195061|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15195062|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195063|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195064|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14697532|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14697533|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14697534|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
14697535|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697536|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14728206|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14728207|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
14728208|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14728209|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15195065|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
15195066|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
15195067|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15195068|NCT03809078|Bombesin|bombesin|mesh-list
15195069|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15195070|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195071|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195072|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195073|NCT03808818|Nicotine|nicotine|mesh-list
15195074|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15195075|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
15195076|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195077|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195078|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15195079|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15195080|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
15195081|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195082|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195083|NCT03808805|Aprepitant|aprepitant|mesh-list
14728210|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728211|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728212|NCT00517179|Urological Agents|urological agents|mesh-ancestor
14728213|NCT00517218|Oblimersen|oblimersen|mesh-list
14728214|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728215|NCT00517257|Atorvastatin|atorvastatin|mesh-list
14728216|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14728217|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14728218|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
14728219|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728220|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14728221|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14728222|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728223|NCT00517270|Rabeprazole|rabeprazole|mesh-list
14728224|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14728225|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14728226|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14728227|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728228|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728229|NCT00517283|Exenatide|exenatide|mesh-list
14728230|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14728231|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728232|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14728233|NCT00517283|Incretins|incretins|mesh-ancestor
14728234|NCT00517283|Hormones|hormones|mesh-ancestor
14728235|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14728236|NCT00517309|Vaccines|vaccines|mesh-list
14728237|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
14728238|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728239|NCT00517322|Ramipril|ramipril|mesh-list
14728240|NCT00517322|Irbesartan|irbesartan|mesh-list
14728241|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14728242|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
14728243|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728244|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195084|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
14697537|NCT00382499|Lidocaine|lidocaine|mesh-list
14697538|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
14697539|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
14697540|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697541|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697542|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
14697543|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697544|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14697545|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14697546|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15195085|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
15195086|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
15195087|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
15195088|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195089|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195090|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195091|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14697547|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697548|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697549|NCT00382538|Mifepristone|mifepristone|mesh-list
14697550|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14697551|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
14697552|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14697553|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697554|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14697555|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14697556|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15195092|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195093|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195094|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
15195095|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
15195096|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15195097|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
15195098|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
15195099|NCT03808649|Mannitol|mannitol|mesh-list
15195100|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15195101|NCT03808649|Diuretics|diuretics|mesh-ancestor
15195102|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
15195103|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697557|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
14697558|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14697559|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14697560|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
14697561|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697562|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
14697563|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14697564|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14697565|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
14697566|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
14697567|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294635|NCT00577135|Diuretics|diuretics|mesh-list
14697568|NCT00382629|Protective Agents|protective agents|mesh-ancestor
15195104|NCT03808168|Nivolumab|nivolumab|mesh-list
15195105|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14697569|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697570|NCT00382642|Ondansetron|ondansetron|mesh-list
14697571|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
14697572|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
14697573|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697574|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697575|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697576|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
14697577|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
14697578|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14697579|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
15195106|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195107|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15195108|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195109|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
15195110|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15195111|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
15195112|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195113|NCT03808259|Ketamine|ketamine|mesh-list
15195114|NCT03808259|Esketamine|esketamine|mesh-list
15195115|NCT03808259|Analgesics|analgesics|mesh-ancestor
15195116|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
15195117|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195118|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195119|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15195120|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15195121|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
15195122|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
15195123|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195124|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15195125|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15195126|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195127|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195128|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
15195129|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224167|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15224168|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
15224169|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224170|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
15224171|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224172|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224173|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15224174|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
15224175|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224176|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224177|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15224178|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224179|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15224180|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15224181|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15224182|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224183|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224184|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
15224185|NCT04479267|Hormones|hormones|mesh-ancestor
15224186|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224187|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224188|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
15224189|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
15224190|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224191|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224192|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14697580|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697581|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697582|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14697583|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697584|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697585|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697586|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14697587|NCT00382668|Dasatinib|dasatinib|mesh-list
14697588|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697589|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14697590|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697591|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697592|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14697593|NCT00382694|Fludarabine|fludarabine|mesh-list
14697594|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697595|NCT00382837|Epratuzumab|epratuzumab|mesh-list
14697596|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195130|NCT03808129|Lidocaine|lidocaine|mesh-list
15195131|NCT03808129|Bupivacaine|bupivacaine|mesh-list
15195132|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195133|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
15195134|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195135|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195136|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
14697597|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697598|NCT00382889|Beclomethasone|beclomethasone|mesh-list
14697599|NCT00382889|Albuterol|albuterol|mesh-list
14697600|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14697601|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
14697602|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697603|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195137|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195138|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15195139|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14697604|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14697605|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
14697606|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
14697607|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14697608|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14697609|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14697610|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14697611|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
14697612|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697613|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697614|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14697615|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
14697616|NCT00382889|Hormones|hormones|mesh-ancestor
14697617|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697618|NCT00382954|Bortezomib|bortezomib|mesh-list
14697619|NCT00382954|Idarubicin|idarubicin|mesh-list
14697620|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697621|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14697622|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14697623|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14697624|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697625|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697626|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14697627|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14697628|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
14697629|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697630|NCT00382980|Antacids|antacids|mesh-ancestor
14697631|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697632|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697633|NCT00383032|Mifepristone|mifepristone|mesh-list
14697634|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15195140|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15195141|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195142|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195143|NCT03808155|Tamsulosin|tamsulosin|mesh-list
15195144|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15195145|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15195146|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15195147|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
15195148|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195149|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195150|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195151|NCT03808155|Urological Agents|urological agents|mesh-ancestor
15195152|NCT03807999|Gemcitabine|gemcitabine|mesh-list
15195153|NCT03807999|Paclitaxel|paclitaxel|mesh-list
15195154|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15195155|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195156|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
15195157|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
15195158|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
15224193|NCT04479267|Protective Agents|protective agents|mesh-ancestor
14697635|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
14697636|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14697637|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697638|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14697639|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14697640|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14697641|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
14697642|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14697643|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14697644|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
14697645|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697646|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
14815293|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815294|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815295|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815296|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14815297|NCT00865449|Diuretics|diuretics|mesh-ancestor
14815298|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
14815299|NCT00865462|Bupropion|bupropion|mesh-list
14815300|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815301|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815302|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815303|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14815304|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815305|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815306|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815307|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
14815308|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815309|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815310|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14815311|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815312|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815313|NCT00865475|Lopinavir|lopinavir|mesh-list
14815314|NCT00865475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14815315|NCT00865475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14815316|NCT00865475|Protease Inhibitors|protease inhibitors|mesh-ancestor
14815317|NCT00865475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815318|NCT00865475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815319|NCT00865475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14815320|NCT00865475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14815321|NCT00865475|Antiviral Agents|antiviral agents|mesh-ancestor
14815322|NCT00865475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815323|NCT00865475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14815324|NCT00865475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815325|NCT00865501|Spironolactone|spironolactone|mesh-list
14815326|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14815327|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815328|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815329|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815330|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14815331|NCT00865501|Diuretics|diuretics|mesh-ancestor
14815332|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
14815333|NCT00865540|Prednisolone|prednisolone|mesh-list
14815334|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14815335|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
14815336|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14815337|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
14815338|NCT00865540|Ketorolac|ketorolac|mesh-list
14815339|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14815340|NCT00865540|Nepafenac|nepafenac|mesh-list
14815341|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14815342|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
14815343|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14815344|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
14815345|NCT00865540|Hormones|hormones|mesh-ancestor
14815346|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815347|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815348|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14815349|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815350|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
14815351|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
15224194|NCT04471597|Bupivacaine|bupivacaine|mesh-list
14697647|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15195159|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195160|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15195161|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
15195162|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
15195163|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195164|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195165|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15195166|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
15195167|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195168|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
15195169|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15195170|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
15195171|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195172|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
15195173|NCT03807596|Protective Agents|protective agents|mesh-ancestor
15195174|NCT03807843|Vaccines|vaccines|mesh-list
15195175|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
15195176|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195177|NCT03807882|Clozapine|clozapine|mesh-list
14697648|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14697649|NCT00383045|Naltrexone|naltrexone|mesh-list
14697650|NCT00383045|Buprenorphine|buprenorphine|mesh-list
14697651|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14697652|NCT00383045|Narcotics|narcotics|mesh-ancestor
14697653|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697654|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697655|NCT00383045|Analgesics|analgesics|mesh-ancestor
14697656|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
14697657|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697658|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14697659|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14697660|NCT00383136|Tirofiban|tirofiban|mesh-list
14697661|NCT00383136|Abciximab|abciximab|mesh-list
14697662|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
14697663|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14697664|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15195178|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15195179|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
15195180|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195181|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195182|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697665|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14697666|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697667|NCT00383214|Epratuzumab|epratuzumab|mesh-list
14697668|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14697669|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697670|NCT00383357|Zolpidem|zolpidem|mesh-list
14697671|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14697672|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14697673|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697674|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697675|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14294636|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14294637|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
14294638|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294639|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294640|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294641|NCT00577382|Sunitinib|sunitinib|mesh-list
14294642|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294643|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14697676|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
14697677|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
15195183|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15195184|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15195185|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195186|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15195187|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
15195188|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
15195189|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
15195190|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
15195191|NCT03807297|Propofol|propofol|mesh-list
15195192|NCT03807297|Sevoflurane|sevoflurane|mesh-list
15195193|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14697678|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697679|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697680|NCT00383370|Aflibercept|aflibercept|mesh-list
14697681|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14697682|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14697683|NCT00383370|Growth Substances|growth substances|mesh-ancestor
14697684|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697685|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
14697686|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697687|NCT00383396|Cyclosporine|cyclosporine|mesh-list
14697688|NCT00383396|Cyclosporins|cyclosporins|mesh-list
14697689|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697690|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697691|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14697692|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
14697693|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697694|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
14697695|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697696|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
14697697|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14697698|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14697699|NCT00383474|Bortezomib|bortezomib|mesh-list
14697700|NCT00383474|Tipifarnib|tipifarnib|mesh-list
14697701|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697702|NCT00383487|Calcitriol|calcitriol|mesh-list
14697703|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14697704|NCT00383487|Naproxen|naproxen|mesh-list
14697705|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
15195194|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195195|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697706|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14697707|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14697708|NCT00383487|Analgesics|analgesics|mesh-ancestor
14697709|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
14697710|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697711|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697712|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14697713|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14697714|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
14697715|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14697716|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697717|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697718|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14697719|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14697720|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697721|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14697722|NCT00383487|Vitamins|vitamins|mesh-ancestor
14697723|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
14697724|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14697725|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14697726|NCT00383526|Vaccines|vaccines|mesh-list
14697727|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
14697728|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697729|NCT00383539|Vaccines|vaccines|mesh-list
14697730|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
14697731|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697732|NCT00383591|Vaccines|vaccines|mesh-list
14697733|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
14697734|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697735|NCT00383656|Hormones|hormones|mesh-list
14697736|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697737|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697738|NCT00383682|Mexiletine|mexiletine|mesh-list
14697739|NCT00383682|Morphine|morphine|mesh-list
14697740|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14697741|NCT00383682|Narcotics|narcotics|mesh-ancestor
14697742|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195196|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15195197|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
15195198|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
15195199|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195200|NCT03807297|Analgesics|analgesics|mesh-ancestor
15195201|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
15195202|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195203|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14697743|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697744|NCT00383682|Analgesics|analgesics|mesh-ancestor
15195204|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15195205|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15195206|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
15195207|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195208|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195209|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14697745|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
14697746|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697747|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14697748|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14697749|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14697750|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697751|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697752|NCT00383695|Capecitabine|capecitabine|mesh-list
14697753|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
14697754|NCT00383695|Cetuximab|cetuximab|mesh-list
14697755|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14697756|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
14697757|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697758|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697759|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14697760|NCT00383708|Lanreotide|lanreotide|mesh-list
14697761|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697762|NCT00383799|Amiodarone|amiodarone|mesh-list
14697763|NCT00383799|Procainamide|procainamide|mesh-list
14697764|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14697765|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
14697766|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14697767|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697768|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697769|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14697770|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14697771|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14697772|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697773|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14697774|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14697775|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14697776|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14697777|NCT00383812|Bevacizumab|bevacizumab|mesh-list
14697778|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14697779|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697780|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14697781|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14697782|NCT00383812|Growth Substances|growth substances|mesh-ancestor
14697783|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697784|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
14697785|NCT00383851|Temozolomide|temozolomide|mesh-list
14697786|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14697787|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14697788|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
14697789|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697790|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697791|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
14697792|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
14697793|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697794|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15195210|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15195211|NCT03807271|Anesthetics|anesthetics|mesh-list
15195212|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195213|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195214|NCT03807479|Ponatinib|ponatinib|mesh-list
15195215|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195216|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15195217|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195218|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697795|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14697796|NCT00383851|Growth Substances|growth substances|mesh-ancestor
14697797|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195219|NCT03806985|Psilocybin|psilocybin|mesh-list
15195220|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
15195221|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195222|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15195223|NCT03806816|Melatonin|melatonin|mesh-list
15195224|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
15195225|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195226|NCT03806816|Protective Agents|protective agents|mesh-ancestor
15195227|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195228|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195229|NCT03807011|Fentanyl|fentanyl|mesh-list
15195230|NCT03807011|Remifentanil|remifentanil|mesh-list
15195231|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195232|NCT03807011|Narcotics|narcotics|mesh-ancestor
15195233|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195234|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195235|NCT03807011|Analgesics|analgesics|mesh-ancestor
15195236|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
15195237|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195238|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15195239|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15195240|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
15195241|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
14697798|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
14697799|NCT00383864|Interferons|interferons|mesh-list
14697800|NCT00383864|Ribavirin|ribavirin|mesh-list
14697801|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697802|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
14697803|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697804|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
14697805|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697806|NCT00383877|Insulin|insulin|mesh-list
14697807|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14697808|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
14697809|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
14697810|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
14697811|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
14697812|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14697813|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697814|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
14697815|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14697816|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697817|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697818|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14697819|NCT00383890|Analgesics|analgesics|mesh-ancestor
14697820|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
15195242|NCT03806673|Bupivacaine|bupivacaine|mesh-list
15195243|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
14697821|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697822|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14697823|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14697824|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14697825|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
14697826|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697827|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697828|NCT00383916|Pantoprazole|pantoprazole|mesh-list
14697829|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14697830|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697831|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14697832|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697833|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697834|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14697835|NCT00383929|Candesartan|candesartan|mesh-list
14697836|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
14697837|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14697838|NCT00383929|Diuretics|diuretics|mesh-ancestor
14697839|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
14697840|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697841|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14697842|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697843|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697844|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14697845|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14697846|NCT00383994|Rituximab|rituximab|mesh-list
14697847|NCT00383994|Sargramostim|sargramostim|mesh-list
14697848|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14697849|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697850|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
14697851|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697852|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14697853|NCT00384020|Citalopram|citalopram|mesh-list
14697854|NCT00384020|Paroxetine|paroxetine|mesh-list
14697855|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14697856|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14697857|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697858|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697859|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697860|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
14697861|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697862|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14697863|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
14697864|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697865|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14697866|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14697867|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697868|NCT00384046|Testosterone|testosterone|mesh-list
14697869|NCT00384046|Androgens|androgens|mesh-ancestor
14697870|NCT00384046|Hormones|hormones|mesh-ancestor
14697871|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697872|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697873|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
14697874|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14697875|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14697876|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
14697877|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697878|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697879|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14697880|NCT00384124|Imiquimod|imiquimod|mesh-list
14697881|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14697882|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
14697883|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697884|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697885|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
14697886|NCT00384137|Tacrolimus|tacrolimus|mesh-list
14697887|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14697888|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
14697889|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697890|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14697891|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697892|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697893|NCT00384202|Tacrolimus|tacrolimus|mesh-list
14697894|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14697895|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
14697896|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697897|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14697898|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697899|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697900|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
14697901|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14697902|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697903|NCT00384280|Rifampin|rifampin|mesh-list
14697904|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14697905|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
14697906|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14697907|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697908|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
14697909|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14697910|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14697911|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697912|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14697913|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14697914|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14697915|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14697916|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14697917|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14697918|NCT00384306|Prednisolone|prednisolone|mesh-list
14697919|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14697920|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
14697921|NCT00384306|Hormones|hormones|mesh-ancestor
14697922|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697923|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697924|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14697925|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697926|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
14815352|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815353|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14815354|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14815355|NCT00865540|Protective Agents|protective agents|mesh-ancestor
14815356|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14815357|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14815358|NCT00865540|Analgesics|analgesics|mesh-ancestor
14815359|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
14815360|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14815361|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14815362|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815363|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815364|NCT00865605|Clobetasol|clobetasol|mesh-list
14815365|NCT00865605|Halobetasol|halobetasol|mesh-list
14815366|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14815367|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14815368|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
14815369|NCT00865605|Hormones|hormones|mesh-ancestor
14815370|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815371|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815372|NCT00865618|Eplerenone|eplerenone|mesh-list
14815373|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14815374|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815375|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815376|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815377|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15195244|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
15195245|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195246|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195247|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
15195248|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195249|NCT03806595|Lidocaine|lidocaine|mesh-list
14697927|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14697928|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14697929|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14697930|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697931|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697932|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
14697933|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697934|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697935|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14697936|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728245|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14728246|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14728247|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14728248|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14728249|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
14728250|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728251|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14728252|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14728253|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728254|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728255|NCT00517426|Acetazolamide|acetazolamide|mesh-list
14728256|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
14728257|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14728258|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728259|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728260|NCT00517426|Diuretics|diuretics|mesh-ancestor
14728261|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
14728262|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728263|NCT00517491|Lanreotide|lanreotide|mesh-list
15195250|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15195251|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195252|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
15195253|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195254|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195255|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
15195256|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195257|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15195258|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15195259|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15195260|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195261|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195262|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
15195263|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15195264|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195265|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195266|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195267|NCT03806777|Analgesics|analgesics|mesh-ancestor
15195268|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
15195269|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195270|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15195271|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14728264|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728265|NCT00517504|Methylphenidate|methylphenidate|mesh-list
14728266|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14728267|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728268|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14728269|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14728270|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728271|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728272|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
14728273|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728274|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
15195272|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15195273|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
15195274|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728275|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
14728276|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
14728277|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728278|NCT00517582|Icatibant|icatibant|mesh-list
14728279|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14728280|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14728281|NCT00517582|Analgesics|analgesics|mesh-ancestor
14728282|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
14728283|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728284|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728285|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14728286|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728287|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14697937|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
14697938|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15195275|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195276|NCT03807037|Tocotrienols|tocotrienols|mesh-list
15195277|NCT03807037|Vitamin E|vitamin e|mesh-list
14697939|NCT00384410|Nabilone|nabilone|mesh-list
14697940|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
14697941|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
14697942|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697943|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697944|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14697945|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14697946|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14697947|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14697948|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697949|NCT00384436|Citalopram|citalopram|mesh-list
14697950|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14697951|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14697952|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14697953|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697954|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697955|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
14697956|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697957|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14697958|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
14697959|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14697960|NCT00384475|Ciclesonide|ciclesonide|mesh-list
14697961|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
14697962|NCT00384475|Hormones|hormones|mesh-ancestor
14697963|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14697964|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697965|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14697966|NCT00384527|Vancomycin|vancomycin|mesh-list
14697967|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
14697968|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14697969|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14697970|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14697971|NCT00384540|Dobutamine|dobutamine|mesh-list
14697972|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14697973|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
14697974|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
14697975|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697976|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697977|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14697978|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14697979|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14697980|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14697981|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14697982|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14697983|NCT00384540|Protective Agents|protective agents|mesh-ancestor
14697984|NCT00384553|Rituximab|rituximab|mesh-list
14697985|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14697986|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14697987|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
14697988|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697989|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14697990|NCT00384566|Metoprolol|metoprolol|mesh-list
14697991|NCT00384566|Carvedilol|carvedilol|mesh-list
14697992|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14697993|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14697994|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
14697995|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
14697996|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14697997|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14697998|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14697999|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14698000|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14698001|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
14698002|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698003|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698004|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
14698005|NCT00384566|Protective Agents|protective agents|mesh-ancestor
14698006|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14698007|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195278|NCT03807037|Tocopherols|tocopherols|mesh-list
14698008|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14698009|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
14698010|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14698011|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14698012|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
14698013|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14698014|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14698015|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698016|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
14698017|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698018|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698019|NCT00384592|Esomeprazole|esomeprazole|mesh-list
14698020|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14698021|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698022|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14698023|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698024|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698025|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14698026|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14698027|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14698028|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195279|NCT03807037|Tocovid|tocovid|mesh-list
15195280|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
15195281|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195282|NCT03807037|Protective Agents|protective agents|mesh-ancestor
14698029|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698030|NCT00384605|Hormones|hormones|mesh-ancestor
14698031|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698032|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698033|NCT00384618|Vitamin E|vitamin e|mesh-list
14698034|NCT00384618|Pravastatin|pravastatin|mesh-list
14698035|NCT00384618|Vitamins|vitamins|mesh-ancestor
14698036|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
14698037|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698038|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
14698039|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698040|NCT00384618|Protective Agents|protective agents|mesh-ancestor
14698041|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14698042|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14698043|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
14698044|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14698045|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14698046|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698047|NCT00384631|Bevacizumab|bevacizumab|mesh-list
14698048|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698049|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698050|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698051|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698052|NCT00384631|Growth Substances|growth substances|mesh-ancestor
14698053|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698054|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698055|NCT00384657|Iron|iron|mesh-list
14698056|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14698057|NCT00384657|Trace Elements|trace elements|mesh-ancestor
14698058|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
14698059|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698060|NCT00384657|Hematinics|hematinics|mesh-ancestor
14698061|NCT00384696|Nicotine|nicotine|mesh-list
14698062|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14698063|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
14698064|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815378|NCT00865618|Diuretics|diuretics|mesh-ancestor
14815379|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
14815380|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14815381|NCT00865631|Gabapentin|gabapentin|mesh-list
14815382|NCT00865631|Analgesics|analgesics|mesh-ancestor
14815383|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
14815384|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815385|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815386|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
14815387|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14815388|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815389|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698065|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698066|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14698067|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14698068|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
14698069|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698070|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698071|NCT00384800|Thalidomide|thalidomide|mesh-list
14698072|NCT00384800|Tegafur|tegafur|mesh-list
15195283|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195284|NCT03807037|Vitamins|vitamins|mesh-ancestor
15195285|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
15195286|NCT03806582|Norepinephrine|norepinephrine|mesh-list
15195287|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15195288|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14698073|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698074|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
14698075|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815390|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815391|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14815392|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14815393|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815394|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195289|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
15195290|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195291|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195292|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195293|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
15195294|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
15195295|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195296|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15195297|NCT03806530|Gabapentin|gabapentin|mesh-list
15195298|NCT03806530|Ropinirole|ropinirole|mesh-list
15195299|NCT03806530|Analgesics|analgesics|mesh-ancestor
14815395|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
14815396|NCT00865644|Imiquimod|imiquimod|mesh-list
15195300|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
15195301|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195302|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195303|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
15195304|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15195305|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15195306|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195307|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224195|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
14698076|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
14698077|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14698078|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698079|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698080|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698081|NCT00384800|Growth Substances|growth substances|mesh-ancestor
14698082|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698083|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698084|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14698085|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
14698086|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195308|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15195309|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15195310|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195311|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195312|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
15195313|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15195314|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15195315|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
15195316|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
15224196|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
15224197|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224198|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224199|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
15224200|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224201|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
15224202|NCT04459416|Narcotics|narcotics|mesh-ancestor
15224203|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224204|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224205|NCT04459416|Analgesics|analgesics|mesh-ancestor
15224206|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
15224207|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225688|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15225689|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15225690|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225691|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698087|NCT00384826|Paclitaxel|paclitaxel|mesh-list
14698088|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14698089|NCT00384826|Carboplatin|carboplatin|mesh-list
14698090|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14698091|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698092|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14698093|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14698094|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
14698095|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698096|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698097|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698098|NCT00384878|Leucovorin|leucovorin|mesh-list
14698099|NCT00384878|Fluorouracil|fluorouracil|mesh-list
14698100|NCT00384878|Cetuximab|cetuximab|mesh-list
14698101|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698102|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
14698103|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698104|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14698105|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698106|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
14698107|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698108|NCT00384878|Antidotes|antidotes|mesh-ancestor
14698109|NCT00384878|Protective Agents|protective agents|mesh-ancestor
14698110|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
14698111|NCT00384878|Vitamins|vitamins|mesh-ancestor
14698112|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
14698113|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698114|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
14698115|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14698116|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
14698117|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698118|NCT00384917|Ketoconazole|ketoconazole|mesh-list
14698119|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
14698120|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698121|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14698122|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14698123|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698124|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698125|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14698126|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
14698127|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195317|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
15195318|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195319|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195320|NCT03806062|Domperidone|domperidone|mesh-list
15195321|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
15195322|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
15195323|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698128|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698129|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14698130|NCT00384969|Sorafenib|sorafenib|mesh-list
14698131|NCT00384969|Everolimus|everolimus|mesh-list
14698132|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698133|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698134|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698135|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698136|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698137|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
14698138|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698139|NCT00385021|Leucovorin|leucovorin|mesh-list
14698140|NCT00385021|Fluorouracil|fluorouracil|mesh-list
14698141|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
14698142|NCT00385021|Bevacizumab|bevacizumab|mesh-list
14698143|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
14698144|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698145|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14698146|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698147|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698148|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
14698149|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698150|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698151|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698152|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698153|NCT00385021|Growth Substances|growth substances|mesh-ancestor
14698154|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698155|NCT00385021|Antidotes|antidotes|mesh-ancestor
14698156|NCT00385021|Protective Agents|protective agents|mesh-ancestor
14698157|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
14698158|NCT00385021|Vitamins|vitamins|mesh-ancestor
14698159|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
14698160|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14698161|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14698162|NCT00385125|Rituximab|rituximab|mesh-list
14698163|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14698164|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698165|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698166|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
14698167|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698168|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14698169|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14698170|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
14698171|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698172|NCT00385307|Amibegron|amibegron|mesh-list
14698173|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14698174|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14698175|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
14698176|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698177|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698178|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698179|NCT00385359|Albuterol|albuterol|mesh-list
14698180|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14698181|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
14698182|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698183|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698184|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14698185|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
14698186|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
14698187|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15195324|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698188|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14698189|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14698190|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14698191|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
14698192|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698193|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698194|NCT00385385|KRM 1648|krm 1648|mesh-list
14698195|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14698196|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
14698197|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14698198|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698199|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
14698200|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14698201|NCT00385398|Temozolomide|temozolomide|mesh-list
14698202|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698203|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698204|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698205|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698206|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15195325|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195326|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15195327|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
15195328|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195329|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195330|NCT03806036|Vitamin D|vitamin d|mesh-list
15195331|NCT03806036|Clomiphene|clomiphene|mesh-list
15195332|NCT03806036|Enclomiphene|enclomiphene|mesh-list
15195333|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
15195334|NCT03806036|Vitamins|vitamins|mesh-ancestor
15195335|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
15195336|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195337|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15195338|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15195339|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
15195340|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195341|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15195342|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
15195343|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14698207|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
14698208|NCT00385411|Valproic Acid|valproic acid|mesh-list
14698209|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
14698210|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698211|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698212|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
14698213|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195344|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14698214|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698215|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
14698216|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14698217|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698218|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14698219|NCT00385437|Mirtazapine|mirtazapine|mesh-list
14698220|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
15195345|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14698221|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14698222|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14698223|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
14698224|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
14698225|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698226|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698227|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698228|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14698229|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14698230|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698231|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14698232|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14698233|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14698234|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
14698235|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14698236|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14698237|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
14698238|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14698239|NCT00385450|Nelfinavir|nelfinavir|mesh-list
14698240|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14698241|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14698242|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
14698243|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698244|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698245|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14698246|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14698247|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
14698248|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698249|NCT00385463|Montelukast|montelukast|mesh-list
14698250|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14698251|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14698252|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14698253|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14698254|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
14698255|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698256|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698257|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14698258|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14698259|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698260|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14815397|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14815398|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
14815399|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815400|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815401|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
14815402|NCT00865657|Alprazolam|alprazolam|mesh-list
14815403|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14815404|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815405|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815406|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14698261|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
14698262|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698263|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
14698264|NCT00385463|Hormones|hormones|mesh-ancestor
14815407|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815408|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815409|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
14815410|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
14815411|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815412|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815413|NCT00865670|Azithromycin|azithromycin|mesh-list
14815414|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14815415|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815416|NCT00865696|Mirtazapine|mirtazapine|mesh-list
14815417|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815418|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815419|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14815420|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
14815421|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
14815422|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698265|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
14698266|NCT00385502|Econazole|econazole|mesh-list
14698267|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
14698268|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698269|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14698270|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14698271|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698272|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698273|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14698274|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
14698275|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698276|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698277|NCT00385554|UC-781|uc-781|mesh-list
14698278|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14698279|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
14698280|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698281|NCT00385606|Gemcitabine|gemcitabine|mesh-list
14698282|NCT00385606|Rofecoxib|rofecoxib|mesh-list
14698283|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698284|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14698285|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
14698286|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698287|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
14698288|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698289|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698290|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698291|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
14698292|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698293|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14698294|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14698295|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14698296|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14698297|NCT00385606|Analgesics|analgesics|mesh-ancestor
14698298|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
14698299|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698300|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14698301|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14698302|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14698303|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
14698304|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698305|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14698306|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14698307|NCT00385645|Zidovudine|zidovudine|mesh-list
14698308|NCT00385645|Lamivudine|lamivudine|mesh-list
14698309|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14698310|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14698311|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
14698312|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698313|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698314|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14698315|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14698316|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
14698317|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698318|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14698319|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698320|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
14698321|NCT00385658|Simvastatin|simvastatin|mesh-list
14698322|NCT00385658|Ezetimibe|ezetimibe|mesh-list
14698323|NCT00385658|Fenofibrate|fenofibrate|mesh-list
14698324|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14698325|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14698326|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
14698327|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698328|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14698329|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14698330|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698331|NCT00385710|Valproic Acid|valproic acid|mesh-list
14698332|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
14698333|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698334|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698335|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
14698336|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698337|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698338|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
14698339|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14698340|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698341|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14698342|NCT00385853|Temozolomide|temozolomide|mesh-list
14698343|NCT00385853|Vatalanib|vatalanib|mesh-list
14698344|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14698345|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
14698346|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698347|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698348|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698349|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698350|NCT00385931|Valsartan|valsartan|mesh-list
14698351|NCT00385931|Simvastatin|simvastatin|mesh-list
14698352|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14698353|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14698354|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
14698355|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698356|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14698357|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14698358|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698359|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14698360|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14698361|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14698362|NCT00385957|Lamivudine|lamivudine|mesh-list
14698363|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14698364|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698365|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698366|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698367|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
14698368|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698369|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14698370|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14698371|NCT00385970|Leucovorin|leucovorin|mesh-list
14698372|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
14698373|NCT00385970|Tegafur|tegafur|mesh-list
14698374|NCT00385970|Calcium|calcium|mesh-list
14698375|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
14698376|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14698377|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698378|NCT00385970|Antidotes|antidotes|mesh-ancestor
14698379|NCT00385970|Protective Agents|protective agents|mesh-ancestor
14698380|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
14698381|NCT00385970|Vitamins|vitamins|mesh-ancestor
14698382|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
14698383|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14698384|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
14698385|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698386|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698387|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14698388|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
14698389|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14698390|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
14698391|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698392|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
14698393|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14698394|NCT00386061|Rimonabant|rimonabant|mesh-list
14698395|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14698396|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14698397|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14698398|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698399|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698400|NCT00386061|Hormones|hormones|mesh-ancestor
14698401|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698402|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698403|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
14698404|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14698405|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
14698406|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
14698407|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698408|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14698409|NCT00386126|Hematinics|hematinics|mesh-ancestor
14698410|NCT00386178|Vitamin E|vitamin e|mesh-list
15195346|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
15195347|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15195348|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195349|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195350|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195351|NCT03805945|Analgesics|analgesics|mesh-ancestor
15195352|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
15195353|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195354|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15195355|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15195356|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15195357|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
15195358|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195359|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195360|NCT03806374|Lidocaine|lidocaine|mesh-list
15195361|NCT03806374|Fentanyl|fentanyl|mesh-list
15195362|NCT03806374|Ketamine|ketamine|mesh-list
15195363|NCT03806374|Propofol|propofol|mesh-list
15195364|NCT03806374|Cisatracurium|cisatracurium|mesh-list
15195365|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195366|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
15195367|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195368|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195369|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
15195370|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195371|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15195372|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15195373|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15195374|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195375|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195376|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15195377|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15195378|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
14698411|NCT00386178|Tocopherols|tocopherols|mesh-list
14698412|NCT00386178|Tocotrienols|tocotrienols|mesh-list
14698413|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
14698414|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
14698415|NCT00386178|Vitamins|vitamins|mesh-ancestor
14698416|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
14698417|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698418|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
14698419|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698420|NCT00386178|Protective Agents|protective agents|mesh-ancestor
14698421|NCT00386191|Clopidogrel|clopidogrel|mesh-list
14698422|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14698423|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14698424|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14698425|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14698426|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
14698427|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698428|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698429|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698430|NCT00386230|Zidovudine|zidovudine|mesh-list
14698431|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
14698432|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698433|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15195379|NCT03806374|Analgesics|analgesics|mesh-ancestor
14294644|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14294645|NCT00577382|Growth Substances|growth substances|mesh-ancestor
14294646|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294647|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
15195380|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15195381|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15195382|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15195383|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195384|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195385|NCT03806374|Narcotics|narcotics|mesh-ancestor
15195386|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15195387|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15195388|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15195389|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15195390|NCT03806101|Abrocitinib|abrocitinib|mesh-list
15195391|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15195392|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15195393|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
15195394|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698434|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698435|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698436|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
14698437|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698438|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14698439|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15195395|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15195396|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15195397|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195398|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14728288|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14728289|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728290|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14728291|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728292|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
14728293|NCT00517621|Paclitaxel|paclitaxel|mesh-list
14728294|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14728295|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728296|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
14728297|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
14728298|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
14728299|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728300|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
14728301|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728302|NCT00517725|Carvedilol|carvedilol|mesh-list
14728303|NCT00517725|Nebivolol|nebivolol|mesh-list
14728304|NCT00517725|Bisoprolol|bisoprolol|mesh-list
14728305|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14728306|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14728307|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
14728308|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728309|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195399|NCT03806049|Paclitaxel|paclitaxel|mesh-list
15195400|NCT03806049|Bevacizumab|bevacizumab|mesh-list
15195401|NCT03806049|Carboplatin|carboplatin|mesh-list
15195402|NCT03806049|Niraparib|niraparib|mesh-list
15195403|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15195404|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195405|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14294648|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14294649|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294650|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294651|NCT00577408|Naltrexone|naltrexone|mesh-list
14294652|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14294653|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14294654|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728310|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728311|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14728312|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
14728313|NCT00517725|Protective Agents|protective agents|mesh-ancestor
14728314|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14728315|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195406|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
14294655|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
14698440|NCT00386269|Codeine|codeine|mesh-list
14698441|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14698442|NCT00386269|Narcotics|narcotics|mesh-ancestor
14698443|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698444|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698445|NCT00386269|Analgesics|analgesics|mesh-ancestor
14698446|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
14698447|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698448|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
14698449|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
14698450|NCT00386282|Misoprostol|misoprostol|mesh-list
14698451|NCT00386282|Mifepristone|mifepristone|mesh-list
14698452|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14815423|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698453|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
14815424|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815425|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14815426|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815427|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815428|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14815429|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14815430|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14815431|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815432|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14815433|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14815434|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
14815435|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14815436|NCT00865748|Metformin|metformin|mesh-list
14815437|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815438|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815439|NCT00865761|Alprazolam|alprazolam|mesh-list
14815440|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14815441|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195407|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
15195408|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195409|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195410|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15195411|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15195412|NCT03806049|Growth Substances|growth substances|mesh-ancestor
14815442|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815443|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14815444|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815445|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815446|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
14815447|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
14815448|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815449|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815450|NCT00865839|Metformin|metformin|mesh-list
14815451|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815452|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815453|NCT00865852|Metformin|metformin|mesh-list
14815454|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815455|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815456|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14815457|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14815458|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
14815459|NCT00865891|Nifedipine|nifedipine|mesh-list
14815460|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14815461|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815462|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815463|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14815464|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815465|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
14815466|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
14815467|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14815468|NCT00865917|Metoprolol|metoprolol|mesh-list
14815469|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14815470|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15195413|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195414|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
15224208|NCT04420455|Enoximone|enoximone|mesh-list
14815471|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14815472|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
14815473|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
14698454|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14698455|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698456|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14698457|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698458|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
14698459|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14698460|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14698461|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14698462|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14698463|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
14698464|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14698465|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14698466|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
14698467|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698468|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
14698469|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14698470|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14698471|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
14698472|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698473|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698474|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698475|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698476|NCT00386399|Mitomycins|mitomycins|mesh-list
14698477|NCT00386399|Mitomycin|mitomycin|mesh-list
14698478|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14698479|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698480|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
14698481|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698482|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698483|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698484|NCT00386412|Valganciclovir|valganciclovir|mesh-list
14698485|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
14698486|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698487|NCT00386503|Artesunate|artesunate|mesh-list
14698488|NCT00386503|Amodiaquine|amodiaquine|mesh-list
14698489|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
14698490|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14698491|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14698492|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698493|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698494|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
14698495|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
14698496|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14698497|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
14698498|NCT00386516|Fluorouracil|fluorouracil|mesh-list
14698499|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
14698500|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698501|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14698502|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698503|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698504|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
14698505|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698506|NCT00386529|Aspirin|aspirin|mesh-list
14698507|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14698508|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14698509|NCT00386529|Analgesics|analgesics|mesh-ancestor
14698510|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
14698511|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698512|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698513|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14698514|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14698515|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14698516|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14698517|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698518|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14698519|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14698520|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698521|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
15195415|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15195416|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195417|NCT03805607|Ketorolac|ketorolac|mesh-list
15195418|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15195419|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15195420|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195421|NCT03805607|Analgesics|analgesics|mesh-ancestor
15195422|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
15195423|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195424|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195425|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15195426|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195427|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15195428|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195429|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195430|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
15195431|NCT03805568|Remifentanil|remifentanil|mesh-list
15195432|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15195433|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195434|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195435|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14698522|NCT00386555|Docetaxel|docetaxel|mesh-list
14698523|NCT00386555|Axitinib|axitinib|mesh-list
14698524|NCT00386555|Crenolanib|crenolanib|mesh-list
14698525|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698526|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
14698527|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
14698528|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
14698529|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698530|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698531|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698532|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14698533|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14698534|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14698535|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14698536|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698537|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14698538|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698539|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698540|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14698541|NCT00386646|Laxatives|laxatives|mesh-ancestor
14698542|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195436|NCT03805568|Analgesics|analgesics|mesh-ancestor
15195437|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
15195438|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698543|NCT00386659|Ritonavir|ritonavir|mesh-list
14698544|NCT00386659|Lopinavir|lopinavir|mesh-list
14698545|NCT00386659|Tenofovir|tenofovir|mesh-list
14698546|NCT00386659|Abacavir|abacavir|mesh-list
14698547|NCT00386659|Efavirenz|efavirenz|mesh-list
14698548|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
14698549|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14698550|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14698551|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
14698552|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698553|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698554|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14698555|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14698556|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
14698557|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698558|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14698559|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15195439|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15195440|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14698560|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14698561|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698562|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14698563|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14698564|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14698565|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14698566|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14698567|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
14698568|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
14698569|NCT00386672|Vitamin D|vitamin d|mesh-list
14698570|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
14698571|NCT00386672|Vitamins|vitamins|mesh-list
14698572|NCT00386672|Calcium|calcium|mesh-list
14698573|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
14698574|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698575|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14698576|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14698577|NCT00386685|Trastuzumab|trastuzumab|mesh-list
14698578|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698579|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698580|NCT00386750|Lumefantrine|lumefantrine|mesh-list
14294656|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294657|NCT00577460|Pramipexole|pramipexole|mesh-list
14294658|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
14294659|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294660|NCT00577460|Protective Agents|protective agents|mesh-ancestor
14698581|NCT00386750|Artemether|artemether|mesh-list
14698582|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14698583|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
14698584|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14698585|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14698586|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698587|NCT00386763|Lumefantrine|lumefantrine|mesh-list
14698588|NCT00386763|Artemether|artemether|mesh-list
14698589|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14698590|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
14698591|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14698592|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14698593|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698594|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
14698595|NCT00386802|Clotrimazole|clotrimazole|mesh-list
14698596|NCT00386802|Miconazole|miconazole|mesh-list
14698597|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698598|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14698599|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14698600|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14698601|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698602|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698603|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14698604|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
14698605|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698606|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698607|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14698608|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14698609|NCT00386815|Pemetrexed|pemetrexed|mesh-list
14698610|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698611|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698612|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698613|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14698614|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698615|NCT00386828|Bevacizumab|bevacizumab|mesh-list
14698616|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698617|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698618|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698619|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698620|NCT00386828|Growth Substances|growth substances|mesh-ancestor
14698621|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698622|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698623|NCT00386841|Citalopram|citalopram|mesh-list
14698624|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14698625|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14698626|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14698627|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698628|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698629|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
14698630|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195441|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15195442|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
15195443|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195444|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195445|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195446|NCT03805568|Narcotics|narcotics|mesh-ancestor
15195447|NCT03805633|Pancrelipase|pancrelipase|mesh-list
15195448|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195449|NCT03805282|Lidocaine|lidocaine|mesh-list
15195450|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195451|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
15195452|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195453|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195454|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
15195455|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195456|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14698631|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14698632|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
14698633|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14698634|NCT00386867|Misoprostol|misoprostol|mesh-list
14698635|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14698636|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
14698637|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14698638|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698639|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14698640|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698641|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
14698642|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
14698643|NCT00386958|Povidone|povidone|mesh-list
14698644|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
14698645|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
14698646|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14815474|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815475|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815476|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14815477|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14815478|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815479|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815480|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815481|NCT00865943|Dexetimide|dexetimide|mesh-list
14815482|NCT00865943|Citalopram|citalopram|mesh-list
14815483|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15195457|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15195458|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15195459|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195460|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195461|NCT03805477|Nintedanib|nintedanib|mesh-list
15195462|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195463|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15195464|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195465|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195466|NCT03805360|Ropivacaine|ropivacaine|mesh-list
15195467|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
15195468|NCT03805360|Anesthetics|anesthetics|mesh-list
15195469|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195470|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195471|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
15195472|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698647|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698648|NCT00386984|Octreotide|octreotide|mesh-list
14698649|NCT00386984|Somatostatin|somatostatin|mesh-list
14698650|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698651|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14698652|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698653|NCT00386984|Hormones|hormones|mesh-ancestor
14698654|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698655|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698656|NCT00386997|Amphotericin B|amphotericin b|mesh-list
14698657|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14698658|NCT00386997|Amebicides|amebicides|mesh-ancestor
14698659|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15195473|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
15195474|NCT03805503|Procaine|procaine|mesh-list
15195475|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195476|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
14698660|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14698661|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698662|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14698663|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
14698664|NCT00387114|Ascorbic Acid|ascorbic acid|mesh-list
14698665|NCT00387114|Vitamins|vitamins|mesh-ancestor
14698666|NCT00387114|Micronutrients|micronutrients|mesh-ancestor
14698667|NCT00387114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698668|NCT00387114|Antioxidants|antioxidants|mesh-ancestor
14698669|NCT00387114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698670|NCT00387114|Protective Agents|protective agents|mesh-ancestor
14698671|NCT00387179|Melatonin|melatonin|mesh-list
14698672|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
14698673|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698674|NCT00387179|Protective Agents|protective agents|mesh-ancestor
14698675|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698676|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698677|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
14698678|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14698679|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698680|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
14698681|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698682|NCT00387322|Pemetrexed|pemetrexed|mesh-list
14698683|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14698684|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698685|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698686|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698687|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14698688|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698689|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698690|NCT00387374|Paclitaxel|paclitaxel|mesh-list
14698691|NCT00387374|Bevacizumab|bevacizumab|mesh-list
14698692|NCT00387374|Carboplatin|carboplatin|mesh-list
14698693|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14698694|NCT00387374|Antibodies|antibodies|mesh-list
14698695|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
14698696|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14698697|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14698698|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698699|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
14698700|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
14815484|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815485|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815486|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815487|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815488|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
14815489|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815490|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815491|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815492|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815493|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14815494|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14815495|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
14815496|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
14815497|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815498|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15195477|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195478|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698701|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
14698702|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698703|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698704|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698705|NCT00387374|Growth Substances|growth substances|mesh-ancestor
14698706|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698707|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698708|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
14698709|NCT00387400|Everolimus|everolimus|mesh-list
14698710|NCT00387400|Temozolomide|temozolomide|mesh-list
14698711|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698712|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698713|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
14698714|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698715|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14698716|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
14698717|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698718|NCT00387413|Niacinamide|niacinamide|mesh-list
14698719|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14698720|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14698721|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14698722|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14698723|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698724|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698725|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698726|NCT00387413|Analgesics|analgesics|mesh-ancestor
14698727|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
14698728|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698729|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
14698730|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14698731|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
14698732|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
14698733|NCT00387413|Vitamins|vitamins|mesh-ancestor
14698734|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
15195479|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
15195480|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195481|NCT03805178|Abatacept|abatacept|mesh-list
15195482|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15195483|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195484|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195485|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15195486|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
14698735|NCT00387504|Fenretinide|fenretinide|mesh-list
14698736|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698737|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14698738|NCT00387504|Protective Agents|protective agents|mesh-ancestor
14698739|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698740|NCT00387530|Valganciclovir|valganciclovir|mesh-list
14698741|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14698742|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
14698743|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698744|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698745|NCT00387556|Ondansetron|ondansetron|mesh-list
14698746|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
14698747|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
14698748|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698749|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698750|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698751|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
14698752|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
14698753|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14698754|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
14698755|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698756|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698757|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14698758|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14698759|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698760|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14698761|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14698762|NCT00387569|Vaccines|vaccines|mesh-list
14698763|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
14698764|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698765|NCT00387582|Ranibizumab|ranibizumab|mesh-list
15195487|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195488|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195489|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
15195490|NCT03804931|Prednisone|prednisone|mesh-list
14698766|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698767|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698768|NCT00387582|Growth Substances|growth substances|mesh-ancestor
14698769|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698770|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698771|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698772|NCT00387608|Veliparib|veliparib|mesh-list
14698773|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14698774|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698775|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698776|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698777|NCT00387699|Bevacizumab|bevacizumab|mesh-list
14698778|NCT00387699|Etoposide|etoposide|mesh-list
14698779|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698780|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698781|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698782|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698783|NCT00387699|Growth Substances|growth substances|mesh-ancestor
14698784|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698785|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698786|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15195491|NCT03804931|Mesalamine|mesalamine|mesh-list
15195492|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15195493|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
14698787|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14698788|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14698789|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698790|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698791|NCT00387738|Histamine|histamine|mesh-list
14698792|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
14698793|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
14698794|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698795|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698796|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698797|NCT00387777|Buprenorphine|buprenorphine|mesh-list
14698798|NCT00387777|Analgesics|analgesics|mesh-list
14698799|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14698800|NCT00387777|Narcotics|narcotics|mesh-ancestor
14698801|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698802|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698803|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
14698804|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698805|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14698806|NCT00387868|Etoposide|etoposide|mesh-list
14698807|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698808|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14698809|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15195494|NCT03804931|Hormones|hormones|mesh-ancestor
15195495|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195496|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195497|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15195498|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224209|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15195499|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15195500|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195501|NCT03804931|Analgesics|analgesics|mesh-ancestor
14698810|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14698811|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698812|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698813|NCT00387920|Sunitinib|sunitinib|mesh-list
14698814|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698815|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698816|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698817|NCT00387920|Growth Substances|growth substances|mesh-ancestor
14698818|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698819|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698820|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698821|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698822|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698823|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
14698824|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
14698825|NCT00387933|Vatalanib|vatalanib|mesh-list
14698826|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698827|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698828|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698829|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698830|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
14698831|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14698832|NCT00388011|Morphine|morphine|mesh-list
14698833|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14698834|NCT00388011|Narcotics|narcotics|mesh-ancestor
14698835|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698836|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698837|NCT00388011|Analgesics|analgesics|mesh-ancestor
14698838|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
14698839|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698840|NCT00388076|Paclitaxel|paclitaxel|mesh-list
14698841|NCT00388076|Carboplatin|carboplatin|mesh-list
14698842|NCT00388076|Lapatinib|lapatinib|mesh-list
14698843|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14698844|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698845|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
14698846|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
15195502|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
15195503|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195504|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195505|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
15195506|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15195507|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195508|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15195509|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15195510|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15195511|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195512|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195513|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
15195514|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195515|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195516|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15224210|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
15195517|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195518|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
15195519|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195520|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195521|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
15195522|NCT03805035|Maleic acid|maleic acid|mesh-list
15195523|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
15195524|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
15195525|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15195526|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195527|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195528|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
15195529|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195530|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195531|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
15195532|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
15195533|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15195534|NCT03804866|Doxorubicin|doxorubicin|mesh-list
15195535|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15195536|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15195537|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195538|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15195539|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14698847|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
14698848|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698849|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698850|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698851|NCT00388089|Bortezomib|bortezomib|mesh-list
14698852|NCT00388089|Topotecan|topotecan|mesh-list
14698853|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698854|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14698855|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14698856|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698857|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728316|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14728317|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
14728318|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14728319|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14728320|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14728321|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14728322|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14728323|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
14728324|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
14728325|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728326|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14728327|NCT00517764|Citalopram|citalopram|mesh-list
14728328|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14728329|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14728330|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728331|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728332|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728333|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
14728334|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728335|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14728336|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
14728337|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728338|NCT00517803|Micronutrients|micronutrients|mesh-list
14728339|NCT00517803|Trace Elements|trace elements|mesh-list
14728340|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728341|NCT00517946|Cetirizine|cetirizine|mesh-list
14728342|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
14728343|NCT00517946|Ephedrine|ephedrine|mesh-list
15195540|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195541|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698858|NCT00388128|Caffeine|caffeine|mesh-list
14698859|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14698860|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698861|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14698862|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698863|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698864|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14698865|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14698866|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
14698867|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698868|NCT00388167|Caspofungin|caspofungin|mesh-list
14698869|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
14698870|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698871|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698872|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698873|NCT00388193|Rituximab|rituximab|mesh-list
14698874|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698875|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698876|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
14815499|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14815500|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815501|NCT00865982|Docetaxel|docetaxel|mesh-list
14698877|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698878|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14698879|NCT00388219|Buprenorphine|buprenorphine|mesh-list
14698880|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14698881|NCT00388219|Narcotics|narcotics|mesh-ancestor
14698882|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698883|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698884|NCT00388219|Analgesics|analgesics|mesh-ancestor
14698885|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
14815502|NCT00865982|Capecitabine|capecitabine|mesh-list
15195542|NCT03804840|Dronabinol|dronabinol|mesh-list
15195543|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
15195544|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195545|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15195546|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195547|NCT03804840|Analgesics|analgesics|mesh-ancestor
15195548|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
15195549|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195550|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15195551|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15195552|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195553|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195554|NCT03804840|Hormones|hormones|mesh-ancestor
15195555|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195556|NCT03804749|Suramin|suramin|mesh-list
15195557|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
15195558|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
15195559|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15195560|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698886|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14698887|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14698888|NCT00388258|Alvimopan|alvimopan|mesh-list
14698889|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698890|NCT00388271|Alfuzosin|alfuzosin|mesh-list
14698891|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14698892|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14698893|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14698894|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14698895|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14698896|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698897|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698898|NCT00388271|Urological Agents|urological agents|mesh-ancestor
14698899|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
14698900|NCT00388336|Hematinics|hematinics|mesh-ancestor
14698901|NCT00388388|Losartan|losartan|mesh-list
14698902|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14698903|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14698904|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14294661|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294662|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14294663|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15195561|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195562|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15195563|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15195564|NCT03804372|Tenofovir|tenofovir|mesh-list
15195565|NCT03804372|Rituximab|rituximab|mesh-list
15195566|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195567|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195568|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
15195569|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195570|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195571|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
15195572|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195573|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15195574|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15195575|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195576|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698905|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14698906|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14698907|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698908|NCT00388388|Diuretics|diuretics|mesh-ancestor
14698909|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
14698910|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698911|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14698912|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14698913|NCT00388401|Alvimopan|alvimopan|mesh-list
14698914|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698915|NCT00388427|Cetuximab|cetuximab|mesh-list
14698916|NCT00388427|Dasatinib|dasatinib|mesh-list
14698917|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698918|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698919|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14698920|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698921|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698922|NCT00388479|Alvimopan|alvimopan|mesh-list
14698923|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14698924|NCT00388557|Ketoconazole|ketoconazole|mesh-list
14698925|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
15195577|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14698926|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14698927|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14698928|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14698929|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14698930|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698931|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14698932|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
14698933|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698934|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698935|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14698936|NCT00388635|Prednisone|prednisone|mesh-list
14698937|NCT00388635|Melphalan|melphalan|mesh-list
14698938|NCT00388635|Bortezomib|bortezomib|mesh-list
14698939|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14698940|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
14698941|NCT00388635|Hormones|hormones|mesh-ancestor
14698942|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698943|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698944|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14698945|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698946|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14698947|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
14698948|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698949|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14698950|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698951|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
14698952|NCT00388661|Melatonin|melatonin|mesh-list
14698953|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
14698954|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698955|NCT00388661|Protective Agents|protective agents|mesh-ancestor
14698956|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698957|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14698958|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14698959|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14698960|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698961|NCT00388700|Leucovorin|leucovorin|mesh-list
14698962|NCT00388700|Bevacizumab|bevacizumab|mesh-list
14698963|NCT00388700|Fluorouracil|fluorouracil|mesh-list
14698964|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14698965|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698966|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14698967|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14698968|NCT00388700|Growth Substances|growth substances|mesh-ancestor
14698969|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698970|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
14698971|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
14698972|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14698973|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14698974|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14698975|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
14698976|NCT00388700|Antidotes|antidotes|mesh-ancestor
14698977|NCT00388700|Protective Agents|protective agents|mesh-ancestor
15195578|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15195579|NCT03804541|Ensartinib|ensartinib|mesh-list
14698978|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
14698979|NCT00388700|Vitamins|vitamins|mesh-ancestor
14698980|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
14698981|NCT00388739|Prednisolone|prednisolone|mesh-list
14698982|NCT00388739|Budesonide|budesonide|mesh-list
14698983|NCT00388739|Albuterol|albuterol|mesh-list
14698984|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14698985|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
14698986|NCT00388739|Hormones|hormones|mesh-ancestor
14698987|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14698988|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14698989|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14698990|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14698991|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
14698992|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195580|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195581|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15195582|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195583|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195584|NCT03804723|Prednisone|prednisone|mesh-list
15195585|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14698993|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14698994|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14698995|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
14698996|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
14698997|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14698998|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14698999|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14699000|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14699001|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
14699002|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699003|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699004|NCT00388778|Doxycycline|doxycycline|mesh-list
14699005|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699006|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699007|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
14699008|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14699009|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14699010|NCT00388856|Ascorbic Acid|ascorbic acid|mesh-list
14699011|NCT00388856|Vitamins|vitamins|mesh-ancestor
14699012|NCT00388856|Micronutrients|micronutrients|mesh-ancestor
14699013|NCT00388856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699014|NCT00388856|Antioxidants|antioxidants|mesh-ancestor
14699015|NCT00388856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294664|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
14294665|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
14294666|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294667|NCT00577473|Mesalamine|mesalamine|mesh-list
14294668|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14699016|NCT00388856|Protective Agents|protective agents|mesh-ancestor
14699017|NCT00388882|Bromides|bromides|mesh-list
14699018|NCT00388882|Albuterol|albuterol|mesh-list
14699019|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
14699020|NCT00388882|Ipratropium|ipratropium|mesh-list
14699021|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14699022|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
14699023|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699024|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699025|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14699026|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
14699027|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
14699028|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14699029|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
14699030|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699031|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699032|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
14699033|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
14699034|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14699035|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14699036|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14699037|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14699038|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14699039|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
14699040|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195586|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
15195587|NCT03804723|Hormones|hormones|mesh-ancestor
15195588|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195589|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195590|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14699041|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699042|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699043|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699044|NCT00388986|Glyburide|glyburide|mesh-list
14699045|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14699046|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699047|NCT00388999|Lectins|lectins|mesh-list
14699048|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
14699049|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
14699050|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699051|NCT00388999|Coagulants|coagulants|mesh-ancestor
14699052|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14699053|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14815503|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195591|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195592|NCT03804359|Rituximab|rituximab|mesh-list
15195593|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195594|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195595|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
15195596|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195597|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699054|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699055|NCT00389025|Analgesics|analgesics|mesh-ancestor
14699056|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
14699057|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224211|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15224212|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15224213|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224214|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224215|NCT04420455|Protective Agents|protective agents|mesh-ancestor
15224216|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224217|NCT04419337|Metformin|metformin|mesh-list
15224218|NCT04419337|Pioglitazone|pioglitazone|mesh-list
15224219|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15224220|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15224221|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224222|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224223|NCT04410796|Carboplatin|carboplatin|mesh-list
15224224|NCT04410796|Pemetrexed|pemetrexed|mesh-list
15224225|NCT04410796|Osimertinib|osimertinib|mesh-list
15224226|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224227|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224228|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224229|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15224230|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14699058|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699059|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224231|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15224232|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
15224233|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224234|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224235|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
15224236|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14699060|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699061|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14699062|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14699063|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14699064|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
14699065|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
14699066|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699067|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699068|NCT00389038|Amitriptyline|amitriptyline|mesh-list
14699069|NCT00389038|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14699070|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14699071|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
14699072|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14699073|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699074|NCT00389038|Analgesics|analgesics|mesh-ancestor
14699075|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
14699076|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699077|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699078|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14699079|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14699080|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14699081|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699082|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
14699083|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699084|NCT00389038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14699085|NCT00389038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14699086|NCT00389038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699087|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14699088|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699089|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
14699090|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699091|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699092|NCT00389090|Temozolomide|temozolomide|mesh-list
14699093|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14699094|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699095|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
14699096|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699097|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699098|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699099|NCT00389129|Aspirin|aspirin|mesh-list
14699100|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14699101|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699102|NCT00389129|Analgesics|analgesics|mesh-ancestor
14699103|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
14699104|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699105|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699106|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699107|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699108|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14699109|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14699110|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699111|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15195598|NCT03804034|Molybdenum|molybdenum|mesh-list
15195599|NCT03804034|Trace Elements|trace elements|mesh-ancestor
15195600|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
14699112|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14699113|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815504|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14815505|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14815506|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14815507|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195601|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195602|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
15195603|NCT03804177|Melatonin|melatonin|mesh-list
15195604|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
15195605|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
15195606|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195607|NCT03804177|Protective Agents|protective agents|mesh-ancestor
14699114|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
14699115|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
14699116|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14699117|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
14699118|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699119|NCT00389233|Protective Agents|protective agents|mesh-ancestor
14699120|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699121|NCT00389233|Vitamins|vitamins|mesh-ancestor
14699122|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
14699123|NCT00389233|Laxatives|laxatives|mesh-ancestor
14699124|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699125|NCT00389272|Acetaminophen|acetaminophen|mesh-list
14699126|NCT00389272|Ibuprofen|ibuprofen|mesh-list
14699127|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699128|NCT00389272|Analgesics|analgesics|mesh-ancestor
14699129|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
14699130|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699131|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699132|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
14699133|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14699134|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699135|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699136|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14699137|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294669|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699138|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699139|NCT00389285|Sorafenib|sorafenib|mesh-list
14699140|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699141|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699142|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699143|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699144|NCT00389311|Nonoxynol|nonoxynol|mesh-list
14699145|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14699146|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14699147|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699148|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14699149|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
14699150|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14699151|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14699152|NCT00389376|Silymarin|silymarin|mesh-list
14699153|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
14699154|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699155|NCT00389376|Protective Agents|protective agents|mesh-ancestor
14699156|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699157|NCT00389402|Ritonavir|ritonavir|mesh-list
14699158|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14699159|NCT00389402|Saquinavir|saquinavir|mesh-list
14699160|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14699161|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14699162|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
14699163|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699164|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699165|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14699166|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14699167|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
14699168|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699169|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14699170|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14699171|NCT00389415|Vildagliptin|vildagliptin|mesh-list
14699172|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14699173|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699174|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14699175|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
14699176|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699177|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699178|NCT00389428|Cytarabine|cytarabine|mesh-list
14699179|NCT00389428|Daunorubicin|daunorubicin|mesh-list
14699180|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14699181|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
14699182|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699183|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699184|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
14699185|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699186|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699187|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
14699188|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699189|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15195608|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195609|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195610|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15195611|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
15195612|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
15195613|NCT03804177|Vitamins|vitamins|mesh-ancestor
15195614|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
15195615|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
15195616|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15195617|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15195618|NCT03804229|Protective Agents|protective agents|mesh-ancestor
15195619|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195620|NCT03803553|Fluorouracil|fluorouracil|mesh-list
14699190|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14699191|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699192|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699193|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
14699194|NCT00389506|Fludarabine|fludarabine|mesh-list
14699195|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
14699196|NCT00389506|Immunotoxins|immunotoxins|mesh-list
14699197|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699198|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
14699199|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699200|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699201|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699202|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
14699203|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699204|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699205|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14699206|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14699207|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
14699208|NCT00389558|Amikacin|amikacin|mesh-list
14699209|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699210|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699211|NCT00389584|Irinotecan|irinotecan|mesh-list
14699212|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14699213|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699214|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699215|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699216|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699217|NCT00389636|Becaplermin|becaplermin|mesh-list
14699218|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
14699219|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14699220|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14699221|NCT00389636|Growth Substances|growth substances|mesh-ancestor
14699222|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699223|NCT00389688|Pemetrexed|pemetrexed|mesh-list
14699224|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699225|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699226|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699227|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14699228|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14699229|NCT00389701|Dexamethasone|dexamethasone|mesh-list
14699230|NCT00389701|Bortezomib|bortezomib|mesh-list
14699231|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699232|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
15195621|NCT03803553|Nivolumab|nivolumab|mesh-list
15195622|NCT03803553|Irinotecan|irinotecan|mesh-list
14699233|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
15195623|NCT03803553|Cetuximab|cetuximab|mesh-list
15195624|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
14699234|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195625|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195626|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15195627|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195628|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15195629|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
15195630|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699235|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699236|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699237|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
14699238|NCT00389701|Hormones|hormones|mesh-ancestor
14699239|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195631|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195632|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15195633|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15195634|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15195635|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195636|NCT03803787|Budesonide|budesonide|mesh-list
15195637|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15195638|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14699240|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14699241|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699242|NCT00389766|Topotecan|topotecan|mesh-list
14699243|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14699244|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14699245|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699246|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699247|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699248|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699249|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14699250|NCT00389870|Cyclosporine|cyclosporine|mesh-list
14699251|NCT00389870|Irinotecan|irinotecan|mesh-list
14699252|NCT00389870|Panitumumab|panitumumab|mesh-list
14699253|NCT00389870|Cyclosporins|cyclosporins|mesh-list
14699254|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14699255|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699256|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699257|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699258|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699259|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699260|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
14294670|NCT00577473|Analgesics|analgesics|mesh-ancestor
14294671|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
14699261|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699262|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
14699263|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699264|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
14699265|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699266|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14699267|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14699268|NCT00389883|Anesthetics|anesthetics|mesh-list
14699269|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699270|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699271|NCT00389909|Doxapram|doxapram|mesh-list
14699272|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14699273|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699274|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
14699275|NCT00389922|Vinorelbine|vinorelbine|mesh-list
14699276|NCT00389922|Lapatinib|lapatinib|mesh-list
14294672|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699277|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14699278|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699279|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
14699280|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
15195639|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
14699281|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
14699282|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699283|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699284|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699285|NCT00389935|Thalidomide|thalidomide|mesh-list
14699286|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699287|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
14699288|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699289|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
14699290|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699291|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699292|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14699293|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14699294|NCT00389935|Growth Substances|growth substances|mesh-ancestor
14699295|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
14699296|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699297|NCT00389987|Tazobactam|tazobactam|mesh-list
14699298|NCT00389987|Piperacillin|piperacillin|mesh-list
14699299|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699300|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699301|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699302|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14699303|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728344|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14728345|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14728346|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14728347|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
14728348|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
14728349|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728350|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728351|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728352|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14728353|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
14728354|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728355|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14728356|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14728357|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
14728358|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14728359|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14728360|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
14728361|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
14728362|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14728363|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14728364|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15195640|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728365|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728366|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728367|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728368|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728369|NCT00517985|Analgesics|analgesics|mesh-ancestor
14728370|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
14728371|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728372|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
14728373|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728374|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
15195641|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195642|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15195643|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
15195644|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
15195645|NCT03803787|Hormones|hormones|mesh-ancestor
15195646|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195647|NCT03803514|Epoetin Alfa|epoetin alfa|mesh-list
15195648|NCT03803514|Hematinics|hematinics|mesh-ancestor
15195649|NCT03803449|Fentanyl|fentanyl|mesh-list
15195650|NCT03803449|Midazolam|midazolam|mesh-list
15195651|NCT03803449|Propofol|propofol|mesh-list
15195652|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15195653|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195654|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195655|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15195656|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
15195657|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
15195658|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195659|NCT03803449|Narcotics|narcotics|mesh-ancestor
14699304|NCT00390000|Pemetrexed|pemetrexed|mesh-list
14699305|NCT00390000|Vatalanib|vatalanib|mesh-list
14699306|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699307|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699308|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699309|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14699310|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14699311|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699312|NCT00390026|Bevacizumab|bevacizumab|mesh-list
14699313|NCT00390026|Verteporfin|verteporfin|mesh-list
14699314|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14699315|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699316|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14699317|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14699318|NCT00390026|Growth Substances|growth substances|mesh-ancestor
14699319|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699320|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
14699321|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14699322|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14699323|NCT00390039|Morphine|morphine|mesh-list
14699324|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14699325|NCT00390039|Narcotics|narcotics|mesh-ancestor
14699326|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699327|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699328|NCT00390039|Analgesics|analgesics|mesh-ancestor
14699329|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
14699330|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699331|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
14699332|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14699333|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
14699334|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699335|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699336|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14699337|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
14699338|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14699339|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
14699340|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699341|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699342|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14699343|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
14699344|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
14699345|NCT00390065|Protective Agents|protective agents|mesh-ancestor
14699346|NCT00390091|Abetimus|abetimus|mesh-list
14699347|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699348|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
14699349|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699350|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14699351|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
14699352|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699353|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
14699354|NCT00390156|Bevacizumab|bevacizumab|mesh-list
14699355|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
14699356|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699357|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
14699358|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195660|NCT03803449|Analgesics|analgesics|mesh-ancestor
15195661|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
15195662|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195663|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14699359|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699360|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699361|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
14699362|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699363|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699364|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14699365|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14699366|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14699367|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14699368|NCT00390156|Growth Substances|growth substances|mesh-ancestor
14699369|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
14699370|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699371|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195664|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14699372|NCT00390195|Everolimus|everolimus|mesh-list
14699373|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195665|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14699374|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699375|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
14699376|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699377|NCT00390208|Dexamethasone|dexamethasone|mesh-list
14699378|NCT00390208|Ranibizumab|ranibizumab|mesh-list
15195666|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15195667|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
15195668|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
15195669|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195670|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699379|NCT00390208|Verteporfin|verteporfin|mesh-list
14699380|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699381|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
14699382|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
14699383|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699384|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699385|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699386|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
14699387|NCT00390208|Hormones|hormones|mesh-ancestor
14699388|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699389|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14699390|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699391|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14699392|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14699393|NCT00390208|Growth Substances|growth substances|mesh-ancestor
14699394|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
14699395|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14699396|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
14699397|NCT00390247|Thalidomide|thalidomide|mesh-list
14699398|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699399|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
14699400|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699401|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
14699402|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699403|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699404|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14699405|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14699406|NCT00390247|Growth Substances|growth substances|mesh-ancestor
14699407|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
14699408|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699409|NCT00390260|Acetaminophen|acetaminophen|mesh-list
14699410|NCT00390260|Rofecoxib|rofecoxib|mesh-list
14699411|NCT00390260|Hydrocodone|hydrocodone|mesh-list
14699412|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699413|NCT00390260|Analgesics|analgesics|mesh-ancestor
14699414|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
14699415|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699416|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699417|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
14699418|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699419|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
14699420|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14699421|NCT00390260|Narcotics|narcotics|mesh-ancestor
14699422|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699423|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
14699424|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14699425|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14699426|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699427|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14699428|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699429|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195671|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
15195672|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15195673|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195674|NCT03803371|Acetaminophen|acetaminophen|mesh-list
15195675|NCT03803371|Tramadol|tramadol|mesh-list
15195676|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195677|NCT03803371|Analgesics|analgesics|mesh-ancestor
15195678|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
15195679|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294673|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699430|NCT00390273|Metformin|metformin|mesh-list
15195680|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699431|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15195681|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
14699432|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699433|NCT00390312|Morphine|morphine|mesh-list
14699434|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14699435|NCT00390312|Narcotics|narcotics|mesh-ancestor
14699436|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699437|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699438|NCT00390312|Analgesics|analgesics|mesh-ancestor
14699439|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
14699440|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699441|NCT00390390|Lansoprazole|lansoprazole|mesh-list
14699442|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
14699443|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14699444|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699445|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14699446|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699447|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699448|NCT00390403|Acetic Acid|acetic acid|mesh-list
14699449|NCT00390403|Temozolomide|temozolomide|mesh-list
14699450|NCT00390403|Retinol acetate|retinol acetate|mesh-list
14699451|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
14699452|NCT00390403|Gossypol|gossypol|mesh-list
15195682|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195683|NCT03803371|Narcotics|narcotics|mesh-ancestor
15195684|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699453|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699454|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
14699455|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699456|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699457|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699458|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699459|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14699460|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
14699461|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699462|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14699463|NCT00390403|Protective Agents|protective agents|mesh-ancestor
14699464|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14699465|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
14699466|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14699467|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14699468|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14699469|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14699470|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14699471|NCT00390520|Vildagliptin|vildagliptin|mesh-list
14699472|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14699473|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699474|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14699475|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
14699476|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699477|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699478|NCT00390598|Sennosides|sennosides|mesh-list
14699479|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14699480|NCT00390598|Laxatives|laxatives|mesh-ancestor
14699481|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699482|NCT00390624|Mannitol|mannitol|mesh-list
15195685|NCT03803254|Lenvatinib|lenvatinib|mesh-list
15195686|NCT03803254|Antibodies|antibodies|mesh-list
15195687|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
15195688|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195689|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699483|NCT00390624|Ularitide|ularitide|mesh-list
14699484|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14699485|NCT00390624|Diuretics|diuretics|mesh-ancestor
14699486|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
14699487|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699488|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14699489|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
14699490|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699491|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14699492|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
14699493|NCT00390676|Carboplatin|carboplatin|mesh-list
14699494|NCT00390676|Docetaxel|docetaxel|mesh-list
14699495|NCT00390676|Capecitabine|capecitabine|mesh-list
14699496|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699497|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14699498|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14294674|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15195690|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699499|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14699500|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699501|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14699502|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
14699503|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
14699504|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14699505|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699506|NCT00390793|Cytarabine|cytarabine|mesh-list
14699507|NCT00390793|Dexamethasone|dexamethasone|mesh-list
14699508|NCT00390793|Prednisone|prednisone|mesh-list
14699509|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
14699510|NCT00390793|Cortisone|cortisone|mesh-list
14699511|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
14699512|NCT00390793|Doxorubicin|doxorubicin|mesh-list
14699513|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14699514|NCT00390793|Methotrexate|methotrexate|mesh-list
14699515|NCT00390793|Vincristine|vincristine|mesh-list
14699516|NCT00390793|Daunorubicin|daunorubicin|mesh-list
14699517|NCT00390793|Dasatinib|dasatinib|mesh-list
14699518|NCT00390793|BB 1101|bb 1101|mesh-list
14815508|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815509|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
14815510|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14815511|NCT00866008|Ganirelix|ganirelix|mesh-list
14815512|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
14815513|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14815514|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
14815515|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14815516|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815517|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14815518|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14815519|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815520|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815521|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815522|NCT00866021|Ritonavir|ritonavir|mesh-list
14815523|NCT00866021|Lopinavir|lopinavir|mesh-list
14815524|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14815525|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14815526|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
14815527|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815528|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815529|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14815530|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14815531|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
14815532|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815533|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14815534|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815535|NCT00866060|Memantine|memantine|mesh-list
14815536|NCT00866060|Donepezil|donepezil|mesh-list
14815537|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14815538|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815539|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815540|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815541|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815542|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815543|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
14815544|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14815545|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14815546|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
14815547|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15195691|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195692|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195693|NCT03803124|Tolvaptan|tolvaptan|mesh-list
15195694|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15195695|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195696|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
15195697|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195698|NCT03803267|Fentanyl|fentanyl|mesh-list
15195699|NCT03803267|Propofol|propofol|mesh-list
15195700|NCT03803267|Atracurium|atracurium|mesh-list
15195701|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
15195702|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815548|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14815549|NCT00866073|Decitabine|decitabine|mesh-list
14815550|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14699519|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699520|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
14699521|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699522|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699523|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699524|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
14699525|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699526|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699527|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14699528|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699529|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
14699530|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
14699531|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699532|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699533|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
14699534|NCT00390793|Hormones|hormones|mesh-ancestor
14699535|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699536|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14699537|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14699538|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14699539|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699540|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699541|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14699542|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
14699543|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14699544|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14699545|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
14699546|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
14699547|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14699548|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14699549|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
14699550|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699551|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14699552|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
14699553|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
14699554|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
14699555|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699556|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
14699557|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
14699558|NCT00390832|Hematinics|hematinics|mesh-ancestor
14699559|NCT00390871|Fentanyl|fentanyl|mesh-list
14699560|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
14699561|NCT00390871|Propofol|propofol|mesh-list
14699562|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14699563|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699564|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699565|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15195703|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195704|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15195705|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15195706|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
15195707|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195708|NCT03803267|Narcotics|narcotics|mesh-ancestor
15195709|NCT03803267|Analgesics|analgesics|mesh-ancestor
15195710|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
14699566|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
14699567|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
14699568|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699569|NCT00390871|Analgesics|analgesics|mesh-ancestor
14699570|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
14699571|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699572|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14699573|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14699574|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14699575|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
14699576|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195711|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195712|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14699577|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699578|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14699579|NCT00390871|Narcotics|narcotics|mesh-ancestor
15225692|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
14699580|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14699581|NCT00390897|Interferons|interferons|mesh-list
14699582|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699583|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
14699584|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699585|NCT00390923|Selegiline|selegiline|mesh-list
15195713|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15195714|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15195715|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15195716|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15195717|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15195718|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
15195719|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195720|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699586|NCT00390923|Nicotine|nicotine|mesh-list
14699587|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14699588|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
14699589|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699590|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699591|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14699592|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15195721|NCT03803007|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15195722|NCT03803007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15195723|NCT03803007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15195724|NCT03803007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195725|NCT03803215|Theophylline|theophylline|mesh-list
15195726|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14699593|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
14699594|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699595|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699596|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
14699597|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14699598|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14699599|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14699600|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14699601|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699602|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14699603|NCT00390923|Protective Agents|protective agents|mesh-ancestor
14699604|NCT00390975|Tegaserod|tegaserod|mesh-list
14699605|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14699606|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
14699607|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699608|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699609|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699610|NCT00391014|Amphotericin B|amphotericin b|mesh-list
14699611|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14699612|NCT00391014|Amebicides|amebicides|mesh-ancestor
14699613|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14699614|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14699615|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699616|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699617|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
14699618|NCT00391105|Remifentanil|remifentanil|mesh-list
14699619|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14699620|NCT00391105|Narcotics|narcotics|mesh-ancestor
14699621|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699622|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699623|NCT00391105|Analgesics|analgesics|mesh-ancestor
14699624|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
14699625|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699626|NCT00391144|Triamcinolone|triamcinolone|mesh-list
14699627|NCT00391144|Bevacizumab|bevacizumab|mesh-list
14699628|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14699629|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699630|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14699631|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14699632|NCT00391144|Growth Substances|growth substances|mesh-ancestor
14699633|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699634|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
14699635|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699636|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
14699637|NCT00391144|Hormones|hormones|mesh-ancestor
14699638|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699639|NCT00391157|Dexamethasone|dexamethasone|mesh-list
14699640|NCT00391157|Bortezomib|bortezomib|mesh-list
14728375|NCT00518102|Becaplermin|becaplermin|mesh-list
15195727|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
15195728|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195729|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195730|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15195731|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
15195732|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15195733|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195734|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195735|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
15195736|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15195737|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15195738|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
15195739|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14699641|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699642|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
14699643|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
14699644|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699645|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699646|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699647|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
14699648|NCT00391157|Hormones|hormones|mesh-ancestor
14699649|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699650|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14699651|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699652|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14699653|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699654|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14699655|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699656|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699657|NCT00391261|Metformin|metformin|mesh-list
14699658|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14699659|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699660|NCT00391313|Chloroquine|chloroquine|mesh-list
14699661|NCT00391313|Amebicides|amebicides|mesh-ancestor
14699662|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14699663|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14699664|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699665|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
14699666|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699667|NCT00391404|Alendronate|alendronate|mesh-list
14699668|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14699669|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699670|NCT00391417|Estradiol|estradiol|mesh-list
14699671|NCT00391417|Estrogens|estrogens|mesh-ancestor
14699672|NCT00391417|Hormones|hormones|mesh-ancestor
14699673|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699674|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699675|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
14699676|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
14699677|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14699678|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14699679|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14699680|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699681|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14699682|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14699683|NCT00391638|Interferons|interferons|mesh-list
14699684|NCT00391638|Tenofovir|tenofovir|mesh-list
14699685|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14699686|NCT00391638|Emtricitabine|emtricitabine|mesh-list
14699687|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14699688|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699689|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
14699690|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699691|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15195740|NCT03803163|Treprostinil|treprostinil|mesh-list
15195741|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15195742|NCT03802747|Durvalumab|durvalumab|mesh-list
15195743|NCT03802747|Tremelimumab|tremelimumab|mesh-list
15195744|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15195745|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195746|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195747|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
15195748|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294675|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728376|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
14699692|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14699693|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699694|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699695|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14699696|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14699697|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
14699698|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14699699|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699700|NCT00391651|Renal Agents|renal agents|mesh-ancestor
14699701|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699702|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
14699703|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14699704|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699705|NCT00391885|Anesthetics|anesthetics|mesh-list
14699706|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195749|NCT03802838|Amisulpride|amisulpride|mesh-list
15195750|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15195751|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15195752|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195753|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699707|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699708|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
14699709|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14699710|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
14699711|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699712|NCT00391911|Expectorants|expectorants|mesh-ancestor
14699713|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
14699714|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14699715|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
14699716|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699717|NCT00391911|Protective Agents|protective agents|mesh-ancestor
14699718|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699719|NCT00391911|Antidotes|antidotes|mesh-ancestor
14699720|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14699721|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14699722|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
14699723|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699724|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
15195754|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15195755|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15195756|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
14699725|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14699726|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728377|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14728378|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14728379|NCT00518102|Growth Substances|growth substances|mesh-ancestor
14728380|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728381|NCT00518141|Aspirin|aspirin|mesh-list
14728382|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
14728383|NCT00518141|Salicylates|salicylates|mesh-list
14728384|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728385|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
14728386|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
14728387|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728388|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14728389|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14728390|NCT00518141|Analgesics|analgesics|mesh-ancestor
14728391|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
14728392|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728393|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728394|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14728395|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728396|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14728397|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195757|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195758|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195759|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15195760|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
14728398|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728399|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14699727|NCT00392002|Esomeprazole|esomeprazole|mesh-list
14699728|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14699729|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699730|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14699731|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699732|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699733|NCT00392028|Ertapenem|ertapenem|mesh-list
14699734|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699735|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699736|NCT00392067|Calcipotriene|calcipotriene|mesh-list
14699737|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
14699738|NCT00392080|Naproxen|naproxen|mesh-list
14699739|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14699740|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699741|NCT00392080|Analgesics|analgesics|mesh-ancestor
14699742|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
14699743|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699744|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699745|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14699746|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699747|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
14699748|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14699749|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699750|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699751|NCT00392093|Estrogens|estrogens|mesh-list
14699752|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14699753|NCT00392093|Hormones|hormones|mesh-ancestor
14699754|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699755|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699756|NCT00392106|Amiodarone|amiodarone|mesh-list
14699757|NCT00392106|Flecainide|flecainide|mesh-list
14699758|NCT00392106|Propafenone|propafenone|mesh-list
14699759|NCT00392106|Dofetilide|dofetilide|mesh-list
14699760|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14699761|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14699762|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14699763|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14699764|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699765|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14699766|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14699767|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14699768|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699769|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14699770|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14699771|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14699772|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14699773|NCT00392158|Anesthetics|anesthetics|mesh-list
14699774|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699775|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699776|NCT00392262|Amlodipine|amlodipine|mesh-list
14699777|NCT00392262|Valsartan|valsartan|mesh-list
14699778|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14699779|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14699780|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14699781|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699782|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14699783|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699784|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
14699785|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14699786|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14699787|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
14699788|NCT00392275|Levofloxacin|levofloxacin|mesh-list
14699789|NCT00392275|Ofloxacin|ofloxacin|mesh-list
14699790|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699791|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699792|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14699793|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699794|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699795|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699796|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699797|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14699798|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14699799|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14294676|NCT00577590|Metformin|metformin|mesh-list
14699800|NCT00392275|Renal Agents|renal agents|mesh-ancestor
14699801|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
14699802|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
14699803|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699804|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
14699805|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699806|NCT00392340|Doxorubicin|doxorubicin|mesh-list
14699807|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14699808|NCT00392340|Vincristine|vincristine|mesh-list
14699809|NCT00392340|Topotecan|topotecan|mesh-list
14699810|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14699811|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699812|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14699813|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699814|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699815|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699816|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14699817|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
14699818|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
14699819|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
14699820|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14699821|NCT00392418|Micronutrients|micronutrients|mesh-list
14699822|NCT00392418|Trace Elements|trace elements|mesh-list
14699823|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699824|NCT00392431|Amiodarone|amiodarone|mesh-list
14699825|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14699826|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
14699827|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14699828|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14699829|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699830|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14699831|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14699832|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14699833|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699834|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14699835|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14699836|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14699837|NCT00392457|Ketoconazole|ketoconazole|mesh-list
14699838|NCT00392457|Hormones|hormones|mesh-list
14699839|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699840|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699841|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
14699842|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699843|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14699844|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14699845|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699846|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699847|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14699848|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815551|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
14815552|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815553|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815554|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815555|NCT00866216|Azithromycin|azithromycin|mesh-list
14815556|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14699849|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14294677|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
14699850|NCT00392470|Irinotecan|irinotecan|mesh-list
14699851|NCT00392470|Cetuximab|cetuximab|mesh-list
14699852|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14699853|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699854|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699855|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699856|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699857|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14699858|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
14699859|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14699860|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
14699861|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
14699862|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699863|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699864|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14699865|NCT00392522|Analgesics|analgesics|mesh-ancestor
14699866|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
14699867|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14699868|NCT00392561|Vitamin E|vitamin e|mesh-list
14699869|NCT00392561|Selenium|selenium|mesh-list
14699870|NCT00392561|Vitamins|vitamins|mesh-ancestor
14699871|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
14699872|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699873|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
14699874|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699875|NCT00392561|Protective Agents|protective agents|mesh-ancestor
14699876|NCT00392561|Trace Elements|trace elements|mesh-ancestor
14699877|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14699878|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14699879|NCT00392652|Protective Agents|protective agents|mesh-ancestor
14699880|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699881|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699882|NCT00392691|Rituximab|rituximab|mesh-list
14699883|NCT00392691|Melphalan|melphalan|mesh-list
14699884|NCT00392691|Vinorelbine|vinorelbine|mesh-list
14699885|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14699886|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699887|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
14699888|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699889|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699890|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699891|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
14699892|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699893|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14699894|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699895|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14699896|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
14699897|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
14699898|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
14699899|NCT00392717|Atorvastatin|atorvastatin|mesh-list
14699900|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14699901|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14699902|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
14699903|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699904|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14699905|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14699906|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699907|NCT00392756|Hormones|hormones|mesh-list
14699908|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15195761|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
15195762|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699909|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699910|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
14699911|NCT00392886|Temozolomide|temozolomide|mesh-list
14699912|NCT00392886|Thiotepa|thiotepa|mesh-list
14699913|NCT00392886|Carboplatin|carboplatin|mesh-list
14699914|NCT00392886|Methotrexate|methotrexate|mesh-list
15195763|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
15195764|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195765|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195766|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15195767|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
15195768|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699915|NCT00392886|Etoposide|etoposide|mesh-list
14699916|NCT00392886|Vincristine|vincristine|mesh-list
14699917|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699918|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
14699919|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699920|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195769|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195770|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15195771|NCT03802552|Cephalexin|cephalexin|mesh-list
15195772|NCT03802552|Cefadroxil|cefadroxil|mesh-list
15195773|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15195774|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14699921|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699922|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
14699923|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699924|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699925|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14699926|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14699927|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
14699928|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14699929|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14699930|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
14699931|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
14699932|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14699933|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14699934|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14699935|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14699936|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14699937|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14699938|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
14699939|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
14699940|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
14699941|NCT00392899|Tegafur|tegafur|mesh-list
14699942|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14699943|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
14699944|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699945|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699946|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
14699947|NCT00392912|Testosterone|testosterone|mesh-list
14699948|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
14699949|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
14699950|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14699951|NCT00392912|Androgens|androgens|mesh-ancestor
14699952|NCT00392912|Hormones|hormones|mesh-ancestor
14699953|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699954|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699955|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14699956|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699957|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
14699958|NCT00392938|Docetaxel|docetaxel|mesh-list
14699959|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
14699960|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699961|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
14699962|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
14699963|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
14699964|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699965|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
15195775|NCT03802318|Amoxicillin|amoxicillin|mesh-list
14294678|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15195776|NCT03802318|Rabeprazole|rabeprazole|mesh-list
15195777|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15195778|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195779|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15195780|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195781|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15195782|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195783|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195784|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
15195785|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
15195786|NCT03802422|Vitamins|vitamins|mesh-ancestor
15195787|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
15195788|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195789|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
15195790|NCT03802422|Hematinics|hematinics|mesh-ancestor
15224237|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224238|NCT04297592|Doxycycline|doxycycline|mesh-list
15224239|NCT04297592|Cephalexin|cephalexin|mesh-list
15224240|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15195791|NCT03802071|Doxorubicin|doxorubicin|mesh-list
15195792|NCT03802071|Durvalumab|durvalumab|mesh-list
15195793|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15195794|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195795|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15195796|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15195797|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195798|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699966|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14699967|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699968|NCT00393003|Anesthetics|anesthetics|mesh-list
14699969|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699970|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195799|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195800|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
15195801|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15195802|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
15195803|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15195804|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195805|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15195806|NCT03802032|Lidocaine|lidocaine|mesh-list
15195807|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195808|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
15195809|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14699971|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
14699972|NCT00393107|Rituximab|rituximab|mesh-list
14699973|NCT00393107|Fludarabine|fludarabine|mesh-list
14699974|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14699975|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
14699976|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699977|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14699978|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14699979|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
14699980|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14699981|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14699982|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14699983|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14699984|NCT00393198|Misoprostol|misoprostol|mesh-list
14699985|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
14699986|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14699987|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
14699988|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14699989|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14699990|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14699991|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14699992|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14699993|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14699994|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
14699995|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14699996|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14699997|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
14699998|NCT00393263|Clobetasol|clobetasol|mesh-list
14699999|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
14700000|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14700001|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
14700002|NCT00393263|Hormones|hormones|mesh-ancestor
14700003|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700004|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700005|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14700006|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14700007|NCT00393263|Analgesics|analgesics|mesh-ancestor
14700008|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
14700009|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700010|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14700011|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
14700012|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700013|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
14700014|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14700015|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700016|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195810|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195811|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
14700017|NCT00393289|Calcium|calcium|mesh-list
15195812|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700018|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14700019|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700020|NCT00393315|Paclitaxel|paclitaxel|mesh-list
14700021|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14700022|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700023|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14700024|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14700025|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14700026|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700027|NCT00393328|Ritonavir|ritonavir|mesh-list
14700028|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14700029|NCT00393328|Aripiprazole|aripiprazole|mesh-list
14700030|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14700031|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14700032|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
14700033|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700034|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700035|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14700036|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14700037|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
14700038|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700039|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14700040|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14700041|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700042|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700043|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14700044|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14700045|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14700046|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700047|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
14700048|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
14700049|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700050|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14700051|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14700052|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
14700053|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14700054|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14700055|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14700056|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14700057|NCT00393393|Hylan|hylan|mesh-list
14700058|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
14700059|NCT00393393|Protective Agents|protective agents|mesh-ancestor
14700060|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700061|NCT00393445|Glucagon|glucagon|mesh-list
14700062|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14700063|NCT00393445|Incretins|incretins|mesh-ancestor
14700064|NCT00393445|Hormones|hormones|mesh-ancestor
14700065|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700066|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700067|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14700068|NCT00393471|Etanercept|etanercept|mesh-list
14700069|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14700070|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14700071|NCT00393471|Analgesics|analgesics|mesh-ancestor
14700072|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
14700073|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700074|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700075|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14700076|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14700077|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14700078|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700079|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
14700080|NCT00393497|Bevacizumab|bevacizumab|mesh-list
14700081|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700082|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700083|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14700084|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14700085|NCT00393497|Growth Substances|growth substances|mesh-ancestor
14700086|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700087|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700088|NCT00393562|Methylphenidate|methylphenidate|mesh-list
14700089|NCT00393562|Modafinil|modafinil|mesh-list
14700090|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14700091|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700092|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14700093|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14700094|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700095|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700096|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
14700097|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700098|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14700099|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14700100|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14700101|NCT00393614|Levetiracetam|levetiracetam|mesh-list
14700102|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
14700103|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
14700104|NCT00393679|Artesunate|artesunate|mesh-list
14700105|NCT00393679|Lumefantrine|lumefantrine|mesh-list
14700106|NCT00393679|Artemether|artemether|mesh-list
14700107|NCT00393679|Piperaquine|piperaquine|mesh-list
14700108|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14700109|NCT00393679|Amodiaquine|amodiaquine|mesh-list
14700110|NCT00393679|Artenimol|artenimol|mesh-list
14700111|NCT00393679|Dapsone|dapsone|mesh-list
14700112|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
14700113|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
14700114|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14700115|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14700116|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700117|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700118|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
14815557|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815558|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14815559|NCT00866229|Simvastatin|simvastatin|mesh-list
14815560|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15195813|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15195814|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14815561|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14815562|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
14815563|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815564|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14815565|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14815566|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815567|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14815568|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14815569|NCT00866437|Estropipate|estropipate|mesh-list
14815570|NCT00866437|Estradiol|estradiol|mesh-list
14815571|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14815572|NCT00866437|Estrone|estrone|mesh-list
14815573|NCT00866437|Progesterone|progesterone|mesh-list
14815574|NCT00866437|Estrogens|estrogens|mesh-ancestor
14815575|NCT00866437|Hormones|hormones|mesh-ancestor
14815576|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815577|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815578|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14815579|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
14815580|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14815581|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14815582|NCT00866437|Progestins|progestins|mesh-ancestor
14815583|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
14815584|NCT00866450|Calcium|calcium|mesh-list
14815585|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14815586|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815587|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14815588|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
14815589|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
14815590|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14815591|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14815592|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815593|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815594|NCT00866463|Urological Agents|urological agents|mesh-ancestor
14815595|NCT00866515|Ketoconazole|ketoconazole|mesh-list
14815596|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
14815597|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815598|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14815599|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815600|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700119|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
14700120|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14700121|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
14700122|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14700123|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700124|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700125|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
14700126|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700127|NCT00393731|Misoprostol|misoprostol|mesh-list
14700128|NCT00393731|Oxytocin|oxytocin|mesh-list
14700129|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
14700130|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14700131|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700132|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14700133|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
14700134|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14700135|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14700136|NCT00393744|Amoxicillin|amoxicillin|mesh-list
14700137|NCT00393744|Pristinamycin|pristinamycin|mesh-list
14700138|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700139|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700140|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
14700141|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
14700142|NCT00393770|Vitamins|vitamins|mesh-ancestor
14700143|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
14700144|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700145|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
14700146|NCT00393783|Trastuzumab|trastuzumab|mesh-list
14700147|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700148|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700149|NCT00393835|Azithromycin|azithromycin|mesh-list
14700150|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700151|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700152|NCT00394056|Paroxetine|paroxetine|mesh-list
14700153|NCT00394056|Vestipitant|vestipitant|mesh-list
14700154|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14700155|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14700156|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700157|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700158|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700159|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
14700160|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700161|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14700162|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700163|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700164|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14700165|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15195815|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15195816|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195817|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700166|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700167|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14728400|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14728401|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14728402|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
14728403|NCT00518193|Cetuximab|cetuximab|mesh-list
14728404|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14728405|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728406|NCT00518232|Methylphenidate|methylphenidate|mesh-list
14728407|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14728408|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728409|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14728410|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14728411|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728412|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728413|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
14728414|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728415|NCT00518245|Enoxaparin|enoxaparin|mesh-list
14728416|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
14728417|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14728418|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14728419|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728420|NCT00518271|Sirolimus|sirolimus|mesh-list
14728421|NCT00518271|Tacrolimus|tacrolimus|mesh-list
14728422|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728423|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
14728424|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728425|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15195818|NCT03802058|Paclitaxel|paclitaxel|mesh-list
14700168|NCT00394147|Gemcitabine|gemcitabine|mesh-list
14700169|NCT00394147|Pemetrexed|pemetrexed|mesh-list
14700170|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700171|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
14700172|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700173|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700174|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
14700175|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700176|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700177|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700178|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
14700179|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700180|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14700181|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14700182|NCT00394186|Solabegron|solabegron|mesh-list
14700183|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14700184|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14700185|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14700186|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
14700187|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700188|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195819|NCT03802058|Carboplatin|carboplatin|mesh-list
15195820|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15195821|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195822|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
15195823|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
15195824|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
15195825|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195826|NCT03802214|Vedolizumab|vedolizumab|mesh-list
15195827|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195828|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
14700189|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700190|NCT00394303|Insulin|insulin|mesh-list
14700191|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700192|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700193|NCT00394368|Fluticasone|fluticasone|mesh-list
14700194|NCT00394368|Xhance|xhance|mesh-list
14700195|NCT00394368|Beclomethasone|beclomethasone|mesh-list
14700196|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
14700197|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14700198|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14700199|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14700200|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
14700201|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700202|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700203|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14700204|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
14700205|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14700206|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14700207|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14700208|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14700209|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14700210|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
14700211|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700212|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700213|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
14700214|NCT00394368|Hormones|hormones|mesh-ancestor
14700215|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700216|NCT00394394|Enalapril|enalapril|mesh-list
14700217|NCT00394394|Amiloride|amiloride|mesh-list
14700218|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14700219|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
14700220|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700221|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700222|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14700223|NCT00394394|Diuretics|diuretics|mesh-ancestor
14700224|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
14700225|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700226|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14700227|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14700228|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700229|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14700230|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15195829|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195830|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14700231|NCT00394407|Insulin|insulin|mesh-list
14700232|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14700233|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700234|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700235|NCT00394459|Anesthetics|anesthetics|mesh-list
15195831|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195832|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195833|NCT03802162|Memantine|memantine|mesh-list
15195834|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14700236|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14700237|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700238|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
14294679|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294680|NCT00577629|Cytarabine|cytarabine|mesh-list
14294681|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
14700239|NCT00394485|Procaterol|procaterol|mesh-list
14700240|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14700241|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
14700242|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700243|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700244|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14700245|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
14700246|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
14700247|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14700248|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
14700249|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700250|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700251|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
14700252|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14700253|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14700254|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14700255|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
14700256|NCT00394498|Sargramostim|sargramostim|mesh-list
14700257|NCT00394498|Lenograstim|lenograstim|mesh-list
14700258|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
14700259|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700260|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14700261|NCT00394537|Labetalol|labetalol|mesh-list
14700262|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14700263|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14700264|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
14700265|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700266|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700267|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700268|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15195835|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15195836|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
15195837|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15195838|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195839|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195840|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15195841|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15195842|NCT03801603|Vaccines|vaccines|mesh-list
15195843|NCT03801603|Immunologic Factors|immunologic factors|mesh-ancestor
15195844|NCT03801603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195845|NCT03801746|Cyclosporine|cyclosporine|mesh-list
15195846|NCT03801746|Rifampin|rifampin|mesh-list
15195847|NCT03801746|Probenecid|probenecid|mesh-list
15195848|NCT03801746|Cyclosporins|cyclosporins|mesh-list
15195849|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195850|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195851|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700269|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
14700270|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
14700271|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700272|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14700273|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14700274|NCT00394628|Temozolomide|temozolomide|mesh-list
14700275|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14700276|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
14700277|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700278|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700279|NCT00394693|Interferons|interferons|mesh-list
14700280|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
15195852|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
14294682|NCT00577629|Rituximab|rituximab|mesh-list
14700281|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700282|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
14700283|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700284|NCT00394745|Valsartan|valsartan|mesh-list
14700285|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14700286|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14700287|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14700288|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700289|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
15195853|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195854|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
15195855|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195856|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
15195857|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195858|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15195859|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15195860|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
15195861|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15195862|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
15195863|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15195864|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15195865|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15195866|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15195867|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15195868|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15195869|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15195870|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
14700290|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700291|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14700292|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14700293|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14700294|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700295|NCT00394966|Rolapitant|rolapitant|mesh-list
14700296|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15195871|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
15195872|NCT03801746|Renal Agents|renal agents|mesh-ancestor
15195873|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
15195874|NCT03801733|Atorvastatin|atorvastatin|mesh-list
15195875|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15195876|NCT03801733|Simvastatin|simvastatin|mesh-list
15195877|NCT03801733|Pravastatin|pravastatin|mesh-list
15195878|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15195879|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15195880|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
15195881|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195882|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14294683|NCT00577629|Doxorubicin|doxorubicin|mesh-list
14700297|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700298|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700299|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700300|NCT00394992|Bevacizumab|bevacizumab|mesh-list
14700301|NCT00394992|Capecitabine|capecitabine|mesh-list
14700302|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
14700303|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700304|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700305|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14700306|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14700307|NCT00394992|Growth Substances|growth substances|mesh-ancestor
14700308|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700309|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700310|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700311|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
14728426|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195883|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15195884|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195885|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700312|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700313|NCT00395031|Ziprasidone|ziprasidone|mesh-list
14700314|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14700315|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
14294684|NCT00577629|Etoposide|etoposide|mesh-list
14294685|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700316|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700317|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700318|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700319|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14700320|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14700321|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14700322|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700323|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14700324|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
14700325|NCT00395070|Temozolomide|temozolomide|mesh-list
14700326|NCT00395070|Dacarbazine|dacarbazine|mesh-list
14700327|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14700328|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
14700329|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700330|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700331|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
14700332|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
14700333|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700334|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
14700335|NCT00395213|Norepinephrine|norepinephrine|mesh-list
14700336|NCT00395213|Serotonin|serotonin|mesh-list
14700337|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14700338|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14700339|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14700340|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
14700341|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700342|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700343|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700344|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
14700345|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
14700346|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700347|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14700348|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14700349|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
14700350|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14700351|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700352|NCT00395239|Budesonide|budesonide|mesh-list
14700353|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14700354|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14700355|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
14700356|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700357|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700358|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14700359|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
14700360|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
14700361|NCT00395239|Hormones|hormones|mesh-ancestor
14700362|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700363|NCT00395252|Gemcitabine|gemcitabine|mesh-list
14700364|NCT00395252|Cetuximab|cetuximab|mesh-list
14700365|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700366|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
14700367|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700368|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815601|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815602|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14815603|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815604|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815605|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815606|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14815607|NCT00866528|Paclitaxel|paclitaxel|mesh-list
14815608|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14815609|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815610|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
14815611|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
14815612|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
14815613|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815614|NCT00866554|Tamoxifen|tamoxifen|mesh-list
14294686|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
14700369|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
14700370|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700371|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700372|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700373|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
14700374|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700375|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700376|NCT00395369|Aprotinin|aprotinin|mesh-list
14700377|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
14700378|NCT00395369|Coagulants|coagulants|mesh-ancestor
14700379|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14700380|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14700381|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
14700382|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700383|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700384|NCT00395382|Alendronate|alendronate|mesh-list
14700385|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14700386|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700387|NCT00395395|Calcitonin|calcitonin|mesh-list
14700388|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
14700389|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14700390|NCT00395395|Katacalcin|katacalcin|mesh-list
14700391|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14700392|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700393|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14700394|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
14700395|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14700396|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
15195886|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14700397|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700398|NCT00395434|Bevacizumab|bevacizumab|mesh-list
14700399|NCT00395434|Combretastatin|combretastatin|mesh-list
14700400|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
14700401|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700402|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700403|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14700404|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14700405|NCT00395434|Growth Substances|growth substances|mesh-ancestor
14700406|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700407|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700408|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14700409|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
14700410|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
14700411|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
14700412|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700413|NCT00395499|Risperidone|risperidone|mesh-list
14700414|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14700415|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
14700416|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700417|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700418|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700419|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14700420|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14700421|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14700422|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700423|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14700424|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
14700425|NCT00395551|Ranibizumab|ranibizumab|mesh-list
14700426|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14700427|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15195887|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15195888|NCT03801733|Analgesics|analgesics|mesh-ancestor
15195889|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
15195890|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700428|NCT00395551|Growth Substances|growth substances|mesh-ancestor
14700429|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700430|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700431|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815615|NCT00866554|Bicalutamide|bicalutamide|mesh-list
14815616|NCT00866554|Dutasteride|dutasteride|mesh-list
14815617|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14815618|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
14815619|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815620|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815621|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14700432|NCT00395655|Hydralazine|hydralazine|mesh-list
14700433|NCT00395655|Valproic Acid|valproic acid|mesh-list
14700434|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
14700435|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195891|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195892|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15195893|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15195894|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195895|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
15195896|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15195897|NCT03801707|Velpatasvir|velpatasvir|mesh-list
14700436|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700437|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
14700438|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700439|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195898|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
15195899|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195900|NCT03801668|Paclitaxel|paclitaxel|mesh-list
15195901|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
15195902|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15195903|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15195904|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195905|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
15195906|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
15195907|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
15195908|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195909|NCT03801629|Morphine|morphine|mesh-list
15195910|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15195911|NCT03801629|Narcotics|narcotics|mesh-ancestor
15195912|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195913|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195914|NCT03801629|Analgesics|analgesics|mesh-ancestor
15195915|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
15195916|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195917|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
14700440|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
14700441|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14700442|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15195918|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15195919|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
15195920|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195921|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
15195922|NCT03801564|Protective Agents|protective agents|mesh-ancestor
15195923|NCT03801590|Riboflavin|riboflavin|mesh-list
15195924|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
15195925|NCT03801590|Vitamins|vitamins|mesh-ancestor
15195926|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
15195927|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195928|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15195929|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
15195930|NCT03801759|Adefovir|adefovir|mesh-list
15195931|NCT03801759|Digoxin|digoxin|mesh-list
15195932|NCT03801759|Furosemide|furosemide|mesh-list
15195933|NCT03801759|Diuretics|diuretics|mesh-ancestor
15195934|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
15195935|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195936|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15195937|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700443|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700444|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14700445|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
15195938|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195939|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15195940|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15195941|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195942|NCT03801759|Protective Agents|protective agents|mesh-ancestor
15195943|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
14700446|NCT00395681|Propofol|propofol|mesh-list
14700447|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14700448|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14700449|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700450|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14700451|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
14700452|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
14700453|NCT00395707|Ranibizumab|ranibizumab|mesh-list
15195944|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195945|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15225693|NCT03961789|Narcotics|narcotics|mesh-ancestor
14700454|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14700455|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14700456|NCT00395707|Growth Substances|growth substances|mesh-ancestor
14700457|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700458|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700459|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700460|NCT00395720|Vaccines|vaccines|mesh-list
14700461|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
14700462|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700463|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
14700464|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14700465|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14815622|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815623|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14815624|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14815625|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14815626|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
14815627|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14815628|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14815629|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815630|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815631|NCT00866593|Dexetimide|dexetimide|mesh-list
14815632|NCT00866593|Citalopram|citalopram|mesh-list
14815633|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14815634|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815635|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815636|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815637|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815638|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
14815639|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815640|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815641|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815642|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815643|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14815644|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14815645|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
14815646|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
14815647|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815648|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14815649|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14815650|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815651|NCT00866645|Haloperidol|haloperidol|mesh-list
14815652|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
14815653|NCT00866645|Sulpiride|sulpiride|mesh-list
14815654|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14815655|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
14815656|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
14815657|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815658|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815659|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14815660|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14815661|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815662|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815663|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815664|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14815665|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
14815666|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815667|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815668|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14815669|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14815670|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
14815671|NCT00866684|Cyclosporine|cyclosporine|mesh-list
14815672|NCT00866684|Sirolimus|sirolimus|mesh-list
14815673|NCT00866684|Azathioprine|azathioprine|mesh-list
15195946|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15195947|NCT03801499|Lenvatinib|lenvatinib|mesh-list
15195948|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195949|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15195950|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15195951|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195952|NCT03801252|Azithromycin|azithromycin|mesh-list
14700466|NCT00395772|Vitamin K|vitamin k|mesh-list
14700467|NCT00395772|Heparin|heparin|mesh-list
14700468|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
14815674|NCT00866684|Tacrolimus|tacrolimus|mesh-list
15195953|NCT03801252|Cefazolin|cefazolin|mesh-list
14815675|NCT00866684|Cyclosporins|cyclosporins|mesh-list
14815676|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14815677|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
15195954|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15195955|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195956|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
15195957|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15195958|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15195959|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
15195960|NCT03801226|Calcium|calcium|mesh-list
15195961|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15195962|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195963|NCT03801031|Lidocaine|lidocaine|mesh-list
14815678|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815679|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14815680|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815681|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815682|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
14815683|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815684|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
14815685|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14815686|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14815687|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815688|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14815689|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
14815690|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815691|NCT00866736|Dasatinib|dasatinib|mesh-list
14815692|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815693|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14815694|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815695|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815696|NCT00866762|Vorinostat|vorinostat|mesh-list
14815697|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14815698|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815699|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815700|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815701|NCT00866840|Riluzole|riluzole|mesh-list
14815702|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
15195964|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
15195965|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
15195966|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815703|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14815704|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14815705|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815706|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815707|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815708|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14815709|NCT00866840|Protective Agents|protective agents|mesh-ancestor
14815710|NCT00866853|Simeprevir|simeprevir|mesh-list
14815711|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
14815712|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815713|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
15195967|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195968|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
15195969|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15195970|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15195971|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15195972|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15195973|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15195974|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195975|NCT03801317|Micronutrients|micronutrients|mesh-list
15195976|NCT03801317|Trace Elements|trace elements|mesh-list
15195977|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195978|NCT03800953|Avelumab|avelumab|mesh-list
15195979|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15195980|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15195981|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
15195982|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15195983|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
15195984|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195985|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
15195986|NCT03800810|Protective Agents|protective agents|mesh-ancestor
14815714|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815715|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815716|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
14815717|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14815718|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
14815719|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815720|NCT00866866|Expectorants|expectorants|mesh-ancestor
14815721|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
14815722|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14815723|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
14815724|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815725|NCT00866866|Protective Agents|protective agents|mesh-ancestor
14815726|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815727|NCT00866866|Antidotes|antidotes|mesh-ancestor
14815728|NCT00866944|Leucovorin|leucovorin|mesh-list
14815729|NCT00866944|Fluorouracil|fluorouracil|mesh-list
14815730|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
14815731|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14815732|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
14815733|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815734|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815735|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815736|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14815737|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
14815738|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815739|NCT00866944|Antidotes|antidotes|mesh-ancestor
14815740|NCT00866944|Protective Agents|protective agents|mesh-ancestor
14815741|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
14815742|NCT00866944|Vitamins|vitamins|mesh-ancestor
14815743|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
14910540|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910541|NCT01357681|Protective Agents|protective agents|mesh-ancestor
14910542|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910543|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14910544|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14910545|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910546|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14910547|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
14910548|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
14910549|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14910550|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14910551|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14910552|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910553|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910554|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
14910555|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910556|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910557|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15195987|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
15195988|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
15195989|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15195990|NCT03800667|Protective Agents|protective agents|mesh-ancestor
15195991|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15195992|NCT03800667|Vitamins|vitamins|mesh-ancestor
15195993|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
15195994|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15195995|NCT03800745|Laxatives|laxatives|mesh-ancestor
15195996|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15195997|NCT03800693|Leucovorin|leucovorin|mesh-list
15195998|NCT03800693|Fluorouracil|fluorouracil|mesh-list
15195999|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
15196000|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
14910558|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910559|NCT01357811|Digoxin|digoxin|mesh-list
14910560|NCT01357811|Eliglustat|eliglustat|mesh-list
14910561|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14910562|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14910563|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196001|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196002|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815744|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
14815745|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
14815746|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14815747|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14815748|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700469|NCT00395772|Vitamins|vitamins|mesh-ancestor
14700470|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
14700471|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815749|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815750|NCT00866983|Urological Agents|urological agents|mesh-ancestor
14815751|NCT00866996|Methylphenidate|methylphenidate|mesh-list
15196003|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196004|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15196005|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
15196006|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196007|NCT03800693|Antidotes|antidotes|mesh-ancestor
14815752|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14815753|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14815754|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815755|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14815756|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14815757|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14815758|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815759|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
14815760|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815761|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14815762|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815763|NCT00867061|ON 01910|on 01910|mesh-list
14815764|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815765|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14815766|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815767|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815768|NCT00867126|Pioglitazone|pioglitazone|mesh-list
14815769|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14815770|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815771|NCT00867152|Ritonavir|ritonavir|mesh-list
14815772|NCT00867152|Lopinavir|lopinavir|mesh-list
14815773|NCT00867152|Darunavir|darunavir|mesh-list
14815774|NCT00867152|Dolutegravir|dolutegravir|mesh-list
14815775|NCT00867152|Etravirine|etravirine|mesh-list
14815776|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14815777|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14815778|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
14815779|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815780|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815781|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14815782|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14815783|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
14815784|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815785|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14815786|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14815787|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14815788|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14815789|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14815790|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14815791|NCT00867295|Cefazolin|cefazolin|mesh-list
14815792|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14815793|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815794|NCT00867672|Decitabine|decitabine|mesh-list
14815795|NCT00867672|Tretinoin|tretinoin|mesh-list
14815796|NCT00867672|Valproic Acid|valproic acid|mesh-list
14815797|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815798|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
14700472|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
14700473|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14700474|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14700475|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700476|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14815799|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815800|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196008|NCT03800693|Protective Agents|protective agents|mesh-ancestor
15196009|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
15196010|NCT03800693|Vitamins|vitamins|mesh-ancestor
14815801|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196011|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
14815802|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
14815803|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14815804|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
14815805|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
14815806|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815807|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815808|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
14815809|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14815810|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14815811|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14815812|NCT00867737|Fluticasone|fluticasone|mesh-list
14815813|NCT00867737|Budesonide|budesonide|mesh-list
14815814|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
15196012|NCT03800550|Clarithromycin|clarithromycin|mesh-list
15196013|NCT03800550|Bedaquiline|bedaquiline|mesh-list
15196014|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15196015|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196016|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15196017|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196018|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196019|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15196020|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15196021|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
15196022|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
14815815|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14815816|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14815817|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14815818|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14815819|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14815820|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
14815821|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815822|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815823|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14815824|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
14815825|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
14815826|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14815827|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
14815828|NCT00867737|Hormones|hormones|mesh-ancestor
14815829|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815830|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14815831|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14815832|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14815833|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815834|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815835|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815836|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
14815837|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
14815838|NCT00867867|Trace Elements|trace elements|mesh-ancestor
14815839|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
14815840|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815841|NCT00868010|Donepezil|donepezil|mesh-list
14815842|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14815843|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815844|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815845|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
14815846|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815847|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815848|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
14815849|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
14815850|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14815851|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
14815852|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815853|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815854|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14815855|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
14815856|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14815857|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14815858|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14815859|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815860|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815861|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815862|NCT00868062|Polygeline|polygeline|mesh-list
15196023|NCT03800264|Bisoprolol|bisoprolol|mesh-list
15196024|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196025|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14700477|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
14700478|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14700479|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
14700480|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700481|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14700482|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
14700483|NCT00395772|Coagulants|coagulants|mesh-ancestor
14700484|NCT00395902|Cinacalcet|cinacalcet|mesh-list
14700485|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14700486|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700487|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14700488|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
14700489|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700490|NCT00395915|Aripiprazole|aripiprazole|mesh-list
14700491|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700492|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700493|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14700494|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14700495|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14700496|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700497|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
14700498|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
14700499|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700500|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700501|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14700502|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14700503|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
14700504|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14700505|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14700506|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14700507|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14700508|NCT00395941|Pioglitazone|pioglitazone|mesh-list
14700509|NCT00395941|Acitretin|acitretin|mesh-list
14700510|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700511|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700512|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
14700513|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
14700514|NCT00396045|Lenalidomide|lenalidomide|mesh-list
14700515|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
14700516|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700517|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14700518|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14700519|NCT00396045|Growth Substances|growth substances|mesh-ancestor
14700520|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700521|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700522|NCT00396058|Methylphenidate|methylphenidate|mesh-list
14700523|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14700524|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700525|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14700526|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14700527|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700528|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700529|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
14700530|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700531|NCT00396071|Vildagliptin|vildagliptin|mesh-list
14700532|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700533|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700534|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14700535|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
14700536|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700537|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700538|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14700539|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700540|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700541|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14700542|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14700543|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196026|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
15196027|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
15196028|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196029|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196030|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15196031|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15196032|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15196033|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
15196034|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196035|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815863|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
14815864|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
14815865|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
14815866|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14815867|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
14815868|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14815869|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815870|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14815871|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14815872|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14815873|NCT00868179|Dabigatran|dabigatran|mesh-list
14815874|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
14815875|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14815876|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
14815877|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14815878|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815879|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
14815880|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
14815881|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14815882|NCT00868283|Protective Agents|protective agents|mesh-ancestor
14815883|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815884|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
14815885|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
14815886|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14815887|NCT00868413|Rituximab|rituximab|mesh-list
14815888|NCT00868413|Fludarabine|fludarabine|mesh-list
14815889|NCT00868413|Navitoclax|navitoclax|mesh-list
14815890|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14815891|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
14815892|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815893|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14815894|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14815895|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
14815896|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815897|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815898|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14815899|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14815900|NCT00868426|Budesonide|budesonide|mesh-list
14815901|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
14815902|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14815903|NCT00868426|Charcoal|charcoal|mesh-list
14815904|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14815905|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14815906|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
14815907|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815908|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815909|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14815910|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
14815911|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
14815912|NCT00868426|Hormones|hormones|mesh-ancestor
14815913|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14815914|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14815915|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14815916|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14815917|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
14815918|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815919|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815920|NCT00868426|Antidotes|antidotes|mesh-ancestor
14815921|NCT00868426|Protective Agents|protective agents|mesh-ancestor
14815922|NCT00868465|Lumefantrine|lumefantrine|mesh-list
14815923|NCT00868465|Artemether|artemether|mesh-list
14815924|NCT00868465|Piperaquine|piperaquine|mesh-list
14815925|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14815926|NCT00868465|Artenimol|artenimol|mesh-list
14815927|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
14815928|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14815929|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14815930|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815931|NCT00868491|Cisplatin|cisplatin|mesh-list
14815932|NCT00868491|Docetaxel|docetaxel|mesh-list
14815933|NCT00868491|Fluorouracil|fluorouracil|mesh-list
14815934|NCT00868491|Cetuximab|cetuximab|mesh-list
14815935|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815936|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
14815937|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
14815938|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
14815939|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815940|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
14815941|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815942|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14815943|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
14815944|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815945|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14815946|NCT00868569|Leucovorin|leucovorin|mesh-list
14815947|NCT00868569|Fluorouracil|fluorouracil|mesh-list
14815948|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
14815949|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
14815950|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196036|NCT03800797|Loxoprofen|loxoprofen|mesh-list
15196037|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15196038|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15196039|NCT03800797|Analgesics|analgesics|mesh-ancestor
15196040|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
15196041|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196042|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196043|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196044|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224241|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224242|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
15224243|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15224244|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15224245|NCT04251715|Leucovorin|leucovorin|mesh-list
15224246|NCT04251715|Dexamethasone|dexamethasone|mesh-list
15224247|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
15224248|NCT04251715|Fluorouracil|fluorouracil|mesh-list
15224249|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
15224250|NCT04251715|Irinotecan|irinotecan|mesh-list
15224251|NCT04251715|Floxuridine|floxuridine|mesh-list
15224252|NCT04251715|BB 1101|bb 1101|mesh-list
15224253|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
15224254|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14815951|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815952|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815953|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14815954|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
14815955|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815956|NCT00868569|Antidotes|antidotes|mesh-ancestor
14815957|NCT00868569|Protective Agents|protective agents|mesh-ancestor
14815958|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
14815959|NCT00868569|Vitamins|vitamins|mesh-ancestor
14815960|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
14815961|NCT00868634|Bevacizumab|bevacizumab|mesh-list
14815962|NCT00868634|Capecitabine|capecitabine|mesh-list
14815963|NCT00868634|Vinorelbine|vinorelbine|mesh-list
15224255|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
15224256|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
15224257|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815964|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14815965|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224258|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224259|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224260|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
15224261|NCT04251715|Hormones|hormones|mesh-ancestor
14815966|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14815967|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14815968|NCT00868634|Growth Substances|growth substances|mesh-ancestor
14815969|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815970|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
14815971|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14815972|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
14815973|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815974|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14815975|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
14815976|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14815977|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14815978|NCT00868738|Vitamin D|vitamin d|mesh-list
14815979|NCT00868738|Vitamins|vitamins|mesh-ancestor
14815980|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
14815981|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815982|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14815983|NCT00868764|Granisetron|granisetron|mesh-list
14815984|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
14815985|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
15196045|NCT03800290|Clenbuterol|clenbuterol|mesh-list
15196046|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14815986|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14815987|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14815988|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14815989|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14815990|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
14815991|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14815992|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14815993|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
14815994|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14815995|NCT00868829|Chromium|chromium|mesh-list
14815996|NCT00868829|Sirolimus|sirolimus|mesh-list
14815997|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14815998|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14815999|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14816000|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816001|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
14816002|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816003|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
14816004|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816005|NCT00868829|Trace Elements|trace elements|mesh-ancestor
14816006|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
14816007|NCT00868855|Bradykinin|bradykinin|mesh-list
14816008|NCT00868855|Kininogens|kininogens|mesh-list
14816009|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
14816010|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14816011|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14816012|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816013|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816014|NCT00868894|Latanoprost|latanoprost|mesh-list
14816015|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14816016|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14910564|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910565|NCT01357811|Protective Agents|protective agents|mesh-ancestor
14910566|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910567|NCT01357876|Metformin|metformin|mesh-list
14910568|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14910569|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910570|NCT01357902|Lamotrigine|lamotrigine|mesh-list
14910571|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
14910572|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14910573|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910574|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910575|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910576|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910577|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14910578|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910579|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910580|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910581|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14910582|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14910583|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
14910584|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910585|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15196047|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14816017|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
14816018|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
14816019|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14816020|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816021|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816022|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14816023|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816024|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14816025|NCT00868946|Ribavirin|ribavirin|mesh-list
14816026|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
14816027|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816028|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
14816029|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816030|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14816031|NCT00868985|Laxatives|laxatives|mesh-ancestor
14700544|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700545|NCT00396227|Pioglitazone|pioglitazone|mesh-list
14700546|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
14700547|NCT00396227|Vildagliptin|vildagliptin|mesh-list
14700548|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14700549|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700550|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700551|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14700552|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
14816032|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816033|NCT00869063|Diclofenac|diclofenac|mesh-list
14816034|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14816035|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14816036|NCT00869063|Analgesics|analgesics|mesh-ancestor
14816037|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
14816038|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816039|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816040|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816041|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816042|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14816043|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816044|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816045|NCT00869180|Diclofenac|diclofenac|mesh-list
14816046|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14816047|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14816048|NCT00869180|Analgesics|analgesics|mesh-ancestor
14816049|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
14816050|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816051|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816052|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816053|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816054|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14816055|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816056|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816057|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
14816058|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14816059|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700553|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700554|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816060|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
14816061|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816062|NCT00869193|Protective Agents|protective agents|mesh-ancestor
14816063|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816064|NCT00869219|Nepafenac|nepafenac|mesh-list
14816065|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14816066|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14816067|NCT00869219|Analgesics|analgesics|mesh-ancestor
15196048|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
15196049|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196050|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196051|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196052|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15196053|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
15196054|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196055|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14816068|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
15196056|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
14700555|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15196057|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
15196058|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
15196059|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
15196060|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196061|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15196062|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196063|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
15196064|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15196065|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196066|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196067|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15196068|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14700556|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14700557|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14700558|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
14700559|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700560|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14700561|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14700562|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728427|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728428|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728429|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728430|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14728431|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728432|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
14728433|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
14728434|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14728435|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14728436|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14728437|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
14728438|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728439|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14728440|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14728441|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728442|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728443|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14728444|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14728445|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
14728446|NCT00518375|Cyclosporine|cyclosporine|mesh-list
14728447|NCT00518375|Sirolimus|sirolimus|mesh-list
14728448|NCT00518375|Cyclosporins|cyclosporins|mesh-list
14728449|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728450|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728451|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728452|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
14728453|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728454|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
14728455|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728456|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728457|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728458|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14728459|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728460|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14728461|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728462|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
14728463|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14728464|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728465|NCT00518466|Topiramate|topiramate|mesh-list
14728466|NCT00518466|Phentermine|phentermine|mesh-list
14728467|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
14728468|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14728469|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728470|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14728471|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
14728472|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14728473|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
14728474|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
14728475|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728476|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
14728477|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196069|NCT03800433|Protective Agents|protective agents|mesh-ancestor
14728478|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196070|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196071|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
15196072|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15196073|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
15196074|NCT03799835|Atezolizumab|atezolizumab|mesh-list
15196075|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
15196076|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196077|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15196078|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
15196079|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196080|NCT03799809|Voriconazole|voriconazole|mesh-list
15196081|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
15196082|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196083|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15196084|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14816069|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816070|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816071|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816072|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816073|NCT00869232|Thalidomide|thalidomide|mesh-list
14816074|NCT00869232|Dexamethasone|dexamethasone|mesh-list
14816075|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
14816076|NCT00869232|Melphalan|melphalan|mesh-list
14816077|NCT00869232|Doxorubicin|doxorubicin|mesh-list
14816078|NCT00869232|Etoposide|etoposide|mesh-list
14816079|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14816080|NCT00869232|Bortezomib|bortezomib|mesh-list
14816081|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816082|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
14816083|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816084|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816085|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14816086|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
14816087|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816088|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816089|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14816090|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816091|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
14816092|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
14816093|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816094|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816095|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
14816096|NCT00869232|Hormones|hormones|mesh-ancestor
14816097|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816098|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14816099|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14816100|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14816101|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14816102|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816103|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14816104|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
14816105|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14816106|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816107|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14816108|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14816109|NCT00869232|Growth Substances|growth substances|mesh-ancestor
14816110|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
14816111|NCT00869271|Leucovorin|leucovorin|mesh-list
14816112|NCT00869271|Fluorouracil|fluorouracil|mesh-list
14816113|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
14816114|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
15196085|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196086|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196087|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15196088|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
15196089|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196090|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196091|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14816115|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816116|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14816117|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700563|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
14816118|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816119|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
14816120|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196092|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
15196093|NCT03799536|Sotalol|sotalol|mesh-list
15196094|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14816121|NCT00869271|Antidotes|antidotes|mesh-ancestor
14816122|NCT00869271|Protective Agents|protective agents|mesh-ancestor
14816123|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
14816124|NCT00869271|Vitamins|vitamins|mesh-ancestor
14816125|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
14816126|NCT00869310|Dexamethasone|dexamethasone|mesh-list
14816127|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
14816128|NCT00869310|Aprepitant|aprepitant|mesh-list
14816129|NCT00869310|Metoclopramide|metoclopramide|mesh-list
14816130|NCT00869310|BB 1101|bb 1101|mesh-list
14816131|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816132|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
14816133|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
14816134|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816135|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816136|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816137|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
15196095|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14700564|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14700565|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14816138|NCT00869310|Hormones|hormones|mesh-ancestor
14816139|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816140|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14816141|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816142|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
14816143|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816144|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816145|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14816146|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816147|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14816148|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14816149|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
14816150|NCT00869427|Ascorbic Acid|ascorbic acid|mesh-list
14816151|NCT00869427|Vitamins|vitamins|mesh-ancestor
14816152|NCT00869427|Micronutrients|micronutrients|mesh-ancestor
14816153|NCT00869427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816154|NCT00869427|Antioxidants|antioxidants|mesh-ancestor
14816155|NCT00869427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816156|NCT00869427|Protective Agents|protective agents|mesh-ancestor
14816157|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14816158|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
14816159|NCT00869570|Capecitabine|capecitabine|mesh-list
14816160|NCT00869570|Sorafenib|sorafenib|mesh-list
14816161|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14816162|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
14816163|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816164|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816165|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14816166|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816167|NCT00869596|Fluticasone|fluticasone|mesh-list
14816168|NCT00869596|Xhance|xhance|mesh-list
14816169|NCT00869596|Albuterol|albuterol|mesh-list
14816170|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816171|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14816172|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
14816173|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816174|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196096|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
15196097|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196098|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196099|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700566|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14700567|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14700568|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
14700569|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14700570|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
14700571|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700572|NCT00396396|Expectorants|expectorants|mesh-ancestor
14700573|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
14700574|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14700575|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
14700576|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816175|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14816176|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
14816177|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
14816178|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14816179|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
14816180|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14816181|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14816182|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14816183|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14816184|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14816185|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816186|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816187|NCT00869700|Lumefantrine|lumefantrine|mesh-list
14816188|NCT00869700|Artemether|artemether|mesh-list
14816189|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14816190|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
14816191|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14816192|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14816193|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816194|NCT00869752|Etoposide|etoposide|mesh-list
14816195|NCT00869752|Antibodies|antibodies|mesh-list
14816196|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14816197|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
14816198|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816199|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816200|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14816201|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14816202|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14816203|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816204|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816205|NCT00869765|Cycloserine|cycloserine|mesh-list
14816206|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14816207|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816208|NCT00869765|Renal Agents|renal agents|mesh-ancestor
14816209|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14816210|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
14816211|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14816212|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
14816213|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816214|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
14816215|NCT00869856|Hematinics|hematinics|mesh-ancestor
14816216|NCT00869869|Melatonin|melatonin|mesh-list
14816217|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
14816218|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816219|NCT00869869|Protective Agents|protective agents|mesh-ancestor
14816220|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196100|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15196101|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
15196102|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
15196103|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196104|NCT03799406|Vitamin D|vitamin d|mesh-list
15196105|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
15196106|NCT03799406|Vitamins|vitamins|mesh-ancestor
15196107|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
15196108|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196109|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15196110|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14816221|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816222|NCT00869908|Insulin|insulin|mesh-list
14816223|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14816224|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
14816225|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
14816226|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14816227|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
14816228|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
14816229|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14816230|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816231|NCT00869973|Dexamethasone|dexamethasone|mesh-list
14816232|NCT00869973|Aprepitant|aprepitant|mesh-list
14816233|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816234|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
14816235|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
14816236|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816237|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816238|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816239|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
14816240|NCT00869973|Hormones|hormones|mesh-ancestor
15196111|NCT03799224|Decitabine|decitabine|mesh-list
14816241|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816242|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14816243|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816244|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14816245|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816246|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816247|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14816248|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14816249|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816250|NCT00870038|Paclitaxel|paclitaxel|mesh-list
14816251|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14816252|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816253|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14816254|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14816255|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14816256|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816257|NCT00870142|Amlodipine|amlodipine|mesh-list
14816258|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14816259|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14816260|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816261|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816262|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14816263|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816264|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
14816265|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14816266|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14816267|NCT00870220|Estradiol|estradiol|mesh-list
14816268|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14816269|NCT00870220|Estrogens|estrogens|mesh-ancestor
14816270|NCT00870220|Hormones|hormones|mesh-ancestor
14816271|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816272|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816273|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14816274|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
14816275|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14816276|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14816277|NCT00870272|Misoprostol|misoprostol|mesh-list
14816278|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14816279|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
14816280|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14816281|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816282|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14700577|NCT00396396|Protective Agents|protective agents|mesh-ancestor
14700578|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700579|NCT00396396|Antidotes|antidotes|mesh-ancestor
14700580|NCT00396487|Fluorouracil|fluorouracil|mesh-list
14700581|NCT00396487|Capecitabine|capecitabine|mesh-list
14700582|NCT00396487|Irinotecan|irinotecan|mesh-list
14700583|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
14700584|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700585|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700586|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700587|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700588|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
14700589|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700590|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14700591|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14700592|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700593|NCT00396500|Vitamin A|vitamin a|mesh-list
14700594|NCT00396500|Albendazole|albendazole|mesh-list
14700595|NCT00396500|Vitamins|vitamins|mesh-ancestor
14700596|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
14700597|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700598|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700599|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700600|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
14700601|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14700602|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700603|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
14700604|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14700605|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14700606|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
14700607|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
14700608|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
14700609|NCT00396513|Metformin|metformin|mesh-list
14700610|NCT00396513|Simvastatin|simvastatin|mesh-list
14700611|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700612|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700613|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14700614|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14700615|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
14700616|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700617|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14700618|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15196112|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15196113|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
15196114|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196115|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196116|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196117|NCT03799315|Nicotine|nicotine|mesh-list
15196118|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15196119|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
15196120|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196121|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196122|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15196123|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15196124|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
15196125|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700619|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700620|NCT00396526|Amoxicillin|amoxicillin|mesh-list
14700621|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14700622|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700623|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700624|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14700625|NCT00396526|Renal Agents|renal agents|mesh-ancestor
14700626|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
14700627|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14700628|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14700629|NCT00396578|Vancomycin|vancomycin|mesh-list
14700630|NCT00396578|Gentamicins|gentamicins|mesh-list
14700631|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700632|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700633|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14816283|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816284|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
14816285|NCT00870298|Trimethoprim|trimethoprim|mesh-list
14816286|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
14816287|NCT00870298|Warfarin|warfarin|mesh-list
14816288|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
14816289|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14816290|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816291|NCT00870298|Renal Agents|renal agents|mesh-ancestor
14816292|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
14816293|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14816294|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14816295|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14816296|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816297|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816298|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14816299|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14816300|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14816301|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
14816302|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
14816303|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816304|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816305|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816306|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
14816307|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14816308|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816309|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196126|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700634|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700635|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196127|NCT03799172|Echinocandins|echinocandins|mesh-list
14700636|NCT00396604|Maleic acid|maleic acid|mesh-list
15196128|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
15196129|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196130|NCT03799120|Tamsulosin|tamsulosin|mesh-list
15196131|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15196132|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15196133|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15196134|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
15196135|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196136|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196137|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196138|NCT03799120|Urological Agents|urological agents|mesh-ancestor
15196139|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
15196140|NCT03799094|Vitamins|vitamins|mesh-ancestor
15196141|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
14816310|NCT00870337|Everolimus|everolimus|mesh-list
14816311|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816312|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816313|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
14816314|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816315|NCT00870402|Spironolactone|spironolactone|mesh-list
14816316|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14816317|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
14816318|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816319|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816320|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14816321|NCT00870402|Diuretics|diuretics|mesh-ancestor
14816322|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
14816323|NCT00870441|Valacyclovir|valacyclovir|mesh-list
14816324|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
14816325|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816326|NCT00870480|Finasteride|finasteride|mesh-list
14816327|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14816328|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15196142|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196143|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
15196144|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196145|NCT03799094|Protective Agents|protective agents|mesh-ancestor
15196146|NCT03798912|Octreotide|octreotide|mesh-list
15196147|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816329|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816330|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816331|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
14816332|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816333|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816334|NCT00870480|Urological Agents|urological agents|mesh-ancestor
14816335|NCT00870532|Sorafenib|sorafenib|mesh-list
14816336|NCT00870532|Vinorelbine|vinorelbine|mesh-list
14816337|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816338|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14816339|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816340|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816341|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14816342|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
15196148|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15196149|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196150|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
15196151|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15196152|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
15196153|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
15196154|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196155|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196156|NCT03798834|Anesthetics|anesthetics|mesh-list
15196157|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196158|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196159|NCT03798821|Sulfalene|sulfalene|mesh-list
15196160|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196161|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15196162|NCT03798821|Renal Agents|renal agents|mesh-ancestor
14294687|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196163|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
15196164|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14294688|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294689|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14816343|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
15196165|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15196166|NCT03798600|Caspofungin|caspofungin|mesh-list
14294690|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
14294691|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294692|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294693|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294694|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294695|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14294696|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14816344|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
14816345|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
14816346|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816347|NCT00870571|Amlodipine|amlodipine|mesh-list
14816348|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14816349|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14816350|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816351|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816352|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14294697|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15196167|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
15196168|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196169|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196170|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196171|NCT03798522|Nalbuphine|nalbuphine|mesh-list
14294698|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294699|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15196172|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15196173|NCT03798522|Narcotics|narcotics|mesh-ancestor
15196174|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196175|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196176|NCT03798522|Analgesics|analgesics|mesh-ancestor
15196177|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
14700637|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700638|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700639|NCT00396669|Bupropion|bupropion|mesh-list
14816353|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816354|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
14816355|NCT00870636|Bevacizumab|bevacizumab|mesh-list
14816356|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196178|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196179|NCT03798405|Analgesics|analgesics|mesh-list
15196180|NCT03798405|Narcotics|narcotics|mesh-list
15196181|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
15196182|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700640|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14700641|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700642|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700643|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14700644|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14700645|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816357|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816358|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14816359|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14816360|NCT00870636|Growth Substances|growth substances|mesh-ancestor
14816361|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816362|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
14816363|NCT00870714|Ketoconazole|ketoconazole|mesh-list
14816364|NCT00870714|Docetaxel|docetaxel|mesh-list
14816365|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816366|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
14816367|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
14816368|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
14816369|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816370|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
14816371|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816372|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14816373|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14816374|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196183|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196184|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196185|NCT03798392|Anesthetics|anesthetics|mesh-list
15196186|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196187|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816375|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14816376|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
14816377|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816378|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816379|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14816380|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14816381|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14816382|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
14910586|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910587|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910588|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910589|NCT01358045|Calcitriol|calcitriol|mesh-list
14910590|NCT01358045|Diclofenac|diclofenac|mesh-list
14910591|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14910592|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910593|NCT01358045|Analgesics|analgesics|mesh-ancestor
14910594|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
14910595|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910596|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910597|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910598|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14910599|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14910600|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910601|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910602|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910603|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14910604|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910605|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14910606|NCT01358045|Vitamins|vitamins|mesh-ancestor
14910607|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
14910608|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14910609|NCT01358071|Doxorubicin|doxorubicin|mesh-list
14910610|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14910611|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14910612|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910613|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14910614|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14910615|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910616|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910617|NCT01358240|Econazole|econazole|mesh-list
14700646|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700647|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
14700648|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700649|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700650|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14700651|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14700652|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700653|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
14700654|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816383|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
14816384|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14816385|NCT00870883|Deferoxamine|deferoxamine|mesh-list
14816386|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
14816387|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816388|NCT00870883|Expectorants|expectorants|mesh-ancestor
14816389|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
14816390|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14816391|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
14816392|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816393|NCT00870883|Protective Agents|protective agents|mesh-ancestor
14816394|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816395|NCT00870883|Antidotes|antidotes|mesh-ancestor
14816396|NCT00870883|Siderophores|siderophores|mesh-ancestor
14816397|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14816398|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
14816399|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
14816400|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
14816401|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14816402|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816403|NCT00870961|Vitamins|vitamins|mesh-ancestor
14816404|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
14816405|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14816406|NCT00870987|Vaccines|vaccines|mesh-list
14816407|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
14816408|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816409|NCT00871039|Midazolam|midazolam|mesh-list
14816410|NCT00871039|Propofol|propofol|mesh-list
14816411|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14816412|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816413|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816414|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14816415|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
14816416|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
14816417|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14816418|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14816419|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14816420|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816421|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
14816422|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
14816423|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816424|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816425|NCT00871052|Vitamin D|vitamin d|mesh-list
14816426|NCT00871052|Calcipotriene|calcipotriene|mesh-list
14816427|NCT00871052|Vitamins|vitamins|mesh-ancestor
14816428|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
14816429|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816430|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14816431|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
14816432|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
14816433|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816434|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
14816435|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14816436|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14816437|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816438|NCT00871065|Urological Agents|urological agents|mesh-ancestor
14816439|NCT00871104|Vancomycin|vancomycin|mesh-list
14816440|NCT00871104|Imipenem|imipenem|mesh-list
14816441|NCT00871104|Fosfomycin|fosfomycin|mesh-list
14816442|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14816443|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816444|NCT00871156|Chloroquine|chloroquine|mesh-list
14816445|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14816446|NCT00871156|Tafenoquine|tafenoquine|mesh-list
14816447|NCT00871156|Amebicides|amebicides|mesh-ancestor
14816448|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14816449|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14816450|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816451|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
14816452|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816453|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14816454|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14816455|NCT00871156|Analgesics|analgesics|mesh-ancestor
14816456|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
14816457|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816458|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816459|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816460|NCT00871156|Filaricides|filaricides|mesh-ancestor
14816461|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
14816462|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
14816463|NCT00871208|Retapamulin|retapamulin|mesh-list
14816464|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
14816465|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14816466|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14816467|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14816468|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
14816469|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
14816470|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816471|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14816472|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816473|NCT00871247|Finasteride|finasteride|mesh-list
14816474|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15196188|NCT03798314|Nivolumab|nivolumab|mesh-list
15196189|NCT03798314|Pomalidomide|pomalidomide|mesh-list
15196190|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196191|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196192|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15196193|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196194|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
15196195|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196196|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14816475|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14816476|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816477|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816478|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
14816479|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816480|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816481|NCT00871247|Urological Agents|urological agents|mesh-ancestor
14816482|NCT00871273|Capecitabine|capecitabine|mesh-list
14816483|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14816484|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
14816485|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816486|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816487|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14816488|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14816489|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14816490|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816491|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816492|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816493|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816494|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14816495|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
14816496|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816497|NCT00871442|Fentanyl|fentanyl|mesh-list
14816498|NCT00871442|Bupivacaine|bupivacaine|mesh-list
14816499|NCT00871442|Anesthetics|anesthetics|mesh-list
15196197|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14700655|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
14700656|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700657|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14700658|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14700659|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
14700660|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700661|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700662|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14700663|NCT00396721|Sirolimus|sirolimus|mesh-list
14700664|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14700665|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14700666|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700667|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700668|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14700669|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700670|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
14700671|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816500|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
14294700|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14294701|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
14294702|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
14294703|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700672|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
14700673|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700674|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14700675|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14700676|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
14700677|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700678|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700679|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14700680|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
14700681|NCT00396734|Topiramate|topiramate|mesh-list
14700682|NCT00396734|Modafinil|modafinil|mesh-list
14700683|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
15196198|NCT03798314|Growth Substances|growth substances|mesh-ancestor
15196199|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
15196200|NCT03798106|Durvalumab|durvalumab|mesh-list
14700684|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700685|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700686|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14816501|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196201|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196202|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196203|NCT03798119|Tenofovir|tenofovir|mesh-list
15196204|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
15196205|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196206|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15196207|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15196208|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816502|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816503|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
14816504|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816505|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14816506|NCT00871442|Narcotics|narcotics|mesh-ancestor
14816507|NCT00871442|Analgesics|analgesics|mesh-ancestor
14816508|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14816509|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14816510|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
14700687|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14816511|NCT00871455|Baclofen|baclofen|mesh-list
15196209|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196210|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15196211|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15196212|NCT03798054|Insulin|insulin|mesh-list
15196213|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15196214|NCT03798054|Metformin|metformin|mesh-list
15196215|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
15196216|NCT03798054|Lixisenatide|lixisenatide|mesh-list
15196217|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15196218|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15196219|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196220|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224262|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224263|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224264|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224265|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
15224266|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224267|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294704|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
14816512|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14294705|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14816513|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196221|NCT03799822|Vitamin K|vitamin k|mesh-list
15196222|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
14700688|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14700689|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14700690|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700691|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
14700692|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14700693|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14700694|NCT00396747|Prednisolone|prednisolone|mesh-list
14700695|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
14700696|NCT00396747|Methotrexate|methotrexate|mesh-list
15196223|NCT03799822|Vitamins|vitamins|mesh-ancestor
15196224|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
15196225|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196226|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15196227|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
15196228|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15196229|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
15196230|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196231|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196232|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
15196233|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15196234|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15196235|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
15196236|NCT03799822|Coagulants|coagulants|mesh-ancestor
15196237|NCT03799900|Ketamine|ketamine|mesh-list
15196238|NCT03799900|Analgesics|analgesics|mesh-ancestor
15196239|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
15196240|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196241|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196242|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15196243|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15196244|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
15196245|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
15196246|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196247|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15196248|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15196249|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196250|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196251|NCT03799757|Bupivacaine|bupivacaine|mesh-list
15196252|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196253|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
14700697|NCT00396747|Infliximab|infliximab|mesh-list
14700698|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14700699|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
14700700|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14700701|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
14700702|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14700703|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700704|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15196254|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196255|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196256|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
15196257|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196258|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
15196259|NCT03799913|Fludarabine|fludarabine|mesh-list
15196260|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15196261|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
15196262|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196263|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196264|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15196265|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
15196266|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196267|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196268|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15196269|NCT03797833|Anesthetics|anesthetics|mesh-list
15196270|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224268|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
15196271|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196272|NCT03799601|Carboplatin|carboplatin|mesh-list
14700705|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
14700706|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700707|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700708|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
14700709|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700710|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14700711|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700712|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
14700713|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816514|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14816515|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816516|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14816517|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
14816518|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
14816519|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816520|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816521|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14816522|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14816523|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816524|NCT00871507|Incretins|incretins|mesh-ancestor
14816525|NCT00871507|Hormones|hormones|mesh-ancestor
14816526|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816527|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14728479|NCT00518479|Amlodipine|amlodipine|mesh-list
14816528|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
14816529|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816530|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816531|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
14816532|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
15196273|NCT03799601|Docetaxel|docetaxel|mesh-list
15196274|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196275|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
15196276|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
15196277|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
15196278|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196279|NCT03797703|Lidocaine|lidocaine|mesh-list
15196280|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196281|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
15196282|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196283|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196284|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
15196285|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196286|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15196287|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15196288|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15196289|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15196290|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196291|NCT03797729|Tirofiban|tirofiban|mesh-list
15196292|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15196293|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15196294|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196295|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15196296|NCT03797924|Ropivacaine|ropivacaine|mesh-list
15196297|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196298|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
15196299|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14700714|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14816533|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14816534|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14816535|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
14816536|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816537|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
14816538|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816539|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816540|NCT00871546|Bortezomib|bortezomib|mesh-list
14816541|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
14816542|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816543|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700715|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14700716|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
14816544|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15196300|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196301|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
15196302|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196303|NCT03797625|Cisplatin|cisplatin|mesh-list
15196304|NCT03797625|Irinotecan|irinotecan|mesh-list
15196305|NCT03797625|Endostar protein|endostar protein|mesh-list
15196306|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196307|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15196308|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15196309|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196310|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196311|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15196312|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15196313|NCT03797625|Growth Substances|growth substances|mesh-ancestor
15196314|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196315|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
15196316|NCT03799445|Nivolumab|nivolumab|mesh-list
14700717|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
14700718|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700719|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14700720|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
14700721|NCT00396747|Hormones|hormones|mesh-ancestor
14700722|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700723|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14700724|NCT00396747|Protective Agents|protective agents|mesh-ancestor
14700725|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14700726|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
14700727|NCT00396760|Aprotinin|aprotinin|mesh-list
14700728|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14816545|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
15196317|NCT03799445|Ipilimumab|ipilimumab|mesh-list
15196318|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196319|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196320|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15196321|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196322|NCT03797508|Progesterone|progesterone|mesh-list
15196323|NCT03797508|Progestins|progestins|mesh-ancestor
15196324|NCT03797508|Hormones|hormones|mesh-ancestor
15196325|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196326|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196327|NCT03797079|Bupivacaine|bupivacaine|mesh-list
15196328|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196329|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
15196330|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196331|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196332|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
15196333|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196334|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
15196335|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
15196336|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196337|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
15196338|NCT03797443|Gemcitabine|gemcitabine|mesh-list
15196339|NCT03797443|Paclitaxel|paclitaxel|mesh-list
15196340|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15196341|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196342|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
15196343|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
15196344|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
15196345|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196346|NCT03797443|Vitamins|vitamins|mesh-ancestor
14700729|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14700730|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816546|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816547|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14816548|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14816549|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816550|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14816551|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14816552|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
14816553|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816554|NCT00871910|Dexamethasone|dexamethasone|mesh-list
14816555|NCT00871910|Ondansetron|ondansetron|mesh-list
14816556|NCT00871910|Aprepitant|aprepitant|mesh-list
14816557|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14816558|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
14816559|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
14816560|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816561|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816562|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816563|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
14816564|NCT00871910|Hormones|hormones|mesh-ancestor
14816565|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816566|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14816567|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700731|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
14700732|NCT00396760|Coagulants|coagulants|mesh-ancestor
14700733|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14700734|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14700735|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
14816568|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
14816569|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14816570|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14700736|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700737|NCT00396786|Enoxaparin|enoxaparin|mesh-list
14700738|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
14816571|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
14816572|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816573|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196347|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
15196348|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700739|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14816574|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14816575|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14816576|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816577|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15196349|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15196350|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
15196351|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
15196352|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196353|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196354|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15196355|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
15196356|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
15196357|NCT03797443|Protective Agents|protective agents|mesh-ancestor
15196358|NCT03796884|Linaclotide|linaclotide|mesh-list
15196359|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14816578|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14816579|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14816580|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
14816581|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816582|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14816583|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196360|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
15196361|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196362|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196363|NCT03797222|Vitamin E|vitamin e|mesh-list
15196364|NCT03797222|Tocopherols|tocopherols|mesh-list
15196365|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
15196366|NCT03797222|Vitamins|vitamins|mesh-ancestor
14816584|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816585|NCT00872131|Sertraline|sertraline|mesh-list
14816586|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
14816587|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816588|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14816589|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14816590|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816591|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816592|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816593|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
14816594|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816595|NCT00872144|Nabiximols|nabiximols|mesh-list
14816596|NCT00872144|Analgesics|analgesics|mesh-ancestor
14816597|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
14816598|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816599|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816600|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
14816601|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14816602|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816603|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14816604|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14816605|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816606|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816607|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816608|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14816609|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14816610|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14816611|NCT00872235|Quinapril|quinapril|mesh-list
15196367|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
15196368|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196369|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
15196370|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196371|NCT03797222|Protective Agents|protective agents|mesh-ancestor
15196372|NCT03796975|Metformin|metformin|mesh-list
15196373|NCT03796975|Pioglitazone|pioglitazone|mesh-list
15196374|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15196375|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196376|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15196377|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196378|NCT03796572|Ropivacaine|ropivacaine|mesh-list
15196379|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196380|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
15196381|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196382|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196383|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
15196384|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196385|NCT03796585|Vaccines|vaccines|mesh-list
15196386|NCT03796585|Immunologic Factors|immunologic factors|mesh-ancestor
15196387|NCT03796585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196388|NCT03796533|Posaconazole|posaconazole|mesh-list
15196389|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
15196390|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196391|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15196392|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15196393|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15196394|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14816612|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14816613|NCT00872235|Diuretics|diuretics|mesh-ancestor
14816614|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
14816615|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816616|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14816617|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816618|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816619|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14816620|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
14816621|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816622|NCT00872248|Anesthetics|anesthetics|mesh-list
14816623|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196395|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15196396|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196397|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196398|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15196399|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
15196400|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196401|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196402|NCT03796403|Diclofenac|diclofenac|mesh-list
14700740|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
14700741|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14700742|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
14700743|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700744|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700745|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
14700746|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14700747|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14700748|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
14700749|NCT00396799|Estrogens|estrogens|mesh-list
14700750|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14700751|NCT00396799|Hormones|hormones|mesh-ancestor
14700752|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700753|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700754|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14700755|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14700756|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
14700757|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14700758|NCT00396851|Metformin|metformin|mesh-list
14700759|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700760|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700761|NCT00396929|Paclitaxel|paclitaxel|mesh-list
14700762|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14700763|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700764|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14700765|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14700766|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14700767|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700768|NCT00396968|Plerixafor|plerixafor|mesh-list
14700769|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14700770|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14700771|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
14816624|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816625|NCT00872274|Sumatriptan|sumatriptan|mesh-list
14816626|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14816627|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14816628|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14816629|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
14816630|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816631|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816632|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816633|NCT00872365|Micronutrients|micronutrients|mesh-list
14816634|NCT00872365|Trace Elements|trace elements|mesh-list
14816635|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816636|NCT00872378|Exenatide|exenatide|mesh-list
14816637|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14816638|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816639|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14816640|NCT00872378|Incretins|incretins|mesh-ancestor
14816641|NCT00872378|Hormones|hormones|mesh-ancestor
14816642|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816643|NCT00872417|Lamivudine|lamivudine|mesh-list
14816644|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14816645|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14816646|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816647|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816648|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
14816649|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816650|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14816651|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14816652|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
14816653|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14816654|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14816655|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816656|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
14816657|NCT00872469|Coagulants|coagulants|mesh-ancestor
14816658|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
14816659|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14816660|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816661|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14816662|NCT00872586|Olmesartan|olmesartan|mesh-list
14816663|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14816664|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14816665|NCT00872586|Diuretics|diuretics|mesh-ancestor
14816666|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
14816667|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816668|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14816669|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816670|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816671|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14816672|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14816673|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
14816674|NCT00872625|Docetaxel|docetaxel|mesh-list
14816675|NCT00872625|Fluorouracil|fluorouracil|mesh-list
14816676|NCT00872625|Epirubicin|epirubicin|mesh-list
14816677|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816678|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
15196403|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15196404|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15196405|NCT03796403|Analgesics|analgesics|mesh-ancestor
15196406|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
15196407|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196408|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196409|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196410|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196411|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14816679|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816680|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816681|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14816682|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
14816683|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816684|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816685|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14816686|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
14816687|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
14816688|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
14816689|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
14816690|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14816691|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14816692|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14816693|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14816694|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816695|NCT00872651|Timolol|timolol|mesh-list
14816696|NCT00872651|Travoprost|travoprost|mesh-list
14816697|NCT00872651|Latanoprost|latanoprost|mesh-list
14816698|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14816699|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14816700|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14816701|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816702|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816703|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816704|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14816705|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14816706|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14816707|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14816708|NCT00872664|Carotenoids|carotenoids|mesh-list
14816709|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
14816710|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816711|NCT00872664|Protective Agents|protective agents|mesh-ancestor
14816712|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816713|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14816714|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
14816715|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816716|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14816717|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14816718|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816719|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816720|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14816721|NCT00872781|Quinapril|quinapril|mesh-list
14816722|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14816723|NCT00872781|Diuretics|diuretics|mesh-ancestor
14816724|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
14816725|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816726|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14816727|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816728|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816729|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14816730|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
14816731|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910618|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
14910619|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910620|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14910621|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14910622|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910623|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910624|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14910625|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
14910626|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910627|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910628|NCT01358253|Cytarabine|cytarabine|mesh-list
14910629|NCT01358253|Dexamethasone|dexamethasone|mesh-list
14910630|NCT01358253|Prednisone|prednisone|mesh-list
14910631|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
14910632|NCT01358253|Rituximab|rituximab|mesh-list
14910633|NCT01358253|Doxorubicin|doxorubicin|mesh-list
14910634|NCT01358253|Methotrexate|methotrexate|mesh-list
14910635|NCT01358253|Vincristine|vincristine|mesh-list
14910636|NCT01358253|Asparaginase|asparaginase|mesh-list
14910637|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
14910638|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14910639|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
15196412|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196413|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196414|NCT03796507|Temozolomide|temozolomide|mesh-list
14816732|NCT00872924|Sumatriptan|sumatriptan|mesh-list
14816733|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14816734|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14816735|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14816736|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
14816737|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816738|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816739|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816740|NCT00872963|Vaccines|vaccines|mesh-list
14816741|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
14816742|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816743|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14816744|NCT00872976|Dasatinib|dasatinib|mesh-list
14816745|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14816746|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
14816747|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816748|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816749|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14816750|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816751|NCT00873002|Sorafenib|sorafenib|mesh-list
14816752|NCT00873002|Panobinostat|panobinostat|mesh-list
14816753|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816754|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14816755|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816756|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196415|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15196416|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
15196417|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196418|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196419|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
15196420|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15196421|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
15196422|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15196423|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
15196424|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196425|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196426|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
15196427|NCT03796364|Endostar protein|endostar protein|mesh-list
15196428|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15196429|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15196430|NCT03796364|Growth Substances|growth substances|mesh-ancestor
15196431|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196432|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
15196433|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224269|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15224270|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224271|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
15224272|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15224273|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15224274|NCT04251715|Antidotes|antidotes|mesh-ancestor
15224275|NCT04251715|Protective Agents|protective agents|mesh-ancestor
15224276|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
15224277|NCT04251715|Vitamins|vitamins|mesh-ancestor
15224278|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
15224279|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
15224280|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224281|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224282|NCT04234464|Budesonide|budesonide|mesh-list
15224283|NCT04234464|Albuterol|albuterol|mesh-list
15224284|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224285|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15224286|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
15224287|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224288|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224289|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14816757|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15224290|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14816758|NCT00873197|Granisetron|granisetron|mesh-list
15196434|NCT03795909|Dexamethasone|dexamethasone|mesh-list
15196435|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196436|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
15196437|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
15196438|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196439|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196440|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196441|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
15196442|NCT03795909|Hormones|hormones|mesh-ancestor
15196443|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196444|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15196445|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196446|NCT03795844|Liver Extracts|liver extracts|mesh-list
15196447|NCT03795844|Hematinics|hematinics|mesh-ancestor
15196448|NCT03795792|Curcumin|curcumin|mesh-list
15196449|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15196450|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15196451|NCT03795792|Analgesics|analgesics|mesh-ancestor
15196452|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
14816759|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
14816760|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
14816761|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816762|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816763|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816764|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14816765|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
14816766|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816767|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816768|NCT00873210|Sunitinib|sunitinib|mesh-list
14816769|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816770|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14816771|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14816772|NCT00873210|Growth Substances|growth substances|mesh-ancestor
14816773|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816774|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
14816775|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14816776|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196453|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700772|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700773|NCT00397059|Citalopram|citalopram|mesh-list
14700774|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14700775|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14700776|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700777|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700778|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700779|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
14816777|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816778|NCT00873223|Liraglutide|liraglutide|mesh-list
14816779|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
14816780|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14816781|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816782|NCT00873223|Incretins|incretins|mesh-ancestor
14816783|NCT00873223|Hormones|hormones|mesh-ancestor
14816784|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816785|NCT00873236|Interferons|interferons|mesh-list
14816786|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
14816787|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
14816788|NCT00873236|Bevacizumab|bevacizumab|mesh-list
14816789|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14816790|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816791|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14816792|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14816793|NCT00873236|Growth Substances|growth substances|mesh-ancestor
14816794|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816795|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
14816796|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
14816797|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816798|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
14816799|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14816800|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14816801|NCT00873262|Estropipate|estropipate|mesh-list
14816802|NCT00873262|Estradiol|estradiol|mesh-list
14816803|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14816804|NCT00873262|Estrone|estrone|mesh-list
14816805|NCT00873262|Progesterone|progesterone|mesh-list
14816806|NCT00873262|Estrogens|estrogens|mesh-ancestor
14816807|NCT00873262|Hormones|hormones|mesh-ancestor
14816808|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816809|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816810|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14816811|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
14816812|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14816813|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14816814|NCT00873262|Progestins|progestins|mesh-ancestor
14816815|NCT00873275|Leucovorin|leucovorin|mesh-list
14816816|NCT00873275|Bevacizumab|bevacizumab|mesh-list
14816817|NCT00873275|Fluorouracil|fluorouracil|mesh-list
14816818|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
14816819|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14816820|NCT00873275|Calcium|calcium|mesh-list
14816821|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
14816822|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14816823|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816824|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14816825|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14816826|NCT00873275|Growth Substances|growth substances|mesh-ancestor
14816827|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816828|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
14816829|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14816830|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
14816831|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816832|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700780|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700781|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14700782|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700783|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700784|NCT00397072|Sagopilone|sagopilone|mesh-list
14700785|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700786|NCT00397098|Amibegron|amibegron|mesh-list
14700787|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14700788|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14700789|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14700790|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196454|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196455|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196456|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196457|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196458|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196459|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196460|NCT03795584|Hemostatics|hemostatics|mesh-list
15196461|NCT03795584|Coagulants|coagulants|mesh-ancestor
15196462|NCT03795571|Gemcitabine|gemcitabine|mesh-list
15196463|NCT03795571|Dexamethasone|dexamethasone|mesh-list
14816833|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816834|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
14816835|NCT00873275|Antidotes|antidotes|mesh-ancestor
14816836|NCT00873275|Protective Agents|protective agents|mesh-ancestor
14816837|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
14816838|NCT00873275|Vitamins|vitamins|mesh-ancestor
14816839|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
14816840|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14816841|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14816842|NCT00873340|Interferons|interferons|mesh-list
14816843|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
14816844|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816845|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
14816846|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816847|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14816848|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
14816849|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816850|NCT00873353|Capecitabine|capecitabine|mesh-list
14816851|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14816852|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14816853|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
14816854|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816855|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816856|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14816857|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816858|NCT00873366|Tamoxifen|tamoxifen|mesh-list
14816859|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
14816860|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816861|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14816862|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
14816863|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196464|NCT03795571|Rituximab|rituximab|mesh-list
15196465|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
15196466|NCT03795571|Lenalidomide|lenalidomide|mesh-list
15196467|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196468|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
15196469|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
15196470|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196471|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196472|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196473|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
15196474|NCT03795571|Hormones|hormones|mesh-ancestor
15196475|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196476|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15196477|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196478|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196479|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
15196480|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196481|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15196482|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
15196483|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196484|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
15196485|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196486|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196487|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15196488|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15196489|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15196490|NCT03795571|Growth Substances|growth substances|mesh-ancestor
15196491|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
15196492|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
15196493|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15196494|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15196495|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196496|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
15196497|NCT03795649|Coagulants|coagulants|mesh-ancestor
15196498|NCT03795597|Melphalan|melphalan|mesh-list
15196499|NCT03795597|Busulfan|busulfan|mesh-list
15196500|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15196501|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
15196502|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196503|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196504|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15196505|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14816864|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196506|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
15196507|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816865|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15196508|NCT03795805|Lidocaine|lidocaine|mesh-list
15196509|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196510|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
15196511|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816866|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816867|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14816868|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14816869|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14816870|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
14816871|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
14816872|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14816873|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14816874|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816875|NCT00873379|Melatonin|melatonin|mesh-list
14816876|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
14816877|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816878|NCT00873379|Protective Agents|protective agents|mesh-ancestor
14816879|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816880|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816881|NCT00873392|Nicotine|nicotine|mesh-list
14816882|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14816883|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
15196512|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196513|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
14816884|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14816885|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816886|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14816887|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15196514|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196515|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15196516|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15196517|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15196518|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15196519|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196520|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
15196521|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15196522|NCT03795259|Rocuronium|rocuronium|mesh-list
15196523|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15196524|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15196525|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15196526|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196527|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196528|NCT03795272|Rucaparib|rucaparib|mesh-list
15196529|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15196530|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196531|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196532|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196533|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
15196534|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15196535|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
15196536|NCT03795194|Ampicillin|ampicillin|mesh-list
15196537|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15196538|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196539|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196540|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15196541|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196542|NCT03795311|Bevacizumab|bevacizumab|mesh-list
15196543|NCT03795311|Folfirinox|folfirinox|mesh-list
15196544|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196545|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196546|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15196547|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15196548|NCT03795311|Growth Substances|growth substances|mesh-ancestor
15196549|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196550|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
14816888|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
14816889|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816890|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816891|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14816892|NCT00873483|Gestodene|gestodene|mesh-list
14816893|NCT00873483|Femovan|femovan|mesh-list
14816894|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14816895|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15196551|NCT03795207|Durvalumab|durvalumab|mesh-list
14816896|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14816897|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
14816898|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14816899|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816900|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14816901|NCT00873483|Estrogens|estrogens|mesh-ancestor
14816902|NCT00873483|Hormones|hormones|mesh-ancestor
14816903|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14816904|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14816905|NCT00873483|Progestins|progestins|mesh-ancestor
14816906|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14816907|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
14816908|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
14816909|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14816910|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14816911|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816912|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816913|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816914|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14816915|NCT00873509|Buspirone|buspirone|mesh-list
14816916|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14816917|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14816918|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816919|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816920|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816921|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14816922|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
14816923|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816924|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816925|NCT00873535|Varenicline|varenicline|mesh-list
14816926|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14816927|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14816928|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
14816929|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816930|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816931|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816932|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
14816933|NCT00873626|Levofloxacin|levofloxacin|mesh-list
14816934|NCT00873626|Ofloxacin|ofloxacin|mesh-list
14816935|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
14816936|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14816937|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14816938|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14816939|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14816940|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14816941|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816942|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816943|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14816944|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14816945|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14816946|NCT00873626|Renal Agents|renal agents|mesh-ancestor
14816947|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14816948|NCT00873639|Insulin|insulin|mesh-list
14816949|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14816950|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
14816951|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
14816952|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15196552|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196553|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196554|NCT03795350|Beclomethasone|beclomethasone|mesh-list
15196555|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
15196556|NCT03795350|Bromides|bromides|mesh-list
15196557|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
15196558|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15196559|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
15196560|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196561|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196562|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15196563|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
15196564|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15196565|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15196566|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15196567|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
14816953|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196568|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816954|NCT00873652|Vaccines|vaccines|mesh-list
14816955|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
14816956|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816957|NCT00873756|Bevacizumab|bevacizumab|mesh-list
14816958|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14816959|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14816960|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14816961|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14816962|NCT00873756|Growth Substances|growth substances|mesh-ancestor
14816963|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816964|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
14816965|NCT00873769|Loxapine|loxapine|mesh-list
14816966|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14816967|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14816968|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816969|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816970|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816971|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14816972|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
14816973|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816974|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816975|NCT00873795|Aripiprazole|aripiprazole|mesh-list
14816976|NCT00873795|Sertraline|sertraline|mesh-list
14816977|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
14816978|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14816979|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14816980|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14816981|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14816982|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816983|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
14816984|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
14816985|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14816986|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14816987|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14816988|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14816989|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
14816990|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14816991|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15196569|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196570|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
15196571|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15196572|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15196573|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15196574|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
15196575|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196576|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
15196577|NCT03795350|Hormones|hormones|mesh-ancestor
15196578|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196579|NCT03794765|Metronidazole|metronidazole|mesh-list
15196580|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
15196581|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196582|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15196583|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15196584|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15196585|NCT03794843|Nimodipine|nimodipine|mesh-list
15196586|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15196587|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15196588|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15196589|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196590|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15196591|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196592|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
15196593|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
15196594|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15196595|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15196596|NCT03794505|Prednisolone|prednisolone|mesh-list
15196597|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
15196598|NCT03794505|Lidocaine|lidocaine|mesh-list
15196599|NCT03794505|Ropivacaine|ropivacaine|mesh-list
15196600|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15196601|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
15196602|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196603|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
15196604|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196605|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14816992|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14816993|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14816994|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14816995|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14816996|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14816997|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
14816998|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
14816999|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
14817000|NCT00873808|Tetracycline|tetracycline|mesh-list
14817001|NCT00873808|Demeclocycline|demeclocycline|mesh-list
14817002|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14817003|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817004|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817005|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817006|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14817007|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817008|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817009|NCT00873834|Fluoxetine|fluoxetine|mesh-list
14817010|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14817011|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14817012|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14817013|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817014|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817015|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
14817016|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817017|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14700791|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700792|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700793|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14700794|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14700795|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14700796|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700797|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700798|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817018|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
14817019|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817020|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14817021|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14817022|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817023|NCT00873886|Oseltamivir|oseltamivir|mesh-list
14817024|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
14817025|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817026|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817027|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817028|NCT00873925|Vitamin D|vitamin d|mesh-list
14817029|NCT00873925|Vitamins|vitamins|mesh-ancestor
14817030|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
14817031|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817032|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14817033|NCT00873951|Caseins|caseins|mesh-list
14817034|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
14817035|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
14817036|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817037|NCT00874003|Mirtazapine|mirtazapine|mesh-list
14817038|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
14817039|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817040|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15196606|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
15196607|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196608|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15196609|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15196610|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15196611|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15196612|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196613|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196614|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
15196615|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
15196616|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196617|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
15196618|NCT03794505|Hormones|hormones|mesh-ancestor
15196619|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196620|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15196621|NCT03794505|Protective Agents|protective agents|mesh-ancestor
15196622|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15196623|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196624|NCT03794544|Durvalumab|durvalumab|mesh-list
15196625|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196626|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196627|NCT03794778|Paclitaxel|paclitaxel|mesh-list
15196628|NCT03794778|Carboplatin|carboplatin|mesh-list
15196629|NCT03794778|Doxorubicin|doxorubicin|mesh-list
15196630|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15196631|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15196632|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196633|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
15196634|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
15196635|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
15196636|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196637|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15196638|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15196639|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15196640|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196641|NCT03794518|Pioglitazone|pioglitazone|mesh-list
15196642|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15196643|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196644|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
15196645|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
15196646|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
15196647|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
15196648|NCT03794492|Prednisolone|prednisolone|mesh-list
15196649|NCT03794492|Tacrolimus|tacrolimus|mesh-list
15196650|NCT03794492|Basiliximab|basiliximab|mesh-list
15196651|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15196652|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
15196653|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196654|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15196655|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196656|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196657|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15196658|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196659|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15196660|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
15196661|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15196662|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196663|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196664|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
15196665|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
15196666|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196667|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196668|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
15196669|NCT03794492|Hormones|hormones|mesh-ancestor
14700799|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700800|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700801|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700802|NCT00397241|Timolol|timolol|mesh-list
14700803|NCT00397241|Dorzolamide|dorzolamide|mesh-list
14700804|NCT00397241|Latanoprost|latanoprost|mesh-list
14700805|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
14700806|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14700807|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14700808|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
14700809|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700810|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700811|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700812|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14700813|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14700814|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14700815|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14700816|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14700817|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700818|NCT00397319|Hormones|hormones|mesh-list
14700819|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700820|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700821|NCT00397332|Alefacept|alefacept|mesh-list
14700822|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
14700823|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
14700824|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224291|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
14817041|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
14817042|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
14817043|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817044|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817045|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817046|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14817047|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14817048|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817049|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14817050|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14817051|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14817052|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
14817053|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15196670|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196671|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15196672|NCT03794492|Protective Agents|protective agents|mesh-ancestor
14700825|NCT00397358|Icodextrin|icodextrin|mesh-list
14817054|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14817055|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
14817056|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14817057|NCT00874042|Gemcitabine|gemcitabine|mesh-list
14817058|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14817059|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
14817060|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817061|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817062|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
14817063|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817064|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817065|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817066|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
14817067|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817068|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
14817069|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817070|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817071|NCT00874107|Paclitaxel|paclitaxel|mesh-list
14817072|NCT00874107|Bevacizumab|bevacizumab|mesh-list
14817073|NCT00874107|Carboplatin|carboplatin|mesh-list
14817074|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14817075|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817076|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14817077|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14817078|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14817079|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817080|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817081|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14817082|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14817083|NCT00874107|Growth Substances|growth substances|mesh-ancestor
14817084|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817085|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
14817086|NCT00874133|Domperidone|domperidone|mesh-list
14817087|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
15196673|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15196674|NCT03794596|Aspirin|aspirin|mesh-list
15196675|NCT03794596|Avelumab|avelumab|mesh-list
15196676|NCT03794596|Lansoprazole|lansoprazole|mesh-list
15196677|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
15196678|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15196679|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15196680|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15196681|NCT03794596|Analgesics|analgesics|mesh-ancestor
15196682|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
14700826|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
14700827|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14700828|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14700829|NCT00397384|Cetuximab|cetuximab|mesh-list
14700830|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14700831|NCT00397384|Antibodies|antibodies|mesh-list
14700832|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
14700833|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14700834|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
14700835|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700836|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700837|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14700838|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196683|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817088|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
14817089|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817090|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817091|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14817092|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14817093|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
14817094|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817095|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817096|NCT00874172|Analgesics|analgesics|mesh-list
14817097|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
14817098|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817099|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817100|NCT00874315|Cyclosporine|cyclosporine|mesh-list
14817101|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
14817102|NCT00874315|Fludarabine|fludarabine|mesh-list
14817103|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
14817104|NCT00874315|Busulfan|busulfan|mesh-list
14817105|NCT00874315|Tacrolimus|tacrolimus|mesh-list
14817106|NCT00874315|Cyclosporins|cyclosporins|mesh-list
14817107|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
14817108|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14817109|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817110|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14817111|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
14817112|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817113|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817114|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
14817115|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817116|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14817117|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196684|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196685|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14817118|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
14817119|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817120|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
14817121|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14817122|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817123|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14817124|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
14817125|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817126|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
14817127|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14817128|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14817129|NCT00874328|Irinotecan|irinotecan|mesh-list
14817130|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817131|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15196686|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196687|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15196688|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15196689|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196690|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15196691|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15196692|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196693|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
15196694|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196695|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196696|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15196697|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196698|NCT03794219|Naproxen|naproxen|mesh-list
15196699|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15196700|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15196701|NCT03794219|Analgesics|analgesics|mesh-ancestor
15196702|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
15196703|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196704|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817132|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817133|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910640|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817134|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817135|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
14817136|NCT00874393|Dopamine|dopamine|mesh-list
14817137|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14817138|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14817139|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
14817140|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
14817141|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817142|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817143|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
14817144|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817145|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817146|NCT00874393|Protective Agents|protective agents|mesh-ancestor
14910641|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196705|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196706|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196707|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
15196708|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15196709|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196710|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224292|NCT04234464|Hormones|hormones|mesh-ancestor
15224293|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224294|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
15224295|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15224296|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15224297|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15224298|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15224299|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
15224300|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224301|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224302|NCT04228965|Varenicline|varenicline|mesh-list
15224303|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15224304|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15224305|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
15224306|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224307|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224308|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224309|NCT04211675|Irinotecan|irinotecan|mesh-list
15224310|NCT04211675|Temozolomide|temozolomide|mesh-list
15224311|NCT04211675|Dinutuximab|dinutuximab|mesh-list
15224312|NCT04211675|Sargramostim|sargramostim|mesh-list
15224313|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15224314|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15224315|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224316|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224317|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224318|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15224319|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
15224320|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
15224321|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224322|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
15224323|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15224324|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224325|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15224326|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15224327|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224328|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224329|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224330|NCT04198805|Vitamins|vitamins|mesh-list
15224331|NCT04198805|Vitamin E|vitamin e|mesh-list
15224332|NCT04198805|Tocopherols|tocopherols|mesh-list
15224333|NCT04198805|Tocotrienols|tocotrienols|mesh-list
14910642|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14910643|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
14910644|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910645|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910646|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14910647|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910648|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
14910649|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
14910650|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910651|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910652|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
14910653|NCT01358253|Hormones|hormones|mesh-ancestor
15224334|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
14817147|NCT00874406|Leucovorin|leucovorin|mesh-list
14817148|NCT00874406|Fluorouracil|fluorouracil|mesh-list
14817149|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
14817150|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
14817151|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817152|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14817153|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817154|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817155|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
14817156|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817157|NCT00874406|Antidotes|antidotes|mesh-ancestor
14817158|NCT00874406|Protective Agents|protective agents|mesh-ancestor
14817159|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
14817160|NCT00874406|Vitamins|vitamins|mesh-ancestor
14817161|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
14817162|NCT00874419|Gemcitabine|gemcitabine|mesh-list
14817163|NCT00874419|Carboplatin|carboplatin|mesh-list
14817164|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14817165|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817166|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14817167|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
14817168|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817169|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
14817170|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817171|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817172|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817173|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
14817174|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817175|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14817176|NCT00874484|Enoxaparin|enoxaparin|mesh-list
14817177|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
14817178|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14817179|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14817180|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817181|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
14817182|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14817183|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14817184|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14817185|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
14817186|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817187|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14817188|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15196711|NCT03794440|Sorafenib|sorafenib|mesh-list
15196712|NCT03794440|Bevacizumab|bevacizumab|mesh-list
15196713|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196714|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15196715|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196716|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196717|NCT03794440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196718|NCT03794440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15196719|NCT03794440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15196720|NCT03794440|Growth Substances|growth substances|mesh-ancestor
15196721|NCT03794440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196722|NCT03794440|Growth Inhibitors|growth inhibitors|mesh-ancestor
15196723|NCT03794037|Montelukast|montelukast|mesh-list
15196724|NCT03794037|Progesterone|progesterone|mesh-list
15196725|NCT03794037|Progestins|progestins|mesh-ancestor
15196726|NCT03794037|Hormones|hormones|mesh-ancestor
15196727|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196728|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196729|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15196730|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
15196731|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15196732|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
15196733|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15196734|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15196735|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196736|NCT03794271|Anesthetics|anesthetics|mesh-list
15196737|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196738|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196739|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15224335|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
14817189|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817190|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817191|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14817192|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15196740|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15196741|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15196742|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15196743|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196744|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817193|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
14817194|NCT00874562|Sirolimus|sirolimus|mesh-list
14817195|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817196|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817197|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817198|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817199|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
14817200|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817201|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
14817202|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817203|NCT00874575|Vitamin D|vitamin d|mesh-list
14817204|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
14817205|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
14817206|NCT00874575|Vitamins|vitamins|mesh-list
14817207|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
14817208|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817209|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14817210|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14817211|NCT00874601|Valsartan|valsartan|mesh-list
14817212|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14817213|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14817214|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14817215|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817216|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
14817217|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14817218|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
14817219|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14817220|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817221|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14817222|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14817223|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14817224|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14817225|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
14817226|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14817227|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14817228|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817229|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817230|NCT00874679|Urological Agents|urological agents|mesh-ancestor
14817231|NCT00874744|Triamcinolone|triamcinolone|mesh-list
14817232|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14817233|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14817234|NCT00874744|Bevacizumab|bevacizumab|mesh-list
14817235|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14817236|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817237|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817238|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14817239|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14817240|NCT00874744|Growth Substances|growth substances|mesh-ancestor
14817241|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817242|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700839|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700840|NCT00397423|Sargramostim|sargramostim|mesh-list
14700841|NCT00397423|Lenograstim|lenograstim|mesh-list
14700842|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
14700843|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700844|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14700845|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
14700846|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14700847|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700848|NCT00397475|Vitamins|vitamins|mesh-ancestor
14700849|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
14700850|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14700851|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
14817243|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14817244|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
14817245|NCT00874744|Hormones|hormones|mesh-ancestor
14817246|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700852|NCT00397501|Carboplatin|carboplatin|mesh-list
14700853|NCT00397501|Methotrexate|methotrexate|mesh-list
14817247|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817248|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
14817249|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817250|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817251|NCT00874809|Insulin|insulin|mesh-list
14817252|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
14817253|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14817254|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817255|NCT00874861|Poly ICLC|poly iclc|mesh-list
14817256|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
14817257|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
14817258|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817259|NCT00874874|Sorafenib|sorafenib|mesh-list
14817260|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817261|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14817262|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700854|NCT00397501|Trastuzumab|trastuzumab|mesh-list
14817263|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817264|NCT00874926|Factor VIII|factor viii|mesh-list
15196745|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196746|NCT03794154|Analgesics|analgesics|mesh-ancestor
15196747|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
15196748|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196749|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
15196750|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15196751|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
15196752|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
15196753|NCT03794167|Melphalan|melphalan|mesh-list
15196754|NCT03794167|Busulfan|busulfan|mesh-list
15196755|NCT03794167|Etoposide|etoposide|mesh-list
15196756|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15196757|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
15196758|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196759|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196760|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15196761|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
15196762|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196763|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196764|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15196765|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15196766|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15196767|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15196768|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196769|NCT03794297|Trametinib|trametinib|mesh-list
15196770|NCT03794297|Dabrafenib|dabrafenib|mesh-list
15196771|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15196772|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196773|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15196774|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196775|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196776|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15196777|NCT03794297|Protective Agents|protective agents|mesh-ancestor
15196778|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196779|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15196780|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
15196781|NCT03793725|Apatinib|apatinib|mesh-list
15196782|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196783|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15196784|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196785|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196786|NCT03793517|Decitabine|decitabine|mesh-list
15196787|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700855|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700856|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14700857|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
14700858|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14700859|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700860|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700861|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
14700862|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700863|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
14700864|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817265|NCT00874926|Coagulants|coagulants|mesh-ancestor
14817266|NCT00874978|Lenalidomide|lenalidomide|mesh-list
15196788|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
15196789|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196790|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196791|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196792|NCT03793309|Vitamin D|vitamin d|mesh-list
15196793|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
15196794|NCT03793309|Vitamins|vitamins|mesh-list
15196795|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
15196796|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196797|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15196798|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15196799|NCT03793283|Insulin|insulin|mesh-list
15196800|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15196801|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15196802|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196803|NCT03793075|Ketamine|ketamine|mesh-list
15196804|NCT03793075|Propofol|propofol|mesh-list
14817267|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
14817268|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196805|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15196806|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196807|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196808|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15196809|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
15196810|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
15196811|NCT03793075|Analgesics|analgesics|mesh-ancestor
15196812|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
15196813|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14700865|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14700866|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700867|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
15196814|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15196815|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15196816|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15196817|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196818|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196819|NCT03793205|Lenograstim|lenograstim|mesh-list
15196820|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15196821|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
15196822|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196823|NCT03793114|Cosyntropin|cosyntropin|mesh-list
15196824|NCT03793114|Hormones|hormones|mesh-ancestor
15196825|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196826|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196827|NCT03792867|Doxorubicin|doxorubicin|mesh-list
15196828|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15196829|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196830|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15196831|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15196832|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196833|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196834|NCT03792776|Lidocaine|lidocaine|mesh-list
15196835|NCT03792776|Anesthetics|anesthetics|mesh-list
15196836|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196837|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196838|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196839|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
15196840|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196841|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15196842|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15196843|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15196844|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700868|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14700869|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14700870|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700871|NCT00397501|Antidotes|antidotes|mesh-ancestor
14700872|NCT00397501|Protective Agents|protective agents|mesh-ancestor
14700873|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
14700874|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
14700875|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700876|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817269|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14817270|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14817271|NCT00874978|Growth Substances|growth substances|mesh-ancestor
14817272|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14817273|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817274|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
14817275|NCT00875004|Hematinics|hematinics|mesh-ancestor
14817276|NCT00875030|Artesunate|artesunate|mesh-list
14817277|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
14294706|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294707|NCT00577655|Albuterol|albuterol|mesh-list
14700877|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
14700878|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
14700879|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
14700880|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14700881|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700882|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
14700883|NCT00397566|BMS-707035|bms-707035|mesh-list
14700884|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
14700885|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700886|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817278|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14817279|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14817280|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196845|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196846|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15196847|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15196848|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15196849|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15196850|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196851|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196852|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196853|NCT03792828|Analgesics|analgesics|mesh-ancestor
15196854|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
15196855|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196856|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
15196857|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15196858|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
15196859|NCT03792724|Nivolumab|nivolumab|mesh-list
15196860|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196861|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196862|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14294708|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14294709|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
14294710|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294711|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294712|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14294713|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
14294714|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
14294715|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14294716|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14294717|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14294718|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14700887|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15196863|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196864|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
15196865|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
15196866|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
15196867|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
15196868|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14700888|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14700889|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
14700890|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700891|NCT00397592|Hormones|hormones|mesh-list
14700892|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14700893|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700894|NCT00397657|Niacin|niacin|mesh-list
14700895|NCT00397657|Ezetimibe|ezetimibe|mesh-list
14700896|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14700897|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14700898|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
14700899|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817281|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817282|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
14817283|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
15196869|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15196870|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196871|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196872|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196873|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
15196874|NCT03792971|Protective Agents|protective agents|mesh-ancestor
15196875|NCT03792984|Vitamin D|vitamin d|mesh-list
15196876|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
15196877|NCT03792984|Metformin|metformin|mesh-list
15196878|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
15196879|NCT03792984|Calcium|calcium|mesh-list
14817284|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14817285|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
14817286|NCT00875069|Ethanol|ethanol|mesh-list
14817287|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14817288|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817289|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817290|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817291|NCT00875082|Montelukast|montelukast|mesh-list
14817292|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14817293|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
14817294|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14817295|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
14817296|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14817297|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817298|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14817299|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14817300|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817301|NCT00875147|Bevacizumab|bevacizumab|mesh-list
14817302|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817303|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817304|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15196880|NCT03792984|Vitamins|vitamins|mesh-ancestor
15196881|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
15196882|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196883|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15196884|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15196885|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15196886|NCT03792984|Antacids|antacids|mesh-ancestor
15196887|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196888|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15196889|NCT03792815|Etoposide|etoposide|mesh-list
15196890|NCT03792815|Melphalan|melphalan|mesh-list
15196891|NCT03792815|Busulfan|busulfan|mesh-list
15196892|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15196893|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196894|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15196895|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15196896|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196897|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196898|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15196899|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
15196900|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15196901|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15196902|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
15196903|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196904|NCT03792906|Norepinephrine|norepinephrine|mesh-list
15196905|NCT03792906|Bupivacaine|bupivacaine|mesh-list
15196906|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
15196907|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
14817305|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14817306|NCT00875147|Growth Substances|growth substances|mesh-ancestor
14817307|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817308|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
14817309|NCT00875173|Selenium|selenium|mesh-list
14817310|NCT00875173|Antioxidants|antioxidants|mesh-list
14817311|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817312|NCT00875173|Protective Agents|protective agents|mesh-ancestor
14817313|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817314|NCT00875173|Trace Elements|trace elements|mesh-ancestor
15196908|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817315|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
14817316|NCT00875238|Doxorubicin|doxorubicin|mesh-list
14817317|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14817318|NCT00875238|Trastuzumab|trastuzumab|mesh-list
14817319|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817320|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817321|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14817322|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817323|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817324|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817325|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817326|NCT00875355|Temozolomide|temozolomide|mesh-list
14817327|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14817328|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
14817329|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817330|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196909|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196910|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
15196911|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196912|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15196913|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15196914|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
15196915|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15196916|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196917|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
15196918|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
15196919|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15196920|NCT03792763|Denosumab|denosumab|mesh-list
15196921|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15196922|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15196923|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196924|NCT03792620|Daratumumab|daratumumab|mesh-list
15196925|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196926|NCT03792503|Pemetrexed|pemetrexed|mesh-list
15196927|NCT03792503|Apatinib|apatinib|mesh-list
15196928|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196929|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196930|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196931|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15196932|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15196933|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15196934|NCT03792490|Fasudil|fasudil|mesh-list
15196935|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15196936|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15196937|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196938|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15196939|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196940|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
15196941|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15196942|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817331|NCT00875368|Maraviroc|maraviroc|mesh-list
14817332|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14817333|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14817334|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817335|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14817336|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14817337|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
14817338|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817339|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15196943|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15196944|NCT03792217|Eusol|eusol|mesh-list
15196945|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
15196946|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224336|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224337|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
15224338|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817340|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
14817341|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14817342|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
14817343|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817344|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817345|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817346|NCT00875537|Capsaicin|capsaicin|mesh-list
14817347|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
14817348|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
14817349|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
14817350|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817351|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224339|NCT04198805|Protective Agents|protective agents|mesh-ancestor
15224340|NCT04183868|Empagliflozin|empagliflozin|mesh-list
15224341|NCT04183868|Glimepiride|glimepiride|mesh-list
15224342|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15224343|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224344|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14817352|NCT00875745|Sorafenib|sorafenib|mesh-list
14817353|NCT00875745|Vorinostat|vorinostat|mesh-list
14817354|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817355|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14817356|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817357|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817358|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14817359|NCT00875771|Bevacizumab|bevacizumab|mesh-list
14817360|NCT00875771|Capecitabine|capecitabine|mesh-list
14817361|NCT00875771|Irinotecan|irinotecan|mesh-list
14817362|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817363|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224345|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224346|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15224347|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224348|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
15224349|NCT04161755|Atezolizumab|atezolizumab|mesh-list
14700900|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14700901|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
14700902|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
14700903|NCT00397657|Vitamins|vitamins|mesh-ancestor
14700904|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
14700905|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700906|NCT00397709|Rifampin|rifampin|mesh-list
14700907|NCT00397709|Isoniazid|isoniazid|mesh-list
14700908|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14700909|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
14700910|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14700911|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700912|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
14700913|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14700914|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700915|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700916|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14700917|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14700918|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14700919|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14700920|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14700921|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14700922|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14700923|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14817364|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14817365|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14817366|NCT00875771|Growth Substances|growth substances|mesh-ancestor
14817367|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817368|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
14817369|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14817370|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
15224350|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817371|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817372|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14817373|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817374|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817375|NCT00875784|Sumatriptan|sumatriptan|mesh-list
14817376|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15196947|NCT03792139|Itraconazole|itraconazole|mesh-list
15196948|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
15196949|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15196950|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15196951|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15196952|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196953|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196954|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15196955|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
15196956|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15196957|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196958|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15196959|NCT03792269|Capecitabine|capecitabine|mesh-list
15196960|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
15196961|NCT03792269|Irinotecan|irinotecan|mesh-list
15196962|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15196963|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
15196964|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196965|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196966|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15196967|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15196968|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196969|NCT03792295|Acetaminophen|acetaminophen|mesh-list
15196970|NCT03792295|Ibuprofen|ibuprofen|mesh-list
15196971|NCT03792295|Oxycodone|oxycodone|mesh-list
15196972|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15196973|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15196974|NCT03792295|Analgesics|analgesics|mesh-ancestor
15196975|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
15196976|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15196977|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15196978|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15196979|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15196980|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15196981|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196982|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196983|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15196984|NCT03792295|Narcotics|narcotics|mesh-ancestor
15196985|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15196986|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
15196987|NCT03792152|Warfarin|warfarin|mesh-list
15196988|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
15196989|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
15196990|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15196991|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
15196992|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15196993|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
15196994|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15196995|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15196996|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
15196997|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15196998|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15196999|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
15197000|NCT03792321|Testosterone|testosterone|mesh-list
15197001|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
15197002|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
15197003|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15197004|NCT03792321|Androgens|androgens|mesh-ancestor
15197005|NCT03792321|Hormones|hormones|mesh-ancestor
15197006|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197007|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197008|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15197009|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197010|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
15197011|NCT03792009|Bupivacaine|bupivacaine|mesh-list
15197012|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197013|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
15197014|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197015|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197016|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
15197017|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197018|NCT03792074|Paclitaxel|paclitaxel|mesh-list
15197019|NCT03792074|Bevacizumab|bevacizumab|mesh-list
15197020|NCT03792074|Carboplatin|carboplatin|mesh-list
15197021|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15197022|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197023|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
15197024|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
15197025|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
15197026|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197027|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15197028|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15197029|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15197030|NCT03792074|Growth Substances|growth substances|mesh-ancestor
15197031|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197032|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
15197033|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15197034|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
15197035|NCT03792113|Coagulants|coagulants|mesh-ancestor
15197036|NCT03791905|Leucovorin|leucovorin|mesh-list
15197037|NCT03791905|Paclitaxel|paclitaxel|mesh-list
15197038|NCT03791905|Fluorouracil|fluorouracil|mesh-list
15197039|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
15197040|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15197041|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197042|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
15197043|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
15197044|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
15197045|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197046|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
15197047|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15197048|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15197049|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
15197050|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197051|NCT03791905|Antidotes|antidotes|mesh-ancestor
15197052|NCT03791905|Protective Agents|protective agents|mesh-ancestor
15197053|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
15197054|NCT03791905|Vitamins|vitamins|mesh-ancestor
15197055|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
15197056|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
15197057|NCT03791918|Lenvatinib|lenvatinib|mesh-list
15197058|NCT03791918|Antibodies|antibodies|mesh-list
15197059|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
15197060|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
15197061|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197062|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15197063|NCT03791918|Estrogens|estrogens|mesh-ancestor
15197064|NCT03791918|Hormones|hormones|mesh-ancestor
15197065|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197066|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15197067|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197068|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15197069|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197070|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197071|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
15197072|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
15197073|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15197074|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
15197075|NCT03791801|Rocuronium|rocuronium|mesh-list
15197076|NCT03791801|Neostigmine|neostigmine|mesh-list
15197077|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15197078|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15197079|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15197080|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197081|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197082|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15197083|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197084|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700924|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
14700925|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14700926|NCT00397722|Paroxetine|paroxetine|mesh-list
14700927|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15197085|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
15197086|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197087|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14700928|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14817377|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14817378|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14817379|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
14817380|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817381|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817382|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817383|NCT00875849|Cetuximab|cetuximab|mesh-list
14817384|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817385|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817386|NCT00875875|Rifaximin|rifaximin|mesh-list
14817387|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817388|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817389|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14817390|NCT00875927|Zinc|zinc|mesh-list
14817391|NCT00875927|Propolis|propolis|mesh-list
14817392|NCT00875927|Trace Elements|trace elements|mesh-ancestor
14817393|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
15197088|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
15197089|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14700929|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14700930|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197090|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15197091|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15197092|NCT03791775|Polidocanol|polidocanol|mesh-list
15197093|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15197094|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15197095|NCT03791827|Cyclosporine|cyclosporine|mesh-list
15197096|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
15197097|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
15197098|NCT03791827|Prednisone|prednisone|mesh-list
15197099|NCT03791827|Prednisolone|prednisolone|mesh-list
15197100|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
15197101|NCT03791827|Rituximab|rituximab|mesh-list
15197102|NCT03791827|Azathioprine|azathioprine|mesh-list
15197103|NCT03791827|Tacrolimus|tacrolimus|mesh-list
15197104|NCT03791827|Cyclosporins|cyclosporins|mesh-list
15197105|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15197106|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
15197107|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197108|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197109|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15197110|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
15197111|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197112|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197113|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15197114|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15197115|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197116|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
15197117|NCT03791827|Hormones|hormones|mesh-ancestor
15197118|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197119|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15197120|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15197121|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197122|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
14700931|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700932|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
14700933|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700934|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14700935|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
14700936|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14700937|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14700938|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14700939|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817394|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817395|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817396|NCT00875966|Azithromycin|azithromycin|mesh-list
14817397|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817398|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817399|NCT00876044|Aflibercept|aflibercept|mesh-list
15197123|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15197124|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14700940|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
14700941|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14817400|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14817401|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14817402|NCT00876044|Growth Substances|growth substances|mesh-ancestor
14817403|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817404|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
15197125|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15197126|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15197127|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
15197128|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15197129|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
15197130|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15197131|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15197132|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
15197133|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15197134|NCT03791736|Octreotide|octreotide|mesh-list
15197135|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197136|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15197137|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197138|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
15197139|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
15197140|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15197141|NCT03791762|Protective Agents|protective agents|mesh-ancestor
15197142|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197143|NCT03791723|Valsartan|valsartan|mesh-list
15197144|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15197145|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15197146|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15197147|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15197148|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197149|NCT03791515|Calcitonin|calcitonin|mesh-list
15197150|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
15197151|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15197152|NCT03791515|Katacalcin|katacalcin|mesh-list
15197153|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15197154|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197155|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15197156|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
15197157|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
15197158|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197159|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197160|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197161|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15197162|NCT03791424|Midazolam|midazolam|mesh-list
15197163|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15197164|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15197165|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197166|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197167|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15197168|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15197169|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15197170|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15197171|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
15197172|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
15197173|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
15197174|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
15197175|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197176|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197177|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
15197178|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
14700942|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
14700943|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14700944|NCT00397735|Expectorants|expectorants|mesh-ancestor
14700945|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
14700946|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14700947|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
14700948|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700949|NCT00397735|Protective Agents|protective agents|mesh-ancestor
14700950|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700951|NCT00397735|Antidotes|antidotes|mesh-ancestor
14700952|NCT00397761|Paclitaxel|paclitaxel|mesh-list
14700953|NCT00397761|Capecitabine|capecitabine|mesh-list
15197179|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15197180|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
15224351|NCT04118387|Acetazolamide|acetazolamide|mesh-list
14817405|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817406|NCT00876135|Albuterol|albuterol|mesh-list
14817407|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14817408|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
14817409|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817410|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817411|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14817412|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
14817413|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
14817414|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14817415|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14817416|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15197181|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197182|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
15197183|NCT03791294|Protective Agents|protective agents|mesh-ancestor
15197184|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
15197185|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15197186|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
15197187|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15197188|NCT03791099|Metronidazole|metronidazole|mesh-list
15197189|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15197190|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15197191|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15197192|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15197193|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
15197194|NCT03791255|Calcium|calcium|mesh-list
15197195|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15197196|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197197|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15197198|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15197199|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15197200|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197201|NCT03790839|Incretins|incretins|mesh-ancestor
15197202|NCT03790839|Hormones|hormones|mesh-ancestor
15197203|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197204|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15197205|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
15197206|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197207|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197208|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
15197209|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197210|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197211|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197212|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15197213|NCT03790800|Urapidil|urapidil|mesh-list
15197214|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15197215|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
15197216|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15197217|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
15197218|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197219|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197220|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197221|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15197222|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15197223|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14700954|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14700955|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14700956|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700957|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14700958|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14700959|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14700960|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700961|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700962|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
14700963|NCT00397787|Sunitinib|sunitinib|mesh-list
14700964|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700965|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14700966|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14700967|NCT00397787|Growth Substances|growth substances|mesh-ancestor
14700968|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700969|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
14700970|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14700971|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197224|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
15197225|NCT03790787|Empagliflozin|empagliflozin|mesh-list
15197226|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15197227|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197228|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15197229|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224352|NCT04118387|Zolpidem|zolpidem|mesh-list
15224353|NCT04118387|Buspirone|buspirone|mesh-list
15224354|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15224355|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15224356|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224357|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224358|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15224359|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
15224360|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
15224361|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14700972|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224362|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224363|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
15224364|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15224365|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224366|NCT04118387|Diuretics|diuretics|mesh-ancestor
15224367|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
15224368|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15224369|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15224370|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224371|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15224372|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
15224373|NCT04093362|Gemcitabine|gemcitabine|mesh-list
15224374|NCT04093362|Futibatinib|futibatinib|mesh-list
15224375|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224376|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15224377|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
15224378|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224379|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
15224380|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224381|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224382|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224383|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
15224384|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224385|NCT04089514|Adalimumab|adalimumab|mesh-list
15224386|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224387|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224388|NCT04027348|Dexamethasone|dexamethasone|mesh-list
15224389|NCT04027348|Octreotide|octreotide|mesh-list
15224390|NCT04027348|Metoclopramide|metoclopramide|mesh-list
15224391|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224392|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
15224393|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
15224394|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224395|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224396|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224397|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
15224398|NCT04027348|Hormones|hormones|mesh-ancestor
15224399|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224400|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224401|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224402|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15224403|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15224404|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
15224405|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224406|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224407|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
15224408|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14700973|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
14700974|NCT00397800|Rituximab|rituximab|mesh-list
14700975|NCT00397800|Fludarabine|fludarabine|mesh-list
14700976|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
14700977|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14700978|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
14700979|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14700980|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14700981|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14700982|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
14728480|NCT00518479|Valsartan|valsartan|mesh-list
14728481|NCT00518479|Moxonidine|moxonidine|mesh-list
15224409|NCT03845114|Insulin|insulin|mesh-list
15224410|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14817417|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14817418|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
14817419|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817420|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817421|NCT00876226|Citalopram|citalopram|mesh-list
14817422|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14817423|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15197230|NCT03790670|Sargramostim|sargramostim|mesh-list
15197231|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
15197232|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197233|NCT03790540|Benzocaine|benzocaine|mesh-list
15197234|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197235|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
15197236|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817424|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14817425|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817426|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817427|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
15197237|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197238|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
15197239|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197240|NCT03790605|Curcumin|curcumin|mesh-list
15197241|NCT03790605|Iproplatin|iproplatin|mesh-list
15197242|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15197243|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197244|NCT03790605|Analgesics|analgesics|mesh-ancestor
15197245|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
15197246|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197247|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197248|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197249|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197250|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197251|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197252|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197253|NCT03790345|Vitamins|vitamins|mesh-list
15197254|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
15197255|NCT03790345|Pyridoxine|pyridoxine|mesh-list
15197256|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
15197257|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
15197258|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
15197259|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197260|NCT03790618|Methamphetamine|methamphetamine|mesh-list
15197261|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15197262|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
15197263|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197264|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15197265|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
15197266|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197267|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197268|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15197269|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15197270|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15197271|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
15197272|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15197273|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
15197274|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
15197275|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197276|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
15197277|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15197278|NCT03790566|Bupivacaine|bupivacaine|mesh-list
15197279|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197280|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
15197281|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197282|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197283|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
15197284|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197285|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
15197286|NCT03790215|Progestins|progestins|mesh-ancestor
15197287|NCT03790215|Hormones|hormones|mesh-ancestor
15197288|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197289|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197290|NCT03790228|Carboplatin|carboplatin|mesh-list
15197291|NCT03790228|Pemetrexed|pemetrexed|mesh-list
15197292|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197293|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224411|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14817428|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817429|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14817430|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
14817431|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910654|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910655|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14910656|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14910657|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14910658|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14910659|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14910660|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910661|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14910662|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
14910663|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14910664|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14910665|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
14910666|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
14910667|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14910668|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14910669|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
15197294|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197295|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15197296|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15197297|NCT03790371|Misoprostol|misoprostol|mesh-list
15197298|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15197299|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
15197300|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15197301|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197302|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15197303|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197304|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
15197305|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
15197306|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197307|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
15197308|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197309|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197310|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
15197311|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197312|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15197313|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
15197314|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197315|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15197316|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15197317|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
15197318|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197319|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197320|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15197321|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15197322|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197323|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197324|NCT03790384|Mitomycins|mitomycins|mesh-list
15197325|NCT03790384|Mitomycin|mitomycin|mesh-list
15197326|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
15197327|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15197328|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197329|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
15197330|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197331|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15197332|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197333|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15197334|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
15197335|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197336|NCT03790397|Osimertinib|osimertinib|mesh-list
15197337|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197338|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15197339|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197340|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197341|NCT03790293|Rituximab|rituximab|mesh-list
15197342|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15197343|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197344|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
15197345|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197346|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197347|NCT03790020|Bupivacaine|bupivacaine|mesh-list
15197348|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197349|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
15197350|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197351|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197352|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
15197353|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197354|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
15197355|NCT03790072|Fludarabine|fludarabine|mesh-list
15197356|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15197357|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
15197358|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197359|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197360|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15197361|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
15197362|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197363|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197364|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15197365|NCT03789890|Itraconazole|itraconazole|mesh-list
15197366|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
15197367|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15197368|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15197369|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15197370|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197371|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197372|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15197373|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
15197374|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197375|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197376|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15197377|NCT03790085|Olanzapine|olanzapine|mesh-list
15197378|NCT03790085|Risperidone|risperidone|mesh-list
15197379|NCT03790085|Aripiprazole|aripiprazole|mesh-list
15197380|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15197381|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
15197382|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197383|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197384|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197385|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15197386|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15197387|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197388|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15197389|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15197390|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
15197391|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
15197392|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
15197393|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197394|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197395|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15197396|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15197397|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15197398|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
15197399|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
15197400|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15197401|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15197402|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15197403|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15197404|NCT03789916|Aspirin|aspirin|mesh-list
15197405|NCT03789916|Ticagrelor|ticagrelor|mesh-list
15197406|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15197407|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14294719|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14817432|NCT00876317|Etoricoxib|etoricoxib|mesh-list
14817433|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14817434|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14817435|NCT00876317|Analgesics|analgesics|mesh-ancestor
14817436|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
14817437|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817438|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817439|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14817440|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14817441|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14817442|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14817443|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817444|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817445|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
14817446|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14817447|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14817448|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14817449|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
14817450|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817451|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817452|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817453|NCT00876421|Urological Agents|urological agents|mesh-ancestor
14817454|NCT00876434|Sirolimus|sirolimus|mesh-list
14817455|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817456|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817457|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817458|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817459|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
14817460|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817461|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
14817462|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817463|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
14817464|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14817465|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817466|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817467|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14817468|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817469|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817470|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817471|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817472|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14817473|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
14817474|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14817475|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817476|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14817477|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14817478|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14817479|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
14817480|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
14817481|NCT00876616|Tacrolimus|tacrolimus|mesh-list
14817482|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817483|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
14817484|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817485|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14817486|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14817487|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
14817488|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817489|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817490|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14817491|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14817492|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817493|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817494|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14817495|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
14817496|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817497|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817498|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
14817499|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817500|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817501|NCT00876772|Olanzapine|olanzapine|mesh-list
14817502|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
14817503|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
14817504|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817505|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817506|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14817507|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14817508|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15197408|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15197409|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15197410|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
15197411|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197412|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197413|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197414|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15197415|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14817509|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817510|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817511|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14817512|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14817513|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14817514|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817515|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817516|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
14817517|NCT00876824|Amphotericin B|amphotericin b|mesh-list
14817518|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14817519|NCT00876824|Amebicides|amebicides|mesh-ancestor
14817520|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14817521|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14817522|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817523|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817524|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
14817525|NCT00876850|Linezolid|linezolid|mesh-list
14817526|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817527|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817528|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14817529|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817530|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817531|NCT00876889|Riluzole|riluzole|mesh-list
14817532|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
14817533|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14817534|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14817535|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817536|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817537|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817538|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14817539|NCT00876889|Protective Agents|protective agents|mesh-ancestor
15197416|NCT03789916|Analgesics|analgesics|mesh-ancestor
15197417|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
15197418|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197419|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197420|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197421|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15197422|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15197423|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15197424|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197425|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
15197426|NCT03790137|Fenfluramine|fenfluramine|mesh-list
15197427|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14817540|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
14817541|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15197428|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15197429|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14817542|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
14817543|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817544|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817545|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817546|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
14817547|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817548|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
14817549|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15197430|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197431|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197432|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
15197433|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197434|NCT03790007|Bupivacaine|bupivacaine|mesh-list
15197435|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
14817550|NCT00876902|Protective Agents|protective agents|mesh-ancestor
14817551|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
14817552|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
14817553|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
14817554|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
14817555|NCT00877097|Trisequens|trisequens|mesh-list
14817556|NCT00877097|Norethindrone|norethindrone|mesh-list
14817557|NCT00877097|Estradiol|estradiol|mesh-list
14817558|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14817559|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817560|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14817561|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14817562|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14817563|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
14817564|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14817565|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14817566|NCT00877097|Estrogens|estrogens|mesh-ancestor
14817567|NCT00877097|Hormones|hormones|mesh-ancestor
14817568|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14817569|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14817570|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
14817571|NCT00877110|Vincristine|vincristine|mesh-list
14817572|NCT00877110|Topotecan|topotecan|mesh-list
14817573|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817574|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
14817575|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817576|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14817577|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14817578|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
14817579|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817580|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817581|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14817582|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14817583|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14817584|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14817585|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14817586|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14817587|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817588|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817589|NCT00877123|Vitamin D|vitamin d|mesh-list
14817590|NCT00877123|Vitamins|vitamins|mesh-ancestor
14817591|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
14817592|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817593|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14817594|NCT00877149|Telbivudine|telbivudine|mesh-list
14817595|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
14817596|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817597|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14817598|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817599|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817600|NCT00877175|Phenylephrine|phenylephrine|mesh-list
14817601|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
14817602|NCT00877175|Tropicamide|tropicamide|mesh-list
14817603|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14700983|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700984|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14700985|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14700986|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14700987|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14700988|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
14700989|NCT00397826|Simvastatin|simvastatin|mesh-list
14700990|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14700991|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14817604|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
14817605|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
14817606|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817607|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817608|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
15197436|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
15197437|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197438|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197439|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
15197440|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197441|NCT03789695|Dabigatran|dabigatran|mesh-list
14817609|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14817610|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
14817611|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
14817612|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14817613|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14817614|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14817615|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
14817616|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817617|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817618|NCT00877175|Protective Agents|protective agents|mesh-ancestor
14817619|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14817620|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14817621|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
14817622|NCT00877214|Rituximab|rituximab|mesh-list
14817623|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817624|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817625|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
14817626|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817627|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14817628|NCT00877227|Leucovorin|leucovorin|mesh-list
14817629|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14817630|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
14817631|NCT00877227|Antidotes|antidotes|mesh-ancestor
14817632|NCT00877227|Protective Agents|protective agents|mesh-ancestor
14817633|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817634|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
14817635|NCT00877227|Vitamins|vitamins|mesh-ancestor
14817636|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
14817637|NCT00877253|Carboplatin|carboplatin|mesh-list
14817638|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817639|NCT00877266|Mepivacaine|mepivacaine|mesh-list
14817640|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
14817641|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
14817642|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817643|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817644|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
14817645|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817646|NCT00877396|Vaccines|vaccines|mesh-list
14817647|NCT00877396|Immunologic Factors|immunologic factors|mesh-ancestor
14817648|NCT00877396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817649|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14817650|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14817651|NCT00877422|Vitamin D|vitamin d|mesh-list
14817652|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
14817653|NCT00877422|Vitamins|vitamins|mesh-ancestor
14817654|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
14817655|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817656|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14817657|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14817658|NCT00877539|Fluticasone|fluticasone|mesh-list
14817659|NCT00877539|Xhance|xhance|mesh-list
14817660|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14817661|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14817662|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
14817663|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817664|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817665|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14817666|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
14817667|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
15197442|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
14817668|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14817669|NCT00877591|Ritonavir|ritonavir|mesh-list
14817670|NCT00877591|Darunavir|darunavir|mesh-list
14817671|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
14294720|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294721|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817672|NCT00877591|Rifampin|rifampin|mesh-list
14817673|NCT00877591|Rifabutin|rifabutin|mesh-list
14817674|NCT00877591|Buprenorphine|buprenorphine|mesh-list
14817675|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14817676|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14817677|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
14817678|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817679|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700992|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
14700993|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14700994|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14700995|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14700996|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14700997|NCT00397917|Folic Acid|folic acid|mesh-list
14700998|NCT00397917|Hematinics|hematinics|mesh-ancestor
14700999|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
14701000|NCT00397917|Vitamins|vitamins|mesh-ancestor
14701001|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
14701002|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701003|NCT00397956|Ertapenem|ertapenem|mesh-list
14817680|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14817681|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14817682|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
14817683|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817684|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14817685|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14701004|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701005|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701006|NCT00398008|Naltrexone|naltrexone|mesh-list
14701007|NCT00398008|Buprenorphine|buprenorphine|mesh-list
14701008|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14701009|NCT00398008|Narcotics|narcotics|mesh-ancestor
14701010|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701011|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701012|NCT00398008|Analgesics|analgesics|mesh-ancestor
14701013|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
14701014|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701015|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14701016|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14701017|NCT00398034|Testosterone|testosterone|mesh-list
15197443|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15197444|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
14294722|NCT00577707|Pemetrexed|pemetrexed|mesh-list
14701018|NCT00398034|Androgens|androgens|mesh-ancestor
14701019|NCT00398034|Hormones|hormones|mesh-ancestor
14701020|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701021|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701022|NCT00398099|Ertapenem|ertapenem|mesh-list
14701023|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701024|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701025|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14701026|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14701027|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728482|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
14728483|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14728484|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14728485|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728486|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728487|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14728488|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728489|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
14728490|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14728491|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14728492|NCT00518479|Diuretics|diuretics|mesh-ancestor
14728493|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
14728494|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14728495|NCT00518570|Levetiracetam|levetiracetam|mesh-list
15197445|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197446|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197447|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
14728496|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
14817686|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14701028|NCT00398281|Dutasteride|dutasteride|mesh-list
14701029|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14701030|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14701031|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701032|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701033|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
14701034|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701035|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701036|NCT00398307|Cisplatin|cisplatin|mesh-list
14701037|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701038|NCT00398372|Rituximab|rituximab|mesh-list
14817687|NCT00877591|Narcotics|narcotics|mesh-ancestor
14817688|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817689|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817690|NCT00877591|Analgesics|analgesics|mesh-ancestor
14817691|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
14817692|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817693|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15197448|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
15197449|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
15197450|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15197451|NCT03789799|Protective Agents|protective agents|mesh-ancestor
15197452|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197453|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
15197454|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15197455|NCT03789370|Propofol|propofol|mesh-list
15197456|NCT03789370|Sevoflurane|sevoflurane|mesh-list
15197457|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15197458|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197459|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197460|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15197461|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
15197462|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
14817694|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14817695|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
14817696|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15197463|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15197464|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15197465|NCT03789539|Vaccines|vaccines|mesh-list
15197466|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
15197467|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197468|NCT03789422|Cetirizine|cetirizine|mesh-list
15197469|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
14817697|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
14817698|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14817699|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14817700|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14817701|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14817702|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14817703|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14817704|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14817705|NCT00877656|Zanolimumab|zanolimumab|mesh-list
14817706|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817707|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817708|NCT00877734|Baclofen|baclofen|mesh-list
14817709|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14817710|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817711|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15197470|NCT03789422|Levocetirizine|levocetirizine|mesh-list
15197471|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15197472|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15197473|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197474|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
15197475|NCT03789422|Coagulants|coagulants|mesh-ancestor
14817712|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817713|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14817714|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
14817715|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
14817716|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817717|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817718|NCT00877760|Interferons|interferons|mesh-list
14701039|NCT00398372|Epratuzumab|epratuzumab|mesh-list
14701040|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14701041|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701042|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
14701043|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817719|NCT00877760|Entecavir|entecavir|mesh-list
14817720|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817721|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
14817722|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817723|NCT00877812|Glycine|glycine|mesh-list
14817724|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
14817725|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817726|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817727|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817728|NCT00877955|Alprazolam|alprazolam|mesh-list
14817729|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14817730|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817731|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817732|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14817733|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14817734|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817735|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
14817736|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
14817737|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817738|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910670|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910671|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14910672|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
14910673|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
14910674|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
14910675|NCT01358344|Pantoprazole|pantoprazole|mesh-list
14910676|NCT01358344|Vorapaxar|vorapaxar|mesh-list
14910677|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14910678|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910679|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14910680|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910681|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910682|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14910683|NCT01358383|Naproxen|naproxen|mesh-list
14910684|NCT01358383|Esomeprazole|esomeprazole|mesh-list
14910685|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14910686|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910687|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14910688|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910689|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910690|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14910691|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910692|NCT01358383|Analgesics|analgesics|mesh-ancestor
14910693|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
14910694|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910695|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910696|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910697|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14910698|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
14701044|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701045|NCT00398385|Gemcitabine|gemcitabine|mesh-list
14701046|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701047|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14910699|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14910700|NCT01358409|Nebivolol|nebivolol|mesh-list
14910701|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15197476|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15197477|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14910702|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
15197478|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
15197479|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
15197480|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197481|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197482|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15197483|NCT03789123|Dienogest|dienogest|mesh-list
15197484|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15197485|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15197486|NCT03789123|Estradiol|estradiol|mesh-list
15197487|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15197488|NCT03789123|Nandrolone|nandrolone|mesh-list
15197489|NCT03789123|Estrogens|estrogens|mesh-ancestor
15197490|NCT03789123|Hormones|hormones|mesh-ancestor
15197491|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197492|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197493|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15197494|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
15197495|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15197496|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15197497|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15197498|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15197499|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15197500|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
15197501|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15197502|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197503|NCT03789123|Androgens|androgens|mesh-ancestor
15197504|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
15197505|NCT03789214|Suvorexant|suvorexant|mesh-list
15197506|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15197507|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15197508|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197509|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197510|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15197511|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197512|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197513|NCT03789058|Ibuprofen|ibuprofen|mesh-list
15197514|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15197515|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197516|NCT03789058|Analgesics|analgesics|mesh-ancestor
15197517|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
15197518|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197519|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197520|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197521|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197522|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15197523|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197524|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197525|NCT03788889|Ketamine|ketamine|mesh-list
15197526|NCT03788889|Lorazepam|lorazepam|mesh-list
15197527|NCT03788889|Phenobarbital|phenobarbital|mesh-list
14817739|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
14817740|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15197528|NCT03788889|Analgesics|analgesics|mesh-ancestor
15197529|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
15197530|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197531|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197532|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15197533|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14817741|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817742|NCT00878124|Ubiquinone|ubiquinone|mesh-list
14817743|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
14817744|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
14817745|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817746|NCT00878124|Vitamins|vitamins|mesh-ancestor
14817747|NCT00878254|Leucovorin|leucovorin|mesh-list
14817748|NCT00878254|Cytarabine|cytarabine|mesh-list
14817749|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
14817750|NCT00878254|Ifosfamide|ifosfamide|mesh-list
14817751|NCT00878254|Rituximab|rituximab|mesh-list
14817752|NCT00878254|Doxorubicin|doxorubicin|mesh-list
14817753|NCT00878254|Methotrexate|methotrexate|mesh-list
14817754|NCT00878254|Etoposide|etoposide|mesh-list
15197534|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
15197535|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
14817755|NCT00878254|Vincristine|vincristine|mesh-list
14817756|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14817757|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
15197536|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817758|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817759|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14817760|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14817761|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
14817762|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817763|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817764|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14817765|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14817766|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817767|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14817768|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817769|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817770|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14817771|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
14817772|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14817773|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14817774|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
14817775|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
14817776|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14817777|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14817778|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14817779|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
14817780|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817781|NCT00878254|Antidotes|antidotes|mesh-ancestor
14817782|NCT00878254|Protective Agents|protective agents|mesh-ancestor
14817783|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
14817784|NCT00878254|Vitamins|vitamins|mesh-ancestor
14817785|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
14817786|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
14817787|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
14817788|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
14817789|NCT00878306|Ritonavir|ritonavir|mesh-list
14817790|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14817791|NCT00878306|Efavirenz|efavirenz|mesh-list
14817792|NCT00878306|Disulfiram|disulfiram|mesh-list
14817793|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14817794|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14817795|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
14817796|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817797|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817798|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14817799|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14817800|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
14817801|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817802|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14817803|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14817804|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14817805|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14817806|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14817807|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14817808|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14817809|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14817810|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14817811|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14817812|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14817813|NCT00878345|Pentobarbital|pentobarbital|mesh-list
14817814|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
14817815|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14817816|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817817|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817818|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14817819|NCT00878345|Analgesics|analgesics|mesh-ancestor
14817820|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
14817821|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817822|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14817823|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14817824|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14817825|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
14817826|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197537|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15197538|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14817827|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817828|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14817829|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
14817830|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
14817831|NCT00878371|Morphine|morphine|mesh-list
14817832|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14817833|NCT00878371|Narcotics|narcotics|mesh-ancestor
14817834|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817835|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817836|NCT00878371|Analgesics|analgesics|mesh-ancestor
14817837|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
14817838|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817839|NCT00878449|Etoposide|etoposide|mesh-list
14817840|NCT00878449|Navitoclax|navitoclax|mesh-list
14817841|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817842|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14817843|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14817844|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817845|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817846|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817847|NCT00878514|Alprazolam|alprazolam|mesh-list
14817848|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14817849|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817850|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817851|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14817852|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14817853|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817854|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
14817855|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
14817856|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817857|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817858|NCT00878540|Mirtazapine|mirtazapine|mesh-list
14817859|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
14817860|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817861|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14817862|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
14817863|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
14817864|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817865|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817866|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817867|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14817868|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14817869|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817870|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14817871|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14817872|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14817873|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14817874|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14817875|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14817876|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
14817877|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14817878|NCT00878631|Dextrans|dextrans|mesh-list
14817879|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
14817880|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
14817881|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
14817882|NCT00878657|Gemcitabine|gemcitabine|mesh-list
14817883|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14817884|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
14817885|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817886|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817887|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
14817888|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817889|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817890|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294723|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14701048|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
14701049|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701050|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
14701051|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701052|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701053|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701054|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
14701055|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817891|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
14817892|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817893|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
14294724|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817894|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14817895|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14817896|NCT00878670|Analgesics|analgesics|mesh-ancestor
14817897|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
14817898|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817899|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817900|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701056|NCT00398424|Cisplatin|cisplatin|mesh-list
14701057|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701058|NCT00398437|Trastuzumab|trastuzumab|mesh-list
14701059|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14701060|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701061|NCT00398450|Interferons|interferons|mesh-list
14701062|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
14817901|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14817902|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14817903|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
14817904|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817905|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14817906|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14817907|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14817908|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14817909|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14817910|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14817911|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817912|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817913|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817914|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14817915|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
14817916|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817917|NCT00878865|Alprazolam|alprazolam|mesh-list
14817918|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14817919|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817920|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817921|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14817922|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14817923|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817924|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
14817925|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
15197539|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197540|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701063|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
14817926|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817927|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817928|NCT00878904|Epirubicin|epirubicin|mesh-list
14817929|NCT00878904|Panobinostat|panobinostat|mesh-list
14817930|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14817931|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817932|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14817933|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817934|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817935|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817936|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14817937|NCT00878917|Dorzolamide|dorzolamide|mesh-list
14817938|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14817939|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14817940|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14817941|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14817942|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197541|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
14701064|NCT00398450|Azacitidine|azacitidine|mesh-list
15197542|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
15197543|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
15197544|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197545|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15197546|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15197547|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15197548|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14701065|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701066|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
14728497|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
14817943|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817944|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
14817945|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817946|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
14817947|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14817948|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14817949|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817950|NCT00878943|Urological Agents|urological agents|mesh-ancestor
14817951|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
14817952|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14817953|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14817954|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817955|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14817956|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14817957|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14817958|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817959|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817960|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14817961|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
14817962|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14817963|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817964|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14817965|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14817966|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14817967|NCT00879021|Pregabalin|pregabalin|mesh-list
14817968|NCT00879021|Analgesics|analgesics|mesh-ancestor
14817969|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
14817970|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14817971|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197549|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
15197550|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
15197551|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15197552|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14817972|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
14817973|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14817974|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14817975|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817976|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14817977|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14817978|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14817979|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817980|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14817981|NCT00879047|Ethanol|ethanol|mesh-list
14817982|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14817983|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14817984|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14817985|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14817986|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14817987|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14817988|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
14817989|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817990|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14817991|NCT00879099|Timolol|timolol|mesh-list
14817992|NCT00879099|Paroxetine|paroxetine|mesh-list
14817993|NCT00879099|Maleic acid|maleic acid|mesh-list
14817994|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14817995|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14817996|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
14817997|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14817998|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14817999|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818000|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14818001|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14818002|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818003|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15197553|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15197554|NCT03788902|Methylphenidate|methylphenidate|mesh-list
15197555|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15197556|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197557|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15197558|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14818004|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14818005|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14818006|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
14818007|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14818008|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
14818009|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818010|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14818011|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14818012|NCT00879164|Bupivacaine|bupivacaine|mesh-list
14818013|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
14818014|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
14818015|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818016|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818017|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
14818018|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818019|NCT00879177|Varenicline|varenicline|mesh-list
14818020|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14818021|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14818022|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
15197559|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15197560|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197561|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
14294725|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294726|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294727|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14294728|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14294729|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14294730|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
14294731|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
14294732|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14701067|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701068|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818023|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818024|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818025|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818026|NCT00879242|Deferasirox|deferasirox|mesh-list
14818027|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14818028|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
14818029|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
14818030|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818031|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14818032|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14818033|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
14818034|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818035|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14818036|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14818037|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197562|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224412|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701069|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
14701070|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701071|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701072|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
14701073|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701074|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
14701075|NCT00398463|Tirofiban|tirofiban|mesh-list
14701076|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14701077|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14701078|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701079|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14701080|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14818038|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818039|NCT00879372|Tianeptine|tianeptine|mesh-list
15224413|NCT03798691|Vaccines|vaccines|mesh-list
15224414|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
15224415|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224416|NCT03789318|Acetaminophen|acetaminophen|mesh-list
15224417|NCT03789318|Fentanyl|fentanyl|mesh-list
15224418|NCT03789318|Oxycodone|oxycodone|mesh-list
15224419|NCT03789318|Hydromorphone|hydromorphone|mesh-list
15224420|NCT03789318|Bupivacaine|bupivacaine|mesh-list
15224421|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
15224422|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
15224423|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818040|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14818041|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
14818042|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818043|NCT00879385|Decitabine|decitabine|mesh-list
14818044|NCT00879385|Panitumumab|panitumumab|mesh-list
14818045|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818046|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
14818047|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818048|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818049|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818050|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14818051|NCT00879424|Vitamin D|vitamin d|mesh-list
14818052|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
14818053|NCT00879424|Vitamins|vitamins|mesh-ancestor
14818054|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
14818055|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818056|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14818057|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14818058|NCT00879476|Ramipril|ramipril|mesh-list
14818059|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14818060|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
14818061|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197563|NCT03788863|Diflucortolone|diflucortolone|mesh-list
15197564|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
15197565|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197566|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
15197567|NCT03788863|Hormones|hormones|mesh-ancestor
15197568|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197569|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197570|NCT03789032|Rabeprazole|rabeprazole|mesh-list
15197571|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15197572|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197573|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15197574|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197575|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197576|NCT03788733|Melatonin|melatonin|mesh-list
15197577|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
15197578|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197579|NCT03788733|Protective Agents|protective agents|mesh-ancestor
15197580|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197581|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197582|NCT03788694|Ketamine|ketamine|mesh-list
15197583|NCT03788694|Analgesics|analgesics|mesh-ancestor
15197584|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
15197585|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197586|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197587|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15197588|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15197589|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
15197590|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
14701081|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
14701082|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701083|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14701084|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701085|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
14701086|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701087|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
14701088|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14701089|NCT00398463|Protective Agents|protective agents|mesh-ancestor
14701090|NCT00398489|Tamoxifen|tamoxifen|mesh-list
14701091|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
14818062|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818063|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14818064|NCT00879489|Vaccines|vaccines|mesh-list
14818065|NCT00879489|Immunologic Factors|immunologic factors|mesh-ancestor
14818066|NCT00879489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818067|NCT00879541|Factor VIII|factor viii|mesh-list
14818068|NCT00879541|Coagulants|coagulants|mesh-ancestor
14818069|NCT00879723|Vitamins|vitamins|mesh-list
14818070|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
14818071|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818072|NCT00879788|Ramipril|ramipril|mesh-list
14818073|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14701092|NCT00398489|Docetaxel|docetaxel|mesh-list
14701093|NCT00398489|Trastuzumab|trastuzumab|mesh-list
14818074|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
15197591|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818075|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818076|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818077|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14910703|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14910704|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14910705|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14910706|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
14910707|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910708|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910709|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910710|NCT01358435|Insulin|insulin|mesh-list
14910711|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14910712|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
14910713|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
14910714|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
14910715|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14910716|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910717|NCT01358500|Fentanyl|fentanyl|mesh-list
14910718|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15197592|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15197593|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15197594|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197595|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197596|NCT03789006|Interleukin-2|interleukin-2|mesh-list
15197597|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
15197598|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15197599|NCT03789006|Antibodies|antibodies|mesh-list
15197600|NCT03789006|Basiliximab|basiliximab|mesh-list
15197601|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
15197602|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15197603|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
15197604|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910719|NCT01358500|Narcotics|narcotics|mesh-ancestor
14910720|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910721|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910722|NCT01358500|Analgesics|analgesics|mesh-ancestor
14910723|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
14910724|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910725|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14910726|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14910727|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
14910728|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
14910729|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
14910730|NCT01358591|Calcium|calcium|mesh-list
14910731|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910732|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910733|NCT01358591|Antacids|antacids|mesh-ancestor
14910734|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910735|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917118|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197605|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197606|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197607|NCT03789006|Analgesics|analgesics|mesh-ancestor
15197608|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
15197609|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197610|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15197611|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
15197612|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
15197613|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197614|NCT03788759|Protective Agents|protective agents|mesh-ancestor
15197615|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197616|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
15197617|NCT03788759|Vitamins|vitamins|mesh-ancestor
15197618|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
15197619|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15197620|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15197621|NCT03788681|Estradiol|estradiol|mesh-list
15197622|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14917119|NCT01395992|Asenapine|asenapine|mesh-list
15197623|NCT03788681|Estrogens|estrogens|mesh-ancestor
15197624|NCT03788681|Hormones|hormones|mesh-ancestor
15197625|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197626|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197627|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14818078|NCT00879827|PENTA|penta|mesh-list
14818079|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
14818080|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15197628|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
15197629|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15197630|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15197631|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
15197632|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14818081|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14818082|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818083|NCT00879892|Xenon|xenon|mesh-list
14818084|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14818085|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
14818086|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
14818087|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818088|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818089|NCT00879918|Nicotine|nicotine|mesh-list
14818090|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14818091|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
14818092|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818093|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818094|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14818095|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14818096|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
14818097|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818098|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818099|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
14818100|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14818101|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14818102|NCT00879931|Prednisolone|prednisolone|mesh-list
14818103|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
14818104|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14818105|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
14818106|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197633|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701094|NCT00398489|Epirubicin|epirubicin|mesh-list
15197634|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197635|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197636|NCT03788538|Analgesics|analgesics|mesh-ancestor
15197637|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
14701095|NCT00398489|Anastrozole|anastrozole|mesh-list
14701096|NCT00398489|Goserelin|goserelin|mesh-list
14701097|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701098|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
14701099|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701100|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701101|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14701102|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
14701103|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701104|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818107|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
14818108|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
14818109|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818110|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818111|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14818112|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
14818113|NCT00879931|Hormones|hormones|mesh-ancestor
14818114|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818115|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14818116|NCT00879931|Protective Agents|protective agents|mesh-ancestor
14818117|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14818118|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818119|NCT00879957|Heparin|heparin|mesh-list
14818120|NCT00879957|Calcium heparin|calcium heparin|mesh-list
14818121|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
14818122|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15197638|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197639|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15197640|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14701105|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14818123|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14701106|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701107|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701108|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
15197641|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15197642|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
15197643|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197644|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818124|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818125|NCT00879983|Azithromycin|azithromycin|mesh-list
14818126|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818127|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818128|NCT00880178|Niacin|niacin|mesh-list
14818129|NCT00880178|Niacinamide|niacinamide|mesh-list
14818130|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
14818131|NCT00880178|Simvastatin|simvastatin|mesh-list
14818132|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14818133|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14818134|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
14818135|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818136|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14818137|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14818138|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818139|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
14818140|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
14818141|NCT00880178|Vitamins|vitamins|mesh-ancestor
14818142|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
14818143|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818144|NCT00880243|Cytarabine|cytarabine|mesh-list
14818145|NCT00880243|Etoposide|etoposide|mesh-list
14818146|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
14818147|NCT00880243|Daunorubicin|daunorubicin|mesh-list
14818148|NCT00880243|Molgramostim|molgramostim|mesh-list
15197645|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15197646|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14818149|NCT00880243|Sargramostim|sargramostim|mesh-list
14818150|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14818151|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818152|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14818153|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15197647|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
15197648|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
15197649|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15197650|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15197651|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15197652|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15197653|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197654|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
15197655|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197656|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197657|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15197658|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701109|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14701110|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14818154|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818155|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818156|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818157|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
14818158|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
14818159|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818160|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818161|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
14818162|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818163|NCT00880243|Analgesics|analgesics|mesh-ancestor
14818164|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
14818165|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818166|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14701111|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14701112|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14701113|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701114|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14701115|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
14701116|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818167|NCT00880282|Sirolimus|sirolimus|mesh-list
14818168|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14818169|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818170|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818171|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14818172|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818173|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
14818174|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818175|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
14818176|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818177|NCT00880321|Dabrafenib|dabrafenib|mesh-list
14818178|NCT00880321|Midazolam|midazolam|mesh-list
14818179|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14818180|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14818181|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818182|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818183|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14818184|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14818185|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818186|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14818187|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
14818188|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
14818189|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
14818190|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
14818191|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818192|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818193|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818194|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14818195|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818196|NCT00880373|Ibuprofen|ibuprofen|mesh-list
14818197|NCT00880373|Morphine|morphine|mesh-list
14818198|NCT00880373|Heroin|heroin|mesh-list
14818199|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14818200|NCT00880373|Narcotics|narcotics|mesh-ancestor
14818201|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818202|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818203|NCT00880373|Analgesics|analgesics|mesh-ancestor
14818204|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
14818205|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818206|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14818207|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14818208|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14818209|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14818210|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14818211|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818212|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818213|NCT00880386|Losartan|losartan|mesh-list
14818214|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14818215|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14818216|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14818217|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14818218|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818219|NCT00880412|Etazolate|etazolate|mesh-list
14818220|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14818221|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818222|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818223|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14818224|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14818225|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818226|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818227|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818228|NCT00880477|Edetic Acid|edetic acid|mesh-list
14818229|NCT00880477|Vaccines|vaccines|mesh-list
14818230|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
15197659|NCT03787992|Gefitinib|gefitinib|mesh-list
15197660|NCT03787992|Aflutinib|aflutinib|mesh-list
15197661|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197662|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15197663|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197664|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197665|NCT03787940|Isoniazid|isoniazid|mesh-list
15197666|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
15197667|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15197668|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15197669|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15197670|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15197671|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
15197672|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197673|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15197674|NCT03787953|Antibodies|antibodies|mesh-list
15197675|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
15197676|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197677|NCT03788018|Lidocaine|lidocaine|mesh-list
15197678|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
15197679|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197680|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
15197681|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197682|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197683|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
15197684|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197685|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15197686|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15197687|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15197688|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14701117|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14701118|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14701119|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14701120|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14701121|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14701122|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14701123|NCT00398515|Sirolimus|sirolimus|mesh-list
14701124|NCT00398515|Lenalidomide|lenalidomide|mesh-list
14701125|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
14701126|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701127|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14701128|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14701129|NCT00398515|Growth Substances|growth substances|mesh-ancestor
14701130|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
14701131|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701132|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701133|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701134|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14701135|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
14701136|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701137|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
14701138|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
14701139|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14701140|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
14701141|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701142|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701143|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701144|NCT00398554|Prednisone|prednisone|mesh-list
14701145|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
14701146|NCT00398554|Doxorubicin|doxorubicin|mesh-list
14701147|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14701148|NCT00398554|Etoposide|etoposide|mesh-list
14701149|NCT00398554|Vincristine|vincristine|mesh-list
14701150|NCT00398554|Vinblastine|vinblastine|mesh-list
14701151|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701152|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
14701153|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701154|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701155|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14701156|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
14701157|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701158|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701159|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14701160|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14701161|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15197689|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197690|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15197691|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197692|NCT03788018|Analgesics|analgesics|mesh-ancestor
15197693|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15197694|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15197695|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15197696|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
15197697|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197698|NCT03788174|Apatinib|apatinib|mesh-list
15197699|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197700|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15197701|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197702|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197703|NCT03787927|Aspirin|aspirin|mesh-list
15197704|NCT03787927|Clopidogrel|clopidogrel|mesh-list
15197705|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15197706|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197707|NCT03787927|Analgesics|analgesics|mesh-ancestor
15197708|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
15197709|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197710|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197711|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197712|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197713|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15197714|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15197715|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197716|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14701162|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14701163|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701164|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701165|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
14701166|NCT00398554|Hormones|hormones|mesh-ancestor
14701167|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701168|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14701169|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14818231|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
14294733|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14818232|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818233|NCT00880477|Antidotes|antidotes|mesh-ancestor
14818234|NCT00880477|Protective Agents|protective agents|mesh-ancestor
14818235|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
14818236|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
14818237|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818238|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14818239|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
14818240|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14818241|NCT00880529|Morphine|morphine|mesh-list
14818242|NCT00880529|Bupivacaine|bupivacaine|mesh-list
14818243|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
14818244|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
14818245|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818246|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818247|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
14818248|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818249|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14818250|NCT00880529|Narcotics|narcotics|mesh-ancestor
14818251|NCT00880529|Analgesics|analgesics|mesh-ancestor
14818252|NCT00880594|Desipramine|desipramine|mesh-list
14818253|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14818254|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
14818255|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818256|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818257|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818258|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14818259|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14818260|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14818261|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
14818262|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818263|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818264|NCT00880672|Dutasteride|dutasteride|mesh-list
14818265|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14818266|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14818267|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818268|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818269|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
14818270|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818271|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818272|NCT00880815|Rituximab|rituximab|mesh-list
14818273|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14818274|NCT00880815|Methotrexate|methotrexate|mesh-list
14818275|NCT00880815|Fludarabine|fludarabine|mesh-list
14818276|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14818277|NCT00880815|Antibodies|antibodies|mesh-list
14818278|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
14818279|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14818280|NCT00880815|Lenograstim|lenograstim|mesh-list
14818281|NCT00880815|Tacrolimus|tacrolimus|mesh-list
14818282|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
14818283|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14818284|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
14818285|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197717|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15197718|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818286|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818287|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14818288|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14818289|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
14818290|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14818291|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818292|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
14818293|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818294|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14818295|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197719|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
15197720|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15197721|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15197722|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15197723|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
14818296|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14818297|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818298|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14818299|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14701170|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701171|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701172|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701173|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
14818300|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14818301|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14818302|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
14818303|NCT00880828|Acetaminophen|acetaminophen|mesh-list
14818304|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14818305|NCT00880828|Analgesics|analgesics|mesh-ancestor
14818306|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
14818307|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818308|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818309|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
14818310|NCT00880841|Buprenorphine|buprenorphine|mesh-list
14818311|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14818312|NCT00880841|Naloxone|naloxone|mesh-list
14818313|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14818314|NCT00880841|Narcotics|narcotics|mesh-ancestor
14818315|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818316|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818317|NCT00880841|Analgesics|analgesics|mesh-ancestor
14818318|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
14818319|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818320|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14818321|NCT00880854|Tremelimumab|tremelimumab|mesh-list
14818322|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818323|NCT00880867|Poly ICLC|poly iclc|mesh-list
14818324|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
14818325|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
14818326|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818327|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
14818328|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818329|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14818330|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818331|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818332|NCT00881088|PENTA|penta|mesh-list
14818333|NCT00881088|Nadroparin|nadroparin|mesh-list
14818334|NCT00881088|Fondaparinux|fondaparinux|mesh-list
14818335|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14818336|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
14818337|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14818338|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
14818339|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818340|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818341|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
14818342|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14818343|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14818344|NCT00881101|Paclitaxel|paclitaxel|mesh-list
14818345|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14818346|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818347|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
14818348|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
14818349|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
14818350|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818351|NCT00881114|Cetuximab|cetuximab|mesh-list
14818352|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818353|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14818354|NCT00881127|Cetirizine|cetirizine|mesh-list
15197724|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197725|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15197726|NCT03787550|Analgesics|analgesics|mesh-list
15197727|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15197728|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701174|NCT00398580|Testosterone|testosterone|mesh-list
14701175|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
14701176|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
14701177|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14701178|NCT00398580|Dutasteride|dutasteride|mesh-list
14701179|NCT00398580|Androgens|androgens|mesh-ancestor
14701180|NCT00398580|Hormones|hormones|mesh-ancestor
14818355|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
14818356|NCT00881127|Ephedrine|ephedrine|mesh-list
14818357|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14728498|NCT00518583|Paclitaxel|paclitaxel|mesh-list
14818358|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14818359|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14818360|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
14818361|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
14818362|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818363|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818364|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818365|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14818366|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
14818367|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818368|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14818369|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
14818370|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
14818371|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14818372|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14818373|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
14818374|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
14818375|NCT00881140|Mifepristone|mifepristone|mesh-list
14818376|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15197729|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
15197730|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197731|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197732|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197733|NCT03787641|Protamines|protamines|mesh-list
15197734|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
15197735|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197736|NCT03787641|Coagulants|coagulants|mesh-ancestor
15197737|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15197738|NCT03787264|Venetoclax|venetoclax|mesh-list
14818377|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
14818378|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14818379|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818380|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14818381|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14818382|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14818383|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
14818384|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14818385|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15197739|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
15197740|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
15197741|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15197742|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
15197743|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197744|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197745|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224424|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224425|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
15224426|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224427|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15224428|NCT03789318|Narcotics|narcotics|mesh-ancestor
15224429|NCT03789318|Analgesics|analgesics|mesh-ancestor
15224430|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15224431|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15224432|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
15224433|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15224434|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
15224435|NCT03781414|Tacrolimus|tacrolimus|mesh-list
15224436|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224437|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
15224438|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224439|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15224440|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224441|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224442|NCT03774875|Apremilast|apremilast|mesh-list
15224443|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15224444|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15224445|NCT03774875|Analgesics|analgesics|mesh-ancestor
15224446|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
15224447|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224448|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224449|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224450|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224451|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15224452|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14818386|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
15197746|NCT03787147|Lidocaine|lidocaine|mesh-list
15197747|NCT03787147|Bupivacaine|bupivacaine|mesh-list
15197748|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197749|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
15197750|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197751|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197752|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
15197753|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197754|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15197755|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15197756|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15197757|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15197758|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197759|NCT03786887|Nalbuphine|nalbuphine|mesh-list
15197760|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15197761|NCT03786887|Narcotics|narcotics|mesh-ancestor
14728499|NCT00518583|Doxorubicin|doxorubicin|mesh-list
14728500|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14728501|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14728502|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728503|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
14728504|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
14728505|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
14728506|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728507|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14728508|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14728509|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14728510|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728511|NCT00518635|Insulin|insulin|mesh-list
14728512|NCT00518635|Hormones|hormones|mesh-list
14728513|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14728514|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728515|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14728516|NCT00518895|Dacarbazine|dacarbazine|mesh-list
14728517|NCT00518895|Oblimersen|oblimersen|mesh-list
14728518|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14728519|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
14728520|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728521|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818387|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818388|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
14818389|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14818390|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14818391|NCT00881153|Cefprozil|cefprozil|mesh-list
14818392|NCT00881153|Cephalosporins|cephalosporins|mesh-list
14818393|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818394|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818395|NCT00881166|Paclitaxel|paclitaxel|mesh-list
14818396|NCT00881166|Etoposide|etoposide|mesh-list
14818397|NCT00881166|Docetaxel|docetaxel|mesh-list
14818398|NCT00881166|Carboplatin|carboplatin|mesh-list
14818399|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14818400|NCT00881166|Topotecan|topotecan|mesh-list
14818401|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14818402|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818403|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
14818404|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
15197762|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197763|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197764|NCT03786887|Analgesics|analgesics|mesh-ancestor
15197765|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
15197766|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197767|NCT03787043|Metformin|metformin|mesh-list
15197768|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15197769|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197770|NCT03787017|Metformin|metformin|mesh-list
15197771|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15197772|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197773|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
15197774|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15197775|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
15197776|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15197777|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
15197778|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197779|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197780|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
15197781|NCT03787030|Vitamin E|vitamin e|mesh-list
15197782|NCT03787030|Tocopherols|tocopherols|mesh-list
15197783|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
14818405|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
14818406|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818407|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14818408|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14818409|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818410|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14818411|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14818412|NCT00881179|Clarithromycin|clarithromycin|mesh-list
14818413|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818414|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818415|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14818416|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818417|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818418|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14818419|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14818420|NCT00881218|Regadenoson|regadenoson|mesh-list
14818421|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14818422|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14818423|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
14818424|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
14818425|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818426|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818427|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197784|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
14818428|NCT00881231|Cilostazol|cilostazol|mesh-list
14818429|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14818430|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
14818431|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818432|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818433|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14818434|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
14818435|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14818436|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14910736|NCT01358812|Panitumumab|panitumumab|mesh-list
15197785|NCT03787030|Vitamins|vitamins|mesh-ancestor
15197786|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
14818437|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818438|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15197787|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197788|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
15197789|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701181|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701182|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701183|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15197790|NCT03787030|Protective Agents|protective agents|mesh-ancestor
15197791|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
15197792|NCT03787069|Lidocaine|lidocaine|mesh-list
14818439|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
14818440|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14818441|NCT00881231|Protective Agents|protective agents|mesh-ancestor
14818442|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14818443|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14818444|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818445|NCT00881296|Gemcitabine|gemcitabine|mesh-list
14818446|NCT00881296|Carboplatin|carboplatin|mesh-list
14818447|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818448|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818449|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
14818450|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818451|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
15197793|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
15197794|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
15197795|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197796|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197797|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
15197798|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197799|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15197800|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15197801|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15197802|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15197803|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197804|NCT03786562|Morphine|morphine|mesh-list
15197805|NCT03786562|Nalbuphine|nalbuphine|mesh-list
14701184|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197806|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15197807|NCT03786562|Narcotics|narcotics|mesh-ancestor
14818452|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818453|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818454|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818455|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
14818456|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818457|NCT00881387|Gemcitabine|gemcitabine|mesh-list
14818458|NCT00881387|Rituximab|rituximab|mesh-list
14818459|NCT00881387|Vinorelbine|vinorelbine|mesh-list
14818460|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14818461|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818462|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
14818463|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818464|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14818465|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818466|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
14818467|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818468|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
14818469|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818470|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818471|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818472|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14818473|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14818474|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14818475|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14818476|NCT00881400|Cefprozil|cefprozil|mesh-list
14818477|NCT00881400|Cephalosporins|cephalosporins|mesh-list
14818478|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818479|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818480|NCT00881413|Esomeprazole|esomeprazole|mesh-list
14701185|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
14701186|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14701187|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14701188|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818481|NCT00881413|Pantoprazole|pantoprazole|mesh-list
14818482|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14818483|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14818484|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14818485|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818486|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818487|NCT00881426|Cefprozil|cefprozil|mesh-list
14818488|NCT00881426|Cephalosporins|cephalosporins|mesh-list
14818489|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818490|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818491|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14818492|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14818493|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818494|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
14818495|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
14818496|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
14818497|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818498|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14818499|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14818500|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14818501|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818502|NCT00881543|Incretins|incretins|mesh-ancestor
14818503|NCT00881543|Hormones|hormones|mesh-ancestor
14818504|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818505|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
14818506|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818507|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818508|NCT00881556|Fludarabine|fludarabine|mesh-list
14818509|NCT00881556|Busulfan|busulfan|mesh-list
14818510|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
14818511|NCT00881556|Lorazepam|lorazepam|mesh-list
14818512|NCT00881556|Tacrolimus|tacrolimus|mesh-list
14818513|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818514|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818515|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818516|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
14818517|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818518|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14818519|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818520|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
14818521|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14818522|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14818523|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14818524|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
14818525|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
14818526|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
14818527|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818528|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14818529|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14818530|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818531|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14818532|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14818533|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818534|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
14818535|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
14818536|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818537|NCT00881582|Interferons|interferons|mesh-list
14818538|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
14818539|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
14818540|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14818541|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728522|NCT00518908|Sevoflurane|sevoflurane|mesh-list
14818542|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
14818543|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818544|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
14818545|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728523|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14728524|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14728525|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
14728526|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
14728527|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728528|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728529|NCT00518947|Verapamil|verapamil|mesh-list
14728530|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
14728531|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
14728532|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818546|NCT00881595|Temozolomide|temozolomide|mesh-list
14818547|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14818548|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
14818549|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818550|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818551|NCT00881634|Cetirizine|cetirizine|mesh-list
14818552|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
14818553|NCT00881634|Ephedrine|ephedrine|mesh-list
14818554|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14818555|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14818556|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14818557|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
14818558|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
14818559|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818560|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818561|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818562|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14818563|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
14818564|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818565|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14818566|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
14818567|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
14818568|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14818569|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14818570|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
14818571|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14818572|NCT00881673|Dexamethasone|dexamethasone|mesh-list
14818573|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14818574|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14818575|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14818576|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
14818577|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
14818578|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818579|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818580|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14818581|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
14818582|NCT00881673|Hormones|hormones|mesh-ancestor
14818583|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818584|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14818585|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818586|NCT00881686|Adenosine|adenosine|mesh-list
14818587|NCT00881686|Analgesics|analgesics|mesh-ancestor
14818588|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
14818589|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818590|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818591|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14818592|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
14818593|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14818594|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
14818595|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
14818596|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818597|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818598|NCT00881725|Metformin|metformin|mesh-list
14818599|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14818600|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818601|NCT00881738|Clarithromycin|clarithromycin|mesh-list
14818602|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818603|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818604|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14818605|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818606|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818607|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14818608|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14818609|NCT00881764|Anesthetics|anesthetics|mesh-list
14818610|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818611|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197808|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197809|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910737|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14910738|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910739|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14910740|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910741|NCT01359020|Acetaminophen|acetaminophen|mesh-list
14910742|NCT01359020|Dipyrone|dipyrone|mesh-list
14910743|NCT01359020|Ibuprofen|ibuprofen|mesh-list
14910744|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910745|NCT01359020|Analgesics|analgesics|mesh-ancestor
14910746|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
14910747|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910748|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910749|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
14910750|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14910751|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910752|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14910753|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14910754|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910755|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910756|NCT01359059|Pregabalin|pregabalin|mesh-list
14910757|NCT01359059|Analgesics|analgesics|mesh-ancestor
14910758|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
14910759|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910760|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910761|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
14910762|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14910763|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910764|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910765|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910766|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14910767|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910768|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910769|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910770|NCT01359085|Pregabalin|pregabalin|mesh-list
14910771|NCT01359085|Analgesics|analgesics|mesh-ancestor
14910772|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
14910773|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910774|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910775|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
14910776|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14910777|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910778|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910779|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910780|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14910781|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910782|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910783|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910784|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
14910785|NCT01359098|Dexamethasone|dexamethasone|mesh-list
14910786|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910787|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
14910788|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
14910789|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910790|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910791|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910792|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
14910793|NCT01359098|Hormones|hormones|mesh-ancestor
14910794|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910795|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14910796|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910797|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910798|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910799|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14910800|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910801|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15197810|NCT03786562|Analgesics|analgesics|mesh-ancestor
15197811|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
15197812|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197813|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
14701189|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701190|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
14701191|NCT00398658|Clindamycin|clindamycin|mesh-list
14701192|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
14701193|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
14818612|NCT00881790|Fluorides|fluorides|mesh-list
14818613|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
14818614|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
14818615|NCT00881790|Protective Agents|protective agents|mesh-ancestor
14818616|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818617|NCT00881816|Paclitaxel|paclitaxel|mesh-list
14818618|NCT00881816|Capecitabine|capecitabine|mesh-list
14818619|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14818620|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818621|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
14818622|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
14818623|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
14818624|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818625|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818626|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
14818627|NCT00881855|Cefprozil|cefprozil|mesh-list
14818628|NCT00881855|Cephalosporins|cephalosporins|mesh-list
14818629|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818630|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818631|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14818632|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14818633|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818634|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
14818635|NCT00882024|Tranilast|tranilast|mesh-list
14818636|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14818637|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14818638|NCT00882024|Analgesics|analgesics|mesh-ancestor
14818639|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
14818640|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818641|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818642|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14818643|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14818644|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15197814|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15197815|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
15197816|NCT03786289|Hematinics|hematinics|mesh-ancestor
15197817|NCT03786419|Atezolizumab|atezolizumab|mesh-list
15197818|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294734|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818645|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14818646|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818647|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14818648|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14818649|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
14818650|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
14818651|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818652|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14818653|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14818654|NCT00882076|Etoposide|etoposide|mesh-list
14818655|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
14818656|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
14818657|NCT00882076|Clofarabine|clofarabine|mesh-list
14818658|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14818659|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701194|NCT00398658|Gentamicins|gentamicins|mesh-list
14701195|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701196|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701197|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14701198|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701199|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701200|NCT00398684|Nevirapine|nevirapine|mesh-list
14701201|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14701202|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14701203|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701204|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701205|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
14701206|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701207|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14818660|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15197819|NCT03786120|Zolpidem|zolpidem|mesh-list
15224453|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197820|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15197821|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14818661|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14818662|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818663|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818664|NCT00882076|Analgesics|analgesics|mesh-ancestor
14818665|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
14818666|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818667|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818668|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818669|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
14818670|NCT00882154|Cefdinir|cefdinir|mesh-list
14818671|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818672|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818673|NCT00882193|Ribavirin|ribavirin|mesh-list
14818674|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14818675|NCT00882193|Betaine|betaine|mesh-list
14818676|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
14818677|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818678|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
14818679|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818680|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197822|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197823|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197824|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15197825|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
15197826|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
14701208|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14701209|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14701210|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14701211|NCT00398697|Gemcitabine|gemcitabine|mesh-list
14701212|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14701213|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
14701214|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197827|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197828|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197829|NCT03785873|Leucovorin|leucovorin|mesh-list
15197830|NCT03785873|Fluorouracil|fluorouracil|mesh-list
15197831|NCT03785873|Nivolumab|nivolumab|mesh-list
15197832|NCT03785873|Irinotecan|irinotecan|mesh-list
15197833|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
15197834|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197835|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15197836|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197837|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15197838|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
15197839|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197840|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15197841|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15197842|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15197843|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15197844|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701215|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701216|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
14701217|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701218|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701219|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701220|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
14701221|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701222|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
14701223|NCT00398749|Hematinics|hematinics|mesh-ancestor
14701224|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14701225|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701226|NCT00398788|Hydromorphone|hydromorphone|mesh-list
14701227|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14701228|NCT00398788|Narcotics|narcotics|mesh-ancestor
14701229|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197845|NCT03785873|Antidotes|antidotes|mesh-ancestor
15197846|NCT03785873|Protective Agents|protective agents|mesh-ancestor
15197847|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
15197848|NCT03785873|Vitamins|vitamins|mesh-ancestor
15197849|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
15197850|NCT03786237|ON 01910|on 01910|mesh-list
15197851|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197852|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15197853|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197854|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197855|NCT03786029|Acetaminophen|acetaminophen|mesh-list
15197856|NCT03786029|Ibuprofen|ibuprofen|mesh-list
15197857|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197858|NCT03786029|Analgesics|analgesics|mesh-ancestor
15197859|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
15197860|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197861|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197862|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
15197863|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15197864|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197865|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197866|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15197867|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197868|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197869|NCT03785756|Ibuprofen|ibuprofen|mesh-list
14818681|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
14818682|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14818683|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14818684|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
14818685|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14818686|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
15197870|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15197871|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197872|NCT03785756|Analgesics|analgesics|mesh-ancestor
15197873|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
15197874|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197875|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197876|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197877|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197878|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15197879|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197880|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197881|NCT03785496|Spartalizumab|spartalizumab|mesh-list
15197882|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15197883|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197884|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197885|NCT03785587|Bromides|bromides|mesh-list
15197886|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
15197887|NCT03785691|Ondansetron|ondansetron|mesh-list
15197888|NCT03785691|Mirtazapine|mirtazapine|mesh-list
15197889|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
15197890|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
15197891|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197892|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197893|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197894|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
15197895|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14818687|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818688|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
14818689|NCT00882232|Protective Agents|protective agents|mesh-ancestor
14818690|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
14818691|NCT00882323|Fludarabine|fludarabine|mesh-list
14818692|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
14818693|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818694|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
14818695|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818696|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14818697|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14818698|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
15197896|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14818699|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818700|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818701|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14818702|NCT00882375|Nicotine|nicotine|mesh-list
14818703|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14818704|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
14818705|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818706|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818707|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14818708|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14818709|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
14818710|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818711|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818712|NCT00882388|Aspirin|aspirin|mesh-list
14818713|NCT00882388|Celecoxib|celecoxib|mesh-list
14818714|NCT00882388|Clopidogrel|clopidogrel|mesh-list
14818715|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14818716|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14818717|NCT00882388|Analgesics|analgesics|mesh-ancestor
14818718|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
14818719|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818720|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818721|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14818722|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14818723|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14818724|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14818725|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818726|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14818727|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14818728|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818729|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
14818730|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14818731|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14818732|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14818733|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
14818734|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818735|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14818736|NCT00882401|Vitamin D|vitamin d|mesh-list
14818737|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
14818738|NCT00882401|Vitamins|vitamins|mesh-ancestor
14818739|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
14818740|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818741|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14818742|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14818743|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
14818744|NCT00882414|Hematinics|hematinics|mesh-ancestor
14818745|NCT00882453|Interferons|interferons|mesh-list
14818746|NCT00882453|Interferon-beta|interferon-beta|mesh-list
14818747|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
15197897|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
15197898|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197899|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197900|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15197901|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15197902|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197903|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15197904|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15197905|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
15197906|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15197907|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
15197908|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
15197909|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14818748|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818749|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
14818750|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818751|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
14701230|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701231|NCT00398788|Analgesics|analgesics|mesh-ancestor
14701232|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
14701233|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701234|NCT00398814|Sorafenib|sorafenib|mesh-list
14701235|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701236|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14701237|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701238|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197910|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15197911|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15197912|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
15197913|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15197914|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15197915|NCT03785613|Buprenorphine|buprenorphine|mesh-list
15197916|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15197917|NCT03785613|Narcotics|narcotics|mesh-ancestor
15197918|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197919|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818752|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818753|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14818754|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
14818755|NCT00882466|Hematinics|hematinics|mesh-ancestor
14818756|NCT00882531|Isotretinoin|isotretinoin|mesh-list
14818757|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
14701239|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
14818758|NCT00882570|Cefdinir|cefdinir|mesh-list
14818759|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818760|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818761|NCT00882609|Fluorides|fluorides|mesh-list
14818762|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
14818763|NCT00882609|Protective Agents|protective agents|mesh-ancestor
14818764|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818765|NCT00882635|Heparin|heparin|mesh-list
14818766|NCT00882635|Enoxaparin|enoxaparin|mesh-list
15197920|NCT03785613|Analgesics|analgesics|mesh-ancestor
15197921|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
15197922|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197923|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15197924|NCT03785522|Insulin|insulin|mesh-list
15197925|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15197926|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197927|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15197928|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15197929|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14701240|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14818767|NCT00882635|Calcium heparin|calcium heparin|mesh-list
14818768|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
14818769|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14818770|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14818771|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818772|NCT00882700|Cefdinir|cefdinir|mesh-list
14818773|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818774|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818775|NCT00882739|Clopidogrel|clopidogrel|mesh-list
14818776|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14818777|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14818778|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14701241|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818779|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15197930|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15197931|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15197932|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
15197933|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818780|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
14818781|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818782|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197934|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818783|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818784|NCT00882765|Genistein|genistein|mesh-list
14818785|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14818786|NCT00882765|Protective Agents|protective agents|mesh-ancestor
14818787|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818788|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818789|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14818790|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818791|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818792|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
14818793|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14818794|NCT00882765|Estrogens|estrogens|mesh-ancestor
14818795|NCT00882765|Hormones|hormones|mesh-ancestor
14818796|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818797|NCT00882856|Bisoprolol|bisoprolol|mesh-list
14818798|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14818799|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
14818800|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
14818801|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818802|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818803|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14818804|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14818805|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14818806|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
14818807|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818808|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818809|NCT00882869|Sorafenib|sorafenib|mesh-list
14818810|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818811|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14818812|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818813|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818814|NCT00882882|Metformin|metformin|mesh-list
14818815|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14818816|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818817|NCT00882947|Iloprost|iloprost|mesh-list
14818818|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14818819|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
14818820|NCT00882960|Fentanyl|fentanyl|mesh-list
14818821|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14818822|NCT00882960|Narcotics|narcotics|mesh-ancestor
14818823|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818824|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818825|NCT00882960|Analgesics|analgesics|mesh-ancestor
14818826|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
14818827|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818828|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14818829|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14818830|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
14818831|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
14818832|NCT00883064|Lisinopril|lisinopril|mesh-list
14818833|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14818834|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
14818835|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818836|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818837|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14818838|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14818839|NCT00883064|Protective Agents|protective agents|mesh-ancestor
14818840|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818841|NCT00883155|Bupropion|bupropion|mesh-list
14818842|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14818843|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
14818844|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14818845|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14818846|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14818847|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14818848|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818849|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
14818850|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818851|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818852|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14818853|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14818854|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818855|NCT00883194|Ropivacaine|ropivacaine|mesh-list
14818856|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
14818857|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
14818858|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14818859|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818860|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
15197935|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197936|NCT03785158|Melatonin|melatonin|mesh-list
15197937|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
14818861|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818862|NCT00883259|Metformin|metformin|mesh-list
15197938|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197939|NCT03785158|Protective Agents|protective agents|mesh-ancestor
15197940|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197941|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197942|NCT03785223|Methylphenidate|methylphenidate|mesh-list
15197943|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15197944|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197945|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15197946|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15197947|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15197948|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15197949|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
15197950|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15197951|NCT03785015|Aspirin|aspirin|mesh-list
15197952|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14818863|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15197953|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15197954|NCT03785015|Analgesics|analgesics|mesh-ancestor
15197955|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
15197956|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197957|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197958|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197959|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15197960|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15197961|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15197962|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818864|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818865|NCT00883298|Bevacizumab|bevacizumab|mesh-list
14818866|NCT00883298|Temozolomide|temozolomide|mesh-list
14818867|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14818868|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818869|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14818870|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14818871|NCT00883298|Growth Substances|growth substances|mesh-ancestor
14818872|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818873|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
14818874|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14818875|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
15197963|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15197964|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15197965|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15197966|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
15197967|NCT03785184|Dexamethasone|dexamethasone|mesh-list
15197968|NCT03785184|Lenalidomide|lenalidomide|mesh-list
15197969|NCT03785184|Venetoclax|venetoclax|mesh-list
15197970|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15197971|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
15197972|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
14818876|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818877|NCT00883480|Gemcitabine|gemcitabine|mesh-list
14818878|NCT00883480|Cisplatin|cisplatin|mesh-list
14818879|NCT00883480|Docetaxel|docetaxel|mesh-list
14818880|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14818881|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818882|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14818883|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
14818884|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818885|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
14818886|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15197973|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197974|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818887|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818888|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14818889|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
14818890|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818891|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
14818892|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
14818893|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
14818894|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14818895|NCT00883506|Lisinopril|lisinopril|mesh-list
14818896|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14818897|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
14818898|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818899|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818900|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14818901|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14818902|NCT00883506|Protective Agents|protective agents|mesh-ancestor
14818903|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818904|NCT00883532|Budesonide|budesonide|mesh-list
14818905|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14818906|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14818907|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14818908|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
14818909|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14818910|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818911|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14818912|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
14818913|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
15197975|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15197976|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
15197977|NCT03785184|Hormones|hormones|mesh-ancestor
15197978|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15197979|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15197980|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197981|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
15197982|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15197983|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15197984|NCT03785184|Growth Substances|growth substances|mesh-ancestor
14818914|NCT00883532|Hormones|hormones|mesh-ancestor
14818915|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910802|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15197985|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
15224454|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224455|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
14910803|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14910804|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14910805|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
14910806|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14910807|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14910808|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14910809|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
14910810|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14910811|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910812|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15224456|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
14910813|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15224457|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224458|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224459|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224460|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
15224461|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
14818916|NCT00883623|Lenalidomide|lenalidomide|mesh-list
14818917|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
14818918|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818919|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14818920|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14818921|NCT00883623|Growth Substances|growth substances|mesh-ancestor
14818922|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
14818923|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15197986|NCT03785041|Tramadol|tramadol|mesh-list
15197987|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
15197988|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15197989|NCT03785041|Narcotics|narcotics|mesh-ancestor
15197990|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15197991|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15197992|NCT03785041|Analgesics|analgesics|mesh-ancestor
15197993|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
15197994|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15197995|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
14818924|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
14818925|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14818926|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
14818927|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14818928|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818929|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14818930|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14818931|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14818932|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
14818933|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14818934|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14818935|NCT00883818|Azithromycin|azithromycin|mesh-list
14818936|NCT00883818|Doxycycline|doxycycline|mesh-list
14818937|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818938|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818939|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
14818940|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14818941|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14818942|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
14818943|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14818944|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14818945|NCT00883883|Cefdinir|cefdinir|mesh-list
14818946|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14818947|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14818948|NCT00883909|Dutasteride|dutasteride|mesh-list
15197996|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
15197997|NCT03784794|Thrombin|thrombin|mesh-list
15197998|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
15197999|NCT03784794|Coagulants|coagulants|mesh-ancestor
15198000|NCT03785067|Amlodipine|amlodipine|mesh-list
15198001|NCT03785067|Telmisartan|telmisartan|mesh-list
15198002|NCT03785067|Indapamide|indapamide|mesh-list
15198003|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15198004|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15198005|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198006|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198007|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15198008|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198009|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
15198010|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15198011|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15198012|NCT03785067|Diuretics|diuretics|mesh-ancestor
15198013|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
15198014|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15198015|NCT03784495|Melatonin|melatonin|mesh-list
15198016|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
15198017|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198018|NCT03784495|Protective Agents|protective agents|mesh-ancestor
15198019|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818949|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14818950|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14818951|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818952|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818953|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
14818954|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14818955|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818956|NCT00883935|Ritonavir|ritonavir|mesh-list
14818957|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14818958|NCT00883935|Dolutegravir|dolutegravir|mesh-list
14818959|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14818960|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14818961|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
14818962|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818963|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818964|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14818965|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14818966|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
14818967|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198020|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198021|NCT03784599|Trastuzumab|trastuzumab|mesh-list
15198022|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14818968|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14818969|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14818970|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14818971|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14818972|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
14818973|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14818974|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14818975|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
15198023|NCT03784599|Osimertinib|osimertinib|mesh-list
15198024|NCT03784599|Maytansine|maytansine|mesh-list
15198025|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198026|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198027|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15198028|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818976|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14818977|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818978|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198029|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198030|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15198031|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
15198032|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
15198033|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
15198034|NCT03784703|Atorvastatin|atorvastatin|mesh-list
15198035|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15198036|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15198037|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15198038|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
15198039|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198040|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15198041|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15198042|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198043|NCT03784677|SOR-C13|sor-c13|mesh-list
15198044|NCT03784677|Calcium|calcium|mesh-list
15198045|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15198046|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198047|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198048|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15198049|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198050|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198051|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
15198052|NCT03784443|Ranibizumab|ranibizumab|mesh-list
14818979|NCT00884104|Urological Agents|urological agents|mesh-ancestor
14818980|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
14818981|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14818982|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
14818983|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14818984|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818985|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14818986|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14818987|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14818988|NCT00884299|Antioxidants|antioxidants|mesh-list
14818989|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818990|NCT00884299|Protective Agents|protective agents|mesh-ancestor
14818991|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14818992|NCT00884416|Sorafenib|sorafenib|mesh-list
14818993|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14818994|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14818995|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14818996|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14818997|NCT00884442|Nifedipine|nifedipine|mesh-list
14818998|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14818999|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14819000|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819001|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15198053|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15198054|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15198055|NCT03784443|Growth Substances|growth substances|mesh-ancestor
15198056|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198057|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
15198058|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198059|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198060|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
15198061|NCT03784443|Hormones|hormones|mesh-ancestor
15198062|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198063|NCT03784378|Agerafenib|agerafenib|mesh-list
14819002|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819003|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
14819004|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
14819005|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14819006|NCT00884481|Natalizumab|natalizumab|mesh-list
14819007|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
14819008|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819009|NCT00884494|Insulin|insulin|mesh-list
14819010|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14819011|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819012|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
14819013|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14819014|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819015|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14819016|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14819017|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819018|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819019|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819020|NCT00884546|Dexamethasone|dexamethasone|mesh-list
14819021|NCT00884546|Lenalidomide|lenalidomide|mesh-list
14819022|NCT00884546|Bortezomib|bortezomib|mesh-list
14819023|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819024|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
14819025|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
14819026|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819027|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198064|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15198065|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819028|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819029|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
14819030|NCT00884546|Hormones|hormones|mesh-ancestor
14819031|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819032|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14819033|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819034|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
14819035|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14819036|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14819037|NCT00884546|Growth Substances|growth substances|mesh-ancestor
14819038|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
14819039|NCT00884663|Propranolol|propranolol|mesh-list
14819040|NCT00884663|Candesartan|candesartan|mesh-list
14819041|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14819042|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14819043|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819044|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819045|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819046|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819047|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14819048|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14819049|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
14819050|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14819051|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14819052|NCT00884676|Sunitinib|sunitinib|mesh-list
14819053|NCT00884676|Epothilone B|epothilone b|mesh-list
14819054|NCT00884676|Epothilones|epothilones|mesh-list
14819055|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819056|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14819057|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14819058|NCT00884676|Growth Substances|growth substances|mesh-ancestor
14819059|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819060|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
14819061|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14819062|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819063|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819064|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14819065|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14819066|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14819067|NCT00884767|Leucovorin|leucovorin|mesh-list
14819068|NCT00884767|Fluorouracil|fluorouracil|mesh-list
14819069|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
14819070|NCT00884767|Calcium|calcium|mesh-list
14819071|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
14819072|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14819073|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819074|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
14819075|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819076|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14819077|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819078|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819079|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
14819080|NCT00884767|Antidotes|antidotes|mesh-ancestor
14819081|NCT00884767|Protective Agents|protective agents|mesh-ancestor
14819082|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
14819083|NCT00884767|Vitamins|vitamins|mesh-ancestor
14819084|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
14819085|NCT00884819|Fenofibrate|fenofibrate|mesh-list
14819086|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14819087|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
14819088|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819089|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14819090|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14819091|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819092|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14819093|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819094|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701242|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701243|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14701244|NCT00398827|Analgesics|analgesics|mesh-ancestor
14701245|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
14701246|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701247|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14701248|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14701249|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15198066|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198067|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
15198068|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
14819095|NCT00884858|Maraviroc|maraviroc|mesh-list
14819096|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15198069|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198070|NCT03784391|Nifurtimox|nifurtimox|mesh-list
15198071|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15198072|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15198073|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15198074|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198075|NCT03784105|Codeine|codeine|mesh-list
15198076|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15198077|NCT03784105|Narcotics|narcotics|mesh-ancestor
15198078|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198079|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198080|NCT03784105|Analgesics|analgesics|mesh-ancestor
14819097|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14819098|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198081|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
15198082|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198083|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
15198084|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
15198085|NCT03784014|Durvalumab|durvalumab|mesh-list
14819099|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14819100|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14819101|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
14819102|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819103|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14819104|NCT00884884|Topiramate|topiramate|mesh-list
14819105|NCT00884884|Aripiprazole|aripiprazole|mesh-list
14819106|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
14819107|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819108|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14819109|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14819110|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819111|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819112|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
14819113|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
14819114|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819115|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819116|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14819117|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14819118|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
14819119|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14819120|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14819121|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14819122|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14819123|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
14819124|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14819125|NCT00885066|Gemcitabine|gemcitabine|mesh-list
14819126|NCT00885066|Capecitabine|capecitabine|mesh-list
14819127|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14819128|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14819129|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
14819130|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819131|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819132|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
14819133|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819134|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819135|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819136|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
14819137|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819138|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15198086|NCT03784014|Olaparib|olaparib|mesh-list
15198087|NCT03784014|Lapatinib|lapatinib|mesh-list
15198088|NCT03784014|Palbociclib|palbociclib|mesh-list
14819139|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
14819140|NCT00885274|Citric Acid|citric acid|mesh-list
14819141|NCT00885274|Antacids|antacids|mesh-ancestor
14819142|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819143|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819144|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
14819145|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14819146|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
14819147|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
14819148|NCT00885287|Lumefantrine|lumefantrine|mesh-list
14819149|NCT00885287|Artemether|artemether|mesh-list
14819150|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14819151|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
14819152|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14819153|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14819154|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819155|NCT00885300|Cloxacillin|cloxacillin|mesh-list
14819156|NCT00885300|Heparin|heparin|mesh-list
14819157|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
14819158|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14819159|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14819160|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819161|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14819162|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819163|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
14819164|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
14819165|NCT00885326|Bevacizumab|bevacizumab|mesh-list
14819166|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819167|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
14819168|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819169|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14819170|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14819171|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
14819172|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819173|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819174|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14819175|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14819176|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14819177|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14819178|NCT00885326|Growth Substances|growth substances|mesh-ancestor
14819179|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
14819180|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14819181|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14819182|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
14819183|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14819184|NCT00885443|Propofol|propofol|mesh-list
14819185|NCT00885443|Sevoflurane|sevoflurane|mesh-list
14819186|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14819187|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819188|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819189|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14819190|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
14819191|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
14819192|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14819193|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14819194|NCT00885508|Lenalidomide|lenalidomide|mesh-list
14819195|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
14819196|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819197|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14819198|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14819199|NCT00885508|Growth Substances|growth substances|mesh-ancestor
14819200|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
14819201|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910814|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14910815|NCT01359228|Rifaximin|rifaximin|mesh-list
14910816|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14910817|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910818|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910819|NCT01359241|Insulin|insulin|mesh-list
14910820|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14910821|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910822|NCT01359397|Bevacizumab|bevacizumab|mesh-list
14910823|NCT01359397|Trastuzumab|trastuzumab|mesh-list
14910824|NCT01359397|Docetaxel|docetaxel|mesh-list
14910825|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
14910826|NCT01359397|Capecitabine|capecitabine|mesh-list
14910827|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14910828|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198089|NCT03784014|Trametinib|trametinib|mesh-list
15198090|NCT03784014|Dabrafenib|dabrafenib|mesh-list
15198091|NCT03784014|Ceritinib|ceritinib|mesh-list
14819202|NCT00885586|Gabapentin|gabapentin|mesh-list
14819203|NCT00885586|Analgesics|analgesics|mesh-ancestor
14819204|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
14819205|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819206|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819207|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
14819208|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14819209|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14819210|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819211|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819212|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14819213|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14819214|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819215|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819216|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
14819217|NCT00885599|Listerine|listerine|mesh-list
14819218|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14819219|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819220|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14819221|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
14819222|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819223|NCT00885664|Ritonavir|ritonavir|mesh-list
14819224|NCT00885664|Lopinavir|lopinavir|mesh-list
14819225|NCT00885664|Tenofovir|tenofovir|mesh-list
14819226|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14819227|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14819228|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14819229|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
14819230|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819231|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819232|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14819233|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14819234|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
14819235|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819236|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14819237|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14819238|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14819239|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14819240|NCT00885690|Olanzapine|olanzapine|mesh-list
14819241|NCT00885690|Sertindole|sertindole|mesh-list
14819242|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
14819243|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
14819244|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819245|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819246|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819247|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14819248|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14819249|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819250|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819251|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14819252|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14819253|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14819254|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819255|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819256|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
14819257|NCT00885781|SMOFlipid|smoflipid|mesh-list
15198092|NCT03784014|Futibatinib|futibatinib|mesh-list
15198093|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198094|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198095|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15198096|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819258|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15198097|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198098|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15198099|NCT03784326|Fluorouracil|fluorouracil|mesh-list
15198100|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
15198101|NCT03784326|Atezolizumab|atezolizumab|mesh-list
14819259|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14819260|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14819261|NCT00885794|Ranibizumab|ranibizumab|mesh-list
14819262|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14819263|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14819264|NCT00885794|Growth Substances|growth substances|mesh-ancestor
14819265|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819266|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
14819267|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819268|NCT00885820|Prednisone|prednisone|mesh-list
14819269|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
14819270|NCT00885820|Tacrolimus|tacrolimus|mesh-list
14819271|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819272|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
14819273|NCT00885820|Hormones|hormones|mesh-ancestor
14819274|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819275|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819276|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14819277|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819278|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819279|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
14819280|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14819281|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819282|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819283|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
14819284|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
14819285|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819286|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819287|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15198102|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15198103|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
15198104|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819288|NCT00885820|Protective Agents|protective agents|mesh-ancestor
14819289|NCT00885833|Fludarabine|fludarabine|mesh-list
14819290|NCT00885833|Busulfan|busulfan|mesh-list
14819291|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
14819292|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819293|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819294|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819295|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
14819296|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819297|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
14819298|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14819299|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14819300|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14819301|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14819302|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14819303|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
14819304|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819305|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14819306|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14819307|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819308|NCT00885885|Panitumumab|panitumumab|mesh-list
14819309|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14819310|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819311|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14819312|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
14819313|NCT00885924|Coagulants|coagulants|mesh-ancestor
14819314|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14819315|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
15198105|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15198106|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198107|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198108|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
15198109|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198110|NCT03784261|Abatacept|abatacept|mesh-list
15198111|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15198112|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198113|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198114|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198115|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
15198116|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198117|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15198118|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15198119|NCT03783897|Norgestimate|norgestimate|mesh-list
14701250|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819316|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819317|NCT00886002|Fentanyl|fentanyl|mesh-list
14819318|NCT00886002|Buprenorphine|buprenorphine|mesh-list
14819319|NCT00886002|Naloxone|naloxone|mesh-list
14819320|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14819321|NCT00886002|Narcotics|narcotics|mesh-ancestor
14819322|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819323|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819324|NCT00886002|Analgesics|analgesics|mesh-ancestor
14819325|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
14819326|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819327|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14819328|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14819329|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
14819330|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
14819331|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14819332|NCT00886028|Doxorubicin|doxorubicin|mesh-list
14819333|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14819334|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819335|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14819336|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14819337|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15198120|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
15198121|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
14819338|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819339|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819340|NCT00886106|Midazolam|midazolam|mesh-list
14819341|NCT00886106|Remifentanil|remifentanil|mesh-list
14819342|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14819343|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14819344|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819345|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819346|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14819347|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14819348|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819349|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14819350|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
14819351|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
14819352|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
14819353|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
14819354|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819355|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819356|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14819357|NCT00886106|Narcotics|narcotics|mesh-ancestor
14819358|NCT00886106|Analgesics|analgesics|mesh-ancestor
14819359|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
14819360|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819361|NCT00886132|Sunitinib|sunitinib|mesh-list
14819362|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819363|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14819364|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14819365|NCT00886132|Growth Substances|growth substances|mesh-ancestor
14819366|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819367|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14819368|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14819369|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198122|NCT03783897|Estradiol|estradiol|mesh-list
15198123|NCT03783897|Estrogens|estrogens|mesh-ancestor
15198124|NCT03783897|Hormones|hormones|mesh-ancestor
15198125|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198126|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198127|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15224462|NCT03646461|Nivolumab|nivolumab|mesh-list
14701251|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701252|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701253|NCT00398853|Chromium|chromium|mesh-list
14701254|NCT00398853|Picolinic acid|picolinic acid|mesh-list
14701255|NCT00398853|Trace Elements|trace elements|mesh-ancestor
14701256|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
14701257|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701258|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14701259|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
14701260|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
14819370|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819371|NCT00886275|Midazolam|midazolam|mesh-list
14819372|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
14819373|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14819374|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819375|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819376|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14819377|NCT00886275|Analgesics|analgesics|mesh-ancestor
14819378|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
14819379|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819380|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14819381|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14819382|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14819383|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819384|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819385|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819386|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14819387|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14819388|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14819389|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15198128|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15198129|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15198130|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15198131|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15198132|NCT03783949|Gemcitabine|gemcitabine|mesh-list
14819390|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14819391|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
14819392|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
14819393|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
14819394|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
14819395|NCT00886314|Midazolam|midazolam|mesh-list
14819396|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14819397|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14819398|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819399|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819400|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14819401|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14819402|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819403|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14819404|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
14819405|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
14819406|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
14819407|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
14819408|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819409|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819410|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
14819411|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
14819412|NCT00886457|Interferons|interferons|mesh-list
14819413|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
14819414|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
15198133|NCT03783949|Paclitaxel|paclitaxel|mesh-list
15198134|NCT03783949|Carboplatin|carboplatin|mesh-list
14819415|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14819416|NCT00886457|Decitabine|decitabine|mesh-list
14819417|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819418|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
14819419|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819420|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
15198135|NCT03783949|Niraparib|niraparib|mesh-list
15198136|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15198137|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198138|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
15198139|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
15198140|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
14819421|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819422|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14819423|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
14819424|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819425|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198141|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198142|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14819426|NCT00886496|Lectins|lectins|mesh-list
14819427|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
14819428|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
14819429|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819430|NCT00886496|Coagulants|coagulants|mesh-ancestor
14819431|NCT00886509|Lenograstim|lenograstim|mesh-list
14819432|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14819433|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
14819434|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819435|NCT00886574|Aspirin|aspirin|mesh-list
14819436|NCT00886574|Cilostazol|cilostazol|mesh-list
14819437|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14819438|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14819439|NCT00886574|Analgesics|analgesics|mesh-ancestor
14819440|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
14819441|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819442|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819443|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819444|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14819445|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14819446|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14819447|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819448|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14819449|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14819450|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819451|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
14819452|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14819453|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
14819454|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14819455|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
14819456|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
14819457|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14819458|NCT00886574|Protective Agents|protective agents|mesh-ancestor
14819459|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14819460|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14819461|NCT00886678|Carboplatin|carboplatin|mesh-list
14819462|NCT00886678|Pemetrexed|pemetrexed|mesh-list
14819463|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819464|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819465|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819466|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14819467|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15198143|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
15198144|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
15198145|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701261|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701262|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
14819468|NCT00886717|Paclitaxel|paclitaxel|mesh-list
14819469|NCT00886717|Carboplatin|carboplatin|mesh-list
14819470|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15198146|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198147|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198148|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
15198149|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198150|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15198151|NCT03783936|Leucovorin|leucovorin|mesh-list
15198152|NCT03783936|Fluorouracil|fluorouracil|mesh-list
15198153|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
14701263|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
14701264|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701265|NCT00398892|Protective Agents|protective agents|mesh-ancestor
14701266|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198154|NCT03783936|Trastuzumab|trastuzumab|mesh-list
15198155|NCT03783936|Avelumab|avelumab|mesh-list
15198156|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
15198157|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198158|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15198159|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701267|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
14701268|NCT00398892|Vitamins|vitamins|mesh-ancestor
14701269|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
14701270|NCT00398905|Enoxaparin|enoxaparin|mesh-list
14701271|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
14701272|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14701273|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
14701274|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14701275|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
14701276|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819471|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819472|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14819473|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14819474|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14819475|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819476|NCT00886860|Misoprostol|misoprostol|mesh-list
14819477|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14819478|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
14819479|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14819480|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819481|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14701277|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701278|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
14701279|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14294735|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14294736|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294737|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14294738|NCT00577824|Exenatide|exenatide|mesh-list
14294739|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14819482|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819483|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
14819484|NCT00886873|Mifepristone|mifepristone|mesh-list
14819485|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14819486|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
14819487|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14819488|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819489|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14819490|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14819491|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14819492|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
14819493|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14819494|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14819495|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
14294740|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294741|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14294742|NCT00577824|Incretins|incretins|mesh-ancestor
14701280|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14701281|NCT00398957|Naltrexone|naltrexone|mesh-list
14701282|NCT00398957|Hydromorphone|hydromorphone|mesh-list
14701283|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
14701284|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14701285|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701286|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
14701287|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701288|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14701289|NCT00398957|Narcotics|narcotics|mesh-ancestor
14701290|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701291|NCT00398957|Analgesics|analgesics|mesh-ancestor
14701292|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14701293|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14701294|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14701295|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14701296|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701297|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701298|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701299|NCT00399022|Analgesics|analgesics|mesh-ancestor
14294743|NCT00577824|Hormones|hormones|mesh-ancestor
14294744|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14294745|NCT00577863|Teriparatide|teriparatide|mesh-list
14294746|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14294747|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294748|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14294749|NCT00577889|Gemcitabine|gemcitabine|mesh-list
14294750|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14294751|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
14294752|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294753|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294754|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
14294755|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294756|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294757|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294758|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
15198160|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198161|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
15198162|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198163|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198164|NCT03783936|Antidotes|antidotes|mesh-ancestor
15198165|NCT03783936|Protective Agents|protective agents|mesh-ancestor
15198166|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
15198167|NCT03783936|Vitamins|vitamins|mesh-ancestor
14819496|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819497|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
14819498|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14819499|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14819500|NCT00886886|Reboxetine|reboxetine|mesh-list
14819501|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
14819502|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819503|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14819504|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14819505|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14819506|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819507|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819508|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819509|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819510|NCT00886990|Ritonavir|ritonavir|mesh-list
14819511|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14819512|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14819513|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
14819514|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819515|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819516|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14819517|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14819518|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
14819519|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819520|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14819521|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14819522|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
14819523|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14819524|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14819525|NCT00887003|Prednisolone|prednisolone|mesh-list
14819526|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
14819527|NCT00887003|Bupivacaine|bupivacaine|mesh-list
14819528|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14819529|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
14819530|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
14819531|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
14819532|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819533|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819534|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
14819535|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819536|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819537|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
14819538|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
14819539|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819540|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
14819541|NCT00887003|Hormones|hormones|mesh-ancestor
14819542|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819543|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15198168|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
15198169|NCT03784040|Nivolumab|nivolumab|mesh-list
15198170|NCT03784040|Ipilimumab|ipilimumab|mesh-list
15198171|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198172|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198173|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15198174|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198175|NCT03783845|Amoxicillin|amoxicillin|mesh-list
15198176|NCT03783845|Metronidazole|metronidazole|mesh-list
15198177|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14819544|NCT00887003|Protective Agents|protective agents|mesh-ancestor
15198178|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819545|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14819546|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819547|NCT00887029|Timolol|timolol|mesh-list
14819548|NCT00887029|Travoprost|travoprost|mesh-list
14819549|NCT00887029|Latanoprost|latanoprost|mesh-list
14819550|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14819551|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14819552|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14819553|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819554|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819555|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819556|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819557|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14819558|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14819559|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14819560|NCT00887042|Fludarabine|fludarabine|mesh-list
14819561|NCT00887042|Busulfan|busulfan|mesh-list
14819562|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
14819563|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819564|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819565|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819566|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
14819567|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819568|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
14819569|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14819570|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14819571|NCT00887081|Ribavirin|ribavirin|mesh-list
14819572|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
14819573|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
14819574|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14819575|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14819576|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14819577|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
14819578|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819579|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
14819580|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198179|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15198180|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15198181|NCT03783728|Pyridoxine|pyridoxine|mesh-list
15198182|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
15198183|NCT03783728|Isoniazid|isoniazid|mesh-list
15198184|NCT03783728|Rifapentine|rifapentine|mesh-list
15198185|NCT03783728|Vitamins|vitamins|mesh-ancestor
15198186|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
15198187|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198188|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
15198189|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
15198190|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198191|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198192|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15198193|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15198194|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
15198195|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198196|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15198197|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15198198|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
15198199|NCT03783754|Amlodipine|amlodipine|mesh-list
15198200|NCT03783754|Telmisartan|telmisartan|mesh-list
14819581|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
14819582|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819583|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819584|NCT00887107|Sorafenib|sorafenib|mesh-list
14819585|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819586|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14819587|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819588|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819589|NCT00887120|Ritonavir|ritonavir|mesh-list
14819590|NCT00887120|Lopinavir|lopinavir|mesh-list
14819591|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14819592|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14819593|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
14819594|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819595|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198201|NCT03783754|Indapamide|indapamide|mesh-list
15198202|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15198203|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15198204|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15224463|NCT03646461|Cetuximab|cetuximab|mesh-list
14294759|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294760|NCT00577993|Interferons|interferons|mesh-list
14294761|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
14294762|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
14294763|NCT00577993|Dexamethasone|dexamethasone|mesh-list
14819596|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14819597|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14819598|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
14819599|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819600|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14819601|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14819602|NCT00887211|Sirolimus|sirolimus|mesh-list
14819603|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14819604|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819605|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14819606|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819607|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
14819608|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819609|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
14819610|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819611|NCT00887263|Budesonide|budesonide|mesh-list
14819612|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819613|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14819614|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
14819615|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819616|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819617|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14819618|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
14819619|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
14819620|NCT00887263|Hormones|hormones|mesh-ancestor
14819621|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819622|NCT00887276|Amoxicillin|amoxicillin|mesh-list
14819623|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
14819624|NCT00887276|Ampicillin|ampicillin|mesh-list
14819625|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14819626|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819627|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14819628|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14819629|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819630|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819631|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819632|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14819633|NCT00887328|Plasminogen|plasminogen|mesh-list
14819634|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14819635|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15198205|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198206|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15198207|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198208|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
14701300|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
14701301|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701302|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
14701303|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14701304|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
14819636|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819637|NCT00887367|Ethanol|ethanol|mesh-list
14819638|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14819639|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819640|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819641|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819642|NCT00887380|Anastrozole|anastrozole|mesh-list
14819643|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14819644|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819645|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15198209|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15198210|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15198211|NCT03783754|Diuretics|diuretics|mesh-ancestor
15198212|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
15198213|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15198214|NCT03783715|Ketoprofen|ketoprofen|mesh-list
14701305|NCT00399048|Hydromorphone|hydromorphone|mesh-list
14701306|NCT00399048|Oxycodone|oxycodone|mesh-list
14701307|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14701308|NCT00399048|Narcotics|narcotics|mesh-ancestor
14294764|NCT00577993|Prednisone|prednisone|mesh-list
14701309|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198215|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15198216|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15198217|NCT03783715|Analgesics|analgesics|mesh-ancestor
15198218|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
15198219|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198220|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198221|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198222|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294765|NCT00577993|Prednisolone|prednisolone|mesh-list
14701310|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701311|NCT00399048|Analgesics|analgesics|mesh-ancestor
14701312|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
14701313|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701314|NCT00399061|Cyclosporine|cyclosporine|mesh-list
14701315|NCT00399061|Cyclosporins|cyclosporins|mesh-list
14701316|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701317|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701318|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701319|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
14701320|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701321|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
14701322|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701323|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
14701324|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701325|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14701326|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
14701327|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
14701328|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14701329|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
14701330|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14701331|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14701332|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701333|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14701334|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701335|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701336|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14701337|NCT00399074|Renal Agents|renal agents|mesh-ancestor
14701338|NCT00399087|Prednisone|prednisone|mesh-list
14701339|NCT00399087|Docetaxel|docetaxel|mesh-list
14701340|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701341|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701342|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701343|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701344|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701345|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701346|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
14701347|NCT00399087|Hormones|hormones|mesh-ancestor
14701348|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701349|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701350|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14701351|NCT00399126|Paclitaxel|paclitaxel|mesh-list
14701352|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14701353|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701354|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701355|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701356|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701357|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701358|NCT00399152|Sunitinib|sunitinib|mesh-list
14701359|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701360|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15198223|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15198224|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701361|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14701362|NCT00399152|Growth Substances|growth substances|mesh-ancestor
14701363|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701364|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
14701365|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14701366|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701367|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819646|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14819647|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819648|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819649|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14819650|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
14819651|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819652|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910829|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14910830|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14910831|NCT01359397|Growth Substances|growth substances|mesh-ancestor
14910832|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910833|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
14910834|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
14910835|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
14910836|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
14910837|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910838|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14910839|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
14910840|NCT01359423|Cilostazol|cilostazol|mesh-list
14910841|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14910842|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
14910843|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910844|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910845|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14910846|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
14910847|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14910848|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14910849|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910850|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14910851|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
14910852|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14910853|NCT01359423|Protective Agents|protective agents|mesh-ancestor
14910854|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14910855|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14910856|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910857|NCT01359436|Antibodies|antibodies|mesh-list
14910858|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
14910859|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910860|NCT01359462|Tolvaptan|tolvaptan|mesh-list
14910861|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14910862|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910863|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
14910864|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910865|NCT01359488|Hormones|hormones|mesh-list
14910866|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14910867|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910868|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910869|NCT01359514|Pregabalin|pregabalin|mesh-list
14910870|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
14910871|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14910872|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910873|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198225|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198226|NCT03783494|Propofol|propofol|mesh-list
15198227|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15198228|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198229|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198230|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15198231|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
14701368|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
14701369|NCT00399165|Testosterone|testosterone|mesh-list
14728533|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294766|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14294767|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
14294768|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14294769|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
14294770|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
14294771|NCT00577993|Rituximab|rituximab|mesh-list
14294772|NCT00577993|Doxorubicin|doxorubicin|mesh-list
14294773|NCT00577993|Fludarabine|fludarabine|mesh-list
14294774|NCT00577993|Etoposide|etoposide|mesh-list
14701370|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
14701371|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
14701372|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15198232|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
15198233|NCT03783676|Remifentanil|remifentanil|mesh-list
15198234|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15198235|NCT03783676|Narcotics|narcotics|mesh-ancestor
15198236|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198237|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198238|NCT03783676|Analgesics|analgesics|mesh-ancestor
15198239|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
15198240|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198241|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
15198242|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15198243|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
15198244|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198245|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
15198246|NCT03783455|Protective Agents|protective agents|mesh-ancestor
15198247|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15198248|NCT03783520|Eusol|eusol|mesh-list
15198249|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
14819653|NCT00887601|Donepezil|donepezil|mesh-list
14819654|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14819655|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819656|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819657|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
14819658|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819659|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198250|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198251|NCT03783338|Vitamin D|vitamin d|mesh-list
15198252|NCT03783338|Vitamins|vitamins|mesh-ancestor
14294775|NCT00577993|Vincristine|vincristine|mesh-list
14701373|NCT00399165|Dutasteride|dutasteride|mesh-list
14701374|NCT00399165|Androgens|androgens|mesh-ancestor
14701375|NCT00399165|Hormones|hormones|mesh-ancestor
14701376|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701377|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701378|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14701379|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701380|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
14701381|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14701382|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14701383|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701384|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294776|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
15198253|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
15198254|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198255|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14701385|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
14701386|NCT00399204|Metformin|metformin|mesh-list
14701387|NCT00399204|Pioglitazone|pioglitazone|mesh-list
14701388|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14701389|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294777|NCT00577993|Bleomycin|bleomycin|mesh-list
14819660|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
15198256|NCT03783312|Acetaminophen|acetaminophen|mesh-list
14294778|NCT00577993|Procarbazine|procarbazine|mesh-list
15198257|NCT03783312|Ibuprofen|ibuprofen|mesh-list
15198258|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14294779|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14819661|NCT00887627|Conivaptan|conivaptan|mesh-list
14819662|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14819663|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819664|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
14819665|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819666|NCT00887757|Gemcitabine|gemcitabine|mesh-list
14819667|NCT00887757|Navitoclax|navitoclax|mesh-list
14819668|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14819669|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
14819670|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819671|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819672|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
14819673|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819674|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819675|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819676|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
14819677|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819678|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
14819679|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14819680|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14819681|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819682|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14819683|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14819684|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819685|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819686|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819687|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14819688|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14819689|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14819690|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
14819691|NCT00888043|Bevacizumab|bevacizumab|mesh-list
14819692|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14819693|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819694|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14819695|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14819696|NCT00888043|Growth Substances|growth substances|mesh-ancestor
14819697|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819698|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
14819699|NCT00888082|Goserelin|goserelin|mesh-list
14819700|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14819701|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819702|NCT00888108|Docetaxel|docetaxel|mesh-list
14819703|NCT00888108|Navitoclax|navitoclax|mesh-list
14819704|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819705|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
14819706|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
14819707|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
14819708|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819709|NCT00888186|Levodopa|levodopa|mesh-list
14819710|NCT00888186|Carbidopa|carbidopa|mesh-list
14819711|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15198259|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15198260|NCT03783312|Analgesics|analgesics|mesh-ancestor
15198261|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
15198262|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198263|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198264|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198265|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15198266|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15198267|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198268|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198269|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
15198270|NCT03783429|Digoxin|digoxin|mesh-list
15198271|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15198272|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14819712|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14819713|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
14819714|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819715|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819716|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819717|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14819718|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819719|NCT00888303|Dexamethasone|dexamethasone|mesh-list
14819720|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819721|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
14819722|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
14819723|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819724|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819725|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819726|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
14819727|NCT00888303|Hormones|hormones|mesh-ancestor
14819728|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819729|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14819730|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819731|NCT00888342|Ethanol|ethanol|mesh-list
14819732|NCT00888342|Zopiclone|zopiclone|mesh-list
14819733|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14819734|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819735|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819736|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819737|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14819738|NCT00888394|Imidacloprid|imidacloprid|mesh-list
14819739|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
14819740|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819741|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819742|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198273|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198274|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198275|NCT03783429|Protective Agents|protective agents|mesh-ancestor
15198276|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198277|NCT03783182|Betamethasone|betamethasone|mesh-list
15198278|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
15198279|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15198280|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
15198281|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15198282|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
15198283|NCT03783182|Hormones|hormones|mesh-ancestor
15198284|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198285|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198286|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198287|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15198288|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
15224464|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224465|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224466|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15224467|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224468|NCT03631004|Olanzapine|olanzapine|mesh-list
15224469|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
15224470|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
15224471|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224472|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224473|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224474|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14819743|NCT00888602|Psyllium|psyllium|mesh-list
14819744|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
14819745|NCT00888602|Cathartics|cathartics|mesh-ancestor
14819746|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819747|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
14819748|NCT00888732|Insulin|insulin|mesh-list
14819749|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14819750|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
14819751|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
14819752|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14819753|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14819754|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819755|NCT00888758|Sirolimus|sirolimus|mesh-list
14819756|NCT00888758|Umirolimus|umirolimus|mesh-list
14819757|NCT00888758|Everolimus|everolimus|mesh-list
14819758|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819759|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198289|NCT03783299|Lumefantrine|lumefantrine|mesh-list
15198290|NCT03783299|Artemether|artemether|mesh-list
15198291|NCT03783299|Primaquine|primaquine|mesh-list
15198292|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15198293|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
15198294|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15198295|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15198296|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819760|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
14819761|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819762|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819763|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198297|NCT03783273|Vitamin D|vitamin d|mesh-list
15198298|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
15198299|NCT03783273|Vitamins|vitamins|mesh-ancestor
15198300|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
15198301|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198302|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15198303|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15198304|NCT03782987|Itraconazole|itraconazole|mesh-list
14294780|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
14819764|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819765|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14819766|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
14819767|NCT00888784|Propranolol|propranolol|mesh-list
14819768|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14819769|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14819770|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819771|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819772|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819773|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819774|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14819775|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14819776|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
14819777|NCT00888797|Etodolac|etodolac|mesh-list
14819778|NCT00888797|Propranolol|propranolol|mesh-list
14819779|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14819780|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14819781|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819782|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819783|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819784|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819785|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14819786|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15198305|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
15198306|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198307|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15198308|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14819787|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
14819788|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14819789|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14819790|NCT00888797|Analgesics|analgesics|mesh-ancestor
14819791|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
14819792|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819793|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819794|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14819795|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14819796|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14819797|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819798|NCT00888810|Topotecan|topotecan|mesh-list
14819799|NCT00888810|Lapatinib|lapatinib|mesh-list
14819800|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14819801|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14819802|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819803|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819804|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819805|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14819806|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14819807|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819808|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14819809|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14819810|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14819811|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14819812|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819813|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819814|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819815|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
14819816|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819817|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14819818|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
14819819|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14819820|NCT00888901|Prednisolone|prednisolone|mesh-list
14819821|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
14819822|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14819823|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
14819824|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819825|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
14819826|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
14819827|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819828|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819829|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819830|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
14819831|NCT00888901|Hormones|hormones|mesh-ancestor
14819832|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819833|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14819834|NCT00888901|Protective Agents|protective agents|mesh-ancestor
14819835|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14819836|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819837|NCT00889018|Carboplatin|carboplatin|mesh-list
14819838|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819839|NCT00889044|Clopidogrel|clopidogrel|mesh-list
14819840|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14819841|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14819842|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14819843|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14819844|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
14819845|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819846|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198309|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198310|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198311|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15198312|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
15198313|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198314|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198315|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15198316|NCT03783065|Propranolol|propranolol|mesh-list
15198317|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15198318|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15198319|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819847|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819848|NCT00889057|Sorafenib|sorafenib|mesh-list
14819849|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819850|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14819851|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819852|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819853|NCT00889096|Propranolol|propranolol|mesh-list
14819854|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14819855|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14819856|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
14819857|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819858|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819859|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819860|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14819861|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14819862|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
14819863|NCT00889135|Droxidopa|droxidopa|mesh-list
14819864|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14819865|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14819866|NCT00889148|Gabapentin|gabapentin|mesh-list
14819867|NCT00889148|Analgesics|analgesics|mesh-ancestor
14819868|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
14819869|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819870|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819871|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
14819872|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14819873|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14819874|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14819875|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819876|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14819877|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14819878|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819879|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819880|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
14819881|NCT00889161|Curcumin|curcumin|mesh-list
14819882|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14819883|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14819884|NCT00889161|Analgesics|analgesics|mesh-ancestor
14819885|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
14819886|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819887|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819888|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14819889|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14819890|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819891|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819892|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819893|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14819894|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
14819895|NCT00889213|Coagulants|coagulants|mesh-ancestor
14819896|NCT00889343|Leucovorin|leucovorin|mesh-list
14819897|NCT00889343|Fluorouracil|fluorouracil|mesh-list
14819898|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
14819899|NCT00889343|Irinotecan|irinotecan|mesh-list
14701390|NCT00399243|Sumatriptan|sumatriptan|mesh-list
14701391|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14701392|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14701393|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14701394|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
14701395|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701396|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701397|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701398|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
14701399|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14701400|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
14701401|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701402|NCT00399256|Expectorants|expectorants|mesh-ancestor
14701403|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14701404|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14701405|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
14701406|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701407|NCT00399256|Protective Agents|protective agents|mesh-ancestor
14701408|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819900|NCT00889343|Sorafenib|sorafenib|mesh-list
14819901|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
14701409|NCT00399256|Antidotes|antidotes|mesh-ancestor
14701410|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
14701411|NCT00399269|Hematinics|hematinics|mesh-ancestor
14701412|NCT00399282|Vitamin E|vitamin e|mesh-list
14701413|NCT00399282|Vitamins|vitamins|mesh-ancestor
14701414|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
14701415|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701416|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
14701417|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701418|NCT00399282|Protective Agents|protective agents|mesh-ancestor
14701419|NCT00399295|Naltrexone|naltrexone|mesh-list
14701420|NCT00399295|Hydromorphone|hydromorphone|mesh-list
14701421|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
14701422|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14701423|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701424|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
14701425|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701426|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14701427|NCT00399295|Narcotics|narcotics|mesh-ancestor
14701428|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701429|NCT00399295|Analgesics|analgesics|mesh-ancestor
14701430|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
14701431|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14701432|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701433|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701434|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14701435|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
14701436|NCT00399399|Azathioprine|azathioprine|mesh-list
14701437|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701438|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
14701439|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701440|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701441|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14819902|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701442|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
14701443|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819903|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14819904|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819905|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14819906|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
14819907|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819908|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14819909|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14819910|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819911|NCT00889343|Antidotes|antidotes|mesh-ancestor
14819912|NCT00889343|Protective Agents|protective agents|mesh-ancestor
14819913|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
14819914|NCT00889343|Vitamins|vitamins|mesh-ancestor
14819915|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
14819916|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14910874|NCT01359514|Analgesics|analgesics|mesh-ancestor
14910875|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
14910876|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910877|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
14910878|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910879|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910880|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14910881|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910882|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910883|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15198320|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198321|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198322|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198323|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15198324|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15198325|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
15198326|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
15198327|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198328|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198329|NCT03782935|Choline|choline|mesh-list
15198330|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
15198331|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15198332|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
15198333|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819917|NCT00889356|Clindamycin|clindamycin|mesh-list
14819918|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
14819919|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
14819920|NCT00889356|Amphotericin B|amphotericin b|mesh-list
14819921|NCT00889356|Tetracycline|tetracycline|mesh-list
14819922|NCT00889356|Ketoconazole|ketoconazole|mesh-list
14819923|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14819924|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14819925|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14819926|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14819927|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14819928|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819929|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
15198334|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15198335|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15198336|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
15198337|NCT03783013|Lycopene|lycopene|mesh-list
15198338|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198339|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
15198340|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198341|NCT03783013|Protective Agents|protective agents|mesh-ancestor
15198342|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198343|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14819930|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14819931|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14819932|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14819933|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
14819934|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14819935|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819936|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14819937|NCT00889356|Amebicides|amebicides|mesh-ancestor
14819938|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14819939|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14819940|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14819941|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14819942|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14819943|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198344|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15198345|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14819944|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819945|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819946|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819947|NCT00889369|Analgesics|analgesics|mesh-ancestor
14819948|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
14819949|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819950|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
14819951|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14819952|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
14819953|NCT00889434|Tocotrienols|tocotrienols|mesh-list
14819954|NCT00889434|Vitamin E|vitamin e|mesh-list
14819955|NCT00889434|Tocopherols|tocopherols|mesh-list
14819956|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
14819957|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819958|NCT00889434|Protective Agents|protective agents|mesh-ancestor
14819959|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819960|NCT00889434|Vitamins|vitamins|mesh-ancestor
14819961|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
14819962|NCT00889499|Tropisetron|tropisetron|mesh-list
14819963|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
14819964|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
14819965|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14819966|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819967|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819968|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14819969|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14819970|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
14819971|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14819972|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819973|NCT00889525|Cabergoline|cabergoline|mesh-list
14819974|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14819975|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14819976|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
14819977|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
14819978|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917120|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15198346|NCT03782831|Antibodies|antibodies|mesh-list
15198347|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
15198348|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294781|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198349|NCT03783000|BI 425809|bi 425809|mesh-list
15198350|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
15198351|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
15198352|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14294782|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
14294783|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294784|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294785|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14294786|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
14294787|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294788|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294789|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294790|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701444|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701445|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14701446|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
14701447|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14701448|NCT00399425|Heparin|heparin|mesh-list
14701449|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14701450|NCT00399425|Tinzaparin|tinzaparin|mesh-list
14701451|NCT00399425|Dalteparin|dalteparin|mesh-list
14701452|NCT00399425|Bemiparin|bemiparin|mesh-list
14701453|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
14701454|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14701455|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14701456|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701457|NCT00399451|Polidocanol|polidocanol|mesh-list
14701458|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14701459|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14701460|NCT00399464|Alfuzosin|alfuzosin|mesh-list
14701461|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14701462|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14701463|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14701464|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
14701465|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701466|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701467|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701468|NCT00399464|Urological Agents|urological agents|mesh-ancestor
14701469|NCT00399477|Levodopa|levodopa|mesh-list
14701470|NCT00399477|Pramipexole|pramipexole|mesh-list
14701471|NCT00399477|Rasagiline|rasagiline|mesh-list
14701472|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14701473|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14701474|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
14701475|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701476|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701477|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917121|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15198353|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198354|NCT03782805|Vitamins|vitamins|mesh-ancestor
15198355|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
15198356|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15198357|NCT03782818|Olaparib|olaparib|mesh-list
15198358|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15198359|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198360|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198361|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198362|NCT03782662|Itraconazole|itraconazole|mesh-list
15198363|NCT03782662|Rifampin|rifampin|mesh-list
15198364|NCT03782662|Verapamil|verapamil|mesh-list
14819979|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819980|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819981|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
14819982|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14819983|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819984|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14819985|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14819986|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
14819987|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819988|NCT00889616|Antacids|antacids|mesh-ancestor
14819989|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14819990|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14819991|NCT00889629|Vitamin D|vitamin d|mesh-list
14819992|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
14819993|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14819994|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
14819995|NCT00889629|Vitamins|vitamins|mesh-ancestor
14819996|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
14819997|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14819998|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14819999|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820000|NCT00889642|Lidocaine|lidocaine|mesh-list
14820001|NCT00889642|Epinephrine|epinephrine|mesh-list
14820002|NCT00889642|Racepinephrine|racepinephrine|mesh-list
14820003|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
14820004|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
14820005|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
14701478|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14701479|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701480|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14701481|NCT00399477|Protective Agents|protective agents|mesh-ancestor
14820006|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820007|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820008|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
14820009|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820010|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14820011|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14820012|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14820013|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820014|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820015|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14820016|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15198365|NCT03782662|Midazolam|midazolam|mesh-list
15198366|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15198367|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15198368|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198369|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198370|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15198371|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15198372|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15198373|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15198374|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
15198375|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
15198376|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
14820017|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
14820018|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198377|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
15198378|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198379|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701482|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
14701483|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
14701484|NCT00399633|Sumatriptan|sumatriptan|mesh-list
14701485|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14701486|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14701487|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14820019|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14820020|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14820021|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
14820022|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14820023|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
14820024|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
14820025|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
14820026|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14820027|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14820028|NCT00889655|Laxatives|laxatives|mesh-ancestor
14820029|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820030|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
14820031|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820032|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14820033|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14820034|NCT00889694|Analgesics|analgesics|mesh-ancestor
14820035|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
14820036|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820037|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820038|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820039|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820040|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820041|NCT00889733|Cisplatin|cisplatin|mesh-list
14820042|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820043|NCT00889837|Loxapine|loxapine|mesh-list
14820044|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820045|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820046|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820047|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820048|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820049|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14820050|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
14820051|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820052|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820053|NCT00889850|Esomeprazole|esomeprazole|mesh-list
14820054|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14820055|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820056|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14820057|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820058|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820059|NCT00889876|Metformin|metformin|mesh-list
14820060|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14820061|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820062|NCT00890110|Sunitinib|sunitinib|mesh-list
14820063|NCT00890110|Vaccines|vaccines|mesh-list
14820064|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
14820065|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820066|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820067|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820068|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820069|NCT00890110|Growth Substances|growth substances|mesh-ancestor
14820070|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820071|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820072|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820073|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820074|NCT00890175|Loxapine|loxapine|mesh-list
14820075|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820076|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820077|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198380|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
15198381|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198382|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15198383|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15198384|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198385|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14701488|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
14701489|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701490|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701491|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701492|NCT00399659|Tegaserod|tegaserod|mesh-list
14701493|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14701494|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
14701495|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701496|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198386|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
14294791|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
14294792|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
14294793|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294794|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14294795|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
14294796|NCT00577993|Hormones|hormones|mesh-ancestor
14294797|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14294798|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14701497|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701498|NCT00399672|Interferons|interferons|mesh-list
14701499|NCT00399672|Ribavirin|ribavirin|mesh-list
14701500|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701501|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
14701502|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701503|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
14701504|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701505|NCT00399685|Efavirenz|efavirenz|mesh-list
14701506|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
14820078|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820079|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820080|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14820081|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
15198387|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198388|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15198389|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15198390|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
15198391|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198392|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
14820082|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820083|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820084|NCT00890188|Thalidomide|thalidomide|mesh-list
14820085|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820086|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
14820087|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820088|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
14820089|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820090|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820091|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820092|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820093|NCT00890188|Growth Substances|growth substances|mesh-ancestor
14820094|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820095|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820096|NCT00890214|Epoprostenol|epoprostenol|mesh-list
14820097|NCT00890214|Heparin|heparin|mesh-list
14820098|NCT00890214|Calcium heparin|calcium heparin|mesh-list
14820099|NCT00890214|Tezosentan|tezosentan|mesh-list
14820100|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
14820101|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14820102|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14820103|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820104|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820105|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14820106|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820107|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
14820108|NCT00890253|Prednisone|prednisone|mesh-list
14820109|NCT00890253|Prednisolone|prednisolone|mesh-list
14820110|NCT00890253|Everolimus|everolimus|mesh-list
14820111|NCT00890253|Basiliximab|basiliximab|mesh-list
14820112|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198393|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15198394|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15198395|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15198396|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14701507|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14701508|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14701509|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14701510|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701511|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701512|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
14701513|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701514|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14701515|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14701516|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14701517|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14701518|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14701519|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15198397|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15198398|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15198399|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15198400|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15198401|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15198402|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198403|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15198404|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
14701520|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701521|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14701522|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14701523|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820113|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
14820114|NCT00890253|Hormones|hormones|mesh-ancestor
14820115|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820116|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820117|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14820118|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820119|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820120|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
14820121|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14820122|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14820123|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
14820124|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820125|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820126|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820127|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820128|NCT00890279|Imidapril|imidapril|mesh-list
14820129|NCT00890279|Cilnidipine|cilnidipine|mesh-list
14820130|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14820131|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820132|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820133|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820134|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820135|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14820136|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
14820137|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820138|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820139|NCT00890318|Ketoconazole|ketoconazole|mesh-list
14820140|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
14820141|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820142|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14820143|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14820144|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820145|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820146|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14820147|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
14820148|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820149|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820150|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14820151|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14820152|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
14820153|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
14820154|NCT00890422|Vaccines|vaccines|mesh-list
14820155|NCT00890422|Immunologic Factors|immunologic factors|mesh-ancestor
14820156|NCT00890422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820157|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
14820158|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14820159|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
14820160|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820161|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
14820162|NCT00890487|Protective Agents|protective agents|mesh-ancestor
14820163|NCT00890500|Sirolimus|sirolimus|mesh-list
14820164|NCT00890500|Fludarabine|fludarabine|mesh-list
14820165|NCT00890500|Melphalan|melphalan|mesh-list
14820166|NCT00890500|Tacrolimus|tacrolimus|mesh-list
14820167|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14820168|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820169|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820170|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820171|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
14820172|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820173|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14820174|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820175|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820176|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820177|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14820178|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
14820179|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14820180|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
14820181|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14820182|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
14820183|NCT00890539|Miotics|miotics|mesh-ancestor
14820184|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
14820185|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820186|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820187|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14820188|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14820189|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
14820190|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14820191|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14820192|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
14820193|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820194|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820195|NCT00890565|Granisetron|granisetron|mesh-list
14820196|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
14820197|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
14294799|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820198|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820199|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820200|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820201|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14820202|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
14820203|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820204|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820205|NCT00890604|Acetaminophen|acetaminophen|mesh-list
14820206|NCT00890604|Ibuprofen|ibuprofen|mesh-list
14820207|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14820208|NCT00890604|Analgesics|analgesics|mesh-ancestor
14820209|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
14820210|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820211|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820212|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
14820213|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14820214|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820215|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820216|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14820217|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198405|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15198406|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15198407|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
15198408|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198409|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
14820218|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820219|NCT00890630|Oxytocin|oxytocin|mesh-list
14820220|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
14820221|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14820222|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820223|NCT00890643|Prazosin|prazosin|mesh-list
14820224|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820225|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14820226|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15198410|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15198411|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15198412|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198413|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
15198414|NCT03782025|Coagulants|coagulants|mesh-ancestor
15198415|NCT03782025|Vitamins|vitamins|mesh-ancestor
15198416|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
15224475|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820227|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14820228|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
14820229|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820230|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820231|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820232|NCT00890708|Voriconazole|voriconazole|mesh-list
14820233|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
14820234|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820235|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14820236|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14820237|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820238|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820239|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14820240|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
14820241|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820242|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820243|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14820244|NCT00890747|Sunitinib|sunitinib|mesh-list
14820245|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820246|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820247|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820248|NCT00890747|Growth Substances|growth substances|mesh-ancestor
14820249|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820250|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820251|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820252|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820253|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820254|NCT00890786|Bevacizumab|bevacizumab|mesh-list
14820255|NCT00890786|Irinotecan|irinotecan|mesh-list
14820256|NCT00890786|Temozolomide|temozolomide|mesh-list
14820257|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14820258|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820259|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820260|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820261|NCT00890786|Growth Substances|growth substances|mesh-ancestor
14820262|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820263|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820264|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14820265|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14820266|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820267|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820268|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14820269|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
14820270|NCT00890942|Naloxone|naloxone|mesh-list
14820271|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14820272|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701524|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14701525|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
14701526|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14701527|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701528|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14701529|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14701530|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14701531|NCT00399698|Risperidone|risperidone|mesh-list
14701532|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14701533|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
14701534|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701535|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820273|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
14820274|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820275|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
14820276|NCT00890955|Amrubicin|amrubicin|mesh-list
14820277|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820278|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
14820279|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198417|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198418|NCT03781947|Antarelix|antarelix|mesh-list
15198419|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
15198420|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198421|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198422|NCT03782064|Nivolumab|nivolumab|mesh-list
15198423|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14820280|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820281|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14820282|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
14820283|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820284|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701536|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701537|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14701538|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14701539|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701540|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14701541|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14701542|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
14701543|NCT00399711|Metformin|metformin|mesh-list
14701544|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
14820285|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14820286|NCT00891033|Bortezomib|bortezomib|mesh-list
14820287|NCT00891033|Panobinostat|panobinostat|mesh-list
14820288|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820289|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14820290|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820291|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820292|NCT00891072|Acetic Acid|acetic acid|mesh-list
14820293|NCT00891072|Paclitaxel|paclitaxel|mesh-list
14820294|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
14820295|NCT00891072|Carboplatin|carboplatin|mesh-list
14820296|NCT00891072|Retinol acetate|retinol acetate|mesh-list
14820297|NCT00891072|Gossypol|gossypol|mesh-list
14820298|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14820299|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820300|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
14820301|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
15198424|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198425|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15198426|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198427|NCT03781960|Nivolumab|nivolumab|mesh-list
15198428|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198429|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820302|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
14820303|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820304|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820305|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820306|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14820307|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
14820308|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820309|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14820310|NCT00891072|Protective Agents|protective agents|mesh-ancestor
14820311|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14820312|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
14820313|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14820314|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14820315|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14820316|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14820317|NCT00891150|Oxytocin|oxytocin|mesh-list
14820318|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
14820319|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14820320|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820321|NCT00891163|Lidocaine|lidocaine|mesh-list
14820322|NCT00891163|Tetracaine|tetracaine|mesh-list
14820323|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
14820324|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
14820325|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820326|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820327|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
15198430|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15198431|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198432|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
14820328|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820329|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14917122|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701545|NCT00399711|Repaglinide|repaglinide|mesh-list
14701546|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15198433|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15198434|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198435|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
15198436|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15198437|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198438|NCT03781895|Vitamins|vitamins|mesh-ancestor
15198439|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
15198440|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15198441|NCT03781843|Lidocaine|lidocaine|mesh-list
15198442|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
14701547|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701548|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
14701549|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14701550|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701551|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14701552|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
14701553|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701554|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701555|NCT00399750|Bevacizumab|bevacizumab|mesh-list
14701556|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
14701557|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14701558|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820330|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14820331|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14820332|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820333|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910884|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14910885|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14910886|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910887|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
14910888|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
14910889|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
14910890|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14910891|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910892|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910893|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
14910894|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14910895|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910896|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910897|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
14910898|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14910899|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14910900|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910901|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14910902|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14910903|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910904|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910905|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910906|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14910907|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
14910908|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14910909|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910910|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14910911|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14910912|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14910913|NCT01359657|Dexamethasone|dexamethasone|mesh-list
14910914|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
14910915|NCT01359657|Lenalidomide|lenalidomide|mesh-list
14910916|NCT01359657|Bortezomib|bortezomib|mesh-list
14910917|NCT01359657|BB 1101|bb 1101|mesh-list
14910918|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14910919|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910920|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
14910921|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
14910922|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910923|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910924|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910925|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
14910926|NCT01359657|Hormones|hormones|mesh-ancestor
14910927|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198443|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
14820334|NCT00891267|Amlodipine|amlodipine|mesh-list
14820335|NCT00891267|Olmesartan|olmesartan|mesh-list
14820336|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14820337|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820338|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14820339|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820340|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820341|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820342|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820343|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820344|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14820345|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14820346|NCT00891306|Cyclosporine|cyclosporine|mesh-list
14820347|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
14820348|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
14820349|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14820350|NCT00891306|Cyclosporins|cyclosporins|mesh-list
14820351|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820352|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820353|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820354|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
14820355|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820356|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
14820357|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820358|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14820359|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820360|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14820361|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14820362|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820363|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14820364|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
14820365|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820366|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820367|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
14820368|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
14820369|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820370|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820371|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
14820372|NCT00891306|Hormones|hormones|mesh-ancestor
14820373|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820374|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14820375|NCT00891306|Protective Agents|protective agents|mesh-ancestor
14820376|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14820377|NCT00891332|Leucovorin|leucovorin|mesh-list
14820378|NCT00891332|Antidotes|antidotes|mesh-ancestor
14820379|NCT00891332|Protective Agents|protective agents|mesh-ancestor
14820380|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820381|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
14820382|NCT00891332|Vitamins|vitamins|mesh-ancestor
14820383|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
14820384|NCT00891384|Lenalidomide|lenalidomide|mesh-list
14820385|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
14820386|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820387|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820388|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820389|NCT00891384|Growth Substances|growth substances|mesh-ancestor
14820390|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820391|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820392|NCT00891397|Pregabalin|pregabalin|mesh-list
14820393|NCT00891397|Analgesics|analgesics|mesh-ancestor
14820394|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
14820395|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820396|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820397|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
14820398|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14820399|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820400|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820401|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820402|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14820403|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820404|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820405|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820406|NCT00891423|Meropenem|meropenem|mesh-list
14820407|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820408|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820409|NCT00891475|Interferons|interferons|mesh-list
15198444|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198445|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198446|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
15198447|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198448|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15198449|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15198450|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14820410|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
14820411|NCT00891475|Sunitinib|sunitinib|mesh-list
14820412|NCT00891475|Maleic acid|maleic acid|mesh-list
14820413|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820414|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
14820415|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820416|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
14820417|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820418|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820419|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820420|NCT00891475|Growth Substances|growth substances|mesh-ancestor
14820421|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820422|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820423|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820424|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820425|NCT00891540|Ropivacaine|ropivacaine|mesh-list
14820426|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
14820427|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
14820428|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820429|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820430|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
14820431|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820432|NCT00891579|Pemetrexed|pemetrexed|mesh-list
14820433|NCT00891579|Gefitinib|gefitinib|mesh-list
14820434|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820435|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820436|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820437|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14820438|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14820439|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820440|NCT00891605|Paclitaxel|paclitaxel|mesh-list
14820441|NCT00891605|Navitoclax|navitoclax|mesh-list
14820442|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14820443|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820444|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
14820445|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
14820446|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
14820447|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820448|NCT00891670|Aspirin|aspirin|mesh-list
14820449|NCT00891670|Cilostazol|cilostazol|mesh-list
14820450|NCT00891670|Clopidogrel|clopidogrel|mesh-list
14820451|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14820452|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14820453|NCT00891670|Analgesics|analgesics|mesh-ancestor
14820454|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
14820455|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820456|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820457|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820458|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820459|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14820460|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14820461|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820462|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14820463|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14820464|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820465|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
14820466|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14820467|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14820468|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14820469|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
14820470|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820471|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14820472|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
14820473|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14820474|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
15198451|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198452|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820475|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820476|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14820477|NCT00891670|Protective Agents|protective agents|mesh-ancestor
14820478|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14820479|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14820480|NCT00891696|Sirolimus|sirolimus|mesh-list
14820481|NCT00891696|Nitroprusside|nitroprusside|mesh-list
14820482|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820483|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820484|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14820485|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820486|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
14820487|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820488|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
15198453|NCT03781869|Cisplatin|cisplatin|mesh-list
15198454|NCT03781869|Etoposide|etoposide|mesh-list
15198455|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
15198456|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198457|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15198458|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15198459|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15198460|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820489|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820490|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820491|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820492|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14820493|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820494|NCT00891761|Dexamethasone|dexamethasone|mesh-list
14820495|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
14820496|NCT00891761|Ondansetron|ondansetron|mesh-list
14820497|NCT00891761|Casopitant|casopitant|mesh-list
14820498|NCT00891761|BB 1101|bb 1101|mesh-list
14820499|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820500|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
14820501|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
14820502|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820503|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820504|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820505|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
14820506|NCT00891761|Hormones|hormones|mesh-ancestor
14820507|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820508|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14820509|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820510|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14820511|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820512|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820513|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
14820514|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14820515|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14820516|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
14820517|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820518|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820519|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820520|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820521|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820522|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14820523|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14820524|NCT00892073|Metformin|metformin|mesh-list
14820525|NCT00892073|Diazoxide|diazoxide|mesh-list
14820526|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14820527|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820528|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820529|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820530|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
15198461|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198462|NCT03781687|Morphine|morphine|mesh-list
15198463|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15198464|NCT03781687|Narcotics|narcotics|mesh-ancestor
15198465|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820531|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
14820532|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14820533|NCT00892112|Antibodies|antibodies|mesh-list
14820534|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
14820535|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14820536|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
14820537|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820538|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
15198466|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198467|NCT03781687|Analgesics|analgesics|mesh-ancestor
15198468|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
15198469|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198470|NCT03781596|Fluticasone|fluticasone|mesh-list
15198471|NCT03781596|Omeprazole|omeprazole|mesh-list
15198472|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820539|NCT00892125|Carbamazepine|carbamazepine|mesh-list
14820540|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14820541|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820542|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820543|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820544|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820545|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820546|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14820547|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14820548|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
14820549|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820550|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820551|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14820552|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14820553|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
14820554|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
14820555|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
14820556|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14820557|NCT00892125|Analgesics|analgesics|mesh-ancestor
14820558|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
14820559|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820560|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14820561|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820562|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14820563|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14820564|NCT00892190|Dasatinib|dasatinib|mesh-list
14820565|NCT00892190|Tretinoin|tretinoin|mesh-list
14820566|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820567|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820568|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820569|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820570|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
14820571|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
14820572|NCT00892229|Misoprostol|misoprostol|mesh-list
14820573|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14820574|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
14820575|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14820576|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820577|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14820578|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820579|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
14820580|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
14820581|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14820582|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820583|NCT00892307|Adenosine|adenosine|mesh-list
14820584|NCT00892307|Analgesics|analgesics|mesh-ancestor
14820585|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
14820586|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820587|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820588|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14820589|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820590|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14820591|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
14820592|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
14820593|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198473|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15198474|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
15198475|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198476|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198477|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14820594|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820595|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14820596|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820597|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820598|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820599|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820600|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820601|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15198478|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
14820602|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14820603|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
14820604|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820605|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820606|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14820607|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14820608|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
14820609|NCT00892346|Thalidomide|thalidomide|mesh-list
14820610|NCT00892346|Melphalan|melphalan|mesh-list
14820611|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14820612|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
14820613|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820614|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820615|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14820616|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820617|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
14820618|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820619|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
14820620|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820621|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820622|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820623|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820624|NCT00892346|Growth Substances|growth substances|mesh-ancestor
14820625|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820626|NCT00892359|Anidulafungin|anidulafungin|mesh-list
14820627|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
14820628|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820629|NCT00892385|Temozolomide|temozolomide|mesh-list
14820630|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14820631|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
14820632|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820633|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820634|NCT00892398|Ranibizumab|ranibizumab|mesh-list
15198479|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
15198480|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15198481|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15198482|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15198483|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15198484|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198485|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820635|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14820636|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14820637|NCT00892398|Growth Substances|growth substances|mesh-ancestor
14820638|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820639|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
14820640|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820641|NCT00892424|Sorafenib|sorafenib|mesh-list
14820642|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820643|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820644|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820645|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820646|NCT00892450|Oxybutynin|oxybutynin|mesh-list
14820647|NCT00892450|Darifenacin|darifenacin|mesh-list
14820648|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
14820649|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
14820650|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820651|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820652|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14820653|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14820654|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
14820655|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820656|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820657|NCT00892450|Urological Agents|urological agents|mesh-ancestor
14820658|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14820659|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
14820660|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15198486|NCT03781674|Progesterone|progesterone|mesh-list
15198487|NCT03781674|Progestins|progestins|mesh-ancestor
15198488|NCT03781674|Hormones|hormones|mesh-ancestor
15198489|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198490|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198491|NCT03781635|Ketamine|ketamine|mesh-list
15198492|NCT03781635|Analgesics|analgesics|mesh-ancestor
14820661|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15198493|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
14820662|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820663|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820664|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820665|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
14820666|NCT00892476|Calcium|calcium|mesh-list
14820667|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820668|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820669|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14820670|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14820671|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820672|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820673|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820674|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820675|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820676|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14820677|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14820678|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
14820679|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820680|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820681|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14820682|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14820683|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
14820684|NCT00892502|Bismuth|bismuth|mesh-list
14820685|NCT00892502|Antacids|antacids|mesh-ancestor
14820686|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820687|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820688|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14820689|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820690|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820691|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820692|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820693|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820694|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14820695|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14820696|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
14701559|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14701560|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14701561|NCT00399750|Growth Substances|growth substances|mesh-ancestor
14701562|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701563|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
14701564|NCT00399867|Simvastatin|simvastatin|mesh-list
14701565|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14701566|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14701567|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
14820697|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820698|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820699|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14820700|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14820701|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
14820702|NCT00892658|Sorafenib|sorafenib|mesh-list
14820703|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820704|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820705|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820706|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820707|NCT00892736|Veliparib|veliparib|mesh-list
14820708|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14820709|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820710|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820711|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820712|NCT00892801|Everolimus|everolimus|mesh-list
14820713|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820714|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14820715|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
14820716|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820717|NCT00892827|Rituximab|rituximab|mesh-list
14820718|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14820719|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820720|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
14820721|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820722|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820723|NCT00892892|Nitrendipine|nitrendipine|mesh-list
14820724|NCT00892892|Rilmenidine|rilmenidine|mesh-list
14820725|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14701568|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820726|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14820727|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820728|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820729|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820730|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820731|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820732|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
14820733|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
14820734|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820735|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14820736|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14820737|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14820738|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
14820739|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820740|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
14820741|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
14820742|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14820743|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14820744|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820745|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820746|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14820747|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14820748|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820749|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820750|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820751|NCT00892996|Dexamethasone|dexamethasone|mesh-list
14820752|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
14820753|NCT00892996|BB 1101|bb 1101|mesh-list
14820754|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820755|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
14820756|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
14820757|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820758|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820759|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14820760|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
14820761|NCT00892996|Hormones|hormones|mesh-ancestor
14820762|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820763|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14820764|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820765|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
14820766|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820767|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820768|NCT00893009|Theophylline|theophylline|mesh-list
14820769|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14820770|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
14820771|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820772|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820773|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14820774|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14820775|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14820776|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820777|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820778|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820779|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14820780|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14820781|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
14820782|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820783|NCT00893048|Prednisone|prednisone|mesh-list
14820784|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820785|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
14820786|NCT00893048|Hormones|hormones|mesh-ancestor
14820787|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820788|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820789|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15198494|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820790|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820791|NCT00893061|Tamoxifen|tamoxifen|mesh-list
14820792|NCT00893061|Letrozole|letrozole|mesh-list
14820793|NCT00893061|Anastrozole|anastrozole|mesh-list
14820794|NCT00893061|Exemestane|exemestane|mesh-list
14820795|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820796|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820797|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14820798|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14820799|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820800|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14820801|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
14820802|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820803|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820804|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14820805|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14820806|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14820807|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14910928|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14910929|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910930|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
14910931|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910932|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910933|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
14910934|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14910935|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14910936|NCT01359657|Growth Substances|growth substances|mesh-ancestor
14910937|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14910938|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
14910939|NCT01359670|Tadalafil|tadalafil|mesh-list
14910940|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
14910941|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14910942|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14910943|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910944|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910945|NCT01359670|Urological Agents|urological agents|mesh-ancestor
14910946|NCT01359696|Gemcitabine|gemcitabine|mesh-list
14910947|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14910948|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
14910949|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910950|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910951|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
14910952|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910953|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910954|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14910955|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
14910956|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910957|NCT01359709|Nicotine|nicotine|mesh-list
14910958|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14910959|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
14910960|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910961|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910962|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14910963|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14910964|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
14701569|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14701570|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14701571|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910965|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910966|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910967|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
14910968|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14910969|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
14910970|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910971|NCT01359722|Expectorants|expectorants|mesh-ancestor
14910972|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14910973|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14910974|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
14910975|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910976|NCT01359722|Protective Agents|protective agents|mesh-ancestor
14910977|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198495|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198496|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14701572|NCT00399945|Tobramycin|tobramycin|mesh-list
14701573|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701574|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701575|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
14701576|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728534|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728535|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
14728536|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15198497|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14820808|NCT00893100|Diltiazem|diltiazem|mesh-list
14820809|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820810|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14820811|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14820812|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820813|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820814|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820815|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820816|NCT00893217|Interferons|interferons|mesh-list
14820817|NCT00893217|Interferon-beta|interferon-beta|mesh-list
14820818|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
14820819|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820820|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
14820821|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820822|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
14820823|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820824|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14820825|NCT00893256|Risperidone|risperidone|mesh-list
14820826|NCT00893256|Citalopram|citalopram|mesh-list
14820827|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14820828|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
14820829|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820830|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820831|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820832|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820833|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820834|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820835|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820836|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14820837|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
14820838|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14820839|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14820840|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198498|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
15198499|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
15198500|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198501|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15198502|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14294800|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14820841|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14820842|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
15198503|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198504|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198505|NCT03781544|Acetaminophen|acetaminophen|mesh-list
14820843|NCT00893269|Zolpidem|zolpidem|mesh-list
14820844|NCT00893269|Eszopiclone|eszopiclone|mesh-list
14820845|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14820846|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14820847|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820848|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820849|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14820850|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
14820851|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
14820852|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820853|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820854|NCT00893373|Sorafenib|sorafenib|mesh-list
14820855|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820856|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14820857|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820858|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820859|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
14820860|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14820861|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820862|NCT00893412|Tramadol|tramadol|mesh-list
14820863|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14820864|NCT00893412|Narcotics|narcotics|mesh-ancestor
14820865|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820866|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820867|NCT00893412|Analgesics|analgesics|mesh-ancestor
15198506|NCT03781544|Diclofenac|diclofenac|mesh-list
15198507|NCT03781544|Tramadol|tramadol|mesh-list
15198508|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14294801|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14820868|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
15198509|NCT03781544|Analgesics|analgesics|mesh-ancestor
14820869|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820870|NCT00893425|Ramipril|ramipril|mesh-list
14820871|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14820872|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
14820873|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820874|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820875|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14820876|NCT00893451|Vitamin D|vitamin d|mesh-list
14820877|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
14820878|NCT00893451|Vitamins|vitamins|mesh-ancestor
14820879|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
14820880|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820881|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14820882|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14820883|NCT00893477|Rituximab|rituximab|mesh-list
14820884|NCT00893477|Sargramostim|sargramostim|mesh-list
14820885|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14820886|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820887|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
14820888|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820889|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820890|NCT00893490|Mitomycins|mitomycins|mesh-list
15198510|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
15198511|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198512|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198513|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
15198514|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15198515|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198516|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820891|NCT00893490|Mitomycin|mitomycin|mesh-list
14820892|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14820893|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820894|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
14820895|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820896|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14820897|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820898|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
14820899|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14820900|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14820901|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14820902|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
14820903|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820904|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820905|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820906|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820907|NCT00893555|Voriconazole|voriconazole|mesh-list
14820908|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
14820909|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820910|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14820911|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14820912|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820913|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820914|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14820915|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
14820916|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14820917|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820918|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14820919|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14820920|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
14820921|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820922|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820923|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820924|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820925|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820926|NCT00893594|Naproxen|naproxen|mesh-list
14820927|NCT00893594|Sumatriptan|sumatriptan|mesh-list
14820928|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14820929|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14820930|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14820931|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
14820932|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198517|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15198518|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820933|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820934|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820935|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14820936|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14820937|NCT00893594|Analgesics|analgesics|mesh-ancestor
14820938|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
14820939|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820940|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14820941|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14820942|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
14820943|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14820944|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14820945|NCT00893607|Methoxamine|methoxamine|mesh-list
14820946|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
14820947|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
14820948|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14820949|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820950|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14820951|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14820952|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14820953|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14820954|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
14820955|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14820956|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820957|NCT00893711|Vitamin D|vitamin d|mesh-list
14701577|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
14701578|NCT00400075|Azathioprine|azathioprine|mesh-list
14701579|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701580|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
14701581|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701582|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701583|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14701584|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
14820958|NCT00893711|Vitamins|vitamins|mesh-ancestor
14820959|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
14820960|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820961|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14820962|NCT00893724|Tocopherols|tocopherols|mesh-list
14820963|NCT00893724|Vitamin E|vitamin e|mesh-list
14820964|NCT00893724|Tocotrienols|tocotrienols|mesh-list
14820965|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
14820966|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
14820967|NCT00893724|Niacinamide|niacinamide|mesh-list
14820968|NCT00893724|Niacin|niacin|mesh-list
14820969|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
14820970|NCT00893724|Ubiquinone|ubiquinone|mesh-list
14820971|NCT00893724|Minocycline|minocycline|mesh-list
14820972|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
14820973|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14820974|NCT00893724|Vitamins|vitamins|mesh-ancestor
14820975|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
14701585|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701586|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701587|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14701588|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
14701589|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14701590|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
14701591|NCT00400088|Paroxetine|paroxetine|mesh-list
14701592|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
14701593|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14701594|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701595|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701596|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
14820976|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14820977|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
14820978|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14820979|NCT00893724|Protective Agents|protective agents|mesh-ancestor
14820980|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14820981|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14820982|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
14820983|NCT00893724|Expectorants|expectorants|mesh-ancestor
14820984|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
14820985|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14820986|NCT00893724|Antidotes|antidotes|mesh-ancestor
14701597|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820987|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
14820988|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14820989|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
14820990|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14820991|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
14820992|NCT00893841|Pramipexole|pramipexole|mesh-list
14820993|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14820994|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
14820995|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14820996|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14820997|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14820998|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14820999|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821000|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
14821001|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821002|NCT00893841|Protective Agents|protective agents|mesh-ancestor
14821003|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14821004|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14821005|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
14821006|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
14821007|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198519|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198520|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14821008|NCT00893854|Triamcinolone|triamcinolone|mesh-list
14821009|NCT00893854|Diclofenac|diclofenac|mesh-list
14821010|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821011|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
14821012|NCT00893854|Hormones|hormones|mesh-ancestor
14821013|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821014|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821015|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821016|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821017|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14821018|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821019|NCT00893854|Analgesics|analgesics|mesh-ancestor
14821020|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
14821021|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821022|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821023|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14821024|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
14821025|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14821026|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
14821027|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821028|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821029|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14821030|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
14821031|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14821032|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
14821033|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198521|NCT03781544|Narcotics|narcotics|mesh-ancestor
15198522|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198523|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
15198524|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15198525|NCT03781505|Acetaminophen|acetaminophen|mesh-list
15198526|NCT03781505|Ropivacaine|ropivacaine|mesh-list
14821034|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821035|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14821036|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
14821037|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
14821038|NCT00893880|Protective Agents|protective agents|mesh-ancestor
14821039|NCT00893906|Vaccines|vaccines|mesh-list
14821040|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
14821041|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821042|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
14821043|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14821044|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821045|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14821046|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
14821047|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14821048|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821049|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821050|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821051|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
14821052|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14821053|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821054|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14821055|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
15198527|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
14821056|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14821057|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821058|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821059|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821060|NCT00894010|Carbamazepine|carbamazepine|mesh-list
14821061|NCT00894010|Levetiracetam|levetiracetam|mesh-list
14821062|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
14821063|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
14821064|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
14821065|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14821066|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821067|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821068|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14821069|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821070|NCT00894010|Analgesics|analgesics|mesh-ancestor
14821071|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
14821072|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821073|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14821074|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14821075|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821076|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14821077|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15198528|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
15198529|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198530|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198531|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
15198532|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198533|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15198534|NCT03781505|Analgesics|analgesics|mesh-ancestor
15198535|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
15198536|NCT03781700|Prednisolone|prednisolone|mesh-list
15198537|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198538|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
15198539|NCT03781700|Hormones|hormones|mesh-ancestor
15198540|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198541|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198542|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15198543|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198544|NCT03781466|Progesterone|progesterone|mesh-list
15198545|NCT03781466|Progestins|progestins|mesh-ancestor
15198546|NCT03781466|Hormones|hormones|mesh-ancestor
14821078|NCT00894023|Abciximab|abciximab|mesh-list
14821079|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
14821080|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14821081|NCT00894062|Everolimus|everolimus|mesh-list
14821082|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821083|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821084|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
14821085|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821086|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
14821087|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14821088|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821089|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14821090|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
14821091|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14821092|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821093|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821094|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821095|NCT00894231|Levocetirizine|levocetirizine|mesh-list
14821096|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14821097|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14821098|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
14821099|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
14821100|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821101|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821102|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821103|NCT00894283|Enoxaparin|enoxaparin|mesh-list
14821104|NCT00894283|PENTA|penta|mesh-list
14821105|NCT00894283|Fondaparinux|fondaparinux|mesh-list
14821106|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
14821107|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14821108|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15198547|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821109|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198548|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821110|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14821111|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
14821112|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14821113|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
15198549|NCT03781388|Bupivacaine|bupivacaine|mesh-list
15198550|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
14821114|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821115|NCT00894374|Artesunate|artesunate|mesh-list
14821116|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
14821117|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14821118|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14821119|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821120|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821121|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
14821122|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
14821123|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14821124|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
14821125|NCT00894439|Piperacillin|piperacillin|mesh-list
14821126|NCT00894439|BLI-489|bli-489|mesh-list
14821127|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14821128|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821129|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14821130|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821131|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821132|NCT00894569|Paclitaxel|paclitaxel|mesh-list
14821133|NCT00894569|Carboplatin|carboplatin|mesh-list
14821134|NCT00894569|Cetuximab|cetuximab|mesh-list
14821135|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821136|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821137|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
14821138|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
14821139|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
14821140|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821141|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14821142|NCT00894608|Letrozole|letrozole|mesh-list
14821143|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821144|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14821145|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14821146|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821147|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821148|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14821149|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
14821150|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821151|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821152|NCT00894621|Norepinephrine|norepinephrine|mesh-list
14821153|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14821154|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14821155|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14821156|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821157|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821158|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821159|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
14821160|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
14821161|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821162|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14821163|NCT00894634|Brompheniramine|brompheniramine|mesh-list
14821164|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821165|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15198551|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
15198552|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198553|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198554|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
15198555|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198556|NCT03781258|Warfarin|warfarin|mesh-list
15198557|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
15198558|NCT03781063|Fulvestrant|fulvestrant|mesh-list
15198559|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15198560|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198561|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15198562|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14821166|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
14821167|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
14821168|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821169|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821170|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14821171|NCT00894660|Amodiaquine|amodiaquine|mesh-list
14821172|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
14821173|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14821174|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14821175|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821176|NCT00894673|Heparin|heparin|mesh-list
14821177|NCT00894673|Calcium heparin|calcium heparin|mesh-list
14821178|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
14821179|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14821180|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14821181|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821182|NCT00894712|Sulforaphane|sulforaphane|mesh-list
14821183|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14821184|NCT00894712|Protective Agents|protective agents|mesh-ancestor
14821185|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821186|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821187|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
14821188|NCT00894751|Propofol|propofol|mesh-list
14821189|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14821190|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821191|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821192|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14701598|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701599|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701600|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14701601|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14701602|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14701603|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701604|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
14701605|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14701606|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14701607|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14294802|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14294803|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14821193|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
14821194|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
14821195|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821196|NCT00894751|Analgesics|analgesics|mesh-ancestor
15198563|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
15198564|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198565|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821197|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
14821198|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821199|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14821200|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14821201|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14821202|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
14821203|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821204|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910978|NCT01359722|Antidotes|antidotes|mesh-ancestor
14910979|NCT01359826|Milnacipran|milnacipran|mesh-list
14910980|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
14910981|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14910982|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14910983|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910984|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910985|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910986|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910987|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910988|NCT01359826|Analgesics|analgesics|mesh-ancestor
14910989|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
14910990|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910991|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
14910992|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910993|NCT01359930|Naltrexone|naltrexone|mesh-list
14910994|NCT01359930|Bupropion|bupropion|mesh-list
14910995|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14910996|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14910997|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821205|NCT00894829|Heparin|heparin|mesh-list
14821206|NCT00894829|Calcium heparin|calcium heparin|mesh-list
14821207|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
14821208|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14294804|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14294805|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
14294806|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294807|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14294808|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14821209|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14821210|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821211|NCT00894920|Biotin|biotin|mesh-list
14821212|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
14821213|NCT00894920|Vitamins|vitamins|mesh-ancestor
14821214|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
14821215|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821216|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
14821217|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821218|NCT00894959|Heparin|heparin|mesh-list
14821219|NCT00894959|Calcium heparin|calcium heparin|mesh-list
14821220|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
14821221|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14821222|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14821223|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821224|NCT00894985|Heparin|heparin|mesh-list
14821225|NCT00894985|Calcium heparin|calcium heparin|mesh-list
14821226|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
14821227|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14821228|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14821229|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821230|NCT00894998|Heparin|heparin|mesh-list
14821231|NCT00894998|Calcium heparin|calcium heparin|mesh-list
14821232|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
14821233|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14821234|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14821235|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821236|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
14821237|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14821238|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14821239|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821240|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
14821241|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821242|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821243|NCT00895076|Dexamethasone|dexamethasone|mesh-list
14821244|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821245|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
14821246|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
14821247|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821248|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821249|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14821250|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
14821251|NCT00895076|Hormones|hormones|mesh-ancestor
14821252|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821253|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14821254|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821255|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
14821256|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
14821257|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14821258|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294809|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14294810|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14294811|NCT00577993|Protective Agents|protective agents|mesh-ancestor
14294812|NCT00577993|Analgesics|analgesics|mesh-ancestor
14294813|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
14294814|NCT00578071|Capecitabine|capecitabine|mesh-list
14294815|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
14294816|NCT00578071|Panitumumab|panitumumab|mesh-list
14701608|NCT00400114|Irinotecan|irinotecan|mesh-list
14294817|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14294818|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
14701609|NCT00400114|Sunitinib|sunitinib|mesh-list
14701610|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701611|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14701612|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14701613|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701614|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701615|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14821259|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821260|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14821261|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14821262|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821263|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821264|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821265|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14821266|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
14821267|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14821268|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821269|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14821270|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14821271|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14821272|NCT00895115|Vitamin E|vitamin e|mesh-list
14821273|NCT00895115|Vitamins|vitamins|mesh-ancestor
14821274|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
14821275|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821276|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
14821277|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821278|NCT00895115|Protective Agents|protective agents|mesh-ancestor
14821279|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14821280|NCT00895128|Dasatinib|dasatinib|mesh-list
14821281|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821282|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14821283|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821284|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821285|NCT00895167|Curcumin|curcumin|mesh-list
14821286|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14821287|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821288|NCT00895167|Analgesics|analgesics|mesh-ancestor
14821289|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
14821290|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821291|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821292|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821293|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821294|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821295|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821296|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821297|NCT00895297|Dasatinib|dasatinib|mesh-list
14821298|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821299|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14821300|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821301|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701616|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14701617|NCT00400114|Growth Substances|growth substances|mesh-ancestor
14701618|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701619|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
14701620|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14701621|NCT00400231|Metformin|metformin|mesh-list
14821302|NCT00895323|Antibodies|antibodies|mesh-list
14821303|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14821304|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14821305|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
14821306|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821307|NCT00895362|Cetuximab|cetuximab|mesh-list
14821308|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14821309|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14821310|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821311|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14821312|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821313|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821314|NCT00895505|Warfarin|warfarin|mesh-list
14821315|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
14821316|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
14821317|NCT00895544|Vaccines|vaccines|mesh-list
14821318|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
14821319|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821320|NCT00895557|Varenicline|varenicline|mesh-list
14821321|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14821322|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14701622|NCT00400231|Fenofibrate|fenofibrate|mesh-list
14701623|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14701624|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821323|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
14701625|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14821324|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821325|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821326|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821327|NCT00895570|Modafinil|modafinil|mesh-list
14821328|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14821329|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198566|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15198567|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
15198568|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198569|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15198570|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15198571|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
15198572|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198573|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198574|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15198575|NCT03781115|Olanzapine|olanzapine|mesh-list
15198576|NCT03781115|Ziprasidone|ziprasidone|mesh-list
15198577|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
15198578|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
15198579|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821330|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14821331|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14821332|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14821333|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821334|NCT00895609|Neostigmine|neostigmine|mesh-list
14821335|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14821336|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821337|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821338|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
14821339|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821340|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294819|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294820|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294821|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294822|NCT00578136|Bupivacaine|bupivacaine|mesh-list
14294823|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
14294824|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
14294825|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821341|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14821342|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
14821343|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821344|NCT00895648|Pemetrexed|pemetrexed|mesh-list
14821345|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821346|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294826|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701626|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
14701627|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701628|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14701629|NCT00400322|Valganciclovir|valganciclovir|mesh-list
14701630|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
14701631|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701632|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
14701633|NCT00400335|Testosterone|testosterone|mesh-list
14701634|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
14701635|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
14821347|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821348|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14821349|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14821350|NCT00895674|Sorafenib|sorafenib|mesh-list
14821351|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821352|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14821353|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821354|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821355|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14821356|NCT00895687|Bortezomib|bortezomib|mesh-list
14821357|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821358|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14821359|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821360|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821361|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
14821362|NCT00895713|Antibodies|antibodies|mesh-list
14821363|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
14821364|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14821365|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14821366|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
14821367|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821368|NCT00895739|Cyclosporine|cyclosporine|mesh-list
14821369|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
14821370|NCT00895739|Cyclosporins|cyclosporins|mesh-list
14821371|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821372|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821373|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821374|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
14821375|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821376|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
14821377|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821378|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
14821379|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821380|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14821381|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14821382|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821383|NCT00895778|Rocuronium|rocuronium|mesh-list
14821384|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14821385|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14821386|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14821387|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821388|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821389|NCT00895791|Umirolimus|umirolimus|mesh-list
14821390|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821391|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821392|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
14821393|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821394|NCT00895804|Pindolol|pindolol|mesh-list
14821395|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14821396|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14821397|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
14821398|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821399|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821400|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821401|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14821402|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14821403|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
14821404|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
14821405|NCT00895882|Interferons|interferons|mesh-list
14821406|NCT00895882|Ribavirin|ribavirin|mesh-list
14821407|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821408|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
14821409|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821410|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
14821411|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821412|NCT00895960|Temozolomide|temozolomide|mesh-list
14821413|NCT00895960|Dasatinib|dasatinib|mesh-list
14821414|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14821415|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
14821416|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821417|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821418|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14821419|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821420|NCT00896077|Lisofylline|lisofylline|mesh-list
15198580|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198581|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14821421|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15198582|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15198583|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15198584|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821422|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
14821423|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821424|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14821425|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821426|NCT00896077|Analgesics|analgesics|mesh-ancestor
14821427|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
14821428|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821429|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821430|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821431|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821432|NCT00896155|Tamoxifen|tamoxifen|mesh-list
14821433|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14821434|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
14821435|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821436|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821437|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14821438|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821439|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14821440|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14821441|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14821442|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14821443|NCT00896285|Analgesics|analgesics|mesh-list
14821444|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
14821445|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
14821446|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821447|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821448|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821449|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821450|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821451|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14821452|NCT00896285|Narcotics|narcotics|mesh-ancestor
14821453|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821454|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
14821455|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14821456|NCT00896376|Trastuzumab|trastuzumab|mesh-list
14821457|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14821458|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821459|NCT00896402|Iodine|iodine|mesh-list
14701636|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14701637|NCT00400335|Dutasteride|dutasteride|mesh-list
14701638|NCT00400335|Androgens|androgens|mesh-ancestor
14701639|NCT00400335|Hormones|hormones|mesh-ancestor
14701640|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701641|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701642|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14821460|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
15198585|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15198586|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15198587|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15198588|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198589|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198590|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198591|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
15198592|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14701643|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701644|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
14701645|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14701646|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14701647|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701648|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701649|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
14701650|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
14701651|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701652|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701653|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701654|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701655|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701656|NCT00400374|Celecoxib|celecoxib|mesh-list
14701657|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14701658|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701659|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14701660|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701661|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198593|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15198594|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
15198595|NCT03781050|Sirolimus|sirolimus|mesh-list
15198596|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14821461|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14821462|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
14821463|NCT00896402|Povidone|povidone|mesh-list
14821464|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14821465|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821466|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
14821467|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
14821468|NCT00896402|Trace Elements|trace elements|mesh-ancestor
14821469|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
14821470|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821471|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
14821472|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
14821473|NCT00896428|Gallopamil|gallopamil|mesh-list
14821474|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14821475|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14821476|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821477|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14821478|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821479|NCT00896493|Cyclosporine|cyclosporine|mesh-list
14821480|NCT00896493|Cyclosporins|cyclosporins|mesh-list
14821481|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14821482|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821483|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821484|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821485|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
15198597|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198598|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15198599|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198600|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
14821486|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821487|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
14821488|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821489|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
14821490|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821491|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14821492|NCT00896519|Prednisone|prednisone|mesh-list
14821493|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
14821494|NCT00896519|Rituximab|rituximab|mesh-list
14821495|NCT00896519|Doxorubicin|doxorubicin|mesh-list
14821496|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14821497|NCT00896519|Vincristine|vincristine|mesh-list
14821498|NCT00896519|Sargramostim|sargramostim|mesh-list
14821499|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821500|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
14821501|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821502|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821503|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14821504|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
14821505|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821506|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821507|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14821508|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14821509|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14821510|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14821511|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14821512|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821513|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821514|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
14821515|NCT00896519|Hormones|hormones|mesh-ancestor
15198601|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821516|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821517|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14821518|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821519|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
14821520|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
14821521|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
14821522|NCT00896558|Midazolam|midazolam|mesh-list
14821523|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14821524|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14821525|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821526|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821527|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14821528|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14821529|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14821530|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14821531|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
14821532|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
14821533|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
14821534|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
14821535|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821536|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821537|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14821538|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14821539|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14821540|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14821541|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
14821542|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14821543|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821544|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14821545|NCT00896571|Estrogens|estrogens|mesh-ancestor
14821546|NCT00896571|Hormones|hormones|mesh-ancestor
14821547|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821548|NCT00896714|Anesthetics|anesthetics|mesh-list
14821549|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821550|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910998|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
14910999|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911000|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14911001|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
14911002|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911003|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14911004|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14911005|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911006|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911007|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
14911008|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911009|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14911010|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14911011|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911012|NCT01360034|Indomethacin|indomethacin|mesh-list
14911013|NCT01360034|Nifedipine|nifedipine|mesh-list
14911014|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14911015|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911016|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911017|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911018|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911019|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
14911020|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
14911021|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14911022|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911023|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911024|NCT01360034|Analgesics|analgesics|mesh-ancestor
14911025|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
14911026|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911027|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911028|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911029|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
14911030|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14911031|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911032|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
14701662|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14701663|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821551|NCT00896727|Antibodies|antibodies|mesh-list
14821552|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
14821553|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821554|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
14821555|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14821556|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14821557|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821558|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821559|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821560|NCT00896948|Antibodies|antibodies|mesh-list
14821561|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
14821562|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821563|NCT00896987|Lamotrigine|lamotrigine|mesh-list
14821564|NCT00896987|Carbamazepine|carbamazepine|mesh-list
14821565|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
14821566|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14821567|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14821568|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821569|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14821570|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821571|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14821572|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14821573|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821574|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14821575|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14821576|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
14821577|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821578|NCT00896987|Analgesics|analgesics|mesh-ancestor
14821579|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
14821580|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821581|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14821582|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14821583|NCT00897026|Paclitaxel|paclitaxel|mesh-list
14821584|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
14821585|NCT00897026|Doxorubicin|doxorubicin|mesh-list
14821586|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14821587|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821588|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821589|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
14821590|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
14821591|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
14821592|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821593|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821594|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
14821595|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821596|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821597|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14821598|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
14821599|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14821600|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14821601|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14821602|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14821603|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821604|NCT00897065|Antibodies|antibodies|mesh-list
14821605|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
14821606|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701664|NCT00400374|Analgesics|analgesics|mesh-ancestor
14701665|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
14701666|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701667|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701668|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701669|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294827|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
14294828|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294829|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14294830|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
14294831|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294832|NCT00578214|Midazolam|midazolam|mesh-list
14701670|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14701671|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14821607|NCT00897130|Azacitidine|azacitidine|mesh-list
14821608|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14821609|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
14821610|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821611|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821612|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821613|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14821614|NCT00897221|Deferiprone|deferiprone|mesh-list
14821615|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14821616|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
14821617|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
14821618|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821619|NCT00897312|Interferons|interferons|mesh-list
14821620|NCT00897312|Ribavirin|ribavirin|mesh-list
14821621|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
14821622|NCT00897312|Tremelimumab|tremelimumab|mesh-list
15198602|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
15198603|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198604|NCT03781011|Choline|choline|mesh-list
15198605|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
15198606|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15198607|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
15198608|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198609|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15198610|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15198611|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
15198612|NCT03780933|Ascorbic Acid|ascorbic acid|mesh-list
15198613|NCT03780933|Vitamins|vitamins|mesh-ancestor
15198614|NCT03780933|Micronutrients|micronutrients|mesh-ancestor
14821623|NCT00897312|Infliximab|infliximab|mesh-list
14821624|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821625|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
14821626|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821627|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
14821628|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821629|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
15198615|NCT03780933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198616|NCT03780933|Antioxidants|antioxidants|mesh-ancestor
14701672|NCT00400387|Riboflavin|riboflavin|mesh-list
14701673|NCT00400387|Thiamine|thiamine|mesh-list
14701674|NCT00400387|Pyridoxine|pyridoxine|mesh-list
15198617|NCT03780933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701675|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
14701676|NCT00400387|Folic Acid|folic acid|mesh-list
14701677|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
14294833|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
14294834|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701678|NCT00400387|Tocopherols|tocopherols|mesh-list
14701679|NCT00400387|Vitamin E|vitamin e|mesh-list
14701680|NCT00400387|Tocotrienols|tocotrienols|mesh-list
14701681|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
14701682|NCT00400387|Heparin|heparin|mesh-list
14701683|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14701684|NCT00400387|Tinzaparin|tinzaparin|mesh-list
14701685|NCT00400387|Dalteparin|dalteparin|mesh-list
14701686|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701687|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
14701688|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14701689|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14821630|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198618|NCT03780933|Protective Agents|protective agents|mesh-ancestor
14821631|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14821632|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14821633|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821634|NCT00897377|Temozolomide|temozolomide|mesh-list
14821635|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14821636|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
14821637|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821638|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821639|NCT00897520|Interferons|interferons|mesh-list
14821640|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
14821641|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821642|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
14821643|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821644|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
14821645|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821646|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
14821647|NCT00897871|Carboplatin|carboplatin|mesh-list
14821648|NCT00897871|Etoposide|etoposide|mesh-list
14821649|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
14821650|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821651|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
14821652|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821653|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821654|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14821655|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
14821656|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821657|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821658|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14821659|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821660|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14821661|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14821662|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821663|NCT00897884|Metformin|metformin|mesh-list
14821664|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14821665|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821666|NCT00897975|Red yeast rice|red yeast rice|mesh-list
14821667|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14821668|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14821669|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14821670|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
14821671|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821672|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821673|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14821674|NCT00898287|Gemcitabine|gemcitabine|mesh-list
14821675|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14821676|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
14821677|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198619|NCT03780673|Rifaximin|rifaximin|mesh-list
15198620|NCT03780673|Simvastatin|simvastatin|mesh-list
15198621|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15198622|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15198623|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
15198624|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198625|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15198626|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15198627|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821678|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821679|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
14821680|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821681|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821682|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821683|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
14821684|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911033|NCT01360060|Analgesics|analgesics|mesh-ancestor
14911034|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
14911035|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911036|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911037|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
14911038|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911039|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14911040|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
14911041|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14911042|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911043|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911044|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911045|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
14911046|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14911047|NCT01360086|Leucovorin|leucovorin|mesh-list
14911048|NCT01360086|Fluorouracil|fluorouracil|mesh-list
14911049|NCT01360086|Cetuximab|cetuximab|mesh-list
14911050|NCT01360086|Calcium|calcium|mesh-list
14911051|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
14911052|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911053|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911054|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911055|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
14911056|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911057|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14911058|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911059|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
14911060|NCT01360086|Antidotes|antidotes|mesh-ancestor
14911061|NCT01360086|Protective Agents|protective agents|mesh-ancestor
14911062|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
14911063|NCT01360086|Vitamins|vitamins|mesh-ancestor
14911064|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
14911065|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14911066|NCT01360151|Ranibizumab|ranibizumab|mesh-list
14911067|NCT01360151|Verteporfin|verteporfin|mesh-list
14911068|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14911069|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14911070|NCT01360151|Growth Substances|growth substances|mesh-ancestor
14911071|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911072|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
14911073|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911074|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14911075|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14911076|NCT01360190|Fluoxetine|fluoxetine|mesh-list
14911077|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14911078|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14911079|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911080|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911081|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911082|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
14911083|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911084|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14911085|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
14911086|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911087|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14911088|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14911089|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917123|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917124|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917125|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
14917126|NCT01396200|Sirolimus|sirolimus|mesh-list
14917127|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
14917128|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14917129|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14917130|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917131|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917132|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917133|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917134|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198628|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198629|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198630|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15198631|NCT03780686|Dopamine|dopamine|mesh-list
15198632|NCT03780686|Norepinephrine|norepinephrine|mesh-list
15198633|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15198634|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15198635|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
15198636|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701690|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701691|NCT00400387|Vitamins|vitamins|mesh-ancestor
14821685|NCT00898417|Paclitaxel|paclitaxel|mesh-list
14821686|NCT00898417|Bevacizumab|bevacizumab|mesh-list
14821687|NCT00898417|Carboplatin|carboplatin|mesh-list
14821688|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821689|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821690|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14821691|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14821692|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14821693|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821694|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14821695|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14821696|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14821697|NCT00898417|Growth Substances|growth substances|mesh-ancestor
14821698|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821699|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
14821700|NCT00898508|Antibodies|antibodies|mesh-list
14821701|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
14821702|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821703|NCT00898573|Lapatinib|lapatinib|mesh-list
14821704|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821705|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14821706|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821707|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821708|NCT00898794|Bevacizumab|bevacizumab|mesh-list
14821709|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14821710|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821711|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14821712|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14821713|NCT00898794|Growth Substances|growth substances|mesh-ancestor
14821714|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821715|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
14821716|NCT00898846|Tegafur|tegafur|mesh-list
14821717|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14821718|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
14821719|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821720|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821721|NCT00898950|Aspirin|aspirin|mesh-list
14821722|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
14821723|NCT00898950|Salicylates|salicylates|mesh-list
14821724|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14821725|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821726|NCT00898950|Analgesics|analgesics|mesh-ancestor
14821727|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
14821728|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821729|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821730|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821731|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821732|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14821733|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14821734|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821735|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14701692|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
14701693|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14701694|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
14701695|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
14701696|NCT00400387|Protective Agents|protective agents|mesh-ancestor
14701697|NCT00400387|Hematinics|hematinics|mesh-ancestor
14701698|NCT00400478|Rituximab|rituximab|mesh-list
14701699|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14701700|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701701|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
14821736|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15198637|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701702|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821737|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821738|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
14821739|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821740|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
14821741|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
14821742|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
14821743|NCT00899197|Tamoxifen|tamoxifen|mesh-list
14821744|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14821745|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
14821746|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198638|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198639|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
15198640|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
15198641|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198642|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15198643|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15198644|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
15198645|NCT03780686|Protective Agents|protective agents|mesh-ancestor
15198646|NCT03780556|Lornoxicam|lornoxicam|mesh-list
15198647|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15198648|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15198649|NCT03780556|Analgesics|analgesics|mesh-ancestor
14821747|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821748|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14821749|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821750|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14821751|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14821752|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14821753|NCT00899483|Insulin|insulin|mesh-list
14821754|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14821755|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821756|NCT00899587|Enalapril|enalapril|mesh-list
14821757|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14821758|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
14821759|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821760|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821761|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14821762|NCT00899821|Aldesleukin|aldesleukin|mesh-list
14821763|NCT00899821|Interleukin-12|interleukin-12|mesh-list
14821764|NCT00899821|Sargramostim|sargramostim|mesh-list
14821765|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
14821766|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821767|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821768|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14821769|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14821770|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
14821771|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821772|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14821773|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14821774|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14821775|NCT00899821|Growth Substances|growth substances|mesh-ancestor
14821776|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
14821777|NCT00899951|Fentanyl|fentanyl|mesh-list
14821778|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14821779|NCT00899951|Narcotics|narcotics|mesh-ancestor
14821780|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821781|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821782|NCT00899951|Analgesics|analgesics|mesh-ancestor
14821783|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
14821784|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821785|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14821786|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14821787|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
14821788|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
14821789|NCT00900172|Paclitaxel|paclitaxel|mesh-list
14821790|NCT00900172|Bevacizumab|bevacizumab|mesh-list
14821791|NCT00900172|Carboplatin|carboplatin|mesh-list
14821792|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821793|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198650|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
15198651|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198652|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821794|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
14821795|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
14821796|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14821797|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821798|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198653|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198654|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15198655|NCT03780621|Andrographolide|andrographolide|mesh-list
15198656|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198657|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15198658|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821799|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14821800|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14821801|NCT00900172|Growth Substances|growth substances|mesh-ancestor
14821802|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821803|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
14911090|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
14911091|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15198659|NCT03780621|Analgesics|analgesics|mesh-ancestor
15198660|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
15198661|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198662|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198663|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15198664|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15198665|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15198666|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198667|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
15198668|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15198669|NCT03780634|Sorafenib|sorafenib|mesh-list
14911092|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911093|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
14911094|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911095|NCT01360424|Teriparatide|teriparatide|mesh-list
14911096|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911097|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911098|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14911099|NCT01360437|Ticagrelor|ticagrelor|mesh-list
14911100|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14911101|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14911102|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14911103|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14911104|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14911105|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
14911106|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911107|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911108|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911109|NCT01360463|Methadone|methadone|mesh-list
14911110|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14911111|NCT01360463|Narcotics|narcotics|mesh-ancestor
14911112|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911113|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911114|NCT01360463|Analgesics|analgesics|mesh-ancestor
14911115|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
14911116|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911117|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
14911118|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14911119|NCT01360476|Vitamin D|vitamin d|mesh-list
14911120|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
14911121|NCT01360476|Vitamins|vitamins|mesh-ancestor
14911122|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
14911123|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911124|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14911125|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911126|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
15198670|NCT03780634|Antibodies|antibodies|mesh-list
15198671|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
14701703|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14701704|NCT00400491|Vitamin D|vitamin d|mesh-list
14701705|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
14701706|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
14821804|NCT00900445|Prednisone|prednisone|mesh-list
14821805|NCT00900445|Prednisolone|prednisolone|mesh-list
14821806|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14821807|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
14821808|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14821809|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
14821810|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
14821811|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14821812|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14821813|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14821814|NCT00900445|Cortisone|cortisone|mesh-list
14821815|NCT00900445|Vincristine|vincristine|mesh-list
14821816|NCT00900445|Daunorubicin|daunorubicin|mesh-list
14821817|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14821818|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
14821819|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701707|NCT00400491|Vitamins|vitamins|mesh-list
14701708|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
14701709|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701710|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14701711|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14701712|NCT00400530|Alendronate|alendronate|mesh-list
14701713|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701714|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14701715|NCT00400556|Lenograstim|lenograstim|mesh-list
14701716|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14701717|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
14701718|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821820|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
14821821|NCT00900445|Hormones|hormones|mesh-ancestor
14821822|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821823|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821824|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14821825|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821826|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821827|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701719|NCT00400582|Candesartan|candesartan|mesh-list
14701720|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14701721|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14701722|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14701723|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701724|NCT00400595|Mupirocin|mupirocin|mesh-list
14701725|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701726|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701727|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14701728|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701729|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701730|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14701731|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14701732|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
14701733|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701734|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701735|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14701736|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
14701737|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
14701738|NCT00400608|Hormones|hormones|mesh-ancestor
14701739|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701740|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
14701741|NCT00400621|Acetaminophen|acetaminophen|mesh-list
14701742|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14701743|NCT00400621|Analgesics|analgesics|mesh-ancestor
14701744|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
14701745|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701746|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701747|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
14701748|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
14701749|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14821828|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701750|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821829|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
14821830|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821831|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
14821832|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
14821833|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821834|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14821835|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14821836|NCT00900445|Protective Agents|protective agents|mesh-ancestor
14821837|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14821838|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14821839|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14821840|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821841|NCT00900510|Trimethoprim|trimethoprim|mesh-list
14821842|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14821843|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
14821844|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14821845|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821846|NCT00900510|Renal Agents|renal agents|mesh-ancestor
14821847|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
14821848|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14821849|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14821850|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14821851|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821852|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821853|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14821854|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14821855|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14821856|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14294835|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821857|NCT00900744|Tamoxifen|tamoxifen|mesh-list
14821858|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14821859|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
14821860|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821861|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821862|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14821863|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821864|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14821865|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14821866|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14821867|NCT00900874|Albuterol|albuterol|mesh-list
14821868|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
14821869|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14821870|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
15198672|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
15198673|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198674|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198675|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15198676|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198677|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198678|NCT03780192|Sirolimus|sirolimus|mesh-list
15198679|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198680|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198681|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15198682|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198683|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
15198684|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198685|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
15198686|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198687|NCT03780569|Temozolomide|temozolomide|mesh-list
15198688|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15198689|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
15198690|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198691|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198692|NCT03780205|Methamphetamine|methamphetamine|mesh-list
15198693|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15198694|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198695|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
15198696|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
15198697|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198698|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
15198699|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821871|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821872|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821873|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14821874|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
14821875|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14821876|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14821877|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14821878|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14821879|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821880|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821881|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
14821882|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14821883|NCT00900887|Ketorolac|ketorolac|mesh-list
14821884|NCT00900887|Nepafenac|nepafenac|mesh-list
14821885|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14821886|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14821887|NCT00900887|Analgesics|analgesics|mesh-ancestor
14821888|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
14821889|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821890|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821891|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14821892|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821893|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14821894|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821895|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821896|NCT00900913|Ropivacaine|ropivacaine|mesh-list
14821897|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
14821898|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
14821899|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14821900|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821901|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
14821902|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821903|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14821904|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
14821905|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821906|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
14821907|NCT00901069|Rituximab|rituximab|mesh-list
14821908|NCT00901069|Vincristine|vincristine|mesh-list
14821909|NCT00901069|Azacitidine|azacitidine|mesh-list
14821910|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14821911|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
14821912|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821913|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14821914|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14821915|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
14821916|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821917|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821918|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14821919|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198700|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198701|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
15198702|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15198703|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15198704|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198705|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15198706|NCT03780361|Aflibercept|aflibercept|mesh-list
15198707|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15198708|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15198709|NCT03780361|Growth Substances|growth substances|mesh-ancestor
15198710|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198711|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
15198712|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821920|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14821921|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14821922|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14821923|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14821924|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14821925|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
14821926|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821927|NCT00901147|Bortezomib|bortezomib|mesh-list
14821928|NCT00901147|Panobinostat|panobinostat|mesh-list
14821929|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821930|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14821931|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821932|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821933|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
14821934|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
14821935|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14821936|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821937|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14821938|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14821939|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14821940|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
14821941|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14821942|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198713|NCT03780270|Fluorides|fluorides|mesh-list
15198714|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
15198715|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
15198716|NCT03780270|Protective Agents|protective agents|mesh-ancestor
14821943|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14821944|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
14821945|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
14821946|NCT00901368|Hormones|hormones|mesh-ancestor
14821947|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14821948|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
14821949|NCT00901381|Lenograstim|lenograstim|mesh-list
14821950|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14821951|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
14821952|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821953|NCT00901407|Lamotrigine|lamotrigine|mesh-list
14821954|NCT00901407|Paroxetine|paroxetine|mesh-list
15198717|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198718|NCT03780127|Fenfluramine|fenfluramine|mesh-list
15198719|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14821955|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14821956|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14821957|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14821958|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821959|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14821960|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
14821961|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821962|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14821963|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
14821964|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14821965|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14821966|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14821967|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821968|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
14821969|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14821970|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14821971|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14821972|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14821973|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198720|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15198721|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198722|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198723|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198724|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
15198725|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198726|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
15198727|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15198728|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198729|NCT03779776|Vitamins|vitamins|mesh-list
15198730|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
14821974|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14821975|NCT00901511|Molgramostim|molgramostim|mesh-list
14821976|NCT00901511|Sargramostim|sargramostim|mesh-list
14821977|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
14821978|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821979|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821980|NCT00901524|Interferons|interferons|mesh-list
14821981|NCT00901524|Ribavirin|ribavirin|mesh-list
14701751|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14701752|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
14701753|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701754|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701755|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701756|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701757|NCT00400725|Clobetasol|clobetasol|mesh-list
14701758|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701759|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
14701760|NCT00400725|Hormones|hormones|mesh-ancestor
14701761|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701762|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701763|NCT00400738|Ritonavir|ritonavir|mesh-list
14701764|NCT00400738|Lopinavir|lopinavir|mesh-list
14701765|NCT00400738|Saquinavir|saquinavir|mesh-list
14701766|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14701767|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14821982|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
14821983|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
14821984|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14821985|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821986|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
14821987|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14821988|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
14821989|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821990|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
14821991|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14821992|NCT00901537|Azacitidine|azacitidine|mesh-list
14821993|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14821994|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14821995|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
14821996|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14821997|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14821998|NCT00901550|Methotrexate|methotrexate|mesh-list
15198731|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198732|NCT03780049|Leucovorin|leucovorin|mesh-list
15198733|NCT03780049|Fluorouracil|fluorouracil|mesh-list
15198734|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
15198735|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
15198736|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198737|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15198738|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198739|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198740|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
15198741|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198742|NCT03780049|Antidotes|antidotes|mesh-ancestor
15198743|NCT03780049|Protective Agents|protective agents|mesh-ancestor
15198744|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
15198745|NCT03780049|Vitamins|vitamins|mesh-ancestor
14821999|NCT00901550|Infliximab|infliximab|mesh-list
14822000|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14822001|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
14822002|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14822003|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822004|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14822005|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
14822006|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822007|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822008|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14822009|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822010|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14822011|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822012|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
14822013|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822014|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14822015|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822016|NCT00901615|Lenalidomide|lenalidomide|mesh-list
14822017|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
14822018|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822019|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14822020|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14822021|NCT00901615|Growth Substances|growth substances|mesh-ancestor
14822022|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
14822023|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198746|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
15198747|NCT03780608|Durvalumab|durvalumab|mesh-list
15198748|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198749|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198750|NCT03779789|Vortioxetine|vortioxetine|mesh-list
14822024|NCT00901654|Vaccines|vaccines|mesh-list
14822025|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
14822026|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822027|NCT00901719|Nitroprusside|nitroprusside|mesh-list
14822028|NCT00901719|Acetylcholine|acetylcholine|mesh-list
14822029|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14822030|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
14822031|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14822032|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822033|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14822034|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
15198751|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
14822035|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198752|NCT03779789|Citalopram|citalopram|mesh-list
15198753|NCT03779789|Fluoxetine|fluoxetine|mesh-list
15198754|NCT03779789|Paroxetine|paroxetine|mesh-list
14822036|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822037|NCT00901732|Calcium|calcium|mesh-list
14822038|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14822039|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822040|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
14822041|NCT00901745|Giapreza|giapreza|mesh-list
14822042|NCT00901745|Norepinephrine|norepinephrine|mesh-list
14822043|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
14822044|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14822045|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14822046|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
14822047|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822048|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822049|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14822050|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14822051|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
14822052|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822053|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822054|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
14822055|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
14822056|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822057|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
14822058|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
15198755|NCT03779789|Sertraline|sertraline|mesh-list
15198756|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15198757|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15198758|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198759|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198760|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198761|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
15198762|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198763|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15198764|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
15198765|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15198766|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15198767|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15198768|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198769|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15198770|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14701768|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
14701769|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701770|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701771|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14701772|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14701773|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
14701774|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701775|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14701776|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14701777|NCT00400777|Amlodipine|amlodipine|mesh-list
14701778|NCT00400777|Valsartan|valsartan|mesh-list
14701779|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14701780|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14701781|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14701782|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14701783|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198771|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198772|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15198773|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15198774|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15198775|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15198776|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15198777|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15198778|NCT03779685|Anesthetics|anesthetics|mesh-list
15198779|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198780|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198781|NCT03779633|Estradiol|estradiol|mesh-list
15198782|NCT03779633|Estrogens|estrogens|mesh-ancestor
15198783|NCT03779633|Hormones|hormones|mesh-ancestor
15198784|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198785|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198786|NCT03779516|Lidocaine|lidocaine|mesh-list
15198787|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
15198788|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
15198789|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198790|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198791|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
15198792|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198793|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15198794|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15198795|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15198796|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15198797|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822059|NCT00901784|Topiramate|topiramate|mesh-list
14822060|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
14822061|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14822062|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822063|NCT00901823|Diazoxide|diazoxide|mesh-list
14822064|NCT00901823|Choline|choline|mesh-list
14822065|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
15198798|NCT03779451|Progesterone|progesterone|mesh-list
15198799|NCT03779451|Progestins|progestins|mesh-ancestor
14822066|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14822067|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
14822068|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822069|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822070|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14822071|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
14822072|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14822073|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
14822074|NCT00901849|Sirolimus|sirolimus|mesh-list
14822075|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14822076|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14822077|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822078|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14822079|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822080|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
14822081|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822082|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
14822083|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822084|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822085|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822086|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822087|NCT00901875|Buprenorphine|buprenorphine|mesh-list
14822088|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14822089|NCT00901875|Naloxone|naloxone|mesh-list
14822090|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14822091|NCT00901875|Narcotics|narcotics|mesh-ancestor
14822092|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822093|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822094|NCT00901875|Analgesics|analgesics|mesh-ancestor
14822095|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
14822096|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822097|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14911127|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14911128|NCT01360658|Antibodies|antibodies|mesh-list
14911129|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
14911130|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14911131|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
15198800|NCT03779451|Hormones|hormones|mesh-ancestor
15198801|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15198802|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198803|NCT03779594|Acetazolamide|acetazolamide|mesh-list
14822098|NCT00901888|Nitroprusside|nitroprusside|mesh-list
14822099|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14822100|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
14822101|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14822102|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822103|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14822104|NCT00902031|Sennosides|sennosides|mesh-list
14822105|NCT00902031|Senna Extract|senna extract|mesh-list
14822106|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
14822107|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822108|NCT00902031|Laxatives|laxatives|mesh-ancestor
14822109|NCT00902031|Cathartics|cathartics|mesh-ancestor
14822110|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14822111|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
14822112|NCT00902057|Coagulants|coagulants|mesh-ancestor
14822113|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14822114|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
14822115|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822116|NCT00902070|Rocuronium|rocuronium|mesh-list
14822117|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14822118|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14822119|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14822120|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822121|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822122|NCT00902135|Interferons|interferons|mesh-list
14822123|NCT00902135|Interferon-beta|interferon-beta|mesh-list
14822124|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
14822125|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822126|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
14822127|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822128|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
14822129|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822130|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14822131|NCT00902187|Fesoterodine|fesoterodine|mesh-list
14822132|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15198804|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
15198805|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15198806|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198807|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198808|NCT03779594|Diuretics|diuretics|mesh-ancestor
15198809|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
14701784|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14822133|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14822134|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
14822135|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822136|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198810|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198811|NCT03779464|Gemcitabine|gemcitabine|mesh-list
15198812|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15198813|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
15198814|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198815|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198816|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
15198817|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198818|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198819|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198820|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
15198821|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198822|NCT03779568|Bupivacaine|bupivacaine|mesh-list
15198823|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
15198824|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
15198825|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198826|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198827|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
14701785|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701786|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
14701787|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14701788|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14701789|NCT00400777|Diuretics|diuretics|mesh-ancestor
14701790|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
14822137|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822138|NCT00902187|Urological Agents|urological agents|mesh-ancestor
14822139|NCT00902395|Midazolam|midazolam|mesh-list
14822140|NCT00902395|Ketamine|ketamine|mesh-list
14822141|NCT00902395|Analgesics|analgesics|mesh-ancestor
14822142|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
14822143|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822144|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822145|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14822146|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14822147|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
14822148|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
14822149|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822150|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14822151|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14822152|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822153|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822154|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14822155|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14822156|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14822157|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14822158|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14822159|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
14822160|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
14822161|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14822162|NCT00902421|Serotonin|serotonin|mesh-list
14822163|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14822164|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14822165|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822166|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822167|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822168|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
14822169|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822170|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14822171|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14822172|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
14822173|NCT00902460|Midazolam|midazolam|mesh-list
14822174|NCT00902460|Tofacitinib|tofacitinib|mesh-list
14822175|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14822176|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14822177|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822178|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822179|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14822180|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14822181|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14822182|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14822183|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
14822184|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
14822185|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
14822186|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
14822187|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822188|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822189|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822190|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822191|NCT00902473|Topiramate|topiramate|mesh-list
14822192|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
14822193|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14822194|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822195|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
14822196|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
14822197|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14822198|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14822199|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822200|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822201|NCT00902512|Urological Agents|urological agents|mesh-ancestor
14701791|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14701792|NCT00400790|Propofol|propofol|mesh-list
14701793|NCT00400790|Desflurane|desflurane|mesh-list
14701794|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14701795|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701796|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701797|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14701798|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
14701799|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
14822202|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14822203|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
14701800|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14822204|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822205|NCT00902603|Iloprost|iloprost|mesh-list
14822206|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14822207|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
14822208|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15198828|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198829|NCT03779659|Anesthetics|anesthetics|mesh-list
15198830|NCT03779659|Benzocaine|benzocaine|mesh-list
15198831|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
15198832|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198833|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198834|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
15198835|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198836|NCT03779646|Bisoprolol|bisoprolol|mesh-list
15198837|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15198838|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
15198839|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
15198840|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198841|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198842|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15198843|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15198844|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15198845|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
15198846|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198847|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198848|NCT03779672|Memantine|memantine|mesh-list
15198849|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15198850|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15198851|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
15198852|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198853|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198854|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198855|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15198856|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15198857|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
15198858|NCT03779282|Ketamine|ketamine|mesh-list
15198859|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15198860|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198861|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198862|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15198863|NCT03779282|Analgesics|analgesics|mesh-ancestor
15198864|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
15198865|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198866|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15198867|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15198868|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15198869|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
14701801|NCT00400816|Temozolomide|temozolomide|mesh-list
14701802|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14701803|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
14701804|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701805|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701806|NCT00400855|Fluticasone|fluticasone|mesh-list
14701807|NCT00400855|Xhance|xhance|mesh-list
14701808|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701809|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14701810|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
14701811|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701812|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701813|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14701814|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
14701815|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
14701816|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14701817|NCT00400998|Fluticasone|fluticasone|mesh-list
14701818|NCT00400998|Xhance|xhance|mesh-list
14701819|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14701820|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14701821|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
14701822|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701823|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701824|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14822209|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
14822210|NCT00902655|Coagulants|coagulants|mesh-ancestor
14822211|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14822212|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
14822213|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822214|NCT00902681|Fesoterodine|fesoterodine|mesh-list
14822215|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14822216|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14822217|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
14822218|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822219|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822220|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822221|NCT00902681|Urological Agents|urological agents|mesh-ancestor
14822222|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
14822223|NCT00902707|Guaifenesin|guaifenesin|mesh-list
14822224|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14822225|NCT00902707|Expectorants|expectorants|mesh-ancestor
14822226|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
14822227|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14822228|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14822229|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
14822230|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822231|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822232|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822233|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
14822234|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14822235|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
14822236|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
14822237|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822238|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
14822239|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14822240|NCT00902772|Lorazepam|lorazepam|mesh-list
14822241|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
14822242|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
14822243|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
14822244|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822245|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822246|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822247|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14822248|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822249|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14822250|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14822251|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14822252|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
14822253|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
14822254|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822255|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822256|NCT00902811|Artesunate|artesunate|mesh-list
14822257|NCT00902811|Amodiaquine|amodiaquine|mesh-list
14822258|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
14701825|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
14701826|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
14701827|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14701828|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
14701829|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701830|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14701831|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701832|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701833|NCT00401115|Sirolimus|sirolimus|mesh-list
14701834|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14701835|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701836|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14701837|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701838|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
14701839|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701840|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
14701841|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701842|NCT00401128|Gemcitabine|gemcitabine|mesh-list
14701843|NCT00401128|Irinotecan|irinotecan|mesh-list
14701844|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14701845|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
14701846|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701847|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701848|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
14701849|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822259|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14822260|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14822261|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822262|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822263|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
14822264|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
14822265|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14822266|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
14822267|NCT00902837|Oxycodone|oxycodone|mesh-list
14822268|NCT00902837|Naloxone|naloxone|mesh-list
14822269|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14822270|NCT00902837|Narcotics|narcotics|mesh-ancestor
14822271|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822272|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822273|NCT00902837|Analgesics|analgesics|mesh-ancestor
14822274|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
14822275|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822276|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14822277|NCT00902915|Dexamethasone|dexamethasone|mesh-list
14822278|NCT00902915|Lenalidomide|lenalidomide|mesh-list
14822279|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822280|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
14822281|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
14822282|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822283|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822284|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822285|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
14822286|NCT00902915|Hormones|hormones|mesh-ancestor
14822287|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14822288|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14822289|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822290|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
14822291|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14822292|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14822293|NCT00902915|Growth Substances|growth substances|mesh-ancestor
14822294|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
14822295|NCT00902941|Rasagiline|rasagiline|mesh-list
14822296|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14822297|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822298|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822299|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14822300|NCT00902941|Protective Agents|protective agents|mesh-ancestor
14822301|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822302|NCT00902954|Letrozole|letrozole|mesh-list
14822303|NCT00902954|Anastrozole|anastrozole|mesh-list
14822304|NCT00902954|Exemestane|exemestane|mesh-list
14822305|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822306|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14822307|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14822308|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822309|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822310|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14822311|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
14822312|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14822313|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822314|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14822315|NCT00902967|Atorvastatin|atorvastatin|mesh-list
14822316|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14822317|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14822318|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
14822319|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822320|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14822321|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14822322|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822323|NCT00903045|Propiverine|propiverine|mesh-list
14822324|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
14822325|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
14822326|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822327|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822328|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14822329|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14822330|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
14822331|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822332|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822333|NCT00903045|Urological Agents|urological agents|mesh-ancestor
14822334|NCT00903084|Tenofovir|tenofovir|mesh-list
14822335|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
14822336|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822337|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14822338|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14822339|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822340|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822341|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14822342|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14822343|NCT00903188|Cyclosporine|cyclosporine|mesh-list
14822344|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
14822345|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
14822346|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14822347|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14822348|NCT00903188|Prednisolone|prednisolone|mesh-list
14822349|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
14822350|NCT00903188|Everolimus|everolimus|mesh-list
14822351|NCT00903188|Cyclosporins|cyclosporins|mesh-list
14822352|NCT00903188|Basiliximab|basiliximab|mesh-list
14822353|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14822354|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
14822355|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822356|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822357|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822358|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
14701850|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701851|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701852|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
14701853|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701854|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14701855|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14822359|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822360|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
15198870|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198871|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198872|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15198873|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15198874|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
15198875|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
15198876|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15198877|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15198878|NCT03779360|Clindamycin|clindamycin|mesh-list
15198879|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
14701856|NCT00401167|Memantine|memantine|mesh-list
14701857|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14701858|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14701859|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
14701860|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701861|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701862|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701863|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14701864|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14701865|NCT00401180|Docetaxel|docetaxel|mesh-list
14701866|NCT00401180|Temozolomide|temozolomide|mesh-list
14701867|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701868|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701869|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701870|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701871|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701872|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14701873|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
14701874|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
14701875|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14822361|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198880|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
14822362|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
14822363|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822364|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14822365|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822366|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822367|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
14822368|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
14822369|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822370|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822371|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
14822372|NCT00903188|Hormones|hormones|mesh-ancestor
14822373|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14822374|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14822375|NCT00903188|Protective Agents|protective agents|mesh-ancestor
14822376|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14822377|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14822378|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15198881|NCT03779360|Erythromycin|erythromycin|mesh-list
15198882|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
14822379|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
14822380|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14822381|NCT00903214|Riluzole|riluzole|mesh-list
14822382|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
14822383|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14822384|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14822385|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822386|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822387|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822388|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14822389|NCT00903214|Protective Agents|protective agents|mesh-ancestor
14822390|NCT00903227|Fluticasone|fluticasone|mesh-list
14822391|NCT00903227|Xhance|xhance|mesh-list
14822392|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822393|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14822394|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
14822395|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822396|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822397|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14822398|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
14822399|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
14822400|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14822401|NCT00903279|Retapamulin|retapamulin|mesh-list
14822402|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14822403|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822404|NCT00903292|Pemetrexed|pemetrexed|mesh-list
14822405|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14822406|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822407|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822408|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198883|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15198884|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
15198885|NCT03779360|Prednisolone|prednisolone|mesh-list
15198886|NCT03779360|Clobetasol|clobetasol|mesh-list
14822409|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14822410|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14822411|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822412|NCT00903656|Lapatinib|lapatinib|mesh-list
14822413|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822414|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822415|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822416|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822417|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14822418|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822419|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822420|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822421|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822422|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
14822423|NCT00903747|Prucalopride|prucalopride|mesh-list
14822424|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14822425|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198887|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15198888|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
15198889|NCT03779360|Hormones|hormones|mesh-ancestor
15198890|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14822426|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14822427|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14822428|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822429|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822430|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822431|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822432|NCT00903747|Laxatives|laxatives|mesh-ancestor
14822433|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822434|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14822435|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14822436|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
14822437|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822438|NCT00903825|Lidocaine|lidocaine|mesh-list
14822439|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
14822440|NCT00903825|Anesthetics|anesthetics|mesh-list
14822441|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822442|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822443|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
15198891|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198892|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15198893|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822444|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822445|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822446|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822447|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822448|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822449|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822450|NCT00903838|Pramipexole|pramipexole|mesh-list
14822451|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
14822452|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822453|NCT00903838|Protective Agents|protective agents|mesh-ancestor
14822454|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822455|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14701876|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14701877|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701878|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14701879|NCT00401206|Analgesics|analgesics|mesh-ancestor
14701880|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
14701881|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701882|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14701883|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14701884|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15198894|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15198895|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198896|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198897|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15198898|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198899|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822456|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14822457|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
14822458|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
14822459|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911132|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911133|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
14911134|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
14911135|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14911136|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14911137|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911138|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911139|NCT01360671|Urological Agents|urological agents|mesh-ancestor
14911140|NCT01360710|Irbesartan|irbesartan|mesh-list
14911141|NCT01360710|Moxonidine|moxonidine|mesh-list
14911142|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14911143|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14911144|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14911145|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911146|NCT01360749|Lidocaine|lidocaine|mesh-list
14911147|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
14911148|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
14911149|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911150|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911151|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
14911152|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822460|NCT00903851|Lidocaine|lidocaine|mesh-list
14822461|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822462|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
14822463|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822464|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822465|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
14822466|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822467|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822468|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822469|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822470|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822471|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822472|NCT00903942|Paclitaxel|paclitaxel|mesh-list
14822473|NCT00903942|Carboplatin|carboplatin|mesh-list
14822474|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14822475|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14822476|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822477|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
14822478|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
14822479|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
14822480|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822481|NCT00903994|Ketoprofen|ketoprofen|mesh-list
14822482|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14822483|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14822484|NCT00903994|Analgesics|analgesics|mesh-ancestor
14822485|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
14822486|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822487|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822488|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822489|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822490|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14822491|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822492|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822493|NCT00904020|Lidocaine|lidocaine|mesh-list
14822494|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822495|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
14822496|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198900|NCT03779347|Praziquantel|praziquantel|mesh-list
15198901|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
15198902|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15198903|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224476|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224477|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224478|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15224479|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15224480|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15224481|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701885|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
14701886|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701887|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701888|NCT00401219|Estrogens|estrogens|mesh-list
14701889|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14701890|NCT00401219|Progestins|progestins|mesh-list
14701891|NCT00401219|Hormones|hormones|mesh-ancestor
14701892|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14701893|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701894|NCT00401323|Docetaxel|docetaxel|mesh-list
14701895|NCT00401323|Fluorouracil|fluorouracil|mesh-list
14701896|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701897|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701898|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701899|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701900|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701901|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
14701902|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14701903|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822497|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822498|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
14822499|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822500|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822501|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822502|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822503|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822504|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822505|NCT00904059|Asunaprevir|asunaprevir|mesh-list
14822506|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
14822507|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822508|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822509|NCT00904085|Oxymorphone|oxymorphone|mesh-list
14822510|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14822511|NCT00904085|Narcotics|narcotics|mesh-ancestor
14822512|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822513|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822514|NCT00904085|Analgesics|analgesics|mesh-ancestor
14822515|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
14822516|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822517|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14822518|NCT00904098|Frovatriptan|frovatriptan|mesh-list
14822519|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14822520|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
14822521|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822522|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822523|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822524|NCT00904111|Lidocaine|lidocaine|mesh-list
14822525|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822526|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
14822527|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822528|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822529|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
14822530|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822531|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822532|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822533|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822534|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822535|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822536|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
14822537|NCT00904176|Digoxin|digoxin|mesh-list
14822538|NCT00904176|Warfarin|warfarin|mesh-list
14822539|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
14822540|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14822541|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822542|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14822543|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822544|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15198904|NCT03779178|Landiolol|landiolol|mesh-list
15198905|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15198906|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15198907|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
15198908|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198909|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822545|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14822546|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822547|NCT00904176|Protective Agents|protective agents|mesh-ancestor
14822548|NCT00904202|Lidocaine|lidocaine|mesh-list
14822549|NCT00904202|Gabapentin|gabapentin|mesh-list
14822550|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822551|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
14822552|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198910|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198911|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15198912|NCT03779035|Gemcitabine|gemcitabine|mesh-list
15198913|NCT03779035|Capecitabine|capecitabine|mesh-list
14294836|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14294837|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14294838|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14294839|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14294840|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14822553|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822554|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
14822555|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822556|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822557|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822558|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822559|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822560|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822561|NCT00904202|Analgesics|analgesics|mesh-ancestor
14822562|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
15198914|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15198915|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
15198916|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198917|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198918|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
15198919|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198920|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198921|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198922|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
15198923|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198924|NCT03779191|Bevacizumab|bevacizumab|mesh-list
15198925|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15198926|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198927|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15198928|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15198929|NCT03779191|Growth Substances|growth substances|mesh-ancestor
15198930|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198931|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
15198932|NCT03779087|Amoxicillin|amoxicillin|mesh-list
15198933|NCT03779087|Levofloxacin|levofloxacin|mesh-list
14822563|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14822564|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14822565|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14822566|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14822567|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14822568|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822569|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
14822570|NCT00904280|Oxymorphone|oxymorphone|mesh-list
14822571|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14822572|NCT00904280|Narcotics|narcotics|mesh-ancestor
14822573|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822574|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822575|NCT00904280|Analgesics|analgesics|mesh-ancestor
14822576|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
14294841|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14822577|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822578|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14822579|NCT00904293|Warfarin|warfarin|mesh-list
15198934|NCT03779087|Ofloxacin|ofloxacin|mesh-list
14822580|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
14822581|NCT00904306|Chromium|chromium|mesh-list
14822582|NCT00904306|Picolinic acid|picolinic acid|mesh-list
14822583|NCT00904306|Trace Elements|trace elements|mesh-ancestor
14822584|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
14822585|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822586|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14822587|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
14822588|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
14822589|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822590|NCT00904397|Celecoxib|celecoxib|mesh-list
14822591|NCT00904397|Lidocaine|lidocaine|mesh-list
14822592|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822593|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
14822594|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822595|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822596|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
14822597|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822598|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822599|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822600|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822601|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822602|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822603|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14822604|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14822605|NCT00904397|Analgesics|analgesics|mesh-ancestor
14822606|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822607|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822608|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14822609|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14822610|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822611|NCT00904436|Ipratropium|ipratropium|mesh-list
14822612|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14822613|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
14822614|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822615|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822616|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14822617|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
14822618|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14822619|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
15198935|NCT03779087|Tetracycline|tetracycline|mesh-list
14822620|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822621|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822622|NCT00904449|Oxymorphone|oxymorphone|mesh-list
14822623|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14822624|NCT00904449|Narcotics|narcotics|mesh-ancestor
14822625|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822626|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822627|NCT00904449|Analgesics|analgesics|mesh-ancestor
14822628|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
14822629|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822630|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14822631|NCT00904462|Lidocaine|lidocaine|mesh-list
14822632|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822633|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
14822634|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822635|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822636|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
14822637|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822638|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822639|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822640|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822641|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822642|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822643|NCT00904475|Lidocaine|lidocaine|mesh-list
14822644|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822645|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
14822646|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822647|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822648|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
14822649|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198936|NCT03779087|Esomeprazole|esomeprazole|mesh-list
15198937|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198938|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198939|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15198940|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15198941|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15198942|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198943|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198944|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15198945|NCT03779087|Renal Agents|renal agents|mesh-ancestor
15198946|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15198947|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15198948|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198949|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15198950|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14822650|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822651|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822652|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822653|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822654|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822655|NCT00904540|Lidocaine|lidocaine|mesh-list
14822656|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
14822657|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
14822658|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822659|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822660|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
14822661|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822662|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822663|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14822664|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822665|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822666|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198951|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15198952|NCT03779100|Lenvatinib|lenvatinib|mesh-list
15198953|NCT03779100|Antibodies|antibodies|mesh-list
15198954|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
15198955|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
14822667|NCT00904605|Celecoxib|celecoxib|mesh-list
14822668|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14701904|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
14701905|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822669|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14822670|NCT00904605|Analgesics|analgesics|mesh-ancestor
14822671|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
14822672|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822673|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822674|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822675|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822676|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14822677|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14822678|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822679|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822680|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
14822681|NCT00904631|Salicylates|salicylates|mesh-list
15198956|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701906|NCT00401362|Naltrexone|naltrexone|mesh-list
14701907|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
14701908|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14701909|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701910|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
14701911|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14701912|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14701913|NCT00401427|Trastuzumab|trastuzumab|mesh-list
14701914|NCT00401427|Vinorelbine|vinorelbine|mesh-list
14701915|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14701916|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701917|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14701918|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
14294842|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
14822682|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822683|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
14822684|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
14822685|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14822686|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14822687|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14822688|NCT00904631|Analgesics|analgesics|mesh-ancestor
14822689|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
14822690|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822691|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822692|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822693|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822694|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14822695|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822696|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822697|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
14822698|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14701919|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701920|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701921|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701922|NCT00401440|Misoprostol|misoprostol|mesh-list
14701923|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14701924|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
14701925|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14701926|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701927|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14701928|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14701929|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
14701930|NCT00401479|Solabegron|solabegron|mesh-list
14701931|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14701932|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14701933|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14701934|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
14701935|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701936|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701937|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822699|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14822700|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
14822701|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822702|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14822703|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14822704|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822705|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822706|NCT00904657|Sunitinib|sunitinib|mesh-list
14822707|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822708|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14822709|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14822710|NCT00904657|Growth Substances|growth substances|mesh-ancestor
14822711|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822712|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14822713|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822714|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822715|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822716|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
14822717|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14822718|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14822719|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822720|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
14822721|NCT00904709|Coagulants|coagulants|mesh-ancestor
14701938|NCT00401492|Gemcitabine|gemcitabine|mesh-list
14701939|NCT00401492|Vinorelbine|vinorelbine|mesh-list
14701940|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701941|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14701942|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
14701943|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701944|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
14822722|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
14822723|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
14822724|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822725|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822726|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822727|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701945|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701946|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822728|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
14822729|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14822730|NCT00904852|Bevacizumab|bevacizumab|mesh-list
14822731|NCT00904852|Temozolomide|temozolomide|mesh-list
14822732|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14822733|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822734|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14822735|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14822736|NCT00904852|Growth Substances|growth substances|mesh-ancestor
14822737|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822738|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
14822739|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14822740|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
14822741|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822742|NCT00904904|Ketorolac|ketorolac|mesh-list
14822743|NCT00904904|Indomethacin|indomethacin|mesh-list
14822744|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14822745|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14822746|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14822747|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14822748|NCT00904904|Analgesics|analgesics|mesh-ancestor
14822749|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
14822750|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822751|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822752|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822753|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822754|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14822755|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822756|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822757|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
14822758|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
14822759|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14822760|NCT00905047|Leucovorin|leucovorin|mesh-list
14701947|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701948|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
14701949|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701950|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14701951|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701952|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701953|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701954|NCT00401596|Omalizumab|omalizumab|mesh-list
14822761|NCT00905047|Folic Acid|folic acid|mesh-list
14822762|NCT00905047|Tegafur|tegafur|mesh-list
14822763|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
14822764|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14822765|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
14822766|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822767|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822768|NCT00905047|Antidotes|antidotes|mesh-ancestor
14822769|NCT00905047|Protective Agents|protective agents|mesh-ancestor
14822770|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822771|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
14822772|NCT00905047|Vitamins|vitamins|mesh-ancestor
14822773|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
14822774|NCT00905047|Hematinics|hematinics|mesh-ancestor
14822775|NCT00905073|Cyclosporine|cyclosporine|mesh-list
14822776|NCT00905073|Methotrexate|methotrexate|mesh-list
14822777|NCT00905073|Cyclosporins|cyclosporins|mesh-list
14822778|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14822779|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
14701955|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14822780|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14822781|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198957|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198958|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15198959|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198960|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294843|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
14701956|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14701957|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
14701958|NCT00401609|Gemcitabine|gemcitabine|mesh-list
14701959|NCT00401609|Carboplatin|carboplatin|mesh-list
14701960|NCT00401609|Etoposide|etoposide|mesh-list
14701961|NCT00401609|Vinorelbine|vinorelbine|mesh-list
14701962|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701963|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14701964|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
14701965|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701966|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
14701967|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14701968|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701969|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14701970|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
14701971|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701972|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14701973|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14701974|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14701975|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
14701976|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
14701977|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
14701978|NCT00401635|Carboplatin|carboplatin|mesh-list
14701979|NCT00401635|Doxorubicin|doxorubicin|mesh-list
14701980|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14701981|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14701982|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14701983|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14701984|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14701985|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14701986|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701987|NCT00401648|Brivaracetam|brivaracetam|mesh-list
14701988|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
14701989|NCT00401661|Alfuzosin|alfuzosin|mesh-list
14701990|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14701991|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14701992|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14701993|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
14701994|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14701995|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14701996|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14701997|NCT00401661|Urological Agents|urological agents|mesh-ancestor
14701998|NCT00401674|Paclitaxel|paclitaxel|mesh-list
14701999|NCT00401674|Carboplatin|carboplatin|mesh-list
14702000|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14702001|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702002|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14702003|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14702004|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14702005|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702006|NCT00401765|Docetaxel|docetaxel|mesh-list
14702007|NCT00401765|Siltuximab|siltuximab|mesh-list
14702008|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702009|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
14702010|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
14702011|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
14728537|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198961|NCT03778996|Sirolimus|sirolimus|mesh-list
15198962|NCT03778996|Phenytoin|phenytoin|mesh-list
15198963|NCT03778996|Methoxsalen|methoxsalen|mesh-list
15198964|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
15198965|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15198966|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15198967|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15198968|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15198969|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
15198970|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15198971|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
15198972|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198973|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
14822782|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14822783|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
14822784|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822785|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822786|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14822787|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822788|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14822789|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822790|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
14822791|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14822792|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14822793|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
14822794|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822795|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14822796|NCT00905190|Ondansetron|ondansetron|mesh-list
14822797|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
14822798|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
14822799|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14822800|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822801|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14822802|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
14822803|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
14822804|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14822805|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
14822806|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14822807|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822808|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14822809|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14822810|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14822811|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14822812|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14822813|NCT00905216|Heparin|heparin|mesh-list
14822814|NCT00905216|Calcium heparin|calcium heparin|mesh-list
14822815|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
14822816|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15198974|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15198975|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15198976|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822817|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14822818|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822819|NCT00905229|Vitamins|vitamins|mesh-list
14822820|NCT00905229|Vitamin K|vitamin k|mesh-list
14822821|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
14822822|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
14822823|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822824|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14822825|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14822826|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822827|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
14822828|NCT00905229|Coagulants|coagulants|mesh-ancestor
15198977|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198978|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15198979|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15198980|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15198981|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
15198982|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15198983|NCT03779048|Phentermine|phentermine|mesh-list
15198984|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15198985|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198986|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
14294844|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
14822829|NCT00905333|Felodipine|felodipine|mesh-list
14822830|NCT00905333|Candesartan|candesartan|mesh-list
14822831|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
14822832|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14822833|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14822834|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14822835|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822836|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822837|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14822838|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822839|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14822840|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822841|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
15198987|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15198988|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
15198989|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
15198990|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15198991|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
15198992|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15198993|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15198994|NCT03778723|Fentanyl|fentanyl|mesh-list
14822842|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14822843|NCT00905528|Telmisartan|telmisartan|mesh-list
14822844|NCT00905528|Ramipril|ramipril|mesh-list
14822845|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14822846|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14822847|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14822848|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822849|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14822850|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
14822851|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822852|NCT00905541|Simvastatin|simvastatin|mesh-list
14822853|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14822854|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14822855|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
14822856|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702012|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728538|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728539|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14728540|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14728541|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728542|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14728543|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
14728544|NCT00519012|Sertraline|sertraline|mesh-list
14728545|NCT00519012|Paroxetine|paroxetine|mesh-list
14728546|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
14822857|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15198995|NCT03778723|Anesthetics|anesthetics|mesh-list
14822858|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14822859|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822860|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14822861|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14822862|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822863|NCT00905723|Estradiol|estradiol|mesh-list
15198996|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15198997|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15198998|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15198999|NCT03778723|Narcotics|narcotics|mesh-ancestor
15199000|NCT03778723|Analgesics|analgesics|mesh-ancestor
15199001|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
15199002|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199003|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15199004|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14822864|NCT00905723|Estrogens|estrogens|mesh-ancestor
14822865|NCT00905723|Hormones|hormones|mesh-ancestor
14822866|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14822867|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822868|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
14822869|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
14822870|NCT00905762|Besifloxacin|besifloxacin|mesh-list
14822871|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14822872|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822873|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14822874|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14822875|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822876|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822877|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822878|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14822879|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14822880|NCT00905814|Axitinib|axitinib|mesh-list
14822881|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822882|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14822883|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822884|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911153|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14911154|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14911155|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14911156|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911157|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911158|NCT01360788|Albuterol|albuterol|mesh-list
14911159|NCT01360788|Ipratropium|ipratropium|mesh-list
14911160|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14911161|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
14702013|NCT00401804|Dexamethasone|dexamethasone|mesh-list
14702014|NCT00401804|Doxorubicin|doxorubicin|mesh-list
14702015|NCT00401804|Bortezomib|bortezomib|mesh-list
14702016|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702017|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
14702018|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
14702019|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702020|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702021|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702022|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
14702023|NCT00401804|Hormones|hormones|mesh-ancestor
14702024|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702025|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14702026|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702027|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14702028|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14911162|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911163|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911164|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14911165|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
14911166|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
14911167|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14911168|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15199005|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
14702029|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14702030|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199006|NCT03779061|Propofol|propofol|mesh-list
15199007|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199008|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199009|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199010|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15199011|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
15199012|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
15199013|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
14702031|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702032|NCT00401856|Eplerenone|eplerenone|mesh-list
14702033|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14702034|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
14702035|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702036|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702037|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14702038|NCT00401856|Diuretics|diuretics|mesh-ancestor
14702039|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
14702040|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14702041|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
14702042|NCT00401869|Hematinics|hematinics|mesh-ancestor
15199014|NCT03778619|Rituximab|rituximab|mesh-list
15199015|NCT03778619|Fludarabine|fludarabine|mesh-list
15199016|NCT03778619|Interleukin-2|interleukin-2|mesh-list
15199017|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702043|NCT00401921|Minocycline|minocycline|mesh-list
14702044|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14702045|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702046|NCT00402012|Pioglitazone|pioglitazone|mesh-list
14702047|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14702048|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702049|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
14702050|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14702051|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702052|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
14702053|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702054|NCT00402077|Pramlintide|pramlintide|mesh-list
14702055|NCT00402077|Phentermine|phentermine|mesh-list
14702056|NCT00402077|Sibutramine|sibutramine|mesh-list
14702057|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15199018|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
14702058|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702059|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14702060|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
14702061|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14702062|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
14702063|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
14702064|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702065|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
14702066|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702067|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702068|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
14702069|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14702070|NCT00402142|Vaccines|vaccines|mesh-list
14702071|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
14702072|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199019|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199020|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199021|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15199022|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
15199023|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702073|NCT00402181|Dexamethasone|dexamethasone|mesh-list
14702074|NCT00402181|Siltuximab|siltuximab|mesh-list
14702075|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702076|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
14702077|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
14822885|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14822886|NCT00905853|Amiodarone|amiodarone|mesh-list
14822887|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
14822888|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14822889|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14822890|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822891|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14822892|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14822893|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14822894|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822895|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14822896|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14822897|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14822898|NCT00905905|Simvastatin|simvastatin|mesh-list
14822899|NCT00905905|Ezetimibe|ezetimibe|mesh-list
14822900|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14822901|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14822902|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14822903|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
14822904|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822905|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14822906|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14822907|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822908|NCT00905918|Vitamin E|vitamin e|mesh-list
14822909|NCT00905918|Vitamins|vitamins|mesh-ancestor
14822910|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
14822911|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702078|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702079|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702080|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702081|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
14702082|NCT00402181|Hormones|hormones|mesh-ancestor
14822912|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
14822913|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822914|NCT00905918|Protective Agents|protective agents|mesh-ancestor
14822915|NCT00905931|Lycopene|lycopene|mesh-list
14822916|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822917|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
14822918|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822919|NCT00905931|Protective Agents|protective agents|mesh-ancestor
14822920|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822921|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14822922|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14822923|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822924|NCT00905983|Gemcitabine|gemcitabine|mesh-list
14822925|NCT00905983|Docetaxel|docetaxel|mesh-list
14822926|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14822927|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
14822928|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822929|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822930|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
14822931|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822932|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822933|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822934|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
14822935|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822936|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
14822937|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
14822938|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
14822939|NCT00905996|Propranolol|propranolol|mesh-list
14822940|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14822941|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14822942|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14822943|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199024|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702083|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14822944|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822945|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822946|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14822947|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14822948|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
14822949|NCT00906048|Levofloxacin|levofloxacin|mesh-list
14822950|NCT00906048|Ofloxacin|ofloxacin|mesh-list
14822951|NCT00906048|Rifampin|rifampin|mesh-list
14822952|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14822953|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14822954|NCT00906048|Renal Agents|renal agents|mesh-ancestor
14822955|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14822956|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14822957|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14822958|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822959|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822960|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822961|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14702084|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14702085|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702086|NCT00402207|Fluticasone|fluticasone|mesh-list
14702087|NCT00402207|Beclomethasone|beclomethasone|mesh-list
14702088|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14822962|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14702089|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14702090|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
14702091|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702092|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702093|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14822963|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14822964|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
14822965|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
14822966|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14822967|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14822968|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14822969|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14822970|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14822971|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14822972|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14822973|NCT00906061|Gemcitabine|gemcitabine|mesh-list
14822974|NCT00906061|Docetaxel|docetaxel|mesh-list
14822975|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14822976|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
14822977|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822978|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822979|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
14822980|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702094|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702095|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702096|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14822981|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14822982|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822983|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
14822984|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822985|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
14822986|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
14822987|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
14822988|NCT00906113|Melphalan|melphalan|mesh-list
14822989|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15199025|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15199026|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199027|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15199028|NCT03778619|Analgesics|analgesics|mesh-ancestor
15199029|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
15199030|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199031|NCT03778645|Epinephrine|epinephrine|mesh-list
15199032|NCT03778645|Racepinephrine|racepinephrine|mesh-list
15199033|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
15199034|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15199035|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14702097|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
14822990|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
14822991|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822992|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14822993|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14822994|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14822995|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
14702098|NCT00402207|Hormones|hormones|mesh-ancestor
14702099|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702100|NCT00402259|Esomeprazole|esomeprazole|mesh-list
14702101|NCT00402259|Omeprazole|omeprazole|mesh-list
14702102|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14702103|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702104|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14702105|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702106|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14822996|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14822997|NCT00906126|Misoprostol|misoprostol|mesh-list
14822998|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14822999|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
14823000|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14823001|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823002|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15199036|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
15199037|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823003|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823004|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
14823005|NCT00906139|Fentanyl|fentanyl|mesh-list
14823006|NCT00906139|Midazolam|midazolam|mesh-list
14823007|NCT00906139|Propofol|propofol|mesh-list
14823008|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14823009|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823010|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823011|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14823012|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
14823013|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
14823014|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14823015|NCT00906139|Narcotics|narcotics|mesh-ancestor
14823016|NCT00906139|Analgesics|analgesics|mesh-ancestor
14823017|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
14823018|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823019|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14823020|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14823021|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14823022|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14823023|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
14823024|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
14823025|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823026|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823027|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
14823028|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
14823029|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14823030|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14823031|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199038|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199039|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199040|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15199041|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15199042|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
15199043|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199044|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15199045|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
15199046|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
15199047|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
15199048|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15199049|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
15199050|NCT03778450|Analgesics|analgesics|mesh-list
15199051|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
14702107|NCT00402272|Everolimus|everolimus|mesh-list
14823032|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823033|NCT00906269|Urological Agents|urological agents|mesh-ancestor
14823034|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14823035|NCT00906360|Cetuximab|cetuximab|mesh-list
14823036|NCT00906360|Sunitinib|sunitinib|mesh-list
14823037|NCT00906360|Antibodies|antibodies|mesh-list
15199052|NCT03778450|Narcotics|narcotics|mesh-ancestor
15199053|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199054|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199055|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
15199056|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823038|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
14823039|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14823040|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
14823041|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823042|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823043|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14823044|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823045|NCT00906360|Growth Substances|growth substances|mesh-ancestor
14823046|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
14823047|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14823048|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823049|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823050|NCT00906386|Varenicline|varenicline|mesh-list
14823051|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14823052|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14823053|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
14823054|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823055|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823056|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823057|NCT00906451|Simvastatin|simvastatin|mesh-list
14823058|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14823059|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14823060|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
14823061|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823062|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14823063|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14823064|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823065|NCT00906516|Bevacizumab|bevacizumab|mesh-list
14823066|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823067|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823068|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14823069|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823070|NCT00906516|Growth Substances|growth substances|mesh-ancestor
14823071|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823072|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
14823073|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
14823074|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
14823075|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14823076|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823077|NCT00906594|Latanoprost|latanoprost|mesh-list
14823078|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14823079|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14823080|NCT00906685|Bevacizumab|bevacizumab|mesh-list
14823081|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823082|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823083|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14823084|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823085|NCT00906685|Growth Substances|growth substances|mesh-ancestor
14823086|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823087|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
14823088|NCT00906724|Insulin|insulin|mesh-list
14823089|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14823090|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823091|NCT00906828|Levodopa|levodopa|mesh-list
14823092|NCT00906828|Carbidopa|carbidopa|mesh-list
15199057|NCT03778359|Leuprolide|leuprolide|mesh-list
15199058|NCT03778359|Dienogest|dienogest|mesh-list
14823093|NCT00906828|Entacapone|entacapone|mesh-list
14823094|NCT00906828|Tolcapone|tolcapone|mesh-list
14823095|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14823096|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14823097|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
14823098|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823099|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199059|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
15199060|NCT03778359|Progestins|progestins|mesh-list
14823100|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823101|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14823102|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823103|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14823104|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
14823105|NCT00906867|Miotics|miotics|mesh-ancestor
14823106|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
14823107|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823108|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823109|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14823110|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14823111|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
14823112|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14823113|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14823114|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
14823115|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823116|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823117|NCT00906880|Eflornithine|eflornithine|mesh-list
14823118|NCT00906880|Nifurtimox|nifurtimox|mesh-list
14823119|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823120|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14823121|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14823122|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14823123|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823124|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14823125|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823126|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823127|NCT00907036|Cyclosporine|cyclosporine|mesh-list
14823128|NCT00907036|Fludarabine|fludarabine|mesh-list
14823129|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
14823130|NCT00907036|Melphalan|melphalan|mesh-list
14823131|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
14823132|NCT00907036|Cyclosporins|cyclosporins|mesh-list
14823133|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823134|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823135|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
14823136|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823137|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823138|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
14823139|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823140|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823141|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
14823142|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823143|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
14823144|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199061|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15199062|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
15199063|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199064|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199065|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15199066|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15199067|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15199068|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15199069|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
15199070|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15199071|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702108|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702109|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702110|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
14702111|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702112|NCT00402350|Fentanyl|fentanyl|mesh-list
14702113|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14702114|NCT00402350|Narcotics|narcotics|mesh-ancestor
14702115|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702116|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702117|NCT00402350|Analgesics|analgesics|mesh-ancestor
14702118|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
14702119|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702120|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14702121|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14702122|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
14702123|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
14702124|NCT00402376|Carvedilol|carvedilol|mesh-list
14702125|NCT00402376|Perindopril|perindopril|mesh-list
14702126|NCT00402376|Pravastatin|pravastatin|mesh-list
14702127|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15199072|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15199073|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15199074|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
15199075|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199076|NCT03778359|Hormones|hormones|mesh-ancestor
15199077|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
15199078|NCT03778502|Apixaban|apixaban|mesh-list
15199079|NCT03778502|Edoxaban|edoxaban|mesh-list
15199080|NCT03778502|Dabigatran|dabigatran|mesh-list
14823145|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14823146|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14823147|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
14823148|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14823149|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823150|NCT00907114|Ketorolac|ketorolac|mesh-list
14823151|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14823152|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14823153|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823154|NCT00907114|Analgesics|analgesics|mesh-ancestor
14823155|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
14823156|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823157|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823158|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823159|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823160|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14823161|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823162|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823163|NCT00907166|Gemcitabine|gemcitabine|mesh-list
14823164|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823165|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
14823166|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823167|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823168|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
14823169|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823170|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823171|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823172|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
14823173|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199081|NCT03778502|Anticoagulants|anticoagulants|mesh-list
15199082|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15199083|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
14823174|NCT00907179|Pemetrexed|pemetrexed|mesh-list
14823175|NCT00907179|Panobinostat|panobinostat|mesh-list
14823176|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823177|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823178|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823179|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14823180|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14823181|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14823182|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
14823183|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14823184|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823185|NCT00907270|Vitamins|vitamins|mesh-ancestor
14823186|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
14823187|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14823188|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14823189|NCT00907283|Deferiprone|deferiprone|mesh-list
14823190|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14823191|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
14823192|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
14823193|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823194|NCT00907400|Naproxen|naproxen|mesh-list
14823195|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14823196|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823197|NCT00907400|Analgesics|analgesics|mesh-ancestor
14823198|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
14823199|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823200|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823201|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823202|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823203|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
14823204|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14823205|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823206|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823207|NCT00907452|Thalidomide|thalidomide|mesh-list
14702128|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14702129|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
14702130|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702131|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702132|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702133|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14702134|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
14702135|NCT00402376|Protective Agents|protective agents|mesh-ancestor
14702136|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14702137|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14702138|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14702139|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
14702140|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14702141|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14702142|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14702143|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14702144|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
14702145|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14702146|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14702147|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702148|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14702149|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
14702150|NCT00402415|Sirolimus|sirolimus|mesh-list
14702151|NCT00402415|Sunitinib|sunitinib|mesh-list
14702152|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728547|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14823208|NCT00907452|Dexamethasone|dexamethasone|mesh-list
14823209|NCT00907452|Prednisone|prednisone|mesh-list
14823210|NCT00907452|Lenalidomide|lenalidomide|mesh-list
14823211|NCT00907452|Melphalan|melphalan|mesh-list
14823212|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823213|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
14823214|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
14823215|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823216|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823217|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823218|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
14823219|NCT00907452|Hormones|hormones|mesh-ancestor
14823220|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823221|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14823222|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823223|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
14823224|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14823225|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823226|NCT00907452|Growth Substances|growth substances|mesh-ancestor
14823227|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
14823228|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14823229|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
14823230|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823231|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14823232|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823233|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
14823234|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14823235|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823236|NCT00907504|Gemcitabine|gemcitabine|mesh-list
14823237|NCT00907504|Cisplatin|cisplatin|mesh-list
14823238|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823239|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823240|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
14823241|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199084|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15199085|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
15199086|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199087|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199088|NCT03778281|Baclofen|baclofen|mesh-list
14823242|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
14823243|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823244|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823245|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823246|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
14823247|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911169|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14911170|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14911171|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
14911172|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911173|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911174|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14911175|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
14911176|NCT01360827|Cisplatin|cisplatin|mesh-list
14911177|NCT01360827|Fluorouracil|fluorouracil|mesh-list
14911178|NCT01360827|Cetuximab|cetuximab|mesh-list
14911179|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911180|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
14911181|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911182|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14911183|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911184|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
14911185|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911186|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14911187|NCT01361022|Brotizolam|brotizolam|mesh-list
14911188|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14911189|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911190|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911191|NCT01361269|Clindamycin|clindamycin|mesh-list
14911192|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
14911193|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
14911194|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
14911195|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911196|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199089|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14911197|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14911198|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199090|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199091|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15199092|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199093|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15199094|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
15199095|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
15199096|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199097|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199098|NCT03778567|Lamivudine|lamivudine|mesh-list
15199099|NCT03778567|Telbivudine|telbivudine|mesh-list
15199100|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14823248|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
14823249|NCT00907608|Hematinics|hematinics|mesh-ancestor
14823250|NCT00907751|Rituximab|rituximab|mesh-list
14823251|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823252|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823253|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
14823254|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823255|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823256|NCT00907764|Regadenoson|regadenoson|mesh-list
14823257|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14823258|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14823259|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
14823260|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
14823261|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823262|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199101|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15199102|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199103|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199104|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
15199105|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199106|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15199107|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15199108|NCT03778541|Temozolomide|temozolomide|mesh-list
15199109|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15199110|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
15199111|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199112|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823263|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823264|NCT00907829|Lidocaine|lidocaine|mesh-list
14823265|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
14823266|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
14823267|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823268|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823269|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
14823270|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823271|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14823272|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14823273|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14823274|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14823275|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823276|NCT00907894|Telbivudine|telbivudine|mesh-list
14823277|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
14823278|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823279|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14823280|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199113|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
15199114|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
14702153|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702154|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14702155|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702156|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
14702157|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702158|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
14702159|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702160|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14702161|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823281|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823282|NCT00907972|Vitamin D|vitamin d|mesh-list
14823283|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
15199115|NCT03778580|Vitamins|vitamins|mesh-ancestor
14702162|NCT00402415|Growth Substances|growth substances|mesh-ancestor
14702163|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702164|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14702165|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702166|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702167|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
14702168|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14702169|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14702170|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702171|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14702172|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702173|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14702174|NCT00402454|Rifampin|rifampin|mesh-list
14702175|NCT00402454|Isoniazid|isoniazid|mesh-list
14702176|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
14702177|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14702178|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
14702179|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14702180|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702181|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
14702182|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14823284|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
14823285|NCT00907972|Vitamins|vitamins|mesh-list
14823286|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
14823287|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823288|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14823289|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14823290|NCT00907985|Lamotrigine|lamotrigine|mesh-list
14823291|NCT00907985|Vofopitant|vofopitant|mesh-list
14823292|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
14823293|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14823294|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14823295|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823296|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14823297|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823298|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14823299|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14823300|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823301|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14823302|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14823303|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
14823304|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
14823305|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823306|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823307|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14823308|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823309|NCT00908024|Cetuximab|cetuximab|mesh-list
14823310|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823311|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823312|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
14823313|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14823314|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14823315|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15199116|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
15199117|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199118|NCT03778372|Methadone|methadone|mesh-list
15199119|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15199120|NCT03778372|Narcotics|narcotics|mesh-ancestor
15199121|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199122|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199123|NCT03778372|Analgesics|analgesics|mesh-ancestor
14823316|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15199124|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
15199125|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823317|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823318|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
14823319|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823320|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823321|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14823322|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823323|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
14823324|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
14823325|NCT00908089|Prednisolone|prednisolone|mesh-list
14823326|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14823327|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
14823328|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14823329|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
14823330|NCT00908089|Infliximab|infliximab|mesh-list
14823331|NCT00908089|Naltrexone|naltrexone|mesh-list
14823332|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14823333|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
14823334|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823335|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
14823336|NCT00908089|Hormones|hormones|mesh-ancestor
14823337|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823338|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823339|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14823340|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823341|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
14702183|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702184|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702185|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14702186|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14702187|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14702188|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14823342|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
14823343|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823344|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823345|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14823346|NCT00908089|Protective Agents|protective agents|mesh-ancestor
14823347|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
14823348|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823349|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823350|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14823351|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823352|NCT00908089|Analgesics|analgesics|mesh-ancestor
14823353|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
14823354|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14823355|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14823356|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
14823357|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14823358|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14823359|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823360|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823361|NCT00908167|Cytarabine|cytarabine|mesh-list
14823362|NCT00908167|Clofarabine|clofarabine|mesh-list
14823363|NCT00908167|Sorafenib|sorafenib|mesh-list
14823364|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823365|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
14823366|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823367|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823368|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
14823369|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823370|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823371|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
14823372|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823373|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14823374|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823375|NCT00908180|Cytarabine|cytarabine|mesh-list
14823376|NCT00908180|Cyclosporine|cyclosporine|mesh-list
14823377|NCT00908180|Etoposide|etoposide|mesh-list
14823378|NCT00908180|Melphalan|melphalan|mesh-list
14823379|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
14823380|NCT00908180|Carmustine|carmustine|mesh-list
14823381|NCT00908180|Cyclosporins|cyclosporins|mesh-list
14823382|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14823383|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702189|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14823384|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14823385|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14823386|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199126|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
15199127|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
15199128|NCT03778593|Leucovorin|leucovorin|mesh-list
15199129|NCT03778593|Fluorouracil|fluorouracil|mesh-list
15199130|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
15199131|NCT03778593|Irinotecan|irinotecan|mesh-list
15199132|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
14294845|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294846|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294847|NCT00578227|Vaccines|vaccines|mesh-list
14294848|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
14294849|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702190|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14702191|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14702192|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14702193|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
14702194|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14702195|NCT00402467|Enoxaparin|enoxaparin|mesh-list
14702196|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
14702197|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
14702198|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14702199|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
14702200|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14823387|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823388|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823389|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
14823390|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
14823391|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823392|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823393|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
14823394|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823395|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
14823396|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
14823397|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823398|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14823399|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14823400|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
14823401|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14823402|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823403|NCT00908219|Bevacizumab|bevacizumab|mesh-list
14823404|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823405|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823406|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14823407|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823408|NCT00908219|Growth Substances|growth substances|mesh-ancestor
14823409|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823410|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
14823411|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
14823412|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14823413|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823414|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14823415|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823416|NCT00908297|Ubiquinone|ubiquinone|mesh-list
14823417|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
15199133|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199134|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15199135|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199136|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199137|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
15199138|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702201|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
15199139|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15199140|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14702202|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702203|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702204|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
14702205|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14702206|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14702207|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
14702208|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702209|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
14702210|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702211|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702212|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14702213|NCT00402493|Ibuprofen|ibuprofen|mesh-list
15199141|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199142|NCT03778593|Antidotes|antidotes|mesh-ancestor
15199143|NCT03778593|Protective Agents|protective agents|mesh-ancestor
15199144|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
14702214|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14702215|NCT00402493|Latanoprost|latanoprost|mesh-list
14702216|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14702217|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823418|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
14823419|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823420|NCT00908297|Vitamins|vitamins|mesh-ancestor
14823421|NCT00908323|Vaccines|vaccines|mesh-list
14823422|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
14823423|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823424|NCT00908336|Docetaxel|docetaxel|mesh-list
14823425|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14702218|NCT00402493|Analgesics|analgesics|mesh-ancestor
14702219|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
14702220|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702221|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702222|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702223|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702224|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14702225|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823426|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823427|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
14823428|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
14823429|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
14823430|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823431|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14823432|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823433|NCT00908362|Fluticasone|fluticasone|mesh-list
14823434|NCT00908362|Xhance|xhance|mesh-list
14823435|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14823436|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14823437|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823438|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14823439|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
14823440|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823441|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823442|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14823443|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
14823444|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
14823445|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14823446|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14823447|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14823448|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14823449|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
14823450|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823451|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823452|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
15199145|NCT03778593|Vitamins|vitamins|mesh-ancestor
15199146|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
15199147|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
14823453|NCT00908362|Hormones|hormones|mesh-ancestor
15199148|NCT03778008|Hydroxocobalamin|hydroxocobalamin|mesh-list
15199149|NCT03778008|Gentamicins|gentamicins|mesh-list
15199150|NCT03778008|Dexamethasone|dexamethasone|mesh-list
15199151|NCT03778008|Lidocaine|lidocaine|mesh-list
15199152|NCT03778008|Mitogens|mitogens|mesh-list
15199153|NCT03778008|Vitamins|vitamins|mesh-ancestor
14702226|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199154|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
15199155|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199156|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15199157|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
15199158|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
15199159|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199160|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15199161|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
15199162|NCT03778008|Hormones|hormones|mesh-ancestor
14702227|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14702228|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14702229|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15199163|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199164|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15199165|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199166|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
15199167|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
15199168|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199169|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
15199170|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15199171|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14294850|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
14702230|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14702231|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14702232|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14702233|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14702234|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702235|NCT00402506|Pyridoxal|pyridoxal|mesh-list
14702236|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
14702237|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
14702238|NCT00402506|Vitamins|vitamins|mesh-ancestor
14702239|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
14702240|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702241|NCT00402532|Everolimus|everolimus|mesh-list
14702242|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702243|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702244|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
14702245|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702246|NCT00402545|Docetaxel|docetaxel|mesh-list
14702247|NCT00402545|Fluorouracil|fluorouracil|mesh-list
14702248|NCT00402545|Cetuximab|cetuximab|mesh-list
14702249|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702250|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
14702251|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
14702252|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
14702253|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702254|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
14702255|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14702256|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702257|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
14702258|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702259|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14702260|NCT00402558|Aldesleukin|aldesleukin|mesh-list
14702261|NCT00402558|Methotrexate|methotrexate|mesh-list
14702262|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
15199172|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14702263|NCT00402558|Fludarabine|fludarabine|mesh-list
14702264|NCT00402558|Busulfan|busulfan|mesh-list
14702265|NCT00402558|Interleukin-2|interleukin-2|mesh-list
14702266|NCT00402558|Tacrolimus|tacrolimus|mesh-list
14702267|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
14702268|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14823454|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823455|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
14823456|NCT00908414|TMC-310911|tmc-310911|mesh-list
14823457|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
14823458|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823459|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823460|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
14823461|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
14823462|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14823463|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14823464|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823465|NCT00908531|Letrozole|letrozole|mesh-list
14823466|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823467|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14823468|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14823469|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823470|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823471|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14823472|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
14823473|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823474|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823475|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
14823476|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
14823477|NCT00908661|Coagulants|coagulants|mesh-ancestor
14823478|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
14823479|NCT00908674|Cyproterone|cyproterone|mesh-list
14823480|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
14823481|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
14823482|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823483|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823484|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823485|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14823486|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
14823487|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199173|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15199174|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702269|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14823488|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
14823489|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14823490|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15199175|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
15199176|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
15199177|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15199178|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199179|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15199180|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199181|NCT03778008|Hematinics|hematinics|mesh-ancestor
15199182|NCT03778242|Oxytocin|oxytocin|mesh-list
15199183|NCT03778242|Oxytocics|oxytocics|mesh-ancestor
15199184|NCT03778242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199185|NCT03778242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199186|NCT03778138|Pemetrexed|pemetrexed|mesh-list
15199187|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199188|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702270|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
14702271|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14702272|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702273|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14702274|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
14702275|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702276|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702277|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702278|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702279|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14702280|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702281|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
14702282|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702283|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14702284|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
14702285|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702286|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14823491|NCT00908713|Prednisolone|prednisolone|mesh-list
14823492|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
14823493|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14823494|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
14823495|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823496|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
14823497|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
14823498|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823499|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823500|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823501|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
14823502|NCT00908713|Hormones|hormones|mesh-ancestor
14823503|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823504|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14823505|NCT00908713|Protective Agents|protective agents|mesh-ancestor
14823506|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14823507|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823508|NCT00908726|Propofol|propofol|mesh-list
14823509|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14823510|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823511|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823512|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14823513|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
14823514|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
14823515|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
14823516|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14823517|NCT00908817|Triamcinolone|triamcinolone|mesh-list
14823518|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14823519|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14823520|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14823521|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14823522|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823523|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
14823524|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
14823525|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823526|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
14823527|NCT00908817|Hormones|hormones|mesh-ancestor
14823528|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823529|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823530|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823531|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
14823532|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823533|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823534|NCT00908869|Interferons|interferons|mesh-list
14823535|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
14823536|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
14823537|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
14823538|NCT00908869|Vinorelbine|vinorelbine|mesh-list
14702287|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
14702288|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14702289|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14702290|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702291|NCT00402558|Analgesics|analgesics|mesh-ancestor
14702292|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
14702293|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702294|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14702295|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14702296|NCT00402571|Acetaminophen|acetaminophen|mesh-list
14702297|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702298|NCT00402571|Analgesics|analgesics|mesh-ancestor
14702299|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
14702300|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702301|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702302|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
14702303|NCT00402584|Sibutramine|sibutramine|mesh-list
14702304|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14702305|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14702306|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
14702307|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14702308|NCT00402610|Rifampin|rifampin|mesh-list
14702309|NCT00402610|Isoniazid|isoniazid|mesh-list
14702310|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
14702311|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14823539|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823540|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
14823541|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823542|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823543|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14823544|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
14823545|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823546|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823547|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14823548|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
14823549|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823550|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14823551|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
14823552|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
14823553|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
14823554|NCT00908921|Glimepiride|glimepiride|mesh-list
14823555|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14823556|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14823557|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823558|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823559|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
14823560|NCT00908986|Rituximab|rituximab|mesh-list
14823561|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823562|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823563|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
14823564|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823565|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823566|NCT00909051|Acarbose|acarbose|mesh-list
14823567|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14823568|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823569|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823570|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14823571|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823572|NCT00909077|Dexamethasone|dexamethasone|mesh-list
14823573|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
14823574|NCT00909077|Rituximab|rituximab|mesh-list
14823575|NCT00909077|BB 1101|bb 1101|mesh-list
14823576|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823577|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
14823578|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
14823579|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823580|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823581|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823582|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
14823583|NCT00909077|Hormones|hormones|mesh-ancestor
14823584|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823585|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14823586|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823587|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
14823588|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823589|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823590|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823591|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
14823592|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823593|NCT00909129|Interferons|interferons|mesh-list
14823594|NCT00909129|Ribavirin|ribavirin|mesh-list
14823595|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
14823596|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14823597|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702312|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
14702313|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14702314|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702315|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
14702316|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14702317|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702318|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702319|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14702320|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14702321|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14702322|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14702323|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14702324|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14823598|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
14823599|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199189|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199190|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15199191|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15199192|NCT03777956|Lacosamide|lacosamide|mesh-list
15199193|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
15199194|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15199195|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15199196|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14702325|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14702326|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14702327|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
14702328|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14702329|NCT00402623|Quercetin|quercetin|mesh-list
14702330|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
14702331|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702332|NCT00402623|Protective Agents|protective agents|mesh-ancestor
14702333|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702334|NCT00402636|Sirolimus|sirolimus|mesh-list
14702335|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14702336|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702337|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14702338|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702339|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
14702340|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702341|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
14702342|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702343|NCT00402662|Everolimus|everolimus|mesh-list
14702344|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
14702345|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702346|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702347|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
14702348|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702349|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14702350|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702351|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702352|NCT00402766|Dexamethasone|dexamethasone|mesh-list
14702353|NCT00402766|Cisplatin|cisplatin|mesh-list
14702354|NCT00402766|Pemetrexed|pemetrexed|mesh-list
14702355|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
14702356|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702357|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702358|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
14702359|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
14702360|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702361|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702362|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702363|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
14702364|NCT00402766|Hormones|hormones|mesh-ancestor
14702365|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702366|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14702367|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702368|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702369|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14702370|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14702371|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14702372|NCT00402792|Acetaminophen|acetaminophen|mesh-list
14702373|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14702374|NCT00402792|Hydrocodone|hydrocodone|mesh-list
14702375|NCT00402792|Oxycodone|oxycodone|mesh-list
14702376|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702377|NCT00402792|Analgesics|analgesics|mesh-ancestor
14702378|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
14702379|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702380|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702381|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
14702382|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14702383|NCT00402792|Narcotics|narcotics|mesh-ancestor
14702384|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702385|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
14702386|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702387|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14823600|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
14823601|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199197|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199198|NCT03777878|Oxytocin|oxytocin|mesh-list
15199199|NCT03777878|Carbetocin|carbetocin|mesh-list
15199200|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
15199201|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199202|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199203|NCT03777813|Leucovorin|leucovorin|mesh-list
15199204|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
15199205|NCT03777813|Durvalumab|durvalumab|mesh-list
15199206|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
15199207|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199208|NCT03777813|Antidotes|antidotes|mesh-ancestor
15199209|NCT03777813|Protective Agents|protective agents|mesh-ancestor
15199210|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199211|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
15199212|NCT03777813|Vitamins|vitamins|mesh-ancestor
15199213|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
15199214|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199215|NCT03777930|Thalidomide|thalidomide|mesh-list
15199216|NCT03777930|Megestrol|megestrol|mesh-list
15199217|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
15199218|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199219|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
15199220|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199221|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
15199222|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15199223|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199224|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15199225|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15199226|NCT03777930|Growth Substances|growth substances|mesh-ancestor
15199227|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
15199228|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199229|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15199230|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15199231|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15199232|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
15199233|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199234|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15199235|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15199236|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15199237|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
15199238|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14823602|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
14823603|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823604|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
14823605|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14823606|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823607|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
14823608|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823609|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823610|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14823611|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
14823612|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14823613|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14823614|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823615|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823616|NCT00909233|Urological Agents|urological agents|mesh-ancestor
14823617|NCT00909311|Ritonavir|ritonavir|mesh-list
14823618|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14823619|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14823620|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
14823621|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823622|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823623|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14823624|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14823625|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
14823626|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823627|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14823628|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15199239|NCT03777579|Paclitaxel|paclitaxel|mesh-list
14823629|NCT00909337|Bosentan|bosentan|mesh-list
15199240|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15199241|NCT03777579|Antibodies|antibodies|mesh-list
15199242|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
15199243|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15199244|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199245|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
15199246|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
15199247|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
15199248|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199249|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
15199250|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199251|NCT03777696|Misoprostol|misoprostol|mesh-list
15199252|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15199253|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
15199254|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199255|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199256|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15199257|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15199258|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
14702388|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823630|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14823631|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14823632|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823633|NCT00909402|Capecitabine|capecitabine|mesh-list
14823634|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823635|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823636|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
14823637|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823638|NCT00909454|Vitamin D|vitamin d|mesh-list
14823639|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
14823640|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
14823641|NCT00909454|Vitamins|vitamins|mesh-list
14823642|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
14823643|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823644|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14823645|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14823646|NCT00909506|Metformin|metformin|mesh-list
14823647|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14823648|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702389|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702390|NCT00402909|Nateglinide|nateglinide|mesh-list
14702391|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14911199|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911200|NCT01361373|Levodopa|levodopa|mesh-list
14911201|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14911202|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14911203|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
14911204|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911205|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911206|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911207|NCT01361399|Aspirin|aspirin|mesh-list
14911208|NCT01361399|Lidocaine|lidocaine|mesh-list
14911209|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
14911210|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
14911211|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911212|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911213|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
15199259|NCT03777423|Cobalt|cobalt|mesh-list
15199260|NCT03777423|Chromium|chromium|mesh-list
15199261|NCT03777423|Trace Elements|trace elements|mesh-ancestor
15199262|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
15199263|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199264|NCT03777787|Denatonium|denatonium|mesh-list
15199265|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
15199266|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199267|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
14702392|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702393|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
14702394|NCT00402974|Vitamin K|vitamin k|mesh-list
14702395|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
14702396|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14702397|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14702398|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702399|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
14702400|NCT00402974|Coagulants|coagulants|mesh-ancestor
14911214|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199268|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702401|NCT00402974|Vitamins|vitamins|mesh-ancestor
15199269|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
14823649|NCT00909519|Naproxen|naproxen|mesh-list
14823650|NCT00909519|Furosemide|furosemide|mesh-list
14823651|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14823652|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14823653|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823654|NCT00909519|Analgesics|analgesics|mesh-ancestor
14823655|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
14823656|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823657|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823658|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823659|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823660|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
14823661|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14823662|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823663|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823664|NCT00909519|Diuretics|diuretics|mesh-ancestor
14823665|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
15199270|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199271|NCT03777644|Morphine|morphine|mesh-list
15199272|NCT03777644|Ropivacaine|ropivacaine|mesh-list
15199273|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15199274|NCT03777644|Narcotics|narcotics|mesh-ancestor
14823666|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14823667|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14823668|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14823669|NCT00909571|Tacrolimus|tacrolimus|mesh-list
14823670|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823671|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
14823672|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823673|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14823674|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823675|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823676|NCT00909688|BLI-489|bli-489|mesh-list
14823677|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14823678|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823679|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823680|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14823681|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823682|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
14823683|NCT00909831|Sirolimus|sirolimus|mesh-list
14823684|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
14823685|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14823686|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14823687|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823688|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823689|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823690|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823691|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14823692|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14823693|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823694|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
14823695|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823696|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
14823697|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823698|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
14823699|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14823700|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14823701|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823702|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
14823703|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823704|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823705|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
14823706|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14702402|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
14702403|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702404|NCT00403000|Dutasteride|dutasteride|mesh-list
14702405|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14702406|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14702407|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702408|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199275|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702409|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
14702410|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199276|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823707|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702411|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702412|NCT00403013|Anesthetics|anesthetics|mesh-list
14823708|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823709|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823710|NCT00909935|Analgesics|analgesics|mesh-ancestor
14823711|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
14823712|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823713|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14823714|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14823715|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14823716|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
14823717|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823718|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823719|NCT00909948|Fludarabine|fludarabine|mesh-list
14823720|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823721|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
14823722|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14823723|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823724|NCT00909974|Micronutrients|micronutrients|mesh-list
14823725|NCT00909974|Trace Elements|trace elements|mesh-list
14823726|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823727|NCT00909987|Bevacizumab|bevacizumab|mesh-list
14823728|NCT00909987|Capecitabine|capecitabine|mesh-list
14823729|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
14823730|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823731|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823732|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14823733|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823734|NCT00909987|Growth Substances|growth substances|mesh-ancestor
14823735|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823736|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
14823737|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823738|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
14823739|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823740|NCT00910013|Ropivacaine|ropivacaine|mesh-list
14823741|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
14823742|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
14823743|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823744|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823745|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
14823746|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823747|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14823748|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
14823749|NCT00910052|Coagulants|coagulants|mesh-ancestor
14823750|NCT00910065|Aspirin|aspirin|mesh-list
14823751|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
14823752|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14823753|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823754|NCT00910065|Analgesics|analgesics|mesh-ancestor
14823755|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
14823756|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823757|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823758|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702413|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702414|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702415|NCT00403026|Bevacizumab|bevacizumab|mesh-list
14823759|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823760|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14823761|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14702416|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14702417|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702418|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14702419|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14702420|NCT00403026|Growth Substances|growth substances|mesh-ancestor
14702421|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702422|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702423|NCT00403039|Ranibizumab|ranibizumab|mesh-list
14702424|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14702425|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823762|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702426|NCT00403039|Growth Substances|growth substances|mesh-ancestor
14823763|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14823764|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14823765|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823766|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
14823767|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
14823768|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823769|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14823770|NCT00910195|Acetaminophen|acetaminophen|mesh-list
14823771|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14823772|NCT00910195|Analgesics|analgesics|mesh-ancestor
14823773|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
14823774|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199277|NCT03777644|Analgesics|analgesics|mesh-ancestor
15199278|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
15199279|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199280|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
15199281|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
15199282|NCT03777657|Capecitabine|capecitabine|mesh-list
15199283|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
14823775|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823776|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
14823777|NCT00910221|Atorvastatin|atorvastatin|mesh-list
14823778|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14823779|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14823780|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
14823781|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823782|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15199284|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702427|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702428|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702429|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702430|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
14702431|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14702432|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
14702433|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702434|NCT00403065|Dexamethasone|dexamethasone|mesh-list
14702435|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702436|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
14702437|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
14823783|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14823784|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823785|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
14823786|NCT00910234|Hematinics|hematinics|mesh-ancestor
14823787|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
14823788|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14823789|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823790|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14823791|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14823792|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823793|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823794|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823795|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14823796|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14823797|NCT00910390|Ethylene|ethylene|mesh-list
14823798|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14823799|NCT00910390|Growth Substances|growth substances|mesh-ancestor
14823800|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823801|NCT00910416|Remifentanil|remifentanil|mesh-list
14823802|NCT00910416|Propofol|propofol|mesh-list
14823803|NCT00910416|Sevoflurane|sevoflurane|mesh-list
14823804|NCT00910416|Atracurium|atracurium|mesh-list
14823805|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14823806|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823807|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823808|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14823809|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
14823810|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
14823811|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14823812|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14823813|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14823814|NCT00910416|Narcotics|narcotics|mesh-ancestor
14823815|NCT00910416|Analgesics|analgesics|mesh-ancestor
14823816|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
14823817|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823818|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14823819|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15199285|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15199286|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
14823820|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14823821|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14823822|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14823823|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
14823824|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823825|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823826|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
14823827|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14823828|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
14823829|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823830|NCT00910442|Expectorants|expectorants|mesh-ancestor
14823831|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14823832|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14823833|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
14823834|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823835|NCT00910442|Protective Agents|protective agents|mesh-ancestor
14823836|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823837|NCT00910442|Antidotes|antidotes|mesh-ancestor
14823838|NCT00910455|SRX246|srx246|mesh-list
14823839|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14823840|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823841|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
14823842|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823843|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
14823844|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14823845|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823846|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
14823847|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
14823848|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14823849|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
14823850|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823851|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823852|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823853|NCT00910637|Gestodene|gestodene|mesh-list
14823854|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14823855|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14823856|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15199287|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199288|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
15199289|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
15224482|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823857|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
14823858|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14823859|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823860|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14823861|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14823862|NCT00910637|Progestins|progestins|mesh-ancestor
14823863|NCT00910637|Hormones|hormones|mesh-ancestor
14823864|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823865|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14823866|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823867|NCT00910741|Gemcitabine|gemcitabine|mesh-list
14823868|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823869|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
14823870|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823871|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823872|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
14823873|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823874|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823875|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823876|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
14823877|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823878|NCT00910754|Prednisone|prednisone|mesh-list
14823879|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
14823880|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823881|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
14823882|NCT00910754|Hormones|hormones|mesh-ancestor
14823883|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823884|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224483|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
15224484|NCT03615664|Gemcitabine|gemcitabine|mesh-list
15224485|NCT03615664|Dexamethasone|dexamethasone|mesh-list
15224486|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14823885|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14823886|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823887|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14823888|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199290|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
15199291|NCT03777761|Tucatinib|tucatinib|mesh-list
15199292|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15199293|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199294|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15199295|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15199296|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199297|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199298|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199299|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15199300|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
15199301|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14823889|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823890|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
14823891|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14823892|NCT00910767|Insulin|insulin|mesh-list
14823893|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14823894|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823895|NCT00910780|Olanzapine|olanzapine|mesh-list
14823896|NCT00910780|Aripiprazole|aripiprazole|mesh-list
14823897|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
14823898|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14823899|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14823900|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14823901|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823902|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823903|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
14823904|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
14823905|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14823906|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823907|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14823908|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14823909|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
14823910|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14823911|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14823912|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14823913|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14823914|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
14823915|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
14823916|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823917|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823918|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14823919|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14823920|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14823921|NCT00910806|Nevirapine|nevirapine|mesh-list
15199302|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15199303|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199304|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
15199305|NCT03777488|Coagulants|coagulants|mesh-ancestor
15199306|NCT03777514|Ascorbic Acid|ascorbic acid|mesh-list
15199307|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15199308|NCT03777514|Vitamins|vitamins|mesh-ancestor
15199309|NCT03777514|Micronutrients|micronutrients|mesh-ancestor
15199310|NCT03777514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199311|NCT03777514|Antioxidants|antioxidants|mesh-ancestor
14294851|NCT00578292|Busulfan|busulfan|mesh-list
14294852|NCT00578292|Fludarabine|fludarabine|mesh-list
14823922|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14823923|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14823924|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823925|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199312|NCT03777514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294853|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
14294854|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294855|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
14294856|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294857|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294858|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14294859|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
14294860|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823926|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
14823927|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823928|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14823929|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14823930|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14823931|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14823932|NCT00910897|Thalidomide|thalidomide|mesh-list
14823933|NCT00910897|Dexamethasone|dexamethasone|mesh-list
14823934|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
14823935|NCT00910897|Bortezomib|bortezomib|mesh-list
14823936|NCT00910897|BB 1101|bb 1101|mesh-list
14823937|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14823938|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
14823939|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
14823940|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823941|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823942|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14823943|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
14823944|NCT00910897|Hormones|hormones|mesh-ancestor
15199313|NCT03777514|Protective Agents|protective agents|mesh-ancestor
15199314|NCT03777514|Hematinics|hematinics|mesh-ancestor
15199315|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15199316|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15199317|NCT03777085|Rituximab|rituximab|mesh-list
15199318|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199319|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199320|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
15199321|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199322|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199323|NCT03777124|Carboplatin|carboplatin|mesh-list
15199324|NCT03777124|Pemetrexed|pemetrexed|mesh-list
15199325|NCT03777124|Apatinib|apatinib|mesh-list
15199326|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199327|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199328|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199329|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15199330|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15199331|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15199332|NCT03777280|Cobalt|cobalt|mesh-list
15199333|NCT03777280|Chromium|chromium|mesh-list
15199334|NCT03777280|Trace Elements|trace elements|mesh-ancestor
15199335|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
15199336|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199337|NCT03777163|Vaccines|vaccines|mesh-list
15199338|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
15199339|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199340|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
15199341|NCT03777033|Calcium|calcium|mesh-list
15199342|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15199343|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199344|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15199345|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
15199346|NCT03776851|Hematinics|hematinics|mesh-ancestor
15199347|NCT03776916|Simethicone|simethicone|mesh-list
15199348|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
15199349|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199350|NCT03776916|Emollients|emollients|mesh-ancestor
15199351|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
15199352|NCT03776838|Fentanyl|fentanyl|mesh-list
15199353|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15199354|NCT03776838|Narcotics|narcotics|mesh-ancestor
15199355|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14823945|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14823946|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15199356|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199357|NCT03776838|Analgesics|analgesics|mesh-ancestor
14823947|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199358|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
15199359|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199360|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15199361|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15199362|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
14823948|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
14823949|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823950|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823951|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823952|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
14823953|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
14823954|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14823955|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823956|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14823957|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14823958|NCT00910897|Growth Substances|growth substances|mesh-ancestor
14823959|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14823960|NCT00910975|Interferons|interferons|mesh-list
14823961|NCT00910975|Ribavirin|ribavirin|mesh-list
14823962|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
14294861|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294862|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294863|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294864|NCT00578305|Folic Acid|folic acid|mesh-list
14823963|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
14294865|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
14294866|NCT00578305|Rituximab|rituximab|mesh-list
14294867|NCT00578305|Methotrexate|methotrexate|mesh-list
14294868|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294869|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294870|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
14294871|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294872|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294873|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14294874|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
14702438|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14823964|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14823965|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823966|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
14823967|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14823968|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
14823969|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702439|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823970|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
14823971|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823972|NCT00911066|Azacitidine|azacitidine|mesh-list
14823973|NCT00911066|Pevonedistat|pevonedistat|mesh-list
14823974|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823975|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
14823976|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823977|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823978|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14823979|NCT00911092|Fluorouracil|fluorouracil|mesh-list
14823980|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14823981|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
14823982|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14823983|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14823984|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199363|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
14702440|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702441|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
14702442|NCT00403065|Hormones|hormones|mesh-ancestor
14702443|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702444|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14702445|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702446|NCT00403156|Ranibizumab|ranibizumab|mesh-list
14702447|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
14702448|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14702449|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14702450|NCT00403156|Growth Substances|growth substances|mesh-ancestor
14702451|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702452|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702453|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702454|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14823985|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
14823986|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14823987|NCT00911183|Prednisone|prednisone|mesh-list
14823988|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
14823989|NCT00911183|Rituximab|rituximab|mesh-list
14823990|NCT00911183|Doxorubicin|doxorubicin|mesh-list
14823991|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14823992|NCT00911183|Vincristine|vincristine|mesh-list
14823993|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14823994|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
14823995|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702455|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702456|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702457|NCT00403182|Letrozole|letrozole|mesh-list
14823996|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14823997|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14823998|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
14823999|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824000|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824001|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14824002|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14824003|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14824004|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14824005|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14824006|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824007|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14824008|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
14824009|NCT00911183|Hormones|hormones|mesh-ancestor
14824010|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824011|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14824012|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14824013|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824014|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14824015|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14824016|NCT00911235|Fluconazole|fluconazole|mesh-list
14824017|NCT00911235|Fesoterodine|fesoterodine|mesh-list
14824018|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
14824019|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824020|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14824021|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14824022|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824023|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824024|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14824025|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
14824026|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824027|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824028|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14824029|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14824030|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14824031|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14824032|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
14824033|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199364|NCT03777345|Cobalt|cobalt|mesh-list
15199365|NCT03777345|Chromium|chromium|mesh-list
15199366|NCT03777345|Trace Elements|trace elements|mesh-ancestor
15199367|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
15199368|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199369|NCT03776955|Carvedilol|carvedilol|mesh-list
15199370|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15199371|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15199372|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
14702458|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824034|NCT00911235|Urological Agents|urological agents|mesh-ancestor
14824035|NCT00911261|Oxymorphone|oxymorphone|mesh-list
14824036|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14824037|NCT00911261|Narcotics|narcotics|mesh-ancestor
14824038|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199373|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199374|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702459|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14702460|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14702461|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702462|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199375|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702463|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14702464|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
14702465|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702466|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702467|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
14702468|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
14702469|NCT00403247|Pyridoxine|pyridoxine|mesh-list
14702470|NCT00403247|Vitamins|vitamins|mesh-ancestor
14702471|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
14702472|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702473|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
14702474|NCT00403247|Hematinics|hematinics|mesh-ancestor
14702475|NCT00403286|Fluticasone|fluticasone|mesh-list
14702476|NCT00403286|Xhance|xhance|mesh-list
14702477|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
14702478|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14702479|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702480|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14702481|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
14824039|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824040|NCT00911261|Analgesics|analgesics|mesh-ancestor
14824041|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
14824042|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824043|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14824044|NCT00911287|Oxymorphone|oxymorphone|mesh-list
14824045|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14824046|NCT00911287|Narcotics|narcotics|mesh-ancestor
14824047|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824048|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824049|NCT00911287|Analgesics|analgesics|mesh-ancestor
14824050|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
14824051|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824052|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14824053|NCT00911313|Metformin|metformin|mesh-list
14824054|NCT00911313|Letrozole|letrozole|mesh-list
14824055|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14824056|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824057|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824058|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14824059|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14824060|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824061|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824062|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14824063|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
14824064|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824065|NCT00911339|Atorvastatin|atorvastatin|mesh-list
14824066|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14824067|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14824068|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
14824069|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824070|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14824071|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14824072|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911215|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14911216|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14911217|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14911218|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911219|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199376|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15199377|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
15199378|NCT03776955|Protective Agents|protective agents|mesh-ancestor
15199379|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15199380|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15199381|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15199382|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
15199383|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15199384|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15199385|NCT03776656|Allopurinol|allopurinol|mesh-list
15199386|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
15199387|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199388|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199389|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
15199390|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199391|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15199392|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
14294875|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14294876|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15199393|NCT03776656|Protective Agents|protective agents|mesh-ancestor
15199394|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199395|NCT03776994|Vaccines|vaccines|mesh-list
15199396|NCT03776994|Immunologic Factors|immunologic factors|mesh-ancestor
15199397|NCT03776994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199398|NCT03776409|Vancomycin|vancomycin|mesh-list
15199399|NCT03776409|Tazobactam|tazobactam|mesh-list
15199400|NCT03776409|Piperacillin|piperacillin|mesh-list
14294877|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
14294878|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294879|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14294880|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294881|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14294882|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294883|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14294884|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294885|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
14294886|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
14294887|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294888|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14294889|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
14294890|NCT00578305|Hormones|hormones|mesh-ancestor
14294891|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14294892|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14294893|NCT00578305|Protective Agents|protective agents|mesh-ancestor
14294894|NCT00578305|Hematinics|hematinics|mesh-ancestor
14294895|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
14294896|NCT00578305|Vitamins|vitamins|mesh-ancestor
14294897|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
14824073|NCT00911521|Vaccines|vaccines|mesh-list
14824074|NCT00911521|Immunologic Factors|immunologic factors|mesh-ancestor
14824075|NCT00911521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824076|NCT00911573|Vancomycin|vancomycin|mesh-list
14824077|NCT00911573|Clindamycin|clindamycin|mesh-list
14824078|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
14824079|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
14824080|NCT00911573|Tigecycline|tigecycline|mesh-list
14824081|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14824082|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824083|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14824084|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824085|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824086|NCT00911651|Bromides|bromides|mesh-list
14824087|NCT00911651|Albuterol|albuterol|mesh-list
14824088|NCT00911651|Ipratropium|ipratropium|mesh-list
14824089|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
14824090|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14824091|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
14824092|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824093|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824094|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824095|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824096|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
14824097|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199401|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15199402|NCT03776409|Lactams|lactams|mesh-list
15199403|NCT03776409|beta-Lactams|beta-lactams|mesh-list
15199404|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15199405|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199406|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15199407|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199408|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199409|NCT03776448|Charcoal|charcoal|mesh-list
15199410|NCT03776448|Antidotes|antidotes|mesh-ancestor
15199411|NCT03776448|Protective Agents|protective agents|mesh-ancestor
14824098|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14824099|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14824100|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14824101|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
15199412|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294898|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14824102|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199413|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14824103|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824104|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14824105|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
14824106|NCT00911664|Vitamin D|vitamin d|mesh-list
14824107|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
14824108|NCT00911664|Vitamins|vitamins|mesh-list
14824109|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
14824110|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199414|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199415|NCT03776487|Fluorouracil|fluorouracil|mesh-list
14824111|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14824112|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14824113|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
14824114|NCT00911716|Bevacizumab|bevacizumab|mesh-list
14824115|NCT00911716|Docetaxel|docetaxel|mesh-list
14824116|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14824117|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
14824118|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824119|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14824120|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14824121|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
14824122|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824123|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824124|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14824125|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14824126|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14824127|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14824128|NCT00911716|Growth Substances|growth substances|mesh-ancestor
14824129|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
14824130|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824131|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14824132|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14824133|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
14824134|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14824135|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14824136|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199416|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
15199417|NCT03776487|Nivolumab|nivolumab|mesh-list
15199418|NCT03776487|Ipilimumab|ipilimumab|mesh-list
15199419|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
15199420|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199421|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15199422|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199423|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199424|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
14294899|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14294900|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14294901|NCT00578331|Analgesics|analgesics|mesh-ancestor
14294902|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
14294903|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702482|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702483|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702484|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14702485|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702486|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702487|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14702488|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14702489|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14702490|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14702491|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
14702492|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702493|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824137|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
15199425|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702494|NCT00403312|Nicotine|nicotine|mesh-list
15199426|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14824138|NCT00912119|Coagulants|coagulants|mesh-ancestor
14824139|NCT00912145|Alprazolam|alprazolam|mesh-list
14824140|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14824141|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824142|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824143|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14824144|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824145|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824146|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
14824147|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
14824148|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199427|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15199428|NCT03776500|Macozinone|macozinone|mesh-list
15199429|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
15199430|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15199431|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199432|NCT03776812|Paclitaxel|paclitaxel|mesh-list
15199433|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15199434|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15199435|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199436|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824149|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824150|NCT00912171|Budesonide|budesonide|mesh-list
14824151|NCT00912171|Montelukast|montelukast|mesh-list
14824152|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14824153|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14824154|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
14824155|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824156|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824157|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824158|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824159|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
14824160|NCT00912171|Hormones|hormones|mesh-ancestor
14824161|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824162|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14824163|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
14824164|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14824165|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14824166|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824167|NCT00912262|Capsaicin|capsaicin|mesh-list
14824168|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
14824169|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
14824170|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
14824171|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824172|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824173|NCT00912275|Vinorelbine|vinorelbine|mesh-list
14824174|NCT00912275|Lapatinib|lapatinib|mesh-list
14824175|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14824176|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824177|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824178|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
14824179|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
14824180|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824181|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14824182|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824183|NCT00912327|Cetuximab|cetuximab|mesh-list
14824184|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14824185|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199437|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14702495|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14702496|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
14702497|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702498|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702499|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14702500|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14702501|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
14702502|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702503|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702504|NCT00403325|Ranibizumab|ranibizumab|mesh-list
14702505|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14702506|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14702507|NCT00403325|Growth Substances|growth substances|mesh-ancestor
14824186|NCT00912392|Carboplatin|carboplatin|mesh-list
14824187|NCT00912392|Etoposide|etoposide|mesh-list
14824188|NCT00912392|Endostar protein|endostar protein|mesh-list
14824189|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824190|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14824191|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14824192|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14824193|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824194|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824195|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14824196|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14824197|NCT00912392|Growth Substances|growth substances|mesh-ancestor
14824198|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824199|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
14824200|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
14824201|NCT00912444|Docetaxel|docetaxel|mesh-list
14824202|NCT00912444|Doxorubicin|doxorubicin|mesh-list
14824203|NCT00912444|Epirubicin|epirubicin|mesh-list
14824204|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14824205|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
14824206|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824207|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14824208|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14824209|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
14824210|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824211|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824212|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14824213|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824214|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
14824215|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
14824216|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14824217|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14824218|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14824219|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824220|NCT00912457|Donepezil|donepezil|mesh-list
14824221|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14824222|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824223|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824224|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
14824225|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824226|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824227|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
14824228|NCT00912483|Heparin|heparin|mesh-list
14824229|NCT00912483|Calcium heparin|calcium heparin|mesh-list
14824230|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
14824231|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14824232|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14824233|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824234|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14824235|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
15199438|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
15199439|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199440|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
15199441|NCT03776279|Analgesics|analgesics|mesh-ancestor
15199442|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
15199443|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702508|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702509|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702510|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702511|NCT00403338|Sirolimus|sirolimus|mesh-list
15199444|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199445|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199446|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15199447|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15199448|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294904|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702512|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14702513|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702514|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14702515|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702516|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
14702517|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702518|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
14824236|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824237|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14824238|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14702519|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702520|NCT00403364|Amoxicillin|amoxicillin|mesh-list
14702521|NCT00403364|Clarithromycin|clarithromycin|mesh-list
14702522|NCT00403364|Tinidazole|tinidazole|mesh-list
14702523|NCT00403364|Pantoprazole|pantoprazole|mesh-list
14824239|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824240|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824241|NCT00912548|Tamoxifen|tamoxifen|mesh-list
14824242|NCT00912548|Goserelin|goserelin|mesh-list
14824243|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15199449|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199450|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
15199451|NCT03776136|Lenvatinib|lenvatinib|mesh-list
15199452|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199453|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199454|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15199455|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199456|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199457|NCT03776305|Imipenem|imipenem|mesh-list
15199458|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14824244|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
14824245|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824246|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824247|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14824248|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824249|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14702524|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14702525|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702526|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14702527|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702528|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702529|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14702530|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14702531|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14702532|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702533|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14702534|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
14702535|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14824250|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14824251|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14824252|NCT00912574|Molgramostim|molgramostim|mesh-list
14824253|NCT00912574|Sargramostim|sargramostim|mesh-list
14824254|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
14824255|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
14824256|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824257|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824258|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14824259|NCT00912639|Paclitaxel|paclitaxel|mesh-list
14824260|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14824261|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824262|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824263|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
14824264|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
14824265|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824266|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
14824267|NCT00912678|Tacrolimus|tacrolimus|mesh-list
15199459|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199460|NCT03776240|Trastuzumab|trastuzumab|mesh-list
15199461|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199462|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199463|NCT03776058|Cinacalcet|cinacalcet|mesh-list
14702536|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14702537|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14702538|NCT00403429|Capecitabine|capecitabine|mesh-list
14702539|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14702540|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
14702541|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702542|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702543|NCT00403442|Bevacizumab|bevacizumab|mesh-list
14702544|NCT00403442|Verteporfin|verteporfin|mesh-list
14702545|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14702546|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199464|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14702547|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14824268|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14824269|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
14824270|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824271|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14824272|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824273|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824274|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14824275|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824276|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14824277|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
14824278|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14824279|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824280|NCT00912756|Cilostazol|cilostazol|mesh-list
14824281|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14824282|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
14824283|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824284|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824285|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824286|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824287|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14824288|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14824289|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824290|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14824291|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
14824292|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14824293|NCT00912756|Protective Agents|protective agents|mesh-ancestor
14824294|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14824295|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14824296|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824297|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
14824298|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14824299|NCT00912860|Interferons|interferons|mesh-list
14824300|NCT00912860|Interferon-beta|interferon-beta|mesh-list
14824301|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
14824302|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824303|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
14824304|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824305|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
14824306|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824307|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14824308|NCT00912899|Noscapine|noscapine|mesh-list
14824309|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
14824310|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824311|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
14824312|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14824313|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824314|NCT00913029|Timolol|timolol|mesh-list
14824315|NCT00913029|Latanoprost|latanoprost|mesh-list
14824316|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14824317|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14824318|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824319|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824320|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824321|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824322|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14824323|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14824324|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14824325|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14824326|NCT00913055|Octreotide|octreotide|mesh-list
14824327|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14824328|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14824329|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824330|NCT00913107|Lamotrigine|lamotrigine|mesh-list
14824331|NCT00913107|Carbamazepine|carbamazepine|mesh-list
14824332|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
14824333|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14824334|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824335|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824336|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14824337|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824338|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14824339|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824340|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824341|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824342|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14824343|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
14702548|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14702549|NCT00403442|Growth Substances|growth substances|mesh-ancestor
14702550|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702551|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702552|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14702553|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702554|NCT00403533|Atorvastatin|atorvastatin|mesh-list
14824344|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14824345|NCT00913107|Analgesics|analgesics|mesh-ancestor
14824346|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
14824347|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824348|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14824349|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14824350|NCT00913120|Enoxaparin|enoxaparin|mesh-list
14824351|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
14824352|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15199465|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199466|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15199467|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
15199468|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199469|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
15199470|NCT03776032|Hematinics|hematinics|mesh-ancestor
14702555|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14824353|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14824354|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824355|NCT00913224|Diclofenac|diclofenac|mesh-list
14824356|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14824357|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14824358|NCT00913224|Analgesics|analgesics|mesh-ancestor
14824359|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
14824360|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824361|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824362|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14824363|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14824364|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14824365|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824366|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824367|NCT00913237|Desipramine|desipramine|mesh-list
14824368|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14824369|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824370|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824371|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824372|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824373|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14824374|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824375|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824376|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824377|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824378|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824379|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
14824380|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14824381|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
14824382|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824383|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824384|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
14824385|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824386|NCT00913276|Propofol|propofol|mesh-list
14824387|NCT00913276|Sevoflurane|sevoflurane|mesh-list
14824388|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14824389|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824390|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824391|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14824392|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
14824393|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
14824394|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14824395|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14824396|NCT00913315|Tamsulosin|tamsulosin|mesh-list
14824397|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14824398|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14824399|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14824400|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14824401|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824402|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824403|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824404|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824405|NCT00913315|Urological Agents|urological agents|mesh-ancestor
14824406|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14824407|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14824408|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
14824409|NCT00913328|Montelukast|montelukast|mesh-list
15199471|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
15199472|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199473|NCT03775993|Hormones|hormones|mesh-list
15199474|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199475|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199476|NCT03775629|Tramadol|tramadol|mesh-list
15199477|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14294905|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14294906|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199478|NCT03775629|Narcotics|narcotics|mesh-ancestor
15199479|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199480|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199481|NCT03775629|Analgesics|analgesics|mesh-ancestor
15199482|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
15199483|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199484|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
15199485|NCT03775876|Propofol|propofol|mesh-list
15199486|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199487|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199488|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199489|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15199490|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
15199491|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
15199492|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15199493|NCT03775876|Analgesics|analgesics|mesh-ancestor
15199494|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
14294907|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14294908|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14294909|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14294910|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
14824410|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824411|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824412|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14824413|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
14294911|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
14294912|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294913|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294914|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
14294915|NCT00578344|Busulfan|busulfan|mesh-list
14294916|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
14702556|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14702557|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
14702558|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702559|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14702560|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14702561|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702562|NCT00403611|Praziquantel|praziquantel|mesh-list
14702563|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
14702564|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14702565|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702566|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
14702567|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702568|NCT00403637|Maleic acid|maleic acid|mesh-list
14702569|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824414|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824415|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824416|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14824417|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14824418|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824419|NCT00913341|Alprazolam|alprazolam|mesh-list
14824420|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199495|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294917|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294918|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
15199496|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14824421|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824422|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824423|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14824424|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824425|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824426|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
14824427|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
14824428|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824429|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911220|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911221|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911222|NCT01361399|Analgesics|analgesics|mesh-ancestor
14911223|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911224|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911225|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14911226|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14911227|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14911228|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14911229|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911230|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
14911231|NCT01361425|Methyldopa|methyldopa|mesh-list
14911232|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14911233|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
14911234|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
14911235|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911236|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911237|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14911238|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14911239|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14911240|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
14911241|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911242|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911243|NCT01361516|Anesthetics|anesthetics|mesh-list
14911244|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911245|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911246|NCT01361542|Etanercept|etanercept|mesh-list
14911247|NCT01361542|Infliximab|infliximab|mesh-list
14911248|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
14911249|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14911250|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911251|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911252|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911253|NCT01361542|Analgesics|analgesics|mesh-ancestor
14911254|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
14911255|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911256|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911257|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911258|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911259|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
14911260|NCT01361763|Dabigatran|dabigatran|mesh-list
14911261|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
14911262|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14911263|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
14911264|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911265|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911266|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
14911267|NCT01361789|Dexamethasone|dexamethasone|mesh-list
14911268|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
14911269|NCT01361789|Etoricoxib|etoricoxib|mesh-list
14911270|NCT01361789|Parecoxib|parecoxib|mesh-list
14911271|NCT01361789|Valdecoxib|valdecoxib|mesh-list
14911272|NCT01361789|BB 1101|bb 1101|mesh-list
14911273|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911274|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
14911275|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
14911276|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911277|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911278|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14911279|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
14911280|NCT01361789|Hormones|hormones|mesh-ancestor
14911281|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14911282|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14911283|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911284|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
14911285|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911286|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824430|NCT00913367|Insulin|insulin|mesh-list
14824431|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14824432|NCT00913367|Metformin|metformin|mesh-list
14824433|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
14824434|NCT00913367|Glimepiride|glimepiride|mesh-list
14824435|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14824436|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824437|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14824438|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14824439|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
14824440|NCT00913419|Amitriptyline|amitriptyline|mesh-list
14824441|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
14824442|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14824443|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824444|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824445|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14824446|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824447|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14824448|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824449|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824450|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824451|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14824452|NCT00913419|Analgesics|analgesics|mesh-ancestor
14824453|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
14824454|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14824455|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824456|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824457|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824458|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824459|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824460|NCT00913484|Disulfiram|disulfiram|mesh-list
14824461|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14824462|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14824463|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824464|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824465|NCT00913497|Insulin|insulin|mesh-list
14824466|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14824467|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
14824468|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
14824469|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14824470|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824471|NCT00913549|Clemastine|clemastine|mesh-list
14824472|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
14824473|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
14824474|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14824475|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
14824476|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
14824477|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824478|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702570|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702571|NCT00403650|Iloprost|iloprost|mesh-list
14702572|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14702573|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
14702574|NCT00403663|Fentanyl|fentanyl|mesh-list
14702575|NCT00403663|Morphine|morphine|mesh-list
14824479|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824480|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14702576|NCT00403663|Bupivacaine|bupivacaine|mesh-list
14702577|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
14702578|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
14702579|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702580|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824481|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14824482|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15199497|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15199498|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15199499|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
15199500|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824483|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14824484|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
14824485|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824486|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14824487|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14824488|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824489|NCT00913588|Fluoxetine|fluoxetine|mesh-list
14824490|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14824491|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824492|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824493|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824494|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824495|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
14824496|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824497|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14824498|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824499|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824500|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14824501|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14824502|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824503|NCT00913614|SR 46349B|sr 46349b|mesh-list
14824504|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15199501|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702581|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
14702582|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702583|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14702584|NCT00403663|Narcotics|narcotics|mesh-ancestor
14702585|NCT00403663|Analgesics|analgesics|mesh-ancestor
14702586|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14702587|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14702588|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
14702589|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14702590|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14728548|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14728549|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14728550|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728551|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199502|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
14728552|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728553|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
15199503|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15199504|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294919|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702591|NCT00403728|Cyclosporine|cyclosporine|mesh-list
14702592|NCT00403728|Cyclosporins|cyclosporins|mesh-list
14702593|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702594|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824505|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14824506|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824507|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14824508|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14824509|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
14824510|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824511|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824512|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14824513|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14824514|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824515|NCT00913666|Interferons|interferons|mesh-list
14824516|NCT00913666|Interferon-beta|interferon-beta|mesh-list
14824517|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
14824518|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824519|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
14824520|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824521|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
14824522|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824523|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14824524|NCT00913705|Carboplatin|carboplatin|mesh-list
14824525|NCT00913705|Paclitaxel|paclitaxel|mesh-list
14824526|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14824527|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824528|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14824529|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824530|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
14824531|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
14824532|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824533|NCT00913718|Fluoxetine|fluoxetine|mesh-list
14824534|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14824535|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824536|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824537|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824538|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824539|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
14824540|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824541|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14824542|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824543|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824544|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15199505|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199506|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15199507|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199508|NCT03775863|Liver Extracts|liver extracts|mesh-list
15199509|NCT03775863|Hematinics|hematinics|mesh-ancestor
15199510|NCT03775707|Lenvatinib|lenvatinib|mesh-list
15199511|NCT03775707|Antibodies|antibodies|mesh-list
15199512|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
15199513|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199514|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199515|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14824545|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14824546|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824547|NCT00913783|Clomipramine|clomipramine|mesh-list
14824548|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14824549|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824550|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824551|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14824552|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824553|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824554|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824555|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702595|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702596|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
14702597|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702598|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
14702599|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294920|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199516|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199517|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199518|NCT03775902|Nicorandil|nicorandil|mesh-list
15199519|NCT03775902|Glimepiride|glimepiride|mesh-list
15199520|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15199521|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15199522|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199523|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199524|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
15199525|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15199526|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
15199527|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
15199528|NCT03775902|Vitamins|vitamins|mesh-ancestor
15199529|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
15199530|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
15199531|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199532|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199533|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199534|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702600|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702601|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702602|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14702603|NCT00403780|Pregabalin|pregabalin|mesh-list
14702604|NCT00403780|Analgesics|analgesics|mesh-ancestor
14702605|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
14702606|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702607|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702608|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
14702609|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14702610|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14702611|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702612|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14702613|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14702614|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14702615|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702616|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14702617|NCT00403806|Dexamethasone|dexamethasone|mesh-list
14702618|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
14702619|NCT00403806|BB 1101|bb 1101|mesh-list
14702620|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702621|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
14702622|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
14702623|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702624|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702625|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702626|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
14702627|NCT00403806|Hormones|hormones|mesh-ancestor
14702628|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702629|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15199535|NCT03775655|Analgesics|analgesics|mesh-ancestor
14824556|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
14824557|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824558|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
14824559|NCT00913796|Diuretics|diuretics|mesh-ancestor
14824560|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
14824561|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824562|NCT00913796|Expectorants|expectorants|mesh-ancestor
14824563|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824564|NCT00913809|Desipramine|desipramine|mesh-list
14824565|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14824566|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824567|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824568|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824569|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824570|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14824571|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824572|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824573|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824574|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824575|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824576|NCT00913822|Desipramine|desipramine|mesh-list
14824577|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14824578|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824579|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824580|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824581|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824582|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14824583|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824584|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824585|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824586|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824587|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824588|NCT00913848|Valproic Acid|valproic acid|mesh-list
14824589|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
14824590|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824591|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824592|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
14824593|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824594|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824595|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
14824596|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824597|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824598|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824599|NCT00913861|Fentanyl|fentanyl|mesh-list
14824600|NCT00913861|Propofol|propofol|mesh-list
14824601|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14824602|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824603|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824604|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14824605|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
14824606|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
14824607|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14824608|NCT00913861|Narcotics|narcotics|mesh-ancestor
14824609|NCT00913861|Analgesics|analgesics|mesh-ancestor
14824610|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
14824611|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824612|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14824613|NCT00913874|Valproic Acid|valproic acid|mesh-list
14824614|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
14824615|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824616|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824617|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
14824618|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824619|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824620|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
14824621|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824622|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199536|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
15199537|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199538|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15199539|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15199540|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15199541|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824623|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15199542|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199543|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224487|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224488|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
15224489|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
15224490|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224491|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224492|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702630|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702631|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
14702632|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702633|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702634|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14702635|NCT00403819|Laxatives|laxatives|mesh-ancestor
14702636|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702637|NCT00403858|Lactulose|lactulose|mesh-list
14294921|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14294922|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
14294923|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294924|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702638|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14702639|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702640|NCT00403858|Laxatives|laxatives|mesh-ancestor
14702641|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14702642|NCT00403897|Laxatives|laxatives|mesh-ancestor
14702643|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702644|NCT00403910|Canrenone|canrenone|mesh-list
14702645|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14702646|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
14702647|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702648|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702649|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14702650|NCT00403910|Diuretics|diuretics|mesh-ancestor
14702651|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
14702652|NCT00403949|Azelaic acid|azelaic acid|mesh-list
14702653|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702654|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702655|NCT00403962|Paroxetine|paroxetine|mesh-list
14702656|NCT00403962|Vestipitant|vestipitant|mesh-list
14702657|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14702658|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14702659|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14702660|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702661|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702662|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
14702663|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702664|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14702665|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
14702666|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14702667|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14702668|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14702669|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702670|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14702671|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14702672|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14702673|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
14702674|NCT00403988|Vinorelbine|vinorelbine|mesh-list
14702675|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702676|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14702677|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
14702678|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
14702679|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
15224493|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
15224494|NCT03615664|Hormones|hormones|mesh-ancestor
15224495|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702680|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702681|NCT00404040|Lactulose|lactulose|mesh-list
15199544|NCT03775590|Acetic Acid|acetic acid|mesh-list
15199545|NCT03775590|Retinol acetate|retinol acetate|mesh-list
15199546|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15199547|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199548|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14824624|NCT00913887|Diclofenac|diclofenac|mesh-list
14824625|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14824626|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14824627|NCT00913887|Analgesics|analgesics|mesh-ancestor
14824628|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
14824629|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824630|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824631|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14824632|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199549|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
15199550|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199551|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15199552|NCT03775590|Protective Agents|protective agents|mesh-ancestor
15199553|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199554|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
15199555|NCT03775746|Clopidogrel|clopidogrel|mesh-list
15199556|NCT03775746|Ticagrelor|ticagrelor|mesh-list
15199557|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14824633|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14824634|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824635|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824636|NCT00913952|Clomipramine|clomipramine|mesh-list
14824637|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14824638|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824639|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824640|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14824641|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15199558|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15199559|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15199560|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15199561|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
15199562|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199563|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199564|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199565|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15199566|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
15199567|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15199568|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
15199569|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199570|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
15199571|NCT03775928|Capecitabine|capecitabine|mesh-list
15199572|NCT03775928|Apatinib|apatinib|mesh-list
15199573|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15199574|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
15199575|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199576|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199577|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15199578|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199579|NCT03775538|Dopamine|dopamine|mesh-list
15199580|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15199581|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
15199582|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
15199583|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199584|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199585|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
15199586|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199587|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199588|NCT03775538|Protective Agents|protective agents|mesh-ancestor
15199589|NCT03775460|Prednisolone|prednisolone|mesh-list
15199590|NCT03775460|Methotrexate|methotrexate|mesh-list
15199591|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15199592|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
15199593|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199594|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824642|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824643|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824644|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702682|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14824645|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
14824646|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824647|NCT00913965|Atenolol|atenolol|mesh-list
15199595|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15199596|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
15199597|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199598|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199599|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
15199600|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199601|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15199602|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199603|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
15199604|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199605|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15199606|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15199607|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
15199608|NCT03775460|Hormones|hormones|mesh-ancestor
15199609|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199610|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15199611|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
15199612|NCT03775382|Vitamins|vitamins|mesh-ancestor
15199613|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
15199614|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199615|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
15199616|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199617|NCT03775382|Protective Agents|protective agents|mesh-ancestor
15199618|NCT03775096|Carvedilol|carvedilol|mesh-list
15199619|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15199620|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15199621|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
15199622|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199623|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199624|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199625|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15199626|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
15199627|NCT03775096|Protective Agents|protective agents|mesh-ancestor
15199628|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15199629|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15199630|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15199631|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
15199632|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15199633|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15199634|NCT03775395|Sorafenib|sorafenib|mesh-list
15199635|NCT03775395|Lenvatinib|lenvatinib|mesh-list
15199636|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199637|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15199638|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199639|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199640|NCT03775356|Anesthetics|anesthetics|mesh-list
15199641|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199642|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199643|NCT03775070|Simvastatin|simvastatin|mesh-list
15199644|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14702683|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702684|NCT00404040|Laxatives|laxatives|mesh-ancestor
14702685|NCT00404053|Clopidogrel|clopidogrel|mesh-list
14702686|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14702687|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14702688|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14702689|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14702690|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
14702691|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199645|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15199646|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
15199647|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199648|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15199649|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14824648|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14824649|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14824650|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
14824651|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
14824652|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824653|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824654|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14824655|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14824656|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14824657|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824658|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824659|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824660|NCT00914004|Desipramine|desipramine|mesh-list
14824661|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15199650|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199651|NCT03774901|Avelumab|avelumab|mesh-list
15199652|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199653|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199654|NCT03774732|Paclitaxel|paclitaxel|mesh-list
14824662|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824663|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824664|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824665|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824666|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14824667|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824668|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824669|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824670|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824671|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824672|NCT00914017|Atorvastatin|atorvastatin|mesh-list
14824673|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14824674|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14824675|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
14824676|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824677|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14824678|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14824679|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824680|NCT00914056|Lactulose|lactulose|mesh-list
15199655|NCT03774732|Cisplatin|cisplatin|mesh-list
14824681|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14824682|NCT00914095|Methylphenidate|methylphenidate|mesh-list
14824683|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14824684|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824685|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14824686|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14824687|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824688|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824689|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
14824690|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824691|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
14824692|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14824693|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824694|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14824695|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14824696|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824697|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824698|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824699|NCT00914134|Levodopa|levodopa|mesh-list
14824700|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15199656|NCT03774732|Carboplatin|carboplatin|mesh-list
15199657|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
15199658|NCT03774732|Pemetrexed|pemetrexed|mesh-list
15199659|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15199660|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199661|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
15199662|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
15199663|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
15199664|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824701|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14824702|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
14824703|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824704|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824705|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824706|NCT00914160|Diclofenac|diclofenac|mesh-list
14824707|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14824708|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14824709|NCT00914160|Analgesics|analgesics|mesh-ancestor
14824710|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
14824711|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824712|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824713|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14824714|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14824715|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14824716|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824717|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824718|NCT00914212|Sibutramine|sibutramine|mesh-list
14824719|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824720|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824721|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
14824722|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15199665|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14702692|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702693|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702694|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14702695|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14702696|NCT00404157|Rituximab|rituximab|mesh-list
14702697|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14702698|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702699|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
14702700|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702701|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702702|NCT00404183|Acetaminophen|acetaminophen|mesh-list
14702703|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14702704|NCT00404183|Hydrocodone|hydrocodone|mesh-list
14702705|NCT00404183|Oxycodone|oxycodone|mesh-list
15199666|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199667|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15199668|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15199669|NCT03774654|Cyclophosphamide|cyclophosphamide|mesh-list
15199670|NCT03774654|Fludarabine|fludarabine|mesh-list
15199671|NCT03774654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199672|NCT03774654|Immunologic Factors|immunologic factors|mesh-ancestor
15199673|NCT03774654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199674|NCT03774654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199675|NCT03774654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14824723|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
14824724|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
14824725|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14824726|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14824727|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824728|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824729|NCT00914277|Urological Agents|urological agents|mesh-ancestor
14824730|NCT00914368|Clopidogrel|clopidogrel|mesh-list
14824731|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14824732|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14824733|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14824734|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14824735|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
14824736|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824737|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824738|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824739|NCT00914394|Phenylephrine|phenylephrine|mesh-list
15199676|NCT03774654|Alkylating Agents|alkylating agents|mesh-ancestor
14294925|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294926|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294927|NCT00578448|Abatacept|abatacept|mesh-list
14294928|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14294929|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294930|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199677|NCT03774654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199678|NCT03774654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199679|NCT03774654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15199680|NCT03774953|Vitamins|vitamins|mesh-list
15199681|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
15199682|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199683|NCT03774706|Misoprostol|misoprostol|mesh-list
14702706|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702707|NCT00404183|Analgesics|analgesics|mesh-ancestor
14702708|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
14702709|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702710|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702711|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
14702712|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14702713|NCT00404183|Narcotics|narcotics|mesh-ancestor
14702714|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702715|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
14702716|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702717|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14702718|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702719|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702720|NCT00404196|Calcipotriene|calcipotriene|mesh-list
14702721|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702722|NCT00404222|Acetaminophen|acetaminophen|mesh-list
14702723|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14702724|NCT00404222|Hydrocodone|hydrocodone|mesh-list
14702725|NCT00404222|Oxycodone|oxycodone|mesh-list
14702726|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702727|NCT00404222|Analgesics|analgesics|mesh-ancestor
14702728|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
14702729|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294931|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294932|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
14294933|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294934|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294935|NCT00578461|Cytarabine|cytarabine|mesh-list
14294936|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
14294937|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294938|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
14294939|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294940|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294941|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14294942|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
14294943|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294944|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294945|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294946|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14294947|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
14294948|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
14294949|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294950|NCT00578539|Cytarabine|cytarabine|mesh-list
14294951|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
14294952|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
14294953|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14294954|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
14294955|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702730|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702731|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
14702732|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14702733|NCT00404222|Narcotics|narcotics|mesh-ancestor
14702734|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702735|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
14702736|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
14294956|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702737|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14702738|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702739|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702740|NCT00404261|Fluticasone|fluticasone|mesh-list
14702741|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14702742|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14702743|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702744|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15199684|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
14702745|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
14824740|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
14294957|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14294958|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
14294959|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294960|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294961|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14294962|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14294963|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
14294964|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
14294965|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14294966|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294967|NCT00578552|Gabapentin|gabapentin|mesh-list
14294968|NCT00578552|Analgesics|analgesics|mesh-ancestor
14294969|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
14294970|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14294971|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294972|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
14294973|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14294974|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14294975|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14294976|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14294977|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14294978|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14702746|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199685|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15199686|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15199687|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199688|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
15199689|NCT03774706|Coagulants|coagulants|mesh-ancestor
15199690|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14702747|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702748|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824741|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14824742|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14824743|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
14824744|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
14824745|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824746|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824747|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
14824748|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14824749|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
14824750|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824751|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14824752|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14824753|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14824754|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824755|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824756|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199691|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
14702749|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702750|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702751|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14702752|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14702753|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14702754|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14294979|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14294980|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294981|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
14294982|NCT00578565|Rituximab|rituximab|mesh-list
14294983|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14294984|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14294985|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
14294986|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14294987|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14294988|NCT00578617|Amiodarone|amiodarone|mesh-list
14294989|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14294990|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14294991|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
14294992|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15199692|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199693|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199694|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15199695|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15199696|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
15199697|NCT03774771|Cinacalcet|cinacalcet|mesh-list
14294993|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14294994|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14294995|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15199698|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15199699|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199700|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15199701|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
15199702|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199703|NCT03774693|Fentanyl|fentanyl|mesh-list
15199704|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
15199705|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199706|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199707|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15199708|NCT03774693|Narcotics|narcotics|mesh-ancestor
14702755|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
14702756|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702757|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702758|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
14702759|NCT00404261|Hormones|hormones|mesh-ancestor
14294996|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14294997|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14294998|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14294999|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14295000|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14295001|NCT00578643|Cyclosporine|cyclosporine|mesh-list
14295002|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
14295003|NCT00578643|Busulfan|busulfan|mesh-list
14295004|NCT00578643|Fludarabine|fludarabine|mesh-list
14702760|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295005|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
14824757|NCT00914394|Protective Agents|protective agents|mesh-ancestor
14295006|NCT00578643|Cyclosporins|cyclosporins|mesh-list
14824758|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295007|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295008|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
14295009|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295010|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295011|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15199709|NCT03774693|Analgesics|analgesics|mesh-ancestor
15199710|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
15199711|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199712|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15199713|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15199714|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
15199715|NCT03774836|Morphine|morphine|mesh-list
15199716|NCT03774836|Tramadol|tramadol|mesh-list
15199717|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15199718|NCT03774836|Narcotics|narcotics|mesh-ancestor
15199719|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199720|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199721|NCT03774836|Analgesics|analgesics|mesh-ancestor
15199722|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
15199723|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199724|NCT03774680|Cetuximab|cetuximab|mesh-list
14295012|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
14295013|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295014|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295015|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295016|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295017|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
14295018|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295019|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
14295020|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14295021|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295022|NCT00578669|Fluoxetine|fluoxetine|mesh-list
15199725|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199726|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199727|NCT03774615|Ferric maltol|ferric maltol|mesh-list
15199728|NCT03774615|Hematinics|hematinics|mesh-ancestor
15199729|NCT03774810|Zolpidem|zolpidem|mesh-list
15199730|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15199731|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199732|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199733|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199734|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15199735|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
14702761|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
14702762|NCT00404274|Casopitant|casopitant|mesh-list
14702763|NCT00404274|Warfarin|warfarin|mesh-list
14824759|NCT00914420|Trapidil|trapidil|mesh-list
14824760|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14824761|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824762|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824763|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14824764|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
14824765|NCT00914472|Heparin|heparin|mesh-list
14824766|NCT00914472|Calcium heparin|calcium heparin|mesh-list
14824767|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
14824768|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14824769|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14824770|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824771|NCT00914498|Lidocaine|lidocaine|mesh-list
14824772|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
14824773|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
14824774|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824775|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824776|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
14824777|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824778|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14824779|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14824780|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14824781|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14824782|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824783|NCT00914524|Olmesartan|olmesartan|mesh-list
14824784|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14702764|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
14702765|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
14702766|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
14702767|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702768|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702769|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702770|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14824785|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14295023|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15199736|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
15199737|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824786|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14824787|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14824788|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824789|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
14824790|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
14824791|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824792|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824793|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824794|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
14824795|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824796|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14824797|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824798|NCT00914576|Vitamins|vitamins|mesh-list
14824799|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
14824800|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824801|NCT00914641|Apixaban|apixaban|mesh-list
15199738|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199739|NCT03774524|Misoprostol|misoprostol|mesh-list
15199740|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15199741|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
15199742|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199743|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199744|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14824802|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14824803|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
14824804|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14824805|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
14824806|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702771|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702772|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824807|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824808|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
14824809|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
14824810|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14824811|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
14824812|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824813|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824814|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824815|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824816|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14824817|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14824818|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14824819|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824820|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824821|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824822|NCT00914667|Warfarin|warfarin|mesh-list
14824823|NCT00914667|Fesoterodine|fesoterodine|mesh-list
14824824|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
14824825|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14824826|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14824827|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
14824828|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824829|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824830|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824831|NCT00914667|Urological Agents|urological agents|mesh-ancestor
14824832|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14824833|NCT00914693|Gestodene|gestodene|mesh-list
14824834|NCT00914693|Femovan|femovan|mesh-list
14824835|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14824836|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14702773|NCT00404326|Hydralazine|hydralazine|mesh-list
14702774|NCT00404326|Valproic Acid|valproic acid|mesh-list
14702775|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
14702776|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702777|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702778|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
14702779|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824837|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14824838|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
14824839|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14824840|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199745|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15199746|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
14824841|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14824842|NCT00914693|Estrogens|estrogens|mesh-ancestor
14824843|NCT00914693|Hormones|hormones|mesh-ancestor
14824844|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824845|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14824846|NCT00914693|Progestins|progestins|mesh-ancestor
14824847|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14824848|NCT00914771|Vaccines|vaccines|mesh-list
14824849|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
14824850|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824851|NCT00914797|Terbutaline|terbutaline|mesh-list
14824852|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14824853|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
14824854|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824855|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824856|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824857|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824858|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
14824859|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
14824860|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14824861|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14824862|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14824863|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14824864|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824865|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824866|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824867|NCT00914836|Betamethasone|betamethasone|mesh-list
14824868|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
14824869|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14702780|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702781|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
14824870|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
14824871|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
14824872|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14824873|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14824874|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
14824875|NCT00914836|Hormones|hormones|mesh-ancestor
14824876|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824877|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824878|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14702782|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14702783|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702784|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824879|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824880|NCT00914888|Metronidazole|metronidazole|mesh-list
14824881|NCT00914888|Clarithromycin|clarithromycin|mesh-list
14824882|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
14824883|NCT00914888|Tigecycline|tigecycline|mesh-list
14824884|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824885|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14824886|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14824887|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14824888|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14824889|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824890|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824891|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14824892|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14702785|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14702786|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
14702787|NCT00404378|Ketoconazole|ketoconazole|mesh-list
14702788|NCT00404378|Casopitant|casopitant|mesh-list
14702789|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
14702790|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824893|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14702791|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14702792|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14702793|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702794|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702795|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14702796|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
14702797|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702798|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702799|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14702800|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
14702801|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
14702802|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702803|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702804|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14702805|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702806|NCT00404391|Acetaminophen|acetaminophen|mesh-list
14702807|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14702808|NCT00404391|Hydrocodone|hydrocodone|mesh-list
14702809|NCT00404391|Oxycodone|oxycodone|mesh-list
14702810|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702811|NCT00404391|Analgesics|analgesics|mesh-ancestor
14702812|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
14702813|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702814|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702815|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
14702816|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14702817|NCT00404391|Narcotics|narcotics|mesh-ancestor
14702818|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702819|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
14702820|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702821|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14702822|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702823|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702824|NCT00404404|Paclitaxel|paclitaxel|mesh-list
14702825|NCT00404404|Bevacizumab|bevacizumab|mesh-list
14702826|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14702827|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14702828|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702829|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
15199747|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
15199748|NCT03774472|Letrozole|letrozole|mesh-list
15199749|NCT03774472|Palbociclib|palbociclib|mesh-list
15199750|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199751|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15199752|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15199753|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295024|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14295025|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14702830|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
14702831|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
14702832|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702833|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14702834|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14702835|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14702836|NCT00404404|Growth Substances|growth substances|mesh-ancestor
14702837|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702838|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702839|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
14702840|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14702841|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14702842|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14702843|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14702844|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199754|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702845|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
14702846|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702847|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824894|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15199755|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15199756|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
15199757|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14702848|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14702849|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199758|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199759|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
15199760|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15199761|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15199762|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702850|NCT00404456|Melatonin|melatonin|mesh-list
14702851|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
14702852|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702853|NCT00404456|Protective Agents|protective agents|mesh-ancestor
14702854|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702855|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702856|NCT00404482|Cyclosporine|cyclosporine|mesh-list
14702857|NCT00404482|Cyclosporins|cyclosporins|mesh-list
14702858|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702859|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702860|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702861|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
14702862|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702863|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
14702864|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702865|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702866|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702867|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14702868|NCT00404508|Hydralazine|hydralazine|mesh-list
14702869|NCT00404508|Valproic Acid|valproic acid|mesh-list
14702870|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
14702871|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702872|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702873|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
14702874|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702875|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702876|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
14702877|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824895|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
14824896|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14824897|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824898|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14824899|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824900|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14824901|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14824902|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14824903|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
14824904|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14824905|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824906|NCT00914953|Oxytocin|oxytocin|mesh-list
15199763|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199764|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14824907|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
14824908|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14824909|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824910|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14824911|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14824912|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14824913|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824914|NCT00915083|Amrubicin|amrubicin|mesh-list
14824915|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911287|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911288|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911289|NCT01361789|Analgesics|analgesics|mesh-ancestor
14911290|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
14911291|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911292|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14911293|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14911294|NCT01361841|Bimatoprost|bimatoprost|mesh-list
14911295|NCT01361841|Travoprost|travoprost|mesh-list
14911296|NCT01361841|Latanoprost|latanoprost|mesh-list
14911297|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14911298|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15199765|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
14702878|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702879|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911299|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14911300|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15199766|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14824916|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
14824917|NCT00915200|Silybin|silybin|mesh-list
14824918|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14824919|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
14702880|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14702881|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
14702882|NCT00404534|Amoxicillin|amoxicillin|mesh-list
14702883|NCT00404534|Clarithromycin|clarithromycin|mesh-list
14702884|NCT00404534|Omeprazole|omeprazole|mesh-list
14702885|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14702886|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14702887|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14702888|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14702889|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14824920|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824921|NCT00915200|Expectorants|expectorants|mesh-ancestor
14824922|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
14824923|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14824924|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
14824925|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824926|NCT00915200|Protective Agents|protective agents|mesh-ancestor
14824927|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824928|NCT00915200|Antidotes|antidotes|mesh-ancestor
14824929|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14824930|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824931|NCT00915239|Pantoprazole|pantoprazole|mesh-list
14824932|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14824933|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14824934|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14824935|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824936|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824937|NCT00915252|Cytarabine|cytarabine|mesh-list
14824938|NCT00915252|Azacitidine|azacitidine|mesh-list
14824939|NCT00915252|Daunorubicin|daunorubicin|mesh-list
15199767|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
15199768|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199769|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824940|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14824941|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
14824942|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824943|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824944|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
14824945|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824946|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14824947|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
14824948|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824949|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14824950|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14702890|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199770|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15199771|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
15199772|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15199773|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
15199774|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199775|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199776|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15199777|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
15199778|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
14702891|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702892|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14824951|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15199779|NCT03773991|Protective Agents|protective agents|mesh-ancestor
15199780|NCT03774108|Metformin|metformin|mesh-list
15199781|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15199782|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199783|NCT03774446|Roscovitine|roscovitine|mesh-list
14824952|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15199784|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199785|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
15199786|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199787|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15199788|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199789|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199790|NCT03774095|Pycnogenols|pycnogenols|mesh-list
15199791|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15199792|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
15199793|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199794|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
15199795|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199796|NCT03774095|Protective Agents|protective agents|mesh-ancestor
15199797|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14702893|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14824953|NCT00915369|Paclitaxel|paclitaxel|mesh-list
14824954|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14824955|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824956|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
14824957|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
14824958|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
14824959|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824960|NCT00915382|Cisplatin|cisplatin|mesh-list
14824961|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824962|NCT00915408|Dexamethasone|dexamethasone|mesh-list
14824963|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
14824964|NCT00915408|Lenalidomide|lenalidomide|mesh-list
14824965|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14824966|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
14824967|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824968|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14824969|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14824970|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
14824971|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14824972|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824973|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14824974|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14824975|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
14824976|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
14824977|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702894|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14702895|NCT00404573|Cariprazine|cariprazine|mesh-list
14824978|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14824979|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
14824980|NCT00915408|Hormones|hormones|mesh-ancestor
14824981|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14824982|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14824983|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14824984|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14824985|NCT00915408|Growth Substances|growth substances|mesh-ancestor
14824986|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
14824987|NCT00915460|Interferons|interferons|mesh-list
14824988|NCT00915460|Interferon-beta|interferon-beta|mesh-list
14824989|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
14824990|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14824991|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
14824992|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14824993|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
14824994|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14824995|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14824996|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15224496|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14702896|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14702897|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14702898|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702899|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702900|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14824997|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15224497|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224498|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14824998|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14824999|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825000|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825001|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825002|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14825003|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14825004|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
14825005|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825006|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825007|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14825008|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14825009|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
14825010|NCT00915564|Simeprevir|simeprevir|mesh-list
14825011|NCT00915564|Methadone|methadone|mesh-list
14825012|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14825013|NCT00915564|Narcotics|narcotics|mesh-ancestor
14825014|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825015|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825016|NCT00915564|Analgesics|analgesics|mesh-ancestor
14702901|NCT00404586|Fluticasone|fluticasone|mesh-list
14702902|NCT00404586|Xhance|xhance|mesh-list
14702903|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702904|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14702905|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
14702906|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702907|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199798|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
15199799|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15199800|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
15199801|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
15199802|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199803|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
15199804|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199805|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15199806|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15199807|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
14825017|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
14825018|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825019|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
14825020|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
14825021|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
14825022|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825023|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
14825024|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825025|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825026|NCT00915577|Interferons|interferons|mesh-list
14825027|NCT00915577|Interferon-beta|interferon-beta|mesh-list
14825028|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
14825029|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825030|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
14825031|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825032|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
14825033|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825034|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14825035|NCT00915616|Melatonin|melatonin|mesh-list
14825036|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
14825037|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825038|NCT00915616|Protective Agents|protective agents|mesh-ancestor
14825039|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825040|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14702908|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14702909|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702910|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
14702911|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14702912|NCT00404599|Simvastatin|simvastatin|mesh-list
14702913|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14702914|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14702915|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
14702916|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702917|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14702918|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14702919|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702920|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14702921|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
14825041|NCT00915694|Nelfinavir|nelfinavir|mesh-list
14825042|NCT00915694|Temozolomide|temozolomide|mesh-list
14825043|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14825044|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
14825045|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825046|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825047|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14825048|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14825049|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14825050|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825051|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14825052|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14825053|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
14825054|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825055|NCT00915733|Aspirin|aspirin|mesh-list
14825056|NCT00915733|Cilostazol|cilostazol|mesh-list
14825057|NCT00915733|Clopidogrel|clopidogrel|mesh-list
14825058|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14825059|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14825060|NCT00915733|Analgesics|analgesics|mesh-ancestor
14825061|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
14825062|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825063|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825064|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825065|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825066|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14825067|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14825068|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825069|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14825070|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14825071|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825072|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
14825073|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14911301|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
15199808|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199809|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199810|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15199811|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199812|NCT03773562|Erenumab|erenumab|mesh-list
15199813|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15199814|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199815|NCT03773562|Analgesics|analgesics|mesh-ancestor
15199816|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
15199817|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199818|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199819|NCT03773536|Artesunate|artesunate|mesh-list
15199820|NCT03773536|Primaquine|primaquine|mesh-list
15199821|NCT03773536|Amodiaquine|amodiaquine|mesh-list
15199822|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
15199823|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15199824|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15199825|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199826|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199827|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
15199828|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
15199829|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15199830|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
15199831|NCT03773809|Vitamin D|vitamin d|mesh-list
15199832|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
14702922|NCT00404703|Bevacizumab|bevacizumab|mesh-list
14702923|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14702924|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702925|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14702926|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14702927|NCT00404703|Growth Substances|growth substances|mesh-ancestor
14702928|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702929|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
14702930|NCT00404716|Cilostazol|cilostazol|mesh-list
14702931|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14702932|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
14702933|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702934|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702935|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14702936|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702937|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14702938|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14702939|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702940|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14702941|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
14702942|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14702943|NCT00404716|Protective Agents|protective agents|mesh-ancestor
14702944|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14825074|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14825075|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14825076|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
14825077|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825078|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14825079|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
14825080|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15199833|NCT03773809|Vitamins|vitamins|mesh-list
15199834|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
15199835|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199836|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15199837|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14825081|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
14825082|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
14825083|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14825084|NCT00915733|Protective Agents|protective agents|mesh-ancestor
14825085|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14825086|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14825087|NCT00915746|Ketoconazole|ketoconazole|mesh-list
14825088|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
14825089|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825090|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14825091|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15199838|NCT03773588|Propofol|propofol|mesh-list
15199839|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199840|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199841|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199842|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15199843|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
15199844|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
14825092|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825093|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825094|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14825095|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
14825096|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825097|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825098|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14825099|NCT00915785|Azacitidine|azacitidine|mesh-list
14825100|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14825101|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
14825102|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825103|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825104|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199845|NCT03773510|Trabectedin|trabectedin|mesh-list
15199846|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15199847|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
14702945|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14702946|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702947|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14702948|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
14702949|NCT00404781|Aspirin|aspirin|mesh-list
14702950|NCT00404781|Cilostazol|cilostazol|mesh-list
14702951|NCT00404781|Clopidogrel|clopidogrel|mesh-list
14702952|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14702953|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14702954|NCT00404781|Analgesics|analgesics|mesh-ancestor
14702955|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
14702956|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14702957|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702958|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14702959|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14702960|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14702961|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14702962|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199848|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199849|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199850|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
15199851|NCT03773484|Narcotics|narcotics|mesh-ancestor
15199852|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199853|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199854|NCT03773484|Analgesics|analgesics|mesh-ancestor
15199855|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
15199856|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199857|NCT03773367|Fluorouracil|fluorouracil|mesh-list
15199858|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
14825105|NCT00915811|Fludarabine|fludarabine|mesh-list
14825106|NCT00915811|Busulfan|busulfan|mesh-list
14825107|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
14825108|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14825109|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825110|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825111|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825112|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
14825113|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825114|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
14825115|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14825116|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14825117|NCT00915837|Triamcinolone|triamcinolone|mesh-list
14825118|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14825119|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14825120|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14825121|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825122|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
14825123|NCT00915837|Hormones|hormones|mesh-ancestor
14825124|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825125|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825126|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825127|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
14825128|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825129|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825130|NCT00915850|Cisplatin|cisplatin|mesh-list
14825131|NCT00915850|Docetaxel|docetaxel|mesh-list
14825132|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825133|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
14825134|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
14825135|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
14825136|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825137|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14825138|NCT00915915|Gestodene|gestodene|mesh-list
14825139|NCT00915915|Femovan|femovan|mesh-list
14825140|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14825141|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14825142|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14825143|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
14825144|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14825145|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825146|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14825147|NCT00915915|Estrogens|estrogens|mesh-ancestor
14825148|NCT00915915|Hormones|hormones|mesh-ancestor
14825149|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825150|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15199859|NCT03773367|Irinotecan|irinotecan|mesh-list
15199860|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
15199861|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199862|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15199863|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199864|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15199865|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
15199866|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199867|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14825151|NCT00915915|Progestins|progestins|mesh-ancestor
14825152|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14825153|NCT00916045|Vidarabine|vidarabine|mesh-list
14825154|NCT00916045|Cyclosporine|cyclosporine|mesh-list
14825155|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
15199868|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15199869|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825156|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
14825157|NCT00916045|Melphalan|melphalan|mesh-list
14825158|NCT00916045|Busulfan|busulfan|mesh-list
14825159|NCT00916045|Thiotepa|thiotepa|mesh-list
15199870|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
15199871|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15199872|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15199873|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15199874|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
15199875|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
15199876|NCT03773042|Propofol|propofol|mesh-list
15199877|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199878|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199879|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199880|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15199881|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
15199882|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
15199883|NCT03772834|Methylphenidate|methylphenidate|mesh-list
15199884|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15199885|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199886|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15199887|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15199888|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15199889|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199890|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
15199891|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199892|NCT03772613|Heparin|heparin|mesh-list
15199893|NCT03772613|Calcium heparin|calcium heparin|mesh-list
15199894|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
15199895|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15199896|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15199897|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199898|NCT03772990|Calcium|calcium|mesh-list
15199899|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15199900|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199901|NCT03772574|Nicotine|nicotine|mesh-list
14825160|NCT00916045|Fludarabine|fludarabine|mesh-list
14825161|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
14825162|NCT00916045|Cyclosporins|cyclosporins|mesh-list
14825163|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
14825164|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14825165|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825166|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
14825167|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825168|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825169|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14825170|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
14825171|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825172|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825173|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14825174|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14825175|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
14825176|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
14825177|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825178|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825179|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
14825180|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825181|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14825182|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14825183|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14825184|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
14825185|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14825186|NCT00916097|Docetaxel|docetaxel|mesh-list
15199902|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15199903|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
15199904|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199905|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199906|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15199907|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15199908|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
15199909|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199910|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199911|NCT03772483|Anesthetics|anesthetics|mesh-list
15199912|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199913|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199914|NCT03772561|Durvalumab|durvalumab|mesh-list
15199915|NCT03772561|Olaparib|olaparib|mesh-list
15199916|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15199917|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199918|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14825187|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825188|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
14825189|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
14825190|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
14825191|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825192|NCT00916123|Prednisone|prednisone|mesh-list
14825193|NCT00916123|Docetaxel|docetaxel|mesh-list
14825194|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825195|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
14825196|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
14702963|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14702964|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14702965|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702966|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
14702967|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15199919|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199920|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199921|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
15199922|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15199923|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
15199924|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15199925|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
15199926|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199927|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199928|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
15199929|NCT03772314|Modafinil|modafinil|mesh-list
15199930|NCT03772314|Amphetamine|amphetamine|mesh-list
15199931|NCT03772314|Adderall|adderall|mesh-list
15199932|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
15199933|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15199934|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199935|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15199936|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15199937|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15199938|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199939|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
15199940|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
15199941|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15199942|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
15199943|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199944|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
15199945|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15199946|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15199947|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15199948|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14702968|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14702969|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14702970|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
14702971|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14702972|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14702973|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
14702974|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14702975|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
14702976|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
14702977|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14702978|NCT00404781|Protective Agents|protective agents|mesh-ancestor
14825197|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
15199949|NCT03772262|Metformin|metformin|mesh-list
15199950|NCT03772262|Furosemide|furosemide|mesh-list
15199951|NCT03772262|Midazolam|midazolam|mesh-list
15199952|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15199953|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15199954|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199955|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15199956|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15199957|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15199958|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15199959|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15199960|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15199961|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15199962|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
14825198|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825199|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825200|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
14825201|NCT00916123|Hormones|hormones|mesh-ancestor
14825202|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825203|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702979|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14702980|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14702981|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
14702982|NCT00404794|Prednisolone|prednisolone|mesh-list
14702983|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14702984|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
14702985|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14702986|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
14702987|NCT00404794|Tacrolimus|tacrolimus|mesh-list
14702988|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14702989|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
14702990|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14702991|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
14702992|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14702993|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14702994|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14702995|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14702996|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14825204|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825205|NCT00916201|Cannabidiol|cannabidiol|mesh-list
14825206|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
14825207|NCT00916253|Modafinil|modafinil|mesh-list
15199963|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
15199964|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
15199965|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
15199966|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199967|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199968|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15199969|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15199970|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
15199971|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15199972|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15199973|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15199974|NCT03772262|Diuretics|diuretics|mesh-ancestor
15199975|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
15199976|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15199977|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15199978|NCT03772223|Budesonide|budesonide|mesh-list
15199979|NCT03772223|Albuterol|albuterol|mesh-list
15199980|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15199981|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15199982|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
15199983|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825208|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14825209|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825210|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14825211|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15199984|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15199985|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15199986|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
15199987|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
15199988|NCT03772223|Hormones|hormones|mesh-ancestor
14825212|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14825213|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825214|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14825215|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14825216|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
14825217|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825218|NCT00916409|Temozolomide|temozolomide|mesh-list
14825219|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14825220|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
14825221|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825222|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825223|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14825224|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14825225|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14825226|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
14825227|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825228|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825229|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14825230|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14825231|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
14825232|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825233|NCT00916461|Minocycline|minocycline|mesh-list
14825234|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14825235|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825236|NCT00916500|Cisplatin|cisplatin|mesh-list
14825237|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825238|NCT00916526|Mannitol|mannitol|mesh-list
15199989|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15199990|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
15199991|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15199992|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14825239|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14825240|NCT00916526|Diuretics|diuretics|mesh-ancestor
14825241|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
14825242|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825243|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
14825244|NCT00916552|Hematinics|hematinics|mesh-ancestor
14825245|NCT00916630|Pemetrexed|pemetrexed|mesh-list
14825246|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825247|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825248|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825249|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14825250|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14825251|NCT00916669|Etoposide|etoposide|mesh-list
14825252|NCT00916669|Enoxaparin|enoxaparin|mesh-list
14825253|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
14825254|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825255|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14825256|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14825257|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14825258|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825259|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825260|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
14825261|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14825262|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14825263|NCT00916695|Everolimus|everolimus|mesh-list
15199993|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15199994|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15199995|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
14825264|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15199996|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15199997|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15199998|NCT03772106|Propofol|propofol|mesh-list
15199999|NCT03772106|Sevoflurane|sevoflurane|mesh-list
14825265|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825266|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
14825267|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825268|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14825269|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14825270|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
14825271|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825272|NCT00916760|Antacids|antacids|mesh-ancestor
14825273|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825274|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825275|NCT00916890|Fentanyl|fentanyl|mesh-list
14825276|NCT00916890|Morphine|morphine|mesh-list
14825277|NCT00916890|Oxycodone|oxycodone|mesh-list
14825278|NCT00916890|Buprenorphine|buprenorphine|mesh-list
14825279|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14825280|NCT00916890|Narcotics|narcotics|mesh-ancestor
14825281|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825282|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825283|NCT00916890|Analgesics|analgesics|mesh-ancestor
14825284|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
14825285|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825286|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14825287|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14825288|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
14825289|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
14825290|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14825291|NCT00916942|Lidocaine|lidocaine|mesh-list
14825292|NCT00916942|Prilocaine|prilocaine|mesh-list
14825293|NCT00916942|Capsaicin|capsaicin|mesh-list
14825294|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
14825295|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
14702997|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14702998|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14702999|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
14703000|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15200000|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15200001|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200002|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200003|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15200004|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
15200005|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
15200006|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15200007|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15200008|NCT03772054|Propofol|propofol|mesh-list
15200009|NCT03772054|Sevoflurane|sevoflurane|mesh-list
15200010|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15200011|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200012|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703001|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703002|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703003|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
14825296|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825297|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825298|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
14825299|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825300|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14825301|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14825302|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14825303|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825304|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200013|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15200014|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
14703004|NCT00404794|Hormones|hormones|mesh-ancestor
14703005|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703006|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200015|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
15200016|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15200017|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15200018|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
15200019|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200020|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200021|NCT03771846|Leucovorin|leucovorin|mesh-list
15200022|NCT03771846|Gemcitabine|gemcitabine|mesh-list
14703007|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
14703008|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
14703009|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825305|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
14825306|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14911302|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14703010|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14703011|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14703012|NCT00404794|Protective Agents|protective agents|mesh-ancestor
14703013|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
14703014|NCT00404833|Prednisolone|prednisolone|mesh-list
14703015|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14703016|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
14703017|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14703018|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
14703019|NCT00404833|Chlorambucil|chlorambucil|mesh-list
14703020|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14703021|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
14703022|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14703023|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703024|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14703025|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
14703026|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703027|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703028|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703029|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703030|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703031|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
14703032|NCT00404833|Hormones|hormones|mesh-ancestor
14703033|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703034|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703035|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825307|NCT00917059|Citalopram|citalopram|mesh-list
14825308|NCT00917059|Bupropion|bupropion|mesh-list
14825309|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14825310|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14825311|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825312|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825313|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825314|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
14825315|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825316|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14825317|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
14825318|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825319|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14825320|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
14825321|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14825322|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14825323|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825324|NCT00917163|Sirolimus|sirolimus|mesh-list
14825325|NCT00917163|Everolimus|everolimus|mesh-list
14825326|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825327|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825328|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
14825329|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825330|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14825331|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825332|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14825333|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
14825334|NCT00917241|Dexamethasone|dexamethasone|mesh-list
14825335|NCT00917241|Methimazole|methimazole|mesh-list
14825336|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825337|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
14825338|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
14825339|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825340|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825341|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14703036|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
14295026|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295027|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295028|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
14295029|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295030|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14295031|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
14703037|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
14703038|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703039|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14703040|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14703041|NCT00404833|Protective Agents|protective agents|mesh-ancestor
14825342|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
14825343|NCT00917241|Hormones|hormones|mesh-ancestor
14825344|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825345|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825346|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825347|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
14825348|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
14825349|NCT00917254|Enoxaparin|enoxaparin|mesh-list
14825350|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
14825351|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14825352|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14825353|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825354|NCT00917345|Captopril|captopril|mesh-list
14825355|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14825356|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
14825357|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825358|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200023|NCT03771846|Fluorouracil|fluorouracil|mesh-list
15200024|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
15200025|NCT03771846|Irinotecan|irinotecan|mesh-list
15200026|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15200027|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
15200028|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200029|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200030|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
15200031|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825359|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14825360|NCT00917358|Interferons|interferons|mesh-list
14825361|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
14825362|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
15200032|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825363|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14825364|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825365|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
14825366|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825367|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
14825368|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825369|NCT00917397|Sertraline|sertraline|mesh-list
14825370|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
14825371|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825372|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14825373|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14825374|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825375|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825376|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825377|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
14825378|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825379|NCT00917527|Atorvastatin|atorvastatin|mesh-list
14825380|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14825381|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14825382|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
14825383|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825384|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14825385|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14825386|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825387|NCT00917592|Amoxicillin|amoxicillin|mesh-list
14703042|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14703043|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
14703044|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14703045|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14703046|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703047|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703048|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
14703049|NCT00404937|Hormones|hormones|mesh-ancestor
14825388|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
14825389|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
14825390|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14825391|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825392|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825393|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825394|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14825395|NCT00917748|Docetaxel|docetaxel|mesh-list
14825396|NCT00917748|Modafinil|modafinil|mesh-list
14825397|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200033|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200034|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
15200035|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200036|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15200037|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15200038|NCT03771846|Antidotes|antidotes|mesh-ancestor
15200039|NCT03771846|Protective Agents|protective agents|mesh-ancestor
15200040|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
15200041|NCT03771846|Vitamins|vitamins|mesh-ancestor
15200042|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
15200043|NCT03771755|Acetaminophen|acetaminophen|mesh-list
15200044|NCT03771755|Ibuprofen|ibuprofen|mesh-list
15200045|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15200046|NCT03771755|Analgesics|analgesics|mesh-ancestor
15200047|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
15200048|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200049|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200050|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
15200051|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15200052|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200053|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200054|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15200055|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200056|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200057|NCT03771729|Valsartan|valsartan|mesh-list
15200058|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15200059|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15200060|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15200061|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15200062|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200063|NCT03772067|Insulin|insulin|mesh-list
15200064|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14825398|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14825399|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14825400|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14825401|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825402|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14825403|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825404|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14825405|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14825406|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14825407|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14825408|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
14825409|NCT00917761|Entecavir|entecavir|mesh-list
14825410|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
14825411|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825412|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
14825413|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825414|NCT00917839|Lamotrigine|lamotrigine|mesh-list
14825415|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
14825416|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14825417|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825418|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825419|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14825420|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825421|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14825422|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14825423|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825424|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825425|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14825426|NCT00917878|Calcium|calcium|mesh-list
14825427|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14825428|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200065|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14825429|NCT00917891|Dapivirine|dapivirine|mesh-list
14825430|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14825431|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14825432|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
14825433|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825434|NCT00917904|Dapivirine|dapivirine|mesh-list
14825435|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14825436|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14825437|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
14825438|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825439|NCT00918021|Olanzapine|olanzapine|mesh-list
14825440|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
14825441|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
14825442|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825443|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825444|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825445|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14825446|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14825447|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825448|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825449|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14825450|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14825451|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825452|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200066|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15200067|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200068|NCT03772067|Incretins|incretins|mesh-ancestor
15200069|NCT03772067|Hormones|hormones|mesh-ancestor
15200070|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224499|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
15224500|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224501|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
15224502|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224503|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224504|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224505|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
15224506|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15224507|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
15224508|NCT03556345|Trastuzumab|trastuzumab|mesh-list
15224509|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224510|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224511|NCT03513250|Scopolamine|scopolamine|mesh-list
14825453|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825454|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
14825455|NCT00918034|Talaporfin|talaporfin|mesh-list
14825456|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825457|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14825458|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825459|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
14825460|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
14825461|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14825462|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14825463|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825464|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825465|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14825466|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14825467|NCT00918086|Vitamin D|vitamin d|mesh-list
14825468|NCT00918086|Vitamins|vitamins|mesh-ancestor
14825469|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
14825470|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825471|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14825472|NCT00918177|Levodopa|levodopa|mesh-list
14825473|NCT00918177|Carbidopa|carbidopa|mesh-list
14825474|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14825475|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14825476|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14825477|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
14825478|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825479|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825480|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825481|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14825482|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825483|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14825484|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
14825485|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
14825486|NCT00918190|Dexamethasone|dexamethasone|mesh-list
14825487|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
14825488|NCT00918190|Midazolam|midazolam|mesh-list
14825489|NCT00918190|Ondansetron|ondansetron|mesh-list
14825490|NCT00918190|BB 1101|bb 1101|mesh-list
14825491|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825492|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
14825493|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
14825494|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825495|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825496|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825497|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
14825498|NCT00918190|Hormones|hormones|mesh-ancestor
14825499|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825500|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825501|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825502|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
14825503|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825504|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825505|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15200071|NCT03771677|Interferons|interferons|mesh-list
15200072|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
15200073|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
15200074|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200075|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
15200076|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200077|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
15200078|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200079|NCT03772028|Cisplatin|cisplatin|mesh-list
15200080|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200081|NCT03771781|Empagliflozin|empagliflozin|mesh-list
15200082|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15200083|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200084|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15200085|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200086|NCT03771768|Triamcinolone|triamcinolone|mesh-list
15200087|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15200088|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14825506|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14825507|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825508|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14825509|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15200089|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14825510|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825511|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14825512|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
14825513|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
14825514|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
14825515|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
14825516|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825517|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
14825518|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825519|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14825520|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
14825521|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14825522|NCT00918307|Varenicline|varenicline|mesh-list
14825523|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14825524|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14825525|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
14825526|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825527|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825528|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825529|NCT00918320|Temozolomide|temozolomide|mesh-list
14825530|NCT00918320|Topotecan|topotecan|mesh-list
14825531|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14825532|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
14825533|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825534|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825535|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14825536|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14825537|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825538|NCT00918411|Ramosetron|ramosetron|mesh-list
14825539|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
14825540|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
14825541|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825542|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825543|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825544|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14825545|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
14825546|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825547|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825548|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
14825549|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
14825550|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14825551|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14825552|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825553|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825554|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14825555|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14825556|NCT00918450|Navitoclax|navitoclax|mesh-list
14825557|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825558|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
14825559|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
14825560|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14825561|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825562|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14825563|NCT00918489|Vorinostat|vorinostat|mesh-list
14825564|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200090|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200091|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
15200092|NCT03771768|Hormones|hormones|mesh-ancestor
15200093|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200094|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200095|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200096|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
15200097|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825565|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14825566|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825567|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825568|NCT00918528|Mitomycins|mitomycins|mesh-list
14825569|NCT00918528|Mitomycin|mitomycin|mesh-list
14825570|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14825571|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825572|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
14825573|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200098|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825574|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14825575|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825576|NCT00918554|Methotrexate|methotrexate|mesh-list
15200099|NCT03771638|Tenofovir|tenofovir|mesh-list
15200100|NCT03771638|Emtricitabine|emtricitabine|mesh-list
15200101|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
15200102|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200103|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14825577|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14825578|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
14825579|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14825580|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825581|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14825582|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
14825583|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825584|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825585|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825586|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825587|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14825588|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825589|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
14825590|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200104|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15200105|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200106|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200107|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15200108|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15200109|NCT03771222|Decitabine|decitabine|mesh-list
15200110|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15200111|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
15200112|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200113|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200114|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825591|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14825592|NCT00918593|Bleomycin|bleomycin|mesh-list
14825593|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14825594|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825595|NCT00918632|Axitinib|axitinib|mesh-list
14825596|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825597|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14825598|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825599|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911303|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
14911304|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911305|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911306|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14911307|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
14911308|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14911309|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14911310|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14911311|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
14911312|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911313|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911314|NCT01361997|Ethanol|ethanol|mesh-list
14911315|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
14911316|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14911317|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911318|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911319|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911320|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
14911321|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14911322|NCT01362010|Minocycline|minocycline|mesh-list
14911323|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911324|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15200115|NCT03771066|Bisphenol A|bisphenol a|mesh-list
15200116|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15200117|NCT03771066|Estrogens|estrogens|mesh-ancestor
14825600|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14825601|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
14825602|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825603|NCT00918853|Pancrelipase|pancrelipase|mesh-list
14825604|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825605|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
14825606|NCT00919022|Cyproterone|cyproterone|mesh-list
14825607|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
14825608|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
14825609|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825610|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825611|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825612|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14825613|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
14825614|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14825615|NCT00919178|Vaccines|vaccines|mesh-list
14825616|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
14825617|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825618|NCT00919204|Axitinib|axitinib|mesh-list
14825619|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825620|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14825621|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825622|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825623|NCT00919243|Prednisone|prednisone|mesh-list
14825624|NCT00919243|Allopurinol|allopurinol|mesh-list
14825625|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200118|NCT03771066|Hormones|hormones|mesh-ancestor
15200119|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200120|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200121|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15200122|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
15200123|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200124|NCT03771066|Protective Agents|protective agents|mesh-ancestor
15200125|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
15200126|NCT03771092|Hematinics|hematinics|mesh-ancestor
15200127|NCT03770923|Montelukast|montelukast|mesh-list
15200128|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15200129|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
15200130|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15200131|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
15200132|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200133|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200134|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14825626|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
14825627|NCT00919243|Hormones|hormones|mesh-ancestor
14825628|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825629|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825630|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825631|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825632|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
14825633|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825634|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825635|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
14825636|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825637|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14825638|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
14825639|NCT00919243|Protective Agents|protective agents|mesh-ancestor
14825640|NCT00919282|Leucovorin|leucovorin|mesh-list
14825641|NCT00919282|Folic Acid|folic acid|mesh-list
14825642|NCT00919282|Gemcitabine|gemcitabine|mesh-list
14825643|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
14825644|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14825645|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
14825646|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200135|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15200136|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200137|NCT03770936|Candesartan|candesartan|mesh-list
15200138|NCT03770936|Ramipril|ramipril|mesh-list
15200139|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14825647|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825648|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
14825649|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825650|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825651|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825652|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
14825653|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825654|NCT00919282|Antidotes|antidotes|mesh-ancestor
14825655|NCT00919282|Protective Agents|protective agents|mesh-ancestor
14825656|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
14825657|NCT00919282|Vitamins|vitamins|mesh-ancestor
14825658|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
14825659|NCT00919282|Hematinics|hematinics|mesh-ancestor
14825660|NCT00919295|Mirtazapine|mirtazapine|mesh-list
14825661|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
14825662|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825663|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14825664|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
14825665|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
14825666|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825667|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825668|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825669|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14825670|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14825671|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825672|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14825673|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14825674|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14825675|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
14825676|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14825677|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14825678|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
14825679|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14825680|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14825681|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
14825682|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825683|NCT00919399|Tamoxifen|tamoxifen|mesh-list
14825684|NCT00919399|Exemestane|exemestane|mesh-list
14825685|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14825686|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
14825687|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825688|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825689|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825690|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825691|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14825692|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14825693|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14825694|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14825695|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14825696|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825697|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825698|NCT00919438|Diuretics|diuretics|mesh-list
14825699|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
14825700|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825701|NCT00919451|Cyclosporine|cyclosporine|mesh-list
14825702|NCT00919451|Cyclosporins|cyclosporins|mesh-list
14825703|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825704|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825705|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825706|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
14825707|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825708|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
14825709|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825710|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825711|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825712|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14825713|NCT00919542|Cyclosporine|cyclosporine|mesh-list
14825714|NCT00919542|Prednisolone|prednisolone|mesh-list
14825715|NCT00919542|Cyclosporins|cyclosporins|mesh-list
14825716|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825717|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825718|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825719|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
14825720|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825721|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
14825722|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825723|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825724|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200140|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14825725|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14825726|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825727|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
14825728|NCT00919542|Hormones|hormones|mesh-ancestor
14825729|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825730|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825731|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825732|NCT00919555|Pioglitazone|pioglitazone|mesh-list
14825733|NCT00919555|Tretinoin|tretinoin|mesh-list
14825734|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14825735|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825736|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825737|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
14825738|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825739|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14825740|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
14825741|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825742|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14825743|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14825744|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825745|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825746|NCT00919776|Cyclosporine|cyclosporine|mesh-list
14825747|NCT00919776|Prednisolone|prednisolone|mesh-list
14825748|NCT00919776|Cyclosporins|cyclosporins|mesh-list
14825749|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825750|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825751|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825752|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
14825753|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825754|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
15200141|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15200142|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200143|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15200144|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
15200145|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200146|NCT03770806|Acetaminophen|acetaminophen|mesh-list
15200147|NCT03770806|Celecoxib|celecoxib|mesh-list
15200148|NCT03770806|Oxycodone|oxycodone|mesh-list
15200149|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15200150|NCT03770806|Analgesics|analgesics|mesh-ancestor
15200151|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
15200152|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703050|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703051|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703052|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14703053|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14703054|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
14703055|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14703056|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703057|NCT00405080|Rifampin|rifampin|mesh-list
14703058|NCT00405080|Casopitant|casopitant|mesh-list
14703059|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14825755|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825756|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
15200153|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200154|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
15200155|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14825757|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825758|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14825759|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825760|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
14825761|NCT00919776|Hormones|hormones|mesh-ancestor
14825762|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825763|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825764|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825765|NCT00919815|Cyclosporine|cyclosporine|mesh-list
14825766|NCT00919815|Prednisolone|prednisolone|mesh-list
14825767|NCT00919815|Cyclosporins|cyclosporins|mesh-list
14825768|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703060|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
14703061|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15200156|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200157|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200158|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15200159|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15200160|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200161|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200162|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15200163|NCT03770806|Narcotics|narcotics|mesh-ancestor
15200164|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200165|NCT03771053|Simvastatin|simvastatin|mesh-list
15200166|NCT03771053|Ezetimibe|ezetimibe|mesh-list
15200167|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15200168|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15200169|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
15200170|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200171|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15200172|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15200173|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200174|NCT03770416|Nivolumab|nivolumab|mesh-list
15200175|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14825769|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825770|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703062|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703063|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
14703064|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14703065|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703066|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703067|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15200176|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200177|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15200178|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200179|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15200180|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703068|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14703069|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14703070|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14703071|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14703072|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14825771|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
14825772|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200181|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
15200182|NCT03770663|Azathioprine|azathioprine|mesh-list
15200183|NCT03770663|Tacrolimus|tacrolimus|mesh-list
15200184|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200185|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
15200186|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200187|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703073|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
14703074|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
14703075|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703076|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825773|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
14825774|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200188|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14825775|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825776|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825777|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14825778|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825779|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
14825780|NCT00919815|Hormones|hormones|mesh-ancestor
15200189|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
14703077|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14703078|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14703079|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703080|NCT00405119|Esomeprazole|esomeprazole|mesh-list
14703081|NCT00405119|Ranitidine|ranitidine|mesh-list
14703082|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14703083|NCT00405119|Loxtidine|loxtidine|mesh-list
14703084|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15200190|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200191|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200192|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15200193|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15200194|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295032|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14295033|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14825781|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825782|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825783|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825784|NCT00919880|Paclitaxel|paclitaxel|mesh-list
14825785|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14825786|NCT00919880|Carboplatin|carboplatin|mesh-list
14825787|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14825788|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825789|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
14825790|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
14825791|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
14825792|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825793|NCT00919919|Progesterone|progesterone|mesh-list
14295034|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15200195|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
14825794|NCT00919919|Progestins|progestins|mesh-ancestor
14825795|NCT00919919|Hormones|hormones|mesh-ancestor
14825796|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825797|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825798|NCT00919984|Paclitaxel|paclitaxel|mesh-list
14825799|NCT00919984|Carboplatin|carboplatin|mesh-list
15200196|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14295035|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703085|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825800|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14825801|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200197|NCT03770637|Glucagon|glucagon|mesh-list
14825802|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
14825803|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
14825804|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
14825805|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825806|NCT00920088|Ritonavir|ritonavir|mesh-list
14825807|NCT00920088|Lopinavir|lopinavir|mesh-list
15200198|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15200199|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15200200|NCT03770637|Hormones|hormones|mesh-ancestor
15200201|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200202|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200203|NCT03770637|Incretins|incretins|mesh-ancestor
15200204|NCT03770767|Insulin|insulin|mesh-list
15200205|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15200206|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
15200207|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15200208|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200209|NCT03770338|Teriparatide|teriparatide|mesh-list
15200210|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15200211|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200212|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15200213|NCT03770208|Lidocaine|lidocaine|mesh-list
15200214|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
15200215|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
15200216|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200217|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200218|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
15200219|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200220|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15200221|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15200222|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15200223|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14703086|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14703087|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703088|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703089|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14703090|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
14825808|NCT00920088|Darunavir|darunavir|mesh-list
14825809|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
14825810|NCT00920088|Midazolam|midazolam|mesh-list
14825811|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
14825812|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14825813|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14825814|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14825815|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825816|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14825817|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14825818|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14825819|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14825820|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
14825821|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
14825822|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
14825823|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
14825824|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825825|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825826|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14825827|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14825828|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
14825829|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825830|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15200224|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200225|NCT03770000|Romidepsin|romidepsin|mesh-list
14703091|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
14703092|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703093|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703094|NCT00405158|Acetaminophen|acetaminophen|mesh-list
14703095|NCT00405158|Antipyretics|antipyretics|mesh-list
14703096|NCT00405158|Penicillins|penicillins|mesh-list
14703097|NCT00405158|Floxacillin|floxacillin|mesh-list
14703098|NCT00405158|Cefadroxil|cefadroxil|mesh-list
14703099|NCT00405158|Oxytocin|oxytocin|mesh-list
15200226|NCT03770000|Tenalisib|tenalisib|mesh-list
15200227|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15200228|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703100|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
14825831|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14825832|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
14825833|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825834|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14825835|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14825836|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
14825837|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
14825838|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14825839|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14825840|NCT00920088|Analgesics|analgesics|mesh-ancestor
14825841|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
14825842|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825843|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14825844|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14825845|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825846|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825847|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14825848|NCT00920101|Atorvastatin|atorvastatin|mesh-list
14825849|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14825850|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14825851|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
14825852|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825853|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14825854|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14825855|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825856|NCT00920153|Gemcitabine|gemcitabine|mesh-list
14825857|NCT00920153|Cytarabine|cytarabine|mesh-list
14825858|NCT00920153|Dexamethasone|dexamethasone|mesh-list
14825859|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
14825860|NCT00920153|Doxorubicin|doxorubicin|mesh-list
14825861|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14825862|NCT00920153|Etoposide|etoposide|mesh-list
15200229|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
15200230|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200231|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825863|NCT00920153|Vincristine|vincristine|mesh-list
14825864|NCT00920153|Melphalan|melphalan|mesh-list
14825865|NCT00920153|Vinorelbine|vinorelbine|mesh-list
14825866|NCT00920153|Ifosfamide|ifosfamide|mesh-list
14825867|NCT00920153|Dacarbazine|dacarbazine|mesh-list
14825868|NCT00920153|Carmustine|carmustine|mesh-list
14825869|NCT00920153|Bleomycin|bleomycin|mesh-list
14825870|NCT00920153|Vindesine|vindesine|mesh-list
14825871|NCT00920153|Mitoguazone|mitoguazone|mesh-list
14825872|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825873|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14825874|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
14825875|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
14825876|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703101|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14703102|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703103|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703104|NCT00405158|Analgesics|analgesics|mesh-ancestor
14703105|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
14825877|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825878|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825879|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
14825880|NCT00920153|Hormones|hormones|mesh-ancestor
14825881|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825882|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14825883|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14825884|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
14825885|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825886|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
14825887|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825888|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825889|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825890|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
15224512|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14703106|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703107|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703108|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703109|NCT00405171|Nevirapine|nevirapine|mesh-list
14703110|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14703111|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14825891|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14825892|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14825893|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14825894|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14825895|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
14825896|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
14825897|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
14825898|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14825899|NCT00920153|Protective Agents|protective agents|mesh-ancestor
14825900|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14825901|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
14825902|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14825903|NCT00920244|Atropine|atropine|mesh-list
14825904|NCT00920244|Amiodarone|amiodarone|mesh-list
14825905|NCT00920244|Epinephrine|epinephrine|mesh-list
14825906|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14825907|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14825908|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
14825909|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14825910|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703112|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703113|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703114|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
14703115|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703116|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14825911|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825912|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14825913|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14825914|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
14825915|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14825916|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14825917|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
14825918|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
14703117|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14703118|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14703119|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14703120|NCT00405210|Docetaxel|docetaxel|mesh-list
14703121|NCT00405210|Sorafenib|sorafenib|mesh-list
14825919|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
14825920|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14825921|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14825922|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14825923|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
14825924|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14825925|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14825926|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
14825927|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
14825928|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14703122|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703123|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703124|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
14703125|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
14703126|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703127|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14703128|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703129|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
14703130|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14703131|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
14703132|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703133|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825929|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14825930|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14825931|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14825932|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14825933|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825934|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14825935|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14825936|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14825937|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14825938|NCT00920270|Colistin|colistin|mesh-list
14825939|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825940|NCT00920283|Cobalt|cobalt|mesh-list
14825941|NCT00920283|Trace Elements|trace elements|mesh-ancestor
14825942|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
14825943|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825944|NCT00920296|Cabotegravir|cabotegravir|mesh-list
14825945|NCT00920296|Etravirine|etravirine|mesh-list
14825946|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14825947|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14825948|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825949|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825950|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14825951|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14825952|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
14825953|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14825954|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14825955|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14825956|NCT00920413|Ascorbic Acid|ascorbic acid|mesh-list
14825957|NCT00920413|Vitamins|vitamins|mesh-ancestor
14825958|NCT00920413|Micronutrients|micronutrients|mesh-ancestor
14825959|NCT00920413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825960|NCT00920413|Antioxidants|antioxidants|mesh-ancestor
14825961|NCT00920413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825962|NCT00920413|Protective Agents|protective agents|mesh-ancestor
14825963|NCT00920465|Misoprostol|misoprostol|mesh-list
14825964|NCT00920465|Mifepristone|mifepristone|mesh-list
14825965|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14825966|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
14825967|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14825968|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825969|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14825970|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14825971|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
14825972|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14825973|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14825974|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14825975|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14825976|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
14825977|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14825978|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14825979|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
14825980|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14825981|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
14825982|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14825983|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14911325|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14911326|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
14703134|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14703135|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
14703136|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
14917135|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14917136|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917137|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
14917138|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917139|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
14917140|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917141|NCT01396291|Asenapine|asenapine|mesh-list
14917142|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14917143|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917144|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917145|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917146|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917147|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14917148|NCT01396304|Calcium|calcium|mesh-list
14917149|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14917150|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917151|NCT01396304|Laxatives|laxatives|mesh-ancestor
14703137|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14703138|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
14703139|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703140|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703141|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
14703142|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14917152|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917153|NCT01396564|Metformin|metformin|mesh-list
14917154|NCT01396564|Pioglitazone|pioglitazone|mesh-list
15200232|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
15200233|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15200234|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15200235|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
15200236|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200237|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200238|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14825984|NCT00920608|Methotrexate|methotrexate|mesh-list
14825985|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14825986|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
14825987|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14825988|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14825989|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14825990|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
14825991|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14825992|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14825993|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
14825994|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14825995|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14825996|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14825997|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
14825998|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14825999|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14826000|NCT00920660|Prednisolone|prednisolone|mesh-list
14826001|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200239|NCT03770039|PF-06700841|pf-06700841|mesh-list
15200240|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15200241|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200242|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200243|NCT03770026|Clomiphene|clomiphene|mesh-list
15200244|NCT03770026|Enclomiphene|enclomiphene|mesh-list
15200245|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
15200246|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15200247|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
15200248|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200249|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200250|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15200251|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
15200252|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15200253|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15200254|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15200255|NCT03770013|Clonidine|clonidine|mesh-list
15200256|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
15200257|NCT03770013|Bupivacaine|bupivacaine|mesh-list
15200258|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
15200259|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
15200260|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200261|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200262|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
15200263|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200264|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15200265|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15200266|NCT03770013|Analgesics|analgesics|mesh-ancestor
15200267|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15200268|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15200269|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15200270|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
15200271|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200272|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200273|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15200274|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
15200275|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
15200276|NCT03769935|Etoposide|etoposide|mesh-list
14703143|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14703144|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703145|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703146|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
14703147|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703148|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14703149|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14703150|NCT00405262|Ketorolac|ketorolac|mesh-list
14703151|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14826002|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
15200277|NCT03769935|Cisplatin|cisplatin|mesh-list
15200278|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15200279|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200280|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14826003|NCT00920660|Hormones|hormones|mesh-ancestor
14826004|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14826005|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826006|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14826007|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826008|NCT00920725|Insulin|insulin|mesh-list
14826009|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14826010|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
14826011|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826012|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826013|NCT00920803|Resveratrol|resveratrol|mesh-list
14826014|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
14826015|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826016|NCT00920803|Protective Agents|protective agents|mesh-ancestor
14826017|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826018|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826019|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14826020|NCT00920868|Bevacizumab|bevacizumab|mesh-list
14826021|NCT00920868|Capecitabine|capecitabine|mesh-list
14826022|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
14826023|NCT00920868|Dasatinib|dasatinib|mesh-list
14826024|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14826025|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826026|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14826027|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14826028|NCT00920868|Growth Substances|growth substances|mesh-ancestor
14826029|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826030|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
14826031|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14826032|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
14826033|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826034|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14826035|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826036|NCT00920933|Prednisolone|prednisolone|mesh-list
14826037|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826038|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
14826039|NCT00920933|Hormones|hormones|mesh-ancestor
14826040|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14826041|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826042|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14826043|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826044|NCT00920998|Z 338|z 338|mesh-list
14826045|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14826046|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826047|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826048|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
14826049|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826050|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826051|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14826052|NCT00921063|Alprazolam|alprazolam|mesh-list
14826053|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14826054|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826055|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826056|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15200281|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15200282|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200283|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224513|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15224514|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
15224515|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
15224516|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224517|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224518|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224519|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
15224520|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15224521|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
15224522|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826057|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14826058|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14826059|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
14826060|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
14826061|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826062|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826063|NCT00921102|Atropine|atropine|mesh-list
14826064|NCT00921102|Morphine|morphine|mesh-list
14826065|NCT00921102|Bupivacaine|bupivacaine|mesh-list
14826066|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
14826067|NCT00921102|Anesthetics|anesthetics|mesh-list
14826068|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826069|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826070|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
14826071|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826072|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14826073|NCT00921102|Narcotics|narcotics|mesh-ancestor
14826074|NCT00921102|Analgesics|analgesics|mesh-ancestor
14826075|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14826076|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14826077|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14826078|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
14826079|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14826080|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
14826081|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
14826082|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
14826083|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14826084|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14826085|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
14826086|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826087|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826088|NCT00921128|Muscimol|muscimol|mesh-list
14826089|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14826090|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
14826091|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
14826092|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826093|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826094|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826095|NCT00921154|Ivermectin|ivermectin|mesh-list
14826096|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14826097|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826098|NCT00921167|Bevacizumab|bevacizumab|mesh-list
14826099|NCT00921167|Irinotecan|irinotecan|mesh-list
14826100|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14826101|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826102|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14826103|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14826104|NCT00921167|Growth Substances|growth substances|mesh-ancestor
14826105|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826106|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14826107|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14826108|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14826109|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826110|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826111|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14826112|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
14826113|NCT00921180|Entecavir|entecavir|mesh-list
14826114|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
14826115|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826116|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
14826117|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826118|NCT00921219|Ivermectin|ivermectin|mesh-list
14826119|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14826120|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826121|NCT00921245|Darifenacin|darifenacin|mesh-list
14826122|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15200284|NCT03769870|Atorvastatin|atorvastatin|mesh-list
15200285|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14826123|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14826124|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
15200286|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15200287|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
14826125|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826126|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826127|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826128|NCT00921245|Urological Agents|urological agents|mesh-ancestor
14826129|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
15225694|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200288|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200289|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14826130|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14826131|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826132|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826133|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826134|NCT00921284|Analgesics|analgesics|mesh-ancestor
14826135|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
14826136|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826137|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14826138|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14826139|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14826140|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
14826141|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826142|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826143|NCT00921349|Nadolol|nadolol|mesh-list
14826144|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14826145|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14826146|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
14826147|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826148|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826149|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826150|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14826151|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14826152|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
14826153|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
14826154|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826155|NCT00921388|Varenicline|varenicline|mesh-list
14826156|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14826157|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15200290|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15200291|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200292|NCT03769818|Dexamethasone|dexamethasone|mesh-list
15200293|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
15200294|NCT03769818|Bupivacaine|bupivacaine|mesh-list
15200295|NCT03769818|BB 1101|bb 1101|mesh-list
15200296|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200297|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
15200298|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
15200299|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200300|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200301|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15200302|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
14703152|NCT00405262|Bupivacaine|bupivacaine|mesh-list
14703153|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
14826158|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
14826159|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826160|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826161|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826162|NCT00921414|Rituximab|rituximab|mesh-list
14911327|NCT01362153|Golimumab|golimumab|mesh-list
15200303|NCT03769818|Hormones|hormones|mesh-ancestor
15200304|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703154|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
14703155|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14703156|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703157|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
14703158|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703159|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14703160|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703161|NCT00405262|Analgesics|analgesics|mesh-ancestor
14703162|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703163|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703164|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14703165|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703166|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703167|NCT00405301|Rifampin|rifampin|mesh-list
15200305|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200306|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200307|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
15200308|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200309|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200310|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
15200311|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
15200312|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200313|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
15200314|NCT03769714|Bupivacaine|bupivacaine|mesh-list
15200315|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
15200316|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
15200317|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200318|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200319|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
15200320|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200321|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
15200322|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200323|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200324|NCT03769402|Citric Acid|citric acid|mesh-list
15200325|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
14826163|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14826164|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826165|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
14826166|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826167|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826168|NCT00921505|Acetaminophen|acetaminophen|mesh-list
14826169|NCT00921505|Ibuprofen|ibuprofen|mesh-list
14826170|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826171|NCT00921505|Analgesics|analgesics|mesh-ancestor
14826172|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
14826173|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826174|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826175|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
14826176|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14826177|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826178|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826179|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14826180|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826181|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826182|NCT00921531|Thalidomide|thalidomide|mesh-list
14826183|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826184|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
14826185|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826186|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
14826187|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826188|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826189|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14826190|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14826191|NCT00921531|Growth Substances|growth substances|mesh-ancestor
14826192|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
14826193|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826194|NCT00921570|Amlodipine|amlodipine|mesh-list
14826195|NCT00921570|Valsartan|valsartan|mesh-list
15200326|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
15200327|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15200328|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
15200329|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
15200330|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200331|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
15200332|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200333|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200334|NCT03769103|Osimertinib|osimertinib|mesh-list
15200335|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826196|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15200336|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15200337|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200338|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826197|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14826198|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826199|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826200|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14826201|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826202|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
14826203|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14826204|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14826205|NCT00921622|Vitamin D|vitamin d|mesh-list
14826206|NCT00921622|Vitamins|vitamins|mesh-list
14826207|NCT00921622|Ascorbic Acid|ascorbic acid|mesh-list
14826208|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
14826209|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200339|NCT03769064|Methylphenidate|methylphenidate|mesh-list
15200340|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15200341|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200342|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15200343|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15200344|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15200345|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200346|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
15200347|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200348|NCT03768908|Artesunate|artesunate|mesh-list
15200349|NCT03768908|Lumefantrine|lumefantrine|mesh-list
15200350|NCT03768908|Artemether|artemether|mesh-list
15200351|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14826210|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14826211|NCT00921622|Antioxidants|antioxidants|mesh-ancestor
14826212|NCT00921622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826213|NCT00921622|Protective Agents|protective agents|mesh-ancestor
14826214|NCT00921661|Aflibercept|aflibercept|mesh-list
14826215|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14826216|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14826217|NCT00921661|Growth Substances|growth substances|mesh-ancestor
14826218|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826219|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
14826220|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826221|NCT00921674|Ivermectin|ivermectin|mesh-list
14826222|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14826223|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826224|NCT00921700|Acetaminophen|acetaminophen|mesh-list
14826225|NCT00921700|Ibuprofen|ibuprofen|mesh-list
14826226|NCT00921700|Codeine|codeine|mesh-list
14826227|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826228|NCT00921700|Analgesics|analgesics|mesh-ancestor
14826229|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
14826230|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826231|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826232|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
14826233|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14826234|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826235|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826236|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14826237|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826238|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826239|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14826240|NCT00921700|Narcotics|narcotics|mesh-ancestor
14826241|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200352|NCT03768908|Amodiaquine|amodiaquine|mesh-list
15200353|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
15200354|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15200355|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15200356|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200357|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200358|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
15200359|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
15200360|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15200361|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
15200362|NCT03768882|Acetaminophen|acetaminophen|mesh-list
15200363|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15200364|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15200365|NCT03768882|Analgesics|analgesics|mesh-ancestor
15200366|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
15200367|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200368|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200369|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
15200370|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14826242|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
14826243|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
14826244|NCT00921726|Oseltamivir|oseltamivir|mesh-list
14826245|NCT00921726|Zanamivir|zanamivir|mesh-list
14826246|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
14826247|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826248|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826249|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826250|NCT00921765|Ketamine|ketamine|mesh-list
14826251|NCT00921765|Naloxone|naloxone|mesh-list
14826252|NCT00921765|Analgesics|analgesics|mesh-ancestor
14826253|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
14826254|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826255|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826256|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14826257|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14826258|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
14826259|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
14826260|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826261|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14826262|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14826263|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826264|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826265|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14826266|NCT00921804|Risperidone|risperidone|mesh-list
14826267|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14826268|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
14826269|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826270|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826271|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826272|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14826273|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14826274|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826275|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15200371|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200372|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200373|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15200374|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15200375|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200376|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
15200377|NCT03768713|Suvorexant|suvorexant|mesh-list
15200378|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15200379|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15200380|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200381|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200382|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15200383|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200384|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200385|NCT03768609|Cyclosporine|cyclosporine|mesh-list
15200386|NCT03768609|Cyclosporins|cyclosporins|mesh-list
15200387|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200388|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200389|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200390|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
15200391|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826276|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14826277|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
14826278|NCT00921830|Ibuprofen|ibuprofen|mesh-list
15200392|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
15200393|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200394|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
15200395|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200396|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15200397|NCT03768596|Vaccines|vaccines|mesh-list
15200398|NCT03768596|Immunologic Factors|immunologic factors|mesh-ancestor
14826279|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14826280|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826281|NCT00921830|Analgesics|analgesics|mesh-ancestor
15200399|NCT03768596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200400|NCT03768557|Minocycline|minocycline|mesh-list
15200401|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15200402|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200403|NCT03768531|Nivolumab|nivolumab|mesh-list
14826282|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
14826283|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826284|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826285|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826286|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826287|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14826288|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826289|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826290|NCT00921973|Vaccines|vaccines|mesh-list
15200404|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200405|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200406|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15200407|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200408|NCT03768518|Exenatide|exenatide|mesh-list
15200409|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826291|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
14826292|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826293|NCT00922129|Cyclosporine|cyclosporine|mesh-list
14826294|NCT00922129|Sirolimus|sirolimus|mesh-list
14826295|NCT00922129|Tacrolimus|tacrolimus|mesh-list
14826296|NCT00922129|Cyclosporins|cyclosporins|mesh-list
14826297|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826298|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
14826299|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200410|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200411|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15200412|NCT03768518|Incretins|incretins|mesh-ancestor
15200413|NCT03768518|Hormones|hormones|mesh-ancestor
15200414|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200415|NCT03768427|Atorvastatin|atorvastatin|mesh-list
15200416|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15200417|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14826300|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14826301|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200418|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
14911328|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15200419|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200420|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15200421|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15200422|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200423|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
15200424|NCT03768258|Anastrozole|anastrozole|mesh-list
15200425|NCT03768258|Testosterone|testosterone|mesh-list
15200426|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
15200427|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
15200428|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15200429|NCT03768258|Androgens|androgens|mesh-ancestor
15200430|NCT03768258|Hormones|hormones|mesh-ancestor
14826302|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826303|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
14826304|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826305|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14826306|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826307|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826308|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14826309|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911329|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14911330|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911331|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911332|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
14911333|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911334|NCT01362218|Aspirin|aspirin|mesh-list
14703168|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
14703169|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14703170|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
14911335|NCT01362218|Ramipril|ramipril|mesh-list
14911336|NCT01362218|Simvastatin|simvastatin|mesh-list
14911337|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14911338|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14911339|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
14911340|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911341|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14911342|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14911343|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911344|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911345|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911346|NCT01362218|Analgesics|analgesics|mesh-ancestor
14911347|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
14911348|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911349|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911350|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911351|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911352|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14911353|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14911354|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14911355|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14911356|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
14911357|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14911358|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
14703171|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911359|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14911360|NCT01362309|Cycloserine|cycloserine|mesh-list
14911361|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14911362|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911363|NCT01362309|Renal Agents|renal agents|mesh-ancestor
14911364|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14911365|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
14911366|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911367|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
14917155|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15224523|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703172|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703173|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
14703174|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14703175|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200431|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200432|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200433|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200434|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200435|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
15200436|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15200437|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15200438|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200439|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200440|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15200441|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
15200442|NCT03768037|Pemetrexed|pemetrexed|mesh-list
15200443|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200444|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200445|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200446|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15200447|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15200448|NCT03768024|Hydromorphone|hydromorphone|mesh-list
15200449|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15200450|NCT03768024|Narcotics|narcotics|mesh-ancestor
14826310|NCT00922389|Lenograstim|lenograstim|mesh-list
14826311|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14826312|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
14826313|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826314|NCT00922402|Insulin|insulin|mesh-list
14826315|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826316|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826317|NCT00922467|Esmolol|esmolol|mesh-list
14826318|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14826319|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14826320|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15200451|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826321|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
14826322|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826323|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826324|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703176|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703177|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14703178|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14703179|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14826325|NCT00922506|Doxazosin|doxazosin|mesh-list
14826326|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14826327|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14826328|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14826329|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
14826330|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826331|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826332|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826333|NCT00922506|Urological Agents|urological agents|mesh-ancestor
14826334|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14826335|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14826336|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14826337|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14826338|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
14826339|NCT00922519|Listerine|listerine|mesh-list
14826340|NCT00922519|Fluorides|fluorides|mesh-list
14703180|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14703181|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14703182|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14703183|NCT00405340|Rituximab|rituximab|mesh-list
14703184|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14826341|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
14826342|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
14826343|NCT00922519|Protective Agents|protective agents|mesh-ancestor
14826344|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826345|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14826346|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826347|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
14826348|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14826349|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
14826350|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826351|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826352|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14826353|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
14826354|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14826355|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
14826356|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826357|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826358|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14826359|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
14826360|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
14826361|NCT00922532|Protective Agents|protective agents|mesh-ancestor
14703185|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703186|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
14703187|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703188|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703189|NCT00405366|Sorafenib|sorafenib|mesh-list
14703190|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703191|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14703192|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703193|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703194|NCT00405405|Bevacizumab|bevacizumab|mesh-list
14703195|NCT00405405|Cisplatin|cisplatin|mesh-list
14703196|NCT00405405|Docetaxel|docetaxel|mesh-list
14703197|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14703198|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703199|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703200|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703201|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703202|NCT00405405|Growth Substances|growth substances|mesh-ancestor
14703203|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703204|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703205|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703206|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
14703207|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
14703208|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826362|NCT00922584|Sorafenib|sorafenib|mesh-list
14826363|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826364|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14826365|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826366|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826367|NCT00922597|Factor VIII|factor viii|mesh-list
14826368|NCT00922597|Coagulants|coagulants|mesh-ancestor
14826369|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
14826370|NCT00922610|Hematinics|hematinics|mesh-ancestor
14826371|NCT00922649|Insulin|insulin|mesh-list
14826372|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826373|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826374|NCT00922844|Sevoflurane|sevoflurane|mesh-list
14826375|NCT00922844|Isoflurane|isoflurane|mesh-list
14826376|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15200452|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200453|NCT03768024|Analgesics|analgesics|mesh-ancestor
15200454|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
15200455|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200456|NCT03767920|Dexamethasone|dexamethasone|mesh-list
15200457|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
15200458|NCT03767920|Bupivacaine|bupivacaine|mesh-list
14826377|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14826378|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
14826379|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
14826380|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200459|NCT03767920|BB 1101|bb 1101|mesh-list
15200460|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200461|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
15200462|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
14826381|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826382|NCT00922896|Gemcitabine|gemcitabine|mesh-list
14826383|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14826384|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826385|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14826386|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
14826387|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826388|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
14826389|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826390|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826391|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826392|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
14826393|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826394|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14826395|NCT00923000|Morphine|morphine|mesh-list
14826396|NCT00923000|Nalbuphine|nalbuphine|mesh-list
14826397|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14826398|NCT00923000|Narcotics|narcotics|mesh-ancestor
14826399|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826400|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826401|NCT00923000|Analgesics|analgesics|mesh-ancestor
14826402|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
15200463|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200464|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200465|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15200466|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
15200467|NCT03767920|Hormones|hormones|mesh-ancestor
14826403|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826404|NCT00923169|Mitogens|mitogens|mesh-list
14826405|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
14826406|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826407|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
14826408|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14826409|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826410|NCT00923234|Lenalidomide|lenalidomide|mesh-list
14826411|NCT00923234|Azacitidine|azacitidine|mesh-list
14826412|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
14826413|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826414|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14826415|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14826416|NCT00923234|Growth Substances|growth substances|mesh-ancestor
14826417|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
14826418|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826419|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14826420|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
14826421|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826422|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826423|NCT00923247|Bortezomib|bortezomib|mesh-list
14826424|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826425|NCT00923299|Trastuzumab|trastuzumab|mesh-list
14826426|NCT00923299|Cetuximab|cetuximab|mesh-list
14826427|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14826428|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826429|NCT00923390|Aldesleukin|aldesleukin|mesh-list
14826430|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
14826431|NCT00923390|Fludarabine|fludarabine|mesh-list
14826432|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826433|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
14826434|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826435|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826436|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14826437|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
14826438|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826439|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826440|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14826441|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15200468|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200469|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200470|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826442|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14826443|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
14826444|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826445|NCT00923494|Ropivacaine|ropivacaine|mesh-list
14826446|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
15200471|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
15200472|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200473|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200474|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
15200475|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
14826447|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
14826448|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826449|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826450|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
14826451|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826452|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14826453|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14826454|NCT00923533|Diuretics|diuretics|mesh-ancestor
14826455|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
14826456|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826457|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14826458|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826459|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826460|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14826461|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14826462|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826463|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
15200476|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200477|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
15224524|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14826464|NCT00923637|Pemetrexed|pemetrexed|mesh-list
14826465|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826466|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826467|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826468|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14826469|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14826470|NCT00923663|Lenalidomide|lenalidomide|mesh-list
14826471|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
14826472|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826473|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14826474|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14826475|NCT00923663|Growth Substances|growth substances|mesh-ancestor
15224525|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
15224526|NCT03436563|Atezolizumab|atezolizumab|mesh-list
15224527|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224528|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15224529|NCT03406156|Venetoclax|venetoclax|mesh-list
14826476|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14826477|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826478|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14826479|NCT00923676|Fenofibrate|fenofibrate|mesh-list
14826480|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14826481|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14826482|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
14826483|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826484|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14826485|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14826486|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224530|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
15224531|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15224532|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
14826487|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
14826488|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826489|NCT00923806|Aldesleukin|aldesleukin|mesh-list
14826490|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826491|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14826492|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14826493|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
14826494|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826495|NCT00923962|Adenosine|adenosine|mesh-list
15224533|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224534|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826496|NCT00923962|Glucagon|glucagon|mesh-list
14826497|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14826498|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14826499|NCT00923962|Hormones|hormones|mesh-ancestor
14826500|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14826501|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826502|NCT00923962|Incretins|incretins|mesh-ancestor
14826503|NCT00923962|Analgesics|analgesics|mesh-ancestor
14826504|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
14826505|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826506|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14826507|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
14826508|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14826509|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
15200478|NCT03767660|Sirolimus|sirolimus|mesh-list
15200479|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15200480|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200481|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15200482|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703209|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14826510|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
14826511|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826512|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826513|NCT00924014|Furosemide|furosemide|mesh-list
14826514|NCT00924014|Conivaptan|conivaptan|mesh-list
14826515|NCT00924014|Diuretics|diuretics|mesh-ancestor
14826516|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
14826517|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826518|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14826519|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826520|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826521|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14826522|NCT00924079|Nalbuphine|nalbuphine|mesh-list
14826523|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14826524|NCT00924079|Narcotics|narcotics|mesh-ancestor
15200483|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
15200484|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200485|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
15200486|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200487|NCT03767569|Folic Acid|folic acid|mesh-list
14703210|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728554|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728555|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14728556|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14728557|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14826525|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826526|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826527|NCT00924079|Analgesics|analgesics|mesh-ancestor
14826528|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
14826529|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826530|NCT00924222|Propofol|propofol|mesh-list
14826531|NCT00924222|Sevoflurane|sevoflurane|mesh-list
14826532|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14826533|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826534|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826535|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14826536|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
14826537|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
14826538|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15200488|NCT03767569|Inositol|inositol|mesh-list
15200489|NCT03767569|Hematinics|hematinics|mesh-ancestor
14728558|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200490|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
14826539|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14911368|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911369|NCT01362361|Nintedanib|nintedanib|mesh-list
14911370|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911371|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14911372|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911373|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911374|NCT01362400|Docetaxel|docetaxel|mesh-list
14911375|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911376|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
14911377|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
14911378|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
14911379|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911380|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14911381|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14911382|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14911383|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911384|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911385|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911386|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14911387|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14911388|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
14911389|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703211|NCT00405418|Insulin|insulin|mesh-list
14703212|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14703213|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
14703214|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
14703215|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14703216|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703217|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
14703218|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14703219|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14911390|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200491|NCT03767569|Vitamins|vitamins|mesh-ancestor
15200492|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
15200493|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911391|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14911392|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14911393|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
14911394|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
14911395|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911396|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14911397|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911398|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911399|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
14911400|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14911401|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911402|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14911403|NCT01363037|Maraviroc|maraviroc|mesh-list
14911404|NCT01363037|Dapivirine|dapivirine|mesh-list
14911405|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14911406|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14911407|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911408|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14911409|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14911410|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
14911411|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911412|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14911413|NCT01363063|Ketorolac|ketorolac|mesh-list
14911414|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14911415|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911416|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911417|NCT01363063|Analgesics|analgesics|mesh-ancestor
14911418|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
14911419|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911420|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911421|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911422|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911423|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14911424|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917156|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200494|NCT03767504|Thymol|thymol|mesh-list
14703220|NCT00405444|Fentanyl|fentanyl|mesh-list
14703221|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14703222|NCT00405444|Narcotics|narcotics|mesh-ancestor
14826540|NCT00924430|Simvastatin|simvastatin|mesh-list
14826541|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14826542|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14826543|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
14826544|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826545|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14826546|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14826547|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826548|NCT00924573|Metformin|metformin|mesh-list
14826549|NCT00924573|Glimepiride|glimepiride|mesh-list
14826550|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826551|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826552|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14826553|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826554|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
14826555|NCT00924586|Landiolol|landiolol|mesh-list
14826556|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14826557|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14826558|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
14826559|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826560|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826561|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826562|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14826563|NCT00924742|Tazobactam|tazobactam|mesh-list
14826564|NCT00924742|Piperacillin|piperacillin|mesh-list
14826565|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826566|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826567|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14826568|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826569|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826570|NCT00924755|Caffeine|caffeine|mesh-list
14826571|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14826572|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826573|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14826574|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826575|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826576|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14826577|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14826578|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
14826579|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826580|NCT00924963|Lidocaine|lidocaine|mesh-list
14826581|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
14826582|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
14826583|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826584|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826585|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
14826586|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826587|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14826588|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14826589|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14826590|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826591|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826592|NCT00925028|Warfarin|warfarin|mesh-list
14826593|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
14826594|NCT00925093|Vancomycin|vancomycin|mesh-list
14826595|NCT00925093|Linezolid|linezolid|mesh-list
14826596|NCT00925093|Teicoplanin|teicoplanin|mesh-list
14826597|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826598|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826599|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14826600|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826601|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826602|NCT00925106|Celecoxib|celecoxib|mesh-list
14826603|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15200495|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200496|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15200497|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
15200498|NCT03767439|Nivolumab|nivolumab|mesh-list
15200499|NCT03767439|Ipilimumab|ipilimumab|mesh-list
15200500|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200501|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200502|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14826604|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826605|NCT00925106|Analgesics|analgesics|mesh-ancestor
14826606|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
14826607|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826608|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826609|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826610|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826611|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14826612|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14826613|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826614|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826615|NCT00925314|Vaccines|vaccines|mesh-list
14826616|NCT00925314|Immunologic Factors|immunologic factors|mesh-ancestor
14826617|NCT00925314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826618|NCT00925327|Riboflavin|riboflavin|mesh-list
14826619|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
14826620|NCT00925327|Vitamins|vitamins|mesh-ancestor
14826621|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
14826622|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826623|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14826624|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
14826625|NCT00925392|Doripenem|doripenem|mesh-list
14826626|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826627|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826628|NCT00925457|Domperidone|domperidone|mesh-list
14826629|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14826630|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826631|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200503|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200504|NCT03767335|Trastuzumab|trastuzumab|mesh-list
15200505|NCT03767335|Fulvestrant|fulvestrant|mesh-list
15200506|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200507|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826632|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
14826633|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
14826634|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826635|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826636|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14826637|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14826638|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
14826639|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826640|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
14826641|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14826642|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826643|NCT00925730|Analgesics|analgesics|mesh-ancestor
14826644|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
14826645|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826646|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826647|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826648|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826649|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
14826650|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826651|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
14826652|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14826653|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200508|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200509|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14295036|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14826654|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826655|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
14826656|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
14826657|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14826658|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826659|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826660|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
14826661|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14826662|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826663|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826664|NCT00925873|Vidarabine|vidarabine|mesh-list
14826665|NCT00925873|Fludarabine|fludarabine|mesh-list
14826666|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
14826667|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200510|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15200511|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
15200512|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200513|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200514|NCT03767322|Allopurinol|allopurinol|mesh-list
14917157|NCT01396642|Emollients|emollients|mesh-list
14826668|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14826669|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
14826670|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826671|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826672|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
14826673|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826674|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
14826675|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826676|NCT00925912|Bupivacaine|bupivacaine|mesh-list
14826677|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
14826678|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
14826679|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826680|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826681|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
14826682|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826683|NCT00925951|Acetaminophen|acetaminophen|mesh-list
14826684|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826685|NCT00925951|Analgesics|analgesics|mesh-ancestor
14826686|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
14826687|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826688|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826689|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
14826690|NCT00925977|Insulin|insulin|mesh-list
14826691|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14826692|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
14826693|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
14826694|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
14826695|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
14826696|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
14826697|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826698|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826699|NCT00926016|Pioglitazone|pioglitazone|mesh-list
14826700|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826701|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826702|NCT00926055|Simvastatin|simvastatin|mesh-list
14826703|NCT00926055|Ezetimibe|ezetimibe|mesh-list
14826704|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14826705|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14826706|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14826707|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
14826708|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826709|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14826710|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14826711|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826712|NCT00926107|Sirolimus|sirolimus|mesh-list
14826713|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826714|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826715|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14826716|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826717|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
14826718|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826719|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
14826720|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826721|NCT00926302|Levetiracetam|levetiracetam|mesh-list
14826722|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
14826723|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
14826724|NCT00926315|Calcitriol|calcitriol|mesh-list
14826725|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14826726|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826727|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14826728|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826729|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826730|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14826731|NCT00926315|Vitamins|vitamins|mesh-ancestor
14826732|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
14826733|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14826734|NCT00926341|Pioglitazone|pioglitazone|mesh-list
14826735|NCT00926341|Telmisartan|telmisartan|mesh-list
14826736|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826737|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826738|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14826739|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14826740|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14826741|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917158|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
14826742|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14826743|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14826744|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
14826745|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826746|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826747|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14826748|NCT00926354|Protective Agents|protective agents|mesh-ancestor
14826749|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14826750|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14826751|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826752|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826753|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
14826754|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911425|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911426|NCT01363089|Ketorolac|ketorolac|mesh-list
14911427|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14911428|NCT01363089|Phenylephrine|phenylephrine|mesh-list
14911429|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
14911430|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911431|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911432|NCT01363089|Analgesics|analgesics|mesh-ancestor
14911433|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
14911434|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911435|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911436|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911437|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911438|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14911439|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911440|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911441|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14911442|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14911443|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
14911444|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911445|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
14703223|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14703224|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703225|NCT00405444|Analgesics|analgesics|mesh-ancestor
15200515|NCT03767322|Febuxostat|febuxostat|mesh-list
15200516|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
14911446|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
14911447|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
14911448|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14911449|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
14911450|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14911451|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
14911452|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14703226|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
14703227|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703228|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14703229|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14911453|NCT01363089|Protective Agents|protective agents|mesh-ancestor
14911454|NCT01363115|Vitamin D|vitamin d|mesh-list
14911455|NCT01363115|Calcium|calcium|mesh-list
14911456|NCT01363115|Vitamins|vitamins|mesh-ancestor
14911457|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
14911458|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703230|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
15200517|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200518|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200519|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
15200520|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200521|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15200522|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
14703231|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
14703232|NCT00405457|Cyclosporine|cyclosporine|mesh-list
14911459|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911460|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14911461|NCT01363167|Vitamin D|vitamin d|mesh-list
15200523|NCT03767322|Protective Agents|protective agents|mesh-ancestor
15200524|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200525|NCT03767296|Phenylephrine|phenylephrine|mesh-list
15200526|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
15200527|NCT03767296|Ephedrine|ephedrine|mesh-list
15200528|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
14911462|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
14826755|NCT00926419|Vaccines|vaccines|mesh-list
14826756|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
14826757|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826758|NCT00926614|Pioglitazone|pioglitazone|mesh-list
14826759|NCT00926614|Atorvastatin|atorvastatin|mesh-list
14826760|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14826761|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14826762|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
14826763|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826764|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14826765|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14826766|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826767|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14826768|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826769|NCT00926627|Bosentan|bosentan|mesh-list
14826770|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14826771|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14826772|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826773|NCT00926640|Etoposide|etoposide|mesh-list
14826774|NCT00926640|Belinostat|belinostat|mesh-list
14826775|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826776|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14826777|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14826778|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14826779|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826780|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826781|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14826782|NCT00926653|Citalopram|citalopram|mesh-list
14826783|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14826784|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14826785|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826786|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826787|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200529|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15200530|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
15200531|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
15200532|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826788|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
14826789|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826790|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14826791|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
14826792|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14826793|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
14703233|NCT00405457|Cyclosporins|cyclosporins|mesh-list
14826794|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
14826795|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
14826796|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826797|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826798|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
14826799|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826800|NCT00926705|Fentanyl|fentanyl|mesh-list
14826801|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
14826802|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14826803|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200533|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200534|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
15200535|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15200536|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
15200537|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
15200538|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15200539|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14703234|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703235|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703236|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703237|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
14703238|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703239|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
14703240|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703241|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14703242|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703243|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14703244|NCT00405496|Difluprednate|difluprednate|mesh-list
14703245|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
15200540|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15200541|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
15200542|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200543|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826804|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826805|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826806|NCT00926705|Analgesics|analgesics|mesh-ancestor
14826807|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
14826808|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826809|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14826810|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14826811|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14826812|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14826813|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826814|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826815|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14826816|NCT00926705|Narcotics|narcotics|mesh-ancestor
14826817|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14826818|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14826819|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
14826820|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
14826821|NCT00926718|Remifentanil|remifentanil|mesh-list
14826822|NCT00926718|Rocuronium|rocuronium|mesh-list
14826823|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14826824|NCT00926718|Narcotics|narcotics|mesh-ancestor
14826825|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826826|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826827|NCT00926718|Analgesics|analgesics|mesh-ancestor
14826828|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
14826829|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826830|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14826831|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14826832|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14826833|NCT00926731|Cytarabine|cytarabine|mesh-list
14826834|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14826835|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
14826836|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826837|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826838|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
14826839|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826840|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14826841|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
15200544|NCT03767296|Protective Agents|protective agents|mesh-ancestor
15200545|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15200546|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15200547|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15200548|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
15200549|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15200550|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15200551|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
15200552|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200553|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15200554|NCT03767075|Atezolizumab|atezolizumab|mesh-list
15200555|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200556|NCT03767036|Ketorolac|ketorolac|mesh-list
14826842|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826843|NCT00926757|Entecavir|entecavir|mesh-list
14826844|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
14826845|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826846|NCT00926809|Amoxicillin|amoxicillin|mesh-list
14826847|NCT00926809|Clarithromycin|clarithromycin|mesh-list
14826848|NCT00926809|Lansoprazole|lansoprazole|mesh-list
14826849|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
14826850|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14826851|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826852|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826853|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14826854|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826855|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826856|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14826857|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14826858|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14826859|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15200557|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15200558|NCT03767036|Tramadol|tramadol|mesh-list
15200559|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15200560|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15200561|NCT03767036|Analgesics|analgesics|mesh-ancestor
15200562|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
15200563|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826860|NCT00926835|Lamotrigine|lamotrigine|mesh-list
14826861|NCT00926835|Dexetimide|dexetimide|mesh-list
14826862|NCT00926835|Aripiprazole|aripiprazole|mesh-list
14826863|NCT00926835|Mirtazapine|mirtazapine|mesh-list
14826864|NCT00926835|Citalopram|citalopram|mesh-list
14826865|NCT00926835|Bupropion|bupropion|mesh-list
14826866|NCT00926835|Paroxetine|paroxetine|mesh-list
14826867|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14826868|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14826869|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14826870|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826871|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826872|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826873|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
14826874|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826875|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14826876|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
15200564|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200565|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200566|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200567|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15200568|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200569|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200570|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14826877|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14826878|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14826879|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14826880|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
14826881|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
14826882|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826883|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14826884|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14826885|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
14826886|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14826887|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
14826888|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14826889|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14826890|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826891|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14826892|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14826893|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826894|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
14826895|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14826896|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14826897|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14826898|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14826899|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14826900|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15200571|NCT03767036|Narcotics|narcotics|mesh-ancestor
14911463|NCT01363167|Vitamins|vitamins|mesh-ancestor
14826901|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14826902|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
14295037|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295038|NCT00578786|Ambrisentan|ambrisentan|mesh-list
14295039|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14295040|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
14295041|NCT00578864|Doxorubicin|doxorubicin|mesh-list
14295042|NCT00578864|Etoposide|etoposide|mesh-list
14295043|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
14295044|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295045|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
14703246|NCT00405496|Hormones|hormones|mesh-ancestor
14703247|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703248|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703249|NCT00405535|Glycine|glycine|mesh-list
14703250|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
14703251|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703252|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826903|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14826904|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14826905|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14826906|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14826907|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
14826908|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
14826909|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14826910|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14826911|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14826912|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14826913|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
14826914|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14826915|NCT00926900|Cycloserine|cycloserine|mesh-list
14826916|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14826917|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826918|NCT00926900|Renal Agents|renal agents|mesh-ancestor
14826919|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14826920|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
14826921|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14826922|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
14826923|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826924|NCT00926926|Oxybutynin|oxybutynin|mesh-list
14826925|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
14826926|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
14826927|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826928|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826929|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14826930|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14826931|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
14826932|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14826933|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200572|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200573|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
15200574|NCT03766997|Betamethasone|betamethasone|mesh-list
15200575|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
15200576|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200577|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
15200578|NCT03766997|Hormones|hormones|mesh-ancestor
14826934|NCT00926926|Urological Agents|urological agents|mesh-ancestor
14826935|NCT00926965|Olanzapine|olanzapine|mesh-list
14826936|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
14826937|NCT00926965|Amisulpride|amisulpride|mesh-list
14826938|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
14826939|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
14826940|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826941|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826942|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14826943|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14826944|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200579|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703253|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826945|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14826946|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15200580|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200581|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14295046|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826947|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14826948|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14826949|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826950|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200582|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
15200583|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
15200584|NCT03766984|Diclofenac|diclofenac|mesh-list
15200585|NCT03766984|Tramadol|tramadol|mesh-list
15200586|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15200587|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703254|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14703255|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
15200588|NCT03766984|Analgesics|analgesics|mesh-ancestor
15200589|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
15200590|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200591|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200592|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826951|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
14826952|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14826953|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
14826954|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15200593|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200594|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15200595|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200596|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200597|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15200598|NCT03766984|Narcotics|narcotics|mesh-ancestor
15200599|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200600|NCT03766893|Naltrexone|naltrexone|mesh-list
15200601|NCT03766893|Buprenorphine|buprenorphine|mesh-list
15200602|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15200603|NCT03766893|Naloxone|naloxone|mesh-list
15200604|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15200605|NCT03766893|Narcotics|narcotics|mesh-ancestor
15200606|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200607|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200608|NCT03766893|Analgesics|analgesics|mesh-ancestor
15200609|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
15200610|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200611|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15200612|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14703256|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
14703257|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703258|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703259|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14826955|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
14826956|NCT00927004|Etoricoxib|etoricoxib|mesh-list
14826957|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14826958|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14826959|NCT00927004|Analgesics|analgesics|mesh-ancestor
14826960|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
14826961|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826962|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826963|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14826964|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14826965|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14826966|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14826967|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826968|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826969|NCT00927030|Melatonin|melatonin|mesh-list
14826970|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
14826971|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826972|NCT00927030|Protective Agents|protective agents|mesh-ancestor
14703260|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703261|NCT00405574|Growth Substances|growth substances|mesh-ancestor
15200613|NCT03766867|Vortioxetine|vortioxetine|mesh-list
15200614|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
15200615|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15200616|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14728559|NCT00519051|Fluoxetine|fluoxetine|mesh-list
14826973|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826974|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826975|NCT00927147|Cetuximab|cetuximab|mesh-list
14826976|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14826977|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826978|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14826979|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14826980|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
14826981|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826982|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14826983|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14826984|NCT00927212|Protective Agents|protective agents|mesh-ancestor
15200617|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14826985|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14826986|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14826987|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14826988|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14826989|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
14826990|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14826991|NCT00927225|Ropivacaine|ropivacaine|mesh-list
14826992|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
14826993|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
14826994|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14826995|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14826996|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
14826997|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14826998|NCT00927290|Pioglitazone|pioglitazone|mesh-list
14826999|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14827000|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827001|NCT00927407|Malathion|malathion|mesh-list
14827002|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14827003|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827004|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827005|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
14827006|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827007|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827008|NCT00927498|Cytarabine|cytarabine|mesh-list
14827009|NCT00927498|Daunorubicin|daunorubicin|mesh-list
14827010|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
14827011|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14827012|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827013|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14827014|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14827015|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827016|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827017|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827018|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14827019|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
14827020|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
14827021|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827022|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827023|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
14827024|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827025|NCT00927511|Fulvestrant|fulvestrant|mesh-list
14827026|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14827027|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827028|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14827029|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14827030|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
14827031|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827032|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827033|NCT00927524|Insulin|insulin|mesh-list
14827034|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14827035|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
14827036|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14827037|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827038|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14827039|NCT00927537|Telmisartan|telmisartan|mesh-list
14827040|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827041|NCT00927537|Diuretics|diuretics|mesh-ancestor
14827042|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
14827043|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827044|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14827045|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14703262|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703263|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703264|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703265|NCT00405717|Atorvastatin|atorvastatin|mesh-list
14703266|NCT00405717|Pravastatin|pravastatin|mesh-list
14703267|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14703268|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14703269|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
14703270|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827046|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827047|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14827048|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14827049|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
14827050|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
14827051|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14827052|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827053|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827054|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
14827055|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14827056|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827057|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827058|NCT00927602|PENTA|penta|mesh-list
14827059|NCT00927602|Fondaparinux|fondaparinux|mesh-list
14827060|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14827061|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
14827062|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15200618|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200619|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827063|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
14827064|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827065|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827066|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
14827067|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14827068|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15200620|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15200621|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15200622|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15200623|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200624|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200625|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
15200626|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15200627|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15200628|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15200629|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15200630|NCT03766854|Insulin|insulin|mesh-list
14827069|NCT00927615|Abciximab|abciximab|mesh-list
14827070|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
14827071|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14827072|NCT00927654|Iloprost|iloprost|mesh-list
14827073|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14827074|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
14827075|NCT00927693|Calcium|calcium|mesh-list
14827076|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14827077|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827078|NCT00927732|Quinidine|quinidine|mesh-list
14827079|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
15200631|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15200632|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
15200633|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15200634|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200635|NCT03766763|Venetoclax|venetoclax|mesh-list
15200636|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200637|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
15200638|NCT03766750|Linagliptin|linagliptin|mesh-list
14827080|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14827081|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
14703271|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14827082|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
14728560|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
14827083|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827084|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827085|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14827086|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14827087|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
14827088|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827089|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827090|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
14827091|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14827092|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14827093|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827094|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827095|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14827096|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14827097|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
14827098|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14827099|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14827100|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827101|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14827102|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14827103|NCT00927771|Azelaic acid|azelaic acid|mesh-list
14827104|NCT00927771|Hydroquinone|hydroquinone|mesh-list
14827105|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827106|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
14827107|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
14827108|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827109|NCT00927771|Protective Agents|protective agents|mesh-ancestor
15200639|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15200640|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200641|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15200642|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200643|NCT03766750|Incretins|incretins|mesh-ancestor
15200644|NCT03766750|Hormones|hormones|mesh-ancestor
15200645|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200646|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15200647|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
14827110|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827111|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14827112|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
14827113|NCT00927797|Rituximab|rituximab|mesh-list
14827114|NCT00927797|Pentostatin|pentostatin|mesh-list
14827115|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827116|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
14827117|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827118|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827119|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14827120|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
14827121|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827122|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827123|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14827124|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827125|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
15200648|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827126|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827127|NCT00927836|Lenograstim|lenograstim|mesh-list
14827128|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14827129|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
14827130|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827131|NCT00927875|Carboplatin|carboplatin|mesh-list
14827132|NCT00927875|Etoposide|etoposide|mesh-list
14827133|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827134|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14827135|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14827136|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14827137|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827138|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827139|NCT00927966|Everolimus|everolimus|mesh-list
14827140|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200649|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
15200650|NCT03766724|Empagliflozin|empagliflozin|mesh-list
15200651|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15200652|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200653|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14827141|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827142|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
14827143|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827144|NCT00927979|Ropivacaine|ropivacaine|mesh-list
14827145|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
14827146|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
14827147|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200654|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200655|NCT03766607|Paclitaxel|paclitaxel|mesh-list
15200656|NCT03766607|Trastuzumab|trastuzumab|mesh-list
15200657|NCT03766607|Ramucirumab|ramucirumab|mesh-list
15200658|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15200659|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200660|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
15200661|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
15200662|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
14827148|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827149|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
14827150|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827151|NCT00928148|Amphetamine|amphetamine|mesh-list
14827152|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14827153|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827154|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
15200663|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200664|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200665|NCT03766594|Folic Acid|folic acid|mesh-list
14827155|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
14827156|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827157|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
14827158|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827159|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827160|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
14827161|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14827162|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14827163|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827164|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14827165|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
14827166|NCT00928161|Lansoprazole|lansoprazole|mesh-list
14827167|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14827168|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827169|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14827170|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827171|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827172|NCT00928213|Heparin|heparin|mesh-list
14827173|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14827174|NCT00928213|Tinzaparin|tinzaparin|mesh-list
14827175|NCT00928213|Dalteparin|dalteparin|mesh-list
14827176|NCT00928213|Progesterone|progesterone|mesh-list
14827177|NCT00928213|Hormones|hormones|mesh-ancestor
14827178|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827179|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827180|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
14827181|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14827182|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14827183|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827184|NCT00928213|Progestins|progestins|mesh-ancestor
14827185|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14827186|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827187|NCT00928330|Trastuzumab|trastuzumab|mesh-list
14827188|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14827189|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827190|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827191|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
14827192|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
14827193|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
14827194|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911464|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
14911465|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911466|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14911467|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911468|NCT01363193|Heparin|heparin|mesh-list
14911469|NCT01363193|Calcium heparin|calcium heparin|mesh-list
14911470|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
14911471|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14911472|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14911473|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911474|NCT01363206|Ipilimumab|ipilimumab|mesh-list
14911475|NCT01363206|Molgramostim|molgramostim|mesh-list
14911476|NCT01363206|Sargramostim|sargramostim|mesh-list
14911477|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14911478|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911479|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14911480|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911481|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
14911482|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911483|NCT01363271|Vancomycin|vancomycin|mesh-list
14911484|NCT01363271|Linezolid|linezolid|mesh-list
14911485|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911486|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911487|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14911488|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911489|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911490|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14911491|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14911492|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14911493|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911494|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911495|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911496|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911497|NCT01363284|Analgesics|analgesics|mesh-ancestor
14911498|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
14911499|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911500|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
14911501|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911502|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
14911503|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14911504|NCT01363310|Citalopram|citalopram|mesh-list
14911505|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14911506|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14911507|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911508|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911509|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200666|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
15200667|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703272|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14703273|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703274|NCT00405730|Ketorolac|ketorolac|mesh-list
14703275|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14703276|NCT00405730|Nepafenac|nepafenac|mesh-list
14703277|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14703278|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14703279|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14703280|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703281|NCT00405730|Analgesics|analgesics|mesh-ancestor
14911510|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
15200668|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
15200669|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15200670|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15200671|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200672|NCT03766594|Urological Agents|urological agents|mesh-ancestor
15200673|NCT03766594|Hematinics|hematinics|mesh-ancestor
15200674|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
15200675|NCT03766594|Vitamins|vitamins|mesh-ancestor
15200676|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
15200677|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200678|NCT03766490|Gefitinib|gefitinib|mesh-list
15200679|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200680|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15200681|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200682|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200683|NCT03766425|Aflibercept|aflibercept|mesh-list
15200684|NCT03766425|Mitomycins|mitomycins|mesh-list
15200685|NCT03766425|Mitomycin|mitomycin|mesh-list
15200686|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15200687|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15200688|NCT03766425|Growth Substances|growth substances|mesh-ancestor
15200689|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200690|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
15200691|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200692|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15200693|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
15200694|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827195|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
14827196|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827197|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14827198|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827199|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827200|NCT00928655|Acetazolamide|acetazolamide|mesh-list
14827201|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
14827202|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14827203|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827204|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827205|NCT00928655|Diuretics|diuretics|mesh-ancestor
14827206|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
14827207|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827208|NCT00928798|Sirolimus|sirolimus|mesh-list
14827209|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14827210|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827211|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14827212|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827213|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
14827214|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827215|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
14827216|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827217|NCT00928811|Basiliximab|basiliximab|mesh-list
14827218|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827219|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
14827220|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827221|NCT00928837|Naproxen|naproxen|mesh-list
14827222|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14827223|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14827224|NCT00928837|Analgesics|analgesics|mesh-ancestor
14827225|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
14827226|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200695|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15200696|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200697|NCT03766269|Dronabinol|dronabinol|mesh-list
15200698|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
14827227|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827228|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827229|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827230|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
14827231|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14827232|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827233|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827234|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14827235|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827236|NCT00928915|Thrombin|thrombin|mesh-list
14827237|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
14827238|NCT00928915|Coagulants|coagulants|mesh-ancestor
14827239|NCT00928967|Interferons|interferons|mesh-list
14827240|NCT00928967|Interferon-beta|interferon-beta|mesh-list
15200699|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827241|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
15200700|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15200701|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15200702|NCT03766269|Analgesics|analgesics|mesh-ancestor
15200703|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
15200704|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200705|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15200706|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15200707|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200708|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200709|NCT03766269|Hormones|hormones|mesh-ancestor
15200710|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200711|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
15200712|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200713|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200714|NCT03766074|Vitamin D|vitamin d|mesh-list
15200715|NCT03766074|Vitamins|vitamins|mesh-ancestor
15200716|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
15200717|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200718|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15224535|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225695|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827242|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827243|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
14827244|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827245|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
14827246|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827247|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14827248|NCT00929006|Progesterone|progesterone|mesh-list
14827249|NCT00929006|Progestins|progestins|mesh-ancestor
14827250|NCT00929006|Hormones|hormones|mesh-ancestor
14827251|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827252|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827253|NCT00929045|Hormones|hormones|mesh-list
14827254|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827255|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827256|NCT00929058|Bevacizumab|bevacizumab|mesh-list
14827257|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827258|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827259|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14827260|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14827261|NCT00929058|Growth Substances|growth substances|mesh-ancestor
14827262|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827263|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
14827264|NCT00929253|Buprenorphine|buprenorphine|mesh-list
14827265|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14827266|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14827267|NCT00929253|Narcotics|narcotics|mesh-ancestor
14827268|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827269|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827270|NCT00929253|Analgesics|analgesics|mesh-ancestor
14827271|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
14827272|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827273|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14827274|NCT00929279|Abciximab|abciximab|mesh-list
14827275|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
14827276|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14827277|NCT00929370|Glycine|glycine|mesh-list
14827278|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
14827279|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827280|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827281|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827282|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14827283|NCT00929591|Tamoxifen|tamoxifen|mesh-list
14827284|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
14827285|NCT00929591|Doxorubicin|doxorubicin|mesh-list
14827286|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14827287|NCT00929591|Fluorouracil|fluorouracil|mesh-list
14827288|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827289|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
14827290|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827291|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827292|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14827293|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
14917159|NCT01396655|Docetaxel|docetaxel|mesh-list
14827294|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827295|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827296|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15200719|NCT03765944|Sirolimus|sirolimus|mesh-list
15200720|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14827297|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14827298|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14827299|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14827300|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827301|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
14827302|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14827303|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14827304|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
14827305|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827306|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14827307|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14827308|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14827309|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14827310|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14827311|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
14827312|NCT00929630|Coagulants|coagulants|mesh-ancestor
14827313|NCT00929799|Hormones|hormones|mesh-list
14827314|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827315|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827316|NCT00929812|Glucagon|glucagon|mesh-list
14827317|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827318|NCT00929812|Hormones|hormones|mesh-ancestor
14827319|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827320|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827321|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
14827322|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14827323|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
14827324|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827325|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827326|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14827327|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
14827328|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14827329|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14827330|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14827331|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
14827332|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827333|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200721|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827334|NCT00929877|Ketoprofen|ketoprofen|mesh-list
14827335|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14827336|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14827337|NCT00929877|Analgesics|analgesics|mesh-ancestor
14827338|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
14827339|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827340|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827341|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827342|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827343|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14827344|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827345|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827346|NCT00929955|Ondansetron|ondansetron|mesh-list
14827347|NCT00929955|Simvastatin|simvastatin|mesh-list
14827348|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14827349|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14827350|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
14827351|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827352|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14827353|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14827354|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827355|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
14827356|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
14827357|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827358|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827359|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827360|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
14827361|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
14827362|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15224536|NCT03368963|Trifluridine|trifluridine|mesh-list
14827363|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
14827364|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827365|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14827366|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14827367|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827368|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14827369|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14827370|NCT00930020|Minocycline|minocycline|mesh-list
14827371|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14827372|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827373|NCT00930033|Sunitinib|sunitinib|mesh-list
14827374|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827375|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14827376|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14827377|NCT00930033|Growth Substances|growth substances|mesh-ancestor
14827378|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827379|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
14827380|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14827381|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827382|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827383|NCT00930072|Clonidine|clonidine|mesh-list
14827384|NCT00930072|Bupivacaine|bupivacaine|mesh-list
14827385|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
14827386|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
14827387|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827388|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827389|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
14827390|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827391|NCT00930072|Analgesics|analgesics|mesh-ancestor
14827392|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827393|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
14827394|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
14827395|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14827396|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14827397|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14827398|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14827399|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827400|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827401|NCT00930098|Clofarabine|clofarabine|mesh-list
14827402|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14827403|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
14827404|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827405|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827406|NCT00930189|Triamcinolone|triamcinolone|mesh-list
14827407|NCT00930189|Ranibizumab|ranibizumab|mesh-list
14827408|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14827409|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14827410|NCT00930189|Growth Substances|growth substances|mesh-ancestor
14827411|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827412|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14827413|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827414|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827415|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
14827416|NCT00930189|Hormones|hormones|mesh-ancestor
14827417|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827418|NCT00930202|Conivaptan|conivaptan|mesh-list
14827419|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14827420|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827421|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
14827422|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827423|NCT00930228|Flutamide|flutamide|mesh-list
14827424|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
14827425|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
14827426|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827427|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827428|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14827429|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827430|NCT00930241|Tacrolimus|tacrolimus|mesh-list
14827431|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827432|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
14827433|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827434|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14827435|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827436|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827437|NCT00930306|Tolbutamide|tolbutamide|mesh-list
14827438|NCT00930306|Midazolam|midazolam|mesh-list
14827439|NCT00930306|Caffeine|caffeine|mesh-list
14827440|NCT00930306|Omeprazole|omeprazole|mesh-list
14827441|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14827442|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14827443|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827444|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827445|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14827446|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14827447|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14827448|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15200722|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15200723|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200724|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
15200725|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200726|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
15200727|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200728|NCT03765931|Amoxicillin|amoxicillin|mesh-list
15200729|NCT03765931|Doxycycline|doxycycline|mesh-list
15200730|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15200731|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200732|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
14827449|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
14827450|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
14827451|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
14827452|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
14827453|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827454|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827455|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14827456|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827457|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14827458|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827459|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14827460|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14827461|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14827462|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14827463|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
14827464|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14827465|NCT00930332|Methadone|methadone|mesh-list
14827466|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14827467|NCT00930332|Narcotics|narcotics|mesh-ancestor
14827468|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200733|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14703282|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
14703283|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703284|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703285|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703286|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827469|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827470|NCT00930332|Analgesics|analgesics|mesh-ancestor
14827471|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
14827472|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827473|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
14827474|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
14827475|NCT00930345|Sunitinib|sunitinib|mesh-list
14827476|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827477|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15200734|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15200735|NCT03765827|Vitamins|vitamins|mesh-list
15200736|NCT03765827|Vitamin E|vitamin e|mesh-list
15200737|NCT03765827|Tocopherols|tocopherols|mesh-list
15200738|NCT03765827|Tocotrienols|tocotrienols|mesh-list
15200739|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
15200740|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
15200741|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703287|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14703288|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703289|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703290|NCT00405769|Red yeast rice|red yeast rice|mesh-list
14703291|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14703292|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14703293|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14703294|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
14703295|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703296|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703297|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14703298|NCT00405808|Rimonabant|rimonabant|mesh-list
14703299|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14703300|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
15200742|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
15200743|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200744|NCT03765827|Protective Agents|protective agents|mesh-ancestor
15200745|NCT03765697|Lidocaine|lidocaine|mesh-list
15200746|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
15200747|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
15200748|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200749|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200750|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
15200751|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200752|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15200753|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15200754|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15200755|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15200756|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200757|NCT03765645|Tazobactam|tazobactam|mesh-list
15200758|NCT03765645|Piperacillin|piperacillin|mesh-list
15200759|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15200760|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15200761|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200762|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15200763|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200764|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200765|NCT03765554|PF-06700841|pf-06700841|mesh-list
15200766|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15200767|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200768|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827478|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14827479|NCT00930345|Growth Substances|growth substances|mesh-ancestor
14827480|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827481|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
14827482|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14827483|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827484|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827485|NCT00930358|Anesthetics|anesthetics|mesh-list
14827486|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827487|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200769|NCT03765541|Cytarabine|cytarabine|mesh-list
15200770|NCT03765541|Dexamethasone|dexamethasone|mesh-list
15200771|NCT03765541|Azacitidine|azacitidine|mesh-list
15200772|NCT03765541|Amsacrine|amsacrine|mesh-list
15200773|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200774|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
15200775|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
15200776|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200777|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200778|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15200779|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
15200780|NCT03765541|Hormones|hormones|mesh-ancestor
15200781|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200782|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200783|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827488|NCT00930475|Carboplatin|carboplatin|mesh-list
14827489|NCT00930475|Everolimus|everolimus|mesh-list
14827490|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827491|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827492|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
14827493|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827494|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
14827495|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14827496|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14827497|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827498|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14827499|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14827500|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827501|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827502|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827503|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14827504|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
14827505|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14827506|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827507|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14827508|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14827509|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14827510|NCT00930514|Rituximab|rituximab|mesh-list
14827511|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827512|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827513|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
14827514|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827515|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200784|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15200785|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
15200786|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200787|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
15200788|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200789|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200790|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
15200791|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200792|NCT03765450|Infliximab|infliximab|mesh-list
15200793|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
15200794|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15200795|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295047|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295048|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295049|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
14703301|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14703302|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703303|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703304|NCT00405808|Hormones|hormones|mesh-ancestor
14703305|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703306|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295050|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295051|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295052|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295053|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14295054|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14295055|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14295056|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295057|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14703307|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
14703308|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15200796|NCT03765346|Oxycodone|oxycodone|mesh-list
15200797|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15200798|NCT03765346|Narcotics|narcotics|mesh-ancestor
15200799|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200800|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200801|NCT03765346|Analgesics|analgesics|mesh-ancestor
15200802|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
15200803|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200804|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
15200805|NCT03765229|Entinostat|entinostat|mesh-list
15200806|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15200807|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827516|NCT00930566|Methoxsalen|methoxsalen|mesh-list
14827517|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14827518|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
14827519|NCT00930579|Metformin|metformin|mesh-list
14827520|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14827521|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827522|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
14827523|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827524|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827525|NCT00930670|Esomeprazole|esomeprazole|mesh-list
14827526|NCT00930670|Omeprazole|omeprazole|mesh-list
14827527|NCT00930670|Pantoprazole|pantoprazole|mesh-list
14827528|NCT00930670|Ranitidine|ranitidine|mesh-list
14827529|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14827530|NCT00930670|Atorvastatin|atorvastatin|mesh-list
14827531|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14827532|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14827533|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14827534|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
14827535|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827536|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14827537|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14827538|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827539|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14827540|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827541|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14827542|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14827543|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
14827544|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
14827545|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827546|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827547|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14827548|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
14827549|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827550|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
14827551|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14827552|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14827553|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14827554|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827555|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827556|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
14827557|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827558|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827559|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14827560|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827561|NCT00930722|Quinapril|quinapril|mesh-list
14827562|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14827563|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
14827564|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827565|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827566|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827567|NCT00930839|Aspirin|aspirin|mesh-list
14827568|NCT00930839|Niacin|niacin|mesh-list
14827569|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
14827570|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14827571|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14827572|NCT00930839|Analgesics|analgesics|mesh-ancestor
14827573|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
14827574|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827575|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827576|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827577|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200808|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15200809|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200810|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200811|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
15200812|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15200813|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15200814|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200815|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
15200816|NCT03765021|Coagulants|coagulants|mesh-ancestor
15200817|NCT03764722|Simendan|simendan|mesh-list
15200818|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15200819|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
15200820|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15200821|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15200822|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200823|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200824|NCT03764722|Protective Agents|protective agents|mesh-ancestor
14827578|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14827579|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14827580|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827581|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14827582|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14827583|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827584|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
14827585|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14827586|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
14827587|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14827588|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
14827589|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
14827590|NCT00930839|Vitamins|vitamins|mesh-ancestor
14827591|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
14827592|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
14827593|NCT00930865|Bumetanide|bumetanide|mesh-list
14827594|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14827595|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827596|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14827597|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827598|NCT00930865|Diuretics|diuretics|mesh-ancestor
14827599|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
14827600|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14827601|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827602|NCT00930891|Bevacizumab|bevacizumab|mesh-list
14827603|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827604|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827605|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14827606|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14827607|NCT00930891|Growth Substances|growth substances|mesh-ancestor
14827608|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200825|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200826|NCT03764683|Suvorexant|suvorexant|mesh-list
15200827|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15200828|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15200829|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200830|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200831|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14827609|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
14827610|NCT00930943|Oxymorphone|oxymorphone|mesh-list
15224537|NCT03368963|Irinotecan|irinotecan|mesh-list
14827611|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14827612|NCT00930943|Narcotics|narcotics|mesh-ancestor
14827613|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827614|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827615|NCT00930943|Analgesics|analgesics|mesh-ancestor
14827616|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
14827617|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827618|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14827619|NCT00930995|Candesartan|candesartan|mesh-list
14827620|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827621|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14827622|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14827623|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827624|NCT00931008|Docetaxel|docetaxel|mesh-list
14827625|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827626|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14827627|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14827628|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14827629|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827630|NCT00931021|Nicotine|nicotine|mesh-list
14827631|NCT00931021|Varenicline|varenicline|mesh-list
14827632|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14827633|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
14827634|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827635|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827636|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14827637|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14827638|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
14827639|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827640|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827641|NCT00931073|Ketoconazole|ketoconazole|mesh-list
14827642|NCT00931073|Omeprazole|omeprazole|mesh-list
14827643|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14827644|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827645|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14827646|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827647|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827648|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
14827649|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827650|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14827651|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15200832|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15200833|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200834|NCT03764605|Metformin|metformin|mesh-list
15200835|NCT03764605|Tolvaptan|tolvaptan|mesh-list
15200836|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15200837|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200838|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15200839|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200840|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
15200841|NCT03764553|Leucovorin|leucovorin|mesh-list
15200842|NCT03764553|Carboplatin|carboplatin|mesh-list
15200843|NCT03764553|Fluorouracil|fluorouracil|mesh-list
15200844|NCT03764553|Capecitabine|capecitabine|mesh-list
15200845|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
14295058|NCT00578877|Nonoxynol|nonoxynol|mesh-list
14295059|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
15200846|NCT03764553|Irinotecan|irinotecan|mesh-list
14295060|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14295061|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295062|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14295063|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
14703309|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14703310|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703311|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703312|NCT00405847|Analgesics|analgesics|mesh-ancestor
14703313|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
14703314|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703315|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14703316|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14703317|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14703318|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
14703319|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827652|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14827653|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
14827654|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827655|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827656|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14827657|NCT00931086|Belimumab|belimumab|mesh-list
14827658|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827659|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
14827660|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827661|NCT00931125|Ranibizumab|ranibizumab|mesh-list
14827662|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14827663|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14827664|NCT00931125|Growth Substances|growth substances|mesh-ancestor
14827665|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827666|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
14827667|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827668|NCT00931138|Cytarabine|cytarabine|mesh-list
14827669|NCT00931138|Daunorubicin|daunorubicin|mesh-list
14827670|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14827671|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827672|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14827673|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14827674|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827675|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827676|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14827677|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
14827678|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
14827679|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827680|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827681|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
14827682|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200847|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200848|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
15200849|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200850|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15200851|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15200852|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
15200853|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200854|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15200855|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15200856|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827683|NCT00931203|Celecoxib|celecoxib|mesh-list
14827684|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14827685|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14827686|NCT00931203|Analgesics|analgesics|mesh-ancestor
14827687|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
14827688|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827689|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827690|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827691|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827692|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14827693|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14827694|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827695|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827696|NCT00931229|Entecavir|entecavir|mesh-list
14827697|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
14827698|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827699|NCT00931281|Ritonavir|ritonavir|mesh-list
14827700|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14827701|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14827702|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
14827703|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827704|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200857|NCT03764553|Antidotes|antidotes|mesh-ancestor
15200858|NCT03764553|Protective Agents|protective agents|mesh-ancestor
15200859|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
15200860|NCT03764553|Vitamins|vitamins|mesh-ancestor
15200861|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
15200862|NCT03764540|Prednisone|prednisone|mesh-list
15200863|NCT03764540|Docetaxel|docetaxel|mesh-list
15200864|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703320|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827705|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14827706|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14827707|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
14827708|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827709|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14827710|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14827711|NCT00931372|Lixisenatide|lixisenatide|mesh-list
14827712|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14827713|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827714|NCT00931398|Methylphenidate|methylphenidate|mesh-list
14827715|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14827716|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827717|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14827718|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14827719|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827720|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827721|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
14827722|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827723|NCT00931437|Vitamin K|vitamin k|mesh-list
14827724|NCT00931437|Vitamins|vitamins|mesh-ancestor
14827725|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
14827726|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827727|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14827728|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14827729|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827730|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
14827731|NCT00931437|Coagulants|coagulants|mesh-ancestor
14827732|NCT00931450|Sunitinib|sunitinib|mesh-list
14703321|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
14703322|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14703323|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703324|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14703325|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
14827733|NCT00931450|Exemestane|exemestane|mesh-list
14827734|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827735|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14827736|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14827737|NCT00931450|Growth Substances|growth substances|mesh-ancestor
14827738|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827739|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14827740|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14827741|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827742|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827743|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14827744|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14703326|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703327|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703328|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703329|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827745|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14827746|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
14827747|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827748|NCT00931580|Vitamin D|vitamin d|mesh-list
14827749|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
14827750|NCT00931580|Vitamins|vitamins|mesh-ancestor
15200865|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703330|NCT00405925|Lamivudine|lamivudine|mesh-list
15200866|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
15200867|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
15200868|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200869|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200870|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
15200871|NCT03764540|Hormones|hormones|mesh-ancestor
14827751|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
15200872|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200873|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827752|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827753|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14827754|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14827755|NCT00931645|Cytarabine|cytarabine|mesh-list
14827756|NCT00931645|Dexamethasone|dexamethasone|mesh-list
14827757|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
14827758|NCT00931645|Cisplatin|cisplatin|mesh-list
14827759|NCT00931645|Fludarabine|fludarabine|mesh-list
14827760|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827761|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
14827762|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827763|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827764|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14827765|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
14827766|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827767|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827768|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14827769|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827770|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
14827771|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
14827772|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827773|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827774|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
14827775|NCT00931645|Hormones|hormones|mesh-ancestor
14827776|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827777|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14827778|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14827779|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
14827780|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
14827781|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827782|NCT00931697|Mefloquine|mefloquine|mesh-list
14827783|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
14827784|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14827785|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14827786|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827787|NCT00931736|Rifampin|rifampin|mesh-list
14827788|NCT00931736|Isoniazid|isoniazid|mesh-list
14827789|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14827790|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
14827791|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14827792|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827793|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
14827794|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14827795|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827796|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827797|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14827798|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14827799|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14827800|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14827801|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14827802|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14827803|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14827804|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14827805|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
14827806|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14827807|NCT00931775|Pindolol|pindolol|mesh-list
14827808|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14827809|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14827810|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14827811|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827812|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827813|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827814|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827815|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14827816|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
15200874|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200875|NCT03764527|Artesunate|artesunate|mesh-list
15200876|NCT03764527|Lumefantrine|lumefantrine|mesh-list
15200877|NCT03764527|Artemether|artemether|mesh-list
15200878|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15200879|NCT03764527|Amodiaquine|amodiaquine|mesh-list
15200880|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
15200881|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15200882|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15200883|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200884|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200885|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
15200886|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
15200887|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14827817|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
14827818|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
14827819|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
14827820|NCT00931827|Etonogestrel|etonogestrel|mesh-list
14827821|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14827822|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
14827823|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14827824|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827825|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14827826|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14827827|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14827828|NCT00931840|Irinotecan|irinotecan|mesh-list
14827829|NCT00931840|Cetuximab|cetuximab|mesh-list
14827830|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14827831|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14827832|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827833|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827834|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827835|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14827836|NCT00931866|Diclofenac|diclofenac|mesh-list
14827837|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14827838|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14827839|NCT00931866|Analgesics|analgesics|mesh-ancestor
15200888|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
15200889|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
15200890|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15200891|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200892|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15200893|NCT03764462|AD 101|ad 101|mesh-list
15200894|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15200895|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
15200896|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200897|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200898|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15200899|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15200900|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15200901|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15200902|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200903|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15200904|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15200905|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
15200906|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703331|NCT00405925|Zidovudine|zidovudine|mesh-list
14703332|NCT00405925|Abacavir|abacavir|mesh-list
14703333|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14703334|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14703335|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703336|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703337|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
14703338|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703339|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14703340|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14703341|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
14703342|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
14703343|NCT00405977|Analgesics|analgesics|mesh-ancestor
14703344|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
14703345|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703346|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703347|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
14827840|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
14827841|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703348|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14703349|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14703350|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
14703351|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14703352|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14703353|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703354|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14703355|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
14703356|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14703357|NCT00406003|Paroxetine|paroxetine|mesh-list
14827842|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827843|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827844|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15200907|NCT03764293|Sorafenib|sorafenib|mesh-list
15200908|NCT03764293|Apatinib|apatinib|mesh-list
15200909|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200910|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15200911|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200912|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200913|NCT03764280|Insulin|insulin|mesh-list
15200914|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
14827845|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14827846|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827847|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827848|NCT00931957|Prednisolone|prednisolone|mesh-list
14827849|NCT00931957|Etanercept|etanercept|mesh-list
14827850|NCT00931957|Methotrexate|methotrexate|mesh-list
14827851|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14827852|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
14827853|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14827854|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827855|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14827856|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
14827857|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827858|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827859|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
14827860|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827861|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14827862|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14827863|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
14827864|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14827865|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15200915|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15200916|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200917|NCT03764267|Lidocaine|lidocaine|mesh-list
15200918|NCT03764267|Remifentanil|remifentanil|mesh-list
15200919|NCT03764267|Anesthetics|anesthetics|mesh-list
14827866|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14827867|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
14827868|NCT00931957|Hormones|hormones|mesh-ancestor
14827869|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827870|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14827871|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827872|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827873|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14827874|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14827875|NCT00931957|Analgesics|analgesics|mesh-ancestor
14827876|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
14827877|NCT00932048|Atorvastatin|atorvastatin|mesh-list
14827878|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14827879|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14827880|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
14911511|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200920|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
14295064|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14295065|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14295066|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
14295067|NCT00578903|Methotrexate|methotrexate|mesh-list
14295068|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
14295069|NCT00578903|Tacrolimus|tacrolimus|mesh-list
14295070|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295071|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
15200921|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
14295072|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295073|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295074|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14827881|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827882|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14827883|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14827884|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14827885|NCT00932100|Heparin|heparin|mesh-list
14827886|NCT00932100|Calcium heparin|calcium heparin|mesh-list
14827887|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15200922|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200923|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200924|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
15200925|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200926|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14295075|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
15200927|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15200928|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15200929|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15200930|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703358|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14703359|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14703360|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14703361|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703362|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703363|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
14703364|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703365|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14703366|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
14703367|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14703368|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14703369|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14703370|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703371|NCT00406042|Prednisolone|prednisolone|mesh-list
14703372|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14703373|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
14703374|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14703375|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
14703376|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14703377|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
14703378|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703379|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
14703380|NCT00406042|Hormones|hormones|mesh-ancestor
14703381|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14827888|NCT00932100|Tinzaparin|tinzaparin|mesh-list
14827889|NCT00932100|Dalteparin|dalteparin|mesh-list
14827890|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
14827891|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14827892|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14827893|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827894|NCT00932217|Lenograstim|lenograstim|mesh-list
14827895|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14827896|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
14827897|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911512|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14911513|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
14911514|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911515|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14911516|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14911517|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911518|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
14911519|NCT01363323|Naltrexone|naltrexone|mesh-list
14911520|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
14911521|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911522|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911523|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14911524|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14911525|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911526|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911527|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911528|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911529|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14911530|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
14911531|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911532|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14911533|NCT01363336|Nifedipine|nifedipine|mesh-list
15200931|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15200932|NCT03764267|Narcotics|narcotics|mesh-ancestor
15200933|NCT03764267|Analgesics|analgesics|mesh-ancestor
15200934|NCT03764241|Vitamin K|vitamin k|mesh-list
15200935|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
15200936|NCT03764241|Vitamins|vitamins|mesh-ancestor
15200937|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
15200938|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200939|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15200940|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
15200941|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15200942|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
15200943|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15200944|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15200945|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
15200946|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15200947|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15200948|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
15200949|NCT03764241|Coagulants|coagulants|mesh-ancestor
15200950|NCT03764202|Sufentanil|sufentanil|mesh-list
15200951|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15200952|NCT03764202|Narcotics|narcotics|mesh-ancestor
15200953|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200954|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200955|NCT03764202|Analgesics|analgesics|mesh-ancestor
14827898|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
14827899|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14827900|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827901|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827902|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14827903|NCT00932386|Analgesics|analgesics|mesh-ancestor
14827904|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
14827905|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827906|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14827907|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14827908|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14827909|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
14827910|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827911|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827912|NCT00932529|Olanzapine|olanzapine|mesh-list
14827913|NCT00932529|Risperidone|risperidone|mesh-list
14827914|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14827915|NCT00932529|Ziprasidone|ziprasidone|mesh-list
14827916|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14827917|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
14827918|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827919|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827920|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827921|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14827922|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14827923|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827924|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14827925|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14827926|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
15200956|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
15200957|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200958|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15200959|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15200960|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
15200961|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
15200962|NCT03764163|Xenon|xenon|mesh-list
14827927|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
15200963|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15200964|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
14827928|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
15200965|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
15200966|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827929|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827930|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14827931|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14827932|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14827933|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827934|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
14827935|NCT00932542|Lidocaine|lidocaine|mesh-list
14827936|NCT00932542|Prilocaine|prilocaine|mesh-list
14827937|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14827938|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
14827939|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14827940|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827941|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
14827942|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14827943|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14827944|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14827945|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14827946|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827947|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827948|NCT00932555|Factor VIII|factor viii|mesh-list
14827949|NCT00932555|Coagulants|coagulants|mesh-ancestor
14827950|NCT00932685|Midazolam|midazolam|mesh-list
14827951|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15200967|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224538|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15224539|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15224540|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224541|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224542|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224543|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
15224544|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
15224545|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224546|NCT03345823|Upadacitinib|upadacitinib|mesh-list
15224547|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15224548|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15224549|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224550|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703382|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827952|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15224551|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703383|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14703384|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703385|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
14703386|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
14703387|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703388|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14703389|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14703390|NCT00406042|Protective Agents|protective agents|mesh-ancestor
14703391|NCT00406094|Montelukast|montelukast|mesh-list
14703392|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14703393|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
14827953|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200968|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
15200969|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15200970|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15200971|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
15200972|NCT03764020|Melatonin|melatonin|mesh-list
15200973|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
15200974|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827954|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827955|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14827956|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14827957|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14827958|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14827959|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
15200975|NCT03764020|Protective Agents|protective agents|mesh-ancestor
15200976|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200977|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15200978|NCT03763786|Cetrorelix|cetrorelix|mesh-list
15200979|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15200980|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
15200981|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15200982|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200983|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
15200984|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200985|NCT03763760|Dexamethasone|dexamethasone|mesh-list
15200986|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200987|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
15200988|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
15200989|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15200990|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15200991|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15200992|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
14703394|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14703395|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
14703396|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703397|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703398|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14703399|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14703400|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703401|NCT00406146|Artesunate|artesunate|mesh-list
14703402|NCT00406146|Lumefantrine|lumefantrine|mesh-list
14703403|NCT00406146|Artemether|artemether|mesh-list
14703404|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14703405|NCT00406146|Amodiaquine|amodiaquine|mesh-list
14703406|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
14703407|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14703408|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14703409|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703410|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703411|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
14703412|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
14703413|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14703414|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
14703415|NCT00406172|Bevacizumab|bevacizumab|mesh-list
14703416|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703417|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703418|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703419|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703420|NCT00406172|Growth Substances|growth substances|mesh-ancestor
14703421|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703422|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703423|NCT00406237|Tigecycline|tigecycline|mesh-list
14703424|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703425|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703426|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14703427|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703428|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703429|NCT00406250|Bevacizumab|bevacizumab|mesh-list
14703430|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703431|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703432|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703433|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703434|NCT00406250|Growth Substances|growth substances|mesh-ancestor
14827960|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
15200993|NCT03763760|Hormones|hormones|mesh-ancestor
15200994|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15200995|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15200996|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15200997|NCT03763734|Dexamethasone|dexamethasone|mesh-list
15200998|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15200999|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
15201000|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
15201001|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201002|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201003|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201004|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
15201005|NCT03763734|Hormones|hormones|mesh-ancestor
15201006|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201007|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15201008|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201009|NCT03763669|Folic Acid|folic acid|mesh-list
15201010|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
15201011|NCT03763669|Inositol|inositol|mesh-list
15201012|NCT03763669|Hematinics|hematinics|mesh-ancestor
15201013|NCT03763669|Vitamins|vitamins|mesh-ancestor
15201014|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
15201015|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201016|NCT03763409|Losartan|losartan|mesh-list
15201017|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14827961|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
14827962|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
14827963|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14827964|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827965|NCT00932763|Amlodipine|amlodipine|mesh-list
14827966|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827967|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14827968|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827969|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827970|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14827971|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827972|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
14827973|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
14827974|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14827975|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14827976|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14827977|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14827978|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14827979|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201018|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14703435|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703436|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703437|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14703438|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14703439|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703440|NCT00406302|Docetaxel|docetaxel|mesh-list
14703441|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
14703442|NCT00406302|Cetuximab|cetuximab|mesh-list
14703443|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703444|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703445|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
14703446|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
14703447|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703448|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703449|NCT00406341|Difluprednate|difluprednate|mesh-list
14703450|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
14827980|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827981|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14827982|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14827983|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
15201019|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15201020|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15201021|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201022|NCT03763396|Ketoconazole|ketoconazole|mesh-list
14703451|NCT00406341|Hormones|hormones|mesh-ancestor
14728561|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14827984|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14827985|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14827986|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14827987|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14827988|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14827989|NCT00932867|Telmisartan|telmisartan|mesh-list
14827990|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827991|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14827992|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14827993|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827994|NCT00932880|Amlodipine|amlodipine|mesh-list
14827995|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14827996|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14827997|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14827998|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14827999|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14828000|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828001|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
14828002|NCT00932971|Tenofovir|tenofovir|mesh-list
14828003|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14828004|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
14828005|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
14828006|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14828007|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
14828008|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828009|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14828010|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14828011|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828012|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828013|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14828014|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14828015|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
14828016|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828017|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828018|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
14828019|NCT00933023|Betamethasone|betamethasone|mesh-list
14828020|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828021|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
14828022|NCT00933023|Hormones|hormones|mesh-ancestor
14828023|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201023|NCT03763396|Posaconazole|posaconazole|mesh-list
15201024|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
15201025|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201026|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15201027|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15201028|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201029|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201030|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14828024|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828025|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14828026|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
14828027|NCT00933049|Amoxicillin|amoxicillin|mesh-list
14828028|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14828029|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828030|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828031|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14828032|NCT00933049|Renal Agents|renal agents|mesh-ancestor
14828033|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
14828034|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14828035|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14828036|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
14828037|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15201031|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
15201032|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201033|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201034|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15201035|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15201036|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15201037|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15201038|NCT03763305|Fentanyl|fentanyl|mesh-list
15201039|NCT03763305|Remifentanil|remifentanil|mesh-list
15201040|NCT03763305|Propofol|propofol|mesh-list
14917160|NCT01396655|Doxorubicin|doxorubicin|mesh-list
14828038|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14703452|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703453|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703454|NCT00406380|Bevacizumab|bevacizumab|mesh-list
14828039|NCT00933179|Gestodene|gestodene|mesh-list
14828040|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14828041|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
14828042|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14828043|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828044|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14828045|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14828046|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14828047|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14828048|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14828049|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14828050|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14828051|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14828052|NCT00933179|Progestins|progestins|mesh-ancestor
14828053|NCT00933179|Hormones|hormones|mesh-ancestor
14828054|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828055|NCT00933205|Tipranavir|tipranavir|mesh-list
14828056|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14828057|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14828058|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
14828059|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828060|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
15201041|NCT03763305|Sevoflurane|sevoflurane|mesh-list
15201042|NCT03763305|Desflurane|desflurane|mesh-list
15201043|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15201044|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201045|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201046|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201047|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15201048|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
15201049|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
15201050|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15201051|NCT03763305|Narcotics|narcotics|mesh-ancestor
15201052|NCT03763305|Analgesics|analgesics|mesh-ancestor
15201053|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
15201054|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201055|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15201056|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15201057|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15201058|NCT03763279|Triclosan|triclosan|mesh-list
15201059|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15201060|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201061|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14828061|NCT00933231|Prednisone|prednisone|mesh-list
14828062|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
14828063|NCT00933231|Ramipril|ramipril|mesh-list
14828064|NCT00933231|Irbesartan|irbesartan|mesh-list
14828065|NCT00933231|Tacrolimus|tacrolimus|mesh-list
14828066|NCT00933231|Basiliximab|basiliximab|mesh-list
14828067|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828068|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
14828069|NCT00933231|Hormones|hormones|mesh-ancestor
14703455|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703456|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703457|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703458|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703459|NCT00406380|Growth Substances|growth substances|mesh-ancestor
14703460|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703461|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703462|NCT00406432|Paroxetine|paroxetine|mesh-list
14703463|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14703464|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14703465|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14703466|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703467|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828070|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201062|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14828071|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201063|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
14703468|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
14828072|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14828073|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703469|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703470|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14703471|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
14703472|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14703473|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14703474|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14703475|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703476|NCT00406471|Ranibizumab|ranibizumab|mesh-list
14703477|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703478|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703479|NCT00406471|Growth Substances|growth substances|mesh-ancestor
14703480|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703481|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703482|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703483|NCT00406497|Difluprednate|difluprednate|mesh-list
14703484|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
14703485|NCT00406497|Hormones|hormones|mesh-ancestor
14703486|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703487|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703488|NCT00406575|Methocarbamol|methocarbamol|mesh-list
14703489|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14703490|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703491|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14703492|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703493|NCT00406601|Sorafenib|sorafenib|mesh-list
14703494|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703495|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14703496|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703497|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703498|NCT00406679|Acetaminophen|acetaminophen|mesh-list
14703499|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14703500|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703501|NCT00406679|Analgesics|analgesics|mesh-ancestor
14703502|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
14703503|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703504|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703505|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
14703506|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14703507|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703508|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703509|NCT00406744|Bevacizumab|bevacizumab|mesh-list
14703510|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703511|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703512|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703513|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703514|NCT00406744|Growth Substances|growth substances|mesh-ancestor
14703515|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703516|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703517|NCT00406796|Ranibizumab|ranibizumab|mesh-list
14703518|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703519|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703520|NCT00406796|Growth Substances|growth substances|mesh-ancestor
14703521|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703522|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703523|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703524|NCT00406861|Montelukast|montelukast|mesh-list
14703525|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14703526|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
14703527|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14703528|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
14703529|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703530|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703531|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14703532|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14703533|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703534|NCT00406874|Folic Acid|folic acid|mesh-list
14703535|NCT00406874|Hematinics|hematinics|mesh-ancestor
14828074|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201064|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201065|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15201066|NCT03763227|Ranibizumab|ranibizumab|mesh-list
15201067|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
15201068|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15201069|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15201070|NCT03763227|Growth Substances|growth substances|mesh-ancestor
15201071|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201072|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
14828075|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
14828076|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15201073|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201074|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201075|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703536|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
14703537|NCT00406874|Vitamins|vitamins|mesh-ancestor
14703538|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
14703539|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703540|NCT00406887|Difluprednate|difluprednate|mesh-list
14703541|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
14703542|NCT00406887|Hormones|hormones|mesh-ancestor
14828077|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828078|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295076|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295077|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295078|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295079|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14828079|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
14828080|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
14828081|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828082|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14828083|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14828084|NCT00933231|Protective Agents|protective agents|mesh-ancestor
14828085|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14828086|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14828087|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
14828088|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828089|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828090|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14828091|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
14828092|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14828093|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14828094|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14828095|NCT00933283|Methadone|methadone|mesh-list
14828096|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14828097|NCT00933283|Narcotics|narcotics|mesh-ancestor
14828098|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14828099|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828100|NCT00933283|Analgesics|analgesics|mesh-ancestor
14828101|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
14828102|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828103|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
14828104|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
14828105|NCT00933309|Metformin|metformin|mesh-list
14828106|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
14828107|NCT00933309|Exemestane|exemestane|mesh-list
14828108|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828109|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295080|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
14828110|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828111|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14828112|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14828113|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828114|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828115|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14703543|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828116|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828117|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201076|NCT03763123|Paclitaxel|paclitaxel|mesh-list
15201077|NCT03763123|Topotecan|topotecan|mesh-list
15201078|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15201079|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201080|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201081|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201082|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
15201083|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201084|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15201085|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828118|NCT00933374|Paclitaxel|paclitaxel|mesh-list
14828119|NCT00933374|Everolimus|everolimus|mesh-list
14828120|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828121|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828122|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201086|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201087|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15201088|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15201089|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201090|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
15201091|NCT03763084|Acetaminophen|acetaminophen|mesh-list
15201092|NCT03763084|Sufentanil|sufentanil|mesh-list
15201093|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15201094|NCT03763084|Analgesics|analgesics|mesh-ancestor
15201095|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
15201096|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201097|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201098|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
15201099|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15201100|NCT03763084|Narcotics|narcotics|mesh-ancestor
15201101|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201102|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15201103|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15201104|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
15201105|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
15201106|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
14828123|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828124|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828125|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828126|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828127|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
14828128|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828129|NCT00933387|Paclitaxel|paclitaxel|mesh-list
14828130|NCT00933387|Cetuximab|cetuximab|mesh-list
14828131|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828132|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828133|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703544|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703545|NCT00406913|Mupirocin|mupirocin|mesh-list
14703546|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703547|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703548|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14703549|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703550|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703551|NCT00406952|Sertraline|sertraline|mesh-list
14703552|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
14703553|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14703554|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14703555|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14828134|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828135|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828136|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828137|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14828138|NCT00933426|Paclitaxel|paclitaxel|mesh-list
14828139|NCT00933426|Lenalidomide|lenalidomide|mesh-list
14828140|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828141|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828142|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828143|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201107|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14703556|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828144|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
15201108|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15201109|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15201110|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828145|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828146|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
14828147|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828148|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14828149|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14828150|NCT00933426|Growth Substances|growth substances|mesh-ancestor
14828151|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
14828152|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14828153|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14828154|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14828155|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828156|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828157|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828158|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828159|NCT00933439|Analgesics|analgesics|mesh-ancestor
14828160|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
14828161|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828162|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
14828163|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14828164|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
14828165|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14828166|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14828167|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14828168|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828169|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828170|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828171|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828172|NCT00933452|Analgesics|analgesics|mesh-ancestor
14828173|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
14828174|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828175|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
14828176|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14828177|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
14828178|NCT00933465|Loperamide|loperamide|mesh-list
14828179|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
14828180|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14828181|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
14828182|NCT00933517|Docetaxel|docetaxel|mesh-list
14828183|NCT00933517|Panitumumab|panitumumab|mesh-list
14828184|NCT00933517|Epirubicin|epirubicin|mesh-list
14703557|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703558|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703559|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
14703560|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703561|NCT00406978|Thalidomide|thalidomide|mesh-list
14703562|NCT00406978|Prednisone|prednisone|mesh-list
14828185|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828186|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
14828187|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828188|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14828189|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14828190|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
14828191|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828192|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828193|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14828194|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828195|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828196|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828197|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14828198|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14828199|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14828200|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828201|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828202|NCT00933582|Naproxen|naproxen|mesh-list
14828203|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14828204|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703563|NCT00406978|Melphalan|melphalan|mesh-list
14703564|NCT00406978|Defibrotide|defibrotide|mesh-list
14703565|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703566|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
14703567|NCT00406978|Hormones|hormones|mesh-ancestor
14703568|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703569|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201111|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828205|NCT00933582|Analgesics|analgesics|mesh-ancestor
14828206|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
14828207|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828208|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828209|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828210|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14828211|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
14828212|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14828213|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828214|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828215|NCT00933634|Propafenone|propafenone|mesh-list
15201112|NCT03763045|Urological Agents|urological agents|mesh-ancestor
15201113|NCT03762967|Hormones|hormones|mesh-list
15201114|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201115|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201116|NCT03762928|Efavirenz|efavirenz|mesh-list
15201117|NCT03762928|Midazolam|midazolam|mesh-list
15201118|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14703570|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14703571|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703572|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14703573|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
14703574|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201119|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201120|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14828216|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14828217|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14828218|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14828219|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828220|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201121|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201122|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15201123|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15201124|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15201125|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15201126|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
15201127|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
15201128|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
15201129|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
15201130|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201131|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703575|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14828221|NCT00933777|Everolimus|everolimus|mesh-list
14828222|NCT00933777|Sorafenib|sorafenib|mesh-list
14828223|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828224|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828225|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
14828226|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828227|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14828228|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828229|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828230|NCT00933790|Rifampin|rifampin|mesh-list
14828231|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
14828232|NCT00933790|Ethambutol|ethambutol|mesh-list
14828233|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14828234|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
14828235|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828236|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828237|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
14828238|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14828239|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828240|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201132|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14703576|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703577|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
14703578|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
14703579|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703580|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703581|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703582|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703583|NCT00406978|Growth Substances|growth substances|mesh-ancestor
14703584|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
15201133|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15201134|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201135|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
15201136|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201137|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15201138|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15201139|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15201140|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15201141|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15201142|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15201143|NCT03762915|Minocycline|minocycline|mesh-list
15201144|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201145|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201146|NCT03762889|Anesthetics|anesthetics|mesh-list
15201147|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201148|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201149|NCT03762850|Irbesartan|irbesartan|mesh-list
15201150|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15201151|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15201152|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15201153|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201154|NCT03762824|Vaccines|vaccines|mesh-list
15201155|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15201156|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
15201157|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201158|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
15201159|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201160|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201161|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201162|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295081|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14295082|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14295083|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
14295084|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14295085|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295086|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14295087|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14295088|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14295089|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295090|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14295091|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14703585|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14703586|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14703587|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14703588|NCT00406991|Aspirin|aspirin|mesh-list
14703589|NCT00406991|Clopidogrel|clopidogrel|mesh-list
14703590|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14703591|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703592|NCT00406991|Analgesics|analgesics|mesh-ancestor
14703593|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
14703594|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703595|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703596|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703597|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703598|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14703599|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14703600|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703601|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14703602|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14703603|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703604|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
14703605|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14703606|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14703607|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14703608|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
14703609|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703610|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
14703611|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
14703612|NCT00407017|Ketorolac|ketorolac|mesh-list
14703613|NCT00407017|Nepafenac|nepafenac|mesh-list
14703614|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
14703615|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828241|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14828242|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14828243|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14828244|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14828245|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14828246|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14828247|NCT00933816|Fluorouracil|fluorouracil|mesh-list
14828248|NCT00933816|Sorafenib|sorafenib|mesh-list
14828249|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828250|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
14828251|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828252|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14828253|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828254|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
14828255|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828256|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14828257|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911534|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14911535|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911536|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911537|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911538|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911539|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
14911540|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
14911541|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14911542|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
14911543|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14911544|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911545|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
14911546|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14911547|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
14911548|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911549|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
14911550|NCT01363414|Protective Agents|protective agents|mesh-ancestor
14911551|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14911552|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911553|NCT01363544|Methylphenidate|methylphenidate|mesh-list
14911554|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14911555|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911556|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14911557|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14911558|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911559|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911560|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
14911561|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911562|NCT01363557|Gefitinib|gefitinib|mesh-list
14911563|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201163|NCT03762785|Analgesics|analgesics|mesh-ancestor
15201164|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
15201165|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201166|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15201167|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15201168|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15201169|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
15201170|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201171|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201172|NCT03762759|Edetic Acid|edetic acid|mesh-list
15201173|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15201174|NCT03762759|Anticoagulants|anticoagulants|mesh-ancestor
14295092|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295093|NCT00578929|Analgesics|analgesics|mesh-ancestor
14295094|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
14295095|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201175|NCT03762759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15201176|NCT03762759|Chelating Agents|chelating agents|mesh-ancestor
15201177|NCT03762759|Sequestering Agents|sequestering agents|mesh-ancestor
15201178|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201179|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15201180|NCT03762564|Paclitaxel|paclitaxel|mesh-list
15201181|NCT03762564|Ramucirumab|ramucirumab|mesh-list
15201182|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15201183|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201184|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201185|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201186|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295096|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295097|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295098|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295099|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14295100|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14828258|NCT00933894|Citalopram|citalopram|mesh-list
14828259|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14828260|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14828261|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828262|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828263|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828264|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
14828265|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201187|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295101|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14295102|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
14828266|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14828267|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
14828268|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14828269|NCT00933985|Doxorubicin|doxorubicin|mesh-list
14828270|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14828271|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
14828272|NCT00933985|Vincristine|vincristine|mesh-list
14828273|NCT00933985|Razoxane|razoxane|mesh-list
14828274|NCT00933985|Obatoclax|obatoclax|mesh-list
14828275|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14828276|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828277|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14828278|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828279|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828280|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828281|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828282|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828283|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828284|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828285|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14828286|NCT00933985|Protective Agents|protective agents|mesh-ancestor
14828287|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828288|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
14828289|NCT00933998|Pyridoxal|pyridoxal|mesh-list
14828290|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
14828291|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
14828292|NCT00933998|Vitamins|vitamins|mesh-ancestor
14828293|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
15201188|NCT03762538|Propofol|propofol|mesh-list
15201189|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201190|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201191|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201192|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15201193|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
15201194|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
15201195|NCT03762395|CXA-10|cxa-10|mesh-list
15201196|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201197|NCT03762382|Tenofovir|tenofovir|mesh-list
15201198|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
14828294|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828295|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14828296|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14828297|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828298|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
14828299|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14828300|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828301|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14828302|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828303|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828304|NCT00934154|Thalidomide|thalidomide|mesh-list
14828305|NCT00934154|Prednisolone|prednisolone|mesh-list
14828306|NCT00934154|Melphalan|melphalan|mesh-list
14828307|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14828308|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
14828309|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828310|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828311|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14828312|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828313|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
14828314|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828315|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828316|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
14828317|NCT00934154|Hormones|hormones|mesh-ancestor
14828318|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828319|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14828320|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
14828321|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828322|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828323|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14828324|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14828325|NCT00934154|Growth Substances|growth substances|mesh-ancestor
14828326|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
14828327|NCT00934167|Heparin|heparin|mesh-list
14828328|NCT00934167|Calcium heparin|calcium heparin|mesh-list
14828329|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
14828330|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14828331|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14828332|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828333|NCT00934193|Gabapentin|gabapentin|mesh-list
14828334|NCT00934193|Analgesics|analgesics|mesh-ancestor
14828335|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
14828336|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828337|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828338|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
14828339|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14828340|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14828341|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14828342|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14828343|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14828344|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14828345|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828346|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828347|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
14828348|NCT00934232|Busulfan|busulfan|mesh-list
14828349|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
14828350|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828351|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828352|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
14828353|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828354|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14828355|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201199|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
15201200|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201201|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15201202|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14828356|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14828357|NCT00934245|Vaccines|vaccines|mesh-list
14828358|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
14828359|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201203|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828360|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15201204|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201205|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15201206|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15201207|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15201208|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
15201209|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15201210|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201211|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15201212|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15201213|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15201214|NCT03762369|Latanoprost|latanoprost|mesh-list
15201215|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15201216|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15201217|NCT03762317|Clonidine|clonidine|mesh-list
15201218|NCT03762317|Analgesics|analgesics|mesh-ancestor
15201219|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
15201220|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201221|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201222|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15201223|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
15201224|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
14828361|NCT00934258|Fenofibrate|fenofibrate|mesh-list
14828362|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14828363|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14828364|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
14828365|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828366|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14828367|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14828368|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828369|NCT00934323|Metformin|metformin|mesh-list
14828370|NCT00934323|Glimepiride|glimepiride|mesh-list
14828371|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828372|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828373|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14828374|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828375|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
14828376|NCT00934414|Insulin|insulin|mesh-list
14828377|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828378|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828379|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
14828380|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
14828381|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
14828382|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
15201225|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15201226|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15201227|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15201228|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
15201229|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201230|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224552|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
15224553|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224554|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224555|NCT03158688|Dexamethasone|dexamethasone|mesh-list
15224556|NCT03158688|Daratumumab|daratumumab|mesh-list
15224557|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224558|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
15224559|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
15224560|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224561|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224562|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224563|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
15224564|NCT03158688|Hormones|hormones|mesh-ancestor
15224565|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224566|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224567|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224568|NCT03152786|Propranolol|propranolol|mesh-list
15224569|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15224570|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15224571|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14828383|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
14828384|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15224572|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225696|NCT03961789|Analgesics|analgesics|mesh-ancestor
15201231|NCT03762226|Bevacizumab|bevacizumab|mesh-list
15201232|NCT03762226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15201233|NCT03762226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295103|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
14295104|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295105|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295106|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
14295107|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295108|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201234|NCT03762226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15201235|NCT03762226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15201236|NCT03762226|Growth Substances|growth substances|mesh-ancestor
15201237|NCT03762226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201238|NCT03762226|Growth Inhibitors|growth inhibitors|mesh-ancestor
15201239|NCT03762148|Vitamins|vitamins|mesh-list
15201240|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
15201241|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
15201242|NCT03762148|Iron|iron|mesh-list
14295109|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
14295110|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14295111|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
14295112|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295113|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828385|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14828386|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828387|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828388|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828389|NCT00934479|Lubiprostone|lubiprostone|mesh-list
14828390|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14828391|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828392|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828393|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14828394|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14828395|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828396|NCT00934492|Renal Agents|renal agents|mesh-ancestor
14828397|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828398|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
15201243|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
15201244|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828399|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14828400|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14828401|NCT00934518|Cetuximab|cetuximab|mesh-list
14828402|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14828403|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828404|NCT00934531|Donepezil|donepezil|mesh-list
14828405|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14828406|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828407|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828408|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
14828409|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828410|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828411|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
14828412|NCT00934570|Metformin|metformin|mesh-list
14828413|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828414|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828415|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
14828416|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14828417|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14828418|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14828419|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828420|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828421|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
14828422|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828423|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828424|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14828425|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828426|NCT00934713|Montelukast|montelukast|mesh-list
14828427|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14828428|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
14828429|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14828430|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828431|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828432|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828433|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14828434|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14828435|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828436|NCT00934739|Thalidomide|thalidomide|mesh-list
15201245|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
15201246|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201247|NCT03762148|Protective Agents|protective agents|mesh-ancestor
15201248|NCT03762148|Trace Elements|trace elements|mesh-ancestor
15201249|NCT03762096|Resveratrol|resveratrol|mesh-list
15201250|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
15201251|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201252|NCT03762096|Protective Agents|protective agents|mesh-ancestor
15201253|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201254|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201255|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15201256|NCT03761511|Niacinamide|niacinamide|mesh-list
15201257|NCT03761511|Niacin|niacin|mesh-list
15201258|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
14828437|NCT00934739|Dexamethasone|dexamethasone|mesh-list
14828438|NCT00934739|Celecoxib|celecoxib|mesh-list
14828439|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
14828440|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828441|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
14828442|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828443|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14828444|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15201259|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
15201260|NCT03761511|Vitamins|vitamins|mesh-ancestor
15201261|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
15201262|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201263|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15201264|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
15201265|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201266|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15201267|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
15201268|NCT03761485|Fluorides|fluorides|mesh-list
15201269|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
15201270|NCT03761485|Protective Agents|protective agents|mesh-ancestor
15201271|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201272|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
14828445|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
14828446|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828447|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828448|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14828449|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828450|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
14828451|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
14828452|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828453|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14828454|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
14828455|NCT00934739|Hormones|hormones|mesh-ancestor
14828456|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828457|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14828458|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
14828459|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828460|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828461|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14828462|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14828463|NCT00934739|Growth Substances|growth substances|mesh-ancestor
14828464|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
14828465|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14828466|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14828467|NCT00934739|Analgesics|analgesics|mesh-ancestor
14828468|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
14828469|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14828470|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14828471|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828472|NCT00934752|Paclitaxel|paclitaxel|mesh-list
14828473|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828474|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828475|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828476|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828477|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828478|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828479|NCT00934817|Metformin|metformin|mesh-list
14828480|NCT00934817|Glimepiride|glimepiride|mesh-list
14828481|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828482|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828483|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14828484|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828485|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
14828486|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14828487|NCT00934830|Amoxicillin|amoxicillin|mesh-list
14828488|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828489|NCT00934895|Paclitaxel|paclitaxel|mesh-list
14828490|NCT00934895|Everolimus|everolimus|mesh-list
14828491|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14828492|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828493|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201273|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15201274|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
15201275|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201276|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
15201277|NCT03761472|Protective Agents|protective agents|mesh-ancestor
15201278|NCT03761329|Lidocaine|lidocaine|mesh-list
15201279|NCT03761329|Anesthetics|anesthetics|mesh-list
15201280|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
15201281|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201282|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201283|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
15201284|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201285|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15201286|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15201287|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15201288|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828494|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828495|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828496|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828497|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828498|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828499|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
14828500|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828501|NCT00934973|Mebeverine|mebeverine|mesh-list
14828502|NCT00934973|Alverine|alverine|mesh-list
15201289|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828503|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
14828504|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
14828505|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
14828506|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828507|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828508|NCT00935116|Etoricoxib|etoricoxib|mesh-list
14828509|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14828510|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14828511|NCT00935116|Analgesics|analgesics|mesh-ancestor
14828512|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
14828513|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828514|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828515|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828516|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14828517|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14828518|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14828519|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828520|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828521|NCT00935194|Oseltamivir|oseltamivir|mesh-list
14828522|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
14828523|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828524|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828525|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828526|NCT00935246|Dexetimide|dexetimide|mesh-list
14828527|NCT00935246|Citalopram|citalopram|mesh-list
14828528|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14828529|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14828530|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828531|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828532|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828533|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
14828534|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828535|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14828536|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
14828537|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14828538|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14828539|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14828540|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
14828541|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
14828542|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201290|NCT03761264|Amoxicillin|amoxicillin|mesh-list
15201291|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
15201292|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201293|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201294|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201295|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
15201296|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
15201297|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15201298|NCT03761264|Protective Agents|protective agents|mesh-ancestor
15201299|NCT03761004|Levodopa|levodopa|mesh-list
15201300|NCT03761004|Carbidopa|carbidopa|mesh-list
15201301|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15201302|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15201303|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15201304|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
15201305|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201306|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201307|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201308|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15201309|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201310|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15201311|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
15201312|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
15201313|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
14295114|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14828543|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14828544|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14828545|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
14828546|NCT00935298|Tacrolimus|tacrolimus|mesh-list
14828547|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828548|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
14828549|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828550|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14828551|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911564|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15201314|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201315|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201316|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201317|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15201318|NCT03760978|Analgesics|analgesics|mesh-ancestor
15201319|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
15201320|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201321|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15201322|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15201323|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15201324|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
15201325|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828552|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828553|NCT00935363|Glyburide|glyburide|mesh-list
14828554|NCT00935363|Rifampin|rifampin|mesh-list
14828555|NCT00935363|Fluconazole|fluconazole|mesh-list
14828556|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14828557|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
14828558|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14828559|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828560|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
14828561|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14828562|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828563|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828564|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14828565|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14828566|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14828567|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14828568|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14828569|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14828570|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
14828571|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14828572|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14703616|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703617|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14703618|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828573|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14828574|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828575|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828576|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828577|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14828578|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14828579|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828580|NCT00935415|Montelukast|montelukast|mesh-list
14828581|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14828582|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
14828583|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14828584|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828585|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828586|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828587|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15201326|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201327|NCT03760848|Midazolam|midazolam|mesh-list
15201328|NCT03760848|Atorvastatin|atorvastatin|mesh-list
15201329|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15201330|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15201331|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
15225697|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
14703619|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828588|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14828589|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828590|NCT00935467|Saxagliptin|saxagliptin|mesh-list
14703620|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703621|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703622|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703623|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14703624|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703625|NCT00407017|Analgesics|analgesics|mesh-ancestor
14703626|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
14703627|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703628|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828591|NCT00935467|Incretins|incretins|mesh-ancestor
14828592|NCT00935467|Hormones|hormones|mesh-ancestor
15201332|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201333|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15201334|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15201335|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201336|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15201337|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201338|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201339|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201340|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15201341|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15201342|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15201343|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14828593|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828594|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828595|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14828596|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
14828597|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828598|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828599|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828600|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
14828601|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14828602|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14828603|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
14828604|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828605|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14828606|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14828607|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828608|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828609|NCT00935506|Aspirin|aspirin|mesh-list
14828610|NCT00935506|Clopidogrel|clopidogrel|mesh-list
14828611|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14828612|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14828613|NCT00935506|Analgesics|analgesics|mesh-ancestor
14828614|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
14828615|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828616|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828617|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828618|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14828619|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14828620|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14828621|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828622|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14828623|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14828624|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828625|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
14828626|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14828627|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14828628|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14828629|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
14828630|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828631|NCT00935558|Interleukin-2|interleukin-2|mesh-list
14828632|NCT00935558|Exemestane|exemestane|mesh-list
14828633|NCT00935558|Anastrozole|anastrozole|mesh-list
14828634|NCT00935558|Letrozole|letrozole|mesh-list
14828635|NCT00935558|Lactitol|lactitol|mesh-list
14828636|NCT00935558|Vaccines|vaccines|mesh-list
14828637|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14828638|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
14828639|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828640|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828641|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14828642|NCT00935558|Analgesics|analgesics|mesh-ancestor
14828643|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
14828644|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828645|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14828646|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828647|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828648|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14828649|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828650|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828651|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14828652|NCT00935558|Cathartics|cathartics|mesh-ancestor
14828653|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14828654|NCT00935571|Remifentanil|remifentanil|mesh-list
14828655|NCT00935571|Propofol|propofol|mesh-list
14828656|NCT00935571|Sevoflurane|sevoflurane|mesh-list
14828657|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14828658|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14828659|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828660|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14828661|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
14828662|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
14828663|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14828664|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14828665|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14828666|NCT00935571|Narcotics|narcotics|mesh-ancestor
14828667|NCT00935571|Analgesics|analgesics|mesh-ancestor
14828668|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
14828669|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828670|NCT00935610|Caseins|caseins|mesh-list
14828671|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
14828672|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
14828673|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828674|NCT00935675|Citalopram|citalopram|mesh-list
14828675|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14828676|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14828677|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828678|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828679|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828680|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
14828681|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828682|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14828683|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
14828684|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911565|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911566|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911567|NCT01363570|Ranibizumab|ranibizumab|mesh-list
14911568|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14911569|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14911570|NCT01363570|Growth Substances|growth substances|mesh-ancestor
14911571|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911572|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
14911573|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911574|NCT01363583|Epoprostenol|epoprostenol|mesh-list
15201344|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
15201345|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
15201346|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
15201347|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
15201348|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911575|NCT01363583|Tezosentan|tezosentan|mesh-list
14911576|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14911577|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14911578|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
14911579|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
14911580|NCT01363609|Liraglutide|liraglutide|mesh-list
14911581|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14911582|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911583|NCT01363609|Incretins|incretins|mesh-ancestor
14911584|NCT01363609|Hormones|hormones|mesh-ancestor
14911585|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14911586|NCT01363648|Choline|choline|mesh-list
14911587|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
14911588|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14911589|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
14911590|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911591|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201349|NCT03760822|Paclitaxel|paclitaxel|mesh-list
14911592|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14911593|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
15201350|NCT03760822|Ramucirumab|ramucirumab|mesh-list
14828685|NCT00935805|Insulin|insulin|mesh-list
14828686|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14828687|NCT00935805|Metformin|metformin|mesh-list
14828688|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
14828689|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
14828690|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
14828691|NCT00935805|Glyburide|glyburide|mesh-list
14828692|NCT00935805|Propranolol|propranolol|mesh-list
14828693|NCT00935805|Amlodipine|amlodipine|mesh-list
14828694|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15201351|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15201352|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201353|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201354|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828695|NCT00935805|Captopril|captopril|mesh-list
14828696|NCT00935805|Diuretics|diuretics|mesh-list
14828697|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828698|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828699|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14828700|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14828701|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828702|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828703|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14828704|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
14828705|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
14828706|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14828707|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14828708|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14828709|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
14828710|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828711|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14828712|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14828713|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
14828714|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828715|NCT00935961|Docetaxel|docetaxel|mesh-list
14828716|NCT00935961|Everolimus|everolimus|mesh-list
14828717|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828718|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828719|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828720|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828721|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828722|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828723|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
14828724|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828725|NCT00936013|Oseltamivir|oseltamivir|mesh-list
14828726|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
14828727|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828728|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828729|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828730|NCT00936091|Vitamin A|vitamin a|mesh-list
14828731|NCT00936091|Vitamins|vitamins|mesh-ancestor
14828732|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
14828733|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828734|NCT00936143|Infliximab|infliximab|mesh-list
14828735|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14828736|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14828737|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14828738|NCT00936156|Carboplatin|carboplatin|mesh-list
14828739|NCT00936156|Etoposide|etoposide|mesh-list
14828740|NCT00936156|Thiotepa|thiotepa|mesh-list
14828741|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828742|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828743|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14828744|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828745|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828746|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828747|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14828748|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
14828749|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14828750|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828751|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
14828752|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828753|NCT00936182|Fluconazole|fluconazole|mesh-list
14828754|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
14828755|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828756|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14828757|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14828758|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828759|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828760|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14828761|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828762|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828763|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828764|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15201355|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
15201356|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201357|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
15201358|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201359|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201360|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201361|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15201362|NCT03760809|Analgesics|analgesics|mesh-ancestor
15201363|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
15201364|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201365|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15201366|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15201367|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15201368|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
15201369|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295115|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295116|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
14828765|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14828766|NCT00936195|Ritonavir|ritonavir|mesh-list
14828767|NCT00936195|Lopinavir|lopinavir|mesh-list
14828768|NCT00936195|Tenofovir|tenofovir|mesh-list
14828769|NCT00936195|Lamivudine|lamivudine|mesh-list
14828770|NCT00936195|Zidovudine|zidovudine|mesh-list
14828771|NCT00936195|Emtricitabine|emtricitabine|mesh-list
14828772|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14828773|NCT00936195|Efavirenz|efavirenz|mesh-list
14828774|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14703629|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703630|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14703631|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14703632|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14703633|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14703634|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14703635|NCT00407056|Difluprednate|difluprednate|mesh-list
14703636|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
14703637|NCT00407056|Hormones|hormones|mesh-ancestor
14295117|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14295118|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
14703638|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703639|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703640|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14703641|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14828775|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14828776|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
14828777|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828778|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828779|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14828780|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14828781|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
14828782|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828783|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14828784|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14828785|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14828786|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14828787|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
14828788|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14828789|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14703642|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
14703643|NCT00407082|Hormones|hormones|mesh-ancestor
14703644|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703645|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703646|NCT00407121|Bevacizumab|bevacizumab|mesh-list
14703647|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703648|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703649|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15201370|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828790|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15201371|NCT03760770|Riboflavin|riboflavin|mesh-list
15201372|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
15201373|NCT03760770|Vitamins|vitamins|mesh-ancestor
15201374|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
15201375|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201376|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15201377|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
15201378|NCT03760666|Ribavirin|ribavirin|mesh-list
15201379|NCT03760666|Brequinar|brequinar|mesh-list
14828791|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14828792|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14828793|NCT00936234|Vildagliptin|vildagliptin|mesh-list
14828794|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14828795|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828796|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14828797|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
14828798|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828799|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828800|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14828801|NCT00936260|Alendronate|alendronate|mesh-list
14828802|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14828803|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828804|NCT00936390|Leuprolide|leuprolide|mesh-list
14828805|NCT00936390|Goserelin|goserelin|mesh-list
14828806|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14828807|NCT00936390|Flutamide|flutamide|mesh-list
14828808|NCT00936390|Bicalutamide|bicalutamide|mesh-list
14828809|NCT00936390|Buserelin|buserelin|mesh-list
14828810|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14828811|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
14828812|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15201380|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
15201381|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201382|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
15201383|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828813|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828814|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14828815|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828816|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-ancestor
14828817|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828818|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828819|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
14828820|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14828821|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
14828822|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14828823|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14828824|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14828825|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
14828826|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828827|NCT00936429|Antacids|antacids|mesh-ancestor
14828828|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828829|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14828830|NCT00936442|Anastrozole|anastrozole|mesh-list
14828831|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14828832|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828833|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14828834|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14828835|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828836|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828837|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14828838|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828839|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828840|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828841|NCT00936520|Lifitegrast|lifitegrast|mesh-list
14828842|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14828843|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14828844|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14828845|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14828846|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
14828847|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14828848|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15201384|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911594|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
15201385|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201386|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828849|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828850|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
14828851|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14828852|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828853|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14828854|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14828855|NCT00936546|Rituximab|rituximab|mesh-list
14828856|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14828857|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828858|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
14828859|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828860|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14828861|NCT00936624|Montelukast|montelukast|mesh-list
15201387|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
15201388|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201389|NCT03760614|Entinostat|entinostat|mesh-list
15201390|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201391|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15201392|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201393|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201394|NCT03760588|Valsartan|valsartan|mesh-list
15201395|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15201396|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15201397|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15201398|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201399|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
15201400|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201401|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828862|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14828863|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
14828864|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14828865|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828866|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828867|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828868|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14828869|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14828870|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828871|NCT00936650|Cinacalcet|cinacalcet|mesh-list
14828872|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14828873|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828874|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14828875|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
14828876|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828877|NCT00936676|Rasagiline|rasagiline|mesh-list
15201402|NCT03760445|Cytarabine|cytarabine|mesh-list
15201403|NCT03760445|Posaconazole|posaconazole|mesh-list
15201404|NCT03760445|Daunorubicin|daunorubicin|mesh-list
15201405|NCT03760445|Idarubicin|idarubicin|mesh-list
15201406|NCT03760445|Midostaurin|midostaurin|mesh-list
15201407|NCT03760445|Midazolam|midazolam|mesh-list
14828878|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15201408|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15201409|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
14828879|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828880|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828881|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14828882|NCT00936676|Protective Agents|protective agents|mesh-ancestor
15201410|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201411|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201412|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
15201413|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201414|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201415|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
14828883|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828884|NCT00936689|Doxorubicin|doxorubicin|mesh-list
14828885|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
14828886|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14828887|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828888|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15201416|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295119|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295120|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295121|NCT00579098|Atorvastatin|atorvastatin|mesh-list
14295122|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14828889|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828890|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828891|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828892|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14828893|NCT00936689|Estrogens|estrogens|mesh-ancestor
14295123|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14295124|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
14295125|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295126|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14295127|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14295128|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295129|NCT00579111|Fludarabine|fludarabine|mesh-list
14295130|NCT00579111|Busulfan|busulfan|mesh-list
14828894|NCT00936689|Hormones|hormones|mesh-ancestor
14828895|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828896|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828897|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14828898|NCT00936767|Artesunate|artesunate|mesh-list
14828899|NCT00936767|Mefloquine|mefloquine|mesh-list
14828900|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
14828901|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14828902|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14828903|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828904|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828905|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
14828906|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
14828907|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14828908|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
14828909|NCT00936780|Paclitaxel|paclitaxel|mesh-list
14828910|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828911|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828912|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828913|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828914|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828915|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828916|NCT00936793|Ritonavir|ritonavir|mesh-list
14828917|NCT00936793|Darunavir|darunavir|mesh-list
14828918|NCT00936793|Beclomethasone|beclomethasone|mesh-list
14828919|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14828920|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14828921|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
14828922|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828923|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828924|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14828925|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14828926|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
14828927|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14828928|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14828929|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14828930|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201417|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14828931|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
14828932|NCT00936793|Hormones|hormones|mesh-ancestor
15201418|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201419|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201420|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15201421|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15201422|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15201423|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15201424|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
15201425|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
15201426|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
15201427|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
15201428|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201429|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14828933|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14828934|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828935|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14828936|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
14828937|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
14828938|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14828939|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14828940|NCT00936832|Leucovorin|leucovorin|mesh-list
14828941|NCT00936832|Fluorouracil|fluorouracil|mesh-list
14828942|NCT00936832|Irinotecan|irinotecan|mesh-list
14828943|NCT00936832|Sunitinib|sunitinib|mesh-list
14828944|NCT00936832|Calcium|calcium|mesh-list
14828945|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
15201430|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15201431|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15201432|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201433|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
15201434|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15201435|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15201436|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15201437|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15201438|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15201439|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15201440|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
15201441|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201442|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15201443|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
15201444|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15201445|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15201446|NCT03760354|Prednisolone|prednisolone|mesh-list
15201447|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
15201448|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15201449|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
15201450|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201451|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
15201452|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
14295131|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
14295132|NCT00579111|Tacrolimus|tacrolimus|mesh-list
14703650|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703651|NCT00407121|Growth Substances|growth substances|mesh-ancestor
14703652|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703653|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703654|NCT00407186|Cisplatin|cisplatin|mesh-list
14703655|NCT00407186|Capecitabine|capecitabine|mesh-list
14703656|NCT00407186|Epirubicin|epirubicin|mesh-list
14703657|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703658|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14703659|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
14703660|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703661|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14703662|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14703663|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14703664|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703665|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14703666|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
14703667|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15201453|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295133|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828946|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15201454|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911595|NCT01363752|Sirolimus|sirolimus|mesh-list
14828947|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828948|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
14828949|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828950|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14828951|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828952|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201455|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201456|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
15201457|NCT03760354|Hormones|hormones|mesh-ancestor
14828953|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
14828954|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14828955|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828956|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828957|NCT00936832|Antidotes|antidotes|mesh-ancestor
14828958|NCT00936832|Protective Agents|protective agents|mesh-ancestor
14828959|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
14828960|NCT00936832|Vitamins|vitamins|mesh-ancestor
14828961|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
14828962|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14828963|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14828964|NCT00936832|Growth Substances|growth substances|mesh-ancestor
14828965|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
14828966|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14828967|NCT00936923|Furosemide|furosemide|mesh-list
14828968|NCT00936923|Diuretics|diuretics|mesh-list
14828969|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
14828970|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828971|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15201458|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201459|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15201460|NCT03760354|Protective Agents|protective agents|mesh-ancestor
15201461|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15201462|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201463|NCT03760302|Analgesics|analgesics|mesh-list
15201464|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15201465|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
14703668|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14828972|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14828973|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828974|NCT00936936|Gemcitabine|gemcitabine|mesh-list
14828975|NCT00936936|Carboplatin|carboplatin|mesh-list
14828976|NCT00936936|Docetaxel|docetaxel|mesh-list
14828977|NCT00936936|Etoposide|etoposide|mesh-list
14828978|NCT00936936|Melphalan|melphalan|mesh-list
14828979|NCT00936936|Ifosfamide|ifosfamide|mesh-list
14828980|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14828981|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14828982|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
14828983|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201466|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703669|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14703670|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14703671|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728562|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14728563|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728564|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728565|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728566|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
14728567|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728568|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14728569|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728570|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14728571|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14728572|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728573|NCT00519116|Sirolimus|sirolimus|mesh-list
14728574|NCT00519116|Tacrolimus|tacrolimus|mesh-list
14728575|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728576|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
14728577|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728578|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14728579|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728580|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828984|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
14828985|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703672|NCT00407212|Maleic acid|maleic acid|mesh-list
14703673|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703674|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14828986|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14828987|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14828988|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
14828989|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14828990|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
14828991|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
14828992|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14828993|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14828994|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14828995|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14828996|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14828997|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
14828998|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14828999|NCT00936962|Vaccines|vaccines|mesh-list
14829000|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
14829001|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829002|NCT00936988|Cinacalcet|cinacalcet|mesh-list
14829003|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829004|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829005|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14829006|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
14829007|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829008|NCT00937027|Aminopterin|aminopterin|mesh-list
14829009|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14829010|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829011|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829012|NCT00937079|Exenatide|exenatide|mesh-list
14829013|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14829014|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829015|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14829016|NCT00937079|Incretins|incretins|mesh-ancestor
14829017|NCT00937079|Hormones|hormones|mesh-ancestor
14829018|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829019|NCT00937092|Dopamine|dopamine|mesh-list
14829020|NCT00937092|Furosemide|furosemide|mesh-list
14829021|NCT00937092|Diuretics|diuretics|mesh-ancestor
14829022|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
14829023|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829024|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15201467|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201468|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201469|NCT03760276|Voriconazole|voriconazole|mesh-list
15201470|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
15201471|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201472|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14703675|NCT00407225|Difluprednate|difluprednate|mesh-list
14703676|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
14703677|NCT00407225|Hormones|hormones|mesh-ancestor
14703678|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703679|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703680|NCT00407251|Epothilone B|epothilone b|mesh-list
14703681|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703682|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703683|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14703684|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14703685|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703686|NCT00407264|Fluticasone|fluticasone|mesh-list
14703687|NCT00407264|Xhance|xhance|mesh-list
14703688|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703689|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14703690|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
14703691|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703692|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703693|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14703694|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
14703695|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
14703696|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14703697|NCT00407277|Nicotine|nicotine|mesh-list
14703698|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14703699|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
14829025|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911596|NCT01363752|Tacrolimus|tacrolimus|mesh-list
14829026|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829027|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14829028|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
14829029|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
14829030|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829031|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
14829032|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829033|NCT00937092|Protective Agents|protective agents|mesh-ancestor
14829034|NCT00937131|Rituximab|rituximab|mesh-list
14829035|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14829036|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829037|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
14829038|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829039|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829040|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
14829041|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
14829042|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14829043|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14829044|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829045|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829046|NCT00937144|Urological Agents|urological agents|mesh-ancestor
14829047|NCT00937183|Vaccines|vaccines|mesh-list
14829048|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
14829049|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829050|NCT00937261|Risperidone|risperidone|mesh-list
14829051|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14829052|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14829053|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
14829054|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829055|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829056|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829057|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14829058|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14829059|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829060|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829061|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14829062|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
14829063|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14829064|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14829065|NCT00937300|Vidarabine|vidarabine|mesh-list
14829066|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
14829067|NCT00937300|Fludarabine|fludarabine|mesh-list
14829068|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
14829069|NCT00937300|Interleukin-2|interleukin-2|mesh-list
14829070|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829071|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
14829072|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829073|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829074|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14829075|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
14829076|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829077|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829078|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14829079|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14829080|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
14829081|NCT00937300|Antiviral Agents|antiviral agents|mesh-ancestor
14829082|NCT00937300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829083|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15201473|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15201474|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201475|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703700|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703701|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703702|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14703703|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14703704|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
14703705|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703706|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703707|NCT00407290|Neostigmine|neostigmine|mesh-list
14703708|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14703709|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829084|NCT00937300|Analgesics|analgesics|mesh-ancestor
14829085|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
14829086|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829087|NCT00937417|Docetaxel|docetaxel|mesh-list
14295134|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295135|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295136|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
14703710|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703711|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
14703712|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703713|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703714|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14703715|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
14703716|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703717|NCT00407342|Alefacept|alefacept|mesh-list
14703718|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
14703719|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
14703720|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703721|NCT00407394|Amoxicillin|amoxicillin|mesh-list
14703722|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703723|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703724|NCT00407407|Carboplatin|carboplatin|mesh-list
14703725|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14703726|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703727|NCT00407433|Gemcitabine|gemcitabine|mesh-list
14703728|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
14703729|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14703730|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
14703731|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703732|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703733|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
14703734|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703735|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703736|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703737|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
14703738|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703739|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
14703740|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
14295137|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295138|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14295139|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295140|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
14295141|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295142|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295143|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295144|NCT00579137|Fludarabine|fludarabine|mesh-list
14295145|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
14295146|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295147|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295148|NCT00579280|Valproic Acid|valproic acid|mesh-list
14295149|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14295150|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
14295151|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14295152|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14295153|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14295154|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295155|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295156|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
14295157|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295158|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295159|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
14703741|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14703742|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14703743|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703744|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703745|NCT00407446|Urological Agents|urological agents|mesh-ancestor
14703746|NCT00407459|Bevacizumab|bevacizumab|mesh-list
14703747|NCT00407459|Carboplatin|carboplatin|mesh-list
14703748|NCT00407459|Pemetrexed|pemetrexed|mesh-list
14703749|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703750|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829088|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703751|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703752|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14829089|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703753|NCT00407459|Growth Substances|growth substances|mesh-ancestor
14703754|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829090|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14829091|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14829092|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829093|NCT00937482|Cediranib|cediranib|mesh-list
14829094|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829095|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829096|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829097|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14829098|NCT00937508|Varenicline|varenicline|mesh-list
14829099|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14829100|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14829101|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14829102|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201476|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15201477|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
15201478|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201479|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201480|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14829103|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829104|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911597|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911598|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
14911599|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911600|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14911601|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911602|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911603|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14911604|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911605|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14911606|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
14911607|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911608|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911609|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
14911610|NCT01363817|Dexamethasone|dexamethasone|mesh-list
14911611|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911612|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
14911613|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
14911614|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911615|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911616|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14911617|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
14911618|NCT01363817|Hormones|hormones|mesh-ancestor
14911619|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14911620|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14911621|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911622|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
14911623|NCT01363934|Hematinics|hematinics|mesh-ancestor
14917161|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917162|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14917163|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201481|NCT03760263|Tacrolimus|tacrolimus|mesh-list
15201482|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201483|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
15201484|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201485|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14917164|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14917165|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917166|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14917167|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14917168|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14917169|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917170|NCT01396668|Gemcitabine|gemcitabine|mesh-list
14917171|NCT01396668|Capecitabine|capecitabine|mesh-list
15201486|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201487|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201488|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15201489|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15201490|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201491|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201492|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15201493|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15225698|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917172|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829105|NCT00937625|Vidarabine|vidarabine|mesh-list
14829106|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
14829107|NCT00937625|Fludarabine|fludarabine|mesh-list
14829108|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
14829109|NCT00937625|Interleukin-2|interleukin-2|mesh-list
14829110|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829111|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
14829112|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829113|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829114|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14829115|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
14829116|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829117|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829118|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14829119|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15201494|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201495|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
15201496|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224573|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829120|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
14829121|NCT00937625|Antiviral Agents|antiviral agents|mesh-ancestor
14829122|NCT00937625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829123|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14829124|NCT00937625|Analgesics|analgesics|mesh-ancestor
14829125|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
14829126|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829127|NCT00937664|Gemcitabine|gemcitabine|mesh-list
14829128|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14829129|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
14829130|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829131|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829132|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
14829133|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829134|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829135|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829136|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
14829137|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829138|NCT00937677|Natalizumab|natalizumab|mesh-list
14829139|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
14829140|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829141|NCT00937807|Sevoflurane|sevoflurane|mesh-list
14829142|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14829143|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14829144|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
14829145|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
15224574|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224575|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15224576|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15224577|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
14829146|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829147|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829148|NCT00937820|Darexaban|darexaban|mesh-list
14829149|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14829150|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
15224578|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15224579|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14829151|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14829152|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
14829153|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829154|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829155|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
14829156|NCT00937911|Darexaban|darexaban|mesh-list
14829157|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14829158|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
14829159|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14829160|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
14829161|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829162|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829163|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
14703755|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703756|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703757|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703758|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14703759|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14829164|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
14829165|NCT00937924|Promethazine|promethazine|mesh-list
14829166|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14829167|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14829168|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829169|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829170|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
14829171|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
14829172|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
14829173|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829174|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
14829175|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
14829176|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14829177|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14829178|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
14829179|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
14829180|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829181|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829182|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14829183|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
14829184|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14829185|NCT00938132|Warfarin|warfarin|mesh-list
15201497|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
15201498|NCT03759938|Apixaban|apixaban|mesh-list
15201499|NCT03759938|Edoxaban|edoxaban|mesh-list
15201500|NCT03759938|Dabigatran|dabigatran|mesh-list
15201501|NCT03759938|Anticoagulants|anticoagulants|mesh-list
15201502|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14703760|NCT00407589|Besifloxacin|besifloxacin|mesh-list
14703761|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14829186|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
14829187|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
14829188|NCT00938158|Incretins|incretins|mesh-ancestor
14829189|NCT00938158|Hormones|hormones|mesh-ancestor
14829190|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829191|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829192|NCT00938171|Anesthetics|anesthetics|mesh-list
14829193|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829194|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829195|NCT00938184|Paroxetine|paroxetine|mesh-list
14829196|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14829197|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14829198|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829199|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829200|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829201|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
14829202|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829203|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14829204|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
14829205|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829206|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14829207|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14829208|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829209|NCT00938197|Amlodipine|amlodipine|mesh-list
14829210|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14829211|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14829212|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829213|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829214|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829215|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829216|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
14829217|NCT00938236|Cyclosporine|cyclosporine|mesh-list
14829218|NCT00938236|Cyclosporins|cyclosporins|mesh-list
15201503|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
14703762|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703763|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14703764|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14829219|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201504|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15201505|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
15201506|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829220|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829221|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829222|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
14829223|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829224|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
14829225|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829226|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14829227|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829228|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14829229|NCT00938262|Rifampin|rifampin|mesh-list
14829230|NCT00938262|Ketoconazole|ketoconazole|mesh-list
14829231|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14829232|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
14829233|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14829234|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829235|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
14829236|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14829237|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829238|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829239|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14829240|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14829241|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14829242|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14829243|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14829244|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14829245|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
14829246|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14829247|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14829248|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14829249|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
14829250|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829251|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829252|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14829253|NCT00938353|Beclomethasone|beclomethasone|mesh-list
15201507|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201508|NCT03759886|Metronidazole|metronidazole|mesh-list
15201509|NCT03759886|Paromomycin|paromomycin|mesh-list
15201510|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201511|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201512|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15201513|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15201514|NCT03759860|Ranibizumab|ranibizumab|mesh-list
15201515|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15201516|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15201517|NCT03759860|Growth Substances|growth substances|mesh-ancestor
15201518|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201519|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
15201520|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201521|NCT03759782|Tenofovir|tenofovir|mesh-list
15201522|NCT03759782|Ribavirin|ribavirin|mesh-list
14295160|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295161|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
14295162|NCT00579345|Vaccines|vaccines|mesh-list
14295163|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
14295164|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703765|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703766|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703767|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703768|NCT00407641|Heparin|heparin|mesh-list
14703769|NCT00407641|Tinzaparin|tinzaparin|mesh-list
14703770|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14703771|NCT00407641|Dalteparin|dalteparin|mesh-list
14703772|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
14703773|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14703774|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14703775|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703776|NCT00407680|Valsartan|valsartan|mesh-list
14703777|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14703778|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14703779|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14703780|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703781|NCT00407719|Bevacizumab|bevacizumab|mesh-list
14703782|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14829254|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14829255|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
14829256|NCT00938353|Hormones|hormones|mesh-ancestor
14829257|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829258|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829259|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14829260|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
14829261|NCT00938379|Insect Repellents|insect repellents|mesh-list
14829262|NCT00938379|Protective Agents|protective agents|mesh-ancestor
14829263|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829264|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14829265|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14829266|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14829267|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
14829268|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829269|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14829270|NCT00938509|Ibuprofen|ibuprofen|mesh-list
14829271|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14829272|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14829273|NCT00938509|Analgesics|analgesics|mesh-ancestor
14829274|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
14829275|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829276|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829277|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14829278|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829279|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14829280|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829281|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829282|NCT00938522|Cilostazol|cilostazol|mesh-list
14829283|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14829284|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
14829285|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829286|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829287|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14829288|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
14829289|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14829290|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14829291|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829292|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14829293|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
14829294|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14829295|NCT00938522|Protective Agents|protective agents|mesh-ancestor
14829296|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14829297|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14829298|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829299|NCT00938600|Vitamin D|vitamin d|mesh-list
14829300|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
14829301|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
14829302|NCT00938600|Vitamins|vitamins|mesh-list
14829303|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
14829304|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829305|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14829306|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829307|NCT00938613|Budesonide|budesonide|mesh-list
14829308|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295165|NCT00579501|Dexamethasone|dexamethasone|mesh-list
14295166|NCT00579501|Trabectedin|trabectedin|mesh-list
14295167|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295168|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
14295169|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
14295170|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295171|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295172|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295173|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
14295174|NCT00579501|Hormones|hormones|mesh-ancestor
14703783|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703784|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14703785|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703786|NCT00407719|Growth Substances|growth substances|mesh-ancestor
14703787|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703788|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703789|NCT00407771|Tirofiban|tirofiban|mesh-list
14703790|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14703791|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14703792|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829309|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14829310|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
14829311|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829312|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829313|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14829314|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
14829315|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
14829316|NCT00938613|Hormones|hormones|mesh-ancestor
14829317|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829318|NCT00938626|Antibodies|antibodies|mesh-list
14829319|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14829320|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
14829321|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829322|NCT00938730|Warfarin|warfarin|mesh-list
14829323|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
14829324|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14829325|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14829326|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14829327|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829328|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829329|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
14829330|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829331|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829332|NCT00938821|Morphine|morphine|mesh-list
14829333|NCT00938821|Bupivacaine|bupivacaine|mesh-list
14829334|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
14829335|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
14829336|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829337|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829338|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
14829339|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829340|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14829341|NCT00938821|Narcotics|narcotics|mesh-ancestor
14829342|NCT00938821|Analgesics|analgesics|mesh-ancestor
14829343|NCT00938899|Simeprevir|simeprevir|mesh-list
14829344|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
14829345|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829346|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14829347|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829348|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829349|NCT00938990|Midazolam|midazolam|mesh-list
14829350|NCT00938990|Etomidate|etomidate|mesh-list
14829351|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14829352|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14829353|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829354|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829355|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14829356|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14829357|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829358|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14829359|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
14829360|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
15201523|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
14295175|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703793|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14703794|NCT00407784|Eplerenone|eplerenone|mesh-list
14703795|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14703796|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
14703797|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703798|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703799|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14703800|NCT00407784|Diuretics|diuretics|mesh-ancestor
14703801|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
14703802|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14703803|NCT00407836|Vaccines|vaccines|mesh-list
14829361|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
14295176|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14295177|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201524|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201525|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15201526|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15201527|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295178|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14829362|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
14829363|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295179|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
14295180|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295181|NCT00579553|Progesterone|progesterone|mesh-list
14295182|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14295183|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14295184|NCT00579553|Progestins|progestins|mesh-ancestor
14295185|NCT00579553|Hormones|hormones|mesh-ancestor
14295186|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295187|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295188|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14295189|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
14295190|NCT00579670|Ziprasidone|ziprasidone|mesh-list
14295191|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14703804|NCT00407836|Immunologic Factors|immunologic factors|mesh-ancestor
14703805|NCT00407836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703806|NCT00407849|Triamcinolone|triamcinolone|mesh-list
14703807|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14703808|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14703809|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14703810|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14703811|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
14703812|NCT00407849|Hormones|hormones|mesh-ancestor
14703813|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295192|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
14295193|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295194|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703814|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201528|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201529|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15201530|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15201531|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
14703815|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703816|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
14703817|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703818|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829364|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829365|NCT00939068|Telbivudine|telbivudine|mesh-list
14829366|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
14829367|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829368|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14829369|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829370|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829371|NCT00939133|Tretinoin|tretinoin|mesh-list
14829372|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829373|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
14829374|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
14829375|NCT00939328|Rituximab|rituximab|mesh-list
14829376|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14829377|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14829378|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829379|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
14829380|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829381|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829382|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14829383|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
14829384|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829385|NCT00939458|Lamotrigine|lamotrigine|mesh-list
14829386|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
14829387|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14829388|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829389|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829390|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829391|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829392|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14829393|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14829394|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14703819|NCT00407862|Losartan|losartan|mesh-list
14703820|NCT00407862|Telmisartan|telmisartan|mesh-list
14703821|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14703822|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14703823|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14829395|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15201532|NCT03759353|Lactoferrin|lactoferrin|mesh-list
14829396|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15201533|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201534|NCT03759301|Cetrorelix|cetrorelix|mesh-list
15201535|NCT03759301|Hormones|hormones|mesh-list
15201536|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201537|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829397|NCT00939497|Risperidone|risperidone|mesh-list
14829398|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14829399|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
14829400|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829401|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829402|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829403|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14829404|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14829405|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829406|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829407|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14829408|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
14829409|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
14829410|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
14829411|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
14829412|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829413|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
14829414|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829415|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829416|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14829417|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
14829418|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829419|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829420|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14829421|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14911624|NCT01364012|Paclitaxel|paclitaxel|mesh-list
14911625|NCT01364012|Bevacizumab|bevacizumab|mesh-list
14911626|NCT01364012|Carboplatin|carboplatin|mesh-list
14911627|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14911628|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911629|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14911630|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14911631|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14911632|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911633|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14911634|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14911635|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14911636|NCT01364012|Growth Substances|growth substances|mesh-ancestor
14911637|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911638|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
14911639|NCT01364181|Udenafil|udenafil|mesh-list
14911640|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14911641|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14911642|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911643|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911644|NCT01364194|Bupivacaine|bupivacaine|mesh-list
14911645|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
14911646|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
14911647|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911648|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911649|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
14911650|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911651|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14911652|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14911653|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14911654|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
14911655|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911656|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14911657|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14911658|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911659|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
14911660|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911661|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911662|NCT01364376|Leucovorin|leucovorin|mesh-list
14911663|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
14911664|NCT01364376|Calcium|calcium|mesh-list
14911665|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
14911666|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14911667|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829422|NCT00939588|Valsartan|valsartan|mesh-list
14829423|NCT00939588|Telmisartan|telmisartan|mesh-list
14829424|NCT00939588|Ramipril|ramipril|mesh-list
14829425|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14829426|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14829427|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14829428|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829429|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14829430|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
14829431|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829432|NCT00939614|Lamotrigine|lamotrigine|mesh-list
14829433|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
14829434|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14829435|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829436|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829437|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829438|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829439|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14829440|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14829441|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829442|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829443|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14829444|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
14829445|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
14829446|NCT00939718|Vitamins|vitamins|mesh-ancestor
14829447|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
14829448|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829449|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
14829450|NCT00939718|Hematinics|hematinics|mesh-ancestor
14829451|NCT00939757|Mirabegron|mirabegron|mesh-list
14829452|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14829453|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14829454|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14829455|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
14829456|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829457|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829458|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829459|NCT00939757|Urological Agents|urological agents|mesh-ancestor
14829460|NCT00939835|Dexetimide|dexetimide|mesh-list
14829461|NCT00939835|Citalopram|citalopram|mesh-list
14829462|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14829463|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14829464|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829465|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829466|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829467|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
14829468|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829469|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14829470|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
14829471|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829472|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14829473|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14829474|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
14829475|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
14829476|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829477|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14829478|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14829479|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
14829480|NCT00939848|Gemcitabine|gemcitabine|mesh-list
14703824|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14703825|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703826|NCT00407927|Epinastine|epinastine|mesh-list
14703827|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14703828|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
14703829|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
14703830|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703831|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703832|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703833|NCT00408031|Cycloserine|cycloserine|mesh-list
14703834|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14703835|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703836|NCT00408031|Renal Agents|renal agents|mesh-ancestor
14703837|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15201538|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15201539|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
15201540|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15201541|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
15201542|NCT03759262|Vitamin D|vitamin d|mesh-list
15201543|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
15201544|NCT03759262|Vitamins|vitamins|mesh-ancestor
15201545|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
15201546|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829481|NCT00939848|Cisplatin|cisplatin|mesh-list
14829482|NCT00939848|Cediranib|cediranib|mesh-list
14829483|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829484|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14829485|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
14829486|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829487|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
14829488|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829489|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829490|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829491|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
14829492|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829493|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14829494|NCT00939926|Risperidone|risperidone|mesh-list
14829495|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14829496|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
14829497|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829498|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829499|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829500|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14829501|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15201547|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15201548|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15201549|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
15201550|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15201551|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
15201552|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201553|NCT03759158|Expectorants|expectorants|mesh-ancestor
15201554|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
15201555|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15201556|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
15201557|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201558|NCT03759158|Protective Agents|protective agents|mesh-ancestor
15201559|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201560|NCT03759158|Antidotes|antidotes|mesh-ancestor
15201561|NCT03759093|Thalidomide|thalidomide|mesh-list
14829502|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829503|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829504|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14829505|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
14829506|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14829507|NCT00939939|Glimepiride|glimepiride|mesh-list
14829508|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14829509|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829510|NCT00939939|Incretins|incretins|mesh-ancestor
14829511|NCT00939939|Hormones|hormones|mesh-ancestor
14829512|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829513|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14829514|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14829515|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829516|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829517|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15201562|NCT03759093|Dexamethasone|dexamethasone|mesh-list
15201563|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
15201564|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
15201565|NCT03759093|Bortezomib|bortezomib|mesh-list
14829518|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829519|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
14829520|NCT00939965|Isotretinoin|isotretinoin|mesh-list
14829521|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
14829522|NCT00940004|Vaccines|vaccines|mesh-list
14829523|NCT00940004|Immunologic Factors|immunologic factors|mesh-ancestor
14829524|NCT00940004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829525|NCT00940069|Pemetrexed|pemetrexed|mesh-list
14829526|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829527|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201566|NCT03759093|BB 1101|bb 1101|mesh-list
15201567|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201568|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
14829528|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829529|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14829530|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14829531|NCT00940121|Mirabegron|mirabegron|mesh-list
15201569|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201570|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15201571|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15201572|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
15201573|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201574|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201575|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15201576|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201577|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
15201578|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
15201579|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201580|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201581|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
15201582|NCT03759093|Hormones|hormones|mesh-ancestor
15201583|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201584|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14829532|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14829533|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14829534|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14829535|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
14829536|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829537|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829538|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829539|NCT00940121|Urological Agents|urological agents|mesh-ancestor
14829540|NCT00940238|Dexetimide|dexetimide|mesh-list
14829541|NCT00940238|Citalopram|citalopram|mesh-list
14829542|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14829543|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14829544|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829545|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829546|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829547|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
14829548|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829549|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14829550|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
14829551|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829552|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14829553|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14829554|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
14829555|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
14829556|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829557|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14829558|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14829559|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
14829560|NCT00940303|Leucovorin|leucovorin|mesh-list
14829561|NCT00940303|Bevacizumab|bevacizumab|mesh-list
14829562|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
14829563|NCT00940303|Irinotecan|irinotecan|mesh-list
14829564|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14829565|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829566|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14829567|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14829568|NCT00940303|Growth Substances|growth substances|mesh-ancestor
15201585|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
15201586|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703838|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
14703839|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703840|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
14703841|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703842|NCT00408135|Telithromycin|telithromycin|mesh-list
14703843|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703844|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703845|NCT00408148|Rimonabant|rimonabant|mesh-list
14703846|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14703847|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14703848|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14703849|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703850|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703851|NCT00408148|Hormones|hormones|mesh-ancestor
14829569|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829570|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
14829571|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14829572|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14829573|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829574|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829575|NCT00940303|Antidotes|antidotes|mesh-ancestor
14829576|NCT00940303|Protective Agents|protective agents|mesh-ancestor
14829577|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
14829578|NCT00940303|Vitamins|vitamins|mesh-ancestor
14829579|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
14829580|NCT00940381|Sirolimus|sirolimus|mesh-list
14829581|NCT00940381|Cetuximab|cetuximab|mesh-list
14829582|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14829583|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829584|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14829585|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829586|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14829587|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
14829588|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829589|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
14829590|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829591|NCT00940420|Ribavirin|ribavirin|mesh-list
14829592|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14829593|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
14829594|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
14829595|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829596|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
14829597|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829598|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
14829599|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829600|NCT00940472|Metformin|metformin|mesh-list
14829601|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14829602|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829603|NCT00940498|Gedatolisib|gedatolisib|mesh-list
14829604|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14829605|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829606|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829607|NCT00940524|Cytarabine|cytarabine|mesh-list
14829608|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
14829609|NCT00940524|Methotrexate|methotrexate|mesh-list
14829610|NCT00940524|Etoposide|etoposide|mesh-list
14829611|NCT00940524|Asparaginase|asparaginase|mesh-list
14829612|NCT00940524|Dasatinib|dasatinib|mesh-list
14829613|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
14829614|NCT00940524|Pegaspargase|pegaspargase|mesh-list
14829615|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829616|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
14829617|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829618|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829619|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14829620|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
14829621|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201587|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
15201588|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201589|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829622|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829623|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14829624|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14829625|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
14829626|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14829627|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14829628|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
14829629|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14829630|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829631|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14829632|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14829633|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14829634|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14829635|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14829636|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
15201590|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15201591|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15201592|NCT03759093|Growth Substances|growth substances|mesh-ancestor
15201593|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
14829637|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829638|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14829639|NCT00940524|Analgesics|analgesics|mesh-ancestor
14829640|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
14829641|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829642|NCT00940550|Melatonin|melatonin|mesh-list
14829643|NCT00940550|Zolpidem|zolpidem|mesh-list
14829644|NCT00940550|Temazepam|temazepam|mesh-list
14829645|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
14829646|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829647|NCT00940550|Protective Agents|protective agents|mesh-ancestor
14829648|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829649|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829650|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14829651|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14829652|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14829653|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
14829654|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
14829655|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829656|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14829657|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14829658|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829659|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
14829660|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
14829661|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829662|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14829663|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829664|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829665|NCT00940628|Orlistat|orlistat|mesh-list
14829666|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829667|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829668|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14829669|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14829670|NCT00940654|Acetaminophen|acetaminophen|mesh-list
14829671|NCT00940654|Antipyretics|antipyretics|mesh-list
14829672|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14829673|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14829674|NCT00940654|Analgesics|analgesics|mesh-ancestor
14829675|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
14829676|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829677|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829678|NCT00940667|Losartan|losartan|mesh-list
14829679|NCT00940667|Amlodipine|amlodipine|mesh-list
14829680|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14829681|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14829682|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829683|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829684|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829685|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829686|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
14829687|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14829688|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14829689|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14829690|NCT00940680|Losartan|losartan|mesh-list
14829691|NCT00940680|Amlodipine|amlodipine|mesh-list
14829692|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14829693|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14829694|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829695|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829696|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829697|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829698|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
14829699|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14829700|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14829701|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14829702|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14829703|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14829704|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14829705|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14829706|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829707|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829708|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829709|NCT00940693|Analgesics|analgesics|mesh-ancestor
14829710|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
14829711|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829712|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
14829713|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829714|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
14829715|NCT00940719|Vitamin D|vitamin d|mesh-list
14829716|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
14829717|NCT00940719|Vitamins|vitamins|mesh-ancestor
15201594|NCT03759067|Clopidogrel|clopidogrel|mesh-list
15201595|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15201596|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15201597|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15201598|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15201599|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
15201600|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201601|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829718|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
14829719|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829720|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14829721|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829722|NCT00940784|Aspirin|aspirin|mesh-list
14829723|NCT00940784|Clopidogrel|clopidogrel|mesh-list
14829724|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14829725|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14829726|NCT00940784|Analgesics|analgesics|mesh-ancestor
14829727|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
14829728|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829729|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829730|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14829731|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829732|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14829733|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14829734|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829735|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14829736|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14829737|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829738|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
14829739|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14829740|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14829741|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14829742|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
14829743|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829744|NCT00940836|Acetaminophen|acetaminophen|mesh-list
14829745|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
14829746|NCT00940836|Phenylephrine|phenylephrine|mesh-list
14829747|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14829748|NCT00940836|Analgesics|analgesics|mesh-ancestor
14829749|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
14829750|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829751|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829752|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
14829753|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14829754|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
14829755|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
14829756|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
14829757|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14829758|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
14829759|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
14829760|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14829761|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14829762|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14829763|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
14829764|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829765|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829766|NCT00940836|Protective Agents|protective agents|mesh-ancestor
14829767|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
14829768|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
14829769|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14829770|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
14829771|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
14829772|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14829773|NCT00940862|Adalimumab|adalimumab|mesh-list
14829774|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14829775|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14829776|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
14829777|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14829778|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829779|NCT00940940|Vaccines|vaccines|mesh-list
14829780|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
14829781|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829782|NCT00940953|Azelastine|azelastine|mesh-list
14829783|NCT00940953|Budesonide|budesonide|mesh-list
14829784|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14829785|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14829786|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
14829787|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829788|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829789|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14829790|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
14829791|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
14829792|NCT00940953|Hormones|hormones|mesh-ancestor
14829793|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829794|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14829795|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829796|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829797|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14829798|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14829799|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14829800|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
14829801|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
15201602|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201603|NCT03759028|Acetaminophen|acetaminophen|mesh-list
15201604|NCT03759028|Ibuprofen|ibuprofen|mesh-list
15201605|NCT03759028|Oxycodone|oxycodone|mesh-list
15201606|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15201607|NCT03759028|Analgesics|analgesics|mesh-ancestor
15201608|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
15201609|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14829802|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829803|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
14829804|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
14829805|NCT00941057|Dienogest|dienogest|mesh-list
14829806|NCT00941057|Calcium|calcium|mesh-list
14829807|NCT00941057|Nandrolone|nandrolone|mesh-list
14829808|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14829809|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829810|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14829811|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14829812|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
14829813|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14829814|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14829815|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14829816|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14829817|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14829818|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
14829819|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829820|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14829821|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829822|NCT00941057|Androgens|androgens|mesh-ancestor
14829823|NCT00941057|Hormones|hormones|mesh-ancestor
14829824|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
14829825|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
14829826|NCT00941057|Vitamins|vitamins|mesh-ancestor
14829827|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
14829828|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
14829829|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14829830|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14829831|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
14829832|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829833|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14829834|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14829835|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829836|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829837|NCT00941096|Timolol|timolol|mesh-list
14829838|NCT00941096|Bimatoprost|bimatoprost|mesh-list
14829839|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14829840|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14829841|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
14829842|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829843|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829844|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829845|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14829846|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15201610|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201611|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
15201612|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15201613|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201614|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15201615|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15201616|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201617|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201618|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15201619|NCT03759028|Narcotics|narcotics|mesh-ancestor
15201620|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14829847|NCT00941109|Decitabine|decitabine|mesh-list
14829848|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14829849|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
14829850|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829851|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829852|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829853|NCT00941135|Docetaxel|docetaxel|mesh-list
14829854|NCT00941135|Cetuximab|cetuximab|mesh-list
14829855|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829856|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
14829857|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
14829858|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
14829859|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829860|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14829861|NCT00941148|Insulin|insulin|mesh-list
15201621|NCT03758989|Prednisone|prednisone|mesh-list
15201622|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
15201623|NCT03758989|Rituximab|rituximab|mesh-list
14829862|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14829863|NCT00941148|Metformin|metformin|mesh-list
14829864|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
14829865|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
14829866|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
14829867|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
14829868|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15201624|NCT03758989|Doxorubicin|doxorubicin|mesh-list
14829869|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829870|NCT00941161|Metformin|metformin|mesh-list
14829871|NCT00941161|Glimepiride|glimepiride|mesh-list
14829872|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14829873|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829874|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14829875|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829876|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
14829877|NCT00941174|Leucovorin|leucovorin|mesh-list
14829878|NCT00941174|Calcium|calcium|mesh-list
14829879|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
14829880|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14295195|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295196|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14295197|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14295198|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295199|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14295200|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14295201|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
14829881|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829882|NCT00941174|Antidotes|antidotes|mesh-ancestor
15201625|NCT03758989|Vincristine|vincristine|mesh-list
15201626|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829883|NCT00941174|Protective Agents|protective agents|mesh-ancestor
14829884|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
14829885|NCT00941174|Vitamins|vitamins|mesh-ancestor
14829886|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
14829887|NCT00941239|Metformin|metformin|mesh-list
15201627|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
14829888|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14829889|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829890|NCT00941252|Imiquimod|imiquimod|mesh-list
14829891|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15201628|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201629|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15201630|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15201631|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
15201632|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201633|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201634|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15201635|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15201636|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15201637|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14829892|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
14829893|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829894|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829895|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
14829896|NCT00941265|Levodopa|levodopa|mesh-list
14829897|NCT00941265|Benserazide|benserazide|mesh-list
14829898|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14829899|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14829900|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
14829901|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829902|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829903|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829904|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829905|NCT00941343|Alfuzosin|alfuzosin|mesh-list
14829906|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14829907|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14829908|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14829909|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
14829910|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14829911|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829912|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829913|NCT00941343|Urological Agents|urological agents|mesh-ancestor
14829914|NCT00941369|Insulin|insulin|mesh-list
14829915|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
14829916|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
14829917|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
14829918|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
14829919|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14829920|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911668|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911669|NCT01364376|Antidotes|antidotes|mesh-ancestor
14911670|NCT01364376|Protective Agents|protective agents|mesh-ancestor
14911671|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
14911672|NCT01364376|Vitamins|vitamins|mesh-ancestor
14911673|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
14911674|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
14703852|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14703853|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703854|NCT00408174|Balsalazide|balsalazide|mesh-list
14703855|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14703856|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14703857|NCT00408174|Analgesics|analgesics|mesh-ancestor
14703858|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
14703859|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703860|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911675|NCT01364402|Hematinics|hematinics|mesh-ancestor
14911676|NCT01364415|Pasireotide|pasireotide|mesh-list
15201638|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14295202|NCT00579813|Pioglitazone|pioglitazone|mesh-list
14295203|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14295204|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295205|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
15201639|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201640|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201641|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
14295206|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
14295207|NCT00579878|Methotrexate|methotrexate|mesh-list
14295208|NCT00579878|Leflunomide|leflunomide|mesh-list
14703861|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911677|NCT01364415|Hormones|hormones|mesh-ancestor
14911678|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14911679|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829921|NCT00941382|Metformin|metformin|mesh-list
14829922|NCT00941382|Sibutramine|sibutramine|mesh-list
14829923|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14829924|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829925|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
14829926|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14829927|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
14829928|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14829929|NCT00941460|Temozolomide|temozolomide|mesh-list
14829930|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14829931|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
14829932|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829933|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201642|NCT03758989|Hormones|hormones|mesh-ancestor
15201643|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201644|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15201645|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15201646|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201647|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201648|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
15201649|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
14829934|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14829935|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14829936|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
14829937|NCT00941473|Hormones|hormones|mesh-ancestor
14829938|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14829939|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829940|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201650|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201651|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
15201652|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15201653|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15201654|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
15201655|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15201656|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
15201657|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201658|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
15201659|NCT03758859|Protective Agents|protective agents|mesh-ancestor
15201660|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15201661|NCT03758729|Nivolumab|nivolumab|mesh-list
15201662|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15201663|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201664|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15201665|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201666|NCT03758677|Gemcitabine|gemcitabine|mesh-list
15201667|NCT03758677|Docetaxel|docetaxel|mesh-list
15201668|NCT03758677|Pemetrexed|pemetrexed|mesh-list
15201669|NCT03758677|Apatinib|apatinib|mesh-list
15201670|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15201671|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
15201672|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201673|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201674|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
15201675|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201676|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201677|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201678|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
15201679|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201680|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201681|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201682|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
15201683|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15201684|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15201685|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15201686|NCT03758469|Rifampin|rifampin|mesh-list
15201687|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15201688|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
15201689|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201690|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201691|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
15201692|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15201693|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201694|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201695|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14829941|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
14829942|NCT00941499|Leucovorin|leucovorin|mesh-list
14829943|NCT00941499|Bevacizumab|bevacizumab|mesh-list
15201696|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15201697|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15201698|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15201699|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15201700|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15201701|NCT03758339|Tucatinib|tucatinib|mesh-list
15201702|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201703|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15201704|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201705|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201706|NCT03758287|Gefitinib|gefitinib|mesh-list
15201707|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295209|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14295210|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
14295211|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14295212|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295213|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14295214|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
14295215|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295216|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295217|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
14295218|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295219|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14295220|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295221|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
14295222|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295223|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14295224|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
14295225|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14295226|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14295227|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703862|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703863|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14703864|NCT00408187|Cyclosporine|cyclosporine|mesh-list
14703865|NCT00408187|Cyclosporins|cyclosporins|mesh-list
15201708|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14703866|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703867|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703868|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703869|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
14703870|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703871|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
14703872|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703873|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
14703874|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14703875|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14703876|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
14703877|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14703878|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703879|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14703880|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
14703881|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703882|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703883|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703884|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703885|NCT00408226|Pemetrexed|pemetrexed|mesh-list
14703886|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703887|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703888|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703889|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14829944|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14295228|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295229|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295230|NCT00579878|Analgesics|analgesics|mesh-ancestor
14295231|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
14295232|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295233|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201709|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295234|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295235|NCT00579982|Lamotrigine|lamotrigine|mesh-list
14295236|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
14829945|NCT00941499|Cetuximab|cetuximab|mesh-list
14829946|NCT00941499|Fluorouracil|fluorouracil|mesh-list
14829947|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
14829948|NCT00941499|Antibodies|antibodies|mesh-list
14829949|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
14829950|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14829951|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829952|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14829953|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14829954|NCT00941499|Growth Substances|growth substances|mesh-ancestor
14829955|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829956|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
14829957|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
14829958|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
14829959|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201710|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201711|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15201712|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15201713|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15201714|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15201715|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201716|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201717|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15201718|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15201719|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201720|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
15201721|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224580|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224581|NCT03127215|Olaparib|olaparib|mesh-list
15224582|NCT03127215|Trabectedin|trabectedin|mesh-list
15224583|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15224584|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224585|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224586|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224587|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15224588|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
15224589|NCT02983071|Fulvestrant|fulvestrant|mesh-list
14295237|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14295238|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14295239|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295240|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14295241|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295242|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14295243|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14295244|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295245|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14295246|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14295247|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
14703890|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14703891|NCT00408239|Enoxaparin|enoxaparin|mesh-list
14703892|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
14703893|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14703894|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14703895|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703896|NCT00408252|Sunitinib|sunitinib|mesh-list
14703897|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703898|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14829960|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14829961|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14829962|NCT00941499|Antidotes|antidotes|mesh-ancestor
14829963|NCT00941499|Protective Agents|protective agents|mesh-ancestor
14829964|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
14829965|NCT00941499|Vitamins|vitamins|mesh-ancestor
14829966|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
14829967|NCT00941525|Latanoprost|latanoprost|mesh-list
14829968|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14829969|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14829970|NCT00941616|Factor VIII|factor viii|mesh-list
14829971|NCT00941616|Coagulants|coagulants|mesh-ancestor
14829972|NCT00941785|Amodiaquine|amodiaquine|mesh-list
14829973|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
14829974|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14829975|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14829976|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829977|NCT00941811|Imiquimod|imiquimod|mesh-list
14829978|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14829979|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
14829980|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14829981|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829982|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
14829983|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
14829984|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14829985|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829986|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14829987|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
14829988|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14829989|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14829990|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14829991|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829992|NCT00941967|Gemcitabine|gemcitabine|mesh-list
14829993|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
14829994|NCT00941967|Sorafenib|sorafenib|mesh-list
14829995|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14829996|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
14829997|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14829998|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14829999|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
14830000|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830001|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830002|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830003|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
14830004|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830005|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14830006|NCT00942006|Doxycycline|doxycycline|mesh-list
14830007|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
14830008|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830009|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830010|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
14830011|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14830012|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14830013|NCT00942136|Dolutegravir|dolutegravir|mesh-list
14830014|NCT00942136|Omeprazole|omeprazole|mesh-list
14830015|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14703899|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14703900|NCT00408252|Growth Substances|growth substances|mesh-ancestor
14703901|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703902|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
14703903|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14703904|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703905|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703906|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
14703907|NCT00408278|Analgesics|analgesics|mesh-ancestor
14703908|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
14703909|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14703910|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703911|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703912|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14703913|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14703914|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830016|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14830017|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14728581|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830018|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830019|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830020|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14830021|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14830022|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14830023|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830024|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
15201722|NCT03758144|Rifaximin|rifaximin|mesh-list
15201723|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201724|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201725|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201726|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15201727|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
15201728|NCT03758079|Gabapentin|gabapentin|mesh-list
15201729|NCT03758079|Doxepin|doxepin|mesh-list
14830025|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830026|NCT00942201|Dexamethasone|dexamethasone|mesh-list
14830027|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
14830028|NCT00942201|BB 1101|bb 1101|mesh-list
14830029|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830030|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
14830031|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
14830032|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830033|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830034|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14830035|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
14830036|NCT00942201|Hormones|hormones|mesh-ancestor
14830037|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830038|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14830039|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830040|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
14830041|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830042|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830043|NCT00942214|Natalizumab|natalizumab|mesh-list
14830044|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
14830045|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830046|NCT00942253|Dopamine|dopamine|mesh-list
14830047|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
14830048|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14830049|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
14830050|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
14830051|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830052|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830053|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
14830054|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830055|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830056|NCT00942253|Protective Agents|protective agents|mesh-ancestor
14830057|NCT00942318|Insulin|insulin|mesh-list
14830058|NCT00942318|Metformin|metformin|mesh-list
14830059|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
14830060|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830061|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830062|NCT00942344|Losartan|losartan|mesh-list
14830063|NCT00942344|Amlodipine|amlodipine|mesh-list
14830064|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15201730|NCT03758079|Analgesics|analgesics|mesh-ancestor
15225699|NCT03951870|Vaccines|vaccines|mesh-list
14830065|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14830066|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14830067|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830068|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14830069|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830070|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
14830071|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14830072|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14830073|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14830074|NCT00942435|Darexaban|darexaban|mesh-list
14830075|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14830076|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
14830077|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14830078|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
14830079|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830080|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830081|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
14830082|NCT00942487|Nebivolol|nebivolol|mesh-list
14830083|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14830084|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
14830085|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14830086|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14830087|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14295248|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703915|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703916|NCT00408330|Azelaic acid|azelaic acid|mesh-list
14703917|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703918|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
14703919|NCT00408369|Pafuramidine|pafuramidine|mesh-list
14703920|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14703921|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14703922|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14703923|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703924|NCT00408382|Atorvastatin|atorvastatin|mesh-list
14703925|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14703926|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14830088|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
14830089|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830090|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830091|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830092|NCT00942526|Nystatin|nystatin|mesh-list
14830093|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830094|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830095|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
14830096|NCT00942526|Ionophores|ionophores|mesh-ancestor
14830097|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14830098|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830099|NCT00942539|Midazolam|midazolam|mesh-list
14830100|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14830101|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14830102|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14830103|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830104|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14830105|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14830106|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830107|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14830108|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
14830109|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
14830110|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
14830111|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
14830112|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830113|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830114|NCT00942565|Acetaminophen|acetaminophen|mesh-list
14830115|NCT00942565|Tramadol|tramadol|mesh-list
14830116|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14830117|NCT00942565|Analgesics|analgesics|mesh-ancestor
14830118|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
14830119|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830120|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830121|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
15201731|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
15201732|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295249|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703927|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
14830122|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14703928|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703929|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14703930|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14703931|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703932|NCT00408447|Fludarabine|fludarabine|mesh-list
14703933|NCT00408447|Busulfan|busulfan|mesh-list
15201733|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201734|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
15201735|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14830123|NCT00942565|Narcotics|narcotics|mesh-ancestor
14830124|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14830125|NCT00942591|Interferons|interferons|mesh-list
14830126|NCT00942591|Interferon-beta|interferon-beta|mesh-list
14830127|NCT00942591|Atorvastatin|atorvastatin|mesh-list
14830128|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
14830129|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830130|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
15201736|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15201737|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201738|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15201739|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15201740|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15201741|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201742|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201743|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
15201744|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15201745|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201746|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15201747|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
15201748|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
15201749|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
15201750|NCT03758014|Lomustine|lomustine|mesh-list
15201751|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15201752|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
15201753|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201754|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201755|NCT03757923|Metformin|metformin|mesh-list
15201756|NCT03757923|Pioglitazone|pioglitazone|mesh-list
14703934|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
14703935|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703936|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703937|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703938|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
14703939|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703940|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
14703941|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14703942|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14830131|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830132|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14830133|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14830134|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
14830135|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830136|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14830137|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14830138|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830139|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
14830140|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830141|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14830142|NCT00942617|Aspirin|aspirin|mesh-list
14830143|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14830144|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14830145|NCT00942617|Analgesics|analgesics|mesh-ancestor
14830146|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
14830147|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830148|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830149|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830150|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830151|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14830152|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14830153|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830154|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14830155|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14830156|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201757|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830157|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
14830158|NCT00942682|Sorafenib|sorafenib|mesh-list
14830159|NCT00942682|Everolimus|everolimus|mesh-list
14830160|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830161|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14830162|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830163|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830164|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830165|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
14830166|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830167|NCT00942747|Sirolimus|sirolimus|mesh-list
14830168|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830169|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830170|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14830171|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830172|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
14830173|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830174|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
14830175|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830176|NCT00942773|Voriconazole|voriconazole|mesh-list
14830177|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
14830178|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830179|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14830180|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14830181|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830182|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830183|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14830184|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14830185|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830186|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830187|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14830188|NCT00942838|Cisplatin|cisplatin|mesh-list
14830189|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830190|NCT00942864|Ranibizumab|ranibizumab|mesh-list
14830191|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14830192|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14830193|NCT00942864|Growth Substances|growth substances|mesh-ancestor
14830194|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830195|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
14830196|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830197|NCT00943059|Acipimox|acipimox|mesh-list
14830198|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14830199|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
14830200|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830201|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14830202|NCT00943137|Fluorouracil|fluorouracil|mesh-list
14830203|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
14830204|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830205|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14830206|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830207|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830208|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
14830209|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830210|NCT00943176|Modafinil|modafinil|mesh-list
14830211|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15201758|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201759|NCT03757910|Corticosterone|corticosterone|mesh-list
15201760|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201761|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
15201762|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15201763|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201764|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201765|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15201766|NCT03757897|Analgesics|analgesics|mesh-ancestor
15201767|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
15201768|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201769|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15201770|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15201771|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14911680|NCT01364493|Capecitabine|capecitabine|mesh-list
14830212|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830213|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14830214|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14830215|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14830216|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830217|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
14830218|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14830219|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830220|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14830221|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
14830222|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830223|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830224|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830225|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830226|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14830227|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911681|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
15201772|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
15201773|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201774|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201775|NCT03757858|Antibodies|antibodies|mesh-list
15201776|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
15201777|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201778|NCT03757650|Amoxicillin|amoxicillin|mesh-list
15201779|NCT03757650|Clarithromycin|clarithromycin|mesh-list
15201780|NCT03757650|Omeprazole|omeprazole|mesh-list
15201781|NCT03757650|Bismuth|bismuth|mesh-list
15201782|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
15201783|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201784|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201785|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15201786|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201787|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15201788|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201789|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201790|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15201791|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15201792|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15201793|NCT03757650|Antacids|antacids|mesh-ancestor
15201794|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
15201795|NCT03757585|Inositol|inositol|mesh-list
15201796|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
15201797|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15201798|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
15201799|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201800|NCT03757585|Expectorants|expectorants|mesh-ancestor
15201801|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
15201802|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15201803|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
15201804|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201805|NCT03757585|Protective Agents|protective agents|mesh-ancestor
15201806|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201807|NCT03757585|Antidotes|antidotes|mesh-ancestor
15201808|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
15201809|NCT03757585|Vitamins|vitamins|mesh-ancestor
15201810|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
15201811|NCT03757559|Hydromorphone|hydromorphone|mesh-list
15201812|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15201813|NCT03757559|Narcotics|narcotics|mesh-ancestor
14703943|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703944|NCT00408525|Donepezil|donepezil|mesh-list
14703945|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14703946|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703947|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703948|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
14703949|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14703950|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703951|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
14703952|NCT00408538|UC-781|uc-781|mesh-list
14703953|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
14703954|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14703955|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
14703956|NCT00408551|Leucovorin|leucovorin|mesh-list
14703957|NCT00408551|Fluorouracil|fluorouracil|mesh-list
15201814|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201815|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201816|NCT03757559|Analgesics|analgesics|mesh-ancestor
14703958|NCT00408551|Floxuridine|floxuridine|mesh-list
15201817|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
15201818|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201819|NCT03757403|Mebendazole|mebendazole|mesh-list
15201820|NCT03757403|Piperazine|piperazine|mesh-list
15201821|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
15201822|NCT03757403|DMP 777|dmp 777|mesh-list
15201823|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
15201824|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
15201825|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15201826|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201827|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201828|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201829|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
15201830|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201831|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201832|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201833|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
15201834|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15201835|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14830228|NCT00943293|Fludarabine|fludarabine|mesh-list
14830229|NCT00943293|Melphalan|melphalan|mesh-list
14830230|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
14830231|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830232|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830233|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830234|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
14830235|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830236|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14830237|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
14830238|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14830239|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14830240|NCT00943345|Indomethacin|indomethacin|mesh-list
14830241|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14830242|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14830243|NCT00943345|Analgesics|analgesics|mesh-ancestor
14830244|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
14830245|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830246|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830247|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830248|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830249|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
15201836|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15201837|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
15201838|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703959|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
14703960|NCT00408551|Irinotecan|irinotecan|mesh-list
14830250|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
14830251|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14830252|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14830253|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830254|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830255|NCT00943358|Vaccines|vaccines|mesh-list
14830256|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
14830257|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830258|NCT00943410|Trastuzumab|trastuzumab|mesh-list
14830259|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14830260|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830261|NCT00943449|Sorafenib|sorafenib|mesh-list
14830262|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830263|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14830264|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830265|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830266|NCT00943462|Temozolomide|temozolomide|mesh-list
14830267|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15201839|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14703961|NCT00408551|Calcium|calcium|mesh-list
14703962|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
14703963|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14703964|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703965|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
14703966|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830268|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
15201840|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15201841|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830269|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830270|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830271|NCT00943501|Liraglutide|liraglutide|mesh-list
14830272|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830273|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830274|NCT00943501|Incretins|incretins|mesh-ancestor
14830275|NCT00943501|Hormones|hormones|mesh-ancestor
14703967|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14703968|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703969|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703970|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
15201842|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15201843|NCT03757364|Methotrexate|methotrexate|mesh-list
15201844|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15201845|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
15201846|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15201847|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201848|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15201849|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
15201850|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201851|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201852|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
15201853|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201854|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15201855|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15201856|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
15201857|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15201858|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15201859|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15201860|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15201861|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201862|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830276|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830277|NCT00943540|Lamivudine|lamivudine|mesh-list
14830278|NCT00943540|Emtricitabine|emtricitabine|mesh-list
14830279|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
14830280|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14830281|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14830282|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14830283|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830284|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830285|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
14830286|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830287|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14830288|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830289|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14830290|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15201863|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
15201864|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201865|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
14703971|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14703972|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14703973|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14703974|NCT00408551|Antidotes|antidotes|mesh-ancestor
14830291|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14830292|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14830293|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
14830294|NCT00943553|Decitabine|decitabine|mesh-list
14830295|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14830296|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
14830297|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830298|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830299|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830300|NCT00943566|Sufentanil|sufentanil|mesh-list
14830301|NCT00943566|Morphine|morphine|mesh-list
14830302|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14830303|NCT00943566|Narcotics|narcotics|mesh-ancestor
14703975|NCT00408551|Protective Agents|protective agents|mesh-ancestor
14703976|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
14703977|NCT00408551|Vitamins|vitamins|mesh-ancestor
14830304|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14703978|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
14703979|NCT00408655|Sirolimus|sirolimus|mesh-list
14830305|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703980|NCT00408655|Paclitaxel|paclitaxel|mesh-list
14830306|NCT00943566|Analgesics|analgesics|mesh-ancestor
14830307|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
14830308|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830309|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14830310|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14830311|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
14703981|NCT00408655|Carboplatin|carboplatin|mesh-list
14703982|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14703983|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14703984|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14703985|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14703986|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14703987|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14703988|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14703989|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14703990|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14703991|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
14703992|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14703993|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
14703994|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14703995|NCT00408772|Bevacizumab|bevacizumab|mesh-list
14703996|NCT00408772|Capecitabine|capecitabine|mesh-list
14703997|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
14703998|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14703999|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704000|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14295250|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
14295251|NCT00580047|Vitamin D|vitamin d|mesh-list
14295252|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
14704001|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14704002|NCT00408772|Growth Substances|growth substances|mesh-ancestor
14704003|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704004|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
14704005|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704006|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
14704007|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704008|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
14704009|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14704010|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14704011|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14704012|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704013|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704014|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704015|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830312|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
14830313|NCT00943709|Insulin|insulin|mesh-list
14830314|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14830315|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
14830316|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830317|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830318|NCT00943748|Deferiprone|deferiprone|mesh-list
14704016|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704017|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14704018|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704019|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
14704020|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14704021|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14830319|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14830320|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
14830321|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
14830322|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830323|NCT00943839|Sunitinib|sunitinib|mesh-list
14830324|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830325|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14830326|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14830327|NCT00943839|Growth Substances|growth substances|mesh-ancestor
14830328|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830329|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
14830330|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14830331|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830332|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830333|NCT00943930|Dronabinol|dronabinol|mesh-list
15201866|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14830334|NCT00943930|Amphetamine|amphetamine|mesh-list
14295253|NCT00580047|Alendronate|alendronate|mesh-list
14830335|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
15201867|NCT03757221|Daratumumab|daratumumab|mesh-list
14830336|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14830337|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830338|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
14830339|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
14830340|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830341|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
14830342|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830343|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830344|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
14830345|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14830346|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14830347|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14830348|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14830349|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
14830350|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830351|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14830352|NCT00943930|Analgesics|analgesics|mesh-ancestor
14830353|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
14830354|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14830355|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14830356|NCT00943930|Hormones|hormones|mesh-ancestor
14830357|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830358|NCT00943943|Plerixafor|plerixafor|mesh-list
14830359|NCT00943943|Sorafenib|sorafenib|mesh-list
14830360|NCT00943943|Sargramostim|sargramostim|mesh-list
14830361|NCT00943943|Lenograstim|lenograstim|mesh-list
14830362|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830363|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14830364|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830365|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830366|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
14830367|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830368|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14830369|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14830370|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830371|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
14830372|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830373|NCT00943956|Everolimus|everolimus|mesh-list
14830374|NCT00943956|Leuprolide|leuprolide|mesh-list
14830375|NCT00943956|Bicalutamide|bicalutamide|mesh-list
14830376|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830377|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830378|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
14830379|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830380|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14830381|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
14830382|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14830383|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14830384|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
14704022|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14704023|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15201868|NCT03757221|Ixazomib|ixazomib|mesh-list
15201869|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201870|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
15201871|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201872|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201873|NCT03757156|Aspirin|aspirin|mesh-list
14295254|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
14704024|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704025|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704026|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704027|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704028|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14704029|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704030|NCT00408850|Pioglitazone|pioglitazone|mesh-list
14704031|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14704032|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704033|NCT00408915|Lisuride|lisuride|mesh-list
14704034|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14704035|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14704036|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14704037|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
14295255|NCT00580047|Calcium|calcium|mesh-list
14830385|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
15201874|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14830386|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830387|NCT00943982|Interferons|interferons|mesh-list
14830388|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
14830389|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830390|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
14830391|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830392|NCT00944177|Metformin|metformin|mesh-list
14830393|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830394|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830395|NCT00944242|Sertraline|sertraline|mesh-list
14830396|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
14830397|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830398|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14830399|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14830400|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14830401|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830402|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830403|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
14830404|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830405|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
14830406|NCT00944307|Antacids|antacids|mesh-list
14830407|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
14830408|NCT00944307|TEMPO|tempo|mesh-list
14830409|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14830410|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830411|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
14830412|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830413|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14830414|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14830415|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830416|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830417|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14830418|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
14830419|NCT00944307|Protective Agents|protective agents|mesh-ancestor
14830420|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830421|NCT00944333|Clopidogrel|clopidogrel|mesh-list
14830422|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14830423|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14830424|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14830425|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14830426|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
14830427|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830428|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830429|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830430|NCT00944346|Metformin|metformin|mesh-list
14830431|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830432|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830433|NCT00944359|Zinc|zinc|mesh-list
14830434|NCT00944359|Trace Elements|trace elements|mesh-ancestor
14830435|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
14830436|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830437|NCT00944385|Urinastatin|urinastatin|mesh-list
14830438|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14830439|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14830440|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
14830441|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830442|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830443|NCT00944398|Vitamins|vitamins|mesh-list
14830444|NCT00944398|Zinc|zinc|mesh-list
14830445|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
14830446|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
14830447|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
14830448|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830449|NCT00944398|Trace Elements|trace elements|mesh-ancestor
14830450|NCT00944398|Astringents|astringents|mesh-ancestor
15201875|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15201876|NCT03757156|Analgesics|analgesics|mesh-ancestor
15201877|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
15201878|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201879|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830451|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
14830452|NCT00944424|Vitamin D|vitamin d|mesh-list
15201880|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201881|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830453|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
14830454|NCT00944424|Vitamins|vitamins|mesh-list
14830455|NCT00944424|Docetaxel|docetaxel|mesh-list
14830456|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
14830457|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830458|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201882|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15201883|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15201884|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201885|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15201886|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15201887|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201888|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
15201889|NCT03757143|Ethanol|ethanol|mesh-list
15201890|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
15201891|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
15201892|NCT03757143|Povidone|povidone|mesh-list
15201893|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15201894|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201895|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201896|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201897|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
15201898|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
15201899|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
15201900|NCT03757117|Hormones|hormones|mesh-list
15201901|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201902|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201903|NCT03757052|Amoxicillin|amoxicillin|mesh-list
14830459|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
14830460|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
14830461|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
14830462|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830463|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14830464|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14830465|NCT00944463|Gemcitabine|gemcitabine|mesh-list
14830466|NCT00944463|Simvastatin|simvastatin|mesh-list
14830467|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14830468|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
14830469|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830470|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830471|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
14830472|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830473|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15201904|NCT03757052|Penicillins|penicillins|mesh-list
15201905|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15201906|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201907|NCT03756987|Ropivacaine|ropivacaine|mesh-list
15201908|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
15201909|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
15201910|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201911|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201912|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
15201913|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201914|NCT03756896|Dexamethasone|dexamethasone|mesh-list
15201915|NCT03756896|Pomalidomide|pomalidomide|mesh-list
15201916|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15201917|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
14830474|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830475|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
15201918|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
15201919|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201920|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830476|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830477|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14830478|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14830479|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14830480|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14830481|NCT00944502|Dexamethasone|dexamethasone|mesh-list
14830482|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830483|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
14830484|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
14830485|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830486|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830487|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201921|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15201922|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
15201923|NCT03756896|Hormones|hormones|mesh-ancestor
15201924|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15201925|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14830488|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
14830489|NCT00944502|Hormones|hormones|mesh-ancestor
14830490|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830491|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14830492|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830493|NCT00944515|Azithromycin|azithromycin|mesh-list
14830494|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830495|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830496|NCT00944541|Maraviroc|maraviroc|mesh-list
14830497|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14830498|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14830499|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830500|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14830501|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830502|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
14830503|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830504|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14830505|NCT00944606|Vitamin D|vitamin d|mesh-list
14830506|NCT00944606|Vitamins|vitamins|mesh-ancestor
14830507|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
14830508|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830509|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14830510|NCT00944619|Insulin|insulin|mesh-list
14830511|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830512|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830513|NCT00944684|Ribavirin|ribavirin|mesh-list
14830514|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
14830515|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830516|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
14830517|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830518|NCT00944723|Vitamins|vitamins|mesh-list
14830519|NCT00944723|Zinc|zinc|mesh-list
14830520|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
14830521|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
14830522|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
14830523|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830524|NCT00944723|Trace Elements|trace elements|mesh-ancestor
14830525|NCT00944723|Astringents|astringents|mesh-ancestor
14830526|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
14830527|NCT00944801|Doxorubicin|doxorubicin|mesh-list
14830528|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14830529|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14830530|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830531|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14830532|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14830533|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830534|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830535|NCT00944814|Zinc|zinc|mesh-list
14830536|NCT00944814|Trace Elements|trace elements|mesh-ancestor
14830537|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
14830538|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830539|NCT00944840|Amodiaquine|amodiaquine|mesh-list
14830540|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
14830541|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14830542|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14830543|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830544|NCT00944853|Zinc|zinc|mesh-list
14830545|NCT00944853|Trace Elements|trace elements|mesh-ancestor
14830546|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
14830547|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830548|NCT00944918|Fulvestrant|fulvestrant|mesh-list
14830549|NCT00944918|Anastrozole|anastrozole|mesh-list
14830550|NCT00944918|Exemestane|exemestane|mesh-list
15201926|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201927|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
15201928|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15201929|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15201930|NCT03756896|Growth Substances|growth substances|mesh-ancestor
15201931|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
15201932|NCT03756818|Paclitaxel|paclitaxel|mesh-list
15201933|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14830551|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14830552|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830553|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14830554|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14830555|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
14295256|NCT00580047|Vitamins|vitamins|mesh-ancestor
14830556|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830557|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830558|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14830559|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14830560|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830561|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830562|NCT00944957|Efavirenz|efavirenz|mesh-list
14830563|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
14830564|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14830565|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14830566|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830567|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830568|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
14704038|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704039|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704040|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830569|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830570|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14830571|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14830572|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14830573|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14830574|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14830575|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14830576|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14704041|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
14704042|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
14704043|NCT00408941|Propofol|propofol|mesh-list
14704044|NCT00408941|Prilocaine|prilocaine|mesh-list
14704045|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14704046|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704047|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704048|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14704049|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
14704050|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
14704051|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14704052|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
14830577|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830578|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14830579|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14830580|NCT00944996|Citalopram|citalopram|mesh-list
14830581|NCT00944996|Fluoxetine|fluoxetine|mesh-list
14830582|NCT00944996|Paroxetine|paroxetine|mesh-list
14830583|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14830584|NCT00944996|Sertraline|sertraline|mesh-list
14830585|NCT00944996|Clomipramine|clomipramine|mesh-list
14830586|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14830587|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14830588|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14830589|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201934|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15201935|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201936|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
15201937|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
15201938|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
15201939|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201940|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
15201941|NCT03756727|Vitamins|vitamins|mesh-ancestor
15201942|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
15201943|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201944|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
15201945|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704053|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704054|NCT00409019|Tenofovir|tenofovir|mesh-list
14704055|NCT00409019|Adefovir|adefovir|mesh-list
14704056|NCT00409019|Telbivudine|telbivudine|mesh-list
14704057|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
14704058|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704059|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14704060|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14704061|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704062|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704063|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15201946|NCT03756727|Protective Agents|protective agents|mesh-ancestor
14704064|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14704065|NCT00409071|Sinomenine|sinomenine|mesh-list
14830590|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830591|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
14830592|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830593|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14830594|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
14830595|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15201947|NCT03756623|Metformin|metformin|mesh-list
15201948|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15201949|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224590|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224591|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830596|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14830597|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14830598|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830599|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14830600|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14830601|NCT00945022|Anesthetics|anesthetics|mesh-list
14830602|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224592|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15224593|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15224594|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
15224595|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704066|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224596|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224597|NCT02935595|Ketamine|ketamine|mesh-list
15224598|NCT02935595|Analgesics|analgesics|mesh-ancestor
15224599|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
15224600|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224601|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224602|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15224603|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15224604|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
15224605|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
15224606|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224607|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15224608|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15224609|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224610|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224611|NCT02887248|Gemcitabine|gemcitabine|mesh-list
15224612|NCT02887248|Paclitaxel|paclitaxel|mesh-list
15224613|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15224614|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224615|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
15224616|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
15224617|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
15224618|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224619|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15224620|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
14704067|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
14704068|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14704069|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728582|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728583|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14728584|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728585|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
14728586|NCT00519181|Valproic Acid|valproic acid|mesh-list
14728587|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
14728588|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728589|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728590|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
14728591|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728592|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728593|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
14830603|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830604|NCT00945152|Vancomycin|vancomycin|mesh-list
14830605|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830606|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830607|NCT00945178|Naproxen|naproxen|mesh-list
14830608|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14830609|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14830610|NCT00945178|Analgesics|analgesics|mesh-ancestor
14830611|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
14830612|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830613|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830614|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830615|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830616|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
14830617|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14830618|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830619|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911682|NCT01364493|Trastuzumab|trastuzumab|mesh-list
14911683|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14911684|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
14911685|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911686|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911687|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14911688|NCT01364519|Fluticasone|fluticasone|mesh-list
14911689|NCT01364519|Xhance|xhance|mesh-list
14911690|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911691|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14911692|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
14911693|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911694|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911695|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14911696|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
14911697|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
14911698|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14911699|NCT01364571|Vaccines|vaccines|mesh-list
14911700|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
14911701|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911702|NCT01364675|Metformin|metformin|mesh-list
14911703|NCT01364675|Enalapril|enalapril|mesh-list
14911704|NCT01364675|Simvastatin|simvastatin|mesh-list
14911705|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14911706|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911707|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14911708|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14911709|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
14911710|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911711|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14911712|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14911713|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911714|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14911715|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
14911716|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14911717|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
14911718|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14911719|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14911720|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201950|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15201951|NCT03756324|Cefdinir|cefdinir|mesh-list
15201952|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15201953|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15201954|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
15201955|NCT03756298|Capecitabine|capecitabine|mesh-list
15201956|NCT03756298|Atezolizumab|atezolizumab|mesh-list
15201957|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15201958|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
15201959|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201960|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15201961|NCT03756272|Bupivacaine|bupivacaine|mesh-list
15201962|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
15201963|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
15201964|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201965|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201966|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
15201967|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911721|NCT01364688|Vitamins|vitamins|mesh-ancestor
15201968|NCT03756246|Vaccines|vaccines|mesh-list
14830620|NCT00945308|Eptifibatide|eptifibatide|mesh-list
14830621|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14830622|NCT00945347|Miglustat|miglustat|mesh-list
14830623|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830624|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830625|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14830626|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830627|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
14830628|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830629|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14830630|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830631|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830632|NCT00945360|Letrozole|letrozole|mesh-list
14830633|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14830634|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830635|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14830636|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830637|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830638|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14830639|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
14830640|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830641|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830642|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
14830643|NCT00945373|Calcium|calcium|mesh-list
14830644|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14830645|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830646|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
14830647|NCT00945373|Coagulants|coagulants|mesh-ancestor
14830648|NCT00945438|Vaccines|vaccines|mesh-list
15201969|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
15201970|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201971|NCT03756233|Remifentanil|remifentanil|mesh-list
15201972|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15201973|NCT03756233|Narcotics|narcotics|mesh-ancestor
15201974|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15201975|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201976|NCT03756233|Analgesics|analgesics|mesh-ancestor
15201977|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
15201978|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201979|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
15201980|NCT03756220|Thiamine|thiamine|mesh-list
14830649|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
14830650|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830651|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
14830652|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14830653|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
14830654|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830655|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830656|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14830657|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
14830658|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14830659|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
14830660|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830661|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830662|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14830663|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
14830664|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
14830665|NCT00945529|Protective Agents|protective agents|mesh-ancestor
14830666|NCT00945542|Hemostatics|hemostatics|mesh-list
14830667|NCT00945542|Coagulants|coagulants|mesh-ancestor
14830668|NCT00945620|Ropivacaine|ropivacaine|mesh-list
14830669|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
14830670|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
14830671|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14830672|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830673|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
15201981|NCT03756220|Vitamins|vitamins|mesh-ancestor
15201982|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
15201983|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201984|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
15201985|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201986|NCT03756220|Protective Agents|protective agents|mesh-ancestor
15201987|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
15201988|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14830674|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201989|NCT03756116|Epinephrine|epinephrine|mesh-list
15201990|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14830675|NCT00945724|Cytarabine|cytarabine|mesh-list
14830676|NCT00945724|Prednisolone|prednisolone|mesh-list
14830677|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
14830678|NCT00945724|Rituximab|rituximab|mesh-list
14830679|NCT00945724|Doxorubicin|doxorubicin|mesh-list
14830680|NCT00945724|Methotrexate|methotrexate|mesh-list
14830681|NCT00945724|Vincristine|vincristine|mesh-list
15201991|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14830682|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830683|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
14830684|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830685|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830686|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14830687|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
14830688|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830689|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830690|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14830691|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14830692|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14830693|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14830694|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14830695|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830696|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14830697|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
14830698|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14830699|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14830700|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
14830701|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
14830702|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14830703|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14830704|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
14830705|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830706|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14830707|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
14830708|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
14830709|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
14830710|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830711|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
14830712|NCT00945724|Hormones|hormones|mesh-ancestor
14830713|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830714|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14830715|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
14830716|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
14830717|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14830718|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
14830719|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830720|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830721|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14830722|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
14830723|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14830724|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
14830725|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830726|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830727|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14830728|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
14830729|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
14830730|NCT00945789|Protective Agents|protective agents|mesh-ancestor
14830731|NCT00945789|Hematinics|hematinics|mesh-ancestor
14830732|NCT00945919|Oxymorphone|oxymorphone|mesh-list
14830733|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14830734|NCT00945919|Narcotics|narcotics|mesh-ancestor
14830735|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14830736|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830737|NCT00945919|Analgesics|analgesics|mesh-ancestor
14830738|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
14830739|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15201992|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
15201993|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15201994|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15201995|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15201996|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15201997|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14830740|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14830741|NCT00945997|Misoprostol|misoprostol|mesh-list
14911722|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
14830742|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14830743|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
14830744|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14830745|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830746|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14830747|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14830748|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
14830749|NCT00946036|Sertraline|sertraline|mesh-list
14830750|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
14830751|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830752|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14830753|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14830754|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14830755|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830756|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830757|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
14830758|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830759|NCT00946166|Simvastatin|simvastatin|mesh-list
14830760|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14830761|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14830762|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
14830763|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830764|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14830765|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14830766|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830767|NCT00946179|Vaccines|vaccines|mesh-list
14830768|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
14830769|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830770|NCT00946335|Temozolomide|temozolomide|mesh-list
14830771|NCT00946335|Veliparib|veliparib|mesh-list
14830772|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15201998|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
15201999|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202000|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15202001|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
15202002|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
15202003|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
15202004|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15202005|NCT03756090|Paclitaxel|paclitaxel|mesh-list
15202006|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
15202007|NCT03756090|Epirubicin|epirubicin|mesh-list
15202008|NCT03756090|Palbociclib|palbociclib|mesh-list
15202009|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15202010|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202011|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
15202012|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
15202013|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
15202014|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202015|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202016|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
14704070|NCT00409201|Reboxetine|reboxetine|mesh-list
15202017|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202018|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704071|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
14704072|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14704073|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14704074|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14704075|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704076|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704077|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
14704078|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704079|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704080|NCT00409214|Talaporfin|talaporfin|mesh-list
14704081|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704082|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14704083|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
14704084|NCT00409227|Alfuzosin|alfuzosin|mesh-list
14704085|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14704086|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14704087|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14704088|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
15202019|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15202020|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
14830773|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
14830774|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830775|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830776|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14830777|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830778|NCT00946374|Cyclosporine|cyclosporine|mesh-list
14830779|NCT00946374|Doxorubicin|doxorubicin|mesh-list
14830780|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14830781|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202021|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15202022|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15202023|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15202024|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15202025|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202026|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14830782|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14830783|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14830784|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830785|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830786|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
14830787|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830788|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830789|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830790|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
14830791|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830792|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
14830793|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14830794|NCT00946387|Ondansetron|ondansetron|mesh-list
14830795|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
14830796|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
15202027|NCT03756064|Carboplatin|carboplatin|mesh-list
15202028|NCT03756064|Docetaxel|docetaxel|mesh-list
15202029|NCT03756064|Trastuzumab|trastuzumab|mesh-list
15202030|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202031|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
15202032|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
15202033|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
15202034|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202035|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202036|NCT03755947|Venetoclax|venetoclax|mesh-list
15202037|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
15202038|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202039|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202040|NCT03755778|Itraconazole|itraconazole|mesh-list
15202041|NCT03755778|Rifampin|rifampin|mesh-list
15202042|NCT03755778|Quinidine|quinidine|mesh-list
15202043|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
15202044|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830797|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830798|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830799|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14830800|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
14830801|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
14830802|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14830803|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
14830804|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830805|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830806|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14830807|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14830808|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14830809|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830810|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14830811|NCT00946465|Ramipril|ramipril|mesh-list
14830812|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14830813|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
14830814|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830815|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830816|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14830817|NCT00946491|Haloperidol|haloperidol|mesh-list
15202045|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15202046|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15202047|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830818|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
15202048|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830819|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
15202049|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14830820|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
14830821|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830822|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830823|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14830824|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15202050|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
15202051|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14830825|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14830826|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14830827|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830828|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14830829|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
14830830|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830831|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830832|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14830833|NCT00946504|Glipizide|glipizide|mesh-list
14830834|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830835|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830836|NCT00946556|Valacyclovir|valacyclovir|mesh-list
14830837|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
14830838|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830839|NCT00946595|Ritonavir|ritonavir|mesh-list
14830840|NCT00946595|Lopinavir|lopinavir|mesh-list
14830841|NCT00946595|Tenofovir|tenofovir|mesh-list
14830842|NCT00946595|Efavirenz|efavirenz|mesh-list
14830843|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14830844|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14830845|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
14830846|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830847|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830848|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14830849|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14830850|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
14830851|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830852|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14830853|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14830854|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14830855|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14830856|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14830857|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14830858|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14830859|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14830860|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14830861|NCT00946608|Loratadine|loratadine|mesh-list
14830862|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
14830863|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
14830864|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14830865|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14830866|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14830867|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
14830868|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
14830869|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202052|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202053|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15202054|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15202055|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
15202056|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14830870|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830871|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202057|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
15202058|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15202059|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15202060|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15202061|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15202062|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15202063|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15202064|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15202065|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15202066|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15202067|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
15202068|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202069|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15202070|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
15202071|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15202072|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15202073|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15202074|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15202075|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
15202076|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15202077|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14830872|NCT00946621|Ramipril|ramipril|mesh-list
14830873|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14830874|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
14830875|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830876|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830877|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14830878|NCT00946673|Vorinostat|vorinostat|mesh-list
14830879|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830880|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14830881|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830882|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830883|NCT00946686|Leflunomide|leflunomide|mesh-list
14830884|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830885|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830886|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830887|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
14830888|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830889|NCT00946725|Atenolol|atenolol|mesh-list
14830890|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14830891|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14830892|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
14830893|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
14830894|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830895|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830896|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14830897|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14830898|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14830899|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
14830900|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830901|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830902|NCT00946751|Levetiracetam|levetiracetam|mesh-list
14830903|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
14830904|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
14830905|NCT00946764|Imipramine|imipramine|mesh-list
14830906|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14830907|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
14830908|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830909|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14830910|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14830911|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15224621|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
14911723|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
14830912|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830913|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
14830914|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830915|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830916|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
14830917|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
14830918|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14830919|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14830920|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14830921|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830922|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830923|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830924|NCT00946829|Telmisartan|telmisartan|mesh-list
14830925|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14830926|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14830927|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14911724|NCT01364701|Tadalafil|tadalafil|mesh-list
15202078|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202079|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15202080|NCT03755765|Amoxicillin|amoxicillin|mesh-list
15202081|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
15202082|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
15202083|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15202084|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15202085|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202086|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15202087|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202088|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202089|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
15202090|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15202091|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15202092|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202093|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15202094|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
15202095|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202096|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202097|NCT03755700|Vitamin E|vitamin e|mesh-list
15202098|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
15202099|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15202100|NCT03755700|Vitamins|vitamins|mesh-ancestor
15202101|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
15202102|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202103|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
14704089|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704090|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704091|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704092|NCT00409227|Urological Agents|urological agents|mesh-ancestor
14704093|NCT00409253|Nicardipine|nicardipine|mesh-list
14704094|NCT00409253|Urapidil|urapidil|mesh-list
14295257|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
14295258|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295259|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14295260|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15202104|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202105|NCT03755700|Protective Agents|protective agents|mesh-ancestor
15202106|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
15202107|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202108|NCT03755700|Expectorants|expectorants|mesh-ancestor
15202109|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
15202110|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15202111|NCT03755700|Antidotes|antidotes|mesh-ancestor
15202112|NCT03755609|Fentanyl|fentanyl|mesh-list
14704095|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14704096|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14704097|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704098|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704099|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14704100|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704101|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14704102|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14704103|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
14704104|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202113|NCT03755609|Oxycodone|oxycodone|mesh-list
15202114|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14830928|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830929|NCT00946907|Aspirin|aspirin|mesh-list
14830930|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14830931|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14830932|NCT00946907|Analgesics|analgesics|mesh-ancestor
14830933|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
14830934|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830935|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830936|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830937|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202115|NCT03755609|Narcotics|narcotics|mesh-ancestor
15202116|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202117|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202118|NCT03755609|Analgesics|analgesics|mesh-ancestor
15202119|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
15202120|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202121|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15202122|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15202123|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
15202124|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
15202125|NCT03755557|Budesonide|budesonide|mesh-list
15202126|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202127|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15202128|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
15202129|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202130|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202131|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15202132|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
15202133|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
15202134|NCT03755557|Hormones|hormones|mesh-ancestor
15202135|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202136|NCT03755531|Oxytocin|oxytocin|mesh-list
14830938|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14830939|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14830940|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830941|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14830942|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14830943|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14830944|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
14830945|NCT00946946|Mesalamine|mesalamine|mesh-list
14830946|NCT00946946|Azathioprine|azathioprine|mesh-list
14830947|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
14830948|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830949|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14830950|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14830951|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14830952|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
14830953|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830954|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14830955|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14830956|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14830957|NCT00946946|Analgesics|analgesics|mesh-ancestor
14830958|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
14830959|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830960|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14830961|NCT00947024|Glipizide|glipizide|mesh-list
14830962|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830963|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830964|NCT00947063|Promethazine|promethazine|mesh-list
14830965|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
14830966|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
14830967|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
14830968|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14830969|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
14830970|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
14830971|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830972|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830973|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830974|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14830975|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15202137|NCT03755531|Carbetocin|carbetocin|mesh-list
15202138|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
15202139|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202140|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202141|NCT03755479|Insulin|insulin|mesh-list
15202142|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14830976|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14830977|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14830978|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
14830979|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
14830980|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
14830981|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14830982|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
14830983|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
14830984|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14830985|NCT00947076|Fluoxetine|fluoxetine|mesh-list
14830986|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14830987|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14830988|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14830989|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14830990|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14830991|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
14830992|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14830993|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14830994|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
14830995|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14830996|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14830997|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14830998|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911725|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
14295261|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295262|NCT00580047|Antacids|antacids|mesh-ancestor
14704105|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14911726|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14911727|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14911728|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911729|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911730|NCT01364701|Urological Agents|urological agents|mesh-ancestor
14911731|NCT01364792|Valacyclovir|valacyclovir|mesh-list
14911732|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
14911733|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911734|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
14911735|NCT01364805|Gemcitabine|gemcitabine|mesh-list
14911736|NCT01364805|Vitamins|vitamins|mesh-ancestor
14911737|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
14911738|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911739|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14911740|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
14911741|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911742|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911743|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
14911744|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911745|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911746|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911747|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
14911748|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
14911749|NCT01364805|Protective Agents|protective agents|mesh-ancestor
14911750|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
14911751|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
14911752|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
14911753|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911754|NCT01364883|Vaccines|vaccines|mesh-list
14911755|NCT01364883|Immunologic Factors|immunologic factors|mesh-ancestor
15202143|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202144|NCT03755466|Tofacitinib|tofacitinib|mesh-list
15202145|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15202146|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704106|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14704107|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14704108|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
14704109|NCT00409305|Betahistine|betahistine|mesh-list
14704110|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
14704111|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
14704112|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
14704113|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704114|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704115|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704116|NCT00409318|Etanercept|etanercept|mesh-list
14704117|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14728594|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15202147|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202148|NCT03755440|Antibodies|antibodies|mesh-list
15202149|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
15202150|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202151|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15202152|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15202153|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
15202154|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202155|NCT03755427|Antacids|antacids|mesh-ancestor
15202156|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202157|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202158|NCT03755310|Suvorexant|suvorexant|mesh-list
14830999|NCT00947128|Ondansetron|ondansetron|mesh-list
14831000|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
14831001|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
14831002|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831003|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831004|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831005|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
14831006|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
14831007|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14831008|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
14831009|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831010|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831011|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14831012|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14831013|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831014|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14831015|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14831016|NCT00947141|Valganciclovir|valganciclovir|mesh-list
14831017|NCT00947141|Ganciclovir|ganciclovir|mesh-list
14831018|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14831019|NCT00947141|Foscarnet|foscarnet|mesh-list
14831020|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14831021|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
14831022|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831023|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14831024|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831025|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831026|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14831027|NCT00947323|Simvastatin|simvastatin|mesh-list
14831028|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14831029|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14831030|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
14831031|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831032|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14831033|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14831034|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202159|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15202160|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15202161|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202162|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202163|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14831035|NCT00947336|Norfloxacin|norfloxacin|mesh-list
14831036|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831037|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831038|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14831039|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14831040|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831041|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831042|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831043|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14831044|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14831045|NCT00947375|Lamotrigine|lamotrigine|mesh-list
14831046|NCT00947375|Haloperidol|haloperidol|mesh-list
14831047|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
14831048|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
14831049|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
14831050|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831051|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831052|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831053|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15202164|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202165|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831054|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14831055|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831056|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14831057|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14831058|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
14831059|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704118|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14704119|NCT00409318|Analgesics|analgesics|mesh-ancestor
14831060|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831061|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14831062|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
14831063|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14831064|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831065|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831066|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14831067|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14831068|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
14831069|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14831070|NCT00947388|Antibodies|antibodies|mesh-list
14831071|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
14831072|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14831073|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
14831074|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831075|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831076|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14831077|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
14831078|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831079|NCT00947453|Montelukast|montelukast|mesh-list
14831080|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14831081|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
14831082|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14831083|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
14831084|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831085|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831086|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14831087|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14831088|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831089|NCT00947466|Buprenorphine|buprenorphine|mesh-list
14831090|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14831091|NCT00947466|Narcotics|narcotics|mesh-ancestor
14831092|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831093|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831094|NCT00947466|Analgesics|analgesics|mesh-ancestor
14831095|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
14831096|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831097|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14831098|NCT00947596|Atropine|atropine|mesh-list
14831099|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14831100|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14831101|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14831102|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
14831103|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831104|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831105|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14831106|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
14831107|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
14831108|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
14831109|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14831110|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14831111|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
14831112|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831113|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831114|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14831115|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14831116|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831117|NCT00947739|Camptothecin|camptothecin|mesh-list
14831118|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14704120|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
14704121|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704122|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704123|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704124|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704125|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831119|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831120|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14831121|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14831122|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831123|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831124|NCT00947843|Aspirin|aspirin|mesh-list
14831125|NCT00947843|Clopidogrel|clopidogrel|mesh-list
14831126|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14831127|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831128|NCT00947843|Analgesics|analgesics|mesh-ancestor
14831129|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
14831130|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831131|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831132|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831133|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831134|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14831135|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14831136|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704126|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704127|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
14704128|NCT00409357|Alfuzosin|alfuzosin|mesh-list
14704129|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14704130|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14704131|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14704132|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
14704133|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295263|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295264|NCT00580073|Leucovorin|leucovorin|mesh-list
14295265|NCT00580073|Fluorouracil|fluorouracil|mesh-list
14295266|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
14295267|NCT00580073|Cetuximab|cetuximab|mesh-list
14295268|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
14295269|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831137|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14831138|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14831139|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831140|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
14831141|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14831142|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15202166|NCT03755193|Diphosphonates|diphosphonates|mesh-list
15202167|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15202168|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202169|NCT03755115|Epirubicin|epirubicin|mesh-list
15202170|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15202171|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202172|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15202173|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15202174|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202175|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202176|NCT03755102|Osimertinib|osimertinib|mesh-list
14831143|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14831144|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
14831145|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831146|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
14831147|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14831148|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14831149|NCT00947895|Prednisolone|prednisolone|mesh-list
14831150|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
14831151|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14831152|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
14295270|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14295271|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295272|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831153|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14831154|NCT00947895|Hormones|hormones|mesh-ancestor
14831155|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831156|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831157|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831158|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
14831159|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
14831160|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831161|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831162|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
15202177|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295273|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
14831163|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14831164|NCT00947895|Protective Agents|protective agents|mesh-ancestor
14831165|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14831166|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831167|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
14831168|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
14831169|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831170|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831171|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
14831172|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14831173|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
14831174|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
14831175|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831176|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831177|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831178|NCT00948103|Analgesics|analgesics|mesh-ancestor
14831179|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
14831180|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831181|NCT00948168|Exenatide|exenatide|mesh-list
14831182|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831183|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831184|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14831185|NCT00948168|Incretins|incretins|mesh-ancestor
14831186|NCT00948168|Hormones|hormones|mesh-ancestor
14831187|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831188|NCT00948220|Ribavirin|ribavirin|mesh-list
14831189|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14831190|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
14831191|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831192|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
14831193|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831194|NCT00948272|Vaccines|vaccines|mesh-list
14831195|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
14831196|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831197|NCT00948402|Metformin|metformin|mesh-list
14831198|NCT00948402|Biguanides|biguanides|mesh-list
14831199|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
14831200|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
14831201|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831202|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831203|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14831204|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14831205|NCT00948480|Sargramostim|sargramostim|mesh-list
14831206|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
14831207|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831208|NCT00948493|Insulin|insulin|mesh-list
14831209|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14831210|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831211|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831212|NCT00948584|Insulin|insulin|mesh-list
14831213|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14831214|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
14831215|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831216|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831217|NCT00948649|Varenicline|varenicline|mesh-list
14831218|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14831219|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14831220|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
14831221|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831222|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831223|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831224|NCT00948662|Ketoconazole|ketoconazole|mesh-list
14831225|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
14831226|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831227|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14831228|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14831229|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831230|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202178|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15202179|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295274|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831231|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14831232|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
14831233|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831234|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831235|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14831236|NCT00948727|Cyclosporine|cyclosporine|mesh-list
14831237|NCT00948727|Cyclosporins|cyclosporins|mesh-list
14831238|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831239|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831240|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831241|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
14831242|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831243|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
14831244|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831245|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
14831246|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831247|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14831248|NCT00948740|Vitamin D|vitamin d|mesh-list
14831249|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
14831250|NCT00948740|Vitamins|vitamins|mesh-ancestor
14831251|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
14831252|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831253|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14831254|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831255|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14831256|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14831257|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831258|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
14831259|NCT00948805|Goserelin|goserelin|mesh-list
14831260|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14831261|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14831262|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831263|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14831264|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831265|NCT00948987|Aspirin|aspirin|mesh-list
14831266|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14831267|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831268|NCT00948987|Analgesics|analgesics|mesh-ancestor
14831269|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
14831270|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831271|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831272|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831273|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831274|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14831275|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14831276|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831277|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14831278|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14831279|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831280|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
14911756|NCT01364883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911757|NCT01364961|Resveratrol|resveratrol|mesh-list
14911758|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
14911759|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911760|NCT01364961|Protective Agents|protective agents|mesh-ancestor
14911761|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911762|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911763|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14911764|NCT01364974|Peficitinib|peficitinib|mesh-list
14911765|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911766|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911767|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911768|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
14911769|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911770|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
14911771|NCT01364987|Peficitinib|peficitinib|mesh-list
14911772|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14911773|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911774|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14911775|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
14911776|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14911777|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911778|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911779|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911780|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14911781|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
14911782|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911783|NCT01365000|Naloxegol|naloxegol|mesh-list
14911784|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15202180|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202181|NCT03755089|Lidocaine|lidocaine|mesh-list
14831281|NCT00949026|Sirolimus|sirolimus|mesh-list
14831282|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831283|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831284|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14831285|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831286|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
14831287|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831288|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
14831289|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831290|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
14831291|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14831292|NCT00949065|Antibodies|antibodies|mesh-list
14831293|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
14831294|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14831295|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
14831296|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831297|NCT00949130|Linezolid|linezolid|mesh-list
14831298|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831299|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831300|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14831301|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831302|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831303|NCT00949182|Doxorubicin|doxorubicin|mesh-list
14831304|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14831305|NCT00949182|Mitomycins|mitomycins|mesh-list
14831306|NCT00949182|Mitomycin|mitomycin|mesh-list
14831307|NCT00949182|Sorafenib|sorafenib|mesh-list
14831308|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14831309|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831310|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14831311|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14831312|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831313|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831314|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14831315|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
14831316|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14831317|NCT00949247|Bevacizumab|bevacizumab|mesh-list
14831318|NCT00949247|Trastuzumab|trastuzumab|mesh-list
14831319|NCT00949247|Carboplatin|carboplatin|mesh-list
14831320|NCT00949247|Docetaxel|docetaxel|mesh-list
14831321|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14831322|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831323|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14831324|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14831325|NCT00949247|Growth Substances|growth substances|mesh-ancestor
14831326|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831327|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
14831328|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
14831329|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
14831330|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
14831331|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831332|NCT00949299|Buprenorphine|buprenorphine|mesh-list
14831333|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14831334|NCT00949299|Narcotics|narcotics|mesh-ancestor
14831335|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202182|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
15202183|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
15202184|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831336|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831337|NCT00949299|Analgesics|analgesics|mesh-ancestor
14831338|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
14831339|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831340|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14831341|NCT00949364|Pomalidomide|pomalidomide|mesh-list
14831342|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
14831343|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831344|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14831345|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14831346|NCT00949364|Growth Substances|growth substances|mesh-ancestor
14831347|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
14831348|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831349|NCT00949377|Bromides|bromides|mesh-list
14831350|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
14831351|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
14831352|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15225700|NCT03951870|Immunologic Factors|immunologic factors|mesh-ancestor
14831353|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831354|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
14831355|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831356|NCT00949442|Insulin|insulin|mesh-list
14831357|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14831358|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
14831359|NCT00949442|Glimepiride|glimepiride|mesh-list
14831360|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831361|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831362|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14831363|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831364|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
14831365|NCT00949455|Lapatinib|lapatinib|mesh-list
14831366|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295275|NCT00580073|Antidotes|antidotes|mesh-ancestor
14295276|NCT00580073|Protective Agents|protective agents|mesh-ancestor
15202185|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202186|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
14295277|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
14704134|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704135|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202187|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202188|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15202189|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15202190|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15202191|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202192|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202193|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15202194|NCT03755037|Estradiol|estradiol|mesh-list
15202195|NCT03755037|Estrogens|estrogens|mesh-ancestor
15202196|NCT03755037|Hormones|hormones|mesh-ancestor
14295278|NCT00580073|Vitamins|vitamins|mesh-ancestor
14295279|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
14704136|NCT00409357|Urological Agents|urological agents|mesh-ancestor
14704137|NCT00409383|Paclitaxel|paclitaxel|mesh-list
14704138|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14704139|NCT00409383|Temozolomide|temozolomide|mesh-list
14704140|NCT00409383|Oblimersen|oblimersen|mesh-list
14704141|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14704142|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704143|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
14704144|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
14704145|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
14704146|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704147|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14704148|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
14704149|NCT00409461|Sirolimus|sirolimus|mesh-list
15202197|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202198|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202199|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15202200|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
15202201|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202202|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15202203|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15202204|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15202205|NCT03754959|Midazolam|midazolam|mesh-list
15202206|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15202207|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14295280|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202208|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704150|NCT00409461|Tacrolimus|tacrolimus|mesh-list
14704151|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704152|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
14295281|NCT00580151|Clonidine|clonidine|mesh-list
14704153|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704154|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14704155|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831367|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14831368|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831369|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831370|NCT00949494|Hylan|hylan|mesh-list
14831371|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
14831372|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
14831373|NCT00949494|Protective Agents|protective agents|mesh-ancestor
14831374|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831375|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15202209|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202210|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15202211|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15202212|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15202213|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14704156|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704157|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14704158|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704159|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14704160|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704161|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
14831376|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
14831377|NCT00949546|Etanercept|etanercept|mesh-list
14831378|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14831379|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831380|NCT00949546|Analgesics|analgesics|mesh-ancestor
14831381|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
14831382|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831383|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831384|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831385|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831386|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831387|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831388|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
14831389|NCT00949572|Vaccines|vaccines|mesh-list
14831390|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
14831391|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
14831392|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831393|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14831394|NCT00949598|Tamoxifen|tamoxifen|mesh-list
15202214|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
15202215|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
15202216|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
15202217|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
15202218|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202219|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202220|NCT03754933|Fludarabine|fludarabine|mesh-list
15202221|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
15202222|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202223|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15202224|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
15202225|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202226|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202227|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
15202228|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202229|NCT03754842|Niacinamide|niacinamide|mesh-list
14831395|NCT00949598|Letrozole|letrozole|mesh-list
14831396|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831397|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831398|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14831399|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14831400|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831401|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14831402|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
14831403|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831404|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831405|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14831406|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14831407|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14704162|NCT00409526|Iloprost|iloprost|mesh-list
14704163|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14704164|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
14704165|NCT00409591|Ritonavir|ritonavir|mesh-list
14704166|NCT00409591|Lopinavir|lopinavir|mesh-list
14704167|NCT00409591|Zidovudine|zidovudine|mesh-list
14704168|NCT00409591|Nevirapine|nevirapine|mesh-list
14704169|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14704170|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14704171|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
14704172|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704173|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704174|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14831408|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14831409|NCT00949624|Docetaxel|docetaxel|mesh-list
15202230|NCT03754842|Niacin|niacin|mesh-list
15202231|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
15202232|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
15202233|NCT03754842|Vitamins|vitamins|mesh-ancestor
15202234|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
15202235|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202236|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15202237|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
15202238|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202239|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14831410|NCT00949624|Axitinib|axitinib|mesh-list
14831411|NCT00949624|Crenolanib|crenolanib|mesh-list
14831412|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831413|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
14831414|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
14831415|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
14831416|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831417|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14831418|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831419|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14831420|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831421|NCT00949663|Incretins|incretins|mesh-ancestor
14831422|NCT00949663|Hormones|hormones|mesh-ancestor
14831423|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831424|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831425|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14831426|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
14831427|NCT00949728|Coagulants|coagulants|mesh-ancestor
14831428|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
14831429|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14831430|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831431|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831432|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
14831433|NCT00949832|Vitamin D|vitamin d|mesh-list
14831434|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
14831435|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
14831436|NCT00949832|Vitamins|vitamins|mesh-list
14831437|NCT00949832|Calcium|calcium|mesh-list
14831438|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
14831439|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831440|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831441|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14831442|NCT00949949|Gemcitabine|gemcitabine|mesh-list
14831443|NCT00949949|Everolimus|everolimus|mesh-list
15202240|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
15202241|NCT03754816|Anesthetics|anesthetics|mesh-list
15202242|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
15202243|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202244|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202245|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
15202246|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
15202247|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202248|NCT03754712|Vitamin D|vitamin d|mesh-list
15202249|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
15202250|NCT03754712|Vitamins|vitamins|mesh-ancestor
15202251|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
15202252|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202253|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14831444|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831445|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831446|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
14831447|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831448|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
14831449|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831450|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831451|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831452|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
14831453|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831454|NCT00949962|Leuprolide|leuprolide|mesh-list
14831455|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
15202254|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831456|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14831457|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
14831458|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202255|NCT03754686|Acetaminophen|acetaminophen|mesh-list
15202256|NCT03754686|Oseltamivir|oseltamivir|mesh-list
15202257|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831459|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831460|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14831461|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831462|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
14831463|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831464|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
14831465|NCT00950027|Povidone|povidone|mesh-list
15202258|NCT03754686|Analgesics|analgesics|mesh-ancestor
15202259|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
15202260|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202261|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202262|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
15202263|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
15202264|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202265|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202266|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202267|NCT03754647|Ascorbic Acid|ascorbic acid|mesh-list
15202268|NCT03754647|Vitamins|vitamins|mesh-ancestor
15202269|NCT03754647|Micronutrients|micronutrients|mesh-ancestor
15202270|NCT03754647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202271|NCT03754647|Antioxidants|antioxidants|mesh-ancestor
15202272|NCT03754647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202273|NCT03754647|Protective Agents|protective agents|mesh-ancestor
15202274|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
15202275|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224622|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224623|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224624|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224625|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
15224626|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224627|NCT02849990|Prednisone|prednisone|mesh-list
15224628|NCT02849990|Cortisone|cortisone|mesh-list
15224629|NCT02849990|Indomethacin|indomethacin|mesh-list
15224630|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
15224631|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224632|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
15224633|NCT02849990|Hormones|hormones|mesh-ancestor
14295282|NCT00580151|Analgesics|analgesics|mesh-ancestor
14295283|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
14295284|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831466|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
14831467|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
14831468|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14831469|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831470|NCT00950066|Amlodipine|amlodipine|mesh-list
14831471|NCT00950066|Irbesartan|irbesartan|mesh-list
14831472|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14831473|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14831474|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831475|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831476|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831477|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831478|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
14831479|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14831480|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14831481|NCT00950105|Semapimod|semapimod|mesh-list
14831482|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14831483|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831484|NCT00950105|Analgesics|analgesics|mesh-ancestor
14831485|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
14831486|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831487|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295285|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295286|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14295287|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
14295288|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
14295289|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14295290|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14831488|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831489|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831490|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831491|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
14831492|NCT00950196|Amantadine|amantadine|mesh-list
15224634|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224635|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831493|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14831494|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14831495|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
14831496|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831497|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
14831498|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831499|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831500|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831501|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831502|NCT00950196|Analgesics|analgesics|mesh-ancestor
14831503|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
14831504|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831505|NCT00950209|Heparin|heparin|mesh-list
14831506|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
14831507|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14831508|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14831509|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202276|NCT03754543|Iron|iron|mesh-list
15202277|NCT03754543|Trace Elements|trace elements|mesh-ancestor
15202278|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
15202279|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831510|NCT00950222|Imipenem|imipenem|mesh-list
14831511|NCT00950222|Amikacin|amikacin|mesh-list
14831512|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831513|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831514|NCT00950261|Cisplatin|cisplatin|mesh-list
14831515|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831516|NCT00950339|Omeprazole|omeprazole|mesh-list
14831517|NCT00950339|Pantoprazole|pantoprazole|mesh-list
14831518|NCT00950339|Famotidine|famotidine|mesh-list
14831519|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14831520|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831521|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14831522|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831523|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831524|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14831525|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
14831526|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
14831527|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831528|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831529|NCT00950391|Tacrolimus|tacrolimus|mesh-list
14831530|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831531|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
14831532|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831533|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14831534|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831535|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831536|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
14831537|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
14831538|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14831539|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14831540|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831541|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831542|NCT00950404|Urological Agents|urological agents|mesh-ancestor
14831543|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
14831544|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14831545|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831546|NCT00950430|Corticosterone|corticosterone|mesh-list
14831547|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831548|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
14831549|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14831550|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831551|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
14831552|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
14831553|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
14831554|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14831555|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14831556|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831557|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831558|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831559|NCT00950625|Lidocaine|lidocaine|mesh-list
14831560|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
14831561|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
14831562|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202280|NCT03754387|Ceftazidime|ceftazidime|mesh-list
14831563|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202281|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831564|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
14831565|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831566|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14831567|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14831568|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14831569|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831570|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911785|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911786|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
14911787|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911788|NCT01365065|Vorinostat|vorinostat|mesh-list
14911789|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911790|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14911791|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911792|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911793|NCT01365104|Deferoxamine|deferoxamine|mesh-list
14911794|NCT01365104|Siderophores|siderophores|mesh-ancestor
14911795|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14911796|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
14911797|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
14911798|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911799|NCT01365117|Insulin|insulin|mesh-list
14911800|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14911801|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14911802|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911803|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14911804|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14911805|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
14911806|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14911807|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
14911808|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911809|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
14911810|NCT01365260|Protective Agents|protective agents|mesh-ancestor
14911811|NCT01365312|Ethanol|ethanol|mesh-list
14911812|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14911813|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911814|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911815|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911816|NCT01365351|Hormones|hormones|mesh-list
14911817|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14911818|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911819|NCT01365403|Carbamazepine|carbamazepine|mesh-list
14911820|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
14911821|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
14911822|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14911823|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911824|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911825|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14911826|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911827|NCT01365403|Analgesics|analgesics|mesh-ancestor
14911828|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
14911829|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911830|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14911831|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911832|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911833|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14911834|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14911835|NCT01365598|Primaquine|primaquine|mesh-list
14911836|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
14911837|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14911838|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14911839|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911840|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14911841|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14917173|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917174|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
14917175|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917176|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
14917177|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917178|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917179|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917180|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
14831571|NCT00950677|Exenatide|exenatide|mesh-list
14831572|NCT00950677|Pramlintide|pramlintide|mesh-list
14831573|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831574|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831575|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14831576|NCT00950677|Incretins|incretins|mesh-ancestor
14831577|NCT00950677|Hormones|hormones|mesh-ancestor
14831578|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831579|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14831580|NCT00950794|Tulobuterol|tulobuterol|mesh-list
15202282|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202283|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
15202284|NCT03754179|Trametinib|trametinib|mesh-list
15202285|NCT03754179|Dabrafenib|dabrafenib|mesh-list
15202286|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
15202287|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14831581|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14831582|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
14831583|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831584|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831585|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14831586|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
14831587|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14831588|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14831589|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14831590|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14831591|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831592|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831593|NCT00950820|Capecitabine|capecitabine|mesh-list
14831594|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
14831595|NCT00950820|Panitumumab|panitumumab|mesh-list
14831596|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831597|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
14831598|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831599|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831600|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14831601|NCT00950898|Caffeine|caffeine|mesh-list
14831602|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14831603|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831604|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14831605|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831606|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831607|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14831608|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14831609|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
14831610|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831611|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
14831612|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14831613|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
14831614|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14831615|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14831616|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831617|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14831618|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831619|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831620|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14831621|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14831622|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14831623|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
14831624|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831625|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14831626|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14831627|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831628|NCT00951223|Interferons|interferons|mesh-list
14831629|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
14831630|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831631|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
14831632|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831633|NCT00951236|Cortisone|cortisone|mesh-list
14831634|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831635|NCT00951431|Esomeprazole|esomeprazole|mesh-list
15202288|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14831636|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14831637|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202289|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831638|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14831639|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831640|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831641|NCT00951444|Gemcitabine|gemcitabine|mesh-list
14831642|NCT00951444|Carboplatin|carboplatin|mesh-list
14831643|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831644|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831645|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
14831646|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831647|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
15202290|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202291|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202292|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831648|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831649|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831650|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831651|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
14831652|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831653|NCT00951574|Nadroparin|nadroparin|mesh-list
14831654|NCT00951574|Calcium|calcium|mesh-list
14831655|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831656|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831657|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
14831658|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14831659|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14831660|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831661|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
14831662|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
14831663|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14831664|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14831665|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831666|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831667|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14831668|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14831669|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15202293|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202294|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15202295|NCT03754140|Polidocanol|polidocanol|mesh-list
15202296|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15202297|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15202298|NCT03754062|Haloperidol|haloperidol|mesh-list
15202299|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
15202300|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
15202301|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
15202302|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202303|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202304|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202305|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15202306|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15202307|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202308|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14831670|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
14831671|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831672|NCT00951834|Protective Agents|protective agents|mesh-ancestor
14831673|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831674|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14831675|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14831676|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831677|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14831678|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
14831679|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
14831680|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14831681|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15202309|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15202310|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
15202311|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202312|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202313|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15202314|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
15202315|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14911842|NCT01365871|Anesthetics|anesthetics|mesh-list
15202316|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
15202317|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202318|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
15202319|NCT03754010|Protective Agents|protective agents|mesh-ancestor
15202320|NCT03753867|Acitretin|acitretin|mesh-list
15202321|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
15202322|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202323|NCT03753685|Ensartinib|ensartinib|mesh-list
14704175|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14704176|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
14704177|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704178|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14704179|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14704180|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
14704181|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14704182|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14704183|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14704184|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14704185|NCT00409630|Fluticasone|fluticasone|mesh-list
14704186|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704187|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14831682|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831683|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831684|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14831685|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14831686|NCT00952003|Bevacizumab|bevacizumab|mesh-list
14831687|NCT00952003|Docetaxel|docetaxel|mesh-list
14831688|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
14831689|NCT00952003|Irinotecan|irinotecan|mesh-list
14831690|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14831691|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831692|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14831693|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14831694|NCT00952003|Growth Substances|growth substances|mesh-ancestor
14831695|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831696|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
14831697|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
14831698|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
14831699|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
14831700|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831701|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14831702|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14831703|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831704|NCT00952016|Methotrexate|methotrexate|mesh-list
15202324|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202325|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15202326|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202327|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202328|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
15202329|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202330|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202331|NCT03753581|Cytarabine|cytarabine|mesh-list
15202332|NCT03753581|Methotrexate|methotrexate|mesh-list
15202333|NCT03753581|Etoposide|etoposide|mesh-list
15202334|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15202335|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
15202336|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202337|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202338|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
15202339|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202340|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202341|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
15202342|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202343|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15202344|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15202345|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15202346|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831705|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14831706|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
15202347|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15202348|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
15202349|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202350|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202351|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15202352|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202353|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15202354|NCT03753477|Amlodipine|amlodipine|mesh-list
15202355|NCT03753477|Olmesartan|olmesartan|mesh-list
15202356|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15202357|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
15202358|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15202359|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15202360|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14831707|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14831708|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831709|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831710|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
14831711|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831712|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831713|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
14831714|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831715|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14831716|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831717|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
14831718|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831719|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14831720|NCT00952029|Leucovorin|leucovorin|mesh-list
14831721|NCT00952029|Bevacizumab|bevacizumab|mesh-list
14831722|NCT00952029|Fluorouracil|fluorouracil|mesh-list
14831723|NCT00952029|Irinotecan|irinotecan|mesh-list
14831724|NCT00952029|Calcium|calcium|mesh-list
14831725|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
14831726|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14831727|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831728|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14831729|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14831730|NCT00952029|Growth Substances|growth substances|mesh-ancestor
14831731|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831732|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
14831733|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831734|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
14831735|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831736|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831737|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831738|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
14831739|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14831740|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14831741|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831742|NCT00952029|Antidotes|antidotes|mesh-ancestor
14831743|NCT00952029|Protective Agents|protective agents|mesh-ancestor
14831744|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
15202361|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202362|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202363|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15202364|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202365|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
15202366|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15202367|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15202368|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
15202369|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15202370|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15202371|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202372|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15202373|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15202374|NCT03753269|Fasudil|fasudil|mesh-list
15202375|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15202376|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202377|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831745|NCT00952029|Vitamins|vitamins|mesh-ancestor
14831746|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
14831747|NCT00952094|Cinacalcet|cinacalcet|mesh-list
14831748|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831749|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831750|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14831751|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
15202378|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15202379|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202380|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
15202381|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15202382|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202383|NCT03752931|Celiprolol|celiprolol|mesh-list
15202384|NCT03752931|Diltiazem|diltiazem|mesh-list
15202385|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15202386|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15202387|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202388|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202389|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15202390|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202391|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
15202392|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15202393|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
15202394|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
15202395|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202396|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15202397|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15202398|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15202399|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
15202400|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224636|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224637|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224638|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15224639|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224640|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224641|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
15224642|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15224643|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15224644|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295291|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14831752|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831753|NCT00952159|Tramadol|tramadol|mesh-list
14831754|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
14831755|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14831756|NCT00952159|Narcotics|narcotics|mesh-ancestor
14831757|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831758|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831759|NCT00952159|Analgesics|analgesics|mesh-ancestor
14831760|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
14831761|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831762|NCT00952185|Antibodies|antibodies|mesh-list
14831763|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
14831764|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831765|NCT00952302|Iron|iron|mesh-list
14831766|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14831767|NCT00952302|Trace Elements|trace elements|mesh-ancestor
14831768|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
14831769|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831770|NCT00952302|Hematinics|hematinics|mesh-ancestor
14831771|NCT00952432|Carbamazepine|carbamazepine|mesh-list
14831772|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
14831773|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
14831774|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14831775|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831776|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831777|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14831778|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831779|NCT00952432|Analgesics|analgesics|mesh-ancestor
14831780|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
14831781|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831782|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14831783|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831784|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831785|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14831786|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14831787|NCT00952497|Capecitabine|capecitabine|mesh-list
14831788|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831789|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831790|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
14831791|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831792|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
14831793|NCT00952562|Vitamins|vitamins|mesh-ancestor
14831794|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
14831795|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831796|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14831797|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14831798|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
14831799|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14831800|NCT00952575|Antibodies|antibodies|mesh-list
15202401|NCT03752749|Prednisolone|prednisolone|mesh-list
15202402|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202403|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
14831801|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14831802|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
14831803|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
14831804|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831805|NCT00952627|Pycnogenols|pycnogenols|mesh-list
14831806|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14831807|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
14831808|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831809|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
14831810|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831811|NCT00952627|Protective Agents|protective agents|mesh-ancestor
14831812|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14911843|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911844|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911845|NCT01365897|Modafinil|modafinil|mesh-list
14911846|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14911847|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911848|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14911849|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14911850|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14911851|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911852|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
14911853|NCT01365923|Remifentanil|remifentanil|mesh-list
14911854|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14911855|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911856|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911857|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911858|NCT01365923|Analgesics|analgesics|mesh-ancestor
14911859|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
14911860|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911861|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15202404|NCT03752749|Hormones|hormones|mesh-ancestor
15202405|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202406|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202407|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15202408|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911862|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14911863|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14911864|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
14911865|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911866|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911867|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14911868|NCT01365923|Narcotics|narcotics|mesh-ancestor
14911869|NCT01365936|Menotropins|menotropins|mesh-list
14911870|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14911871|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
14911872|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202409|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
15202410|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15202411|NCT03752736|Protective Agents|protective agents|mesh-ancestor
15202412|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202413|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202414|NCT03752658|Tenofovir|tenofovir|mesh-list
15202415|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
15202416|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202417|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15202418|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15202419|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202420|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202421|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15202422|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15202423|NCT03752476|Lactams|lactams|mesh-list
15202424|NCT03752476|beta-Lactams|beta-lactams|mesh-list
15202425|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15202426|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202427|NCT03752437|Heparin|heparin|mesh-list
14831813|NCT00952640|Vitamin A|vitamin a|mesh-list
14831814|NCT00952640|Vitamins|vitamins|mesh-ancestor
14831815|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
14831816|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831817|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
14831818|NCT00952796|Ampicillin|ampicillin|mesh-list
14831819|NCT00952796|Sulbactam|sulbactam|mesh-list
14831820|NCT00952796|Sultamicillin|sultamicillin|mesh-list
14831821|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831822|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831823|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14831824|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14831825|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831826|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831827|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831828|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14831829|NCT00952861|Doxycycline|doxycycline|mesh-list
14831830|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14831831|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831832|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
14831833|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14831834|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14831835|NCT00952913|Lansoprazole|lansoprazole|mesh-list
14831836|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
14831837|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14831838|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202428|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
15202429|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15202430|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15202431|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202432|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
15202433|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15202434|NCT03752398|Ipilimumab|ipilimumab|mesh-list
15202435|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202436|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831839|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15202437|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15202438|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202439|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
15202440|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202441|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202442|NCT03752294|Dabigatran|dabigatran|mesh-list
15202443|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
15202444|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15202445|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
15202446|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202447|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202448|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
15202449|NCT03752229|Diazepam|diazepam|mesh-list
15202450|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15202451|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
15202452|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
15202453|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
14831840|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831841|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831842|NCT00952952|Mesalamine|mesalamine|mesh-list
15224645|NCT02849990|Analgesics|analgesics|mesh-ancestor
15202454|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202455|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202456|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202457|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14831843|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14831844|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14831845|NCT00952952|Analgesics|analgesics|mesh-ancestor
14831846|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
14831847|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831848|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831849|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831850|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14831851|NCT00952978|Omeprazole|omeprazole|mesh-list
14831852|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14831853|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831854|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14831855|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831856|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831857|NCT00952991|Vildagliptin|vildagliptin|mesh-list
14831858|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831859|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831860|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14831861|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
14831862|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831863|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831864|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14831865|NCT00953108|Citalopram|citalopram|mesh-list
14831866|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14831867|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14831868|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831869|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831870|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831871|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
14831872|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831873|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14831874|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
14704188|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
14704189|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704190|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704191|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14704192|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14704193|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202458|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202459|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15202460|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15202461|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15202462|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15202463|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15202464|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15202465|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
15202466|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
15202467|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
15202468|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
15202469|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202470|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202471|NCT03752190|Cosyntropin|cosyntropin|mesh-list
15202472|NCT03752190|Hormones|hormones|mesh-ancestor
14831875|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14831876|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14831877|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14831878|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14831879|NCT00953134|Folic Acid|folic acid|mesh-list
14831880|NCT00953134|Micronutrients|micronutrients|mesh-list
14831881|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
14831882|NCT00953134|Trace Elements|trace elements|mesh-list
14831883|NCT00953134|Hematinics|hematinics|mesh-ancestor
14831884|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
14831885|NCT00953134|Vitamins|vitamins|mesh-ancestor
14831886|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831887|NCT00953303|Dexamethasone|dexamethasone|mesh-list
14831888|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
14831889|NCT00953303|Prednisone|prednisone|mesh-list
14704194|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14704195|NCT00409643|Amlodipine|amlodipine|mesh-list
14704196|NCT00409643|Valsartan|valsartan|mesh-list
14704197|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14831890|NCT00953303|Torsemide|torsemide|mesh-list
14831891|NCT00953303|Dobutamine|dobutamine|mesh-list
14831892|NCT00953303|Dopamine|dopamine|mesh-list
14831893|NCT00953303|Furosemide|furosemide|mesh-list
14831894|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
14831895|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
14831896|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14831897|NCT00953303|BB 1101|bb 1101|mesh-list
14831898|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14831899|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
15202473|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202474|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202475|NCT03752138|Decitabine|decitabine|mesh-list
15202476|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15202477|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
15202478|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202479|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202480|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202481|NCT03752125|Caffeine|caffeine|mesh-list
15202482|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15202483|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202484|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15202485|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202486|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202487|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15202488|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15202489|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
15202490|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202491|NCT03752112|Penicillins|penicillins|mesh-list
15202492|NCT03752112|Cefixime|cefixime|mesh-list
15202493|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
15202494|NCT03752112|Penicillin G|penicillin g|mesh-list
15202495|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
15202496|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15202497|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202498|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
15202499|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202500|NCT03751761|Paclitaxel|paclitaxel|mesh-list
15202501|NCT03751761|Durvalumab|durvalumab|mesh-list
15202502|NCT03751761|Tremelimumab|tremelimumab|mesh-list
15202503|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15202504|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202505|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
15202506|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
15202507|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
15202508|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202509|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202510|NCT03751514|Azithromycin|azithromycin|mesh-list
15202511|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15202512|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202513|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15202514|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15202515|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15202516|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202517|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202518|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15202519|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15202520|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15202521|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
15202522|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202523|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704198|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14704199|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704200|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704201|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14704202|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704203|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
14704204|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14704205|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14704206|NCT00409656|Basiliximab|basiliximab|mesh-list
14704207|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704208|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
14831900|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
14831901|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831902|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831903|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831904|NCT00953303|Hormones|hormones|mesh-ancestor
14831905|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831906|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14831907|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831908|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
15202524|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15202525|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15202526|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
15202527|NCT03751436|Venetoclax|venetoclax|mesh-list
15202528|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202529|NCT03751423|Fentanyl|fentanyl|mesh-list
14704209|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704210|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
14704211|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14831909|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831910|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831911|NCT00953303|Diuretics|diuretics|mesh-ancestor
14831912|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
14831913|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14831914|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14831915|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
14831916|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14831917|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
14831918|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15202530|NCT03751423|Ketamine|ketamine|mesh-list
15202531|NCT03751423|Morphine|morphine|mesh-list
15202532|NCT03751423|Analgesics|analgesics|mesh-ancestor
15202533|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
15202534|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202535|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202536|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15202537|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15202538|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
15202539|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
15202540|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202541|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15202542|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15202543|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202544|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831919|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14831920|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14831921|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
14831922|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14831923|NCT00953303|Protective Agents|protective agents|mesh-ancestor
14831924|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
14831925|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14831926|NCT00953355|Metformin|metformin|mesh-list
14831927|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831928|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831929|NCT00953381|Omeprazole|omeprazole|mesh-list
14831930|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14831931|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831932|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14704212|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
14704213|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704214|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704215|NCT00409721|Memantine|memantine|mesh-list
14704216|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14831933|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831934|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202545|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704217|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15202546|NCT03751423|Narcotics|narcotics|mesh-ancestor
14704218|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
14831935|NCT00953394|Octreotide|octreotide|mesh-list
14831936|NCT00953394|Fluorouracil|fluorouracil|mesh-list
14831937|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831938|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14831939|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831940|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
14831941|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831942|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831943|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14831944|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
14831945|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831946|NCT00953459|Sunitinib|sunitinib|mesh-list
14831947|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14831948|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831949|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14831950|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15202547|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15202548|NCT03751358|Anesthetics|anesthetics|mesh-list
15202549|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
15202550|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202551|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202552|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
15202553|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202554|NCT03751332|Tacrolimus|tacrolimus|mesh-list
14831951|NCT00953459|Growth Substances|growth substances|mesh-ancestor
14831952|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831953|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
14831954|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14831955|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14831956|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831957|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14831958|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14831959|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
14831960|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831961|NCT00953498|Pioglitazone|pioglitazone|mesh-list
14831962|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
14831963|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14831964|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831965|NCT00953537|Capecitabine|capecitabine|mesh-list
14831966|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14831967|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
14831968|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831969|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14831970|NCT00953550|Rocuronium|rocuronium|mesh-list
14831971|NCT00953550|Succinylcholine|succinylcholine|mesh-list
14831972|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14831973|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14831974|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14831975|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14831976|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831977|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14831978|NCT00953589|Ribavirin|ribavirin|mesh-list
14831979|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
14831980|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14831981|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
14831982|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14831983|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14831984|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14831985|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831986|NCT00953641|Misoprostol|misoprostol|mesh-list
14831987|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14831988|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
14831989|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14831990|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831991|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15202555|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202556|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
15202557|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202558|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15202559|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202560|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202561|NCT03751228|BMS-986165|bms-986165|mesh-list
14831992|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14831993|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
14831994|NCT00953771|Danazol|danazol|mesh-list
14831995|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14831996|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
14831997|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14831998|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14831999|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14832000|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14832001|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832002|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832003|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
14832004|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832005|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832006|NCT00954005|Gemcitabine|gemcitabine|mesh-list
14832007|NCT00954005|Rituximab|rituximab|mesh-list
14832008|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
14832009|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832010|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832011|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
14832012|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832013|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14832014|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14832015|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
15202562|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202563|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15202564|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202565|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202566|NCT03751202|Fluticasone|fluticasone|mesh-list
15202567|NCT03751202|Xhance|xhance|mesh-list
15202568|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15202569|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15202570|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14832016|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832017|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
14832018|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832019|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832020|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832021|NCT00954096|Nicotine|nicotine|mesh-list
14832022|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14832023|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
14832024|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832025|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832026|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14832027|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14832028|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
14832029|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832030|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832031|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
14832032|NCT00954135|Sorafenib|sorafenib|mesh-list
14832033|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832034|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
14832035|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832036|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14832037|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15202571|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15202572|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
15202573|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202574|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202575|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15202576|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
15202577|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202578|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15202579|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15202580|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15202581|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14832038|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
14832039|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832040|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832041|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14832042|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14832043|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832044|NCT00954200|Ibuprofen|ibuprofen|mesh-list
14832045|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14832046|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14832047|NCT00954200|Analgesics|analgesics|mesh-ancestor
15202582|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
15202583|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202584|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202585|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
15202586|NCT03751202|Hormones|hormones|mesh-ancestor
15202587|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202588|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
15202589|NCT03751176|Leucovorin|leucovorin|mesh-list
15202590|NCT03751176|Folic Acid|folic acid|mesh-list
15202591|NCT03751176|Fluorouracil|fluorouracil|mesh-list
15202592|NCT03751176|Irinotecan|irinotecan|mesh-list
15202593|NCT03751176|Panitumumab|panitumumab|mesh-list
15202594|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
15202595|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
15202596|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202597|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15202598|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202599|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202600|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
15202601|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202602|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15202603|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15202604|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202605|NCT03751176|Antidotes|antidotes|mesh-ancestor
15202606|NCT03751176|Protective Agents|protective agents|mesh-ancestor
15202607|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
15202608|NCT03751176|Vitamins|vitamins|mesh-ancestor
15202609|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
15202610|NCT03751176|Hematinics|hematinics|mesh-ancestor
15202611|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15202612|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
15202613|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
14295292|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
14295293|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295294|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704219|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704220|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704221|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704222|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14704223|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14704224|NCT00409760|Amlodipine|amlodipine|mesh-list
14704225|NCT00409760|Valsartan|valsartan|mesh-list
14704226|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14704227|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14704228|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704229|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704230|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14704231|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704232|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
14704233|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15202614|NCT03751163|Hydroquinone|hydroquinone|mesh-list
15202615|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15202616|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14832048|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
14832049|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832050|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832051|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14832052|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202617|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202618|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
15202619|NCT03751163|Coagulants|coagulants|mesh-ancestor
15202620|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15202621|NCT03751163|Protective Agents|protective agents|mesh-ancestor
15202622|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202623|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202624|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
15202625|NCT03751111|Naloxone|naloxone|mesh-list
15202626|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15202627|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202628|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
15202629|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224646|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
15224647|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224648|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224649|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
15224650|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
15224651|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15224652|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15224653|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
14832053|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14832054|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832055|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832056|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
14832057|NCT00954252|Analgesics|analgesics|mesh-ancestor
14832058|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
14832059|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224654|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224655|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224656|NCT02817347|Tazobactam|tazobactam|mesh-list
15224657|NCT02817347|Piperacillin|piperacillin|mesh-list
15224658|NCT02817347|Dexamethasone|dexamethasone|mesh-list
15224659|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
15224660|NCT02817347|BB 1101|bb 1101|mesh-list
15224661|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224662|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
15224663|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
14832060|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832061|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14832062|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14832063|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14832064|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14832065|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14832066|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832067|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832068|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14832069|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14832070|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832071|NCT00954278|Sorafenib|sorafenib|mesh-list
14832072|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832073|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15224664|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704234|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14704235|NCT00409851|Amlodipine|amlodipine|mesh-list
14832074|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704236|NCT00409851|Valsartan|valsartan|mesh-list
14704237|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14704238|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14704239|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704240|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704241|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14704242|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832075|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832076|NCT00954304|Loperamide|loperamide|mesh-list
14832077|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
15224665|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224666|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832078|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832079|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
14832080|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
14832081|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14832082|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14832083|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832084|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
14832085|NCT00954395|Coagulants|coagulants|mesh-ancestor
14832086|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
14704243|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
14704244|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14704245|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14704246|NCT00409890|Scopolamine|scopolamine|mesh-list
14704247|NCT00409890|Bromides|bromides|mesh-list
14704248|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14704249|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
14704250|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14704251|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
14704252|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
14704253|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832087|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
14832088|NCT00954486|Hematinics|hematinics|mesh-ancestor
14832089|NCT00954525|Ascorbic Acid|ascorbic acid|mesh-list
14832090|NCT00954525|Gemcitabine|gemcitabine|mesh-list
14832091|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14832092|NCT00954525|Vitamins|vitamins|mesh-ancestor
14832093|NCT00954525|Micronutrients|micronutrients|mesh-ancestor
14832094|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832095|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14832096|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
14832097|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832098|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832099|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
14832100|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832101|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832102|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832103|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
14832104|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14832105|NCT00954525|Antioxidants|antioxidants|mesh-ancestor
14832106|NCT00954525|Protective Agents|protective agents|mesh-ancestor
14832107|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14832108|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14832109|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832110|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832111|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14832112|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
14832113|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832114|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911873|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911874|NCT01366001|Buprenorphine|buprenorphine|mesh-list
14911875|NCT01366001|ALKS-33|alks-33|mesh-list
14911876|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14911877|NCT01366001|Narcotics|narcotics|mesh-ancestor
14911878|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911879|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911880|NCT01366001|Analgesics|analgesics|mesh-ancestor
14911881|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
14911882|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911883|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14911884|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
15202630|NCT03751059|Dexamethasone|dexamethasone|mesh-list
15202631|NCT03751059|Bromfenac|bromfenac|mesh-list
15202632|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202633|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
15202634|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
15202635|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202636|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202637|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202638|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
15202639|NCT03751059|Hormones|hormones|mesh-ancestor
15202640|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202641|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15202642|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202643|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14704254|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911885|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911886|NCT01366183|Paclitaxel|paclitaxel|mesh-list
14832115|NCT00954603|Haloperidol|haloperidol|mesh-list
14832116|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14832117|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
14832118|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
14832119|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832120|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14832121|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14832122|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832123|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832124|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
15202644|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15202645|NCT03751059|Analgesics|analgesics|mesh-ancestor
15202646|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
15202647|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202648|NCT03750916|Docetaxel|docetaxel|mesh-list
15202649|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202650|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
15202651|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
15202652|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
15202653|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202654|NCT03750773|Gabapentin|gabapentin|mesh-list
15202655|NCT03750773|Analgesics|analgesics|mesh-ancestor
15202656|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
15202657|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832125|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
14832126|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832127|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832128|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14832129|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
14832130|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832131|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832132|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14832133|NCT00954642|Paclitaxel|paclitaxel|mesh-list
14832134|NCT00954642|Bevacizumab|bevacizumab|mesh-list
14832135|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14832136|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832137|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
14832138|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
14832139|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
14832140|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832141|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832142|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14832143|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14832144|NCT00954642|Growth Substances|growth substances|mesh-ancestor
14832145|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832146|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
14832147|NCT00954785|Diclofenac|diclofenac|mesh-list
14832148|NCT00954785|Etoricoxib|etoricoxib|mesh-list
14832149|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14832150|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14832151|NCT00954785|Analgesics|analgesics|mesh-ancestor
14832152|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
14832153|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832154|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832155|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14832156|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14832157|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14832158|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832159|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832160|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14832161|NCT00954798|Vaccines|vaccines|mesh-list
14832162|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
14832163|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832164|NCT00954811|Progesterone|progesterone|mesh-list
14832165|NCT00954811|Progestins|progestins|mesh-ancestor
14832166|NCT00954811|Hormones|hormones|mesh-ancestor
14832167|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202658|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202659|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
15202660|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15202661|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14832168|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202662|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202663|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15202664|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15224667|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
14832169|NCT00954889|Tamsulosin|tamsulosin|mesh-list
14832170|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14832171|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14832172|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14832173|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
14832174|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832175|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832176|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832177|NCT00954889|Urological Agents|urological agents|mesh-ancestor
14832178|NCT00954902|Antioxidants|antioxidants|mesh-list
14832179|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832180|NCT00954902|Protective Agents|protective agents|mesh-ancestor
14832181|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832182|NCT00955045|Istradefylline|istradefylline|mesh-list
14832183|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14832184|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14832185|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14832186|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
14832187|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832188|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832189|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832190|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14832191|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832192|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14832193|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832194|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832195|NCT00955162|Buprenorphine|buprenorphine|mesh-list
14832196|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14832197|NCT00955162|Naloxone|naloxone|mesh-list
14832198|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14832199|NCT00955162|Narcotics|narcotics|mesh-ancestor
14832200|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832201|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832202|NCT00955162|Analgesics|analgesics|mesh-ancestor
14832203|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
14832204|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832205|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14832206|NCT00955214|Paclitaxel|paclitaxel|mesh-list
14832207|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14832208|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832209|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
14832210|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
14832211|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
14832212|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832213|NCT00955227|Ezetimibe|ezetimibe|mesh-list
14832214|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14832215|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14832216|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
14832217|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832218|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14832219|NCT00955240|Fluorouracil|fluorouracil|mesh-list
14832220|NCT00955240|Cetuximab|cetuximab|mesh-list
14832221|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832222|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
14832223|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202665|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15202666|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202667|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832224|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14832225|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832226|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
14832227|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832228|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832229|NCT00955318|Apomorphine|apomorphine|mesh-list
14832230|NCT00955318|Emetics|emetics|mesh-ancestor
15202668|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
15202669|NCT03750760|Atorvastatin|atorvastatin|mesh-list
15202670|NCT03750760|Ezetimibe|ezetimibe|mesh-list
15202671|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15202672|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15202673|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
15202674|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224668|NCT02817347|Hormones|hormones|mesh-ancestor
14911887|NCT01366183|Carboplatin|carboplatin|mesh-list
14832231|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832232|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
14832233|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832234|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832235|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
14832236|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
14832237|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832238|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832239|NCT00955526|Istradefylline|istradefylline|mesh-list
14832240|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14832241|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14832242|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14832243|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
14832244|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832245|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832246|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832247|NCT00955604|Rasagiline|rasagiline|mesh-list
14832248|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
14832249|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832250|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14832251|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832252|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832253|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14832254|NCT00955604|Protective Agents|protective agents|mesh-ancestor
14832255|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832256|NCT00955630|Ranibizumab|ranibizumab|mesh-list
14832257|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14832258|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14832259|NCT00955630|Growth Substances|growth substances|mesh-ancestor
14832260|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832261|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
14832262|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832263|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14832264|NCT00955695|Gefitinib|gefitinib|mesh-list
14832265|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832266|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14832267|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832268|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832269|NCT00955773|Everolimus|everolimus|mesh-list
14832270|NCT00955773|Trametinib|trametinib|mesh-list
14832271|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832272|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832273|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
14832274|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832275|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14832276|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832277|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202675|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15202676|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15202677|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202678|NCT03750721|Rifampin|rifampin|mesh-list
15202679|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15202680|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
15202681|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15202682|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202683|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
15202684|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15202685|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202686|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704255|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14704256|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
14704257|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14704258|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704259|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704260|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704261|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14704262|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
14704263|NCT00409903|Eprosartan|eprosartan|mesh-list
14704264|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14704265|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14704266|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14832278|NCT00955851|Vaccines|vaccines|mesh-list
14832279|NCT00955851|Immunologic Factors|immunologic factors|mesh-ancestor
14832280|NCT00955851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832281|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
14832282|NCT00955890|Razoxane|razoxane|mesh-list
14832283|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832284|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14832285|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14832286|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14832287|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832288|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832289|NCT00955890|Protective Agents|protective agents|mesh-ancestor
14832290|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832291|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14832292|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14832293|NCT00956007|Cetuximab|cetuximab|mesh-list
14832294|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832295|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832296|NCT00956046|Vaccines|vaccines|mesh-list
15202687|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15202688|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15202689|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15202690|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15202691|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15202692|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15202693|NCT03750669|Folic Acid|folic acid|mesh-list
15202694|NCT03750669|Gemcitabine|gemcitabine|mesh-list
15202695|NCT03750669|Paclitaxel|paclitaxel|mesh-list
15202696|NCT03750669|Fluorouracil|fluorouracil|mesh-list
15202697|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
15202698|NCT03750669|Irinotecan|irinotecan|mesh-list
15202699|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15202700|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202701|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
15202702|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
15202703|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
15202704|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202705|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15202706|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
15202707|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
15202708|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202709|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832297|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
14832298|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832299|NCT00956059|Prednisone|prednisone|mesh-list
14832300|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14832301|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
14832302|NCT00956059|Hormones|hormones|mesh-ancestor
14832303|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832304|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832305|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14832306|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832307|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
14832308|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832309|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14832310|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832311|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832312|NCT00956098|Oltipraz|oltipraz|mesh-list
14832313|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
14832314|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832315|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
14832316|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14832317|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
14832318|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14832319|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14832320|NCT00956098|Protective Agents|protective agents|mesh-ancestor
14832321|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832322|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832323|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14832324|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14832325|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832326|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832327|NCT00956111|Vaccines|vaccines|mesh-list
15202710|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202711|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
14832328|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
14832329|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832330|NCT00956150|Rifaximin|rifaximin|mesh-list
14832331|NCT00956150|Lactulose|lactulose|mesh-list
14832332|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14832333|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832334|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832335|NCT00956163|Diphosphonates|diphosphonates|mesh-list
14832336|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
14832337|NCT00956163|Listerine|listerine|mesh-list
14832338|NCT00956163|Fluorides|fluorides|mesh-list
14832339|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
14832340|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
14832341|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
14832342|NCT00956163|Protective Agents|protective agents|mesh-ancestor
14832343|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832344|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14832345|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832346|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14832347|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832348|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14832349|NCT00956176|Cidofovir|cidofovir|mesh-list
14832350|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
14832351|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832352|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832353|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832354|NCT00956189|Aripiprazole|aripiprazole|mesh-list
14832355|NCT00956189|Amisulpride|amisulpride|mesh-list
14704267|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704268|NCT00409942|Torsemide|torsemide|mesh-list
14704269|NCT00409942|Furosemide|furosemide|mesh-list
14704270|NCT00409942|Diuretics|diuretics|mesh-ancestor
14704271|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
14704272|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704273|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14704274|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704275|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704276|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14832356|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
14832357|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832358|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14832359|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14832360|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832361|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832362|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
15202712|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202713|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15202714|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14704277|NCT00409981|Paclitaxel|paclitaxel|mesh-list
14704278|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14704279|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704280|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
14832363|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
14832364|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832365|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832366|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14832367|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14832368|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
14832369|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14832370|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14832371|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14832372|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14832373|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14832374|NCT00956202|Vaccines|vaccines|mesh-list
14832375|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
14832376|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832377|NCT00956215|Aprepitant|aprepitant|mesh-list
14832378|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
14832379|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
14832380|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
14832381|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832382|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832383|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832384|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15202715|NCT03750669|Hematinics|hematinics|mesh-ancestor
15202716|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
15202717|NCT03750669|Vitamins|vitamins|mesh-ancestor
15202718|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
14832385|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832386|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832387|NCT00956267|Letrozole|letrozole|mesh-list
14832388|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832389|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14832390|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14832391|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832392|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832393|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14832394|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
14832395|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832396|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832397|NCT00956306|Udenafil|udenafil|mesh-list
14832398|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14832399|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14832400|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832401|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832402|NCT00956319|Estazolam|estazolam|mesh-list
14832403|NCT00956319|Zolpidem|zolpidem|mesh-list
14832404|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14832405|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14832406|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832407|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832408|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14832409|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
14832410|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
15202719|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
15202720|NCT03750656|Tamsulosin|tamsulosin|mesh-list
15202721|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15202722|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15202723|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15202724|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
15202725|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832411|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832412|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832413|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
14832414|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14832415|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14832416|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832417|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
14911888|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14911889|NCT01366183|Lenograstim|lenograstim|mesh-list
14911890|NCT01366183|Sargramostim|sargramostim|mesh-list
14911891|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14911892|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911893|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14911894|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14911895|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14911896|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911897|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14911898|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
14911899|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911900|NCT01366235|Chloroquine|chloroquine|mesh-list
14911901|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14911902|NCT01366235|Amebicides|amebicides|mesh-ancestor
14911903|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14911904|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14911905|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911906|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
14911907|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14911908|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14911909|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911910|NCT01366235|Analgesics|analgesics|mesh-ancestor
14911911|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
14911912|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911913|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911914|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14911915|NCT01366235|Filaricides|filaricides|mesh-ancestor
14911916|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
14911917|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
15202726|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202727|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911918|NCT01366300|Lidocaine|lidocaine|mesh-list
15202728|NCT03750656|Urological Agents|urological agents|mesh-ancestor
15202729|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15202730|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15202731|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15202732|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
15202733|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202734|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15202735|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
15202736|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
15202737|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
15202738|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15202739|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15202740|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
15202741|NCT03750383|Cyclosporine|cyclosporine|mesh-list
15202742|NCT03750383|Prednisone|prednisone|mesh-list
15202743|NCT03750383|Cyclosporins|cyclosporins|mesh-list
15202744|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202745|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
15202746|NCT03750383|Hormones|hormones|mesh-ancestor
15202747|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202748|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704281|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
14704282|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
14704283|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704284|NCT00409994|Sirolimus|sirolimus|mesh-list
14704285|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14704286|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832418|NCT00956397|Rifaximin|rifaximin|mesh-list
14832419|NCT00956397|Lactulose|lactulose|mesh-list
14832420|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14832421|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832422|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832423|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14832424|NCT00956436|Sorafenib|sorafenib|mesh-list
14832425|NCT00956436|Liver Extracts|liver extracts|mesh-list
14832426|NCT00956436|Antibodies|antibodies|mesh-list
14832427|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
14832428|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14832429|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
14832430|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832431|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832432|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14832433|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832434|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832435|NCT00956436|Hematinics|hematinics|mesh-ancestor
14832436|NCT00956462|Dexamethasone|dexamethasone|mesh-list
14832437|NCT00956462|Ketorolac|ketorolac|mesh-list
14832438|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15202749|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704287|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14704288|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704289|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
14704290|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704291|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
14704292|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704293|NCT00410033|Insulin|insulin|mesh-list
14704294|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14704295|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
14704296|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
14704297|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
14704298|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
14704299|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14704300|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202750|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704301|NCT00410215|Bisacodyl|bisacodyl|mesh-list
14704302|NCT00410215|Cathartics|cathartics|mesh-ancestor
14832439|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202751|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202752|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202753|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832440|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
14832441|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
14832442|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832443|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832444|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832445|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
14832446|NCT00956462|Hormones|hormones|mesh-ancestor
14832447|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832448|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14832449|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832450|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14832451|NCT00956462|Analgesics|analgesics|mesh-ancestor
14832452|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
14832453|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14832454|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14832455|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832456|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832457|NCT00956644|Amlodipine|amlodipine|mesh-list
14832458|NCT00956644|Irbesartan|irbesartan|mesh-list
14832459|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15202754|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
15202755|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
15202756|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202757|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202758|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202759|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15202760|NCT03750136|Furosemide|furosemide|mesh-list
14832460|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14832461|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14832462|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832463|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14832464|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832465|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
14832466|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14832467|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14832468|NCT00956696|Topiramate|topiramate|mesh-list
14832469|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
14832470|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14832471|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832472|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
14832473|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
14832474|NCT00956748|Dexamethasone|dexamethasone|mesh-list
14832475|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14832476|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
14832477|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
14832478|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832479|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832480|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832481|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
14832482|NCT00956748|Hormones|hormones|mesh-ancestor
15202761|NCT03750136|Diuretics|diuretics|mesh-ancestor
15202762|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
15202763|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202764|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14832483|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832484|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14832485|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832486|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832487|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832488|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
14832489|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832490|NCT00956748|Expectorants|expectorants|mesh-ancestor
14832491|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14832492|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14832493|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
14832494|NCT00956748|Protective Agents|protective agents|mesh-ancestor
14832495|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14832496|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14832497|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14832498|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15202765|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202766|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202767|NCT03750071|Avelumab|avelumab|mesh-list
15202768|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295295|NCT00580229|Prednisone|prednisone|mesh-list
14832499|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14832500|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
14832501|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14832502|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832503|NCT00956982|Interferons|interferons|mesh-list
14832504|NCT00956982|Ribavirin|ribavirin|mesh-list
14832505|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
14832506|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
14832507|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14832508|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832509|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
14832510|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832511|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
14832512|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832513|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
14832514|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832515|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14295296|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704303|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832516|NCT00957060|Glimepiride|glimepiride|mesh-list
14704304|NCT00410215|Laxatives|laxatives|mesh-ancestor
14832517|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14832518|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832519|NCT00957060|Incretins|incretins|mesh-ancestor
14832520|NCT00957060|Hormones|hormones|mesh-ancestor
14832521|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832522|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14832523|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
14832524|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832525|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832526|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14832527|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832528|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
14832529|NCT00957125|Bevacizumab|bevacizumab|mesh-list
14832530|NCT00957125|Docetaxel|docetaxel|mesh-list
14832531|NCT00957125|Epirubicin|epirubicin|mesh-list
14832532|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832533|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832534|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14832535|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14832536|NCT00957125|Growth Substances|growth substances|mesh-ancestor
14832537|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832538|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
14832539|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14832540|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14832541|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14832542|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832543|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14832544|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14832545|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14832546|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832547|NCT00957177|Pregabalin|pregabalin|mesh-list
14832548|NCT00957177|Analgesics|analgesics|mesh-ancestor
14832549|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
14832550|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832551|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832552|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
14832553|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14832554|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704305|NCT00410254|Midazolam|midazolam|mesh-list
14704306|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14704307|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14704308|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704309|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704310|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14704311|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14704312|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14704313|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14832555|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911919|NCT01366300|Propofol|propofol|mesh-list
14295297|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
14832556|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14832557|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14832558|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14832559|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832560|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832561|NCT00957190|Timolol|timolol|mesh-list
14832562|NCT00957190|Dorzolamide|dorzolamide|mesh-list
14832563|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14832564|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14832565|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14832566|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832567|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832568|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832569|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14832570|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14832571|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14832572|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832573|NCT00957203|Istradefylline|istradefylline|mesh-list
14832574|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14832575|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14832576|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14832577|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
14832578|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832579|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832580|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832581|NCT00957216|Ubiquinone|ubiquinone|mesh-list
14832582|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
14832583|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
14832584|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832585|NCT00957216|Vitamins|vitamins|mesh-ancestor
14832586|NCT00957320|Sirolimus|sirolimus|mesh-list
14832587|NCT00957320|Asparaginase|asparaginase|mesh-list
14832588|NCT00957320|Pegaspargase|pegaspargase|mesh-list
14832589|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14832590|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832591|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14832592|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832593|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
14832594|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832595|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
14832596|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832597|NCT00957346|Misoprostol|misoprostol|mesh-list
14832598|NCT00957346|Mifepristone|mifepristone|mesh-list
15202769|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704314|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
14704315|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
14832599|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14832600|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
14832601|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14832602|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832603|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14832604|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14832605|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
14832606|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14832607|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14832608|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14832609|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14704316|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
14704317|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
14704318|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704319|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704320|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
14704321|NCT00410306|Testosterone|testosterone|mesh-list
14704322|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
14704323|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
14704324|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14704325|NCT00410306|Androgens|androgens|mesh-ancestor
14704326|NCT00410306|Hormones|hormones|mesh-ancestor
14704327|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704328|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832610|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
14832611|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14832612|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15202770|NCT03749915|Tetracaine|tetracaine|mesh-list
15202771|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
15202772|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
15202773|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202774|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202775|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
15202776|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202777|NCT03749902|Misoprostol|misoprostol|mesh-list
15202778|NCT03749902|Oxytocin|oxytocin|mesh-list
15202779|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
15202780|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202781|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202782|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15202783|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
14295298|NCT00580229|Hormones|hormones|mesh-ancestor
14295299|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295300|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295301|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704329|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704330|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704331|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
14704332|NCT00410345|Mifepristone|mifepristone|mesh-list
14704333|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14704334|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
14704335|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14704336|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704337|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14704338|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14704339|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14704340|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
14704341|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14704342|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14704343|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
14704344|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704345|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
14704346|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14704347|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14704348|NCT00410371|Lamotrigine|lamotrigine|mesh-list
14704349|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
14704350|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14704351|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704352|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704353|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14704354|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704355|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14704356|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14704357|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704358|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14704359|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14704360|NCT00410449|Tocopherols|tocopherols|mesh-list
14704361|NCT00410449|Vitamin E|vitamin e|mesh-list
14704362|NCT00410449|Tocotrienols|tocotrienols|mesh-list
14704363|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
14704364|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
14704365|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704366|NCT00410449|Protective Agents|protective agents|mesh-ancestor
14704367|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704368|NCT00410449|Vitamins|vitamins|mesh-ancestor
14704369|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
14704370|NCT00410462|Doxorubicin|doxorubicin|mesh-list
14704371|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14704372|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14832613|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
14832614|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832615|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
14832616|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14832617|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14832618|NCT00957385|Lenalidomide|lenalidomide|mesh-list
14832619|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
14832620|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832621|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14832622|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14832623|NCT00957385|Growth Substances|growth substances|mesh-ancestor
14832624|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
14832625|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832626|NCT00957411|Cetuximab|cetuximab|mesh-list
14832627|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832628|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832629|NCT00957554|Amlodipine|amlodipine|mesh-list
14832630|NCT00957554|Irbesartan|irbesartan|mesh-list
14832631|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14832632|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14832633|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14832634|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832635|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14832636|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832637|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
14832638|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14832639|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14832640|NCT00957866|Interferons|interferons|mesh-list
14832641|NCT00957866|Ribavirin|ribavirin|mesh-list
14832642|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832643|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
14832644|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832645|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
14832646|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832647|NCT00957879|Calcitriol|calcitriol|mesh-list
14832648|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
14832649|NCT00957879|Vitamin D|vitamin d|mesh-list
14704373|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704374|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14704375|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14704376|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704377|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704378|NCT00410527|Meropenem|meropenem|mesh-list
14704379|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14704380|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704381|NCT00410540|Morphine|morphine|mesh-list
14704382|NCT00410540|Hydromorphone|hydromorphone|mesh-list
14704383|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704384|NCT00410540|Narcotics|narcotics|mesh-ancestor
14704385|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704386|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704387|NCT00410540|Analgesics|analgesics|mesh-ancestor
14704388|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
14704389|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704390|NCT00410553|Gemcitabine|gemcitabine|mesh-list
14704391|NCT00410553|Halichondrin B|halichondrin b|mesh-list
14704392|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704393|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
14704394|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704395|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704396|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
14704397|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704398|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704399|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704400|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
14704401|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704402|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
14704403|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
14704404|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
14704405|NCT00410592|Esomeprazole|esomeprazole|mesh-list
14704406|NCT00410592|Pantoprazole|pantoprazole|mesh-list
14704407|NCT00410592|Lansoprazole|lansoprazole|mesh-list
14704408|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
14704409|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14704410|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14704411|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15202784|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15202785|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202786|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
15202787|NCT03749850|Doxorubicin|doxorubicin|mesh-list
15202788|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15202789|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202790|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
15202791|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202792|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202793|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15202794|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
15202795|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202796|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202797|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15202798|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15202799|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15202800|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15202801|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202802|NCT03749733|Megestrol|megestrol|mesh-list
15202803|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15202804|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15202805|NCT03749733|Estradiol|estradiol|mesh-list
15202806|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15202807|NCT03749733|Estrogens|estrogens|mesh-ancestor
14832650|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14832651|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832652|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14832653|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14832654|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832655|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14832656|NCT00957879|Vitamins|vitamins|mesh-ancestor
14704412|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704413|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704414|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
14832657|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
14832658|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14832659|NCT00958022|Carboplatin|carboplatin|mesh-list
14832660|NCT00958022|Etoposide|etoposide|mesh-list
14832661|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
15202808|NCT03749733|Hormones|hormones|mesh-ancestor
15202809|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704415|NCT00410631|Melphalan|melphalan|mesh-list
14704416|NCT00410631|Ifosfamide|ifosfamide|mesh-list
15202810|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202811|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15202812|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
15202813|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202814|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15202815|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15202816|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15202817|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15202818|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15202819|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202820|NCT03749642|Gabapentin|gabapentin|mesh-list
15202821|NCT03749642|Trazodone|trazodone|mesh-list
15202822|NCT03749642|Analgesics|analgesics|mesh-ancestor
15202823|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
15202824|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704417|NCT00410631|Dacarbazine|dacarbazine|mesh-list
14704418|NCT00410631|Carboplatin|carboplatin|mesh-list
14704419|NCT00410631|Doxorubicin|doxorubicin|mesh-list
14704420|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14704421|NCT00410631|Etoposide|etoposide|mesh-list
15202825|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704422|NCT00410631|Vincristine|vincristine|mesh-list
14704423|NCT00410631|Topotecan|topotecan|mesh-list
15202826|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
14704424|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
14704425|NCT00410631|Vindesine|vindesine|mesh-list
14704426|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14704427|NCT00410631|Isotretinoin|isotretinoin|mesh-list
14832662|NCT00958022|Panobinostat|panobinostat|mesh-list
14832663|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
14832664|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832665|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14832666|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14832667|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14832668|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832669|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832670|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15202827|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15202828|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15202829|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202830|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832671|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
14832672|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
14832673|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14832674|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14832675|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14832676|NCT00958100|Tenofovir|tenofovir|mesh-list
14832677|NCT00958100|Lamivudine|lamivudine|mesh-list
14832678|NCT00958100|Emtricitabine|emtricitabine|mesh-list
14832679|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
14832680|NCT00958100|Abacavir|abacavir|mesh-list
14832681|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
14832682|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
14832683|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832684|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14832685|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14832686|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832687|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832688|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14832689|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14832690|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14832691|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14832692|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
14832693|NCT00958139|Permethrin|permethrin|mesh-list
14832694|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832695|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832696|NCT00958204|Fluoxetine|fluoxetine|mesh-list
15202831|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15202832|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15202833|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202834|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202835|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
14704428|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704429|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
14704430|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704431|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704432|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14704433|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
14704434|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704435|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704436|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14704437|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14704438|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14704439|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14704440|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704441|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14704442|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
14704443|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
14704444|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
14704445|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14704446|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14704447|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14704448|NCT00410644|Hydromorphone|hydromorphone|mesh-list
14704449|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704450|NCT00410644|Narcotics|narcotics|mesh-ancestor
14704451|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704452|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704453|NCT00410644|Analgesics|analgesics|mesh-ancestor
14704454|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
15202836|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15202837|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15202838|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202839|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
15202840|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15202841|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
15202842|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
14832697|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14832698|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14832699|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202843|NCT03749590|Analgesics|analgesics|mesh-ancestor
14704455|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704456|NCT00410657|Prednisone|prednisone|mesh-list
14704457|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
14832700|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832701|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832702|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
14832703|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832704|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14832705|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
14832706|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832707|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14832708|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14832709|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832710|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14832711|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14832712|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832713|NCT00958269|Incretins|incretins|mesh-ancestor
14832714|NCT00958269|Hormones|hormones|mesh-ancestor
14832715|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832716|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14832717|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
14832718|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832719|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832720|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14832721|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14832722|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832723|NCT00958386|Irinotecan|irinotecan|mesh-list
14832724|NCT00958386|Panitumumab|panitumumab|mesh-list
14832725|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14832726|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14832727|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832728|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832729|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832730|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832731|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
14832732|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15202844|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
14704458|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14704459|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14704460|NCT00410657|Prednisolone|prednisolone|mesh-list
14704461|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
14704462|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
14704463|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14704464|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
14704465|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704466|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
14704467|NCT00410657|Hormones|hormones|mesh-ancestor
14704468|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704469|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704470|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704471|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704472|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
14704473|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
14704474|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704475|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14704476|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14704477|NCT00410657|Protective Agents|protective agents|mesh-ancestor
14704478|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14704479|NCT00410696|Lenograstim|lenograstim|mesh-list
14704480|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14704481|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
14832733|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
14832734|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832735|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
14832736|NCT00958425|Protective Agents|protective agents|mesh-ancestor
14832737|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
14832738|NCT00958451|Vitamin D|vitamin d|mesh-list
14832739|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14832740|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832741|NCT00958451|Vitamins|vitamins|mesh-ancestor
14832742|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
14832743|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14911920|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
14911921|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
14911922|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911923|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911924|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
14911925|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911926|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14911927|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14911928|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14911929|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14911930|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911931|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14911932|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14911933|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
14911934|NCT01366313|Acetaminophen|acetaminophen|mesh-list
14911935|NCT01366313|Morphine|morphine|mesh-list
14911936|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14911937|NCT01366313|Narcotics|narcotics|mesh-ancestor
15202845|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202846|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202847|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
15202848|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202849|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15202850|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
15202851|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15202852|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202853|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202854|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15202855|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
15202856|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202857|NCT03749408|Mannitol|mannitol|mesh-list
15202858|NCT03749408|Bupivacaine|bupivacaine|mesh-list
15202859|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
14704482|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704483|NCT00410735|Pranlukast|pranlukast|mesh-list
14704484|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14704485|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
14704486|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14704487|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
14704488|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704489|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704490|NCT00410748|Hydromorphone|hydromorphone|mesh-list
14704491|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704492|NCT00410748|Narcotics|narcotics|mesh-ancestor
14704493|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704494|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704495|NCT00410748|Analgesics|analgesics|mesh-ancestor
14704496|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
14704497|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704498|NCT00410774|Gemcitabine|gemcitabine|mesh-list
14704499|NCT00410774|Bevacizumab|bevacizumab|mesh-list
14911938|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14911939|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911940|NCT01366313|Analgesics|analgesics|mesh-ancestor
14911941|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
14911942|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911943|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14911944|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
14911945|NCT01366326|Bromides|bromides|mesh-list
14911946|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
14704500|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295302|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704501|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704502|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14704503|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15202860|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
15202861|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202862|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202863|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
15202864|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202865|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15202866|NCT03749408|Diuretics|diuretics|mesh-ancestor
15202867|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
14704504|NCT00410774|Growth Substances|growth substances|mesh-ancestor
14704505|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704506|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
14704507|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704508|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
14704509|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704510|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
14704511|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704512|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704513|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704514|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
14704515|NCT00410787|Hydromorphone|hydromorphone|mesh-list
14704516|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704517|NCT00410787|Narcotics|narcotics|mesh-ancestor
14704518|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704519|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704520|NCT00410787|Analgesics|analgesics|mesh-ancestor
14704521|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
14704522|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704523|NCT00410852|Insulin|insulin|mesh-list
14704524|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14704525|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14704526|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704527|NCT00410878|Hydromorphone|hydromorphone|mesh-list
14704528|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704529|NCT00410878|Narcotics|narcotics|mesh-ancestor
14704530|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704531|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704532|NCT00410878|Analgesics|analgesics|mesh-ancestor
14704533|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
14704534|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704535|NCT00410943|Hydromorphone|hydromorphone|mesh-list
14704536|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704537|NCT00410943|Narcotics|narcotics|mesh-ancestor
14704538|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704539|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704540|NCT00410943|Analgesics|analgesics|mesh-ancestor
14704541|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
14704542|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704543|NCT00410956|Dexamethasone|dexamethasone|mesh-list
14704544|NCT00410956|Bevacizumab|bevacizumab|mesh-list
14704545|NCT00410956|Floxuridine|floxuridine|mesh-list
14704546|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14704547|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202868|NCT03749356|Tacrolimus|tacrolimus|mesh-list
15202869|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202870|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
15202871|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202872|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15202873|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202874|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224669|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224670|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224671|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704548|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14704549|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14704550|NCT00410956|Growth Substances|growth substances|mesh-ancestor
14832744|NCT05352516|Denosumab|denosumab|mesh-list
14832745|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14832746|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832747|NCT05352373|Calcium|calcium|mesh-list
14832748|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14832749|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832750|NCT05352321|Gemcitabine|gemcitabine|mesh-list
14832751|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832752|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14832753|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
14832754|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832755|NCT05352321|Antiviral Agents|antiviral agents|mesh-ancestor
14832756|NCT05352321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832757|NCT05352321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832758|NCT05352321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832759|NCT05352321|Immunologic Factors|immunologic factors|mesh-ancestor
14832760|NCT05352321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202875|NCT03749226|Aztreonam|aztreonam|mesh-list
15202876|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14832761|NCT05352282|Fentanyl|fentanyl|mesh-list
14832762|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14832763|NCT05352282|Narcotics|narcotics|mesh-ancestor
14832764|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832765|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832766|NCT05352282|Analgesics|analgesics|mesh-ancestor
14832767|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
14832768|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832769|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14832770|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14832771|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
14832772|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
14832773|NCT05352191|Beclomethasone|beclomethasone|mesh-list
14832774|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202877|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15202878|NCT03749174|Anesthetics|anesthetics|mesh-list
14704551|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704552|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
14704553|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704554|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
14704555|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
14704556|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704557|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14704558|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
14704559|NCT00410956|Hormones|hormones|mesh-ancestor
15202879|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202880|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202881|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
15202882|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15202883|NCT03749096|Antibodies|antibodies|mesh-list
14832775|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
14832776|NCT05352191|Hormones|hormones|mesh-ancestor
14911947|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
15202884|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
14704560|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704561|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704562|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704563|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
14704564|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704565|NCT00410982|Gemcitabine|gemcitabine|mesh-list
14704566|NCT00410982|Rituximab|rituximab|mesh-list
14704567|NCT00410982|Melphalan|melphalan|mesh-list
14704568|NCT00410982|Busulfan|busulfan|mesh-list
14832777|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832778|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832779|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14832780|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
14832781|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
14832782|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
14832783|NCT05352178|Androgens|androgens|mesh-list
14832784|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14832785|NCT05352178|Hormones|hormones|mesh-ancestor
14832786|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832787|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832788|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
14832789|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832790|NCT05352178|Protective Agents|protective agents|mesh-ancestor
14832791|NCT05352178|Vitamins|vitamins|mesh-ancestor
14832792|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
14832793|NCT05352178|Estrogens|estrogens|mesh-ancestor
14832794|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14832795|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832796|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
14832797|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
14832798|NCT05352165|Fluorouracil|fluorouracil|mesh-list
14832799|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832800|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832801|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
14832802|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832803|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14832804|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832805|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
14832806|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832807|NCT05352126|Disinfectants|disinfectants|mesh-list
14832808|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832809|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
14832810|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15202885|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15202886|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
15202887|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202888|NCT03749018|Prednisone|prednisone|mesh-list
15202889|NCT03749018|Cortisone|cortisone|mesh-list
15202890|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
15202891|NCT03749018|Rituximab|rituximab|mesh-list
15202892|NCT03749018|Doxorubicin|doxorubicin|mesh-list
15202893|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15202894|NCT03749018|Nivolumab|nivolumab|mesh-list
15202895|NCT03749018|Etoposide|etoposide|mesh-list
15202896|NCT03749018|Vincristine|vincristine|mesh-list
15202897|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
15202898|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
15202899|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15202900|NCT03749018|Antibodies|antibodies|mesh-list
14704569|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14704570|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704571|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
14704572|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704573|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704574|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704575|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
14704576|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704577|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
14704578|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704579|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704580|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704581|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14704582|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
14704583|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14728595|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728596|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15202901|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
15202902|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15202903|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15202904|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
15202905|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202906|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202907|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15202908|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
15202909|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202910|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15202911|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15202912|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15202913|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15202914|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15202915|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202916|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202917|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
15202918|NCT03749018|Hormones|hormones|mesh-ancestor
15202919|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15202920|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15202921|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14832811|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14832812|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14832813|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14832814|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14832815|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832816|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
14832817|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832818|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832819|NCT05351801|Dronabinol|dronabinol|mesh-list
14832820|NCT05351801|Nabiximols|nabiximols|mesh-list
14832821|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
14832822|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832823|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832824|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14832825|NCT05351801|Analgesics|analgesics|mesh-ancestor
14832826|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
14832827|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832828|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14832829|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14832830|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832831|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832832|NCT05351801|Hormones|hormones|mesh-ancestor
14832833|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832834|NCT05351788|Carboplatin|carboplatin|mesh-list
14832835|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832836|NCT05351762|Paclitaxel|paclitaxel|mesh-list
14832837|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
14832838|NCT05351762|Nedaplatin|nedaplatin|mesh-list
14832839|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14832840|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832841|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14832842|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14832843|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
15202922|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14832844|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832845|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14832846|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14832847|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14832848|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14832849|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832850|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832851|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832852|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14832853|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14832854|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14832855|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
14832856|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832857|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832858|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14832859|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14832860|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
14832861|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14832862|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14832863|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
14832864|NCT05351684|Dolutegravir|dolutegravir|mesh-list
14832865|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14832866|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14832867|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832868|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832869|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14832870|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14832871|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
14832872|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14832873|NCT05351606|Bupropion|bupropion|mesh-list
14832874|NCT05351606|Nicotine|nicotine|mesh-list
14832875|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14832876|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
14832877|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832878|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832879|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14832880|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14832881|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
14832882|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832883|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832884|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14832885|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
14832886|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832887|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14832888|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14832889|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14832890|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
14832891|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14832892|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14832893|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832894|NCT05351593|Lenalidomide|lenalidomide|mesh-list
14832895|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
14832896|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832897|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14832898|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14832899|NCT05351593|Growth Substances|growth substances|mesh-ancestor
14832900|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
14832901|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832902|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14832903|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
14832904|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832905|NCT05351541|Psilocybin|psilocybin|mesh-list
14832906|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14704584|NCT00410995|Naproxen|naproxen|mesh-list
14704585|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14704586|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14704587|NCT00410995|Analgesics|analgesics|mesh-ancestor
14704588|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
14704589|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704590|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704591|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704592|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704593|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
14704594|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14704595|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704596|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704597|NCT00411034|Hydromorphone|hydromorphone|mesh-list
14704598|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14832907|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
14832908|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832909|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14832910|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14832911|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
14832912|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832913|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832914|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14832915|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
14832916|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14832917|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
14832918|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832919|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832920|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14832921|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
14832922|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14832923|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
14832924|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832925|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14832926|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14832927|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
14832928|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
14832929|NCT05351502|Protective Agents|protective agents|mesh-ancestor
15202923|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
15202924|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
15202925|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
15202926|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
14704599|NCT00411034|Narcotics|narcotics|mesh-ancestor
14704600|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704601|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202927|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
15202928|NCT03748940|Mirikizumab|mirikizumab|mesh-list
15202929|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15202930|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15202931|NCT03748940|Analgesics|analgesics|mesh-ancestor
15202932|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
15202933|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202934|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202935|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202936|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15202937|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15202938|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202939|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
15202940|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15202941|NCT03748446|Xenon|xenon|mesh-list
14295303|NCT00580294|Oxymorphone|oxymorphone|mesh-list
14295304|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14295305|NCT00580294|Narcotics|narcotics|mesh-ancestor
14295306|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295307|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295308|NCT00580294|Analgesics|analgesics|mesh-ancestor
14704602|NCT00411034|Analgesics|analgesics|mesh-ancestor
14704603|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
14704604|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704605|NCT00411047|Gefitinib|gefitinib|mesh-list
14704606|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704607|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14295309|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
14295310|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295311|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14295312|NCT00580333|Paclitaxel|paclitaxel|mesh-list
14295313|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
14704608|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704609|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704610|NCT00411073|Darapladib|darapladib|mesh-list
15202942|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15202943|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
15202944|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
15202945|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202946|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202947|NCT03748303|Pregnanolone|pregnanolone|mesh-list
15202948|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
15202949|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202950|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202951|NCT03748290|Pregabalin|pregabalin|mesh-list
15202952|NCT03748290|Analgesics|analgesics|mesh-ancestor
15202953|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
15202954|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202955|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202956|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
15202957|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15202958|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202959|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202960|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15202961|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15202962|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15202963|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202964|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15202965|NCT03748173|Calfactant|calfactant|mesh-list
14704611|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
15202966|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15202967|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295314|NCT00580333|Bevacizumab|bevacizumab|mesh-list
14704612|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15202968|NCT03748147|Misoprostol|misoprostol|mesh-list
14832947|NCT05351346|Prednisone|prednisone|mesh-list
14832948|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
14832949|NCT05351346|Rituximab|rituximab|mesh-list
14832950|NCT05351346|Doxorubicin|doxorubicin|mesh-list
14832951|NCT05351346|Vincristine|vincristine|mesh-list
14832952|NCT05351346|Lenalidomide|lenalidomide|mesh-list
14832953|NCT05351346|Decitabine|decitabine|mesh-list
14832954|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14832955|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
14832956|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832957|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14832958|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14832959|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
14832960|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14832961|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14832962|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14832963|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14704613|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704614|NCT00411125|Calcitonin|calcitonin|mesh-list
14704615|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
14832964|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14832965|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14832966|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14832967|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14832968|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14832969|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
14832970|NCT05351346|Hormones|hormones|mesh-ancestor
14832971|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14832972|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14832973|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14832974|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
14832975|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
14832976|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
14832977|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14832978|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14832979|NCT05351346|Growth Substances|growth substances|mesh-ancestor
14832980|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
14832981|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14832982|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
14832983|NCT05351229|Morphine|morphine|mesh-list
14832984|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704616|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14704617|NCT00411125|Katacalcin|katacalcin|mesh-list
14704618|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14704619|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704620|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14704621|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
14704622|NCT00411164|Hydromorphone|hydromorphone|mesh-list
14704623|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704624|NCT00411164|Narcotics|narcotics|mesh-ancestor
14704625|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704626|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704627|NCT00411164|Analgesics|analgesics|mesh-ancestor
14704628|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
14704629|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704630|NCT00411190|Acetaminophen|acetaminophen|mesh-list
14704631|NCT00411190|Ibuprofen|ibuprofen|mesh-list
14832985|NCT05351229|Narcotics|narcotics|mesh-ancestor
14832986|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202969|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15202970|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
14704632|NCT00411190|Atorvastatin|atorvastatin|mesh-list
14704633|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15202971|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15202972|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202973|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15202974|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15202975|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
15202976|NCT03748108|Lidocaine|lidocaine|mesh-list
15202977|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
15202978|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
15202979|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15202980|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832987|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832988|NCT05351229|Analgesics|analgesics|mesh-ancestor
14832989|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
14832990|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832991|NCT05351151|Lidocaine|lidocaine|mesh-list
14832992|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
14832993|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
14832994|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14832995|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14832996|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
14832997|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14832998|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14832999|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14833000|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14833001|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14833002|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833003|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
14833004|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14833005|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
14833006|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
14833007|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833008|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833009|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833010|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14833011|NCT05351086|Analgesics|analgesics|mesh-ancestor
14833012|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
14833013|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833014|NCT05351021|Metformin|metformin|mesh-list
14833015|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14833016|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833017|NCT05350943|Gemcitabine|gemcitabine|mesh-list
14833018|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
14833019|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833020|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
14833021|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833022|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833023|NCT05350943|Antiviral Agents|antiviral agents|mesh-ancestor
14833024|NCT05350943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833025|NCT05350943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833026|NCT05350943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833027|NCT05350943|Immunologic Factors|immunologic factors|mesh-ancestor
14833028|NCT05350943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833029|NCT05350917|Maleic acid|maleic acid|mesh-list
14833030|NCT05350917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833031|NCT05350917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833032|NCT05350774|Methylprednisolone|methylprednisolone|mesh-list
14833033|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
14833034|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14833035|NCT05350774|Antibodies|antibodies|mesh-list
14833036|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
14833037|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14833038|NCT05350774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833039|NCT05350774|Antiemetics|antiemetics|mesh-ancestor
14833040|NCT05350774|Autonomic Agents|autonomic agents|mesh-ancestor
14833041|NCT05350774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833042|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833043|NCT05350774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833044|NCT05350774|Glucocorticoids|glucocorticoids|mesh-ancestor
14833045|NCT05350774|Hormones|hormones|mesh-ancestor
14833046|NCT05350774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833047|NCT05350774|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14833048|NCT05350774|Protective Agents|protective agents|mesh-ancestor
14833049|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
14833050|NCT05350696|Morphine|morphine|mesh-list
14833051|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15202981|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
15202982|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202983|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15202984|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15202985|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15202986|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15202987|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202988|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
14833052|NCT05350696|Narcotics|narcotics|mesh-ancestor
14833053|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14833054|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833055|NCT05350696|Analgesics|analgesics|mesh-ancestor
14833056|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
14833057|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833058|NCT05350592|Dobutamine|dobutamine|mesh-list
14833059|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14833060|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
14833061|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
14833062|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833063|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833064|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14833065|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14833066|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14833067|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
14833068|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833069|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833070|NCT05350592|Protective Agents|protective agents|mesh-ancestor
14833071|NCT05350501|Nivolumab|nivolumab|mesh-list
14833072|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833073|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833074|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14833075|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833076|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
14833077|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14833078|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14833079|NCT05350384|Prednisolone|prednisolone|mesh-list
14833080|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
14833081|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14833082|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
14833083|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833084|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
14833085|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
14833086|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833087|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833088|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833089|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
14833090|NCT05350384|Hormones|hormones|mesh-ancestor
14833091|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833092|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14833093|NCT05350384|Protective Agents|protective agents|mesh-ancestor
14833094|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833095|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833096|NCT05350371|Pirfenidone|pirfenidone|mesh-list
14833097|NCT05350371|Analgesics|analgesics|mesh-ancestor
14833098|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
14833099|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833100|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833101|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14833102|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14833103|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833104|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833105|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833106|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14833107|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14833108|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14833109|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14833110|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833111|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
14833112|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833113|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833114|NCT05350202|Empagliflozin|empagliflozin|mesh-list
14704634|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14704635|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
14833115|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14833116|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833117|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15202989|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15202990|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
15202991|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15202992|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15202993|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15202994|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
15202995|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15202996|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
15202997|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15202998|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15202999|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15203000|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
15203001|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
15203002|NCT03748082|Protective Agents|protective agents|mesh-ancestor
15203003|NCT03748043|Lactoferrin|lactoferrin|mesh-list
15203004|NCT03748043|Teferrol|teferrol|mesh-list
14833118|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833119|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14833120|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833121|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833122|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
14833123|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14833124|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833125|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14833126|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833127|NCT05328440|Fulvestrant|fulvestrant|mesh-list
14833128|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833129|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704636|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704637|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14704638|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14704639|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203005|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15203006|NCT03748043|Hematinics|hematinics|mesh-ancestor
14704640|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14704641|NCT00411190|Analgesics|analgesics|mesh-ancestor
14704642|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
14704643|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833130|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14833131|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14833132|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
14833133|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833134|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833135|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
15203007|NCT03747978|Amlodipine|amlodipine|mesh-list
15203008|NCT03747978|Perindopril|perindopril|mesh-list
15203009|NCT03747978|Indapamide|indapamide|mesh-list
14833136|NCT05327023|Sirolimus|sirolimus|mesh-list
14833137|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
14833138|NCT05327023|Busulfan|busulfan|mesh-list
14833139|NCT05327023|Fludarabine|fludarabine|mesh-list
14833140|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833141|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
14833142|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833143|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833144|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833145|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
14833146|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833147|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833148|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833149|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14833150|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14833151|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
14833152|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14833153|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833154|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833155|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
14833156|NCT05312385|Propofol|propofol|mesh-list
14833157|NCT05312385|Isoflurane|isoflurane|mesh-list
14833158|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14833159|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14833160|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833161|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14833162|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
14833163|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
14833164|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14833165|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
14833166|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14833167|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833168|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14833169|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833170|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
14833171|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
14833172|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833173|NCT05286827|Olaparib|olaparib|mesh-list
14833174|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14833175|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833176|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833177|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833178|NCT05286814|Leucovorin|leucovorin|mesh-list
14833179|NCT05286814|Gemcitabine|gemcitabine|mesh-list
14833180|NCT05286814|Dexamethasone|dexamethasone|mesh-list
14833181|NCT05286814|Fluorouracil|fluorouracil|mesh-list
14833182|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
14833183|NCT05286814|Irinotecan|irinotecan|mesh-list
14833184|NCT05286814|Floxuridine|floxuridine|mesh-list
14833185|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833186|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
14833187|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
14833188|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833189|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833190|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833191|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
14833192|NCT05286814|Hormones|hormones|mesh-ancestor
14833193|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833194|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833195|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833196|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833197|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
14833198|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833199|NCT05286814|Antiviral Agents|antiviral agents|mesh-ancestor
14833200|NCT05286814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833201|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833202|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833203|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
14833204|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14295315|NCT00580333|Doxorubicin|doxorubicin|mesh-list
14295316|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295317|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833205|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14833206|NCT05286814|Antidotes|antidotes|mesh-ancestor
14833207|NCT05286814|Protective Agents|protective agents|mesh-ancestor
14833208|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
14295318|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833209|NCT05286814|Vitamins|vitamins|mesh-ancestor
14833210|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
14833211|NCT05285904|Ofatumumab|ofatumumab|mesh-list
14833212|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833213|NCT05280457|Nivolumab|nivolumab|mesh-list
14833214|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833215|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833216|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14833217|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833218|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14833219|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14833220|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833221|NCT05275426|Gemcitabine|gemcitabine|mesh-list
14833222|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833223|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
14833224|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833225|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833226|NCT05275426|Antiviral Agents|antiviral agents|mesh-ancestor
14833227|NCT05275426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833228|NCT05275426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833229|NCT05275426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833230|NCT05275426|Immunologic Factors|immunologic factors|mesh-ancestor
14833231|NCT05275426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833232|NCT05255900|Metyrapone|metyrapone|mesh-list
14833233|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
14833234|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833235|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833236|NCT05254106|Paclitaxel|paclitaxel|mesh-list
14833237|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295319|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833238|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833239|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833240|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833241|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833242|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833243|NCT05252533|Ustekinumab|ustekinumab|mesh-list
14833244|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
14833245|NCT05249569|Avelumab|avelumab|mesh-list
14833246|NCT05249569|Bavituximab|bavituximab|mesh-list
14833247|NCT05249569|Axitinib|axitinib|mesh-list
14833248|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833249|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833250|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833251|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833252|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833253|NCT05242458|Ustekinumab|ustekinumab|mesh-list
14833254|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14833255|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14833256|NCT05236738|Cobicistat|cobicistat|mesh-list
14833257|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14833258|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14833259|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
14833260|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203010|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
15203011|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15203012|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15203013|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15203014|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203015|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15203016|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203017|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
15203018|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15203019|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
15203020|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203021|NCT03747978|Diuretics|diuretics|mesh-ancestor
15203022|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
15203023|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15203024|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
15203025|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15203026|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15203027|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15203028|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15224672|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
14911948|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14704644|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704645|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
14704646|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14704647|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704648|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704649|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14704650|NCT00411203|Tamoxifen|tamoxifen|mesh-list
14704651|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14704652|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
14704653|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833261|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833262|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14833263|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15203029|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203030|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
15203031|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203032|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203033|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15203034|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203035|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15203036|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203037|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203038|NCT03747679|Mannitol|mannitol|mesh-list
15203039|NCT03747679|Sorbitol|sorbitol|mesh-list
15203040|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15203041|NCT03747679|Diuretics|diuretics|mesh-ancestor
15203042|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
15203043|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203044|NCT03747679|Cathartics|cathartics|mesh-ancestor
15203045|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203046|NCT03747614|Fluorometholone|fluorometholone|mesh-list
15203047|NCT03747614|Tacrolimus|tacrolimus|mesh-list
15203048|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15203049|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
15203050|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203051|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15203052|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203053|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203054|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203055|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
15203056|NCT03747614|Hormones|hormones|mesh-ancestor
15203057|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203058|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15203059|NCT03747562|Gabapentin|gabapentin|mesh-list
15203060|NCT03747562|Analgesics|analgesics|mesh-ancestor
15203061|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
15203062|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203063|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203064|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
15203065|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15203066|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15203067|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203068|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15203069|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15203070|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15203071|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203072|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203073|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
15203074|NCT03747536|Bromides|bromides|mesh-list
15203075|NCT03747536|Ipratropium|ipratropium|mesh-list
15203076|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
15203077|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15203078|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
15203079|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203080|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203081|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15203082|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
15203083|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15203084|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
15203085|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203086|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203087|NCT03747523|Vitamin D|vitamin d|mesh-list
15203088|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
14704654|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203089|NCT03747523|Vitamins|vitamins|mesh-ancestor
15203090|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
15203091|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203092|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14833264|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
14833265|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833266|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14833267|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14833268|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14833269|NCT05228314|Vaccines|vaccines|mesh-list
14833270|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
14833271|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
14833272|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833273|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14833274|NCT05228314|Antacids|antacids|mesh-ancestor
14833275|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833276|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833277|NCT05226598|Paclitaxel|paclitaxel|mesh-list
14833278|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14833279|NCT05226598|Carboplatin|carboplatin|mesh-list
14833280|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
14833281|NCT05226598|Pemetrexed|pemetrexed|mesh-list
14833282|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14833283|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833284|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833285|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833286|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833287|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833288|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833289|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833290|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14833291|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14833292|NCT05213728|Vaccines|vaccines|mesh-list
14833293|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
14833294|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833295|NCT05212012|Methadone|methadone|mesh-list
14833296|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14833297|NCT05212012|Narcotics|narcotics|mesh-ancestor
14833298|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14833299|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833300|NCT05212012|Analgesics|analgesics|mesh-ancestor
14833301|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
14833302|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833303|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
15203093|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15203094|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
15203095|NCT03747432|Propofol|propofol|mesh-list
15203096|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15203097|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203098|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833304|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
14833305|NCT05211895|Durvalumab|durvalumab|mesh-list
14833306|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833307|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833308|NCT05211336|Prednisone|prednisone|mesh-list
14833309|NCT05211336|Nivolumab|nivolumab|mesh-list
14833310|NCT05211336|Lenalidomide|lenalidomide|mesh-list
14833311|NCT05211336|Venetoclax|venetoclax|mesh-list
14833312|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
14833313|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833314|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
14833315|NCT05211336|Hormones|hormones|mesh-ancestor
14833316|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833317|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203099|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15203100|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
15203101|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
15203102|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203103|NCT03747432|Analgesics|analgesics|mesh-ancestor
15203104|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
15203105|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203106|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15203107|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15203108|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15203109|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
15203110|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203111|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203112|NCT03747341|Fentanyl|fentanyl|mesh-list
15203113|NCT03747341|Oxycodone|oxycodone|mesh-list
15203114|NCT03747341|Buprenorphine|buprenorphine|mesh-list
15203115|NCT03747341|Ondansetron|ondansetron|mesh-list
15203116|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15203117|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15203118|NCT03747341|Narcotics|narcotics|mesh-ancestor
15203119|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704655|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704656|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203120|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203121|NCT03747341|Analgesics|analgesics|mesh-ancestor
15203122|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
15203123|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203124|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14704657|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14704658|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14704659|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14704660|NCT00411229|Capecitabine|capecitabine|mesh-list
14704661|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
14704662|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704663|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
14704664|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704665|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704666|NCT00411268|Hydromorphone|hydromorphone|mesh-list
14704667|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704668|NCT00411268|Narcotics|narcotics|mesh-ancestor
14833318|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833319|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203125|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15203126|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
14704669|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295320|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295321|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295322|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295323|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
14295324|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295325|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295326|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295327|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
14295328|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295329|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295330|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14295331|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14295332|NCT00580333|Growth Substances|growth substances|mesh-ancestor
14295333|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
14295334|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14295335|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14295336|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14295337|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295338|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
14833320|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833321|NCT05211336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14911949|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295339|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295340|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
14295341|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295342|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295343|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295344|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
14295345|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295346|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295347|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295348|NCT00580398|Varenicline|varenicline|mesh-list
14295349|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14295350|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14295351|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
14295352|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295353|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295354|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295355|NCT00580606|Glycerol|glycerol|mesh-list
14295356|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14295357|NCT00580606|Protective Agents|protective agents|mesh-ancestor
14295358|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295359|NCT00580645|Varenicline|varenicline|mesh-list
14295360|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14295361|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14295362|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
14295363|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295364|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295365|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295366|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
14295367|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14295368|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833322|NCT05211336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833323|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
14833324|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14833325|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14833326|NCT05211336|Growth Substances|growth substances|mesh-ancestor
14833327|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
14833328|NCT05211323|Gemcitabine|gemcitabine|mesh-list
14833329|NCT05211323|Bevacizumab|bevacizumab|mesh-list
14833330|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14833331|NCT05211323|Cisplatin|cisplatin|mesh-list
14833332|NCT05211323|Atezolizumab|atezolizumab|mesh-list
14833333|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
14833334|NCT05211323|Antibodies|antibodies|mesh-list
14833335|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
14833336|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14833337|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
14833338|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833339|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14833340|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14833341|NCT05211323|Growth Substances|growth substances|mesh-ancestor
14833342|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833343|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
14833344|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
14833345|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833346|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
14833347|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833348|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
14833349|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833350|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833351|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833352|NCT05199051|Cytarabine|cytarabine|mesh-list
14833353|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
14833354|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833355|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
14833356|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833357|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833358|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
14833359|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833360|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833361|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
14833362|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833363|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833364|NCT05194969|Petrolatum|petrolatum|mesh-list
14833365|NCT05194969|Emollients|emollients|mesh-ancestor
14833366|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14833367|NCT05192889|Leucovorin|leucovorin|mesh-list
14833368|NCT05192889|Cytarabine|cytarabine|mesh-list
14833369|NCT05192889|Dexamethasone|dexamethasone|mesh-list
14833370|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
14833371|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
14833372|NCT05192889|Methotrexate|methotrexate|mesh-list
14833373|NCT05192889|Etoposide|etoposide|mesh-list
14833374|NCT05192889|Vincristine|vincristine|mesh-list
14833375|NCT05192889|Asparaginase|asparaginase|mesh-list
14833376|NCT05192889|Dasatinib|dasatinib|mesh-list
14833377|NCT05192889|Venetoclax|venetoclax|mesh-list
14833378|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
14833379|NCT05192889|Pegaspargase|pegaspargase|mesh-list
14833380|NCT05192889|Blinatumomab|blinatumomab|mesh-list
14833381|NCT05192889|Navitoclax|navitoclax|mesh-list
14833382|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833383|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
14833384|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833385|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833386|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833387|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
14833388|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833389|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833390|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833391|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833392|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
14833393|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
14833394|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833395|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833396|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
14833397|NCT05192889|Hormones|hormones|mesh-ancestor
14833398|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833399|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833400|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14833401|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
14833402|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14833403|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833404|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
14833405|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
14833406|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833407|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14833408|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14833409|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14833410|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14833411|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14833412|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
14833413|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833414|NCT05192889|Antidotes|antidotes|mesh-ancestor
14833415|NCT05192889|Protective Agents|protective agents|mesh-ancestor
14833416|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
14833417|NCT05192889|Vitamins|vitamins|mesh-ancestor
14833418|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
14833419|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833420|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833421|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833422|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833423|NCT05185947|Paclitaxel|paclitaxel|mesh-list
14833424|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14833425|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833426|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833427|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833428|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833429|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833430|NCT05178550|Heparin|heparin|mesh-list
14833431|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
14833432|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14833433|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14833434|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833435|NCT05170672|Abatacept|abatacept|mesh-list
14833436|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14833437|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833438|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833439|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833440|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
14833441|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833442|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833443|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14833444|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
14833445|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833446|NCT05155033|Aldesleukin|aldesleukin|mesh-list
14833447|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
14833448|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833449|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833450|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14833451|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14833452|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
14833453|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833454|NCT05148234|Decitabine|decitabine|mesh-list
14833455|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833456|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
14833457|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833458|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833459|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833460|NCT05138575|Empagliflozin|empagliflozin|mesh-list
15203127|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
15203128|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15203129|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
15203130|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
15203131|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203132|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
15203133|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
15203134|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15203135|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
15203136|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203137|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203138|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14833461|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14833462|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833463|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15203139|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15203140|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15203141|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15224673|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833464|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833465|NCT05131061|Fludrocortisone|fludrocortisone|mesh-list
14833466|NCT05131061|Captopril|captopril|mesh-list
15224674|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224675|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15224676|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224677|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15224678|NCT02800824|Budesonide|budesonide|mesh-list
15224679|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224680|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14295369|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14295370|NCT00580801|Interferons|interferons|mesh-list
14295371|NCT00580801|Ribavirin|ribavirin|mesh-list
14295372|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
14295373|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
14295374|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14295375|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295376|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
14295377|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295378|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
14295379|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224681|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
15224682|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224683|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224684|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15224685|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295380|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
14295381|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295382|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
14704670|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704671|NCT00411268|Analgesics|analgesics|mesh-ancestor
14704672|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
14704673|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704674|NCT00411281|Cytarabine|cytarabine|mesh-list
14704675|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704676|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
14704677|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704678|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704679|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
14728597|NCT00519207|Lidocaine|lidocaine|mesh-list
14833467|NCT05131061|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14833468|NCT05131061|Protease Inhibitors|protease inhibitors|mesh-ancestor
14833469|NCT05131061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833470|NCT05131061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833471|NCT05131061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14833472|NCT05131061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833473|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
14833474|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
14833475|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203142|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
15203143|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203144|NCT03747094|Fentanyl|fentanyl|mesh-list
15203145|NCT03747094|Ketamine|ketamine|mesh-list
15203146|NCT03747094|Analgesics|analgesics|mesh-ancestor
15203147|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
15203148|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203149|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203150|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14833476|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833477|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833478|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
14833479|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
14833480|NCT05112601|Nivolumab|nivolumab|mesh-list
14833481|NCT05112601|Ipilimumab|ipilimumab|mesh-list
14833482|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833483|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833484|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14833485|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833486|NCT05108870|Paclitaxel|paclitaxel|mesh-list
14833487|NCT05108870|Carboplatin|carboplatin|mesh-list
14833488|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14833489|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833490|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833491|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
15203151|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15203152|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
15203153|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
15203154|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295383|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833492|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833493|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833494|NCT05106153|Zolpidem|zolpidem|mesh-list
14833495|NCT05106153|Suvorexant|suvorexant|mesh-list
14833496|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14833497|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14833498|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14833499|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833500|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14833501|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
14833502|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
14833503|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833504|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833505|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14833506|NCT05104723|Tofacitinib|tofacitinib|mesh-list
14295384|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
14833507|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833508|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833509|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833510|NCT05102721|Avelumab|avelumab|mesh-list
14833511|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833512|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833513|NCT05100654|Doxycycline|doxycycline|mesh-list
14833514|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
14833515|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14833516|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14833517|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14833518|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833519|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
14833520|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14833521|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14833522|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14833523|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14833524|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833525|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203155|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15203156|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15203157|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203158|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833526|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833527|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14833528|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14833529|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14833530|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14833531|NCT05100654|Renal Agents|renal agents|mesh-ancestor
14833532|NCT05100628|Doxorubicin|doxorubicin|mesh-list
14833533|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14833534|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833535|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14833536|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14833537|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833538|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833539|NCT05096481|Temozolomide|temozolomide|mesh-list
14833540|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833541|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
14833542|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833543|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833544|NCT05092269|Ustekinumab|ustekinumab|mesh-list
14833545|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
14833546|NCT05089370|Nivolumab|nivolumab|mesh-list
14295385|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833547|NCT05089370|Decitabine|decitabine|mesh-list
14833548|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833549|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833550|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15203159|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15203160|NCT03747094|Narcotics|narcotics|mesh-ancestor
15203161|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15203162|NCT03747081|Warfarin|warfarin|mesh-list
15203163|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
15203164|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
15203165|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15203166|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
15203167|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15203168|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
15203169|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203170|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203171|NCT03746821|Biotin|biotin|mesh-list
15203172|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
15203173|NCT03746821|Vitamins|vitamins|mesh-ancestor
15203174|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
15203175|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203176|NCT03746782|Thrombin|thrombin|mesh-list
15203177|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
14833551|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833552|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833553|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
14833554|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833555|NCT05078879|Empagliflozin|empagliflozin|mesh-list
14833556|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14833557|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833558|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14833559|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833560|NCT05067933|Vaccines|vaccines|mesh-list
14833561|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
14833562|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833563|NCT05050916|Vitamin D|vitamin d|mesh-list
14833564|NCT05050916|Vitamins|vitamins|mesh-ancestor
14833565|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
14833566|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833567|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14833568|NCT05035407|Aldesleukin|aldesleukin|mesh-list
14833569|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
14833570|NCT05035407|Fludarabine|fludarabine|mesh-list
14833571|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833572|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
14833573|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833574|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833575|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833576|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
14833577|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833578|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833579|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833580|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14833581|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15203178|NCT03746782|Coagulants|coagulants|mesh-ancestor
15203179|NCT03746691|Citalopram|citalopram|mesh-list
15203180|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15203181|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15203182|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15203183|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203184|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203185|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
15203186|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203187|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15203188|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
15203189|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15203190|NCT03746652|Dexamethasone|dexamethasone|mesh-list
15203191|NCT03746652|Daratumumab|daratumumab|mesh-list
15203192|NCT03746652|Ixazomib|ixazomib|mesh-list
15203193|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203194|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
15203195|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
15203196|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203197|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203198|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203199|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
15203200|NCT03746652|Hormones|hormones|mesh-ancestor
15203201|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203202|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15203203|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203204|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
15203205|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203206|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203207|NCT03746444|Anesthetics|anesthetics|mesh-list
15203208|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14833582|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
14833583|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295386|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295387|NCT00580853|Bupropion|bupropion|mesh-list
14833584|NCT05033080|Ivacaftor|ivacaftor|mesh-list
14833585|NCT05033080|Elexacaftor|elexacaftor|mesh-list
14833586|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14833587|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14833588|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833589|NCT05030766|Nicotine|nicotine|mesh-list
14833590|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14833591|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
14833592|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833593|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203209|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203210|NCT03746366|Corticosterone|corticosterone|mesh-list
15203211|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833594|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14833595|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14833596|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
14833597|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833598|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203212|NCT03746340|Propofol|propofol|mesh-list
15203213|NCT03746340|Sevoflurane|sevoflurane|mesh-list
15203214|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15203215|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203216|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203217|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14295388|NCT00580853|Varenicline|varenicline|mesh-list
14295389|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14295390|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
14295391|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14295392|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14295393|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14295394|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14295395|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295396|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
14704680|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704681|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704682|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
14704683|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704684|NCT00411307|Hydromorphone|hydromorphone|mesh-list
14704685|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704686|NCT00411307|Narcotics|narcotics|mesh-ancestor
14704687|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704688|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704689|NCT00411307|Analgesics|analgesics|mesh-ancestor
14704690|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
14704691|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704692|NCT00411320|Dexamethasone|dexamethasone|mesh-list
14704693|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704694|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
14704695|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
14704696|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704697|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704698|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14704699|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
14833599|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
14833600|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14833601|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14833602|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14833603|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14833604|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833605|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
14833606|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833607|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833608|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14833609|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833610|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
14833611|NCT05027945|Sirolimus|sirolimus|mesh-list
14833612|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
14833613|NCT05027945|Busulfan|busulfan|mesh-list
14833614|NCT05027945|Fludarabine|fludarabine|mesh-list
14833615|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833616|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
15203218|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
15203219|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
15203220|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15203221|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15203222|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
15203223|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14833617|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833618|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833619|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833620|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
14833621|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833622|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833623|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833624|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14833625|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14833626|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
14833627|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14833628|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15203224|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704700|NCT00411320|Hormones|hormones|mesh-ancestor
14704701|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704702|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704703|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833629|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833630|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
15203225|NCT03746275|Aspirin|aspirin|mesh-list
15203226|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
15203227|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15203228|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203229|NCT03746275|Analgesics|analgesics|mesh-ancestor
15224686|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
14704704|NCT00411333|Triamcinolone|triamcinolone|mesh-list
14833631|NCT05019534|Cetuximab|cetuximab|mesh-list
14833632|NCT05019534|Vemurafenib|vemurafenib|mesh-list
14833633|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833634|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833635|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833636|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833637|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833638|NCT05017571|Colchicine|colchicine|mesh-list
14833639|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
14833640|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833641|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833642|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833643|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833644|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833645|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833646|NCT05017025|Osimertinib|osimertinib|mesh-list
14833647|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833648|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833649|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833650|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833651|NCT05014438|Branebrutinib|branebrutinib|mesh-list
14833652|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833653|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833654|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833655|NCT05014061|Adenosine|adenosine|mesh-list
14833656|NCT05014061|Analgesics|analgesics|mesh-ancestor
14833657|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
14833658|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833659|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833660|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14833661|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
14833662|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14833663|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
14833664|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
14833665|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704705|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14704706|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14704707|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14704708|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704709|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
14704710|NCT00411333|Hormones|hormones|mesh-ancestor
14704711|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704712|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704713|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704714|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
14704715|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704716|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704717|NCT00411372|Fluticasone|fluticasone|mesh-list
14704718|NCT00411372|Xhance|xhance|mesh-list
14704719|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14704720|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14704721|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704722|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14704723|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
14704724|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704725|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704726|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14704727|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
14704728|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
14704729|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14704730|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14704731|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14704732|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15224687|NCT02800824|Hormones|hormones|mesh-ancestor
15224688|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224689|NCT02780401|Vaccines|vaccines|mesh-list
15224690|NCT02780401|Sargramostim|sargramostim|mesh-list
15224691|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
15224692|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224693|NCT02760498|Cemiplimab|cemiplimab|mesh-list
15224694|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833666|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833667|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14833668|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14833669|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295397|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295398|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295399|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14833670|NCT05007106|Gemcitabine|gemcitabine|mesh-list
14833671|NCT05007106|Docetaxel|docetaxel|mesh-list
14833672|NCT05007106|Bevacizumab|bevacizumab|mesh-list
14833673|NCT05007106|Carboplatin|carboplatin|mesh-list
14833674|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
14833675|NCT05007106|Fluorouracil|fluorouracil|mesh-list
14833676|NCT05007106|Capecitabine|capecitabine|mesh-list
14833677|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
14833678|NCT05007106|Lenvatinib|lenvatinib|mesh-list
14833679|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833680|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
15203230|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
15203231|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203232|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203233|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203234|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203235|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15203236|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15203237|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203238|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15203239|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15203240|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704733|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
14833681|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833682|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833683|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833684|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833685|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14833686|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14833687|NCT05007106|Growth Substances|growth substances|mesh-ancestor
14833688|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833689|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
14833690|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833691|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
14833692|NCT05007106|Antiviral Agents|antiviral agents|mesh-ancestor
14833693|NCT05007106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833694|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833695|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833696|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
14833697|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833698|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
14833699|NCT05003895|Fludarabine|fludarabine|mesh-list
14833700|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833701|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
14704734|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704735|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704736|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
14704737|NCT00411372|Hormones|hormones|mesh-ancestor
14704738|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704739|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
14704740|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14704741|NCT00411437|Oxybutynin|oxybutynin|mesh-list
14704742|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14704743|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14704744|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704745|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704746|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704747|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833702|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833703|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833704|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833705|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
14833706|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833707|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833708|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833709|NCT05003245|Ranibizumab|ranibizumab|mesh-list
14833710|NCT05003245|Antibodies|antibodies|mesh-list
14833711|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14833712|NCT05003245|Mitogens|mitogens|mesh-list
14833713|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
14833714|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
14833715|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833716|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833717|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833718|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14833719|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14833720|NCT05003245|Growth Substances|growth substances|mesh-ancestor
14833721|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
14833722|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833723|NCT05002569|Nivolumab|nivolumab|mesh-list
14833724|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833725|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833726|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14833727|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833728|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
14833729|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833730|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833731|NCT04994977|Carboplatin|carboplatin|mesh-list
14833732|NCT04994977|Melphalan|melphalan|mesh-list
14833733|NCT04994977|Topotecan|topotecan|mesh-list
14833734|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833735|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833736|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
14833737|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833738|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833739|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833740|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
14833741|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833742|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14833743|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14833744|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833745|NCT04990388|Acetaminophen|acetaminophen|mesh-list
14833746|NCT04990388|Antipyretics|antipyretics|mesh-list
14833747|NCT04990388|Cetirizine|cetirizine|mesh-list
14833748|NCT04990388|Ibuprofen|ibuprofen|mesh-list
14833749|NCT04990388|Famotidine|famotidine|mesh-list
14833750|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14833751|NCT04990388|Analgesics|analgesics|mesh-ancestor
14833752|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
14833753|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833754|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833755|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14833756|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704748|NCT00411437|Urological Agents|urological agents|mesh-ancestor
14704749|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
14704750|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
14704751|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704752|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
14704753|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14833757|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704754|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704755|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14704756|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
14833758|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14833759|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833760|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833761|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14833762|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833763|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14833764|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
14833765|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
14833766|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833767|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14833768|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14833769|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14833770|NCT04975997|Dexamethasone|dexamethasone|mesh-list
14833771|NCT04975997|Bortezomib|bortezomib|mesh-list
14833772|NCT04975997|Daratumumab|daratumumab|mesh-list
14833773|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833774|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
14704757|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14704758|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704759|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704760|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704761|NCT00411541|Dexamethasone|dexamethasone|mesh-list
14704762|NCT00411541|Vincristine|vincristine|mesh-list
14704763|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704764|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
14704765|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
14704766|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704767|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704768|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14704769|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
14704770|NCT00411541|Hormones|hormones|mesh-ancestor
14704771|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704772|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833775|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
14833776|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833777|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833778|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833779|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
14833780|NCT04975997|Hormones|hormones|mesh-ancestor
14833781|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704773|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704774|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14704775|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
14704776|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
15203241|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
15203242|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14833782|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833783|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833784|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
14833785|NCT04971226|Dasatinib|dasatinib|mesh-list
14833786|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833787|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14833788|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833789|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833790|NCT04966663|Gemcitabine|gemcitabine|mesh-list
14833791|NCT04966663|Carboplatin|carboplatin|mesh-list
14833792|NCT04966663|Nivolumab|nivolumab|mesh-list
14833793|NCT04966663|Pemetrexed|pemetrexed|mesh-list
15203243|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
15203244|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14295400|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14833794|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833795|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833796|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
14833797|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833798|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
14833799|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833800|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833801|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833802|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
14833803|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833804|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833805|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14833806|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15203245|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
14833807|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15203246|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
15203247|NCT03746249|Lenvatinib|lenvatinib|mesh-list
15203248|NCT03746249|Antibodies|antibodies|mesh-list
15203249|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
14833808|NCT04965493|Rituximab|rituximab|mesh-list
14833809|NCT04965493|Venetoclax|venetoclax|mesh-list
14833810|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833811|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833812|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
14833813|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295401|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704777|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
14704778|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704779|NCT00411593|Bevacizumab|bevacizumab|mesh-list
14704780|NCT00411593|Bortezomib|bortezomib|mesh-list
14704781|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14704782|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704783|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14704784|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14704785|NCT00411593|Growth Substances|growth substances|mesh-ancestor
14704786|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704787|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
14704788|NCT00411736|Azithromycin|azithromycin|mesh-list
14833814|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833815|NCT04963725|Ustekinumab|ustekinumab|mesh-list
14833816|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
14833817|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
14833818|NCT04959175|Sirolimus|sirolimus|mesh-list
14833819|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
14833820|NCT04959175|Fludarabine|fludarabine|mesh-list
14833821|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833822|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
14833823|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833824|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833825|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833826|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
14833827|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833828|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833829|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833830|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14833831|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14833832|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
14833833|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14833834|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833835|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833836|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
15203250|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
15203251|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704789|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14704790|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704791|NCT00411866|Ketoconazole|ketoconazole|mesh-list
14833837|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
14833838|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15203252|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203253|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203254|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203255|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203256|NCT03746223|Rituximab|rituximab|mesh-list
14833839|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833840|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
14833841|NCT04940039|Risperidone|risperidone|mesh-list
14833842|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14833843|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14833844|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
14833845|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14833846|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833847|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833848|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14833849|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14833850|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14833851|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14833852|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14833853|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
14833854|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14833855|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14833856|NCT04938830|Palivizumab|palivizumab|mesh-list
14833857|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
14833858|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14833859|NCT04933617|Prednisone|prednisone|mesh-list
14833860|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
14833861|NCT04933617|Rituximab|rituximab|mesh-list
14833862|NCT04933617|Doxorubicin|doxorubicin|mesh-list
14833863|NCT04933617|Etoposide|etoposide|mesh-list
14833864|NCT04933617|Vincristine|vincristine|mesh-list
14833865|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833866|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
14833867|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833868|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14833869|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833870|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
14833871|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833872|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833873|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14833874|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833875|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14833876|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14833877|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14833878|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833879|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833880|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
14704792|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
14704793|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704794|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14704795|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14704796|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704797|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704798|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14704799|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
14704800|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704801|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833881|NCT04933617|Hormones|hormones|mesh-ancestor
14833882|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833883|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833884|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14833885|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
14833886|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
14833887|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
14833888|NCT04933539|Dexamethasone|dexamethasone|mesh-list
14833889|NCT04933539|Daratumumab|daratumumab|mesh-list
14833890|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14833891|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
14833892|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
14833893|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14833894|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833895|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14833896|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
14833897|NCT04933539|Hormones|hormones|mesh-ancestor
14833898|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833899|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14833900|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833901|NCT04919629|Bevacizumab|bevacizumab|mesh-list
14833902|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14833903|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
14833904|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
14833905|NCT04919629|Antibodies|antibodies|mesh-list
14833906|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
14833907|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14833908|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
14833909|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833910|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14833911|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14833912|NCT04919629|Growth Substances|growth substances|mesh-ancestor
14833913|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833914|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
14833915|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
15203257|NCT03746223|Methotrexate|methotrexate|mesh-list
15203258|NCT03746223|Lenalidomide|lenalidomide|mesh-list
15203259|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203260|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203261|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
15203262|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203263|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203264|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15203265|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
15203266|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15203267|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15203268|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
15203269|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203270|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
15203271|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203272|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15203273|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15203274|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15203275|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15203276|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15203277|NCT03746223|Growth Substances|growth substances|mesh-ancestor
15203278|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
15203279|NCT03746158|Curcumin|curcumin|mesh-list
15203280|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15203281|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203282|NCT03746158|Analgesics|analgesics|mesh-ancestor
15203283|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
15203284|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203285|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203286|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203287|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203288|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203289|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203290|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833916|NCT04919369|Vitamins|vitamins|mesh-list
14833917|NCT04919369|Vitamin A|vitamin a|mesh-list
14833918|NCT04919369|Atezolizumab|atezolizumab|mesh-list
14833919|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
14833920|NCT04919369|Tretinoin|tretinoin|mesh-list
14833921|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14833922|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
14833923|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833924|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833925|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
14833926|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
14833927|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833928|NCT04919369|Protective Agents|protective agents|mesh-ancestor
14833929|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14833930|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
14833931|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
14833932|NCT04919226|Leucovorin|leucovorin|mesh-list
14833933|NCT04919226|Folic Acid|folic acid|mesh-list
14833934|NCT04919226|Fluorouracil|fluorouracil|mesh-list
14833935|NCT04919226|Capecitabine|capecitabine|mesh-list
14833936|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
14833937|NCT04919226|Everolimus|everolimus|mesh-list
14833938|NCT04919226|Temozolomide|temozolomide|mesh-list
14833939|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14833940|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
14833941|NCT04919226|Edotreotide|edotreotide|mesh-list
14833942|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
14833943|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833944|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14833945|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833946|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14833947|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
14833948|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833949|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14833950|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
14833951|NCT04919226|Antidotes|antidotes|mesh-ancestor
14833952|NCT04919226|Protective Agents|protective agents|mesh-ancestor
14833953|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
14833954|NCT04919226|Vitamins|vitamins|mesh-ancestor
14833955|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
14833956|NCT04919226|Hematinics|hematinics|mesh-ancestor
14833957|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14833958|NCT04916613|Androgens|androgens|mesh-list
14833959|NCT04916613|Hormones|hormones|mesh-ancestor
14833960|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14833961|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833962|NCT04915183|Atorvastatin|atorvastatin|mesh-list
14833963|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14833964|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14833965|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
14833966|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833967|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14833968|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14833969|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14833970|NCT04913805|Niacinamide|niacinamide|mesh-list
14833971|NCT04913805|Niacin|niacin|mesh-list
14833972|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
14833973|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
14833974|NCT04913805|Vitamins|vitamins|mesh-ancestor
14833975|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
14833976|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833977|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14833978|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
14833979|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833980|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14833981|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
14833982|NCT04902443|Nivolumab|nivolumab|mesh-list
14833983|NCT04902443|Pomalidomide|pomalidomide|mesh-list
14833984|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14833985|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14833986|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14833987|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14833988|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
14833989|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14833990|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14833991|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14833992|NCT04902443|Growth Substances|growth substances|mesh-ancestor
14833993|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
14833994|NCT04901377|Dienogest|dienogest|mesh-list
14833995|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14833996|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14833997|NCT04901377|Estradiol|estradiol|mesh-list
14833998|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14833999|NCT04901377|Estrogens|estrogens|mesh-ancestor
14834000|NCT04901377|Hormones|hormones|mesh-ancestor
14834001|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834002|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834003|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14834004|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
14834005|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14834006|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14834007|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14834008|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14834009|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14834010|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
14834011|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834012|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834013|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
14834014|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14834015|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
15203291|NCT03746119|Nicotine|nicotine|mesh-list
15203292|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14704802|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14704803|NCT00411879|Vasopressins|vasopressins|mesh-list
14704804|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
14704805|NCT00411879|Epinephrine|epinephrine|mesh-list
14704806|NCT00411879|Racepinephrine|racepinephrine|mesh-list
14704807|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
14704808|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14704809|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15203293|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
15203294|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704810|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
15203295|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203296|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15203297|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15203298|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
15203299|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203300|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203301|NCT03746106|Thiamine|thiamine|mesh-list
15203302|NCT03746106|Metformin|metformin|mesh-list
14295402|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14295403|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14295404|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704811|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704812|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704813|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704814|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14704815|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14704816|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
14834016|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834017|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834018|NCT04890093|Vincristine|vincristine|mesh-list
14834019|NCT04890093|Temozolomide|temozolomide|mesh-list
14834020|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14834021|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834022|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834023|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
14834024|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
14834025|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834026|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14834027|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
14834028|NCT04884815|Prednisolone|prednisolone|mesh-list
14834029|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834030|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
14834031|NCT04884815|Hormones|hormones|mesh-ancestor
14834032|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834033|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834034|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834035|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834036|NCT04883346|Liraglutide|liraglutide|mesh-list
14834037|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14834038|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834039|NCT04883346|Incretins|incretins|mesh-ancestor
14295405|NCT00580957|Trimethaphan|trimethaphan|mesh-list
14704817|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704818|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14704819|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
14704820|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
14704821|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
14704822|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14704823|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
14704824|NCT00411879|Coagulants|coagulants|mesh-ancestor
14704825|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14704826|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
14704827|NCT00411905|Bortezomib|bortezomib|mesh-list
14704828|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704829|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14295406|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14834040|NCT04883346|Hormones|hormones|mesh-ancestor
14834041|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834042|NCT04882072|Ustekinumab|ustekinumab|mesh-list
14834043|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
14834044|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
14834045|NCT04880434|Fludarabine|fludarabine|mesh-list
14704830|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14834046|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704831|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14834047|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
14834048|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834049|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834050|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14834051|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
14834052|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834053|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834054|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15203303|NCT03746106|Trimethoprim|trimethoprim|mesh-list
15203304|NCT03746106|Vitamins|vitamins|mesh-ancestor
15203305|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
15203306|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203307|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15203308|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
15203309|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15203310|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834060|NCT04857034|BMS-986165|bms-986165|mesh-list
14834061|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14834062|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14834063|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834064|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834065|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
14834066|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834067|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834068|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
14834069|NCT04847063|Doxorubicin|doxorubicin|mesh-list
14834070|NCT04847063|Fluorouracil|fluorouracil|mesh-list
14834071|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
14834072|NCT04847063|Mitomycins|mitomycins|mesh-list
14834073|NCT04847063|Mitomycin|mitomycin|mesh-list
14834074|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834075|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14834076|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14834077|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14834078|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834079|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834080|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
14834081|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14834082|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834083|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
14834084|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834085|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
14834086|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14834087|NCT04847063|Antidotes|antidotes|mesh-ancestor
14834088|NCT04847063|Protective Agents|protective agents|mesh-ancestor
14834089|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
14834090|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
14834091|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14834092|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834093|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
14834094|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
14834095|NCT04840615|Ipilimumab|ipilimumab|mesh-list
14834096|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834097|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834098|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14911950|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
15203311|NCT03746106|Renal Agents|renal agents|mesh-ancestor
14834099|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834100|NCT04829318|Esketamine|esketamine|mesh-list
14834101|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
14834102|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834103|NCT04817345|Plerixafor|plerixafor|mesh-list
14834104|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14834105|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14834106|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
14834107|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834108|NCT04817254|Nivolumab|nivolumab|mesh-list
14834109|NCT04817254|Ipilimumab|ipilimumab|mesh-list
14834110|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834111|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834112|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14834113|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834114|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14295407|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14295408|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14295409|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
14704832|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
14704833|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704834|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704835|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14704836|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14704837|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
14704838|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704839|NCT00411996|Ritonavir|ritonavir|mesh-list
14704840|NCT00411996|Indinavir|indinavir|mesh-list
14704841|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14704842|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14704843|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
14704844|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704845|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704846|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14704847|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14704848|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
14704849|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704850|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14704851|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14704852|NCT00412022|Tamoxifen|tamoxifen|mesh-list
14704853|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
14704854|NCT00412022|Letrozole|letrozole|mesh-list
14704855|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14704856|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834115|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
14704857|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14704858|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14704859|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704860|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704861|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14704862|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
14704863|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834116|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834117|NCT04799288|Teriflunomide|teriflunomide|mesh-list
14834118|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14834119|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14834120|NCT04799288|Analgesics|analgesics|mesh-ancestor
14834121|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
14834122|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834123|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834124|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834125|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834126|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834127|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
14834128|NCT04785924|Imipenem|imipenem|mesh-list
14834129|NCT04785924|Relebactam|relebactam|mesh-list
14834130|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14834131|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834132|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14834133|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834134|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834135|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14834136|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14834137|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834138|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14834139|NCT04773353|Hormones|hormones|mesh-ancestor
14834140|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704864|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834141|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834142|NCT04770493|Lamotrigine|lamotrigine|mesh-list
14834143|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
14834144|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14834145|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704865|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704866|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14704867|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14704868|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15203312|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
15203313|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15203314|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15203315|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15203316|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203317|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203318|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15203319|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15203320|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15203321|NCT03745950|Olaparib|olaparib|mesh-list
15203322|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15203323|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203324|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203325|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203326|NCT03745911|Paclitaxel|paclitaxel|mesh-list
15203327|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14834146|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834147|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14834148|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834149|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14295410|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295411|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704869|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
14834150|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15203328|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203329|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834151|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834152|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834153|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14834154|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
14834155|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834156|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834157|NCT04767061|Propranolol|propranolol|mesh-list
14834158|NCT04767061|Metoprolol|metoprolol|mesh-list
14834159|NCT04767061|Atenolol|atenolol|mesh-list
14834160|NCT04767061|Sotalol|sotalol|mesh-list
14834161|NCT04767061|Nadolol|nadolol|mesh-list
14834162|NCT04767061|Acebutolol|acebutolol|mesh-list
14834163|NCT04767061|Carvedilol|carvedilol|mesh-list
14834164|NCT04767061|Nebivolol|nebivolol|mesh-list
14834165|NCT04767061|Bisoprolol|bisoprolol|mesh-list
15203330|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
15203331|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
15203332|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203333|NCT03745807|Nivolumab|nivolumab|mesh-list
15203334|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203335|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203336|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15203337|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203338|NCT03745716|Azacitidine|azacitidine|mesh-list
15203339|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15203340|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
14834166|NCT04767061|Labetalol|labetalol|mesh-list
14834167|NCT04767061|Pindolol|pindolol|mesh-list
14704870|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14704871|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
14704872|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14704873|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14704874|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
14704875|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14704876|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14704877|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14704878|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704879|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704880|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704881|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704882|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704883|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14704884|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704885|NCT00412100|Oxycodone|oxycodone|mesh-list
14704886|NCT00412100|Naloxone|naloxone|mesh-list
14704887|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704888|NCT00412100|Narcotics|narcotics|mesh-ancestor
14704889|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704890|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704891|NCT00412100|Analgesics|analgesics|mesh-ancestor
14704892|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
14704893|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704894|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14704895|NCT00412126|Insulin|insulin|mesh-list
14704896|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14834168|NCT04767061|Betaxolol|betaxolol|mesh-list
14834169|NCT04767061|Penbutolol|penbutolol|mesh-list
14834170|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14834171|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14834172|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
14834173|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834174|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834175|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834176|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14834177|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14704897|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834178|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
14834179|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
14834180|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
14834181|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834182|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14834183|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
14834184|NCT04767061|Protective Agents|protective agents|mesh-ancestor
14834185|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14834186|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14834187|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14834188|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14834189|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14834190|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14834191|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14834192|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14834193|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
14834194|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14834195|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
15203341|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203342|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203343|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203344|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
15203345|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15203346|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15203347|NCT03745664|Prednisolone|prednisolone|mesh-list
15203348|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
15203349|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15203350|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
15203351|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203352|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
15203353|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
15203354|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203355|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203356|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203357|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
15203358|NCT03745664|Hormones|hormones|mesh-ancestor
15203359|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295412|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14704898|NCT00412152|Oxycodone|oxycodone|mesh-list
15203360|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15203361|NCT03745664|Protective Agents|protective agents|mesh-ancestor
15203362|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14704899|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14704900|NCT00412152|Narcotics|narcotics|mesh-ancestor
14704901|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704902|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704903|NCT00412152|Analgesics|analgesics|mesh-ancestor
14704904|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
14704905|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704906|NCT00412191|Lamotrigine|lamotrigine|mesh-list
14704907|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
14295413|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14295414|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704908|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14295415|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295416|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295417|NCT00580970|Lovastatin|lovastatin|mesh-list
14295418|NCT00580970|L 647318|l 647318|mesh-list
14295419|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
14295420|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14295421|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14295422|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
14295423|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295424|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14295425|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15203363|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203364|NCT03745625|Propofol|propofol|mesh-list
15203365|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15203366|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203367|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203368|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15203369|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
15203370|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
15203371|NCT03745599|Diclofenac|diclofenac|mesh-list
15203372|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
15203373|NCT03745599|Benzydamine|benzydamine|mesh-list
15203374|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15203375|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203376|NCT03745599|Analgesics|analgesics|mesh-ancestor
15203377|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
15203378|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203379|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203380|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203381|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203382|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15203383|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203384|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203385|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
15203386|NCT03745586|Hormones|hormones|mesh-ancestor
15203387|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203388|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224695|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295426|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295427|NCT00580983|Paclitaxel|paclitaxel|mesh-list
15203389|NCT03745404|Lidocaine|lidocaine|mesh-list
15203390|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
15203391|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
15203392|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203393|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203394|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
15203395|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203396|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15203397|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15203398|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15203399|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15203400|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704909|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14704910|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704911|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14704912|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704913|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14704914|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14834252|NCT04757584|Propranolol|propranolol|mesh-list
14834253|NCT04757584|Metoprolol|metoprolol|mesh-list
14834254|NCT04757584|Atenolol|atenolol|mesh-list
14834255|NCT04757584|Sotalol|sotalol|mesh-list
14834256|NCT04757584|Nadolol|nadolol|mesh-list
14834257|NCT04757584|Acebutolol|acebutolol|mesh-list
14834258|NCT04757584|Carvedilol|carvedilol|mesh-list
14834259|NCT04757584|Nebivolol|nebivolol|mesh-list
14834260|NCT04757584|Bisoprolol|bisoprolol|mesh-list
14834261|NCT04757584|Labetalol|labetalol|mesh-list
14834262|NCT04757584|Pindolol|pindolol|mesh-list
14834263|NCT04757584|Betaxolol|betaxolol|mesh-list
14834264|NCT04757584|Penbutolol|penbutolol|mesh-list
14834265|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14834266|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14834267|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
14834268|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834269|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834270|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834271|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14834272|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14834273|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
14834274|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
14834275|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
14834276|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834277|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14704915|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14704916|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834278|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
14834279|NCT04757584|Protective Agents|protective agents|mesh-ancestor
14834280|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14834281|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15203401|NCT03745300|Atorvastatin|atorvastatin|mesh-list
14704917|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14704918|NCT00412204|Bromides|bromides|mesh-list
14704919|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
14834282|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14834283|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14834284|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14834285|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14834286|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14834287|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14834288|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
14834289|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14834290|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
14834291|NCT04739813|Prednisone|prednisone|mesh-list
14834292|NCT04739813|Lenalidomide|lenalidomide|mesh-list
14834293|NCT04739813|Venetoclax|venetoclax|mesh-list
14834294|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
14834295|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203402|NCT03745300|Simvastatin|simvastatin|mesh-list
15203403|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15203404|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15203405|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
15203406|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203407|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15203408|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15203409|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203410|NCT03745261|Fluticasone|fluticasone|mesh-list
15203411|NCT03745261|Xhance|xhance|mesh-list
15203412|NCT03745261|Bromides|bromides|mesh-list
15203413|NCT03745261|Albuterol|albuterol|mesh-list
14834296|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
14834297|NCT04739813|Hormones|hormones|mesh-ancestor
14834298|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834299|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834300|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834301|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834302|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
15203414|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
15203415|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14834303|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14834304|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14834305|NCT04739813|Growth Substances|growth substances|mesh-ancestor
14834306|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
14834307|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834308|NCT04722718|Paclitaxel|paclitaxel|mesh-list
14834309|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14704920|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14704921|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
14704922|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14704923|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704924|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14704925|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
14704926|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
14704927|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14295428|NCT00580983|Carboplatin|carboplatin|mesh-list
14295429|NCT00580983|Fluorouracil|fluorouracil|mesh-list
14295430|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14704928|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
14704929|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14704930|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834310|NCT04722718|Carboplatin|carboplatin|mesh-list
14834311|NCT04722718|Apatinib|apatinib|mesh-list
14834312|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14704931|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
14704932|NCT00412321|Siltuximab|siltuximab|mesh-list
14834313|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834314|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834315|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
14834316|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
14834317|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834318|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14834319|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834320|NCT04720547|Zolpidem|zolpidem|mesh-list
14834321|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14834322|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14834323|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834324|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834325|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14834326|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
14834327|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
14834328|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834329|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834330|NCT04718285|Favipiravir|favipiravir|mesh-list
14834331|NCT04718285|Montelukast|montelukast|mesh-list
14834332|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14834333|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
14834334|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14704933|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704934|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14704935|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
14704936|NCT00412334|Ribavirin|ribavirin|mesh-list
14704937|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
14704938|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704939|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
14704940|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704941|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
14704942|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704943|NCT00412347|Insulin|insulin|mesh-list
14704944|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14704945|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704946|NCT00412412|Trastuzumab|trastuzumab|mesh-list
14704947|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14704948|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704949|NCT00412503|Temozolomide|temozolomide|mesh-list
14704950|NCT00412503|Topotecan|topotecan|mesh-list
14704951|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14704952|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
14834335|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
14834336|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834337|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834338|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14834339|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14834340|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834341|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
14834342|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834343|NCT04708470|Entinostat|entinostat|mesh-list
14834344|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834345|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14834346|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834347|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834348|NCT04699604|Levocetirizine|levocetirizine|mesh-list
15203416|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15203417|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203418|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15203419|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
15203420|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203421|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203422|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14834349|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14834350|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14834351|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
14834352|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
14834353|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834354|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834355|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834356|NCT04692831|Pertuzumab|pertuzumab|mesh-list
14834357|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834358|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834359|NCT04687800|Dexamethasone|dexamethasone|mesh-list
14834360|NCT04687800|Difluprednate|difluprednate|mesh-list
14834361|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834362|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
14834363|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
14834364|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834365|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834366|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14834367|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
14834368|NCT04687800|Hormones|hormones|mesh-ancestor
14834369|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834370|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834371|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834372|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15203423|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
15203424|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
15203425|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14704953|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704954|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704955|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14704956|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14704957|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704958|NCT00412555|Oseltamivir|oseltamivir|mesh-list
14704959|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
14704960|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834373|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834374|NCT04678089|Bortezomib|bortezomib|mesh-list
14834375|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834376|NCT04673357|Ustekinumab|ustekinumab|mesh-list
14704961|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704962|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704963|NCT00412581|Lenalidomide|lenalidomide|mesh-list
14834377|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
14834378|NCT04673175|Tazobactam|tazobactam|mesh-list
14834379|NCT04673175|Ceftolozane|ceftolozane|mesh-list
14834380|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14834381|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14834382|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834383|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14834384|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834385|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834386|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14834387|NCT04673175|Renal Agents|renal agents|mesh-ancestor
14834388|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
14834389|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
14834390|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834391|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14834392|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834393|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834394|NCT04643002|Dexamethasone|dexamethasone|mesh-list
14704964|NCT00412581|Dacarbazine|dacarbazine|mesh-list
14704965|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
14704966|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704967|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14704968|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14704969|NCT00412581|Growth Substances|growth substances|mesh-ancestor
14834395|NCT04643002|Pomalidomide|pomalidomide|mesh-list
14834396|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14704970|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
14704971|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704972|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14704973|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
14834397|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
15203426|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
15203427|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14834398|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
14834399|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834400|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834401|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14834402|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
14834403|NCT04643002|Hormones|hormones|mesh-ancestor
14834404|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834405|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834406|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834407|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
14834408|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14834409|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14834410|NCT04643002|Growth Substances|growth substances|mesh-ancestor
14834411|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
14834412|NCT04639843|Doxorubicin|doxorubicin|mesh-list
14834413|NCT04639843|Romidepsin|romidepsin|mesh-list
14834414|NCT04639843|Azacitidine|azacitidine|mesh-list
14834415|NCT04639843|Cc-486|cc-486|mesh-list
14834416|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14834417|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834418|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14834419|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14834420|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834421|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834422|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14834423|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
14834424|NCT04633252|Prednisone|prednisone|mesh-list
14834425|NCT04633252|Docetaxel|docetaxel|mesh-list
14834426|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834427|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834428|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14834429|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14834430|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834431|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834432|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
14834433|NCT04633252|Hormones|hormones|mesh-ancestor
14834434|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834435|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834436|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834437|NCT04630028|Ustekinumab|ustekinumab|mesh-list
14834438|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
14834439|NCT04619082|Tenofovir|tenofovir|mesh-list
14704974|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704975|NCT00412594|Rituximab|rituximab|mesh-list
14704976|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14704977|NCT00412594|Cladribine|cladribine|mesh-list
14704978|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14704979|NCT00412594|Antibodies|antibodies|mesh-list
14704980|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
14834440|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
14834441|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834442|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14834443|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14834444|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834445|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704981|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14704982|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
14704983|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14704984|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14704985|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14704986|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14704987|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14704988|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
14704989|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834446|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14834447|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14834448|NCT04602221|Lamotrigine|lamotrigine|mesh-list
14834449|NCT04602221|BI 425809|bi 425809|mesh-list
14834450|NCT04602221|BI 409306|bi 409306|mesh-list
14834451|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
14834452|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14834453|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14834454|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834455|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14834456|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834457|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14834458|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14834459|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834460|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834461|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14834462|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14834463|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834464|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
14834465|NCT04599855|Esketamine|esketamine|mesh-list
14834466|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
14834467|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834468|NCT04599634|Venetoclax|venetoclax|mesh-list
14834469|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
14834470|NCT04599634|Magrolimab|magrolimab|mesh-list
14834471|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834472|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834473|NCT04591431|Nivolumab|nivolumab|mesh-list
14834474|NCT04591431|Trastuzumab|trastuzumab|mesh-list
14834475|NCT04591431|Ipilimumab|ipilimumab|mesh-list
14834476|NCT04591431|Pertuzumab|pertuzumab|mesh-list
14834477|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14834478|NCT04591431|Everolimus|everolimus|mesh-list
14834479|NCT04591431|Atezolizumab|atezolizumab|mesh-list
14834480|NCT04591431|Lapatinib|lapatinib|mesh-list
14834481|NCT04591431|Palbociclib|palbociclib|mesh-list
14834482|NCT04591431|Vemurafenib|vemurafenib|mesh-list
14834483|NCT04591431|Maytansine|maytansine|mesh-list
14834484|NCT04591431|Ponatinib|ponatinib|mesh-list
14834485|NCT04591431|Entrectinib|entrectinib|mesh-list
14834486|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834487|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834488|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14834489|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834490|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834491|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
14834492|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834493|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14834494|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834495|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14834496|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834497|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
14834498|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
14834499|NCT04588948|Aflibercept|aflibercept|mesh-list
14834500|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14834501|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14834502|NCT04588948|Growth Substances|growth substances|mesh-ancestor
14834503|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834504|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
14834505|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834506|NCT04577014|Gemcitabine|gemcitabine|mesh-list
14834507|NCT04577014|Docetaxel|docetaxel|mesh-list
14834508|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14834509|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
14834510|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834511|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834512|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
14834513|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834514|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834515|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834516|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
14834517|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834518|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834519|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
14834520|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
14834521|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
14834522|NCT04566133|Trametinib|trametinib|mesh-list
14834523|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
14834524|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14834525|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15203428|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
15203429|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203430|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834526|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834527|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834528|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834529|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834530|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834531|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14834532|NCT04562129|Aldesleukin|aldesleukin|mesh-list
14834533|NCT04562129|Nivolumab|nivolumab|mesh-list
14834534|NCT04562129|Ipilimumab|ipilimumab|mesh-list
14834535|NCT04562129|Interleukin-2|interleukin-2|mesh-list
14834536|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834537|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834538|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14834539|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834540|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14834541|NCT04562129|Analgesics|analgesics|mesh-ancestor
14834542|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
14834543|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834544|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834545|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14834546|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14834547|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
14834548|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834549|NCT04545736|Metformin|metformin|mesh-list
14834550|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14834551|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834552|NCT04544293|Molgramostim|molgramostim|mesh-list
14834553|NCT04544293|Sargramostim|sargramostim|mesh-list
14834554|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
14834555|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834556|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834557|NCT04538378|Durvalumab|durvalumab|mesh-list
14834558|NCT04538378|Olaparib|olaparib|mesh-list
15203431|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15203432|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15203433|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15203434|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
15203435|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
15203436|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
15203437|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15203438|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
15203439|NCT03745261|Hormones|hormones|mesh-ancestor
15203440|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14704990|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
14704991|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704992|NCT00412646|Etravirine|etravirine|mesh-list
14704993|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14704994|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14704995|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14704996|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14704997|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
14704998|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14704999|NCT00412698|Rimonabant|rimonabant|mesh-list
14705000|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14705001|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14705002|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14705003|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705004|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705005|NCT00412698|Hormones|hormones|mesh-ancestor
14705006|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705007|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705008|NCT00412763|Silymarin|silymarin|mesh-list
14705009|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
14705010|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705011|NCT00412763|Protective Agents|protective agents|mesh-ancestor
14705012|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705013|NCT00412789|Epothilone B|epothilone b|mesh-list
14705014|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705015|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705016|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
15203441|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
15203442|NCT03745170|Capecitabine|capecitabine|mesh-list
14834559|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834560|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834561|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14834562|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834563|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834564|NCT04534023|Idebenone|idebenone|mesh-list
14834565|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
14834566|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834567|NCT04534023|Protective Agents|protective agents|mesh-ancestor
14834568|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834569|NCT04524663|Camostat|camostat|mesh-list
14834570|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
14834571|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834572|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834573|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14834574|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14834575|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14834576|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
14834577|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834578|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14834579|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14834580|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834581|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834582|NCT04513522|Nivolumab|nivolumab|mesh-list
14834583|NCT04513522|Ipilimumab|ipilimumab|mesh-list
14834584|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834585|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834586|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14834587|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834588|NCT04496960|Tofacitinib|tofacitinib|mesh-list
14834589|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14834590|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834591|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834592|NCT04492956|Ecopipam|ecopipam|mesh-list
14834593|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14834594|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14834595|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834596|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834597|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834598|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14834599|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
14834600|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203443|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
15203444|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15203445|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
15203446|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203447|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203448|NCT03745157|Insulin|insulin|mesh-list
15203449|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
15203450|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15203451|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203452|NCT03745105|Dexamethasone|dexamethasone|mesh-list
15203453|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
15203454|NCT03745105|Piroxicam|piroxicam|mesh-list
15203455|NCT03745105|Mepivacaine|mepivacaine|mesh-list
15203456|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15203457|NCT03745105|BB 1101|bb 1101|mesh-list
15203458|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203459|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
15203460|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
15203461|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203462|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203463|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203464|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
15203465|NCT03745105|Hormones|hormones|mesh-ancestor
15203466|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203467|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15203468|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203469|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
15203470|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
15203471|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203472|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
15203473|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
14295431|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834601|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834602|NCT04491877|Vaccines|vaccines|mesh-list
14834603|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
14834604|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834605|NCT04488952|Anesthetics|anesthetics|mesh-list
14834606|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834607|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203474|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203475|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203476|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15203477|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203478|NCT03745105|Analgesics|analgesics|mesh-ancestor
15203479|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203480|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15203481|NCT03745040|Bupivacaine|bupivacaine|mesh-list
14834608|NCT04480554|Naltrexone|naltrexone|mesh-list
14834609|NCT04480554|Buprenorphine|buprenorphine|mesh-list
14834610|NCT04480554|Methadone|methadone|mesh-list
14834611|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14834612|NCT04480554|Naloxone|naloxone|mesh-list
14834613|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14834614|NCT04480554|Narcotics|narcotics|mesh-ancestor
14834615|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834616|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834617|NCT04480554|Analgesics|analgesics|mesh-ancestor
14834618|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
14834619|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834620|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14834621|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14834622|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
14834623|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
15203482|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
15203483|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
14834624|NCT04479072|Aspirin|aspirin|mesh-list
14834625|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14834626|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14834627|NCT04479072|Analgesics|analgesics|mesh-ancestor
14834628|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
14834629|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834630|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834631|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834632|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834633|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15203484|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203485|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203486|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
14834634|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14834635|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834636|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14834637|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14834638|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834639|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
14834640|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
14834641|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14834642|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
14834643|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834644|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834645|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14834646|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
14834647|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14834648|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
14834649|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834650|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834651|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15203487|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203488|NCT03744988|Androgens|androgens|mesh-list
15203489|NCT03744988|Hormones|hormones|mesh-ancestor
15203490|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203491|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203492|NCT03744949|Remifentanil|remifentanil|mesh-list
15203493|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15203494|NCT03744949|Narcotics|narcotics|mesh-ancestor
15203495|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224696|NCT02673151|Edetic Acid|edetic acid|mesh-list
14834652|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
14834653|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
14295432|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295433|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
14295434|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295435|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295436|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
14295437|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14295438|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295439|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
14295440|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295441|NCT00581048|Vitamin E|vitamin e|mesh-list
14834654|NCT04476992|Protective Agents|protective agents|mesh-ancestor
14834655|NCT04476446|Esketamine|esketamine|mesh-list
14834656|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
14834657|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834658|NCT04476277|Biotin|biotin|mesh-list
14834659|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
14834660|NCT04476277|Vitamins|vitamins|mesh-ancestor
14834661|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
14834662|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834663|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
14834664|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834665|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
14834666|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14834667|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834668|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834669|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834670|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14834671|NCT04449549|Paclitaxel|paclitaxel|mesh-list
14834672|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14834673|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834674|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834675|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
14834676|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14834677|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834678|NCT04447027|Dexamethasone|dexamethasone|mesh-list
14834679|NCT04447027|Lenalidomide|lenalidomide|mesh-list
14834680|NCT04447027|Azacitidine|azacitidine|mesh-list
14834681|NCT04447027|Romidepsin|romidepsin|mesh-list
14834682|NCT04447027|Cc-486|cc-486|mesh-list
14834683|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834684|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
14834685|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
14834686|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834687|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834688|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14834689|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
14834690|NCT04447027|Hormones|hormones|mesh-ancestor
14834691|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834692|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834693|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834694|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
14834695|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14834696|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14834697|NCT04447027|Growth Substances|growth substances|mesh-ancestor
14834698|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
14834699|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14834700|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
14834701|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834702|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834703|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14834704|NCT04444921|Paclitaxel|paclitaxel|mesh-list
14834705|NCT04444921|Carboplatin|carboplatin|mesh-list
14834706|NCT04444921|Nivolumab|nivolumab|mesh-list
15203496|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203497|NCT03744949|Analgesics|analgesics|mesh-ancestor
15203498|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
15203499|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834707|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15203500|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15203501|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834708|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14834709|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834710|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
14834711|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
14834712|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
15203502|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203503|NCT03744806|Bevacizumab|bevacizumab|mesh-list
15203504|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203505|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203506|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15203507|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15203508|NCT03744806|Growth Substances|growth substances|mesh-ancestor
15203509|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834713|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834714|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834715|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14834716|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
14834717|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
14834718|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14834719|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
14834720|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14834721|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
14834722|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834723|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203510|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
15203511|NCT03744767|Spironolactone|spironolactone|mesh-list
15203512|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14295442|NCT00581048|Tocopherols|tocopherols|mesh-list
14295443|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
14295444|NCT00581048|Vitamins|vitamins|mesh-ancestor
14295445|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
14295446|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203513|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
15203514|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834724|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
14834725|NCT04426825|Bevacizumab|bevacizumab|mesh-list
14834726|NCT04426825|Atezolizumab|atezolizumab|mesh-list
14834727|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834728|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834729|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14834730|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14705017|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705018|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705019|NCT00412802|Enoxaparin|enoxaparin|mesh-list
14705020|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
14705021|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
14834731|NCT04426825|Growth Substances|growth substances|mesh-ancestor
14834732|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834733|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
14834734|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
14834735|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834736|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834737|NCT04413799|Lidocaine|lidocaine|mesh-list
14834738|NCT04413799|Ketamine|ketamine|mesh-list
14834739|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
14834740|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
14834741|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295447|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
14705022|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14705023|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14705024|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705025|NCT00412919|Azacitidine|azacitidine|mesh-list
14705026|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14834742|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834743|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
15203515|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203516|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15203517|NCT03744767|Diuretics|diuretics|mesh-ancestor
15203518|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
15203519|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
15203520|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
14295448|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295449|NCT00581048|Protective Agents|protective agents|mesh-ancestor
14705027|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
14705028|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705029|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705030|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705031|NCT00412997|Panobinostat|panobinostat|mesh-list
14834744|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705032|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834745|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14834746|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14834747|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14834748|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14834749|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203521|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203522|NCT03744702|Protective Agents|protective agents|mesh-ancestor
15203523|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203524|NCT03744702|Vitamins|vitamins|mesh-ancestor
14834750|NCT04413799|Analgesics|analgesics|mesh-ancestor
14834751|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14834752|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14834753|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
14834754|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14834755|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14834756|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834757|NCT04410991|Teriflunomide|teriflunomide|mesh-list
14834758|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14834759|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14834760|NCT04410991|Analgesics|analgesics|mesh-ancestor
14834761|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
14834762|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834763|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705033|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14705034|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705035|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705036|NCT00413023|Casopitant|casopitant|mesh-list
14705037|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
14705038|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
14705039|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705040|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705041|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14834764|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834765|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834766|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834767|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
14834768|NCT04410978|Teriflunomide|teriflunomide|mesh-list
14834769|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14834770|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14834771|NCT04410978|Analgesics|analgesics|mesh-ancestor
14834772|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
14834773|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834774|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834775|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834776|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834777|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834778|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
14834779|NCT04402788|Atezolizumab|atezolizumab|mesh-list
14834780|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14834781|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834782|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
14834783|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834784|NCT04401761|Aspirin|aspirin|mesh-list
14834785|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
14834786|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14834787|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203525|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
15203526|NCT03744689|Bupivacaine|bupivacaine|mesh-list
15203527|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
15203528|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
15203529|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203530|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203531|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
14834788|NCT04401761|Analgesics|analgesics|mesh-ancestor
14834789|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
14834790|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834791|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834792|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834793|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834794|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14834795|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14834796|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203532|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728598|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
14834797|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14834798|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14834799|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834800|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
14834801|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14834802|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
14834803|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14834804|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14834805|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
14834806|NCT04396873|11C-PS13|11c-ps13|mesh-list
14834807|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14834808|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834809|NCT04370795|Sirolimus|sirolimus|mesh-list
14834810|NCT04370795|Busulfan|busulfan|mesh-list
14834811|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14834812|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15203533|NCT03744663|Buprenorphine|buprenorphine|mesh-list
15203534|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15203535|NCT03744663|Naloxone|naloxone|mesh-list
14705042|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14705043|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705044|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705045|NCT00413075|Belinostat|belinostat|mesh-list
14705046|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705047|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14705048|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705049|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705050|NCT00413088|Bemiparin|bemiparin|mesh-list
14705051|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
14705052|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
14705053|NCT00413101|Hematinics|hematinics|mesh-ancestor
14705054|NCT00413127|Lidocaine|lidocaine|mesh-list
14705055|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
14705056|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
14705057|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14705058|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705059|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
14705060|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203536|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15203537|NCT03744663|Narcotics|narcotics|mesh-ancestor
15203538|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203539|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203540|NCT03744663|Analgesics|analgesics|mesh-ancestor
15203541|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
14834813|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14834814|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834815|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
14834816|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834817|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
14834818|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834819|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
14834820|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834821|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14834822|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14834823|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
14834824|NCT04370509|Axitinib|axitinib|mesh-list
14834825|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834826|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834827|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14834828|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834829|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834830|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
14834831|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
14834832|NCT04355130|Vitamins|vitamins|mesh-ancestor
14834833|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
14834834|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834835|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
15203542|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834836|NCT04355130|Hematinics|hematinics|mesh-ancestor
14705061|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14834837|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14834838|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834839|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
14834840|NCT04340505|Hormones|hormones|mesh-ancestor
14834841|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203543|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15203544|NCT03744364|Misoprostol|misoprostol|mesh-list
15203545|NCT03744364|Dinoprostone|dinoprostone|mesh-list
15203546|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15203547|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
15203548|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15203549|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203550|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15203551|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203552|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
15203553|NCT03744247|Lenvatinib|lenvatinib|mesh-list
15203554|NCT03744247|Antibodies|antibodies|mesh-list
15203555|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
15203556|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
15203557|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834842|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834843|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
14834844|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
14834845|NCT04339777|Busulfan|busulfan|mesh-list
14834846|NCT04339777|Fludarabine|fludarabine|mesh-list
14834847|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
14834848|NCT04339777|Tacrolimus|tacrolimus|mesh-list
14834849|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15203558|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203559|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203560|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203561|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834850|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
14834851|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834852|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834853|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14834854|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
14834855|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203562|NCT03744208|Cetuximab|cetuximab|mesh-list
15203563|NCT03744208|Antibodies|antibodies|mesh-list
14705062|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14705063|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14705064|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14705065|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728599|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
14728600|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728601|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728602|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
14728603|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728604|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14728605|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14728606|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14728607|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728608|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728609|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14728610|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
14728611|NCT00519246|Narcotics|narcotics|mesh-ancestor
14728612|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728613|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728614|NCT00519246|Analgesics|analgesics|mesh-ancestor
14728615|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
14728616|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728617|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14728618|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203564|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15203565|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
15203566|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834856|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295450|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
14295451|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14295452|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14295453|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
14295454|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295455|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295456|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295457|NCT00581061|Urological Agents|urological agents|mesh-ancestor
15203567|NCT03744208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203568|NCT03744208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203569|NCT03744104|Vaccines|vaccines|mesh-list
15203570|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
15203571|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203572|NCT03744091|Dronabinol|dronabinol|mesh-list
15203573|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
15203574|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203575|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15203576|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203577|NCT03744091|Analgesics|analgesics|mesh-ancestor
15203578|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
14705066|NCT00413179|Metformin|metformin|mesh-list
14705067|NCT00413179|Clomiphene|clomiphene|mesh-list
14705068|NCT00413179|Enclomiphene|enclomiphene|mesh-list
14834857|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14834858|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14834859|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834860|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15203579|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203580|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15203581|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14705069|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
14834861|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14834862|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
14834863|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14834864|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834865|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834866|NCT04339751|Vorinostat|vorinostat|mesh-list
14834867|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834868|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14834869|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834870|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834871|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14834872|NCT04338321|Esketamine|esketamine|mesh-list
14834873|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
14834874|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14834875|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14834876|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14834877|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14834878|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834879|NCT04334759|Cisplatin|cisplatin|mesh-list
14834880|NCT04334759|Carboplatin|carboplatin|mesh-list
14834881|NCT04334759|Pemetrexed|pemetrexed|mesh-list
14834882|NCT04334759|Durvalumab|durvalumab|mesh-list
14834883|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834884|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834885|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834886|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14834887|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14834888|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834889|NCT04327206|Vaccines|vaccines|mesh-list
14834890|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
14705070|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14705071|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705072|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14705073|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
14705074|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705075|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14705076|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
14705077|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14705078|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14834891|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
14834892|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834893|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14834894|NCT04312659|Infliximab|infliximab|mesh-list
15203582|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14834895|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
14834896|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14834897|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834898|NCT04304820|Cyclosporine|cyclosporine|mesh-list
14834899|NCT04304820|Cyclosporins|cyclosporins|mesh-list
14834900|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14834901|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834902|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834903|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14834904|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
14834905|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834906|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
14834907|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14834908|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
14834909|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14834910|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14834911|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14834912|NCT04291105|Cemiplimab|cemiplimab|mesh-list
14834913|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14834914|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834915|NCT04285580|Bimatoprost|bimatoprost|mesh-list
14834916|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14834917|NCT04270409|Dexamethasone|dexamethasone|mesh-list
14834918|NCT04270409|Lenalidomide|lenalidomide|mesh-list
14834919|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834920|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
14834921|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
14834922|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834923|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834924|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14834925|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
14834926|NCT04270409|Hormones|hormones|mesh-ancestor
14834927|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834928|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834929|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834930|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
14834931|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14834932|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14834933|NCT04270409|Growth Substances|growth substances|mesh-ancestor
14834934|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
15203583|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203584|NCT03744091|Hormones|hormones|mesh-ancestor
15203585|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203586|NCT03743987|Pemetrexed|pemetrexed|mesh-list
15203587|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203588|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203589|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203590|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15203591|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15203592|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
15203593|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
15203594|NCT03743922|Vitamin D|vitamin d|mesh-list
14834959|NCT04237012|Dexamethasone|dexamethasone|mesh-list
14834960|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
14834961|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834962|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
14834963|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
14834964|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834965|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834966|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14834967|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
14834968|NCT04237012|Hormones|hormones|mesh-ancestor
14834969|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834970|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834971|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834972|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14834973|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14834974|NCT04236414|Olaparib|olaparib|mesh-list
14834975|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14834976|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14834977|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14834978|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834979|NCT04234360|Prednisone|prednisone|mesh-list
14834980|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834981|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
14834982|NCT04234360|Hormones|hormones|mesh-ancestor
14834983|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14834984|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834985|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14834986|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14834987|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
14834988|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14834989|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14834990|NCT04233164|Prednisolone|prednisolone|mesh-list
14834991|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
15203595|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15224697|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14834992|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14834993|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
14834994|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14834995|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
14834996|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
14834997|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14834998|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14834999|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835000|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
14835001|NCT04233164|Hormones|hormones|mesh-ancestor
14835002|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835003|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14835004|NCT04233164|Protective Agents|protective agents|mesh-ancestor
14835005|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705079|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14705080|NCT00413257|Nefopam|nefopam|mesh-list
14835006|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835007|NCT04232306|Bupivacaine|bupivacaine|mesh-list
14835008|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
14835009|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
14835010|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835011|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835012|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
14835013|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835014|NCT04225221|Leuprolide|leuprolide|mesh-list
14295458|NCT00581100|Etanercept|etanercept|mesh-list
14705081|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14835015|NCT04225221|Estradiol|estradiol|mesh-list
14835016|NCT04225221|Progesterone|progesterone|mesh-list
14835017|NCT04225221|Estrogens|estrogens|mesh-ancestor
14835018|NCT04225221|Hormones|hormones|mesh-ancestor
14835019|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835020|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835021|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14835022|NCT04225221|Progestins|progestins|mesh-ancestor
14835023|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14835024|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
14835025|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14835026|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835027|NCT04216329|Temozolomide|temozolomide|mesh-list
14835028|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835029|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
14835030|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835031|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203596|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203597|NCT03743922|Vitamins|vitamins|mesh-ancestor
15203598|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
15203599|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15203600|NCT03743896|Capsaicin|capsaicin|mesh-list
15203601|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
15203602|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
15203603|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
14705082|NCT00413257|Analgesics|analgesics|mesh-ancestor
14705083|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
14705084|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705085|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705086|NCT00413296|Levetiracetam|levetiracetam|mesh-list
14705087|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
14705088|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
14705089|NCT00413322|Fluorouracil|fluorouracil|mesh-list
14705090|NCT00413322|Belinostat|belinostat|mesh-list
14835037|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14835038|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14835039|NCT04209595|Rucaparib|rucaparib|mesh-list
14835040|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14705091|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
14705092|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705093|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14705094|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705095|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705096|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
14705097|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705098|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14705099|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705100|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
14705101|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
14705102|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14705103|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14705104|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705105|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705106|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705107|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705108|NCT00413387|Budesonide|budesonide|mesh-list
14705109|NCT00413387|Beclomethasone|beclomethasone|mesh-list
14705110|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
14705111|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705112|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14705113|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
14705114|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705115|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835041|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835042|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835043|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835044|NCT04206319|Listerine|listerine|mesh-list
14835045|NCT04206319|Fluorides|fluorides|mesh-list
14835046|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
14835047|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
14835048|NCT04206319|Protective Agents|protective agents|mesh-ancestor
14835049|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835050|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14835051|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835052|NCT04206163|Edotreotide|edotreotide|mesh-list
14835053|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14835054|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835055|NCT04170153|Niraparib|niraparib|mesh-list
14835056|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14835057|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835058|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835059|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835060|NCT04166383|Nivolumab|nivolumab|mesh-list
14835061|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835062|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835063|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14835064|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835065|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
14835066|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835067|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
14835068|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835069|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705116|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14705117|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
14835070|NCT04154956|Docetaxel|docetaxel|mesh-list
14835071|NCT04154956|Maytansine|maytansine|mesh-list
14835072|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835073|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
14835074|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
14835075|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
14835076|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835077|NCT04154956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295459|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295460|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295461|NCT00581100|Analgesics|analgesics|mesh-ancestor
14295462|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
14295463|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295464|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295465|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295466|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295467|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295468|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295469|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
14295470|NCT00581360|Doxorubicin|doxorubicin|mesh-list
14295471|NCT00581360|Bortezomib|bortezomib|mesh-list
14295472|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14295473|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295474|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14295475|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14295476|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295477|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295478|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
14295479|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14295480|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295481|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14295482|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14295483|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295484|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295485|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295486|NCT00581555|Etanercept|etanercept|mesh-list
14295487|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295488|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295489|NCT00581555|Analgesics|analgesics|mesh-ancestor
14295490|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
14295491|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835078|NCT04141696|Midazolam|midazolam|mesh-list
14835079|NCT04141696|Ketamine|ketamine|mesh-list
14295492|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835080|NCT04141696|Analgesics|analgesics|mesh-ancestor
14835081|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
14835082|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835083|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835084|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14835085|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14835086|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
14835087|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
14835088|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835089|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14835090|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14835091|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14835092|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835093|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14835094|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14835095|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14835096|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14835097|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14835098|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
15203604|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203605|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203606|NCT03743883|Aspirin|aspirin|mesh-list
15203607|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15203608|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203609|NCT03743883|Analgesics|analgesics|mesh-ancestor
15203610|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
15203611|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835099|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
14835100|NCT04140305|Ozanimod|ozanimod|mesh-list
14835101|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14835102|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835103|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835104|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
14835105|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835106|NCT04137068|Benzocaine|benzocaine|mesh-list
14835107|NCT04137068|Anesthetics, Local|anesthetics, local|mesh-ancestor
14835108|NCT04137068|Anesthetics|anesthetics|mesh-ancestor
14835109|NCT04137068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835110|NCT04137068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835111|NCT04137068|Sensory System Agents|sensory system agents|mesh-ancestor
14835112|NCT04137068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835113|NCT04136353|Hormones|hormones|mesh-list
14835114|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14835115|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835116|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835117|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
14835118|NCT04119024|Fludarabine|fludarabine|mesh-list
14835119|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
14835120|NCT04119024|Interleukin-2|interleukin-2|mesh-list
14835121|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835122|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
14835123|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835124|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835125|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835126|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
14835127|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835128|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835129|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835130|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835131|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
14835132|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14835133|NCT04119024|Analgesics|analgesics|mesh-ancestor
14835134|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
14835135|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835136|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14835137|NCT04113382|Laxatives|laxatives|mesh-ancestor
14835138|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835139|NCT04102436|Aldesleukin|aldesleukin|mesh-list
14835140|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
14835141|NCT04102436|Fludarabine|fludarabine|mesh-list
14835142|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835143|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
14835144|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835145|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835146|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835147|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
14835148|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835149|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835150|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835151|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14835152|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14835153|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
14835154|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835155|NCT04102098|Bevacizumab|bevacizumab|mesh-list
14835156|NCT04102098|Atezolizumab|atezolizumab|mesh-list
14835157|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835158|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835159|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14835160|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14835161|NCT04102098|Growth Substances|growth substances|mesh-ancestor
14835162|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835163|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
14835164|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14835165|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14835166|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835167|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835168|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
14835169|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835170|NCT04086485|Olaparib|olaparib|mesh-list
14835171|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14835172|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295493|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835173|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835174|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835175|NCT04085276|Paclitaxel|paclitaxel|mesh-list
14835176|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14835177|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14835178|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835179|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
14835180|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
14835181|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
14835182|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835183|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14835184|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
14835185|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835186|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14835187|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14835188|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835189|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835190|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14835191|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14835192|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14835193|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835194|NCT04065841|Licogliflozin|licogliflozin|mesh-list
14835195|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14835196|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835197|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14835198|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835199|NCT04054752|Vaccines|vaccines|mesh-list
14835200|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
14835201|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835202|NCT04045795|Dexamethasone|dexamethasone|mesh-list
14835203|NCT04045795|Pomalidomide|pomalidomide|mesh-list
14835204|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14835205|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835206|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
14835207|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
14835208|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203612|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705118|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
14705119|NCT00413387|Hormones|hormones|mesh-ancestor
14705120|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705121|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14705122|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14705123|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14705124|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
14705125|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705126|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705127|NCT00413426|Darifenacin|darifenacin|mesh-list
14705128|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14705129|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14705130|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
14705131|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705132|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705133|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705134|NCT00413426|Urological Agents|urological agents|mesh-ancestor
14705135|NCT00413439|Isavuconazole|isavuconazole|mesh-list
14705136|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
14705137|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705138|NCT00413452|Etanercept|etanercept|mesh-list
14705139|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14705140|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14705141|NCT00413452|Analgesics|analgesics|mesh-ancestor
14705142|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
14705143|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705144|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705145|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705146|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203613|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203614|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203615|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15203616|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15203617|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203618|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15203619|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14835209|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835210|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835211|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
14835212|NCT04045795|Hormones|hormones|mesh-ancestor
14835213|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835214|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14835215|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835216|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
14835217|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14835218|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14835219|NCT04045795|Growth Substances|growth substances|mesh-ancestor
14835220|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14835221|NCT04041050|Celecoxib|celecoxib|mesh-list
14835222|NCT04041050|Navitoclax|navitoclax|mesh-list
14835223|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14835224|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14835225|NCT04041050|Analgesics|analgesics|mesh-ancestor
14835226|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
14835227|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835228|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835229|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835230|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835231|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15203620|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203621|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
15203622|NCT03743870|Bupivacaine|bupivacaine|mesh-list
15203623|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
15203624|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
15203625|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
15203626|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203627|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203628|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
15203629|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835232|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14835233|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835234|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835235|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835236|NCT04034251|Paclitaxel|paclitaxel|mesh-list
14835237|NCT04034251|Capecitabine|capecitabine|mesh-list
14835238|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14835239|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835240|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14835241|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14835242|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14835243|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835244|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835245|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
14835246|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
14835247|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835248|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835249|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14835250|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835251|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14835252|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14835253|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
14835254|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835255|NCT04009824|Antacids|antacids|mesh-ancestor
14835256|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835257|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835258|NCT04007029|Vidarabine|vidarabine|mesh-list
14835259|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
14835260|NCT04007029|Fludarabine|fludarabine|mesh-list
14835261|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
14835262|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
14835263|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
14835264|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15203630|NCT03743805|Naloxone|naloxone|mesh-list
15203631|NCT03743805|Flumazenil|flumazenil|mesh-list
14835265|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
14835266|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835267|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835268|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835269|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
14835270|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835271|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835272|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835273|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835274|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
14835275|NCT04007029|Antiviral Agents|antiviral agents|mesh-ancestor
14835276|NCT04007029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835277|NCT04002947|Rituximab|rituximab|mesh-list
14835278|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
14835279|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835280|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835281|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
14835282|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835283|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835284|NCT03986034|Venetoclax|venetoclax|mesh-list
14835285|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835286|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
14835287|NCT03983850|Sirolimus|sirolimus|mesh-list
14835288|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
14835289|NCT03983850|Busulfan|busulfan|mesh-list
14835290|NCT03983850|Fludarabine|fludarabine|mesh-list
14835291|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835292|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
15203632|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15203633|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203634|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
15203635|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203636|NCT03743805|Antidotes|antidotes|mesh-ancestor
15203637|NCT03743805|Protective Agents|protective agents|mesh-ancestor
14835293|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835294|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835295|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835296|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
14835297|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835298|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835299|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835300|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14835301|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14835302|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
14835303|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15203638|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
15203639|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
15203640|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203641|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203642|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
15203643|NCT03743727|Ledipasvir|ledipasvir|mesh-list
15203644|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15203645|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
15203646|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15203647|NCT03743649|Lorazepam|lorazepam|mesh-list
15203648|NCT03743649|Haloperidol|haloperidol|mesh-list
15203649|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
14835304|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835305|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835306|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
14835307|NCT03981744|Ustekinumab|ustekinumab|mesh-list
14835308|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835309|NCT03975231|Trametinib|trametinib|mesh-list
14835310|NCT03975231|Dabrafenib|dabrafenib|mesh-list
14835311|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203650|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
15203651|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
15203652|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203653|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835312|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203654|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835313|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203655|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14705147|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14705148|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705149|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
14705150|NCT00413504|PENTA|penta|mesh-list
14705151|NCT00413504|Fondaparinux|fondaparinux|mesh-list
14705152|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14705153|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
14705154|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14705155|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
14835314|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835315|NCT03973268|Complement Factor H|complement factor h|mesh-list
14835316|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14835317|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835318|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
14835319|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835320|NCT03973177|Phenol|phenol|mesh-list
14835321|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
14835322|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14835323|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14835324|NCT03973177|Prednisolone|prednisolone|mesh-list
14835325|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
14835326|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14835327|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
14835328|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835329|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
14835330|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
14835331|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835332|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835333|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835334|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
14835335|NCT03973177|Hormones|hormones|mesh-ancestor
14835336|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835337|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14835338|NCT03973177|Protective Agents|protective agents|mesh-ancestor
14835339|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14835340|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835341|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14835342|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835343|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
14835344|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14835345|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14835346|NCT03964090|Cytarabine|cytarabine|mesh-list
14835347|NCT03964090|Isavuconazole|isavuconazole|mesh-list
14835348|NCT03964090|Methotrexate|methotrexate|mesh-list
14835349|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15203656|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15203657|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203658|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15203659|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15203660|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
15203661|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203662|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203663|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14705156|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705157|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835350|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
14835351|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14835352|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835353|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835354|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
14835355|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835356|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835357|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835358|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835359|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14835360|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835361|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
14835362|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835363|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14835364|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
14835365|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835366|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
14835367|NCT03952637|Sirolimus|sirolimus|mesh-list
14835368|NCT03952637|Prednisone|prednisone|mesh-list
14835369|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
14835370|NCT03952637|Rituximab|rituximab|mesh-list
14835371|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835372|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835373|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
14835374|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835375|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835376|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835377|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
14835378|NCT03952637|Hormones|hormones|mesh-ancestor
14835379|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835380|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14835381|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14835382|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835383|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14835384|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
14835385|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835386|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
14835387|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
14835388|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835389|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835390|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14835391|NCT03952637|Protective Agents|protective agents|mesh-ancestor
14835398|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
14835399|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14835400|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835401|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
14835402|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14835403|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835404|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
14835405|NCT03937830|Bevacizumab|bevacizumab|mesh-list
14835406|NCT03937830|Durvalumab|durvalumab|mesh-list
14835407|NCT03937830|Doxorubicin|doxorubicin|mesh-list
14835408|NCT03937830|Tremelimumab|tremelimumab|mesh-list
14835409|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835410|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835411|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14835412|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14835413|NCT03937830|Growth Substances|growth substances|mesh-ancestor
14835414|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835415|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14835416|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14835417|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14835418|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14835419|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835420|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835421|NCT03916003|Primaquine|primaquine|mesh-list
14835422|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
14835423|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14835424|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14835425|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835426|NCT03913559|Acetaminophen|acetaminophen|mesh-list
14835427|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
14835428|NCT03913559|Promethazine|promethazine|mesh-list
14835429|NCT03913559|Cytarabine|cytarabine|mesh-list
14835430|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
14835431|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14835432|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
14835433|NCT03913559|Methotrexate|methotrexate|mesh-list
14835434|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14835435|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14835436|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
14835437|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14835438|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835439|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835440|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
14835441|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835442|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835443|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835444|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835445|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14835446|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835447|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
14835448|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835449|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14835450|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
14835451|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835452|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14835453|NCT03913559|Analgesics|analgesics|mesh-ancestor
14835454|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
14835455|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835456|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
14835457|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835458|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
14835459|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
14835460|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835461|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
14835462|NCT03913559|Hormones|hormones|mesh-ancestor
14835463|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835464|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14835465|NCT03913559|Protective Agents|protective agents|mesh-ancestor
14835466|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14835467|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15203664|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
15203665|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15203666|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15203667|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
15203668|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
14835468|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14835469|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835470|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
15224698|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
15224699|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
15224700|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224701|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
15224702|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15224703|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15224704|NCT02653092|Heparin|heparin|mesh-list
15224705|NCT02653092|Anticoagulants|anticoagulants|mesh-list
15224706|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15224707|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15224708|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15224709|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224710|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15224711|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14835471|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
15224712|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15224713|NCT02593175|Paclitaxel|paclitaxel|mesh-list
15224714|NCT02593175|Carboplatin|carboplatin|mesh-list
15224715|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15203669|NCT03743428|Bevacizumab|bevacizumab|mesh-list
15203670|NCT03743428|Apatinib|apatinib|mesh-list
14295494|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835472|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14835473|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
14835474|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
14835475|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14835476|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14835477|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
14835478|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835479|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14835480|NCT03912428|Celecoxib|celecoxib|mesh-list
14835481|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14835482|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14835483|NCT03912428|Analgesics|analgesics|mesh-ancestor
14835484|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
14835485|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835486|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835487|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835488|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835489|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14835490|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14835491|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835492|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835493|NCT03910452|Sirolimus|sirolimus|mesh-list
14835494|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
14835495|NCT03910452|Busulfan|busulfan|mesh-list
14835496|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
14835497|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835498|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
14835499|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835500|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835501|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835502|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
14835503|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835504|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835505|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835506|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14835507|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835508|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14835509|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
14835510|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835511|NCT03908437|Buprenorphine|buprenorphine|mesh-list
14835512|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14835513|NCT03908437|Naloxone|naloxone|mesh-list
14835514|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14835515|NCT03908437|Narcotics|narcotics|mesh-ancestor
14835516|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835517|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835518|NCT03908437|Analgesics|analgesics|mesh-ancestor
14835519|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
14835520|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835521|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14835522|NCT03891446|Bimatoprost|bimatoprost|mesh-list
14835523|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14835524|NCT03871348|Cemiplimab|cemiplimab|mesh-list
14835525|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835526|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295495|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295496|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295497|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
14835527|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
14835528|NCT03867383|Calcium|calcium|mesh-list
14835529|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14835530|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835531|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14295498|NCT00581776|Dexamethasone|dexamethasone|mesh-list
14295499|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
14295500|NCT00581776|Rituximab|rituximab|mesh-list
14295501|NCT00581776|Doxorubicin|doxorubicin|mesh-list
14295502|NCT00581776|Vincristine|vincristine|mesh-list
14835532|NCT03866499|Gefitinib|gefitinib|mesh-list
14835533|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835534|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14835535|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203671|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295503|NCT00581776|Bortezomib|bortezomib|mesh-list
15203672|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203673|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15203674|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15203675|NCT03743428|Growth Substances|growth substances|mesh-ancestor
15203676|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203677|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
15203678|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203679|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203680|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203681|NCT03743376|UB-421|ub-421|mesh-list
15203682|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15203683|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
15203684|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835536|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835537|NCT03864406|Darunavir|darunavir|mesh-list
14835538|NCT03864406|Cobicistat|cobicistat|mesh-list
14835539|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
14835540|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
14835541|NCT03864406|Apixaban|apixaban|mesh-list
14835542|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14835543|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
14835544|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14835545|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
14835546|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835547|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835548|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
14835549|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14835550|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14835551|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14835552|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14835553|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
14835554|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835555|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14835556|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14835557|NCT03860987|Prednisone|prednisone|mesh-list
14835558|NCT03860987|Goserelin|goserelin|mesh-list
14835559|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835560|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
14835561|NCT03860987|Hormones|hormones|mesh-ancestor
14835562|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835563|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835564|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14835565|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835566|NCT03850782|Bimatoprost|bimatoprost|mesh-list
14835567|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14835568|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
14835569|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835570|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835571|NCT03841617|Hormones|hormones|mesh-list
14835572|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835573|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835574|NCT03829501|Atezolizumab|atezolizumab|mesh-list
14835575|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835576|NCT03824561|Vedolizumab|vedolizumab|mesh-list
14835577|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835578|NCT03811015|Cisplatin|cisplatin|mesh-list
14835579|NCT03811015|Nivolumab|nivolumab|mesh-list
14835580|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835581|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835582|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14835583|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835584|NCT03805932|Rituximab|rituximab|mesh-list
14835585|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
14835586|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835587|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835588|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
14835589|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835590|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835606|NCT03789240|Rituximab|rituximab|mesh-list
14835607|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835608|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835609|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
14835610|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835611|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835612|NCT03785210|Vancomycin|vancomycin|mesh-list
14835613|NCT03785210|Nivolumab|nivolumab|mesh-list
14835614|NCT03785210|Tadalafil|tadalafil|mesh-list
14835615|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835616|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835617|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14835618|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835619|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14835620|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835621|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
14835622|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14835623|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15203685|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
15203686|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15203687|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203688|NCT03743259|Charcoal|charcoal|mesh-list
15203689|NCT03743259|Antidotes|antidotes|mesh-ancestor
15203690|NCT03743259|Protective Agents|protective agents|mesh-ancestor
15203691|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203692|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
15203693|NCT03743246|Fludarabine|fludarabine|mesh-list
14835624|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835625|NCT03785210|Urological Agents|urological agents|mesh-ancestor
14835626|NCT03783403|Rituximab|rituximab|mesh-list
14835627|NCT03783403|Cetuximab|cetuximab|mesh-list
14835628|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835629|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835630|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
14835631|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835632|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835633|NCT03782376|Ustekinumab|ustekinumab|mesh-list
14835634|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835635|NCT03776071|Temozolomide|temozolomide|mesh-list
14835636|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835637|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
14835638|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835639|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203694|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835660|NCT03745326|Aldesleukin|aldesleukin|mesh-list
14835661|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
14835662|NCT03745326|Fludarabine|fludarabine|mesh-list
14835663|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835664|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
14835665|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835666|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835667|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835668|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
14835669|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835670|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835671|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835672|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14835673|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14835674|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
14835675|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835676|NCT03741101|Trametinib|trametinib|mesh-list
14835677|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835678|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14835679|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835680|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835681|NCT03735121|Atezolizumab|atezolizumab|mesh-list
14835682|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835683|NCT03733067|Abatacept|abatacept|mesh-list
14835684|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14835685|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835686|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835687|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835688|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
14835689|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835690|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835691|NCT03693300|Durvalumab|durvalumab|mesh-list
14835692|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835693|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835694|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
14835695|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14835696|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
14835697|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835698|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835699|NCT03648892|Raclopride|raclopride|mesh-list
14835700|NCT03648892|Fallypride|fallypride|mesh-list
14835701|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14835702|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14835703|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835704|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835705|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14835706|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14835707|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
14835708|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14835709|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835710|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14835711|NCT03641547|Capecitabine|capecitabine|mesh-list
14835712|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835713|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835714|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
14835715|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835716|NCT03606499|Ustekinumab|ustekinumab|mesh-list
14835717|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835718|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
14835719|NCT03602612|Fludarabine|fludarabine|mesh-list
14835720|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835721|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
14835722|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835723|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835724|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835725|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
14835726|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835727|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835728|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835729|NCT03598257|Olaparib|olaparib|mesh-list
14835730|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14835731|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835732|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835733|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835734|NCT03596645|Golimumab|golimumab|mesh-list
14835735|NCT03596645|Infliximab|infliximab|mesh-list
14835736|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835737|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835738|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835739|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14835740|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835741|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835742|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
14835743|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835744|NCT03591510|Cytarabine|cytarabine|mesh-list
14835745|NCT03591510|Fludarabine|fludarabine|mesh-list
14835746|NCT03591510|Etoposide|etoposide|mesh-list
14835747|NCT03591510|Daunorubicin|daunorubicin|mesh-list
14835748|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
14835749|NCT03591510|Idarubicin|idarubicin|mesh-list
14835750|NCT03591510|Midostaurin|midostaurin|mesh-list
14835751|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835752|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835753|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
14295504|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835754|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835755|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835756|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
14835757|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835758|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14835759|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14835760|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14835761|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835762|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
14835763|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835764|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14835765|NCT03591510|Analgesics|analgesics|mesh-ancestor
14835766|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
14835767|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835768|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14835769|NCT03581240|Eflornithine|eflornithine|mesh-list
14835770|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835771|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14835772|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14835773|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14835774|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835775|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14835776|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835777|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835778|NCT03554473|Temozolomide|temozolomide|mesh-list
14835779|NCT03554473|Topotecan|topotecan|mesh-list
15203695|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
15203696|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203697|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203698|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15203699|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
15203700|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203701|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203702|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15203703|NCT03743103|Nitroprusside|nitroprusside|mesh-list
15203704|NCT03743103|Esmolol|esmolol|mesh-list
15203705|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15203706|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
14835780|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15203707|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14835781|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
14835782|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295505|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
14295506|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835783|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835784|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14835785|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14835786|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835787|NCT03549715|Durvalumab|durvalumab|mesh-list
14835788|NCT03549715|Tremelimumab|tremelimumab|mesh-list
14835789|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835790|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835791|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14835792|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
14835793|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835794|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
14835795|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835796|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
14835797|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835798|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835799|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295507|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295508|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705158|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
14705159|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14705160|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14705161|NCT00413608|Clopidogrel|clopidogrel|mesh-list
14705162|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14705163|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14705164|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14705165|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14705166|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
14705167|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705168|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705169|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705170|NCT00413686|Gemcitabine|gemcitabine|mesh-list
14705171|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14705172|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
14705173|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705174|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705175|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
14705176|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705177|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705178|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705179|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
14705180|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705181|NCT00413699|Tofacitinib|tofacitinib|mesh-list
14705182|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14705183|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835800|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
14835801|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295509|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
14835802|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835803|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835804|NCT03510468|Pyridoxine|pyridoxine|mesh-list
14835805|NCT03510468|Isoniazid|isoniazid|mesh-list
14835806|NCT03510468|Rifapentine|rifapentine|mesh-list
14835807|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
14835808|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14835809|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835810|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14835811|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14835812|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
14835813|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835814|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14835815|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
14835816|NCT03510468|Vitamins|vitamins|mesh-ancestor
14835817|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
14835818|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835819|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14835820|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
14835821|NCT03478878|Vitamin A|vitamin a|mesh-list
14835822|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
14835823|NCT03478878|Vitamins|vitamins|mesh-ancestor
14835824|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
14835825|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835826|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
14835827|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835828|NCT03478878|Protective Agents|protective agents|mesh-ancestor
14835829|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14835830|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835831|NCT03478865|Vitamin A|vitamin a|mesh-list
14835832|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
14835833|NCT03478865|Vitamins|vitamins|mesh-ancestor
14835834|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
14835835|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835836|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
14835837|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295510|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295511|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295512|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14705184|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705185|NCT00413712|Adenosine|adenosine|mesh-list
14705186|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
14705187|NCT00413712|Calcium|calcium|mesh-list
14705188|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14705189|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705190|NCT00413712|Analgesics|analgesics|mesh-ancestor
14705191|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
14705192|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705193|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14705194|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
14705195|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14705196|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
14705197|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
14705198|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705199|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705200|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14705201|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14835838|NCT03478865|Protective Agents|protective agents|mesh-ancestor
14835839|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14835840|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835841|NCT03467373|Prednisone|prednisone|mesh-list
14835842|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
14835843|NCT03467373|Rituximab|rituximab|mesh-list
14835844|NCT03467373|Doxorubicin|doxorubicin|mesh-list
14835845|NCT03467373|Vincristine|vincristine|mesh-list
14835846|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
14835847|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835848|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
14835849|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835850|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835851|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835852|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
14835853|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835854|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835855|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835856|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835857|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14835858|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14835859|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14835860|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835861|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835862|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
14835863|NCT03467373|Hormones|hormones|mesh-ancestor
14835864|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835865|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14835866|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14835867|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
14835868|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
14835869|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
14835870|NCT03466411|Ustekinumab|ustekinumab|mesh-list
14835871|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14835872|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835873|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
14835874|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835875|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
14835876|NCT03449758|Chloroquine|chloroquine|mesh-list
14835877|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
14835878|NCT03449758|Methotrexate|methotrexate|mesh-list
14835879|NCT03449758|Azathioprine|azathioprine|mesh-list
14835880|NCT03449758|Leflunomide|leflunomide|mesh-list
14835881|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14835882|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
14835883|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14835884|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835885|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14835886|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
14835887|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835888|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835889|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835890|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835891|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14835892|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835893|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
14835894|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835895|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14728619|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728620|NCT00519259|Lobeline|lobeline|mesh-list
14728621|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14728622|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
14728623|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728624|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728625|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14728626|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14728627|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
14728628|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728629|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728630|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
14728631|NCT00519298|Donepezil|donepezil|mesh-list
14728632|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14728633|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728634|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728635|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
14728636|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705202|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705203|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14705204|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14705205|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14705206|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14705207|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14705208|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14705209|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14705210|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
14835896|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
14835897|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14835898|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14835899|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835900|NCT03449758|Amebicides|amebicides|mesh-ancestor
14835901|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14835902|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14835903|NCT03449758|Analgesics|analgesics|mesh-ancestor
14835904|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
14835905|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14835906|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14835907|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14835908|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
14835909|NCT03448393|Fludarabine|fludarabine|mesh-list
14835910|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835911|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
14835912|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835913|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835914|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835915|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
14835916|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835917|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835918|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14835919|NCT03436745|Zolpidem|zolpidem|mesh-list
14835920|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14835921|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14705211|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705212|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705213|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705214|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14835922|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835923|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835924|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14835925|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
14835926|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
14835927|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14835928|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835929|NCT03412877|Aldesleukin|aldesleukin|mesh-list
14835930|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
14835931|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
14835932|NCT03412877|Fludarabine|fludarabine|mesh-list
14835933|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14835934|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
14835935|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835936|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14835937|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14835938|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
14835939|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835940|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835941|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15203708|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835942|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835943|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15203709|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15203710|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14835944|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14835945|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
14835946|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835950|NCT03388632|Nivolumab|nivolumab|mesh-list
14835951|NCT03388632|Ipilimumab|ipilimumab|mesh-list
14835952|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835953|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835954|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14835955|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835956|NCT03387761|Nivolumab|nivolumab|mesh-list
14835957|NCT03387761|Ipilimumab|ipilimumab|mesh-list
14835958|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203711|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15203712|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
15203713|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203714|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203715|NCT03743025|Dulaglutide|dulaglutide|mesh-list
15203716|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15203717|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835959|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835960|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14835961|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835962|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
14835963|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835964|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835965|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
14835966|NCT03366155|Irinotecan|irinotecan|mesh-list
14835967|NCT03366155|Cetuximab|cetuximab|mesh-list
14835968|NCT03366155|Panitumumab|panitumumab|mesh-list
14835969|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835970|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14835971|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14835972|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14835973|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835974|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14835975|NCT03366142|Ustekinumab|ustekinumab|mesh-list
14835976|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14835977|NCT03326245|Methylphenidate|methylphenidate|mesh-list
14835978|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14835979|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835980|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14835981|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14835982|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14835983|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14835984|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
14835985|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14835986|NCT03312400|Danazol|danazol|mesh-list
14835987|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14835988|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
14835989|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14835990|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835991|NCT03294460|Ethanol|ethanol|mesh-list
14835992|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14835993|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14835994|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14835995|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14835996|NCT03284957|Everolimus|everolimus|mesh-list
14835997|NCT03284957|Palbociclib|palbociclib|mesh-list
14835998|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14835999|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836000|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
14836001|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836002|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836003|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836004|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836005|NCT03284502|Cetuximab|cetuximab|mesh-list
14836006|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836007|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836008|NCT03282799|Etonogestrel|etonogestrel|mesh-list
14836009|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14836010|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
14836011|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14836012|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836013|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14836014|NCT03280030|Midostaurin|midostaurin|mesh-list
14836015|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836016|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836017|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836018|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836019|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
14836020|NCT03267277|Antidotes|antidotes|mesh-ancestor
14836021|NCT03267277|Protective Agents|protective agents|mesh-ancestor
14836022|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836023|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
14836024|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836025|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
14836026|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836027|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836028|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
14836029|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
14836030|NCT03258593|Durvalumab|durvalumab|mesh-list
14836031|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836032|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836033|NCT03258567|Nivolumab|nivolumab|mesh-list
14836034|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836035|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836036|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14836037|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836038|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
14836039|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836040|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836041|NCT03246347|Docetaxel|docetaxel|mesh-list
14836042|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836043|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836044|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836045|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836046|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836047|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
14836048|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836049|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836050|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
14836051|NCT03233724|Decitabine|decitabine|mesh-list
14836052|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
14836053|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836054|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836055|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14836056|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
14836057|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836058|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836059|NCT03223610|Prednisone|prednisone|mesh-list
15203718|NCT03742947|Hemostatics|hemostatics|mesh-list
15203719|NCT03742947|Coagulants|coagulants|mesh-ancestor
15203720|NCT03742921|Romidepsin|romidepsin|mesh-list
15203721|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15203722|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203723|NCT03742908|Clindamycin|clindamycin|mesh-list
15203724|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
15203725|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
15203726|NCT03742908|Cefazolin|cefazolin|mesh-list
15203727|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836060|NCT03223610|Lenalidomide|lenalidomide|mesh-list
14836061|NCT03223610|Venetoclax|venetoclax|mesh-list
14836062|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
14836063|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836064|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
14836065|NCT03223610|Hormones|hormones|mesh-ancestor
14836066|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836067|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836068|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14836069|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836070|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
14836071|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14836072|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14836073|NCT03223610|Growth Substances|growth substances|mesh-ancestor
14836074|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
14836075|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836076|NCT03218488|Ustekinumab|ustekinumab|mesh-list
14836077|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
14836078|NCT03215030|Dexamethasone|dexamethasone|mesh-list
14836079|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203728|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15203729|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15203730|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203731|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203732|NCT03742713|Docetaxel|docetaxel|mesh-list
15203733|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203734|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
15203735|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
15203736|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
15203737|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203738|NCT03742557|Ketamine|ketamine|mesh-list
15203739|NCT03742557|Analgesics|analgesics|mesh-ancestor
15203740|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
15203741|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203742|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203743|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15203744|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15203745|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
15203746|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
14836080|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
14836081|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
15203747|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203748|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14836082|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836083|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836084|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14836085|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
14836086|NCT03215030|Hormones|hormones|mesh-ancestor
14836087|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836088|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14836089|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836090|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14836091|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14836092|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836093|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
14836094|NCT03204188|Fludarabine|fludarabine|mesh-list
14836095|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836096|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836116|NCT03198351|Teriflunomide|teriflunomide|mesh-list
14836117|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14836118|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14836119|NCT03198351|Analgesics|analgesics|mesh-ancestor
14836120|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
14836121|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836122|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836123|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836124|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836125|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836126|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
14836127|NCT03190954|Raclopride|raclopride|mesh-list
14836128|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14836129|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14836130|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14836131|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836132|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14836133|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14836134|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
14836135|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14836136|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836137|NCT03190941|Aldesleukin|aldesleukin|mesh-list
14836138|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
15203749|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15203750|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203751|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203752|NCT03742531|Oxytocin|oxytocin|mesh-list
15203753|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
15203754|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15203755|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203756|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
15203757|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15203758|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15203759|NCT03742466|Prednisolone|prednisolone|mesh-list
15203760|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
15203761|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15203762|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
14836139|NCT03190941|Fludarabine|fludarabine|mesh-list
14836140|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836141|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
14836142|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836143|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836144|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836145|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
14836146|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836147|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836148|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14836149|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14836150|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14836151|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
14836152|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836153|NCT03187262|Daratumumab|daratumumab|mesh-list
14836154|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836155|NCT03185819|Midazolam|midazolam|mesh-list
14836156|NCT03185819|Esketamine|esketamine|mesh-list
14836157|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14836158|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14836159|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14836160|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836161|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14836162|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14836163|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14836164|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14836165|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
14705215|NCT00413790|Darifenacin|darifenacin|mesh-list
14705216|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14705217|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14705218|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
14705219|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705220|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705221|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705222|NCT00413790|Urological Agents|urological agents|mesh-ancestor
14705223|NCT00413829|Ranibizumab|ranibizumab|mesh-list
14705224|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14705225|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14836166|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
14836167|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
14836168|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
14836169|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14836170|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836171|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
14836172|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14836173|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14836174|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836175|NCT03173950|Nivolumab|nivolumab|mesh-list
14836176|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836177|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836178|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14836179|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836180|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14836181|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14836182|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836183|NCT03169101|Nicotine|nicotine|mesh-list
14836184|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14836185|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
14836186|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836187|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836188|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14836189|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14836190|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
14836191|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14836192|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836193|NCT03167437|Vorinostat|vorinostat|mesh-list
14836194|NCT03167437|Ustekinumab|ustekinumab|mesh-list
14836195|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836196|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14836197|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836198|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836199|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14836200|NCT03141684|Bevacizumab|bevacizumab|mesh-list
15203763|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203764|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
15203765|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
14836201|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14836202|NCT03141684|Atezolizumab|atezolizumab|mesh-list
14836203|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
14836204|NCT03141684|Antibodies|antibodies|mesh-list
15203766|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203767|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203768|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203769|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
15203770|NCT03742466|Hormones|hormones|mesh-ancestor
15203771|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203772|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15203773|NCT03742466|Protective Agents|protective agents|mesh-ancestor
15203774|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15203775|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203776|NCT03742336|Dabigatran|dabigatran|mesh-list
15203777|NCT03742336|Abrocitinib|abrocitinib|mesh-list
15203778|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
15203779|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15203780|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
15203781|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203782|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203783|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
15203784|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203785|NCT03742323|Idelalisib|idelalisib|mesh-list
15224716|NCT02593175|Panitumumab|panitumumab|mesh-list
14295513|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295514|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
14295515|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
14295516|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295517|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295518|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
14295519|NCT00581776|Hormones|hormones|mesh-ancestor
14295520|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295521|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14295522|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14705226|NCT00413829|Growth Substances|growth substances|mesh-ancestor
14705227|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705228|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
14705229|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705230|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
14705231|NCT00413946|Hematinics|hematinics|mesh-ancestor
14705232|NCT00414024|Tegaserod|tegaserod|mesh-list
14705233|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14705234|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
14705235|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705236|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705237|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705238|NCT00414037|Eszopiclone|eszopiclone|mesh-list
14705239|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14705240|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14705241|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705242|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14705243|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
14705244|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705245|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
14705246|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
14705247|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705248|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
14705249|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705250|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705251|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705252|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
14705253|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705254|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705255|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14705256|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14705257|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14705258|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
14705259|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836205|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
14836206|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14836207|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
14705260|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705261|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705262|NCT00414180|Bupropion|bupropion|mesh-list
14705263|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14705264|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
14705265|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14705266|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14836208|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836209|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14836210|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14836211|NCT03141684|Growth Substances|growth substances|mesh-ancestor
14836212|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836213|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14836214|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
14836215|NCT03109288|Pioglitazone|pioglitazone|mesh-list
14705267|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14705268|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14705269|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705270|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
14836216|NCT03109288|Clemastine|clemastine|mesh-list
14836217|NCT03109288|Pirfenidone|pirfenidone|mesh-list
14836218|NCT03109288|Dantrolene|dantrolene|mesh-list
14836219|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14836220|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836221|NCT03109288|Analgesics|analgesics|mesh-ancestor
14836222|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
14836223|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836224|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14836225|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14836226|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836227|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836228|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836229|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
14836230|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
14836231|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14836232|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
14836233|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
14836234|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14836235|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836236|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14836237|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14836238|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14836239|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
14836240|NCT03092518|Mitomycins|mitomycins|mesh-list
14836241|NCT03092518|Mitomycin|mitomycin|mesh-list
14836242|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836243|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14836244|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
14836245|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836246|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14836247|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836248|NCT03092518|Antidotes|antidotes|mesh-ancestor
14836249|NCT03092518|Protective Agents|protective agents|mesh-ancestor
14836250|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836251|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
14836252|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
14836253|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836254|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836255|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
14836256|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
14836257|NCT03077542|Sirolimus|sirolimus|mesh-list
14836258|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
14836259|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
14836260|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
14836261|NCT03077542|Pentostatin|pentostatin|mesh-list
14836262|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836263|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
14836264|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836265|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836266|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836267|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
14836268|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836269|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836270|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14836271|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836272|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836273|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14836274|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
14836275|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836276|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
14836277|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836278|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14836279|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14836280|NCT03076554|Avelumab|avelumab|mesh-list
15203786|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203787|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203788|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203789|NCT03742310|Vitamin D|vitamin d|mesh-list
15203790|NCT03742310|Calcitriol|calcitriol|mesh-list
15203791|NCT03742310|Vitamins|vitamins|mesh-ancestor
15203792|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
15203793|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203794|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15203795|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15203796|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15203797|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15203798|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203799|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15203800|NCT03742297|Dexamethasone|dexamethasone|mesh-list
14836281|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836282|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836283|NCT03065335|Ketamine|ketamine|mesh-list
14836284|NCT03065335|Analgesics|analgesics|mesh-ancestor
14836285|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
14836286|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836287|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836288|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14836289|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14836290|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
14836291|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
14836292|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14836293|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14836294|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14836295|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295523|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14295524|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14295525|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14295526|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295527|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295528|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295529|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836296|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836297|NCT03049462|Ascorbic Acid|ascorbic acid|mesh-list
14836298|NCT03049462|Mirabegron|mirabegron|mesh-list
14836299|NCT03049462|Vitamins|vitamins|mesh-ancestor
14836300|NCT03049462|Micronutrients|micronutrients|mesh-ancestor
14836301|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836302|NCT03049462|Antioxidants|antioxidants|mesh-ancestor
14836303|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203801|NCT03742297|Prednisone|prednisone|mesh-list
14295530|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295531|NCT00581828|Vitamin D|vitamin d|mesh-list
14295532|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
15203802|NCT03742297|Lenalidomide|lenalidomide|mesh-list
14295533|NCT00581828|Vitamins|vitamins|mesh-list
14295534|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
14836304|NCT03049462|Protective Agents|protective agents|mesh-ancestor
14836305|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14836306|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14836307|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14836308|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
14836309|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14836310|NCT03049462|Urological Agents|urological agents|mesh-ancestor
14836311|NCT03047070|Lidocaine|lidocaine|mesh-list
14836312|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
14836313|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
14836314|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14836315|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836316|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
14836317|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836318|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14836319|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14836320|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14836321|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14836322|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836323|NCT03043313|Trastuzumab|trastuzumab|mesh-list
14836324|NCT03043313|Tucatinib|tucatinib|mesh-list
14836325|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836326|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836327|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836328|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836329|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836330|NCT03040778|Vitamin E|vitamin e|mesh-list
14836331|NCT03040778|Tocopherols|tocopherols|mesh-list
14836332|NCT03040778|Tocotrienols|tocotrienols|mesh-list
14836333|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
14836334|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
14836335|NCT03040778|Vitamins|vitamins|mesh-ancestor
14295535|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836336|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
14836337|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836338|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
14836339|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836340|NCT03040778|Protective Agents|protective agents|mesh-ancestor
14836341|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14836342|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836343|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14836344|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14836345|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
14836346|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14836347|NCT03032328|Vitamin D|vitamin d|mesh-list
15203803|NCT03742297|Bortezomib|bortezomib|mesh-list
15203804|NCT03742297|Melphalan|melphalan|mesh-list
15203805|NCT03742297|Daratumumab|daratumumab|mesh-list
15203806|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203807|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
15203808|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
15203809|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203810|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203811|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203812|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
15203813|NCT03742297|Hormones|hormones|mesh-ancestor
15203814|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203815|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15203816|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203817|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
15203818|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15203819|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15203820|NCT03742297|Growth Substances|growth substances|mesh-ancestor
14836348|NCT03032328|Vitamins|vitamins|mesh-ancestor
14836349|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
15203821|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
15203822|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15203823|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
15203824|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203825|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15203826|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836350|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836351|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14705271|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14836352|NCT03027388|LB100|lb100|mesh-list
14836353|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836354|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836355|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836356|NCT03024684|Atorvastatin|atorvastatin|mesh-list
15203827|NCT03742258|Prednisone|prednisone|mesh-list
15203828|NCT03742258|Cortisone|cortisone|mesh-list
15203829|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
15203830|NCT03742258|Rituximab|rituximab|mesh-list
15203831|NCT03742258|Doxorubicin|doxorubicin|mesh-list
15203832|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15203833|NCT03742258|Vincristine|vincristine|mesh-list
15203834|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15203835|NCT03742258|Antibodies|antibodies|mesh-list
15203836|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
15203837|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15203838|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15203839|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
15203840|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203841|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203842|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15203843|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
15203844|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203845|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203846|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14836357|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14836358|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14836359|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
14836360|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836361|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14836362|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14836363|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203847|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15203848|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15203849|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15203850|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203851|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705272|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705273|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14705274|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14705275|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705276|NCT00414245|Metformin|metformin|mesh-list
14705277|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14705278|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705279|NCT00414284|Lopinavir|lopinavir|mesh-list
14705280|NCT00414284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14836364|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
14836365|NCT03018288|Temozolomide|temozolomide|mesh-list
15203852|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
15203853|NCT03742258|Hormones|hormones|mesh-ancestor
14836366|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836367|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836368|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836369|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
14836370|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836371|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
15203854|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203855|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14836372|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836373|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836374|NCT03000439|Tofacitinib|tofacitinib|mesh-list
14836375|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836376|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836377|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836378|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
14836379|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14836380|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
14836381|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14836382|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705281|NCT00414284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14705282|NCT00414284|Protease Inhibitors|protease inhibitors|mesh-ancestor
14705283|NCT00414284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705284|NCT00414284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705285|NCT00414284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14705286|NCT00414284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14705287|NCT00414284|Antiviral Agents|antiviral agents|mesh-ancestor
14836383|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14836384|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14836385|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14836386|NCT02979873|Sirolimus|sirolimus|mesh-list
14836387|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836388|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836389|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14836390|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836391|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
14836392|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836393|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
14836394|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836395|NCT02968108|Ustekinumab|ustekinumab|mesh-list
14836396|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
14836397|NCT02960659|Metformin|metformin|mesh-list
14836398|NCT02960659|Liraglutide|liraglutide|mesh-list
14836399|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14836400|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836401|NCT02960659|Incretins|incretins|mesh-ancestor
14836402|NCT02960659|Hormones|hormones|mesh-ancestor
14836403|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836404|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14836405|NCT02942095|Ixazomib|ixazomib|mesh-list
14836406|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836407|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836408|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836409|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203856|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15203857|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
15203858|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
15203859|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
15203860|NCT03742245|Olaparib|olaparib|mesh-list
15203861|NCT03742245|Vorinostat|vorinostat|mesh-list
15203862|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15203863|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705288|NCT00414284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705289|NCT00414284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14705290|NCT00414284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14705291|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14705292|NCT00414323|Citalopram|citalopram|mesh-list
14705293|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14705294|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14705295|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14705296|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705297|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705298|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
14836410|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
15224717|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14836411|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14836412|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14836413|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14836414|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
14836415|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836416|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836417|NCT02940522|Progestins|progestins|mesh-ancestor
14836418|NCT02940522|Hormones|hormones|mesh-ancestor
14836419|NCT02938923|Testosterone|testosterone|mesh-list
14836420|NCT02938923|Androgens|androgens|mesh-ancestor
14836421|NCT02938923|Hormones|hormones|mesh-ancestor
14836422|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836423|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836424|NCT02933255|Nivolumab|nivolumab|mesh-list
14836425|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836426|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836427|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14836428|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836429|NCT02923739|Paclitaxel|paclitaxel|mesh-list
14705299|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836430|NCT02923739|Bevacizumab|bevacizumab|mesh-list
14836431|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14836432|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14836433|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
14836434|NCT02923739|Antibodies|antibodies|mesh-list
14836435|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
14836436|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14836437|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
14836438|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836439|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836440|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836441|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836442|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836443|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836444|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14836445|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14836446|NCT02923739|Growth Substances|growth substances|mesh-ancestor
14836447|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836448|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
14836449|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
14836450|NCT02913313|Nivolumab|nivolumab|mesh-list
14836451|NCT02913313|Ipilimumab|ipilimumab|mesh-list
14836452|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836453|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836454|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14836455|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705300|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14705301|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
14705302|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14705303|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705304|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14705305|NCT00414323|Analgesics|analgesics|mesh-ancestor
14705306|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
14705307|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
14705308|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14705309|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14836480|NCT02911142|Prednisone|prednisone|mesh-list
14836481|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
14836482|NCT02911142|Rituximab|rituximab|mesh-list
14836483|NCT02911142|Doxorubicin|doxorubicin|mesh-list
14836484|NCT02911142|Vincristine|vincristine|mesh-list
14836485|NCT02911142|Lenalidomide|lenalidomide|mesh-list
14836486|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836487|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
14836488|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836489|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836490|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836491|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
14836492|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836493|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836494|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14836495|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836496|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14836497|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14836498|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14836499|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836500|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836501|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
14836502|NCT02911142|Hormones|hormones|mesh-ancestor
14836503|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836504|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14836505|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836506|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836507|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836508|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836509|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14836510|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14836511|NCT02911142|Growth Substances|growth substances|mesh-ancestor
14836512|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
15203864|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203865|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203866|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15203867|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15203868|NCT03742232|Laxatives|laxatives|mesh-ancestor
15203869|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203870|NCT03742193|Apatinib|apatinib|mesh-list
15203871|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203872|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203873|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203874|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203875|NCT03742180|Ketorolac|ketorolac|mesh-list
15203876|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
15203877|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15203878|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203879|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203880|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14836513|NCT02897778|Entinostat|entinostat|mesh-list
14836514|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836515|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14836516|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836517|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836518|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
14836519|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836520|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836521|NCT02879409|Insulin|insulin|mesh-list
14836522|NCT02879409|Metformin|metformin|mesh-list
14836523|NCT02879409|Pioglitazone|pioglitazone|mesh-list
14836524|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14836525|NCT02879409|Liraglutide|liraglutide|mesh-list
14836526|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
14836527|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14836528|NCT02879409|Gliclazide|gliclazide|mesh-list
14836529|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14836530|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836531|NCT02879409|Incretins|incretins|mesh-ancestor
14836532|NCT02879409|Hormones|hormones|mesh-ancestor
14836533|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836534|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14836535|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
14836536|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836537|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836538|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14836539|NCT02858310|Aldesleukin|aldesleukin|mesh-list
14836540|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
14836541|NCT02858310|Fludarabine|fludarabine|mesh-list
14836542|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836543|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
14836544|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836545|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836546|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836547|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
14836548|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836549|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836550|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14836551|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14836552|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14836553|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
15203881|NCT03742180|Analgesics|analgesics|mesh-ancestor
15203882|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
14836554|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836555|NCT02835222|Cytarabine|cytarabine|mesh-list
14836556|NCT02835222|Daunorubicin|daunorubicin|mesh-list
14836557|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14836558|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
14836559|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836560|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836561|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
14836562|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836563|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836564|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
14836565|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203883|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203884|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15203885|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15203886|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15203887|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
15203888|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203889|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203890|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15203891|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203892|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203893|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15203894|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203895|NCT03742115|Dexamethasone|dexamethasone|mesh-list
15203896|NCT03742115|Etoposide|etoposide|mesh-list
14705310|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
14705311|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705312|NCT00414336|Antacids|antacids|mesh-ancestor
14705313|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705314|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14705315|NCT00414349|Analgesics|analgesics|mesh-list
14705316|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
14836566|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14836567|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14836568|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14836569|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836570|NCT02830724|Aldesleukin|aldesleukin|mesh-list
14836571|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
14836572|NCT02830724|Fludarabine|fludarabine|mesh-list
14836573|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836574|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
14836575|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836576|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836577|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836578|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
14836579|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836580|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836581|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14836582|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14836583|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14836584|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
14836585|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836586|NCT02826486|Leucovorin|leucovorin|mesh-list
14836587|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
14836588|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836589|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836590|NCT02826486|Antidotes|antidotes|mesh-ancestor
14705317|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705318|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705319|NCT00414414|Prednisone|prednisone|mesh-list
14705320|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705321|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
14705322|NCT00414414|Hormones|hormones|mesh-ancestor
14705323|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705324|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836591|NCT02826486|Protective Agents|protective agents|mesh-ancestor
14836592|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836593|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
14836594|NCT02826486|Vitamins|vitamins|mesh-ancestor
14836595|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
14836596|NCT02821832|Rifampin|rifampin|mesh-list
14836597|NCT02821832|Isoniazid|isoniazid|mesh-list
14836598|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
14836599|NCT02821832|Ethambutol|ethambutol|mesh-list
14836600|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14836601|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
15203897|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
15203898|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203899|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
15203900|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
15203901|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203902|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203903|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14705325|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705326|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705327|NCT00414531|Atorvastatin|atorvastatin|mesh-list
14836602|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836603|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836604|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
14836605|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14836606|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836607|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836608|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14836609|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14836610|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14836611|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14836612|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14836613|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14836614|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14836615|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14836616|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
14836617|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14836618|NCT02815592|Carboplatin|carboplatin|mesh-list
14836619|NCT02815592|Etoposide|etoposide|mesh-list
14836620|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836621|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836622|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14705328|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14705329|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14705330|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
14705331|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705332|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14705333|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14705334|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705335|NCT00414648|Sirolimus|sirolimus|mesh-list
14705336|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14705337|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705338|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14705339|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705340|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
14705341|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705342|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
14705343|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705344|NCT00414687|Iloprost|iloprost|mesh-list
14836623|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14836624|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836625|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836626|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
14836627|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14836628|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14836629|NCT02798523|Prednisolone|prednisolone|mesh-list
14836630|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
14836631|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
14836632|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14836633|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
14705345|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14705346|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
15203904|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
15203905|NCT03742115|Hormones|hormones|mesh-ancestor
15203906|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15203907|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15203908|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203909|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15203910|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15203911|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15203912|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203913|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203914|NCT03741933|Apremilast|apremilast|mesh-list
15203915|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15203916|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15203917|NCT03741933|Analgesics|analgesics|mesh-ancestor
15203918|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
15203919|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705347|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14836634|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836635|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
15203920|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203921|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15203922|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15203923|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15203924|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15203925|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203926|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203927|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
15203928|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15203929|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15203930|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
15203931|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
15203932|NCT03741686|Cathartics|cathartics|mesh-ancestor
15203933|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203934|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
15203935|NCT03741660|Cathartics|cathartics|mesh-ancestor
15203936|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15224718|NCT02593175|Antibodies|antibodies|mesh-list
15224719|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
15224720|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15224721|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15224722|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224723|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
15224724|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
15224725|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225701|NCT03951870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203937|NCT03741621|Psyllium|psyllium|mesh-list
15203938|NCT03741621|Cathartics|cathartics|mesh-ancestor
15203939|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203940|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14836636|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
14836637|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836638|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836639|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14836640|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
14836641|NCT02798523|Hormones|hormones|mesh-ancestor
14836642|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836643|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14836644|NCT02798523|Protective Agents|protective agents|mesh-ancestor
14836645|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14836646|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836647|NCT02789657|Paclitaxel|paclitaxel|mesh-list
14836648|NCT02789657|Carboplatin|carboplatin|mesh-list
14836649|NCT02789657|Trastuzumab|trastuzumab|mesh-list
14836650|NCT02789657|Pertuzumab|pertuzumab|mesh-list
14836651|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836652|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836653|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836654|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836655|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836656|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836657|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836658|NCT02784210|Prednisone|prednisone|mesh-list
14836659|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
14836660|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14836661|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14836662|NCT02784210|Prednisolone|prednisolone|mesh-list
14836663|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
14836664|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14836665|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
14836666|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836667|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
14836668|NCT02784210|Hormones|hormones|mesh-ancestor
14836669|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836670|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836671|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14836672|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836673|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
14836674|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
14836675|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836676|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14836677|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14836678|NCT02784210|Protective Agents|protective agents|mesh-ancestor
14836679|NCT02773030|Dexamethasone|dexamethasone|mesh-list
15203941|NCT03741517|Edotreotide|edotreotide|mesh-list
15203942|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15203943|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836680|NCT02773030|Bortezomib|bortezomib|mesh-list
15203944|NCT03741478|Insulin|insulin|mesh-list
15203945|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15203946|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
15203947|NCT03741478|Olanzapine|olanzapine|mesh-list
14705348|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14705349|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705350|NCT00414921|Clonidine|clonidine|mesh-list
14705351|NCT00414921|Methylphenidate|methylphenidate|mesh-list
14705352|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14705353|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705354|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14705355|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14705356|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14705357|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705358|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
14836681|NCT02773030|Daratumumab|daratumumab|mesh-list
14836682|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836683|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
15203948|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15203949|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836684|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
14836685|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836686|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836687|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14836688|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
14836689|NCT02773030|Hormones|hormones|mesh-ancestor
14836690|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836691|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14836692|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836693|NCT02769962|Olaparib|olaparib|mesh-list
14836694|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14836695|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836696|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836697|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836698|NCT02759835|Osimertinib|osimertinib|mesh-list
15203950|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
15203951|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
15203952|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15203953|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15203954|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15203955|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15203956|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15203957|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15203958|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15203959|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15203960|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15203961|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203962|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203963|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
15203964|NCT03741426|Durvalumab|durvalumab|mesh-list
15203965|NCT03741426|Olaparib|olaparib|mesh-list
15203966|NCT03741426|Cediranib|cediranib|mesh-list
15203967|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203968|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203969|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15203970|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203971|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705359|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15203972|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203973|NCT03741309|Calcium|calcium|mesh-list
15203974|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15203975|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203976|NCT03741244|Temozolomide|temozolomide|mesh-list
15203977|NCT03741244|Apatinib|apatinib|mesh-list
14705360|NCT00414921|Analgesics|analgesics|mesh-ancestor
14705361|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
14705362|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705363|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14705364|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
14705365|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
14705366|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14705367|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14705368|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14705369|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
14705370|NCT00414947|Vildagliptin|vildagliptin|mesh-list
14705371|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14705372|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705373|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14836699|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836700|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836701|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836702|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836703|NCT02748707|Celecoxib|celecoxib|mesh-list
14836704|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14836705|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836706|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836707|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836708|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836709|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14836710|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14836711|NCT02748707|Analgesics|analgesics|mesh-ancestor
14836712|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
14836713|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836714|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836715|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836716|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836717|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14836718|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14836719|NCT02711137|Gemcitabine|gemcitabine|mesh-list
14836720|NCT02711137|Paclitaxel|paclitaxel|mesh-list
14836721|NCT02711137|Azacitidine|azacitidine|mesh-list
14836722|NCT02711137|Rucaparib|rucaparib|mesh-list
14836723|NCT02711137|INCB057643|incb057643|mesh-list
14836724|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836725|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836726|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836727|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836728|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836729|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836730|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14836731|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
14836732|NCT02711137|Antiviral Agents|antiviral agents|mesh-ancestor
14836733|NCT02711137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836734|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836735|NCT02711137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836736|NCT02711137|Immunologic Factors|immunologic factors|mesh-ancestor
14836737|NCT02711137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836738|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14836739|NCT02707042|Amoxicillin|amoxicillin|mesh-list
14836740|NCT02707042|Azithromycin|azithromycin|mesh-list
14836741|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836742|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836743|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14836744|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14836745|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836746|NCT02679144|Eflornithine|eflornithine|mesh-list
14836747|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836748|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14836749|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14836750|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14836751|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836752|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14836753|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836754|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836755|NCT02659930|Doxorubicin|doxorubicin|mesh-list
14836756|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14836757|NCT02659930|Pomalidomide|pomalidomide|mesh-list
14836758|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14836759|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836760|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14836761|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14836762|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836763|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836764|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
14836765|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836766|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14836767|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14836768|NCT02659930|Growth Substances|growth substances|mesh-ancestor
14836769|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
14836770|NCT02639273|Nalmefene|nalmefene|mesh-list
14836771|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14836772|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836773|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
14836774|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836775|NCT02630459|Erenumab|erenumab|mesh-list
14836776|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14836777|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14836778|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836779|NCT02630459|Analgesics|analgesics|mesh-ancestor
14836780|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
14836781|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836782|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836783|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
14836784|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
14836785|NCT02630043|Tolcapone|tolcapone|mesh-list
14836786|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836787|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14836788|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14836789|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14836790|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836791|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836792|NCT02621021|Aldesleukin|aldesleukin|mesh-list
14836793|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
14836794|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
14836795|NCT02621021|Fludarabine|fludarabine|mesh-list
14836796|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14836797|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
14836798|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836799|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836800|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836801|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
14836802|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836803|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836804|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14836805|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836806|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14836807|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14836808|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
14836809|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836810|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
14836811|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836812|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14836813|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836814|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836815|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
14836816|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836817|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836818|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14836819|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
14836820|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836821|NCT02573324|Temozolomide|temozolomide|mesh-list
15203978|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15203979|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
15203980|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203981|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203982|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15203983|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15203984|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
15203985|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15203986|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14836822|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
14836823|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14836824|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
15203987|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15203988|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
15203989|NCT03741075|Coagulants|coagulants|mesh-ancestor
15203990|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15203991|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14836825|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836826|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836827|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
14836828|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836829|NCT02564978|Minocycline|minocycline|mesh-list
14836830|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14836831|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836832|NCT02559778|Eflornithine|eflornithine|mesh-list
14836833|NCT02559778|Sorafenib|sorafenib|mesh-list
14836834|NCT02559778|Dasatinib|dasatinib|mesh-list
14836835|NCT02559778|Vorinostat|vorinostat|mesh-list
14836836|NCT02559778|Ceritinib|ceritinib|mesh-list
14836837|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836838|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836839|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836840|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836841|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14836842|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14836843|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14836844|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14836845|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836846|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14836847|NCT02545868|Vaccines|vaccines|mesh-list
14836848|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
14836849|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836850|NCT02543983|Ketamine|ketamine|mesh-list
14836851|NCT02543983|Analgesics|analgesics|mesh-ancestor
14836852|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
14836853|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836854|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836855|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14836856|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15203992|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
14836857|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
14836858|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
14836859|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14836860|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14836861|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14836862|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14836863|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836864|NCT02520154|Paclitaxel|paclitaxel|mesh-list
14836865|NCT02520154|Carboplatin|carboplatin|mesh-list
15203993|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15203994|NCT03740893|Durvalumab|durvalumab|mesh-list
15203995|NCT03740893|Olaparib|olaparib|mesh-list
15203996|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15203997|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15203998|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15203999|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836866|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
14836867|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14836868|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836869|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836870|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836871|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836872|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836873|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836874|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836875|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14836876|NCT02511028|Hematinics|hematinics|mesh-ancestor
14836877|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14836878|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14836879|NCT02507687|Bimatoprost|bimatoprost|mesh-list
14836880|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14836881|NCT02505984|Oxytocin|oxytocin|mesh-list
14836882|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
14836883|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14836884|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836885|NCT02484404|Durvalumab|durvalumab|mesh-list
14836886|NCT02484404|Olaparib|olaparib|mesh-list
14836887|NCT02484404|Cediranib|cediranib|mesh-list
14836888|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836889|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836890|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14836891|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836892|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836893|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14836894|NCT02470091|Denosumab|denosumab|mesh-list
14836895|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14836896|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836897|NCT02465138|Ketorolac|ketorolac|mesh-list
14836898|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14836899|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14836900|NCT02465138|Analgesics|analgesics|mesh-ancestor
14836901|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
14836902|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836903|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836904|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14836905|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14836906|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14836907|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836908|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204000|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204001|NCT03740581|Insulin|insulin|mesh-list
15204002|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15204003|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204004|NCT03740568|Progesterone|progesterone|mesh-list
15204005|NCT03740568|Progestins|progestins|mesh-ancestor
15204006|NCT03740568|Hormones|hormones|mesh-ancestor
15204007|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204008|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204009|NCT03740516|Apremilast|apremilast|mesh-list
15204010|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15204011|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204012|NCT03740516|Analgesics|analgesics|mesh-ancestor
14295536|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14295537|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15204013|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
15204014|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204015|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204016|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204017|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204018|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14836946|NCT02440425|Paclitaxel|paclitaxel|mesh-list
14836947|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
14836948|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836949|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836950|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836951|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836952|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836953|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836954|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14836955|NCT02437110|Ritonavir|ritonavir|mesh-list
14836956|NCT02437110|Darunavir|darunavir|mesh-list
14836957|NCT02437110|Tenofovir|tenofovir|mesh-list
14836958|NCT02437110|Dolutegravir|dolutegravir|mesh-list
14836959|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14836960|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14836961|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
14836962|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836963|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836964|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14836965|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14836966|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
15204019|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15204020|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204021|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204022|NCT03740464|Sargramostim|sargramostim|mesh-list
15204023|NCT03740464|Lenograstim|lenograstim|mesh-list
15204024|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
15204025|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204026|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15204027|NCT03740399|Anesthetics|anesthetics|mesh-list
15204028|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204029|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204030|NCT03740386|Phentolamine|phentolamine|mesh-list
15204031|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15204032|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15204033|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204034|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204035|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204036|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204037|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15204038|NCT03740373|Budesonide|budesonide|mesh-list
15204039|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
15204040|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
15204041|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204042|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15204043|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
15204044|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204045|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836967|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14836968|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14836969|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14836970|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14836971|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14836972|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14836973|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14836974|NCT02404870|Canagliflozin|canagliflozin|mesh-list
14836975|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14836976|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836977|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14836978|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836979|NCT02379416|Paclitaxel|paclitaxel|mesh-list
14836980|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14836981|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14836982|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295538|NCT00581867|Insulin|insulin|mesh-list
14295539|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14295540|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
14295541|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14705374|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
14836983|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
14836984|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
14836985|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836986|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15204046|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15204047|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
15204048|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
15204049|NCT03740373|Hormones|hormones|mesh-ancestor
15204050|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204051|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15204052|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14705375|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705376|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705377|NCT00415064|Dexamethasone|dexamethasone|mesh-list
14705378|NCT00415064|Lenalidomide|lenalidomide|mesh-list
14705379|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705380|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
14705381|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
14705382|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705383|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705384|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14705385|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
14705386|NCT00415064|Hormones|hormones|mesh-ancestor
14705387|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705388|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705389|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705390|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
14705391|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14705392|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14705393|NCT00415064|Growth Substances|growth substances|mesh-ancestor
14705394|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
14705395|NCT00415090|Nevirapine|nevirapine|mesh-list
14295542|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295543|NCT00581893|Phenytoin|phenytoin|mesh-list
14295544|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
14836987|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15204053|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15204054|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204055|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204056|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204057|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15204058|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15204059|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15204060|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
15204061|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15204062|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
15204063|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204064|NCT03740295|Protective Agents|protective agents|mesh-ancestor
15204065|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204066|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15204067|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15204068|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204069|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15204070|NCT03740243|Buprenorphine|buprenorphine|mesh-list
15204071|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15204072|NCT03740243|Naloxone|naloxone|mesh-list
15204073|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14295545|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14836988|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14836989|NCT02363335|Incretins|incretins|mesh-ancestor
14836990|NCT02363335|Hormones|hormones|mesh-ancestor
14836991|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14836992|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14295546|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14295547|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14836993|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
14836994|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14836995|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14836996|NCT02356159|Rituximab|rituximab|mesh-list
14836997|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204074|NCT03740243|Narcotics|narcotics|mesh-ancestor
15204075|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204076|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204077|NCT03740243|Analgesics|analgesics|mesh-ancestor
15204078|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
15204079|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204080|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15204081|NCT03740178|Donepezil|donepezil|mesh-list
15204082|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15204083|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204084|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204085|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
15204086|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204087|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204088|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
15204089|NCT03740165|Paclitaxel|paclitaxel|mesh-list
15204090|NCT03740165|Docetaxel|docetaxel|mesh-list
15204091|NCT03740165|Bevacizumab|bevacizumab|mesh-list
15204092|NCT03740165|Carboplatin|carboplatin|mesh-list
15204093|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
15204094|NCT03740165|Olaparib|olaparib|mesh-list
15204095|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15204096|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204097|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
15204098|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
15204099|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
15204100|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204101|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204102|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15204103|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15204104|NCT03740165|Growth Substances|growth substances|mesh-ancestor
15204105|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204106|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
15204107|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15204108|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204109|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
15204110|NCT03739853|Adalimumab|adalimumab|mesh-list
15204111|NCT03739853|Methotrexate|methotrexate|mesh-list
15204112|NCT03739853|Leflunomide|leflunomide|mesh-list
15204113|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15204114|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
15204115|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15204116|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204117|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15204118|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
15204119|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204120|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204121|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
15204122|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204123|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15204124|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204125|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
15204126|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204127|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15204128|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204129|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204130|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15204131|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204132|NCT03739853|Analgesics|analgesics|mesh-ancestor
15204133|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
15204134|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14836998|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295548|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295549|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14295550|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14295551|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
14295552|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295553|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
14295554|NCT00581919|Vitamins|vitamins|mesh-ancestor
14295555|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
14295556|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
14295557|NCT00581971|Celecoxib|celecoxib|mesh-list
14295558|NCT00581971|Paclitaxel|paclitaxel|mesh-list
14295559|NCT00581971|Carboplatin|carboplatin|mesh-list
14295560|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295561|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295562|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
14836999|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
15204135|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15204136|NCT03739801|Irinotecan|irinotecan|mesh-list
15204137|NCT03739801|Ramucirumab|ramucirumab|mesh-list
15204138|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15204139|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15204140|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204141|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204142|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204143|NCT03739788|BMS-986165|bms-986165|mesh-list
15204144|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
15204145|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15204146|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204147|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204148|NCT03739671|Vitamin D|vitamin d|mesh-list
15204149|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
15204150|NCT03739671|Vitamins|vitamins|mesh-list
15204151|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
15204152|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204153|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15204154|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15204155|NCT03739619|Gemcitabine|gemcitabine|mesh-list
15204156|NCT03739619|Nivolumab|nivolumab|mesh-list
15204157|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15204158|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15204159|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
15204160|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204161|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204162|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
15204163|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295563|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
14837000|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204164|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204165|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837001|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837002|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
14837003|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837004|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837005|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837006|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204166|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
15204167|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204168|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204169|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15204170|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15204171|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
15204172|NCT03739606|Antibodies|antibodies|mesh-list
15204173|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
15204174|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15204175|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15204176|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
15204177|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204178|NCT03739541|Benzonidazole|benzonidazole|mesh-list
15204179|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204180|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
15204181|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204182|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15204183|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15204184|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15204185|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224726|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224727|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
15224728|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224729|NCT02589600|Vitamin D|vitamin d|mesh-list
15224730|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
15224731|NCT02589600|Calcium|calcium|mesh-list
15224732|NCT02589600|Vitamins|vitamins|mesh-ancestor
15224733|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
15224734|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224735|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15224736|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15224737|NCT02567578|YH12852|yh12852|mesh-list
15224738|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15224739|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15224740|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
15224741|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224742|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224743|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224744|NCT02523274|Resveratrol|resveratrol|mesh-list
15224745|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
15224746|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224747|NCT02523274|Protective Agents|protective agents|mesh-ancestor
15224748|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224749|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224750|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15224751|NCT02467270|Ponatinib|ponatinib|mesh-list
15224752|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224753|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14705396|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14705397|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14705398|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705399|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705400|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
14705401|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705402|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14705403|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14705404|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14705405|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14705406|NCT00415103|Aprepitant|aprepitant|mesh-list
14705407|NCT00415103|Palonosetron|palonosetron|mesh-list
14705408|NCT00415103|Granisetron|granisetron|mesh-list
14705409|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
14837016|NCT02304458|Nivolumab|nivolumab|mesh-list
14837017|NCT02304458|Ipilimumab|ipilimumab|mesh-list
14837018|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837019|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837020|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14837021|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837022|NCT02296684|Cisplatin|cisplatin|mesh-list
14837023|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
14837024|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837025|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837026|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
14837027|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14837028|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837029|NCT02264678|Carboplatin|carboplatin|mesh-list
14837030|NCT02264678|Durvalumab|durvalumab|mesh-list
14837031|NCT02264678|Olaparib|olaparib|mesh-list
14837032|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837033|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837034|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14837035|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837036|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837037|NCT02233829|Dopamine|dopamine|mesh-list
14837038|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14837039|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
14837040|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
14837041|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837042|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837043|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
14837044|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837045|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837046|NCT02233829|Protective Agents|protective agents|mesh-ancestor
14837047|NCT02211755|Bortezomib|bortezomib|mesh-list
14837048|NCT02211755|Clofarabine|clofarabine|mesh-list
15204186|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15204187|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
15204188|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15204189|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15204190|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15204191|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204192|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204193|NCT03739411|Temozolomide|temozolomide|mesh-list
15204194|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15204195|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
15204196|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204197|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204198|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
15204199|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15204200|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204201|NCT03739294|Fluticasone|fluticasone|mesh-list
15204202|NCT03739294|Xhance|xhance|mesh-list
15204203|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204204|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15204205|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
15204206|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705410|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
14705411|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705412|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705413|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14705414|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14705415|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204207|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204208|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14295564|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295565|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295566|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295567|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295568|NCT00581971|Analgesics|analgesics|mesh-ancestor
14295569|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
14705416|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705417|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14837049|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837050|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837051|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
14837052|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837053|NCT02203526|Cytarabine|cytarabine|mesh-list
14837054|NCT02203526|Isavuconazole|isavuconazole|mesh-list
14837055|NCT02203526|Rituximab|rituximab|mesh-list
14837056|NCT02203526|Methotrexate|methotrexate|mesh-list
14837057|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837058|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837059|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
14837060|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837061|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837062|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14837063|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
14837064|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14705418|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14705419|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
14705420|NCT00415116|Carboplatin|carboplatin|mesh-list
14705421|NCT00415116|Docetaxel|docetaxel|mesh-list
14705422|NCT00415116|Lenalidomide|lenalidomide|mesh-list
14705423|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705424|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705425|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705426|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705427|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705428|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
14705429|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705430|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837065|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837066|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
14837067|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837068|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
14837069|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837070|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14837071|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705431|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14705432|NCT00415116|Growth Substances|growth substances|mesh-ancestor
14705433|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
14728637|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728638|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
14728639|NCT00519324|Everolimus|everolimus|mesh-list
14728640|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728641|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837072|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14837073|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
14837074|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837075|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
15204209|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
15204210|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
15204211|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15204212|NCT03739112|Vaccines|vaccines|mesh-list
15204213|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
15204214|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204215|NCT03739021|Ropivacaine|ropivacaine|mesh-list
15204216|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
15204217|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
15204218|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204219|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204220|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
15204221|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204222|NCT03738956|Tofacitinib|tofacitinib|mesh-list
15204223|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15204224|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204225|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728642|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
15204226|NCT03738943|Pyridoxine|pyridoxine|mesh-list
15204227|NCT03738943|Pyridoxal|pyridoxal|mesh-list
15204228|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
15204229|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
15204230|NCT03738943|Adenosine|adenosine|mesh-list
15204231|NCT03738943|Nitroprusside|nitroprusside|mesh-list
15204232|NCT03738943|Acetylcholine|acetylcholine|mesh-list
15204233|NCT03738943|Vitamins|vitamins|mesh-ancestor
15204234|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
15204235|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204236|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
15204237|NCT03738943|Analgesics|analgesics|mesh-ancestor
15204238|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
15204239|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204240|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15204241|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
15204242|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15204243|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
15204244|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
15204245|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204246|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204247|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15204248|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15204249|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15204250|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
15204251|NCT03738917|Bromides|bromides|mesh-list
15204252|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
15204253|NCT03738917|Ipratropium|ipratropium|mesh-list
15204254|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
15204255|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
15204256|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
15204257|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
15204258|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15204259|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15204260|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204261|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204262|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204263|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15204264|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
15204265|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204266|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15204267|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
15204268|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15204269|NCT03738878|Valsartan|valsartan|mesh-list
15204270|NCT03738878|Bradykinin|bradykinin|mesh-list
15204271|NCT03738878|Kininogens|kininogens|mesh-list
15204272|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15204273|NCT03738878|Substance P|substance p|mesh-list
15204274|NCT03738878|Neurokinin A|neurokinin a|mesh-list
15204275|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15204276|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204277|NCT03738878|Incretins|incretins|mesh-ancestor
15204278|NCT03738878|Hormones|hormones|mesh-ancestor
15204279|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204280|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15204281|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
15204282|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204283|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204284|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14837104|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14837105|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14837106|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837107|NCT02169310|Raclopride|raclopride|mesh-list
14837108|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14837109|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14837110|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14837111|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837112|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14837113|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14837114|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
14837115|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837116|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837117|NCT02139397|Eflornithine|eflornithine|mesh-list
14837118|NCT02139397|Bortezomib|bortezomib|mesh-list
14837119|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837120|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14837121|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14837122|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14837123|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837124|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14837125|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837126|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837127|NCT02133196|Aldesleukin|aldesleukin|mesh-list
14837128|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
14837129|NCT02133196|Fludarabine|fludarabine|mesh-list
14837130|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837131|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
14837132|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837133|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837134|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837135|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
14837136|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837137|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837138|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837139|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837140|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837141|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
14837142|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837143|NCT02107976|Ascorbic Acid|ascorbic acid|mesh-list
14837144|NCT02107976|Vitamins|vitamins|mesh-ancestor
14837145|NCT02107976|Micronutrients|micronutrients|mesh-ancestor
14837146|NCT02107976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837147|NCT02107976|Antioxidants|antioxidants|mesh-ancestor
14837148|NCT02107976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837149|NCT02107976|Protective Agents|protective agents|mesh-ancestor
14837150|NCT02105766|Sirolimus|sirolimus|mesh-list
14837151|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
14837152|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
14837153|NCT02105766|Pentostatin|pentostatin|mesh-list
14837154|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837155|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
14837156|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837157|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204285|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15204286|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15204287|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
15204288|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
15204289|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204290|NCT03738800|Trifarotene|trifarotene|mesh-list
15204291|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
15204292|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14837158|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837159|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
15204293|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837160|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837161|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837162|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837163|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837164|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837165|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837166|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
14837167|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837168|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14837169|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837170|NCT02066415|Erenumab|erenumab|mesh-list
14837171|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14837172|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837173|NCT02066415|Analgesics|analgesics|mesh-ancestor
15204294|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
15204295|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15204296|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15204297|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204298|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
15204299|NCT03738527|Coagulants|coagulants|mesh-ancestor
15204300|NCT03738176|Triamcinolone|triamcinolone|mesh-list
15204301|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204302|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
15204303|NCT03738176|Hormones|hormones|mesh-ancestor
14705434|NCT00415233|Hormones|hormones|mesh-list
15204304|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204305|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204306|NCT03738137|Lidocaine|lidocaine|mesh-list
15204307|NCT03738137|Midazolam|midazolam|mesh-list
15204308|NCT03738137|Sufentanil|sufentanil|mesh-list
15204309|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
15204310|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
15204311|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204312|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204313|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
15204314|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204315|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15204316|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15204317|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15204318|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15204319|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204320|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15204321|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15204322|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15204323|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15204324|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15204325|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15204326|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
15204327|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
15204328|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
15204329|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204330|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15204331|NCT03738137|Narcotics|narcotics|mesh-ancestor
15204332|NCT03738137|Analgesics|analgesics|mesh-ancestor
15204333|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
14705435|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705436|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705437|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14705438|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
14705439|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14705440|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
15204334|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15204335|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14705441|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14705442|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705443|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14705444|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705445|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705446|NCT00415285|Docetaxel|docetaxel|mesh-list
14705447|NCT00415285|Capecitabine|capecitabine|mesh-list
14705448|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204336|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837174|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
14837175|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837176|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837177|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14837178|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
14837179|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837180|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837181|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837182|NCT02015013|Plerixafor|plerixafor|mesh-list
14837183|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837184|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837185|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
14837186|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837187|NCT02008292|Physostigmine|physostigmine|mesh-list
14837188|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14837189|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204337|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204338|NCT03738059|Analgesics|analgesics|mesh-ancestor
15204339|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
15204340|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204341|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15204342|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15204343|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15204344|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204345|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204346|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204347|NCT03737968|Durvalumab|durvalumab|mesh-list
15204348|NCT03737968|Tremelimumab|tremelimumab|mesh-list
15204349|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15204350|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204351|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204352|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
15204353|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204354|NCT03737773|Methamphetamine|methamphetamine|mesh-list
15204355|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14837190|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837191|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
14837192|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837193|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837194|NCT02008292|Miotics|miotics|mesh-ancestor
14837195|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
14837196|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837197|NCT01993719|Aldesleukin|aldesleukin|mesh-list
14837198|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
15204356|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204357|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
15204358|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
15204359|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204360|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
15204361|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204362|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204363|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204364|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15204365|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15204366|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15204367|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15204368|NCT03737721|Avelumab|avelumab|mesh-list
15204369|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204370|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204371|NCT03737708|Adalimumab|adalimumab|mesh-list
15204372|NCT03737708|Methotrexate|methotrexate|mesh-list
15204373|NCT03737708|Abatacept|abatacept|mesh-list
15204374|NCT03737708|Tacrolimus|tacrolimus|mesh-list
15204375|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15204376|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
15204377|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15204378|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204379|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15204380|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
15204381|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204382|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837199|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
14837200|NCT01993719|Fludarabine|fludarabine|mesh-list
15204383|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
15204384|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837201|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837202|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
14837203|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204385|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15204386|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204387|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
15204388|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204389|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15204390|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15204391|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204392|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15204393|NCT03737656|Progesterone|progesterone|mesh-list
15204394|NCT03737656|Progestins|progestins|mesh-ancestor
15204395|NCT03737656|Hormones|hormones|mesh-ancestor
15204396|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204397|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204398|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
15204399|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
15204400|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204401|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204402|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204403|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
15204404|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
15204405|NCT03737448|Trimetazidine|trimetazidine|mesh-list
15204406|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
15224754|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224755|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224756|NCT02452554|Maytansine|maytansine|mesh-list
15224757|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
15224758|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15224759|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15224760|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224761|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
15224762|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
15224763|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
15224764|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224765|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224766|NCT02432560|Sirolimus|sirolimus|mesh-list
15224767|NCT02432560|Everolimus|everolimus|mesh-list
15224768|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224769|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224770|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
14295570|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295571|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224771|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224772|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837204|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837205|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837206|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
14837207|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837208|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837209|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837210|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837211|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837212|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837213|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
14837214|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837215|NCT01952574|Erenumab|erenumab|mesh-list
14837216|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14837217|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14837218|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837219|NCT01952574|Analgesics|analgesics|mesh-ancestor
15204407|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15204408|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204409|NCT03737292|Bupivacaine|bupivacaine|mesh-list
15204410|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
15204411|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
15204412|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204413|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837220|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
15204414|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
15204415|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204416|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
15204417|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15204418|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15204419|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204420|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
15204421|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
15204422|NCT03736980|Psilocybin|psilocybin|mesh-list
15204423|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
15204424|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204425|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15204426|NCT03736616|Cytarabine|cytarabine|mesh-list
15204427|NCT03736616|Rituximab|rituximab|mesh-list
15204428|NCT03736616|Carboplatin|carboplatin|mesh-list
15204429|NCT03736616|Etoposide|etoposide|mesh-list
15204430|NCT03736616|Melphalan|melphalan|mesh-list
15204431|NCT03736616|Ifosfamide|ifosfamide|mesh-list
15204432|NCT03736616|Carmustine|carmustine|mesh-list
15204433|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
15204434|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204435|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204436|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
15204437|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204438|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204439|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15204440|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15204441|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15204442|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204443|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204444|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15204445|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
15204446|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
15204447|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204448|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204449|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15204450|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
15204451|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15204452|NCT03736369|Esomeprazole|esomeprazole|mesh-list
15204453|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15204454|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15204455|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15204456|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204457|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204458|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
15204459|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204460|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204461|NCT03736187|Metronidazole|metronidazole|mesh-list
15204462|NCT03736187|Cephalexin|cephalexin|mesh-list
15204463|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204464|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15204465|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15204466|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15204467|NCT03736161|Methotrexate|methotrexate|mesh-list
15204468|NCT03736161|Tofacitinib|tofacitinib|mesh-list
15204469|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15204470|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
15204471|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15204472|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204473|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837221|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204474|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
15204475|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204476|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837222|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837223|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
14837224|NCT01950520|Topiramate|topiramate|mesh-list
14837225|NCT01950520|Phentermine|phentermine|mesh-list
14837226|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
14837227|NCT01950520|Propranolol|propranolol|mesh-list
14837228|NCT01950520|Pindolol|pindolol|mesh-list
14837229|NCT01950520|Naltrexone|naltrexone|mesh-list
14837230|NCT01950520|Caffeine|caffeine|mesh-list
14837231|NCT01950520|Dantrolene|dantrolene|mesh-list
14837232|NCT01950520|Mirabegron|mirabegron|mesh-list
14837233|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14837234|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14837235|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837236|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
14837237|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837238|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14837239|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14837240|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837241|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837242|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14837243|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15204477|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
15204478|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204479|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15204480|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204481|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
15204482|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204483|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15204484|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15204485|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
15204486|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204487|NCT03735979|Argatroban|argatroban|mesh-list
15204488|NCT03735979|Eptifibatide|eptifibatide|mesh-list
15204489|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
15204490|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15204491|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
15204492|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204493|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204494|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
15204495|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15204496|NCT03735966|Carboplatin|carboplatin|mesh-list
15204497|NCT03735966|Docetaxel|docetaxel|mesh-list
15204498|NCT03735966|Trastuzumab|trastuzumab|mesh-list
15204499|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204500|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
15204501|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
15204502|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
15204503|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204504|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204505|NCT03735875|Venetoclax|venetoclax|mesh-list
15204506|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204507|NCT03735771|Bupivacaine|bupivacaine|mesh-list
15204508|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
15204509|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
14705449|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705450|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705451|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705452|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705453|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14705454|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
14705455|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
14705456|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705457|NCT00415311|Lectins|lectins|mesh-list
14705458|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
14705459|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
14705460|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705461|NCT00415311|Coagulants|coagulants|mesh-ancestor
14705462|NCT00415324|Cisplatin|cisplatin|mesh-list
14705463|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705464|NCT00415350|Azithromycin|azithromycin|mesh-list
15204510|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14705465|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837244|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
14837245|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204511|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837246|NCT01950520|Analgesics|analgesics|mesh-ancestor
15204512|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
15204513|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204514|NCT03735563|Fentanyl|fentanyl|mesh-list
15204515|NCT03735563|Ketamine|ketamine|mesh-list
15204516|NCT03735563|Analgesics|analgesics|mesh-ancestor
15204517|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
15204518|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204519|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204520|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14705466|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705467|NCT00415376|Levetiracetam|levetiracetam|mesh-list
14705468|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
14705469|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
14705470|NCT00415402|Vitamin D|vitamin d|mesh-list
14705471|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
15204521|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15204522|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
15204523|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
15204524|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204525|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15204526|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15204527|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204528|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204529|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15204530|NCT03735563|Narcotics|narcotics|mesh-ancestor
15204531|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15204532|NCT03735446|Cytarabine|cytarabine|mesh-list
15204533|NCT03735446|Etoposide|etoposide|mesh-list
15204534|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
15204535|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15204536|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204537|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15204538|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15204539|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204540|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204541|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15204542|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
15204543|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
15204544|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204545|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204546|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
15204547|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204548|NCT03735446|Analgesics|analgesics|mesh-ancestor
15204549|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
15204550|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204551|NCT03735433|Aspirin|aspirin|mesh-list
15204552|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15204553|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204554|NCT03735433|Analgesics|analgesics|mesh-ancestor
15204555|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
15204556|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204557|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204558|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204559|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204560|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15204561|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15204562|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204563|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15204564|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15204565|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204566|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
15204567|NCT03735368|Pregabalin|pregabalin|mesh-list
15204568|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
15204569|NCT03735368|Benoxinate|benoxinate|mesh-list
15204570|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
15204571|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204572|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705472|NCT00415402|Vitamins|vitamins|mesh-ancestor
14705473|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
14705474|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705475|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14705476|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15204573|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14705477|NCT00415584|Cinacalcet|cinacalcet|mesh-list
14728643|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204574|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204575|NCT03735368|Analgesics|analgesics|mesh-ancestor
15204576|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
14837247|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
14837248|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14837249|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14837250|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
14837251|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14837252|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14837253|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14837254|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
15204577|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204578|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15204579|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15204580|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15204581|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204582|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204583|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204584|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
15204585|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15204586|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15204587|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15204588|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15204589|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15204590|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15204591|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
15224773|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224774|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15224775|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
15224776|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15224777|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
15224778|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224779|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224780|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
15224781|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224782|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224783|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15224784|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15224785|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15224786|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
15224787|NCT02359175|Acetaminophen|acetaminophen|mesh-list
15224788|NCT02359175|Fentanyl|fentanyl|mesh-list
15224789|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
15224790|NCT02359175|Bupivacaine|bupivacaine|mesh-list
15224791|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
15224792|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
15224793|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224794|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224795|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
15224796|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224797|NCT02359175|Narcotics|narcotics|mesh-ancestor
15224798|NCT02359175|Analgesics|analgesics|mesh-ancestor
15224799|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15224800|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15224801|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
15224802|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15224803|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
15224804|NCT02332577|Amoxicillin|amoxicillin|mesh-list
15224805|NCT02332577|Pristinamycin|pristinamycin|mesh-list
14837255|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14837256|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14837257|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14837258|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
14837259|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14837260|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
14837261|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14837262|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14837263|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14837264|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14837265|NCT01950520|Urological Agents|urological agents|mesh-ancestor
14837266|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
14837267|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14837268|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
14837269|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
14837270|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14837271|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
14837272|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14837273|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14837274|NCT01867333|Metronidazole|metronidazole|mesh-list
14837275|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837276|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837277|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14837278|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14837279|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
14837280|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837281|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837282|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
14837283|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837284|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14837285|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14837286|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837287|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837288|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
14837289|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
14837290|NCT01861106|Busulfan|busulfan|mesh-list
14837291|NCT01861106|Fludarabine|fludarabine|mesh-list
14837292|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
14837293|NCT01861106|Tacrolimus|tacrolimus|mesh-list
14837294|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14837295|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837296|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
14837297|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837298|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837299|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837300|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
14837301|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837302|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204592|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
15204593|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
15204594|NCT03735316|Vitamins|vitamins|mesh-ancestor
15204595|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
15204596|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204597|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
15204598|NCT03735316|Hematinics|hematinics|mesh-ancestor
15204599|NCT03735264|Docetaxel|docetaxel|mesh-list
15204600|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204601|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
15204602|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
15204603|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
15204604|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204605|NCT03735251|Metoprolol|metoprolol|mesh-list
15204606|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15204607|NCT03735251|Diuretics|diuretics|mesh-list
15204608|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
15204609|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204610|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15204611|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14837303|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837304|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837305|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
14837306|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14837307|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837308|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837309|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14837310|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
14837311|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837312|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837313|NCT01842399|Resveratrol|resveratrol|mesh-list
14837314|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
15204612|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
15204613|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
15204614|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204615|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15204616|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15204617|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15204618|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204619|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204620|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204621|NCT03735134|Colchicine|colchicine|mesh-list
14837315|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837316|NCT01842399|Protective Agents|protective agents|mesh-ancestor
14837317|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204622|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
14837318|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837319|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14837320|NCT01842386|Rituximab|rituximab|mesh-list
14837321|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837322|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837323|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
14837324|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837325|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837326|NCT01799538|Albuterol|albuterol|mesh-list
14837327|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14837328|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
14837329|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837330|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837331|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14837332|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
14837333|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
14837334|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14837335|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14837336|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14837337|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14837338|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
14837339|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837340|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837341|NCT01795586|Carboplatin|carboplatin|mesh-list
15204623|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204624|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
15204625|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
15204626|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
15204627|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204628|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204629|NCT03735082|Paclitaxel|paclitaxel|mesh-list
15204630|NCT03735082|Carboplatin|carboplatin|mesh-list
15204631|NCT03735082|Apatinib|apatinib|mesh-list
15204632|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15204633|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204634|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
15204635|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
15204636|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
15204637|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204638|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15204639|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204640|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
15204641|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204642|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204643|NCT03734770|Progesterone|progesterone|mesh-list
15204644|NCT03734770|Progestins|progestins|mesh-ancestor
15204645|NCT03734770|Hormones|hormones|mesh-ancestor
15204646|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204647|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204648|NCT03734744|Vitamin D|vitamin d|mesh-list
15204649|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
15204650|NCT03734744|Vitamins|vitamins|mesh-ancestor
15204651|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
15204652|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204653|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15204654|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15204655|NCT03734627|Acetaminophen|acetaminophen|mesh-list
15204656|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
15204657|NCT03734627|Octreotide|octreotide|mesh-list
15204658|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204659|NCT03734627|Analgesics|analgesics|mesh-ancestor
15204660|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
15204661|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204662|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204663|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
15204664|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15204665|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15204666|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204667|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204668|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15204669|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204670|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837342|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204671|NCT03734614|Aspirin|aspirin|mesh-list
14837343|NCT01712620|Spironolactone|spironolactone|mesh-list
15204672|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14705478|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14705479|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705480|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14837344|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14837345|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
14911951|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204673|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204674|NCT03734614|Analgesics|analgesics|mesh-ancestor
15204675|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
15204676|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204677|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204678|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204679|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204680|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15204681|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15204682|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204683|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15204684|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15204685|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204686|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
15204687|NCT03734562|Amiodarone|amiodarone|mesh-list
15204688|NCT03734562|Sotalol|sotalol|mesh-list
15204689|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
15204690|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
15204691|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15204692|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15204693|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204694|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15204695|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15204696|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15204697|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204698|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15204699|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15204700|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15204701|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15204702|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15204703|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204704|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204705|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204706|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
15204707|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
15204708|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204709|NCT03734445|Vitamins|vitamins|mesh-list
15204710|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
15204711|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204712|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
15204713|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
15204714|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204715|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204716|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204717|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
15204718|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
15204719|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
15204720|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
15204721|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204722|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204723|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204724|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
14705481|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
14705482|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705483|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
14705484|NCT00415701|Propofol|propofol|mesh-list
14705485|NCT00415701|Etomidate|etomidate|mesh-list
14705486|NCT00415701|Cosyntropin|cosyntropin|mesh-list
14705487|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14705488|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14705489|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705490|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14705491|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
14705492|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
14705493|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705494|NCT00415701|Hormones|hormones|mesh-ancestor
14705495|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837346|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837347|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837348|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14837349|NCT01712620|Diuretics|diuretics|mesh-ancestor
14837350|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
14837351|NCT01696734|Domperidone|domperidone|mesh-list
14837352|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
14837353|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
14837354|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837355|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837356|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14837357|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14837358|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
14837359|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837360|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837361|NCT01659151|Aldesleukin|aldesleukin|mesh-list
14837362|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
14837363|NCT01659151|Fludarabine|fludarabine|mesh-list
15204725|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
14837364|NCT01659151|Interleukin-2|interleukin-2|mesh-list
14837365|NCT01659151|Vemurafenib|vemurafenib|mesh-list
14837366|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14837367|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837368|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
14837369|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837370|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837371|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837372|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
15204726|NCT03734211|Evolocumab|evolocumab|mesh-list
15204727|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15204728|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14705496|NCT00415740|Levodopa|levodopa|mesh-list
14705497|NCT00415740|Carbidopa|carbidopa|mesh-list
14705498|NCT00415740|Entacapone|entacapone|mesh-list
14705499|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14705500|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14705501|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14705502|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
14705503|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705504|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837373|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837374|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837375|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837376|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14837377|NCT01659151|Analgesics|analgesics|mesh-ancestor
14837378|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
14837379|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837380|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837381|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837382|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
14837383|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837384|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837385|NCT01631617|Doxycycline|doxycycline|mesh-list
14837386|NCT01631617|Cephalexin|cephalexin|mesh-list
14837387|NCT01631617|Trimethoprim|trimethoprim|mesh-list
14837388|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
14837389|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14837390|NCT01631617|Eusol|eusol|mesh-list
15204729|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
15204730|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204731|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15204732|NCT03734198|Daratumumab|daratumumab|mesh-list
15204733|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15204734|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204735|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
15204736|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705505|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837391|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837392|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837393|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
14837394|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14837395|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14837396|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14837397|NCT01631617|Renal Agents|renal agents|mesh-ancestor
14837398|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14837399|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837400|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837401|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14837402|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14837403|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14837404|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
14837405|NCT01590069|Aldesleukin|aldesleukin|mesh-list
14837406|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837407|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837408|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837409|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
14837410|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837411|NCT01572662|Vidarabine|vidarabine|mesh-list
14837412|NCT01572662|Methotrexate|methotrexate|mesh-list
14837413|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
14837414|NCT01572662|Fludarabine|fludarabine|mesh-list
14837415|NCT01572662|Busulfan|busulfan|mesh-list
14837416|NCT01572662|Tacrolimus|tacrolimus|mesh-list
14837417|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14837418|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
14837419|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14837420|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837421|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837422|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
14837423|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837424|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837425|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14837426|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837427|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14837428|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837429|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
14837430|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837431|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14837432|NCT01572662|Antiviral Agents|antiviral agents|mesh-ancestor
14705506|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14295572|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295573|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705507|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705508|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14705509|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14837433|NCT01572662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837434|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14837435|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
14837436|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837437|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837438|NCT01572506|Biotin|biotin|mesh-list
14837439|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
14705510|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
14705511|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
14705512|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14705513|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705514|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14705515|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14705516|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705517|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
14705518|NCT00415779|Docetaxel|docetaxel|mesh-list
14705519|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837440|NCT01572506|Vitamins|vitamins|mesh-ancestor
14837441|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
15204737|NCT03734159|Ropivacaine|ropivacaine|mesh-list
15204738|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
15204739|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
15204740|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204741|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204742|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
15204743|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204744|NCT03734068|Doxorubicin|doxorubicin|mesh-list
15204745|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15204746|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204747|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15204748|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15204749|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837442|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837443|NCT01572480|Dexamethasone|dexamethasone|mesh-list
14837444|NCT01572480|Lenalidomide|lenalidomide|mesh-list
14837445|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14837446|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
14837447|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
14837448|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295574|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14295575|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14295576|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295577|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
14295578|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14837449|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837450|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14837451|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
14837452|NCT01572480|Hormones|hormones|mesh-ancestor
14837453|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837454|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14837455|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837456|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
14837457|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837458|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14837459|NCT01572480|Growth Substances|growth substances|mesh-ancestor
14837460|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837461|NCT01553214|Dexamethasone|dexamethasone|mesh-list
14837462|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14837463|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
14837464|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
14837465|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14837466|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837467|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14837468|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
14837469|NCT01553214|Hormones|hormones|mesh-ancestor
14837470|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837471|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14837472|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837473|NCT01529593|Metformin|metformin|mesh-list
14837474|NCT01529593|Sirolimus|sirolimus|mesh-list
14837475|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14837476|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837477|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837478|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837479|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837480|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837481|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
14837482|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837483|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
14837484|NCT01517100|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14837485|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837486|NCT01495598|Pomalidomide|pomalidomide|mesh-list
14837487|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
14837488|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837489|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837490|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14837491|NCT01495598|Growth Substances|growth substances|mesh-ancestor
14837492|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837493|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837494|NCT01446133|Rituximab|rituximab|mesh-list
14837495|NCT01446133|Lenalidomide|lenalidomide|mesh-list
14837496|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837497|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837498|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
14837499|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837500|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837501|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837502|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14295579|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
14837503|NCT01446133|Growth Substances|growth substances|mesh-ancestor
14837504|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837505|NCT01445509|Bevacizumab|bevacizumab|mesh-list
14837506|NCT01445509|Dasatinib|dasatinib|mesh-list
14837507|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837508|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837509|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837510|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14837511|NCT01445509|Growth Substances|growth substances|mesh-ancestor
14837512|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837513|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837514|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837515|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837516|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837517|NCT01419561|Zidovudine|zidovudine|mesh-list
14837518|NCT01419561|Rituximab|rituximab|mesh-list
14837519|NCT01419561|Doxorubicin|doxorubicin|mesh-list
14837520|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14837521|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837522|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837523|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
14837524|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837525|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837526|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837527|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14837528|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14837529|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837530|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837531|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
14837532|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14837533|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14837534|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
14837535|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837536|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837537|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837538|NCT01391962|Sunitinib|sunitinib|mesh-list
14837539|NCT01391962|Cediranib|cediranib|mesh-list
14837540|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837541|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837542|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14837543|NCT01391962|Growth Substances|growth substances|mesh-ancestor
14837544|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837545|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837546|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837547|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837548|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837549|NCT01352962|Gemcitabine|gemcitabine|mesh-list
14837550|NCT01352962|Carboplatin|carboplatin|mesh-list
14837551|NCT01352962|Lenalidomide|lenalidomide|mesh-list
14837552|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837553|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837554|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
14837555|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204750|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204751|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15204752|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
15204753|NCT03733873|Coagulants|coagulants|mesh-ancestor
15204754|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15204755|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
15204756|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204757|NCT03733860|Alprostadil|alprostadil|mesh-list
14837556|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
14837557|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837558|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837559|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837560|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
14837561|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837562|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837563|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14837564|NCT01352962|Growth Substances|growth substances|mesh-ancestor
14837565|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837566|NCT01319565|Aldesleukin|aldesleukin|mesh-list
14837567|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
14837568|NCT01319565|Fludarabine|fludarabine|mesh-list
14837569|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837570|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
14837571|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837572|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837573|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837574|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
14837575|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837576|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837577|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837578|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837579|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837580|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
14837581|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837582|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14837583|NCT01306045|Sunitinib|sunitinib|mesh-list
14837584|NCT01306045|Lapatinib|lapatinib|mesh-list
14837585|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837586|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837587|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837588|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837589|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837590|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14837591|NCT01306045|Growth Substances|growth substances|mesh-ancestor
14837592|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837593|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837594|NCT01306019|Busulfan|busulfan|mesh-list
14837595|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
14837596|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837597|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837598|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
14837599|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837600|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837601|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837602|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837603|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14837604|NCT01264679|Hematinics|hematinics|mesh-ancestor
14837605|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14837606|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14837607|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
14837608|NCT01176006|Busulfan|busulfan|mesh-list
14837609|NCT01176006|Fludarabine|fludarabine|mesh-list
14837610|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
14837611|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837612|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
14837613|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837614|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837615|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837616|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
14837617|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837618|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837619|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837620|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837621|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
14837622|NCT01174121|Aldesleukin|aldesleukin|mesh-list
14837623|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
14837624|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
14837625|NCT01174121|Fludarabine|fludarabine|mesh-list
14837626|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837627|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
14837628|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837629|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837630|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837631|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
14837632|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837633|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837634|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837635|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837636|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837637|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837638|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
14837639|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837640|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
14837641|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14837642|NCT01155388|Hematinics|hematinics|mesh-ancestor
14837643|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14837644|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14837645|NCT01155388|Trace Elements|trace elements|mesh-ancestor
14837646|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
14837647|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837648|NCT01130519|Bevacizumab|bevacizumab|mesh-list
14837649|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14837650|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837651|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837652|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14837653|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14837654|NCT01130519|Growth Substances|growth substances|mesh-ancestor
14837655|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837656|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
14837657|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837658|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837659|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705520|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705521|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
14837660|NCT01095003|Capecitabine|capecitabine|mesh-list
14837661|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837662|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
14837663|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705522|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705523|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705524|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14705525|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705526|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14705527|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14705528|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705529|NCT00415831|Levodopa|levodopa|mesh-list
14705530|NCT00415831|Carbidopa|carbidopa|mesh-list
14705531|NCT00415831|Entacapone|entacapone|mesh-list
14705532|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14837664|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705533|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14705534|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14837665|NCT01059786|Rituximab|rituximab|mesh-list
14837666|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14837667|NCT01059786|Pentostatin|pentostatin|mesh-list
14837668|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837669|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837670|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
14837671|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837672|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837673|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837674|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
14837675|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837676|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14837677|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837678|NCT01026220|Prednisone|prednisone|mesh-list
14837679|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
14837680|NCT01026220|Ifosfamide|ifosfamide|mesh-list
14837681|NCT01026220|Doxorubicin|doxorubicin|mesh-list
14837682|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14837683|NCT01026220|Etoposide|etoposide|mesh-list
14837684|NCT01026220|Vincristine|vincristine|mesh-list
14837685|NCT01026220|Vinorelbine|vinorelbine|mesh-list
14837686|NCT01026220|Bleomycin|bleomycin|mesh-list
14837687|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
14837688|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837689|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
14837690|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837691|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837692|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837693|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
14837694|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837695|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837696|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837697|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837698|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14837699|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14837700|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837701|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14837702|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
14837703|NCT01026220|Hormones|hormones|mesh-ancestor
14837704|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837705|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14837706|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14837707|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
14837708|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
14837709|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
14837710|NCT00977977|Cyclosporine|cyclosporine|mesh-list
14837711|NCT00977977|Rituximab|rituximab|mesh-list
14837712|NCT00977977|Cyclosporins|cyclosporins|mesh-list
14837713|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837714|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837715|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
14837716|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837717|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837718|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837719|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837720|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837721|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
14837722|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837723|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
14837724|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14837725|NCT00967785|Plerixafor|plerixafor|mesh-list
14837726|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837727|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837728|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
14837729|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837730|NCT00923013|Rituximab|rituximab|mesh-list
14837731|NCT00923013|Cladribine|cladribine|mesh-list
14837732|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837733|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837734|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
14837735|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837736|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837737|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837738|NCT00862433|Vitamins|vitamins|mesh-list
14837739|NCT00862433|Vitamin E|vitamin e|mesh-list
14837740|NCT00862433|Tocopherols|tocopherols|mesh-list
14837741|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
14837742|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
14837743|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837744|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
14837745|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837746|NCT00862433|Protective Agents|protective agents|mesh-ancestor
14837747|NCT00720785|Bortezomib|bortezomib|mesh-list
14837748|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837749|NCT00606346|Infliximab|infliximab|mesh-list
14837750|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
14837751|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14837752|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837753|NCT00601003|Nifurtimox|nifurtimox|mesh-list
14837754|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
14837755|NCT00601003|Topotecan|topotecan|mesh-list
14837756|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837757|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
14837758|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837759|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837760|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837761|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
14837762|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837763|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837764|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837765|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14837766|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14837767|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837768|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14837769|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14837770|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14837771|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837772|NCT00567567|Vitamin A|vitamin a|mesh-list
14837773|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
14837774|NCT00567567|Melphalan|melphalan|mesh-list
14837775|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
14837776|NCT00567567|Thiotepa|thiotepa|mesh-list
14837777|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14837778|NCT00567567|Cisplatin|cisplatin|mesh-list
14837779|NCT00567567|Carboplatin|carboplatin|mesh-list
14837780|NCT00567567|Doxorubicin|doxorubicin|mesh-list
14837781|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14837782|NCT00567567|Etoposide|etoposide|mesh-list
14837783|NCT00567567|Vincristine|vincristine|mesh-list
14837784|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
14837785|NCT00567567|Topotecan|topotecan|mesh-list
14837786|NCT00567567|Tretinoin|tretinoin|mesh-list
14837787|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
14837788|NCT00567567|Isotretinoin|isotretinoin|mesh-list
14837789|NCT00567567|Lenograstim|lenograstim|mesh-list
15204758|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15204759|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
15204760|NCT03733860|Urological Agents|urological agents|mesh-ancestor
15204761|NCT03733691|Lenalidomide|lenalidomide|mesh-list
14837790|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837791|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
14837792|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837793|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837794|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15204762|NCT03733691|Ixazomib|ixazomib|mesh-list
15204763|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
15204764|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204765|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15204766|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15204767|NCT03733691|Growth Substances|growth substances|mesh-ancestor
15204768|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
15204769|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204770|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
15204771|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204772|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837795|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
14837796|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837797|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837798|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837799|NCT00567567|Vitamins|vitamins|mesh-ancestor
15204773|NCT03733652|Interferons|interferons|mesh-list
14837800|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
14837801|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837802|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14837803|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14837804|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837805|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14837806|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14837807|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
14837808|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
14837809|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
14837810|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14837811|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
14837812|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
14837813|NCT00450450|Lenograstim|lenograstim|mesh-list
14705535|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
14705536|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837814|NCT00450450|Sargramostim|sargramostim|mesh-list
14837815|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14837816|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
14837817|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837818|NCT00392821|Everolimus|everolimus|mesh-list
14837819|NCT00392821|Sorafenib|sorafenib|mesh-list
14837820|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837821|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837822|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
14837823|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837824|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837825|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837826|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837827|NCT00353158|Doxycycline|doxycycline|mesh-list
14837828|NCT00353158|Voriconazole|voriconazole|mesh-list
14837829|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837830|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837831|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
14837832|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14837833|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14837834|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
14837835|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15204774|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
15204775|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
15204776|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204777|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
15204778|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204779|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
15204780|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204781|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15204782|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
15204783|NCT03733639|Coagulants|coagulants|mesh-ancestor
15204784|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
15204785|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705537|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705538|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705539|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14705540|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705541|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14705542|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14705543|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
14705544|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
14705545|NCT00415844|Levodopa|levodopa|mesh-list
14705546|NCT00415844|Carbidopa|carbidopa|mesh-list
14705547|NCT00415844|Entacapone|entacapone|mesh-list
14837836|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14837837|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837838|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204786|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
14837839|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14837840|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
14837841|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837842|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204787|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204788|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204789|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15204790|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
15204791|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705548|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14705549|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14705550|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14705551|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
14705552|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705553|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705554|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705555|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14837843|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14837844|NCT00346164|Doxorubicin|doxorubicin|mesh-list
14837845|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14837846|NCT00346164|Ifosfamide|ifosfamide|mesh-list
14837847|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837848|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837849|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14837850|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14837851|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837852|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837853|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837854|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
14837855|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
14837856|NCT00097474|Melatonin|melatonin|mesh-list
14837857|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14837858|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
14837859|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837860|NCT00097474|Protective Agents|protective agents|mesh-ancestor
14837861|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837862|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14837863|NCT00092222|Interferons|interferons|mesh-list
14837864|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
14837865|NCT00092222|Zidovudine|zidovudine|mesh-list
14837866|NCT00092222|Valganciclovir|valganciclovir|mesh-list
14837867|NCT00092222|Sirolimus|sirolimus|mesh-list
14837868|NCT00092222|Prednisone|prednisone|mesh-list
14837869|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
14837870|NCT00092222|Rituximab|rituximab|mesh-list
14837871|NCT00092222|Doxorubicin|doxorubicin|mesh-list
14837872|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14837873|NCT00092222|Etoposide|etoposide|mesh-list
14837874|NCT00092222|Vincristine|vincristine|mesh-list
14837875|NCT00092222|Bortezomib|bortezomib|mesh-list
14837876|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837877|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
14837878|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837879|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837880|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14837881|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
14837882|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837883|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837884|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14837885|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837886|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837887|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14837888|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14705556|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705557|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14705558|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14705559|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
14705560|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
14837889|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837890|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204792|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204793|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15204794|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15204795|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14837891|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
14837892|NCT00092222|Hormones|hormones|mesh-ancestor
14837893|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837894|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14837895|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14837896|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
14837897|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837898|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
14837899|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
14837900|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
14837901|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837902|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
14837903|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
14837904|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14837905|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14837906|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14837907|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14837908|NCT00082706|Leucovorin|leucovorin|mesh-list
14837909|NCT00082706|Gemcitabine|gemcitabine|mesh-list
14837910|NCT00082706|Cisplatin|cisplatin|mesh-list
14837911|NCT00082706|Fluorouracil|fluorouracil|mesh-list
14837912|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837913|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14837914|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
14837915|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837916|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
14837917|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837918|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837919|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837920|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
14837921|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837922|NCT00082706|Antidotes|antidotes|mesh-ancestor
14837923|NCT00082706|Protective Agents|protective agents|mesh-ancestor
14837924|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
14837925|NCT00082706|Vitamins|vitamins|mesh-ancestor
14837926|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
14837927|NCT00065676|Quercetin|quercetin|mesh-list
14837928|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
14837929|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837930|NCT00065676|Protective Agents|protective agents|mesh-ancestor
14837931|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837932|NCT00061568|Sirolimus|sirolimus|mesh-list
14837933|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
14837934|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14837935|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837936|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14837937|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837938|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
14837939|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14837940|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
14837941|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837942|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837943|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
14837944|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837945|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14837946|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837947|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837948|NCT00018057|Fluoxetine|fluoxetine|mesh-list
14837949|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14837950|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14837951|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14837952|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837953|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14837954|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
14837955|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837956|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14837957|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
14837958|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14837959|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14837960|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14837961|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837962|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
14837963|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
14837964|NCT00001521|Letrozole|letrozole|mesh-list
14837965|NCT00001521|Flutamide|flutamide|mesh-list
14837966|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837967|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14837968|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14837969|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14837970|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14837971|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14837972|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
14837973|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837974|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837975|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14837976|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
14837977|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14837978|NCT00001481|Estradiol|estradiol|mesh-list
14837979|NCT00001481|Progesterone|progesterone|mesh-list
14837980|NCT00001481|Estrogens|estrogens|mesh-ancestor
14837981|NCT00001481|Hormones|hormones|mesh-ancestor
14837982|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14837983|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837984|NCT00001481|Progestins|progestins|mesh-ancestor
14837985|NCT00001379|Interferons|interferons|mesh-list
14837986|NCT00001379|Rituximab|rituximab|mesh-list
14837987|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837988|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
14837989|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14837990|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837991|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
14837992|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837993|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14837994|NCT00001337|Rituximab|rituximab|mesh-list
14837995|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14837996|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14837997|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
14837998|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14837999|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838000|NCT00001309|Ascorbic Acid|ascorbic acid|mesh-list
14838001|NCT00001309|Vitamins|vitamins|mesh-ancestor
14838002|NCT00001309|Micronutrients|micronutrients|mesh-ancestor
14838003|NCT00001309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838004|NCT00001309|Antioxidants|antioxidants|mesh-ancestor
14838005|NCT00001309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838006|NCT00001309|Protective Agents|protective agents|mesh-ancestor
14911952|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
14911953|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14911954|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911955|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
14911956|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911957|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
14911958|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14911959|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911960|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
14911961|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911962|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
14911963|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14911964|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705561|NCT00415883|Valsartan|valsartan|mesh-list
14705562|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14705563|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14705564|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14705565|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705566|NCT00415922|Levodopa|levodopa|mesh-list
14705567|NCT00415922|Carbidopa|carbidopa|mesh-list
14705568|NCT00415922|Entacapone|entacapone|mesh-list
14705569|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14705570|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14705571|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14705572|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
14705573|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14911965|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
14911966|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728644|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
14838007|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
14838008|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14838009|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838010|NCT00958633|Citalopram|citalopram|mesh-list
14838011|NCT00958633|Bupropion|bupropion|mesh-list
14838012|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14838013|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14838014|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14838015|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838016|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838017|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
14838018|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838019|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14838020|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
14838021|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14838022|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14838023|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
14838024|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14838025|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14838026|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838027|NCT00958750|Minoxidil|minoxidil|mesh-list
14838028|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14838029|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
14838030|NCT00958854|Thalidomide|thalidomide|mesh-list
14838031|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
14838032|NCT00958854|Fludarabine|fludarabine|mesh-list
14838033|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
14838034|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838035|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
14838036|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838037|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838038|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838039|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
14838040|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838041|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838042|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14838043|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838044|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
14295580|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295581|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295582|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14295583|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295584|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14295585|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
14295586|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295587|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295588|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14705574|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838045|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
14838046|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14838047|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838048|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14838049|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14838050|NCT00958854|Growth Substances|growth substances|mesh-ancestor
14838051|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
14705575|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705576|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14705577|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705578|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14705579|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14705580|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
14705581|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
14705582|NCT00415935|Methotrexate|methotrexate|mesh-list
14705583|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14705584|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
14838052|NCT00958906|Infliximab|infliximab|mesh-list
14838053|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14838054|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14838055|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838056|NCT00959062|Clonidine|clonidine|mesh-list
14838057|NCT00959062|Analgesics|analgesics|mesh-ancestor
14838058|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
14838059|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838060|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838061|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14838062|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
14838063|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
14838064|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14838065|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14838066|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14838067|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14838068|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838069|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838070|NCT00959075|Thiamine|thiamine|mesh-list
14838071|NCT00959075|Vitamins|vitamins|mesh-ancestor
14838072|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
14838073|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838074|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
14838075|NCT00959101|Metformin|metformin|mesh-list
14838076|NCT00959101|Repaglinide|repaglinide|mesh-list
14838077|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838078|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838079|NCT00959218|Dronabinol|dronabinol|mesh-list
14838080|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
14838081|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838082|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14838083|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14838084|NCT00959218|Analgesics|analgesics|mesh-ancestor
14838085|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
14838086|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838087|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14838088|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14838089|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838090|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838091|NCT00959218|Hormones|hormones|mesh-ancestor
14838092|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838093|NCT00959231|Cyclosporine|cyclosporine|mesh-list
14838094|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
14838095|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
14838096|NCT00959231|Fludarabine|fludarabine|mesh-list
14838097|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
15204796|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15204797|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15204798|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204799|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204800|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204801|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
15204802|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14838098|NCT00959231|Cyclosporins|cyclosporins|mesh-list
14838099|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838100|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
15204803|NCT03733561|Rotigotine|rotigotine|mesh-list
15204804|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
15204805|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
15204806|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204807|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204808|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204809|NCT03733535|Benralizumab|benralizumab|mesh-list
15204810|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15204811|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
15224806|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15224807|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224808|NCT02323698|Caffeine|caffeine|mesh-list
14295589|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
14838101|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838102|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838103|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838104|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
14838105|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838106|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838107|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14838108|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838109|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
14838110|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838111|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
14838112|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838113|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
14838114|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14838115|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14838116|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14838117|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
14838118|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14838119|NCT00959335|Bicalutamide|bicalutamide|mesh-list
14838120|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
15204812|NCT03733379|Amoxicillin|amoxicillin|mesh-list
15204813|NCT03733379|Metronidazole|metronidazole|mesh-list
15204814|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15204815|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204816|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15204817|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14838121|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
14838122|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838123|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838124|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838125|NCT00959387|Paclitaxel|paclitaxel|mesh-list
14838126|NCT00959387|Cisplatin|cisplatin|mesh-list
14838127|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14838128|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838129|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14838130|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14838131|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14838132|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838133|NCT00959400|Fentanyl|fentanyl|mesh-list
14838134|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14838135|NCT00959400|Narcotics|narcotics|mesh-ancestor
14838136|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14838137|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838138|NCT00959400|Analgesics|analgesics|mesh-ancestor
14838139|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
14838140|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838141|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14838142|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14838143|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
14838144|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
14838145|NCT00959439|Naproxen|naproxen|mesh-list
14838146|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14838147|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14838148|NCT00959439|Analgesics|analgesics|mesh-ancestor
14838149|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
14838150|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838151|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838152|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838153|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838154|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
14838155|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14838156|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838157|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838158|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
14838159|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
14838160|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838161|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
14838162|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838163|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838164|NCT00959517|Artesunate|artesunate|mesh-list
14838165|NCT00959517|Chloroquine|chloroquine|mesh-list
14838166|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
14838167|NCT00959517|Primaquine|primaquine|mesh-list
14838168|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
15204818|NCT03733340|Imipenem|imipenem|mesh-list
14838169|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14838170|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
14838171|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14838172|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14838173|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838174|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838175|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
14838176|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
14838177|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14838178|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
14838179|NCT00959517|Amebicides|amebicides|mesh-ancestor
14838180|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838181|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14838182|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838183|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838184|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14838185|NCT00959517|Renal Agents|renal agents|mesh-ancestor
14838186|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14838187|NCT00959569|Esmolol|esmolol|mesh-list
14838188|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14838189|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
14838190|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838191|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838192|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838193|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14838194|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14838195|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14838196|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838197|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14838198|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
14838199|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
14838200|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14838201|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838202|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
14838203|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838204|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14838205|NCT00959621|Aspirin|aspirin|mesh-list
14838206|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14838207|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14838208|NCT00959621|Analgesics|analgesics|mesh-ancestor
14838209|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
14838210|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838211|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838212|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838213|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838214|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14838215|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14838216|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838217|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14838218|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14838219|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838220|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
14838221|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14838222|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838223|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
14838224|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838225|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838226|NCT00959725|Infliximab|infliximab|mesh-list
14838227|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
14838228|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14838229|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838230|NCT00959777|Lenograstim|lenograstim|mesh-list
14838231|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14838232|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
14838233|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838234|NCT00959881|Donepezil|donepezil|mesh-list
14838235|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14838236|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838237|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838238|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
15204819|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15204820|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204821|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
15204822|NCT03733327|Busulfan|busulfan|mesh-list
15204823|NCT03733327|Etoposide|etoposide|mesh-list
15204824|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204825|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
15204826|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838239|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838240|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838241|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
14838242|NCT00959933|Ribavirin|ribavirin|mesh-list
14838243|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
14838244|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838245|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
14838246|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838247|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
14838248|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838249|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838250|NCT00959972|Nicotine|nicotine|mesh-list
14838251|NCT00959972|Varenicline|varenicline|mesh-list
14838252|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14838253|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
14838254|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838255|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838256|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14838257|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14838258|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
14838259|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838260|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838261|NCT00960037|Vitamin D|vitamin d|mesh-list
14838262|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
14838263|NCT00960037|Vitamins|vitamins|mesh-ancestor
14838264|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
15204827|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15204828|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705585|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14705586|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705587|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838265|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838266|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14838267|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14838268|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
14838269|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14838270|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838271|NCT00960232|Vitamins|vitamins|mesh-ancestor
14838272|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
14838273|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14838274|NCT00960245|Nadolol|nadolol|mesh-list
14838275|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14838276|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14838277|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
14838278|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838279|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838280|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838281|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14838282|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14838283|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
14838284|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
14838285|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838286|NCT00960284|Gemcitabine|gemcitabine|mesh-list
14838287|NCT00960284|Fluorouracil|fluorouracil|mesh-list
14838288|NCT00960284|Capecitabine|capecitabine|mesh-list
14838289|NCT00960284|Epirubicin|epirubicin|mesh-list
14838290|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838291|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838292|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
14838293|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838294|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
14838295|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838296|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838297|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838298|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
14838299|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838300|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14838301|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14838302|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14838303|NCT00960310|Bicalutamide|bicalutamide|mesh-list
14838304|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
14838305|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
14838306|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838307|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838308|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838309|NCT00960336|Doxorubicin|doxorubicin|mesh-list
14838310|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14838311|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14838312|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838313|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14838314|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14838315|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838316|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838317|NCT00960349|Cisplatin|cisplatin|mesh-list
14838318|NCT00960349|Capecitabine|capecitabine|mesh-list
14838319|NCT00960349|Cediranib|cediranib|mesh-list
14838320|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838321|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838322|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
14911967|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
14705588|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
14705589|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705590|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705591|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
14705592|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705593|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14705594|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705595|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
14705596|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838323|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838324|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14838325|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911968|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14705597|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14705598|NCT00415961|Paclitaxel|paclitaxel|mesh-list
14705599|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14911969|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911970|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
14911971|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14911972|NCT01366391|Metformin|metformin|mesh-list
14911973|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14911974|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14911975|NCT01366547|Lamivudine|lamivudine|mesh-list
14911976|NCT01366547|Abacavir|abacavir|mesh-list
14911977|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
14911978|NCT01366547|Dolutegravir|dolutegravir|mesh-list
14911979|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14911980|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14911981|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14911982|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14911983|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
14911984|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204829|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
15204830|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204831|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204832|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15204833|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14911985|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14911986|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14911987|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
14911988|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14911989|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14911990|NCT01366651|Doripenem|doripenem|mesh-list
14911991|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15204834|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15204835|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14911992|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14911993|NCT01367028|Bevacizumab|bevacizumab|mesh-list
14911994|NCT01367028|Trastuzumab|trastuzumab|mesh-list
14911995|NCT01367028|Docetaxel|docetaxel|mesh-list
14911996|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14911997|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14911998|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14911999|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912000|NCT01367028|Growth Substances|growth substances|mesh-ancestor
14912001|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912002|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912003|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14912004|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14912005|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14912006|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204836|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204837|NCT03733275|Lidocaine|lidocaine|mesh-list
15204838|NCT03733275|Bupivacaine|bupivacaine|mesh-list
15204839|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
15204840|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
15204841|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14705600|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705601|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705602|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705603|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705604|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705605|NCT00416039|Midazolam|midazolam|mesh-list
14912007|NCT01367054|Metformin|metformin|mesh-list
14912008|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838326|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14838327|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838328|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204842|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204843|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
15204844|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204845|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15204846|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15204847|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15204848|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14838329|NCT00960453|Incretins|incretins|mesh-ancestor
14838330|NCT00960453|Hormones|hormones|mesh-ancestor
14838331|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838332|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14838333|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
14838334|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838335|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838336|NCT00960479|Ribavirin|ribavirin|mesh-list
14838337|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
14838338|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838339|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
14838340|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838341|NCT00960492|Temozolomide|temozolomide|mesh-list
14838342|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838343|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
14838344|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838345|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204849|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204850|NCT03733210|Panitumumab|panitumumab|mesh-list
15204851|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204852|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204853|NCT03733171|Epinephrine|epinephrine|mesh-list
15204854|NCT03733171|Hemostatics|hemostatics|mesh-list
15204855|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15204856|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15204857|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
15204858|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204859|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204860|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204861|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15204862|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15204863|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
15204864|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204865|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15204866|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
15204867|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
15204868|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
15204869|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15204870|NCT03733171|Coagulants|coagulants|mesh-ancestor
15204871|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
15204872|NCT03733145|Giapreza|giapreza|mesh-list
15204873|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
15204874|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15204875|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15204876|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
15204877|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204878|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204879|NCT03732963|Melatonin|melatonin|mesh-list
15204880|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
15204881|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204882|NCT03732963|Protective Agents|protective agents|mesh-ancestor
15204883|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204884|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204885|NCT03732703|Thalidomide|thalidomide|mesh-list
15204886|NCT03732703|Dexamethasone|dexamethasone|mesh-list
15204887|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
15204888|NCT03732703|Venetoclax|venetoclax|mesh-list
15204889|NCT03732703|Daratumumab|daratumumab|mesh-list
15204890|NCT03732703|Pomalidomide|pomalidomide|mesh-list
15204891|NCT03732703|Ixazomib|ixazomib|mesh-list
15204892|NCT03732703|BB 1101|bb 1101|mesh-list
15204893|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15204894|NCT03732703|Glycine|glycine|mesh-list
15204895|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15204896|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
14838346|NCT00960518|Adefovir|adefovir|mesh-list
14838347|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
14838348|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838349|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14838350|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14838351|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838352|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838353|NCT00960544|Capecitabine|capecitabine|mesh-list
14838354|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838355|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
14838356|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838357|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838358|NCT00960557|Combretastatin|combretastatin|mesh-list
14838359|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14838360|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838361|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
14838362|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
14838363|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
14838364|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838365|NCT00960635|Vitamin D|vitamin d|mesh-list
14838366|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
14838367|NCT00960635|Calcitriol|calcitriol|mesh-list
14838368|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14838369|NCT00960635|Vitamins|vitamins|mesh-ancestor
14838370|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
14838371|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838372|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14838373|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14838374|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14838375|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15204897|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
15204898|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204899|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204900|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15204901|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
15204902|NCT03732703|Hormones|hormones|mesh-ancestor
15204903|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204904|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15204905|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204906|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
15204907|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204908|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204909|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
14838376|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838377|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14838378|NCT00960713|Rituximab|rituximab|mesh-list
14838379|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14838380|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838381|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
14838382|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838383|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838384|NCT00960739|Topotecan|topotecan|mesh-list
14838385|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14838386|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14838387|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14838388|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838389|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838390|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838391|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14838392|NCT00960817|Aspirin|aspirin|mesh-list
14838393|NCT00960817|Dipyridamole|dipyridamole|mesh-list
14838394|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14838395|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14838396|NCT00960817|Analgesics|analgesics|mesh-ancestor
14838397|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
14838398|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838399|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838400|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838401|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838402|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14838403|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14838404|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838405|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14838406|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14838407|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838408|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
14705606|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14838409|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14838410|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
14838411|NCT00960830|Mirtazapine|mirtazapine|mesh-list
14838412|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
14838413|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14838414|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14838415|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
14838416|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
14838417|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705607|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14705608|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14705609|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705610|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14705611|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14705612|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14705613|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14705614|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
14705615|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
14705616|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
14705617|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
14705618|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838418|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838419|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838420|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14838421|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14838422|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14838423|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14838424|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14838425|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14838426|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
14838427|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14838428|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14705619|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705620|NCT00416130|Vorinostat|vorinostat|mesh-list
14838429|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
14838430|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14838431|NCT00960921|Iron|iron|mesh-list
14838432|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14838433|NCT00960921|Trace Elements|trace elements|mesh-ancestor
14838434|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
14838435|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838436|NCT00960921|Hematinics|hematinics|mesh-ancestor
14838437|NCT00960960|Paclitaxel|paclitaxel|mesh-list
14838438|NCT00960960|Bevacizumab|bevacizumab|mesh-list
14838439|NCT00960960|Trastuzumab|trastuzumab|mesh-list
14838440|NCT00960960|Letrozole|letrozole|mesh-list
14838441|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14838442|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838443|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
14838444|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
14838445|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
14838446|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838447|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14838448|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14838449|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14838450|NCT00960960|Growth Substances|growth substances|mesh-ancestor
14838451|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838452|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
14838453|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14838454|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14838455|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838456|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14838457|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
14838458|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838459|NCT00960973|Menatetrenone|menatetrenone|mesh-list
14838460|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
14838461|NCT00960973|Coagulants|coagulants|mesh-ancestor
14838462|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
14838463|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14838464|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838465|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14838466|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14838467|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838468|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838469|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838470|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14838471|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14838472|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
14838473|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838474|NCT00961142|Fludarabine|fludarabine|mesh-list
14838475|NCT00961142|Melphalan|melphalan|mesh-list
14838476|NCT00961142|Thiotepa|thiotepa|mesh-list
14838477|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
14838478|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838479|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838480|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838481|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
14838482|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838483|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838484|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
14838485|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14838486|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
15204910|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15204911|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15204912|NCT03732703|Growth Substances|growth substances|mesh-ancestor
14838487|NCT00961155|Montelukast|montelukast|mesh-list
14838488|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14838489|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
14838490|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838491|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838492|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14838493|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
14838494|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15204913|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
15204914|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204915|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
15204916|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14838495|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15204917|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838496|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14838497|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
14838498|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838499|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838500|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14838501|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
14838502|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838503|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14838504|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14838505|NCT00961194|Ketamine|ketamine|mesh-list
14838506|NCT00961194|Analgesics|analgesics|mesh-ancestor
14838507|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
14838508|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838509|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838510|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14838511|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14838512|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
14838513|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
14838514|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14838515|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14838516|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14838517|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838518|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838519|NCT00961324|Insulin|insulin|mesh-list
14838520|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14838521|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
14838522|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838523|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838524|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14838525|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838526|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838527|NCT00961363|Incretins|incretins|mesh-ancestor
14838528|NCT00961363|Hormones|hormones|mesh-ancestor
14838529|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838530|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14838531|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
14838532|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838533|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838534|NCT00961467|Thalidomide|thalidomide|mesh-list
14838535|NCT00961467|Prednisone|prednisone|mesh-list
14838536|NCT00961467|Melphalan|melphalan|mesh-list
15204918|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
15204919|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15204920|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
15204921|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15204922|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14705621|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705622|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14705623|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705624|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705625|NCT00416143|Prednisone|prednisone|mesh-list
14705626|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705627|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
14705628|NCT00416143|Hormones|hormones|mesh-ancestor
14705629|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705630|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838537|NCT00961467|Lenalidomide|lenalidomide|mesh-list
14838538|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838539|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
14838540|NCT00961467|Hormones|hormones|mesh-ancestor
14838541|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838542|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838543|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14838544|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838545|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15204923|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
15204924|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204925|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15204926|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15204927|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838546|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
15204928|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204929|NCT03732547|Poly I-C|poly i-c|mesh-list
14705631|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705632|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705633|NCT00416169|Galantamine|galantamine|mesh-list
14838547|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838548|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14838549|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838550|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
14838551|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14838552|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14838553|NCT00961467|Growth Substances|growth substances|mesh-ancestor
14838554|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
14838555|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
14838556|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14838557|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838558|NCT00961480|Metformin|metformin|mesh-list
14838559|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14838560|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838561|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838562|NCT00961480|Incretins|incretins|mesh-ancestor
14838563|NCT00961480|Hormones|hormones|mesh-ancestor
14838564|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838565|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14838566|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
14705634|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14705635|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705636|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705637|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
14705638|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705639|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705640|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14705641|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
14705642|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705643|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
14705644|NCT00416208|Bortezomib|bortezomib|mesh-list
14705645|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705646|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
14838567|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838568|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838569|NCT00961753|Ibuprofen|ibuprofen|mesh-list
14838570|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15204930|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
15204931|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204932|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
15204933|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
15204934|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204935|NCT03732508|Fluorouracil|fluorouracil|mesh-list
15204936|NCT03732508|Irinotecan|irinotecan|mesh-list
15204937|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
15204938|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204939|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15204940|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204941|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15204942|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
15204943|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204944|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15204945|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15204946|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204947|NCT03732482|Temozolomide|temozolomide|mesh-list
15204948|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15204949|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
15204950|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204951|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204952|NCT03732469|Acetaminophen|acetaminophen|mesh-list
15204953|NCT03732469|Fentanyl|fentanyl|mesh-list
15204954|NCT03732469|Propofol|propofol|mesh-list
15204955|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15204956|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15204957|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204958|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15204959|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
15204960|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
15204961|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15204962|NCT03732469|Narcotics|narcotics|mesh-ancestor
15204963|NCT03732469|Analgesics|analgesics|mesh-ancestor
14838571|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14838572|NCT00961753|Analgesics|analgesics|mesh-ancestor
14838573|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
14838574|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838575|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838576|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838577|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838578|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14838579|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838580|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838581|NCT00961844|Temozolomide|temozolomide|mesh-list
14838582|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838583|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
14838584|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838585|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838586|NCT00961857|Metformin|metformin|mesh-list
14838587|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14838588|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838589|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838590|NCT00961857|Incretins|incretins|mesh-ancestor
14838591|NCT00961857|Hormones|hormones|mesh-ancestor
14838592|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838593|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14838594|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
14838595|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838596|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838597|NCT00961909|Metformin|metformin|mesh-list
14838598|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838599|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838600|NCT00962026|Rilonacept|rilonacept|mesh-list
14838601|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838602|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14838603|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
14838604|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
14838605|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
14838606|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838607|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14838608|NCT00962234|Protective Agents|protective agents|mesh-ancestor
14838609|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838610|NCT00962286|Furosemide|furosemide|mesh-list
14838611|NCT00962286|Diuretics|diuretics|mesh-ancestor
14838612|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
14838613|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838614|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14838615|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14838616|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838617|NCT00962299|Beclomethasone|beclomethasone|mesh-list
14838618|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838619|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
14838620|NCT00962299|Hormones|hormones|mesh-ancestor
14838621|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838622|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838623|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14838624|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
14838625|NCT00962312|Capecitabine|capecitabine|mesh-list
14838626|NCT00962312|Lapatinib|lapatinib|mesh-list
14838627|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838628|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
14838629|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838630|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838631|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14838632|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912009|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912010|NCT01367210|Maraviroc|maraviroc|mesh-list
14912011|NCT01367210|Darunavir|darunavir|mesh-list
14912012|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14838633|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
14838634|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14838635|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
14838636|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838637|NCT00962442|Expectorants|expectorants|mesh-ancestor
14838638|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14838639|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14838640|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
14838641|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838642|NCT00962442|Protective Agents|protective agents|mesh-ancestor
14838643|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838644|NCT00962442|Antidotes|antidotes|mesh-ancestor
14838645|NCT00962507|Everolimus|everolimus|mesh-list
14838646|NCT00962507|Panobinostat|panobinostat|mesh-list
14838647|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838648|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838649|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
14838650|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838651|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14838652|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838653|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838654|NCT00962533|Telbivudine|telbivudine|mesh-list
14838655|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
14838656|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838657|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14838658|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838659|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838660|NCT00962624|Vaccines|vaccines|mesh-list
14838661|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
14838662|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838663|NCT00962637|Citric Acid|citric acid|mesh-list
14838664|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
14838665|NCT00962637|Enclomiphene|enclomiphene|mesh-list
14838666|NCT00962637|Clomiphene|clomiphene|mesh-list
14838667|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
14838668|NCT00962637|Testosterone|testosterone|mesh-list
14838669|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
14838670|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14838671|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
14838672|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
14705647|NCT00416221|Citalopram|citalopram|mesh-list
14705648|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14705649|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14705650|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14705651|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14705652|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705653|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705654|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
14705655|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705656|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14705657|NCT00416273|Bortezomib|bortezomib|mesh-list
14705658|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705659|NCT00416325|Lycopene|lycopene|mesh-list
14705660|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838673|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838674|NCT00962637|Androgens|androgens|mesh-ancestor
14838675|NCT00962637|Hormones|hormones|mesh-ancestor
14838676|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705661|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
14838677|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295590|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
14705662|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705663|NCT00416325|Protective Agents|protective agents|mesh-ancestor
14705664|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705665|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14705666|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14705667|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705668|NCT00416351|Clofarabine|clofarabine|mesh-list
14705669|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14705670|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
14705671|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705672|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705673|NCT00416377|Prednisolone|prednisolone|mesh-list
14705674|NCT00416377|Doxorubicin|doxorubicin|mesh-list
14705675|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14705676|NCT00416377|Bleomycin|bleomycin|mesh-list
14705677|NCT00416377|Vincristine|vincristine|mesh-list
14705678|NCT00416377|Dacarbazine|dacarbazine|mesh-list
14705679|NCT00416377|Vinblastine|vinblastine|mesh-list
14705680|NCT00416377|Procarbazine|procarbazine|mesh-list
14705681|NCT00416377|Chlorambucil|chlorambucil|mesh-list
14705682|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14705683|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705684|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14705685|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14705686|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705687|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705688|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14705689|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705690|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705691|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705692|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705693|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
14705694|NCT00416377|Hormones|hormones|mesh-ancestor
14705695|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705696|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705697|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705698|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705699|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
14705700|NCT00416390|Lycopene|lycopene|mesh-list
14705701|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705702|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
14705703|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705704|NCT00416390|Protective Agents|protective agents|mesh-ancestor
14705705|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705706|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14705707|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14705708|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705709|NCT00416429|Interferons|interferons|mesh-list
14705710|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
14705711|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
14705712|NCT00416429|Aldesleukin|aldesleukin|mesh-list
14705713|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14705714|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
14705715|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705716|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
14705717|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705718|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
14705719|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838678|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14838679|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
14838680|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14838681|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
14838682|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14838683|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14838684|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14838685|NCT00962663|Ibuprofen|ibuprofen|mesh-list
14838686|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14705720|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14705721|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14705722|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14838687|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14838688|NCT00962663|Analgesics|analgesics|mesh-ancestor
14838689|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
14838690|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705723|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14705724|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14705725|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
14705726|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14705727|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14705728|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14705729|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14705730|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705731|NCT00416468|Valsartan|valsartan|mesh-list
14705732|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14705733|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14705734|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14705735|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838691|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838692|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838693|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838694|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14838695|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838696|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838697|NCT00962715|Interferons|interferons|mesh-list
14838698|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
14838699|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
14838700|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14838701|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838702|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
14838703|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838704|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
14838705|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838706|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
14838707|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14838708|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838709|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
14838710|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
14838711|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14838712|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14838713|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838714|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838715|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838716|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838717|NCT00962936|Pidilizumab|pidilizumab|mesh-list
14838718|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14838719|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838720|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14838721|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
14838722|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838723|NCT00963001|Treprostinil|treprostinil|mesh-list
14838724|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14838725|NCT00963027|Treprostinil|treprostinil|mesh-list
14838726|NCT00963027|Esomeprazole|esomeprazole|mesh-list
14838727|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14838728|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14838729|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14838730|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838731|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838732|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14838733|NCT00963040|Oxytocin|oxytocin|mesh-list
14838734|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
14838735|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14838736|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838737|NCT00963131|Antioxidants|antioxidants|mesh-list
14838738|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838739|NCT00963131|Protective Agents|protective agents|mesh-ancestor
14838740|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838741|NCT00963209|Tamoxifen|tamoxifen|mesh-list
14838742|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14838743|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
14838744|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838745|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838746|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14838747|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838748|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14838749|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14838750|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14705736|NCT00416507|Gemcitabine|gemcitabine|mesh-list
14705737|NCT00416507|Fluorouracil|fluorouracil|mesh-list
14705738|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705739|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14705740|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
14705741|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705742|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
14705743|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705744|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705745|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838751|NCT00963222|Vitamin A|vitamin a|mesh-list
14838752|NCT00963222|Vitamins|vitamins|mesh-ancestor
14838753|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
14838754|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838755|NCT00963274|Bortezomib|bortezomib|mesh-list
15204964|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
15204965|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15204966|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15204967|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15204968|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
15204969|NCT03732391|Carboplatin|carboplatin|mesh-list
15204970|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
15204971|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705746|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
14705747|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705748|NCT00416533|Prednisone|prednisone|mesh-list
14705749|NCT00416533|Docetaxel|docetaxel|mesh-list
14705750|NCT00416533|Doxorubicin|doxorubicin|mesh-list
14705751|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14705752|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705753|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
14838756|NCT00963274|Romidepsin|romidepsin|mesh-list
14705754|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
14295591|NCT00582010|Protective Agents|protective agents|mesh-ancestor
14295592|NCT00582075|Temozolomide|temozolomide|mesh-list
14295593|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295594|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
14295595|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295596|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295597|NCT00582114|Atenolol|atenolol|mesh-list
14295598|NCT00582114|Lisinopril|lisinopril|mesh-list
14295599|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14705755|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705756|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838757|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838758|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14838759|NCT00963313|Adalimumab|adalimumab|mesh-list
14838760|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838761|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838762|NCT00963443|Aspirin|aspirin|mesh-list
14838763|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
14838764|NCT00963443|Ephedrine|ephedrine|mesh-list
14838765|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14838766|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14838767|NCT00963443|Analgesics|analgesics|mesh-ancestor
14838768|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
14838769|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838770|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838771|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838772|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838773|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14838774|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14838775|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838776|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14838777|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14838778|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295600|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
14705757|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14705758|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14705759|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14705760|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705761|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705762|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
14705763|NCT00416533|Hormones|hormones|mesh-ancestor
14705764|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705765|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705766|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705767|NCT00416585|Isotretinoin|isotretinoin|mesh-list
14838779|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
14838780|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14838781|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
14838782|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14838783|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
14838784|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
14838785|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14838786|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14838787|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
14838788|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
14838789|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838790|NCT00963534|Rituximab|rituximab|mesh-list
14838791|NCT00963534|Lenalidomide|lenalidomide|mesh-list
14838792|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14838793|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14838794|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838795|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
14838796|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838797|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838798|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14838799|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14838800|NCT00963534|Growth Substances|growth substances|mesh-ancestor
14838801|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
14838802|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838803|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
14838804|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838805|NCT00963573|Loratadine|loratadine|mesh-list
14838806|NCT00963573|Betamethasone|betamethasone|mesh-list
14838807|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14838808|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
14838809|NCT00963573|Hormones|hormones|mesh-ancestor
14838810|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838811|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838812|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14838813|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
14838814|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
14838815|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
14838816|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14838817|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14838818|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14838819|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
14838820|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
14838821|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838822|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838823|NCT00963664|Interferons|interferons|mesh-list
14838824|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
14838825|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
14838826|NCT00963664|Lovastatin|lovastatin|mesh-list
14838827|NCT00963664|L 647318|l 647318|mesh-list
14838828|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
14838829|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838830|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
14838831|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838832|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
14838833|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838834|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14838835|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14838836|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
14838837|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838838|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14838839|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14838840|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838841|NCT00963690|Hemostatics|hemostatics|mesh-list
14838842|NCT00963690|Coagulants|coagulants|mesh-ancestor
14838843|NCT00963703|Rituximab|rituximab|mesh-list
14838844|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14838845|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838846|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
14838847|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838848|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838849|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
14838850|NCT00963729|Docetaxel|docetaxel|mesh-list
14838851|NCT00963729|Fluorouracil|fluorouracil|mesh-list
14838852|NCT00963729|Letrozole|letrozole|mesh-list
14838853|NCT00963729|Epirubicin|epirubicin|mesh-list
14838854|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838855|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
14838856|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838857|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14838858|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14838859|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
14838860|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838861|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838862|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14838863|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
14838864|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
14838865|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295601|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295602|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705768|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14705769|NCT00416637|Bevacizumab|bevacizumab|mesh-list
14705770|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14705771|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705772|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14705773|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14295603|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14295604|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14705774|NCT00416637|Growth Substances|growth substances|mesh-ancestor
14705775|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705776|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
14838866|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
14838867|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838868|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14838869|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14838870|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838871|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14838872|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
14838873|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14838874|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14838875|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14838876|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14838877|NCT00963768|Canagliflozin|canagliflozin|mesh-list
14838878|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14838879|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838880|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14838881|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838882|NCT00963833|Interferons|interferons|mesh-list
14838883|NCT00963833|Interferon-beta|interferon-beta|mesh-list
14838884|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
14838885|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838886|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
14838887|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838888|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
14838889|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705777|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14705778|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705779|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14705780|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705781|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705782|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
14705783|NCT00416676|Carboplatin|carboplatin|mesh-list
14705784|NCT00416676|Etoposide|etoposide|mesh-list
14705785|NCT00416676|Vincristine|vincristine|mesh-list
14705786|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705787|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
14705788|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838890|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14838891|NCT00963846|Huperzine A|huperzine a|mesh-list
14838892|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14838893|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838894|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838895|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
14838896|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838897|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838898|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14838899|NCT00963846|Protective Agents|protective agents|mesh-ancestor
14838900|NCT00963976|Enalapril|enalapril|mesh-list
14838901|NCT00963976|Hydralazine|hydralazine|mesh-list
14838902|NCT00963976|Labetalol|labetalol|mesh-list
14838903|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14838904|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
14838905|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838906|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838907|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14838908|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
14838909|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14838910|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14838911|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
14838912|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838913|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838914|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
14838915|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
14838916|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14838917|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14838918|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14838919|NCT00964002|Efavirenz|efavirenz|mesh-list
14838920|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14838921|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14838922|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838923|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838924|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
14838925|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838926|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14838927|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14838928|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14838929|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14838930|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15204972|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204973|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15204974|NCT03732365|Cefazolin|cefazolin|mesh-list
15204975|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15204976|NCT03732287|Anesthetics|anesthetics|mesh-list
15204977|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14838931|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14838932|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14838933|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
14838934|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
14838935|NCT00964041|Cycloserine|cycloserine|mesh-list
14838936|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14838937|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14838938|NCT00964041|Renal Agents|renal agents|mesh-ancestor
14838939|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14838940|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
14838941|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14838942|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
14838943|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838944|NCT00964080|Leucovorin|leucovorin|mesh-list
15204978|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838945|NCT00964080|Fluorouracil|fluorouracil|mesh-list
14838946|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
14838947|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
14838948|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838949|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14838950|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14838951|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14838952|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
14838953|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838954|NCT00964080|Antidotes|antidotes|mesh-ancestor
14838955|NCT00964080|Protective Agents|protective agents|mesh-ancestor
15204979|NCT03732235|Bevacizumab|bevacizumab|mesh-list
15204980|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
15204981|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15204982|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204983|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15204984|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15204985|NCT03732235|Growth Substances|growth substances|mesh-ancestor
15204986|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15204987|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
14838956|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
14838957|NCT00964080|Vitamins|vitamins|mesh-ancestor
14838958|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
14838959|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
14838960|NCT00964106|Rifampin|rifampin|mesh-list
14838961|NCT00964106|Fluconazole|fluconazole|mesh-list
14838962|NCT00964106|Ketoconazole|ketoconazole|mesh-list
14838963|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
14838964|NCT00964106|Midazolam|midazolam|mesh-list
14838965|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
14838966|NCT00964106|Caffeine|caffeine|mesh-list
14838967|NCT00964106|Omeprazole|omeprazole|mesh-list
14838968|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14838969|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14838970|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14838971|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14838972|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14838973|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14838974|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14838975|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14838976|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14838977|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
14838978|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
14838979|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
14838980|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
14838981|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14838982|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14838983|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14838984|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14838985|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
14838986|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14838987|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14838988|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14838989|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14838990|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14838991|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14838992|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14838993|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14838994|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14838995|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14838996|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
14838997|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14838998|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
14838999|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14839000|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839001|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
15204988|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15204989|NCT03732235|Estrogens|estrogens|mesh-ancestor
15204990|NCT03732235|Hormones|hormones|mesh-ancestor
14839002|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14839003|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14839004|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14839005|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14839006|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14839007|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14839008|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14839009|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839010|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
14839011|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14839012|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14839013|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14839014|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
14839015|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839016|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14839017|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14839018|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14839019|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
14839020|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
14839021|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14839022|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14839023|NCT00964106|Analgesics|analgesics|mesh-ancestor
14839024|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
14839025|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839026|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14839027|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14839028|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839029|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839030|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14839031|NCT00964171|Efavirenz|efavirenz|mesh-list
14839032|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14839033|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15204991|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15204992|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15204993|NCT03732105|Apatinib|apatinib|mesh-list
15204994|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
15204995|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15204996|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15204997|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15204998|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15204999|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15205000|NCT03732105|Growth Substances|growth substances|mesh-ancestor
15205001|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205002|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
15205003|NCT03732040|Fluorides|fluorides|mesh-list
15205004|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
15205005|NCT03732040|Protective Agents|protective agents|mesh-ancestor
15205006|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205007|NCT03732001|Docetaxel|docetaxel|mesh-list
15205008|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205009|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
15205010|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
15205011|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205012|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205013|NCT03731988|Lidocaine|lidocaine|mesh-list
15205014|NCT03731988|Prilocaine|prilocaine|mesh-list
15205015|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15205016|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205017|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
15205018|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205019|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205020|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
15205021|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205022|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15205023|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15205024|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15205025|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205026|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205027|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15205028|NCT03731897|Lidocaine|lidocaine|mesh-list
15205029|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205030|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
14839034|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839035|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839036|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
14839037|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839038|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14839039|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14839040|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14839041|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14839042|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14839043|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14839044|NCT00964184|Metformin|metformin|mesh-list
14839045|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839046|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912013|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14912014|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14912015|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912016|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14912017|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
14912018|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912019|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14912020|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14912021|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14912022|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
14912023|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912024|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
14912025|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14912026|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14912027|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
14912028|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14912029|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912030|NCT01367301|Paclitaxel|paclitaxel|mesh-list
14912031|NCT01367301|Carboplatin|carboplatin|mesh-list
14912032|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14912033|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912034|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
14912035|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
14912036|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
14912037|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912038|NCT01367418|Sufentanil|sufentanil|mesh-list
14912039|NCT01367418|Morphine|morphine|mesh-list
14912040|NCT01367418|Bupivacaine|bupivacaine|mesh-list
14912041|NCT01367418|Ropivacaine|ropivacaine|mesh-list
14912042|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
14912043|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
14912044|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912045|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912046|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
14912047|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912048|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14912049|NCT01367418|Narcotics|narcotics|mesh-ancestor
14912050|NCT01367418|Analgesics|analgesics|mesh-ancestor
14912051|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14912052|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14912053|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
14912054|NCT01367431|Xanthohumol|xanthohumol|mesh-list
14912055|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912056|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14912057|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912058|NCT01367431|Growth Substances|growth substances|mesh-ancestor
14912059|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912060|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912061|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
14912062|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912063|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912064|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
14912065|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912066|NCT01367496|Naltrexone|naltrexone|mesh-list
14912067|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
14912068|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912069|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912070|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
14912071|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839047|NCT00964262|Exenatide|exenatide|mesh-list
14839048|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839049|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839050|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14839051|NCT00964262|Incretins|incretins|mesh-ancestor
14839052|NCT00964262|Hormones|hormones|mesh-ancestor
14839053|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839054|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14839055|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14839056|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839057|NCT00964288|Lidocaine|lidocaine|mesh-list
14839058|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
14839059|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
14839060|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295605|NCT00582114|Protective Agents|protective agents|mesh-ancestor
14839061|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839062|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
14839063|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839064|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14839065|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14839066|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14839067|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839068|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839069|NCT00964327|Darunavir|darunavir|mesh-list
14839070|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14839071|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15205031|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205032|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205033|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
15205034|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205035|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15205036|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15205037|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15205038|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839072|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
14839073|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839074|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839075|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14839076|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14839077|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
14839078|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839079|NCT00964418|Insulin|insulin|mesh-list
14839080|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14839081|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
14839082|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839083|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839084|NCT00964457|Cetuximab|cetuximab|mesh-list
14839085|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839086|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839087|NCT00964535|Budesonide|budesonide|mesh-list
14839088|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
14839089|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14839090|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839091|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14839092|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
14839093|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839094|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839095|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14839096|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
14839097|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
14839098|NCT00964535|Hormones|hormones|mesh-ancestor
14839099|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839100|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14839101|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15205039|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205040|NCT03731832|Dexamethasone|dexamethasone|mesh-list
15205041|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
15205042|NCT03731832|Pomalidomide|pomalidomide|mesh-list
15205043|NCT03731832|Ixazomib|ixazomib|mesh-list
15205044|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15205045|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
15205046|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205047|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15205048|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15205049|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
15205050|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205051|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205052|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15205053|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205054|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
15205055|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
15205056|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205057|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15205058|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
15205059|NCT03731832|Hormones|hormones|mesh-ancestor
15205060|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205061|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15205062|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15205063|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15205064|NCT03731832|Growth Substances|growth substances|mesh-ancestor
15205065|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
15205066|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
15205067|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205068|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
15205069|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14839102|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14839103|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
14839104|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839105|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839106|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14839107|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
14839108|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14839109|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839110|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
14839111|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14839112|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14839113|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839114|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839115|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839116|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14839117|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14839118|NCT00964574|Insulin|insulin|mesh-list
14839119|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14839120|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
14839121|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
14839122|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15205070|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205071|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
14839123|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839124|NCT00964626|Paclitaxel|paclitaxel|mesh-list
14839125|NCT00964626|Cisplatin|cisplatin|mesh-list
14839126|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14839127|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839128|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14839129|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705789|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705790|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705791|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
14839130|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14839131|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839132|NCT00964639|Ropivacaine|ropivacaine|mesh-list
14839133|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
14839134|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
14839135|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839136|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839137|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
14839138|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839139|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14839140|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
14839141|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
14839142|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839143|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
14839144|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839145|NCT00964691|Chloroquine|chloroquine|mesh-list
14839146|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
14839147|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
14839148|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14839149|NCT00964691|Amebicides|amebicides|mesh-ancestor
14839150|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14839151|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14839152|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839153|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
14839154|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839155|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14839156|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839157|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839158|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14839159|NCT00964691|Renal Agents|renal agents|mesh-ancestor
14839160|NCT00964704|Bevacizumab|bevacizumab|mesh-list
14839161|NCT00964704|Trastuzumab|trastuzumab|mesh-list
14839162|NCT00964704|Docetaxel|docetaxel|mesh-list
14839163|NCT00964704|Capecitabine|capecitabine|mesh-list
14839164|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839165|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839166|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14839167|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14839168|NCT00964704|Growth Substances|growth substances|mesh-ancestor
14839169|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839170|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14839171|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
14839172|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
14839173|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
14839174|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839175|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14839176|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
14705792|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705793|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705794|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14705795|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14839177|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
14839178|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14839179|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839180|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14839181|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14839182|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839183|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839184|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839185|NCT00964756|Ganciclovir|ganciclovir|mesh-list
14839186|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14839187|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
15205072|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
15205073|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15205074|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205075|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839188|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839189|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14839190|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839191|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839192|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14839193|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
14839194|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839195|NCT00964808|Oxycodone|oxycodone|mesh-list
14839196|NCT00964808|Buprenorphine|buprenorphine|mesh-list
14839197|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14839198|NCT00964808|Narcotics|narcotics|mesh-ancestor
14839199|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839200|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839201|NCT00964808|Analgesics|analgesics|mesh-ancestor
14839202|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
14839203|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839204|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14839205|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14839206|NCT00964834|Doxycycline|doxycycline|mesh-list
14839207|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14839208|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839209|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
14839210|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
14839211|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14839212|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14839213|NCT00964964|Insulin|insulin|mesh-list
14839214|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14839215|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
15205076|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15205077|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15205078|NCT03731741|Protective Agents|protective agents|mesh-ancestor
15205079|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205080|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
15205081|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15205082|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
15224809|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15224810|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224811|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15224812|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839216|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839217|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839218|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
14839219|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14839220|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14839221|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839222|NCT00965107|Thiopental|thiopental|mesh-list
14839223|NCT00965107|Propofol|propofol|mesh-list
14839224|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14839225|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839226|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839227|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14839228|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
14839229|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
14839230|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
14839231|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
14839232|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
14839233|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839234|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839235|NCT00965120|Bradykinin|bradykinin|mesh-list
14839236|NCT00965120|Kininogens|kininogens|mesh-list
14839237|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
14839238|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
14839239|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14839240|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
14839241|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839242|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839243|NCT00965172|Calcium|calcium|mesh-list
14839244|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14839245|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839246|NCT00965224|Vaccines|vaccines|mesh-list
14839247|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
14839248|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224813|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224814|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14839249|NCT00965289|Rituximab|rituximab|mesh-list
14912072|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14839250|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839251|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839252|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
14839253|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839254|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839255|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14839256|NCT00965315|Fenofibrate|fenofibrate|mesh-list
14839257|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15205083|NCT03731494|Nickel|nickel|mesh-list
15205084|NCT03731494|Trace Elements|trace elements|mesh-ancestor
14839258|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14839259|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
14839260|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839261|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14839262|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14839263|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839264|NCT00965393|Bradykinin|bradykinin|mesh-list
14839265|NCT00965393|Kininogens|kininogens|mesh-list
14839266|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
14839267|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
14839268|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14839269|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
14839270|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839271|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839272|NCT00965406|Insulin|insulin|mesh-list
14839273|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839274|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839275|NCT00965549|Insulin|insulin|mesh-list
14839276|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14839277|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
14839278|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
14839279|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
14839280|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839281|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839282|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
14839283|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14839284|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839285|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839286|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
14839287|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839288|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839289|NCT00965653|Folic Acid|folic acid|mesh-list
14839290|NCT00965653|Methotrexate|methotrexate|mesh-list
14839291|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14839292|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
14839293|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14839294|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839295|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14839296|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
14839297|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839298|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839299|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
14839300|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839301|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14839302|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839303|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
14839304|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839305|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14839306|NCT00965653|Hematinics|hematinics|mesh-ancestor
14839307|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
15205085|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
15205086|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205087|NCT03731468|Dexamethasone|dexamethasone|mesh-list
15205088|NCT03731468|Anesthetics|anesthetics|mesh-list
15205089|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
15205090|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205091|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
15205092|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
15205093|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839308|NCT00965653|Vitamins|vitamins|mesh-ancestor
14839309|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
15205094|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839310|NCT00965666|Etanercept|etanercept|mesh-list
14839311|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14839312|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14839313|NCT00965666|Analgesics|analgesics|mesh-ancestor
14839314|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
14839315|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839316|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839317|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839318|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839319|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14839320|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839321|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
14839322|NCT00965796|Lidocaine|lidocaine|mesh-list
14839323|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
14839324|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
14839325|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839326|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839327|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
14839328|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839329|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14839330|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14839331|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14839332|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839333|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839334|NCT00965809|Dronabinol|dronabinol|mesh-list
14839335|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
14839336|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839337|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14839338|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14839339|NCT00965809|Analgesics|analgesics|mesh-ancestor
14839340|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
14839341|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839342|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14839343|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14839344|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839345|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839346|NCT00965809|Hormones|hormones|mesh-ancestor
14839347|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839348|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
14839349|NCT00965874|Analgesics|analgesics|mesh-ancestor
14839350|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
14839351|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839352|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839353|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
14839354|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839355|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14839356|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
14839357|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14839358|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839359|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839360|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14839361|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
14839362|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14839363|NCT00965900|Propranolol|propranolol|mesh-list
14839364|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14839365|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14839366|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
14839367|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839368|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839369|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839370|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14839371|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14839372|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
14839373|NCT00965913|Nicotine|nicotine|mesh-list
14839374|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14839375|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
14839376|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839377|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839378|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14839379|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14839380|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
14839381|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839382|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839383|NCT00965926|Mirabegron|mirabegron|mesh-list
14839384|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14839385|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14839386|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14839387|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
14839388|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839389|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839390|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839391|NCT00965926|Urological Agents|urological agents|mesh-ancestor
14839392|NCT00965991|Metformin|metformin|mesh-list
14839393|NCT00965991|Glyburide|glyburide|mesh-list
14839394|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839395|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839396|NCT00966004|Mirabegron|mirabegron|mesh-list
14839397|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14839398|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14839399|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14839400|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14839401|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
14839402|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839403|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839404|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839405|NCT00966004|Urological Agents|urological agents|mesh-ancestor
14839406|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14839407|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14839408|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
14839409|NCT00966056|Mitomycins|mitomycins|mesh-list
14839410|NCT00966056|Mitomycin|mitomycin|mesh-list
14839411|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14839412|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839413|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
14839414|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839415|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14839416|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912073|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
14912074|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912075|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912076|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
15205095|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15205096|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
15205097|NCT03731468|Hormones|hormones|mesh-ancestor
15205098|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205099|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15205100|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205101|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205102|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
15205103|NCT03731442|Paclitaxel|paclitaxel|mesh-list
15205104|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15205105|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205106|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
15205107|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
15205108|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205109|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205110|NCT03731429|Lidocaine|lidocaine|mesh-list
15205111|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
14912077|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912078|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
14912079|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912080|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912081|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
14912082|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205112|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
14912083|NCT01367535|Naltrexone|naltrexone|mesh-list
14839417|NCT00966082|Propranolol|propranolol|mesh-list
14839418|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14839419|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14839420|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
14839421|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839422|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839423|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839424|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14839425|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14839426|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
14839427|NCT00966121|Propranolol|propranolol|mesh-list
14839428|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14839429|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14839430|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
14839431|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839432|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839433|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839434|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14839435|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14839436|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
14839437|NCT00966160|Ritonavir|ritonavir|mesh-list
14839438|NCT00966160|Lopinavir|lopinavir|mesh-list
14839439|NCT00966160|Lamivudine|lamivudine|mesh-list
14839440|NCT00966160|Zidovudine|zidovudine|mesh-list
14839441|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14839442|NCT00966160|Efavirenz|efavirenz|mesh-list
14839443|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14839444|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14839445|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
14839446|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839447|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839448|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14839449|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14839450|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
14839451|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839452|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14839453|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14839454|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14839455|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14839456|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
14839457|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14839458|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14839459|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14839460|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14839461|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14839462|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
14839463|NCT00966251|Pidilizumab|pidilizumab|mesh-list
14839464|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839465|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839466|NCT00966290|Warfarin|warfarin|mesh-list
14839467|NCT00966290|Anticoagulants|anticoagulants|mesh-list
14839468|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
14839469|NCT00966290|Fluindione|fluindione|mesh-list
14839470|NCT00966290|Phenindione|phenindione|mesh-list
14839471|NCT00966316|Aspirin|aspirin|mesh-list
14839472|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14839473|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14839474|NCT00966316|Analgesics|analgesics|mesh-ancestor
14839475|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
14839476|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839477|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839478|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839479|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839480|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14839481|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14839482|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839483|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14839484|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14839485|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839486|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
14839487|NCT00966329|Maraviroc|maraviroc|mesh-list
14839488|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14839489|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14839490|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839491|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14705796|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14705797|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14705798|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839492|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14839493|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
14839494|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839495|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14839496|NCT00966368|Insulin|insulin|mesh-list
15205113|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205114|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205115|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
14839497|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14839498|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
14839499|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839500|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839501|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14839502|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14839503|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839504|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14839505|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839506|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839507|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14839508|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14839509|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
14839510|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14839511|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14839512|NCT00966576|Timolol|timolol|mesh-list
14839513|NCT00966576|Brinzolamide|brinzolamide|mesh-list
14839514|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14839515|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15205116|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205117|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15205118|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15205119|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15205120|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205121|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205122|NCT03731403|Fluorides|fluorides|mesh-list
15205123|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
15205124|NCT03731403|Protective Agents|protective agents|mesh-ancestor
14705799|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705800|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705801|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705802|NCT00416728|Valsartan|valsartan|mesh-list
14705803|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14705804|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14705805|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14705806|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705807|NCT00416767|Leucovorin|leucovorin|mesh-list
14705808|NCT00416767|Fluorouracil|fluorouracil|mesh-list
14705809|NCT00416767|Irinotecan|irinotecan|mesh-list
14705810|NCT00416767|Calcium|calcium|mesh-list
14705811|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
14705812|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14705813|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705814|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
14705815|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705816|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14705817|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705818|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705819|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
14705820|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14705821|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14839516|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
14705822|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839517|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839518|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839519|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839520|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14839521|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14839522|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839523|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14839524|NCT00966602|Ivacaftor|ivacaftor|mesh-list
14839525|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14839526|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839527|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839528|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
14839529|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14839530|NCT00966680|Anesthetics|anesthetics|mesh-list
14839531|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839532|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839533|NCT00966706|Gemcitabine|gemcitabine|mesh-list
14839534|NCT00966706|Docetaxel|docetaxel|mesh-list
14839535|NCT00966706|Capecitabine|capecitabine|mesh-list
14839536|NCT00966706|Epirubicin|epirubicin|mesh-list
14839537|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839538|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14839539|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
14839540|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839541|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
14839542|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839543|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839544|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839545|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
14839546|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839547|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
14839548|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
14839549|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205125|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205126|NCT03731286|Caffeine|caffeine|mesh-list
15205127|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15205128|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205129|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15205130|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205131|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205132|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15205133|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15205134|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
15205135|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205136|NCT03731169|Voriconazole|voriconazole|mesh-list
15205137|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
15205138|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705823|NCT00416767|Antidotes|antidotes|mesh-ancestor
14705824|NCT00416767|Protective Agents|protective agents|mesh-ancestor
14705825|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
14705826|NCT00416767|Vitamins|vitamins|mesh-ancestor
14705827|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
14728645|NCT00519337|Vitamins|vitamins|mesh-ancestor
14728646|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
14728647|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728648|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
14728649|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728650|NCT00519337|Protective Agents|protective agents|mesh-ancestor
14728651|NCT00519363|Atorvastatin|atorvastatin|mesh-list
14728652|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14839550|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14839551|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14839552|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14839553|NCT00966745|Milrinone|milrinone|mesh-list
14728653|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14728654|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
14728655|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839554|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14839555|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14839556|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
14839557|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14839558|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14839559|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839560|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839561|NCT00966745|Protective Agents|protective agents|mesh-ancestor
14839562|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839563|NCT00966771|Copper|copper|mesh-list
14839564|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
14839565|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14839566|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
14839567|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14839568|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839569|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14839570|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14839571|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14839572|NCT00966771|Trace Elements|trace elements|mesh-ancestor
14839573|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
14839574|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
14839575|NCT00966836|Valganciclovir|valganciclovir|mesh-list
14839576|NCT00966836|Everolimus|everolimus|mesh-list
14839577|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839578|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839579|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
14839580|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839581|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14839582|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14839583|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
14839584|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14839585|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839586|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839587|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839588|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
14839589|NCT00966901|Nicotine|nicotine|mesh-list
14839590|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14839591|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
14839592|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839593|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839594|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14839595|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14839596|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
14839597|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839598|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839599|NCT00966914|Paclitaxel|paclitaxel|mesh-list
14839600|NCT00966914|Docetaxel|docetaxel|mesh-list
14839601|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14839602|NCT00966914|Cisplatin|cisplatin|mesh-list
14839603|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
14839604|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14839605|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839606|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14839607|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705828|NCT00416819|Leucovorin|leucovorin|mesh-list
14705829|NCT00416819|Cytarabine|cytarabine|mesh-list
14705830|NCT00416819|Rituximab|rituximab|mesh-list
14705831|NCT00416819|Methotrexate|methotrexate|mesh-list
14705832|NCT00416819|Etoposide|etoposide|mesh-list
14705833|NCT00416819|Temozolomide|temozolomide|mesh-list
14705834|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
14705835|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
14705836|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14705837|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705838|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
14705839|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705840|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705841|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14705842|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
14705843|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14839608|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705844|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14839609|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705845|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
14705846|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839610|NCT00966914|Protective Agents|protective agents|mesh-ancestor
14839611|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839612|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
14839613|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14839614|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
14839615|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839616|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14839617|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14839618|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14839619|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839620|NCT00967031|Capecitabine|capecitabine|mesh-list
14839621|NCT00967031|Lapatinib|lapatinib|mesh-list
14839622|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14839623|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
14839624|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839625|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839626|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14839627|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839628|NCT00967057|Dexamethasone|dexamethasone|mesh-list
14839629|NCT00967057|Methotrexate|methotrexate|mesh-list
14839630|NCT00967057|Vincristine|vincristine|mesh-list
14839631|NCT00967057|Asparaginase|asparaginase|mesh-list
14839632|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
14839633|NCT00967057|Idarubicin|idarubicin|mesh-list
14839634|NCT00967057|Pegaspargase|pegaspargase|mesh-list
14839635|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839636|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
14839637|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
14839638|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839639|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839640|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14839641|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
14839642|NCT00967057|Hormones|hormones|mesh-ancestor
14839643|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839644|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14839645|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839646|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14839647|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
14839648|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14839649|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14839650|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
14839651|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839652|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14839653|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839654|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14839655|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839656|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
14839657|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839658|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14839659|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14839660|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
15205139|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15205140|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15205141|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205142|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205143|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14839661|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14839662|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14839663|NCT00967057|Analgesics|analgesics|mesh-ancestor
14839664|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
14839665|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14839666|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14839667|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14839668|NCT00967070|Nicotine|nicotine|mesh-list
14839669|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14839670|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
14839671|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839672|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839673|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14839674|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14839675|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
14839676|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839677|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839678|NCT00967096|Rifaximin|rifaximin|mesh-list
14839679|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14839680|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839681|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14839682|NCT00967135|Pregabalin|pregabalin|mesh-list
14839683|NCT00967135|Analgesics|analgesics|mesh-ancestor
14839684|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
14839685|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839686|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839687|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
14839688|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14839689|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839690|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839691|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14839692|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14839693|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14839694|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839695|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14839696|NCT00967148|Tinzaparin|tinzaparin|mesh-list
14839697|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14839698|NCT00967148|Dalteparin|dalteparin|mesh-list
14839699|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
14839700|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14839701|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14839702|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839703|NCT00967174|Nicotine|nicotine|mesh-list
14839704|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14839705|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
14839706|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839707|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839708|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14839709|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14839710|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
14839711|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839712|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839713|NCT00967213|Ranibizumab|ranibizumab|mesh-list
14839714|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14839715|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14839716|NCT00967213|Growth Substances|growth substances|mesh-ancestor
14839717|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839718|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
14839719|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839720|NCT00967252|Atorvastatin|atorvastatin|mesh-list
14839721|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14839722|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14839723|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
14839724|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839725|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14839726|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14839727|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839728|NCT00967291|Ifosfamide|ifosfamide|mesh-list
15205144|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
14839729|NCT00967291|Mitomycins|mitomycins|mesh-list
14839730|NCT00967291|Mitomycin|mitomycin|mesh-list
14839731|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295606|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839732|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
14839733|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839734|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839735|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14839736|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14839737|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839738|NCT00967382|Dalteparin|dalteparin|mesh-list
14839739|NCT00967382|Tinzaparin|tinzaparin|mesh-list
14839740|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14839741|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
14839742|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14839743|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14839744|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839745|NCT00967408|Citalopram|citalopram|mesh-list
14839746|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14839747|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14839748|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839749|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839750|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839751|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
14839752|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839753|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14839754|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
14839755|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14839756|NCT00967421|Ethanol|ethanol|mesh-list
14839757|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14839758|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839759|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839760|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839761|NCT00967434|Atorvastatin|atorvastatin|mesh-list
14839762|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14839763|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14839764|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
14839765|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839766|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14839767|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14839768|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839769|NCT00967512|Cytarabine|cytarabine|mesh-list
14839770|NCT00967512|Idarubicin|idarubicin|mesh-list
14839771|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15205145|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205146|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205147|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15205148|NCT03731117|Furosemide|furosemide|mesh-list
15205149|NCT03731117|Diuretics|diuretics|mesh-ancestor
15205150|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
15205151|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205152|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15205153|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205154|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205155|NCT03731091|Calcitriol|calcitriol|mesh-list
15205156|NCT03731091|Betamethasone|betamethasone|mesh-list
15205157|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
15225702|NCT03912064|Ipilimumab|ipilimumab|mesh-list
14839772|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
14839773|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839774|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839775|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
14839776|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14839777|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839778|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
14839779|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839780|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14839781|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14839782|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14839783|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839784|NCT00967538|Etanercept|etanercept|mesh-list
14839785|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14839786|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14839787|NCT00967538|Analgesics|analgesics|mesh-ancestor
14839788|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
14839789|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839790|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839791|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839792|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839793|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14839794|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839795|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
14839796|NCT00967603|Sunitinib|sunitinib|mesh-list
14839797|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839798|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14839799|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14839800|NCT00967603|Growth Substances|growth substances|mesh-ancestor
14839801|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839802|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
14839803|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14839804|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839805|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839806|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
14839807|NCT00967629|Calcium|calcium|mesh-list
14839808|NCT00967629|Sevelamer|sevelamer|mesh-list
14839809|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14839810|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839811|NCT00967629|Antacids|antacids|mesh-ancestor
14839812|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839813|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14839814|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
14839815|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
14839816|NCT00967642|Insulin|insulin|mesh-list
14839817|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839818|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839819|NCT00967655|Capecitabine|capecitabine|mesh-list
14839820|NCT00967655|Irinotecan|irinotecan|mesh-list
14839821|NCT00967655|Panitumumab|panitumumab|mesh-list
14839822|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14839823|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
14839824|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839825|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839826|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14839827|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14839828|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839829|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839830|NCT00967707|Gabapentin|gabapentin|mesh-list
14839831|NCT00967707|Donepezil|donepezil|mesh-list
14839832|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14839833|NCT00967707|Analgesics|analgesics|mesh-ancestor
14839834|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
14839835|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839836|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839837|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
14839838|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14839839|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14839840|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14839841|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14839842|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14839843|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14839844|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839845|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839846|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
14839847|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14839848|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839849|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
14705847|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
14839850|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
14839851|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14839852|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14839853|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839854|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14839855|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
14839856|NCT00967772|Naftopidil|naftopidil|mesh-list
14839857|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14839858|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14839859|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
14839860|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839861|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839862|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839863|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14839864|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14839865|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14839866|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14839867|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14839868|NCT00967837|Insulin|insulin|mesh-list
14839869|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14839870|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839871|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839872|NCT00967850|Verteporfin|verteporfin|mesh-list
14839873|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14839874|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
14912084|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
14912085|NCT01367535|Paroxetine|paroxetine|mesh-list
14912086|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14705848|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705849|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14705850|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705851|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14705852|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14705853|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14705854|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14705855|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
14705856|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705857|NCT00416819|Antidotes|antidotes|mesh-ancestor
14705858|NCT00416819|Protective Agents|protective agents|mesh-ancestor
14705859|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
14705860|NCT00416819|Vitamins|vitamins|mesh-ancestor
14705861|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
14705862|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705863|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
14705864|NCT00416832|Prednisone|prednisone|mesh-list
14705865|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
14705866|NCT00416832|Dacarbazine|dacarbazine|mesh-list
14705867|NCT00416832|Doxorubicin|doxorubicin|mesh-list
14705868|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14705869|NCT00416832|Etoposide|etoposide|mesh-list
14705870|NCT00416832|Vincristine|vincristine|mesh-list
14705871|NCT00416832|Procarbazine|procarbazine|mesh-list
14705872|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705873|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
14705874|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839875|NCT00967928|Everolimus|everolimus|mesh-list
14839876|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839877|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839878|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
14839879|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839880|NCT00967954|Hormones|hormones|mesh-list
14839881|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
14839882|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839883|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839884|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
14839885|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
14839886|NCT00967967|Desloratadine|desloratadine|mesh-list
14839887|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839888|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
14839889|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14839890|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14839891|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14705875|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705876|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705877|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
14705878|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705879|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839892|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839893|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839894|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839895|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14839896|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14839897|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
14839898|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
14839899|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14839900|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14839901|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839902|NCT00968006|Incretins|incretins|mesh-ancestor
14839903|NCT00968006|Hormones|hormones|mesh-ancestor
14839904|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839905|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14839906|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
14839907|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839908|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839909|NCT00968110|Omalizumab|omalizumab|mesh-list
14839910|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14839911|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14839912|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14839913|NCT00968162|Fludarabine|fludarabine|mesh-list
14839914|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839915|NCT00968240|Bevacizumab|bevacizumab|mesh-list
14839916|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839917|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839918|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15205158|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15205159|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
15205160|NCT03731091|Calcipotriene|calcipotriene|mesh-list
15205161|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15205162|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205163|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
15205164|NCT03731091|Hormones|hormones|mesh-ancestor
15205165|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705880|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14705881|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14705882|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14705883|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14705884|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705885|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705886|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
14705887|NCT00416832|Hormones|hormones|mesh-ancestor
14839919|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14839920|NCT00968240|Growth Substances|growth substances|mesh-ancestor
14839921|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839922|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
14839923|NCT00968331|Rituximab|rituximab|mesh-list
14839924|NCT00968331|Lenalidomide|lenalidomide|mesh-list
14839925|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839926|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839927|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
14839928|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839929|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14839930|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14839931|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14839932|NCT00968331|Growth Substances|growth substances|mesh-ancestor
14839933|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
14839934|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14839935|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14839936|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
14839937|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14839938|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14839939|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
14839940|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839941|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839942|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14839943|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839944|NCT00968396|Melphalan|melphalan|mesh-list
15205166|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205167|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15205168|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
15205169|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
14705888|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705889|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705890|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14705891|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705892|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705893|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705894|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14705895|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14839945|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14839946|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
14839947|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839948|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839949|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14839950|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839951|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
14839952|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839953|NCT00968435|Bevacizumab|bevacizumab|mesh-list
14839954|NCT00968435|Cetuximab|cetuximab|mesh-list
14839955|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14839956|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839957|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14839958|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14839959|NCT00968435|Growth Substances|growth substances|mesh-ancestor
14839960|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839961|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
14839962|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
14839963|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14839964|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839965|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14839966|NCT00968461|Protective Agents|protective agents|mesh-ancestor
14839967|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839968|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839969|NCT00968565|Citric Acid|citric acid|mesh-list
14839970|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
14839971|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
14839972|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14839973|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
14839974|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
14839975|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705896|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14839976|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
14839977|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14839978|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14839979|NCT00968578|Prednisolone|prednisolone|mesh-list
14839980|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
14839981|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14839982|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
14839983|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14839984|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
14839985|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
14839986|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14839987|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14839988|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14839989|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
14839990|NCT00968578|Hormones|hormones|mesh-ancestor
14839991|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14839992|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14839993|NCT00968578|Protective Agents|protective agents|mesh-ancestor
14839994|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14839995|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839996|NCT00968591|Everolimus|everolimus|mesh-list
14839997|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14839998|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14839999|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
14840000|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840001|NCT00968682|Trastuzumab|trastuzumab|mesh-list
14840002|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840003|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840004|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
14840005|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14840006|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840007|NCT00968734|Vitamins|vitamins|mesh-ancestor
14840008|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
14840009|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14840010|NCT00968760|Cytarabine|cytarabine|mesh-list
14840011|NCT00968760|Etoposide|etoposide|mesh-list
14840012|NCT00968760|Melphalan|melphalan|mesh-list
14840013|NCT00968760|Interleukin-2|interleukin-2|mesh-list
14840014|NCT00968760|Carmustine|carmustine|mesh-list
14840015|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295607|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14295608|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
14295609|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
14295610|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840016|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840017|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14840018|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14840019|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840020|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840021|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14840022|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
14840023|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
14840024|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840025|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14840026|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
14840027|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840028|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14840029|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
14840030|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14840031|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840032|NCT00968760|Analgesics|analgesics|mesh-ancestor
14840033|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
14840034|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840035|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
14840036|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14840037|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840038|NCT00968877|Vitamins|vitamins|mesh-ancestor
14840039|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
14840040|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14840041|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
14840042|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14840043|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14840044|NCT00968903|Prednisolone|prednisolone|mesh-list
14840045|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
14840046|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14295611|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14840047|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
14840048|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840049|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
14840050|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
14840051|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840052|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840053|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840054|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
14840055|NCT00968903|Hormones|hormones|mesh-ancestor
14840056|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840057|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14840058|NCT00968903|Protective Agents|protective agents|mesh-ancestor
14840059|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840060|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840061|NCT00968929|Streptokinase|streptokinase|mesh-list
14840062|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14840063|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14840064|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840065|NCT00968955|Ropivacaine|ropivacaine|mesh-list
14840066|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
14840067|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
14840068|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840069|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840070|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
14840071|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840072|NCT00968994|Petrolatum|petrolatum|mesh-list
14840073|NCT00968994|Emollients|emollients|mesh-ancestor
14840074|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
14840075|NCT00969033|Irinotecan|irinotecan|mesh-list
14840076|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14840077|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14840078|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840079|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840080|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840081|NCT00969046|Epothilone B|epothilone b|mesh-list
14840082|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840083|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14840084|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14840085|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14840086|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840087|NCT00969072|Dutasteride|dutasteride|mesh-list
14840088|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14840089|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14840090|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840091|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840092|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
15205170|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15205171|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15205172|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205173|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205174|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15205175|NCT03731091|Vitamins|vitamins|mesh-ancestor
15205176|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
15205177|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15205178|NCT03730857|Olanzapine|olanzapine|mesh-list
15205179|NCT03730857|Risperidone|risperidone|mesh-list
15205180|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15205181|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
15205182|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15205183|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
15205184|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840093|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840094|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840095|NCT00969085|Curcumin|curcumin|mesh-list
14840096|NCT00969085|Turmeric extract|turmeric extract|mesh-list
14840097|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14840098|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840099|NCT00969085|Analgesics|analgesics|mesh-ancestor
14840100|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
14840101|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840102|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840103|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840104|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840105|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840106|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840107|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840108|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
14840109|NCT00969085|Protective Agents|protective agents|mesh-ancestor
14840110|NCT00969137|Nicotine|nicotine|mesh-list
14840111|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14840112|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
14840113|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840114|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840115|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14840116|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14840117|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
14840118|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840119|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840120|NCT00969163|Testosterone|testosterone|mesh-list
14840121|NCT00969163|Androgens|androgens|mesh-ancestor
14840122|NCT00969163|Hormones|hormones|mesh-ancestor
14840123|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840124|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840125|NCT00969176|Acetaminophen|acetaminophen|mesh-list
14840126|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840127|NCT00969176|Analgesics|analgesics|mesh-ancestor
15205185|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840128|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
14840129|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840130|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840131|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
14840132|NCT00969293|Ecallantide|ecallantide|mesh-list
14840133|NCT00969293|Analgesics|analgesics|mesh-ancestor
14840134|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
14840135|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840136|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840137|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14840138|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840139|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840140|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840141|NCT00969306|Chloroquine|chloroquine|mesh-list
14840142|NCT00969306|Amebicides|amebicides|mesh-ancestor
14840143|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14840144|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14840145|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840146|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
14840147|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840148|NCT00969319|Factor VIII|factor viii|mesh-list
14840149|NCT00969319|Coagulants|coagulants|mesh-ancestor
14840150|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14840151|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840152|NCT00969397|Growth Substances|growth substances|mesh-ancestor
14840153|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840154|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
14840155|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840156|NCT00969449|Naproxen|naproxen|mesh-list
14840157|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14840158|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840159|NCT00969449|Analgesics|analgesics|mesh-ancestor
14840160|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
14705897|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705898|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
14705899|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840161|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840162|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840163|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840164|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840165|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
14840166|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14840167|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840168|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840169|NCT00969462|Doxorubicin|doxorubicin|mesh-list
14840170|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14840171|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840172|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14840173|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14840174|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840175|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840176|NCT00969566|Metformin|metformin|mesh-list
14840177|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14840178|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14840179|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840180|NCT00969566|Incretins|incretins|mesh-ancestor
14840181|NCT00969566|Hormones|hormones|mesh-ancestor
14840182|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295612|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14705900|NCT00416858|Fluorouracil|fluorouracil|mesh-list
14705901|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705902|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
14705903|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705904|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14705905|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705906|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
14705907|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705908|NCT00416871|Interferons|interferons|mesh-list
14705909|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
14705910|NCT00416871|Aldesleukin|aldesleukin|mesh-list
14705911|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840183|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14295613|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14840184|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
14705912|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
14840185|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840186|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840187|NCT00969592|Insulin|insulin|mesh-list
14840188|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14840189|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
14840190|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
14840191|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14840192|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
14840193|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14840194|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840195|NCT00969631|Metformin|metformin|mesh-list
14840196|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14840197|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912087|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14912088|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912089|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912090|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912091|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
14912092|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912093|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912094|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912095|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912096|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14912097|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14912098|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912099|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912100|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
14912101|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912102|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14917181|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917182|NCT01396681|Gemcitabine|gemcitabine|mesh-list
14917183|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917184|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917185|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
14917186|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917187|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
14917188|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917189|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917190|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917191|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
14917192|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917193|NCT01396707|Capecitabine|capecitabine|mesh-list
14917194|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
14917195|NCT01396707|Trastuzumab|trastuzumab|mesh-list
14917196|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917197|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
14917198|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917199|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917200|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917201|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
14917202|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14917203|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917204|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917205|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917206|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917207|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14917208|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14917209|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14917210|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917211|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917212|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
14917213|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14917214|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
14917215|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14917216|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14917217|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917218|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14917219|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
14917220|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
14917221|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917222|NCT01396733|Protective Agents|protective agents|mesh-ancestor
14917223|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840198|NCT00969696|Galantamine|galantamine|mesh-list
14840199|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14840200|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840201|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840202|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
14840203|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840204|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840205|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14840206|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
14840207|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840208|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
14840209|NCT00969813|Tofacitinib|tofacitinib|mesh-list
14840210|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14840211|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840212|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840213|NCT00969852|Sertraline|sertraline|mesh-list
14840214|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
14840215|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14840216|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14840217|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14840218|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14840219|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840220|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840221|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
14840222|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840223|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
14840224|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14840225|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
14840226|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840227|NCT00969904|Expectorants|expectorants|mesh-ancestor
14840228|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
14840229|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15205186|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205187|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15205188|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205189|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15205190|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15205191|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
15205192|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
15205193|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
15205194|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205195|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15205196|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15205197|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15205198|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205199|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15205200|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15205201|NCT03730766|Amoxicillin|amoxicillin|mesh-list
15205202|NCT03730766|Metronidazole|metronidazole|mesh-list
15205203|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
15205204|NCT03730766|Esomeprazole|esomeprazole|mesh-list
15205205|NCT03730766|Bismuth|bismuth|mesh-list
15205206|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205207|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15205208|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205209|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15205210|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15205211|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15205212|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15205213|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15205214|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205215|NCT03730766|Antacids|antacids|mesh-ancestor
15205216|NCT03730766|Diuretics|diuretics|mesh-ancestor
15205217|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
15205218|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205219|NCT03730766|Expectorants|expectorants|mesh-ancestor
15205220|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
15205221|NCT03730740|Lenalidomide|lenalidomide|mesh-list
15205222|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
15205223|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205224|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14295614|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
14840230|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
14912103|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
15205225|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15205226|NCT03730740|Growth Substances|growth substances|mesh-ancestor
14840231|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840232|NCT00969904|Protective Agents|protective agents|mesh-ancestor
14840233|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840234|NCT00969904|Antidotes|antidotes|mesh-ancestor
14840235|NCT00969982|Misoprostol|misoprostol|mesh-list
14840236|NCT00969982|Mifepristone|mifepristone|mesh-list
14840237|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14840238|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
14840239|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14840240|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840241|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14840242|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840243|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
14840244|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14840245|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14840246|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14840247|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14840248|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
14840249|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14840250|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14840251|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
14840252|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840253|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
14840254|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14840255|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14840256|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
14840257|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14840258|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14840259|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
14840260|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840261|NCT00970086|Bupivacaine|bupivacaine|mesh-list
14840262|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
14840263|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
14840264|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
14840265|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840266|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840267|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
14840268|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840269|NCT00970138|Apatinib|apatinib|mesh-list
14840270|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840271|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14840272|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840273|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840274|NCT00970450|Acetaminophen|acetaminophen|mesh-list
14840275|NCT00970450|Tropisetron|tropisetron|mesh-list
14840276|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840277|NCT00970450|Analgesics|analgesics|mesh-ancestor
14840278|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
14840279|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840280|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840281|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
14840282|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
14840283|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
14840284|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840285|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14840286|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14840287|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
14840288|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840289|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840290|NCT00970528|Acarbose|acarbose|mesh-list
14840291|NCT00970528|Voglibose|voglibose|mesh-list
14840292|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14840293|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840294|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840295|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14840296|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840297|NCT00970567|Insulin|insulin|mesh-list
14840298|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14840299|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840300|NCT00970580|Paclitaxel|paclitaxel|mesh-list
14840301|NCT00970580|Carboplatin|carboplatin|mesh-list
14840302|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
14840303|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14840304|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840305|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
14840306|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
14840307|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
14840308|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840309|NCT00970697|Becaplermin|becaplermin|mesh-list
14840310|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
14840311|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14840312|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840313|NCT00970697|Growth Substances|growth substances|mesh-ancestor
14840314|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840315|NCT00970762|Rocuronium|rocuronium|mesh-list
14840316|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
14840317|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14840318|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14840319|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14840320|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840321|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840322|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14840323|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14840324|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
14840325|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840326|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840327|NCT00970879|Mefloquine|mefloquine|mesh-list
14840328|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14840329|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
14840330|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14840331|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14840332|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840333|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14840334|NCT00970879|Renal Agents|renal agents|mesh-ancestor
14840335|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14840336|NCT00970892|Warfarin|warfarin|mesh-list
14840337|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
14840338|NCT00970905|Ondansetron|ondansetron|mesh-list
14840339|NCT00970905|Aprepitant|aprepitant|mesh-list
14840340|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
14840341|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
14840342|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840343|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840344|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840345|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
14840346|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
14840347|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14840348|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
14840349|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840350|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840351|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14840352|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14840353|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840354|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14840355|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14705913|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14705914|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
14705915|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705916|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14705917|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14705918|NCT00416897|Dexamethasone|dexamethasone|mesh-list
14705919|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705920|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
14705921|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
14705922|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705923|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705924|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14705925|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
14705926|NCT00416897|Hormones|hormones|mesh-ancestor
14840356|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14840357|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
14840358|NCT00970931|Amiloride|amiloride|mesh-list
14840359|NCT00970931|Diuretics|diuretics|mesh-list
14840360|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
14840361|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840362|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14840363|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14840364|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14840365|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840366|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14840367|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14840368|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14840369|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14840370|NCT00970957|Bevacizumab|bevacizumab|mesh-list
14840371|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840372|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840373|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14840374|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840375|NCT00970957|Growth Substances|growth substances|mesh-ancestor
14840376|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840377|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
14840378|NCT00970970|Bevacizumab|bevacizumab|mesh-list
14840379|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
14840380|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840381|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840382|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14840383|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840384|NCT00970970|Growth Substances|growth substances|mesh-ancestor
14840385|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840386|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
14840387|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14840388|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840389|NCT00970996|Interferons|interferons|mesh-list
14840390|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
14840391|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
14840392|NCT00970996|Paclitaxel|paclitaxel|mesh-list
14840393|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14840394|NCT00970996|Cisplatin|cisplatin|mesh-list
14840395|NCT00970996|Temozolomide|temozolomide|mesh-list
14840396|NCT00970996|Interleukin-2|interleukin-2|mesh-list
14840397|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14840398|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840399|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
14840400|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
14840401|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
14840402|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840403|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
14840404|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840405|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14840406|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
14840407|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
14840408|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840409|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840410|NCT00970996|Analgesics|analgesics|mesh-ancestor
14840411|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
14840412|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840413|NCT00971074|Hylan|hylan|mesh-list
14840414|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
14840415|NCT00971074|Protective Agents|protective agents|mesh-ancestor
14840416|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840417|NCT00971126|Thalidomide|thalidomide|mesh-list
14840418|NCT00971126|Sorafenib|sorafenib|mesh-list
14840419|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840420|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14840421|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840422|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840423|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14840424|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
14840425|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840426|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
14840427|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14840428|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205227|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
14840429|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14840430|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840431|NCT00971126|Growth Substances|growth substances|mesh-ancestor
15205228|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205229|NCT03730714|Epinephrine|epinephrine|mesh-list
15205230|NCT03730714|Racepinephrine|racepinephrine|mesh-list
15205231|NCT03730714|Morphine|morphine|mesh-list
15205232|NCT03730714|Anesthetics|anesthetics|mesh-list
14840432|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
14840433|NCT00971152|Menotropins|menotropins|mesh-list
14840434|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14840435|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
14840436|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14840437|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840438|NCT00971165|Losartan|losartan|mesh-list
14840439|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
14840440|NCT00971165|Amiloride|amiloride|mesh-list
14840441|NCT00971165|Diuretics|diuretics|mesh-list
14840442|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14840443|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14840444|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14840445|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14840446|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840447|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
14840448|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840449|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14840450|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14840451|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14840452|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14840453|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14840454|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14840455|NCT00971399|Ondansetron|ondansetron|mesh-list
14840456|NCT00971399|Ramosetron|ramosetron|mesh-list
14840457|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
14840458|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
14840459|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840460|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840461|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840462|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
14840463|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
14840464|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14840465|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
14840466|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840467|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840468|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14840469|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14840470|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840471|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14840472|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14912104|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912105|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912106|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
14912107|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912108|NCT01367561|Naloxone|naloxone|mesh-list
14912109|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
14912110|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912111|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912112|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
14912113|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912114|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
14912115|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912116|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912117|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
14912118|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912119|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
14912120|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912121|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912122|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
14912123|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912124|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
14912125|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912126|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912127|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
14912128|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912129|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
14912130|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912131|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912132|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
14917224|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
15205233|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
14840473|NCT00971581|Ketoprofen|ketoprofen|mesh-list
14840474|NCT00971581|Omeprazole|omeprazole|mesh-list
14840475|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14840476|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840477|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14840478|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840479|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840480|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14840481|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840482|NCT00971581|Analgesics|analgesics|mesh-ancestor
14840483|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
14840484|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840485|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840486|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840487|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840488|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14840489|NCT00971607|Sevoflurane|sevoflurane|mesh-list
14840490|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14840491|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14840492|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
14840493|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
14840494|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840495|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840496|NCT00971659|Insulin|insulin|mesh-list
14840497|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14840498|NCT00971659|Metformin|metformin|mesh-list
14840499|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
14840500|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14840501|NCT00971659|Exenatide|exenatide|mesh-list
14840502|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14840503|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840504|NCT00971659|Incretins|incretins|mesh-ancestor
14840505|NCT00971659|Hormones|hormones|mesh-ancestor
15205234|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
15205235|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15205236|NCT03730714|Narcotics|narcotics|mesh-ancestor
15205237|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205238|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205239|NCT03730714|Analgesics|analgesics|mesh-ancestor
15205240|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
15205241|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205242|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15205243|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15205244|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
15205245|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295615|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295616|NCT00582166|Rituximab|rituximab|mesh-list
14295617|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14295618|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295619|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295620|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
14295621|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295622|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705927|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705928|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705929|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705930|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
14705931|NCT00416910|Fludarabine|fludarabine|mesh-list
14705932|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
14705933|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14705934|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
14705935|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705936|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15205246|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205247|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15205248|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15205249|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
14295623|NCT00582205|Paclitaxel|paclitaxel|mesh-list
14840506|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840507|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14840508|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
14840509|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840510|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840511|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14840512|NCT00971685|Dexamethasone|dexamethasone|mesh-list
14840513|NCT00971685|Lenalidomide|lenalidomide|mesh-list
14840514|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840515|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
14840516|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
14840517|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840518|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840519|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840520|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
14840521|NCT00971685|Hormones|hormones|mesh-ancestor
14840522|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840523|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840524|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840525|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
14840526|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14840527|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840528|NCT00971685|Growth Substances|growth substances|mesh-ancestor
14840529|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
14840530|NCT00971724|Prednisolone|prednisolone|mesh-list
14840531|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840532|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
14840533|NCT00971724|Hormones|hormones|mesh-ancestor
14840534|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840535|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840536|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840537|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840538|NCT00971763|Gemcitabine|gemcitabine|mesh-list
14840539|NCT00971763|Prednisolone|prednisolone|mesh-list
14840540|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
14840541|NCT00971763|Rituximab|rituximab|mesh-list
14840542|NCT00971763|Vincristine|vincristine|mesh-list
14840543|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14840544|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
14840545|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840546|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840547|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14840548|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
14840549|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840550|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840551|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14840552|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840553|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14840554|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
14840555|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
14840556|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840557|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840558|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14840559|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
14840560|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
14840561|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
14840562|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840563|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
14840564|NCT00971763|Hormones|hormones|mesh-ancestor
14840565|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840566|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840567|NCT00971815|Dexetimide|dexetimide|mesh-list
14840568|NCT00971815|Citalopram|citalopram|mesh-list
14840569|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14840570|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14840571|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14840572|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840573|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840574|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
14840575|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840576|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14840577|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
14840578|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14840579|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14840580|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14295624|NCT00582205|Cisplatin|cisplatin|mesh-list
14295625|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14705937|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14840581|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
14840582|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
14840583|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840584|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14840585|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14840586|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
14840587|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
14840588|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14840589|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14840590|NCT00971893|Prednisolone|prednisolone|mesh-list
14840591|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
14840592|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14840593|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
14840594|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840595|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
14840596|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
14840597|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840598|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840599|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840600|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
14840601|NCT00971893|Hormones|hormones|mesh-ancestor
14840602|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205250|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15205251|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
15205252|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
14840603|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14840604|NCT00971893|Protective Agents|protective agents|mesh-ancestor
14840605|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840606|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840607|NCT00972075|Melatonin|melatonin|mesh-list
14840608|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
15205253|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
15205254|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15205255|NCT03730675|Sorafenib|sorafenib|mesh-list
15205256|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205257|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15205258|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205259|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705938|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
14705939|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705940|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705941|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15205260|NCT03730649|Sulforaphane|sulforaphane|mesh-list
15205261|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15205262|NCT03730649|Protective Agents|protective agents|mesh-ancestor
15205263|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205264|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205265|NCT03730584|Ropivacaine|ropivacaine|mesh-list
14705942|NCT00416910|Analgesics|analgesics|mesh-ancestor
14705943|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
14705944|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705945|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14705946|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14705947|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705948|NCT00416923|Rituximab|rituximab|mesh-list
14705949|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14705950|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705951|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
14705952|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705953|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14705954|NCT00416962|Oseltamivir|oseltamivir|mesh-list
14705955|NCT00416962|Amantadine|amantadine|mesh-list
14705956|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
14705957|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840609|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205266|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
14840610|NCT00972075|Protective Agents|protective agents|mesh-ancestor
14840611|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840612|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840613|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
14840614|NCT00972101|Rituximab|rituximab|mesh-list
15205267|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
15205268|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205269|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205270|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
15205271|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205272|NCT03730558|Aflibercept|aflibercept|mesh-list
15205273|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15205274|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15205275|NCT03730558|Growth Substances|growth substances|mesh-ancestor
14840615|NCT00972101|Fludarabine|fludarabine|mesh-list
14840616|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
14840617|NCT00972101|Etoposide|etoposide|mesh-list
14840618|NCT00972101|Melphalan|melphalan|mesh-list
14840619|NCT00972101|Thiotepa|thiotepa|mesh-list
14840620|NCT00972101|Tacrolimus|tacrolimus|mesh-list
14840621|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14840622|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840623|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840624|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
14840625|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840626|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840627|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14840628|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
14840629|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840630|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14840631|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840632|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14840633|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14840634|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14840635|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840636|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14840637|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14840638|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14840639|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
14840640|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14840641|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14840642|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
14840643|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14840644|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
14840645|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14840646|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
14840647|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840648|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840649|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14840650|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
14840651|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14840652|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14840653|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14705958|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14705959|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705960|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14705961|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14705962|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
14705963|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14705964|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705965|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14705966|NCT00416962|Analgesics|analgesics|mesh-ancestor
14705967|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
14705968|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14705969|NCT00417014|Prednisolone|prednisolone|mesh-list
14840654|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
14840655|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840656|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840657|NCT00972218|Adalimumab|adalimumab|mesh-list
14840658|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705970|NCT00417014|Vinblastine|vinblastine|mesh-list
14840659|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840660|NCT00972257|Timolol|timolol|mesh-list
14840661|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14840662|NCT00972257|Dorzolamide|dorzolamide|mesh-list
14840663|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14840664|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14840665|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
14840666|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840667|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840668|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840669|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14840670|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14840671|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14840672|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14840673|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14840674|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14840675|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840676|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
14840677|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14840678|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840679|NCT00972387|Prednisone|prednisone|mesh-list
14840680|NCT00972387|Prednisolone|prednisolone|mesh-list
14840681|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
14840682|NCT00972387|Doxorubicin|doxorubicin|mesh-list
14840683|NCT00972387|Vincristine|vincristine|mesh-list
14840684|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14840685|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
14840686|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840687|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840688|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14840689|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
14840690|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840691|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840692|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14840693|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14840694|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14840695|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14840696|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840697|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840698|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
14840699|NCT00972387|Hormones|hormones|mesh-ancestor
14840700|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705971|NCT00417014|Procarbazine|procarbazine|mesh-list
14705972|NCT00417014|Chlorambucil|chlorambucil|mesh-list
14705973|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14705974|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
14705975|NCT00417014|Hormones|hormones|mesh-ancestor
14705976|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14705977|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705978|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14705979|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14705980|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14705981|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
14705982|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
14705983|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
14705984|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840701|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840702|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14840703|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14840704|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14840705|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14840706|NCT00972426|Timolol|timolol|mesh-list
14840707|NCT00972426|Carteolol|carteolol|mesh-list
14840708|NCT00972426|Latanoprost|latanoprost|mesh-list
14840709|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14840710|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14840711|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
14840712|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840713|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840714|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840715|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14840716|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14840717|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14840718|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14840719|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
14840720|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
14840721|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840722|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
14840723|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840724|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840725|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14840726|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
14840727|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840728|NCT00972660|Cyclosporine|cyclosporine|mesh-list
14840729|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
14840730|NCT00972660|Prednisone|prednisone|mesh-list
14840731|NCT00972660|Cyclosporins|cyclosporins|mesh-list
14840732|NCT00972660|Tacrolimus|tacrolimus|mesh-list
14840733|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840734|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
14840735|NCT00972660|Hormones|hormones|mesh-ancestor
14840736|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840737|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840738|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840739|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840740|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840741|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840742|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14840743|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
14840744|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
14840745|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840746|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
14840747|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14840748|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14840749|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14840750|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14840751|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
14840752|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14840753|NCT00972712|Bortezomib|bortezomib|mesh-list
14840754|NCT00972712|Tipifarnib|tipifarnib|mesh-list
14840755|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840756|NCT00972790|Bupivacaine|bupivacaine|mesh-list
14840757|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
14840758|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
14840759|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840760|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840761|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
14840762|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840763|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
14840764|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14840765|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840766|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
14840767|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14840768|NCT00972829|Ezetimibe|ezetimibe|mesh-list
14840769|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14840770|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14840771|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
14840772|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840773|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14840774|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14840775|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840776|NCT00972842|Lenalidomide|lenalidomide|mesh-list
14840777|NCT00972842|Vorinostat|vorinostat|mesh-list
14840778|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
14840779|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840780|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14840781|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840782|NCT00972842|Growth Substances|growth substances|mesh-ancestor
14840783|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
14840784|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840785|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14840786|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840787|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840788|NCT00972855|Bicalutamide|bicalutamide|mesh-list
14840789|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
14840790|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
14840791|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205276|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205277|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
14705985|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14705986|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
14705987|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
14705988|NCT00417053|Melphalan|melphalan|mesh-list
14705989|NCT00417053|Busulfan|busulfan|mesh-list
14705990|NCT00417053|Carboplatin|carboplatin|mesh-list
14705991|NCT00417053|Doxorubicin|doxorubicin|mesh-list
14705992|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14840792|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840793|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840794|NCT00972881|Capecitabine|capecitabine|mesh-list
14840795|NCT00972881|Irinotecan|irinotecan|mesh-list
14840796|NCT00972881|Cetuximab|cetuximab|mesh-list
14840797|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14840798|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
14840799|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840800|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840801|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14840802|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14840803|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840804|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840805|NCT00972907|Nifedipine|nifedipine|mesh-list
14840806|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14840807|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14840808|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840809|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14840810|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840811|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
14840812|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
14840813|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14840814|NCT00972933|Ipilimumab|ipilimumab|mesh-list
14840815|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840816|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840817|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14840818|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840819|NCT00972946|Dextrans|dextrans|mesh-list
14840820|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
14840821|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
14840822|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
14840823|NCT00972985|Lorazepam|lorazepam|mesh-list
14840824|NCT00972985|Methylphenidate|methylphenidate|mesh-list
14705993|NCT00417053|Etoposide|etoposide|mesh-list
14705994|NCT00417053|Vincristine|vincristine|mesh-list
14705995|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
14840825|NCT00972985|Modafinil|modafinil|mesh-list
14840826|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14840827|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840828|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14840829|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14840830|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14840831|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14705996|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295626|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295627|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
14840832|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
14840833|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14840834|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14840835|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14840836|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14840837|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
14840838|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
14840839|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
14840840|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840841|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14840842|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14840843|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14840844|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14840845|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14705997|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
14840846|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14840847|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
14840848|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
14840849|NCT00973037|Tamoxifen|tamoxifen|mesh-list
14840850|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14705998|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14705999|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706000|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14706001|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
14706002|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706003|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706004|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14706005|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14706006|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14840851|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
14840852|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840853|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840854|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840855|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840856|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14840857|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14840858|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14840859|NCT00973050|Bicalutamide|bicalutamide|mesh-list
14840860|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
14840861|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
14840862|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840863|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840864|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840865|NCT00973115|Simvastatin|simvastatin|mesh-list
14840866|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14840867|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14840868|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
14840869|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840870|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14840871|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14840872|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840873|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14840874|NCT00973128|Sargramostim|sargramostim|mesh-list
14840875|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
14840876|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840877|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14840878|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14840879|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840880|NCT00973154|Prednisone|prednisone|mesh-list
14840881|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14840882|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
14840883|NCT00973154|Hormones|hormones|mesh-ancestor
14840884|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840885|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840886|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840887|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840888|NCT00973193|Panitumumab|panitumumab|mesh-list
14840889|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840890|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840891|NCT00973219|Interferons|interferons|mesh-list
14840892|NCT00973219|Tenofovir|tenofovir|mesh-list
14840893|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
14840894|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
14840895|NCT00973219|Adefovir|adefovir|mesh-list
14840896|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14840897|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14840898|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840899|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
14840900|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840901|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14840902|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14840903|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840904|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840905|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14840906|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14840907|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
14840908|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840909|NCT00973232|Acetaminophen|acetaminophen|mesh-list
14840910|NCT00973232|Tramadol|tramadol|mesh-list
14840911|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14840912|NCT00973232|Analgesics|analgesics|mesh-ancestor
14840913|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
14840914|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14840915|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840916|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
14840917|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14840918|NCT00973232|Narcotics|narcotics|mesh-ancestor
14840919|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912133|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912134|NCT01367626|Letrozole|letrozole|mesh-list
14912135|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912136|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14912137|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14912138|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912139|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912140|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14912141|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
14912142|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912143|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912144|NCT01367652|Letrozole|letrozole|mesh-list
14912145|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912146|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14912147|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14912148|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912149|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912150|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14912151|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
14912152|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912153|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912154|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
14912155|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14912156|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912157|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
14912158|NCT01367743|Epinephrine|epinephrine|mesh-list
14912159|NCT01367743|Norepinephrine|norepinephrine|mesh-list
14912160|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14912161|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14912162|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14912163|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
14912164|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912165|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912166|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912167|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14840920|NCT00973245|Warfarin|warfarin|mesh-list
14840921|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
14840922|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
14840923|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14840924|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
14706007|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14706008|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706009|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14706010|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
14706011|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
14706012|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14840925|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14840926|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
14840927|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840928|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840929|NCT00973271|Atorvastatin|atorvastatin|mesh-list
14840930|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
14840931|NCT00973271|Fenofibrate|fenofibrate|mesh-list
14840932|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14840933|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14840934|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
14840935|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840936|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14840937|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14840938|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840939|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14840940|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840941|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14840942|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840943|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840944|NCT00973323|Warfarin|warfarin|mesh-list
14840945|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
14840946|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
14840947|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14840948|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
14840949|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14840950|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
14840951|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840952|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840953|NCT00973336|Vitamin D|vitamin d|mesh-list
14840954|NCT00973336|Calcium|calcium|mesh-list
14840955|NCT00973336|Vitamins|vitamins|mesh-ancestor
14840956|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
14840957|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840958|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14840959|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14840960|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
14840961|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706013|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14706014|NCT00417066|Ganirelix|ganirelix|mesh-list
14706015|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
14706016|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14706017|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
14840962|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14840963|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14840964|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14840965|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840966|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840967|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840968|NCT00973401|Insulin|insulin|mesh-list
14840969|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14840970|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840971|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
14840972|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840973|NCT00973505|Anastrozole|anastrozole|mesh-list
14840974|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14840975|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840976|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14840977|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14840978|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14840979|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14840980|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
14840981|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14840982|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840983|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14840984|NCT00973583|Vitamin D|vitamin d|mesh-list
14840985|NCT00973583|Vitamins|vitamins|mesh-ancestor
14840986|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
14840987|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14840988|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14840989|NCT00973609|Folic Acid|folic acid|mesh-list
14840990|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
14840991|NCT00973609|Bevacizumab|bevacizumab|mesh-list
14840992|NCT00973609|Fluorouracil|fluorouracil|mesh-list
14840993|NCT00973609|Capecitabine|capecitabine|mesh-list
14840994|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14840995|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14840996|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14840997|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14840998|NCT00973609|Growth Substances|growth substances|mesh-ancestor
14840999|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841000|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
14841001|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
14841002|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841003|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841004|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841005|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
14841006|NCT00973609|Hematinics|hematinics|mesh-ancestor
14841007|NCT00973609|Vitamins|vitamins|mesh-ancestor
14841008|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
14841009|NCT00973687|Dexamethasone|dexamethasone|mesh-list
14841010|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841011|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
14841012|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
14841013|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841014|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841015|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841016|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
14841017|NCT00973687|Hormones|hormones|mesh-ancestor
14841018|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841019|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14841020|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841021|NCT00973713|Everolimus|everolimus|mesh-list
14841022|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841023|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841024|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
14841025|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841026|NCT00973778|Capecitabine|capecitabine|mesh-list
14841027|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841028|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
14841029|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841030|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841031|NCT00973804|Sirolimus|sirolimus|mesh-list
14841032|NCT00973804|Tacrolimus|tacrolimus|mesh-list
14841033|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841034|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
14841035|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841036|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14841037|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841038|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841039|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14841040|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917225|NCT01396733|Vitamins|vitamins|mesh-ancestor
14841041|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14841042|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841043|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
14841044|NCT00973869|Curcumin|curcumin|mesh-list
14841045|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14841046|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14841047|NCT00973869|Analgesics|analgesics|mesh-ancestor
14841048|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
14841049|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841050|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841051|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841052|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14841053|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841054|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841055|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841056|NCT00973882|Carboplatin|carboplatin|mesh-list
14841057|NCT00973882|Etoposide|etoposide|mesh-list
14841058|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841059|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14841060|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14841061|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14841062|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841063|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841064|NCT00973986|Atorvastatin|atorvastatin|mesh-list
14841065|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14841066|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14841067|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
14841068|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841069|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14841070|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14841071|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841072|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
14841073|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14841074|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841075|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841076|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
14841077|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841078|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841079|NCT00974012|Valproic Acid|valproic acid|mesh-list
14841080|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
14841081|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841082|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841083|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
14841084|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841085|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841086|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
14841087|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14841088|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841089|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14841090|NCT00974025|Ascorbic Acid|ascorbic acid|mesh-list
14841091|NCT00974025|Vitamins|vitamins|mesh-ancestor
14841092|NCT00974025|Micronutrients|micronutrients|mesh-ancestor
14841093|NCT00974025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841094|NCT00974025|Antioxidants|antioxidants|mesh-ancestor
14841095|NCT00974025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841096|NCT00974025|Protective Agents|protective agents|mesh-ancestor
14841097|NCT00974155|Dexetimide|dexetimide|mesh-list
14841098|NCT00974155|Citalopram|citalopram|mesh-list
14841099|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14841100|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14841101|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14841102|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841103|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841104|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841105|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
14841106|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841107|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14841108|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
14841109|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14841110|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14841111|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14841112|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
14841113|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
14841114|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841115|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14841116|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14841117|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14841118|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14841119|NCT00974181|Paclitaxel|paclitaxel|mesh-list
14841120|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14841121|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14841122|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841123|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14841124|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
14841125|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14841126|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841127|NCT00974272|Exenatide|exenatide|mesh-list
14841128|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841129|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841130|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14841131|NCT00974272|Incretins|incretins|mesh-ancestor
14841132|NCT00974272|Hormones|hormones|mesh-ancestor
14841133|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841134|NCT00974324|Endostar protein|endostar protein|mesh-list
14841135|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14841136|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14841137|NCT00974324|Growth Substances|growth substances|mesh-ancestor
14841138|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841139|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
14841140|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841141|NCT00974389|Bevacizumab|bevacizumab|mesh-list
14841142|NCT00974389|Tegafur|tegafur|mesh-list
14841143|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14841144|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841145|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14841146|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14841147|NCT00974389|Growth Substances|growth substances|mesh-ancestor
14841148|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841149|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
14841150|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841151|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
14841152|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841153|NCT00974428|Wobenzym|wobenzym|mesh-list
14841154|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14841155|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
14841156|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841157|NCT00974441|Valproic Acid|valproic acid|mesh-list
14841158|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
14841159|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841160|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841161|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
14841162|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841163|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841164|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
14841165|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14841166|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841167|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14841168|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
14841169|NCT00974532|Calcium|calcium|mesh-list
14841170|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14841171|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841172|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14841173|NCT00974584|Paclitaxel|paclitaxel|mesh-list
14841174|NCT00974584|Bevacizumab|bevacizumab|mesh-list
14841175|NCT00974584|Carboplatin|carboplatin|mesh-list
14841176|NCT00974584|Pemetrexed|pemetrexed|mesh-list
14841177|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14841178|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841179|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
14841180|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
14841181|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
14841182|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841183|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14841184|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14841185|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14841186|NCT00974584|Growth Substances|growth substances|mesh-ancestor
14841187|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841188|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
14841189|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841190|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14841191|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14841192|NCT00974740|Atorvastatin|atorvastatin|mesh-list
14841193|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14841194|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14841195|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
14841196|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841197|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14841198|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14841199|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841200|NCT00974753|Ketorolac|ketorolac|mesh-list
14841201|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14841202|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14841203|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14841204|NCT00974753|Analgesics|analgesics|mesh-ancestor
14841205|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
14841206|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841207|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841208|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841209|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14841210|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14841211|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841212|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841213|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
14841214|NCT00974766|Hormones|hormones|mesh-ancestor
14841215|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841216|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841217|NCT00974792|Leucovorin|leucovorin|mesh-list
14841218|NCT00974792|Cytarabine|cytarabine|mesh-list
14841219|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
14841220|NCT00974792|Ifosfamide|ifosfamide|mesh-list
14841221|NCT00974792|Rituximab|rituximab|mesh-list
14841222|NCT00974792|Doxorubicin|doxorubicin|mesh-list
14841223|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14841224|NCT00974792|Methotrexate|methotrexate|mesh-list
14841225|NCT00974792|Etoposide|etoposide|mesh-list
14841226|NCT00974792|Vincristine|vincristine|mesh-list
14841227|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
14841228|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
14841229|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841230|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
14841231|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841232|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14841233|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14841234|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
14841235|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841236|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841237|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14841238|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14841239|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14841240|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14841241|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14841242|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841243|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14841244|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
14841245|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14841246|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841247|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
14841248|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14841249|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14841250|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14841251|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295628|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
14295629|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295630|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295631|NCT00582309|Insulin|insulin|mesh-list
14295632|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14295633|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14295634|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295635|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
14295636|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295637|NCT00582426|Octreotide|octreotide|mesh-list
14295638|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295639|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14841252|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
14841253|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841254|NCT00974792|Antidotes|antidotes|mesh-ancestor
14841255|NCT00974792|Protective Agents|protective agents|mesh-ancestor
14841256|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
14841257|NCT00974792|Vitamins|vitamins|mesh-ancestor
14841258|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
14841259|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
14841260|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
14841261|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
14841262|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14841263|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14841264|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
14841265|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841266|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841267|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14841268|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
14841269|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
14841270|NCT00974805|Hormones|hormones|mesh-ancestor
14841271|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841272|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
14841273|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14841274|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14841275|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
14841276|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841277|NCT00974935|Antacids|antacids|mesh-ancestor
14841278|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841279|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841280|NCT00974961|Bupivacaine|bupivacaine|mesh-list
14841281|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
14841282|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
14841283|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
14841284|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841285|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841286|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
14841287|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841288|NCT00974987|Temozolomide|temozolomide|mesh-list
14841289|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14841290|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
14841291|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841292|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912168|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14912169|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
14912170|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912171|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14912172|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
14912173|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
14912174|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
14912175|NCT01367756|Citalopram|citalopram|mesh-list
14912176|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14912177|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14912178|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912179|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912180|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912181|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
14912182|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912183|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912184|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912185|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912186|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14912187|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14912188|NCT01367912|Estradiol|estradiol|mesh-list
14295640|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295641|NCT00582491|Modafinil|modafinil|mesh-list
14841293|NCT00975052|Metformin|metformin|mesh-list
14841294|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14841295|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841296|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841297|NCT00975052|Incretins|incretins|mesh-ancestor
14841298|NCT00975052|Hormones|hormones|mesh-ancestor
14841299|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841300|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14841301|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
14841302|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841303|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841304|NCT00975065|Metformin|metformin|mesh-list
14841305|NCT00975065|Vildagliptin|vildagliptin|mesh-list
14841306|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841307|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841308|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14841309|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
14841310|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841311|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841312|NCT00975078|Prednisone|prednisone|mesh-list
14841313|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841314|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
14841315|NCT00975078|Hormones|hormones|mesh-ancestor
14841316|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841317|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841318|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14841319|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841320|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
14841321|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
14841322|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841323|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14841324|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841325|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14841326|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841327|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841328|NCT00975299|Bombesin|bombesin|mesh-list
14841329|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841330|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841331|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841332|NCT00975312|Tretinoin|tretinoin|mesh-list
14841333|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841334|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
14841335|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14841336|NCT00975325|Yohimbine|yohimbine|mesh-list
14841337|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
14841338|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
14706018|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14706019|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706020|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14706021|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14706022|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706023|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
14706024|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917226|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
14706025|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14706026|NCT00417144|Ganirelix|ganirelix|mesh-list
14706027|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
14706028|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14841339|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841340|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841341|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14841342|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14841343|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14841344|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
14841345|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841346|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841347|NCT00975325|Urological Agents|urological agents|mesh-ancestor
14841348|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
14841349|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841350|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
14841351|NCT00975351|Vitamins|vitamins|mesh-ancestor
14841352|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
14841353|NCT00975390|Caffeine|caffeine|mesh-list
14841354|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14841355|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841356|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14841357|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841358|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841359|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14841360|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14841361|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
14841362|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841363|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
14841364|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
14841365|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14841366|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14841367|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841368|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841369|NCT00975494|Urological Agents|urological agents|mesh-ancestor
14841370|NCT00975533|Insulin|insulin|mesh-list
14841371|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841372|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841373|NCT00975572|Vaccines|vaccines|mesh-list
14841374|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
14841375|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841376|NCT00975663|Tacrolimus|tacrolimus|mesh-list
14841377|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841378|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
14841379|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841380|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14841381|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841382|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841383|NCT00975728|Antioxidants|antioxidants|mesh-list
14841384|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841385|NCT00975728|Protective Agents|protective agents|mesh-ancestor
14841386|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841387|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
14841388|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841389|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
14841390|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14841391|NCT00975754|Budesonide|budesonide|mesh-list
14841392|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841393|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14841394|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
14841395|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841396|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841397|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14841398|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
14841399|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
14841400|NCT00975754|Hormones|hormones|mesh-ancestor
15205278|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205279|NCT03730402|Bupivacaine|bupivacaine|mesh-list
15205280|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205281|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
15205282|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205283|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205284|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
15205285|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205286|NCT03730363|Pentamidine|pentamidine|mesh-list
15205287|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
15205288|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841401|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841402|NCT00975767|Docetaxel|docetaxel|mesh-list
14841403|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14841404|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841405|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
14841406|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
14841407|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
14841408|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841409|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14841410|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841411|NCT00975819|Sirolimus|sirolimus|mesh-list
14706029|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
14841412|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14841413|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841414|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14841415|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841416|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
14841417|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841418|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
14841419|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841420|NCT00975897|Leucovorin|leucovorin|mesh-list
14841421|NCT00975897|Bevacizumab|bevacizumab|mesh-list
14841422|NCT00975897|Cetuximab|cetuximab|mesh-list
14841423|NCT00975897|Fluorouracil|fluorouracil|mesh-list
14841424|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
14841425|NCT00975897|Irinotecan|irinotecan|mesh-list
14841426|NCT00975897|Calcium|calcium|mesh-list
14841427|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
14841428|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14841429|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841430|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14841431|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14841432|NCT00975897|Growth Substances|growth substances|mesh-ancestor
14841433|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841434|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14841435|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14841436|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
14841437|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841438|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841439|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841440|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
14841441|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14841442|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14841443|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841444|NCT00975897|Antidotes|antidotes|mesh-ancestor
14841445|NCT00975897|Protective Agents|protective agents|mesh-ancestor
14841446|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
14841447|NCT00975897|Vitamins|vitamins|mesh-ancestor
14841448|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
14841449|NCT00975910|Lidocaine|lidocaine|mesh-list
14841450|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
14841451|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
15205289|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15205290|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15205291|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15205292|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
15205293|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15205294|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15205295|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
15205296|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205297|NCT03730272|Analgesics|analgesics|mesh-list
14706030|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14706031|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706032|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14706033|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14706034|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706035|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
14706036|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706037|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14706038|NCT00417157|Ganirelix|ganirelix|mesh-list
14706039|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
14706040|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841452|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841453|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841454|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
15205298|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
14841455|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841456|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14841457|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14841458|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14841459|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841460|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841461|NCT00975936|Ketoconazole|ketoconazole|mesh-list
14841462|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
14841463|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841464|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14841465|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14841466|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841467|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841468|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14841469|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
14841470|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841471|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841472|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14841473|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14841474|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14841475|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14841476|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841477|NCT00975988|Lapatinib|lapatinib|mesh-list
14841478|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841479|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14841480|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841481|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841482|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14841483|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
14841484|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841485|NCT00976066|Naltrexone|naltrexone|mesh-list
14841486|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14841487|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14841488|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841489|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
14841490|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841491|NCT00976092|Heparin|heparin|mesh-list
14841492|NCT00976092|Calcium heparin|calcium heparin|mesh-list
14841493|NCT00976092|Bivalirudin|bivalirudin|mesh-list
14841494|NCT00976092|Clopidogrel|clopidogrel|mesh-list
14841495|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14841496|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14841497|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14841498|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14841499|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14841500|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
14841501|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841502|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841503|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841504|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
14841505|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14841506|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14841507|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
14841508|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14841509|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
14841510|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841511|NCT00976105|Zolpidem|zolpidem|mesh-list
14841512|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14841513|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14841514|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917227|NCT01397006|Pregabalin|pregabalin|mesh-list
14706041|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706042|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14706043|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14706044|NCT00417183|Ganirelix|ganirelix|mesh-list
14706045|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
14706046|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14706047|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
14706048|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14706049|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706050|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14841515|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841516|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14841517|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
14841518|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
14841519|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841520|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841521|NCT00976131|Ubiquinone|ubiquinone|mesh-list
14841522|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
14706051|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14706052|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706053|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
14295642|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14706054|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706055|NCT00417222|Olmesartan|olmesartan|mesh-list
14706056|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14706057|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14706058|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14706059|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14706060|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706061|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
14841523|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
14841524|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841525|NCT00976131|Vitamins|vitamins|mesh-ancestor
14841526|NCT00976170|Sorafenib|sorafenib|mesh-list
14841527|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841528|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14841529|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841530|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841531|NCT00976222|Ranibizumab|ranibizumab|mesh-list
14841532|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14841533|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14841534|NCT00976222|Growth Substances|growth substances|mesh-ancestor
14841535|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841536|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14841537|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841538|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14841539|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841540|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841541|NCT00976261|Incretins|incretins|mesh-ancestor
14841542|NCT00976261|Hormones|hormones|mesh-ancestor
14841543|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841544|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14841545|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
14841546|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841547|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841548|NCT00976300|Cyclosporine|cyclosporine|mesh-list
14841549|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
14841550|NCT00976300|Cyclosporins|cyclosporins|mesh-list
14841551|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841552|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
14841553|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841554|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14841555|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14841556|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
14841557|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841558|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841559|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14841560|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841561|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
14841562|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841563|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
14841564|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14841565|NCT00976326|Insulin|insulin|mesh-list
14841566|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841567|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841568|NCT00976469|Vaccines|vaccines|mesh-list
14841569|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
14841570|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841571|NCT00976651|Menotropins|menotropins|mesh-list
14841572|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14841573|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
14841574|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14841575|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841576|NCT00976690|Mesalamine|mesalamine|mesh-list
14841577|NCT00976690|Azathioprine|azathioprine|mesh-list
14841578|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
14841579|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841580|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841581|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841582|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841583|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
14841584|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706062|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15205299|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841585|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14841586|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14841587|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14841588|NCT00976690|Analgesics|analgesics|mesh-ancestor
14841589|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
14841590|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841591|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841592|NCT00976755|Everolimus|everolimus|mesh-list
15205300|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205301|NCT03730194|Melatonin|melatonin|mesh-list
15205302|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
15205303|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205304|NCT03730194|Protective Agents|protective agents|mesh-ancestor
15205305|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205306|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205307|NCT03730181|Isoniazid|isoniazid|mesh-list
15205308|NCT03730181|Rifapentine|rifapentine|mesh-list
15205309|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
15205310|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706063|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706064|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
14706065|NCT00417326|Sivelestat|sivelestat|mesh-list
14706066|NCT00417326|Glycine|glycine|mesh-list
14706067|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14706068|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
14706069|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706070|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706071|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
14706072|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706073|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706074|NCT00417404|Vitamins|vitamins|mesh-list
14706075|NCT00417404|Vitamin A|vitamin a|mesh-list
14706076|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
14706077|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
14706078|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706079|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
14706080|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706081|NCT00417404|Protective Agents|protective agents|mesh-ancestor
14841593|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841594|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841595|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
14841596|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841597|NCT00976768|Fluorouracil|fluorouracil|mesh-list
14841598|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
14841599|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
14841600|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841601|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841602|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841603|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841604|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
14841605|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841606|NCT00976794|Carbamazepine|carbamazepine|mesh-list
14841607|NCT00976794|Valproic Acid|valproic acid|mesh-list
14841608|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
14841609|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
14841610|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14841611|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841612|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841613|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
14841614|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14841615|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841616|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841617|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
14841618|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
14841619|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841620|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14841621|NCT00976794|Analgesics|analgesics|mesh-ancestor
14841622|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
14841623|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841624|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14841625|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841626|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14841627|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14841628|NCT00976963|Fosfomycin|fosfomycin|mesh-list
14841629|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14841630|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841631|NCT00976976|Cisplatin|cisplatin|mesh-list
14841632|NCT00976976|Docetaxel|docetaxel|mesh-list
14841633|NCT00976976|Capecitabine|capecitabine|mesh-list
14841634|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841635|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
14841636|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
14841637|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
14841638|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841639|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14841640|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
14912189|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14912190|NCT01367912|Estrogens|estrogens|mesh-ancestor
14912191|NCT01367912|Hormones|hormones|mesh-ancestor
14295643|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295644|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14295645|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14295646|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14706082|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14706083|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706084|NCT00417430|Fulvestrant|fulvestrant|mesh-list
14706085|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14706086|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706087|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14706088|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14706089|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
14728656|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14912192|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912193|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841641|NCT00977028|Lidocaine|lidocaine|mesh-list
14841642|NCT00977028|Epinephrine|epinephrine|mesh-list
14841643|NCT00977028|Racepinephrine|racepinephrine|mesh-list
14841644|NCT00977028|Anesthetics|anesthetics|mesh-list
14841645|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
14841646|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
14841647|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841648|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841649|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
14841650|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841651|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14841652|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14841653|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14841654|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841655|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841656|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14841657|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14841658|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
14841659|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841660|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14841661|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14841662|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
14841663|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14841664|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
14841665|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
14841666|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
14841667|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14841668|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14841669|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
14841670|NCT00977054|Ribavirin|ribavirin|mesh-list
14841671|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
14841672|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14841673|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
14841674|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841675|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
14841676|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841677|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
14841678|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841679|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841680|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
14841681|NCT00977093|Antidotes|antidotes|mesh-ancestor
14841682|NCT00977093|Protective Agents|protective agents|mesh-ancestor
14841683|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841684|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
14841685|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
14841686|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841687|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14841688|NCT00977132|Lenalidomide|lenalidomide|mesh-list
14841689|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
14841690|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841691|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14841692|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14295647|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295648|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
14295649|NCT00582556|Leuprolide|leuprolide|mesh-list
14295650|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14295651|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295652|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14295653|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
14295654|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14295655|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14295656|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205311|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205312|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15205313|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15205314|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
15205315|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205316|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15205317|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15205318|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
15205319|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
15205320|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15205321|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
14841693|NCT00977132|Growth Substances|growth substances|mesh-ancestor
14841694|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14841695|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841696|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
14841697|NCT00977145|Vaccines|vaccines|mesh-list
14841698|NCT00977145|Immunologic Factors|immunologic factors|mesh-ancestor
14841699|NCT00977145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841700|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
14841701|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841702|NCT00977223|Aprepitant|aprepitant|mesh-list
14841703|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
14841704|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
14841705|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
14841706|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841707|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841708|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841709|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14841710|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841711|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841712|NCT00977249|Varenicline|varenicline|mesh-list
14841713|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14841714|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14841715|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
14841716|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841717|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841718|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841719|NCT00977288|Atorvastatin|atorvastatin|mesh-list
14841720|NCT00977288|Anacetrapib|anacetrapib|mesh-list
14841721|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14841722|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14841723|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
14841724|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841725|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14841726|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14841727|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205322|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841728|NCT00977301|Ritonavir|ritonavir|mesh-list
14841729|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
14841730|NCT00977301|Olanzapine|olanzapine|mesh-list
14841731|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14841732|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14841733|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
14841734|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841735|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841736|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14841737|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14841738|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
14841739|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841740|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14841741|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14841742|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
14841743|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
14841744|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841745|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841746|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841747|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14841748|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14841749|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841750|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14841751|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14841752|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14841753|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841754|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841755|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
14841756|NCT00977353|Citalopram|citalopram|mesh-list
14841757|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15205323|NCT03730064|Expectorants|expectorants|mesh-ancestor
15205324|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
15205325|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15205326|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
15205327|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205328|NCT03730064|Protective Agents|protective agents|mesh-ancestor
15205329|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205330|NCT03730064|Antidotes|antidotes|mesh-ancestor
15205331|NCT03730038|Pitavastatin|pitavastatin|mesh-list
14841758|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14841759|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205332|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14295657|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
14706090|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706091|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706092|NCT00417443|Clonidine|clonidine|mesh-list
14706093|NCT00417443|Analgesics|analgesics|mesh-ancestor
14706094|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
14706095|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706096|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706097|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14706098|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
14706099|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
14706100|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14912194|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15205333|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15205334|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15205335|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
15205336|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205337|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205338|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15205339|NCT03730012|Atezolizumab|atezolizumab|mesh-list
14295658|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14295659|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205340|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205341|NCT03729973|Lidocaine|lidocaine|mesh-list
15205342|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
15205343|NCT03729973|Ketamine|ketamine|mesh-list
15205344|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15205345|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205346|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
15205347|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205348|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205349|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
15205350|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205351|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15205352|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15205353|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15205354|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205355|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205356|NCT03729973|Analgesics|analgesics|mesh-ancestor
15205357|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15205358|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205359|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
15205360|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15205361|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15205362|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205363|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
15205364|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15205365|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15205366|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
15205367|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15224815|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15224816|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
15224817|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224818|NCT02323659|Interferons|interferons|mesh-list
15224819|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
15224820|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
15224821|NCT02323659|Methotrexate|methotrexate|mesh-list
15224822|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15224823|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
15224824|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15224825|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224826|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15224827|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
15224828|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224829|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224830|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
15224831|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224832|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15224833|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224834|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
15224835|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224836|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15224837|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
14295660|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706101|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14706102|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14706103|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706104|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706105|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706106|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14706107|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
14706108|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706109|NCT00417664|Midazolam|midazolam|mesh-list
14706110|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
15224838|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224839|NCT02318277|Durvalumab|durvalumab|mesh-list
15224840|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14841760|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841761|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841762|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
14841763|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841764|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14841765|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14841766|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14841767|NCT00977405|Gentamicins|gentamicins|mesh-list
14841768|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14841769|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841770|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14841771|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841772|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841773|NCT00977444|Prednisolone|prednisolone|mesh-list
14841774|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14841775|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
14841776|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14841777|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
14841778|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14841779|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
14841780|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14841781|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
14841782|NCT00977444|Hormones|hormones|mesh-ancestor
14841783|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841784|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841785|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14841786|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841787|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
14841788|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
14841789|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841790|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841791|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14841792|NCT00977444|Protective Agents|protective agents|mesh-ancestor
14841793|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14841794|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841795|NCT00977756|Ritonavir|ritonavir|mesh-list
15205368|NCT03729804|Dexamethasone|dexamethasone|mesh-list
15205369|NCT03729804|Lenalidomide|lenalidomide|mesh-list
15205370|NCT03729804|Bortezomib|bortezomib|mesh-list
15205371|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205372|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
15205373|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
15205374|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205375|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205376|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841796|NCT00977756|Lopinavir|lopinavir|mesh-list
14841797|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14841798|NCT00977756|Darunavir|darunavir|mesh-list
14841799|NCT00977756|Tenofovir|tenofovir|mesh-list
14841800|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
14841801|NCT00977756|Maraviroc|maraviroc|mesh-list
14841802|NCT00977756|Etravirine|etravirine|mesh-list
15205377|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
15205378|NCT03729804|Hormones|hormones|mesh-ancestor
15205379|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205380|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14841803|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14841804|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14841805|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
14841806|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841807|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841808|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14841809|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14841810|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
14841811|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841812|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14841813|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14841814|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14841815|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14841816|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14841817|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14841818|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14841819|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14841820|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14841821|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14841822|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14841823|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
14841824|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
14841825|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14841826|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841827|NCT00977873|Vitamins|vitamins|mesh-ancestor
14841828|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
14841829|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14841830|NCT00977964|Caseins|caseins|mesh-list
14841831|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
14841832|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
14841833|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841834|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14841835|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14841836|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
14841837|NCT00978107|Flucytosine|flucytosine|mesh-list
14841838|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
14841839|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841840|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
14841841|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841842|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
14841843|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841844|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
14841845|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841846|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841847|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14841848|NCT00978159|Esomeprazole|esomeprazole|mesh-list
14841849|NCT00978159|Famotidine|famotidine|mesh-list
14841850|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14841851|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841852|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14841853|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841854|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912195|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
14841855|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14841856|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
14841857|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
14841858|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841859|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841860|NCT00978172|Artesunate|artesunate|mesh-list
14841861|NCT00978172|Mefloquine|mefloquine|mesh-list
14841862|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
14841863|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14841864|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14841865|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841866|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841867|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
14841868|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
14841869|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14841870|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
14841871|NCT00978211|Octreotide|octreotide|mesh-list
14841872|NCT00978211|Somatostatin|somatostatin|mesh-list
14841873|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14841874|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14841875|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841876|NCT00978211|Hormones|hormones|mesh-ancestor
14841877|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841878|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841879|NCT00978263|Metformin|metformin|mesh-list
14841880|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14841881|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841882|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
14841883|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14841884|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841885|NCT00978315|Vitamins|vitamins|mesh-ancestor
14841886|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
14841887|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14841888|NCT00978328|Oxycodone|oxycodone|mesh-list
14841889|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15205381|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205382|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
15205383|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15205384|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15205385|NCT03729804|Growth Substances|growth substances|mesh-ancestor
14841890|NCT00978328|Narcotics|narcotics|mesh-ancestor
14841891|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841892|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841893|NCT00978328|Analgesics|analgesics|mesh-ancestor
14841894|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
14841895|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841896|NCT00978354|Furosemide|furosemide|mesh-list
14841897|NCT00978354|Diuretics|diuretics|mesh-ancestor
14841898|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
14841899|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841900|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14841901|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841902|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841903|NCT00978393|Liraglutide|liraglutide|mesh-list
14841904|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841905|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841906|NCT00978393|Incretins|incretins|mesh-ancestor
14841907|NCT00978393|Hormones|hormones|mesh-ancestor
14841908|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841909|NCT00978471|Thiotepa|thiotepa|mesh-list
14841910|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14841911|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
14841912|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841913|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841914|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14841915|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841916|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
14841917|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841918|NCT00978549|Docetaxel|docetaxel|mesh-list
14841919|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841920|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
15205386|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
15205387|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14841921|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
14841922|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14841923|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841924|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14841925|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
14841926|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
14841927|NCT00978601|Analgesics|analgesics|mesh-list
14841928|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
14841929|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841930|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841931|NCT00978653|Allopurinol|allopurinol|mesh-list
14841932|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
14841933|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841934|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841935|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
14841936|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14841937|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14841938|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
14841939|NCT00978653|Protective Agents|protective agents|mesh-ancestor
14841940|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841941|NCT00978718|Selenium|selenium|mesh-list
14841942|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
14841943|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841944|NCT00978718|Protective Agents|protective agents|mesh-ancestor
14841945|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841946|NCT00978718|Trace Elements|trace elements|mesh-ancestor
14841947|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
14841948|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14841949|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14841950|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841951|NCT00978796|Incretins|incretins|mesh-ancestor
14841952|NCT00978796|Hormones|hormones|mesh-ancestor
14841953|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14841954|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14841955|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
14841956|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14841957|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841958|NCT00978822|Clevidipine|clevidipine|mesh-list
14841959|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14841960|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14841961|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841962|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14841963|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841964|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14841965|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14841966|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14841967|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
14841968|NCT00978913|Vaccines|vaccines|mesh-list
14841969|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
14841970|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841971|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14841972|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14841973|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14841974|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
14841975|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14841976|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14841977|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14912196|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14912197|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14912198|NCT01367964|Hormones|hormones|mesh-list
14912199|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14912200|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14912201|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
14912202|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912203|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912204|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912205|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912206|NCT01367990|Norepinephrine|norepinephrine|mesh-list
14912207|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14912208|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14841978|NCT00978978|Fentanyl|fentanyl|mesh-list
14841979|NCT00978978|Midazolam|midazolam|mesh-list
14841980|NCT00978978|Propofol|propofol|mesh-list
14841981|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14841982|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14841983|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14841984|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14841985|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
14841986|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
14841987|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14841988|NCT00978978|Narcotics|narcotics|mesh-ancestor
14841989|NCT00978978|Analgesics|analgesics|mesh-ancestor
14841990|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
14841991|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14841992|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14841993|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14841994|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14841995|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14841996|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
14841997|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
14841998|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14841999|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842000|NCT00979056|Rifaximin|rifaximin|mesh-list
14842001|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842002|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842003|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14842004|NCT00979160|Dasatinib|dasatinib|mesh-list
14842005|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842006|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842007|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842008|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842009|NCT00979186|Hemostatics|hemostatics|mesh-list
14842010|NCT00979186|Coagulants|coagulants|mesh-ancestor
14842011|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
14842012|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842013|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842014|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14842015|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14706111|NCT00417664|Propofol|propofol|mesh-list
14706112|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14706113|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14706114|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706115|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14706116|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
14706117|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
14706118|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706119|NCT00417664|Analgesics|analgesics|mesh-ancestor
14706120|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
14706121|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706122|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14842016|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842017|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842018|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842019|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
14842020|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14842021|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14842022|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
14842023|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842024|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842025|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842026|NCT00979472|Urological Agents|urological agents|mesh-ancestor
14842027|NCT00979537|Nisoldipine|nisoldipine|mesh-list
14842028|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842029|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14842030|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14842031|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842032|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14842033|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842034|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
14842035|NCT00979563|Irinotecan|irinotecan|mesh-list
14842036|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14842037|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14842038|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842039|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912209|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706123|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14842040|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842041|NCT00979589|Aspirin|aspirin|mesh-list
14842042|NCT00979589|Clopidogrel|clopidogrel|mesh-list
14842043|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14842044|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14842045|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14842046|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14842047|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
14842048|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842049|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842050|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842051|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14842052|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14842053|NCT00979589|Analgesics|analgesics|mesh-ancestor
14842054|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
14842055|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842056|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842057|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842058|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14842059|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14842060|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14842061|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842062|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
14842063|NCT00979641|Docetaxel|docetaxel|mesh-list
14842064|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842065|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842066|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842067|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842068|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842069|NCT00979667|Oseltamivir|oseltamivir|mesh-list
14842070|NCT00979667|Zanamivir|zanamivir|mesh-list
14842071|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
14842072|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842073|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842074|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842075|NCT00979693|Psilocybin|psilocybin|mesh-list
14842076|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
14842077|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842078|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14842079|NCT00979706|Cyclosporine|cyclosporine|mesh-list
14842080|NCT00979706|Interleukin-2|interleukin-2|mesh-list
14842081|NCT00979706|Cyclosporins|cyclosporins|mesh-list
14842082|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842083|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842084|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842085|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
14842086|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842087|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
14842088|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842089|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
14842090|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842091|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14842092|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842093|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14842094|NCT00979706|Analgesics|analgesics|mesh-ancestor
14842095|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
14842096|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842097|NCT00979758|Atorvastatin|atorvastatin|mesh-list
14842098|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14842099|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14842100|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
14842101|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842102|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14842103|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14842104|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842105|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
14842106|NCT00979836|Calcium|calcium|mesh-list
14842107|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14842108|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842109|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
14842110|NCT00979836|Coagulants|coagulants|mesh-ancestor
14842111|NCT00979862|Cediranib|cediranib|mesh-list
14842112|NCT00979862|Maleic acid|maleic acid|mesh-list
14842113|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842114|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842115|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842116|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842117|NCT00979966|Sirolimus|sirolimus|mesh-list
14842118|NCT00979966|Sunitinib|sunitinib|mesh-list
14842119|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842120|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14842121|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14842122|NCT00979966|Growth Substances|growth substances|mesh-ancestor
14842123|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842124|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
14842125|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842126|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842127|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842128|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842129|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842130|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14842131|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
14842132|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842133|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
14842134|NCT00980031|Eplerenone|eplerenone|mesh-list
14842135|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15205388|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
15205389|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842136|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
14842137|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842138|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842139|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14842140|NCT00980031|Diuretics|diuretics|mesh-ancestor
14842141|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
14842142|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842143|NCT00980109|Oseltamivir|oseltamivir|mesh-list
14842144|NCT00980109|Zanamivir|zanamivir|mesh-list
14842145|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
14842146|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842147|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842148|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842149|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
14842150|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842151|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14842152|NCT00980187|Indapamide|indapamide|mesh-list
14842153|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842154|NCT00980187|Diuretics|diuretics|mesh-ancestor
14842155|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
14842156|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842157|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14842158|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14842159|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842160|NCT00980213|Sunitinib|sunitinib|mesh-list
14842161|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842162|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14842163|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14842164|NCT00980213|Growth Substances|growth substances|mesh-ancestor
14842165|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842166|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
14842167|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842168|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842169|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842170|NCT00980239|Bevacizumab|bevacizumab|mesh-list
14842171|NCT00980239|Cetuximab|cetuximab|mesh-list
14842172|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
14842173|NCT00980239|Irinotecan|irinotecan|mesh-list
14842174|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842175|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842176|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14842177|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14842178|NCT00980239|Growth Substances|growth substances|mesh-ancestor
14842179|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842180|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
14842181|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14842182|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14842183|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842184|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842185|NCT00980304|Rituximab|rituximab|mesh-list
14842186|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842187|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842188|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
14842189|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842190|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842191|NCT00980356|Vildagliptin|vildagliptin|mesh-list
14842192|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14842193|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842194|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14842195|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
14842196|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842197|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842198|NCT00980382|Docetaxel|docetaxel|mesh-list
14842199|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842200|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842201|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842202|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842203|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842204|NCT00980408|Cycloserine|cycloserine|mesh-list
14842205|NCT00980408|Memantine|memantine|mesh-list
14842206|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14842207|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14842208|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
14842209|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842210|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842211|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842212|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14842213|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14842214|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14842215|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842216|NCT00980408|Renal Agents|renal agents|mesh-ancestor
14842217|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14842218|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
14842219|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842220|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
14842221|NCT00980473|Timolol|timolol|mesh-list
14842222|NCT00980473|Travoprost|travoprost|mesh-list
14842223|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14842224|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14842225|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14842226|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842227|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842228|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842229|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14842230|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842231|NCT00980551|Carboplatin|carboplatin|mesh-list
14842232|NCT00980551|Vincristine|vincristine|mesh-list
14842233|NCT00980551|Topotecan|topotecan|mesh-list
14842234|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842235|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14842236|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842237|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842238|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842239|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842240|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14842241|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14842242|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842243|NCT00980603|Docetaxel|docetaxel|mesh-list
14842244|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842245|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842246|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842247|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842248|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842249|NCT00980616|Ropivacaine|ropivacaine|mesh-list
14842250|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
14842251|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
14842252|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842253|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842254|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
14842255|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842256|NCT00980707|Fluticasone|fluticasone|mesh-list
14842257|NCT00980707|Xhance|xhance|mesh-list
14842258|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842259|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14842260|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
14842261|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842262|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842263|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14842264|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
14842265|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14842266|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14842267|NCT00980850|Vaccines|vaccines|mesh-list
14842268|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
14842269|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842270|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
14842271|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
14842272|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842273|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842274|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842275|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14842276|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14842277|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842278|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842279|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842280|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14842281|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14842282|NCT00981006|Mitogens|mitogens|mesh-list
14842283|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842284|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912210|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912211|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912212|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912213|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
14912214|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
14912215|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842285|NCT00981162|Everolimus|everolimus|mesh-list
14842286|NCT00981162|Sorafenib|sorafenib|mesh-list
14842287|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842288|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842289|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
14842290|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842291|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842292|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842293|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842294|NCT00981201|Celecoxib|celecoxib|mesh-list
14842295|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14842296|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14842297|NCT00981201|Analgesics|analgesics|mesh-ancestor
14842298|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
14842299|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842300|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842301|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842302|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842303|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14842304|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14842305|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842306|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842307|NCT00981318|Ritonavir|ritonavir|mesh-list
14842308|NCT00981318|Lopinavir|lopinavir|mesh-list
14842309|NCT00981318|Maraviroc|maraviroc|mesh-list
14842310|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14842311|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14842312|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
14842313|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842314|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842315|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14842316|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14842317|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
14842318|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842319|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14842320|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14842321|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14842322|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14842323|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14842324|NCT00981487|Ondansetron|ondansetron|mesh-list
14842325|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
14842326|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
14842327|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842328|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842329|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14842330|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
14842331|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
14842332|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14842333|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
14842334|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842335|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842336|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14842337|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14842338|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842339|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14842340|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14842341|NCT00981513|Vaccines|vaccines|mesh-list
14842342|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
14842343|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842344|NCT00981591|Iloprost|iloprost|mesh-list
14917228|NCT01397006|Analgesics|analgesics|mesh-ancestor
15205390|NCT03729687|Capecitabine|capecitabine|mesh-list
15205391|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
15205392|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15205393|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
15205394|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205395|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205396|NCT03729674|Infliximab|infliximab|mesh-list
15205397|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
14842345|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14842346|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
14842347|NCT00981708|Dexamethasone|dexamethasone|mesh-list
14842348|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
14842349|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
14842350|NCT00981708|Lenalidomide|lenalidomide|mesh-list
14842351|NCT00981708|BB 1101|bb 1101|mesh-list
14842352|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842353|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
14842354|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842355|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842356|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14842357|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
14842358|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842359|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842360|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14842361|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842362|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
14842363|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
14842364|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842365|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14842366|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
14842367|NCT00981708|Hormones|hormones|mesh-ancestor
14842368|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842369|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14842370|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
14842371|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842372|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14842373|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14842374|NCT00981708|Growth Substances|growth substances|mesh-ancestor
14842375|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
14842376|NCT00981721|Cediranib|cediranib|mesh-list
14842377|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842378|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842379|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842380|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842381|NCT00981773|Maraviroc|maraviroc|mesh-list
14842382|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14842383|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14842384|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842385|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14842386|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14842387|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
14842388|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842389|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14842390|NCT00981786|Timolol|timolol|mesh-list
14842391|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14842392|NCT00981786|Travoprost|travoprost|mesh-list
14842393|NCT00981786|Brinzolamide|brinzolamide|mesh-list
14842394|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14842395|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14842396|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14842397|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842398|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842399|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842400|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14842401|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842402|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14842403|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14842404|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14842405|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14842406|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842407|NCT00981838|Rituximab|rituximab|mesh-list
14842408|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842409|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842410|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
14842411|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842412|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842413|NCT00981851|Albuterol|albuterol|mesh-list
14842414|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
14842415|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14842416|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
14842417|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842418|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842419|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14842420|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
14842421|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
14842422|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14842423|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
14842424|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842425|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842426|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
14842427|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14842428|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14842429|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14842430|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14842431|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
14842432|NCT00981890|Sunitinib|sunitinib|mesh-list
14842433|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842434|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14842435|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14842436|NCT00981890|Growth Substances|growth substances|mesh-ancestor
14842437|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842438|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
14842439|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842440|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842441|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842442|NCT00981903|Tinzaparin|tinzaparin|mesh-list
14842443|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14842444|NCT00981903|Dalteparin|dalteparin|mesh-list
14842445|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
14842446|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14842447|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14842448|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842449|NCT00981929|Losartan|losartan|mesh-list
14842450|NCT00981929|Tramadol|tramadol|mesh-list
14842451|NCT00981929|Caffeine|caffeine|mesh-list
14842452|NCT00981929|Omeprazole|omeprazole|mesh-list
14842453|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14842454|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842455|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14842456|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14842457|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842458|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14842459|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14842460|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14842461|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842462|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14842463|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842464|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14842465|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14842466|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14842467|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
14842468|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842469|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14842470|NCT00981929|Narcotics|narcotics|mesh-ancestor
14842471|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842472|NCT00981929|Analgesics|analgesics|mesh-ancestor
14842473|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
14842474|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706124|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14706125|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706126|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706127|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706128|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14706129|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14706130|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14706131|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706132|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
14706133|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
14706134|NCT00417677|Sirolimus|sirolimus|mesh-list
14706135|NCT00417677|Sunitinib|sunitinib|mesh-list
14706136|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706137|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14842475|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
14842476|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842477|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842478|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842479|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706138|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14842480|NCT00981955|Caffeine|caffeine|mesh-list
14842481|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14842482|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842483|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14842484|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842485|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842486|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14842487|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14842488|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
14842489|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842490|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
14842491|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14842492|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842493|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14842494|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
14842495|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14842496|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842497|NCT00982202|Pioglitazone|pioglitazone|mesh-list
14842498|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14842499|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842500|NCT00982215|Acetaminophen|acetaminophen|mesh-list
14842501|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14842502|NCT00982215|Analgesics|analgesics|mesh-ancestor
14842503|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
14842504|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842505|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842506|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
14842507|NCT00982254|Insulin|insulin|mesh-list
14842508|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14842509|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14842510|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842511|NCT00982332|Betamethasone|betamethasone|mesh-list
14842512|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
14842513|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842514|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
14842515|NCT00982332|Hormones|hormones|mesh-ancestor
14842516|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842517|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842518|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14842519|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
14842520|NCT00982358|Valsartan|valsartan|mesh-list
14842521|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842522|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14842523|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14842524|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842525|NCT00982436|Carboplatin|carboplatin|mesh-list
14842526|NCT00982436|Docetaxel|docetaxel|mesh-list
14842527|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842528|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842529|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842530|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205398|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15205399|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15205400|NCT03729505|Lidocaine|lidocaine|mesh-list
14842531|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842532|NCT00982449|Fialuridine|fialuridine|mesh-list
14842533|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
14842534|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205401|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
15205402|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205403|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
15205404|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205405|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205406|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
15205407|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205408|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15205409|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15205410|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15205411|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205412|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205413|NCT03729505|Analgesics|analgesics|mesh-ancestor
15205414|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
15205415|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14842535|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14842536|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842537|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842538|NCT00982527|Fenoldopam|fenoldopam|mesh-list
14842539|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842540|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
14842541|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
14842542|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
14842543|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842544|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842545|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842546|NCT00982540|Caspofungin|caspofungin|mesh-list
14842547|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
14842548|NCT00982540|Clotrimazole|clotrimazole|mesh-list
14842549|NCT00982540|Miconazole|miconazole|mesh-list
14842550|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842551|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842552|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842553|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14842554|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14842555|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14842556|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14842557|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
14842558|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842559|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842560|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14842561|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14842562|NCT00982566|Navitoclax|navitoclax|mesh-list
14842563|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842564|NCT00982618|Lidocaine|lidocaine|mesh-list
14842565|NCT00982618|Morphine|morphine|mesh-list
14842566|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
14842567|NCT00982618|Anesthetics|anesthetics|mesh-list
14842568|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842569|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842570|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
14842571|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842572|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14842573|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14842574|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14842575|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14842576|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842577|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14842578|NCT00982618|Narcotics|narcotics|mesh-ancestor
14842579|NCT00982618|Analgesics|analgesics|mesh-ancestor
14842580|NCT00982631|Sirolimus|sirolimus|mesh-list
14842581|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842582|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842583|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14842584|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842585|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
14842586|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842587|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
14842588|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842589|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
14842590|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
14842591|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
14842592|NCT00982722|Calcium|calcium|mesh-list
14842593|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14842594|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842595|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14842596|NCT00982722|Vitamins|vitamins|mesh-ancestor
14842597|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
14842598|NCT00982722|Antacids|antacids|mesh-ancestor
14842599|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842600|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14842601|NCT00982800|Gabapentin|gabapentin|mesh-list
14842602|NCT00982800|Analgesics|analgesics|mesh-ancestor
14842603|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
14842604|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842605|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842606|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
14842607|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14842608|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14842609|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842610|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14842611|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14842612|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14842613|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842614|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842615|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
14842616|NCT00982891|Morphine|morphine|mesh-list
14842617|NCT00982891|Hydromorphone|hydromorphone|mesh-list
14842618|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14842619|NCT00982891|Narcotics|narcotics|mesh-ancestor
14842620|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842621|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842622|NCT00982891|Analgesics|analgesics|mesh-ancestor
14706139|NCT00417677|Growth Substances|growth substances|mesh-ancestor
14706140|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706141|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
14706142|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14706143|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706144|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706145|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842623|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
14842624|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842625|NCT00983021|Insulin|insulin|mesh-list
14842626|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14842627|NCT00983021|Liraglutide|liraglutide|mesh-list
14842628|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
14842629|NCT00983021|Xultophy|xultophy|mesh-list
14842630|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14842631|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842632|NCT00983021|Incretins|incretins|mesh-ancestor
14842633|NCT00983021|Hormones|hormones|mesh-ancestor
14842634|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842635|NCT00983034|Amoxicillin|amoxicillin|mesh-list
14842636|NCT00983034|Clarithromycin|clarithromycin|mesh-list
14842637|NCT00983034|Lansoprazole|lansoprazole|mesh-list
14842638|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
14842639|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842640|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842641|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14842642|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842643|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842644|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14842645|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14842646|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14842647|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14842648|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14842649|NCT00983047|Docetaxel|docetaxel|mesh-list
14842650|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
14842651|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842652|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842653|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
14706146|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706147|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14706148|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
14706149|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706150|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
14706151|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14706152|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
14706153|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706154|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706155|NCT00417716|Bevacizumab|bevacizumab|mesh-list
14842654|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842655|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842656|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842657|NCT00983112|Thrombin|thrombin|mesh-list
14842658|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
14842659|NCT00983112|Coagulants|coagulants|mesh-ancestor
14842660|NCT00983125|Clonidine|clonidine|mesh-list
14842661|NCT00983125|Analgesics|analgesics|mesh-ancestor
14842662|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
14842663|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842664|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842665|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14842666|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
14842667|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
14842668|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14842669|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14842670|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14842671|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14842672|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842673|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912216|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14912217|NCT01368003|Dutasteride|dutasteride|mesh-list
14912218|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14912219|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14912220|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912221|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912222|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
14912223|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912224|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912225|NCT01368016|Nicotine|nicotine|mesh-list
14912226|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14912227|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
14912228|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912229|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912230|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14912231|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14912232|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
14912233|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912234|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205416|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15205417|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
15205418|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15205419|NCT03729375|Bupivacaine|bupivacaine|mesh-list
15205420|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205421|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
14912235|NCT01368068|Tibolone|tibolone|mesh-list
14912236|NCT01368068|Citalopram|citalopram|mesh-list
14912237|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14912238|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14912239|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912240|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912241|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912242|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
14912243|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912244|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912245|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912246|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912247|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
14912248|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
14912249|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912250|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14912251|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14912252|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912253|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14912254|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
14912255|NCT01368068|Hormones|hormones|mesh-ancestor
14912256|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14912257|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
14912258|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14912259|NCT01368328|Chromium|chromium|mesh-list
14912260|NCT01368328|Niacin|niacin|mesh-list
14912261|NCT01368328|Trace Elements|trace elements|mesh-ancestor
14912262|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
14912263|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912264|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14912265|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
15205422|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205423|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205424|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
15205425|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205426|NCT03729310|Triamcinolone|triamcinolone|mesh-list
15205427|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205428|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
14842674|NCT00983138|Asparaginase|asparaginase|mesh-list
14842675|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842676|NCT00983151|Tramadol|tramadol|mesh-list
14842677|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14842678|NCT00983151|Narcotics|narcotics|mesh-ancestor
14842679|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842680|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842681|NCT00983151|Analgesics|analgesics|mesh-ancestor
14842682|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
14842683|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842684|NCT00983164|Antioxidants|antioxidants|mesh-list
14842685|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842686|NCT00983164|Protective Agents|protective agents|mesh-ancestor
14842687|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842688|NCT00983177|Colchicine|colchicine|mesh-list
14842689|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
14842690|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842691|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842692|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842693|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842694|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842695|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842696|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14842697|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
14842698|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15205429|NCT03729310|Hormones|hormones|mesh-ancestor
15205430|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205431|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205432|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15205433|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15205434|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14706156|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14706157|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706158|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14706159|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14706160|NCT00417716|Growth Substances|growth substances|mesh-ancestor
14706161|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706162|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
14706163|NCT00417729|Acarbose|acarbose|mesh-list
14706164|NCT00417729|Glyburide|glyburide|mesh-list
14706165|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14706166|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706167|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706168|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706169|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706170|NCT00417768|Plasminogen|plasminogen|mesh-list
14706171|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14706172|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14706173|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14706174|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706175|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14706176|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14842699|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
14842700|NCT00983255|Tedizolid|tedizolid|mesh-list
14842701|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
14842702|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842703|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842704|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14842705|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842706|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842707|NCT00983268|Capecitabine|capecitabine|mesh-list
14842708|NCT00983268|Vorinostat|vorinostat|mesh-list
14842709|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14842710|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
14842711|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842712|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842713|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14842714|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842715|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14842716|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
14842717|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14842718|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14842719|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14842720|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842721|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842722|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
14842723|NCT00983398|Carboplatin|carboplatin|mesh-list
14842724|NCT00983398|Melphalan|melphalan|mesh-list
14842725|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
14842726|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14842727|NCT00983398|Mannitol|mannitol|mesh-list
14842728|NCT00983398|Antidotes|antidotes|mesh-list
14842729|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842730|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14842731|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
14842732|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842733|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14842734|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842735|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
14842736|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842737|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14842738|NCT00983398|Diuretics|diuretics|mesh-ancestor
14842739|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
14842740|NCT00983398|Protective Agents|protective agents|mesh-ancestor
14842741|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
14842742|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
14842743|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14842744|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842745|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
14842746|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
14842747|NCT00983424|Cyclosporine|cyclosporine|mesh-list
14842748|NCT00983424|Paclitaxel|paclitaxel|mesh-list
14842749|NCT00983424|Cyclosporins|cyclosporins|mesh-list
14842750|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14842751|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842752|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842753|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842754|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842755|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842756|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842757|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842758|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
14842759|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842760|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
14842761|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842762|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
14842763|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842764|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14842765|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14842766|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14842767|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
14842768|NCT00983450|Hormones|hormones|mesh-ancestor
14842769|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205435|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205436|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205437|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205438|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205439|NCT03729284|Analgesics|analgesics|mesh-ancestor
15205440|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
14842770|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842771|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842772|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842773|NCT00983554|Anastrozole|anastrozole|mesh-list
14842774|NCT00983554|Testosterone|testosterone|mesh-list
14842775|NCT00983554|Dutasteride|dutasteride|mesh-list
14842776|NCT00983554|Androgens|androgens|mesh-ancestor
14842777|NCT00983554|Hormones|hormones|mesh-ancestor
14842778|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842779|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842780|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14842781|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842782|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14842783|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14842784|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842785|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295661|NCT00582660|Celecoxib|celecoxib|mesh-list
14842786|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
14842787|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14842788|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14842789|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14842790|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14842791|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842792|NCT00983736|Tramadol|tramadol|mesh-list
14842793|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14842794|NCT00983736|Narcotics|narcotics|mesh-ancestor
14842795|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842796|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842797|NCT00983736|Analgesics|analgesics|mesh-ancestor
14842798|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
14842799|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842800|NCT00983788|Bezafibrate|bezafibrate|mesh-list
14842801|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14842802|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
14842803|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842804|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14842805|NCT00983944|Prednisone|prednisone|mesh-list
14842806|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
14842807|NCT00983944|Rituximab|rituximab|mesh-list
14842808|NCT00983944|Doxorubicin|doxorubicin|mesh-list
14842809|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15205441|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205442|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
15205443|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15205444|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
15205445|NCT03729128|Memantine|memantine|mesh-list
15205446|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
15205447|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14842810|NCT00983944|Etoposide|etoposide|mesh-list
14842811|NCT00983944|Vincristine|vincristine|mesh-list
14842812|NCT00983944|Bleomycin|bleomycin|mesh-list
14842813|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14842814|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
14842815|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842816|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14842817|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14842818|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
14842819|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842820|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842821|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14842822|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842823|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14842824|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14842825|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14842826|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842827|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14842828|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
14842829|NCT00983944|Hormones|hormones|mesh-ancestor
15205448|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15205449|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
15205450|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205451|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205452|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205453|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14842830|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842831|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14842832|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14842833|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842834|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842835|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842836|NCT00983996|Alendronate|alendronate|mesh-list
14842837|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14842838|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842839|NCT00984152|Efavirenz|efavirenz|mesh-list
14842840|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14842841|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
14842842|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14842843|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14842844|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842845|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842846|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
14842847|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842848|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14842849|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14842850|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14842851|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14842852|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14842853|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14842854|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14842855|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14842856|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14706177|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14706178|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14706179|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706180|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706181|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706182|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706183|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
14706184|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706185|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14706186|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706187|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706188|NCT00417833|Bevacizumab|bevacizumab|mesh-list
14706189|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842857|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14842858|NCT00984178|Sargramostim|sargramostim|mesh-list
14842859|NCT00984178|Immunologic Factors|immunologic factors|mesh-ancestor
14842860|NCT00984178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842861|NCT00984217|Panitumumab|panitumumab|mesh-list
14842862|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842863|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842864|NCT00984230|Lactoferrin|lactoferrin|mesh-list
14842865|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14842866|NCT00984347|Oxytocin|oxytocin|mesh-list
14842867|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
14842868|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14842869|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842870|NCT00984360|Naltrexone|naltrexone|mesh-list
14842871|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14842872|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14842873|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842874|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
14842875|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842876|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14842877|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14842878|NCT00984386|Estradiol|estradiol|mesh-list
14842879|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14842880|NCT00984386|Estrogens|estrogens|mesh-ancestor
15205454|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15205455|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
15205456|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
15205457|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
15205458|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
15205459|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205460|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
15205461|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842881|NCT00984386|Hormones|hormones|mesh-ancestor
14842882|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842883|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842884|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14842885|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
14842886|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14842887|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14842888|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14842889|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14842890|NCT00984399|Estradiol|estradiol|mesh-list
14842891|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14842892|NCT00984399|Estrogens|estrogens|mesh-ancestor
14842893|NCT00984399|Hormones|hormones|mesh-ancestor
14842894|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842895|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842896|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14842897|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
14842898|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14842899|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14842900|NCT00984425|Sorafenib|sorafenib|mesh-list
14842901|NCT00984425|Lapatinib|lapatinib|mesh-list
14842902|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842903|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14842904|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842905|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842906|NCT00984438|Bevacizumab|bevacizumab|mesh-list
14842907|NCT00984438|Irinotecan|irinotecan|mesh-list
14842908|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14842909|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842910|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14842911|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14842912|NCT00984438|Growth Substances|growth substances|mesh-ancestor
14842913|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842914|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
14842915|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14842916|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14842917|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842918|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842919|NCT00984451|Vaccines|vaccines|mesh-list
14842920|NCT00984451|Immunologic Factors|immunologic factors|mesh-ancestor
14842921|NCT00984451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842922|NCT00984464|Paclitaxel|paclitaxel|mesh-list
14842923|NCT00984464|Carboplatin|carboplatin|mesh-list
14842924|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14842925|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14842926|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
14842927|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
14842928|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
14842929|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842930|NCT00984633|Bromides|bromides|mesh-list
14842931|NCT00984633|Propofol|propofol|mesh-list
14842932|NCT00984633|Sevoflurane|sevoflurane|mesh-list
14842933|NCT00984633|Rocuronium|rocuronium|mesh-list
14842934|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14842935|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14842936|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842937|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14842938|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
14842939|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
14842940|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14842941|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14842942|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
14842943|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14842944|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15205462|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205463|NCT03729011|Propofol|propofol|mesh-list
15205464|NCT03729011|Sevoflurane|sevoflurane|mesh-list
15205465|NCT03729011|Desflurane|desflurane|mesh-list
15205466|NCT03729011|Isoflurane|isoflurane|mesh-list
15205467|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15205468|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205469|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205470|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205471|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
15205472|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
15205473|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14842945|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14842946|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842947|NCT00984724|Nicotine|nicotine|mesh-list
14842948|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14842949|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
14842950|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14842951|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842952|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14842953|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14842954|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
14842955|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14842956|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842957|NCT00984737|Insulin|insulin|mesh-list
14842958|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14842959|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842960|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
14842961|NCT00984750|Simvastatin|simvastatin|mesh-list
14842962|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14842963|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14842964|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
14842965|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842966|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14842967|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14842968|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14842969|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
14842970|NCT00984750|Vitamins|vitamins|mesh-ancestor
14842971|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
14842972|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842973|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
14842974|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14842975|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14842976|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
14842977|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842978|NCT00984763|Antacids|antacids|mesh-ancestor
14842979|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14842980|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14842981|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14842982|NCT00984789|Gestodene|gestodene|mesh-list
14842983|NCT00984789|Norelgestromin|norelgestromin|mesh-list
14842984|NCT00984789|Femovan|femovan|mesh-list
14842985|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14842986|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14842987|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14842988|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
14842989|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14842990|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14842991|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14842992|NCT00984789|Estrogens|estrogens|mesh-ancestor
14842993|NCT00984789|Hormones|hormones|mesh-ancestor
14842994|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14842995|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14842996|NCT00984789|Progestins|progestins|mesh-ancestor
14842997|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14842998|NCT00984828|Bortezomib|bortezomib|mesh-list
14842999|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843000|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
14843001|NCT00984893|Diphosphonates|diphosphonates|mesh-list
14843002|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14843003|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843004|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14843005|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14843006|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14843007|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
14843008|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843009|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15205474|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15205475|NCT03728946|Bupivacaine|bupivacaine|mesh-list
15205476|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205477|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
15205478|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205479|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205480|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
15205481|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205482|NCT03728933|Rotigotine|rotigotine|mesh-list
14843010|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15205483|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
14843011|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843012|NCT00984945|Vaccines|vaccines|mesh-list
14843013|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
14843014|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843015|NCT00984971|Tenofovir|tenofovir|mesh-list
14843016|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
14843017|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843018|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14843019|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14843020|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843021|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843022|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14843023|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14843024|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
14843025|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14843026|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14843027|NCT00984984|Prednisolone|prednisolone|mesh-list
14843028|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
14843029|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14843030|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
14843031|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843032|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
14843033|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
14843034|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843035|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843036|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843037|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
14843038|NCT00984984|Hormones|hormones|mesh-ancestor
14843039|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14843040|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14843041|NCT00984984|Protective Agents|protective agents|mesh-ancestor
14843042|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14843043|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843044|NCT00984997|Etoposide|etoposide|mesh-list
14843045|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843046|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14843047|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14843048|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14843049|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843050|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912266|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912267|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14912268|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
14912269|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
14912270|NCT01368328|Vitamins|vitamins|mesh-ancestor
14912271|NCT01368341|Amoxicillin|amoxicillin|mesh-list
14912272|NCT01368341|Doxycycline|doxycycline|mesh-list
14912273|NCT01368341|Penicillin V|penicillin v|mesh-list
14912274|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14912275|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912276|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
14912277|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14912278|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14912279|NCT01368419|Endostar protein|endostar protein|mesh-list
14912280|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14912281|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912282|NCT01368419|Growth Substances|growth substances|mesh-ancestor
14912283|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912284|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912285|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912286|NCT01368445|Azelastine|azelastine|mesh-list
14912287|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14912288|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
14912289|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912290|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912291|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14912292|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
14912293|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14912294|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912295|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912296|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14912297|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14912298|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14912299|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
15205484|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
15205485|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295662|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295663|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295664|NCT00582660|Analgesics|analgesics|mesh-ancestor
14295665|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
14295666|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295667|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843051|NCT00985244|Azithromycin|azithromycin|mesh-list
14843052|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843053|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843054|NCT00985270|Rifampin|rifampin|mesh-list
14843055|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14843056|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
14843057|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843058|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843059|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
14843060|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14843061|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843062|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843063|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14843064|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14843065|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14843066|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14843067|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14843068|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14843069|NCT00985322|Ramipril|ramipril|mesh-list
14843070|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
14843071|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14843072|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
14295668|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295669|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295670|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14295671|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14295672|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295673|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295674|NCT00582738|Everolimus|everolimus|mesh-list
14295675|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843073|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843074|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843075|NCT00985348|Levetiracetam|levetiracetam|mesh-list
14843076|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
14843077|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
14843078|NCT00985361|Vitamin D|vitamin d|mesh-list
14843079|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
14843080|NCT00985361|Vitamins|vitamins|mesh-list
14843081|NCT00985361|Ascorbic Acid|ascorbic acid|mesh-list
14843082|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
14843083|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843084|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14843085|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14843086|NCT00985361|Antioxidants|antioxidants|mesh-ancestor
14843087|NCT00985361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843088|NCT00985361|Protective Agents|protective agents|mesh-ancestor
14843089|NCT00985374|Everolimus|everolimus|mesh-list
14843090|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843091|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843092|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
14843093|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843094|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
14843095|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14843096|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14843097|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
14843098|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843099|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843100|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843101|NCT00985387|Urological Agents|urological agents|mesh-ancestor
14843102|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
14843103|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843104|NCT00985556|Capecitabine|capecitabine|mesh-list
14843105|NCT00985556|Tegafur|tegafur|mesh-list
14843106|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
14843107|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14843108|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
14843109|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843110|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843111|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14843112|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14295676|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843113|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843114|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
14843115|NCT00985647|Lamivudine|lamivudine|mesh-list
14843116|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14843117|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14843118|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843119|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843120|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
14843121|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843122|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14843123|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14843124|NCT00985660|Nisoldipine|nisoldipine|mesh-list
14843125|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14843126|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14843127|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843128|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843129|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14843130|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843131|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
14843132|NCT00985777|Vitamin E|vitamin e|mesh-list
14843133|NCT00985777|Tocopherols|tocopherols|mesh-list
14843134|NCT00985777|Tocotrienols|tocotrienols|mesh-list
14843135|NCT00985777|Vitamins|vitamins|mesh-ancestor
14843136|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
14843137|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843138|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
14843139|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843140|NCT00985777|Protective Agents|protective agents|mesh-ancestor
14843141|NCT00985855|Etoposide|etoposide|mesh-list
14843142|NCT00985855|Cetuximab|cetuximab|mesh-list
14843143|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843144|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14843145|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14843146|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14843147|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843148|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843149|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14843150|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
14843151|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14843152|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14843153|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843154|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
14843155|NCT00985920|Coagulants|coagulants|mesh-ancestor
14843156|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
14843157|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14843158|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843159|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14843160|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
14843161|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843162|NCT00986050|Sirolimus|sirolimus|mesh-list
14843163|NCT00986050|Abciximab|abciximab|mesh-list
14843164|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843165|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843166|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14843167|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843168|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
14843169|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843170|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
14843171|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843172|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
14843173|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14843174|NCT00986076|Enoxaparin|enoxaparin|mesh-list
14843175|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
14843176|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14843177|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14843178|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843179|NCT00986115|Memantine|memantine|mesh-list
14843180|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14843181|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14843182|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
14843183|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843184|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843185|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843186|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14843187|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14843188|NCT00986128|Topiramate|topiramate|mesh-list
14843189|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
14843190|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14843191|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843192|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14843193|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
14843194|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14843195|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14843196|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14843197|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843198|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843199|NCT00986284|Gefitinib|gefitinib|mesh-list
14843200|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843201|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14843202|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843203|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843204|NCT00986336|Topiramate|topiramate|mesh-list
14843205|NCT00986336|Risperidone|risperidone|mesh-list
14843206|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14843207|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
14843208|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843209|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843210|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843211|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14843212|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14843213|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843214|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14843215|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14843216|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
14843217|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
14843218|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14843219|NCT00986466|Vitamin D|vitamin d|mesh-list
14843220|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
14843221|NCT00986466|Vitamins|vitamins|mesh-list
14843222|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
14843223|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843224|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14843225|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14843226|NCT00986505|Lidocaine|lidocaine|mesh-list
14843227|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
14843228|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
14843229|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14706190|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843230|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843231|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
14843232|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843233|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14843234|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14843235|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14843236|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843237|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843238|NCT00986557|Ganciclovir|ganciclovir|mesh-list
14843239|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14843240|NCT00986557|Foscarnet|foscarnet|mesh-list
14843241|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14843242|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
14843243|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14843244|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843245|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
14843246|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843247|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14843248|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843249|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843250|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14843251|NCT00986596|Vitamin D|vitamin d|mesh-list
14843252|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
15205486|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205487|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205488|NCT03728894|Midazolam|midazolam|mesh-list
15205489|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
15205490|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15205491|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15205492|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205493|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205494|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15205495|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15205496|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15205497|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205498|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
15205499|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
15205500|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
15205501|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
15205502|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205503|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205504|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
14706191|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14706192|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14706193|NCT00417833|Growth Substances|growth substances|mesh-ancestor
14706194|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706195|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
14706196|NCT00417872|Metronidazole|metronidazole|mesh-list
14706197|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
14706198|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706199|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706200|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14706201|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14706202|NCT00417898|Aspirin|aspirin|mesh-list
15205505|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
15205506|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14295677|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
14706203|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14843253|NCT00986596|Vitamins|vitamins|mesh-ancestor
14843254|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
15205507|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
15205508|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
15205509|NCT03728829|Carboplatin|carboplatin|mesh-list
15205510|NCT03728829|Docetaxel|docetaxel|mesh-list
15205511|NCT03728829|Trastuzumab|trastuzumab|mesh-list
14295678|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843255|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843256|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14843257|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14843258|NCT00986609|Poly I-C|poly i-c|mesh-list
14843259|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14843260|NCT00986609|Vaccines|vaccines|mesh-list
14843261|NCT00986609|Poly ICLC|poly iclc|mesh-list
14843262|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
14843263|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843264|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
14843265|NCT00986609|Laxatives|laxatives|mesh-ancestor
14843266|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843267|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
14843268|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843269|NCT00986713|Amphotericin B|amphotericin b|mesh-list
14843270|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14843271|NCT00986713|Amebicides|amebicides|mesh-ancestor
14843272|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14843273|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14843274|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843275|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843276|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
14843277|NCT00986765|Aspirin|aspirin|mesh-list
14843278|NCT00986765|Enoxaparin|enoxaparin|mesh-list
14843279|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14843280|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14843281|NCT00986765|Analgesics|analgesics|mesh-ancestor
14843282|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
14843283|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843284|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843285|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843286|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843287|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14843288|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14843289|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843290|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14843291|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14843292|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843293|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
14843294|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
14843295|NCT00986778|Lamivudine|lamivudine|mesh-list
14295679|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
14706204|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706205|NCT00417898|Analgesics|analgesics|mesh-ancestor
14706206|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
14706207|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706208|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706209|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706210|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706211|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14706212|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14706213|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706214|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14706215|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14706216|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706217|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
14843296|NCT00986778|Adefovir|adefovir|mesh-list
15205512|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205513|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
15205514|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
14843297|NCT00986778|Entecavir|entecavir|mesh-list
14843298|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14843299|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14843300|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205515|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
14843301|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843302|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
14843303|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843304|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14843305|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14843306|NCT00986804|Decitabine|decitabine|mesh-list
14843307|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14843308|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
14843309|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843310|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843311|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843312|NCT00986817|Terlipressin|terlipressin|mesh-list
14843313|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14843314|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14843315|NCT00986843|Irinotecan|irinotecan|mesh-list
14843316|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14843317|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14843318|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843319|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843320|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843321|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14843322|NCT00986960|Hormones|hormones|mesh-ancestor
14843323|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295680|NCT00582790|Interleukin-2|interleukin-2|mesh-list
14843324|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843325|NCT00987038|Midazolam|midazolam|mesh-list
14843326|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14843327|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14843328|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843329|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843330|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14843331|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14843332|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14843333|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14843334|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
14843335|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
14843336|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
14843337|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
14843338|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843339|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843340|NCT00987103|Tacrolimus|tacrolimus|mesh-list
14843341|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843342|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
14843343|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843344|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14843345|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843346|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843347|NCT00987116|Prednisone|prednisone|mesh-list
14843348|NCT00987116|Azathioprine|azathioprine|mesh-list
14843349|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843350|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
14843351|NCT00987116|Hormones|hormones|mesh-ancestor
14843352|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14843353|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843354|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14843355|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843356|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
14843357|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843358|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14843359|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843360|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
14843361|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843362|NCT00987168|Octreotide|octreotide|mesh-list
14843363|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843364|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14295681|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843365|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843366|NCT00987207|Cyclosporine|cyclosporine|mesh-list
14843367|NCT00987207|Cyclosporins|cyclosporins|mesh-list
14843368|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843369|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843370|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843371|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
14843372|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843373|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
14843374|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843375|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
14843376|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843377|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14843378|NCT00987220|Donepezil|donepezil|mesh-list
14843379|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14843380|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843381|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843382|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
14843383|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843384|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843385|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
14912300|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
14912301|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912302|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
14912303|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14912304|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912305|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912306|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912307|NCT01368627|Sirolimus|sirolimus|mesh-list
14706218|NCT00417911|Bortezomib|bortezomib|mesh-list
14912308|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14912309|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912310|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14912311|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912312|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
14912313|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14912314|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
14912315|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912316|NCT01368757|Lenalidomide|lenalidomide|mesh-list
14912317|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
14912318|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912319|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14912320|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912321|NCT01368757|Growth Substances|growth substances|mesh-ancestor
14912322|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912323|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912324|NCT01368783|Ritonavir|ritonavir|mesh-list
14912325|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14912326|NCT01368783|Tenofovir|tenofovir|mesh-list
14912327|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14912328|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14912329|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14912330|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912331|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912332|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14912333|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14706219|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706220|NCT00417937|Azelaic acid|azelaic acid|mesh-list
14706221|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706222|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14706223|NCT00417950|Acarbose|acarbose|mesh-list
14706224|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14706225|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843386|NCT00987233|Triamcinolone|triamcinolone|mesh-list
14843387|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14843388|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14843389|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14843390|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843391|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
14843392|NCT00987233|Hormones|hormones|mesh-ancestor
14843393|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14843394|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843395|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843396|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
14843397|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843398|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843399|NCT00987376|Choline|choline|mesh-list
14843400|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
14843401|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14843402|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
14843403|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843404|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843405|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14843406|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
14843407|NCT00987441|Sufentanil|sufentanil|mesh-list
14843408|NCT00987441|Dsuvia|dsuvia|mesh-list
14843409|NCT00987441|Ropivacaine|ropivacaine|mesh-list
14843410|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
14843411|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
14843412|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843413|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843414|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
14843415|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843416|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14843417|NCT00987441|Narcotics|narcotics|mesh-ancestor
14843418|NCT00987441|Analgesics|analgesics|mesh-ancestor
14843419|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14843420|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14843421|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
14843422|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
14843423|NCT00987454|Hematinics|hematinics|mesh-ancestor
14843424|NCT00987493|Rituximab|rituximab|mesh-list
14843425|NCT00987493|Lenalidomide|lenalidomide|mesh-list
14843426|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14843427|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14843428|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843429|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
14843430|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843431|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843432|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14843433|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14843434|NCT00987493|Growth Substances|growth substances|mesh-ancestor
14843435|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
14843436|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14843437|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
14843438|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843439|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
14843440|NCT00987636|Diphosphonates|diphosphonates|mesh-list
14843441|NCT00987636|Busulfan|busulfan|mesh-list
14843442|NCT00987636|Treosulfan|treosulfan|mesh-list
14843443|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
14843444|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843445|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15205516|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205517|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15205518|NCT03728777|Resveratrol|resveratrol|mesh-list
15205519|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
15205520|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843446|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
14843447|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843448|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14843449|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843450|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14843451|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14843452|NCT00987662|Amlodipine|amlodipine|mesh-list
14843453|NCT00987662|Irbesartan|irbesartan|mesh-list
14843454|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14843455|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14843456|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843457|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843458|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14843459|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843460|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
14843461|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14843462|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14843463|NCT00987766|Gemcitabine|gemcitabine|mesh-list
14843464|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
14843465|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14843466|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14843467|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
14843468|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843469|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843470|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
14843471|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843472|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843473|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843474|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
14843475|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843476|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14843477|NCT00987779|Gabapentin|gabapentin|mesh-list
15205521|NCT03728777|Protective Agents|protective agents|mesh-ancestor
14843478|NCT00987779|Analgesics|analgesics|mesh-ancestor
14843479|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
14843480|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843481|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843482|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
15205522|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205523|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205524|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14843483|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14843484|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14843485|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843486|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14843487|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14843488|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14843489|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843490|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843491|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
14843492|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
14843493|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14843494|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843495|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843496|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14843497|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14843498|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843499|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843500|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843501|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15205525|NCT03728673|Dexetimide|dexetimide|mesh-list
15205526|NCT03728673|Citalopram|citalopram|mesh-list
15205527|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15205528|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14843502|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
14843503|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14843504|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843505|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14843506|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14843507|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14843508|NCT00987844|Prucalopride|prucalopride|mesh-list
14843509|NCT00987844|Laxatives|laxatives|mesh-ancestor
14843510|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843511|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14843512|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14843513|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
14843514|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843515|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843516|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843517|NCT00987870|Betamethasone|betamethasone|mesh-list
14843518|NCT00987870|Calcipotriene|calcipotriene|mesh-list
14843519|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843520|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
14843521|NCT00987870|Hormones|hormones|mesh-ancestor
14843522|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14843523|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205529|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205530|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205531|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205532|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
15205533|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843524|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14843525|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
14843526|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
14843527|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
14843528|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843529|NCT00987974|Atorvastatin|atorvastatin|mesh-list
14843530|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14843531|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14843532|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15205534|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15205535|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
15205536|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15205537|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15205538|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15205539|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
15205540|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
15205541|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205542|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15205543|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15205544|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
15205545|NCT03728478|Etanercept|etanercept|mesh-list
15205546|NCT03728478|Methotrexate|methotrexate|mesh-list
15205547|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15205548|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
15205549|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14706226|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706227|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706228|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706229|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14706230|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
14706231|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
14706232|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
14706233|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706234|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
14706235|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706236|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14706237|NCT00418067|Sirolimus|sirolimus|mesh-list
14843533|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
14843534|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843535|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14843536|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14843537|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843538|NCT00988026|Minocycline|minocycline|mesh-list
15205550|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205551|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15205552|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
15205553|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205554|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205555|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
15205556|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205557|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14843539|NCT00988026|Lymecycline|lymecycline|mesh-list
14843540|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843541|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843542|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
14843543|NCT00988039|Lopinavir|lopinavir|mesh-list
14843544|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14843545|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14843546|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
14843547|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843548|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14843549|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14843550|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843551|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843552|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14843553|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14843554|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
14843555|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14843556|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14843557|NCT00988078|Metformin|metformin|mesh-list
14843558|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14843559|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843560|NCT00988195|Doxorubicin|doxorubicin|mesh-list
14843561|NCT00988195|BCT-100|bct-100|mesh-list
14843562|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14843563|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843564|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14843565|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14843566|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843567|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843568|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14843569|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
14843570|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843571|NCT00988364|Simvastatin|simvastatin|mesh-list
14843572|NCT00988364|Ezetimibe|ezetimibe|mesh-list
14843573|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14843574|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14843575|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14843576|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
14843577|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843578|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14843579|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14843580|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843581|NCT00988403|Levan|levan|mesh-list
14843582|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843583|NCT00988481|Topiramate|topiramate|mesh-list
14843584|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
14843585|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14843586|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843587|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14843588|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15205558|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15205559|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
15205560|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15205561|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15205562|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14843589|NCT00988507|Artesunate|artesunate|mesh-list
14295682|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295683|NCT00582790|Analgesics|analgesics|mesh-ancestor
14295684|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
14295685|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295686|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295687|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14295688|NCT00582894|Fludarabine|fludarabine|mesh-list
14295689|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
14295690|NCT00582894|Busulfan|busulfan|mesh-list
14295691|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295692|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295693|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295694|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
14843590|NCT00988507|Ferroquine|ferroquine|mesh-list
14843591|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
14843592|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14843593|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14843594|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843595|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843596|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
14843597|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
14843598|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14843599|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
14843600|NCT00988520|Bromides|bromides|mesh-list
14843601|NCT00988520|Propofol|propofol|mesh-list
14843602|NCT00988520|Sevoflurane|sevoflurane|mesh-list
14843603|NCT00988520|Rocuronium|rocuronium|mesh-list
14843604|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14843605|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843606|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843607|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14843608|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
14843609|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
14843610|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14843611|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14843612|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
14843613|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14843614|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14843615|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14843616|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843617|NCT00988663|Memantine|memantine|mesh-list
14843618|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14843619|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14843620|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
14843621|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843622|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843623|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843624|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14843625|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14843626|NCT00988715|Cyclosporine|cyclosporine|mesh-list
14843627|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
14843628|NCT00988715|Fludarabine|fludarabine|mesh-list
14843629|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
14843630|NCT00988715|Cyclosporins|cyclosporins|mesh-list
14843631|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843632|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14843633|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
14843634|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843635|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843636|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
14843637|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843638|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843639|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
14843640|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843641|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
14843642|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843643|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14843644|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14843645|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14843646|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
14843647|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843648|NCT00988728|Olanzapine|olanzapine|mesh-list
14295695|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843649|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
14843650|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
14843651|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912334|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
14843652|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843653|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843654|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14843655|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14843656|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843657|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14843658|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14843659|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14843660|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843661|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843662|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843663|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
14843664|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14843665|NCT00988780|Efavirenz|efavirenz|mesh-list
14843666|NCT00988780|Maraviroc|maraviroc|mesh-list
14843667|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14843668|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15205563|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15205564|NCT03728478|Analgesics|analgesics|mesh-ancestor
15205565|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
15205566|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205567|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843669|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843670|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843671|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
14843672|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205568|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15205569|NCT03728465|Nivolumab|nivolumab|mesh-list
15205570|NCT03728465|Ipilimumab|ipilimumab|mesh-list
15205571|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15205572|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205573|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14295696|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295697|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
14295698|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295699|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14327533|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327534|NCT00802880|Dacarbazine|dacarbazine|mesh-list
14327535|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14327536|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
14327537|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327538|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327539|NCT00802919|Varenicline|varenicline|mesh-list
14327540|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14327541|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14327542|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
14327543|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706238|NCT00418067|Paclitaxel|paclitaxel|mesh-list
14706239|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15205574|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205575|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
15205576|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14706240|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706241|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
14706242|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
14706243|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205577|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
14327544|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706244|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706245|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706246|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843673|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14843674|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14843675|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14843676|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14706247|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14706248|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
14706249|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706250|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
14706251|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706252|NCT00418080|Bicalutamide|bicalutamide|mesh-list
14843677|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14843678|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14843679|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14843680|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14843681|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14843682|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14843683|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14843684|NCT00988806|Simendan|simendan|mesh-list
14843685|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14843686|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
14843687|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14843688|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14843689|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843690|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843691|NCT00988806|Protective Agents|protective agents|mesh-ancestor
14843692|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843693|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
14843694|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14843695|NCT00988845|Protective Agents|protective agents|mesh-ancestor
14843696|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843697|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843698|NCT00988897|Leucovorin|leucovorin|mesh-list
14843699|NCT00988897|Bevacizumab|bevacizumab|mesh-list
14843700|NCT00988897|Fluorouracil|fluorouracil|mesh-list
14843701|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
14843702|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14843703|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843704|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14843705|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14843706|NCT00988897|Growth Substances|growth substances|mesh-ancestor
14843707|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843708|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14843709|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
14843710|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295700|NCT00582907|Rilonacept|rilonacept|mesh-list
14843711|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14843712|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843713|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
14843714|NCT00988897|Antidotes|antidotes|mesh-ancestor
14843715|NCT00988897|Protective Agents|protective agents|mesh-ancestor
14843716|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
14843717|NCT00988897|Vitamins|vitamins|mesh-ancestor
14843718|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
14843719|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
14706253|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
14706254|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
14706255|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706256|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706257|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706258|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
14706259|NCT00418119|Hematinics|hematinics|mesh-ancestor
14843720|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
14843721|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14843722|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14843723|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843724|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14295701|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843725|NCT00988949|Spiradoline|spiradoline|mesh-list
14843726|NCT00988949|Analgesics|analgesics|mesh-ancestor
14843727|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
14843728|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843729|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843730|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14843731|NCT00988949|Diuretics|diuretics|mesh-ancestor
14843732|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
14843733|NCT00989027|Oxytocin|oxytocin|mesh-list
14843734|NCT00989027|Ergonovine|ergonovine|mesh-list
14843735|NCT00989027|Carboprost|carboprost|mesh-list
14843736|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
14843737|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
14843738|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14843739|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843740|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14843741|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
14843742|NCT00989053|Citalopram|citalopram|mesh-list
14843743|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14843744|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14843745|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843746|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843747|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843748|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
14843749|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843750|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14843751|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
14843752|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912335|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912336|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14912337|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14912338|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14912339|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14912340|NCT01368848|Bevacizumab|bevacizumab|mesh-list
14912341|NCT01368848|Docetaxel|docetaxel|mesh-list
14912342|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14912343|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912344|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14912345|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912346|NCT01368848|Growth Substances|growth substances|mesh-ancestor
14912347|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912348|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
15205578|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912349|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
14912350|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
14912351|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205579|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
15205580|NCT03728244|Protective Agents|protective agents|mesh-ancestor
15205581|NCT03728192|Camptothecin|camptothecin|mesh-list
15205582|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15205583|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205584|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14912352|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912353|NCT01368887|Niacinamide|niacinamide|mesh-list
14912354|NCT01368887|Niacin|niacin|mesh-list
14912355|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
14912356|NCT01368887|Calcipotriene|calcipotriene|mesh-list
14912357|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
15205585|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15205586|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205587|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205588|NCT03728153|Fluoxetine|fluoxetine|mesh-list
15205589|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15205590|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15205591|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843753|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
14843754|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14843755|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843756|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14843757|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843758|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
14843759|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14843760|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14843761|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14843762|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843763|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843764|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
14843765|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843766|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843767|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14843768|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843769|NCT00989274|Vaccines|vaccines|mesh-list
14843770|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
14843771|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843772|NCT00989300|Omeprazole|omeprazole|mesh-list
14843773|NCT00989300|Rabeprazole|rabeprazole|mesh-list
14843774|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14843775|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843776|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14843777|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843778|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843779|NCT00989352|Rituximab|rituximab|mesh-list
14843780|NCT00989352|Methotrexate|methotrexate|mesh-list
14843781|NCT00989352|Lomustine|lomustine|mesh-list
14843782|NCT00989352|Procarbazine|procarbazine|mesh-list
14843783|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14843784|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843785|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
14843786|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843787|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843788|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14843789|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
14843790|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14843791|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14843792|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
14843793|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843794|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
14843795|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843796|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14843797|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843798|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14843799|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14843800|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
14843801|NCT00989404|Zanamivir|zanamivir|mesh-list
14843802|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
14843803|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843804|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843805|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205592|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205593|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205594|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
15205595|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205596|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15205597|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
15205598|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15205599|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15205600|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15205601|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205602|NCT03728101|Dabigatran|dabigatran|mesh-list
15205603|NCT03728101|Simvastatin|simvastatin|mesh-list
15205604|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15205605|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15205606|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
15205607|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205608|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15205609|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14843806|NCT00989443|Cidofovir|cidofovir|mesh-list
14843807|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
14843808|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843809|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843810|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843811|NCT00989469|Irinotecan|irinotecan|mesh-list
14843812|NCT00989469|Sorafenib|sorafenib|mesh-list
14843813|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14843814|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14843815|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843816|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843817|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843818|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14843819|NCT00989508|Perhexiline|perhexiline|mesh-list
14843820|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14843821|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843822|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843823|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14843824|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843825|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
14843826|NCT00989625|Naproxen|naproxen|mesh-list
14843827|NCT00989625|Sumatriptan|sumatriptan|mesh-list
14843828|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14843829|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14843830|NCT00989625|Analgesics|analgesics|mesh-ancestor
14843831|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
14843832|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843833|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843834|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843835|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843836|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
14843837|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14843838|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843839|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843840|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14843841|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14843842|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14843843|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
14843844|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843845|NCT00989651|Paclitaxel|paclitaxel|mesh-list
14843846|NCT00989651|Bevacizumab|bevacizumab|mesh-list
14843847|NCT00989651|Cisplatin|cisplatin|mesh-list
14843848|NCT00989651|Carboplatin|carboplatin|mesh-list
14843849|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14843850|NCT00989651|Veliparib|veliparib|mesh-list
14843851|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14843852|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
14843853|NCT00989651|Antibodies|antibodies|mesh-list
14843854|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
14843855|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14843856|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
14843857|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14843858|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843859|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
14843860|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
14843861|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
14843862|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843863|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14843864|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14843865|NCT00989651|Growth Substances|growth substances|mesh-ancestor
14843866|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843867|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
14843868|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
14843869|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14843870|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843871|NCT00989690|Docetaxel|docetaxel|mesh-list
14843872|NCT00989690|Pemetrexed|pemetrexed|mesh-list
14843873|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14843874|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843875|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295702|NCT00582933|Vidarabine|vidarabine|mesh-list
14843876|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
15205610|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205611|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
15205612|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15205613|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
15205614|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
15205615|NCT03727867|Mitogens|mitogens|mesh-list
15205616|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205617|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224841|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224842|NCT02296801|Letrozole|letrozole|mesh-list
15224843|NCT02296801|Palbociclib|palbociclib|mesh-list
15224844|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706260|NCT00418132|Thalidomide|thalidomide|mesh-list
14706261|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706262|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
14843877|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14843878|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843879|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843880|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14843881|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14843882|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14843883|NCT00989703|Methotrexate|methotrexate|mesh-list
14843884|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14843885|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
14843886|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14843887|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843888|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14706263|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706264|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
14706265|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706266|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706267|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14706268|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14706269|NCT00418132|Growth Substances|growth substances|mesh-ancestor
14706270|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14706271|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706272|NCT00418171|Olanzapine|olanzapine|mesh-list
14706273|NCT00418171|Ziprasidone|ziprasidone|mesh-list
14706274|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
14706275|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
14706276|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706277|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706278|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14706279|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14706280|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14706281|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14843889|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
14843890|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843891|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843892|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
14843893|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843894|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14843895|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14843896|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
14843897|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14843898|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14706282|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706283|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14706284|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14706285|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14706286|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706287|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706288|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
14706289|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14706290|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14706291|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
14706292|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14843899|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
14843900|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
14843901|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
14843902|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
14843903|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15224845|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14843904|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14843905|NCT00989729|Prednisolone|prednisolone|mesh-list
14843906|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
14843907|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14843908|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
14843909|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14843910|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
14843911|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
14843912|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843913|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843914|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14843915|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
14843916|NCT00989729|Hormones|hormones|mesh-ancestor
14843917|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14843918|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14843919|NCT00989729|Protective Agents|protective agents|mesh-ancestor
14843920|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14843921|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14843922|NCT00989742|Doxycycline|doxycycline|mesh-list
14843923|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843924|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843925|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
14843926|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14843927|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14843928|NCT00989807|Aztreonam|aztreonam|mesh-list
14843929|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14843930|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843931|NCT00989820|Coal Tar|coal tar|mesh-list
14843932|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
14843933|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
15205618|NCT03727763|Cetuximab|cetuximab|mesh-list
15205619|NCT03727763|Vemurafenib|vemurafenib|mesh-list
15205620|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15205621|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205622|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14843934|NCT00989898|Insulin|insulin|mesh-list
14843935|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14843936|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843937|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14843938|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14843939|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14843940|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
14843941|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843942|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14843943|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14843944|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843945|NCT00990054|Plerixafor|plerixafor|mesh-list
14843946|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14843947|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14843948|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
14843949|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14843950|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14843951|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14843952|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14843953|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14843954|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14843955|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843956|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205623|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205624|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205625|NCT03727646|Niacinamide|niacinamide|mesh-list
15205626|NCT03727646|Niacin|niacin|mesh-list
15205627|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
15205628|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
14706293|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14706294|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
14706295|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706296|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706297|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14706298|NCT00418249|Protective Agents|protective agents|mesh-ancestor
14706299|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14706300|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14706301|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14843957|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843958|NCT00990067|Analgesics|analgesics|mesh-ancestor
14843959|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
15205629|NCT03727646|Vitamins|vitamins|mesh-ancestor
15205630|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
14843960|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843961|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
14843962|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14843963|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
14843964|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
14843965|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
14843966|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14843967|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
14843968|NCT00990158|Vitamin K|vitamin k|mesh-list
14843969|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
14843970|NCT00990158|Vitamins|vitamins|mesh-ancestor
14843971|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
14843972|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843973|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14843974|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14843975|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843976|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
14843977|NCT00990158|Coagulants|coagulants|mesh-ancestor
14843978|NCT00990197|Nicotine|nicotine|mesh-list
14843979|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14843980|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
14843981|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14843982|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843983|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14843984|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14843985|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
14843986|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14843987|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14843988|NCT00990223|Eplerenone|eplerenone|mesh-list
14843989|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14843990|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
14843991|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14843992|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14843993|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14843994|NCT00990223|Diuretics|diuretics|mesh-ancestor
14843995|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
14843996|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14843997|NCT00990275|Ethanol|ethanol|mesh-list
14843998|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14843999|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844000|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844001|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844002|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14844003|NCT00990301|Moexipril|moexipril|mesh-list
14844004|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844005|NCT00990301|Diuretics|diuretics|mesh-ancestor
14844006|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
14844007|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844008|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14844009|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844010|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844011|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14844012|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
14844013|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844014|NCT00990392|Polymyxins|polymyxins|mesh-list
14844015|NCT00990392|Bacitracin|bacitracin|mesh-list
14844016|NCT00990392|Polymyxin B|polymyxin b|mesh-list
14844017|NCT00990392|Gramicidin|gramicidin|mesh-list
14844018|NCT00990392|Petrolatum|petrolatum|mesh-list
14844019|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14844020|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844021|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14844022|NCT00990392|Emollients|emollients|mesh-ancestor
14844023|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
14844024|NCT00990405|Amoxicillin|amoxicillin|mesh-list
14844025|NCT00990405|Clarithromycin|clarithromycin|mesh-list
14844026|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14844027|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844028|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14844029|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706302|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706303|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
14706304|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706305|NCT00418275|Plasminogen|plasminogen|mesh-list
14706306|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14706307|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14844030|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844031|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14844032|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14844033|NCT00990418|Fentanyl|fentanyl|mesh-list
14844034|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14844035|NCT00990418|Narcotics|narcotics|mesh-ancestor
14844036|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844037|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844038|NCT00990418|Analgesics|analgesics|mesh-ancestor
14844039|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
14844040|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844041|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14844042|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14844043|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
14844044|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
14844045|NCT00990444|Insulin|insulin|mesh-list
14844046|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14844047|NCT00990444|Dextrans|dextrans|mesh-list
14844048|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14844049|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844050|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
14844051|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
14844052|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
14844053|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
14844054|NCT00990496|Fludarabine|fludarabine|mesh-list
14844055|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844056|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
14844057|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844058|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844059|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14844060|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
14844061|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844062|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706308|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844063|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14844064|NCT00990535|Octreotide|octreotide|mesh-list
14844065|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844066|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14844067|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844068|NCT00990574|Anesthetics|anesthetics|mesh-list
14844069|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844070|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844071|NCT00990587|Ciclopirox|ciclopirox|mesh-list
14844072|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
14844073|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844074|NCT00990600|Tenofovir|tenofovir|mesh-list
14844075|NCT00990600|Emtricitabine|emtricitabine|mesh-list
14844076|NCT00990600|Efavirenz|efavirenz|mesh-list
14844077|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
14844078|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844079|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14706309|NCT00418288|Glucagon|glucagon|mesh-list
14706310|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14844080|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14844081|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912358|NCT01368887|Vitamins|vitamins|mesh-ancestor
14844082|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844083|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14844084|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14844085|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14844086|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14295703|NCT00582933|Fludarabine|fludarabine|mesh-list
14295704|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
14295705|NCT00582933|Melphalan|melphalan|mesh-list
14295706|NCT00582933|Busulfan|busulfan|mesh-list
14295707|NCT00582933|Lenograstim|lenograstim|mesh-list
14295708|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295709|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14295710|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
14295711|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205631|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205632|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15205633|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
15205634|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706311|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844087|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14844088|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14844089|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14844090|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14844091|NCT00990639|Candesartan|candesartan|mesh-list
14844092|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844093|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14844094|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14844095|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706312|NCT00418288|Hormones|hormones|mesh-ancestor
14706313|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706314|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706315|NCT00418288|Incretins|incretins|mesh-ancestor
14706316|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14706317|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706318|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14706319|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706320|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706321|NCT00418353|Dexamethasone|dexamethasone|mesh-list
14706322|NCT00418353|Betamethasone|betamethasone|mesh-list
14706323|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
14706324|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14706325|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
14706326|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
14706327|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14706328|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706329|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
14844096|NCT00990678|Vitamin D|vitamin d|mesh-list
14844097|NCT00990678|Calcitriol|calcitriol|mesh-list
14844098|NCT00990678|Calcium|calcium|mesh-list
14844099|NCT00990678|Vitamins|vitamins|mesh-ancestor
15205635|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15205636|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
15205637|NCT03727620|Amoxicillin|amoxicillin|mesh-list
15205638|NCT03727620|Metronidazole|metronidazole|mesh-list
15205639|NCT03727620|Doxycycline|doxycycline|mesh-list
15205640|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14295712|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15205641|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205642|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14706330|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
14844100|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
14844101|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844102|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14844103|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15205643|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15205644|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
15205645|NCT03727607|Propofol|propofol|mesh-list
15205646|NCT03727607|Desflurane|desflurane|mesh-list
14706331|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706332|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844104|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14844105|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844106|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844107|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15205647|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15205648|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205649|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205650|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205651|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
15205652|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
15205653|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15205654|NCT03727464|Propofol|propofol|mesh-list
15205655|NCT03727464|Sevoflurane|sevoflurane|mesh-list
15205656|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15205657|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205658|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205659|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205660|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
15205661|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
15205662|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15205663|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15205664|NCT03727412|Naproxen|naproxen|mesh-list
15205665|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15205666|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15205667|NCT03727412|Analgesics|analgesics|mesh-ancestor
14844108|NCT00990691|Desipramine|desipramine|mesh-list
14844109|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14844110|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
14844111|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14844112|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844113|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844114|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14844115|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14844116|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844117|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
14844118|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844119|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844120|NCT00990795|Cyclosporine|cyclosporine|mesh-list
14844121|NCT00990795|Cyclosporins|cyclosporins|mesh-list
14844122|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844123|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844124|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844125|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
14844126|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844127|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
14844128|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844129|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
14844130|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844131|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14912359|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
14912360|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912361|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14912362|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
14912363|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912364|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14912365|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
14912366|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
14912367|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14912368|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14912369|NCT01369043|Vitamins|vitamins|mesh-list
14912370|NCT01369043|Ascorbic Acid|ascorbic acid|mesh-list
14912371|NCT01369043|Vitamin E|vitamin e|mesh-list
14912372|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
15205668|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
14844132|NCT00990808|Atorvastatin|atorvastatin|mesh-list
14844133|NCT00990808|Anacetrapib|anacetrapib|mesh-list
14844134|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14844135|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14844136|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
14844137|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844138|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14844139|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14844140|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844141|NCT00990834|Simvastatin|simvastatin|mesh-list
14844142|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14844143|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14844144|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
14844145|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844146|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14844147|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14844148|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844149|NCT00990847|Procaterol|procaterol|mesh-list
14844150|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14844151|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
14844152|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844153|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844154|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14844155|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
14844156|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
14844157|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14844158|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14844159|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14844160|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
14844161|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844162|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844163|NCT00990860|Doxorubicin|doxorubicin|mesh-list
14844164|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14844165|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844166|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14844167|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14844168|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844169|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844170|NCT00990886|Oxybutynin|oxybutynin|mesh-list
14844171|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
14844172|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
14844173|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844174|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844175|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14844176|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14844177|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
14844178|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844179|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844180|NCT00990886|Urological Agents|urological agents|mesh-ancestor
14844181|NCT00990990|Linezolid|linezolid|mesh-list
14844182|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
14844183|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14844184|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844185|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14844186|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844187|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844188|NCT00991055|Pioglitazone|pioglitazone|mesh-list
14844189|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14844190|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844191|NCT00991133|Clofarabine|clofarabine|mesh-list
14844192|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844193|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844194|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14844195|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
14844196|NCT00991159|Bococizumab|bococizumab|mesh-list
14844197|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14844198|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14844199|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
14844200|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844201|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14844202|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
14844203|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14844204|NCT00991211|Doxorubicin|doxorubicin|mesh-list
14844205|NCT00991211|Vincristine|vincristine|mesh-list
14844206|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844207|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
14844208|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844209|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844210|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14844211|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
14844212|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844213|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844214|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14844215|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14844216|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14844217|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14844218|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844219|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14844220|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
14844221|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
14844222|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
14844223|NCT00991250|Temozolomide|temozolomide|mesh-list
14844224|NCT00991250|Dacarbazine|dacarbazine|mesh-list
14844225|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14844226|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
14844227|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844228|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844229|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
14844230|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14844231|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14844232|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844233|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14844234|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14706333|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14706334|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
14706335|NCT00418353|Hormones|hormones|mesh-ancestor
14706336|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706337|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14706338|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706339|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14844235|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14844236|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14844237|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844238|NCT00991627|Atropine|atropine|mesh-list
14844239|NCT00991627|Ephedrine|ephedrine|mesh-list
14844240|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
14844241|NCT00991627|Morphine|morphine|mesh-list
14844242|NCT00991627|Bupivacaine|bupivacaine|mesh-list
14844243|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
14844244|NCT00991627|Anesthetics|anesthetics|mesh-list
14844245|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844246|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844247|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
14844248|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844249|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14844250|NCT00991627|Narcotics|narcotics|mesh-ancestor
14844251|NCT00991627|Analgesics|analgesics|mesh-ancestor
14844252|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14706340|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
14706341|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14844253|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14844254|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14844255|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
14844256|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14844257|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
14844258|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
14844259|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
14844260|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14844261|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14844262|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
14844263|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844264|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844265|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14844266|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
14844267|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14844268|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
14844269|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
14844270|NCT00991705|Atorvastatin|atorvastatin|mesh-list
14844271|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14844272|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14844273|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
14844274|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844275|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14844276|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14844277|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844278|NCT00991744|Cytarabine|cytarabine|mesh-list
14844279|NCT00991744|Cortisone|cortisone|mesh-list
14844280|NCT00991744|Prednisolone|prednisolone|mesh-list
14844281|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14844282|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
14844283|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14844284|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
14844285|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14844286|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
14844287|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14844288|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
14844289|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844290|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844291|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
14844292|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844293|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844294|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
14844295|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844296|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14844297|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
14844298|NCT00991744|Hormones|hormones|mesh-ancestor
14844299|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14844300|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14844301|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
14844302|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
14844303|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844304|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844305|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14844306|NCT00991744|Protective Agents|protective agents|mesh-ancestor
14844307|NCT00991783|Digoxin|digoxin|mesh-list
14844308|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14844309|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14844310|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844311|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844312|NCT00991783|Protective Agents|protective agents|mesh-ancestor
14844313|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844314|NCT00991796|Paclitaxel|paclitaxel|mesh-list
14844315|NCT00991796|Carboplatin|carboplatin|mesh-list
14844316|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14844317|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844318|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14844319|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
14844320|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14844321|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844322|NCT00991822|Timolol|timolol|mesh-list
14844323|NCT00991822|Dorzolamide|dorzolamide|mesh-list
14844324|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14844325|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14844326|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
14844327|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844328|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844329|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844330|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14295713|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
14706342|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14706343|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706344|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706345|NCT00418366|Incretins|incretins|mesh-ancestor
14706346|NCT00418366|Hormones|hormones|mesh-ancestor
14706347|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295714|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844331|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844332|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14844333|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844334|NCT00991848|Lidocaine|lidocaine|mesh-list
14844335|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
14844336|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
15205669|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205670|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205671|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205672|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295715|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
14295716|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706348|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14706349|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
14706350|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706351|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706352|NCT00418392|Minocycline|minocycline|mesh-list
14706353|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706354|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706355|NCT00418431|Bevacizumab|bevacizumab|mesh-list
14706356|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14706357|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706358|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14706359|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14706360|NCT00418431|Growth Substances|growth substances|mesh-ancestor
14706361|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706362|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
14706363|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14706364|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14706365|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706366|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
14706367|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
14706368|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14706369|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14706370|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706371|NCT00418496|Aldesleukin|aldesleukin|mesh-list
14706372|NCT00418496|Sorafenib|sorafenib|mesh-list
14706373|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706374|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14706375|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706376|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706377|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14706378|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14706379|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
14706380|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728657|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14728658|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728659|NCT00519467|Artesunate|artesunate|mesh-list
14728660|NCT00519467|Dapsone|dapsone|mesh-list
14728661|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
14728662|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
14728663|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14728664|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14728665|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728666|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728667|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
14728668|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
14728669|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14728670|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
14728671|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14728672|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728673|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728674|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
14728675|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728676|NCT00519480|Metformin|metformin|mesh-list
14728677|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15205673|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
14844337|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844338|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844339|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
14844340|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844341|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14844342|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14844343|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14844344|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844345|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844346|NCT00991926|Orlistat|orlistat|mesh-list
14844347|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844348|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844349|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14844350|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14844351|NCT00991978|Bevacizumab|bevacizumab|mesh-list
14844352|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
14844353|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14844354|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844355|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14844356|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14844357|NCT00991978|Growth Substances|growth substances|mesh-ancestor
14844358|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844359|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14844360|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14844361|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844362|NCT00992004|Turmeric extract|turmeric extract|mesh-list
14844363|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
14844364|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844365|NCT00992004|Protective Agents|protective agents|mesh-ancestor
14844366|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844367|NCT00992030|Rituximab|rituximab|mesh-list
14844368|NCT00992030|Doxorubicin|doxorubicin|mesh-list
14844369|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14844370|NCT00992030|Dacarbazine|dacarbazine|mesh-list
14844371|NCT00992030|Bleomycin|bleomycin|mesh-list
14844372|NCT00992030|Vinblastine|vinblastine|mesh-list
14844373|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14844374|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844375|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
14844376|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844377|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844378|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14844379|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14844380|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14844381|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844382|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706381|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
14706382|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
14706383|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14706384|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
14706385|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706386|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706387|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14706388|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
14706389|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14706390|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14706391|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14706392|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706393|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706394|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706395|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706396|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
14706397|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14706398|NCT00418535|Cisplatin|cisplatin|mesh-list
14706399|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706400|NCT00418548|Etanercept|etanercept|mesh-list
14706401|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14706402|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706403|NCT00418548|Analgesics|analgesics|mesh-ancestor
14706404|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
14295717|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295718|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
14295719|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295720|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14295721|NCT00582972|Omeprazole|omeprazole|mesh-list
14295722|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14295723|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295724|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14295725|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706405|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706406|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844383|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14844384|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
14844385|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14844386|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14844387|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14844388|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14844389|NCT00992069|Efavirenz|efavirenz|mesh-list
14844390|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14844391|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14844392|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844393|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844394|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
14844395|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844396|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14844397|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14844398|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14844399|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14844400|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14844401|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14844402|NCT00992082|Ketorolac|ketorolac|mesh-list
14844403|NCT00992082|Epinephrine|epinephrine|mesh-list
14844404|NCT00992082|Morphine|morphine|mesh-list
14844405|NCT00992082|Ropivacaine|ropivacaine|mesh-list
14844406|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14844407|NCT00992082|Narcotics|narcotics|mesh-ancestor
14844408|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844409|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844410|NCT00992082|Analgesics|analgesics|mesh-ancestor
14844411|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
14844412|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844413|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
14844414|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
14844415|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14844416|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14844417|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
15205674|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15205675|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205676|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205677|NCT03727295|Idebenone|idebenone|mesh-list
15205678|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
15205679|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205680|NCT03727295|Protective Agents|protective agents|mesh-ancestor
15205681|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205682|NCT03727282|Dobutamine|dobutamine|mesh-list
15205683|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15205684|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
14706407|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706408|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706409|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14706410|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706411|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
14706412|NCT00418587|Vitamin D|vitamin d|mesh-list
14706413|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
14706414|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
14844418|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844419|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844420|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14844421|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14844422|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
14844423|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14844424|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
15205685|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
15205686|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205687|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844425|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
14844426|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
14844427|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14844428|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14844429|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14844430|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14844431|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844432|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14844433|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844434|NCT00992095|Buprenorphine|buprenorphine|mesh-list
14844435|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14844436|NCT00992095|Narcotics|narcotics|mesh-ancestor
14844437|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844438|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844439|NCT00992095|Analgesics|analgesics|mesh-ancestor
14844440|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
14844441|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844442|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14844443|NCT00992121|Bevacizumab|bevacizumab|mesh-list
14844444|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14844445|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844446|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14844447|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14844448|NCT00992121|Growth Substances|growth substances|mesh-ancestor
14844449|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844450|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14844451|NCT00992134|Cytarabine|cytarabine|mesh-list
14844452|NCT00992134|Rituximab|rituximab|mesh-list
14844453|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14844454|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14844455|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844456|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
14844457|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844458|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706415|NCT00418587|Vitamins|vitamins|mesh-list
14706416|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
14706417|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844459|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14844460|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
14844461|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844462|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
14844463|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844464|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844465|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14844466|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
14844467|NCT00992160|Vestipitant|vestipitant|mesh-list
14844468|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14844469|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844470|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706418|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14706419|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14706420|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14706421|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
14844471|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844472|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15205688|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15205689|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15205690|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15205691|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
15205692|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205693|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205694|NCT03727282|Protective Agents|protective agents|mesh-ancestor
15205695|NCT03727100|Clonidine|clonidine|mesh-list
15205696|NCT03727100|Analgesics|analgesics|mesh-ancestor
15205697|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
15205698|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205699|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205700|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14706422|NCT00418600|Vitamins|vitamins|mesh-ancestor
14706423|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
14706424|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706425|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14706426|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14706427|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
14844473|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844474|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844475|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844476|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14844477|NCT00992199|Fluorouracil|fluorouracil|mesh-list
14844478|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844479|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
14844480|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844481|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14844482|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844483|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
14844484|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844485|NCT00992238|Flavoxate|flavoxate|mesh-list
14844486|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
14844487|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
14844488|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844489|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844490|NCT00992238|Urological Agents|urological agents|mesh-ancestor
14844491|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
14844492|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14844493|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844494|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14844495|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14844496|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844497|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844498|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844499|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14844500|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14844501|NCT00992355|Tobramycin|tobramycin|mesh-list
14844502|NCT00992355|Dexamethasone|dexamethasone|mesh-list
14844503|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
14844504|NCT00992355|Ketorolac|ketorolac|mesh-list
14844505|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14844506|NCT00992355|BB 1101|bb 1101|mesh-list
14844507|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14844508|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
14844509|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
14844510|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844511|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844512|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844513|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
14844514|NCT00992355|Hormones|hormones|mesh-ancestor
14844515|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14844516|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14844517|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844518|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
14844519|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844520|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844521|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14844522|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14844523|NCT00992355|Analgesics|analgesics|mesh-ancestor
14844524|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
14844525|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844526|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14844527|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14844528|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844529|NCT00992381|Naproxen|naproxen|mesh-list
14844530|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14844531|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14844532|NCT00992381|Analgesics|analgesics|mesh-ancestor
14844533|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
14844534|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844535|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844536|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14844537|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844538|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
14844539|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14844540|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205701|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
15205702|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
15205703|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15205704|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15205705|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15205706|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
14844541|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844542|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
14844543|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
14844544|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
14844545|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844546|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844547|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844548|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14844549|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14844550|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844551|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14844552|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14844553|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
14844554|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844555|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844556|NCT00992524|Misoprostol|misoprostol|mesh-list
14844557|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14844558|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
14844559|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14844560|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844561|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14844562|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844563|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
14844564|NCT00992537|Insulin|insulin|mesh-list
14844565|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14844566|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
14844567|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
14844568|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14844569|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14844570|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912373|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912374|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
14912375|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912376|NCT01369043|Protective Agents|protective agents|mesh-ancestor
14912377|NCT01369082|Cyclosporine|cyclosporine|mesh-list
14912378|NCT01369082|Sirolimus|sirolimus|mesh-list
14912379|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
14912380|NCT01369082|Tacrolimus|tacrolimus|mesh-list
14912381|NCT01369082|Cyclosporins|cyclosporins|mesh-list
14912382|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14912383|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
14912384|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912385|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14912386|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706428|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14706429|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706430|NCT00418678|Nabilone|nabilone|mesh-list
14706431|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
14706432|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
14706433|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706434|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706435|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14912387|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912388|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
14912389|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912390|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
14912391|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14912392|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14912393|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912394|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14912395|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
14912396|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14912397|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14912398|NCT01369121|Hormones|hormones|mesh-ancestor
14912399|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912400|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706436|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14706437|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14706438|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14706439|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706440|NCT00418704|Docetaxel|docetaxel|mesh-list
14706441|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14912401|NCT01369186|Morphine|morphine|mesh-list
14912402|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14912403|NCT01369186|Narcotics|narcotics|mesh-ancestor
14706442|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844571|NCT00992576|Hydromorphone|hydromorphone|mesh-list
14844572|NCT00992576|Naloxone|naloxone|mesh-list
14844573|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14844574|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844575|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
14844576|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844577|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14844578|NCT00992576|Narcotics|narcotics|mesh-ancestor
14844579|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844580|NCT00992576|Analgesics|analgesics|mesh-ancestor
14844581|NCT00992654|Maraviroc|maraviroc|mesh-list
14844582|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14844583|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14844584|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844585|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14844586|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14844587|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
14844588|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844589|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14844590|NCT00992667|Acetovanillone|acetovanillone|mesh-list
14844591|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14844592|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14844593|NCT00992667|Analgesics|analgesics|mesh-ancestor
14844594|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
14844595|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844596|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844597|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14844598|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844599|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
14844600|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844601|NCT00992667|Protective Agents|protective agents|mesh-ancestor
14844602|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844603|NCT00992693|Ribavirin|ribavirin|mesh-list
14844604|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
14844605|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844606|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
14844607|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844608|NCT00992706|Doxorubicin|doxorubicin|mesh-list
14844609|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14844610|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14844611|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844612|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14844613|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14844614|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844615|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844616|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
14844617|NCT00992758|Antibodies|antibodies|mesh-list
14844618|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
14844619|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844620|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844621|NCT00992771|Varenicline|varenicline|mesh-list
14844622|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14844623|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14844624|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
14844625|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844626|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844627|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706443|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
14706444|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
14706445|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
14706446|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706447|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14706448|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706449|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14844628|NCT00992797|Vitamin D|vitamin d|mesh-list
14844629|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
14844630|NCT00992797|Vitamins|vitamins|mesh-ancestor
14844631|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
14844632|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844633|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14844634|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14844635|NCT00992823|Iron|iron|mesh-list
14844636|NCT00992823|Trace Elements|trace elements|mesh-ancestor
14844637|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
14844638|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844639|NCT00992849|Bevacizumab|bevacizumab|mesh-list
14844640|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14844641|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844642|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14844643|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14844644|NCT00992849|Growth Substances|growth substances|mesh-ancestor
15205707|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205708|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205709|NCT03727048|Ketorolac|ketorolac|mesh-list
15205710|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14844645|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844646|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
14844647|NCT00992862|Moexipril|moexipril|mesh-list
14844648|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14844649|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
14844650|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844651|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844652|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844653|NCT00992901|Atropine|atropine|mesh-list
14844654|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14844655|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14844656|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14844657|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14844658|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
14844659|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844660|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844661|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14844662|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
14844663|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
14844664|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
14844665|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14844666|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14844667|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
14844668|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844669|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844670|NCT00992901|Incretins|incretins|mesh-ancestor
14844671|NCT00992901|Hormones|hormones|mesh-ancestor
14844672|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14844673|NCT00992914|Lidocaine|lidocaine|mesh-list
14844674|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
14844675|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
14844676|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844677|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844678|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
14844679|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844680|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14844681|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14844682|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14844683|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844684|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844685|NCT00993057|Insulin|insulin|mesh-list
14844686|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706450|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
14706451|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844687|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844688|NCT00993070|Capsaicin|capsaicin|mesh-list
14844689|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
14844690|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
14844691|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
14844692|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844693|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844694|NCT00993096|Insulin|insulin|mesh-list
14844695|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14844696|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
14844697|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
14844698|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14844699|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
14844700|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14844701|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
14844702|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14844703|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844704|NCT00993109|Valsartan|valsartan|mesh-list
14844705|NCT00993109|Nifedipine|nifedipine|mesh-list
14844706|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844707|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14844708|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14844709|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844710|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14844711|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844712|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14844713|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844714|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
14844715|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
14844716|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14844717|NCT00993122|Ribavirin|ribavirin|mesh-list
14844718|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
14844719|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844720|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
14844721|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844722|NCT00993135|Methotrexate|methotrexate|mesh-list
14844723|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14844724|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
14844725|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14844726|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844727|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14844728|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
14844729|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844730|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844731|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
14844732|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844733|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14844734|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844735|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
14844736|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844737|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14844738|NCT00993304|Liraglutide|liraglutide|mesh-list
14844739|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14844740|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844741|NCT00993304|Incretins|incretins|mesh-ancestor
14844742|NCT00993304|Hormones|hormones|mesh-ancestor
14844743|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706452|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706453|NCT00418782|Naproxen|naproxen|mesh-list
14706454|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14706455|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706456|NCT00418782|Analgesics|analgesics|mesh-ancestor
14706457|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
14706458|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706459|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205711|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14844744|NCT00993343|Cyclosporine|cyclosporine|mesh-list
14844745|NCT00993343|Sirolimus|sirolimus|mesh-list
14844746|NCT00993343|Methotrexate|methotrexate|mesh-list
14844747|NCT00993343|Tacrolimus|tacrolimus|mesh-list
14844748|NCT00993343|Cyclosporins|cyclosporins|mesh-list
14844749|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14844750|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
14844751|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14844752|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844753|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14844754|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
14844755|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844756|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844757|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
14844758|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844759|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14844760|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844761|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
14844762|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844763|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14844764|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14844765|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
14844766|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844767|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14844768|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14844769|NCT00993356|Lanreotide|lanreotide|mesh-list
14844770|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844771|NCT00993408|Selexipag|selexipag|mesh-list
14844772|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844773|NCT00993512|Bleomycin|bleomycin|mesh-list
14844774|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14844775|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844776|NCT00993525|Ranibizumab|ranibizumab|mesh-list
14844777|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14844778|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14844779|NCT00993525|Growth Substances|growth substances|mesh-ancestor
14844780|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844781|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
14844782|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844783|NCT00993642|Panobinostat|panobinostat|mesh-list
14844784|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844785|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14844786|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205712|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15205713|NCT03727048|Analgesics|analgesics|mesh-ancestor
15205714|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
15205715|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205716|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205717|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205718|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15205719|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15205720|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205721|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205722|NCT03726788|Triamcinolone|triamcinolone|mesh-list
15205723|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15205724|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15205725|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
15205726|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15205727|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15205728|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14844787|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844788|NCT00993681|Vaccines|vaccines|mesh-list
14844789|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
14844790|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844791|NCT00993694|Dapsone|dapsone|mesh-list
14844792|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844793|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
14844794|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14844795|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14844796|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14844797|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844798|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844799|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
14844800|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14844801|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
14844802|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14844803|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
14844804|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844805|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
14844806|NCT00993707|Protective Agents|protective agents|mesh-ancestor
14844807|NCT00993720|Liraglutide|liraglutide|mesh-list
14844808|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14844809|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844810|NCT00993720|Incretins|incretins|mesh-ancestor
14844811|NCT00993720|Hormones|hormones|mesh-ancestor
14844812|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14844813|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
14844814|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14844815|NCT00993746|Lidocaine|lidocaine|mesh-list
14844816|NCT00993746|Bupivacaine|bupivacaine|mesh-list
14844817|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
14844818|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
14844819|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844820|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844821|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
14844822|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844823|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14844824|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14844825|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14844826|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844827|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844828|NCT00993863|Ibuprofen|ibuprofen|mesh-list
14844829|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14844830|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14844831|NCT00993863|Analgesics|analgesics|mesh-ancestor
14844832|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
14844833|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844834|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844835|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14844836|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14844837|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14844838|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844839|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844840|NCT00993876|Citalopram|citalopram|mesh-list
14844841|NCT00993876|Reboxetine|reboxetine|mesh-list
14844842|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14844843|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14844844|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844845|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844846|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14844847|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
14844848|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844849|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14844850|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
14844851|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14844852|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14844853|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
14844854|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
14844855|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
14844856|NCT00994006|Levulinic acid|levulinic acid|mesh-list
14844857|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844858|NCT00994006|Cathartics|cathartics|mesh-ancestor
14844859|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844860|NCT00994006|Antacids|antacids|mesh-ancestor
14844861|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844862|NCT00994071|Temozolomide|temozolomide|mesh-list
14844863|NCT00994071|Veliparib|veliparib|mesh-list
14844864|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14844865|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
14844866|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844867|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844868|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14844869|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844870|NCT00994097|Gemcitabine|gemcitabine|mesh-list
14844871|NCT00994097|Pemetrexed|pemetrexed|mesh-list
14844872|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844873|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14844874|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
14844875|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844876|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
14844877|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844878|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844879|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14844880|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
14844881|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844882|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14844883|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14844884|NCT00994149|Diazoxide|diazoxide|mesh-list
14844885|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844886|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
14844887|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14844888|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844889|NCT00994253|Diuretics|diuretics|mesh-ancestor
14844890|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
14844891|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844892|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14844893|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844894|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844895|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
14844896|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14844897|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
14844898|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844899|NCT00994305|Expectorants|expectorants|mesh-ancestor
14844900|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
14844901|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14844902|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
14844903|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844904|NCT00994305|Protective Agents|protective agents|mesh-ancestor
14844905|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844906|NCT00994305|Antidotes|antidotes|mesh-ancestor
14844907|NCT00994344|Ritonavir|ritonavir|mesh-list
14844908|NCT00994344|Lopinavir|lopinavir|mesh-list
14844909|NCT00994344|Darunavir|darunavir|mesh-list
14844910|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14844911|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14844912|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
14844913|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844914|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844915|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14844916|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14844917|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
14844918|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844919|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14844920|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14844921|NCT00994383|Morphine|morphine|mesh-list
14844922|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14844923|NCT00994383|Narcotics|narcotics|mesh-ancestor
14844924|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844925|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844926|NCT00994383|Analgesics|analgesics|mesh-ancestor
14706460|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706461|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706462|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
14706463|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14706464|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844927|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
14844928|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14844929|NCT00994396|Vitamin D|vitamin d|mesh-list
14844930|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
14844931|NCT00994396|Vitamins|vitamins|mesh-ancestor
14706465|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706466|NCT00418847|Miglustat|miglustat|mesh-list
14844932|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
14844933|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844934|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14844935|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14912404|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912405|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912406|NCT01369186|Analgesics|analgesics|mesh-ancestor
14912407|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
14912408|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912409|NCT01369212|Tenofovir|tenofovir|mesh-list
14912410|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14912411|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
14912412|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912413|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14912414|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14912415|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912416|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912417|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14912418|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14912419|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
14912420|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14912421|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14912422|NCT01369238|Analgesics|analgesics|mesh-ancestor
14912423|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
14912424|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912425|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205729|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15205730|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205731|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205732|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
15205733|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205734|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205735|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15205736|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205737|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205738|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
15205739|NCT03726788|Hormones|hormones|mesh-ancestor
15205740|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706467|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706468|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912426|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14912427|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14912428|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
14917229|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
14917230|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917231|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706469|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14706470|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14706471|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
14706472|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14844936|NCT00994500|Bortezomib|bortezomib|mesh-list
14844937|NCT00994500|Vorinostat|vorinostat|mesh-list
14844938|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844939|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14844940|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844941|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844942|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
14844943|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
14844944|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844945|NCT00994513|Protective Agents|protective agents|mesh-ancestor
14844946|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844947|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
14844948|NCT00994513|Vitamins|vitamins|mesh-ancestor
14844949|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
14844950|NCT00994526|Vitamin E|vitamin e|mesh-list
14844951|NCT00994526|Calcium|calcium|mesh-list
14844952|NCT00994526|Vitamins|vitamins|mesh-ancestor
14844953|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
14844954|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844955|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14844956|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
14844957|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844958|NCT00994526|Protective Agents|protective agents|mesh-ancestor
14844959|NCT00994539|Morphine|morphine|mesh-list
14844960|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14844961|NCT00994539|Narcotics|narcotics|mesh-ancestor
14844962|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14844963|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844964|NCT00994539|Analgesics|analgesics|mesh-ancestor
14844965|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
14844966|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706473|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14706474|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706475|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706476|NCT00418860|Aspirin|aspirin|mesh-list
14706477|NCT00418860|Clopidogrel|clopidogrel|mesh-list
14706478|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14706479|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706480|NCT00418860|Analgesics|analgesics|mesh-ancestor
14706481|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
14706482|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706483|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706484|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706485|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706486|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14844967|NCT00994617|Losartan|losartan|mesh-list
14844968|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14844969|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14844970|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14844971|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14844972|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14844973|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844974|NCT00994617|Diuretics|diuretics|mesh-ancestor
14844975|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
15205741|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15205742|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
15205743|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205744|NCT03726775|Durvalumab|durvalumab|mesh-list
15205745|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15205746|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205747|NCT03726749|Prednisone|prednisone|mesh-list
15205748|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
15205749|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205750|NCT03726749|Hormones|hormones|mesh-ancestor
15205751|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205752|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205753|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15205754|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205755|NCT03726736|Docetaxel|docetaxel|mesh-list
14706487|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14706488|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205756|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14844976|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844977|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14844978|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14844979|NCT00994695|Vaccines|vaccines|mesh-list
14844980|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
14844981|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844982|NCT00994708|Esomeprazole|esomeprazole|mesh-list
14844983|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14844984|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14844985|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14844986|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14844987|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14844988|NCT00994734|Mifepristone|mifepristone|mesh-list
14844989|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14844990|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
14844991|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14844992|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14844993|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14844994|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14844995|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14844996|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
14844997|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14844998|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14844999|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
14845000|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845001|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
14845002|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14845003|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14845004|NCT00994773|Tenofovir|tenofovir|mesh-list
14845005|NCT00994773|Entecavir|entecavir|mesh-list
14845006|NCT00994773|Simvastatin|simvastatin|mesh-list
14845007|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
14845008|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845009|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14845010|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14845011|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845012|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845013|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14845014|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14845015|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14845016|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14845017|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
14845018|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14845019|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14845020|NCT00994786|Pregabalin|pregabalin|mesh-list
14845021|NCT00994786|Analgesics|analgesics|mesh-ancestor
14845022|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
14845023|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845024|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845025|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
14845026|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14845027|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845028|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845029|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14845030|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14845031|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14845032|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845033|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845034|NCT00994799|Ranibizumab|ranibizumab|mesh-list
14845035|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14706489|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14706490|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14706491|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706492|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
14706493|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14706494|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14706495|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14706496|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
14706497|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706498|NCT00418873|Risperidone|risperidone|mesh-list
14706499|NCT00418873|Zotepine|zotepine|mesh-list
14706500|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14706501|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
14845036|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14845037|NCT00994799|Growth Substances|growth substances|mesh-ancestor
14845038|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845039|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
14845040|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845041|NCT00994812|Metformin|metformin|mesh-list
14845042|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14845043|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845044|NCT00994825|Simendan|simendan|mesh-list
14845045|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14845046|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
14845047|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14845048|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14845049|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845050|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845051|NCT00994825|Protective Agents|protective agents|mesh-ancestor
14845052|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845053|NCT00994903|Simvastatin|simvastatin|mesh-list
14845054|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14845055|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14845056|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
14845057|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845058|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14845059|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14845060|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845061|NCT00994916|Amifampridine|amifampridine|mesh-list
14845062|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14845063|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845064|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845065|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14845066|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845067|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845068|NCT00994942|Morphine|morphine|mesh-list
14706502|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706503|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706504|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706505|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14706506|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14706507|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14706508|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706509|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14706510|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
14706511|NCT00418925|Dronabinol|dronabinol|mesh-list
14706512|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
14706513|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706514|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706515|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706516|NCT00418925|Analgesics|analgesics|mesh-ancestor
14706517|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
14706518|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706519|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14706520|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14706521|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845069|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14845070|NCT00994942|Narcotics|narcotics|mesh-ancestor
14845071|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845072|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845073|NCT00994942|Analgesics|analgesics|mesh-ancestor
14845074|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
14845075|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845076|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
14845077|NCT00994968|Docetaxel|docetaxel|mesh-list
14845078|NCT00994968|Doxorubicin|doxorubicin|mesh-list
14845079|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14845080|NCT00994968|Tegafur|tegafur|mesh-list
14845081|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845082|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
14845083|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845084|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14845085|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14845086|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
14845087|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845088|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845089|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14845090|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
14845091|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
14845092|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
14845093|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14845094|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14845095|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14845096|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845097|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14845098|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
14845099|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
14845100|NCT00994981|Analgesics|analgesics|mesh-ancestor
14845101|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
14845102|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845103|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845104|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
14845105|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845106|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14845107|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
14845108|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14845109|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845110|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845111|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14845112|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
14845113|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14845114|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
14845115|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
14845116|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
14845117|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14845118|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845119|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
14845120|NCT00994994|Coagulants|coagulants|mesh-ancestor
14845121|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
14845122|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845123|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14845124|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845125|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14845126|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14845127|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845128|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845129|NCT00995033|Varenicline|varenicline|mesh-list
14845130|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14845131|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14845132|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
14845133|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845134|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706522|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706523|NCT00418925|Hormones|hormones|mesh-ancestor
14706524|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706525|NCT00419042|Gemcitabine|gemcitabine|mesh-list
14706526|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14706527|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14706528|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
14845135|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845136|NCT00995046|Factor VIII|factor viii|mesh-list
14845137|NCT00995046|Coagulants|coagulants|mesh-ancestor
14845138|NCT00995059|Sirolimus|sirolimus|mesh-list
14845139|NCT00995059|Bortezomib|bortezomib|mesh-list
14845140|NCT00995059|Melphalan|melphalan|mesh-list
14845141|NCT00995059|Tacrolimus|tacrolimus|mesh-list
14845142|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
14845143|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14845144|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
14845145|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845146|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
14845147|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845148|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14845149|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845150|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845151|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845152|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845153|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845154|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14845155|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
14845156|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14845157|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
14845158|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14845159|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14845160|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
14845161|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14845162|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
14845163|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14845164|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706529|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706530|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706531|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
14706532|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706533|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706534|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706535|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
14706536|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706537|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14706538|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
14706539|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14706540|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706541|NCT00419068|Vitamins|vitamins|mesh-ancestor
14706542|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
14706543|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14706544|NCT00419146|Vitamins|vitamins|mesh-list
14706545|NCT00419146|Vitamin E|vitamin e|mesh-list
14706546|NCT00419146|Tocopherols|tocopherols|mesh-list
14706547|NCT00419146|Tocotrienols|tocotrienols|mesh-list
14706548|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
14706549|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14706550|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
14706551|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706552|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
14706553|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706554|NCT00419146|Protective Agents|protective agents|mesh-ancestor
14706555|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14706556|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14706557|NCT00419172|Rifampin|rifampin|mesh-list
14706558|NCT00419172|Deferasirox|deferasirox|mesh-list
14706559|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14706560|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
14706561|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706562|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706563|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
14706564|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14706565|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845165|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14845166|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14845167|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14845168|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
14845169|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14706566|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706567|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14706568|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14706569|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14706570|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14706571|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14706572|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14706573|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14706574|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
14706575|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
14706576|NCT00419250|Lenalidomide|lenalidomide|mesh-list
14706577|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
14706578|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706579|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14706580|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14706581|NCT00419250|Growth Substances|growth substances|mesh-ancestor
14845170|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14845171|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
14845172|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845173|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14845174|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14845175|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845176|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845177|NCT00995293|Docetaxel|docetaxel|mesh-list
14845178|NCT00995293|Fluorouracil|fluorouracil|mesh-list
14845179|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845180|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
14845181|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
14845182|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
14845183|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845184|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
14845185|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14845186|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845187|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
14845188|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845189|NCT00995306|Capsaicin|capsaicin|mesh-list
14845190|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
14845191|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14845192|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
14845193|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845194|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845195|NCT00995332|Cytarabine|cytarabine|mesh-list
14845196|NCT00995332|Tretinoin|tretinoin|mesh-list
14845197|NCT00995332|Valproic Acid|valproic acid|mesh-list
14845198|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14845199|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
14845200|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845201|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845202|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
14845203|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845204|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845205|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
14845206|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845207|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
14845208|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
14845209|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
14706582|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
14706583|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706584|NCT00419302|Insulin|insulin|mesh-list
14706585|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14845210|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845211|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
14845212|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845213|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
14845214|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14845215|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845216|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845217|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
14845218|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14845219|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14845220|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
14845221|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
14845222|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845223|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845224|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845225|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
14845226|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
14845227|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14845228|NCT00995423|Paclitaxel|paclitaxel|mesh-list
14845229|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14845230|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845231|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
14845232|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
14845233|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
14845234|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845235|NCT00995618|Tranilast|tranilast|mesh-list
14845236|NCT00995618|Febuxostat|febuxostat|mesh-list
14845237|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
14845238|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14845239|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14845240|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14845241|NCT00995618|Analgesics|analgesics|mesh-ancestor
14845242|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
14845243|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845244|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845245|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845246|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14845247|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845248|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845249|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14845250|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14845251|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
14845252|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
14845253|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845254|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14845255|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14845256|NCT00995657|Fluticasone|fluticasone|mesh-list
14845257|NCT00995657|Xhance|xhance|mesh-list
14845258|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845259|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14845260|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
14845261|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845262|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845263|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14845264|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845265|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
14845266|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14845267|NCT00995800|Fluticasone|fluticasone|mesh-list
14845268|NCT00995800|Xhance|xhance|mesh-list
14845269|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
14845270|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845271|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14845272|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
14845273|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845274|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845275|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14845276|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845277|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
14845278|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14845279|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14845280|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14845281|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14845282|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
14845283|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912429|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
14845284|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845285|NCT00995826|Laninamivir|laninamivir|mesh-list
14845286|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
14845287|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845288|NCT00995839|Terlipressin|terlipressin|mesh-list
14845289|NCT00995839|Vasopressins|vasopressins|mesh-list
14845290|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
14845291|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
14845292|NCT00995839|Coagulants|coagulants|mesh-ancestor
14845293|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14845294|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14845295|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
14845296|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845297|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14845298|NCT00995917|Vitamin K|vitamin k|mesh-list
14845299|NCT00995917|Vitamins|vitamins|mesh-ancestor
14845300|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
14845301|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845302|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14845303|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14845304|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845305|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
14845306|NCT00995917|Coagulants|coagulants|mesh-ancestor
14845307|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
14706586|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706587|NCT00419367|Vorinostat|vorinostat|mesh-list
14706588|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706589|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14706590|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706591|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706592|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
14706593|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
14706594|NCT00419471|Citalopram|citalopram|mesh-list
14706595|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14706596|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14706597|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14706598|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845308|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14845309|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845310|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
14845311|NCT00996021|Dolutegravir|dolutegravir|mesh-list
14845312|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14845313|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845314|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845315|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14845316|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14845317|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845318|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845319|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845320|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14845321|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
14845322|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14845323|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845324|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14845325|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14845326|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14845327|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14845328|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14845329|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14845330|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14845331|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
14845332|NCT00996060|Hydralazine|hydralazine|mesh-list
14845333|NCT00996060|Valproic Acid|valproic acid|mesh-list
14845334|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
14845335|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845336|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845337|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
14845338|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845339|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845340|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
14845341|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14845342|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845343|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845344|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14845345|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
14845346|NCT00996099|Insulin|insulin|mesh-list
14845347|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14845348|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14845349|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845350|NCT00996151|Testosterone|testosterone|mesh-list
14845351|NCT00996151|Androgens|androgens|mesh-ancestor
14845352|NCT00996151|Hormones|hormones|mesh-ancestor
14845353|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845354|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845355|NCT00996177|Fentanyl|fentanyl|mesh-list
14845356|NCT00996177|Morphine|morphine|mesh-list
14845357|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14845358|NCT00996177|Narcotics|narcotics|mesh-ancestor
14845359|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845360|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845361|NCT00996177|Analgesics|analgesics|mesh-ancestor
14845362|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
14845363|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845364|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14845365|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14845366|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
14845367|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
14845368|NCT00996190|Phenylephrine|phenylephrine|mesh-list
14706599|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706600|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
14706601|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706602|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14706603|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
14706604|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706605|NCT00419484|Pioglitazone|pioglitazone|mesh-list
14706606|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706607|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706608|NCT00419536|Panobinostat|panobinostat|mesh-list
14706609|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706610|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14845369|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
14845370|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14845371|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
14845372|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
14845373|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845374|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845375|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
14845376|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14845377|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
14845378|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845379|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14845380|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14845381|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14845382|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14845383|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845384|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845385|NCT00996190|Protective Agents|protective agents|mesh-ancestor
14912430|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14912431|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912432|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912433|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
14912434|NCT01369277|Vitamins|vitamins|mesh-ancestor
14912435|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
14912436|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912437|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14912438|NCT01369290|Citalopram|citalopram|mesh-list
14912439|NCT01369290|Bupropion|bupropion|mesh-list
14845386|NCT00996229|Resveratrol|resveratrol|mesh-list
14845387|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
14706611|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706612|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205757|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
15205758|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
15205759|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
15205760|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205761|NCT03726593|Artesunate|artesunate|mesh-list
15205762|NCT03726593|Mefloquine|mefloquine|mesh-list
15205763|NCT03726593|Atovaquone|atovaquone|mesh-list
15205764|NCT03726593|Proguanil|proguanil|mesh-list
15205765|NCT03726593|Pyronaridine|pyronaridine|mesh-list
15205766|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14845388|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845389|NCT00996229|Protective Agents|protective agents|mesh-ancestor
14845390|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845391|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845392|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14845393|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
14845394|NCT00996385|Bortezomib|bortezomib|mesh-list
14845395|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845396|NCT00996411|Salvinorin A|salvinorin a|mesh-list
14845397|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
14845398|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845399|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845400|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
14845401|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14845402|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
14845403|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845404|NCT00996424|Expectorants|expectorants|mesh-ancestor
14845405|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845406|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14845407|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
14845408|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845409|NCT00996424|Protective Agents|protective agents|mesh-ancestor
14845410|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845411|NCT00996424|Antidotes|antidotes|mesh-ancestor
14845412|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14845413|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14845414|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14845415|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845416|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
14845417|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14845418|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
14706613|NCT00419549|Valdecoxib|valdecoxib|mesh-list
14706614|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14706615|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14706616|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706617|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845419|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14845420|NCT00996515|Azacitidine|azacitidine|mesh-list
14845421|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845422|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14845423|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845424|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845425|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14845426|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
15205767|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
14706618|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14706619|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706620|NCT00419549|Analgesics|analgesics|mesh-ancestor
14706621|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
14706622|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706623|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706624|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706625|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706626|NCT00419601|Fentanyl|fentanyl|mesh-list
14706627|NCT00419601|Remifentanil|remifentanil|mesh-list
14706628|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14706629|NCT00419601|Narcotics|narcotics|mesh-ancestor
14706630|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845427|NCT00996567|Cetuximab|cetuximab|mesh-list
14845428|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14845429|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205768|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14845430|NCT00996684|Plasminogen|plasminogen|mesh-list
14845431|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14845432|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14845433|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845434|NCT00996697|Budesonide|budesonide|mesh-list
14845435|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
14845436|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
14845437|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14845438|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845439|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14845440|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
14845441|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845442|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845443|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14845444|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845445|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
14845446|NCT00996697|Hormones|hormones|mesh-ancestor
14845447|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845448|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14845449|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14845450|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14845451|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
15205769|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15205770|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205771|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205772|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
15205773|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
14845452|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845453|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845454|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
14845455|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14845456|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
14845457|NCT00996723|Dasatinib|dasatinib|mesh-list
14845458|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845459|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14845460|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845461|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845462|NCT00996762|Lapatinib|lapatinib|mesh-list
14845463|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845464|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14845465|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845466|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845467|NCT00996788|Rebamipide|rebamipide|mesh-list
14845468|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14845469|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14845470|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
15205774|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15205775|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
14845471|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845472|NCT00996788|Protective Agents|protective agents|mesh-ancestor
14845473|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205776|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205777|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205778|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
15205779|NCT03726580|Propofol|propofol|mesh-list
15205780|NCT03726580|Sevoflurane|sevoflurane|mesh-list
15205781|NCT03726580|Isoflurane|isoflurane|mesh-list
14845474|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706631|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706632|NCT00419601|Analgesics|analgesics|mesh-ancestor
14845475|NCT00996866|Vitamin D|vitamin d|mesh-list
14845476|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
14845477|NCT00996866|Vitamins|vitamins|mesh-ancestor
14845478|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
14845479|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845480|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14845481|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14845482|NCT00996879|Midazolam|midazolam|mesh-list
14845483|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14845484|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14845485|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845486|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845487|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14845488|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14845489|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845490|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14845491|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
14845492|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
14845493|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
14845494|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
14845495|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845496|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845497|NCT00996983|Ziconotide|ziconotide|mesh-list
14845498|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14845499|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845500|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845501|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14845502|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845503|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14845504|NCT00996983|Protective Agents|protective agents|mesh-ancestor
14845505|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14845506|NCT00996983|Analgesics|analgesics|mesh-ancestor
14845507|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
14845508|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845509|NCT00997009|Paclitaxel|paclitaxel|mesh-list
14845510|NCT00997009|Carboplatin|carboplatin|mesh-list
14845511|NCT00997009|Cetuximab|cetuximab|mesh-list
14845512|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14845513|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845514|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14845515|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14845516|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14845517|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845518|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14845519|NCT00997022|Sorafenib|sorafenib|mesh-list
14845520|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845521|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14845522|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845523|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845524|NCT00997061|Topotecan|topotecan|mesh-list
14845525|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14845526|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14845527|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845528|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845529|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845530|NCT00997074|Ibuprofen|ibuprofen|mesh-list
14706633|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
14706634|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706635|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14706636|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14706637|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
14706638|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
14706639|NCT00419653|Haloperidol|haloperidol|mesh-list
14706640|NCT00419653|Olanzapine|olanzapine|mesh-list
14706641|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
14706642|NCT00419653|Amisulpride|amisulpride|mesh-list
14706643|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
14706644|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
14706645|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706646|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845531|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15205782|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14845532|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14845533|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14845534|NCT00997074|Analgesics|analgesics|mesh-ancestor
14845535|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
14845536|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845537|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205783|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205784|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205785|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205786|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
15205787|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
15205788|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15205789|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15205790|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
15205791|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15205792|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205793|NCT03726398|Macitentan|macitentan|mesh-list
14845538|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14845539|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14845540|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845541|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845542|NCT00997087|Flumazenil|flumazenil|mesh-list
14845543|NCT00997087|Antidotes|antidotes|mesh-ancestor
14845544|NCT00997087|Protective Agents|protective agents|mesh-ancestor
14845545|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845546|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
14845547|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
14845548|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845549|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845550|NCT00997191|Triamcinolone|triamcinolone|mesh-list
14845551|NCT00997191|Bevacizumab|bevacizumab|mesh-list
14845552|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14845553|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845554|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14845555|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14845556|NCT00997191|Growth Substances|growth substances|mesh-ancestor
14845557|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845558|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
14845559|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845560|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
14845561|NCT00997191|Hormones|hormones|mesh-ancestor
14845562|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845563|NCT00997269|Ubiquinone|ubiquinone|mesh-list
14845564|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
14845565|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
14845566|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845567|NCT00997269|Vitamins|vitamins|mesh-ancestor
14845568|NCT00997347|Misoprostol|misoprostol|mesh-list
14845569|NCT00997347|Mifepristone|mifepristone|mesh-list
14845570|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14845571|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
14845572|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14706647|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14706648|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14706649|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14706650|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14706651|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706652|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14706653|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14706654|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14706655|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845573|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845574|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14845575|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14845576|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
14845577|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14845578|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15205794|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14845579|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14845580|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14845581|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
14845582|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14845583|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14845584|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
14845585|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845586|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
14845587|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14845588|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14845589|NCT00997399|Panobinostat|panobinostat|mesh-list
14845590|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845591|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14845592|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845593|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845594|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
14845595|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14845596|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845597|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14845598|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
14845599|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845600|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845601|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845602|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845603|NCT00997477|Budesonide|budesonide|mesh-list
14845604|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
14845605|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845606|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14845607|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
14845608|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845609|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845610|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14845611|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845612|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
14845613|NCT00997477|Hormones|hormones|mesh-ancestor
14845614|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845615|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14845616|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14845617|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14845618|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
14845619|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845620|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845621|NCT00997542|Allopurinol|allopurinol|mesh-list
14845622|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
14845623|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845624|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845625|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
14845626|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706656|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706657|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
14706658|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14706659|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
14845627|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14845628|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
14845629|NCT00997542|Protective Agents|protective agents|mesh-ancestor
14845630|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845631|NCT00997581|Apremilast|apremilast|mesh-list
14845632|NCT00997581|Indomethacin|indomethacin|mesh-list
15205795|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15205796|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205797|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15205798|NCT03726372|Bromides|bromides|mesh-list
15205799|NCT03726372|Rocuronium|rocuronium|mesh-list
15205800|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
15205801|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15205802|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15205803|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15205804|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706660|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14706661|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14706662|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
14706663|NCT00419692|Ropinirole|ropinirole|mesh-list
14845633|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14845634|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14845635|NCT00997581|Analgesics|analgesics|mesh-ancestor
14295726|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845636|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
14845637|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845638|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845639|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845640|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14845641|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14845642|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14845643|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845644|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845645|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
14845646|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
14845647|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14845648|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14845649|NCT00997607|Vaccines|vaccines|mesh-list
14845650|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
14845651|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845652|NCT00997659|Chromium|chromium|mesh-list
14845653|NCT00997659|Picolinic acid|picolinic acid|mesh-list
14845654|NCT00997659|Trace Elements|trace elements|mesh-ancestor
14845655|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
14845656|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845657|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14845658|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
14845659|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
14845660|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845661|NCT00997685|Capecitabine|capecitabine|mesh-list
14845662|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
14845663|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14845664|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
14845665|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845666|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845667|NCT00997711|Sirolimus|sirolimus|mesh-list
14845668|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845669|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845670|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14845671|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845672|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
14845673|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845674|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
14845675|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845676|NCT00997750|Lornoxicam|lornoxicam|mesh-list
14845677|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14845678|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14845679|NCT00997750|Analgesics|analgesics|mesh-ancestor
14845680|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
14845681|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845682|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845683|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845684|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14845685|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
14845686|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14845687|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14845688|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14845689|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845690|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845691|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
14845692|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845693|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845694|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14845695|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845696|NCT00997828|Everolimus|everolimus|mesh-list
14845697|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845698|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845699|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
14845700|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845701|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
14845702|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14845703|NCT00997880|Calcium|calcium|mesh-list
14845704|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14845705|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845706|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14845707|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14845708|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14845709|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
14845710|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845711|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14845712|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14845713|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845714|NCT00997906|Gemcitabine|gemcitabine|mesh-list
14845715|NCT00997906|Paclitaxel|paclitaxel|mesh-list
14845716|NCT00997906|Carboplatin|carboplatin|mesh-list
14845717|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14845718|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845719|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
14845720|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
14845721|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
14845722|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845723|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14845724|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
14845725|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
15205805|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205806|NCT03726281|Nivolumab|nivolumab|mesh-list
15205807|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15205808|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205809|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15205810|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205811|NCT03726268|Fentanyl|fentanyl|mesh-list
15205812|NCT03726268|Sufentanil|sufentanil|mesh-list
15205813|NCT03726268|Morphine|morphine|mesh-list
15205814|NCT03726268|Methadone|methadone|mesh-list
14706664|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14845726|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845727|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845728|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845729|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
14845730|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845731|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14845732|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
14845733|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845734|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
14845735|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14845736|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845737|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14845738|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
14845739|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845740|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845741|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845742|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845743|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
14845744|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14845745|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845746|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706665|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14706666|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
14706667|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
14706668|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845747|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14845748|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15205815|NCT03726268|Hydromorphone|hydromorphone|mesh-list
15205816|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14706669|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706670|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706671|NCT00419718|Insulin|insulin|mesh-list
14706672|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14706673|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706674|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706675|NCT00419731|Naltrexone|naltrexone|mesh-list
14706676|NCT00419731|Bupropion|bupropion|mesh-list
14706677|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15205817|NCT03726268|Narcotics|narcotics|mesh-ancestor
15205818|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845749|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845750|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845751|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845752|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14845753|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
14845754|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14845755|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845756|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14845757|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14845758|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14845759|NCT00998036|Sirolimus|sirolimus|mesh-list
14845760|NCT00998036|Cisplatin|cisplatin|mesh-list
14845761|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14845762|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845763|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14845764|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845765|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845766|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845767|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845768|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14845769|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
14845770|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845771|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
14845772|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845773|NCT00998075|Aspirin|aspirin|mesh-list
14845774|NCT00998075|Esomeprazole|esomeprazole|mesh-list
14845775|NCT00998075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14845776|NCT00998075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14845777|NCT00998075|Analgesics|analgesics|mesh-ancestor
14845778|NCT00998075|Sensory System Agents|sensory system agents|mesh-ancestor
14845779|NCT00998075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845780|NCT00998075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845781|NCT00998075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14845782|NCT00998075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14845783|NCT00998075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14845784|NCT00998075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14845785|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845786|NCT00998075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14845787|NCT00998075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14845788|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845789|NCT00998075|Antipyretics|antipyretics|mesh-ancestor
14845790|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14845791|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14845792|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14845793|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
14845794|NCT00998088|Hematinics|hematinics|mesh-ancestor
14845795|NCT00998101|Carboplatin|carboplatin|mesh-list
14845796|NCT00998101|Cetuximab|cetuximab|mesh-list
14845797|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845798|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14706678|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14706679|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706680|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
14706681|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706682|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14706683|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
14706684|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14706685|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14706686|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14706687|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14706688|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706689|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
14706690|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706691|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14706692|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14706693|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706694|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
14706695|NCT00419783|Ketoconazole|ketoconazole|mesh-list
14706696|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706697|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706698|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14912440|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14912441|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14845799|NCT00998166|Bevacizumab|bevacizumab|mesh-list
14845800|NCT00998166|Pemetrexed|pemetrexed|mesh-list
14845801|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14845802|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845803|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14845804|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14845805|NCT00998166|Growth Substances|growth substances|mesh-ancestor
14295727|NCT00583011|Anesthetics|anesthetics|mesh-list
14295728|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295729|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295730|NCT00583102|Cytarabine|cytarabine|mesh-list
14295731|NCT00583102|Lovastatin|lovastatin|mesh-list
14295732|NCT00583102|L 647318|l 647318|mesh-list
14295733|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
14706699|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14706700|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706701|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706702|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706703|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706704|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
15205819|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205820|NCT03726268|Analgesics|analgesics|mesh-ancestor
15205821|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
15205822|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706705|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14706706|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15205823|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15205824|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205825|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
15205826|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
15205827|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
15205828|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845806|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845807|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
14845808|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205829|NCT03726242|Cromakalim|cromakalim|mesh-list
15205830|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15205831|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15205832|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
15205833|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205834|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205835|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15205836|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
15205837|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
15205838|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
15205839|NCT03726216|Dalbavancin|dalbavancin|mesh-list
15205840|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845809|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845810|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14845811|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14845812|NCT00998192|Paclitaxel|paclitaxel|mesh-list
14845813|NCT00998192|Carboplatin|carboplatin|mesh-list
15205841|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845814|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15205842|NCT03726177|Aspirin|aspirin|mesh-list
14845815|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845816|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
14845817|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
14845818|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
14845819|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845820|NCT00998218|Ranolazine|ranolazine|mesh-list
14845821|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14845822|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845823|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845824|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15205843|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15205844|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14845825|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
14845826|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845827|NCT00998322|Gemcitabine|gemcitabine|mesh-list
14845828|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14845829|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
14845830|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845831|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845832|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
14845833|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845834|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845835|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845836|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
14845837|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845838|NCT00998439|Paclitaxel|paclitaxel|mesh-list
14845839|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14845840|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845841|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
14845842|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
14845843|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
14845844|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845845|NCT00998504|Resveratrol|resveratrol|mesh-list
14845846|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
14845847|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845848|NCT00998504|Protective Agents|protective agents|mesh-ancestor
14845849|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845850|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845851|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14845852|NCT00998556|Bromocriptine|bromocriptine|mesh-list
14845853|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14845854|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14845855|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
14845856|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845857|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845858|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
14845859|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
14845860|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845861|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845862|NCT00998608|Risperidone|risperidone|mesh-list
14845863|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14845864|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
14845865|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845866|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845867|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205845|NCT03726177|Analgesics|analgesics|mesh-ancestor
15205846|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
15205847|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205848|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205849|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15205850|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15205851|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15205852|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14845868|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14845869|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15205853|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205854|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15205855|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15205856|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205857|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
15205858|NCT03726125|Insulin|insulin|mesh-list
15205859|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14706707|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14706708|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
14706709|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706710|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15205860|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
15205861|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15205862|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205863|NCT03726099|Amoxicillin|amoxicillin|mesh-list
15205864|NCT03726099|Tetracycline|tetracycline|mesh-list
15205865|NCT03726099|Furazolidone|furazolidone|mesh-list
15205866|NCT03726099|Esomeprazole|esomeprazole|mesh-list
15205867|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845870|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845871|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845872|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14845873|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
14845874|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
14845875|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
14845876|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14845877|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845878|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845879|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
14845880|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14845881|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845882|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845883|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14845884|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14845885|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205868|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706711|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
14706712|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14706713|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14706714|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706715|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706716|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14845886|NCT00998686|Incretins|incretins|mesh-ancestor
14845887|NCT00998686|Hormones|hormones|mesh-ancestor
14845888|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845889|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14845890|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
14845891|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845892|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845893|NCT00998816|Pregabalin|pregabalin|mesh-list
14845894|NCT00998816|Analgesics|analgesics|mesh-ancestor
14845895|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
14845896|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845897|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845898|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
14845899|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14845900|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845901|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845902|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14845903|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14845904|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14845905|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845906|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15205869|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15205870|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14845907|NCT00998920|Equol|equol|mesh-list
14845908|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
14845909|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14845910|NCT00998920|Estrogens|estrogens|mesh-ancestor
14845911|NCT00998920|Hormones|hormones|mesh-ancestor
14845912|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845913|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845914|NCT00998933|Testosterone|testosterone|mesh-list
14845915|NCT00998933|Androgens|androgens|mesh-ancestor
14845916|NCT00998933|Hormones|hormones|mesh-ancestor
14845917|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845918|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845919|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
14845920|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14845921|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
14845922|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15205871|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15205872|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205873|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205874|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15205875|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15205876|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14295734|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14295735|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
14295736|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295737|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706717|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14706718|NCT00419796|Analgesics|analgesics|mesh-ancestor
14706719|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
14706720|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706721|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706722|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706723|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15205877|NCT03726099|Renal Agents|renal agents|mesh-ancestor
15205878|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15205879|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14706724|NCT00419835|Losartan|losartan|mesh-list
14706725|NCT00419835|Enalapril|enalapril|mesh-list
14706726|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14706727|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15205880|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15205881|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14845923|NCT00998972|Expectorants|expectorants|mesh-ancestor
14845924|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
14845925|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14845926|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
14845927|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845928|NCT00998972|Protective Agents|protective agents|mesh-ancestor
14845929|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845930|NCT00998972|Antidotes|antidotes|mesh-ancestor
14845931|NCT00999128|Rabeprazole|rabeprazole|mesh-list
14845932|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14845933|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14845934|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14845935|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845936|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845937|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
14845938|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14845939|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14845940|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14845941|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14845942|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845943|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
14845944|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845945|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845946|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14845947|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845948|NCT00999206|Vaccines|vaccines|mesh-list
14845949|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
14845950|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845951|NCT00999219|Zolpidem|zolpidem|mesh-list
14845952|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14845953|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14845954|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14845955|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845956|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14845957|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
14845958|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
14845959|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14845960|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845961|NCT00999232|Erythromycin|erythromycin|mesh-list
14845962|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
14845963|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14845964|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
14845965|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845966|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845967|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14845968|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14845969|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845970|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845971|NCT00999258|Sirolimus|sirolimus|mesh-list
14845972|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14845973|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14845974|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14845975|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14845976|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
14845977|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14845978|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
14845979|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845980|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14845981|NCT00999271|Hormones|hormones|mesh-list
14845982|NCT00999271|Incretins|incretins|mesh-list
14845983|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14845984|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845985|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14845986|NCT00999297|Capsaicin|capsaicin|mesh-list
14845987|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
15205882|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
15205883|NCT03726021|Irinotecan|irinotecan|mesh-list
15205884|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205885|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15205886|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15205887|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205888|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845988|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
14845989|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
14845990|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14845991|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14845992|NCT00999336|Betrixaban|betrixaban|mesh-list
14845993|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14845994|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
14845995|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14845996|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
14845997|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14845998|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14845999|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
14846000|NCT00999349|Silymarin|silymarin|mesh-list
14846001|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
14846002|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846003|NCT00999349|Protective Agents|protective agents|mesh-ancestor
14846004|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846005|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
14846006|NCT00999427|Povidone|povidone|mesh-list
14846007|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
14846008|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
14846009|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14846010|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846011|NCT00999440|Methadone|methadone|mesh-list
14846012|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14846013|NCT00999440|Narcotics|narcotics|mesh-ancestor
14846014|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14846015|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846016|NCT00999440|Analgesics|analgesics|mesh-ancestor
14846017|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
14846018|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846019|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
14295738|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
14295739|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295740|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295741|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
14295742|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295743|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14295744|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14846020|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
14846021|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
14846022|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14846023|NCT00999479|Norethindrone|norethindrone|mesh-list
14846024|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
14846025|NCT00999479|Estradiol|estradiol|mesh-list
15224846|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14295745|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14846026|NCT00999479|Estrogens|estrogens|mesh-ancestor
15224847|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224848|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224849|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15224850|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
15224851|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224852|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224853|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15224854|NCT02283853|Interferons|interferons|mesh-list
15224855|NCT02283853|Interferon-beta|interferon-beta|mesh-list
15224856|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
15224857|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14846027|NCT00999479|Hormones|hormones|mesh-ancestor
14846028|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846029|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846030|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14846031|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
14846032|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14846033|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14846034|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14846035|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14846036|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14846037|NCT00999479|Trace Elements|trace elements|mesh-ancestor
14846038|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
14846039|NCT00999505|Amantadine|amantadine|mesh-list
14846040|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14846041|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14846042|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
14846043|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846044|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
14295746|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14295747|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846045|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846046|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846047|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846048|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846049|NCT00999505|Analgesics|analgesics|mesh-ancestor
14295748|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14295749|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14295750|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14295751|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14706728|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14706729|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14706730|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706731|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15205889|NCT03725995|Lidocaine|lidocaine|mesh-list
15205890|NCT03725995|Midazolam|midazolam|mesh-list
14706732|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
14706733|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706734|NCT00419848|Azithromycin|azithromycin|mesh-list
14846050|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
14846051|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846052|NCT00999557|Bimatoprost|bimatoprost|mesh-list
14846053|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14846054|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14846055|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14846056|NCT00999700|Cisplatin|cisplatin|mesh-list
14846057|NCT00999700|Docetaxel|docetaxel|mesh-list
14846058|NCT00999700|Fluorouracil|fluorouracil|mesh-list
14846059|NCT00999700|Cetuximab|cetuximab|mesh-list
14846060|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846061|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846062|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846063|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14846064|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846065|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
14846066|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14846067|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846068|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
14846069|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295752|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205891|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205892|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
15205893|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205894|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205895|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
15205896|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205897|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15205898|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15205899|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15205900|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14846070|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14846071|NCT00999739|Vaccines|vaccines|mesh-list
14846072|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14846073|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
14846074|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846075|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14846076|NCT00999752|Nebivolol|nebivolol|mesh-list
14846077|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14846078|NCT00999752|Diuretics|diuretics|mesh-ancestor
14846079|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
14846080|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846081|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14846082|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14846083|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846084|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
14846085|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14846086|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14846087|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14846088|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
14846089|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846090|NCT00999791|Diclofenac|diclofenac|mesh-list
14846091|NCT00999791|Bevacizumab|bevacizumab|mesh-list
14846092|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14846093|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846094|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14846095|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14846096|NCT00999791|Growth Substances|growth substances|mesh-ancestor
14846097|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846098|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
14846099|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14846100|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846101|NCT00999791|Analgesics|analgesics|mesh-ancestor
14846102|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
14846103|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846104|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846105|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846106|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14846107|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846108|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846109|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
14846110|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
14846111|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
14846112|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14846113|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14846114|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912442|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14706735|NCT00419848|Doxycycline|doxycycline|mesh-list
14706736|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706737|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706738|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
14706739|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14706740|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14706741|NCT00419887|Vildagliptin|vildagliptin|mesh-list
14706742|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706743|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706744|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14706745|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
14846115|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846116|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846117|NCT00999843|Sorafenib|sorafenib|mesh-list
14846118|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846119|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846120|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846121|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846122|NCT00999869|Triamcinolone|triamcinolone|mesh-list
14846123|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14846124|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14846125|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
14846126|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14846127|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14846128|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14846129|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14846130|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14846131|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846132|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
14846133|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846134|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846135|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846136|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
14846137|NCT00999869|Hormones|hormones|mesh-ancestor
14846138|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846139|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846140|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
14846141|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846142|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14846143|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912443|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912444|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912445|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912446|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
14912447|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912448|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912449|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912450|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912451|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912452|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14912453|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
14912454|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14912455|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14912456|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912457|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14912458|NCT01369290|Analgesics|analgesics|mesh-ancestor
14912459|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
14912460|NCT01369303|Tenofovir|tenofovir|mesh-list
14912461|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
14912462|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912463|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15205901|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205902|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15205903|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15205904|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15205905|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15205906|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15205907|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15205908|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
14846144|NCT00999973|Mitomycins|mitomycins|mesh-list
14846145|NCT00999973|Mitomycin|mitomycin|mesh-list
14846146|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14846147|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846148|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
14846149|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846150|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14846151|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846152|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
14846153|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846154|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
14846155|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846156|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846157|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846158|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
14846159|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846160|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846161|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14846162|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14846163|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
14846164|NCT01000116|Coagulants|coagulants|mesh-ancestor
14846165|NCT01000220|Omeprazole|omeprazole|mesh-list
14846166|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14846167|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14846168|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14846169|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846170|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846171|NCT01000233|Inositol|inositol|mesh-list
14846172|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
14706746|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706747|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706748|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14706749|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14706750|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
14706751|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706752|NCT00419991|Tigecycline|tigecycline|mesh-list
14706753|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706754|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846173|NCT01000233|Vitamins|vitamins|mesh-ancestor
14846174|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
14846175|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846176|NCT01000298|Amoxicillin|amoxicillin|mesh-list
14846177|NCT01000298|Cefdinir|cefdinir|mesh-list
14846178|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14846179|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846180|NCT01000415|Cisplatin|cisplatin|mesh-list
14846181|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846182|NCT01000441|Adalimumab|adalimumab|mesh-list
14846183|NCT01000441|Etanercept|etanercept|mesh-list
14846184|NCT01000441|Rituximab|rituximab|mesh-list
14846185|NCT01000441|Abatacept|abatacept|mesh-list
14846186|NCT01000441|Infliximab|infliximab|mesh-list
14846187|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14846188|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846189|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
14846190|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846191|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846192|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846193|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
14846194|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14846195|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14846196|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846197|NCT01000441|Analgesics|analgesics|mesh-ancestor
14846198|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
14846199|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846200|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15205909|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
15205910|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
15205911|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205912|NCT03725930|Clonidine|clonidine|mesh-list
15205913|NCT03725930|Analgesics|analgesics|mesh-ancestor
15205914|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
15205915|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706755|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14846201|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14846202|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917232|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
15205916|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846203|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14846204|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
14846205|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14846206|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
14846207|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846208|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14846209|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14846210|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14846211|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14846212|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846213|NCT01000597|Fluticasone|fluticasone|mesh-list
14846214|NCT01000597|Xhance|xhance|mesh-list
14846215|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846216|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14846217|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
14706756|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846218|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846219|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846220|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14846221|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
14846222|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
14846223|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14846224|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14846225|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14846226|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14846227|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14846228|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846229|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846230|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846231|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14846232|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
14846233|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14846234|NCT01000688|Vildagliptin|vildagliptin|mesh-list
14846235|NCT01000688|Acarbose|acarbose|mesh-list
14846236|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14706757|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706758|NCT00420030|Abciximab|abciximab|mesh-list
14706759|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
14706760|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14846237|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846238|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14846239|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
14846240|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846241|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846242|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14846243|NCT01000779|Propranolol|propranolol|mesh-list
14846244|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14846245|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14846246|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14846247|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846248|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846249|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846250|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14846251|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14846252|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
14846253|NCT01000792|Cetirizine|cetirizine|mesh-list
14846254|NCT01000792|Levocetirizine|levocetirizine|mesh-list
14846255|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14846256|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14846257|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
14706761|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
14706762|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706763|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14706764|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706765|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706766|NCT00420082|Cetirizine|cetirizine|mesh-list
14706767|NCT00420082|Fexofenadine|fexofenadine|mesh-list
14706768|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14706769|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14706770|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14327545|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846258|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
14846259|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846260|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846261|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846262|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14846263|NCT01000831|Vaccines|vaccines|mesh-list
14846264|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
14846265|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846266|NCT01000857|Paroxetine|paroxetine|mesh-list
14846267|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14846268|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14846269|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14846270|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846271|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846272|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
14846273|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846274|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14846275|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
14846276|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14846277|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14846278|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14846279|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846280|NCT01000896|Paclitaxel|paclitaxel|mesh-list
14846281|NCT01000896|Carboplatin|carboplatin|mesh-list
14846282|NCT01000896|Saracatinib|saracatinib|mesh-list
14846283|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14846284|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846285|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846286|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846287|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
14846288|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846289|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846290|NCT01001013|Pioglitazone|pioglitazone|mesh-list
14846291|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14846292|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846293|NCT01001130|Fluticasone|fluticasone|mesh-list
14846294|NCT01001130|Xhance|xhance|mesh-list
14846295|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846296|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14846297|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
14846298|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846299|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846300|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14846301|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
14846302|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
14295753|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295754|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
14846303|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14846304|NCT01001143|Decitabine|decitabine|mesh-list
14846305|NCT01001143|Bexarotene|bexarotene|mesh-list
14846306|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14846307|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
14846308|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846309|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846310|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846311|NCT01001247|Rilpivirine|rilpivirine|mesh-list
14846312|NCT01001247|Omeprazole|omeprazole|mesh-list
14846313|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14846314|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14846315|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14846316|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846317|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846318|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14706771|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
14706772|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
14706773|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706774|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706775|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706776|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14706777|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14706778|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
14706779|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
15205917|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15205918|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
15205919|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
15205920|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15205921|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14295755|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295756|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295757|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14295758|NCT00583219|Protective Agents|protective agents|mesh-ancestor
14295759|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14295760|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
14295761|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14295762|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295763|NCT00583362|Belimumab|belimumab|mesh-list
14846319|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14846320|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
14846321|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846322|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14846323|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14846324|NCT01001260|Aspirin|aspirin|mesh-list
14846325|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14846326|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846327|NCT01001260|Analgesics|analgesics|mesh-ancestor
14846328|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
14846329|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846330|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846331|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846332|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846333|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14846334|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14846335|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846336|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14846337|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14846338|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846339|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
14846340|NCT01001364|Budesonide|budesonide|mesh-list
14846341|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
14846342|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846343|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14846344|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
14846345|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846346|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846347|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14846348|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295764|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706780|NCT00420355|Ritonavir|ritonavir|mesh-list
15205922|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14846349|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
14846350|NCT01001364|Hormones|hormones|mesh-ancestor
14846351|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846352|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14846353|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14846354|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14846355|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
14846356|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846357|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846358|NCT01001585|Sevoflurane|sevoflurane|mesh-list
14846359|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14846360|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14846361|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
14846362|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
14846363|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14846364|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846365|NCT01001624|Hydroquinone|hydroquinone|mesh-list
14846366|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
14846367|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846368|NCT01001624|Protective Agents|protective agents|mesh-ancestor
14846369|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846370|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14846371|NCT01001637|Curcumin|curcumin|mesh-list
14846372|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14846373|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846374|NCT01001637|Analgesics|analgesics|mesh-ancestor
14846375|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
14846376|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846377|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846378|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846379|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846380|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846381|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846382|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846383|NCT01001676|Paclitaxel|paclitaxel|mesh-list
14846384|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14846385|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846386|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846387|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846388|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14846389|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846390|NCT01001754|Ribavirin|ribavirin|mesh-list
14846391|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14846392|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
14846393|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846394|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
14846395|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846396|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
14846397|NCT01001780|Rituximab|rituximab|mesh-list
14846398|NCT01001780|Pentostatin|pentostatin|mesh-list
14846399|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846400|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
14846401|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846402|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846403|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846404|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
14846405|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846406|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846407|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14846408|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14846409|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14846410|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846411|NCT01001845|Vitamin E|vitamin e|mesh-list
14846412|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
14846413|NCT01001845|Tocopherols|tocopherols|mesh-list
14846414|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
14846415|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846416|NCT01001845|Protective Agents|protective agents|mesh-ancestor
14846417|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846418|NCT01001845|Vitamins|vitamins|mesh-ancestor
14846419|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
14846420|NCT01001871|Vitamins|vitamins|mesh-list
14846421|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
14846422|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846423|NCT01001897|Misoprostol|misoprostol|mesh-list
14846424|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14846425|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
14846426|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14846427|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846428|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14846429|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14846430|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
14846431|NCT01001962|Metformin|metformin|mesh-list
14846432|NCT01001962|Empagliflozin|empagliflozin|mesh-list
14846433|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14846434|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846435|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14846436|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912464|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14912465|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912466|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912467|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14912468|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14912469|NCT01369368|Azacitidine|azacitidine|mesh-list
14912470|NCT01369368|Valproic Acid|valproic acid|mesh-list
14912471|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14912472|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
14912473|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912474|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912475|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912476|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
14912477|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
14912478|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912479|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205923|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
15205924|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15205925|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205926|NCT03725904|Progesterone|progesterone|mesh-list
15205927|NCT03725904|Progestins|progestins|mesh-ancestor
15205928|NCT03725904|Hormones|hormones|mesh-ancestor
15205929|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15205930|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205931|NCT03725891|Aspirin|aspirin|mesh-list
15205932|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15205933|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15205934|NCT03725891|Analgesics|analgesics|mesh-ancestor
15205935|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
15205936|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205937|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205938|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14912480|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
14912481|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14912482|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14846437|NCT01002079|Rifampin|rifampin|mesh-list
14846438|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14846439|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
14846440|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14846441|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846442|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
14846443|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14846444|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846445|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846446|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14846447|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14846448|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14846449|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14846450|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14846451|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14846452|NCT01002092|Endostar protein|endostar protein|mesh-list
14846453|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14846454|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14846455|NCT01002092|Growth Substances|growth substances|mesh-ancestor
14846456|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846457|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
14846458|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205939|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846459|NCT01002157|Vitamin K|vitamin k|mesh-list
14846460|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
14846461|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
14846462|NCT01002157|Vitamins|vitamins|mesh-ancestor
14846463|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
14846464|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846465|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14846466|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14846467|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846468|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
14846469|NCT01002157|Coagulants|coagulants|mesh-ancestor
14846470|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
14846471|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14846472|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846473|NCT01002300|Oxytocin|oxytocin|mesh-list
14846474|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
14846475|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14846476|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846477|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14846478|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
14846479|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15205940|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14846480|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15205941|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15205942|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205943|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15205944|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15205945|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205946|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
15205947|NCT03725878|Folic Acid|folic acid|mesh-list
15205948|NCT03725878|Hematinics|hematinics|mesh-ancestor
15205949|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
15205950|NCT03725878|Vitamins|vitamins|mesh-ancestor
14846481|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205951|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
14846482|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846483|NCT01002534|Urological Agents|urological agents|mesh-ancestor
14846484|NCT01002690|Etoricoxib|etoricoxib|mesh-list
14846485|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14846486|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846487|NCT01002690|Analgesics|analgesics|mesh-ancestor
14846488|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
14846489|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846490|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846491|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846492|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846493|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14846494|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14846495|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846496|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846497|NCT01002703|Prednisone|prednisone|mesh-list
14846498|NCT01002703|Lenalidomide|lenalidomide|mesh-list
14846499|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14846500|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846501|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
14846502|NCT01002703|Hormones|hormones|mesh-ancestor
14846503|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846504|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846505|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14846506|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846507|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
14846508|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14846509|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14846510|NCT01002703|Growth Substances|growth substances|mesh-ancestor
14846511|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
14846512|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846513|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
14846514|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846515|NCT01002716|Vaccines|vaccines|mesh-list
14846516|NCT01002716|Immunologic Factors|immunologic factors|mesh-ancestor
14846517|NCT01002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846518|NCT01002729|Oseltamivir|oseltamivir|mesh-list
14846519|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
14846520|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846521|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846522|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846523|NCT01002768|Insulin|insulin|mesh-list
14846524|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14846525|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
14846526|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14846527|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846528|NCT01002807|Metformin|metformin|mesh-list
14846529|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
14846530|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14846531|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846532|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14846533|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846534|NCT01002898|Ritonavir|ritonavir|mesh-list
14846535|NCT01002898|Lopinavir|lopinavir|mesh-list
14846536|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14846537|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14846538|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
14846539|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846540|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846541|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14846542|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14846543|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
14846544|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846545|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14846546|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14846547|NCT01002911|Cefazolin|cefazolin|mesh-list
14846548|NCT01002911|Cephalexin|cephalexin|mesh-list
14846549|NCT01002911|Bacitracin|bacitracin|mesh-list
14846550|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14846551|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846552|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14846553|NCT01003002|Levodopa|levodopa|mesh-list
14846554|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14846555|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14846556|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
14846557|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706781|NCT00420355|Lopinavir|lopinavir|mesh-list
14706782|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14706783|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14706784|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14706785|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
14706786|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706787|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706788|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14706789|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14706790|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
14846558|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846559|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846560|NCT01003028|Remifentanil|remifentanil|mesh-list
14706791|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706792|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14706793|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14846561|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14846562|NCT01003028|Narcotics|narcotics|mesh-ancestor
14846563|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14706794|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
14706795|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14706796|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706797|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14706798|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
14706799|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706800|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706801|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706802|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706803|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14846564|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846565|NCT01003028|Analgesics|analgesics|mesh-ancestor
14846566|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
14846567|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846568|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
14846569|NCT01003054|Busulfan|busulfan|mesh-list
14846570|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
14846571|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846572|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
14846573|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846574|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846575|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846576|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
14846577|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846578|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846579|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14846580|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846581|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846582|NCT01003158|Paclitaxel|paclitaxel|mesh-list
14846583|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14846584|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846585|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846586|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846587|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
14706804|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14706805|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14846588|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706806|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14706807|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706808|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706809|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706810|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706811|NCT00420524|Epothilone B|epothilone b|mesh-list
14706812|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846589|NCT01003314|Vaccines|vaccines|mesh-list
15205952|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205953|NCT03725709|Anesthetics|anesthetics|mesh-list
15205954|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205955|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205956|NCT03725553|Vasopressins|vasopressins|mesh-list
15205957|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
15205958|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
15205959|NCT03725553|Coagulants|coagulants|mesh-ancestor
15205960|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15205961|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15205962|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
15205963|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205964|NCT03725501|Ranibizumab|ranibizumab|mesh-list
15205965|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15205966|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15205967|NCT03725501|Growth Substances|growth substances|mesh-ancestor
15205968|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205969|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
14846590|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
14846591|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846592|NCT01003483|Orlistat|orlistat|mesh-list
14846593|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846594|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846595|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14846596|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14846597|NCT01003522|Anesthetics|anesthetics|mesh-list
14846598|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
14846599|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14846600|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846601|NCT01003561|Anesthetics|anesthetics|mesh-list
14846602|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14846603|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846604|NCT01003613|Tranilast|tranilast|mesh-list
14846605|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14846606|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14846607|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846608|NCT01003613|Analgesics|analgesics|mesh-ancestor
14846609|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
14846610|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846611|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846612|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846613|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846614|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14846615|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14846616|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846617|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14846618|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14846619|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
14846620|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
14846621|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846622|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14846623|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14846624|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
14846625|NCT01003613|Coagulants|coagulants|mesh-ancestor
14846626|NCT01003678|Clofarabine|clofarabine|mesh-list
15205970|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205971|NCT03725423|Apatinib|apatinib|mesh-list
15205972|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15205973|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15205974|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15205975|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205976|NCT03725267|Melatonin|melatonin|mesh-list
15205977|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
15205978|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205979|NCT03725267|Protective Agents|protective agents|mesh-ancestor
15205980|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205981|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205982|NCT03725228|Lidocaine|lidocaine|mesh-list
15205983|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
15205984|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
15205985|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
15205986|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15205987|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15205988|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
15205989|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15205990|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15205991|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15205992|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15205993|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15205994|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15205995|NCT03725228|Analgesics|analgesics|mesh-ancestor
15205996|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
15205997|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15205998|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15205999|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
15206000|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15206001|NCT03725020|Fluorides|fluorides|mesh-list
15206002|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
15206003|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
14846627|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14846628|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
14846629|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846630|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912483|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912484|NCT01369472|Carvedilol|carvedilol|mesh-list
14912485|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14912486|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14912487|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
14912488|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912489|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912490|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912491|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14912492|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
14912493|NCT01369472|Protective Agents|protective agents|mesh-ancestor
14912494|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14912495|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912496|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14912497|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
14912498|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14912499|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14912500|NCT01369576|Zopiclone|zopiclone|mesh-list
14912501|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14912502|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912503|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912504|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
14912505|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14912506|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912507|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912508|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
14912509|NCT01369602|Vitamins|vitamins|mesh-ancestor
14912510|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
14912511|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912512|NCT01369667|Vitamin D|vitamin d|mesh-list
14912513|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
14912514|NCT01369667|Vitamins|vitamins|mesh-ancestor
14912515|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
14912516|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912517|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14912518|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14912519|NCT01369693|Lobeline|lobeline|mesh-list
14912520|NCT01369693|Nicotine|nicotine|mesh-list
14912521|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14912522|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
14912523|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912524|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912525|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14912526|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14912527|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
14912528|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912529|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912530|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
14912531|NCT01369719|Deferasirox|deferasirox|mesh-list
14912532|NCT01369719|Deferoxamine|deferoxamine|mesh-list
14912533|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14912534|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
14912535|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
14912536|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912537|NCT01369719|Siderophores|siderophores|mesh-ancestor
14912538|NCT01369979|Imidacloprid|imidacloprid|mesh-list
14912539|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
14912540|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912541|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912542|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912543|NCT01370031|Charcoal|charcoal|mesh-list
14912544|NCT01370031|Antidotes|antidotes|mesh-ancestor
14846631|NCT01003847|Fenofibrate|fenofibrate|mesh-list
14846632|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14846633|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
14846634|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846635|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14846636|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
14846637|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14846638|NCT01004068|Clomiphene|clomiphene|mesh-list
14846639|NCT01004068|Enclomiphene|enclomiphene|mesh-list
14295765|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
14295766|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846640|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
14846641|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14846642|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
14846643|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846644|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846645|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14846646|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
14846647|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14846648|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14846649|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14846650|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14846651|NCT01004224|Infigratinib|infigratinib|mesh-list
14846652|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846653|NCT01004237|Valsartan|valsartan|mesh-list
14846654|NCT01004237|Pravastatin|pravastatin|mesh-list
14846655|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14846656|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14846657|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14846658|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846659|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14846660|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14846661|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
14846662|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14846663|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14846664|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846665|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14846666|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14846667|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14846668|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
14846669|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846670|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846671|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846672|NCT01004315|Urological Agents|urological agents|mesh-ancestor
14846673|NCT01004380|Carboplatin|carboplatin|mesh-list
14846674|NCT01004380|Farletuzumab|farletuzumab|mesh-list
14846675|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846676|NCT01004419|Fulvestrant|fulvestrant|mesh-list
14846677|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14846678|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846679|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14846680|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14846681|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
14846682|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846683|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846684|NCT01004445|Amikacin|amikacin|mesh-list
14846685|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14846686|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846687|NCT01004497|Cytarabine|cytarabine|mesh-list
14846688|NCT01004497|Dexamethasone|dexamethasone|mesh-list
14846689|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
14846690|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
14846691|NCT01004497|Vincristine|vincristine|mesh-list
14846692|NCT01004497|Daunorubicin|daunorubicin|mesh-list
14846693|NCT01004497|Dasatinib|dasatinib|mesh-list
14846694|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
14846695|NCT01004497|BB 1101|bb 1101|mesh-list
14846696|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846697|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
14846698|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846699|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846700|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846701|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
14846702|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846703|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295767|NCT00583453|Celecoxib|celecoxib|mesh-list
14846704|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14846705|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846706|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
14846707|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
14846708|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846709|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14846710|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
14846711|NCT01004497|Hormones|hormones|mesh-ancestor
14846712|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846713|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14846714|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
14846715|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846716|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14846717|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
14846718|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
14846719|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846720|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14846721|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846722|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846723|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
14846724|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14846725|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14846726|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14846727|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846728|NCT01004497|Analgesics|analgesics|mesh-ancestor
14846729|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
14846730|NCT01004575|Cobalt|cobalt|mesh-list
14846731|NCT01004575|Chromium|chromium|mesh-list
14846732|NCT01004575|Trace Elements|trace elements|mesh-ancestor
14846733|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
14846734|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846735|NCT01004601|Docetaxel|docetaxel|mesh-list
14846736|NCT01004601|Pemetrexed|pemetrexed|mesh-list
14846737|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846738|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846739|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846740|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
14846741|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846742|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846743|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14846744|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14846745|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
14846746|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846747|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
14846748|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
14846749|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
14846750|NCT01004731|Gemcitabine|gemcitabine|mesh-list
14846751|NCT01004731|Carboplatin|carboplatin|mesh-list
14846752|NCT01004731|Cetuximab|cetuximab|mesh-list
14846753|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846754|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14846755|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
14846756|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846757|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
14846758|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846759|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846760|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846761|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
14846762|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846763|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14846764|NCT01004809|Dutasteride|dutasteride|mesh-list
14846765|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14846766|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14846767|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846768|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846769|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
14846770|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846771|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846772|NCT01004900|Timolol|timolol|mesh-list
14846773|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14846774|NCT01004900|Travoprost|travoprost|mesh-list
14846775|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14846776|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14846777|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
14846778|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846779|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846780|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846781|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14846782|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14846783|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14846784|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14846785|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14846786|NCT01005095|Vitamin D|vitamin d|mesh-list
14846787|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
14846788|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
14846789|NCT01005095|Vitamins|vitamins|mesh-list
14846790|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
14846791|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846792|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14846793|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14846794|NCT01005121|Colchicine|colchicine|mesh-list
14846795|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
14846796|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846797|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846798|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846799|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
14846800|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846801|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846802|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
14846803|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14846804|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14846805|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846806|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
14846807|NCT01005147|Coagulants|coagulants|mesh-ancestor
14846808|NCT01005160|Metformin|metformin|mesh-list
14846809|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14846810|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846811|NCT01005199|Everolimus|everolimus|mesh-list
14846812|NCT01005199|Sorafenib|sorafenib|mesh-list
14846813|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846814|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846815|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
14846816|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846817|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846818|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846819|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846820|NCT01005238|Lamivudine|lamivudine|mesh-list
14846821|NCT01005238|Telbivudine|telbivudine|mesh-list
14846822|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14846823|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14846824|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846825|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846826|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
14846827|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846828|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14846829|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14846830|NCT01005303|Vitamin D|vitamin d|mesh-list
14846831|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
14846832|NCT01005303|Vitamins|vitamins|mesh-ancestor
14846833|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
14846834|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846835|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14846836|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14846837|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
14846838|NCT01005381|Vitamin D|vitamin d|mesh-list
14846839|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
14846840|NCT01005381|Calcium|calcium|mesh-list
14846841|NCT01005381|Vitamins|vitamins|mesh-ancestor
14846842|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
14846843|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846844|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14846845|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14846846|NCT01005381|Antacids|antacids|mesh-ancestor
14846847|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846848|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14846849|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
14846850|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14846851|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14846852|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846853|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14846854|NCT01005433|Analgesics|analgesics|mesh-ancestor
14846855|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
14846856|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846857|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14846858|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14846859|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14846860|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
14846861|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14846862|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295768|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295769|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14295770|NCT00583453|Analgesics|analgesics|mesh-ancestor
14295771|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
14295772|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706813|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
14706814|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
14706815|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
14706816|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706817|NCT00420537|Cyclosporine|cyclosporine|mesh-list
14706818|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
14706819|NCT00420537|Everolimus|everolimus|mesh-list
14706820|NCT00420537|Cyclosporins|cyclosporins|mesh-list
14706821|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706822|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706823|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706824|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
14706825|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706826|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
14846863|NCT01005472|Temozolomide|temozolomide|mesh-list
14846864|NCT01005472|Sunitinib|sunitinib|mesh-list
14846865|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846866|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
14846867|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846868|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846869|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14846870|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14846871|NCT01005472|Growth Substances|growth substances|mesh-ancestor
14846872|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846873|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
14846874|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846875|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846876|NCT01005537|Aldesleukin|aldesleukin|mesh-list
14846877|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
14846878|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846879|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
14846880|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846881|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846882|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846883|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
14846884|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846885|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846886|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14846887|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14846888|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14846889|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
14846890|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846891|NCT01005550|Ropivacaine|ropivacaine|mesh-list
14846892|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
14846893|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
14846894|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14846895|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846896|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
14846897|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846898|NCT01005628|Bortezomib|bortezomib|mesh-list
14846899|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846900|NCT01005641|Lapatinib|lapatinib|mesh-list
14846901|NCT01005641|Exemestane|exemestane|mesh-list
14846902|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846903|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846904|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846905|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846906|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14846907|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14846908|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14846909|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
14846910|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846911|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912545|NCT01370031|Protective Agents|protective agents|mesh-ancestor
14912546|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912547|NCT01370096|Epoprostenol|epoprostenol|mesh-list
14912548|NCT01370096|Vasopressins|vasopressins|mesh-list
14912549|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
14912550|NCT01370096|Tezosentan|tezosentan|mesh-list
14912551|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
14912552|NCT01370096|Coagulants|coagulants|mesh-ancestor
14912553|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14912554|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14912555|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
14912556|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912557|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14912558|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14912559|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
14912560|NCT01370135|Ranibizumab|ranibizumab|mesh-list
14846912|NCT01005758|Cytarabine|cytarabine|mesh-list
14846913|NCT01005758|Dexamethasone|dexamethasone|mesh-list
14846914|NCT01005758|Prednisone|prednisone|mesh-list
14846915|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
14846916|NCT01005758|Prednisolone|prednisolone|mesh-list
14846917|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
14846918|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14846919|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14846920|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14846921|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
14846922|NCT01005758|Doxorubicin|doxorubicin|mesh-list
14846923|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14846924|NCT01005758|Methotrexate|methotrexate|mesh-list
14846925|NCT01005758|Etoposide|etoposide|mesh-list
14846926|NCT01005758|Vincristine|vincristine|mesh-list
14846927|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
14846928|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
14846929|NCT01005758|Pegaspargase|pegaspargase|mesh-list
14846930|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
14846931|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846932|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
14846933|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846934|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846935|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846936|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
14846937|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846938|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846939|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14846940|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14846941|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
14846942|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
14846943|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14846944|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14846945|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
14846946|NCT01005758|Hormones|hormones|mesh-ancestor
14846947|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846948|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14846949|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14846950|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14846951|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14846952|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846953|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14846954|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
14846955|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14846956|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14846957|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
14846958|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
14846959|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14846960|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14846961|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14846962|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
14846963|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14846964|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
14846965|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
14846966|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
14846967|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14846968|NCT01005758|Protective Agents|protective agents|mesh-ancestor
14846969|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846970|NCT01005784|Cetrorelix|cetrorelix|mesh-list
14846971|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14846972|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
15206004|NCT03725020|Protective Agents|protective agents|mesh-ancestor
15206005|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206006|NCT03724955|Estradiol|estradiol|mesh-list
15206007|NCT03724955|Estrogens|estrogens|mesh-ancestor
15206008|NCT03724955|Hormones|hormones|mesh-ancestor
15206009|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206010|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206011|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
15206012|NCT03724838|Esomeprazole|esomeprazole|mesh-list
14846973|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14846974|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846975|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
15206013|NCT03724838|Citric Acid|citric acid|mesh-list
14846976|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14846977|NCT01005797|Sorafenib|sorafenib|mesh-list
14846978|NCT01005797|Panobinostat|panobinostat|mesh-list
14846979|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846980|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14846981|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14846982|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14846983|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14846984|NCT01005927|Calcium|calcium|mesh-list
14846985|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14846986|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846987|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
14846988|NCT01005979|Rituximab|rituximab|mesh-list
14846989|NCT01005979|Lenalidomide|lenalidomide|mesh-list
14846990|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846991|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
14846992|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14846993|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14846994|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14846995|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
14846996|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706827|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706828|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
14706829|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706830|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14706831|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706832|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14706833|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14706834|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
14706835|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706836|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
14706837|NCT00420563|Megestrol|megestrol|mesh-list
14706838|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14846997|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14846998|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14846999|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14847000|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14847001|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14847002|NCT01005979|Growth Substances|growth substances|mesh-ancestor
14847003|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
14847004|NCT01006031|Interferons|interferons|mesh-list
14847005|NCT01006031|Ribavirin|ribavirin|mesh-list
14847006|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
14847007|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
14847008|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14847009|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847010|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
14847011|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847012|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
14847013|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847014|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
14847015|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847016|NCT01006057|Insulin|insulin|mesh-list
14847017|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14847018|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
14847019|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14847020|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847021|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14847022|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847023|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14847024|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847025|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847026|NCT01006187|Lidocaine|lidocaine|mesh-list
14847027|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
14847028|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
14847029|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847030|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706839|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
14847031|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
14847032|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847033|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14847034|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14847035|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14847036|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14847037|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847038|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
14847039|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14847040|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847041|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
14847042|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14847043|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706840|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706841|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706842|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14706843|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
14706844|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706845|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706846|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14706847|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14706848|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14706849|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14706850|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
14706851|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14847044|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847045|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14847046|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14847047|NCT01006499|Protective Agents|protective agents|mesh-ancestor
14847048|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847049|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
14847050|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14847051|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
14847052|NCT01006525|Zolpidem|zolpidem|mesh-list
14847053|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14847054|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14847055|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847056|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847057|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14847058|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
14847059|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
14847060|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847061|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847062|NCT01006551|Ziprasidone|ziprasidone|mesh-list
14847063|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14847064|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
14847065|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847066|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847067|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847068|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14847069|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14847070|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847071|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847072|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14847073|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
14847074|NCT01006668|Propofol|propofol|mesh-list
14847075|NCT01006668|Sevoflurane|sevoflurane|mesh-list
14847076|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14847077|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847078|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847079|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14847080|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
14847081|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
14847082|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14847083|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14847084|NCT01006681|Vaccines|vaccines|mesh-list
14847085|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14847086|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
15206014|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
15206015|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
15206016|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15206017|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
15206018|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
14706852|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14706853|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14706854|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14706855|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14847087|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847088|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14847089|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
14847090|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847091|NCT01006720|Neostigmine|neostigmine|mesh-list
14847092|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14847093|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847094|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847095|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
14847096|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847097|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847098|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14847099|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
14847100|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847101|NCT01006798|Vaccines|vaccines|mesh-list
14847102|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
14847103|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847104|NCT01006863|Phenylephrine|phenylephrine|mesh-list
14847105|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
14847106|NCT01006863|Ephedrine|ephedrine|mesh-list
14847107|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14706856|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14706857|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14706858|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847108|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
14847109|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
14847110|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847111|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847112|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
14847113|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14847114|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
14847115|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847116|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14847117|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14706859|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847118|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14847119|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
14847120|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847121|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847122|NCT01006863|Protective Agents|protective agents|mesh-ancestor
14847123|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14847124|NCT01006876|Warfarin|warfarin|mesh-list
14847125|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
14847126|NCT01007019|Esomeprazole|esomeprazole|mesh-list
14847127|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14847128|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847129|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14847130|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847131|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847132|NCT01007084|Propranolol|propranolol|mesh-list
14847133|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14847134|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14847135|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706860|NCT00420589|Hormones|hormones|mesh-ancestor
14706861|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847136|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847137|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847138|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847139|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14847140|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14847141|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
14847142|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14847143|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14847144|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14847145|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
14706862|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706863|NCT00420615|Epothilone B|epothilone b|mesh-list
14706864|NCT00420615|Epothilones|epothilones|mesh-list
14847146|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847147|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14847148|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14847149|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847150|NCT01007500|Dexamethasone|dexamethasone|mesh-list
14847151|NCT01007500|Ondansetron|ondansetron|mesh-list
14847152|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14847153|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
14847154|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
14847155|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847156|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847157|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847158|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
14847159|NCT01007500|Hormones|hormones|mesh-ancestor
14847160|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847161|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14847162|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847163|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
14847164|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
14847165|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14847166|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
14847167|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847168|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847169|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14847170|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14847171|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847172|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847173|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14847174|NCT01007539|Choline|choline|mesh-list
14847175|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14847176|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
14847177|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14847178|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
14847179|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706865|NCT00420615|Omeprazole|omeprazole|mesh-list
14706866|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14706867|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14706868|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14706869|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706870|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706871|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847180|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847181|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14847182|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
14912561|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14912562|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912563|NCT01370135|Growth Substances|growth substances|mesh-ancestor
14912564|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912565|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912566|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912567|NCT01370148|Conivaptan|conivaptan|mesh-list
14912568|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14912569|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912570|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
14912571|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912572|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14295773|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912573|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14912574|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
14912575|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847183|NCT01007565|Anesthetics|anesthetics|mesh-list
14847184|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847185|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847186|NCT01007578|Paclitaxel|paclitaxel|mesh-list
14847187|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14847188|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847189|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
14847190|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
14847191|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
14847192|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847193|NCT01007630|Rasagiline|rasagiline|mesh-list
14847194|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14847195|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847196|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847197|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14847198|NCT01007630|Protective Agents|protective agents|mesh-ancestor
14847199|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847200|NCT01007695|Valproic Acid|valproic acid|mesh-list
14847201|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
14847202|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847203|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847204|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
14847205|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847206|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847207|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
14847208|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14847209|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847210|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847211|NCT01007773|Fentanyl|fentanyl|mesh-list
14847212|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
14847213|NCT01007773|Propofol|propofol|mesh-list
14847214|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14847215|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847216|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847217|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14847218|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
14847219|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
14847220|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14847221|NCT01007773|Analgesics|analgesics|mesh-ancestor
14847222|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
14847223|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847224|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14847225|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14847226|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14847227|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
14847228|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847229|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847230|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14847231|NCT01007773|Narcotics|narcotics|mesh-ancestor
14847232|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14847233|NCT01007799|Vitamin D|vitamin d|mesh-list
14847234|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
14847235|NCT01007799|Vitamins|vitamins|mesh-list
14847236|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
14847237|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847238|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14847239|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14847240|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14847241|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
14847242|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14847243|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
14847244|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14847245|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847246|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14847247|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14847248|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847249|NCT01007864|Pramipexole|pramipexole|mesh-list
14847250|NCT01007864|Ropinirole|ropinirole|mesh-list
14847251|NCT01007864|Piribedil|piribedil|mesh-list
14847252|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
14847253|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847254|NCT01007864|Protective Agents|protective agents|mesh-ancestor
14847255|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847256|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14847257|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14847258|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
14847259|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
14847260|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847261|NCT01007968|Panobinostat|panobinostat|mesh-list
14847262|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847263|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14847264|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847265|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847266|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14847267|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
14847268|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847269|NCT01008020|Protective Agents|protective agents|mesh-ancestor
14706872|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14706873|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14706874|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14706875|NCT00420654|Hormones|hormones|mesh-list
14706876|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706877|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706878|NCT00420667|Enoxaparin|enoxaparin|mesh-list
14706879|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
14706880|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15206019|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206020|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
15206021|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15206022|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15206023|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295774|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706881|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14847270|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847271|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14847272|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14847273|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847274|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14847275|NCT01008046|Metformin|metformin|mesh-list
14847276|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
14847277|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14847278|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14847279|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847280|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
14847281|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847282|NCT01008046|Expectorants|expectorants|mesh-ancestor
14847283|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847284|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14847285|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
14847286|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847287|NCT01008046|Protective Agents|protective agents|mesh-ancestor
14847288|NCT01008046|Antidotes|antidotes|mesh-ancestor
14847289|NCT01008098|Citalopram|citalopram|mesh-list
14847290|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14847291|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14847292|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14847293|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847294|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847295|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
15206024|NCT03724838|Urological Agents|urological agents|mesh-ancestor
15206025|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15206026|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206027|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15206028|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
15206029|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15206030|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
15206031|NCT03724578|Fluorides|fluorides|mesh-list
15206032|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
15206033|NCT03724578|Protective Agents|protective agents|mesh-ancestor
15206034|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847296|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847297|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14847298|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
14847299|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847300|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14847301|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14847302|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847303|NCT01008137|Vaccines|vaccines|mesh-list
14847304|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
14847305|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847306|NCT01008293|Lactulose|lactulose|mesh-list
14847307|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847308|NCT01008345|Ezetimibe|ezetimibe|mesh-list
14847309|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14847310|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14847311|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
14847312|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847313|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14847314|NCT01008358|Tremelimumab|tremelimumab|mesh-list
14847315|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847316|NCT01008384|Vitamin D|vitamin d|mesh-list
14847317|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
14847318|NCT01008384|Vitamins|vitamins|mesh-ancestor
14847319|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
14847320|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847321|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14847322|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14847323|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14847324|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847325|NCT01008527|Poly ICLC|poly iclc|mesh-list
14847326|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
14847327|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
14847328|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847329|NCT01008566|Sorafenib|sorafenib|mesh-list
14847330|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14847331|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847332|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14847333|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847334|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847335|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
14847336|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847337|NCT01008592|Levocetirizine|levocetirizine|mesh-list
14847338|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15206035|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15206036|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206037|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
14847339|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14847340|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
14847341|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
14847342|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847343|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847344|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847345|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
14847346|NCT01008631|Antidotes|antidotes|mesh-ancestor
14847347|NCT01008631|Protective Agents|protective agents|mesh-ancestor
14847348|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847349|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
14847350|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847351|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
14847352|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14847353|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847354|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
14847355|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
14847356|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14847357|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14847358|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
14847359|NCT01008709|Hormones|hormones|mesh-ancestor
14847360|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847361|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847362|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847363|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847364|NCT01008761|Azithromycin|azithromycin|mesh-list
14847365|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14847366|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847367|NCT01008813|Vaccines|vaccines|mesh-list
14847368|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
14847369|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847370|NCT01008917|Sirolimus|sirolimus|mesh-list
14847371|NCT01008917|Sorafenib|sorafenib|mesh-list
14847372|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847373|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14847374|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847375|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847376|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14847377|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847378|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14847379|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
14847380|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847381|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
14847382|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847383|NCT01008982|Belimumab|belimumab|mesh-list
14847384|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847385|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
14847386|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847387|NCT01009021|Diclofenac|diclofenac|mesh-list
14847388|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14847389|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14847390|NCT01009021|Analgesics|analgesics|mesh-ancestor
14847391|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
14847392|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847393|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847394|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14847395|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14847396|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14847397|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847398|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847399|NCT01009073|Irinotecan|irinotecan|mesh-list
14847400|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14847401|NCT01009073|Navitoclax|navitoclax|mesh-list
14847402|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14847403|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14847404|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847405|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847406|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847407|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14847408|NCT01009177|Bosentan|bosentan|mesh-list
14847409|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14847410|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14847411|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847412|NCT01009190|Carboplatin|carboplatin|mesh-list
14847413|NCT01009190|Rucaparib|rucaparib|mesh-list
14847414|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847415|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14847416|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847417|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912576|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912577|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912578|NCT01370187|Montelukast|montelukast|mesh-list
14912579|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14912580|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
14912581|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14912582|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
14912583|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912584|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912585|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14912586|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14912587|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912588|NCT01370291|Risperidone|risperidone|mesh-list
15206038|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206039|NCT03724266|Chitosan|chitosan|mesh-list
15206040|NCT03724266|Calcium|calcium|mesh-list
15206041|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206042|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206043|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15206044|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15206045|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
15206046|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847418|NCT01009437|Ritonavir|ritonavir|mesh-list
14847419|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14847420|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14847421|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
14847422|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847423|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847424|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14847425|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14847426|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
14847427|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847428|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14847429|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14847430|NCT01009476|Nicergoline|nicergoline|mesh-list
14847431|NCT01009476|Piracetam|piracetam|mesh-list
14847432|NCT01009476|Galantamine|galantamine|mesh-list
14847433|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
14847434|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14847435|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847436|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847437|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
14847438|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847439|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847440|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14847441|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
14847442|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847443|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14847444|NCT01009476|Protective Agents|protective agents|mesh-ancestor
14847445|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14847446|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14847447|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
14847448|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
14847449|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14847450|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14847451|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14847452|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847453|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
14847454|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14847455|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
14847456|NCT01009541|Pregabalin|pregabalin|mesh-list
14847457|NCT01009541|Analgesics|analgesics|mesh-ancestor
14847458|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
14847459|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847460|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847461|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
14847462|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14847463|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14847464|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295775|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14706882|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706883|NCT00420693|Sevoflurane|sevoflurane|mesh-list
14706884|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14706885|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14706886|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
14706887|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
14706888|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14706889|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706890|NCT00420797|Phenylephrine|phenylephrine|mesh-list
14706891|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
14706892|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14706893|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
14706894|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
14706895|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847465|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14847466|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14847467|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14847468|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847469|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847470|NCT01009567|Cabergoline|cabergoline|mesh-list
14847471|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14847472|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14847473|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
14847474|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
14847475|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206047|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15206048|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
15206049|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
14847476|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847477|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847478|NCT01009593|Sorafenib|sorafenib|mesh-list
14847479|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847480|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14847481|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847482|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847483|NCT01009697|Codeine|codeine|mesh-list
14847484|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14847485|NCT01009697|Narcotics|narcotics|mesh-ancestor
14847486|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847487|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847488|NCT01009697|Analgesics|analgesics|mesh-ancestor
14847489|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
14847490|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847491|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
14847492|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847493|NCT01009788|Temozolomide|temozolomide|mesh-list
14847494|NCT01009788|Veliparib|veliparib|mesh-list
15206050|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
14847495|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14847496|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
15206051|NCT03724266|Coagulants|coagulants|mesh-ancestor
15206052|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15206053|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15206054|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206055|NCT03724071|Flucytosine|flucytosine|mesh-list
15206056|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
15206057|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206058|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
15206059|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206060|NCT03723941|Etoposide|etoposide|mesh-list
15206061|NCT03723941|Mitotane|mitotane|mesh-list
15206062|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206063|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15206064|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15206065|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15206066|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206067|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206068|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224858|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224859|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
15224860|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224861|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
14706896|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224862|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206069|NCT03723824|Grazoprevir|grazoprevir|mesh-list
15206070|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
15206071|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
14847497|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847498|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847499|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14847500|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847501|NCT01009801|Doxorubicin|doxorubicin|mesh-list
14847502|NCT01009801|Everolimus|everolimus|mesh-list
14847503|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14847504|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847505|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14847506|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14847507|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847508|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847509|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847510|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
14847511|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847512|NCT01009853|Codeine|codeine|mesh-list
14847513|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14847514|NCT01009853|Narcotics|narcotics|mesh-ancestor
14847515|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847516|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847517|NCT01009853|Analgesics|analgesics|mesh-ancestor
14847518|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
14847519|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847520|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
14847521|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847522|NCT01009879|Etanercept|etanercept|mesh-list
14847523|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14847524|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14847525|NCT01009879|Analgesics|analgesics|mesh-ancestor
14847526|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
14847527|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847528|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847529|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14847530|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14847531|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847532|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847533|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
14847534|NCT01009892|Codeine|codeine|mesh-list
14847535|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14847536|NCT01009892|Narcotics|narcotics|mesh-ancestor
14847537|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847538|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847539|NCT01009892|Analgesics|analgesics|mesh-ancestor
14847540|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
14847541|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847542|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
14847543|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847544|NCT01009944|Atenolol|atenolol|mesh-list
14847545|NCT01009944|Lisinopril|lisinopril|mesh-list
14847546|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14847547|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14847548|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847549|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847550|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14847551|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14847552|NCT01009944|Protective Agents|protective agents|mesh-ancestor
14847553|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847554|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14847555|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
14847556|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
14847557|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847558|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14847559|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14847560|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14847561|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
15206072|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206073|NCT03723785|Insulin|insulin|mesh-list
15206074|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15206075|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15206076|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206077|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
14847562|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847563|NCT01009957|Everolimus|everolimus|mesh-list
14847564|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847565|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847566|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
14847567|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847568|NCT01009970|Prednisone|prednisone|mesh-list
14847569|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
14847570|NCT01009970|Rituximab|rituximab|mesh-list
14847571|NCT01009970|Doxorubicin|doxorubicin|mesh-list
14847572|NCT01009970|Vincristine|vincristine|mesh-list
14847573|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847574|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
14847575|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847576|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14847577|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14847578|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
14847579|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847580|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847581|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14847582|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14847583|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14847584|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14847585|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14847586|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847587|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14847588|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
14847589|NCT01009970|Hormones|hormones|mesh-ancestor
14847590|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847591|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14847592|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14847593|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
14847594|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
14847595|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
14847596|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14847597|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
14847598|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
14847599|NCT01010048|Nifedipine|nifedipine|mesh-list
14847600|NCT01010048|Bromides|bromides|mesh-list
14847601|NCT01010048|Propantheline|propantheline|mesh-list
14847602|NCT01010048|Tamsulosin|tamsulosin|mesh-list
14847603|NCT01010048|Progesterone|progesterone|mesh-list
14847604|NCT01010048|Progestins|progestins|mesh-ancestor
14847605|NCT01010048|Hormones|hormones|mesh-ancestor
14847606|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847607|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847608|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
14847609|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14847610|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14847611|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14847612|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14847613|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847614|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847615|NCT01010048|Urological Agents|urological agents|mesh-ancestor
14847616|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14847617|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14847618|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14847619|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
14847620|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
14847621|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14847622|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14847623|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847624|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14847625|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14847626|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
14847627|NCT01010087|Oseltamivir|oseltamivir|mesh-list
14847628|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
14847629|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847630|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847631|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847632|NCT01010100|Acarbose|acarbose|mesh-list
14847633|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14847634|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847635|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847636|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15206078|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
14847637|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847638|NCT01010139|Codeine|codeine|mesh-list
14847639|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14847640|NCT01010139|Narcotics|narcotics|mesh-ancestor
14847641|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847642|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847643|NCT01010139|Analgesics|analgesics|mesh-ancestor
14847644|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
14847645|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847646|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
14847647|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847648|NCT01010152|Codeine|codeine|mesh-list
14847649|NCT01010152|Analgesics|analgesics|mesh-ancestor
14847650|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
14847651|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847652|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847653|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14847654|NCT01010152|Narcotics|narcotics|mesh-ancestor
14847655|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847656|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
14847657|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847658|NCT01010178|Theophylline|theophylline|mesh-list
14847659|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14847660|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
14847661|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847662|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847663|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14847664|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847665|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14847666|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847667|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847668|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
14847669|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14847670|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14847671|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
15206079|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15206080|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15206081|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206082|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15206083|NCT03723395|Repaglinide|repaglinide|mesh-list
15206084|NCT03723395|Tolbutamide|tolbutamide|mesh-list
15206085|NCT03723395|Itraconazole|itraconazole|mesh-list
14847672|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847673|NCT01010243|Pioglitazone|pioglitazone|mesh-list
14847674|NCT01010243|Dexamethasone|dexamethasone|mesh-list
14847675|NCT01010243|Lenalidomide|lenalidomide|mesh-list
14847676|NCT01010243|Treosulfan|treosulfan|mesh-list
14847677|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14847678|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
14847679|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
14847680|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847681|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847682|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847683|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
14847684|NCT01010243|Hormones|hormones|mesh-ancestor
14847685|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847686|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15206086|NCT03723395|Rifampin|rifampin|mesh-list
15206087|NCT03723395|Tucatinib|tucatinib|mesh-list
15206088|NCT03723395|Digoxin|digoxin|mesh-list
15206089|NCT03723395|Midazolam|midazolam|mesh-list
15206090|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
15206091|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15206092|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14847687|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847688|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
14847689|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14847690|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14847691|NCT01010243|Growth Substances|growth substances|mesh-ancestor
14847692|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
14847693|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14847694|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14847695|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
14847696|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847697|NCT01010295|Doxycycline|doxycycline|mesh-list
14847698|NCT01010295|Tetracycline|tetracycline|mesh-list
14847699|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14847700|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847701|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
14847702|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14847703|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14847704|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14847705|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847706|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847707|NCT01010308|Nadolol|nadolol|mesh-list
14847708|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14847709|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15206093|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206094|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206095|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15206096|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15206097|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15206098|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15206099|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
15206100|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
15206101|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
15206102|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
14847710|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
14847711|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847712|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847713|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847714|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14847715|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14847716|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
14847717|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
14847718|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847719|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14847720|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14847721|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
14847722|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847723|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847724|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14847725|NCT01010373|Protective Agents|protective agents|mesh-ancestor
14847726|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14847727|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14847728|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847729|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847730|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
14847731|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847732|NCT01010425|Hormones|hormones|mesh-list
14847733|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847734|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847735|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
14847736|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14847737|NCT01010451|Calcium|calcium|mesh-list
14847738|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14847739|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847740|NCT01010490|Dipivefrin|dipivefrin|mesh-list
14847741|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14847742|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
14847743|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847744|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847745|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847746|NCT01010516|Niacin|niacin|mesh-list
14847747|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15206103|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295776|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14295777|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14295778|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295779|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295780|NCT00583557|Belimumab|belimumab|mesh-list
14295781|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14295782|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
14295783|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706897|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
14847748|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14847749|NCT01010516|Fenofibrate|fenofibrate|mesh-list
14847750|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14847751|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14847752|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
14847753|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847754|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14847755|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847756|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
14847757|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
14847758|NCT01010516|Vitamins|vitamins|mesh-ancestor
14847759|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
14847760|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847761|NCT01010581|Folic Acid|folic acid|mesh-list
14847762|NCT01010581|Methotrexate|methotrexate|mesh-list
14847763|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14706898|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14706899|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
14706900|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
14706901|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14706902|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14706903|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14706904|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706905|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706906|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706907|NCT00420797|Protective Agents|protective agents|mesh-ancestor
14706908|NCT00420836|Tobramycin|tobramycin|mesh-list
14706909|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14706910|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706911|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
14847764|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
14847765|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14847766|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847767|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14847768|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
14847769|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847770|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847771|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
14847772|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847773|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14847774|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847775|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
14847776|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14847777|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14847778|NCT01010581|Hematinics|hematinics|mesh-ancestor
14847779|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
14847780|NCT01010581|Vitamins|vitamins|mesh-ancestor
14847781|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
14847782|NCT01010646|Ribavirin|ribavirin|mesh-list
14706912|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
14706913|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14706914|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14706915|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706916|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706917|NCT00420901|Urological Agents|urological agents|mesh-ancestor
14706918|NCT00420953|Amiodarone|amiodarone|mesh-list
14847783|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
15206104|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206105|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
15206106|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206107|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15206108|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15206109|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206110|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15206111|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
15224863|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
14706919|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14706920|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
14706921|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14706922|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14706923|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706924|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14706925|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14706926|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14706927|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706928|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14847784|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
14847785|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14847786|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
14847787|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847788|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
14847789|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847790|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
14847791|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847792|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847793|NCT01010672|Sirolimus|sirolimus|mesh-list
14847794|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14847795|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847796|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14847797|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847798|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
14847799|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847800|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
14847801|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847802|NCT01010698|Acyclovir|acyclovir|mesh-list
14847803|NCT01010698|Cimetidine|cimetidine|mesh-list
14847804|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
14847805|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847806|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14847807|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847808|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14847809|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
14847810|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
14847811|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847812|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847813|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847814|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14847815|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14847816|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847817|NCT01010789|Modafinil|modafinil|mesh-list
14847818|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14847819|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706929|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14847820|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14847821|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14847822|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14847823|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847824|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
14847825|NCT01010802|Hematinics|hematinics|mesh-ancestor
14847826|NCT01010893|Vaccines|vaccines|mesh-list
14847827|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
14847828|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847829|NCT01010945|Gemcitabine|gemcitabine|mesh-list
14847830|NCT01010945|Paclitaxel|paclitaxel|mesh-list
14847831|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14847832|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14847833|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847834|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14847835|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14847836|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14706930|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14706931|NCT00421018|Montelukast|montelukast|mesh-list
14706932|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14706933|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
14706934|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14706935|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
14706936|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847837|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847838|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14847839|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
14847840|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
14847841|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847842|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847843|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847844|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
14847845|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706937|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706938|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14706939|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14706940|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706941|NCT00421044|Epothilone B|epothilone b|mesh-list
14706942|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706943|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
14706944|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
14706945|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
14706946|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706947|NCT00421083|Tadalafil|tadalafil|mesh-list
14706948|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
14706949|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14847846|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14847847|NCT01010958|Valproic Acid|valproic acid|mesh-list
14847848|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
14847849|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847850|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847851|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
14847852|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847853|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847854|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
14847855|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14847856|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847857|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847858|NCT01011010|Doxorubicin|doxorubicin|mesh-list
14847859|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14847860|NCT01011010|Mitomycins|mitomycins|mesh-list
14847861|NCT01011010|Mitomycin|mitomycin|mesh-list
14847862|NCT01011010|Sorafenib|sorafenib|mesh-list
14847863|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14847864|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847865|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14847866|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14847867|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847868|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847869|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14847870|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
14847871|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14847872|NCT01011036|Clonazepam|clonazepam|mesh-list
14847873|NCT01011036|Clobazam|clobazam|mesh-list
14847874|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14847875|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14847876|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14847877|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
14847878|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847879|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847880|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847881|NCT01011036|Urological Agents|urological agents|mesh-ancestor
14847882|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
14847883|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
14847884|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
14847885|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14847886|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14847887|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14847888|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14847889|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14295784|NCT00583622|Gemcitabine|gemcitabine|mesh-list
14706950|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14847890|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
14847891|NCT01011062|Losartan|losartan|mesh-list
14847892|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14847893|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14847894|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14847895|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14847896|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847897|NCT01011114|Cinacalcet|cinacalcet|mesh-list
14847898|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14847899|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847900|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14847901|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
14847902|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847903|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14847904|NCT01011127|Pravastatin|pravastatin|mesh-list
14847905|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14847906|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14847907|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
14847908|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847909|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14847910|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14847911|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847912|NCT01011166|Ribavirin|ribavirin|mesh-list
14847913|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14847914|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
14847915|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847916|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
14847917|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847918|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
14847919|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
14847920|NCT01011205|Tacrolimus|tacrolimus|mesh-list
14847921|NCT01011205|Basiliximab|basiliximab|mesh-list
14847922|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14847923|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
14847924|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847925|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15206112|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206113|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15206114|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14847926|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847927|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847928|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14847929|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847930|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14847931|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
14847932|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14847933|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14847934|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14847935|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
14847936|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
14847937|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14847938|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847939|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
14847940|NCT01011205|Hormones|hormones|mesh-ancestor
14847941|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847942|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14847943|NCT01011205|Protective Agents|protective agents|mesh-ancestor
14847944|NCT01011257|Clopidogrel|clopidogrel|mesh-list
15206115|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
15206116|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15206117|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
15206118|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15206119|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15206120|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14847945|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14847946|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14847947|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14847948|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14847949|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
14847950|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14847951|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847952|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912589|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14912590|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
14912591|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912592|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912593|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912594|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14912595|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14912596|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912597|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912598|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14912599|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
14912600|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14912601|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14912602|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14912603|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912604|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912605|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912606|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912607|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912608|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912609|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912610|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14912611|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912612|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706951|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706952|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847953|NCT01011348|Ubiquinone|ubiquinone|mesh-list
14847954|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
14706953|NCT00421083|Urological Agents|urological agents|mesh-ancestor
14706954|NCT00421096|Gemcitabine|gemcitabine|mesh-list
14706955|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14706956|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14706957|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
14706958|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847955|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
14847956|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847957|NCT01011348|Vitamins|vitamins|mesh-ancestor
14847958|NCT01011374|Ranibizumab|ranibizumab|mesh-list
14847959|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14847960|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14847961|NCT01011374|Growth Substances|growth substances|mesh-ancestor
14847962|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847963|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
14847964|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14847965|NCT01011426|Bisacodyl|bisacodyl|mesh-list
14847966|NCT01011426|Cathartics|cathartics|mesh-ancestor
14847967|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14847968|NCT01011426|Laxatives|laxatives|mesh-ancestor
14847969|NCT01011452|Montelukast|montelukast|mesh-list
14847970|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14847971|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
14847972|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14847973|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
14847974|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14847975|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847976|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14847977|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14847978|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847979|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14847980|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14847981|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14847982|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
14847983|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847984|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14847985|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14847986|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14847987|NCT01011530|Pevonedistat|pevonedistat|mesh-list
14847988|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706959|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
14706960|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14706961|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14706962|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14706963|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
14706964|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14847989|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14847990|NCT01011621|Prednisolone|prednisolone|mesh-list
15206121|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15206122|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15206123|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14706965|NCT00421109|Levocetirizine|levocetirizine|mesh-list
14706966|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14706967|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14706968|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
14706969|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
14706970|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706971|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14706972|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706973|NCT00421122|Budesonide|budesonide|mesh-list
14706974|NCT00421122|Terbutaline|terbutaline|mesh-list
14706975|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
14847991|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15206124|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15206125|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15206126|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15206127|NCT03723395|Protective Agents|protective agents|mesh-ancestor
15206128|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14847992|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
14847993|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14847994|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
14847995|NCT01011621|Betamethasone|betamethasone|mesh-list
14847996|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
14847997|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14847998|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
14847999|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14848000|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
14848001|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14848002|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848003|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
14848004|NCT01011621|Hormones|hormones|mesh-ancestor
14848005|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848006|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848007|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848008|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848009|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
14848010|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
14848011|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848012|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14848013|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14848014|NCT01011621|Protective Agents|protective agents|mesh-ancestor
14848015|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14848016|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
14848017|NCT01011660|Amlodipine|amlodipine|mesh-list
14848018|NCT01011660|Telmisartan|telmisartan|mesh-list
14848019|NCT01011660|Amiloride|amiloride|mesh-list
14848020|NCT01011660|Simvastatin|simvastatin|mesh-list
14848021|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14848022|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14848023|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14848024|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848025|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14848026|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848027|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
14848028|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14848029|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14848030|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
14706976|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14706977|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14706978|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14706979|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
14706980|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14706981|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14706982|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14706983|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
14706984|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
14706985|NCT00421122|Hormones|hormones|mesh-ancestor
14706986|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14706987|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14706988|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14706989|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14706990|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
14706991|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14706992|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848031|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14848032|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14848033|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848034|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14848035|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14848036|NCT01011660|Diuretics|diuretics|mesh-ancestor
14848037|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
14848038|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14848039|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14848040|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14848041|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14848042|NCT01011699|Niacinamide|niacinamide|mesh-list
14848043|NCT01011699|Niacin|niacin|mesh-list
14848044|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
14848045|NCT01011699|Sevelamer|sevelamer|mesh-list
14848046|NCT01011699|Cinacalcet|cinacalcet|mesh-list
14848047|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
14848048|NCT01011699|Vitamins|vitamins|mesh-ancestor
14848049|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
14706993|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
14706994|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
14706995|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14706996|NCT00421187|Amphotericin B|amphotericin b|mesh-list
14706997|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14706998|NCT00421187|Amebicides|amebicides|mesh-ancestor
14706999|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14707000|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14707001|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707002|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14707003|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
14707004|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14707005|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14707006|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
14707007|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
14707008|NCT00421252|Clopidogrel|clopidogrel|mesh-list
14707009|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14707010|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14707011|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14707012|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14707013|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
14707014|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707015|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707016|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707017|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
14848050|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848051|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14848052|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
14848053|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848054|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14848055|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
14848056|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
14848057|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
14848058|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14848059|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14848060|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
14848061|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848062|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14848063|NCT01011751|Leuprolide|leuprolide|mesh-list
14848064|NCT01011751|Flutamide|flutamide|mesh-list
14848065|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
14848066|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14848067|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
14848068|NCT01011751|Cyproterone|cyproterone|mesh-list
14848069|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14848070|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14848071|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14848072|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848073|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848074|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707018|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295785|NCT00583622|Bevacizumab|bevacizumab|mesh-list
14295786|NCT00583622|Carboplatin|carboplatin|mesh-list
14295787|NCT00583622|Docetaxel|docetaxel|mesh-list
14295788|NCT00583622|Melphalan|melphalan|mesh-list
14295789|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14295790|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295791|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14295792|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14848075|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14848076|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
14848077|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14848078|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14848079|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14848080|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14848081|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
14848082|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14848083|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14848084|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14848085|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14707019|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14707020|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707021|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707022|NCT00421369|Sertraline|sertraline|mesh-list
14707023|NCT00421369|Reboxetine|reboxetine|mesh-list
14707024|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
14707025|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707026|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14707027|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14707028|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14707029|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707030|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707031|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
14707032|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295793|NCT00583622|Growth Substances|growth substances|mesh-ancestor
14848086|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848087|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848088|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14848089|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
14848090|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
14848091|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
14848092|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848093|NCT01011920|Cytarabine|cytarabine|mesh-list
14848094|NCT01011920|Rituximab|rituximab|mesh-list
14848095|NCT01011920|Methotrexate|methotrexate|mesh-list
14848096|NCT01011920|Thiotepa|thiotepa|mesh-list
14848097|NCT01011920|Carmustine|carmustine|mesh-list
14848098|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14848099|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848100|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
14848101|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848102|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848103|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14848104|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
14848105|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14848106|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14848107|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
14848108|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848109|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
14848110|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848111|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14848112|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848113|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14848114|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
14848115|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848116|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14848117|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
14848118|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14848119|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
14848120|NCT01011998|Valproic Acid|valproic acid|mesh-list
14848121|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848122|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14295794|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848123|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848124|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848125|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
14848126|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
14848127|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848128|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848129|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
14848130|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14848131|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848132|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14848133|NCT01012011|Sorafenib|sorafenib|mesh-list
14848134|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848135|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14848136|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848137|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848138|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
14848139|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14848140|NCT01012063|Hematinics|hematinics|mesh-ancestor
14848141|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
14848142|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14848143|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
14848144|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848145|NCT01012141|Docetaxel|docetaxel|mesh-list
14848146|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848147|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
14848148|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
14295795|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
14848149|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
14848150|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848151|NCT01012193|Cilostazol|cilostazol|mesh-list
14707033|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14707034|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
14707035|NCT00421395|Epratuzumab|epratuzumab|mesh-list
14707036|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707037|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707038|NCT00421421|Dutasteride|dutasteride|mesh-list
14848152|NCT01012193|Clopidogrel|clopidogrel|mesh-list
14848153|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14848154|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14848155|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14848156|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14848157|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
14848158|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848159|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848160|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848161|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14848162|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
14848163|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848164|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14848165|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
14848166|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14848167|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14848168|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
14848169|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14848170|NCT01012193|Protective Agents|protective agents|mesh-ancestor
14848171|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14848172|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14848173|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848174|NCT01012232|Ropivacaine|ropivacaine|mesh-list
14848175|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
14848176|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
14848177|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848178|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848179|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
14848180|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848181|NCT01012284|Bedaquiline|bedaquiline|mesh-list
14848182|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
14848183|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848184|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848185|NCT01012349|Aspirin|aspirin|mesh-list
14848186|NCT01012349|Citric Acid|citric acid|mesh-list
14848187|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
14707039|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14707040|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14848188|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14848189|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14707041|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848190|NCT01012349|Analgesics|analgesics|mesh-ancestor
14848191|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
14848192|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848193|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848194|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848195|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848196|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14848197|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14848198|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848199|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14848200|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14848201|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848202|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
14848203|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
14848204|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14848205|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
14848206|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
14848207|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14848208|NCT01012479|Candesartan|candesartan|mesh-list
14848209|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
14848210|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14848211|NCT01012479|Diuretics|diuretics|mesh-ancestor
14848212|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
14848213|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848214|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14848215|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14848216|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848217|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14848218|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14848219|NCT01012544|Clopidogrel|clopidogrel|mesh-list
14848220|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14848221|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14848222|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14848223|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14848224|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
14848225|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848226|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848227|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848228|NCT01012570|Adalimumab|adalimumab|mesh-list
14848229|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848230|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848231|NCT01012687|Perindopril|perindopril|mesh-list
14848232|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14848233|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
14848234|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848235|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848236|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14848237|NCT01012700|Poly ICLC|poly iclc|mesh-list
14848238|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
14848239|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
14848240|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206129|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206130|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206131|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15206132|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
15206133|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15206134|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15206135|NCT03723291|Tocopherols|tocopherols|mesh-list
15206136|NCT03723291|Vitamin E|vitamin e|mesh-list
14848241|NCT01012830|Huperzine A|huperzine a|mesh-list
14848242|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14848243|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848244|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848245|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
14848246|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848247|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848248|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15206137|NCT03723291|Tocotrienols|tocotrienols|mesh-list
15206138|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
15206139|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
15206140|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15206141|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206142|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206143|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15206144|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15206145|NCT03723291|Protective Agents|protective agents|mesh-ancestor
15206146|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848249|NCT01012830|Protective Agents|protective agents|mesh-ancestor
14848250|NCT01012843|Amoxicillin|amoxicillin|mesh-list
14848251|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
14848252|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
14848253|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14848254|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848255|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848256|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14848257|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848258|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848259|NCT01012869|Everolimus|everolimus|mesh-list
14848260|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848261|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848262|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
14848263|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848264|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
14848265|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848266|NCT01012934|Alendronate|alendronate|mesh-list
14848267|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14848268|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848269|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
14848270|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14848271|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848272|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
14848273|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848274|NCT01013012|Dexamethasone|dexamethasone|mesh-list
14848275|NCT01013012|Ramosetron|ramosetron|mesh-list
14848276|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848277|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
14848278|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
14848279|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848280|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206147|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
15206148|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15206149|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
15206150|NCT03723291|Vitamins|vitamins|mesh-ancestor
15206151|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
15206152|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
15206153|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14848281|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206154|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206155|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15206156|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206157|NCT03723187|Heparin|heparin|mesh-list
15206158|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
15206159|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15206160|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15206161|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206162|NCT03723135|Azacitidine|azacitidine|mesh-list
15206163|NCT03723135|Cc-486|cc-486|mesh-list
15206164|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15206165|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
15206166|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206167|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206168|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206169|NCT03723109|Anesthetics|anesthetics|mesh-list
15206170|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206171|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848282|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
15206172|NCT03723096|Pomalidomide|pomalidomide|mesh-list
14848283|NCT01013012|Hormones|hormones|mesh-ancestor
14848284|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848285|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848286|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848287|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14848288|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
14848289|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848290|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848291|NCT01013103|Atorvastatin|atorvastatin|mesh-list
14848292|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14848293|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14848294|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
14848295|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848296|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14848297|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14848298|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848299|NCT01013155|Perindopril|perindopril|mesh-list
14848300|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14848301|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
14848302|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848303|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848304|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14912613|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912614|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14912615|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
14912616|NCT01370343|Cyclosporine|cyclosporine|mesh-list
14912617|NCT01370343|Cyclosporins|cyclosporins|mesh-list
14912618|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14912619|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912620|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912621|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14912622|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
14912623|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912624|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
14912625|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912626|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
14912627|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14912628|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14912629|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
14912630|NCT01370343|Vitamins|vitamins|mesh-ancestor
14912631|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
14912632|NCT01370434|Dexamethasone|dexamethasone|mesh-list
14912633|NCT01370434|Doxorubicin|doxorubicin|mesh-list
14912634|NCT01370434|Vincristine|vincristine|mesh-list
14912635|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14912636|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
14912637|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
14912638|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206173|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
15206174|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206175|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15206176|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15206177|NCT03723096|Growth Substances|growth substances|mesh-ancestor
14912639|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912640|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14912641|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
14912642|NCT01370434|Hormones|hormones|mesh-ancestor
14912643|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912644|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14912645|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912646|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912647|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912648|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15206178|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
15206179|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206180|NCT03723083|Thalidomide|thalidomide|mesh-list
15206181|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206182|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
15206183|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848305|NCT01013272|Lamivudine|lamivudine|mesh-list
14848306|NCT01013272|Entecavir|entecavir|mesh-list
14848307|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14848308|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14848309|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848310|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848311|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
14848312|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848313|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14848314|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14848315|NCT01013402|Insulin|insulin|mesh-list
14848316|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14848317|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14848318|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848319|NCT01013454|Varenicline|varenicline|mesh-list
14848320|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14848321|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14848322|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
14848323|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848324|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848325|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848326|NCT01013480|Baclofen|baclofen|mesh-list
14848327|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14848328|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848329|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14848330|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848331|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14848332|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
14848333|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
14848334|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848335|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848336|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14295796|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14848337|NCT01013506|Letrozole|letrozole|mesh-list
14848338|NCT01013506|Goserelin|goserelin|mesh-list
14848339|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848340|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14848341|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848342|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848343|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14848344|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14848345|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14848346|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
14848347|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848348|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848349|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848350|NCT01013532|Aspirin|aspirin|mesh-list
14848351|NCT01013532|Cilostazol|cilostazol|mesh-list
14848352|NCT01013532|Probucol|probucol|mesh-list
14848353|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14848354|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14848355|NCT01013532|Analgesics|analgesics|mesh-ancestor
14848356|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
14848357|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848358|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848359|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848360|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848361|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14848362|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14848363|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848364|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14848365|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14848366|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848367|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
14848368|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14848369|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
14848370|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14848371|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
14848372|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
14848373|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14848374|NCT01013532|Protective Agents|protective agents|mesh-ancestor
14848375|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14848376|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14848377|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14848378|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14848379|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
14848380|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14848381|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
14848382|NCT01013558|Remifentanil|remifentanil|mesh-list
14848383|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14848384|NCT01013558|Narcotics|narcotics|mesh-ancestor
14848385|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848386|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848387|NCT01013558|Analgesics|analgesics|mesh-ancestor
14848388|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
14848389|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848390|NCT01013571|Insulin|insulin|mesh-list
14848391|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14848392|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
14848393|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
14848394|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14848395|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848396|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
14848397|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14848398|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848399|NCT01013584|Vitamins|vitamins|mesh-ancestor
14848400|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
14848401|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14848402|NCT01013675|Vaccines|vaccines|mesh-list
14848403|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
14848404|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848405|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
14848406|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14848407|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848408|NCT01013779|Carboplatin|carboplatin|mesh-list
14848409|NCT01013779|Etoposide|etoposide|mesh-list
14848410|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848411|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14848412|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14848413|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14848414|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848415|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848416|NCT01013805|Leucovorin|leucovorin|mesh-list
14848417|NCT01013805|Fluorouracil|fluorouracil|mesh-list
14848418|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
14848419|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
14848420|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848421|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14848422|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848423|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848424|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
14848425|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848426|NCT01013805|Antidotes|antidotes|mesh-ancestor
14848427|NCT01013805|Protective Agents|protective agents|mesh-ancestor
14848428|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
14848429|NCT01013805|Vitamins|vitamins|mesh-ancestor
14848430|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
14848431|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14848432|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848433|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14848434|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848435|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295797|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
14707042|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707043|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
14707044|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707045|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707046|NCT00421434|Ribavirin|ribavirin|mesh-list
14707047|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14707048|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
14707049|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
14707050|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
14848436|NCT01013909|Terbinafine|terbinafine|mesh-list
14848437|NCT01013909|Bifonazole|bifonazole|mesh-list
14707051|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707052|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
14707053|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707054|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
14707055|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707056|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14707057|NCT00421447|Anastrozole|anastrozole|mesh-list
14707058|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848438|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
14848439|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848440|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848441|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848442|NCT01013987|Ritonavir|ritonavir|mesh-list
14848443|NCT01013987|Darunavir|darunavir|mesh-list
14848444|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
14848445|NCT01013987|Maraviroc|maraviroc|mesh-list
14848446|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14848447|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14848448|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
14848449|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206184|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
14848450|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848451|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14848452|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14848453|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
14848454|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848455|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14848456|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14848457|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14848458|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14848459|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14848460|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14848461|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14848462|NCT01014052|Retinol acetate|retinol acetate|mesh-list
14848463|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14848464|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
14848465|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848466|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14848467|NCT01014052|Protective Agents|protective agents|mesh-ancestor
14848468|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848469|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
14848470|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14848471|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14848472|NCT01014104|Prednisolone|prednisolone|mesh-list
14848473|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
14848474|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14848475|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
14848476|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848477|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
14848478|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
14848479|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707059|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848480|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848481|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14848482|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
14848483|NCT01014104|Hormones|hormones|mesh-ancestor
14848484|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848485|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14848486|NCT01014104|Protective Agents|protective agents|mesh-ancestor
14848487|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848488|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848489|NCT01014156|Epoprostenol|epoprostenol|mesh-list
15206185|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15206186|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206187|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15206188|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15206189|NCT03723083|Growth Substances|growth substances|mesh-ancestor
15206190|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
15206191|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707060|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14848490|NCT01014156|Tezosentan|tezosentan|mesh-list
15206192|NCT03723031|Misoprostol|misoprostol|mesh-list
14848491|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14848492|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14848493|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
14707061|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14707062|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707063|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707064|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14848494|NCT01014221|Prednisolone|prednisolone|mesh-list
14848495|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848496|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
14848497|NCT01014221|Hormones|hormones|mesh-ancestor
14848498|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848499|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848500|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848501|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848502|NCT01014234|Cyclosporine|cyclosporine|mesh-list
14848503|NCT01014234|Sirolimus|sirolimus|mesh-list
14848504|NCT01014234|Cyclosporins|cyclosporins|mesh-list
14848505|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848506|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848507|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848508|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
14848509|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848510|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
14848511|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848512|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
14848513|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848514|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14848515|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848516|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14848517|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848518|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
14848519|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14848520|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848521|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848522|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14707065|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
14848523|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14848524|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848525|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848526|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848527|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14848528|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
14848529|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14848530|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848531|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14848532|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14848533|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14848534|NCT01014260|Doxycycline|doxycycline|mesh-list
14848535|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848536|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848537|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
14848538|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14707066|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707067|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707068|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
14707069|NCT00421460|Testosterone|testosterone|mesh-list
14848539|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14848540|NCT01014338|Fosinopril|fosinopril|mesh-list
14848541|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14848542|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
14848543|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848544|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848545|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14848546|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
14848547|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14848548|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14848549|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14848550|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848551|NCT01014416|Tolvaptan|tolvaptan|mesh-list
14848552|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14848553|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848554|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
14848555|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848556|NCT01014468|Bevacizumab|bevacizumab|mesh-list
14848557|NCT01014468|Ranibizumab|ranibizumab|mesh-list
14848558|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14848559|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848560|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14848561|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14848562|NCT01014468|Growth Substances|growth substances|mesh-ancestor
14848563|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848564|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
14848565|NCT01014481|Tenofovir|tenofovir|mesh-list
14848566|NCT01014481|Lamivudine|lamivudine|mesh-list
14848567|NCT01014481|Efavirenz|efavirenz|mesh-list
14848568|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
14848569|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848570|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14848571|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14848572|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848573|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848574|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14848575|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14848576|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14848577|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14848578|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14848579|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14848580|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14848581|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14848582|NCT01014507|Goserelin|goserelin|mesh-list
14848583|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
14848584|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
14848585|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14848586|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848587|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14848588|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848589|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14848590|NCT01014520|Gabapentin|gabapentin|mesh-list
14848591|NCT01014520|Amitriptyline|amitriptyline|mesh-list
14848592|NCT01014520|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14848593|NCT01014520|Analgesics|analgesics|mesh-ancestor
14848594|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
14848595|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848596|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848597|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
14848598|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14848599|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14848600|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848601|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14848602|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14848603|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14848604|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848605|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848606|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
14848607|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14848608|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
14848609|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14848610|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14848611|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14848612|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14848613|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
14848614|NCT01014520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14848615|NCT01014546|Vitamins|vitamins|mesh-list
14848616|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
14848617|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
14848618|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
14848619|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848620|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
14848621|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848622|NCT01014546|Protective Agents|protective agents|mesh-ancestor
14848623|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848624|NCT01014559|Oxycodone|oxycodone|mesh-list
14848625|NCT01014559|Naloxone|naloxone|mesh-list
14848626|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14848627|NCT01014559|Narcotics|narcotics|mesh-ancestor
14848628|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848629|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848630|NCT01014559|Analgesics|analgesics|mesh-ancestor
14848631|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
14848632|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848633|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14848634|NCT01014598|Cisplatin|cisplatin|mesh-list
14848635|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707070|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
14707071|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
14707072|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14707073|NCT00421460|Androgens|androgens|mesh-ancestor
14707074|NCT00421460|Hormones|hormones|mesh-ancestor
14707075|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707076|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707077|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14707078|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707079|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
14707080|NCT00421473|Atovaquone|atovaquone|mesh-list
14707081|NCT00421473|Proguanil|proguanil|mesh-list
14707082|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14707083|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707084|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
14707085|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14707086|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14707087|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707088|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707089|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
14707090|NCT00421512|Bevacizumab|bevacizumab|mesh-list
14848636|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
14848637|NCT01014637|Clotrimazole|clotrimazole|mesh-list
14848638|NCT01014637|Miconazole|miconazole|mesh-list
14848639|NCT01014637|Amorolfine|amorolfine|mesh-list
14848640|NCT01014637|Ciclopirox|ciclopirox|mesh-list
14848641|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
14848642|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848643|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14848644|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14848645|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14848646|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848647|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848648|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14848649|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
14848650|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14848651|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848652|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14848653|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14848654|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
14848655|NCT01014650|Glycine|glycine|mesh-list
14848656|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
14848657|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848658|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848659|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848660|NCT01014793|Cabergoline|cabergoline|mesh-list
14848661|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14848662|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14848663|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
14848664|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
14848665|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848666|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848667|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848668|NCT01014832|Insulin|insulin|mesh-list
14848669|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14848670|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14848671|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848672|NCT01014845|Vaccines|vaccines|mesh-list
14848673|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
14848674|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848675|NCT01014858|Donepezil|donepezil|mesh-list
14848676|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14848677|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848678|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848679|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
14848680|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848681|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848682|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
14848683|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
14848684|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14848685|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14848686|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
15206193|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15206194|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
15206195|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15206196|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206197|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15206198|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206199|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
15206200|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
15206201|NCT03722940|Analgesics|analgesics|mesh-ancestor
15206202|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
15206203|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206204|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206205|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
15206206|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206207|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15206208|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
15206209|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14848687|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848688|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848689|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848690|NCT01015040|Urological Agents|urological agents|mesh-ancestor
14848691|NCT01015053|Ropivacaine|ropivacaine|mesh-list
14848692|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
14848693|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
14848694|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707091|NCT00421512|Sunitinib|sunitinib|mesh-list
14707092|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707093|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707094|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14707095|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14707096|NCT00421512|Growth Substances|growth substances|mesh-ancestor
14707097|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848695|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848696|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
14848697|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848698|NCT01015066|Naltrexone|naltrexone|mesh-list
14848699|NCT01015066|Buprenorphine|buprenorphine|mesh-list
14848700|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14848701|NCT01015066|Naloxone|naloxone|mesh-list
14848702|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14848703|NCT01015066|Narcotics|narcotics|mesh-ancestor
14848704|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848705|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848706|NCT01015066|Analgesics|analgesics|mesh-ancestor
14848707|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
14848708|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848709|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14848710|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14912649|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14912650|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14912651|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14912652|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
14912653|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
14912654|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
14912655|NCT01370486|Melatonin|melatonin|mesh-list
14707098|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
14707099|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14707100|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707101|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912656|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
14912657|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912658|NCT01370486|Protective Agents|protective agents|mesh-ancestor
14912659|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912660|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912661|NCT01370707|Metformin|metformin|mesh-list
14912662|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14912663|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912664|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
14912665|NCT01370772|Rituximab|rituximab|mesh-list
14912666|NCT01370772|Fludarabine|fludarabine|mesh-list
14912667|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14912668|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
14912669|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912670|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15206210|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912671|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15206211|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206212|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206213|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
15206214|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15206215|NCT03722927|Bupivacaine|bupivacaine|mesh-list
15206216|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
15206217|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
15206218|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848711|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
14848712|NCT01015183|Astringents|astringents|mesh-ancestor
14848713|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848714|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
14848715|NCT01015196|Daunorubicin|daunorubicin|mesh-list
14848716|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14848717|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848718|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14848719|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14848720|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848721|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848722|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
14848723|NCT01015209|Chitosan|chitosan|mesh-list
14848724|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14848725|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14848726|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14848727|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
14707102|NCT00421538|Nadroparin|nadroparin|mesh-list
14707103|NCT00421538|Calcium|calcium|mesh-list
14707104|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14707105|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707106|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
14707107|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14707108|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14707109|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707110|NCT00421551|Ritonavir|ritonavir|mesh-list
14707111|NCT00421551|Darunavir|darunavir|mesh-list
14707112|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14707113|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14707114|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
14707115|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707116|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707117|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14707118|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14707119|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
14848728|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848729|NCT01015209|Expectorants|expectorants|mesh-ancestor
14848730|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14707120|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707121|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14707122|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14848731|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14848732|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
14848733|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848734|NCT01015209|Protective Agents|protective agents|mesh-ancestor
14848735|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848736|NCT01015209|Antidotes|antidotes|mesh-ancestor
14848737|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14848738|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14848739|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
14848740|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14848741|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
14848742|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
14848743|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
14848744|NCT01015209|Coagulants|coagulants|mesh-ancestor
14848745|NCT01015235|Ketorolac|ketorolac|mesh-list
14848746|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14848747|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14848748|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14848749|NCT01015235|Analgesics|analgesics|mesh-ancestor
14848750|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
14848751|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848752|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848753|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848754|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848755|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14848756|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848757|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848758|NCT01015248|Rituximab|rituximab|mesh-list
14848759|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14848760|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14848761|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206219|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206220|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
15206221|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206222|NCT03722914|Benzonatate|benzonatate|mesh-list
14848762|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
14848763|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848764|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848765|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14848766|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
14848767|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848768|NCT01015300|Bevacizumab|bevacizumab|mesh-list
14848769|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14848770|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848771|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14848772|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14848773|NCT01015300|Growth Substances|growth substances|mesh-ancestor
14848774|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848775|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
14848776|NCT01015339|Paclitaxel|paclitaxel|mesh-list
14848777|NCT01015339|Capecitabine|capecitabine|mesh-list
14848778|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14848779|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848780|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
14848781|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
14848782|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
14848783|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848784|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14848785|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
14848786|NCT01015352|Azacitidine|azacitidine|mesh-list
14848787|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
14848788|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14848789|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
14848790|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848791|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848792|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848793|NCT01015352|Hematinics|hematinics|mesh-ancestor
14848794|NCT01015391|Azathioprine|azathioprine|mesh-list
14848795|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
14848796|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848797|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14848798|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848799|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848800|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
14848801|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848802|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848803|NCT01015417|Amoxicillin|amoxicillin|mesh-list
14848804|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14848805|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
14848806|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
14848807|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848808|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848809|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14848810|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848811|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848812|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
14848813|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
14848814|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848815|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
14848816|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848817|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848818|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15206223|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
15206224|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
15206225|NCT03722875|Apatinib|apatinib|mesh-list
15206226|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848819|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
14848820|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848821|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848822|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14848823|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14848824|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14848825|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
14848826|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848827|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848828|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848829|NCT01015482|Midazolam|midazolam|mesh-list
14848830|NCT01015482|Remifentanil|remifentanil|mesh-list
14848831|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14848832|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14848833|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848834|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848835|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14848836|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14848837|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14848838|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14848839|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
14848840|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
14848841|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
14848842|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
14848843|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848844|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848845|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14848846|NCT01015482|Narcotics|narcotics|mesh-ancestor
14848847|NCT01015482|Analgesics|analgesics|mesh-ancestor
14848848|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
14848849|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848850|NCT01015495|Ranibizumab|ranibizumab|mesh-list
14848851|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14848852|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14848853|NCT01015495|Growth Substances|growth substances|mesh-ancestor
15206227|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206228|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206229|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206230|NCT03722849|Adenosine|adenosine|mesh-list
15206231|NCT03722849|Capsaicin|capsaicin|mesh-list
15206232|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
15206233|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
15206234|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
14848854|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848855|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
14848856|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848857|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
14848858|NCT01015547|Methotrexate|methotrexate|mesh-list
14848859|NCT01015547|Infliximab|infliximab|mesh-list
14848860|NCT01015547|Naltrexone|naltrexone|mesh-list
14848861|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14848862|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
14848863|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14848864|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848865|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14848866|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
14848867|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848868|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848869|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
14848870|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848871|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14848872|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206235|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707123|NCT00421642|Adalimumab|adalimumab|mesh-list
14707124|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707125|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707126|NCT00421694|Bicalutamide|bicalutamide|mesh-list
14848873|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
14848874|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848875|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14848876|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14848877|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848878|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14848879|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14848880|NCT01015547|Analgesics|analgesics|mesh-ancestor
14848881|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
14848882|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848883|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848884|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14848885|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14848886|NCT01015651|Remifentanil|remifentanil|mesh-list
14848887|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14848888|NCT01015651|Narcotics|narcotics|mesh-ancestor
14848889|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848890|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848891|NCT01015651|Analgesics|analgesics|mesh-ancestor
14848892|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
14848893|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848894|NCT01015664|Sirolimus|sirolimus|mesh-list
14848895|NCT01015664|Cetuximab|cetuximab|mesh-list
14848896|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848897|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14848898|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14848899|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848900|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14848901|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
14848902|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848903|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
14848904|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848905|NCT01015729|Aspirin|aspirin|mesh-list
14848906|NCT01015729|Esomeprazole|esomeprazole|mesh-list
14848907|NCT01015729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14848908|NCT01015729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14848909|NCT01015729|Analgesics|analgesics|mesh-ancestor
14848910|NCT01015729|Sensory System Agents|sensory system agents|mesh-ancestor
14707127|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
14707128|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
14707129|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707130|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707131|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707132|NCT00421720|Sufentanil|sufentanil|mesh-list
14707133|NCT00421720|Remifentanil|remifentanil|mesh-list
14707134|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14707135|NCT00421720|Narcotics|narcotics|mesh-ancestor
14707136|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707137|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707138|NCT00421720|Analgesics|analgesics|mesh-ancestor
14707139|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
14707140|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848911|NCT01015729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848912|NCT01015729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707141|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14848913|NCT01015729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14848914|NCT01015729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14848915|NCT01015729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14848916|NCT01015729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14848917|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848918|NCT01015729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14848919|NCT01015729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14848920|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848921|NCT01015729|Antipyretics|antipyretics|mesh-ancestor
14848922|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14848923|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14848924|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14848925|NCT01015794|Ephedrine|ephedrine|mesh-list
14848926|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
14848927|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14848928|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848929|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
14848930|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
14848931|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14848932|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14848933|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14848934|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14848935|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848936|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14848937|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14848938|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
14848939|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
14848940|NCT01015937|Losartan|losartan|mesh-list
14848941|NCT01015937|Enalapril|enalapril|mesh-list
14848942|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
14848943|NCT01015937|Giapreza|giapreza|mesh-list
14848944|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14848945|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
14848946|NCT01015937|Turmeric extract|turmeric extract|mesh-list
14848947|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14848948|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14848949|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14848950|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14848951|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848952|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
14848953|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848954|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
14848955|NCT01015937|Protective Agents|protective agents|mesh-ancestor
14848956|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848957|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14848958|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14848959|NCT01016002|Temoporfin|temoporfin|mesh-list
14848960|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848961|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14848962|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
14848963|NCT01016041|Paclitaxel|paclitaxel|mesh-list
14848964|NCT01016041|Everolimus|everolimus|mesh-list
14848965|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14848966|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14848967|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14848968|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14848969|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14848970|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848971|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848972|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
14848973|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848974|NCT01016054|Gemcitabine|gemcitabine|mesh-list
14848975|NCT01016054|Carboplatin|carboplatin|mesh-list
14848976|NCT01016054|Doxorubicin|doxorubicin|mesh-list
14848977|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14912672|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
14848978|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707142|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14707143|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
14707144|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
14707145|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
14707146|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14707147|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
14707148|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707149|NCT00421785|Expectorants|expectorants|mesh-ancestor
14707150|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
14707151|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14707152|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
14707153|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707154|NCT00421785|Protective Agents|protective agents|mesh-ancestor
14707155|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707156|NCT00421785|Antidotes|antidotes|mesh-ancestor
14707157|NCT00421811|Melphalan|melphalan|mesh-list
14707158|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14707159|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
14707160|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848979|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15206236|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848980|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
15206237|NCT03722849|Analgesics|analgesics|mesh-ancestor
15206238|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15206239|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
15206240|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15206241|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
15206242|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
15206243|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206244|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206245|NCT03722823|Tucatinib|tucatinib|mesh-list
15206246|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206247|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206248|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206249|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206250|NCT03722680|Riluzole|riluzole|mesh-list
15206251|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
15206252|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15206253|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15206254|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206255|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848981|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14848982|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
14848983|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14848984|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14848985|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14848986|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
14848987|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848988|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14848989|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14848990|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14848991|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
14848992|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14848993|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848994|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
14848995|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14848996|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14848997|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14848998|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14848999|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14849000|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14849001|NCT01016184|Vitamin D|vitamin d|mesh-list
14849002|NCT01016184|Vitamins|vitamins|mesh-ancestor
14849003|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
14849004|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849005|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14849006|NCT01016223|Beclomethasone|beclomethasone|mesh-list
14849007|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14849008|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
14849009|NCT01016223|Hormones|hormones|mesh-ancestor
14849010|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206256|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707161|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849011|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849012|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14849013|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
14849014|NCT01016249|Epinephrine|epinephrine|mesh-list
14849015|NCT01016249|Racepinephrine|racepinephrine|mesh-list
14849016|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
14849017|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14849018|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14849019|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
14849020|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849021|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849022|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849023|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14849024|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14849025|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
14849026|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849027|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14849028|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
14849029|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
14849030|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
14849031|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14849032|NCT01016509|Insulin|insulin|mesh-list
14849033|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14849034|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14849035|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849036|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
14849037|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14849038|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849039|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14849040|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
14849041|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849042|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849043|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849044|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849045|NCT01016639|Capecitabine|capecitabine|mesh-list
14849046|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
14849047|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14849048|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
14849049|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849050|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849051|NCT01016665|Anastrozole|anastrozole|mesh-list
14849052|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14849053|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849054|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14849055|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14849056|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849057|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849058|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14849059|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
14707162|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14707163|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206257|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15206258|NCT03722680|Protective Agents|protective agents|mesh-ancestor
15206259|NCT03722498|Leucovorin|leucovorin|mesh-list
15206260|NCT03722498|Fluorouracil|fluorouracil|mesh-list
15206261|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
15206262|NCT03722498|Sorafenib|sorafenib|mesh-list
14707164|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
14707165|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707166|NCT00421824|Capecitabine|capecitabine|mesh-list
14707167|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
14707168|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707169|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
14707170|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707171|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707172|NCT00421863|Amlodipine|amlodipine|mesh-list
14707173|NCT00421863|Telmisartan|telmisartan|mesh-list
14707174|NCT00421863|Clonidine|clonidine|mesh-list
14707175|NCT00421863|Ramipril|ramipril|mesh-list
14707176|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14707177|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14707178|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849060|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206263|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
15206264|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849061|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849062|NCT01016717|Omeprazole|omeprazole|mesh-list
14849063|NCT01016717|Pantoprazole|pantoprazole|mesh-list
14849064|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14849065|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849066|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14849067|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849068|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849069|NCT01016730|Bortezomib|bortezomib|mesh-list
14849070|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849071|NCT01016795|Lenograstim|lenograstim|mesh-list
14849072|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14849073|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
14849074|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849075|NCT01016821|Oxycodone|oxycodone|mesh-list
14849076|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14849077|NCT01016821|Narcotics|narcotics|mesh-ancestor
14849078|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849079|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849080|NCT01016821|Analgesics|analgesics|mesh-ancestor
14849081|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
14849082|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849083|NCT01016860|Irinotecan|irinotecan|mesh-list
14849084|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14849085|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14849086|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849087|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849088|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849089|NCT01016886|Bisoprolol|bisoprolol|mesh-list
14849090|NCT01016886|Perindopril|perindopril|mesh-list
14849091|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14849092|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
14849093|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
14849094|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849095|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849096|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14849097|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14849098|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14849099|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14849100|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849101|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849102|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15206265|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15206266|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206267|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206268|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
15206269|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206270|NCT03722498|Antidotes|antidotes|mesh-ancestor
15206271|NCT03722498|Protective Agents|protective agents|mesh-ancestor
15206272|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
14849103|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
14849104|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849105|NCT01016990|Valproic Acid|valproic acid|mesh-list
14849106|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
14849107|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849108|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849109|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
14849110|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849111|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849112|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
14849113|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14849114|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849115|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912673|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912674|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912675|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15206273|NCT03722498|Vitamins|vitamins|mesh-ancestor
15206274|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
14912676|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14912677|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14849116|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14849117|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14849118|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849119|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14849120|NCT01017107|Protein C|protein c|mesh-list
14849121|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
14849122|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14849123|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14849124|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849125|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849126|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
14849127|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14849128|NCT01017133|Fluorides|fluorides|mesh-list
14849129|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14849130|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849131|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
14849132|NCT01017133|Protective Agents|protective agents|mesh-ancestor
14849133|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849134|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
14849135|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
14849136|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849137|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
14849138|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14849139|NCT01017159|Antibodies|antibodies|mesh-list
14849140|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
14849141|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849142|NCT01017198|Antacids|antacids|mesh-list
14849143|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849144|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849145|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14849146|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14849147|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849148|NCT01017354|Calcifediol|calcifediol|mesh-list
14849149|NCT01017354|Vitamins|vitamins|mesh-ancestor
14849150|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
14849151|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849152|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14849153|NCT01017367|Antibodies|antibodies|mesh-list
14849154|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
14849155|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849156|NCT01017380|Celecoxib|celecoxib|mesh-list
14849157|NCT01017380|Etoricoxib|etoricoxib|mesh-list
14849158|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14849159|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849160|NCT01017380|Analgesics|analgesics|mesh-ancestor
14849161|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
14849162|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849163|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849164|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14849165|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849166|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14707179|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707180|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14707181|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707182|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
14707183|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14707184|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14707185|NCT00421863|Analgesics|analgesics|mesh-ancestor
14707186|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
14849167|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14849168|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849169|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849170|NCT01017393|Ketamine|ketamine|mesh-list
14849171|NCT01017393|Analgesics|analgesics|mesh-ancestor
14849172|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
14849173|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849174|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849175|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14849176|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14849177|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
14849178|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
14849179|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849180|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14849181|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14849182|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849183|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849184|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
14849185|NCT01017458|Testosterone|testosterone|mesh-list
14849186|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
14849187|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
14849188|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14849189|NCT01017458|Androgens|androgens|mesh-ancestor
14849190|NCT01017458|Hormones|hormones|mesh-ancestor
14849191|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14849192|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849193|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14849194|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849195|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
14849196|NCT01017640|Mitomycins|mitomycins|mesh-list
14849197|NCT01017640|Mitomycin|mitomycin|mesh-list
14707187|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707188|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
14707189|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
14707190|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14707191|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14849198|NCT01017640|Veliparib|veliparib|mesh-list
14849199|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14849200|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849201|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
14849202|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849203|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14849204|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849205|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14849206|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
14849207|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14849208|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14849209|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14849210|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
14849211|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849212|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849213|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849214|NCT01017679|Gefitinib|gefitinib|mesh-list
14849215|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849216|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14849217|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849218|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849219|NCT01017744|Anesthetics|anesthetics|mesh-list
14849220|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849221|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849222|NCT01017770|Artesunate|artesunate|mesh-list
14849223|NCT01017770|Lumefantrine|lumefantrine|mesh-list
14849224|NCT01017770|Artemether|artemether|mesh-list
14849225|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14849226|NCT01017770|Amodiaquine|amodiaquine|mesh-list
14849227|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
14849228|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14849229|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14849230|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707192|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14707193|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
14707194|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707195|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14707196|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
14707197|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707198|NCT00421915|Etanercept|etanercept|mesh-list
14707199|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14849231|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849232|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
14849233|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
14849234|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14849235|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
14849236|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
14849237|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
14849238|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14849239|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
14849240|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849241|NCT01017796|Expectorants|expectorants|mesh-ancestor
14849242|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
14849243|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14849244|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
14849245|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849246|NCT01017796|Protective Agents|protective agents|mesh-ancestor
14849247|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707200|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14707201|NCT00421915|Analgesics|analgesics|mesh-ancestor
14707202|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
14707203|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707204|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707205|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707206|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707207|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849248|NCT01017796|Antidotes|antidotes|mesh-ancestor
14849249|NCT01017796|Vitamins|vitamins|mesh-ancestor
14849250|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
14849251|NCT01017809|Aprepitant|aprepitant|mesh-list
14849252|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
14849253|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
14849254|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849255|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849256|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849257|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14849258|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849259|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849260|NCT01017822|Gemcitabine|gemcitabine|mesh-list
14849261|NCT01017822|Capecitabine|capecitabine|mesh-list
14849262|NCT01017822|Conatumumab|conatumumab|mesh-list
14849263|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14849264|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
14849265|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849266|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849267|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
14849268|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849269|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849270|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849271|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
14849272|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849273|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14849274|NCT01017926|Triazolam|triazolam|mesh-list
14849275|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14849276|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14849277|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14849278|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849279|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849280|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14849281|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
14849282|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
14849283|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849284|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849285|NCT01017939|Prednisone|prednisone|mesh-list
14849286|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
14849287|NCT01017939|Theophylline|theophylline|mesh-list
14849288|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
14849289|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14849290|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
14849291|NCT01017939|Hormones|hormones|mesh-ancestor
14849292|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14295798|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707208|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707209|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
14707210|NCT00421967|Ketorolac|ketorolac|mesh-list
14849293|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849294|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14849295|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849296|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14849297|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849298|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849299|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
14849300|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14849301|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
14849302|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
14849303|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14849304|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14849305|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849306|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14849307|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
14849308|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849309|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14849310|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14849311|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
14849312|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14849313|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14849314|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
14849315|NCT01018160|Rabeprazole|rabeprazole|mesh-list
14849316|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14849317|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849318|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14849319|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849320|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849321|NCT01018225|Darifenacin|darifenacin|mesh-list
14849322|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14849323|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14849324|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
14849325|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849326|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849327|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849328|NCT01018225|Urological Agents|urological agents|mesh-ancestor
14849329|NCT01018251|Alovudine|alovudine|mesh-list
14849330|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
14849331|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849332|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
14849333|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14849334|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849335|NCT01018342|Renal Agents|renal agents|mesh-ancestor
14849336|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849337|NCT01018368|Rifampin|rifampin|mesh-list
14849338|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14849339|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
14849340|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849341|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849342|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
14849343|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14849344|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849345|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849346|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14849347|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14849348|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14912678|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
14849349|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14849350|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14849351|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14849352|NCT01018381|Ethanol|ethanol|mesh-list
14849353|NCT01018381|Entecavir|entecavir|mesh-list
14849354|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14849355|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849356|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849357|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849358|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
14849359|NCT01018446|Busulfan|busulfan|mesh-list
14849360|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
14849361|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849362|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849363|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
14849364|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849365|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14849366|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849367|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14849368|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
14849369|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14849370|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14849371|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14849372|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849373|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707211|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14707212|NCT00421967|Epinephrine|epinephrine|mesh-list
14707213|NCT00421967|Racepinephrine|racepinephrine|mesh-list
14849374|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
14849375|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849376|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849377|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14849378|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849379|NCT01018602|Vildagliptin|vildagliptin|mesh-list
14849380|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14849381|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849382|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14849383|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
14849384|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849385|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849386|NCT01018615|Silymarin|silymarin|mesh-list
14849387|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
15206275|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206276|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206277|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
15206278|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206279|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206280|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206281|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206282|NCT03722381|Amlodipine|amlodipine|mesh-list
14707214|NCT00421967|Ropivacaine|ropivacaine|mesh-list
14707215|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
14707216|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
14707217|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
14707218|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707219|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707220|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
14707221|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707222|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14707223|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14707224|NCT00421967|Analgesics|analgesics|mesh-ancestor
14707225|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707226|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707227|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14707228|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707229|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849388|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849389|NCT01018615|Protective Agents|protective agents|mesh-ancestor
14849390|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912679|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912680|NCT01370889|Resveratrol|resveratrol|mesh-list
14912681|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
14912682|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912683|NCT01370889|Protective Agents|protective agents|mesh-ancestor
14912684|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912685|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912686|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14912687|NCT01370915|Vitamins|vitamins|mesh-list
14912688|NCT01370915|Pregabalin|pregabalin|mesh-list
14912689|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
14912690|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912691|NCT01370915|Analgesics|analgesics|mesh-ancestor
14912692|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
14912693|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912694|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
14912695|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14912696|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912697|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912698|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14912699|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14912700|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14912701|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912702|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912703|NCT01371058|Clopidogrel|clopidogrel|mesh-list
14912704|NCT01371058|Policosanol|policosanol|mesh-list
14912705|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14912706|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14912707|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14912708|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14912709|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
14912710|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912711|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912712|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912713|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14912714|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14912715|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
14912716|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14912717|NCT01371201|Sunitinib|sunitinib|mesh-list
14912718|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912719|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14912720|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912721|NCT01371201|Growth Substances|growth substances|mesh-ancestor
14912722|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912723|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912724|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14912725|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912726|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917233|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14917234|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14917235|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917236|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14917237|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14917238|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917239|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917240|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917241|NCT01397019|Leucovorin|leucovorin|mesh-list
14917242|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
14917243|NCT01397019|Irinotecan|irinotecan|mesh-list
14849391|NCT01018758|Palonosetron|palonosetron|mesh-list
14849392|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
14849393|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
14849394|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849395|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849396|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849397|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14707230|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14707231|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14707232|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
14707233|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707234|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14707235|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14707236|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
14849398|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14849399|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
14849400|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849401|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849402|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
14849403|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14849404|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849405|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14849406|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849407|NCT01018836|Riluzole|riluzole|mesh-list
14849408|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
14849409|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14849410|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14849411|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849412|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849413|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849414|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14849415|NCT01018836|Protective Agents|protective agents|mesh-ancestor
14849416|NCT01018849|Vitamin D|vitamin d|mesh-list
14849417|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
14849418|NCT01018849|Vitamins|vitamins|mesh-ancestor
14849419|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
14849420|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849421|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14849422|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14849423|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
14849424|NCT01018914|Tacrolimus|tacrolimus|mesh-list
14849425|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849426|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
14849427|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849428|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14849429|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849430|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849431|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14849432|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849433|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14849434|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
14849435|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14295799|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
14707237|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14707238|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
14707239|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
14707240|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
14707241|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14707242|NCT00421980|Etanercept|etanercept|mesh-list
14849436|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707243|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14707244|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849437|NCT01019070|Asunaprevir|asunaprevir|mesh-list
14849438|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14849439|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849440|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849441|NCT01019083|Zinc|zinc|mesh-list
14849442|NCT01019083|Albendazole|albendazole|mesh-list
14849443|NCT01019083|Secnidazole|secnidazole|mesh-list
14849444|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
14849445|NCT01019083|Trace Elements|trace elements|mesh-ancestor
14849446|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
14849447|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849448|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
14849449|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14849450|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849451|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
14849452|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14849453|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14849454|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14849455|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14849456|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14849457|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849458|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849459|NCT01019083|Astringents|astringents|mesh-ancestor
14849460|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
14849461|NCT01019109|Cobalt|cobalt|mesh-list
14849462|NCT01019109|Trace Elements|trace elements|mesh-ancestor
14849463|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
14849464|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849465|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
14849466|NCT01019174|Lenalidomide|lenalidomide|mesh-list
14849467|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849468|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
14707245|NCT00421980|Analgesics|analgesics|mesh-ancestor
14707246|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
14707247|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707248|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707249|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707250|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707251|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14707252|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707253|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
14849469|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849470|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849471|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14849472|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
14849473|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849474|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849475|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14849476|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14849477|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14849478|NCT01019174|Growth Substances|growth substances|mesh-ancestor
14849479|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
14849480|NCT01019265|Buprenorphine|buprenorphine|mesh-list
14849481|NCT01019265|Tramadol|tramadol|mesh-list
14849482|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14849483|NCT01019265|Narcotics|narcotics|mesh-ancestor
14849484|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849485|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849486|NCT01019265|Analgesics|analgesics|mesh-ancestor
14849487|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
14849488|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206283|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15206284|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15206285|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849489|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14849490|NCT01019278|Cisplatin|cisplatin|mesh-list
14849491|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849492|NCT01019291|Formaldehyde|formaldehyde|mesh-list
14849493|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
14849494|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849495|NCT01019382|Gemcitabine|gemcitabine|mesh-list
14849496|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14849497|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
14849498|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849499|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849500|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
14849501|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849502|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849503|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849504|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
14849505|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849506|NCT01019395|Daptomycin|daptomycin|mesh-list
14849507|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849508|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849509|NCT01019408|Chloroquine|chloroquine|mesh-list
14849510|NCT01019408|Amebicides|amebicides|mesh-ancestor
14849511|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14849512|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14849513|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849514|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
14849515|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849516|NCT01019434|Sirolimus|sirolimus|mesh-list
14849517|NCT01019434|Temozolomide|temozolomide|mesh-list
14849518|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14849519|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
15206286|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206287|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206288|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206289|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
15206290|NCT03722355|Carmustine|carmustine|mesh-list
15206291|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15206292|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
15224864|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849520|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707254|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14849521|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849522|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849523|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849524|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14849525|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
14849526|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849527|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
14849528|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849529|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
14849530|NCT01019447|Triclosan|triclosan|mesh-list
14849531|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14849532|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14849533|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14849534|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14849535|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
14849536|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849537|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14849538|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14849539|NCT01019590|Olmesartan|olmesartan|mesh-list
14707255|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
14707256|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707257|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14849540|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14849541|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14849542|NCT01019590|Diuretics|diuretics|mesh-ancestor
14849543|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
14849544|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849545|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14849546|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849547|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849548|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14849549|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14849550|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
14849551|NCT01019603|Tazarotene|tazarotene|mesh-list
14849552|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14849553|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
14849554|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
14849555|NCT01019603|Vitamins|vitamins|mesh-ancestor
14849556|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
14849557|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849558|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
14849559|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14849560|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849561|NCT01019642|Vitamins|vitamins|mesh-ancestor
14849562|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
14849563|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14849564|NCT01019655|Nadroparin|nadroparin|mesh-list
14849565|NCT01019655|Calcium|calcium|mesh-list
14849566|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14849567|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849568|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
14849569|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14849570|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14849571|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849572|NCT01019668|Verteporfin|verteporfin|mesh-list
14849573|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14849574|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
14849575|NCT01019746|Propofol|propofol|mesh-list
14849576|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14849577|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849578|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849579|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14849580|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
15206293|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707258|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14707259|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707260|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728678|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728679|NCT00519519|Omeprazole|omeprazole|mesh-list
14728680|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14849581|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
15206294|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849582|NCT01019772|Vaccines|vaccines|mesh-list
14849583|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
14728681|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206295|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
15206296|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15206297|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206298|NCT03722329|Eculizumab|eculizumab|mesh-list
15206299|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15206300|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206301|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
15206302|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206303|NCT03722303|Cortisone|cortisone|mesh-list
14849584|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849585|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
14849586|NCT01019785|Vitamin D|vitamin d|mesh-list
14849587|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14849588|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849589|NCT01019785|Vitamins|vitamins|mesh-ancestor
14849590|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
14849591|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14849592|NCT01019798|Docetaxel|docetaxel|mesh-list
14849593|NCT01019798|Sunitinib|sunitinib|mesh-list
14849594|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849595|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14849596|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14849597|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14849598|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849599|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14849600|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14849601|NCT01019798|Growth Substances|growth substances|mesh-ancestor
14849602|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849603|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
14849604|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14849605|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849606|NCT01019850|Vorinostat|vorinostat|mesh-list
14849607|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14849608|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849609|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14849610|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849611|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849612|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14849613|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
14849614|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849615|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
14849616|NCT01019876|Fludarabine|fludarabine|mesh-list
14849617|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849618|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
14849619|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849620|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849621|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14849622|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
14849623|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849624|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849625|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14849626|NCT01019941|Docetaxel|docetaxel|mesh-list
14849627|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849628|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
14849629|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
14849630|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
14849631|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849632|NCT01020136|Axitinib|axitinib|mesh-list
15206304|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14849633|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849634|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14849635|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849636|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849637|NCT01020162|Gabapentin|gabapentin|mesh-list
14849638|NCT01020162|Amitriptyline|amitriptyline|mesh-list
14849639|NCT01020162|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14849640|NCT01020162|Analgesics|analgesics|mesh-ancestor
14849641|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
14849642|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849643|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849644|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
14849645|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14849646|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14849647|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849648|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14849649|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14849650|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14849651|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849652|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849653|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
14849654|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14849655|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
14849656|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849657|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14849658|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14849659|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849660|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
14849661|NCT01020162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14849662|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14849663|NCT01020214|Olmesartan|olmesartan|mesh-list
14849664|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14849665|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14849666|NCT01020214|Diuretics|diuretics|mesh-ancestor
14849667|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
14849668|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849669|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14849670|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849671|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849672|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14849673|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15206305|NCT03722290|Metformin|metformin|mesh-list
15206306|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15206307|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206308|NCT03722173|Itraconazole|itraconazole|mesh-list
15206309|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
15206310|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206311|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15206312|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15206313|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206314|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206315|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15206316|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
14849674|NCT01020253|Alendronate|alendronate|mesh-list
14849675|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
14849676|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14849677|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14849678|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849679|NCT01020253|Vitamins|vitamins|mesh-ancestor
14849680|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
14849681|NCT01020279|Celecoxib|celecoxib|mesh-list
14849682|NCT01020279|Ketoprofen|ketoprofen|mesh-list
14849683|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14849684|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849685|NCT01020279|Analgesics|analgesics|mesh-ancestor
14849686|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
14849687|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849688|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849689|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707261|NCT00422175|Siponimod|siponimod|mesh-list
14707262|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14707263|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707264|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707265|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
14707266|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707267|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
14707268|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14707269|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14707270|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14707271|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
14849690|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849691|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14849692|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14849693|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849694|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849695|NCT01020292|Nelfinavir|nelfinavir|mesh-list
14849696|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14849697|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14849698|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
14849699|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849700|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849701|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14849702|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14849703|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
14849704|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849705|NCT01020331|Memantine|memantine|mesh-list
14849706|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14849707|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14849708|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
14849709|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849710|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849711|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849712|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14849713|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15206317|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206318|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206319|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15224865|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15224866|NCT02176668|Esomeprazole|esomeprazole|mesh-list
15224867|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15224868|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327546|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
14849714|NCT01020357|Caffeine|caffeine|mesh-list
14849715|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
14849716|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849717|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14849718|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849719|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14849720|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849721|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14849722|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14849723|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
14849724|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849725|NCT01020383|Abciximab|abciximab|mesh-list
14849726|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
14849727|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14849728|NCT01020396|Metronidazole|metronidazole|mesh-list
14849729|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849730|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849731|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14849732|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14912727|NCT01371240|Secretin|secretin|mesh-list
14912728|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14707272|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707273|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14707274|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14707275|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707276|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707277|NCT00422240|Adapalene|adapalene|mesh-list
14707278|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14707279|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14707280|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
14707281|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14707282|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849733|NCT01020539|Fludarabine|fludarabine|mesh-list
14849734|NCT01020539|Busulfan|busulfan|mesh-list
14849735|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
14849736|NCT01020539|Isotretinoin|isotretinoin|mesh-list
14849737|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
14849738|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14849739|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849740|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849741|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849742|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
14849743|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849744|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
14849745|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14849746|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14849747|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
14849748|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14849749|NCT01020630|Sunitinib|sunitinib|mesh-list
14849750|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849751|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14849752|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14849753|NCT01020630|Growth Substances|growth substances|mesh-ancestor
14849754|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849755|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
14849756|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14849757|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849758|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849759|NCT01020643|Propofol|propofol|mesh-list
14849760|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14849761|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849762|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849763|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14849764|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
14849765|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
14849766|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
14849767|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14849768|NCT01020708|Mesalamine|mesalamine|mesh-list
14849769|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14849770|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
14849771|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849772|NCT01020708|Expectorants|expectorants|mesh-ancestor
14849773|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
14849774|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14849775|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
14849776|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849777|NCT01020708|Protective Agents|protective agents|mesh-ancestor
14849778|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849779|NCT01020708|Antidotes|antidotes|mesh-ancestor
14849780|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14849781|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849782|NCT01020708|Analgesics|analgesics|mesh-ancestor
14849783|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
14849784|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849785|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14849786|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849787|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
14849788|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849789|NCT01020734|Cyclosporine|cyclosporine|mesh-list
14849790|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
14849791|NCT01020734|Busulfan|busulfan|mesh-list
14849792|NCT01020734|Methotrexate|methotrexate|mesh-list
14849793|NCT01020734|Fludarabine|fludarabine|mesh-list
14849794|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
14707283|NCT00422240|Analgesics|analgesics|mesh-ancestor
14707284|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
14707285|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707286|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707287|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707288|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707289|NCT00422318|Benzbromarone|benzbromarone|mesh-list
14707290|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
14707291|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
14707292|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707293|NCT00422318|Renal Agents|renal agents|mesh-ancestor
14707294|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
14707295|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
14849795|NCT01020734|Cyclosporins|cyclosporins|mesh-list
14849796|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14849797|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849798|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
14849799|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849800|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849801|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14849802|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
14849803|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849804|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849805|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14849806|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14849807|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
14849808|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14849809|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14849810|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
14849811|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
14849812|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849813|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14849814|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14849815|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
14849816|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849817|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14849818|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14849819|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
14849820|NCT01020825|Coagulants|coagulants|mesh-ancestor
14849821|NCT01020864|Carboplatin|carboplatin|mesh-list
14849822|NCT01020864|Cetuximab|cetuximab|mesh-list
14849823|NCT01020864|Vinorelbine|vinorelbine|mesh-list
14849824|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849825|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14849826|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14849827|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
14849828|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
14849829|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
14849830|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849831|NCT01020955|Mecasermin|mecasermin|mesh-list
14849832|NCT01020955|Growth Substances|growth substances|mesh-ancestor
14849833|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849834|NCT01021150|Cisplatin|cisplatin|mesh-list
14849835|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849836|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
14849837|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14849838|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
14849839|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849840|NCT01021163|Expectorants|expectorants|mesh-ancestor
14849841|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
14849842|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14849843|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
14849844|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849845|NCT01021163|Protective Agents|protective agents|mesh-ancestor
14849846|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849847|NCT01021163|Antidotes|antidotes|mesh-ancestor
14849848|NCT01021176|Diltiazem|diltiazem|mesh-list
14849849|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14849850|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14849851|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849852|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849853|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14849854|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849855|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
14849856|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
14849857|NCT01021267|Urological Agents|urological agents|mesh-ancestor
14849858|NCT01021358|Ketoconazole|ketoconazole|mesh-list
14849859|NCT01021358|Navitoclax|navitoclax|mesh-list
14849860|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
14849861|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849862|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14849863|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14849864|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849865|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849866|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14849867|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
14849868|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14849869|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849870|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14849871|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849872|NCT01021436|Amikacin|amikacin|mesh-list
14849873|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14849874|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14849875|NCT01021475|Domperidone|domperidone|mesh-list
14849876|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
14849877|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
14849878|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849879|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849880|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849881|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14849882|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
14849883|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849884|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849885|NCT01021488|Enoxaparin|enoxaparin|mesh-list
14849886|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14849887|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14849888|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14849889|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
14849890|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849891|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14849892|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14849893|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849894|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
14849895|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14849896|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14849897|NCT01021501|Nifedipine|nifedipine|mesh-list
14849898|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14849899|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849900|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849901|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14849902|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849903|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
14849904|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
14849905|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14849906|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14849907|NCT01021540|Hormones|hormones|mesh-ancestor
14849908|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14849909|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849910|NCT01021566|Methadone|methadone|mesh-list
14849911|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14849912|NCT01021566|Narcotics|narcotics|mesh-ancestor
14849913|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849914|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849915|NCT01021566|Analgesics|analgesics|mesh-ancestor
14849916|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
15206320|NCT03721991|Butyric Acid|butyric acid|mesh-list
15206321|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206322|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206323|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206324|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
15206325|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
15206326|NCT03721900|Ketamine|ketamine|mesh-list
15206327|NCT03721900|Analgesics|analgesics|mesh-ancestor
15206328|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
15206329|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206330|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206331|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15206332|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15206333|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
15206334|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
15206335|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206336|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15206337|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15206338|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206339|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206340|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
15206341|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15206342|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849917|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849918|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
14849919|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
14849920|NCT01021579|Metformin|metformin|mesh-list
14849921|NCT01021579|Simvastatin|simvastatin|mesh-list
14849922|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14849923|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849924|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14849925|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14849926|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
14849927|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849928|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14849929|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14849930|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14849931|NCT01021592|Bortezomib|bortezomib|mesh-list
14849932|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849933|NCT01021696|Acetaminophen|acetaminophen|mesh-list
14849934|NCT01021696|Pregabalin|pregabalin|mesh-list
14849935|NCT01021696|Morphine|morphine|mesh-list
14849936|NCT01021696|Buprenorphine|buprenorphine|mesh-list
14849937|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14849938|NCT01021696|Narcotics|narcotics|mesh-ancestor
14849939|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14849940|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849941|NCT01021696|Analgesics|analgesics|mesh-ancestor
14849942|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
14849943|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849944|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
14849945|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14849946|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14849947|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849948|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14849949|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14849950|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14849951|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14849952|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849953|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
14849954|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14849955|NCT01021735|Adalimumab|adalimumab|mesh-list
14849956|NCT01021735|Etanercept|etanercept|mesh-list
14849957|NCT01021735|Rituximab|rituximab|mesh-list
14849958|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14849959|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849960|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
14849961|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849962|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14849963|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14849964|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14849965|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14849966|NCT01021735|Analgesics|analgesics|mesh-ancestor
14849967|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
14849968|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14849969|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849970|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14849971|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
14849972|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
14849973|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14849974|NCT01021787|Protective Agents|protective agents|mesh-ancestor
14849975|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849976|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
14849977|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14849978|NCT01021865|Glucagon|glucagon|mesh-list
14849979|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14849980|NCT01021865|Regadenoson|regadenoson|mesh-list
14849981|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14849982|NCT01021865|Hormones|hormones|mesh-ancestor
14849983|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14849984|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849985|NCT01021865|Incretins|incretins|mesh-ancestor
14849986|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14849987|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14849988|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
14849989|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
14849990|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14849991|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14849992|NCT01021891|Insulin|insulin|mesh-list
14849993|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14849994|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14849995|NCT01021930|Sirolimus|sirolimus|mesh-list
14849996|NCT01021930|Paclitaxel|paclitaxel|mesh-list
14849997|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14849998|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14849999|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
14850000|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
14850001|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
14850002|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850003|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850004|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850005|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14850006|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
14850007|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850008|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
14850009|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850010|NCT01021943|Spironolactone|spironolactone|mesh-list
14850011|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14850012|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
14850013|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14850014|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850015|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14850016|NCT01021943|Diuretics|diuretics|mesh-ancestor
14850017|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
14850018|NCT01022021|Rituximab|rituximab|mesh-list
14850019|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14850020|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850021|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850022|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
14850023|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850024|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850025|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14850026|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
14850027|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850028|NCT01022047|Budesonide|budesonide|mesh-list
14850029|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14850030|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14850031|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
14850032|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850033|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850034|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14850035|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295800|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707296|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707297|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707298|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707299|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
14707300|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14707301|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850036|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
14850037|NCT01022047|Hormones|hormones|mesh-ancestor
14850038|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14850039|NCT01022125|Simeprevir|simeprevir|mesh-list
14850040|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
14850041|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850042|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
14850043|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850044|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850045|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
14850046|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850047|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
14850048|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850049|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850050|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14850051|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
14850052|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850053|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850054|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14850055|NCT01022151|Aminophylline|aminophylline|mesh-list
15206343|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15206344|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206345|NCT03721757|Nivolumab|nivolumab|mesh-list
15206346|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15206347|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206348|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15206349|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206350|NCT03721744|Gemcitabine|gemcitabine|mesh-list
15206351|NCT03721744|Paclitaxel|paclitaxel|mesh-list
15206352|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15206353|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850056|NCT01022151|Doxapram|doxapram|mesh-list
14850057|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14850058|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
14850059|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850060|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850061|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14850062|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
14850063|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14850064|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14850065|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850066|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850067|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14850068|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14850069|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
14850070|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206354|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
15206355|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
15206356|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
15206357|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206358|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15206359|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
15206360|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
14707302|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707303|NCT00422344|Sunitinib|sunitinib|mesh-list
14850071|NCT01022151|Protective Agents|protective agents|mesh-ancestor
14850072|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14850073|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14295801|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850074|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
14850075|NCT01022164|Coagulants|coagulants|mesh-ancestor
14850076|NCT01022229|Vitamins|vitamins|mesh-list
14850077|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
14850078|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
14850079|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850080|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
14912729|NCT01371240|Hormones|hormones|mesh-ancestor
14912730|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912731|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912732|NCT01371331|Tacrolimus|tacrolimus|mesh-list
14912733|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14912734|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
14707304|NCT00422344|Everolimus|everolimus|mesh-list
14707305|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707306|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14707307|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14707308|NCT00422344|Growth Substances|growth substances|mesh-ancestor
14707309|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707310|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
14707311|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14912735|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912736|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14912737|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912738|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912739|NCT01371344|Tacrolimus|tacrolimus|mesh-list
14912740|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14912741|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
14912742|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206361|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206362|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206363|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206364|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
15206365|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206366|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
15206367|NCT03721679|Nivolumab|nivolumab|mesh-list
15206368|NCT03721679|Durvalumab|durvalumab|mesh-list
15206369|NCT03721679|Atezolizumab|atezolizumab|mesh-list
15206370|NCT03721679|Poly ICLC|poly iclc|mesh-list
15206371|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15206372|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912743|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14912744|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912745|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912746|NCT01371435|Paroxetine|paroxetine|mesh-list
14912747|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14912748|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14912749|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912750|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912751|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912752|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
14912753|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912754|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912755|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912756|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912757|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14912758|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14912759|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912760|NCT01371448|Paroxetine|paroxetine|mesh-list
14912761|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14912762|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14912763|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912764|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912765|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912766|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
14912767|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912768|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15206373|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15206374|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295802|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707312|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850081|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14850082|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14850083|NCT01022333|Protective Agents|protective agents|mesh-ancestor
14850084|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850085|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850086|NCT01022463|Atenolol|atenolol|mesh-list
14850087|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14850088|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14850089|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
14850090|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
14850091|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850092|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850093|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14850094|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14850095|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14850096|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
14850097|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850098|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850099|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
15206375|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
15206376|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
15206377|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850100|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14850101|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15206378|NCT03721653|Leucovorin|leucovorin|mesh-list
14850102|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
15206379|NCT03721653|Bevacizumab|bevacizumab|mesh-list
15206380|NCT03721653|Fluorouracil|fluorouracil|mesh-list
15206381|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
15206382|NCT03721653|Irinotecan|irinotecan|mesh-list
15206383|NCT03721653|Atezolizumab|atezolizumab|mesh-list
15206384|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
15206385|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15206386|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206387|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15206388|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850103|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850104|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15206389|NCT03721653|Growth Substances|growth substances|mesh-ancestor
15206390|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206391|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
14850105|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14850106|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850107|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850108|NCT01022528|Dexamethasone|dexamethasone|mesh-list
14850109|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
14850110|NCT01022528|BB 1101|bb 1101|mesh-list
14850111|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14850112|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
14850113|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
14850114|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850115|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850116|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14850117|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
14850118|NCT01022528|Hormones|hormones|mesh-ancestor
14850119|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14850120|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14850121|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850122|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
14850123|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850124|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850125|NCT01022541|Bevacizumab|bevacizumab|mesh-list
14850126|NCT01022541|Capecitabine|capecitabine|mesh-list
14850127|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
14850128|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850129|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850130|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14850131|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850132|NCT01022541|Growth Substances|growth substances|mesh-ancestor
14850133|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850134|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
14850135|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14850136|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
14850137|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850138|NCT01022632|Curcumin|curcumin|mesh-list
14850139|NCT01022632|Fluoxetine|fluoxetine|mesh-list
14850140|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14850141|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14850142|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14850143|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850144|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850145|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
14850146|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850147|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14850148|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
14850149|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850150|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14850151|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14850152|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850153|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14850154|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14850155|NCT01022632|Analgesics|analgesics|mesh-ancestor
14850156|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
14850157|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850158|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14850159|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850160|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850161|NCT01022645|Copper|copper|mesh-list
14850162|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
14850163|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14850164|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
14850165|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15206392|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
15206393|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206394|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15206395|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206396|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
15206397|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14295803|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
14850166|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850167|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14850168|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14850169|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14850170|NCT01022645|Trace Elements|trace elements|mesh-ancestor
14850171|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
14850172|NCT01022658|Insulin|insulin|mesh-list
14850173|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
14850174|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
14850175|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14850176|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850177|NCT01022671|Belotecan|belotecan|mesh-list
14850178|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14850179|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14850180|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850181|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850182|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850183|NCT01022736|Gabapentin|gabapentin|mesh-list
14850184|NCT01022736|Analgesics|analgesics|mesh-ancestor
14850185|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
14850186|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850187|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850188|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
14850189|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14850190|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14850191|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850192|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707313|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707314|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707315|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
14707316|NCT00422396|Fenofibrate|fenofibrate|mesh-list
14707317|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14707318|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
14707319|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707320|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14707321|NCT00422435|Paclitaxel|paclitaxel|mesh-list
14707322|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14707323|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707324|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
14707325|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
14707326|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
14707327|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707328|NCT00422526|Progesterone|progesterone|mesh-list
14707329|NCT00422526|Progestins|progestins|mesh-ancestor
14707330|NCT00422526|Hormones|hormones|mesh-ancestor
14707331|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707332|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707333|NCT00422565|Sirolimus|sirolimus|mesh-list
14707334|NCT00422565|Paclitaxel|paclitaxel|mesh-list
14707335|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14850193|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14850194|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14850195|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850196|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850197|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
14850198|NCT01022749|Vaccines|vaccines|mesh-list
14850199|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
14850200|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850201|NCT01022840|Ketamine|ketamine|mesh-list
14850202|NCT01022840|Esketamine|esketamine|mesh-list
14850203|NCT01022840|Analgesics|analgesics|mesh-ancestor
14850204|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
14850205|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850206|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850207|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14850208|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14850209|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
14850210|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
14850211|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850212|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14850213|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14850214|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850215|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850216|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
14850217|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850218|NCT01022918|Bevacizumab|bevacizumab|mesh-list
14850219|NCT01022918|Temozolomide|temozolomide|mesh-list
14850220|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850221|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850222|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14850223|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850224|NCT01022918|Growth Substances|growth substances|mesh-ancestor
14850225|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850226|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
14850227|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14850228|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
14850229|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850230|NCT01022983|Simendan|simendan|mesh-list
14850231|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14850232|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
14850233|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14850234|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14850235|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850236|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850237|NCT01022983|Protective Agents|protective agents|mesh-ancestor
14850238|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850239|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14850240|NCT01023087|Colistin|colistin|mesh-list
14850241|NCT01023087|Polymyxins|polymyxins|mesh-list
14850242|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14850243|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850244|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
14850245|NCT01023100|Tofacitinib|tofacitinib|mesh-list
14850246|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14850247|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850248|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850249|NCT01023139|Sibutramine|sibutramine|mesh-list
14850250|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
14850251|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850252|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
14850253|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14850254|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
14850255|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
14850256|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14850257|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850258|NCT01023230|Entecavir|entecavir|mesh-list
14850259|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
14850260|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850261|NCT01023243|Aspirin|aspirin|mesh-list
14850262|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14850263|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14850264|NCT01023243|Analgesics|analgesics|mesh-ancestor
14850265|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
14850266|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850267|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850268|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14850269|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850270|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14850271|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14850272|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850273|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14850274|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14850275|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850276|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
14850277|NCT01023334|Lidocaine|lidocaine|mesh-list
14850278|NCT01023334|Anesthetics|anesthetics|mesh-list
14850279|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
15206398|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15206399|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206400|NCT03721653|Antidotes|antidotes|mesh-ancestor
15206401|NCT03721653|Protective Agents|protective agents|mesh-ancestor
15206402|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
15206403|NCT03721653|Vitamins|vitamins|mesh-ancestor
15206404|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
15206405|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
15206406|NCT03721627|Ledipasvir|ledipasvir|mesh-list
15206407|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14295804|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
14850280|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850281|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850282|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
15206408|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
14850283|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850284|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14850285|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14850286|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14850287|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14850288|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850289|NCT01023347|Paclitaxel|paclitaxel|mesh-list
14850290|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14850291|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14850292|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850293|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
14850294|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
14850295|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
14850296|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850297|NCT01023360|Esomeprazole|esomeprazole|mesh-list
14850298|NCT01023360|Rabeprazole|rabeprazole|mesh-list
14850299|NCT01023360|Pantoprazole|pantoprazole|mesh-list
14850300|NCT01023360|Clopidogrel|clopidogrel|mesh-list
14850301|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14850302|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14850303|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14850304|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14850305|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14850306|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
14850307|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850308|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850309|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850310|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14850311|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14850312|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850313|NCT01023399|Artesunate|artesunate|mesh-list
14850314|NCT01023399|Amodiaquine|amodiaquine|mesh-list
14850315|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
14850316|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14850317|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14850318|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850319|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850320|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
14850321|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
14850322|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14850323|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
14850324|NCT01023425|Donepezil|donepezil|mesh-list
14850325|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14850326|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850327|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850328|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
14850329|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850330|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850331|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
14850332|NCT01023464|Emollients|emollients|mesh-list
14850333|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14850334|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14850335|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
14850336|NCT01023490|Vitamin D|vitamin d|mesh-list
14850337|NCT01023490|Vitamins|vitamins|mesh-ancestor
14707336|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707337|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
14707338|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
14707339|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
14707340|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707341|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14707342|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707343|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14707344|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
14707345|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707346|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
14850338|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
14850339|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707347|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850340|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14850341|NCT01023542|Everolimus|everolimus|mesh-list
14850342|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850343|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850344|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
14850345|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850346|NCT01023607|Atorvastatin|atorvastatin|mesh-list
14850347|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14850348|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14850349|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14850350|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
14850351|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850352|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14850353|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14850354|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850355|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
14850356|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850357|NCT01023750|Fenofibrate|fenofibrate|mesh-list
14850358|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14850359|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
14850360|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850361|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14850362|NCT01023867|Donepezil|donepezil|mesh-list
14850363|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14850364|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850365|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850366|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
14850367|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850368|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850369|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
14850370|NCT01023919|Sirolimus|sirolimus|mesh-list
14850371|NCT01023919|Paclitaxel|paclitaxel|mesh-list
14850372|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14850373|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850374|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
14850375|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
14850376|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
14850377|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850378|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850379|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850380|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14850381|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
14850382|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850383|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
14850384|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850385|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
14850386|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14850387|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850388|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14850389|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850390|NCT01024075|Dexamethasone|dexamethasone|mesh-list
14850391|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14850392|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
14850393|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
14850394|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850395|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850396|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14850397|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
14850398|NCT01024075|Hormones|hormones|mesh-ancestor
14850399|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14850400|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14850401|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850402|NCT01024140|Citalopram|citalopram|mesh-list
14850403|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14850404|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14850405|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14850406|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850407|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850408|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
14850409|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850410|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14850411|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
14295805|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
14295806|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14850412|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912769|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912770|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912771|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14912772|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14912773|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912774|NCT01371461|Paroxetine|paroxetine|mesh-list
14912775|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14912776|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14912777|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912778|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912779|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912780|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
14912781|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912782|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912783|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
14707348|NCT00422578|Tadalafil|tadalafil|mesh-list
14707349|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
14707350|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15206409|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206410|NCT03721614|Sirolimus|sirolimus|mesh-list
14912784|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912785|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14912786|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14912787|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912788|NCT01371474|Paroxetine|paroxetine|mesh-list
14912789|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14912790|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14295807|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14295808|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
14295809|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14295810|NCT00583700|Vitamin E|vitamin e|mesh-list
14295811|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
14295812|NCT00583700|Vitamins|vitamins|mesh-ancestor
14295813|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
14295814|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295815|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
15206411|NCT03721614|Everolimus|everolimus|mesh-list
14912791|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912792|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912793|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912794|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
14912795|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912796|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14912797|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
14912798|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14912799|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14912800|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14912801|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206412|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206413|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206414|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
14295816|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707351|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15206415|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206416|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15206417|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707352|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707353|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707354|NCT00422578|Urological Agents|urological agents|mesh-ancestor
14707355|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
15206418|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15206419|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
14295817|NCT00583700|Protective Agents|protective agents|mesh-ancestor
15206420|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
15206421|NCT03721497|Testosterone|testosterone|mesh-list
15206422|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
15206423|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
15206424|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15206425|NCT03721497|Androgens|androgens|mesh-ancestor
15206426|NCT03721497|Hormones|hormones|mesh-ancestor
15206427|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206428|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850413|NCT01024179|Sirolimus|sirolimus|mesh-list
14850414|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850415|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850416|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14850417|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850418|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
14850419|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850420|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
14850421|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850422|NCT01024192|Zolpidem|zolpidem|mesh-list
14850423|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14850424|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14850425|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850426|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850427|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14850428|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
14850429|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
14850430|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850431|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850432|NCT01024205|Sunitinib|sunitinib|mesh-list
14850433|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850434|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14850435|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850436|NCT01024205|Growth Substances|growth substances|mesh-ancestor
14850437|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850438|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
14850439|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14850440|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850441|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850442|NCT01024270|Misoprostol|misoprostol|mesh-list
14850443|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14850444|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
14850445|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14850446|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850447|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14850448|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14850449|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
14850450|NCT01024322|Diclofenac|diclofenac|mesh-list
14850451|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
14850452|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14850453|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
15206429|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15206430|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206431|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
15206432|NCT03721432|Pregabalin|pregabalin|mesh-list
15206433|NCT03721432|Analgesics|analgesics|mesh-ancestor
15206434|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
15206435|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206436|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206437|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
15206438|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15206439|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15206440|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206441|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206442|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15206443|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15206444|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206445|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15206446|NCT03721380|Methadone|methadone|mesh-list
15206447|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15206448|NCT03721380|Narcotics|narcotics|mesh-ancestor
15206449|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850454|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14850455|NCT01024322|Prednisolone|prednisolone|mesh-list
14850456|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14850457|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
14850458|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14850459|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14850460|NCT01024322|Analgesics|analgesics|mesh-ancestor
14850461|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
14850462|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850463|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850464|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14850465|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850466|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14850467|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850468|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850469|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850470|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
14850471|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
14850472|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14707356|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14850473|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
14850474|NCT01024322|Hormones|hormones|mesh-ancestor
14850475|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14850476|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14850477|NCT01024322|Protective Agents|protective agents|mesh-ancestor
14850478|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14850479|NCT01024348|Acetaminophen|acetaminophen|mesh-list
14850480|NCT01024348|Tramadol|tramadol|mesh-list
14850481|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14850482|NCT01024348|Analgesics|analgesics|mesh-ancestor
14850483|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
14850484|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850485|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850486|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
14850487|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14850488|NCT01024348|Narcotics|narcotics|mesh-ancestor
14850489|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850490|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14850491|NCT01024413|Gefitinib|gefitinib|mesh-list
14850492|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850493|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14850494|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850495|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850496|NCT01024491|Paroxetine|paroxetine|mesh-list
14850497|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14850498|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14850499|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14850500|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850501|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850502|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
14707357|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14707358|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
14707359|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707360|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707361|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14707362|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
14707363|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
14707364|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14707365|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
14707366|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707367|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707368|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14707369|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14707370|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14707371|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
14707372|NCT00422617|Alefacept|alefacept|mesh-list
14850503|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850504|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14850505|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
14850506|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850507|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14850508|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14850509|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850510|NCT01024504|Bevacizumab|bevacizumab|mesh-list
14850511|NCT01024504|Capecitabine|capecitabine|mesh-list
14850512|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
14850513|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850514|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850515|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14850516|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850517|NCT01024504|Growth Substances|growth substances|mesh-ancestor
14850518|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850519|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14850520|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14850521|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
14850522|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850523|NCT01024543|Phenylephrine|phenylephrine|mesh-list
14850524|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
14850525|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
14850526|NCT01024543|Giapreza|giapreza|mesh-list
14850527|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
14850528|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14850529|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
14850530|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
14850531|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850532|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850533|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
14850534|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14850535|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
14850536|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
14850537|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14850538|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14850539|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14850540|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
14850541|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850542|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850543|NCT01024543|Protective Agents|protective agents|mesh-ancestor
14850544|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14850545|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
14850546|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850547|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
14850548|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850549|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
14850550|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850551|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850552|NCT01024660|Donepezil|donepezil|mesh-list
14850553|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14850554|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850555|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850556|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
14850557|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850558|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850559|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
14850560|NCT01024712|Paclitaxel|paclitaxel|mesh-list
14850561|NCT01024712|Carboplatin|carboplatin|mesh-list
14850562|NCT01024712|Gefitinib|gefitinib|mesh-list
14850563|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14850564|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850565|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
14850566|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
15206450|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206451|NCT03721380|Analgesics|analgesics|mesh-ancestor
15206452|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
15206453|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206454|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
15206455|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
15206456|NCT03721081|Lidocaine|lidocaine|mesh-list
15206457|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
15206458|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
15206459|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850567|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
14850568|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850569|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14850570|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850571|NCT01024777|Vitamin D|vitamin d|mesh-list
14850572|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
14850573|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
14850574|NCT01024777|Vitamins|vitamins|mesh-list
14850575|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
14850576|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850577|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14850578|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14850579|NCT01024868|Ropivacaine|ropivacaine|mesh-list
14850580|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
14850581|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
14850582|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850583|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850584|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
14850585|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850586|NCT01025102|Sufentanil|sufentanil|mesh-list
14850587|NCT01025102|Ropivacaine|ropivacaine|mesh-list
14850588|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14850589|NCT01025102|Narcotics|narcotics|mesh-ancestor
14850590|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850591|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850592|NCT01025102|Analgesics|analgesics|mesh-ancestor
14850593|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
14850594|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850595|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14850596|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14850597|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
14850598|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
14850599|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
14850600|NCT01025128|Vitamin D|vitamin d|mesh-list
14850601|NCT01025128|Vitamins|vitamins|mesh-ancestor
14850602|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
14850603|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850604|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14850605|NCT01025245|Remifentanil|remifentanil|mesh-list
14850606|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14850607|NCT01025245|Narcotics|narcotics|mesh-ancestor
14850608|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850609|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850610|NCT01025245|Analgesics|analgesics|mesh-ancestor
14850611|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
14850612|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850613|NCT01025349|Bevacizumab|bevacizumab|mesh-list
14850614|NCT01025349|Docetaxel|docetaxel|mesh-list
14850615|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850616|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850617|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14850618|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850619|NCT01025349|Growth Substances|growth substances|mesh-ancestor
14850620|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850621|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
14850622|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
14850623|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
14850624|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
14850625|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850626|NCT01025466|Memantine|memantine|mesh-list
14850627|NCT01025466|Rivastigmine|rivastigmine|mesh-list
14850628|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14850629|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14850630|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
14850631|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850632|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707373|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
14707374|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
14707375|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707376|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
14707377|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14707378|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
14707379|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850633|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850634|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14850635|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14707380|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
14850636|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14850637|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850638|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
14850639|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14850640|NCT01025466|Protective Agents|protective agents|mesh-ancestor
14850641|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
14850642|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850643|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14850644|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850645|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850646|NCT01025544|Vaccines|vaccines|mesh-list
14850647|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
14850648|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850649|NCT01025570|Gemcitabine|gemcitabine|mesh-list
14850650|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14850651|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
14850652|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850653|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850654|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
14850655|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850656|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850657|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850658|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
14850659|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850660|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14850661|NCT01025700|Nabilone|nabilone|mesh-list
14850662|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
14850663|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
14850664|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850665|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850666|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14850667|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14850668|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14850669|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850670|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850671|NCT01025765|Metformin|metformin|mesh-list
14850672|NCT01025765|Pioglitazone|pioglitazone|mesh-list
14850673|NCT01025765|Acarbose|acarbose|mesh-list
14850674|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14850675|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850676|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14850677|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850678|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850679|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
14850680|NCT01025778|Thiotepa|thiotepa|mesh-list
14850681|NCT01025778|Etoposide|etoposide|mesh-list
14850682|NCT01025778|Clofarabine|clofarabine|mesh-list
14850683|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850684|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
14850685|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850686|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850687|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14850688|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
14850689|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850690|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850691|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14850692|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14850693|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14850694|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14850695|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850696|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14850697|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
14850698|NCT01025882|Gemcitabine|gemcitabine|mesh-list
14850699|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14850700|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
14850701|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850702|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850703|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
14850704|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850705|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850706|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850707|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
14850708|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850709|NCT01025921|Colistin|colistin|mesh-list
14850710|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850711|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850712|NCT01025934|Bevacizumab|bevacizumab|mesh-list
14850713|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850714|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850715|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14707381|NCT00422643|Protective Agents|protective agents|mesh-ancestor
14707382|NCT00422682|Gemcitabine|gemcitabine|mesh-list
14707383|NCT00422682|Paclitaxel|paclitaxel|mesh-list
14707384|NCT00422682|Carboplatin|carboplatin|mesh-list
14707385|NCT00422682|Temozolomide|temozolomide|mesh-list
14707386|NCT00422682|Topotecan|topotecan|mesh-list
14707387|NCT00422682|Iniparib|iniparib|mesh-list
14707388|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14707389|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850716|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850717|NCT01025934|Growth Substances|growth substances|mesh-ancestor
14850718|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850719|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912802|NCT01371487|Trametinib|trametinib|mesh-list
14912803|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912804|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14912805|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912806|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912807|NCT01371526|Cosyntropin|cosyntropin|mesh-list
14912808|NCT01371526|Hormones|hormones|mesh-ancestor
14912809|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912810|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912811|NCT01371604|Ribavirin|ribavirin|mesh-list
14912812|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14912813|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
14912814|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912815|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
14912816|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912817|NCT01371682|Ropinirole|ropinirole|mesh-list
14912818|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14912819|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14912820|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
14912821|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
14912822|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912823|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912824|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912825|NCT01371968|Alfentanil|alfentanil|mesh-list
14912826|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14912827|NCT01371968|Narcotics|narcotics|mesh-ancestor
14912828|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912829|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912830|NCT01371968|Analgesics|analgesics|mesh-ancestor
14912831|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
14912832|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912833|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14912834|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
14912835|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
14912836|NCT01372007|Lanreotide|lanreotide|mesh-list
14707390|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14707391|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14912837|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850720|NCT01026064|Azithromycin|azithromycin|mesh-list
14850721|NCT01026064|Cantharidin|cantharidin|mesh-list
14850722|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850723|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850724|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850725|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850726|NCT01026090|Dronedarone|dronedarone|mesh-list
14850727|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14850728|NCT01026116|Paclitaxel|paclitaxel|mesh-list
14850729|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
14850730|NCT01026116|Epirubicin|epirubicin|mesh-list
14850731|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14850732|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850733|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
14850734|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14850735|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14850736|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850737|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850738|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
14850739|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850740|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850741|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14850742|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
14850743|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14850744|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14850745|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15206460|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206461|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
15206462|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206463|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15206464|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15206465|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15206466|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15206467|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206468|NCT03720990|Cholic Acids|cholic acids|mesh-list
15206469|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206470|NCT03720899|Nicotine|nicotine|mesh-list
15206471|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15206472|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
15206473|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206474|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206475|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15206476|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15206477|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
15206478|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206479|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206480|NCT03720886|Teriparatide|teriparatide|mesh-list
15206481|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206482|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206483|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15206484|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15206485|NCT03720873|Gefitinib|gefitinib|mesh-list
14707392|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14707393|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850746|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14850747|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850748|NCT01026129|Lidocaine|lidocaine|mesh-list
14850749|NCT01026129|Remifentanil|remifentanil|mesh-list
14850750|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
14850751|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
14850752|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850753|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850754|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
14707394|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707395|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
14707396|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
14707397|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707398|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206486|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206487|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206488|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206489|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707399|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14850755|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850756|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14850757|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14850758|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14850759|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14850760|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850761|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14850762|NCT01026129|Narcotics|narcotics|mesh-ancestor
14850763|NCT01026129|Analgesics|analgesics|mesh-ancestor
14850764|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14850765|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850766|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850767|NCT01026285|Risperidone|risperidone|mesh-list
14850768|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
14850769|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14850770|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
14850771|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850772|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850773|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850774|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14850775|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850776|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850777|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14850778|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
14850779|NCT01026311|Ubiquinone|ubiquinone|mesh-list
14850780|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
14850781|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
14850782|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850783|NCT01026311|Vitamins|vitamins|mesh-ancestor
14850784|NCT01026337|Sunitinib|sunitinib|mesh-list
14850785|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850786|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14850787|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14850788|NCT01026337|Growth Substances|growth substances|mesh-ancestor
14850789|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850790|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
14850791|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14850792|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850793|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850794|NCT01026350|Antibodies|antibodies|mesh-list
14850795|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
14850796|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850797|NCT01026363|Vitamin D|vitamin d|mesh-list
14850798|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
14850799|NCT01026363|Calcitriol|calcitriol|mesh-list
14850800|NCT01026363|Vitamins|vitamins|mesh-list
14850801|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
14850802|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850803|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14850804|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14850805|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14850806|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14850807|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850808|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14850809|NCT01026376|Decitabine|decitabine|mesh-list
14850810|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14850811|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
14850812|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850813|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850814|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206490|NCT03720756|Nickel|nickel|mesh-list
15206491|NCT03720756|Trace Elements|trace elements|mesh-ancestor
15206492|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
15206493|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206494|NCT03720717|Baclofen|baclofen|mesh-list
15206495|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15206496|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206497|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15206498|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206499|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15206500|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
15206501|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
15206502|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206503|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206504|NCT03720665|Caffeine|caffeine|mesh-list
14850815|NCT01026415|Rifampin|rifampin|mesh-list
14850816|NCT01026415|Ketoconazole|ketoconazole|mesh-list
14850817|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14850818|NCT01026415|Midazolam|midazolam|mesh-list
14850819|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14850820|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14850821|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14850822|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850823|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850824|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14850825|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14850826|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850827|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14850828|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
14850829|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
14850830|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
14850831|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
14850832|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850833|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850834|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14850835|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
14850836|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15206505|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15206506|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206507|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14850837|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850838|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
14850839|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14850840|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850841|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14850842|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14850843|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14850844|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14850845|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14850846|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14850847|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850848|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850849|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
14850850|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
14850851|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14850852|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14850853|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14850854|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
14850855|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14850856|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14850857|NCT01026428|Levodopa|levodopa|mesh-list
14850858|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14850859|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14850860|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
14850861|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850862|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850863|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850864|NCT01026467|Carboplatin|carboplatin|mesh-list
14850865|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850866|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
14850867|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14850868|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850869|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850870|NCT01026584|Aripiprazole|aripiprazole|mesh-list
14850871|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14850872|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14850873|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14850874|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14850875|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14850876|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850877|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
14850878|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
14850879|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850880|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850881|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14850882|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14850883|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
14850884|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14850885|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14850886|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14850887|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14850888|NCT01026610|Entecavir|entecavir|mesh-list
14850889|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
14850890|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850891|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
14850892|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14850893|NCT01026636|Cephalosporins|cephalosporins|mesh-list
14850894|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850895|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850896|NCT01026701|Bortezomib|bortezomib|mesh-list
14850897|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14850898|NCT01026714|Fluconazole|fluconazole|mesh-list
14707400|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
14707401|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707402|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14707403|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
14707404|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14707405|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14707406|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14707407|NCT00422708|Anesthetics|anesthetics|mesh-list
14707408|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707409|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850899|NCT01026714|Rifampin|rifampin|mesh-list
14850900|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
14850901|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
14850902|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850903|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14850904|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14850905|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850906|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850907|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14850908|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
14850909|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14850910|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850911|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14707410|NCT00422773|Cetuximab|cetuximab|mesh-list
14707411|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14850912|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14850913|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14850914|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
14850915|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850916|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
14850917|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14850918|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14850919|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14850920|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14850921|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14850922|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14850923|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14850924|NCT01026714|Analgesics|analgesics|mesh-ancestor
14850925|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
14850926|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850927|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14850928|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14850929|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14850930|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14850931|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14850932|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14850933|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
15206508|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206509|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206510|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15206511|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15206512|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
15206513|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206514|NCT03720522|Adenosine|adenosine|mesh-list
15206515|NCT03720522|Analgesics|analgesics|mesh-ancestor
15206516|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
15206517|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206518|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206519|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14850934|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850935|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
14850936|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14850937|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14850938|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850939|NCT01026961|Acetaminophen|acetaminophen|mesh-list
14850940|NCT01026961|Dimethindene|dimethindene|mesh-list
14850941|NCT01026961|Phenylephrine|phenylephrine|mesh-list
14850942|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
14850943|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14850944|NCT01026961|Analgesics|analgesics|mesh-ancestor
14850945|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
14850946|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14850947|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14850948|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
14850949|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850950|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14850951|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
14850952|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
14850953|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
14850954|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14850955|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
14850956|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
14850957|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14850958|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14850959|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14850960|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14850961|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14850962|NCT01026961|Protective Agents|protective agents|mesh-ancestor
14850963|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
14850964|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14850965|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14850966|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
14850967|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
14850968|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14850969|NCT01026987|Plerixafor|plerixafor|mesh-list
14850970|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14850971|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14850972|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
14850973|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707412|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707413|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
14707414|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707415|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14707416|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707417|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850974|NCT01027065|Tenofovir|tenofovir|mesh-list
14850975|NCT01027065|Entecavir|entecavir|mesh-list
14850976|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
14850977|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850978|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15206520|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
15206521|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15206522|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
15206523|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
14707418|NCT00422864|Leucovorin|leucovorin|mesh-list
15206524|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206525|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206526|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
15206527|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15206528|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
15206529|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206530|NCT03720483|Expectorants|expectorants|mesh-ancestor
15206531|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
15206532|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15206533|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
14707419|NCT00422864|Fluorouracil|fluorouracil|mesh-list
14707420|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
14707421|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
14728682|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14850979|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14850980|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850981|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850982|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14850983|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14850984|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
14850985|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
14850986|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14850987|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14850988|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850989|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14850990|NCT01027117|Urological Agents|urological agents|mesh-ancestor
14850991|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
14850992|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14850993|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14850994|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
14850995|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14850996|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14850997|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14850998|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14850999|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851000|NCT01027377|Factor VIII|factor viii|mesh-list
14851001|NCT01027377|Coagulants|coagulants|mesh-ancestor
14851002|NCT01027429|Amoxicillin|amoxicillin|mesh-list
14851003|NCT01027429|Gentamicins|gentamicins|mesh-list
14851004|NCT01027429|Penicillins|penicillins|mesh-list
14851005|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
14851006|NCT01027429|Penicillin G|penicillin g|mesh-list
14851007|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14851008|NCT01027429|Procaine|procaine|mesh-list
14851009|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851010|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851011|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14851012|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851013|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851014|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
14851015|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
14851016|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14851017|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206534|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206535|NCT03720483|Protective Agents|protective agents|mesh-ancestor
15206536|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206537|NCT03720483|Antidotes|antidotes|mesh-ancestor
15206538|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
15206539|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15206540|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206541|NCT03720340|Oprelvekin|oprelvekin|mesh-list
15206542|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224869|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15224870|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707422|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707423|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707424|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707425|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707426|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
14707427|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707428|NCT00422864|Antidotes|antidotes|mesh-ancestor
14707429|NCT00422864|Protective Agents|protective agents|mesh-ancestor
14707430|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
14707431|NCT00422864|Vitamins|vitamins|mesh-ancestor
14707432|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
14707433|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
14707434|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14728683|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851018|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
14851019|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851020|NCT01027481|Ranibizumab|ranibizumab|mesh-list
14851021|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851022|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851023|NCT01027481|Growth Substances|growth substances|mesh-ancestor
14851024|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851025|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851026|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851027|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
14851028|NCT01027494|Dexamethasone|dexamethasone|mesh-list
14851029|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851030|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
14851031|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
14851032|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851033|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851034|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851035|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
14851036|NCT01027494|Hormones|hormones|mesh-ancestor
14851037|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851038|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14851039|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851040|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851041|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851042|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14851043|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14851044|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851045|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851046|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14851047|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14851048|NCT01027520|Monensin|monensin|mesh-list
14851049|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
14851050|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851051|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14851052|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14851053|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
14851054|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
14851055|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
14851056|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851057|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851058|NCT01027520|Ionophores|ionophores|mesh-ancestor
14851059|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851060|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
14851061|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
14851062|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14851063|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14851064|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851065|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
14851066|NCT01027546|Coagulants|coagulants|mesh-ancestor
14851067|NCT01027611|Lidocaine|lidocaine|mesh-list
14851068|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
14851069|NCT01027611|Propoxycaine|propoxycaine|mesh-list
14707435|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707436|NCT00422994|Ropinirole|ropinirole|mesh-list
14707437|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14707438|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14707439|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
14707440|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
14707441|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707442|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707443|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851070|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
14851071|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
15206543|NCT03720288|Acetazolamide|acetazolamide|mesh-list
15206544|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
14707444|NCT00423007|Bromfenac|bromfenac|mesh-list
14707445|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14707446|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14707447|NCT00423007|Analgesics|analgesics|mesh-ancestor
14851072|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14851073|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851074|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
14851075|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851076|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14851077|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14851078|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14851079|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851080|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851081|NCT01027689|Alprazolam|alprazolam|mesh-list
14851082|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14707448|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
14707449|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707450|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707451|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707452|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707453|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
14851083|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14851084|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851085|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14851086|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14851087|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851088|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
14851089|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
14851090|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851091|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851092|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
14851093|NCT01027832|Tazobactam|tazobactam|mesh-list
14851094|NCT01027832|Piperacillin|piperacillin|mesh-list
14851095|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14851096|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851097|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851098|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14851099|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851100|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851101|NCT01027923|Cytarabine|cytarabine|mesh-list
14851102|NCT01027923|Plerixafor|plerixafor|mesh-list
14851103|NCT01027923|Etoposide|etoposide|mesh-list
14851104|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
14851105|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14851106|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851107|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14851108|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14851109|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851110|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851111|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14851112|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
14851113|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
14851114|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851115|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851116|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
14851117|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851118|NCT01027923|Analgesics|analgesics|mesh-ancestor
14851119|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
14851120|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851121|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14851122|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14912838|NCT01372111|Cisplatin|cisplatin|mesh-list
15206545|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15206546|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206547|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206548|NCT03720288|Diuretics|diuretics|mesh-ancestor
15206549|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
15206550|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206551|NCT03720249|Vitamins|vitamins|mesh-list
15206552|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
14912839|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912840|NCT01372280|Galantamine|galantamine|mesh-list
14851123|NCT01028079|Aspirin|aspirin|mesh-list
14851124|NCT01028079|Ibuprofen|ibuprofen|mesh-list
14851125|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14851126|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14851127|NCT01028079|Analgesics|analgesics|mesh-ancestor
14851128|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
14851129|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851130|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851131|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851132|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851133|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14851134|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14851135|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851136|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14851137|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14851138|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851139|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
14851140|NCT01028092|Cyclosporine|cyclosporine|mesh-list
14851141|NCT01028092|Everolimus|everolimus|mesh-list
14851142|NCT01028092|Interleukin-2|interleukin-2|mesh-list
14851143|NCT01028092|Cyclosporins|cyclosporins|mesh-list
14851144|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
14851145|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851146|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851147|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851148|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
14851149|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851150|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
14851151|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851152|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
14851153|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851154|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14851155|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851156|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14851157|NCT01028092|Analgesics|analgesics|mesh-ancestor
14851158|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
14851159|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851160|NCT01028170|Furosemide|furosemide|mesh-list
14851161|NCT01028170|Diuretics|diuretics|mesh-ancestor
14851162|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
14851163|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851164|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14851165|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851166|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851167|NCT01028248|Ranibizumab|ranibizumab|mesh-list
14851168|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851169|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851170|NCT01028248|Growth Substances|growth substances|mesh-ancestor
14851171|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851172|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851173|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851174|NCT01028261|CKD732|ckd732|mesh-list
14851175|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851176|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851177|NCT01028261|Growth Substances|growth substances|mesh-ancestor
14851178|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851179|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851180|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851181|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14851182|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14851183|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
14851184|NCT01028287|Hormones|hormones|mesh-ancestor
14851185|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851186|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851187|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851188|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851189|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
14851190|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14851191|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14851192|NCT01028313|Prednisolone|prednisolone|mesh-list
14851193|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
14851194|NCT01028313|Panobinostat|panobinostat|mesh-list
14851195|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14851196|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
14851197|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851198|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
14851199|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
14851200|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851201|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851202|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851203|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
14851204|NCT01028313|Hormones|hormones|mesh-ancestor
14851205|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851206|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14851207|NCT01028313|Protective Agents|protective agents|mesh-ancestor
14851208|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14851209|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851210|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14851211|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851212|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851213|NCT01028339|Mannitol|mannitol|mesh-list
14851214|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14851215|NCT01028339|Diuretics|diuretics|mesh-ancestor
14851216|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
14851217|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851218|NCT01028404|Insulin|insulin|mesh-list
14851219|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14851220|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
14851221|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
14851222|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14851223|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14851224|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851225|NCT01028443|Cyclosporine|cyclosporine|mesh-list
14851226|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
14851227|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851228|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
14851229|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851230|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851231|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851232|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
14851233|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851234|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851235|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14851236|NCT01028482|Sertraline|sertraline|mesh-list
14851237|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
14851238|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851239|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14851240|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14851241|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851242|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851243|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851244|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
14851245|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851246|NCT01028495|Gemcitabine|gemcitabine|mesh-list
14851247|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14851248|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
14851249|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851250|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851251|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
14851252|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851253|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851254|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851255|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
14851256|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851257|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14851258|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
14851259|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851260|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851261|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851262|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14851263|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14851264|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851265|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851266|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14851267|NCT01028534|Olmesartan|olmesartan|mesh-list
14851268|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14851269|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
14851270|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
14851271|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14851272|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14851273|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851274|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14851275|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14851276|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851277|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14851278|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851279|NCT01028547|Dexamethasone|dexamethasone|mesh-list
14851280|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851281|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
14851282|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
14851283|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851284|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851285|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851286|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
14851287|NCT01028547|Hormones|hormones|mesh-ancestor
14851288|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851289|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14851290|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851291|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14851292|NCT01028573|Laxatives|laxatives|mesh-ancestor
14851293|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851294|NCT01028638|Bevacizumab|bevacizumab|mesh-list
14851295|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
14851296|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14851297|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851298|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851299|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851300|NCT01028638|Growth Substances|growth substances|mesh-ancestor
14851301|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851302|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851303|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15206553|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
15206554|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
15206555|NCT03720249|Betaine|betaine|mesh-list
15206556|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
15206557|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206558|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206559|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
15206560|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15206561|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
15206562|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707454|NCT00423020|Hematinics|hematinics|mesh-ancestor
14851304|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851305|NCT01028729|Gemcitabine|gemcitabine|mesh-list
14851306|NCT01028729|Endostar protein|endostar protein|mesh-list
14851307|NCT01028729|Endostatins|endostatins|mesh-list
14851308|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851309|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14851310|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
14851311|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851312|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
14851313|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851314|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707455|NCT00423059|Bevacizumab|bevacizumab|mesh-list
14707456|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707457|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707458|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14707459|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14707460|NCT00423059|Growth Substances|growth substances|mesh-ancestor
14707461|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851315|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851316|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
14851317|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851318|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851319|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851320|NCT01028729|Growth Substances|growth substances|mesh-ancestor
14851321|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851322|NCT01028768|Teduglutide|teduglutide|mesh-list
14851323|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851324|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14851325|NCT01028768|Protective Agents|protective agents|mesh-ancestor
14851326|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851327|NCT01028781|Thalidomide|thalidomide|mesh-list
14851328|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851329|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
14851330|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851331|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
14851332|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851333|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851334|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851335|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851336|NCT01028781|Growth Substances|growth substances|mesh-ancestor
14851337|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851338|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851339|NCT01028846|Diazoxide|diazoxide|mesh-list
14851340|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14851341|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
14851342|NCT01028924|Teduglutide|teduglutide|mesh-list
14851343|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851344|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14851345|NCT01028924|Protective Agents|protective agents|mesh-ancestor
14851346|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851347|NCT01028950|Darexaban|darexaban|mesh-list
14851348|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14851349|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
14851350|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14851351|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
14851352|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851353|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851354|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
14851355|NCT01028963|Pioglitazone|pioglitazone|mesh-list
14851356|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14851357|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851358|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
15206563|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15206564|NCT03720223|Bupivacaine|bupivacaine|mesh-list
14707462|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
14707463|NCT00423163|Voriconazole|voriconazole|mesh-list
14851359|NCT01028976|Vitamins|vitamins|mesh-ancestor
15206565|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
15206566|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
15206567|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206568|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206569|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
14851360|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
14851361|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707464|NCT00423163|Micafungin|micafungin|mesh-list
14851362|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
14851363|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851364|NCT01028976|Protective Agents|protective agents|mesh-ancestor
14851365|NCT01029002|Vitamin D|vitamin d|mesh-list
14851366|NCT01029002|Vitamins|vitamins|mesh-ancestor
14851367|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
14851368|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851369|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14851370|NCT01029132|Galantamine|galantamine|mesh-list
14851371|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14851372|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851373|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851374|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
14851375|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851376|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206570|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206571|NCT03720067|Propranolol|propranolol|mesh-list
15206572|NCT03720067|Carvedilol|carvedilol|mesh-list
15206573|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15206574|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15206575|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15206576|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
15206577|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707465|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
14707466|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707467|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14707468|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14707469|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206578|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15206579|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15206580|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206581|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15206582|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15206583|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
15206584|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206585|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206586|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15206587|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15206588|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
15206589|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
15206590|NCT03720067|Protective Agents|protective agents|mesh-ancestor
15206591|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15206592|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15206593|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206594|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14851377|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14707470|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707471|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14707472|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
14707473|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851378|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
14851379|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851380|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
14851381|NCT01029223|Metoprolol|metoprolol|mesh-list
14851382|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14851383|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14851384|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
14851385|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
14851386|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851387|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851388|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14851389|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14851390|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14851391|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
14851392|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851393|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851394|NCT01029275|Octreotide|octreotide|mesh-list
14851395|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851396|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14851397|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851398|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14851399|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851400|NCT01029418|Sorafenib|sorafenib|mesh-list
14851401|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851402|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14851403|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851404|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851405|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
14851406|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14851407|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851408|NCT01029522|Atorvastatin|atorvastatin|mesh-list
14851409|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14851410|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14851411|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
14851412|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851413|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14851414|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14851415|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912841|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14912842|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912843|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912844|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
14912845|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912846|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912847|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14912848|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
14912849|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912850|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
14912851|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
14912852|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
14912853|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14912854|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14912855|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912856|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14912857|NCT01372306|Galantamine|galantamine|mesh-list
14912858|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14912859|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912860|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912861|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
14912862|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912863|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912864|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14912865|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
14912866|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912867|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
14912868|NCT01372371|Vancomycin|vancomycin|mesh-list
14912869|NCT01372371|Gentamicins|gentamicins|mesh-list
14912870|NCT01372371|Cefuroxime|cefuroxime|mesh-list
14912871|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
14912872|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14912873|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14912874|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14912875|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707474|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206595|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14707475|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14707476|NCT00423202|Ambrisentan|ambrisentan|mesh-list
14851416|NCT01029613|Adalimumab|adalimumab|mesh-list
14851417|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851418|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851419|NCT01029639|Insulin|insulin|mesh-list
14851420|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
14851421|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14851422|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14851423|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851424|NCT01029678|Vinorelbine|vinorelbine|mesh-list
14851425|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851426|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14851427|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
14851428|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
14851429|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
14851430|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851431|NCT01029743|Aspirin|aspirin|mesh-list
14851432|NCT01029743|PENTA|penta|mesh-list
14851433|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
14851434|NCT01029743|Fondaparinux|fondaparinux|mesh-list
14851435|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14851436|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14851437|NCT01029743|Analgesics|analgesics|mesh-ancestor
14851438|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
14851439|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851440|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851441|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851442|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851443|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14851444|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14851445|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851446|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14851447|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14851448|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851449|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
14851450|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14851451|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
14851452|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14851453|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
14851454|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
14851455|NCT01029769|Olanzapine|olanzapine|mesh-list
14851456|NCT01029769|Amisulpride|amisulpride|mesh-list
14851457|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
14851458|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
14851459|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851460|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851461|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851462|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14851463|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14851464|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14851465|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851466|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14851467|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14851468|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851469|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851470|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851471|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
14851472|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14851473|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
15206596|NCT03720041|Dexamethasone|dexamethasone|mesh-list
15206597|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
14851474|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14707477|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15206598|NCT03720041|Lenalidomide|lenalidomide|mesh-list
15206599|NCT03720041|Ixazomib|ixazomib|mesh-list
14707478|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
14707479|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14707480|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707481|NCT00423228|Donepezil|donepezil|mesh-list
14851475|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
15206600|NCT03720041|BB 1101|bb 1101|mesh-list
14851476|NCT01029821|Heparin|heparin|mesh-list
15206601|NCT03720041|Glycine|glycine|mesh-list
15206602|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15206603|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
15206604|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
14707482|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14707483|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707484|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707485|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
14851477|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14851478|NCT01029821|Tinzaparin|tinzaparin|mesh-list
14851479|NCT01029821|Dalteparin|dalteparin|mesh-list
14851480|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
14851481|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14851482|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14851483|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851484|NCT01029847|Adalimumab|adalimumab|mesh-list
14851485|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851486|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851487|NCT01030016|Atenolol|atenolol|mesh-list
14851488|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14851489|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14851490|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14851491|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851492|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851493|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851494|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14851495|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14851496|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
14851497|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
14851498|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851499|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14851500|NCT01030042|Leucovorin|leucovorin|mesh-list
14851501|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
14851502|NCT01030042|Irinotecan|irinotecan|mesh-list
14851503|NCT01030042|Cetuximab|cetuximab|mesh-list
14851504|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851505|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14851506|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14851507|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851508|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851509|NCT01030042|Antidotes|antidotes|mesh-ancestor
14851510|NCT01030042|Protective Agents|protective agents|mesh-ancestor
14851511|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851512|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
14707486|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707487|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707488|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
14707489|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
14851513|NCT01030042|Vitamins|vitamins|mesh-ancestor
14851514|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
14851515|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14851516|NCT01030081|Amlodipine|amlodipine|mesh-list
14851517|NCT01030081|Nifedipine|nifedipine|mesh-list
14851518|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14851519|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14851520|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851521|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851522|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14851523|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851524|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
14851525|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
14851526|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14851527|NCT01030094|Topiramate|topiramate|mesh-list
14851528|NCT01030094|Carbamazepine|carbamazepine|mesh-list
14851529|NCT01030094|Valproic Acid|valproic acid|mesh-list
14851530|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
14851531|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14851532|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851533|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851534|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851535|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
14851536|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851537|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
14851538|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14851539|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14851540|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851541|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14851542|NCT01030094|Analgesics|analgesics|mesh-ancestor
14851543|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
14851544|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851545|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14851546|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851547|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14851548|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15206605|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206606|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851549|NCT01030120|Etanercept|etanercept|mesh-list
14851550|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15206607|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206608|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
15206609|NCT03720041|Hormones|hormones|mesh-ancestor
15206610|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206611|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15206612|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851551|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14851552|NCT01030120|Analgesics|analgesics|mesh-ancestor
14851553|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
14851554|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851555|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851556|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851557|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851558|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851559|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851560|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
14851561|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14851562|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
14851563|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14851564|NCT01030302|Bortezomib|bortezomib|mesh-list
14851565|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851566|NCT01030328|Fenofibrate|fenofibrate|mesh-list
14851567|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14851568|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
14851569|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851570|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14851571|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14851572|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14851573|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851574|NCT01030510|Rocuronium|rocuronium|mesh-list
14851575|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14851576|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14851577|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14851578|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851579|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851580|NCT01030601|Dexamethasone|dexamethasone|mesh-list
14851581|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
14851582|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14851583|NCT01030601|BB 1101|bb 1101|mesh-list
14851584|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851585|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
14851586|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
14851587|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851588|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851589|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851590|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
14851591|NCT01030601|Hormones|hormones|mesh-ancestor
14851592|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851593|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14851594|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851595|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
14851596|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851597|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851598|NCT01030614|Dexamethasone|dexamethasone|mesh-list
14851599|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851600|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
14851601|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
14851602|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851603|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851604|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851605|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
14851606|NCT01030614|Hormones|hormones|mesh-ancestor
14851607|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851608|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14851609|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851610|NCT01030640|Tanezumab|tanezumab|mesh-list
14851611|NCT01030640|Analgesics|analgesics|mesh-ancestor
14851612|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
14851613|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851614|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851615|NCT01030692|Rivastigmine|rivastigmine|mesh-list
14851616|NCT01030692|Huperzine A|huperzine a|mesh-list
14851617|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14851618|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851619|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851620|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
14851621|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851622|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851623|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14851624|NCT01030692|Protective Agents|protective agents|mesh-ancestor
14851625|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
14851626|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14851627|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851628|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851629|NCT01030770|Ranibizumab|ranibizumab|mesh-list
14851630|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851631|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851632|NCT01030770|Growth Substances|growth substances|mesh-ancestor
14851633|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851634|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851635|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851636|NCT01030796|Caffeine|caffeine|mesh-list
14851637|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14851638|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851639|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14851640|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851641|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851642|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14851643|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14851644|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
14851645|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851646|NCT01030900|Rituximab|rituximab|mesh-list
14851647|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
14851648|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14851649|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851650|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
14851651|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851652|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851653|NCT01030926|Insulin|insulin|mesh-list
14851654|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14851655|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
14851656|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14851657|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851658|NCT01031017|Progesterone|progesterone|mesh-list
14851659|NCT01031017|Progestins|progestins|mesh-ancestor
14851660|NCT01031017|Hormones|hormones|mesh-ancestor
14851661|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851662|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851663|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
14851664|NCT01031030|Fluorouracil|fluorouracil|mesh-list
14851665|NCT01031030|Methotrexate|methotrexate|mesh-list
14851666|NCT01031030|Epirubicin|epirubicin|mesh-list
14851667|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851668|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
14851669|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851670|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851671|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14851672|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
14851673|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851674|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851675|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14851676|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
14707490|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14707491|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
14707492|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851677|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14851678|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14851679|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
14851680|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14851681|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14851682|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851683|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14851684|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14851685|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14707493|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
14707494|NCT00423371|Protective Agents|protective agents|mesh-ancestor
14707495|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
14707496|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14707497|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707498|NCT00423397|Interferons|interferons|mesh-list
14707499|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
14707500|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
14707501|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14851686|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14851687|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14851688|NCT01031212|Acetic Acid|acetic acid|mesh-list
14851689|NCT01031212|Paclitaxel|paclitaxel|mesh-list
14851690|NCT01031212|Carboplatin|carboplatin|mesh-list
14851691|NCT01031212|Cetuximab|cetuximab|mesh-list
14851692|NCT01031212|Vadimezan|vadimezan|mesh-list
14851693|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14851694|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851695|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
14851696|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
14851697|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
14851698|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851699|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14851700|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851701|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851702|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
14851703|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
14851704|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14851705|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14851706|NCT01031355|Calcium|calcium|mesh-list
14851707|NCT01031355|Estradiol|estradiol|mesh-list
14851708|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14851709|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14851710|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851711|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14851712|NCT01031355|Estrogens|estrogens|mesh-ancestor
14851713|NCT01031355|Hormones|hormones|mesh-ancestor
14851714|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851715|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14851716|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
14851717|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14851718|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14851719|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
14851720|NCT01031355|Vitamins|vitamins|mesh-ancestor
14851721|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
15206613|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
15206614|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707502|NCT00423397|Gefitinib|gefitinib|mesh-list
14707503|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707504|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
14707505|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707506|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
14707507|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206615|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206616|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
14707508|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14707509|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707510|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206617|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15206618|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14707511|NCT00423475|Goserelin|goserelin|mesh-list
14707512|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14851722|NCT01031368|Cytarabine|cytarabine|mesh-list
14851723|NCT01031368|Clofarabine|clofarabine|mesh-list
15206619|NCT03720041|Growth Substances|growth substances|mesh-ancestor
15206620|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
14707513|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206621|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
14851724|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14851725|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
14851726|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851727|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851728|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
14851729|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851730|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851731|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
14851732|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851733|NCT01031459|Interferons|interferons|mesh-list
14851734|NCT01031459|Interferon-beta|interferon-beta|mesh-list
14851735|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
14851736|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851737|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
14851738|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851739|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
14851740|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851741|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14912876|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912877|NCT01372423|Lubiprostone|lubiprostone|mesh-list
14912878|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14912879|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14912880|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912881|NCT01372449|Memantine|memantine|mesh-list
14912882|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14912883|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14912884|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
14912885|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912886|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912887|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912888|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14912889|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14912890|NCT01372540|Filanesib|filanesib|mesh-list
14912891|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
14912892|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
14912893|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912894|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912895|NCT01372579|Carboplatin|carboplatin|mesh-list
14912896|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912897|NCT01372644|Pasireotide|pasireotide|mesh-list
14912898|NCT01372644|Hormones|hormones|mesh-ancestor
14912899|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912900|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912901|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
14912902|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
14912903|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14912904|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14912905|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
14912906|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
14912907|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912908|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912909|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912910|NCT01372761|CKD732|ckd732|mesh-list
14912911|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14912912|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14912913|NCT01372761|Growth Substances|growth substances|mesh-ancestor
14912914|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912915|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
14912916|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912917|NCT01372826|Naloxegol|naloxegol|mesh-list
14912918|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14912919|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851742|NCT01031589|Rilpivirine|rilpivirine|mesh-list
14851743|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14851744|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14851745|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707514|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14707515|NCT00423501|Incretins|incretins|mesh-ancestor
14707516|NCT00423501|Hormones|hormones|mesh-ancestor
14707517|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707518|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707519|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
15206622|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206623|NCT03719989|Azacitidine|azacitidine|mesh-list
15206624|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15206625|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
15206626|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707520|NCT00423514|Melphalan|melphalan|mesh-list
14707521|NCT00423514|Thiotepa|thiotepa|mesh-list
14707522|NCT00423514|Clofarabine|clofarabine|mesh-list
14707523|NCT00423514|Tacrolimus|tacrolimus|mesh-list
14707524|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
14707525|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707526|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707527|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14707528|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851746|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851747|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
14851748|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851749|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14851750|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14851751|NCT01031667|Cilostazol|cilostazol|mesh-list
14851752|NCT01031667|Probucol|probucol|mesh-list
14851753|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14851754|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
14851755|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851756|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851757|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14851758|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
14851759|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14851760|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14851761|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851762|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14851763|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
14851764|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14851765|NCT01031667|Protective Agents|protective agents|mesh-ancestor
14851766|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14851767|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14851768|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851769|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14851770|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14851771|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
14851772|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14851773|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
14851774|NCT01031719|Vaccines|vaccines|mesh-list
14851775|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
14851776|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851777|NCT01031732|Tacrine|tacrine|mesh-list
14851778|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14851779|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851780|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851781|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
14851782|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851783|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851784|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14851785|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
14851786|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851787|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
14851788|NCT01031849|Lopinavir|lopinavir|mesh-list
14851789|NCT01031849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14851790|NCT01031849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15206627|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206628|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206629|NCT03719820|Aspirin|aspirin|mesh-list
15206630|NCT03719820|Clopidogrel|clopidogrel|mesh-list
15206631|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15206632|NCT03719820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15206633|NCT03719820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15206634|NCT03719820|Analgesics|analgesics|mesh-ancestor
14851791|NCT01031849|Protease Inhibitors|protease inhibitors|mesh-ancestor
14851792|NCT01031849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851793|NCT01031849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851794|NCT01031849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14851795|NCT01031849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14851796|NCT01031849|Antiviral Agents|antiviral agents|mesh-ancestor
14851797|NCT01031849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851798|NCT01031849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14851799|NCT01031849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14851800|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14851801|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14851802|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851803|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14851804|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14851805|NCT01031901|Sirolimus|sirolimus|mesh-list
14851806|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851807|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851808|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14851809|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851810|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
14851811|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851812|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
14851813|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851814|NCT01031927|Glycine|glycine|mesh-list
14851815|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
14851816|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851817|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851818|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851819|NCT01031966|Thymalfasin|thymalfasin|mesh-list
14851820|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14851821|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
14851822|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851823|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
14851824|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14851825|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14851826|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851827|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
14851828|NCT01031992|Coagulants|coagulants|mesh-ancestor
14851829|NCT01032031|Ascorbic Acid|ascorbic acid|mesh-list
14851830|NCT01032031|Vitamins|vitamins|mesh-ancestor
14851831|NCT01032031|Micronutrients|micronutrients|mesh-ancestor
14851832|NCT01032031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851833|NCT01032031|Antioxidants|antioxidants|mesh-ancestor
14851834|NCT01032031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851835|NCT01032031|Protective Agents|protective agents|mesh-ancestor
14851836|NCT01032057|Gemcitabine|gemcitabine|mesh-list
14851837|NCT01032057|Capecitabine|capecitabine|mesh-list
14851838|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14851839|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
14851840|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851841|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851842|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
14851843|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851844|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851845|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851846|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
14851847|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851848|NCT01032083|Citalopram|citalopram|mesh-list
14851849|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14851850|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14851851|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851852|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851853|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707529|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707530|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14707531|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707532|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14707533|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
15206635|NCT03719820|Sensory System Agents|sensory system agents|mesh-ancestor
15206636|NCT03719820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206637|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206638|NCT03719820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15206639|NCT03719820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15206640|NCT03719820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15206641|NCT03719820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15206642|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206643|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15206644|NCT03719820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15206645|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206646|NCT03719820|Antipyretics|antipyretics|mesh-ancestor
15206647|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15206648|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15206649|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14851854|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
14851855|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851856|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14851857|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
14851858|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851859|NCT01032109|Bevacizumab|bevacizumab|mesh-list
14851860|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14851861|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851862|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14851863|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14851864|NCT01032109|Growth Substances|growth substances|mesh-ancestor
14851865|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851866|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
14851867|NCT01032122|Rituximab|rituximab|mesh-list
14851868|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14851869|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206650|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
15206651|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206652|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15206653|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15206654|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
15206655|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15206656|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15206657|NCT03719729|Rifaximin|rifaximin|mesh-list
15206658|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15206659|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206660|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206661|NCT03719690|Tipifarnib|tipifarnib|mesh-list
15206662|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206663|NCT03719625|Norepinephrine|norepinephrine|mesh-list
15206664|NCT03719625|Ephedrine|ephedrine|mesh-list
15206665|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15206666|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15206667|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
14707534|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14707535|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707536|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14707537|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
14707538|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14707539|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707540|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
14707541|NCT00423527|Levetiracetam|levetiracetam|mesh-list
14851870|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
15206668|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851871|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851872|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851873|NCT01032148|Panobinostat|panobinostat|mesh-list
14851874|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14851875|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14851876|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851877|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851878|NCT01032187|Amphotericin B|amphotericin b|mesh-list
14851879|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14851880|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14851881|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14851882|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
14851883|NCT01032187|Amebicides|amebicides|mesh-ancestor
14851884|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14851885|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14851886|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851887|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851888|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
14851889|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14851890|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14851891|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
14851892|NCT01032213|Analgesics|analgesics|mesh-ancestor
14851893|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
14851894|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851895|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206669|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206670|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206671|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
14851896|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
14851897|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14851898|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14851899|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
14851900|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14851901|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851902|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851903|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14851904|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
14851905|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14851906|NCT01032304|Erdosteine|erdosteine|mesh-list
14851907|NCT01032304|Expectorants|expectorants|mesh-ancestor
14851908|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14851909|NCT01032434|Sertraline|sertraline|mesh-list
14851910|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
14851911|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851912|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15206672|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
15206673|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206674|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15206675|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15206676|NCT03719560|Cytarabine|cytarabine|mesh-list
15206677|NCT03719560|Methotrexate|methotrexate|mesh-list
15206678|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15206679|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
15206680|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15206681|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206682|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15206683|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
15206684|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707542|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
14707543|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
14707544|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
14707545|NCT00423540|Analgesics|analgesics|mesh-ancestor
14707546|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
14707547|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707548|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707549|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
14707550|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707551|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14707552|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
14707553|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14851913|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14851914|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14295818|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15206685|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206686|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
15206687|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206688|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15206689|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206690|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
15206691|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15206692|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15206693|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
15206694|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206695|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
15206696|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15206697|NCT03719404|Eusol|eusol|mesh-list
15206698|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15206699|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206700|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
15206701|NCT03719391|Nicotine|nicotine|mesh-list
15206702|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15206703|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
15206704|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707554|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14707555|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707556|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206705|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206706|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15206707|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14707557|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
14851915|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851916|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851917|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
14851918|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851919|NCT01032486|Rasagiline|rasagiline|mesh-list
14851920|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14851921|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851922|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851923|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14851924|NCT01032486|Protective Agents|protective agents|mesh-ancestor
14851925|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851926|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
14851927|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14851928|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851929|NCT01032668|Clopidogrel|clopidogrel|mesh-list
14851930|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14851931|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14851932|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14851933|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14851934|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
14851935|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707558|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14707559|NCT00423696|Leucovorin|leucovorin|mesh-list
14707560|NCT00423696|Bevacizumab|bevacizumab|mesh-list
14707561|NCT00423696|Fluorouracil|fluorouracil|mesh-list
14707562|NCT00423696|Capecitabine|capecitabine|mesh-list
14707563|NCT00423696|Irinotecan|irinotecan|mesh-list
14707564|NCT00423696|Calcium|calcium|mesh-list
14707565|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
14707566|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707567|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707568|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14707569|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14707570|NCT00423696|Growth Substances|growth substances|mesh-ancestor
14707571|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707572|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
14707573|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14707574|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
15206708|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
15206709|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206710|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206711|NCT03719313|Interferons|interferons|mesh-list
14851936|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851937|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851938|NCT01032798|Mepivacaine|mepivacaine|mesh-list
14851939|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
14851940|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
14851941|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14851942|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851943|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
14851944|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14851945|NCT01033058|Atorvastatin|atorvastatin|mesh-list
14851946|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14851947|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14851948|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
14851949|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851950|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14851951|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14851952|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14851953|NCT01033084|Sertraline|sertraline|mesh-list
14851954|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
14851955|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14851956|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14851957|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14851958|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14851959|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851960|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14851961|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
14851962|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851963|NCT01033097|Betamethasone|betamethasone|mesh-list
14851964|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14851965|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
14851966|NCT01033097|Hormones|hormones|mesh-ancestor
14851967|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14851968|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851969|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14851970|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
14851971|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
14851972|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14851973|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
14851974|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851975|NCT01033149|Expectorants|expectorants|mesh-ancestor
14851976|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14851977|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14851978|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
14851979|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851980|NCT01033149|Protective Agents|protective agents|mesh-ancestor
14851981|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851982|NCT01033149|Antidotes|antidotes|mesh-ancestor
14851983|NCT01033279|Warfarin|warfarin|mesh-list
14851984|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
14851985|NCT01033305|Cyclosporine|cyclosporine|mesh-list
14851986|NCT01033305|Cyclosporins|cyclosporins|mesh-list
14851987|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206712|NCT03719313|Ritonavir|ritonavir|mesh-list
14295819|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206713|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
15206714|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15206715|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
15206716|NCT03719313|Lonafarnib|lonafarnib|mesh-list
15206717|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206718|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
15206719|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206720|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15206721|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15206722|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
15206723|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206724|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851988|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14851989|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14851990|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
14851991|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14851992|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
14851993|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14851994|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14851995|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14851996|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14851997|NCT01033318|Losartan|losartan|mesh-list
14851998|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14851999|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14852000|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14852001|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14852002|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912920|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
14912921|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912922|NCT01372839|Atorvastatin|atorvastatin|mesh-list
14912923|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14912924|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14912925|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
14912926|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912927|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14912928|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14912929|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912930|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
14912931|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14912932|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
14912933|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14912934|NCT01372904|Dexamethasone|dexamethasone|mesh-list
14912935|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
14912936|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14912937|NCT01372904|BB 1101|bb 1101|mesh-list
14912938|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14912939|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
14912940|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
14912941|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912942|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912943|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14912944|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
14912945|NCT01372904|Hormones|hormones|mesh-ancestor
14912946|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912947|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14912948|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912949|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
14912950|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14912951|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912952|NCT01372930|Etanercept|etanercept|mesh-list
14912953|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14912954|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14912955|NCT01372930|Analgesics|analgesics|mesh-ancestor
14912956|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
14912957|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912958|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912959|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14912960|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14912961|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14912962|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14912963|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
14912964|NCT01372982|Letrozole|letrozole|mesh-list
14912965|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14912966|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14912967|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14912968|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852003|NCT01033370|Clevidipine|clevidipine|mesh-list
14852004|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14852005|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14852006|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852007|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14852008|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852009|NCT01033396|Fexofenadine|fexofenadine|mesh-list
14852010|NCT01033396|Terfenadine|terfenadine|mesh-list
14852011|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14852012|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14852013|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14852014|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
14852015|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
14852016|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852017|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852018|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852019|NCT01033409|Vaccines|vaccines|mesh-list
14852020|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
14852021|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852022|NCT01033461|Calcium|calcium|mesh-list
14852023|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14852024|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852025|NCT01033500|Abatacept|abatacept|mesh-list
14852026|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14852027|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852028|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852029|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852030|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
14852031|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852032|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852033|NCT01033526|Aspirin|aspirin|mesh-list
14852034|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14852035|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14852036|NCT01033526|Analgesics|analgesics|mesh-ancestor
14852037|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
14852038|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852039|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852040|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852041|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852042|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14852043|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14852044|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852045|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14852046|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14852047|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852048|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
14852049|NCT01033656|Methotrexate|methotrexate|mesh-list
14852050|NCT01033656|Azathioprine|azathioprine|mesh-list
14852051|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14852052|NCT01033656|Leflunomide|leflunomide|mesh-list
14852053|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14852054|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
14852055|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14852056|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852057|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14852058|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
14852059|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852060|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852061|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
14852062|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852063|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14852064|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852065|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
14852066|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852067|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14852068|NCT01033760|Ritonavir|ritonavir|mesh-list
14852069|NCT01033760|Darunavir|darunavir|mesh-list
14852070|NCT01033760|Tenofovir|tenofovir|mesh-list
14852071|NCT01033760|Emtricitabine|emtricitabine|mesh-list
14852072|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
14852073|NCT01033760|Maraviroc|maraviroc|mesh-list
14852074|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14852075|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14852076|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
14852077|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852078|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852079|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14852080|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14852081|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
14852082|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852083|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14852084|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14852085|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14852086|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14852087|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14852088|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14852089|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14852090|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14852091|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14852092|NCT01033877|Vaccines|vaccines|mesh-list
14852093|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
14852094|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852095|NCT01033903|Misoprostol|misoprostol|mesh-list
14852096|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14852097|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
14852098|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14852099|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852100|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14852101|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852102|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
14852103|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14852104|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14852105|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14852106|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
14852107|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852108|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14852109|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14852110|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852111|NCT01033981|Sunitinib|sunitinib|mesh-list
14852112|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852113|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14852114|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14852115|NCT01033981|Growth Substances|growth substances|mesh-ancestor
14852116|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852117|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
14852118|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14852119|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852120|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852121|NCT01033994|Mitogens|mitogens|mesh-list
14852122|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
14852123|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852124|NCT01034020|Nicotine|nicotine|mesh-list
14852125|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14852126|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
14852127|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852128|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852129|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14852130|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14852131|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
14852132|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852133|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852134|NCT01034124|Vitamin K|vitamin k|mesh-list
14852135|NCT01034124|Midazolam|midazolam|mesh-list
14852136|NCT01034124|Warfarin|warfarin|mesh-list
14852137|NCT01034124|Vitamins|vitamins|mesh-ancestor
14852138|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
14852139|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852140|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14852141|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14852142|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14852143|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14852144|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14852145|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14852146|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14852147|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
14852148|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
14852149|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
14852150|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
14852151|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852152|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852153|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
14852154|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14852155|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14852156|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
14852157|NCT01034124|Coagulants|coagulants|mesh-ancestor
14852158|NCT01034189|Paclitaxel|paclitaxel|mesh-list
14852159|NCT01034189|Cetuximab|cetuximab|mesh-list
14852160|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14852161|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852162|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
14852163|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
14852164|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
14852165|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852166|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14852167|NCT01034345|Sirolimus|sirolimus|mesh-list
14852168|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14852169|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14852170|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852171|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14852172|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707575|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707576|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707577|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707578|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
14707579|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14707580|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14707581|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707582|NCT00423696|Antidotes|antidotes|mesh-ancestor
14707583|NCT00423696|Protective Agents|protective agents|mesh-ancestor
14707584|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
14707585|NCT00423696|Vitamins|vitamins|mesh-ancestor
14707586|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
15206725|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15206726|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15206727|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15206728|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15206729|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
15206730|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206731|NCT03719274|Ascorbic Acid|ascorbic acid|mesh-list
15206732|NCT03719274|Vitamins|vitamins|mesh-ancestor
15206733|NCT03719274|Micronutrients|micronutrients|mesh-ancestor
14707587|NCT00423709|Fludarabine|fludarabine|mesh-list
14707588|NCT00423709|Melphalan|melphalan|mesh-list
14707589|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852173|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
14852174|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206734|NCT03719274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206735|NCT03719274|Antioxidants|antioxidants|mesh-ancestor
15206736|NCT03719274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206737|NCT03719274|Protective Agents|protective agents|mesh-ancestor
15206738|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15206739|NCT03719261|Eusol|eusol|mesh-list
15206740|NCT03719261|Chitosan|chitosan|mesh-list
15206741|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15206742|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15206743|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
15206744|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206745|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15206746|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
15206747|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
15206748|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
14852175|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
14852176|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852177|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852178|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852179|NCT01034410|Cytarabine|cytarabine|mesh-list
14852180|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14852181|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
14852182|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852183|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852184|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
14852185|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852186|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852187|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
14852188|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852189|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
14852190|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14852191|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852192|NCT01034683|Leucovorin|leucovorin|mesh-list
14852193|NCT01034683|Antidotes|antidotes|mesh-ancestor
14852194|NCT01034683|Protective Agents|protective agents|mesh-ancestor
14852195|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852196|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
14852197|NCT01034683|Vitamins|vitamins|mesh-ancestor
14852198|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
14852199|NCT01034787|Tremelimumab|tremelimumab|mesh-list
14852200|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852201|NCT01034878|Sunitinib|sunitinib|mesh-list
14852202|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852203|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14852204|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14852205|NCT01034878|Growth Substances|growth substances|mesh-ancestor
14852206|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852207|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
14852208|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14852209|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852210|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852211|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14852212|NCT01034917|Etravirine|etravirine|mesh-list
14852213|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
14852214|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852215|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14852216|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14852217|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852218|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852219|NCT01034956|Calcium|calcium|mesh-list
14852220|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
14852221|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206749|NCT03719261|Coagulants|coagulants|mesh-ancestor
14852222|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206750|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
14852223|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14852224|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
14852225|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
14852226|NCT01034956|Protective Agents|protective agents|mesh-ancestor
14852227|NCT01034995|Citalopram|citalopram|mesh-list
14852228|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14852229|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14852230|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14852231|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852232|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852233|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
14852234|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852235|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14852236|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
14852237|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14852238|NCT01035021|Rocuronium|rocuronium|mesh-list
14852239|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14852240|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14852241|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14852242|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852243|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912969|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912970|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14912971|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
14912972|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912973|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912974|NCT01373008|Beclomethasone|beclomethasone|mesh-list
14912975|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14912976|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
14912977|NCT01373008|Hormones|hormones|mesh-ancestor
14912978|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14912979|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912980|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14912981|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
14912982|NCT01373021|Fentanyl|fentanyl|mesh-list
14912983|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
14912984|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14912985|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14912986|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14912987|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14912988|NCT01373021|Analgesics|analgesics|mesh-ancestor
14912989|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
14912990|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14912991|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14912992|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14912993|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14912994|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14912995|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14912996|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14912997|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14912998|NCT01373021|Narcotics|narcotics|mesh-ancestor
14912999|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14913000|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14913001|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
14913002|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
14917244|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917245|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14917246|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14917247|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917248|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917249|NCT01397019|Antidotes|antidotes|mesh-ancestor
14917250|NCT01397019|Protective Agents|protective agents|mesh-ancestor
14917251|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917252|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
14917253|NCT01397019|Vitamins|vitamins|mesh-ancestor
14917254|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
14917255|NCT01397097|Etonogestrel|etonogestrel|mesh-list
14917256|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14917257|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
14852244|NCT01035190|Budesonide|budesonide|mesh-list
14852245|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852246|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14852247|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
14852248|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852249|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852250|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14852251|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
14852252|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
14852253|NCT01035190|Hormones|hormones|mesh-ancestor
14852254|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14852255|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
14852256|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14852257|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
14852258|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852259|NCT01035281|Nabilone|nabilone|mesh-list
15206751|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206752|NCT03719157|Anesthetics|anesthetics|mesh-list
15206753|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
15206754|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206755|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206756|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
15206757|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852260|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
14852261|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
14852262|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852263|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852264|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852265|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14852266|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14852267|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14852268|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14852269|NCT01035320|Simvastatin|simvastatin|mesh-list
14852270|NCT01035320|Ezetimibe|ezetimibe|mesh-list
14852271|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14852272|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14852273|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
14852274|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852275|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14852276|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14852277|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852278|NCT01035450|Sirolimus|sirolimus|mesh-list
14852279|NCT01035450|Everolimus|everolimus|mesh-list
14852280|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852281|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852282|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
14852283|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852284|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14852285|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206758|NCT03719131|Rituximab|rituximab|mesh-list
15206759|NCT03719131|Nivolumab|nivolumab|mesh-list
15206760|NCT03719131|Ipilimumab|ipilimumab|mesh-list
15206761|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15206762|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852286|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15206763|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
14852287|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
14852288|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
14852289|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14707590|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707591|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707592|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
14852290|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14852291|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14852292|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
14852293|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852294|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206764|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206765|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15206766|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14707593|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707594|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14707595|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
14707596|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14707597|NCT00423748|Ambrisentan|ambrisentan|mesh-list
14707598|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14707599|NCT00423761|Midazolam|midazolam|mesh-list
14707600|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15206767|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206768|NCT03719105|Dexamethasone|dexamethasone|mesh-list
15206769|NCT03719105|Prednisone|prednisone|mesh-list
15206770|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
15206771|NCT03719105|Ifosfamide|ifosfamide|mesh-list
15206772|NCT03719105|Doxorubicin|doxorubicin|mesh-list
15206773|NCT03719105|Methotrexate|methotrexate|mesh-list
15206774|NCT03719105|Etoposide|etoposide|mesh-list
14707601|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14852295|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852296|NCT01035528|Metformin|metformin|mesh-list
14852297|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
14852298|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14852299|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852300|NCT01035580|Curcumin|curcumin|mesh-list
14852301|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14852302|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14852303|NCT01035580|Analgesics|analgesics|mesh-ancestor
14852304|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
14852305|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852306|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852307|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852308|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852309|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852310|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852311|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852312|NCT01035619|Moxidectin|moxidectin|mesh-list
14852313|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
14852314|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14852315|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852316|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
14852317|NCT01035671|Vitamin E|vitamin e|mesh-list
14852318|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
14852319|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
14852320|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14852321|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
14852322|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852323|NCT01035671|Protective Agents|protective agents|mesh-ancestor
14852324|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852325|NCT01035671|Vitamins|vitamins|mesh-ancestor
14852326|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
14852327|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
14852328|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14852329|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852330|NCT01035853|Colistin|colistin|mesh-list
14852331|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14707602|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707603|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707604|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14707605|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14707606|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707607|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14707608|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
14707609|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
14707610|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
14707611|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
14707612|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707613|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707614|NCT00423826|Cytarabine|cytarabine|mesh-list
14707615|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
14707616|NCT00423826|Fludarabine|fludarabine|mesh-list
14707617|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
14707618|NCT00423826|Busulfan|busulfan|mesh-list
14707619|NCT00423826|Tacrolimus|tacrolimus|mesh-list
14707620|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707621|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707622|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
14852332|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852333|NCT01035983|Frovatriptan|frovatriptan|mesh-list
14852334|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14852335|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
14852336|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852337|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852338|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852339|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14852340|NCT01036035|Pilocarpine|pilocarpine|mesh-list
14852341|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14852342|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14852343|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
14852344|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852345|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852346|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852347|NCT01036035|Urological Agents|urological agents|mesh-ancestor
14852348|NCT01036035|Miotics|miotics|mesh-ancestor
14852349|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
14852350|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852351|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14852352|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14852353|NCT01036087|Paclitaxel|paclitaxel|mesh-list
14852354|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14852355|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
14852356|NCT01036087|Carboplatin|carboplatin|mesh-list
14852357|NCT01036087|Fluorouracil|fluorouracil|mesh-list
14852358|NCT01036087|Epirubicin|epirubicin|mesh-list
14852359|NCT01036087|Panitumumab|panitumumab|mesh-list
14852360|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14852361|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852362|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14852363|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14852364|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14852365|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852366|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852367|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
14852368|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852369|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852370|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14852371|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
14852372|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14852373|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
14852374|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14852375|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14852376|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14852377|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852378|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707623|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707624|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707625|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
14707626|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707627|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
14707628|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707629|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14707630|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707631|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14707632|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14707633|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
14707634|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14707635|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
14707636|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14852379|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14852380|NCT01036399|Lenalidomide|lenalidomide|mesh-list
14852381|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
14852382|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852383|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14852384|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14852385|NCT01036399|Growth Substances|growth substances|mesh-ancestor
14852386|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
14852387|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852388|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
14852389|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14852390|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14852391|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852392|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
14852393|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14852394|NCT01036659|Ecallantide|ecallantide|mesh-list
14852395|NCT01036659|Bradykinin|bradykinin|mesh-list
14852396|NCT01036659|Kallikreins|kallikreins|mesh-list
14852397|NCT01036659|Kininogens|kininogens|mesh-list
14852398|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
14852399|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14852400|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
14852401|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852402|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852403|NCT01036659|Analgesics|analgesics|mesh-ancestor
14852404|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
14852405|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852406|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852407|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14852408|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14852409|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852410|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852411|NCT01036659|Coagulants|coagulants|mesh-ancestor
14852412|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14852413|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
14852414|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14852415|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14852416|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
14852417|NCT01036841|Coagulants|coagulants|mesh-ancestor
14852418|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14852419|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
14852420|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852421|NCT01036854|Ondansetron|ondansetron|mesh-list
14852422|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
14852423|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
14852424|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852425|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852426|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852427|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
14852428|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
14852429|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14852430|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
14852431|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852432|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852433|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14852434|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14852435|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14852436|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14852437|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14852438|NCT01036893|Prucalopride|prucalopride|mesh-list
14852439|NCT01036893|Laxatives|laxatives|mesh-ancestor
14852440|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852441|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14852442|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14852443|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
14852444|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852445|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852446|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852447|NCT01036932|Sargramostim|sargramostim|mesh-list
14852448|NCT01036932|Lenograstim|lenograstim|mesh-list
14852449|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
14852450|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852451|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14852452|NCT01037023|Topotecan|topotecan|mesh-list
14852453|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14852454|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852455|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852456|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852457|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852458|NCT01037101|Cycloserine|cycloserine|mesh-list
14852459|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14852460|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852461|NCT01037101|Renal Agents|renal agents|mesh-ancestor
14852462|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14852463|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
14852464|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14852465|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
15206775|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15206776|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15206777|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
15206778|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206779|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15206780|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15206781|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
15206782|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852466|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852467|NCT01037140|Vitamin D|vitamin d|mesh-list
14852468|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
14295820|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14707637|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14707638|NCT00423865|Everolimus|everolimus|mesh-list
14852469|NCT01037140|Vitamins|vitamins|mesh-ancestor
14852470|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
14852471|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852472|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14852473|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14852474|NCT01037322|Cannabidiol|cannabidiol|mesh-list
14852475|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
14852476|NCT01037335|Morphine|morphine|mesh-list
14852477|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14852478|NCT01037335|Narcotics|narcotics|mesh-ancestor
14852479|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14852480|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852481|NCT01037335|Analgesics|analgesics|mesh-ancestor
14852482|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
14852483|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852484|NCT01037348|Ranibizumab|ranibizumab|mesh-list
14852485|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14852486|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14852487|NCT01037348|Growth Substances|growth substances|mesh-ancestor
14852488|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852489|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
14852490|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852491|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
14852492|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
14852493|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852494|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852495|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14852496|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
14852497|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
15206783|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852498|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14707639|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707640|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707641|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
14707642|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707643|NCT00423969|Galantamine|galantamine|mesh-list
14707644|NCT00423969|Citalopram|citalopram|mesh-list
14707645|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14707646|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14707647|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14707648|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852499|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
14852500|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852501|NCT01037465|Expectorants|expectorants|mesh-ancestor
14852502|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
14852503|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14852504|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
14852505|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852506|NCT01037465|Protective Agents|protective agents|mesh-ancestor
14852507|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852508|NCT01037465|Antidotes|antidotes|mesh-ancestor
14852509|NCT01037491|Aspirin|aspirin|mesh-list
14852510|NCT01037491|Rabeprazole|rabeprazole|mesh-list
14852511|NCT01037491|Clopidogrel|clopidogrel|mesh-list
14852512|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14852513|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14852514|NCT01037491|Analgesics|analgesics|mesh-ancestor
14852515|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
14852516|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852517|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852518|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852519|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852520|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14852521|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14852522|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852523|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14852524|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14852525|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852526|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
14852527|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14852528|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14852529|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14852530|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
14852531|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852532|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14852533|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852534|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14852535|NCT01037517|Plerixafor|plerixafor|mesh-list
14852536|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14852537|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14852538|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
14852539|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852540|NCT01037530|Ramipril|ramipril|mesh-list
14707649|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707650|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
14707651|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707652|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14707653|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
14707654|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707655|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
14707656|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707657|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
14707658|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14707659|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707660|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14707661|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
14707662|NCT00423982|Vancomycin|vancomycin|mesh-list
14707663|NCT00423982|Rifampin|rifampin|mesh-list
14707664|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14707665|NCT00423982|Cloxacillin|cloxacillin|mesh-list
14707666|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
14913003|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
14707667|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14707668|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
14707669|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
14852541|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14852542|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
14852543|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852544|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852545|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14852546|NCT01037595|Turmeric extract|turmeric extract|mesh-list
14852547|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
14852548|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852549|NCT01037595|Protective Agents|protective agents|mesh-ancestor
14852550|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852551|NCT01037608|Nabiximols|nabiximols|mesh-list
14852552|NCT01037608|Analgesics|analgesics|mesh-ancestor
14852553|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
14852554|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852555|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707670|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14707671|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852556|NCT01037621|Valacyclovir|valacyclovir|mesh-list
14852557|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
14852558|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707672|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707673|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14707674|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14707675|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14707676|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14707677|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14707678|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14707679|NCT00424060|Sagopilone|sagopilone|mesh-list
14707680|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707681|NCT00424086|Vaccines|vaccines|mesh-list
14707682|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
14707683|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707684|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14707685|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14707686|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707687|NCT00424151|Rituximab|rituximab|mesh-list
14707688|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14852559|NCT01037634|Oseltamivir|oseltamivir|mesh-list
14295821|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14295822|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
14295823|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14295824|NCT00583947|Albuterol|albuterol|mesh-list
14295825|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
14295826|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14295827|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
14295828|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295829|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295830|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14295831|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295832|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
14852560|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
14852561|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852562|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852563|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852564|NCT01037660|Metformin|metformin|mesh-list
14852565|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14852566|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852567|NCT01037699|Hormones|hormones|mesh-list
14852568|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14852569|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14852570|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913004|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14913005|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913006|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14913007|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913008|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
14913009|NCT01373138|Ephedrine|ephedrine|mesh-list
14913010|NCT01373138|Desloratadine|desloratadine|mesh-list
14913011|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14913012|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14913013|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913014|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913015|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913016|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14913017|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14913018|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
14913019|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
14913020|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14913021|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
14913022|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206784|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14707689|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707690|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
14707691|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707692|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707693|NCT00424164|Tamoxifen|tamoxifen|mesh-list
14707694|NCT00424164|Lapatinib|lapatinib|mesh-list
14707695|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707696|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15206785|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295833|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15206786|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
15206787|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
15206788|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206789|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206790|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
15206791|NCT03719105|Hormones|hormones|mesh-ancestor
14707697|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
14295834|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14707698|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707699|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707700|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14707701|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707702|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14707703|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15206792|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206793|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15206794|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14707704|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14707705|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206795|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15206796|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14707706|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707707|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
14707708|NCT00424203|Doxorubicin|doxorubicin|mesh-list
14707709|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14707710|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707711|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
14707712|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707713|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707714|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14707715|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
14852571|NCT01037712|Valacyclovir|valacyclovir|mesh-list
14852572|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
14852573|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852574|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
14852575|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852576|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14852577|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852578|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852579|NCT01037842|Mitiglinide|mitiglinide|mesh-list
14852580|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14852581|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852582|NCT01037959|Norfloxacin|norfloxacin|mesh-list
14852583|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14852584|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852585|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14852586|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852587|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852588|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852589|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852590|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14852591|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14852592|NCT01037998|Gefitinib|gefitinib|mesh-list
14729405|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852593|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852594|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14852595|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852596|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852597|NCT01038024|Antioxidants|antioxidants|mesh-list
14852598|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852599|NCT01038024|Protective Agents|protective agents|mesh-ancestor
14852600|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852601|NCT01038037|Carboplatin|carboplatin|mesh-list
14852602|NCT01038037|Vinorelbine|vinorelbine|mesh-list
14852603|NCT01038037|Panitumumab|panitumumab|mesh-list
14852604|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852605|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14852606|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14852607|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14852608|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14852609|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852610|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14852611|NCT01038063|Lumefantrine|lumefantrine|mesh-list
14852612|NCT01038063|Artemether|artemether|mesh-list
15206797|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206798|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15206799|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
15206800|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15206801|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14852613|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14852614|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
14852615|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14852616|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14852617|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852618|NCT01038089|Resveratrol|resveratrol|mesh-list
14852619|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
14852620|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852621|NCT01038089|Protective Agents|protective agents|mesh-ancestor
14852622|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852623|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852624|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14852625|NCT01038154|Pravastatin|pravastatin|mesh-list
14852626|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14852627|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14852628|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
14852629|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852630|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14852631|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14852632|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852633|NCT01038167|Cyclosporine|cyclosporine|mesh-list
14852634|NCT01038167|Tacrolimus|tacrolimus|mesh-list
14852635|NCT01038167|Cyclosporins|cyclosporins|mesh-list
14852636|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852637|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
14852638|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852639|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14852640|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852641|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852642|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
14852643|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852644|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
14852645|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852646|NCT01038349|Methotrexate|methotrexate|mesh-list
14852647|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14852648|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
14852649|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14852650|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852651|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14852652|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
14852653|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852654|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852655|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14852656|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852657|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14852658|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852659|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
14852660|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852661|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14852662|NCT01038388|Dexamethasone|dexamethasone|mesh-list
14852663|NCT01038388|Lenalidomide|lenalidomide|mesh-list
14852664|NCT01038388|Bortezomib|bortezomib|mesh-list
14852665|NCT01038388|Vorinostat|vorinostat|mesh-list
14852666|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852667|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
14852668|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
14852669|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852670|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852671|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852672|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
14852673|NCT01038388|Hormones|hormones|mesh-ancestor
14852674|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14852675|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14852676|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852677|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
15206802|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
15206803|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
15206804|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15206805|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15206806|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15206807|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15206808|NCT03719053|Tenofovir|tenofovir|mesh-list
15206809|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
14852678|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14852679|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14852680|NCT01038388|Growth Substances|growth substances|mesh-ancestor
14852681|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
14852682|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14852683|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852684|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852685|NCT01038453|Vitamin D|vitamin d|mesh-list
14852686|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
14852687|NCT01038453|Vitamins|vitamins|mesh-ancestor
14852688|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
14852689|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852690|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14852691|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14852692|NCT01038505|Sirolimus|sirolimus|mesh-list
14852693|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
14852694|NCT01038505|Tacrolimus|tacrolimus|mesh-list
14852695|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852696|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
14852697|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852698|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14852699|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852700|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852701|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14852702|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852703|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14852704|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852705|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
14852706|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14852707|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
14852708|NCT01038570|Oxytocin|oxytocin|mesh-list
14852709|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
14852710|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14852711|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852712|NCT01038583|Aspirin|aspirin|mesh-list
14852713|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14852714|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14852715|NCT01038583|Analgesics|analgesics|mesh-ancestor
14852716|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
14852717|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852718|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852719|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852720|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852721|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14852722|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14852723|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852724|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14852725|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14852726|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852727|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
14852728|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14852729|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14852730|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852731|NCT01038648|Incretins|incretins|mesh-ancestor
14852732|NCT01038648|Hormones|hormones|mesh-ancestor
14852733|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14852734|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14852735|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
14852736|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852737|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852738|NCT01038661|Docetaxel|docetaxel|mesh-list
14852739|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852740|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
14852741|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
14852742|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
14852743|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852744|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
14852745|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
14852746|NCT01038817|Protective Agents|protective agents|mesh-ancestor
14852747|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852748|NCT01038882|Midazolam|midazolam|mesh-list
14852749|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14852750|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14852751|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14852752|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852753|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14852754|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14852755|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14852756|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14852757|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
14852758|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
14852759|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
14852760|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
14852761|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852762|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852763|NCT01038895|Ramipril|ramipril|mesh-list
14852764|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14852765|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
14852766|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852767|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852768|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14852769|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
14852770|NCT01039025|Melphalan|melphalan|mesh-list
14852771|NCT01039025|Topotecan|topotecan|mesh-list
14852772|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852773|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
14852774|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852775|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852776|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14852777|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
14852778|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852779|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852780|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14852781|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14852782|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852783|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852784|NCT01039090|Dopamine|dopamine|mesh-list
14852785|NCT01039090|Apomorphine|apomorphine|mesh-list
14852786|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
15206810|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15206811|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15206812|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15206813|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206814|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206815|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15206816|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15206817|NCT03719001|Clevidipine|clevidipine|mesh-list
15206818|NCT03719001|Phenylephrine|phenylephrine|mesh-list
15206819|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
15206820|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
15206821|NCT03719001|Calcium|calcium|mesh-list
15206822|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206823|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206824|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15206825|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729406|NCT00523185|Diazepam|diazepam|mesh-list
14729407|NCT00523185|Lorazepam|lorazepam|mesh-list
14729408|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
14729409|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
14729410|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
14729411|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729412|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729413|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729414|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14729415|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729416|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14852787|NCT01039090|Emetics|emetics|mesh-ancestor
14852788|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852789|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
14852790|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852791|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852792|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
14852793|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852794|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852795|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14852796|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
14852797|NCT01039090|Protective Agents|protective agents|mesh-ancestor
14852798|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
14852799|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14852800|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14852801|NCT01039103|Prednisolone|prednisolone|mesh-list
14852802|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
14852803|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14852804|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
14852805|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852806|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
14852807|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
15206826|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15206827|NCT03719001|Analgesics|analgesics|mesh-ancestor
15206828|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
15206829|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206830|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15206831|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15206832|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15206833|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
15206834|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206835|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206836|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15206837|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
15206838|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
15206839|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
15206840|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15206841|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
15206842|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
15206843|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15206844|NCT03719001|Protective Agents|protective agents|mesh-ancestor
15206845|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15206846|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15206847|NCT03718884|Mirikizumab|mirikizumab|mesh-list
15206848|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15206849|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15206850|NCT03718884|Analgesics|analgesics|mesh-ancestor
15206851|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
15206852|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206853|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206854|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15206855|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15206856|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15206857|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206858|NCT03718715|Metformin|metformin|mesh-list
15206859|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15206860|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206861|NCT03718676|Pemetrexed|pemetrexed|mesh-list
15206862|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852808|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852809|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852810|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852811|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
14852812|NCT01039103|Hormones|hormones|mesh-ancestor
14852813|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14852814|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14852815|NCT01039103|Protective Agents|protective agents|mesh-ancestor
14852816|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14852817|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852818|NCT01039142|Acitretin|acitretin|mesh-list
14852819|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
14852820|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14852821|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
15206863|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852822|NCT01039155|Azacitidine|azacitidine|mesh-list
14852823|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206864|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852824|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14852825|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
14852826|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852827|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852828|NCT01039181|Vitamin D|vitamin d|mesh-list
14852829|NCT01039181|Calcitriol|calcitriol|mesh-list
14852830|NCT01039181|Vitamins|vitamins|mesh-ancestor
14852831|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
14852832|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852833|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14852834|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14852835|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14852836|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14852837|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852838|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14852839|NCT01039194|Galantamine|galantamine|mesh-list
14852840|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14852841|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852842|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852843|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
14852844|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852845|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852846|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14852847|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
14852848|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852849|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
14852850|NCT01039233|Bicalutamide|bicalutamide|mesh-list
14852851|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
14852852|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
14852853|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14852854|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852855|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852856|NCT01039285|Poractant alfa|poractant alfa|mesh-list
14852857|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14852858|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913023|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14913024|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913025|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
14913026|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14913027|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14913028|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
14913029|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14913030|NCT01373216|Exenatide|exenatide|mesh-list
14913031|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14913032|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913033|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14913034|NCT01373216|Incretins|incretins|mesh-ancestor
14913035|NCT01373216|Hormones|hormones|mesh-ancestor
14913036|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913037|NCT01373333|Amifampridine|amifampridine|mesh-list
14913038|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14913039|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913040|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206865|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15206866|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15206867|NCT03718624|Paclitaxel|paclitaxel|mesh-list
15206868|NCT03718624|Apatinib|apatinib|mesh-list
15206869|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15206870|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206871|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
15206872|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
14852859|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
14852860|NCT01039350|Hematinics|hematinics|mesh-ancestor
14852861|NCT01039363|Cytarabine|cytarabine|mesh-list
14852862|NCT01039363|Vorinostat|vorinostat|mesh-list
14852863|NCT01039363|Idarubicin|idarubicin|mesh-list
14852864|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
14852865|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14852866|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
14852867|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852868|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852869|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
14852870|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852871|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14852872|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
14852873|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852874|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14852875|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852876|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14852877|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14852878|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852879|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14852880|NCT01039441|Bupivacaine|bupivacaine|mesh-list
14852881|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
14852882|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
14852883|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14852884|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852885|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
14852886|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852887|NCT01039506|Irinotecan|irinotecan|mesh-list
14852888|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14852889|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852890|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852891|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852892|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852893|NCT01039545|Norfloxacin|norfloxacin|mesh-list
14852894|NCT01039545|Diclofenac|diclofenac|mesh-list
14852895|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14852896|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14852897|NCT01039545|Analgesics|analgesics|mesh-ancestor
14852898|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
14852899|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14852900|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852901|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14852902|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14852903|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14852904|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852905|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852906|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14852907|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852908|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14852909|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852910|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852911|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14852912|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14852913|NCT01039558|Ecabet|ecabet|mesh-list
14852914|NCT01039558|Lansoprazole|lansoprazole|mesh-list
14852915|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
14852916|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14852917|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14852918|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14852919|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852920|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852921|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852922|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
14852923|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14852924|NCT01039558|Protective Agents|protective agents|mesh-ancestor
14852925|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852926|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852927|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
14852928|NCT01039610|Linezolid|linezolid|mesh-list
14852929|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14852930|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852931|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14852932|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14852933|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852934|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852935|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852936|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14852937|NCT01039740|Mirtazapine|mirtazapine|mesh-list
14852938|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
14852939|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14852940|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14852941|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
14852942|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
14852943|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14852944|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852945|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852946|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14852947|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14852948|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14852949|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14852950|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14852951|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14852952|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
14852953|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14852954|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14852955|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
14852956|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14852957|NCT01039766|Oxytocin|oxytocin|mesh-list
14852958|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
14852959|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14852960|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852961|NCT01039844|Paclitaxel|paclitaxel|mesh-list
14852962|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14852963|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852964|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
14852965|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
14852966|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
14852967|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852968|NCT01039883|Albaconazole|albaconazole|mesh-list
14852969|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
14852970|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852971|NCT01039948|Gefitinib|gefitinib|mesh-list
14852972|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14852973|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14852974|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852975|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852976|NCT01039974|Ketoconazole|ketoconazole|mesh-list
14852977|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
14852978|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852979|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14852980|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14852981|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14852982|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14852983|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14852984|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
14852985|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206873|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
14852986|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852987|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14852988|NCT01040078|Vaccines|vaccines|mesh-list
14852989|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
14852990|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14852991|NCT01040091|Tenofovir|tenofovir|mesh-list
14852992|NCT01040091|Emtricitabine|emtricitabine|mesh-list
14852993|NCT01040091|Efavirenz|efavirenz|mesh-list
14852994|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14852995|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
14852996|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14852997|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14852998|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14852999|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853000|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853001|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14853002|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14853003|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14853004|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14853005|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14853006|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14853007|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14853008|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14853009|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
14853010|NCT01040195|Methotrexate|methotrexate|mesh-list
14853011|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14853012|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
14853013|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14853014|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853015|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853016|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
14853017|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853018|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853019|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
14853020|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206874|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206875|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15206876|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206877|NCT03718559|Edoxaban|edoxaban|mesh-list
15206878|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
15206879|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15206880|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
15206881|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15206882|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
14853021|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14853022|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853023|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
14853024|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853025|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14853026|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
14853027|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14853028|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14853029|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853030|NCT01040234|Bupivacaine|bupivacaine|mesh-list
14853031|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
14853032|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
14853033|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14853034|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853035|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
14853036|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853037|NCT01040273|Bupivacaine|bupivacaine|mesh-list
14853038|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
14853039|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
14853040|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14853041|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853042|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
14853043|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853044|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
14853045|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
14853046|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14853047|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853048|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
14853049|NCT01040286|Analgesics|analgesics|mesh-ancestor
14853050|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
14853051|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853052|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853053|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14853054|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15206883|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206884|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206885|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
15224871|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224872|NCT02143063|Cocaine|cocaine|mesh-list
15224873|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
15224874|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
15224875|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15224876|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224877|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
15224878|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224879|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15224880|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14853055|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853056|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853057|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14853058|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853059|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853060|NCT01040312|Cisplatin|cisplatin|mesh-list
14853061|NCT01040312|Carboplatin|carboplatin|mesh-list
14853062|NCT01040312|Nedaplatin|nedaplatin|mesh-list
14853063|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853064|NCT01040325|Vaccines|vaccines|mesh-list
14853065|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
14853066|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853067|NCT01040338|Nicotine|nicotine|mesh-list
14853068|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14853069|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
14853070|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853071|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853072|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14853073|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14853074|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
15224881|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14853075|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853076|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853077|NCT01040429|Clonidine|clonidine|mesh-list
14853078|NCT01040429|Analgesics|analgesics|mesh-ancestor
14853079|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
14853080|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853081|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853082|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14853083|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
14853084|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
14853085|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14853086|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14853087|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14853088|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14853089|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853090|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853091|NCT01040455|Lansoprazole|lansoprazole|mesh-list
14853092|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
14853093|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14853094|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853095|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14853096|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853097|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853098|NCT01040559|Idarubicin|idarubicin|mesh-list
14853099|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14853100|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853101|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14853102|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14853103|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853104|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853105|NCT01040585|Linezolid|linezolid|mesh-list
14853106|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14853107|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853108|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14853109|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853110|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853111|NCT01040598|Omalizumab|omalizumab|mesh-list
14853112|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14853113|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14853114|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
14853115|NCT01040702|Methylphenidate|methylphenidate|mesh-list
14853116|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14853117|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853118|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14853119|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14853120|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14853121|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853122|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
14853123|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853124|NCT01040936|Atorvastatin|atorvastatin|mesh-list
14853125|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14853126|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14853127|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
14853128|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853129|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15206886|NCT03718507|Atropine|atropine|mesh-list
15206887|NCT03718507|Fentanyl|fentanyl|mesh-list
15206888|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15206889|NCT03718507|Narcotics|narcotics|mesh-ancestor
15206890|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206891|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206892|NCT03718507|Analgesics|analgesics|mesh-ancestor
15206893|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
15206894|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206895|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15206896|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15206897|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
15206898|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
14707716|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853130|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14853131|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913041|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14913042|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913043|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913044|NCT01373359|Misoprostol|misoprostol|mesh-list
14913045|NCT01373359|Oxytocin|oxytocin|mesh-list
14913046|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
14913047|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14913048|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913049|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14913050|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
14913051|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14913052|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14913053|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14913054|NCT01373372|Hormones|hormones|mesh-ancestor
14913055|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913056|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913057|NCT01373398|Apaziquone|apaziquone|mesh-list
14913058|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913059|NCT01373411|Ticagrelor|ticagrelor|mesh-list
14913060|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14913061|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14913062|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14913063|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14913064|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
14913065|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913066|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913067|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913068|NCT01373463|Carboplatin|carboplatin|mesh-list
14913069|NCT01373463|Pemetrexed|pemetrexed|mesh-list
14913070|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913071|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913072|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913073|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14913074|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14913075|NCT01373528|Budesonide|budesonide|mesh-list
15206899|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15206900|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15206901|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
15206902|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15206903|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
15206904|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
15206905|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
15206906|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15206907|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15206908|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
15206909|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206910|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206911|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
15206912|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15206913|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
14707717|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707718|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14707719|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14707720|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14707721|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14707722|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728684|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728685|NCT00519675|Alitretinoin|alitretinoin|mesh-list
14728686|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728687|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728688|NCT00519688|Thalidomide|thalidomide|mesh-list
14728689|NCT00519688|Tegafur|tegafur|mesh-list
14728690|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14728691|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
14728692|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853132|NCT01041027|Paclitaxel|paclitaxel|mesh-list
14853133|NCT01041027|Carboplatin|carboplatin|mesh-list
14853134|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14853135|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707723|NCT00424229|Lenalidomide|lenalidomide|mesh-list
14707724|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
14707725|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707726|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14707727|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14707728|NCT00424229|Growth Substances|growth substances|mesh-ancestor
14707729|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14707730|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707731|NCT00424242|Pemetrexed|pemetrexed|mesh-list
14707732|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15206914|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15206915|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
15206916|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206917|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206918|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
14853136|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
14853137|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
14853138|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
14853139|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853140|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
14853141|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853142|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853143|NCT01041066|Labetalol|labetalol|mesh-list
14853144|NCT01041066|Nicardipine|nicardipine|mesh-list
14853145|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14853146|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14853147|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14853148|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853149|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853150|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853151|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14853152|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
14853153|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
14853154|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853155|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14853156|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14853157|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14853158|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14853159|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14853160|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
14853161|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14853162|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14853163|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
14853164|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853165|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853166|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14853167|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14853168|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14853169|NCT01041170|Rimonabant|rimonabant|mesh-list
14853170|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14853171|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14853172|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14853173|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853174|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853175|NCT01041170|Hormones|hormones|mesh-ancestor
14853176|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853177|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853178|NCT01041183|Ramosetron|ramosetron|mesh-list
14853179|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
14853180|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
14853181|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853182|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206919|NCT03718403|Theophylline|theophylline|mesh-list
15206920|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15206921|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
15206922|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206923|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206924|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14707733|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853183|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853184|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14853185|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
14853186|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853187|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853188|NCT01041235|Docetaxel|docetaxel|mesh-list
14853189|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853190|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14853191|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14853192|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14853193|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853194|NCT01041313|Memantine|memantine|mesh-list
14853195|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14853196|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14853197|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
14853198|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853199|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853200|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853201|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14853202|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14853203|NCT01041378|Dexamethasone|dexamethasone|mesh-list
14853204|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853205|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
14853206|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
14853207|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853208|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853209|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853210|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
14853211|NCT01041378|Hormones|hormones|mesh-ancestor
14853212|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853213|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14853214|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853215|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
14853216|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
14853217|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853218|NCT01041482|Sorafenib|sorafenib|mesh-list
14853219|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853220|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14853221|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853222|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853223|NCT01041508|Cyclosporine|cyclosporine|mesh-list
14853224|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
14853225|NCT01041508|Clofarabine|clofarabine|mesh-list
14853226|NCT01041508|Cyclosporins|cyclosporins|mesh-list
14853227|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853228|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853229|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853230|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
14853231|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853232|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
14853233|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853234|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
14853235|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853236|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14853237|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14853238|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853239|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14853240|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
14853241|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14853242|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853243|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
14853244|NCT01041625|Apremilast|apremilast|mesh-list
14853245|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14853246|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14853247|NCT01041625|Analgesics|analgesics|mesh-ancestor
14853248|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
14853249|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853250|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853251|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853252|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853253|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14853254|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14853255|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853256|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853257|NCT01041690|Bevacizumab|bevacizumab|mesh-list
14853258|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853259|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853260|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14853261|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14853262|NCT01041690|Growth Substances|growth substances|mesh-ancestor
14853263|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853264|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
14853265|NCT01041729|Atorvastatin|atorvastatin|mesh-list
14853266|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14853267|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14853268|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
14853269|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853270|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14853271|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14853272|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853273|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
14853274|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14853275|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14853276|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853277|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853278|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853279|NCT01041872|Lidocaine|lidocaine|mesh-list
14853280|NCT01041872|Propofol|propofol|mesh-list
14853281|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
14853282|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
14853283|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14853284|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853285|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
14853286|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853287|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14853288|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14853289|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14853290|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14853291|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853292|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14853293|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14853294|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
14853295|NCT01041963|Losartan|losartan|mesh-list
14853296|NCT01041963|Enalapril|enalapril|mesh-list
14853297|NCT01041963|Enalaprilat|enalaprilat|mesh-list
14853298|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14853299|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14853300|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14853301|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14853302|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853303|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14853304|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
14853305|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853306|NCT01042028|Capecitabine|capecitabine|mesh-list
14853307|NCT01042028|Irinotecan|irinotecan|mesh-list
14853308|NCT01042028|Cetuximab|cetuximab|mesh-list
14853309|NCT01042028|Everolimus|everolimus|mesh-list
15206925|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
15206926|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15206927|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206928|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206929|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
15206930|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15206931|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15206932|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
14853310|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
14853311|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853312|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
15206933|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206934|NCT03718377|Anesthetics|anesthetics|mesh-list
15206935|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206936|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206937|NCT03718273|Digoxin|digoxin|mesh-list
14853313|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853314|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853315|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14853316|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14853317|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853318|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853319|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853320|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
14853321|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853322|NCT01042041|Doxorubicin|doxorubicin|mesh-list
14853323|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14853324|NCT01042041|Sorafenib|sorafenib|mesh-list
14853325|NCT01042041|Mitomycins|mitomycins|mesh-list
14853326|NCT01042041|Mitomycin|mitomycin|mesh-list
14853327|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853328|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14853329|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14853330|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14853331|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853332|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853333|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14853334|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
14853335|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14853336|NCT01042314|Donepezil|donepezil|mesh-list
14853337|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14853338|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853339|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853340|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
14853341|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853342|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853343|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
14295835|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15206938|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15206939|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15206940|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206941|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853387|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
14853388|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14853389|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853390|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14853391|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
14853392|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14853393|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853394|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853395|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853396|NCT01042561|Vitamin D|vitamin d|mesh-list
14853397|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
14853398|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
14853399|NCT01042561|Vitamins|vitamins|mesh-list
14853400|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
14853401|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853402|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14853403|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14853404|NCT01042574|Clevidipine|clevidipine|mesh-list
14853405|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14853406|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14853407|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853408|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14853409|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853410|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
14853411|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14853412|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14853413|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
14853414|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853415|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14853416|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14853417|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853418|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853419|NCT01042665|Latanoprost|latanoprost|mesh-list
14853420|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14853421|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14853422|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
14853423|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853424|NCT01042704|Aspirin|aspirin|mesh-list
14853425|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14853426|NCT01042704|Dexamethasone|dexamethasone|mesh-list
14853427|NCT01042704|Lenalidomide|lenalidomide|mesh-list
14853428|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14853429|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853430|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
14853431|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
14853432|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853433|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853434|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853435|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
14853436|NCT01042704|Hormones|hormones|mesh-ancestor
14853437|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853438|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14853439|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853440|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14853441|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14853442|NCT01042704|Analgesics|analgesics|mesh-ancestor
14853443|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
14853444|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853445|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14853446|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14853447|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853448|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14853449|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14853450|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853451|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
14853452|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
15206942|NCT03718273|Protective Agents|protective agents|mesh-ancestor
15206943|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206944|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
14853453|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14853454|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14853455|NCT01042704|Growth Substances|growth substances|mesh-ancestor
15206945|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15206946|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15206947|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15206948|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
15206949|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15206950|NCT03718234|Hormones|hormones|mesh-ancestor
15206951|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15206952|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206953|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
15206954|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15206955|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206956|NCT03718182|Vitamins|vitamins|mesh-ancestor
15206957|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
15206958|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15206959|NCT03718130|Vaccines|vaccines|mesh-list
15206960|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
15206961|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206962|NCT03718039|Aprepitant|aprepitant|mesh-list
15206963|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
14853456|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14853457|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853458|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14853459|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
14853460|NCT01042717|Plerixafor|plerixafor|mesh-list
14853461|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14853462|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14853463|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
14853464|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853465|NCT01042730|Pitavastatin|pitavastatin|mesh-list
14853466|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14853467|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14853468|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14853469|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
14853470|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206964|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
15206965|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206966|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206967|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15206968|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15206969|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206970|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295836|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15206971|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
15206972|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15206973|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15206974|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14853471|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206975|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15206976|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206977|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
15206978|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853472|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14853473|NCT01042782|Everolimus|everolimus|mesh-list
14853474|NCT01042782|Mitomycin|mitomycin|mesh-list
14853475|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853476|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853477|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
14853478|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206979|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15206980|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15206981|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15206982|NCT03717909|Valproic Acid|valproic acid|mesh-list
14853479|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
14853480|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853481|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14853482|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14853483|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913076|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913077|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14913078|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
14913079|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913080|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913081|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14913082|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913083|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
14913084|NCT01373528|Hormones|hormones|mesh-ancestor
14913085|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913086|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
15206983|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
15206984|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206985|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206986|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
15206987|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15206988|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913087|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206989|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
15206990|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15206991|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15206992|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15206993|NCT03717740|Esomeprazole|esomeprazole|mesh-list
15206994|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15206995|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14295837|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
15206996|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14853484|NCT01042873|Dobutamine|dobutamine|mesh-list
14853485|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14853486|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
14853487|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
14853488|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853489|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853490|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14853491|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14853492|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14853493|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14853494|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853495|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853496|NCT01042873|Protective Agents|protective agents|mesh-ancestor
14853497|NCT01042951|Vaccines|vaccines|mesh-list
14853498|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
14853499|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853500|NCT01043172|Gemcitabine|gemcitabine|mesh-list
14853501|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853502|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
14853503|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853504|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853505|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
14853506|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853507|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853508|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853509|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
14853510|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853511|NCT01043211|Lidocaine|lidocaine|mesh-list
14853512|NCT01043211|Epinephrine|epinephrine|mesh-list
14853513|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14853514|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
14853515|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14853516|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853517|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
14853518|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853519|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14853520|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14853521|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14853522|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14853523|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853524|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14853525|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14853526|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
14853527|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853528|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14853529|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14853530|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
14853531|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14853532|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
14853533|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
14853534|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
14853535|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14853536|NCT01043224|Clobetasol|clobetasol|mesh-list
14853537|NCT01043224|Calcipotriene|calcipotriene|mesh-list
14853538|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853539|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
14853540|NCT01043224|Hormones|hormones|mesh-ancestor
14853541|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853542|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853543|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
14853544|NCT01043341|Vaccines|vaccines|mesh-list
14853545|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
14853546|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853547|NCT01043380|Atorvastatin|atorvastatin|mesh-list
14853548|NCT01043380|Ezetimibe|ezetimibe|mesh-list
14853549|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14853550|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14853551|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
14853552|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206997|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15206998|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15206999|NCT03717701|Metformin|metformin|mesh-list
15207000|NCT03717701|Esomeprazole|esomeprazole|mesh-list
14853553|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14853554|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15207001|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14853555|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853556|NCT01043419|Xenon|xenon|mesh-list
14853557|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14853558|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
14853559|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
14853560|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14853561|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853562|NCT01043445|Glycerol|glycerol|mesh-list
14853563|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14853564|NCT01043445|Protective Agents|protective agents|mesh-ancestor
14853565|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853566|NCT01043484|Bevacizumab|bevacizumab|mesh-list
14853567|NCT01043484|Capecitabine|capecitabine|mesh-list
14853568|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853569|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853570|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14853571|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14853572|NCT01043484|Growth Substances|growth substances|mesh-ancestor
14853573|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853574|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
14853575|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853576|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
14853577|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707734|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707735|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14707736|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14707737|NCT00424281|PENTA|penta|mesh-list
14707738|NCT00424281|Fondaparinux|fondaparinux|mesh-list
14707739|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14707740|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
14707741|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14707742|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
14853578|NCT01043510|Insulin|insulin|mesh-list
14853579|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14853580|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
14853581|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14853582|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853583|NCT01043536|Temozolomide|temozolomide|mesh-list
14853584|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14853585|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
14853586|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853587|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853588|NCT01043575|Rifampin|rifampin|mesh-list
14853589|NCT01043575|Rifapentine|rifapentine|mesh-list
14853590|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14853591|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
14853592|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14853593|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853594|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
14853595|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14853596|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853597|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853598|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14853599|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14853600|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14853601|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14853602|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14853603|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14853604|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
14707743|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707744|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707745|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
14707746|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14707747|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14707748|NCT00424333|Insulin|insulin|mesh-list
14707749|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14853605|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14853606|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
14853607|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853608|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853609|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14853610|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
14853611|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14853612|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14853613|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14853614|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
14853615|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853616|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853617|NCT01043666|Mirabegron|mirabegron|mesh-list
14853618|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14853619|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14853620|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14853621|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14853622|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
14853623|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853624|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853625|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853626|NCT01043666|Urological Agents|urological agents|mesh-ancestor
14853627|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14853628|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14853629|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
14853630|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14853631|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
14853632|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14853633|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14853634|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14853635|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14853636|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853637|NCT01043744|Lumefantrine|lumefantrine|mesh-list
14853638|NCT01043744|Artemether|artemether|mesh-list
14853639|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14853640|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
14853641|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14853642|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14853643|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853644|NCT01043952|Remifentanil|remifentanil|mesh-list
14853645|NCT01043952|Propofol|propofol|mesh-list
14853646|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14853647|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14853648|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853649|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14853650|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
14853651|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
14853652|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14853653|NCT01043952|Narcotics|narcotics|mesh-ancestor
14853654|NCT01043952|Analgesics|analgesics|mesh-ancestor
14707750|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14707751|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707752|NCT00424411|Insulin|insulin|mesh-list
14707753|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14707754|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14707755|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853655|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
14853656|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853657|NCT01043965|Metformin|metformin|mesh-list
14853658|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14853659|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853660|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
14707756|NCT00424437|Insulin|insulin|mesh-list
14707757|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14707758|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14707759|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707760|NCT00424580|Montelukast|montelukast|mesh-list
14707761|NCT00424580|Desloratadine|desloratadine|mesh-list
14707762|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14707763|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
14707764|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14853661|NCT01043991|Hematinics|hematinics|mesh-ancestor
14853662|NCT01044004|Modafinil|modafinil|mesh-list
14853663|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14853664|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853665|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14853666|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14853667|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14853668|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707765|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
14728693|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
14853669|NCT01044095|Vaccines|vaccines|mesh-list
14853670|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
14853671|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853672|NCT01044186|Deferasirox|deferasirox|mesh-list
14853673|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14853674|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
14853675|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
14853676|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853677|NCT01044199|Vaccines|vaccines|mesh-list
14853678|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
14853679|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853680|NCT01044225|Cetuximab|cetuximab|mesh-list
14853681|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853682|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853683|NCT01044238|Methylphenidate|methylphenidate|mesh-list
14853684|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14853685|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853686|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14853687|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14853688|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14853689|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853690|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
14853691|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853692|NCT01044251|Frovatriptan|frovatriptan|mesh-list
14853693|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14853694|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
14853695|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853696|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853697|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853698|NCT01044329|Triamcinolone|triamcinolone|mesh-list
14853699|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14853700|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14853701|NCT01044329|Bevacizumab|bevacizumab|mesh-list
14853702|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14853703|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853704|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853705|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14853706|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14853707|NCT01044329|Growth Substances|growth substances|mesh-ancestor
14853708|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853709|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
14853710|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853711|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
14853712|NCT01044329|Hormones|hormones|mesh-ancestor
14853713|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853714|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853715|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
14853716|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707766|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707767|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853717|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853718|NCT01044342|Donepezil|donepezil|mesh-list
14853719|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14853720|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853721|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707768|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14707769|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14707770|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707771|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14707772|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
14707773|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707774|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14707775|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14707776|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
14707777|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
14707778|NCT00424606|Docetaxel|docetaxel|mesh-list
14707779|NCT00424606|Epirubicin|epirubicin|mesh-list
14707780|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707781|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
14707782|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
14707783|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
14707784|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707785|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14707786|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14707787|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14853722|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
14853723|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853724|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853725|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
14853726|NCT01044394|Bisacodyl|bisacodyl|mesh-list
14853727|NCT01044394|Cathartics|cathartics|mesh-ancestor
14853728|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853729|NCT01044394|Laxatives|laxatives|mesh-ancestor
14853730|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
14853731|NCT01044446|Icodextrin|icodextrin|mesh-list
14853732|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14853733|NCT01044485|Docetaxel|docetaxel|mesh-list
14853734|NCT01044485|Lapatinib|lapatinib|mesh-list
14853735|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853736|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
14707788|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707789|NCT00424710|Ranibizumab|ranibizumab|mesh-list
14707790|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14707791|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14707792|NCT00424710|Growth Substances|growth substances|mesh-ancestor
14707793|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707794|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
14853737|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
14853738|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
14853739|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853740|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14707795|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707796|NCT00424723|Pemetrexed|pemetrexed|mesh-list
14707797|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707798|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707799|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707800|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14707801|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14707802|NCT00424788|Natalizumab|natalizumab|mesh-list
14707803|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
14707804|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707805|NCT00424801|Nicorandil|nicorandil|mesh-list
14707806|NCT00424801|Valsartan|valsartan|mesh-list
14707807|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14707808|NCT00424801|Doxazosin|doxazosin|mesh-list
14707809|NCT00424801|Lercanidipine|lercanidipine|mesh-list
14707810|NCT00424801|Pindolol|pindolol|mesh-list
14707811|NCT00424801|Moxonidine|moxonidine|mesh-list
14707812|NCT00424801|Amiloride|amiloride|mesh-list
14707813|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14707814|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14707815|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14853741|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913088|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913089|NCT01373554|Oltipraz|oltipraz|mesh-list
14913090|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
14913091|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913092|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
14913093|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14913094|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
14913095|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14913096|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14913097|NCT01373554|Protective Agents|protective agents|mesh-ancestor
14913098|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913099|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913100|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14913101|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14913102|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913103|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913104|NCT01373593|Lidocaine|lidocaine|mesh-list
14913105|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
14913106|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
14913107|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707816|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707817|NCT00424801|Diuretics|diuretics|mesh-ancestor
15207002|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207003|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15207004|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207005|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14707818|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
14913108|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913109|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
14913110|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853742|NCT01044719|Meropenem|meropenem|mesh-list
14853743|NCT01044719|Tobramycin|tobramycin|mesh-list
14853744|NCT01044719|Ceftazidime|ceftazidime|mesh-list
15207006|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207007|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853745|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14853746|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853747|NCT01044810|Efavirenz|efavirenz|mesh-list
14853748|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14853749|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14853750|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853751|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853752|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
14853753|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853754|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14853755|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14853756|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14853757|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14853758|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14853759|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14853760|NCT01044888|Heparin|heparin|mesh-list
14853761|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
14853762|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14853763|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14853764|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853765|NCT01044992|Levodopa|levodopa|mesh-list
14853766|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14853767|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14853768|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
14853769|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853770|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853771|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853772|NCT01045018|Mesalamine|mesalamine|mesh-list
14853773|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14853774|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14853775|NCT01045018|Analgesics|analgesics|mesh-ancestor
14853776|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
14853777|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853778|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853779|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853780|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853781|NCT01045083|Methylphenidate|methylphenidate|mesh-list
14853782|NCT01045083|Citalopram|citalopram|mesh-list
14853783|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14853784|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14853785|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207008|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15207009|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15207010|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15207011|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207012|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207013|NCT03717688|Incretins|incretins|mesh-ancestor
15207014|NCT03717688|Hormones|hormones|mesh-ancestor
15207015|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207016|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
15207017|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207018|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207019|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15207020|NCT03717662|Nicotine|nicotine|mesh-list
15207021|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15207022|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
15207023|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207024|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853786|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853787|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14853788|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
14853789|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707819|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707820|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14707821|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14853790|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14853791|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
14853792|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14853793|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14853794|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14853795|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
14853796|NCT01045109|Vitamin D|vitamin d|mesh-list
14853797|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
14853798|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
14853799|NCT01045109|Vitamins|vitamins|mesh-list
14853800|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
14853801|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853802|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14853803|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14853804|NCT01045278|Interferons|interferons|mesh-list
14853805|NCT01045278|Ribavirin|ribavirin|mesh-list
14853806|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
14707822|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14707823|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14707824|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14707825|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14729417|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14853807|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
14853808|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14853809|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853810|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
14853811|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853812|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
14853813|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853814|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
14853815|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853816|NCT01045304|Gemcitabine|gemcitabine|mesh-list
14853817|NCT01045304|Carboplatin|carboplatin|mesh-list
14853818|NCT01045304|Iniparib|iniparib|mesh-list
14853819|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853820|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853821|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
14853822|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853823|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
14853824|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853825|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853826|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853827|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
14853828|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853829|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14853830|NCT01045369|Etravirine|etravirine|mesh-list
14853831|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853832|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853833|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
14853834|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853835|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14853836|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14853837|NCT01045434|Omeprazole|omeprazole|mesh-list
14853838|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14853839|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853840|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14853841|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853842|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853843|NCT01045538|Capecitabine|capecitabine|mesh-list
14853844|NCT01045538|Vorinostat|vorinostat|mesh-list
14853845|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853846|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853847|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
14853848|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853849|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14853850|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207025|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15207026|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15207027|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
14853851|NCT01045642|Omeprazole|omeprazole|mesh-list
14853852|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14853853|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853854|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14853855|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853856|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853857|NCT01045681|Dexamethasone|dexamethasone|mesh-list
14853858|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
14853859|NCT01045681|Bortezomib|bortezomib|mesh-list
14853860|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14853861|NCT01045681|BB 1101|bb 1101|mesh-list
14853862|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853863|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
14853864|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
14853865|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853866|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853867|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853868|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
14853869|NCT01045681|Hormones|hormones|mesh-ancestor
14853870|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853871|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14853872|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853873|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
14853874|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853875|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853876|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14853877|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
14853878|NCT01045772|Rilonacept|rilonacept|mesh-list
14853879|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853880|NCT01045837|Prednisolone|prednisolone|mesh-list
14853881|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853882|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
14853883|NCT01045837|Hormones|hormones|mesh-ancestor
14853884|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853885|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853886|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14853887|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853888|NCT01045876|Dexamethasone|dexamethasone|mesh-list
14853889|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853890|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
14853891|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
15207028|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207029|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207030|NCT03717558|Ivermectin|ivermectin|mesh-list
15207031|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14853892|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14853893|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853894|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853895|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
14853896|NCT01045876|Hormones|hormones|mesh-ancestor
14853897|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207032|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853898|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14853899|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853900|NCT01045889|Prednisone|prednisone|mesh-list
14853901|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
14853902|NCT01045889|Melphalan|melphalan|mesh-list
14853903|NCT01045889|Rituximab|rituximab|mesh-list
14853904|NCT01045889|Etoposide|etoposide|mesh-list
14853905|NCT01045889|Vincristine|vincristine|mesh-list
14853906|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853907|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
14853908|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853909|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853910|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14853911|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
14853912|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853913|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853914|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14853915|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853916|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853917|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
14853918|NCT01045889|Hormones|hormones|mesh-ancestor
14853919|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853920|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14853921|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14853922|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14853923|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14853924|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853925|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
14853926|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
14853927|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
14853928|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
14853929|NCT01045902|Ampicillin|ampicillin|mesh-list
14853930|NCT01045902|Sulbactam|sulbactam|mesh-list
14853931|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14707826|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14707827|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14707828|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14707829|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14707830|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707831|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14707832|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
14707833|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
14853932|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14853933|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14853934|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14853935|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14853936|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853937|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853938|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853939|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14853940|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
14853941|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14853942|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853943|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14853944|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14853945|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14853946|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14853947|NCT01045928|Rituximab|rituximab|mesh-list
14853948|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14853949|NCT01045928|Lenalidomide|lenalidomide|mesh-list
14853950|NCT01045928|Antibodies|antibodies|mesh-list
14853951|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
14853952|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14853953|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
14853954|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853955|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853956|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14853957|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14853958|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14853959|NCT01045928|Growth Substances|growth substances|mesh-ancestor
14853960|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
14853961|NCT01045941|Gemcitabine|gemcitabine|mesh-list
14853962|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14853963|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
14853964|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853965|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853966|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
14853967|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207033|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
15207034|NCT03717467|Analgesics|analgesics|mesh-ancestor
15207035|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
15207036|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207037|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207038|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
15207039|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207040|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15207041|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
15207042|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15207043|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207044|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853968|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14853969|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14853970|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
14853971|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853972|NCT01045954|Insulin|insulin|mesh-list
14853973|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
14853974|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
14853975|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14853976|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853977|NCT01045980|Vitamin D|vitamin d|mesh-list
14853978|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
14853979|NCT01045980|Vitamins|vitamins|mesh-list
14853980|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
14853981|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853982|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14853983|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15207045|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15207046|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
15207047|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15207048|NCT03717415|Carboplatin|carboplatin|mesh-list
15207049|NCT03717415|Rebastinib|rebastinib|mesh-list
15207050|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207051|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15207052|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207053|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14853984|NCT01046006|Dexamethasone|dexamethasone|mesh-list
14853985|NCT01046006|Rituximab|rituximab|mesh-list
14853986|NCT01046006|Bortezomib|bortezomib|mesh-list
14853987|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14853988|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
15207054|NCT03717350|Meropenem|meropenem|mesh-list
15207055|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207056|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207057|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
15207058|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15207059|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207060|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207061|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207062|NCT03717168|Hormones|hormones|mesh-list
14707834|NCT00424801|Vitamins|vitamins|mesh-ancestor
14707835|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
14707836|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14707837|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14707838|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14707839|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14707840|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
14853989|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
14853990|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707841|NCT00424814|Ritonavir|ritonavir|mesh-list
14707842|NCT00424814|Lopinavir|lopinavir|mesh-list
14853991|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14853992|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14853993|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
14853994|NCT01046006|Hormones|hormones|mesh-ancestor
14853995|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14853996|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14853997|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14853998|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14853999|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
14854000|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854001|NCT01046032|Metformin|metformin|mesh-list
14854002|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14854003|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854004|NCT01046045|Everolimus|everolimus|mesh-list
14854005|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854006|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854007|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
14854008|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854009|NCT01046058|Simeprevir|simeprevir|mesh-list
14854010|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
14854011|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854012|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
14854013|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854014|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854015|NCT01046162|Alprazolam|alprazolam|mesh-list
14854016|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14854017|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854018|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854019|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14854020|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14854021|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854022|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
14854023|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
14854024|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854025|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854026|NCT01046214|Bupropion|bupropion|mesh-list
14854027|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14854028|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
14854029|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854030|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14854031|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14854032|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854033|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854034|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
14854035|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854036|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854037|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14854038|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15207063|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207064|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207065|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
15207066|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15207067|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207068|NCT03717038|Trifluridine|trifluridine|mesh-list
15207069|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
15207070|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207071|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
15207072|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207073|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
15207074|NCT03716856|Fludarabine|fludarabine|mesh-list
15207075|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207076|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
14854039|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854040|NCT01046227|Vaccines|vaccines|mesh-list
14854041|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
14854042|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854043|NCT01046240|Palonosetron|palonosetron|mesh-list
14854044|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
14854045|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
14854046|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854047|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854048|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854049|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14854050|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14854051|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
14854052|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854053|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854054|NCT01046266|Cetuximab|cetuximab|mesh-list
14854055|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14854056|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854057|NCT01046279|Bevacizumab|bevacizumab|mesh-list
14854058|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707843|NCT00424814|Lamivudine|lamivudine|mesh-list
14707844|NCT00424814|Zidovudine|zidovudine|mesh-list
14707845|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14707846|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14707847|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14707848|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
14707849|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707850|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707851|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14854059|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854060|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14854061|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14854062|NCT01046279|Growth Substances|growth substances|mesh-ancestor
14854063|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854064|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
14913111|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14913112|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14913113|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14913114|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913115|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913116|NCT01373606|Terlipressin|terlipressin|mesh-list
14913117|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14913118|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14913119|NCT01373632|Sirolimus|sirolimus|mesh-list
14913120|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14913121|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913122|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14913123|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913124|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
14913125|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913126|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
14913127|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913128|NCT01373684|Tenofovir|tenofovir|mesh-list
14913129|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14913130|NCT01373684|Entecavir|entecavir|mesh-list
14913131|NCT01373684|Adefovir|adefovir|mesh-list
14913132|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
14913133|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854065|NCT01046383|Caseins|caseins|mesh-list
14854066|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
14854067|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
14854068|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854069|NCT01046435|Amoxicillin|amoxicillin|mesh-list
14854070|NCT01046435|Metronidazole|metronidazole|mesh-list
14854071|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14854072|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854073|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14854074|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14854075|NCT01046461|Dexamethasone|dexamethasone|mesh-list
14854076|NCT01046461|Aprepitant|aprepitant|mesh-list
14854077|NCT01046461|Ramosetron|ramosetron|mesh-list
14854078|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14854079|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
14854080|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
14854081|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854082|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854083|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854084|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
14854085|NCT01046461|Hormones|hormones|mesh-ancestor
14854086|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854087|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14854088|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854089|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14854090|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854091|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854092|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14854093|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
14854094|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
14854095|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
14854096|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854097|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
14854098|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854099|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207077|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207078|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207079|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15207080|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
15207081|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207082|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207083|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15207084|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
15207085|NCT03716804|Cefuroxime|cefuroxime|mesh-list
15207086|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
15207087|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
15207088|NCT03716804|Cefixime|cefixime|mesh-list
15207089|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14854100|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854101|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
15207090|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207091|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14854102|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854103|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854104|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14854105|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14854106|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854107|NCT01046500|Inositol|inositol|mesh-list
14854108|NCT01046500|Metformin|metformin|mesh-list
14854109|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14854110|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854111|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
14854112|NCT01046500|Vitamins|vitamins|mesh-ancestor
14854113|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
14854114|NCT01046539|Buprenorphine|buprenorphine|mesh-list
14854115|NCT01046539|ALKS-33|alks-33|mesh-list
14854116|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14854117|NCT01046539|Narcotics|narcotics|mesh-ancestor
14854118|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14707852|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14707853|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
14707854|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707855|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14707856|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14707857|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14707858|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14707859|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
14707860|NCT00424853|Gemcitabine|gemcitabine|mesh-list
14707861|NCT00424853|Cisplatin|cisplatin|mesh-list
14707862|NCT00424853|Docetaxel|docetaxel|mesh-list
14707863|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707864|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707865|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
14707866|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707867|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
14707868|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707869|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707870|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707871|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
14707872|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707873|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
14707874|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
14707875|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
14707876|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14707877|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14707878|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14707879|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14707880|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707881|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707882|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707883|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
14854119|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854120|NCT01046539|Analgesics|analgesics|mesh-ancestor
14854121|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
14854122|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854123|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14854124|NCT01046578|Letrozole|letrozole|mesh-list
14854125|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854126|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14854127|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14854128|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854129|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854130|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14854131|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
14854132|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854133|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707884|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854134|NCT01046630|Ketamine|ketamine|mesh-list
14854135|NCT01046630|Analgesics|analgesics|mesh-ancestor
14854136|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
14854137|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854138|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854139|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14854140|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14854141|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
14854142|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
14854143|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854144|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14854145|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14854146|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854147|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854148|NCT01046708|Progesterone|progesterone|mesh-list
14854149|NCT01046708|Progestins|progestins|mesh-ancestor
14854150|NCT01046708|Hormones|hormones|mesh-ancestor
14854151|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854152|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854153|NCT01046721|Exenatide|exenatide|mesh-list
14854154|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14854155|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854156|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14854157|NCT01046721|Incretins|incretins|mesh-ancestor
14854158|NCT01046721|Hormones|hormones|mesh-ancestor
14854159|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854160|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
14854161|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14854162|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854163|NCT01046773|Vitamins|vitamins|mesh-ancestor
14854164|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
14854165|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14854166|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
14854167|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14854168|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14854169|NCT01046786|Prednisolone|prednisolone|mesh-list
14707885|NCT00424931|Modafinil|modafinil|mesh-list
14707886|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14707887|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707888|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14707889|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14707890|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14707891|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707892|NCT00424944|Vaccines|vaccines|mesh-list
14854170|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
14854171|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14854172|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
14854173|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707893|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
14707894|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707895|NCT00424970|Acetazolamide|acetazolamide|mesh-list
14707896|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
14707897|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14707898|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707899|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707900|NCT00424970|Diuretics|diuretics|mesh-ancestor
14707901|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
14707902|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854174|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
14854175|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
14854176|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854177|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707903|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
14707904|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14707905|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707906|NCT00425009|Metformin|metformin|mesh-list
14707907|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14707908|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707909|NCT00425035|Panitumumab|panitumumab|mesh-list
14707910|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707911|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707912|NCT00425074|Aspirin|aspirin|mesh-list
14854178|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854179|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
14854180|NCT01046786|Hormones|hormones|mesh-ancestor
14854181|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14707913|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
14707914|NCT00425074|Salicylates|salicylates|mesh-list
14707915|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707916|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
14854182|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14854183|NCT01046786|Protective Agents|protective agents|mesh-ancestor
14854184|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14854185|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854186|NCT01046799|Entecavir|entecavir|mesh-list
14854187|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
14854188|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854189|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
14854190|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
14854191|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14854192|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14854193|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854194|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854195|NCT01046838|Urological Agents|urological agents|mesh-ancestor
14854196|NCT01046864|Leucovorin|leucovorin|mesh-list
14854197|NCT01046864|Fluorouracil|fluorouracil|mesh-list
14854198|NCT01046864|Irinotecan|irinotecan|mesh-list
14854199|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
14854200|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854201|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854202|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854203|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854204|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
14854205|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854206|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14854207|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15207092|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15207093|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207094|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207095|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207096|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15207097|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15207098|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15207099|NCT03716804|Renal Agents|renal agents|mesh-ancestor
14707917|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
14707918|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
14707919|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14854208|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854209|NCT01046864|Antidotes|antidotes|mesh-ancestor
14854210|NCT01046864|Protective Agents|protective agents|mesh-ancestor
14854211|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
14854212|NCT01046864|Vitamins|vitamins|mesh-ancestor
14854213|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
14854214|NCT01046942|Aspirin|aspirin|mesh-list
14854215|NCT01046942|Clopidogrel|clopidogrel|mesh-list
14854216|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14854217|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14854218|NCT01046942|Analgesics|analgesics|mesh-ancestor
14854219|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
14854220|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854221|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854222|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14854223|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854224|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14854225|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14854226|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854227|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14854228|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14854229|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854230|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
14854231|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14854232|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14854233|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14854234|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
14854235|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854236|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
14854237|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
14854238|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14854239|NCT01046955|Daclizumab|daclizumab|mesh-list
14854240|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
14854241|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854242|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854243|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14854244|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854245|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14854246|NCT01046981|Metronidazole|metronidazole|mesh-list
14854247|NCT01046981|Cefazolin|cefazolin|mesh-list
14854248|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14854249|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854250|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
14854251|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14854252|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14854253|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14854254|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854255|NCT01047059|Bevacizumab|bevacizumab|mesh-list
14854256|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14854257|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14854258|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854259|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14854260|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14854261|NCT01047059|Growth Substances|growth substances|mesh-ancestor
14854262|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854263|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
14854264|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14854265|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854266|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854267|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
14854268|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
14854269|NCT01047072|Rituximab|rituximab|mesh-list
14854270|NCT01047072|Fludarabine|fludarabine|mesh-list
14854271|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
14854272|NCT01047072|Tacrolimus|tacrolimus|mesh-list
14854273|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854274|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
14854275|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854276|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854277|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854278|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
14854279|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854280|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854281|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14854282|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14854283|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854284|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
14854285|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14854286|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854287|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14854288|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14854289|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
14854290|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14854291|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854292|NCT01047098|Iron|iron|mesh-list
14854293|NCT01047098|Trace Elements|trace elements|mesh-ancestor
14854294|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
14854295|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854296|NCT01047202|Vaccines|vaccines|mesh-list
14854297|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
14854298|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854299|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14854300|NCT01047215|Aripiprazole|aripiprazole|mesh-list
14854301|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
14854302|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854303|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14854304|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14854305|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854306|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854307|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
14854308|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
14854309|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854310|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854311|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14854312|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14854313|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
14854314|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14854315|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14854316|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14854317|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14854318|NCT01047423|Simvastatin|simvastatin|mesh-list
14854319|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14854320|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14854321|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
14854322|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854323|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14854324|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14854325|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854326|NCT01047488|Pregabalin|pregabalin|mesh-list
14854327|NCT01047488|Imipramine|imipramine|mesh-list
14854328|NCT01047488|Analgesics|analgesics|mesh-ancestor
14854329|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
14854330|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854331|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854332|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
14854333|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14854334|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854335|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854336|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14854337|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14854338|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14854339|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854340|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854341|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14854342|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
14854343|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14854344|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14854345|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
14854346|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854347|NCT01047566|Digoxin|digoxin|mesh-list
14854348|NCT01047566|Dronedarone|dronedarone|mesh-list
14854349|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
14854350|NCT01047566|Calcium|calcium|mesh-list
14854351|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14854352|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14854353|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854354|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14854355|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14854356|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854357|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854358|NCT01047566|Protective Agents|protective agents|mesh-ancestor
14854359|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14854360|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
14854361|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854362|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854363|NCT01047579|Rivastigmine|rivastigmine|mesh-list
14854364|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14854365|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854366|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854367|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
14854368|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854369|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854370|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14854371|NCT01047579|Protective Agents|protective agents|mesh-ancestor
14854372|NCT01047657|Orlistat|orlistat|mesh-list
14854373|NCT01047657|Sibutramine|sibutramine|mesh-list
14854374|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854375|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854376|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15207100|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
15207101|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207102|NCT03716765|Vitamin D|vitamin d|mesh-list
15207103|NCT03716765|Vitamins|vitamins|mesh-ancestor
15207104|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
15207105|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207106|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15207107|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
15207108|NCT03716739|Testosterone|testosterone|mesh-list
15207109|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
15207110|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
15207111|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15207112|NCT03716739|Androgens|androgens|mesh-ancestor
15207113|NCT03716739|Hormones|hormones|mesh-ancestor
15207114|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207115|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854377|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14854378|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
14854379|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854380|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
14854381|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
14854382|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14854383|NCT01047722|Aspirin|aspirin|mesh-list
14854384|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14854385|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14854386|NCT01047722|Analgesics|analgesics|mesh-ancestor
14854387|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
14854388|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854389|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854390|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14854391|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854392|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14854393|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14854394|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854395|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14854396|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14854397|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854398|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
14854399|NCT01047748|Digoxin|digoxin|mesh-list
14854400|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14854401|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14854402|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854403|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854404|NCT01047748|Protective Agents|protective agents|mesh-ancestor
14854405|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854406|NCT01047774|Caseins|caseins|mesh-list
14854407|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
14854408|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
14854409|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854410|NCT01047891|Sorafenib|sorafenib|mesh-list
14854411|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854412|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14854413|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854414|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854415|NCT01047956|Methadone|methadone|mesh-list
14854416|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14854417|NCT01047956|Narcotics|narcotics|mesh-ancestor
14854418|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854419|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854420|NCT01047956|Analgesics|analgesics|mesh-ancestor
14854421|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
14854422|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854423|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
14854424|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
14854425|NCT01047982|Folic Acid|folic acid|mesh-list
14854426|NCT01047982|Inositol|inositol|mesh-list
14854427|NCT01047982|Hematinics|hematinics|mesh-ancestor
15207116|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14854428|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
14854429|NCT01047982|Vitamins|vitamins|mesh-ancestor
14854430|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
14854431|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854432|NCT01047995|Ritonavir|ritonavir|mesh-list
14854433|NCT01047995|Darunavir|darunavir|mesh-list
14854434|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
14854435|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14854436|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14854437|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
14854438|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854439|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854440|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14854441|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14854442|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
14854443|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854444|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14854445|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14854446|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14854447|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14913134|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14913135|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14913136|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913137|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913138|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14913139|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14913140|NCT01373697|Ibuprofen|ibuprofen|mesh-list
14913141|NCT01373697|Ketoprofen|ketoprofen|mesh-list
14913142|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14913143|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14913144|NCT01373697|Analgesics|analgesics|mesh-ancestor
14913145|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
14913146|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913147|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913148|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913149|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913150|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14913151|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913152|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913153|NCT01373710|Trastuzumab|trastuzumab|mesh-list
14913154|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14913155|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913156|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14913157|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913158|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913159|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913160|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14913161|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
14913162|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
14913163|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14913164|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14913165|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913166|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913167|NCT01373749|Urological Agents|urological agents|mesh-ancestor
14913168|NCT01373970|Pantoprazole|pantoprazole|mesh-list
14913169|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14707920|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14707921|NCT00425074|Analgesics|analgesics|mesh-ancestor
14707922|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
14707923|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707924|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707925|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14707926|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707927|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14707928|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707929|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707930|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14707931|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14707932|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14707933|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
14707934|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
14707935|NCT00425126|Hematinics|hematinics|mesh-ancestor
14707936|NCT00425152|Leucovorin|leucovorin|mesh-list
14854448|NCT01048034|Azacitidine|azacitidine|mesh-list
14854449|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
14854450|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854451|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
14854452|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854453|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854454|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854455|NCT01048034|Hematinics|hematinics|mesh-ancestor
14854456|NCT01048047|Amlodipine|amlodipine|mesh-list
14854457|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14854458|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14854459|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854460|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854461|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14854462|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854463|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
14854464|NCT01048086|Tretinoin|tretinoin|mesh-list
14854465|NCT01048086|Isotretinoin|isotretinoin|mesh-list
14854466|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854467|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
14854468|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14854469|NCT01048138|Biperiden|biperiden|mesh-list
14854470|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
14854471|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14854472|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14854473|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
14854474|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
14854475|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854476|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854477|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14854478|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14854479|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14854480|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854481|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854482|NCT01048177|Lidocaine|lidocaine|mesh-list
14854483|NCT01048177|Heparin|heparin|mesh-list
14854484|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
14854485|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
14854486|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854487|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854488|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
14854489|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854490|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14854491|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14854492|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14854493|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854494|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854495|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
14854496|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14854497|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14854498|NCT01048190|Vaccines|vaccines|mesh-list
14854499|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
14854500|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854501|NCT01048229|Pramipexole|pramipexole|mesh-list
14854502|NCT01048229|Rasagiline|rasagiline|mesh-list
14854503|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
14854504|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854505|NCT01048229|Protective Agents|protective agents|mesh-ancestor
14854506|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854507|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14854508|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14854509|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
14854510|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
14854511|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854512|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14854513|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854514|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14854515|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14854516|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854517|NCT01048268|Incretins|incretins|mesh-ancestor
14854518|NCT01048268|Hormones|hormones|mesh-ancestor
14854519|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854520|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854521|NCT01048307|Polihexanide|polihexanide|mesh-list
14854522|NCT01048307|Betaine|betaine|mesh-list
14854523|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14854524|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854525|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
14854526|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14854527|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
14854528|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854529|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14854530|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
14854531|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854532|NCT01048320|Gemcitabine|gemcitabine|mesh-list
14854533|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
14854534|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
14854535|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854536|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
14854537|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854538|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854539|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
14854540|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854541|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854542|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854543|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
14854544|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854545|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15207117|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207118|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
15224882|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15224883|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224884|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
15224885|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224886|NCT02073097|Acyclovir|acyclovir|mesh-list
15224887|NCT02073097|Prednisone|prednisone|mesh-list
14854546|NCT01048385|Ubiquinone|ubiquinone|mesh-list
14854547|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
14854548|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
14854549|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854550|NCT01048385|Vitamins|vitamins|mesh-ancestor
14854551|NCT01048398|Acetaminophen|acetaminophen|mesh-list
14854552|NCT01048398|Remifentanil|remifentanil|mesh-list
14854553|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14854554|NCT01048398|Analgesics|analgesics|mesh-ancestor
15224888|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
14295838|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707937|NCT00425152|Levamisole|levamisole|mesh-list
14707938|NCT00425152|Fluorouracil|fluorouracil|mesh-list
14707939|NCT00425152|Calcium|calcium|mesh-list
14707940|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
14707941|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14707942|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707943|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
14707944|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707945|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15224889|NCT02073097|Rituximab|rituximab|mesh-list
14707946|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854555|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
15224890|NCT02073097|Doxorubicin|doxorubicin|mesh-list
14854556|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224891|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15224892|NCT02073097|Vincristine|vincristine|mesh-list
14854557|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854558|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
14854559|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14854560|NCT01048398|Narcotics|narcotics|mesh-ancestor
14854561|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854562|NCT01048515|Caffeine|caffeine|mesh-list
14854563|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14854564|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854565|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14854566|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854567|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854568|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14854569|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14854570|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
14854571|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854572|NCT01048554|Bevacizumab|bevacizumab|mesh-list
14854573|NCT01048554|Temozolomide|temozolomide|mesh-list
14854574|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14854575|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207119|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
15207120|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
15207121|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15207122|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15207123|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
15207124|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207125|NCT03716622|Clarithromycin|clarithromycin|mesh-list
14854576|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14854577|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14854578|NCT01048554|Growth Substances|growth substances|mesh-ancestor
14854579|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854580|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
14854581|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854582|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
14854583|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707947|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707948|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
14707949|NCT00425152|Antidotes|antidotes|mesh-ancestor
14707950|NCT00425152|Protective Agents|protective agents|mesh-ancestor
14707951|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
14707952|NCT00425152|Vitamins|vitamins|mesh-ancestor
14707953|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
14707954|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14707955|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
14707956|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
14854584|NCT01048580|Capecitabine|capecitabine|mesh-list
14854585|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854586|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
14854587|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854588|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854589|NCT01048619|ON 01910|on 01910|mesh-list
14854590|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854591|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14854592|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854593|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854594|NCT01048632|Oxandrolone|oxandrolone|mesh-list
14854595|NCT01048632|Androgens|androgens|mesh-ancestor
14854596|NCT01048632|Hormones|hormones|mesh-ancestor
14854597|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854598|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854599|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
14854600|NCT01048684|Mannitol|mannitol|mesh-list
14854601|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14854602|NCT01048684|Diuretics|diuretics|mesh-ancestor
15207126|NCT03716622|Furazolidone|furazolidone|mesh-list
15207127|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14854603|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
14854604|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854605|NCT01048827|Busulfan|busulfan|mesh-list
14854606|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
14854607|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854608|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854609|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
14854610|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854611|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854612|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854613|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14854614|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
14854615|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854616|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
14854617|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854618|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854619|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854620|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
14854621|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854622|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854623|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14854624|NCT01048983|Minocycline|minocycline|mesh-list
14854625|NCT01048983|Curcumin|curcumin|mesh-list
14854626|NCT01048983|Modafinil|modafinil|mesh-list
14854627|NCT01048983|Bupropion|bupropion|mesh-list
14854628|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14854629|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
14854630|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854631|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14854632|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14707957|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14707958|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707959|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707960|NCT00425191|Gemcitabine|gemcitabine|mesh-list
14707961|NCT00425191|Docetaxel|docetaxel|mesh-list
14707962|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707963|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14707964|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
14707965|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707966|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
14707967|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854633|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14707968|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14707969|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14707970|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
14707971|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707972|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
14707973|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
14707974|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
14707975|NCT00425204|Panitumumab|panitumumab|mesh-list
14854634|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854635|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
14854636|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854637|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854638|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14854639|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14854640|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854641|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14854642|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854643|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14854644|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14854645|NCT01048983|Analgesics|analgesics|mesh-ancestor
14854646|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
14854647|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854648|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14854649|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854650|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854651|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14854652|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14854653|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14854654|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14854655|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
14854656|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14854657|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14854658|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854659|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14854660|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14854661|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854662|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854663|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854664|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14854665|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
14854666|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14854667|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854668|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14854669|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14854670|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14854671|NCT01049048|Vitamin D|vitamin d|mesh-list
14854672|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
14854673|NCT01049048|Vitamins|vitamins|mesh-ancestor
14854674|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
14854675|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854676|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14854677|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14854678|NCT01049061|Farletuzumab|farletuzumab|mesh-list
14854679|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854680|NCT01049178|Silymarin|silymarin|mesh-list
14854681|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
14854682|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854683|NCT01049178|Protective Agents|protective agents|mesh-ancestor
14854684|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854685|NCT01049204|Maraviroc|maraviroc|mesh-list
14707976|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707977|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707978|NCT00425217|Rituximab|rituximab|mesh-list
14707979|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14707980|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14707981|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
14707982|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707983|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14707984|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14707985|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14707986|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14707987|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729418|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854686|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14854687|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14854688|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854689|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14854690|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14854691|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
14854692|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854693|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14854694|NCT01049347|Amitriptyline|amitriptyline|mesh-list
14854695|NCT01049347|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14854696|NCT01049347|Paroxetine|paroxetine|mesh-list
14854697|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14854698|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14854699|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854700|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854701|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854702|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
14854703|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854704|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14854705|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
14854706|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14854707|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14854708|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14854709|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854710|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14854711|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14854712|NCT01049347|Analgesics|analgesics|mesh-ancestor
14854713|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
14854714|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854715|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15207128|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14707988|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14707989|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14707990|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14707991|NCT00425230|Analgesics|analgesics|mesh-ancestor
14707992|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
14707993|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14707994|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
14707995|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14707996|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
14707997|NCT00425243|Zolpidem|zolpidem|mesh-list
14707998|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14707999|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14708000|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708001|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708002|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14708003|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
14708004|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
14708005|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708006|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708007|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14708008|NCT00425347|Elotuzumab|elotuzumab|mesh-list
14729419|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
15207129|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15207130|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207131|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207132|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15207133|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15207134|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15207135|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15207136|NCT03716622|Renal Agents|renal agents|mesh-ancestor
14854716|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14854717|NCT01049347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14854718|NCT01049347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14854719|NCT01049347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854720|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
14854721|NCT01049425|Docetaxel|docetaxel|mesh-list
14854722|NCT01049425|Epirubicin|epirubicin|mesh-list
14854723|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854724|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
14854725|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854726|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854727|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854728|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
14854729|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854730|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854731|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14854732|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
14854733|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
14854734|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
14854735|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14854736|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14854737|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14854738|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854739|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14854740|NCT01049438|Doxycycline|doxycycline|mesh-list
14854741|NCT01049438|Minocycline|minocycline|mesh-list
14854742|NCT01049438|Mupirocin|mupirocin|mesh-list
14854743|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14854744|NCT01049438|Trimethoprim|trimethoprim|mesh-list
14854745|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
14854746|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
14854747|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854748|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
14854749|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14854750|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14854751|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14854752|NCT01049438|Renal Agents|renal agents|mesh-ancestor
14854753|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14854754|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708009|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708010|NCT00425360|Gemcitabine|gemcitabine|mesh-list
14708011|NCT00425360|Capecitabine|capecitabine|mesh-list
14708012|NCT00425360|Sargramostim|sargramostim|mesh-list
14708013|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708014|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
14708015|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708016|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708017|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
14708018|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708019|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708020|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708021|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
14854755|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729420|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
14854756|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14854757|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14854758|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14854759|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14854760|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14854761|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
14854762|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14854763|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14854764|NCT01049451|Prednisolone|prednisolone|mesh-list
14854765|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
14854766|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14854767|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
14854768|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14854769|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
14854770|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
14854771|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854772|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854773|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854774|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
14854775|NCT01049451|Hormones|hormones|mesh-ancestor
14854776|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854777|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14854778|NCT01049451|Protective Agents|protective agents|mesh-ancestor
14854779|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14854780|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854781|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
14854782|NCT01049464|Analgesics|analgesics|mesh-ancestor
14854783|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
14854784|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854785|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854786|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
14854787|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854788|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14854789|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
14854790|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14854791|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854792|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854793|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14854794|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
14854795|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14854796|NCT01049542|Astressin|astressin|mesh-list
14854797|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14854798|NCT01049542|Protective Agents|protective agents|mesh-ancestor
14854799|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854800|NCT01049620|Capecitabine|capecitabine|mesh-list
14854801|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
14854802|NCT01049620|Everolimus|everolimus|mesh-list
14854803|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854804|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
14854805|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854806|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854807|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854808|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
14854809|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854810|NCT01049633|Aspirin|aspirin|mesh-list
14854811|NCT01049633|Sirolimus|sirolimus|mesh-list
14854812|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14854813|NCT01049633|Clotrimazole|clotrimazole|mesh-list
14854814|NCT01049633|Miconazole|miconazole|mesh-list
14854815|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
15207137|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15207138|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15207139|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15207140|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15207141|NCT03716596|Antibodies|antibodies|mesh-list
15207142|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
15207143|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207144|NCT03716583|Melatonin|melatonin|mesh-list
15207145|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15207146|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
15207147|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207148|NCT03716583|Protective Agents|protective agents|mesh-ancestor
15207149|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207150|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207151|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15207152|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15207153|NCT03716427|Tolbutamide|tolbutamide|mesh-list
14854816|NCT01049633|Trimethoprim|trimethoprim|mesh-list
15207154|NCT03716427|Midazolam|midazolam|mesh-list
14854817|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
14854818|NCT01049633|Valganciclovir|valganciclovir|mesh-list
14854819|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
14854820|NCT01049633|Heparin|heparin|mesh-list
14854821|NCT01049633|Enoxaparin|enoxaparin|mesh-list
14854822|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
14854823|NCT01049633|Tacrolimus|tacrolimus|mesh-list
14854824|NCT01049633|Basiliximab|basiliximab|mesh-list
14854825|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14854826|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14854827|NCT01049633|Analgesics|analgesics|mesh-ancestor
14854828|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
14854829|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854830|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854831|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14854832|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854833|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14854834|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14854835|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854836|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14854837|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14854838|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854839|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
14854840|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854841|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
14854842|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14854843|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854844|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14854845|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854846|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
14854847|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14854848|NCT01049633|Renal Agents|renal agents|mesh-ancestor
14854849|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
14854850|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14854851|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14854852|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14854853|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14854854|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14854855|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14854856|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14854857|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14854858|NCT01049633|Protective Agents|protective agents|mesh-ancestor
14854859|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
14854860|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14854861|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
14854862|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14854863|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14854864|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14854865|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
14854866|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14854867|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14854868|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14854869|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
14854870|NCT01049646|Giapreza|giapreza|mesh-list
14854871|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
14854872|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14854873|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14854874|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
14708022|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708023|NCT00425425|Fluorouracil|fluorouracil|mesh-list
14708024|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
14708025|NCT00425425|Cetuximab|cetuximab|mesh-list
14708026|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
14708027|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708028|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708029|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708030|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708031|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
14708032|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708033|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708034|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
14854875|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854876|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708035|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14854877|NCT01049672|Alfentanil|alfentanil|mesh-list
14854878|NCT01049672|Heroin|heroin|mesh-list
14854879|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14854880|NCT01049672|Narcotics|narcotics|mesh-ancestor
14854881|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14854882|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854883|NCT01049672|Analgesics|analgesics|mesh-ancestor
14854884|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
14854885|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854886|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14854887|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
14854888|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
14854889|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14854890|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
14708036|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
14708037|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14708038|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708039|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
15207155|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
15207156|NCT03716427|Omeprazole|omeprazole|mesh-list
15207157|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15207158|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15207159|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708040|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
14708041|NCT00425451|Analgesics|analgesics|mesh-ancestor
14708042|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
14708043|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854891|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854892|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
14854893|NCT01049711|Hematinics|hematinics|mesh-ancestor
14913170|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14913171|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14913172|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913173|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913174|NCT01373983|Ziconotide|ziconotide|mesh-list
14913175|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14913176|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913177|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913178|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14913179|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913180|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14913181|NCT01373983|Protective Agents|protective agents|mesh-ancestor
14913182|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708044|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913183|NCT01373983|Analgesics|analgesics|mesh-ancestor
14913184|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
14913185|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913186|NCT01374126|Azithromycin|azithromycin|mesh-list
14913187|NCT01374126|Artesunate|artesunate|mesh-list
14913188|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14913189|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913190|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
14913191|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14913192|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14913193|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913194|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
14913195|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
14913196|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14913197|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
14913198|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
14913199|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14913200|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14913201|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14913202|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913203|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913204|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
14913205|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913206|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913207|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14913208|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913209|NCT01374282|Penicillamine|penicillamine|mesh-list
14913210|NCT01374282|Antidotes|antidotes|mesh-ancestor
14913211|NCT01374282|Protective Agents|protective agents|mesh-ancestor
14913212|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207160|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708045|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14913213|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
15207161|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14854894|NCT01049763|Oseltamivir|oseltamivir|mesh-list
14854895|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
14854896|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854897|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854898|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854899|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
14854900|NCT01049815|Calcium|calcium|mesh-list
14854901|NCT01049815|Sevelamer|sevelamer|mesh-list
14854902|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14854903|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708046|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708047|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708048|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708049|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14708050|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708051|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708052|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14708053|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14708054|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708055|NCT00425490|Incretins|incretins|mesh-ancestor
14708056|NCT00425490|Hormones|hormones|mesh-ancestor
14708057|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708058|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14708059|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
14708060|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708061|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708062|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
14708063|NCT00425516|Docetaxel|docetaxel|mesh-list
14708064|NCT00425516|Fluorouracil|fluorouracil|mesh-list
14708065|NCT00425516|Epirubicin|epirubicin|mesh-list
14708066|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708067|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
14708068|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708069|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708070|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14708071|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
14708072|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708073|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854904|NCT01049815|Antacids|antacids|mesh-ancestor
14854905|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854906|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854907|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
14854908|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
14854909|NCT01049841|Sirolimus|sirolimus|mesh-list
14854910|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14854911|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854912|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14854913|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854914|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
14854915|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854916|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
14854917|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854918|NCT01049854|Vidarabine|vidarabine|mesh-list
14854919|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
14854920|NCT01049854|Thiotepa|thiotepa|mesh-list
14854921|NCT01049854|Busulfan|busulfan|mesh-list
14854922|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
14854923|NCT01049854|Fludarabine|fludarabine|mesh-list
14854924|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14854925|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854926|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
14854927|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708074|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14708075|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
14708076|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
14708077|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
14708078|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
14854928|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14854929|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854930|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
14854931|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854932|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854933|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14854934|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854935|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
14854936|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
14854937|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854938|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
14854939|NCT01049880|Gemcitabine|gemcitabine|mesh-list
14854940|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14854941|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
14854942|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708079|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708080|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14708081|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14708082|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14708083|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708084|NCT00425568|Testosterone|testosterone|mesh-list
14708085|NCT00425568|Androgens|androgens|mesh-ancestor
14708086|NCT00425568|Hormones|hormones|mesh-ancestor
14708087|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708088|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708089|NCT00425594|Bisacodyl|bisacodyl|mesh-list
14708090|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14708091|NCT00425594|Cathartics|cathartics|mesh-ancestor
14708092|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854943|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854944|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
14854945|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854946|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14854947|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854948|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
14854949|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708093|NCT00425594|Laxatives|laxatives|mesh-ancestor
14708094|NCT00425620|Amphotericin B|amphotericin b|mesh-list
14708095|NCT00425620|Amebicides|amebicides|mesh-ancestor
14854950|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
14854951|NCT01049880|Protective Agents|protective agents|mesh-ancestor
14854952|NCT01049880|Vitamins|vitamins|mesh-ancestor
14854953|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
14854954|NCT01049932|Rilpivirine|rilpivirine|mesh-list
14854955|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14708096|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14708097|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14708098|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708099|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14708100|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
14708101|NCT00425646|Bevacizumab|bevacizumab|mesh-list
14708102|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
14708103|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708104|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708105|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14708106|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14708107|NCT00425646|Growth Substances|growth substances|mesh-ancestor
14708108|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708109|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
14708110|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14708111|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708112|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708113|NCT00425711|Acamprosate|acamprosate|mesh-list
14708114|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14708115|NCT00425724|Cyclosporine|cyclosporine|mesh-list
14708116|NCT00425724|Prednisone|prednisone|mesh-list
14708117|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
14708118|NCT00425724|Cyclosporins|cyclosporins|mesh-list
14708119|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708120|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
14708121|NCT00425724|Hormones|hormones|mesh-ancestor
14708122|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708123|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708124|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14854956|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14708125|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14854957|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708126|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708127|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854958|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854959|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
14854960|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14854961|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14854962|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14854963|NCT01050036|Busulfan|busulfan|mesh-list
14854964|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
14854965|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854966|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14854967|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
15207162|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15207163|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15207164|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14708128|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708129|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
14708130|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
14295839|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295840|NCT00584701|Risperidone|risperidone|mesh-list
14854968|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854969|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14854970|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207165|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
15207166|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
15207167|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
15207168|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
15207169|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207170|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207171|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14295841|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14295842|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
14295843|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295844|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295845|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708131|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708132|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
14708133|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708134|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15207172|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708135|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
14708136|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
14708137|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708138|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708139|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14708140|NCT00425724|Protective Agents|protective agents|mesh-ancestor
14708141|NCT00425841|Gemcitabine|gemcitabine|mesh-list
14708142|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
14708143|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708144|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
14708145|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708146|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708147|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
14708148|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708149|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708150|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708151|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
14708152|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708153|NCT00425906|Nicotine|nicotine|mesh-list
14708154|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14854971|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14854972|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14854973|NCT01050114|Oxybutynin|oxybutynin|mesh-list
14854974|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14854975|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14854976|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854977|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854978|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14854979|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14854980|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14854981|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
14854982|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14854983|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
14854984|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
14854985|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14854986|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14854987|NCT01050114|Urological Agents|urological agents|mesh-ancestor
14854988|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
14854989|NCT01050270|Ondansetron|ondansetron|mesh-list
14854990|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14854991|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
14854992|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
14854993|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14854994|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14854995|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14854996|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
14854997|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
14854998|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14854999|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
14855000|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855001|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855002|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14855003|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14855004|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855005|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14855006|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14855007|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
14855008|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855009|NCT01050270|Expectorants|expectorants|mesh-ancestor
14855010|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
14855011|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14855012|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
14855013|NCT01050270|Protective Agents|protective agents|mesh-ancestor
14855014|NCT01050270|Antidotes|antidotes|mesh-ancestor
14855015|NCT01050322|Gemcitabine|gemcitabine|mesh-list
14708155|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
14708156|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708157|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708158|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14708159|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14708160|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
14708161|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708162|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708163|NCT00425932|Rituximab|rituximab|mesh-list
14708164|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708165|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708166|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
14708167|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708168|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708169|NCT00425997|Amlodipine|amlodipine|mesh-list
14708170|NCT00425997|Valsartan|valsartan|mesh-list
14708171|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14855016|NCT01050322|Capecitabine|capecitabine|mesh-list
14855017|NCT01050322|Vinorelbine|vinorelbine|mesh-list
14855018|NCT01050322|Lapatinib|lapatinib|mesh-list
14855019|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14855020|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
14855021|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855022|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855023|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
14855024|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855025|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855026|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855027|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
14855028|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855029|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14855030|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
14855031|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
14855032|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
14855033|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14855034|NCT01050348|Atorvastatin|atorvastatin|mesh-list
14855035|NCT01050348|Calcium|calcium|mesh-list
14855036|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15207173|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15207174|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207175|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
15207176|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
15207177|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14855037|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855038|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14855039|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14855040|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
14855041|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855042|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14855043|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14855044|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855045|NCT01050374|Albendazole|albendazole|mesh-list
14855046|NCT01050374|Praziquantel|praziquantel|mesh-list
14855047|NCT01050374|Mebendazole|mebendazole|mesh-list
14855048|NCT01050374|Piperazine|piperazine|mesh-list
14855049|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
14855050|NCT01050374|DMP 777|dmp 777|mesh-list
14855051|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
14855052|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14855053|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855054|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
14855055|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14855056|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855057|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
14855058|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
14855059|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
14855060|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855061|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855062|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
14855063|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855064|NCT01050387|Vitamin D|vitamin d|mesh-list
14855065|NCT01050387|Vitamins|vitamins|mesh-ancestor
14855066|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
14855067|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855068|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14855069|NCT01050426|Leucovorin|leucovorin|mesh-list
14855070|NCT01050426|Cetuximab|cetuximab|mesh-list
14855071|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
14855072|NCT01050426|Antidotes|antidotes|mesh-ancestor
14855073|NCT01050426|Protective Agents|protective agents|mesh-ancestor
14855074|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855075|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
14855076|NCT01050426|Vitamins|vitamins|mesh-ancestor
14855077|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
14855078|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14855079|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855080|NCT01050452|Ivermectin|ivermectin|mesh-list
14855081|NCT01050452|Albendazole|albendazole|mesh-list
14855082|NCT01050452|Mebendazole|mebendazole|mesh-list
14855083|NCT01050452|Piperazine|piperazine|mesh-list
14855084|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
14855085|NCT01050452|DMP 777|dmp 777|mesh-list
14855086|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14855087|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855088|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
14855089|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
14855090|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14855091|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855092|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
14855093|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
14855094|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
14855095|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855096|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855097|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
14855098|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855099|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14855100|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14855101|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14855102|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855103|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855104|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14855105|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14855106|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14855107|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
14855108|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855109|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855110|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14855111|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14855112|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
14855113|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
14855114|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14855115|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855116|NCT01050517|Ivermectin|ivermectin|mesh-list
14855117|NCT01050517|Albendazole|albendazole|mesh-list
14855118|NCT01050517|Praziquantel|praziquantel|mesh-list
14855119|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14855120|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855121|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
14855122|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
14855123|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14855124|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855125|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
14855126|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
14855127|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
14855128|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855129|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855130|NCT01050556|Folic Acid|folic acid|mesh-list
14855131|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
14855132|NCT01050556|Hematinics|hematinics|mesh-ancestor
14855133|NCT01050556|Vitamins|vitamins|mesh-ancestor
14855134|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
14855135|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855136|NCT01050595|Naltrexone|naltrexone|mesh-list
14855137|NCT01050595|Bromides|bromides|mesh-list
14855138|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
14855139|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
14855140|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14855141|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855142|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
14855143|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855144|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14855145|NCT01050608|Ethanol|ethanol|mesh-list
14855146|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14855147|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855148|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855149|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855150|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
14855151|NCT01050621|Vitamins|vitamins|mesh-ancestor
14855152|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
14855153|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855154|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
14855155|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855156|NCT01050621|Protective Agents|protective agents|mesh-ancestor
14855157|NCT01050699|Fentanyl|fentanyl|mesh-list
14855158|NCT01050699|Midazolam|midazolam|mesh-list
14855159|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
14855160|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14855161|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855162|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855163|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855164|NCT01050699|Analgesics|analgesics|mesh-ancestor
14855165|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
14855166|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855167|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14855168|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14855169|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14855170|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
14855171|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855172|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855173|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14855174|NCT01050699|Narcotics|narcotics|mesh-ancestor
14855175|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14855176|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14855177|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
14855178|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
14855179|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14855180|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14855181|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14708172|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14708173|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14708174|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14708175|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708176|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14708177|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708178|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
14708179|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14708180|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14708181|NCT00425997|Diuretics|diuretics|mesh-ancestor
14708182|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
14708183|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14708184|NCT00426010|Caffeine|caffeine|mesh-list
14855182|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
14855183|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
14855184|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
14855185|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
14855186|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855187|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
14708185|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14708186|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295846|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14295847|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14295848|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14295849|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14295850|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14295851|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
14295852|NCT00584857|Paclitaxel|paclitaxel|mesh-list
14295853|NCT00584857|Carboplatin|carboplatin|mesh-list
14295854|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295855|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295856|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295857|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
14855188|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855189|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855190|NCT01050777|Paromomycin|paromomycin|mesh-list
14855191|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14855192|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14295858|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295859|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295860|NCT00584870|Naproxen|naproxen|mesh-list
14295861|NCT00584870|Tanezumab|tanezumab|mesh-list
14708187|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14855193|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855194|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855195|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14855196|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14855197|NCT01050842|Bicalutamide|bicalutamide|mesh-list
14855198|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
14855199|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
14855200|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855201|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855202|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855203|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14855204|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14855205|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14855206|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14855207|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
14855208|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
14855209|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855210|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
14855211|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855212|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855213|NCT01050985|Sirolimus|sirolimus|mesh-list
14855214|NCT01050985|Capecitabine|capecitabine|mesh-list
14855215|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14855216|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
14855217|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855218|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855219|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14855220|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855221|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14855222|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
14855223|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855224|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
14708188|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708189|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708190|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14708191|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14708192|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
14708193|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708194|NCT00426023|Ketotifen|ketotifen|mesh-list
14708195|NCT00426023|Cyclosporine|cyclosporine|mesh-list
14708196|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14708197|NCT00426023|Cyclosporins|cyclosporins|mesh-list
14708198|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708199|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708200|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855225|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708201|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
14855226|NCT01051011|Metformin|metformin|mesh-list
14295862|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295863|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15207178|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15207179|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207180|NCT03716388|Mesalamine|mesalamine|mesh-list
15207181|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15207182|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15207183|NCT03716388|Analgesics|analgesics|mesh-ancestor
15207184|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
14295864|NCT00584870|Analgesics|analgesics|mesh-ancestor
14295865|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
14855227|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
14855228|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14855229|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855230|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295866|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708202|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708203|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
14708204|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708205|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
14708206|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708207|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14855231|NCT01051011|Incretins|incretins|mesh-ancestor
14855232|NCT01051011|Hormones|hormones|mesh-ancestor
14855233|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855234|NCT01051102|Insulin|insulin|mesh-list
14855235|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14855236|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
14855237|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
14855238|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14855239|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
14855240|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14855241|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855242|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855243|NCT01051115|Dasatinib|dasatinib|mesh-list
14855244|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855245|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14855246|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855247|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855248|NCT01051167|Cetuximab|cetuximab|mesh-list
14708208|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14708209|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
14708210|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14708211|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
14708212|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
14708213|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708214|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14708215|NCT00426049|Everolimus|everolimus|mesh-list
14708216|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708217|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708218|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
14708219|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708220|NCT00426101|Cyclosporine|cyclosporine|mesh-list
14708221|NCT00426101|Dexamethasone|dexamethasone|mesh-list
14708222|NCT00426101|Etoposide|etoposide|mesh-list
14708223|NCT00426101|Cyclosporins|cyclosporins|mesh-list
14708224|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708225|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
14295867|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708226|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
14708227|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913214|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
14855249|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14855250|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855251|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
14855252|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
14855253|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14855254|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14855255|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14855256|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855257|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14855258|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14855259|NCT01051219|Losartan|losartan|mesh-list
14855260|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14855261|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14855262|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14708228|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708229|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708230|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
14708231|NCT00426101|Hormones|hormones|mesh-ancestor
14708232|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708233|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14708234|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708235|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14708236|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14708237|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14708238|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708239|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855263|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14855264|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855265|NCT01051271|Midazolam|midazolam|mesh-list
14855266|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14855267|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14855268|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855269|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207185|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708240|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708241|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
14708242|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
14708243|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855270|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14855271|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14855272|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14855273|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14855274|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
14855275|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
14855276|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
14855277|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
14855278|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855279|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855280|NCT01051284|Gemcitabine|gemcitabine|mesh-list
14855281|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14855282|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
14855283|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855284|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855285|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
14855286|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855287|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855288|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855289|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
15207186|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207187|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708244|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14708245|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708246|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14708247|NCT00426140|Epothilone B|epothilone b|mesh-list
14855290|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855291|NCT01051362|Carboplatin|carboplatin|mesh-list
15207188|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207189|NCT03716115|Budesonide|budesonide|mesh-list
15207190|NCT03716115|Teduglutide|teduglutide|mesh-list
15207191|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207192|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15207193|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
15207194|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855292|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855293|NCT01051388|Rabeprazole|rabeprazole|mesh-list
14855294|NCT01051388|Gefarnate|gefarnate|mesh-list
14855295|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14855296|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14855297|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14855298|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855299|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207195|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207196|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15207197|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
15207198|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
15207199|NCT03716115|Hormones|hormones|mesh-ancestor
15207200|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207201|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207202|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15207203|NCT03716115|Protective Agents|protective agents|mesh-ancestor
14855300|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14855301|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14855302|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14855303|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
14855304|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855305|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14855306|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14855307|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855308|NCT01051427|Hemostatics|hemostatics|mesh-list
14855309|NCT01051427|Surgiflo|surgiflo|mesh-list
14855310|NCT01051427|Coagulants|coagulants|mesh-ancestor
14855311|NCT01051479|Choline|choline|mesh-list
14855312|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
14855313|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14855314|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
14855315|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855316|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14855317|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14855318|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
14913215|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913216|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913217|NCT01374308|Interferons|interferons|mesh-list
14913218|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
14913219|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
14913220|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14913221|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913222|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
14913223|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913224|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
14913225|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913226|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
14913227|NCT01374373|Hematinics|hematinics|mesh-ancestor
14913228|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
14913229|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
14913230|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
14913231|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913232|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913233|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
14913234|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913235|NCT01374581|Artesunate|artesunate|mesh-list
14913236|NCT01374581|Lumefantrine|lumefantrine|mesh-list
14913237|NCT01374581|Artemether|artemether|mesh-list
14913238|NCT01374581|Amodiaquine|amodiaquine|mesh-list
14913239|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14913240|NCT01374581|Quinine|quinine|mesh-list
14913241|NCT01374581|Clindamycin|clindamycin|mesh-list
14913242|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
14913243|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
14913244|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
15207204|NCT03715998|Ramipril|ramipril|mesh-list
14913245|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855319|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14855320|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14855321|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14855322|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855323|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855324|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14855325|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14855326|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14855327|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
14855328|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855329|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855330|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14855331|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14855332|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
14855333|NCT01051544|Factor VIII|factor viii|mesh-list
14855334|NCT01051544|Coagulants|coagulants|mesh-ancestor
14855335|NCT01051583|Bevacizumab|bevacizumab|mesh-list
14855336|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14855337|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855338|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14855339|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14855340|NCT01051583|Growth Substances|growth substances|mesh-ancestor
14855341|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855342|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
14855343|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
14855344|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14855345|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855346|NCT01051648|Triamcinolone|triamcinolone|mesh-list
14855347|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14855348|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14855349|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14855350|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855351|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
14855352|NCT01051648|Hormones|hormones|mesh-ancestor
14855353|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855354|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855355|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855356|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
14855357|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855358|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855359|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
14855360|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14855361|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14855362|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14855363|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14855364|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855365|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
14855366|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855367|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855368|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14855369|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855370|NCT01051765|Irinotecan|irinotecan|mesh-list
14855371|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855372|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14855373|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14855374|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855375|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855376|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14855377|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
14855378|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14855379|NCT01051934|Paclitaxel|paclitaxel|mesh-list
14855380|NCT01051934|Bevacizumab|bevacizumab|mesh-list
14855381|NCT01051934|Carboplatin|carboplatin|mesh-list
14855382|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14855383|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855384|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
14855385|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
14855386|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
14855387|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855388|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14855389|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14855390|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14855391|NCT01051934|Growth Substances|growth substances|mesh-ancestor
14855392|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855393|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
14855394|NCT01051947|Metoprolol|metoprolol|mesh-list
14855395|NCT01051947|Nebivolol|nebivolol|mesh-list
14855396|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14855397|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14855398|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
14855399|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
14855400|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855401|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855402|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14855403|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14855404|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14855405|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
14855406|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855407|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855408|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
14855409|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14855410|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14855411|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14855412|NCT01052025|Curcumin|curcumin|mesh-list
14855413|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855414|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855415|NCT01052025|Analgesics|analgesics|mesh-ancestor
14855416|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
14708248|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855417|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855418|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855419|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855420|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708249|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14855421|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855422|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855423|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855424|NCT01052051|Vitamin D|vitamin d|mesh-list
14855425|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
14855426|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
14855427|NCT01052051|Calcium|calcium|mesh-list
14855428|NCT01052051|Vitamins|vitamins|mesh-ancestor
14855429|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
14855430|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855431|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14855432|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14708250|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14708251|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14708252|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708253|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
14708254|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708255|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14708256|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708257|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708258|NCT00426192|Mannitol|mannitol|mesh-list
14708259|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14708260|NCT00426192|Diuretics|diuretics|mesh-ancestor
14708261|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
14708262|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728694|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728695|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728696|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14728697|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14728698|NCT00519688|Growth Substances|growth substances|mesh-ancestor
14855433|NCT01052051|Antacids|antacids|mesh-ancestor
14855434|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855435|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14855436|NCT01052129|Naproxen|naproxen|mesh-list
14855437|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855438|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855439|NCT01052129|Analgesics|analgesics|mesh-ancestor
14855440|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
14855441|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855442|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855443|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855444|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855445|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
14855446|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14855447|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855448|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855449|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
14855450|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14855451|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855452|NCT01052181|Vitamins|vitamins|mesh-ancestor
14855453|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
14855454|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14855455|NCT01052246|Clindamycin|clindamycin|mesh-list
14708263|NCT00426296|Ritonavir|ritonavir|mesh-list
14708264|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14708265|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14708266|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14708267|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
14708268|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708269|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708270|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14708271|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14708272|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
14708273|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708274|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14708275|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14708276|NCT00426348|Valsartan|valsartan|mesh-list
14708277|NCT00426348|Probucol|probucol|mesh-list
14708278|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14708279|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14855456|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
14855457|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
14855458|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14855459|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14855460|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855461|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14855462|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855463|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855464|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
14855465|NCT01052259|Gusperimus|gusperimus|mesh-list
14855466|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14855467|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855468|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855469|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855470|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855471|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
14855472|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14855473|NCT01052259|Protective Agents|protective agents|mesh-ancestor
14855474|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
14855475|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14913246|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15207205|NCT03715998|Firibastat|firibastat|mesh-list
15207206|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15207207|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
15207208|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207209|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207210|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15207211|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
15207212|NCT03715972|Acetazolamide|acetazolamide|mesh-list
15207213|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207214|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
15207215|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207216|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207217|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15207218|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
14855476|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855477|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14855478|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14855479|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855480|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855481|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855482|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14855483|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14855484|NCT01052311|Niacin|niacin|mesh-list
14855485|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14855486|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
14855487|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855488|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14855489|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14708280|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14708281|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708282|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14708283|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14708284|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
14855490|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
14855491|NCT01052311|Vitamins|vitamins|mesh-ancestor
14855492|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
14855493|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855494|NCT01052324|Remifentanil|remifentanil|mesh-list
14855495|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14708285|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14708286|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
14708287|NCT00426348|Protective Agents|protective agents|mesh-ancestor
14708288|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708289|NCT00426413|Pioglitazone|pioglitazone|mesh-list
14708290|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14708291|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855496|NCT01052324|Narcotics|narcotics|mesh-ancestor
14855497|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855498|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855499|NCT01052324|Analgesics|analgesics|mesh-ancestor
14855500|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
14855501|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855502|NCT01052337|Anesthetics|anesthetics|mesh-list
14855503|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855504|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855505|NCT01052363|Bevacizumab|bevacizumab|mesh-list
14855506|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14855507|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855508|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14855509|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14855510|NCT01052363|Growth Substances|growth substances|mesh-ancestor
14855511|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855512|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
14855513|NCT01052389|Haloperidol|haloperidol|mesh-list
14855514|NCT01052389|Olanzapine|olanzapine|mesh-list
14855515|NCT01052389|Aripiprazole|aripiprazole|mesh-list
14855516|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
14855517|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
14855518|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
14855519|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855520|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855521|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14855522|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14855523|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14855524|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708292|NCT00426439|Chloroquine|chloroquine|mesh-list
14708293|NCT00426439|Lumefantrine|lumefantrine|mesh-list
14708294|NCT00426439|Artemether|artemether|mesh-list
14708295|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14708296|NCT00426439|Amebicides|amebicides|mesh-ancestor
14855525|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14708297|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855526|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14855527|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14855528|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14855529|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855530|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855531|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
14855532|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
14855533|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
14855534|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
14855535|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14855536|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14855537|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14855538|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14855539|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14855540|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14855541|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14855542|NCT01052584|Chloroquine|chloroquine|mesh-list
14855543|NCT01052584|Lumefantrine|lumefantrine|mesh-list
14855544|NCT01052584|Artemether|artemether|mesh-list
14855545|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14855546|NCT01052584|Amebicides|amebicides|mesh-ancestor
14855547|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855548|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14855549|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855550|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
14855551|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855552|NCT01052597|Curcumin|curcumin|mesh-list
14855553|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855554|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855555|NCT01052597|Analgesics|analgesics|mesh-ancestor
14855556|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
14855557|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855558|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855559|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855560|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855561|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855562|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855563|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855564|NCT01052623|Clonidine|clonidine|mesh-list
14855565|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14855566|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14855567|NCT01052623|Estradiol|estradiol|mesh-list
14855568|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14855569|NCT01052623|Hormones|hormones|mesh-ancestor
14855570|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855571|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207219|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15207220|NCT03715972|Diuretics|diuretics|mesh-ancestor
15207221|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
15207222|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207223|NCT03715881|Prednisolone|prednisolone|mesh-list
15207224|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
15207225|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207226|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
15207227|NCT03715881|Hormones|hormones|mesh-ancestor
15207228|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207229|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207230|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15207231|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207232|NCT03715881|Hematinics|hematinics|mesh-ancestor
15207233|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15207234|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15207235|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207236|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708298|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14708299|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708300|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
14708301|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708302|NCT00426452|Vatalanib|vatalanib|mesh-list
14708303|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14708304|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708305|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855572|NCT01052623|Estrogens|estrogens|mesh-ancestor
14855573|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14708306|NCT00426478|Amlodipine|amlodipine|mesh-list
14708307|NCT00426478|Valsartan|valsartan|mesh-list
14708308|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14708309|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14708310|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14855574|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
14855575|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14855576|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14855577|NCT01052623|Analgesics|analgesics|mesh-ancestor
14855578|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
14855579|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855580|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14855581|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
14855582|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
14855583|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14855584|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14855585|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14855586|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
14855587|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855588|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855589|NCT01052792|Naproxen|naproxen|mesh-list
14855590|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855591|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855592|NCT01052792|Analgesics|analgesics|mesh-ancestor
14855593|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
14855594|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855595|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855596|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855597|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855598|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
14855599|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14855600|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855601|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855602|NCT01052870|Finasteride|finasteride|mesh-list
14855603|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14855604|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14855605|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855606|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855607|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
14855608|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855609|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855610|NCT01052870|Urological Agents|urological agents|mesh-ancestor
14855611|NCT01052896|Gabapentin|gabapentin|mesh-list
14855612|NCT01052896|Analgesics|analgesics|mesh-ancestor
14855613|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
14855614|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855615|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855616|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
14855617|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14855618|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14708311|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14708312|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855619|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708313|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14708314|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708315|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
14708316|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14728699|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
14295868|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855620|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14855621|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14855622|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14855623|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855624|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855625|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
14855626|NCT01052909|Glimepiride|glimepiride|mesh-list
14855627|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14855628|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855629|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855630|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855631|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
14855632|NCT01052961|Oseltamivir|oseltamivir|mesh-list
14855633|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
14855634|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855635|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855636|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855637|NCT01052974|Ropivacaine|ropivacaine|mesh-list
14855638|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
14855639|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
14855640|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207237|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15207238|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207239|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207240|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
15207241|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207242|NCT03715725|Warfarin|warfarin|mesh-list
15207243|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
15207244|NCT03715725|Dabigatran|dabigatran|mesh-list
15207245|NCT03715725|Apixaban|apixaban|mesh-list
15207246|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
15207247|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15207248|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
15207249|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15207250|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
15207251|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207252|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207253|NCT03715699|Prednisone|prednisone|mesh-list
15207254|NCT03715699|Leflunomide|leflunomide|mesh-list
15207255|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207256|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
15207257|NCT03715699|Hormones|hormones|mesh-ancestor
15207258|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855641|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855642|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
14855643|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855644|NCT01052987|Tranilast|tranilast|mesh-list
14855645|NCT01052987|Allopurinol|allopurinol|mesh-list
14855646|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
14855647|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855648|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855649|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
14855650|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855651|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14855652|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
15207259|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207260|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15207261|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855653|NCT01052987|Protective Agents|protective agents|mesh-ancestor
14855654|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855655|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855656|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855657|NCT01052987|Analgesics|analgesics|mesh-ancestor
14855658|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
14855659|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855660|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855661|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14855662|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14855663|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14855664|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14855665|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
14855666|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
14855667|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855668|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14855669|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14855670|NCT01053026|Olmesartan|olmesartan|mesh-list
14855671|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14855672|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14855673|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14855674|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855675|NCT01053039|Morphine|morphine|mesh-list
14855676|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14855677|NCT01053039|Narcotics|narcotics|mesh-ancestor
14855678|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855679|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855680|NCT01053039|Analgesics|analgesics|mesh-ancestor
14855681|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
14855682|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855683|NCT01053065|Atorvastatin|atorvastatin|mesh-list
14855684|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
14855685|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
15207262|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207263|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207264|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207265|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
15207266|NCT03715634|Buprenorphine|buprenorphine|mesh-list
15207267|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15207268|NCT03715634|Narcotics|narcotics|mesh-ancestor
15207269|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207270|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207271|NCT03715634|Analgesics|analgesics|mesh-ancestor
15207272|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
15207273|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207274|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15207275|NCT03715582|Trimetazidine|trimetazidine|mesh-list
15207276|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
15207277|NCT03715556|Amiodarone|amiodarone|mesh-list
15207278|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15207279|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
15207280|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15207281|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207282|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207283|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15207284|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15207285|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15207286|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207287|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15207288|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15207289|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15207290|NCT03715517|Morphine|morphine|mesh-list
15207291|NCT03715517|Hydromorphone|hydromorphone|mesh-list
15207292|NCT03715517|Bupivacaine|bupivacaine|mesh-list
15207293|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15207294|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
15207295|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
15207296|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207297|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207298|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
15207299|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855686|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14855687|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14855688|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
14855689|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855690|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14855691|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14855692|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855693|NCT01053169|Thrombin|thrombin|mesh-list
14855694|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
14855695|NCT01053169|Coagulants|coagulants|mesh-ancestor
14855696|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
14855697|NCT01053208|Promethazine|promethazine|mesh-list
14855698|NCT01053208|Ibuprofen|ibuprofen|mesh-list
14855699|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855700|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855701|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855702|NCT01053208|Analgesics|analgesics|mesh-ancestor
15207300|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15207301|NCT03715517|Narcotics|narcotics|mesh-ancestor
14855703|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
14855704|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855705|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855706|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855707|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855708|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14855709|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855710|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14855711|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14855712|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855713|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
14855714|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
14855715|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
14855716|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
14855717|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207302|NCT03715517|Analgesics|analgesics|mesh-ancestor
15207303|NCT03715478|Dexamethasone|dexamethasone|mesh-list
15207304|NCT03715478|Pomalidomide|pomalidomide|mesh-list
14855718|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15207305|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207306|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
15207307|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
15207308|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855719|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
14855720|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
14855721|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207309|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855722|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14855723|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
14855724|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
14855725|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14855726|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
14855727|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14855728|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14855729|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855730|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14855731|NCT01053325|Renal Agents|renal agents|mesh-ancestor
14855732|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14855733|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
14855734|NCT01053338|Promethazine|promethazine|mesh-list
14855735|NCT01053338|Ibuprofen|ibuprofen|mesh-list
14855736|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855737|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855738|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855739|NCT01053338|Analgesics|analgesics|mesh-ancestor
14855740|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
14855741|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855742|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855743|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855744|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855745|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14855746|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855747|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14855748|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14855749|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855750|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
14855751|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
14855752|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
14855753|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
14855754|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14855755|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14855756|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
14855757|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
14855758|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855759|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14855760|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
14855761|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
14913247|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913248|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913249|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
14913250|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
14913251|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14913252|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
14913253|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14913254|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14913255|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913256|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913257|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14913258|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913259|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14913260|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913261|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14913262|NCT01374581|Analgesics|analgesics|mesh-ancestor
14913263|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
14913264|NCT01374620|Paclitaxel|paclitaxel|mesh-list
14913265|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14913266|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
14913267|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14913268|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913269|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
14913270|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
14913271|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
14913272|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913273|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913274|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
14913275|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913276|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913277|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14913278|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
14855762|NCT01053377|Oseltamivir|oseltamivir|mesh-list
14855763|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
14855764|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855765|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855766|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855767|NCT01053390|Leucovorin|leucovorin|mesh-list
14855768|NCT01053390|Fluorouracil|fluorouracil|mesh-list
14855769|NCT01053390|Epirubicin|epirubicin|mesh-list
15207310|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207311|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
15207312|NCT03715478|Hormones|hormones|mesh-ancestor
14855770|NCT01053390|Somatostatin|somatostatin|mesh-list
14855771|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855772|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
14855773|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855774|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14855775|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855776|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
14855777|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855778|NCT01053390|Antidotes|antidotes|mesh-ancestor
14855779|NCT01053390|Protective Agents|protective agents|mesh-ancestor
14855780|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
14855781|NCT01053390|Vitamins|vitamins|mesh-ancestor
14855782|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
14855783|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14855784|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14855785|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14855786|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855787|NCT01053390|Hormones|hormones|mesh-ancestor
14855788|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855789|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14855790|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
14855791|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855792|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14855793|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
14855794|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855795|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855796|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14855797|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14855798|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14855799|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
14855800|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
14855801|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14855802|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
14855803|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
14855804|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855805|NCT01053481|Vitamin D|vitamin d|mesh-list
14855806|NCT01053481|Vitamins|vitamins|mesh-ancestor
14855807|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
14855808|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855809|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14855810|NCT01053520|Navitoclax|navitoclax|mesh-list
14855811|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855812|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
14855813|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708317|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14708318|NCT00426478|Diuretics|diuretics|mesh-ancestor
14708319|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
14708320|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14708321|NCT00426491|Misoprostol|misoprostol|mesh-list
14708322|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14708323|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
14708324|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14708325|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708326|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14708327|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14855814|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
15207313|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207314|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15207315|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207316|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
15207317|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15207318|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15207319|NCT03715478|Growth Substances|growth substances|mesh-ancestor
15207320|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
15207321|NCT03715413|Tamoxifen|tamoxifen|mesh-list
15207322|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15207323|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
15207324|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207325|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207326|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15207327|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207328|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15207329|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15207330|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15207331|NCT03715387|Bacitracin|bacitracin|mesh-list
15207332|NCT03715387|Polymyxin B|polymyxin b|mesh-list
15207333|NCT03715387|Tacrolimus|tacrolimus|mesh-list
15207334|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207335|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
14855815|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855816|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855817|NCT01053585|Baclofen|baclofen|mesh-list
14855818|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14855819|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855820|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14855821|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855822|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14855823|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
14855824|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
14855825|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855826|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855827|NCT01053611|Remifentanil|remifentanil|mesh-list
14855828|NCT01053611|Propofol|propofol|mesh-list
14855829|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14855830|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855831|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855832|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14855833|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
14855834|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
14855835|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14855836|NCT01053611|Narcotics|narcotics|mesh-ancestor
14855837|NCT01053611|Analgesics|analgesics|mesh-ancestor
14855838|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
14855839|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855840|NCT01053637|Acetaminophen|acetaminophen|mesh-list
14855841|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14855842|NCT01053637|Hydrocodone|hydrocodone|mesh-list
14855843|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14855844|NCT01053637|Analgesics|analgesics|mesh-ancestor
14855845|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
14855846|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855847|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855848|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
14855849|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14855850|NCT01053637|Narcotics|narcotics|mesh-ancestor
14855851|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855852|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
14855853|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
14855854|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14855855|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855856|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14855857|NCT01053650|Acetaminophen|acetaminophen|mesh-list
14855858|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15207336|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207337|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15207338|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207339|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207340|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15207341|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207342|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207343|NCT03715348|Thrombin|thrombin|mesh-list
14855859|NCT01053650|Analgesics|analgesics|mesh-ancestor
15207344|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
15207345|NCT03715348|Coagulants|coagulants|mesh-ancestor
15207346|NCT03715322|Tobramycin|tobramycin|mesh-list
15207347|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207348|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855860|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
15207349|NCT03715309|Lenalidomide|lenalidomide|mesh-list
14855861|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708328|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
14708329|NCT00426530|Everolimus|everolimus|mesh-list
14708330|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708331|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708332|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
14708333|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708334|NCT00426543|Rituximab|rituximab|mesh-list
14708335|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708336|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708337|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
14708338|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708339|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708340|NCT00426582|Epothilone B|epothilone b|mesh-list
14708341|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708342|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14708343|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14708344|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14708345|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708346|NCT00426595|Omeprazole|omeprazole|mesh-list
14708347|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14708348|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708349|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14708350|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708351|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708352|NCT00426608|Alprazolam|alprazolam|mesh-list
14708353|NCT00426608|Metyrapone|metyrapone|mesh-list
14708354|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14708355|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708356|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708357|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14708358|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14708359|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14708360|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
14708361|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
14708362|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708363|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708364|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
14708365|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708366|NCT00426621|Diclofenac|diclofenac|mesh-list
14708367|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14708368|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708369|NCT00426621|Analgesics|analgesics|mesh-ancestor
14708370|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
14708371|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708372|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708373|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708374|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708375|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14708376|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708377|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855862|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855863|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
14855864|NCT01053689|Glimepiride|glimepiride|mesh-list
14855865|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14855866|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855867|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855868|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855869|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
14855870|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
14855871|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855872|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855873|NCT01053806|Lenalidomide|lenalidomide|mesh-list
14855874|NCT01053806|Azacitidine|azacitidine|mesh-list
14855875|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
14855876|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855877|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14855878|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14855879|NCT01053806|Growth Substances|growth substances|mesh-ancestor
14855880|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
14855881|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855882|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708378|NCT00426647|Buprenorphine|buprenorphine|mesh-list
14708379|NCT00426647|Tramadol|tramadol|mesh-list
14708380|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14708381|NCT00426647|Narcotics|narcotics|mesh-ancestor
14855883|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
14855884|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855885|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855886|NCT01053871|Fentanyl|fentanyl|mesh-list
14855887|NCT01053871|Midazolam|midazolam|mesh-list
14855888|NCT01053871|Propofol|propofol|mesh-list
14855889|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14855890|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14855891|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855892|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14855893|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
14855894|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
14855895|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14855896|NCT01053871|Narcotics|narcotics|mesh-ancestor
14855897|NCT01053871|Analgesics|analgesics|mesh-ancestor
14708382|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708383|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708384|NCT00426647|Analgesics|analgesics|mesh-ancestor
14708385|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
14708386|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708387|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14708388|NCT00426673|Brivaracetam|brivaracetam|mesh-list
14708389|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
14708390|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
14708391|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14708392|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
14855898|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
14855899|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855900|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14855901|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14855902|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14855903|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14855904|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
14855905|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
14855906|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855907|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855908|NCT01053884|Anidulafungin|anidulafungin|mesh-list
14855909|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
14855910|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855911|NCT01053910|Ramipril|ramipril|mesh-list
14855912|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14855913|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
14855914|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855915|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855916|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14855917|NCT01053949|Thalidomide|thalidomide|mesh-list
14855918|NCT01053949|Pomalidomide|pomalidomide|mesh-list
14855919|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
14855920|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855921|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14855922|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14855923|NCT01053949|Growth Substances|growth substances|mesh-ancestor
14855924|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
14855925|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855926|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855927|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
14855928|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14855929|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855930|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
14855931|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
14855932|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14855933|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14855934|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855935|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855936|NCT01054001|Urological Agents|urological agents|mesh-ancestor
14855937|NCT01054027|Phenylephrine|phenylephrine|mesh-list
14855938|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
14855939|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
14855940|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14855941|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
14855942|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
14855943|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14855944|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855945|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
14855946|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14855947|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
14855948|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
14855949|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14855950|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14855951|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14855952|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
14855953|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14855954|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855955|NCT01054027|Protective Agents|protective agents|mesh-ancestor
14855956|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
14855957|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14855958|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14855959|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
14855960|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
14855961|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14855962|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855963|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855964|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855965|NCT01054105|Iloprost|iloprost|mesh-list
14855966|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14855967|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
14855968|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14855969|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14855970|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855971|NCT01054118|Incretins|incretins|mesh-ancestor
14855972|NCT01054118|Hormones|hormones|mesh-ancestor
14855973|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855974|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15207350|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
15207351|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207352|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15207353|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15207354|NCT03715309|Growth Substances|growth substances|mesh-ancestor
15207355|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
15207356|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207357|NCT03715296|Lenalidomide|lenalidomide|mesh-list
15207358|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
15207359|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207360|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15207361|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15207362|NCT03715296|Growth Substances|growth substances|mesh-ancestor
15207363|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
15207364|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207365|NCT03715244|Anesthetics|anesthetics|mesh-list
15207366|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
15207367|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207368|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855975|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
14855976|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14855977|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207369|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
14708393|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708394|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
14708395|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
14708396|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14708397|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14708398|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708399|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14708400|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855978|NCT01054313|Sirolimus|sirolimus|mesh-list
14855979|NCT01054313|Prednisone|prednisone|mesh-list
14855980|NCT01054313|Docetaxel|docetaxel|mesh-list
14855981|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14855982|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
14855983|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
14855984|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
14855985|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14855986|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14855987|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
14855988|NCT01054313|Hormones|hormones|mesh-ancestor
14855989|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14855990|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14855991|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14855992|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14855993|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14855994|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14855995|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
14855996|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14855997|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
14855998|NCT01054469|Ropivacaine|ropivacaine|mesh-list
14855999|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
14856000|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
14856001|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856002|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856003|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
14856004|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856005|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
14856006|NCT01054508|Niacin|niacin|mesh-list
14856007|NCT01054508|Niacinamide|niacinamide|mesh-list
14856008|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
14856009|NCT01054508|Vitamins|vitamins|mesh-ancestor
14856010|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
14856011|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856012|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14856013|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
14856014|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856015|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14856016|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
14856017|NCT01054547|Anesthetics|anesthetics|mesh-list
14856018|NCT01054547|Ropivacaine|ropivacaine|mesh-list
14856019|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856020|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856021|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
15207370|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207371|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
15207372|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15207373|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207374|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15207375|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15207376|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15207377|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
15207378|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856022|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
14856023|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856024|NCT01054651|Artesunate|artesunate|mesh-list
14856025|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
14856026|NCT01054651|Sulfalene|sulfalene|mesh-list
14856027|NCT01054651|Praziquantel|praziquantel|mesh-list
14856028|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
14856029|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14856030|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14856031|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856032|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856033|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
14856034|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
14856035|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14856036|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
14856037|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14856038|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856039|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856040|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14856041|NCT01054651|Renal Agents|renal agents|mesh-ancestor
14856042|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14856043|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856044|NCT01054781|Rituximab|rituximab|mesh-list
14856045|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14856046|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856047|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
14856048|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856049|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856050|NCT01054872|Vaccines|vaccines|mesh-list
14856051|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
14856052|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856053|NCT01055041|Budesonide|budesonide|mesh-list
14856054|NCT01055041|Doxofylline|doxofylline|mesh-list
14856055|NCT01055041|Montelukast|montelukast|mesh-list
14856056|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856057|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14856058|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
14856059|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856060|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856061|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14856062|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
14856063|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
15207379|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15207380|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15207381|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224893|NCT02073097|Sargramostim|sargramostim|mesh-list
15224894|NCT02073097|Lenograstim|lenograstim|mesh-list
15224895|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224896|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
15224897|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224898|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15224899|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15224900|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
15224901|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224902|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224903|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15224904|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15224905|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15224906|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15224907|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15207382|NCT03715023|PC-786|pc-786|mesh-list
15207383|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
15207384|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207385|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207386|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207387|NCT03714958|Trametinib|trametinib|mesh-list
14856064|NCT01055041|Hormones|hormones|mesh-ancestor
14856065|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856066|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14856067|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
14856068|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14856069|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14856070|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856071|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
14856072|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14856073|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856074|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
14856075|NCT01055145|Levofloxacin|levofloxacin|mesh-list
14856076|NCT01055145|Ofloxacin|ofloxacin|mesh-list
14856077|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14856078|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856079|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14856080|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14856081|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856082|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856083|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856084|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14856085|NCT01055145|Renal Agents|renal agents|mesh-ancestor
14856086|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14856087|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14708401|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14708402|NCT00426829|Bevacizumab|bevacizumab|mesh-list
14708403|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708404|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708405|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14708406|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14708407|NCT00426829|Growth Substances|growth substances|mesh-ancestor
14708408|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856088|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
14856089|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
14856090|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14856091|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15207388|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708409|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
14708410|NCT00426920|Insulin|insulin|mesh-list
14708411|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14708412|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708413|NCT00426933|Vancomycin|vancomycin|mesh-list
14708414|NCT00426933|Daptomycin|daptomycin|mesh-list
14708415|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14708416|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708417|NCT00426946|Reboxetine|reboxetine|mesh-list
14708418|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
14708419|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14708420|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14708421|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15207389|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15207390|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207391|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207392|NCT03714880|Mifepristone|mifepristone|mesh-list
15207393|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14856092|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
14856093|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
14856094|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856095|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856096|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856097|NCT01055249|Ibuprofen|ibuprofen|mesh-list
14856098|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
14856099|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14856100|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14856101|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14856102|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856103|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856104|NCT01055249|Analgesics|analgesics|mesh-ancestor
14856105|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
14856106|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856107|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856108|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856109|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856110|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14856111|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856112|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913279|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14913280|NCT01374633|Sevoflurane|sevoflurane|mesh-list
14913281|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14913282|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14913283|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
14913284|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
14913285|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913286|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917258|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14917259|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917260|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14917261|NCT01397175|Everolimus|everolimus|mesh-list
14917262|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917263|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917264|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
14917265|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917266|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
14917267|NCT01397214|Megestrol|megestrol|mesh-list
14917268|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14917269|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917270|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
14917271|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14917272|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917273|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14917274|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14917275|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14917276|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
14917277|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14917278|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14917279|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14917596|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14917597|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917598|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
14917599|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917600|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917601|NCT04920981|Atezolizumab|atezolizumab|mesh-list
14917602|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917603|NCT04893096|Felzartamab|felzartamab|mesh-list
14708422|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14708423|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708424|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
14708425|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708426|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708427|NCT00426972|Estradiol|estradiol|mesh-list
14708428|NCT00426972|Estrogens|estrogens|mesh-ancestor
14708429|NCT00426972|Hormones|hormones|mesh-ancestor
14708430|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708431|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708432|NCT00426985|Ketoprofen|ketoprofen|mesh-list
14708433|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856113|NCT01055301|Thalidomide|thalidomide|mesh-list
14856114|NCT01055301|Dexamethasone|dexamethasone|mesh-list
14856115|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
14856116|NCT01055301|Melphalan|melphalan|mesh-list
14856117|NCT01055301|Doxorubicin|doxorubicin|mesh-list
14856118|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14856119|NCT01055301|Etoposide|etoposide|mesh-list
14708434|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708435|NCT00426985|Analgesics|analgesics|mesh-ancestor
14708436|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
14708437|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708438|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856120|NCT01055301|Lenalidomide|lenalidomide|mesh-list
14856121|NCT01055301|Bortezomib|bortezomib|mesh-list
14708439|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708440|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708441|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14708442|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708443|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856122|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856123|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
14856124|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856125|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856126|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14856127|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
14856128|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856129|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856130|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14856131|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856132|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
14856133|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
14856134|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856135|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14856136|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
14856137|NCT01055301|Hormones|hormones|mesh-ancestor
14856138|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856139|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14856140|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14856141|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14708444|NCT00426998|Bevacizumab|bevacizumab|mesh-list
14856142|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14856143|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856144|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14856145|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14856146|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14856147|NCT01055301|Growth Substances|growth substances|mesh-ancestor
14856148|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
14856149|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
14856150|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14708445|NCT00426998|Verteporfin|verteporfin|mesh-list
14856151|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856152|NCT01055327|Lamotrigine|lamotrigine|mesh-list
14856153|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
14856154|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14856155|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14856156|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856157|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14856158|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856159|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14856160|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14708446|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708447|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708448|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14708449|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14708450|NCT00426998|Growth Substances|growth substances|mesh-ancestor
14708451|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708452|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
14708453|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14708454|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
14856161|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856162|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856163|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14856164|NCT01055379|Rasagiline|rasagiline|mesh-list
14856165|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14856166|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856167|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856168|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14856169|NCT01055379|Protective Agents|protective agents|mesh-ancestor
14856170|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856171|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
14856172|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
14856173|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856174|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856175|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856176|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
14856177|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14856178|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856179|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856180|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
14856181|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
14856182|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14856183|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14856184|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856185|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856186|NCT01055405|Urological Agents|urological agents|mesh-ancestor
14856187|NCT01055418|Ascorbic Acid|ascorbic acid|mesh-list
14856188|NCT01055418|Vitamins|vitamins|mesh-ancestor
14856189|NCT01055418|Micronutrients|micronutrients|mesh-ancestor
14856190|NCT01055418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856191|NCT01055418|Antioxidants|antioxidants|mesh-ancestor
14856192|NCT01055418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856193|NCT01055418|Protective Agents|protective agents|mesh-ancestor
14856194|NCT01055431|Iron|iron|mesh-list
14856195|NCT01055431|Trace Elements|trace elements|mesh-ancestor
14856196|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
14856197|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856198|NCT01055470|Diclofenac|diclofenac|mesh-list
14856199|NCT01055470|Lornoxicam|lornoxicam|mesh-list
14856200|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856201|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856202|NCT01055470|Analgesics|analgesics|mesh-ancestor
14856203|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
14856204|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856205|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856206|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856207|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856208|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14856209|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856210|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856211|NCT01055483|Panobinostat|panobinostat|mesh-list
14856212|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856213|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14856214|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856215|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856216|NCT01055522|Interleukin-2|interleukin-2|mesh-list
14856217|NCT01055522|Dacarbazine|dacarbazine|mesh-list
14856218|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856219|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856220|NCT01055522|Analgesics|analgesics|mesh-ancestor
14856221|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
14856222|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856223|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856224|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14856225|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
14856226|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856227|NCT01055535|Plasminogen|plasminogen|mesh-list
14856228|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14856229|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15207394|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
15207395|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15207396|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207397|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15207398|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14856230|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856231|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
14856232|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14856233|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856234|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14856235|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856236|NCT01055691|Metformin|metformin|mesh-list
14856237|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
14856238|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14856239|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856240|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14856241|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856242|NCT01055743|Fluorouracil|fluorouracil|mesh-list
14856243|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
14856244|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856245|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14856246|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856247|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856248|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
14856249|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856250|NCT01055756|Loratadine|loratadine|mesh-list
14856251|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
14856252|NCT01055756|Ephedrine|ephedrine|mesh-list
14856253|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
14856254|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14856255|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14856256|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14856257|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14856258|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
14856259|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
14856260|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856261|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856262|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856263|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14856264|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
14856265|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856266|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15207399|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15207400|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
15207401|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15207402|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15207403|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
15224908|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856267|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
14856268|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
14856269|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14856270|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14856271|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
14856272|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
14856273|NCT01055795|Bevacizumab|bevacizumab|mesh-list
14856274|NCT01055795|Everolimus|everolimus|mesh-list
14856275|NCT01055795|Panobinostat|panobinostat|mesh-list
14856276|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14856277|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856278|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14856279|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14856280|NCT01055795|Growth Substances|growth substances|mesh-ancestor
14856281|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856282|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14856283|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856284|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
14856285|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14856286|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856287|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856288|NCT01055808|Insulin|insulin|mesh-list
14856289|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14708455|NCT00427076|Vancomycin|vancomycin|mesh-list
14708456|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14856290|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856291|NCT01055821|Interferons|interferons|mesh-list
15207404|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207405|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
15207406|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15207407|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15207408|NCT03714867|Pregabalin|pregabalin|mesh-list
15207409|NCT03714867|Analgesics|analgesics|mesh-ancestor
15207410|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
15207411|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856292|NCT01055821|Ribavirin|ribavirin|mesh-list
14856293|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856294|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
14856295|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856296|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
14856297|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856298|NCT01055847|Aztreonam|aztreonam|mesh-list
14856299|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14856300|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856301|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14856302|NCT01055925|Laxatives|laxatives|mesh-ancestor
14856303|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14856304|NCT01055938|Valproic Acid|valproic acid|mesh-list
14856305|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
14856306|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856307|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856308|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
14856309|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856310|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856311|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
15207412|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708457|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14708458|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708459|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14708460|NCT00427076|Renal Agents|renal agents|mesh-ancestor
14708461|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
14708462|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14708463|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14708464|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
14708465|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14708466|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
14708467|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708468|NCT00427089|Protective Agents|protective agents|mesh-ancestor
14708469|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708470|NCT00427089|Vitamins|vitamins|mesh-ancestor
14856312|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14856313|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856314|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856315|NCT01055964|Tacrolimus|tacrolimus|mesh-list
14856316|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856317|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
14856318|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708471|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
14708472|NCT00427089|Laxatives|laxatives|mesh-ancestor
14708473|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14856319|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14856320|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856321|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856322|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14856323|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14856324|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
14856325|NCT01056042|Gestodene|gestodene|mesh-list
14856326|NCT01056042|Estradiol|estradiol|mesh-list
14856327|NCT01056042|Estrogens|estrogens|mesh-ancestor
14856328|NCT01056042|Hormones|hormones|mesh-ancestor
14856329|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856330|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856331|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14856332|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
14856333|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14856334|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14856335|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14856336|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14856337|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14856338|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14856339|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14856340|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856341|NCT01056042|Progestins|progestins|mesh-ancestor
14856342|NCT01056172|Ribavirin|ribavirin|mesh-list
14856343|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14856344|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
14856345|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
14856346|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856347|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
14856348|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856349|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
14856350|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708474|NCT00427102|Cisplatin|cisplatin|mesh-list
14708475|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856351|NCT01056224|Remifentanil|remifentanil|mesh-list
14856352|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14856353|NCT01056224|Narcotics|narcotics|mesh-ancestor
14856354|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856355|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856356|NCT01056224|Analgesics|analgesics|mesh-ancestor
14856357|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
15207413|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
15207414|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15207415|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207416|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207417|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15207418|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15207419|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14708476|NCT00427128|Fluoxetine|fluoxetine|mesh-list
14708477|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14708478|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14708479|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14708480|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856358|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856359|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
14856360|NCT01056237|Azathioprine|azathioprine|mesh-list
14856361|NCT01056237|Tacrolimus|tacrolimus|mesh-list
14708481|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708482|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
14708483|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708484|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14708485|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
14708486|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856362|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856363|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
14856364|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856365|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14856366|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856367|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856368|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14856369|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856370|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14856371|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
14856372|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14856373|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856374|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
14856375|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14856376|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856377|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
14856378|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
14856379|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708487|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14708488|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14708489|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708490|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14708491|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14708492|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
14708493|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708494|NCT00427167|Antacids|antacids|mesh-ancestor
14708495|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708496|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708497|NCT00427206|Acetaminophen|acetaminophen|mesh-list
14708498|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708499|NCT00427206|Analgesics|analgesics|mesh-ancestor
14708500|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
14856380|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
14856381|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
14856382|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856383|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856384|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
14856385|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
14856386|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856387|NCT01056497|Protective Agents|protective agents|mesh-ancestor
14913287|NCT01374698|Aspirin|aspirin|mesh-list
15207420|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207421|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15207422|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
15207423|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15207424|NCT03714737|Vaccines|vaccines|mesh-list
15207425|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
15207426|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207427|NCT03714685|Firibastat|firibastat|mesh-list
15207428|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15207429|NCT03714620|Ketamine|ketamine|mesh-list
15207430|NCT03714620|Analgesics|analgesics|mesh-ancestor
15207431|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
15207432|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207433|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207434|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15207435|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15207436|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
15207437|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
15207438|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207439|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15207440|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15207441|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207442|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207443|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
15207444|NCT03714594|Saxagliptin|saxagliptin|mesh-list
14856388|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856389|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
14856390|NCT01056497|Vitamins|vitamins|mesh-ancestor
14856391|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
14856392|NCT01056549|Exenatide|exenatide|mesh-list
14856393|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14856394|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856395|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14856396|NCT01056549|Incretins|incretins|mesh-ancestor
14856397|NCT01056549|Hormones|hormones|mesh-ancestor
14856398|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856399|NCT01056614|Methotrexate|methotrexate|mesh-list
14856400|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
14856401|NCT01056614|Fludarabine|fludarabine|mesh-list
14856402|NCT01056614|Busulfan|busulfan|mesh-list
14856403|NCT01056614|Tacrolimus|tacrolimus|mesh-list
14856404|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
14856405|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14856406|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
14856407|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14856408|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
14856409|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14856410|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856411|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14856412|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
14856413|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856414|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856415|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
14856416|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856417|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14856418|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856419|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
14856420|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856421|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14856422|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14856423|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
14856424|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14856425|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14856426|NCT01056627|Valproic Acid|valproic acid|mesh-list
14856427|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
14856428|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856429|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856430|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
14856431|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856432|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856433|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
14856434|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14856435|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856436|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856437|NCT01056679|Doxorubicin|doxorubicin|mesh-list
14856438|NCT01056679|Lenalidomide|lenalidomide|mesh-list
14856439|NCT01056679|Vinblastine|vinblastine|mesh-list
14856440|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14856441|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856442|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14856443|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14856444|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917280|NCT01397305|Pemetrexed|pemetrexed|mesh-list
14856445|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856446|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
14856447|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856448|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14856449|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14856450|NCT01056679|Growth Substances|growth substances|mesh-ancestor
14856451|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
14856452|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14856453|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
14856454|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
14856455|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
14856456|NCT01056705|Vaccines|vaccines|mesh-list
14856457|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
14856458|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856459|NCT01056757|Ribavirin|ribavirin|mesh-list
14856460|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
14856461|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856462|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
14856463|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856464|NCT01056835|Epoprostenol|epoprostenol|mesh-list
14856465|NCT01056835|Tezosentan|tezosentan|mesh-list
14856466|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14856467|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14856468|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
14856469|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
14856470|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14856471|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14856472|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14856473|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14856474|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856475|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
14856476|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856477|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856478|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14856479|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856480|NCT01056874|Maraviroc|maraviroc|mesh-list
14856481|NCT01056874|Digoxin|digoxin|mesh-list
14856482|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14856483|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14856484|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856485|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14856486|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14856487|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
14856488|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856489|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14856490|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14856491|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14856492|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856493|NCT01056874|Protective Agents|protective agents|mesh-ancestor
14856494|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856495|NCT01056926|Nicotine|nicotine|mesh-list
14856496|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14856497|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
14856498|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856499|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856500|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14856501|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14856502|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
14856503|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856504|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856505|NCT01057069|Paclitaxel|paclitaxel|mesh-list
14856506|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14856507|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
14856508|NCT01057069|Carboplatin|carboplatin|mesh-list
14856509|NCT01057069|Doxorubicin|doxorubicin|mesh-list
14856510|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14856511|NCT01057069|Thiotepa|thiotepa|mesh-list
14856512|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14856513|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856514|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14856515|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14856516|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14856517|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856518|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856519|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
14856520|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856521|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856522|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14856523|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
14856524|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14856525|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14856526|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14856527|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14856528|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913288|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14913289|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14913290|NCT01374698|Analgesics|analgesics|mesh-ancestor
14913291|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
14913292|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913293|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913294|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913295|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207445|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15207446|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207447|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207448|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207449|NCT03714594|Incretins|incretins|mesh-ancestor
15207450|NCT03714594|Hormones|hormones|mesh-ancestor
15207451|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207452|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15207453|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
15207454|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207455|NCT03714555|Copper|copper|mesh-list
15207456|NCT03714555|Gemcitabine|gemcitabine|mesh-list
15207457|NCT03714555|Paclitaxel|paclitaxel|mesh-list
15207458|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15207459|NCT03714555|Folfirinox|folfirinox|mesh-list
15207460|NCT03714555|Disulfiram|disulfiram|mesh-list
15207461|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15207462|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207463|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
15207464|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
15207465|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
14856529|NCT01057160|Rizatriptan|rizatriptan|mesh-list
14856530|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14856531|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
14856532|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856533|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856534|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856535|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
14856536|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14856537|NCT01057186|Sevelamer|sevelamer|mesh-list
14856538|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
14856539|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
14856540|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856541|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14856542|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856543|NCT01057186|Vitamins|vitamins|mesh-ancestor
14856544|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
14856545|NCT01057212|Bevacizumab|bevacizumab|mesh-list
14856546|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14856547|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856548|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14856549|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14856550|NCT01057212|Growth Substances|growth substances|mesh-ancestor
14856551|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856552|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
14856553|NCT01057264|Gemcitabine|gemcitabine|mesh-list
14856554|NCT01057264|Paclitaxel|paclitaxel|mesh-list
14856555|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14856556|NCT01057264|Bevacizumab|bevacizumab|mesh-list
14856557|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14856558|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856559|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
14856560|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
14856561|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
14856562|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856563|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14856564|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14856565|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14856566|NCT01057264|Growth Substances|growth substances|mesh-ancestor
14856567|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856568|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
14856569|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14856570|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
14856571|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
14856572|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856573|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856574|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856575|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
14856576|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14856577|NCT01057329|Olanzapine|olanzapine|mesh-list
14856578|NCT01057329|Aripiprazole|aripiprazole|mesh-list
14856579|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14856580|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
14856581|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
14856582|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856583|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856584|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14856585|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14856586|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14856587|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856588|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856589|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14856590|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14856591|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14856592|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856593|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856594|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
14856595|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
14856596|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
14856597|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
14856598|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14856599|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14856600|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14856601|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14856602|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14856603|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14856604|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14856605|NCT01057329|Analgesics|analgesics|mesh-ancestor
14856606|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
14856607|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14856608|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
14856609|NCT01057342|Paclitaxel|paclitaxel|mesh-list
15207466|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207467|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14856610|NCT01057342|Carboplatin|carboplatin|mesh-list
14856611|NCT01057342|Vadimezan|vadimezan|mesh-list
14856612|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14856613|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856614|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
14856615|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
14856616|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
14856617|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856618|NCT01057355|Ethanol|ethanol|mesh-list
14856619|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14856620|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856621|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856622|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856623|NCT01057407|Sevelamer|sevelamer|mesh-list
14856624|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
14856625|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
14856626|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856627|NCT01057498|RNS60|rns60|mesh-list
14856628|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856629|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856630|NCT01057498|Analgesics|analgesics|mesh-ancestor
14856631|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
14856632|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856633|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856634|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856635|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207468|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
15207469|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
15207470|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207471|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207472|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207473|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
15207474|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207475|NCT03714555|Trace Elements|trace elements|mesh-ancestor
15207476|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
15207477|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15207478|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15207479|NCT03714490|Capecitabine|capecitabine|mesh-list
15207480|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
15207481|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15207482|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
15207483|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207484|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856636|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14856637|NCT01057511|Progesterone|progesterone|mesh-list
14856638|NCT01057511|Progestins|progestins|mesh-ancestor
14856639|NCT01057511|Hormones|hormones|mesh-ancestor
15207485|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
15207486|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14856640|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856641|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856642|NCT01057563|Paclitaxel|paclitaxel|mesh-list
14856643|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14856644|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14856645|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856646|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14856647|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14856648|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14856649|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856650|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
14856651|NCT01057615|Vitamins|vitamins|mesh-ancestor
14856652|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
14856653|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856654|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
14856655|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856656|NCT01057615|Protective Agents|protective agents|mesh-ancestor
14856657|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
14708501|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708502|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708503|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
14708504|NCT00427232|BQ 788|bq 788|mesh-list
14708505|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14708506|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14708507|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856658|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14856659|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708508|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14856660|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14856661|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856662|NCT01057654|Pravastatin|pravastatin|mesh-list
14856663|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14856664|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14856665|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
14856666|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856667|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14856668|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14856669|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856670|NCT01057758|Simvastatin|simvastatin|mesh-list
14856671|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14856672|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14856673|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
14856674|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856675|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14856676|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14856677|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856678|NCT01057849|Olanzapine|olanzapine|mesh-list
14856679|NCT01057849|Risperidone|risperidone|mesh-list
14856680|NCT01057849|Aripiprazole|aripiprazole|mesh-list
14856681|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14856682|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
14856683|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856684|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856685|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856686|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14295869|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14295870|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
14708509|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
14708510|NCT00427245|Goserelin|goserelin|mesh-list
14708511|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708512|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
14708513|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708514|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708515|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14708516|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
14708517|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295871|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14295872|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708518|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856687|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14856688|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856689|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856690|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14856691|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
14856692|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
14856693|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
14856694|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856695|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14856696|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14856697|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14856698|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14856699|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
14856700|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
14856701|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14856702|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14856703|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14856704|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14856705|NCT01057875|Caffeine|caffeine|mesh-list
14856706|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14856707|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856708|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14856709|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856710|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856711|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14856712|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14856713|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
14856714|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856715|NCT01057966|Vitamins|vitamins|mesh-list
14856716|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
14856717|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856718|NCT01058057|Atorvastatin|atorvastatin|mesh-list
14856719|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14856720|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14856721|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
14856722|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856723|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14856724|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14856725|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856726|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
14856727|NCT01058109|Calcium|calcium|mesh-list
14856728|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14856729|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856730|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14856731|NCT01058174|Fluconazole|fluconazole|mesh-list
14856732|NCT01058174|Amphotericin B|amphotericin b|mesh-list
14856733|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14856734|NCT01058174|Caspofungin|caspofungin|mesh-list
14856735|NCT01058174|Micafungin|micafungin|mesh-list
14856736|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
14856737|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856738|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14856739|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14856740|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856741|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856742|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14856743|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
14856744|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856745|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856746|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14856747|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14856748|NCT01058174|Amebicides|amebicides|mesh-ancestor
14856749|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14856750|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14856751|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14856752|NCT01058252|Indomethacin|indomethacin|mesh-list
14856753|NCT01058252|Letrozole|letrozole|mesh-list
14856754|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856755|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14856756|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14856757|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856758|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856759|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14856760|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
14856761|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856762|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856763|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856764|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856765|NCT01058252|Analgesics|analgesics|mesh-ancestor
14856766|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
14856767|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856768|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856769|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856770|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
14856771|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
14856772|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14856773|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14856774|NCT01058291|Apomorphine|apomorphine|mesh-list
14856775|NCT01058291|Emetics|emetics|mesh-ancestor
14856776|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856777|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
14856778|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856779|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14856780|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
14856781|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
14856782|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856783|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708519|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14708520|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14708521|NCT00427271|Aspirin|aspirin|mesh-list
14708522|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14708523|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708524|NCT00427271|Analgesics|analgesics|mesh-ancestor
14708525|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
14708526|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708527|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708528|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708529|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708530|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14856784|NCT01058317|Propranolol|propranolol|mesh-list
14856785|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14856786|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14856787|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
14856788|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856789|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856790|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856791|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14856792|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14856793|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
14856794|NCT01058382|Progesterone|progesterone|mesh-list
14856795|NCT01058382|Progestins|progestins|mesh-ancestor
14856796|NCT01058382|Hormones|hormones|mesh-ancestor
14856797|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856798|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856799|NCT01058408|Cisplatin|cisplatin|mesh-list
14856800|NCT01058408|Everolimus|everolimus|mesh-list
14856801|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856802|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856803|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
14856804|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856805|NCT01058577|Somatostatin|somatostatin|mesh-list
14856806|NCT01058577|Hormones|hormones|mesh-ancestor
14856807|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856808|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856809|NCT01058720|Vitamin D|vitamin d|mesh-list
14856810|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
14856811|NCT01058720|Vitamins|vitamins|mesh-ancestor
14856812|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
14856813|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856814|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14856815|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14856816|NCT01058759|Enoxaparin|enoxaparin|mesh-list
14856817|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
14856818|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
14708531|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14708532|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708533|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14708534|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14708535|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708536|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
14708537|NCT00427310|Fluorouracil|fluorouracil|mesh-list
14708538|NCT00427310|Heparin|heparin|mesh-list
14856819|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14856820|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14856821|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207487|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15207488|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207489|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
15207490|NCT03714360|Coagulants|coagulants|mesh-ancestor
15207491|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15207492|NCT03714165|Defensins|defensins|mesh-list
15207493|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
15207494|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207495|NCT03714113|Antibodies|antibodies|mesh-list
15207496|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
15207497|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207498|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
15207499|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
15207500|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15207501|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207502|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207503|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
14708539|NCT00427310|Calcium heparin|calcium heparin|mesh-list
14708540|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
14913296|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14913297|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14913298|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913299|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14913300|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14913301|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913302|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
14913303|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
14913304|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14913305|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913306|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207504|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15207505|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207506|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708541|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207507|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14856822|NCT01058824|Lincomycin|lincomycin|mesh-list
14856823|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207508|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207509|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207510|NCT03713879|Indomethacin|indomethacin|mesh-list
15207511|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15207512|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15207513|NCT03713879|Analgesics|analgesics|mesh-ancestor
15207514|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
15207515|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207516|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207517|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207518|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207519|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
15207520|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
15207521|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15207522|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15207523|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207524|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207525|NCT03713762|Lidocaine|lidocaine|mesh-list
15207526|NCT03713762|Fentanyl|fentanyl|mesh-list
15207527|NCT03713762|Bupivacaine|bupivacaine|mesh-list
15207528|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
14856824|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856825|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14856826|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856827|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856828|NCT01058850|Rindopepimut|rindopepimut|mesh-list
14856829|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14856830|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856831|NCT01058876|Nicotine|nicotine|mesh-list
14856832|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14856833|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
14856834|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856835|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856836|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14856837|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14856838|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
14856839|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856840|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856841|NCT01058902|Aspirin|aspirin|mesh-list
14856842|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856843|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856844|NCT01058902|Analgesics|analgesics|mesh-ancestor
14856845|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
14856846|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856847|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856848|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856849|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856850|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14856851|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14856852|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856853|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14856854|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14856855|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856856|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
14856857|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14856858|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14856859|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14856860|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
14856861|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856862|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14856863|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14856864|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856865|NCT01059058|Fluorides|fluorides|mesh-list
14856866|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
14856867|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
14856868|NCT01059058|Protective Agents|protective agents|mesh-ancestor
14856869|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856870|NCT01059084|Valacyclovir|valacyclovir|mesh-list
14856871|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
14856872|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207529|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
14856873|NCT01059110|Salicylates|salicylates|mesh-list
14856874|NCT01059110|Imiquimod|imiquimod|mesh-list
14856875|NCT01059110|Fluorouracil|fluorouracil|mesh-list
14856876|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14856877|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
14856878|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856879|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856880|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
14856881|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
14856882|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856883|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14856884|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14856885|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856886|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856887|NCT01059110|Analgesics|analgesics|mesh-ancestor
14856888|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
14856889|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856890|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856891|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856892|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14856893|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856894|NCT01059123|Amoxicillin|amoxicillin|mesh-list
14856895|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14856896|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856897|NCT01059136|Spironolactone|spironolactone|mesh-list
14856898|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14856899|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
14856900|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14856901|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856902|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14856903|NCT01059136|Diuretics|diuretics|mesh-ancestor
14856904|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
14856905|NCT01059331|Pregabalin|pregabalin|mesh-list
14856906|NCT01059331|Analgesics|analgesics|mesh-ancestor
14856907|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
14856908|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856909|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856910|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
14856911|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14856912|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14856913|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856914|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14856915|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14856916|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14295873|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856917|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14856918|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14856919|NCT01059383|Esomeprazole|esomeprazole|mesh-list
14856920|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14856921|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14856922|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14856923|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856924|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856925|NCT01059396|Propranolol|propranolol|mesh-list
14856926|NCT01059396|Carvedilol|carvedilol|mesh-list
14856927|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14856928|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14856929|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
14856930|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856931|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856932|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856933|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14856934|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14856935|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
14856936|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
14856937|NCT01059396|Protective Agents|protective agents|mesh-ancestor
14856938|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14856939|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14856940|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14856941|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14856942|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14856943|NCT01059422|Lamivudine|lamivudine|mesh-list
14856944|NCT01059422|Abacavir|abacavir|mesh-list
14856945|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
14856946|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14856947|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14856948|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856949|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856950|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
14856951|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856952|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14856953|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14856954|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14856955|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14856956|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
14856957|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14856958|NCT01059461|Protective Agents|protective agents|mesh-ancestor
14856959|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856960|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
14856961|NCT01059552|Vorinostat|vorinostat|mesh-list
14856962|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856963|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14856964|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856965|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856966|NCT01059604|Naproxen|naproxen|mesh-list
14856967|NCT01059604|Sumatriptan|sumatriptan|mesh-list
14856968|NCT01059604|Naratriptan|naratriptan|mesh-list
14856969|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14856970|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14856971|NCT01059604|Analgesics|analgesics|mesh-ancestor
14856972|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
14856973|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14856974|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14856975|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14856976|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14856977|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
14856978|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14856979|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856980|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856981|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14856982|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14856983|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14856984|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
14856985|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14856986|NCT01059890|Metronidazole|metronidazole|mesh-list
14856987|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
14856988|NCT01059890|Cefotaxime|cefotaxime|mesh-list
14856989|NCT01059890|Cefoxitin|cefoxitin|mesh-list
14856990|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14856991|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14856992|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14856993|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14856994|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14856995|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14856996|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14856997|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14856998|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14856999|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14857000|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14857001|NCT01059955|Dexamethasone|dexamethasone|mesh-list
14857002|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
14857003|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14857004|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14857005|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14857006|NCT01059955|BB 1101|bb 1101|mesh-list
14857007|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857008|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
14857009|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
14857010|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857011|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857012|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857013|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
14857014|NCT01059955|Hormones|hormones|mesh-ancestor
14857015|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857016|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14857017|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857018|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
14857019|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857020|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857021|NCT01060137|Fentanyl|fentanyl|mesh-list
14857022|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14857023|NCT01060137|Narcotics|narcotics|mesh-ancestor
14857024|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857025|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857026|NCT01060137|Analgesics|analgesics|mesh-ancestor
14857027|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
14857028|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857029|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14857030|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14857031|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
14857032|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
14857033|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
14857034|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14857035|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14857036|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857037|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
14857038|NCT01060163|Coagulants|coagulants|mesh-ancestor
14857039|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
14857040|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14857041|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14857042|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857043|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
14857044|NCT01060176|Coagulants|coagulants|mesh-ancestor
14857045|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
14857046|NCT01060189|Urinastatin|urinastatin|mesh-list
14857047|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14857048|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14857049|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857050|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
14857051|NCT01060189|Coagulants|coagulants|mesh-ancestor
14857052|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14857053|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14857054|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
14857055|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857056|NCT01060228|Valproic Acid|valproic acid|mesh-list
14857057|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14857058|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14857059|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14857060|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857061|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857062|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14857063|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14857064|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14857065|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
14857066|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857067|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857068|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14857069|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14857070|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
14857071|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
14857072|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857073|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
14857074|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
14857075|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14857076|NCT01060267|Erythromycin|erythromycin|mesh-list
14857077|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
14857078|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14857079|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
14857080|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857081|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857082|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14857083|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857084|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857085|NCT01060293|Dopamine|dopamine|mesh-list
14857086|NCT01060293|Furosemide|furosemide|mesh-list
14857087|NCT01060293|Diuretics|diuretics|mesh-ancestor
14857088|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
14857089|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857090|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14857091|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857092|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857093|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14857094|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
14857095|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
14857096|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857097|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
14857098|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857099|NCT01060293|Protective Agents|protective agents|mesh-ancestor
14857100|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
14857101|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857102|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
14857103|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857104|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14857105|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857106|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
14857107|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857108|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857109|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14857110|NCT01060423|Irinotecan|irinotecan|mesh-list
14857111|NCT01060423|Cetuximab|cetuximab|mesh-list
14857112|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14857113|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14857114|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857115|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857116|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857117|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14857118|NCT01060475|Tacrolimus|tacrolimus|mesh-list
14857119|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857120|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
14857121|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857122|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14857123|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857124|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857125|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14857126|NCT01060488|Hormones|hormones|mesh-ancestor
14857127|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857128|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857129|NCT01060501|Leucovorin|leucovorin|mesh-list
14857130|NCT01060501|Folic Acid|folic acid|mesh-list
14857131|NCT01060501|Interferons|interferons|mesh-list
14857132|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
14857133|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
14857134|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857135|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
14857136|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857137|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
14857138|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857139|NCT01060501|Antidotes|antidotes|mesh-ancestor
14857140|NCT01060501|Protective Agents|protective agents|mesh-ancestor
14857141|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
14857142|NCT01060501|Vitamins|vitamins|mesh-ancestor
14857143|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
14857144|NCT01060501|Hematinics|hematinics|mesh-ancestor
14857145|NCT01060514|Vinorelbine|vinorelbine|mesh-list
14857146|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14857147|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857148|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
14857149|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
14857150|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
14857151|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857152|NCT01060566|Ivacaftor|ivacaftor|mesh-list
14857153|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14857154|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857155|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857156|NCT01060605|Sirolimus|sirolimus|mesh-list
14857157|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14857158|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857159|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14857160|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857161|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
14857162|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857163|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
14857164|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857165|NCT01060618|Maraviroc|maraviroc|mesh-list
14857166|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14857167|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14857168|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857169|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14857170|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14857171|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
14857172|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857173|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14857174|NCT01060631|Propofol|propofol|mesh-list
14857175|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14857176|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857177|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857178|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14857179|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
14857180|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
14857181|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
14857182|NCT01060696|Scopolamine|scopolamine|mesh-list
14857183|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14857184|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14857185|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
14857186|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
14857187|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857188|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857189|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857190|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
14857191|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14857192|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
14857193|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857194|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857195|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14857196|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
14857197|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14857198|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14857199|NCT01060696|Analgesics|analgesics|mesh-ancestor
14857200|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
14857201|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857202|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14857203|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14857204|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857205|NCT01060735|Vitamin D|vitamin d|mesh-list
14857206|NCT01060735|Vitamins|vitamins|mesh-ancestor
14857207|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
14857208|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857209|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14913307|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14913308|NCT01374737|Analgesics|analgesics|mesh-ancestor
14857210|NCT01060774|Lidocaine|lidocaine|mesh-list
14857211|NCT01060774|Bupivacaine|bupivacaine|mesh-list
14857212|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
14857213|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
14857214|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857215|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857216|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
14857217|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857218|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14857219|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14857220|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14857221|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857222|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857223|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14857224|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857225|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
14857226|NCT01060787|Hormones|hormones|mesh-ancestor
14857227|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857228|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857229|NCT01060826|Somatostatin|somatostatin|mesh-list
14857230|NCT01060826|Hormones|hormones|mesh-ancestor
14857231|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857232|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857233|NCT01060891|Colistin|colistin|mesh-list
14857234|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14857235|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857236|NCT01060904|Doxorubicin|doxorubicin|mesh-list
14857237|NCT01060904|Bleomycin|bleomycin|mesh-list
14857238|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14857239|NCT01060904|Dacarbazine|dacarbazine|mesh-list
14857240|NCT01060904|Vinblastine|vinblastine|mesh-list
14857241|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14857242|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14857243|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857244|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14857245|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14857246|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857247|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857248|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14857249|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
14857250|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857251|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857252|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
14857253|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14857254|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
14857255|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
14857256|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14857257|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14857258|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857259|NCT01060930|Epinephrine|epinephrine|mesh-list
14857260|NCT01060930|Norepinephrine|norepinephrine|mesh-list
14857261|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14857262|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14857263|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14857264|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
14857265|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857266|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857267|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857268|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14857269|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14857270|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
14857271|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857272|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14857273|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
14857274|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
14857275|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
14857276|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14857277|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857278|NCT01060969|Acetazolamide|acetazolamide|mesh-list
14857279|NCT01060969|Tadalafil|tadalafil|mesh-list
14857280|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
14857281|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14857282|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14857283|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857284|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857285|NCT01060969|Urological Agents|urological agents|mesh-ancestor
14857286|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
14857287|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14857288|NCT01060969|Diuretics|diuretics|mesh-ancestor
14857289|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
14857290|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857291|NCT01061060|Epoprostenol|epoprostenol|mesh-list
14857292|NCT01061060|Beraprost|beraprost|mesh-list
14857293|NCT01061060|Tezosentan|tezosentan|mesh-list
14857294|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14857295|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
14857296|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14857297|NCT01061112|Tolbutamide|tolbutamide|mesh-list
14857298|NCT01061112|Fluconazole|fluconazole|mesh-list
14857299|NCT01061112|Ketoprofen|ketoprofen|mesh-list
14857300|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
14857301|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
15207530|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207531|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207532|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
15207533|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207534|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14857302|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857303|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14857304|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14857305|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857306|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857307|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14857308|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
14857309|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857310|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857311|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14857312|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14857313|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14857314|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14857315|NCT01061112|Analgesics|analgesics|mesh-ancestor
14857316|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
14857317|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857318|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857319|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14857320|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14857321|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14857322|NCT01061190|Propranolol|propranolol|mesh-list
14857323|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14857324|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14857325|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14857326|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207535|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15207536|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15207537|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14295874|NCT00584909|Paclitaxel|paclitaxel|mesh-list
14857327|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857328|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857329|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14857330|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14857331|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
14857332|NCT01061216|Insulin|insulin|mesh-list
14857333|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14857334|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14857335|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857336|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14857337|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
14857338|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14857339|NCT01061320|Tocopherols|tocopherols|mesh-list
14857340|NCT01061320|Vitamin E|vitamin e|mesh-list
14857341|NCT01061320|Tocotrienols|tocotrienols|mesh-list
14857342|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
14857343|NCT01061320|Vitamins|vitamins|mesh-ancestor
14857344|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
14857345|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857346|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
14857347|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857348|NCT01061320|Protective Agents|protective agents|mesh-ancestor
14857349|NCT01061372|Pregabalin|pregabalin|mesh-list
14857350|NCT01061372|Analgesics|analgesics|mesh-ancestor
14857351|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
14857352|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857353|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857354|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
14857355|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14857356|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857357|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857358|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14857359|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14857360|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14857361|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857362|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14857363|NCT01061411|Sunitinib|sunitinib|mesh-list
14857364|NCT01061411|Dalteparin|dalteparin|mesh-list
14857365|NCT01061411|Tinzaparin|tinzaparin|mesh-list
14857366|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14857367|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857368|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14857369|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14857370|NCT01061411|Growth Substances|growth substances|mesh-ancestor
14857371|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857372|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
14857373|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14857374|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857375|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857376|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
14857377|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14857378|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14857379|NCT01061437|Lansoprazole|lansoprazole|mesh-list
14857380|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
14857381|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14857382|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857383|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14857384|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857385|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857386|NCT01061450|Simvastatin|simvastatin|mesh-list
14857387|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14857388|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14857389|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
14857390|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857391|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14857392|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14857393|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857394|NCT01061658|Vaccines|vaccines|mesh-list
14857395|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
14857396|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857397|NCT01061697|Pregabalin|pregabalin|mesh-list
14857398|NCT01061697|Analgesics|analgesics|mesh-ancestor
14857399|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
14857400|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857401|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857402|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
14857403|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14857404|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857405|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857406|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14857407|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14857408|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14857409|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857410|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14857411|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14857412|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
14857413|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857414|NCT01061788|Everolimus|everolimus|mesh-list
14857415|NCT01061788|Panitumumab|panitumumab|mesh-list
14857416|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857417|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857418|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
14857419|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857420|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14857421|NCT01061814|Mipomersen|mipomersen|mesh-list
14857422|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14857423|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14857424|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
14857425|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857426|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14857427|NCT01061853|Sirolimus|sirolimus|mesh-list
14857428|NCT01061853|Betamethasone|betamethasone|mesh-list
14857429|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14857430|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857431|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14857432|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857433|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
14857434|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857435|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
14857436|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857437|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857438|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
14857439|NCT01061853|Hormones|hormones|mesh-ancestor
14857440|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857441|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14857442|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
14857443|NCT01061996|Basiliximab|basiliximab|mesh-list
14857444|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857445|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
14857446|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857447|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14857448|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14857449|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857450|NCT01062048|Incretins|incretins|mesh-ancestor
14857451|NCT01062048|Hormones|hormones|mesh-ancestor
14857452|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857453|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14857454|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
14857455|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857456|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857457|NCT01062087|Lidocaine|lidocaine|mesh-list
14857458|NCT01062087|Bupivacaine|bupivacaine|mesh-list
14857459|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
14857460|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
14857461|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857462|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857463|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
14857464|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857465|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14857466|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14857467|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14857468|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857469|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857470|NCT01062139|Cetirizine|cetirizine|mesh-list
14857471|NCT01062139|Levocetirizine|levocetirizine|mesh-list
14857472|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14857473|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14857474|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
14857475|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
14857476|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857477|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857478|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857479|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14857480|NCT01062152|Lenalidomide|lenalidomide|mesh-list
14857481|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
14857482|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857483|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14857484|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14857485|NCT01062152|Growth Substances|growth substances|mesh-ancestor
14857486|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
15207538|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207539|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15207540|NCT03713762|Narcotics|narcotics|mesh-ancestor
14857487|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857488|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14857489|NCT01062191|Laxatives|laxatives|mesh-ancestor
14857490|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857491|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14857492|NCT01062204|Laxatives|laxatives|mesh-ancestor
14857493|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857494|NCT01062282|Iloprost|iloprost|mesh-list
14857495|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14857496|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
14857497|NCT01062360|Aspirin|aspirin|mesh-list
14857498|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
14857499|NCT01062360|Ephedrine|ephedrine|mesh-list
14857500|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14857501|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14857502|NCT01062360|Analgesics|analgesics|mesh-ancestor
14857503|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
14857504|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857505|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857506|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857507|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14857508|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14857509|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14857510|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857511|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14857512|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14857513|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857514|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
14857515|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14857516|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
14857517|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14857518|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
14857519|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
15207541|NCT03713762|Analgesics|analgesics|mesh-ancestor
15207542|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15207543|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15207544|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
15207545|NCT03713658|Risperidone|risperidone|mesh-list
14857520|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14857521|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14857522|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
14857523|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
14857524|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857525|NCT01062477|Vaccines|vaccines|mesh-list
14857526|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
14857527|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857528|NCT01062490|Treosulfan|treosulfan|mesh-list
14857529|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857530|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
14857531|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857532|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857533|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
14857534|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14857535|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857536|NCT01062516|Esomeprazole|esomeprazole|mesh-list
14857537|NCT01062516|Famotidine|famotidine|mesh-list
14857538|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14857539|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857540|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14857541|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857542|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857543|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14857544|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
14857545|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
14857546|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857547|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913309|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
14913310|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913311|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14913312|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14913313|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14913314|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
14913315|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913316|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913317|NCT01374750|Cyclosporine|cyclosporine|mesh-list
14913318|NCT01374750|Sirolimus|sirolimus|mesh-list
14913319|NCT01374750|Tacrolimus|tacrolimus|mesh-list
14913320|NCT01374750|Cyclosporins|cyclosporins|mesh-list
14913321|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913322|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
14913323|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913324|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14913325|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913326|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913327|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
14913328|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913329|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14913330|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913331|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14913332|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14913333|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913334|NCT01374763|Oxycodone|oxycodone|mesh-list
14913335|NCT01374763|Naloxone|naloxone|mesh-list
14913336|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14913337|NCT01374763|Narcotics|narcotics|mesh-ancestor
14913338|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913339|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913340|NCT01374763|Analgesics|analgesics|mesh-ancestor
14913341|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
14913342|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913343|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14913344|NCT01374789|Panitumumab|panitumumab|mesh-list
14913345|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15207546|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14857548|NCT01062529|Somatostatin|somatostatin|mesh-list
14857549|NCT01062529|Hormones|hormones|mesh-ancestor
14857550|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857551|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857552|NCT01062633|Erythritol|erythritol|mesh-list
14857553|NCT01062633|Sorbitol|sorbitol|mesh-list
14857554|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
14857555|NCT01062633|Cathartics|cathartics|mesh-ancestor
14857556|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857557|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14857558|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14857559|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14857560|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857561|NCT01062776|Furosemide|furosemide|mesh-list
14857562|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14857563|NCT01062776|Diuretics|diuretics|mesh-ancestor
14857564|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
14857565|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857566|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14857567|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857568|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857569|NCT01062802|Atorvastatin|atorvastatin|mesh-list
14857570|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14857571|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14857572|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
14857573|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857574|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14857575|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14857576|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857577|NCT01062906|Lidocaine|lidocaine|mesh-list
14857578|NCT01062906|Fentanyl|fentanyl|mesh-list
14857579|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
14857580|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
14857581|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857582|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857583|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
14857584|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857585|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14857586|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14857587|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14857588|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857589|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857590|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14857591|NCT01062906|Narcotics|narcotics|mesh-ancestor
14857592|NCT01062906|Analgesics|analgesics|mesh-ancestor
14857593|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14857594|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14857595|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
14857596|NCT01062932|Cycloserine|cycloserine|mesh-list
14857597|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14857598|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857599|NCT01062932|Renal Agents|renal agents|mesh-ancestor
14857600|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14857601|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
14857602|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14857603|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
14857604|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857605|NCT01062945|Doxazosin|doxazosin|mesh-list
14857606|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14857607|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14857608|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14857609|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14857610|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
14857611|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857612|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857613|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857614|NCT01062958|Vitamins|vitamins|mesh-list
14857615|NCT01062958|Folic Acid|folic acid|mesh-list
14857616|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
14857617|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
14857618|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
14857619|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857620|NCT01062958|Hematinics|hematinics|mesh-ancestor
14708542|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708543|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708544|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708545|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
14708546|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708547|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
14708548|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14708549|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14708550|NCT00427362|Adalimumab|adalimumab|mesh-list
14708551|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708552|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708553|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
14708554|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14708555|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15207547|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15207548|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
15207549|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207550|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207551|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207552|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15207553|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15207554|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207555|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15207556|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15207557|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
14708556|NCT00427388|Prednisolone|prednisolone|mesh-list
14708557|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
14708558|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14708559|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
14708560|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708561|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
14708562|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
14708563|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708564|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708565|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708566|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
14708567|NCT00427388|Hormones|hormones|mesh-ancestor
14708568|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708569|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14708570|NCT00427388|Protective Agents|protective agents|mesh-ancestor
14708571|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14708572|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708573|NCT00427414|Daunorubicin|daunorubicin|mesh-list
14708574|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708575|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14708576|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708577|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14708578|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14708579|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708580|NCT00427427|Trastuzumab|trastuzumab|mesh-list
14708581|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708582|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708583|NCT00427466|Pemetrexed|pemetrexed|mesh-list
14708584|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708585|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708586|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708587|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14708588|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14708589|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
14708590|NCT00427492|Antacids|antacids|mesh-ancestor
14708591|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708592|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857621|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
15207558|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15207559|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15207560|NCT03713437|Insulin|insulin|mesh-list
15207561|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207562|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207563|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
14857622|NCT01063010|Bevacizumab|bevacizumab|mesh-list
14857623|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14857624|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857625|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14857626|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14857627|NCT01063010|Growth Substances|growth substances|mesh-ancestor
14857628|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857629|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
14857630|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
14857631|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14857632|NCT01063023|Asunaprevir|asunaprevir|mesh-list
14857633|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
14857634|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857635|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857636|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15207564|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
15207565|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207566|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207567|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207568|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207569|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15207570|NCT03713372|Cetuximab|cetuximab|mesh-list
15207571|NCT03713372|Antibodies|antibodies|mesh-list
15207572|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15207573|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
14857637|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
14857638|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14857639|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207574|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207575|NCT03713372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15207576|NCT03713372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207577|NCT03713346|Caseins|caseins|mesh-list
15207578|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
15207579|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
15207580|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224909|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224910|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
15224911|NCT02073097|Hormones|hormones|mesh-ancestor
15224912|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224913|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15224914|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15224915|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
15224916|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
15224917|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
15224918|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15224919|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
14857640|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14857641|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14857642|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14857643|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14857644|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857645|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14857646|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14857647|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857648|NCT01063101|Fucoidan|fucoidan|mesh-list
14857649|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14857650|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857651|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
14857652|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857653|NCT01063127|Insulin|insulin|mesh-list
14857654|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14857655|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857656|NCT01063140|Vaccines|vaccines|mesh-list
14857657|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
14857658|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857659|NCT01063179|Thalidomide|thalidomide|mesh-list
15224920|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224921|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
14857660|NCT01063179|Prednisone|prednisone|mesh-list
14857661|NCT01063179|Bortezomib|bortezomib|mesh-list
14857662|NCT01063179|Melphalan|melphalan|mesh-list
14857663|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857664|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
14857665|NCT01063179|Hormones|hormones|mesh-ancestor
14857666|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857667|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857668|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14857669|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857670|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857671|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
14857672|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708593|NCT00427505|Deferasirox|deferasirox|mesh-list
14708594|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14708595|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
14708596|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
14708597|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708598|NCT00427570|Fluorouracil|fluorouracil|mesh-list
14708599|NCT00427570|Vincristine|vincristine|mesh-list
14708600|NCT00427570|Semustine|semustine|mesh-list
14857673|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14857674|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207581|NCT03713216|Morphine|morphine|mesh-list
15207582|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15207583|NCT03713216|Narcotics|narcotics|mesh-ancestor
15207584|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207585|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857675|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
14857676|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
14857677|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14857678|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857679|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14857680|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14857681|NCT01063179|Growth Substances|growth substances|mesh-ancestor
15207586|NCT03713216|Analgesics|analgesics|mesh-ancestor
15207587|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
15207588|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295875|NCT00584909|Carboplatin|carboplatin|mesh-list
14295876|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14295877|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295878|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295879|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
14295880|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295881|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295882|NCT00584948|Memantine|memantine|mesh-list
14295883|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14295884|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14295885|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
14708601|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
14857682|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
14857683|NCT01063192|Leucovorin|leucovorin|mesh-list
14857684|NCT01063192|Gemcitabine|gemcitabine|mesh-list
14857685|NCT01063192|Fluorouracil|fluorouracil|mesh-list
14857686|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
14857687|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14857688|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
14857689|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857690|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857691|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
14857692|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857693|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857694|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857695|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
14857696|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857697|NCT01063192|Antidotes|antidotes|mesh-ancestor
14857698|NCT01063192|Protective Agents|protective agents|mesh-ancestor
14857699|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
14857700|NCT01063192|Vitamins|vitamins|mesh-ancestor
14857701|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
14857702|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
14857703|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14857704|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
14857705|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857706|NCT01063205|Expectorants|expectorants|mesh-ancestor
14857707|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
14857708|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14857709|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
14857710|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857711|NCT01063205|Protective Agents|protective agents|mesh-ancestor
14857712|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857713|NCT01063205|Antidotes|antidotes|mesh-ancestor
14857714|NCT01063218|Emollients|emollients|mesh-list
14857715|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
14857716|NCT01063257|Clofarabine|clofarabine|mesh-list
14857717|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14857718|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
14857719|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857720|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857721|NCT01063270|Rifampin|rifampin|mesh-list
14857722|NCT01063270|Clindamycin|clindamycin|mesh-list
14857723|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
14857724|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
14857725|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14857726|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
14857727|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14857728|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857729|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
14857730|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14857731|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857732|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857733|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14857734|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14857735|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14857736|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14857737|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14857738|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14857739|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14857740|NCT01063426|Enoxaparin|enoxaparin|mesh-list
14857741|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
14857742|NCT01063426|Atorvastatin|atorvastatin|mesh-list
14857743|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14857744|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14857745|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
14857746|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857747|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14857748|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14857749|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857750|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
14857751|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14857752|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14857753|NCT01063439|Cytarabine|cytarabine|mesh-list
14857754|NCT01063439|Etoposide|etoposide|mesh-list
14857755|NCT01063439|Melphalan|melphalan|mesh-list
14857756|NCT01063439|Busulfan|busulfan|mesh-list
14857757|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14857758|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857759|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14857760|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14857761|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857762|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857763|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14857764|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
14857765|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
14857766|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857767|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857768|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
14857769|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857770|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857771|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
14857772|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14857773|NCT01063478|Everolimus|everolimus|mesh-list
14857774|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857775|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857776|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
14708602|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
14708603|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708604|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708605|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708606|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708607|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
14708608|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708609|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14708610|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
14708611|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
14708612|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
14857777|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857778|NCT01063504|Teriparatide|teriparatide|mesh-list
14857779|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14857780|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857781|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14857782|NCT01063530|Fluorides|fluorides|mesh-list
14857783|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
14857784|NCT01063530|Protective Agents|protective agents|mesh-ancestor
14857785|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857786|NCT01063556|Donepezil|donepezil|mesh-list
14857787|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14857788|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857789|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857790|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
14857791|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857792|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857793|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
14857794|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
14857795|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14857796|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14857797|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14857798|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857799|NCT01063621|Apomorphine|apomorphine|mesh-list
14857800|NCT01063621|Emetics|emetics|mesh-ancestor
14857801|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857802|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
14857803|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857804|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14857805|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
14857806|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
14857807|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857808|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857809|NCT01063647|Treosulfan|treosulfan|mesh-list
14857810|NCT01063647|Busulfan|busulfan|mesh-list
14857811|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857812|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
14857813|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857814|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857815|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857816|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
14857817|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857818|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14708613|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14708614|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14708615|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
14708616|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
14708617|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708618|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14708619|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708620|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708621|NCT00427596|Solabegron|solabegron|mesh-list
14708622|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14708623|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14708624|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14857819|NCT01063660|Treosulfan|treosulfan|mesh-list
14857820|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857821|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
14857822|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857823|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857824|NCT01063816|Gemcitabine|gemcitabine|mesh-list
14857825|NCT01063816|Carboplatin|carboplatin|mesh-list
14857826|NCT01063816|Veliparib|veliparib|mesh-list
14857827|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708625|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14708626|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708627|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207589|NCT03713190|Empagliflozin|empagliflozin|mesh-list
15207590|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15207591|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708628|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708629|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14708630|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14708631|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857828|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14857829|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
14857830|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857831|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
14857832|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857833|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857834|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857835|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
14857836|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857837|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15207592|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207593|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857838|NCT01063842|Acetaminophen|acetaminophen|mesh-list
14857839|NCT01063842|Tramadol|tramadol|mesh-list
14857840|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14857841|NCT01063842|Analgesics|analgesics|mesh-ancestor
14857842|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
14857843|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857844|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857845|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
14857846|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14857847|NCT01063842|Narcotics|narcotics|mesh-ancestor
14857848|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857849|NCT01063920|Naproxen|naproxen|mesh-list
14857850|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14857851|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14857852|NCT01063920|Analgesics|analgesics|mesh-ancestor
14857853|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
14857854|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857855|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857856|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857857|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14857858|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
14857859|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14857860|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207594|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15207595|NCT03712956|Doxorubicin|doxorubicin|mesh-list
15207596|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15207597|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207598|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15207599|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15207600|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207601|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207602|NCT03712904|Aflibercept|aflibercept|mesh-list
15207603|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
15207604|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15207605|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14708632|NCT00427713|Capecitabine|capecitabine|mesh-list
14857861|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857862|NCT01063933|Peramivir|peramivir|mesh-list
14857863|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
14857864|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14857865|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857866|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857867|NCT01064102|Cetirizine|cetirizine|mesh-list
14857868|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14857869|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14857870|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14857871|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
14857872|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
14857873|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857874|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857875|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857876|NCT01064115|Cetirizine|cetirizine|mesh-list
14857877|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14857878|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14857879|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14857880|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
14857881|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
14857882|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857883|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857884|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857885|NCT01064141|Vaccines|vaccines|mesh-list
14857886|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
14857887|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857888|NCT01064154|Carvedilol|carvedilol|mesh-list
14857889|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14857890|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14857891|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
14857892|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857893|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857894|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857895|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14857896|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
14857897|NCT01064154|Protective Agents|protective agents|mesh-ancestor
14857898|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14857899|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857900|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14857901|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
14857902|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14857903|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14857904|NCT01064180|Carvedilol|carvedilol|mesh-list
14857905|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14857906|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14857907|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
14857908|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857909|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857910|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857911|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14857912|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
14857913|NCT01064180|Protective Agents|protective agents|mesh-ancestor
14857914|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14857915|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14857916|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14857917|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
14857918|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14857919|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14857920|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14857921|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14857922|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857923|NCT01064232|Risperidone|risperidone|mesh-list
14857924|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14857925|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
14857926|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857927|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857928|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857929|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14857930|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14857931|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857932|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14857933|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14857934|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
14913346|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857935|NCT01064271|Risperidone|risperidone|mesh-list
14857936|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14857937|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
14857938|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14857939|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857940|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857941|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14857942|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14857943|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14857944|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14857945|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14857946|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
14857947|NCT01064349|Trastuzumab|trastuzumab|mesh-list
14857948|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14857949|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857950|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
14857951|NCT01064375|Molgramostim|molgramostim|mesh-list
14857952|NCT01064375|Sargramostim|sargramostim|mesh-list
14857953|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14857954|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
14857955|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857956|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14857957|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14857958|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
14857959|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857960|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857961|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14857962|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14857963|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14857964|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857965|NCT01064466|Etoposide|etoposide|mesh-list
14857966|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
14857967|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14857968|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857969|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14857970|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14857971|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857972|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857973|NCT01064557|Tretinoin|tretinoin|mesh-list
14913347|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14857974|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857975|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
14857976|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
14857977|NCT01064570|Tretinoin|tretinoin|mesh-list
14857978|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857979|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
14857980|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
14857981|NCT01064635|Letrozole|letrozole|mesh-list
14857982|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14857983|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14857984|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14857985|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14857986|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14857987|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14857988|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
14857989|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14857990|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857991|NCT01064726|Fluticasone|fluticasone|mesh-list
14857992|NCT01064726|Xhance|xhance|mesh-list
14857993|NCT01064726|Ibuprofen|ibuprofen|mesh-list
14857994|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14857995|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14857996|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
14857997|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14857998|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14857999|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14858000|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
14858001|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
14858002|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14858003|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14858004|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14858005|NCT01064726|Analgesics|analgesics|mesh-ancestor
14858006|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
14858007|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858008|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14858009|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858010|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858011|NCT01064752|Minocycline|minocycline|mesh-list
14858012|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14858013|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858014|NCT01064921|Vorinostat|vorinostat|mesh-list
14858015|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858016|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14858017|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858018|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858019|NCT01064973|Baclofen|baclofen|mesh-list
14858020|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14858021|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858022|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14858023|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858024|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14858025|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
14858026|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
14858027|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858028|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858029|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
14858030|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14858031|NCT01064986|Epinephrine|epinephrine|mesh-list
14858032|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14858033|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14858034|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
14858035|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858036|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858037|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858038|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14858039|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14858040|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
14858041|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858042|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14858043|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
14858044|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
14858045|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
14858046|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14858047|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858048|NCT01064999|Capecitabine|capecitabine|mesh-list
14858049|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
14858050|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858051|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
14858052|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858053|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858054|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
14858055|NCT01065038|Anagrelide|anagrelide|mesh-list
14858056|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858057|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
14858058|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858059|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858060|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14858061|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14858062|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14858063|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14858064|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14858065|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
14858066|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14858067|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14858068|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858069|NCT01065129|Plerixafor|plerixafor|mesh-list
14858070|NCT01065129|Azacitidine|azacitidine|mesh-list
14858071|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858072|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
14858073|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858074|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858075|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858076|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14858077|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14858078|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
14858079|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858080|NCT01065194|Simendan|simendan|mesh-list
14858081|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14858082|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
14858083|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14858084|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14858085|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858086|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858087|NCT01065194|Protective Agents|protective agents|mesh-ancestor
14858088|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858089|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
14858090|NCT01065220|Testolactone|testolactone|mesh-list
14858091|NCT01065220|Lynestrenol|lynestrenol|mesh-list
14858092|NCT01065220|Estradiol|estradiol|mesh-list
14858093|NCT01065220|Cyproterone|cyproterone|mesh-list
14858094|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
14858095|NCT01065220|Estrogens|estrogens|mesh-ancestor
14858096|NCT01065220|Hormones|hormones|mesh-ancestor
14858097|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14858098|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858099|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14858100|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
14858101|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14858102|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14858103|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
14858104|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
14858105|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858106|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14858107|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14858108|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858109|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858110|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14858111|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14858112|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14858113|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14858114|NCT01065246|Catumaxomab|catumaxomab|mesh-list
14858115|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858116|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14858117|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14858118|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14858119|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14858120|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858121|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
14858122|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858123|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858124|NCT01065272|Dexamethasone|dexamethasone|mesh-list
14858125|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858126|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
14858127|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
14858128|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858129|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858130|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858131|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
14858132|NCT01065272|Hormones|hormones|mesh-ancestor
14858133|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14858134|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14858135|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858136|NCT01065285|Vaccines|vaccines|mesh-list
14858137|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
14858138|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858139|NCT01065376|Cabergoline|cabergoline|mesh-list
14858140|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14858141|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14858142|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
14858143|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
14858144|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858145|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858146|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858147|NCT01065467|Panobinostat|panobinostat|mesh-list
14708633|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
14708634|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708635|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
14708636|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708637|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708638|NCT00427882|Alfuzosin|alfuzosin|mesh-list
14708639|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14708640|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14708641|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14708642|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14708643|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708644|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708645|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708646|NCT00427882|Urological Agents|urological agents|mesh-ancestor
14708647|NCT00427947|Ropivacaine|ropivacaine|mesh-list
14708648|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
14708649|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
14708650|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708651|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708652|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
14708653|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708654|NCT00428025|Diclofenac|diclofenac|mesh-list
14708655|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14858148|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858149|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14858150|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858151|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858152|NCT01065519|Umirolimus|umirolimus|mesh-list
14858153|NCT01065519|Everolimus|everolimus|mesh-list
14858154|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858155|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858156|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
14858157|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858158|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858159|NCT01065532|Paclitaxel|paclitaxel|mesh-list
14858160|NCT01065532|Everolimus|everolimus|mesh-list
14858161|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14858162|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858163|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
14858164|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
14858165|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
14858166|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858167|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858168|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
14858169|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858170|NCT01065545|Clofarabine|clofarabine|mesh-list
14858171|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858172|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
14858173|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858174|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858175|NCT01065610|Oxytocin|oxytocin|mesh-list
14858176|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
14858177|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14858178|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858179|NCT01065649|Nortriptyline|nortriptyline|mesh-list
14858180|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14858181|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
14858182|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14858183|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14858184|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14858185|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14858186|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858187|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14858188|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858189|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858190|NCT01065662|Sirolimus|sirolimus|mesh-list
14858191|NCT01065662|Cediranib|cediranib|mesh-list
14858192|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14858193|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858194|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14858195|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858196|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
14858197|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858198|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
14858199|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858200|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14858201|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858202|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858203|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
14858204|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14858205|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14858206|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858207|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14858208|NCT01065701|Analgesics|analgesics|mesh-ancestor
14858209|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
14858210|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858211|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14858212|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14858213|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14858214|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
14858215|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858216|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858217|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
14858218|NCT01065727|Natalizumab|natalizumab|mesh-list
14858219|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
14858220|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14858221|NCT01065727|Analgesics|analgesics|mesh-ancestor
14858222|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
14858223|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858224|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858225|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858226|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14858227|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14858228|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858229|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858230|NCT01065805|Alovudine|alovudine|mesh-list
14858231|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
14858232|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858233|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
14858234|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
14858235|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
14858236|NCT01065857|Citric Acid|citric acid|mesh-list
14858237|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
14858238|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
14858239|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14858240|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
14858241|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
14858242|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858243|NCT01065857|Cathartics|cathartics|mesh-ancestor
14858244|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858245|NCT01065857|Antacids|antacids|mesh-ancestor
14858246|NCT01065870|Gemcitabine|gemcitabine|mesh-list
14858247|NCT01065870|Capecitabine|capecitabine|mesh-list
14858248|NCT01065870|Docetaxel|docetaxel|mesh-list
14858249|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858250|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
14858251|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858252|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858253|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
14858254|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858255|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858256|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858257|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
14858258|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858259|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
14858260|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
14858261|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
14858262|NCT01065961|Dexamethasone|dexamethasone|mesh-list
14858263|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
14858264|NCT01065961|BB 1101|bb 1101|mesh-list
14858265|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858266|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
14858267|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
14858268|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858269|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858270|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858271|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
14858272|NCT01065961|Hormones|hormones|mesh-ancestor
14858273|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14858274|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14858275|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858276|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
14858277|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858278|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858279|NCT01065987|Tizanidine|tizanidine|mesh-list
14858280|NCT01065987|Analgesics|analgesics|mesh-ancestor
14858281|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
14858282|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858283|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858284|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
14858285|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14858286|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14858287|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
14858288|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
14858289|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14858290|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14708656|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708657|NCT00428025|Analgesics|analgesics|mesh-ancestor
14708658|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
14708659|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708660|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708661|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708662|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708663|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15207606|NCT03712904|Growth Substances|growth substances|mesh-ancestor
15207607|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207608|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
15207609|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708664|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708665|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728700|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858291|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14858292|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
14858293|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858294|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858295|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
14858296|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14858297|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
14858298|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858299|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913348|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14913349|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14913350|NCT01374828|Analgesics|analgesics|mesh-ancestor
14913351|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
14913352|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913353|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913354|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913355|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913356|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14913357|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913358|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913359|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
14913360|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913361|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
14913362|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913363|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913364|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14913365|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
14913366|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913367|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913368|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14913369|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
14913370|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
14913371|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14913372|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14913373|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
14913374|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207610|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
15207611|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
15207612|NCT03712878|Tacrolimus|tacrolimus|mesh-list
14913375|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
14913376|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14913377|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
14913378|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913379|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913380|NCT01375088|Propolis|propolis|mesh-list
14913381|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913382|NCT01375101|Quercetin|quercetin|mesh-list
15207613|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207614|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
14858300|NCT01066169|Lactitol|lactitol|mesh-list
14858301|NCT01066169|Cathartics|cathartics|mesh-ancestor
14858302|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858303|NCT01066195|Pemetrexed|pemetrexed|mesh-list
14858304|NCT01066195|Gefitinib|gefitinib|mesh-list
14858305|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858306|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858307|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858308|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14858309|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14858310|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14858311|NCT01066247|Midazolam|midazolam|mesh-list
14858312|NCT01066247|Morphine|morphine|mesh-list
14858313|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14858314|NCT01066247|Narcotics|narcotics|mesh-ancestor
14858315|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14858316|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858317|NCT01066247|Analgesics|analgesics|mesh-ancestor
14858318|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
14858319|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858320|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14858321|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14858322|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14858323|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14858324|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14858325|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14858326|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
14858327|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
14858328|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
14858329|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
14858330|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858331|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858332|NCT01066299|Oxytocin|oxytocin|mesh-list
14858333|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
14858334|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14858335|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858336|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
14858337|NCT01066351|Hematinics|hematinics|mesh-ancestor
14858338|NCT01066377|Sulfalene|sulfalene|mesh-list
14858339|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858340|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14858341|NCT01066377|Renal Agents|renal agents|mesh-ancestor
14858342|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
14858343|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14858344|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14858345|NCT01066403|Pergolide|pergolide|mesh-list
14858346|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
14858347|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
14858348|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858349|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858350|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858351|NCT01066429|Dexamethasone|dexamethasone|mesh-list
14858352|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
14858353|NCT01066429|BB 1101|bb 1101|mesh-list
14858354|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858355|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
14858356|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
14858357|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858358|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858359|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858360|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
14858361|NCT01066429|Hormones|hormones|mesh-ancestor
14858362|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14858363|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14858364|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858365|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
14858366|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858367|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858368|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
14913383|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
15207615|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207616|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207617|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15207618|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
15207619|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207620|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207621|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15207622|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15207623|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207624|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15207625|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15207626|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
15207627|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207628|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207629|NCT03712826|Ustekinumab|ustekinumab|mesh-list
15207630|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
15207631|NCT03712735|Fentanyl|fentanyl|mesh-list
15207632|NCT03712735|Bupivacaine|bupivacaine|mesh-list
15207633|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
14858369|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858370|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14858371|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858372|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858373|NCT01066494|Cytarabine|cytarabine|mesh-list
14858374|NCT01066494|Amonafide|amonafide|mesh-list
14858375|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858376|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
14858377|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858378|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858379|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
14858380|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858381|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858382|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
14858383|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858384|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858385|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14858386|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
14858387|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14858388|NCT01066559|Protective Agents|protective agents|mesh-ancestor
14858389|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858390|NCT01066572|Lisinopril|lisinopril|mesh-list
14858391|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14858392|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
14858393|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858394|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858395|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14858396|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14858397|NCT01066572|Protective Agents|protective agents|mesh-ancestor
14858398|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858399|NCT01066598|Rituximab|rituximab|mesh-list
14858400|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14858401|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858402|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
14858403|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858404|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858405|NCT01066650|Everolimus|everolimus|mesh-list
14858406|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858407|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858408|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
14858409|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858410|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
14858411|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
14858412|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14858413|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14858414|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858415|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14858416|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858417|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858418|NCT01066676|Ibuprofen|ibuprofen|mesh-list
14858419|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14858420|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14858421|NCT01066676|Analgesics|analgesics|mesh-ancestor
14858422|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
14858423|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207634|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
14295886|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295887|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295888|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295889|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14295890|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14295891|NCT00584987|Fluticasone|fluticasone|mesh-list
14295892|NCT00584987|Xhance|xhance|mesh-list
14295893|NCT00584987|Phenylephrine|phenylephrine|mesh-list
14295894|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
14295895|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295896|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14708666|NCT00428064|Cyclosporine|cyclosporine|mesh-list
14708667|NCT00428064|Sirolimus|sirolimus|mesh-list
14858424|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858425|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858426|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858427|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14858428|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858429|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858430|NCT01066689|Rituximab|rituximab|mesh-list
14858431|NCT01066689|Citric Acid|citric acid|mesh-list
14858432|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
14858433|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14858434|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858435|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
14858436|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858437|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858438|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
14858439|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14858440|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
14708668|NCT00428064|Cyclosporins|cyclosporins|mesh-list
14708669|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708670|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708671|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708672|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
14858441|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
14858442|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858443|NCT01066728|Theophylline|theophylline|mesh-list
14858444|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14858445|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
14858446|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858447|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858448|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14858449|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
14858450|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14858451|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858452|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858453|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
14858454|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14858455|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14858456|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
14858457|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858458|NCT01066754|Fexofenadine|fexofenadine|mesh-list
14858459|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14858460|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14858461|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14858462|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
14858463|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
14858464|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858465|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858466|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858467|NCT01066767|Fexofenadine|fexofenadine|mesh-list
14858468|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14858469|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15207635|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207636|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708673|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708674|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
15207637|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
15207638|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207639|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15207640|NCT03712735|Narcotics|narcotics|mesh-ancestor
15207641|NCT03712735|Analgesics|analgesics|mesh-ancestor
14295897|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
15207642|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14858470|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14858471|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
14858472|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
14858473|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858474|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858475|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858476|NCT01066806|Calcium|calcium|mesh-list
14858477|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14858478|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858479|NCT01066832|Paclitaxel|paclitaxel|mesh-list
14858480|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14858481|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858482|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
14858483|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
14858484|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
14858485|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858486|NCT01066845|Tadalafil|tadalafil|mesh-list
14858487|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
14858488|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14858489|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14858490|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858491|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858492|NCT01066845|Urological Agents|urological agents|mesh-ancestor
14858493|NCT01066858|Tenofovir|tenofovir|mesh-list
14858494|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
14858495|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858496|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14858497|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14858498|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858499|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858500|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14708675|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708676|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
14708677|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708678|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14708679|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14708680|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14708681|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708682|NCT00428129|Plasminogen|plasminogen|mesh-list
14708683|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14708684|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14708685|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708686|NCT00428142|Prednisone|prednisone|mesh-list
14708687|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
14708688|NCT00428142|Rituximab|rituximab|mesh-list
14708689|NCT00428142|Vincristine|vincristine|mesh-list
14708690|NCT00428142|Bortezomib|bortezomib|mesh-list
14708691|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708692|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
14708693|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708694|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708695|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14708696|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
14708697|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708698|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708699|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14708700|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708701|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708702|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
14708703|NCT00428142|Hormones|hormones|mesh-ancestor
14708704|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708705|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14708706|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14708707|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
14708708|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
14708709|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
14708710|NCT00428168|Betahistine|betahistine|mesh-list
14708711|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
14708712|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
14708713|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
14708714|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858501|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14858502|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14858503|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858504|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14858505|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858506|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858507|NCT01066962|Ritonavir|ritonavir|mesh-list
14858508|NCT01066962|Darunavir|darunavir|mesh-list
14858509|NCT01066962|Tenofovir|tenofovir|mesh-list
14858510|NCT01066962|Emtricitabine|emtricitabine|mesh-list
14858511|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
14858512|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14858513|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14858514|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
14858515|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858516|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858517|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14858518|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14858519|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
14858520|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858521|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14858522|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14858523|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14858524|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14858525|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14858526|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14858527|NCT01066988|Emollients|emollients|mesh-list
14858528|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14858529|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14858530|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
14858531|NCT01067053|Bevacizumab|bevacizumab|mesh-list
14858532|NCT01067053|Capecitabine|capecitabine|mesh-list
14858533|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
14858534|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14858535|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858536|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14858537|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14858538|NCT01067053|Growth Substances|growth substances|mesh-ancestor
14858539|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858540|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
14708715|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708716|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708717|NCT00428181|Ethanol|ethanol|mesh-list
14708718|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14708719|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708720|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708721|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708722|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14708723|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708724|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14708725|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708726|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708727|NCT00428272|Interferons|interferons|mesh-list
14708728|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
14708729|NCT00428272|Lexatumumab|lexatumumab|mesh-list
14708730|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14708731|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708732|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
14708733|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708734|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
14708735|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708736|NCT00428311|Metformin|metformin|mesh-list
14708737|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
14708738|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14708739|NCT00428311|Estradiol|estradiol|mesh-list
14708740|NCT00428311|Cyproterone|cyproterone|mesh-list
14708741|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14858541|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858542|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
14858543|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858544|NCT01067066|Temozolomide|temozolomide|mesh-list
14858545|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14858546|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
14858547|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858548|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858549|NCT01067118|Insulin|insulin|mesh-list
14858550|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14858551|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
14858552|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14858553|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858554|NCT01067222|Modafinil|modafinil|mesh-list
14858555|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14858556|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858557|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14858558|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14858559|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14858560|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858561|NCT01067235|Modafinil|modafinil|mesh-list
14858562|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14858563|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858564|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14858565|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14858566|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14858567|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858568|NCT01067274|Cytarabine|cytarabine|mesh-list
14858569|NCT01067274|Azacitidine|azacitidine|mesh-list
14858570|NCT01067274|Tretinoin|tretinoin|mesh-list
14858571|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858572|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
14858573|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858574|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858575|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
14858576|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858577|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858578|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
14858579|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858580|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858581|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
14858582|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
14858583|NCT01067287|Pidilizumab|pidilizumab|mesh-list
14858584|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14858585|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858586|NCT01067365|Citric Acid|citric acid|mesh-list
14858587|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
14858588|NCT01067365|Enclomiphene|enclomiphene|mesh-list
14858589|NCT01067365|Clomiphene|clomiphene|mesh-list
14858590|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
14858591|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
14858592|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14858593|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
14858594|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
14858595|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858596|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14858597|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
14858598|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14858599|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858600|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14858601|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
14858602|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14858603|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14858604|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14858605|NCT01067391|Tadalafil|tadalafil|mesh-list
14858606|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
14858607|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14858608|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14858609|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858610|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858611|NCT01067391|Urological Agents|urological agents|mesh-ancestor
14858612|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
14858613|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
14858614|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14858615|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14295898|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14295899|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295900|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14295901|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295902|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14295903|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14295904|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14295905|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14708742|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708743|NCT00428311|Estrogens|estrogens|mesh-ancestor
14708744|NCT00428311|Hormones|hormones|mesh-ancestor
14708745|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14708746|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14708747|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
14708748|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14708749|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14708750|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14708751|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14708752|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
14708753|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
14708754|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708755|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14708756|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14858616|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858617|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858618|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708757|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
14708758|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14858619|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858620|NCT01067430|Diclofenac|diclofenac|mesh-list
14858621|NCT01067430|Etoricoxib|etoricoxib|mesh-list
14858622|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14858623|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14858624|NCT01067430|Analgesics|analgesics|mesh-ancestor
14858625|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
14858626|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858627|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858628|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858629|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858630|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14858631|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858632|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708759|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14708760|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14858633|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14858634|NCT01067443|Amphotericin B|amphotericin b|mesh-list
14858635|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14708761|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708762|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708763|NCT00428428|Isoproterenol|isoproterenol|mesh-list
14708764|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14708765|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14708766|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
14708767|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708768|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708769|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708770|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14708771|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
14858636|NCT01067443|Miltefosine|miltefosine|mesh-list
14858637|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14858638|NCT01067443|Amebicides|amebicides|mesh-ancestor
14295906|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
14858639|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14858640|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14858641|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858642|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14858643|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
14858644|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858645|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
14858646|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14858647|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
14858648|NCT01067534|Albuterol|albuterol|mesh-list
14858649|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14858650|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
14858651|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858652|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858653|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14858654|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
14858655|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
14858656|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14708772|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708773|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14708774|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
14708775|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14708776|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
14708777|NCT00428428|Protective Agents|protective agents|mesh-ancestor
14708778|NCT00428454|Sirolimus|sirolimus|mesh-list
14858657|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14858658|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14858659|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14858660|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
14858661|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858662|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858663|NCT01067547|Iron|iron|mesh-list
14858664|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14858665|NCT01067547|Trace Elements|trace elements|mesh-ancestor
14858666|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
14858667|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858668|NCT01067547|Hematinics|hematinics|mesh-ancestor
14858669|NCT01067599|Nicotine|nicotine|mesh-list
14858670|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14858671|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
14858672|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858673|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858674|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14858675|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14858676|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
14858677|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858678|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858679|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
14858680|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14858681|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14858682|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858683|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
14858684|NCT01067638|Coagulants|coagulants|mesh-ancestor
14858685|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
14858686|NCT01067677|Promethazine|promethazine|mesh-list
14708779|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14858687|NCT01067677|Ondansetron|ondansetron|mesh-list
15207643|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15207644|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
15207645|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
15207646|NCT03712670|Aflibercept|aflibercept|mesh-list
15207647|NCT03712670|Carotenoids|carotenoids|mesh-list
15207648|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15207649|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15207650|NCT03712670|Growth Substances|growth substances|mesh-ancestor
15207651|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207652|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
14858688|NCT01067677|Metoclopramide|metoclopramide|mesh-list
14858689|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
14708780|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858690|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
15224922|NCT02017964|Carboplatin|carboplatin|mesh-list
14858691|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858692|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858693|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708781|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14708782|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708783|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
14708784|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708785|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
14708786|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708787|NCT00428480|Methamphetamine|methamphetamine|mesh-list
14708788|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14708789|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708790|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
14708791|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
14708792|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708793|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
14708794|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858694|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
14858695|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
14858696|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14858697|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
14858698|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858699|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858700|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14858701|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14858702|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14858703|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14858704|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14858705|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14858706|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14858707|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
14858708|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
14858709|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
14858710|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14858711|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
14858712|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
14858713|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14858714|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14858715|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14858716|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
14858717|NCT01067690|Indinavir|indinavir|mesh-list
14858718|NCT01067690|Bleomycin|bleomycin|mesh-list
14858719|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14858720|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14858721|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
14858722|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858723|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858724|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14858725|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14858726|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
14858727|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708795|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708796|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
14708797|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14708798|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14708799|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207653|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858728|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14858729|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913384|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913385|NCT01375101|Protective Agents|protective agents|mesh-ancestor
14913386|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913387|NCT01375244|Lisinopril|lisinopril|mesh-list
14913388|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15207654|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
15207655|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708800|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14708801|NCT00428519|Aprepitant|aprepitant|mesh-list
14913389|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
15207656|NCT03712670|Protective Agents|protective agents|mesh-ancestor
15207657|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15207658|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15207659|NCT03712670|Analgesics|analgesics|mesh-ancestor
15207660|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
14858730|NCT01067898|Vitamin D|vitamin d|mesh-list
14858731|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
14858732|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
14858733|NCT01067898|Vitamins|vitamins|mesh-list
14858734|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
14858735|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
14858736|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858737|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14858738|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14858739|NCT01067898|Antacids|antacids|mesh-ancestor
14858740|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858741|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858742|NCT01067950|Pancrelipase|pancrelipase|mesh-list
14858743|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858744|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
14858745|NCT01067989|Pamidronate|pamidronate|mesh-list
14858746|NCT01067989|Celecoxib|celecoxib|mesh-list
14858747|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
14858748|NCT01067989|Capecitabine|capecitabine|mesh-list
14858749|NCT01067989|Methotrexate|methotrexate|mesh-list
14858750|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858751|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
14858752|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858753|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858754|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14858755|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
14858756|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858757|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858758|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14858759|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858760|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
14858761|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14858762|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
14858763|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14858764|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
14858765|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858766|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14858767|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14858768|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14858769|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14858770|NCT01067989|Analgesics|analgesics|mesh-ancestor
14858771|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
14858772|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858773|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858774|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15207661|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207662|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207663|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207664|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
15207665|NCT03712540|Rifampin|rifampin|mesh-list
15207666|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15207667|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
15207668|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207669|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207670|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
15207671|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15207672|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207673|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207674|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15207675|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14708802|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
14708803|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
14708804|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
14708805|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708806|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708807|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708808|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14708809|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708810|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708811|NCT00428545|Bevacizumab|bevacizumab|mesh-list
14708812|NCT00428545|Bortezomib|bortezomib|mesh-list
14708813|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14858775|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14858776|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14858777|NCT01068054|Cyclosporine|cyclosporine|mesh-list
14858778|NCT01068054|Tacrolimus|tacrolimus|mesh-list
14858779|NCT01068054|Cyclosporins|cyclosporins|mesh-list
14858780|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858781|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
14858782|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858783|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14858784|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858785|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858786|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
14858787|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858788|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
14858789|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858790|NCT01068067|Tacrolimus|tacrolimus|mesh-list
14858791|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858792|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
14858793|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858794|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14708814|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708815|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14295907|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708816|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14708817|NCT00428545|Growth Substances|growth substances|mesh-ancestor
14708818|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708819|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
14708820|NCT00428558|Cytarabine|cytarabine|mesh-list
14708821|NCT00428558|Daunorubicin|daunorubicin|mesh-list
14858795|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858796|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858797|NCT01068093|Ezetimibe|ezetimibe|mesh-list
14858798|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14858799|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14858800|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
14858801|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858802|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15207676|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15207677|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15207678|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15207679|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15207680|NCT03712475|Pregabalin|pregabalin|mesh-list
15207681|NCT03712475|Analgesics|analgesics|mesh-ancestor
15207682|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
15207683|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207684|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858803|NCT01068132|Cetuximab|cetuximab|mesh-list
14858804|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14858805|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858806|NCT01068223|Cetirizine|cetirizine|mesh-list
14858807|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14858808|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14708822|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708823|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
14708824|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708825|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708826|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
14858809|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14858810|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
14858811|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
14858812|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858813|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858814|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858815|NCT01068301|Plerixafor|plerixafor|mesh-list
14858816|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14858817|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14858818|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
14858819|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858820|NCT01068327|Leucovorin|leucovorin|mesh-list
14858821|NCT01068327|Gemcitabine|gemcitabine|mesh-list
14858822|NCT01068327|Nelfinavir|nelfinavir|mesh-list
14858823|NCT01068327|Fluorouracil|fluorouracil|mesh-list
14858824|NCT01068327|Calcium|calcium|mesh-list
14858825|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
14858826|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858827|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
14858828|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858829|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858830|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
15207685|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
14708827|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708828|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708829|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
15207686|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15207687|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207688|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207689|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15207690|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14708830|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708831|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14708832|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14708833|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14708834|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708835|NCT00428649|Selenium|selenium|mesh-list
14708836|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
14708837|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708838|NCT00428649|Protective Agents|protective agents|mesh-ancestor
14708839|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708840|NCT00428649|Trace Elements|trace elements|mesh-ancestor
14708841|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
14708842|NCT00428701|Esomeprazole|esomeprazole|mesh-list
14858831|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858832|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858833|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858834|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
14858835|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858836|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14858837|NCT01068327|Antidotes|antidotes|mesh-ancestor
14858838|NCT01068327|Protective Agents|protective agents|mesh-ancestor
14858839|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
14858840|NCT01068327|Vitamins|vitamins|mesh-ancestor
14858841|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
14858842|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14858843|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14858844|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
14858845|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14858846|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14858847|NCT01068353|Etanercept|etanercept|mesh-list
14858848|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14858849|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14858850|NCT01068353|Analgesics|analgesics|mesh-ancestor
14858851|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
14858852|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858853|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858854|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858855|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858856|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14858857|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858858|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
14858859|NCT01068392|Prednisolone|prednisolone|mesh-list
14858860|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
14858861|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858862|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858863|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
14858864|NCT01068392|Hormones|hormones|mesh-ancestor
14858865|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14858866|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858867|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14858868|NCT01068405|Methotrexate|methotrexate|mesh-list
14858869|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14858870|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
14858871|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14858872|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858873|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14858874|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
14858875|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858876|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858877|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
14858878|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858879|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14858880|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14858881|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
14858882|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858883|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15207691|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14858884|NCT01068444|Pioglitazone|pioglitazone|mesh-list
14858885|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14858886|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858887|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14858888|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858889|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14858890|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858891|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858892|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
14858893|NCT01068756|Rifampin|rifampin|mesh-list
14858894|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15207692|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207693|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15207694|NCT03712423|Docetaxel|docetaxel|mesh-list
15207695|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207696|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
15207697|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
15207698|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
15207699|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858895|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858896|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14858897|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858898|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14858899|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
14858900|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14858901|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858902|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
14858903|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14858904|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858905|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14858906|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14858907|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14858908|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14858909|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14858910|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14858911|NCT01068795|Enoxaparin|enoxaparin|mesh-list
14858912|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
14858913|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14858914|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14858915|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858916|NCT01068847|Cycloserine|cycloserine|mesh-list
14858917|NCT01068847|Verapamil|verapamil|mesh-list
14858918|NCT01068847|Nifedipine|nifedipine|mesh-list
14858919|NCT01068847|Tizanidine|tizanidine|mesh-list
14858920|NCT01068847|Naloxone|naloxone|mesh-list
14858921|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14858922|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858923|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
14858924|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858925|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14858926|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14858927|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858928|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14858929|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
14858930|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
14858931|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14858932|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14858933|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858934|NCT01068847|Renal Agents|renal agents|mesh-ancestor
14858935|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14858936|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
14858937|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14858938|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
14858939|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14858940|NCT01068847|Analgesics|analgesics|mesh-ancestor
14858941|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
14858942|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14858943|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14858944|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
14858945|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
14858946|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14858947|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14858948|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14858949|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
15207700|NCT03712397|Irinotecan|irinotecan|mesh-list
15207701|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14295908|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295909|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
14295910|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
14858950|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14858951|NCT01068925|Dolutegravir|dolutegravir|mesh-list
14858952|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14858953|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14858954|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858955|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858956|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14858957|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14858958|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
14858959|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14858960|NCT01068977|Bevacizumab|bevacizumab|mesh-list
14858961|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14858962|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14858963|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858964|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14858965|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14858966|NCT01068977|Growth Substances|growth substances|mesh-ancestor
14858967|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858968|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
14858969|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
14858970|NCT01069042|Enalapril|enalapril|mesh-list
14858971|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14858972|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
14858973|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858974|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858975|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14858976|NCT01069055|Acetaminophen|acetaminophen|mesh-list
14858977|NCT01069055|Lornoxicam|lornoxicam|mesh-list
14858978|NCT01069055|Piroxicam|piroxicam|mesh-list
14858979|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14858980|NCT01069055|Analgesics|analgesics|mesh-ancestor
14858981|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
14858982|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14858983|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14858984|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
14858985|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14858986|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14858987|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14858988|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14858989|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14858990|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858991|NCT01069081|Cisplatin|cisplatin|mesh-list
14858992|NCT01069081|Docetaxel|docetaxel|mesh-list
14858993|NCT01069081|Esomeprazole|esomeprazole|mesh-list
14858994|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14858995|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295911|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14295912|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14295913|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
14295914|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14295915|NCT00584987|Protective Agents|protective agents|mesh-ancestor
14295916|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
14295917|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14858996|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
14858997|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
14858998|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14858999|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15207702|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15207703|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295918|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
14859000|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859001|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14859002|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859003|NCT01069094|Leuprolide|leuprolide|mesh-list
15207704|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207705|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207706|NCT03712345|Vilobelimab|vilobelimab|mesh-list
15207707|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15207708|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207709|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
15207710|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859004|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14859005|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
14859006|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859007|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859008|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14859009|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859010|NCT01069133|Rifaximin|rifaximin|mesh-list
14859011|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859012|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859013|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859014|NCT01069159|Propranolol|propranolol|mesh-list
14859015|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14859016|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14859017|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
14859018|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859019|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859020|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859021|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14859022|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859023|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859024|NCT01069198|Vitamin A|vitamin a|mesh-list
14859025|NCT01069198|Albendazole|albendazole|mesh-list
14859026|NCT01069198|Vitamins|vitamins|mesh-ancestor
14859027|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
14859028|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859029|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708843|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14708844|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14708845|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14859030|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859031|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
14859032|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14859033|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859034|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
14859035|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14859036|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14859037|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859038|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
14859039|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859040|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14859041|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14708846|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708847|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859042|NCT01069263|Protective Agents|protective agents|mesh-ancestor
14859043|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859044|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14859045|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
14859046|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859047|NCT01069302|Clopidogrel|clopidogrel|mesh-list
14859048|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14859049|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14708848|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
14708849|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14708850|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
14708851|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708852|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708853|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14708854|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
14708855|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14859050|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14859051|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14859052|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
14859053|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859054|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859055|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859056|NCT01069328|Paclitaxel|paclitaxel|mesh-list
14859057|NCT01069328|Bevacizumab|bevacizumab|mesh-list
14859058|NCT01069328|Carboplatin|carboplatin|mesh-list
14859059|NCT01069328|Sorafenib|sorafenib|mesh-list
14859060|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14859061|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859062|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859063|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
14859064|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859065|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859066|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14859067|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14859068|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14859069|NCT01069328|Growth Substances|growth substances|mesh-ancestor
14859070|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859071|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
14859072|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859073|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859074|NCT01069536|Metoclopramide|metoclopramide|mesh-list
14859075|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
14859076|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
14859077|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859078|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859079|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859080|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14859081|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14859082|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
14859083|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859084|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913390|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913391|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913392|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14913393|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14913394|NCT01375244|Protective Agents|protective agents|mesh-ancestor
14913395|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913396|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14913397|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14913398|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913399|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
14913400|NCT01375322|Amlodipine|amlodipine|mesh-list
14913401|NCT01375322|Valsartan|valsartan|mesh-list
14913402|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14913403|NCT01375322|Benazepril|benazepril|mesh-list
14913404|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14913405|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14913406|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913407|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913408|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14913409|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913410|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
14913411|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14913412|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14913413|NCT01375322|Diuretics|diuretics|mesh-ancestor
14913414|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
14913415|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14913416|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14913417|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
14913418|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913419|NCT01375335|Dobutamine|dobutamine|mesh-list
14913420|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14913421|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
14913422|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
14913423|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913424|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913425|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14913426|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14913427|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15207711|NCT03712241|Indomethacin|indomethacin|mesh-list
14859085|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14859086|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859087|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859088|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859089|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859090|NCT01069770|Sunitinib|sunitinib|mesh-list
14708856|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
14708857|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708858|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708859|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14708860|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
14708861|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
14708862|NCT00428727|Protective Agents|protective agents|mesh-ancestor
14708863|NCT00428766|Farletuzumab|farletuzumab|mesh-list
14708864|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708865|NCT00428818|Doxycycline|doxycycline|mesh-list
14708866|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14708867|NCT00428818|Trimethoprim|trimethoprim|mesh-list
14708868|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
14708869|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859091|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859092|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14859093|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14859094|NCT01069770|Growth Substances|growth substances|mesh-ancestor
14859095|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859096|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
14859097|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859098|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859099|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859100|NCT01069796|Paclitaxel|paclitaxel|mesh-list
14859101|NCT01069796|Bevacizumab|bevacizumab|mesh-list
14859102|NCT01069796|Capecitabine|capecitabine|mesh-list
14859103|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14859104|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859105|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859106|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
15207712|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14708870|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708871|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
15207713|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15207714|NCT03712241|Analgesics|analgesics|mesh-ancestor
15207715|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
15207716|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207717|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207718|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14295919|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708872|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14708873|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14708874|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14708875|NCT00428818|Renal Agents|renal agents|mesh-ancestor
14708876|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14708877|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708878|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708879|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14708880|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14708881|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14708882|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
14708883|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14708884|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
14708885|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859107|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859108|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859109|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14859110|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14859111|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14859112|NCT01069796|Growth Substances|growth substances|mesh-ancestor
14859113|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859114|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
14708886|NCT00428883|Expectorants|expectorants|mesh-ancestor
14708887|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
14708888|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14708889|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
14708890|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708891|NCT00428883|Protective Agents|protective agents|mesh-ancestor
14708892|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708893|NCT00428883|Antidotes|antidotes|mesh-ancestor
14859115|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14859116|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
14859117|NCT01069822|Midazolam|midazolam|mesh-list
14859118|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14859119|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14859120|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859121|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859122|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14859123|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14859124|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14859125|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14859126|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
14859127|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
14859128|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
14859129|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
14859130|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859131|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859132|NCT01069874|Vitamin D|vitamin d|mesh-list
14859133|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
14859134|NCT01069874|Vitamins|vitamins|mesh-ancestor
14859135|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
14859136|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859137|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14859138|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14859139|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14859140|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
14859141|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859142|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
14859143|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859144|NCT01069965|BGP 15|bgp 15|mesh-list
14859145|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859146|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859147|NCT01070030|Amlodipine|amlodipine|mesh-list
14859148|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14859149|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859150|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14859151|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14859152|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859153|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14859154|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859155|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
15207719|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207720|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
15207721|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
15207722|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15207723|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15207724|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207725|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207726|NCT03712163|Ketotifen|ketotifen|mesh-list
15207727|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
15207728|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
15207729|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15207730|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
14859156|NCT01070030|Diuretics|diuretics|mesh-ancestor
15207731|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
15207732|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708894|NCT00428896|Gefitinib|gefitinib|mesh-list
14859157|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
14859158|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14859159|NCT01070108|Ketamine|ketamine|mesh-list
14859160|NCT01070108|Analgesics|analgesics|mesh-ancestor
14859161|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
14859162|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859163|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859164|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14859165|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14859166|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
14859167|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
14859168|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859169|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14859170|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14859171|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859172|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859173|NCT01070160|Metformin|metformin|mesh-list
14859174|NCT01070160|Progesterone|progesterone|mesh-list
14859175|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14859176|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859177|NCT01070160|Progestins|progestins|mesh-ancestor
14859178|NCT01070160|Hormones|hormones|mesh-ancestor
14859179|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859180|NCT01070186|Sunitinib|sunitinib|mesh-list
14859181|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859182|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14859183|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14859184|NCT01070186|Growth Substances|growth substances|mesh-ancestor
14859185|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859186|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14859187|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859188|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859189|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859190|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
14859191|NCT01070225|Propranolol|propranolol|mesh-list
14859192|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859193|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14859194|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14859195|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
14859196|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859197|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859198|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859199|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14859200|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859201|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859202|NCT01070277|Albendazole|albendazole|mesh-list
14859203|NCT01070277|Tinidazole|tinidazole|mesh-list
14859204|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
14859205|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14859206|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859207|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
14859208|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14859209|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14859210|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859211|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
14859212|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859213|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859214|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859215|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
14859216|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859217|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14859218|NCT01070290|Capecitabine|capecitabine|mesh-list
14859219|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
14859220|NCT01070290|Irinotecan|irinotecan|mesh-list
14859221|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14859222|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
14859223|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859224|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859225|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14859226|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14859227|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859228|NCT01070407|Cloricromen|cloricromen|mesh-list
14859229|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14859230|NCT01070446|Choline|choline|mesh-list
14859231|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
14859232|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14859233|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
14859234|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859235|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859236|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14859237|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
14859238|NCT01070472|Misoprostol|misoprostol|mesh-list
14859239|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14859240|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
14859241|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859242|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859243|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14859244|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859245|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
14859246|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14859247|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859248|NCT01070511|Tadalafil|tadalafil|mesh-list
14859249|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859250|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14859251|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14859252|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859253|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859254|NCT01070511|Urological Agents|urological agents|mesh-ancestor
14859255|NCT01070524|Budesonide|budesonide|mesh-list
14859256|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14859257|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859258|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14859259|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
14859260|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859261|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859262|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14295920|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295921|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14859263|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
14859264|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
14859265|NCT01070524|Hormones|hormones|mesh-ancestor
14859266|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859267|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
14859268|NCT01070615|Prucalopride|prucalopride|mesh-list
14859269|NCT01070615|Laxatives|laxatives|mesh-ancestor
14859270|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859271|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14859272|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14859273|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
14859274|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859275|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859276|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859277|NCT01070628|Levodopa|levodopa|mesh-list
14859278|NCT01070628|Carbidopa|carbidopa|mesh-list
14859279|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14859280|NCT01070628|Entacapone|entacapone|mesh-list
14859281|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14859282|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14859283|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
14859284|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859285|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859286|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859287|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14859288|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859289|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14859290|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
14859291|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
14859292|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14859293|NCT01070641|Carvedilol|carvedilol|mesh-list
14859294|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14859295|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14859296|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
14859297|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859298|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859299|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859300|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859301|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
14859302|NCT01070641|Protective Agents|protective agents|mesh-ancestor
14859303|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14859304|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14859305|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14859306|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859307|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14859308|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14859309|NCT01070667|Dronedarone|dronedarone|mesh-list
14859310|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14859311|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
15207733|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207734|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207735|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15207736|NCT03712111|Norepinephrine|norepinephrine|mesh-list
15207737|NCT03712111|Bupivacaine|bupivacaine|mesh-list
15207738|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
15207739|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
15207740|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207741|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207742|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
15207743|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859312|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14859313|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15207744|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15207745|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15207746|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14859314|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859315|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14859316|NCT01070680|Analgesics|analgesics|mesh-ancestor
14859317|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
14859318|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859319|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14859320|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14859321|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14859322|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
14859323|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859324|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859325|NCT01070706|Gemcitabine|gemcitabine|mesh-list
14859326|NCT01070706|Paclitaxel|paclitaxel|mesh-list
14859327|NCT01070706|Sunitinib|sunitinib|mesh-list
14859328|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14859329|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859330|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859331|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
14859332|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859333|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859334|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14859335|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
14859336|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
14859337|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859338|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859339|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859340|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
14859341|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859342|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14859343|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14859344|NCT01070706|Growth Substances|growth substances|mesh-ancestor
14859345|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
14859346|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859347|NCT01070732|Acetaminophen|acetaminophen|mesh-list
14859348|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14859349|NCT01070732|Analgesics|analgesics|mesh-ancestor
14859350|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
14859351|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859352|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859353|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
14859354|NCT01070745|Ibuprofen|ibuprofen|mesh-list
14859355|NCT01070745|Indomethacin|indomethacin|mesh-list
14859356|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14859357|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15207747|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207748|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207749|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
15207750|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
15207751|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15207752|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15207753|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15207754|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207755|NCT03711708|Sertraline|sertraline|mesh-list
15207756|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
15207757|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15207758|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15207759|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15207760|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207761|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207762|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859358|NCT01070745|Analgesics|analgesics|mesh-ancestor
14859359|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
14859360|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859361|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859362|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859363|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859364|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14859365|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859366|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859367|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
14859368|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
14859369|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859370|NCT01070758|Lanreotide|lanreotide|mesh-list
14859371|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859372|NCT01070823|Natalizumab|natalizumab|mesh-list
14859373|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
14859374|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859375|NCT01070836|Natalizumab|natalizumab|mesh-list
14859376|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
14859377|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859378|NCT01070862|Thalidomide|thalidomide|mesh-list
14859379|NCT01070862|Dexamethasone|dexamethasone|mesh-list
14859380|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
14859381|NCT01070862|Doxorubicin|doxorubicin|mesh-list
14859382|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14859383|NCT01070862|Melphalan|melphalan|mesh-list
14859384|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
14859385|NCT01070862|Vincristine|vincristine|mesh-list
14859386|NCT01070862|BB 1101|bb 1101|mesh-list
14859387|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859388|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
14859389|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
14859390|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859391|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859392|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859393|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
14859394|NCT01070862|Hormones|hormones|mesh-ancestor
14859395|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859396|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14859397|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859398|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
14859399|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859400|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859401|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14859402|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14859403|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14859404|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14859405|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
14859406|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14859407|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859408|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
14859409|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
14859410|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859411|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859412|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14859413|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14859414|NCT01070862|Growth Substances|growth substances|mesh-ancestor
14859415|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
14859416|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859417|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14859418|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859419|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
14859420|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859421|NCT01070875|Heparin|heparin|mesh-list
14859422|NCT01070875|Calcium heparin|calcium heparin|mesh-list
14859423|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
14859424|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14859425|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14859426|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859427|NCT01070927|R04929097|r04929097|mesh-list
14859428|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859429|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859430|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14859431|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859432|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859433|NCT01071005|Leuprolide|leuprolide|mesh-list
14859434|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14859435|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
14859436|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859437|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859438|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14859439|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859440|NCT01071057|Morphine|morphine|mesh-list
14859441|NCT01071057|Naloxone|naloxone|mesh-list
14859442|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14859443|NCT01071057|Narcotics|narcotics|mesh-ancestor
14859444|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859445|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859446|NCT01071057|Analgesics|analgesics|mesh-ancestor
14859447|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
14859448|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859449|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14859450|NCT01071122|Valsartan|valsartan|mesh-list
14859451|NCT01071122|Nifedipine|nifedipine|mesh-list
14859452|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859453|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14859454|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14859455|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859456|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14859457|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14859458|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14859459|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859460|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859461|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
14859462|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859463|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14859464|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
14859465|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14859466|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14859467|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14859468|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859469|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859470|NCT01071161|Azithromycin|azithromycin|mesh-list
14859471|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859472|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859473|NCT01071174|Dapivirine|dapivirine|mesh-list
14859474|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14859475|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14859476|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
14859477|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859478|NCT01071187|Varenicline|varenicline|mesh-list
14859479|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14859480|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14859481|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
14859482|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859483|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859484|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859485|NCT01071291|Niacin|niacin|mesh-list
14859486|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
14859487|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14859488|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
14859489|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859490|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14859491|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859492|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
14859493|NCT01071291|Vitamins|vitamins|mesh-ancestor
14859494|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
14859495|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859496|NCT01071304|Midazolam|midazolam|mesh-list
14859497|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14859498|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14859499|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859500|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859501|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14859502|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14859503|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14859504|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14859505|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
14859506|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
14859507|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
14859508|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
14859509|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859510|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859511|NCT01071369|Betamethasone|betamethasone|mesh-list
14859512|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
14859513|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14859514|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
14859515|NCT01071369|Lidocaine|lidocaine|mesh-list
14859516|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14859517|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
14859518|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
14859519|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859520|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859521|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
14859522|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859523|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14859524|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14859525|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14859526|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14859527|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859528|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859529|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
14859530|NCT01071369|Hormones|hormones|mesh-ancestor
14859531|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859532|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14859533|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913428|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
14913429|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913430|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913431|NCT01375335|Protective Agents|protective agents|mesh-ancestor
14913432|NCT01375348|Remifentanil|remifentanil|mesh-list
14913433|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14913434|NCT01375348|Narcotics|narcotics|mesh-ancestor
14913435|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913436|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913437|NCT01375348|Analgesics|analgesics|mesh-ancestor
14913438|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
14913439|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913440|NCT01375361|Albuterol|albuterol|mesh-list
14913441|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14913442|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
14913443|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913444|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913445|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14913446|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913447|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
14859534|NCT01071499|Morphine|morphine|mesh-list
14859535|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14859536|NCT01071499|Narcotics|narcotics|mesh-ancestor
14859537|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859538|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859539|NCT01071499|Analgesics|analgesics|mesh-ancestor
14859540|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
14859541|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859542|NCT01071525|Niacin|niacin|mesh-list
14859543|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14859544|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
14859545|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859546|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14859547|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859548|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
14859549|NCT01071525|Vitamins|vitamins|mesh-ancestor
14859550|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
14859551|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859552|NCT01071564|R04929097|r04929097|mesh-list
14859553|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859554|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859555|NCT01071655|Fluorouracil|fluorouracil|mesh-list
14859556|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
14859557|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859558|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14859559|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859560|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859561|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
14859562|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859563|NCT01071681|Telmisartan|telmisartan|mesh-list
14859564|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859565|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14859566|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14859567|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859568|NCT01071694|Interferons|interferons|mesh-list
14859569|NCT01071694|Interferon-beta|interferon-beta|mesh-list
14859570|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
14859571|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859572|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
14859573|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859574|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
14859575|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859576|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14859577|NCT01071772|Insulin|insulin|mesh-list
14859578|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14859579|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859580|NCT01071889|Flumazenil|flumazenil|mesh-list
14859581|NCT01071889|Antidotes|antidotes|mesh-ancestor
14859582|NCT01071889|Protective Agents|protective agents|mesh-ancestor
14859583|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859584|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
14859585|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
14859586|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859587|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859588|NCT01071928|Docetaxel|docetaxel|mesh-list
14859589|NCT01071928|Vadimezan|vadimezan|mesh-list
14859590|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859591|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859592|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
14859593|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859594|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859595|NCT01072045|Prednisone|prednisone|mesh-list
14859596|NCT01072045|Propranolol|propranolol|mesh-list
14859597|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859598|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
14859599|NCT01072045|Hormones|hormones|mesh-ancestor
14859600|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859601|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859602|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14859603|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859604|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14859605|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14859606|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
14859607|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859608|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859609|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14859610|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859611|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859612|NCT01072058|Adalimumab|adalimumab|mesh-list
14859613|NCT01072058|Etanercept|etanercept|mesh-list
14859614|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14859615|NCT01072058|Infliximab|infliximab|mesh-list
14859616|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859617|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859618|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
14859619|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859620|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14859621|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14859622|NCT01072058|Analgesics|analgesics|mesh-ancestor
14859623|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
14859624|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859625|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859626|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859627|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
14859628|NCT01072071|Furosemide|furosemide|mesh-list
14859629|NCT01072071|Diuretics|diuretics|mesh-ancestor
14859630|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
14859631|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859632|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14859633|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14859634|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859635|NCT01072097|Atorvastatin|atorvastatin|mesh-list
14859636|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14859637|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14859638|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
14859639|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859640|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14859641|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14859642|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859643|NCT01072175|Trametinib|trametinib|mesh-list
14859644|NCT01072175|Dabrafenib|dabrafenib|mesh-list
14859645|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859646|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859647|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859648|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859649|NCT01072240|Rituximab|rituximab|mesh-list
14859650|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14859651|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859652|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
14859653|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859654|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859655|NCT01072318|Letrozole|letrozole|mesh-list
15207763|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
15207764|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207765|NCT03711474|Dexamethasone|dexamethasone|mesh-list
15207766|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207767|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
14859656|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859657|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14708895|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708896|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14708897|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708898|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708899|NCT00428909|Acetaminophen|acetaminophen|mesh-list
14295922|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
14295923|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14295924|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
14295925|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295926|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295927|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14295928|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
14295929|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
14708900|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
14708901|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708902|NCT00428909|Analgesics|analgesics|mesh-ancestor
14708903|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
14708904|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708905|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708906|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
14708907|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708908|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859658|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14859659|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859660|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859661|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14859662|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
14859663|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859664|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859665|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
14859666|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14859667|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859668|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14859669|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859670|NCT01072604|Aspirin|aspirin|mesh-list
14859671|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14859672|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14859673|NCT01072604|Analgesics|analgesics|mesh-ancestor
14859674|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
14859675|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859676|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859677|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207768|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
15207769|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207770|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207771|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207772|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
15207773|NCT03711474|Hormones|hormones|mesh-ancestor
15207774|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207775|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15207776|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207777|NCT03711422|Afatinib|afatinib|mesh-list
15207778|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207779|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15207780|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207781|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224923|NCT02017964|Methotrexate|methotrexate|mesh-list
15224924|NCT02017964|Etoposide|etoposide|mesh-list
15224925|NCT02017964|Vincristine|vincristine|mesh-list
15224926|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
15224927|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
15224928|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224929|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
15224930|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224931|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859678|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859679|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14859680|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14859681|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859682|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14859683|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14859684|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859685|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
14859686|NCT01072695|Ribavirin|ribavirin|mesh-list
14859687|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14859688|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
14859689|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859690|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
14859691|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859692|NCT01072734|Vaccines|vaccines|mesh-list
14859693|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
14859694|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859695|NCT01072747|Heparin|heparin|mesh-list
14859696|NCT01072747|Calcium heparin|calcium heparin|mesh-list
14859697|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
14859698|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14859699|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14859700|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859701|NCT01072786|Vaccines|vaccines|mesh-list
14859702|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
14859703|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859704|NCT01072812|Phenserine|phenserine|mesh-list
14859705|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14859706|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859707|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859708|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
14859709|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859710|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859711|NCT01072890|Sirolimus|sirolimus|mesh-list
14859712|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859713|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859714|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14859715|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859716|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
14859717|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859718|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
14859719|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859720|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
14859721|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859722|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295930|NCT00585013|Protective Agents|protective agents|mesh-ancestor
14859723|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14295931|NCT00585039|Albuterol|albuterol|mesh-list
15207782|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15207783|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207784|NCT03711279|Apatinib|apatinib|mesh-list
15207785|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207786|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15207787|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207788|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708909|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708910|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708911|NCT00429065|Rituximab|rituximab|mesh-list
14708912|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14859724|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14859725|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859726|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859727|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859728|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14859729|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14859730|NCT01072955|Heparin|heparin|mesh-list
14859731|NCT01072955|Calcium heparin|calcium heparin|mesh-list
14859732|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
14859733|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14708913|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708914|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
14859734|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14859735|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859736|NCT01073007|Simvastatin|simvastatin|mesh-list
14859737|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14859738|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14859739|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
14859740|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859741|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14859742|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14859743|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859744|NCT01073059|Ertapenem|ertapenem|mesh-list
14859745|NCT01073059|Valproic Acid|valproic acid|mesh-list
14859746|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
14859747|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859748|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859749|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
14859750|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859751|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859752|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
14859753|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14859754|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859755|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14859756|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859757|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859758|NCT01073111|Sirolimus|sirolimus|mesh-list
14859759|NCT01073111|Everolimus|everolimus|mesh-list
14859760|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859761|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859762|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
14859763|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859764|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859765|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859766|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14859767|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
14859768|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
14708915|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708916|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207789|NCT03711253|Tenofovir|tenofovir|mesh-list
15207790|NCT03711253|Emtricitabine|emtricitabine|mesh-list
15207791|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
14859769|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14859770|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859771|NCT01073189|Fenoldopam|fenoldopam|mesh-list
14859772|NCT01073189|Furosemide|furosemide|mesh-list
14859773|NCT01073189|Diuretics|diuretics|mesh-ancestor
14859774|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
14859775|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859776|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14859777|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14859778|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859779|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14859780|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859781|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
14859782|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
14859783|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859784|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14859785|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14859786|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859787|NCT01073319|Rivastigmine|rivastigmine|mesh-list
14859788|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14859789|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859790|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859791|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
14859792|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859793|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859794|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14859795|NCT01073319|Protective Agents|protective agents|mesh-ancestor
14913448|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14913449|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14913450|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14913451|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14913452|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
14913453|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913454|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913455|NCT01375387|Lacosamide|lacosamide|mesh-list
14913456|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
14913457|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14913458|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14913459|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913460|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913461|NCT01375400|Aspirin|aspirin|mesh-list
14913462|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14913463|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14913464|NCT01375400|Analgesics|analgesics|mesh-ancestor
14913465|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
14913466|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913467|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913468|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913469|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913470|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14913471|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14913472|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913473|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14913474|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14913475|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913476|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
14913477|NCT01375426|Amoxicillin|amoxicillin|mesh-list
14913478|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14913479|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913480|NCT01375452|Letrozole|letrozole|mesh-list
14708917|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14708918|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14708919|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14708920|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14708921|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708922|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
14708923|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708924|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708925|NCT00429208|Nicotine|nicotine|mesh-list
14708926|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14859796|NCT01073332|Antioxidants|antioxidants|mesh-list
14859797|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859798|NCT01073332|Protective Agents|protective agents|mesh-ancestor
14859799|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859800|NCT01073371|Prilocaine|prilocaine|mesh-list
14859801|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
14859802|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
14859803|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859804|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859805|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
14859806|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859807|NCT01073384|Beclomethasone|beclomethasone|mesh-list
14859808|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859809|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
14859810|NCT01073384|Hormones|hormones|mesh-ancestor
14859811|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859812|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859813|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14859814|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
14859815|NCT01073501|Pregabalin|pregabalin|mesh-list
14859816|NCT01073501|Analgesics|analgesics|mesh-ancestor
14859817|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
14859818|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859819|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859820|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
14859821|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14859822|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14859823|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859824|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14859825|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14859826|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14859827|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14859828|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14859829|NCT01073527|Adenosine|adenosine|mesh-list
14859830|NCT01073527|Albuterol|albuterol|mesh-list
14859831|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14859832|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
14859833|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859834|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859835|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14859836|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
14859837|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
14859838|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859839|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14859840|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14859841|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14859842|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
14859843|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859844|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859845|NCT01073527|Analgesics|analgesics|mesh-ancestor
14859846|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
14859847|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14859848|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
14859849|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14859850|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
14859851|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
14859852|NCT01073540|Cephalexin|cephalexin|mesh-list
14708927|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
14708928|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708929|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708930|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14708931|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14708932|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
14708933|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859853|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859854|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859855|NCT01073553|Cephalexin|cephalexin|mesh-list
14859856|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859857|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859858|NCT01073579|Vigabatrin|vigabatrin|mesh-list
14859859|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
14859860|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859861|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859862|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
14859863|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859864|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859865|NCT01073644|Sunitinib|sunitinib|mesh-list
14859866|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859867|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14859868|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14859869|NCT01073644|Growth Substances|growth substances|mesh-ancestor
14859870|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859871|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
14859872|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14859873|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859874|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859875|NCT01073670|Acetaminophen|acetaminophen|mesh-list
14859876|NCT01073670|Indomethacin|indomethacin|mesh-list
14859877|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14859878|NCT01073670|Analgesics|analgesics|mesh-ancestor
14859879|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
14859880|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859881|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859882|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
14859883|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14859884|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14859885|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859886|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
14859887|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
14859888|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859889|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14859890|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859891|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859892|NCT01073683|Docetaxel|docetaxel|mesh-list
14859893|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859894|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
14859895|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
14859896|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
14859897|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859898|NCT01073696|Granisetron|granisetron|mesh-list
14859899|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
14859900|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
14859901|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859902|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859903|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14859904|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14859905|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
14859906|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14859907|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859908|NCT01073709|Acetaminophen|acetaminophen|mesh-list
14859909|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14859910|NCT01073709|Analgesics|analgesics|mesh-ancestor
14859911|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
14859912|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859913|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859914|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
14859915|NCT01073748|Acetaminophen|acetaminophen|mesh-list
14859916|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14859917|NCT01073748|Analgesics|analgesics|mesh-ancestor
14859918|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
14859919|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14859920|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859921|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
14708934|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708935|NCT00429234|Gemcitabine|gemcitabine|mesh-list
14708936|NCT00429234|Dasatinib|dasatinib|mesh-list
14708937|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14708938|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
14708939|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708940|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708941|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
14859922|NCT01073761|Ritonavir|ritonavir|mesh-list
14859923|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14859924|NCT01073761|Darunavir|darunavir|mesh-list
14859925|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14859926|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14859927|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14859928|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859929|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859930|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14859931|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14859932|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
14859933|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859934|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14859935|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14859936|NCT01073800|Atorvastatin|atorvastatin|mesh-list
14859937|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14859938|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14859939|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
14859940|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859941|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14859942|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14708942|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708943|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859943|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859944|NCT01073813|Minocycline|minocycline|mesh-list
14859945|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859946|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859947|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14859948|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14859949|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859950|NCT01073826|Incretins|incretins|mesh-ancestor
14859951|NCT01073826|Hormones|hormones|mesh-ancestor
14859952|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14859953|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14859954|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
14859955|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859956|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859957|NCT01073839|Gemcitabine|gemcitabine|mesh-list
14859958|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859959|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14859960|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
14859961|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859962|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
14859963|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859964|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859965|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14859966|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
14859967|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859968|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
14859969|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
14859970|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14859971|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14859972|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859973|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859974|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859975|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14859976|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
14859977|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14859978|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14859979|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14859980|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14859981|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14859982|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14859983|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14859984|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14859985|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14859986|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
14859987|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859988|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859989|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14859990|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14859991|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14859992|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
14859993|NCT01073904|Norgestrel|norgestrel|mesh-list
14859994|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14859995|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
14859996|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14859997|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14859998|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14859999|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14860000|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14860001|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14860002|NCT01073995|Triamcinolone|triamcinolone|mesh-list
14860003|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14860004|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14860005|NCT01073995|Bupivacaine|bupivacaine|mesh-list
14860006|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14860007|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
14860008|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
14860009|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860010|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860011|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
14860012|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860013|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14860014|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
14860015|NCT01073995|Hormones|hormones|mesh-ancestor
14860016|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860017|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860018|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
14860019|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860020|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860021|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
14860022|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860023|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860024|NCT01074060|Plerixafor|plerixafor|mesh-list
14860025|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
14860026|NCT01074060|Lenograstim|lenograstim|mesh-list
14860027|NCT01074060|Sargramostim|sargramostim|mesh-list
14860028|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860029|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
14860030|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860031|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860032|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14860033|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
14860034|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860035|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860036|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14860037|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14860038|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14860039|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14860040|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
14860041|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860042|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14708944|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708945|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
14708946|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708947|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14708948|NCT00429247|Trastuzumab|trastuzumab|mesh-list
14708949|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14708950|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14708951|NCT00429377|Tacrolimus|tacrolimus|mesh-list
14708952|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14708953|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
14708954|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708955|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14708956|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708957|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860043|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14860044|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14860045|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860046|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860047|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14860048|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14860049|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14860050|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14860051|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860052|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860053|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860054|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14860055|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14860056|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
14860057|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14860058|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14860059|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
14860060|NCT01074086|Everolimus|everolimus|mesh-list
14708958|NCT00429442|Simvastatin|simvastatin|mesh-list
14708959|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14708960|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14860061|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860062|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860063|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
14860064|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860065|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
14860066|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860067|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860068|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14860069|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14860070|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14860071|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14860072|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860073|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860074|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860075|NCT01074151|Analgesics|analgesics|mesh-ancestor
14860076|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
14708961|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
14708962|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14708963|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14708964|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14708965|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14708966|NCT00429468|Acetaminophen|acetaminophen|mesh-list
14708967|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14708968|NCT00429468|Hydrocodone|hydrocodone|mesh-list
14708969|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14708970|NCT00429468|Analgesics|analgesics|mesh-ancestor
14708971|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
14708972|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14708973|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860077|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860078|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
14860079|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14860080|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
14860081|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
14860082|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14860083|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860084|NCT01074281|Enalapril|enalapril|mesh-list
14860085|NCT01074281|Enalaprilat|enalaprilat|mesh-list
14860086|NCT01074281|Nitrendipine|nitrendipine|mesh-list
14860087|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860088|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860089|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14860090|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
14860091|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14860092|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14860093|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14860094|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14860095|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860096|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
14860097|NCT01074333|Cetuximab|cetuximab|mesh-list
14860098|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860099|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860100|NCT01074346|Interferons|interferons|mesh-list
14860101|NCT01074346|Interferon-beta|interferon-beta|mesh-list
14860102|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
14860103|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860104|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
14860105|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860106|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
14860107|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860108|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14860109|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
14860110|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
14860111|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14860112|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
14860113|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860114|NCT01074359|Protective Agents|protective agents|mesh-ancestor
14860115|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860116|NCT01074411|Carboplatin|carboplatin|mesh-list
14860117|NCT01074411|Bortezomib|bortezomib|mesh-list
14860118|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860119|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14860120|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14860121|NCT01074567|Protective Agents|protective agents|mesh-ancestor
14860122|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860123|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14860124|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
14860125|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860126|NCT01074593|Interferons|interferons|mesh-list
14860127|NCT01074593|Interferon-beta|interferon-beta|mesh-list
14860128|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
14860129|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860130|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
14860131|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860132|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
14860133|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860134|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14860135|NCT01074619|Memantine|memantine|mesh-list
14860136|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14860137|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14860138|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
14860139|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860140|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860141|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860142|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14860143|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14860144|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14860145|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14860146|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14860147|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860148|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860149|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14860150|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14860151|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14860152|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14860153|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860154|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860155|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860156|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14860157|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14860158|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
14860159|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14860160|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14860161|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
14860162|NCT01074645|Tenofovir|tenofovir|mesh-list
14860163|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
14860164|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860165|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14860166|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14860167|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860168|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860169|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14860170|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14860171|NCT01074697|Dexamethasone|dexamethasone|mesh-list
14860172|NCT01074697|Palonosetron|palonosetron|mesh-list
14860173|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
14860174|NCT01074697|Aprepitant|aprepitant|mesh-list
14860175|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14860176|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
14860177|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
14860178|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860179|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860180|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14860181|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
14860182|NCT01074697|Hormones|hormones|mesh-ancestor
14860183|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860184|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14860185|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860186|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860187|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14860188|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14860189|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
14860190|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860191|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14860192|NCT01074723|Carotenoids|carotenoids|mesh-list
14860193|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
14860194|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860195|NCT01074723|Protective Agents|protective agents|mesh-ancestor
14860196|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860197|NCT01074801|Insulin|insulin|mesh-list
14860198|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14860199|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14860200|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860201|NCT01074853|Propranolol|propranolol|mesh-list
14860202|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14860203|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14860204|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860205|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860206|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860207|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860208|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14860209|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14860210|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
14708974|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
14708975|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14708976|NCT00429468|Narcotics|narcotics|mesh-ancestor
14708977|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14708978|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
14708979|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
14708980|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14708981|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14708982|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14708983|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
14708984|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14708985|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
14860211|NCT01074879|Caseins|caseins|mesh-list
14860212|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
14860213|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
14860214|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860215|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14860216|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
14860217|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
14860218|NCT01074892|Progestins|progestins|mesh-list
14860219|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14860220|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
14860221|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14860222|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860223|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14860224|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14860225|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14860226|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14860227|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14860228|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14860229|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860230|NCT01074892|Hormones|hormones|mesh-ancestor
14860231|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860232|NCT01074905|Artesunate|artesunate|mesh-list
14860233|NCT01074905|Chloroquine|chloroquine|mesh-list
14860234|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14860235|NCT01074905|Primaquine|primaquine|mesh-list
14860236|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
14860237|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14860238|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14860239|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860240|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860241|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
14860242|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
14860243|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14860244|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
14860245|NCT01074905|Amebicides|amebicides|mesh-ancestor
14860246|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860247|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14860248|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14860249|NCT01074905|Analgesics|analgesics|mesh-ancestor
14860250|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
14860251|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860252|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860253|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14860254|NCT01074905|Filaricides|filaricides|mesh-ancestor
14860255|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
14860256|NCT01074970|Cisplatin|cisplatin|mesh-list
14860257|NCT01074970|Rucaparib|rucaparib|mesh-list
14860258|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860259|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14860260|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860261|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860262|NCT01074996|Leucovorin|leucovorin|mesh-list
14860263|NCT01074996|Antidotes|antidotes|mesh-ancestor
14860264|NCT01074996|Protective Agents|protective agents|mesh-ancestor
14860265|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860266|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
14860267|NCT01074996|Vitamins|vitamins|mesh-ancestor
14860268|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
14860269|NCT01075022|Vitamin D|vitamin d|mesh-list
14860270|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
14860271|NCT01075022|Vitamins|vitamins|mesh-ancestor
14860272|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
14860273|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860274|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14860275|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14860276|NCT01075113|Sorafenib|sorafenib|mesh-list
14860277|NCT01075113|Vorinostat|vorinostat|mesh-list
14860278|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860279|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14860280|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860281|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860282|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14860283|NCT01075126|Valproic Acid|valproic acid|mesh-list
14860284|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14860285|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860286|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860287|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
14860288|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14860289|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860290|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860291|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
14860292|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
14860293|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14708986|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708987|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
14708988|NCT00429520|Protective Agents|protective agents|mesh-ancestor
14913481|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913482|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14913483|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14913484|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913485|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913486|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14913487|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
14913488|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913489|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913490|NCT01375556|Ethanol|ethanol|mesh-list
14913491|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14913492|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913493|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913494|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913495|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14913496|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
14913497|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14913498|NCT01375634|Midazolam|midazolam|mesh-list
14913499|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14913500|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14913501|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913502|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913503|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14913504|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14913505|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14913506|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14913507|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
14913508|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
15207792|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207793|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15207794|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15207795|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207796|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207797|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15207798|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15207799|NCT03711240|Leucovorin|leucovorin|mesh-list
15207800|NCT03711240|Bevacizumab|bevacizumab|mesh-list
15207801|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
15207802|NCT03711240|Irinotecan|irinotecan|mesh-list
15207803|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15207804|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207805|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15207806|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15207807|NCT03711240|Growth Substances|growth substances|mesh-ancestor
15207808|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14708989|NCT00429533|Dapsone|dapsone|mesh-list
14708990|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14708991|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
14708992|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14708993|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14708994|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15207809|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
14708995|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860294|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14860295|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860296|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860297|NCT01075425|Bortezomib|bortezomib|mesh-list
14860298|NCT01075425|Belinostat|belinostat|mesh-list
14860299|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860300|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14860301|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860302|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860303|NCT01075438|Vaccines|vaccines|mesh-list
14860304|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14860305|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
14860306|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860307|NCT01075464|Paclitaxel|paclitaxel|mesh-list
14860308|NCT01075464|Bevacizumab|bevacizumab|mesh-list
14860309|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14860310|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860311|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
14860312|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
14860313|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
14708996|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860314|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860315|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860316|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14860317|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14860318|NCT01075464|Growth Substances|growth substances|mesh-ancestor
14860319|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860320|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
14860321|NCT01075477|Rituximab|rituximab|mesh-list
14860322|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860323|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860324|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
15207810|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15207811|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15207812|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207813|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207814|NCT03711240|Antidotes|antidotes|mesh-ancestor
15207815|NCT03711240|Protective Agents|protective agents|mesh-ancestor
15207816|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
15207817|NCT03711240|Vitamins|vitamins|mesh-ancestor
15207818|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
14708997|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
14708998|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14708999|NCT00429559|Gemcitabine|gemcitabine|mesh-list
14709000|NCT00429559|Topotecan|topotecan|mesh-list
14709001|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709002|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
14709003|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709004|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709005|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
14709006|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709007|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709008|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709009|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
14709010|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709011|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14709012|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709013|NCT00429624|Acetaminophen|acetaminophen|mesh-list
14709014|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14709015|NCT00429624|Analgesics|analgesics|mesh-ancestor
14709016|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
14709017|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709018|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709019|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
14709020|NCT00429676|Haloperidol|haloperidol|mesh-list
14709021|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
14709022|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
14860325|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860326|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860327|NCT01075490|Clonidine|clonidine|mesh-list
14860328|NCT01075490|Analgesics|analgesics|mesh-ancestor
14860329|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
14860330|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860331|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860332|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14709023|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
14709024|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709025|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709026|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709027|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14709028|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14709029|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14709030|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14860333|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
14860334|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
14860335|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14860336|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14860337|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14860338|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860339|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860340|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860341|NCT01075503|Ropivacaine|ropivacaine|mesh-list
14860342|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
14860343|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
14860344|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860345|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860346|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
14860347|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860348|NCT01075529|Fluoxetine|fluoxetine|mesh-list
14860349|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14860350|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14860351|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14860352|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860353|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860354|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
14860355|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860356|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14860357|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
15207819|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
15207820|NCT03710863|Vorolanib|vorolanib|mesh-list
15207821|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15207822|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207823|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207824|NCT03710811|Insulin|insulin|mesh-list
15207825|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207826|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207827|NCT03710655|Histamine|histamine|mesh-list
15207828|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
15207829|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
15207830|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709031|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15207831|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860358|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14860359|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14860360|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14860361|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860362|NCT01075555|Sorafenib|sorafenib|mesh-list
14860363|NCT01075555|Pravastatin|pravastatin|mesh-list
14860364|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860365|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14860366|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860367|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860368|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14860369|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14860370|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
14860371|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14860372|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14860373|NCT01075581|Epinephrine|epinephrine|mesh-list
14860374|NCT01075581|Racepinephrine|racepinephrine|mesh-list
14860375|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
14860376|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14860377|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14860378|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860379|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860380|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860381|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860382|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14860383|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14860384|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
14860385|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860386|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14860387|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
14860388|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
14860389|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
14860390|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14860391|NCT01075659|Nicotine|nicotine|mesh-list
14860392|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14860393|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
14295932|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14860394|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860395|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860396|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14860397|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14860398|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14860399|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860400|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860401|NCT01075698|Telmisartan|telmisartan|mesh-list
14860402|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14860403|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14860404|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14860405|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860406|NCT01075711|Prednisone|prednisone|mesh-list
14295933|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
14860407|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14860408|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
14860409|NCT01075711|Hormones|hormones|mesh-ancestor
14860410|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860411|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860412|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14860413|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860414|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
14860415|NCT01075776|Acetylcholine|acetylcholine|mesh-list
14860416|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14860417|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14860418|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
14860419|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860420|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860421|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860422|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
14860423|NCT01075789|Lidocaine|lidocaine|mesh-list
14860424|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
14860425|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
14860426|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860427|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860428|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
14860429|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860430|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14860431|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14860432|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14860433|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14860434|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860435|NCT01075802|Tamoxifen|tamoxifen|mesh-list
14860436|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14860437|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
14860438|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860439|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860440|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14860441|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860442|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14860443|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14860444|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14860445|NCT01075828|Cetuximab|cetuximab|mesh-list
14860446|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860447|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860448|NCT01075841|Cetuximab|cetuximab|mesh-list
14860449|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860450|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860451|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14860452|NCT01075854|Hormones|hormones|mesh-ancestor
14860453|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860454|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860455|NCT01075880|Interferons|interferons|mesh-list
14860456|NCT01075880|Interferon-beta|interferon-beta|mesh-list
14860457|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
14860458|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860459|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
14860460|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860461|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
14860462|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860463|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14860464|NCT01075906|Colchicine|colchicine|mesh-list
14860465|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
14860466|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860467|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
14860468|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
14860469|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
14860470|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860471|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860472|NCT01075945|Lumefantrine|lumefantrine|mesh-list
14860473|NCT01075945|Artemether|artemether|mesh-list
14860474|NCT01075945|Piperaquine|piperaquine|mesh-list
14860475|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14860476|NCT01075945|Artenimol|artenimol|mesh-list
14860477|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
14860478|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14860479|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14860480|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860481|NCT01076062|Misoprostol|misoprostol|mesh-list
14860482|NCT01076062|Oxytocin|oxytocin|mesh-list
14860483|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
14860484|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14860485|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860486|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14860487|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
14860488|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14860489|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14860490|NCT01076140|Lisinopril|lisinopril|mesh-list
14860491|NCT01076140|Nebivolol|nebivolol|mesh-list
14860492|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14860493|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
14860494|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860495|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860496|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14860497|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14860498|NCT01076140|Protective Agents|protective agents|mesh-ancestor
14860499|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860500|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
14860501|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14860502|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14860503|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14860504|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860505|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860506|NCT01076322|Albuterol|albuterol|mesh-list
14860507|NCT01076322|Procaterol|procaterol|mesh-list
14860508|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14860509|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
14860510|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860511|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860512|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14860513|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
14860514|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
14860515|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14860516|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14860517|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14860518|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14860519|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860520|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860521|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860522|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
14860523|NCT01076439|Fluticasone|fluticasone|mesh-list
14860524|NCT01076439|Xhance|xhance|mesh-list
14860525|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14860526|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14860527|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14860528|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
14860529|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860530|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860531|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14860532|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
14860533|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14860534|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14860535|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14860536|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14860537|NCT01076439|Analgesics|analgesics|mesh-ancestor
14860538|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
14860539|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860540|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15207832|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207833|NCT03710603|Dexamethasone|dexamethasone|mesh-list
15207834|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
14860541|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14860542|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
14860543|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
14860544|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860545|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860546|NCT01076478|Cilostazol|cilostazol|mesh-list
14860547|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14860548|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
14860549|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860550|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860551|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14860552|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
14860553|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14860554|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15207835|NCT03710603|Lenalidomide|lenalidomide|mesh-list
15207836|NCT03710603|Bortezomib|bortezomib|mesh-list
15207837|NCT03710603|Daratumumab|daratumumab|mesh-list
15207838|NCT03710603|BB 1101|bb 1101|mesh-list
15207839|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15207840|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
15207841|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
15207842|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207843|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207844|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207845|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
15207846|NCT03710603|Hormones|hormones|mesh-ancestor
15207847|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207848|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14709032|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
14709033|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207849|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207850|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
15207851|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207852|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207853|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
14709034|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709035|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14709036|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
14709037|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14709038|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
14709039|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709040|NCT00429754|Aprepitant|aprepitant|mesh-list
14709041|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
14709042|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
14709043|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709044|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709045|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207854|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14709046|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14709047|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860555|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860556|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14860557|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
14860558|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14860559|NCT01076478|Protective Agents|protective agents|mesh-ancestor
14860560|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14860561|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14860562|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860563|NCT01076491|Mannitol|mannitol|mesh-list
14860564|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14860565|NCT01076491|Diuretics|diuretics|mesh-ancestor
14860566|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
14860567|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860568|NCT01076530|Temozolomide|temozolomide|mesh-list
14860569|NCT01076530|Vorinostat|vorinostat|mesh-list
14860570|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14860571|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
14860572|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860573|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860574|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15207855|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15207856|NCT03710603|Growth Substances|growth substances|mesh-ancestor
15207857|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
15207858|NCT03710460|Metformin|metformin|mesh-list
15207859|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
15207860|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15207861|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207862|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15207863|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207864|NCT03710434|Lansoprazole|lansoprazole|mesh-list
15207865|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
15207866|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15207867|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207868|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15207869|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860575|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860576|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
14860577|NCT01076556|Rituximab|rituximab|mesh-list
14860578|NCT01076556|Alvocidib|alvocidib|mesh-list
14860579|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14860580|NCT01076556|Antibodies|antibodies|mesh-list
14860581|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
14860582|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15207870|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709048|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709049|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
14709050|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14709051|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
14709052|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709053|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14709054|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14709055|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
14709056|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709057|NCT00429832|Promethazine|promethazine|mesh-list
14709058|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
14709059|NCT00429832|Ondansetron|ondansetron|mesh-list
14709060|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
14709061|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
14709062|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709063|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709064|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709065|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
14709066|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
14709067|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14709068|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
14709069|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709070|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709071|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14860583|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860584|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
15207871|NCT03710395|Nifedipine|nifedipine|mesh-list
14709072|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14860585|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860586|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860587|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14860588|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
14860589|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207872|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15207873|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207874|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860590|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860591|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14860592|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
14860593|NCT01076556|Growth Substances|growth substances|mesh-ancestor
14860594|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14860595|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860596|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14860597|NCT01076582|Desogestrel|desogestrel|mesh-list
14860598|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14860599|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14860600|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14860601|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
14860602|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14860603|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860604|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14860605|NCT01076582|Estrogens|estrogens|mesh-ancestor
14860606|NCT01076582|Hormones|hormones|mesh-ancestor
14860607|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860608|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14860609|NCT01076582|Progestins|progestins|mesh-ancestor
14860610|NCT01076595|Interferons|interferons|mesh-list
14860611|NCT01076595|Interferon-beta|interferon-beta|mesh-list
14860612|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
14860613|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860614|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
14860615|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860616|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
14860617|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860618|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14860619|NCT01076621|Norethindrone|norethindrone|mesh-list
14860620|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
14860621|NCT01076621|Estradiol|estradiol|mesh-list
14860622|NCT01076621|Estrogens|estrogens|mesh-ancestor
14860623|NCT01076621|Hormones|hormones|mesh-ancestor
14860624|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207875|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15207876|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207877|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
15207878|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
15207879|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15207880|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
14860625|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860626|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14860627|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
14860628|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14860629|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14860630|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14860631|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14860632|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14860633|NCT01076634|Insulin|insulin|mesh-list
14860634|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14860635|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
14860636|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14860637|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860638|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
14860639|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14860640|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
14860641|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860642|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
14860643|NCT01076673|Protective Agents|protective agents|mesh-ancestor
14860644|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
14860645|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14860646|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860647|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860648|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14860649|NCT01076790|Analgesics|analgesics|mesh-ancestor
14860650|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
14860651|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860652|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14860653|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14860654|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14860655|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860656|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860657|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709073|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860658|NCT01076803|Lanreotide|lanreotide|mesh-list
14860659|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860660|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
14860661|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14860662|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860663|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860664|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14860665|NCT01076816|Analgesics|analgesics|mesh-ancestor
14860666|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
14860667|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860668|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14860669|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14860670|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14860671|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
14709074|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14709075|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14709076|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14709077|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
14709078|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
14709079|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14709080|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14709081|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14709082|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
14709083|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
14709084|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
14295934|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709085|NCT00429871|Docetaxel|docetaxel|mesh-list
14709086|NCT00429871|Capecitabine|capecitabine|mesh-list
14709087|NCT00429871|Epirubicin|epirubicin|mesh-list
14709088|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709089|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709090|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
14860672|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860673|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860674|NCT01076842|Insulin|insulin|mesh-list
14860675|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14860676|NCT01076842|Exenatide|exenatide|mesh-list
14860677|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
14860678|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14860679|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860680|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14860681|NCT01076842|Incretins|incretins|mesh-ancestor
14860682|NCT01076842|Hormones|hormones|mesh-ancestor
14860683|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860684|NCT01076868|Primaquine|primaquine|mesh-list
14860685|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
14860686|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14860687|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14860688|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860689|NCT01076894|Anesthetics|anesthetics|mesh-list
14860690|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860691|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860692|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14860693|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
14860694|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14860695|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14860696|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
14709091|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709092|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709093|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709094|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
14709095|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709096|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14860697|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14913509|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
14913510|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
14913511|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913512|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913513|NCT01375699|Doxorubicin|doxorubicin|mesh-list
14913514|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14913515|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
14913516|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14913517|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913518|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14913519|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14913520|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913521|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913522|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
14913523|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14913524|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14913525|NCT01375699|Urological Agents|urological agents|mesh-ancestor
14913526|NCT01375816|Leucovorin|leucovorin|mesh-list
14913527|NCT01375816|Bevacizumab|bevacizumab|mesh-list
14913528|NCT01375816|Fluorouracil|fluorouracil|mesh-list
14913529|NCT01375816|Irinotecan|irinotecan|mesh-list
14913530|NCT01375816|Calcium|calcium|mesh-list
14913531|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
14913532|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14913533|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913534|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14913535|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14913536|NCT01375816|Growth Substances|growth substances|mesh-ancestor
14913537|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913538|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
14295935|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913539|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14913540|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
14913541|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860698|NCT01077206|Simvastatin|simvastatin|mesh-list
14860699|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14860700|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14860701|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
14860702|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860703|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14860704|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14860705|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860706|NCT01077427|Gemcitabine|gemcitabine|mesh-list
14860707|NCT01077427|Capecitabine|capecitabine|mesh-list
14860708|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860709|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14860710|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
14860711|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860712|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
14860713|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860714|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860715|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860716|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
14860717|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860718|NCT01077453|Letrozole|letrozole|mesh-list
14860719|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860720|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14860721|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14860722|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860723|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860724|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14860725|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
14860726|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860727|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709097|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709098|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709099|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
14709100|NCT00429897|Amiloride|amiloride|mesh-list
14709101|NCT00429897|Spironolactone|spironolactone|mesh-list
14709102|NCT00429897|Furosemide|furosemide|mesh-list
14709103|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14709104|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
14709105|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709106|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709107|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14709108|NCT00429897|Diuretics|diuretics|mesh-ancestor
14709109|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
14709110|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14709111|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14709112|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14709113|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709114|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14709115|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14709116|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14709117|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14728701|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14728702|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
14728703|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728704|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
14728705|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728706|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
14728707|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728708|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860728|NCT01077466|Natalizumab|natalizumab|mesh-list
14860729|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
14860730|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860731|NCT01077479|Metformin|metformin|mesh-list
14860732|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14860733|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860734|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
14860735|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14860736|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
14860737|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
14860738|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14860739|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860740|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14860741|NCT01077505|Incretins|incretins|mesh-ancestor
14860742|NCT01077505|Hormones|hormones|mesh-ancestor
14860743|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14860744|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14860745|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14860746|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14860747|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14860748|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14860749|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14860750|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
14860751|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860752|NCT01077570|Repaglinide|repaglinide|mesh-list
14860753|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14860754|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860755|NCT01077609|Fluticasone|fluticasone|mesh-list
14860756|NCT01077609|Xhance|xhance|mesh-list
14860757|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14860758|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14860759|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
14860760|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860761|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860762|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14860763|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
14860764|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
14860765|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14860766|NCT01077648|Trastuzumab|trastuzumab|mesh-list
14860767|NCT01077648|Lapatinib|lapatinib|mesh-list
14860768|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860769|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860770|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14860771|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860772|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860773|NCT01077661|Nebivolol|nebivolol|mesh-list
14860774|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14860775|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
14860776|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14860777|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14860778|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14860779|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
14860780|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860781|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860782|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860783|NCT01077726|Capecitabine|capecitabine|mesh-list
14860784|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14860785|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
14860786|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860787|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860788|NCT01077752|Acetaminophen|acetaminophen|mesh-list
14860789|NCT01077752|Lidocaine|lidocaine|mesh-list
14860790|NCT01077752|Morphine|morphine|mesh-list
14860791|NCT01077752|Ropivacaine|ropivacaine|mesh-list
14860792|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
14860793|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
14860794|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860795|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860796|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
14860797|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860798|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14860799|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14860800|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14860801|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14860802|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860803|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14860804|NCT01077752|Narcotics|narcotics|mesh-ancestor
14860805|NCT01077752|Analgesics|analgesics|mesh-ancestor
14860806|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14860807|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
14860808|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
14860809|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860810|NCT01077947|Anesthetics|anesthetics|mesh-list
14860811|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860812|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860813|NCT01077986|Capecitabine|capecitabine|mesh-list
14860814|NCT01077986|Cetuximab|cetuximab|mesh-list
14860815|NCT01077986|Everolimus|everolimus|mesh-list
14860816|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14860817|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
14860818|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709118|NCT00429936|Fenretinide|fenretinide|mesh-list
14709119|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709120|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14709121|NCT00429936|Protective Agents|protective agents|mesh-ancestor
14709122|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709123|NCT00429962|Ranibizumab|ranibizumab|mesh-list
14709124|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14860819|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860820|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860821|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860822|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
14860823|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860824|NCT01077999|Paclitaxel|paclitaxel|mesh-list
14860825|NCT01077999|Carboplatin|carboplatin|mesh-list
14860826|NCT01077999|Panitumumab|panitumumab|mesh-list
14860827|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14860828|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860829|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
14860830|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
14860831|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
14860832|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860833|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860834|NCT01078038|Sirolimus|sirolimus|mesh-list
14860835|NCT01078038|Everolimus|everolimus|mesh-list
14860836|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860837|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860838|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
14860839|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860840|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14860841|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860842|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14860843|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
14860844|NCT01078142|Sirolimus|sirolimus|mesh-list
14860845|NCT01078142|Rituximab|rituximab|mesh-list
14860846|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14860847|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15207881|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
15207882|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15207883|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15207884|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207885|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295936|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14295937|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
15207886|NCT03710369|Urological Agents|urological agents|mesh-ancestor
15207887|NCT03710356|Danazol|danazol|mesh-list
15207888|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15207889|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
15207890|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15207891|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207892|NCT03710343|Metformin|metformin|mesh-list
15207893|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14709125|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14709126|NCT00429962|Growth Substances|growth substances|mesh-ancestor
14709127|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709128|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14860848|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860849|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
14860850|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860851|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860852|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14860853|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
14860854|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860855|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14860856|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860857|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14860858|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
14860859|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860860|NCT01078428|Petrolatum|petrolatum|mesh-list
14860861|NCT01078428|Emollients|emollients|mesh-ancestor
14860862|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
14860863|NCT01078519|Anesthetics|anesthetics|mesh-list
14860864|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
14860865|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860866|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860867|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
14860868|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860869|NCT01078610|Adalimumab|adalimumab|mesh-list
14860870|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14860871|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860872|NCT01078714|Bumetanide|bumetanide|mesh-list
14860873|NCT01078714|Diuretics|diuretics|mesh-ancestor
14860874|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
14860875|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860876|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14860877|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14860878|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860879|NCT01078779|Chloroquine|chloroquine|mesh-list
14860880|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14860881|NCT01078779|Amebicides|amebicides|mesh-ancestor
14860882|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14860883|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14860884|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860885|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
14860886|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14860887|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14860888|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14860889|NCT01078779|Analgesics|analgesics|mesh-ancestor
14860890|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
14860891|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860892|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860893|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14709129|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709130|NCT00429975|Levofloxacin|levofloxacin|mesh-list
14709131|NCT00429975|Ofloxacin|ofloxacin|mesh-list
14709132|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
14709133|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14709134|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709135|NCT00429975|Renal Agents|renal agents|mesh-ancestor
14709136|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14709137|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14709138|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709139|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709140|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709141|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709142|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14709143|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14295938|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
14709144|NCT00430001|Docetaxel|docetaxel|mesh-list
14709145|NCT00430001|Trastuzumab|trastuzumab|mesh-list
14709146|NCT00430001|Vinorelbine|vinorelbine|mesh-list
14709147|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709148|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709149|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709150|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709151|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709152|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14860894|NCT01078779|Filaricides|filaricides|mesh-ancestor
14860895|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
14860896|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
14860897|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
14860898|NCT01078818|Trace Elements|trace elements|mesh-ancestor
14860899|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
14860900|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860901|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14860902|NCT01078870|Citalopram|citalopram|mesh-list
14860903|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14860904|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14860905|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14295939|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14295940|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14295941|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14709153|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14860906|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860907|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860908|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
14860909|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860910|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14295942|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14709154|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
14709155|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709156|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14709157|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709158|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709159|NCT00430079|Etanidazole|etanidazole|mesh-list
14709160|NCT00430079|Imidazole|imidazole|mesh-list
14709161|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709162|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709163|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860911|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
14860912|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14860913|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860914|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14860915|NCT01078870|Analgesics|analgesics|mesh-ancestor
14860916|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
14860917|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
14860918|NCT01078961|Bortezomib|bortezomib|mesh-list
14860919|NCT01078961|Sorafenib|sorafenib|mesh-list
14860920|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860921|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14860922|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860923|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860924|NCT01079013|Treosulfan|treosulfan|mesh-list
14860925|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14860926|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
14860927|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860928|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860929|NCT01079052|Famotidine|famotidine|mesh-list
14860930|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14860931|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14860932|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14860933|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
14860934|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
14860935|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860936|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860937|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860938|NCT01079065|Famotidine|famotidine|mesh-list
14860939|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14860940|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14860941|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14860942|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
14860943|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
15207894|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207895|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
15207896|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15207897|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15207898|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207899|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
15207900|NCT03710330|Coagulants|coagulants|mesh-ancestor
15207901|NCT03710317|Misoprostol|misoprostol|mesh-list
15207902|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
15207903|NCT03710317|Carbetocin|carbetocin|mesh-list
14295943|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
14295944|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295945|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295946|NCT00585052|Paclitaxel|paclitaxel|mesh-list
14295947|NCT00585052|Lovastatin|lovastatin|mesh-list
14295948|NCT00585052|L 647318|l 647318|mesh-list
14295949|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
14295950|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14709164|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
14709165|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709166|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
14709167|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709168|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709169|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14709170|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
14709171|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709172|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709173|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14709174|NCT00430118|Cytarabine|cytarabine|mesh-list
14709175|NCT00430118|Dexamethasone|dexamethasone|mesh-list
14709176|NCT00430118|Prednisone|prednisone|mesh-list
14709177|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
14709178|NCT00430118|Ifosfamide|ifosfamide|mesh-list
14709179|NCT00430118|Doxorubicin|doxorubicin|mesh-list
14709180|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14709181|NCT00430118|Methotrexate|methotrexate|mesh-list
14709182|NCT00430118|Etoposide|etoposide|mesh-list
14709183|NCT00430118|Vincristine|vincristine|mesh-list
14709184|NCT00430118|Daunorubicin|daunorubicin|mesh-list
14709185|NCT00430118|Asparaginase|asparaginase|mesh-list
14709186|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
14709187|NCT00430118|Thioguanine|thioguanine|mesh-list
14709188|NCT00430118|Vindesine|vindesine|mesh-list
14709189|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709190|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
14709191|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860944|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14860945|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860946|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860947|NCT01079078|Acetaminophen|acetaminophen|mesh-list
14860948|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14709192|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709193|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14709194|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
14709195|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709196|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709197|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14860949|NCT01079078|Analgesics|analgesics|mesh-ancestor
14860950|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
14860951|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860952|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860953|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
14860954|NCT01079117|Morphine|morphine|mesh-list
14860955|NCT01079117|Methadone|methadone|mesh-list
15207904|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14709198|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14709199|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
14709200|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
14709201|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709202|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709203|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
14709204|NCT00430118|Hormones|hormones|mesh-ancestor
14709205|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709206|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14709207|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709208|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14709209|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709210|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709211|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14709212|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
14709213|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14709214|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709215|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
14709216|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
14709217|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14709218|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14709219|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14709220|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
14709221|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709222|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709223|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709224|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709225|NCT00430144|Belotecan|belotecan|mesh-list
14709226|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14709227|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709228|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709229|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709230|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207905|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15207906|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207907|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
15207908|NCT03710317|Coagulants|coagulants|mesh-ancestor
15207909|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15207910|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
15207911|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15207912|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207913|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15207914|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207915|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
15207916|NCT03710304|Misoprostol|misoprostol|mesh-list
15207917|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
15207918|NCT03710304|Oxytocin|oxytocin|mesh-list
15207919|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
15207920|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15207921|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207922|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14709231|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
14860956|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15207923|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14709232|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14709233|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14709234|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709235|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709236|NCT00430170|Dipyridamole|dipyridamole|mesh-list
14709237|NCT00430170|Caffeine|caffeine|mesh-list
14709238|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14709239|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709240|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14860957|NCT01079117|Narcotics|narcotics|mesh-ancestor
14860958|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860959|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860960|NCT01079117|Analgesics|analgesics|mesh-ancestor
14860961|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
14860962|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860963|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
14860964|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913542|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14913543|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913544|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
14913545|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14913546|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14913547|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913548|NCT01375816|Antidotes|antidotes|mesh-ancestor
14913549|NCT01375816|Protective Agents|protective agents|mesh-ancestor
14913550|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
14913551|NCT01375816|Vitamins|vitamins|mesh-ancestor
14913552|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
14913553|NCT01375842|Atezolizumab|atezolizumab|mesh-list
14913554|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913555|NCT01375881|Ritonavir|ritonavir|mesh-list
14913556|NCT01375881|Darunavir|darunavir|mesh-list
14913557|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14913558|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14913559|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
14913560|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913561|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913562|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14913563|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14913564|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
14913565|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913566|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14913567|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14913568|NCT01375920|Metyrapone|metyrapone|mesh-list
14913569|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
14913570|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913571|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913572|NCT01375972|Gemcitabine|gemcitabine|mesh-list
14913573|NCT01375972|Cisplatin|cisplatin|mesh-list
14913574|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913575|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14913576|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
14913577|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913578|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
14913579|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913580|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913581|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207924|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207925|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
14709241|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709242|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913582|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
15207926|NCT03710304|Coagulants|coagulants|mesh-ancestor
15207927|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15207928|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
15207929|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15207930|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15207931|NCT03710252|Ritonavir|ritonavir|mesh-list
14913583|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913584|NCT01375985|Radavirsen|radavirsen|mesh-list
14913585|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
15207932|NCT03710252|Ribavirin|ribavirin|mesh-list
15207933|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14860965|NCT01079286|Sirolimus|sirolimus|mesh-list
14860966|NCT01079286|Nelfinavir|nelfinavir|mesh-list
14860967|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14860968|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14860969|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709243|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14709244|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14709245|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
14709246|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709247|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14709248|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
14709249|NCT00430196|Tizanidine|tizanidine|mesh-list
14709250|NCT00430196|Analgesics|analgesics|mesh-ancestor
14860970|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14860971|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
14860972|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14860973|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
14860974|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860975|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14860976|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14860977|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
14860978|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14860979|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14860980|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14860981|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14860982|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
14860983|NCT01079312|Fentanyl|fentanyl|mesh-list
14860984|NCT01079312|Remifentanil|remifentanil|mesh-list
14860985|NCT01079312|Propofol|propofol|mesh-list
14860986|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14860987|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14860988|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14860989|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14860990|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
14860991|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
14860992|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14860993|NCT01079312|Narcotics|narcotics|mesh-ancestor
14860994|NCT01079312|Analgesics|analgesics|mesh-ancestor
14860995|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
14860996|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14860997|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14860998|NCT01079338|Caffeine|caffeine|mesh-list
14860999|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14709251|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
14709252|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709253|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861000|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861001|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14861002|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861003|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861004|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14861005|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14861006|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
14861007|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861008|NCT01079351|Carbamazepine|carbamazepine|mesh-list
14861009|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
14861010|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
14861011|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861012|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861013|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861014|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861015|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14861016|NCT01079351|Analgesics|analgesics|mesh-ancestor
14861017|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
14861018|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861019|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14861020|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14861021|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861022|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14861023|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14861024|NCT01079364|Insulin|insulin|mesh-list
14861025|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14861026|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
14861027|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
14861028|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
14861029|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14861030|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14861031|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861032|NCT01079455|Corticosterone|corticosterone|mesh-list
14861033|NCT01079455|Bupivacaine|bupivacaine|mesh-list
14861034|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
14861035|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
14861036|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
14861037|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861038|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861039|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
14295951|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295952|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
14295953|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
14295954|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
14295955|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295956|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14295957|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14295958|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
14861040|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861041|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14861042|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
14861043|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
14861044|NCT01079455|Protective Agents|protective agents|mesh-ancestor
14861045|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861046|NCT01079481|Everolimus|everolimus|mesh-list
14861047|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861048|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861049|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
14861050|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861051|NCT01079559|Tobramycin|tobramycin|mesh-list
14861052|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14861053|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14295959|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14709254|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
14709255|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14709256|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14709257|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
14709258|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
14709259|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14709260|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14709261|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14709262|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
14709263|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709264|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709265|NCT00430235|Sorafenib|sorafenib|mesh-list
14709266|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709267|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14709268|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709269|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709270|NCT00430261|Sunitinib|sunitinib|mesh-list
14709271|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709272|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14709273|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14709274|NCT00430261|Growth Substances|growth substances|mesh-ancestor
14709275|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709276|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14861054|NCT01079624|Glucagon|glucagon|mesh-list
14861055|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15207934|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15207935|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
15207936|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207937|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207938|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15207939|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15207940|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
15207941|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207942|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15207943|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15207944|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
14861056|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14861057|NCT01079624|Hormones|hormones|mesh-ancestor
14861058|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861059|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861060|NCT01079624|Incretins|incretins|mesh-ancestor
14861061|NCT01079676|Lenograstim|lenograstim|mesh-list
14861062|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14861063|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
14861064|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861065|NCT01079702|Capecitabine|capecitabine|mesh-list
14861066|NCT01079702|Everolimus|everolimus|mesh-list
14861067|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14861068|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
14861069|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861070|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861071|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861072|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
14861073|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861074|NCT01079715|Propranolol|propranolol|mesh-list
14861075|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14861076|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14861077|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861078|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709277|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14709278|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709279|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709280|NCT00430365|Lenalidomide|lenalidomide|mesh-list
14709281|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
14709282|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709283|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14709284|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14709285|NCT00430365|Growth Substances|growth substances|mesh-ancestor
14709286|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
14709287|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709288|NCT00430443|Annamycin|annamycin|mesh-list
14709289|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709290|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709291|NCT00430469|Lactoferrin|lactoferrin|mesh-list
14709292|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709293|NCT00430547|Carbimazole|carbimazole|mesh-list
14709294|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
14709295|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
14709296|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709297|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709298|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14709299|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14709300|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
14709301|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14709302|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14709303|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861079|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861080|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861081|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14861082|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14861083|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
14861084|NCT01079754|Morphine|morphine|mesh-list
14861085|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
14861086|NCT01079754|Narcotics|narcotics|mesh-ancestor
14861087|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861088|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861089|NCT01079754|Analgesics|analgesics|mesh-ancestor
14861090|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
14861091|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861092|NCT01079767|Sirolimus|sirolimus|mesh-list
14861093|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14861094|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709304|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861095|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14861096|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861097|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
14861098|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861099|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
14861100|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861101|NCT01079780|Irinotecan|irinotecan|mesh-list
14861102|NCT01079780|Cetuximab|cetuximab|mesh-list
14861103|NCT01079780|Ramucirumab|ramucirumab|mesh-list
14861104|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14861105|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14861106|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861107|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861108|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861109|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14861110|NCT01079884|Esomeprazole|esomeprazole|mesh-list
14861111|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14861112|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14861113|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14861114|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861115|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861116|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
14861117|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861118|NCT01079910|Fluorides|fluorides|mesh-list
14861119|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
14861120|NCT01079910|Protective Agents|protective agents|mesh-ancestor
14861121|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861122|NCT01079923|Vitamin D|vitamin d|mesh-list
14861123|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
14861124|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
14861125|NCT01079923|Vitamins|vitamins|mesh-list
15207945|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
15207946|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207947|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
15207948|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
15207949|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
15207950|NCT03710122|Vancomycin|vancomycin|mesh-list
15207951|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207952|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207953|NCT03710044|Cyclosporine|cyclosporine|mesh-list
15207954|NCT03710044|Cyclosporins|cyclosporins|mesh-list
14709305|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14709306|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14709307|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709308|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
14709309|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709310|NCT00430651|Carboplatin|carboplatin|mesh-list
14709311|NCT00430651|Docetaxel|docetaxel|mesh-list
14709312|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709313|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709314|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709315|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709316|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709317|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
14709318|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14709319|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709320|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
14709321|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14709322|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14709323|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709324|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709325|NCT00430742|Hormones|hormones|mesh-ancestor
14709326|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861126|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
14861127|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861128|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14861129|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14861130|NCT01080027|Interferons|interferons|mesh-list
14861131|NCT01080027|Interferon-beta|interferon-beta|mesh-list
14861132|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
14861133|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861134|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
14861135|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861136|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
14861137|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861138|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14861139|NCT01080066|Cetuximab|cetuximab|mesh-list
14861140|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14861141|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861142|NCT01080079|Terbinafine|terbinafine|mesh-list
14861143|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
14709327|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709328|NCT00430794|Spironolactone|spironolactone|mesh-list
14861144|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861145|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861146|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861147|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
14861148|NCT01080352|Vitamins|vitamins|mesh-ancestor
14861149|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
14861150|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861151|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
14861152|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861153|NCT01080352|Protective Agents|protective agents|mesh-ancestor
14861154|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
14861155|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14861156|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861157|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14861158|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
14861159|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14861160|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861161|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861162|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861163|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
14861164|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14861165|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861166|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14861167|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
14861168|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14861169|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861170|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861171|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861172|NCT01080456|Tacrolimus|tacrolimus|mesh-list
14861173|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861174|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
14861175|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861176|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14861177|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861178|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861179|NCT01080469|Tacrolimus|tacrolimus|mesh-list
14709329|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14709330|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
14709331|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709332|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709333|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14709334|NCT00430794|Diuretics|diuretics|mesh-ancestor
14709335|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
14709336|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
14709337|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
14709338|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14709339|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14709340|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709341|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709342|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861180|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861181|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
14861182|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861183|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14861184|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861185|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861186|NCT01080482|Tacrolimus|tacrolimus|mesh-list
14861187|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861188|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
14861189|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861190|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14709343|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14861191|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861192|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861193|NCT01080534|Tacrolimus|tacrolimus|mesh-list
14861194|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861195|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
14861196|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861197|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14861198|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861199|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861200|NCT01080547|Capecitabine|capecitabine|mesh-list
14861201|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
14861202|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14861203|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
14861204|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861205|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861206|NCT01080560|Cyclosporine|cyclosporine|mesh-list
14861207|NCT01080560|Cyclosporins|cyclosporins|mesh-list
14709344|NCT00430833|Candesartan|candesartan|mesh-list
14709345|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14709346|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14861208|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861209|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861210|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861211|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
14861212|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861213|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
14861214|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861215|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861216|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14861217|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14861218|NCT01080586|Cyclosporine|cyclosporine|mesh-list
14861219|NCT01080586|Cyclosporins|cyclosporins|mesh-list
14861220|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861221|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861222|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861223|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
14861224|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861225|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
14861226|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861227|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861228|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14861229|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14861230|NCT01080612|Pregabalin|pregabalin|mesh-list
14861231|NCT01080612|Analgesics|analgesics|mesh-ancestor
14709347|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14709348|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709349|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14709350|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14709351|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709352|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
14709353|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14709354|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
14709355|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14709356|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
14709357|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709358|NCT00430898|Basiliximab|basiliximab|mesh-list
14709359|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709360|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
14709361|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709362|NCT00430924|Eplerenone|eplerenone|mesh-list
14709363|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15207955|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15207956|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207957|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15207958|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
15207959|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207960|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
15207961|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207962|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
15207963|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15207964|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15207965|NCT03709992|Tamsulosin|tamsulosin|mesh-list
15207966|NCT03709992|Trospium chloride|trospium chloride|mesh-list
15207967|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15207968|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15207969|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15207970|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
15207971|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15207972|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207973|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207974|NCT03709992|Urological Agents|urological agents|mesh-ancestor
15207975|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
15207976|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
15207977|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15207978|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15207979|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15207980|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
15207981|NCT03709953|Apatinib|apatinib|mesh-list
15207982|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15207983|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15207984|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709364|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
14709365|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709366|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709367|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14709368|NCT00430924|Diuretics|diuretics|mesh-ancestor
14709369|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
14709370|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15207985|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861232|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
14861233|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861234|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861235|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
14861236|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14861237|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14861238|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861239|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14861240|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14709371|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14709372|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14709373|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861241|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861242|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861243|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861244|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
14861245|NCT01080638|Abciximab|abciximab|mesh-list
14861246|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
14861247|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14861248|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14861249|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
14861250|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861251|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14861252|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861253|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
14861254|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861255|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
14861256|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14861257|NCT01080638|Protective Agents|protective agents|mesh-ancestor
14861258|NCT01080651|Voriconazole|voriconazole|mesh-list
14861259|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
14861260|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861261|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14861262|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14861263|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861264|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861265|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14861266|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
14861267|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861268|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861269|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14861270|NCT01080729|Hormones|hormones|mesh-list
14861271|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14861272|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861273|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861274|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14861275|NCT01080742|Bisoprolol|bisoprolol|mesh-list
14861276|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14861277|NCT01080742|Diuretics|diuretics|mesh-ancestor
14861278|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
14861279|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207986|NCT03709940|Methylphenidate|methylphenidate|mesh-list
15207987|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15207988|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15207989|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15207990|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15207991|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15207992|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15207993|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
15207994|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709374|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861280|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14861281|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14709375|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14709376|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14709377|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709378|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
14709379|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709380|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
14709381|NCT00431028|Triamcinolone|triamcinolone|mesh-list
14709382|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861282|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861283|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
14861284|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
14861285|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861286|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14861287|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14861288|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14861289|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861290|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861291|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
14861292|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
14861293|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861294|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14861295|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14861296|NCT01080846|Misoprostol|misoprostol|mesh-list
14861297|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14861298|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
14861299|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14861300|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861301|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14861302|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14861303|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
14861304|NCT01080911|Morphine|morphine|mesh-list
14861305|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
14861306|NCT01080911|Narcotics|narcotics|mesh-ancestor
14861307|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861308|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861309|NCT01080911|Analgesics|analgesics|mesh-ancestor
14861310|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
14861311|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913586|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913587|NCT01376011|Quercetin|quercetin|mesh-list
14913588|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
14913589|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913590|NCT01376011|Protective Agents|protective agents|mesh-ancestor
14913591|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913592|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
14913593|NCT01376076|Risperidone|risperidone|mesh-list
14913594|NCT01376076|Cariprazine|cariprazine|mesh-list
14913595|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14913596|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14913597|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913598|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14913599|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14861312|NCT01080963|Daptomycin|daptomycin|mesh-list
14861313|NCT01080963|Cefuroxime|cefuroxime|mesh-list
14861314|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
14861315|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14861316|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861317|NCT01081002|Lidocaine|lidocaine|mesh-list
14861318|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
14861319|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
14861320|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861321|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861322|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
14861323|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861324|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14861325|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14861326|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14861327|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14861328|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861329|NCT01081158|Ritonavir|ritonavir|mesh-list
14861330|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14861331|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
14861332|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14861333|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14861334|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
14861335|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861336|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861337|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14861338|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14861339|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
14861340|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861341|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14861342|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14861343|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
14861344|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861345|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14861346|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
14861347|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861348|NCT01081353|Aspirin|aspirin|mesh-list
14861349|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14861350|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14861351|NCT01081353|Analgesics|analgesics|mesh-ancestor
14861352|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
14861353|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861354|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861355|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861356|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14861357|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14861358|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14861359|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861360|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14861361|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14861362|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861363|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
14861364|NCT01081431|Lenalidomide|lenalidomide|mesh-list
14861365|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
14861366|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861367|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14861368|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14861369|NCT01081431|Growth Substances|growth substances|mesh-ancestor
14861370|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
14861371|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861372|NCT01081535|Ketorolac|ketorolac|mesh-list
14861373|NCT01081535|Fentanyl|fentanyl|mesh-list
14861374|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14861375|NCT01081535|Narcotics|narcotics|mesh-ancestor
14861376|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861377|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861378|NCT01081535|Analgesics|analgesics|mesh-ancestor
14861379|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
14861380|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861381|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14861382|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14861383|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
14861384|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
14861385|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14861386|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14861387|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861388|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14861389|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14861390|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861391|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861392|NCT01081548|Atorvastatin|atorvastatin|mesh-list
14861393|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14861394|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14861395|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
14861396|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861397|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14861398|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14861399|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861400|NCT01081561|Riboflavin|riboflavin|mesh-list
14861401|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
14861402|NCT01081561|Vitamins|vitamins|mesh-ancestor
14861403|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
14861404|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861405|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14861406|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861407|NCT01081600|Trastuzumab|trastuzumab|mesh-list
14861408|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14861409|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861410|NCT01081613|Bevacizumab|bevacizumab|mesh-list
14861411|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
14861412|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14861413|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861414|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14861415|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14861416|NCT01081613|Growth Substances|growth substances|mesh-ancestor
14861417|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861418|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
14861419|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14861420|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861421|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14861422|NCT01081639|Hormones|hormones|mesh-ancestor
15207995|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
15207996|NCT03709927|Fosfomycin|fosfomycin|mesh-list
15207997|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15207998|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15207999|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15208000|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15208001|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861423|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861424|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224932|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14861425|NCT01081652|Progesterone|progesterone|mesh-list
14861426|NCT01081652|Progestins|progestins|mesh-ancestor
14861427|NCT01081652|Hormones|hormones|mesh-ancestor
14861428|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861429|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861430|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14861431|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
14861432|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861433|NCT01081704|Ustekinumab|ustekinumab|mesh-list
14861434|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861435|NCT01081717|Golimumab|golimumab|mesh-list
14861436|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14861437|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861438|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861439|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
14861440|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861441|NCT01081730|Ustekinumab|ustekinumab|mesh-list
14861442|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861443|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14861444|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14861445|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861446|NCT01081847|Mannitol|mannitol|mesh-list
14861447|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
14861448|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14861449|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
14861450|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861451|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14861452|NCT01081847|Diuretics|diuretics|mesh-ancestor
14861453|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
14861454|NCT01081938|Insulin|insulin|mesh-list
14861455|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15208002|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208003|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861456|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
14861457|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
14861458|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14861459|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861460|NCT01081964|Levofloxacin|levofloxacin|mesh-list
14861461|NCT01081964|Ofloxacin|ofloxacin|mesh-list
14861462|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
14861463|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14861464|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861465|NCT01081964|Renal Agents|renal agents|mesh-ancestor
14861466|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14861467|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14861468|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15208004|NCT03709849|Citric Acid|citric acid|mesh-list
15208005|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
15208006|NCT03709849|Clomiphene|clomiphene|mesh-list
15208007|NCT03709849|Enclomiphene|enclomiphene|mesh-list
15208008|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
15208009|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
15208010|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14861469|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861470|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861471|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861472|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14861473|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14861474|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14861475|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
14861476|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14861477|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
14861478|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861479|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14913600|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208011|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
15208012|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
14861480|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861481|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14295960|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14295961|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295962|NCT00585078|Capecitabine|capecitabine|mesh-list
14295963|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
14709383|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
14709384|NCT00431028|Hormones|hormones|mesh-ancestor
14709385|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861482|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861483|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861484|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861485|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
14861486|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14861487|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861488|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861489|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14861490|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14861491|NCT01082003|Protective Agents|protective agents|mesh-ancestor
14861492|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861493|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
14861494|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14861495|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
14861496|NCT01082029|Lansoprazole|lansoprazole|mesh-list
14861497|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
14709386|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709387|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709388|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709389|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14709390|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709391|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14861498|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14861499|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14861500|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14861501|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861502|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861503|NCT01082120|Pioglitazone|pioglitazone|mesh-list
14861504|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14861505|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861506|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14861507|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861508|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15208013|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208014|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15208015|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
15208016|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208017|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709392|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709393|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709394|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14709395|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14709396|NCT00431054|Docetaxel|docetaxel|mesh-list
14709397|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709398|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709399|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709400|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709401|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709402|NCT00431080|Paclitaxel|paclitaxel|mesh-list
14709403|NCT00431080|Docetaxel|docetaxel|mesh-list
14861509|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861510|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861511|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15208018|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15208019|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
15208020|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14709404|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
14861512|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14861513|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14861514|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14861515|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861516|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861517|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861518|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14861519|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14861520|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
14861521|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14861522|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14861523|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
14861524|NCT01082198|Vaccines|vaccines|mesh-list
14861525|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14861526|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
14861527|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861528|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14861529|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
14861530|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861531|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14861532|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861533|NCT01082237|Citalopram|citalopram|mesh-list
14861534|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14861535|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14861536|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14861537|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861538|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861539|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
14861540|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861541|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14861542|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
14861543|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861544|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14861545|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861546|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861547|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861548|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861549|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861550|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14861551|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14861552|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14861553|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861554|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861555|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861556|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14861557|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14861558|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
14861559|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14861560|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14861561|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
14861562|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14861563|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861564|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861565|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861566|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861567|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861568|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14861569|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14861570|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14861571|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861572|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861573|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861574|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14861575|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14861576|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
14861577|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14861578|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14861579|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
14861580|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14861581|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861582|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861583|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861584|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861585|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861586|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14861587|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14861588|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14861589|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861590|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861591|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861592|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14861593|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14861594|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
14861595|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14861596|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14861597|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
14861598|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14861599|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861600|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861601|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861602|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861603|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861604|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14861605|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14861606|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14861607|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861608|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861609|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861610|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14861611|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14861612|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
14861613|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14861614|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14861615|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
14861616|NCT01082315|Cetuximab|cetuximab|mesh-list
14861617|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14861618|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861619|NCT01082341|Vaccines|vaccines|mesh-list
14861620|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
14861621|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861622|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
14861623|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
14861624|NCT01082393|Tacrolimus|tacrolimus|mesh-list
15208021|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15208022|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15208023|NCT03709745|Ranibizumab|ranibizumab|mesh-list
15208024|NCT03709745|Aflibercept|aflibercept|mesh-list
15208025|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15208026|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15208027|NCT03709745|Growth Substances|growth substances|mesh-ancestor
15224933|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
14861625|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14861626|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
14861627|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861628|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14861629|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861630|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861631|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861632|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861633|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14861634|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14861635|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14861636|NCT01082393|Analgesics|analgesics|mesh-ancestor
14861637|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
14861638|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861639|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14861640|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
14861641|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14861642|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
14861643|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861644|NCT01082445|Expectorants|expectorants|mesh-ancestor
14861645|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
14861646|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14861647|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
14861648|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861649|NCT01082445|Protective Agents|protective agents|mesh-ancestor
14861650|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861651|NCT01082445|Antidotes|antidotes|mesh-ancestor
14861652|NCT01082458|Lidocaine|lidocaine|mesh-list
14861653|NCT01082458|Remifentanil|remifentanil|mesh-list
14861654|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
14861655|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
14861656|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861657|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861658|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
14861659|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861660|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14861661|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14861662|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14861663|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14861664|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861665|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14861666|NCT01082458|Narcotics|narcotics|mesh-ancestor
14861667|NCT01082458|Analgesics|analgesics|mesh-ancestor
14861668|NCT01082471|Morphine|morphine|mesh-list
14861669|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14861670|NCT01082471|Narcotics|narcotics|mesh-ancestor
14861671|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861672|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861673|NCT01082471|Analgesics|analgesics|mesh-ancestor
14861674|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
14861675|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861676|NCT01082484|Treprostinil|treprostinil|mesh-list
14861677|NCT01082484|Iloprost|iloprost|mesh-list
14295964|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14861678|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14861679|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14861680|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
14861681|NCT01082510|Tegafur|tegafur|mesh-list
14861682|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14861683|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
14861684|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861685|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861686|NCT01082627|Somatostatin|somatostatin|mesh-list
14861687|NCT01082627|Hormones|hormones|mesh-ancestor
14861688|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861689|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861690|NCT01082679|Buprenorphine|buprenorphine|mesh-list
14861691|NCT01082679|Methadone|methadone|mesh-list
14861692|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14861693|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14861694|NCT01082679|Narcotics|narcotics|mesh-ancestor
14861695|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861696|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861697|NCT01082679|Analgesics|analgesics|mesh-ancestor
14861698|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
14861699|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861700|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14861701|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
14861702|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913601|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913602|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913603|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14913604|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
14913605|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14913606|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913607|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14913608|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14913609|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14913610|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14913611|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
14913612|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913613|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14913614|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14913615|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913616|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14913617|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14913618|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
14913619|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
14913620|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14913621|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913622|NCT01376128|Paroxetine|paroxetine|mesh-list
14913623|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14913624|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14913625|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913626|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913627|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913628|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
14913629|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913630|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14913631|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
14913632|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14913633|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14913634|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14913635|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913636|NCT01376141|Sumatriptan|sumatriptan|mesh-list
14913637|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14913638|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14913639|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14913640|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
14709405|NCT00431080|Epirubicin|epirubicin|mesh-list
14709406|NCT00431080|Fluorouracil|fluorouracil|mesh-list
14709407|NCT00431080|Mitogens|mitogens|mesh-list
14709408|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14861703|NCT01082705|Lumefantrine|lumefantrine|mesh-list
14861704|NCT01082705|Artemether|artemether|mesh-list
14861705|NCT01082705|Piperaquine|piperaquine|mesh-list
14861706|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14861707|NCT01082705|Artenimol|artenimol|mesh-list
14861708|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
14861709|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14861710|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14861711|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861712|NCT01082718|Artesunate|artesunate|mesh-list
14861713|NCT01082718|Mefloquine|mefloquine|mesh-list
14861714|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
14861715|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14861716|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15208028|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208029|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
15208030|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208031|NCT03709719|Blinatumomab|blinatumomab|mesh-list
15208032|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208033|NCT03709550|Decitabine|decitabine|mesh-list
15208034|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15208035|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
15208036|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208037|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208038|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224934|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224935|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224936|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15224937|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15224938|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
15224939|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14295965|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
14709409|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709410|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709411|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709412|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709413|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709414|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709415|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
15224940|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709416|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861717|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861718|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709417|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709418|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14709419|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
14709420|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14709421|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709422|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14709423|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709424|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861719|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
14861720|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
14861721|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14861722|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
14861723|NCT01082731|Artesunate|artesunate|mesh-list
14861724|NCT01082731|Lumefantrine|lumefantrine|mesh-list
14861725|NCT01082731|Artemether|artemether|mesh-list
14861726|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14861727|NCT01082731|Mefloquine|mefloquine|mesh-list
14861728|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
14861729|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14861730|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14861731|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861732|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861733|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
14861734|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
14861735|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14861736|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
14861737|NCT01082744|Sufentanil|sufentanil|mesh-list
14861738|NCT01082744|Ropivacaine|ropivacaine|mesh-list
14861739|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
14861740|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
14861741|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861742|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861743|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
14861744|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861745|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14861746|NCT01082744|Narcotics|narcotics|mesh-ancestor
14861747|NCT01082744|Analgesics|analgesics|mesh-ancestor
14861748|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14861749|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14861750|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
14861751|NCT01082796|Glipizide|glipizide|mesh-list
14861752|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14861753|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861754|NCT01082809|Sunitinib|sunitinib|mesh-list
14861755|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861756|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14861757|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14861758|NCT01082809|Growth Substances|growth substances|mesh-ancestor
15208039|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15208040|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15208041|NCT03709381|Cosyntropin|cosyntropin|mesh-list
15208042|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
15208043|NCT03709381|Hormones|hormones|mesh-ancestor
15208044|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208045|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208046|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208047|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208048|NCT03709160|Bumetanide|bumetanide|mesh-list
15208049|NCT03709160|Diuretics|diuretics|mesh-ancestor
14709425|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
14709426|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709427|NCT00431106|Gemcitabine|gemcitabine|mesh-list
14709428|NCT00431106|Capecitabine|capecitabine|mesh-list
14861759|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861760|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
14861761|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14861762|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861763|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861764|NCT01082848|Aripiprazole|aripiprazole|mesh-list
14861765|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
15208050|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
14861766|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224941|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
14861767|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861768|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861769|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861770|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861771|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
14861772|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
14861773|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861774|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861775|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14861776|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14861777|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
14861778|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15208051|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208052|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15208053|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15208054|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208055|NCT03709147|Metformin|metformin|mesh-list
15208056|NCT03709147|Carboplatin|carboplatin|mesh-list
14709429|NCT00431106|Vinorelbine|vinorelbine|mesh-list
15208057|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
15208058|NCT03709147|Pemetrexed|pemetrexed|mesh-list
15208059|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208060|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15208061|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208062|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208063|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224942|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
14295966|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709430|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709431|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
14709432|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709433|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709434|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
14709435|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709436|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709437|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709438|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
14709439|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709440|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14709441|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709442|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709443|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709444|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
14709445|NCT00431119|Azathioprine|azathioprine|mesh-list
14709446|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709447|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709448|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14709449|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
14709450|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14709451|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709452|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709453|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709454|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
14861779|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14861780|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14861781|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14861782|NCT01082926|Aldesleukin|aldesleukin|mesh-list
14861783|NCT01082926|Interleukin-2|interleukin-2|mesh-list
14861784|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709455|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709456|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709457|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
14709458|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709459|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709460|NCT00431145|Niacin|niacin|mesh-list
14709461|NCT00431145|Niacinamide|niacinamide|mesh-list
14709462|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
14861785|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14861786|NCT01082926|Analgesics|analgesics|mesh-ancestor
14861787|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
14861788|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861789|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861790|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14861791|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14861792|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
14861793|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861794|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
14861795|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
14861796|NCT01083017|Diuretics|diuretics|mesh-ancestor
14861797|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
14861798|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861799|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14861800|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14861801|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861802|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
14861803|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14861804|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
14861805|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861806|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14861807|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14861808|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14861809|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861810|NCT01083251|Vitamin D|vitamin d|mesh-list
14861811|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
14861812|NCT01083251|Vitamins|vitamins|mesh-list
15208064|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208065|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15208066|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15208067|NCT03709082|Trastuzumab|trastuzumab|mesh-list
15208068|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15208069|NCT03709082|Letrozole|letrozole|mesh-list
15208070|NCT03709082|Palbociclib|palbociclib|mesh-list
15208071|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208072|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208073|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15208074|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15208075|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208076|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208077|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15208078|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
15208079|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208080|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208081|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208082|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
15208083|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
15208084|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
15208085|NCT03709056|Propofol|propofol|mesh-list
15208086|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15208087|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208088|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208089|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15208090|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
15208091|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
15208092|NCT03709017|Ponatinib|ponatinib|mesh-list
15208093|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208094|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208095|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709463|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14709464|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
14709465|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709466|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14709467|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
14709468|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
14861813|NCT01083251|Entecavir|entecavir|mesh-list
14861814|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
14861815|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861816|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14861817|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14861818|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
14861819|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208096|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208097|NCT03708926|Abaloparatide|abaloparatide|mesh-list
15208098|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15208099|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208100|NCT03708861|Ritonavir|ritonavir|mesh-list
15208101|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15208102|NCT03708861|Maraviroc|maraviroc|mesh-list
15208103|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15208104|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15208105|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
15208106|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861820|NCT01083264|Gestodene|gestodene|mesh-list
14861821|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14861822|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14861823|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14861824|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
14861825|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14861826|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861827|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14861828|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14861829|NCT01083264|Progestins|progestins|mesh-ancestor
14861830|NCT01083264|Hormones|hormones|mesh-ancestor
14861831|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861832|NCT01083290|Spironolactone|spironolactone|mesh-list
14861833|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14861834|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
14861835|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861836|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861837|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15208107|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208108|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15208109|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15208110|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
15208111|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208112|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15208113|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15208114|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15208115|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15208116|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15208117|NCT03708848|Metronidazole|metronidazole|mesh-list
14709469|NCT00431145|Vitamins|vitamins|mesh-ancestor
14709470|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
14709471|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709472|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
14709473|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
14709474|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14709475|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709476|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709477|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
14709478|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14709479|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14709480|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709481|NCT00431197|Ketoconazole|ketoconazole|mesh-list
14709482|NCT00431197|Testosterone|testosterone|mesh-list
14709483|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
14709484|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709485|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14709486|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15208118|NCT03708848|Clarithromycin|clarithromycin|mesh-list
15208119|NCT03708848|Levofloxacin|levofloxacin|mesh-list
14709487|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861838|NCT01083290|Diuretics|diuretics|mesh-ancestor
14861839|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
14861840|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
14861841|NCT01083329|Niacin|niacin|mesh-list
14861842|NCT01083329|Niacinamide|niacinamide|mesh-list
14861843|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
14861844|NCT01083329|Vitamins|vitamins|mesh-ancestor
14861845|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
14861846|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861847|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14861848|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
14861849|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861850|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14861851|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
14861852|NCT01083381|Risperidone|risperidone|mesh-list
14861853|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14861854|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
14861855|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861856|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861857|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861858|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861859|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861860|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861861|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861862|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14861863|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
14861864|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
14861865|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14861866|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14861867|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861868|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
14861869|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
14861870|NCT01083420|Minocycline|minocycline|mesh-list
14861871|NCT01083420|Dexamethasone|dexamethasone|mesh-list
14861872|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14861873|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
14861874|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
14861875|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861876|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861877|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14861878|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
15208120|NCT03708848|Ofloxacin|ofloxacin|mesh-list
15208121|NCT03708848|Tetracycline|tetracycline|mesh-list
15208122|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
15208123|NCT03708848|Esomeprazole|esomeprazole|mesh-list
15208124|NCT03708848|Bismuth|bismuth|mesh-list
15208125|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208126|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208127|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15208128|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15208129|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14709488|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709489|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14709490|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
14709491|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709492|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709493|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14709494|NCT00431197|Androgens|androgens|mesh-ancestor
14709495|NCT00431197|Hormones|hormones|mesh-ancestor
14709496|NCT00431236|Dexamethasone|dexamethasone|mesh-list
14709497|NCT00431236|Ondansetron|ondansetron|mesh-list
14709498|NCT00431236|Casopitant|casopitant|mesh-list
14709499|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14709500|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
14709501|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
14861879|NCT01083420|Hormones|hormones|mesh-ancestor
14861880|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14861881|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15208130|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15208131|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14861882|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861883|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14861884|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14861885|NCT01083537|Paclitaxel|paclitaxel|mesh-list
14861886|NCT01083537|Cisplatin|cisplatin|mesh-list
14861887|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14861888|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861889|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14861890|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
14861891|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
14861892|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861893|NCT01083589|Docetaxel|docetaxel|mesh-list
14861894|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
14861895|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861896|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
14861897|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
14861898|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
14861899|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861900|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14861901|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861902|NCT01083784|Valproic Acid|valproic acid|mesh-list
14861903|NCT01083784|Clonazepam|clonazepam|mesh-list
14861904|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
14861905|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861906|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861907|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
14861908|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861909|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861910|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
14861911|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14861912|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861913|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14861914|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
14861915|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
14861916|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
14861917|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14861918|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861919|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861920|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14861921|NCT01083797|Analgesics|analgesics|mesh-ancestor
14861922|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
14861923|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14861924|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14861925|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14861926|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14861927|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
14861928|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14861929|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861930|NCT01083875|Amlexanox|amlexanox|mesh-list
14709502|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709503|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709504|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709505|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
14709506|NCT00431236|Hormones|hormones|mesh-ancestor
14709507|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709508|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14709509|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709510|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
14709511|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14709512|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14709513|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
14709514|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709515|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709516|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14861931|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14861932|NCT01083953|Sevoflurane|sevoflurane|mesh-list
15208132|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15208133|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208134|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15208135|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15208136|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15208137|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15208138|NCT03708848|Renal Agents|renal agents|mesh-ancestor
15208139|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15208140|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15208141|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208142|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15208143|NCT03708848|Antacids|antacids|mesh-ancestor
15208144|NCT03708848|Diuretics|diuretics|mesh-ancestor
15208145|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
15208146|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208147|NCT03708848|Expectorants|expectorants|mesh-ancestor
15208148|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
15208149|NCT03708822|Docetaxel|docetaxel|mesh-list
15208150|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
15208151|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861933|NCT01083953|Desflurane|desflurane|mesh-list
14861934|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14861935|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14861936|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
14861937|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
14861938|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861939|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208152|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
15208153|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
15208154|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
15208155|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208156|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208157|NCT03708718|Prednisolone|prednisolone|mesh-list
15208158|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15208159|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
15208160|NCT03708718|Hormones|hormones|mesh-ancestor
15208161|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208162|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208163|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15208164|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861940|NCT01083966|Bevacizumab|bevacizumab|mesh-list
14861941|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14861942|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861943|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14861944|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14861945|NCT01083966|Growth Substances|growth substances|mesh-ancestor
14861946|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861947|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
14861948|NCT01083992|Vitamin D|vitamin d|mesh-list
14861949|NCT01083992|Vildagliptin|vildagliptin|mesh-list
14861950|NCT01083992|Vitamins|vitamins|mesh-ancestor
14861951|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
14861952|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861953|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14861954|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14861955|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14861956|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
14861957|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861958|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861959|NCT01084031|Propofol|propofol|mesh-list
14861960|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14861961|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861962|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861963|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14861964|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
14861965|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
14861966|NCT01084044|Urinastatin|urinastatin|mesh-list
14861967|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14861968|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14861969|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
14861970|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861971|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861972|NCT01084057|Vorinostat|vorinostat|mesh-list
14861973|NCT01084057|Epothilone B|epothilone b|mesh-list
14861974|NCT01084057|Epothilones|epothilones|mesh-list
14861975|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14861976|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15208165|NCT03708588|Ticagrelor|ticagrelor|mesh-list
15208166|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15208167|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15224943|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861977|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861978|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861979|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14861980|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14861981|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14861982|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14861983|NCT01084122|Hematinics|hematinics|mesh-ancestor
14861984|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14861985|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
14861986|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14861987|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14861988|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14861989|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14861990|NCT01084187|Urological Agents|urological agents|mesh-ancestor
14861991|NCT01084200|Propofol|propofol|mesh-list
14861992|NCT01084200|Sevoflurane|sevoflurane|mesh-list
15208168|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15208169|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15208170|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
15208171|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208172|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208173|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208174|NCT03708536|Bevacizumab|bevacizumab|mesh-list
15208175|NCT03708536|Capecitabine|capecitabine|mesh-list
15208176|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208177|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208178|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15208179|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15208180|NCT03708536|Growth Substances|growth substances|mesh-ancestor
15208181|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208182|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
15208183|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15208184|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
15208185|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208186|NCT03708497|Misoprostol|misoprostol|mesh-list
15208187|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
15208188|NCT03708497|Carbetocin|carbetocin|mesh-list
15208189|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15208190|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15208191|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208192|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
15208193|NCT03708497|Coagulants|coagulants|mesh-ancestor
15208194|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15208195|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
15208196|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15208197|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208198|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15208199|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15208200|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
15208201|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
15208202|NCT03708458|Indomethacin|indomethacin|mesh-list
15208203|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15208204|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
15208205|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208206|NCT03708458|Expectorants|expectorants|mesh-ancestor
15208207|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
15208208|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15208209|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
15208210|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208211|NCT03708458|Protective Agents|protective agents|mesh-ancestor
14861993|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14861994|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14861995|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14861996|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14861997|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
14861998|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
14861999|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14862000|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14862001|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14862002|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
14862003|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14862004|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14862005|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208212|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208213|NCT03708458|Antidotes|antidotes|mesh-ancestor
14709517|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14709518|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14709519|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14709520|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14709521|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14709522|NCT00431249|Cilostazol|cilostazol|mesh-list
14709523|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14862006|NCT01084291|Vaccines|vaccines|mesh-list
14862007|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
14862008|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862009|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
14862010|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14862011|NCT01084369|Testosterone|testosterone|mesh-list
14862012|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
14862013|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
14862014|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14862015|NCT01084369|Androgens|androgens|mesh-ancestor
15208214|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15208215|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15208216|NCT03708458|Analgesics|analgesics|mesh-ancestor
15208217|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
15208218|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208219|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15208220|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15208221|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
15208222|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
15208223|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15208224|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15208225|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208226|NCT03708341|Melatonin|melatonin|mesh-list
15208227|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
15208228|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208229|NCT03708341|Protective Agents|protective agents|mesh-ancestor
15208230|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208231|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208232|NCT03708237|Gabapentin|gabapentin|mesh-list
15208233|NCT03708237|Ropinirole|ropinirole|mesh-list
15208234|NCT03708237|Analgesics|analgesics|mesh-ancestor
15208235|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
15208236|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208237|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208238|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
15208239|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15208240|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15208241|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208242|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15208243|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15208244|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15208245|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208246|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709524|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
15208247|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
15208248|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15208249|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15208250|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
15208251|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
15208252|NCT03708198|Bupivacaine|bupivacaine|mesh-list
15208253|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
15208254|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
15208255|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14862016|NCT01084369|Hormones|hormones|mesh-ancestor
14862017|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862018|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208256|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208257|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
15208258|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208259|NCT03708146|Zamicastat|zamicastat|mesh-list
15208260|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208261|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208262|NCT03708133|Nifurtimox|nifurtimox|mesh-list
15208263|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15208264|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15208265|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14709525|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208266|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208267|NCT03708120|Insect Repellents|insect repellents|mesh-list
14709526|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709527|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14709528|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
14709529|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14709530|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14709531|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709532|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14709533|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
14709534|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14709535|NCT00431249|Protective Agents|protective agents|mesh-ancestor
14862019|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14862020|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862021|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
14709536|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14709537|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14709538|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709539|NCT00431262|Disulfiram|disulfiram|mesh-list
14709540|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14862022|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
15208268|NCT03708120|Protective Agents|protective agents|mesh-ancestor
15208269|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208270|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
15208271|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15208272|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
15208273|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208274|NCT03707951|Expectorants|expectorants|mesh-ancestor
15208275|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
15208276|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15208277|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
15208278|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208279|NCT03707951|Protective Agents|protective agents|mesh-ancestor
15208280|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208281|NCT03707951|Antidotes|antidotes|mesh-ancestor
15208282|NCT03707899|Amlodipine|amlodipine|mesh-list
15208283|NCT03707899|Telmisartan|telmisartan|mesh-list
15208284|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
15208285|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15208286|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15208287|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15208288|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15208289|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208290|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15208291|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208292|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
15208293|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15208294|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15208295|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
15208296|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15208297|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15208298|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208299|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15208300|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15208301|NCT03707847|Etoposide|etoposide|mesh-list
15208302|NCT03707847|Crizotinib|crizotinib|mesh-list
15208303|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15208304|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208305|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15208306|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15208307|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208308|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208309|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208310|NCT03707808|Nivolumab|nivolumab|mesh-list
14709541|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14862023|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14862024|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14862025|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862026|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862027|NCT01084369|Urological Agents|urological agents|mesh-ancestor
14862028|NCT01084408|Paclitaxel|paclitaxel|mesh-list
15208311|NCT03707808|Ipilimumab|ipilimumab|mesh-list
14862029|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14862030|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862031|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862032|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862033|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862034|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862035|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862036|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
14862037|NCT01084473|Morphine|morphine|mesh-list
14862038|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14862039|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14862040|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862041|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15208312|NCT03707808|Avelumab|avelumab|mesh-list
15208313|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208314|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208315|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15208316|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208317|NCT03707795|Betamethasone|betamethasone|mesh-list
15208318|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
15208319|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15208320|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
15208321|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
15208322|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
15208323|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15208324|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15208325|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
15208326|NCT03707795|Hormones|hormones|mesh-ancestor
15208327|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208328|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208329|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15208330|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
15208331|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15208332|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
15208333|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224944|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15224945|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15224946|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15224947|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14295967|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295968|NCT00585104|Simendan|simendan|mesh-list
14295969|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14295970|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
14295971|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14295972|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14709542|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709543|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709544|NCT00431275|Tremelimumab|tremelimumab|mesh-list
14709545|NCT00431275|Ipilimumab|ipilimumab|mesh-list
14709546|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709547|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14709548|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14709549|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709550|NCT00431340|Belinostat|belinostat|mesh-list
14709551|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709552|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15224948|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15224949|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
15224950|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
15224951|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
15224952|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
15224953|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14709553|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224954|NCT01956110|Hormones|hormones|mesh-ancestor
15225703|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862042|NCT01084473|Analgesics|analgesics|mesh-ancestor
14862043|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
14862044|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862045|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14862046|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14862047|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14862048|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14862049|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862050|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862051|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14862052|NCT01084473|Narcotics|narcotics|mesh-ancestor
14862053|NCT01084486|Metformin|metformin|mesh-list
14862054|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862055|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862056|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14862057|NCT01084577|Laxatives|laxatives|mesh-ancestor
14862058|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15208334|NCT03707678|Albuterol|albuterol|mesh-list
15208335|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15208336|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
15208337|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208338|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208339|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15208340|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
15208341|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
15208342|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15208343|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15208344|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15208345|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15208346|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
15208347|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208348|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208349|NCT03707652|Vitamins|vitamins|mesh-list
15208350|NCT03707652|Niacinamide|niacinamide|mesh-list
15208351|NCT03707652|Niacin|niacin|mesh-list
15208352|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
15208353|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
15208354|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
15208355|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208356|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14709554|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709555|NCT00431353|Valganciclovir|valganciclovir|mesh-list
14709556|NCT00431353|Ganciclovir|ganciclovir|mesh-list
14709557|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14709558|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
14913641|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913642|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913643|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913644|NCT01376154|Lamivudine|lamivudine|mesh-list
14913645|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14913646|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14913647|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913648|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913649|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
15208357|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
15208358|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208359|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15208360|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
15208361|NCT03707639|Apatinib|apatinib|mesh-list
15208362|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208363|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208364|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208365|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208366|NCT03707535|Infliximab|infliximab|mesh-list
15208367|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
14913650|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913651|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14913652|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15208368|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709559|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709560|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14709561|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709562|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709563|NCT00431379|Tenecteplase|tenecteplase|mesh-list
14709564|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14862059|NCT01084720|V0034CR|v0034cr|mesh-list
14862060|NCT01084720|Emollients|emollients|mesh-ancestor
14862061|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
14862062|NCT01084824|Cantharidin|cantharidin|mesh-list
14862063|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862064|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862065|NCT01084837|Bortezomib|bortezomib|mesh-list
14862066|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862067|NCT01084863|Paclitaxel|paclitaxel|mesh-list
14862068|NCT01084863|Trastuzumab|trastuzumab|mesh-list
14862069|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862070|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862071|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862072|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862073|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862074|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862075|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862076|NCT01084876|Paclitaxel|paclitaxel|mesh-list
14862077|NCT01084876|Trastuzumab|trastuzumab|mesh-list
14862078|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862079|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862080|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862081|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862082|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862083|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208369|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15208370|NCT03707509|Gemcitabine|gemcitabine|mesh-list
15208371|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208372|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15208373|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
15208374|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208375|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
15208376|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208377|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208378|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15208379|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
14295973|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14295974|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295975|NCT00585104|Protective Agents|protective agents|mesh-ancestor
14295976|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295977|NCT00585169|Memantine|memantine|mesh-list
14295978|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14295979|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14295980|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
14295981|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14295982|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295983|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14295984|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14295985|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14295986|NCT00585182|Enoxaparin|enoxaparin|mesh-list
14295987|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
14295988|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14295989|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14295990|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14295991|NCT00585247|Imiquimod|imiquimod|mesh-list
14295992|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15208380|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208381|NCT03707483|Ascorbic Acid|ascorbic acid|mesh-list
15208382|NCT03707483|Vitamins|vitamins|mesh-ancestor
15208383|NCT03707483|Micronutrients|micronutrients|mesh-ancestor
15208384|NCT03707483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208385|NCT03707483|Antioxidants|antioxidants|mesh-ancestor
15208386|NCT03707483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208387|NCT03707483|Protective Agents|protective agents|mesh-ancestor
15208388|NCT03707457|Nivolumab|nivolumab|mesh-list
15208389|NCT03707457|Ipilimumab|ipilimumab|mesh-list
15208390|NCT03707457|Antibodies|antibodies|mesh-list
15208391|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15208392|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
15208393|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208394|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208395|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295993|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
14862084|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862085|NCT01084902|Latanoprost|latanoprost|mesh-list
15208396|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14862086|NCT01084902|Brinzolamide|brinzolamide|mesh-list
14862087|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14862088|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14862089|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14862090|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862091|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862092|NCT01084980|Tacrolimus|tacrolimus|mesh-list
15208397|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208398|NCT03707418|Heparin|heparin|mesh-list
15208399|NCT03707418|Calcium heparin|calcium heparin|mesh-list
15208400|NCT03707418|Bivalirudin|bivalirudin|mesh-list
15208401|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
15208402|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15208403|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15208404|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208405|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
15208406|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15208407|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
15208408|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208409|NCT03707353|Vaccines|vaccines|mesh-list
15208410|NCT03707353|Immunologic Factors|immunologic factors|mesh-ancestor
14709565|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14709566|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709567|NCT00431392|Atropine|atropine|mesh-list
15208411|NCT03707353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208412|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
15208413|NCT03707249|Hematinics|hematinics|mesh-ancestor
15208414|NCT03707171|Liraglutide|liraglutide|mesh-list
15208415|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15208416|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208417|NCT03707171|Incretins|incretins|mesh-ancestor
15208418|NCT03707171|Hormones|hormones|mesh-ancestor
15208419|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208420|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15208421|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
15208422|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15208423|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15208424|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208425|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208426|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
15208427|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208428|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15208429|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15208430|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
15208431|NCT03706781|Benzydamine|benzydamine|mesh-list
15208432|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15208433|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208434|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15208435|NCT03706755|Norepinephrine|norepinephrine|mesh-list
15208436|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15208437|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15208438|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
15208439|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208440|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208441|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208442|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
15208443|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
15208444|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709568|NCT00431392|Propranolol|propranolol|mesh-list
14709569|NCT00431392|Phenylephrine|phenylephrine|mesh-list
14709570|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
14709571|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14709572|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14709573|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
14709574|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
14709575|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709576|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709577|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
14709578|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14709579|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
15208445|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14862093|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862094|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
14862095|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862096|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14862097|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862098|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862099|NCT01084993|Heparin|heparin|mesh-list
14862100|NCT01084993|Bivalirudin|bivalirudin|mesh-list
14862101|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
14862102|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14862103|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14862104|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862105|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
14862106|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14862107|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
14862108|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862109|NCT01085032|Nicotine|nicotine|mesh-list
14862110|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14862111|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
14862112|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862113|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862114|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14862115|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14862116|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
14862117|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862118|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862119|NCT01085058|Lenograstim|lenograstim|mesh-list
14862120|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15208446|NCT03706703|Carboplatin|carboplatin|mesh-list
15208447|NCT03706703|Docetaxel|docetaxel|mesh-list
15208448|NCT03706703|Pemetrexed|pemetrexed|mesh-list
15208449|NCT03706703|Endostar protein|endostar protein|mesh-list
15208450|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208451|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
15208452|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
15208453|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
15208454|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208455|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208456|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15208457|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862121|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
14862122|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862123|NCT01085149|Simvastatin|simvastatin|mesh-list
14862124|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14862125|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15208458|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15208459|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15208460|NCT03706703|Growth Substances|growth substances|mesh-ancestor
15208461|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208462|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
15208463|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
15208464|NCT03706547|Fludarabine|fludarabine|mesh-list
15208465|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15208466|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
15208467|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208468|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15208469|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15208470|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
15208471|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208472|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208473|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15208474|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
15208475|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15208476|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15208477|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208478|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
15208479|NCT03706339|Coagulants|coagulants|mesh-ancestor
14862126|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
14913653|NCT01376180|Lamotrigine|lamotrigine|mesh-list
15208480|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
15208481|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
15208482|NCT03706300|Ephedrine|ephedrine|mesh-list
14862127|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862128|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14862129|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14862130|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862131|NCT01085383|Aripiprazole|aripiprazole|mesh-list
14862132|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
15208483|NCT03706300|Guaifenesin|guaifenesin|mesh-list
15208484|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
15208485|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15208486|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
15208487|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208488|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208489|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15208490|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
15208491|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
15208492|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15208493|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15208494|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
15208495|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
15208496|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208497|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208498|NCT03706300|Expectorants|expectorants|mesh-ancestor
15208499|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15208500|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15208501|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
15208502|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15208503|NCT03706287|Cisplatin|cisplatin|mesh-list
15208504|NCT03706287|Carboplatin|carboplatin|mesh-list
15208505|NCT03706287|Pemetrexed|pemetrexed|mesh-list
15208506|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208507|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208508|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208509|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15208510|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15208511|NCT03706222|Grazoprevir|grazoprevir|mesh-list
15208512|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
15208513|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208514|NCT03706157|Doxorubicin|doxorubicin|mesh-list
15208515|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15208516|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15208517|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208518|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15208519|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15208520|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208521|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224955|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15224956|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224957|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15224958|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
15224959|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224960|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15224961|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
15224962|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224963|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224964|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15224965|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15224966|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15224967|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
15224968|NCT01335581|Tretinoin|tretinoin|mesh-list
15224969|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224970|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
14709580|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
14709581|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14709582|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14709583|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14709584|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
14709585|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709586|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709587|NCT00431392|Protective Agents|protective agents|mesh-ancestor
14709588|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14862133|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14709589|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14862134|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14862135|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14862136|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14862137|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862138|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
14862139|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
14862140|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862141|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862142|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14862143|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14862144|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
14862145|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14862146|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14862147|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14862148|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14862149|NCT01085422|Temozolomide|temozolomide|mesh-list
14862150|NCT01085422|Veliparib|veliparib|mesh-list
14862151|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15208522|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
15208523|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
15208524|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15208525|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
15208526|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208527|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
15208528|NCT03705949|Protective Agents|protective agents|mesh-ancestor
15208529|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15208530|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15208531|NCT03705884|Prednisolone|prednisolone|mesh-list
15208532|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15208533|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
15208534|NCT03705884|Hormones|hormones|mesh-ancestor
15208535|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208536|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208537|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15208538|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208539|NCT03705858|Lintuzumab|lintuzumab|mesh-list
15208540|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208541|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208542|NCT03705780|Fentanyl|fentanyl|mesh-list
15208543|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15208544|NCT03705780|Narcotics|narcotics|mesh-ancestor
15208545|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208546|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208547|NCT03705780|Analgesics|analgesics|mesh-ancestor
15208548|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
15208549|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208550|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15208551|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15208552|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
15208553|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
15208554|NCT03705728|Remifentanil|remifentanil|mesh-list
15208555|NCT03705728|Propofol|propofol|mesh-list
15208556|NCT03705728|Sevoflurane|sevoflurane|mesh-list
15208557|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15208558|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208559|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208560|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15208561|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
15208562|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
15208563|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15208564|NCT03705728|Narcotics|narcotics|mesh-ancestor
15208565|NCT03705728|Analgesics|analgesics|mesh-ancestor
15208566|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
15208567|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208568|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15208569|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15208570|NCT03705585|Vaccines|vaccines|mesh-list
15208571|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
15208572|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208573|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
14862152|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
14862153|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208574|NCT03705559|Narcotics|narcotics|mesh-ancestor
15208575|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208576|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208577|NCT03705559|Analgesics|analgesics|mesh-ancestor
14862154|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862155|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14862156|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862157|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
14862158|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
14862159|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14862160|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
14862161|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14862162|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208578|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
15208579|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208580|NCT03705533|Telmisartan|telmisartan|mesh-list
15208581|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15208582|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15208583|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15208584|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208585|NCT05177666|Trastuzumab|trastuzumab|mesh-list
15208586|NCT05177666|Pertuzumab|pertuzumab|mesh-list
15208587|NCT05177666|Vemurafenib|vemurafenib|mesh-list
15208588|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208589|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208590|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208591|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208592|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208593|NCT05177601|Cycloserine|cycloserine|mesh-list
15208594|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15208595|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208596|NCT05177601|Renal Agents|renal agents|mesh-ancestor
15208597|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15208598|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
15208599|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15208600|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
15208601|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208602|NCT05177588|Metformin|metformin|mesh-list
15208603|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15208604|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208605|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15208606|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
15208607|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208608|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15208609|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15208610|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
15208611|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208612|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208613|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15208614|NCT05177406|Erenumab|erenumab|mesh-list
14862163|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14862164|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14862165|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14862166|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14862167|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862168|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
14862169|NCT01085487|Coagulants|coagulants|mesh-ancestor
14862170|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
14913654|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
14862171|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862172|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
14862173|NCT01085552|Hematinics|hematinics|mesh-ancestor
14862174|NCT01085617|Cytarabine|cytarabine|mesh-list
14862175|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
14862176|NCT01085617|Melphalan|melphalan|mesh-list
14862177|NCT01085617|Rituximab|rituximab|mesh-list
14862178|NCT01085617|Methotrexate|methotrexate|mesh-list
14862179|NCT01085617|Fludarabine|fludarabine|mesh-list
14862180|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
14862181|NCT01085617|Etoposide|etoposide|mesh-list
14862182|NCT01085617|Vincristine|vincristine|mesh-list
14862183|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
14862184|NCT01085617|Daunorubicin|daunorubicin|mesh-list
14862185|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
14862186|NCT01085617|Pegaspargase|pegaspargase|mesh-list
14862187|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862188|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
14862189|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862190|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14862191|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14862192|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
14862193|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862194|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862195|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14862196|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862197|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14862198|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
14862199|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14862200|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14862201|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
14862202|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
14862203|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862204|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14862205|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862206|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862207|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14862208|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14862209|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
14862210|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862211|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862212|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862213|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862214|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14862215|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14862216|NCT01085656|Combretastatin|combretastatin|mesh-list
14862217|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862218|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862219|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862220|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862221|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862222|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862223|NCT01085695|Rabeprazole|rabeprazole|mesh-list
14862224|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14862225|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14862226|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14862227|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862228|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862229|NCT01085708|Rabeprazole|rabeprazole|mesh-list
14862230|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14862231|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14862232|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14862233|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862234|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862235|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
14862236|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
14862237|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
14862238|NCT01085721|Ephedrine|ephedrine|mesh-list
14862239|NCT01085721|Guaifenesin|guaifenesin|mesh-list
14862240|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14862241|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14862242|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14862243|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
14862244|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862245|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862246|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14862247|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
14862248|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
14862249|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14862250|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14862251|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
14862252|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14862253|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862254|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862255|NCT01085721|Expectorants|expectorants|mesh-ancestor
14862256|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14862257|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14862258|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
14862259|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14862260|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14862261|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
14862262|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
14862263|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
14862264|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
14862265|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14862266|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14862267|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862268|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14862269|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862270|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862271|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
14862272|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14862273|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14862274|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
14862275|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
14862276|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862277|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862278|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709590|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14709591|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14709592|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
14709593|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14709594|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14709595|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
14709596|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14709597|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14862279|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
14862280|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
14862281|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14862282|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14862283|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14862284|NCT01085877|Estradiol|estradiol|mesh-list
14862285|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14862286|NCT01085877|Estrogens|estrogens|mesh-ancestor
14862287|NCT01085877|Hormones|hormones|mesh-ancestor
14862288|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709598|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14709599|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
14709600|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709601|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
14709602|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
14709603|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14709604|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14862289|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862290|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14862291|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
15208615|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15208616|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208617|NCT05177406|Analgesics|analgesics|mesh-ancestor
15208618|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
15208619|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208620|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208621|NCT05177276|Irinotecan|irinotecan|mesh-list
14862292|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14862293|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14862294|NCT01085981|Niacin|niacin|mesh-list
14862295|NCT01085981|Niacinamide|niacinamide|mesh-list
14862296|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
14862297|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14862298|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
14862299|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862300|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14862301|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
14862302|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
14862303|NCT01085981|Vitamins|vitamins|mesh-ancestor
14862304|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
14862305|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862306|NCT01086020|Atorvastatin|atorvastatin|mesh-list
14862307|NCT01086020|Ezetimibe|ezetimibe|mesh-list
14862308|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14862309|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14862310|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
14862311|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862312|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14862313|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14862314|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862315|NCT01086046|Heparin|heparin|mesh-list
14862316|NCT01086046|Enoxaparin|enoxaparin|mesh-list
14862317|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14862318|NCT01086046|Tinzaparin|tinzaparin|mesh-list
14862319|NCT01086046|Dalteparin|dalteparin|mesh-list
14862320|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
14862321|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14862322|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14862323|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862324|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14862325|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
14862326|NCT01086085|Adefovir|adefovir|mesh-list
14862327|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
14862328|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862329|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
14862330|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862331|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14862332|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862333|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862334|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862335|NCT01086254|Gemcitabine|gemcitabine|mesh-list
14862336|NCT01086254|Iniparib|iniparib|mesh-list
15208622|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14295994|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709605|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709606|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709607|NCT00431418|Urological Agents|urological agents|mesh-ancestor
14709608|NCT00431522|Valproic Acid|valproic acid|mesh-list
14709609|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
14709610|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709611|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709612|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
14709613|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709614|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709615|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
14862337|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862338|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14862339|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
14862340|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862341|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
14862342|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862343|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862344|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862345|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
14862346|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862347|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14862348|NCT01086332|Gemcitabine|gemcitabine|mesh-list
14862349|NCT01086332|Nelfinavir|nelfinavir|mesh-list
14862350|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14862351|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
14862352|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862353|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862354|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
14862355|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862356|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862357|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862358|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
14862359|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862360|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14862361|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14862362|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
14862363|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14862364|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14862365|NCT01086345|Bevacizumab|bevacizumab|mesh-list
14862366|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14862367|NCT01086345|Irinotecan|irinotecan|mesh-list
14862368|NCT01086345|Camptothecin|camptothecin|mesh-list
14862369|NCT01086345|Antibodies|antibodies|mesh-list
14862370|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
14862371|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14862372|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862373|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14862374|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14862375|NCT01086345|Growth Substances|growth substances|mesh-ancestor
14862376|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862377|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
14862378|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
14862379|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14862380|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14862381|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862382|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862383|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14913655|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14913656|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913657|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913658|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14913659|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913660|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14913661|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14913662|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913663|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14913664|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14913665|NCT01376193|Naratriptan|naratriptan|mesh-list
14913666|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14913667|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14913668|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14913669|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
14913670|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913671|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913672|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913673|NCT01376206|Fluticasone|fluticasone|mesh-list
14913674|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913675|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14913676|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
15208623|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15208624|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208625|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208626|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208627|NCT05177237|Endostar protein|endostar protein|mesh-list
15208628|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15224971|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
14862384|NCT01086527|Montelukast|montelukast|mesh-list
14862385|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14862386|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
14862387|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14862388|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
14862389|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862390|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862391|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15208629|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15208630|NCT05177237|Growth Substances|growth substances|mesh-ancestor
15208631|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208632|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
15208633|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208634|NCT05176821|Amoxicillin|amoxicillin|mesh-list
15208635|NCT05176821|Furazolidone|furazolidone|mesh-list
15208636|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
15208637|NCT05176821|Esomeprazole|esomeprazole|mesh-list
14862392|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14862393|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862394|NCT01086553|Budesonide|budesonide|mesh-list
14862395|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862396|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14862397|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
14862398|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862399|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862400|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14862401|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
14862402|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
14862403|NCT01086553|Hormones|hormones|mesh-ancestor
15208638|NCT05176821|Bismuth|bismuth|mesh-list
15208639|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208640|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14709616|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14709617|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14709618|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14709619|NCT00431561|Temozolomide|temozolomide|mesh-list
14709620|NCT00431561|Lomustine|lomustine|mesh-list
14709621|NCT00431561|Trabedersen|trabedersen|mesh-list
14709622|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14709623|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
15208641|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208642|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15208643|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14862404|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862405|NCT01086579|Paclitaxel|paclitaxel|mesh-list
14862406|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14862407|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862408|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862409|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862410|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862411|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862412|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862413|NCT01086631|Rituximab|rituximab|mesh-list
14862414|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862415|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862416|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
14862417|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862418|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14862419|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14862420|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
14862421|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14862422|NCT01086826|Cisplatin|cisplatin|mesh-list
14862423|NCT01086826|Docetaxel|docetaxel|mesh-list
14862424|NCT01086826|Fluorouracil|fluorouracil|mesh-list
14862425|NCT01086826|Cetuximab|cetuximab|mesh-list
14862426|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862427|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862428|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862429|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
15208644|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15208645|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208646|NCT05176821|Antacids|antacids|mesh-ancestor
15208647|NCT05176821|Diuretics|diuretics|mesh-ancestor
15208648|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
15208649|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862430|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862431|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
14862432|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14862433|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862434|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
14862435|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862436|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862437|NCT01086878|Trimethoprim|trimethoprim|mesh-list
14862438|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14862439|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
14862440|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14862441|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862442|NCT01086878|Renal Agents|renal agents|mesh-ancestor
14862443|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
14862444|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14862445|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14862446|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14862447|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862448|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862449|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14862450|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14862451|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14862452|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14862453|NCT01086956|Sufentanil|sufentanil|mesh-list
14862454|NCT01086956|Ropivacaine|ropivacaine|mesh-list
14862455|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
14862456|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
14862457|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14862458|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862459|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
14862460|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862461|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14862462|NCT01086956|Narcotics|narcotics|mesh-ancestor
14862463|NCT01086956|Analgesics|analgesics|mesh-ancestor
14862464|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14862465|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14862466|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
14862467|NCT01086982|Octreotide|octreotide|mesh-list
14862468|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14862469|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14862470|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862471|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
14862472|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14862473|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862474|NCT01087099|Albendazole|albendazole|mesh-list
14862475|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
14862476|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14862477|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862478|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
14862479|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14862480|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14862481|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862482|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862483|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862484|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862485|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862486|NCT01087138|Calcium|calcium|mesh-list
14862487|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14862488|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862489|NCT01087190|Isoniazid|isoniazid|mesh-list
14862490|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
14862491|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14862492|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862493|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14862494|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14862495|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
14862496|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862497|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14862498|NCT01087203|Tanezumab|tanezumab|mesh-list
14862499|NCT01087203|Analgesics|analgesics|mesh-ancestor
14862500|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
14862501|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862502|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862503|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
14862504|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14862505|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
14862506|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
14862507|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14862508|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862509|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14862510|NCT01087229|Analgesics|analgesics|mesh-ancestor
14862511|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
14862512|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862513|NCT01087359|Melatonin|melatonin|mesh-list
14862514|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
14862515|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862516|NCT01087359|Protective Agents|protective agents|mesh-ancestor
14862517|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862518|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14862519|NCT01087398|Cyclosporine|cyclosporine|mesh-list
14709624|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709625|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709626|NCT00431613|Gemcitabine|gemcitabine|mesh-list
14862520|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
14862521|NCT01087398|Busulfan|busulfan|mesh-list
14862522|NCT01087398|Methotrexate|methotrexate|mesh-list
14862523|NCT01087398|Fludarabine|fludarabine|mesh-list
14862524|NCT01087398|Cyclosporins|cyclosporins|mesh-list
14862525|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
14862526|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862527|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
14862528|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862529|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14862530|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14862531|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
14862532|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862533|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862534|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14862535|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14709627|NCT00431613|Carboplatin|carboplatin|mesh-list
14295995|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14295996|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
14295997|NCT00585312|Celecoxib|celecoxib|mesh-list
14295998|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14295999|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296000|NCT00585312|Analgesics|analgesics|mesh-ancestor
14296001|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
14296002|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296003|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296004|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296005|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14296006|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14296007|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14709628|NCT00431613|Docetaxel|docetaxel|mesh-list
14862536|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
14862537|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14709629|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709630|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709631|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
14709632|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709633|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
14709634|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709635|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709636|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709637|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
14709638|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709639|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709640|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709641|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862538|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296008|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862539|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
14862540|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
14862541|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862542|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14862543|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862544|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
14862545|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862546|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14862547|NCT01087437|Calcium|calcium|mesh-list
14862548|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14862549|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862550|NCT01087476|Doxycycline|doxycycline|mesh-list
14862551|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14862552|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862553|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
14862554|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14862555|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14862556|NCT01087554|Sirolimus|sirolimus|mesh-list
14862557|NCT01087554|Everolimus|everolimus|mesh-list
14862558|NCT01087554|Vorinostat|vorinostat|mesh-list
14862559|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862560|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862561|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
14862562|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862563|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14862564|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862565|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14862566|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
14862567|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14862568|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862569|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862570|NCT01087567|Insulin|insulin|mesh-list
14862571|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14862572|NCT01087567|Metformin|metformin|mesh-list
14862573|NCT01087567|Pioglitazone|pioglitazone|mesh-list
14862574|NCT01087567|Glimepiride|glimepiride|mesh-list
14862575|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862576|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862577|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14862578|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862579|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
14862580|NCT01087580|Prednisone|prednisone|mesh-list
14862581|NCT01087580|Docetaxel|docetaxel|mesh-list
14862582|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862583|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862584|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862585|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862586|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862587|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862588|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
14862589|NCT01087580|Hormones|hormones|mesh-ancestor
14862590|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862591|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862592|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14862593|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14862594|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14862595|NCT01087593|Estradiol|estradiol|mesh-list
14862596|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14862597|NCT01087593|Estrogens|estrogens|mesh-ancestor
14862598|NCT01087593|Hormones|hormones|mesh-ancestor
14862599|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862600|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862601|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14862602|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
14862603|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14862604|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14862605|NCT01087632|Folic Acid|folic acid|mesh-list
14862606|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
14862607|NCT01087632|Policosanol|policosanol|mesh-list
14862608|NCT01087632|Red yeast rice|red yeast rice|mesh-list
14862609|NCT01087632|Hematinics|hematinics|mesh-ancestor
14862610|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
15208650|NCT05176821|Expectorants|expectorants|mesh-ancestor
14862611|NCT01087632|Vitamins|vitamins|mesh-ancestor
15208651|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
14862612|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
15208652|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14862613|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224972|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
14862614|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14862615|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14862616|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14862617|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
14862618|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862619|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862620|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14862621|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14862622|NCT01087658|Calcium|calcium|mesh-list
14862623|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14862624|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862625|NCT01087710|Vitamins|vitamins|mesh-list
14862626|NCT01087710|Antioxidants|antioxidants|mesh-list
14862627|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
14862628|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862629|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862630|NCT01087710|Protective Agents|protective agents|mesh-ancestor
14862631|NCT01087749|Losartan|losartan|mesh-list
14862632|NCT01087749|Propranolol|propranolol|mesh-list
14862633|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14862634|NCT01087749|Eprosartan|eprosartan|mesh-list
14862635|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14862636|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14862637|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14862638|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14862639|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862640|NCT01087749|Diuretics|diuretics|mesh-ancestor
14862641|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
14862642|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862643|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14862644|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14862645|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14862646|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14862647|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
14862648|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862649|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
14862650|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14862651|NCT01087840|Tenofovir|tenofovir|mesh-list
14862652|NCT01087840|Emtricitabine|emtricitabine|mesh-list
14862653|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
14862654|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
14862655|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862656|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14862657|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862658|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862659|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862660|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14862661|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14862662|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14862663|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14862664|NCT01087866|Metformin|metformin|mesh-list
14862665|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862666|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862667|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14862668|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14862669|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14862670|NCT01087879|Etonogestrel|etonogestrel|mesh-list
14862671|NCT01087879|Desogestrel|desogestrel|mesh-list
14862672|NCT01087879|NuvaRing|nuvaring|mesh-list
14862673|NCT01087879|Norelgestromin|norelgestromin|mesh-list
14862674|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
14862675|NCT01087879|Estradiol|estradiol|mesh-list
14862676|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14862677|NCT01087879|Estrogens|estrogens|mesh-ancestor
14862678|NCT01087879|Hormones|hormones|mesh-ancestor
14862679|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862680|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862681|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14862682|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14862683|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15208653|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15208654|NCT05176821|Renal Agents|renal agents|mesh-ancestor
14862684|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14862685|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14862686|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14862687|NCT01087879|Progestins|progestins|mesh-ancestor
14862688|NCT01087983|Metformin|metformin|mesh-list
14862689|NCT01087983|Sirolimus|sirolimus|mesh-list
14862690|NCT01087983|Lapatinib|lapatinib|mesh-list
14862691|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862692|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862693|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14862694|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862695|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14862696|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862697|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
14862698|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862699|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
14862700|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14862701|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862702|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862703|NCT01088009|Lamivudine|lamivudine|mesh-list
14862704|NCT01088009|Adefovir|adefovir|mesh-list
14862705|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14862706|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862707|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862708|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862709|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
14296009|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296010|NCT00585325|Lidocaine|lidocaine|mesh-list
14709642|NCT00431665|Heparin|heparin|mesh-list
14709643|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14709644|NCT00431665|Somatostatin|somatostatin|mesh-list
14709645|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14709646|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709647|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
14709648|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15208655|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15208656|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15208657|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15208658|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15208659|NCT05176626|Phentermine|phentermine|mesh-list
15208660|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15208661|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208662|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
15208663|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15208664|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
15208665|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
15208666|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862710|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862711|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14862712|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14862713|NCT01088022|Dexamethasone|dexamethasone|mesh-list
15208667|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
15208668|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709649|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14709650|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862714|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
14862715|NCT01088022|Aprepitant|aprepitant|mesh-list
14862716|NCT01088022|Palonosetron|palonosetron|mesh-list
14862717|NCT01088022|BB 1101|bb 1101|mesh-list
14862718|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862719|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
14862720|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
14862721|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862722|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862723|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14862724|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
14862725|NCT01088022|Hormones|hormones|mesh-ancestor
14862726|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862727|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14862728|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208669|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208670|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14709651|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14709652|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14709653|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14709654|NCT00431665|Hormones|hormones|mesh-ancestor
14862729|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
14862730|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862731|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862732|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14862733|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862734|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14862735|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14862736|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
14862737|NCT01088035|Carboplatin|carboplatin|mesh-list
14862738|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862739|NCT01088165|Adalimumab|adalimumab|mesh-list
14862740|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862741|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14862742|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
14862743|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14862744|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
14862745|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14862746|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862747|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14862748|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15208671|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
15208672|NCT05176548|Paraproteins|paraproteins|mesh-list
15208673|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
14862749|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14862750|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
14862751|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14862752|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
14862753|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862754|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
14862755|NCT01088191|Protective Agents|protective agents|mesh-ancestor
14862756|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
14862757|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14862758|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14862759|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862760|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
14862761|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862762|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862763|NCT01088256|Etoricoxib|etoricoxib|mesh-list
14862764|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14862765|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15208674|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208675|NCT05176379|Fluconazole|fluconazole|mesh-list
15208676|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
15208677|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208678|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15208679|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14862766|NCT01088256|Analgesics|analgesics|mesh-ancestor
14862767|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
14862768|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862769|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862770|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862771|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14862772|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14862773|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14862774|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862775|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862776|NCT01088282|Dipivefrin|dipivefrin|mesh-list
14862777|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15208680|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208681|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208682|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15208683|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
14862778|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
14862779|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15224973|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
14862780|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862781|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913677|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913678|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913679|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14913680|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913681|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
14913682|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14913683|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
14913684|NCT01376232|Glycine|glycine|mesh-list
14913685|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
14913686|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913687|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913688|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913689|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14913690|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
14913691|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14913692|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14913693|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14296011|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
14296012|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
14296013|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296014|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296015|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
14296016|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296017|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14913694|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913695|NCT01376258|Finasteride|finasteride|mesh-list
14913696|NCT01376258|Dutasteride|dutasteride|mesh-list
14913697|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14913698|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14709655|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709656|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709657|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
14709658|NCT00431678|Levofloxacin|levofloxacin|mesh-list
14709659|NCT00431678|Ofloxacin|ofloxacin|mesh-list
14709660|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
14709661|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14709662|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14709663|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913699|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862782|NCT01088347|Mapatumumab|mapatumumab|mesh-list
14862783|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862784|NCT01088373|Lenalidomide|lenalidomide|mesh-list
14862785|NCT01088373|Azacitidine|azacitidine|mesh-list
14862786|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
14862787|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862788|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14862789|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14862790|NCT01088373|Growth Substances|growth substances|mesh-ancestor
14862791|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
14862792|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862793|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14709664|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14709665|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709666|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709667|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709668|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709669|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14709670|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
15208684|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15208685|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709671|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14709672|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862794|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
14296018|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14862795|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862796|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862797|NCT01088451|Insulin|insulin|mesh-list
14862798|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862799|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862800|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14862801|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14296019|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14296020|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14862802|NCT01088477|Estradiol|estradiol|mesh-list
14862803|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14862804|NCT01088477|Estrogens|estrogens|mesh-ancestor
14862805|NCT01088477|Hormones|hormones|mesh-ancestor
14862806|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862807|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296021|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296022|NCT00585351|Ranitidine|ranitidine|mesh-list
14296023|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14296024|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14296025|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296026|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14296027|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
14709673|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14862808|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14862809|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
14862810|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14862811|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14862812|NCT01088516|Ritonavir|ritonavir|mesh-list
14862813|NCT01088516|Lopinavir|lopinavir|mesh-list
15208686|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15208687|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15208688|NCT05176288|Palbociclib|palbociclib|mesh-list
15208689|NCT05176288|Avelumab|avelumab|mesh-list
15208690|NCT05176288|Axitinib|axitinib|mesh-list
15208691|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208692|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208693|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709674|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14862814|NCT01088516|Zidovudine|zidovudine|mesh-list
14862815|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14862816|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14862817|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
14862818|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862819|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862820|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14862821|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14862822|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
14862823|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296028|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
14862824|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14862825|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14862826|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
14862827|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14862828|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862829|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
14862830|NCT01088555|Antidotes|antidotes|mesh-ancestor
14862831|NCT01088555|Protective Agents|protective agents|mesh-ancestor
14862832|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862833|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
14862834|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862835|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
14862836|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14862837|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862838|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
14862839|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
14862840|NCT01088594|Pioglitazone|pioglitazone|mesh-list
14862841|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
14862842|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862843|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862844|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14862845|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14862846|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14862847|NCT01088620|Pemetrexed|pemetrexed|mesh-list
14862848|NCT01088620|Panitumumab|panitumumab|mesh-list
14862849|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862850|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862851|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862852|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14862853|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862854|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862855|NCT01088659|Tenofovir|tenofovir|mesh-list
14862856|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14862857|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
14862858|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862859|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14862860|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862861|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862862|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862863|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14862864|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14862865|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
14709675|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14709676|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14709677|NCT00431678|Renal Agents|renal agents|mesh-ancestor
14709678|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14709679|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14709680|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
14862866|NCT01088724|Rituximab|rituximab|mesh-list
14862867|NCT01088724|Doxorubicin|doxorubicin|mesh-list
14862868|NCT01088724|Fludarabine|fludarabine|mesh-list
14862869|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862870|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
14862871|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862872|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14862873|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14862874|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
14862875|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862876|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862877|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14862878|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14862879|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14862880|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14862881|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14862882|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862883|NCT01088737|Imiquimod|imiquimod|mesh-list
14862884|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14862885|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
14862886|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709681|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
14709682|NCT00431704|Carboplatin|carboplatin|mesh-list
14709683|NCT00431704|Trastuzumab|trastuzumab|mesh-list
14862887|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709684|NCT00431704|Vinorelbine|vinorelbine|mesh-list
14709685|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862888|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
14862889|NCT01088750|Prednisolone|prednisolone|mesh-list
14862890|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
14862891|NCT01088750|Vinblastine|vinblastine|mesh-list
14862892|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709686|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14709687|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14709688|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862893|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
14862894|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862895|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14862896|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14862897|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
14862898|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862899|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862900|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14862901|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862902|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
14862903|NCT01088750|Hormones|hormones|mesh-ancestor
14862904|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862905|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14862906|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862907|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862908|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862909|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862910|NCT01088763|Dexamethasone|dexamethasone|mesh-list
14862911|NCT01088763|R04929097|r04929097|mesh-list
14862912|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862913|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
14862914|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
14862915|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14862916|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862917|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14862918|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
14862919|NCT01088763|Hormones|hormones|mesh-ancestor
14862920|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14862921|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14862922|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862923|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862924|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862925|NCT01088802|Carboplatin|carboplatin|mesh-list
14862926|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709689|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709690|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709691|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728709|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14728710|NCT00519753|Timolol|timolol|mesh-list
14728711|NCT00519753|Travoprost|travoprost|mesh-list
14728712|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14728713|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14728714|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14728715|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14728716|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
14728717|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14862927|NCT01088815|Gemcitabine|gemcitabine|mesh-list
14862928|NCT01088815|Paclitaxel|paclitaxel|mesh-list
14862929|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14862930|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862931|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14862932|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14862933|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14862934|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862935|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14862936|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
14862937|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
14862938|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862939|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862940|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862941|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
14862942|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862943|NCT01088893|Everolimus|everolimus|mesh-list
14862944|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862945|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862946|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
14862947|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862948|NCT01088906|Pemetrexed|pemetrexed|mesh-list
14862949|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862950|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862951|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862952|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14862953|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14862954|NCT01088919|Pioglitazone|pioglitazone|mesh-list
14862955|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
14862956|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862957|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862958|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14862959|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862960|NCT01088932|SRX246|srx246|mesh-list
14862961|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14862962|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862963|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
14862964|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862965|NCT01088958|Micronutrients|micronutrients|mesh-list
14862966|NCT01088958|Trace Elements|trace elements|mesh-list
14709692|NCT00431769|Bortezomib|bortezomib|mesh-list
14709693|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709694|NCT00431795|Doxorubicin|doxorubicin|mesh-list
14709695|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14709696|NCT00431795|Epirubicin|epirubicin|mesh-list
14709697|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709698|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709699|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14709700|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709701|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709702|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709703|NCT00431990|Dexamethasone|dexamethasone|mesh-list
14862967|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862968|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
14862969|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15208694|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208695|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208696|NCT05176119|Ketamine|ketamine|mesh-list
14709704|NCT00431990|Bortezomib|bortezomib|mesh-list
14862970|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15208697|NCT05176119|Nalbuphine|nalbuphine|mesh-list
15208698|NCT05176119|Analgesics|analgesics|mesh-ancestor
15208699|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
15208700|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208701|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208702|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14709705|NCT00431990|Romidepsin|romidepsin|mesh-list
14709706|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862971|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14862972|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14862973|NCT01089088|Gemcitabine|gemcitabine|mesh-list
14862974|NCT01089088|Sunitinib|sunitinib|mesh-list
14862975|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14862976|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14862977|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
14862978|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862979|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
14862980|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14862981|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14862982|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14862983|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
14862984|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862985|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14862986|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14862987|NCT01089088|Growth Substances|growth substances|mesh-ancestor
14862988|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
14862989|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14862990|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
14862991|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14862992|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14862993|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14862994|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
14862995|NCT01089140|Coagulants|coagulants|mesh-ancestor
14862996|NCT01089166|Metformin|metformin|mesh-list
14862997|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14862998|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14862999|NCT01089179|Metformin|metformin|mesh-list
14863000|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14863001|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863002|NCT01089192|Metformin|metformin|mesh-list
14863003|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14863004|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863005|NCT01089205|Metformin|metformin|mesh-list
14863006|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14863007|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863008|NCT01089218|Amoxicillin|amoxicillin|mesh-list
14863009|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
14863010|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
14863011|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14863012|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863013|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863014|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14863015|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863016|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863017|NCT01089309|Spironolactone|spironolactone|mesh-list
14863018|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14863019|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
14863020|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863021|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863022|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14863023|NCT01089309|Diuretics|diuretics|mesh-ancestor
14863024|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
14863025|NCT01089348|Metronidazole|metronidazole|mesh-list
14863026|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863027|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863028|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14863029|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14863030|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
14709707|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
14709708|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
14709709|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709710|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709711|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709712|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
14709713|NCT00431990|Hormones|hormones|mesh-ancestor
14709714|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709715|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14709716|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863031|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14863032|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
14863033|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863034|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863035|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14863036|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
14863037|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14863038|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
14863039|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863040|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863041|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14863042|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863043|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
14863044|NCT01089439|Protective Agents|protective agents|mesh-ancestor
14863045|NCT01089452|Amlodipine|amlodipine|mesh-list
14863046|NCT01089452|Olmesartan|olmesartan|mesh-list
14863047|NCT01089452|Perindopril|perindopril|mesh-list
14863048|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14863049|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14863050|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863051|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863052|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14863053|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863054|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863055|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14863056|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14863057|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14863058|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
14863059|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863060|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
15208703|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15208704|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
15208705|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
15208706|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208707|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15208708|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15208709|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208710|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208711|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15208712|NCT05176119|Narcotics|narcotics|mesh-ancestor
15224974|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15224975|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15224976|NCT00882895|Prednisolone|prednisolone|mesh-list
15224977|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
15224978|NCT00882895|Tacrolimus|tacrolimus|mesh-list
15224979|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
15224980|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15224981|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15224982|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
15224983|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15224984|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
15224985|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15224986|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15224987|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15224988|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15224989|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15224990|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15224991|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15224992|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
15224993|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15224994|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15224995|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15224996|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
15224997|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
15224998|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15224999|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15225000|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
15225001|NCT00882895|Hormones|hormones|mesh-ancestor
15225002|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225003|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15225004|NCT00882895|Protective Agents|protective agents|mesh-ancestor
15225005|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15225006|NCT00867178|Vitamin A|vitamin a|mesh-list
14863061|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14863062|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14863063|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14863064|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863065|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863066|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863067|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863068|NCT01089621|Analgesics|analgesics|mesh-ancestor
14863069|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
14863070|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863071|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
14863072|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14863073|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
14863074|NCT01089660|Vaccines|vaccines|mesh-list
14863075|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
14863076|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863077|NCT01089855|Carbamazepine|carbamazepine|mesh-list
14863078|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
14863079|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
14863080|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14863081|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863082|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863083|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14863084|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14863085|NCT01089855|Analgesics|analgesics|mesh-ancestor
14863086|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
14863087|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863088|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14863089|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863090|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863091|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14863092|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14863093|NCT01089933|Anesthetics|anesthetics|mesh-list
14863094|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
14863095|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863096|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863097|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
14863098|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863099|NCT01089959|Esomeprazole|esomeprazole|mesh-list
14863100|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14863101|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863102|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14863103|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863104|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863105|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14863106|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14863107|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14863108|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14863109|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863110|NCT01090037|Epoprostenol|epoprostenol|mesh-list
14863111|NCT01090037|Beraprost|beraprost|mesh-list
14863112|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14863113|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863114|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14863115|NCT01090128|Paclitaxel|paclitaxel|mesh-list
14863116|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
14863117|NCT01090128|Doxorubicin|doxorubicin|mesh-list
14863118|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14863119|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14863120|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863121|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14863122|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14863123|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
14863124|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863125|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863126|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
14863127|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863128|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14863129|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14863130|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
14863131|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14863132|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14863133|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14863134|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14863135|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913700|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913701|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
14913702|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913703|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913704|NCT01376258|Urological Agents|urological agents|mesh-ancestor
14913705|NCT01376271|Paroxetine|paroxetine|mesh-list
14913706|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14913707|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14913708|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14913709|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913710|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913711|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
15208713|NCT05175703|Paclitaxel|paclitaxel|mesh-list
15208714|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15208715|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208716|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
15208717|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
15208718|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
15208719|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208720|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
15208721|NCT05175625|Paraproteins|paraproteins|mesh-list
14709717|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709718|NCT00432016|Zidovudine|zidovudine|mesh-list
14709719|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
14709720|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709721|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14709722|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15208722|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
14709723|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709724|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
15208723|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208724|NCT05175547|Clevidipine|clevidipine|mesh-list
15208725|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15208726|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15208727|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208728|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15208729|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208730|NCT05175508|Azacitidine|azacitidine|mesh-list
15208731|NCT05175508|Tretinoin|tretinoin|mesh-list
15208732|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15208733|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
15208734|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208735|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208736|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208737|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
15208738|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
15208739|NCT05175430|Paroxetine|paroxetine|mesh-list
15208740|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15208741|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15208742|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15208743|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15208744|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208745|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208746|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
15208747|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208748|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15208749|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
15208750|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15208751|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15208752|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15208753|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208754|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
15208755|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15208756|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15208757|NCT05175235|Nivolumab|nivolumab|mesh-list
15208758|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208759|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208760|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15208761|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208762|NCT05175131|Mebeverine|mebeverine|mesh-list
15208763|NCT05175131|Simethicone|simethicone|mesh-list
15208764|NCT05175131|Alverine|alverine|mesh-list
15208765|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
15208766|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208767|NCT05175131|Emollients|emollients|mesh-ancestor
15208768|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
15208769|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
15208770|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
14709725|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709726|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14709727|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14709728|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
14709729|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14709730|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14709731|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14709732|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729421|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863136|NCT01090167|Clofarabine|clofarabine|mesh-list
14863137|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14863138|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
14863139|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863140|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863141|NCT01090206|Vitamin D|vitamin d|mesh-list
14863142|NCT01090206|Calcium|calcium|mesh-list
14863143|NCT01090206|Vitamins|vitamins|mesh-ancestor
14863144|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
14863145|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863146|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14863147|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14863148|NCT01090466|Gemcitabine|gemcitabine|mesh-list
14863149|NCT01090466|Sirolimus|sirolimus|mesh-list
14863150|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863151|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14863152|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
14863153|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863154|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
14863155|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863156|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863157|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863158|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
14863159|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863160|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863161|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14863162|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
14863163|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
14863164|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863165|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
14863166|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14863167|NCT01090596|Naproxen|naproxen|mesh-list
14863168|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14863169|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14863170|NCT01090596|Analgesics|analgesics|mesh-ancestor
14863171|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
14863172|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863173|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863174|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14863175|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14863176|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
14863177|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14863178|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863179|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863180|NCT01090648|Etravirine|etravirine|mesh-list
14863181|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14863182|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14863183|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863184|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863185|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
14863186|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863187|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
14863188|NCT01090661|Mipomersen|mipomersen|mesh-list
14863189|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14863190|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863191|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863192|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14863193|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14863194|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863195|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863196|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863197|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14863198|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
14863199|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14863200|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863201|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14863202|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14863203|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14863204|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14863205|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14863206|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
14863207|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14863208|NCT01090700|Simeprevir|simeprevir|mesh-list
14863209|NCT01090700|Dexetimide|dexetimide|mesh-list
14863210|NCT01090700|Citalopram|citalopram|mesh-list
14863211|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14863212|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14863213|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863214|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863215|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863216|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
14863217|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863218|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14863219|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
14863220|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14863221|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14863222|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14863223|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
14863224|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
14863225|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863226|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14863227|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14863228|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
14863229|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
14863230|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863231|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
14863232|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863233|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14863234|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14863235|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863236|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14863237|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14863238|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863239|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863240|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
14863241|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863242|NCT01090778|Hormones|hormones|mesh-list
14863243|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863244|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863245|NCT01090830|Paclitaxel|paclitaxel|mesh-list
14863246|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14863247|NCT01090830|Bevacizumab|bevacizumab|mesh-list
14863248|NCT01090830|Carboplatin|carboplatin|mesh-list
14863249|NCT01090830|Belinostat|belinostat|mesh-list
14863250|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14863251|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863252|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
14863253|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
14863254|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
14863255|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863256|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14863257|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14863258|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14863259|NCT01090830|Growth Substances|growth substances|mesh-ancestor
14863260|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863261|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14863262|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14863263|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863264|NCT01090882|Bupivacaine|bupivacaine|mesh-list
14863265|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
14863266|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
14863267|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208771|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
15208772|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208773|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208774|NCT05175066|Bisoprolol|bisoprolol|mesh-list
15208775|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15208776|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
15208777|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
15208778|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208779|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208780|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15208781|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15208782|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15208783|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14709733|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709734|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
14709735|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709736|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863268|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863269|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
14863270|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863271|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
14863272|NCT01090895|Vitamins|vitamins|mesh-ancestor
14863273|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
14863274|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863275|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
14863276|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863277|NCT01090895|Protective Agents|protective agents|mesh-ancestor
14863278|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14863279|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863280|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
14863281|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863282|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14863283|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14863284|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863285|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709737|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14709738|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709739|NCT00432068|Octreotide|octreotide|mesh-list
14709740|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709741|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14709742|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709743|NCT00432081|Indomethacin|indomethacin|mesh-list
14709744|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14709745|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14709746|NCT00432081|Analgesics|analgesics|mesh-ancestor
14709747|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
14709748|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709749|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863286|NCT01091012|Urological Agents|urological agents|mesh-ancestor
14863287|NCT01091051|Ustekinumab|ustekinumab|mesh-list
14863288|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
14863289|NCT01091077|Naringenin|naringenin|mesh-list
14709750|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14709751|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14863290|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14863291|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863292|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14863293|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
14863294|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863295|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863296|NCT01091207|Sorafenib|sorafenib|mesh-list
14709752|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
14709753|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
14709754|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14863297|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863298|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14863299|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208784|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208785|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208786|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
15208787|NCT05175027|Povidone|povidone|mesh-list
15208788|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
15208789|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
15208790|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15208791|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208792|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
15208793|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
15208794|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208795|NCT05174845|Protective Agents|protective agents|mesh-ancestor
15208796|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208797|NCT05174845|Vitamins|vitamins|mesh-ancestor
15208798|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
15208799|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
15208800|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
15208801|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208802|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
15208803|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15208804|NCT05173441|Antibodies|antibodies|mesh-list
14863300|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863301|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
14863302|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863303|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
14863304|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863305|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14863306|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
14863307|NCT01091324|Silymarin|silymarin|mesh-list
14863308|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
14863309|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
14863310|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14863311|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14863312|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863313|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863314|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863315|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
14863316|NCT01091324|Protective Agents|protective agents|mesh-ancestor
14863317|NCT01091337|Albuterol|albuterol|mesh-list
14863318|NCT01091337|Procaterol|procaterol|mesh-list
14863319|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14863320|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
14863321|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863322|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863323|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14863324|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
14863325|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
14863326|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14863327|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14863328|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14863329|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14863330|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
14863331|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863332|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863333|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
14863334|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14863335|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863336|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14863337|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863338|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863339|NCT01091415|Calcium|calcium|mesh-list
14863340|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14863341|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863342|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
14863343|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863344|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863345|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14863346|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14863347|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863348|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863349|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863350|NCT01091571|Dipyridamole|dipyridamole|mesh-list
14863351|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14863352|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863353|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863354|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14863355|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863356|NCT01091649|Ritonavir|ritonavir|mesh-list
14863357|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14863358|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14863359|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
14863360|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863361|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208805|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
14709755|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14709756|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709757|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709758|NCT00432094|Paclitaxel|paclitaxel|mesh-list
14709759|NCT00432094|Etoposide|etoposide|mesh-list
14709760|NCT00432094|Carboplatin|carboplatin|mesh-list
14709761|NCT00432094|Ifosfamide|ifosfamide|mesh-list
14709762|NCT00432094|Thiotepa|thiotepa|mesh-list
14709763|NCT00432094|Mesna|mesna|mesh-list
15225007|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
14863362|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14709764|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14863363|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14863364|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
14863365|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863366|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14863367|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14863368|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
14863369|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14863370|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14863371|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
14863372|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14863373|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14863374|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14863375|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863376|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863377|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
14863378|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863379|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863380|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14863381|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863382|NCT01091753|Amlodipine|amlodipine|mesh-list
14863383|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14863384|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14863385|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15208806|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208807|NCT05170919|Olanzapine|olanzapine|mesh-list
15208808|NCT05170919|Mirtazapine|mirtazapine|mesh-list
14709765|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709766|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
14863386|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863387|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14863388|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863389|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863390|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14913712|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913713|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14913714|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
14913715|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14913716|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14913717|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14913718|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913719|NCT01376284|Dutasteride|dutasteride|mesh-list
14913720|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14913721|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14913722|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913723|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913724|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
14913725|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913726|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913727|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14913728|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14913729|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913730|NCT01376323|Incretins|incretins|mesh-ancestor
14913731|NCT01376323|Hormones|hormones|mesh-ancestor
14913732|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913733|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14913734|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
14913735|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913736|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913737|NCT01376401|Prednisone|prednisone|mesh-list
14913738|NCT01376401|Bortezomib|bortezomib|mesh-list
14913739|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15208809|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
14709767|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709768|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709769|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709770|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14709771|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14709772|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709773|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
14709774|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709775|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15208810|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
14709776|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
14709777|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14709778|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709779|NCT00432094|Protective Agents|protective agents|mesh-ancestor
14709780|NCT00432120|Clopidogrel|clopidogrel|mesh-list
14709781|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14709782|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14709783|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14863391|NCT01091792|Bevacizumab|bevacizumab|mesh-list
14863392|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14863393|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863394|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14863395|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14863396|NCT01091792|Growth Substances|growth substances|mesh-ancestor
14863397|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863398|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
14863399|NCT01091818|Midazolam|midazolam|mesh-list
14863400|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
14863401|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14863402|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863403|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863404|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14863405|NCT01091818|Analgesics|analgesics|mesh-ancestor
14863406|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
14863407|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863408|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14863409|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14863410|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14863411|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
14863412|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863413|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863414|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14863415|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14863416|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14863417|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14863418|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14863419|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
14863420|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
14863421|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
14863422|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
14863423|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
14863424|NCT01091870|Citric Acid|citric acid|mesh-list
14863425|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
14863426|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
14863427|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14863428|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
14863429|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
14863430|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863431|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863432|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14863433|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14863434|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863435|NCT01091870|Urological Agents|urological agents|mesh-ancestor
14863436|NCT01091896|Bevacizumab|bevacizumab|mesh-list
14863437|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14863438|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863439|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14863440|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14863441|NCT01091896|Growth Substances|growth substances|mesh-ancestor
14863442|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863443|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14863444|NCT01092039|Lactoferrin|lactoferrin|mesh-list
15208811|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208812|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208813|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15208814|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15208815|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15208816|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208817|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15208818|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15208819|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15208820|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863445|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863446|NCT01092091|BCT-100|bct-100|mesh-list
14863447|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863448|NCT01092130|Vitamin D|vitamin d|mesh-list
14863449|NCT01092130|Vitamins|vitamins|mesh-ancestor
14863450|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
14863451|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863452|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14863453|NCT01092221|Allopurinol|allopurinol|mesh-list
14863454|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
14863455|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863456|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863457|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
14863458|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14863459|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14863460|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
14863461|NCT01092221|Protective Agents|protective agents|mesh-ancestor
14863462|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863463|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
14863464|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14863465|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709784|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14709785|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
14709786|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709787|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709788|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709789|NCT00432146|Lugol's solution|lugol's solution|mesh-list
14709790|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
14709791|NCT00432146|Coagulants|coagulants|mesh-ancestor
14709792|NCT00432198|Zolpidem|zolpidem|mesh-list
14863466|NCT01092351|Renal Agents|renal agents|mesh-ancestor
14863467|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863468|NCT01092455|Heparin|heparin|mesh-list
14863469|NCT01092455|Calcium heparin|calcium heparin|mesh-list
14863470|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
14863471|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14863472|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14863473|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863474|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
15208821|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208822|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208823|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
15208824|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
15208825|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15208826|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
15208827|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
14863475|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863476|NCT01092520|Gabapentin|gabapentin|mesh-list
14863477|NCT01092520|Analgesics|analgesics|mesh-ancestor
14863478|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
14863479|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863480|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863481|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
14863482|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14863483|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14863484|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863485|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14863486|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14863487|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14863488|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863489|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863490|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
14863491|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
14863492|NCT01092533|Prednisolone|prednisolone|mesh-list
14709793|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14709794|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14709795|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14709796|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709797|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14709798|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
14709799|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
14709800|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863493|NCT01092533|Prednisone|prednisone|mesh-list
14863494|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14863495|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863496|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14863497|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
14863498|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15208828|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15208829|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15208830|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15208831|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15208832|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
15208833|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15208834|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15208835|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15208836|NCT05156684|Zinc|zinc|mesh-list
15208837|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
15208838|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
15208839|NCT05156684|Trace Elements|trace elements|mesh-ancestor
14709801|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709802|NCT00432302|Sagopilone|sagopilone|mesh-list
14709803|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709804|NCT00432315|Docetaxel|docetaxel|mesh-list
15208840|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
15208841|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208842|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15208843|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709805|NCT00432315|Cisplatin|cisplatin|mesh-list
14709806|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709807|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14709808|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14709809|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14709810|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208844|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208845|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15208846|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15208847|NCT05156684|Protective Agents|protective agents|mesh-ancestor
15208848|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
15208849|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15208850|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
14709811|NCT00432354|Atorvastatin|atorvastatin|mesh-list
14863499|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208851|NCT05156684|Astringents|astringents|mesh-ancestor
14296029|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709812|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14709813|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14709814|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
14709815|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709816|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14863500|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863501|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863502|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14863503|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
14863504|NCT01092533|Hormones|hormones|mesh-ancestor
14863505|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863506|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863507|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14863508|NCT01092572|Simvastatin|simvastatin|mesh-list
14863509|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14863510|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14863511|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
14863512|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863513|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14863514|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14863515|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863516|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
14863517|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14863518|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14863519|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
14863520|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863521|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863522|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863523|NCT01092624|Urological Agents|urological agents|mesh-ancestor
14863524|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
14863525|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863526|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14863527|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863528|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863529|NCT01092806|Tacrolimus|tacrolimus|mesh-list
14863530|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863531|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
14863532|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863533|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14863534|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863535|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863536|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
14863537|NCT01092858|Testosterone|testosterone|mesh-list
14863538|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
14863539|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
14863540|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14863541|NCT01092858|Androgens|androgens|mesh-ancestor
14863542|NCT01092858|Hormones|hormones|mesh-ancestor
14863543|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863544|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863545|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14863546|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863547|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
14863548|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
14863549|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
14863550|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863551|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
14863552|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863553|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709817|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14709818|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709819|NCT00432367|Artesunate|artesunate|mesh-list
14709820|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
14709821|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
14709822|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14709823|NCT00432367|Amodiaquine|amodiaquine|mesh-list
14709824|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
14709825|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14863554|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14296030|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709826|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14709827|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863555|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
14863556|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863557|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863558|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14863559|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14863560|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14863561|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
14863562|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863563|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863564|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863565|NCT01092975|Phenylephrine|phenylephrine|mesh-list
14863566|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
14863567|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14863568|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
14863569|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
14863570|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863571|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863572|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
14863573|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14863574|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
14863575|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
14863576|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14863577|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14863578|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14863579|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14863580|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863581|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863582|NCT01092975|Protective Agents|protective agents|mesh-ancestor
14863583|NCT01093040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14863584|NCT01093040|Immunologic Factors|immunologic factors|mesh-ancestor
14863585|NCT01093040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863586|NCT01093092|Calcitriol|calcitriol|mesh-list
14863587|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14863588|NCT01093092|Gemcitabine|gemcitabine|mesh-list
14863589|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863590|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14863591|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
14863592|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863593|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
14863594|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863595|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863596|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863597|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
14863598|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863599|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14863600|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14863601|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863602|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14863603|NCT01093092|Vitamins|vitamins|mesh-ancestor
14863604|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
14863605|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14863606|NCT01093157|Hormones|hormones|mesh-list
14863607|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14863608|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863609|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863610|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
14863611|NCT01093235|Bevacizumab|bevacizumab|mesh-list
14863612|NCT01093235|Docetaxel|docetaxel|mesh-list
14863613|NCT01093235|Fluorouracil|fluorouracil|mesh-list
14863614|NCT01093235|Epirubicin|epirubicin|mesh-list
14863615|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863616|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
14863617|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709828|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709829|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
14709830|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
14709831|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14709832|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
14709833|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14709834|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709835|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709836|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14709837|NCT00432367|Renal Agents|renal agents|mesh-ancestor
14709838|NCT00432393|Levodopa|levodopa|mesh-list
14863618|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709839|NCT00432393|Carbidopa|carbidopa|mesh-list
14863619|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14863620|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
14863621|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863622|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863623|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14863624|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14863625|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14863626|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14863627|NCT01093235|Growth Substances|growth substances|mesh-ancestor
14863628|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
14863629|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14863630|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14863631|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14863632|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
14863633|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14863634|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14863635|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14863636|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14863637|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863638|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
14863639|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
14863640|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14863641|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
14863642|NCT01093274|Cathartics|cathartics|mesh-ancestor
14863643|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863644|NCT01093300|Paclitaxel|paclitaxel|mesh-list
14863645|NCT01093300|Everolimus|everolimus|mesh-list
14863646|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14863647|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863648|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
14863649|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
14863650|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
14863651|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863652|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863653|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
14863654|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863655|NCT01093365|Varenicline|varenicline|mesh-list
14863656|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14863657|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14863658|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
14863659|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863660|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863661|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863662|NCT01093638|Insulin|insulin|mesh-list
14863663|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14863664|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913740|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913741|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
14863665|NCT01093768|Vasopressins|vasopressins|mesh-list
14863666|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
14863667|NCT01093768|Oxytocin|oxytocin|mesh-list
14863668|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
14863669|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14863670|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863671|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
14863672|NCT01093768|Coagulants|coagulants|mesh-ancestor
14863673|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14863674|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14863675|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
14863676|NCT01093807|Enalapril|enalapril|mesh-list
14863677|NCT01093807|Enalaprilat|enalaprilat|mesh-list
14863678|NCT01093807|Lercanidipine|lercanidipine|mesh-list
14863679|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14863680|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
14863681|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863682|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863683|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14863684|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14863685|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863686|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14863687|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863688|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
14863689|NCT01093820|Hematinics|hematinics|mesh-ancestor
14863690|NCT01093937|Varenicline|varenicline|mesh-list
14863691|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14863692|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14863693|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
14863694|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863695|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863696|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863697|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14863698|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14863699|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863700|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14863701|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14863702|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863703|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863704|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
14863705|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863706|NCT01094015|Lidocaine|lidocaine|mesh-list
14863707|NCT01094015|Prilocaine|prilocaine|mesh-list
14863708|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14863709|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
14863710|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
14863711|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863712|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863713|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
14863714|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863715|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14863716|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14863717|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14863718|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863719|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863720|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14863721|NCT01094028|Oxytocin|oxytocin|mesh-list
14863722|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
14863723|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14863724|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863725|NCT01094158|Cholic Acids|cholic acids|mesh-list
14863726|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863727|NCT01094210|Fluorides|fluorides|mesh-list
14863728|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
14863729|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
14863730|NCT01094210|Protective Agents|protective agents|mesh-ancestor
14863731|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863732|NCT01094249|Valproic Acid|valproic acid|mesh-list
14863733|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14863734|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14863735|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14863736|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863737|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863738|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14863739|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14863740|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14863741|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
14863742|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863743|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863744|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14863745|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14863746|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
14863747|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
14863748|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863749|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
14863750|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
14863751|NCT01094275|Omeprazole|omeprazole|mesh-list
14863752|NCT01094275|Clopidogrel|clopidogrel|mesh-list
14863753|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14863754|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14863755|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14863756|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14863757|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
14863758|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863759|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863760|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863761|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14863762|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863763|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14863764|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863765|NCT01094340|Thalidomide|thalidomide|mesh-list
14863766|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863767|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
14863768|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863769|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
14863770|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14863771|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863772|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14863773|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14863774|NCT01094340|Growth Substances|growth substances|mesh-ancestor
14863775|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
14863776|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863777|NCT01094444|Vitamin K|vitamin k|mesh-list
14863778|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
14863779|NCT01094444|Vitamins|vitamins|mesh-ancestor
14863780|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
14863781|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863782|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14863783|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14863784|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863785|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
14863786|NCT01094444|Coagulants|coagulants|mesh-ancestor
14863787|NCT01094457|Aspirin|aspirin|mesh-list
14863788|NCT01094457|Cilostazol|cilostazol|mesh-list
14863789|NCT01094457|Clopidogrel|clopidogrel|mesh-list
14863790|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14863791|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14863792|NCT01094457|Analgesics|analgesics|mesh-ancestor
14863793|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
14863794|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863795|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863796|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14863797|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14863798|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14863799|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14863800|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863801|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14863802|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14863803|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863804|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
14863805|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14863806|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14863807|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14863808|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
14863809|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863810|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14863811|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
14863812|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14863813|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
14863814|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
14863815|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14863816|NCT01094457|Protective Agents|protective agents|mesh-ancestor
14863817|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14863818|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14863819|NCT01094535|Secretin|secretin|mesh-list
14863820|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863821|NCT01094535|Hormones|hormones|mesh-ancestor
14863822|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863823|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863824|NCT01094600|Secretin|secretin|mesh-list
14863825|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863826|NCT01094600|Hormones|hormones|mesh-ancestor
14863827|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863828|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863829|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
14863830|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
14863831|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863832|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14863833|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863834|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863835|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
14863836|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863837|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14863838|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863839|NCT01094626|Secretin|secretin|mesh-list
14863840|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863841|NCT01094626|Hormones|hormones|mesh-ancestor
14863842|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863843|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863844|NCT01094769|Moxonidine|moxonidine|mesh-list
14863845|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14863846|NCT01094821|ATI 7505|ati 7505|mesh-list
14863847|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14863848|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14863849|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
14863850|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863851|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863852|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863853|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
14863854|NCT01094912|Narcotics|narcotics|mesh-ancestor
14863855|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863856|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863857|NCT01094912|Analgesics|analgesics|mesh-ancestor
14863858|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
14863859|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863860|NCT01094925|Gabapentin|gabapentin|mesh-list
14863861|NCT01094925|Analgesics|analgesics|mesh-ancestor
14863862|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
14863863|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863864|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863865|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
14863866|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14863867|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14863868|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14863869|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14863870|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14863871|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14863872|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863873|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863874|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
14863875|NCT01094964|Interferons|interferons|mesh-list
14863876|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
14863877|NCT01094964|Epirubicin|epirubicin|mesh-list
14863878|NCT01094964|Mitomycins|mitomycins|mesh-list
14863879|NCT01094964|Mitomycin|mitomycin|mesh-list
14863880|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863881|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
14863882|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863883|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
14863884|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863885|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14863886|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14863887|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14863888|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863889|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863890|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
14863891|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14863892|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
15208852|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
15208853|NCT05155540|Plasminogen|plasminogen|mesh-list
15208854|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15208855|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15208856|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15208857|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208858|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
15208859|NCT05148637|Lidocaine|lidocaine|mesh-list
15208860|NCT05148637|Fentanyl|fentanyl|mesh-list
15208861|NCT05148637|Anesthetics|anesthetics|mesh-list
14863893|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14863894|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15208862|NCT05148637|Sevoflurane|sevoflurane|mesh-list
14863895|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863896|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
14863897|NCT01094977|Coagulants|coagulants|mesh-ancestor
14863898|NCT01094990|Dexamethasone|dexamethasone|mesh-list
14863899|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14863900|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
14863901|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
14863902|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863903|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863904|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863905|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
14863906|NCT01094990|Hormones|hormones|mesh-ancestor
14863907|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863908|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15208863|NCT05148637|Desflurane|desflurane|mesh-list
15208864|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
15208865|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208866|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208867|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
15208868|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208869|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15208870|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15208871|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15208872|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15208873|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208874|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15208875|NCT05148637|Narcotics|narcotics|mesh-ancestor
15208876|NCT05148637|Analgesics|analgesics|mesh-ancestor
15208877|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15208878|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15208879|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
15208880|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15208881|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14709840|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14863909|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863910|NCT01095016|Fenoterol|fenoterol|mesh-list
14863911|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14863912|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
14863913|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863914|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863915|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14863916|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14863917|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
14863918|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
14863919|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14863920|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14863921|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14863922|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14863923|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14863924|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863925|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709841|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14709842|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14709843|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
14709844|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709845|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709846|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709847|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14709848|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709849|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14709850|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
14709851|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
14709852|NCT00432406|Etanercept|etanercept|mesh-list
14709853|NCT00432406|Infliximab|infliximab|mesh-list
14709854|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
14709855|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709856|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709857|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14709858|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14709859|NCT00432406|Analgesics|analgesics|mesh-ancestor
14863926|NCT01095133|Amiloride|amiloride|mesh-list
14863927|NCT01095133|Diuretics|diuretics|mesh-ancestor
14863928|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
14863929|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863930|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14863931|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14863932|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14863933|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863934|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14863935|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14863936|NCT01095172|Prednisolone|prednisolone|mesh-list
14863937|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14863938|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
14863939|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14863940|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
14863941|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
14863942|NCT01095172|Rituximab|rituximab|mesh-list
14863943|NCT01095172|Tacrolimus|tacrolimus|mesh-list
14863944|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14863945|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
14863946|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14863947|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863948|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
14863949|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863950|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14863951|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14863952|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14863953|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863954|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863955|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14863956|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
14863957|NCT01095172|Hormones|hormones|mesh-ancestor
14863958|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14863959|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14863960|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
14863961|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
14863962|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14863963|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14863964|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14863965|NCT01095172|Protective Agents|protective agents|mesh-ancestor
14863966|NCT01095185|Simvastatin|simvastatin|mesh-list
14863967|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14863968|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14863969|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
14863970|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863971|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14863972|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14863973|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14863974|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
14863975|NCT01095211|Vitamins|vitamins|mesh-ancestor
14863976|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
14863977|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863978|NCT01095302|Docetaxel|docetaxel|mesh-list
14863979|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14863980|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14863981|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
14863982|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
14863983|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913742|NCT01376401|Hormones|hormones|mesh-ancestor
14913743|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913744|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913745|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14913746|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913747|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14913748|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
14913749|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913750|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14913751|NCT01376440|Eusol|eusol|mesh-list
14913752|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
14913753|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863984|NCT01095445|Ribavirin|ribavirin|mesh-list
14863985|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14863986|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
14863987|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863988|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
14863989|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14863990|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14863991|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
14863992|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863993|NCT01095484|Rotigotine|rotigotine|mesh-list
14863994|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
14863995|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
14863996|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14863997|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14863998|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14863999|NCT01095575|Morphine|morphine|mesh-list
14864000|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14864001|NCT01095575|Narcotics|narcotics|mesh-ancestor
14864002|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864003|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864004|NCT01095575|Analgesics|analgesics|mesh-ancestor
14864005|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
14864006|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864007|NCT01095640|Adapalene|adapalene|mesh-list
14864008|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14709860|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
14709861|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709862|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709863|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14709864|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709865|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
14709866|NCT00432432|Infliximab|infliximab|mesh-list
14709867|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
14709868|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14864009|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14864010|NCT01095640|Analgesics|analgesics|mesh-ancestor
14864011|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
14864012|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864013|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864014|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14864015|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864016|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
14864017|NCT01095679|Baclofen|baclofen|mesh-list
14864018|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14864019|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864020|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14864021|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864022|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14864023|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
14864024|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
14709869|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709870|NCT00432510|Complement C1s|complement c1s|mesh-list
14709871|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14709872|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14709873|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
14709874|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709875|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14709876|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14709877|NCT00432549|Topiramate|topiramate|mesh-list
14709878|NCT00432549|Almotriptan|almotriptan|mesh-list
14709879|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
14709880|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14709881|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709882|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14709883|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
14709884|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709885|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709886|NCT00432575|Surinabant|surinabant|mesh-list
14709887|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14864025|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864026|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709888|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14864027|NCT01095731|Acetic Acid|acetic acid|mesh-list
14864028|NCT01095731|Retinol acetate|retinol acetate|mesh-list
14864029|NCT01095731|Glycine|glycine|mesh-list
14864030|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
14864031|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864032|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864033|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864034|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14864035|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864036|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14864037|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
14864038|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14864039|NCT01095731|Protective Agents|protective agents|mesh-ancestor
14864040|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864041|NCT01095809|Triamcinolone|triamcinolone|mesh-list
14864042|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14864043|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14864044|NCT01095809|Bevacizumab|bevacizumab|mesh-list
14864045|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14864046|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14864047|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864048|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14864049|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14864050|NCT01095809|Growth Substances|growth substances|mesh-ancestor
14864051|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864052|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
14864053|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14864054|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
14864055|NCT01095809|Hormones|hormones|mesh-ancestor
14864056|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864057|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864058|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
14864059|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864060|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864061|NCT01095822|Valsartan|valsartan|mesh-list
14864062|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14864063|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14864064|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14864065|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864066|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
14864067|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14864068|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864069|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864070|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864071|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709889|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709890|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709891|NCT00432575|Hormones|hormones|mesh-ancestor
14709892|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14709893|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709894|NCT00432588|Misoprostol|misoprostol|mesh-list
14709895|NCT00432588|Dinoprostone|dinoprostone|mesh-list
14864072|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864073|NCT01095926|Doxorubicin|doxorubicin|mesh-list
14864074|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14709896|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14709897|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
14709898|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14709899|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709900|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14709901|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709902|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
14709903|NCT00432614|Citalopram|citalopram|mesh-list
14709904|NCT00432614|Amibegron|amibegron|mesh-list
14709905|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14709906|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14709907|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14709908|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709909|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709910|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
15208882|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
15208883|NCT05147558|Lenvatinib|lenvatinib|mesh-list
15208884|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208885|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208886|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208887|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208888|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208889|NCT05133310|Simvastatin|simvastatin|mesh-list
15208890|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15208891|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15208892|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
15208893|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208894|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15208895|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15208896|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208897|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
15208898|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15208899|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
15208900|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15208901|NCT05122559|Expectorants|expectorants|mesh-ancestor
15208902|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
15208903|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15208904|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
14864075|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864076|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14864077|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14864078|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864079|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864080|NCT01095939|Benazepril|benazepril|mesh-list
14864081|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14864082|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14864083|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864084|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864085|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14864086|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14864087|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864088|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864089|NCT01095991|Incretins|incretins|mesh-ancestor
14864090|NCT01095991|Hormones|hormones|mesh-ancestor
14864091|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864092|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15208905|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208906|NCT05122559|Protective Agents|protective agents|mesh-ancestor
15208907|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208908|NCT05122559|Antidotes|antidotes|mesh-ancestor
15225008|NCT00867178|Thiotepa|thiotepa|mesh-list
15225009|NCT00867178|Cisplatin|cisplatin|mesh-list
15225010|NCT00867178|Carboplatin|carboplatin|mesh-list
15225011|NCT00867178|Etoposide|etoposide|mesh-list
15225012|NCT00867178|Vincristine|vincristine|mesh-list
15225013|NCT00867178|Vorinostat|vorinostat|mesh-list
14864093|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
15225014|NCT00867178|Tretinoin|tretinoin|mesh-list
15225015|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
15225016|NCT00867178|Isotretinoin|isotretinoin|mesh-list
14864094|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864095|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864096|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
14864097|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
14864098|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14864099|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864100|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864101|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
14864102|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14864103|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15208909|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
15208910|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15208911|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208912|NCT05095831|Pancrelipase|pancrelipase|mesh-list
15208913|NCT05095831|Pancreatin|pancreatin|mesh-list
14864104|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864105|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14864106|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864107|NCT01096121|Enalapril|enalapril|mesh-list
14864108|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14864109|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
14864110|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864111|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864112|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14864113|NCT01096199|Cisplatin|cisplatin|mesh-list
14864114|NCT01096199|Everolimus|everolimus|mesh-list
14864115|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864116|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864117|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
14864118|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864119|NCT01096212|Sevoflurane|sevoflurane|mesh-list
14864120|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14864121|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14864122|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
14864123|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
14864124|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864125|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864126|NCT01096225|Vaccines|vaccines|mesh-list
14864127|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
14864128|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864129|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14864130|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864131|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864132|NCT01096277|Incretins|incretins|mesh-ancestor
14864133|NCT01096277|Hormones|hormones|mesh-ancestor
14864134|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864135|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14864136|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
14864137|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864138|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864139|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
14864140|NCT01096329|Testosterone|testosterone|mesh-list
14864141|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
14864142|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
14864143|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14864144|NCT01096329|Androgens|androgens|mesh-ancestor
14864145|NCT01096329|Hormones|hormones|mesh-ancestor
14864146|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864147|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864148|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14864149|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864150|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
14864151|NCT01096355|R04929097|r04929097|mesh-list
14864152|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14709911|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709912|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14709913|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
14709914|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14709915|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14709916|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14913754|NCT01376453|Fluorouracil|fluorouracil|mesh-list
15208914|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709917|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14709918|NCT00432627|Deferasirox|deferasirox|mesh-list
15208915|NCT05065801|Folfirinox|folfirinox|mesh-list
14709919|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14864153|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864154|NCT01096420|Topiramate|topiramate|mesh-list
14864155|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
14864156|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864157|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864158|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
14864159|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14864160|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
14709920|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
14709921|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
14709922|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709923|NCT00432653|Rituximab|rituximab|mesh-list
14709924|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14709925|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709926|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
14709927|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709928|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14709929|NCT00432757|Ketotifen|ketotifen|mesh-list
14709930|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
14709931|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
14709932|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14864161|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14864162|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864163|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14864164|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14864165|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14864166|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
14864167|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14864168|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
14864169|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14864170|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864171|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14864172|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14864173|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14864174|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
14864175|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14864176|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14864177|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864178|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14864179|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15208916|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208917|NCT05052307|Vaccines|vaccines|mesh-list
15208918|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
15208919|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208920|NCT05051436|Tadalafil|tadalafil|mesh-list
15208921|NCT05051436|Mirabegron|mirabegron|mesh-list
15208922|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
15208923|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15208924|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15208925|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208926|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208927|NCT05051436|Urological Agents|urological agents|mesh-ancestor
15208928|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15208929|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15208930|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14864180|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208931|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14864181|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864182|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864183|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14864184|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
14864185|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14864186|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709933|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
14709934|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
14709935|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709936|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709937|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709938|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14709939|NCT00432796|Dalteparin|dalteparin|mesh-list
14709940|NCT00432796|Tinzaparin|tinzaparin|mesh-list
14709941|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14709942|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
14709943|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14864187|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14864188|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14864189|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14864190|NCT01096654|Epinephrine|epinephrine|mesh-list
14864191|NCT01096654|Racepinephrine|racepinephrine|mesh-list
14864192|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
14864193|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14864194|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14864195|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14864196|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864197|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864198|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864199|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14864200|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14864201|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
14864202|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864203|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14864204|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
14864205|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
14864206|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
14864207|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14864208|NCT01096693|Substance P|substance p|mesh-list
14864209|NCT01096693|Neurokinin A|neurokinin a|mesh-list
14864210|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864211|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864212|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864213|NCT01096706|Aspirin|aspirin|mesh-list
14864214|NCT01096706|Fluconazole|fluconazole|mesh-list
14864215|NCT01096706|Substance P|substance p|mesh-list
14864216|NCT01096706|Neurokinin A|neurokinin a|mesh-list
14864217|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14864218|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14864219|NCT01096706|Analgesics|analgesics|mesh-ancestor
14864220|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
14864221|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864222|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864223|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14864224|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864225|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14864226|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14864227|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864228|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15208932|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208933|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208934|NCT05041842|Trastuzumab|trastuzumab|mesh-list
15208935|NCT05041842|Pertuzumab|pertuzumab|mesh-list
15208936|NCT05041842|Tucatinib|tucatinib|mesh-list
15208937|NCT05041842|Hormones|hormones|mesh-list
15208938|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15208939|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208940|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864229|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14864230|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864231|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
14864232|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
14864233|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864234|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14864235|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14864236|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14864237|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
14864238|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864239|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14864240|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14864241|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864242|NCT01096745|Gemcitabine|gemcitabine|mesh-list
14864243|NCT01096745|Cisplatin|cisplatin|mesh-list
14864244|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864245|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14864246|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
14864247|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864248|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
14864249|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864250|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864251|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864252|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
14864253|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864254|NCT01096797|Sevoflurane|sevoflurane|mesh-list
14864255|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14864256|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14864257|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
14864258|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
14864259|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864260|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864261|NCT01096927|Amoxicillin|amoxicillin|mesh-list
14864262|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
14864263|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
14864264|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14864265|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864266|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864267|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864268|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14709944|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14709945|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709946|NCT00432861|Pancrelipase|pancrelipase|mesh-list
14709947|NCT00432861|Pancreatin|pancreatin|mesh-list
14709948|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14709949|NCT00432887|Caffeine|caffeine|mesh-list
14709950|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14709951|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864269|NCT01096940|Simvastatin|simvastatin|mesh-list
14864270|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14864271|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14864272|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
14864273|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864274|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14864275|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14864276|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864277|NCT01097148|Atracurium|atracurium|mesh-list
14864278|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14864279|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14864280|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14864281|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864282|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864283|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15208941|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208942|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15208943|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208944|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208945|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
15208946|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208947|NCT05035277|Aspirin|aspirin|mesh-list
15208948|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
15208949|NCT05035277|Apixaban|apixaban|mesh-list
15208950|NCT05035277|Edoxaban|edoxaban|mesh-list
15208951|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15208952|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
15208953|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15208954|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
15208955|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225017|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864284|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14864285|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864286|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864287|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913755|NCT01376453|Sorafenib|sorafenib|mesh-list
14913756|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
14913757|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913758|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14913759|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913760|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913761|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
14913762|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913763|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14913764|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917281|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917282|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917283|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917284|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14917285|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14917286|NCT01397331|Propofol|propofol|mesh-list
14917287|NCT01397331|Isoflurane|isoflurane|mesh-list
14709952|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14709953|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917288|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14917289|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917290|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917291|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14917292|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
14917293|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
14917294|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14917295|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
14917296|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
14917297|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917298|NCT05269030|Ivermectin|ivermectin|mesh-list
14917299|NCT05269030|Budesonide|budesonide|mesh-list
14917300|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917301|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14917302|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
14917303|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917304|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917305|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14917306|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
14917307|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
14917308|NCT05269030|Hormones|hormones|mesh-ancestor
14917309|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917310|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14917311|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917312|NCT05269017|Vitamin D|vitamin d|mesh-list
14917313|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
14917314|NCT05269017|Budesonide|budesonide|mesh-list
14917315|NCT05269017|Vitamins|vitamins|mesh-ancestor
14917316|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
14917317|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917318|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14917319|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14917320|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917321|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14917322|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
14917323|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917324|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14917325|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
14917326|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
14917327|NCT05269017|Hormones|hormones|mesh-ancestor
14917328|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917329|NCT05268835|Clindamycin|clindamycin|mesh-list
14917330|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15208956|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208957|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
15208958|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14709954|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709955|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14709956|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14709957|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
14709958|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864288|NCT01097213|Ethanol|ethanol|mesh-list
14864289|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14864290|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864291|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864292|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208959|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15208960|NCT05035277|Analgesics|analgesics|mesh-ancestor
15208961|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
15208962|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208963|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208964|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15208965|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864293|NCT01097252|Cisplatin|cisplatin|mesh-list
14864294|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864295|NCT01097265|Capecitabine|capecitabine|mesh-list
14864296|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
14864297|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14864298|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
14864299|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864300|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864301|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
14864302|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14864303|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709959|NCT00432978|Bosentan|bosentan|mesh-list
14709960|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14709961|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14709962|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864304|NCT01097278|Vitamins|vitamins|mesh-ancestor
14864305|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
14864306|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14864307|NCT01097317|Carboplatin|carboplatin|mesh-list
14864308|NCT01097317|Vinorelbine|vinorelbine|mesh-list
14864309|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864310|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14864311|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
14864312|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
14864313|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
14864314|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864315|NCT01097382|Zolpidem|zolpidem|mesh-list
14864316|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14864317|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14864318|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864319|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864320|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14864321|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
14864322|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
14709963|NCT00433043|Metoprolol|metoprolol|mesh-list
14709964|NCT00433043|Carvedilol|carvedilol|mesh-list
14709965|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14709966|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14709967|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14709968|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
14709969|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
14709970|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14709971|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709972|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14709973|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14709974|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14709975|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14709976|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864323|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208966|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14864324|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864325|NCT01097512|Gemcitabine|gemcitabine|mesh-list
14864326|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14864327|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
14864328|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864329|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864330|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
14864331|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864332|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208967|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15208968|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15208969|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15208970|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
15208971|NCT05022147|Dopamine|dopamine|mesh-list
15208972|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
15208973|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15208974|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
15208975|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
15208976|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15208977|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208978|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
15208979|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208980|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864333|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864334|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
14864335|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864336|NCT01097551|Phenylephrine|phenylephrine|mesh-list
14864337|NCT01097551|Acetylcholine|acetylcholine|mesh-list
14864338|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
14864339|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
14864340|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14864341|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864342|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15208981|NCT05022147|Protective Agents|protective agents|mesh-ancestor
15208982|NCT05003037|Carboplatin|carboplatin|mesh-list
15208983|NCT05003037|Pemetrexed|pemetrexed|mesh-list
15208984|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208985|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208986|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208987|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15208988|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15208989|NCT04996771|Cisplatin|cisplatin|mesh-list
15208990|NCT04996771|Etoposide|etoposide|mesh-list
14864343|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864344|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864345|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14864346|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
14864347|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
14864348|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864349|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
14864350|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14864351|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
14864352|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
14864353|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15208991|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
15208992|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15208993|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14864354|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14864355|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14864356|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
14864357|NCT01097551|Protective Agents|protective agents|mesh-ancestor
14864358|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
14864359|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14864360|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864361|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864362|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864363|NCT01097811|Erythromycin|erythromycin|mesh-list
14864364|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
14864365|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14864366|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
14864367|NCT01097811|Neomycin|neomycin|mesh-list
14864368|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14864369|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864370|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14864371|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14864372|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864373|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864374|NCT01097902|Ibuprofen|ibuprofen|mesh-list
14864375|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14864376|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14864377|NCT01097902|Analgesics|analgesics|mesh-ancestor
14864378|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
15208994|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15208995|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14296031|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864379|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864380|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864381|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14864382|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864383|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14864384|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864385|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864386|NCT01097941|Vaccines|vaccines|mesh-list
14864387|NCT01097941|Immunoglobulins|immunoglobulins|mesh-list
14864388|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
14296032|NCT00585377|Bevacizumab|bevacizumab|mesh-list
14296033|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14296034|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296035|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864389|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864390|NCT01097980|Trazodone|trazodone|mesh-list
14864391|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14864392|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14864393|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864394|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864395|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14864396|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14864397|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14864398|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864399|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864400|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864401|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
14864402|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14864403|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
14864404|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
14864405|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14864406|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14864407|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14864408|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864409|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864410|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864411|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864412|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15208996|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15208997|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15208998|NCT04977232|Citalopram|citalopram|mesh-list
15208999|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15209000|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15225018|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
14864413|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14864414|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864415|NCT01098084|Decitabine|decitabine|mesh-list
14864416|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14864417|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
14864418|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864419|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864420|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864421|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
14864422|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864423|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
14864424|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864425|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864426|NCT01098344|Gemcitabine|gemcitabine|mesh-list
14864427|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14864428|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
14864429|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864430|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864431|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
14864432|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864433|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864434|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864435|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
14864436|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864437|NCT01098357|Becaplermin|becaplermin|mesh-list
14864438|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
14864439|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14864440|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14864441|NCT01098357|Growth Substances|growth substances|mesh-ancestor
14864442|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864443|NCT01098383|Acetylcholine|acetylcholine|mesh-list
14864444|NCT01098383|Donepezil|donepezil|mesh-list
14864445|NCT01098383|Choline|choline|mesh-list
14864446|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14864447|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864448|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864449|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864450|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864451|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864452|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
14864453|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
14864454|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14864455|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
14864456|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14864457|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14864458|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
14864459|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14864460|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14864461|NCT01098448|Amoxicillin|amoxicillin|mesh-list
14864462|NCT01098448|Metronidazole|metronidazole|mesh-list
14864463|NCT01098448|Tetracycline|tetracycline|mesh-list
14864464|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864465|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14864466|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14864467|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14864468|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864469|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864470|NCT01098513|Dolutegravir|dolutegravir|mesh-list
14864471|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14864472|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14864473|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864474|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864475|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14864476|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14864477|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
14864478|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864479|NCT01098526|Efavirenz|efavirenz|mesh-list
14864480|NCT01098526|Dolutegravir|dolutegravir|mesh-list
14864481|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14864482|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14864483|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864484|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864485|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
14864486|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864487|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14864488|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14864489|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14864490|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14864491|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14864492|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14864493|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14864494|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14864495|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14864496|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14864497|NCT01098656|Lenalidomide|lenalidomide|mesh-list
14864498|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
14864499|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864500|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14864501|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14864502|NCT01098656|Growth Substances|growth substances|mesh-ancestor
14864503|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
14864504|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864505|NCT01098760|Sorafenib|sorafenib|mesh-list
14864506|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864507|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14864508|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864509|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864510|NCT01098890|Plasminogen|plasminogen|mesh-list
14864511|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14864512|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14864513|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14864514|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864515|NCT01098955|Varenicline|varenicline|mesh-list
14864516|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14296036|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14296037|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14296038|NCT00585377|Growth Substances|growth substances|mesh-ancestor
14296039|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296040|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
14296041|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296042|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296043|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864517|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14864518|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864519|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864520|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864521|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864522|NCT01098994|Vitamin E|vitamin e|mesh-list
14864523|NCT01098994|Tocopherols|tocopherols|mesh-list
14864524|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
14864525|NCT01098994|Vitamins|vitamins|mesh-ancestor
14864526|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
14864527|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864528|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
14864529|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864530|NCT01098994|Protective Agents|protective agents|mesh-ancestor
14913765|NCT01376505|Vaccines|vaccines|mesh-list
14913766|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
14913767|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913768|NCT01376713|Dacarbazine|dacarbazine|mesh-list
14913769|NCT01376713|Ofatumumab|ofatumumab|mesh-list
14913770|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14913771|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14913772|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
14913773|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913774|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913775|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
14709977|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
14709978|NCT00433043|Protective Agents|protective agents|mesh-ancestor
14709979|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14709980|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14709981|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14709982|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
14709983|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14709984|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14709985|NCT00433069|Pioglitazone|pioglitazone|mesh-list
14709986|NCT00433069|Interferons|interferons|mesh-list
14709987|NCT00433069|Ribavirin|ribavirin|mesh-list
14709988|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
14709989|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
14709990|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14709991|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
14864531|NCT01099059|Amantadine|amantadine|mesh-list
14864532|NCT01099059|Methylphenidate|methylphenidate|mesh-list
14864533|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14864534|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864535|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14864536|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14864537|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864538|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864539|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
14864540|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864541|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14864542|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14864543|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
14864544|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864545|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14864546|NCT01099059|Analgesics|analgesics|mesh-ancestor
14864547|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
14864548|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864549|NCT01099072|Methylphenidate|methylphenidate|mesh-list
14864550|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14864551|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864552|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14864553|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14864554|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864555|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864556|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
14864557|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864558|NCT01099085|Simvastatin|simvastatin|mesh-list
14864559|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14864560|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14864561|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
14864562|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864563|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14864564|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14864565|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864566|NCT01099137|Vildagliptin|vildagliptin|mesh-list
14864567|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864568|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864569|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14864570|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
14864571|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864572|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864573|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
14864574|NCT01099150|Procyanidin|procyanidin|mesh-list
14864575|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
14864576|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864577|NCT01099150|Protective Agents|protective agents|mesh-ancestor
14296044|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
14864578|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864579|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14864580|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14864581|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864582|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14864583|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864584|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864585|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709992|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14709993|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
14709994|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14709995|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
14709996|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14709997|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14709998|NCT00433095|Trastuzumab|trastuzumab|mesh-list
14709999|NCT00433095|Vinorelbine|vinorelbine|mesh-list
14710000|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710001|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710002|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14710003|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14710004|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14710005|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710006|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710007|NCT00433121|Olanzapine|olanzapine|mesh-list
14710008|NCT00433121|Risperidone|risperidone|mesh-list
14710009|NCT00433121|Citalopram|citalopram|mesh-list
14710010|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14710011|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
14710012|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710013|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710014|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710015|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14710016|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14710017|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14710018|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14710019|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15209001|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209002|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209003|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209004|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
15209005|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209006|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15209007|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
15209008|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15209009|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
14710020|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
14710021|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14710022|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14710023|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14710024|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14710025|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
14710026|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
14710027|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710028|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
14864586|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14864587|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
14864588|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
14864589|NCT01099436|Docetaxel|docetaxel|mesh-list
14864590|NCT01099436|Doxorubicin|doxorubicin|mesh-list
14864591|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14864592|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864593|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
14864594|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864595|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864596|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14864597|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
14864598|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864599|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864600|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14864601|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14864602|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14864603|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
14864604|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14864605|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14864606|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14864607|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864608|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14864609|NCT01099462|Ibuprofen|ibuprofen|mesh-list
14864610|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14864611|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14864612|NCT01099462|Analgesics|analgesics|mesh-ancestor
14864613|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
14864614|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864615|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864616|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14864617|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864618|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14864619|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864620|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864621|NCT01099527|Capecitabine|capecitabine|mesh-list
14864622|NCT01099527|Everolimus|everolimus|mesh-list
14864623|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14864624|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
14864625|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864626|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864627|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864628|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
14864629|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864630|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14864631|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14864632|NCT01099592|Citalopram|citalopram|mesh-list
14864633|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14864634|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14864635|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864636|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864637|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864638|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
15209010|NCT04976790|Analgesics|analgesics|mesh-ancestor
15209011|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
15209012|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209013|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209014|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14864639|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209015|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209016|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209017|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864640|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14864641|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
14864642|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14864643|NCT01099605|Bupivacaine|bupivacaine|mesh-list
14864644|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
14864645|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
14864646|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864647|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864648|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
14864649|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864650|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14864651|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14864652|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14864653|NCT01099748|Methadone|methadone|mesh-list
14864654|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14864655|NCT01099748|Narcotics|narcotics|mesh-ancestor
14864656|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864657|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864658|NCT01099748|Analgesics|analgesics|mesh-ancestor
14864659|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
14864660|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864661|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
14864662|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14864663|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
14864664|NCT01099839|Miglitol|miglitol|mesh-list
14864665|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14864666|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864667|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864668|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864669|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864670|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14864671|NCT01100021|Doxazosin|doxazosin|mesh-list
14864672|NCT01100021|Tamsulosin|tamsulosin|mesh-list
14864673|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14864674|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14864675|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14864676|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14864677|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864678|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864679|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864680|NCT01100021|Urological Agents|urological agents|mesh-ancestor
14864681|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14864682|NCT01100060|Azithromycin|azithromycin|mesh-list
14864683|NCT01100060|Chloroquine|chloroquine|mesh-list
14864684|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14864685|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14864686|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864687|NCT01100060|Amebicides|amebicides|mesh-ancestor
14864688|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14864689|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14864690|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
14864691|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14864692|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14864693|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14864694|NCT01100060|Analgesics|analgesics|mesh-ancestor
14864695|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
14864696|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864697|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864698|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14864699|NCT01100060|Filaricides|filaricides|mesh-ancestor
14864700|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
14864701|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
14864702|NCT01100125|Insulin|insulin|mesh-list
14864703|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14864704|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14864705|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
14864706|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864707|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864708|NCT01100125|Incretins|incretins|mesh-ancestor
14864709|NCT01100125|Hormones|hormones|mesh-ancestor
14864710|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864711|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14864712|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
14864713|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864714|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864715|NCT01100164|Eszopiclone|eszopiclone|mesh-list
14864716|NCT01100164|Zopiclone|zopiclone|mesh-list
14864717|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14864718|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864719|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864720|NCT01100177|Sunitinib|sunitinib|mesh-list
14864721|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864722|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14864723|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14864724|NCT01100177|Growth Substances|growth substances|mesh-ancestor
14864725|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864726|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
14864727|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14864728|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864729|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864730|NCT01100203|Eplerenone|eplerenone|mesh-list
14864731|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14864732|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
14864733|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864734|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864735|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14864736|NCT01100203|Diuretics|diuretics|mesh-ancestor
14864737|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
14864738|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14864739|NCT01100216|Nicotine|nicotine|mesh-list
15209018|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15209019|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209020|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209021|NCT04973670|Sivelestat|sivelestat|mesh-list
15209022|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15209023|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
15209024|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209025|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209026|NCT04969198|Nicotine|nicotine|mesh-list
15209027|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15209028|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
15209029|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209030|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209031|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15209032|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15209033|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
15209034|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209035|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209036|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15209037|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15209038|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15209039|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209040|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209041|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15209042|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209043|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209044|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
15209045|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209046|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
15209047|NCT04944368|Paraproteins|paraproteins|mesh-list
15209048|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
15209049|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209050|NCT04940338|Dexamethasone|dexamethasone|mesh-list
15209051|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
15209052|NCT04940338|Bromfenac|bromfenac|mesh-list
15209053|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15209054|NCT04940338|BB 1101|bb 1101|mesh-list
15209055|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209056|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
14864740|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14864741|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
14864742|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864743|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864744|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14864745|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14864746|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864747|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864748|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864749|NCT01100294|Vaccines|vaccines|mesh-list
14864750|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
14864751|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864752|NCT01100333|Hormones|hormones|mesh-list
14864753|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14864754|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864755|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864756|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14864757|NCT01100346|Hormones|hormones|mesh-ancestor
14864758|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864759|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864760|NCT01100359|Carboplatin|carboplatin|mesh-list
14864761|NCT01100359|Doxorubicin|doxorubicin|mesh-list
14864762|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14864763|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864764|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14864765|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14864766|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14864767|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864768|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864769|NCT01100372|Gemcitabine|gemcitabine|mesh-list
14864770|NCT01100372|Doxorubicin|doxorubicin|mesh-list
14864771|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14864772|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14864773|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
14864774|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864775|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864776|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
14864777|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864778|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864779|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14864780|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
14864781|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864782|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14710029|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710030|NCT00433173|Anastrozole|anastrozole|mesh-list
14710031|NCT00433173|Goserelin|goserelin|mesh-list
14710032|NCT00433173|Testosterone|testosterone|mesh-list
14710033|NCT00433173|Androgens|androgens|mesh-ancestor
14710034|NCT00433173|Hormones|hormones|mesh-ancestor
14710035|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710036|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710037|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14710038|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710039|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14710040|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15209057|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
15209058|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710041|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864783|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14864784|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14864785|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
14864786|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864787|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864788|NCT01100736|Bosentan|bosentan|mesh-list
14864789|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
14864790|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14864791|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14864792|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864793|NCT01100775|Galantamine|galantamine|mesh-list
14864794|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14864795|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864796|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864797|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
14864798|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864799|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864800|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14864801|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
14864802|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864803|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
14864804|NCT01100801|Cisplatin|cisplatin|mesh-list
14864805|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
14864806|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296045|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14913776|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913777|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14913778|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14913779|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
14913780|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913781|NCT01376765|Antacids|antacids|mesh-ancestor
14296046|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296047|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14296048|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
14296049|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14296050|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296051|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296052|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296053|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14296054|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913782|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209059|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209060|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209061|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
15209062|NCT04940338|Hormones|hormones|mesh-ancestor
15209063|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209064|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209065|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209066|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
15209067|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209068|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209069|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15209070|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15209071|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209072|NCT04940338|Analgesics|analgesics|mesh-ancestor
15209073|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
15209074|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15209075|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
14296055|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296056|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296057|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296058|NCT00585546|Clenbuterol|clenbuterol|mesh-list
14296059|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14296060|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14296061|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
14864807|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
14864808|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864809|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864810|NCT01101009|Amlodipine|amlodipine|mesh-list
14864811|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14864812|NCT01101009|Olmesartan|olmesartan|mesh-list
14864813|NCT01101009|Perindopril|perindopril|mesh-list
14864814|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14864815|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14864816|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864817|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864818|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14864819|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864820|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
14864821|NCT01101009|Diuretics|diuretics|mesh-ancestor
14864822|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
14864823|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14864824|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14864825|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14864826|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14864827|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
14864828|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864829|NCT01101113|Cinacalcet|cinacalcet|mesh-list
14864830|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14864831|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864832|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14864833|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
14913783|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14864834|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864835|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14864836|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14864837|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14864838|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14864839|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864840|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296062|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710042|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710043|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14710044|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
14710045|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
14710046|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14710047|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710048|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14710049|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
14710050|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14710051|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710052|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710053|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710054|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
14864841|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864842|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
14864843|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14864844|NCT01101204|Metformin|metformin|mesh-list
14864845|NCT01101204|Simvastatin|simvastatin|mesh-list
14864846|NCT01101204|Fenofibrate|fenofibrate|mesh-list
14864847|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14864848|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864849|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15209076|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15209077|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209078|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15209079|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
15209080|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15209081|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209082|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209083|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209084|NCT04911361|Dexamethasone|dexamethasone|mesh-list
15209085|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209086|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
14864850|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14864851|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
14864852|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864853|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14864854|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14864855|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864856|NCT01101269|Lisinopril|lisinopril|mesh-list
14864857|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14864858|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
14864859|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864860|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864861|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15209087|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
15209088|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209089|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296063|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296064|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296065|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14296066|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
14710055|NCT00433225|Prednisolone|prednisolone|mesh-list
14710056|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14710057|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
15209090|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209091|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
15209092|NCT04911361|Hormones|hormones|mesh-ancestor
15209093|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710058|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14710059|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
15209094|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14296067|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864862|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14864863|NCT01101269|Protective Agents|protective agents|mesh-ancestor
14864864|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864865|NCT01101386|Voriconazole|voriconazole|mesh-list
14864866|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
14864867|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864868|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14864869|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14864870|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864871|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864872|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14864873|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
14864874|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14864875|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864876|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14864877|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
14864878|NCT01101412|Ethanol|ethanol|mesh-list
14864879|NCT01101412|Trimethoprim|trimethoprim|mesh-list
14864880|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
14864881|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14864882|NCT01101412|Edetic Acid|edetic acid|mesh-list
14864883|NCT01101412|Calcium|calcium|mesh-list
14864884|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
14864885|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14710060|NCT00433225|Ketorolac|ketorolac|mesh-list
14710061|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14710062|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
14710063|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710064|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
14710065|NCT00433225|Hormones|hormones|mesh-ancestor
14710066|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710067|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710068|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14710069|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710070|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
14710071|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
14710072|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710073|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710074|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14710075|NCT00433225|Protective Agents|protective agents|mesh-ancestor
14710076|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14710077|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14710078|NCT00433225|Analgesics|analgesics|mesh-ancestor
14710079|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
14710080|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710081|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14864886|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864887|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14864888|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14864889|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864890|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864891|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14864892|NCT01101412|Renal Agents|renal agents|mesh-ancestor
14864893|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
14864894|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14864895|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14864896|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14864897|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864898|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864899|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14864900|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14864901|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14864902|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14864903|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
14864904|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14864905|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
14864906|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
14864907|NCT01101412|Antidotes|antidotes|mesh-ancestor
14864908|NCT01101412|Protective Agents|protective agents|mesh-ancestor
14864909|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14864910|NCT01101451|Cisplatin|cisplatin|mesh-list
14864911|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864912|NCT01101529|Aprepitant|aprepitant|mesh-list
14864913|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
14864914|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
14864915|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864916|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864917|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14864918|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14864919|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864920|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864921|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14864922|NCT01101568|Simvastatin|simvastatin|mesh-list
14864923|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14864924|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14864925|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
14864926|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864927|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14864928|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14864929|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864930|NCT01101581|Epratuzumab|epratuzumab|mesh-list
14864931|NCT01101581|Veltuzumab|veltuzumab|mesh-list
14864932|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14864933|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14864934|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864935|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
14864936|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
14864937|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864938|NCT01101620|Simendan|simendan|mesh-list
14864939|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14864940|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
15209095|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209096|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15209097|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15209098|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209099|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
15209100|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
15209101|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209102|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209103|NCT04870034|Palbociclib|palbociclib|mesh-list
15209104|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209105|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209106|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209107|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864941|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14864942|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14864943|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864944|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209108|NCT04869371|Prednisone|prednisone|mesh-list
15209109|NCT04869371|Docetaxel|docetaxel|mesh-list
14864945|NCT01101620|Protective Agents|protective agents|mesh-ancestor
14864946|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864947|NCT01101646|Rabeprazole|rabeprazole|mesh-list
14864948|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14864949|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14864950|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14864951|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14864952|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864953|NCT01101659|Ketamine|ketamine|mesh-list
14864954|NCT01101659|Analgesics|analgesics|mesh-ancestor
14864955|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
14864956|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14864957|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864958|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14864959|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14864960|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
14864961|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
14864962|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14864963|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14864964|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14864965|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864966|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864967|NCT01101685|Citalopram|citalopram|mesh-list
14864968|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14864969|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14864970|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14296068|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14296069|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
14296070|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
14296071|NCT00585637|Vitamin D|vitamin d|mesh-list
14864971|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864972|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14864973|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
14864974|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864975|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15209110|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15209111|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209112|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209113|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209114|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209115|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209116|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209117|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
15209118|NCT04869371|Hormones|hormones|mesh-ancestor
15209119|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296072|NCT00585637|Vitamins|vitamins|mesh-ancestor
14864976|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
14864977|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14864978|NCT01101698|Vitamin D|vitamin d|mesh-list
14864979|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
14864980|NCT01101698|Vitamins|vitamins|mesh-list
14864981|NCT01101698|Vitamin K|vitamin k|mesh-list
14864982|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
14864983|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
14864984|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14864985|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14864986|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14864987|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14864988|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14864989|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14864990|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
14864991|NCT01101698|Coagulants|coagulants|mesh-ancestor
14864992|NCT01101776|Interferons|interferons|mesh-list
14864993|NCT01101776|Interferon-beta|interferon-beta|mesh-list
14864994|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
14864995|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14864996|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
14864997|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14864998|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
14864999|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865000|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14865001|NCT01101789|Triclosan|triclosan|mesh-list
14865002|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14296073|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
14865003|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865004|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14865005|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14865006|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
14865007|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865008|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14865009|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
14865010|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14865011|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865012|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14865013|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
14865014|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14865015|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865016|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865017|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865018|NCT01101815|Naltrexone|naltrexone|mesh-list
14865019|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14865020|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14865021|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865022|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
14865023|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865024|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
14865025|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14865026|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14865027|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
14865028|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865029|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14865030|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14865031|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865032|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865033|NCT01101919|Tofacitinib|tofacitinib|mesh-list
14865034|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14865035|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865036|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865037|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14865038|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14865039|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
14865040|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14865041|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
14865042|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865043|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
14865044|NCT01101984|Protective Agents|protective agents|mesh-ancestor
14865045|NCT01102101|Remifentanil|remifentanil|mesh-list
14865046|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14865047|NCT01102101|Narcotics|narcotics|mesh-ancestor
14865048|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865049|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865050|NCT01102101|Analgesics|analgesics|mesh-ancestor
15209120|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209121|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209122|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
15209123|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15209124|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
15209125|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15209126|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15209127|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
15209128|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15209129|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209130|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15209131|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209132|NCT04860518|Dexamethasone|dexamethasone|mesh-list
15209133|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296074|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296075|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14710082|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710083|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710084|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14710085|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710086|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14710087|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14710088|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14710089|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14710090|NCT00433277|Cyclosporine|cyclosporine|mesh-list
15209134|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
14865051|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
14865052|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865053|NCT01102114|Vaccines|vaccines|mesh-list
14865054|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
14865055|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865056|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14865057|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865058|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14865059|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865060|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
14865061|NCT01102244|Hormones|hormones|mesh-ancestor
14865062|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865063|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865064|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14865065|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14865066|NCT01102335|Telbivudine|telbivudine|mesh-list
14865067|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
14865068|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865069|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14865070|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865071|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865072|NCT01102439|Aspirin|aspirin|mesh-list
14865073|NCT01102439|Clopidogrel|clopidogrel|mesh-list
14865074|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14865075|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865076|NCT01102439|Analgesics|analgesics|mesh-ancestor
14865077|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
14710091|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15209135|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
14865078|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865079|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865080|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865081|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865082|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14865083|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14865084|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865085|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14865086|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14865087|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865088|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
14865089|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14865090|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15209136|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209137|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296076|NCT00585650|Etanercept|etanercept|mesh-list
14296077|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14296078|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296079|NCT00585650|Analgesics|analgesics|mesh-ancestor
15209138|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209139|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
14710092|NCT00433277|Cyclosporins|cyclosporins|mesh-list
14710093|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710094|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710095|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710096|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
14710097|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710098|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
14710099|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710100|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
14710101|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710102|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14710103|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14710104|NCT00433316|Ropivacaine|ropivacaine|mesh-list
14710105|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
14710106|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
14710107|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14710108|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710109|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
14710110|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710111|NCT00433342|Floxacillin|floxacillin|mesh-list
14710112|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14865091|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14865092|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
14296080|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
14865093|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865094|NCT01102465|Losartan|losartan|mesh-list
14865095|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14865096|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865097|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14865098|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14865099|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14865100|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865101|NCT01102465|Diuretics|diuretics|mesh-ancestor
14865102|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
14865103|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296081|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296082|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296083|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296084|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865104|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14865105|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14865106|NCT01102478|Losartan|losartan|mesh-list
14865107|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14865108|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865109|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14865110|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14865111|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14865112|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865113|NCT01102478|Diuretics|diuretics|mesh-ancestor
14865114|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
14865115|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865116|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14865117|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14865118|NCT01102595|Bevacizumab|bevacizumab|mesh-list
14865119|NCT01102595|Temozolomide|temozolomide|mesh-list
14865120|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865121|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865122|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14865123|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14865124|NCT01102595|Growth Substances|growth substances|mesh-ancestor
14865125|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865126|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
14865127|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14865128|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
14865129|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865130|NCT01102608|Ifosfamide|ifosfamide|mesh-list
14865131|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14865132|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
14865133|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865134|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913784|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14913785|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14913786|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14865135|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14865136|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865137|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865138|NCT01102686|Leucovorin|leucovorin|mesh-list
14865139|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
14865140|NCT01102686|Antidotes|antidotes|mesh-ancestor
14865141|NCT01102686|Protective Agents|protective agents|mesh-ancestor
14865142|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865143|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
14865144|NCT01102686|Vitamins|vitamins|mesh-ancestor
14865145|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
14865146|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
14865147|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14865148|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14865149|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865150|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14865151|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865152|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865153|NCT01102699|Lenograstim|lenograstim|mesh-list
14865154|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14865155|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
14865156|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865157|NCT01102946|Ranibizumab|ranibizumab|mesh-list
14865158|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14865159|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14865160|NCT01102946|Growth Substances|growth substances|mesh-ancestor
14865161|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865162|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
14865163|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865164|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14865165|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
14865166|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865167|NCT01103050|Cetirizine|cetirizine|mesh-list
14865168|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14865169|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14865170|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14865171|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
14865172|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
14865173|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865174|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865175|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865176|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
14865177|NCT01103115|Vitamin D|vitamin d|mesh-list
14865178|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
14865179|NCT01103115|Calcium|calcium|mesh-list
14865180|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14865181|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865182|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14865183|NCT01103115|Vitamins|vitamins|mesh-ancestor
14865184|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
14865185|NCT01103115|Antacids|antacids|mesh-ancestor
14865186|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865187|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14865188|NCT01103154|Nadolol|nadolol|mesh-list
14865189|NCT01103154|Carvedilol|carvedilol|mesh-list
14865190|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14865191|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14865192|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
14865193|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865194|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865195|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865196|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14865197|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
14865198|NCT01103154|Protective Agents|protective agents|mesh-ancestor
14865199|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14865200|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14865201|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14865202|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
14865203|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14865204|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14865205|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865206|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
14865207|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
14865208|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865209|NCT01103193|Remifentanil|remifentanil|mesh-list
14865210|NCT01103193|Sevoflurane|sevoflurane|mesh-list
14865211|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14865212|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14865213|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
14865214|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
14865215|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865216|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865217|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14865218|NCT01103193|Narcotics|narcotics|mesh-ancestor
14865219|NCT01103193|Analgesics|analgesics|mesh-ancestor
14865220|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
14865221|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865222|NCT01103206|Cinacalcet|cinacalcet|mesh-list
14865223|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14865224|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865225|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14865226|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
14865227|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865228|NCT01103336|Nicorandil|nicorandil|mesh-list
14865229|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865230|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14865231|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
14865232|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
14865233|NCT01103336|Vitamins|vitamins|mesh-ancestor
14865234|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
14865235|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710113|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710114|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
14710115|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14710116|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15209140|NCT04860518|Hormones|hormones|mesh-ancestor
15209141|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209142|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209143|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225019|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225020|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225021|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225022|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
15225023|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225024|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710117|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710118|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710119|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710120|NCT00433407|Trastuzumab|trastuzumab|mesh-list
14710121|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710122|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710123|NCT00433420|Paclitaxel|paclitaxel|mesh-list
14710124|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
14710125|NCT00433420|Fluorouracil|fluorouracil|mesh-list
14710126|NCT00433420|Epirubicin|epirubicin|mesh-list
14865236|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14865237|NCT01103375|Isotretinoin|isotretinoin|mesh-list
14865238|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865239|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14865240|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865241|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225025|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14865242|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
14865243|NCT01103388|Rituximab|rituximab|mesh-list
15225026|NCT00867178|Vitamins|vitamins|mesh-ancestor
15225027|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
15225028|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14865244|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865245|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865246|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
14865247|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865248|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865249|NCT01103401|Tobramycin|tobramycin|mesh-list
14865250|NCT01103401|Dexamethasone|dexamethasone|mesh-list
14865251|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
14865252|NCT01103401|Ketorolac|ketorolac|mesh-list
14865253|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14865254|NCT01103401|BB 1101|bb 1101|mesh-list
14865255|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865256|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
14865257|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
14865258|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865259|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865260|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14865261|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
14865262|NCT01103401|Hormones|hormones|mesh-ancestor
14865263|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865264|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14865265|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865266|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
14865267|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865268|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865269|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14865270|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865271|NCT01103401|Analgesics|analgesics|mesh-ancestor
14865272|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
14710127|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14710128|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865273|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865274|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14865275|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14865276|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865277|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
14865278|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14865279|NCT01103518|Estradiol|estradiol|mesh-list
14865280|NCT01103518|Cyproterone|cyproterone|mesh-list
14865281|NCT01103518|Estrogens|estrogens|mesh-ancestor
14865282|NCT01103518|Hormones|hormones|mesh-ancestor
14865283|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865284|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865285|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14865286|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
14865287|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14865288|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14865289|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14865290|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14865291|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
14865292|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
14710129|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14710130|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14710131|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710132|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710133|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14865293|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865294|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14865295|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
14865296|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865297|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
14865298|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865299|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865300|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14865301|NCT01103609|Warfarin|warfarin|mesh-list
14865302|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
14865303|NCT01103622|Digoxin|digoxin|mesh-list
14865304|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865305|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14865306|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865307|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865308|NCT01103622|Protective Agents|protective agents|mesh-ancestor
14865309|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865310|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14865311|NCT01103635|Ipilimumab|ipilimumab|mesh-list
14865312|NCT01103635|Tremelimumab|tremelimumab|mesh-list
14865313|NCT01103635|Antibodies|antibodies|mesh-list
14865314|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
14865315|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14865316|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
14865317|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865318|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865319|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14865320|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865321|NCT01103648|Simvastatin|simvastatin|mesh-list
14710134|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
14710135|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710136|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710137|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14710138|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
14710139|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14710140|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
14710141|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14865322|NCT01103648|Ezetimibe|ezetimibe|mesh-list
14865323|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
14865324|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14865325|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14865326|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
14865327|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865328|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14865329|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865330|NCT01103739|Simvastatin|simvastatin|mesh-list
14865331|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14865332|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14710142|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14710143|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14710144|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14710145|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710146|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14710147|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14710148|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710149|NCT00433459|Prednisone|prednisone|mesh-list
14710150|NCT00433459|Prednisolone|prednisolone|mesh-list
14710151|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
14710152|NCT00433459|Dacarbazine|dacarbazine|mesh-list
14710153|NCT00433459|Vincristine|vincristine|mesh-list
14710154|NCT00433459|Procarbazine|procarbazine|mesh-list
14710155|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14710156|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710157|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
14710158|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710159|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710160|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14710161|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
14710162|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710163|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710164|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14710165|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710166|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
14710167|NCT00433459|Hormones|hormones|mesh-ancestor
14710168|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710169|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14865333|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
14710170|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14865334|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865335|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14865336|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14865337|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865338|NCT01103791|Docetaxel|docetaxel|mesh-list
14865339|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209144|NCT04763928|Decitabine|decitabine|mesh-list
15209145|NCT04763928|Venetoclax|venetoclax|mesh-list
15209146|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15209147|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
15209148|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209149|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209150|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209151|NCT04761822|Vaccines|vaccines|mesh-list
15209152|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
15209153|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710171|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
14710172|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
14710173|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710174|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14710175|NCT00433485|Sirolimus|sirolimus|mesh-list
14710176|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15209154|NCT04749108|Folfirinox|folfirinox|mesh-list
15209155|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209156|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
15209157|NCT04748224|Bupivacaine|bupivacaine|mesh-list
15209158|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
15209159|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
15209160|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865340|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
14865341|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
14865342|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
14865343|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865344|NCT01103817|Vitamin D|vitamin d|mesh-list
14865345|NCT01103817|Vitamins|vitamins|mesh-ancestor
14865346|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
14865347|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865348|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14865349|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
14865350|NCT01103830|Lumefantrine|lumefantrine|mesh-list
14865351|NCT01103830|Artemether|artemether|mesh-list
14865352|NCT01103830|Piperaquine|piperaquine|mesh-list
14865353|NCT01103830|Artenimol|artenimol|mesh-list
14865354|NCT01103830|Artemisinins|artemisinins|mesh-list
14865355|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14865356|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14865357|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14865358|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865359|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14865360|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14865361|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865362|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865363|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865364|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14865365|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
14865366|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14865367|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209161|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710177|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710178|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14710179|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710180|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
14710181|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710182|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
14710183|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728718|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728719|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728720|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865368|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15209162|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
14865369|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14865370|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14865371|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
14865372|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14865373|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14865374|NCT01103843|Clopidogrel|clopidogrel|mesh-list
14865375|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14865376|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14865377|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14865378|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14865379|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14865380|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
14865381|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865382|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865383|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865384|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
14865385|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14865386|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14865387|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865388|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
14865389|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
14865390|NCT01104259|Vinorelbine|vinorelbine|mesh-list
14865391|NCT01104259|Veliparib|veliparib|mesh-list
14865392|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865393|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14865394|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
14865395|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
14865396|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
14865397|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865398|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14865399|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865400|NCT01104298|Doxorubicin|doxorubicin|mesh-list
14865401|NCT01104298|Trabectedin|trabectedin|mesh-list
14865402|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14865403|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865404|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14865405|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14865406|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865407|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865408|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14865409|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
14865410|NCT01104337|Acetaminophen|acetaminophen|mesh-list
14865411|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865412|NCT01104337|Analgesics|analgesics|mesh-ancestor
14865413|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
14865414|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865415|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865416|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
14865417|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
14865418|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14865419|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14865420|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913787|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14913788|NCT01376882|Caffeine|caffeine|mesh-list
14913789|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14913790|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913791|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14913792|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913793|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913794|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14913795|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14913796|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
14913797|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913798|NCT01376999|Hormones|hormones|mesh-list
14913799|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913800|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913801|NCT01377025|Sorafenib|sorafenib|mesh-list
14913802|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913803|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14865421|NCT01104519|Niacin|niacin|mesh-list
14865422|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
14865423|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14865424|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
14865425|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865426|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14865427|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
14865428|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
14865429|NCT01104519|Vitamins|vitamins|mesh-ancestor
14865430|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
14865431|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865432|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14865433|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
14865434|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14865435|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865436|NCT01104532|Incretins|incretins|mesh-ancestor
14865437|NCT01104532|Hormones|hormones|mesh-ancestor
14865438|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865439|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14865440|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
14865441|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865442|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865443|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14865444|NCT01104571|Trastuzumab|trastuzumab|mesh-list
14865445|NCT01104571|Lapatinib|lapatinib|mesh-list
14865446|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865447|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865448|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14865449|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865450|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865451|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
14865452|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
14865453|NCT01104649|Riluzole|riluzole|mesh-list
14865454|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
14865455|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14865456|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14865457|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865458|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865459|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865460|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14865461|NCT01104649|Protective Agents|protective agents|mesh-ancestor
14865462|NCT01104844|Acetaminophen|acetaminophen|mesh-list
14865463|NCT01104844|Ibuprofen|ibuprofen|mesh-list
14865464|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865465|NCT01104844|Analgesics|analgesics|mesh-ancestor
14865466|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
14865467|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865468|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865469|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
14865470|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14865471|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865472|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865473|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14865474|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865475|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865476|NCT01104883|Iodine|iodine|mesh-list
14865477|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14865478|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865479|NCT01104883|Trace Elements|trace elements|mesh-ancestor
15209163|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209164|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15209165|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209166|NCT04748224|Analgesics|analgesics|mesh-ancestor
15209167|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15209168|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15209169|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15209170|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
15209171|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209172|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209173|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14865480|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
14865481|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865482|NCT01104896|Nicotine|nicotine|mesh-list
14865483|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14865484|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
14865485|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865486|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865487|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14865488|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14865489|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14865490|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865491|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710184|NCT00433498|Carboplatin|carboplatin|mesh-list
14710185|NCT00433498|Etoposide|etoposide|mesh-list
14710186|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
14710187|NCT00433498|Pravastatin|pravastatin|mesh-list
14710188|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710189|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14710190|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14710191|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14865492|NCT01104935|Trastuzumab|trastuzumab|mesh-list
14865493|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865494|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865495|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14865496|NCT01104987|Alendronate|alendronate|mesh-list
14865497|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14865498|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865499|NCT01105013|Clotrimazole|clotrimazole|mesh-list
14865500|NCT01105013|Miconazole|miconazole|mesh-list
14865501|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14865502|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865503|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
14865504|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14865505|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14865506|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865507|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865508|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14865509|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
14865510|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865511|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865512|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14865513|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14865514|NCT01105208|Cephalexin|cephalexin|mesh-list
14865515|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14865516|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865517|NCT01105234|Vitamin D|vitamin d|mesh-list
14865518|NCT01105234|Calcipotriene|calcipotriene|mesh-list
14865519|NCT01105234|Vitamins|vitamins|mesh-ancestor
14865520|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
14865521|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865522|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14865523|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
14865524|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
14865525|NCT01105273|Fludarabine|fludarabine|mesh-list
14865526|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14865527|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14865528|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
14865529|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865530|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865531|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14865532|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
14865533|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865534|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865535|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14865536|NCT01105286|Vitamin D|vitamin d|mesh-list
14865537|NCT01105286|Calcipotriene|calcipotriene|mesh-list
14865538|NCT01105286|Vitamins|vitamins|mesh-ancestor
14865539|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
14865540|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865541|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14865542|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
14710192|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710193|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710194|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14710195|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14865543|NCT01105299|Anastrozole|anastrozole|mesh-list
14865544|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14865545|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865546|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14865547|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14865548|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865549|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865550|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14865551|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
14865552|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865553|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865554|NCT01105338|Lycopene|lycopene|mesh-list
14865555|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865556|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
14865557|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865558|NCT01105338|Protective Agents|protective agents|mesh-ancestor
14865559|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865560|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14865561|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14865562|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865563|NCT01105351|Folic Acid|folic acid|mesh-list
14865564|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
14865565|NCT01105351|Hematinics|hematinics|mesh-ancestor
14865566|NCT01105351|Vitamins|vitamins|mesh-ancestor
14865567|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
14865568|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865569|NCT01105390|Pemetrexed|pemetrexed|mesh-list
14865570|NCT01105390|Rilotumumab|rilotumumab|mesh-list
14865571|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14865572|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865573|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865574|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865575|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14865576|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14865577|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865578|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
14865579|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865580|NCT01105481|Amisulpride|amisulpride|mesh-list
14865581|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14865582|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14865583|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865584|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865585|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14865586|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14865587|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
14865588|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865589|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865590|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14865591|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
14865592|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
14865593|NCT01105494|Hematinics|hematinics|mesh-ancestor
14865594|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14865595|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14865596|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
14865597|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865598|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15209174|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209175|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209176|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209177|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
15209178|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209179|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15209180|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209181|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209182|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
15209183|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209184|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209185|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15209186|NCT04724668|Melatonin|melatonin|mesh-list
14865599|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209187|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
15209188|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209189|NCT04724668|Protective Agents|protective agents|mesh-ancestor
15209190|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209191|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15209192|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
15209193|NCT04722848|Blinatumomab|blinatumomab|mesh-list
15209194|NCT04722848|Ponatinib|ponatinib|mesh-list
15209195|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209196|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209197|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209198|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209199|NCT04682860|Scopolamine|scopolamine|mesh-list
14865600|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15209200|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15209201|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15209202|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
15209203|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
15209204|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209205|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209206|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710196|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
14296085|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296086|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15209207|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
15209208|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15209209|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
14865601|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865602|NCT01105611|Ritonavir|ritonavir|mesh-list
14865603|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14865604|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
14865605|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14865606|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14865607|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
14865608|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865609|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865610|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14865611|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14865612|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
14865613|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865614|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14865615|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14865616|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14865617|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14865618|NCT01105793|Danazol|danazol|mesh-list
14865619|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14865620|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
14865621|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865622|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865623|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
14865624|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14865625|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865626|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
14865627|NCT01105832|Teriparatide|teriparatide|mesh-list
14865628|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14865629|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865630|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14865631|NCT01105871|Naloxone|naloxone|mesh-list
14865632|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14865633|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865634|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
14865635|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710197|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14710198|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14710199|NCT00433576|Resveratrol|resveratrol|mesh-list
14710200|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
14710201|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710202|NCT00433576|Protective Agents|protective agents|mesh-ancestor
14710203|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710204|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710205|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14710206|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
14710207|NCT00433615|Hematinics|hematinics|mesh-ancestor
14710208|NCT00433641|Sibutramine|sibutramine|mesh-list
14710209|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
14710210|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14865636|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14865637|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
14865638|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14865639|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
14865640|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
14865641|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
14865642|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865643|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865644|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
14865645|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865646|NCT01106053|Pramipexole|pramipexole|mesh-list
14865647|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
14865648|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865649|NCT01106053|Protective Agents|protective agents|mesh-ancestor
15209210|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209211|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209212|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15209213|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
15209214|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15209215|NCT04666636|Mirabegron|mirabegron|mesh-list
14865650|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865651|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15209216|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15209217|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15209218|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15209219|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
15209220|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209221|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209222|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209223|NCT04666636|Urological Agents|urological agents|mesh-ancestor
15209224|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
15209225|NCT04664946|Protective Agents|protective agents|mesh-ancestor
14865652|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14865653|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
14865654|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
14865655|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865656|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
14865657|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865658|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14865659|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
14865660|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14865661|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14865662|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865663|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865664|NCT01106118|Urological Agents|urological agents|mesh-ancestor
14865665|NCT01106131|Pioglitazone|pioglitazone|mesh-list
14865666|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14865667|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913804|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296087|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
14296088|NCT00585689|Gemcitabine|gemcitabine|mesh-list
14913805|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865668|NCT01106235|Aldesleukin|aldesleukin|mesh-list
14865669|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
14865670|NCT01106235|Interleukin-2|interleukin-2|mesh-list
14865671|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14865672|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
14865673|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865674|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865675|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14865676|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
14865677|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865678|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865679|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14865680|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865681|NCT01106235|Analgesics|analgesics|mesh-ancestor
14865682|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
14865683|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865684|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14865685|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14865686|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
14865687|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865688|NCT01106495|Simvastatin|simvastatin|mesh-list
14865689|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14865690|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14865691|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
14865692|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865693|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14865694|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14865695|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865696|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
14865697|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14865698|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14865699|NCT01106547|Prednisolone|prednisolone|mesh-list
14865700|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
14865701|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14865702|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
14865703|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865704|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
14865705|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
14710211|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
14710212|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14710213|NCT00433719|Efavirenz|efavirenz|mesh-list
14710214|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14710215|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14710216|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14710217|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865706|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865707|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865708|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14865709|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
14865710|NCT01106547|Hormones|hormones|mesh-ancestor
14865711|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865712|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14865713|NCT01106547|Protective Agents|protective agents|mesh-ancestor
14865714|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14865715|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865716|NCT01106716|Lidocaine|lidocaine|mesh-list
14865717|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
14865718|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
14865719|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14710218|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710219|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
14710220|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710221|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14710222|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14710223|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14710224|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14710225|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14710226|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14710227|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14710228|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14710229|NCT00433732|Naproxen|naproxen|mesh-list
14710230|NCT00433732|Sumatriptan|sumatriptan|mesh-list
14710231|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14710232|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14710233|NCT00433732|Analgesics|analgesics|mesh-ancestor
14710234|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
14710235|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710236|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710237|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865720|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865721|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
14865722|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865723|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865724|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14865725|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14865726|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14865727|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865728|NCT01106872|Gemcitabine|gemcitabine|mesh-list
14710238|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865729|NCT01106872|Bevacizumab|bevacizumab|mesh-list
14865730|NCT01106872|Docetaxel|docetaxel|mesh-list
14865731|NCT01106872|Valproic Acid|valproic acid|mesh-list
14865732|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865733|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865734|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14865735|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14865736|NCT01106872|Growth Substances|growth substances|mesh-ancestor
14865737|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865738|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
14865739|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14865740|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
14865741|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865742|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
14865743|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865744|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865745|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14865746|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
14865747|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
14865748|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
14865749|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
14865750|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
14865751|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
14865752|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865753|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
14865754|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14865755|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865756|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14865757|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
14865758|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14865759|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865760|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14865761|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14865762|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865763|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865764|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865765|NCT01107067|Testosterone|testosterone|mesh-list
14710239|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
14710240|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14710241|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710242|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710243|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14710244|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14710245|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14710246|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
14710247|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710248|NCT00433784|Clopidogrel|clopidogrel|mesh-list
14710249|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14710250|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14710251|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14710252|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14710253|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
14710254|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710255|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710256|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209226|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209227|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
15209228|NCT04664933|Protective Agents|protective agents|mesh-ancestor
14865766|NCT01107067|Androgens|androgens|mesh-ancestor
14865767|NCT01107067|Hormones|hormones|mesh-ancestor
14865768|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865769|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865770|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
14865771|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14865772|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
14865773|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14865774|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865775|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14710257|NCT00433823|Atorvastatin|atorvastatin|mesh-list
14710258|NCT00433823|Ezetimibe|ezetimibe|mesh-list
14710259|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14710260|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14710261|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
14710262|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710263|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14710264|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14710265|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209229|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209230|NCT04654052|Clopidogrel|clopidogrel|mesh-list
15209231|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15209232|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15209233|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15209234|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15209235|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
14296089|NCT00585689|Carboplatin|carboplatin|mesh-list
14865776|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
14913806|NCT01377051|Maleic acid|maleic acid|mesh-list
15209236|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209237|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209238|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209239|NCT04621500|Vitamin D|vitamin d|mesh-list
15209240|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
15209241|NCT04621500|Vitamins|vitamins|mesh-ancestor
15209242|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
15209243|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209244|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15209245|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14865777|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14865778|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
14865779|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14865780|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865781|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14865782|NCT01107145|Artesunate|artesunate|mesh-list
14865783|NCT01107145|Chloroquine|chloroquine|mesh-list
14865784|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14865785|NCT01107145|Lumefantrine|lumefantrine|mesh-list
14865786|NCT01107145|Artemether|artemether|mesh-list
14865787|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14865788|NCT01107145|Mefloquine|mefloquine|mesh-list
14865789|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
14865790|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15209246|NCT04613453|Midazolam|midazolam|mesh-list
15209247|NCT04613453|Ketamine|ketamine|mesh-list
14710266|NCT00433927|Leucovorin|leucovorin|mesh-list
14710267|NCT00433927|Folic Acid|folic acid|mesh-list
14710268|NCT00433927|Bevacizumab|bevacizumab|mesh-list
14710269|NCT00433927|Cetuximab|cetuximab|mesh-list
14710270|NCT00433927|Irinotecan|irinotecan|mesh-list
14710271|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
14710272|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710273|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710274|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14710275|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14710276|NCT00433927|Growth Substances|growth substances|mesh-ancestor
14710277|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710278|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
14710279|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14710280|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14710281|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710282|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710283|NCT00433927|Antidotes|antidotes|mesh-ancestor
14710284|NCT00433927|Protective Agents|protective agents|mesh-ancestor
14710285|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
14710286|NCT00433927|Vitamins|vitamins|mesh-ancestor
14710287|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
14865791|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15209248|NCT04613453|Analgesics|analgesics|mesh-ancestor
14865792|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865793|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865794|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
14865795|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
14865796|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14865797|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
14865798|NCT01107145|Amebicides|amebicides|mesh-ancestor
14865799|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865800|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14865801|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865802|NCT01107145|Analgesics|analgesics|mesh-ancestor
14865803|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
14865804|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865805|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865806|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865807|NCT01107145|Filaricides|filaricides|mesh-ancestor
14865808|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
14865809|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14865810|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14865811|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14865812|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
14865813|NCT01107236|Naproxen|naproxen|mesh-list
14865814|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14865815|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865816|NCT01107236|Analgesics|analgesics|mesh-ancestor
14865817|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
14865818|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865819|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865820|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865821|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865822|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
14865823|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14865824|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296090|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14296091|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296092|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296093|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
14865825|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865826|NCT01107431|Chromium|chromium|mesh-list
14865827|NCT01107431|Trace Elements|trace elements|mesh-ancestor
14865828|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
14865829|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865830|NCT01107509|Everolimus|everolimus|mesh-list
14865831|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865832|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14865833|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
14865834|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865835|NCT01107522|Temozolomide|temozolomide|mesh-list
14865836|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14865837|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
14865838|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865839|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865840|NCT01107574|Gabapentin|gabapentin|mesh-list
14865841|NCT01107574|Analgesics|analgesics|mesh-ancestor
14865842|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
14865843|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865844|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865845|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
14865846|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14865847|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14865848|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865849|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14865850|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14865851|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14913807|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865852|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865853|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865854|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
14865855|NCT01107639|Docetaxel|docetaxel|mesh-list
14865856|NCT01107639|Cetuximab|cetuximab|mesh-list
14865857|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865858|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
14865859|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
14865860|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
14865861|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865862|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865863|NCT01107756|Lenograstim|lenograstim|mesh-list
14865864|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14865865|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
14865866|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865867|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
14865868|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
14865869|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14865870|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14865871|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865872|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865873|NCT01107782|Urological Agents|urological agents|mesh-ancestor
14865874|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
14865875|NCT01107808|Vitamin D|vitamin d|mesh-list
14865876|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
14865877|NCT01107808|Metformin|metformin|mesh-list
14865878|NCT01107808|Calcium|calcium|mesh-list
14865879|NCT01107808|Vitamins|vitamins|mesh-ancestor
14865880|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
14865881|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865882|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14865883|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14865884|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14865885|NCT01107938|Esomeprazole|esomeprazole|mesh-list
14865886|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14865887|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14865888|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14865889|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14865890|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865891|NCT01107951|Dexamethasone|dexamethasone|mesh-list
14865892|NCT01107951|Rituximab|rituximab|mesh-list
14865893|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865894|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
14865895|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
14865896|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865897|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865898|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14865899|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
14865900|NCT01107951|Hormones|hormones|mesh-ancestor
14865901|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865902|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14865903|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865904|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865905|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
14865906|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865907|NCT01108029|Memantine|memantine|mesh-list
14865908|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14865909|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14865910|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
14865911|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14865912|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865913|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865914|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14865915|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14865916|NCT01108042|Docetaxel|docetaxel|mesh-list
14865917|NCT01108042|Fluorouracil|fluorouracil|mesh-list
14865918|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865919|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14865920|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14865921|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14865922|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865923|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
14865924|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14865925|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14865926|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
14865927|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865928|NCT01108055|Paclitaxel|paclitaxel|mesh-list
14865929|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14865930|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865931|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14865932|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14865933|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14865934|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865935|NCT01108107|Capecitabine|capecitabine|mesh-list
14865936|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
14865937|NCT01108107|Panitumumab|panitumumab|mesh-list
14865938|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14865939|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
14865940|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865941|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865942|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14865943|NCT01108133|Dexamethasone|dexamethasone|mesh-list
14865944|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865945|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
14865946|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
14865947|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865948|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865949|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14865950|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
14865951|NCT01108133|Hormones|hormones|mesh-ancestor
14865952|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14865953|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14865954|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14865955|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
14865956|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14865957|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14865958|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14865959|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865960|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
14865961|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865962|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
14865963|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14913808|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913809|NCT01377103|Testosterone|testosterone|mesh-list
14913810|NCT01377103|Androgens|androgens|mesh-ancestor
14913811|NCT01377103|Hormones|hormones|mesh-ancestor
14913812|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913813|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913814|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
14913815|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14913816|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913817|NCT01377168|Naltrexone|naltrexone|mesh-list
15209249|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
15209250|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209251|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209252|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15209253|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15209254|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
15209255|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
15209256|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15209257|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14913818|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14913819|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14865964|NCT01108289|Oxytocin|oxytocin|mesh-list
14865965|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
14865966|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14865967|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865968|NCT01108302|Oxytocin|oxytocin|mesh-list
14865969|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
14865970|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14865971|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865972|NCT01108393|S 20098|s 20098|mesh-list
14865973|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14865974|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865975|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865976|NCT01108562|Lidocaine|lidocaine|mesh-list
14865977|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
14865978|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
14865979|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14865980|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865981|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
15209258|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15209259|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209260|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209261|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14865982|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865983|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14865984|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14865985|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14865986|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14865987|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14865988|NCT01108588|Aspirin|aspirin|mesh-list
14865989|NCT01108588|Clopidogrel|clopidogrel|mesh-list
14865990|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14865991|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14865992|NCT01108588|Analgesics|analgesics|mesh-ancestor
14865993|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
14865994|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14865995|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14865996|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14865997|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14865998|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14865999|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14866000|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866001|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14866002|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14866003|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866004|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
15209262|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15209263|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15209264|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15209265|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14710288|NCT00433927|Hematinics|hematinics|mesh-ancestor
14710289|NCT00433940|Prednisolone|prednisolone|mesh-list
14710290|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710291|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
14710292|NCT00433940|Hormones|hormones|mesh-ancestor
14710293|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710294|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710295|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14710296|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710297|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
14710298|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14710299|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710300|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14710301|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
14710302|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14710303|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710304|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710305|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710306|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14710307|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
14710308|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710309|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
14866005|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14866006|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14866007|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14866008|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
14866009|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866010|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
14866011|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866012|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866013|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14866014|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14866015|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866016|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866017|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866018|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14866019|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14866020|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
14866021|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14866022|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
14866023|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866024|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866025|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14866026|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
14866027|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14866028|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14866029|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14866030|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866031|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866032|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866033|NCT01108744|Mannitol|mannitol|mesh-list
14866034|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14866035|NCT01108744|Diuretics|diuretics|mesh-ancestor
14866036|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
14866037|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866038|NCT01108783|Desloratadine|desloratadine|mesh-list
14866039|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14866040|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
14866041|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866042|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866043|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866044|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14866045|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14866046|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
14866047|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
14866048|NCT01108848|Complement C1s|complement c1s|mesh-list
14866049|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14866050|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14866051|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
14866052|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866053|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14866054|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14866055|NCT01108874|Metaraminol|metaraminol|mesh-list
14866056|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
14866057|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
14866058|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866059|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866060|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14866061|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14866062|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14866063|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14866064|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866065|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866066|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866067|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
14866068|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
14866069|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14866070|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14866071|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913820|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866072|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866073|NCT01108900|Urological Agents|urological agents|mesh-ancestor
14866074|NCT01108926|Tenofovir|tenofovir|mesh-list
14866075|NCT01108926|Emtricitabine|emtricitabine|mesh-list
14866076|NCT01108926|Efavirenz|efavirenz|mesh-list
14866077|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14866078|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
14866079|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866080|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14866081|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14866082|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866083|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866084|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14866085|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14866086|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14866087|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14866088|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14866089|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14866090|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14866091|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14866092|NCT01108939|Antimalarials|antimalarials|mesh-list
14866093|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14866094|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14866095|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866096|NCT01109030|Pioglitazone|pioglitazone|mesh-list
14866097|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
14866098|NCT01109030|Dexetimide|dexetimide|mesh-list
14866099|NCT01109030|Citalopram|citalopram|mesh-list
14866100|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14866101|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866102|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14866103|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14866104|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866105|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866106|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866107|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
14866108|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14866109|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
14866110|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866111|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14866112|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14866113|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
14866114|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
14866115|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866116|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14866117|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14866118|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
14866119|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14866120|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14866121|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866122|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14866123|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14866124|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
14866125|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
14866126|NCT01109043|Bisoprolol|bisoprolol|mesh-list
14866127|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14866128|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
14866129|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
14866130|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866131|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209266|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
15209267|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
15209268|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
15209269|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209270|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209271|NCT04602507|Ivermectin|ivermectin|mesh-list
15209272|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15209273|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209274|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
15209275|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15209276|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15209277|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14866132|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14866133|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14866134|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14866135|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866136|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866137|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866138|NCT01109121|Allopurinol|allopurinol|mesh-list
14866139|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
14866140|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866141|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866142|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
14866143|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14866144|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14866145|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
14866146|NCT01109121|Protective Agents|protective agents|mesh-ancestor
14866147|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866148|NCT01109134|Tirofiban|tirofiban|mesh-list
14866149|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14866150|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14866151|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866152|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15209278|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866153|NCT01109160|Azithromycin|azithromycin|mesh-list
14866154|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866155|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866156|NCT01109212|Bindarit|bindarit|mesh-list
14866157|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14866158|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14866159|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866160|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866161|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14866162|NCT01109264|Chlorambucil|chlorambucil|mesh-list
14866163|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14866164|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
14866165|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866166|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866167|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14866168|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14866169|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14866170|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14866171|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14866172|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14866173|NCT01109485|Analgesics|analgesics|mesh-ancestor
14866174|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
14866175|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866176|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866177|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14866178|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14866179|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14866180|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14866181|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14866182|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
14866183|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
14866184|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866185|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866186|NCT01109498|Cyclosporine|cyclosporine|mesh-list
14866187|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
14866188|NCT01109498|Cyclosporins|cyclosporins|mesh-list
14866189|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209279|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209280|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
15209281|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866190|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866191|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14866192|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
14866193|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866194|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
14866195|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209282|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209283|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15209284|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209285|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15209286|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209287|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209288|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209289|NCT04552197|Tofacitinib|tofacitinib|mesh-list
15209290|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209291|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209292|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209293|NCT04537793|Ivacaftor|ivacaftor|mesh-list
15209294|NCT04537793|Elexacaftor|elexacaftor|mesh-list
15209295|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15209296|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209297|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209298|NCT04533568|Ibuprofen|ibuprofen|mesh-list
14866196|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
14866197|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14866198|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14866199|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14866200|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866201|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14866202|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
14866203|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866204|NCT01109511|Oxycodone|oxycodone|mesh-list
14866205|NCT01109511|Naloxone|naloxone|mesh-list
14866206|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14866207|NCT01109511|Narcotics|narcotics|mesh-ancestor
14866208|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866209|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866210|NCT01109511|Analgesics|analgesics|mesh-ancestor
14866211|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
14866212|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866213|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14866214|NCT01109615|Gemcitabine|gemcitabine|mesh-list
14866215|NCT01109615|Pemetrexed|pemetrexed|mesh-list
14866216|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14866217|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
14866218|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866219|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866220|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
14866221|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866222|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866223|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14866224|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
14866225|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866226|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14866227|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14866228|NCT01109654|Cetrorelix|cetrorelix|mesh-list
14866229|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14866230|NCT01109654|Hormones|hormones|mesh-ancestor
14866231|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866232|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866233|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14866234|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
14866235|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14866236|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
14866237|NCT01109693|Mirtazapine|mirtazapine|mesh-list
14866238|NCT01109693|Sertraline|sertraline|mesh-list
14866239|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
14866240|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866241|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15209299|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14866242|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14866243|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866244|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866245|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866246|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
14866247|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866248|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14866249|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
14866250|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
14866251|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14866252|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14866253|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866254|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14866255|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14866256|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14866257|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866258|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14866259|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14866260|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14866261|NCT01109758|Fenofibrate|fenofibrate|mesh-list
14866262|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14866263|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
14866264|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866265|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14866266|NCT01109784|Clopidogrel|clopidogrel|mesh-list
14866267|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14866268|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14866269|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14866270|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14866271|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15209300|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15209301|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209302|NCT04533568|Analgesics|analgesics|mesh-ancestor
15209303|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
15209304|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209305|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209306|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209307|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15209308|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15209309|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209310|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710310|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14710311|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
14710312|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710313|NCT00434005|Expectorants|expectorants|mesh-ancestor
14710314|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
14710315|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14710316|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
14710317|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710318|NCT00434005|Protective Agents|protective agents|mesh-ancestor
14710319|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710320|NCT00434005|Antidotes|antidotes|mesh-ancestor
14710321|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
14710322|NCT00434031|Docetaxel|docetaxel|mesh-list
14866272|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
14866273|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866274|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866275|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866276|NCT01109823|Levofloxacin|levofloxacin|mesh-list
14866277|NCT01109823|Ofloxacin|ofloxacin|mesh-list
14710323|NCT00434031|Doxorubicin|doxorubicin|mesh-list
14710324|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14866278|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14866279|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866280|NCT01109823|Renal Agents|renal agents|mesh-ancestor
14866281|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866282|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14866283|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14866284|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866285|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866286|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866287|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14866288|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14866289|NCT01109888|Cetrorelix|cetrorelix|mesh-list
14866290|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14866291|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
14866292|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14866293|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866294|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
14866295|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866296|NCT01109927|Insulin|insulin|mesh-list
14866297|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14866298|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913821|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
14913822|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913823|NCT01377220|Choline|choline|mesh-list
14913824|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
14913825|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14913826|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
14913827|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913828|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14913829|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15209311|NCT04511078|Panitumumab|panitumumab|mesh-list
15209312|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209313|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209314|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
15209315|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15209316|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209317|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209318|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15209319|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
14710325|NCT00434031|Trastuzumab|trastuzumab|mesh-list
14710326|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14913830|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
14913831|NCT01377246|Octreotide|octreotide|mesh-list
14913832|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14913833|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14913834|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710327|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
14710328|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710329|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710330|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14710331|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
14913835|NCT01377259|Anesthetics|anesthetics|mesh-list
14710332|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913836|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866299|NCT01110031|Ofatumumab|ofatumumab|mesh-list
14866300|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866301|NCT01110226|Cisplatin|cisplatin|mesh-list
14866302|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
14866303|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866304|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866305|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866306|NCT01110291|Docetaxel|docetaxel|mesh-list
14866307|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866308|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14866309|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14866310|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14866311|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866312|NCT01110304|Analgesics|analgesics|mesh-list
14866313|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
14866314|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866315|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866316|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14866317|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14866318|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14866319|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866320|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866321|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866322|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14866323|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14866324|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
14866325|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296094|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866326|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866327|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14866328|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14866329|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
14866330|NCT01110473|Azacitidine|azacitidine|mesh-list
14866331|NCT01110473|Ilorasertib|ilorasertib|mesh-list
14866332|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14866333|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
14866334|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866335|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866336|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866337|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14866338|NCT01110486|Carboplatin|carboplatin|mesh-list
14866339|NCT01110486|Docetaxel|docetaxel|mesh-list
14866340|NCT01110486|Ilorasertib|ilorasertib|mesh-list
15209320|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209321|NCT04508634|Metformin|metformin|mesh-list
15209322|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15209323|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209324|NCT04507373|Simvastatin|simvastatin|mesh-list
15209325|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15209326|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15209327|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
15209328|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866341|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866342|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
14866343|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
14866344|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
14866345|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866346|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14866347|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866348|NCT01110551|Vaccines|vaccines|mesh-list
14866349|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
14866350|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866351|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14866352|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
14866353|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14866354|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14866355|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866356|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866357|NCT01110590|Urological Agents|urological agents|mesh-ancestor
14866358|NCT01110603|Paclitaxel|paclitaxel|mesh-list
14866359|NCT01110603|Carboplatin|carboplatin|mesh-list
14866360|NCT01110603|Doxorubicin|doxorubicin|mesh-list
14866361|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14866362|NCT01110603|Niraparib|niraparib|mesh-list
14866363|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14866364|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866365|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14866366|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14866367|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14866368|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866369|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14866370|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14866371|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14866372|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866373|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14866374|NCT01110616|Lorazepam|lorazepam|mesh-list
14866375|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
14866376|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
14866377|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
14866378|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866379|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866380|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14866381|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14866382|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866383|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14866384|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14866385|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866386|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
14866387|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
14866388|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866389|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866390|NCT01110642|Lovastatin|lovastatin|mesh-list
14866391|NCT01110642|L 647318|l 647318|mesh-list
14866392|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
14866393|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14866394|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14866395|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
14866396|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866397|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14866398|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14866399|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866400|NCT01110785|Panitumumab|panitumumab|mesh-list
14866401|NCT01110785|Simvastatin|simvastatin|mesh-list
14866402|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14866403|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14866404|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
14866405|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866406|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14866407|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14866408|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866409|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14866410|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866411|NCT01110824|Carvedilol|carvedilol|mesh-list
14866412|NCT01110824|Enalapril|enalapril|mesh-list
14866413|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14866414|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14866415|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866416|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866417|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866418|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866419|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14866420|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
14866421|NCT01110824|Protective Agents|protective agents|mesh-ancestor
14866422|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14866423|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866424|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14866425|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
14866426|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14866427|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14866428|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14866429|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
14866430|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866431|NCT01110941|Leucovorin|leucovorin|mesh-list
14866432|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
14866433|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866434|NCT01110941|Antidotes|antidotes|mesh-ancestor
14866435|NCT01110941|Protective Agents|protective agents|mesh-ancestor
14866436|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866437|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
14866438|NCT01110941|Vitamins|vitamins|mesh-ancestor
14866439|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
14866440|NCT01111019|Hormones|hormones|mesh-list
14866441|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866442|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866443|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14866444|NCT01111084|Hormones|hormones|mesh-ancestor
14866445|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866446|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866447|NCT01111188|Bortezomib|bortezomib|mesh-list
14866448|NCT01111188|Palbociclib|palbociclib|mesh-list
14866449|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866450|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14866451|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866452|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209329|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15209330|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15209331|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710333|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710334|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14710335|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
14710336|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14710337|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710338|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14710339|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14710340|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14866453|NCT01111227|Propofol|propofol|mesh-list
15225029|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15225030|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15225031|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225032|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225033|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225034|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225035|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15225036|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
14866454|NCT01111227|Isoflurane|isoflurane|mesh-list
14866455|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14866456|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866457|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866458|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14866459|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
14866460|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
14866461|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14866462|NCT01111253|Amoxicillin|amoxicillin|mesh-list
14866463|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
14866464|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
14866465|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14866466|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866467|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866468|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14866469|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866470|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866471|NCT01111383|Tobramycin|tobramycin|mesh-list
14866472|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866473|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296095|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
14296096|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296097|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710341|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710342|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710343|NCT00434044|Etanercept|etanercept|mesh-list
14710344|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14710345|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14710346|NCT00434044|Analgesics|analgesics|mesh-ancestor
14710347|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
14710348|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710349|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710350|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710351|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710352|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710353|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710354|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
14710355|NCT00434083|Naproxen|naproxen|mesh-list
14710356|NCT00434083|Sumatriptan|sumatriptan|mesh-list
14866474|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
14866475|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14866476|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
14866477|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866478|NCT01111422|Expectorants|expectorants|mesh-ancestor
14866479|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14866480|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14866481|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
14866482|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866483|NCT01111422|Protective Agents|protective agents|mesh-ancestor
14866484|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866485|NCT01111422|Antidotes|antidotes|mesh-ancestor
14866486|NCT01111448|Sirolimus|sirolimus|mesh-list
14866487|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866488|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866489|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14866490|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866491|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
14866492|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14866493|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
14866494|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866495|NCT01111513|Analgesics|analgesics|mesh-list
14866496|NCT01111513|Ropivacaine|ropivacaine|mesh-list
14866497|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
14866498|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
14866499|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866500|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866501|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
14866502|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866503|NCT01111591|Celecoxib|celecoxib|mesh-list
14866504|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14866505|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14866506|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14866507|NCT01111591|Analgesics|analgesics|mesh-ancestor
14866508|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
14866509|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866510|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866511|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14866512|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14866513|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14866514|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866515|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866516|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
14866517|NCT01111630|Hematinics|hematinics|mesh-ancestor
14866518|NCT01111656|Interferons|interferons|mesh-list
14866519|NCT01111656|Interferon-beta|interferon-beta|mesh-list
14866520|NCT01111656|Atorvastatin|atorvastatin|mesh-list
14866521|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
14866522|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866523|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
14866524|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866525|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14866526|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14866527|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
14866528|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866529|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14866530|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14866531|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866532|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
14866533|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866534|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14866535|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
14866536|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14866537|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14866538|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866539|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
14866540|NCT01111669|Coagulants|coagulants|mesh-ancestor
14866541|NCT01111682|Mannitol|mannitol|mesh-list
14866542|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14866543|NCT01111682|Diuretics|diuretics|mesh-ancestor
14866544|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
14866545|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866546|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
14866547|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14866548|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866549|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
14866550|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866551|NCT01111734|Expectorants|expectorants|mesh-ancestor
14866552|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14866553|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14866554|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
14866555|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866556|NCT01111734|Protective Agents|protective agents|mesh-ancestor
14866557|NCT01111734|Antidotes|antidotes|mesh-ancestor
14866558|NCT01111747|Mitogens|mitogens|mesh-list
14866559|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
14866560|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913837|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913838|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
14913839|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14913840|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14913841|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913842|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913843|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14913844|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14913845|NCT01377285|Protective Agents|protective agents|mesh-ancestor
15209332|NCT04501653|Methylphenidate|methylphenidate|mesh-list
15209333|NCT04501653|Psilocybin|psilocybin|mesh-list
15209334|NCT04501653|Psilocin|psilocin|mesh-list
15209335|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15209336|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209337|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15209338|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15209339|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209340|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209341|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
15209342|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913846|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913847|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
14913848|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14913849|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
14913850|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14913851|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14913852|NCT01377324|Estradiol|estradiol|mesh-list
14913853|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14913854|NCT01377324|Estrogens|estrogens|mesh-ancestor
14913855|NCT01377324|Hormones|hormones|mesh-ancestor
14913856|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913857|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913858|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14913859|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
14913860|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14913861|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14913862|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14913863|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913864|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14913865|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913866|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913867|NCT01377415|Bupivacaine|bupivacaine|mesh-list
14913868|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
14913869|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
14913870|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913871|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913872|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
14913873|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866561|NCT01111864|Micronutrients|micronutrients|mesh-list
14866562|NCT01111864|Trace Elements|trace elements|mesh-list
14866563|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866564|NCT01111890|Timolol|timolol|mesh-list
14866565|NCT01111890|Dorzolamide|dorzolamide|mesh-list
14866566|NCT01111890|Brinzolamide|brinzolamide|mesh-list
14866567|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14866568|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14866569|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866570|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866571|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866572|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866573|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14866574|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14866575|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14866576|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866577|NCT01111903|Lenalidomide|lenalidomide|mesh-list
14866578|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
14866579|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866580|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14866581|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14866582|NCT01111903|Growth Substances|growth substances|mesh-ancestor
14866583|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
14866584|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710357|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14710358|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14710359|NCT00434083|Analgesics|analgesics|mesh-ancestor
14710360|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
14710361|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710362|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710363|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710364|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710365|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
14710366|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14710367|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710368|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710369|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14710370|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14710371|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14710372|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
14710373|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710374|NCT00434096|Rimonabant|rimonabant|mesh-list
14710375|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14710376|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14710377|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14710378|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710379|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710380|NCT00434096|Hormones|hormones|mesh-ancestor
14728721|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14866585|NCT01111942|Cisplatin|cisplatin|mesh-list
14866586|NCT01111942|Carboplatin|carboplatin|mesh-list
14866587|NCT01111942|Docetaxel|docetaxel|mesh-list
14866588|NCT01111942|Fluorouracil|fluorouracil|mesh-list
14866589|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866590|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
14866591|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
14866592|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
14866593|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866594|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
14866595|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14866596|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14866597|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
14866598|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866599|NCT01111968|Vaccines|vaccines|mesh-list
14866600|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
14866601|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866602|NCT01111981|Clobetasol|clobetasol|mesh-list
14866603|NCT01111981|Emollients|emollients|mesh-list
14866604|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14866605|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
14866606|NCT01111981|Hormones|hormones|mesh-ancestor
14866607|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866608|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866609|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
14866610|NCT01111994|Clindamycin|clindamycin|mesh-list
14866611|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
14866612|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
14866613|NCT01111994|Tretinoin|tretinoin|mesh-list
14866614|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866615|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866616|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14866617|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866618|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866619|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866620|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
14866621|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
14866622|NCT01112085|Ranibizumab|ranibizumab|mesh-list
14866623|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14866624|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14866625|NCT01112085|Growth Substances|growth substances|mesh-ancestor
14866626|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866627|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
14866628|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866629|NCT01112137|Clopidogrel|clopidogrel|mesh-list
14866630|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14866631|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14866632|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14866633|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14866634|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
14866635|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866636|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866637|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866638|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
14866639|NCT01112215|Azathioprine|azathioprine|mesh-list
14866640|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14866641|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866642|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14866643|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
14866644|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866645|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866646|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866647|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209343|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
15209344|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15209345|NCT04481009|Gemcitabine|gemcitabine|mesh-list
15209346|NCT04481009|Paclitaxel|paclitaxel|mesh-list
15209347|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209348|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209349|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209350|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209351|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209352|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209353|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15209354|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
15209355|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
15209356|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209357|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209358|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15209359|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
15209360|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866648|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
15209361|NCT04475731|Ponatinib|ponatinib|mesh-list
14866649|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14866650|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14866651|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
14866652|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866653|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14866654|NCT01112449|Selenium|selenium|mesh-list
14866655|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
14866656|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866657|NCT01112449|Protective Agents|protective agents|mesh-ancestor
14866658|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866659|NCT01112449|Trace Elements|trace elements|mesh-ancestor
14866660|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
14866661|NCT01112462|Acetaminophen|acetaminophen|mesh-list
14866662|NCT01112462|Phenylephrine|phenylephrine|mesh-list
14866663|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
14866664|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14866665|NCT01112462|Analgesics|analgesics|mesh-ancestor
14866666|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
14866667|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866668|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866669|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
14866670|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14866671|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
14866672|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
14866673|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
14866674|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14866675|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
14866676|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
14866677|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14866678|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14866679|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14866680|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866681|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866682|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866683|NCT01112462|Protective Agents|protective agents|mesh-ancestor
14866684|NCT01112540|Morphine|morphine|mesh-list
14866685|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14866686|NCT01112540|Narcotics|narcotics|mesh-ancestor
14866687|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15209362|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209363|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209364|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209365|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209366|NCT04469491|Interferons|interferons|mesh-list
15209367|NCT04469491|Interferon Type I|interferon type i|mesh-list
15209368|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209369|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
15209370|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209371|NCT04398524|Cemiplimab|cemiplimab|mesh-list
15209372|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209373|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209374|NCT04397354|Dexamethasone|dexamethasone|mesh-list
15209375|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
15209376|NCT04397354|BB 1101|bb 1101|mesh-list
15209377|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209378|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
15209379|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
15209380|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209381|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209382|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209383|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
15209384|NCT04397354|Hormones|hormones|mesh-ancestor
15209385|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866688|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866689|NCT01112540|Analgesics|analgesics|mesh-ancestor
15209386|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14866690|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
14866691|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866692|NCT01112644|Oxycodone|oxycodone|mesh-list
14866693|NCT01112644|Naloxone|naloxone|mesh-list
14866694|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14866695|NCT01112644|Narcotics|narcotics|mesh-ancestor
14866696|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866697|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866698|NCT01112644|Analgesics|analgesics|mesh-ancestor
14866699|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
14866700|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866701|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14866702|NCT01112722|Histamine|histamine|mesh-list
14866703|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
14866704|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
14866705|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866706|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866707|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866708|NCT01112748|Lidocaine|lidocaine|mesh-list
14866709|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
14866710|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
14866711|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866712|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866713|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
14866714|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866715|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14866716|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14866717|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14866718|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866719|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866720|NCT01112787|Tazarotene|tazarotene|mesh-list
14866721|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
14866722|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
14866723|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
14866724|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
14866725|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866726|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866727|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866728|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
14866729|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14866730|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866731|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866732|NCT01112826|Capecitabine|capecitabine|mesh-list
14866733|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14866734|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
14866735|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866736|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866737|NCT01112852|Terlipressin|terlipressin|mesh-list
14866738|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14866739|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14866740|NCT01112852|Somatostatin|somatostatin|mesh-list
14866741|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14866742|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866743|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866744|NCT01112852|Hormones|hormones|mesh-ancestor
14866745|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866746|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866747|NCT01112878|Clonidine|clonidine|mesh-list
14866748|NCT01112878|Gabapentin|gabapentin|mesh-list
14866749|NCT01112878|Analgesics|analgesics|mesh-ancestor
14866750|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
14866751|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866752|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866753|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
14866754|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14866755|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14866756|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866757|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866758|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14866759|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14866760|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866761|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866762|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
14866763|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14866764|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
14866765|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
14866766|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14866767|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14866768|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14866769|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866770|NCT01112891|Vitamin D|vitamin d|mesh-list
14866771|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
14866772|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
14866773|NCT01112891|Vitamins|vitamins|mesh-list
14866774|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
14866775|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866776|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14866777|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14866778|NCT01113047|Amlodipine|amlodipine|mesh-list
14866779|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14866780|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14866781|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866782|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866783|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14866784|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866785|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
14866786|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
14866787|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866788|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866789|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14866790|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866791|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866792|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
14866793|NCT01113138|Analgesics|analgesics|mesh-ancestor
14866794|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
14866795|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866796|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866797|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
14866798|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866799|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14866800|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
14866801|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14866802|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866803|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866804|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14866805|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
14866806|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14866807|NCT01113164|Ondansetron|ondansetron|mesh-list
14866808|NCT01113164|Sertraline|sertraline|mesh-list
14866809|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
14866810|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
14866811|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866812|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866813|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209387|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209388|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
15209389|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209390|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209391|NCT04394481|Dexamethasone|dexamethasone|mesh-list
15209392|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
14710381|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866814|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
14866815|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
14866816|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14710382|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710383|NCT00434135|Gemcitabine|gemcitabine|mesh-list
14710384|NCT00434135|Paclitaxel|paclitaxel|mesh-list
14710385|NCT00434135|Pemetrexed|pemetrexed|mesh-list
14710386|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14710387|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710388|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
14866817|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
14866818|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866819|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866820|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14866821|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14866822|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14866823|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866824|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14866825|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
14866826|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14866827|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14866828|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866829|NCT01113229|Misoprostol|misoprostol|mesh-list
14866830|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14866831|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
14866832|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14866833|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866834|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14866835|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14866836|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
14866837|NCT01113281|Vaccines|vaccines|mesh-list
14866838|NCT01113281|Immunoglobulins|immunoglobulins|mesh-list
14866839|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
14866840|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866841|NCT01113372|Clopidogrel|clopidogrel|mesh-list
14866842|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14866843|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14866844|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14866845|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14866846|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
14866847|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866848|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866849|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866850|NCT01113424|Nicotine|nicotine|mesh-list
14866851|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14866852|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
14866853|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866854|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866855|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14866856|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14866857|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
14866858|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866859|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866860|NCT01113437|Omalizumab|omalizumab|mesh-list
14866861|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14866862|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14866863|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913874|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
14913875|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14913876|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
14913877|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913878|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913879|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14913880|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
14913881|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14913882|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15209393|NCT04394481|Ropivacaine|ropivacaine|mesh-list
14866864|NCT01113489|Beclomethasone|beclomethasone|mesh-list
14866865|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14866866|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
14710389|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
14866867|NCT01113489|Hormones|hormones|mesh-ancestor
14866868|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866869|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866870|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14866871|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
14866872|NCT01113515|Esmolol|esmolol|mesh-list
14866873|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14866874|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14866875|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14866876|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866877|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866878|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866879|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866880|NCT01113528|Aspirin|aspirin|mesh-list
14866881|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14866882|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14866883|NCT01113528|Analgesics|analgesics|mesh-ancestor
14866884|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
14866885|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866886|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866887|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14866888|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14866889|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14866890|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14866891|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866892|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14866893|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14866894|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866895|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
14866896|NCT01113671|Vitamin E|vitamin e|mesh-list
14866897|NCT01113671|Tocopherols|tocopherols|mesh-list
14866898|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
14866899|NCT01113671|Vitamins|vitamins|mesh-ancestor
14866900|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
14866901|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866902|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
14710390|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710391|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710392|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710393|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
14710394|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
14710395|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710396|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710397|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710398|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
14710399|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710400|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14710401|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14866903|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866904|NCT01113671|Protective Agents|protective agents|mesh-ancestor
14866905|NCT01113762|Cimetidine|cimetidine|mesh-list
14866906|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14866907|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14866908|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14866909|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
14866910|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
14866911|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866912|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866913|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866914|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14866915|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14866916|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866917|NCT01114048|Thalidomide|thalidomide|mesh-list
14866918|NCT01114048|Dexamethasone|dexamethasone|mesh-list
14866919|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
14866920|NCT01114048|Bortezomib|bortezomib|mesh-list
14866921|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14866922|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
14866923|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866924|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14866925|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14866926|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
14866927|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866928|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866929|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14866930|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14866931|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
14296098|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296099|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
14296100|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296101|NCT00585780|Prazosin|prazosin|mesh-list
14296102|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14296103|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14296104|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14296105|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14296106|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
14296107|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296108|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296109|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296110|NCT00585910|Methylphenidate|methylphenidate|mesh-list
14866932|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
14866933|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14866934|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14866935|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
14866936|NCT01114048|Hormones|hormones|mesh-ancestor
14866937|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866938|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14866939|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
14866940|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14866941|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866942|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14866943|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14866944|NCT01114048|Growth Substances|growth substances|mesh-ancestor
14866945|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
14866946|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
14866947|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866948|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14866949|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866950|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866951|NCT01114100|Sertraline|sertraline|mesh-list
14866952|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
14866953|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14866954|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14866955|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14866956|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14866957|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209394|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209395|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
15209396|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
15209397|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209398|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866958|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14866959|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
14866960|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866961|NCT01114191|Ketoconazole|ketoconazole|mesh-list
14866962|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
14866963|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866964|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14866965|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14866966|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866967|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866968|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14866969|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
14866970|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14866971|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866972|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14866973|NCT01114282|Bortezomib|bortezomib|mesh-list
14866974|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14866975|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
14866976|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14866977|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14866978|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14866979|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
14866980|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14866981|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14866982|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14866983|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14866984|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866985|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14866986|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14866987|NCT01114490|Anacetrapib|anacetrapib|mesh-list
14866988|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14866989|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14866990|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
14866991|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14866992|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14866993|NCT01114542|Insulin|insulin|mesh-list
15209399|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209400|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
15209401|NCT04394481|Hormones|hormones|mesh-ancestor
15209402|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209403|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209404|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209405|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15209406|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15209407|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209408|NCT04394481|Analgesics|analgesics|mesh-ancestor
15209409|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
15209410|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15209411|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15209412|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15209413|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
14866994|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14866995|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
14866996|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14866997|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14866998|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
14866999|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14867000|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867001|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14867002|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867003|NCT01114750|Dextrans|dextrans|mesh-list
14867004|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
14867005|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
14867006|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
14867007|NCT01114841|Tazarotene|tazarotene|mesh-list
14867008|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867009|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
14867010|NCT01114854|Topiramate|topiramate|mesh-list
14867011|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
14867012|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14867013|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867014|NCT01114958|Cisplatin|cisplatin|mesh-list
14867015|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867016|NCT01115036|Panobinostat|panobinostat|mesh-list
14867017|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867018|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14867019|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867020|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867021|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
14867022|NCT01115049|Hexetidine|hexetidine|mesh-list
14867023|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14867024|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867025|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
14867026|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
14867027|NCT01115062|Lidocaine|lidocaine|mesh-list
14867028|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
14867029|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
14867030|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867031|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867032|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
14867033|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296111|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14296112|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14296113|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296114|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14296115|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14296116|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14296117|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296118|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
14296119|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296120|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14296121|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
14710402|NCT00434174|Pemetrexed|pemetrexed|mesh-list
14710403|NCT00434174|Everolimus|everolimus|mesh-list
14710404|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710405|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710406|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710407|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14710408|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14710409|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710410|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
14728722|NCT00519805|Dalteparin|dalteparin|mesh-list
14867034|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14867035|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14710411|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710412|NCT00434239|Lenalidomide|lenalidomide|mesh-list
14710413|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
14710414|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710415|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14710416|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14710417|NCT00434239|Growth Substances|growth substances|mesh-ancestor
14710418|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
14710419|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710420|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
14710421|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14710422|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867036|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14867037|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867038|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867039|NCT01115127|Inositol|inositol|mesh-list
14867040|NCT01115127|Melatonin|melatonin|mesh-list
14867041|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
14867042|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867043|NCT01115127|Protective Agents|protective agents|mesh-ancestor
14867044|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867045|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867046|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
14867047|NCT01115127|Vitamins|vitamins|mesh-ancestor
14867048|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
14867049|NCT01115140|Folic Acid|folic acid|mesh-list
14867050|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
14867051|NCT01115140|Metformin|metformin|mesh-list
14867052|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14867053|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867054|NCT01115140|Hematinics|hematinics|mesh-ancestor
14867055|NCT01115140|Vitamins|vitamins|mesh-ancestor
14710423|NCT00434382|Fentanyl|fentanyl|mesh-list
14867056|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
14867057|NCT01115179|Propofol|propofol|mesh-list
14867058|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14867059|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14867060|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867061|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867062|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14867063|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
14867064|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
14867065|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14867066|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14867067|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14867068|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
14867069|NCT01115322|Tazarotene|tazarotene|mesh-list
14867070|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867071|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
14710424|NCT00434382|Sufentanil|sufentanil|mesh-list
14710425|NCT00434382|Remifentanil|remifentanil|mesh-list
14867072|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
14867073|NCT01115322|Vitamins|vitamins|mesh-ancestor
14867074|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
14867075|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867076|NCT01115426|Losartan|losartan|mesh-list
14867077|NCT01115426|Ramipril|ramipril|mesh-list
14867078|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14867079|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14867080|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14867081|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14867082|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867083|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14867084|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867085|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867086|NCT01115439|Artesunate|artesunate|mesh-list
14867087|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
14867088|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
14867089|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14867090|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
14867091|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14867092|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14867093|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867094|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867095|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
14867096|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
14867097|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14867098|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
14867099|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14867100|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296122|NCT00585975|Bromfenac|bromfenac|mesh-list
14296123|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14296124|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14867101|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867102|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14867103|NCT01115439|Renal Agents|renal agents|mesh-ancestor
14867104|NCT01115478|Vitamin A|vitamin a|mesh-list
14867105|NCT01115478|Vitamins|vitamins|mesh-ancestor
14867106|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
14867107|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867108|NCT01115504|Thiamine|thiamine|mesh-list
14867109|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
14867110|NCT01115504|Vitamins|vitamins|mesh-ancestor
14867111|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
14867112|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867113|NCT01115543|Calcitriol|calcitriol|mesh-list
14867114|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
14867115|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14867116|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14867117|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867118|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14867119|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867120|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867121|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14867122|NCT01115543|Vitamins|vitamins|mesh-ancestor
14867123|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
14867124|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14867125|NCT01115712|Pioglitazone|pioglitazone|mesh-list
14867126|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14867127|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867128|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14867129|NCT01115725|Hormones|hormones|mesh-ancestor
14867130|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867131|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867132|NCT01115842|Vitamin D|vitamin d|mesh-list
14867133|NCT01115842|Vitamins|vitamins|mesh-ancestor
14867134|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
14867135|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867136|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14867137|NCT01115894|Naltrexone|naltrexone|mesh-list
14867138|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14867139|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14867140|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867141|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
14867142|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867143|NCT01115946|Enalapril|enalapril|mesh-list
14867144|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14867145|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867146|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867147|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867148|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14867149|NCT01115959|Valproic Acid|valproic acid|mesh-list
14867150|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
14867151|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867152|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867153|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
14867154|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867155|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867156|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
14867157|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14867158|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867159|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867160|NCT01115972|Valsartan|valsartan|mesh-list
14867161|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14867162|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14867163|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14867164|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867165|NCT01115985|Atorvastatin|atorvastatin|mesh-list
14867166|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14867167|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14867168|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
14867169|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867170|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14867171|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14867172|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867173|NCT01116050|Misoprostol|misoprostol|mesh-list
14867174|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14867175|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
14867176|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14867177|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867178|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14867179|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867180|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
14867181|NCT01116063|Iloprost|iloprost|mesh-list
14867182|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14867183|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
14867184|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
14867185|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867186|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867187|NCT01116128|Prednisone|prednisone|mesh-list
14867188|NCT01116128|Melphalan|melphalan|mesh-list
14867189|NCT01116128|Dasatinib|dasatinib|mesh-list
14867190|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867191|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
14867192|NCT01116128|Hormones|hormones|mesh-ancestor
14867193|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867194|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867195|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14867196|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867197|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14867198|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
14867199|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867200|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14867201|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14867202|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
14867203|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14867204|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867205|NCT01116154|Lenalidomide|lenalidomide|mesh-list
14867206|NCT01116154|Vorinostat|vorinostat|mesh-list
14867207|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
14867208|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867209|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14913883|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14867210|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14867211|NCT01116154|Growth Substances|growth substances|mesh-ancestor
14867212|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
14867213|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867214|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14867215|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867216|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867217|NCT01116167|Letrozole|letrozole|mesh-list
14867218|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867219|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14867220|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14867221|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867222|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867223|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14867224|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
14867225|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867226|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867227|NCT01116180|Candesartan|candesartan|mesh-list
14867228|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
14867229|NCT01116180|Giapreza|giapreza|mesh-list
14867230|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14867231|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
14867232|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14867233|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14867234|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867235|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14867236|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14867237|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867238|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867239|NCT01116193|Dexamethasone|dexamethasone|mesh-list
14867240|NCT01116193|Lenalidomide|lenalidomide|mesh-list
14867241|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867242|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
14867243|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
14867244|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867245|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867246|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867247|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
14867248|NCT01116193|Hormones|hormones|mesh-ancestor
14867249|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867250|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209414|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209415|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209416|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
15209417|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
15209418|NCT04370847|Ephedrine|ephedrine|mesh-list
15209419|NCT04370847|Fentanyl|fentanyl|mesh-list
15209420|NCT04370847|Bupivacaine|bupivacaine|mesh-list
15209421|NCT04370847|Oxytocin|oxytocin|mesh-list
15209422|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
15209423|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
15209424|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15209425|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209426|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
15209427|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209428|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15209429|NCT04370847|Narcotics|narcotics|mesh-ancestor
15209430|NCT04370847|Analgesics|analgesics|mesh-ancestor
14867251|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867252|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
14867253|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14867254|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15209431|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15209432|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15209433|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
14867255|NCT01116193|Growth Substances|growth substances|mesh-ancestor
14867256|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
14867257|NCT01116206|Prucalopride|prucalopride|mesh-list
14867258|NCT01116206|Laxatives|laxatives|mesh-ancestor
14867259|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867260|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14867261|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14867262|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
14867263|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867264|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867265|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867266|NCT01116219|Bevacizumab|bevacizumab|mesh-list
14867267|NCT01116219|Pemetrexed|pemetrexed|mesh-list
14867268|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14867269|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14867270|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867271|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14867272|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14867273|NCT01116219|Growth Substances|growth substances|mesh-ancestor
14867274|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867275|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
14867276|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867277|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867278|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14867279|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14867280|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14867281|NCT01116271|Irinotecan|irinotecan|mesh-list
14867282|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14867283|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14867284|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867285|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867286|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867287|NCT01116310|Glycine|glycine|mesh-list
14867288|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
14867289|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867290|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867291|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867292|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14867293|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209434|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
15209435|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15209436|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15209437|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
15209438|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
15209439|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14867294|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14867295|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867296|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867297|NCT01116388|Caseins|caseins|mesh-list
14867298|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
14867299|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
14867300|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867301|NCT01116531|Pregabalin|pregabalin|mesh-list
14867302|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14867303|NCT01116531|Tramadol|tramadol|mesh-list
14867304|NCT01116531|Analgesics|analgesics|mesh-ancestor
14867305|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
14867306|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867307|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867308|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
14867309|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15209440|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
15209441|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209442|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209443|NCT04356430|Prednisone|prednisone|mesh-list
15209444|NCT04356430|Goserelin|goserelin|mesh-list
15209445|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
15209446|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209447|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
15209448|NCT04356430|Hormones|hormones|mesh-ancestor
15209449|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209450|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209451|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209452|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867310|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867311|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867312|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14867313|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14867314|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14867315|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867316|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867317|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14867318|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14867319|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867320|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
14867321|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
14867322|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14867323|NCT01116531|Narcotics|narcotics|mesh-ancestor
14867324|NCT01116583|Gabapentin|gabapentin|mesh-list
14867325|NCT01116583|Analgesics|analgesics|mesh-ancestor
14867326|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
14867327|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867328|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867329|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
14867330|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14867331|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14867332|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867333|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867334|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14867335|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14867336|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867337|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867338|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
14867339|NCT01116596|Acetaminophen|acetaminophen|mesh-list
14867340|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14867341|NCT01116596|Analgesics|analgesics|mesh-ancestor
14867342|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
14867343|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867344|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867345|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
14867346|NCT01116609|Epinephrine|epinephrine|mesh-list
14867347|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14867348|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14867349|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14867350|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867351|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867352|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867353|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14867354|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14867355|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
14867356|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867357|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14867358|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
14867359|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
14867360|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
14867361|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14867362|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14867363|NCT01116622|Bexarotene|bexarotene|mesh-list
14867364|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867365|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14867366|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867367|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867368|NCT01116635|Doxorubicin|doxorubicin|mesh-list
14867369|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14867370|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867371|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14867372|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14867373|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867374|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867375|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
14867376|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14867377|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867378|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867379|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14867380|NCT01116700|Analgesics|analgesics|mesh-ancestor
14867381|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
14867382|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867383|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14867384|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14867385|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14867386|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
14867387|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867388|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867389|NCT01116713|Dexamethasone|dexamethasone|mesh-list
14867390|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867391|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
14867392|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
14867393|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867394|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867395|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867396|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
14867397|NCT01116713|Hormones|hormones|mesh-ancestor
14867398|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867399|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14867400|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867401|NCT01116791|Cisplatin|cisplatin|mesh-list
14867402|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867403|NCT01116817|Ritonavir|ritonavir|mesh-list
14867404|NCT01116817|Lopinavir|lopinavir|mesh-list
14867405|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14867406|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14867407|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
15209453|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15209454|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209455|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209456|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
15209457|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15209458|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
15209459|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
15209460|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15209461|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15209462|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209463|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209464|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209465|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15209466|NCT05310344|Paclitaxel|paclitaxel|mesh-list
15209467|NCT05310344|Bevacizumab|bevacizumab|mesh-list
15209468|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15209469|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209470|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209471|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209472|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209473|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209474|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209475|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209476|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15209477|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15209478|NCT05310344|Growth Substances|growth substances|mesh-ancestor
15225037|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
15209479|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209480|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
15209481|NCT05310331|Paclitaxel|paclitaxel|mesh-list
15209482|NCT05310331|Antibodies|antibodies|mesh-list
15209483|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209484|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209485|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209486|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209487|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209488|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209489|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
14867408|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867409|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867410|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15209490|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209491|NCT05310305|Antibodies|antibodies|mesh-list
15209492|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
15209493|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209494|NCT05310110|Lidocaine|lidocaine|mesh-list
15209495|NCT05310110|Propofol|propofol|mesh-list
15209496|NCT05310110|Cisatracurium|cisatracurium|mesh-list
15209497|NCT05310110|Atracurium|atracurium|mesh-list
15209498|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
15209499|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
14867411|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14867412|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
14867413|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867414|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14867415|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14867416|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
14867417|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14867418|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867419|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867420|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867421|NCT01117038|Amlodipine|amlodipine|mesh-list
14867422|NCT01117038|Enalapril|enalapril|mesh-list
14296125|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14296126|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296127|NCT00585975|Analgesics|analgesics|mesh-ancestor
14867423|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14867424|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14867425|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867426|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867427|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14867428|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867429|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
14913884|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
15209500|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15209501|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296128|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
14296129|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296130|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296131|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296132|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14296133|NCT00586066|Memantine|memantine|mesh-list
14296134|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14296135|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14296136|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
14296137|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710426|NCT00434382|Alfentanil|alfentanil|mesh-list
14710427|NCT00434382|Propofol|propofol|mesh-list
14710428|NCT00434382|Sevoflurane|sevoflurane|mesh-list
14710429|NCT00434382|Desflurane|desflurane|mesh-list
14710430|NCT00434382|Isoflurane|isoflurane|mesh-list
14710431|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14710432|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14710433|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710434|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14296138|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296139|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296140|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14296141|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14296142|NCT00586105|Sorafenib|sorafenib|mesh-list
14296143|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296144|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296145|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296146|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867430|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14867431|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867432|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867433|NCT01117116|Fluticasone|fluticasone|mesh-list
14867434|NCT01117116|Xhance|xhance|mesh-list
14867435|NCT01117116|Budesonide|budesonide|mesh-list
14867436|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
14867437|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14867438|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867439|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15209502|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
15209503|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209504|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15209505|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15209506|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15209507|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209508|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209509|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15209510|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15209511|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
15209512|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15209513|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14296147|NCT00586157|Methylphenidate|methylphenidate|mesh-list
14710435|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
14710436|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
14710437|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14710438|NCT00434382|Narcotics|narcotics|mesh-ancestor
14710439|NCT00434382|Analgesics|analgesics|mesh-ancestor
14710440|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
14710441|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710442|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14710443|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14710444|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14710445|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
14710446|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14710447|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710448|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
14710449|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710450|NCT00434668|Cisplatin|cisplatin|mesh-list
14710451|NCT00434668|Docetaxel|docetaxel|mesh-list
14710452|NCT00434668|Vinorelbine|vinorelbine|mesh-list
14710453|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710454|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
14867440|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
15209514|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15209515|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15209516|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15209517|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
15209518|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209519|NCT05309928|Amoxicillin|amoxicillin|mesh-list
14710455|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
14710456|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710457|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710458|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14710459|NCT00434681|Acetaminophen|acetaminophen|mesh-list
14710460|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209520|NCT05309928|Probenecid|probenecid|mesh-list
15209521|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15209522|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209523|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
15209524|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
15209525|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867441|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867442|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867443|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14867444|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
14867445|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867446|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14867447|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
14867448|NCT01117116|Hormones|hormones|mesh-ancestor
14867449|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867450|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14867451|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14867452|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14867453|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
14710461|NCT00434681|Analgesics|analgesics|mesh-ancestor
14710462|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
14710463|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867454|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867455|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710464|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710465|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
14710466|NCT00434746|Fezakinumab|fezakinumab|mesh-list
14710467|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
14710468|NCT00434772|Glucagon|glucagon|mesh-list
14710469|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710470|NCT00434772|Hormones|hormones|mesh-ancestor
14867456|NCT01117129|Rituximab|rituximab|mesh-list
14867457|NCT01117129|Methotrexate|methotrexate|mesh-list
14867458|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14867459|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867460|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
14867461|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867462|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15209526|NCT05309928|Renal Agents|renal agents|mesh-ancestor
15209527|NCT05309785|Canagliflozin|canagliflozin|mesh-list
15209528|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15209529|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209530|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15209531|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710471|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710472|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710473|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
14710474|NCT00434824|Testosterone|testosterone|mesh-list
14710475|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
14710476|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
14710477|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14710478|NCT00434824|Androgens|androgens|mesh-ancestor
14710479|NCT00434824|Hormones|hormones|mesh-ancestor
14710480|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710481|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710482|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14710483|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710484|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
14710485|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
14710486|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14710487|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14710488|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14710489|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14710490|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209532|NCT05309694|Copper|copper|mesh-list
15209533|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
15209534|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15209535|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710491|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
14710492|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710493|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710494|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14710495|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710496|NCT00434941|Capecitabine|capecitabine|mesh-list
14710497|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710498|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
14710499|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710500|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710501|NCT00435058|Timolol|timolol|mesh-list
14710502|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14710503|NCT00435058|Travoprost|travoprost|mesh-list
14710504|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14710505|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14710506|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
14710507|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710508|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710509|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710510|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14710511|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14710512|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14710513|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14710514|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14867463|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14867464|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
14867465|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14867466|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710515|NCT00435175|Estradiol|estradiol|mesh-list
14710516|NCT00435175|Estrogens|estrogens|mesh-ancestor
14710517|NCT00435175|Hormones|hormones|mesh-ancestor
14728723|NCT00519805|Tinzaparin|tinzaparin|mesh-list
14867467|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
14867468|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867469|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867470|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867471|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14867472|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14867473|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14867474|NCT01117220|Ziprasidone|ziprasidone|mesh-list
14867475|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14867476|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
14867477|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867478|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209536|NCT05309694|Trace Elements|trace elements|mesh-ancestor
15209537|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
15209538|NCT05309629|Carboplatin|carboplatin|mesh-list
15209539|NCT05309629|Etoposide|etoposide|mesh-list
14867479|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867480|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14710518|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867481|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14867482|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867483|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867484|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14867485|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
14913885|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14913886|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913887|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14913888|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913889|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209540|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209541|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209542|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15209543|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15209544|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710519|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710520|NCT00435279|Eszopiclone|eszopiclone|mesh-list
14710521|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14710522|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14710523|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14710524|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14710525|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710526|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710527|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710528|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14710529|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
14710530|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15225038|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15209545|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710531|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14867486|NCT01117298|Tadalafil|tadalafil|mesh-list
14867487|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
14867488|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14867489|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14867490|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867491|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867492|NCT01117298|Urological Agents|urological agents|mesh-ancestor
14867493|NCT01117376|Erythromycin|erythromycin|mesh-list
14867494|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
14867495|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15209546|NCT05309616|Ixekizumab|ixekizumab|mesh-list
15209547|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
15209548|NCT05309538|Betahistine|betahistine|mesh-list
15209549|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
15209550|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
15209551|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
15209552|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209553|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209554|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209555|NCT05309460|Labetalol|labetalol|mesh-list
15209556|NCT05309460|Nifedipine|nifedipine|mesh-list
15209557|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15209558|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209559|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209560|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15209561|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209562|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
15209563|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
15209564|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15209565|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15209566|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15209567|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
15209568|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209569|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15209570|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
14710532|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14710533|NCT00435292|Naproxen|naproxen|mesh-list
14867496|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
14867497|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
14867498|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14867499|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867500|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867501|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14867502|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710534|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14710535|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14710536|NCT00435292|Analgesics|analgesics|mesh-ancestor
14710537|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
14710538|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710539|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710540|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710541|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710542|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
14710543|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14710544|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710545|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710546|NCT00435305|Vancomycin|vancomycin|mesh-list
14710547|NCT00435305|Meropenem|meropenem|mesh-list
14710548|NCT00435305|Tazobactam|tazobactam|mesh-list
14710549|NCT00435305|Linezolid|linezolid|mesh-list
14710550|NCT00435305|Piperacillin|piperacillin|mesh-list
14710551|NCT00435305|Ceftazidime|ceftazidime|mesh-list
14710552|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14710553|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14710554|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710555|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14867503|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867504|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14867505|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710556|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867506|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
14867507|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867508|NCT01117441|Cytarabine|cytarabine|mesh-list
14867509|NCT01117441|Dexamethasone|dexamethasone|mesh-list
14867510|NCT01117441|Prednisone|prednisone|mesh-list
14867511|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
14867512|NCT01117441|Ifosfamide|ifosfamide|mesh-list
14867513|NCT01117441|Doxorubicin|doxorubicin|mesh-list
14867514|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14867515|NCT01117441|Methotrexate|methotrexate|mesh-list
14867516|NCT01117441|Fludarabine|fludarabine|mesh-list
14867517|NCT01117441|Etoposide|etoposide|mesh-list
14867518|NCT01117441|Vincristine|vincristine|mesh-list
14867519|NCT01117441|Daunorubicin|daunorubicin|mesh-list
14867520|NCT01117441|Asparaginase|asparaginase|mesh-list
14867521|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
14867522|NCT01117441|Thioguanine|thioguanine|mesh-list
14867523|NCT01117441|Pegaspargase|pegaspargase|mesh-list
14867524|NCT01117441|Vindesine|vindesine|mesh-list
14867525|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14867526|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
14867527|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867528|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867529|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14867530|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
14867531|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867532|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867533|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14867534|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867535|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
14867536|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
14867537|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867538|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867539|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
14867540|NCT01117441|Hormones|hormones|mesh-ancestor
14867541|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14867542|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209571|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
15209572|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209573|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15209574|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15209575|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
15209576|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209577|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867543|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14867544|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14867545|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15209578|NCT05309304|Cefazolin|cefazolin|mesh-list
15209579|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15209580|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225039|NCT00787176|Oxytocin|oxytocin|mesh-list
15225040|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
15225041|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15225042|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225043|NCT00352534|Dactinomycin|dactinomycin|mesh-list
15225044|NCT00352534|Cactinomycin|cactinomycin|mesh-list
15225045|NCT00352534|Doxorubicin|doxorubicin|mesh-list
15225046|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15225047|NCT00352534|Vincristine|vincristine|mesh-list
15225048|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15225049|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225050|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15225051|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15225052|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225053|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225054|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225055|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225056|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225057|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225058|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15225059|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225060|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15225061|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15225062|NCT00033293|Prednisone|prednisone|mesh-list
15225063|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
14710557|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710558|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14710559|NCT00435331|Verapamil|verapamil|mesh-list
14710560|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14710561|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15225064|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
15225065|NCT00033293|Antibodies|antibodies|mesh-list
15225066|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
15225067|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15225068|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15225069|NCT00033293|Hormones|hormones|mesh-list
14867546|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867547|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14867548|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
14867549|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14867550|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14867551|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
14867552|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867553|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14867554|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14867555|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14867556|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
14867557|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867558|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
14867559|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225070|NCT00033293|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15225071|NCT00033293|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14710562|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14710563|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710564|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14710565|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710566|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
14728724|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14728725|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
14728726|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14728727|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14728728|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728729|NCT00519870|Losartan|losartan|mesh-list
15225072|NCT00033293|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
15225073|NCT00033293|beta-Endorphin|beta-endorphin|mesh-list
15225074|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225075|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
15209581|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
15209582|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209583|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209584|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
15209585|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15209586|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
15209587|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209588|NCT05309070|Expectorants|expectorants|mesh-ancestor
15209589|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
15209590|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14867560|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
14867561|NCT01117610|Ropivacaine|ropivacaine|mesh-list
14867562|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
14867563|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
14867564|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867565|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209591|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
15209592|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209593|NCT05309070|Protective Agents|protective agents|mesh-ancestor
15209594|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209595|NCT05309070|Antidotes|antidotes|mesh-ancestor
15209596|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15209597|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15209598|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14867566|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
15209599|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867567|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867568|NCT01117636|Aspirin|aspirin|mesh-list
14867569|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14867570|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14867571|NCT01117636|Analgesics|analgesics|mesh-ancestor
14867572|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
14867573|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867574|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867575|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867576|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867577|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14867578|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14867579|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867580|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14867581|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14867582|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867583|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
14867584|NCT01117662|Rituximab|rituximab|mesh-list
14867585|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14867586|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867587|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
14867588|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867589|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867590|NCT01118039|Sunitinib|sunitinib|mesh-list
14867591|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867592|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15209600|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209601|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15209602|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209603|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209604|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
15209605|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209606|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15209607|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15209608|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209609|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15209610|NCT05308849|beta-Lactams|beta-lactams|mesh-list
14867593|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14867594|NCT01118039|Growth Substances|growth substances|mesh-ancestor
14867595|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867596|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14867597|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14867598|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867599|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867600|NCT01118065|Everolimus|everolimus|mesh-list
14867601|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867602|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14867603|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
14867604|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867605|NCT01118234|Rituximab|rituximab|mesh-list
14867606|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14867607|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867608|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
14867609|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867610|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867611|NCT01118260|Anesthetics|anesthetics|mesh-list
14867612|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867613|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867614|NCT01118286|Nifedipine|nifedipine|mesh-list
14867615|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14867616|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867617|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867618|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14867619|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867620|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14867621|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
14867622|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14867623|NCT01118403|Ampicillin|ampicillin|mesh-list
14867624|NCT01118403|Sulbactam|sulbactam|mesh-list
14867625|NCT01118403|Sultamicillin|sultamicillin|mesh-list
14867626|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14710567|NCT00435435|Disulfiram|disulfiram|mesh-list
14710568|NCT00435435|Acamprosate|acamprosate|mesh-list
14710569|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14710570|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14710571|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710572|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710573|NCT00435448|Lonidamine|lonidamine|mesh-list
14710574|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710575|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14867627|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867628|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14867629|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867630|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867631|NCT01118429|Oxybutynin|oxybutynin|mesh-list
14867632|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
14867633|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
14867634|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867635|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867636|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14867637|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14867638|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
14867639|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867640|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209611|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209612|NCT05308628|Complement C3|complement c3|mesh-list
15209613|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
15209614|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209615|NCT05308602|Vaccines|vaccines|mesh-list
15209616|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
15209617|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209618|NCT05308576|Vaccines|vaccines|mesh-list
15209619|NCT05308576|Immunologic Factors|immunologic factors|mesh-ancestor
15209620|NCT05308576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209621|NCT05308342|Hormones|hormones|mesh-list
15209622|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209623|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209624|NCT05308212|Vaccines|vaccines|mesh-list
15209625|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
15209626|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209627|NCT05306899|Ketamine|ketamine|mesh-list
15209628|NCT05306899|Analgesics|analgesics|mesh-ancestor
15209629|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
15209630|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867641|NCT01118429|Urological Agents|urological agents|mesh-ancestor
14867642|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
14867643|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
14867644|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867645|NCT01118559|Darexaban|darexaban|mesh-list
14867646|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14867647|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
15209631|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209632|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15209633|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15209634|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
15209635|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
14710576|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710577|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14710578|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
14710579|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14867648|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15209636|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867649|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867650|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710580|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14710581|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14710582|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15209637|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15209638|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15209639|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209640|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209641|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
15209642|NCT05303324|Choline|choline|mesh-list
15209643|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
15209644|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15209645|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
15209646|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209647|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209648|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15209649|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
14710583|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710584|NCT00435500|Fluorides|fluorides|mesh-list
14710585|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
14710586|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
14710587|NCT00435500|Protective Agents|protective agents|mesh-ancestor
14710588|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710589|NCT00435747|Parecoxib|parecoxib|mesh-list
14710590|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14710591|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14710592|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710593|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209650|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
15209651|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
15209652|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209653|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15209654|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15209655|NCT05303324|Growth Substances|growth substances|mesh-ancestor
15209656|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209657|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
15209658|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209659|NCT05294172|Gemcitabine|gemcitabine|mesh-list
15209660|NCT05294172|Cisplatin|cisplatin|mesh-list
15209661|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209662|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15209663|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
15209664|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209665|NCT05294172|Antiviral Agents|antiviral agents|mesh-ancestor
14710594|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14710595|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209666|NCT05294172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209667|NCT05294172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209668|NCT05294172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15209669|NCT05294172|Immunologic Factors|immunologic factors|mesh-ancestor
15209670|NCT05294172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209671|NCT05293548|Vaccines|vaccines|mesh-list
15209672|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
15209673|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209674|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
15209675|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
15209676|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
15209677|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15209678|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
15209679|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209680|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
15209681|NCT05291650|Protective Agents|protective agents|mesh-ancestor
15209682|NCT05291650|Hormones|hormones|mesh-ancestor
14867651|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867652|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
14867653|NCT01118572|Celecoxib|celecoxib|mesh-list
14867654|NCT01118572|Etodolac|etodolac|mesh-list
14867655|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15209683|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209684|NCT05288361|Acetylcholine|acetylcholine|mesh-list
15209685|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
15209686|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14710596|NCT00435747|Analgesics|analgesics|mesh-ancestor
15209687|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
14710597|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
14867656|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14867657|NCT01118572|Analgesics|analgesics|mesh-ancestor
14867658|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
14710598|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867659|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867660|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867661|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867662|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867663|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14867664|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14867665|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867666|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867667|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
14867668|NCT01118598|Niacin|niacin|mesh-list
14867669|NCT01118598|Niacinamide|niacinamide|mesh-list
14867670|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
14867671|NCT01118598|Vitamins|vitamins|mesh-ancestor
14867672|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
14867673|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209688|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209689|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209690|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225076|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225077|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225078|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225079|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
15225080|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867674|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14867675|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
14867676|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867677|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14867678|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
15225081|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225082|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15225083|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15225084|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
15225085|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225086|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15225087|NCT00033293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225088|NCT05193370|Vasopressins|vasopressins|mesh-list
15225089|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
15225090|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
15225091|NCT05193370|Giapreza|giapreza|mesh-list
15225092|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
15225093|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
15225094|NCT05193370|Coagulants|coagulants|mesh-ancestor
15225095|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15225096|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15225097|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
14867679|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14867680|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14867681|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710599|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710600|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710601|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710602|NCT00435760|Bromides|bromides|mesh-list
14710603|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
14710604|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14710605|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
14710606|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710607|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710608|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14710609|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
14710610|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
14710611|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14710612|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
14710613|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710614|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867682|NCT01118702|Methylphenidate|methylphenidate|mesh-list
14867683|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15225098|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225099|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15209691|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
15209692|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15209693|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15209694|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209695|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209696|NCT05283083|Analgesics|analgesics|mesh-ancestor
15209697|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
15209698|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209699|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15209700|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14867684|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867685|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14867686|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14867687|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867688|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867689|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
14867690|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867691|NCT01118793|Clopidogrel|clopidogrel|mesh-list
15209701|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15209702|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
15209703|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209704|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209705|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
15209706|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14867692|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15209707|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15209708|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14710615|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
14710616|NCT00435799|Riboflavin|riboflavin|mesh-list
14710617|NCT00435799|Dextrans|dextrans|mesh-list
14710618|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14710619|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
14710620|NCT00435799|Vitamins|vitamins|mesh-ancestor
14710621|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
14710622|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710623|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14710624|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
15209709|NCT05282940|Estradiol|estradiol|mesh-list
15209710|NCT05282940|Estrogens|estrogens|mesh-ancestor
15209711|NCT05282940|Hormones|hormones|mesh-ancestor
15209712|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710625|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
14710626|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
14710627|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
14710628|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14710629|NCT00435851|Hormones|hormones|mesh-list
14710630|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710631|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710632|NCT00435955|Rituximab|rituximab|mesh-list
14710633|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710634|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710635|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
14710636|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710637|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710638|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14710639|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14710640|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
14710641|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710642|NCT00435981|Antacids|antacids|mesh-ancestor
14710643|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710644|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710645|NCT00436033|Milnacipran|milnacipran|mesh-list
14710646|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
15209713|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209714|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15209715|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
15209716|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15209717|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15209718|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15209719|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15209720|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15209721|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15209722|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
15209723|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15209724|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15209725|NCT05278676|Dotinurad|dotinurad|mesh-list
15209726|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
15209727|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
15209728|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15209729|NCT05278676|Renal Agents|renal agents|mesh-ancestor
15209730|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
15209731|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209732|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710647|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14710648|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14710649|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14710650|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710651|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710652|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710653|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14710654|NCT00436033|Analgesics|analgesics|mesh-ancestor
14710655|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
14710656|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710657|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
14710658|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14710659|NCT00436059|Bortezomib|bortezomib|mesh-list
14710660|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710661|NCT00436072|Irinotecan|irinotecan|mesh-list
15209733|NCT05275569|Antiemetics|antiemetics|mesh-list
15209734|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
15209735|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209736|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209737|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209738|NCT05275010|Trastuzumab|trastuzumab|mesh-list
15209739|NCT05275010|Pertuzumab|pertuzumab|mesh-list
14867693|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14867694|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14867695|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14867696|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
15209740|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209741|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867697|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867698|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867699|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867700|NCT01118871|Ritonavir|ritonavir|mesh-list
14867701|NCT01118871|Darunavir|darunavir|mesh-list
14867702|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14867703|NCT01118871|Etravirine|etravirine|mesh-list
14867704|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14867705|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15209742|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
15209743|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
15209744|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209745|NCT05255653|Paclitaxel|paclitaxel|mesh-list
15209746|NCT05255653|Cisplatin|cisplatin|mesh-list
15209747|NCT05255653|Carboplatin|carboplatin|mesh-list
15209748|NCT05255653|Durvalumab|durvalumab|mesh-list
15209749|NCT05255653|Olaparib|olaparib|mesh-list
15209750|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15209751|NCT05255653|Megestrol|megestrol|mesh-list
15209752|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
15209753|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
15209754|NCT05255653|Progestins|progestins|mesh-list
15209755|NCT05255653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209756|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209757|NCT05255653|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209758|NCT05255653|Antimitotic Agents|antimitotic agents|mesh-ancestor
14867706|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867707|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867708|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867709|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15209759|NCT05255653|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209760|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209761|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209762|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15209763|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209764|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15209765|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14867710|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14867711|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
14867712|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867713|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14867714|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14867715|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14867716|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14867717|NCT01118884|Promethazine|promethazine|mesh-list
14867718|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
14867719|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
14867720|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867721|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14867722|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
14867723|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
14867724|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867725|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867726|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867727|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14867728|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14867729|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14867730|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867731|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
14867732|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
14867733|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
14867734|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867735|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
14867736|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
14867737|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867738|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14867739|NCT01118923|Antacids|antacids|mesh-ancestor
14867740|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867741|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867742|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14867743|NCT01118936|Antacids|antacids|mesh-ancestor
14867744|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867745|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209766|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15209767|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
15225100|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867746|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14867747|NCT01119014|Aripiprazole|aripiprazole|mesh-list
14867748|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
14867749|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867750|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14867751|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14710662|NCT00436072|Cetuximab|cetuximab|mesh-list
14867752|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867753|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867754|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
14867755|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
14867756|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867757|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867758|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14867759|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14867760|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
14867761|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14867762|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14867763|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14867764|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14867765|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
14867766|NCT01119066|Melphalan|melphalan|mesh-list
14867767|NCT01119066|Busulfan|busulfan|mesh-list
14867768|NCT01119066|Thiotepa|thiotepa|mesh-list
14867769|NCT01119066|Fludarabine|fludarabine|mesh-list
14867770|NCT01119066|Clofarabine|clofarabine|mesh-list
14867771|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710663|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14710664|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14710665|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710666|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710667|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710668|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710669|NCT00436124|Oseltamivir|oseltamivir|mesh-list
14710670|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
14710671|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710672|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710673|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710674|NCT00436241|Capecitabine|capecitabine|mesh-list
14710675|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
14710676|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710677|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
14710678|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710679|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710685|NCT00436267|Fluorouracil|fluorouracil|mesh-list
14710686|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
14710687|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710688|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710689|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710690|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710691|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
14710692|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710693|NCT00436293|Docetaxel|docetaxel|mesh-list
14710694|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710695|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
14710696|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209768|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15209769|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209770|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15209771|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15209772|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15209773|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209774|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
15209775|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15209776|NCT05255653|Hormones|hormones|mesh-ancestor
15209777|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209778|NCT05254847|Capecitabine|capecitabine|mesh-list
14710697|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710698|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710699|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
14710700|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14710701|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710702|NCT00436371|Amisulpride|amisulpride|mesh-list
14710703|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14710704|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14710705|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14710706|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710707|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14710708|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14710709|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
14710710|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710711|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710712|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14710713|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
14710714|NCT00436423|Gemcitabine|gemcitabine|mesh-list
14710715|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710716|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
14710717|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710718|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710719|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
14710720|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710721|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710722|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710723|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
14710724|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209779|NCT05254847|Lenvatinib|lenvatinib|mesh-list
15209780|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15209781|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
15209782|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209783|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209784|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209785|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209786|NCT05249725|Irsogladine|irsogladine|mesh-list
15209787|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
15209788|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209789|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15209790|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14867772|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
14867773|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867774|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867775|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14867776|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
14867777|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867778|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867779|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14867780|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14867781|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
14867782|NCT01119079|Anesthetics|anesthetics|mesh-list
14867783|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867784|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867785|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
14867786|NCT01119144|Calcium|calcium|mesh-list
15209791|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209792|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15209793|NCT05249725|Protective Agents|protective agents|mesh-ancestor
15209794|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867787|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14867788|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867789|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14867790|NCT01119157|Vaccines|vaccines|mesh-list
14867791|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
14867792|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913890|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913891|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14913892|NCT01377545|Anesthetics|anesthetics|mesh-list
14913893|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
14913894|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913895|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913896|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
14913897|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913898|NCT01377597|Ranibizumab|ranibizumab|mesh-list
14913899|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14913900|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14913901|NCT01377597|Growth Substances|growth substances|mesh-ancestor
14913902|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913903|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
14913904|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913905|NCT01377610|Naltrexone|naltrexone|mesh-list
14913906|NCT01377610|Buprenorphine|buprenorphine|mesh-list
14913907|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14913908|NCT01377610|Narcotics|narcotics|mesh-ancestor
14913909|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14913910|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913911|NCT01377610|Analgesics|analgesics|mesh-ancestor
14913912|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
14913913|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14913914|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14913915|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14913916|NCT01377961|Lycopene|lycopene|mesh-list
14913917|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913918|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
14913919|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913920|NCT01377961|Protective Agents|protective agents|mesh-ancestor
15209795|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14867793|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
14867794|NCT01119196|Icodextrin|icodextrin|mesh-list
14867795|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14867796|NCT01119209|Ropivacaine|ropivacaine|mesh-list
14867797|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
14867798|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
14867799|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867800|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209796|NCT05249725|Antacids|antacids|mesh-ancestor
15209797|NCT05249699|Isoniazid|isoniazid|mesh-list
15209798|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
15209799|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15209800|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867801|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
14867802|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867803|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14867804|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14867805|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14867806|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867807|NCT01119430|Fluoxetine|fluoxetine|mesh-list
14867808|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14867809|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14867810|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867811|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867812|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867813|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
14867814|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867815|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14867816|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
14867817|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867818|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14867819|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14867820|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867821|NCT01119482|Vaccines|vaccines|mesh-list
14867822|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
14867823|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867824|NCT01119521|Isoniazid|isoniazid|mesh-list
14867825|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
14867826|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14867827|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209801|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15209802|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15209803|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
15209804|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209805|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15209806|NCT05244213|Paclitaxel|paclitaxel|mesh-list
15209807|NCT05244213|Carboplatin|carboplatin|mesh-list
15209808|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209809|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209810|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
14867828|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14867829|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14867830|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
15209811|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209812|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209813|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209814|NCT05243745|Fluorides|fluorides|mesh-list
15209815|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
15209816|NCT05243745|Protective Agents|protective agents|mesh-ancestor
15209817|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209818|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
15209819|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15209820|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209821|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15209822|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15209823|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209824|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209825|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209826|NCT05207709|Paclitaxel|paclitaxel|mesh-list
15209827|NCT05207709|Letrozole|letrozole|mesh-list
15209828|NCT05207709|Fulvestrant|fulvestrant|mesh-list
15209829|NCT05207709|Palbociclib|palbociclib|mesh-list
14867831|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867832|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14867833|NCT01119534|Camphor|camphor|mesh-list
14867834|NCT01119534|Eucalyptol|eucalyptol|mesh-list
14867835|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
14867836|NCT01119534|Menthol|menthol|mesh-list
14867837|NCT01119534|Guaifenesin|guaifenesin|mesh-list
14867838|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14867839|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
14867840|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867841|NCT01119534|Expectorants|expectorants|mesh-ancestor
14867842|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
14867843|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14867844|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14867845|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
14867846|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867847|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867848|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867849|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
14867850|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14867851|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
14867852|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
15209830|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209831|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209832|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209833|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209834|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209835|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209836|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15209837|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15209838|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209839|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15209840|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
15209841|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209842|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209843|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209844|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15209845|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15209846|NCT05201248|Prednisone|prednisone|mesh-list
15209847|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
15209848|NCT05201248|Rituximab|rituximab|mesh-list
14867853|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867854|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
15209849|NCT05201248|Doxorubicin|doxorubicin|mesh-list
15209850|NCT05201248|Vincristine|vincristine|mesh-list
15209851|NCT05201248|Lenalidomide|lenalidomide|mesh-list
14867855|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14867856|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14867857|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867858|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
14867859|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
14867860|NCT01119534|Protective Agents|protective agents|mesh-ancestor
14867861|NCT01119599|Temozolomide|temozolomide|mesh-list
14867862|NCT01119599|R04929097|r04929097|mesh-list
14867863|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14867864|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
14867865|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867866|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867867|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867868|NCT01119638|Risperidone|risperidone|mesh-list
14867869|NCT01119638|Citalopram|citalopram|mesh-list
14867870|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14867871|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
14867872|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14867873|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867874|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867875|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14867876|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14867877|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867878|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14867879|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14867880|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
14710725|NCT00436527|Metronidazole|metronidazole|mesh-list
14710726|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710727|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14710728|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14710729|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14710730|NCT00436540|Clobetasol|clobetasol|mesh-list
14710731|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710732|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
14710733|NCT00436540|Hormones|hormones|mesh-ancestor
14710734|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209852|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15209853|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
15209854|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209855|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15209856|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15209857|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
15209858|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209859|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209860|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15209861|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209862|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15209863|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15209864|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15209865|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209866|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209867|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
15209868|NCT05201248|Hormones|hormones|mesh-ancestor
15209869|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209870|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209871|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209872|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209873|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209874|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209875|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15209876|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15209877|NCT05201248|Growth Substances|growth substances|mesh-ancestor
15209878|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
14710735|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710736|NCT00436579|Sorafenib|sorafenib|mesh-list
15209879|NCT05194995|Cetuximab|cetuximab|mesh-list
15209880|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710737|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710738|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14710739|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710740|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710741|NCT00436657|Cisplatin|cisplatin|mesh-list
14710742|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710743|NCT00436709|Paclitaxel|paclitaxel|mesh-list
14710744|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
14710745|NCT00436709|Bevacizumab|bevacizumab|mesh-list
14710746|NCT00436709|Doxorubicin|doxorubicin|mesh-list
14710747|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14867881|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14867882|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14867883|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867884|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14867885|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
14867886|NCT01119651|Tazarotene|tazarotene|mesh-list
14867887|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867888|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
14710748|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14710749|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14710750|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710751|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
14710752|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
14710753|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710754|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710755|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710756|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
14710757|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710758|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710759|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14867889|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
14867890|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14867891|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
14867892|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867893|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867894|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
14867895|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867896|NCT01119742|Butenafine|butenafine|mesh-list
14867897|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
14867898|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14867899|NCT01119885|Fentanyl|fentanyl|mesh-list
14867900|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14867901|NCT01119885|Narcotics|narcotics|mesh-ancestor
14867902|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14867903|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209881|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209882|NCT05194735|Aldesleukin|aldesleukin|mesh-list
15209883|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209884|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15209885|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15209886|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
15209887|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209888|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
14867904|NCT01119885|Analgesics|analgesics|mesh-ancestor
14867905|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
14867906|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867907|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14867908|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14867909|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
14867910|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
14867911|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
14867912|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867913|NCT01120106|Simendan|simendan|mesh-list
14867914|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14867915|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14867916|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14867917|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14867918|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867919|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867920|NCT01120106|Protective Agents|protective agents|mesh-ancestor
14867921|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867922|NCT01120119|Calcitriol|calcitriol|mesh-list
14867923|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14867924|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867925|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14867926|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867927|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867928|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15209889|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209890|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209891|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
15209892|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15209893|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
15209894|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209895|NCT05177848|Nicotine|nicotine|mesh-list
15209896|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15209897|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
15209898|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209899|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867929|NCT01120119|Vitamins|vitamins|mesh-ancestor
14867930|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
14867931|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14867932|NCT01120158|Paclitaxel|paclitaxel|mesh-list
14867933|NCT01120158|Bevacizumab|bevacizumab|mesh-list
14867934|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14867935|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867936|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
14867937|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
14867938|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209900|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15209901|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15209902|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
15209903|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209904|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209905|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15209906|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15209907|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15209908|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867939|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867940|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14867941|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14867942|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14867943|NCT01120158|Growth Substances|growth substances|mesh-ancestor
14867944|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867945|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
14867946|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
14867947|NCT01120171|Doxorubicin|doxorubicin|mesh-list
14867948|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14867949|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14867950|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
14867951|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867952|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867953|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14867954|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
14867955|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867956|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867957|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14867958|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14867959|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14867960|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14867961|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867962|NCT01120314|Otamixaban|otamixaban|mesh-list
14867963|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14867964|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
14867965|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14867966|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
14867967|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867968|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867969|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
14867970|NCT01120327|Amlodipine|amlodipine|mesh-list
14867971|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14867972|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14867973|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14867974|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867975|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14867976|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867977|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
14867978|NCT01120340|Mesalamine|mesalamine|mesh-list
14867979|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14867980|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14867981|NCT01120340|Analgesics|analgesics|mesh-ancestor
14867982|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
14867983|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14867984|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867985|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14867986|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14867987|NCT01120366|Methotrexate|methotrexate|mesh-list
14867988|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14867989|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
14867990|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14867991|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14867992|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14867993|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
14867994|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14867995|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14867996|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
14867997|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14867998|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15209909|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209910|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209911|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209912|NCT05115123|Analgesics|analgesics|mesh-ancestor
14867999|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868000|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
14868001|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14868002|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15209913|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
15209914|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209915|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
15209916|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15209917|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
14868003|NCT01120418|Besifloxacin|besifloxacin|mesh-list
14868004|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868005|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868006|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14868007|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15225101|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225102|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225704|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225705|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15225706|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710760|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
14710761|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14710762|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710763|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14710764|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14710765|NCT00436709|Growth Substances|growth substances|mesh-ancestor
14710766|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
14710767|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14710768|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15209918|NCT05077969|Celecoxib|celecoxib|mesh-list
15209919|NCT05077969|Famotidine|famotidine|mesh-list
15209920|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15209921|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15209922|NCT05077969|Analgesics|analgesics|mesh-ancestor
15209923|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
15209924|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209925|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209926|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209927|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710769|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15209928|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15209929|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15209930|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209931|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209932|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15209933|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15209934|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14868008|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868009|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868010|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868011|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14868012|NCT01120444|Insulin|insulin|mesh-list
15209935|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
15209936|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
15209937|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209938|NCT05055024|Mazindol|mazindol|mesh-list
15209939|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15209940|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209941|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14868013|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868014|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868015|NCT01120561|Trastuzumab|trastuzumab|mesh-list
14868016|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14868017|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15209942|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15209943|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15209944|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209945|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
15209946|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15209947|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15209948|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
15209949|NCT05031975|Irinotecan|irinotecan|mesh-list
15209950|NCT05031975|Temozolomide|temozolomide|mesh-list
15209951|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15209952|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15209953|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209954|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209955|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209956|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15209957|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
15209958|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
15209959|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
15209960|NCT05031897|Melphalan|melphalan|mesh-list
15209961|NCT05031897|Fludarabine|fludarabine|mesh-list
15209962|NCT05031897|Tacrolimus|tacrolimus|mesh-list
15209963|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15209964|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
15209965|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209966|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710770|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710771|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
14710772|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14710773|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
14710774|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710775|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710776|NCT00436761|Cyclosporine|cyclosporine|mesh-list
15209967|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14710777|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
15209968|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
14868018|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868019|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
14868020|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
14868021|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
14868022|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868023|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14868024|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14868025|NCT01120665|Estradiol|estradiol|mesh-list
14868026|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14868027|NCT01120665|Hormones|hormones|mesh-ancestor
14868028|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14868029|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868030|NCT01120665|Estrogens|estrogens|mesh-ancestor
14868031|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14868032|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
14868033|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14868034|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14868035|NCT01120769|Acetaminophen|acetaminophen|mesh-list
14868036|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14868037|NCT01120769|Analgesics|analgesics|mesh-ancestor
14868038|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
14868039|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868040|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868041|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
14868042|NCT01120795|Interferons|interferons|mesh-list
14868043|NCT01120795|Ribavirin|ribavirin|mesh-list
14868044|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14868045|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
14868046|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868047|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
14868048|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868049|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
14868050|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868051|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
14868052|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868053|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
14868054|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209969|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15209970|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209971|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14868055|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14868056|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868057|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868058|NCT01120912|Insulin|insulin|mesh-list
14868059|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868060|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868061|NCT01121016|Montelukast|montelukast|mesh-list
14868062|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14868063|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14868064|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14868065|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
14868066|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209972|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15209973|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15209974|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15209975|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15209976|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
15209977|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15209978|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15209979|NCT05023369|Dexamethasone|dexamethasone|mesh-list
15209980|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15209981|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
15209982|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
15209983|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209984|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15209985|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14868067|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868068|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14868069|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14868070|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868071|NCT01121042|Ondansetron|ondansetron|mesh-list
14868072|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
14868073|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
14868074|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15209986|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
15209987|NCT05023369|Hormones|hormones|mesh-ancestor
15209988|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15209989|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15209990|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209991|NCT05002127|Paclitaxel|paclitaxel|mesh-list
15209992|NCT05002127|Trastuzumab|trastuzumab|mesh-list
15209993|NCT05002127|Ramucirumab|ramucirumab|mesh-list
15209994|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15209995|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15209996|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
15209997|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
15209998|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
15209999|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210000|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210001|NCT04999969|Gemcitabine|gemcitabine|mesh-list
15210002|NCT04999969|Paclitaxel|paclitaxel|mesh-list
15210003|NCT04999969|Durvalumab|durvalumab|mesh-list
15210004|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210005|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210006|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210007|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210008|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210009|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210010|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15210011|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
15210012|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
15210013|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210014|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210015|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210016|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
15210017|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210018|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210019|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
15210020|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
15210021|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15210022|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15210023|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210024|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210025|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868075|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868076|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14868077|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
14868078|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14868079|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15210026|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210027|NCT04959812|Sufentanil|sufentanil|mesh-list
15210028|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15210029|NCT04959812|Narcotics|narcotics|mesh-ancestor
15210030|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210031|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210032|NCT04959812|Analgesics|analgesics|mesh-ancestor
15210033|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
15210034|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210035|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15210036|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15210037|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
15210038|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
15210039|NCT04952610|Etripamil|etripamil|mesh-list
15210040|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15210041|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15210042|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210043|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15210044|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210045|NCT04943848|Iodine|iodine|mesh-list
15210046|NCT04943848|Vaccines|vaccines|mesh-list
15210047|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
15210048|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210049|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15210050|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210051|NCT04943848|Trace Elements|trace elements|mesh-ancestor
15210052|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
15210053|NCT04941716|Venetoclax|venetoclax|mesh-list
15210054|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
15210055|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210056|NCT04928339|Bupivacaine|bupivacaine|mesh-list
15210057|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
15210058|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
15210059|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210060|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210061|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
15210062|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210063|NCT04923594|Mazindol|mazindol|mesh-list
14868080|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
14868081|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868082|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868083|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14868084|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14868085|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868086|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14868087|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14868088|NCT01121055|Lorazepam|lorazepam|mesh-list
14868089|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
14868090|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
14868091|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
14868092|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868093|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868094|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14868095|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14868096|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868097|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14868098|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14868099|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14868100|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
14868101|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
14868102|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868103|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913921|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913922|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14913923|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14913924|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913925|NCT01377974|Miltefosine|miltefosine|mesh-list
14913926|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14913927|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
14913928|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913929|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913930|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14913931|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14913932|NCT01378039|Budesonide|budesonide|mesh-list
14913933|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913934|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14913935|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
14913936|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210064|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15210065|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868104|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14868105|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14868106|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
14868107|NCT01121133|Rifampin|rifampin|mesh-list
14868108|NCT01121133|Navitoclax|navitoclax|mesh-list
14868109|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14868110|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
14868111|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868112|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868113|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
14868114|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15210066|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15210067|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15210068|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15210069|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210070|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
15210071|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210072|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15210073|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
15210074|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
15210075|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15210076|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15210077|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210078|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15210079|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210080|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15210081|NCT04909021|Vaccines|vaccines|mesh-list
15210082|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
15210083|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210084|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
14868115|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868116|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868117|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14868118|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14868119|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14868120|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15210085|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210086|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210087|NCT04892173|Cetuximab|cetuximab|mesh-list
15210088|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210089|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210090|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
15210091|NCT04862585|Promethazine|promethazine|mesh-list
15210092|NCT04862585|Dexamethasone|dexamethasone|mesh-list
15210093|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
15210094|NCT04862585|Paclitaxel|paclitaxel|mesh-list
15210095|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15210096|NCT04862585|Famotidine|famotidine|mesh-list
15210097|NCT04862585|Ranitidine|ranitidine|mesh-list
15210098|NCT04862585|Cimetidine|cimetidine|mesh-list
15210099|NCT04862585|BB 1101|bb 1101|mesh-list
15210100|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210101|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210102|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210103|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210104|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210105|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868121|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15210106|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210107|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
15210108|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
15210109|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210110|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210111|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15210112|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
15210113|NCT04862585|Hormones|hormones|mesh-ancestor
15210114|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15210115|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15210116|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
15210117|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210118|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15210119|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15210120|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210121|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
15210122|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
15210123|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
15210124|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14868122|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14868123|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868124|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
14868125|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14868126|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868127|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868128|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868129|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
14868130|NCT01121237|Hematinics|hematinics|mesh-ancestor
14868131|NCT01121276|Insulin|insulin|mesh-list
14868132|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14868133|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
14868134|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
14868135|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14868136|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868137|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868138|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
14868139|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868140|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868141|NCT01121354|Cefazolin|cefazolin|mesh-list
14868142|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868143|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868144|NCT01121458|Clevidipine|clevidipine|mesh-list
14868145|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14868146|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868147|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868148|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14868149|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868150|NCT01121497|Physostigmine|physostigmine|mesh-list
14868151|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14868152|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868153|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868154|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
14868155|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868156|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868157|NCT01121497|Miotics|miotics|mesh-ancestor
14868158|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
14868159|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868160|NCT01121588|Crizotinib|crizotinib|mesh-list
14868161|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868162|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210125|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
15210126|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
15210127|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210128|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15210129|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
15210130|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
15210131|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15210132|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15210133|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15210134|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15210135|NCT04847596|Ofatumumab|ofatumumab|mesh-list
15210136|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210137|NCT04844268|Vaccines|vaccines|mesh-list
15210138|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
15210139|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210140|NCT04818216|Niacinamide|niacinamide|mesh-list
15210141|NCT04818216|Niacin|niacin|mesh-list
15210142|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
15210143|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
15210144|NCT04818216|Vitamins|vitamins|mesh-ancestor
15210145|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
14868163|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868164|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868165|NCT01121705|Interferons|interferons|mesh-list
14868166|NCT01121705|Ribavirin|ribavirin|mesh-list
14868167|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
14868168|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
14868169|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14868170|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868171|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
14868172|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868173|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
14868174|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868175|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
14868176|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210146|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210147|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15210148|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
15210149|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868177|NCT01121731|Interferons|interferons|mesh-list
14868178|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
14868179|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868180|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
14868181|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868182|NCT01121744|Sirolimus|sirolimus|mesh-list
14868183|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868184|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868185|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14868186|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868187|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
14868188|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210150|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14868189|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
14868190|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868191|NCT01121770|PENTA|penta|mesh-list
14868192|NCT01121770|Fondaparinux|fondaparinux|mesh-list
14868193|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14868194|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
14868195|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14868196|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
14868197|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868198|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868199|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
14868200|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14868201|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14868202|NCT01121796|Vitamin D|vitamin d|mesh-list
14868203|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
14868204|NCT01121796|Vitamins|vitamins|mesh-list
14868205|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
14868206|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868207|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14868208|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14868209|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
14868210|NCT01121809|Etravirine|etravirine|mesh-list
14868211|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14868212|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14868213|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
14868214|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210151|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
15210152|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
15210153|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210154|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210155|NCT04808843|Dienogest|dienogest|mesh-list
15210156|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15210157|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
15210158|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15210159|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210160|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15210161|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15210162|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15210163|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15210164|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
14710778|NCT00436761|Melphalan|melphalan|mesh-list
14710779|NCT00436761|Busulfan|busulfan|mesh-list
14710780|NCT00436761|Cyclosporins|cyclosporins|mesh-list
14710781|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14710782|NCT00436761|Sargramostim|sargramostim|mesh-list
14710783|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710784|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710785|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710786|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
14710787|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710788|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
14710789|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710790|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14710791|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14710792|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14710793|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710794|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
14710795|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
14710796|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868215|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14868216|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14868217|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868218|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868219|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14868220|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14868221|NCT01121822|Vaccines|vaccines|mesh-list
14868222|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
14868223|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868224|NCT01121835|Insulin|insulin|mesh-list
14868225|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14868226|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
14868227|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
14868228|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868229|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868230|NCT01121848|Leucovorin|leucovorin|mesh-list
14868231|NCT01121848|Fluorouracil|fluorouracil|mesh-list
14868232|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
14868233|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
14868234|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868235|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14868236|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710797|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710798|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
14868237|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868238|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
14710799|NCT00436761|Hormones|hormones|mesh-ancestor
15210165|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15210166|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15210167|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210168|NCT04802759|Trastuzumab|trastuzumab|mesh-list
15210169|NCT04802759|Pertuzumab|pertuzumab|mesh-list
15210170|NCT04802759|Everolimus|everolimus|mesh-list
15210171|NCT04802759|Palbociclib|palbociclib|mesh-list
15210172|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210173|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210174|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710800|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710801|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14710802|NCT00436761|Protective Agents|protective agents|mesh-ancestor
14710803|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868239|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868240|NCT01121848|Antidotes|antidotes|mesh-ancestor
14868241|NCT01121848|Protective Agents|protective agents|mesh-ancestor
14868242|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
14868243|NCT01121848|Vitamins|vitamins|mesh-ancestor
14868244|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
14868245|NCT01122004|Pregabalin|pregabalin|mesh-list
14868246|NCT01122004|Analgesics|analgesics|mesh-ancestor
14868247|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
14868248|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868249|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868250|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
14868251|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14868252|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868253|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868254|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14868255|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14868256|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14868257|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868258|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14868259|NCT01122056|Interferons|interferons|mesh-list
14868260|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
15210175|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
14868261|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868262|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
14868263|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868264|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14868265|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
14868266|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868267|NCT01122121|Leuprolide|leuprolide|mesh-list
14868268|NCT01122121|Flutamide|flutamide|mesh-list
14868269|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14868270|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
14868271|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14868272|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868273|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14868274|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868275|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
14868276|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
14868277|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14868278|NCT01122134|Artesunate|artesunate|mesh-list
14868279|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
14868280|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14868281|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14868282|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868283|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868284|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
14868285|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
14868286|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14868287|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
14868288|NCT01122199|Everolimus|everolimus|mesh-list
14868289|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868290|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868291|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
14868292|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868293|NCT01122251|Valsartan|valsartan|mesh-list
14868294|NCT01122251|Lercanidipine|lercanidipine|mesh-list
14868295|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14868296|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14868297|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14868298|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868299|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14868300|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868301|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14868302|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868303|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
14868304|NCT01122342|Testosterone|testosterone|mesh-list
14868305|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
14868306|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
14868307|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14868308|NCT01122342|Androgens|androgens|mesh-ancestor
14868309|NCT01122342|Hormones|hormones|mesh-ancestor
14868310|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14868311|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868312|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14868313|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868314|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
14868315|NCT01122368|Micafungin|micafungin|mesh-list
14868316|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
14868317|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868318|NCT01122407|Trimethaphan|trimethaphan|mesh-list
14868319|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
14868320|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868321|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14868322|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14868323|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14868324|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
14868325|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868326|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868327|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14868328|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14868329|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
14868330|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868331|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
14868332|NCT01122472|Lenalidomide|lenalidomide|mesh-list
14868333|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
14868334|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868335|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14868336|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14868337|NCT01122472|Growth Substances|growth substances|mesh-ancestor
14868338|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
14868339|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710804|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14710805|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
14710806|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14710807|NCT00436787|PENTA|penta|mesh-list
14710808|NCT00436787|Fondaparinux|fondaparinux|mesh-list
14710809|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14710810|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
14710811|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14868340|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
14868341|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14868342|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14868343|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
14868344|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868345|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868346|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868347|NCT01122563|Urological Agents|urological agents|mesh-ancestor
14868348|NCT01122602|Aspirin|aspirin|mesh-list
14868349|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14868350|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14868351|NCT01122602|Analgesics|analgesics|mesh-ancestor
14868352|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
14868353|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868354|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868355|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14868356|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210176|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210177|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210178|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868357|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14868358|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14868359|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710812|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
14710813|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710814|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710815|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
14710816|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14710817|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14710818|NCT00436800|Gemcitabine|gemcitabine|mesh-list
14710819|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
14710820|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710821|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
14710822|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710823|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710824|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
14710825|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710826|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710827|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868360|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15210179|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225103|NCT05193318|Ketamine|ketamine|mesh-list
15225104|NCT05193318|Analgesics|analgesics|mesh-ancestor
15225105|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
15225106|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868361|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14868362|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868363|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
15210180|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
14710828|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
14710829|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710830|NCT00436826|Interferons|interferons|mesh-list
14710831|NCT00436826|Interferon-beta|interferon-beta|mesh-list
14710832|NCT00436826|Cladribine|cladribine|mesh-list
14710833|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
14710834|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710835|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
14710836|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710837|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
14710838|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710839|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210181|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210182|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210183|NCT04788667|Erenumab|erenumab|mesh-list
15210184|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
15210185|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15210186|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15210187|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210188|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
15210189|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868364|NCT01122615|Sirolimus|sirolimus|mesh-list
14868365|NCT01122615|Sunitinib|sunitinib|mesh-list
14868366|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868367|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14868368|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14868369|NCT01122615|Growth Substances|growth substances|mesh-ancestor
14868370|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868371|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
14868372|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14868373|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868374|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868375|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868376|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14710840|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14710841|NCT00436839|Prednisone|prednisone|mesh-list
14710842|NCT00436839|Docetaxel|docetaxel|mesh-list
14710843|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
14710844|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710845|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
14710846|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
14710847|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
14710848|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710849|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710850|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
14868377|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14868378|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
14868379|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868380|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
14868381|NCT01122641|Vildagliptin|vildagliptin|mesh-list
14868382|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868383|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868384|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14868385|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
14868386|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868387|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868388|NCT01122667|Anacetrapib|anacetrapib|mesh-list
14868389|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14868390|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14868391|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
14868392|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868393|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14868394|NCT01122771|Amphotericin B|amphotericin b|mesh-list
14868395|NCT01122771|Paromomycin|paromomycin|mesh-list
14868396|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14868397|NCT01122771|Miltefosine|miltefosine|mesh-list
14868398|NCT01122771|Amebicides|amebicides|mesh-ancestor
14868399|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14868400|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14868401|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868402|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868403|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
14868404|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913937|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710851|NCT00436839|Hormones|hormones|mesh-ancestor
14710852|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913938|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14868405|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14868406|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14868407|NCT01122940|Phenytoin|phenytoin|mesh-list
14868408|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
14868409|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15210190|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210191|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15210192|NCT04788667|Analgesics|analgesics|mesh-ancestor
15210193|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
15210194|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210195|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15210196|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15210197|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210198|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
15210199|NCT04776499|Perphenazine|perphenazine|mesh-list
14868410|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14868411|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868412|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868413|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14868414|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15210200|NCT04776499|Riociguat|riociguat|mesh-list
15210201|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
15210202|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
15210203|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868415|NCT01122953|Phenytoin|phenytoin|mesh-list
14868416|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
14868417|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14868418|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14868419|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868420|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210204|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15210205|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15210206|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210207|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210208|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15210209|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15210210|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
14868421|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14868422|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14868423|NCT01122966|Bevacizumab|bevacizumab|mesh-list
14868424|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14868425|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868426|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14868427|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14868428|NCT01122966|Growth Substances|growth substances|mesh-ancestor
14868429|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868430|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
14868431|NCT01122979|Insulin|insulin|mesh-list
14868432|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14868433|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
14868434|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
14868435|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
14868436|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
14868437|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
14868438|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15210211|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868439|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868440|NCT01123031|Esomeprazole|esomeprazole|mesh-list
15210212|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
15210213|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
14868441|NCT01123031|Lansoprazole|lansoprazole|mesh-list
14868442|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
14868443|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14868444|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15210214|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
15210215|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15210216|NCT04767711|Prednisolone|prednisolone|mesh-list
15210217|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210218|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
15210219|NCT04767711|Hormones|hormones|mesh-ancestor
15210220|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15210221|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210222|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15210223|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210224|NCT04756427|Citric Acid|citric acid|mesh-list
15210225|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
15210226|NCT04756427|Anticoagulants|anticoagulants|mesh-list
15210227|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15210228|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
15210229|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
15210230|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210231|NCT04753749|Aspirin|aspirin|mesh-list
15210232|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15210233|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15210234|NCT04753749|Analgesics|analgesics|mesh-ancestor
15210235|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
15210236|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210237|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210238|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210239|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210240|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15210241|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15210242|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210243|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15210244|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15210245|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210246|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
15210247|NCT04753372|Aspirin|aspirin|mesh-list
14728730|NCT00519870|Nifedipine|nifedipine|mesh-list
14728731|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14728732|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14728733|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14728734|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14728735|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728736|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14728737|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728738|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14728739|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710853|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710854|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14710855|NCT00436839|Analgesics|analgesics|mesh-ancestor
14710856|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
14710857|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710858|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15210248|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
15210249|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15210250|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
15210251|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15210252|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
15210253|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210254|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210255|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
15210256|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15210257|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15210258|NCT04753372|Analgesics|analgesics|mesh-ancestor
15210259|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
15210260|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210261|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210262|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210263|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210264|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15210265|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15210266|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15210267|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14868445|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14868446|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868447|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868448|NCT01123057|Riboflavin|riboflavin|mesh-list
14868449|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
14868450|NCT01123057|Vitamins|vitamins|mesh-ancestor
14868451|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
14868452|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868453|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14868454|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14868455|NCT01123265|Methotrexate|methotrexate|mesh-list
14868456|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14710859|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14710860|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710861|NCT00436930|Sargramostim|sargramostim|mesh-list
14868457|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
14868458|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15210268|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
14868459|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868460|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14868461|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
14868462|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868463|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868464|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
14868465|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868466|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14868467|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868468|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
14868469|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14868470|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14868471|NCT01123278|Testosterone|testosterone|mesh-list
14868472|NCT01123278|Androgens|androgens|mesh-ancestor
14868473|NCT01123278|Hormones|hormones|mesh-ancestor
14868474|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14868475|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868476|NCT01123317|Oxytocin|oxytocin|mesh-list
14868477|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
14868478|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15210269|NCT04747496|Edoxaban|edoxaban|mesh-list
15210270|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15210271|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
15210272|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15210273|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
15210274|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210275|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210276|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
15210277|NCT04741386|Vaccines|vaccines|mesh-list
15210278|NCT04741386|Immunologic Factors|immunologic factors|mesh-ancestor
15210279|NCT04741386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210280|NCT04733534|Dasatinib|dasatinib|mesh-list
15210281|NCT04733534|Quercetin|quercetin|mesh-list
15210282|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210283|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210284|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210285|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210286|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
15210287|NCT04733534|Protective Agents|protective agents|mesh-ancestor
15210288|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210289|NCT04733118|Trastuzumab|trastuzumab|mesh-list
15210290|NCT04733118|Pertuzumab|pertuzumab|mesh-list
15210291|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210292|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210293|NCT04732910|Ivacaftor|ivacaftor|mesh-list
15210294|NCT04732910|Elexacaftor|elexacaftor|mesh-list
15210295|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14868479|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868480|NCT01123408|Haloperidol|haloperidol|mesh-list
14868481|NCT01123408|Olanzapine|olanzapine|mesh-list
14868482|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
14868483|NCT01123408|Clozapine|clozapine|mesh-list
14868484|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
15210296|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15210297|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210298|NCT04721977|Capecitabine|capecitabine|mesh-list
14868485|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
14868486|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868487|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868488|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14868489|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14868490|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14868491|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210299|NCT04721977|Trastuzumab|trastuzumab|mesh-list
15210300|NCT04721977|Tucatinib|tucatinib|mesh-list
15210301|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15210302|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
15210303|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210304|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210305|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210306|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210307|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210308|NCT04712097|Rituximab|rituximab|mesh-list
14710862|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
14296148|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14710863|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710864|NCT00436943|Bupropion|bupropion|mesh-list
14710865|NCT00436943|Nicotine|nicotine|mesh-list
14710866|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14710867|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
14710868|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710869|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710870|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14710871|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14296149|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296150|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14710872|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
14710873|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710874|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710875|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14868492|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15210309|NCT04712097|Lenalidomide|lenalidomide|mesh-list
14710876|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
14710877|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14868493|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14868494|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14868495|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868496|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868497|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868498|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
14868499|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14868500|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
14868501|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14868502|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14868503|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
14868504|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
14868505|NCT01123473|Fluorouracil|fluorouracil|mesh-list
14868506|NCT01123473|Capecitabine|capecitabine|mesh-list
14868507|NCT01123473|Epirubicin|epirubicin|mesh-list
14868508|NCT01123473|Lapatinib|lapatinib|mesh-list
14868509|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868510|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
14868511|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868512|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14710878|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14710879|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14710880|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14710881|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
14710882|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14710883|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14710884|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710885|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
14710886|NCT00436995|Hematinics|hematinics|mesh-ancestor
14710887|NCT00437008|Benphothiamine|benphothiamine|mesh-list
14710888|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14710889|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
14710890|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868513|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868514|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
14710891|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
14710892|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
14710893|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710894|NCT00437086|Bortezomib|bortezomib|mesh-list
14710895|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710896|NCT00437164|Insulin|insulin|mesh-list
14710897|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15210310|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210311|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210312|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
15210313|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210314|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210315|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210316|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15210317|NCT04712097|Growth Substances|growth substances|mesh-ancestor
14710898|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14710899|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868515|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868516|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14868517|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14296151|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14710900|NCT00437177|Apomorphine|apomorphine|mesh-list
14710901|NCT00437177|Emetics|emetics|mesh-ancestor
15210318|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210319|NCT04703920|Talazoparib|talazoparib|mesh-list
15210320|NCT04703920|Belinostat|belinostat|mesh-list
15210321|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15210322|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210323|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210324|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210325|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15210326|NCT04698031|Aspirin|aspirin|mesh-list
15210327|NCT04698031|Clopidogrel|clopidogrel|mesh-list
15210328|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15210329|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15210330|NCT04698031|Analgesics|analgesics|mesh-ancestor
15210331|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
15210332|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210333|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210334|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210335|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210336|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15210337|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15210338|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210339|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15210340|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15210341|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210342|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
15210343|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15210344|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15210345|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15210346|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
15210347|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710902|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710903|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
14710904|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14710905|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15210348|NCT04689347|Leucovorin|leucovorin|mesh-list
15210349|NCT04689347|Bevacizumab|bevacizumab|mesh-list
15210350|NCT04689347|Fluorouracil|fluorouracil|mesh-list
15210351|NCT04689347|Irinotecan|irinotecan|mesh-list
15210352|NCT04689347|Temozolomide|temozolomide|mesh-list
14868518|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14868519|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868520|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14868521|NCT01123486|Hydromorphone|hydromorphone|mesh-list
14868522|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14868523|NCT01123486|Narcotics|narcotics|mesh-ancestor
14868524|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868525|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210353|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210354|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710906|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
14710907|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
14710908|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868526|NCT01123486|Analgesics|analgesics|mesh-ancestor
14868527|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
14868528|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868529|NCT01123525|Adenosine|adenosine|mesh-list
15210355|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210356|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15210357|NCT04689347|Growth Substances|growth substances|mesh-ancestor
14868530|NCT01123525|Analgesics|analgesics|mesh-ancestor
14868531|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
14868532|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868533|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868534|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14868535|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
14868536|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15210358|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210359|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210360|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
15210361|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210362|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15210363|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210364|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
15210365|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15210366|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15210367|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210368|NCT04689347|Antidotes|antidotes|mesh-ancestor
14868537|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
14868538|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
14868539|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868540|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868541|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
14868542|NCT01123538|Progesterone|progesterone|mesh-list
14868543|NCT01123538|Progestins|progestins|mesh-ancestor
14868544|NCT01123538|Hormones|hormones|mesh-ancestor
15210369|NCT04689347|Protective Agents|protective agents|mesh-ancestor
15210370|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
15210371|NCT04689347|Vitamins|vitamins|mesh-ancestor
15210372|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
15210373|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15210374|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
15210375|NCT04678479|Ganaxolone|ganaxolone|mesh-list
15210376|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
15210377|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210378|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210379|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210380|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
15210381|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
14868545|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14868546|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868547|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
14868548|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
14868549|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14868550|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14868551|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14868552|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
14868553|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14868554|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14868555|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15210382|NCT04672291|Poly I-C|poly i-c|mesh-list
15210383|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14868556|NCT01123551|Morphine|morphine|mesh-list
14868557|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14868558|NCT01123551|Narcotics|narcotics|mesh-ancestor
14868559|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868560|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868561|NCT01123551|Analgesics|analgesics|mesh-ancestor
14868562|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
14868563|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868564|NCT01123564|Ranibizumab|ranibizumab|mesh-list
14868565|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14868566|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14868567|NCT01123564|Growth Substances|growth substances|mesh-ancestor
15210384|NCT04672291|Poly ICLC|poly iclc|mesh-list
15210385|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
14868568|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868569|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
14868570|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868571|NCT01123811|Cetuximab|cetuximab|mesh-list
14868572|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14868573|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868574|NCT01123824|Clopidogrel|clopidogrel|mesh-list
15210386|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
15210387|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210388|NCT04672291|Laxatives|laxatives|mesh-ancestor
15210389|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15210390|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
15210391|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210392|NCT04663750|Aflibercept|aflibercept|mesh-list
15210393|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15210394|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210395|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15210396|NCT04663750|Growth Substances|growth substances|mesh-ancestor
15210397|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210398|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210399|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210400|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15210401|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15210402|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210403|NCT04660812|Bevacizumab|bevacizumab|mesh-list
14710909|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710910|NCT00437216|Clobetasol|clobetasol|mesh-list
14868575|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14868576|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14868577|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14868578|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14868579|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
14868580|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868581|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868582|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868583|NCT01123876|Veliparib|veliparib|mesh-list
14868584|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14868585|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710911|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710912|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
14710913|NCT00437216|Hormones|hormones|mesh-ancestor
14710914|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710915|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710916|NCT00437229|Dexamethasone|dexamethasone|mesh-list
14710917|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
14710918|NCT00437229|Ondansetron|ondansetron|mesh-list
14710919|NCT00437229|Casopitant|casopitant|mesh-list
14710920|NCT00437229|BB 1101|bb 1101|mesh-list
14710921|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710922|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
14710923|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
14710924|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868586|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868587|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868588|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14868589|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15210404|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14710925|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710926|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14710927|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
14710928|NCT00437229|Hormones|hormones|mesh-ancestor
15210405|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210406|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210407|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15210408|NCT04660812|Growth Substances|growth substances|mesh-ancestor
15210409|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210410|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210411|NCT04623684|Phenylephrine|phenylephrine|mesh-list
15210412|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
15210413|NCT04623684|Tropicamide|tropicamide|mesh-list
15210414|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15210415|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
14710929|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15210416|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
15210417|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210418|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210419|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
15210420|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15210421|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
15210422|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
15210423|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15210424|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15210425|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14868590|NCT01123915|Protective Agents|protective agents|mesh-ancestor
14868591|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868592|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14868593|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
14868594|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868595|NCT01123967|Nicotine|nicotine|mesh-list
14868596|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14868597|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
14868598|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210426|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
15210427|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210428|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210429|NCT04623684|Protective Agents|protective agents|mesh-ancestor
15210430|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15210431|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15210432|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
15210433|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14710930|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14710931|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710932|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
14710933|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710934|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710935|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
14710936|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
15210434|NCT04616196|Cetuximab|cetuximab|mesh-list
15210435|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210436|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210437|NCT04603807|Crizotinib|crizotinib|mesh-list
15210438|NCT04603807|Entrectinib|entrectinib|mesh-list
15210439|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210440|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210441|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210442|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210443|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
15210444|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15210445|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210446|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15210447|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210448|NCT04589845|Trastuzumab|trastuzumab|mesh-list
15210449|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15210450|NCT04589845|Atezolizumab|atezolizumab|mesh-list
15210451|NCT04589845|Maytansine|maytansine|mesh-list
15210452|NCT04589845|Pralsetinib|pralsetinib|mesh-list
15210453|NCT04589845|Entrectinib|entrectinib|mesh-list
15210454|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210455|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210456|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210457|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210458|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210459|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210460|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210461|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210462|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210463|NCT04578652|Metformin|metformin|mesh-list
15210464|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15210465|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210466|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15210467|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
15210468|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14710937|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14710938|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
15210469|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
15210470|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210471|NCT04550494|Talazoparib|talazoparib|mesh-list
15210472|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15210473|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210474|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868599|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868600|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14868601|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14868602|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14868603|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210475|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710939|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14710940|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14710941|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15210476|NCT04546581|Remdesivir|remdesivir|mesh-list
15210477|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
15210478|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14868604|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868605|NCT01124032|Methylphenidate|methylphenidate|mesh-list
14868606|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14868607|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868608|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14868609|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14868610|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868611|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868612|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
14868613|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868614|NCT01124058|Heparin|heparin|mesh-list
14868615|NCT01124058|Calcium heparin|calcium heparin|mesh-list
14868616|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14868617|NCT01124058|Tinzaparin|tinzaparin|mesh-list
14868618|NCT01124058|Dalteparin|dalteparin|mesh-list
14868619|NCT01124058|Warfarin|warfarin|mesh-list
14868620|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
14868621|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14868622|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14868623|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868624|NCT01124227|Icodextrin|icodextrin|mesh-list
14868625|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
14868626|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14868627|NCT01124240|Temozolomide|temozolomide|mesh-list
14868628|NCT01124240|Procarbazine|procarbazine|mesh-list
14868629|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14868630|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
15210479|NCT04546581|Antibodies|antibodies|mesh-list
14710942|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14710943|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14710944|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14710945|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14710946|NCT00437255|Betamethasone|betamethasone|mesh-list
14868631|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868632|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868633|NCT01124253|Endostatins|endostatins|mesh-list
14868634|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14868635|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14868636|NCT01124253|Growth Substances|growth substances|mesh-ancestor
14868637|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868638|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
14868639|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868640|NCT01124318|Lactulose|lactulose|mesh-list
14868641|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14868642|NCT01124383|Lidocaine|lidocaine|mesh-list
15210480|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
15210481|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210482|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
15210483|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210484|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
15210485|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210486|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
15210487|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
15210488|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
15210489|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15210490|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210491|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
14868643|NCT01124383|Ephedrine|ephedrine|mesh-list
14868644|NCT01124383|Midazolam|midazolam|mesh-list
14868645|NCT01124383|Sufentanil|sufentanil|mesh-list
14868646|NCT01124383|Dsuvia|dsuvia|mesh-list
14868647|NCT01124383|Anesthetics|anesthetics|mesh-list
14868648|NCT01124383|Propofol|propofol|mesh-list
14868649|NCT01124383|Sevoflurane|sevoflurane|mesh-list
14868650|NCT01124383|Rocuronium|rocuronium|mesh-list
14868651|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
14868652|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868653|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868654|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
14868655|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868656|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14868657|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14868658|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14868659|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868660|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868661|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14868662|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14868663|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
14868664|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14868665|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14868666|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14868667|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14868668|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
14868669|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
14868670|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868671|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15210492|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
15210493|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210494|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210495|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15210496|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
14710947|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
14710948|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14710949|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
14710950|NCT00437255|Clobetasol|clobetasol|mesh-list
14710951|NCT00437255|Calcipotriene|calcipotriene|mesh-list
14710952|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14710953|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14710954|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
14710955|NCT00437255|Hormones|hormones|mesh-ancestor
14710956|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710957|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710958|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14710959|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
14710960|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728740|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
14728741|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
14728742|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14728743|NCT00519909|Calcium|calcium|mesh-list
14868672|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14868673|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15210497|NCT04544436|Hormones|hormones|mesh-ancestor
15210498|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15210499|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15210500|NCT04544436|Protective Agents|protective agents|mesh-ancestor
15210501|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
15210502|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
15210503|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210504|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710961|NCT00437307|Topotecan|topotecan|mesh-list
14710962|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14710963|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14868674|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14868675|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14868676|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14868677|NCT01124383|Narcotics|narcotics|mesh-ancestor
14868678|NCT01124383|Analgesics|analgesics|mesh-ancestor
14868679|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14868680|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
14868681|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
14868682|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14868683|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
14868684|NCT01124435|Celecoxib|celecoxib|mesh-list
14868685|NCT01124435|Carboplatin|carboplatin|mesh-list
14868686|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868687|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14868688|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14868689|NCT01124435|Analgesics|analgesics|mesh-ancestor
14868690|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
14868691|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868692|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868693|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14868694|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14868695|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14868696|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14868697|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868698|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868699|NCT01124487|Insulin|insulin|mesh-list
14868700|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868701|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868702|NCT01124500|Methylphenidate|methylphenidate|mesh-list
14868703|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14868704|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868705|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14868706|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14868707|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868708|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868709|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
14868710|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868711|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
14868712|NCT01124526|Rituximab|rituximab|mesh-list
14868713|NCT01124526|Fludarabine|fludarabine|mesh-list
14868714|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210505|NCT04511702|Methotrexate|methotrexate|mesh-list
14710964|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710965|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710966|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710967|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14710968|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14710969|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
14710970|NCT00437333|Metformin|metformin|mesh-list
14710971|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868715|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
14868716|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868717|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14868718|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14710972|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710973|NCT00437359|Toremifene|toremifene|mesh-list
14710974|NCT00437359|Anastrozole|anastrozole|mesh-list
14868719|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
14868720|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868721|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868722|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14868723|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14868724|NCT01124539|Camptothecin|camptothecin|mesh-list
14868725|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
14296152|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14296153|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296154|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
14296155|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296156|NCT00586196|Donepezil|donepezil|mesh-list
14710975|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710976|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14710977|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710978|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14710979|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14710980|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710981|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14710982|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
14710983|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14710984|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868726|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14868727|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868728|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14868729|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14868730|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868731|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210506|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15210507|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
15210508|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15210509|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210510|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15210511|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
15210512|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210513|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210514|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
15210515|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868732|NCT01124630|Leucovorin|leucovorin|mesh-list
14868733|NCT01124630|Fluorouracil|fluorouracil|mesh-list
14868734|NCT01124630|Irinotecan|irinotecan|mesh-list
14868735|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
14868736|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868737|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14868738|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868739|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868740|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
14868741|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210516|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15210517|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210518|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
15210519|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210520|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15210521|NCT04499248|Bimatoprost|bimatoprost|mesh-list
15210522|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15210523|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15210524|NCT04466475|Melphalan|melphalan|mesh-list
15210525|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
15210526|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15210527|NCT04466475|Daratumumab|daratumumab|mesh-list
15210528|NCT04466475|Antibodies|antibodies|mesh-list
15210529|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
15210530|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15210531|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
15210532|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210533|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710985|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14710986|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14710987|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14710988|NCT00437372|Sunitinib|sunitinib|mesh-list
14710989|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14710990|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14710991|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14710992|NCT00437372|Growth Substances|growth substances|mesh-ancestor
14710993|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14710994|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
14710995|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14710996|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14710997|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14710998|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
14710999|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
14711000|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711001|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711002|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711003|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
15210534|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15210535|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
15210536|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868742|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14868743|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14868744|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868745|NCT01124630|Antidotes|antidotes|mesh-ancestor
14868746|NCT01124630|Protective Agents|protective agents|mesh-ancestor
14868747|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
14868748|NCT01124630|Vitamins|vitamins|mesh-ancestor
14868749|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
14711004|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14711005|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711006|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868750|NCT01124656|Pioglitazone|pioglitazone|mesh-list
14868751|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14868752|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15210537|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15210538|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225107|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225108|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15225109|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15225110|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
15225111|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
15225112|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225113|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15225114|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15225115|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225116|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225117|NCT05193292|Trastuzumab|trastuzumab|mesh-list
15225118|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225119|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225120|NCT05193227|Lidocaine|lidocaine|mesh-list
14711007|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
14711008|NCT00437450|Hematinics|hematinics|mesh-ancestor
14711009|NCT00437463|Ramipril|ramipril|mesh-list
14711010|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14868753|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868754|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14868755|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14868756|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868757|NCT01124695|Tamoxifen|tamoxifen|mesh-list
14868758|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14868759|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
14868760|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14868761|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868762|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14868763|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868764|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14711011|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
14711012|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711013|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711014|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14711015|NCT00437476|Ribavirin|ribavirin|mesh-list
14711016|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14711017|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14711018|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
14711019|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711020|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
14711021|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868765|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14868766|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14913939|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14711022|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14711023|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868767|NCT01124760|Ketoconazole|ketoconazole|mesh-list
14868768|NCT01124760|Diltiazem|diltiazem|mesh-list
14868769|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
14868770|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210539|NCT04421378|Bevacizumab|bevacizumab|mesh-list
15210540|NCT04421378|Temozolomide|temozolomide|mesh-list
15210541|NCT04421378|Carmustine|carmustine|mesh-list
15210542|NCT04421378|Lomustine|lomustine|mesh-list
15210543|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210544|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210545|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14711024|NCT00437502|Vaccines|vaccines|mesh-list
14711025|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
14711026|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711027|NCT00437554|Glimepiride|glimepiride|mesh-list
14711028|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14711029|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14711030|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711031|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210546|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15210547|NCT04421378|Growth Substances|growth substances|mesh-ancestor
15210548|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210549|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210550|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15210551|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
15210552|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210553|NCT04410445|Nivolumab|nivolumab|mesh-list
15210554|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210555|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210556|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15210557|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210558|NCT04401384|Pyridoxine|pyridoxine|mesh-list
15210559|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
14868771|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14868772|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14868773|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868774|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868775|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14868776|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
14711032|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
14711033|NCT00437606|Ethanol|ethanol|mesh-list
14711034|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14711035|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711036|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711037|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711038|NCT00437619|Calcipotriene|calcipotriene|mesh-list
14711039|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
15210560|NCT04401384|Doxylamine|doxylamine|mesh-list
15210561|NCT04401384|Dicyclomine|dicyclomine|mesh-list
15210562|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
14711040|NCT00437632|Caffeine|caffeine|mesh-list
14711041|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14711042|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711043|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14711044|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210563|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
15210564|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210565|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210566|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15210567|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15210568|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
15210569|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
14711045|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868777|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913940|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
14711046|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15210570|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225121|NCT05193227|Bupivacaine|bupivacaine|mesh-list
14711047|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14711048|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
14711049|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711050|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
14711051|NCT00437671|Antibodies|antibodies|mesh-list
14711052|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
14711053|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14711054|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14711055|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
14711056|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711057|NCT00437684|Ribavirin|ribavirin|mesh-list
14711058|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14711059|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
14711060|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711061|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
14711062|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711063|NCT00437697|Dalteparin|dalteparin|mesh-list
14711064|NCT00437697|Tinzaparin|tinzaparin|mesh-list
14711065|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14711066|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
14711067|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14296157|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14296158|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711068|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14711069|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711070|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
14711071|NCT00437723|Hematinics|hematinics|mesh-ancestor
14711072|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
14711073|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14711074|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14711075|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14711076|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14711077|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711078|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
14711079|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711080|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711081|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14711082|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711083|NCT00437814|Ketamine|ketamine|mesh-list
14711084|NCT00437814|Analgesics|analgesics|mesh-ancestor
14868778|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868779|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14711085|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
14711086|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711087|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868780|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14868781|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14868782|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868783|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14868784|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
14868785|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
14868786|NCT01124799|Simeprevir|simeprevir|mesh-list
14868787|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868788|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868789|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15210571|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210572|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
15210573|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15210574|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15210575|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
15210576|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
15210577|NCT04401384|Vitamins|vitamins|mesh-ancestor
15210578|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
15210579|NCT04329065|Paclitaxel|paclitaxel|mesh-list
15210580|NCT04329065|Trastuzumab|trastuzumab|mesh-list
15210581|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15210582|NCT04329065|Pertuzumab|pertuzumab|mesh-list
15210583|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15210584|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14711088|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15210585|NCT04329065|Vaccines|vaccines|mesh-list
14868790|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15210586|NCT04329065|Antibodies|antibodies|mesh-list
15210587|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
15210588|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15210589|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
14868791|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868792|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868793|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868794|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14868795|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14868796|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
14868797|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
14868798|NCT01124877|Ziprasidone|ziprasidone|mesh-list
14868799|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14868800|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
14868801|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868802|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868803|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868804|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15210590|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
15210591|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711089|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14711090|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
14868805|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14868806|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711091|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
14711092|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210592|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210593|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210594|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210595|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210596|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210597|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210598|NCT04303858|Atezolizumab|atezolizumab|mesh-list
14296159|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868807|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14868808|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14868809|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
15210599|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210600|NCT04276493|Docetaxel|docetaxel|mesh-list
15210601|NCT04276493|Capecitabine|capecitabine|mesh-list
15210602|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
15210603|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210604|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210605|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210606|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210607|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210608|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15210609|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
15210610|NCT04239222|Ibuprofen|ibuprofen|mesh-list
15210611|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15210612|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15210613|NCT04239222|Analgesics|analgesics|mesh-ancestor
14711093|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14711094|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14711095|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711096|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711097|NCT00437853|Anastrozole|anastrozole|mesh-list
14711098|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711099|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210614|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
15210615|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868810|NCT01125020|Gemcitabine|gemcitabine|mesh-list
14868811|NCT01125020|Doxorubicin|doxorubicin|mesh-list
14868812|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
14868813|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868814|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15210616|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210617|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210618|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210619|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15210620|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210621|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210622|NCT04194203|Paclitaxel|paclitaxel|mesh-list
15210623|NCT04194203|Bevacizumab|bevacizumab|mesh-list
15210624|NCT04194203|Carboplatin|carboplatin|mesh-list
15210625|NCT04194203|Pemetrexed|pemetrexed|mesh-list
15210626|NCT04194203|Atezolizumab|atezolizumab|mesh-list
15210627|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210628|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210629|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210630|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210631|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210632|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868815|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
14868816|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868817|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
14868818|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868819|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868820|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14868821|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
14868822|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868823|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14868824|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14868825|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14868826|NCT01125033|Vitamins|vitamins|mesh-list
14868827|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
14868828|NCT01125033|Vitamin E|vitamin e|mesh-list
14868829|NCT01125033|Tocopherols|tocopherols|mesh-list
14868830|NCT01125033|Tocotrienols|tocotrienols|mesh-list
14868831|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
14868832|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
14868833|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868834|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
14868835|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210633|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210634|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210635|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15210636|NCT04194203|Growth Substances|growth substances|mesh-ancestor
15210637|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210638|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210639|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210640|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15210641|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14296160|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
14296161|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868836|NCT01125033|Protective Agents|protective agents|mesh-ancestor
14868837|NCT01125059|Methadone|methadone|mesh-list
14868838|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14868839|NCT01125059|Narcotics|narcotics|mesh-ancestor
14868840|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868841|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868842|NCT01125059|Analgesics|analgesics|mesh-ancestor
14868843|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
14868844|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868845|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
14868846|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
14868847|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
14868848|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14868849|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868850|NCT01125150|Metformin|metformin|mesh-list
14868851|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14868852|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210642|NCT04147494|Edetic Acid|edetic acid|mesh-list
14868853|NCT01125215|Capsaicin|capsaicin|mesh-list
14868854|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
14868855|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
15210643|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14868856|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
14868857|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868858|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868859|NCT01125254|Amlodipine|amlodipine|mesh-list
14868860|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14868861|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14868862|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14868863|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210644|NCT04147494|FAPI-46|fapi-46|mesh-list
15210645|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
15210646|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
15210647|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210648|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
15210649|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15210650|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15210651|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
15210652|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14711100|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14711101|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14711102|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711103|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711104|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14711105|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
14711106|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711107|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711108|NCT00437892|Atorvastatin|atorvastatin|mesh-list
14711109|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14711110|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14711111|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
14711112|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711113|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14711114|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14711115|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711116|NCT00437918|Acarbose|acarbose|mesh-list
14868864|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14868865|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868866|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
14868867|NCT01125371|Ethanol|ethanol|mesh-list
15210653|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711117|NCT00437918|Nateglinide|nateglinide|mesh-list
14711118|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15210654|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15210655|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15210656|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15210657|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210658|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210659|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210660|NCT04137107|Analgesics|analgesics|mesh-ancestor
15210661|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
15210662|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210663|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
15210664|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15210665|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
15210666|NCT04093323|Interferons|interferons|mesh-list
15210667|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
15210668|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
15210669|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
15210670|NCT04093323|Celecoxib|celecoxib|mesh-list
15210671|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15210672|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
15210673|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210674|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
15210675|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210676|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
15210677|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210678|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15210679|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15210680|NCT04093323|Analgesics|analgesics|mesh-ancestor
15210681|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
15210682|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210683|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210684|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210685|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15210686|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15210687|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210688|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210689|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15210690|NCT04080804|Nivolumab|nivolumab|mesh-list
15210691|NCT04080804|Ipilimumab|ipilimumab|mesh-list
15210692|NCT04080804|Antibodies|antibodies|mesh-list
14711119|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711120|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711121|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14711122|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868868|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14868869|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868870|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14868871|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868872|NCT01125410|Clindamycin|clindamycin|mesh-list
14868873|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
14868874|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
14868875|NCT01125410|Dequalinium|dequalinium|mesh-list
14868876|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14868877|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868878|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14868879|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868880|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210693|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
14711123|NCT00437957|Temozolomide|temozolomide|mesh-list
14711124|NCT00437957|Valproic Acid|valproic acid|mesh-list
14711125|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14711126|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
14711127|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711128|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711129|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
14711130|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711131|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
14711132|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711133|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711134|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
14711135|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14913941|NCT01378039|Hormones|hormones|mesh-ancestor
15210694|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
14711136|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711137|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711138|NCT00437970|Metformin|metformin|mesh-list
14711139|NCT00437970|Pioglitazone|pioglitazone|mesh-list
14711140|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14711141|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296162|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711142|NCT00437996|Clonidine|clonidine|mesh-list
14711143|NCT00437996|Sufentanil|sufentanil|mesh-list
14711144|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
14711145|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
14711146|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
14711147|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711148|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711149|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
14711150|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711151|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14711152|NCT00437996|Narcotics|narcotics|mesh-ancestor
14711153|NCT00437996|Analgesics|analgesics|mesh-ancestor
14711154|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14711155|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14711156|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
14711157|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14711158|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
14711159|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
14711160|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14711161|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14296163|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
14711162|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14711163|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14711164|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711165|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711166|NCT00438048|Pilocarpine|pilocarpine|mesh-list
14711167|NCT00438048|Miotics|miotics|mesh-ancestor
14711168|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
14711169|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711170|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711171|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15210695|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210696|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210697|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210698|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14868881|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14868882|NCT01125423|Milnacipran|milnacipran|mesh-list
15210699|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210700|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
15210701|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210702|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210703|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
15210704|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
15210705|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210706|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
15210707|NCT04042701|Trastuzumab|trastuzumab|mesh-list
15210708|NCT04042701|Camptothecin|camptothecin|mesh-list
14711172|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14711173|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
14711174|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711175|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711176|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
14711177|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14711178|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14711179|NCT00438087|Prednisolone|prednisolone|mesh-list
14868883|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
14868884|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14868885|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15210709|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
15210710|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210711|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210712|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210713|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15210714|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15210715|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210716|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210717|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
15210718|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210719|NCT04005690|Olaparib|olaparib|mesh-list
15210720|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15210721|NCT04005690|Onvansertib|onvansertib|mesh-list
15210722|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210723|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210724|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210725|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210726|NCT03978611|Ipilimumab|ipilimumab|mesh-list
15210727|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210728|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210729|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15210730|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868886|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14296164|NCT00586261|Pioglitazone|pioglitazone|mesh-list
14711180|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
15210731|NCT03969212|Baloxavir|baloxavir|mesh-list
15210732|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
15210733|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868887|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868888|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868889|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296165|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
14296166|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14711181|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14711182|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
14711183|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711184|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
14711185|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
14711186|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868890|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14868891|NCT01125423|Analgesics|analgesics|mesh-ancestor
14868892|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
14868893|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868894|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
14868895|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14868896|NCT01125436|Vitamin D|vitamin d|mesh-list
14868897|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
14868898|NCT01125436|Vitamins|vitamins|mesh-ancestor
14868899|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
14868900|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868901|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14868902|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14868903|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
14868904|NCT01125449|Vitamins|vitamins|mesh-ancestor
14868905|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
14868906|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868907|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
14868908|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868909|NCT01125449|Protective Agents|protective agents|mesh-ancestor
14868910|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14868911|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
14868912|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14868913|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
14868914|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15210734|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711187|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711188|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14711189|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
14711190|NCT00438087|Hormones|hormones|mesh-ancestor
14711191|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711192|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14711193|NCT00438087|Protective Agents|protective agents|mesh-ancestor
14711194|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711195|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711196|NCT00438113|Atenolol|atenolol|mesh-list
14711197|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14711198|NCT00438113|Terazosin|terazosin|mesh-list
14711199|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14711200|NCT00438113|Diuretics|diuretics|mesh-ancestor
14711201|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
14711202|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711203|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14711204|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14711205|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711206|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14711207|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
14711208|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
14711209|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210735|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210736|NCT03968822|Lidocaine|lidocaine|mesh-list
15210737|NCT03968822|Bupivacaine|bupivacaine|mesh-list
15210738|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15210739|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
15210740|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
15210741|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210742|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296167|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296168|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
14296169|NCT00586482|Nicotine|nicotine|mesh-list
14868915|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868916|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14868917|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14868918|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868919|NCT01125527|Vaccines|vaccines|mesh-list
14296170|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14296171|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
14296172|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711210|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14711211|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14711212|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14711213|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
14711214|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711215|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14711216|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14711217|NCT00438113|Urological Agents|urological agents|mesh-ancestor
14296173|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296174|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14296175|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14296176|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
14296177|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296178|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296179|NCT00586495|Sorafenib|sorafenib|mesh-list
14868920|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
14868921|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868922|NCT01125553|Insulin|insulin|mesh-list
14868923|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
14868924|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14711218|NCT00438139|Dronabinol|dronabinol|mesh-list
14711219|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
14711220|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711221|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711222|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296180|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296181|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296182|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868925|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868926|NCT01125657|Darexaban|darexaban|mesh-list
14868927|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14868928|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
14868929|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14868930|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
15210743|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
15210744|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210745|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15210746|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15210747|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14868931|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868932|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868933|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
14868934|NCT01125670|Darexaban|darexaban|mesh-list
14868935|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14868936|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
14868937|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14868938|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
14868939|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868940|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210748|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15210749|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210750|NCT03961971|Spartalizumab|spartalizumab|mesh-list
15210751|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15210752|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210753|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210754|NCT03926143|Maytansine|maytansine|mesh-list
15210755|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
15210756|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14868941|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
14868942|NCT01125683|Donepezil|donepezil|mesh-list
14868943|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14868944|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868945|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868946|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
14868947|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868948|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868949|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
14868950|NCT01125696|Ritonavir|ritonavir|mesh-list
14868951|NCT01125696|Lopinavir|lopinavir|mesh-list
14868952|NCT01125696|Tenofovir|tenofovir|mesh-list
14868953|NCT01125696|Lamivudine|lamivudine|mesh-list
14868954|NCT01125696|Zidovudine|zidovudine|mesh-list
15210757|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210758|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210759|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210760|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210761|NCT03915626|Rivastigmine|rivastigmine|mesh-list
15210762|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15210763|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210764|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210765|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
15210766|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210767|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210768|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15210769|NCT03915626|Protective Agents|protective agents|mesh-ancestor
14711223|NCT00438139|Analgesics|analgesics|mesh-ancestor
14711224|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
14711225|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711226|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14711227|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14711228|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868955|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14868956|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14868957|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
14868958|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868959|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14868960|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14868961|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14868962|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
14868963|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14868964|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14868965|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14868966|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14868967|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14868968|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
14868969|NCT01125761|Clemastine|clemastine|mesh-list
14868970|NCT01125761|Dexamethasone|dexamethasone|mesh-list
14868971|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
14868972|NCT01125761|BB 1101|bb 1101|mesh-list
14868973|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14868974|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
14868975|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
14868976|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14868977|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14868978|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14868979|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
14868980|NCT01125761|Hormones|hormones|mesh-ancestor
14711229|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711230|NCT00438139|Hormones|hormones|mesh-ancestor
14711231|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711232|NCT00438152|Ritonavir|ritonavir|mesh-list
14711233|NCT00438152|Lopinavir|lopinavir|mesh-list
14711234|NCT00438152|Saquinavir|saquinavir|mesh-list
14868981|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14868982|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14868983|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14868984|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14868985|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14868986|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711235|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14868987|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
15210770|NCT03909165|Atropine|atropine|mesh-list
14868988|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14868989|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14868990|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
14868991|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
14868992|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14868993|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14868994|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14868995|NCT01125787|Ofatumumab|ofatumumab|mesh-list
14868996|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14868997|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14868998|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
14868999|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869000|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869001|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
14869002|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869003|NCT01125891|Gemcitabine|gemcitabine|mesh-list
14869004|NCT01125891|ON 01910|on 01910|mesh-list
14869005|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869006|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
14869007|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869008|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869009|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
14869010|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869011|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869012|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869013|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
14869014|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869015|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869016|NCT01125904|Crizotinib|crizotinib|mesh-list
14869017|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869018|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869019|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869020|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869021|NCT01125943|Bevacizumab|bevacizumab|mesh-list
14869022|NCT01125943|Nitroprusside|nitroprusside|mesh-list
14869023|NCT01125943|Acetylcholine|acetylcholine|mesh-list
14869024|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869025|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869026|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869027|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869028|NCT01125943|Growth Substances|growth substances|mesh-ancestor
14869029|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869030|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869031|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14869032|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
14869033|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14869034|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869035|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14869036|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
14869037|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711236|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14869038|NCT01125982|Propofol|propofol|mesh-list
14869039|NCT01125982|Desflurane|desflurane|mesh-list
14869040|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14711237|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
14711238|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711239|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711240|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14711241|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14711242|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
14711243|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711244|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14711245|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14869041|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869042|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869043|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14869044|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
14869045|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
14869046|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14869047|NCT01126008|Docetaxel|docetaxel|mesh-list
14869048|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869049|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14869050|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14869051|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14869052|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869053|NCT01126073|Niacin|niacin|mesh-list
14869054|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14869055|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
14869056|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869057|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14869058|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
14869059|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
14869060|NCT01126073|Vitamins|vitamins|mesh-ancestor
15210771|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
14711246|NCT00438178|Obatoclax|obatoclax|mesh-list
14711247|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711248|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711249|NCT00438217|Leuprolide|leuprolide|mesh-list
14711250|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14711251|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14711252|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14711253|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
14711254|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14711255|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869061|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
15210772|NCT03909165|Neostigmine|neostigmine|mesh-list
15210773|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15210774|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15210775|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15210776|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
15210777|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210778|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210779|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15210780|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
15210781|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
15210782|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
15210783|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15210784|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15210785|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
15210786|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210787|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210788|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15210789|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210790|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15210791|NCT03907046|Aspirin|aspirin|mesh-list
15210792|NCT03907046|Apixaban|apixaban|mesh-list
15210793|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14869062|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869063|NCT01126086|Otamixaban|otamixaban|mesh-list
15210794|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15210795|NCT03907046|Analgesics|analgesics|mesh-ancestor
15210796|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
15210797|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711256|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711257|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711258|NCT00438217|Hormones|hormones|mesh-ancestor
14711259|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711260|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
14711261|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14711262|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
14711263|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14711264|NCT00438230|Warfarin|warfarin|mesh-list
14711265|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
14711266|NCT00438243|Bromfenac|bromfenac|mesh-list
14711267|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14711268|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14711269|NCT00438243|Analgesics|analgesics|mesh-ancestor
14711270|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
14711271|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711272|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711273|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210798|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210799|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15210800|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15210801|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15210802|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15210803|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210804|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15210805|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15210806|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210807|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
15210808|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15210809|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
15210810|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15210811|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
14711274|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711275|NCT00438269|Metronidazole|metronidazole|mesh-list
14711276|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
14711277|NCT00438269|Meropenem|meropenem|mesh-list
14711278|NCT00438269|Cefazolin|cefazolin|mesh-list
14711279|NCT00438269|Tazobactam|tazobactam|mesh-list
14711280|NCT00438269|Piperacillin|piperacillin|mesh-list
14711281|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14711282|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711283|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14711284|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14711285|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14711286|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14711287|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14711288|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711289|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711290|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711291|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14711292|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14711293|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14711294|NCT00438321|Anastrozole|anastrozole|mesh-list
14711295|NCT00438321|Goserelin|goserelin|mesh-list
14711296|NCT00438321|Testosterone|testosterone|mesh-list
15210812|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
14711297|NCT00438321|Androgens|androgens|mesh-ancestor
14711298|NCT00438321|Hormones|hormones|mesh-ancestor
14711299|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869064|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14869065|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
14869066|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14869067|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
14869068|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869069|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869070|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
14869071|NCT01126112|Panitumumab|panitumumab|mesh-list
15210813|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
15210814|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869072|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869073|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869074|NCT01126138|Docetaxel|docetaxel|mesh-list
14869075|NCT01126138|Capecitabine|capecitabine|mesh-list
14869076|NCT01126138|Vinorelbine|vinorelbine|mesh-list
14869077|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869078|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
14869079|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
14869080|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
14869081|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869082|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869083|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
14869084|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14869085|NCT01126177|Interferons|interferons|mesh-list
14869086|NCT01126177|Interferon-beta|interferon-beta|mesh-list
14869087|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
14869088|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869089|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
14869090|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869091|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
14869092|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869093|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14869094|NCT01126216|Paclitaxel|paclitaxel|mesh-list
14869095|NCT01126216|Cisplatin|cisplatin|mesh-list
14869096|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14869097|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210815|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210816|NCT03842228|Durvalumab|durvalumab|mesh-list
15210817|NCT03842228|Olaparib|olaparib|mesh-list
15210818|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14711300|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711301|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711302|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711303|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14711304|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14711305|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711306|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711307|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14711308|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
14711309|NCT00438386|Aripiprazole|aripiprazole|mesh-list
14711310|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
14711311|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711312|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14869098|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14869099|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14869100|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14869101|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869102|NCT01126229|Resveratrol|resveratrol|mesh-list
14869103|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
14869104|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869105|NCT01126229|Protective Agents|protective agents|mesh-ancestor
14869106|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869107|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869108|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14869109|NCT01126294|Melatonin|melatonin|mesh-list
14869110|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
14869111|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869112|NCT01126294|Protective Agents|protective agents|mesh-ancestor
14869113|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869114|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869115|NCT01126307|Verapamil|verapamil|mesh-list
14869116|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15210819|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
14869117|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14869118|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14869119|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869120|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14711313|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14711314|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711315|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869121|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869122|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
14869123|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14869124|NCT01126450|Cetuximab|cetuximab|mesh-list
14869125|NCT01126450|Lenalidomide|lenalidomide|mesh-list
14869126|NCT01126450|Antibodies|antibodies|mesh-list
14869127|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
14869128|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14869129|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
14869130|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869131|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711316|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
14711317|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
14711318|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711319|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711320|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14711321|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14711322|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
15210820|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15210821|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
15210822|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210823|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210824|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
15210825|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210826|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210827|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210828|NCT03822013|Miglustat|miglustat|mesh-list
15210829|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711323|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14711324|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15210830|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210831|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15210832|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14869132|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210833|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
15210834|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210835|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15210836|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15210837|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210838|NCT03785925|Nivolumab|nivolumab|mesh-list
15210839|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210840|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210841|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14869133|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869134|NCT01126450|Growth Substances|growth substances|mesh-ancestor
14869135|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210842|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210843|NCT03779334|Risdiplam|risdiplam|mesh-list
15210844|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15210845|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210846|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210847|NCT03729245|Nivolumab|nivolumab|mesh-list
15210848|NCT03729245|Sunitinib|sunitinib|mesh-list
15210849|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210850|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210851|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15210852|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210853|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210854|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15210855|NCT03729245|Growth Substances|growth substances|mesh-ancestor
15210856|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210857|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
15210858|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210859|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210860|NCT03706690|Durvalumab|durvalumab|mesh-list
15210861|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210862|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210863|NCT03698279|Vaccines|vaccines|mesh-list
15210864|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
15210865|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210866|NCT03692403|Quinagolide|quinagolide|mesh-list
14711325|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14711326|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14711327|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14711328|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14711329|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711330|NCT00438568|Insulin|insulin|mesh-list
14711331|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15210867|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
15210868|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
15210869|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210870|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210871|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210872|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
14711332|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14711333|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711334|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14711335|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
14711336|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711337|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
14711338|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14711339|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14711340|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15210873|NCT03680274|Vitamins|vitamins|mesh-ancestor
15210874|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
15210875|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210876|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
15210877|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711341|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
14711342|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711343|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711344|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711345|NCT00438737|Leucovorin|leucovorin|mesh-list
14711346|NCT00438737|Bevacizumab|bevacizumab|mesh-list
14711347|NCT00438737|Cetuximab|cetuximab|mesh-list
14296183|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296184|NCT00586508|Bevacizumab|bevacizumab|mesh-list
14296185|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
14711348|NCT00438737|Fluorouracil|fluorouracil|mesh-list
14711349|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
14711350|NCT00438737|Calcium|calcium|mesh-list
14711351|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
15210878|NCT03680274|Protective Agents|protective agents|mesh-ancestor
15210879|NCT03653364|Baloxavir|baloxavir|mesh-list
15210880|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
14711352|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14711353|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711354|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15210881|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210882|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711355|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14711356|NCT00438737|Growth Substances|growth substances|mesh-ancestor
14711357|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711358|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
14711359|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15210883|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210884|NCT03653247|Plerixafor|plerixafor|mesh-list
15210885|NCT03653247|Busulfan|busulfan|mesh-list
15210886|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
15210887|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210888|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296186|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210889|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
15210890|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210891|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15210892|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210893|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15210894|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15210895|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15210896|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
15210897|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210898|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
15210899|NCT03593811|Ondansetron|ondansetron|mesh-list
15210900|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
15210901|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
15210902|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15210903|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210904|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15210905|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
15210906|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
15210907|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15210908|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
15210909|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15210910|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210911|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15210912|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15210913|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15210914|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15210915|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15210916|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15210917|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
14869136|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
14869137|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210918|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
15210919|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15210920|NCT03572764|Cytarabine|cytarabine|mesh-list
15210921|NCT03572764|Daunorubicin|daunorubicin|mesh-list
14913942|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913943|NCT01378091|Prednisone|prednisone|mesh-list
14913944|NCT01378091|Docetaxel|docetaxel|mesh-list
15210922|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296187|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296188|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14296189|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14296190|NCT00586508|Growth Substances|growth substances|mesh-ancestor
14296191|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296192|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
14296193|NCT00586521|Factor VIII|factor viii|mesh-list
14296194|NCT00586521|Coagulants|coagulants|mesh-ancestor
14296195|NCT00586573|Memantine|memantine|mesh-list
14296196|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14296197|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14296198|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
14711360|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
14913945|NCT01378091|Lenalidomide|lenalidomide|mesh-list
14913946|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210923|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
15210924|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210925|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210926|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
15210927|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711361|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711362|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14711363|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14711364|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
15210928|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15210929|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
15210930|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210931|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15210932|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15210933|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15210934|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210935|NCT03559010|Norgestrel|norgestrel|mesh-list
15210936|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15210937|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15210938|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15210939|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
15210940|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15210941|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15210942|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15210943|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14711365|NCT00438737|Antidotes|antidotes|mesh-ancestor
14711366|NCT00438737|Protective Agents|protective agents|mesh-ancestor
14711367|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
14711368|NCT00438737|Vitamins|vitamins|mesh-ancestor
14711369|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
14711370|NCT00438776|Olanzapine|olanzapine|mesh-list
14711371|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
14711372|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
14711373|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711374|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711375|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14711376|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15210944|NCT03533283|Atezolizumab|atezolizumab|mesh-list
15210945|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
15210946|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210947|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210948|NCT03520686|Paclitaxel|paclitaxel|mesh-list
15210949|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15210950|NCT03520686|Cisplatin|cisplatin|mesh-list
15210951|NCT03520686|Carboplatin|carboplatin|mesh-list
15210952|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
15210953|NCT03520686|Pemetrexed|pemetrexed|mesh-list
15210954|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210955|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210956|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210957|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210958|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210959|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210960|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210961|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210962|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14711377|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14711378|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711379|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711380|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14711381|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14711382|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14711383|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711384|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711385|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
14711386|NCT00438789|Eculizumab|eculizumab|mesh-list
14711387|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14711388|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14711389|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
14711390|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711391|NCT00438828|Dexamethasone|dexamethasone|mesh-list
14711392|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711393|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
14711394|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
14711395|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711396|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711397|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14711398|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
14711399|NCT00438828|Hormones|hormones|mesh-ancestor
14711400|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711401|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711402|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711403|NCT00438841|Thalidomide|thalidomide|mesh-list
14711404|NCT00438841|Dexamethasone|dexamethasone|mesh-list
14711405|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
14711406|NCT00438841|Bortezomib|bortezomib|mesh-list
14711407|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14711408|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
14711409|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711410|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711411|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15210963|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15210964|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
15210965|NCT03516981|Lenvatinib|lenvatinib|mesh-list
14711412|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
14869138|NCT01126528|Vitamin D|vitamin d|mesh-list
14869139|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
14869140|NCT01126528|Vitamins|vitamins|mesh-ancestor
14869141|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
14869142|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869143|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14869144|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14711413|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711414|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711415|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14711416|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711417|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
14711418|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
14711419|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711420|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14711421|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
14711422|NCT00438841|Hormones|hormones|mesh-ancestor
14711423|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711424|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711425|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
14711426|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14711427|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711428|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14711429|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14711430|NCT00438841|Growth Substances|growth substances|mesh-ancestor
14711431|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
14711432|NCT00438906|Secretin|secretin|mesh-list
14711433|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869145|NCT01126606|Glycerol|glycerol|mesh-list
14869146|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14869147|NCT01126606|Protective Agents|protective agents|mesh-ancestor
14711434|NCT00438906|Hormones|hormones|mesh-ancestor
14711435|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711436|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728744|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14869148|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869149|NCT01126645|Sorafenib|sorafenib|mesh-list
14869150|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869151|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869152|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869153|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869154|NCT01126684|Atorvastatin|atorvastatin|mesh-list
14869155|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14869156|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14869157|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
14869158|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869159|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14869160|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14869161|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869162|NCT01126697|Ubiquinone|ubiquinone|mesh-list
14869163|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
14869164|NCT01126697|Lisinopril|lisinopril|mesh-list
14869165|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14728745|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728746|NCT00519987|Ketamine|ketamine|mesh-list
14728747|NCT00519987|Analgesics|analgesics|mesh-ancestor
14728748|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
14728749|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728750|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728751|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14728752|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14869166|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
14869167|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869168|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869169|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14869170|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14711437|NCT00438945|Eprosartan|eprosartan|mesh-list
14711438|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14711439|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14711440|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14711441|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711442|NCT00438958|Lenograstim|lenograstim|mesh-list
14711443|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14711444|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
14711445|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711446|NCT00438984|Aldesleukin|aldesleukin|mesh-list
14711447|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
14711448|NCT00438984|Interleukin-2|interleukin-2|mesh-list
15210966|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15210967|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210968|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15210969|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210970|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210971|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14869171|NCT01126697|Protective Agents|protective agents|mesh-ancestor
14869172|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869173|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
14869174|NCT01126697|Vitamins|vitamins|mesh-ancestor
14869175|NCT01126736|Pemetrexed|pemetrexed|mesh-list
14869176|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869177|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210972|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15210973|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15210974|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210975|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210976|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
15210977|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210978|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15210979|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15225122|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
14869178|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869179|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14869180|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14869181|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
14869182|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869183|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869184|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869185|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869186|NCT01126866|Bevacizumab|bevacizumab|mesh-list
14869187|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869188|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711449|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14711450|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
14711451|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711452|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711453|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14711454|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
14711455|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711456|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711457|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14711458|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14711459|NCT00438984|Analgesics|analgesics|mesh-ancestor
14711460|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
14711461|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711462|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14711463|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14869189|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869190|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869191|NCT01126866|Growth Substances|growth substances|mesh-ancestor
14869192|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869193|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869194|NCT01127009|Cytarabine|cytarabine|mesh-list
14869195|NCT01127009|Etoposide|etoposide|mesh-list
14869196|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
14869197|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
14869198|NCT01127009|Bortezomib|bortezomib|mesh-list
14869199|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
14869200|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210980|NCT03509012|Paclitaxel|paclitaxel|mesh-list
15210981|NCT03509012|Etoposide|etoposide|mesh-list
15210982|NCT03509012|Cisplatin|cisplatin|mesh-list
15210983|NCT03509012|Carboplatin|carboplatin|mesh-list
15210984|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
15210985|NCT03509012|Pemetrexed|pemetrexed|mesh-list
14711464|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
14711465|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711466|NCT00439049|Naltrexone|naltrexone|mesh-list
14711467|NCT00439049|Modafinil|modafinil|mesh-list
14711468|NCT00439049|Amphetamine|amphetamine|mesh-list
14711469|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
14711470|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14711471|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14711472|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711473|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
14711474|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711475|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14711476|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14711477|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14711478|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14711479|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711480|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
14711481|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
14711482|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
14711483|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711484|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
14711485|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14711486|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14711487|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14711488|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14711489|NCT00439062|Roxithromycin|roxithromycin|mesh-list
14711490|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14711491|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15210986|NCT03509012|Durvalumab|durvalumab|mesh-list
15210987|NCT03509012|Tremelimumab|tremelimumab|mesh-list
15210988|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15210989|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15210990|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
15210991|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
15210992|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
15210993|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15210994|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15210995|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15210996|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15210997|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15210998|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15210999|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211000|NCT03478930|Omalizumab|omalizumab|mesh-list
15211001|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15211002|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15211003|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
15211004|NCT03477539|Lenalidomide|lenalidomide|mesh-list
15211005|NCT03477539|Daratumumab|daratumumab|mesh-list
15211006|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
15211007|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211008|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15211009|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15211010|NCT03477539|Growth Substances|growth substances|mesh-ancestor
15211011|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211012|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711492|NCT00439166|Doxycycline|doxycycline|mesh-list
14711493|NCT00439166|Rifampin|rifampin|mesh-list
14711494|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14711495|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711496|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
14711497|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14711498|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14711499|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14711500|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
14711501|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
14711502|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14711503|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711504|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211013|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
15211014|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211015|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211016|NCT03476603|Irbesartan|irbesartan|mesh-list
15211017|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15211018|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14296199|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296200|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296201|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296202|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14296203|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14296204|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14711505|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15211019|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15211020|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211021|NCT03476577|Ibuprofen|ibuprofen|mesh-list
15211022|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15211023|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14869201|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869202|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14869203|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14869204|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711506|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14711507|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14711508|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14711509|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14711510|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14711511|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14869205|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869206|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869207|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
14869208|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
14869209|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869210|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869211|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
14869212|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869213|NCT01127009|Analgesics|analgesics|mesh-ancestor
14869214|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
14869215|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869216|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
14869217|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211024|NCT03476577|Analgesics|analgesics|mesh-ancestor
14711512|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14711513|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14711514|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
14711515|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711516|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869218|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14869219|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14869220|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14869221|NCT01127022|Choline|choline|mesh-list
14869222|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
14869223|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14869224|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
14869225|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913947|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
14869226|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869227|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14869228|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
14869229|NCT01127100|Fentanyl|fentanyl|mesh-list
14869230|NCT01127100|Gabapentin|gabapentin|mesh-list
14869231|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14869232|NCT01127100|Narcotics|narcotics|mesh-ancestor
14869233|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869234|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869235|NCT01127100|Analgesics|analgesics|mesh-ancestor
14869236|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
14869237|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869238|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14869239|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14869240|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
14869241|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
14869242|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
14869243|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14869244|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14869245|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14869246|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14869247|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14869248|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869249|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869250|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
14869251|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
14869252|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14869253|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869254|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869255|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869256|NCT01127204|Lamivudine|lamivudine|mesh-list
14869257|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14869258|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14869259|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869260|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869261|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
14913948|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
14711517|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711518|NCT00439192|Urological Agents|urological agents|mesh-ancestor
14711519|NCT00439283|Methotrexate|methotrexate|mesh-list
14711520|NCT00439283|Infliximab|infliximab|mesh-list
14711521|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14711522|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
14711523|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14711524|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711525|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14711526|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
14711527|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711528|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711529|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14711530|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711531|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14711532|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14711533|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
14711534|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711535|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14711536|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211025|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
15211026|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211027|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211028|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15211029|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211030|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15211031|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711537|NCT00439361|Carboplatin|carboplatin|mesh-list
14711538|NCT00439361|Etoposide|etoposide|mesh-list
14711539|NCT00439361|Bortezomib|bortezomib|mesh-list
14711540|NCT00439361|Ifosfamide|ifosfamide|mesh-list
14711541|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711542|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14711543|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14711544|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14711545|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711546|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711547|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14711548|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
14711549|NCT00439400|Doxycycline|doxycycline|mesh-list
14711550|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14711551|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711552|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
14711553|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14711554|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14711555|NCT00439426|Capecitabine|capecitabine|mesh-list
14711556|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
14711557|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14711558|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
14711559|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711560|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211032|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211033|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15211034|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15211035|NCT03476551|Diuretics|diuretics|mesh-ancestor
15211036|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
15211037|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211038|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15211039|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15211040|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211041|NCT03476538|Gabapentin|gabapentin|mesh-list
15211042|NCT03476538|Analgesics|analgesics|mesh-ancestor
15211043|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
15211044|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211045|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211046|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
14711561|NCT00439504|Lobeline|lobeline|mesh-list
14711562|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14711563|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
14711564|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711565|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211047|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15211048|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15211049|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15211050|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711566|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14711567|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14711568|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
14711569|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711570|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711571|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
14711572|NCT00439530|Oseltamivir|oseltamivir|mesh-list
14711573|NCT00439530|Probenecid|probenecid|mesh-list
15211051|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15211052|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14869262|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869263|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14869264|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14869265|NCT01127217|Losartan|losartan|mesh-list
14869266|NCT01127217|Amlodipine|amlodipine|mesh-list
14869267|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15211053|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869268|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14869269|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15211054|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211055|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
15211056|NCT03476525|Fluoxetine|fluoxetine|mesh-list
15211057|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15211058|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15211059|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15211060|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711574|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
14711575|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711576|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711577|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711578|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
14711579|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
14711580|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711581|NCT00439530|Renal Agents|renal agents|mesh-ancestor
14711582|NCT00439543|Iloprost|iloprost|mesh-list
14711583|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14711584|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
14711585|NCT00439699|Memantine|memantine|mesh-list
14711586|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14711587|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14711588|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
14711589|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711590|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711591|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711592|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14711593|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14711594|NCT00439712|Levocetirizine|levocetirizine|mesh-list
14711595|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14711596|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14711597|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
14711598|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
14711599|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711600|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711601|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711602|NCT00439751|Goserelin|goserelin|mesh-list
14711603|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711604|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711605|NCT00439829|Cetrorelix|cetrorelix|mesh-list
14711606|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14869270|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711607|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
14711608|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14711609|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711610|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
14711611|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869271|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14869272|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869273|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
14869274|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14869275|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14869276|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14869277|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
14869278|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14869279|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869280|NCT01127282|Vitamins|vitamins|mesh-list
14869281|NCT01127282|Vitamin A|vitamin a|mesh-list
14869282|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
14869283|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869284|NCT01127295|Tamoxifen|tamoxifen|mesh-list
14869285|NCT01127295|Letrozole|letrozole|mesh-list
14869286|NCT01127295|Anastrozole|anastrozole|mesh-list
14869287|NCT01127295|Exemestane|exemestane|mesh-list
14869288|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869289|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14869290|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14869291|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869292|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869293|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14869294|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
14869295|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211061|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211062|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
15211063|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711612|NCT00439855|Heparin|heparin|mesh-list
14711613|NCT00439855|Enoxaparin|enoxaparin|mesh-list
14711614|NCT00439855|Calcium heparin|calcium heparin|mesh-list
14711615|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
14711616|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15211064|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15211065|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
15211066|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15211067|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15211068|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15211069|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211070|NCT03440112|Clarithromycin|clarithromycin|mesh-list
15211071|NCT03440112|Flumazenil|flumazenil|mesh-list
15211072|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15211073|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211074|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15211075|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211076|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211077|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15211078|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14711617|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14711618|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711619|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
14869296|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211079|NCT03440112|Antidotes|antidotes|mesh-ancestor
15211080|NCT03440112|Protective Agents|protective agents|mesh-ancestor
15211081|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211082|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
15211083|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
15211084|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211085|NCT03435640|Nivolumab|nivolumab|mesh-list
15211086|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211087|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211088|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15211089|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211090|NCT03434262|Gemcitabine|gemcitabine|mesh-list
15211091|NCT03434262|Trametinib|trametinib|mesh-list
15211092|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211093|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
15211094|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211095|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211096|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
15211097|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211098|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211099|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211100|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
15225123|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
14711620|NCT00439972|Ortho Evra|ortho evra|mesh-list
14711621|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14711622|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14711623|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
14711624|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14711625|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711626|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14711627|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869297|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14869298|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14869299|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14869300|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14869301|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
14869302|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14869303|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711628|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14711629|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14711630|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711631|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711632|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711633|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14711634|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14869304|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14869305|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869306|NCT01127360|Bevacizumab|bevacizumab|mesh-list
14869307|NCT01127360|Ranibizumab|ranibizumab|mesh-list
14869308|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869309|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869310|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869311|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869312|NCT01127360|Growth Substances|growth substances|mesh-ancestor
14869313|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869314|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869315|NCT01127386|Lenalidomide|lenalidomide|mesh-list
14869316|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
14869317|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869318|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869319|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869320|NCT01127386|Growth Substances|growth substances|mesh-ancestor
14869321|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869322|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211101|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211102|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211103|NCT03425838|Letrozole|letrozole|mesh-list
15211104|NCT03425838|Fulvestrant|fulvestrant|mesh-list
14711635|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14711636|NCT00440024|Tazarotene|tazarotene|mesh-list
14711637|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
14869323|NCT01127464|Poly ICLC|poly iclc|mesh-list
14869324|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
14869325|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
14869326|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869327|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14869328|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
14711638|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
14711639|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
14711640|NCT00440063|Hematinics|hematinics|mesh-ancestor
14711641|NCT00440076|Bortezomib|bortezomib|mesh-list
14711642|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711643|NCT00440102|Ketamine|ketamine|mesh-list
14711644|NCT00440102|Etomidate|etomidate|mesh-list
14711645|NCT00440102|Analgesics|analgesics|mesh-ancestor
14711646|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
14711647|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711648|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711649|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14711650|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14711651|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
14711652|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
14711653|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711654|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14711655|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14711656|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711657|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711658|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14711659|NCT00440128|Docetaxel|docetaxel|mesh-list
14711660|NCT00440128|Casopitant|casopitant|mesh-list
14711661|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711662|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14711663|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14711664|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
14711665|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711666|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
14711667|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
14869329|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
14869330|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14869331|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14869332|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14869333|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15211105|NCT03425838|Palbociclib|palbociclib|mesh-list
14711668|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711669|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711670|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211106|NCT03425838|Anastrozole|anastrozole|mesh-list
15211107|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15211108|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211109|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15211110|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211111|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211112|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15211113|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
15211114|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211115|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211116|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15211117|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15211118|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211119|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
14711671|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15211120|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
14711672|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711673|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15211121|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211122|NCT03404960|Nivolumab|nivolumab|mesh-list
15211123|NCT03404960|Ipilimumab|ipilimumab|mesh-list
15211124|NCT03404960|Niraparib|niraparib|mesh-list
14711674|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14711675|NCT00440141|Latanoprost|latanoprost|mesh-list
14711676|NCT00440141|Brinzolamide|brinzolamide|mesh-list
14711677|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14711678|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14711679|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14711680|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14711681|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14711682|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
14711683|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211125|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14711684|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711685|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711686|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14711687|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711688|NCT00440154|Ezetimibe|ezetimibe|mesh-list
14711689|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14711690|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14711691|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
14711692|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711693|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14711694|NCT00440167|Gemcitabine|gemcitabine|mesh-list
14711695|NCT00440167|Capecitabine|capecitabine|mesh-list
14711696|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14711697|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14711698|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
14711699|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711700|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711701|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
14711702|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711703|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711704|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296205|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
14296206|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296207|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
14296208|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14296209|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
14296210|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14711705|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
14711706|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711707|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14711708|NCT00440219|Prednisone|prednisone|mesh-list
14711709|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711710|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
14711711|NCT00440219|Hormones|hormones|mesh-ancestor
14711712|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711713|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711714|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711715|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711716|NCT00440245|Albuterol|albuterol|mesh-list
15211126|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211127|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15211128|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211129|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15211130|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211131|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
15211132|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15211133|NCT03401749|Allantoin|allantoin|mesh-list
15211134|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15211135|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211136|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
15211137|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211138|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
15211139|NCT03399773|Thiotepa|thiotepa|mesh-list
15211140|NCT03399773|Fludarabine|fludarabine|mesh-list
15211141|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296211|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14296212|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14711717|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14711718|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
14711719|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711720|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711721|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14711722|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
14711723|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
14711724|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14711725|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14711726|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14711727|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14711728|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
14711729|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711730|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711731|NCT00440258|Cabergoline|cabergoline|mesh-list
14711732|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14711733|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14711734|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
14711735|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
14711736|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211142|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
15211143|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211144|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211145|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15211146|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
15211147|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211148|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869334|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869335|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869336|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869337|NCT01127490|Analgesics|analgesics|mesh-ancestor
14869338|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
14869339|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869340|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
14869341|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15211149|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15211150|NCT03367689|Olaparib|olaparib|mesh-list
15211151|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15211152|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211153|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211154|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211155|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
15211156|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
15211157|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14711737|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711738|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711739|NCT00440284|Insulin|insulin|mesh-list
14711740|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14711741|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869342|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
14869343|NCT01127529|Protein C|protein c|mesh-list
14869344|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
14711742|NCT00440323|Zolpidem|zolpidem|mesh-list
14711743|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14869345|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14869346|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14869347|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869348|NCT01127542|Lenalidomide|lenalidomide|mesh-list
14869349|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
14869350|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869351|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869352|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869353|NCT01127542|Growth Substances|growth substances|mesh-ancestor
14869354|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869355|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869356|NCT01127555|Leucovorin|leucovorin|mesh-list
14869357|NCT01127555|Fluorouracil|fluorouracil|mesh-list
14869358|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
14869359|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
14869360|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869361|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869362|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869363|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869364|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
14711744|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14711745|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711746|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711747|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14711748|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
14711749|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
14711750|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711751|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711752|NCT00440336|Latanoprost|latanoprost|mesh-list
14711753|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14711754|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14711755|NCT00440349|Tamoxifen|tamoxifen|mesh-list
14711756|NCT00440349|Prednisone|prednisone|mesh-list
14711757|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711758|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
14711759|NCT00440349|Hormones|hormones|mesh-ancestor
14711760|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711761|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711762|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14711763|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711764|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14711765|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
14711766|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14711767|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14711768|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14711769|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
14711770|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14869365|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869366|NCT01127555|Antidotes|antidotes|mesh-ancestor
14869367|NCT01127555|Protective Agents|protective agents|mesh-ancestor
14869368|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
14711771|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711772|NCT00440414|Pemetrexed|pemetrexed|mesh-list
14711773|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14711774|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711775|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711776|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711777|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14711778|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14711779|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14711780|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14711781|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14711782|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14711783|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14711784|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711785|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711786|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711787|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
14711788|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711789|NCT00440440|Testosterone|testosterone|mesh-list
14711790|NCT00440440|Androgens|androgens|mesh-ancestor
14711791|NCT00440440|Hormones|hormones|mesh-ancestor
14711792|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14711793|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711794|NCT00440479|Bortezomib|bortezomib|mesh-list
14711795|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711796|NCT00440609|Ranibizumab|ranibizumab|mesh-list
14711797|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15211158|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15211159|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211160|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869369|NCT01127555|Vitamins|vitamins|mesh-ancestor
14869370|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
14869371|NCT01127568|Propranolol|propranolol|mesh-list
14869372|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14869373|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14869374|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
14869375|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711798|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14711799|NCT00440609|Growth Substances|growth substances|mesh-ancestor
14869376|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869377|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869378|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14869379|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14711800|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869380|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
14869381|NCT01127594|Temozolomide|temozolomide|mesh-list
14869382|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14869383|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
14711801|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
14711802|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711803|NCT00440622|Gemcitabine|gemcitabine|mesh-list
14711804|NCT00440622|Capecitabine|capecitabine|mesh-list
14711805|NCT00440622|Trastuzumab|trastuzumab|mesh-list
14711806|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14711807|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
14711808|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711809|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869384|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869385|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869386|NCT01127620|Cetirizine|cetirizine|mesh-list
14869387|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14869388|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14869389|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14869390|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
14869391|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
14869392|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869393|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869394|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211161|NCT03364244|Urological Agents|urological agents|mesh-ancestor
15211162|NCT03351244|BI 409306|bi 409306|mesh-list
15211163|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14711810|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
14711811|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711812|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711813|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14711814|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
14711815|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711816|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211164|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211165|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211166|NCT03334617|Trastuzumab|trastuzumab|mesh-list
15211167|NCT03334617|Durvalumab|durvalumab|mesh-list
15211168|NCT03334617|Olaparib|olaparib|mesh-list
15211169|NCT03334617|Cediranib|cediranib|mesh-list
15211170|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211171|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211172|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15211173|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211174|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711817|NCT00440635|Bortezomib|bortezomib|mesh-list
14711818|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711819|NCT00440648|Sevelamer|sevelamer|mesh-list
14711820|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
14711821|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
14711822|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711823|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
14711824|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711825|NCT00440674|Paclitaxel|paclitaxel|mesh-list
14711826|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14711827|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711828|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14711829|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14711830|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14711831|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711832|NCT00440687|Fluticasone|fluticasone|mesh-list
14711833|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711834|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14711835|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
14711836|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711837|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711838|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14711839|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14711840|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14711841|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14711842|NCT00440713|Aripiprazole|aripiprazole|mesh-list
14711843|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
14711844|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711845|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14711846|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14711847|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711848|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711849|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
14711850|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
14711851|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711852|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711853|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14711854|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14711855|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
14711856|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14711857|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14869395|NCT01127672|Betamethasone|betamethasone|mesh-list
14869396|NCT01127672|Lidocaine|lidocaine|mesh-list
14711858|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14711859|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14711860|NCT00440739|Etoricoxib|etoricoxib|mesh-list
14711861|NCT00440739|Flavoxate|flavoxate|mesh-list
14711862|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15211175|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211176|NCT03323151|Ixazomib|ixazomib|mesh-list
15211177|NCT03323151|Glycine|glycine|mesh-list
15211178|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211179|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
15211180|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211181|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211182|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
15211183|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211184|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211185|NCT03290794|Aflibercept|aflibercept|mesh-list
15211186|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15211187|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15211188|NCT03290794|Growth Substances|growth substances|mesh-ancestor
15211189|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211190|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211191|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211192|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
15211193|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211194|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211195|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
15211196|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15211197|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
15211198|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
15211199|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15211200|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211201|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15211202|NCT03283670|Analgesics|analgesics|mesh-ancestor
15211203|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
14869397|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14869398|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
14869399|NCT01127672|Hormones|hormones|mesh-ancestor
14869400|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869401|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869402|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14869403|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
14869404|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
14869405|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
14869406|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869407|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
14869408|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869409|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15211204|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869410|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14869411|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14869412|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14869413|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211205|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
15211206|NCT03239145|Trebananib|trebananib|mesh-list
15211207|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211208|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211209|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15211210|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15211211|NCT03239145|Growth Substances|growth substances|mesh-ancestor
15211212|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211213|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211214|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
15211215|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
15211216|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211217|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211218|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211219|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
15211220|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
15211221|NCT03233217|Vaccines|vaccines|mesh-list
15211222|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
15211223|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211224|NCT03206047|Poly I-C|poly i-c|mesh-list
15211225|NCT03206047|Atezolizumab|atezolizumab|mesh-list
14869414|NCT01127724|Vitamins|vitamins|mesh-list
14869415|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
14869416|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
14869417|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
14869418|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
14869419|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869420|NCT01127724|Hematinics|hematinics|mesh-ancestor
14869421|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14869422|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14869423|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869424|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869425|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
14869426|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869427|NCT01127841|Rituximab|rituximab|mesh-list
14869428|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14869429|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869430|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869431|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
14869432|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869433|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14869434|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14869435|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
14869436|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869437|NCT01127880|Clindamycin|clindamycin|mesh-list
14869438|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
14869439|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
14869440|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14869441|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869442|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14869443|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869444|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869445|NCT01127906|Oxycodone|oxycodone|mesh-list
14869446|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14869447|NCT01127906|Narcotics|narcotics|mesh-ancestor
14869448|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869449|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869450|NCT01127906|Analgesics|analgesics|mesh-ancestor
14869451|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
14869452|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869453|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15211226|NCT03206047|Guadecitabine|guadecitabine|mesh-list
15211227|NCT03206047|Azacitidine|azacitidine|mesh-list
15211228|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15211229|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14869454|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
14869455|NCT01127984|Coagulants|coagulants|mesh-ancestor
14869456|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
14869457|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14869458|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
15211230|NCT03206047|Poly ICLC|poly iclc|mesh-list
15211231|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711863|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14869459|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869460|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869461|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
14869462|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869463|NCT01128101|Spironolactone|spironolactone|mesh-list
14869464|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14869465|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
14869466|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869467|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711864|NCT00440739|Analgesics|analgesics|mesh-ancestor
14711865|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
14711866|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711867|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711868|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711869|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711870|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14711871|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14711872|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711873|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711874|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
14711875|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
14711876|NCT00440739|Urological Agents|urological agents|mesh-ancestor
14711877|NCT00440765|Bortezomib|bortezomib|mesh-list
14711878|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711879|NCT00440778|Abciximab|abciximab|mesh-list
14711880|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
14711881|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14711882|NCT00440804|Ibuprofen|ibuprofen|mesh-list
14711883|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14711884|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14711885|NCT00440804|Analgesics|analgesics|mesh-ancestor
14711886|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
14711887|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711888|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711889|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711890|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711891|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14711892|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211232|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
15211233|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211234|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
15211235|NCT03206047|Laxatives|laxatives|mesh-ancestor
15211236|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211237|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
15211238|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211239|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211240|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
14711893|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728753|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
14869468|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14869469|NCT01128101|Diuretics|diuretics|mesh-ancestor
14869470|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
14869471|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14869472|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14728754|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
15211241|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211242|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211243|NCT03205358|Vaccines|vaccines|mesh-list
15211244|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
14728755|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15211245|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211246|NCT03198078|Aripiprazole|aripiprazole|mesh-list
15211247|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
15211248|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
15211249|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15211250|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15211251|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14728756|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14728757|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14728758|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225707|NCT03894540|Paclitaxel|paclitaxel|mesh-list
14728759|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728760|NCT00520000|Carboplatin|carboplatin|mesh-list
14869473|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211252|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15211253|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211254|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
15211255|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
15211256|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296213|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14296214|NCT00586690|Antibodies|antibodies|mesh-list
14296215|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
14296216|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14296217|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
14296218|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296219|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296220|NCT00586729|Mafenide|mafenide|mesh-list
14296221|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14296222|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711894|NCT00440843|Olanzapine|olanzapine|mesh-list
15211257|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211258|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15211259|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15211260|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
15211261|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15211262|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15211263|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15211264|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15211265|NCT03182426|Liraglutide|liraglutide|mesh-list
14711895|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
14711896|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
14711897|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711898|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711899|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14711900|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14711901|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14711902|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711903|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711904|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14711905|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14711906|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14711907|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711908|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711909|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
14711910|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
14711911|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14711912|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
14711913|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711914|NCT00440869|Expectorants|expectorants|mesh-ancestor
15211266|NCT03182426|Plerixafor|plerixafor|mesh-list
15211267|NCT03182426|Etanercept|etanercept|mesh-list
15211268|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
15211269|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15211270|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15211271|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211272|NCT03182426|Incretins|incretins|mesh-ancestor
15211273|NCT03182426|Hormones|hormones|mesh-ancestor
15211274|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211275|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15211276|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15211277|NCT03182426|Analgesics|analgesics|mesh-ancestor
15211278|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
15211279|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211280|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15211281|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211282|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211283|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211284|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
15211285|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14711915|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
14711916|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14711917|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
14711918|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711919|NCT00440869|Protective Agents|protective agents|mesh-ancestor
15211286|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296223|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15211287|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14869474|NCT01128257|Alendronate|alendronate|mesh-list
14869475|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
14869476|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14869477|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913949|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
14913950|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913951|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14913952|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
14913953|NCT01378091|Hormones|hormones|mesh-ancestor
14913954|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14913955|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913956|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14913957|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
14913958|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14913959|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14913960|NCT01378091|Growth Substances|growth substances|mesh-ancestor
14913961|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
14917331|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917332|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15211288|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15211289|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
14917333|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917334|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917335|NCT05268718|Voriconazole|voriconazole|mesh-list
14917336|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14917337|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14917338|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
14917339|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296224|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14296225|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296226|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296227|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14296228|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14296229|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14296230|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296231|NCT00586846|Doxorubicin|doxorubicin|mesh-list
14296232|NCT00586846|Methotrexate|methotrexate|mesh-list
14296233|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296234|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14296235|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14711920|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711921|NCT00440869|Antidotes|antidotes|mesh-ancestor
14711922|NCT00440895|Abciximab|abciximab|mesh-list
14711923|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
14711924|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14711925|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14711926|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
15211290|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14711927|NCT00440921|Coagulants|coagulants|mesh-ancestor
14711928|NCT00440960|Lidocaine|lidocaine|mesh-list
14711929|NCT00440960|Midazolam|midazolam|mesh-list
14711930|NCT00440960|Alfentanil|alfentanil|mesh-list
14711931|NCT00440960|Propofol|propofol|mesh-list
14711932|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
14711933|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
14711934|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14711935|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711936|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
14711937|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917340|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15211291|NCT03153111|Macitentan|macitentan|mesh-list
15211292|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15211293|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15211294|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225708|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
14296236|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14711938|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14869478|NCT01128322|Niacin|niacin|mesh-list
14869479|NCT01128322|Amlodipine|amlodipine|mesh-list
14869480|NCT01128322|Telmisartan|telmisartan|mesh-list
14869481|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14869482|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14869483|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14869484|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869485|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14869486|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869487|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
14869488|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14869489|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14869490|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14869491|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
14869492|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14869493|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
14869494|NCT01128322|Vitamins|vitamins|mesh-ancestor
14869495|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
14869496|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
14869497|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14869498|NCT01128699|Bevacizumab|bevacizumab|mesh-list
14869499|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869500|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869501|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869502|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869503|NCT01128699|Growth Substances|growth substances|mesh-ancestor
14869504|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869505|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869506|NCT01128712|Pregabalin|pregabalin|mesh-list
14296237|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711939|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14711940|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14711941|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14711942|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711943|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14711944|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15211295|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15211296|NCT03138889|Paclitaxel|paclitaxel|mesh-list
15211297|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15211298|NCT03138889|Carboplatin|carboplatin|mesh-list
15211299|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
15211300|NCT03138889|Pemetrexed|pemetrexed|mesh-list
15211301|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211302|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211303|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
14296238|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296239|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14711945|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
14711946|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14711947|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14711948|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14711949|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14711950|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
14711951|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
14711952|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14711953|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14711954|NCT00440960|Narcotics|narcotics|mesh-ancestor
14711955|NCT00440960|Analgesics|analgesics|mesh-ancestor
14711956|NCT00440973|Bevacizumab|bevacizumab|mesh-list
14711957|NCT00440973|Interleukin-2|interleukin-2|mesh-list
14711958|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14711959|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711960|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869507|NCT01128712|Analgesics|analgesics|mesh-ancestor
14711961|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15211304|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211305|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
14869508|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
14869509|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869510|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869511|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
14869512|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14869513|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14869514|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869515|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14869516|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14869517|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14869518|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869519|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14869520|NCT01128985|Canagliflozin|canagliflozin|mesh-list
14869521|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14869522|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869523|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14869524|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869525|NCT01128998|Sorafenib|sorafenib|mesh-list
14869526|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869527|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869528|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869529|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869530|NCT01129063|Clopidogrel|clopidogrel|mesh-list
14869531|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14869532|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15211306|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211307|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211308|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211309|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15211310|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15211311|NCT03093064|Natalizumab|natalizumab|mesh-list
15211312|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
15211313|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211314|NCT03063749|Sirolimus|sirolimus|mesh-list
15211315|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14869533|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14869534|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14869535|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
14869536|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869537|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869538|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869539|NCT01129089|Micronutrients|micronutrients|mesh-list
14869540|NCT01129089|Trace Elements|trace elements|mesh-list
14869541|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869542|NCT01129154|Panitumumab|panitumumab|mesh-list
14869543|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869544|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869545|NCT01129180|Bortezomib|bortezomib|mesh-list
14869546|NCT01129180|Azacitidine|azacitidine|mesh-list
14869547|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869548|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869549|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
14869550|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869551|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869552|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14869553|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211316|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211317|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14711962|NCT00440973|Growth Substances|growth substances|mesh-ancestor
14711963|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711964|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
14711965|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14711966|NCT00440973|Analgesics|analgesics|mesh-ancestor
14711967|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
14711968|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711969|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
14711970|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14711971|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711972|NCT00441051|Diclofenac|diclofenac|mesh-list
14711973|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14711974|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14711975|NCT00441051|Analgesics|analgesics|mesh-ancestor
14711976|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
14711977|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14711978|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711979|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14711980|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14711981|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14711982|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711983|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711984|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
14711985|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14711986|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14711987|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14711988|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711989|NCT00441181|Travoprost|travoprost|mesh-list
14913962|NCT01378143|Pentamidine|pentamidine|mesh-list
14869554|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869555|NCT01129271|Clopidogrel|clopidogrel|mesh-list
14711990|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14711991|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
14711992|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
14711993|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14711994|NCT00441207|Protective Agents|protective agents|mesh-ancestor
14711995|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14711996|NCT00441207|Vitamins|vitamins|mesh-ancestor
14711997|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
15211318|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211319|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
15211320|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211321|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
15211322|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211323|NCT03013998|Cytarabine|cytarabine|mesh-list
15211324|NCT03013998|Azacitidine|azacitidine|mesh-list
15211325|NCT03013998|Decitabine|decitabine|mesh-list
15211326|NCT03013998|Daunorubicin|daunorubicin|mesh-list
15211327|NCT03013998|Venetoclax|venetoclax|mesh-list
15211328|NCT03013998|AZD5991|azd5991|mesh-list
15211329|NCT03013998|Pevonedistat|pevonedistat|mesh-list
15211330|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211331|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
15211332|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211333|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211334|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
15211335|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211336|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211337|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
15211338|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211339|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211340|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211341|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15211342|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211343|NCT03011671|Temozolomide|temozolomide|mesh-list
15211344|NCT03011671|Acetazolamide|acetazolamide|mesh-list
15211345|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15211346|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
15211347|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211348|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211349|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
15211350|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15211351|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211352|NCT03011671|Diuretics|diuretics|mesh-ancestor
15211353|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
15211354|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211355|NCT03008616|Digoxin|digoxin|mesh-list
15211356|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15211357|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15211358|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211359|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211360|NCT03008616|Protective Agents|protective agents|mesh-ancestor
15211361|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211362|NCT02989636|Nivolumab|nivolumab|mesh-list
15211363|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211364|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211365|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15211366|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211367|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14711998|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
15211368|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15211369|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15211370|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
15211371|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211372|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211373|NCT02931695|Hormones|hormones|mesh-list
15211374|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211375|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211376|NCT02922777|Docetaxel|docetaxel|mesh-list
15211377|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211378|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211379|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211380|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211381|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211382|NCT02921035|Interferons|interferons|mesh-list
15211383|NCT02921035|Interferon-beta|interferon-beta|mesh-list
15211384|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
15211385|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211386|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
14869556|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14869557|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14869558|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14869559|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14869560|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
14869561|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869562|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869563|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869564|NCT01129310|Capecitabine|capecitabine|mesh-list
14869565|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
14869566|NCT01129310|Irinotecan|irinotecan|mesh-list
14869567|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869568|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
14869569|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869570|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869571|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14869572|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14869573|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211387|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211388|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
15211389|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211390|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15211391|NCT02885753|Leucovorin|leucovorin|mesh-list
15211392|NCT02885753|Folic Acid|folic acid|mesh-list
15211393|NCT02885753|Bevacizumab|bevacizumab|mesh-list
15211394|NCT02885753|Panitumumab|panitumumab|mesh-list
15211395|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
15211396|NCT02885753|Irinotecan|irinotecan|mesh-list
15211397|NCT02885753|Fluorouracil|fluorouracil|mesh-list
15211398|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
15211399|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211400|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211401|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15211402|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15211403|NCT02885753|Growth Substances|growth substances|mesh-ancestor
15211404|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211405|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211406|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15211407|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211408|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211409|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211410|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
15211411|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211412|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211413|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
15211414|NCT02885753|Antidotes|antidotes|mesh-ancestor
15211415|NCT02885753|Protective Agents|protective agents|mesh-ancestor
15211416|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
15211417|NCT02885753|Vitamins|vitamins|mesh-ancestor
15211418|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
15211419|NCT02885753|Hematinics|hematinics|mesh-ancestor
15211420|NCT02881086|Cytarabine|cytarabine|mesh-list
15211421|NCT02881086|Dexamethasone|dexamethasone|mesh-list
15211422|NCT02881086|Prednisolone|prednisolone|mesh-list
15211423|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
15211424|NCT02881086|Rituximab|rituximab|mesh-list
15211425|NCT02881086|Methotrexate|methotrexate|mesh-list
15211426|NCT02881086|Fludarabine|fludarabine|mesh-list
15211427|NCT02881086|Vincristine|vincristine|mesh-list
15211428|NCT02881086|Doxorubicin|doxorubicin|mesh-list
15211429|NCT02881086|Daunorubicin|daunorubicin|mesh-list
15211430|NCT02881086|Asparaginase|asparaginase|mesh-list
14296240|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
14711999|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
15211431|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
15211432|NCT02881086|Idarubicin|idarubicin|mesh-list
15211433|NCT02881086|Pegaspargase|pegaspargase|mesh-list
15211434|NCT02881086|Vindesine|vindesine|mesh-list
15211435|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211436|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
15211437|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211438|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211439|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15211440|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
15211441|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211442|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211443|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15211444|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712000|NCT00441246|Ephedrine|ephedrine|mesh-list
14712001|NCT00441246|Guaifenesin|guaifenesin|mesh-list
14712002|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14712003|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14712004|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
14712005|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712006|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712007|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14712008|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
14712009|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
14712010|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14712011|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15211445|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
15211446|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
15211447|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211448|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712012|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
15211449|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
15211450|NCT02881086|Hormones|hormones|mesh-ancestor
15211451|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211452|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15211453|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869574|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
14869575|NCT01129323|Fludarabine|fludarabine|mesh-list
14712013|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
14869576|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
14712014|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712015|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712016|NCT00441246|Expectorants|expectorants|mesh-ancestor
14712017|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14712018|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14712019|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
14712020|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14712021|NCT00441298|Tenofovir|tenofovir|mesh-list
14712022|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
14712023|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712024|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14712025|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14712026|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712027|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712028|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14712029|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14712030|NCT00441415|Adapalene|adapalene|mesh-list
14712031|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712032|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712033|NCT00441415|Analgesics|analgesics|mesh-ancestor
14712034|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
14712035|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712036|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712037|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712038|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712039|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
14869577|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869578|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
14869579|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869580|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14869581|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14869582|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
14869583|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869584|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869585|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14869586|NCT01129375|Omeprazole|omeprazole|mesh-list
14869587|NCT01129375|Clopidogrel|clopidogrel|mesh-list
14869588|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14869589|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14869590|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14869591|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14869592|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
14869593|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869594|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869595|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869596|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14869597|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869598|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14869599|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869600|NCT01129388|Omeprazole|omeprazole|mesh-list
14869601|NCT01129388|Clopidogrel|clopidogrel|mesh-list
14869602|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14869603|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14869604|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14869605|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14869606|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
14869607|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869608|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869609|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869610|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14869611|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869612|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14869613|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869614|NCT01129414|Omeprazole|omeprazole|mesh-list
14869615|NCT01129414|Clopidogrel|clopidogrel|mesh-list
14869616|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14869617|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14869618|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14869619|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14869620|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
14869621|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869622|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869623|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712040|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
14712041|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14712042|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14712043|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
14712044|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712045|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712046|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712047|NCT00441428|Urological Agents|urological agents|mesh-ancestor
14712048|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14712049|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712050|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712051|NCT00441519|Aspirin|aspirin|mesh-list
14712052|NCT00441519|Omeprazole|omeprazole|mesh-list
14712053|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712054|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712055|NCT00441519|Analgesics|analgesics|mesh-ancestor
14712056|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
14712057|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712058|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712059|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712060|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712061|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14712062|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14712063|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712064|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14712065|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14869624|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15211454|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15211455|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
15211456|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15211457|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211458|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
15211459|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211460|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211461|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15211462|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15211463|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
15211464|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211465|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211466|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211467|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211468|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14869625|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869626|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14869627|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869628|NCT01129427|Pantoprazole|pantoprazole|mesh-list
14869629|NCT01129427|Clopidogrel|clopidogrel|mesh-list
14712066|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712067|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
14712068|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712069|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712070|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14712071|NCT00441532|Lidocaine|lidocaine|mesh-list
14712072|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
14712073|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
14712074|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712075|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869630|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14869631|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14869632|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14869633|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14869634|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
14869635|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869636|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869637|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869638|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14869639|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869640|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14869641|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869642|NCT01129479|Galantamine|galantamine|mesh-list
14869643|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14869644|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869645|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869646|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
14869647|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869648|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869649|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14869650|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
14869651|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869652|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
14869653|NCT01129518|Vaccines|vaccines|mesh-list
14869654|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
14869655|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869656|NCT01129570|Silybin|silybin|mesh-list
14869657|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14869658|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869659|NCT01129570|Protective Agents|protective agents|mesh-ancestor
14869660|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869661|NCT01129596|Donepezil|donepezil|mesh-list
14869662|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14869663|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869664|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869665|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
14869666|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869667|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869668|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
14869669|NCT01129713|Esomeprazole|esomeprazole|mesh-list
14869670|NCT01129713|Omeprazole|omeprazole|mesh-list
14869671|NCT01129713|Lansoprazole|lansoprazole|mesh-list
14869672|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14869673|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869674|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14869675|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869676|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869677|NCT01129739|Cyclosporine|cyclosporine|mesh-list
14869678|NCT01129739|Cyclosporins|cyclosporins|mesh-list
14869679|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869680|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712076|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
14869681|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869682|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
14869683|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296241|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14296242|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296243|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869684|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
14869685|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869686|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
14869687|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14869688|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14869689|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14869690|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14869691|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
14869692|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869693|NCT01129856|Dexamethasone|dexamethasone|mesh-list
14869694|NCT01129856|Citric Acid|citric acid|mesh-list
14869695|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
14869696|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14869697|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14869698|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14869699|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14869700|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
14869701|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
14869702|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869703|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869704|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712077|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712078|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14712079|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14712080|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14712081|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14869705|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
14869706|NCT01129856|Hormones|hormones|mesh-ancestor
14869707|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869708|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14869709|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869710|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
14869711|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14869712|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
14869713|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
14869714|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869715|NCT01129934|Promethazine|promethazine|mesh-list
14869716|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
14869717|NCT01129934|Morphine|morphine|mesh-list
14869718|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14869719|NCT01129934|Narcotics|narcotics|mesh-ancestor
14869720|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869721|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869722|NCT01129934|Analgesics|analgesics|mesh-ancestor
14869723|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
14869724|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869725|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
14869726|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
14712082|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712083|NCT00441597|Atorvastatin|atorvastatin|mesh-list
14712084|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14712085|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14712086|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
14712087|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712088|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14712089|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14712090|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712091|NCT00441649|Methylphenidate|methylphenidate|mesh-list
14712092|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14712093|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712094|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14712095|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14712096|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712097|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712098|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
14712099|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712100|NCT00441662|Triamcinolone|triamcinolone|mesh-list
14712101|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712102|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
14712103|NCT00441662|Hormones|hormones|mesh-ancestor
14712104|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14712105|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869727|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14869728|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
14869729|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
14869730|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869731|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869732|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14869733|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14869734|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14869735|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
14869736|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
14869737|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
14869738|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
14712106|NCT00441740|Gemcitabine|gemcitabine|mesh-list
14712107|NCT00441740|Docetaxel|docetaxel|mesh-list
14712108|NCT00441740|Vinorelbine|vinorelbine|mesh-list
14712109|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14712110|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
14712111|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712112|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712113|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
14712114|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712115|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869739|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712116|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712117|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
14712118|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712119|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14712120|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14869740|NCT01130025|Tinzaparin|tinzaparin|mesh-list
14869741|NCT01130025|Warfarin|warfarin|mesh-list
14869742|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
14869743|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14869744|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14869745|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869746|NCT01130077|Poly ICLC|poly iclc|mesh-list
14869747|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
14869748|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
14869749|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869750|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
14869751|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14869752|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869753|NCT01130181|Vitamins|vitamins|mesh-ancestor
14869754|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
14869755|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14869756|NCT01130194|Procarbazine|procarbazine|mesh-list
14869757|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869758|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
14869759|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14869760|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869761|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869762|NCT01130259|Iniparib|iniparib|mesh-list
14869763|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14869764|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869765|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869766|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869767|NCT01130298|Testosterone|testosterone|mesh-list
14869768|NCT01130298|Androgens|androgens|mesh-ancestor
14869769|NCT01130298|Hormones|hormones|mesh-ancestor
14869770|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869771|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913963|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
14712121|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14712122|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14712123|NCT00441844|Simvastatin|simvastatin|mesh-list
14712124|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14712125|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14712126|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
14712127|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712128|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14913964|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913965|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14913966|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14913967|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15211469|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211470|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15211471|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211472|NCT02862171|Dapivirine|dapivirine|mesh-list
15211473|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15211474|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15211475|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
15211476|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869772|NCT01130311|Vitamin D|vitamin d|mesh-list
14869773|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
14869774|NCT01130311|Vitamins|vitamins|mesh-ancestor
14869775|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
14869776|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869777|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14869778|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14869779|NCT01130324|Telavancin|telavancin|mesh-list
14869780|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14869781|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869782|NCT01130376|Aldesleukin|aldesleukin|mesh-list
14869783|NCT01130376|Interleukin-2|interleukin-2|mesh-list
14869784|NCT01130376|Hormones|hormones|mesh-list
14869785|NCT01130376|Sargramostim|sargramostim|mesh-list
14869786|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869787|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869788|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869789|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14869790|NCT01130376|Analgesics|analgesics|mesh-ancestor
14869791|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
14869792|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869793|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
14869794|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14869795|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14869796|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
14869797|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869798|NCT01130467|Methylphenidate|methylphenidate|mesh-list
14869799|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14869800|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14869801|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869802|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14869803|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14869804|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14869805|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869806|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
14869807|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869808|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14869809|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
14869810|NCT01130506|Cytarabine|cytarabine|mesh-list
14869811|NCT01130506|Decitabine|decitabine|mesh-list
14869812|NCT01130506|Vorinostat|vorinostat|mesh-list
14869813|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869814|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
14869815|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869816|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296244|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
14296245|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
14869817|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
14869818|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869819|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869820|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
14869821|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869822|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869823|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14869824|NCT01130636|Oseltamivir|oseltamivir|mesh-list
14869825|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
14869826|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869827|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869828|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869829|NCT01130662|Decitabine|decitabine|mesh-list
14869830|NCT01130662|Midostaurin|midostaurin|mesh-list
14869831|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869832|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
14869833|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869834|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869835|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869836|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869837|NCT01130688|Zileuton|zileuton|mesh-list
14869838|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14869839|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14869840|NCT01130688|Analgesics|analgesics|mesh-ancestor
14869841|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
14869842|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869843|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869844|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14869845|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14869846|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14869847|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869848|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869849|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14869850|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
14869851|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14869852|NCT01130701|Capecitabine|capecitabine|mesh-list
14869853|NCT01130701|Panitumumab|panitumumab|mesh-list
14869854|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869855|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
14869856|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869857|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869858|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869859|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14869860|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869861|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211477|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
15211478|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15211479|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
15211480|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712129|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14712130|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712131|NCT00441870|Folic Acid|folic acid|mesh-list
14712132|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
14712133|NCT00441870|Hematinics|hematinics|mesh-ancestor
14712134|NCT00441870|Vitamins|vitamins|mesh-ancestor
14712135|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
14712136|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712137|NCT00441909|UC-781|uc-781|mesh-list
15211481|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211482|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15211483|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
14869862|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869863|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869864|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14869865|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869866|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869867|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869868|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869869|NCT01130805|Capecitabine|capecitabine|mesh-list
14869870|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
14869871|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869872|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
14869873|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869874|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869875|NCT01130909|Ketamine|ketamine|mesh-list
14869876|NCT01130909|Analgesics|analgesics|mesh-ancestor
14869877|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
14869878|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869879|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869880|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14869881|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14869882|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
14869883|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
14869884|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869885|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14869886|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14869887|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14869888|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869889|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
14869890|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14869891|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14869892|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869893|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14869894|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14869895|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869896|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869897|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211484|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14712138|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14869898|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14869899|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
14869900|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14869901|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869902|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14869903|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14869904|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14869905|NCT01131000|Ibuprofen|ibuprofen|mesh-list
14869906|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14869907|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14869908|NCT01131000|Analgesics|analgesics|mesh-ancestor
14869909|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
14869910|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14869911|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869912|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14869913|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14869914|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14869915|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869916|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869917|NCT01131026|Amoxicillin|amoxicillin|mesh-list
14869918|NCT01131026|Levofloxacin|levofloxacin|mesh-list
14869919|NCT01131026|Ofloxacin|ofloxacin|mesh-list
14869920|NCT01131026|Lansoprazole|lansoprazole|mesh-list
14869921|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
14869922|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14869923|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869924|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14869925|NCT01131026|Renal Agents|renal agents|mesh-ancestor
14869926|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14869927|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14869928|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869929|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869930|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869931|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14869932|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14869933|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14869934|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14869935|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14869936|NCT01131039|Gemcitabine|gemcitabine|mesh-list
14869937|NCT01131039|Bevacizumab|bevacizumab|mesh-list
15211485|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
15211486|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211487|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211488|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15211489|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
15211490|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
15211491|NCT02836899|Protective Agents|protective agents|mesh-ancestor
15211492|NCT02824575|Paclitaxel|paclitaxel|mesh-list
15211493|NCT02824575|Rebastinib|rebastinib|mesh-list
15211494|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211495|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211496|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211497|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211498|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211499|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211500|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211501|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869938|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869939|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869940|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869941|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869942|NCT01131039|Growth Substances|growth substances|mesh-ancestor
14869943|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869944|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869945|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211502|NCT02822378|Vitamin D|vitamin d|mesh-list
14712139|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
14712140|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712141|NCT00441922|Docetaxel|docetaxel|mesh-list
14712142|NCT00441922|Vinorelbine|vinorelbine|mesh-list
14712143|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712144|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
14712145|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
14869946|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
14869947|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869948|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
14869949|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14869950|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869951|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869952|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
14869953|NCT01131195|Paclitaxel|paclitaxel|mesh-list
14869954|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
14869955|NCT01131195|Bevacizumab|bevacizumab|mesh-list
14869956|NCT01131195|Capecitabine|capecitabine|mesh-list
14869957|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14869958|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869959|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
14869960|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
14869961|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
14869962|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869963|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14869964|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
14869965|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869966|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14869967|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14869968|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
14869969|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14869970|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14869971|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14869972|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14869973|NCT01131195|Growth Substances|growth substances|mesh-ancestor
14869974|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
14869975|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14869976|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
14869977|NCT01131234|Cediranib|cediranib|mesh-list
14869978|NCT01131234|R04929097|r04929097|mesh-list
14869979|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14869980|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869981|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869982|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14869983|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14869984|NCT01131247|Ofatumumab|ofatumumab|mesh-list
14869985|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14869986|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14869987|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
14869988|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14869989|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14869990|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
14869991|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14869992|NCT01131273|Buprenorphine|buprenorphine|mesh-list
14869993|NCT01131273|Methadone|methadone|mesh-list
14869994|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14869995|NCT01131273|Naloxone|naloxone|mesh-list
14869996|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14869997|NCT01131273|Narcotics|narcotics|mesh-ancestor
14869998|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14869999|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712146|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
14712147|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712148|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14712149|NCT00441961|Methotrexate|methotrexate|mesh-list
14870000|NCT01131273|Analgesics|analgesics|mesh-ancestor
14870001|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
14870002|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870003|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14870004|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
14870005|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870006|NCT01131364|Doxorubicin|doxorubicin|mesh-list
14870007|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14870008|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870009|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14870010|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14870011|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870012|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712150|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14712151|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
14712152|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14712153|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712154|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14870013|NCT01131377|Acetazolamide|acetazolamide|mesh-list
14870014|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
14870015|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14712155|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
14712156|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712157|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712158|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14870016|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870017|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870018|NCT01131377|Diuretics|diuretics|mesh-ancestor
14870019|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
14870020|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870021|NCT01131429|Cisplatin|cisplatin|mesh-list
14870022|NCT01131429|Docetaxel|docetaxel|mesh-list
14870023|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14870024|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870025|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14870026|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14870027|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14870028|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870029|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14870030|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870031|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
14870032|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14870033|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
14712159|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870034|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712160|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14712161|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712162|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
14712163|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712164|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14712165|NCT00442026|Gemcitabine|gemcitabine|mesh-list
14712166|NCT00442026|Docetaxel|docetaxel|mesh-list
14296246|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14296247|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296248|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
14296249|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14296250|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14296251|NCT00586898|Ketoconazole|ketoconazole|mesh-list
14296252|NCT00586898|Bicalutamide|bicalutamide|mesh-list
14296253|NCT00586898|Testosterone|testosterone|mesh-list
14296254|NCT00586898|Estrogens|estrogens|mesh-list
14296255|NCT00586898|Androgens|androgens|mesh-ancestor
14296256|NCT00586898|Hormones|hormones|mesh-ancestor
14296257|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296258|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296259|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296260|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
14296261|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712167|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14712168|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
14712169|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712170|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712171|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
14712172|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712173|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712174|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712175|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
14712176|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712177|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
14712178|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
14712179|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
14712180|NCT00442052|Aspirin|aspirin|mesh-list
14712181|NCT00442052|Omeprazole|omeprazole|mesh-list
14712182|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712183|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712184|NCT00442052|Analgesics|analgesics|mesh-ancestor
14712185|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
14712186|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870035|NCT01131468|Expectorants|expectorants|mesh-ancestor
14870036|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870037|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14870038|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
14870039|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870040|NCT01131468|Protective Agents|protective agents|mesh-ancestor
14870041|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870042|NCT01131468|Antidotes|antidotes|mesh-ancestor
14870043|NCT01131546|Amlodipine|amlodipine|mesh-list
14870044|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14870045|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14870046|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870047|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870048|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14870049|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870050|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
14870051|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14870052|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14870053|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870054|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14870055|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14870056|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870057|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870058|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
14870059|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870060|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
14870061|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14870062|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
14870063|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870064|NCT01131572|Expectorants|expectorants|mesh-ancestor
14870065|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870066|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14870067|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
14712187|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712188|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712189|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712190|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14712191|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14870068|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870069|NCT01131572|Protective Agents|protective agents|mesh-ancestor
14870070|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870071|NCT01131572|Antidotes|antidotes|mesh-ancestor
14870072|NCT01131689|Sorafenib|sorafenib|mesh-list
14870073|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870074|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14870075|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870076|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870077|NCT01131702|Ranitidine|ranitidine|mesh-list
14712192|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712193|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14712194|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14712195|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712196|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
15211503|NCT02822378|Calcium|calcium|mesh-list
15211504|NCT02822378|Vitamins|vitamins|mesh-ancestor
15211505|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
14712197|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712198|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712199|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14712200|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14712201|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14712202|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712203|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712204|NCT00442221|Naproxen|naproxen|mesh-list
14712205|NCT00442221|Sumatriptan|sumatriptan|mesh-list
14712206|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712207|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712208|NCT00442221|Analgesics|analgesics|mesh-ancestor
14712209|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
14712210|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211506|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211507|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15211508|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15211509|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
15211510|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14712211|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712212|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712213|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712214|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
14712215|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14712216|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712217|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712218|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14712219|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14712220|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14712221|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
14712222|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870078|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14870079|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712223|NCT00442234|Monteplase|monteplase|mesh-list
14712224|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14712225|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14870080|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870081|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14870082|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
14870083|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
14870084|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870085|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870086|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870087|NCT01131728|Naproxen|naproxen|mesh-list
14870088|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
15211511|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712226|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712227|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14712228|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14712229|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
14712230|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14712231|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14712232|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712233|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712234|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712235|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712236|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14712237|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14712238|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14712239|NCT00442325|Atorvastatin|atorvastatin|mesh-list
14712240|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14712241|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14712242|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
14712243|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870089|NCT01131728|Ephedrine|ephedrine|mesh-list
15211512|NCT02807181|Gemcitabine|gemcitabine|mesh-list
15211513|NCT02807181|Cisplatin|cisplatin|mesh-list
15211514|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211515|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211516|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
15211517|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211518|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
15211519|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211520|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211521|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211522|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
15211523|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211524|NCT02749968|Bupivacaine|bupivacaine|mesh-list
14712244|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14712245|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14712246|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712247|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
14712248|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870090|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14870091|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14870092|NCT01131728|Analgesics|analgesics|mesh-ancestor
14870093|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
14870094|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870095|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870096|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870097|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14870098|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
14870099|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14870100|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870101|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870102|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870103|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
14870104|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870105|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870106|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
14870107|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14870108|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15211525|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
15211526|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
15211527|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15211528|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211529|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
15211530|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211531|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
15211532|NCT02730546|Leucovorin|leucovorin|mesh-list
15211533|NCT02730546|Folic Acid|folic acid|mesh-list
15211534|NCT02730546|Paclitaxel|paclitaxel|mesh-list
14712249|NCT00442403|Chloroquine|chloroquine|mesh-list
14712250|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14712251|NCT00442403|Amebicides|amebicides|mesh-ancestor
14712252|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14712253|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14712254|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712255|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
14712256|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712257|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712258|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14712259|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
14712260|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14712261|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712262|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14712263|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870109|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
14870110|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870111|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870112|NCT01131741|Epinephrine|epinephrine|mesh-list
14870113|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14870114|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14870115|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870116|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870117|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870118|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870119|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14870120|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870121|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
14712264|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712265|NCT00442481|Citalopram|citalopram|mesh-list
15211535|NCT02730546|Carboplatin|carboplatin|mesh-list
14712266|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14712267|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14712268|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712269|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712270|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712271|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
15211536|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
14870122|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211537|NCT02730546|Fluorouracil|fluorouracil|mesh-list
14712272|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712273|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14870123|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14712274|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
14870124|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870125|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
14870126|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
14870127|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14870128|NCT01131754|Heparin|heparin|mesh-list
14870129|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
14870130|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14870131|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14870132|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870133|NCT01131767|Naproxen|naproxen|mesh-list
14870134|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
14870135|NCT01131767|Ephedrine|ephedrine|mesh-list
14870136|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14870137|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14870138|NCT01131767|Analgesics|analgesics|mesh-ancestor
14870139|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
14870140|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712275|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14712276|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
14712277|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712278|NCT00442546|Pregabalin|pregabalin|mesh-list
14712279|NCT00442546|Analgesics|analgesics|mesh-ancestor
14712280|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
15211538|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
14870141|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870142|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15211539|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15211540|NCT02730546|Calcium|calcium|mesh-list
15211541|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
15211542|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211543|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211544|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211545|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211546|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
14712281|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712282|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712283|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
14712284|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14712285|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870143|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211547|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211548|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15211549|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211550|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14870144|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
14870145|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14870146|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870147|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870148|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870149|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
14870150|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870151|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870152|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
14870153|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14870154|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14870155|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
14870156|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870157|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870158|NCT01131780|Ibuprofen|ibuprofen|mesh-list
14870159|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
14870160|NCT01131780|Ephedrine|ephedrine|mesh-list
14870161|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14870162|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14870163|NCT01131780|Analgesics|analgesics|mesh-ancestor
14870164|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
14870165|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870166|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870167|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870168|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14870169|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14870170|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870171|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870172|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870173|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
14870174|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870175|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870176|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
14870177|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14870178|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14870179|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
14870180|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870181|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870182|NCT01131806|Fluticasone|fluticasone|mesh-list
14870183|NCT01131806|Xhance|xhance|mesh-list
14870184|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14870185|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14870186|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870187|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870188|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
14870189|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870190|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870191|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870192|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870193|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
14870194|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14870195|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14870196|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14870197|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15211551|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211552|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
15211553|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14870198|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870199|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870200|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870201|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
14870202|NCT01131806|Hormones|hormones|mesh-ancestor
14870203|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870204|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
14870205|NCT01131845|Treprostinil|treprostinil|mesh-list
14870206|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14870207|NCT01131897|Levetiracetam|levetiracetam|mesh-list
14870208|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
14870209|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
14870210|NCT01131910|Vaccines|vaccines|mesh-list
14870211|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
14870212|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870213|NCT01131923|Amlodipine|amlodipine|mesh-list
15211554|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870214|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14870215|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15211555|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
15211556|NCT02730546|Antidotes|antidotes|mesh-ancestor
14712286|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712287|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14712288|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14712289|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14712290|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870216|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870217|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870218|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14870219|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870220|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
14870221|NCT01131936|Amlodipine|amlodipine|mesh-list
14870222|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14712291|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14712292|NCT00442585|Ibuprofen|ibuprofen|mesh-list
14712293|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712294|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712295|NCT00442585|Analgesics|analgesics|mesh-ancestor
14712296|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
14712297|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712298|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870223|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14870224|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870225|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870226|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14870227|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870228|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
14870229|NCT01131949|Lamotrigine|lamotrigine|mesh-list
14870230|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
14870231|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14870232|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870233|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870234|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14870235|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870236|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14870237|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14870238|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870239|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14870240|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14870241|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
14870242|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14870243|NCT01131975|Lamotrigine|lamotrigine|mesh-list
14870244|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
14870245|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14870246|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870247|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870248|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14870249|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870250|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14870251|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14870252|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870253|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14870254|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14870255|NCT01131988|Tacrolimus|tacrolimus|mesh-list
14870256|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870257|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
14870258|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870259|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14870260|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211557|NCT02730546|Protective Agents|protective agents|mesh-ancestor
14712299|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712300|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712301|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14712302|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712303|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712304|NCT00442637|Bevacizumab|bevacizumab|mesh-list
14712305|NCT00442637|Capecitabine|capecitabine|mesh-list
14712306|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14712307|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712308|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14712309|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14870261|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870262|NCT01132027|Tacrolimus|tacrolimus|mesh-list
14870263|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870264|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
14870265|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870266|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14870267|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870268|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870269|NCT01132040|Primidone|primidone|mesh-list
14870270|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
14712310|NCT00442637|Growth Substances|growth substances|mesh-ancestor
14712311|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712312|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211558|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
15211559|NCT02730546|Vitamins|vitamins|mesh-ancestor
15211560|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
15211561|NCT02730546|Hematinics|hematinics|mesh-ancestor
15211562|NCT02713776|Pasireotide|pasireotide|mesh-list
15211563|NCT02713776|Somatostatin|somatostatin|mesh-list
15211564|NCT02713776|Hormones|hormones|mesh-ancestor
14870271|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
14870272|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
14870273|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870274|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870275|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913968|NCT01378156|Vaccines|vaccines|mesh-list
14913969|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
14913970|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14913971|NCT01378286|Artesunate|artesunate|mesh-list
15211565|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211566|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211567|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
15211568|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211569|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913972|NCT01378286|Chloroquine|chloroquine|mesh-list
14913973|NCT01378286|Amodiaquine|amodiaquine|mesh-list
14913974|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
14913975|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14913976|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14913977|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14913978|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913979|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
14913980|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
14913981|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14913982|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
14913983|NCT01378286|Amebicides|amebicides|mesh-ancestor
14913984|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14913985|NCT01378481|Vorinostat|vorinostat|mesh-list
14913986|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913987|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14913988|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14913989|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913990|NCT01378533|Paclitaxel|paclitaxel|mesh-list
14913991|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
14913992|NCT01378533|Carboplatin|carboplatin|mesh-list
14712313|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14712314|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
14712315|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14913993|NCT01378533|Epirubicin|epirubicin|mesh-list
14913994|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14913995|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14913996|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
14913997|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211570|NCT02637531|Nivolumab|nivolumab|mesh-list
14712316|NCT00442676|Celecoxib|celecoxib|mesh-list
14712317|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712318|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712319|NCT00442676|Analgesics|analgesics|mesh-ancestor
14712320|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
14712321|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712322|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712323|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15211571|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14913998|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
14913999|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914000|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14914001|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
14712324|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14870276|NCT01132157|Propofol|propofol|mesh-list
14870277|NCT01132157|Desflurane|desflurane|mesh-list
14870278|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14870279|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870280|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870281|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14870282|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
14870283|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
14870284|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14870285|NCT01132170|Valproic Acid|valproic acid|mesh-list
14870286|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
14870287|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870288|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870289|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
14870290|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870291|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870292|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
14870293|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14870294|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15211572|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211573|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15211574|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211575|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
15211576|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14870295|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14870296|NCT01132183|Valproic Acid|valproic acid|mesh-list
14870297|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
15211577|NCT02573233|Fluticasone|fluticasone|mesh-list
14296262|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14712325|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14712326|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14712327|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712328|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712329|NCT00442741|Epothilone B|epothilone b|mesh-list
15211578|NCT02573233|Xhance|xhance|mesh-list
15211579|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
15211580|NCT02573233|Budesonide|budesonide|mesh-list
15211581|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
15211582|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14712330|NCT00442741|Epothilones|epothilones|mesh-list
14712331|NCT00442741|Omeprazole|omeprazole|mesh-list
14712332|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712333|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211583|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15211584|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870298|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870299|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211585|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
14870300|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
15211586|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870301|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870302|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870303|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
14870304|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14870305|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870306|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14870307|NCT01132196|Valproic Acid|valproic acid|mesh-list
14870308|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
14870309|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870310|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870311|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
14870312|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870313|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870314|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
14870315|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14870316|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870317|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14870318|NCT01132222|Ibuprofen|ibuprofen|mesh-list
14870319|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
14870320|NCT01132222|Ephedrine|ephedrine|mesh-list
14870321|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14870322|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14870323|NCT01132222|Analgesics|analgesics|mesh-ancestor
14870324|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
14870325|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870326|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870327|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870328|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14870329|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14870330|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211587|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211588|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15211589|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
15211590|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211591|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15211592|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
15211593|NCT02573233|Hormones|hormones|mesh-ancestor
15211594|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211595|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15211596|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15211597|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15211598|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
15211599|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712334|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14712335|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712336|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712337|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712338|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
14712339|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211600|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211601|NCT02568267|Entrectinib|entrectinib|mesh-list
14712340|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
14712341|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
14870331|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870332|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15211602|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211603|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211604|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225124|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225125|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225126|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
15225127|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225128|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15225129|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15225130|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15225131|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15225132|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225133|NCT05193214|Antibodies|antibodies|mesh-list
15225134|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15225135|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
15225136|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225137|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15225138|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225139|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225140|NCT05192902|Anesthetics|anesthetics|mesh-list
15225141|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225142|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225143|NCT05192681|Docetaxel|docetaxel|mesh-list
15225144|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225145|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
14712342|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14712343|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14870333|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
14870334|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870335|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870336|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
14870337|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14296263|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14296264|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712344|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14712345|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
14712346|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712347|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712348|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728761|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14728762|NCT00520000|Paclitaxel|paclitaxel|mesh-list
14728763|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728764|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14728765|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
14728766|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
14728767|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
14728768|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728769|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
14728770|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
14728771|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728772|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728773|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728774|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
14728775|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14728776|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728777|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728778|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
14728779|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14728780|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728781|NCT00520091|Celecoxib|celecoxib|mesh-list
14728782|NCT00520091|Irinotecan|irinotecan|mesh-list
14728783|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728784|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14728785|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14870338|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14870339|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
14870340|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870341|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870342|NCT01132235|Etanercept|etanercept|mesh-list
14870343|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14870344|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712349|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
14712350|NCT00442793|Hematinics|hematinics|mesh-ancestor
14712351|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
15211605|NCT02439658|Sotalol|sotalol|mesh-list
15211606|NCT02439658|Dofetilide|dofetilide|mesh-list
14870345|NCT01132235|Analgesics|analgesics|mesh-ancestor
14870346|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
14870347|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870348|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870349|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870350|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14870351|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870352|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870353|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
14870354|NCT01132248|Mefloquine|mefloquine|mesh-list
14870355|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
14870356|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14870357|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15211607|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15211608|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15211609|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
15211610|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211611|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211612|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211613|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15211614|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
14870358|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870359|NCT01132352|Levetiracetam|levetiracetam|mesh-list
14870360|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
15211615|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
14712352|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
15211616|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211617|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14870361|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
14870362|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
14870363|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
14870364|NCT01132404|Leuprolide|leuprolide|mesh-list
14870365|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14712353|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14712354|NCT00442819|Protective Agents|protective agents|mesh-ancestor
14712355|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211618|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15211619|NCT02425904|Clofarabine|clofarabine|mesh-list
15211620|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211621|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
15211622|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211623|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211624|NCT02420795|TIC10 compound|tic10 compound|mesh-list
14712356|NCT00442832|Vancomycin|vancomycin|mesh-list
14712357|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14712358|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712359|NCT00442845|Atorvastatin|atorvastatin|mesh-list
14712360|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14712361|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14712362|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
14712363|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712364|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15211625|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211626|NCT02403323|Etrolizumab|etrolizumab|mesh-list
14712365|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14712366|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870366|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
14870367|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15211627|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870368|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870369|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14870370|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870371|NCT01132417|Tigecycline|tigecycline|mesh-list
14870372|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870373|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870374|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14870375|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870376|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870377|NCT01132443|Clindamycin|clindamycin|mesh-list
14870378|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
14870379|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
14870380|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14870381|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870382|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870383|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14870384|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870385|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870386|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
14870387|NCT01132521|Urinastatin|urinastatin|mesh-list
14870388|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
14870389|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14870390|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
14870391|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870392|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870393|NCT01132573|Clofarabine|clofarabine|mesh-list
14870394|NCT01132573|Entinostat|entinostat|mesh-list
14870395|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14870396|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14870397|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
14870398|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870399|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870400|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870401|NCT01132586|Cytarabine|cytarabine|mesh-list
14870402|NCT01132586|Lenalidomide|lenalidomide|mesh-list
14870403|NCT01132586|Idarubicin|idarubicin|mesh-list
14870404|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14870405|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
14870406|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870407|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870408|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
14870409|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870410|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870411|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
14870412|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870413|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14870414|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14870415|NCT01132586|Growth Substances|growth substances|mesh-ancestor
14870416|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
14870417|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14870418|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14870419|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14870420|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870421|NCT01132599|Choline|choline|mesh-list
14870422|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
14870423|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14870424|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
14870425|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870426|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870427|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14870428|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
14870429|NCT01132638|Esomeprazole|esomeprazole|mesh-list
14870430|NCT01132638|Pantoprazole|pantoprazole|mesh-list
14870431|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14870432|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870433|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14870434|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870435|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870436|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
14870437|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14870438|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14870439|NCT01132677|Prednisolone|prednisolone|mesh-list
14870440|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
14870441|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14870442|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
14870443|NCT01132677|Hylan|hylan|mesh-list
14870444|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870445|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
15211628|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
15211629|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211630|NCT02384759|Aflibercept|aflibercept|mesh-list
15211631|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15211632|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15211633|NCT02384759|Growth Substances|growth substances|mesh-ancestor
15211634|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211635|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211636|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211637|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
15211638|NCT02367846|NuvaRing|nuvaring|mesh-list
15211639|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
15211640|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15211641|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15211642|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712367|NCT00443105|Tacrolimus|tacrolimus|mesh-list
14712368|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712369|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
14712370|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712371|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14870446|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
14870447|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870448|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712372|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712373|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712374|NCT00443144|Hormones|hormones|mesh-list
14712375|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14712376|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211643|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14870449|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870450|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
14870451|NCT01132677|Hormones|hormones|mesh-ancestor
14870452|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870453|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14870454|NCT01132677|Protective Agents|protective agents|mesh-ancestor
14870455|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14870456|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870457|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
14870458|NCT01132703|Glyburide|glyburide|mesh-list
14870459|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14870460|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870461|NCT01132716|Valacyclovir|valacyclovir|mesh-list
14870462|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
14870463|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870464|NCT01132729|Valacyclovir|valacyclovir|mesh-list
14870465|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
15211644|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15211645|NCT02274662|Cyclosporine|cyclosporine|mesh-list
14712377|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
14712378|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
14712379|NCT00443170|Midazolam|midazolam|mesh-list
14712380|NCT00443170|Caffeine|caffeine|mesh-list
14712381|NCT00443170|Omeprazole|omeprazole|mesh-list
14712382|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14712383|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14712384|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712385|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870466|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870467|NCT01132768|Atenolol|atenolol|mesh-list
14712386|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14870468|NCT01132768|Olmesartan|olmesartan|mesh-list
14870469|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14870470|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14870471|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14712387|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14712388|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14870472|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14870473|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870474|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14870475|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
14870476|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
15211646|NCT02274662|Tacrolimus|tacrolimus|mesh-list
15211647|NCT02274662|Cyclosporins|cyclosporins|mesh-list
15211648|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14712389|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14870477|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870478|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870479|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14870480|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14870481|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14870482|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870483|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870484|NCT01132781|Theophylline|theophylline|mesh-list
14870485|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870486|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
14870487|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870488|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870489|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870490|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870491|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14870492|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870493|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870494|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
14870495|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14870496|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14712390|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
14712391|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
14712392|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
14712393|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
14712394|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712395|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712396|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712397|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712398|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14712399|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712400|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14712401|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14712402|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14712403|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14712404|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
14712405|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14712406|NCT00443170|Analgesics|analgesics|mesh-ancestor
14712407|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
14712408|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712409|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712410|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712411|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870497|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
14870498|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870499|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
14870500|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14870501|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870502|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870503|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15211649|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
15211650|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211651|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
15211652|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211653|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15211654|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225146|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211655|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211656|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
15211657|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211658|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211659|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211660|NCT02243878|Ranibizumab|ranibizumab|mesh-list
15211661|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14712412|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712413|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14712414|NCT00443222|Infliximab|infliximab|mesh-list
14712415|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
14712416|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211662|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14870504|NCT01132794|Analgesics|analgesics|mesh-ancestor
14870505|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
14870506|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870507|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15211663|NCT02243878|Growth Substances|growth substances|mesh-ancestor
15211664|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211665|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211666|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211667|NCT02199691|Vaccines|vaccines|mesh-list
15211668|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
15211669|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211670|NCT02199665|Dexamethasone|dexamethasone|mesh-list
15211671|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15211672|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
15211673|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
15211674|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211675|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211676|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211677|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
15211678|NCT02199665|Hormones|hormones|mesh-ancestor
15211679|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211680|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14712417|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712418|NCT00443235|Thalidomide|thalidomide|mesh-list
14712419|NCT00443235|Prednisone|prednisone|mesh-list
14712420|NCT00443235|Melphalan|melphalan|mesh-list
14712421|NCT00443235|Bortezomib|bortezomib|mesh-list
14712422|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712423|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
14712424|NCT00443235|Hormones|hormones|mesh-ancestor
14712425|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14712426|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712427|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14712428|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712429|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14712430|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
14712431|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712432|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14712433|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712434|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
14712435|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
14712436|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870508|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15211681|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712437|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211682|NCT02163694|Paclitaxel|paclitaxel|mesh-list
14712438|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14712439|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14712440|NCT00443235|Growth Substances|growth substances|mesh-ancestor
14712441|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
14712442|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
14712443|NCT00443339|Hematinics|hematinics|mesh-ancestor
14712444|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
14712445|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14712446|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
14712447|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712448|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712449|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14712450|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
14712451|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14712452|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14712453|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14870509|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14870510|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870511|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870512|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870513|NCT01132911|Bortezomib|bortezomib|mesh-list
14870514|NCT01132911|Vorinostat|vorinostat|mesh-list
14870515|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870516|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14870517|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870518|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870519|NCT01132989|Lenalidomide|lenalidomide|mesh-list
14870520|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
14870521|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870522|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14870523|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14870524|NCT01132989|Growth Substances|growth substances|mesh-ancestor
14870525|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
14870526|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870527|NCT01133080|Minocycline|minocycline|mesh-list
14870528|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870529|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870530|NCT01133119|Bupivacaine|bupivacaine|mesh-list
14870531|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
14870532|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
14870533|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870534|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870535|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
14870536|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870537|NCT01133210|Maraviroc|maraviroc|mesh-list
14870538|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14870539|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14870540|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870541|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14870542|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14870543|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
14870544|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870545|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14870546|NCT01133223|Plasminogen|plasminogen|mesh-list
14870547|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14870548|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14870549|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14870550|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870551|NCT01133301|Naltrexone|naltrexone|mesh-list
14870552|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14870553|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14712454|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712455|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712456|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712457|NCT00443508|Everolimus|everolimus|mesh-list
14712458|NCT00443508|Tacrolimus|tacrolimus|mesh-list
14712459|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712460|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
14712461|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712462|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14712463|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870554|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712464|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712465|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712466|NCT00443521|Triamcinolone|triamcinolone|mesh-list
14712467|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14712468|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14712469|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14712470|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712471|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
14870555|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
14712472|NCT00443521|Hormones|hormones|mesh-ancestor
14712473|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870556|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870557|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
14870558|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14870559|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14870560|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870561|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870562|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870563|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870564|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870565|NCT01133366|Warfarin|warfarin|mesh-list
14870566|NCT01133366|Mipomersen|mipomersen|mesh-list
14870567|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
14870568|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14712474|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712475|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712476|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
14712477|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712478|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712479|NCT00443573|Protein C|protein c|mesh-list
14712480|NCT00443573|Anticoagulants|anticoagulants|mesh-list
14712481|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14712482|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14712483|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870569|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14870570|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
14870571|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870572|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14870573|NCT01133431|Glimepiride|glimepiride|mesh-list
14870574|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14870575|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14870576|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870577|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870578|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
14870579|NCT01133444|Finasteride|finasteride|mesh-list
14870580|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14870581|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15211683|NCT02163694|Carboplatin|carboplatin|mesh-list
15211684|NCT02163694|Veliparib|veliparib|mesh-list
14712484|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14712485|NCT00443612|Irbesartan|irbesartan|mesh-list
14712486|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14712487|NCT00443612|Diuretics|diuretics|mesh-ancestor
14712488|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
14870582|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870583|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870584|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
14870585|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870586|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870587|NCT01133444|Urological Agents|urological agents|mesh-ancestor
15211685|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211686|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211687|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211688|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211689|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211690|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211691|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15211692|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211693|NCT02143726|Everolimus|everolimus|mesh-list
15211694|NCT02143726|Sorafenib|sorafenib|mesh-list
15211695|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211696|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870588|NCT01133457|Finasteride|finasteride|mesh-list
14870589|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14870590|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14870591|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870592|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870593|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
14870594|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870595|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870596|NCT01133457|Urological Agents|urological agents|mesh-ancestor
14870597|NCT01133470|Fexofenadine|fexofenadine|mesh-list
14870598|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
15211697|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
15211698|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211699|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211700|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211701|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211702|NCT02091141|Trastuzumab|trastuzumab|mesh-list
15211703|NCT02091141|Pertuzumab|pertuzumab|mesh-list
14870599|NCT01133470|Ephedrine|ephedrine|mesh-list
14870600|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870601|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
14870602|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870603|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870604|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870605|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870606|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
15211704|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15211705|NCT02091141|Atezolizumab|atezolizumab|mesh-list
15211706|NCT02091141|Vemurafenib|vemurafenib|mesh-list
15211707|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14870607|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14870608|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14870609|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
14712489|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712490|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14712491|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712492|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712493|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14712494|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14712495|NCT00443690|Rolofylline|rolofylline|mesh-list
14712496|NCT00443690|Diuretics|diuretics|mesh-ancestor
14870610|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870611|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870612|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870613|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14870614|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14870615|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14870616|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
14870617|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
14870618|NCT01133483|Fexofenadine|fexofenadine|mesh-list
14870619|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
14870620|NCT01133483|Ephedrine|ephedrine|mesh-list
14870621|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14870622|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
14870623|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870624|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870625|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14870626|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870627|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
14870628|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14870629|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14870630|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
14870631|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870632|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870633|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870634|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14870635|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14712497|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
14712498|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712499|NCT00443716|Estrogens|estrogens|mesh-list
14712500|NCT00443716|Hormones|hormones|mesh-ancestor
14712501|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14712502|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712503|NCT00443794|Aspirin|aspirin|mesh-list
14712504|NCT00443794|Atenolol|atenolol|mesh-list
14712505|NCT00443794|Ramipril|ramipril|mesh-list
14712506|NCT00443794|Simvastatin|simvastatin|mesh-list
14712507|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14712508|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712509|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712510|NCT00443794|Analgesics|analgesics|mesh-ancestor
14712511|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
14712512|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712513|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712514|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712515|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712516|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14712517|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14712518|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712519|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14712520|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14712521|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712522|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
14712523|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14712524|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14712525|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
14712526|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14712527|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14712528|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14712529|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
14712530|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14712531|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14712532|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
14712533|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
15211708|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211709|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211710|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211711|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211712|NCT02088112|Durvalumab|durvalumab|mesh-list
15211713|NCT02088112|Gefitinib|gefitinib|mesh-list
15211714|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211715|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211716|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211717|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211718|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712534|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14712535|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14712536|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14712537|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712538|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712539|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712540|NCT00443794|Diuretics|diuretics|mesh-ancestor
14712541|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
14870636|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15211719|NCT02085148|Irinotecan|irinotecan|mesh-list
15211720|NCT02085148|Vincristine|vincristine|mesh-list
14870637|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
14870638|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
14870639|NCT01133496|Alendronate|alendronate|mesh-list
15211721|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15211722|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211723|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211724|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211725|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211726|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211727|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211728|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211729|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211730|NCT02076620|Doxorubicin|doxorubicin|mesh-list
15211731|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211732|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211733|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15211734|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211735|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211736|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211737|NCT02010593|Dapivirine|dapivirine|mesh-list
15211738|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14712542|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14712543|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14712544|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
14712545|NCT00443937|Everolimus|everolimus|mesh-list
14712546|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712547|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712548|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
14712549|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870640|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14870641|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870642|NCT01133509|Vaccines|vaccines|mesh-list
14870643|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
14870644|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870645|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
14870646|NCT01133548|Testosterone|testosterone|mesh-list
14870647|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
14870648|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
14870649|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14870650|NCT01133548|Androgens|androgens|mesh-ancestor
14870651|NCT01133548|Hormones|hormones|mesh-ancestor
14870652|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870653|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870654|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15211739|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14712550|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211740|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
15225147|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14870655|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870656|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
14870657|NCT01133600|Vancomycin|vancomycin|mesh-list
14870658|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870659|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870660|NCT01133743|Thalidomide|thalidomide|mesh-list
14870661|NCT01133743|Dexamethasone|dexamethasone|mesh-list
14870662|NCT01133743|Lenalidomide|lenalidomide|mesh-list
14870663|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870664|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
14870665|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
14870666|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870667|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870668|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211741|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211742|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15211743|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
15211744|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211745|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15211746|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
14712551|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14712552|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
14712553|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15211747|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211748|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211749|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15211750|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14712554|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712555|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712556|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712557|NCT00443950|Etanercept|etanercept|mesh-list
14712558|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712559|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712560|NCT00443950|Analgesics|analgesics|mesh-ancestor
14712561|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
14712562|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870669|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
14870670|NCT01133743|Hormones|hormones|mesh-ancestor
14870671|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870672|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14870673|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870674|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
14870675|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14870676|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14870677|NCT01133743|Growth Substances|growth substances|mesh-ancestor
14870678|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
14870679|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870680|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
14870681|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870682|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870683|NCT01133795|Midodrine|midodrine|mesh-list
14870684|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
14870685|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
14870686|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870687|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870688|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14870689|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14870690|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14870691|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14870692|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870693|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870694|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870695|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
14870696|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
14870697|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14870698|NCT01133873|Narcotics|narcotics|mesh-ancestor
14870699|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870700|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870701|NCT01133873|Analgesics|analgesics|mesh-ancestor
14870702|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
14870703|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870704|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
14870705|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
14870706|NCT01133886|Decitabine|decitabine|mesh-list
14870707|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14870708|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
14870709|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870710|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870711|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914002|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914003|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914004|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14914005|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
14914006|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14914007|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14914008|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14914009|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14914010|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914011|NCT01378546|Amifampridine|amifampridine|mesh-list
14914012|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14914013|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914014|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914015|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14914016|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14914017|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914018|NCT01378650|Cilostazol|cilostazol|mesh-list
14914019|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14914020|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
14712563|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712564|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712565|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712566|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870712|NCT01133912|Gemcitabine|gemcitabine|mesh-list
14870713|NCT01133912|Paclitaxel|paclitaxel|mesh-list
14870714|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14870715|NCT01133912|Lapatinib|lapatinib|mesh-list
14870716|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14870717|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870718|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
14870719|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
14870720|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
14870721|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870722|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14870723|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
14870724|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
14870725|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870726|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870727|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870728|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
14870729|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870730|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14870731|NCT01133925|Sirolimus|sirolimus|mesh-list
14870732|NCT01133925|Paclitaxel|paclitaxel|mesh-list
14870733|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14870734|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870735|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
14870736|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
14870737|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
14870738|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870739|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870740|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870741|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14870742|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
14870743|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870744|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
14870745|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870746|NCT01134185|Prucalopride|prucalopride|mesh-list
14870747|NCT01134185|Laxatives|laxatives|mesh-ancestor
14870748|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712567|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712568|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
14712569|NCT00443963|Esomeprazole|esomeprazole|mesh-list
14712570|NCT00443963|Ranitidine|ranitidine|mesh-list
14712571|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712572|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712573|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14712574|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712575|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712576|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14712577|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
14712578|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
14870749|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14870750|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14870751|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
14870752|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870753|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870754|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870755|NCT01134224|Insulin|insulin|mesh-list
14870756|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15211751|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15211752|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
15211753|NCT01946074|Paclitaxel|paclitaxel|mesh-list
15211754|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211755|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211756|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211757|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
15211758|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211759|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211760|NCT01932125|Bevacizumab|bevacizumab|mesh-list
15211761|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211762|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211763|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15211764|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14712579|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712580|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712581|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14870757|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
14870758|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
14870759|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14870760|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
14870761|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14870762|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
14870763|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14870764|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712582|NCT00444015|Dasatinib|dasatinib|mesh-list
14712583|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712584|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14712585|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712586|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870765|NCT01134289|Bupivacaine|bupivacaine|mesh-list
14870766|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
14870767|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
14870768|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
14870769|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870770|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870771|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
14870772|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870773|NCT01134341|Vitamins|vitamins|mesh-list
14870774|NCT01134341|Folic Acid|folic acid|mesh-list
14870775|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
14870776|NCT01134341|Hydroxocobalamin|hydroxocobalamin|mesh-list
14870777|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
14870778|NCT01134341|Bexarotene|bexarotene|mesh-list
14870779|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14870780|NCT01134341|Aminopterin|aminopterin|mesh-list
14870781|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
14712587|NCT00444041|Bevacizumab|bevacizumab|mesh-list
14870782|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870783|NCT01134341|Hematinics|hematinics|mesh-ancestor
14870784|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14712588|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14712589|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712590|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14712591|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14712592|NCT00444041|Growth Substances|growth substances|mesh-ancestor
14712593|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712594|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
14712595|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
14712596|NCT00444093|Loperamide|loperamide|mesh-list
14870785|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211765|NCT01932125|Growth Substances|growth substances|mesh-ancestor
14870786|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870787|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870788|NCT01134406|Hylan|hylan|mesh-list
14870789|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
14870790|NCT01134406|Protective Agents|protective agents|mesh-ancestor
14870791|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870792|NCT01134432|Prednisolone|prednisolone|mesh-list
14870793|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14870794|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
14870795|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14870796|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
14870797|NCT01134432|Rituximab|rituximab|mesh-list
14870798|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14870799|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
14870800|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14870801|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870802|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
14870803|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870804|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712597|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712598|NCT00444132|Clopidogrel|clopidogrel|mesh-list
14712599|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14712600|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14712601|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14712602|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14712603|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
14712604|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712605|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712606|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712607|NCT00444171|Insulin|insulin|mesh-list
14712608|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14712609|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14712610|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712611|NCT00444184|Timolol|timolol|mesh-list
14712612|NCT00444184|Travoprost|travoprost|mesh-list
14870805|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870806|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
14870807|NCT01134432|Hormones|hormones|mesh-ancestor
14870808|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870809|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14870810|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
14712613|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14712614|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14712615|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712616|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712617|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870811|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
14712618|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712619|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14870812|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870813|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870814|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14870815|NCT01134432|Protective Agents|protective agents|mesh-ancestor
14870816|NCT01134484|Thalidomide|thalidomide|mesh-list
14870817|NCT01134484|Dexamethasone|dexamethasone|mesh-list
14870818|NCT01134484|Bortezomib|bortezomib|mesh-list
14712620|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14712621|NCT00444223|Fluorides|fluorides|mesh-list
14712622|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
14712623|NCT00444223|Protective Agents|protective agents|mesh-ancestor
14870819|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870820|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
14870821|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
14870822|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870823|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870824|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870825|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
14870826|NCT01134484|Hormones|hormones|mesh-ancestor
14712624|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712625|NCT00444236|Esomeprazole|esomeprazole|mesh-list
14712626|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712627|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712628|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14712629|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870827|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870828|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14870829|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870830|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14870831|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
14870832|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
14870833|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870834|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870835|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14870836|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14870837|NCT01134484|Growth Substances|growth substances|mesh-ancestor
14870838|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
14870839|NCT01134523|Paclitaxel|paclitaxel|mesh-list
14870840|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14870841|NCT01134523|Epirubicin|epirubicin|mesh-list
14870842|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14870843|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712630|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712631|NCT00444249|Dipivefrin|dipivefrin|mesh-list
14712632|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14712633|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712634|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712635|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296265|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712636|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712637|NCT00444314|Sunitinib|sunitinib|mesh-list
14712638|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712639|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14712640|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14712641|NCT00444314|Growth Substances|growth substances|mesh-ancestor
14728786|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870844|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
14870845|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
14712642|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712643|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
14712644|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14712645|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712646|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712647|NCT00444340|Etanercept|etanercept|mesh-list
14712648|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14712649|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14712650|NCT00444340|Analgesics|analgesics|mesh-ancestor
14712651|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
14712652|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712653|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712654|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712655|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712656|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712657|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712658|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
14712659|NCT00444379|Ritonavir|ritonavir|mesh-list
14712660|NCT00444379|Lopinavir|lopinavir|mesh-list
14712661|NCT00444379|Tenofovir|tenofovir|mesh-list
14712662|NCT00444379|Emtricitabine|emtricitabine|mesh-list
14296266|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14296267|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
14296268|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14870846|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211766|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870847|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870848|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14870849|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14870850|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14870851|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870852|NCT01134536|Tapentadol|tapentadol|mesh-list
14870853|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14870854|NCT01134536|Narcotics|narcotics|mesh-ancestor
14870855|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712663|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14870856|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870857|NCT01134536|Analgesics|analgesics|mesh-ancestor
14870858|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
14870859|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870860|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14870861|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15211767|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
15211768|NCT01842035|Regadenoson|regadenoson|mesh-list
15211769|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15211770|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15211771|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
15211772|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
15211773|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211774|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211775|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211776|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
15211777|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15211778|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
14712664|NCT00444379|Efavirenz|efavirenz|mesh-list
14712665|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14712666|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14712667|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
14712668|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712669|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712670|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14870862|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14870863|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870864|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870865|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870866|NCT01134666|Cetuximab|cetuximab|mesh-list
14870867|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14870868|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870869|NCT01134692|Norfloxacin|norfloxacin|mesh-list
14870870|NCT01134692|Propranolol|propranolol|mesh-list
14870871|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14870872|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14870873|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
14870874|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870875|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870876|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870877|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14870878|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14870879|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
14870880|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870881|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870882|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14870883|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14870884|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870885|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870886|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14870887|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14870888|NCT01134718|Simeprevir|simeprevir|mesh-list
14870889|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
14870890|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870891|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
14870892|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870893|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870894|NCT01134848|Morphine|morphine|mesh-list
14870895|NCT01134848|Secretin|secretin|mesh-list
14870896|NCT01134848|Neostigmine|neostigmine|mesh-list
15211779|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211780|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15211781|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211782|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14712671|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14712672|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
14712673|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712674|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14712675|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14712676|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14712677|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14712678|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14712679|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14712680|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14712681|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14712682|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14712683|NCT00444418|Naltrexone|naltrexone|mesh-list
14712684|NCT00444418|Naloxone|naloxone|mesh-list
14870897|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14870898|NCT01134848|Narcotics|narcotics|mesh-ancestor
15211783|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211784|NCT01732627|Vaccines|vaccines|mesh-list
15211785|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
15211786|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211787|NCT01702571|Trastuzumab|trastuzumab|mesh-list
15211788|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14296269|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
14870899|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870900|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870901|NCT01134848|Analgesics|analgesics|mesh-ancestor
14870902|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
14870903|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870904|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14870905|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870906|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870907|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
14870908|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14870909|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14870910|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
14870911|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870912|NCT01134848|Hormones|hormones|mesh-ancestor
14870913|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870914|NCT01134861|Cisplatin|cisplatin|mesh-list
14870915|NCT01134861|Etoposide|etoposide|mesh-list
14870916|NCT01134861|Vinblastine|vinblastine|mesh-list
14870917|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870918|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14870919|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14870920|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14870921|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712685|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14712686|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14712687|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712688|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
14712689|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712690|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
14712691|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14712692|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14712693|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712694|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
14712695|NCT00444470|Coagulants|coagulants|mesh-ancestor
14712696|NCT00444522|Alprazolam|alprazolam|mesh-list
14712697|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14712698|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14870922|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870923|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
14870924|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
14870925|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
14870926|NCT01134926|Misoprostol|misoprostol|mesh-list
14870927|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14870928|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
14870929|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14712699|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712700|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14712701|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14712702|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14712703|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
14712704|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
14712705|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712706|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712707|NCT00444548|Reboxetine|reboxetine|mesh-list
14870930|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870931|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14870932|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870933|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
14870934|NCT01134965|Digoxin|digoxin|mesh-list
14870935|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14870936|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14870937|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870938|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870939|NCT01134965|Protective Agents|protective agents|mesh-ancestor
14870940|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870941|NCT01134991|Minocycline|minocycline|mesh-list
14870942|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14870943|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14870944|NCT01135056|Sorafenib|sorafenib|mesh-list
14870945|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870946|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14870947|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712708|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
14712709|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14712710|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14712711|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14712712|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712713|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712714|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712715|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712716|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712717|NCT00444561|Pramlintide|pramlintide|mesh-list
14712718|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14712719|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712720|NCT00444574|Methylphenidate|methylphenidate|mesh-list
14870948|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870949|NCT01135199|Pomalidomide|pomalidomide|mesh-list
14870950|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
14870951|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870952|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14870953|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14870954|NCT01135199|Growth Substances|growth substances|mesh-ancestor
14870955|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
14870956|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870957|NCT01135212|Candesartan|candesartan|mesh-list
14870958|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
14870959|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14870960|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14870961|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14870962|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870963|NCT01135290|Petrolatum|petrolatum|mesh-list
14870964|NCT01135290|Emollients|emollients|mesh-ancestor
14870965|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
14870966|NCT01135433|Metformin|metformin|mesh-list
14870967|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
14870968|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14870969|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870970|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14870971|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870972|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
14870973|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14870974|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870975|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14870976|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870977|NCT01135472|Esomeprazole|esomeprazole|mesh-list
14870978|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14870979|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870980|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14870981|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870982|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14870983|NCT01135550|Dexamethasone|dexamethasone|mesh-list
14870984|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
14870985|NCT01135550|BB 1101|bb 1101|mesh-list
14870986|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14870987|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
14870988|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
14870989|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14870990|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14870991|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14870992|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
14870993|NCT01135550|Hormones|hormones|mesh-ancestor
14870994|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14870995|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14870996|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14870997|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
14870998|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14870999|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712721|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14712722|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712723|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14712724|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14871000|NCT01135563|Sirolimus|sirolimus|mesh-list
14871001|NCT01135563|Vinblastine|vinblastine|mesh-list
14871002|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14712725|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712726|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712727|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
14712728|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728787|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728788|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14728789|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14728790|NCT00520091|Analgesics|analgesics|mesh-ancestor
14728791|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
14728792|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728793|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728794|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14728795|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728796|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14871003|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871004|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14871005|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871006|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
14871007|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871008|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
14871009|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871010|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14871011|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14871012|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14871013|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14871014|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871015|NCT01135589|Micafungin|micafungin|mesh-list
14871016|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
14871017|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871018|NCT01135602|Topiramate|topiramate|mesh-list
14871019|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
14871020|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871021|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871022|NCT01135615|Calcium|calcium|mesh-list
14871023|NCT01135615|Sevelamer|sevelamer|mesh-list
14871024|NCT01135615|Calcium acetate|calcium acetate|mesh-list
14871025|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14871026|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871027|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
14871028|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
14871029|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871030|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
14871031|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14871032|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871033|NCT01135641|Cyclosporine|cyclosporine|mesh-list
14871034|NCT01135641|Rituximab|rituximab|mesh-list
14871035|NCT01135641|Cyclosporins|cyclosporins|mesh-list
14871036|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14871037|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871038|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
14871039|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871040|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871041|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871042|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871043|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871044|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
14871045|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871046|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14871047|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14871048|NCT01135667|Clopidogrel|clopidogrel|mesh-list
14871049|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14871050|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14871051|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14871052|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14871053|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14871054|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
14871055|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871056|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871057|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871058|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
14871059|NCT01135680|Glycerol|glycerol|mesh-list
14871060|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871061|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871062|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14871063|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871064|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871065|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871066|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871067|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871068|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14871069|NCT01135680|Protective Agents|protective agents|mesh-ancestor
14871070|NCT01135758|Ketamine|ketamine|mesh-list
14871071|NCT01135758|Analgesics|analgesics|mesh-ancestor
14296270|NCT00587067|Floxuridine|floxuridine|mesh-list
14871072|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
14871073|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871074|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871075|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15211789|NCT01702571|Maytansine|maytansine|mesh-list
14871076|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15211790|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211791|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871077|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
14871078|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
14871079|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871080|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14871081|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14871082|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871083|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871084|NCT01135771|Insulin|insulin|mesh-list
14871085|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871086|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914021|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914022|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914023|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14914024|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
14914025|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14914026|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14914027|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914028|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914029|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914030|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14914031|NCT01378650|Protective Agents|protective agents|mesh-ancestor
14914032|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14914033|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14914034|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914035|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14914036|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14914037|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14914038|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
14914039|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914040|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914041|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14914042|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712729|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
14712730|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
14712731|NCT00444613|Vitamins|vitamins|mesh-ancestor
14712732|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
14712733|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712734|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14712735|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
14712736|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14712737|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
14712738|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14712739|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712740|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14712741|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14712742|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712743|NCT00444652|Enoxaparin|enoxaparin|mesh-list
14712744|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
15211792|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211793|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
15211794|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14712745|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14712746|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14712747|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712748|NCT00444665|Travoprost|travoprost|mesh-list
14712749|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15211795|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211796|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211797|NCT01581840|Panitumumab|panitumumab|mesh-list
15211798|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211799|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211800|NCT01578239|Octreotide|octreotide|mesh-list
15211801|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15211802|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211803|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15211804|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211805|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15211806|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211807|NCT01411267|Cytarabine|cytarabine|mesh-list
14914043|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
14914044|NCT01378741|Propofol|propofol|mesh-list
14914045|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14914046|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712750|NCT00444717|Pitavastatin|pitavastatin|mesh-list
14871087|NCT01135927|Insulin|insulin|mesh-list
14871088|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14871089|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
14871090|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871091|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871092|NCT01135953|Cycloserine|cycloserine|mesh-list
14871093|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14871094|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871095|NCT01135953|Renal Agents|renal agents|mesh-ancestor
14871096|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14871097|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
14871098|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871099|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
14871100|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871101|NCT01136005|Provitamins|provitamins|mesh-list
14871102|NCT01136005|Vitamins|vitamins|mesh-ancestor
14871103|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
14871104|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871105|NCT01136031|Paclitaxel|paclitaxel|mesh-list
14871106|NCT01136031|Irinotecan|irinotecan|mesh-list
14871107|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14871108|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871109|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
14871110|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14871111|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14871112|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871113|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14871114|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871115|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871116|NCT01136213|Fluoxetine|fluoxetine|mesh-list
14871117|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14871118|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14871119|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14871120|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871121|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871122|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
14871123|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871124|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14871125|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
14871126|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14871127|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14871128|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14871129|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871130|NCT01136252|Adalimumab|adalimumab|mesh-list
14871131|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14871132|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871133|NCT01136278|Clonidine|clonidine|mesh-list
14871134|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14871135|NCT01136278|Analgesics|analgesics|mesh-ancestor
14871136|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
14871137|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871138|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871139|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14871140|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
14871141|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
14871142|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14871143|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14871144|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14871145|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
14871146|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871147|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871148|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
14871149|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14871150|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
14871151|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14871152|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14871153|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14871154|NCT01136317|Omeprazole|omeprazole|mesh-list
14871155|NCT01136317|Rabeprazole|rabeprazole|mesh-list
14871156|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14871157|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871158|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14871159|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871160|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871161|NCT01136395|Rituximab|rituximab|mesh-list
14871162|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14871163|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871164|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
14871165|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871166|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871167|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
14871168|NCT01136421|Bromides|bromides|mesh-list
14871169|NCT01136421|Ipratropium|ipratropium|mesh-list
14871170|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
14871171|NCT01136421|Analgesics|analgesics|mesh-ancestor
14871172|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
14871173|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871174|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712751|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14712752|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14871175|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
14871176|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871177|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14871178|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14871179|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14871180|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871181|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14871182|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
14871183|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14871184|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14871185|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
14871186|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14871187|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
14871188|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14871189|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
14871190|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871191|NCT01136499|Panobinostat|panobinostat|mesh-list
14871192|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871193|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14871194|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871195|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871196|NCT01136525|Valacyclovir|valacyclovir|mesh-list
14871197|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
14871198|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712753|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14871199|NCT01136538|Valacyclovir|valacyclovir|mesh-list
14871200|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
14871201|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871202|NCT01136551|Huperzine A|huperzine a|mesh-list
14871203|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14871204|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871205|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871206|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
14871207|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871208|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871209|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14871210|NCT01136551|Protective Agents|protective agents|mesh-ancestor
14871211|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
14871212|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14871213|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14871214|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871215|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
14871216|NCT01136590|Coagulants|coagulants|mesh-ancestor
14871217|NCT01136642|Nicotine|nicotine|mesh-list
14871218|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14712754|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
14712755|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712756|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712757|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14712758|NCT00444756|Lidocaine|lidocaine|mesh-list
14712759|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
14871219|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
14871220|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871221|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871222|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14712760|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
14712761|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712762|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712763|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
14871223|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14871224|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
14871225|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871226|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871227|NCT01136759|Tenofovir|tenofovir|mesh-list
14871228|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
14871229|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871230|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14871231|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14871232|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871233|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871234|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14871235|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14871236|NCT01136850|Azithromycin|azithromycin|mesh-list
14871237|NCT01136850|Chloroquine|chloroquine|mesh-list
14871238|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
14871239|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
14871240|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14871241|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871242|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871243|NCT01136850|Amebicides|amebicides|mesh-ancestor
14871244|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14871245|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14871246|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
14871247|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871248|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14871249|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871250|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871251|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14871252|NCT01136850|Renal Agents|renal agents|mesh-ancestor
14871253|NCT01136863|Felodipine|felodipine|mesh-list
14871254|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14871255|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14712764|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712765|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14712766|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14712767|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14712768|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712769|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712770|NCT00444808|Calcitonin|calcitonin|mesh-list
14712771|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
14712772|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14712773|NCT00444808|Katacalcin|katacalcin|mesh-list
14712774|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14712775|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712776|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14712777|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
14871256|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14871257|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14871258|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871259|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14871260|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871261|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
14871262|NCT01136941|Zileuton|zileuton|mesh-list
14871263|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14871264|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14871265|NCT01136941|Analgesics|analgesics|mesh-ancestor
14871266|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
14871267|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871268|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871269|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712778|NCT00444834|Carvedilol|carvedilol|mesh-list
14712779|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14712780|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14712781|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712782|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712783|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712784|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712785|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14712786|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
14712787|NCT00444834|Protective Agents|protective agents|mesh-ancestor
14712788|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14712789|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712790|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14712791|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
14871270|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871271|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14871272|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871273|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871274|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14871275|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
14871276|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871277|NCT01136967|Lenvatinib|lenvatinib|mesh-list
14871278|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871279|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871280|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871281|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871282|NCT01137019|Everolimus|everolimus|mesh-list
14871283|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871284|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871285|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
14871286|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871287|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
14871288|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14871289|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14871290|NCT01137084|Prednisolone|prednisolone|mesh-list
14871291|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
14871292|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14871293|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
14871294|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14871295|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
14871296|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
14871297|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871298|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871299|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871300|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
14871301|NCT01137084|Hormones|hormones|mesh-ancestor
14871302|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871303|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14871304|NCT01137084|Protective Agents|protective agents|mesh-ancestor
14871305|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14871306|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871307|NCT01137253|Trimethaphan|trimethaphan|mesh-list
14871308|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
14871309|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14871310|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14871311|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14871312|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
14871313|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871314|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871315|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14871316|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15211808|NCT01411267|Methotrexate|methotrexate|mesh-list
14712792|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14712793|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14712794|NCT00444873|Lanreotide|lanreotide|mesh-list
14712795|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712796|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
14712797|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14712798|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14712799|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14712800|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712801|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712802|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
14712803|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712804|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712805|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14712806|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712807|NCT00445016|Anesthetics|anesthetics|mesh-list
14871317|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
14871318|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211809|NCT01411267|Etoposide|etoposide|mesh-list
14712808|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712809|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712810|NCT00445042|Sorafenib|sorafenib|mesh-list
14712811|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712812|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14712813|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712814|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712815|NCT00445055|Droperidol|droperidol|mesh-list
14712816|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14712817|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
14712818|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
14712819|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712820|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712821|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712822|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14712823|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14871319|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871320|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14871321|NCT01137383|Interferons|interferons|mesh-list
14871322|NCT01137383|Ribavirin|ribavirin|mesh-list
14871323|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
14871324|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
14712824|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14712825|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14712826|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14712827|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14712828|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
14712829|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712830|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712831|NCT00445081|Cyclosporine|cyclosporine|mesh-list
14712832|NCT00445081|Prednisolone|prednisolone|mesh-list
14712833|NCT00445081|Cyclosporins|cyclosporins|mesh-list
14712834|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712835|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
14712836|NCT00445081|Hormones|hormones|mesh-ancestor
14871325|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14871326|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871327|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
14871328|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871329|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
14871330|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871331|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
14871332|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914047|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914048|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14914049|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
14914050|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
14914051|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914052|NCT01378741|Analgesics|analgesics|mesh-ancestor
14914053|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
14914054|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914055|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14914056|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14914057|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14914058|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
14914059|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914060|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914061|NCT01378754|Fospropofol|fospropofol|mesh-list
14914062|NCT01378754|Propofol|propofol|mesh-list
14914063|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14914064|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14914065|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914066|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14914067|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
14914068|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
14914069|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14914070|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914071|NCT01378845|Bosentan|bosentan|mesh-list
14914072|NCT01378845|Alprostadil|alprostadil|mesh-list
14712837|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14914073|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15211810|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
14871333|NCT01137591|Acetaminophen|acetaminophen|mesh-list
14871334|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
14871335|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14871336|NCT01137591|Analgesics|analgesics|mesh-ancestor
14871337|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
14871338|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871339|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871340|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
14871341|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
14871342|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871343|NCT01137591|Expectorants|expectorants|mesh-ancestor
14871344|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
14871345|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14871346|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
14871347|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871348|NCT01137591|Protective Agents|protective agents|mesh-ancestor
14871349|NCT01137656|Acetylcholine|acetylcholine|mesh-list
14871350|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
14871351|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14871352|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
14871353|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871354|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871355|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871356|NCT01137695|Pramlintide|pramlintide|mesh-list
14871357|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14871358|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871359|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871360|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
14871361|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14871362|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14871363|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871364|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
14871365|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14871366|NCT01137708|Tofacitinib|tofacitinib|mesh-list
15211811|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15211812|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
15211813|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14712838|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712839|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14712840|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712841|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712842|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712843|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712844|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
14712845|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
15211814|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211815|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211816|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
15211817|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211818|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211819|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211820|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211821|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14712846|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712847|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
14712848|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14712849|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14712850|NCT00445094|Vancomycin|vancomycin|mesh-list
14712851|NCT00445094|Imipenem|imipenem|mesh-list
14712852|NCT00445094|Amikacin|amikacin|mesh-list
14712853|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14712854|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
15211822|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14712855|NCT00445094|Cilastatin|cilastatin|mesh-list
14712856|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871367|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14871368|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
15211823|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
15211824|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211825|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15211826|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211827|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14871369|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14871370|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871371|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14871372|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14871373|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14871374|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871375|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871376|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871377|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14871378|NCT01137708|Estrogens|estrogens|mesh-ancestor
14871379|NCT01137708|Hormones|hormones|mesh-ancestor
14871380|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871381|NCT01137903|Amoxicillin|amoxicillin|mesh-list
14871382|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
14871383|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
14871384|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
14871385|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14871386|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14871387|NCT01137903|Trimethoprim|trimethoprim|mesh-list
14871388|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
14871389|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871390|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871391|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14871392|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871393|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871394|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871395|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871396|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14871397|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14871398|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15211828|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211829|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
15211830|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211831|NCT01357772|Tamoxifen|tamoxifen|mesh-list
15211832|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15211833|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
15211834|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211835|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211836|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15211837|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712857|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712858|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712859|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
14712860|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712861|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14712862|NCT00445159|Treprostinil|treprostinil|mesh-list
14712863|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14712864|NCT00445185|Vaccines|vaccines|mesh-list
14712865|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
14871399|NCT01137903|Renal Agents|renal agents|mesh-ancestor
14871400|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
14871401|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14871402|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14871403|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14871404|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14871405|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14871406|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14871407|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
14871408|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871409|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871410|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211838|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14871411|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871412|NCT01137942|Metronidazole|metronidazole|mesh-list
14871413|NCT01137942|Clarithromycin|clarithromycin|mesh-list
14871414|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14871415|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871416|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14712866|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712867|NCT00445250|Calcipotriene|calcipotriene|mesh-list
14712868|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14712869|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
14712870|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712871|NCT00445406|Bevacizumab|bevacizumab|mesh-list
14712872|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14712873|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712874|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14712875|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14712876|NCT00445406|Growth Substances|growth substances|mesh-ancestor
14712877|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712878|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
14712879|NCT00445497|Amoxicillin|amoxicillin|mesh-list
14712880|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
14712881|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
14712882|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
14712883|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14712884|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14712885|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712886|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14712887|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14712888|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871417|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14712889|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712890|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712891|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14712892|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14712893|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14712894|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
14871418|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14871419|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14871420|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871421|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871422|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14712895|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14712896|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14712897|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712898|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712899|NCT00445523|Interferons|interferons|mesh-list
14712900|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
14712901|NCT00445523|Vaccines|vaccines|mesh-list
14712902|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712903|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
14712904|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712905|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
14712906|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712907|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
14712908|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
14712909|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14712910|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14712911|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712912|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14712913|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712914|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14712915|NCT00445796|Artesunate|artesunate|mesh-list
14712916|NCT00445796|Amodiaquine|amodiaquine|mesh-list
14712917|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
14871423|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14871424|NCT01137955|Rifaximin|rifaximin|mesh-list
14871425|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14712918|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14712919|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14871426|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871427|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871428|NCT01137994|Paclitaxel|paclitaxel|mesh-list
14871429|NCT01137994|Vinorelbine|vinorelbine|mesh-list
14871430|NCT01137994|Docetaxel|docetaxel|mesh-list
14871431|NCT01137994|Trastuzumab|trastuzumab|mesh-list
14871432|NCT01137994|Lapatinib|lapatinib|mesh-list
14871433|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14871434|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871435|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
14871436|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
14871437|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211839|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15211840|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15211841|NCT01336634|Trametinib|trametinib|mesh-list
15211842|NCT01336634|Dabrafenib|dabrafenib|mesh-list
15211843|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211844|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15211845|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211846|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211847|NCT01312857|Panitumumab|panitumumab|mesh-list
15211848|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211849|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211850|NCT01220531|Cyclosporine|cyclosporine|mesh-list
14871438|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871439|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14871440|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871441|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871442|NCT01138072|Atorvastatin|atorvastatin|mesh-list
14871443|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14871444|NCT01138072|Simvastatin|simvastatin|mesh-list
14871445|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14871446|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14712920|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712921|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712922|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
14712923|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
14712924|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14712925|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
14712926|NCT00445861|Docetaxel|docetaxel|mesh-list
14712927|NCT00445861|Cetuximab|cetuximab|mesh-list
14712928|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712929|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
14712930|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
14712931|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
14712932|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712933|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14712934|NCT00445874|Ketotifen|ketotifen|mesh-list
14712935|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
14712936|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
14712937|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14712938|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
14871447|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
14871448|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871449|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14871450|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14871451|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871452|NCT01138085|Trametinib|trametinib|mesh-list
15211851|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
15211852|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
15211853|NCT01220531|Prednisolone|prednisolone|mesh-list
15211854|NCT01220531|Tacrolimus|tacrolimus|mesh-list
15211855|NCT01220531|Cyclosporins|cyclosporins|mesh-list
15211856|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15211857|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
15211858|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211859|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
15211860|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211861|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15211862|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211863|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211864|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
15211865|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211866|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211867|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211868|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211869|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211870|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15211871|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
14871453|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871454|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871455|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871456|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871457|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
14871458|NCT01138137|Paclitaxel|paclitaxel|mesh-list
14871459|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14871460|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14871461|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871462|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14871463|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14871464|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14871465|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871466|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
14871467|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871468|NCT01138137|Expectorants|expectorants|mesh-ancestor
15211872|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15211873|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15211874|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
15211875|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
15211876|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211877|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15211878|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
14712939|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
14712940|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712941|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712942|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712943|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14712944|NCT00445900|Thalidomide|thalidomide|mesh-list
14712945|NCT00445900|Prednisone|prednisone|mesh-list
14712946|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
14712947|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871469|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
14871470|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14871471|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
14712948|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
14712949|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712950|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871472|NCT01138137|Protective Agents|protective agents|mesh-ancestor
14871473|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871474|NCT01138137|Antidotes|antidotes|mesh-ancestor
14871475|NCT01138215|Vaccines|vaccines|mesh-list
14871476|NCT01138215|Immunologic Factors|immunologic factors|mesh-ancestor
14712951|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14712952|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
14712953|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871477|NCT01138215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871478|NCT01138384|Lapatinib|lapatinib|mesh-list
14871479|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871480|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871481|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871482|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871483|NCT01138397|Vaccines|vaccines|mesh-list
14871484|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
14871485|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871486|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14871487|NCT01138423|Moxonidine|moxonidine|mesh-list
14871488|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14871489|NCT01138423|Diuretics|diuretics|mesh-ancestor
14871490|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
14871491|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871492|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14871493|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15211879|NCT01220531|Hormones|hormones|mesh-ancestor
15211880|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211881|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15211882|NCT01220531|Protective Agents|protective agents|mesh-ancestor
15211883|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15211884|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
15211885|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14871494|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871495|NCT01138449|Vitamin A|vitamin a|mesh-list
14871496|NCT01138449|Vitamins|vitamins|mesh-ancestor
14871497|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
14871498|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712954|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712955|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14712956|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14712957|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
15211886|NCT01155375|Hematinics|hematinics|mesh-ancestor
15211887|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15211888|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14871499|NCT01138488|Insulin|insulin|mesh-list
14871500|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
14871501|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871502|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871503|NCT01138553|Mifepristone|mifepristone|mesh-list
14871504|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14871505|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
14871506|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14712958|NCT00445900|Hormones|hormones|mesh-ancestor
14712959|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14712960|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14712961|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
14712962|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14712963|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14712964|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14712965|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14712966|NCT00445900|Growth Substances|growth substances|mesh-ancestor
14871507|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871508|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14871509|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14871510|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14871511|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
14871512|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14712967|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
14712968|NCT00445965|Antibodies|antibodies|mesh-list
14712969|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14712970|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
14712971|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712972|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
14712973|NCT00446004|Omeprazole|omeprazole|mesh-list
14712974|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14712975|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14712976|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14712977|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14712978|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712979|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14712980|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14712981|NCT00446017|Milrinone|milrinone|mesh-list
14712982|NCT00446017|Epinephrine|epinephrine|mesh-list
14712983|NCT00446017|Racepinephrine|racepinephrine|mesh-list
14712984|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
14712985|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14712986|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14712987|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14712988|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14712989|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14712990|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14712991|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14712992|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14712993|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
15211889|NCT01155375|Trace Elements|trace elements|mesh-ancestor
15211890|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
15211891|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211892|NCT00799058|Dapivirine|dapivirine|mesh-list
15211893|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15211894|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14712994|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14712995|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14871513|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14871514|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
14871515|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871516|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
14871517|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14871518|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14871519|NCT01138605|Ritonavir|ritonavir|mesh-list
14871520|NCT01138605|Darunavir|darunavir|mesh-list
14712996|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
14712997|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
14712998|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
14712999|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14713000|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14713001|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14713002|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
14871521|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14871522|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14871523|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
14871524|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713003|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14713004|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14713005|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713006|NCT00446017|Protective Agents|protective agents|mesh-ancestor
14713007|NCT00446043|Adapalene|adapalene|mesh-list
14713008|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14713009|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14713010|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
15211895|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
15211896|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211897|NCT00788684|Rituximab|rituximab|mesh-list
15211898|NCT00788684|Navitoclax|navitoclax|mesh-list
15211899|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15211900|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211901|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
14713011|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14713012|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15211902|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211903|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211904|NCT00785798|Doxorubicin|doxorubicin|mesh-list
15211905|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15211906|NCT00785798|Vorinostat|vorinostat|mesh-list
15211907|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211908|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713013|NCT00446043|Analgesics|analgesics|mesh-ancestor
15211909|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15211910|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211911|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211912|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211913|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15211914|NCT00673010|Iodine|iodine|mesh-list
15211915|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15211916|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211917|NCT00673010|Trace Elements|trace elements|mesh-ancestor
15211918|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
15211919|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713014|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
14713015|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713016|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713017|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914074|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15211920|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
14713018|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713019|NCT00446069|Morphine|morphine|mesh-list
14871525|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871526|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14871527|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14871528|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
14871529|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871530|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14871531|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14871532|NCT01138683|Diuretics|diuretics|mesh-list
14871533|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
15211921|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15211922|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211923|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
15211924|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15211925|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713020|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14713021|NCT00446069|Narcotics|narcotics|mesh-ancestor
14713022|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14713023|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713024|NCT00446069|Analgesics|analgesics|mesh-ancestor
14713025|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
14713026|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713027|NCT00446082|Pasireotide|pasireotide|mesh-list
14713028|NCT00446082|Hormones|hormones|mesh-ancestor
14713029|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713030|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713031|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
14713032|NCT00446173|Busulfan|busulfan|mesh-list
14713033|NCT00446173|Sargramostim|sargramostim|mesh-list
14713034|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713035|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
14713036|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713037|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713038|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14713039|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
14713040|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713041|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713042|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14713043|NCT00446212|Propofol|propofol|mesh-list
14713044|NCT00446212|Desflurane|desflurane|mesh-list
14713045|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14713046|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871534|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871535|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
14871536|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
14713047|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713048|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14713049|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
14871537|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871538|NCT01138774|Protective Agents|protective agents|mesh-ancestor
14871539|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871540|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
14871541|NCT01138774|Vitamins|vitamins|mesh-ancestor
14871542|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
14871543|NCT01138839|Dexamethasone|dexamethasone|mesh-list
15211926|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15211927|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15211928|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211929|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871544|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14871545|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
14871546|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
14871547|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871548|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871549|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871550|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
14871551|NCT01138839|Hormones|hormones|mesh-ancestor
14871552|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871553|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14871554|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871555|NCT01138852|Ampicillin|ampicillin|mesh-list
14871556|NCT01138852|Cefuroxime|cefuroxime|mesh-list
14871557|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
14871558|NCT01138852|Sulbactam|sulbactam|mesh-list
14871559|NCT01138852|Sultamicillin|sultamicillin|mesh-list
14871560|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871561|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871562|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14871563|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871564|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871565|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
14871566|NCT01138904|Irinotecan|irinotecan|mesh-list
14871567|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871568|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14871569|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871570|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871571|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871572|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
14871573|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14871574|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
14871575|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871576|NCT01138956|Expectorants|expectorants|mesh-ancestor
14871577|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
14871578|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14871579|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
14871580|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871581|NCT01138956|Protective Agents|protective agents|mesh-ancestor
14871582|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871583|NCT01138956|Antidotes|antidotes|mesh-ancestor
14871584|NCT01139138|Irinotecan|irinotecan|mesh-list
14871585|NCT01139138|Everolimus|everolimus|mesh-list
14871586|NCT01139138|Panitumumab|panitumumab|mesh-list
14871587|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14871588|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871589|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871590|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871591|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871592|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871593|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
14871594|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871595|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14871596|NCT01139151|Cytarabine|cytarabine|mesh-list
14871597|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14871598|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
14871599|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871600|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871601|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
14871602|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871603|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871604|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
14871605|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871606|NCT01139203|Lamivudine|lamivudine|mesh-list
14871607|NCT01139203|Adefovir|adefovir|mesh-list
14871608|NCT01139203|Entecavir|entecavir|mesh-list
14871609|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14871610|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14871611|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871612|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211930|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211931|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211932|NCT00360425|Hematinics|hematinics|mesh-ancestor
15211933|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15211934|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14713050|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
14713051|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14713052|NCT00446225|Gemcitabine|gemcitabine|mesh-list
14713053|NCT00446225|Carboplatin|carboplatin|mesh-list
14713054|NCT00446225|Docetaxel|docetaxel|mesh-list
14713055|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14713056|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713057|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713058|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
14713059|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713060|NCT00446225|Antiviral Agents|antiviral agents|mesh-ancestor
14713061|NCT00446225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713062|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713063|NCT00446225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713064|NCT00446225|Immunologic Factors|immunologic factors|mesh-ancestor
14713065|NCT00446225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713066|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713067|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713068|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713069|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871613|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
14871614|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871615|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14871616|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14914075|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914076|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914077|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914078|NCT01378845|Urological Agents|urological agents|mesh-ancestor
14914079|NCT01378884|Domperidone|domperidone|mesh-list
14914080|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
14914081|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
14914082|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914083|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914084|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14914085|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14914086|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
14914087|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914088|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914089|NCT01378949|Morphine|morphine|mesh-list
14914090|NCT01378949|Bupivacaine|bupivacaine|mesh-list
14914091|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
14914092|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
14914093|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14713070|NCT00446303|Azacitidine|azacitidine|mesh-list
14914094|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211935|NCT00346125|Doxorubicin|doxorubicin|mesh-list
15211936|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15211937|NCT00346125|Ifosfamide|ifosfamide|mesh-list
15211938|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15211939|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211940|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211941|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15211942|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15211943|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211944|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211945|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15211946|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
15211947|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15211948|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15211949|NCT00233597|Hematinics|hematinics|mesh-ancestor
14871617|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14871618|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
14871619|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14871620|NCT01139437|Vaccines|vaccines|mesh-list
14871621|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
14871622|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871623|NCT01139463|Haloperidol|haloperidol|mesh-list
14871624|NCT01139463|Olanzapine|olanzapine|mesh-list
14871625|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
14871626|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
14871627|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
15211950|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15211951|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14713071|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713072|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
14713073|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713074|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713075|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713076|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
14713077|NCT00446316|Antacids|antacids|mesh-list
14713078|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713079|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14713080|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713081|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713082|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14713083|NCT00446329|Cinacalcet|cinacalcet|mesh-list
14713084|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713085|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713086|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14713087|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
14728797|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14871628|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15211952|NCT04335669|Paclitaxel|paclitaxel|mesh-list
15211953|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15211954|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
15211955|NCT04335669|Carboplatin|carboplatin|mesh-list
15211956|NCT04335669|Capecitabine|capecitabine|mesh-list
15211957|NCT04335669|Epirubicin|epirubicin|mesh-list
15211958|NCT04335669|Taxane|taxane|mesh-list
15211959|NCT04335669|Antimetabolites|antimetabolites|mesh-list
14871629|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871630|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871631|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15211960|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15211961|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211962|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14871632|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14871633|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871634|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14871635|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14871636|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14871637|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14871638|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871639|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871640|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
15211963|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14871641|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14871642|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
14871643|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14871644|NCT01139645|Esomeprazole|esomeprazole|mesh-list
14871645|NCT01139645|Rabeprazole|rabeprazole|mesh-list
14871646|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14871647|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871648|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14871649|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871650|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871651|NCT01139671|Remifentanil|remifentanil|mesh-list
14871652|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14871653|NCT01139671|Narcotics|narcotics|mesh-ancestor
14871654|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871655|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871656|NCT01139671|Analgesics|analgesics|mesh-ancestor
14871657|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
14871658|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871659|NCT01139723|Bevacizumab|bevacizumab|mesh-list
14871660|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14871661|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871662|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14871663|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14871664|NCT01139723|Growth Substances|growth substances|mesh-ancestor
14871665|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871666|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14871667|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
14871668|NCT01139749|Ciclopirox|ciclopirox|mesh-list
14871669|NCT01139749|Salicylates|salicylates|mesh-list
15211964|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
15211965|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713088|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713089|NCT00446368|Everolimus|everolimus|mesh-list
14713090|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713091|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211966|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15211967|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
15211968|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211969|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15211970|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15211971|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
15211972|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15211973|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15211974|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15211975|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15211976|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871670|NCT01139749|Isotretinoin|isotretinoin|mesh-list
14871671|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14871672|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871673|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
14713092|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
14713093|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713094|NCT00446420|Fentanyl|fentanyl|mesh-list
14713095|NCT00446420|Midazolam|midazolam|mesh-list
14713096|NCT00446420|Propofol|propofol|mesh-list
14713097|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14713098|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14713099|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713100|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14713101|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
14713102|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
14713103|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14713104|NCT00446420|Narcotics|narcotics|mesh-ancestor
14871674|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
14713105|NCT00446420|Analgesics|analgesics|mesh-ancestor
14713106|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
14713107|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713108|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14713109|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14713110|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14713111|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14713112|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
14713113|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
14713114|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713115|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713116|NCT00446433|Lenalidomide|lenalidomide|mesh-list
14713117|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
14713118|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713119|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14713120|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14713121|NCT00446433|Growth Substances|growth substances|mesh-ancestor
14713122|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
14713123|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713124|NCT00446472|Becaplermin|becaplermin|mesh-list
14713125|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
14713126|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14713127|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14713128|NCT00446472|Growth Substances|growth substances|mesh-ancestor
14713129|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713130|NCT00446524|Amlodipine|amlodipine|mesh-list
14713131|NCT00446524|Valsartan|valsartan|mesh-list
14713132|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14713133|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14713134|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14713135|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713136|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713137|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713138|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
14713139|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14713140|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14713141|NCT00446537|Methylphenidate|methylphenidate|mesh-list
14713142|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14713143|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713144|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14713145|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14713146|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14713147|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713148|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
14713149|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713150|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
14713151|NCT00446576|Hematinics|hematinics|mesh-ancestor
14713152|NCT00446589|Teriparatide|teriparatide|mesh-list
14713153|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
14713154|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713155|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713156|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14713157|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
14713158|NCT00446602|Hematinics|hematinics|mesh-ancestor
14728798|NCT00520104|Ketamine|ketamine|mesh-list
14728799|NCT00520104|Analgesics|analgesics|mesh-ancestor
14728800|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
14728801|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728802|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728803|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14728804|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14728805|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
14728806|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
14728807|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728808|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14871675|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14871676|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14871677|NCT01139749|Analgesics|analgesics|mesh-ancestor
14871678|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
14871679|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871680|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871681|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14871682|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871683|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14871684|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871685|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871686|NCT01139840|Vitamin D|vitamin d|mesh-list
14871687|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
14871688|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
14871689|NCT01139840|Vitamins|vitamins|mesh-list
14871690|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
14871691|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871692|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14871693|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14871694|NCT01139905|Ritonavir|ritonavir|mesh-list
14871695|NCT01139905|Lopinavir|lopinavir|mesh-list
14871696|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14871697|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14871698|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
14871699|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871700|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871701|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14871702|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14871703|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
14871704|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713159|NCT00446667|Mannitol|mannitol|mesh-list
14713160|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14713161|NCT00446667|Diuretics|diuretics|mesh-ancestor
14713162|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
14713163|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713164|NCT00446680|Mannitol|mannitol|mesh-list
14713165|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14713166|NCT00446680|Diuretics|diuretics|mesh-ancestor
14713167|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
14713168|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713169|NCT00446771|Mannitol|mannitol|mesh-list
14713170|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14713171|NCT00446771|Diuretics|diuretics|mesh-ancestor
14713172|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
14713173|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713174|NCT00446784|Methotrexate|methotrexate|mesh-list
14713175|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14713176|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
14713177|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14713178|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713179|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14871705|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14871706|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14871707|NCT01140009|Vaccines|vaccines|mesh-list
14871708|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
14871709|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871710|NCT01140035|Insulin|insulin|mesh-list
14871711|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871712|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871713|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
14713180|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
14713181|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713182|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713183|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
14713184|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713185|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14713186|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713187|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
14713188|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713189|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14713190|NCT00446810|Benphothiamine|benphothiamine|mesh-list
14713191|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14713192|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
14713193|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713194|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
14713195|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
15211977|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211978|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
15211979|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15211980|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14871714|NCT01140074|Astringents|astringents|mesh-ancestor
14871715|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871716|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
14871717|NCT01140100|Thiopental|thiopental|mesh-list
14871718|NCT01140100|Propofol|propofol|mesh-list
14871719|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14871720|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871721|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211981|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15211982|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15211983|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211984|NCT04323189|Incretins|incretins|mesh-ancestor
15211985|NCT04323189|Hormones|hormones|mesh-ancestor
15211986|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15211987|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15211988|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
15211989|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15211990|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15211991|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
15211992|NCT04313153|Hematinics|hematinics|mesh-ancestor
15211993|NCT04282811|Venetoclax|venetoclax|mesh-list
15211994|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15211995|NCT04279197|Ascorbic Acid|ascorbic acid|mesh-list
15211996|NCT04279197|Vitamins|vitamins|mesh-ancestor
14871722|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14871723|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
14871724|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
14871725|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
14871726|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
14871727|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
14871728|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15211997|NCT04279197|Micronutrients|micronutrients|mesh-ancestor
14713196|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713197|NCT00446836|Paclitaxel|paclitaxel|mesh-list
14713198|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14713199|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14713200|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713201|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713202|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713203|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713204|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713205|NCT00446862|Losartan|losartan|mesh-list
14713206|NCT00446862|Enalapril|enalapril|mesh-list
14713207|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14871729|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871730|NCT01140126|UB-421|ub-421|mesh-list
15211998|NCT04279197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15211999|NCT04279197|Antioxidants|antioxidants|mesh-ancestor
14871731|NCT01140126|Antibodies|antibodies|mesh-list
14713208|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14713209|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14713210|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14713211|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14713212|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14713213|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713214|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
15212000|NCT04279197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212001|NCT04279197|Protective Agents|protective agents|mesh-ancestor
15212002|NCT04274426|Gemcitabine|gemcitabine|mesh-list
14871732|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
14871733|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871734|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14871735|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
14871736|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871737|NCT01140308|Ubiquinone|ubiquinone|mesh-list
14871738|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
14871739|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
14871740|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871741|NCT01140308|Vitamins|vitamins|mesh-ancestor
14871742|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
14871743|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871744|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
14871745|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871746|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871747|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14871748|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
14871749|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871750|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871751|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14871752|NCT01140399|Dopamine|dopamine|mesh-list
14871753|NCT01140399|Furosemide|furosemide|mesh-list
14871754|NCT01140399|Diuretics|diuretics|mesh-ancestor
14871755|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
14871756|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871757|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14871758|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14871759|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871760|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14871761|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
14871762|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
14871763|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212003|NCT04274426|Paclitaxel|paclitaxel|mesh-list
15212004|NCT04274426|Maytansine|maytansine|mesh-list
15212005|NCT04274426|Carboplatin|carboplatin|mesh-list
14713215|NCT00446901|Selenium|selenium|mesh-list
14713216|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
14713217|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871764|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
14871765|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871766|NCT01140399|Protective Agents|protective agents|mesh-ancestor
14871767|NCT01140412|Ritonavir|ritonavir|mesh-list
14871768|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
14871769|NCT01140412|Maraviroc|maraviroc|mesh-list
14871770|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14871771|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14871772|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
14871773|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871774|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713218|NCT00446901|Protective Agents|protective agents|mesh-ancestor
14713219|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713220|NCT00446901|Trace Elements|trace elements|mesh-ancestor
14713221|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
14713222|NCT00446940|Atorvastatin|atorvastatin|mesh-list
14713223|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14713224|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14713225|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14713226|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
14713227|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713228|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14713229|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14713230|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871775|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14871776|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14871777|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
15212006|NCT04274426|Doxorubicin|doxorubicin|mesh-list
15212007|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14713231|NCT00446953|Betamethasone|betamethasone|mesh-list
14713232|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713233|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
14713234|NCT00446953|Hormones|hormones|mesh-ancestor
14871778|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871779|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14713235|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871780|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14871781|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14871782|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14871783|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14713236|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713237|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14713238|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
14713239|NCT00446979|UC-781|uc-781|mesh-list
14713240|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14713241|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
14871784|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
14871785|NCT01140425|PF 232798|pf 232798|mesh-list
14871786|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713242|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713243|NCT00447018|Mannitol|mannitol|mesh-list
14713244|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14713245|NCT00447018|Diuretics|diuretics|mesh-ancestor
14713246|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
14713247|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713248|NCT00447031|Triamcinolone|triamcinolone|mesh-list
14713249|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14713250|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14713251|NCT00447031|Bevacizumab|bevacizumab|mesh-list
14713252|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14713253|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14713254|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713255|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14713256|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14713257|NCT00447031|Growth Substances|growth substances|mesh-ancestor
14713258|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713259|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14713260|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713261|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
14871787|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871788|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14713262|NCT00447031|Hormones|hormones|mesh-ancestor
14713263|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713264|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713265|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
14713266|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713267|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713268|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14713269|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14713270|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14713271|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14871789|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871790|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871791|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871792|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871793|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14871794|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14871795|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14871796|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
14713272|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713273|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713274|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14713275|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14871797|NCT01140438|Metformin|metformin|mesh-list
14871798|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14871799|NCT01140438|Repaglinide|repaglinide|mesh-list
14871800|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
14871801|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
14871802|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
14871803|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871804|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871805|NCT01140438|Incretins|incretins|mesh-ancestor
14871806|NCT01140438|Hormones|hormones|mesh-ancestor
14871807|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871808|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14871809|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
14871810|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871811|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871812|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
14871813|NCT01140529|Haloperidol|haloperidol|mesh-list
14871814|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
14871815|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14871816|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871817|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871818|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14871819|NCT01140529|Analgesics|analgesics|mesh-ancestor
14871820|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
14871821|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871822|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14871823|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14871824|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14871825|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14871826|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871827|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871828|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
14871829|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
14871830|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871831|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14713276|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
14713277|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713278|NCT00447213|Insulin|insulin|mesh-list
14713279|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14713280|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
14713281|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14713282|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713283|NCT00447239|Insulin|insulin|mesh-list
14713284|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14713285|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713286|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
14713287|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713288|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713289|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14713290|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14713291|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871832|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14871833|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14871834|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14713292|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713293|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713294|NCT00447356|Interferons|interferons|mesh-list
14713295|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
14713296|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713297|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
14713298|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713299|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
14713300|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871835|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
14871836|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14871837|NCT01140581|Dronedarone|dronedarone|mesh-list
14871838|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14871839|NCT01140620|Ketamine|ketamine|mesh-list
14871840|NCT01140620|Risperidone|risperidone|mesh-list
14871841|NCT01140620|Analgesics|analgesics|mesh-ancestor
14871842|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
14871843|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871844|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871845|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14871846|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14871847|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
14713301|NCT00447369|Pregabalin|pregabalin|mesh-list
14713302|NCT00447369|Valproic Acid|valproic acid|mesh-list
14713303|NCT00447369|Analgesics|analgesics|mesh-ancestor
14713304|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
14871848|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
14871849|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871850|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14871851|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14871852|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713305|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713306|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713307|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
14713308|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14713309|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14713310|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713311|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713312|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14871853|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871854|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15212008|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14713313|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15212009|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212010|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
15212011|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
15212012|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
15212013|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212014|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15212015|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
15212016|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
15212017|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212018|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212019|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212020|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
15212021|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212022|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15212023|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15212024|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212025|NCT04245085|Paclitaxel|paclitaxel|mesh-list
15212026|NCT04245085|Bevacizumab|bevacizumab|mesh-list
15212027|NCT04245085|Carboplatin|carboplatin|mesh-list
15212028|NCT04245085|Pemetrexed|pemetrexed|mesh-list
15212029|NCT04245085|Atezolizumab|atezolizumab|mesh-list
15212030|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15212031|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212032|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
15212033|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
14871855|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
14871856|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14871857|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14871858|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14871859|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14871860|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
14871861|NCT01140737|Axitinib|axitinib|mesh-list
14871862|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871863|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14871864|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871865|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871866|NCT01140828|Rabeprazole|rabeprazole|mesh-list
14871867|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14871868|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212034|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
15212035|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296271|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296272|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
14296273|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296274|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296275|NCT00587132|Secretin|secretin|mesh-list
15212036|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212037|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15212038|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212039|NCT04245085|Growth Substances|growth substances|mesh-ancestor
15212040|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212041|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212042|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212043|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15212044|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14871869|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14871870|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871871|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871872|NCT01140893|Exenatide|exenatide|mesh-list
14871873|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14871874|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871875|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14871876|NCT01140893|Incretins|incretins|mesh-ancestor
14871877|NCT01140893|Hormones|hormones|mesh-ancestor
14871878|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871879|NCT01140932|Prednisolone|prednisolone|mesh-list
14871880|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14871881|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
15212045|NCT04235855|Liver Extracts|liver extracts|mesh-list
14713314|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212046|NCT04235855|Hematinics|hematinics|mesh-ancestor
15212047|NCT04234945|Doxycycline|doxycycline|mesh-list
14713315|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14713316|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713317|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
14713318|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713319|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
14713320|NCT00447473|Ketoconazole|ketoconazole|mesh-list
14713321|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
14713322|NCT00447473|Analgesics|analgesics|mesh-ancestor
14713323|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
14871882|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14713324|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713325|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713326|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713327|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14713328|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14713329|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713330|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713331|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
14713332|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871883|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
15212048|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871884|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14871885|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
14871886|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14871887|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
14871888|NCT01140932|Hormones|hormones|mesh-ancestor
14871889|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871890|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871891|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14871892|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871893|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
14871894|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
14871895|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871896|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871897|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14871898|NCT01140932|Protective Agents|protective agents|mesh-ancestor
14871899|NCT01140971|Misoprostol|misoprostol|mesh-list
14871900|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14713333|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14713334|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14713335|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14713336|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
14713337|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713338|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14713339|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14713340|NCT00447577|Tobramycin|tobramycin|mesh-list
15212049|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212050|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
15212051|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15212052|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15225148|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225149|NCT05192304|Maleic acid|maleic acid|mesh-list
14713341|NCT00447577|Dexamethasone|dexamethasone|mesh-list
14713342|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713343|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
14871901|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
14871902|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14871903|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871904|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14871905|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871906|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
14871907|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
14871908|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14871909|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14871910|NCT01140984|Prednisolone|prednisolone|mesh-list
14871911|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
14871912|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14871913|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
14871914|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14871915|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
14713344|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
14713345|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713346|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713347|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14713348|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
14713349|NCT00447577|Hormones|hormones|mesh-ancestor
14713350|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713351|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14713352|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713353|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713354|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713355|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14713356|NCT00447681|Fezakinumab|fezakinumab|mesh-list
14713357|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
14713358|NCT00447759|Ibuprofen|ibuprofen|mesh-list
14713359|NCT00447759|Celecoxib|celecoxib|mesh-list
14871916|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
14871917|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871918|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871919|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14871920|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
14871921|NCT01140984|Hormones|hormones|mesh-ancestor
14871922|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14871923|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14713360|NCT00447759|Diclofenac|diclofenac|mesh-list
14713361|NCT00447759|Naproxen|naproxen|mesh-list
14713362|NCT00447759|Meloxicam|meloxicam|mesh-list
15225150|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871924|NCT01140984|Protective Agents|protective agents|mesh-ancestor
14871925|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14871926|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871927|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14871928|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14871929|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
14871930|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871931|NCT01141036|Midazolam|midazolam|mesh-list
14871932|NCT01141036|Propofol|propofol|mesh-list
14871933|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14871934|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14871935|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871936|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14871937|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
14871938|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
14871939|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14871940|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14713363|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14713364|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14871941|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14871942|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14871943|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
14871944|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
14871945|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871946|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914095|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
14914096|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914097|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14914098|NCT01378949|Narcotics|narcotics|mesh-ancestor
14914099|NCT01378949|Analgesics|analgesics|mesh-ancestor
14914100|NCT01379001|Scopolamine|scopolamine|mesh-list
14914101|NCT01379001|Donepezil|donepezil|mesh-list
14713365|NCT00447759|Analgesics|analgesics|mesh-ancestor
14713366|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
14713367|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713368|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713369|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713370|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212053|NCT04209543|Progesterone|progesterone|mesh-list
15212054|NCT04209543|Progestins|progestins|mesh-ancestor
15212055|NCT04209543|Hormones|hormones|mesh-ancestor
15212056|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212057|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212058|NCT04192370|Cannabidiol|cannabidiol|mesh-list
15212059|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
14713371|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14713372|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713373|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713374|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14713375|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
14713376|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
14713377|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14713378|NCT00447863|Estradiol|estradiol|mesh-list
14713379|NCT00447863|Estrogens|estrogens|mesh-ancestor
14713380|NCT00447863|Hormones|hormones|mesh-ancestor
14713381|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713382|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713383|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14713384|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
14713385|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14713386|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14713387|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14713388|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14713389|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14713390|NCT00447915|Vitamin D|vitamin d|mesh-list
14713391|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
14713392|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
14713393|NCT00447915|Calcium|calcium|mesh-list
14713394|NCT00447915|Vitamins|vitamins|mesh-ancestor
14713395|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
14713396|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914102|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14914103|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14914104|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212060|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
15212061|NCT04188028|Paroxetine|paroxetine|mesh-list
15212062|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15212063|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15212064|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15212065|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212066|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713397|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713398|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14713399|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
14713400|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
14713401|NCT00447967|Leucovorin|leucovorin|mesh-list
14713402|NCT00447967|Fluorouracil|fluorouracil|mesh-list
14713403|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
14713404|NCT00447967|Irinotecan|irinotecan|mesh-list
14713405|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
14713406|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871947|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
14871948|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14871949|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14871950|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871951|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
14871952|NCT01141127|Coagulants|coagulants|mesh-ancestor
14871953|NCT01141153|Aspirin|aspirin|mesh-list
14871954|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
14871955|NCT01141153|Clopidogrel|clopidogrel|mesh-list
14871956|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14871957|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14871958|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14871959|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14871960|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
14871961|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14871962|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871963|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871964|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14871965|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14871966|NCT01141153|Analgesics|analgesics|mesh-ancestor
14871967|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
14871968|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14871969|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14871970|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14871971|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14871972|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14871973|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14871974|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871975|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
14871976|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
14871977|NCT01141192|Vitamin D|vitamin d|mesh-list
14871978|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
14871979|NCT01141192|Vitamins|vitamins|mesh-ancestor
14871980|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
14871981|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14871982|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14871983|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14871984|NCT01141244|Sirolimus|sirolimus|mesh-list
14871985|NCT01141244|Irinotecan|irinotecan|mesh-list
14871986|NCT01141244|Temozolomide|temozolomide|mesh-list
14871987|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14871988|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14871989|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14871990|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14871991|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14871992|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14871993|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
14871994|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14871995|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14871996|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14871997|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
14871998|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14871999|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
14872000|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872001|NCT01141296|Fenofibrate|fenofibrate|mesh-list
14872002|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14872003|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
14713407|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713408|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713409|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713410|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
14713411|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713412|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14713413|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14713414|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713415|NCT00447967|Antidotes|antidotes|mesh-ancestor
14713416|NCT00447967|Protective Agents|protective agents|mesh-ancestor
14713417|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
14713418|NCT00447967|Vitamins|vitamins|mesh-ancestor
14713419|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
14713420|NCT00448097|Docetaxel|docetaxel|mesh-list
14713421|NCT00448097|Cetuximab|cetuximab|mesh-list
14713422|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872004|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872005|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14872006|NCT01141309|Everolimus|everolimus|mesh-list
14872007|NCT01141309|Sorafenib|sorafenib|mesh-list
14872008|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872009|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872010|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
14872011|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872012|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14872013|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872014|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872015|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14296276|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296277|NCT00587132|Hormones|hormones|mesh-ancestor
14296278|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713423|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
14872016|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14713424|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713425|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713426|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713427|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14713428|NCT00448110|Diclofenac|diclofenac|mesh-list
14713429|NCT00448110|Ketorolac|ketorolac|mesh-list
14713430|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14872017|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14872018|NCT01141439|Fluticasone|fluticasone|mesh-list
14872019|NCT01141439|Xhance|xhance|mesh-list
14872020|NCT01141439|Beclomethasone|beclomethasone|mesh-list
14872021|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872022|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14872023|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
14872024|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872025|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872026|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14872027|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872028|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14872029|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14872030|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
14872031|NCT01141439|Hormones|hormones|mesh-ancestor
14872032|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872033|NCT01141452|Fluticasone|fluticasone|mesh-list
14713431|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14713432|NCT00448110|Analgesics|analgesics|mesh-ancestor
14713433|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
14713434|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872034|NCT01141452|Xhance|xhance|mesh-list
14872035|NCT01141452|Beclomethasone|beclomethasone|mesh-list
14713435|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713436|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713437|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713438|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14713439|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713440|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713441|NCT00448149|Everolimus|everolimus|mesh-list
14713442|NCT00448149|Sorafenib|sorafenib|mesh-list
14713443|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713444|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872036|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872037|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14872038|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
14713445|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
14713446|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212067|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
15212068|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212069|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14872039|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872040|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872041|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14872042|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872043|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
14872044|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14872045|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
14872046|NCT01141452|Hormones|hormones|mesh-ancestor
15212070|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
15212071|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15212072|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15212073|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15212074|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212075|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
15212076|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
15212077|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15212078|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15212079|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
15212080|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212081|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212082|NCT04154800|Itraconazole|itraconazole|mesh-list
15212083|NCT04154800|Diltiazem|diltiazem|mesh-list
15212084|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
15212085|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212086|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15212087|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15212088|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212089|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212090|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14872047|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872048|NCT01141465|Fluticasone|fluticasone|mesh-list
14872049|NCT01141465|Xhance|xhance|mesh-list
14713447|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14713448|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713449|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713450|NCT00448214|Warfarin|warfarin|mesh-list
14713451|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
14713452|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14713453|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713454|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14713455|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713456|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713457|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
14872050|NCT01141465|Budesonide|budesonide|mesh-list
14872051|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
14713458|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
14713459|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872052|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14872053|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14872054|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14872055|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872056|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14872057|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
14872058|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872059|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872060|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14872061|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872062|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
14872063|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14872064|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
14872065|NCT01141465|Hormones|hormones|mesh-ancestor
14872066|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872067|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14872068|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14872069|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14872070|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
14872071|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713460|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
14872072|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872073|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
14872074|NCT01141543|Plerixafor|plerixafor|mesh-list
15212091|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
15212092|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212093|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212094|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14713461|NCT00448266|Thiotepa|thiotepa|mesh-list
14713462|NCT00448266|Carboplatin|carboplatin|mesh-list
14713463|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713464|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
14713465|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713466|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713467|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14713468|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
14713469|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713470|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713471|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15212095|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15212096|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15212097|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15212098|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713472|NCT00448292|Naluzotan|naluzotan|mesh-list
14713473|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14713474|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14713475|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
14713476|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713477|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713478|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713479|NCT00448305|Paclitaxel|paclitaxel|mesh-list
14713480|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14713481|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14713482|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713483|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713484|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713485|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713486|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713487|NCT00448383|Adalimumab|adalimumab|mesh-list
14713488|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713489|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713490|NCT00448396|Epothilone B|epothilone b|mesh-list
14872075|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14872076|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14872077|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
14872078|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872079|NCT01141556|Selenium|selenium|mesh-list
14872080|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
14872081|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872082|NCT01141556|Protective Agents|protective agents|mesh-ancestor
14872083|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212099|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
14713491|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713492|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713493|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713494|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713495|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713496|NCT00448409|Sargramostim|sargramostim|mesh-list
14713497|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
14713498|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713499|NCT00448461|Heparin|heparin|mesh-list
14713500|NCT00448461|Bivalirudin|bivalirudin|mesh-list
14713501|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
14713502|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14713503|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14713504|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713505|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
14713506|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14713507|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
14713508|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728809|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14728810|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728811|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728812|NCT00520169|Ketamine|ketamine|mesh-list
14728813|NCT00520169|Analgesics|analgesics|mesh-ancestor
14728814|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
14728815|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728816|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728817|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14728818|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14728819|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
14728820|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
14728821|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728822|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14728823|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14872084|NCT01141556|Trace Elements|trace elements|mesh-ancestor
15212100|NCT04127968|Vitamin A|vitamin a|mesh-list
15212101|NCT04127968|Vitamins|vitamins|mesh-ancestor
15212102|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
15212103|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212104|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
15212105|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15212106|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212107|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15212108|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212109|NCT04056962|Tacrolimus|tacrolimus|mesh-list
15212110|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212111|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
15212112|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212113|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15212114|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212115|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212116|NCT04051268|Vaccines|vaccines|mesh-list
14713509|NCT00448552|Capecitabine|capecitabine|mesh-list
14713510|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
14713511|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713512|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
14713513|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713514|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713515|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14713516|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
14713517|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14713518|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14713519|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14713520|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872085|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
14872086|NCT01141855|Varenicline|varenicline|mesh-list
14872087|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14872088|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14872089|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872090|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872091|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872092|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872093|NCT01141881|Bevacizumab|bevacizumab|mesh-list
14872094|NCT01141881|Plasminogen|plasminogen|mesh-list
14872095|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14872096|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872097|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872098|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14872099|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14872100|NCT01141881|Growth Substances|growth substances|mesh-ancestor
14872101|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872102|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
14872103|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14872104|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14872105|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872106|NCT01141894|Phenylephrine|phenylephrine|mesh-list
14872107|NCT01141894|Dobutamine|dobutamine|mesh-list
14872108|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
14872109|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14872110|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14872111|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
14872112|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
14872113|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872114|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872115|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
14713521|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713522|NCT00448643|Cisplatin|cisplatin|mesh-list
14713523|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713524|NCT00448734|Docetaxel|docetaxel|mesh-list
14713525|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713526|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713527|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713528|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713529|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713530|NCT00448786|Niacinamide|niacinamide|mesh-list
14713531|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
14713532|NCT00448786|Imetelstat|imetelstat|mesh-list
14713533|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14713534|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713535|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713536|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
14713537|NCT00448786|Vitamins|vitamins|mesh-ancestor
14713538|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
14713539|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713540|NCT00448825|Topiramate|topiramate|mesh-list
14713541|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
14713542|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14713543|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713544|NCT00448838|Gemcitabine|gemcitabine|mesh-list
14713545|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
14713546|NCT00448838|Cetuximab|cetuximab|mesh-list
14713547|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713548|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
14872116|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14872117|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
15212117|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
14713549|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713550|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713551|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
14713552|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713553|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713554|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713555|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
14713556|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713557|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14713558|NCT00448903|Bemiparin|bemiparin|mesh-list
14713559|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
14713560|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
14713561|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14872118|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872119|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14296279|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327547|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327548|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14327549|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14327550|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327551|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327552|NCT00803010|Sirolimus|sirolimus|mesh-list
14327553|NCT00803010|Methotrexate|methotrexate|mesh-list
14327554|NCT00803010|Tacrolimus|tacrolimus|mesh-list
14327555|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14327556|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
14872120|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14872121|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15212118|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327557|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14713562|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713563|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
14713564|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
14713565|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14713566|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713567|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
14713568|NCT00449020|Carboplatin|carboplatin|mesh-list
14713569|NCT00449020|Docetaxel|docetaxel|mesh-list
14713570|NCT00449020|Irinotecan|irinotecan|mesh-list
14713571|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327558|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327559|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14327560|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
14713572|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713573|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713574|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713575|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713576|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14713577|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212119|NCT04038515|Menthol|menthol|mesh-list
15212120|NCT04038515|Nicotine|nicotine|mesh-list
15212121|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15212122|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
15212123|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212124|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212125|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15212126|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14713578|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713579|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
14713580|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
14713581|NCT00449137|Leucovorin|leucovorin|mesh-list
14713582|NCT00449137|Fluorouracil|fluorouracil|mesh-list
14713583|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
14713584|NCT00449137|Calcium|calcium|mesh-list
14713585|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
14713586|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713587|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713588|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
14713589|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713590|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713591|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713592|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713593|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
14713594|NCT00449137|Antidotes|antidotes|mesh-ancestor
14713595|NCT00449137|Protective Agents|protective agents|mesh-ancestor
14713596|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
14713597|NCT00449137|Vitamins|vitamins|mesh-ancestor
14713598|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
14713599|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
14713600|NCT00449202|Estrone|estrone|mesh-list
14713601|NCT00449202|Estrogens|estrogens|mesh-ancestor
14872122|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
14872123|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713602|NCT00449202|Hormones|hormones|mesh-ancestor
14713603|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713604|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713605|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14713606|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
14713607|NCT00449254|Estrone|estrone|mesh-list
14713608|NCT00449254|Estrogens|estrogens|mesh-ancestor
14713609|NCT00449254|Hormones|hormones|mesh-ancestor
14713610|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713611|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713612|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14713613|NCT00449280|Sirolimus|sirolimus|mesh-list
14713614|NCT00449280|Sorafenib|sorafenib|mesh-list
14713615|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713616|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14917341|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14713617|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713618|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713619|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713620|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713621|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14713622|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
14713623|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713624|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
14713625|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713626|NCT00449319|Daunorubicin|daunorubicin|mesh-list
14713627|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14713628|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713629|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14713630|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14713631|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713632|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713633|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14713634|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
14713635|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14713636|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14713637|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14713638|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14713639|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713640|NCT00449410|Atorvastatin|atorvastatin|mesh-list
14713641|NCT00449410|Ezetimibe|ezetimibe|mesh-list
14713642|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14713643|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14713644|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
14713645|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713646|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14713647|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14713648|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713649|NCT00449423|Acipimox|acipimox|mesh-list
14713650|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14713651|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
14713652|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713653|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14713654|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14872124|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872125|NCT01141894|Protective Agents|protective agents|mesh-ancestor
14872126|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14713655|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14713656|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
14713657|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14713658|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713659|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713660|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
14713661|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713662|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14713663|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14713664|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14713665|NCT00449449|Lidocaine|lidocaine|mesh-list
14872127|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14872128|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
14713666|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
14713667|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
14713668|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14713669|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872129|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
14872130|NCT01141972|Vitamin D|vitamin d|mesh-list
14872131|NCT01141972|Vitamins|vitamins|mesh-ancestor
14872132|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
14872133|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872134|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14713670|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
14713671|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713672|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14713673|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14713674|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14713675|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14713676|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713677|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
14872135|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
14872136|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
14872137|NCT01141998|Calcium|calcium|mesh-list
14872138|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14872139|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872140|NCT01141998|Vitamins|vitamins|mesh-ancestor
14872141|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
14872142|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14872143|NCT01142011|Belimumab|belimumab|mesh-list
14872144|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872145|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
14872146|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713678|NCT00449488|Hematinics|hematinics|mesh-ancestor
14713679|NCT00449501|Budesonide|budesonide|mesh-list
14713680|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
14872147|NCT01142245|Esomeprazole|esomeprazole|mesh-list
14872148|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14872149|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14872150|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14872151|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872152|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872153|NCT01142258|Trazodone|trazodone|mesh-list
14872154|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14872155|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14872156|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872157|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872158|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14713681|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713682|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14713683|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
14713684|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713685|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713686|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14713687|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
14713688|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
14713689|NCT00449501|Hormones|hormones|mesh-ancestor
14728824|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872159|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14872160|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14872161|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14872162|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872163|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872164|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
14872165|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14872166|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
14872167|NCT01142284|Cilostazol|cilostazol|mesh-list
14872168|NCT01142284|Probucol|probucol|mesh-list
14872169|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14872170|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
14872171|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872172|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872173|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14872174|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872175|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14872176|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14917342|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713690|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713691|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14713692|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14713693|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14713694|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
14713695|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713696|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713697|NCT00449514|Tamoxifen|tamoxifen|mesh-list
14713698|NCT00449514|Clomiphene|clomiphene|mesh-list
14713699|NCT00449514|Enclomiphene|enclomiphene|mesh-list
14713700|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
14713701|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14713702|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
14713703|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713704|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713705|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14713706|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713707|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14713708|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14713709|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14713710|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14713711|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
14713712|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14713713|NCT00449527|Budesonide|budesonide|mesh-list
14713714|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
14713715|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713716|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14713717|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
14713718|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713719|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713720|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14713721|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
14713722|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
14713723|NCT00449527|Hormones|hormones|mesh-ancestor
14713724|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713725|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14713726|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14713727|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14713728|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
14713729|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713730|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713731|NCT00449553|Metformin|metformin|mesh-list
14872177|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872178|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14872179|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
14872180|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14872181|NCT01142284|Protective Agents|protective agents|mesh-ancestor
14872182|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14872183|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14872184|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872185|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14872186|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14872187|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
14872188|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14713732|NCT00449553|Pioglitazone|pioglitazone|mesh-list
14713733|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14713734|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713735|NCT00449618|Aspirin|aspirin|mesh-list
14713736|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14713737|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14713738|NCT00449618|Analgesics|analgesics|mesh-ancestor
14713739|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
14713740|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713741|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713742|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713743|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713744|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14713745|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14713746|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713747|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14713748|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14713749|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713750|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
14713751|NCT00449657|Gemcitabine|gemcitabine|mesh-list
14713752|NCT00449657|Paclitaxel|paclitaxel|mesh-list
14713753|NCT00449657|Carboplatin|carboplatin|mesh-list
14713754|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14713755|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713756|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713757|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713758|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713759|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713760|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713761|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
14713762|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
14713763|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713764|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713765|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713766|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
14713767|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713768|NCT00449683|Terazosin|terazosin|mesh-list
14713769|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14713770|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14713771|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14713772|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
14713773|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713774|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713775|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713776|NCT00449683|Urological Agents|urological agents|mesh-ancestor
14713777|NCT00449722|Mesalamine|mesalamine|mesh-list
14713778|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14713779|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14713780|NCT00449722|Analgesics|analgesics|mesh-ancestor
14713781|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
14713782|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713783|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872189|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
14872190|NCT01142401|Bortezomib|bortezomib|mesh-list
14872191|NCT01142401|Fulvestrant|fulvestrant|mesh-list
14872192|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872193|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14872194|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14872195|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14872196|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
14872197|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872198|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872199|NCT01142414|Fluorouracil|fluorouracil|mesh-list
14872200|NCT01142414|Panitumumab|panitumumab|mesh-list
14872201|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872202|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
14872203|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212127|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
14713784|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713785|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713786|NCT00449774|Lamotrigine|lamotrigine|mesh-list
14713787|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
14713788|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14713789|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14713790|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713791|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14713792|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713793|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14713794|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14713795|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14713796|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14713797|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14713798|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
14713799|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713800|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713801|NCT00449813|Pantoprazole|pantoprazole|mesh-list
14713802|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14713803|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14713804|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14713805|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212128|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212129|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212130|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
15212131|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
15212132|NCT04031508|SMOFlipid|smoflipid|mesh-list
15212133|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15212134|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14713806|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713807|NCT00449839|Insulin|insulin|mesh-list
14713808|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14713809|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
14713810|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
14713811|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14713812|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14713813|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713814|NCT00450008|Thalidomide|thalidomide|mesh-list
14713815|NCT00450008|Docetaxel|docetaxel|mesh-list
14713816|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713817|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713818|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14713819|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713820|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713821|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713822|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
14713823|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713824|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
14713825|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713826|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713827|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14713828|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14872204|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14872205|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872206|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
14872207|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872208|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872209|NCT01142453|Interferons|interferons|mesh-list
14872210|NCT01142453|Interferon-beta|interferon-beta|mesh-list
14872211|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
14872212|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872213|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
14872214|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872215|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
14872216|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872217|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14872218|NCT01142492|Interferons|interferons|mesh-list
14872219|NCT01142492|Interferon-beta|interferon-beta|mesh-list
14872220|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
14872221|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872222|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
14872223|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872224|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
14872225|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713829|NCT00450008|Growth Substances|growth substances|mesh-ancestor
14713830|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
14713831|NCT00450086|Budesonide|budesonide|mesh-list
14713832|NCT00450086|Mesalamine|mesalamine|mesh-list
14713833|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713834|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14713835|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
14713836|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713837|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713838|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14713839|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
14713840|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
14713841|NCT00450086|Hormones|hormones|mesh-ancestor
14713842|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14713843|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14713844|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14713845|NCT00450086|Analgesics|analgesics|mesh-ancestor
14713846|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
14713847|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713848|NCT00450099|Bupivacaine|bupivacaine|mesh-list
14713849|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
14713850|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
14713851|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14713852|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713853|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
14713854|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713855|NCT00450138|Cisplatin|cisplatin|mesh-list
14872226|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14872227|NCT01142505|Mannitol|mannitol|mesh-list
15212135|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15212136|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15212137|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14713856|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872228|NCT01142505|Montelukast|montelukast|mesh-list
14872229|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14872230|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872231|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15212138|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212139|NCT04017832|Incretins|incretins|mesh-ancestor
15212140|NCT04017832|Hormones|hormones|mesh-ancestor
15212141|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212142|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15212143|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
15212144|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212145|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212146|NCT04006522|Atezolizumab|atezolizumab|mesh-list
15212147|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212148|NCT03945825|Vaccines|vaccines|mesh-list
15212149|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
15212150|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713857|NCT00450164|Nadolol|nadolol|mesh-list
14713858|NCT00450164|Prazosin|prazosin|mesh-list
14713859|NCT00450164|Isosorbide|isosorbide|mesh-list
14713860|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14713861|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14713862|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14713863|NCT00450164|Diuretics|diuretics|mesh-ancestor
14713864|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
14713865|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713866|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
14713867|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14713868|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713869|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14713870|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14713871|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14713872|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14713873|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
15212151|NCT03942419|Atropine|atropine|mesh-list
15212152|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15212153|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15212154|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15212155|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15212156|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15212157|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
15212158|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713874|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14713875|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14713876|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14713877|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
14713878|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
14713879|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713880|NCT00450203|Bevacizumab|bevacizumab|mesh-list
14713881|NCT00450203|Capecitabine|capecitabine|mesh-list
14713882|NCT00450203|Epirubicin|epirubicin|mesh-list
14713883|NCT00450203|Lapatinib|lapatinib|mesh-list
14713884|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14713885|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713886|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14713887|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14713888|NCT00450203|Growth Substances|growth substances|mesh-ancestor
14713889|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713890|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
14713891|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713892|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
14713893|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713894|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14713895|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14713896|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14713897|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713898|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296280|NCT00587288|Reslizumab|reslizumab|mesh-list
14713899|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
15212159|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872232|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
14872233|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212160|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15212161|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
15212162|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
15212163|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
14872234|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872235|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14872236|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14917604|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212164|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15212165|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15212166|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
15212167|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212168|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212169|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
15212170|NCT03889418|Narcotics|narcotics|mesh-ancestor
15212171|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212172|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212173|NCT03889418|Analgesics|analgesics|mesh-ancestor
14713900|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14713901|NCT00450229|Protective Agents|protective agents|mesh-ancestor
14713902|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713903|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713904|NCT00450281|Antibodies|antibodies|mesh-list
14713905|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
14713906|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713907|NCT00450307|Antibodies|antibodies|mesh-list
14713908|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14713909|NCT00450307|Sargramostim|sargramostim|mesh-list
14713910|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
14713911|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713912|NCT00450320|Sirolimus|sirolimus|mesh-list
14713913|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14713914|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713915|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14713916|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713917|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
14713918|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713919|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
14713920|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713921|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
14713922|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14713923|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
14713924|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713925|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14713926|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713927|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
14713928|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713929|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
14713930|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14713931|NCT00450398|Protective Agents|protective agents|mesh-ancestor
14728825|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728826|NCT00520247|Folic Acid|folic acid|mesh-list
14728827|NCT00520247|Enalapril|enalapril|mesh-list
14728828|NCT00520247|Hematinics|hematinics|mesh-ancestor
14728829|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
14728830|NCT00520247|Vitamins|vitamins|mesh-ancestor
14728831|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
14728832|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728833|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14728834|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
14728835|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728836|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728837|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14728838|NCT00520260|Ketorolac|ketorolac|mesh-list
14872237|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872238|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14872239|NCT01142505|Diuretics|diuretics|mesh-ancestor
14872240|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
14872241|NCT01142518|Interferons|interferons|mesh-list
14872242|NCT01142518|Interferon-beta|interferon-beta|mesh-list
14872243|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
14872244|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872245|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
14872246|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872247|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
14872248|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872249|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14872250|NCT01142557|Interferons|interferons|mesh-list
14872251|NCT01142557|Interferon-beta|interferon-beta|mesh-list
14872252|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
14872253|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872254|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
14872255|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872256|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
14728839|NCT00520260|Bromfenac|bromfenac|mesh-list
14872257|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713932|NCT00450515|Capecitabine|capecitabine|mesh-list
14296281|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14296282|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
14296283|NCT00587431|Docetaxel|docetaxel|mesh-list
14296284|NCT00587431|Leuprolide|leuprolide|mesh-list
14296285|NCT00587431|Testosterone|testosterone|mesh-list
14296286|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296287|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
14713933|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14872258|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14872259|NCT01142622|Ropivacaine|ropivacaine|mesh-list
14872260|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
14872261|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
14872262|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872263|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872264|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
14713934|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
14713935|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713936|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713937|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14713938|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14713939|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713940|NCT00450645|Heparin|heparin|mesh-list
14713941|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14713942|NCT00450645|Tinzaparin|tinzaparin|mesh-list
14713943|NCT00450645|Dalteparin|dalteparin|mesh-list
14713944|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
14713945|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14713946|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14713947|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713948|NCT00450736|Celecoxib|celecoxib|mesh-list
14713949|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14713950|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14872265|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872266|NCT01142635|Bromides|bromides|mesh-list
14872267|NCT01142635|Rocuronium|rocuronium|mesh-list
14872268|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
14872269|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14872270|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14872271|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14872272|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872273|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872274|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
14713951|NCT00450736|Analgesics|analgesics|mesh-ancestor
14713952|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
14713953|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713954|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872275|NCT01142648|Neostigmine|neostigmine|mesh-list
14872276|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14713955|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14713956|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14713957|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14713958|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14713959|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713960|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713961|NCT00450762|Gemcitabine|gemcitabine|mesh-list
14713962|NCT00450762|Carboplatin|carboplatin|mesh-list
14713963|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872277|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917605|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
14296288|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
14296289|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
14713964|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14713965|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
14713966|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713967|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
14713968|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14713969|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713970|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14713971|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
14872278|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872279|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872280|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872281|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872282|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14872283|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
14872284|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872285|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14872286|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14872287|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14872288|NCT01142700|Ribavirin|ribavirin|mesh-list
14872289|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14713972|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713973|NCT00450827|Bevacizumab|bevacizumab|mesh-list
14713974|NCT00450827|Antibodies|antibodies|mesh-list
14713975|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14713976|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14713977|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14713978|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14713979|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14713980|NCT00450827|Growth Substances|growth substances|mesh-ancestor
14713981|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713982|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
14713983|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
14713984|NCT00450840|Simvastatin|simvastatin|mesh-list
14713985|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14713986|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14713987|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
14713988|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14713989|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14713990|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14713991|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14713992|NCT00450853|Granisetron|granisetron|mesh-list
14872290|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
14872291|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872292|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
14872293|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914105|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914106|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
14914107|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914108|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914109|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
14914110|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14914111|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
14914112|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
14713993|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
14713994|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
14713995|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14713996|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14713997|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14713998|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14713999|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
14714000|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714001|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714002|NCT00450892|Docetaxel|docetaxel|mesh-list
14714003|NCT00450892|Trastuzumab|trastuzumab|mesh-list
14714004|NCT00450892|Lapatinib|lapatinib|mesh-list
14714005|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714006|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714007|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
14714008|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
14714009|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714010|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14714011|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14714012|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714013|NCT00450944|Immunotoxins|immunotoxins|mesh-list
14872294|NCT01142778|Bevacizumab|bevacizumab|mesh-list
14872295|NCT01142778|Trastuzumab|trastuzumab|mesh-list
14872296|NCT01142778|Docetaxel|docetaxel|mesh-list
14872297|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872298|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872299|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14872300|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14872301|NCT01142778|Growth Substances|growth substances|mesh-ancestor
14872302|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872303|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
14872304|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714014|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
14714015|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714016|NCT00450957|Lycopene|lycopene|mesh-list
14714017|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714018|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
14714019|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714020|NCT00450957|Protective Agents|protective agents|mesh-ancestor
14714021|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714022|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14714023|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14714024|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872305|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
14872306|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14872307|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872308|NCT01142843|Propolis|propolis|mesh-list
14714025|NCT00451061|Tamsulosin|tamsulosin|mesh-list
14714026|NCT00451061|Alfuzosin|alfuzosin|mesh-list
14714027|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14714028|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14714029|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14714030|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
14714031|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872309|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872310|NCT01142869|Cetuximab|cetuximab|mesh-list
14872311|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872312|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872313|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
14872314|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14714032|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714033|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714034|NCT00451061|Urological Agents|urological agents|mesh-ancestor
14714035|NCT00451074|Gentamicins|gentamicins|mesh-list
14714036|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714037|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714038|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14714039|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714040|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714041|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
14714042|NCT00451100|Neostigmine|neostigmine|mesh-list
14714043|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14714044|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714045|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714046|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
14714047|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872315|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14872316|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872317|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
14872318|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
15212174|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
15212175|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212176|NCT03877354|Anesthetics|anesthetics|mesh-list
15212177|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872319|NCT01143025|Ropivacaine|ropivacaine|mesh-list
14872320|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
14872321|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
14872322|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872323|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872324|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
14872325|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872326|NCT01143129|Dexamethasone|dexamethasone|mesh-list
14872327|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212178|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212179|NCT03733925|Golimumab|golimumab|mesh-list
14872328|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
14872329|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
14872330|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872331|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872332|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14872333|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
14872334|NCT01143129|Hormones|hormones|mesh-ancestor
14872335|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872336|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14872337|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872338|NCT01143545|Celecoxib|celecoxib|mesh-list
14872339|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
14872340|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872341|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
14872342|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872343|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14872344|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14872345|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
14872346|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872347|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872348|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14872349|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14872350|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14714048|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714049|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14872351|NCT01143545|Analgesics|analgesics|mesh-ancestor
14872352|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
14872353|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872354|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872355|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14872356|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14872357|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872358|NCT01143584|Dopamine|dopamine|mesh-list
14872359|NCT01143584|Cabergoline|cabergoline|mesh-list
14872360|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
14872361|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14872362|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
14714050|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
14714051|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714052|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14714053|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14714054|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14714055|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14872363|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
14872364|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212180|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15212181|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212182|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212183|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
15212184|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212185|NCT03670355|Tenofovir|tenofovir|mesh-list
15212186|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
15212187|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212188|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15212189|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15212190|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212191|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212192|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15212193|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14714056|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14872365|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212194|NCT03659578|Thymalfasin|thymalfasin|mesh-list
15212195|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15212196|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
15212197|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212198|NCT03629873|Cytarabine|cytarabine|mesh-list
15212199|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
15212200|NCT03629873|Carmustine|carmustine|mesh-list
15212201|NCT03629873|Etoposide|etoposide|mesh-list
15212202|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212203|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
15212204|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212205|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212206|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15212207|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
15212208|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212209|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212210|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15212211|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15212212|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15212213|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212214|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872366|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
15212215|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15212216|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
15212217|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
15212218|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212219|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
15212220|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872367|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872368|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872369|NCT01143584|Protective Agents|protective agents|mesh-ancestor
14872370|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14872371|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14872372|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14872373|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
14872374|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872375|NCT01143805|Tofacitinib|tofacitinib|mesh-list
14872376|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14872377|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872378|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872379|NCT01143831|Vitamins|vitamins|mesh-list
14872380|NCT01143831|Vitamin K|vitamin k|mesh-list
14872381|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
14872382|NCT01143831|Menatetrenone|menatetrenone|mesh-list
14872383|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
14872384|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872385|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14872386|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14872387|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872388|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
14872389|NCT01143831|Coagulants|coagulants|mesh-ancestor
14872390|NCT01143857|Varenicline|varenicline|mesh-list
15212221|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212222|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15212223|NCT03608865|Durvalumab|durvalumab|mesh-list
15212224|NCT03608865|Tremelimumab|tremelimumab|mesh-list
15212225|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212226|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212227|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
14872391|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14872392|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15212228|NCT03602235|Melphalan|melphalan|mesh-list
15212229|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14872393|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
14714057|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14714058|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714059|NCT00451113|Incretins|incretins|mesh-ancestor
15212230|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
15212231|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212232|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212233|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15212234|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212235|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
15212236|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212237|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
15212238|NCT03602235|Protective Agents|protective agents|mesh-ancestor
15212239|NCT03602235|Vitamins|vitamins|mesh-ancestor
15212240|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
14872394|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872395|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872396|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872397|NCT01143948|Insulin|insulin|mesh-list
14872398|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14872399|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15225151|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225152|NCT05192213|Ascorbic Acid|ascorbic acid|mesh-list
15225153|NCT05192213|Thiamine|thiamine|mesh-list
15225154|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
15225155|NCT05192213|Vitamins|vitamins|mesh-ancestor
15225156|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
15225157|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225158|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15225159|NCT05192213|Antioxidants|antioxidants|mesh-ancestor
15225160|NCT05192213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225161|NCT05192213|Protective Agents|protective agents|mesh-ancestor
15225162|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
15225163|NCT05191914|Fulvestrant|fulvestrant|mesh-list
15225164|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15225165|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225166|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14872400|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872401|NCT01143974|Pemetrexed|pemetrexed|mesh-list
14872402|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872403|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225167|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14714060|NCT00451113|Hormones|hormones|mesh-ancestor
14714061|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714062|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
14714063|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714064|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714065|NCT00451139|Lumefantrine|lumefantrine|mesh-list
14714066|NCT00451139|Artemether|artemether|mesh-list
14714067|NCT00451139|Quinine|quinine|mesh-list
14714068|NCT00451139|Atovaquone|atovaquone|mesh-list
14714069|NCT00451139|Proguanil|proguanil|mesh-list
15225168|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
14872404|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225169|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872405|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14872406|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14872407|NCT01143987|Cinacalcet|cinacalcet|mesh-list
14872408|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14872409|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872410|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14872411|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
14872412|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872413|NCT01144000|Daptomycin|daptomycin|mesh-list
14872414|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15212241|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
15212242|NCT03560193|Ethanol|ethanol|mesh-list
15212243|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
15212244|NCT03560193|Povidone|povidone|mesh-list
15212245|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15212246|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212247|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
15212248|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212249|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212250|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
14714070|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14714071|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14714072|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
14714073|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14714074|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14714075|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212251|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
15212252|NCT03557281|GSK656|gsk656|mesh-list
15212253|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15212254|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212255|NCT03557242|Aspirin|aspirin|mesh-list
15212256|NCT03557242|Warfarin|warfarin|mesh-list
15212257|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15212258|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14714076|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14714077|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714078|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14714079|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714080|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15212259|NCT03557242|Analgesics|analgesics|mesh-ancestor
15212260|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
15212261|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212262|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212263|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212264|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212265|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15212266|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15212267|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714081|NCT00451139|Analgesics|analgesics|mesh-ancestor
14714082|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
14714083|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212268|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14872415|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872416|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
14872417|NCT01144065|Testosterone|testosterone|mesh-list
14872418|NCT01144065|Androgens|androgens|mesh-ancestor
14872419|NCT01144065|Hormones|hormones|mesh-ancestor
14872420|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872421|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872422|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872423|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
14872424|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14872425|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872426|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212269|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14714084|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212270|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212271|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
15212272|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
15212273|NCT03540420|Atezolizumab|atezolizumab|mesh-list
15212274|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212275|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
15212276|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
15212277|NCT03516279|Dasatinib|dasatinib|mesh-list
15212278|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212279|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872427|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14872428|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14872429|NCT01144091|Protective Agents|protective agents|mesh-ancestor
14872430|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872431|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
14872432|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14872433|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
14872434|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
15212280|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15212281|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212282|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212283|NCT03508739|Valsartan|valsartan|mesh-list
14714085|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
14872435|NCT01144117|Hematinics|hematinics|mesh-ancestor
14872436|NCT01144156|Adalimumab|adalimumab|mesh-list
14872437|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872438|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14872439|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
15212284|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15212285|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15212286|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15212287|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212288|NCT03473561|Racecadotril|racecadotril|mesh-list
15212289|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
15212290|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212291|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
14714086|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
14714087|NCT00451230|Cocaine|cocaine|mesh-list
14714088|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714089|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
14714090|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
14714091|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714092|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714093|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
15212292|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212293|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212294|NCT03455517|Rituximab|rituximab|mesh-list
15212295|NCT03455517|Venetoclax|venetoclax|mesh-list
15212296|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212297|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212298|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
15212299|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212300|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212301|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
15212302|NCT03419234|Prednisone|prednisone|mesh-list
15212303|NCT03419234|Cortisone|cortisone|mesh-list
15212304|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
15212305|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
15212306|NCT03419234|Hormones|hormones|mesh-list
15212307|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15212308|NCT03419234|Androgens|androgens|mesh-list
15212309|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
15212310|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212311|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
14872440|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
14872441|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14872442|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14872443|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872444|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872445|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872446|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212312|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212313|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212314|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15212315|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212316|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15212317|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212318|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212319|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
14714094|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714095|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14872447|NCT01144195|Panitumumab|panitumumab|mesh-list
15212320|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15212321|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
15212322|NCT03419234|Protective Agents|protective agents|mesh-ancestor
15212323|NCT03419234|Vitamins|vitamins|mesh-ancestor
15212324|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
15212325|NCT03419234|Estrogens|estrogens|mesh-ancestor
15212326|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
15212327|NCT03383679|Capecitabine|capecitabine|mesh-list
15212328|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15212329|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
15212330|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212331|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212332|NCT03367299|Blinatumomab|blinatumomab|mesh-list
15212333|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212334|NCT03341806|Avelumab|avelumab|mesh-list
15212335|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212336|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212337|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
15212338|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212339|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212340|NCT03271047|Nivolumab|nivolumab|mesh-list
15212341|NCT03271047|Ipilimumab|ipilimumab|mesh-list
15212342|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212343|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212344|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15212345|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212346|NCT03171480|Isosorbide|isosorbide|mesh-list
15212347|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15212348|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15212349|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15212350|NCT03171480|Diuretics|diuretics|mesh-ancestor
15212351|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
15212352|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212353|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
15212354|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15212355|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212356|NCT03164655|Leucovorin|leucovorin|mesh-list
15212357|NCT03164655|Bevacizumab|bevacizumab|mesh-list
15212358|NCT03164655|Cetuximab|cetuximab|mesh-list
15212359|NCT03164655|Panitumumab|panitumumab|mesh-list
15212360|NCT03164655|Fluorouracil|fluorouracil|mesh-list
15212361|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
15212362|NCT03164655|Irinotecan|irinotecan|mesh-list
14872448|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872449|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212363|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212364|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212365|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14872450|NCT01144260|Bafetinib|bafetinib|mesh-list
14872451|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15212366|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212367|NCT03164655|Growth Substances|growth substances|mesh-ancestor
15212368|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212369|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212370|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
15212371|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212372|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15212373|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212374|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
15212375|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15212376|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212377|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212378|NCT03164655|Antidotes|antidotes|mesh-ancestor
15212379|NCT03164655|Protective Agents|protective agents|mesh-ancestor
15212380|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
15212381|NCT03164655|Vitamins|vitamins|mesh-ancestor
15212382|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
15212383|NCT03162627|Olaparib|olaparib|mesh-list
15212384|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15212385|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212386|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212387|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212388|NCT03115424|Liraglutide|liraglutide|mesh-list
14872452|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212389|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15212390|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212391|NCT03115424|Incretins|incretins|mesh-ancestor
15212392|NCT03115424|Hormones|hormones|mesh-ancestor
15225170|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212393|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212394|NCT03074240|Anesthetics|anesthetics|mesh-list
14872453|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872454|NCT01144312|Fentanyl|fentanyl|mesh-list
14872455|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14872456|NCT01144312|Narcotics|narcotics|mesh-ancestor
14872457|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872458|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872459|NCT01144312|Analgesics|analgesics|mesh-ancestor
14872460|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
15212395|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
15212396|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212397|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212398|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
15212399|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15212400|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212401|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212402|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15212403|NCT05276830|Analgesics|analgesics|mesh-ancestor
15212404|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
15212405|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212406|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15212407|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15212408|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15212409|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
15212410|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212411|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212412|NCT05276687|Vancomycin|vancomycin|mesh-list
15212413|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
15212414|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15212415|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212416|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15212417|NCT05276596|Norepinephrine|norepinephrine|mesh-list
15212418|NCT05276596|Ephedrine|ephedrine|mesh-list
15212419|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15212420|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15212421|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
15212422|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212423|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212424|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212425|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
14714096|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14714097|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14714098|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14714099|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714100|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
14714101|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714102|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
14714103|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714104|NCT00451373|Vancomycin|vancomycin|mesh-list
14714105|NCT00451373|Daptomycin|daptomycin|mesh-list
14714106|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714107|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714108|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
14714109|NCT00451386|Ertapenem|ertapenem|mesh-list
14714110|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714111|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714112|NCT00451399|Metformin|metformin|mesh-list
14714113|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14714114|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714115|NCT00451412|Heparin|heparin|mesh-list
14714116|NCT00451412|Calcium heparin|calcium heparin|mesh-list
14714117|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14714118|NCT00451412|Tinzaparin|tinzaparin|mesh-list
14714119|NCT00451412|Dalteparin|dalteparin|mesh-list
14714120|NCT00451412|Certoparin|certoparin|mesh-list
14714121|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
14714122|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14714123|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14714124|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714125|NCT00451490|S 20098|s 20098|mesh-list
14714126|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15212426|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
14714127|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714128|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714129|NCT00451568|Metformin|metformin|mesh-list
15212427|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212428|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15212429|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15212430|NCT05276531|Progesterone|progesterone|mesh-list
15212431|NCT05276531|Progestins|progestins|mesh-ancestor
15212432|NCT05276531|Hormones|hormones|mesh-ancestor
15212433|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212434|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212435|NCT05276492|Prednisone|prednisone|mesh-list
15212436|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212437|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
15212438|NCT05276492|Hormones|hormones|mesh-ancestor
15212439|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212440|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212441|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15212442|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212443|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
15212444|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212445|NCT05276284|Atezolizumab|atezolizumab|mesh-list
15212446|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
15212447|NCT05276284|Thioguanine|thioguanine|mesh-list
15212448|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212449|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
15212450|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212451|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15212452|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212453|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
15212454|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212455|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15212456|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212457|NCT05276258|Bupivacaine|bupivacaine|mesh-list
15212458|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
15212459|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
15212460|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212461|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212462|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
15212463|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212464|NCT05276219|Furosemide|furosemide|mesh-list
15212465|NCT05276219|Isosorbide|isosorbide|mesh-list
15212466|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15212467|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15212468|NCT05276219|Diuretics|diuretics|mesh-ancestor
15212469|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
15212470|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212471|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15212472|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15212473|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212474|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15212475|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
15212476|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15225171|NCT05191888|Amoxicillin|amoxicillin|mesh-list
15225172|NCT05191888|Metronidazole|metronidazole|mesh-list
15212477|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15212478|NCT05275894|Metronidazole|metronidazole|mesh-list
15212479|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212480|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15212481|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15212482|NCT05275777|Paclitaxel|paclitaxel|mesh-list
15212483|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
15212484|NCT05275777|Doxorubicin|doxorubicin|mesh-list
15212485|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15212486|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212487|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
15212488|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
15212489|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
15212490|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212491|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212492|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
15212493|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212494|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212495|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15212496|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
15212497|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15212498|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15212499|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15212500|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212501|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212502|NCT05275699|Glycine|glycine|mesh-list
15212503|NCT05275699|Glycine Agents|glycine agents|mesh-ancestor
15212504|NCT05275699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212505|NCT05275699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212506|NCT05275699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212507|NCT05275270|Oxytocin|oxytocin|mesh-list
15212508|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
15212509|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14296290|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296291|NCT00587431|Androgens|androgens|mesh-ancestor
14296292|NCT00587431|Hormones|hormones|mesh-ancestor
14296293|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296294|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296295|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14296296|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14296297|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
14296298|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14296299|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
14296300|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296301|NCT00587483|Lidocaine|lidocaine|mesh-list
14714130|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15212510|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212511|NCT05275205|Aflibercept|aflibercept|mesh-list
15212512|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14714131|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714132|NCT00451594|Dexamethasone|dexamethasone|mesh-list
14714133|NCT00451594|Prednisolone|prednisolone|mesh-list
14714134|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212513|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212514|NCT05275205|Growth Substances|growth substances|mesh-ancestor
15212515|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212516|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212517|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212518|NCT05275179|Posaconazole|posaconazole|mesh-list
15212519|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
15212520|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212521|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14714135|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
14714136|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
14714137|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714138|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714139|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14714140|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
14714141|NCT00451594|Hormones|hormones|mesh-ancestor
15212522|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15212523|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15212524|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15212525|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15212526|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212527|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212528|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15212529|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
15212530|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212531|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212532|NCT05274984|Lidocaine|lidocaine|mesh-list
15212533|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
15212534|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
15212535|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872461|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872462|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14872463|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14872464|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
14872465|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
14872466|NCT01144390|Methadone|methadone|mesh-list
14872467|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14872468|NCT01144390|Narcotics|narcotics|mesh-ancestor
14872469|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296302|NCT00587483|Amiodarone|amiodarone|mesh-list
14296303|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
14296304|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
14296305|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296306|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296307|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
15212536|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212537|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
15212538|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212539|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15212540|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15212541|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15212542|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15212543|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212544|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15212545|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212546|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
15212547|NCT05274672|Cephalexin|cephalexin|mesh-list
15212548|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15212549|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
15212550|NCT05274672|Trimethoprim|trimethoprim|mesh-list
15212551|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
15212552|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15212553|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212554|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15212555|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212556|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212557|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212558|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212559|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15212560|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15212561|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15212562|NCT05274672|Renal Agents|renal agents|mesh-ancestor
15212563|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
15212564|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15212565|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15212566|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15212567|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15212568|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15212569|NCT05255471|Olaparib|olaparib|mesh-list
15212570|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15212571|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212572|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212573|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212574|NCT05248139|Moxifloxacin|moxifloxacin|mesh-list
15212575|NCT05248139|Dexamethasone|dexamethasone|mesh-list
15212576|NCT05248139|Triamcinolone|triamcinolone|mesh-list
15212577|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15212578|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15212579|NCT05248139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15212580|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212581|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
14872470|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872471|NCT01144390|Analgesics|analgesics|mesh-ancestor
15212582|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
15212583|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212584|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212585|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212586|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
15212587|NCT05248139|Hormones|hormones|mesh-ancestor
15212588|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212589|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15212590|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212591|NCT05248139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15212592|NCT05248139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714142|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714143|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14714144|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714145|NCT00451620|Glyburide|glyburide|mesh-list
14714146|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14714147|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714148|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14714149|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14296308|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296309|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14296310|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14296311|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14296312|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14296313|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296314|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
14296315|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14714150|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14714151|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14714152|NCT00451672|Bromocriptine|bromocriptine|mesh-list
14714153|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14714154|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14714155|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
15212593|NCT05248139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15212594|NCT05248139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212595|NCT05248139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212596|NCT05248139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212597|NCT05248139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15212598|NCT05248139|Contraceptive Agents|contraceptive agents|mesh-ancestor
15212599|NCT05248139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15212600|NCT05248139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15212601|NCT05248139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15212602|NCT05248139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15225173|NCT05191888|Clarithromycin|clarithromycin|mesh-list
14872472|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
14872473|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872474|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
14872475|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872476|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
14872477|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14872478|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
14872479|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872480|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
14872481|NCT01144533|Protective Agents|protective agents|mesh-ancestor
14872482|NCT01144650|Dapsone|dapsone|mesh-list
15212603|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212604|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
15212605|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15212606|NCT05232734|Caffeine|caffeine|mesh-list
15212607|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
15212608|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212609|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15212610|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212611|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15212612|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212613|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15212614|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15212615|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
15212616|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212617|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15212618|NCT05232396|Antibodies|antibodies|mesh-list
15212619|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
15212620|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15212621|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
15212622|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212623|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212624|NCT05228613|Vaccines|vaccines|mesh-list
15212625|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
15212626|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212627|NCT05222724|Ibuprofen|ibuprofen|mesh-list
15212628|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15212629|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15212630|NCT05222724|Analgesics|analgesics|mesh-ancestor
15212631|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
15212632|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212633|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212634|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212635|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212636|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15212637|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212638|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212639|NCT05219929|Tetracycline|tetracycline|mesh-list
15212640|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15212641|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212642|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15212643|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212644|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212645|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15212646|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212647|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212648|NCT05218603|Bortezomib|bortezomib|mesh-list
15212649|NCT05218603|Daratumumab|daratumumab|mesh-list
15212650|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212651|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
15212652|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15212653|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15212654|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212655|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212656|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15212657|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15212658|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15212659|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15212660|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212661|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212662|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
15212663|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15212664|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
15212665|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15212666|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15212667|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872483|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212668|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15212669|NCT05200884|Lidocaine|lidocaine|mesh-list
15212670|NCT05200884|Carticaine|carticaine|mesh-list
14872484|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
14872485|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14872486|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14872487|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14872488|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872489|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872490|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
14872491|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14872492|NCT01144676|Dapivirine|dapivirine|mesh-list
14872493|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14872494|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14872495|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
14872496|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872497|NCT01144702|Artesunate|artesunate|mesh-list
14872498|NCT01144702|Mefloquine|mefloquine|mesh-list
14872499|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
14872500|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14872501|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14872502|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872503|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872504|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
14872505|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
14872506|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14872507|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
15212671|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
15212672|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
15212673|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212674|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212675|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
15212676|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212677|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15212678|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15212679|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15212680|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15212681|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212682|NCT05200312|Prednisone|prednisone|mesh-list
15212683|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
15212684|NCT05200312|Rituximab|rituximab|mesh-list
15212685|NCT05200312|Doxorubicin|doxorubicin|mesh-list
15212686|NCT05200312|Vincristine|vincristine|mesh-list
15212687|NCT05200312|Lenalidomide|lenalidomide|mesh-list
15212688|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
15212689|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296316|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14296317|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14296318|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296319|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14296320|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14296321|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14296322|NCT00587678|Simvastatin|simvastatin|mesh-list
14296323|NCT00587678|Ezetimibe|ezetimibe|mesh-list
14296324|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14296325|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14296326|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
15212690|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
15212691|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212692|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212693|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15212694|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
15212695|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872508|NCT01144728|Metformin|metformin|mesh-list
14872509|NCT01144728|Glimepiride|glimepiride|mesh-list
14872510|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15212696|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212697|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15212698|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225174|NCT05191888|Rabeprazole|rabeprazole|mesh-list
15212699|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15212700|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15212701|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15212702|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212703|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212704|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
15212705|NCT05200312|Hormones|hormones|mesh-ancestor
15212706|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714156|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714157|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714158|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
14714159|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
14714160|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714161|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714162|NCT00451711|Amphotericin B|amphotericin b|mesh-list
14714163|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14714164|NCT00451711|Amebicides|amebicides|mesh-ancestor
14714165|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14714166|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14714167|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714168|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714169|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
15212707|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15212708|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15212709|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
15212710|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
15212711|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
15212712|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15212713|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212714|NCT05200312|Growth Substances|growth substances|mesh-ancestor
15212715|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
14872511|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872512|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14872513|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212716|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15212717|NCT05199753|Antibodies|antibodies|mesh-list
15212718|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
15212719|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212720|NCT05197270|Aflibercept|aflibercept|mesh-list
15212721|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15212722|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212723|NCT05197270|Growth Substances|growth substances|mesh-ancestor
15212724|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212725|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212726|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225175|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15225176|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225177|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15225178|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15225179|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14714170|NCT00451724|Ketamine|ketamine|mesh-list
14714171|NCT00451724|Analgesics|analgesics|mesh-ancestor
15225180|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225181|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872514|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
15212727|NCT05194111|Valsartan|valsartan|mesh-list
15212728|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15212729|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15212730|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15212731|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15212732|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212733|NCT05150587|Rifaximin|rifaximin|mesh-list
15212734|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15212735|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212736|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212737|NCT05116202|Nivolumab|nivolumab|mesh-list
15212738|NCT05116202|Ipilimumab|ipilimumab|mesh-list
15212739|NCT05116202|Atezolizumab|atezolizumab|mesh-list
15212740|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296327|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296328|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14296329|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14296330|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296331|NCT00587769|Bupropion|bupropion|mesh-list
15212741|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212742|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14296332|NCT00587769|Varenicline|varenicline|mesh-list
14296333|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14296334|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
14296335|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14296336|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14296337|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14296338|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14714172|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
15212743|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212744|NCT05090566|Dexamethasone|dexamethasone|mesh-list
15212745|NCT05090566|Lenalidomide|lenalidomide|mesh-list
15212746|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212747|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
15212748|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
15212749|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212750|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212751|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212752|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
15212753|NCT05090566|Hormones|hormones|mesh-ancestor
15212754|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212755|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15212756|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212757|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
14872515|NCT01144754|Rituximab|rituximab|mesh-list
14872516|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872517|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872518|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
14872519|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872520|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14872521|NCT01144832|Ebastine|ebastine|mesh-list
14296339|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296340|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
14296341|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872522|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14872523|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
14872524|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
14872525|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872526|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872527|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914113|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914114|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14914115|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
14914116|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14914117|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14914118|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
14296342|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296343|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14914119|NCT01379079|Aspirin|aspirin|mesh-list
15212758|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14872528|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
15212759|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212760|NCT05090566|Growth Substances|growth substances|mesh-ancestor
15212761|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212762|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
15212763|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
15212764|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
15212765|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212766|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212767|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15212768|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
15212769|NCT05051735|Acetaminophen|acetaminophen|mesh-list
15212770|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15212771|NCT05051735|Analgesics|analgesics|mesh-ancestor
15212772|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
15212773|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212774|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212775|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
14872529|NCT01144910|Miotics|miotics|mesh-ancestor
14872530|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
15212776|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
15212777|NCT05040984|Mirabegron|mirabegron|mesh-list
15212778|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15212779|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15212780|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
15212781|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212782|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212783|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212784|NCT05040984|Urological Agents|urological agents|mesh-ancestor
15212785|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15212786|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15212787|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15212788|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
15212789|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
15212790|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15212791|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212792|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212793|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15212794|NCT05037500|Decitabine|decitabine|mesh-list
15212795|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15212796|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
15212797|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212798|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212799|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212800|NCT05027308|Teduglutide|teduglutide|mesh-list
15212801|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296344|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14296345|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296346|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14872531|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212802|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15212803|NCT05027308|Protective Agents|protective agents|mesh-ancestor
15212804|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212805|NCT04995029|Buprenorphine|buprenorphine|mesh-list
15212806|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15212807|NCT04995029|Narcotics|narcotics|mesh-ancestor
15212808|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15212809|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212810|NCT04995029|Analgesics|analgesics|mesh-ancestor
15212811|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
15212812|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212813|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15212814|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
15212815|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212816|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212817|NCT04973254|Rilpivirine|rilpivirine|mesh-list
15212818|NCT04973254|Cabotegravir|cabotegravir|mesh-list
15212819|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15212820|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15212821|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212822|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212823|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
15212824|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212825|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15212826|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15212827|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15212828|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15212829|NCT04949269|BMS-986165|bms-986165|mesh-list
15212830|NCT04949269|Famotidine|famotidine|mesh-list
15212831|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15212832|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212833|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15212834|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
15212835|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
15212836|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212837|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212838|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212839|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
15212840|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15212841|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212842|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15212843|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15212844|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
15212845|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212846|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212847|NCT04931342|Paclitaxel|paclitaxel|mesh-list
15212848|NCT04931342|Maytansine|maytansine|mesh-list
15212849|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15212850|NCT04931342|Bevacizumab|bevacizumab|mesh-list
15212851|NCT04931342|Trastuzumab|trastuzumab|mesh-list
15212852|NCT04931342|Atezolizumab|atezolizumab|mesh-list
15212853|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15212854|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212855|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
15212856|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
15212857|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
15212858|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212859|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212860|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15212861|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212862|NCT04931342|Growth Substances|growth substances|mesh-ancestor
15212863|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212864|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212865|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
15212866|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15212867|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212868|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
15212869|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15212870|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
15212871|NCT04893915|Fludarabine|fludarabine|mesh-list
15212872|NCT04893915|Interleukin-2|interleukin-2|mesh-list
15212873|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15212874|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
15212875|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212876|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15212877|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15212878|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
15212879|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212880|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212881|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15212882|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15212883|NCT04893915|Analgesics|analgesics|mesh-ancestor
15212884|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
15212885|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212886|NCT04837716|Bevacizumab|bevacizumab|mesh-list
15212887|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15212888|NCT04837716|Carboplatin|carboplatin|mesh-list
15212889|NCT04837716|Pemetrexed|pemetrexed|mesh-list
15212890|NCT04837716|Ensartinib|ensartinib|mesh-list
15212891|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
15212892|NCT04837716|Antibodies|antibodies|mesh-list
15212893|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
15212894|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15212895|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
15212896|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212897|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15212898|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15212899|NCT04837716|Growth Substances|growth substances|mesh-ancestor
15212900|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212901|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212902|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
15212903|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212904|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212905|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15212906|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15212907|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15225182|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15225183|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15225184|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15225185|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14872532|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296347|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14296348|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872533|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14714173|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714174|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714175|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14714176|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14714177|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
14714178|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
14714179|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714180|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14714181|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14714182|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714183|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714184|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
14714185|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714186|NCT00451763|Bevacizumab|bevacizumab|mesh-list
14714187|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14714188|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714189|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14714190|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14714191|NCT00451763|Growth Substances|growth substances|mesh-ancestor
14872534|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14872535|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872536|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14872537|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14872538|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872539|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872540|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872541|NCT01144923|Gabapentin|gabapentin|mesh-list
14872542|NCT01144923|Nortriptyline|nortriptyline|mesh-list
14872543|NCT01144923|Analgesics|analgesics|mesh-ancestor
14872544|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
14872545|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872546|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872547|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
14872548|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14872549|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14872550|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872551|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14872552|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14872553|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14872554|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872555|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872556|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
14872557|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14872558|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
14872559|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14714192|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714193|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
14714194|NCT00451776|Propofol|propofol|mesh-list
14714195|NCT00451776|Etomidate|etomidate|mesh-list
14714196|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14714197|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714198|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714199|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14714200|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
14714201|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
14714202|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
14872560|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14914120|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
14872561|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14872562|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
14872563|NCT01144988|Bevacizumab|bevacizumab|mesh-list
14872564|NCT01144988|Irinotecan|irinotecan|mesh-list
14872565|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872566|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872567|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14872568|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14872569|NCT01144988|Growth Substances|growth substances|mesh-ancestor
14872570|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872571|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
14872572|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14872573|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14872574|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872575|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872576|NCT01145079|Sirolimus|sirolimus|mesh-list
14872577|NCT01145079|Everolimus|everolimus|mesh-list
14872578|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872579|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872580|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
14872581|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872582|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14872583|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872584|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14872585|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
14872586|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14872587|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14872588|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
14872589|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872590|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
14872591|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14872592|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872593|NCT01145326|Lidocaine|lidocaine|mesh-list
14872594|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
14872595|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
14872596|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872597|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872598|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
14872599|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872600|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14872601|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14872602|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14872603|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14872604|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872605|NCT01145365|Anesthetics|anesthetics|mesh-list
14872606|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872607|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872608|NCT01145404|Capecitabine|capecitabine|mesh-list
14872609|NCT01145404|Lapatinib|lapatinib|mesh-list
14872610|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14872611|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
14872612|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872613|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872614|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14872615|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872616|NCT01145430|Doxorubicin|doxorubicin|mesh-list
14872617|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14872618|NCT01145430|Veliparib|veliparib|mesh-list
14872619|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14872620|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872621|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14872622|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14872623|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872624|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872625|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14872626|NCT01145456|Gemcitabine|gemcitabine|mesh-list
14872627|NCT01145456|R04929097|r04929097|mesh-list
14872628|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14872629|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
14872630|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872631|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872632|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
14872633|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872634|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872635|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872636|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
14872637|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872638|NCT01145534|Glyburide|glyburide|mesh-list
14872639|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14872640|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872641|NCT01145573|Calcium|calcium|mesh-list
14872642|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14872643|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212908|NCT04817189|Dexamethasone|dexamethasone|mesh-list
15212909|NCT04817189|Ondansetron|ondansetron|mesh-list
15212910|NCT04817189|Palonosetron|palonosetron|mesh-list
15212911|NCT04817189|Granisetron|granisetron|mesh-list
15212912|NCT04817189|Tropisetron|tropisetron|mesh-list
15212913|NCT04817189|Dolasetron|dolasetron|mesh-list
15212914|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212915|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
15212916|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
15212917|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212918|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212919|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212920|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
15212921|NCT04817189|Hormones|hormones|mesh-ancestor
15212922|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15212923|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15212924|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212925|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
15212926|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
15212927|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15212928|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
15212929|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872644|NCT01145612|Losartan|losartan|mesh-list
14872645|NCT01145612|Atenolol|atenolol|mesh-list
14872646|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14872647|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14872648|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14872649|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14872650|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872651|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
14872652|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
14872653|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872654|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872655|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14872656|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14872657|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14872658|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14872659|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872660|NCT01145677|Topiramate|topiramate|mesh-list
14872661|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
14872662|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14872663|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872664|NCT01145703|Vitamin D|vitamin d|mesh-list
14872665|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
14872666|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
14872667|NCT01145703|Vitamins|vitamins|mesh-list
14872668|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
14872669|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212930|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212931|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14714203|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14714204|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14714205|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14714206|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
14872670|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14714207|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714208|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714209|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714210|NCT00451828|Simvastatin|simvastatin|mesh-list
14872671|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14872672|NCT01145807|Terbinafine|terbinafine|mesh-list
14872673|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
14872674|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872675|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872676|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872677|NCT01145846|Cytarabine|cytarabine|mesh-list
14872678|NCT01145846|Daunorubicin|daunorubicin|mesh-list
14872679|NCT01145846|Idarubicin|idarubicin|mesh-list
14872680|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14872681|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
14872682|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872683|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872684|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
14872685|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872686|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872687|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
14872688|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872689|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14872690|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14872691|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14872692|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872693|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
14872694|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14872695|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
14872696|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14872697|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
14872698|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872699|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872700|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
14872701|NCT01145950|Etanercept|etanercept|mesh-list
14872702|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14872703|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14872704|NCT01145950|Analgesics|analgesics|mesh-ancestor
14872705|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
14872706|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872707|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872708|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872709|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14872710|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14872711|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872712|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
14872713|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
14872714|NCT01145976|Fludarabine|fludarabine|mesh-list
14872715|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
14872716|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14872717|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872718|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
14872719|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872720|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14714211|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14714212|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14714213|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
14714214|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714215|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14714216|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14714217|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714218|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
14714219|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14714220|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872721|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14872722|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
14872723|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872724|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714221|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14714222|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
14714223|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714224|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714225|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714226|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714227|NCT00451880|Famotidine|famotidine|mesh-list
14714228|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14714229|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14872725|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14872726|NCT01146002|Guanfacine|guanfacine|mesh-list
14872727|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14872728|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14872729|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14872730|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14872731|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
14872732|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872733|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872734|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872735|NCT01146028|Tizanidine|tizanidine|mesh-list
14872736|NCT01146028|Analgesics|analgesics|mesh-ancestor
14872737|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
14872738|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872739|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872740|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
14872741|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14872742|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14872743|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
14872744|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
14872745|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14872746|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15212932|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15212933|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872747|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14872748|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
14872749|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872750|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872751|NCT01146041|Rivastigmine|rivastigmine|mesh-list
14872752|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14872753|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872754|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872755|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872756|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872757|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872758|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14872759|NCT01146041|Protective Agents|protective agents|mesh-ancestor
14872760|NCT01146067|Rivastigmine|rivastigmine|mesh-list
14872761|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14872762|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872763|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872764|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872765|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872766|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872767|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14872768|NCT01146067|Protective Agents|protective agents|mesh-ancestor
14872769|NCT01146093|Pravastatin|pravastatin|mesh-list
14872770|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14872771|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14872772|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
14872773|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872774|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15212934|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15212935|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15212936|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15212937|NCT04782830|Midodrine|midodrine|mesh-list
15212938|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15212939|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14872775|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14872776|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212940|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15212941|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14714230|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14714231|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
14714232|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
14714233|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714234|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714235|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714236|NCT00451971|Leflunomide|leflunomide|mesh-list
14872777|NCT01146106|Pravastatin|pravastatin|mesh-list
14872778|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14872779|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14872780|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
14714237|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714238|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714239|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714240|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
14872781|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872782|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14872783|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14872784|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872785|NCT01146145|Ketamine|ketamine|mesh-list
14872786|NCT01146145|Morphine|morphine|mesh-list
14872787|NCT01146145|Analgesics|analgesics|mesh-ancestor
14872788|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
14872789|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872790|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872791|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14872792|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14872793|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
14872794|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
14872795|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872796|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14872797|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14872798|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212942|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212943|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
15212944|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15212945|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212946|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
15212947|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
15212948|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212949|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15212950|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15212951|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15212952|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15212953|NCT04781426|Tenofovir|tenofovir|mesh-list
15212954|NCT04781426|Lamivudine|lamivudine|mesh-list
15212955|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
15212956|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15212957|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15212958|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15212959|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15212960|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212961|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15212962|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15212963|NCT04774666|Antibodies|antibodies|mesh-list
15212964|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
15212965|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212966|NCT04740931|Aflibercept|aflibercept|mesh-list
15212967|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15212968|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14872799|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872800|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14872801|NCT01146145|Narcotics|narcotics|mesh-ancestor
14872802|NCT01146301|Clopidogrel|clopidogrel|mesh-list
14872803|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14872804|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14872805|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14872806|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14872807|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
14872808|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872809|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872810|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872811|NCT01146431|Anesthetics|anesthetics|mesh-list
14872812|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872813|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872814|NCT01146483|Pantoprazole|pantoprazole|mesh-list
14872815|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14872816|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14872817|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14872818|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
14872819|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872820|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14872821|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14872822|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872823|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14872824|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14872825|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14872826|NCT01146509|Donepezil|donepezil|mesh-list
14872827|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14872828|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872829|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872830|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872831|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872832|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872833|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
14872834|NCT01146535|Interferons|interferons|mesh-list
14872835|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
14872836|NCT01146535|Oseltamivir|oseltamivir|mesh-list
14872837|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872838|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
14872839|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872840|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
14872841|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872842|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872843|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872844|NCT01146548|Fluoxetine|fluoxetine|mesh-list
14872845|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14872846|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14872847|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14872848|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872849|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872850|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
14872851|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872852|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14872853|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
14872854|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14872855|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15212969|NCT04740931|Growth Substances|growth substances|mesh-ancestor
15212970|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212971|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
15212972|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212973|NCT04730856|Tinzaparin|tinzaparin|mesh-list
15212974|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15212975|NCT04730856|Dalteparin|dalteparin|mesh-list
15212976|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
15212977|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15212978|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15225186|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14872856|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14872857|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914121|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
14914122|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
14914123|NCT01379079|Calcium|calcium|mesh-list
14914124|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14914125|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914126|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14914127|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14914128|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914129|NCT01379079|Analgesics|analgesics|mesh-ancestor
14914130|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
14914131|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914132|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914133|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914134|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14914135|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14914136|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914137|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914138|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14914139|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914140|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
14914141|NCT01379144|Latanoprost|latanoprost|mesh-list
14914142|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14914143|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14914144|NCT01379157|Imipenem|imipenem|mesh-list
14914145|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914146|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914147|NCT01379196|Azithromycin|azithromycin|mesh-list
14914148|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914149|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914150|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
14914151|NCT01379300|Dabigatran|dabigatran|mesh-list
14914152|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14914153|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
14914154|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14914155|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
14914156|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914157|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914158|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
14914159|NCT01379326|Mebendazole|mebendazole|mesh-list
14914160|NCT01379326|Piperazine|piperazine|mesh-list
14914161|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
14914162|NCT01379326|DMP 777|dmp 777|mesh-list
14914163|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
14914164|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
14914165|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14914166|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914167|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
14914168|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
14914169|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14914170|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914171|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914172|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914173|NCT01379482|Paclitaxel|paclitaxel|mesh-list
14914174|NCT01379482|Docetaxel|docetaxel|mesh-list
14914175|NCT01379482|Cisplatin|cisplatin|mesh-list
14914176|NCT01379482|Doxorubicin|doxorubicin|mesh-list
14914177|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
14914178|NCT01379482|Irinotecan|irinotecan|mesh-list
14914179|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14914180|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914181|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
14914182|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
14914183|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
14914184|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914185|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14914186|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14914187|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14914188|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914189|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14914190|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14914191|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872858|NCT01146626|Vitamin D|vitamin d|mesh-list
14872859|NCT01146626|Ribavirin|ribavirin|mesh-list
14872860|NCT01146626|Vitamins|vitamins|mesh-ancestor
14872861|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
14872862|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872863|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14872864|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
14872865|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872866|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
14872867|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872868|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
14872869|NCT01146678|Lixisenatide|lixisenatide|mesh-list
14872870|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14872871|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872872|NCT01146925|Deferiprone|deferiprone|mesh-list
14872873|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14872874|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
14872875|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
14872876|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872877|NCT01146977|Cytarabine|cytarabine|mesh-list
14872878|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14872879|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
14872880|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872881|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872882|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
14872883|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14872884|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14872885|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
14872886|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872887|NCT01147016|Paclitaxel|paclitaxel|mesh-list
14872888|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
14872889|NCT01147016|Doxorubicin|doxorubicin|mesh-list
14872890|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14872891|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14872892|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872893|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
14872894|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
14872895|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
14872896|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872897|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714241|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714242|NCT00451984|Interleukin-2|interleukin-2|mesh-list
14714243|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714244|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14714245|NCT00451984|Analgesics|analgesics|mesh-ancestor
14714246|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
14714247|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714248|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714249|NCT00451997|Cytarabine|cytarabine|mesh-list
14714250|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
14714251|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14714252|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
14714253|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872898|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
14714254|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714255|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
14714256|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714257|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714258|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
14714259|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714260|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14714261|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714262|NCT00452062|Dexamethasone|dexamethasone|mesh-list
14714263|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714264|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
14714265|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
14714266|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872899|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872900|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14872901|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14872902|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
14872903|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14872904|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14872905|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14872906|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14714267|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872907|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872908|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14872909|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14872910|NCT01147029|Growth Substances|growth substances|mesh-ancestor
14872911|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872912|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
14872913|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14872914|NCT01147133|Clopidogrel|clopidogrel|mesh-list
14872915|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14872916|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14872917|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14872918|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15212979|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15212980|NCT04707534|Dexamethasone|dexamethasone|mesh-list
15212981|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15212982|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
15212983|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
15212984|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15212985|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212986|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15212987|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
15212988|NCT04707534|Hormones|hormones|mesh-ancestor
15212989|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872919|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
14872920|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872921|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872922|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872923|NCT01147146|Fentanyl|fentanyl|mesh-list
14872924|NCT01147146|Midazolam|midazolam|mesh-list
14872925|NCT01147146|Bupivacaine|bupivacaine|mesh-list
14872926|NCT01147146|Propofol|propofol|mesh-list
14872927|NCT01147146|Atracurium|atracurium|mesh-list
14872928|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
14872929|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
14872930|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14872931|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872932|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
14872933|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872934|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14872935|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14872936|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
14872937|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14872938|NCT01147146|Narcotics|narcotics|mesh-ancestor
14872939|NCT01147146|Analgesics|analgesics|mesh-ancestor
14872940|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14872941|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14872942|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14872943|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14872944|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
14872945|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
14872946|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14872947|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872948|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14872949|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14872950|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14872951|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14872952|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14872953|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
14872954|NCT01147224|Ciclesonide|ciclesonide|mesh-list
14872955|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
14872956|NCT01147224|Hormones|hormones|mesh-ancestor
14872957|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14872958|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872959|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14872960|NCT01147276|Vildagliptin|vildagliptin|mesh-list
15212990|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15212991|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15212992|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
15212993|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15212994|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
15212995|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872961|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14872962|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872963|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14872964|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
15212996|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
14872965|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872966|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872967|NCT01147289|Meloxicam|meloxicam|mesh-list
14872968|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14872969|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14872970|NCT01147289|Analgesics|analgesics|mesh-ancestor
14872971|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
14872972|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872973|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872974|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14872975|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14872976|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14872977|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14872978|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14872979|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872980|NCT01147354|Selenium|selenium|mesh-list
14872981|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
14872982|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14872983|NCT01147354|Protective Agents|protective agents|mesh-ancestor
14872984|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872985|NCT01147354|Trace Elements|trace elements|mesh-ancestor
14872986|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
14872987|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
14872988|NCT01147432|Capsaicin|capsaicin|mesh-list
14872989|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
14872990|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
14872991|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
14872992|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14872993|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14872994|NCT01147510|Montelukast|montelukast|mesh-list
14872995|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14872996|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
14872997|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14872998|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
14872999|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873000|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873001|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14873002|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14873003|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873004|NCT01147523|Vitamin E|vitamin e|mesh-list
14873005|NCT01147523|Spironolactone|spironolactone|mesh-list
14873006|NCT01147523|Vitamins|vitamins|mesh-ancestor
14873007|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
14873008|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873009|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
14873010|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873011|NCT01147523|Protective Agents|protective agents|mesh-ancestor
14873012|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14873013|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
14873014|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873015|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14873016|NCT01147523|Diuretics|diuretics|mesh-ancestor
14873017|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
14873018|NCT01147588|Esomeprazole|esomeprazole|mesh-list
14873019|NCT01147588|Omeprazole|omeprazole|mesh-list
14873020|NCT01147588|Lansoprazole|lansoprazole|mesh-list
14873021|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
14873022|NCT01147588|Clopidogrel|clopidogrel|mesh-list
14873023|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14873024|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14873025|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14873026|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14873027|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
14873028|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873029|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873030|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873031|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14873032|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873033|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14873034|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873035|NCT01147692|Simvastatin|simvastatin|mesh-list
14873036|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
14873037|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14873038|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14873039|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
14873040|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873041|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14873042|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14873043|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873044|NCT01147692|Incretins|incretins|mesh-ancestor
14873045|NCT01147692|Hormones|hormones|mesh-ancestor
14873046|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873047|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873048|NCT01147705|Allopurinol|allopurinol|mesh-list
14873049|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
14873050|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873051|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873052|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
14873053|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873054|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14873055|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
14873056|NCT01147705|Protective Agents|protective agents|mesh-ancestor
14873057|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873058|NCT01147718|Digoxin|digoxin|mesh-list
14873059|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
14873060|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14873061|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14873062|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873063|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873064|NCT01147718|Protective Agents|protective agents|mesh-ancestor
14873065|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873066|NCT01147718|Incretins|incretins|mesh-ancestor
14873067|NCT01147718|Hormones|hormones|mesh-ancestor
14873068|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873069|NCT01147731|Warfarin|warfarin|mesh-list
14873070|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
14873071|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
14873072|NCT01147731|Incretins|incretins|mesh-ancestor
14873073|NCT01147731|Hormones|hormones|mesh-ancestor
14873074|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296349|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
14296350|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14714268|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296351|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714269|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
14714270|NCT00452062|Hormones|hormones|mesh-ancestor
14714271|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714272|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14714273|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714274|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14714275|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714276|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14714277|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714278|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714279|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
14714280|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14714281|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728840|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14728841|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14728842|NCT00520260|Analgesics|analgesics|mesh-ancestor
14728843|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
14728844|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728845|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728846|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14728847|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728848|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14728849|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728850|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728851|NCT00520325|Lectins|lectins|mesh-list
14728852|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
14728853|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
14728854|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728855|NCT00520325|Coagulants|coagulants|mesh-ancestor
14728856|NCT00520338|Celecoxib|celecoxib|mesh-list
14728857|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14728858|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14728859|NCT00520338|Analgesics|analgesics|mesh-ancestor
14728860|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
14728861|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728862|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15212997|NCT04697823|Protective Agents|protective agents|mesh-ancestor
15212998|NCT04691856|Acetaminophen|acetaminophen|mesh-list
15212999|NCT04691856|Ibuprofen|ibuprofen|mesh-list
15213000|NCT04691856|Morphine|morphine|mesh-list
15213001|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15213002|NCT04691856|Narcotics|narcotics|mesh-ancestor
15213003|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15213004|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213005|NCT04691856|Analgesics|analgesics|mesh-ancestor
15213006|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
15213007|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213008|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213009|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213010|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213011|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728863|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14728864|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873075|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213012|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15213013|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873076|NCT01147757|Remifentanil|remifentanil|mesh-list
14873077|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14873078|NCT01147757|Narcotics|narcotics|mesh-ancestor
14873079|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873080|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873081|NCT01147757|Analgesics|analgesics|mesh-ancestor
14873082|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
14873083|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873084|NCT01147770|Progesterone|progesterone|mesh-list
14873085|NCT01147770|Progestins|progestins|mesh-ancestor
14873086|NCT01147770|Hormones|hormones|mesh-ancestor
14873087|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873088|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873089|NCT01148004|Ritonavir|ritonavir|mesh-list
14873090|NCT01148004|Lopinavir|lopinavir|mesh-list
14873091|NCT01148004|Fenofibrate|fenofibrate|mesh-list
14873092|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14873093|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14873094|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
14873095|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873096|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873097|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14873098|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14873099|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
14873100|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873101|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14873102|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14873103|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14873104|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
14873105|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14873106|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14873107|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873108|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
14873109|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
14873110|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14873111|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14873112|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873113|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873114|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873115|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873116|NCT01148147|Adenosine|adenosine|mesh-list
14873117|NCT01148147|Analgesics|analgesics|mesh-ancestor
14873118|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
14873119|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873120|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873121|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14873122|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
14873123|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14873124|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
14873125|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
14873126|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873127|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873128|NCT01148160|Voriconazole|voriconazole|mesh-list
14873129|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
14873130|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873131|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14873132|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14873133|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873134|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873135|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14873136|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
14873137|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873138|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873139|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14873140|NCT01148173|Ifosfamide|ifosfamide|mesh-list
14873141|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14873142|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
14873143|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873144|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873145|NCT01148264|Olanzapine|olanzapine|mesh-list
14873146|NCT01148264|Metoclopramide|metoclopramide|mesh-list
14873147|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
14873148|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
14873149|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873150|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873151|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873152|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14873153|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14873154|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873155|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873156|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14873157|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873158|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873159|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873160|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873161|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
14873162|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14873163|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14873164|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
14873165|NCT01148277|Fentanyl|fentanyl|mesh-list
14873166|NCT01148277|Midazolam|midazolam|mesh-list
14873167|NCT01148277|Propofol|propofol|mesh-list
14873168|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14873169|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873170|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873171|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14873172|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
14873173|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
14873174|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14873175|NCT01148277|Narcotics|narcotics|mesh-ancestor
14873176|NCT01148277|Analgesics|analgesics|mesh-ancestor
14873177|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
14873178|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873179|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14873180|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14873181|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14873182|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873183|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
14873184|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
14873185|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873186|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873187|NCT01148303|Etoricoxib|etoricoxib|mesh-list
14873188|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14873189|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873190|NCT01148303|Analgesics|analgesics|mesh-ancestor
14873191|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
14873192|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873193|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873194|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14873195|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873196|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14873197|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14873198|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873199|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873200|NCT01148316|Fluoxetine|fluoxetine|mesh-list
14873201|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14873202|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873203|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873204|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873205|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873206|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
14873207|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873208|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14873209|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
14873210|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873211|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14873212|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14873213|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873214|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14873215|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
14873216|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873217|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873218|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
14873219|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873220|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873221|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14873222|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873223|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873224|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
14873225|NCT01148446|Prednisone|prednisone|mesh-list
14873226|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
14873227|NCT01148446|Rituximab|rituximab|mesh-list
14873228|NCT01148446|Doxorubicin|doxorubicin|mesh-list
14873229|NCT01148446|Vincristine|vincristine|mesh-list
14873230|NCT01148446|Epirubicin|epirubicin|mesh-list
14873231|NCT01148446|Vinblastine|vinblastine|mesh-list
14873232|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873233|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
14873234|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873235|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873236|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14873237|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
14873238|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873239|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873240|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14873241|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14873242|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14873243|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14873244|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14873245|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873246|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14873247|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
14873248|NCT01148446|Hormones|hormones|mesh-ancestor
14873249|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873250|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14873251|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14873252|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
14873253|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
14873254|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
14873255|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14873256|NCT01148472|Citalopram|citalopram|mesh-list
14873257|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14873258|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873259|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873260|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873261|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873262|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
14873263|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873264|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14873265|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
14873266|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873267|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914192|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
14873268|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14873269|NCT01148472|Analgesics|analgesics|mesh-ancestor
14873270|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
15213014|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213015|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
15213016|NCT04671966|Cetrorelix|cetrorelix|mesh-list
15213017|NCT04671966|Estradiol|estradiol|mesh-list
15213018|NCT04671966|Estrogens|estrogens|mesh-ancestor
15213019|NCT04671966|Hormones|hormones|mesh-ancestor
15213020|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213021|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873271|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
14873272|NCT01148576|Vitamin E|vitamin e|mesh-list
14873273|NCT01148576|Entecavir|entecavir|mesh-list
14873274|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
14873275|NCT01148576|Vitamins|vitamins|mesh-ancestor
14873276|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
14873277|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873278|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
14873279|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873280|NCT01148576|Protective Agents|protective agents|mesh-ancestor
14873281|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
14873282|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873283|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14873284|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
14873285|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14873286|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14873287|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
14873288|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14873289|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14873290|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
14873291|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14873292|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914193|NCT01379560|Dinoprost|dinoprost|mesh-list
14914194|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14914195|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14914196|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
14914197|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14914198|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914199|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
14914200|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
14914201|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14914202|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917343|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213022|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14873293|NCT01148615|Docetaxel|docetaxel|mesh-list
14873294|NCT01148615|Aflibercept|aflibercept|mesh-list
14873295|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873296|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14873297|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14873298|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14873299|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873300|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14873301|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14873302|NCT01148615|Growth Substances|growth substances|mesh-ancestor
14873303|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873304|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
14873305|NCT01148628|Everolimus|everolimus|mesh-list
14873306|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873307|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873308|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
14873309|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873310|NCT01148667|Caseins|caseins|mesh-list
14873311|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
14873312|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
14873313|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873314|NCT01148901|Infliximab|infliximab|mesh-list
14714282|NCT00452192|Telmisartan|telmisartan|mesh-list
14714283|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14714284|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14714285|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14714286|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714287|NCT00452218|Sorafenib|sorafenib|mesh-list
14714288|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714289|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14873315|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14873316|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873317|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873318|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14873319|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14873320|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
14873321|NCT01148992|Lofexidine|lofexidine|mesh-list
14873322|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14873323|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14873324|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873325|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
14873326|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873327|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14873328|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14873329|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14873330|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
14873331|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873332|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873333|NCT01149005|Insulin|insulin|mesh-list
14873334|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14873335|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
14873336|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
14873337|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
14873338|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873339|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873340|NCT01149018|Dronabinol|dronabinol|mesh-list
14873341|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
14873342|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873343|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873344|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873345|NCT01149018|Analgesics|analgesics|mesh-ancestor
14873346|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
14873347|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873348|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14873349|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14873350|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873351|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873352|NCT01149018|Hormones|hormones|mesh-ancestor
14873353|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873354|NCT01149109|Temozolomide|temozolomide|mesh-list
14714290|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213023|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15213024|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
15213025|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
15213026|NCT04666688|Gemcitabine|gemcitabine|mesh-list
15213027|NCT04666688|Paclitaxel|paclitaxel|mesh-list
14714291|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714292|NCT00452231|Cycloserine|cycloserine|mesh-list
15213028|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15213029|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213030|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213031|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213032|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
14873355|NCT01149109|Lomustine|lomustine|mesh-list
14873356|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14873357|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
14873358|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873359|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873360|NCT01149122|Gemcitabine|gemcitabine|mesh-list
14873361|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
14873362|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14873363|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14873364|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
14873365|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873366|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873367|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
14873368|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873369|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873370|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873371|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
14873372|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873373|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14873374|NCT01149174|Mitomycins|mitomycins|mesh-list
14873375|NCT01149174|Mitomycin|mitomycin|mesh-list
14873376|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14873377|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873378|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
14873379|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873380|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14873381|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873382|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
14873383|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14873384|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873385|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873386|NCT01149278|Benzocaine|benzocaine|mesh-list
14873387|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
14873388|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
14873389|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714293|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14714294|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714295|NCT00452231|Renal Agents|renal agents|mesh-ancestor
14714296|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14714297|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
14873390|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873391|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
14714298|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714299|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
14714300|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213033|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213034|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213035|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
14714301|NCT00452244|Gefitinib|gefitinib|mesh-list
14714302|NCT00452244|Simvastatin|simvastatin|mesh-list
14873392|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873393|NCT01149304|Enoxaparin|enoxaparin|mesh-list
14873394|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
14873395|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14873396|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
14873397|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14873398|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14873399|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873400|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14873401|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873402|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14873403|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14873404|NCT01149304|Protective Agents|protective agents|mesh-ancestor
14873405|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873406|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
14873407|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14873408|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
14873409|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14873410|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873411|NCT01149330|Adapalene|adapalene|mesh-list
14873412|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14873413|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873414|NCT01149330|Analgesics|analgesics|mesh-ancestor
14873415|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
14873416|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873417|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873418|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14873419|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873420|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
14873421|NCT01149356|Exemestane|exemestane|mesh-list
14873422|NCT01149356|Goserelin|goserelin|mesh-list
14873423|NCT01149356|R04929097|r04929097|mesh-list
14873424|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873425|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14873426|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14873427|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873428|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873429|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14873430|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
14873431|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873432|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873433|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14873434|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
14873435|NCT01149395|Lansoprazole|lansoprazole|mesh-list
14873436|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14873437|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873438|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14873439|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873440|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873441|NCT01149408|Decitabine|decitabine|mesh-list
14873442|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14873443|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
14873444|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873445|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873446|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873447|NCT01149499|Valacyclovir|valacyclovir|mesh-list
14873448|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
14873449|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873450|NCT01149564|Ibuprofen|ibuprofen|mesh-list
14873451|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14873452|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873453|NCT01149564|Analgesics|analgesics|mesh-ancestor
14873454|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
14873455|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873456|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873457|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14873458|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873459|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14873460|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873461|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873462|NCT01149577|Olanzapine|olanzapine|mesh-list
14873463|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
14873464|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
14873465|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873466|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873467|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873468|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14873469|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14873470|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873471|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873472|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14873473|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873474|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873475|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873476|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873477|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
14873478|NCT01149629|Droxidopa|droxidopa|mesh-list
14873479|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14873480|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14873481|NCT01149668|Abexinostat|abexinostat|mesh-list
14873482|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14873483|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873484|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873485|NCT01149746|Tamsulosin|tamsulosin|mesh-list
14873486|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14873487|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14873488|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14873489|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
14873490|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873491|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873492|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873493|NCT01149746|Urological Agents|urological agents|mesh-ancestor
14873494|NCT01149798|Cisplatin|cisplatin|mesh-list
14873495|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14873496|NCT01149798|Paclitaxel|paclitaxel|mesh-list
14873497|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873498|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14873499|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14873500|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14873501|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14873502|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873503|NCT01149824|Salvinorin A|salvinorin a|mesh-list
14873504|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
14873505|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873506|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873507|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
14873508|NCT01149902|Docetaxel|docetaxel|mesh-list
15213036|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
15213037|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213038|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213039|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213040|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
15213041|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213042|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
15213043|NCT04632459|Ramucirumab|ramucirumab|mesh-list
15213044|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14873509|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873510|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
14873511|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873512|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873513|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14873514|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
14873515|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873516|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873517|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14873518|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
14873519|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
14873520|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
14873521|NCT01149941|Ibuprofen|ibuprofen|mesh-list
14873522|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14873523|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873524|NCT01149941|Analgesics|analgesics|mesh-ancestor
14873525|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
14873526|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873527|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873528|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14873529|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873530|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14873531|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873532|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873533|NCT01149954|Ibuprofen|ibuprofen|mesh-list
14873534|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14714303|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14714304|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14714305|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
14714306|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714307|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14714308|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14714309|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714310|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714311|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14714312|NCT00452270|Xylometazoline|xylometazoline|mesh-list
14714313|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
14714314|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14873535|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873536|NCT01149954|Analgesics|analgesics|mesh-ancestor
14873537|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
14873538|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873539|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873540|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14873541|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14873542|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14873543|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873544|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873545|NCT01149967|Dexetimide|dexetimide|mesh-list
14873546|NCT01149967|Citalopram|citalopram|mesh-list
14873547|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14873548|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873549|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873550|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873551|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873552|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
14873553|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873554|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14873555|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
14873556|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873557|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14873558|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14873559|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
14873560|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
14873561|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873562|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14873563|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14873564|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14873565|NCT01149980|Dexetimide|dexetimide|mesh-list
14873566|NCT01149980|Citalopram|citalopram|mesh-list
14914203|NCT01379807|Docetaxel|docetaxel|mesh-list
15213045|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213046|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
15213047|NCT04581382|Nivolumab|nivolumab|mesh-list
15213048|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213049|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714315|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
14714316|NCT00452296|Insulin|insulin|mesh-list
14714317|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873567|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14873568|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873569|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873570|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873571|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873572|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
14873573|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873574|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14873575|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
14873576|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873577|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14873578|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14873579|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
14873580|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
14873581|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873582|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14873583|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14873584|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
14873585|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
14873586|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
14873587|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14873588|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
14873589|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873590|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873591|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14873592|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873593|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14873594|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
14873595|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14873596|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873597|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873598|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873599|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
14714318|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714319|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
14714320|NCT00452322|Testosterone|testosterone|mesh-list
14714321|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
14714322|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
14714323|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14714324|NCT00452322|Androgens|androgens|mesh-ancestor
14714325|NCT00452322|Hormones|hormones|mesh-ancestor
14714326|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714327|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714328|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14714329|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714330|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
14296352|NCT05247424|Heparin|heparin|mesh-list
14714331|NCT00452556|Docetaxel|docetaxel|mesh-list
14714332|NCT00452556|Leuprolide|leuprolide|mesh-list
14714333|NCT00452556|Androgens|androgens|mesh-list
14714334|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873600|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873601|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
14714335|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714336|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14714337|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14714338|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714339|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14714340|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
14714341|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14714342|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714343|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14873602|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
14873603|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14873604|NCT01150162|Omeprazole|omeprazole|mesh-list
14873605|NCT01150162|Rebamipide|rebamipide|mesh-list
14873606|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14873607|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873608|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14873609|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873610|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873611|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
14873612|NCT01150162|Protective Agents|protective agents|mesh-ancestor
14873613|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873614|NCT01150201|Losartan|losartan|mesh-list
14873615|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15213050|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213051|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213052|NCT04534218|Aspirin|aspirin|mesh-list
15213053|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
15213054|NCT04534218|Capecitabine|capecitabine|mesh-list
15213055|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213056|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
15213057|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213058|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213059|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15213060|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
15213061|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213062|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213063|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15213064|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213065|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
15213066|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213067|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213068|NCT04534218|Analgesics|analgesics|mesh-ancestor
14714344|NCT00452556|Hormones|hormones|mesh-ancestor
14714345|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714346|NCT00452569|Thalidomide|thalidomide|mesh-list
14873616|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14873617|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14873618|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14873619|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873620|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14873621|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14873622|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14873623|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873624|NCT01150318|Iodine|iodine|mesh-list
14873625|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14873626|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873627|NCT01150318|Trace Elements|trace elements|mesh-ancestor
14873628|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
14873629|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873630|NCT01150331|Levetiracetam|levetiracetam|mesh-list
15213069|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
14714347|NCT00452569|Dexamethasone|dexamethasone|mesh-list
14714348|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714349|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
14714350|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
14714351|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714352|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714353|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14714354|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
14873631|NCT01150331|Clonazepam|clonazepam|mesh-list
14873632|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
15213070|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714355|NCT00452569|Hormones|hormones|mesh-ancestor
14714356|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714357|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14714358|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714359|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714360|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
14714361|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
14873633|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
14873634|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
14873635|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
14873636|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873637|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873638|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873639|NCT01150344|Artemether|artemether|mesh-list
14873640|NCT01150344|Atovaquone|atovaquone|mesh-list
14873641|NCT01150344|Proguanil|proguanil|mesh-list
14873642|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14873643|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
14873644|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14873645|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14714362|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714363|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714364|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14714365|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14714366|NCT00452569|Growth Substances|growth substances|mesh-ancestor
14714367|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
14714368|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
14873646|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873647|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714369|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
14873648|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873649|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
14914204|NCT01379807|Panitumumab|panitumumab|mesh-list
14914205|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914206|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14914207|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14914208|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14914209|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914210|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14914211|NCT01379846|Vaccines|vaccines|mesh-list
14914212|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
14914213|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914214|NCT01379898|Doxazosin|doxazosin|mesh-list
14914215|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
14914216|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14914217|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14914218|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14914219|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14914220|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
14914221|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914222|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914223|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914224|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914225|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
14914226|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
14914227|NCT01379976|Vitamins|vitamins|mesh-ancestor
14914228|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
14914229|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914230|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
15213071|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213072|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15213073|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15213074|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15213075|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15213076|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213077|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
15213078|NCT04528082|Apremilast|apremilast|mesh-list
15213079|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213080|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213081|NCT04528082|Analgesics|analgesics|mesh-ancestor
14873650|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14873651|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14873652|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14873653|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873654|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873655|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873656|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14873657|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14873658|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
14873659|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873660|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873661|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14873662|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14873663|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
14873664|NCT01150617|Insulin|insulin|mesh-list
14873665|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14873666|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
14873667|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14873668|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
14873669|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873670|NCT01150630|Gemcitabine|gemcitabine|mesh-list
14873671|NCT01150630|Capecitabine|capecitabine|mesh-list
14873672|NCT01150630|Epirubicin|epirubicin|mesh-list
14873673|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873674|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14873675|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
14873676|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873677|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
14873678|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213082|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
14873679|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213083|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873680|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873681|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
14873682|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873683|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14873684|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14873685|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14873686|NCT01150747|Azithromycin|azithromycin|mesh-list
14873687|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
14873688|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14873689|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873690|NCT01150786|Selenium|selenium|mesh-list
14873691|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
14873692|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873693|NCT01150786|Protective Agents|protective agents|mesh-ancestor
14873694|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873695|NCT01150786|Trace Elements|trace elements|mesh-ancestor
14873696|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
14873697|NCT01150877|Vitamin D|vitamin d|mesh-list
14873698|NCT01150877|Vitamins|vitamins|mesh-ancestor
14873699|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
14873700|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873701|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14873702|NCT01150955|Resveratrol|resveratrol|mesh-list
14873703|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
14873704|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873705|NCT01150955|Protective Agents|protective agents|mesh-ancestor
14873706|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873707|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873708|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14873709|NCT01151072|Insulin|insulin|mesh-list
14873710|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873711|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873712|NCT01151176|Insulin|insulin|mesh-list
14873713|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14714370|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14714371|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14714372|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714373|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714374|NCT00452582|Urological Agents|urological agents|mesh-ancestor
14714375|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14714376|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14714377|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873714|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873715|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873716|NCT01151241|Anesthetics|anesthetics|mesh-list
14873717|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
14873718|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873719|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873720|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
14873721|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873722|NCT01151254|Propofol|propofol|mesh-list
14873723|NCT01151254|Sevoflurane|sevoflurane|mesh-list
14873724|NCT01151254|Isoflurane|isoflurane|mesh-list
14873725|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14873726|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873727|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873728|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14873729|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
14873730|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
14873731|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14873732|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14873733|NCT01151267|Anesthetics|anesthetics|mesh-list
14873734|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873735|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873736|NCT01151306|Simvastatin|simvastatin|mesh-list
14873737|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14873738|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14873739|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
14873740|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873741|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14873742|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14873743|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873744|NCT01151384|Docetaxel|docetaxel|mesh-list
14873745|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873746|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
14873747|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
14873748|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
14873749|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873750|NCT01151397|Vitamin D|vitamin d|mesh-list
14873751|NCT01151397|Ribavirin|ribavirin|mesh-list
15213084|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213085|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213086|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213087|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15213088|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15213089|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213090|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714378|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15213091|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
14714379|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714380|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714381|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714382|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
14714383|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14714384|NCT00452608|Atorvastatin|atorvastatin|mesh-list
14714385|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14714386|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14714387|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
14714388|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714389|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14714390|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14714391|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714392|NCT00452634|Irinotecan|irinotecan|mesh-list
14714393|NCT00452634|Simvastatin|simvastatin|mesh-list
14873752|NCT01151397|Vitamins|vitamins|mesh-ancestor
14873753|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
14873754|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873755|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14873756|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
14873757|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873758|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
14714394|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714395|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14714396|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14714397|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714398|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714399|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14873759|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873760|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14873761|NCT01151592|Hematinics|hematinics|mesh-ancestor
14873762|NCT01151605|Insulin|insulin|mesh-list
14873763|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14873764|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873765|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873766|NCT01151670|Pioglitazone|pioglitazone|mesh-list
14873767|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873768|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873769|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
14873770|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
14873771|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
14873772|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14873773|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
14873774|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
14873775|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873776|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873777|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873778|NCT01151722|Bevacizumab|bevacizumab|mesh-list
14714400|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14714401|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
14714402|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14714403|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14714404|NCT00452660|Deferasirox|deferasirox|mesh-list
14714405|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14714406|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
14714407|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
14873779|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14873780|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873781|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14873782|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14873783|NCT01151722|Growth Substances|growth substances|mesh-ancestor
14873784|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873785|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
14873786|NCT01151735|Complement C1s|complement c1s|mesh-list
14873787|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
14873788|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873789|NCT01151787|Amitriptyline|amitriptyline|mesh-list
14873790|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
14873791|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14873792|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
14873793|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873794|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14873795|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873796|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14873797|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873798|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14873799|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873800|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873801|NCT01151787|Analgesics|analgesics|mesh-ancestor
14873802|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
14873803|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14873804|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873805|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873806|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873807|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
14873808|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873809|NCT01151800|Benzocaine|benzocaine|mesh-list
14873810|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
14873811|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
14873812|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873813|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873814|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
14873815|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873816|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
14873817|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15213092|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15213093|NCT04509791|Antibodies|antibodies|mesh-list
15213094|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
15213095|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
15213096|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213097|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213098|NCT04401059|Gefitinib|gefitinib|mesh-list
15213099|NCT04401059|Osimertinib|osimertinib|mesh-list
15213100|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213101|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213102|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213103|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213104|NCT04301765|Testosterone|testosterone|mesh-list
15213105|NCT04301765|Androgens|androgens|mesh-ancestor
15213106|NCT04301765|Hormones|hormones|mesh-ancestor
15213107|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14873818|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15213108|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873819|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873820|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14873821|NCT01151865|Analgesics|analgesics|mesh-ancestor
14873822|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
14873823|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714408|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873824|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14873825|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14873826|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14873827|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
14873828|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213109|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15213110|NCT04280328|Daratumumab|daratumumab|mesh-list
15213111|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213112|NCT04251884|Ropivacaine|ropivacaine|mesh-list
15213113|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
15213114|NCT04251884|Anesthetics|anesthetics|mesh-list
15213115|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15213116|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213117|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
15213118|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213119|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
15213120|NCT04209660|Lenvatinib|lenvatinib|mesh-list
15213121|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213122|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213123|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213124|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213125|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213126|NCT04196283|Paclitaxel|paclitaxel|mesh-list
15213127|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15213128|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213129|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714409|NCT00452725|Hormones|hormones|mesh-list
14714410|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714411|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714412|NCT00452829|Folic Acid|folic acid|mesh-list
14714413|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
14714414|NCT00452829|Inositol|inositol|mesh-list
14714415|NCT00452829|Hematinics|hematinics|mesh-ancestor
14714416|NCT00452829|Vitamins|vitamins|mesh-ancestor
14714417|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
14873829|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873830|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14873831|NCT01151878|Cathartics|cathartics|mesh-ancestor
14873832|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14873833|NCT01151943|Anesthetics|anesthetics|mesh-list
14873834|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
14873835|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873836|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714418|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714419|NCT00452855|Remifentanil|remifentanil|mesh-list
14714420|NCT00452855|Sevoflurane|sevoflurane|mesh-list
14714421|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
14714422|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714423|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714424|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14714425|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14714426|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
14714427|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14714428|NCT00452855|Narcotics|narcotics|mesh-ancestor
14714429|NCT00452855|Analgesics|analgesics|mesh-ancestor
14714430|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
14714431|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714432|NCT00452881|Gemcitabine|gemcitabine|mesh-list
14873837|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
14873838|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873839|NCT01152047|Oxytocin|oxytocin|mesh-list
14873840|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
14873841|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14873842|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714433|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
14914231|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
14914232|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14914233|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914234|NCT01380015|Analgesics|analgesics|mesh-ancestor
14914235|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
14914236|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914237|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714434|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714435|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14714436|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
14714437|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714438|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
14714439|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714440|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714441|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873843|NCT01152203|Bevacizumab|bevacizumab|mesh-list
14873844|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14873845|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14873846|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873847|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14873848|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14873849|NCT01152203|Growth Substances|growth substances|mesh-ancestor
14873850|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873851|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
14873852|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14873853|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
14873854|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873855|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
14873856|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873857|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873858|NCT01152346|Azacitidine|azacitidine|mesh-list
14873859|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14873860|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
14873861|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873862|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873863|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873864|NCT01152372|Insulin|insulin|mesh-list
14873865|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873866|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873867|NCT01152476|Remifentanil|remifentanil|mesh-list
14873868|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14873869|NCT01152476|Narcotics|narcotics|mesh-ancestor
14873870|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14873871|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873872|NCT01152476|Analgesics|analgesics|mesh-ancestor
14873873|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
14873874|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873875|NCT01152593|Mupirocin|mupirocin|mesh-list
14873876|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14873877|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873878|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14873879|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873880|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873881|NCT01152606|Trastuzumab|trastuzumab|mesh-list
14873882|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14873883|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873884|NCT01152710|Capecitabine|capecitabine|mesh-list
14873885|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14873886|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
14873887|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873888|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873889|NCT01152723|Nicotine|nicotine|mesh-list
14873890|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14873891|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
14873892|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873893|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873894|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14873895|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14873896|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
14873897|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873898|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873899|NCT01152736|Nicotine|nicotine|mesh-list
14873900|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14873901|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
14873902|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873903|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873904|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14873905|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14873906|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
14873907|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873908|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873909|NCT01152749|Nicotine|nicotine|mesh-list
14873910|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14873911|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
14873912|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14873913|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873914|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14873915|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14873916|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
14873917|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873918|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873919|NCT01152801|Everolimus|everolimus|mesh-list
14873920|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873921|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873922|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
14873923|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873924|NCT01152827|Everolimus|everolimus|mesh-list
14873925|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873926|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873927|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
14873928|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873929|NCT01152840|Everolimus|everolimus|mesh-list
14873930|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873931|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14873932|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
14873933|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873934|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14873935|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14873936|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873937|NCT01152931|Vitamins|vitamins|mesh-list
14873938|NCT01152931|Vitamin E|vitamin e|mesh-list
14873939|NCT01152931|Tocopherols|tocopherols|mesh-list
14873940|NCT01152931|Tocotrienols|tocotrienols|mesh-list
14873941|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
14873942|NCT01152931|Vitamin A|vitamin a|mesh-list
14873943|NCT01152931|Zinc|zinc|mesh-list
14873944|NCT01152931|Selenium|selenium|mesh-list
14873945|NCT01152931|Artesunate|artesunate|mesh-list
14873946|NCT01152931|Lumefantrine|lumefantrine|mesh-list
14873947|NCT01152931|Artemether|artemether|mesh-list
14873948|NCT01152931|Amodiaquine|amodiaquine|mesh-list
14873949|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
14873950|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
14873951|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873952|NCT01152931|Trace Elements|trace elements|mesh-ancestor
14873953|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
14873954|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873955|NCT01152931|Protective Agents|protective agents|mesh-ancestor
14873956|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
14873957|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14873958|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14873959|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873960|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14873961|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
14873962|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
14873963|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15213130|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213131|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213132|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213133|NCT04188405|Decitabine|decitabine|mesh-list
15213134|NCT04188405|Venetoclax|venetoclax|mesh-list
15213135|NCT04188405|Ponatinib|ponatinib|mesh-list
15213136|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213137|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
15213138|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213139|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213140|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213141|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213142|NCT04175613|Apremilast|apremilast|mesh-list
15213143|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213144|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213145|NCT04175613|Analgesics|analgesics|mesh-ancestor
15213146|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
15213147|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213148|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213149|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213150|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225187|NCT05191875|Doxycycline|doxycycline|mesh-list
14873964|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
14873965|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14873966|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
14873967|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14873968|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873969|NCT01153165|Citalopram|citalopram|mesh-list
14873970|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14873971|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14873972|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14873973|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873974|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14873975|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
14873976|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14873977|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14873978|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
14873979|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14873980|NCT01153191|Gentamicins|gentamicins|mesh-list
14873981|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14873982|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14873983|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14873984|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873985|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873986|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
14873987|NCT01153204|Citric Acid|citric acid|mesh-list
14873988|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
14873989|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
14873990|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14873991|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
14873992|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
14873993|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14873994|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
14873995|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14873996|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14873997|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14873998|NCT01153204|Urological Agents|urological agents|mesh-ancestor
14873999|NCT01153217|Tenofovir|tenofovir|mesh-list
14874000|NCT01153217|Abacavir|abacavir|mesh-list
14874001|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
14874002|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874003|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14874004|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14874005|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874006|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874007|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14874008|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14874009|NCT01153243|Vitamin D|vitamin d|mesh-list
14874010|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
14874011|NCT01153243|Vitamins|vitamins|mesh-ancestor
14874012|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
14874013|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874014|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14874015|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874016|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
14874017|NCT01153256|Analgesics|analgesics|mesh-ancestor
14874018|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
14874019|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874020|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874021|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
14874022|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874023|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14874024|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
14874025|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14874026|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874027|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874028|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874029|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
14874030|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15213151|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15213152|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15213153|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213154|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874031|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14874032|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15213155|NCT03891953|Spartalizumab|spartalizumab|mesh-list
15213156|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213157|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213158|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225188|NCT05191875|Furazolidone|furazolidone|mesh-list
15225189|NCT05191875|Bismuth|bismuth|mesh-list
15225190|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15225191|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225192|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
15225193|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15225194|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15225195|NCT05191875|Antacids|antacids|mesh-ancestor
14874033|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14874034|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
14874035|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874036|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14874037|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14874038|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874039|NCT01153373|Ethanol|ethanol|mesh-list
14874040|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14874041|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874042|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874043|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874044|NCT01153386|Treprostinil|treprostinil|mesh-list
14874045|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14874046|NCT01153542|Ivacaftor|ivacaftor|mesh-list
14874047|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14874048|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874049|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874050|NCT01153568|Vitamin D|vitamin d|mesh-list
14874051|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
14874052|NCT01153568|Vitamins|vitamins|mesh-ancestor
14874053|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
14874054|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874055|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14874056|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874057|NCT01153659|Esomeprazole|esomeprazole|mesh-list
14874058|NCT01153659|Rabeprazole|rabeprazole|mesh-list
14874059|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14874060|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14714442|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
14714443|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714444|NCT00452894|Varenicline|varenicline|mesh-list
14714445|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14714446|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14714447|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
14714448|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714449|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714450|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714451|NCT00452907|Artesunate|artesunate|mesh-list
14714452|NCT00452907|Lumefantrine|lumefantrine|mesh-list
14874061|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14874062|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874063|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874064|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
14874065|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874066|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14874067|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874068|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874069|NCT01153802|Dopamine|dopamine|mesh-list
14874070|NCT01153802|Norepinephrine|norepinephrine|mesh-list
14874071|NCT01153802|Serotonin|serotonin|mesh-list
14874072|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
14874073|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14874074|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14874075|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
14874076|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874077|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874078|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
14874079|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
14874080|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874081|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14874082|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14874083|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
14874084|NCT01153802|Protective Agents|protective agents|mesh-ancestor
14874085|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14874086|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
14874087|NCT01153828|Mupirocin|mupirocin|mesh-list
14874088|NCT01153828|Retapamulin|retapamulin|mesh-list
14874089|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
14874090|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874091|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874092|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14874093|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874094|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874095|NCT01153854|Racecadotril|racecadotril|mesh-list
14874096|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
14874097|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874098|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
14874099|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874100|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874101|NCT01153880|Mupirocin|mupirocin|mesh-list
14874102|NCT01153880|Retapamulin|retapamulin|mesh-list
14874103|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874104|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874105|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14874106|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874107|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213159|NCT03800134|Gemcitabine|gemcitabine|mesh-list
15213160|NCT03800134|Paclitaxel|paclitaxel|mesh-list
15213161|NCT03800134|Cisplatin|cisplatin|mesh-list
15213162|NCT03800134|Carboplatin|carboplatin|mesh-list
15213163|NCT03800134|Pemetrexed|pemetrexed|mesh-list
15213164|NCT03800134|Durvalumab|durvalumab|mesh-list
15213165|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15213166|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213167|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213168|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213169|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
14874108|NCT01153919|Interferons|interferons|mesh-list
14874109|NCT01153919|Ribavirin|ribavirin|mesh-list
15213170|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874110|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
14874111|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
14874112|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14874113|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213171|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14874114|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
14874115|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874116|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
14874117|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874118|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
14874119|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914238|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914239|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914240|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
14914241|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914242|NCT01380015|Protective Agents|protective agents|mesh-ancestor
14914243|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914244|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14914245|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
14914246|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914247|NCT01380249|Bromides|bromides|mesh-list
14914248|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
14914249|NCT01380275|Docetaxel|docetaxel|mesh-list
14914250|NCT01380275|Irinotecan|irinotecan|mesh-list
14914251|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914252|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
14914253|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
14914254|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
14914255|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914256|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14914257|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14914258|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914259|NCT01380288|Rivastigmine|rivastigmine|mesh-list
14914260|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14914261|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914262|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914263|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
14914264|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914265|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914266|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14914267|NCT01380288|Protective Agents|protective agents|mesh-ancestor
14914268|NCT01380301|Miltefosine|miltefosine|mesh-list
14914269|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
14914270|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914271|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914272|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14914273|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14874120|NCT01154114|Darapladib|darapladib|mesh-list
14874121|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14874122|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874123|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874124|NCT01154348|Metformin|metformin|mesh-list
14874125|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14874126|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874127|NCT01154361|Cortisone|cortisone|mesh-list
14874128|NCT01154361|Icatibant|icatibant|mesh-list
14874129|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14874130|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14874131|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14874132|NCT01154361|Analgesics|analgesics|mesh-ancestor
14874133|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
14874134|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874135|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874136|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874137|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14874138|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14874139|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874140|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14874141|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874142|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
14874143|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
14874144|NCT01154387|Tacrolimus|tacrolimus|mesh-list
14874145|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
14874146|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14874147|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874148|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
14874149|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874150|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14874151|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874152|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874153|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14874154|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874155|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14874156|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
14874157|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874158|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874159|NCT01154400|Caseins|caseins|mesh-list
14874160|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
14874161|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
14874162|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874163|NCT01154426|Gemcitabine|gemcitabine|mesh-list
14874164|NCT01154426|Veliparib|veliparib|mesh-list
14874165|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14874166|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
14874167|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874168|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874169|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
14874170|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874171|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874172|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874173|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
14874174|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874175|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14874176|NCT01154439|Cytarabine|cytarabine|mesh-list
14874177|NCT01154439|Etoposide|etoposide|mesh-list
14874178|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
14874179|NCT01154439|Idarubicin|idarubicin|mesh-list
14874180|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
14874181|NCT01154439|Everolimus|everolimus|mesh-list
14874182|NCT01154439|Ifosfamide|ifosfamide|mesh-list
14874183|NCT01154439|Carboplatin|carboplatin|mesh-list
14874184|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14874185|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874186|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14874187|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14874188|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874189|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874190|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14874191|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
14874192|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
14874193|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874194|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874195|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
14874196|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874197|NCT01154439|Analgesics|analgesics|mesh-ancestor
14874198|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
14874199|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874200|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14874201|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14874202|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
14874203|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
14874204|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14874205|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874206|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
14874207|NCT01154491|Hematinics|hematinics|mesh-ancestor
14874208|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
14874209|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14874210|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14874211|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
14874212|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874213|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874214|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14874215|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
14874216|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14874217|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
14874218|NCT01154504|Protective Agents|protective agents|mesh-ancestor
14874219|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
14874220|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14874221|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874222|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
14874223|NCT01154569|Azithromycin|azithromycin|mesh-list
14874224|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874225|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874226|NCT01154647|Citalopram|citalopram|mesh-list
14874227|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14874228|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14874229|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874230|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874231|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874232|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
14874233|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874234|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14874235|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
14874236|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14874237|NCT01154738|Lidocaine|lidocaine|mesh-list
14874238|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
14874239|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
14874240|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874241|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874242|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
14874243|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874244|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14874245|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14874246|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14874247|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874248|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874249|NCT01154764|Ketoconazole|ketoconazole|mesh-list
14874250|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
14874251|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874252|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14874253|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14874254|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874255|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874256|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14874257|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
14874258|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874259|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874260|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14874261|NCT01154790|Naproxen|naproxen|mesh-list
14874262|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14874263|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14874264|NCT01154790|Analgesics|analgesics|mesh-ancestor
14874265|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
14874266|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874267|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874268|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14874269|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874270|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
14874271|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14874272|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874273|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874274|NCT01154803|Micronutrients|micronutrients|mesh-list
14874275|NCT01154803|Trace Elements|trace elements|mesh-list
14874276|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874277|NCT01154829|Aripiprazole|aripiprazole|mesh-list
14874278|NCT01154829|Amisulpride|amisulpride|mesh-list
14874279|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
14874280|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14874281|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14874282|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14874283|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874284|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874285|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
14874286|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
14874287|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874288|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874289|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14874290|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14874291|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
14874292|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14874293|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14874294|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14874295|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14874296|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14874297|NCT01154881|Insulin|insulin|mesh-list
14874298|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14874299|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874300|NCT01154907|Praziquantel|praziquantel|mesh-list
14874301|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
14874302|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14874303|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874304|NCT01154933|Exenatide|exenatide|mesh-list
14874305|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14874306|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874307|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14874308|NCT01154933|Incretins|incretins|mesh-ancestor
14874309|NCT01154933|Hormones|hormones|mesh-ancestor
14874310|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874311|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
14874312|NCT01154959|Rifampin|rifampin|mesh-list
14874313|NCT01154959|Isoniazid|isoniazid|mesh-list
14874314|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
14874315|NCT01154959|Ethambutol|ethambutol|mesh-list
14874316|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874317|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874318|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14874319|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14874320|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874321|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874322|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874323|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14874324|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
14874325|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
14874326|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14874327|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14874328|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14874329|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14874330|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14874331|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14874332|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14874333|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14874334|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14874335|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
14874336|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14874337|NCT01155037|Vaccines|vaccines|mesh-list
14874338|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
14874339|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874340|NCT01155089|Anastrozole|anastrozole|mesh-list
14874341|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874342|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874343|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14874344|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14874345|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874346|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874347|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14874348|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
14874349|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874350|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874351|NCT01155102|Anastrozole|anastrozole|mesh-list
14874352|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874353|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874354|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14874355|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14874356|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874357|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874358|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14874359|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
14874360|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874361|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874362|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
14874363|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14874364|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
14874365|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874366|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874367|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14874368|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
14874369|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14874370|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
14874371|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874372|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874373|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14874374|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
14874375|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
14874376|NCT01155115|Protective Agents|protective agents|mesh-ancestor
14874377|NCT01155206|Glucagon|glucagon|mesh-list
14874378|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14874379|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874380|NCT01155206|Hormones|hormones|mesh-ancestor
14874381|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874382|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874383|NCT01155206|Incretins|incretins|mesh-ancestor
14874384|NCT01155232|Teriparatide|teriparatide|mesh-list
14874385|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
14874386|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714453|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
14874387|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14714454|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
14714455|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14714456|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
14714457|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14714458|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14714459|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714460|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714461|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
14714462|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
14714463|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14874388|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14874389|NCT01155245|Teriparatide|teriparatide|mesh-list
14874390|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874391|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874392|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14874393|NCT01155258|Sirolimus|sirolimus|mesh-list
14874394|NCT01155258|Vinorelbine|vinorelbine|mesh-list
14874395|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874396|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874397|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14874398|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874399|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
14874400|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874401|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
14874402|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874403|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14874404|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
14874405|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
14874406|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
14874407|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874408|NCT01155440|Lidocaine|lidocaine|mesh-list
14874409|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
14874410|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
14874411|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874412|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874413|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
14874414|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874415|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14874416|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14874417|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14874418|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874419|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874420|NCT01155453|Trametinib|trametinib|mesh-list
14874421|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874422|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14874423|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874424|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874425|NCT01155505|Lenalidomide|lenalidomide|mesh-list
14874426|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
14874427|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874428|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14874429|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14874430|NCT01155505|Growth Substances|growth substances|mesh-ancestor
14874431|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
14874432|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874433|NCT01155635|Carvedilol|carvedilol|mesh-list
14874434|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14874435|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14874436|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
14874437|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874438|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874439|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874440|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14874441|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
14714464|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
14714465|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14714466|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714467|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714468|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14714469|NCT00452907|Renal Agents|renal agents|mesh-ancestor
14714470|NCT00452920|Docetaxel|docetaxel|mesh-list
14714471|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714472|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
14874442|NCT01155635|Protective Agents|protective agents|mesh-ancestor
14874443|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14874444|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874445|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874446|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
14874447|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14874448|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14874449|NCT01155700|Omalizumab|omalizumab|mesh-list
14874450|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14874451|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14874452|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
14874453|NCT01155765|Clopidogrel|clopidogrel|mesh-list
14874454|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14874455|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14874456|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14874457|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14874458|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14874459|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
14874460|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874461|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874462|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874463|NCT01155791|Prednisone|prednisone|mesh-list
14874464|NCT01155791|Docetaxel|docetaxel|mesh-list
14296353|NCT05247424|Calcium heparin|calcium heparin|mesh-list
14296354|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
14296355|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14296356|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14296357|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296358|NCT05247385|Ticagrelor|ticagrelor|mesh-list
14714473|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
14296359|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14874465|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874466|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
14874467|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
14874468|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
14874469|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874470|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14874471|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
14874472|NCT01155791|Hormones|hormones|mesh-ancestor
14874473|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874474|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874475|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874476|NCT01155895|Amlodipine|amlodipine|mesh-list
14874477|NCT01155895|Benazepril|benazepril|mesh-list
14874478|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14874479|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14874480|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874481|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874482|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874483|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874484|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
14874485|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14874486|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
14874487|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874488|NCT01155908|Amlodipine|amlodipine|mesh-list
14874489|NCT01155908|Benazepril|benazepril|mesh-list
14874490|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14714474|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
14296360|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14714475|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714476|NCT00452972|Anesthetics|anesthetics|mesh-list
14714477|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714478|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714479|NCT00452985|Carboplatin|carboplatin|mesh-list
14714480|NCT00452985|Docetaxel|docetaxel|mesh-list
14714481|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714482|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714483|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14874491|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14874492|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874493|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874494|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874495|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874496|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
14874497|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14874498|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
14874499|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874500|NCT01155921|Risperidone|risperidone|mesh-list
14874501|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14874502|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
14874503|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874504|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874505|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874506|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14874507|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14874508|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874509|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14874510|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15213172|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
15213173|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
15213174|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213175|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213176|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213177|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
15213178|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213179|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15213180|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15213181|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213182|NCT03783286|Ivacaftor|ivacaftor|mesh-list
14714484|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213183|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15213184|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15213185|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213186|NCT03708003|Venetoclax|venetoclax|mesh-list
15213187|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213188|NCT03699865|Nicotine|nicotine|mesh-list
15213189|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15213190|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
15213191|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213192|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714485|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714486|NCT00453050|Imiquimod|imiquimod|mesh-list
14714487|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14714488|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
14714489|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714490|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714491|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
14714492|NCT00453076|Paclitaxel|paclitaxel|mesh-list
14714493|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14714494|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874511|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
14714495|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
14874512|NCT01155934|Risperidone|risperidone|mesh-list
14874513|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14874514|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
14874515|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874516|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874517|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874518|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14874519|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14874520|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874521|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14874522|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14874523|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
14874524|NCT01155947|Anastrozole|anastrozole|mesh-list
14874525|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874526|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874527|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15213193|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15213194|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15213195|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
15213196|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213197|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213198|NCT03678506|Apixaban|apixaban|mesh-list
15213199|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15213200|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
15213201|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15213202|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
15213203|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213204|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213205|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
15213206|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
15213207|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213208|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213209|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14874528|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14874529|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874530|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874531|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14874532|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
14874533|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874534|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874535|NCT01155960|Anastrozole|anastrozole|mesh-list
14874536|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874537|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874538|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14874539|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14874540|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874541|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874542|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14874543|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
14874544|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874545|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914274|NCT01380314|Miltefosine|miltefosine|mesh-list
14914275|NCT01380314|Imiquimod|imiquimod|mesh-list
14914276|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14914277|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
14914278|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914279|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914280|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
14914281|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
14914282|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914283|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14914284|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14914285|NCT01380353|Diclofenac|diclofenac|mesh-list
14914286|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14914287|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14914288|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914289|NCT01380353|Analgesics|analgesics|mesh-ancestor
14914290|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
14914291|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914292|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914293|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914294|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914295|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14914296|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914297|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914298|NCT01380431|Lisinopril|lisinopril|mesh-list
14914299|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14914300|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
14914301|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914302|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914303|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14914304|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14914305|NCT01380431|Protective Agents|protective agents|mesh-ancestor
14914306|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914307|NCT01380457|Dronabinol|dronabinol|mesh-list
14914308|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
14914309|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914310|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14914311|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914312|NCT01380457|Analgesics|analgesics|mesh-ancestor
14914313|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
14914314|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914315|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14914316|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14914317|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914318|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914319|NCT01380457|Hormones|hormones|mesh-ancestor
14914320|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874546|NCT01155986|Lidocaine|lidocaine|mesh-list
14874547|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
14874548|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
14874549|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874550|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874551|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
14874552|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874553|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14874554|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14874555|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14874556|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874557|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874558|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
14874559|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874560|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874561|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14874562|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
14874563|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874564|NCT01156220|Furosemide|furosemide|mesh-list
14874565|NCT01156220|Diuretics|diuretics|mesh-ancestor
14874566|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
14874567|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874568|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14874569|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874570|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874571|NCT01156233|Anesthetics|anesthetics|mesh-list
14874572|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874573|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874574|NCT01156246|Metformin|metformin|mesh-list
14874575|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
14874576|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14874577|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874578|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14914321|NCT01380483|Doxycycline|doxycycline|mesh-list
14874579|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874580|NCT01156350|Fludarabine|fludarabine|mesh-list
14874581|NCT01156350|Busulfan|busulfan|mesh-list
14874582|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874583|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874584|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874585|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
14874586|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874587|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
14874588|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14874589|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14874590|NCT01156389|Ritonavir|ritonavir|mesh-list
14874591|NCT01156389|Artesunate|artesunate|mesh-list
14874592|NCT01156389|Pyronaridine|pyronaridine|mesh-list
14874593|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14874594|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14874595|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
14874596|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874597|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874598|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14874599|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14874600|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
14874601|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874602|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14874603|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14874604|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
14874605|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14874606|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14874607|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874608|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
14874609|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14874610|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
14874611|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
14874612|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14874613|NCT01156584|Flucytosine|flucytosine|mesh-list
14874614|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
14874615|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874616|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
14874617|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874618|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
14874619|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
14874620|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14874621|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14874622|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874623|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874624|NCT01156636|Urological Agents|urological agents|mesh-ancestor
14874625|NCT01156649|Acetaminophen|acetaminophen|mesh-list
14874626|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14874627|NCT01156649|Analgesics|analgesics|mesh-ancestor
14874628|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
14874629|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874630|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874631|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
14874632|NCT01156688|Misoprostol|misoprostol|mesh-list
14874633|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14874634|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
14874635|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14874636|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874637|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14874638|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874639|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
14874640|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14874641|NCT01156740|Amoxicillin|amoxicillin|mesh-list
14874642|NCT01156740|Penicillins|penicillins|mesh-list
14874643|NCT01156740|beta-Lactams|beta-lactams|mesh-list
14874644|NCT01156740|Penicillin G|penicillin g|mesh-list
14874645|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14874646|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
14714496|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
14714497|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
14714498|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714499|NCT00453115|Gemcitabine|gemcitabine|mesh-list
14714500|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
14714501|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14714502|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
14714503|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714504|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714505|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
14714506|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714507|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714508|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714509|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
14714510|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714511|NCT00453141|Betamethasone|betamethasone|mesh-list
14714512|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714513|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
14714514|NCT00453141|Hormones|hormones|mesh-ancestor
14714515|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714516|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874647|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874648|NCT01156779|Exenatide|exenatide|mesh-list
14874649|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14874650|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874651|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14874652|NCT01156779|Incretins|incretins|mesh-ancestor
14874653|NCT01156779|Hormones|hormones|mesh-ancestor
14874654|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874655|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
14874656|NCT01156857|Progestins|progestins|mesh-list
14874657|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14874658|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
14874659|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14874660|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874661|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14874662|NCT01156857|Hormones|hormones|mesh-ancestor
14874663|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874664|NCT01156883|Cytarabine|cytarabine|mesh-list
14874665|NCT01156883|Dexamethasone|dexamethasone|mesh-list
14874666|NCT01156883|Prednisone|prednisone|mesh-list
14874667|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
14874668|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
14874669|NCT01156883|Ifosfamide|ifosfamide|mesh-list
14874670|NCT01156883|Doxorubicin|doxorubicin|mesh-list
14874671|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14874672|NCT01156883|Methotrexate|methotrexate|mesh-list
14874673|NCT01156883|Vincristine|vincristine|mesh-list
14874674|NCT01156883|Daunorubicin|daunorubicin|mesh-list
14874675|NCT01156883|Asparaginase|asparaginase|mesh-list
14874676|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
14874677|NCT01156883|Thioguanine|thioguanine|mesh-list
14874678|NCT01156883|Vindesine|vindesine|mesh-list
14874679|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874680|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
14874681|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874682|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874683|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14874684|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
14874685|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874686|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874687|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14874688|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14874689|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
14874690|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
14874691|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874692|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874693|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
14874694|NCT01156883|Hormones|hormones|mesh-ancestor
14874695|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874696|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874697|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15213210|NCT03648489|Paclitaxel|paclitaxel|mesh-list
15213211|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15213212|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874698|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14874699|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14874700|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874701|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14874702|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
14874703|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14874704|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14874705|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
14874706|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
14874707|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14874708|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14874709|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
14874710|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874711|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14874712|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
14874713|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
14874714|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
14874715|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14874716|NCT01156883|Protective Agents|protective agents|mesh-ancestor
14874717|NCT01156909|Rituximab|rituximab|mesh-list
14874718|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14874719|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874720|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
14874721|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874722|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874723|NCT01156922|Rituximab|rituximab|mesh-list
14874724|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14874725|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874726|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
14874727|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874728|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874729|NCT01156948|Misoprostol|misoprostol|mesh-list
14874730|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14874731|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
14874732|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14874733|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874734|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14874735|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874736|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
14874737|NCT01156961|Paclitaxel|paclitaxel|mesh-list
15213213|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213214|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213215|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213216|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213217|NCT03637660|Penicillins|penicillins|mesh-list
15213218|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
15213219|NCT03637660|Penicillin G|penicillin g|mesh-list
15213220|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
15213221|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874738|NCT01156961|Bevacizumab|bevacizumab|mesh-list
14874739|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14874740|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874741|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
14874742|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
14874743|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
14874744|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874745|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14874746|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14874747|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14874748|NCT01156961|Growth Substances|growth substances|mesh-ancestor
14874749|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874750|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
14874751|NCT01157000|Canagliflozin|canagliflozin|mesh-list
14874752|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14874753|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874754|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14874755|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874756|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14874757|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14874758|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874759|NCT01157026|Tamoxifen|tamoxifen|mesh-list
14874760|NCT01157026|Tocotrienols|tocotrienols|mesh-list
14874761|NCT01157026|Vitamin E|vitamin e|mesh-list
14874762|NCT01157026|Tocopherols|tocopherols|mesh-list
14874763|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14874764|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
14874765|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874766|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874767|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874768|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874769|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14874770|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14874771|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14874772|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
14874773|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874774|NCT01157026|Protective Agents|protective agents|mesh-ancestor
14874775|NCT01157026|Vitamins|vitamins|mesh-ancestor
14874776|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
14874777|NCT01157052|Capecitabine|capecitabine|mesh-list
14874778|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
14874779|NCT01157052|Calcium|calcium|mesh-list
14874780|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874781|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874782|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14874783|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
14874784|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874785|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874786|NCT01157247|Fentanyl|fentanyl|mesh-list
14874787|NCT01157247|Anesthetics|anesthetics|mesh-list
14874788|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
14874789|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14874790|NCT01157247|Narcotics|narcotics|mesh-ancestor
14874791|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874792|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874793|NCT01157247|Analgesics|analgesics|mesh-ancestor
14874794|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
14874795|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874796|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14874797|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14874798|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
14874799|NCT01157312|Citric Acid|citric acid|mesh-list
14874800|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
14874801|NCT01157312|Clomiphene|clomiphene|mesh-list
14874802|NCT01157312|Enclomiphene|enclomiphene|mesh-list
14874803|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
14874804|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
14874805|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14874806|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
14874807|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
14874808|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874809|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14874810|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
14874811|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874812|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874813|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14874814|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
14874815|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14874816|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14874817|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14874818|NCT01157455|Aspirin|aspirin|mesh-list
14874819|NCT01157455|Everolimus|everolimus|mesh-list
14874820|NCT01157455|Heparin|heparin|mesh-list
14874821|NCT01157455|Bivalirudin|bivalirudin|mesh-list
14874822|NCT01157455|Clopidogrel|clopidogrel|mesh-list
14874823|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14874824|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14874825|NCT01157455|Analgesics|analgesics|mesh-ancestor
14874826|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
14874827|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874828|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874829|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14874830|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874831|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14874832|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14874833|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874834|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14874835|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14874836|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874837|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
14874838|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874839|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874840|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
14874841|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14874842|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14874843|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14874844|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
14874845|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874846|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
14874847|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
14874848|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14874849|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
14874850|NCT01157481|Nifedipine|nifedipine|mesh-list
14874851|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14874852|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874853|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874854|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14874855|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874856|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
14874857|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
14874858|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14874859|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14874860|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14874861|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14874862|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874863|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874864|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14874865|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874866|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874867|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
14874868|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874869|NCT01157546|Lidocaine|lidocaine|mesh-list
14874870|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
14874871|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
14874872|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874873|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874874|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
14874875|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874876|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14874877|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14874878|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15213222|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213223|NCT03622073|Misoprostol|misoprostol|mesh-list
15213224|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15213225|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
15213226|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15213227|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213228|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15213229|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15213230|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
15213231|NCT03541447|Octreotide|octreotide|mesh-list
15213232|NCT03541447|Tolvaptan|tolvaptan|mesh-list
15213233|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874879|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14874880|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874881|NCT01157559|Ziprasidone|ziprasidone|mesh-list
14874882|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14874883|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
14874884|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874885|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874886|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874887|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14874888|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14874889|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874890|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14874891|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14874892|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
14874893|NCT01157572|Metoprolol|metoprolol|mesh-list
14874894|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14874895|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14874896|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
14874897|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
14874898|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14874899|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874900|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14874901|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14874902|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14874903|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
14874904|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874905|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874906|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14874907|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14874908|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14874909|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14874910|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213234|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15213235|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213236|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15213237|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213238|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
15213239|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213240|NCT03469492|Insulin|insulin|mesh-list
15213241|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15213242|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213243|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
15213244|NCT03448978|Fludarabine|fludarabine|mesh-list
15213245|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213246|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
15213247|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213248|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874911|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14874912|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14874913|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14874914|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
14874915|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14874916|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874917|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14874918|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14874919|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
14874920|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
14874921|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14874922|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
14874923|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14874924|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874925|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14874926|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14874927|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14914322|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914323|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914324|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
14914325|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14914326|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14914327|NCT01380496|Doxycycline|doxycycline|mesh-list
14914328|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914329|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914330|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
14914331|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14914332|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14914333|NCT01380509|Metronidazole|metronidazole|mesh-list
14914334|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914335|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914336|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14914337|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14914338|NCT01380522|Metronidazole|metronidazole|mesh-list
14914339|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914340|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914341|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14914342|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14914343|NCT01380548|Iron|iron|mesh-list
14914344|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14914345|NCT01380548|Trace Elements|trace elements|mesh-ancestor
14914346|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
14914347|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914348|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14914349|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
15213249|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15213250|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
15213251|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914350|NCT01380600|Molgramostim|molgramostim|mesh-list
14914351|NCT01380600|Sargramostim|sargramostim|mesh-list
14914352|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
14914353|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914354|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914355|NCT01380678|Bevacizumab|bevacizumab|mesh-list
14914356|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14914357|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
14914358|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14914359|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14914360|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914361|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14914362|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14914363|NCT01380678|Growth Substances|growth substances|mesh-ancestor
14914364|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914365|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
14914366|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
14914367|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914368|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914369|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
14914370|NCT01380717|Calcium|calcium|mesh-list
14914371|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14914372|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14914373|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15213252|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914374|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213253|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14914375|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14874928|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
14874929|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14874930|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14874931|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14874932|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14874933|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874934|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874935|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874936|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14874937|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14874938|NCT01157858|Everolimus|everolimus|mesh-list
14874939|NCT01157858|Octreotide|octreotide|mesh-list
14874940|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874941|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874942|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
14874943|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874944|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14874945|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874946|NCT01157936|Allopurinol|allopurinol|mesh-list
14874947|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
14874948|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874949|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874950|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
14874951|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14874952|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14874953|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
14874954|NCT01157936|Protective Agents|protective agents|mesh-ancestor
14874955|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874956|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
14874957|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
14874958|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874959|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14874960|NCT01157975|Pioglitazone|pioglitazone|mesh-list
14874961|NCT01157975|Prednisone|prednisone|mesh-list
14874962|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14874963|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
14874964|NCT01157975|Hormones|hormones|mesh-ancestor
14874965|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14874966|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874967|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14874968|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874969|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14874970|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14874971|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
14874972|NCT01158014|Coagulants|coagulants|mesh-ancestor
14874973|NCT01158105|Bortezomib|bortezomib|mesh-list
14874974|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874975|NCT01158144|Paclitaxel|paclitaxel|mesh-list
14874976|NCT01158144|Carboplatin|carboplatin|mesh-list
14874977|NCT01158144|Endostar protein|endostar protein|mesh-list
14874978|NCT01158144|Endostatins|endostatins|mesh-list
14874979|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14874980|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874981|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
14874982|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
14874983|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
14874984|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874985|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14874986|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14874987|NCT01158144|Growth Substances|growth substances|mesh-ancestor
14874988|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14874989|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
14874990|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14874991|NCT01158170|Gefitinib|gefitinib|mesh-list
14874992|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14874993|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14874994|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14874995|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14874996|NCT01158183|Interferons|interferons|mesh-list
14874997|NCT01158183|Interferon-beta|interferon-beta|mesh-list
14874998|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
14874999|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875000|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
14875001|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875002|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
14875003|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875004|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14875005|NCT01158248|Panitumumab|panitumumab|mesh-list
14875006|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875007|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14875008|NCT01158274|Capecitabine|capecitabine|mesh-list
14875009|NCT01158274|R04929097|r04929097|mesh-list
14875010|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14875011|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
14875012|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875013|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875014|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875015|NCT01158287|Sorafenib|sorafenib|mesh-list
14875016|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875017|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14875018|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875019|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875020|NCT01158365|Glycerol|glycerol|mesh-list
14875021|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14875022|NCT01158365|Protective Agents|protective agents|mesh-ancestor
14875023|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875024|NCT01158560|Vitamin D|vitamin d|mesh-list
14875025|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
14875026|NCT01158560|Vitamins|vitamins|mesh-ancestor
14875027|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
14875028|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875029|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14875030|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14875031|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
14875032|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
14875033|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
14875034|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875035|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875036|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
15213254|NCT03439891|Nivolumab|nivolumab|mesh-list
15213255|NCT03439891|Sorafenib|sorafenib|mesh-list
15213256|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14875037|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875038|NCT01158612|Hormones|hormones|mesh-list
14875039|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875040|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875041|NCT01158729|Antithrombins|antithrombins|mesh-list
15213257|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213258|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213259|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213260|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213261|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213262|NCT03439033|Edetic Acid|edetic acid|mesh-list
15213263|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
14875042|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
14875043|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14875044|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14875045|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875046|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875047|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
14875048|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
14875049|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14875050|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875051|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14875052|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14875053|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875054|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875055|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875056|NCT01158846|Bivalirudin|bivalirudin|mesh-list
14875057|NCT01158846|Abciximab|abciximab|mesh-list
14875058|NCT01158846|Clopidogrel|clopidogrel|mesh-list
14875059|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14875060|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14875061|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14875062|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14875063|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14875064|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
14875065|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875066|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875067|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875068|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
14875069|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14875070|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
14875071|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875072|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
14875073|NCT01158859|Pregabalin|pregabalin|mesh-list
14875074|NCT01158859|Analgesics|analgesics|mesh-ancestor
14875075|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
14875076|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875077|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875078|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
14875079|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14875080|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875081|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875082|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14875083|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14875084|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14875085|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875086|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14875087|NCT01158937|Meropenem|meropenem|mesh-list
14875088|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14875089|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875090|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
14875091|NCT01159080|Tacrolimus|tacrolimus|mesh-list
14875092|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875093|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
14875094|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875095|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14875096|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875097|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875098|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14875099|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875100|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14875101|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
14875102|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14875103|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875104|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
14875105|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14875106|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14875107|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
14875108|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875109|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14875110|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14875111|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875112|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875113|NCT01159145|Omeprazole|omeprazole|mesh-list
14875114|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15213264|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
14875115|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875116|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14875117|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875118|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875119|NCT01159158|Nateglinide|nateglinide|mesh-list
14875120|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14875121|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875122|NCT01159210|Thrombin|thrombin|mesh-list
14875123|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
14875124|NCT01159210|Coagulants|coagulants|mesh-ancestor
14875125|NCT01159236|Paclitaxel|paclitaxel|mesh-list
14875126|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
14875127|NCT01159236|Bevacizumab|bevacizumab|mesh-list
14875128|NCT01159236|Doxorubicin|doxorubicin|mesh-list
14875129|NCT01159236|Fluorouracil|fluorouracil|mesh-list
14875130|NCT01159236|Epirubicin|epirubicin|mesh-list
14875131|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875132|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875133|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875134|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875135|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875136|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875137|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875138|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
14875139|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875140|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14875141|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14875142|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
14875143|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14875144|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14875145|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14875146|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14875147|NCT01159236|Growth Substances|growth substances|mesh-ancestor
14875148|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
14875149|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14875150|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14875151|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14875152|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875153|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
14875154|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14875155|NCT01159275|Lopinavir|lopinavir|mesh-list
14875156|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14875157|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14875158|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
14875159|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875160|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875161|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14875162|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14875163|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
14875164|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875165|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14875166|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14875167|NCT01159301|Sorafenib|sorafenib|mesh-list
14875168|NCT01159301|Entinostat|entinostat|mesh-list
14875169|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14875170|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875171|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14875172|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875173|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875174|NCT01159327|Sorafenib|sorafenib|mesh-list
14875175|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875176|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14875177|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875178|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875179|NCT01159353|Insulin|insulin|mesh-list
14875180|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14875181|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
14875182|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
14875183|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14875184|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875185|NCT01159379|Ertapenem|ertapenem|mesh-list
14875186|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14875187|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875188|NCT01159418|Paclitaxel|paclitaxel|mesh-list
14875189|NCT01159418|Carboplatin|carboplatin|mesh-list
14875190|NCT01159418|Panobinostat|panobinostat|mesh-list
14875191|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875192|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875193|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875194|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875195|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875196|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875197|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14875198|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914376|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
14914377|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914378|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914379|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
14296361|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14296362|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14296363|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14914380|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914381|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14914382|NCT01380808|Capecitabine|capecitabine|mesh-list
14914383|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14914384|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
14914385|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914386|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914387|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14914388|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
14914389|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14914390|NCT01380912|Prednisolone|prednisolone|mesh-list
14914391|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
14914392|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14914393|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
14296364|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
14714517|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14714518|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
15213265|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
15213266|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213267|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
15213268|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15213269|NCT03396874|Edetic Acid|edetic acid|mesh-list
15213270|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14914394|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914395|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
14914396|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
14914397|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914398|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213271|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15213272|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213273|NCT03396874|Anticoagulants|anticoagulants|mesh-ancestor
14714519|NCT00453167|Gemcitabine|gemcitabine|mesh-list
14714520|NCT00453167|Paclitaxel|paclitaxel|mesh-list
14714521|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14714522|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714523|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714524|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
14714525|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
14714526|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714527|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14714528|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
14714529|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
14714530|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914399|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14914400|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
14914401|NCT01380912|Hormones|hormones|mesh-ancestor
15213274|NCT03396874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14714531|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714532|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714533|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
14714534|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714535|NCT00453232|Etoposide|etoposide|mesh-list
14714536|NCT00453232|Bleomycin|bleomycin|mesh-list
14714537|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714538|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14714539|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14714540|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14714541|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714542|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714543|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14714544|NCT00453323|Paclitaxel|paclitaxel|mesh-list
14875199|NCT01159457|Vaccines|vaccines|mesh-list
14875200|NCT01159457|Immunologic Factors|immunologic factors|mesh-ancestor
14875201|NCT01159457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875202|NCT01159548|Promethazine|promethazine|mesh-list
14875203|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
14875204|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
14875205|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
14875206|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14875207|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
14875208|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
14875209|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875210|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875211|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875212|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14875213|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14875214|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14875215|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875216|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
14875217|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
14875218|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
14875219|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875220|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
14875221|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
14875222|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875223|NCT01159587|Factor VIII|factor viii|mesh-list
14875224|NCT01159587|Coagulants|coagulants|mesh-ancestor
14875225|NCT01159639|Clopidogrel|clopidogrel|mesh-list
14714545|NCT00453323|Capecitabine|capecitabine|mesh-list
14714546|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14714547|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714548|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714549|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
14714550|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
14714551|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714552|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14875226|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14875227|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14875228|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14875229|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14875230|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
14875231|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875232|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875233|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875234|NCT01159652|Zaleplon|zaleplon|mesh-list
14875235|NCT01159652|Zolpidem|zolpidem|mesh-list
14875236|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14875237|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14875238|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875239|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875240|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14875241|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
15213275|NCT03396874|Chelating Agents|chelating agents|mesh-ancestor
15213276|NCT03396874|Sequestering Agents|sequestering agents|mesh-ancestor
15213277|NCT03383575|Azacitidine|azacitidine|mesh-list
15213278|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213279|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
15213280|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714553|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
14714554|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
14714555|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
14875242|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
14875243|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875244|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875245|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
14875246|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
14875247|NCT01159821|Paroxetine|paroxetine|mesh-list
14875248|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14875249|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14875250|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875251|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875252|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875253|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
14875254|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875255|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14875256|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
14875257|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14875258|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14875259|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14875260|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875261|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14875262|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14875263|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875264|NCT01159847|Incretins|incretins|mesh-ancestor
14875265|NCT01159847|Hormones|hormones|mesh-ancestor
14875266|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875267|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14875268|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
14875269|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875270|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875271|NCT01160029|Nateglinide|nateglinide|mesh-list
14875272|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14875273|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875274|NCT01160042|Metformin|metformin|mesh-list
14875275|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14875276|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875277|NCT01160068|Metformin|metformin|mesh-list
14875278|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14875279|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875280|NCT01160172|Vaccines|vaccines|mesh-list
14875281|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
14875282|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875283|NCT01160185|Paclitaxel|paclitaxel|mesh-list
14875284|NCT01160185|Topotecan|topotecan|mesh-list
14875285|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875286|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875287|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875288|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875289|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875290|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875291|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14875292|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14875293|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875294|NCT01160276|Cyclosporine|cyclosporine|mesh-list
14714556|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714557|NCT00453375|Protective Agents|protective agents|mesh-ancestor
14875295|NCT01160276|Colchicine|colchicine|mesh-list
14875296|NCT01160276|Tacrolimus|tacrolimus|mesh-list
14875297|NCT01160276|Cyclosporins|cyclosporins|mesh-list
14714558|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714559|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
14714560|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
14714561|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714562|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714563|NCT00453414|Iloprost|iloprost|mesh-list
14714564|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14714565|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
14714566|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
14714567|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14875298|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875299|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
14875300|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875301|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15213281|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213282|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213283|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
14296365|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875302|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875303|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875304|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
14875305|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875306|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
14875307|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14875308|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
14875309|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875310|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875311|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875312|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875313|NCT01160302|Curcumin|curcumin|mesh-list
14875314|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14875315|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14875316|NCT01160302|Analgesics|analgesics|mesh-ancestor
14875317|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
14875318|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875319|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875320|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875321|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14875322|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875323|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875324|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875325|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14875326|NCT01160315|Norethindrone|norethindrone|mesh-list
14875327|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
14875328|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
14875329|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14875330|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
14875331|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14875332|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875333|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14875334|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14875335|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875336|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14875337|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14875338|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14875339|NCT01160328|Leuprolide|leuprolide|mesh-list
14875340|NCT01160328|Testosterone|testosterone|mesh-list
14875341|NCT01160328|Androgens|androgens|mesh-ancestor
14875342|NCT01160328|Hormones|hormones|mesh-ancestor
15213284|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
14296366|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296367|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296368|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
14296369|NCT05247177|Ketamine|ketamine|mesh-list
14714568|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714569|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14714570|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
14714571|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296370|NCT05247177|Anesthetics|anesthetics|mesh-list
14296371|NCT05247177|Sevoflurane|sevoflurane|mesh-list
14296372|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296373|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296374|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14296375|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296376|NCT05247177|Analgesics|analgesics|mesh-ancestor
14296377|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
14714572|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
14714573|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14714574|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14714575|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714576|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14714577|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714578|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14714579|NCT00453609|Naltrexone|naltrexone|mesh-list
14714580|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14714581|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14875343|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213285|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213286|NCT03362099|Bupropion|bupropion|mesh-list
14875344|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875345|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15213287|NCT03362099|Varenicline|varenicline|mesh-list
15213288|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15213289|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
15213290|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15213291|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15213292|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14875346|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875347|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14875348|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
14875349|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14875350|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
14875351|NCT01160341|Testosterone|testosterone|mesh-list
14875352|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
14875353|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
14875354|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14875355|NCT01160341|Androgens|androgens|mesh-ancestor
14875356|NCT01160341|Hormones|hormones|mesh-ancestor
14875357|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213293|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15213294|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213295|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
15213296|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213297|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213298|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15213299|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15213300|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213301|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14875358|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875359|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14875360|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875361|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
14875362|NCT01160419|Leucovorin|leucovorin|mesh-list
14875363|NCT01160419|Folic Acid|folic acid|mesh-list
14875364|NCT01160419|Docetaxel|docetaxel|mesh-list
14875365|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
14875366|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
14875367|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875368|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875369|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875370|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875371|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875372|NCT01160419|Antidotes|antidotes|mesh-ancestor
14875373|NCT01160419|Protective Agents|protective agents|mesh-ancestor
14875374|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875375|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
14875376|NCT01160419|Vitamins|vitamins|mesh-ancestor
14875377|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
14875378|NCT01160419|Hematinics|hematinics|mesh-ancestor
14875379|NCT01160432|Methadone|methadone|mesh-list
14875380|NCT01160432|Naloxone|naloxone|mesh-list
14875381|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14875382|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875383|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
14875384|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875385|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14875386|NCT01160432|Narcotics|narcotics|mesh-ancestor
14875387|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875388|NCT01160432|Analgesics|analgesics|mesh-ancestor
14875389|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
14875390|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
14875391|NCT01160588|Sertraline|sertraline|mesh-list
14875392|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
14875393|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14875394|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14875395|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14875396|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875397|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875398|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875399|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
14875400|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875401|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
14875402|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14875403|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
14875404|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875405|NCT01160627|Expectorants|expectorants|mesh-ancestor
14875406|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
14875407|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14875408|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
14875409|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875410|NCT01160627|Protective Agents|protective agents|mesh-ancestor
14875411|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875412|NCT01160627|Antidotes|antidotes|mesh-ancestor
14875413|NCT01160666|Belimumab|belimumab|mesh-list
14875414|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875415|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
14875416|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875417|NCT01160705|Docetaxel|docetaxel|mesh-list
14875418|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875419|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875420|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875421|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875422|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875423|NCT01160718|Fulvestrant|fulvestrant|mesh-list
14875424|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14875425|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875426|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14875427|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14875428|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
14875429|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875430|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875431|NCT01160731|Etoposide|etoposide|mesh-list
15213302|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15213303|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
15213304|NCT03340896|Docetaxel|docetaxel|mesh-list
15213305|NCT03340896|Fluorouracil|fluorouracil|mesh-list
15213306|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213307|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213308|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213309|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875432|NCT01160731|Panobinostat|panobinostat|mesh-list
14875433|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
14875434|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875435|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875436|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14875437|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14875438|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875439|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875440|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14875441|NCT01160900|Bivalirudin|bivalirudin|mesh-list
14875442|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14875443|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14875444|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
14875445|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14875446|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
14875447|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875448|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875449|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
14875450|NCT01160926|Cediranib|cediranib|mesh-list
14875451|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875452|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14875453|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213310|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213311|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
15213312|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213313|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213314|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
14875454|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875455|NCT01160952|Itraconazole|itraconazole|mesh-list
14875456|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
14875457|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875458|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14875459|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14875460|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875461|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875462|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14875463|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
14875464|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875465|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875466|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14875467|NCT01160965|Ropivacaine|ropivacaine|mesh-list
14875468|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
14875469|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
14875470|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
14875471|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875472|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875473|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
14875474|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875475|NCT01160978|Simvastatin|simvastatin|mesh-list
14875476|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14875477|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14875478|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
14875479|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875480|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14875481|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14875482|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875483|NCT01160991|Olanzapine|olanzapine|mesh-list
14875484|NCT01160991|Amisulpride|amisulpride|mesh-list
14875485|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
14875486|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
14875487|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875488|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875489|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875490|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14875491|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15213315|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213316|NCT03340064|Levetiracetam|levetiracetam|mesh-list
15213317|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
15213318|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
15213319|NCT03330249|Cisplatin|cisplatin|mesh-list
15213320|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213321|NCT03328026|Interferons|interferons|mesh-list
15213322|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
15213323|NCT03328026|Vaccines|vaccines|mesh-list
14714582|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714583|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
14714584|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714585|NCT00453635|Carboplatin|carboplatin|mesh-list
14714586|NCT00453635|Docetaxel|docetaxel|mesh-list
14714587|NCT00453635|Trastuzumab|trastuzumab|mesh-list
14714588|NCT00453635|Vinorelbine|vinorelbine|mesh-list
14714589|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296378|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296379|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14296380|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14296381|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14296382|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
14296383|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714590|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14714591|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14714592|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14714593|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714594|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14714595|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875492|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875493|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14875494|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14875495|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14875496|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875497|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875498|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875499|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
14875500|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14875501|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
14875502|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14875503|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
14875504|NCT01161017|Topiramate|topiramate|mesh-list
14875505|NCT01161017|Amitriptyline|amitriptyline|mesh-list
14875506|NCT01161017|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14875507|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
14875508|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14875509|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875510|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14875511|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
14875512|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14875513|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14875514|NCT01161017|Analgesics|analgesics|mesh-ancestor
14875515|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
14875516|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875517|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14875518|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14875519|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875520|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875521|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14875522|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875523|NCT01161017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14875524|NCT01161017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14875525|NCT01161017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875526|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
14875527|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14875528|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14875529|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875530|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875531|NCT01161108|Melatonin|melatonin|mesh-list
14875532|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
15213324|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213325|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
15213326|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213327|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213328|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15213329|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
15213330|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213331|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213332|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15213333|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
14875533|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875534|NCT01161108|Protective Agents|protective agents|mesh-ancestor
14875535|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875536|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875537|NCT01161134|Meloxicam|meloxicam|mesh-list
14875538|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14875539|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14875540|NCT01161134|Analgesics|analgesics|mesh-ancestor
14875541|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
14875542|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875543|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875544|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875545|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14875546|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14875547|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14875548|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875549|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914402|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14914403|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14914404|NCT01380912|Protective Agents|protective agents|mesh-ancestor
14914405|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14914406|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914407|NCT01380951|Telbivudine|telbivudine|mesh-list
14914408|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
14914409|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914410|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14914411|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914412|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914413|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
14914414|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14914415|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914416|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914417|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914418|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14914419|NCT01381055|Protective Agents|protective agents|mesh-ancestor
14914420|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914421|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914422|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14914423|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
14914424|NCT01381185|Aspirin|aspirin|mesh-list
14914425|NCT01381185|Clopidogrel|clopidogrel|mesh-list
14914426|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14914427|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914428|NCT01381185|Analgesics|analgesics|mesh-ancestor
14914429|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
14914430|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914431|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875550|NCT01161147|Meloxicam|meloxicam|mesh-list
14875551|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14875552|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14875553|NCT01161147|Analgesics|analgesics|mesh-ancestor
14875554|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
14875555|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213334|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213335|NCT03316807|Vaccines|vaccines|mesh-list
14875556|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875557|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875558|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14875559|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14875560|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14875561|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875562|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875563|NCT01161186|Gemcitabine|gemcitabine|mesh-list
14875564|NCT01161186|Paclitaxel|paclitaxel|mesh-list
14875565|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14875566|NCT01161186|Capecitabine|capecitabine|mesh-list
15213336|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
14875567|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875568|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875569|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875570|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875571|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875572|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875573|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14875574|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
15213337|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213338|NCT03304379|Celecoxib|celecoxib|mesh-list
15213339|NCT03304379|Diclofenac|diclofenac|mesh-list
15213340|NCT03304379|Fasinumab|fasinumab|mesh-list
15213341|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213342|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213343|NCT03304379|Analgesics|analgesics|mesh-ancestor
15213344|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
15213345|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213346|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213347|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213348|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213349|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15213350|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15213351|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213352|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875575|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
14875576|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875577|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213353|NCT03268499|Cisplatin|cisplatin|mesh-list
15213354|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875578|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875579|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
14875580|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875581|NCT01161277|Haloperidol|haloperidol|mesh-list
14875582|NCT01161277|Aripiprazole|aripiprazole|mesh-list
14875583|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
14875584|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
15213355|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
15213356|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
15213357|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213358|NCT03122522|Nivolumab|nivolumab|mesh-list
14875585|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14875586|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14875587|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14875588|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875589|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875590|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
15213359|NCT03122522|Ipilimumab|ipilimumab|mesh-list
15213360|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213361|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213362|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213363|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213364|NCT03110978|Nivolumab|nivolumab|mesh-list
15213365|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213366|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213367|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213368|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213369|NCT03085056|Paclitaxel|paclitaxel|mesh-list
15213370|NCT03085056|Trametinib|trametinib|mesh-list
15213371|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15213372|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213373|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213374|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213375|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213376|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213377|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213378|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213379|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
15213380|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213381|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213382|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
15213383|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15213384|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
15213385|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14875591|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
14875592|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875593|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875594|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14875595|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14875596|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
14875597|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14875598|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14875599|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14875600|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14875601|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
14875602|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
14296384|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875603|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875604|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15213386|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
14875605|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15213387|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875606|NCT01161316|Cetuximab|cetuximab|mesh-list
14875607|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14875608|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875609|NCT01161368|Vinorelbine|vinorelbine|mesh-list
14875610|NCT01161368|Lapatinib|lapatinib|mesh-list
14875611|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875612|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875613|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875614|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875615|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875616|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875617|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14875618|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875619|NCT01161459|Prednisone|prednisone|mesh-list
14875620|NCT01161459|Tacrolimus|tacrolimus|mesh-list
14875621|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875622|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
14875623|NCT01161459|Hormones|hormones|mesh-ancestor
14875624|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875625|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875626|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14875627|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875628|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875629|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
14875630|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14875631|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875632|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875633|NCT01161550|Cytarabine|cytarabine|mesh-list
14875634|NCT01161550|Tretinoin|tretinoin|mesh-list
14875635|NCT01161550|Cladribine|cladribine|mesh-list
14875636|NCT01161550|Midostaurin|midostaurin|mesh-list
14875637|NCT01161550|Sargramostim|sargramostim|mesh-list
14875638|NCT01161550|Lenograstim|lenograstim|mesh-list
14875639|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14875640|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
14875641|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875642|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875643|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
14875644|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875645|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875646|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
14875647|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875648|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14875649|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
14875650|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14875651|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14875652|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875653|NCT01161654|Naratriptan|naratriptan|mesh-list
14875654|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14875655|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14875656|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14875657|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
14875658|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875659|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875660|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875661|NCT01161667|Naratriptan|naratriptan|mesh-list
14875662|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14875663|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14875664|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14875665|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
14875666|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875667|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875668|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875669|NCT01161836|Iniparib|iniparib|mesh-list
14875670|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14875671|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875672|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875673|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875674|NCT01161888|Imiquimod|imiquimod|mesh-list
14875675|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14875676|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
14875677|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875678|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875679|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
14875680|NCT01161927|Nizatidine|nizatidine|mesh-list
14875681|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14714596|NCT00453648|Vitamin A|vitamin a|mesh-list
14714597|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
14714598|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
14714599|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714600|NCT00453648|Protective Agents|protective agents|mesh-ancestor
14714601|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714602|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14714603|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714604|NCT00453648|Vitamins|vitamins|mesh-ancestor
14714605|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
14714606|NCT00453765|Montelukast|montelukast|mesh-list
14714607|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14714608|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
14875682|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875683|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14714609|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14714610|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
14714611|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714612|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714613|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14714614|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14714615|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714616|NCT00453778|Fluticasone|fluticasone|mesh-list
14714617|NCT00453778|Xhance|xhance|mesh-list
14714618|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875684|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
14875685|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
14875686|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875687|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875688|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875689|NCT01161940|Nizatidine|nizatidine|mesh-list
14875690|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14714619|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14714620|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
14875691|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875692|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14875693|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
15213388|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213389|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
15213390|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
15213391|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
15213392|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875694|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
14875695|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875696|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875697|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875698|NCT01161966|Zonisamide|zonisamide|mesh-list
14875699|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
14875700|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14875701|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15213393|NCT02999087|Cetuximab|cetuximab|mesh-list
15213394|NCT02999087|Avelumab|avelumab|mesh-list
15213395|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213396|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213397|NCT02998385|Cisplatin|cisplatin|mesh-list
15213398|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875702|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213399|NCT02987543|Olaparib|olaparib|mesh-list
14875703|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14875704|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875705|NCT01161979|Zonisamide|zonisamide|mesh-list
14875706|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
14875707|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14875708|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875709|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875710|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14875711|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875712|NCT01162031|Bortezomib|bortezomib|mesh-list
14875713|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875714|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14875715|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
14875716|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14875717|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14875718|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875719|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875720|NCT01162603|Latanoprost|latanoprost|mesh-list
14875721|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14875722|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14875723|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
14875724|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14875725|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14875726|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
14875727|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875728|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875729|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875730|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
14875731|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
14875732|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875733|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
14875734|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14875735|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
14875736|NCT01162746|Dexamethasone|dexamethasone|mesh-list
14875737|NCT01162746|Ranibizumab|ranibizumab|mesh-list
14875738|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875739|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
14875740|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
14875741|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875742|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875743|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875744|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
14875745|NCT01162746|Hormones|hormones|mesh-ancestor
14875746|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875747|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14875748|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875749|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14875750|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14875751|NCT01162746|Growth Substances|growth substances|mesh-ancestor
14875752|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
14875753|NCT01162824|Adenosine|adenosine|mesh-list
14875754|NCT01162824|Acetylcholine|acetylcholine|mesh-list
14875755|NCT01162824|Analgesics|analgesics|mesh-ancestor
14875756|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
14875757|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875758|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875759|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14875760|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
14875761|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14875762|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
14875763|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
14875764|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875765|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875766|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14875767|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
14875768|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14875769|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
14875770|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213400|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
15213401|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15213402|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213403|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213404|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213405|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15213406|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
15213407|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213408|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213409|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15213410|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
15213411|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15213412|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15213413|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213414|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213415|NCT02958150|Analgesics|analgesics|mesh-ancestor
15213416|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
15213417|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213418|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15213419|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15213420|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15213421|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
14875771|NCT01162902|Candesartan|candesartan|mesh-list
14875772|NCT01162902|Diltiazem|diltiazem|mesh-list
14875773|NCT01162902|Bisoprolol|bisoprolol|mesh-list
14875774|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14875775|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14875776|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14875777|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875778|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14875779|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875780|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14875781|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875782|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
14875783|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
14875784|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
14875785|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875786|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14714621|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714622|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714623|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14714624|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
14714625|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
14714626|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14714627|NCT00453804|Naltrexone|naltrexone|mesh-list
14714628|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14714629|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14714630|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714631|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
14714632|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714633|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
14714634|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
14714635|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14714636|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
14875787|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14875788|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14875789|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
14875790|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914432|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914433|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914434|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14914435|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14914436|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914437|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914438|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14914439|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914440|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
14914441|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14914442|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14914443|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14914444|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
14914445|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914446|NCT01381276|Beta Carotene|beta carotene|mesh-list
14914447|NCT01381276|Vitamin A|vitamin a|mesh-list
14914448|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
14914449|NCT01381276|Carotenoids|carotenoids|mesh-list
14914450|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
14914451|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914452|NCT01381276|Protective Agents|protective agents|mesh-ancestor
14914453|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914454|NCT01381276|Provitamins|provitamins|mesh-ancestor
14914455|NCT01381276|Vitamins|vitamins|mesh-ancestor
14914456|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
14914457|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14914458|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914459|NCT01381289|Ivacaftor|ivacaftor|mesh-list
14914460|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14914461|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14914462|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914463|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
14914464|NCT01381354|Riboflavin|riboflavin|mesh-list
14914465|NCT01381354|Thiamine|thiamine|mesh-list
14914466|NCT01381354|Niacinamide|niacinamide|mesh-list
14914467|NCT01381354|Niacin|niacin|mesh-list
14914468|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
14914469|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
14914470|NCT01381354|Ubiquinone|ubiquinone|mesh-list
14914471|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
14875791|NCT01162941|Prednisolone|prednisolone|mesh-list
14875792|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875793|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
14875794|NCT01162941|Hormones|hormones|mesh-ancestor
14875795|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875796|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875797|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14875798|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875799|NCT01162967|Posaconazole|posaconazole|mesh-list
14875800|NCT01162967|Benzonidazole|benzonidazole|mesh-list
14875801|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
14875802|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875803|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14875804|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14875805|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14875806|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14875807|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14875808|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875809|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714637|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14714638|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14714639|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714640|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14714641|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714642|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714643|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14714644|NCT00453856|Renal Agents|renal agents|mesh-ancestor
14875810|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14714645|NCT00453908|Alfuzosin|alfuzosin|mesh-list
14875811|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
14875812|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14875813|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875814|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875815|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
14875816|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
14875817|NCT01163201|Fludarabine|fludarabine|mesh-list
14875818|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875819|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
15213422|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213423|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213424|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
14875820|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875821|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14875822|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15213425|NCT02955290|Nivolumab|nivolumab|mesh-list
15213426|NCT02955290|Vaccines|vaccines|mesh-list
15213427|NCT02955290|Mitogens|mitogens|mesh-list
15213428|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
15213429|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213430|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213431|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875823|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
14875824|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875825|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875826|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14875827|NCT01163396|Leucovorin|leucovorin|mesh-list
14875828|NCT01163396|Bevacizumab|bevacizumab|mesh-list
14875829|NCT01163396|Fluorouracil|fluorouracil|mesh-list
14875830|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
14875831|NCT01163396|Irinotecan|irinotecan|mesh-list
14875832|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14875833|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875834|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14875835|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14875836|NCT01163396|Growth Substances|growth substances|mesh-ancestor
14875837|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875838|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
14875839|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
14875840|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875841|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14875842|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875843|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
14875844|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14875845|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14875846|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875847|NCT01163396|Antidotes|antidotes|mesh-ancestor
14875848|NCT01163396|Protective Agents|protective agents|mesh-ancestor
14875849|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
14875850|NCT01163396|Vitamins|vitamins|mesh-ancestor
14875851|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
14875852|NCT01163435|Clarithromycin|clarithromycin|mesh-list
15213432|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15225709|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875853|NCT01163435|Levofloxacin|levofloxacin|mesh-list
14875854|NCT01163435|Ofloxacin|ofloxacin|mesh-list
15213433|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875855|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14875856|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875857|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14875858|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875859|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296385|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14296386|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14296387|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
14296388|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14296389|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14875860|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14875861|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14875862|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14875863|NCT01163435|Renal Agents|renal agents|mesh-ancestor
14875864|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14875865|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14875866|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875867|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14875868|NCT01163500|Ubiquinone|ubiquinone|mesh-list
14875869|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
14875870|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
14875871|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875872|NCT01163500|Vitamins|vitamins|mesh-ancestor
14875873|NCT01163630|Esomeprazole|esomeprazole|mesh-list
14875874|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14875875|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875876|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14875877|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875878|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875879|NCT01163734|Ranolazine|ranolazine|mesh-list
14875880|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14875881|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875882|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875883|NCT01163799|Alefacept|alefacept|mesh-list
14875884|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14875885|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
14875886|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875887|NCT01163825|Mitogens|mitogens|mesh-list
14875888|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875889|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875890|NCT01163903|Doxorubicin|doxorubicin|mesh-list
14875891|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14875892|NCT01163903|Pantoprazole|pantoprazole|mesh-list
14875893|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14875894|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875895|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14875896|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14875897|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213434|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213435|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
15213436|NCT02955134|Antacids|antacids|mesh-ancestor
15213437|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213438|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15213439|NCT02935205|Indomethacin|indomethacin|mesh-list
15213440|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213441|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213442|NCT02935205|Analgesics|analgesics|mesh-ancestor
15213443|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
15213444|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213445|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213446|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213447|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213448|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
14875898|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875899|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14875900|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14875901|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14875902|NCT01163929|Paclitaxel|paclitaxel|mesh-list
14875903|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14875904|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875905|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14875906|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14875907|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14875908|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875909|NCT01163994|Doxycycline|doxycycline|mesh-list
14875910|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
14875911|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14875912|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14875913|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
14875914|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14875915|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14875916|NCT01164046|Vitamin K|vitamin k|mesh-list
14875917|NCT01164046|Heparin|heparin|mesh-list
14875918|NCT01164046|Enoxaparin|enoxaparin|mesh-list
14875919|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14875920|NCT01164046|Tinzaparin|tinzaparin|mesh-list
14875921|NCT01164046|Dalteparin|dalteparin|mesh-list
14875922|NCT01164046|Nadroparin|nadroparin|mesh-list
14875923|NCT01164046|Reviparin|reviparin|mesh-list
14875924|NCT01164046|Warfarin|warfarin|mesh-list
14875925|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
14875926|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
14875927|NCT01164046|Bemiparin|bemiparin|mesh-list
14875928|NCT01164046|Certoparin|certoparin|mesh-list
14875929|NCT01164046|Vitamins|vitamins|mesh-ancestor
14875930|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
14875931|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875932|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
14875933|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14875934|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14875935|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875936|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14875937|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
14875938|NCT01164046|Coagulants|coagulants|mesh-ancestor
14875939|NCT01164059|Haloperidol|haloperidol|mesh-list
14875940|NCT01164059|Olanzapine|olanzapine|mesh-list
14875941|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14875942|NCT01164059|Aripiprazole|aripiprazole|mesh-list
14875943|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
14875944|NCT01164059|Flupenthixol|flupenthixol|mesh-list
14875945|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14875946|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
14875947|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
14875948|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875949|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875950|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296390|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14296391|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14296392|NCT05247151|Oxytocin|oxytocin|mesh-list
14296393|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
14296394|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14296395|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296396|NCT05247125|Melatonin|melatonin|mesh-list
14296397|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875951|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14875952|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14875953|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14875954|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14875955|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14875956|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14875957|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14875958|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875959|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14875960|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
14875961|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
14875962|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
14875963|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
15213449|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
15213450|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15213451|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14875964|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14875965|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14875966|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14875967|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14875968|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14875969|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14875970|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14875971|NCT01164085|Ketorolac|ketorolac|mesh-list
14875972|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14875973|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14875974|NCT01164085|Analgesics|analgesics|mesh-ancestor
14875975|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
14875976|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14875977|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875978|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14875979|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14875980|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14875981|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14875982|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14875983|NCT01164176|Everolimus|everolimus|mesh-list
14875984|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875985|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14875986|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
14875987|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875988|NCT01164189|Bevacizumab|bevacizumab|mesh-list
14875989|NCT01164189|Temozolomide|temozolomide|mesh-list
14875990|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14875991|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14875992|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14875993|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14875994|NCT01164189|Growth Substances|growth substances|mesh-ancestor
14875995|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14875996|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14875997|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14875998|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
14875999|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876000|NCT01164215|Leucovorin|leucovorin|mesh-list
14876001|NCT01164215|Fluorouracil|fluorouracil|mesh-list
14876002|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
14876003|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
14876004|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876005|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
14876006|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876007|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14876008|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876009|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876010|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
14876011|NCT01164215|Antidotes|antidotes|mesh-ancestor
14876012|NCT01164215|Protective Agents|protective agents|mesh-ancestor
14876013|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
14876014|NCT01164215|Vitamins|vitamins|mesh-ancestor
14876015|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
14876016|NCT01164267|Everolimus|everolimus|mesh-list
14876017|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876018|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876019|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
14876020|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876021|NCT01164306|Nicotine|nicotine|mesh-list
14876022|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14876023|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
15213452|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213453|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213454|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
15213455|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15213456|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
15213457|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213458|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
15213459|NCT02861183|Protective Agents|protective agents|mesh-ancestor
14876024|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876025|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876026|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14876027|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14876028|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
14876029|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876030|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876031|NCT01164345|Plerixafor|plerixafor|mesh-list
14876032|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14876033|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14876034|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
14876035|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213460|NCT02807805|Niclosamide|niclosamide|mesh-list
15213461|NCT02807805|Prednisone|prednisone|mesh-list
15213462|NCT02807805|Cortisone|cortisone|mesh-list
15213463|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
15213464|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876036|NCT01164488|Ritonavir|ritonavir|mesh-list
14876037|NCT01164488|Ketoconazole|ketoconazole|mesh-list
14876038|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14876039|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14876040|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876041|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876042|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876043|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14876044|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14876045|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
14876046|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876047|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15213465|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
15213466|NCT02807805|Hormones|hormones|mesh-ancestor
15213467|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876048|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876049|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
14876050|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14876051|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14876052|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
14876053|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876054|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876055|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14876056|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14876057|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14876058|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
14876059|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876060|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14876061|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14876062|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876063|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
14876064|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14876065|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14876066|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
14876067|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876068|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14876069|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14876070|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876071|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876072|NCT01164709|Nelfinavir|nelfinavir|mesh-list
14876073|NCT01164709|Bortezomib|bortezomib|mesh-list
14876074|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876075|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14876076|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14876077|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876078|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876079|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876080|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14876081|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14876082|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
14876083|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914472|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
14914473|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14914474|NCT01381354|Vitamins|vitamins|mesh-ancestor
14914475|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
14914476|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914477|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
14914478|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914479|NCT01381354|Expectorants|expectorants|mesh-ancestor
14914480|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
14914481|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14914482|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
14914483|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914484|NCT01381354|Protective Agents|protective agents|mesh-ancestor
14914485|NCT01381354|Antidotes|antidotes|mesh-ancestor
14914486|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
14914487|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14914488|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
14914489|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14914490|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
14914491|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914492|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914493|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914494|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
14914495|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14914496|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
14914497|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914498|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
14876084|NCT01164761|Ramipril|ramipril|mesh-list
14876085|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14876086|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876087|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876088|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876089|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14876090|NCT01164774|Ramipril|ramipril|mesh-list
14876091|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14876092|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876093|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876094|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876095|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14876096|NCT01164787|Trandolapril|trandolapril|mesh-list
14876097|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14876098|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876099|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876100|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876101|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14876102|NCT01164800|Trandolapril|trandolapril|mesh-list
14876103|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14876104|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876105|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876106|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876107|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14876108|NCT01164813|Nabumetone|nabumetone|mesh-list
14876109|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14876110|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14876111|NCT01164813|Analgesics|analgesics|mesh-ancestor
14876112|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
14876113|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876114|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876115|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876116|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14876117|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14876118|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14876119|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876120|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876121|NCT01164826|Nabumetone|nabumetone|mesh-list
14876122|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14876123|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14876124|NCT01164826|Analgesics|analgesics|mesh-ancestor
15213468|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213469|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15213470|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213471|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15213472|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213473|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213474|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
15213475|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15213476|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
15213477|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14876125|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
14876126|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876127|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876128|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876129|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14876130|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14876131|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14876132|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876133|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876134|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14876135|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
14876136|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876137|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14876138|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876139|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14876140|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14876141|NCT01165060|Bezafibrate|bezafibrate|mesh-list
14876142|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14876143|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
14876144|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876145|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14876146|NCT01165125|Ketoconazole|ketoconazole|mesh-list
14876147|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
14876148|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876149|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14876150|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876151|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876152|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876153|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14876154|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
14876155|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876156|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876157|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14876158|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14876159|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
14876160|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14876161|NCT01165255|Bupropion|bupropion|mesh-list
14876162|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
14876163|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14876164|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876165|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14876166|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14876167|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14876168|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876169|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
14876170|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876171|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876172|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14876173|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876174|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876175|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
14876176|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14876177|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876178|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14876179|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876180|NCT01165294|Ketamine|ketamine|mesh-list
14876181|NCT01165294|Analgesics|analgesics|mesh-ancestor
14876182|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
14876183|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876184|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876185|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14876186|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14876187|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
14876188|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
14876189|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876190|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14876191|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14876192|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876193|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876194|NCT01165372|Artesunate|artesunate|mesh-list
14876195|NCT01165372|Piperaquine|piperaquine|mesh-list
14876196|NCT01165372|Artenimol|artenimol|mesh-list
14876197|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
14876198|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14876199|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14876200|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876201|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876202|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
14876203|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
14876204|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14876205|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
14876206|NCT01165385|Cisplatin|cisplatin|mesh-list
14876207|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213478|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
14876208|NCT01165476|Treprostinil|treprostinil|mesh-list
14876209|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14876210|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
14876211|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14876212|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14876213|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876214|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14876215|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14876216|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
14876217|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876218|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876219|NCT01165580|Valganciclovir|valganciclovir|mesh-list
14876220|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
14876221|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876222|NCT01165645|Ritonavir|ritonavir|mesh-list
14876223|NCT01165645|Lopinavir|lopinavir|mesh-list
14876224|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14876225|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14876226|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876227|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876228|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876229|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14876230|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14876231|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
14876232|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876233|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14876234|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876235|NCT01165814|Naproxen|naproxen|mesh-list
14876236|NCT01165814|Tramadol|tramadol|mesh-list
14876237|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14876238|NCT01165814|Narcotics|narcotics|mesh-ancestor
14876239|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876240|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876241|NCT01165814|Analgesics|analgesics|mesh-ancestor
14876242|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
14876243|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876244|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14876245|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14876246|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876247|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14876248|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
14876249|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14876250|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876251|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876252|NCT01165866|Ondansetron|ondansetron|mesh-list
14876253|NCT01165866|Metoclopramide|metoclopramide|mesh-list
14876254|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
14876255|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
14876256|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876257|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876258|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876259|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
14876260|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
14876261|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14876262|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
14876263|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876264|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876265|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14876266|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14876267|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876268|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876269|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14876270|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14876271|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14876272|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
14876273|NCT01165905|Gemcitabine|gemcitabine|mesh-list
14876274|NCT01165905|ON 01910|on 01910|mesh-list
14876275|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14876276|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
14296398|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
14876277|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876278|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876279|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
14876280|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876281|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876282|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876283|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
14876284|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876285|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14876286|NCT01165931|Riociguat|riociguat|mesh-list
14876287|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
14876288|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876289|NCT01165944|Pramlintide|pramlintide|mesh-list
14876290|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14876291|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876292|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14876293|NCT01165970|Laxatives|laxatives|mesh-ancestor
14876294|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876295|NCT01166035|Lenalidomide|lenalidomide|mesh-list
14876296|NCT01166035|Cetuximab|cetuximab|mesh-list
14876297|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
14876298|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876299|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14876300|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14876301|NCT01166035|Growth Substances|growth substances|mesh-ancestor
14876302|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
14876303|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876304|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14876305|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14876306|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14876307|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14876308|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14876309|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876310|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876311|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876312|NCT01166048|Analgesics|analgesics|mesh-ancestor
14876313|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
14876314|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876315|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
14876316|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876317|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
14876318|NCT01166087|Fluoxetine|fluoxetine|mesh-list
14876319|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14876320|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14728865|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14728866|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14728867|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728868|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728869|NCT00520442|Ibuprofen|ibuprofen|mesh-list
14728870|NCT00520442|Codeine|codeine|mesh-list
14728871|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14728872|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14876321|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14876322|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876323|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876324|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
14876325|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876326|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14876327|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
14876328|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876329|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14876330|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876331|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876332|NCT01166100|Fluoxetine|fluoxetine|mesh-list
14876333|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14876334|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14876335|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14876336|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876337|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876338|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
14876339|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876340|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14876341|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
14876342|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876343|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14876344|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876345|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876346|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
14876347|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14876348|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876349|NCT01166165|Vitamins|vitamins|mesh-ancestor
14876350|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
14876351|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14876352|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
14876353|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
14876354|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876355|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876356|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876357|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
14876358|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14876359|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876360|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876361|NCT01166451|Iron|iron|mesh-list
14876362|NCT01166451|Trace Elements|trace elements|mesh-ancestor
14876363|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
14876364|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876365|NCT01166477|Ritonavir|ritonavir|mesh-list
14876366|NCT01166477|Lopinavir|lopinavir|mesh-list
14876367|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14876368|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14876369|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876370|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876371|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876372|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14876373|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14876374|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
14876375|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876376|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14876377|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876378|NCT01166542|Paclitaxel|paclitaxel|mesh-list
14876379|NCT01166542|Carboplatin|carboplatin|mesh-list
14876380|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14876381|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876382|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14876383|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14876384|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14876385|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914499|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14914500|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914501|NCT01381432|Azathioprine|azathioprine|mesh-list
14914502|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
14914503|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914504|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14914505|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914506|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14914507|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
14914508|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914509|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914510|NCT01381445|Clobetasol|clobetasol|mesh-list
14914511|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914512|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
14914513|NCT01381445|Hormones|hormones|mesh-ancestor
14914514|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14914515|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914516|NCT01381497|Naproxen|naproxen|mesh-list
14914517|NCT01381497|Sumatriptan|sumatriptan|mesh-list
14914518|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14914519|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914520|NCT01381497|Analgesics|analgesics|mesh-ancestor
14914521|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
14914522|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914523|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914524|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876386|NCT01166594|Bevacizumab|bevacizumab|mesh-list
14876387|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213479|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15213480|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213481|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
14714646|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14714647|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14714648|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14714649|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
14714650|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714651|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714652|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714653|NCT00453908|Urological Agents|urological agents|mesh-ancestor
14728873|NCT00520442|Analgesics|analgesics|mesh-ancestor
14728874|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
14728875|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876388|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876389|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14876390|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14876391|NCT01166594|Growth Substances|growth substances|mesh-ancestor
14876392|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876393|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14876394|NCT01166685|Everolimus|everolimus|mesh-list
14876395|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876396|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876397|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
14876398|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876399|NCT01166711|Chromium|chromium|mesh-list
14876400|NCT01166711|Paclitaxel|paclitaxel|mesh-list
14876401|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14876402|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14876403|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876404|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14876405|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14876406|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
14876407|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876408|NCT01166711|Trace Elements|trace elements|mesh-ancestor
14876409|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
14876410|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876411|NCT01166789|Lubiprostone|lubiprostone|mesh-list
14876412|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14876413|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14876414|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876415|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
14876416|NCT01166815|Astringents|astringents|mesh-ancestor
14876417|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876418|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14876419|NCT01166932|Amoxicillin|amoxicillin|mesh-list
14876420|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
14876421|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
14876422|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
14876423|NCT01166932|Oxacillin|oxacillin|mesh-list
14876424|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14876425|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876426|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876427|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876428|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14876429|NCT01167010|Budesonide|budesonide|mesh-list
14876430|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
14876431|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876432|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14876433|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
15213482|NCT02764268|Apatinib|apatinib|mesh-list
15213483|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213484|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213485|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213486|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213487|NCT02714322|Adalimumab|adalimumab|mesh-list
15213488|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876434|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914525|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14714654|NCT00453960|Norethindrone|norethindrone|mesh-list
14876435|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876436|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14876437|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
14876438|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
14876439|NCT01167010|Hormones|hormones|mesh-ancestor
14876440|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876441|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14876442|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14876443|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14876444|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
14876445|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876446|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876447|NCT01167049|Capecitabine|capecitabine|mesh-list
14876448|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14876449|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
14876450|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876451|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876452|NCT01167062|Tamsulosin|tamsulosin|mesh-list
14876453|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14876454|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14876455|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14876456|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
15213489|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213490|NCT02607813|Spartalizumab|spartalizumab|mesh-list
15213491|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213492|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213493|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213494|NCT02553473|Doxycycline|doxycycline|mesh-list
15213495|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15213496|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213497|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
15213498|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15213499|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15213500|NCT02472912|Adalimumab|adalimumab|mesh-list
15213501|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714655|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
14714656|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14714657|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14714658|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14714659|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
14714660|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14714661|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714662|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14714663|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14714664|NCT00454168|Sargramostim|sargramostim|mesh-list
14714665|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
14714666|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714667|NCT00454233|Metformin|metformin|mesh-list
14714668|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14714669|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213502|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14876457|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876458|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876459|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714670|NCT00454259|Fentanyl|fentanyl|mesh-list
14714671|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14714672|NCT00454259|Narcotics|narcotics|mesh-ancestor
14714673|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714674|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714675|NCT00454259|Analgesics|analgesics|mesh-ancestor
14714676|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
14876460|NCT01167062|Urological Agents|urological agents|mesh-ancestor
14876461|NCT01167101|Pantoprazole|pantoprazole|mesh-list
14876462|NCT01167101|Rebamipide|rebamipide|mesh-list
14876463|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14876464|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876465|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14876466|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876467|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876468|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
14876469|NCT01167101|Protective Agents|protective agents|mesh-ancestor
14876470|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876471|NCT01167127|Oxycodone|oxycodone|mesh-list
14876472|NCT01167127|Naloxone|naloxone|mesh-list
14876473|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14876474|NCT01167127|Narcotics|narcotics|mesh-ancestor
14876475|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876476|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876477|NCT01167127|Analgesics|analgesics|mesh-ancestor
14876478|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
14714677|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714678|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14714679|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14876479|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876480|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14876481|NCT01167231|Acarbose|acarbose|mesh-list
14876482|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14876483|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876484|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876485|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14876486|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876487|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
14876488|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
14876489|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
14876490|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14876491|NCT01167465|Protective Agents|protective agents|mesh-ancestor
14876492|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876493|NCT01167478|Caffeine|caffeine|mesh-list
14714680|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
14714681|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
14714682|NCT00454272|Vancomycin|vancomycin|mesh-list
14876494|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15213503|NCT02467582|Aspirin|aspirin|mesh-list
14876495|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213504|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213505|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213506|NCT02467582|Analgesics|analgesics|mesh-ancestor
15213507|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
15213508|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213509|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213510|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213511|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213512|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15213513|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14714683|NCT00454272|Teicoplanin|teicoplanin|mesh-list
14714684|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14714685|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714686|NCT00454337|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14714687|NCT00454337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14876496|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14876497|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876498|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714688|NCT00454337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14876499|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14876500|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14876501|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
14714689|NCT00454337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714690|NCT00454337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714691|NCT00454337|Antiviral Agents|antiviral agents|mesh-ancestor
14714692|NCT00454337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714693|NCT00454337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14714694|NCT00454337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14714695|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14714696|NCT00454350|Vitamins|vitamins|mesh-ancestor
14714697|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
14714698|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714699|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14714700|NCT00454389|Ranibizumab|ranibizumab|mesh-list
14714701|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14714702|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14714703|NCT00454389|Growth Substances|growth substances|mesh-ancestor
14714704|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714705|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
14714706|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714707|NCT00454402|Alfuzosin|alfuzosin|mesh-list
14714708|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14714709|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14714710|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14714711|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14714712|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714713|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714714|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714715|NCT00454402|Urological Agents|urological agents|mesh-ancestor
14714716|NCT00454480|Cytarabine|cytarabine|mesh-list
14714717|NCT00454480|Fludarabine|fludarabine|mesh-list
14876502|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876503|NCT01167530|Everolimus|everolimus|mesh-list
14876504|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876505|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876506|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
14876507|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876508|NCT01167699|Oxycodone|oxycodone|mesh-list
14876509|NCT01167699|Naloxone|naloxone|mesh-list
14876510|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14876511|NCT01167699|Narcotics|narcotics|mesh-ancestor
14876512|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876513|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876514|NCT01167699|Analgesics|analgesics|mesh-ancestor
14876515|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
14876516|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876517|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14876518|NCT01167725|Leucovorin|leucovorin|mesh-list
14876519|NCT01167725|Bevacizumab|bevacizumab|mesh-list
14876520|NCT01167725|Cetuximab|cetuximab|mesh-list
14876521|NCT01167725|Fluorouracil|fluorouracil|mesh-list
14876522|NCT01167725|Capecitabine|capecitabine|mesh-list
14876523|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
14876524|NCT01167725|Irinotecan|irinotecan|mesh-list
14714718|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
14714719|NCT00454480|Azacitidine|azacitidine|mesh-list
14876525|NCT01167725|Mitomycins|mitomycins|mesh-list
14876526|NCT01167725|Mitomycin|mitomycin|mesh-list
14714720|NCT00454480|Melphalan|melphalan|mesh-list
15213514|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213515|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15213516|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15213517|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213518|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
15213519|NCT02356458|Bortezomib|bortezomib|mesh-list
15213520|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876527|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
14876528|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14876529|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876530|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14876531|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14876532|NCT01167725|Growth Substances|growth substances|mesh-ancestor
14876533|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876534|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
14876535|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
14714721|NCT00454480|Busulfan|busulfan|mesh-list
14714722|NCT00454480|Daunorubicin|daunorubicin|mesh-list
14714723|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
14714724|NCT00454480|Clofarabine|clofarabine|mesh-list
14714725|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
14714726|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
14714727|NCT00454480|Tipifarnib|tipifarnib|mesh-list
14714728|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876536|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876537|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14876538|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876539|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
14876540|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14876541|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14876542|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876543|NCT01167725|Antidotes|antidotes|mesh-ancestor
14876544|NCT01167725|Protective Agents|protective agents|mesh-ancestor
14876545|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
14876546|NCT01167725|Vitamins|vitamins|mesh-ancestor
14876547|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
14876548|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14876549|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
14876550|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14876551|NCT01167738|Metformin|metformin|mesh-list
14876552|NCT01167738|Gemcitabine|gemcitabine|mesh-list
14876553|NCT01167738|Capecitabine|capecitabine|mesh-list
14876554|NCT01167738|Epirubicin|epirubicin|mesh-list
14876555|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876556|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14876557|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
14876558|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876559|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
14876560|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876561|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876562|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876563|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
14876564|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876565|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14876566|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14876567|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14876568|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14876569|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
14876570|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14876571|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14876572|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213521|NCT02254278|Cisplatin|cisplatin|mesh-list
15213522|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213523|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15213524|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
15213525|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213526|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
15213527|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213528|NCT01974609|Acetaminophen|acetaminophen|mesh-list
15213529|NCT01974609|Ibuprofen|ibuprofen|mesh-list
15213530|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14876573|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
14876574|NCT01167764|Coagulants|coagulants|mesh-ancestor
15213531|NCT01974609|Hydrocodone|hydrocodone|mesh-list
14714729|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14714730|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
14714731|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876575|NCT01167803|Desflurane|desflurane|mesh-list
14876576|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14876577|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
14876578|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
14876579|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876580|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876581|NCT01167816|Azacitidine|azacitidine|mesh-list
14876582|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14876583|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
14876584|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876585|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876586|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876587|NCT01167894|Simvastatin|simvastatin|mesh-list
14876588|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14876589|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14876590|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
14876591|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876592|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14876593|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14876594|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876595|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
14876596|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
14876597|NCT01167920|Diuretics|diuretics|mesh-list
14876598|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14876599|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14876600|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876601|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
14876602|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
15213532|NCT01974609|Narcotics|narcotics|mesh-list
15213533|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296399|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296400|NCT05247125|Protective Agents|protective agents|mesh-ancestor
14296401|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296402|NCT05246982|Capecitabine|capecitabine|mesh-list
14296403|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
14296404|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296405|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
14296406|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296407|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296408|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
14876603|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213534|NCT01974609|Analgesics|analgesics|mesh-ancestor
15213535|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
15213536|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213537|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213538|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
15213539|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213540|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213541|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213542|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15213543|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213544|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213545|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14876604|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876605|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14876606|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14876607|NCT01167933|Simvastatin|simvastatin|mesh-list
14876608|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14876609|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14876610|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
14876611|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876612|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14876613|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14876614|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876615|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
14876616|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14876617|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14876618|NCT01167946|Prednisolone|prednisolone|mesh-list
14876619|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
14876620|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14876621|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
14876622|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876623|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
14876624|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
14876625|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876626|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876627|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876628|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
14876629|NCT01167946|Hormones|hormones|mesh-ancestor
14876630|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876631|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14876632|NCT01167946|Protective Agents|protective agents|mesh-ancestor
14876633|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14876634|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876635|NCT01168011|ON 01910|on 01910|mesh-list
14876636|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876637|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14876638|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876639|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876640|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14876641|NCT01168063|Amoxicillin|amoxicillin|mesh-list
14876642|NCT01168063|Metronidazole|metronidazole|mesh-list
14876643|NCT01168063|Clarithromycin|clarithromycin|mesh-list
14876644|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14876645|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876646|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
14876647|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14876648|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14876649|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14876650|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876651|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876652|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14876653|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876654|NCT01168336|Betahistine|betahistine|mesh-list
14876655|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
14876656|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
14876657|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
14876658|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876659|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876660|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876661|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14876662|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14914526|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
14914527|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14914528|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914529|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914530|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14876663|NCT01168440|Sunitinib|sunitinib|mesh-list
14876664|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876665|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14876666|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14876667|NCT01168440|Growth Substances|growth substances|mesh-ancestor
14876668|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876669|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
14876670|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14876671|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876672|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876673|NCT01168492|Ketamine|ketamine|mesh-list
14714732|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714733|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
14876674|NCT01168492|Analgesics|analgesics|mesh-ancestor
14876675|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
14876676|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876677|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876678|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14876679|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14876680|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
14876681|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
14876682|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876683|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14876684|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14876685|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876686|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714734|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714735|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
14714736|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714737|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714738|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14714739|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
14714740|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14714741|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14876687|NCT01168505|Teferrol|teferrol|mesh-list
14876688|NCT01168505|Hematinics|hematinics|mesh-ancestor
14876689|NCT01168531|Dexamethasone|dexamethasone|mesh-list
14876690|NCT01168531|Pregabalin|pregabalin|mesh-list
14876691|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876692|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
14876693|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
14876694|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876695|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876696|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876697|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
14876698|NCT01168531|Hormones|hormones|mesh-ancestor
14876699|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876700|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14876701|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876702|NCT01168531|Analgesics|analgesics|mesh-ancestor
14876703|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
14876704|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
14876705|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14876706|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14876707|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876708|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14876709|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14876710|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14876711|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876712|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876713|NCT01168544|Vitamin D|vitamin d|mesh-list
14876714|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
14876715|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
14876716|NCT01168544|Vitamins|vitamins|mesh-list
14876717|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
14876718|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876719|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14876720|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14876721|NCT01168739|Quercetin|quercetin|mesh-list
14876722|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
14876723|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876724|NCT01168739|Protective Agents|protective agents|mesh-ancestor
14876725|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876726|NCT01168791|Doxorubicin|doxorubicin|mesh-list
14876727|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14876728|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
14876729|NCT01168791|Ifosfamide|ifosfamide|mesh-list
14876730|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14876731|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876732|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14876733|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14876734|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876735|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876736|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14876737|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
14876738|NCT01168804|Dexamethasone|dexamethasone|mesh-list
14876739|NCT01168804|Bortezomib|bortezomib|mesh-list
14876740|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14876741|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876742|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
14876743|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
14876744|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876745|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876746|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876747|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
14876748|NCT01168804|Hormones|hormones|mesh-ancestor
14876749|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876750|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14876751|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876752|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14876753|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
14876754|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876755|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14876756|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
14876757|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14876758|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14876759|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876760|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876761|NCT01168817|Urological Agents|urological agents|mesh-ancestor
14876762|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
14876763|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14876764|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876765|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14876766|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14876767|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876768|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876769|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876770|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14876771|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876772|NCT01169012|Clofarabine|clofarabine|mesh-list
14876773|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14876774|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
14876775|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876776|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876777|NCT01169025|Fentanyl|fentanyl|mesh-list
14876778|NCT01169025|Ketamine|ketamine|mesh-list
14876779|NCT01169025|Analgesics|analgesics|mesh-ancestor
14876780|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
14876781|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876782|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876783|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14876784|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14876785|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
14876786|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
14876787|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876788|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14876789|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14876790|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876791|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876792|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14876793|NCT01169025|Narcotics|narcotics|mesh-ancestor
14876794|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14876795|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14876796|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14876797|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876798|NCT01169090|Incretins|incretins|mesh-ancestor
14876799|NCT01169090|Hormones|hormones|mesh-ancestor
14876800|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876801|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14876802|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876803|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876804|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876805|NCT01169142|Vitamin D|vitamin d|mesh-list
14876806|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
14296409|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14714742|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14714743|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14714744|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14714745|NCT00454519|Mitomycins|mitomycins|mesh-list
14714746|NCT00454519|Mitomycin|mitomycin|mesh-list
14714747|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876807|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
14876808|NCT01169142|Vitamins|vitamins|mesh-list
14876809|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
14876810|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876811|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14876812|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14876813|NCT01169298|Lenalidomide|lenalidomide|mesh-list
14876814|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
14876815|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876816|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14876817|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14876818|NCT01169298|Growth Substances|growth substances|mesh-ancestor
14876819|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
14876820|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876821|NCT01169389|Bupivacaine|bupivacaine|mesh-list
14876822|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
14876823|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
14876824|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876825|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876826|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
14876827|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876828|NCT01169402|Fluconazole|fluconazole|mesh-list
14876829|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
14876830|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876831|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14876832|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14876833|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876834|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876835|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14876836|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
14876837|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213546|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15213547|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
15213548|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
15213549|NCT01850524|Dexamethasone|dexamethasone|mesh-list
15213550|NCT01850524|Lenalidomide|lenalidomide|mesh-list
14296410|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14714748|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14714749|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
14714750|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714751|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14714752|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714753|NCT00454545|Atorvastatin|atorvastatin|mesh-list
14714754|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14714755|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14714756|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
14714757|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714758|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14714759|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14714760|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714761|NCT00454558|Riociguat|riociguat|mesh-list
14714762|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
14714763|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714764|NCT00454662|Amlodipine|amlodipine|mesh-list
14714765|NCT00454662|Olmesartan|olmesartan|mesh-list
14714766|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14714767|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14714768|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14714769|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14714770|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714771|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14714772|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296411|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296412|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
15213551|NCT01850524|Ixazomib|ixazomib|mesh-list
14876838|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876839|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14876840|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14876841|NCT01169415|Dexamethasone|dexamethasone|mesh-list
14876842|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
14876843|NCT01169415|BB 1101|bb 1101|mesh-list
14876844|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876845|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
14876846|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
14876847|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876848|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876849|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876850|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
14876851|NCT01169415|Hormones|hormones|mesh-ancestor
14876852|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876853|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14876854|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876855|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876856|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876857|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876858|NCT01169506|Silicon|silicon|mesh-list
14876859|NCT01169506|Trace Elements|trace elements|mesh-ancestor
14876860|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
14876861|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876862|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
14876863|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14876864|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876865|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714773|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
14714774|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14714775|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14714776|NCT00454701|Alefacept|alefacept|mesh-list
14714777|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14714778|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
14714779|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714780|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
14714781|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
14714782|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14876866|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14876867|NCT01169571|Analgesics|analgesics|mesh-ancestor
14876868|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
14876869|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876870|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14876871|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14876872|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14876873|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
14876874|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876875|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876876|NCT01169584|Molgramostim|molgramostim|mesh-list
14876877|NCT01169584|Sargramostim|sargramostim|mesh-list
14876878|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
14876879|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876880|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876881|NCT01169597|Prednisone|prednisone|mesh-list
14876882|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14876883|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
14876884|NCT01169597|Hormones|hormones|mesh-ancestor
14876885|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876886|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876887|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14876888|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876889|NCT01169688|Phenylephrine|phenylephrine|mesh-list
14876890|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
14876891|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
14876892|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14876893|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
14876894|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
14296413|NCT05246943|Coagulants|coagulants|mesh-ancestor
14296414|NCT05246865|Androgens|androgens|mesh-list
14296415|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14296416|NCT05246865|Hormones|hormones|mesh-ancestor
14296417|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876895|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876896|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876897|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
14876898|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14876899|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
14876900|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
14876901|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14876902|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14296418|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876903|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14876904|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14876905|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876906|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876907|NCT01169688|Protective Agents|protective agents|mesh-ancestor
14876908|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
14876909|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14876910|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14876911|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
14876912|NCT01169740|Bilirubin|bilirubin|mesh-list
14876913|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
14876914|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876915|NCT01169740|Protective Agents|protective agents|mesh-ancestor
14876916|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876917|NCT01169792|Tamoxifen|tamoxifen|mesh-list
14876918|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14876919|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
14876920|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14876921|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876922|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14876923|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876924|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14296419|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14876925|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14876926|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14876927|NCT01169805|Ondansetron|ondansetron|mesh-list
14876928|NCT01169805|Palonosetron|palonosetron|mesh-list
14876929|NCT01169805|Ramosetron|ramosetron|mesh-list
14876930|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
14876931|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
14296420|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
14296421|NCT05246644|Acetaminophen|acetaminophen|mesh-list
14296422|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296423|NCT05246644|Analgesics|analgesics|mesh-ancestor
14296424|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
14296425|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296426|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296427|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
15213552|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213553|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
15213554|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
15213555|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213556|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213557|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15213558|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
15213559|NCT01850524|Hormones|hormones|mesh-ancestor
14876932|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14876933|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876934|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14876935|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
14876936|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
14876937|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14876938|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
14876939|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14876940|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876941|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14876942|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15225196|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296428|NCT05246631|Dexamethasone|dexamethasone|mesh-list
14876943|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876944|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14876945|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14876946|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14876947|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
14876948|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14876949|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876950|NCT01169857|Bortezomib|bortezomib|mesh-list
14876951|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14876952|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876953|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
14876954|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876955|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876956|NCT01169870|Paclitaxel|paclitaxel|mesh-list
14876957|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14876958|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876959|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
14876960|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
14876961|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
14876962|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876963|NCT01169909|Ranibizumab|ranibizumab|mesh-list
14876964|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14876965|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14876966|NCT01169909|Growth Substances|growth substances|mesh-ancestor
14876967|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876968|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
14876969|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876970|NCT01169922|Ethanol|ethanol|mesh-list
14876971|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14876972|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876973|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14876974|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876975|NCT01169935|Dextrans|dextrans|mesh-list
14876976|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
14876977|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
14876978|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
14876979|NCT01170052|Sirolimus|sirolimus|mesh-list
14876980|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14876981|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14876982|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
14876983|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876984|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14876985|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14876986|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14876987|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14876988|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
14876989|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14876990|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
14876991|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14876992|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
14876993|NCT01170078|Hematinics|hematinics|mesh-ancestor
14876994|NCT01170104|Sorafenib|sorafenib|mesh-list
14876995|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714783|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14714784|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714785|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714786|NCT00454714|Urological Agents|urological agents|mesh-ancestor
14714787|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
14714788|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14714789|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14714790|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
14714791|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714792|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714793|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714794|NCT00454740|Urological Agents|urological agents|mesh-ancestor
14714795|NCT00454831|Chitosan|chitosan|mesh-list
14714796|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14714797|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14714798|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
14714799|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714800|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14714801|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
14714802|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
14876996|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14876997|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14876998|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14876999|NCT01170130|Lidocaine|lidocaine|mesh-list
14877000|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
14877001|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
14877002|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877003|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877004|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
14877005|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877006|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14877007|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14877008|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14877009|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14877010|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296429|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
14296430|NCT05246631|Haloperidol|haloperidol|mesh-list
14714803|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
14877011|NCT01170143|Trastuzumab|trastuzumab|mesh-list
14877012|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14877013|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877014|NCT01170169|Omeprazole|omeprazole|mesh-list
14877015|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14877016|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877017|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14877018|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877019|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877020|NCT01170182|Omeprazole|omeprazole|mesh-list
14877021|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14714804|NCT00454831|Coagulants|coagulants|mesh-ancestor
14714805|NCT00454883|Ziprasidone|ziprasidone|mesh-list
14714806|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14714807|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
14714808|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714809|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714810|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714811|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14714812|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14714813|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877022|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877023|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14877024|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877025|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877026|NCT01170260|Ethanol|ethanol|mesh-list
14877027|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14877028|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877029|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877030|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914531|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14914532|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14914533|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
14914534|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914535|NCT01381510|Finasteride|finasteride|mesh-list
14914536|NCT01381510|Dutasteride|dutasteride|mesh-list
14914537|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
14914538|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14914539|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914540|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914541|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
14914542|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14914543|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914544|NCT01381510|Urological Agents|urological agents|mesh-ancestor
14914545|NCT01381523|Naproxen|naproxen|mesh-list
14914546|NCT01381523|Sumatriptan|sumatriptan|mesh-list
14914547|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14914548|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914549|NCT01381523|Analgesics|analgesics|mesh-ancestor
14914550|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
14914551|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914552|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914553|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914554|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914555|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
14914556|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14914557|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914558|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914559|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14914560|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14714814|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15213560|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213561|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14877031|NCT01170325|Valproic Acid|valproic acid|mesh-list
14877032|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
14877033|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877034|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877035|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
14877036|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877037|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877038|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
14877039|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14877040|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877041|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14877042|NCT01170338|Varenicline|varenicline|mesh-list
14877043|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14877044|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14877045|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
14877046|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877047|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877048|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877049|NCT01170351|Cyclosporine|cyclosporine|mesh-list
14877050|NCT01170351|Cyclosporins|cyclosporins|mesh-list
14877051|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877052|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877053|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877054|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
14877055|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877056|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
14877057|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877058|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
14877059|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14877060|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14877061|NCT01170429|Procaterol|procaterol|mesh-list
14877062|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14877063|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
14877064|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877065|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877066|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14877067|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
14877068|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
14877069|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14877070|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14877071|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14877072|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14877073|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877074|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877075|NCT01170442|Vitamin D|vitamin d|mesh-list
14877076|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
14877077|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
14877078|NCT01170442|Vitamins|vitamins|mesh-list
14877079|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
15213562|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213563|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
15213564|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15213565|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15213566|NCT01850524|Growth Substances|growth substances|mesh-ancestor
14296431|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
14877080|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877081|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14877082|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15213567|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
15213568|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
15213569|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877083|NCT01170468|Vitamin D|vitamin d|mesh-list
14877084|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
14877085|NCT01170468|Vitamins|vitamins|mesh-ancestor
14877086|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
14877087|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877088|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14877089|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14877090|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
14877091|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
14877092|NCT01170494|Vitamin D|vitamin d|mesh-list
14877093|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14877094|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877095|NCT01170494|Vitamins|vitamins|mesh-ancestor
14877096|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
14877097|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14877098|NCT01170507|Vitamin D|vitamin d|mesh-list
14877099|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
14877100|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
14877101|NCT01170507|Vitamins|vitamins|mesh-list
14877102|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
14877103|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877104|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14877105|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14877106|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14877107|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14877108|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14877109|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
14877110|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877111|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14877112|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14877113|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877114|NCT01170637|Ibuprofen|ibuprofen|mesh-list
14877115|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
14877116|NCT01170637|Ephedrine|ephedrine|mesh-list
14877117|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14877118|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14877119|NCT01170637|Analgesics|analgesics|mesh-ancestor
14877120|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
14877121|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877122|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877123|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877124|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14877125|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14877126|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877127|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877128|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14877129|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
14877130|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14877131|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
14877132|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
14877133|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14877134|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14877135|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
14877136|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
14877137|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877138|NCT01170767|Bevacizumab|bevacizumab|mesh-list
14877139|NCT01170767|Ranibizumab|ranibizumab|mesh-list
14877140|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14877141|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877142|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14877143|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14877144|NCT01170767|Growth Substances|growth substances|mesh-ancestor
14877145|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877146|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
14877147|NCT01170780|Dexamethasone|dexamethasone|mesh-list
14877148|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877149|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
14877150|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
14877151|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877152|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877153|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877154|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
14877155|NCT01170780|Hormones|hormones|mesh-ancestor
14877156|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877157|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14877158|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877159|NCT01170806|Orlistat|orlistat|mesh-list
14877160|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877161|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877162|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14877163|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14877164|NCT01170819|Dinoprostone|dinoprostone|mesh-list
14877165|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
14877166|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14877167|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877168|NCT01170845|Sivelestat|sivelestat|mesh-list
14877169|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14877170|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
14877171|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877172|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877173|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14877174|NCT01170858|Icodextrin|icodextrin|mesh-list
14877175|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
14877176|NCT01170871|Pemetrexed|pemetrexed|mesh-list
14877177|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877178|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877179|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877180|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14877181|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877182|NCT01171092|Bortezomib|bortezomib|mesh-list
14877183|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877184|NCT01171170|Paclitaxel|paclitaxel|mesh-list
14877185|NCT01171170|Bevacizumab|bevacizumab|mesh-list
14877186|NCT01171170|Carboplatin|carboplatin|mesh-list
14877187|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14877188|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
14877189|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14877190|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877191|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14877192|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877193|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14877194|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877195|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14877196|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14877197|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14877198|NCT01171170|Growth Substances|growth substances|mesh-ancestor
14877199|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877200|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
14877201|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
14877202|NCT01171209|Interferons|interferons|mesh-list
14877203|NCT01171209|Interferon-beta|interferon-beta|mesh-list
14877204|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
14877205|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
14877206|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877207|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
14877208|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877209|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
14877210|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877211|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14877212|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14877213|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14877214|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877215|NCT01171326|Minocycline|minocycline|mesh-list
14877216|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14877217|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714815|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14714816|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
14714817|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
14714818|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14714819|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14714820|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14714821|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14714822|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714823|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714824|NCT00454896|Urological Agents|urological agents|mesh-ancestor
14714825|NCT00454961|Lumefantrine|lumefantrine|mesh-list
14714826|NCT00454961|Artemether|artemether|mesh-list
14714827|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14714828|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
14714829|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14714830|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14877218|NCT01171365|Ciclesonide|ciclesonide|mesh-list
14877219|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
14877220|NCT01171365|Hormones|hormones|mesh-ancestor
14877221|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877222|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877223|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14877224|NCT01171378|Ofatumumab|ofatumumab|mesh-list
14877225|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877226|NCT01171456|Metformin|metformin|mesh-list
14877227|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14877228|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877229|NCT01171469|Imiquimod|imiquimod|mesh-list
14877230|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14877231|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
14877232|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877233|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877234|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
14877235|NCT01171482|Fluorouracil|fluorouracil|mesh-list
14877236|NCT01171482|Sorafenib|sorafenib|mesh-list
14877237|NCT01171482|Mitomycins|mitomycins|mesh-list
14877238|NCT01171482|Mitomycin|mitomycin|mesh-list
14877239|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
14877240|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877241|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14877242|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877243|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877244|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
14877245|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877246|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14877247|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877248|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14877249|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
14877250|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877251|NCT01171547|Daptomycin|daptomycin|mesh-list
14877252|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14877253|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877254|NCT01171651|Sorafenib|sorafenib|mesh-list
14877255|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877256|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14877257|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877258|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877259|NCT01171755|Gemcitabine|gemcitabine|mesh-list
14877260|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14877261|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
14877262|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877263|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877264|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
14877265|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877266|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877267|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877268|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
14877269|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877270|NCT01171781|Cisplatin|cisplatin|mesh-list
14877271|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877272|NCT01171807|Dexamethasone|dexamethasone|mesh-list
14877273|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14877274|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877275|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
14877276|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
14877277|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877278|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877279|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877280|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
14877281|NCT01171807|Hormones|hormones|mesh-ancestor
14877282|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877283|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14877284|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877285|NCT01171833|Sevoflurane|sevoflurane|mesh-list
14877286|NCT01171833|Desflurane|desflurane|mesh-list
14877287|NCT01171833|Isoflurane|isoflurane|mesh-list
14877288|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14877289|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14877290|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
14877291|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
14877292|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877293|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877294|NCT01171859|Doxycycline|doxycycline|mesh-list
14877295|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14877296|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14877297|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877298|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
14877299|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14877300|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14877301|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
14877302|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15213570|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213571|NCT01758081|Vitamin D|vitamin d|mesh-list
15213572|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
15213573|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
15213574|NCT01758081|Vitamins|vitamins|mesh-list
15213575|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
15213576|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213577|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14877303|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877304|NCT01171885|Ropivacaine|ropivacaine|mesh-list
14877305|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
14877306|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
14877307|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877308|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877309|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
14877310|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877311|NCT01171911|Nicardipine|nicardipine|mesh-list
14877312|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
14877313|NCT01171911|Esmolol|esmolol|mesh-list
14877314|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14877315|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877316|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14877317|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14877318|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14877319|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
14877320|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213578|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15213579|NCT01673867|Docetaxel|docetaxel|mesh-list
15213580|NCT01673867|Nivolumab|nivolumab|mesh-list
15213581|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213582|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213583|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213584|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213585|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213586|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213587|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213588|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
15213589|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213590|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213591|NCT01182727|Analgesics|analgesics|mesh-ancestor
15213592|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
15213593|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213594|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213595|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213596|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213597|NCT01059188|Docetaxel|docetaxel|mesh-list
15213598|NCT01059188|Cetuximab|cetuximab|mesh-list
15213599|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914561|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14877321|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877322|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14877323|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14877324|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914562|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
14914563|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914564|NCT01381536|Belimumab|belimumab|mesh-list
14914565|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14914566|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
14914567|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917344|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14917345|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
14917346|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917347|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917348|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14917349|NCT05268627|Liraglutide|liraglutide|mesh-list
14917350|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14917351|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917352|NCT05268627|Incretins|incretins|mesh-ancestor
14917353|NCT05268627|Hormones|hormones|mesh-ancestor
14917354|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917355|NCT05268562|Ketamine|ketamine|mesh-list
14917356|NCT05268562|Propofol|propofol|mesh-list
14917357|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14917358|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917359|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917360|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14917361|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
14917362|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
14917363|NCT05268562|Analgesics|analgesics|mesh-ancestor
14917364|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
14917365|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917366|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14917367|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14917368|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14917369|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917370|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917371|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
14917372|NCT05268510|Olaparib|olaparib|mesh-list
14917373|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917374|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917375|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14917376|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917377|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917378|NCT05268237|Liraglutide|liraglutide|mesh-list
14917379|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14917380|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917381|NCT05268237|Incretins|incretins|mesh-ancestor
14917382|NCT05268237|Hormones|hormones|mesh-ancestor
14917383|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917384|NCT05268185|Vaccines|vaccines|mesh-list
14917385|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
14917386|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917387|NCT05268120|Doxycycline|doxycycline|mesh-list
14917388|NCT05268120|Rifampin|rifampin|mesh-list
14917389|NCT05268120|Trimethoprim|trimethoprim|mesh-list
14917390|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14917391|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917392|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
14917393|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14917394|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14917395|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14917396|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
14917397|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
14917398|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14917399|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917400|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917401|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14917402|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14917403|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14917404|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14917405|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14917406|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14877325|NCT01171937|Risperidone|risperidone|mesh-list
14877326|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14877327|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
14877328|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877329|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877330|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877331|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14877332|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14877333|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877334|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14877335|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14877336|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
14877337|NCT01172002|Azathioprine|azathioprine|mesh-list
14877338|NCT01172002|Leflunomide|leflunomide|mesh-list
14877339|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
14877340|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714831|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714832|NCT00455026|Remifentanil|remifentanil|mesh-list
14714833|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14714834|NCT00455026|Narcotics|narcotics|mesh-ancestor
14714835|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714836|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877341|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14877342|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877343|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877344|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
14877345|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877346|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14877347|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877348|NCT01172028|Docetaxel|docetaxel|mesh-list
14877349|NCT01172028|Pemetrexed|pemetrexed|mesh-list
14877350|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877351|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14877352|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877353|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14877354|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877355|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877356|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14877357|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877358|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14877359|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14877360|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877361|NCT01172171|Melatonin|melatonin|mesh-list
14877362|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
14877363|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213600|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213601|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213602|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
14296432|NCT05246631|BB 1101|bb 1101|mesh-list
14714837|NCT00455026|Analgesics|analgesics|mesh-ancestor
14714838|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
14714839|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714840|NCT00455039|Lapatinib|lapatinib|mesh-list
14714841|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714842|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14714843|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714844|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877364|NCT01172171|Protective Agents|protective agents|mesh-ancestor
15213603|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213604|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213605|NCT01033552|Cyclosporine|cyclosporine|mesh-list
15213606|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
14714845|NCT00455091|Lamivudine|lamivudine|mesh-list
14914568|NCT01381601|Bevacizumab|bevacizumab|mesh-list
15213607|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
15213608|NCT01033552|Fludarabine|fludarabine|mesh-list
14877365|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877366|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877367|NCT01172223|Paclitaxel|paclitaxel|mesh-list
14877368|NCT01172223|Doxorubicin|doxorubicin|mesh-list
14877369|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14877370|NCT01172223|Lapatinib|lapatinib|mesh-list
14877371|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14877372|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877373|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
14877374|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877375|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
14877376|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877377|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14877378|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14877379|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14877380|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877381|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14877382|NCT01172236|Lactoferrin|lactoferrin|mesh-list
14877383|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877384|NCT01172392|Interferons|interferons|mesh-list
14877385|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
14877386|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
14877387|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14877388|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877389|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
14877390|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877391|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
14877392|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877393|NCT01172405|Ibuprofen|ibuprofen|mesh-list
14877394|NCT01172405|Caffeine|caffeine|mesh-list
14877395|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14877396|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14877397|NCT01172405|Analgesics|analgesics|mesh-ancestor
14877398|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
14877399|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877400|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877401|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877402|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14877403|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14877404|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877405|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877406|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14877407|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14877408|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15213609|NCT01033552|Cyclosporins|cyclosporins|mesh-list
15213610|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15213611|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213612|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
15213613|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213614|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213615|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15213616|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
14877409|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14877410|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
14877411|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877412|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14877413|NCT01172431|Indapamide|indapamide|mesh-list
15213617|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877414|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14296433|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877415|NCT01172431|Diuretics|diuretics|mesh-ancestor
14877416|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
14877417|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877418|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14877419|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14877420|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877421|NCT01172444|Mesalamine|mesalamine|mesh-list
14877422|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14877423|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14877424|NCT01172444|Analgesics|analgesics|mesh-ancestor
14877425|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
14877426|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877427|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877428|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877429|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14877430|NCT01172470|Gemcitabine|gemcitabine|mesh-list
15213618|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213619|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15213620|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213621|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
15213622|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213623|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
15213624|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15213625|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15213626|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15213627|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
15213628|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15213629|NCT00877500|Epothilones|epothilones|mesh-list
14877431|NCT01172470|Carboplatin|carboplatin|mesh-list
14877432|NCT01172470|Pemetrexed|pemetrexed|mesh-list
14877433|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877434|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14877435|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
14877436|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877437|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
14877438|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877439|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877440|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877441|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
14877442|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877443|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14877444|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877445|NCT01172496|Treprostinil|treprostinil|mesh-list
14877446|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14877447|NCT01172509|Baclofen|baclofen|mesh-list
14877448|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14877449|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877450|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14877451|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877452|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14877453|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
14877454|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
14877455|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877456|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877457|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
14877458|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213630|NCT00877500|Epothilone B|epothilone b|mesh-list
14714846|NCT00455091|Adefovir|adefovir|mesh-list
14714847|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14714848|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14714849|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14714850|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714851|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714852|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
14714853|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714854|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14714855|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14714856|NCT00455117|Parecoxib|parecoxib|mesh-list
14714857|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14714858|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14714859|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714860|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714861|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14714862|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14714863|NCT00455117|Analgesics|analgesics|mesh-ancestor
14714864|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
15213631|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213632|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877459|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14877460|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877461|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877462|NCT01172626|Valproic Acid|valproic acid|mesh-list
14877463|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
14877464|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877465|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877466|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
14877467|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877468|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877469|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
14877470|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14877471|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877472|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14877473|NCT01172652|Ziprasidone|ziprasidone|mesh-list
14877474|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14877475|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
14877476|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877477|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877478|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877479|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14877480|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14877481|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877482|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14877483|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14877484|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
14877485|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
14877486|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14877487|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
14877488|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877489|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877490|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14877491|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
14877492|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15213633|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213634|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213635|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213636|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
14296434|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
14296435|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
14296436|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296437|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877493|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
14877494|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877495|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877496|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14877497|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
14877498|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
14877499|NCT01172691|Protective Agents|protective agents|mesh-ancestor
14877500|NCT01172717|Panitumumab|panitumumab|mesh-list
14877501|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14877502|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877503|NCT01172756|Riociguat|riociguat|mesh-list
14877504|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
15213637|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15213638|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
15213639|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
15213640|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213641|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213642|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877505|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877506|NCT01172769|Sirolimus|sirolimus|mesh-list
14877507|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
14877508|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14877509|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877510|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14877511|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877512|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
14877513|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877514|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
14877515|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877516|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877517|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877518|NCT01172782|Hydromorphone|hydromorphone|mesh-list
14877519|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14877520|NCT01172782|Narcotics|narcotics|mesh-ancestor
14877521|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877522|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877523|NCT01172782|Analgesics|analgesics|mesh-ancestor
14877524|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
14877525|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877526|NCT01172912|Dexamethasone|dexamethasone|mesh-list
14877527|NCT01172912|Carboplatin|carboplatin|mesh-list
14877528|NCT01172912|Etoposide|etoposide|mesh-list
14877529|NCT01172912|Ifosfamide|ifosfamide|mesh-list
14877530|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877531|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877532|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
14877533|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
14877534|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877535|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877536|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877537|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
14877538|NCT01172912|Hormones|hormones|mesh-ancestor
14877539|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877540|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14877541|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14877542|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14877543|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14877544|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877545|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877546|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14877547|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
14877548|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
14877549|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14877550|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
14877551|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877552|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877553|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14877554|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
14877555|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
14877556|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14877557|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
14877558|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877559|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877560|NCT01172964|Flucytosine|flucytosine|mesh-list
14877561|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
14877562|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877563|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
14877564|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877565|NCT01173003|Misoprostol|misoprostol|mesh-list
14877566|NCT01173003|Mifepristone|mifepristone|mesh-list
14877567|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14877568|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
14877569|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14877570|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877571|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14877572|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877573|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
14877574|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14877575|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14877576|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14877577|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14877578|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
14877579|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14877580|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14877581|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
14877582|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877583|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
14296438|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877584|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14877585|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14877586|NCT01173068|Ertapenem|ertapenem|mesh-list
14877587|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14877588|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877589|NCT01173081|Teriparatide|teriparatide|mesh-list
14877590|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14877591|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877592|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14877593|NCT01173107|Colchicine|colchicine|mesh-list
14877594|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
14877595|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14877596|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14877597|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877598|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14877599|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877600|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877601|NCT01173172|Boron|boron|mesh-list
14877602|NCT01173172|Trace Elements|trace elements|mesh-ancestor
14877603|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
14877604|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877605|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14877606|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
14877607|NCT01173263|Propofol|propofol|mesh-list
14877608|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14877609|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877610|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714865|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714866|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714867|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714868|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14714869|NCT00455130|Mannitol|mannitol|mesh-list
14714870|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14714871|NCT00455130|Diuretics|diuretics|mesh-ancestor
14714872|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
14714873|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714874|NCT00455234|Promethazine|promethazine|mesh-list
14714875|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
14714876|NCT00455234|Haloperidol|haloperidol|mesh-list
14714877|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
14877611|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14877612|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
14877613|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
14296439|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
14714878|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
14714879|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
14877614|NCT01173315|Vitamins|vitamins|mesh-list
14877615|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
14296440|NCT05246631|Hormones|hormones|mesh-ancestor
14877616|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877617|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
14877618|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14877619|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14877620|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14877621|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14877622|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
14877623|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877624|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14877625|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14877626|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877627|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877628|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14877629|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877630|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
14877631|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14877632|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877633|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14877634|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14877635|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877636|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877637|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877638|NCT01173549|Canagliflozin|canagliflozin|mesh-list
14877639|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14877640|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877641|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14877642|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877643|NCT01173562|Mebendazole|mebendazole|mesh-list
14877644|NCT01173562|Piperazine|piperazine|mesh-list
14877645|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
14877646|NCT01173562|DMP 777|dmp 777|mesh-list
14877647|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
14877648|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
14877649|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14877650|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877651|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14877652|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877653|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14877654|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877655|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877656|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877657|NCT01173627|Fentanyl|fentanyl|mesh-list
14877658|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14877659|NCT01173627|Narcotics|narcotics|mesh-ancestor
14877660|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877661|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877662|NCT01173627|Analgesics|analgesics|mesh-ancestor
14877663|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
14877664|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877665|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14877666|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14877667|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
14877668|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
14327561|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877669|NCT01173640|Midazolam|midazolam|mesh-list
14877670|NCT01173640|Resveratrol|resveratrol|mesh-list
14877671|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14877672|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14877673|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877674|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877675|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14877676|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14877677|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15213643|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213644|NCT00335777|Analgesics|analgesics|mesh-ancestor
15213645|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
15213646|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213647|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
15213648|NCT00159588|Gabapentin|gabapentin|mesh-list
15213649|NCT00159588|Valproic Acid|valproic acid|mesh-list
15213650|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
15213651|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
15213652|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15213653|NCT00159588|Analgesics|analgesics|mesh-ancestor
15213654|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
15213655|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213656|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213657|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
15213658|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15213659|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15213660|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714880|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714881|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714882|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14714883|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14714884|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14714885|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14714886|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14714887|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14714888|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
14714889|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877678|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14877679|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
14877680|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
14877681|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
14877682|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
14877683|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877684|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877685|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
14877686|NCT01173640|Protective Agents|protective agents|mesh-ancestor
14877687|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877688|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914569|NCT01381601|Sunitinib|sunitinib|mesh-list
14914570|NCT01381601|Sorafenib|sorafenib|mesh-list
14914571|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14914572|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914573|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14914574|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15213661|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14914575|NCT01381601|Growth Substances|growth substances|mesh-ancestor
14914576|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877689|NCT01173809|Amiodarone|amiodarone|mesh-list
14877690|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14877691|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
14877692|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14877693|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14877694|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877695|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14877696|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14877697|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14877698|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877699|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14877700|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14877701|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14877702|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
14877703|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877704|NCT01173926|Insulin|insulin|mesh-list
14877705|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14877706|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
14877707|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
14877708|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14877709|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14877710|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877711|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14877712|NCT01173939|Pravastatin|pravastatin|mesh-list
14877713|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14877714|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14877715|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
14877716|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877717|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14877718|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14877719|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877720|NCT01173978|Prednisolone|prednisolone|mesh-list
14877721|NCT01173978|Hormones|hormones|mesh-list
14877722|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877723|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877724|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877725|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
14877726|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14877727|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877728|NCT01174017|Iodine|iodine|mesh-list
14877729|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
14877730|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14877731|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877732|NCT01174017|Trace Elements|trace elements|mesh-ancestor
14877733|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
14877734|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877735|NCT01174056|Pioglitazone|pioglitazone|mesh-list
14877736|NCT01174056|Zileuton|zileuton|mesh-list
14877737|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
14714890|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714891|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14714892|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
14714893|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
14714894|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14714895|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
14714896|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
14714897|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14714898|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14714899|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14714900|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
14714901|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
14714902|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
14714903|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
14714904|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14877738|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14877739|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877740|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14877741|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14877742|NCT01174056|Analgesics|analgesics|mesh-ancestor
14877743|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
14877744|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877745|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14877746|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14877747|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14877748|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877749|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877750|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14877751|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
14877752|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877753|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877754|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
14877755|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877756|NCT01174199|Sirolimus|sirolimus|mesh-list
14877757|NCT01174199|Vorinostat|vorinostat|mesh-list
14877758|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14877759|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877760|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14877761|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877762|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
14877763|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877764|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
14877765|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877766|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14877767|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877768|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877769|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14877770|NCT01174212|Vancomycin|vancomycin|mesh-list
14714905|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14714906|NCT00455286|Prednisolone|prednisolone|mesh-list
14714907|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
14714908|NCT00455286|Methotrexate|methotrexate|mesh-list
14877771|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14877772|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877773|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
14877774|NCT01174290|Haloperidol|haloperidol|mesh-list
14877775|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
14877776|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
14877777|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
14877778|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877779|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877780|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877781|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14877782|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14877783|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877784|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14877785|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14877786|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
14877787|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877788|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877789|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14877790|NCT01174303|Insulin|insulin|mesh-list
14877791|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14877792|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
14877793|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
14877794|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14877795|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
14877796|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14877797|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14877798|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877799|NCT01174394|Fluoxetine|fluoxetine|mesh-list
14877800|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14877801|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14877802|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14877803|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877804|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877805|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
14877806|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877807|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14877808|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
14877809|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14877810|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14877811|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14877812|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877813|NCT01174420|Mitomycins|mitomycins|mesh-list
14877814|NCT01174420|Mitomycin|mitomycin|mesh-list
14877815|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14877816|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877817|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
14877818|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877819|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877820|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877821|NCT01174472|Paclitaxel|paclitaxel|mesh-list
14877822|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14877823|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877824|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14877825|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877826|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14877827|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877828|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14877829|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14877830|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14877831|NCT01174524|Gestodene|gestodene|mesh-list
14877832|NCT01174524|Femovan|femovan|mesh-list
14877833|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
14877834|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
14877835|NCT01174524|Estradiol|estradiol|mesh-list
14877836|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14877837|NCT01174524|Estrogens|estrogens|mesh-ancestor
14877838|NCT01174524|Hormones|hormones|mesh-ancestor
14877839|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877840|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877841|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14877842|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14877843|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14877844|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14877845|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14877846|NCT01174524|Progestins|progestins|mesh-ancestor
14877847|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14877848|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14877849|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877850|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14877851|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877852|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877853|NCT01174693|Clopidogrel|clopidogrel|mesh-list
14877854|NCT01174693|Triflusal|triflusal|mesh-list
14877855|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15213662|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15213663|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15213664|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213665|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213666|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
15213667|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213668|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
15213669|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15213670|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15213671|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
14714909|NCT00455286|Temozolomide|temozolomide|mesh-list
15213672|NCT03060473|Amoxicillin|amoxicillin|mesh-list
15213673|NCT03060473|Azithromycin|azithromycin|mesh-list
15213674|NCT03060473|Erythromycin|erythromycin|mesh-list
15213675|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
14714910|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14714911|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
14714912|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14714913|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
14714914|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14714915|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714916|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14714917|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
14714918|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714919|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714920|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
14714921|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714922|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14714923|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714924|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
14714925|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14714926|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14714927|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14714928|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
14714929|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714930|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
14714931|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
14877856|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15213676|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14877857|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14877858|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14877859|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
14877860|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877861|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877862|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877863|NCT01174810|Exenatide|exenatide|mesh-list
14877864|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14877865|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877866|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14877867|NCT01174810|Incretins|incretins|mesh-ancestor
14877868|NCT01174810|Hormones|hormones|mesh-ancestor
14877869|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877870|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14877871|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
14877872|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877873|NCT01174888|Cytarabine|cytarabine|mesh-list
14877874|NCT01174888|Etoposide|etoposide|mesh-list
14877875|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
14877876|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
14877877|NCT01174888|Bortezomib|bortezomib|mesh-list
14877878|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
14877879|NCT01174888|Midostaurin|midostaurin|mesh-list
14877880|NCT01174888|Staurosporine|staurosporine|mesh-list
14877881|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14877882|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877883|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14877884|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14877885|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877886|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877887|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14877888|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
14877889|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
14877890|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877891|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877892|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
14877893|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877894|NCT01174888|Analgesics|analgesics|mesh-ancestor
14877895|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
14877896|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877897|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
14877898|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
14877899|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14877900|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14877901|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14877902|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14877903|NCT01174914|Tenofovir|tenofovir|mesh-list
14877904|NCT01174914|Lamivudine|lamivudine|mesh-list
14877905|NCT01174914|Emtricitabine|emtricitabine|mesh-list
14877906|NCT01174914|Efavirenz|efavirenz|mesh-list
14877907|NCT01174914|Lopinavir|lopinavir|mesh-list
14877908|NCT01174914|Nevirapine|nevirapine|mesh-list
14877909|NCT01174914|Stavudine|stavudine|mesh-list
14877910|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
14877911|NCT01174914|Naltrexone|naltrexone|mesh-list
14877912|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
14877913|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877914|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14877915|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14877916|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877917|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877918|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14877919|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14877920|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14877921|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14877922|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877923|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
14877924|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877925|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14877926|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14877927|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14877928|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14877929|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14877930|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14877931|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14877932|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14877933|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
14877934|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14877935|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
14877936|NCT01174927|Heroin|heroin|mesh-list
14877937|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14877938|NCT01174927|Narcotics|narcotics|mesh-ancestor
14877939|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14877940|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877941|NCT01174927|Analgesics|analgesics|mesh-ancestor
14877942|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
14877943|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14877944|NCT01174953|Finasteride|finasteride|mesh-list
14877945|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14877946|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14877947|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877948|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877949|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
14877950|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14877951|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877952|NCT01174953|Urological Agents|urological agents|mesh-ancestor
14877953|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
14877954|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14877955|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14877956|NCT01175096|Everolimus|everolimus|mesh-list
14877957|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877958|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14877959|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
14877960|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877961|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
14877962|NCT01175109|Panobinostat|panobinostat|mesh-list
14877963|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877964|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14877965|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877966|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877967|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14877968|NCT01175161|Copper|copper|mesh-list
14877969|NCT01175161|Trace Elements|trace elements|mesh-ancestor
14877970|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
14877971|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877972|NCT01175200|Lansoprazole|lansoprazole|mesh-list
14877973|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
14877974|NCT01175200|Clopidogrel|clopidogrel|mesh-list
14877975|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14877976|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14877977|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14877978|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14877979|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14877980|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
14877981|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14877982|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14877983|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877984|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14877985|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14877986|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14877987|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14877988|NCT01175291|Leucovorin|leucovorin|mesh-list
14877989|NCT01175291|Bevacizumab|bevacizumab|mesh-list
14877990|NCT01175291|Fluorouracil|fluorouracil|mesh-list
14877991|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
14877992|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
14877993|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14877994|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14877995|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14877996|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14877997|NCT01175291|Growth Substances|growth substances|mesh-ancestor
14877998|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14877999|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
14878000|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
14878001|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878002|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14878003|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878004|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
14878005|NCT01175291|Antidotes|antidotes|mesh-ancestor
14878006|NCT01175291|Protective Agents|protective agents|mesh-ancestor
14878007|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
14878008|NCT01175291|Vitamins|vitamins|mesh-ancestor
14878009|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
14878010|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14878011|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14878012|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14878013|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14878014|NCT01175460|Nedaplatin|nedaplatin|mesh-list
14878015|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878016|NCT01175486|Pioglitazone|pioglitazone|mesh-list
14878017|NCT01175486|Acarbose|acarbose|mesh-list
14878018|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14878019|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878020|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14878021|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878022|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878023|NCT01175512|Naltrexone|naltrexone|mesh-list
14878024|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14878025|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14878026|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714932|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878027|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
14878028|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878029|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
14878030|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14878031|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
14714933|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14714934|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
14714935|NCT00455286|Hormones|hormones|mesh-ancestor
14714936|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14714937|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14714938|NCT00455286|Protective Agents|protective agents|mesh-ancestor
14714939|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14714940|NCT00455325|Chloroquine|chloroquine|mesh-list
14714941|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14714942|NCT00455325|Amebicides|amebicides|mesh-ancestor
14714943|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14714944|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14714945|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714946|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
14714947|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878032|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878033|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878034|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878035|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
14714948|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213677|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
15213678|NCT03060473|Ampicillin|ampicillin|mesh-list
15213679|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15213680|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213681|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15213682|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15213683|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213684|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213685|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
15213686|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213687|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
15213688|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213689|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213690|NCT03008382|Metoprolol|metoprolol|mesh-list
15213691|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15213692|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15213693|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
15213694|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
15213695|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213696|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213697|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15213698|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15213699|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15213700|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
14714949|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14714950|NCT00455325|Analgesics|analgesics|mesh-ancestor
14714951|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
14878036|NCT01175538|Lactulose|lactulose|mesh-list
14878037|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14914577|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
14914578|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14914579|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914580|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914581|NCT01381614|Bevacizumab|bevacizumab|mesh-list
14914582|NCT01381614|Sunitinib|sunitinib|mesh-list
14914583|NCT01381614|Sorafenib|sorafenib|mesh-list
14914584|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213701|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213702|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213703|NCT02988401|Insulin|insulin|mesh-list
15213704|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15213705|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213706|NCT02987530|Tenofovir|tenofovir|mesh-list
15213707|NCT02987530|Emtricitabine|emtricitabine|mesh-list
15213708|NCT02987530|Darunavir|darunavir|mesh-list
15213709|NCT02987530|Dolutegravir|dolutegravir|mesh-list
15213710|NCT02987530|Cobicistat|cobicistat|mesh-list
15213711|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
14714952|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14714953|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213712|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914585|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213713|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14878038|NCT01175577|Carotenoids|carotenoids|mesh-list
14878039|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
14878040|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878041|NCT01175577|Protective Agents|protective agents|mesh-ancestor
14878042|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878043|NCT01175733|Panitumumab|panitumumab|mesh-list
14878044|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14878045|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878046|NCT01175746|Nicardipine|nicardipine|mesh-list
14878047|NCT01175746|Remifentanil|remifentanil|mesh-list
14878048|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14878049|NCT01175746|Narcotics|narcotics|mesh-ancestor
14878050|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878051|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878052|NCT01175746|Analgesics|analgesics|mesh-ancestor
14878053|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
14878054|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878055|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14878056|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14878057|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878058|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878059|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14878060|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
14878061|NCT01175772|Celecoxib|celecoxib|mesh-list
14878062|NCT01175772|Methotrexate|methotrexate|mesh-list
14878063|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
14878064|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14878065|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
14878066|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14878067|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878068|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14878069|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
14878070|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878071|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878072|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
14878073|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878074|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14878075|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878076|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
14878077|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878078|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14878079|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14878080|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14878081|NCT01175772|Analgesics|analgesics|mesh-ancestor
14878082|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
14878083|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878084|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878085|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14878086|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14878087|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878088|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
14878089|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14878090|NCT01175954|Lacosamide|lacosamide|mesh-list
14878091|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
14878092|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14878093|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14878094|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878095|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878096|NCT01176175|Progesterone|progesterone|mesh-list
14878097|NCT01176175|Progestins|progestins|mesh-ancestor
14878098|NCT01176175|Hormones|hormones|mesh-ancestor
14878099|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878100|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878101|NCT01176318|Erdosteine|erdosteine|mesh-list
14878102|NCT01176318|Expectorants|expectorants|mesh-ancestor
14878103|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878104|NCT01176344|Vitamin D|vitamin d|mesh-list
14878105|NCT01176344|Vitamins|vitamins|mesh-ancestor
14878106|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
14878107|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878108|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14878109|NCT01176409|Valacyclovir|valacyclovir|mesh-list
14878110|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
14878111|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878112|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
14878113|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
14878114|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14878115|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
14878116|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878117|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
14878118|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878119|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878120|NCT01176669|Apatinib|apatinib|mesh-list
14878121|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213714|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14878122|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14878123|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213715|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213716|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213717|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15213718|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15213719|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15213720|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15213721|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
15213722|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15213723|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15213724|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14878124|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714954|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14714955|NCT00455325|Filaricides|filaricides|mesh-ancestor
14714956|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
14714957|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
14878125|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14878126|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
14878127|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878128|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878129|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14878130|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878131|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
14878132|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14878133|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
14878134|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878135|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878136|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878137|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878138|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14878139|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14878140|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14878141|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878142|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878143|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878144|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14878145|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
14878146|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878147|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878148|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14878149|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878150|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
14878151|NCT01176799|Doxorubicin|doxorubicin|mesh-list
14878152|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14878153|NCT01176799|Sunitinib|sunitinib|mesh-list
14878154|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878155|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
14878156|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878157|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878158|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878159|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
14878160|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878161|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878162|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14878163|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14878164|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14878165|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14878166|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878167|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14878168|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14878169|NCT01176799|Growth Substances|growth substances|mesh-ancestor
14878170|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
14878171|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14878172|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
14878173|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14878174|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14878175|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14878176|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878177|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878178|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878179|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878180|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
14878181|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
14878182|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14714958|NCT00455351|Vorinostat|vorinostat|mesh-list
14714959|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14714960|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14714961|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714962|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213725|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15213726|NCT02965690|Cimetidine|cimetidine|mesh-list
15213727|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15213728|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15213729|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14878183|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
14878184|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878185|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878186|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878187|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878188|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
14878189|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14878190|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878191|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878192|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878193|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14878194|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14878195|NCT01177176|Bupropion|bupropion|mesh-list
14878196|NCT01177176|Nicotine|nicotine|mesh-list
14878197|NCT01177176|Varenicline|varenicline|mesh-list
14878198|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14878199|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
14878200|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878201|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878202|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14878203|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14878204|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878205|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878206|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878207|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14878208|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
14878209|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14878210|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14878211|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14878212|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878213|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
14878214|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14878215|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14878216|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878217|NCT01177306|Guanfacine|guanfacine|mesh-list
14878218|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14878219|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14878220|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14878221|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14878222|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878223|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878224|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878225|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878226|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
14878227|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14878228|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14878229|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14878230|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878231|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878232|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878233|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878234|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878235|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14878236|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914586|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14914587|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14914588|NCT01381614|Growth Substances|growth substances|mesh-ancestor
14914589|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914590|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
14914591|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14914592|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914593|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914594|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
14914595|NCT01381627|Remifentanil|remifentanil|mesh-list
15213730|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
15213731|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
15213732|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225197|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878237|NCT01177371|Cyclosporine|cyclosporine|mesh-list
14878238|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
14878239|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14878240|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14878241|NCT01177371|Prednisolone|prednisolone|mesh-list
14878242|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
14878243|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
14878244|NCT01177371|Busulfan|busulfan|mesh-list
14878245|NCT01177371|Methotrexate|methotrexate|mesh-list
14878246|NCT01177371|Cyclosporins|cyclosporins|mesh-list
14878247|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14878248|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
14878249|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878250|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
14878251|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878252|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878253|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878254|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
14878255|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878256|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878257|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14878258|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14878259|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
14878260|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14878261|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14878262|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
14878263|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
14878264|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878265|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14878266|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14878267|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
14878268|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878269|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14878270|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878271|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
14878272|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
14878273|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878274|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878275|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
14878276|NCT01177371|Hormones|hormones|mesh-ancestor
14878277|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878278|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14878279|NCT01177371|Protective Agents|protective agents|mesh-ancestor
14878280|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14878281|NCT01177423|Anesthetics|anesthetics|mesh-list
14878282|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878283|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878284|NCT01177501|Topotecan|topotecan|mesh-list
14878285|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14878286|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14878287|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878288|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878289|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878290|NCT01177514|Gabapentin|gabapentin|mesh-list
14878291|NCT01177514|Analgesics|analgesics|mesh-ancestor
14878292|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
14878293|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878294|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878295|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
14878296|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14878297|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14878298|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878299|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14878300|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14878301|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14878302|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878303|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878304|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
14878305|NCT01177540|Decitabine|decitabine|mesh-list
14878306|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14878307|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
14878308|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878309|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878310|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878311|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
14878312|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14878313|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14878314|NCT01177566|Analgesics|analgesics|mesh-ancestor
14878315|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
14878316|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878317|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878318|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878319|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878320|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
14878321|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878322|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
14878323|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14878324|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878325|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878326|NCT01177579|Copper|copper|mesh-list
14878327|NCT01177579|Trace Elements|trace elements|mesh-ancestor
14878328|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
14878329|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878330|NCT01177683|Doxorubicin|doxorubicin|mesh-list
14878331|NCT01177683|Bortezomib|bortezomib|mesh-list
14878332|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14878333|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14878334|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878335|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14878336|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14878337|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878338|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878339|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878340|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
14878341|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
14878342|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
14878343|NCT01177852|Promethazine|promethazine|mesh-list
14878344|NCT01177852|Brompheniramine|brompheniramine|mesh-list
14878345|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
14878346|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
14878347|NCT01177852|Ephedrine|ephedrine|mesh-list
14878348|NCT01177852|Dipropizine|dipropizine|mesh-list
14878349|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878350|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14878351|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14878352|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878353|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878354|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
14878355|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
14878356|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
14878357|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878358|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
14878359|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
14878360|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878361|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14878362|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
15213733|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213734|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213735|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15213736|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15213737|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213738|NCT02964182|Nicotine|nicotine|mesh-list
15213739|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15213740|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
15213741|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213742|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213743|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15213744|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15213745|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878363|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
14878364|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878365|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14878366|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
14878367|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14878368|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14878369|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878370|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878371|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
14878372|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14878373|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14878374|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
14878375|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878376|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
14878377|NCT01177904|Progesterone|progesterone|mesh-list
14878378|NCT01177904|Progestins|progestins|mesh-ancestor
14878379|NCT01177904|Hormones|hormones|mesh-ancestor
14878380|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878381|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878382|NCT01178021|Chloroquine|chloroquine|mesh-list
14878383|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14878384|NCT01178021|Primaquine|primaquine|mesh-list
14878385|NCT01178021|Amebicides|amebicides|mesh-ancestor
14878386|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14878387|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14878388|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878389|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
14878390|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878391|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14878392|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14878393|NCT01178021|Analgesics|analgesics|mesh-ancestor
14878394|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
14878395|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878396|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878397|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213746|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213747|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213748|NCT02889809|Fluticasone|fluticasone|mesh-list
15213749|NCT02889809|Xhance|xhance|mesh-list
15213750|NCT02889809|Montelukast|montelukast|mesh-list
15213751|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213752|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15213753|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
15213754|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213755|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213756|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878398|NCT01178021|Filaricides|filaricides|mesh-ancestor
14878399|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
14878400|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
14878401|NCT01178034|Warfarin|warfarin|mesh-list
14878402|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
14878403|NCT01178047|Rasagiline|rasagiline|mesh-list
14878404|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14878405|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878406|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878407|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14878408|NCT01178047|Protective Agents|protective agents|mesh-ancestor
14878409|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878410|NCT01178112|Carboplatin|carboplatin|mesh-list
14878411|NCT01178112|Trientine|trientine|mesh-list
14878412|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878413|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
14878414|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
14878415|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878416|NCT01178151|Everolimus|everolimus|mesh-list
14878417|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878418|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878419|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
14878420|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878421|NCT01178203|Naproxen|naproxen|mesh-list
14878422|NCT01178203|Tramadol|tramadol|mesh-list
14878423|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14878424|NCT01178203|Narcotics|narcotics|mesh-ancestor
14878425|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878426|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878427|NCT01178203|Analgesics|analgesics|mesh-ancestor
14878428|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
14878429|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878430|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14878431|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14878432|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878433|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878434|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
14878435|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14878436|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878437|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878438|NCT01178320|Niacin|niacin|mesh-list
14878439|NCT01178320|Niacinamide|niacinamide|mesh-list
14878440|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
14878441|NCT01178320|Simvastatin|simvastatin|mesh-list
14878442|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14878443|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14878444|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
14878445|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878446|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14878447|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14878448|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878449|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
14878450|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
14878451|NCT01178320|Vitamins|vitamins|mesh-ancestor
14878452|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
14878453|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878454|NCT01178372|Lactulose|lactulose|mesh-list
14878455|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878456|NCT01178450|Cinacalcet|cinacalcet|mesh-list
14878457|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14878458|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878459|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14878460|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
14878461|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878462|NCT01178645|Cytarabine|cytarabine|mesh-list
14878463|NCT01178645|Etoposide|etoposide|mesh-list
14878464|NCT01178645|Melphalan|melphalan|mesh-list
14878465|NCT01178645|Busulfan|busulfan|mesh-list
14878466|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14878467|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878468|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14878469|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14878470|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878471|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213757|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878472|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213758|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
15213759|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15213760|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15213761|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
15213762|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213763|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15213764|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14878473|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
14878474|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
14878475|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878476|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878477|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
14878478|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878479|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878480|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
14878481|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14878482|NCT01178658|Cytarabine|cytarabine|mesh-list
14878483|NCT01178658|Etoposide|etoposide|mesh-list
14878484|NCT01178658|Melphalan|melphalan|mesh-list
14878485|NCT01178658|Busulfan|busulfan|mesh-list
14878486|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14878487|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878488|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14878489|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14878490|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878491|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878492|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14878493|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
14878494|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
14878495|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878496|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878497|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
14878498|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878499|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878500|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
14878501|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14878502|NCT01178697|Triamcinolone|triamcinolone|mesh-list
14878503|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14878504|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14878505|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14878506|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878507|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
14878508|NCT01178697|Hormones|hormones|mesh-ancestor
14878509|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878510|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878511|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878512|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
14878513|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878514|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878515|NCT01178710|Simvastatin|simvastatin|mesh-list
14878516|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14878517|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14878518|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
14878519|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878520|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14878521|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14878522|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878523|NCT01178788|Progesterone|progesterone|mesh-list
14878524|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14878525|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14878526|NCT01178788|Progestins|progestins|mesh-ancestor
14878527|NCT01178788|Hormones|hormones|mesh-ancestor
14878528|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878529|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878530|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14878531|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
14878532|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
14878533|NCT01178931|Progesterone|progesterone|mesh-list
14878534|NCT01178931|Progestins|progestins|mesh-ancestor
14878535|NCT01178931|Hormones|hormones|mesh-ancestor
14878536|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878537|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878538|NCT01178996|Ribavirin|ribavirin|mesh-list
14878539|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14878540|NCT01178996|Thymalfasin|thymalfasin|mesh-list
14878541|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
14878542|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878543|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
14878544|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878545|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14878546|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
14878547|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878548|NCT01179009|Clonidine|clonidine|mesh-list
14878549|NCT01179009|Scopolamine|scopolamine|mesh-list
14878550|NCT01179009|Ketamine|ketamine|mesh-list
14878551|NCT01179009|Lorazepam|lorazepam|mesh-list
14878552|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14878553|NCT01179009|Analgesics|analgesics|mesh-ancestor
14714963|NCT00455364|Voriconazole|voriconazole|mesh-list
14714964|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
14714965|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714966|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14714967|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14714968|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714969|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878554|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
14878555|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878556|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878557|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14878558|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14878559|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
14878560|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
14878561|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878562|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14878563|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14878564|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878565|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878566|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14878567|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
14878568|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
14878569|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14714970|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14714971|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
14714972|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878570|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14878571|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14878572|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878573|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
14878574|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
14878575|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878576|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14878577|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14878578|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14878579|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14878580|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
14878581|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
14878582|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14878583|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
14878584|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14878585|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878586|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14878587|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
14878588|NCT01179100|Lidocaine|lidocaine|mesh-list
14878589|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
14878590|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
14878591|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878592|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878593|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
14878594|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878595|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14878596|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14878597|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14878598|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878599|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914596|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14914597|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14914598|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914599|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914600|NCT01381627|Analgesics|analgesics|mesh-ancestor
14914601|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
14914602|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914603|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14914604|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14914605|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14914606|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
14914607|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914608|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914609|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14914610|NCT01381627|Narcotics|narcotics|mesh-ancestor
14914611|NCT01381640|Acetaminophen|acetaminophen|mesh-list
14914612|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15213765|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213766|NCT02884648|Bevacizumab|bevacizumab|mesh-list
15213767|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213768|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213769|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14914613|NCT01381640|Analgesics|analgesics|mesh-ancestor
14914614|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
14914615|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914616|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914617|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
14914618|NCT01381705|Rituximab|rituximab|mesh-list
14914619|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14914620|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914621|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
14914622|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914623|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914624|NCT01381796|Sumatriptan|sumatriptan|mesh-list
14914625|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15213770|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15213771|NCT02884648|Growth Substances|growth substances|mesh-ancestor
15213772|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914626|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14914627|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14878600|NCT01179152|Budesonide|budesonide|mesh-list
14878601|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
14878602|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878603|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14878604|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
14878605|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878606|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878607|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878608|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878609|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
14878610|NCT01179152|Hormones|hormones|mesh-ancestor
14878611|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878612|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14878613|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14878614|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14878615|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878616|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878617|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878618|NCT01179230|Dipyridamole|dipyridamole|mesh-list
14878619|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14878620|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878621|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878622|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14878623|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
14878624|NCT01179256|Curcumin|curcumin|mesh-list
14878625|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14878626|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14878627|NCT01179256|Analgesics|analgesics|mesh-ancestor
14878628|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
14878629|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878630|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878631|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878632|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878633|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878634|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878635|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878636|NCT01179269|Paclitaxel|paclitaxel|mesh-list
14878637|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14878638|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878639|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
14878640|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
14878641|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
14878642|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878643|NCT01179308|Anesthetics|anesthetics|mesh-list
14878644|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878645|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878646|NCT01179412|Iodine|iodine|mesh-list
14878647|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
14878648|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
14878649|NCT01179412|Povidone|povidone|mesh-list
14878650|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14878651|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878652|NCT01179412|Trace Elements|trace elements|mesh-ancestor
14878653|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
14878654|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878655|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
14878656|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
14878657|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
14878658|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14878659|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878660|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213773|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
15213774|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
15213775|NCT02818023|Vemurafenib|vemurafenib|mesh-list
15213776|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213777|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213778|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213779|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213780|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213781|NCT02815540|Cannabidiol|cannabidiol|mesh-list
15213782|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
15213783|NCT02808572|Mitogens|mitogens|mesh-list
15213784|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213785|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213786|NCT02785224|Vasopressins|vasopressins|mesh-list
14878661|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14878662|NCT01179438|Analgesics|analgesics|mesh-ancestor
14878663|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
14878664|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213787|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
15213788|NCT02785224|Epinephrine|epinephrine|mesh-list
15213789|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14878665|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14878666|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14878667|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14878668|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878669|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878670|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878671|NCT01179464|Simvastatin|simvastatin|mesh-list
14878672|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14878673|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14878674|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
14878675|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878676|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14878677|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14878678|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878679|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
14878680|NCT01179503|Vitamin D|vitamin d|mesh-list
14878681|NCT01179503|Calcium|calcium|mesh-list
14878682|NCT01179503|Vitamins|vitamins|mesh-ancestor
14878683|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
14878684|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878685|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14878686|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14878687|NCT01179529|Omalizumab|omalizumab|mesh-list
14878688|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14878689|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878690|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878691|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14878692|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
14878693|NCT01179594|Entecavir|entecavir|mesh-list
15213790|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15213791|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
15213792|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213793|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213794|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213795|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15213796|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15213797|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
15213798|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213799|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15213800|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
15213801|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
15213802|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
15213803|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15213804|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
15213805|NCT02785224|Coagulants|coagulants|mesh-ancestor
15213806|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15213807|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
14878694|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
15213808|NCT02781883|Decitabine|decitabine|mesh-list
15213809|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14878695|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878696|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
14878697|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878698|NCT01179620|Certoparin|certoparin|mesh-list
14878699|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
14878700|NCT01179646|Pantoprazole|pantoprazole|mesh-list
14878701|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14878702|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878703|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14878704|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878705|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878706|NCT01179659|Pantoprazole|pantoprazole|mesh-list
14878707|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14878708|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878709|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14878710|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878711|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878712|NCT01179724|Pantoprazole|pantoprazole|mesh-list
14878713|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14878714|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14878715|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878716|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878717|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878718|NCT01179776|Iloprost|iloprost|mesh-list
14878719|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14878720|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14878721|NCT01179828|Oxycodone|oxycodone|mesh-list
14878722|NCT01179828|Clobazam|clobazam|mesh-list
14878723|NCT01179828|Imipramine|imipramine|mesh-list
14878724|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14878725|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14878726|NCT01179828|Narcotics|narcotics|mesh-ancestor
14878727|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878728|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878729|NCT01179828|Analgesics|analgesics|mesh-ancestor
14878730|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
14878731|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878732|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14878733|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14878734|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878735|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878736|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878737|NCT01179828|Urological Agents|urological agents|mesh-ancestor
14878738|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14878739|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
14878740|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14878741|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14878742|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14878743|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878744|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878745|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
14878746|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14878747|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14878748|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14878749|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
14878750|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
14878751|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
14878752|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14878753|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14878754|NCT01179971|Analgesics|analgesics|mesh-ancestor
14878755|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
14878756|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878757|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878758|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878759|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878760|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14878761|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
14878762|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878763|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14878764|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
14878765|NCT01180062|Latanoprost|latanoprost|mesh-list
14878766|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14878767|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14878768|NCT01180075|Ritonavir|ritonavir|mesh-list
14878769|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14878770|NCT01180075|Tenofovir|tenofovir|mesh-list
14878771|NCT01180075|Emtricitabine|emtricitabine|mesh-list
14878772|NCT01180075|Efavirenz|efavirenz|mesh-list
14878773|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14878774|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14878775|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
14878776|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878777|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878778|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14878779|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14878780|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
14878781|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878782|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14878783|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14878784|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14878785|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14878786|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14878787|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14878788|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14878789|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14878790|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14878791|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
14878792|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878793|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
14878794|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14878795|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878796|NCT01180179|Lansoprazole|lansoprazole|mesh-list
14878797|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
14878798|NCT01180179|Famotidine|famotidine|mesh-list
14878799|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14878800|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878801|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14878802|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878803|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878804|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14878805|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
14878806|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
14878807|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878808|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878809|NCT01180205|Amlodipine|amlodipine|mesh-list
14878810|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14878811|NCT01180205|Telmisartan|telmisartan|mesh-list
14878812|NCT01180205|Olmesartan|olmesartan|mesh-list
14878813|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14878814|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14878815|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14878816|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878817|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878818|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14878819|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878820|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
14878821|NCT01180205|Diuretics|diuretics|mesh-ancestor
14878822|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
14878823|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14878824|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14878825|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14878826|NCT01180231|Moxonidine|moxonidine|mesh-list
14878827|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14878828|NCT01180322|Cytarabine|cytarabine|mesh-list
14878829|NCT01180322|Etoposide|etoposide|mesh-list
14878830|NCT01180322|Idarubicin|idarubicin|mesh-list
14878831|NCT01180322|Azacitidine|azacitidine|mesh-list
14878832|NCT01180322|Lenograstim|lenograstim|mesh-list
14878833|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14878834|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878835|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14878836|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14878837|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878838|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878839|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14878840|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
14878841|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
14878842|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878843|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14878844|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
14878845|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878846|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14878847|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14878848|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
14296441|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296442|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14296443|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296444|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
14296445|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296446|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878849|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15213810|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
15213811|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213812|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213813|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213814|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15213815|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213816|NCT02778204|Maraviroc|maraviroc|mesh-list
15213817|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15213818|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15213819|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878850|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14878851|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14878852|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878853|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878854|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878855|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878856|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878857|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14878858|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878859|NCT01180413|Losartan|losartan|mesh-list
14878860|NCT01180413|Amlodipine|amlodipine|mesh-list
15213820|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15213821|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14878861|NCT01180413|Ramipril|ramipril|mesh-list
14878862|NCT01180413|Lercanidipine|lercanidipine|mesh-list
14878863|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14878864|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14878865|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14878866|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878867|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14878868|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878869|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
14878870|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14878871|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14878872|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14878873|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14878874|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
14878875|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878876|NCT01180426|Tosedostat|tosedostat|mesh-list
14878877|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878878|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878879|NCT01180569|Lenalidomide|lenalidomide|mesh-list
14878880|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
14878881|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878882|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14878883|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14878884|NCT01180569|Growth Substances|growth substances|mesh-ancestor
14878885|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
14878886|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878887|NCT01180621|Vaccines|vaccines|mesh-list
14878888|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
14878889|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878890|NCT01180725|Psyllium|psyllium|mesh-list
14878891|NCT01180725|Cathartics|cathartics|mesh-ancestor
14878892|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878893|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14878894|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14878895|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878896|NCT01180816|Temozolomide|temozolomide|mesh-list
14878897|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878898|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
14878899|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878900|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914628|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
14914629|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914630|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914631|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914632|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
14914633|NCT01381809|Hematinics|hematinics|mesh-ancestor
14914634|NCT01381835|Simeprevir|simeprevir|mesh-list
14914635|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
14914636|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914637|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
14914638|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914639|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914640|NCT01381848|Doripenem|doripenem|mesh-list
14914641|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15213822|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
14914642|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213823|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15213824|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15213825|NCT02743364|Simvastatin|simvastatin|mesh-list
15213826|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14296447|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14296448|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14878901|NCT01180933|Folic Acid|folic acid|mesh-list
14878902|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
14878903|NCT01180933|Hematinics|hematinics|mesh-ancestor
14878904|NCT01180933|Vitamins|vitamins|mesh-ancestor
14878905|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
14878906|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878907|NCT01180946|Vitamin D|vitamin d|mesh-list
14878908|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
14878909|NCT01180946|Vitamins|vitamins|mesh-ancestor
14878910|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
14878911|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878912|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14878913|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14878914|NCT01180959|Bevacizumab|bevacizumab|mesh-list
14878915|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14878916|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14878917|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878918|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14878919|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14878920|NCT01180959|Growth Substances|growth substances|mesh-ancestor
14878921|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878922|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
14878923|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14878924|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878925|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878926|NCT01181063|Budesonide|budesonide|mesh-list
14878927|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
14878928|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14878929|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14878930|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
14878931|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878932|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878933|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14878934|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
14878935|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
14878936|NCT01181063|Hormones|hormones|mesh-ancestor
14878937|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14878938|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14878939|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14878940|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14878941|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
14878942|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878943|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213827|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15213828|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
15213829|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213830|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15213831|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15213832|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213833|NCT02670044|Venetoclax|venetoclax|mesh-list
15213834|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213835|NCT02648997|Nivolumab|nivolumab|mesh-list
15213836|NCT02648997|Ipilimumab|ipilimumab|mesh-list
15213837|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213838|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213839|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213840|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213841|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
15213842|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296449|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296450|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14878944|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
14878945|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14878946|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
14878947|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878948|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878949|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
14878950|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14878951|NCT01181154|Rituximab|rituximab|mesh-list
14878952|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14878953|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878954|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
14878955|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878956|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14878957|NCT01181193|Vitamin D|vitamin d|mesh-list
14878958|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
14878959|NCT01181193|Temozolomide|temozolomide|mesh-list
14878960|NCT01181193|Vitamins|vitamins|mesh-ancestor
14878961|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
14878962|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878963|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14878964|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14878965|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
14878966|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878967|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14878968|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14878969|NCT01181232|Zolpidem|zolpidem|mesh-list
14878970|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14878971|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14878972|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14878973|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878974|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14878975|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
14878976|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
14878977|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878978|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878979|NCT01181310|Scopolamine|scopolamine|mesh-list
14878980|NCT01181310|Donepezil|donepezil|mesh-list
14878981|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14878982|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14878983|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14878984|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14878985|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
14878986|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14878987|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14878988|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
14878989|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14878990|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
14878991|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
14878992|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14878993|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14878994|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
14878995|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14878996|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14878997|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
14878998|NCT01181388|Tirofiban|tirofiban|mesh-list
14878999|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14879000|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14879001|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879002|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14879003|NCT01181401|Cisplatin|cisplatin|mesh-list
14879004|NCT01181401|Docetaxel|docetaxel|mesh-list
14879005|NCT01181401|Cetuximab|cetuximab|mesh-list
14879006|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879007|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
14879008|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
14879009|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
14879010|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879011|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14879012|NCT01181414|Amiodarone|amiodarone|mesh-list
14879013|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14879014|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14879015|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
14879016|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14879017|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14879018|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879019|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14879020|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14879021|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14879022|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879023|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14879024|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14879025|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14879026|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14879027|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
14879028|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879029|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879030|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
14879031|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879032|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879033|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14879034|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14879035|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14879036|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
14879037|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879038|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879039|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879040|NCT01181505|Urological Agents|urological agents|mesh-ancestor
14714973|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714974|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14714975|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
14714976|NCT00455416|Selenium|selenium|mesh-list
14714977|NCT00455416|Allicin|allicin|mesh-list
14714978|NCT00455416|Resveratrol|resveratrol|mesh-list
14714979|NCT00455416|Quercetin|quercetin|mesh-list
14714980|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
14714981|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14714982|NCT00455416|Protective Agents|protective agents|mesh-ancestor
14714983|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714984|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14714985|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14879041|NCT01181544|Heparin|heparin|mesh-list
14879042|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
14879043|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14879044|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14879045|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879046|NCT01181570|Adalimumab|adalimumab|mesh-list
14879047|NCT01181570|Mannitol|mannitol|mesh-list
14879048|NCT01181570|Citric Acid|citric acid|mesh-list
14879049|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
14879050|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
14879051|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14879052|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
14879053|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
14879054|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879055|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879056|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879057|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14879058|NCT01181570|Diuretics|diuretics|mesh-ancestor
14879059|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
14879060|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879061|NCT01181765|Infliximab|infliximab|mesh-list
14879062|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
14879063|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879064|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879065|NCT01181882|Aspirin|aspirin|mesh-list
14879066|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14879067|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14879068|NCT01181882|Analgesics|analgesics|mesh-ancestor
14879069|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
14879070|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879071|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879072|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879073|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879074|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14879075|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14879076|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879077|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14879078|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14879079|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879080|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
14879081|NCT01181934|Nicotine|nicotine|mesh-list
14879082|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14879083|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
14879084|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879085|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879086|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14879087|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14879088|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
14879089|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879090|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879091|NCT01181960|Risperidone|risperidone|mesh-list
14879092|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14879093|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
14879094|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14879095|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
14879096|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879097|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879098|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879099|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879100|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879101|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15213843|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213844|NCT02560298|Paclitaxel|paclitaxel|mesh-list
15213845|NCT02560298|Cisplatin|cisplatin|mesh-list
15213846|NCT02560298|Carboplatin|carboplatin|mesh-list
15213847|NCT02560298|Fluorouracil|fluorouracil|mesh-list
15213848|NCT02560298|Capecitabine|capecitabine|mesh-list
15213849|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15213850|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15213851|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213852|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213853|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213854|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213855|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879102|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14879103|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
14879104|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15213856|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
14296451|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14714986|NCT00455416|Trace Elements|trace elements|mesh-ancestor
14714987|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
14714988|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14714989|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15213857|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213858|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14714990|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
14714991|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14714992|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14714993|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14879105|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14879106|NCT01181999|Rituximab|rituximab|mesh-list
14714994|NCT00455442|Mifepristone|mifepristone|mesh-list
14714995|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14714996|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
14714997|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14879107|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14879108|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879109|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
14879110|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879111|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879112|NCT01182077|Midazolam|midazolam|mesh-list
14879113|NCT01182077|Peficitinib|peficitinib|mesh-list
14879114|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14879115|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14879116|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879117|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879118|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14879119|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879120|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879121|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14879122|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
14879123|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
14879124|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
14879125|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
14879126|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879127|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879128|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879129|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879130|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
14879131|NCT01182129|Nicotine|nicotine|mesh-list
14879132|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14879133|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
14879134|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879135|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879136|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14879137|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14879138|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
14879139|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879140|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879141|NCT01182142|Capecitabine|capecitabine|mesh-list
14879142|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14879143|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
14879144|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879145|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879146|NCT01182168|Gemcitabine|gemcitabine|mesh-list
14879147|NCT01182168|Everolimus|everolimus|mesh-list
14879148|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879149|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14879150|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
14879151|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879152|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
14879153|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879154|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879155|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879156|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
15213859|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
15213860|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213861|NCT02547493|Abatacept|abatacept|mesh-list
15213862|NCT02547493|Vaccines|vaccines|mesh-list
15213863|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15213864|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
15213865|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213866|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15213867|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879157|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879158|NCT01182246|Genistein|genistein|mesh-list
14879159|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14879160|NCT01182246|Protective Agents|protective agents|mesh-ancestor
14879161|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879162|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879163|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14879164|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879165|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879166|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
14879167|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14879168|NCT01182246|Estrogens|estrogens|mesh-ancestor
14879169|NCT01182246|Hormones|hormones|mesh-ancestor
14879170|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14879171|NCT01182272|Sorafenib|sorafenib|mesh-list
14879172|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879173|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14879174|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879175|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879176|NCT01182597|Pantoprazole|pantoprazole|mesh-list
14879177|NCT01182597|Lansoprazole|lansoprazole|mesh-list
14879178|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
14879179|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14879180|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879181|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14879182|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879183|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879184|NCT01182636|Adapalene|adapalene|mesh-list
14879185|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14879186|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14879187|NCT01182636|Analgesics|analgesics|mesh-ancestor
14879188|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
14879189|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879190|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879191|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879192|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879193|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14879194|NCT01182662|Cyclosporine|cyclosporine|mesh-list
14879195|NCT01182662|Cyclosporins|cyclosporins|mesh-list
14879196|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879197|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879198|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879199|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
14879200|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879201|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
14879202|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879203|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14879204|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879205|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14914643|NCT01381887|Canagliflozin|canagliflozin|mesh-list
14914644|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14914645|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914646|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14879206|NCT01182766|Topiramate|topiramate|mesh-list
14879207|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
14879208|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14879209|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879210|NCT01182792|Ascorbic Acid|ascorbic acid|mesh-list
14879211|NCT01182792|Vitamins|vitamins|mesh-ancestor
14879212|NCT01182792|Micronutrients|micronutrients|mesh-ancestor
14879213|NCT01182792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879214|NCT01182792|Antioxidants|antioxidants|mesh-ancestor
14879215|NCT01182792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879216|NCT01182792|Protective Agents|protective agents|mesh-ancestor
14879217|NCT01182883|Sirolimus|sirolimus|mesh-list
14879218|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14879219|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879220|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14879221|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879222|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
14879223|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879224|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
14879225|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879226|NCT01182974|Acetaminophen|acetaminophen|mesh-list
14879227|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14879228|NCT01182974|Analgesics|analgesics|mesh-ancestor
14879229|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
14879230|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879231|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879232|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
14879233|NCT01183247|Sirolimus|sirolimus|mesh-list
14879234|NCT01183247|Prednisone|prednisone|mesh-list
14879235|NCT01183247|Everolimus|everolimus|mesh-list
14879236|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879237|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
14879238|NCT01183247|Hormones|hormones|mesh-ancestor
14879239|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14879240|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879241|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14879242|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879243|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879244|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
14879245|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14879246|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879247|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14879248|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
14879249|NCT01183364|Docetaxel|docetaxel|mesh-list
14879250|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879251|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
14879252|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
14879253|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
14879254|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879255|NCT01183442|Vitamin D|vitamin d|mesh-list
14879256|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
14879257|NCT01183442|Vitamins|vitamins|mesh-list
14879258|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
14879259|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879260|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14879261|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14879262|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
14879263|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14879264|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879265|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879266|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14879267|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14879268|NCT01183494|Irinotecan|irinotecan|mesh-list
14879269|NCT01183494|Bevacizumab|bevacizumab|mesh-list
14879270|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14879271|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14879272|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879273|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879274|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879275|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14879276|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14879277|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14879278|NCT01183494|Growth Substances|growth substances|mesh-ancestor
14879279|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879280|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
14879281|NCT01183572|Iron|iron|mesh-list
14879282|NCT01183572|Folic Acid|folic acid|mesh-list
14879283|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
14879284|NCT01183572|Trace Elements|trace elements|mesh-ancestor
14879285|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
14879286|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879287|NCT01183572|Hematinics|hematinics|mesh-ancestor
14879288|NCT01183572|Vitamins|vitamins|mesh-ancestor
14879289|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14879290|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14879291|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14879292|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
14879293|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879294|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14879295|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14879296|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879297|NCT01183611|Vaccines|vaccines|mesh-list
14879298|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
14879299|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879300|NCT01183624|Analgesics|analgesics|mesh-list
14879301|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
14879302|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879303|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879304|NCT01183663|Leucovorin|leucovorin|mesh-list
14879305|NCT01183663|Sirolimus|sirolimus|mesh-list
14879306|NCT01183663|Bevacizumab|bevacizumab|mesh-list
14879307|NCT01183663|Lenalidomide|lenalidomide|mesh-list
14879308|NCT01183663|Fluorouracil|fluorouracil|mesh-list
14879309|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
14879310|NCT01183663|Sorafenib|sorafenib|mesh-list
14879311|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14879312|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879313|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14879314|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14879315|NCT01183663|Growth Substances|growth substances|mesh-ancestor
14879316|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879317|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14879318|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
14879319|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879320|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14879321|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879322|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
14879323|NCT01183663|Antidotes|antidotes|mesh-ancestor
14879324|NCT01183663|Protective Agents|protective agents|mesh-ancestor
14879325|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
14879326|NCT01183663|Vitamins|vitamins|mesh-ancestor
14879327|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
14879328|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14879329|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879330|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14879331|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879332|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14879333|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
14879334|NCT01183676|Valproic Acid|valproic acid|mesh-list
14879335|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
14879336|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879337|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879338|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
14879339|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879340|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879341|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
14879342|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879343|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879344|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879345|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14879346|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
14879347|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879348|NCT01183767|Protective Agents|protective agents|mesh-ancestor
14879349|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879350|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14879351|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14879352|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879353|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14879354|NCT01183806|Rivastigmine|rivastigmine|mesh-list
14879355|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14879356|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879357|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879358|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
14879359|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879360|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879361|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14879362|NCT01183806|Protective Agents|protective agents|mesh-ancestor
14879363|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
14879364|NCT01183910|Calcium|calcium|mesh-list
14879365|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14879366|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879367|NCT01183910|Antacids|antacids|mesh-ancestor
14879368|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879369|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879370|NCT01183962|Vitamin D|vitamin d|mesh-list
14879371|NCT01183962|Vitamins|vitamins|mesh-ancestor
14879372|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
14879373|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879374|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14879375|NCT01184144|Pioglitazone|pioglitazone|mesh-list
14879376|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14879377|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879378|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
14879379|NCT01184196|Povidone|povidone|mesh-list
14879380|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
14879381|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
14879382|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14879383|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879384|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
14879385|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
14879386|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879387|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879388|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879389|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879390|NCT01184287|Ranpirnase|ranpirnase|mesh-list
14879391|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879392|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14879393|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879394|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879395|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14879396|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14879397|NCT01184378|Caseins|caseins|mesh-list
14879398|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
14879399|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
14879400|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879401|NCT01184391|Valproic Acid|valproic acid|mesh-list
14879402|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
14879403|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879404|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879405|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
14879406|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879407|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879408|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
14879409|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879410|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879411|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879412|NCT01184404|Bosentan|bosentan|mesh-list
14879413|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14879414|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14879415|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879416|NCT01184443|Olanzapine|olanzapine|mesh-list
14879417|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
14879418|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
14879419|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879420|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879421|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296452|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
14879422|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14879423|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879424|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879425|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15213868|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213869|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213870|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15213871|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
14879426|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14879427|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14879428|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14879429|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879430|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879431|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
14879432|NCT01184482|Cetuximab|cetuximab|mesh-list
14879433|NCT01184482|Lapatinib|lapatinib|mesh-list
14879434|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14879435|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879436|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14879437|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879438|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879439|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
14879440|NCT01184495|Hematinics|hematinics|mesh-ancestor
14914647|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914648|NCT01382004|Azithromycin|azithromycin|mesh-list
14914649|NCT01382004|Penicillins|penicillins|mesh-list
14914650|NCT01382004|Penicillin G|penicillin g|mesh-list
14914651|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14914652|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
14914653|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914654|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914655|NCT01382017|Lacosamide|lacosamide|mesh-list
14914656|NCT01382017|Carbamazepine|carbamazepine|mesh-list
14914657|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
14914658|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14914659|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14914660|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14914661|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914662|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
14914663|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14914664|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14914665|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914666|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14914667|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14914668|NCT01382017|Analgesics|analgesics|mesh-ancestor
14914669|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
14914670|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914671|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14914672|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14914673|NCT01382134|Aspirin|aspirin|mesh-list
14914674|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14914675|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15213872|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15213873|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213874|NCT02496611|Exenatide|exenatide|mesh-list
15213875|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15213876|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213877|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15213878|NCT02496611|Incretins|incretins|mesh-ancestor
15213879|NCT02496611|Hormones|hormones|mesh-ancestor
15225198|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14879441|NCT01184560|Orlistat|orlistat|mesh-list
14879442|NCT01184560|Sibutramine|sibutramine|mesh-list
14879443|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879444|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879445|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14879446|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14879447|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
14879448|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879449|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
14879450|NCT01184638|Propofol|propofol|mesh-list
14879451|NCT01184638|Sevoflurane|sevoflurane|mesh-list
14879452|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14879453|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879454|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879455|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14879456|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
14879457|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
14879458|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14879459|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14879460|NCT01184664|Nicotine|nicotine|mesh-list
14879461|NCT01184664|Varenicline|varenicline|mesh-list
14879462|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14879463|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
14879464|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879465|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879466|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14879467|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14879468|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
14879469|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879470|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879471|NCT01184716|Vitamin D|vitamin d|mesh-list
14879472|NCT01184716|Vitamins|vitamins|mesh-ancestor
14879473|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
14879474|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879475|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14879476|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
14879477|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
14879478|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
14879479|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879480|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879481|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
14879482|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879483|NCT01184820|Factor VIII|factor viii|mesh-list
14879484|NCT01184820|Coagulants|coagulants|mesh-ancestor
14879485|NCT01184833|Interferons|interferons|mesh-list
14879486|NCT01184833|Interferon-beta|interferon-beta|mesh-list
14879487|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
14879488|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879489|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
14879490|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879491|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
14879492|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879493|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14879494|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
14879495|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
14879496|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14879497|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
14879498|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14879499|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14879500|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879501|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14879502|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879503|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879504|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14879505|NCT01184911|Renal Agents|renal agents|mesh-ancestor
14879506|NCT01185015|Nicorandil|nicorandil|mesh-list
14714998|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14714999|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14715000|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14715001|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14715002|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
14715003|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14715004|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14715005|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
14879507|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14879508|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14879509|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
14879510|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
14879511|NCT01185015|Vitamins|vitamins|mesh-ancestor
14879512|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
14879513|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879514|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
14879515|NCT01185067|Resveratrol|resveratrol|mesh-list
14879516|NCT01185067|Antioxidants|antioxidants|mesh-list
14879517|NCT01185067|Quercetin|quercetin|mesh-list
14879518|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879519|NCT01185067|Protective Agents|protective agents|mesh-ancestor
14879520|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879521|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879522|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14879523|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14879524|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879525|NCT01185119|Glucagon|glucagon|mesh-list
14879526|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14879527|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879528|NCT01185119|Hormones|hormones|mesh-ancestor
14879529|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14879530|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879531|NCT01185119|Incretins|incretins|mesh-ancestor
14879532|NCT01185158|Gefitinib|gefitinib|mesh-list
14879533|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879534|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14879535|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879536|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879537|NCT01185184|Tofacitinib|tofacitinib|mesh-list
14879538|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14879539|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879540|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879541|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
14879542|NCT01185197|Prednisolone|prednisolone|mesh-list
14879543|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14879544|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879545|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14879546|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
14879547|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14879548|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879549|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879550|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879551|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879552|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
14879553|NCT01185197|Hormones|hormones|mesh-ancestor
14879554|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14879555|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879556|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14879557|NCT01185223|Valganciclovir|valganciclovir|mesh-list
14879558|NCT01185223|Ganciclovir|ganciclovir|mesh-list
14879559|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14879560|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
14879561|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879562|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14879563|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879564|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879565|NCT01185236|Atorvastatin|atorvastatin|mesh-list
14879566|NCT01185236|Simvastatin|simvastatin|mesh-list
14879567|NCT01185236|Ezetimibe|ezetimibe|mesh-list
14879568|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14879569|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14879570|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
14879571|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879572|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14879573|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14879574|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879575|NCT01185262|Rituximab|rituximab|mesh-list
14879576|NCT01185262|Lenalidomide|lenalidomide|mesh-list
14879577|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14879578|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879579|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
14879580|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879581|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879582|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14879583|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14879584|NCT01185262|Growth Substances|growth substances|mesh-ancestor
14879585|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
14879586|NCT01185405|Voriconazole|voriconazole|mesh-list
14879587|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
14879588|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879589|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14879590|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14879591|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879592|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879593|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14879594|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
14879595|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14879596|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879597|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14879598|NCT01185418|Haloperidol|haloperidol|mesh-list
14879599|NCT01185418|Risperidone|risperidone|mesh-list
14879600|NCT01185418|Aripiprazole|aripiprazole|mesh-list
14879601|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
14879602|NCT01185418|Amisulpride|amisulpride|mesh-list
14879603|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14879604|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
14879605|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879606|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879607|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879608|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14879609|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879610|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879611|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879612|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14879613|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
14879614|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
14879615|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
14879616|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14879617|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14879618|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14879619|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14879620|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
14879621|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
14879622|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879623|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879624|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14879625|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14879626|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
14879627|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14879628|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
14879629|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879630|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
14879631|NCT01185444|Protective Agents|protective agents|mesh-ancestor
14879632|NCT01185470|Morphine|morphine|mesh-list
14879633|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14879634|NCT01185470|Narcotics|narcotics|mesh-ancestor
14879635|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879636|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879637|NCT01185470|Analgesics|analgesics|mesh-ancestor
14879638|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
14879639|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879640|NCT01185535|Anesthetics|anesthetics|mesh-list
14879641|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879642|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879643|NCT01185574|Vitamin D|vitamin d|mesh-list
14879644|NCT01185574|Vitamins|vitamins|mesh-ancestor
14879645|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
14879646|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879647|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14879648|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
14879649|NCT01185678|Desogestrel|desogestrel|mesh-list
14879650|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
14879651|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14879652|NCT01185678|Progestins|progestins|mesh-list
14879653|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14879654|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879655|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14879656|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14879657|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15213880|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225199|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15225200|NCT05191875|Renal Agents|renal agents|mesh-ancestor
15225201|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15225202|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15225203|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225204|NCT05191862|Cilostazol|cilostazol|mesh-list
14879658|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14879659|NCT01185678|Hormones|hormones|mesh-ancestor
14914676|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15225205|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15225206|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
15225207|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225208|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225209|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15225210|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
15225211|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15225212|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15225213|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225214|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15225215|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
15225216|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15225217|NCT05191862|Protective Agents|protective agents|mesh-ancestor
15225218|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15225219|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15225220|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225221|NCT05189483|Paclitaxel|paclitaxel|mesh-list
15225222|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15225223|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225224|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225225|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
14879660|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14879661|NCT01185743|Olanzapine|olanzapine|mesh-list
14879662|NCT01185743|Ziprasidone|ziprasidone|mesh-list
14879663|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
14879664|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
14879665|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879666|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879667|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879668|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14879669|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14879670|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879671|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879672|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14879673|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14879674|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14879675|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879676|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879677|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
14879678|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14879679|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14879680|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
14879681|NCT01185769|Tocotrienols|tocotrienols|mesh-list
14879682|NCT01185769|Vitamin E|vitamin e|mesh-list
14879683|NCT01185769|Tocopherols|tocopherols|mesh-list
14879684|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
14879685|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879686|NCT01185769|Protective Agents|protective agents|mesh-ancestor
14879687|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879688|NCT01185769|Vitamins|vitamins|mesh-ancestor
14879689|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
14914677|NCT01382134|Analgesics|analgesics|mesh-ancestor
14914678|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
14914679|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914680|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914681|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914682|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914683|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14914684|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14914685|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914686|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914687|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14914688|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914689|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
14914690|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
14914691|NCT01382134|Coagulants|coagulants|mesh-ancestor
14914692|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14914693|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
14914694|NCT01382147|Daunorubicin|daunorubicin|mesh-list
14914695|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
14914696|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14914697|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914698|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14914699|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14914700|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914701|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914702|NCT01382147|Analgesics|analgesics|mesh-ancestor
14914703|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
14914704|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914705|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914706|NCT01382160|Adalimumab|adalimumab|mesh-list
14715006|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715007|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
14715008|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14715009|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14715010|NCT00455507|Istradefylline|istradefylline|mesh-list
14715011|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14715012|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14715013|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14715014|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
14715015|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914707|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914708|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914709|NCT01382199|Lactoferrin|lactoferrin|mesh-list
14914710|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914711|NCT01382238|Dolutegravir|dolutegravir|mesh-list
15213881|NCT02476097|Esomeprazole|esomeprazole|mesh-list
15213882|NCT02476097|Omeprazole|omeprazole|mesh-list
15213883|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15213884|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15213885|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15213886|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213887|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213888|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15213889|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
15213890|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15213891|NCT02459392|Prednisolone|prednisolone|mesh-list
15213892|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
15213893|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
15213894|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15213895|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
15213896|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15213897|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
15213898|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213899|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
15213900|NCT02459392|Protective Agents|protective agents|mesh-ancestor
15213901|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15213902|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
14879690|NCT01185808|Vitamin D|vitamin d|mesh-list
14879691|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
14879692|NCT01185808|Vitamins|vitamins|mesh-list
14715016|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715017|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715018|NCT00455572|Vinorelbine|vinorelbine|mesh-list
14715019|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715020|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14715021|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
14715022|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
14715023|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
14715024|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715025|NCT00455585|Lamivudine|lamivudine|mesh-list
15213903|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
14879693|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
15213904|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213905|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879694|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879695|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14879696|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14879697|NCT01185847|Gemcitabine|gemcitabine|mesh-list
14879698|NCT01185847|Pemetrexed|pemetrexed|mesh-list
14879699|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879700|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14879701|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
14879702|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296453|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296454|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14296455|NCT05246514|Trastuzumab|trastuzumab|mesh-list
14296456|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296457|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296458|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
14879703|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
14879704|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879705|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879706|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879707|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
14879708|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879709|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14879710|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14879711|NCT01185860|Ritonavir|ritonavir|mesh-list
14879712|NCT01185860|Ribavirin|ribavirin|mesh-list
14879713|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14879714|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14879715|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14879716|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
14879717|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879718|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879719|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14879720|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14879721|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
14879722|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879723|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14879724|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14879725|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
14879726|NCT01185873|Ritonavir|ritonavir|mesh-list
14879727|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14879728|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14879729|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
14879730|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879731|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879732|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14879733|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14879734|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
14879735|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879736|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14296459|NCT05246371|Propofol|propofol|mesh-list
14879737|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14879738|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
14879739|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
14879740|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14879741|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14879742|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879743|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879744|NCT01185925|Urological Agents|urological agents|mesh-ancestor
14879745|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14879746|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14879747|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14879748|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
14879749|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879750|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14879751|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14879752|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879753|NCT01185951|Polidocanol|polidocanol|mesh-list
14879754|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14879755|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14879756|NCT01185977|Fluoxetine|fluoxetine|mesh-list
14879757|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14879758|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14879759|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14879760|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879761|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879762|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
14879763|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879764|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14879765|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
14879766|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14879767|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14879768|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14879769|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879770|NCT01186029|Aprepitant|aprepitant|mesh-list
14879771|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
14879772|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
14715026|NCT00455585|Nevirapine|nevirapine|mesh-list
14715027|NCT00455585|Stavudine|stavudine|mesh-list
14715028|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14715029|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14715030|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715031|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715032|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
14715033|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715034|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14715035|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14715036|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14715037|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14715038|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
14715039|NCT00455624|Androgens|androgens|mesh-list
14715040|NCT00455624|Hormones|hormones|mesh-ancestor
14715041|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213906|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
15213907|NCT02459392|Hormones|hormones|mesh-ancestor
15213908|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213909|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15213910|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15213911|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213912|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
15213913|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715042|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715043|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
14715044|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14715045|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14715046|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14715047|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715048|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715049|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
14715050|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715051|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715052|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14715053|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715054|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
14715055|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
14715056|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14715057|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14715058|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715059|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715060|NCT00455715|Urological Agents|urological agents|mesh-ancestor
14715061|NCT00455754|Esomeprazole|esomeprazole|mesh-list
14715062|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14715063|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879773|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879774|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879775|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879776|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14879777|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879778|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879779|NCT01186094|Sirolimus|sirolimus|mesh-list
14879780|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14879781|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879782|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14879783|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879784|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
14879785|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879786|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
14879787|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879788|NCT01186120|Umirolimus|umirolimus|mesh-list
14879789|NCT01186120|Everolimus|everolimus|mesh-list
14879790|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715064|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14715065|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715066|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715067|NCT00455806|Amoxicillin|amoxicillin|mesh-list
14715068|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
14715069|NCT00455806|Esomeprazole|esomeprazole|mesh-list
14715070|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14715071|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715072|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14715073|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14715074|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715075|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715076|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715077|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14715078|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14715079|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14715080|NCT00455832|Ribavirin|ribavirin|mesh-list
14715081|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
14715082|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715083|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
14879791|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14879792|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
14879793|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879794|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879795|NCT01186146|Aspirin|aspirin|mesh-list
14879796|NCT01186146|Clopidogrel|clopidogrel|mesh-list
14879797|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14715084|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715085|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
14879798|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14879799|NCT01186146|Analgesics|analgesics|mesh-ancestor
14879800|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
14879801|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879802|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879803|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879804|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879805|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14879806|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14879807|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879808|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14879809|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14879810|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879811|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
14879812|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14879813|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14879814|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14879815|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
14879816|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879817|NCT01186159|Parecoxib|parecoxib|mesh-list
14879818|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14879819|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14879820|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879821|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879822|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14879823|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14879824|NCT01186159|Analgesics|analgesics|mesh-ancestor
14879825|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
14879826|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879827|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879828|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879829|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879830|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14879831|NCT01186172|Ethanol|ethanol|mesh-list
14879832|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879833|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14879834|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879835|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879836|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
14879837|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879838|NCT01186224|Plerixafor|plerixafor|mesh-list
14879839|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14879840|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14879841|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
14879842|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914712|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14914713|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14914714|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914715|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914716|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14914717|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14914718|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
14914719|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914720|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14914721|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14914722|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14914723|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
14914724|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914725|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914726|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14914727|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715086|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14715087|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
14879843|NCT01186289|Atorvastatin|atorvastatin|mesh-list
14879844|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14879845|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14879846|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
14879847|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879848|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14879849|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14879850|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879851|NCT01186445|Morphine|morphine|mesh-list
14879852|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14879853|NCT01186445|Narcotics|narcotics|mesh-ancestor
14879854|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879855|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879856|NCT01186445|Analgesics|analgesics|mesh-ancestor
14879857|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
14879858|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879859|NCT01186471|Nicotine|nicotine|mesh-list
14879860|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14879861|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
14879862|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879863|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879864|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14879865|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14879866|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
14879867|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879868|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879869|NCT01186497|Rabeprazole|rabeprazole|mesh-list
14879870|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14879871|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14879872|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14879873|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879874|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879875|NCT01186549|Lidocaine|lidocaine|mesh-list
14879876|NCT01186549|Ephedrine|ephedrine|mesh-list
14879877|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
14879878|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
14879879|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
14879880|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14879881|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879882|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
14879883|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879884|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14879885|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14879886|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14879887|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14879888|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879889|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14879890|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
14715088|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14715089|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715090|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14715091|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14715092|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14715093|NCT00455871|Ranibizumab|ranibizumab|mesh-list
14715094|NCT00455871|Verteporfin|verteporfin|mesh-list
14715095|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715096|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715097|NCT00455871|Growth Substances|growth substances|mesh-ancestor
14715098|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879891|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
14715099|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
14879892|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14879893|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
14879894|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879895|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14879896|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14879897|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
14879898|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
14879899|NCT01186588|Canagliflozin|canagliflozin|mesh-list
14879900|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14879901|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879902|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14879903|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879904|NCT01186653|Fluticasone|fluticasone|mesh-list
14879905|NCT01186653|Budesonide|budesonide|mesh-list
14879906|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
14879907|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14879908|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14879909|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879910|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14879911|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
14879912|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879913|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879914|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14879915|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
14879916|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
14879917|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14879918|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
14879919|NCT01186653|Hormones|hormones|mesh-ancestor
14879920|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14879921|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14879922|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14879923|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14879924|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
14879925|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879926|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879927|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
14879928|NCT01186731|Docetaxel|docetaxel|mesh-list
14879929|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879930|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
14879931|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
14879932|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
14879933|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879934|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
14879935|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14879936|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14879937|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
14879938|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14879939|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14879940|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879941|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
14879942|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14879943|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879944|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14879945|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
14879946|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
14879947|NCT01186835|Protective Agents|protective agents|mesh-ancestor
14879948|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14879949|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879950|NCT01186887|Celecoxib|celecoxib|mesh-list
14879951|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14879952|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14879953|NCT01186887|Analgesics|analgesics|mesh-ancestor
14879954|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
14879955|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14879956|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879957|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14879958|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14879959|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14879960|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14879961|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879962|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879963|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
14296460|NCT05246371|Desflurane|desflurane|mesh-list
14879964|NCT01187108|Acetazolamide|acetazolamide|mesh-list
14879965|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14879966|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
14879967|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14879968|NCT01187108|Expectorants|expectorants|mesh-ancestor
14879969|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
14879970|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14879971|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
14879972|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879973|NCT01187108|Protective Agents|protective agents|mesh-ancestor
14879974|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879975|NCT01187108|Antidotes|antidotes|mesh-ancestor
14879976|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
14879977|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14879978|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879979|NCT01187108|Diuretics|diuretics|mesh-ancestor
14879980|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
14879981|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
14879982|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14879983|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879984|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14879985|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14879986|NCT01187212|Cisplatin|cisplatin|mesh-list
14879987|NCT01187212|Capecitabine|capecitabine|mesh-list
14879988|NCT01187212|Sorafenib|sorafenib|mesh-list
14879989|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879990|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14879991|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
14879992|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14879993|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14879994|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14879995|NCT01187238|Cisplatin|cisplatin|mesh-list
14879996|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14879997|NCT01187264|Methotrexate|methotrexate|mesh-list
14879998|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14879999|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
14880000|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14880001|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880002|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14880003|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
14880004|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880005|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880006|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
14880007|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880008|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14880009|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14880010|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
14880011|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880012|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880013|NCT01187303|Ofatumumab|ofatumumab|mesh-list
14880014|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880015|NCT01187459|Vitamin D|vitamin d|mesh-list
14880016|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
14880017|NCT01187459|Vitamins|vitamins|mesh-list
14880018|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
14880019|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880020|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14880021|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14880022|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
14715100|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715101|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14715102|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728876|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880023|NCT01187485|Testosterone|testosterone|mesh-list
14880024|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
14880025|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
14880026|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14880027|NCT01187485|Androgens|androgens|mesh-ancestor
14880028|NCT01187485|Hormones|hormones|mesh-ancestor
14880029|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14880030|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880031|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14880032|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880033|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
14880034|NCT01187537|Bupivacaine|bupivacaine|mesh-list
14880035|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
14880036|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
14880037|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880038|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880039|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
14880040|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880041|NCT01187589|Albuterol|albuterol|mesh-list
14880042|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14880043|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
14880044|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880045|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880046|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14880047|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880048|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
14880049|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14880050|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14880051|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14880052|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14880053|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
14880054|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880055|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880056|NCT01187615|Cisplatin|cisplatin|mesh-list
14880057|NCT01187615|Pemetrexed|pemetrexed|mesh-list
14880058|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880059|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880060|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880061|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14880062|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880063|NCT01187719|Phenytoin|phenytoin|mesh-list
14880064|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
14880065|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14880066|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14880067|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14880068|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880069|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14880070|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14880071|NCT01187849|Metformin|metformin|mesh-list
14880072|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14880073|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880074|NCT01187862|Efavirenz|efavirenz|mesh-list
14880075|NCT01187862|Losartan|losartan|mesh-list
14880076|NCT01187862|Metoprolol|metoprolol|mesh-list
14880077|NCT01187862|Midazolam|midazolam|mesh-list
14880078|NCT01187862|Caffeine|caffeine|mesh-list
14880079|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
14880080|NCT01187862|Omeprazole|omeprazole|mesh-list
14880081|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14728877|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14728878|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14728879|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14728880|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728881|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880082|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14880083|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715103|NCT00455897|Rituximab|rituximab|mesh-list
14715104|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14715105|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715106|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
14715107|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880084|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880085|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14880086|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14880087|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14880088|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14880089|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
14880090|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
14880091|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
14880092|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
14880093|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880094|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880095|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14880096|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14880097|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14880098|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14880099|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14880100|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14880101|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14880102|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880103|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14880104|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14880105|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14880106|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14880107|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
14715108|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880108|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14880109|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880110|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
14880111|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880112|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14880113|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14880114|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14880115|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14880116|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14880117|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14880118|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
14880119|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
14880120|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880121|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14715109|NCT00455910|Thalidomide|thalidomide|mesh-list
14715110|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715111|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
14715112|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715113|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
14715114|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14715115|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715116|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715117|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715118|NCT00455910|Growth Substances|growth substances|mesh-ancestor
14715119|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880122|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14880123|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14880124|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
14880125|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14880126|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14880127|NCT01187888|Rasagiline|rasagiline|mesh-list
14880128|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14880129|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880130|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880131|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14880132|NCT01187888|Protective Agents|protective agents|mesh-ancestor
14880133|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880134|NCT01187992|Atorvastatin|atorvastatin|mesh-list
14880135|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14880136|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14880137|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
14715120|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880138|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880139|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14880140|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14880141|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880142|NCT01188005|Vitamins|vitamins|mesh-list
14880143|NCT01188005|Vitamin E|vitamin e|mesh-list
14880144|NCT01188005|Vitamin A|vitamin a|mesh-list
14880145|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
14880146|NCT01188005|Allopurinol|allopurinol|mesh-list
14880147|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15213914|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15213915|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213916|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213917|NCT02361125|Methylphenidate|methylphenidate|mesh-list
15213918|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15213919|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880148|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
14880149|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880150|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
14880151|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880152|NCT01188005|Protective Agents|protective agents|mesh-ancestor
14880153|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
14880154|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880155|NCT01188005|Expectorants|expectorants|mesh-ancestor
14880156|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880157|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14880158|NCT01188005|Antidotes|antidotes|mesh-ancestor
14880159|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
14880160|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880161|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
14880162|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880163|NCT01188031|Alprazolam|alprazolam|mesh-list
14880164|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14880165|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880166|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880167|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14880168|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14880169|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14880170|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
14880171|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
14880172|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880173|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914728|NCT01382342|Rasagiline|rasagiline|mesh-list
14914729|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14914730|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914731|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914732|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14914733|NCT01382342|Protective Agents|protective agents|mesh-ancestor
14914734|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914735|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
14914736|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914737|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14914738|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14914739|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914740|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914741|NCT01382368|Urological Agents|urological agents|mesh-ancestor
14914742|NCT01382407|Cetuximab|cetuximab|mesh-list
14914743|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14914744|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914745|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14914746|NCT01382472|Simvastatin|simvastatin|mesh-list
14914747|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15213920|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15213921|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15213922|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15213923|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213924|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
15213925|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213926|NCT02338921|Metformin|metformin|mesh-list
15213927|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15213928|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
15213929|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14914748|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14715121|NCT00455936|Gefitinib|gefitinib|mesh-list
14715122|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715123|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14715124|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715125|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715126|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14880174|NCT01188057|Alprazolam|alprazolam|mesh-list
14880175|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14880176|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880177|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880178|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14880179|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14880180|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14880181|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
14880182|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
14880183|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880184|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880185|NCT01188148|Memantine|memantine|mesh-list
14880186|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14880187|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14880188|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
14880189|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880190|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880191|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880192|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14880193|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14880194|NCT01188174|Clofarabine|clofarabine|mesh-list
14880195|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14880196|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
14880197|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880198|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880199|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
14880200|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14880201|NCT01188265|Valproic Acid|valproic acid|mesh-list
14880202|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
14880203|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
14880204|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880205|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14880206|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14880207|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880208|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880209|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880210|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
14880211|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880212|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
14880213|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
14880214|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14880215|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880216|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14880217|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
14880218|NCT01188278|Dasatinib|dasatinib|mesh-list
14880219|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880220|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14880221|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880222|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880223|NCT01188304|Aspirin|aspirin|mesh-list
14715127|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14715128|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
14715129|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715130|NCT00456027|Antacids|antacids|mesh-ancestor
14715131|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880224|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14880225|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14880226|NCT01188304|Analgesics|analgesics|mesh-ancestor
14880227|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
14880228|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880229|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880230|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14880231|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880232|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14880233|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15213930|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213931|NCT02338921|Incretins|incretins|mesh-ancestor
15213932|NCT02338921|Hormones|hormones|mesh-ancestor
15213933|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213934|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15213935|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
15213936|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213937|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880234|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880235|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14880236|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14880237|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880238|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
14880239|NCT01188317|Ibuprofen|ibuprofen|mesh-list
14880240|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14880241|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14880242|NCT01188317|Analgesics|analgesics|mesh-ancestor
14880243|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
14880244|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880245|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880246|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14880247|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880248|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14880249|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880250|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880251|NCT01188408|Docetaxel|docetaxel|mesh-list
14880252|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880253|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14880254|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14880255|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14880256|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880257|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14880258|NCT01188707|Belinostat|belinostat|mesh-list
14880259|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880260|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14880261|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213938|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14880262|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880263|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14880264|NCT01188733|Octreotide|octreotide|mesh-list
14880265|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14880266|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14880267|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880268|NCT01188759|Voriconazole|voriconazole|mesh-list
14880269|NCT01188759|Anidulafungin|anidulafungin|mesh-list
14880270|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
14880271|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880272|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14880273|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14880274|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880275|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880276|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14880277|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
14880278|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14880279|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880280|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14880281|NCT01188824|Cilostazol|cilostazol|mesh-list
14880282|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14880283|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
14880284|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880285|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880286|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14880287|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880288|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14880289|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14880290|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880291|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14880292|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
14880293|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14880294|NCT01188824|Protective Agents|protective agents|mesh-ancestor
14880295|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14880296|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14880297|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880298|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14880299|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14880300|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880301|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14880302|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880303|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
14880304|NCT01188889|Everolimus|everolimus|mesh-list
14880305|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880306|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14880307|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880308|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880309|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14880310|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
14880311|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880312|NCT01188954|Doxycycline|doxycycline|mesh-list
14880313|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14880314|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880315|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
14880316|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14880317|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14880318|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
14880319|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
14880320|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880321|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14880322|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14880323|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15213939|NCT02245308|Bupropion|bupropion|mesh-list
15213940|NCT02245308|Nicotine|nicotine|mesh-list
14880324|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880325|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213941|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15213942|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
14880326|NCT01189019|Ranibizumab|ranibizumab|mesh-list
14880327|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880328|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14880329|NCT01189019|Growth Substances|growth substances|mesh-ancestor
14880330|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880331|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880332|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880333|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
14880334|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
14880335|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880336|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14880337|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14880338|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880339|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880340|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880341|NCT01189214|Memantine|memantine|mesh-list
14880342|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14880343|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14880344|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
14880345|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880346|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880347|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880348|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14880349|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15213943|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15213944|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15213945|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15213946|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15213947|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
14880350|NCT01189253|Doxorubicin|doxorubicin|mesh-list
14880351|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14880352|NCT01189253|Trabectedin|trabectedin|mesh-list
14880353|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14880354|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880355|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14880356|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14880357|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880358|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880359|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14880360|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
14880361|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14880362|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
14880363|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15213948|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296461|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
14880364|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15213949|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213950|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15213951|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
15213952|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14880365|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14914749|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
14880366|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880367|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880368|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
14880369|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
14880370|NCT01189448|Spiramycin|spiramycin|mesh-list
14880371|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
14880372|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14880373|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14880374|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880375|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14880376|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880377|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880378|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14880379|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
14880380|NCT01189526|Ranibizumab|ranibizumab|mesh-list
14880381|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880382|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14880383|NCT01189526|Growth Substances|growth substances|mesh-ancestor
14880384|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880385|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880386|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880387|NCT01189643|Bevacizumab|bevacizumab|mesh-list
14880388|NCT01189643|Irinotecan|irinotecan|mesh-list
14880389|NCT01189643|Temozolomide|temozolomide|mesh-list
14880390|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14880391|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880392|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880393|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715132|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14715133|NCT00456144|Hormones|hormones|mesh-list
14715134|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715135|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715136|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
14715137|NCT00456235|Cyclosporine|cyclosporine|mesh-list
14715138|NCT00456235|Tacrolimus|tacrolimus|mesh-list
14715139|NCT00456235|Cyclosporins|cyclosporins|mesh-list
14715140|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715141|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
14715142|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715143|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14715144|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715145|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880394|NCT01189643|Growth Substances|growth substances|mesh-ancestor
14880395|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880396|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880397|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14880398|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14880399|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880400|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880401|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14880402|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
14880403|NCT01189656|Vaccines|vaccines|mesh-list
14880404|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
14880405|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880406|NCT01189695|Ritonavir|ritonavir|mesh-list
14880407|NCT01189695|Lopinavir|lopinavir|mesh-list
14880408|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14880409|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14880410|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
14880411|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880412|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213953|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15213954|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15213955|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15213956|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
15213957|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15213958|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15213959|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213960|NCT02227199|Carboplatin|carboplatin|mesh-list
15213961|NCT02227199|Etoposide|etoposide|mesh-list
15213962|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
15213963|NCT02227199|Ifosfamide|ifosfamide|mesh-list
14715146|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14715147|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880413|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14880414|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14880415|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
14880416|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880417|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14880418|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14880419|NCT01189721|Propofol|propofol|mesh-list
14880420|NCT01189721|Sevoflurane|sevoflurane|mesh-list
14880421|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14880422|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880423|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880424|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14880425|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
14880426|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
14880427|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14880428|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14880429|NCT01189773|Ibuprofen|ibuprofen|mesh-list
14880430|NCT01189773|Codeine|codeine|mesh-list
14880431|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14880432|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14880433|NCT01189773|Analgesics|analgesics|mesh-ancestor
14880434|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
14880435|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880436|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880437|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14728882|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14880438|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880439|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14880440|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213964|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
15213965|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15213966|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
15213967|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15213968|NCT02227199|Antibodies|antibodies|mesh-list
15213969|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
15213970|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15213971|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
15213972|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
14728883|NCT00520442|Narcotics|narcotics|mesh-ancestor
15213973|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728884|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728885|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
14728886|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14728887|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
14728888|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14728889|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
14728890|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15213974|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213975|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15213976|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14880441|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880442|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14880443|NCT01189773|Narcotics|narcotics|mesh-ancestor
14880444|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880445|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
14880446|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880447|NCT01189864|Diclofenac|diclofenac|mesh-list
14880448|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
14880449|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14880450|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
14880451|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14880452|NCT01189864|Prednisolone|prednisolone|mesh-list
14880453|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14880454|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
14880455|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14880456|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14880457|NCT01189864|Analgesics|analgesics|mesh-ancestor
14880458|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
14880459|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880460|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880461|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14880462|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880463|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14880464|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880465|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880466|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880467|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
14880468|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
14880469|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14880470|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
14880471|NCT01189864|Hormones|hormones|mesh-ancestor
14880472|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15213977|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15213978|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213979|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15213980|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15213981|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
15213982|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
15213983|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
15213984|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
15213985|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
15213986|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
15213987|NCT02177695|Gemcitabine|gemcitabine|mesh-list
15213988|NCT02177695|Doxorubicin|doxorubicin|mesh-list
15213989|NCT02177695|Methotrexate|methotrexate|mesh-list
15213990|NCT02177695|Vinblastine|vinblastine|mesh-list
15213991|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15213992|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15213993|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
15213994|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880473|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14880474|NCT01189864|Protective Agents|protective agents|mesh-ancestor
14880475|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14880476|NCT01189929|Gemcitabine|gemcitabine|mesh-list
14880477|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14880478|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14880479|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
14880480|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880481|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880482|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
14880483|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880484|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880485|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14880486|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
14880487|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914750|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914751|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914752|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14914753|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914754|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
14914755|NCT01382498|Calcium|calcium|mesh-list
14914756|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15213995|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
15213996|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880488|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
14880489|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
14880490|NCT01190137|Vitamin D|vitamin d|mesh-list
14880491|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14880492|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880493|NCT01190137|Vitamins|vitamins|mesh-ancestor
14880494|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
14880495|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14880496|NCT01190163|Oxytocin|oxytocin|mesh-list
14880497|NCT01190163|Dinoprostone|dinoprostone|mesh-list
14880498|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
14880499|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14880500|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880501|NCT01190241|Everolimus|everolimus|mesh-list
14880502|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14715148|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14715149|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
14715150|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14715151|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715152|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
14880503|NCT01190241|Sorafenib|sorafenib|mesh-list
14880504|NCT01190241|Sunitinib|sunitinib|mesh-list
14880505|NCT01190241|Lapatinib|lapatinib|mesh-list
14880506|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880507|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14880508|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
14880509|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880510|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14715153|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
14715154|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14715155|NCT00456248|Ribavirin|ribavirin|mesh-list
14880511|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880512|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880513|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880514|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14880515|NCT01190241|Growth Substances|growth substances|mesh-ancestor
14880516|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
14715156|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
14880517|NCT01190293|Efavirenz|efavirenz|mesh-list
14880518|NCT01190293|Maraviroc|maraviroc|mesh-list
14880519|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14715157|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
14880520|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880521|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880522|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880523|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
14880524|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880525|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14880526|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14880527|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14880528|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14880529|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14880530|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14880531|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14880532|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14880533|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14880534|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14880535|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14880536|NCT01190345|Bevacizumab|bevacizumab|mesh-list
14880537|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14880538|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880539|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880540|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14880541|NCT01190345|Growth Substances|growth substances|mesh-ancestor
14880542|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880543|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880544|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
14880545|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14880546|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880547|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
14880548|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880549|NCT01190358|Protective Agents|protective agents|mesh-ancestor
14880550|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880551|NCT01190371|Artesunate|artesunate|mesh-list
14880552|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
14880553|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14880554|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14880555|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880556|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880557|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
14880558|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
14880559|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14880560|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
14880561|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
14880562|NCT01190384|Antioxidants|antioxidants|mesh-list
14880563|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880564|NCT01190384|Protective Agents|protective agents|mesh-ancestor
14880565|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880566|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14880567|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296462|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880568|NCT01190462|Cetuximab|cetuximab|mesh-list
14880569|NCT01190462|Simvastatin|simvastatin|mesh-list
14880570|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14880571|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880572|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14880573|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14880574|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
14880575|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880576|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14880577|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14880578|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880579|NCT01190553|Amantadine|amantadine|mesh-list
14880580|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14880581|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14880582|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
14880583|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880584|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
14880585|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880586|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880587|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880588|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14880589|NCT01190553|Analgesics|analgesics|mesh-ancestor
14880590|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
14880591|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880592|NCT01190670|Tacrolimus|tacrolimus|mesh-list
14880593|NCT01190670|Peficitinib|peficitinib|mesh-list
14880594|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14880595|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
14880596|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880597|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14880598|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296463|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715158|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715159|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
14880599|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880600|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
14880601|NCT01190683|Vitamin D|vitamin d|mesh-list
14880602|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
14715160|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715161|NCT00456313|Fluticasone|fluticasone|mesh-list
14715162|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14880603|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
14880604|NCT01190683|Vitamins|vitamins|mesh-list
14880605|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
14880606|NCT01190683|Calcium|calcium|mesh-list
14880607|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
14880608|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880609|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14880610|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14880611|NCT01190683|Antacids|antacids|mesh-ancestor
14880612|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880613|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14880614|NCT01190722|Diclofenac|diclofenac|mesh-list
14880615|NCT01190722|Etoricoxib|etoricoxib|mesh-list
14880616|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14880617|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14880618|NCT01190722|Analgesics|analgesics|mesh-ancestor
14880619|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
14880620|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880621|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880622|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14880623|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880624|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14880625|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880626|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880627|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14880628|NCT01190735|Caffeine|caffeine|mesh-list
14880629|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14880630|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880631|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14880632|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880633|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880634|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14880635|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14880636|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
14880637|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880638|NCT01190748|Galantamine|galantamine|mesh-list
14880639|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14880640|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880641|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880642|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
14880643|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880644|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880645|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14880646|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
14880647|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880648|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
14880649|NCT01190761|Galantamine|galantamine|mesh-list
14880650|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14880651|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880652|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880653|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
14880654|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880655|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880656|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14715163|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14715164|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
14715165|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715166|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880657|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
14880658|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880659|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
14880660|NCT01190982|Paclitaxel|paclitaxel|mesh-list
14715167|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14715168|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
14715169|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
14715170|NCT00456313|Hormones|hormones|mesh-ancestor
14715171|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715172|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
14715173|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715174|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
14715175|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14715176|NCT00456339|Amoxicillin|amoxicillin|mesh-list
14715177|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
14715178|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
14715179|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14715180|NCT00456339|Prednisolone|prednisolone|mesh-list
14880661|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14880662|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880663|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14880664|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14880665|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14880666|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880667|NCT01191021|Propofol|propofol|mesh-list
14880668|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
15213997|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15213998|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15213999|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
15214000|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214001|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15214002|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14715181|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14880669|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880670|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880671|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14880672|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14880673|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
14880674|NCT01191034|Imiquimod|imiquimod|mesh-list
14880675|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14880676|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
14880677|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880678|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880679|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
14880680|NCT01191060|Lenalidomide|lenalidomide|mesh-list
14880681|NCT01191060|Bortezomib|bortezomib|mesh-list
14880682|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
14880683|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880684|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880685|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14880686|NCT01191060|Growth Substances|growth substances|mesh-ancestor
14880687|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880688|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880689|NCT01191203|Copper|copper|mesh-list
15214003|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15214004|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15214005|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
15214006|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15214007|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214008|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15214009|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225226|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
14715182|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880690|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14880691|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
14880692|NCT01191203|Trace Elements|trace elements|mesh-ancestor
15214010|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15214011|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15214012|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
15214013|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14715183|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715184|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
14715185|NCT00456339|Hormones|hormones|mesh-ancestor
14715186|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715187|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715188|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14715189|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715190|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14715191|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715192|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715193|NCT00456430|Citalopram|citalopram|mesh-list
14880693|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
14880694|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880695|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14880696|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14880697|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14880698|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
14880699|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14880700|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14880701|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14880702|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14880703|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14880704|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880705|NCT01191216|Docetaxel|docetaxel|mesh-list
14880706|NCT01191216|Tryptophan|tryptophan|mesh-list
14880707|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880708|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14880709|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14880710|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14880711|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880712|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14880713|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
14880714|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14880715|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
14880716|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14880717|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
14880718|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880719|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880720|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14880721|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
15214014|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
15214015|NCT02145403|Tacrolimus|tacrolimus|mesh-list
15214016|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214017|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
15214018|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214019|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15214020|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214021|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214022|NCT02105636|Docetaxel|docetaxel|mesh-list
15214023|NCT02105636|Methotrexate|methotrexate|mesh-list
15214024|NCT02105636|Nivolumab|nivolumab|mesh-list
15214025|NCT02105636|Cetuximab|cetuximab|mesh-list
14880722|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14880723|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14880724|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14880725|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
14880726|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880727|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880728|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
14880729|NCT01191450|Amiloride|amiloride|mesh-list
15214026|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214027|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
15214028|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
14880730|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14880731|NCT01191450|Diuretics|diuretics|mesh-ancestor
14880732|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
14880733|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880734|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14880735|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14880736|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880737|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14880738|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14880739|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14880740|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14880741|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
14880742|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14880743|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14880744|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880745|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
14880746|NCT01191554|Coagulants|coagulants|mesh-ancestor
14880747|NCT01191593|Ropivacaine|ropivacaine|mesh-list
14880748|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
14880749|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
14880750|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880751|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880752|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
14880753|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880754|NCT01191645|Remifentanil|remifentanil|mesh-list
14880755|NCT01191645|Metoclopramide|metoclopramide|mesh-list
14880756|NCT01191645|Naloxone|naloxone|mesh-list
14880757|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14880758|NCT01191645|Narcotics|narcotics|mesh-ancestor
14880759|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880760|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880761|NCT01191645|Analgesics|analgesics|mesh-ancestor
14880762|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
14880763|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880764|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14880765|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
14880766|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
14880767|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14880768|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14880769|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14880770|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
14880771|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880772|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880773|NCT01191684|Vaccines|vaccines|mesh-list
14880774|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
14880775|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880776|NCT01191697|Bevacizumab|bevacizumab|mesh-list
14880777|NCT01191697|Trastuzumab|trastuzumab|mesh-list
14880778|NCT01191697|Capecitabine|capecitabine|mesh-list
14880779|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
14880780|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14880781|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880782|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880783|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14880784|NCT01191697|Growth Substances|growth substances|mesh-ancestor
14880785|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880786|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880787|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14880788|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
14880789|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880790|NCT01191710|Progesterone|progesterone|mesh-list
14880791|NCT01191710|Progestins|progestins|mesh-ancestor
14880792|NCT01191710|Hormones|hormones|mesh-ancestor
14880793|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14880794|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880795|NCT01191892|Gemcitabine|gemcitabine|mesh-list
14880796|NCT01191892|Carboplatin|carboplatin|mesh-list
14880797|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880798|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14880799|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
14880800|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880801|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
14880802|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715194|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14880803|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880804|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14880805|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
14880806|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880807|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
14880808|NCT01191918|Donepezil|donepezil|mesh-list
14880809|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14880810|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880811|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880812|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
14715195|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15214029|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
15214030|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214031|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15214032|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
15214033|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15214034|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214035|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715196|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715197|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715198|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715199|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
14715200|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715201|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14715202|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715203|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715204|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14715205|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715206|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
15214036|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
15214037|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214038|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214039|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15214040|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214041|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
15214042|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214043|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880813|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880814|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880815|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
14880816|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
14880817|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14880818|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
14880819|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14880820|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880821|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
14880822|NCT01191957|Busulfan|busulfan|mesh-list
14880823|NCT01191957|Fludarabine|fludarabine|mesh-list
14880824|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14880825|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
14880826|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880827|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880828|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14880829|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
14880830|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880831|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880832|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14880833|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
14880834|NCT01191983|Hematinics|hematinics|mesh-ancestor
14880835|NCT01192087|Cetuximab|cetuximab|mesh-list
14880836|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14880837|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914757|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914758|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
14914759|NCT01382498|Coagulants|coagulants|mesh-ancestor
15214044|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214045|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15214046|NCT02038946|Nivolumab|nivolumab|mesh-list
15214047|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214048|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214049|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15214050|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214051|NCT01988571|Atorvastatin|atorvastatin|mesh-list
15214052|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15214053|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15214054|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
15214055|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214056|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914760|NCT01382511|Simvastatin|simvastatin|mesh-list
14914761|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14914762|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14914763|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
14914764|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914765|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914766|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14914767|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914768|NCT01382589|Afamelanotide|afamelanotide|mesh-list
14914769|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14914770|NCT01382706|Docetaxel|docetaxel|mesh-list
15214057|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15214058|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214059|NCT01979367|Analgesics|analgesics|mesh-list
15214060|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
15214061|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214062|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214063|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
15214064|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15214065|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14914771|NCT01382706|Lapatinib|lapatinib|mesh-list
14914772|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914773|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
14715207|NCT00456482|Hormones|hormones|mesh-ancestor
14715208|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14880838|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
14880839|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
14880840|NCT01192113|Vitamins|vitamins|mesh-ancestor
14880841|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
14880842|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880843|NCT01192165|Paclitaxel|paclitaxel|mesh-list
14880844|NCT01192165|Docetaxel|docetaxel|mesh-list
14880845|NCT01192165|Carboplatin|carboplatin|mesh-list
14880846|NCT01192165|Pemetrexed|pemetrexed|mesh-list
14880847|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14880848|NCT01192165|Trametinib|trametinib|mesh-list
14880849|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14880850|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880851|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
14880852|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
14715209|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715210|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
14715211|NCT00456560|Paroxetine|paroxetine|mesh-list
14715212|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14715213|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14715214|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715215|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715216|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715217|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
14715218|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880853|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
14880854|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880855|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880856|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14880857|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880858|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14880859|NCT01192230|Docetaxel|docetaxel|mesh-list
14880860|NCT01192230|Endostatins|endostatins|mesh-list
14880861|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880862|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14880863|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14880864|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14880865|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880866|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14880867|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14880868|NCT01192230|Growth Substances|growth substances|mesh-ancestor
14880869|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880870|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
14880871|NCT01192243|Carboplatin|carboplatin|mesh-list
14880872|NCT01192243|Pemetrexed|pemetrexed|mesh-list
14880873|NCT01192243|Gefitinib|gefitinib|mesh-list
14880874|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880875|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880876|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880877|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14880878|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880879|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14880880|NCT01192308|Tamoxifen|tamoxifen|mesh-list
14880881|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14880882|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
14880883|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14880884|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880885|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14880886|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880887|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14880888|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14880889|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14880890|NCT01192490|Lidocaine|lidocaine|mesh-list
14880891|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
14880892|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
14880893|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14880894|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880895|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
14880896|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880897|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14880898|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14880899|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14880900|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14880901|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880902|NCT01192503|Rasagiline|rasagiline|mesh-list
14880903|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14880904|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880905|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880906|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14880907|NCT01192503|Protective Agents|protective agents|mesh-ancestor
14880908|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880909|NCT01192529|Phentermine|phentermine|mesh-list
14880910|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14880911|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880912|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
14880913|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14880914|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
14880915|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
14880916|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880917|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14880918|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880919|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880920|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14880921|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
14880922|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
14880923|NCT01192724|Aspirin|aspirin|mesh-list
14880924|NCT01192724|Cilostazol|cilostazol|mesh-list
14880925|NCT01192724|Clopidogrel|clopidogrel|mesh-list
14880926|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14880927|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14880928|NCT01192724|Analgesics|analgesics|mesh-ancestor
14880929|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
14880930|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14880931|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14880932|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14880933|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14880934|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14880935|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14880936|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880937|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14880938|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14880939|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880940|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
14880941|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14880942|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14880943|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14880944|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
14880945|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880946|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14880947|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
14880948|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14880949|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
14880950|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
14880951|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14880952|NCT01192724|Protective Agents|protective agents|mesh-ancestor
14880953|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14880954|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14880955|NCT01192763|R04929097|r04929097|mesh-list
14880956|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880957|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880958|NCT01192789|Amoxicillin|amoxicillin|mesh-list
14880959|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14880960|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880961|NCT01192802|Albendazole|albendazole|mesh-list
14880962|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
14880963|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14880964|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880965|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
14880966|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14880967|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14880968|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
14880969|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
14880970|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
14880971|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880972|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880973|NCT01192854|Adefovir|adefovir|mesh-list
14880974|NCT01192854|Clevudine|clevudine|mesh-list
14880975|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
14880976|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14880977|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14880978|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14880979|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880980|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880981|NCT01192971|Apatinib|apatinib|mesh-list
14880982|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880983|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14880984|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14880985|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880986|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
14880987|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14880988|NCT01193166|Olanzapine|olanzapine|mesh-list
14880989|NCT01193166|Risperidone|risperidone|mesh-list
14880990|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14880991|NCT01193166|Aripiprazole|aripiprazole|mesh-list
14880992|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14880993|NCT01193166|Perphenazine|perphenazine|mesh-list
14880994|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14880995|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
14880996|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14880997|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14880998|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715219|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14715220|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715221|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715222|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14715223|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14880999|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14881000|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14296464|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14296465|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14296466|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
14296467|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296468|NCT05246371|Analgesics|analgesics|mesh-ancestor
14296469|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
14296470|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296471|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14296472|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14296473|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14715224|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715225|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14715226|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14715227|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715228|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14296474|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14914774|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
14296475|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296476|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296477|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14881001|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881002|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14881003|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14881004|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
14881005|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
14881006|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
14881007|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881008|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14881009|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14881010|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14881011|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881012|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
14881013|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
14881014|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14881015|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14881016|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14881017|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14881018|NCT01193192|Vitamins|vitamins|mesh-list
14881019|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
14881020|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881021|NCT01193270|Vitamin E|vitamin e|mesh-list
14881022|NCT01193270|Vitamins|vitamins|mesh-ancestor
14881023|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
14881024|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881025|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
14881026|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881027|NCT01193270|Protective Agents|protective agents|mesh-ancestor
14881028|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14881029|NCT01193296|Vildagliptin|vildagliptin|mesh-list
14881030|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14881031|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881032|NCT01193296|Incretins|incretins|mesh-ancestor
14881033|NCT01193296|Hormones|hormones|mesh-ancestor
14881034|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881035|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14881036|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
14881037|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881038|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881039|NCT01193387|Insulin|insulin|mesh-list
14881040|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14881041|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
14881042|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14881043|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881044|NCT01193400|Cytarabine|cytarabine|mesh-list
14881045|NCT01193400|Clofarabine|clofarabine|mesh-list
14881046|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881047|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
14881048|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881049|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881050|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
14881051|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881052|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881053|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
14881054|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881055|NCT01193452|Leucovorin|leucovorin|mesh-list
14881056|NCT01193452|Fluorouracil|fluorouracil|mesh-list
14881057|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
14881058|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
14881059|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881060|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881061|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881062|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881063|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
14881064|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881065|NCT01193452|Antidotes|antidotes|mesh-ancestor
14881066|NCT01193452|Protective Agents|protective agents|mesh-ancestor
14881067|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
14296478|NCT05246111|Topotecan|topotecan|mesh-list
14881068|NCT01193452|Vitamins|vitamins|mesh-ancestor
14881069|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
14881070|NCT01193465|Anesthetics|anesthetics|mesh-list
14881071|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881072|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881073|NCT01193478|Ledipasvir|ledipasvir|mesh-list
14881074|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
14881075|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715229|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14715230|NCT00456586|Istradefylline|istradefylline|mesh-list
14715231|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14715232|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14715233|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14715234|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
14715235|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715236|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715237|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715238|NCT00456677|Minocycline|minocycline|mesh-list
14715239|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14715240|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715241|NCT00456716|Sorafenib|sorafenib|mesh-list
15214066|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214067|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15214068|NCT01973452|Analgesics|analgesics|mesh-ancestor
15214069|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
15214070|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214071|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15214072|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14715242|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715243|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14715244|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715245|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715246|NCT00456729|Metronidazole|metronidazole|mesh-list
14715247|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715248|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14715249|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14715250|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14715251|NCT00456794|Istradefylline|istradefylline|mesh-list
14715252|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14715253|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14715254|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14715255|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
14715256|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715257|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715258|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715259|NCT00456820|Bupropion|bupropion|mesh-list
14715260|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14715261|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715262|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715263|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14715264|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14715265|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715266|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715267|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
14715268|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715269|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715270|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14715271|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14715272|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881076|NCT01193491|Geldanamycin|geldanamycin|mesh-list
14881077|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14881078|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881079|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
14881080|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881081|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914775|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
15214073|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15214074|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214075|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225227|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
14881082|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881083|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14881084|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
14881085|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14881086|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
14881087|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14881088|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
14881089|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14881090|NCT01193504|Prednisolone|prednisolone|mesh-list
14881091|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14881092|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
14881093|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715273|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14715274|NCT00456833|Everolimus|everolimus|mesh-list
14715275|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881094|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
14881095|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
14881096|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881097|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881098|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14881099|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
14881100|NCT01193504|Hormones|hormones|mesh-ancestor
14881101|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881102|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14881103|NCT01193504|Protective Agents|protective agents|mesh-ancestor
14881104|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881105|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881106|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14881107|NCT01193595|Bevacizumab|bevacizumab|mesh-list
14881108|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14881109|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881110|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14881111|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14881112|NCT01193595|Growth Substances|growth substances|mesh-ancestor
14881113|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881114|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
14881115|NCT01193621|Haloperidol|haloperidol|mesh-list
14881116|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
14881117|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
14881118|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
14881119|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214076|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214077|NCT01863550|Dexamethasone|dexamethasone|mesh-list
15214078|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
15214079|NCT01863550|Lenalidomide|lenalidomide|mesh-list
15214080|NCT01863550|Bortezomib|bortezomib|mesh-list
14715276|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14715277|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715278|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715279|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715280|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
14715281|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715282|NCT00456872|Lidocaine|lidocaine|mesh-list
14715283|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
14715284|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
14715285|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214081|NCT01863550|Ichthammol|ichthammol|mesh-list
15214082|NCT01863550|BB 1101|bb 1101|mesh-list
15214083|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214084|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
15214085|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
15214086|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214087|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214088|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214089|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
14715286|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715287|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
14881120|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881121|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14881122|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15214090|NCT01863550|Hormones|hormones|mesh-ancestor
15225710|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881123|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14881124|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881125|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14881126|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14881127|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
14881128|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881129|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881130|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14881131|NCT01193816|Loxapine|loxapine|mesh-list
14881132|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14881133|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14881134|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881135|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881136|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14881137|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14881138|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
14881139|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881140|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881141|NCT01193855|Dutasteride|dutasteride|mesh-list
14881142|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14881143|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14881144|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881145|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881146|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
14881147|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881148|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881149|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14881150|NCT01193881|R04929097|r04929097|mesh-list
15214091|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214092|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15214093|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214094|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
15214095|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214096|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15214097|NCT01863550|Growth Substances|growth substances|mesh-ancestor
15214098|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
14881151|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881152|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14881153|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881154|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881155|NCT01194037|Interferons|interferons|mesh-list
14881156|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
14881157|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
14881158|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15214099|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
15214100|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214101|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881159|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881160|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
14881161|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881162|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
14881163|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914776|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914777|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14914778|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914779|NCT01382732|Oxytocin|oxytocin|mesh-list
14914780|NCT01382732|Carbetocin|carbetocin|mesh-list
14914781|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
14715288|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715289|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14715290|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14715291|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14715292|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715293|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914782|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14914783|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914784|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
14715294|NCT00456898|Codeine|codeine|mesh-list
14715295|NCT00456898|Paroxetine|paroxetine|mesh-list
14914785|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14914786|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914787|NCT01382888|Heparin|heparin|mesh-list
14914788|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
14914789|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14914790|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14914791|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914792|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
14914793|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14914794|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914795|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
14914796|NCT01383044|Carvedilol|carvedilol|mesh-list
14914797|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14914798|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14914799|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
14914800|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914801|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914802|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914803|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14914804|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
14914805|NCT01383044|Protective Agents|protective agents|mesh-ancestor
14914806|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14914807|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14914808|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14914809|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914810|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14881164|NCT01194115|Metronidazole|metronidazole|mesh-list
14881165|NCT01194115|Cephalexin|cephalexin|mesh-list
14881166|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881167|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881168|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14881169|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14881170|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
14881171|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881172|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14881173|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14881174|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881175|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881176|NCT01194232|Urological Agents|urological agents|mesh-ancestor
14881177|NCT01194284|Mifamurtide|mifamurtide|mesh-list
14881178|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14881179|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
14881180|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881181|NCT01194336|Huperzine A|huperzine a|mesh-list
14881182|NCT01194336|Donepezil|donepezil|mesh-list
14881183|NCT01194336|Galantamine|galantamine|mesh-list
14881184|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14881185|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881186|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881187|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
14881188|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881189|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881190|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
14881191|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14881192|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
14881193|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881194|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14881195|NCT01194336|Protective Agents|protective agents|mesh-ancestor
14881196|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14881197|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14881198|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
14881199|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881200|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881201|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14881202|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
14881203|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
14881204|NCT01194700|Hormones|hormones|mesh-ancestor
14881205|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881206|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
14881207|NCT01194778|Vitamins|vitamins|mesh-list
14881208|NCT01194778|Vitamin K|vitamin k|mesh-list
14881209|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
14881210|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
14881211|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
14881212|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881213|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14881214|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14881215|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881216|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
14881217|NCT01194778|Coagulants|coagulants|mesh-ancestor
14881218|NCT01194791|Dexamethasone|dexamethasone|mesh-list
14881219|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
14881220|NCT01194791|Lenalidomide|lenalidomide|mesh-list
14881221|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881222|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
14881223|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881224|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14881225|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14881226|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
14881227|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881228|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881229|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14881230|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881231|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
14881232|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
14881233|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881234|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14881235|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
14881236|NCT01194791|Hormones|hormones|mesh-ancestor
14881237|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881238|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881239|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214102|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14881240|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14881241|NCT01194791|Growth Substances|growth substances|mesh-ancestor
14881242|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
14881243|NCT01194843|Ropivacaine|ropivacaine|mesh-list
14881244|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
14881245|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
14881246|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881247|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881248|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
14881249|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881250|NCT01194882|Insulin|insulin|mesh-list
14881251|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14881252|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14881253|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881254|NCT01194934|Lenograstim|lenograstim|mesh-list
14881255|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14881256|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
14881257|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881258|NCT01195181|Ribavirin|ribavirin|mesh-list
14881259|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
14881260|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881261|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
14881262|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881263|NCT01195246|Vaccines|vaccines|mesh-list
14881264|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
14881265|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881266|NCT01195259|Metformin|metformin|mesh-list
14881267|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
14881268|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14881269|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881270|NCT01195298|Bevacizumab|bevacizumab|mesh-list
14881271|NCT01195298|Capecitabine|capecitabine|mesh-list
14881272|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14881273|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881274|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14881275|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14881276|NCT01195298|Growth Substances|growth substances|mesh-ancestor
14881277|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881278|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
14881279|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881280|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
14881281|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881282|NCT01195324|Canagliflozin|canagliflozin|mesh-list
14881283|NCT01195324|Warfarin|warfarin|mesh-list
14881284|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
14881285|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14881286|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881287|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14881288|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881289|NCT01195376|Dactolisib|dactolisib|mesh-list
14881290|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881291|NCT01195428|Simvastatin|simvastatin|mesh-list
14881292|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14881293|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14881294|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
14881295|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881296|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15214103|NCT01824875|Capecitabine|capecitabine|mesh-list
15214104|NCT01824875|Temozolomide|temozolomide|mesh-list
15214105|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214106|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
15214107|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214108|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214109|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15214110|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
15214111|NCT01792583|Modafinil|modafinil|mesh-list
15214112|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15214113|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214114|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14881297|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14881298|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881299|NCT01195454|Insulin|insulin|mesh-list
14881300|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14881301|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
14881302|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14881303|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881304|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14881305|NCT01195571|Vaccines|vaccines|mesh-list
14881306|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
14881307|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881308|NCT01195649|Sorafenib|sorafenib|mesh-list
14881309|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881310|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14881311|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881312|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881313|NCT01195714|Ofatumumab|ofatumumab|mesh-list
14881314|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881315|NCT01195727|Apixaban|apixaban|mesh-list
14881316|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14881317|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
14881318|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14881319|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
14881320|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881321|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881322|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
14881323|NCT01195766|Ofatumumab|ofatumumab|mesh-list
14881324|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881325|NCT01195805|Amiloride|amiloride|mesh-list
14881326|NCT01195805|Spironolactone|spironolactone|mesh-list
14881327|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14881328|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
14881329|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881330|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881331|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14881332|NCT01195805|Diuretics|diuretics|mesh-ancestor
14881333|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
14881334|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14881335|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14881336|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881337|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881338|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14881339|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14881340|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14881341|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881342|NCT01196013|Clofarabine|clofarabine|mesh-list
14881343|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881344|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
14881345|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881346|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881347|NCT01196065|Memantine|memantine|mesh-list
14881348|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14881349|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14881350|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
14881351|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881352|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881353|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881354|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14881355|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14914811|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14881356|NCT01196169|Vancomycin|vancomycin|mesh-list
14881357|NCT01196169|Daptomycin|daptomycin|mesh-list
14881358|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881359|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881360|NCT01196195|Lopinavir|lopinavir|mesh-list
14881361|NCT01196195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14881362|NCT01196195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14881363|NCT01196195|Protease Inhibitors|protease inhibitors|mesh-ancestor
14881364|NCT01196195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881365|NCT01196195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881366|NCT01196195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14881367|NCT01196195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14881368|NCT01196195|Antiviral Agents|antiviral agents|mesh-ancestor
14881369|NCT01196195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881370|NCT01196195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14881371|NCT01196195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14881372|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14881373|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14881374|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881375|NCT01196234|Paclitaxel|paclitaxel|mesh-list
14881376|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14881377|NCT01196234|Carboplatin|carboplatin|mesh-list
14881378|NCT01196234|Gefitinib|gefitinib|mesh-list
14881379|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14881380|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881381|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
14881382|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
14881383|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
14881384|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881385|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14881386|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881387|NCT01196260|Capecitabine|capecitabine|mesh-list
14881388|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
14881389|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881390|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
14881391|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881392|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881393|NCT01196455|Capecitabine|capecitabine|mesh-list
14881394|NCT01196455|Mitomycins|mitomycins|mesh-list
14881395|NCT01196455|Mitomycin|mitomycin|mesh-list
14881396|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881397|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
14881398|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881399|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881400|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14881401|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
14881402|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14881403|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881404|NCT01196481|Carvedilol|carvedilol|mesh-list
14881405|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14881406|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14881407|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214115|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15214116|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15214117|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214118|NCT01755975|Lenalidomide|lenalidomide|mesh-list
15214119|NCT01755975|Romidepsin|romidepsin|mesh-list
15214120|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
15214121|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214122|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214123|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14881408|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214124|NCT01755975|Growth Substances|growth substances|mesh-ancestor
14881409|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881410|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881411|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14881412|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
14881413|NCT01196481|Protective Agents|protective agents|mesh-ancestor
14881414|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14881415|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715296|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14715297|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14715298|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14715299|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715300|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715301|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715302|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
14715303|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715304|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14715305|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715306|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715307|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14715308|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14715309|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715310|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14715311|NCT00456898|Narcotics|narcotics|mesh-ancestor
14715312|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715313|NCT00456898|Analgesics|analgesics|mesh-ancestor
14881416|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881417|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881418|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14881419|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14881420|NCT01196507|Carvedilol|carvedilol|mesh-list
14881421|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14881422|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14881423|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
14881424|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881425|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881426|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881427|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14881428|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
14881429|NCT01196507|Protective Agents|protective agents|mesh-ancestor
14881430|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14881431|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881432|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881433|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881434|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14881435|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14881436|NCT01196546|Metformin|metformin|mesh-list
14881437|NCT01196546|Vildagliptin|vildagliptin|mesh-list
14881438|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14881439|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881440|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14881441|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
14881442|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881443|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881444|NCT01196559|Gemcitabine|gemcitabine|mesh-list
14881445|NCT01196559|Vinorelbine|vinorelbine|mesh-list
14881446|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881447|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
14881448|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881449|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881450|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
14881451|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881452|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881453|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881454|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
14881455|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881456|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14881457|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
14881458|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
14881459|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
14881460|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
14881461|NCT01196715|Hematinics|hematinics|mesh-ancestor
14881462|NCT01196754|Sevoflurane|sevoflurane|mesh-list
14881463|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14881464|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14881465|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
14881466|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
14881467|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881468|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881469|NCT01196767|Ropivacaine|ropivacaine|mesh-list
14881470|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
14881471|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
14881472|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881473|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881474|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
14881475|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881476|NCT01197001|Losartan|losartan|mesh-list
14881477|NCT01197001|Amlodipine|amlodipine|mesh-list
14881478|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14881479|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14881480|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881481|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881482|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881483|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881484|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881485|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14881486|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14881487|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14881488|NCT01197014|Losartan|losartan|mesh-list
14881489|NCT01197014|Amlodipine|amlodipine|mesh-list
14881490|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14881491|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14881492|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881493|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881494|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881495|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881496|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881497|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14881498|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14881499|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14881500|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
14881501|NCT01197040|Prednisone|prednisone|mesh-list
14881502|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881503|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
14881504|NCT01197040|Hormones|hormones|mesh-ancestor
14881505|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881506|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881507|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881508|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881509|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14881510|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14881511|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
14881512|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881513|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881514|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881515|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881516|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
14881517|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881518|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
14715314|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
14715315|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715316|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
14715317|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
14715318|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14715319|NCT00456937|Citalopram|citalopram|mesh-list
14715320|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14715321|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14715322|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881519|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881520|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14881521|NCT01197144|Adalimumab|adalimumab|mesh-list
14881522|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881523|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14881524|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
14881525|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14881526|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881527|NCT01197170|Bevacizumab|bevacizumab|mesh-list
14881528|NCT01197170|Everolimus|everolimus|mesh-list
14881529|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14881530|NCT01197170|Sorafenib|sorafenib|mesh-list
14881531|NCT01197170|Anastrozole|anastrozole|mesh-list
14881532|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14881533|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881534|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14881535|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14881536|NCT01197170|Growth Substances|growth substances|mesh-ancestor
14881537|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881538|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
14881539|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881540|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
14881541|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14881542|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881543|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881544|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881545|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14881546|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14881547|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14881548|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
14881549|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881550|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
14881551|NCT01197235|Hematinics|hematinics|mesh-ancestor
14881552|NCT01197261|Oxycodone|oxycodone|mesh-list
14881553|NCT01197261|Naloxone|naloxone|mesh-list
14881554|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14881555|NCT01197261|Narcotics|narcotics|mesh-ancestor
14881556|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881557|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881558|NCT01197261|Analgesics|analgesics|mesh-ancestor
14881559|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
14881560|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881561|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14881562|NCT01197469|Tadalafil|tadalafil|mesh-list
14881563|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881564|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14881565|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14881566|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715323|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881567|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881568|NCT01197469|Urological Agents|urological agents|mesh-ancestor
14881569|NCT01197664|Fluorouracil|fluorouracil|mesh-list
14881570|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
14881571|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881572|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881573|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881574|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881575|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
14881576|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881577|NCT01197781|Verapamil|verapamil|mesh-list
14881578|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14881579|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14715324|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715325|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
14715326|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715327|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14715328|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715329|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715330|NCT00456963|Losartan|losartan|mesh-list
14715331|NCT00456963|Enalapril|enalapril|mesh-list
14715332|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14715333|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14881580|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881581|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881582|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881583|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881584|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881585|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14881586|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
14881587|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14881588|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14881589|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14881590|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881591|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914812|NCT01383148|Gemcitabine|gemcitabine|mesh-list
14914813|NCT01383148|Paclitaxel|paclitaxel|mesh-list
14914814|NCT01383148|Cisplatin|cisplatin|mesh-list
14914815|NCT01383148|Carboplatin|carboplatin|mesh-list
14914816|NCT01383148|Pemetrexed|pemetrexed|mesh-list
14914817|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14914818|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914819|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
14914820|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
14914821|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
14914822|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914823|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914824|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14914825|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
15214125|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
15214126|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214127|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15214128|NCT01715285|Prednisone|prednisone|mesh-list
15214129|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
15214130|NCT01715285|Androgens|androgens|mesh-list
15214131|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14914826|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
14914827|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914828|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914829|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14914830|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
14914831|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14914832|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14917407|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14917408|NCT05268120|Renal Agents|renal agents|mesh-ancestor
14917409|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14917410|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14917411|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14917412|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14917413|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14917414|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
14917415|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917416|NCT05267977|Cephalosporins|cephalosporins|mesh-list
14917417|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14917418|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917419|NCT05244252|Bupivacaine|bupivacaine|mesh-list
14917420|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
14917421|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
14917422|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917423|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917424|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
14917425|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917426|NCT05243251|Olanzapine|olanzapine|mesh-list
14917427|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
14917428|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
14917429|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917430|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917431|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917432|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14296479|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14917433|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917434|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214132|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
15214133|NCT01715285|Hormones|hormones|mesh-ancestor
14917435|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917436|NCT05243251|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15225711|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
14881592|NCT01198054|Lenalidomide|lenalidomide|mesh-list
14881593|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
14881594|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881595|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14881596|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14881597|NCT01198054|Growth Substances|growth substances|mesh-ancestor
14881598|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
14881599|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881600|NCT01198106|Cinnarizine|cinnarizine|mesh-list
14881601|NCT01198106|Scopolamine|scopolamine|mesh-list
14881602|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14881603|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14881604|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
14881605|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
14881606|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881607|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881608|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14881609|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
14881610|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14881611|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
14881612|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881613|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881614|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14881615|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
14881616|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14881617|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881618|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881619|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14881620|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
14881621|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
14881622|NCT01198184|Sirolimus|sirolimus|mesh-list
14881623|NCT01198184|R04929097|r04929097|mesh-list
14881624|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881625|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881626|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14881627|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881628|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
14881629|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881630|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
14881631|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881632|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881633|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881634|NCT01198210|Dexamethasone|dexamethasone|mesh-list
14881635|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
14881636|NCT01198210|Ketamine|ketamine|mesh-list
14881637|NCT01198210|BB 1101|bb 1101|mesh-list
14881638|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881639|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
14881640|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
14881641|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881642|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881643|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214134|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214135|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214136|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15214137|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214138|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15214139|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214140|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214141|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
15214142|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15214143|NCT01670409|Cisplatin|cisplatin|mesh-list
15214144|NCT01670409|Fluorouracil|fluorouracil|mesh-list
15214145|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881644|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
14881645|NCT01198210|Hormones|hormones|mesh-ancestor
15214146|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
14914833|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
14881646|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881647|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881648|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881649|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
14881650|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881651|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881652|NCT01198210|Analgesics|analgesics|mesh-ancestor
14881653|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
14881654|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14881655|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14881656|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
14881657|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
14881658|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881659|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14881660|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14881661|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881662|NCT01198223|Nystatin|nystatin|mesh-list
14881663|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881664|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881665|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
14881666|NCT01198223|Ionophores|ionophores|mesh-ancestor
14881667|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881668|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881669|NCT01198236|Itraconazole|itraconazole|mesh-list
14881670|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
14881671|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881672|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14881673|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14881674|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881675|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881676|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14881677|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
15214147|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214148|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296480|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14296481|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715334|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14715335|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14715336|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715337|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14715338|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
14715339|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715340|NCT00456976|Selegiline|selegiline|mesh-list
14715341|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715342|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715343|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15214149|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214150|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
15214151|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214152|NCT01526135|Gemcitabine|gemcitabine|mesh-list
15214153|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214154|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
15214155|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214156|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214157|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
14881678|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881679|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881680|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14881681|NCT01198249|Losartan|losartan|mesh-list
14881682|NCT01198249|Amlodipine|amlodipine|mesh-list
14881683|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14881684|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14881685|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14881686|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881687|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881688|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881689|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881690|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881691|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14881692|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14881693|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14881694|NCT01198249|Diuretics|diuretics|mesh-ancestor
14881695|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
14881696|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14881697|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14881698|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
14881699|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881700|NCT01198340|Ropivacaine|ropivacaine|mesh-list
14881701|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
14881702|NCT01198340|Anesthetics|anesthetics|mesh-list
14881703|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881704|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881705|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
14881706|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881707|NCT01198353|Ziprasidone|ziprasidone|mesh-list
14881708|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14881709|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
14881710|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881711|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715344|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14715345|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14715346|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715347|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715348|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14715349|NCT00456976|Protective Agents|protective agents|mesh-ancestor
14715350|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715351|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
14881712|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881713|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14881714|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14881715|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881716|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14881717|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14881718|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
14881719|NCT01198379|Aspirin|aspirin|mesh-list
14881720|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14881721|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14881722|NCT01198379|Analgesics|analgesics|mesh-ancestor
14881723|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
14881724|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881725|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881726|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881727|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14881728|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14881729|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14881730|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881731|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14881732|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14881733|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881734|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
14881735|NCT01198392|Cisplatin|cisplatin|mesh-list
14881736|NCT01198392|Tegafur|tegafur|mesh-list
14881737|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881738|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715352|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715353|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715354|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715355|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715356|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
14881739|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
14881740|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881741|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14881742|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14881743|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881744|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
14881745|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14881746|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881747|NCT01198496|Losartan|losartan|mesh-list
14881748|NCT01198496|Amlodipine|amlodipine|mesh-list
14881749|NCT01198496|Valsartan|valsartan|mesh-list
14881750|NCT01198496|Telmisartan|telmisartan|mesh-list
14881751|NCT01198496|Candesartan|candesartan|mesh-list
14881752|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
14881753|NCT01198496|Olmesartan|olmesartan|mesh-list
14881754|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14881755|NCT01198496|Spironolactone|spironolactone|mesh-list
14881756|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14881757|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14881758|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14881759|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881760|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14881761|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881762|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
14881763|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14881764|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14881765|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14881766|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14881767|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
14881768|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881769|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14881770|NCT01198496|Diuretics|diuretics|mesh-ancestor
14881771|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
14881772|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14715357|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14715358|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715359|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715360|NCT00457067|Ranibizumab|ranibizumab|mesh-list
14715361|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715362|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715363|NCT00457067|Growth Substances|growth substances|mesh-ancestor
14715364|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881773|NCT01198535|Cetuximab|cetuximab|mesh-list
14881774|NCT01198535|Antibodies|antibodies|mesh-list
14881775|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
14296482|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881776|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14881777|NCT01198535|R04929097|r04929097|mesh-list
14881778|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
14881779|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881780|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881781|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914834|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881782|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881783|NCT01198639|Remifentanil|remifentanil|mesh-list
14881784|NCT01198639|Propofol|propofol|mesh-list
14881785|NCT01198639|Anesthetics|anesthetics|mesh-list
14881786|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14881787|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881788|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881789|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14881790|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
14881791|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14881792|NCT01198639|Narcotics|narcotics|mesh-ancestor
14881793|NCT01198639|Analgesics|analgesics|mesh-ancestor
14881794|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
14881795|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881796|NCT01198665|Prednisolone|prednisolone|mesh-list
14881797|NCT01198665|Doxorubicin|doxorubicin|mesh-list
14881798|NCT01198665|Vincristine|vincristine|mesh-list
14881799|NCT01198665|Everolimus|everolimus|mesh-list
14881800|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14881801|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715365|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
14715366|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715367|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
14715368|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14715369|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715370|NCT00457106|Risperidone|risperidone|mesh-list
14715371|NCT00457106|Paroxetine|paroxetine|mesh-list
14881802|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14881803|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14881804|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881805|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881806|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14881807|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
14881808|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
14881809|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14881810|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715372|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14715373|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
14715374|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715375|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715376|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715377|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14715378|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14715379|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715380|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715381|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14715382|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
14881811|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
14715383|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14715384|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14715385|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715386|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14715387|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715388|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14715389|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14881812|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881813|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881814|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
14881815|NCT01198665|Hormones|hormones|mesh-ancestor
14881816|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881817|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881818|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14881819|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
14881820|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14881821|NCT01198821|Gemcitabine|gemcitabine|mesh-list
14881822|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881823|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
14881824|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881825|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881826|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
14881827|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881828|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881829|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881830|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
14881831|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881832|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
14881833|NCT01198860|Tenofovir|tenofovir|mesh-list
14881834|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
14881835|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881836|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14881837|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14881838|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881839|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881840|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14881841|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14881842|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
14881843|NCT01198860|Protective Agents|protective agents|mesh-ancestor
14881844|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881845|NCT01198860|Vitamins|vitamins|mesh-ancestor
14881846|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
14881847|NCT01198912|Doxycycline|doxycycline|mesh-list
14881848|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881849|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881850|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
14881851|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14881852|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14881853|NCT01198925|Piperacillin|piperacillin|mesh-list
14881854|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881855|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881856|NCT01198938|Melatonin|melatonin|mesh-list
14881857|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
14881858|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881859|NCT01198938|Protective Agents|protective agents|mesh-ancestor
14881860|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881861|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881862|NCT01199029|Prednisone|prednisone|mesh-list
14881863|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881864|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
14881865|NCT01199029|Hormones|hormones|mesh-ancestor
15214158|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214159|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214160|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214161|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
15214162|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715390|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715391|NCT00457119|Everolimus|everolimus|mesh-list
14715392|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715393|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715394|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
14881866|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881867|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214163|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
14881868|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14881869|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881870|NCT01199081|Dronedarone|dronedarone|mesh-list
14881871|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14881872|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
14881873|NCT01199159|Pyridoxal|pyridoxal|mesh-list
14881874|NCT01199159|Pyridoxine|pyridoxine|mesh-list
14881875|NCT01199159|Misoprostol|misoprostol|mesh-list
14881876|NCT01199159|Vitamins|vitamins|mesh-ancestor
14881877|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
14881878|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881879|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14881880|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
14881881|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14881882|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14881883|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14881884|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
14881885|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
14881886|NCT01199224|Veliparib|veliparib|mesh-list
14881887|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14881888|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881889|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881890|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881891|NCT01199276|Sevoflurane|sevoflurane|mesh-list
14881892|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14881893|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14881894|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
14881895|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
14881896|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881897|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881898|NCT01199328|Aspirin|aspirin|mesh-list
14881899|NCT01199328|Esomeprazole|esomeprazole|mesh-list
14881900|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14881901|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14881902|NCT01199328|Analgesics|analgesics|mesh-ancestor
14881903|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
14881904|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881905|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881906|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14881907|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14881908|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14881909|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14881910|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881911|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14881912|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14881913|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881914|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
14881915|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14881916|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14881917|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14881918|NCT01199341|Warfarin|warfarin|mesh-list
14881919|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
14881920|NCT01199367|Letrozole|letrozole|mesh-list
14881921|NCT01199367|Lapatinib|lapatinib|mesh-list
14881922|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881923|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14881924|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14881925|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881926|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881927|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14881928|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
14881929|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14881930|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881931|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14881932|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
14715395|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715396|NCT00457145|Ranibizumab|ranibizumab|mesh-list
14715397|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715398|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715399|NCT00457145|Growth Substances|growth substances|mesh-ancestor
14715400|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715401|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
14715402|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715403|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14881933|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
14881934|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
15225712|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
14881935|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881936|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881937|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
14881938|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881939|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
14881940|NCT01199432|Fluorouracil|fluorouracil|mesh-list
14881941|NCT01199432|Epirubicin|epirubicin|mesh-list
14881942|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14881943|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
14881944|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881945|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14881946|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14881947|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
14881948|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881949|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881950|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14881951|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
14881952|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14881953|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14881954|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14881955|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14881956|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881957|NCT01199445|Vitamin A|vitamin a|mesh-list
14881958|NCT01199445|Vitamins|vitamins|mesh-ancestor
14881959|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
14881960|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881961|NCT01199458|Alfentanil|alfentanil|mesh-list
14881962|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14881963|NCT01199458|Narcotics|narcotics|mesh-ancestor
14881964|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14881965|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881966|NCT01199458|Analgesics|analgesics|mesh-ancestor
14881967|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
14881968|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14881969|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14881970|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
14881971|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
14881972|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14881973|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
14881974|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14881975|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
14881976|NCT01199523|Mirabegron|mirabegron|mesh-list
14881977|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14881978|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881979|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14881980|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14715404|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
14715405|NCT00457223|Coagulants|coagulants|mesh-ancestor
14715406|NCT00457340|Atorvastatin|atorvastatin|mesh-list
14715407|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14715408|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14715409|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
14881981|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14881982|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14881983|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14881984|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14881985|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14881986|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14881987|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14881988|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14881989|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14881990|NCT01199523|Urological Agents|urological agents|mesh-ancestor
14715410|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715411|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14715412|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14881991|NCT01199562|Valganciclovir|valganciclovir|mesh-list
14881992|NCT01199562|Ganciclovir|ganciclovir|mesh-list
14715413|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715414|NCT00457405|Dipyridamole|dipyridamole|mesh-list
14881993|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14881994|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
14881995|NCT01199562|Foscarnet|foscarnet|mesh-list
14881996|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
14881997|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14881998|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14881999|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882000|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882001|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14882002|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
14882003|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882004|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14914835|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914836|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
14914837|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14914838|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914839|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
14914840|NCT01383343|Leucovorin|leucovorin|mesh-list
14914841|NCT01383343|Folic Acid|folic acid|mesh-list
14914842|NCT01383343|Bevacizumab|bevacizumab|mesh-list
14914843|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14914844|NCT01383343|Fluorouracil|fluorouracil|mesh-list
14914845|NCT01383343|Irinotecan|irinotecan|mesh-list
14914846|NCT01383343|Sorafenib|sorafenib|mesh-list
14914847|NCT01383343|Camptothecin|camptothecin|mesh-list
14914848|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
14914849|NCT01383343|Antibodies|antibodies|mesh-list
14914850|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
14914851|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14914852|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
14914853|NCT01383343|Calcium|calcium|mesh-list
14914854|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
14914855|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914856|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715415|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14715416|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715417|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715418|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14715419|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
14715420|NCT00457470|Rucaparib|rucaparib|mesh-list
14715421|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14914857|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14914858|NCT01383343|Growth Substances|growth substances|mesh-ancestor
14914859|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914860|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
14914861|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
14914862|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14914863|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14914864|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
14914865|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914866|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14914867|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715422|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715423|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715424|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715425|NCT00457483|Valsartan|valsartan|mesh-list
14715426|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14715427|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14715428|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15214164|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214165|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15214166|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214167|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214168|NCT01415752|Rituximab|rituximab|mesh-list
15214169|NCT01415752|Lenalidomide|lenalidomide|mesh-list
15214170|NCT01415752|Bortezomib|bortezomib|mesh-list
15214171|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15214172|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214173|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214174|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
14715429|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14914868|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14914869|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14914870|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914871|NCT01383343|Antidotes|antidotes|mesh-ancestor
15214175|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214176|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214177|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214178|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15214179|NCT01415752|Growth Substances|growth substances|mesh-ancestor
15214180|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
15214181|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15214182|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
15214183|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214184|NCT01398852|Riboflavin|riboflavin|mesh-list
15214185|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
15214186|NCT01398852|Vitamins|vitamins|mesh-ancestor
15214187|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
15214188|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882005|NCT01199757|Fluticasone|fluticasone|mesh-list
14882006|NCT01199757|Xhance|xhance|mesh-list
14882007|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
14882008|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882009|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14882010|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
14882011|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882012|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882013|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14882014|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
14882015|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
14882016|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14882017|NCT01199783|Vancomycin|vancomycin|mesh-list
14882018|NCT01199783|Daptomycin|daptomycin|mesh-list
14882019|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882020|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882021|NCT01199835|Calcium|calcium|mesh-list
14882022|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14882023|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882024|NCT01199900|Prednisone|prednisone|mesh-list
15214189|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14882025|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882026|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
14882027|NCT01199900|Hormones|hormones|mesh-ancestor
14882028|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882029|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882030|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14882031|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882032|NCT01200004|Lenalidomide|lenalidomide|mesh-list
14882033|NCT01200004|Azacitidine|azacitidine|mesh-list
14882034|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
14882035|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882036|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882037|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882038|NCT01200004|Growth Substances|growth substances|mesh-ancestor
14882039|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
14715430|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715431|NCT00457483|Diuretics|diuretics|mesh-ancestor
14715432|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
14715433|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715434|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14715435|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882040|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882041|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882042|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
14715436|NCT00457509|Vaccines|vaccines|mesh-list
14715437|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
14715438|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728891|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728892|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14728893|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14728894|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14728895|NCT00520507|Olanzapine|olanzapine|mesh-list
14728896|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
14728897|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
14728898|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728899|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882043|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882044|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882045|NCT01200056|Atorvastatin|atorvastatin|mesh-list
14882046|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14882047|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14882048|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
14882049|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882050|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14882051|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14882052|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882053|NCT01200108|Budesonide|budesonide|mesh-list
14882054|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882055|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14882056|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
14882057|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882058|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882059|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14882060|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
14882061|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
14882062|NCT01200108|Hormones|hormones|mesh-ancestor
14882063|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882064|NCT01200121|Bevacizumab|bevacizumab|mesh-list
14882065|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14882066|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882067|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882068|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882069|NCT01200121|Growth Substances|growth substances|mesh-ancestor
14882070|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882071|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14296483|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14728900|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14882072|NCT01200186|Progestins|progestins|mesh-list
14882073|NCT01200186|Hormones|hormones|mesh-ancestor
14882074|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882075|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882076|NCT01200212|Bevacizumab|bevacizumab|mesh-list
14882077|NCT01200212|Taxane|taxane|mesh-list
14882078|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14882079|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882080|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882081|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882082|NCT01200212|Growth Substances|growth substances|mesh-ancestor
14882083|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882084|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
14882085|NCT01200251|Bimatoprost|bimatoprost|mesh-list
14882086|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14882087|NCT01200264|Apremilast|apremilast|mesh-list
14882088|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882089|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882090|NCT01200264|Analgesics|analgesics|mesh-ancestor
14882091|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
14882092|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882093|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882094|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882095|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882096|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14882097|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14882098|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882099|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882100|NCT01200472|Apremilast|apremilast|mesh-list
14882101|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882102|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882103|NCT01200472|Analgesics|analgesics|mesh-ancestor
14882104|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
14882105|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882106|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882107|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882108|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882109|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14882110|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14882111|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882112|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882113|NCT01200537|Norinyl|norinyl|mesh-list
14882114|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
14882115|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
14882116|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14882117|NCT01200537|Estradiol|estradiol|mesh-list
14882118|NCT01200537|Estrogens|estrogens|mesh-ancestor
14882119|NCT01200537|Hormones|hormones|mesh-ancestor
14882120|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882121|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882122|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14882123|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14882124|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14882125|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14882126|NCT01200641|Gabapentin|gabapentin|mesh-list
14882127|NCT01200641|Melatonin|melatonin|mesh-list
14882128|NCT01200641|Analgesics|analgesics|mesh-ancestor
14882129|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
14882130|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882131|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882132|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
14882133|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14882134|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14882135|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882136|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882137|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14882138|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14882139|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882140|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882141|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
14882142|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
14882143|NCT01200641|Protective Agents|protective agents|mesh-ancestor
14882144|NCT01200654|Linezolid|linezolid|mesh-list
14882145|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882146|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882147|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14882148|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882149|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882150|NCT01200693|Sirolimus|sirolimus|mesh-list
14882151|NCT01200693|Everolimus|everolimus|mesh-list
14882152|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882153|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882154|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
14882155|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882156|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882157|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882158|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882159|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
14882160|NCT01200706|Amoxicillin|amoxicillin|mesh-list
14882161|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882162|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882163|NCT01200732|Tadalafil|tadalafil|mesh-list
14882164|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
14882165|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14882166|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14882167|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882168|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882169|NCT01200732|Urological Agents|urological agents|mesh-ancestor
14882170|NCT01200745|Capsaicin|capsaicin|mesh-list
14882171|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
14882172|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
14882173|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
14882174|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882175|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882176|NCT01200784|Niacinamide|niacinamide|mesh-list
14882177|NCT01200784|Niacin|niacin|mesh-list
14882178|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
14882179|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
14882180|NCT01200784|Vitamins|vitamins|mesh-ancestor
14882181|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
14882182|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882183|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14882184|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
14882185|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882186|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14882187|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
14882188|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14882189|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
14882190|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882191|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14882192|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14882193|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882194|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882195|NCT01200914|Heparin|heparin|mesh-list
14882196|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
14882197|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14882198|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15214190|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214191|NCT01332266|Cetuximab|cetuximab|mesh-list
15214192|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214193|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214194|NCT01261728|Gemcitabine|gemcitabine|mesh-list
15214195|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214196|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214197|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
15214198|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214199|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
14882199|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882200|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
14882201|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
14882202|NCT01201005|Hematinics|hematinics|mesh-ancestor
14882203|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
14882204|NCT01201005|Vitamins|vitamins|mesh-ancestor
14882205|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
14882206|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882207|NCT01201044|Gemcitabine|gemcitabine|mesh-list
14882208|NCT01201044|Nedaplatin|nedaplatin|mesh-list
14882209|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882210|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
14882211|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882212|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882213|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
14882214|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882215|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882216|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882217|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
14882218|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882219|NCT01201070|Antithrombins|antithrombins|mesh-list
14882220|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
14882221|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14882222|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14882223|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882224|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882225|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
14882226|NCT01201122|Mesalamine|mesalamine|mesh-list
14882227|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882228|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882229|NCT01201122|Analgesics|analgesics|mesh-ancestor
14882230|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
14882231|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882232|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882233|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882234|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882235|NCT01201161|Ranibizumab|ranibizumab|mesh-list
14882236|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882237|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882238|NCT01201161|Growth Substances|growth substances|mesh-ancestor
14882239|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882240|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
14882241|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882242|NCT01201213|Anesthetics|anesthetics|mesh-list
14882243|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
14882244|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882245|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882246|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
14882247|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882248|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
14882249|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14882250|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14882251|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
14882252|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882253|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14882254|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14882255|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882256|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882257|NCT01201278|Insulin|insulin|mesh-list
14882258|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14715439|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14715440|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14715441|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14715442|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
14715443|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715444|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14715445|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14715446|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715447|NCT00457678|Dexamethasone|dexamethasone|mesh-list
14882259|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
14882260|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14882261|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882262|NCT01201499|Morphine|morphine|mesh-list
14882263|NCT01201499|Remifentanil|remifentanil|mesh-list
14882264|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14882265|NCT01201499|Narcotics|narcotics|mesh-ancestor
14882266|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882267|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882268|NCT01201499|Analgesics|analgesics|mesh-ancestor
14882269|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
14715448|NCT00457678|Ranibizumab|ranibizumab|mesh-list
14882270|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882271|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14296484|NCT05246072|Ivermectin|ivermectin|mesh-list
14882272|NCT01201551|Latanoprost|latanoprost|mesh-list
14882273|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14882274|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14882275|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14882276|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14882277|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14882278|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14882279|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
14882280|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882281|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882282|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914872|NCT01383343|Protective Agents|protective agents|mesh-ancestor
14914873|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
14914874|NCT01383343|Vitamins|vitamins|mesh-ancestor
14914875|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
14914876|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14914877|NCT01383343|Hematinics|hematinics|mesh-ancestor
14914878|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14914879|NCT01383395|Cilostazol|cilostazol|mesh-list
15214200|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214201|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214202|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214203|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
15214204|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214205|NCT01222754|Lenalidomide|lenalidomide|mesh-list
15214206|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
15214207|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296485|NCT05246072|Colchicine|colchicine|mesh-list
14296486|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
14296487|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14296488|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
15214208|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214209|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15214210|NCT01222754|Growth Substances|growth substances|mesh-ancestor
15214211|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
15214212|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214213|NCT01150890|Brodalumab|brodalumab|mesh-list
15214214|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214215|NCT01143779|Telbivudine|telbivudine|mesh-list
15214216|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
15214217|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214218|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15214219|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214220|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914880|NCT01383395|Simvastatin|simvastatin|mesh-list
14296489|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
15214221|NCT01140867|Zonisamide|zonisamide|mesh-list
15214222|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
14882283|NCT01201577|Azithromycin|azithromycin|mesh-list
14882284|NCT01201577|Sulfalene|sulfalene|mesh-list
14882285|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882286|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882287|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14882288|NCT01201577|Renal Agents|renal agents|mesh-ancestor
15214223|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15214224|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15214225|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214226|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15214227|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214228|NCT01137773|Insulin|insulin|mesh-list
15214229|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15214230|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14882289|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
14882290|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14882291|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14882292|NCT01201642|Prednisolone|prednisolone|mesh-list
14882293|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882294|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
14882295|NCT01201642|Hormones|hormones|mesh-ancestor
14882296|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882297|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882298|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14882299|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882300|NCT01201694|Curcumin|curcumin|mesh-list
14882301|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882302|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882303|NCT01201694|Analgesics|analgesics|mesh-ancestor
14882304|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
14882305|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882306|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882307|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882308|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882309|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882310|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882311|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882312|NCT01201902|Vaccines|vaccines|mesh-list
14882313|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
14882314|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882315|NCT01201928|Insulin|insulin|mesh-list
14882316|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14882317|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882318|NCT01202032|Bevacizumab|bevacizumab|mesh-list
14882319|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14882320|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882321|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882322|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882323|NCT01202032|Growth Substances|growth substances|mesh-ancestor
14882324|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882325|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
14882326|NCT01202058|Sirolimus|sirolimus|mesh-list
14882327|NCT01202058|Everolimus|everolimus|mesh-list
14882328|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882329|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882330|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
14882331|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882332|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882333|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882334|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882335|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
14882336|NCT01202084|Fluticasone|fluticasone|mesh-list
14882337|NCT01202084|Xhance|xhance|mesh-list
14882338|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
14882339|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882340|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14882341|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
14882342|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882343|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882344|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14882345|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
14882346|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
14882347|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14882348|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14882349|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14882350|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14882351|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
14882352|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882353|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882354|NCT01202097|Fluticasone|fluticasone|mesh-list
14882355|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14882356|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14882357|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882358|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14882359|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
14882360|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882361|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882362|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14882363|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
14882364|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
14882365|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14882366|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14882367|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14882368|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14882369|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
14882370|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882371|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882372|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
14882373|NCT01202097|Hormones|hormones|mesh-ancestor
14882374|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882375|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
14882376|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
14882377|NCT01202149|Emollients|emollients|mesh-list
14882378|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882379|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882380|NCT01202149|Analgesics|analgesics|mesh-ancestor
14882381|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
14882382|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882383|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882384|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882385|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882386|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
14882387|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882388|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
14882389|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14882390|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715449|NCT00457678|Verteporfin|verteporfin|mesh-list
14715450|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296490|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
14296491|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296492|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882391|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882392|NCT01202240|Ketoconazole|ketoconazole|mesh-list
14882393|NCT01202240|Tofacitinib|tofacitinib|mesh-list
14882394|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
14882395|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882396|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14882397|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14882398|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882399|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882400|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14882401|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
14882402|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882403|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882404|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14882405|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14882406|NCT01202331|Azithromycin|azithromycin|mesh-list
14882407|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882408|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882409|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
14882410|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14882411|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882412|NCT01202422|Pregabalin|pregabalin|mesh-list
14882413|NCT01202422|Analgesics|analgesics|mesh-ancestor
14882414|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
14882415|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882416|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882417|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
14882418|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14882419|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882420|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882421|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14882422|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14882423|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14882424|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882425|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715451|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
14715452|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
14715453|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715454|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715455|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14715456|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
14715457|NCT00457678|Hormones|hormones|mesh-ancestor
14715458|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715459|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14882426|NCT01202435|Pregabalin|pregabalin|mesh-list
14882427|NCT01202435|Analgesics|analgesics|mesh-ancestor
14882428|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
14882429|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882430|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882431|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
14882432|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14882433|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882434|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882435|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14882436|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14882437|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14882438|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882439|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882440|NCT01202474|Insulin|insulin|mesh-list
14882441|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14882442|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
14882443|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
14882444|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14882445|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882446|NCT01202487|Lidocaine|lidocaine|mesh-list
14882447|NCT01202487|Epinephrine|epinephrine|mesh-list
14882448|NCT01202487|Tetracaine|tetracaine|mesh-list
14882449|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
14882450|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
14882451|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882452|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882453|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
14882454|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882455|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14882456|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14882457|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14882458|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882459|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882460|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14882461|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14882462|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
14882463|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882464|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14882465|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14882466|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
14882467|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14882468|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
14882469|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
14882470|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
14882471|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14882472|NCT01202513|Bimatoprost|bimatoprost|mesh-list
14882473|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14882474|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14882475|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14882476|NCT01202552|Vaccines|vaccines|mesh-list
14882477|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
14882478|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882479|NCT01202734|Methylphenidate|methylphenidate|mesh-list
14882480|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14882481|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882482|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14882483|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14882484|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882485|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882486|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
14882487|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882488|NCT01202799|Diclofenac|diclofenac|mesh-list
14882489|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882490|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882491|NCT01202799|Analgesics|analgesics|mesh-ancestor
14882492|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
14882493|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882494|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882495|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882496|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882497|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14882498|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882499|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882500|NCT01202825|Simeprevir|simeprevir|mesh-list
14882501|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
14882502|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882503|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
14882504|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882505|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882506|NCT01202890|Bevacizumab|bevacizumab|mesh-list
14882507|NCT01202890|Lenalidomide|lenalidomide|mesh-list
14882508|NCT01202890|Doxorubicin|doxorubicin|mesh-list
14882509|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14882510|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14882511|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882512|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882513|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882514|NCT01202890|Growth Substances|growth substances|mesh-ancestor
14882515|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882516|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
14882517|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882518|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14882519|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14882520|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882521|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882522|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
14882523|NCT01203020|Vidarabine|vidarabine|mesh-list
14882524|NCT01203020|Fludarabine|fludarabine|mesh-list
14882525|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
14882526|NCT01203020|Busulfan|busulfan|mesh-list
14882527|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882528|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214231|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214232|NCT01127256|Carbamazepine|carbamazepine|mesh-list
15214233|NCT01127256|Zonisamide|zonisamide|mesh-list
15214234|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
15214235|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
15214236|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15214237|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214238|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214239|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15214240|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15214241|NCT01127256|Analgesics|analgesics|mesh-ancestor
15214242|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
15214243|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296493|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14296494|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715460|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715461|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715462|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715463|NCT00457678|Growth Substances|growth substances|mesh-ancestor
14715464|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
14715465|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14715466|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
14715467|NCT00457717|Atropine|atropine|mesh-list
14715468|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14715469|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14715470|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14715471|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
14715472|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715473|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715474|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14715475|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
14715476|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
14715477|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
14715478|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14715479|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14715480|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
14715481|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715482|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715483|NCT00457769|Donepezil|donepezil|mesh-list
14715484|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14715485|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715486|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882529|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
14882530|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882531|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214244|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15214245|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882532|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
14882533|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882534|NCT01203020|Antiviral Agents|antiviral agents|mesh-ancestor
14882535|NCT01203020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882536|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
14882537|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14882538|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14882539|NCT01203111|Insulin|insulin|mesh-list
14882540|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14882541|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
14882542|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
14882543|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15214246|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214247|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15214248|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15214249|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15214250|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15214251|NCT00978458|Temozolomide|temozolomide|mesh-list
15214252|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15214253|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
15214254|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214255|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214256|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
15214257|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882544|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882545|NCT01203202|Clomipramine|clomipramine|mesh-list
14882546|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14882547|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
14882548|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882549|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14882550|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14882551|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882552|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882553|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882554|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
14882555|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882556|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
14882557|NCT01203228|Busulfan|busulfan|mesh-list
14882558|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
14882559|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882560|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
14882561|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882562|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882563|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14882564|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
14882565|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882566|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882567|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14882568|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882569|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
14882570|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14882571|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14882572|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14882573|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
14882574|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882575|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14882576|NCT01203267|Paclitaxel|paclitaxel|mesh-list
14882577|NCT01203267|Carboplatin|carboplatin|mesh-list
14882578|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14882579|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882580|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
14882581|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
14882582|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
14882583|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882584|NCT01203306|Bevacizumab|bevacizumab|mesh-list
14882585|NCT01203306|Capecitabine|capecitabine|mesh-list
14882586|NCT01203306|Octreotide|octreotide|mesh-list
14882587|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14882588|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882589|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882590|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882591|NCT01203306|Growth Substances|growth substances|mesh-ancestor
14882592|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882593|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
14882594|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882595|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
14882596|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882597|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14882598|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14882599|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14882600|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
14882601|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882602|NCT01203358|Beractant|beractant|mesh-list
14882603|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14882604|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
14914881|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14914882|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14914883|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
14914884|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914885|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914886|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14914887|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914888|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14914889|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
14914890|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914891|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914892|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15214258|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15214259|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214260|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214261|NCT00482833|Methotrexate|methotrexate|mesh-list
15214262|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
15214263|NCT00482833|Idarubicin|idarubicin|mesh-list
15214264|NCT00482833|Tretinoin|tretinoin|mesh-list
15214265|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
15214266|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15214267|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
15214268|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15214269|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914893|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
15225713|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
14882605|NCT01203371|Naftopidil|naftopidil|mesh-list
14882606|NCT01203371|Tamsulosin|tamsulosin|mesh-list
14882607|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14882608|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14882609|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14882610|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14882611|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882612|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882613|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882614|NCT01203371|Urological Agents|urological agents|mesh-ancestor
14882615|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14882616|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14882617|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882618|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14882619|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14882620|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
14882621|NCT01203384|Analgesics|analgesics|mesh-ancestor
14715487|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
14715488|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715489|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715490|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
14715491|NCT00457808|Sirolimus|sirolimus|mesh-list
14715492|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882622|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
14882623|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882624|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882625|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882626|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882627|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882628|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882629|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14882630|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882631|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882632|NCT01203488|Vitamin A|vitamin a|mesh-list
14882633|NCT01203488|Vitamins|vitamins|mesh-ancestor
14882634|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
14882635|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882636|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
14882637|NCT01203514|Hematinics|hematinics|mesh-ancestor
14882638|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14882639|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14882640|NCT01203592|Albuterol|albuterol|mesh-list
14715493|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715494|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14715495|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715496|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
14715497|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715498|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
14715499|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715500|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
14715501|NCT00457860|Immunotoxins|immunotoxins|mesh-list
14715502|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
14715503|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214270|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715504|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715505|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14882641|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14882642|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
14882643|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214271|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
15214272|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214273|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214274|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214275|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214276|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15214277|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214278|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
15214279|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214280|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14728901|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14715506|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
14715507|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882644|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882645|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14882646|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
14882647|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
14882648|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14882649|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14882650|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14882651|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14882652|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
14882653|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715508|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14715509|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14715510|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715511|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715512|NCT00457964|Everolimus|everolimus|mesh-list
14715513|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715514|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715515|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
14715516|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715517|NCT00458003|Phenylephrine|phenylephrine|mesh-list
14882654|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882655|NCT01203618|Farletuzumab|farletuzumab|mesh-list
14882656|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882657|NCT01203696|Amlodipine|amlodipine|mesh-list
14882658|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14882659|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14882660|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882661|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882662|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14882663|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882664|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
14882665|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
14882666|NCT01203709|Tacrolimus|tacrolimus|mesh-list
14882667|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882668|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
14882669|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882670|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14882671|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882672|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882673|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882674|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882675|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14882676|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
14882677|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882678|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882679|NCT01203735|Valproic Acid|valproic acid|mesh-list
14715518|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
14882680|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
14715519|NCT00458003|Ephedrine|ephedrine|mesh-list
14882681|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882682|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882683|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
14882684|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882685|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882686|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
14882687|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14882688|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882689|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882690|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14882691|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14882692|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14882693|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
14882694|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882695|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14882696|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14882697|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882698|NCT01204086|Fluoxetine|fluoxetine|mesh-list
14882699|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14882700|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14882701|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14882702|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14882703|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882704|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882705|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
14882706|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882707|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14882708|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
15214281|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15214282|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15214283|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15214284|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
14296495|NCT05245994|Carboplatin|carboplatin|mesh-list
14882709|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882710|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14882711|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14882712|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882713|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14882714|NCT01204112|Rifampin|rifampin|mesh-list
15214285|NCT00381381|Donepezil|donepezil|mesh-list
15214286|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15214287|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214288|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214289|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
15214290|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214291|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214292|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
15214293|NCT00102648|Temozolomide|temozolomide|mesh-list
15214294|NCT00102648|Lonafarnib|lonafarnib|mesh-list
15214295|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15214296|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
14296496|NCT05245994|Etoposide|etoposide|mesh-list
14882715|NCT01204112|Tofacitinib|tofacitinib|mesh-list
14882716|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14882717|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
14882718|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882719|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882720|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
14882721|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14882722|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882723|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882724|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14882725|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14882726|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14882727|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14882728|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14882729|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14882730|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14882731|NCT01204125|Paclitaxel|paclitaxel|mesh-list
14882732|NCT01204125|Iniparib|iniparib|mesh-list
14882733|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14882734|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882735|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14882736|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14882737|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14882738|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882739|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14882740|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882741|NCT01204138|Apremilast|apremilast|mesh-list
14882742|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14882743|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14882744|NCT01204138|Analgesics|analgesics|mesh-ancestor
14882745|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
14882746|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882747|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882748|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882749|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882750|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14882751|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14882752|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882753|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882754|NCT01204164|Dexamethasone|dexamethasone|mesh-list
14882755|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14882756|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
15214297|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214298|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214299|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214300|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
15214301|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214302|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15214303|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214304|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214305|NCT05179733|Rituximab|rituximab|mesh-list
15214306|NCT05179733|Lenalidomide|lenalidomide|mesh-list
15214307|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
14882757|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
14882758|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882759|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882760|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14882761|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
14882762|NCT01204164|Hormones|hormones|mesh-ancestor
14882763|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882764|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14882765|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882766|NCT01204177|Sorafenib|sorafenib|mesh-list
14882767|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882768|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14882769|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882770|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882771|NCT01204190|Gestodene|gestodene|mesh-list
14882772|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14882773|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14882774|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14882775|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
14882776|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14882777|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882778|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14882779|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14882780|NCT01204190|Progestins|progestins|mesh-ancestor
14882781|NCT01204190|Hormones|hormones|mesh-ancestor
14882782|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882783|NCT01204216|Biotin|biotin|mesh-list
14882784|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
14882785|NCT01204216|Vitamins|vitamins|mesh-ancestor
14882786|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
14882787|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882788|NCT01204268|Sevoflurane|sevoflurane|mesh-list
14882789|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14882790|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14882791|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
14882792|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
14882793|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882794|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882795|NCT01204307|Cisplatin|cisplatin|mesh-list
14882796|NCT01204307|Docetaxel|docetaxel|mesh-list
14882797|NCT01204307|Pemetrexed|pemetrexed|mesh-list
14882798|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882799|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
14882800|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
14882801|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
14882802|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882803|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882804|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14882805|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14882806|NCT01204320|Paclitaxel|paclitaxel|mesh-list
14882807|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14882808|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14882809|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882810|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
14882811|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
14882812|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
14882813|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882814|NCT01204333|Heparin|heparin|mesh-list
14882815|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
14882816|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14882817|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14882818|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882819|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
14882820|NCT01204372|Gemcitabine|gemcitabine|mesh-list
14882821|NCT01204372|Trastuzumab|trastuzumab|mesh-list
14882822|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14882823|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882824|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
14882825|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882826|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882827|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
14882828|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882829|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882830|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882831|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
14882832|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882833|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14882834|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14882835|NCT01204411|Artesunate|artesunate|mesh-list
14882836|NCT01204411|Amodiaquine|amodiaquine|mesh-list
14882837|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
14882838|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14882839|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14882840|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214308|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214309|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214310|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
15214311|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214312|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214313|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214314|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15214315|NCT05179733|Growth Substances|growth substances|mesh-ancestor
15214316|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
15214317|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15214318|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214319|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214320|NCT05179525|Risperidone|risperidone|mesh-list
15214321|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15214322|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
15214323|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214324|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214325|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214326|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15214327|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15214328|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214329|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15214330|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15214331|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
15214332|NCT05179512|Fluticasone|fluticasone|mesh-list
15214333|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
14882841|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882842|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
14882843|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
14882844|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14882845|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
14882846|NCT01204437|Paclitaxel|paclitaxel|mesh-list
14882847|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
14882848|NCT01204437|Capecitabine|capecitabine|mesh-list
14882849|NCT01204437|Methotrexate|methotrexate|mesh-list
14882850|NCT01204437|Epirubicin|epirubicin|mesh-list
14882851|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14882852|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214334|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15214335|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14715520|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14715521|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
14715522|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
14715523|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715524|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715525|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
14715526|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15214336|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715527|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
15214337|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15214338|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
15214339|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214340|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214341|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14715528|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
14715529|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14715530|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14715531|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14715532|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
14715533|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715534|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715535|NCT00458003|Protective Agents|protective agents|mesh-ancestor
14882853|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
15214342|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
14882854|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
14882855|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
14882856|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882857|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882858|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
14882859|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882860|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14882861|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14882862|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
14882863|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14882864|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882865|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
14882866|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14882867|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
14882868|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14882869|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14882870|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882871|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14882872|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14882873|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882874|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14882875|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14882876|NCT01204450|Sirolimus|sirolimus|mesh-list
14882877|NCT01204450|Valproic Acid|valproic acid|mesh-list
14882878|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14882879|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882880|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882881|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882882|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
14882883|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882884|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
14882885|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882886|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
14882887|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882888|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882889|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
14882890|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882891|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
14882892|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14882893|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14882894|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14882895|NCT01204476|Everolimus|everolimus|mesh-list
14882896|NCT01204476|Octreotide|octreotide|mesh-list
14882897|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14882898|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882899|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882900|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
14882901|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882902|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14882903|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14882904|NCT01204580|Metformin|metformin|mesh-list
14882905|NCT01204580|Glimepiride|glimepiride|mesh-list
14882906|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14882907|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882908|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14882909|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214343|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214344|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15214345|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
15214346|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15214347|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
15214348|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214349|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214350|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14882910|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
14882911|NCT01204593|Insulin|insulin|mesh-list
14882912|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14882913|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
14882914|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
14882915|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14882916|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882917|NCT01204723|Aprepitant|aprepitant|mesh-list
14882918|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
14882919|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
14882920|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
14882921|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14882922|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882923|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14882924|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14882925|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14882926|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882927|NCT01204801|Doxorubicin|doxorubicin|mesh-list
14882928|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14882929|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882930|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882931|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14882932|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14882933|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882934|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882935|NCT01204840|Hormones|hormones|mesh-list
14882936|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14882937|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882938|NCT01204996|Gemcitabine|gemcitabine|mesh-list
14882939|NCT01204996|Paclitaxel|paclitaxel|mesh-list
14882940|NCT01204996|Docetaxel|docetaxel|mesh-list
14882941|NCT01204996|Carboplatin|carboplatin|mesh-list
14882942|NCT01204996|Doxorubicin|doxorubicin|mesh-list
14882943|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14882944|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14882945|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882946|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
14882947|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
14882948|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
14882949|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882950|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882951|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
14882952|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
14882953|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14882954|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882955|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882956|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
14882957|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882958|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14882959|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14715536|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14715537|NCT00458042|Treprostinil|treprostinil|mesh-list
14715538|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14715539|NCT00458055|Niacin|niacin|mesh-list
14715540|NCT00458055|Atorvastatin|atorvastatin|mesh-list
14715541|NCT00458055|Fenofibrate|fenofibrate|mesh-list
14715542|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14715543|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14715544|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
14715545|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715546|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14728902|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14882960|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14882961|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14882962|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14882963|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882964|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
14882965|NCT01205022|Leucovorin|leucovorin|mesh-list
14882966|NCT01205022|Bevacizumab|bevacizumab|mesh-list
14882967|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14882968|NCT01205022|Fluorouracil|fluorouracil|mesh-list
14882969|NCT01205022|Irinotecan|irinotecan|mesh-list
14882970|NCT01205022|Camptothecin|camptothecin|mesh-list
14882971|NCT01205022|Antibodies|antibodies|mesh-list
14882972|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
14882973|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14882974|NCT01205022|Calcium|calcium|mesh-list
14882975|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
14882976|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14882977|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14882978|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14882979|NCT01205022|Growth Substances|growth substances|mesh-ancestor
14882980|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14882981|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
14882982|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
14882983|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14882984|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14882985|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
14882986|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882987|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14882988|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14882989|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14882990|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15214351|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15214352|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15214353|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214354|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
15214355|NCT05179512|Hormones|hormones|mesh-ancestor
15214356|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214357|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
15214358|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
15214359|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15214360|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214361|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15214362|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214363|NCT05179213|Azacitidine|azacitidine|mesh-list
15214364|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214365|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
15214366|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214367|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214368|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225228|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14882991|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14882992|NCT01205022|Antidotes|antidotes|mesh-ancestor
14882993|NCT01205022|Protective Agents|protective agents|mesh-ancestor
14882994|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
14882995|NCT01205022|Vitamins|vitamins|mesh-ancestor
14882996|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
14882997|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14882998|NCT01205074|Ethanol|ethanol|mesh-list
14882999|NCT01205074|Propranolol|propranolol|mesh-list
14883000|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14883001|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14883002|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
14883003|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883004|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883005|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883006|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14883007|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14883008|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
14883009|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14883010|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883011|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883012|NCT01205087|Omeprazole|omeprazole|mesh-list
14883013|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14883014|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883015|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14883016|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883017|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883018|NCT01205139|Simeprevir|simeprevir|mesh-list
14883019|NCT01205139|Rilpivirine|rilpivirine|mesh-list
14883020|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
14883021|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883022|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
14883023|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883024|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883025|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14883026|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14883027|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14883028|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14883029|NCT01205178|Chloroquine|chloroquine|mesh-list
14883030|NCT01205178|Primaquine|primaquine|mesh-list
14883031|NCT01205178|Tafenoquine|tafenoquine|mesh-list
14883032|NCT01205178|Amebicides|amebicides|mesh-ancestor
14883033|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14883034|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14883035|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883036|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
14883037|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914894|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14914895|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14914896|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914897|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
14914898|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14914899|NCT01383395|Protective Agents|protective agents|mesh-ancestor
14914900|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14914901|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14914902|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
14914903|NCT01383460|Sargramostim|sargramostim|mesh-list
14914904|NCT01383460|Lenograstim|lenograstim|mesh-list
14914905|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
14914906|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914907|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14914908|NCT01383460|Hematinics|hematinics|mesh-ancestor
14914909|NCT01383538|Leucovorin|leucovorin|mesh-list
14914910|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
14914911|NCT01383538|Irinotecan|irinotecan|mesh-list
14914912|NCT01383538|Folfirinox|folfirinox|mesh-list
14914913|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914914|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14914915|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14914916|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914917|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914918|NCT01383538|Antidotes|antidotes|mesh-ancestor
14914919|NCT01383538|Protective Agents|protective agents|mesh-ancestor
14914920|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914921|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
14914922|NCT01383538|Vitamins|vitamins|mesh-ancestor
14715547|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14715548|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715549|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
14715550|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
14715551|NCT00458055|Vitamins|vitamins|mesh-ancestor
14715552|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
14715553|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715554|NCT00458081|Rimonabant|rimonabant|mesh-list
14715555|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14914923|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
14914924|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
14914925|NCT01383655|Analgesics|analgesics|mesh-ancestor
14914926|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
14914927|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14914928|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914929|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
15214369|NCT05179070|Carvedilol|carvedilol|mesh-list
14883038|NCT01205204|Clonidine|clonidine|mesh-list
14883039|NCT01205204|Fentanyl|fentanyl|mesh-list
14883040|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14883041|NCT01205204|Narcotics|narcotics|mesh-ancestor
14883042|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883043|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883044|NCT01205204|Analgesics|analgesics|mesh-ancestor
14883045|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
14883046|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883047|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14883048|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14883049|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
14883050|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
14883051|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14883052|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
14883053|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
14883054|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14883055|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14883056|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14883057|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
14883058|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883059|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883060|NCT01205217|Paclitaxel|paclitaxel|mesh-list
14883061|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
14883062|NCT01205217|Trastuzumab|trastuzumab|mesh-list
14883063|NCT01205217|Epirubicin|epirubicin|mesh-list
14883064|NCT01205217|Lapatinib|lapatinib|mesh-list
14883065|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14883066|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883067|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14883068|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14883069|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14883070|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883071|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883072|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
14883073|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883074|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883075|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14883076|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
14883077|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14883078|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14883079|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14883080|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14883081|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14883082|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883083|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14883084|NCT01205243|Abacavir|abacavir|mesh-list
14883085|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14883086|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14883087|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883088|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883089|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
14883090|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883091|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14883092|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14883093|NCT01205256|Methadone|methadone|mesh-list
14883094|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14883095|NCT01205256|Narcotics|narcotics|mesh-ancestor
14883096|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883097|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883098|NCT01205256|Analgesics|analgesics|mesh-ancestor
14883099|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
14883100|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715556|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14715557|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14715558|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715559|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715560|NCT00458081|Hormones|hormones|mesh-ancestor
14715561|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715562|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715563|NCT00458185|Etanercept|etanercept|mesh-list
14715564|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14715565|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14715566|NCT00458185|Analgesics|analgesics|mesh-ancestor
14715567|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
14715568|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883101|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
14883102|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14883103|NCT01205282|Pioglitazone|pioglitazone|mesh-list
14883104|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883105|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883106|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
14883107|NCT01205321|Bombesin|bombesin|mesh-list
14883108|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883109|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883110|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883111|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883112|NCT01205347|Simvastatin|simvastatin|mesh-list
14883113|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14883114|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14883115|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
14883116|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883117|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14883118|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14883119|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883120|NCT01205360|Fentanyl|fentanyl|mesh-list
14883121|NCT01205360|Bupivacaine|bupivacaine|mesh-list
14883122|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
14883123|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
14883124|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883125|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883126|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
14883127|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883128|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14883129|NCT01205360|Narcotics|narcotics|mesh-ancestor
14883130|NCT01205360|Analgesics|analgesics|mesh-ancestor
14883131|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14883132|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14883133|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
14883134|NCT01205464|Doxycycline|doxycycline|mesh-list
14883135|NCT01205464|Tetracycline|tetracycline|mesh-list
14883136|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883137|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883138|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
14883139|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14883140|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14883141|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14883142|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883143|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883144|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14883145|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883146|NCT01205516|Morphine|morphine|mesh-list
14883147|NCT01205516|Methadone|methadone|mesh-list
14883148|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14883149|NCT01205516|Narcotics|narcotics|mesh-ancestor
14883150|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883151|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883152|NCT01205516|Analgesics|analgesics|mesh-ancestor
14883153|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
14883154|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883155|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
14883156|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
14883157|NCT01205672|Metformin|metformin|mesh-list
14883158|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883159|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883160|NCT01205711|Leucovorin|leucovorin|mesh-list
14883161|NCT01205711|Fluorouracil|fluorouracil|mesh-list
14883162|NCT01205711|Irinotecan|irinotecan|mesh-list
14883163|NCT01205711|Calcium|calcium|mesh-list
14883164|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
14883165|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14883166|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883167|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
14883168|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883169|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14883170|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883171|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883172|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
14883173|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14883174|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14883175|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883176|NCT01205711|Antidotes|antidotes|mesh-ancestor
14883177|NCT01205711|Protective Agents|protective agents|mesh-ancestor
14883178|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
14883179|NCT01205711|Vitamins|vitamins|mesh-ancestor
14883180|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
14883181|NCT01205724|Factor VIII|factor viii|mesh-list
14883182|NCT01205724|Coagulants|coagulants|mesh-ancestor
14883183|NCT01205737|Rituximab|rituximab|mesh-list
14883184|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14883185|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883186|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
14883187|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883188|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883189|NCT01205750|Insulin|insulin|mesh-list
14883190|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14883191|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883192|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883193|NCT01205880|Calcitriol|calcitriol|mesh-list
14883194|NCT01205880|Clobetasol|clobetasol|mesh-list
14883195|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14883196|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883197|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14883198|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14883199|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883200|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14883201|NCT01205880|Vitamins|vitamins|mesh-ancestor
14883202|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
14883203|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14883204|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883205|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
14883206|NCT01205880|Hormones|hormones|mesh-ancestor
14883207|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883208|NCT01205932|Enoxaparin|enoxaparin|mesh-list
14883209|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
14883210|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14883211|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
14883212|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14883213|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
14883214|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883215|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883216|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
14883217|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14883218|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14883219|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
15214370|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15214371|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15214372|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214373|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214374|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214375|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214376|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15214377|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
14883220|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14883221|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14883222|NCT01205958|Analgesics|analgesics|mesh-ancestor
14883223|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
14715569|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715570|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715571|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214378|NCT05179070|Protective Agents|protective agents|mesh-ancestor
15214379|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15214380|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15214381|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15214382|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
15214383|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15214384|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15214385|NCT05179018|Autoantibodies|autoantibodies|mesh-list
15214386|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
15214387|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214388|NCT05179005|Imidacloprid|imidacloprid|mesh-list
15214389|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
15214390|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214391|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214392|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715572|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14715573|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715574|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
14715575|NCT00458250|Cyclosporine|cyclosporine|mesh-list
14715576|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
14715577|NCT00458250|Busulfan|busulfan|mesh-list
14715578|NCT00458250|Methotrexate|methotrexate|mesh-list
14715579|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
14715580|NCT00458250|Cyclosporins|cyclosporins|mesh-list
14715581|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715582|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
14715583|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715584|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14715585|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14715586|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
14715587|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715588|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715589|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14715590|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14715591|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
14715592|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14715593|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715594|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
14715595|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14715596|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715597|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14715598|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14715599|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
14715600|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715601|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14715602|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14715603|NCT00458263|Hormones|hormones|mesh-list
14715604|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715605|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715606|NCT00458315|Gemcitabine|gemcitabine|mesh-list
14715607|NCT00458315|Paclitaxel|paclitaxel|mesh-list
14715608|NCT00458315|Bevacizumab|bevacizumab|mesh-list
14715609|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14715610|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883224|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883225|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883226|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883227|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883228|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
14883229|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14883230|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
14883231|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14883232|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14883233|NCT01205984|Prednisolone|prednisolone|mesh-list
14883234|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
14883235|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15214393|NCT05178953|Zinc|zinc|mesh-list
15214394|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
15214395|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
15214396|NCT05178953|Trace Elements|trace elements|mesh-ancestor
15214397|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
15214398|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214399|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15214400|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214401|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214402|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15214403|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15214404|NCT05178953|Protective Agents|protective agents|mesh-ancestor
15214405|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
15214406|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14715611|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14715612|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14715613|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14715614|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715615|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14715616|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715617|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715618|NCT00458315|Growth Substances|growth substances|mesh-ancestor
14715619|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715620|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
14715621|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715622|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
14715623|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
14883236|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
14883237|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883238|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
14883239|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
14883240|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883241|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883242|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883243|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
14883244|NCT01205984|Hormones|hormones|mesh-ancestor
14883245|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883246|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14883247|NCT01205984|Protective Agents|protective agents|mesh-ancestor
15214407|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
15214408|NCT05178953|Astringents|astringents|mesh-ancestor
14715624|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715625|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715626|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715627|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
14715628|NCT00458328|Z 338|z 338|mesh-list
14715629|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14296497|NCT05245994|Durvalumab|durvalumab|mesh-list
14715630|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715631|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715632|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
14715633|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715634|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715635|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14715636|NCT00458367|Risperidone|risperidone|mesh-list
14715637|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14715638|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
14715639|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715640|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715641|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715642|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14883248|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14883249|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883250|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883251|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883252|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14883253|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883254|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883255|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
14883256|NCT01205997|Fentanyl|fentanyl|mesh-list
14883257|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14883258|NCT01205997|Narcotics|narcotics|mesh-ancestor
14883259|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883260|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883261|NCT01205997|Analgesics|analgesics|mesh-ancestor
14883262|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
14883263|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883264|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14883265|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14883266|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
14883267|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
14883268|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14883269|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
14883270|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14883271|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14883272|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883273|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14883274|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
14883275|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14883276|NCT01206010|Varenicline|varenicline|mesh-list
14883277|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14883278|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14883279|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
14883280|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883281|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883282|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883283|NCT01206036|Sirolimus|sirolimus|mesh-list
14883284|NCT01206036|Docetaxel|docetaxel|mesh-list
14883285|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883286|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
14883287|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
14883288|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
14883289|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883290|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883291|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883292|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14883293|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
14883294|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883295|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
14883296|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883297|NCT01206049|Gemcitabine|gemcitabine|mesh-list
14883298|NCT01206049|Bevacizumab|bevacizumab|mesh-list
14883299|NCT01206049|Panitumumab|panitumumab|mesh-list
14296498|NCT05245994|Olaparib|olaparib|mesh-list
14883300|NCT01206049|Capecitabine|capecitabine|mesh-list
14883301|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
14715643|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14883302|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14883303|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883304|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14883305|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14883306|NCT01206049|Growth Substances|growth substances|mesh-ancestor
14883307|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883308|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
14883309|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14883310|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
14883311|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883312|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
14883313|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883314|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883315|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883316|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
14883317|NCT01206075|Plerixafor|plerixafor|mesh-list
14883318|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14883319|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14883320|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
14883321|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883322|NCT01206153|Metformin|metformin|mesh-list
14883323|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883324|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883325|NCT01206205|Lenalidomide|lenalidomide|mesh-list
14883326|NCT01206205|Bortezomib|bortezomib|mesh-list
14883327|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
14883328|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883329|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14883330|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14883331|NCT01206205|Growth Substances|growth substances|mesh-ancestor
14883332|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
14883333|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883334|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
14883335|NCT01206270|Castor Oil|castor oil|mesh-list
14883336|NCT01206270|Testosterone|testosterone|mesh-list
14883337|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
14883338|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
14883339|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14883340|NCT01206270|Androgens|androgens|mesh-ancestor
14883341|NCT01206270|Hormones|hormones|mesh-ancestor
14883342|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883343|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883344|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14883345|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883346|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
14883347|NCT01206270|Cathartics|cathartics|mesh-ancestor
14883348|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214409|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214410|NCT05178862|Fluconazole|fluconazole|mesh-list
15214411|NCT05178862|Caspofungin|caspofungin|mesh-list
15214412|NCT05178862|Micafungin|micafungin|mesh-list
15214413|NCT05178862|Anidulafungin|anidulafungin|mesh-list
15214414|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
14715644|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214415|NCT05178862|Echinocandins|echinocandins|mesh-list
15214416|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
15214417|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715645|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715646|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14715647|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
15214418|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15214419|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14715648|NCT00458419|Naloxone|naloxone|mesh-list
14715649|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14715650|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715651|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
14715652|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715653|NCT00458458|Leuprolide|leuprolide|mesh-list
14883349|NCT01206348|Minocycline|minocycline|mesh-list
14883350|NCT01206348|Clindamycin|clindamycin|mesh-list
14296499|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715654|NCT00458458|Norethindrone|norethindrone|mesh-list
14883351|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
14883352|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
15214420|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883353|NCT01206348|Tretinoin|tretinoin|mesh-list
14883354|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14883355|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883356|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883357|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14883358|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883359|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883360|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
14883361|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883362|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
14883363|NCT01206530|Leucovorin|leucovorin|mesh-list
14883364|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
14883365|NCT01206530|Bevacizumab|bevacizumab|mesh-list
14883366|NCT01206530|Fluorouracil|fluorouracil|mesh-list
14883367|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
14883368|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14883369|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883370|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14883371|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14883372|NCT01206530|Growth Substances|growth substances|mesh-ancestor
14883373|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883374|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
14883375|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
14883376|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883377|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14883378|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883379|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
14883380|NCT01206530|Antidotes|antidotes|mesh-ancestor
14883381|NCT01206530|Protective Agents|protective agents|mesh-ancestor
14883382|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
14883383|NCT01206530|Vitamins|vitamins|mesh-ancestor
14883384|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
14883385|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
14883386|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14883387|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14883388|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883389|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883390|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883391|NCT01206569|Tacrolimus|tacrolimus|mesh-list
14883392|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883393|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
14883394|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883395|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14883396|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883397|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883398|NCT01206647|Metformin|metformin|mesh-list
14883399|NCT01206647|Saxagliptin|saxagliptin|mesh-list
14883400|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883401|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883402|NCT01206647|Incretins|incretins|mesh-ancestor
14883403|NCT01206647|Hormones|hormones|mesh-ancestor
14883404|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883405|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14883406|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
14883407|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883408|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883409|NCT01206803|Ganirelix|ganirelix|mesh-list
14883410|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
15214421|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214422|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15214423|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
15214424|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214425|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214426|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15214427|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15214428|NCT05178745|Fluorouracil|fluorouracil|mesh-list
15214429|NCT05178745|Irinotecan|irinotecan|mesh-list
15214430|NCT05178745|Aflibercept|aflibercept|mesh-list
15214431|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
15214432|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214433|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14883411|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883412|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883413|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
14883414|NCT01206881|Docetaxel|docetaxel|mesh-list
14883415|NCT01206881|Doxorubicin|doxorubicin|mesh-list
14883416|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14883417|NCT01206881|Trastuzumab|trastuzumab|mesh-list
14883418|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883419|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
14883420|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883421|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883422|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14883423|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
14883424|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883425|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883426|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15214434|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214435|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214436|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
15214437|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715655|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
14715656|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14715657|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
15214438|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15214439|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15214440|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715658|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14715659|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715660|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15214441|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214442|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15214443|NCT05178745|Growth Substances|growth substances|mesh-ancestor
15214444|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
15214445|NCT05178511|Ensartinib|ensartinib|mesh-list
15214446|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214447|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15214448|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214449|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214450|NCT05178407|Micronutrients|micronutrients|mesh-list
15214451|NCT05178407|Trace Elements|trace elements|mesh-list
15214452|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214453|NCT05178043|Nivolumab|nivolumab|mesh-list
15214454|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214455|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214456|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15214457|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214458|NCT05177926|Tenofovir|tenofovir|mesh-list
15214459|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
15214460|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214461|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14715661|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715662|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14715663|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14883427|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14883428|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14883429|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14883430|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14883431|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14883432|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14883433|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883434|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14883435|NCT01206907|Oxymorphone|oxymorphone|mesh-list
14883436|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14883437|NCT01206907|Narcotics|narcotics|mesh-ancestor
14883438|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883439|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883440|NCT01206907|Analgesics|analgesics|mesh-ancestor
14883441|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
14883442|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883443|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14914930|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14914931|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14914932|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
14914933|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14914934|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14914935|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914936|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14914937|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
14914938|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14296500|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14296501|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14296502|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14296503|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715664|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14296504|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296505|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296506|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14715665|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
14715666|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14715667|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14715668|NCT00458510|Fentanyl|fentanyl|mesh-list
14715669|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14715670|NCT00458510|Narcotics|narcotics|mesh-ancestor
14715671|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14914939|NCT01383668|Sirolimus|sirolimus|mesh-list
14914940|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
14914941|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14914942|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914943|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14914944|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914945|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
14914946|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14914947|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
14914948|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914949|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14914950|NCT01383694|Piperine|piperine|mesh-list
14914951|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14914952|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914953|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914954|NCT01383785|Abciximab|abciximab|mesh-list
14914955|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
14914956|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14914957|NCT01384058|Simvastatin|simvastatin|mesh-list
14914958|NCT01384058|Ezetimibe|ezetimibe|mesh-list
14914959|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14914960|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14914961|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
15214462|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15214463|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214464|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214465|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15214466|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15214467|NCT05161468|Triamcinolone|triamcinolone|mesh-list
14715672|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715673|NCT00458510|Analgesics|analgesics|mesh-ancestor
15214468|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15214469|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14883444|NCT01206946|Betamethasone|betamethasone|mesh-list
14883445|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883446|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
14883447|NCT01206946|Hormones|hormones|mesh-ancestor
14883448|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883449|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883450|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14883451|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14883452|NCT01206972|Enoxaparin|enoxaparin|mesh-list
14883453|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
14883454|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14883455|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
14883456|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14883457|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
14883458|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883459|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883460|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
14883461|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14883462|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14883463|NCT01206998|Progesterone|progesterone|mesh-list
14883464|NCT01206998|Progestins|progestins|mesh-ancestor
14883465|NCT01206998|Hormones|hormones|mesh-ancestor
14883466|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883467|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883468|NCT01207128|Voriconazole|voriconazole|mesh-list
14883469|NCT01207128|Micafungin|micafungin|mesh-list
14883470|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
14883471|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214470|NCT05161468|Lidocaine|lidocaine|mesh-list
15214471|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
15214472|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
15214473|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15214474|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
15214475|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
15214476|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214477|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214478|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
15214479|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214480|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15214481|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15214482|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15214483|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15214484|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214485|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
15214486|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715674|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
14715675|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715676|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14715677|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14715678|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
14715679|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
14715680|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
14715681|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14715682|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715683|NCT00458614|Lansoprazole|lansoprazole|mesh-list
14715684|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
14715685|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14715686|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14715687|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14715688|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715689|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715690|NCT00458718|Rimonabant|rimonabant|mesh-list
14715691|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14715692|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14715693|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14883472|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14883473|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14883474|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883475|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715694|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214487|NCT05161468|Hormones|hormones|mesh-ancestor
14883476|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14883477|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
14883478|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883479|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883480|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14883481|NCT01207206|Ketamine|ketamine|mesh-list
14883482|NCT01207206|Analgesics|analgesics|mesh-ancestor
14883483|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
14883484|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883485|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883486|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14883487|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14883488|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
14883489|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
14883490|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883491|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14883492|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14883493|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883494|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883495|NCT01207245|Tobramycin|tobramycin|mesh-list
14883496|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883497|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883498|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
14883499|NCT01207297|Tacrolimus|tacrolimus|mesh-list
14883500|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883501|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
14883502|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883503|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883504|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14883505|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
14883506|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883507|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883508|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14883509|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14883510|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883511|NCT01207310|Nicotine|nicotine|mesh-list
14883512|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14883513|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
14883514|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883515|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883516|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14883517|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14883518|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
14883519|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883520|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883521|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15214488|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214489|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214490|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
15214491|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214492|NCT05158491|Irinotecan|irinotecan|mesh-list
15214493|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15214494|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15214495|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214496|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214497|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214498|NCT05157464|Losartan|losartan|mesh-list
15214499|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15214500|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14883522|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14883523|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14883524|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14883525|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883526|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
14883527|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883528|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883529|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
14883530|NCT01207739|Doxycycline|doxycycline|mesh-list
14883531|NCT01207739|Clarithromycin|clarithromycin|mesh-list
14883532|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
14883533|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14883534|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14883535|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883536|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883537|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883538|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883539|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883540|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14883541|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14883542|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14883543|NCT01207921|Lenalidomide|lenalidomide|mesh-list
14883544|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
14883545|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883546|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14883547|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14883548|NCT01207921|Growth Substances|growth substances|mesh-ancestor
14883549|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
14883550|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883551|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
15214501|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15214502|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15214503|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214504|NCT05156905|Docetaxel|docetaxel|mesh-list
15214505|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214506|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
15214507|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
15214508|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
15214509|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214510|NCT05135910|Terbinafine|terbinafine|mesh-list
15214511|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
15214512|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214513|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214514|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214515|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
15214516|NCT05121714|Caffeine|caffeine|mesh-list
14883552|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
14883553|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14883554|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14883555|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883556|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883557|NCT01207947|Urological Agents|urological agents|mesh-ancestor
14883558|NCT01208012|Liraglutide|liraglutide|mesh-list
15214517|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14883559|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883560|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883561|NCT01208012|Incretins|incretins|mesh-ancestor
14883562|NCT01208012|Hormones|hormones|mesh-ancestor
14883563|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883564|NCT01208090|Ponesimod|ponesimod|mesh-list
14883565|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14883566|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883567|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883568|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
14883569|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883570|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
14883571|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883572|NCT01208285|Ivacaftor|ivacaftor|mesh-list
14883573|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14883574|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14883575|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883576|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
14883577|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14883578|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
14883579|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
14883580|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883581|NCT01208441|Letrozole|letrozole|mesh-list
14883582|NCT01208441|R04929097|r04929097|mesh-list
14883583|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883584|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14883585|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14883586|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883587|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883588|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14883589|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
14883590|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883591|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214518|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214519|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15214520|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214521|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214522|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15214523|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15214524|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
15214525|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214526|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15214527|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15214528|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214529|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15214530|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15214531|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15214532|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15214533|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
15214534|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15214535|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
15214536|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15214537|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15214538|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15214539|NCT05117710|Ebselen|ebselen|mesh-list
15214540|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15214541|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15214542|NCT05117710|Analgesics|analgesics|mesh-ancestor
15214543|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
15214544|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214545|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214546|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883592|NCT01208454|Vitamin A|vitamin a|mesh-list
14883593|NCT01208454|Vorinostat|vorinostat|mesh-list
14883594|NCT01208454|Tretinoin|tretinoin|mesh-list
14883595|NCT01208454|Isotretinoin|isotretinoin|mesh-list
14883596|NCT01208454|Vitamins|vitamins|mesh-ancestor
14883597|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
14883598|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883599|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883600|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14883601|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883602|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883603|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
14883604|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
14883605|NCT01208480|Carboplatin|carboplatin|mesh-list
14883606|NCT01208480|Docetaxel|docetaxel|mesh-list
15214547|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214548|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15214549|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214550|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
15214551|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214552|NCT05117710|Protective Agents|protective agents|mesh-ancestor
15214553|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15214554|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214555|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15225229|NCT05173857|Paclitaxel|paclitaxel|mesh-list
15225230|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225231|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715695|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715696|NCT00458718|Hormones|hormones|mesh-ancestor
15225232|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225233|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225234|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225235|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225236|NCT05169008|Vaccines|vaccines|mesh-list
15225237|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
15225238|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296507|NCT05245968|Sunitinib|sunitinib|mesh-list
14715697|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715698|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715699|NCT00458731|Bevacizumab|bevacizumab|mesh-list
14715700|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14715701|NCT00458731|Cediranib|cediranib|mesh-list
14715702|NCT00458731|Antibodies|antibodies|mesh-list
14715703|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
14715704|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14715705|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715706|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14883607|NCT01208480|Bevacizumab|bevacizumab|mesh-list
14883608|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883609|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
14883610|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
14883611|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
14883612|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883613|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14883614|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14883615|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14883616|NCT01208480|Growth Substances|growth substances|mesh-ancestor
15214556|NCT05107219|Linaclotide|linaclotide|mesh-list
15214557|NCT05107219|Plecanatide|plecanatide|mesh-list
15214558|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15214559|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
15214560|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214561|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214562|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
15214563|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214564|NCT05060315|Treprostinil|treprostinil|mesh-list
15214565|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15214566|NCT05043870|Infliximab|infliximab|mesh-list
15214567|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15214568|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214569|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214570|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214571|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
15214572|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296508|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
14296509|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296510|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14296511|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14296512|NCT05245968|Growth Substances|growth substances|mesh-ancestor
14296513|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296514|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
14296515|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296516|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296517|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296518|NCT05245916|Rituximab|rituximab|mesh-list
14296519|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296520|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296521|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
14883617|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214573|NCT05035303|Epinephrine|epinephrine|mesh-list
15214574|NCT05035303|Norepinephrine|norepinephrine|mesh-list
15214575|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15214576|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15214577|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214578|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214579|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214580|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214581|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15214582|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15214583|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
15214584|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883618|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
14883619|NCT01208649|Exenatide|exenatide|mesh-list
14883620|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883621|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883622|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14883623|NCT01208649|Incretins|incretins|mesh-ancestor
14883624|NCT01208649|Hormones|hormones|mesh-ancestor
14883625|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883626|NCT01208701|Atorvastatin|atorvastatin|mesh-list
14883627|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14883628|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14883629|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
14917437|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14883630|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883631|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14883632|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14883633|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914962|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914963|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14914964|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14914965|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14914966|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
14914967|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14914968|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15214585|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15214586|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
15214587|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
15214588|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
15214589|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15214590|NCT05029960|Brivaracetam|brivaracetam|mesh-list
14914969|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14914970|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14914971|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14914972|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
14914973|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14914974|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914975|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15214591|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
15214592|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
15214593|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15214594|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
15214595|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214596|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
15214597|NCT05025865|Protective Agents|protective agents|mesh-ancestor
15214598|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
15214599|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15214600|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
15214601|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214602|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
15214603|NCT05018481|Protective Agents|protective agents|mesh-ancestor
15214604|NCT05011149|Ibuprofen|ibuprofen|mesh-list
15214605|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15214606|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15214607|NCT05011149|Analgesics|analgesics|mesh-ancestor
15214608|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
15214609|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214610|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214611|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214612|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214613|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15214614|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214615|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214616|NCT04995978|Pioglitazone|pioglitazone|mesh-list
14296522|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214617|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15214618|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214619|NCT04950426|Propranolol|propranolol|mesh-list
15214620|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15214621|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15214622|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214623|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214624|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214625|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214626|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15214627|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15214628|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
14296523|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14296524|NCT05245877|Enoxaparin|enoxaparin|mesh-list
14296525|NCT05245877|Dalteparin|dalteparin|mesh-list
14715707|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14883634|NCT01208740|Metformin|metformin|mesh-list
14883635|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15214629|NCT04950322|Leucovorin|leucovorin|mesh-list
14715708|NCT00458731|Growth Substances|growth substances|mesh-ancestor
15214630|NCT04950322|Fluorouracil|fluorouracil|mesh-list
15214631|NCT04950322|Oxaliplatin|oxaliplatin|mesh-list
15214632|NCT04950322|Antimetabolites|antimetabolites|mesh-ancestor
15214633|NCT04950322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214634|NCT04950322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214635|NCT04950322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214636|NCT04950322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214637|NCT04950322|Immunologic Factors|immunologic factors|mesh-ancestor
15214638|NCT04950322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214639|NCT04950322|Antidotes|antidotes|mesh-ancestor
15214640|NCT04950322|Protective Agents|protective agents|mesh-ancestor
15214641|NCT04950322|Vitamin B Complex|vitamin b complex|mesh-ancestor
15214642|NCT04950322|Vitamins|vitamins|mesh-ancestor
15214643|NCT04950322|Micronutrients|micronutrients|mesh-ancestor
15214644|NCT04939636|Vitamin D|vitamin d|mesh-list
15214645|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
15214646|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
15214647|NCT04939636|Vitamins|vitamins|mesh-list
15214648|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
15214649|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214650|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15214651|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15214652|NCT04929548|Maleic acid|maleic acid|mesh-list
15214653|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214654|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214655|NCT04921722|Sirolimus|sirolimus|mesh-list
15214656|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15214657|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214658|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15214659|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214660|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
15214661|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214662|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
15214663|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214664|NCT04781972|Methylphenidate|methylphenidate|mesh-list
15214665|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15214666|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214667|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15214668|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15214669|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15214670|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214671|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
15214672|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214673|NCT04745845|Norepinephrine|norepinephrine|mesh-list
15214674|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14715709|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715710|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
14715711|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
14715712|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715713|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715714|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15214675|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15214676|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214677|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296526|NCT05245877|Tinzaparin|tinzaparin|mesh-list
15214678|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214679|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214680|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
15214681|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
15214682|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214683|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15214684|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
15214685|NCT04740294|Analgesics|analgesics|mesh-ancestor
15214686|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
15214687|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214688|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214689|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
15214690|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214691|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15214692|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
14883636|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883637|NCT01208766|Dexamethasone|dexamethasone|mesh-list
14883638|NCT01208766|Prednisone|prednisone|mesh-list
14883639|NCT01208766|Lenalidomide|lenalidomide|mesh-list
14883640|NCT01208766|Bortezomib|bortezomib|mesh-list
14883641|NCT01208766|Melphalan|melphalan|mesh-list
14883642|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883643|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
14883644|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
14883645|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883646|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883647|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883648|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
14883649|NCT01208766|Hormones|hormones|mesh-ancestor
14883650|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883651|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14883652|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883653|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
14883654|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14883655|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14883656|NCT01208766|Growth Substances|growth substances|mesh-ancestor
14883657|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
14883658|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14883659|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
14883660|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883661|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14883662|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883663|NCT01208818|Dexamethasone|dexamethasone|mesh-list
14883664|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
14883665|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
14883666|NCT01208818|Bortezomib|bortezomib|mesh-list
14883667|NCT01208818|BB 1101|bb 1101|mesh-list
14883668|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883669|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
14883670|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883671|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883672|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14883673|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
14883674|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883675|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883676|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14883677|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883678|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
14883679|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
14883680|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883681|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883682|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
14883683|NCT01208818|Hormones|hormones|mesh-ancestor
14883684|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883685|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14883686|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
14883687|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883688|NCT01208935|Nicotine|nicotine|mesh-list
14883689|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14883690|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
14883691|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883692|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883693|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14883694|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15214693|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14883695|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
14883696|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883697|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883698|NCT01209026|Fluticasone|fluticasone|mesh-list
14883699|NCT01209026|Xhance|xhance|mesh-list
14883700|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
14883701|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14883702|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883703|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14883704|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
14883705|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883706|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883707|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14883708|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
15214694|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15214695|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214696|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15214697|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
15214698|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15214699|NCT04730349|Nivolumab|nivolumab|mesh-list
15214700|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214701|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214702|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15214703|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214704|NCT04728646|Dexamethasone|dexamethasone|mesh-list
15214705|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214706|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
15214707|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
15214708|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214709|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214710|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214711|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
15214712|NCT04728646|Hormones|hormones|mesh-ancestor
15214713|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214714|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15214715|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214716|NCT04708886|Alendronate|alendronate|mesh-list
15214717|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15214718|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214719|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15214720|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
15214721|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214722|NCT04671043|Caffeine|caffeine|mesh-list
15214723|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15214724|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214725|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15214726|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715715|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
14715716|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15214727|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214728|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15214729|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15214730|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
15214731|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214732|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15214733|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
15214734|NCT04664738|Coagulants|coagulants|mesh-ancestor
15225239|NCT05168527|Gemcitabine|gemcitabine|mesh-list
14715717|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715718|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
14715719|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715720|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
14715721|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14715722|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715723|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14715724|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14715725|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715726|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715727|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715728|NCT00458913|Bortezomib|bortezomib|mesh-list
14715729|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715730|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
14883709|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14883710|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14883711|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883712|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883713|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14883714|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14883715|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883716|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883717|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883718|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14883719|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
14883720|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14883721|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14883722|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14883723|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14883724|NCT01209065|Ritonavir|ritonavir|mesh-list
14883725|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
14883726|NCT01209065|Dolutegravir|dolutegravir|mesh-list
14883727|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14883728|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14883729|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
14883730|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883731|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883732|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14883733|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14883734|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
14883735|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883736|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14883737|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14883738|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14883739|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14883740|NCT01209130|Rituximab|rituximab|mesh-list
14883741|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14883742|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883743|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
14883744|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883745|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883746|NCT01209208|Budesonide|budesonide|mesh-list
14883747|NCT01209208|Mesalamine|mesalamine|mesh-list
15214735|NCT04594408|Epinephrine|epinephrine|mesh-list
15214736|NCT04594408|Racepinephrine|racepinephrine|mesh-list
15214737|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
14883748|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214738|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
15214739|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15214740|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15214741|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
15214742|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214743|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214744|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214745|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15214746|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15214747|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
15225240|NCT05168527|Paclitaxel|paclitaxel|mesh-list
14883749|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14883750|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
14883751|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883752|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883753|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14883754|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
14883755|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
14883756|NCT01209208|Hormones|hormones|mesh-ancestor
14883757|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883758|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14883759|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14883760|NCT01209208|Analgesics|analgesics|mesh-ancestor
14883761|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
14883762|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14883763|NCT01209351|Teduglutide|teduglutide|mesh-list
14883764|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883765|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14883766|NCT01209351|Protective Agents|protective agents|mesh-ancestor
14883767|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883768|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
14883769|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14883770|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14883771|NCT01209364|Prednisolone|prednisolone|mesh-list
14883772|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
14883773|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14883774|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
14883775|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883776|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
15214748|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214749|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15214750|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
15214751|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
15214752|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
15214753|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15214754|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15214755|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15214756|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
15214757|NCT04594408|Coagulants|coagulants|mesh-ancestor
15214758|NCT04580134|Risperidone|risperidone|mesh-list
15214759|NCT04580134|Clozapine|clozapine|mesh-list
15214760|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15214761|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
15214762|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214763|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214764|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214765|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15214766|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15214767|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214768|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15214769|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15214770|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
15214771|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
15214772|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
14883777|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
14883778|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883779|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883780|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883781|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
15214773|NCT04567420|Fulvestrant|fulvestrant|mesh-list
14883782|NCT01209364|Hormones|hormones|mesh-ancestor
15214774|NCT04567420|Palbociclib|palbociclib|mesh-list
15214775|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14883783|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883784|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14883785|NCT01209364|Protective Agents|protective agents|mesh-ancestor
14883786|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14883787|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883788|NCT01209403|Insulin|insulin|mesh-list
14883789|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
14883790|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14883791|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883792|NCT01209416|Acipimox|acipimox|mesh-list
14883793|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14883794|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
14883795|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883796|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14883797|NCT01209429|Hormones|hormones|mesh-list
14883798|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883799|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883800|NCT01209455|Acetaminophen|acetaminophen|mesh-list
14883801|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
14883802|NCT01209455|Ranitidine|ranitidine|mesh-list
14883803|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14883804|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14883805|NCT01209455|Analgesics|analgesics|mesh-ancestor
14883806|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
14883807|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883808|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214776|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214777|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15214778|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15214779|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
15214780|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214781|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214782|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15214783|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214784|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214785|NCT04555811|Rituximab|rituximab|mesh-list
15214786|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214787|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214788|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
15214789|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214790|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214791|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15214792|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15214793|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214794|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214795|NCT04543383|Thrombin|thrombin|mesh-list
15214796|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
15214797|NCT04543383|Coagulants|coagulants|mesh-ancestor
15214798|NCT04529720|Vaccines|vaccines|mesh-list
15214799|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
15214800|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214801|NCT04522284|Capecitabine|capecitabine|mesh-list
15214802|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214803|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
15214804|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214805|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214806|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
15214807|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15214808|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
15214809|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15214810|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214811|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15214812|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15214813|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15214814|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214815|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
15214816|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214817|NCT04423237|Deferasirox|deferasirox|mesh-list
15214818|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15214819|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
15214820|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
15214821|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214822|NCT04413266|Curcumin|curcumin|mesh-list
14883809|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
14883810|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14883811|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883812|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14883813|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
14883814|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
14883815|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883816|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883817|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
14883818|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
14883819|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14883820|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14883821|NCT01209533|Iloprost|iloprost|mesh-list
14883822|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14883823|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
14883824|NCT01209650|Afatinib|afatinib|mesh-list
14883825|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883826|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14883827|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883828|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214823|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15214824|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15214825|NCT04413266|Analgesics|analgesics|mesh-ancestor
15214826|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
15214827|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214828|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214829|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214830|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214831|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214832|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214833|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214834|NCT04409795|Metformin|metformin|mesh-list
15214835|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15214836|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15214837|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214838|NCT04409795|Incretins|incretins|mesh-ancestor
15214839|NCT04409795|Hormones|hormones|mesh-ancestor
15214840|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214841|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15214842|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
15214843|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214844|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214845|NCT04375033|Buprenorphine|buprenorphine|mesh-list
15214846|NCT04375033|Naloxone|naloxone|mesh-list
15214847|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15214848|NCT04375033|Narcotics|narcotics|mesh-ancestor
15214849|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15214850|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214851|NCT04375033|Analgesics|analgesics|mesh-ancestor
15214852|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
15214853|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214854|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15214855|NCT04367740|Antibodies|antibodies|mesh-list
15214856|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
15214857|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
15214858|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214859|NCT04297605|Paclitaxel|paclitaxel|mesh-list
15214860|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
15214861|NCT04297605|Pemetrexed|pemetrexed|mesh-list
15214862|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15214863|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214864|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
15214865|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
15214866|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
15214867|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214868|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214869|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214870|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15214871|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15214872|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
15214873|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15214874|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
14883829|NCT01209715|Fluticasone|fluticasone|mesh-list
14883830|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15214875|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15214876|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214877|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
14883831|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14883832|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14883833|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14883834|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
14883835|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883836|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883837|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14883838|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
15214878|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214879|NCT04262024|Cabergoline|cabergoline|mesh-list
15214880|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15214881|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15214882|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
15214883|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
15214884|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214885|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214886|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214887|NCT04222426|Atezolizumab|atezolizumab|mesh-list
15214888|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214889|NCT04195204|Tropisetron|tropisetron|mesh-list
15214890|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
15214891|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
15214892|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214893|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214894|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15214895|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15214896|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15214897|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
14715731|NCT00458991|Caffeine|caffeine|mesh-list
14715732|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15214898|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15214899|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214900|NCT04183101|Enalapril|enalapril|mesh-list
15214901|NCT04183101|Enalaprilat|enalaprilat|mesh-list
15214902|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15214903|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
15214904|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214905|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214906|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15214907|NCT04084626|Lenalidomide|lenalidomide|mesh-list
15214908|NCT04084626|Antibodies|antibodies|mesh-list
15214909|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
15214910|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214911|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15214912|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15214913|NCT04084626|Growth Substances|growth substances|mesh-ancestor
15214914|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
15214915|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214916|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
15214917|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214918|NCT04081337|Tirzepatide|tirzepatide|mesh-list
15214919|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15214920|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214921|NCT04081337|Incretins|incretins|mesh-ancestor
15214922|NCT04081337|Hormones|hormones|mesh-ancestor
15214923|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214924|NCT04078568|Aspirin|aspirin|mesh-list
15214925|NCT04078568|Prednisolone|prednisolone|mesh-list
15214926|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
15214927|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15214928|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
14715733|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715734|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14715735|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715736|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715737|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14715738|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14715739|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
15214929|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15214930|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15214931|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15214932|NCT04078568|Analgesics|analgesics|mesh-ancestor
15214933|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
15214934|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15214935|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214936|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214937|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214938|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15214939|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15214940|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214941|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15214942|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15214943|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214944|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
15214945|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
15214946|NCT04078568|Hormones|hormones|mesh-ancestor
15214947|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214948|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15214949|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214950|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
15214951|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15214952|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15214953|NCT03979365|Tacrolimus|tacrolimus|mesh-list
15214954|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15214955|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
15214956|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214957|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15214958|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214959|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214960|NCT03962465|Cytarabine|cytarabine|mesh-list
15214961|NCT03962465|Prednisone|prednisone|mesh-list
15214962|NCT03962465|Methotrexate|methotrexate|mesh-list
15214963|NCT03962465|Vincristine|vincristine|mesh-list
15214964|NCT03962465|Daunorubicin|daunorubicin|mesh-list
15214965|NCT03962465|Pegaspargase|pegaspargase|mesh-list
15214966|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
15214967|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15214968|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
15214969|NCT03962465|Hormones|hormones|mesh-ancestor
15214970|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15214971|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15214972|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15214973|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15214974|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15214975|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
15214976|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15214977|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15214978|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
15214979|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15214980|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
15214981|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15214982|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15214983|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715740|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715741|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
14715742|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
14715743|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14715744|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14715745|NCT00459004|Rimonabant|rimonabant|mesh-list
14715746|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14715747|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14715748|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14715749|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715750|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715751|NCT00459004|Hormones|hormones|mesh-ancestor
14883839|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
14883840|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15214984|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
15214985|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15214986|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15214987|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
15214988|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15214989|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15214990|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
15214991|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
15214992|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
14715752|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14715753|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715754|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
15214993|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15214994|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15214995|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15214996|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15214997|NCT03953898|Olaparib|olaparib|mesh-list
15214998|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15214999|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215000|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215001|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215002|NCT03948035|Dexamethasone|dexamethasone|mesh-list
15215003|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
15215004|NCT03948035|Lenalidomide|lenalidomide|mesh-list
15215005|NCT03948035|Elotuzumab|elotuzumab|mesh-list
15215006|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215007|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
15215008|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
15215009|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215010|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215011|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15215012|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
15215013|NCT03948035|Hormones|hormones|mesh-ancestor
15215014|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215015|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215016|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215017|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
15215018|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215019|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15215020|NCT03948035|Growth Substances|growth substances|mesh-ancestor
15215021|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
15225241|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225242|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225243|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225244|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225245|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225246|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225247|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15225248|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
15225249|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
15225250|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225251|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225252|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225253|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
15225254|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225255|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
15225256|NCT05166811|Analgesics|analgesics|mesh-ancestor
15225257|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
15225258|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225259|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225260|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
15225261|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225262|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15225263|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
15225264|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15225265|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715755|NCT00459173|Rimonabant|rimonabant|mesh-list
14715756|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14715757|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14715758|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14715759|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728903|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225266|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215022|NCT03861390|Prednisone|prednisone|mesh-list
15215023|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215024|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
15215025|NCT03861390|Hormones|hormones|mesh-ancestor
15215026|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215027|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215028|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215029|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215030|NCT03861078|Nicotine|nicotine|mesh-list
15215031|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15215032|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
15215033|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215034|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215035|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15215036|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15215037|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
15215038|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215039|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215040|NCT03849443|Ascorbic Acid|ascorbic acid|mesh-list
15215041|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
15215042|NCT03849443|Vitamins|vitamins|mesh-ancestor
15215043|NCT03849443|Micronutrients|micronutrients|mesh-ancestor
15215044|NCT03849443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215045|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15215046|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15215047|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715760|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715761|NCT00459173|Hormones|hormones|mesh-ancestor
14715762|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215048|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
15215049|NCT03849443|Coagulants|coagulants|mesh-ancestor
15215050|NCT03849443|Antioxidants|antioxidants|mesh-ancestor
15215051|NCT03849443|Protective Agents|protective agents|mesh-ancestor
15215052|NCT03810417|Digoxin|digoxin|mesh-list
15215053|NCT03810417|Antibodies|antibodies|mesh-list
15215054|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
15215055|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
15215056|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215057|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15215058|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15215059|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215060|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215061|NCT03810417|Protective Agents|protective agents|mesh-ancestor
15215062|NCT03781362|Capecitabine|capecitabine|mesh-list
15215063|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215064|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
15215065|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215066|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215067|NCT03746041|Abaloparatide|abaloparatide|mesh-list
15215068|NCT03746041|Bevacizumab|bevacizumab|mesh-list
15215069|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215070|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215071|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215072|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15215073|NCT03746041|Growth Substances|growth substances|mesh-ancestor
15215074|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215075|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
15215076|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15215077|NCT03689582|Edetic Acid|edetic acid|mesh-list
15215078|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15215079|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15215080|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215081|NCT03689582|Anticoagulants|anticoagulants|mesh-ancestor
14715763|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715764|NCT00459264|Folic Acid|folic acid|mesh-list
14715765|NCT00459264|Hematinics|hematinics|mesh-ancestor
14715766|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
14715767|NCT00459264|Vitamins|vitamins|mesh-ancestor
14715768|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
14715769|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715770|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14715771|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
14715772|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215082|NCT03689582|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15215083|NCT03689582|Chelating Agents|chelating agents|mesh-ancestor
15215084|NCT03689582|Sequestering Agents|sequestering agents|mesh-ancestor
14883841|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14883842|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14883843|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14883844|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14883845|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215085|NCT03597568|Resveratrol|resveratrol|mesh-list
15215086|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
15215087|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215088|NCT03597568|Protective Agents|protective agents|mesh-ancestor
15215089|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215090|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215091|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15215092|NCT03591770|Vaccines|vaccines|mesh-list
15215093|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
15215094|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215095|NCT03532555|Zinc|zinc|mesh-list
15215096|NCT03532555|Trace Elements|trace elements|mesh-ancestor
15215097|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
15215098|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215099|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
15215100|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
15215101|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15215102|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15215103|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215104|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15215105|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
15215106|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215107|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215108|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
15215109|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
15215110|NCT03511599|Cycloserine|cycloserine|mesh-list
15215111|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15215112|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215113|NCT03511599|Renal Agents|renal agents|mesh-ancestor
15215114|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15215115|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
15215116|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15215117|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
15215118|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215119|NCT03503318|Risperidone|risperidone|mesh-list
15215120|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15215121|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
15215122|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215123|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215124|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215125|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15215126|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15215127|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15215128|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15215129|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15215130|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
15215131|NCT03441282|Fentanyl|fentanyl|mesh-list
15215132|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15215133|NCT03441282|Narcotics|narcotics|mesh-ancestor
15215134|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15215135|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215136|NCT03441282|Analgesics|analgesics|mesh-ancestor
15215137|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
15215138|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215139|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15215140|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15215141|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
15215142|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
15215143|NCT03432741|Gemcitabine|gemcitabine|mesh-list
15215144|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
15215145|NCT03432741|Rituximab|rituximab|mesh-list
15215146|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15215147|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
15215148|NCT03432741|Nivolumab|nivolumab|mesh-list
15215149|NCT03432741|Trastuzumab|trastuzumab|mesh-list
15215150|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
15215151|NCT03432741|Daratumumab|daratumumab|mesh-list
15215152|NCT03432741|Romidepsin|romidepsin|mesh-list
15215153|NCT03432741|Belinostat|belinostat|mesh-list
15215154|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15215155|NCT03432741|Antibodies|antibodies|mesh-list
15215156|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
15215157|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15215158|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15215159|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
15215160|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215161|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215162|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215163|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215164|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
15215165|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215166|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
15215167|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215168|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215169|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215170|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15215171|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15215172|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15215173|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15215174|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
15215175|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15215176|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
15215177|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15215178|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
15215179|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215180|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215181|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
15215182|NCT03406715|Nivolumab|nivolumab|mesh-list
15215183|NCT03406715|Ipilimumab|ipilimumab|mesh-list
15215184|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215185|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215186|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15215187|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215188|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15215189|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
15215190|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215191|NCT03223883|Curcumin|curcumin|mesh-list
15215192|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15215193|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14715773|NCT00459407|Protective Agents|protective agents|mesh-ancestor
14715774|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715775|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15215194|NCT03223883|Analgesics|analgesics|mesh-ancestor
15215195|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
15215196|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215197|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215198|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215199|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215200|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215201|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215202|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215203|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
15215204|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215205|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215206|NCT03125642|Cytarabine|cytarabine|mesh-list
15215207|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
15215208|NCT03125642|Melphalan|melphalan|mesh-list
15215209|NCT03125642|Carmustine|carmustine|mesh-list
15215210|NCT03125642|Etoposide|etoposide|mesh-list
15215211|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215212|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
15215213|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215214|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14715776|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14715777|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715778|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14715779|NCT00459420|Caffeine|caffeine|mesh-list
14715780|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14715781|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728904|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15215215|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15215216|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
15215217|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215218|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215219|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15215220|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15215221|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15215222|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15215223|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215224|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215225|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
15215226|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
15215227|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215228|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
15215229|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215230|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215231|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
15215232|NCT03103971|Fludarabine|fludarabine|mesh-list
15215233|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215234|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
15215235|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215236|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215237|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15215238|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
15215239|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215240|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215241|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15215242|NCT03086616|Irinotecan|irinotecan|mesh-list
15215243|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15215244|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15215245|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215246|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215247|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215248|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15215249|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15215250|NCT03007030|Antibodies|antibodies|mesh-list
15215251|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
15215252|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15215253|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
15215254|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
15215255|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215256|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215257|NCT02995252|Tenofovir|tenofovir|mesh-list
15215258|NCT02995252|Liver Extracts|liver extracts|mesh-list
15215259|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
15215260|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215261|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15215262|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15215263|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215264|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215265|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15215266|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15215267|NCT02995252|Hematinics|hematinics|mesh-ancestor
15215268|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
15215269|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215270|NCT02991144|Prednisone|prednisone|mesh-list
14715782|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14715783|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715784|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715785|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14715786|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14715787|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
14715788|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715789|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
14715790|NCT00459485|Astringents|astringents|mesh-ancestor
14715791|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715792|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
14715793|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
14715794|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715795|NCT00459563|Vitamin D|vitamin d|mesh-list
14715796|NCT00459563|Calcitriol|calcitriol|mesh-list
14715797|NCT00459563|Vitamins|vitamins|mesh-ancestor
14715798|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
14914976|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215271|NCT02991144|Prednisolone|prednisolone|mesh-list
15215272|NCT02991144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215273|NCT02991144|Glucocorticoids|glucocorticoids|mesh-ancestor
14715799|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715800|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15215274|NCT02991144|Hormones|hormones|mesh-ancestor
15215275|NCT02991144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215276|NCT02991144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215277|NCT02991144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215278|NCT02991144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215279|NCT02953509|Gemcitabine|gemcitabine|mesh-list
15215280|NCT02953509|Rituximab|rituximab|mesh-list
15215281|NCT02953509|Magrolimab|magrolimab|mesh-list
15215282|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
15215283|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215284|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215285|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
15215286|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215287|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215288|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215289|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
15215290|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215291|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
15215292|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215293|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215294|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215295|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
15215296|NCT02921789|Prednisone|prednisone|mesh-list
15215297|NCT02921789|Tacrolimus|tacrolimus|mesh-list
15215298|NCT02921789|Basiliximab|basiliximab|mesh-list
15215299|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215300|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
15215301|NCT02921789|Hormones|hormones|mesh-ancestor
15215302|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215303|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215304|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215305|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215306|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215307|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
15215308|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15215309|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215310|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215311|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15215312|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15215313|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
15215314|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15215315|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215316|NCT02918500|Nicotine|nicotine|mesh-list
15215317|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15215318|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
15215319|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215320|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215321|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15215322|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15215323|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
15215324|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215325|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225267|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15225268|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
15225269|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15225270|NCT05159245|Trastuzumab|trastuzumab|mesh-list
15225271|NCT05159245|Pertuzumab|pertuzumab|mesh-list
15225272|NCT05159245|Atezolizumab|atezolizumab|mesh-list
15225273|NCT05159245|Vemurafenib|vemurafenib|mesh-list
15225274|NCT05159245|Entrectinib|entrectinib|mesh-list
15225275|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225276|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883846|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883847|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
14883848|NCT01209715|Hormones|hormones|mesh-ancestor
14883849|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14883850|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
15215326|NCT02903381|Dexamethasone|dexamethasone|mesh-list
15215327|NCT02903381|Nivolumab|nivolumab|mesh-list
15215328|NCT02903381|Lenalidomide|lenalidomide|mesh-list
15215329|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215330|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
15215331|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
15215332|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215333|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215334|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15215335|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
15215336|NCT02903381|Hormones|hormones|mesh-ancestor
15215337|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215338|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215339|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215340|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215341|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15215342|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215343|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
15215344|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215345|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15215346|NCT02903381|Growth Substances|growth substances|mesh-ancestor
15215347|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
15215348|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
15215349|NCT02866279|Etonogestrel|etonogestrel|mesh-list
15215350|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15215351|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215352|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15215353|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15215354|NCT02774265|Aspirin|aspirin|mesh-list
15215355|NCT02774265|Heparin|heparin|mesh-list
15215356|NCT02774265|Enoxaparin|enoxaparin|mesh-list
15215357|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15215358|NCT02774265|Tinzaparin|tinzaparin|mesh-list
15215359|NCT02774265|Dalteparin|dalteparin|mesh-list
15215360|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15215361|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15215362|NCT02774265|Analgesics|analgesics|mesh-ancestor
15215363|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
15215364|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215365|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215366|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215367|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215368|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15215369|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15215370|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215371|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15215372|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15215373|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215374|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
15215375|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
15215376|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
15215377|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215378|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215379|NCT02695992|Metoprolol|metoprolol|mesh-list
15215380|NCT02695992|Diltiazem|diltiazem|mesh-list
15215381|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15215382|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15215383|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
15215384|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
15215385|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215386|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215387|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15215388|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15215389|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15215390|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
15215391|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215392|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215393|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14883851|NCT01209728|Ethanol|ethanol|mesh-list
14883852|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14883853|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883854|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883855|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883856|NCT01209806|Simethicone|simethicone|mesh-list
14883857|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
14883858|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14883859|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14883860|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
14883861|NCT01209806|TEMPO|tempo|mesh-list
14883862|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
14883863|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883864|NCT01209806|Emollients|emollients|mesh-ancestor
14883865|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
14883866|NCT01209806|Antacids|antacids|mesh-ancestor
14883867|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883868|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14883869|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
14883870|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883871|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
14883872|NCT01209806|Protective Agents|protective agents|mesh-ancestor
14883873|NCT01209845|Ketamine|ketamine|mesh-list
14883874|NCT01209845|Analgesics|analgesics|mesh-ancestor
14883875|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
14883876|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883877|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883878|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14883879|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14883880|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
14883881|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
14883882|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883883|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14883884|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14883885|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883886|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883887|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14914977|NCT01384227|Proflavine|proflavine|mesh-list
15215394|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15215395|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15215396|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
15215397|NCT02667418|Vancomycin|vancomycin|mesh-list
15215398|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
15215399|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15215400|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215401|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
15215402|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
15215403|NCT02652468|Rituximab|rituximab|mesh-list
15215404|NCT02652468|Fludarabine|fludarabine|mesh-list
15215405|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
15215406|NCT02652468|Tacrolimus|tacrolimus|mesh-list
15215407|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215408|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
15215409|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883888|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14883889|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14883890|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
14883891|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14883892|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883893|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14883894|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14883895|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14883896|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14883897|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14883898|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14883899|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14883900|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14883901|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
14883902|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14883903|NCT01209871|Antibodies|antibodies|mesh-list
14883904|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
14883905|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883906|NCT01209988|Tamsulosin|tamsulosin|mesh-list
14883907|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14883908|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14883909|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14883910|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
14883911|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883912|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883913|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883914|NCT01209988|Urological Agents|urological agents|mesh-ancestor
14883915|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
14883916|NCT01210014|Astringents|astringents|mesh-ancestor
14883917|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883918|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
14883919|NCT01210040|Folic Acid|folic acid|mesh-list
14883920|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
14883921|NCT01210040|Hematinics|hematinics|mesh-ancestor
14883922|NCT01210040|Vitamins|vitamins|mesh-ancestor
14883923|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
14883924|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883925|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14883926|NCT01210066|Fentanyl|fentanyl|mesh-list
14883927|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
14883928|NCT01210066|Narcotics|narcotics|mesh-ancestor
14883929|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14883930|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883931|NCT01210066|Analgesics|analgesics|mesh-ancestor
14883932|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
14883933|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14883934|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14883935|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14883936|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
14883937|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
14883938|NCT01210287|Lamivudine|lamivudine|mesh-list
14883939|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14883940|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14883941|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883942|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883943|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
14883944|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883945|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14883946|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14883947|NCT01210339|Esomeprazole|esomeprazole|mesh-list
14883948|NCT01210339|Clopidogrel|clopidogrel|mesh-list
14883949|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14883950|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14883951|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14883952|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14883953|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
14883954|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14883955|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883956|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883957|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14883958|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14883959|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14883960|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14883961|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
14883962|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
14883963|NCT01210391|Caseins|caseins|mesh-list
14883964|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
14883965|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
14883966|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883967|NCT01210430|Vitamins|vitamins|mesh-list
14883968|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
14883969|NCT01210430|Losartan|losartan|mesh-list
14883970|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
14883971|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883972|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14883973|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14883974|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14883975|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14883976|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883977|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
14883978|NCT01210430|Protective Agents|protective agents|mesh-ancestor
14883979|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
14883980|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14883981|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
14883982|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883983|NCT01210456|Expectorants|expectorants|mesh-ancestor
14883984|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
14883985|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14883986|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
14883987|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14883988|NCT01210456|Protective Agents|protective agents|mesh-ancestor
14883989|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14883990|NCT01210456|Antidotes|antidotes|mesh-ancestor
14914978|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14914979|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914980|NCT01384240|Proflavine|proflavine|mesh-list
14914981|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14914982|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14914983|NCT01384253|Trastuzumab|trastuzumab|mesh-list
14914984|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14914985|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14914986|NCT01384279|Metformin|metformin|mesh-list
14914987|NCT01384279|Topiramate|topiramate|mesh-list
14914988|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14914989|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914990|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
14914991|NCT01384331|NuvaRing|nuvaring|mesh-list
14914992|NCT01384331|Desogestrel|desogestrel|mesh-list
15215410|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215411|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15215412|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
14883991|NCT01210482|Sirolimus|sirolimus|mesh-list
14883992|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14883993|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14883994|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14883995|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14883996|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
14883997|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14883998|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
14883999|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884000|NCT01210521|Vitamin D|vitamin d|mesh-list
14884001|NCT01210521|Vitamins|vitamins|mesh-ancestor
14884002|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
14884003|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884004|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14884005|NCT01210599|Pamidronate|pamidronate|mesh-list
14884006|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14884007|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884008|NCT01210625|Psyllium|psyllium|mesh-list
14884009|NCT01210625|Cathartics|cathartics|mesh-ancestor
14884010|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884011|NCT01210638|Oxymorphone|oxymorphone|mesh-list
14884012|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14884013|NCT01210638|Narcotics|narcotics|mesh-ancestor
14884014|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884015|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884016|NCT01210638|Analgesics|analgesics|mesh-ancestor
14884017|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
14884018|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884019|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14884020|NCT01210677|Prednisone|prednisone|mesh-list
14884021|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14884022|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
14884023|NCT01210677|Hormones|hormones|mesh-ancestor
14884024|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14884025|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884026|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215413|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215414|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215415|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15215416|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14715801|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14715802|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14715803|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715804|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715805|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14728905|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14728906|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14728907|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14728908|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728909|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884027|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884028|NCT01210742|Hylan|hylan|mesh-list
14884029|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
15215417|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215418|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
15215419|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15215420|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884030|NCT01210742|Protective Agents|protective agents|mesh-ancestor
14884031|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884032|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
14884033|NCT01210755|Dabigatran|dabigatran|mesh-list
14884034|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14884035|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
14884036|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14884037|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
14884038|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884039|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884040|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
14884041|NCT01210911|Metformin|metformin|mesh-list
14884042|NCT01210911|Gemcitabine|gemcitabine|mesh-list
14884043|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14884044|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884045|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
14884046|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884047|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884048|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
14884049|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884050|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715806|NCT00459615|Artesunate|artesunate|mesh-list
14715807|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
14715808|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14884051|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884052|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
14884053|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884054|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14884055|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884056|NCT01210976|Simendan|simendan|mesh-list
14884057|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14884058|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884059|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14884060|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14884061|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884062|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884063|NCT01210976|Protective Agents|protective agents|mesh-ancestor
14884064|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884065|NCT01211002|Endostatins|endostatins|mesh-list
14884066|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884067|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14884068|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14884069|NCT01211002|Growth Substances|growth substances|mesh-ancestor
14884070|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884071|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
14884072|NCT01211080|Propranolol|propranolol|mesh-list
14884073|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14884074|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14884075|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
14884076|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884077|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884078|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884079|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14884080|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884081|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884082|NCT01211158|Ketamine|ketamine|mesh-list
14884083|NCT01211158|Propofol|propofol|mesh-list
14884084|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14296527|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14715809|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14715810|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715811|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715812|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
14715813|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
14715814|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14715815|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
14884085|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884086|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884087|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14296528|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
14884088|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
14884089|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
14884090|NCT01211158|Analgesics|analgesics|mesh-ancestor
14884091|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
14884092|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884093|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14884094|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14884095|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14884096|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884097|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884098|NCT01211171|Telmisartan|telmisartan|mesh-list
14884099|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884100|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14884101|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14884102|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884103|NCT01211210|Fluorouracil|fluorouracil|mesh-list
14884104|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
14884105|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
14884106|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884107|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884108|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884109|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884110|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
14884111|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884112|NCT01211223|Amoxicillin|amoxicillin|mesh-list
14884113|NCT01211223|Metronidazole|metronidazole|mesh-list
14884114|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14884115|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884116|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14884117|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14884118|NCT01211275|Cisplatin|cisplatin|mesh-list
14884119|NCT01211275|Pemetrexed|pemetrexed|mesh-list
14884120|NCT01211275|Axitinib|axitinib|mesh-list
14884121|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884122|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884123|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884124|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14884125|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14884126|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884127|NCT01211314|Enalapril|enalapril|mesh-list
14884128|NCT01211314|Lercanidipine|lercanidipine|mesh-list
14884129|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14884130|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
14884131|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884132|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884133|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884134|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14296529|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14884135|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884136|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14884137|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884138|NCT01211327|Cyclosporine|cyclosporine|mesh-list
14884139|NCT01211327|Dexamethasone|dexamethasone|mesh-list
14884140|NCT01211327|Cyclosporins|cyclosporins|mesh-list
14884141|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14884142|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
14884143|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
14884144|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884145|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884146|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884147|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
14884148|NCT01211327|Hormones|hormones|mesh-ancestor
14884149|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14884150|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14884151|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884152|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884153|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884154|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884155|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
14884156|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
14884157|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884158|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
14884159|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14884160|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14884161|NCT01211457|Decitabine|decitabine|mesh-list
14884162|NCT01211457|Venetoclax|venetoclax|mesh-list
14884163|NCT01211457|Sapacitabine|sapacitabine|mesh-list
14884164|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884165|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
14884166|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884167|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884168|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884169|NCT01211470|Daptomycin|daptomycin|mesh-list
14884170|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14884171|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884172|NCT01211496|Methamphetamine|methamphetamine|mesh-list
14884173|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14884174|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884175|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
14884176|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
14884177|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884178|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
14884179|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884180|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884181|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
14884182|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14884183|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14884184|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884185|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14884186|NCT01211509|Montelukast|montelukast|mesh-list
14884187|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14884188|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
14884189|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14884190|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
14884191|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14884192|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884193|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14884194|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14884195|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884196|NCT01211561|Selenium|selenium|mesh-list
14884197|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
14884198|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884199|NCT01211561|Protective Agents|protective agents|mesh-ancestor
14884200|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884201|NCT01211561|Trace Elements|trace elements|mesh-ancestor
14884202|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
14884203|NCT01211691|Antibodies|antibodies|mesh-list
14884204|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14884205|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
14884206|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884207|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14884208|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14884209|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14884210|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884211|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884212|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14884213|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14884214|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14884215|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
14884216|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884217|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884218|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14884219|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14884220|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
14884221|NCT01211795|Ketoprofen|ketoprofen|mesh-list
14884222|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14884223|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14884224|NCT01211795|Analgesics|analgesics|mesh-ancestor
14884225|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
14884226|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884227|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884228|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14884229|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14884230|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14884231|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215421|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15215422|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15215423|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
15215424|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15215425|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215426|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15215427|NCT02579265|SMOFlipid|smoflipid|mesh-list
15215428|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
15215429|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15215430|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15215431|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15215432|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14884232|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884233|NCT01211808|Diltiazem|diltiazem|mesh-list
14884234|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884235|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14884236|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884237|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884238|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14884239|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884240|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884241|NCT01211821|Metoprolol|metoprolol|mesh-list
14884242|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14884243|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884244|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
14884245|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
14884246|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884247|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884248|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14884249|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14884250|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14884251|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
14884252|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884253|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884254|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
14884255|NCT01211847|Diazoxide|diazoxide|mesh-list
14884256|NCT01211847|Choline|choline|mesh-list
14884257|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
14884258|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14884259|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
14884260|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884261|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884262|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14884263|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
14884264|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884265|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884266|NCT01211860|Diazoxide|diazoxide|mesh-list
14884267|NCT01211860|Choline|choline|mesh-list
14884268|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
14884269|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14884270|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
14884271|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884272|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884273|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14884274|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
14884275|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884276|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884277|NCT01211912|Acetaminophen|acetaminophen|mesh-list
14884278|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14884279|NCT01211912|Analgesics|analgesics|mesh-ancestor
14884280|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
14884281|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884282|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884283|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
14884284|NCT01211925|Aspirin|aspirin|mesh-list
14884285|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14884286|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14884287|NCT01211925|Analgesics|analgesics|mesh-ancestor
14884288|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
14884289|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884290|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884291|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14884292|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14884293|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14884294|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14884295|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884296|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14884297|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14884298|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884299|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
14884300|NCT01211938|Cetuximab|cetuximab|mesh-list
14884301|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14884302|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884303|NCT01212133|Liraglutide|liraglutide|mesh-list
14884304|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14884305|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884306|NCT01212133|Incretins|incretins|mesh-ancestor
14884307|NCT01212133|Hormones|hormones|mesh-ancestor
14884308|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14884309|NCT01212250|Carvedilol|carvedilol|mesh-list
14884310|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14715816|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14715817|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715818|NCT00459719|Tacrolimus|tacrolimus|mesh-list
14715819|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715820|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
14715821|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715822|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14715823|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715824|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715825|NCT00459771|Candesartan|candesartan|mesh-list
14715826|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14715827|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14296530|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14884311|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14884312|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14884313|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884314|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884315|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884316|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14884317|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
14884318|NCT01212250|Protective Agents|protective agents|mesh-ancestor
14884319|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14884320|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884321|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14884322|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884323|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14884324|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14914993|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14914994|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
14914995|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14914996|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14914997|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14914998|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14914999|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14915000|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14915001|NCT01384331|Progestins|progestins|mesh-ancestor
14915002|NCT01384331|Hormones|hormones|mesh-ancestor
14915003|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915004|NCT01384448|Dobutamine|dobutamine|mesh-list
14915005|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14915006|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
14296531|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884325|NCT01212315|Triclosan|triclosan|mesh-list
14884326|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14884327|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884328|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14884329|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14884330|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
14884331|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884332|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14884333|NCT01212367|Interferons|interferons|mesh-list
14884334|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
14884335|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
14884336|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14884337|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884338|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
14884339|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884340|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
14884341|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884342|NCT01212406|Vitamin D|vitamin d|mesh-list
14884343|NCT01212406|Vitamins|vitamins|mesh-ancestor
14884344|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
14884345|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884346|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14884347|NCT01212432|Daptomycin|daptomycin|mesh-list
14884348|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14884349|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884350|NCT01212523|Propofol|propofol|mesh-list
15215433|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215434|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
15215435|NCT02484391|Cytarabine|cytarabine|mesh-list
15215436|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
15215437|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215438|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
15215439|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215440|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215441|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
15215442|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215443|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884351|NCT01212523|Isoflurane|isoflurane|mesh-list
14884352|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14884353|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884354|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884355|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14884356|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
14884357|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
14884358|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14884359|NCT01212653|Golimumab|golimumab|mesh-list
14884360|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14884361|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14884362|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884363|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
14884364|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884365|NCT01212666|Ropivacaine|ropivacaine|mesh-list
14884366|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
14884367|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
14884368|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884369|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215444|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
14296532|NCT05245786|Copper|copper|mesh-list
14884370|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
14884371|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884372|NCT01212679|Mitogens|mitogens|mesh-list
14296533|NCT05245786|Antibodies|antibodies|mesh-list
14884373|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
15215445|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884374|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884375|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
14884376|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14884377|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
14884378|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884379|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
14884380|NCT01212809|Protective Agents|protective agents|mesh-ancestor
14884381|NCT01212822|Leucovorin|leucovorin|mesh-list
14884382|NCT01212822|Bevacizumab|bevacizumab|mesh-list
14884383|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14884384|NCT01212822|Fluorouracil|fluorouracil|mesh-list
14884385|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
14884386|NCT01212822|Antibodies|antibodies|mesh-list
14884387|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
14884388|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14884389|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
14884390|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884391|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14884392|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14884393|NCT01212822|Growth Substances|growth substances|mesh-ancestor
14884394|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884395|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
14884396|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
14884397|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
14884398|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884399|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884400|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884401|NCT01212822|Antidotes|antidotes|mesh-ancestor
14884402|NCT01212822|Protective Agents|protective agents|mesh-ancestor
14884403|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
14884404|NCT01212822|Vitamins|vitamins|mesh-ancestor
14884405|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
14884406|NCT01212887|Aldesleukin|aldesleukin|mesh-list
14884407|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
14884408|NCT01212887|Fludarabine|fludarabine|mesh-list
14884409|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
14884410|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884411|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
14884412|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884413|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14884414|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14884415|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
14884416|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884417|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884418|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14884419|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884420|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
14884421|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14884422|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14884423|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
14884424|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884425|NCT01212913|Insulin|insulin|mesh-list
14884426|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14884427|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
14884428|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
14715828|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14715829|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715830|NCT00459836|Gemcitabine|gemcitabine|mesh-list
14715831|NCT00459836|Docetaxel|docetaxel|mesh-list
14715832|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715833|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
14715834|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715835|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715836|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
14715837|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715838|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715839|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715840|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
14715841|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715842|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
14715843|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
14715844|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
14715845|NCT00459901|Capecitabine|capecitabine|mesh-list
14715846|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14884429|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
14884430|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14884431|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14884432|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884433|NCT01212965|Selenium|selenium|mesh-list
14884434|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
14884435|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884436|NCT01212965|Protective Agents|protective agents|mesh-ancestor
14884437|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884438|NCT01212965|Trace Elements|trace elements|mesh-ancestor
14884439|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
14884440|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
14884441|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884442|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
14884443|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884444|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14884445|NCT01213095|Rituximab|rituximab|mesh-list
14884446|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14884447|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884448|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
14884449|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884450|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14884451|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14884452|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
14884453|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14884454|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14884455|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14884456|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884457|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884458|NCT01213147|Clomiphene|clomiphene|mesh-list
14884459|NCT01213147|Enclomiphene|enclomiphene|mesh-list
14884460|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
14884461|NCT01213147|Buserelin|buserelin|mesh-list
14884462|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14884463|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
14884464|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14884465|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884466|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14884467|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
14884468|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14884469|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14884470|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14884471|NCT01213238|Bevacizumab|bevacizumab|mesh-list
14884472|NCT01213238|Capecitabine|capecitabine|mesh-list
14884473|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
14884474|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14884475|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884476|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14884477|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14884478|NCT01213238|Growth Substances|growth substances|mesh-ancestor
14884479|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884480|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
14884481|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884482|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
14884483|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884484|NCT01213355|Scopolamine|scopolamine|mesh-list
14884485|NCT01213355|Donepezil|donepezil|mesh-list
14884486|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14884487|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14884488|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296534|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14915007|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
14884489|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215446|NCT02484391|Analgesics|analgesics|mesh-ancestor
15215447|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
15215448|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215449|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15215450|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15215451|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215452|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
14715847|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715848|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
14715849|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715850|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715851|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14715852|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715853|NCT00459940|Pioglitazone|pioglitazone|mesh-list
15215453|NCT02484391|Protective Agents|protective agents|mesh-ancestor
15215454|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
15215455|NCT02484391|Vitamins|vitamins|mesh-ancestor
15215456|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
15215457|NCT02448095|Ponatinib|ponatinib|mesh-list
14715854|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14715855|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715856|NCT00459992|Betahistine|betahistine|mesh-list
14715857|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
14715858|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
14715859|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
14715860|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715861|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715862|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715863|NCT00460057|Alendronate|alendronate|mesh-list
14715864|NCT00460057|Diphosphonates|diphosphonates|mesh-list
14715865|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14715866|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715867|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
14715868|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14715869|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14715870|NCT00460083|Analgesics|analgesics|mesh-ancestor
14715871|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
14715872|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14715873|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715874|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14715875|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14715876|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
14715877|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715878|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
14715879|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14715880|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715881|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715882|NCT00460148|Ropinirole|ropinirole|mesh-list
14715883|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14715884|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14715885|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
14715886|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
14715887|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715888|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715889|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715890|NCT00460174|Gemcitabine|gemcitabine|mesh-list
14715891|NCT00460174|Bevacizumab|bevacizumab|mesh-list
14715892|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14715893|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715894|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14715895|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14715896|NCT00460174|Growth Substances|growth substances|mesh-ancestor
14715897|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715898|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
14728910|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
14884490|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
14884491|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884492|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884493|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
14884494|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14884495|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
14884496|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
14884497|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884498|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884499|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
14884500|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14884501|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14884502|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
14884503|NCT01213368|Dronedarone|dronedarone|mesh-list
14884504|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14884505|NCT01213381|Gemcitabine|gemcitabine|mesh-list
14884506|NCT01213381|Carboplatin|carboplatin|mesh-list
14884507|NCT01213381|Iniparib|iniparib|mesh-list
14884508|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884509|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884510|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
14884511|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884512|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
14884513|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884514|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884515|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884516|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
14884517|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884518|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14884519|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
14884520|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14884521|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884522|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14884523|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
14884524|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14884525|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884526|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884527|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884528|NCT01213407|Temozolomide|temozolomide|mesh-list
14884529|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14884530|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
14884531|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884532|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884533|NCT01213433|Artesunate|artesunate|mesh-list
14884534|NCT01213433|Amodiaquine|amodiaquine|mesh-list
14884535|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
14884536|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14884537|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14884538|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884539|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884540|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
14884541|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
14884542|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14884543|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
14884544|NCT01213498|Atorvastatin|atorvastatin|mesh-list
14884545|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14884546|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14884547|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
14884548|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884549|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14884550|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14884551|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884552|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
15215458|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215459|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15215460|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215461|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215462|NCT02398825|Ponatinib|ponatinib|mesh-list
15215463|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215464|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15215465|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215466|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884553|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15215467|NCT02393248|Gemcitabine|gemcitabine|mesh-list
15215468|NCT02393248|Docetaxel|docetaxel|mesh-list
15215469|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
15215470|NCT02393248|Trastuzumab|trastuzumab|mesh-list
15215471|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884554|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14884555|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884556|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
14884557|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14884558|NCT01213563|Insulin|insulin|mesh-list
15215472|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215473|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
15215474|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215475|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
15215476|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215477|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215478|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215479|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
15215480|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215481|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
15215482|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
15215483|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
15215484|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14884559|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14884560|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
14884561|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
14884562|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14884563|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884564|NCT01213667|Ranibizumab|ranibizumab|mesh-list
14884565|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14884566|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14884567|NCT01213667|Growth Substances|growth substances|mesh-ancestor
14884568|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884569|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
14884570|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884571|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
14884572|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14884573|NCT01213680|Hematinics|hematinics|mesh-ancestor
14884574|NCT01213693|Fluticasone|fluticasone|mesh-list
14884575|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14884576|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14884577|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14884578|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
14884579|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884580|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215485|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14884581|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14884582|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
14884583|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
15215486|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
14884584|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14884585|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14884586|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14884587|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14884588|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
14884589|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884590|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884591|NCT01213719|Betaine|betaine|mesh-list
14884592|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884593|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
14884594|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14884595|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
14884596|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884597|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14884598|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14884599|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715899|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14715900|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
14715901|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715902|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
14715903|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715904|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715905|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14715906|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
14715907|NCT00460213|Valsartan|valsartan|mesh-list
14715908|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14715909|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14715910|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14715911|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715912|NCT00460226|Lamotrigine|lamotrigine|mesh-list
14715913|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
14715914|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14715915|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715916|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715917|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14715918|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715919|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14715920|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14884600|NCT01213849|Fluticasone|fluticasone|mesh-list
14884601|NCT01213849|Xhance|xhance|mesh-list
14884602|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215487|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
15215488|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15215489|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215490|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
15215491|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884603|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14884604|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
14884605|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884606|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884607|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14884608|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
14884609|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
14884610|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14884611|NCT01213888|Trientine|trientine|mesh-list
14884612|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
14884613|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
14884614|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884615|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
14884616|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14884617|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915008|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915009|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915010|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14915011|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14915012|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14915013|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
14915014|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915015|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915016|NCT01384448|Protective Agents|protective agents|mesh-ancestor
14915017|NCT01384513|Vidarabine|vidarabine|mesh-list
14915018|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
14915019|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
14915020|NCT01384513|Busulfan|busulfan|mesh-list
14915021|NCT01384513|Fludarabine|fludarabine|mesh-list
14915022|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
14915023|NCT01384513|Tacrolimus|tacrolimus|mesh-list
14915024|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915025|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
14915026|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915027|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14915028|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14915029|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
14915030|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915031|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915032|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14915033|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915034|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
14915035|NCT01384513|Antiviral Agents|antiviral agents|mesh-ancestor
14915036|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915037|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14915038|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915039|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14915040|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14915041|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
14915042|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14915043|NCT01384578|Vitamins|vitamins|mesh-list
14915044|NCT01384578|Vitamin E|vitamin e|mesh-list
14915045|NCT01384578|Tocopherols|tocopherols|mesh-list
14915046|NCT01384578|Tocotrienols|tocotrienols|mesh-list
14915047|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
14915048|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
14915049|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
14915050|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915051|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
14915052|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915053|NCT01384578|Protective Agents|protective agents|mesh-ancestor
15215492|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15215493|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15215494|NCT02307656|Cobicistat|cobicistat|mesh-list
15215495|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15215496|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15215497|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
15215498|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915054|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14915055|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715921|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715922|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14715923|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14715924|NCT00460252|Insulin|insulin|mesh-list
14715925|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14715926|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884618|NCT01213979|Iron|iron|mesh-list
14884619|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14884620|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
14884621|NCT01213979|Trace Elements|trace elements|mesh-ancestor
14884622|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
14884623|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884624|NCT01213979|Hematinics|hematinics|mesh-ancestor
14884625|NCT01213992|Iron|iron|mesh-list
14884626|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14884627|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
14884628|NCT01213992|Trace Elements|trace elements|mesh-ancestor
14884629|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
14884630|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884631|NCT01213992|Hematinics|hematinics|mesh-ancestor
14884632|NCT01214122|Warfarin|warfarin|mesh-list
14884633|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
14884634|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
14884635|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14884636|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884637|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884638|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14884639|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14884640|NCT01214226|Protective Agents|protective agents|mesh-ancestor
14715927|NCT00460304|Pramlintide|pramlintide|mesh-list
14715928|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14715929|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715930|NCT00460369|Artesunate|artesunate|mesh-list
14715931|NCT00460369|Lumefantrine|lumefantrine|mesh-list
14715932|NCT00460369|Artemether|artemether|mesh-list
14715933|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
14296535|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
14715934|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
14715935|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14884641|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884642|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884643|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14715936|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14884644|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
14884645|NCT01214291|Toremifene|toremifene|mesh-list
14884646|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14884647|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884648|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14884649|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14884650|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
14884651|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14884652|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884653|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14884654|NCT01214343|Sorafenib|sorafenib|mesh-list
14884655|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884656|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884657|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884658|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884659|NCT01214382|Sertraline|sertraline|mesh-list
14884660|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
14884661|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14884662|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14884663|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14884664|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14715937|NCT00460369|Amodiaquine|amodiaquine|mesh-list
14715938|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
14715939|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14715940|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14715941|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884665|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884666|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884667|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
14884668|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884669|NCT01214408|Pantoprazole|pantoprazole|mesh-list
14884670|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14884671|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884672|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14884673|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884674|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884675|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
14884676|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14884677|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14884678|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
14884679|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884680|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14884681|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14884682|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296536|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715942|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715943|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
14715944|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
14296537|NCT05245786|Trace Elements|trace elements|mesh-ancestor
14715945|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14715946|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
14884683|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884684|NCT01214746|Atorvastatin|atorvastatin|mesh-list
14884685|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14884686|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14884687|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
14884688|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884689|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14884690|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14884691|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884692|NCT01214772|Heparin|heparin|mesh-list
14884693|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
14884694|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14884695|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14884696|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884697|NCT01214889|Vaccines|vaccines|mesh-list
14884698|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
14884699|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884700|NCT01214928|Vitamin D|vitamin d|mesh-list
14884701|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
14884702|NCT01214928|Vitamins|vitamins|mesh-ancestor
14884703|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
14884704|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884705|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14884706|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14884707|NCT01214941|Itraconazole|itraconazole|mesh-list
14884708|NCT01214941|Ticlopidine|ticlopidine|mesh-list
14884709|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
14884710|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884711|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14884712|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14884713|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715947|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14715948|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14715949|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715950|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14715951|NCT00460369|Renal Agents|renal agents|mesh-ancestor
14715952|NCT00460382|Ritonavir|ritonavir|mesh-list
14715953|NCT00460382|Darunavir|darunavir|mesh-list
14715954|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
14715955|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
14715956|NCT00460382|Etravirine|etravirine|mesh-list
14715957|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14884714|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884715|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14884716|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
14884717|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14884718|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884719|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14884720|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14884721|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14715958|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14715959|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
14715960|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884722|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14884723|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14884724|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15215499|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215500|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15215501|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15215502|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
15215503|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215504|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15215505|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15215506|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
15215507|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15215508|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15215509|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15215510|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15215511|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215512|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
14884725|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14884726|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
14728911|NCT00520585|Atorvastatin|atorvastatin|mesh-list
14884727|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884728|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14884729|NCT01214993|Dolutegravir|dolutegravir|mesh-list
14884730|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14884731|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14884732|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884733|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884734|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14884735|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14884736|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
14884737|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884738|NCT01215019|Mannitol|mannitol|mesh-list
14884739|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14884740|NCT01215019|Diuretics|diuretics|mesh-ancestor
14884741|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
14884742|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884743|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
14884744|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14884745|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884746|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884747|NCT01215136|Paclitaxel|paclitaxel|mesh-list
14884748|NCT01215136|Everolimus|everolimus|mesh-list
14884749|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14884750|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884751|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
14884752|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
14884753|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
14884754|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884755|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884756|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
14884757|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884758|NCT01215149|Vaccines|vaccines|mesh-list
14884759|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
14884760|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884761|NCT01215214|Midazolam|midazolam|mesh-list
14884762|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14884763|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14884764|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884765|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884766|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14884767|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14884768|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14884769|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14884770|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
14884771|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
14296538|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
14296539|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
14296540|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14715961|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715962|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14715963|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14715964|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
14715965|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715966|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14715967|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14715968|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14715969|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14715970|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14715971|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14715972|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14715973|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14715974|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
14715975|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14715976|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14715977|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
14715978|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14715979|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14715980|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715981|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14715982|NCT00460473|Analgesics|analgesics|mesh-ancestor
14715983|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
14715984|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884772|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
14296541|NCT05245734|Antibodies|antibodies|mesh-list
14884773|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
14715985|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14715986|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14715987|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14884774|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884775|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884776|NCT01215266|Sorafenib|sorafenib|mesh-list
14884777|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884778|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884779|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884780|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884781|NCT01215331|Insulin|insulin|mesh-list
14884782|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14884783|NCT01215331|Metformin|metformin|mesh-list
14884784|NCT01215331|Glyburide|glyburide|mesh-list
14884785|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14884786|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884787|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14884788|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
14884789|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14884790|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14884791|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884792|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884793|NCT01215409|Urological Agents|urological agents|mesh-ancestor
14884794|NCT01215539|Panitumumab|panitumumab|mesh-list
14884795|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14884796|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884797|NCT01215565|Sunitinib|sunitinib|mesh-list
14884798|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884799|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14884800|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14884801|NCT01215565|Growth Substances|growth substances|mesh-ancestor
14884802|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884803|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
14884804|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884805|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884806|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884807|NCT01215578|Sunitinib|sunitinib|mesh-list
14884808|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884809|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14884810|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14884811|NCT01215578|Growth Substances|growth substances|mesh-ancestor
14884812|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884813|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
14884814|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884815|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884816|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884817|NCT01215669|Vaccines|vaccines|mesh-list
14884818|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
14884819|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884820|NCT01215682|Vitamin D|vitamin d|mesh-list
14884821|NCT01215682|Vitamins|vitamins|mesh-ancestor
14884822|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
14884823|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884824|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14884825|NCT01215708|Tamsulosin|tamsulosin|mesh-list
14884826|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14884827|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14884828|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14884829|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
14884830|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715988|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14715989|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14715990|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14715991|NCT00460486|Formaldehyde|formaldehyde|mesh-list
14715992|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
14715993|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14715994|NCT00460499|Insulin|insulin|mesh-list
14715995|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14715996|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14715997|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14715998|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14715999|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14716000|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884831|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884832|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884833|NCT01215708|Urological Agents|urological agents|mesh-ancestor
14884834|NCT01215799|Bafetinib|bafetinib|mesh-list
14884835|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884836|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884837|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884838|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
14884839|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14884840|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884841|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884842|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14884843|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884844|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14884845|NCT01216007|Propofol|propofol|mesh-list
15215513|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215514|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215515|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14884846|NCT01216007|Sevoflurane|sevoflurane|mesh-list
14884847|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14884848|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884849|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884850|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15215516|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215517|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
15215518|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
15215519|NCT02090114|Testosterone|testosterone|mesh-list
15215520|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
14296542|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
14716001|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215521|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
15215522|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15215523|NCT02090114|Androgens|androgens|mesh-ancestor
15215524|NCT02090114|Hormones|hormones|mesh-ancestor
15215525|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215526|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296543|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14296544|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
14716002|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14716003|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14716004|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14716005|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
14716006|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716007|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716008|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14716009|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14716010|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
14716011|NCT00460616|Cabergoline|cabergoline|mesh-list
14716012|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14716013|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14716014|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
14716015|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
14716016|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884851|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
14884852|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
14884853|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14884854|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14884855|NCT01216020|Cisplatin|cisplatin|mesh-list
14884856|NCT01216020|Cetuximab|cetuximab|mesh-list
14884857|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884858|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14884859|NCT01216046|Ivacaftor|ivacaftor|mesh-list
14884860|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14884861|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884862|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915056|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14915057|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14915058|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
14915059|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14915060|NCT01384643|Propofol|propofol|mesh-list
14915061|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14915062|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14915063|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915064|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14915065|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
14915066|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
14915067|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14915068|NCT01384682|Maraviroc|maraviroc|mesh-list
14915069|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14915070|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14915071|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915072|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14915073|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14915074|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
14915075|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915076|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14915077|NCT01384695|Proflavine|proflavine|mesh-list
14915078|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14915079|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915080|NCT01384708|Proflavine|proflavine|mesh-list
14915081|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14915082|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915083|NCT01384773|Riboflavin|riboflavin|mesh-list
14915084|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14915085|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14915086|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
14915087|NCT01384773|Vitamins|vitamins|mesh-ancestor
14915088|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
14915089|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915090|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14915091|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
14915092|NCT01384799|Cisplatin|cisplatin|mesh-list
14915093|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915094|NCT01384812|Dinoprostone|dinoprostone|mesh-list
14915095|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
14915096|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14915097|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915098|NCT01384864|Proflavine|proflavine|mesh-list
15215527|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215528|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215529|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
15215530|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15215531|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215532|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215533|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
15215534|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14915099|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14915100|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915101|NCT01384903|Antithrombins|antithrombins|mesh-list
14915102|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
14915103|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14915104|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
14884863|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
14884864|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884865|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884866|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884867|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884868|NCT01216111|Paclitaxel|paclitaxel|mesh-list
14884869|NCT01216111|Docetaxel|docetaxel|mesh-list
14884870|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
14884871|NCT01216111|Fluorouracil|fluorouracil|mesh-list
14884872|NCT01216111|Epirubicin|epirubicin|mesh-list
14884873|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14884874|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884875|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14884876|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14884877|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14884878|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884879|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884880|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
14884881|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884882|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14884883|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14884884|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
14884885|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14884886|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
14884887|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884888|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14884889|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14884890|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14884891|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884892|NCT01216124|Docetaxel|docetaxel|mesh-list
14884893|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
14884894|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884895|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
14884896|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
14884897|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
14884898|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884899|NCT01216267|Lansoprazole|lansoprazole|mesh-list
14884900|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
14884901|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14884902|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884903|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14884904|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884905|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884906|NCT01216293|Esomeprazole|esomeprazole|mesh-list
14884907|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
14884908|NCT01216293|Lansoprazole|lansoprazole|mesh-list
14884909|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14884910|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14884911|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14884912|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884913|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884914|NCT01216345|Gemcitabine|gemcitabine|mesh-list
14884915|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
14884916|NCT01216345|Cetuximab|cetuximab|mesh-list
14884917|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884918|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
14884919|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884920|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884921|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
14884922|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14884923|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884924|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884925|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
14884926|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915105|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884927|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14884928|NCT01216371|Sunitinib|sunitinib|mesh-list
14884929|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884930|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14884931|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14884932|NCT01216371|Growth Substances|growth substances|mesh-ancestor
14884933|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884934|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
14884935|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14884936|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884937|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884938|NCT01216436|Vaccines|vaccines|mesh-list
14884939|NCT01216436|Immunologic Factors|immunologic factors|mesh-ancestor
14884940|NCT01216436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884941|NCT01216449|Citalopram|citalopram|mesh-list
14884942|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14884943|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14884944|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884945|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884946|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14884947|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
14884948|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884949|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14884950|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
14884951|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14884952|NCT01216488|Lidocaine|lidocaine|mesh-list
14884953|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
14884954|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
14884955|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14884956|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884957|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
14884958|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14884959|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14884960|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14884961|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14884962|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14884963|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884964|NCT01216579|Mannitol|mannitol|mesh-list
14884965|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14884966|NCT01216579|Diuretics|diuretics|mesh-ancestor
14884967|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
14884968|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884969|NCT01216605|Oxytocin|oxytocin|mesh-list
14884970|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
14884971|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14884972|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884973|NCT01216644|Leucovorin|leucovorin|mesh-list
14884974|NCT01216644|Docetaxel|docetaxel|mesh-list
14884975|NCT01216644|Fluorouracil|fluorouracil|mesh-list
14884976|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
14716017|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716018|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716019|NCT00460642|Cetrorelix|cetrorelix|mesh-list
14716020|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14716021|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
14716022|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716023|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716024|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716025|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716026|NCT00460681|Thymopentin|thymopentin|mesh-list
14884977|NCT01216644|Epirubicin|epirubicin|mesh-list
14884978|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14884979|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
14884980|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
14716027|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14716028|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
14716029|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716030|NCT00460707|Ketoconazole|ketoconazole|mesh-list
14884981|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
14884982|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884983|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
14884984|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14884985|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14884986|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
14884987|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14884988|NCT01216644|Antidotes|antidotes|mesh-ancestor
14884989|NCT01216644|Protective Agents|protective agents|mesh-ancestor
14884990|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
14884991|NCT01216644|Vitamins|vitamins|mesh-ancestor
14884992|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
14884993|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14884994|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14884995|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14884996|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14884997|NCT01216657|Sunitinib|sunitinib|mesh-list
14884998|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716031|NCT00460707|Casopitant|casopitant|mesh-list
14716032|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
14716033|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716034|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14716035|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14716036|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716037|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14884999|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885000|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14716038|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14716039|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885001|NCT01216657|Growth Substances|growth substances|mesh-ancestor
14885002|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885003|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885004|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14885005|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885006|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885007|NCT01216696|Ipilimumab|ipilimumab|mesh-list
14885008|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14885009|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885010|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14885011|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885012|NCT01216709|Iron|iron|mesh-list
14885013|NCT01216709|Trace Elements|trace elements|mesh-ancestor
14885014|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
14885015|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885016|NCT01216787|R04929097|r04929097|mesh-list
14885017|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885018|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885019|NCT01216826|Everolimus|everolimus|mesh-list
14885020|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885021|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885022|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
14885023|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885024|NCT01216839|Everolimus|everolimus|mesh-list
14885025|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885026|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885027|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
14885028|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885029|NCT01216852|Losartan|losartan|mesh-list
14885030|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14885031|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885032|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15215535|NCT02031250|Carboplatin|carboplatin|mesh-list
15215536|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296545|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296546|NCT05245721|Nalbuphine|nalbuphine|mesh-list
14296547|NCT05245721|Bupivacaine|bupivacaine|mesh-list
14885033|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14885034|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885035|NCT01216878|Losartan|losartan|mesh-list
14885036|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14885037|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885038|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14885039|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14885040|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885041|NCT01216904|Nicotine|nicotine|mesh-list
14885042|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14885043|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
14885044|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885045|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215537|NCT02015351|Bevacizumab|bevacizumab|mesh-list
15215538|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215539|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215540|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215541|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15215542|NCT02015351|Growth Substances|growth substances|mesh-ancestor
15215543|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215544|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
15215545|NCT02013167|Blinatumomab|blinatumomab|mesh-list
15215546|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215547|NCT02004522|Ofatumumab|ofatumumab|mesh-list
15215548|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215549|NCT02000427|Blinatumomab|blinatumomab|mesh-list
15215550|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215551|NCT01996436|Verapamil|verapamil|mesh-list
15215552|NCT01996436|Nicardipine|nicardipine|mesh-list
15215553|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
14885046|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14885047|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14885048|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
14885049|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885050|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885051|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
14885052|NCT01216956|Niacin|niacin|mesh-list
14885053|NCT01216956|Niacinamide|niacinamide|mesh-list
14885054|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
14885055|NCT01216956|Vitamins|vitamins|mesh-ancestor
14885056|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
14885057|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885058|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14885059|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
14885060|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885061|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14885062|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885063|NCT01217034|Sorafenib|sorafenib|mesh-list
14885064|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
14885065|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885066|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14885067|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885068|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885069|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14885070|NCT01217034|Estrogens|estrogens|mesh-ancestor
14716040|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716041|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716042|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14716043|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
14716044|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
14716045|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716046|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716047|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14716048|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716049|NCT00460733|Vitamin D|vitamin d|mesh-list
14716050|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
14716051|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
14716052|NCT00460733|Calcium|calcium|mesh-list
14885071|NCT01217034|Hormones|hormones|mesh-ancestor
14885072|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885073|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885074|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885075|NCT01217086|Infliximab|infliximab|mesh-list
14885076|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14885077|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885078|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14885079|NCT01217099|Azithromycin|azithromycin|mesh-list
14885080|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
14885081|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14885082|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14885083|NCT01217099|Prednisolone|prednisolone|mesh-list
14885084|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
14885085|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14885086|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
14885087|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885088|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
14885089|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
14885090|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885091|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885092|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885093|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
14885094|NCT01217099|Hormones|hormones|mesh-ancestor
14885095|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885096|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14885097|NCT01217099|Protective Agents|protective agents|mesh-ancestor
14885098|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885099|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885100|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885101|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885102|NCT01217125|Sirolimus|sirolimus|mesh-list
14885103|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885104|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885105|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14885106|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885107|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
14885108|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885109|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
14885110|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885111|NCT01217138|Epinephrine|epinephrine|mesh-list
14885112|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14885113|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14885114|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14885115|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885116|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885117|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885118|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14885119|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14885120|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
14885121|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885122|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14885123|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
14885124|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
14885125|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
14885126|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14885127|NCT01217177|Everolimus|everolimus|mesh-list
14885128|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885129|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885130|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
14885131|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885132|NCT01217203|Lenalidomide|lenalidomide|mesh-list
14885133|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
14885134|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885135|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885136|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14885137|NCT01217203|Growth Substances|growth substances|mesh-ancestor
15215554|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
15215555|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15215556|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15215557|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15215558|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215559|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15215560|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215561|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15215562|NCT01957332|Trastuzumab|trastuzumab|mesh-list
15215563|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215564|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215565|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
15215566|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215567|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15215568|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885138|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885139|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885140|NCT01217294|Morphine|morphine|mesh-list
14716053|NCT00460733|Vitamins|vitamins|mesh-ancestor
14716054|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
14885141|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14885142|NCT01217294|Narcotics|narcotics|mesh-ancestor
14885143|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885144|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885145|NCT01217294|Analgesics|analgesics|mesh-ancestor
14885146|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
14885147|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885148|NCT01217359|Interferons|interferons|mesh-list
14885149|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
14885150|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
14885151|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885152|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
14885153|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885154|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
14885155|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885156|NCT01217398|Bevacizumab|bevacizumab|mesh-list
14885157|NCT01217398|Temozolomide|temozolomide|mesh-list
14885158|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14885159|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885160|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885161|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14885162|NCT01217398|Growth Substances|growth substances|mesh-ancestor
14885163|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885164|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885165|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14885166|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
14885167|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215569|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716055|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716056|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14716057|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14716058|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14716059|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14716060|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716061|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
14716062|NCT00460759|Rifapentine|rifapentine|mesh-list
14716063|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716064|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716065|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14716066|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14716067|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716068|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716069|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716070|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14716071|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
14716072|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
14716073|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
14716074|NCT00460785|Narcotics|narcotics|mesh-ancestor
14716075|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885168|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15215570|NCT01807182|Aldesleukin|aldesleukin|mesh-list
15215571|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
15215572|NCT01807182|Fludarabine|fludarabine|mesh-list
15215573|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
15215574|NCT01807182|Interleukin-2|interleukin-2|mesh-list
15215575|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215576|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
15215577|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215578|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215579|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15215580|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
15215581|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215582|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885169|NCT01217450|Cetuximab|cetuximab|mesh-list
14885170|NCT01217450|Antibodies|antibodies|mesh-list
14885171|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
14885172|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14885173|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
14885174|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885175|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885176|NCT01217580|Ropivacaine|ropivacaine|mesh-list
14885177|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
14885178|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
14885179|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885180|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885181|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
14885182|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885183|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14885184|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885185|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14885186|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885187|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885188|NCT01217632|Entecavir|entecavir|mesh-list
14885189|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
14885190|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885191|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
14885192|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14885193|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885194|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885195|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14885196|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14885197|NCT01217697|Prednisone|prednisone|mesh-list
14885198|NCT01217697|Prednisolone|prednisolone|mesh-list
14885199|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
14885200|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885201|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
14885202|NCT01217697|Hormones|hormones|mesh-ancestor
14885203|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885204|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885205|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885206|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885207|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14885208|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885209|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215583|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15215584|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215585|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
15215586|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15215587|NCT01807182|Analgesics|analgesics|mesh-ancestor
15215588|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
15215589|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215590|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15215591|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15215592|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
15215593|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215594|NCT01765140|Amifampridine|amifampridine|mesh-list
15215595|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14885210|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885211|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14885212|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
14885213|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14885214|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
14885215|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885216|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915106|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915107|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
14917438|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14917439|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917440|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917441|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
14917442|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
14917443|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917444|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917606|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917607|NCT04835129|Dexamethasone|dexamethasone|mesh-list
15215596|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215597|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215598|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14917608|NCT04835129|Pomalidomide|pomalidomide|mesh-list
14917609|NCT04835129|Elotuzumab|elotuzumab|mesh-list
14917610|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14917611|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917612|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
14917613|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
14917614|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917615|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917616|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917617|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
14917618|NCT04835129|Hormones|hormones|mesh-ancestor
14917619|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917620|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14917621|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917622|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
14917623|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215599|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15215600|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215601|NCT01761890|Dasatinib|dasatinib|mesh-list
15215602|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215603|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14885217|NCT01217879|Telmisartan|telmisartan|mesh-list
14885218|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885219|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14885220|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14885221|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885222|NCT01217931|Bevacizumab|bevacizumab|mesh-list
14885223|NCT01217931|Everolimus|everolimus|mesh-list
14885224|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14885225|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885226|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885227|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14885228|NCT01217931|Growth Substances|growth substances|mesh-ancestor
14885229|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885230|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885231|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885232|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
14885233|NCT01217970|Ibudilast|ibudilast|mesh-list
14885234|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14885235|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
14885236|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885237|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885238|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14885239|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
14885240|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14885241|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885242|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885243|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14885244|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885245|NCT01218022|Losartan|losartan|mesh-list
14885246|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14885247|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885248|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14885249|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14885250|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885251|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
14885252|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14885253|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885254|NCT01218217|Rifampin|rifampin|mesh-list
14885255|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14885256|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
14885257|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885258|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885259|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
14885260|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14885261|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885262|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885263|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14885264|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14885265|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14885266|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14885267|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14885268|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14885269|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
14885270|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14885271|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14885272|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14885273|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
14885274|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885275|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14885276|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14885277|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885278|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14885279|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14885280|NCT01218386|Estradiol|estradiol|mesh-list
14885281|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14885282|NCT01218386|Estrogens|estrogens|mesh-ancestor
14885283|NCT01218386|Hormones|hormones|mesh-ancestor
14885284|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885285|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885286|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14885287|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
14885288|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14885289|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14885290|NCT01218425|Levodopa|levodopa|mesh-list
14885291|NCT01218425|Carbidopa|carbidopa|mesh-list
14885292|NCT01218425|Domperidone|domperidone|mesh-list
14885293|NCT01218425|Methylphenidate|methylphenidate|mesh-list
14885294|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14885295|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885296|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14885297|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14885298|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885299|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885300|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
14885301|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885302|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14885303|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14885304|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14885305|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885306|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
14885307|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
14885308|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885309|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885310|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14885311|NCT01218451|Vaccines|vaccines|mesh-list
14885312|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
14885313|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885314|NCT01218529|Lapatinib|lapatinib|mesh-list
14885315|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885316|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14885317|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885318|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885319|NCT01218568|Rifaximin|rifaximin|mesh-list
14885320|NCT01218568|Lactulose|lactulose|mesh-list
14885321|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885322|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885323|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885324|NCT01218581|Letrozole|letrozole|mesh-list
14885325|NCT01218581|Goserelin|goserelin|mesh-list
14885326|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885327|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14885328|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14885329|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885330|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885331|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14885332|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885333|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885334|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885335|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885336|NCT01218607|Bosentan|bosentan|mesh-list
14885337|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885338|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14885339|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885340|NCT01218620|Tolbutamide|tolbutamide|mesh-list
14885341|NCT01218620|Rifampin|rifampin|mesh-list
14885342|NCT01218620|Ketoconazole|ketoconazole|mesh-list
14885343|NCT01218620|Midazolam|midazolam|mesh-list
14885344|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
14885345|NCT01218620|Omeprazole|omeprazole|mesh-list
14885346|NCT01218620|R04929097|r04929097|mesh-list
14885347|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14885348|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14885349|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885350|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885351|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14885352|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14885353|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14885354|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14885355|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
14885356|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
14885357|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
14885358|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
14885359|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885360|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885361|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14885362|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885363|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14885364|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885365|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14885366|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
14885367|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885368|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885369|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
14885370|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14885371|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14885372|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14885373|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14885374|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14885375|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14885376|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14885377|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
14885378|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14885379|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14885380|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14885381|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885382|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885383|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14885384|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
14885385|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
14885386|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14885387|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15215604|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215605|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215606|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15215607|NCT01703949|Nivolumab|nivolumab|mesh-list
14885388|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14885389|NCT01218698|Losartan|losartan|mesh-list
14885390|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14885391|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885392|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14885393|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14885394|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885395|NCT01218711|Losartan|losartan|mesh-list
14885396|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14885397|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14885398|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885399|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15215608|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15215609|NCT01703949|Antibodies|antibodies|mesh-list
15215610|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
15215611|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15215612|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
15215613|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
15215614|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215615|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215616|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15215617|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215618|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
14885400|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14885401|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885402|NCT01218711|Diuretics|diuretics|mesh-ancestor
14885403|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
14885404|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716076|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716077|NCT00460785|Analgesics|analgesics|mesh-ancestor
14716078|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
14885405|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14885406|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14716079|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716080|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
14716081|NCT00460837|Cathartics|cathartics|mesh-ancestor
14885407|NCT01218724|Losartan|losartan|mesh-list
14885408|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14885409|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14885410|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885411|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14885412|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14885413|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716082|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716083|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14716084|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
14716085|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716086|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
14885414|NCT01218724|Diuretics|diuretics|mesh-ancestor
14885415|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
14885416|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885417|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14885418|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885419|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
14885420|NCT01218737|Prednisolone|prednisolone|mesh-list
14885421|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14885422|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
14885423|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14885424|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
14885425|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14885426|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
14885427|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885428|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
14885429|NCT01218737|Hormones|hormones|mesh-ancestor
14885430|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885431|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885432|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885433|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885434|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
14885435|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
14885436|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885437|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885438|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14885439|NCT01218737|Protective Agents|protective agents|mesh-ancestor
14885440|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885441|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885442|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14885443|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14885444|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14885445|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14885446|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885447|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885448|NCT01218750|Bevacizumab|bevacizumab|mesh-list
14885449|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14885450|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885451|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885452|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14885453|NCT01218750|Growth Substances|growth substances|mesh-ancestor
14885454|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885455|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885456|NCT01218893|Chloroquine|chloroquine|mesh-list
14885457|NCT01218893|Proguanil|proguanil|mesh-list
14885458|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14885459|NCT01218893|Vaccines|vaccines|mesh-list
14885460|NCT01218893|Amebicides|amebicides|mesh-ancestor
14885461|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14885462|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14885463|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885464|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
14885465|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14885466|NCT01218893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885467|NCT01218893|Immunologic Factors|immunologic factors|mesh-ancestor
14885468|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
14885469|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885470|NCT01219010|Siltuximab|siltuximab|mesh-list
14885471|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885472|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
14885473|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885474|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885475|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14885476|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14885477|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885478|NCT01219023|Urological Agents|urological agents|mesh-ancestor
14885479|NCT01219036|Budesonide|budesonide|mesh-list
14885480|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215619|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15215620|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15215621|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15215622|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15215623|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215624|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
14885481|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14885482|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
14915108|NCT01384994|Folic Acid|folic acid|mesh-list
14885483|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885484|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885485|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14885486|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
14885487|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
14885488|NCT01219036|Hormones|hormones|mesh-ancestor
14885489|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885490|NCT01219062|Morphine|morphine|mesh-list
14885491|NCT01219062|Bupivacaine|bupivacaine|mesh-list
14885492|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
14885493|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
14885494|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885495|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885496|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
14885497|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885498|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14885499|NCT01219062|Narcotics|narcotics|mesh-ancestor
14885500|NCT01219062|Analgesics|analgesics|mesh-ancestor
14885501|NCT01219088|Morphine|morphine|mesh-list
14885502|NCT01219088|Bupivacaine|bupivacaine|mesh-list
14885503|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
14885504|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
14885505|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885506|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885507|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
14885508|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885509|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14885510|NCT01219088|Narcotics|narcotics|mesh-ancestor
14885511|NCT01219088|Analgesics|analgesics|mesh-ancestor
14885512|NCT01219101|Citric Acid|citric acid|mesh-list
14885513|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
14885514|NCT01219101|Clomiphene|clomiphene|mesh-list
14885515|NCT01219101|Enclomiphene|enclomiphene|mesh-list
14885516|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
14885517|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
14885518|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14885519|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
14885520|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
14885521|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885522|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14885523|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885524|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885525|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885526|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14885527|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
14885528|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14885529|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14885530|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14885531|NCT01219153|Letrozole|letrozole|mesh-list
14885532|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
14885533|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14885534|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885535|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14885536|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14885537|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885538|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885539|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14885540|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885541|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885542|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885543|NCT01219153|Hormones|hormones|mesh-ancestor
14885544|NCT01219205|Bevacizumab|bevacizumab|mesh-list
14885545|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14885546|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885547|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885548|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14885549|NCT01219205|Growth Substances|growth substances|mesh-ancestor
14885550|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885551|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885552|NCT01219244|Resveratrol|resveratrol|mesh-list
14885553|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
14885554|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885555|NCT01219244|Protective Agents|protective agents|mesh-ancestor
14885556|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885557|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885558|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14885559|NCT01219257|Adalimumab|adalimumab|mesh-list
14885560|NCT01219257|Etanercept|etanercept|mesh-list
14885561|NCT01219257|Golimumab|golimumab|mesh-list
14885562|NCT01219257|Infliximab|infliximab|mesh-list
15215625|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215626|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215627|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14885563|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885564|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14885565|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14885566|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885567|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14885568|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14885569|NCT01219257|Analgesics|analgesics|mesh-ancestor
14885570|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
14885571|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885572|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885573|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885574|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
14885575|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14885576|NCT01219348|Vaccines|vaccines|mesh-list
14885577|NCT01219348|Immunologic Factors|immunologic factors|mesh-ancestor
14885578|NCT01219348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885579|NCT01219400|Vildagliptin|vildagliptin|mesh-list
14885580|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14885581|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885582|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14885583|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
14885584|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885585|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885586|NCT01219413|Perindopril|perindopril|mesh-list
14885587|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14885588|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
14885589|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215628|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215629|NCT01556776|Lenalidomide|lenalidomide|mesh-list
14716087|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15215630|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
15215631|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215632|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215633|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14716088|NCT00460876|Topotecan|topotecan|mesh-list
14716089|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14716090|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14716091|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716092|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716093|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716094|NCT00460915|Amlodipine|amlodipine|mesh-list
14716095|NCT00460915|Lacidipine|lacidipine|mesh-list
14716096|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14716097|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14716098|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14716099|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716100|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14716101|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716102|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
14716103|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
14716104|NCT00460928|Antibodies|antibodies|mesh-list
14716105|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
14716106|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14716107|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14716108|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
14716109|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716110|NCT00460954|Levodopa|levodopa|mesh-list
14716111|NCT00460954|Carbidopa|carbidopa|mesh-list
14885590|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885591|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885592|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14885593|NCT01219556|Olmesartan|olmesartan|mesh-list
14885594|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885595|NCT01219556|Diuretics|diuretics|mesh-ancestor
14885596|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
14885597|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885598|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14885599|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885600|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885601|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14885602|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14915109|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
14915110|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
14915111|NCT01384994|Fluorouracil|fluorouracil|mesh-list
14915112|NCT01384994|Panitumumab|panitumumab|mesh-list
14915113|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915114|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
14915115|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915116|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915117|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915118|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
14915119|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915120|NCT01384994|Hematinics|hematinics|mesh-ancestor
14915121|NCT01384994|Vitamins|vitamins|mesh-ancestor
14915122|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
14915123|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915124|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
14915125|NCT01385020|Red yeast rice|red yeast rice|mesh-list
14915126|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14915127|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
14915128|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915129|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14915130|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14915131|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14915132|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915133|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14915134|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14915135|NCT01385059|Axitinib|axitinib|mesh-list
14915136|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915137|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14915138|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915139|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915140|NCT01385124|Cannabidiol|cannabidiol|mesh-list
14915141|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
14915142|NCT01385228|Prednisone|prednisone|mesh-list
14915143|NCT01385228|Docetaxel|docetaxel|mesh-list
14915144|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915145|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
14915146|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
14915147|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
14915148|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915149|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14915150|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
14296548|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
14915151|NCT01385228|Hormones|hormones|mesh-ancestor
15215634|NCT01556776|Growth Substances|growth substances|mesh-ancestor
15215635|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
15215636|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215637|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15215638|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
15215639|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
15215640|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215641|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
15215642|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215643|NCT01186640|Vidarabine|vidarabine|mesh-list
15215644|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
15215645|NCT01186640|Fludarabine|fludarabine|mesh-list
15215646|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
14885603|NCT01219569|Propofol|propofol|mesh-list
14885604|NCT01219569|Sevoflurane|sevoflurane|mesh-list
14885605|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14885606|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885607|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885608|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14885609|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
14885610|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
14885611|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14885612|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14885613|NCT01219582|Metformin|metformin|mesh-list
14885614|NCT01219582|Acarbose|acarbose|mesh-list
14885615|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14885616|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885617|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14885618|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885619|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885620|NCT01219686|Pindolol|pindolol|mesh-list
14885621|NCT01219686|Dexetimide|dexetimide|mesh-list
15215647|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
15215648|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
15215649|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215650|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
15215651|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215652|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215653|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15215654|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
14885622|NCT01219686|Citalopram|citalopram|mesh-list
14885623|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14885624|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14885625|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885626|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716112|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14716113|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14716114|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14716115|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
14885627|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885628|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
14885629|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885630|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14885631|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
14885632|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14885633|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14885634|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14885635|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
14716116|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716117|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716118|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716119|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14716120|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885636|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
15225277|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14716121|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14885637|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885638|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14885639|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14885640|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
14885641|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14885642|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14885643|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
14885644|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885645|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14885646|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885647|NCT01219699|Fulvestrant|fulvestrant|mesh-list
14885648|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885649|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885650|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14885651|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14885652|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885653|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885654|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885655|NCT01219712|Simendan|simendan|mesh-list
14885656|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14885657|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885658|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14885659|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14885660|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885661|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885662|NCT01219712|Protective Agents|protective agents|mesh-ancestor
14885663|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885664|NCT01219751|Sunitinib|sunitinib|mesh-list
14885665|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885666|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885667|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14885668|NCT01219751|Growth Substances|growth substances|mesh-ancestor
14885669|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885670|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885671|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14885672|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885673|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885674|NCT01219764|Amoxicillin|amoxicillin|mesh-list
14885675|NCT01219764|Metronidazole|metronidazole|mesh-list
14885676|NCT01219764|Clarithromycin|clarithromycin|mesh-list
14885677|NCT01219764|Rabeprazole|rabeprazole|mesh-list
14885678|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885679|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885680|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14885681|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14885682|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14885683|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885684|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885685|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14885686|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14885687|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14885688|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885689|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14885690|NCT01219816|Epratuzumab|epratuzumab|mesh-list
14885691|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14885692|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885693|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
14885694|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885695|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
14885696|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885697|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14885698|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14716122|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
14716123|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
14716124|NCT00461084|Clarithromycin|clarithromycin|mesh-list
14716125|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716126|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716127|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14716128|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716129|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716130|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14885699|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
14885700|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885701|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885702|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14885703|NCT01219920|Leucovorin|leucovorin|mesh-list
14885704|NCT01219920|Irinotecan|irinotecan|mesh-list
14885705|NCT01219920|Antidotes|antidotes|mesh-ancestor
14885706|NCT01219920|Protective Agents|protective agents|mesh-ancestor
14885707|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885708|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
14885709|NCT01219920|Vitamins|vitamins|mesh-ancestor
14885710|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
14885711|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885712|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885713|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14885714|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14885715|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885716|NCT01220063|Irinotecan|irinotecan|mesh-list
14885717|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14885718|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14885719|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885720|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885721|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885722|NCT01220076|Tamoxifen|tamoxifen|mesh-list
14885723|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14885724|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
14885725|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885726|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885727|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885728|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885729|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14885730|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14885731|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14885732|NCT01220102|Adapalene|adapalene|mesh-list
14885733|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14885734|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
14885735|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14885736|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14885737|NCT01220102|Analgesics|analgesics|mesh-ancestor
14885738|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
14885739|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885740|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885741|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885742|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14885743|NCT01220154|Paclitaxel|paclitaxel|mesh-list
14885744|NCT01220154|Bevacizumab|bevacizumab|mesh-list
14885745|NCT01220154|Carboplatin|carboplatin|mesh-list
14885746|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14885747|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885748|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
14885749|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
14885750|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
14885751|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885752|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14885753|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14885754|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14885755|NCT01220154|Growth Substances|growth substances|mesh-ancestor
14885756|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885757|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
14885758|NCT01220219|Pregabalin|pregabalin|mesh-list
14885759|NCT01220219|Analgesics|analgesics|mesh-ancestor
14885760|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
14885761|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885762|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885763|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
14885764|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14885765|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885766|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885767|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14885768|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14885769|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15225278|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885770|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885771|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14885772|NCT01220232|Lamivudine|lamivudine|mesh-list
14885773|NCT01220232|Abacavir|abacavir|mesh-list
14885774|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
14885775|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14885776|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14885777|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885778|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885779|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
14885780|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885781|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14885782|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14885783|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
14885784|NCT01220245|Heparin|heparin|mesh-list
14885785|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
14885786|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14885787|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14885788|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885789|NCT01220258|Azithromycin|azithromycin|mesh-list
14885790|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14885791|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14885792|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14885793|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885794|NCT01220284|Vinorelbine|vinorelbine|mesh-list
14885795|NCT01220284|Satraplatin|satraplatin|mesh-list
14885796|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14885797|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885798|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
14885799|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
14885800|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
14885801|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885802|NCT01220362|Fentanyl|fentanyl|mesh-list
14885803|NCT01220362|Bupivacaine|bupivacaine|mesh-list
14885804|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
14885805|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
14885806|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14885807|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885808|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
14885809|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885810|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14885811|NCT01220362|Narcotics|narcotics|mesh-ancestor
14885812|NCT01220362|Analgesics|analgesics|mesh-ancestor
14885813|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14885814|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14885815|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
14885816|NCT01220375|Plerixafor|plerixafor|mesh-list
14885817|NCT01220375|Vinorelbine|vinorelbine|mesh-list
14885818|NCT01220375|Lenograstim|lenograstim|mesh-list
14885819|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14885820|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
14885821|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885822|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14885823|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885824|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
14885825|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
14885826|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
14885827|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885828|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14885829|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14885830|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
14885831|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885832|NCT01220440|Methylphenidate|methylphenidate|mesh-list
14885833|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
14885834|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14885835|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885836|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14885837|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14885838|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885839|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885840|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
14885841|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885842|NCT01220518|Infliximab|infliximab|mesh-list
14885843|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
14885844|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885845|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14885846|NCT01220570|Sirolimus|sirolimus|mesh-list
14885847|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14885848|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716131|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14716132|NCT00461149|Octreotide|octreotide|mesh-list
14716133|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716134|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14716135|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716136|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14716137|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
14885849|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885850|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14885851|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885852|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
14885853|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885854|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
14885855|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885856|NCT01220596|Interferons|interferons|mesh-list
14885857|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14885858|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
14885859|NCT01220596|Entecavir|entecavir|mesh-list
14885860|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885861|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
14885862|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885863|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
14885864|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885865|NCT01220622|Nimodipine|nimodipine|mesh-list
14716138|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
14716139|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885866|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885867|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14885868|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885869|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885870|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14885871|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885872|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885873|NCT01220648|Interferons|interferons|mesh-list
14885874|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
14885875|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885876|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
14885877|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885878|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
14885879|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885880|NCT01220661|Cefotetan|cefotetan|mesh-list
14885881|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15215655|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215656|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215657|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15215658|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215659|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
15215660|NCT01186640|Antiviral Agents|antiviral agents|mesh-ancestor
15215661|NCT01186640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215662|NCT01186640|Analgesics|analgesics|mesh-ancestor
15215663|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
14885882|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14885883|NCT01220791|Progesterone|progesterone|mesh-list
14716140|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14885884|NCT01220791|Progestins|progestins|mesh-ancestor
14885885|NCT01220791|Hormones|hormones|mesh-ancestor
14885886|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885887|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885888|NCT01220843|Sevelamer|sevelamer|mesh-list
14885889|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
14885890|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
14885891|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885892|NCT01221025|Parecoxib|parecoxib|mesh-list
14885893|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14885894|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14885895|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885896|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885897|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14885898|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14885899|NCT01221025|Analgesics|analgesics|mesh-ancestor
14885900|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
14885901|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885902|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885903|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885904|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14885905|NCT01221103|Dexamethasone|dexamethasone|mesh-list
14885906|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14885907|NCT01221103|Ofatumumab|ofatumumab|mesh-list
14885908|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14885909|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885910|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
14885911|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
14885912|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885913|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885914|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14885915|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
14885916|NCT01221103|Hormones|hormones|mesh-ancestor
14885917|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14885918|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14885919|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885920|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14885921|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
14885922|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885923|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
14885924|NCT01221116|Simendan|simendan|mesh-list
14885925|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14885926|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885927|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14885928|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14885929|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885930|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885931|NCT01221116|Protective Agents|protective agents|mesh-ancestor
14885932|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885933|NCT01221129|Zinc|zinc|mesh-list
14885934|NCT01221129|Trace Elements|trace elements|mesh-ancestor
14885935|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
14885936|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885937|NCT01221337|Heparin|heparin|mesh-list
14885938|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
14885939|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14885940|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14917445|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14885941|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885942|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
14885943|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885944|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14885945|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14885946|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885947|NCT01221402|Niacin|niacin|mesh-list
14885948|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14885949|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
14885950|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885951|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14885952|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
14885953|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
14885954|NCT01221402|Vitamins|vitamins|mesh-ancestor
14716141|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14716142|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716143|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14716144|NCT00461344|Docetaxel|docetaxel|mesh-list
14716145|NCT00461344|Doxorubicin|doxorubicin|mesh-list
14716146|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716147|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
14716148|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
14716149|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
14716150|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885955|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
14885956|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915152|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915153|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915154|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14915155|NCT01385345|Vitamin D|vitamin d|mesh-list
14915156|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
14915157|NCT01385345|Vitamins|vitamins|mesh-ancestor
14296549|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
14915158|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
14915159|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915160|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14915161|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14915162|NCT01385527|Triamcinolone|triamcinolone|mesh-list
14915163|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14915164|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
14915165|NCT01385527|Hormones|hormones|mesh-ancestor
14915166|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915167|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915168|NCT01385631|Ezetimibe|ezetimibe|mesh-list
14915169|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14915170|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14915171|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
14915172|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915173|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14915174|NCT01385683|Clarithromycin|clarithromycin|mesh-list
14915175|NCT01385683|Dabigatran|dabigatran|mesh-list
14915176|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14915177|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915178|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14915179|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215664|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215665|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15215666|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14716151|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14716152|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14716153|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14716154|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716155|NCT00461396|Interferons|interferons|mesh-list
14716156|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
14716157|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716158|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
15215667|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215668|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215669|NCT01112306|Selexipag|selexipag|mesh-list
15215670|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15215671|NCT00688376|Donepezil|donepezil|mesh-list
15215672|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15215673|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716159|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915180|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716160|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14716161|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
14716162|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716163|NCT00461422|Ganirelix|ganirelix|mesh-list
14716164|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716165|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716166|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728912|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14728913|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14728914|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
14728915|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728916|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14728917|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14885957|NCT01221558|Lycopene|lycopene|mesh-list
14885958|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14885959|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
14885960|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885961|NCT01221558|Protective Agents|protective agents|mesh-ancestor
14885962|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885963|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14885964|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14728918|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729422|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729423|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14729424|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14729425|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14885965|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885966|NCT01221636|Abatacept|abatacept|mesh-list
14885967|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14885968|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885969|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14885970|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14885971|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
14885972|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885973|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729426|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14729427|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
14729428|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
14729429|NCT00523263|Heparin|heparin|mesh-list
14729430|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
14729431|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14885974|NCT01221675|Antibodies|antibodies|mesh-list
14885975|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
14885976|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885977|NCT01221740|Milnacipran|milnacipran|mesh-list
14885978|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
14885979|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14885980|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14885981|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14885982|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885983|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885984|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885985|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14885986|NCT01221740|Analgesics|analgesics|mesh-ancestor
14885987|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
14885988|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14885989|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
14885990|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14885991|NCT01221792|Carvedilol|carvedilol|mesh-list
14885992|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14885993|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15215674|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215675|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
15215676|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215677|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215678|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
15215679|NCT00492349|Varenicline|varenicline|mesh-list
15215680|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15215681|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15215682|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
15215683|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215684|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885994|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
14885995|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14885996|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14885997|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14885998|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14885999|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
14886000|NCT01221792|Protective Agents|protective agents|mesh-ancestor
14886001|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14886002|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15215685|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215686|NCT00003102|Antibodies|antibodies|mesh-list
15215687|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15215688|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
15215689|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215690|NCT05181852|Pregabalin|pregabalin|mesh-list
15215691|NCT05181852|Analgesics|analgesics|mesh-ancestor
15215692|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
14716167|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
14886003|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14886004|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
14886005|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14886006|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14886007|NCT01221831|Dienogest|dienogest|mesh-list
14886008|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14886009|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14886010|NCT01221831|Estradiol|estradiol|mesh-list
14716168|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14886011|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14886012|NCT01221831|Estrogens|estrogens|mesh-ancestor
14886013|NCT01221831|Hormones|hormones|mesh-ancestor
14886014|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716169|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
14716170|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14716171|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14716172|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716173|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716174|NCT00461565|Urological Agents|urological agents|mesh-ancestor
14716175|NCT00461578|Artesunate|artesunate|mesh-list
14886015|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886016|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14716176|NCT00461578|Dapsone|dapsone|mesh-list
15215693|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886017|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
14886018|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14886019|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14886020|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14886021|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14886022|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14886023|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
14886024|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14886025|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886026|NCT01221883|Diazepam|diazepam|mesh-list
14886027|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14886028|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
14886029|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
14886030|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
14886031|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886032|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886033|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14886034|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14886035|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886036|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14886037|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14886038|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14886039|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14886040|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886041|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14886042|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
14886043|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
14886044|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
14886045|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
14886046|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886047|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886048|NCT01221896|Choline|choline|mesh-list
14886049|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
14886050|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14886051|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
14886052|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886053|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14886054|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14886055|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
14886056|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
14886057|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14886058|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14886059|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886060|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
14886061|NCT01221909|Coagulants|coagulants|mesh-ancestor
14886062|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14886063|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
14886064|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14886065|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14886066|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886067|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886068|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886069|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
14886070|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886071|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
14917446|NCT05217680|Bevacizumab|bevacizumab|mesh-list
14886072|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886073|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14886074|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886075|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886076|NCT01222026|Vitamin D|vitamin d|mesh-list
14886077|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
14886078|NCT01222026|Vitamins|vitamins|mesh-ancestor
14886079|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
14886080|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886081|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14886082|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
14886083|NCT01222052|Docetaxel|docetaxel|mesh-list
14886084|NCT01222052|Fluorouracil|fluorouracil|mesh-list
14886085|NCT01222052|Epirubicin|epirubicin|mesh-list
14886086|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886087|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
14886088|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886089|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886090|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14886091|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
14886092|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886093|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886094|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14886095|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886096|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886097|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886098|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
14886099|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14886100|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14716177|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
14716178|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
14716179|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14716180|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14716181|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716182|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716183|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
14716184|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
14716185|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14716186|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
14716187|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14716188|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716189|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716190|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
14716191|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716192|NCT00461617|Mitiglinide|mitiglinide|mesh-list
14716193|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886101|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14886102|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14886103|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716194|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886104|NCT01222169|Propofol|propofol|mesh-list
14886105|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14886106|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886107|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886108|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14886109|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
14886110|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
14886111|NCT01222182|Atorvastatin|atorvastatin|mesh-list
14886112|NCT01222182|Simvastatin|simvastatin|mesh-list
14886113|NCT01222182|Pravastatin|pravastatin|mesh-list
14886114|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14886115|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14886116|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
14886117|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886118|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14886119|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14886120|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886121|NCT01222221|Temozolomide|temozolomide|mesh-list
14886122|NCT01222221|Sargramostim|sargramostim|mesh-list
14886123|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14886124|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
14886125|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886126|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886127|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
14886128|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886129|NCT01222312|Docetaxel|docetaxel|mesh-list
14886130|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
14886131|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886132|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886133|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886134|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886135|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886136|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
14886137|NCT01222442|AZD-3199|azd-3199|mesh-list
14886138|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14886139|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886140|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14886141|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14886142|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886143|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886144|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886145|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886146|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14886147|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14886148|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14886149|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14886150|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886151|NCT01222468|Nabilone|nabilone|mesh-list
14886152|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
14886153|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
14886154|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886155|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886156|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14886157|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14886158|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14886159|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886160|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886161|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
14886162|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14886163|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14886164|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
14886165|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886166|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886167|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14886168|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14886169|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
14886170|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886171|NCT01222650|Silodosin|silodosin|mesh-list
14886172|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14886173|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14886174|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14886175|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
14886176|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886177|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886178|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886179|NCT01222650|Urological Agents|urological agents|mesh-ancestor
14886180|NCT01222676|Gemcitabine|gemcitabine|mesh-list
14886181|NCT01222676|Sorafenib|sorafenib|mesh-list
14886182|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14886183|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886184|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14886185|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
14886186|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886187|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
14886188|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296550|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886189|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886190|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886191|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
14886192|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886193|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14886194|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14886195|NCT01222780|Vincristine|vincristine|mesh-list
14886196|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14716195|NCT00461643|Metformin|metformin|mesh-list
14296551|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296552|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
14296553|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296554|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14296555|NCT05245721|Narcotics|narcotics|mesh-ancestor
14296556|NCT05245721|Analgesics|analgesics|mesh-ancestor
14296557|NCT05245708|Oxytocin|oxytocin|mesh-list
14716196|NCT00461643|Citric Acid|citric acid|mesh-list
14716197|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
14886197|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716198|NCT00461643|Clomiphene|clomiphene|mesh-list
14716199|NCT00461643|Enclomiphene|enclomiphene|mesh-list
14716200|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
14716201|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14716202|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886198|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
14296558|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
14716203|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
14716204|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14716205|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
14886199|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886200|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886201|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886202|NCT01222819|Lenograstim|lenograstim|mesh-list
14886203|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14886204|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
14886205|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886206|NCT01222897|Valacyclovir|valacyclovir|mesh-list
14886207|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
14886208|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886209|NCT01222910|Valacyclovir|valacyclovir|mesh-list
14886210|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
14886211|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886212|NCT01222923|Risperidone|risperidone|mesh-list
14886213|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14886214|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
14886215|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886216|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886217|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886218|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14886219|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14886220|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886221|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886222|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14886223|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
14886224|NCT01222936|Panobinostat|panobinostat|mesh-list
14886225|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886226|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14886227|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886228|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886229|NCT01222975|Risperidone|risperidone|mesh-list
14886230|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14886231|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
14886232|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886233|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886234|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886235|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14886236|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14886237|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886238|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886239|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14296559|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14296560|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296561|NCT05245604|Cyclosporine|cyclosporine|mesh-list
14296562|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14296563|NCT05245604|Cyclosporins|cyclosporins|mesh-list
14296564|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296565|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296566|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296567|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
14296568|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886240|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
14886241|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14296569|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
14886242|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
14886243|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14886244|NCT01223053|Ketoprofen|ketoprofen|mesh-list
14886245|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14886246|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14886247|NCT01223053|Analgesics|analgesics|mesh-ancestor
14886248|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
14886249|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296570|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917447|NCT05217680|Ranibizumab|ranibizumab|mesh-list
14886250|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886251|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14886252|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886253|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14886254|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886255|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886256|NCT01223131|Insulin|insulin|mesh-list
14886257|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14886258|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
14886259|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
14886260|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
14886261|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
14886262|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886263|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915181|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14296571|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14915182|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14915183|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
14915184|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14915185|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
14915186|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
14915187|NCT01385735|Rasagiline|rasagiline|mesh-list
14915188|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14915189|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915190|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915191|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14915192|NCT01385735|Protective Agents|protective agents|mesh-ancestor
14915193|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915194|NCT01385826|Antibodies|antibodies|mesh-list
14915195|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14915196|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
14915197|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915198|NCT01385891|Etoposide|etoposide|mesh-list
14915199|NCT01385891|Clofarabine|clofarabine|mesh-list
14915200|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14915201|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915202|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14915203|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15215694|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215695|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
15215696|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15215697|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15215698|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215699|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15215700|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15215701|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15215702|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15215703|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886264|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
15215704|NCT05181735|Luspatercept|luspatercept|mesh-list
15215705|NCT05181735|Hematinics|hematinics|mesh-ancestor
15215706|NCT05181605|Folfirinox|folfirinox|mesh-list
15215707|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215708|NCT05181592|Luspatercept|luspatercept|mesh-list
15215709|NCT05181592|Hematinics|hematinics|mesh-ancestor
15215710|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15215711|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15215712|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15215713|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15225279|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225280|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15225281|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15225282|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225283|NCT05149365|Incretins|incretins|mesh-ancestor
15225284|NCT05149365|Hormones|hormones|mesh-ancestor
15225285|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225286|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14886265|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14886266|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
14886267|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886268|NCT01223326|Expectorants|expectorants|mesh-ancestor
14886269|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
14886270|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15225287|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
14716206|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
14716207|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716208|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14716209|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716210|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716211|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14716212|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
14716213|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716214|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14716215|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14716216|NCT00461695|Vaccines|vaccines|mesh-list
14716217|NCT00461695|Immunologic Factors|immunologic factors|mesh-ancestor
14716218|NCT00461695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716219|NCT00461747|Thalidomide|thalidomide|mesh-list
14716220|NCT00461747|Dexamethasone|dexamethasone|mesh-list
14716221|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
14716222|NCT00461747|Bortezomib|bortezomib|mesh-list
14716223|NCT00461747|BB 1101|bb 1101|mesh-list
14716224|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14716225|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
14716226|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
14716227|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716228|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716229|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716230|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
14716231|NCT00461747|Hormones|hormones|mesh-ancestor
15225288|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886271|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
15215714|NCT05181150|Glucagon|glucagon|mesh-list
15215715|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15215716|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15215717|NCT05181150|Hormones|hormones|mesh-ancestor
15215718|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215719|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215720|NCT05181150|Incretins|incretins|mesh-ancestor
15215721|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15215722|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15215723|NCT05181033|Letrozole|letrozole|mesh-list
15215724|NCT05181033|Fulvestrant|fulvestrant|mesh-list
15215725|NCT05181033|Lenvatinib|lenvatinib|mesh-list
15215726|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215727|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15215728|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15215729|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215730|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215731|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15215732|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
15215733|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215734|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215735|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215736|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15215737|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15215738|NCT05181007|Valproic Acid|valproic acid|mesh-list
15215739|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
15215740|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215741|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886272|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886273|NCT01223326|Protective Agents|protective agents|mesh-ancestor
14886274|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886275|NCT01223326|Antidotes|antidotes|mesh-ancestor
14716232|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716233|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14716234|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716235|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
14716236|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716237|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716238|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886276|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
14886277|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14886278|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886279|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886280|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886281|NCT01223443|Paclitaxel|paclitaxel|mesh-list
14886282|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886283|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886284|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886285|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886286|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886287|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886288|NCT01223534|Isoniazid|isoniazid|mesh-list
14886289|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
14886290|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14886291|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886292|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14886293|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14886294|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
14886295|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886296|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14886297|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
14886298|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886299|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886300|NCT01223612|Ranibizumab|ranibizumab|mesh-list
15215742|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
14886301|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215743|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886302|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14886303|NCT01223612|Growth Substances|growth substances|mesh-ancestor
14886304|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886305|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
14886306|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886307|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14886308|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14886309|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14886310|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
14886311|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886312|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14886313|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14886314|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886315|NCT01223690|Clarithromycin|clarithromycin|mesh-list
14886316|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14886317|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886318|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14886319|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886320|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886321|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14886322|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14886323|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
14886324|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
14886325|NCT01223729|Vitamins|vitamins|mesh-ancestor
14886326|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
14886327|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886328|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
14886329|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
14886330|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
14886331|NCT01223742|Vitamins|vitamins|mesh-ancestor
14886332|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
14886333|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886334|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
14886335|NCT01223755|Sirolimus|sirolimus|mesh-list
14886336|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14886337|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886338|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14886339|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886340|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
14886341|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886342|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
14886343|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886344|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
14886345|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
14886346|NCT01223768|Vitamins|vitamins|mesh-ancestor
14886347|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
14886348|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886349|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
14886350|NCT01223820|Capsaicin|capsaicin|mesh-list
14886351|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
14886352|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
14886353|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
14886354|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886355|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886356|NCT01224028|Tacrolimus|tacrolimus|mesh-list
14886357|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886358|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
14886359|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886360|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14886361|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886362|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886363|NCT01224041|Tacrolimus|tacrolimus|mesh-list
14886364|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886365|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
14886366|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886367|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14886368|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886369|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886370|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14886371|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
14886372|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886373|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14886374|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14886375|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886376|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886377|NCT01224093|Rituximab|rituximab|mesh-list
14886378|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14886379|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886380|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
14886381|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716239|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
14716240|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
14716241|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716242|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716243|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14716244|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14716245|NCT00461747|Growth Substances|growth substances|mesh-ancestor
14716246|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
14886382|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886383|NCT01224197|Simeprevir|simeprevir|mesh-list
14886384|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
14886385|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886386|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
14886387|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886388|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886389|NCT01224301|Vaccines|vaccines|mesh-list
14886390|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
14886391|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886392|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
14886393|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14886394|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
14886395|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
14886396|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886397|NCT01224353|Protective Agents|protective agents|mesh-ancestor
14886398|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886399|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
14886400|NCT01224353|Vitamins|vitamins|mesh-ancestor
14886401|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
14886402|NCT01224366|Vildagliptin|vildagliptin|mesh-list
14886403|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886404|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886405|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14886406|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
14886407|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886408|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886409|NCT01224392|Capecitabine|capecitabine|mesh-list
14886410|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14886411|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
14886412|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886413|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886414|NCT01224405|Docetaxel|docetaxel|mesh-list
14886415|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886416|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886417|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886418|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886419|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886420|NCT01224418|Tacrolimus|tacrolimus|mesh-list
14886421|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886422|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
14886423|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886424|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14886425|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886426|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886427|NCT01224457|Phenobarbital|phenobarbital|mesh-list
14886428|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
14886429|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14886430|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886431|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886432|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14886433|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14886434|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886435|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886436|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
14886437|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
14886438|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14886439|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14886440|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14886441|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
14886442|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14886443|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886444|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886445|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14886446|NCT01224470|Analgesics|analgesics|mesh-ancestor
14886447|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
14886448|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886449|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14886450|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14886451|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14886452|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14886453|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886454|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886455|NCT01224509|Mifepristone|mifepristone|mesh-list
14886456|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14886457|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
14886458|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14886459|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886460|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14886461|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14886462|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14886463|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
14886464|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14886465|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14886466|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
14886467|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14886468|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
14886469|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14886470|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14886471|NCT01224535|Micronutrients|micronutrients|mesh-list
14886472|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886473|NCT01224613|Vaccines|vaccines|mesh-list
14886474|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
14886475|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886476|NCT01224652|Paclitaxel|paclitaxel|mesh-list
14886477|NCT01224652|Irinotecan|irinotecan|mesh-list
14886478|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886479|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886480|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886481|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886482|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886483|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886484|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14886485|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14886486|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886487|NCT01224717|Teriparatide|teriparatide|mesh-list
14886488|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14886489|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886490|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14886491|NCT01224756|Tinoridine|tinoridine|mesh-list
14886492|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14886493|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14886494|NCT01224756|Analgesics|analgesics|mesh-ancestor
14886495|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
14886496|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886497|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886498|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14886499|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886500|NCT01224769|Rituximab|rituximab|mesh-list
14886501|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14886502|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14886503|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886504|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
14886505|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886506|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886507|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15215744|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215745|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
15215746|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15215747|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15215748|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15215749|NCT05180994|Infliximab|infliximab|mesh-list
15215750|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
15215751|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15215752|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886508|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
14886509|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886510|NCT01224847|Lidocaine|lidocaine|mesh-list
14886511|NCT01224847|Cocaine|cocaine|mesh-list
14886512|NCT01224847|Tetracaine|tetracaine|mesh-list
14886513|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
14886514|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
14886515|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886516|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886517|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
14886518|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886519|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14886520|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14886521|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14886522|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14886523|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886524|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14886525|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14886526|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14886527|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
14886528|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886529|NCT01224860|Losartan|losartan|mesh-list
14886530|NCT01224860|Telmisartan|telmisartan|mesh-list
14886531|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14886532|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14886533|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14886534|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14886535|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886536|NCT01224951|Beclomethasone|beclomethasone|mesh-list
14886537|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14886538|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
14886539|NCT01224951|Hormones|hormones|mesh-ancestor
14886540|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14886541|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886542|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14886543|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
14886544|NCT01224964|Montelukast|montelukast|mesh-list
14886545|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14886546|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
14886547|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14886548|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
14886549|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14886550|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886551|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14886552|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14886553|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886554|NCT01224977|Azithromycin|azithromycin|mesh-list
14886555|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14886556|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915204|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215753|NCT05180968|Dronabinol|dronabinol|mesh-list
15215754|NCT05180968|Nabilone|nabilone|mesh-list
15215755|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
15215756|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
15215757|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215758|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215759|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15215760|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15215761|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15215762|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15215763|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15215764|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
15215765|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15215766|NCT05180968|Analgesics|analgesics|mesh-ancestor
14886557|NCT01225081|Pioglitazone|pioglitazone|mesh-list
14886558|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
14886559|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886560|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886561|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14886562|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886563|NCT01225094|Curcumin|curcumin|mesh-list
14886564|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14886565|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14886566|NCT01225094|Analgesics|analgesics|mesh-ancestor
14886567|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
14886568|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886569|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886570|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14886571|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886572|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886573|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716247|NCT00461799|Orlistat|orlistat|mesh-list
14716248|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716249|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716250|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14716251|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14716252|NCT00461825|Cyclosporine|cyclosporine|mesh-list
14716253|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
14886574|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886575|NCT01225198|Vitamins|vitamins|mesh-list
14886576|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
15215767|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
15215768|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15215769|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15215770|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886577|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886578|NCT01225224|Peficitinib|peficitinib|mesh-list
15215771|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215772|NCT05180968|Hormones|hormones|mesh-ancestor
15215773|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215774|NCT05180825|Trametinib|trametinib|mesh-list
15215775|NCT05180825|Vinblastine|vinblastine|mesh-list
15215776|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215777|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15215778|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215779|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215780|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886579|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886580|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886581|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886582|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
14886583|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886584|NCT01225237|Ramosetron|ramosetron|mesh-list
14886585|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
14886586|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
14886587|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886588|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886589|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14886590|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14886591|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
14886592|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886593|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886594|NCT01225302|Paclitaxel|paclitaxel|mesh-list
14886595|NCT01225302|Carboplatin|carboplatin|mesh-list
14886596|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886597|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886598|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886599|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886600|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886601|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886602|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14716254|NCT00461825|Azathioprine|azathioprine|mesh-list
14886603|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15215781|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14716255|NCT00461825|Cyclosporins|cyclosporins|mesh-list
14716256|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886604|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14886605|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886606|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886607|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14886608|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14886609|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886610|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
14886611|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886612|NCT01225406|Tenofovir|tenofovir|mesh-list
14886613|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
14886614|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886615|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14886616|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14886617|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886618|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886619|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14886620|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14886621|NCT01225419|Plerixafor|plerixafor|mesh-list
14886622|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14886623|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14886624|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
14886625|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886626|NCT01225445|Ramipril|ramipril|mesh-list
14886627|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14886628|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
14886629|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886630|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886631|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14886632|NCT01225484|Ropivacaine|ropivacaine|mesh-list
14886633|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
14886634|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
14886635|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886636|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886637|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
14886638|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886639|NCT01225523|Paclitaxel|paclitaxel|mesh-list
14886640|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14886641|NCT01225523|Cisplatin|cisplatin|mesh-list
14886642|NCT01225523|Fluorouracil|fluorouracil|mesh-list
14886643|NCT01225523|Capecitabine|capecitabine|mesh-list
14886644|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886645|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886646|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886647|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886648|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886649|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215782|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
15215783|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
15215784|NCT05180799|Nivolumab|nivolumab|mesh-list
15215785|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215786|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215787|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14886650|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
15215788|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215789|NCT05180461|Ivermectin|ivermectin|mesh-list
15215790|NCT05180461|Emodepside|emodepside|mesh-list
15215791|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14716257|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716258|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716259|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
14716260|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716261|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
14716262|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716263|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
14716264|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215792|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215793|NCT05173298|Bevacizumab|bevacizumab|mesh-list
14886651|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14886652|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886653|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
14886654|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886655|NCT01225653|Latanoprost|latanoprost|mesh-list
14886656|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14886657|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14886658|NCT01225705|Ritonavir|ritonavir|mesh-list
14886659|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14886660|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
14886661|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14886662|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14886663|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
14886664|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886665|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886666|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14886667|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14886668|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
14886669|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886670|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14886671|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14886672|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14886673|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14886674|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
14886675|NCT01225744|Irinotecan|irinotecan|mesh-list
14886676|NCT01225744|Cetuximab|cetuximab|mesh-list
14886677|NCT01225744|Tegafur|tegafur|mesh-list
14886678|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886679|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14886680|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14886681|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886682|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886683|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14886684|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14886685|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
14886686|NCT01225874|Cytarabine|cytarabine|mesh-list
14886687|NCT01225874|Dexamethasone|dexamethasone|mesh-list
14886688|NCT01225874|Prednisone|prednisone|mesh-list
14886689|NCT01225874|Methotrexate|methotrexate|mesh-list
15215794|NCT05173298|Atezolizumab|atezolizumab|mesh-list
15215795|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215796|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215797|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15215798|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14886690|NCT01225874|Vincristine|vincristine|mesh-list
14886691|NCT01225874|Daunorubicin|daunorubicin|mesh-list
15215799|NCT05173298|Growth Substances|growth substances|mesh-ancestor
15215800|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215801|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
15215802|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
15215803|NCT05156814|Progestins|progestins|mesh-ancestor
15215804|NCT05156814|Hormones|hormones|mesh-ancestor
15215805|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215806|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215807|NCT05154734|Belimumab|belimumab|mesh-list
15215808|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215809|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
15215810|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215811|NCT05152888|Evolocumab|evolocumab|mesh-list
15215812|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15215813|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15215814|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
15215815|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215816|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15215817|NCT05152017|Vaccines|vaccines|mesh-list
15215818|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
14886692|NCT01225874|Asparaginase|asparaginase|mesh-list
14886693|NCT01225874|Pegaspargase|pegaspargase|mesh-list
14886694|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14886695|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
14886696|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
14886697|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886698|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215819|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215820|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
14886699|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14886700|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
14886701|NCT01225874|Hormones|hormones|mesh-ancestor
14886702|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14886703|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14886704|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886705|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14886706|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
14886707|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14886708|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14886709|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
14886710|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886711|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
14886712|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886713|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14886714|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886715|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
14886716|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886717|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14886718|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
14886719|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886720|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886721|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886722|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886723|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886724|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14886725|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14886726|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14886727|NCT01225913|Fluticasone|fluticasone|mesh-list
14886728|NCT01225913|Xhance|xhance|mesh-list
14886729|NCT01225913|Budesonide|budesonide|mesh-list
14886730|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
14886731|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14886732|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14886733|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14886734|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14886735|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14886736|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
14886737|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886738|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886739|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14886740|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
14886741|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
14886742|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14886743|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
14886744|NCT01225913|Hormones|hormones|mesh-ancestor
14886745|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14886746|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14886747|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14886748|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14886749|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
14886750|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14886751|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886752|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
14886753|NCT01226017|Oxytocin|oxytocin|mesh-list
14886754|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
14886755|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15215821|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15215822|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
15215823|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215824|NCT05142735|Expectorants|expectorants|mesh-ancestor
15215825|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
15215826|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15215827|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
15215828|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215829|NCT05142735|Protective Agents|protective agents|mesh-ancestor
15215830|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215831|NCT05142735|Antidotes|antidotes|mesh-ancestor
15215832|NCT05140694|Empagliflozin|empagliflozin|mesh-list
15215833|NCT05140694|Dulaglutide|dulaglutide|mesh-list
15215834|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15215835|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15215836|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215837|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15215838|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215839|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
15215840|NCT05135312|Etanercept|etanercept|mesh-list
15215841|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15215842|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15215843|NCT05135312|Analgesics|analgesics|mesh-ancestor
15215844|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
15215845|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215846|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215847|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14886756|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886757|NCT01226056|Everolimus|everolimus|mesh-list
14886758|NCT01226056|Sorafenib|sorafenib|mesh-list
14886759|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886760|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886761|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
14886762|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215848|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886763|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14886764|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886765|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886766|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
14886767|NCT01226069|Glycerol|glycerol|mesh-list
14886768|NCT01226069|Analgesics|analgesics|mesh-ancestor
14886769|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
14886770|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886771|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886772|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
14886773|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886774|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14886775|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
14886776|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14886777|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14886778|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716265|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14716266|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14716267|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716268|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14716269|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
14886779|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14886780|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
14886781|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14886782|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14886783|NCT01226069|Protective Agents|protective agents|mesh-ancestor
14886784|NCT01226186|Morphine|morphine|mesh-list
14886785|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14886786|NCT01226186|Narcotics|narcotics|mesh-ancestor
14886787|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886788|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886789|NCT01226186|Analgesics|analgesics|mesh-ancestor
14886790|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
14886791|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886792|NCT01226212|Sulfalene|sulfalene|mesh-list
14886793|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886794|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14886795|NCT01226212|Renal Agents|renal agents|mesh-ancestor
14886796|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
14886797|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14886798|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14886799|NCT01226303|Tretinoin|tretinoin|mesh-list
14886800|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886801|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
14886802|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
14886803|NCT01226355|Sirolimus|sirolimus|mesh-list
14886804|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14886805|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886806|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14886807|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886808|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
14886809|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296572|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14716270|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716271|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
14716272|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716273|NCT00461890|Naltrexone|naltrexone|mesh-list
14716274|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14716275|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14716276|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716277|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
14716278|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716279|NCT00461903|Perindopril|perindopril|mesh-list
14716280|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14716281|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
14716282|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716283|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716284|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14716285|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14886810|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
14886811|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886812|NCT01226446|Vitamin D|vitamin d|mesh-list
14886813|NCT01226446|Vitamins|vitamins|mesh-ancestor
14886814|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
14886815|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886816|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14886817|NCT01226602|Ticagrelor|ticagrelor|mesh-list
14886818|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14886819|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14886820|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14886821|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14886822|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
15215849|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15215850|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886823|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215851|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
15225289|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225290|NCT05133297|Tofacitinib|tofacitinib|mesh-list
15225291|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15225292|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225293|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225294|NCT05123820|Midazolam|midazolam|mesh-list
15225295|NCT05123820|Omeprazole|omeprazole|mesh-list
15225296|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15225297|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15225298|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225299|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225300|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15225301|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15225302|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15225303|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15225304|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
14716286|NCT00461916|Buserelin|buserelin|mesh-list
14716287|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
14716288|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14716289|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
14716290|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716291|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716292|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14716293|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14716294|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716295|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14716296|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
14716297|NCT00461968|Simvastatin|simvastatin|mesh-list
14716298|NCT00461968|Ezetimibe|ezetimibe|mesh-list
14716299|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14716300|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14716301|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
14716302|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716303|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14716304|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14716305|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716306|NCT00462111|Indomethacin|indomethacin|mesh-list
14716307|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14716308|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14716309|NCT00462111|Analgesics|analgesics|mesh-ancestor
14716310|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
14716311|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716312|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716313|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14716314|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14716315|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
14716316|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
14716317|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716318|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14716319|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716320|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716321|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
14716322|NCT00462189|Immunotoxins|immunotoxins|mesh-list
14716323|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
15225305|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
14886824|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886825|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886826|NCT01226667|Pregabalin|pregabalin|mesh-list
14886827|NCT01226667|Analgesics|analgesics|mesh-ancestor
14886828|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
14886829|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886830|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886831|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
14886832|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14886833|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14886834|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886835|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14886836|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14886837|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14886838|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886839|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14886840|NCT01226680|Tofacitinib|tofacitinib|mesh-list
14886841|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14886842|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886843|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886844|NCT01226771|Ribavirin|ribavirin|mesh-list
14886845|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
14886846|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886847|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
14886848|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886849|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14886850|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14886851|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14886852|NCT01226849|Rituximab|rituximab|mesh-list
14886853|NCT01226849|Carboplatin|carboplatin|mesh-list
14886854|NCT01226849|Etoposide|etoposide|mesh-list
14886855|NCT01226849|Bortezomib|bortezomib|mesh-list
14886856|NCT01226849|Ifosfamide|ifosfamide|mesh-list
14886857|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14886858|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886859|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
14716324|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716325|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716326|NCT00462215|Vaccines|vaccines|mesh-list
14716327|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
14716328|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716329|NCT00462358|Filanesib|filanesib|mesh-list
14716330|NCT00462358|Lenograstim|lenograstim|mesh-list
14716331|NCT00462358|Sargramostim|sargramostim|mesh-list
14716332|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14716333|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
14716334|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716335|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14716336|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14716337|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716338|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716339|NCT00462371|Insulin|insulin|mesh-list
14716340|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14716341|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716342|NCT00462397|Paclitaxel|paclitaxel|mesh-list
14716343|NCT00462397|Carboplatin|carboplatin|mesh-list
14716344|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14716345|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716346|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
14716347|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
14716348|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
14716349|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716350|NCT00462475|Hormones|hormones|mesh-list
14886860|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716351|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716352|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716353|NCT00462540|Bromides|bromides|mesh-list
14716354|NCT00462540|Albuterol|albuterol|mesh-list
14716355|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
14716356|NCT00462540|Ipratropium|ipratropium|mesh-list
14716357|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14716358|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
14716359|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716360|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716361|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14716362|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
14716363|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14716364|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14716365|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14716366|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14716367|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215852|NCT05116774|Eculizumab|eculizumab|mesh-list
15215853|NCT05116774|Ravulizumab|ravulizumab|mesh-list
15215854|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15215855|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716368|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716369|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
14716370|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
14716371|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716372|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14716373|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
14716374|NCT00462553|Gemcitabine|gemcitabine|mesh-list
14716375|NCT00462553|Sunitinib|sunitinib|mesh-list
15215856|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
14886861|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886862|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886863|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14886864|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14886865|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886866|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886867|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14886868|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
14886869|NCT01226901|Niraparib|niraparib|mesh-list
14886870|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14886871|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886872|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886873|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915205|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915206|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915207|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
14915208|NCT01385956|Gemcitabine|gemcitabine|mesh-list
14915209|NCT01385956|Pasireotide|pasireotide|mesh-list
14915210|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915211|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
15215857|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215858|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
15215859|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15215860|NCT05109104|Protective Agents|protective agents|mesh-ancestor
15215861|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215862|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
15215863|NCT05089123|Vaccines|vaccines|mesh-list
15215864|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
15215865|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915212|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915213|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915214|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
14915215|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915216|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915217|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915218|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
14915219|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915220|NCT01385956|Hormones|hormones|mesh-ancestor
15215866|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15215867|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
14886874|NCT01226966|Liraglutide|liraglutide|mesh-list
14886875|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886876|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886877|NCT01226966|Incretins|incretins|mesh-ancestor
14886878|NCT01226966|Hormones|hormones|mesh-ancestor
14886879|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14886880|NCT01226992|Vancomycin|vancomycin|mesh-list
14886881|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14886882|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886883|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
14886884|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
14886885|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886886|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14886887|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886888|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886889|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
14886890|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14886891|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14886892|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886893|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886894|NCT01227148|Insulin|insulin|mesh-list
14886895|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886896|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886897|NCT01227174|Propofol|propofol|mesh-list
14886898|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14886899|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886900|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886901|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14886902|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
14886903|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
14886904|NCT01227200|Tramadol|tramadol|mesh-list
14886905|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14886906|NCT01227200|Narcotics|narcotics|mesh-ancestor
14886907|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14886908|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886909|NCT01227200|Analgesics|analgesics|mesh-ancestor
14886910|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
14886911|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886912|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
14886913|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14886914|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14886915|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
14886916|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886917|NCT01227356|Interferons|interferons|mesh-list
14886918|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
14886919|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886920|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
14886921|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886922|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15215868|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
15215869|NCT05064332|Estradiol|estradiol|mesh-list
15215870|NCT05064332|Estrogens|estrogens|mesh-ancestor
15215871|NCT05064332|Hormones|hormones|mesh-ancestor
15215872|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215873|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215874|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15215875|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15215876|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15215877|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15215878|NCT05035927|Psilocybin|psilocybin|mesh-list
15215879|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
14886923|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917448|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15215880|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215881|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15215882|NCT05034029|Metformin|metformin|mesh-list
15215883|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15215884|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215885|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
15215886|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15215887|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15215888|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15215889|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15215890|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215891|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215892|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215893|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
15215894|NCT04938024|Vitamins|vitamins|mesh-ancestor
15215895|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
15215896|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215897|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
15215898|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215899|NCT04938024|Protective Agents|protective agents|mesh-ancestor
15215900|NCT04936984|Abaloparatide|abaloparatide|mesh-list
15215901|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
15215902|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15215903|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215904|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15215905|NCT04855526|Dronabinol|dronabinol|mesh-list
15215906|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
15215907|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215908|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15215909|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15215910|NCT04855526|Analgesics|analgesics|mesh-ancestor
15215911|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
15215912|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215913|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15215914|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15215915|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215916|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215917|NCT04855526|Hormones|hormones|mesh-ancestor
15215918|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14886924|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886925|NCT01227408|Paclitaxel|paclitaxel|mesh-list
14886926|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
14886927|NCT01227408|Doxorubicin|doxorubicin|mesh-list
14886928|NCT01227408|Capecitabine|capecitabine|mesh-list
14886929|NCT01227408|Methotrexate|methotrexate|mesh-list
14886930|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14886931|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14886932|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14886933|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14886934|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14886935|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14886936|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886937|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14886938|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
14886939|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886940|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14886941|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14886942|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
15215919|NCT04842552|Hydralazine|hydralazine|mesh-list
14886943|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14886944|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14886945|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14886946|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14886947|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886948|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14886949|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
14886950|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14886951|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
14886952|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14886953|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
14886954|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14886955|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14886956|NCT01227460|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14886957|NCT01227460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14886958|NCT01227460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215920|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15215921|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
15215922|NCT04818944|Tirofiban|tirofiban|mesh-list
15215923|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15215924|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15215925|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215926|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15215927|NCT04812951|Cyclosporine|cyclosporine|mesh-list
15215928|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15215929|NCT04812951|Cyclosporins|cyclosporins|mesh-list
14716376|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716377|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
14886959|NCT01227460|Incretins|incretins|mesh-ancestor
14886960|NCT01227460|Hormones|hormones|mesh-ancestor
14886961|NCT01227460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716378|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716379|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716380|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
14716381|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716382|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716383|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716384|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
14716385|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716386|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14716387|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14716388|NCT00462553|Growth Substances|growth substances|mesh-ancestor
14716389|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
14886962|NCT01227460|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14886963|NCT01227460|Protease Inhibitors|protease inhibitors|mesh-ancestor
14886964|NCT01227460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886965|NCT01227460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886966|NCT01227590|Ritonavir|ritonavir|mesh-list
14886967|NCT01227590|Lopinavir|lopinavir|mesh-list
14886968|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14886969|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14886970|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14886971|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14886972|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886973|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14886974|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14886975|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
14886976|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14886977|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14886978|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14886979|NCT01227603|Candesartan|candesartan|mesh-list
14886980|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
14886981|NCT01227603|Nifedipine|nifedipine|mesh-list
14886982|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14886983|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14886984|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14886985|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14886986|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14886987|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14886988|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14886989|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886990|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
14886991|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
14886992|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14886993|NCT01227720|Nicotine|nicotine|mesh-list
14886994|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14886995|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
14886996|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14886997|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14886998|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14886999|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14887000|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
14887001|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887002|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887003|NCT01227759|Tyrothricin|tyrothricin|mesh-list
14887004|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14887005|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887006|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887007|NCT01227798|Interferons|interferons|mesh-list
14887008|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
14887009|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887010|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
14887011|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887012|NCT01227811|Darifenacin|darifenacin|mesh-list
14887013|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14887014|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
14887015|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14887016|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887017|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887018|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887019|NCT01227811|Urological Agents|urological agents|mesh-ancestor
14887020|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
14887021|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887022|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887023|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14887024|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
14887025|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14887026|NCT01227876|Prednisolone|prednisolone|mesh-list
14887027|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
14887028|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14887029|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
14887030|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887031|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
14887032|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
14887033|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887034|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887035|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14887036|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
14887037|NCT01227876|Hormones|hormones|mesh-ancestor
14887038|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14887039|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14887040|NCT01227876|Protective Agents|protective agents|mesh-ancestor
14887041|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14887042|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887043|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14887044|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887045|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887046|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887047|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
14887048|NCT01227915|Hormones|hormones|mesh-ancestor
14887049|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14887050|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887051|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14887052|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14887053|NCT01227941|Doxorubicin|doxorubicin|mesh-list
14887054|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14887055|NCT01227941|Niraparib|niraparib|mesh-list
14887056|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14887057|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887058|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14887059|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15215930|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215931|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215932|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14887060|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887061|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887062|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15215933|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
14887063|NCT01228045|Trastuzumab|trastuzumab|mesh-list
15215934|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215935|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
15215936|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887064|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887065|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14887066|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
14887067|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887068|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
14887069|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14887070|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14887071|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887072|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
14887073|NCT01228136|Coagulants|coagulants|mesh-ancestor
14887074|NCT01228214|Aspirin|aspirin|mesh-list
14887075|NCT01228214|Amiloride|amiloride|mesh-list
14887076|NCT01228214|Clopidogrel|clopidogrel|mesh-list
14887077|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887078|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887079|NCT01228214|Analgesics|analgesics|mesh-ancestor
14887080|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
14887081|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887082|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887083|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887084|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887085|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14887086|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14887087|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887088|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14887089|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887090|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887091|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
14887092|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14887093|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14887094|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14887095|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
14887096|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887097|NCT01228214|Diuretics|diuretics|mesh-ancestor
14887098|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
14887099|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14887100|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14887101|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14887102|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14887103|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14887104|NCT01228227|Atorvastatin|atorvastatin|mesh-list
14887105|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14887106|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14887107|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14887108|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
14887109|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887110|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14887111|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14887112|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887113|NCT01228240|Metformin|metformin|mesh-list
14887114|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14887115|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887116|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14887117|NCT01228279|Icodextrin|icodextrin|mesh-list
14887118|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
14887119|NCT01228292|Heparin|heparin|mesh-list
14887120|NCT01228292|Calcium heparin|calcium heparin|mesh-list
14887121|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
14887122|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14887123|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14887124|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887125|NCT01228305|Acetaminophen|acetaminophen|mesh-list
14887126|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887127|NCT01228305|Analgesics|analgesics|mesh-ancestor
14887128|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
14887129|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887130|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887131|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
14887132|NCT01228331|Cytarabine|cytarabine|mesh-list
14728919|NCT00520650|Aripiprazole|aripiprazole|mesh-list
14728920|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
14728921|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14728922|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14728923|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14728924|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14728925|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728926|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
14296573|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14296574|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14296575|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
14296576|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
14887133|NCT01228331|Dexamethasone|dexamethasone|mesh-list
14887134|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
14887135|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
14887136|NCT01228331|Doxorubicin|doxorubicin|mesh-list
14887137|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14887138|NCT01228331|Methotrexate|methotrexate|mesh-list
14887139|NCT01228331|Etoposide|etoposide|mesh-list
14887140|NCT01228331|Vincristine|vincristine|mesh-list
14887141|NCT01228331|Daunorubicin|daunorubicin|mesh-list
14887142|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
14887143|NCT01228331|Clofarabine|clofarabine|mesh-list
14887144|NCT01228331|Pegaspargase|pegaspargase|mesh-list
14887145|NCT01228331|Thioguanine|thioguanine|mesh-list
14887146|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
14887147|NCT01228331|Amsacrine|amsacrine|mesh-list
14887148|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14887149|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
14887150|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887151|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327562|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716390|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14716391|NCT00462592|Budesonide|budesonide|mesh-list
14716392|NCT00462592|Montelukast|montelukast|mesh-list
14716393|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14716394|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14716395|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
14716396|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716397|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716398|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14716399|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
14716400|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
14716401|NCT00462592|Hormones|hormones|mesh-ancestor
14716402|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716403|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14716404|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716405|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14716406|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14716407|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716408|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14716409|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
14716410|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14887152|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14887153|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
14887154|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887155|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887156|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14887157|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887158|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
14887159|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
14887160|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887161|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14887162|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
14887163|NCT01228331|Hormones|hormones|mesh-ancestor
14887164|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14887165|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14887166|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14887167|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14887168|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14887169|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887170|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14887171|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
14887172|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14887173|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14887174|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
14887175|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
14887176|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14887177|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14887178|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14887179|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
14887180|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887181|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
14887182|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
14887183|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
14887184|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14887185|NCT01228331|Protective Agents|protective agents|mesh-ancestor
14887186|NCT01228344|Lumefantrine|lumefantrine|mesh-list
14887187|NCT01228344|Artemether|artemether|mesh-list
14887188|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14887189|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
14887190|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14887191|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14887192|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887193|NCT01228357|Milnacipran|milnacipran|mesh-list
14887194|NCT01228357|Mirtazapine|mirtazapine|mesh-list
14887195|NCT01228357|Sertraline|sertraline|mesh-list
14887196|NCT01228357|Fluoxetine|fluoxetine|mesh-list
14887197|NCT01228357|Paroxetine|paroxetine|mesh-list
14887198|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14887199|NCT01228357|Nortriptyline|nortriptyline|mesh-list
14887200|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
14887201|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14887202|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14887203|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14887204|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14887205|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887206|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887207|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
14887208|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887209|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14887210|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14887211|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14887212|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887213|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14716411|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14716412|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14716413|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14716414|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716415|NCT00462631|Paclitaxel|paclitaxel|mesh-list
14716416|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14716417|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14887214|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14887215|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
14887216|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
14716418|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887217|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14887218|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14887219|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14887220|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14887221|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14887222|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14887223|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
14887224|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14887225|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14887226|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14887227|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887228|NCT01228357|Analgesics|analgesics|mesh-ancestor
14887229|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
14887230|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887231|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14887232|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14887233|NCT01228370|Silodosin|silodosin|mesh-list
14887234|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14887235|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14887236|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14887237|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
14887238|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887239|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887240|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887241|NCT01228370|Urological Agents|urological agents|mesh-ancestor
14887242|NCT01228409|Acitretin|acitretin|mesh-list
14887243|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
14887244|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
15215937|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
15215938|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215939|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15215940|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15215941|NCT04772313|Methotrexate|methotrexate|mesh-list
14887245|NCT01228422|Interferons|interferons|mesh-list
14887246|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
14887247|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
14887248|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887249|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
14887250|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887251|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
14887252|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887253|NCT01228552|Ketoprofen|ketoprofen|mesh-list
14887254|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887255|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887256|NCT01228552|Analgesics|analgesics|mesh-ancestor
14887257|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
14887258|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887259|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887260|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887261|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887262|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887263|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887264|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887265|NCT01228565|Cetuximab|cetuximab|mesh-list
14887266|NCT01228565|OTD70DERM|otd70derm|mesh-list
14887267|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14887268|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887269|NCT01228565|Protective Agents|protective agents|mesh-ancestor
14887270|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887271|NCT01228604|Methylphenidate|methylphenidate|mesh-list
14887272|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15215942|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15215943|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
15225306|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
14887273|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887274|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14887275|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14887276|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14887277|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887278|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
14887279|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887280|NCT01228617|Nicotine|nicotine|mesh-list
14887281|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14887282|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
14887283|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887284|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887285|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14887286|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14887287|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
14887288|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887289|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887290|NCT01228630|Loratadine|loratadine|mesh-list
14887291|NCT01228630|Fexofenadine|fexofenadine|mesh-list
14887292|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
14887293|NCT01228630|Ephedrine|ephedrine|mesh-list
14887294|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
14887295|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
14887296|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14887297|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14887298|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14887299|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
14887300|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
14887301|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887302|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887303|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887304|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14887305|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
14887306|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887307|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14887308|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14887309|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
14887310|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14887311|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14887312|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
14887313|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
14887314|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
14887315|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
14887316|NCT01228656|Salicylates|salicylates|mesh-list
14887317|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887318|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
14887319|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14887320|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887321|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
14887322|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
14887323|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887324|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887325|NCT01228656|Analgesics|analgesics|mesh-ancestor
14887326|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
14887327|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887328|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887329|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887330|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887331|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887332|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887333|NCT01228682|Tolvaptan|tolvaptan|mesh-list
14887334|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14887335|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887336|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
14887337|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915221|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915222|NCT01386086|Aripiprazole|aripiprazole|mesh-list
14915223|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
14915224|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14915225|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14915226|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14915227|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14915228|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915229|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
14915230|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
14915231|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915232|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915233|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14915234|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14915235|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
14915236|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14915237|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14915238|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14915239|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14915240|NCT01386151|Mitogens|mitogens|mesh-list
14915241|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
14915242|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915243|NCT01386164|Vaccines|vaccines|mesh-list
14915244|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
14915245|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915246|NCT01386177|Doxazosin|doxazosin|mesh-list
14915247|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14915248|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14915249|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14915250|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14915251|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14915252|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
14915253|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915254|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915255|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915256|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
14915257|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14915258|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
14915259|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14915260|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14915261|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14915262|NCT01386229|Ketamine|ketamine|mesh-list
14915263|NCT01386229|Etomidate|etomidate|mesh-list
14915264|NCT01386229|Analgesics|analgesics|mesh-ancestor
14915265|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
14915266|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915267|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915268|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14915269|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14915270|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
14915271|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
14915272|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225307|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
14887338|NCT01228994|Baclofen|baclofen|mesh-list
14887339|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14887340|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887341|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14887342|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887343|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14887344|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
14887345|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
14887346|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887347|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887348|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
14887349|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
14887350|NCT01229046|Ticarcillin|ticarcillin|mesh-list
14887351|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
14887352|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887353|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887354|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887355|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887356|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14887357|NCT01229072|Heparin|heparin|mesh-list
14887358|NCT01229072|Calcium heparin|calcium heparin|mesh-list
14887359|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
14296577|NCT05245552|Vaccines|vaccines|mesh-list
14296578|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
14296579|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296580|NCT05245448|Tetrandrine|tetrandrine|mesh-list
14296581|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
14296582|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14296583|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14296584|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296585|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14296586|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296587|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
14296588|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14296589|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14296590|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296591|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14296592|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296593|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296594|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
14296595|NCT05243823|Estradiol|estradiol|mesh-list
14296596|NCT05243823|Estrogens|estrogens|mesh-ancestor
14296597|NCT05243823|Hormones|hormones|mesh-ancestor
14296598|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296599|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716419|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
14716420|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
14716421|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
14716422|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716423|NCT00462696|Docetaxel|docetaxel|mesh-list
14716424|NCT00462696|Epirubicin|epirubicin|mesh-list
14716425|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716426|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14716427|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14296600|NCT05220917|Insulin|insulin|mesh-list
14296601|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14716428|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14716429|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716430|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14716431|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14716432|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14887360|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14887361|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15215944|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15215945|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215946|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15215947|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
15215948|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215949|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215950|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
15215951|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716433|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887362|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887363|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
14887364|NCT01229085|Salicylates|salicylates|mesh-list
14887365|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887366|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
14887367|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
14887368|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
14887369|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887370|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887371|NCT01229085|Analgesics|analgesics|mesh-ancestor
14887372|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
14887373|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887374|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887375|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887376|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887377|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887378|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887379|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887380|NCT01229189|Vitamin D|vitamin d|mesh-list
14887381|NCT01229189|Vitamins|vitamins|mesh-ancestor
14716434|NCT00462787|Dexamethasone|dexamethasone|mesh-list
14716435|NCT00462787|Topotecan|topotecan|mesh-list
14716436|NCT00462787|Vinorelbine|vinorelbine|mesh-list
14716437|NCT00462787|Thiotepa|thiotepa|mesh-list
14716438|NCT00462787|Clofarabine|clofarabine|mesh-list
14716439|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14716440|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
14716441|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
14716442|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716443|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887382|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
14887383|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887384|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14887385|NCT01229202|Bevacizumab|bevacizumab|mesh-list
14887386|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14887387|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887388|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14887389|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14887390|NCT01229202|Growth Substances|growth substances|mesh-ancestor
14887391|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887392|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
14887393|NCT01229241|Anesthetics|anesthetics|mesh-list
14887394|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
14887395|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14887396|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887397|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
14887398|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887399|NCT01229280|Darifenacin|darifenacin|mesh-list
14887400|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14887401|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
14887402|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14716444|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716445|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
14887403|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887404|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887405|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887406|NCT01229280|Urological Agents|urological agents|mesh-ancestor
14887407|NCT01229319|Imiquimod|imiquimod|mesh-list
14887408|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14887409|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
14887410|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887411|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215952|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14887412|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
15215953|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15215954|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
15215955|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15215956|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15215957|NCT04756401|Dexamethasone|dexamethasone|mesh-list
15215958|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
15215959|NCT04756401|Daratumumab|daratumumab|mesh-list
15215960|NCT04756401|Ichthammol|ichthammol|mesh-list
15215961|NCT04756401|BB 1101|bb 1101|mesh-list
15215962|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15215963|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
15215964|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
14296602|NCT05220917|Metformin|metformin|mesh-list
14296603|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
14296604|NCT05220917|Pioglitazone|pioglitazone|mesh-list
14296605|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14296606|NCT05220917|Liraglutide|liraglutide|mesh-list
14296607|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
14296608|NCT05220917|Empagliflozin|empagliflozin|mesh-list
14296609|NCT05220917|Exenatide|exenatide|mesh-list
14296610|NCT05220917|Glimepiride|glimepiride|mesh-list
14887413|NCT01229332|Carbidopa|carbidopa|mesh-list
14887414|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14887415|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14887416|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
14887417|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887418|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887419|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887420|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14887421|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887422|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
14887423|NCT01229579|Astringents|astringents|mesh-ancestor
14887424|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887425|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
14887426|NCT01229592|Ethanol|ethanol|mesh-list
14887427|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14887428|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887429|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14887430|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887431|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
14887432|NCT01229605|Docetaxel|docetaxel|mesh-list
14887433|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14887434|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
14296611|NCT05220917|Linagliptin|linagliptin|mesh-list
14296612|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
14887435|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887436|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887437|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14887438|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
14887439|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887440|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887441|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14887442|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
14887443|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
14887444|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
15215965|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15215966|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215967|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15215968|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
15215969|NCT04756401|Hormones|hormones|mesh-ancestor
15215970|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15215971|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15215972|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215973|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
15215974|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296613|NCT05220917|Saxagliptin|saxagliptin|mesh-list
14296614|NCT05220917|Canagliflozin|canagliflozin|mesh-list
14296615|NCT05220917|Alogliptin|alogliptin|mesh-list
15215975|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215976|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
15215977|NCT04707625|Aflibercept|aflibercept|mesh-list
15215978|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14887445|NCT01229761|Trimethoprim|trimethoprim|mesh-list
14887446|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14887447|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
14887448|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14887449|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887450|NCT01229761|Renal Agents|renal agents|mesh-ancestor
14887451|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
14887452|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14887453|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14887454|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14887455|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887456|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887457|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14887458|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14887459|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14887460|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887461|NCT01229774|Diclofenac|diclofenac|mesh-list
14887462|NCT01229774|Etoricoxib|etoricoxib|mesh-list
14887463|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887464|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887465|NCT01229774|Analgesics|analgesics|mesh-ancestor
14887466|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
14887467|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887468|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887469|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887470|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887471|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887472|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887473|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887474|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14887475|NCT01229813|Bevacizumab|bevacizumab|mesh-list
14887476|NCT01229813|Capecitabine|capecitabine|mesh-list
14887477|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14887478|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14887479|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887480|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14887481|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14887482|NCT01229813|Growth Substances|growth substances|mesh-ancestor
14887483|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887484|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
14887485|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14887486|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
14887487|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887488|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14887489|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887490|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
14887491|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
14887492|NCT01229930|Paclitaxel|paclitaxel|mesh-list
14887493|NCT01229930|Carboplatin|carboplatin|mesh-list
14887494|NCT01229930|Cediranib|cediranib|mesh-list
14887495|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14887496|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887497|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
14887498|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
14887499|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
14887500|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887501|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887502|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14887503|NCT01230034|Ramipril|ramipril|mesh-list
14887504|NCT01230034|Imidapril|imidapril|mesh-list
14887505|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14887506|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
14887507|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887508|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887509|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14887510|NCT01230359|Pyridoxine|pyridoxine|mesh-list
14887511|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
14887512|NCT01230359|Vitamins|vitamins|mesh-ancestor
14887513|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
14887514|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887515|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
14887516|NCT01230411|Ibuprofen|ibuprofen|mesh-list
14887517|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887518|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887519|NCT01230411|Analgesics|analgesics|mesh-ancestor
14887520|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
14887521|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887522|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887523|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887524|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887525|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887526|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887527|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887528|NCT01230463|Ketorolac|ketorolac|mesh-list
14887529|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14887530|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887531|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887532|NCT01230463|Analgesics|analgesics|mesh-ancestor
14887533|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
14887534|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887535|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887536|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887537|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887538|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887539|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887540|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887541|NCT01230476|Cetuximab|cetuximab|mesh-list
14887542|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14887543|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887544|NCT01230541|Udenafil|udenafil|mesh-list
14887545|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14887546|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14887547|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215979|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15215980|NCT04707625|Growth Substances|growth substances|mesh-ancestor
15215981|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215982|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
15215983|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15215984|NCT04698525|Valproic Acid|valproic acid|mesh-list
15215985|NCT04698525|Memantine|memantine|mesh-list
15215986|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15215987|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15215988|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
15215989|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15215990|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15215991|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15215992|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15215993|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15215994|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
15215995|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215996|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
14716446|NCT00462787|Hormones|hormones|mesh-ancestor
14716447|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716448|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14716449|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716450|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
14716451|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14716452|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14716453|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716454|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716455|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14716456|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
14716457|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
14716458|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
14716459|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14716460|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
14716461|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14716462|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716463|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716464|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
14716465|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14716466|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14887548|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887549|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14887550|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14887551|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
14887552|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
14887553|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887554|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887555|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887556|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14887557|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14915273|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14915274|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14915275|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915276|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915277|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14915278|NCT01386242|Interferons|interferons|mesh-list
14915279|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915280|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
14915281|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915282|NCT01386255|Baclofen|baclofen|mesh-list
14915283|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14915284|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915285|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14915286|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915287|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14915288|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
14915289|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
14915290|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915291|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915292|NCT01386268|Factor VIII|factor viii|mesh-list
14296616|NCT05220917|Glyburide|glyburide|mesh-list
14296617|NCT05220917|Dulaglutide|dulaglutide|mesh-list
14296618|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
14296619|NCT05220917|Lixisenatide|lixisenatide|mesh-list
14296620|NCT05220917|Glipizide|glipizide|mesh-list
14296621|NCT05220917|Xultophy|xultophy|mesh-list
14296622|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14296623|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14915293|NCT01386268|Coagulants|coagulants|mesh-ancestor
14915294|NCT01386294|Tenofovir|tenofovir|mesh-list
14915295|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
14915296|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915297|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14915298|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14296624|NCT05220917|Simvastatin|simvastatin|mesh-list
14296625|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
14887558|NCT01230697|Sorafenib|sorafenib|mesh-list
14887559|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887560|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14887561|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15215997|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
15215998|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15215999|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14887562|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887563|NCT01230723|Everolimus|everolimus|mesh-list
14887564|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887565|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14887566|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
14887567|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887568|NCT01230736|Timolol|timolol|mesh-list
14887569|NCT01230736|Travoprost|travoprost|mesh-list
14887570|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14887571|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14887572|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14887573|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14887574|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
15216000|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15216001|NCT04696146|Complement C1s|complement c1s|mesh-list
15216002|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
15216003|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
15216004|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
14716467|NCT00462813|Protective Agents|protective agents|mesh-ancestor
14887575|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887576|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887577|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887578|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14887579|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14887580|NCT01230775|Anagrelide|anagrelide|mesh-list
14887581|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14887582|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14887583|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887584|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14887585|NCT01230983|Leucovorin|leucovorin|mesh-list
14887586|NCT01230983|Cytarabine|cytarabine|mesh-list
14887587|NCT01230983|Prednisone|prednisone|mesh-list
14887588|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
14887589|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14887590|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14887591|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14887592|NCT01230983|Doxorubicin|doxorubicin|mesh-list
14887593|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14887594|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
14887595|NCT01230983|Methotrexate|methotrexate|mesh-list
14887596|NCT01230983|Vincristine|vincristine|mesh-list
14887597|NCT01230983|Asparaginase|asparaginase|mesh-list
14887598|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
14887599|NCT01230983|Razoxane|razoxane|mesh-list
14887600|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
14887601|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14887602|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887603|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14887604|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14887605|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887606|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887607|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887608|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887609|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
14887610|NCT01230983|Hormones|hormones|mesh-ancestor
14887611|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14887612|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14887613|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15216005|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716468|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716469|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716470|NCT00462852|Gemcitabine|gemcitabine|mesh-list
14716471|NCT00462852|Dalteparin|dalteparin|mesh-list
14716472|NCT00462852|Tinzaparin|tinzaparin|mesh-list
14716473|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14716474|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716475|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
14728927|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
14887614|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
14915299|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887615|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14887616|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14887617|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
14887618|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
14716476|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887619|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14887620|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14887621|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
14887622|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887623|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14887624|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
14887625|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887626|NCT01230983|Antidotes|antidotes|mesh-ancestor
14887627|NCT01230983|Protective Agents|protective agents|mesh-ancestor
14887628|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
14887629|NCT01230983|Vitamins|vitamins|mesh-ancestor
14887630|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
14887631|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14887632|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
14887633|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
14887634|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
14887635|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14887636|NCT01230996|Cisplatin|cisplatin|mesh-list
14887637|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887638|NCT01231074|Metformin|metformin|mesh-list
14887639|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14887640|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887641|NCT01231113|Artesunate|artesunate|mesh-list
14887642|NCT01231113|Piperaquine|piperaquine|mesh-list
14887643|NCT01231113|Amodiaquine|amodiaquine|mesh-list
14887644|NCT01231113|Artenimol|artenimol|mesh-list
14887645|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
14887646|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14887647|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14887648|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887649|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887650|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
14887651|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
14887652|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14887653|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
14887654|NCT01231126|Misoprostol|misoprostol|mesh-list
14887655|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14887656|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
14887657|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14887658|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716477|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716478|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
14716479|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716480|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716481|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716482|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
14716483|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716484|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
14716485|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14887659|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14887660|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14887661|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
14887662|NCT01231139|Acetaminophen|acetaminophen|mesh-list
14887663|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887664|NCT01231139|Analgesics|analgesics|mesh-ancestor
14887665|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
14887666|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887667|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887668|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
14887669|NCT01231165|Aspirin|aspirin|mesh-list
14887670|NCT01231165|Amiloride|amiloride|mesh-list
14887671|NCT01231165|Clopidogrel|clopidogrel|mesh-list
14887672|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14887673|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887674|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887675|NCT01231165|Analgesics|analgesics|mesh-ancestor
14887676|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
14887677|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887678|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887679|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887680|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887681|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14887682|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14887683|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887684|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14887685|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887686|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887687|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
14887688|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14887689|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14887690|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14887691|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
14887692|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887693|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14887694|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14887695|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
14887696|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14887697|NCT01231165|Diuretics|diuretics|mesh-ancestor
14887698|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
14887699|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14887700|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14887701|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14887702|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14887703|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14887704|NCT01231191|Acetaminophen|acetaminophen|mesh-list
14887705|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887706|NCT01231191|Analgesics|analgesics|mesh-ancestor
14887707|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
14887708|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887709|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887710|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
14887711|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14887712|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14887713|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887714|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
14887715|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14887716|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887717|NCT01231490|Naproxen|naproxen|mesh-list
14887718|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887719|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14716486|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14716487|NCT00462878|Vancomycin|vancomycin|mesh-list
14716488|NCT00462878|Meropenem|meropenem|mesh-list
14716489|NCT00462878|Teicoplanin|teicoplanin|mesh-list
14716490|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887720|NCT01231490|Analgesics|analgesics|mesh-ancestor
14887721|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
14716491|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716492|NCT00462956|Lapatinib|lapatinib|mesh-list
14716493|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716494|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14716495|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716496|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716497|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14716498|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887722|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716499|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14887723|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887724|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887725|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887726|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
14887727|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887728|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887729|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887730|NCT01231529|Dolutegravir|dolutegravir|mesh-list
14887731|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14887732|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14887733|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887734|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887735|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14887736|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14887737|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
14887738|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887739|NCT01231542|Rifampin|rifampin|mesh-list
14887740|NCT01231542|Rifabutin|rifabutin|mesh-list
14887741|NCT01231542|Dolutegravir|dolutegravir|mesh-list
14887742|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14887743|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
14887744|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887745|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887746|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
14887747|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14887748|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887749|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887750|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14887751|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14887752|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14887753|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14887754|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14887755|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14887756|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14887757|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14887758|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14887759|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14887760|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
14887761|NCT01231594|Trametinib|trametinib|mesh-list
14887762|NCT01231594|Dabrafenib|dabrafenib|mesh-list
14887763|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
14887764|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14887765|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887766|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887767|NCT01231685|Ritonavir|ritonavir|mesh-list
14887768|NCT01231685|Lopinavir|lopinavir|mesh-list
14887769|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14887770|NCT01231685|Darunavir|darunavir|mesh-list
14887771|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14296626|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14887772|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
14887773|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
14887774|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14887775|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887776|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887777|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14887778|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14887779|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
14887780|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887781|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14887782|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14887783|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14887784|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14887785|NCT01231698|Esmolol|esmolol|mesh-list
14887786|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14887787|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14887788|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14887789|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14887790|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887791|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887792|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887793|NCT01231711|Ethanol|ethanol|mesh-list
14887794|NCT01231711|Povidone-Iodine|povidone-iodine|mesh-list
14887795|NCT01231711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14887796|NCT01231711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887797|NCT01231711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14887798|NCT01231711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887799|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
14887800|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887801|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887802|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14887803|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14887804|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887805|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887806|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887807|NCT01231802|Leucovorin|leucovorin|mesh-list
14887808|NCT01231802|Fluorouracil|fluorouracil|mesh-list
14887809|NCT01231802|Capecitabine|capecitabine|mesh-list
14887810|NCT01231802|Eniluracil|eniluracil|mesh-list
15216006|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15216007|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216008|NCT04663464|Abaloparatide|abaloparatide|mesh-list
15216009|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
15216010|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15216011|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216012|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15216013|NCT04650282|Lidocaine|lidocaine|mesh-list
15216014|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
15216015|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
15216016|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216017|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216018|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
15216019|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216020|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15216021|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15216022|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15216023|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15216024|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216025|NCT04639466|Vaccines|vaccines|mesh-list
14887811|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
14887812|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887813|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14887814|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887815|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14887816|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
14887817|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887818|NCT01231802|Antidotes|antidotes|mesh-ancestor
14887819|NCT01231802|Protective Agents|protective agents|mesh-ancestor
14887820|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
14887821|NCT01231802|Vitamins|vitamins|mesh-ancestor
14887822|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
14887823|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887824|NCT01231828|Lactulose|lactulose|mesh-list
14887825|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14887826|NCT01231854|Cyclosporine|cyclosporine|mesh-list
14887827|NCT01231854|Alitretinoin|alitretinoin|mesh-list
14887828|NCT01231854|Cyclosporins|cyclosporins|mesh-list
14887829|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887830|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887831|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14887832|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
14887833|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887834|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
14887835|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887836|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
14887837|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887838|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14887839|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887840|NCT01231880|Piperaquine|piperaquine|mesh-list
14887841|NCT01231880|Artenimol|artenimol|mesh-list
14887842|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
14887843|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14887844|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14887845|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887846|NCT01231997|Udenafil|udenafil|mesh-list
14887847|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14887848|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14887849|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887850|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887851|NCT01232010|Mirodenafil|mirodenafil|mesh-list
14887852|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14887853|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14887854|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887855|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887856|NCT01232023|Indobufen|indobufen|mesh-list
14887857|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14887858|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14887859|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887860|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887861|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14887862|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14887863|NCT01232023|Analgesics|analgesics|mesh-ancestor
14887864|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
14887865|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887866|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887867|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14887868|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887869|NCT01232036|Metformin|metformin|mesh-list
14887870|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14887871|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887872|NCT01232075|Letrozole|letrozole|mesh-list
14887873|NCT01232075|Citric Acid|citric acid|mesh-list
14887874|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
14887875|NCT01232075|Clomiphene|clomiphene|mesh-list
14887876|NCT01232075|Enclomiphene|enclomiphene|mesh-list
14887877|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
14887878|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
14887879|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14887880|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
14887881|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
14887882|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887883|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887884|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14887885|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14887886|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887887|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14887888|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
14887889|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14887890|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887891|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14887892|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
14887893|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14887894|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14887895|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14887896|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14887897|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887898|NCT01232244|Glucagon|glucagon|mesh-list
14887899|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14887900|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14887901|NCT01232244|Hormones|hormones|mesh-ancestor
14887902|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14887903|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887904|NCT01232244|Incretins|incretins|mesh-ancestor
14887905|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
14887906|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14887907|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
14887908|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887909|NCT01232257|Expectorants|expectorants|mesh-ancestor
14887910|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
14887911|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14887912|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
14887913|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887914|NCT01232257|Protective Agents|protective agents|mesh-ancestor
14887915|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887916|NCT01232257|Antidotes|antidotes|mesh-ancestor
14887917|NCT01232270|Propofol|propofol|mesh-list
14887918|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14887919|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14887920|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887921|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14887922|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
14887923|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
14887924|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
14887925|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887926|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14887927|NCT01232400|Esmolol|esmolol|mesh-list
14887928|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14887929|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14887930|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14887931|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
14887932|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887933|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887934|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887935|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
14887936|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
14887937|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887938|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716500|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716501|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716502|NCT00463008|Methotrexate|methotrexate|mesh-list
14716503|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14716504|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
14716505|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716506|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716507|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716508|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
14716509|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716510|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716511|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
14716512|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716513|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14716514|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716515|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
14716516|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14716517|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14887939|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14887940|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14887941|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887942|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887943|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887944|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887945|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14887946|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14915300|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915301|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14915302|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14915303|NCT01386333|Oxytocin|oxytocin|mesh-list
14915304|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
14915305|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14915306|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915307|NCT01386346|Capecitabine|capecitabine|mesh-list
14915308|NCT01386346|Azacitidine|azacitidine|mesh-list
14915309|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
14915310|NCT01386346|Epirubicin|epirubicin|mesh-list
14915311|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915312|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
14915313|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915314|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915315|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915316|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14915317|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14915318|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14915319|NCT01386372|Tolvaptan|tolvaptan|mesh-list
14915320|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14915321|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915322|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
14915323|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915324|NCT01386398|Bortezomib|bortezomib|mesh-list
14915325|NCT01386398|Vorinostat|vorinostat|mesh-list
14915326|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915327|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14915328|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915329|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915330|NCT01386502|Pidilizumab|pidilizumab|mesh-list
14915331|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915332|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917449|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716518|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14716519|NCT00463021|Vitamins|vitamins|mesh-ancestor
14716520|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
14716521|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716522|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14716523|NCT00463073|Bevacizumab|bevacizumab|mesh-list
14716524|NCT00463073|Cetuximab|cetuximab|mesh-list
14716525|NCT00463073|Irinotecan|irinotecan|mesh-list
14716526|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14716527|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716528|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14716529|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14716530|NCT00463073|Growth Substances|growth substances|mesh-ancestor
14716531|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716532|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
14716533|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14716534|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14887947|NCT01232439|Aticaprant|aticaprant|mesh-list
14887948|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887949|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
14887950|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14887951|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14887952|NCT01232647|Vitamins|vitamins|mesh-list
14887953|NCT01232647|Vitamin K|vitamin k|mesh-list
14716535|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716536|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716537|NCT00463086|Isoniazid|isoniazid|mesh-list
14716538|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
14716539|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14887954|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
14887955|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
14887956|NCT01232647|Menatetrenone|menatetrenone|mesh-list
14887957|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
14887958|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887959|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14887960|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14887961|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887962|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
14887963|NCT01232647|Coagulants|coagulants|mesh-ancestor
14887964|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
14887965|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
14887966|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14887967|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14887968|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887969|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887970|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887971|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14887972|NCT01232777|Bevacizumab|bevacizumab|mesh-list
14887973|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14887974|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14887975|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14887976|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14887977|NCT01232777|Growth Substances|growth substances|mesh-ancestor
14887978|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887979|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
14887980|NCT01232803|Tenofovir|tenofovir|mesh-list
14887981|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
14887982|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14887983|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14887984|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14887985|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14887986|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887987|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14887988|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14887989|NCT01233167|Clopidogrel|clopidogrel|mesh-list
14887990|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14716540|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716541|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14716542|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14716543|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
14716544|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887991|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14887992|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14887993|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14887994|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
14887995|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14887996|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14887997|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14887998|NCT01233206|Metformin|metformin|mesh-list
14887999|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14888000|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888001|NCT01233219|Morphine|morphine|mesh-list
14888002|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14888003|NCT01233219|Narcotics|narcotics|mesh-ancestor
14888004|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888005|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888006|NCT01233219|Analgesics|analgesics|mesh-ancestor
14888007|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
14888008|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888009|NCT01233245|Interferons|interferons|mesh-list
14888010|NCT01233245|Interferon-beta|interferon-beta|mesh-list
14888011|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
14888012|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888013|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
14888014|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888015|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
14888016|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888017|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14888018|NCT01233362|Vaccines|vaccines|mesh-list
14888019|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
14716545|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14716546|NCT00463112|Sibutramine|sibutramine|mesh-list
14716547|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
14716548|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14716549|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
14716550|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14888020|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888021|NCT01233453|Umirolimus|umirolimus|mesh-list
14888022|NCT01233453|Everolimus|everolimus|mesh-list
14888023|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888024|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888025|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
14888026|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888027|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14888028|NCT01233492|Mannitol|mannitol|mesh-list
14888029|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14888030|NCT01233492|Diuretics|diuretics|mesh-ancestor
14888031|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
14888032|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888033|NCT01233505|Capecitabine|capecitabine|mesh-list
14888034|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
14888035|NCT01233505|Veliparib|veliparib|mesh-list
14888036|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716551|NCT00463203|Bevacizumab|bevacizumab|mesh-list
14716552|NCT00463203|Irinotecan|irinotecan|mesh-list
14716553|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14716554|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716555|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14716556|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14716557|NCT00463203|Growth Substances|growth substances|mesh-ancestor
14716558|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716559|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
14716560|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14716561|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14716562|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728928|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888037|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
14888038|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888039|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888040|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14888041|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888042|NCT01233570|Tacrolimus|tacrolimus|mesh-list
14888043|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888044|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
14888045|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888046|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14888047|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888048|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888049|NCT01233583|Adalimumab|adalimumab|mesh-list
14888050|NCT01233583|Etanercept|etanercept|mesh-list
14888051|NCT01233583|Infliximab|infliximab|mesh-list
14888052|NCT01233583|Acitretin|acitretin|mesh-list
14888053|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14888054|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14888055|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
14888056|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14888057|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14888058|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14888059|NCT01233583|Analgesics|analgesics|mesh-ancestor
14888060|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
14888061|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888062|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888063|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888064|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
14888065|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
14888066|NCT01233622|Vildagliptin|vildagliptin|mesh-list
14888067|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14888068|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888069|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14888070|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
14888071|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888072|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888073|NCT01233635|Losartan|losartan|mesh-list
14888074|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14888075|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14888076|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14888077|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14888078|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888079|NCT01233752|Morphine|morphine|mesh-list
14888080|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14888081|NCT01233752|Narcotics|narcotics|mesh-ancestor
14888082|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888083|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888084|NCT01233752|Analgesics|analgesics|mesh-ancestor
14888085|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
14888086|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888087|NCT01233791|Diazepam|diazepam|mesh-list
14888088|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14888089|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
14888090|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
14888091|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
14888092|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888093|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888094|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14888095|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14888096|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888097|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14888098|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14888099|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14888100|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14888101|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14888102|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14888103|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
14888104|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
14888105|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
14888106|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
14888107|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888108|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888109|NCT01233843|Carboplatin|carboplatin|mesh-list
14888110|NCT01233843|Fluorouracil|fluorouracil|mesh-list
14888111|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888112|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
14888113|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888114|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216026|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
14888115|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296627|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296628|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14296629|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14296630|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
14296631|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296632|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14296633|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14296634|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888116|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
14888117|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888118|NCT01233895|Bortezomib|bortezomib|mesh-list
14888119|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888120|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
14888121|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14888122|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14888123|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
14888124|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
14888125|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888126|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888127|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888128|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
14888129|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
14888130|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14888131|NCT01233947|Fulvestrant|fulvestrant|mesh-list
14888132|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14888133|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888134|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14296635|NCT05220917|Incretins|incretins|mesh-ancestor
14296636|NCT05220917|Hormones|hormones|mesh-ancestor
14296637|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296638|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
14296639|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14296640|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14296641|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296642|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
14296643|NCT05220046|Psilocybin|psilocybin|mesh-list
14888135|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14888136|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
14888137|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888138|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888139|NCT01234051|Docetaxel|docetaxel|mesh-list
14888140|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
14296644|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
14296645|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296646|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14296647|NCT05219877|Levofloxacin|levofloxacin|mesh-list
14296648|NCT05219877|Ofloxacin|ofloxacin|mesh-list
14888141|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888142|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
14888143|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
14888144|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
14888145|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888146|NCT01234116|Tenofovir|tenofovir|mesh-list
14888147|NCT01234116|Emtricitabine|emtricitabine|mesh-list
14888148|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14888149|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
14888150|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888151|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14888152|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14888153|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888154|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888155|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14888156|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14888157|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
14888158|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14888159|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888160|NCT01234142|Varenicline|varenicline|mesh-list
14888161|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14888162|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14888163|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
14888164|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888165|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888166|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888167|NCT01234194|Remifentanil|remifentanil|mesh-list
14888168|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14888169|NCT01234194|Narcotics|narcotics|mesh-ancestor
14888170|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888171|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888172|NCT01234194|Analgesics|analgesics|mesh-ancestor
14888173|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
14888174|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915333|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
14915334|NCT01386567|Citric Acid|citric acid|mesh-list
14915335|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
14915336|NCT01386567|Enclomiphene|enclomiphene|mesh-list
14915337|NCT01386567|Clomiphene|clomiphene|mesh-list
14915338|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
14915339|NCT01386567|Testosterone|testosterone|mesh-list
14915340|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
14915341|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
14915342|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14915343|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
14915344|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14915345|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
14915346|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
14915347|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915348|NCT01386567|Androgens|androgens|mesh-ancestor
14915349|NCT01386567|Hormones|hormones|mesh-ancestor
14915350|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915351|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915352|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14915353|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915354|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
14915355|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14915356|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
14915357|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14915358|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
14915359|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14915360|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14915361|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14915362|NCT01386580|Doxorubicin|doxorubicin|mesh-list
14915363|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14915364|NCT01386580|Trastuzumab|trastuzumab|mesh-list
14915365|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14915366|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915367|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14915368|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14915369|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915370|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915371|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915372|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
14915373|NCT01386593|Rifampin|rifampin|mesh-list
14915374|NCT01386593|Fluconazole|fluconazole|mesh-list
14915375|NCT01386593|Paroxetine|paroxetine|mesh-list
14915376|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14915377|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915378|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14915379|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14915380|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915381|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915382|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915383|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14915384|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14888175|NCT01234272|Morphine|morphine|mesh-list
14888176|NCT01234272|Ropivacaine|ropivacaine|mesh-list
14888177|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14888178|NCT01234272|Narcotics|narcotics|mesh-ancestor
14888179|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888180|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888181|NCT01234272|Analgesics|analgesics|mesh-ancestor
14888182|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
14888183|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888184|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
14888185|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
14888186|NCT01234285|Heparin|heparin|mesh-list
14888187|NCT01234285|Calcium heparin|calcium heparin|mesh-list
14888188|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
14888189|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14888190|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14888191|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888192|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14888193|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14888194|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888195|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14888196|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14888197|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888198|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888199|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
14888200|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888201|NCT01234324|Cisplatin|cisplatin|mesh-list
14888202|NCT01234324|Capecitabine|capecitabine|mesh-list
14888203|NCT01234324|Epirubicin|epirubicin|mesh-list
14888204|NCT01234324|Panitumumab|panitumumab|mesh-list
14888205|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888206|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14888207|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
14888208|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888209|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14888210|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14888211|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14888212|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888213|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14888214|NCT01234454|Olanzapine|olanzapine|mesh-list
14888215|NCT01234454|Risperidone|risperidone|mesh-list
14888216|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14888217|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
14888218|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888219|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888220|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888221|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14888222|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14888223|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888224|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14888225|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14888226|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
14888227|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
14888228|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
14888229|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888230|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14888231|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14888232|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14888233|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888234|NCT01234506|Vitamin D|vitamin d|mesh-list
14888235|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
14888236|NCT01234506|Vitamins|vitamins|mesh-ancestor
14888237|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
14888238|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888239|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14888240|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
14888241|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14888242|NCT01234506|Estrogens|estrogens|mesh-ancestor
14888243|NCT01234506|Hormones|hormones|mesh-ancestor
14888244|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888245|NCT01234532|Anastrozole|anastrozole|mesh-list
14716563|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888246|NCT01234532|Entinostat|entinostat|mesh-list
14716564|NCT00463268|Vitamin D|vitamin d|mesh-list
14716565|NCT00463268|Alendronate|alendronate|mesh-list
14716566|NCT00463268|Calcium|calcium|mesh-list
14716567|NCT00463268|Vitamins|vitamins|mesh-ancestor
14716568|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
14716569|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716570|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14716571|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14716572|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14716573|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14716574|NCT00463359|Imiquimod|imiquimod|mesh-list
14888247|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14888248|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888249|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14888250|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14888251|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888252|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888253|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14888254|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716575|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14888255|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888256|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888257|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14888258|NCT01234597|Insulin|insulin|mesh-list
14888259|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14888260|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
14888261|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
14888262|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14888263|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888264|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14888265|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14888266|NCT01234701|Liver Extracts|liver extracts|mesh-list
15216027|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216028|NCT04624945|Thromboplastin|thromboplastin|mesh-list
15216029|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
15216030|NCT04624945|Coagulants|coagulants|mesh-ancestor
14888267|NCT01234701|Hematinics|hematinics|mesh-ancestor
14888268|NCT01234740|Bafetinib|bafetinib|mesh-list
14888269|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14888270|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888271|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888272|NCT01234792|Nicotine|nicotine|mesh-list
14888273|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14888274|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
14888275|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888276|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888277|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14888278|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14888279|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
14888280|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888281|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888282|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
14888283|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14888284|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
14888285|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14888286|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888287|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14888288|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14888289|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14888290|NCT01234857|Sirolimus|sirolimus|mesh-list
14888291|NCT01234857|Exemestane|exemestane|mesh-list
14888292|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14888293|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888294|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14888295|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14888296|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888297|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888298|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14888299|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14888300|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888301|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888302|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14888303|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888304|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14888305|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
14888306|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888307|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
14888308|NCT01234896|Nicotine|nicotine|mesh-list
14888309|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14888310|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
14888311|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888312|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888313|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14888314|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14888315|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14888316|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888317|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888318|NCT01234935|Gemcitabine|gemcitabine|mesh-list
14888319|NCT01234935|Dasatinib|dasatinib|mesh-list
14888320|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14888321|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
14888322|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888323|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888324|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
14888325|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216031|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
15216032|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
14888326|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888327|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888328|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
14888329|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888330|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14888331|NCT01234974|Everolimus|everolimus|mesh-list
14888332|NCT01234974|Pasireotide|pasireotide|mesh-list
14888333|NCT01234974|Somatostatin|somatostatin|mesh-list
14888334|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888335|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888336|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
14888337|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888338|NCT01234974|Hormones|hormones|mesh-ancestor
14888339|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888340|NCT01235013|Maraviroc|maraviroc|mesh-list
14888341|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14888342|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14888343|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888344|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14888345|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14888346|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
14888347|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888348|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14888349|NCT01235117|Azacitidine|azacitidine|mesh-list
14888350|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14888351|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
14888352|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888353|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888354|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888355|NCT01235143|Sevoflurane|sevoflurane|mesh-list
14888356|NCT01235143|Desflurane|desflurane|mesh-list
14888357|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14888358|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14888359|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
14888360|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
14888361|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888362|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888363|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
14888364|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14888365|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888366|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888367|NCT01235260|Becaplermin|becaplermin|mesh-list
14888368|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
14888369|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14888370|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14888371|NCT01235260|Growth Substances|growth substances|mesh-ancestor
14888372|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888373|NCT01235273|Hormones|hormones|mesh-list
14888374|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888375|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888376|NCT01235325|Vitamin K|vitamin k|mesh-list
14716576|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
14716577|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716578|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888377|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
14888378|NCT01235325|Vitamins|vitamins|mesh-ancestor
14888379|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
14888380|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888381|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14888382|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14888383|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888384|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
14888385|NCT01235325|Coagulants|coagulants|mesh-ancestor
14888386|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
14888387|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14888388|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888389|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888390|NCT01235455|Interferons|interferons|mesh-list
14888391|NCT01235455|Interferon-beta|interferon-beta|mesh-list
14888392|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
14888393|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888394|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
14888395|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716579|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
14728929|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728930|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14728931|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14728932|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
14728933|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14728934|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14728935|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14728936|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14728937|NCT00520754|Levocetirizine|levocetirizine|mesh-list
14728938|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14728939|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14728940|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
14728941|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
14728942|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728943|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888396|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
14327563|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
14888397|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888398|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14888399|NCT01235637|Sufentanil|sufentanil|mesh-list
14888400|NCT01235637|Alfentanil|alfentanil|mesh-list
14888401|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14888402|NCT01235637|Narcotics|narcotics|mesh-ancestor
14888403|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888404|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888405|NCT01235637|Analgesics|analgesics|mesh-ancestor
14888406|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
14888407|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888408|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14888409|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14888410|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
14888411|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
14888412|NCT01235819|Insulin|insulin|mesh-list
14888413|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14888414|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14888415|NCT01235819|Exenatide|exenatide|mesh-list
14888416|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14888417|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14888418|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888419|NCT01235819|Incretins|incretins|mesh-ancestor
14888420|NCT01235819|Hormones|hormones|mesh-ancestor
14888421|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888422|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
14888423|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888424|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888425|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14888426|NCT01236040|Vaccines|vaccines|mesh-list
14888427|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
14888428|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915385|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14915386|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14915387|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14915388|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915389|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
14915390|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915391|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14915392|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
14915393|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14915394|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14915395|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
14915396|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14915397|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14716580|NCT00463502|Metformin|metformin|mesh-list
14716581|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14716582|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716583|NCT00463515|Gemcitabine|gemcitabine|mesh-list
14716584|NCT00463515|Carboplatin|carboplatin|mesh-list
14716585|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716586|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716587|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
14716588|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716589|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
14716590|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716591|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716592|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716593|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
14716594|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716595|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
14716596|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14716597|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14716598|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
14296649|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14296650|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296651|NCT05219877|Renal Agents|renal agents|mesh-ancestor
14888429|NCT01236144|Plerixafor|plerixafor|mesh-list
14888430|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14888431|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14888432|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
14888433|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888434|NCT01236482|Oxytocin|oxytocin|mesh-list
14888435|NCT01236482|Ergonovine|ergonovine|mesh-list
14296652|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14296653|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14296654|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14296655|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296656|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296657|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296658|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14296659|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14296660|NCT05216432|Fulvestrant|fulvestrant|mesh-list
14296661|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14296662|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296663|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14296664|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14296665|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
14888436|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
14888437|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14888438|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888439|NCT01236495|Morphine|morphine|mesh-list
14888440|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14888441|NCT01236495|Narcotics|narcotics|mesh-ancestor
14888442|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888443|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888444|NCT01236495|Analgesics|analgesics|mesh-ancestor
14888445|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
14888446|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888447|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14888448|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14888449|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888450|NCT01236586|Dexamethasone|dexamethasone|mesh-list
14888451|NCT01236586|R04929097|r04929097|mesh-list
14888452|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14888453|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
14888454|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
14888455|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888456|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888457|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14888458|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
14888459|NCT01236586|Hormones|hormones|mesh-ancestor
14888460|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888461|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14888462|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888463|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888464|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888465|NCT01236612|Chloroquine|chloroquine|mesh-list
14888466|NCT01236612|Proguanil|proguanil|mesh-list
14888467|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14888468|NCT01236612|Vaccines|vaccines|mesh-list
14888469|NCT01236612|Amebicides|amebicides|mesh-ancestor
14888470|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14888471|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14888472|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888473|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
14888474|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15216033|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15216034|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216035|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216036|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
15216037|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15216038|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216039|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216040|NCT04596657|Vitamin D|vitamin d|mesh-list
15216041|NCT04596657|Vitamins|vitamins|mesh-ancestor
15216042|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
15216043|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915398|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
14888475|NCT01236612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888476|NCT01236612|Immunologic Factors|immunologic factors|mesh-ancestor
14888477|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
14888478|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888479|NCT01236651|Drotaverin|drotaverin|mesh-list
14888480|NCT01236651|Meperidine|meperidine|mesh-list
14888481|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14888482|NCT01236651|Narcotics|narcotics|mesh-ancestor
14888483|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888484|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888485|NCT01236651|Analgesics|analgesics|mesh-ancestor
14888486|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
14888487|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888488|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14888489|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
14888490|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
14888491|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
14888492|NCT01236716|Gemcitabine|gemcitabine|mesh-list
14888493|NCT01236716|Paclitaxel|paclitaxel|mesh-list
14888494|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14888495|NCT01236716|Carboplatin|carboplatin|mesh-list
14888496|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14888497|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888498|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14888499|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14888500|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14888501|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888502|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14888503|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
14888504|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
14888505|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888506|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888507|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888508|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
14888509|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888510|NCT01236859|Gabapentin|gabapentin|mesh-list
14888511|NCT01236859|Analgesics|analgesics|mesh-ancestor
14888512|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
14888513|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888514|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888515|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
14888516|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14888517|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14888518|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888519|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14888520|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14888521|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14888522|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888523|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888524|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
14888525|NCT01236911|Calcium|calcium|mesh-list
14888526|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14888527|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888528|NCT01236950|Listerine|listerine|mesh-list
14888529|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14888530|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888531|NCT01236963|Listerine|listerine|mesh-list
14888532|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14888533|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216044|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14888534|NCT01236989|Liver Extracts|liver extracts|mesh-list
14888535|NCT01236989|Hematinics|hematinics|mesh-ancestor
14888536|NCT01237028|Calcitriol|calcitriol|mesh-list
14888537|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15216045|NCT04550546|Nystatin|nystatin|mesh-list
15216046|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15216047|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216048|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
15216049|NCT04550546|Ionophores|ionophores|mesh-ancestor
15216050|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15216051|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216052|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
15216053|NCT04540380|Rituximab|rituximab|mesh-list
15216054|NCT04540380|Fludarabine|fludarabine|mesh-list
15216055|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888538|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888539|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14888540|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888541|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888542|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14888543|NCT01237028|Vitamins|vitamins|mesh-ancestor
14888544|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
14888545|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14888546|NCT01237067|Carboplatin|carboplatin|mesh-list
14888547|NCT01237067|Olaparib|olaparib|mesh-list
14888548|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888549|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14888550|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888551|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888552|NCT01237119|Liraglutide|liraglutide|mesh-list
14888553|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14888554|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888555|NCT01237119|Incretins|incretins|mesh-ancestor
14888556|NCT01237119|Hormones|hormones|mesh-ancestor
14888557|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888558|NCT01237249|Dexamethasone|dexamethasone|mesh-list
14888559|NCT01237249|Prednisone|prednisone|mesh-list
14888560|NCT01237249|Melphalan|melphalan|mesh-list
14888561|NCT01237249|Lenalidomide|lenalidomide|mesh-list
14888562|NCT01237249|Bortezomib|bortezomib|mesh-list
14888563|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14888564|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
14888565|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
14888566|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888567|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888568|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14888569|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
14888570|NCT01237249|Hormones|hormones|mesh-ancestor
14888571|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888572|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14888573|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888574|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14888575|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
14888576|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888577|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14888578|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888579|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
14888580|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14888581|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14888582|NCT01237249|Growth Substances|growth substances|mesh-ancestor
14888583|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
14888584|NCT01237262|Adalimumab|adalimumab|mesh-list
14888585|NCT01237262|Etanercept|etanercept|mesh-list
14888586|NCT01237262|Infliximab|infliximab|mesh-list
14888587|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14888588|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14888589|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
14888590|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14888591|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14888592|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14888593|NCT01237262|Analgesics|analgesics|mesh-ancestor
14888594|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
14888595|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888596|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888597|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888598|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
14888599|NCT01237275|Sertraline|sertraline|mesh-list
14888600|NCT01237275|Fluoxetine|fluoxetine|mesh-list
14888601|NCT01237275|Paroxetine|paroxetine|mesh-list
14888602|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
14888603|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14888604|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14888605|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14888606|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888607|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216056|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
14716599|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716600|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716601|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716602|NCT00463541|Urological Agents|urological agents|mesh-ancestor
14716603|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
14716604|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14716605|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
14716606|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716607|NCT00463671|Expectorants|expectorants|mesh-ancestor
14716608|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
14716609|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14888608|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888609|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
14888610|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888611|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14888612|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14888613|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14888614|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888615|NCT01237444|Ritonavir|ritonavir|mesh-list
14888616|NCT01237444|Lopinavir|lopinavir|mesh-list
14888617|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14888618|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14888619|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
14888620|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888621|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888622|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14888623|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14888624|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
14888625|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888626|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15216057|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216058|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14716610|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
14888627|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14888628|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14888629|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14888630|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888631|NCT01237483|Cetuximab|cetuximab|mesh-list
14888632|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14888633|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888634|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14888635|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
14888636|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888637|NCT01237522|Metformin|metformin|mesh-list
14888638|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14888639|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888640|NCT01237535|Progesterone|progesterone|mesh-list
14888641|NCT01237535|Estrogens|estrogens|mesh-list
14888642|NCT01237535|Progestins|progestins|mesh-ancestor
14888643|NCT01237535|Hormones|hormones|mesh-ancestor
14888644|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14888645|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888646|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14888647|NCT01237730|Cefuroxime|cefuroxime|mesh-list
14888648|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
14888649|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888650|NCT01237769|Vitamin D|vitamin d|mesh-list
14888651|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
14888652|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
14888653|NCT01237769|Vitamins|vitamins|mesh-list
14888654|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
14888655|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888656|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14888657|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14888658|NCT01237782|Propolis|propolis|mesh-list
14888659|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14888660|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888661|NCT01237808|Cytarabine|cytarabine|mesh-list
14888662|NCT01237808|Etoposide|etoposide|mesh-list
14888663|NCT01237808|Tretinoin|tretinoin|mesh-list
14888664|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14888665|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888666|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14888667|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14888668|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888669|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296666|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296667|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888670|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216059|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15216060|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
15216061|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888671|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
14888672|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
14888673|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888674|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888675|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
14888676|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888677|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
14888678|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
14915399|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915400|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14915401|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14915402|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14915403|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
14915404|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
14915405|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14915406|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14915407|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14915408|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14915409|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14915410|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14915411|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14915412|NCT01386658|Icatibant|icatibant|mesh-list
14915413|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14915414|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14915415|NCT01386658|Analgesics|analgesics|mesh-ancestor
14915416|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
14915417|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915418|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915419|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14915420|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14915421|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14915422|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14915423|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915424|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15216062|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216063|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15216064|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15216065|NCT04537715|Itraconazole|itraconazole|mesh-list
15216066|NCT04537715|Rifampin|rifampin|mesh-list
15216067|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
14888679|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
14888680|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14888681|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14888682|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
14888683|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
14888684|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888685|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888686|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888687|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
14888688|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
14888689|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14888690|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
14888691|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14888692|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14888693|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14888694|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888695|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888696|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
14888697|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888698|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888699|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14888700|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888701|NCT01238029|Capecitabine|capecitabine|mesh-list
14888702|NCT01238029|Vinorelbine|vinorelbine|mesh-list
14888703|NCT01238029|Lapatinib|lapatinib|mesh-list
14888704|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14888705|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
14888706|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888707|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888708|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14888709|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
14888710|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
14888711|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
14888712|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14888713|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888714|NCT01238055|Docetaxel|docetaxel|mesh-list
14888715|NCT01238055|Sunitinib|sunitinib|mesh-list
14888716|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888717|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14888718|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14888719|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14888720|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888721|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14888722|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14888723|NCT01238055|Growth Substances|growth substances|mesh-ancestor
14888724|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888725|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
14888726|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14888727|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888728|NCT01238094|Simvastatin|simvastatin|mesh-list
14888729|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14888730|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14888731|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
14888732|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888733|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14888734|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14888735|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888736|NCT01238133|Paclitaxel|paclitaxel|mesh-list
14888737|NCT01238133|Carboplatin|carboplatin|mesh-list
14888738|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14888739|NCT01238133|R04929097|r04929097|mesh-list
14888740|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14888741|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888742|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
14888743|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
14888744|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
14888745|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888746|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888747|NCT01238146|Rituximab|rituximab|mesh-list
14888748|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14888749|NCT01238146|Obatoclax|obatoclax|mesh-list
14888750|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14888751|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888752|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
14888753|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888754|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14888755|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14888756|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
14888757|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888758|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716611|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716612|NCT00463671|Protective Agents|protective agents|mesh-ancestor
14716613|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716614|NCT00463671|Antidotes|antidotes|mesh-ancestor
14716615|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
14888759|NCT01238185|Aspirin|aspirin|mesh-list
14888760|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14888761|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14888762|NCT01238185|Analgesics|analgesics|mesh-ancestor
14888763|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
14888764|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888765|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888766|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14888767|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14888768|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14888769|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14888770|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888771|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14888772|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14888773|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716616|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14716617|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
14716618|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888774|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
14888775|NCT01238224|Tadalafil|tadalafil|mesh-list
14716619|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888776|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
14716620|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
14888777|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14888778|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14888779|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888780|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888781|NCT01238224|Urological Agents|urological agents|mesh-ancestor
14888782|NCT01238237|Cetuximab|cetuximab|mesh-list
14888783|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14888784|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888785|NCT01238276|Cefazolin|cefazolin|mesh-list
14888786|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14888787|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888788|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
14888789|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14888790|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888791|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
14888792|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888793|NCT01238367|Factor VIII|factor viii|mesh-list
14888794|NCT01238367|Coagulants|coagulants|mesh-ancestor
14888795|NCT01238393|Ranibizumab|ranibizumab|mesh-list
14888796|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14888797|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14888798|NCT01238393|Growth Substances|growth substances|mesh-ancestor
14888799|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888800|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
14888801|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888802|NCT01238406|Pancrelipase|pancrelipase|mesh-list
14888803|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14888804|NCT01238523|Calpastatin|calpastatin|mesh-list
14888805|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14888806|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
14888807|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888808|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888809|NCT01238562|Lenograstim|lenograstim|mesh-list
14888810|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14888811|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
14888812|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888813|NCT01238627|Nicotine|nicotine|mesh-list
14888814|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14888815|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
14888816|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888817|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888818|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14888819|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14888820|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
14888821|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888822|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888823|NCT01238692|Rituximab|rituximab|mesh-list
14888824|NCT01238692|Panobinostat|panobinostat|mesh-list
14888825|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14888826|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888827|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
14888828|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888829|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14888830|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14888831|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888832|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888833|NCT01238705|Metoprolol|metoprolol|mesh-list
14888834|NCT01238705|Felodipine|felodipine|mesh-list
14888835|NCT01238705|Irbesartan|irbesartan|mesh-list
14888836|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14888837|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14888838|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
14888839|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
14888840|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888841|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888842|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14888843|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14888844|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14888845|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14888846|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888847|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888848|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14888849|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14888850|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14888851|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888852|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14888853|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
14888854|NCT01238718|Lidocaine|lidocaine|mesh-list
14888855|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
14888856|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
14888857|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888858|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888859|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
14888860|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888861|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14888862|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14888863|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14888864|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888865|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888866|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
14888867|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888868|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
14888869|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888870|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14888871|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14888872|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
14888873|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888874|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888875|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14888876|NCT01238796|Telavancin|telavancin|mesh-list
14888877|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14888878|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888879|NCT01238926|Vitamins|vitamins|mesh-list
14888880|NCT01238926|Folic Acid|folic acid|mesh-list
14888881|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
14888882|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
14888883|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
14888884|NCT01238926|Pyridoxal|pyridoxal|mesh-list
14888885|NCT01238926|Pyridoxine|pyridoxine|mesh-list
14888886|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
14888887|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
14888888|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888889|NCT01238926|Hematinics|hematinics|mesh-ancestor
14888890|NCT01238952|Carboplatin|carboplatin|mesh-list
14888891|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888892|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
14888893|NCT01238965|Leucovorin|leucovorin|mesh-list
14888894|NCT01238965|Fluorouracil|fluorouracil|mesh-list
14888895|NCT01238965|Panobinostat|panobinostat|mesh-list
14888896|NCT01238965|Calcium|calcium|mesh-list
14888897|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
14888898|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14888899|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14888900|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888901|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14888902|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
14888903|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888904|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14888905|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888906|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888907|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
14888908|NCT01238965|Antidotes|antidotes|mesh-ancestor
14888909|NCT01238965|Protective Agents|protective agents|mesh-ancestor
14888910|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
14888911|NCT01238965|Vitamins|vitamins|mesh-ancestor
14888912|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
14888913|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888914|NCT01238978|Vildagliptin|vildagliptin|mesh-list
14888915|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14888916|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888917|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14888918|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
14888919|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888920|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888921|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14888922|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14888923|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14888924|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
14888925|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888926|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14888927|NCT01239017|Fasinumab|fasinumab|mesh-list
14888928|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14888929|NCT01239017|Analgesics|analgesics|mesh-ancestor
14888930|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
14888931|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888932|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888933|NCT01239030|Methylphenidate|methylphenidate|mesh-list
14888934|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14888935|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888936|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14888937|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14888938|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888939|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888940|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
14888941|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888942|NCT01239173|Propranolol|propranolol|mesh-list
14888943|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14888944|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14888945|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14888946|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14888947|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888948|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888949|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14888950|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14888951|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
14888952|NCT01239368|Sirolimus|sirolimus|mesh-list
14888953|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14888954|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14888955|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14888956|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888957|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
14888958|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888959|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
14888960|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216068|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216069|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15216070|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15216071|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216072|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216073|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15216074|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
15216075|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216076|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716621|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716622|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14716623|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14716624|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
14716625|NCT00463736|Analgesics|analgesics|mesh-ancestor
14716626|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
14716627|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888961|NCT01239459|Teriflunomide|teriflunomide|mesh-list
14888962|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
14888963|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14888964|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14888965|NCT01239459|Analgesics|analgesics|mesh-ancestor
14888966|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
14888967|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888968|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888969|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14888970|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14888971|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14888972|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
14888973|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14888974|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14716628|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888975|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
14888976|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888977|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14888978|NCT01239485|Irinotecan|irinotecan|mesh-list
14888979|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14888980|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14888981|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14888982|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14888983|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14888984|NCT01239498|Lidocaine|lidocaine|mesh-list
14888985|NCT01239498|Epinephrine|epinephrine|mesh-list
14888986|NCT01239498|Racepinephrine|racepinephrine|mesh-list
14888987|NCT01239498|Anesthetics|anesthetics|mesh-list
14888988|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
14888989|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
14888990|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14888991|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14888992|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
14888993|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14888994|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14888995|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14888996|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14888997|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14888998|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716629|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
14716630|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14716631|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14716632|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
14716633|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14716634|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14716635|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716636|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14888999|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14889000|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14889001|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
14889002|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716637|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
14716638|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716639|NCT00463762|Sulbactam|sulbactam|mesh-list
14716640|NCT00463762|Cefoperazone|cefoperazone|mesh-list
14716641|NCT00463762|Sulperazone|sulperazone|mesh-list
14716642|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716643|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716644|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14716645|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716646|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716647|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14716648|NCT00463762|Renal Agents|renal agents|mesh-ancestor
14716649|NCT00463775|Topiramate|topiramate|mesh-list
14716650|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
14716651|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14716652|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716653|NCT00463827|Atorvastatin|atorvastatin|mesh-list
14716654|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14716655|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14889003|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14889004|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14889005|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
14889006|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889007|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889008|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
14889009|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
14889010|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14889011|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
14889012|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889013|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889014|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
14889015|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14889016|NCT01239563|Basiliximab|basiliximab|mesh-list
14716656|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
14716657|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716658|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14716659|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14716660|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716661|NCT00463879|Galantamine|galantamine|mesh-list
14716662|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14716663|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716664|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716665|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
14716666|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716667|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716668|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14716669|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
14889017|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
14716670|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889018|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716671|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
14716672|NCT00463918|Varenicline|varenicline|mesh-list
14716673|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14889019|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915425|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915426|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
14915427|NCT01386671|Metformin|metformin|mesh-list
14915428|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14915429|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915430|NCT01386710|Bevacizumab|bevacizumab|mesh-list
14915431|NCT01386710|Carboplatin|carboplatin|mesh-list
14915432|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915433|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915434|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14915435|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14915436|NCT01386710|Growth Substances|growth substances|mesh-ancestor
14915437|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915438|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
14915439|NCT01386736|Vitamin D|vitamin d|mesh-list
14915440|NCT01386736|Vitamins|vitamins|mesh-ancestor
14915441|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
14915442|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915443|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14915444|NCT01386827|Vaccines|vaccines|mesh-list
14915445|NCT01386827|Immunologic Factors|immunologic factors|mesh-ancestor
14915446|NCT01386827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915447|NCT01386853|Atorvastatin|atorvastatin|mesh-list
14915448|NCT01386853|Pitavastatin|pitavastatin|mesh-list
14915449|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14915450|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14915451|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
14915452|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915453|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14915454|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14915455|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915456|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
14915457|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14915458|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915459|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915460|NCT01386879|Methylene Blue|methylene blue|mesh-list
14915461|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915462|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915463|NCT01386996|Budesonide|budesonide|mesh-list
14915464|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
14915465|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14915466|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14915467|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14915468|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
14915469|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915470|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915471|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14915472|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
14915473|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
14915474|NCT01386996|Hormones|hormones|mesh-ancestor
14915475|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716674|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14716675|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
14716676|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915476|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15216077|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15216078|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15216079|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
15216080|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15216081|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
14716677|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716678|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716679|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
14716680|NCT00463957|Tadalafil|tadalafil|mesh-list
14716681|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
14716682|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14716683|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14716684|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915477|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14915478|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14889020|NCT01239719|Clemastine|clemastine|mesh-list
14889021|NCT01239719|Dexamethasone|dexamethasone|mesh-list
14889022|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
14889023|NCT01239719|BB 1101|bb 1101|mesh-list
14889024|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889025|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
14327564|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889026|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
14889027|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889028|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889029|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14889030|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
14889031|NCT01239719|Hormones|hormones|mesh-ancestor
14889032|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889033|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889034|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889035|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14889036|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889037|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889038|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
14889039|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14889040|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14889041|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
14889042|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
14889043|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889044|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14889045|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
14889046|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14889047|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
14889048|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889049|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
14889050|NCT01239810|Protective Agents|protective agents|mesh-ancestor
14889051|NCT01239849|Atorvastatin|atorvastatin|mesh-list
14889052|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14889053|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14889054|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
14889055|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889056|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14889057|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14889058|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889059|NCT01239875|Vaccines|vaccines|mesh-list
14889060|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15216082|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15216083|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15216084|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15216085|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15216086|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15216087|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15216088|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15216089|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15216090|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15225308|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225309|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225310|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15225311|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15225312|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15225313|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225314|NCT05113745|Reboxetine|reboxetine|mesh-list
15225315|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
15225316|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15225317|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15225318|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15225319|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15225320|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225321|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
15225322|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225323|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225714|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889061|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
14889062|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889063|NCT01239888|Tibolone|tibolone|mesh-list
14889064|NCT01239888|Oxytocin|oxytocin|mesh-list
14716685|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716686|NCT00463957|Urological Agents|urological agents|mesh-ancestor
14716687|NCT00463983|Octreotide|octreotide|mesh-list
14716688|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716689|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14716690|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716691|NCT00464035|Calcium|calcium|mesh-list
14889065|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
14889066|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14889067|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889068|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
14889069|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
14889070|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216091|NCT04499131|Progesterone|progesterone|mesh-list
15216092|NCT04499131|Progestins|progestins|mesh-ancestor
15216093|NCT04499131|Hormones|hormones|mesh-ancestor
15216094|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216095|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216096|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
15216097|NCT04469595|Aflibercept|aflibercept|mesh-list
15216098|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14889071|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14889072|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889073|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716692|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14889074|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14889075|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
14889076|NCT01239888|Hormones|hormones|mesh-ancestor
14889077|NCT01239940|Paclitaxel|paclitaxel|mesh-list
14889078|NCT01239940|Everolimus|everolimus|mesh-list
14889079|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14889080|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889081|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
14889082|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
14889083|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
14889084|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889085|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889086|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
14889087|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889088|NCT01239953|Paclitaxel|paclitaxel|mesh-list
15216099|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14716693|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716694|NCT00464165|Rimonabant|rimonabant|mesh-list
14716695|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14889089|NCT01239953|Everolimus|everolimus|mesh-list
14889090|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14889091|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889092|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14889093|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14889094|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14889095|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889096|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889097|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
14889098|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889099|NCT01240096|Mirtazapine|mirtazapine|mesh-list
14889100|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
14889101|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14889102|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14889103|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
14889104|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
14889105|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889106|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889107|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889108|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14889109|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14889110|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889111|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14889112|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14889113|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14889114|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
14889115|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15216100|NCT04469595|Growth Substances|growth substances|mesh-ancestor
15216101|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216102|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
15216103|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216104|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216105|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
15216106|NCT04469595|Hormones|hormones|mesh-ancestor
15216107|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216108|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15216109|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
15216110|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216111|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15216112|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
15216113|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216114|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216115|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15225324|NCT05103631|Cyclophosphamide|cyclophosphamide|mesh-list
14889116|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14889117|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
14889118|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14889119|NCT01240109|Remifentanil|remifentanil|mesh-list
14889120|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14889121|NCT01240109|Narcotics|narcotics|mesh-ancestor
14889122|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889123|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889124|NCT01240109|Analgesics|analgesics|mesh-ancestor
14889125|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
14889126|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889127|NCT01240148|Lidocaine|lidocaine|mesh-list
14889128|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
14889129|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
14889130|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889131|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889132|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
14889133|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889134|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14889135|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14889136|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14889137|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14889138|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889139|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14889140|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889141|NCT01240213|Vitamin D|vitamin d|mesh-list
14889142|NCT01240213|Vitamins|vitamins|mesh-ancestor
14889143|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
14889144|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889145|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14889146|NCT01240226|Ketoconazole|ketoconazole|mesh-list
14889147|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
14889148|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889149|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14889150|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14889151|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889152|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889153|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14889154|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
14889155|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889156|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889157|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14889158|NCT01240252|Insulin|insulin|mesh-list
14889159|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14889160|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889161|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889162|NCT01240265|Vitamin D|vitamin d|mesh-list
14889163|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
14889164|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
14889165|NCT01240265|Vitamins|vitamins|mesh-list
14889166|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
14889167|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889168|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14889169|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14889170|NCT01240408|Lenvatinib|lenvatinib|mesh-list
14889171|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889172|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14889173|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889174|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889175|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
14889176|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889177|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
14889178|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889179|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14889180|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14889181|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
14889182|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889183|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889184|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14889185|NCT01240629|Doxorubicin|doxorubicin|mesh-list
14889186|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14889187|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14889188|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889189|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14889190|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14889191|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889192|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889193|NCT01240642|Vadimezan|vadimezan|mesh-list
14889194|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889195|NCT01240655|Paclitaxel|paclitaxel|mesh-list
14889196|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14889197|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225325|NCT05103631|Fludarabine|fludarabine|mesh-list
14889198|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14889199|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14889200|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14889201|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889202|NCT01240824|Aminophylline|aminophylline|mesh-list
14889203|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14889204|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
14889205|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889206|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889207|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889208|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889209|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14889210|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14889211|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889212|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889213|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14889214|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14889215|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
14889216|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889217|NCT01240824|Protective Agents|protective agents|mesh-ancestor
14889218|NCT01240850|Prednisone|prednisone|mesh-list
14889219|NCT01240850|Methotrexate|methotrexate|mesh-list
14889220|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889221|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
14889222|NCT01240850|Hormones|hormones|mesh-ancestor
14889223|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889224|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889225|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889226|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889227|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14889228|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
15216116|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15216117|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15216118|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
15216119|NCT04454424|Midazolam|midazolam|mesh-list
15216120|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15216121|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15216122|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216123|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216124|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15216125|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14889229|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14889230|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14889231|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
14889232|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889233|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
14889234|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889235|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14889236|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889237|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
14889238|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14889239|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14889240|NCT01240889|Fluticasone|fluticasone|mesh-list
14889241|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889242|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14889243|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
14889244|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889245|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889246|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889247|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889248|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
14889249|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14889250|NCT01240928|Exemestane|exemestane|mesh-list
14889251|NCT01240928|Goserelin|goserelin|mesh-list
14889252|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889253|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14889254|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14889255|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889256|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889257|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14889258|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
14889259|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716696|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14716697|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14716698|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716699|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716700|NCT00464165|Hormones|hormones|mesh-ancestor
14716701|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716702|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716703|NCT00464191|Citalopram|citalopram|mesh-list
14716704|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14716705|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14716706|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14716707|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716708|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716709|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
14889260|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889261|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889262|NCT01240941|Exemestane|exemestane|mesh-list
14889263|NCT01240941|Goserelin|goserelin|mesh-list
14889264|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889265|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14889266|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14889267|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889268|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889269|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14889270|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
14889271|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889272|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889273|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889274|NCT01241006|Dexamethasone|dexamethasone|mesh-list
14889275|NCT01241006|Prednisone|prednisone|mesh-list
14889276|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
14889277|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889278|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
14889279|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
14889280|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889281|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889282|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14889283|NCT01241006|Hormones|hormones|mesh-ancestor
14889284|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889285|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889286|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889287|NCT01241019|Topiramate|topiramate|mesh-list
14889288|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
14889289|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889290|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889291|NCT01241032|Udenafil|udenafil|mesh-list
14889292|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14889293|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14889294|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889295|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889296|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14889297|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
14889298|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889299|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889300|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889301|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889302|NCT01241097|Simvastatin|simvastatin|mesh-list
14889303|NCT01241097|Ezetimibe|ezetimibe|mesh-list
14889304|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14889305|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14889306|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
14889307|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889308|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14889309|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14889310|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889311|NCT01241110|Ofloxacin|ofloxacin|mesh-list
14889312|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14889313|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889314|NCT01241110|Renal Agents|renal agents|mesh-ancestor
14889315|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14889316|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14889317|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14889318|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889319|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889320|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889321|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14889322|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14889323|NCT01241162|Decitabine|decitabine|mesh-list
14889324|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14889325|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
14889326|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889327|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889328|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889329|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
14889330|NCT01241175|Analgesics|analgesics|mesh-ancestor
14889331|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
14889332|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889333|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889334|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
14889335|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889336|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14889337|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
14889338|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14889339|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14889340|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889341|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14889342|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
14889343|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14915479|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14915480|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716710|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716711|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14716712|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
14716713|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14716714|NCT00464217|Idarubicin|idarubicin|mesh-list
14716715|NCT00464217|Molgramostim|molgramostim|mesh-list
14716716|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14716717|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716718|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14716719|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14716720|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716721|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716722|NCT00464256|Rimonabant|rimonabant|mesh-list
14716723|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14889344|NCT01241383|Bosentan|bosentan|mesh-list
14889345|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14889346|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14889347|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889348|NCT01241409|Rabeprazole|rabeprazole|mesh-list
14889349|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14889350|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14889351|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14889352|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889353|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889354|NCT01241422|Montelukast|montelukast|mesh-list
14889355|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889356|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889357|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14889358|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
14889359|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889360|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889361|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14889362|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14889363|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889364|NCT01241487|Amlodipine|amlodipine|mesh-list
14889365|NCT01241487|Valsartan|valsartan|mesh-list
14889366|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14889367|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14889368|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14889369|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889370|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14889371|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889372|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
14889373|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14889374|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14889375|NCT01241500|ON 01910|on 01910|mesh-list
14889376|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889377|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14889378|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889379|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889380|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
14889381|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889382|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
14889383|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889384|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14889385|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14889386|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
14889387|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889388|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889389|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14889390|NCT01241708|Bortezomib|bortezomib|mesh-list
15216126|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15216127|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15216128|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
14716724|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14716725|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14716726|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716727|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716728|NCT00464256|Hormones|hormones|mesh-ancestor
14716729|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716730|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716731|NCT00464295|Capecitabine|capecitabine|mesh-list
14716732|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716733|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
14716734|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216129|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
15216130|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
15216131|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
15216132|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216133|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216134|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
15216135|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15216136|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889391|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889392|NCT01241734|Lenalidomide|lenalidomide|mesh-list
14889393|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
14889394|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889395|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14889396|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14889397|NCT01241734|Growth Substances|growth substances|mesh-ancestor
14889398|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14889399|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889400|NCT01241773|Efavirenz|efavirenz|mesh-list
14889401|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
14889402|NCT01241773|Simeprevir|simeprevir|mesh-list
14889403|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14889404|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14889405|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889406|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889407|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
14889408|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889409|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14889410|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14889411|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14889412|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14889413|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14889414|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14889415|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14889416|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14889417|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14889418|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14889419|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
14889420|NCT01241786|Lenalidomide|lenalidomide|mesh-list
14889421|NCT01241786|Azacitidine|azacitidine|mesh-list
14889422|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
14889423|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889424|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14889425|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14889426|NCT01241786|Growth Substances|growth substances|mesh-ancestor
14716735|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889427|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14889428|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889429|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14889430|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
14889431|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889432|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216137|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
15216138|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15216139|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
15216140|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216141|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216142|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15216143|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
15216144|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15216145|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
15216146|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716736|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14716737|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
14716738|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716739|NCT00464347|Triamcinolone|triamcinolone|mesh-list
14716740|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14716741|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14716742|NCT00464347|Bevacizumab|bevacizumab|mesh-list
14716743|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14716744|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14889433|NCT01242046|Caffeine|caffeine|mesh-list
15216147|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216148|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15216149|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
14716745|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716746|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14716747|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14889434|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14889435|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889436|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14889437|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889438|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889439|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14889440|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14889441|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
14889442|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889443|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
14889444|NCT01242072|Ifosfamide|ifosfamide|mesh-list
14889445|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14889446|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
14889447|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889448|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889449|NCT01242098|Fluticasone|fluticasone|mesh-list
14889450|NCT01242098|Beclomethasone|beclomethasone|mesh-list
14889451|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
14889452|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14889453|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889454|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14889455|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
14889456|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889457|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889458|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889459|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889460|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
14889461|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14889462|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15216150|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
14716748|NCT00464347|Growth Substances|growth substances|mesh-ancestor
14716749|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716750|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
14716751|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14716752|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
14716753|NCT00464347|Hormones|hormones|mesh-ancestor
14716754|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716755|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14716756|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
14716757|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716758|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216151|NCT04338828|Protective Agents|protective agents|mesh-ancestor
15216152|NCT04331288|Ethanol|ethanol|mesh-list
15216153|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15216154|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216155|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216156|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216157|NCT04283500|Buprenorphine|buprenorphine|mesh-list
15216158|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15216159|NCT04283500|Naloxone|naloxone|mesh-list
15216160|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15216161|NCT04283500|Narcotics|narcotics|mesh-ancestor
15216162|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216163|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216164|NCT04283500|Analgesics|analgesics|mesh-ancestor
15216165|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
14889463|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14889464|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14889465|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14889466|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889467|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889468|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
14889469|NCT01242098|Hormones|hormones|mesh-ancestor
14889470|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889471|NCT01242202|Acarbose|acarbose|mesh-list
14889472|NCT01242202|Voglibose|voglibose|mesh-list
14889473|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14889474|NCT01242202|Miglitol|miglitol|mesh-list
14889475|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
14889476|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889477|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889478|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889479|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889480|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14889481|NCT01242215|Glimepiride|glimepiride|mesh-list
14889482|NCT01242215|Gliclazide|gliclazide|mesh-list
14889483|NCT01242215|Glyburide|glyburide|mesh-list
14889484|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
14889485|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14889486|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889487|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889488|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889489|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
14889490|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14889491|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889492|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14889493|NCT01242228|Vildagliptin|vildagliptin|mesh-list
14889494|NCT01242228|Saxagliptin|saxagliptin|mesh-list
14889495|NCT01242228|Alogliptin|alogliptin|mesh-list
14889496|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
14889497|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14889498|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889499|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889500|NCT01242228|Incretins|incretins|mesh-ancestor
14889501|NCT01242228|Hormones|hormones|mesh-ancestor
14889502|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889503|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
14889504|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889505|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889506|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14889507|NCT01242267|Thalidomide|thalidomide|mesh-list
14889508|NCT01242267|Bortezomib|bortezomib|mesh-list
14716759|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
14889509|NCT01242267|Melphalan|melphalan|mesh-list
14889510|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889511|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14889512|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
14889513|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889514|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14889515|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889516|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
14889517|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889518|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
14889519|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14889520|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889521|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14889522|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14889523|NCT01242267|Growth Substances|growth substances|mesh-ancestor
14889524|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
14889525|NCT01242306|Acetylcholine|acetylcholine|mesh-list
14889526|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
14889527|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14889528|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
14889529|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889530|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889531|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889532|NCT01242332|Pregabalin|pregabalin|mesh-list
14889533|NCT01242332|Analgesics|analgesics|mesh-ancestor
14889534|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
14889535|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889536|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716760|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14716761|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14716762|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14716763|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14716764|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716765|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
14716766|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716767|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716768|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14716769|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716770|NCT00464399|Everolimus|everolimus|mesh-list
14716771|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716772|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216166|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716773|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
14716774|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716775|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
14716776|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
14716777|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14716778|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14716779|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716780|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14716781|NCT00464451|Analgesics|analgesics|mesh-ancestor
14716782|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
14716783|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716784|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14716785|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14716786|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14716787|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
14716788|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716789|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889537|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
14889538|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15216167|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15216168|NCT04241549|Azacitidine|azacitidine|mesh-list
15216169|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216170|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
15216171|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216172|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889539|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14889540|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889541|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14889542|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14889543|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14889544|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889545|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14889546|NCT01242384|Silicon|silicon|mesh-list
14889547|NCT01242384|Trace Elements|trace elements|mesh-ancestor
14889548|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
15216173|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216174|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
15216175|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
15216176|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216177|NCT04225026|Protective Agents|protective agents|mesh-ancestor
15216178|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216179|NCT04217135|Hydralazine|hydralazine|mesh-list
15216180|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15216181|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
15216182|NCT04205838|Vidarabine|vidarabine|mesh-list
15216183|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
15216184|NCT04205838|Fludarabine|fludarabine|mesh-list
14296672|NCT05213481|Tepotinib|tepotinib|mesh-list
14296673|NCT05213481|Carbamazepine|carbamazepine|mesh-list
14296674|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
14296675|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
14296676|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14296677|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296678|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296679|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14296680|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14296681|NCT05213481|Analgesics|analgesics|mesh-ancestor
14296682|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
14296683|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296684|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14296685|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14296686|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296687|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14296688|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14296689|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296690|NCT05208710|Vaccines|vaccines|mesh-list
14889549|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889550|NCT01242410|Silicon|silicon|mesh-list
14889551|NCT01242410|Trace Elements|trace elements|mesh-ancestor
14889552|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
14889553|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889554|NCT01242449|Trastuzumab|trastuzumab|mesh-list
14889555|NCT01242449|Vinorelbine|vinorelbine|mesh-list
14889556|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14889557|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889558|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14889559|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14889560|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14889561|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14889562|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889563|NCT01242566|Temozolomide|temozolomide|mesh-list
14889564|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14889565|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
14889566|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889567|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889568|NCT01242579|Maraviroc|maraviroc|mesh-list
14889569|NCT01242579|Dapivirine|dapivirine|mesh-list
14889570|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15216185|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
14889571|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14889572|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889573|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14889574|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14889575|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
14889576|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889577|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14889578|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
14296691|NCT05208710|Immunologic Factors|immunologic factors|mesh-ancestor
14716790|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14889579|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14889580|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216186|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15216187|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216188|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
14889581|NCT01242605|Gemcitabine|gemcitabine|mesh-list
14889582|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889583|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14889584|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
14889585|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889586|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
14889587|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889588|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889589|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889590|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
14889591|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889592|NCT01242631|Everolimus|everolimus|mesh-list
14889593|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889594|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889595|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
14889596|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889597|NCT01242774|Panobinostat|panobinostat|mesh-list
14889598|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889599|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14889600|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889601|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889602|NCT01242787|Entecavir|entecavir|mesh-list
14889603|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
14889604|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889605|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
14889606|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
14889607|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889608|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889609|NCT01242904|Icodextrin|icodextrin|mesh-list
14889610|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
14889611|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14915481|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915482|NCT01387048|Adapalene|adapalene|mesh-list
14915483|NCT01387048|Azelaic acid|azelaic acid|mesh-list
14915484|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14915485|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14915486|NCT01387048|Analgesics|analgesics|mesh-ancestor
15216189|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216190|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15216191|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15216192|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
15216193|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216194|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216195|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15216196|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716791|NCT00464503|Pravastatin|pravastatin|mesh-list
14716792|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14716793|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14716794|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
14716795|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716796|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14716797|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14716798|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716799|NCT00464594|Metformin|metformin|mesh-list
14915487|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
14716800|NCT00464594|Acarbose|acarbose|mesh-list
15216197|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
14889612|NCT01243060|Zolpidem|zolpidem|mesh-list
14889613|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14889614|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14889615|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889616|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889617|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14889618|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
14889619|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
14889620|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889621|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889622|NCT01243086|Dexamethasone|dexamethasone|mesh-list
14889623|NCT01243086|Ranibizumab|ranibizumab|mesh-list
14889624|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889625|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
14889626|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
14889627|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889628|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889629|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14889630|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
14889631|NCT01243086|Hormones|hormones|mesh-ancestor
14889632|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889633|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889634|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889635|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14889636|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14889637|NCT01243086|Growth Substances|growth substances|mesh-ancestor
14889638|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
14889639|NCT01243203|Varenicline|varenicline|mesh-list
14889640|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15216198|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
15216199|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889641|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14889642|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
14889643|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889644|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889645|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889646|NCT01243281|Entecavir|entecavir|mesh-list
14889647|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
14889648|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889649|NCT01243359|Bevacizumab|bevacizumab|mesh-list
14889650|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14889651|NCT01243359|Sunitinib|sunitinib|mesh-list
14889652|NCT01243359|Antibodies|antibodies|mesh-list
14889653|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
14889654|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14889655|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889656|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14889657|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14889658|NCT01243359|Growth Substances|growth substances|mesh-ancestor
14889659|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889660|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
14889661|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
14889662|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14889663|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889664|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889665|NCT01243385|Metformin|metformin|mesh-list
14889666|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889667|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889668|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
14889669|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15216200|NCT04178603|Insulin|insulin|mesh-list
15216201|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15216202|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216203|NCT04170972|Insulin|insulin|mesh-list
15216204|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15216205|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216206|NCT04133623|Ibuprofen|ibuprofen|mesh-list
15216207|NCT04133623|Ketorolac|ketorolac|mesh-list
15216208|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15216209|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14889670|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216210|NCT04133623|Analgesics|analgesics|mesh-ancestor
14889671|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14889672|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15216211|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
14889673|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889674|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889675|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889676|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14889677|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14889678|NCT01243476|Lenalidomide|lenalidomide|mesh-list
14889679|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
14889680|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889681|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14889682|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14889683|NCT01243476|Growth Substances|growth substances|mesh-ancestor
14889684|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
14889685|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889686|NCT01243528|Vitamin D|vitamin d|mesh-list
14889687|NCT01243528|Vitamins|vitamins|mesh-ancestor
14889688|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
14889689|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889690|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14889691|NCT01243632|Gemcitabine|gemcitabine|mesh-list
14889692|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14889693|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
14889694|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889695|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889696|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
14889697|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889698|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889699|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889700|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
14889701|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889702|NCT01243658|Oxytocin|oxytocin|mesh-list
14889703|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
14889704|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14889705|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889706|NCT01243697|Desogestrel|desogestrel|mesh-list
14889707|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14889708|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14889709|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14889710|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
14889711|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14889712|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889713|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14889714|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14889715|NCT01243697|Progestins|progestins|mesh-ancestor
14889716|NCT01243697|Hormones|hormones|mesh-ancestor
14889717|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889718|NCT01243710|Taurolidine|taurolidine|mesh-list
14889719|NCT01243710|Heparin|heparin|mesh-list
14889720|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
14889721|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14889722|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14889723|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889724|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889725|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14889726|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889727|NCT01243736|Metoclopramide|metoclopramide|mesh-list
14889728|NCT01243736|Simethicone|simethicone|mesh-list
14889729|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
14889730|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
14889731|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889732|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889733|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14889734|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14889735|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14889736|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
14889737|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889738|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889739|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
14889740|NCT01243736|Emollients|emollients|mesh-ancestor
14889741|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14889742|NCT01243788|Fluticasone|fluticasone|mesh-list
14889743|NCT01243788|Xhance|xhance|mesh-list
14889744|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14889745|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889746|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14889747|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
14889748|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889749|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889750|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889751|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889752|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
14889753|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14889754|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14889755|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14889756|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14889757|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
14889758|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889759|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889760|NCT01243801|Ketamine|ketamine|mesh-list
14889761|NCT01243801|Analgesics|analgesics|mesh-ancestor
14889762|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
14889763|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889764|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889765|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14889766|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14889767|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
14889768|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
14889769|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889770|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14889771|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14889772|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889773|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889774|NCT01243827|Carvedilol|carvedilol|mesh-list
14889775|NCT01243827|Bisoprolol|bisoprolol|mesh-list
14889776|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14889777|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14889778|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
14889779|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889780|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889781|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889782|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14889783|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
14889784|NCT01243827|Protective Agents|protective agents|mesh-ancestor
14889785|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14889786|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14889787|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14889788|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
14889789|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14889790|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14889791|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
14889792|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
14889793|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889794|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14889795|NCT01243970|Phenylephrine|phenylephrine|mesh-list
14889796|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
14889797|NCT01243970|Ephedrine|ephedrine|mesh-list
14889798|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14889799|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
14889800|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
14889801|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889802|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889803|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
14889804|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14889805|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
14889806|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889807|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14889808|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14889809|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14889810|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
15216212|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216213|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216214|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889811|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889812|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216215|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15216216|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15216217|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216218|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216219|NCT04064411|Abaloparatide|abaloparatide|mesh-list
15216220|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
15216221|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15216222|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216223|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15216224|NCT04057937|Apremilast|apremilast|mesh-list
15216225|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15216226|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15216227|NCT04057937|Analgesics|analgesics|mesh-ancestor
15216228|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
15216229|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216230|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889813|NCT01243970|Protective Agents|protective agents|mesh-ancestor
14889814|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14889815|NCT01243996|Ibuprofen|ibuprofen|mesh-list
14889816|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14889817|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14889818|NCT01243996|Analgesics|analgesics|mesh-ancestor
14889819|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
14889820|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889821|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889822|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889823|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14889824|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14889825|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889826|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889827|NCT01244009|Niraparib|niraparib|mesh-list
14889828|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14889829|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889830|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889831|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889832|NCT01244100|Aspirin|aspirin|mesh-list
14889833|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14889834|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14889835|NCT01244100|Analgesics|analgesics|mesh-ancestor
15216231|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216232|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15216233|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15216234|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15216235|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216236|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216237|NCT04042831|Olaparib|olaparib|mesh-list
15216238|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15216239|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216240|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216241|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216242|NCT04017962|Letermovir|letermovir|mesh-list
15216243|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15216244|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716801|NCT00464594|Gliclazide|gliclazide|mesh-list
14716802|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14716803|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716804|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14716805|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716806|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716807|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
14716808|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14716809|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14716810|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716811|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14716812|NCT00464763|Analgesics|analgesics|mesh-ancestor
14716813|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
14716814|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716815|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14716816|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14716817|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14716818|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
14716819|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716820|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889836|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
14889837|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889838|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889839|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889840|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14889841|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14889842|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14889843|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889844|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14889845|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14889846|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716821|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
14716822|NCT00464789|Estrogens|estrogens|mesh-list
14716823|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14716824|NCT00464789|Hormones|hormones|mesh-ancestor
14716825|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716826|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716827|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14889847|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
14889848|NCT01244113|Propofol|propofol|mesh-list
14889849|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14889850|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889851|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889852|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14889853|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
14889854|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
14889855|NCT01244178|Insulin|insulin|mesh-list
14889856|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14889857|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14889858|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889859|NCT01244204|Vitamin D|vitamin d|mesh-list
14889860|NCT01244204|Vitamins|vitamins|mesh-ancestor
14889861|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
15216245|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216246|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216247|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
15216248|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216249|NCT03907826|Antibodies|antibodies|mesh-list
15216250|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
15216251|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
14716828|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14889862|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216252|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216253|NCT03905889|Sunitinib|sunitinib|mesh-list
15216254|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216255|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15216256|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15216257|NCT03905889|Growth Substances|growth substances|mesh-ancestor
15216258|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216259|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
15216260|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15216261|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216262|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216263|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
15216264|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889863|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14889864|NCT01244217|Fexofenadine|fexofenadine|mesh-list
15225326|NCT05103631|Fludarabine phosphate|fludarabine phosphate|mesh-list
14889865|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14889866|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14889867|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14889868|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
14889869|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
14889870|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889871|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889872|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889873|NCT01244230|Fexofenadine|fexofenadine|mesh-list
14889874|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14889875|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14889876|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14889877|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
14889878|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
14889879|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889880|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889881|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889882|NCT01244256|Gentamicins|gentamicins|mesh-list
14889883|NCT01244256|Clotrimazole|clotrimazole|mesh-list
14889884|NCT01244256|Miconazole|miconazole|mesh-list
14889885|NCT01244256|Beclomethasone|beclomethasone|mesh-list
14889886|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14889887|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889888|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14889889|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889890|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889891|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889892|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
14889893|NCT01244256|Hormones|hormones|mesh-ancestor
14889894|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889895|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889896|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14889897|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14889898|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14889899|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
14889900|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14889901|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14889902|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14889903|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
14889904|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14889905|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14889906|NCT01244269|Methylphenidate|methylphenidate|mesh-list
14889907|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14889908|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889909|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14889910|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14889911|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14889912|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889913|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
14889914|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14889915|NCT01244334|Prednisolone|prednisolone|mesh-list
14889916|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14889917|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
14889918|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14889919|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
14889920|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14889921|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
14889922|NCT01244334|Difluprednate|difluprednate|mesh-list
14889923|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14889924|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
14889925|NCT01244334|Hormones|hormones|mesh-ancestor
14889926|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14889927|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889928|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14889929|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889930|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
14889931|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
14889932|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889933|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14889934|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14889935|NCT01244334|Protective Agents|protective agents|mesh-ancestor
14889936|NCT01244347|Folic Acid|folic acid|mesh-list
14889937|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
14889938|NCT01244347|Hematinics|hematinics|mesh-ancestor
14889939|NCT01244347|Vitamins|vitamins|mesh-ancestor
14889940|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
14889941|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889942|NCT01244360|Resveratrol|resveratrol|mesh-list
14889943|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
14889944|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889945|NCT01244360|Protective Agents|protective agents|mesh-ancestor
14889946|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889947|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889948|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14889949|NCT01244399|Inositol|inositol|mesh-list
14889950|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
14889951|NCT01244399|Vitamins|vitamins|mesh-ancestor
14716829|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716830|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14716831|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
14716832|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14716833|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716834|NCT00464893|Catumaxomab|catumaxomab|mesh-list
14716835|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14716836|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716837|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
14889952|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
14889953|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889954|NCT01244581|Amoxicillin|amoxicillin|mesh-list
14889955|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
14716838|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889956|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
14889957|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14889958|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716839|NCT00464919|Sorafenib|sorafenib|mesh-list
14716840|NCT00464919|Tegafur|tegafur|mesh-list
14889959|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889960|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14889961|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889962|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889963|NCT01244659|Tacrolimus|tacrolimus|mesh-list
14889964|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14889965|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
14889966|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889967|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14889968|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889969|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889970|NCT01244698|Clindamycin|clindamycin|mesh-list
14889971|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
14889972|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
14889973|NCT01244698|Cefazolin|cefazolin|mesh-list
14889974|NCT01244698|Cefadroxil|cefadroxil|mesh-list
14889975|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14889976|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14889977|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14889978|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14889979|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889980|NCT01244789|Paclitaxel|paclitaxel|mesh-list
14889981|NCT01244789|Carboplatin|carboplatin|mesh-list
14889982|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14889983|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14889984|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
14889985|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
14889986|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
14889987|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14889988|NCT01244880|Ketamine|ketamine|mesh-list
14889989|NCT01244880|Analgesics|analgesics|mesh-ancestor
14889990|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
14889991|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14889992|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14889993|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14889994|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14889995|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
14889996|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
14889997|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14889998|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14889999|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14890000|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890001|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890002|NCT01244932|Bupivacaine|bupivacaine|mesh-list
14890003|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
14890004|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
14890005|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890006|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890007|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
14890008|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890009|NCT01244958|Rituximab|rituximab|mesh-list
14890010|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14890011|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890012|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
14890013|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716841|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716842|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14716843|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716844|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716845|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14716846|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
14716847|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
14716848|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716849|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
14716850|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14716851|NCT00464932|Protective Agents|protective agents|mesh-ancestor
14716852|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716853|NCT00464958|Tizanidine|tizanidine|mesh-list
14716854|NCT00464958|Analgesics|analgesics|mesh-ancestor
14890014|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890015|NCT01244971|Acarbose|acarbose|mesh-list
14890016|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14890017|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890018|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890019|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14296692|NCT05208710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296693|NCT05204563|Imipenem|imipenem|mesh-list
14296694|NCT05204563|Relebactam|relebactam|mesh-list
14296695|NCT05204563|Cilastatin|cilastatin|mesh-list
14296696|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14890020|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915488|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915489|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915490|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14915491|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14915492|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
14915493|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915494|NCT01387087|Peficitinib|peficitinib|mesh-list
14915495|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915496|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915497|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915498|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
14915499|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915500|NCT01387191|Epoprostenol|epoprostenol|mesh-list
14915501|NCT01387191|Tezosentan|tezosentan|mesh-list
14915502|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14915503|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14915504|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
14915505|NCT01387204|Trametinib|trametinib|mesh-list
14915506|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915507|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14915508|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915509|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915510|NCT01387243|Orlistat|orlistat|mesh-list
14915511|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915512|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915513|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14915514|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14915515|NCT01387295|Capecitabine|capecitabine|mesh-list
14915516|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
14915517|NCT01387295|Trastuzumab|trastuzumab|mesh-list
14915518|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915519|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
14915520|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296697|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890021|NCT01245166|Metformin|metformin|mesh-list
14890022|NCT01245166|Acarbose|acarbose|mesh-list
14890023|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14890024|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890025|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14890026|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890027|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890028|NCT01245179|Panobinostat|panobinostat|mesh-list
14890029|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890030|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14890031|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890032|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890033|NCT01245205|Lapatinib|lapatinib|mesh-list
14890034|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890035|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14890036|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216265|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15216266|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15216267|NCT03847311|Analgesics|analgesics|mesh-ancestor
15216268|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
15216269|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216270|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216271|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216272|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15216273|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15216274|NCT03823989|Mitomycins|mitomycins|mesh-list
15216275|NCT03823989|Mitomycin|mitomycin|mesh-list
15216276|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15216277|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216278|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
14716855|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
14716856|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716857|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890037|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890038|NCT01245244|Morphine|morphine|mesh-list
14890039|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14890040|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14716858|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
14716859|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14716860|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14716861|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
14716862|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
14716863|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14716864|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14716865|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14716866|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
14716867|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716868|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716869|NCT00464971|Estradiol|estradiol|mesh-list
14716870|NCT00464971|Estrogens|estrogens|mesh-ancestor
14716871|NCT00464971|Hormones|hormones|mesh-ancestor
14716872|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716873|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716874|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14716875|NCT00465036|Cathartics|cathartics|mesh-ancestor
14890041|NCT01245244|Narcotics|narcotics|mesh-ancestor
14890042|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890043|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890044|NCT01245244|Analgesics|analgesics|mesh-ancestor
14890045|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
14890046|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890047|NCT01245361|Infliximab|infliximab|mesh-list
14890048|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
14890049|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890050|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14716876|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716877|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
14716878|NCT00465075|Estrogens|estrogens|mesh-list
14716879|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14716880|NCT00465075|Hormones|hormones|mesh-ancestor
14890051|NCT01245452|Methotrexate|methotrexate|mesh-list
14890052|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14890053|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
14890054|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14890055|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890056|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890057|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
14890058|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890059|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890060|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
14890061|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890062|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14890063|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890064|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
14890065|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890066|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14890067|NCT01245530|Donepezil|donepezil|mesh-list
14890068|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14890069|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716881|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14716882|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890070|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890071|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
14890072|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890073|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216279|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716883|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14716884|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14890074|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
15216280|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15216281|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216282|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
15216283|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15216284|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216285|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
15216286|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
15216287|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216288|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216289|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15216290|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
15216291|NCT03818737|Hormones|hormones|mesh-ancestor
15216292|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216293|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15216294|NCT03818737|Protective Agents|protective agents|mesh-ancestor
15216295|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
15216296|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15216297|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216298|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216299|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15216300|NCT03770130|Analgesics|analgesics|mesh-ancestor
15216301|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
15216302|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216303|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15216304|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15216305|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15216306|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
15216307|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890075|NCT01245543|Docetaxel|docetaxel|mesh-list
14890076|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890077|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14890078|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14890079|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14890080|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890081|NCT01245556|Ipilimumab|ipilimumab|mesh-list
14890082|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14890083|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890084|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14890085|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890086|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14890087|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14890088|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
14890089|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890090|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890091|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14890092|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
14890093|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
14890094|NCT01245569|Hormones|hormones|mesh-ancestor
14890095|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890096|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
14890097|NCT01245582|Capecitabine|capecitabine|mesh-list
14890098|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
14890099|NCT01245582|Sorafenib|sorafenib|mesh-list
14890100|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890101|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
14890102|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890103|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890104|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14890105|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890106|NCT01245660|Lapatinib|lapatinib|mesh-list
14890107|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890108|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14890109|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890110|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890111|NCT01245725|Tirofiban|tirofiban|mesh-list
14890112|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14890113|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14890114|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890115|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14890116|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14890117|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14890118|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14890119|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
14890120|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890121|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14890122|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14890123|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890124|NCT01245816|Eflornithine|eflornithine|mesh-list
14890125|NCT01245816|Sulindac|sulindac|mesh-list
14890126|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890127|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14890128|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14890129|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14890130|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890131|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14890132|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890133|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890134|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14890135|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14890136|NCT01245816|Analgesics|analgesics|mesh-ancestor
14890137|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
14890138|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890139|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890140|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890141|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890142|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14890143|NCT01245855|Alprostadil|alprostadil|mesh-list
14890144|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14890145|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
14890146|NCT01245855|Urological Agents|urological agents|mesh-ancestor
14890147|NCT01245868|Lidocaine|lidocaine|mesh-list
14890148|NCT01245868|Bupivacaine|bupivacaine|mesh-list
14890149|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
14890150|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
14890151|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890152|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890153|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
14890154|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890155|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14890156|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14890157|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14890158|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14890159|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890160|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
14890161|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14890162|NCT01245881|Protective Agents|protective agents|mesh-ancestor
14890163|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890164|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
14890165|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14890166|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14890167|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14890168|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
14890169|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890170|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14890171|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14890172|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890173|NCT01245946|Doxycycline|doxycycline|mesh-list
14890174|NCT01245946|Adapalene|adapalene|mesh-list
14890175|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14890176|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890177|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
14890178|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14890179|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14890180|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14890181|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14890182|NCT01245946|Analgesics|analgesics|mesh-ancestor
14890183|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
14890184|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890185|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890186|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890187|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890188|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
14890189|NCT01245959|Cisplatin|cisplatin|mesh-list
14890190|NCT01245959|Docetaxel|docetaxel|mesh-list
14890191|NCT01245959|Fluorouracil|fluorouracil|mesh-list
14890192|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890193|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
14890194|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
14890195|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
14890196|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890197|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
14890198|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890199|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890200|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
14890201|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890202|NCT01245998|Dalteparin|dalteparin|mesh-list
14890203|NCT01245998|Tinzaparin|tinzaparin|mesh-list
14890204|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14890205|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
15216308|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296698|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
14890206|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14890207|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14890208|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890209|NCT01246037|Bisoprolol|bisoprolol|mesh-list
14890210|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14890211|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
14890212|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
14890213|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890214|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890215|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14890216|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14890217|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14890218|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
14890219|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890220|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890221|NCT01246089|Ranibizumab|ranibizumab|mesh-list
14890222|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890223|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890224|NCT01246089|Growth Substances|growth substances|mesh-ancestor
14890225|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890226|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890227|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890228|NCT01246180|Diclofenac|diclofenac|mesh-list
14890229|NCT01246180|Amiloride|amiloride|mesh-list
14890230|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14890231|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14890232|NCT01246180|Analgesics|analgesics|mesh-ancestor
14890233|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
14890234|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890235|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890236|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890237|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890238|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14890239|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890240|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890241|NCT01246180|Diuretics|diuretics|mesh-ancestor
14890242|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
14890243|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14890244|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14890245|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14890246|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14890247|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14890248|NCT01246232|Amisulpride|amisulpride|mesh-list
14890249|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14890250|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14890251|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890252|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890253|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14890254|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14890255|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
14890256|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890257|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890258|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14890259|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
14890260|NCT01246284|Triamcinolone|triamcinolone|mesh-list
15216309|NCT03747939|Thalidomide|thalidomide|mesh-list
15216310|NCT03747939|Apremilast|apremilast|mesh-list
15216311|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15216312|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15216313|NCT03747939|Analgesics|analgesics|mesh-ancestor
15216314|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
15216315|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216316|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216317|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216318|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15216319|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15216320|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14296699|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890261|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14890262|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14890263|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14890264|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890265|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
14890266|NCT01246284|Hormones|hormones|mesh-ancestor
14890267|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890268|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890269|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890270|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
14890271|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890272|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890273|NCT01246323|Fentanyl|fentanyl|mesh-list
14890274|NCT01246323|Morphine|morphine|mesh-list
14890275|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
14890276|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890277|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890278|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14890279|NCT01246323|Narcotics|narcotics|mesh-ancestor
14890280|NCT01246323|Analgesics|analgesics|mesh-ancestor
14890281|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
14890282|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890283|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14890284|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14890285|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
14890286|NCT01246362|Etoricoxib|etoricoxib|mesh-list
14890287|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14890288|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14890289|NCT01246362|Analgesics|analgesics|mesh-ancestor
14890290|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
14890291|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890292|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890293|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890294|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890295|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14890296|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14890297|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890298|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890299|NCT01246440|Catumaxomab|catumaxomab|mesh-list
14890300|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890301|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14890302|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14890303|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14890304|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890305|NCT01246557|Dexamethasone|dexamethasone|mesh-list
14890306|NCT01246557|Lenalidomide|lenalidomide|mesh-list
14890307|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890308|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
14890309|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
14890310|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890311|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890312|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890313|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
14890314|NCT01246557|Hormones|hormones|mesh-ancestor
14890315|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890316|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14890317|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890318|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
14890319|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890320|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890321|NCT01246557|Growth Substances|growth substances|mesh-ancestor
14890322|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890323|NCT01246622|Cytarabine|cytarabine|mesh-list
14890324|NCT01246622|Lenalidomide|lenalidomide|mesh-list
14890325|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890326|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
14890327|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890328|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890329|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
14890330|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890331|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890332|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
14890333|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890334|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890335|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890336|NCT01246622|Growth Substances|growth substances|mesh-ancestor
14890337|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890338|NCT01246752|Cytarabine|cytarabine|mesh-list
14890339|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890340|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
14890341|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890342|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890343|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
14890344|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890345|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890346|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
14890347|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915521|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915522|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915523|NCT01387373|Capecitabine|capecitabine|mesh-list
14915524|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
14915525|NCT01387373|Trastuzumab|trastuzumab|mesh-list
14915526|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915527|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
14915528|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915529|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915530|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915531|NCT01387399|Cisplatin|cisplatin|mesh-list
14915532|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915533|NCT01387425|Varenicline|varenicline|mesh-list
14915534|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14915535|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14915536|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
14296700|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296701|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14296702|NCT05204368|Meropenem|meropenem|mesh-list
14296703|NCT05204368|Imipenem|imipenem|mesh-list
14915537|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915538|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915539|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915540|NCT01387568|Lidocaine|lidocaine|mesh-list
14915541|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
14915542|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
14915543|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14915544|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915545|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
14915546|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915547|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14296704|NCT05204368|Cilastatin|cilastatin|mesh-list
14296705|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14716885|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716886|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14716887|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14716888|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14716889|NCT00465192|Estradiol|estradiol|mesh-list
14716890|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14716891|NCT00465192|Estrogens|estrogens|mesh-ancestor
14716892|NCT00465192|Hormones|hormones|mesh-ancestor
14716893|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296706|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296707|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
14890348|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
14890349|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14890350|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14890351|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
14890352|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890353|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14890354|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14890355|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890356|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890357|NCT01246817|Sirolimus|sirolimus|mesh-list
14890358|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14890359|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890360|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14890361|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890362|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
14890363|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890364|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
14890365|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890366|NCT01246921|Fluticasone|fluticasone|mesh-list
14890367|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890368|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14890369|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
14890370|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890371|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890372|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14890373|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
14890374|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
14890375|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14890376|NCT01247077|Selenium|selenium|mesh-list
14890377|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
14890378|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890379|NCT01247077|Protective Agents|protective agents|mesh-ancestor
14890380|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890381|NCT01247077|Trace Elements|trace elements|mesh-ancestor
14890382|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
14890383|NCT01247311|Vitamin D|vitamin d|mesh-list
14890384|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
14890385|NCT01247311|Vitamins|vitamins|mesh-list
14890386|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
14890387|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890388|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14890389|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14890390|NCT01247337|Gemcitabine|gemcitabine|mesh-list
14890391|NCT01247337|Capecitabine|capecitabine|mesh-list
14890392|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
14890393|NCT01247337|Cetuximab|cetuximab|mesh-list
14890394|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890395|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
14890396|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890397|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890398|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
14890399|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296708|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890400|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890401|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890402|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
14890403|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890404|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14890405|NCT01247493|Cytarabine|cytarabine|mesh-list
14890406|NCT01247493|Fludarabine|fludarabine|mesh-list
14890407|NCT01247493|Idarubicin|idarubicin|mesh-list
14890408|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890409|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890410|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
14890411|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890412|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890413|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
14890414|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890415|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
14890416|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890417|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14890418|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14890419|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14890420|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890421|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
14890422|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
14890423|NCT01247558|Vitamins|vitamins|mesh-ancestor
14890424|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
14890425|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890426|NCT01247688|Fludarabine|fludarabine|mesh-list
14890427|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
14890428|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890429|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890430|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890431|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
14890432|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890433|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890434|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14890435|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
14890436|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14890437|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
14890438|NCT01247701|Busulfan|busulfan|mesh-list
14890439|NCT01247701|Fludarabine|fludarabine|mesh-list
14890440|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890441|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
14890442|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890443|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890444|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14890445|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
14890446|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890447|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890448|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14890449|NCT01247714|Phentermine|phentermine|mesh-list
14890450|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14890451|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890452|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
14890453|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14890454|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
14890455|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
14890456|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890457|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
14890458|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890459|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890460|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
14890461|NCT01247805|Citric Acid|citric acid|mesh-list
14890462|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
14890463|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
14890464|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14890465|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
14890466|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
14890467|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890468|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
14890469|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14890470|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14890471|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890472|NCT01247805|Urological Agents|urological agents|mesh-ancestor
14890473|NCT01247857|Ropivacaine|ropivacaine|mesh-list
14890474|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
14890475|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
14890476|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890477|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890478|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
14890479|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890480|NCT01247870|Metformin|metformin|mesh-list
14890481|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14890482|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890483|NCT01247909|Gentamicins|gentamicins|mesh-list
14890484|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
14890485|NCT01247909|Penicillins|penicillins|mesh-list
14890486|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14890487|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890488|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14890489|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890490|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890491|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14890492|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890493|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890494|NCT01247961|Dexamethasone|dexamethasone|mesh-list
14890495|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
14890496|NCT01247961|BB 1101|bb 1101|mesh-list
14890497|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890498|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
14890499|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
14890500|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890501|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890502|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890503|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
14890504|NCT01247961|Hormones|hormones|mesh-ancestor
14890505|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890506|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14890507|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890508|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
14890509|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890510|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890511|NCT01248078|Cephalexin|cephalexin|mesh-list
14890512|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14890513|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890514|NCT01248091|Nitroprusside|nitroprusside|mesh-list
14890515|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14890516|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
14890517|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14890518|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890519|NCT01248117|Ranibizumab|ranibizumab|mesh-list
14890520|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890521|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890522|NCT01248117|Growth Substances|growth substances|mesh-ancestor
14890523|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890524|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890525|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890526|NCT01248195|Olanzapine|olanzapine|mesh-list
14890527|NCT01248195|Clozapine|clozapine|mesh-list
14890528|NCT01248195|Amisulpride|amisulpride|mesh-list
14890529|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
14890530|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
14890531|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890532|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890533|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890534|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14890535|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14890536|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890537|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14890538|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14890539|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14890540|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14890541|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890542|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890543|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
14890544|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14890545|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
14890546|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
14890547|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14890548|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
14890549|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14890550|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
14890551|NCT01248234|Propofol|propofol|mesh-list
14890552|NCT01248234|Etomidate|etomidate|mesh-list
14890553|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14890554|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890555|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890556|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14890557|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
14890558|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
14890559|NCT01248260|Folic Acid|folic acid|mesh-list
14890560|NCT01248260|Hematinics|hematinics|mesh-ancestor
14890561|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
14890562|NCT01248260|Vitamins|vitamins|mesh-ancestor
14890563|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
14890564|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890565|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14890566|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
14890567|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890568|NCT01248299|Cisplatin|cisplatin|mesh-list
14890569|NCT01248299|Docetaxel|docetaxel|mesh-list
14890570|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
14890571|NCT01248299|Fluorouracil|fluorouracil|mesh-list
14890572|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890573|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
14890574|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
14890575|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
14890576|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890577|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
14890578|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890579|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890580|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
14890581|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890582|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14890583|NCT01248338|Metoprolol|metoprolol|mesh-list
14890584|NCT01248338|Nebivolol|nebivolol|mesh-list
14890585|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14890586|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14890587|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
14890588|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
14890589|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890590|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890591|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14890592|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14890593|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14890594|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
14890595|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890596|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890597|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
14890598|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14890599|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14890600|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14890601|NCT01248403|Paclitaxel|paclitaxel|mesh-list
14890602|NCT01248403|Everolimus|everolimus|mesh-list
14890603|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14890604|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890605|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
14890606|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
14890607|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
14890608|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890609|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890610|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
14716894|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716895|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14716896|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
14716897|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14716898|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14716899|NCT00465205|Valacyclovir|valacyclovir|mesh-list
14716900|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
14716901|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716902|NCT00465231|Fentanyl|fentanyl|mesh-list
14716903|NCT00465231|Bupivacaine|bupivacaine|mesh-list
14716904|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
14716905|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
14716906|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14716907|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716908|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
14890611|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890612|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
14890613|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15216321|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216322|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216323|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216324|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
15216325|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
15216326|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15216327|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216328|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15216329|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15216330|NCT03747939|Growth Substances|growth substances|mesh-ancestor
14890614|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890615|NCT01248442|Vitamins|vitamins|mesh-ancestor
14890616|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
14890617|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14890618|NCT01248481|Acarbose|acarbose|mesh-list
14890619|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14890620|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890621|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890622|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14890623|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890624|NCT01248494|Letrozole|letrozole|mesh-list
14890625|NCT01248494|Dactolisib|dactolisib|mesh-list
14890626|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890627|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14890628|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14890629|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890630|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890631|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14890632|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
14890633|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890634|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915548|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14915549|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14915550|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14915551|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915552|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
14915553|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14915554|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
14915555|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915556|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
14915557|NCT01387620|Protective Agents|protective agents|mesh-ancestor
14915558|NCT01387880|Everolimus|everolimus|mesh-list
14915559|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915560|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915561|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
14915562|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915563|NCT01387906|Bimatoprost|bimatoprost|mesh-list
14915564|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14915565|NCT01387997|Antibodies|antibodies|mesh-list
14915566|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
14915567|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915568|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
14915569|NCT01388023|Listerine|listerine|mesh-list
14915570|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14915571|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915572|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
14915573|NCT01388036|Esmolol|esmolol|mesh-list
14915574|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14915575|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14915576|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14915577|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
14915578|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915579|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915580|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915581|NCT01388049|Antibodies|antibodies|mesh-list
14915582|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
14915583|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915584|NCT01388062|Antibodies|antibodies|mesh-list
14915585|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
15216331|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
15216332|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296709|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216333|NCT03727971|Omalizumab|omalizumab|mesh-list
14890635|NCT01248611|Fentanyl|fentanyl|mesh-list
14890636|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14890637|NCT01248611|Narcotics|narcotics|mesh-ancestor
14890638|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890639|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890640|NCT01248611|Analgesics|analgesics|mesh-ancestor
14890641|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
14890642|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890643|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14890644|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14890645|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
14890646|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
14890647|NCT01248819|Ropivacaine|ropivacaine|mesh-list
14890648|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
14890649|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
14890650|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890651|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890652|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
14890653|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890654|NCT01248858|Trametinib|trametinib|mesh-list
14890655|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890656|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14890657|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890658|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890659|NCT01248871|Sufentanil|sufentanil|mesh-list
14890660|NCT01248871|Remifentanil|remifentanil|mesh-list
14890661|NCT01248871|Dsuvia|dsuvia|mesh-list
14890662|NCT01248871|Propofol|propofol|mesh-list
14890663|NCT01248871|Sevoflurane|sevoflurane|mesh-list
14890664|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14890665|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890666|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890667|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14890668|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
14890669|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
14890670|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14890671|NCT01248871|Narcotics|narcotics|mesh-ancestor
14890672|NCT01248871|Analgesics|analgesics|mesh-ancestor
14890673|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
14716909|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716910|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14716911|NCT00465231|Narcotics|narcotics|mesh-ancestor
14716912|NCT00465231|Analgesics|analgesics|mesh-ancestor
14716913|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14716914|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14716915|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
14716916|NCT00465244|Levetiracetam|levetiracetam|mesh-list
14716917|NCT00465244|Lorazepam|lorazepam|mesh-list
14716918|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
14716919|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
14716920|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
14716921|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
14716922|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716923|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716924|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14716925|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14716926|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14716927|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14716928|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14890674|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890675|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14890676|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14716929|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14890677|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14890678|NCT01248923|Dexamethasone|dexamethasone|mesh-list
14890679|NCT01248923|Bortezomib|bortezomib|mesh-list
14890680|NCT01248923|Filanesib|filanesib|mesh-list
14890681|NCT01248923|Lenograstim|lenograstim|mesh-list
14890682|NCT01248923|Sargramostim|sargramostim|mesh-list
14890683|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14890684|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890685|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
14890686|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
14890687|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890688|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890689|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890690|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
14890691|NCT01248923|Hormones|hormones|mesh-ancestor
14890692|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890693|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14890694|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890695|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14890696|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
14890697|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
14890698|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890699|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890700|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
14890701|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
14890702|NCT01249001|Aprepitant|aprepitant|mesh-list
14890703|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
14890704|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
14890705|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
14890706|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890707|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890708|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890709|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14890710|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890711|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890712|NCT01249339|Lobeline|lobeline|mesh-list
14890713|NCT01249339|Nicotine|nicotine|mesh-list
14890714|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14890715|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
14890716|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890717|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890718|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14890719|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14890720|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
14890721|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890722|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890723|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
14890724|NCT01249352|Fluorouracil|fluorouracil|mesh-list
14890725|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
14890726|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890727|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
14890728|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890729|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890730|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890731|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
14890732|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890733|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14890734|NCT01249430|Cytarabine|cytarabine|mesh-list
14890735|NCT01249430|Etoposide|etoposide|mesh-list
14890736|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
14890737|NCT01249430|Azacitidine|azacitidine|mesh-list
14890738|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
14890739|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14296710|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
14890740|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890741|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14890742|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14890743|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890744|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890745|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890746|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
14890747|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
14890748|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890749|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890750|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
14890751|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890752|NCT01249430|Analgesics|analgesics|mesh-ancestor
14890753|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
14890754|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890755|NCT01249443|Paclitaxel|paclitaxel|mesh-list
14890756|NCT01249443|Carboplatin|carboplatin|mesh-list
14890757|NCT01249443|Vorinostat|vorinostat|mesh-list
14890758|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14890759|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890760|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
14890761|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
14890762|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
14890763|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890764|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14890765|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890766|NCT01249521|Bevacizumab|bevacizumab|mesh-list
14890767|NCT01249521|Trebananib|trebananib|mesh-list
14890768|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14890769|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890770|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890771|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890772|NCT01249521|Growth Substances|growth substances|mesh-ancestor
14890773|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890774|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890775|NCT01249547|Axitinib|axitinib|mesh-list
14890776|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890777|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14890778|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890779|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890780|NCT01249638|Bevacizumab|bevacizumab|mesh-list
14890781|NCT01249638|Capecitabine|capecitabine|mesh-list
14890782|NCT01249638|Irinotecan|irinotecan|mesh-list
14890783|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14890784|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890785|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890786|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890787|NCT01249638|Growth Substances|growth substances|mesh-ancestor
14890788|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890789|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890790|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14890791|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
14296711|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14890792|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890793|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14890794|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14890795|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890796|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
14890797|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14890798|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890799|NCT01249690|Thalidomide|thalidomide|mesh-list
14890800|NCT01249690|Dexamethasone|dexamethasone|mesh-list
14890801|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
14890802|NCT01249690|Bortezomib|bortezomib|mesh-list
14890803|NCT01249690|Pirarubicin|pirarubicin|mesh-list
14890804|NCT01249690|Doxorubicin|doxorubicin|mesh-list
14890805|NCT01249690|BB 1101|bb 1101|mesh-list
14890806|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890807|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
14890808|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
14890809|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216334|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15216335|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15216336|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
15216337|NCT03593018|Gemcitabine|gemcitabine|mesh-list
15216338|NCT03593018|Azacitidine|azacitidine|mesh-list
15216339|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15216340|NCT03593018|Romidepsin|romidepsin|mesh-list
15216341|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216342|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
15216343|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216344|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216345|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
14716930|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
14716931|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
14716932|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716933|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716934|NCT00465257|Artesunate|artesunate|mesh-list
14716935|NCT00465257|Amodiaquine|amodiaquine|mesh-list
14716936|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
14716937|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14716938|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14716939|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14716940|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14716941|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
14716942|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
14716943|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14716944|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
14716945|NCT00465283|Donepezil|donepezil|mesh-list
14716946|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14890810|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890811|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14890812|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
14890813|NCT01249690|Hormones|hormones|mesh-ancestor
14890814|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890815|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14890816|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890817|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
14890818|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890819|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890820|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890821|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
14890822|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
14890823|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14890824|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890825|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890826|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890827|NCT01249690|Growth Substances|growth substances|mesh-ancestor
14890828|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890829|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14890830|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14890831|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14890832|NCT01249820|Anidulafungin|anidulafungin|mesh-list
14890833|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
14890834|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890835|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
14890836|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14890837|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14890838|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890839|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
14890840|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
14890841|NCT01249937|Triamcinolone|triamcinolone|mesh-list
14890842|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14890843|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14890844|NCT01249937|Ranibizumab|ranibizumab|mesh-list
14890845|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14890846|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14890847|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14890848|NCT01249937|Growth Substances|growth substances|mesh-ancestor
14890849|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890850|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
14890851|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14890852|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890853|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
14890854|NCT01249937|Hormones|hormones|mesh-ancestor
14890855|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890856|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14890857|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
14890858|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890859|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890860|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14890861|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14890862|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14890863|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14890864|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14890865|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
14890866|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890867|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890868|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890869|NCT01250249|Vaccines|vaccines|mesh-list
14890870|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
14890871|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
14890872|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890873|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14915586|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915587|NCT01388075|Rifampin|rifampin|mesh-list
15216346|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216347|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216348|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216349|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
15216350|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216351|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15216352|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
15216353|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15216354|NCT03563742|Tenofovir|tenofovir|mesh-list
15216355|NCT03563742|Lamivudine|lamivudine|mesh-list
15216356|NCT03563742|Rilpivirine|rilpivirine|mesh-list
15216357|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
15216358|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216359|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15216360|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15216361|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216362|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216363|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15216364|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15216365|NCT03548428|Atezolizumab|atezolizumab|mesh-list
15216366|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216367|NCT03517969|Carboplatin|carboplatin|mesh-list
15216368|NCT03517969|Docetaxel|docetaxel|mesh-list
15216369|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216370|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
15216371|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
15216372|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
15216373|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225327|NCT05103631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225328|NCT05103631|Immunologic Factors|immunologic factors|mesh-ancestor
15225329|NCT05103631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225330|NCT05103631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890874|NCT01250340|Aspirin|aspirin|mesh-list
14890875|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15225331|NCT05103631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225332|NCT05103631|Alkylating Agents|alkylating agents|mesh-ancestor
15225333|NCT05103631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890876|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14890877|NCT01250340|Analgesics|analgesics|mesh-ancestor
14890878|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
14890879|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225334|NCT05103631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225335|NCT05103631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15225336|NCT05103631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15225337|NCT05103631|Antimetabolites|antimetabolites|mesh-ancestor
15225338|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
14716947|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716948|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225339|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
15225340|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15225341|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
15225342|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15225343|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15225344|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225345|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15225346|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225347|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225348|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15225349|NCT05085340|Renal Agents|renal agents|mesh-ancestor
15225350|NCT05078671|Cobicistat|cobicistat|mesh-list
14716949|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
14890880|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890881|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14716950|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716951|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716952|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
14716953|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
14716954|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14716955|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728944|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728945|NCT00520806|Methocarbamol|methocarbamol|mesh-list
14890882|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14890883|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15225351|NCT05078671|Olaparib|olaparib|mesh-list
15225352|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14890884|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14890885|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890886|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14890887|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14890888|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890889|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
14890890|NCT01250366|Ribavirin|ribavirin|mesh-list
14890891|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
14890892|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890893|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
14890894|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890895|NCT01250405|Cinacalcet|cinacalcet|mesh-list
14890896|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14890897|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890898|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14890899|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
14890900|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14890901|NCT01250457|Timolol|timolol|mesh-list
14890902|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14890903|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14890904|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
14890905|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890906|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890907|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890908|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14890909|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14890910|NCT01250470|Sargramostim|sargramostim|mesh-list
14890911|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
14890912|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890913|NCT01250496|Aminophylline|aminophylline|mesh-list
14890914|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14890915|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
14890916|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890917|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890918|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14890919|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
14890920|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14890921|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14890922|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890923|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890924|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14890925|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14890926|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
14890927|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890928|NCT01250496|Protective Agents|protective agents|mesh-ancestor
14890929|NCT01250535|Warfarin|warfarin|mesh-list
14890930|NCT01250535|Lovastatin|lovastatin|mesh-list
14890931|NCT01250535|L 647318|l 647318|mesh-list
14890932|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
14890933|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
14890934|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14890935|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14890936|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
14890937|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890938|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14890939|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14890940|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890941|NCT01250548|Apremilast|apremilast|mesh-list
15216374|NCT03493425|Cisplatin|cisplatin|mesh-list
15216375|NCT03493425|Carboplatin|carboplatin|mesh-list
15216376|NCT03493425|Docetaxel|docetaxel|mesh-list
15216377|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216378|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
15216379|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
15216380|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
15216381|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216382|NCT03477396|Estrogens|estrogens|mesh-list
15216383|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15216384|NCT03477396|Hormones|hormones|mesh-ancestor
15216385|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216386|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216387|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15216388|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216389|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890942|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14890943|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14890944|NCT01250548|Analgesics|analgesics|mesh-ancestor
14890945|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
14890946|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890947|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890948|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890949|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14716956|NCT00465439|Lidocaine|lidocaine|mesh-list
14716957|NCT00465439|Epinephrine|epinephrine|mesh-list
14716958|NCT00465439|Racepinephrine|racepinephrine|mesh-list
14890950|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14890951|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14890952|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14890953|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890954|NCT01250561|Valacyclovir|valacyclovir|mesh-list
14890955|NCT01250561|Gabapentin|gabapentin|mesh-list
14890956|NCT01250561|Analgesics|analgesics|mesh-ancestor
14890957|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
14890958|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890959|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890960|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
14890961|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14890962|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14890963|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14890964|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14890965|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14890966|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14890967|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216390|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15216391|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
14716959|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
14716960|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
14716961|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
14716962|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14716963|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716964|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
14716965|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716966|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14716967|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14716968|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14716969|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15216392|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
15216393|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15216394|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
15216395|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15216396|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
15216397|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14716970|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716971|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14716972|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15216398|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216399|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
15216400|NCT03420521|Nivolumab|nivolumab|mesh-list
15216401|NCT03420521|Ipilimumab|ipilimumab|mesh-list
15216402|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15216403|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216404|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15216405|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216406|NCT03386214|Pevonedistat|pevonedistat|mesh-list
15216407|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216408|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216409|NCT03373188|Nivolumab|nivolumab|mesh-list
15216410|NCT03373188|Ipilimumab|ipilimumab|mesh-list
15216411|NCT03373188|Antibodies|antibodies|mesh-list
15216412|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15216413|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
15216414|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216415|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14890968|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890969|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
14890970|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
14890971|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14890972|NCT01250652|Cetirizine|cetirizine|mesh-list
14890973|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
14890974|NCT01250652|Levocetirizine|levocetirizine|mesh-list
14890975|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14890976|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14890977|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
14890978|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
14890979|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14890980|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890981|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890982|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14890983|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
14890984|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
14890985|NCT01250743|Vitamins|vitamins|mesh-list
14890986|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
14890987|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
14890988|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14890989|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
14890990|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14890991|NCT01250743|Protective Agents|protective agents|mesh-ancestor
14890992|NCT01250808|Dexamethasone|dexamethasone|mesh-list
14890993|NCT01250808|Bortezomib|bortezomib|mesh-list
14890994|NCT01250808|Melphalan|melphalan|mesh-list
14890995|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14890996|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
14890997|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
14890998|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14890999|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891000|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891001|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
14891002|NCT01250808|Hormones|hormones|mesh-ancestor
14891003|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891004|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14891005|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891006|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14891007|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
14891008|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891009|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14891010|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891011|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
14891012|NCT01250821|Menotropins|menotropins|mesh-list
14891013|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14891014|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
14891015|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14891016|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891017|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14891018|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
14891019|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14891020|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14891021|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14891022|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891023|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891024|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14891025|NCT01250951|Deferasirox|deferasirox|mesh-list
14891026|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14891027|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
14891028|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
14891029|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891030|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
14891031|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14891032|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
14891033|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891034|NCT01251029|Expectorants|expectorants|mesh-ancestor
14891035|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891036|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14891037|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
14891038|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891039|NCT01251029|Protective Agents|protective agents|mesh-ancestor
14891040|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891041|NCT01251029|Antidotes|antidotes|mesh-ancestor
14891042|NCT01251107|Prednisone|prednisone|mesh-list
14891043|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
14891044|NCT01251107|Dacarbazine|dacarbazine|mesh-list
14891045|NCT01251107|Doxorubicin|doxorubicin|mesh-list
14891046|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14891047|NCT01251107|Etoposide|etoposide|mesh-list
14891048|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
14891049|NCT01251107|Vincristine|vincristine|mesh-list
14891050|NCT01251107|Bleomycin|bleomycin|mesh-list
14891051|NCT01251107|Vinblastine|vinblastine|mesh-list
14891052|NCT01251107|Procarbazine|procarbazine|mesh-list
14891053|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891054|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
14891055|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891056|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14891057|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14891058|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
14891059|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891060|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891061|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14891062|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14891063|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14891064|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14891065|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891066|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891067|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
14891068|NCT01251107|Hormones|hormones|mesh-ancestor
14891069|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891070|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14891071|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14891072|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891073|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891074|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891075|NCT01251133|Vaccines|vaccines|mesh-list
14891076|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
14891077|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891078|NCT01251172|Melphalan|melphalan|mesh-list
14891079|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
14891080|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14891081|NCT01251172|R04929097|r04929097|mesh-list
14891082|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14891083|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
14891084|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891085|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891086|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14891087|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891088|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
14891089|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891090|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891091|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
14891092|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14891093|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14891094|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14891095|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891096|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891097|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
14891098|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891099|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891100|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14891101|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891102|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14891103|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14891104|NCT01251263|Estradiol|estradiol|mesh-list
14891105|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14891106|NCT01251263|Estrogens|estrogens|mesh-ancestor
14891107|NCT01251263|Hormones|hormones|mesh-ancestor
14891108|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891109|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891110|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14891111|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
14891112|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14891113|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14891114|NCT01251328|Anesthetics|anesthetics|mesh-list
14891115|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891116|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891117|NCT01251458|Sirolimus|sirolimus|mesh-list
14891118|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14891119|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891120|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14891121|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891122|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
14891123|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891124|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
14891125|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891126|NCT01251471|Citalopram|citalopram|mesh-list
14891127|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14891128|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14891129|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891130|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891131|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891132|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
14891133|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891134|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14891135|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
14891136|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14891137|NCT01251484|Nintedanib|nintedanib|mesh-list
14891138|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891139|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14891140|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891141|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891142|NCT01251627|Decitabine|decitabine|mesh-list
14891143|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14891144|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
14891145|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891146|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891147|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891148|NCT01251640|Gemcitabine|gemcitabine|mesh-list
14891149|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14891150|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
14891151|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891152|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891153|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
14891154|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891155|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891156|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891157|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
14891158|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891159|NCT01251718|Donepezil|donepezil|mesh-list
14891160|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14891161|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891162|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891163|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
14891164|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891165|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891166|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
14891167|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14891168|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891169|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14891170|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891171|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891172|NCT01251809|Pegaspargase|pegaspargase|mesh-list
14891173|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891174|NCT01251822|Prucalopride|prucalopride|mesh-list
14891175|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14891176|NCT01251822|Laxatives|laxatives|mesh-ancestor
14891177|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891178|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14891179|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14891180|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
14891181|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891182|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891183|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891184|NCT01251835|Rifampin|rifampin|mesh-list
14891185|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
14891186|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14891187|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
14891188|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14891189|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891190|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
14891191|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14891192|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891193|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891194|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14891195|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14891196|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14891197|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14891198|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14891199|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14891200|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14891201|NCT01251848|Ritonavir|ritonavir|mesh-list
14891202|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
14891203|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14891204|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14891205|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
14891206|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891207|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891208|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14891209|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14891210|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
14891211|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891212|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14891213|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14891214|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14891215|NCT01251874|Alovudine|alovudine|mesh-list
14891216|NCT01251874|Carboplatin|carboplatin|mesh-list
14891217|NCT01251874|Veliparib|veliparib|mesh-list
14891218|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891219|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14891220|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891221|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891222|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
14891223|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891224|NCT01251926|Bevacizumab|bevacizumab|mesh-list
14891225|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14891226|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891227|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891228|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891229|NCT01251926|Growth Substances|growth substances|mesh-ancestor
14891230|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891231|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891232|NCT01251991|Psyllium|psyllium|mesh-list
14891233|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
14891234|NCT01251991|Cathartics|cathartics|mesh-ancestor
14891235|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891236|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
14891237|NCT01252056|Cilostazol|cilostazol|mesh-list
14891238|NCT01252056|Probucol|probucol|mesh-list
14891239|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14891240|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
14891241|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891242|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891243|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14891244|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891245|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14891246|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14891247|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891248|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15216416|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216417|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15216418|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216419|NCT03369665|Cladribine|cladribine|mesh-list
15216420|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216421|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216422|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
14891249|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
14891250|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14891251|NCT01252056|Protective Agents|protective agents|mesh-ancestor
14891252|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14891253|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14891254|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891255|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15216423|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216424|NCT03303339|Cytarabine|cytarabine|mesh-list
15216425|NCT03303339|Decitabine|decitabine|mesh-list
15216426|NCT03303339|Onvansertib|onvansertib|mesh-list
15216427|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216428|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
15216429|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891256|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15216430|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216431|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
14891257|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
14891258|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14891259|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
14915588|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14915589|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
14915590|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14915591|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915592|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
14915593|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14915594|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915595|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915596|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14915597|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14915598|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14915599|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14915600|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14915601|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14915602|NCT01388088|Amiloride|amiloride|mesh-list
14915603|NCT01388088|Spironolactone|spironolactone|mesh-list
14915604|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14915605|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
14915606|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915607|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296712|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14296713|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14915608|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14915609|NCT01388088|Diuretics|diuretics|mesh-ancestor
14915610|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
14915611|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14915612|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14915613|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14915614|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915615|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14915616|NCT01388101|Antibodies|antibodies|mesh-list
14915617|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
14915618|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216432|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216433|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216434|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
15216435|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216436|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216437|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15216438|NCT03220178|Letrozole|letrozole|mesh-list
15216439|NCT03220178|Fulvestrant|fulvestrant|mesh-list
15216440|NCT03220178|Palbociclib|palbociclib|mesh-list
15216441|NCT03220178|Anastrozole|anastrozole|mesh-list
15216442|NCT03220178|Exemestane|exemestane|mesh-list
15216443|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216444|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15216445|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15216446|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216447|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216448|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15216449|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
15225353|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891260|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
14891261|NCT01252069|Progestins|progestins|mesh-list
14891262|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14891263|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
14891264|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14891265|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891266|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14891267|NCT01252069|Hormones|hormones|mesh-ancestor
14891268|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891269|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14891270|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
14891271|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14891272|NCT01252160|Capsaicin|capsaicin|mesh-list
14891273|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
14891274|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
14891275|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
14891276|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891277|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891278|NCT01252225|Lidocaine|lidocaine|mesh-list
14891279|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
14891280|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
14891281|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891282|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891283|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
14891284|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891285|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14891286|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14891287|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14891288|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891289|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891290|NCT01252342|Oxytocin|oxytocin|mesh-list
14891291|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
14891292|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14891293|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891294|NCT01252420|Enoxaparin|enoxaparin|mesh-list
14891295|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
14891296|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14891297|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14891298|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891299|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
14891300|NCT01252524|Psyllium|psyllium|mesh-list
14891301|NCT01252524|Calcium|calcium|mesh-list
14891302|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14891303|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891304|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
14891305|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891306|NCT01252524|Cathartics|cathartics|mesh-ancestor
14891307|NCT01252680|Vaccines|vaccines|mesh-list
14891308|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
14891309|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891310|NCT01252719|Vancomycin|vancomycin|mesh-list
14891311|NCT01252719|Oritavancin|oritavancin|mesh-list
14891312|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14891313|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891314|NCT01252758|Albuterol|albuterol|mesh-list
14891315|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14891316|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
14891317|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296714|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891318|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891319|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14891320|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891321|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
14891322|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14891323|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14891324|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14891325|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14891326|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14891327|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891328|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891329|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14891330|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14891331|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891332|NCT01253382|Ecallantide|ecallantide|mesh-list
14891333|NCT01253382|Analgesics|analgesics|mesh-ancestor
14891334|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
14891335|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891336|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891337|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14891338|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14891339|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296715|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716973|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
14716974|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716975|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14716976|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14296716|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
14716977|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
14891340|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14891341|NCT01253473|Budesonide|budesonide|mesh-list
14891342|NCT01253473|Albuterol|albuterol|mesh-list
14891343|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
14891344|NCT01253473|Ipratropium|ipratropium|mesh-list
14891345|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891346|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14891347|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
14891348|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891349|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891350|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14891351|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891352|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
14891353|NCT01253473|Hormones|hormones|mesh-ancestor
14891354|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891355|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14891356|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14891357|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14891358|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14891359|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891360|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891361|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
14891362|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14891363|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14891364|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
14891365|NCT01253681|Paclitaxel|paclitaxel|mesh-list
14891366|NCT01253681|Carboplatin|carboplatin|mesh-list
14891367|NCT01253681|Trebananib|trebananib|mesh-list
14891368|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14891369|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891370|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891371|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891372|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891373|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891374|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14716978|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14716979|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
14716980|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
14716981|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
14891375|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891376|NCT01253681|Growth Substances|growth substances|mesh-ancestor
14716982|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14891377|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891378|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891379|NCT01253694|Ranibizumab|ranibizumab|mesh-list
14891380|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891381|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891382|NCT01253694|Growth Substances|growth substances|mesh-ancestor
14891383|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891384|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891385|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891386|NCT01253928|Pioglitazone|pioglitazone|mesh-list
14891387|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14891388|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915619|NCT01388114|Antibodies|antibodies|mesh-list
14915620|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
14915621|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915622|NCT01388153|Acarbose|acarbose|mesh-list
14915623|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14915624|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915625|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915626|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14915627|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917450|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14917451|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14917452|NCT05217680|Growth Substances|growth substances|mesh-ancestor
14917453|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917454|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
14917455|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
14917456|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917457|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917458|NCT05186558|Gemcitabine|gemcitabine|mesh-list
14917459|NCT05186558|Rituximab|rituximab|mesh-list
14917460|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
14917461|NCT05186558|Lenalidomide|lenalidomide|mesh-list
14917462|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917463|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917464|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
14917465|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917466|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917467|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917468|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
14917469|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917470|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
14917471|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917472|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917473|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917474|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14917475|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14917476|NCT05186558|Growth Substances|growth substances|mesh-ancestor
14917477|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
14917478|NCT05092698|Vitamin D|vitamin d|mesh-list
14917479|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
14917480|NCT05092698|Vitamins|vitamins|mesh-ancestor
14917481|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
14917482|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917483|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14917484|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14917485|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
14917486|NCT05077254|Vaccines|vaccines|mesh-list
14917487|NCT05077254|Tacrolimus|tacrolimus|mesh-list
14917488|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
14917489|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216450|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216451|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216452|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15216453|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15216454|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15216455|NCT03122301|Bupivacaine|bupivacaine|mesh-list
15216456|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
15216457|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
15216458|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891389|NCT01254006|Thiamine|thiamine|mesh-list
14891390|NCT01254006|Vitamins|vitamins|mesh-ancestor
14891391|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
14891392|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891393|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
14891394|NCT01254071|Tamsulosin|tamsulosin|mesh-list
14891395|NCT01254071|Dutasteride|dutasteride|mesh-list
14891396|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14891397|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14891398|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14891399|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
14891400|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891401|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891402|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891403|NCT01254071|Urological Agents|urological agents|mesh-ancestor
14891404|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14891405|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14891406|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891407|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
14891408|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891409|NCT01254123|Exenatide|exenatide|mesh-list
14891410|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14891411|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891412|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14891413|NCT01254123|Incretins|incretins|mesh-ancestor
14891414|NCT01254123|Hormones|hormones|mesh-ancestor
14891415|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891416|NCT01254175|Vaccines|vaccines|mesh-list
14891417|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
14891418|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891419|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
14891420|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
14891421|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14891422|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14891423|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891424|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891425|NCT01254383|Urological Agents|urological agents|mesh-ancestor
14891426|NCT01254461|Pravastatin|pravastatin|mesh-list
14891427|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14891428|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14891429|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
14891430|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891431|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14891432|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14891433|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891434|NCT00701207|Nicotine|nicotine|mesh-list
14891435|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14891436|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
14891437|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891438|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891439|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14891440|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14891441|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
14891442|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891443|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891444|NCT01254513|Prednisone|prednisone|mesh-list
14891445|NCT01254513|Docetaxel|docetaxel|mesh-list
14891446|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891447|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891448|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891449|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
14915628|NCT01388270|Heparin|heparin|mesh-list
15216459|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216460|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
15216461|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216462|NCT03085147|Olaparib|olaparib|mesh-list
15216463|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15216464|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216465|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216466|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216467|NCT03034356|Levetiracetam|levetiracetam|mesh-list
15216468|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
15216469|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
15216470|NCT03032510|Levofloxacin|levofloxacin|mesh-list
15216471|NCT03032510|Ofloxacin|ofloxacin|mesh-list
15216472|NCT03032510|Ertapenem|ertapenem|mesh-list
15216473|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15216474|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216475|NCT03032510|Renal Agents|renal agents|mesh-ancestor
15216476|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15216477|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15216478|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14891450|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891451|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891452|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
14891453|NCT01254513|Hormones|hormones|mesh-ancestor
14891454|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891455|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891456|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14296717|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296718|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296719|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14296720|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891457|NCT01254526|Paclitaxel|paclitaxel|mesh-list
14891458|NCT01254526|Bevacizumab|bevacizumab|mesh-list
14891459|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14891460|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891461|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891462|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891463|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891464|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891465|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14891466|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891467|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891468|NCT01254526|Growth Substances|growth substances|mesh-ancestor
14891469|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891470|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891471|NCT01254578|Lenalidomide|lenalidomide|mesh-list
14891472|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
14891473|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891474|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891475|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891476|NCT01254578|Growth Substances|growth substances|mesh-ancestor
14891477|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891478|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891479|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14891480|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14891481|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891482|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14891483|NCT01254617|Cetuximab|cetuximab|mesh-list
14891484|NCT01254617|Lenalidomide|lenalidomide|mesh-list
14891485|NCT01254617|Antibodies|antibodies|mesh-list
14891486|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
14891487|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14891488|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
14891489|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891490|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891491|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891492|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891493|NCT01254617|Growth Substances|growth substances|mesh-ancestor
14891494|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891495|NCT00660673|Levodopa|levodopa|mesh-list
14891496|NCT00660673|Carbidopa|carbidopa|mesh-list
14891497|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14891498|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14891499|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14891500|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
14891501|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891502|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216479|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891503|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915629|NCT01388270|Calcium heparin|calcium heparin|mesh-list
15216480|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891504|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14891505|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891506|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14891507|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
14891508|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
14891509|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14891510|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
14891511|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891512|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14891513|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14891514|NCT01254799|Doxycycline|doxycycline|mesh-list
14891515|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14891516|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891517|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
14891518|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14891519|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14891520|NCT01254825|Ropivacaine|ropivacaine|mesh-list
14891521|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
14891522|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
14891523|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891524|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891525|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
14891526|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891527|NCT00660218|Paclitaxel|paclitaxel|mesh-list
14891528|NCT00660218|Cetuximab|cetuximab|mesh-list
14891529|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14891530|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14891531|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891532|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891533|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891534|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891535|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891536|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296721|NCT05183984|Bevacizumab|bevacizumab|mesh-list
14716983|NCT00465452|Dopamine|dopamine|mesh-list
14716984|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
14716985|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14716986|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
14716987|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
14716988|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14716989|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14716990|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
14716991|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14716992|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14716993|NCT00465452|Protective Agents|protective agents|mesh-ancestor
14716994|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
14716995|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14716996|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14716997|NCT00465543|Analgesics|analgesics|mesh-ancestor
14716998|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
14716999|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891537|NCT01254929|Frovatriptan|frovatriptan|mesh-list
14891538|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14891539|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
14717000|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717001|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717002|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14717003|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
14717004|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717005|NCT00465543|Protective Agents|protective agents|mesh-ancestor
14717006|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14717007|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14717008|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
14717009|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717010|NCT00465608|Propranolol|propranolol|mesh-list
14717011|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14717012|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14717013|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
14717014|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717015|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717016|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717017|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14717018|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14717019|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
14296722|NCT05183984|Niraparib|niraparib|mesh-list
14296723|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14891540|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891541|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891542|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891543|NCT01254994|Entecavir|entecavir|mesh-list
14891544|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
14891545|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891546|NCT01255046|Donepezil|donepezil|mesh-list
14891547|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14891548|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891549|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891550|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
14891551|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891552|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891553|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
14891554|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
14891555|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14891556|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
14891557|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891558|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891559|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14891560|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891561|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14891562|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
14891563|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891564|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891565|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14891566|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
14891567|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
14891568|NCT01255215|Protective Agents|protective agents|mesh-ancestor
14891569|NCT01255358|Dexamethasone|dexamethasone|mesh-list
14891570|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
14891571|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14891572|NCT01255358|BB 1101|bb 1101|mesh-list
14891573|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891574|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
14891575|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
14891576|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717020|NCT00465621|Latanoprost|latanoprost|mesh-list
14891577|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891578|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891579|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
14717021|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14891580|NCT01255358|Hormones|hormones|mesh-ancestor
14891581|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891582|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14891583|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891584|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
14891585|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891586|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891587|NCT01255371|Lopinavir|lopinavir|mesh-list
14891588|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14891589|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14891590|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14891591|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
14891592|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891593|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891594|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14891595|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14891596|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
14891597|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891598|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14891599|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14891600|NCT01255410|Vaccines|vaccines|mesh-list
14891601|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
14891602|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891603|NCT01255475|Amlodipine|amlodipine|mesh-list
14891604|NCT01255475|Hydralazine|hydralazine|mesh-list
14891605|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14891606|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14891607|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891608|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891609|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14891610|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891611|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
14891612|NCT01255527|Bortezomib|bortezomib|mesh-list
14891613|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891614|NCT01255579|Fluticasone|fluticasone|mesh-list
14891615|NCT01255579|Beclomethasone|beclomethasone|mesh-list
14891616|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
14891617|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14891618|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14891619|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891620|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14891621|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
14891622|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891623|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891624|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14891625|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891626|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
14891627|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14891628|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14891629|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14891630|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14891631|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
14891632|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891633|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891634|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
14891635|NCT01255579|Hormones|hormones|mesh-ancestor
14891636|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717022|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14717023|NCT00465673|Doxorubicin|doxorubicin|mesh-list
14717024|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14717025|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14717026|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717027|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14717028|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14717029|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891637|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
14891638|NCT01255644|Valganciclovir|valganciclovir|mesh-list
14891639|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
14891640|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891641|NCT01255774|Ranibizumab|ranibizumab|mesh-list
14891642|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891643|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891644|NCT01255774|Growth Substances|growth substances|mesh-ancestor
14717030|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891645|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891646|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891647|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891648|NCT01255800|Cetuximab|cetuximab|mesh-list
14891649|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14891650|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915630|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
14915631|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14915632|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14915633|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915634|NCT01388322|Enoxaparin|enoxaparin|mesh-list
14915635|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
14915636|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14915637|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14915638|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915639|NCT01388387|Tacrolimus|tacrolimus|mesh-list
14915640|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915641|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
14915642|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915643|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14915644|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915645|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915646|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14915647|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915648|NCT01388439|Oseltamivir|oseltamivir|mesh-list
14915649|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
14915650|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915651|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915652|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915653|NCT01388517|Vitamin D|vitamin d|mesh-list
14915654|NCT01388517|Calcitriol|calcitriol|mesh-list
14915655|NCT01388517|Petrolatum|petrolatum|mesh-list
14915656|NCT01388517|Tacrolimus|tacrolimus|mesh-list
14915657|NCT01388517|Vitamins|vitamins|mesh-ancestor
14915658|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
14915659|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915660|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14915661|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915662|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
14915663|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14915664|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915665|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915666|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14915667|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14915668|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14915669|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14915670|NCT01388517|Emollients|emollients|mesh-ancestor
14915671|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
14915672|NCT01388582|Copper|copper|mesh-list
14915673|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
14915674|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
14915675|NCT01388582|Etonogestrel|etonogestrel|mesh-list
14915676|NCT01388582|Desogestrel|desogestrel|mesh-list
14915677|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
14915678|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14915679|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915680|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14915681|NCT01388582|Trace Elements|trace elements|mesh-ancestor
14915682|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
14915683|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14717031|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14717032|NCT00465751|Cathartics|cathartics|mesh-ancestor
14717033|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14717034|NCT00465907|Paclitaxel|paclitaxel|mesh-list
14717035|NCT00465907|Carboplatin|carboplatin|mesh-list
14717036|NCT00465907|Irinotecan|irinotecan|mesh-list
14717037|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14717038|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717039|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14717040|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14717041|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14915684|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14915685|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14915686|NCT01388582|Progestins|progestins|mesh-ancestor
14915687|NCT01388582|Hormones|hormones|mesh-ancestor
14717042|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891651|NCT01255852|Atorvastatin|atorvastatin|mesh-list
14891652|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14891653|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14891654|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
14891655|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891656|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14891657|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14891658|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891659|NCT01255878|Gabapentin|gabapentin|mesh-list
14891660|NCT01255878|Analgesics|analgesics|mesh-ancestor
14891661|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
14891662|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891663|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891664|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
14891665|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14891666|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14891667|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891668|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14891669|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14891670|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14717043|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14717044|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14717045|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717046|NCT00466063|Deferasirox|deferasirox|mesh-list
14717047|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14717048|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
14717049|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
14717050|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717051|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
15216481|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216482|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15216483|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15216484|NCT03029000|Lenograstim|lenograstim|mesh-list
15216485|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15216486|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
15216487|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891671|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891672|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891673|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
14891674|NCT01255891|Androgens|androgens|mesh-list
14891675|NCT01255891|Hormones|hormones|mesh-ancestor
14891676|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891677|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717052|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
14717053|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14891678|NCT01255956|Sirolimus|sirolimus|mesh-list
14891679|NCT01255956|Paclitaxel|paclitaxel|mesh-list
14891680|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14891681|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891682|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891683|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891684|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891685|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891686|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14891687|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891688|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14891689|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
14891690|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891691|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
14891692|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891693|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
14891694|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14891695|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14891696|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14891697|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891698|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891699|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
15216488|NCT03022292|Aflibercept|aflibercept|mesh-list
14891700|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891701|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891702|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14891703|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891704|NCT01256151|Alprazolam|alprazolam|mesh-list
14891705|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14891706|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891707|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891708|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14891709|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14891710|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14891711|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
14891712|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
14891713|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891714|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891715|NCT01256268|Paclitaxel|paclitaxel|mesh-list
14891716|NCT01256268|Carboplatin|carboplatin|mesh-list
14891717|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14891718|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891719|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891720|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891721|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891722|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891723|NCT01256359|Docetaxel|docetaxel|mesh-list
14891724|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891725|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891726|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891727|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891728|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891729|NCT01256489|Infliximab|infliximab|mesh-list
14891730|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
14891731|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891732|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14891733|NCT01256541|Lactulose|lactulose|mesh-list
14891734|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891735|NCT01256580|Dexamethasone|dexamethasone|mesh-list
14891736|NCT01256580|Bevacizumab|bevacizumab|mesh-list
14891737|NCT01256580|Verteporfin|verteporfin|mesh-list
14891738|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14891739|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891740|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891741|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891742|NCT01256580|Growth Substances|growth substances|mesh-ancestor
14891743|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891744|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891745|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891746|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
14891747|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
14891748|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891749|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14891750|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
14891751|NCT01256580|Hormones|hormones|mesh-ancestor
14891752|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891753|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14891754|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14891755|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
14891756|NCT01256619|Desogestrel|desogestrel|mesh-list
14891757|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14891758|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14891759|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14891760|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
14891761|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14891762|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891763|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14891764|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14891765|NCT01256619|Progestins|progestins|mesh-ancestor
14891766|NCT01256619|Hormones|hormones|mesh-ancestor
14891767|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891768|NCT01256632|Ranibizumab|ranibizumab|mesh-list
14891769|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14891770|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14891771|NCT01256632|Growth Substances|growth substances|mesh-ancestor
14891772|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891773|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
14891774|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891775|NCT01256775|Aspirin|aspirin|mesh-list
14891776|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
14891777|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14891778|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14891779|NCT01256775|Analgesics|analgesics|mesh-ancestor
14891780|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
14891781|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891782|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891783|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891784|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14891785|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14891786|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14891787|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891788|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14891789|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14891790|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
14891791|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891792|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14891793|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
14891794|NCT01256801|Interleukin-2|interleukin-2|mesh-list
14891795|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891796|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14891797|NCT01256801|Analgesics|analgesics|mesh-ancestor
14891798|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
14891799|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891800|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891801|NCT01256866|Midazolam|midazolam|mesh-list
14891802|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
14891803|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14891804|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891805|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891806|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14891807|NCT01256866|Analgesics|analgesics|mesh-ancestor
14891808|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
14891809|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891810|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14891811|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14891812|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14891813|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
14891814|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891815|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296724|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296725|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14296726|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14296727|NCT05183984|Growth Substances|growth substances|mesh-ancestor
14891816|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14891817|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14296728|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296729|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
14296730|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14296731|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891818|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14891819|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14891820|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14891821|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
14891822|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
14891823|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
14891824|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
14891825|NCT01256905|Modafinil|modafinil|mesh-list
14891826|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14891827|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891828|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14891829|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14891830|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14891831|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891832|NCT01257009|Atorvastatin|atorvastatin|mesh-list
14891833|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14891834|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14891835|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
14891836|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891837|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14891838|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14891839|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891840|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14891841|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14891842|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891843|NCT01257048|Budesonide|budesonide|mesh-list
14891844|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
14891845|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891846|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14891847|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
14891848|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891849|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891850|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14891851|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891852|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
14891853|NCT01257048|Hormones|hormones|mesh-ancestor
14891854|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891855|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14891856|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14891857|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14891858|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14891859|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891860|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891861|NCT01257074|Acyclovir|acyclovir|mesh-list
14891862|NCT01257074|Penciclovir|penciclovir|mesh-list
14891863|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
14891864|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891865|NCT01257126|Diclofenac|diclofenac|mesh-list
14891866|NCT01257126|Nimesulide|nimesulide|mesh-list
14891867|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14891868|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14891869|NCT01257126|Analgesics|analgesics|mesh-ancestor
14891870|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
14891871|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891872|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216489|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15216490|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15216491|NCT03022292|Growth Substances|growth substances|mesh-ancestor
14891873|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891874|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14891875|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14891876|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891877|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891878|NCT01257139|Docetaxel|docetaxel|mesh-list
15216492|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717054|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
14717055|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717056|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717057|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14717058|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14717059|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717060|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14717061|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717062|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717063|NCT00466102|Everolimus|everolimus|mesh-list
14891879|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891880|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
14891881|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14891882|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14891883|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891884|NCT01257165|Ethanol|ethanol|mesh-list
14891885|NCT01257165|Zopiclone|zopiclone|mesh-list
14891886|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14891887|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891888|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14891889|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891890|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14891891|NCT01257243|Potassium iodate|potassium iodate|mesh-list
14891892|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
14891893|NCT01257243|Guaifenesin|guaifenesin|mesh-list
14891894|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14891895|NCT01257243|Expectorants|expectorants|mesh-ancestor
14891896|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
14891897|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14891898|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14891899|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14891900|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891901|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891902|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891903|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
14891904|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14891905|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
14891906|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
14891907|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891908|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
14891909|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14891910|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
14891911|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14891912|NCT01257334|Empagliflozin|empagliflozin|mesh-list
14891913|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14891914|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891915|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14891916|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891917|NCT01257360|Panitumumab|panitumumab|mesh-list
14891918|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14891919|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891920|NCT01257373|Cobalt|cobalt|mesh-list
14891921|NCT01257373|Chromium|chromium|mesh-list
14891922|NCT01257373|Sirolimus|sirolimus|mesh-list
14891923|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14891924|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717064|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717065|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891925|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14891926|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14891927|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
14891928|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14891929|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
14891930|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891931|NCT01257373|Trace Elements|trace elements|mesh-ancestor
14891932|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
14891933|NCT01257386|Mesalamine|mesalamine|mesh-list
14891934|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14891935|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14891936|NCT01257386|Analgesics|analgesics|mesh-ancestor
14891937|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
14891938|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891939|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891940|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891941|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14891942|NCT01257399|Mesalamine|mesalamine|mesh-list
14891943|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14891944|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14891945|NCT01257399|Analgesics|analgesics|mesh-ancestor
14891946|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
14891947|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891948|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891949|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14891950|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14891951|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
14891952|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14891953|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891954|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14891955|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891956|NCT01257451|Vildagliptin|vildagliptin|mesh-list
14891957|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14891958|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891959|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14891960|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
14891961|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891962|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891963|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14891964|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14891965|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14891966|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891967|NCT01257464|Incretins|incretins|mesh-ancestor
14891968|NCT01257464|Hormones|hormones|mesh-ancestor
14891969|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14891970|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
14891971|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891972|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891973|NCT01257490|Bupropion|bupropion|mesh-list
14891974|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14891975|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
14891976|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14891977|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15216493|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
15216494|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216495|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
15216496|NCT03012100|Vaccines|vaccines|mesh-list
15216497|NCT03012100|Sargramostim|sargramostim|mesh-list
15216498|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
15216499|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216500|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216501|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15216502|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15216503|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
15216504|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216505|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216506|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14717066|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
14717067|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891978|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14891979|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891980|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891981|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
14891982|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14891983|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891984|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14891985|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14891986|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14891987|NCT01257516|Pregabalin|pregabalin|mesh-list
14891988|NCT01257516|Analgesics|analgesics|mesh-ancestor
14891989|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
14891990|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14891991|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14891992|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
14891993|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14891994|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14891995|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14891996|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14891997|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14891998|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14891999|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892000|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14892001|NCT01257529|Pregabalin|pregabalin|mesh-list
14892002|NCT01257529|Analgesics|analgesics|mesh-ancestor
14892003|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
14892004|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892005|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892006|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
15216507|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
15216508|NCT02973997|Lenvatinib|lenvatinib|mesh-list
15216509|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15216510|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216511|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15216512|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216513|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216514|NCT02968602|Minocycline|minocycline|mesh-list
15216515|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14296732|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296733|NCT05175768|Niacinamide|niacinamide|mesh-list
14296734|NCT05175768|Niacin|niacin|mesh-list
14296735|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
14296736|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
14296737|NCT05175768|Vitamins|vitamins|mesh-ancestor
14296738|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
14296739|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296740|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14296741|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
14296742|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296743|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14717068|NCT00466128|Indomethacin|indomethacin|mesh-list
14717069|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14717070|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14717071|NCT00466128|Analgesics|analgesics|mesh-ancestor
14717072|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
14296744|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
14892007|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14892008|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892009|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892010|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14892011|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14892012|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14892013|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892014|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14892015|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14892016|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892017|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14892018|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892019|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915688|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915689|NCT01388595|Fluticasone|fluticasone|mesh-list
14915690|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14915691|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14915692|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14915693|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
14915694|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915695|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915696|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14915697|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
14915698|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
14915699|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14915700|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14915701|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14915702|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14915703|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
14915704|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915705|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915706|NCT01388621|Gemcitabine|gemcitabine|mesh-list
14915707|NCT01388621|Carboplatin|carboplatin|mesh-list
14915708|NCT01388621|Doxorubicin|doxorubicin|mesh-list
14915709|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14915710|NCT01388621|Panitumumab|panitumumab|mesh-list
14915711|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915712|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915713|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
14915714|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915715|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
14915716|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915717|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915718|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915719|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
14915720|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915721|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14915722|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14915723|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14915724|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915725|NCT01388660|Clopidogrel|clopidogrel|mesh-list
14915726|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14915727|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14915728|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14915729|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14915730|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
14915731|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915732|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915733|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915734|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
14915735|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14915736|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
14915737|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15216516|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216517|NCT02946047|Ixazomib|ixazomib|mesh-list
15216518|NCT02946047|Glycine|glycine|mesh-list
15216519|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216520|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
15216521|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216522|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216523|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
15216524|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216525|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892020|NCT01257672|Ondansetron|ondansetron|mesh-list
14892021|NCT01257672|Domperidone|domperidone|mesh-list
14892022|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
14892023|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
14892024|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892025|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892026|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14892027|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
14892028|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892029|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14892030|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
14892031|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892032|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892033|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14892034|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14892035|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892036|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14892037|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14892038|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14892039|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
14892040|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
14892041|NCT00077285|Ifosfamide|ifosfamide|mesh-list
14892042|NCT00077285|Carboplatin|carboplatin|mesh-list
14892043|NCT00077285|Doxorubicin|doxorubicin|mesh-list
14892044|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14892045|NCT00077285|Irinotecan|irinotecan|mesh-list
14892046|NCT00077285|Etoposide|etoposide|mesh-list
14892047|NCT00077285|Vincristine|vincristine|mesh-list
14892048|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
14892049|NCT00077285|Razoxane|razoxane|mesh-list
14892050|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14892051|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
14892052|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892053|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892054|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14892055|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
14892056|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892057|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892058|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14892059|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14892060|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14892061|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14892062|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892063|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14892064|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14892065|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
14892066|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14892067|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14892068|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14892069|NCT00077285|Protective Agents|protective agents|mesh-ancestor
14892070|NCT01257815|Ranibizumab|ranibizumab|mesh-list
14892071|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14892072|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14892073|NCT01257815|Growth Substances|growth substances|mesh-ancestor
14892074|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892075|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14892076|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892077|NCT01257828|Riluzole|riluzole|mesh-list
14892078|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
14892079|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14892080|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14892081|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892082|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892083|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892084|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14892085|NCT01257828|Protective Agents|protective agents|mesh-ancestor
14892086|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
14892087|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
14892088|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14892089|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892090|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892091|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
14892092|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14892093|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892094|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892095|NCT01257893|Aspirin|aspirin|mesh-list
14892096|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14892097|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14892098|NCT01257893|Analgesics|analgesics|mesh-ancestor
14892099|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
14892100|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892101|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892102|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892103|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892104|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14892105|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14892106|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892107|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14892108|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14892109|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892110|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
14892111|NCT01257906|Tretinoin|tretinoin|mesh-list
14892112|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892113|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
14892114|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892115|NCT01257919|Azelaic acid|azelaic acid|mesh-list
14892116|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892117|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892118|NCT01257958|Vitamin D|vitamin d|mesh-list
14892119|NCT01257958|Vitamins|vitamins|mesh-ancestor
14892120|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
14892121|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892122|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14892123|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
14892124|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14892125|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14892126|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892127|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
14892128|NCT01258010|Coagulants|coagulants|mesh-ancestor
14892129|NCT01258036|Hormones|hormones|mesh-list
14892130|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14892131|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892132|NCT01258192|Paclitaxel|paclitaxel|mesh-list
14892133|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14892134|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14892135|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892136|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
14892137|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
14892138|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
14892139|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892140|NCT01258296|Fentanyl|fentanyl|mesh-list
14296745|NCT05166616|Osimertinib|osimertinib|mesh-list
14892141|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14892142|NCT01258296|Narcotics|narcotics|mesh-ancestor
14892143|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892144|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892145|NCT01258296|Analgesics|analgesics|mesh-ancestor
14892146|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
14892147|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892148|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14892149|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14892150|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
14892151|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
14892152|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14892153|NCT01258309|Ketorolac|ketorolac|mesh-list
14892154|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14892155|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14892156|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14892157|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14892158|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14892159|NCT01258309|Analgesics|analgesics|mesh-ancestor
14892160|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
14892161|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892162|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892163|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892164|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892165|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14892166|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892167|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892168|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14892169|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14892170|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14892171|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
14892172|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
14892173|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892174|NCT01258322|Pioglitazone|pioglitazone|mesh-list
14892175|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14892176|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892177|NCT01258439|Ritonavir|ritonavir|mesh-list
14892178|NCT01258439|Darunavir|darunavir|mesh-list
14892179|NCT01258439|Tenofovir|tenofovir|mesh-list
14892180|NCT01258439|Emtricitabine|emtricitabine|mesh-list
14892181|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
14892182|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14892183|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14892184|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14892185|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
14892186|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892187|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892188|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14892189|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14892190|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
14892191|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892192|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14892193|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14892194|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14892195|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14892196|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14892197|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14892198|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
14892199|NCT01258491|Niacin|niacin|mesh-list
14892200|NCT01258491|Niacinamide|niacinamide|mesh-list
14892201|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
14892202|NCT01258491|Vitamins|vitamins|mesh-ancestor
14892203|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
15216526|NCT02860000|Fulvestrant|fulvestrant|mesh-list
15216527|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15216528|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216529|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15216530|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15216531|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
15216532|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216533|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216534|NCT02832648|Selenium|selenium|mesh-list
15216535|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
14892204|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892205|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14892206|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
14892207|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892208|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14892209|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
14892210|NCT01258530|Oseltamivir|oseltamivir|mesh-list
14892211|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
14892212|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892213|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892214|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892215|NCT01258569|Alvimopan|alvimopan|mesh-list
14892216|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14892217|NCT01258634|Leucovorin|leucovorin|mesh-list
14892218|NCT01258634|Doxorubicin|doxorubicin|mesh-list
14892219|NCT01258634|Etoposide|etoposide|mesh-list
14892220|NCT01258634|Ifosfamide|ifosfamide|mesh-list
14892221|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
14892222|NCT01258634|Razoxane|razoxane|mesh-list
14892223|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892224|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14892225|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14892226|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14892227|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892228|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892229|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14892230|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892231|NCT01258634|Antidotes|antidotes|mesh-ancestor
14892232|NCT01258634|Protective Agents|protective agents|mesh-ancestor
14892233|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
14892234|NCT01258634|Vitamins|vitamins|mesh-ancestor
14892235|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
14892236|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14892237|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
14892238|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14892239|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14892240|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14892241|NCT01258686|Silymarin|silymarin|mesh-list
14892242|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
14892243|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892244|NCT01258686|Protective Agents|protective agents|mesh-ancestor
14892245|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892246|NCT01258712|Methotrexate|methotrexate|mesh-list
14892247|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14892248|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
14892249|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14892250|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892251|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216536|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216537|NCT02832648|Protective Agents|protective agents|mesh-ancestor
15216538|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216539|NCT02832648|Trace Elements|trace elements|mesh-ancestor
15216540|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
15216541|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15216542|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216543|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216544|NCT02784704|Meropenem|meropenem|mesh-list
15216545|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14892252|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
14892253|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892254|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892255|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892256|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892257|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14892258|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14892259|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
14892260|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892261|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14892262|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14892263|NCT01258764|Lisinopril|lisinopril|mesh-list
14892264|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14892265|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14892266|NCT01258764|Diuretics|diuretics|mesh-ancestor
14892267|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
14892268|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892269|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14892270|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892271|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892272|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
14892273|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892274|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14892275|NCT01258764|Protective Agents|protective agents|mesh-ancestor
14892276|NCT01258777|Golimumab|golimumab|mesh-list
14892277|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14892278|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14892279|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892280|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14892281|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
14892282|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892283|NCT01258868|Celecoxib|celecoxib|mesh-list
14892284|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14892285|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14892286|NCT01258868|Analgesics|analgesics|mesh-ancestor
14892287|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
14892288|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892289|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892290|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892291|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892292|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14892293|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14892294|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892295|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892296|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14892297|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14892298|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14892299|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892300|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892301|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14892302|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14892303|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14892304|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
14892305|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892306|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892307|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14892308|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14892309|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
14892310|NCT01258933|Ofatumumab|ofatumumab|mesh-list
14892311|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892312|NCT01258959|Anesthetics|anesthetics|mesh-list
14892313|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
14892314|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892315|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892316|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
14892317|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892318|NCT01259050|Copper|copper|mesh-list
14892319|NCT01259050|Trace Elements|trace elements|mesh-ancestor
14892320|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
14892321|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892322|NCT01259141|Azithromycin|azithromycin|mesh-list
14892323|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
14892324|NCT01259141|Cephalosporins|cephalosporins|mesh-list
14892325|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14892326|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892327|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14892328|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14892329|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892330|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892331|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892332|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
14892333|NCT01259193|Sorafenib|sorafenib|mesh-list
14892334|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892335|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14892336|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892337|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892338|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14892339|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892340|NCT01259219|Rifabutin|rifabutin|mesh-list
14892341|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14892342|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892343|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14892344|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
14892345|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14892346|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
14892347|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892348|NCT01259336|Itraconazole|itraconazole|mesh-list
14892349|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
14892350|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892351|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14892352|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14892353|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892354|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892355|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14892356|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
14892357|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14892358|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892359|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14892360|NCT01259362|Cocaine|cocaine|mesh-list
14892361|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
14892362|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
14892363|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892364|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892365|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
14892366|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892367|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14892368|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14892369|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14892370|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892371|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892372|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
14296746|NCT05166616|Triptolide|triptolide|mesh-list
14296747|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296748|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296749|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717073|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717074|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717075|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717076|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14717077|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
14717078|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
14717079|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14717080|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14717081|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717082|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717083|NCT00466154|Aspirin|aspirin|mesh-list
14717084|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14717085|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14717086|NCT00466154|Analgesics|analgesics|mesh-ancestor
14717087|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
14717088|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717089|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717090|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717091|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14717092|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14327565|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14892373|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892374|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
14892375|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892376|NCT01259453|Vaccines|vaccines|mesh-list
14892377|NCT01259453|Immunologic Factors|immunologic factors|mesh-ancestor
14892378|NCT01259453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892379|NCT01259479|Satraplatin|satraplatin|mesh-list
14892380|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915738|NCT01388738|Protective Agents|protective agents|mesh-ancestor
14915739|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915740|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
14915741|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14915742|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
14915743|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915744|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915745|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14915746|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
14915747|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14915748|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
14915749|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915750|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915751|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14915752|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
14915753|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
14915754|NCT01388842|Protective Agents|protective agents|mesh-ancestor
14915755|NCT01388855|Vitamin D|vitamin d|mesh-list
14915756|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
14915757|NCT01388855|Vitamins|vitamins|mesh-ancestor
14915758|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
14915759|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915760|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14915761|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14915762|NCT01388959|Rituximab|rituximab|mesh-list
14915763|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915764|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915765|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
14915766|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915767|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14915768|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
14915769|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915770|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
14915771|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915772|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915773|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14915774|NCT01389063|Maraviroc|maraviroc|mesh-list
14915775|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14915776|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14915777|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915778|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14915779|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14915780|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
14915781|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915782|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14915783|NCT01389167|Naltrexone|naltrexone|mesh-list
14915784|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14915785|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14915786|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915787|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
14915788|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915789|NCT01389193|Ibudilast|ibudilast|mesh-list
14915790|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14915791|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
14915792|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915793|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915794|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14915795|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
14915796|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14915797|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915798|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915799|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14892381|NCT01259531|Silodosin|silodosin|mesh-list
14892382|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14892383|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14892384|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14892385|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
14892386|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892387|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892388|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892389|NCT01259531|Urological Agents|urological agents|mesh-ancestor
14892390|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
14892391|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14892392|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14892393|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14892394|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892395|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892396|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
14892397|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892398|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892399|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14892400|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892401|NCT01259817|Aspirin|aspirin|mesh-list
14892402|NCT01259817|Interferons|interferons|mesh-list
14892403|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
14892404|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
14892405|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14892406|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892407|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
14892408|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892409|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14892410|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14892411|NCT01259817|Analgesics|analgesics|mesh-ancestor
14892412|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
14892413|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892414|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892415|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892416|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892417|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14892418|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14892419|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892420|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14892421|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14892422|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892423|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
14892424|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
14892425|NCT01259830|Etoricoxib|etoricoxib|mesh-list
14892426|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14892427|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14892428|NCT01259830|Analgesics|analgesics|mesh-ancestor
14892429|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
14892430|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892431|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892432|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892433|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892434|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14892435|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14892436|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892437|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892438|NCT01259934|Interferons|interferons|mesh-list
14892439|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
14892440|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
14892441|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892442|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
14892443|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892444|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
14892445|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892446|NCT01259973|Haloperidol|haloperidol|mesh-list
14892447|NCT01259973|Risperidone|risperidone|mesh-list
14892448|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
14892449|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14892450|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
14892451|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892452|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892453|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892454|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14892455|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14892456|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892457|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14892458|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14892459|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
14892460|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
14892461|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
14892462|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892463|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14892464|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14892465|NCT01260012|Praziquantel|praziquantel|mesh-list
14892466|NCT01260012|Antioxidants|antioxidants|mesh-list
14892467|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717093|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14717094|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717095|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14717096|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14717097|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892468|NCT01260012|Protective Agents|protective agents|mesh-ancestor
14892469|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892470|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
14892471|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14892472|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892473|NCT01260025|Endostatins|endostatins|mesh-list
14892474|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892475|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14892476|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14892477|NCT01260025|Growth Substances|growth substances|mesh-ancestor
14892478|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892479|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
14892480|NCT01260103|Temozolomide|temozolomide|mesh-list
14892481|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14892482|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
14892483|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892484|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892485|NCT01260129|Silodosin|silodosin|mesh-list
14892486|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14892487|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14892488|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14892489|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
14892490|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892491|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892492|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892493|NCT01260129|Urological Agents|urological agents|mesh-ancestor
14892494|NCT01260233|Nicotine|nicotine|mesh-list
14892495|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14892496|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
14892497|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717098|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
14717099|NCT00466180|Nevirapine|nevirapine|mesh-list
14717100|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14717101|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14892498|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892499|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14892500|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14892501|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
14892502|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892503|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892504|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14892505|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14892506|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892507|NCT01260246|Incretins|incretins|mesh-ancestor
14892508|NCT01260246|Hormones|hormones|mesh-ancestor
14892509|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14892510|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14892511|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
14892512|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892513|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892514|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14892515|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
14892516|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14892517|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14892518|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892519|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892520|NCT01260285|Urological Agents|urological agents|mesh-ancestor
14892521|NCT01260376|Acipimox|acipimox|mesh-list
14892522|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14892523|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
14892524|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892525|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14892526|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
14892527|NCT01260415|Panitumumab|panitumumab|mesh-list
14892528|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892529|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14892530|NCT01260506|Bevacizumab|bevacizumab|mesh-list
14892531|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14892532|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892533|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14892534|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14892535|NCT01260506|Growth Substances|growth substances|mesh-ancestor
14892536|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892537|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
14892538|NCT01260519|Heparin|heparin|mesh-list
14892539|NCT01260519|Calcium heparin|calcium heparin|mesh-list
14892540|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
14892541|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14892542|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14892543|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892544|NCT01260558|Sirolimus|sirolimus|mesh-list
14892545|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14892546|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892547|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14892548|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892549|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
14892550|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14892551|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
14892552|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892553|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14892554|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892555|NCT01260610|Tenofovir|tenofovir|mesh-list
14892556|NCT01260610|Telbivudine|telbivudine|mesh-list
14892557|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
14892558|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892559|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14892560|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14892561|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892562|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892563|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14892564|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14892565|NCT01260623|Prednisone|prednisone|mesh-list
14892566|NCT01260623|Prednisolone|prednisolone|mesh-list
14892567|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216546|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216547|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15216548|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216549|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15216550|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216551|NCT05241275|Xenon|xenon|mesh-list
15216552|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15216553|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
15216554|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
15216555|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216556|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216557|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
14892568|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
14892569|NCT01260623|Hormones|hormones|mesh-ancestor
14892570|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14892571|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892572|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14892573|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892574|NCT01260675|Buprenorphine|buprenorphine|mesh-list
14892575|NCT01260675|Naloxone|naloxone|mesh-list
14892576|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15216558|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15216559|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
15216560|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216561|NCT05241262|Expectorants|expectorants|mesh-ancestor
15216562|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
15216563|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14892577|NCT01260675|Narcotics|narcotics|mesh-ancestor
14892578|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892579|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892580|NCT01260675|Analgesics|analgesics|mesh-ancestor
14892581|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
14892582|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892583|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14892584|NCT01260714|Etoposide|etoposide|mesh-list
14892585|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
14892586|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
14892587|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
14892588|NCT01260714|Azacitidine|azacitidine|mesh-list
14892589|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14892590|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892591|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14892592|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14892593|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892594|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892595|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14892596|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
14892597|NCT01260714|Analgesics|analgesics|mesh-ancestor
14892598|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
14892599|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892600|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892601|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
14892602|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892603|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
14892604|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
14892605|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
14892606|NCT01260727|Vaccines|vaccines|mesh-list
14892607|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
14892608|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892609|NCT01260753|Fluticasone|fluticasone|mesh-list
14892610|NCT01260753|Xhance|xhance|mesh-list
15216564|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
15216565|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717102|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717103|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717104|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
14717105|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717106|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14717107|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14717108|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14717109|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14717110|NCT00466219|Interferons|interferons|mesh-list
14717111|NCT00466219|Ribavirin|ribavirin|mesh-list
14717112|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
14717113|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
14892611|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892612|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14892613|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
14892614|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892615|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892616|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14892617|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
14892618|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892619|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14892620|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
14892621|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14892622|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14892623|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892624|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
14717114|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14717115|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717116|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
14717117|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717118|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
14717119|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717120|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
14717121|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717122|NCT00466232|Sorafenib|sorafenib|mesh-list
14717123|NCT00466232|Topotecan|topotecan|mesh-list
14717124|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717125|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14717126|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717127|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717128|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14717129|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14717130|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14717131|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
14717132|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717133|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14717134|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717135|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14717136|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717137|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717138|NCT00466388|Cevimeline|cevimeline|mesh-list
14717139|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14717140|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
14717141|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717142|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717143|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14717144|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14717145|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
14717146|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717147|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717148|NCT00466401|Simvastatin|simvastatin|mesh-list
14717149|NCT00466401|Ezetimibe|ezetimibe|mesh-list
14717150|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14717151|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14717152|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
14717153|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717154|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14717155|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14892625|NCT01260818|Coagulants|coagulants|mesh-ancestor
14892626|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14892627|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
14892628|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892629|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
14892630|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14892631|NCT01260857|Diuretics|diuretics|mesh-ancestor
14892632|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
14892633|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892634|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14892635|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892636|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892637|NCT01260974|Caspofungin|caspofungin|mesh-list
14892638|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
14892639|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892640|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892641|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892642|NCT01261065|Carvedilol|carvedilol|mesh-list
14892643|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14892644|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14892645|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14892646|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892647|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892648|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892649|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14892650|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
14892651|NCT01261065|Protective Agents|protective agents|mesh-ancestor
14892652|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14892653|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892654|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14892655|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
14892656|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14892657|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14892658|NCT01261078|Epinephrine|epinephrine|mesh-list
14892659|NCT01261078|Racepinephrine|racepinephrine|mesh-list
14892660|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
14892661|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14892662|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14892663|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
14892664|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892665|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892666|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892667|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14892668|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14892669|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
14892670|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892671|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14892672|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
14892673|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
14892674|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
14892675|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14892676|NCT01261117|Ibuprofen|ibuprofen|mesh-list
14892677|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14892678|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14892679|NCT01261117|Analgesics|analgesics|mesh-ancestor
14892680|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
14892681|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892682|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892683|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892684|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14892685|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14892686|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892687|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892688|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14892689|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14892690|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
14892691|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892692|NCT01261130|Antacids|antacids|mesh-ancestor
14892693|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892694|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14892695|NCT01261156|Diltiazem|diltiazem|mesh-list
14892696|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14892697|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14892698|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892699|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892700|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14892701|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892702|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
14892703|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
14892704|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14892705|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892706|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14892707|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
14892708|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14892709|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892710|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892711|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915800|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
14915801|NCT01389206|Bosentan|bosentan|mesh-list
14915802|NCT01389206|Selexipag|selexipag|mesh-list
14915803|NCT01389206|Iloprost|iloprost|mesh-list
14915804|NCT01389206|Macitentan|macitentan|mesh-list
14915805|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14915806|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
14915807|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14915808|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14915809|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915810|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14915811|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14915812|NCT01389271|Iloprost|iloprost|mesh-list
14915813|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14915814|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
14915815|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14915816|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14915817|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14915818|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
14915819|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915820|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14915821|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14915822|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915823|NCT01389401|Omeprazole|omeprazole|mesh-list
14915824|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14915825|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14915826|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15216566|NCT05241262|Protective Agents|protective agents|mesh-ancestor
15216567|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216568|NCT05241262|Antidotes|antidotes|mesh-ancestor
15216569|NCT05241249|Gemcitabine|gemcitabine|mesh-list
15216570|NCT05241249|Paclitaxel|paclitaxel|mesh-list
15216571|NCT05241249|Bethanechol|bethanechol|mesh-list
15216572|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15216573|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216574|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
15216575|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
15216576|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
15216577|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892712|NCT01261234|Cilostazol|cilostazol|mesh-list
14892713|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14892714|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
14892715|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892716|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892717|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14892718|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
14892719|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14892720|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14892721|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892722|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14892723|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
14892724|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14892725|NCT01261234|Protective Agents|protective agents|mesh-ancestor
14892726|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14892727|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14892728|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892729|NCT01261286|Verapamil|verapamil|mesh-list
14892730|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14892731|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14892732|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892733|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892734|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14892735|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892736|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14892737|NCT01261299|Carboplatin|carboplatin|mesh-list
14892738|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892739|NCT01261416|Levetiracetam|levetiracetam|mesh-list
14892740|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
14717156|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717157|NCT00466466|Everolimus|everolimus|mesh-list
14717158|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717159|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717160|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
14717161|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717162|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14717163|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14717164|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14717165|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14717166|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14717167|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
14717168|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717169|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717170|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717171|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14717172|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717173|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717174|NCT00466518|Incretins|incretins|mesh-ancestor
14717175|NCT00466518|Hormones|hormones|mesh-ancestor
14717176|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14892741|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
14892742|NCT01261481|Tolvaptan|tolvaptan|mesh-list
14892743|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14892744|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892745|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
14892746|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892747|NCT01261546|Dexamethasone|dexamethasone|mesh-list
14892748|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892749|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
14296750|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296751|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14296752|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296753|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14296754|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
14296755|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14296756|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296757|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
14892750|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
14892751|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892752|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892753|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14892754|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
14892755|NCT01261546|Hormones|hormones|mesh-ancestor
14892756|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14892757|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14892758|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892759|NCT01261637|Ropivacaine|ropivacaine|mesh-list
14892760|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
14892761|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
14892762|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892763|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892764|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
14892765|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892766|NCT01261689|Sufentanil|sufentanil|mesh-list
14892767|NCT01261689|Dsuvia|dsuvia|mesh-list
14892768|NCT01261689|Ropivacaine|ropivacaine|mesh-list
14892769|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
14892770|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
14892771|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892772|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892773|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
14892774|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892775|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14892776|NCT01261689|Narcotics|narcotics|mesh-ancestor
14892777|NCT01261689|Analgesics|analgesics|mesh-ancestor
14892778|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14892779|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14892780|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
14892781|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
14892782|NCT01261702|Analgesics|analgesics|mesh-ancestor
14892783|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
14296758|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14296759|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
14296760|NCT05145010|Infigratinib|infigratinib|mesh-list
14296761|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296762|NCT05139043|Dexamethasone|dexamethasone|mesh-list
14296763|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
14296764|NCT05139043|Ichthammol|ichthammol|mesh-list
14296765|NCT05139043|BB 1101|bb 1101|mesh-list
14717177|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14717178|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
14717179|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717180|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717181|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
14717182|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
14717183|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717184|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717185|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14717186|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14296766|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14892784|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892785|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892786|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
14892787|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892788|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14892789|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
14892790|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14892791|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14892792|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892793|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14892794|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
14892795|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14892796|NCT01261741|Memantine|memantine|mesh-list
14892797|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14892798|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14892799|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
14892800|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892801|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892802|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892803|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14892804|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14892805|NCT01261832|Cilostazol|cilostazol|mesh-list
14892806|NCT01261832|Clopidogrel|clopidogrel|mesh-list
14892807|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14892808|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14892809|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14892810|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14892811|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
14892812|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717187|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717188|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892813|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892814|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892815|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14892816|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
14892817|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892818|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14892819|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
14892820|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14892821|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14892822|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
14717189|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717190|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14717191|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14717192|NCT00466596|Vitamins|vitamins|mesh-list
14717193|NCT00466596|Vitamin E|vitamin e|mesh-list
14717194|NCT00466596|Tocopherols|tocopherols|mesh-list
14717195|NCT00466596|Tocotrienols|tocotrienols|mesh-list
14717196|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
14717197|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
14717198|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
14717199|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717200|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
14717201|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717202|NCT00466596|Protective Agents|protective agents|mesh-ancestor
14717203|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14717204|NCT00466609|Fluoxetine|fluoxetine|mesh-list
14892823|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14892824|NCT01261832|Protective Agents|protective agents|mesh-ancestor
14892825|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14892826|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14892827|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892828|NCT01261897|Ropivacaine|ropivacaine|mesh-list
14717205|NCT00466609|Clomipramine|clomipramine|mesh-list
14717206|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
14892829|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
14892830|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
14892831|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892832|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892833|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
14892834|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14892835|NCT01261923|Alitretinoin|alitretinoin|mesh-list
14892836|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892837|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
14892838|NCT01262183|Panitumumab|panitumumab|mesh-list
14892839|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14892840|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892841|NCT01262274|Anastrozole|anastrozole|mesh-list
14892842|NCT01262274|Tegafur|tegafur|mesh-list
14892843|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14892844|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892845|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14892846|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14892847|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892848|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892849|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14892850|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
14892851|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14892852|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892853|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14892854|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
14892855|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
14892856|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14892857|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14892858|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
14892859|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892860|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892861|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892862|NCT01262391|Urological Agents|urological agents|mesh-ancestor
14892863|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
14892864|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14892865|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
14892866|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892867|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
14892868|NCT01262417|Protective Agents|protective agents|mesh-ancestor
14892869|NCT01262469|Capecitabine|capecitabine|mesh-list
14892870|NCT01262469|Lapatinib|lapatinib|mesh-list
14892871|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14892872|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
14892873|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892874|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892875|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14892876|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892877|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
14717207|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14717208|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14717209|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14717210|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717211|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717212|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14717213|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14717214|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14717215|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717216|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717217|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
14892878|NCT01262482|Sorafenib|sorafenib|mesh-list
14892879|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892880|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14892881|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892882|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892883|NCT01262586|Glimepiride|glimepiride|mesh-list
14892884|NCT01262586|Vildagliptin|vildagliptin|mesh-list
14892885|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14892886|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14892887|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892888|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14892889|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
14892890|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14892891|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
14892892|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892893|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296767|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
14892894|NCT01262612|Cediranib|cediranib|mesh-list
14892895|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892896|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14892897|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892898|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892899|NCT01262729|Xenon|xenon|mesh-list
14892900|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14892901|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
14892902|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
14892903|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892904|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892905|NCT01262742|Carbetocin|carbetocin|mesh-list
14892906|NCT01262742|Oxytocin|oxytocin|mesh-list
14892907|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
14892908|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14892909|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892910|NCT01262859|Bevacizumab|bevacizumab|mesh-list
14892911|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14892912|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892913|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14892914|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14892915|NCT01262859|Growth Substances|growth substances|mesh-ancestor
14892916|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892917|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
14892918|NCT01262924|Vaccines|vaccines|mesh-list
14892919|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
14892920|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892921|NCT01262963|Dabrafenib|dabrafenib|mesh-list
14892922|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892923|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14892924|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14892925|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216578|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216579|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
15216580|NCT05241249|Antiviral Agents|antiviral agents|mesh-ancestor
14892926|NCT01263002|Adefovir|adefovir|mesh-list
14892927|NCT01263002|Clevudine|clevudine|mesh-list
14892928|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
14892929|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14892930|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14892931|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14892932|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915827|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216581|NCT05241249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216582|NCT05241249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216583|NCT05241249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216584|NCT05241249|Immunologic Factors|immunologic factors|mesh-ancestor
15216585|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216586|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15216587|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
15216588|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216589|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15216590|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15216591|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
14892933|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892934|NCT01263080|Folic Acid|folic acid|mesh-list
14892935|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
14892936|NCT01263080|Mirtazapine|mirtazapine|mesh-list
14892937|NCT01263080|Vitamins|vitamins|mesh-ancestor
14892938|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
14892939|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216592|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216593|NCT05241132|Paclitaxel|paclitaxel|mesh-list
14892940|NCT01263080|Hematinics|hematinics|mesh-ancestor
14892941|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
14892942|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14892943|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14892944|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
14892945|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
14892946|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14892947|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892948|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14892949|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14892950|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14892951|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14892952|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14892953|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14892954|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
14892955|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14892956|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14892957|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
14892958|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14915828|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915829|NCT01389414|Gemcitabine|gemcitabine|mesh-list
14915830|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
14915831|NCT01389414|Panitumumab|panitumumab|mesh-list
14915832|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915833|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
14915834|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915835|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915836|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
14915837|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915838|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915839|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915840|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
14915841|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915842|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915843|NCT01389427|Sirolimus|sirolimus|mesh-list
14915844|NCT01389427|Prednisone|prednisone|mesh-list
14915845|NCT01389427|Doxorubicin|doxorubicin|mesh-list
14915846|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
15216594|NCT05241132|Cisplatin|cisplatin|mesh-list
15216595|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15216596|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216597|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
15216598|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
15216599|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
15216600|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216601|NCT05241093|Cytarabine|cytarabine|mesh-list
14915847|NCT01389427|Vincristine|vincristine|mesh-list
14915848|NCT01389427|Rituximab|rituximab|mesh-list
14892959|NCT01263145|Paclitaxel|paclitaxel|mesh-list
14892960|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14892961|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892962|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
14892963|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
14892964|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
14892965|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892966|NCT01263158|Oxytocin|oxytocin|mesh-list
14892967|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
14892968|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14892969|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892970|NCT01263171|Leucovorin|leucovorin|mesh-list
14892971|NCT01263171|Fluorouracil|fluorouracil|mesh-list
14892972|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
14892973|NCT01263171|Calcium|calcium|mesh-list
14892974|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
14717218|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14717219|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14717220|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14717221|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717222|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14717223|NCT00466622|Metformin|metformin|mesh-list
14717224|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717225|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717226|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
14717227|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717228|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717229|NCT00466791|Methylphenidate|methylphenidate|mesh-list
14717230|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14717231|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717232|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14717233|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14717234|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14717235|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717236|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
14717237|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717238|NCT00466843|Prednisone|prednisone|mesh-list
14717239|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14717240|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717241|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
14717242|NCT00466843|Hormones|hormones|mesh-ancestor
14717243|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717244|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717245|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14717246|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717247|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
14717248|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717249|NCT00466856|Octreotide|octreotide|mesh-list
14892975|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14892976|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892977|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
14892978|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14892979|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14892980|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14892981|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14892982|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
14892983|NCT01263171|Antidotes|antidotes|mesh-ancestor
14892984|NCT01263171|Protective Agents|protective agents|mesh-ancestor
14892985|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
14892986|NCT01263171|Vitamins|vitamins|mesh-ancestor
14892987|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
14892988|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14892989|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
14892990|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892991|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
14892992|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14892993|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14892994|NCT01263288|Vitamins|vitamins|mesh-ancestor
14892995|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
14892996|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14892997|NCT01263353|Everolimus|everolimus|mesh-list
14892998|NCT01263353|Pasireotide|pasireotide|mesh-list
14892999|NCT01263353|Somatostatin|somatostatin|mesh-list
14893000|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893001|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893002|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
14893003|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893004|NCT01263353|Hormones|hormones|mesh-ancestor
14893005|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893006|NCT01263366|Norepinephrine|norepinephrine|mesh-list
14893007|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14893008|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14893009|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
14893010|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893011|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893012|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893013|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
14893014|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
14893015|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893016|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14893017|NCT01263418|Ofatumumab|ofatumumab|mesh-list
14893018|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893019|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14893020|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14893021|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893022|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14893023|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14893024|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14893025|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893026|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
14893027|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893028|NCT01263574|Ethanol|ethanol|mesh-list
14893029|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14893030|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893031|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14893032|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893033|NCT01263652|Dipyrone|dipyrone|mesh-list
14893034|NCT01263652|Diclofenac|diclofenac|mesh-list
14893035|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14893036|NCT01263652|Tramadol|tramadol|mesh-list
14893037|NCT01263652|Orphenadrine|orphenadrine|mesh-list
14893038|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14893039|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893040|NCT01263652|Analgesics|analgesics|mesh-ancestor
14893041|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
14893042|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893043|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893044|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893045|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893046|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14893047|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893048|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893049|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14893050|NCT01263652|Narcotics|narcotics|mesh-ancestor
14893051|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14893052|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
14893053|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14893054|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14893055|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14893056|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14893057|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
14893058|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
14893059|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14893060|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14893061|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
14893062|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893063|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
14893064|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14893065|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
14893066|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893067|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893068|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14893069|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14893070|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893071|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893072|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893073|NCT01263834|Bevacizumab|bevacizumab|mesh-list
14893074|NCT01263834|Mitomycins|mitomycins|mesh-list
14893075|NCT01263834|Mitomycin|mitomycin|mesh-list
14893076|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893077|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893078|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14893079|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14893080|NCT01263834|Growth Substances|growth substances|mesh-ancestor
14893081|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893082|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
14893083|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14893084|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
14893085|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893086|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14893087|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893088|NCT01263860|Ribavirin|ribavirin|mesh-list
14893089|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14893090|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
14893091|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
14893092|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893093|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
15216602|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216603|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
14893094|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893095|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
14893096|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893097|NCT01263951|Everolimus|everolimus|mesh-list
14893098|NCT01263951|Sorafenib|sorafenib|mesh-list
14893099|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893100|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893101|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
14893102|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893103|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14893104|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893105|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893106|NCT01264094|Clevudine|clevudine|mesh-list
14893107|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
14893108|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893109|NCT01264133|Adefovir|adefovir|mesh-list
14893110|NCT01264133|Clevudine|clevudine|mesh-list
14893111|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
14893112|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893113|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14893114|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14893115|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893116|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893117|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
14893118|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893119|NCT01264237|Etoricoxib|etoricoxib|mesh-list
14893120|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14893121|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893122|NCT01264237|Analgesics|analgesics|mesh-ancestor
14296768|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
14893123|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
14893124|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893125|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893126|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893127|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893128|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14893129|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14893130|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893131|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893132|NCT01264289|Finasteride|finasteride|mesh-list
14893133|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14893134|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14893135|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893136|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893137|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
14893138|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893139|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893140|NCT01264289|Urological Agents|urological agents|mesh-ancestor
14893141|NCT01264302|Finasteride|finasteride|mesh-list
14893142|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14893143|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14893144|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893145|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893146|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
14893147|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893148|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893149|NCT01264302|Urological Agents|urological agents|mesh-ancestor
14893150|NCT01264315|Lenalidomide|lenalidomide|mesh-list
14893151|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
14893152|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893153|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14893154|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14893155|NCT01264315|Growth Substances|growth substances|mesh-ancestor
14893156|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
14893157|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893158|NCT01264328|Paclitaxel|paclitaxel|mesh-list
14893159|NCT01264328|Panitumumab|panitumumab|mesh-list
14893160|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14893161|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893162|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
14893163|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
14893164|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
14893165|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893166|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893167|NCT01264341|Sirolimus|sirolimus|mesh-list
14893168|NCT01264341|Bevacizumab|bevacizumab|mesh-list
14893169|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893170|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893171|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14893172|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14893173|NCT01264341|Growth Substances|growth substances|mesh-ancestor
14893174|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893175|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
14893176|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893177|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893178|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14893179|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
14893180|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893181|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
14893182|NCT01264354|Adefovir|adefovir|mesh-list
14893183|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14893184|NCT01264354|Clevudine|clevudine|mesh-list
14893185|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
14893186|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893187|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14893188|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14893189|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893190|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893191|NCT01264367|Interferons|interferons|mesh-list
14893192|NCT01264367|Clevudine|clevudine|mesh-list
14893193|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893194|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
14893195|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893196|NCT01264432|Veliparib|veliparib|mesh-list
14893197|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14893198|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893199|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893200|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893201|NCT01264445|Vaccines|vaccines|mesh-list
14893202|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
14893203|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893204|NCT01264484|Imidacloprid|imidacloprid|mesh-list
14893205|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
14893206|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893207|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893208|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893209|NCT01264497|Tesamorelin|tesamorelin|mesh-list
14893210|NCT01264497|Growth Substances|growth substances|mesh-ancestor
14893211|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893212|NCT01264536|Lactoferrin|lactoferrin|mesh-list
14893213|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893214|NCT01264575|Epinephrine|epinephrine|mesh-list
14893215|NCT01264575|Racepinephrine|racepinephrine|mesh-list
14893216|NCT01264575|Bupivacaine|bupivacaine|mesh-list
14893217|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
14893218|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
14893219|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
14893220|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14893221|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893222|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
14893223|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893224|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14893225|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14893226|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
14893227|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893228|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893229|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14893230|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14893231|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
14893232|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14893233|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14893234|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
14893235|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
14893236|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14893237|NCT01264588|Calcium|calcium|mesh-list
14893238|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14893239|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893240|NCT01264640|Aspirin|aspirin|mesh-list
14893241|NCT01264640|Clopidogrel|clopidogrel|mesh-list
14893242|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14893243|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893244|NCT01264640|Analgesics|analgesics|mesh-ancestor
14893245|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
14893246|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893247|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893248|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893249|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893250|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14893251|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14893252|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893253|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14893254|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14893255|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893256|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
14893257|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14893258|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14893259|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14893260|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
14893261|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893262|NCT01264653|Epinephrine|epinephrine|mesh-list
14893263|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14893264|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14893265|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
14893266|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893267|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893268|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893269|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14893270|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14893271|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
14893272|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893273|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14893274|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
14893275|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
14893276|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
14893277|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14893278|NCT01264692|Amlodipine|amlodipine|mesh-list
14893279|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14893280|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14893281|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14893282|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893283|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14893284|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893285|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
14893286|NCT01264731|Imiquimod|imiquimod|mesh-list
14893287|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14893288|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
14893289|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893290|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893291|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
14893292|NCT01264783|RNS60|rns60|mesh-list
14893293|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14893294|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893295|NCT01264783|Analgesics|analgesics|mesh-ancestor
14893296|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
14893297|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893298|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893299|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893300|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893301|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14893302|NCT01264822|Rabeprazole|rabeprazole|mesh-list
14893303|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14893304|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14893305|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14893306|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893307|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893308|NCT01264874|Vitamin D|vitamin d|mesh-list
14893309|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
14893310|NCT01264874|Vitamins|vitamins|mesh-ancestor
14893311|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
14893312|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893313|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14893314|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14915849|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14915850|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915851|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14915852|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915853|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
14915854|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915855|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
15216604|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216605|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216606|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
15216607|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216608|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915856|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915857|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14915858|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14915859|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
14915860|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915861|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14915862|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14915863|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
14915864|NCT01389427|Hormones|hormones|mesh-ancestor
14915865|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216609|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
15216610|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216611|NCT05241054|Acetaminophen|acetaminophen|mesh-list
15216612|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
15216613|NCT05241054|Fentanyl|fentanyl|mesh-list
15216614|NCT05241054|Bupivacaine|bupivacaine|mesh-list
15216615|NCT05241054|Propofol|propofol|mesh-list
15216616|NCT05241054|Sevoflurane|sevoflurane|mesh-list
15216617|NCT05241054|Atracurium|atracurium|mesh-list
15216618|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
15216619|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
15216620|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216621|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216622|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
14893315|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14893316|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
14893317|NCT01265004|Coagulants|coagulants|mesh-ancestor
14893318|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
14893319|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14893320|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14893321|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14893322|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14893323|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14893324|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14893325|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
14893326|NCT01265017|Estradiol|estradiol|mesh-list
14893327|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14893328|NCT01265017|Hormones|hormones|mesh-ancestor
14893329|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893330|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893331|NCT01265017|Estrogens|estrogens|mesh-ancestor
14893332|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14893333|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
14893334|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14893335|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14893336|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893337|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14893338|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14893339|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14893340|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14893341|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14893342|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893343|NCT01265030|Sirolimus|sirolimus|mesh-list
14893344|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893345|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893346|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14893347|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893348|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
14893349|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893350|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
14893351|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893352|NCT01265108|Iron|iron|mesh-list
14893353|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14893354|NCT01265108|Trace Elements|trace elements|mesh-ancestor
14893355|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
14893356|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893357|NCT01265108|Hematinics|hematinics|mesh-ancestor
14893358|NCT01265147|Nedaplatin|nedaplatin|mesh-list
14893359|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893360|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
14893361|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
14893362|NCT01265173|Cefotaxime|cefotaxime|mesh-list
14893363|NCT01265173|Cefoxitin|cefoxitin|mesh-list
14893364|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893365|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893366|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14893367|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14893368|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893369|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893370|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893371|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14893372|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14893373|NCT01265199|Cytarabine|cytarabine|mesh-list
14893374|NCT01265199|Daunorubicin|daunorubicin|mesh-list
14893375|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14893376|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
14893377|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893378|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893379|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
14893380|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893381|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893382|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
14893383|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893384|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14893385|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14893386|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14893387|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893388|NCT01265342|Beclomethasone|beclomethasone|mesh-list
14893389|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893390|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
14893391|NCT01265342|Hormones|hormones|mesh-ancestor
14893392|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893393|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893394|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14893395|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
14893396|NCT01265433|Molgramostim|molgramostim|mesh-list
14893397|NCT01265433|Sargramostim|sargramostim|mesh-list
14893398|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
14893399|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893400|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893401|NCT01265576|Etodolac|etodolac|mesh-list
14893402|NCT01265576|Sorafenib|sorafenib|mesh-list
14893403|NCT01265576|Propranolol|propranolol|mesh-list
14893404|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893405|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14893406|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893407|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893408|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14893409|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14893410|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
14893411|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893412|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893413|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14893414|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14893415|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
14893416|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14893417|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893418|NCT01265576|Analgesics|analgesics|mesh-ancestor
14893419|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
14893420|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893421|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893422|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893423|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14893424|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14893425|NCT01265589|Vitamin A|vitamin a|mesh-list
14893426|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14893427|NCT01265589|Vitamins|vitamins|mesh-ancestor
14893428|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
14893429|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893430|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
14893431|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
14893432|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893433|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893434|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14893435|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14893436|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893437|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893438|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893439|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
14893440|NCT01265680|Hematinics|hematinics|mesh-ancestor
15216623|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893441|NCT01265810|Calcium|calcium|mesh-list
14893442|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14893443|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893444|NCT01265849|Indomethacin|indomethacin|mesh-list
14893445|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
14893446|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893447|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
14893448|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893449|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893450|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14893451|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
14893452|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893453|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893454|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14893455|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14893456|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893457|NCT01265849|Analgesics|analgesics|mesh-ancestor
14893458|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
14893459|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893460|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893461|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
14893462|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
14893463|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14893464|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14893465|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893466|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
14893467|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14893468|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
14893469|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893470|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893471|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14893472|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
14893473|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14893474|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
14893475|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893476|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893477|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14893478|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
14893479|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
14893480|NCT01265888|Protective Agents|protective agents|mesh-ancestor
14893481|NCT01265927|Trastuzumab|trastuzumab|mesh-list
14893482|NCT01265927|Imetelstat|imetelstat|mesh-list
14893483|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893484|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893485|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893486|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893487|NCT01265940|Vinblastine|vinblastine|mesh-list
14893488|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14893489|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893490|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
14893491|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
14893492|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
14893493|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893494|NCT01266005|Entecavir|entecavir|mesh-list
14893495|NCT01266005|Clevudine|clevudine|mesh-list
14893496|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
14893497|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717250|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14717251|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14717252|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717253|NCT00466869|Betahistine|betahistine|mesh-list
14717254|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
14717255|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
14717256|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
14893498|NCT01266031|Bevacizumab|bevacizumab|mesh-list
14893499|NCT01266031|Vorinostat|vorinostat|mesh-list
14893500|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893501|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893502|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14893503|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14893504|NCT01266031|Growth Substances|growth substances|mesh-ancestor
14893505|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893506|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14893507|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14893508|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893509|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893510|NCT01266057|Sirolimus|sirolimus|mesh-list
14893511|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
14893512|NCT01266057|Vorinostat|vorinostat|mesh-list
14893513|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893514|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893515|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14893516|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893517|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
14893518|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893519|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
14893520|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893521|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
14893522|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14717257|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717258|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717259|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717260|NCT00466895|Lenalidomide|lenalidomide|mesh-list
14717261|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
14717262|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717263|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717264|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717265|NCT00466895|Growth Substances|growth substances|mesh-ancestor
14717266|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717267|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717268|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14717269|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717270|NCT00466999|Misoprostol|misoprostol|mesh-list
14717271|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14717272|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
14717273|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14717274|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893523|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14893524|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893525|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893526|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893527|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14893528|NCT01266174|Eltoprazine|eltoprazine|mesh-list
14893529|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14893530|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
14893531|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893532|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893533|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893534|NCT01266187|Leucovorin|leucovorin|mesh-list
14893535|NCT01266187|Cetuximab|cetuximab|mesh-list
14893536|NCT01266187|Fluorouracil|fluorouracil|mesh-list
14893537|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
14893538|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893539|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893540|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
14893541|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893542|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14893543|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893544|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
14893545|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893546|NCT01266187|Antidotes|antidotes|mesh-ancestor
14893547|NCT01266187|Protective Agents|protective agents|mesh-ancestor
14893548|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
14893549|NCT01266187|Vitamins|vitamins|mesh-ancestor
14893550|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
14893551|NCT01266213|Fulvestrant|fulvestrant|mesh-list
14893552|NCT01266213|Anastrozole|anastrozole|mesh-list
14893553|NCT01266213|Goserelin|goserelin|mesh-list
14893554|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14893555|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893556|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14893557|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14893558|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
14893559|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893560|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893561|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14893562|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14893563|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893564|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717275|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14717276|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14717277|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
14717278|NCT00467012|Paclitaxel|paclitaxel|mesh-list
14717279|NCT00467012|Bevacizumab|bevacizumab|mesh-list
14717280|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14717281|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717282|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14717283|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14717284|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14893565|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
14893566|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14893567|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14893568|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893569|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893570|NCT01266252|Analgesics|analgesics|mesh-ancestor
14893571|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
14893572|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893573|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14893574|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14893575|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14893576|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
14893577|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893578|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893579|NCT01266434|Simvastatin|simvastatin|mesh-list
14893580|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14893581|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14893582|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
14893583|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893584|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14893585|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14893586|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893587|NCT01266486|Metformin|metformin|mesh-list
14893588|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14893589|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893590|NCT01266499|Colistin|colistin|mesh-list
14893591|NCT01266499|Polymyxins|polymyxins|mesh-list
14893592|NCT01266499|Gentamicins|gentamicins|mesh-list
14893593|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893594|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893595|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14893596|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893597|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893598|NCT01266512|Docetaxel|docetaxel|mesh-list
14893599|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893600|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
14893601|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
14893602|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
14893603|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893604|NCT01266655|Baclofen|baclofen|mesh-list
14893605|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14893606|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893607|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14893608|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893609|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14893610|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
14893611|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
14893612|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893613|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893614|NCT01266681|Amiodarone|amiodarone|mesh-list
14893615|NCT01266681|Dronedarone|dronedarone|mesh-list
14893616|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14893617|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
14893618|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14893619|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14893620|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893621|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14893622|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14893623|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14893624|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893625|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14893626|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14893627|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14893628|NCT01266694|Colchicine|colchicine|mesh-list
14893629|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
14893630|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893631|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
14893632|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
14893633|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
14893634|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893635|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893636|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14893637|NCT01266707|Vaccines|vaccines|mesh-list
14893638|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
14893639|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893640|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14893641|NCT01266707|Growth Substances|growth substances|mesh-ancestor
14893642|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14893643|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893644|NCT01266720|Gemcitabine|gemcitabine|mesh-list
14893645|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
14893646|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893647|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14893648|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
14893649|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893650|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893651|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
15216624|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15216625|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14893652|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893653|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893654|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893655|NCT01266759|NuvaRing|nuvaring|mesh-list
14893656|NCT01266759|Norethindrone|norethindrone|mesh-list
14893657|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
14893658|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14893659|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
14893660|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14893661|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893662|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15216626|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
15216627|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15216628|NCT05241054|Narcotics|narcotics|mesh-ancestor
15216629|NCT05241054|Analgesics|analgesics|mesh-ancestor
15216630|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15216631|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893663|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14893664|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14893665|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14893666|NCT01266772|Budesonide|budesonide|mesh-list
14893667|NCT01266772|Montelukast|montelukast|mesh-list
14893668|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893669|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14893670|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
14893671|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216632|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
14893672|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893673|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14893674|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
15216633|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15216634|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15216635|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
15216636|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15216637|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15216638|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15216639|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15216640|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15216641|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
15216642|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216643|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216644|NCT05241028|Ensartinib|ensartinib|mesh-list
15216645|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296769|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296770|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717285|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893675|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
14893676|NCT01266772|Hormones|hormones|mesh-ancestor
14893677|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893678|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14893679|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
14296771|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296772|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
14296773|NCT05139043|Hormones|hormones|mesh-ancestor
14296774|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296775|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14296776|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296777|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
14296778|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296779|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296780|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
14296781|NCT05139004|Fludarabine|fludarabine|mesh-list
14296782|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
14296783|NCT05139004|Melphalan|melphalan|mesh-list
14296784|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
14717286|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717287|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717288|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717289|NCT00467012|Growth Substances|growth substances|mesh-ancestor
14717290|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717291|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
14728946|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14728947|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728948|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14728949|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14728950|NCT00520819|Antioxidants|antioxidants|mesh-list
14728951|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728952|NCT00520819|Protective Agents|protective agents|mesh-ancestor
14728953|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728954|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
14728955|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14728956|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14728957|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
14728958|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216646|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296785|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14296786|NCT05139004|Basiliximab|basiliximab|mesh-list
14296787|NCT05139004|Mitogens|mitogens|mesh-list
14296788|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14893680|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14893681|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14893682|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915866|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14915867|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14915868|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
14915869|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
14915870|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14915871|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915872|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14915873|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14915874|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915875|NCT01389440|Gemcitabine|gemcitabine|mesh-list
14915876|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14915877|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14915878|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
14915879|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915880|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915881|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
14915882|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915883|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915884|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14915885|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
14915886|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915887|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14915888|NCT01389505|Bevacizumab|bevacizumab|mesh-list
14915889|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14915890|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915891|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14915892|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14915893|NCT01389505|Growth Substances|growth substances|mesh-ancestor
14915894|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915895|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
14915896|NCT01389544|Ritonavir|ritonavir|mesh-list
14915897|NCT01389544|Methadone|methadone|mesh-list
14915898|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14915899|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14915900|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
14915901|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915902|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915903|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14915904|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14915905|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
14915906|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915907|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14915908|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14915909|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14296789|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296790|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296791|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
14296792|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296793|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296794|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
14717292|NCT00467116|Gemcitabine|gemcitabine|mesh-list
14717293|NCT00467116|Cetuximab|cetuximab|mesh-list
14717294|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717295|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
14717296|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717297|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717298|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
14717299|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717300|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717301|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717302|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
14717303|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717304|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717305|NCT00467181|Fenoldopam|fenoldopam|mesh-list
14717306|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14717307|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
14893683|NCT01266785|Infliximab|infliximab|mesh-list
14893684|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14893685|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14893686|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893687|NCT01266811|Dexamethasone|dexamethasone|mesh-list
14893688|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
14893689|NCT01266811|Bortezomib|bortezomib|mesh-list
14893690|NCT01266811|Siltuximab|siltuximab|mesh-list
14893691|NCT01266811|BB 1101|bb 1101|mesh-list
14893692|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893693|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
14893694|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
14893695|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216647|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216648|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216649|NCT05240755|Cannabidiol|cannabidiol|mesh-list
15216650|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
15225354|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225355|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225356|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15225357|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15225358|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
15225359|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225360|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15225361|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15225362|NCT05077800|Losartan|losartan|mesh-list
15225363|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15225364|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15225365|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15225366|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15225367|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225368|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
15225369|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225370|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225371|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15225372|NCT05070585|Protective Agents|protective agents|mesh-ancestor
15225373|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893696|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893697|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14893698|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
14893699|NCT01266811|Hormones|hormones|mesh-ancestor
14893700|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893701|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14893702|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893703|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
14893704|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893705|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893706|NCT01266837|Everolimus|everolimus|mesh-list
14893707|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893708|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893709|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
14893710|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893711|NCT01266928|Ascorbic Acid|ascorbic acid|mesh-list
14893712|NCT01266928|Vitamins|vitamins|mesh-ancestor
14893713|NCT01266928|Micronutrients|micronutrients|mesh-ancestor
14893714|NCT01266928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893715|NCT01266928|Antioxidants|antioxidants|mesh-ancestor
14893716|NCT01266928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893717|NCT01266928|Protective Agents|protective agents|mesh-ancestor
14893718|NCT01267058|Vaccines|vaccines|mesh-list
14893719|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
14893720|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893721|NCT01267084|Ketoconazole|ketoconazole|mesh-list
14893722|NCT01267084|Dexamethasone|dexamethasone|mesh-list
14893723|NCT01267084|Trabectedin|trabectedin|mesh-list
14893724|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893725|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
14893726|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
14893727|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893728|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893729|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296795|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296796|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14296797|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
14893730|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
14893731|NCT01267084|Hormones|hormones|mesh-ancestor
14893732|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893733|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14893734|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893735|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
14893736|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893737|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14893738|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14893739|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296798|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14296799|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14296800|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
14296801|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
14296802|NCT05132153|Milrinone|milrinone|mesh-list
14296803|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14717308|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
14717309|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
14893740|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893741|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14717310|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717311|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717312|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717313|NCT00467194|Sirolimus|sirolimus|mesh-list
14717314|NCT00467194|Bevacizumab|bevacizumab|mesh-list
14893742|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
14893743|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14296804|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14717315|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717316|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296805|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
14893744|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14893745|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
14893746|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
14296806|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14296807|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14296808|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296809|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296810|NCT05132153|Protective Agents|protective agents|mesh-ancestor
14296811|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296812|NCT05121350|Epirubicin|epirubicin|mesh-list
14296813|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14296814|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296815|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14893747|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14893748|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
14893749|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893750|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
14893751|NCT01267214|Protective Agents|protective agents|mesh-ancestor
14893752|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
14893753|NCT01267305|PENTA|penta|mesh-list
14893754|NCT01267305|Nadroparin|nadroparin|mesh-list
14893755|NCT01267305|Fondaparinux|fondaparinux|mesh-list
14893756|NCT01267305|Calcium|calcium|mesh-list
14893757|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14893758|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893759|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14893760|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14893761|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
14893762|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14893763|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
14893764|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893765|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893766|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
14893767|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14893768|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14893769|NCT01267344|Gemcitabine|gemcitabine|mesh-list
14893770|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
14893771|NCT01267344|Cetuximab|cetuximab|mesh-list
14893772|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14893773|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
14893774|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893775|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893776|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
14893777|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893778|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893779|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296816|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14296817|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296818|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296819|NCT05098457|Lidocaine|lidocaine|mesh-list
14296820|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
14296821|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
14893780|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
14893781|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893782|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893783|NCT01267383|Sertraline|sertraline|mesh-list
14893784|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
14893785|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14893786|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14893787|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14893788|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14893789|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893790|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893791|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
14893792|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893793|NCT01267396|Sertraline|sertraline|mesh-list
14893794|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
14893795|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14893796|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14893797|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14296822|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14915910|NCT01389544|Narcotics|narcotics|mesh-ancestor
14893798|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14893799|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893800|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893801|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
14893802|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893803|NCT01267448|Metformin|metformin|mesh-list
14893804|NCT01267448|Saxagliptin|saxagliptin|mesh-list
14893805|NCT01267448|Glipizide|glipizide|mesh-list
14893806|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14893807|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296823|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296824|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
14296825|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296826|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14893808|NCT01267448|Incretins|incretins|mesh-ancestor
14893809|NCT01267448|Hormones|hormones|mesh-ancestor
14893810|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893811|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14893812|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
14893813|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893814|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893815|NCT01267487|Heparin|heparin|mesh-list
14893816|NCT01267487|Calcium heparin|calcium heparin|mesh-list
14893817|NCT01267487|Protamines|protamines|mesh-list
14893818|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
14893819|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14893820|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14893821|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893822|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
14893823|NCT01267487|Coagulants|coagulants|mesh-ancestor
14893824|NCT01267578|Vaccines|vaccines|mesh-list
14893825|NCT01267578|Immunologic Factors|immunologic factors|mesh-ancestor
14893826|NCT01267578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893827|NCT01267604|Inositol|inositol|mesh-list
14893828|NCT01267604|Melatonin|melatonin|mesh-list
14893829|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
14893830|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893831|NCT01267604|Protective Agents|protective agents|mesh-ancestor
14893832|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893833|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14893834|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
14893835|NCT01267604|Vitamins|vitamins|mesh-ancestor
14893836|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
14893837|NCT01267643|Alefacept|alefacept|mesh-list
14893838|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
14893839|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
14893840|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893841|NCT01267669|Somatostatin|somatostatin|mesh-list
14893842|NCT01267669|Hormones|hormones|mesh-ancestor
14893843|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893844|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893845|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
14893846|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893847|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14893848|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893849|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893850|NCT01267734|Everolimus|everolimus|mesh-list
14893851|NCT01267734|Clopidogrel|clopidogrel|mesh-list
14893852|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893853|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893854|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
14893855|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893856|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14893857|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14893858|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14893859|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14893860|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
14893861|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893862|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893863|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
14893864|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14893865|NCT01267903|Vaccines|vaccines|mesh-list
14893866|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
14893867|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893868|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14893869|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14893870|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893871|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14893872|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893873|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893874|NCT01268033|Rituximab|rituximab|mesh-list
14893875|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14893876|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893877|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
14893878|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893879|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893880|NCT01268163|Docetaxel|docetaxel|mesh-list
14893881|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893882|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14893883|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14893884|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14893885|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893886|NCT01268176|Vitamin D|vitamin d|mesh-list
14893887|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
14893888|NCT01268176|Vitamins|vitamins|mesh-ancestor
15216651|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
15216652|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
15216653|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
15216654|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
14296827|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14296828|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14296829|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14717317|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15216655|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
15216656|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15216657|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
15216658|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216659|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216660|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216661|NCT05240456|Urological Agents|urological agents|mesh-ancestor
15216662|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15216663|NCT05240391|Midodrine|midodrine|mesh-list
14717318|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717319|NCT00467194|Growth Substances|growth substances|mesh-ancestor
14717320|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717321|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717322|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717323|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717324|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14717325|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
14717326|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717327|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
14717328|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
14717329|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14717330|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14717331|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14717332|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14717333|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717334|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
14717335|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717336|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717337|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14717338|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717339|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
14717340|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717341|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717342|NCT00467376|Insulin|insulin|mesh-list
14717343|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14717344|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
14717345|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
14717346|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717347|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893889|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
14893890|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893891|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14893892|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14893893|NCT01268202|Pravastatin|pravastatin|mesh-list
14893894|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14893895|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14893896|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
14893897|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893898|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14893899|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14296830|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296831|NCT05097846|Amoxicillin|amoxicillin|mesh-list
14296832|NCT05097846|Doxycycline|doxycycline|mesh-list
14296833|NCT05097846|Furazolidone|furazolidone|mesh-list
14296834|NCT05097846|Esomeprazole|esomeprazole|mesh-list
14296835|NCT05097846|Bismuth|bismuth|mesh-list
14296836|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14296837|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296838|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14296839|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296840|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14296841|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296842|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296843|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
14296844|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14296845|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14893900|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893901|NCT01268215|Budesonide|budesonide|mesh-list
14893902|NCT01268215|Calfactant|calfactant|mesh-list
14893903|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893904|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14893905|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
14893906|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893907|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893908|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14893909|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
14893910|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
14893911|NCT01268215|Hormones|hormones|mesh-ancestor
14893912|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893913|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14893914|NCT01268371|Everolimus|everolimus|mesh-list
14893915|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893916|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893917|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
14893918|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893919|NCT01268384|Gemcitabine|gemcitabine|mesh-list
14893920|NCT01268384|Capecitabine|capecitabine|mesh-list
14893921|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14893922|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
14893923|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893924|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14893925|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
14893926|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14893927|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893928|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14893929|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
14893930|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893931|NCT01268579|Ribavirin|ribavirin|mesh-list
14893932|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
14893933|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893934|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
14893935|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915911|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14915912|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915913|NCT01389544|Analgesics|analgesics|mesh-ancestor
14915914|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
14296846|NCT05097846|Antacids|antacids|mesh-ancestor
14296847|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14296848|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14296849|NCT05097846|Renal Agents|renal agents|mesh-ancestor
14296850|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14296851|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14915915|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915916|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
14915917|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
14296852|NCT05085496|Atezolizumab|atezolizumab|mesh-list
14296853|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14296854|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296855|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
14893936|NCT01268631|Pregabalin|pregabalin|mesh-list
14893937|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14893938|NCT01268631|Analgesics|analgesics|mesh-ancestor
14893939|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
14893940|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893941|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893942|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
14893943|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14893944|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14893945|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893946|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14893947|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14893948|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14893949|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14893950|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14893951|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14893952|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14893953|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296856|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296857|NCT05084222|Budesonide|budesonide|mesh-list
14296858|NCT05084222|Albuterol|albuterol|mesh-list
14296859|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
14296860|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296861|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14296862|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
14893954|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
14893955|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
14893956|NCT01268670|Ibuprofen|ibuprofen|mesh-list
14296863|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296864|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296865|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14296866|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
14296867|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
14296868|NCT05084222|Hormones|hormones|mesh-ancestor
14296869|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296870|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14296871|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14296872|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14296873|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14296874|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14296875|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296876|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
14893957|NCT01268670|Oxycodone|oxycodone|mesh-list
14893958|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14893959|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14893960|NCT01268670|Analgesics|analgesics|mesh-ancestor
14893961|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
14893962|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14893963|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717348|NCT00467454|Naltrexone|naltrexone|mesh-list
14717349|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14717350|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14893964|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14893965|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14893966|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14893967|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14893968|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893969|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14893970|NCT01268670|Narcotics|narcotics|mesh-ancestor
14893971|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296877|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14717351|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717352|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
14893972|NCT01268709|Doxepin|doxepin|mesh-list
14717353|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717354|NCT00467467|Alfuzosin|alfuzosin|mesh-list
14717355|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14717356|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14717357|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14893973|NCT01268709|Nortriptyline|nortriptyline|mesh-list
14893974|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14893975|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
14893976|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14893977|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14893978|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14893979|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14893980|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14893981|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
14893982|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14893983|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893984|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14893985|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14893986|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14893987|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
14893988|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
14893989|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14893990|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
14893991|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14893992|NCT01268761|Cetrorelix|cetrorelix|mesh-list
14893993|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14296878|NCT05069051|Belimumab|belimumab|mesh-list
14296879|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296880|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
14296881|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296882|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
14296883|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296884|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296885|NCT05036408|Coal Tar|coal tar|mesh-list
14296886|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
14296887|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
14893994|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
14893995|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14893996|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14893997|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
14893998|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14893999|NCT01268839|Efavirenz|efavirenz|mesh-list
14894000|NCT01268839|Rilpivirine|rilpivirine|mesh-list
14894001|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14894002|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14894003|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894004|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894005|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
14296888|NCT05032183|Leucovorin|leucovorin|mesh-list
14296889|NCT05032183|Cytarabine|cytarabine|mesh-list
14296890|NCT05032183|Dexamethasone|dexamethasone|mesh-list
14296891|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
14296892|NCT05032183|Prednisone|prednisone|mesh-list
14296893|NCT05032183|Cortisone|cortisone|mesh-list
14894006|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894007|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14894008|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14894009|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14894010|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14894011|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14894012|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14894013|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14717358|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
14717359|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717360|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717361|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717362|NCT00467467|Urological Agents|urological agents|mesh-ancestor
14717363|NCT00467493|Anastrozole|anastrozole|mesh-list
14717364|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14717365|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717366|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14717367|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14717368|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717369|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717370|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14717371|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
14717372|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717373|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717374|NCT00467506|Antibodies|antibodies|mesh-list
14717375|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14296894|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
14894014|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14894015|NCT01268904|Valproic Acid|valproic acid|mesh-list
14894016|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
14894017|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216664|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
15216665|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
15216666|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894018|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894019|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
14894020|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894021|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717376|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
14717377|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717378|NCT00467545|Telbivudine|telbivudine|mesh-list
14717379|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
14717380|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894022|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
14894023|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14894024|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894025|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894026|NCT01268917|Aspirin|aspirin|mesh-list
14894027|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14894028|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14894029|NCT01268917|Analgesics|analgesics|mesh-ancestor
14894030|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
14894031|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894032|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894033|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894034|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894035|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14894036|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14894037|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894038|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14894039|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14894040|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894041|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
14717381|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14717382|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717383|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717384|NCT00467571|Amoxicillin|amoxicillin|mesh-list
14717385|NCT00467571|Clarithromycin|clarithromycin|mesh-list
15216667|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216668|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15216669|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15216670|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14717386|NCT00467571|Lansoprazole|lansoprazole|mesh-list
14717387|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
14717388|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717389|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717390|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14717391|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894042|NCT01268930|Hemostatics|hemostatics|mesh-list
14894043|NCT01268930|Coagulants|coagulants|mesh-ancestor
14894044|NCT01268995|Cyclosporine|cyclosporine|mesh-list
14894045|NCT01268995|Tacrolimus|tacrolimus|mesh-list
14894046|NCT01268995|Cyclosporins|cyclosporins|mesh-list
14894047|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894048|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
14894049|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894050|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14894051|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894052|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216671|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15216672|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
15216673|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216674|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216675|NCT05240274|Metformin|metformin|mesh-list
15216676|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15216677|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216678|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15216679|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
15216680|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15216681|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15216682|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15216683|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894053|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
14894054|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894055|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
14894056|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894057|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
14894058|NCT01269021|Prednisone|prednisone|mesh-list
14894059|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894060|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
14894061|NCT01269021|Hormones|hormones|mesh-ancestor
14894062|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894063|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894064|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14894065|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894066|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14894067|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14894068|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
14894069|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894070|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717392|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717393|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14717394|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14717395|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14717396|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14717397|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14717398|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
14717399|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717400|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717401|NCT00467662|Acyclovir|acyclovir|mesh-list
14717402|NCT00467662|Docosanol|docosanol|mesh-list
14717403|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
14717404|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717405|NCT00467766|Donepezil|donepezil|mesh-list
14717406|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14717407|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717408|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717409|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
14717410|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894071|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894072|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894073|NCT01269099|Fentanyl|fentanyl|mesh-list
14894074|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14894075|NCT01269099|Narcotics|narcotics|mesh-ancestor
14894076|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894077|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894078|NCT01269099|Analgesics|analgesics|mesh-ancestor
14894079|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
14894080|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894081|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14894082|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14894083|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
14894084|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
14894085|NCT01269112|Citric Acid|citric acid|mesh-list
14894086|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
14894087|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
14894088|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14894089|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
14296895|NCT05032183|Rituximab|rituximab|mesh-list
14296896|NCT05032183|Methotrexate|methotrexate|mesh-list
14296897|NCT05032183|Vincristine|vincristine|mesh-list
14296898|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
14296899|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14296900|NCT05032183|Antibodies|antibodies|mesh-list
14296901|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
14296902|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14296903|NCT05032183|Lenograstim|lenograstim|mesh-list
15216684|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216685|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15216686|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216687|NCT05240131|Atezolizumab|atezolizumab|mesh-list
15216688|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216689|NCT05239884|Nicotine|nicotine|mesh-list
15216690|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15216691|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
15216692|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216693|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216694|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15216695|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15216696|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
15216697|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216698|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216699|NCT05224895|Anesthetics|anesthetics|mesh-list
15216700|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15216701|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296904|NCT05032183|BB 1101|bb 1101|mesh-list
14296905|NCT05032183|Mesna|mesna|mesh-list
14296906|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14296907|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
15216702|NCT05209867|Cannabidiol|cannabidiol|mesh-list
15216703|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
15216704|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
15216705|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15216706|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216707|NCT05208619|Anesthetics|anesthetics|mesh-list
15216708|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296908|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296909|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14296910|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14894090|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
15216709|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216710|NCT05190770|Triamcinolone|triamcinolone|mesh-list
15216711|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15216712|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15216713|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15216714|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216715|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
15216716|NCT05190770|Hormones|hormones|mesh-ancestor
15216717|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216718|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216719|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216720|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
15216721|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216722|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216723|NCT05186623|Ustekinumab|ustekinumab|mesh-list
15216724|NCT05186623|Vedolizumab|vedolizumab|mesh-list
14296911|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
14296912|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296913|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296914|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14296915|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14296916|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
14296917|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
14894091|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894092|NCT01269138|Thrombin|thrombin|mesh-list
14894093|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
14894094|NCT01269138|Coagulants|coagulants|mesh-ancestor
14894095|NCT01269151|Ranibizumab|ranibizumab|mesh-list
14894096|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894097|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14894098|NCT01269151|Growth Substances|growth substances|mesh-ancestor
14894099|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894100|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
14894101|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894102|NCT01269203|Curcumin|curcumin|mesh-list
14894103|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14894104|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14894105|NCT01269203|Analgesics|analgesics|mesh-ancestor
15216725|NCT05186623|Tofacitinib|tofacitinib|mesh-list
15216726|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
15216727|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15216728|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216729|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296918|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14296919|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14296920|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
14894106|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
14894107|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894108|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894109|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894110|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894111|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894112|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894113|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296921|NCT05032183|Hormones|hormones|mesh-ancestor
14296922|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14296923|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14296924|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
14296925|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296926|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14296927|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
14296928|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14894114|NCT01269216|Leucovorin|leucovorin|mesh-list
14894115|NCT01269216|Irinotecan|irinotecan|mesh-list
14894116|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14894117|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14894118|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894119|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894120|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894121|NCT01269216|Antidotes|antidotes|mesh-ancestor
14894122|NCT01269216|Protective Agents|protective agents|mesh-ancestor
14894123|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894124|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
14894125|NCT01269216|Vitamins|vitamins|mesh-ancestor
14894126|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
14894127|NCT01269242|Bindarit|bindarit|mesh-list
14894128|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894129|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14894130|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296929|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14296930|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
14296931|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
14296932|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14296933|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14296934|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
14296935|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14296936|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14894131|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894132|NCT01269255|Cisplatin|cisplatin|mesh-list
14894133|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894134|NCT01269281|Sumatriptan|sumatriptan|mesh-list
14894135|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14894136|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14894137|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14894138|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
14894139|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894140|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894141|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216730|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15216731|NCT05168163|Atezolizumab|atezolizumab|mesh-list
15216732|NCT05168163|Lenvatinib|lenvatinib|mesh-list
15216733|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15216734|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216735|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15216736|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216737|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216738|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
15216739|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296937|NCT05032183|Antidotes|antidotes|mesh-ancestor
14296938|NCT05032183|Protective Agents|protective agents|mesh-ancestor
14296939|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
14296940|NCT05032183|Vitamins|vitamins|mesh-ancestor
14296941|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
14296942|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14296943|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14894142|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
14894143|NCT01269294|Simeprevir|simeprevir|mesh-list
14894144|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14894145|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894146|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894147|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14894148|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14894149|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894150|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894151|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894152|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14894153|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
14894154|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14894155|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894156|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14894157|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14894158|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14894159|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
14894160|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
14894161|NCT01269307|Ketamine|ketamine|mesh-list
14894162|NCT01269307|Propofol|propofol|mesh-list
14894163|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14894164|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225374|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296944|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14894165|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894166|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14296945|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14296946|NCT05023993|Niacinamide|niacinamide|mesh-list
14894167|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
14894168|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
14894169|NCT01269307|Analgesics|analgesics|mesh-ancestor
14894170|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
14894171|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894172|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14894173|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14894174|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14894175|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894176|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894177|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
14894178|NCT01269333|Omeprazole|omeprazole|mesh-list
14894179|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14894180|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894181|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14894182|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894183|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894184|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14296947|NCT05023993|Niacin|niacin|mesh-list
14296948|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
14296949|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
14296950|NCT05023993|Vitamins|vitamins|mesh-ancestor
14296951|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
14296952|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296953|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14296954|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
14894185|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14894186|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14296955|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894187|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894188|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894189|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14894190|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14894191|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894192|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894193|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
14894194|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14894195|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
14894196|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14894197|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14894198|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14894199|NCT01269411|R04929097|r04929097|mesh-list
14894200|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894201|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894202|NCT01269437|Budesonide|budesonide|mesh-list
14894203|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894204|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14894205|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
14894206|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894207|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894208|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14894209|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
14894210|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
14894211|NCT01269437|Hormones|hormones|mesh-ancestor
14894212|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894213|NCT01269450|Progesterone|progesterone|mesh-list
14894214|NCT01269450|Progestins|progestins|mesh-ancestor
14894215|NCT01269450|Hormones|hormones|mesh-ancestor
14894216|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894217|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894218|NCT01269463|Methylphenidate|methylphenidate|mesh-list
14894219|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14894220|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894221|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14894222|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14894223|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894224|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894225|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
14894226|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894227|NCT01269476|Fluorides|fluorides|mesh-list
14894228|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
14894229|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
14894230|NCT01269476|Protective Agents|protective agents|mesh-ancestor
14894231|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894232|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14894233|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894234|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894235|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
14894236|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894237|NCT01269515|Etoricoxib|etoricoxib|mesh-list
14894238|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14894239|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14894240|NCT01269515|Analgesics|analgesics|mesh-ancestor
14894241|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
14894242|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894243|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894244|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894245|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894246|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14894247|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14894248|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894249|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894250|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
14894251|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
14894252|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14894253|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
14894254|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894255|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894256|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14894257|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
14894258|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14894259|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
14894260|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894261|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894262|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14894263|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
14894264|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
14894265|NCT01269528|Protective Agents|protective agents|mesh-ancestor
14894266|NCT01269528|Miotics|miotics|mesh-ancestor
14894267|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14894268|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14894269|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14894270|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14894271|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
14894272|NCT01269541|Rifampin|rifampin|mesh-list
14894273|NCT01269541|Mupirocin|mupirocin|mesh-list
14894274|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14894275|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
14894276|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894277|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894278|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
14894279|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14894280|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894281|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894282|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14894283|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14894284|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14894285|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14894286|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14894287|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14894288|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14894289|NCT01269606|Insulin|insulin|mesh-list
14894290|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14894291|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
14894292|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
14894293|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14894294|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894295|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894296|NCT01269671|Peppermint oil|peppermint oil|mesh-list
14894297|NCT01269671|Melatonin|melatonin|mesh-list
14717411|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717412|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
14717413|NCT00467883|Amphotericin B|amphotericin b|mesh-list
14717414|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14717415|NCT00467883|Amebicides|amebicides|mesh-ancestor
14717416|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14717417|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14717418|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717419|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717420|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
14894298|NCT01269671|Simethicone|simethicone|mesh-list
14717421|NCT00467909|Micronutrients|micronutrients|mesh-list
14894299|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
14894300|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894301|NCT01269671|Protective Agents|protective agents|mesh-ancestor
14894302|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894303|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894304|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
14894305|NCT01269671|Emollients|emollients|mesh-ancestor
14894306|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
14894307|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
14894308|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
14894309|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894310|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894311|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
14894312|NCT01269684|Everolimus|everolimus|mesh-list
14894313|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894314|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894315|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
14894316|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894317|NCT01269788|Fluoxetine|fluoxetine|mesh-list
14894318|NCT01269788|Omeprazole|omeprazole|mesh-list
14894319|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14894320|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894321|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14894322|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894323|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894324|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14894325|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14894326|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894327|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894328|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
14894329|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894330|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14894331|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
14894332|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894333|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14894334|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14894335|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
14894336|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14894337|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894338|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894339|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14894340|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14894341|NCT01269827|Protective Agents|protective agents|mesh-ancestor
14894342|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894343|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
14894344|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14894345|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
14894346|NCT01269853|Bevacizumab|bevacizumab|mesh-list
14894347|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14894348|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894349|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894350|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14894351|NCT01269853|Growth Substances|growth substances|mesh-ancestor
14894352|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894353|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
14894354|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14894355|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14894356|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14894357|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14915918|NCT01389557|Piperaquine|piperaquine|mesh-list
14894358|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894359|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894360|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894361|NCT01269866|Analgesics|analgesics|mesh-ancestor
14894362|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
14894363|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894364|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14894365|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894366|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
14894367|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14894368|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14894369|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894370|NCT01269996|Metformin|metformin|mesh-list
14894371|NCT01269996|Gliclazide|gliclazide|mesh-list
14894372|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894373|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894374|NCT01270035|Adalimumab|adalimumab|mesh-list
14894375|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894376|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894377|NCT01270074|Azithromycin|azithromycin|mesh-list
14894378|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894379|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894380|NCT01270087|Adalimumab|adalimumab|mesh-list
14894381|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894382|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894383|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
14894384|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
14894385|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894386|NCT01270152|Protective Agents|protective agents|mesh-ancestor
14894387|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894388|NCT01270152|Vitamins|vitamins|mesh-ancestor
14894389|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
14894390|NCT01270165|Telbivudine|telbivudine|mesh-list
14894391|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
14894392|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894393|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14894394|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894395|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894396|NCT01270178|Entecavir|entecavir|mesh-list
14894397|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
14894398|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915919|NCT01389557|Primaquine|primaquine|mesh-list
14915920|NCT01389557|Artenimol|artenimol|mesh-list
14915921|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
14915922|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14915923|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14915924|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915925|NCT01389609|Doxazosin|doxazosin|mesh-list
14915926|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14915927|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14915928|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14915929|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14915930|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14915931|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915932|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915933|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915934|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14915935|NCT01389713|Clomiphene|clomiphene|mesh-list
14915936|NCT01389713|Enclomiphene|enclomiphene|mesh-list
14915937|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
14915938|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14296956|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14296957|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
14327566|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327567|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
14717422|NCT00467909|Trace Elements|trace elements|mesh-list
14717423|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717424|NCT00467935|Ranibizumab|ranibizumab|mesh-list
14717425|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717426|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717427|NCT00467935|Growth Substances|growth substances|mesh-ancestor
14717428|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717429|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717430|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717431|NCT00467948|Cefazolin|cefazolin|mesh-list
14717432|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717433|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717434|NCT00467987|Testosterone|testosterone|mesh-list
14915939|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
14894399|NCT01270191|Exenatide|exenatide|mesh-list
14894400|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
14894401|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894402|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894403|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14894404|NCT01270191|Incretins|incretins|mesh-ancestor
14894405|NCT01270191|Hormones|hormones|mesh-ancestor
14894406|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894407|NCT01270308|Lansoprazole|lansoprazole|mesh-list
14894408|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
14894409|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14894410|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894411|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14894412|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894413|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894414|NCT01270373|Docetaxel|docetaxel|mesh-list
14894415|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894416|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
14894417|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
14894418|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
14894419|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894420|NCT01270386|Apatinib|apatinib|mesh-list
14894421|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894422|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14894423|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894424|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894425|NCT01270412|Mitogens|mitogens|mesh-list
14894426|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
14894427|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
14894428|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894429|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14894430|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
14894431|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894432|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
14894433|NCT01270412|Protective Agents|protective agents|mesh-ancestor
14894434|NCT01270438|Leucovorin|leucovorin|mesh-list
14894435|NCT01270438|Bevacizumab|bevacizumab|mesh-list
14894436|NCT01270438|Fluorouracil|fluorouracil|mesh-list
14894437|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
14894438|NCT01270438|Calcium|calcium|mesh-list
14894439|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
14894440|NCT01270438|R04929097|r04929097|mesh-list
14894441|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14894442|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894443|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894444|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14894445|NCT01270438|Growth Substances|growth substances|mesh-ancestor
14894446|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894447|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
14894448|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14894449|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
14894450|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894451|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14894452|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894453|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
14894454|NCT01270438|Antidotes|antidotes|mesh-ancestor
14894455|NCT01270438|Protective Agents|protective agents|mesh-ancestor
14894456|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
14894457|NCT01270438|Vitamins|vitamins|mesh-ancestor
14894458|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
14894459|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216740|NCT05118724|Atezolizumab|atezolizumab|mesh-list
15216741|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216742|NCT05099666|Doxorubicin|doxorubicin|mesh-list
15216743|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15216744|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216745|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15216746|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15216747|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216748|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216749|NCT05095064|Irinotecan|irinotecan|mesh-list
15216750|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15216751|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15216752|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296963|NCT05012371|Everolimus|everolimus|mesh-list
14296964|NCT05012371|Lenvatinib|lenvatinib|mesh-list
14296965|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296966|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894460|NCT01270451|Insulin|insulin|mesh-list
14894461|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894462|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894463|NCT01270490|Interferons|interferons|mesh-list
14894464|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
14894465|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894466|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
14894467|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894468|NCT01270672|Carvedilol|carvedilol|mesh-list
14894469|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14894470|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14894471|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14894472|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
14894473|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894474|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894475|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894476|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14894477|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
14894478|NCT01270672|Protective Agents|protective agents|mesh-ancestor
14894479|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14894480|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894481|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14894482|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
15216753|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296967|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
14296968|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894483|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14894484|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14296969|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14894485|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
14894486|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894487|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
14894488|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14894489|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14894490|NCT01270724|Gemcitabine|gemcitabine|mesh-list
14894491|NCT01270724|Paclitaxel|paclitaxel|mesh-list
14894492|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
14296970|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296971|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717435|NCT00467987|Androgens|androgens|mesh-ancestor
14717436|NCT00467987|Hormones|hormones|mesh-ancestor
14717437|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717438|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296972|NCT04941144|Vaccines|vaccines|mesh-list
14296973|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
14296974|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296975|NCT04929392|Paclitaxel|paclitaxel|mesh-list
14296976|NCT04929392|Carboplatin|carboplatin|mesh-list
14296977|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
14296978|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14296979|NCT04929392|Lenvatinib|lenvatinib|mesh-list
14296980|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14296981|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14296982|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
14296983|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
14296984|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
14296985|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296986|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14296987|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14296988|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14296989|NCT04906213|Dapagliflozin|dapagliflozin|mesh-list
14296990|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14296991|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14296992|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14296993|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14296994|NCT04892888|Vaccines|vaccines|mesh-list
14296995|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
14296996|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717439|NCT00468091|Atropine|atropine|mesh-list
14717440|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14717441|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14717442|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14717443|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
14717444|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717445|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717446|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14717447|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
14717448|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
14717449|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
14717450|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14717451|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14717452|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
14717453|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717454|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717455|NCT00468182|Interferons|interferons|mesh-list
14717456|NCT00468182|Interferon-beta|interferon-beta|mesh-list
14717457|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
14717458|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717459|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
14717460|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717461|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
14717462|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717463|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14717464|NCT00468234|Nicotine|nicotine|mesh-list
14717465|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14717466|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
14894493|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14894494|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717467|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717468|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717469|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14717470|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14717471|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
14717472|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717473|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894495|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
14894496|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
14894497|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
14894498|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894499|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14894500|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
14894501|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
14894502|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894503|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894504|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894505|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
14894506|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894507|NCT01270737|Daidzein|daidzein|mesh-list
14894508|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
14717474|NCT00468260|Epothilone B|epothilone b|mesh-list
14717475|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717476|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
14717477|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
14894509|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14894510|NCT01270737|Estrogens|estrogens|mesh-ancestor
14894511|NCT01270737|Hormones|hormones|mesh-ancestor
14894512|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894513|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894514|NCT01270750|Bosentan|bosentan|mesh-list
14894515|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14894516|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14894517|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894518|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
14894519|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14894520|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14894521|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894522|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
14894523|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
15216754|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216755|NCT05093959|Metformin|metformin|mesh-list
15216756|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15216757|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717478|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
14717479|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717480|NCT00468351|Triamcinolone|triamcinolone|mesh-list
14717481|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14717482|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14717483|NCT00468351|Bevacizumab|bevacizumab|mesh-list
14717484|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14717485|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717486|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717487|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15216758|NCT05045794|Liver Extracts|liver extracts|mesh-list
15216759|NCT05045794|Hematinics|hematinics|mesh-ancestor
15216760|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14717488|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717489|NCT00468351|Growth Substances|growth substances|mesh-ancestor
14717490|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717491|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717492|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894524|NCT01270789|Liraglutide|liraglutide|mesh-list
15216761|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894525|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894526|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717493|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
15216762|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
14894527|NCT01270789|Incretins|incretins|mesh-ancestor
14894528|NCT01270789|Hormones|hormones|mesh-ancestor
14894529|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894530|NCT01270815|Pregabalin|pregabalin|mesh-list
14894531|NCT01270815|Analgesics|analgesics|mesh-ancestor
14894532|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
14717494|NCT00468351|Hormones|hormones|mesh-ancestor
14717495|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717496|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717497|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
14717498|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717499|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717500|NCT00468364|Insulin|insulin|mesh-list
14717501|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14717502|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
14717503|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
14717504|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
14717505|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
14717506|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717507|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717508|NCT00468429|Bevacizumab|bevacizumab|mesh-list
14717509|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717510|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717511|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717512|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717513|NCT00468429|Growth Substances|growth substances|mesh-ancestor
14717514|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717515|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717516|NCT00468520|Oxytocin|oxytocin|mesh-list
14717517|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
14894533|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894534|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894535|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
15216763|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15216764|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216765|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
15216766|NCT04984083|Vitamin K|vitamin k|mesh-list
15216767|NCT04984083|Vitamins|vitamins|mesh-ancestor
15216768|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
15216769|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216770|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15216771|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15216772|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216773|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
15216774|NCT04984083|Coagulants|coagulants|mesh-ancestor
15216775|NCT04976777|Dexamethasone|dexamethasone|mesh-list
15216776|NCT04976777|Dexamethasone acetate|dexamethasone acetate|mesh-list
15216777|NCT04976777|BB 1101|bb 1101|mesh-list
15216778|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216779|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
15216780|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
14717518|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14717519|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894536|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14894537|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894538|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894539|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14894540|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14894541|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14894542|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717520|NCT00468533|Aripiprazole|aripiprazole|mesh-list
14717521|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
14717522|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14717523|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14717524|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14717525|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717526|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717527|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
14717528|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
14894543|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894544|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
15216781|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216782|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216783|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15216784|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
15216785|NCT04976777|Hormones|hormones|mesh-ancestor
14717529|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717530|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717531|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14717532|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14717533|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
14717534|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14894545|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14894546|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15216786|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216787|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15216788|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216789|NCT04976777|Protease Inhibitors|protease inhibitors|mesh-ancestor
15216790|NCT04976777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216791|NCT04976777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216792|NCT04971954|Nicotine|nicotine|mesh-list
15216793|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15216794|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
15225375|NCT05059223|Reboxetine|reboxetine|mesh-list
14717535|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14717536|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14297034|NCT04856228|Lidocaine|lidocaine|mesh-list
14297035|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
14297036|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
14297037|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14327568|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14717537|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14717538|NCT00468689|Ketoconazole|ketoconazole|mesh-list
14717539|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
14717540|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717541|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14894547|NCT01270932|Dexamethasone|dexamethasone|mesh-list
14894548|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
14894549|NCT01270932|Lenalidomide|lenalidomide|mesh-list
14894550|NCT01270932|BB 1101|bb 1101|mesh-list
14894551|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894552|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
14894553|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
14894554|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894555|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894556|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894557|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
14894558|NCT01270932|Hormones|hormones|mesh-ancestor
14717542|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14717543|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717544|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717545|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14894559|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894560|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14894561|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894562|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
14894563|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894564|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894565|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
14894566|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894567|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14894568|NCT01270932|Growth Substances|growth substances|mesh-ancestor
14894569|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
14894570|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
14894571|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894572|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14894573|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894574|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894575|NCT01270997|Etanercept|etanercept|mesh-list
14894576|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14894577|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14894578|NCT01270997|Analgesics|analgesics|mesh-ancestor
14894579|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
14894580|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894581|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717546|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
14717547|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717548|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894582|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894583|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894584|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894585|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894586|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
14894587|NCT01271023|Insulin|insulin|mesh-list
14894588|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894589|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894590|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
14894591|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14894592|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
14894593|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894594|NCT01271088|Expectorants|expectorants|mesh-ancestor
14894595|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
14894596|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14894597|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
14894598|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894599|NCT01271088|Protective Agents|protective agents|mesh-ancestor
14894600|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894601|NCT01271088|Antidotes|antidotes|mesh-ancestor
14894602|NCT01271114|Terlipressin|terlipressin|mesh-list
14894603|NCT01271114|Norepinephrine|norepinephrine|mesh-list
14894604|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14894605|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14894606|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
14894607|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894608|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894609|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894610|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
14894611|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
14894612|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894613|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14717549|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14717550|NCT00468715|Bicalutamide|bicalutamide|mesh-list
14717551|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
14717552|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
14728959|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14894614|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14894615|NCT01271140|Insulin|insulin|mesh-list
14894616|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894617|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894618|NCT01271153|Dobutamine|dobutamine|mesh-list
14894619|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14894620|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
14894621|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
14894622|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894623|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894624|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14894625|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14894626|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14894627|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
14894628|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894629|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894630|NCT01271153|Protective Agents|protective agents|mesh-ancestor
14894631|NCT01271166|Leucovorin|leucovorin|mesh-list
14894632|NCT01271166|Bevacizumab|bevacizumab|mesh-list
14894633|NCT01271166|Fluorouracil|fluorouracil|mesh-list
14894634|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
14894635|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
14894636|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14894637|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894638|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894639|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14894640|NCT01271166|Growth Substances|growth substances|mesh-ancestor
14894641|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894642|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
14894643|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
14894644|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894645|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14894646|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894647|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
14894648|NCT01271166|Antidotes|antidotes|mesh-ancestor
14894649|NCT01271166|Protective Agents|protective agents|mesh-ancestor
14894650|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
14894651|NCT01271166|Vitamins|vitamins|mesh-ancestor
14894652|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
14894653|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14894654|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894655|NCT01271179|Insulin|insulin|mesh-list
14894656|NCT01271179|Allopurinol|allopurinol|mesh-list
14894657|NCT01271179|Adenosine|adenosine|mesh-list
14894658|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14894659|NCT01271179|Analgesics|analgesics|mesh-ancestor
14894660|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
14894661|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894662|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894663|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14894664|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
14894665|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14894666|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
14894667|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
14894668|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894669|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894670|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
14894671|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894672|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
14894673|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894674|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14894675|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
14717553|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717554|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717555|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717556|NCT00468754|Insulin|insulin|mesh-list
14717557|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717558|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717559|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14717560|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14717561|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717562|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
14717563|NCT00468871|Hormones|hormones|mesh-ancestor
14717564|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717565|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717566|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
14717567|NCT00468923|Candesartan|candesartan|mesh-list
14717568|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14717569|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14717570|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14717571|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
14717572|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894676|NCT01271179|Protective Agents|protective agents|mesh-ancestor
14894677|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894678|NCT01271231|Azithromycin|azithromycin|mesh-list
14894679|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894680|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717573|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14894681|NCT01271257|Misoprostol|misoprostol|mesh-list
14894682|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14894683|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
14894684|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14894685|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894686|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14894687|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894688|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
14894689|NCT01271283|Lenalidomide|lenalidomide|mesh-list
14894690|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
14894691|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894692|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894693|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14894694|NCT01271283|Growth Substances|growth substances|mesh-ancestor
14894695|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
14894696|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894697|NCT01271348|Etoricoxib|etoricoxib|mesh-list
14894698|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14894699|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14894700|NCT01271348|Analgesics|analgesics|mesh-ancestor
14894701|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
14894702|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894703|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894704|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894705|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894706|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14894707|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14894708|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894709|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894710|NCT01271361|Sirolimus|sirolimus|mesh-list
14894711|NCT01271361|Umirolimus|umirolimus|mesh-list
14894712|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717574|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14717575|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717576|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14717577|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14717578|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14717579|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
14717580|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14717581|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717582|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14717583|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
14717584|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717585|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717586|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717587|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717588|NCT00468988|Travoprost|travoprost|mesh-list
14717589|NCT00468988|Latanoprost|latanoprost|mesh-list
14717590|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14717591|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14894713|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894714|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
14894715|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894716|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894717|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894718|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14894719|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894720|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
14894721|NCT01271374|Losartan|losartan|mesh-list
14894722|NCT01271374|Amlodipine|amlodipine|mesh-list
14894723|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14894724|NCT01271374|Olmesartan|olmesartan|mesh-list
14894725|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
14717592|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14717593|NCT00469053|Buprenorphine|buprenorphine|mesh-list
14717594|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14717595|NCT00469053|Narcotics|narcotics|mesh-ancestor
14717596|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717597|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717598|NCT00469053|Analgesics|analgesics|mesh-ancestor
14894726|NCT01271374|Spironolactone|spironolactone|mesh-list
14894727|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14894728|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14894729|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894730|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894731|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14894732|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894733|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
14894734|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14894735|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14894736|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14894737|NCT01271374|Diuretics|diuretics|mesh-ancestor
14894738|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
14894739|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14894740|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14894741|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
14894742|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14894743|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14894744|NCT01271439|Cetuximab|cetuximab|mesh-list
14894745|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14894746|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894747|NCT01271478|Telmisartan|telmisartan|mesh-list
14894748|NCT01271478|Captopril|captopril|mesh-list
14894749|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14894750|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14894751|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14894752|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894753|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14894754|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
14894755|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297038|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297039|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
14297040|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717599|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
14717600|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717601|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14717602|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
14717603|NCT00469131|Tacrolimus|tacrolimus|mesh-list
14717604|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717605|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
14717606|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717607|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14717608|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728960|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14297041|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14297042|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14297043|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14297044|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297045|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297046|NCT04842604|Azacitidine|azacitidine|mesh-list
14297047|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297048|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
14297049|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297050|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297051|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297052|NCT04820023|Cetuximab|cetuximab|mesh-list
14297053|NCT04820023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297054|NCT04820023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297055|NCT04810546|Lactoferrin|lactoferrin|mesh-list
14894756|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
14894757|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
14894758|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
14894759|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14894760|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894761|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14894762|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
14297056|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894763|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
14894764|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894765|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894766|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14894767|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
14894768|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14894769|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14894770|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14894771|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
14894772|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894773|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216795|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216796|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216797|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15216798|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15216799|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
15216800|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216801|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216802|NCT04965077|Antibodies|antibodies|mesh-list
15216803|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15216804|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
15216805|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216806|NCT04959006|Antioxidants|antioxidants|mesh-list
15216807|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216808|NCT04959006|Protective Agents|protective agents|mesh-ancestor
14894774|NCT01271569|Fospropofol|fospropofol|mesh-list
14894775|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14894776|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894777|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894778|NCT01271582|Leucovorin|leucovorin|mesh-list
14894779|NCT01271582|Irinotecan|irinotecan|mesh-list
14894780|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14717609|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717610|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14717611|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717612|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14717613|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
14717614|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717615|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717616|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14717617|NCT00469183|Tretinoin|tretinoin|mesh-list
14717618|NCT00469183|Hydroquinone|hydroquinone|mesh-list
14717619|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717620|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
14717621|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
14717622|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717623|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
14717624|NCT00469183|Hormones|hormones|mesh-ancestor
14717625|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717626|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717627|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
14717628|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717629|NCT00469183|Protective Agents|protective agents|mesh-ancestor
14717630|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14728961|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728962|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728963|NCT00520949|Amoxicillin|amoxicillin|mesh-list
14728964|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14728965|NCT00520949|Furazolidone|furazolidone|mesh-list
14728966|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14728967|NCT00520949|Esomeprazole|esomeprazole|mesh-list
14728968|NCT00520949|Bismuth|bismuth|mesh-list
14728969|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14728970|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14728971|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14728972|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14728973|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14728974|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14728975|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728976|NCT00520949|Antacids|antacids|mesh-ancestor
14728977|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14728978|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14728979|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14728980|NCT00520949|Renal Agents|renal agents|mesh-ancestor
14728981|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14728982|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14728983|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14728984|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14728985|NCT00521040|Levocetirizine|levocetirizine|mesh-list
14728986|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14728987|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14728988|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
14728989|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
14728990|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14728991|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728992|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14728993|NCT00521092|Sunitinib|sunitinib|mesh-list
14728994|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894781|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14894782|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894783|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14728995|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894784|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894785|NCT01271582|Antidotes|antidotes|mesh-ancestor
14894786|NCT01271582|Protective Agents|protective agents|mesh-ancestor
14894787|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894788|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
14894789|NCT01271582|Vitamins|vitamins|mesh-ancestor
14894790|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
14894791|NCT01271660|Pregabalin|pregabalin|mesh-list
14894792|NCT01271660|Analgesics|analgesics|mesh-ancestor
14894793|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
14894794|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894795|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894796|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
14894797|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14894798|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894799|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894800|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14894801|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14894802|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14894803|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894804|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894805|NCT01271881|Heparin|heparin|mesh-list
14894806|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
14894807|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14894808|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14894809|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894810|NCT01271894|Efavirenz|efavirenz|mesh-list
14894811|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14894812|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14894813|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894814|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894815|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
14894816|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216809|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216810|NCT04942470|Propolis|propolis|mesh-list
15216811|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216812|NCT04933383|Budesonide|budesonide|mesh-list
15216813|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216814|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15216815|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
15216816|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216817|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216818|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15216819|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
15216820|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
15216821|NCT04933383|Hormones|hormones|mesh-ancestor
15216822|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216823|NCT04926571|Dexamethasone|dexamethasone|mesh-list
15216824|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216825|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
15216826|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
15216827|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216828|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216829|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15216830|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
15216831|NCT04926571|Hormones|hormones|mesh-ancestor
15216832|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216833|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15216834|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216835|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
15216836|NCT04904562|Giapreza|giapreza|mesh-list
15216837|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
14894817|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14894818|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14894819|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14894820|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14894821|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14894822|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14894823|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
14894824|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894825|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14915940|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14915941|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915942|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14915943|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
14915944|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14915945|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14915946|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14915947|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
14915948|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14915949|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
14915950|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14915951|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14915952|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915953|NCT01389778|Metformin|metformin|mesh-list
14915954|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14915955|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915956|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
14915957|NCT01389791|Rocuronium|rocuronium|mesh-list
14915958|NCT01389791|Analgesics|analgesics|mesh-ancestor
14915959|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
14915960|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915961|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915962|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
14915963|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14915964|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14915965|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
14915966|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14915967|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894826|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14894827|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14894828|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14894829|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14894830|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14894831|NCT01272089|Analgesics|analgesics|mesh-ancestor
14894832|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
14894833|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894834|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894835|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14894836|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894837|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14894838|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14894839|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14894840|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
14894841|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
14894842|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894843|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894844|NCT01272128|Interferons|interferons|mesh-list
14894845|NCT01272128|Interferon-beta|interferon-beta|mesh-list
14894846|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
14894847|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894848|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
14894849|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894850|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
14894851|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894852|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14894853|NCT01272258|Leronlimab|leronlimab|mesh-list
14894854|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14717631|NCT00469261|Doxycycline|doxycycline|mesh-list
14894855|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14894856|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894857|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14894858|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14894859|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
14894860|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894861|NCT01272310|Interferons|interferons|mesh-list
14894862|NCT01272310|Ribavirin|ribavirin|mesh-list
14894863|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
14894864|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
14894865|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14894866|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
14894867|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894868|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
14894869|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894870|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
14894871|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717632|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717633|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717634|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
14717635|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14717636|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14717637|NCT00469300|Acyclovir|acyclovir|mesh-list
14717638|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
14717639|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717640|NCT00469326|Atorvastatin|atorvastatin|mesh-list
14717641|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14717642|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14717643|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
14717644|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717645|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14717646|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14717647|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717648|NCT00469352|Ranibizumab|ranibizumab|mesh-list
14717649|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14894872|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
14894873|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894874|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
14894875|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14894876|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14894877|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894878|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894879|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
14894880|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14894881|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14894882|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14894883|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14894884|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894885|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
14894886|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894887|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894888|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14894889|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894890|NCT01272531|Valproic Acid|valproic acid|mesh-list
14894891|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
14894892|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
14894893|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894894|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894895|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
14894896|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894897|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894898|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
14894899|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14894900|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894901|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894902|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
14894903|NCT01272557|Doxorubicin|doxorubicin|mesh-list
14894904|NCT01272557|Sorafenib|sorafenib|mesh-list
14894905|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14894906|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894907|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14894908|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14894909|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894910|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894911|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14894912|NCT01272609|Timolol|timolol|mesh-list
14894913|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14894914|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14894915|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14894916|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894917|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894918|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894919|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14894920|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14894921|NCT01272778|Lorazepam|lorazepam|mesh-list
14894922|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
14894923|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
14894924|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
14894925|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894926|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894927|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14894928|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14894929|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894930|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14894931|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14894932|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14894933|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
14894934|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
14894935|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894936|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894937|NCT01272856|Abatacept|abatacept|mesh-list
14894938|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14894939|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894940|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894941|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14894942|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
14894943|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297057|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
14297058|NCT04784052|Rituximab|rituximab|mesh-list
14297059|NCT04784052|Fludarabine|fludarabine|mesh-list
14297060|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
14894944|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14894945|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
14297061|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14297062|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297063|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
14297064|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297065|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297066|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14297067|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
14297068|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297069|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297070|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14297071|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297072|NCT04771871|Paclitaxel|paclitaxel|mesh-list
14297073|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
14297074|NCT04771871|Carboplatin|carboplatin|mesh-list
14297075|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14297076|NCT04771871|Epirubicin|epirubicin|mesh-list
14894946|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
14894947|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894948|NCT01273051|Capecitabine|capecitabine|mesh-list
14894949|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14894950|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
14894951|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894952|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14894953|NCT01273090|Imetelstat|imetelstat|mesh-list
14894954|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
14894955|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894956|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894957|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14894958|NCT01273233|Vaccines|vaccines|mesh-list
14894959|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
14894960|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894961|NCT01273246|Vaccines|vaccines|mesh-list
14894962|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
14894963|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894964|NCT01273298|Bisoprolol|bisoprolol|mesh-list
14297077|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14297078|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297079|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
14297080|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
14297081|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
14297082|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297083|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297084|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
14717650|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717651|NCT00469352|Growth Substances|growth substances|mesh-ancestor
14717652|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717653|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717654|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717655|NCT00469404|Buprenorphine|buprenorphine|mesh-list
14717656|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14717657|NCT00469404|Narcotics|narcotics|mesh-ancestor
14717658|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717659|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717660|NCT00469404|Analgesics|analgesics|mesh-ancestor
14717661|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
14717662|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717663|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14717664|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14717665|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14894965|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14894966|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
14894967|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
14894968|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14894969|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894970|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14894971|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14894972|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14894973|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14894974|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14894975|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216838|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15216839|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15216840|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
15216841|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717666|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14894976|NCT01273402|Antibodies|antibodies|mesh-list
14894977|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
14894978|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14894979|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
14894980|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894981|NCT01273441|Amoxicillin|amoxicillin|mesh-list
14894982|NCT01273441|Metronidazole|metronidazole|mesh-list
14894983|NCT01273441|Clarithromycin|clarithromycin|mesh-list
14894984|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14894985|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14894986|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14894987|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14894988|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14894989|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14894990|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14894991|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14894992|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14894993|NCT01273454|Hydromorphone|hydromorphone|mesh-list
14894994|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14894995|NCT01273454|Narcotics|narcotics|mesh-ancestor
14894996|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14894997|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14894998|NCT01273454|Analgesics|analgesics|mesh-ancestor
14894999|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
14895000|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895001|NCT01273493|Dexamethasone|dexamethasone|mesh-list
14895002|NCT01273493|Trabectedin|trabectedin|mesh-list
14895003|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895004|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
14895005|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
14895006|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895007|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895008|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895009|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
14895010|NCT01273493|Hormones|hormones|mesh-ancestor
14895011|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895012|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895013|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895014|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14297085|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297086|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297087|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14297088|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
14297089|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14895015|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
14895016|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895017|NCT01273506|Tapentadol|tapentadol|mesh-list
14895018|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14895019|NCT01273506|Narcotics|narcotics|mesh-ancestor
14895020|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895021|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895022|NCT01273506|Analgesics|analgesics|mesh-ancestor
14895023|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
14895024|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895025|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14895026|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14895027|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895028|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895029|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
14895030|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297090|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14297091|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14297092|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14297093|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895031|NCT01273532|Tapentadol|tapentadol|mesh-list
14895032|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14895033|NCT01273532|Narcotics|narcotics|mesh-ancestor
14895034|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895035|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895036|NCT01273532|Analgesics|analgesics|mesh-ancestor
14895037|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
14717667|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
14717668|NCT00469430|Metronidazole|metronidazole|mesh-list
14717669|NCT00469430|Cefotaxime|cefotaxime|mesh-list
14717670|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717671|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717672|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14717673|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14895038|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895039|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14895040|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14895041|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895042|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895043|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
14895044|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895045|NCT01273558|Canagliflozin|canagliflozin|mesh-list
14895046|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14895047|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895048|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14895049|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895050|NCT01273571|Metformin|metformin|mesh-list
14895051|NCT01273571|Canagliflozin|canagliflozin|mesh-list
14895052|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14895053|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895054|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14895055|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895056|NCT01273584|Metformin|metformin|mesh-list
14895057|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14895058|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895059|NCT01273610|Trastuzumab|trastuzumab|mesh-list
14895060|NCT01273610|Lapatinib|lapatinib|mesh-list
14895061|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14895062|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895063|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14895064|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895065|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895066|NCT01273662|Axitinib|axitinib|mesh-list
14895067|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895068|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14895069|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895070|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895071|NCT01273727|Dexamethasone|dexamethasone|mesh-list
14895072|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
14297094|NCT04756232|Mecamylamine|mecamylamine|mesh-list
14717674|NCT00469443|Leucovorin|leucovorin|mesh-list
14717675|NCT00469443|Bevacizumab|bevacizumab|mesh-list
14717676|NCT00469443|Fluorouracil|fluorouracil|mesh-list
14717677|NCT00469443|Capecitabine|capecitabine|mesh-list
14717678|NCT00469443|Irinotecan|irinotecan|mesh-list
14717679|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717680|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717681|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717682|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717683|NCT00469443|Growth Substances|growth substances|mesh-ancestor
14717684|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717685|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
14895073|NCT01273727|BB 1101|bb 1101|mesh-list
14895074|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895075|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
14895076|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
14895077|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297095|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15216842|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216843|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15216844|NCT04851522|Eusol|eusol|mesh-list
15216845|NCT04851522|Petrolatum|petrolatum|mesh-list
14895078|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895079|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895080|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
14895081|NCT01273727|Hormones|hormones|mesh-ancestor
14895082|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895083|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895084|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895085|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
14895086|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216846|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
14717686|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
14717687|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717688|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216847|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216848|NCT04851522|Emollients|emollients|mesh-ancestor
15216849|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
15216850|NCT04847440|Tenofovir|tenofovir|mesh-list
15216851|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
15216852|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216853|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15216854|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15216855|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216856|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216857|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14297096|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14717689|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717690|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
14717691|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14717692|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14717693|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895087|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895088|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
15216858|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15225376|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
15225377|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15225378|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15225379|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14895089|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895090|NCT01273831|Cisatracurium|cisatracurium|mesh-list
14895091|NCT01273831|Atracurium|atracurium|mesh-list
14895092|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14895093|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14895094|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895095|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895096|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14895097|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15225380|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15225381|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225382|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
15225383|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225384|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225385|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14895098|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14895099|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
14895100|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895101|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895102|NCT01273844|Bortezomib|bortezomib|mesh-list
14895103|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915968|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915969|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14915970|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
14915971|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14915972|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14915973|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14915974|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14915975|NCT01389908|Olanzapine|olanzapine|mesh-list
14915976|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
14915977|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
14915978|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915979|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915980|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14915981|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14915982|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14915983|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14915984|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14915985|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14915986|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14915987|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14915988|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14915989|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915990|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
14917490|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917491|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14917492|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225386|NCT05026736|Antibodies|antibodies|mesh-list
15225387|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
15225388|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15225389|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
15225390|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225391|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225392|NCT05011812|Ritonavir|ritonavir|mesh-list
14717694|NCT00469443|Antidotes|antidotes|mesh-ancestor
14717695|NCT00469443|Protective Agents|protective agents|mesh-ancestor
14717696|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
14717697|NCT00469443|Vitamins|vitamins|mesh-ancestor
14717698|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
14717699|NCT00469469|Bevacizumab|bevacizumab|mesh-list
14895104|NCT01273948|Interferons|interferons|mesh-list
15216859|NCT04834024|Antibodies|antibodies|mesh-list
14717700|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717701|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717702|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717703|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717704|NCT00469469|Growth Substances|growth substances|mesh-ancestor
14717705|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717706|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717707|NCT00469495|Anthelmintics|anthelmintics|mesh-list
14717708|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14717709|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895105|NCT01273948|Bavituximab|bavituximab|mesh-list
14895106|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895107|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
14297097|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
14297098|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717710|NCT00469547|Ethanol|ethanol|mesh-list
14717711|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
14717712|NCT00469547|Emollients|emollients|mesh-list
14717713|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14717714|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717715|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717716|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
14717717|NCT00469560|Deferasirox|deferasirox|mesh-list
14717718|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14717719|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
14717720|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
14895108|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895109|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717721|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717722|NCT00469586|Insulin|insulin|mesh-list
14895110|NCT01273974|Vaccines|vaccines|mesh-list
14895111|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
14895112|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895113|NCT01274000|Ramosetron|ramosetron|mesh-list
14895114|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
14895115|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
14895116|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895117|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895118|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895119|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14895120|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
14895121|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895122|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895123|NCT01274026|Verapamil|verapamil|mesh-list
14895124|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14895125|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14895126|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895127|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895128|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14895129|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895130|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
14895131|NCT01274039|Acetazolamide|acetazolamide|mesh-list
14895132|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
14895133|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14895134|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895135|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216860|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15216861|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
15216862|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216863|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
15216864|NCT04821141|Estrogens|estrogens|mesh-list
15216865|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15216866|NCT04821141|Hormones|hormones|mesh-ancestor
15216867|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15216868|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216869|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15216870|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14717723|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14717724|NCT00469586|Metformin|metformin|mesh-list
14717725|NCT00469586|Glimepiride|glimepiride|mesh-list
14297099|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297100|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14297101|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14297102|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
14297103|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297104|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297105|NCT04740905|Aflibercept|aflibercept|mesh-list
14297106|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14297107|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14297108|NCT04740905|Growth Substances|growth substances|mesh-ancestor
14297109|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297110|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
14297111|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297112|NCT04692077|Tenofovir|tenofovir|mesh-list
14297113|NCT04692077|Emtricitabine|emtricitabine|mesh-list
14297114|NCT04692077|Cabotegravir|cabotegravir|mesh-list
14297115|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
14297116|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297117|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14297118|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14297119|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297120|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297121|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14895136|NCT01274039|Diuretics|diuretics|mesh-ancestor
14895137|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
14895138|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895139|NCT01274104|Vitamin D|vitamin d|mesh-list
14895140|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
14895141|NCT01274104|Vitamins|vitamins|mesh-ancestor
14895142|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
14895143|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895144|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14895145|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14895146|NCT01274130|Metformin|metformin|mesh-list
14895147|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14895148|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895149|NCT01274195|Busulfan|busulfan|mesh-list
14895150|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
14895151|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895152|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895153|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
14895154|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895155|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14895156|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895157|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14895158|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14895159|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14895160|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895161|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14895162|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14895163|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895164|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895165|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
14895166|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895167|NCT01274247|Benzocaine|benzocaine|mesh-list
14895168|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
14895169|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
14895170|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895171|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895172|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
14895173|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895174|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
14895175|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14895176|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15216871|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
15216872|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15216873|NCT04788017|Ziresovir|ziresovir|mesh-list
15216874|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
15216875|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216876|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
15216877|NCT04767776|Charcoal|charcoal|mesh-list
15216878|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15216879|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
15225393|NCT05011812|Midazolam|midazolam|mesh-list
14297122|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895177|NCT01274260|Prednisolone|prednisolone|mesh-list
15216880|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15216881|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
15216882|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216883|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216884|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
15216885|NCT04767776|Antidotes|antidotes|mesh-ancestor
15216886|NCT04767776|Protective Agents|protective agents|mesh-ancestor
15216887|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895178|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
14297123|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14297124|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14297125|NCT04603391|Cannabidiol|cannabidiol|mesh-list
14297126|NCT04603391|Methylphenidate|methylphenidate|mesh-list
14895179|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14895180|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
14895181|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895182|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
14895183|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
14895184|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895185|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895186|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895187|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
14895188|NCT01274260|Hormones|hormones|mesh-ancestor
14895189|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895190|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14895191|NCT01274260|Protective Agents|protective agents|mesh-ancestor
14895192|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895193|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895194|NCT01274273|Interferons|interferons|mesh-list
14895195|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
14895196|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
14895197|NCT01274273|Aldesleukin|aldesleukin|mesh-list
14895198|NCT01274273|Bevacizumab|bevacizumab|mesh-list
14895199|NCT01274273|Interleukin-2|interleukin-2|mesh-list
14895200|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14895201|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895202|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14895203|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14895204|NCT01274273|Growth Substances|growth substances|mesh-ancestor
14895205|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297127|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14895206|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
14895207|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
14717726|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14717727|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717728|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14717729|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717730|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
14717731|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
14717732|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14717733|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14717734|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717735|NCT00469599|Vitamins|vitamins|mesh-ancestor
14717736|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
14717737|NCT00469651|Vaccines|vaccines|mesh-list
14717738|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
14717739|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717740|NCT00469664|Guanfacine|guanfacine|mesh-list
14895208|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895209|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
14895210|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14895211|NCT01274273|Analgesics|analgesics|mesh-ancestor
14895212|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
14895213|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895214|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14895215|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895216|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14895217|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14895218|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
14895219|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895220|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895221|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14895222|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
14895223|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
14895224|NCT01274325|Hormones|hormones|mesh-ancestor
14895225|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895226|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
14895227|NCT01274403|Thalidomide|thalidomide|mesh-list
14895228|NCT01274403|Prednisone|prednisone|mesh-list
14895229|NCT01274403|Melphalan|melphalan|mesh-list
14895230|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895231|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
14895232|NCT01274403|Hormones|hormones|mesh-ancestor
14895233|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895234|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895235|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14717741|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14717742|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14717743|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14717744|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14717745|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
14717746|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895236|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895237|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14895238|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
14717747|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717748|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717749|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14717750|NCT00469690|Bromfenac|bromfenac|mesh-list
14895239|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895240|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14895241|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895242|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
14895243|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
14895244|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14895245|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895246|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14895247|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14895248|NCT01274403|Growth Substances|growth substances|mesh-ancestor
14895249|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
14895250|NCT01274481|Iloprost|iloprost|mesh-list
14895251|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14895252|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
14895253|NCT01274624|Leucovorin|leucovorin|mesh-list
14895254|NCT01274624|Bevacizumab|bevacizumab|mesh-list
14895255|NCT01274624|Fluorouracil|fluorouracil|mesh-list
14895256|NCT01274624|Irinotecan|irinotecan|mesh-list
14895257|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14895258|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895259|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14895260|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14895261|NCT01274624|Growth Substances|growth substances|mesh-ancestor
14895262|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717751|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14717752|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14717753|NCT00469690|Analgesics|analgesics|mesh-ancestor
14717754|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
14717755|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717756|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717757|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717758|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14717759|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14717760|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895263|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
14895264|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
14895265|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895266|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717761|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717762|NCT00469703|Thalidomide|thalidomide|mesh-list
14717763|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717764|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
14895267|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895268|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
14895269|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14895270|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14895271|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895272|NCT01274624|Antidotes|antidotes|mesh-ancestor
14895273|NCT01274624|Protective Agents|protective agents|mesh-ancestor
14895274|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
14895275|NCT01274624|Vitamins|vitamins|mesh-ancestor
14717765|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717766|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
14717767|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14717768|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717769|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717770|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14717771|NCT00469703|Growth Substances|growth substances|mesh-ancestor
14717772|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717773|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717774|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14717775|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
14717776|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
14717777|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
14717778|NCT00469755|Adapalene|adapalene|mesh-list
14717779|NCT00469755|Tazarotene|tazarotene|mesh-list
14717780|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14717781|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14717782|NCT00469755|Analgesics|analgesics|mesh-ancestor
14717783|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
14717784|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717785|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717786|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895276|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
14895277|NCT01274780|Ritonavir|ritonavir|mesh-list
14895278|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14895279|NCT01274780|Darunavir|darunavir|mesh-list
14895280|NCT01274780|Tenofovir|tenofovir|mesh-list
14895281|NCT01274780|Emtricitabine|emtricitabine|mesh-list
14895282|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14895283|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14297128|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297129|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14297130|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14297131|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297132|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297133|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
14297134|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216888|NCT04756765|Talazoparib|talazoparib|mesh-list
15216889|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15216890|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216891|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216892|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216893|NCT04753970|Cilostazol|cilostazol|mesh-list
15216894|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15216895|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
15216896|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15216897|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216898|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15216899|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
14297135|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
14297136|NCT04599790|Lenvatinib|lenvatinib|mesh-list
14297137|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297138|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14297139|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297140|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297141|NCT04575857|Atorvastatin|atorvastatin|mesh-list
14717787|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14895284|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
14895285|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895286|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216900|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14895287|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14895288|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895289|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
14895290|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895291|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14895292|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14895293|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14895294|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14895295|NCT01274793|Mosapride|mosapride|mesh-list
14895296|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895297|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895298|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14297142|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14297143|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14297144|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
14297145|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297146|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14297147|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14297148|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717788|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14895299|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
14895300|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895301|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895302|NCT01274988|Methadone|methadone|mesh-list
14895303|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14895304|NCT01274988|Narcotics|narcotics|mesh-ancestor
14895305|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717789|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
14895306|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895307|NCT01274988|Analgesics|analgesics|mesh-ancestor
14895308|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
14895309|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895310|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
14895311|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
15216901|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15216902|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216903|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15216904|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
15216905|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15216906|NCT04753970|Protective Agents|protective agents|mesh-ancestor
15216907|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15216908|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15216909|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216910|NCT04727242|Gemcitabine|gemcitabine|mesh-list
14717790|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
14717791|NCT00469755|Vitamins|vitamins|mesh-ancestor
14717792|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
14717793|NCT00469768|Dapivirine|dapivirine|mesh-list
14717794|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14717795|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14717796|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
14717797|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717798|NCT00469781|Bromfenac|bromfenac|mesh-list
14717799|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
14717800|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14717801|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
14717802|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14717803|NCT00469781|Prednisolone|prednisolone|mesh-list
14717804|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14717805|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
14717806|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14717807|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14717808|NCT00469781|Analgesics|analgesics|mesh-ancestor
14717809|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
14717810|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297149|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14297150|NCT04561206|Nivolumab|nivolumab|mesh-list
14895312|NCT01275014|Dexamethasone|dexamethasone|mesh-list
14895313|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895314|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
14895315|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
14895316|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895317|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895318|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895319|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
14895320|NCT01275014|Hormones|hormones|mesh-ancestor
14895321|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895322|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895323|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895324|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
14895325|NCT01275183|Cisplatin|cisplatin|mesh-list
14895326|NCT01275183|Docetaxel|docetaxel|mesh-list
14895327|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895328|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14895329|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14895330|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14895331|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895332|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14895333|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895334|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
14895335|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895336|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14895337|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14895338|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895339|NCT01275248|Ondansetron|ondansetron|mesh-list
14895340|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
14895341|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
14895342|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895343|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895344|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895345|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
14895346|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14895347|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14895348|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
14895349|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895350|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895351|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14895352|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14895353|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895354|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14895355|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14895356|NCT01275274|Tretinoin|tretinoin|mesh-list
14895357|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895358|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
14895359|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
14895360|NCT01275287|Eculizumab|eculizumab|mesh-list
14895361|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14895362|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895363|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
14895364|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895365|NCT01275352|Eplerenone|eplerenone|mesh-list
14895366|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14895367|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
14895368|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895369|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895370|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14895371|NCT01275352|Diuretics|diuretics|mesh-ancestor
14895372|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
14895373|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14895374|NCT01275443|Rilpivirine|rilpivirine|mesh-list
14895375|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14895376|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14297151|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14895377|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895378|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895379|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
14895380|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895381|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14895382|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895383|NCT01275508|Adalimumab|adalimumab|mesh-list
14895384|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895385|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14895386|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14895387|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14895388|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895389|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895390|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14895391|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895392|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895393|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
14895394|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14915991|NCT01390012|Dexamethasone|dexamethasone|mesh-list
15216911|NCT04727242|Dacarbazine|dacarbazine|mesh-list
15216912|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15216913|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
15216914|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216915|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216916|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
15216917|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216918|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216919|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15216920|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
15216921|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14915992|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
14915993|NCT01390012|BB 1101|bb 1101|mesh-list
14297152|NCT04561206|Antibodies|antibodies|mesh-list
14895395|NCT01275547|Midazolam|midazolam|mesh-list
14895396|NCT01275547|Ketamine|ketamine|mesh-list
14895397|NCT01275547|Morphine|morphine|mesh-list
14895398|NCT01275547|Esketamine|esketamine|mesh-list
14895399|NCT01275547|Analgesics|analgesics|mesh-ancestor
14895400|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
14717811|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717812|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717813|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14895401|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895402|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895403|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14895404|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14895405|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
14895406|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
14895407|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895408|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14895409|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14895410|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895411|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895412|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14717814|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
14717815|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
14717816|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14717817|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
14717818|NCT00469781|Hormones|hormones|mesh-ancestor
14717819|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14717820|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14717821|NCT00469781|Protective Agents|protective agents|mesh-ancestor
14717822|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14717823|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717824|NCT00469846|Ascorbic Acid|ascorbic acid|mesh-list
14717825|NCT00469846|Vitamins|vitamins|mesh-ancestor
14717826|NCT00469846|Micronutrients|micronutrients|mesh-ancestor
14717827|NCT00469846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717828|NCT00469846|Antioxidants|antioxidants|mesh-ancestor
14717829|NCT00469846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895413|NCT01275547|Narcotics|narcotics|mesh-ancestor
14895414|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14717830|NCT00469846|Protective Agents|protective agents|mesh-ancestor
14717831|NCT00469885|Nicotine|nicotine|mesh-list
14717832|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14717833|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
14717834|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717835|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717836|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14717837|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14717838|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
14717839|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717840|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717841|NCT00469924|Caffeine|caffeine|mesh-list
14717842|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14717843|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895415|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14895416|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14895417|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14895418|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14895419|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
14895420|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
14895421|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
14895422|NCT01275560|Metronidazole|metronidazole|mesh-list
14895423|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895424|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14297153|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
14717844|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14717845|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895425|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14895426|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14895427|NCT01275599|Buprenorphine|buprenorphine|mesh-list
14895428|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14895429|NCT01275599|Naloxone|naloxone|mesh-list
14895430|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14895431|NCT01275599|Narcotics|narcotics|mesh-ancestor
14895432|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895433|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895434|NCT01275599|Analgesics|analgesics|mesh-ancestor
14895435|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
14895436|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895437|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14895438|NCT01275638|Prednisolone|prednisolone|mesh-list
14895439|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14895440|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
14895441|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14895442|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
14895443|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14895444|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
14895445|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895446|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
14895447|NCT01275638|Hormones|hormones|mesh-ancestor
14895448|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895449|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895450|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895451|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895452|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
14895453|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
14895454|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895455|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895456|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14895457|NCT01275638|Protective Agents|protective agents|mesh-ancestor
14895458|NCT01275729|Furosemide|furosemide|mesh-list
14895459|NCT01275729|Diuretics|diuretics|mesh-ancestor
14895460|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
14895461|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895462|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14895463|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15216922|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15216923|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
15216924|NCT04724447|Valganciclovir|valganciclovir|mesh-list
15216925|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
15216926|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216927|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
15216928|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15216929|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15216930|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216931|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
15216932|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
15216933|NCT04710732|Enoxaparin|enoxaparin|mesh-list
15216934|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
15216935|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
15216936|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15216937|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14895464|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895465|NCT01275859|Letrozole|letrozole|mesh-list
14895466|NCT01275859|Lapatinib|lapatinib|mesh-list
14895467|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895468|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14895469|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14297154|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15216938|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895470|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915994|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15216939|NCT04688294|Valsartan|valsartan|mesh-list
14895471|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895472|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14895473|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
14895474|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895475|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895476|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14895477|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
14895478|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14895479|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895480|NCT01275885|Vitamins|vitamins|mesh-ancestor
14895481|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
14895482|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14895483|NCT01275911|Remifentanil|remifentanil|mesh-list
14895484|NCT01275911|Esmolol|esmolol|mesh-list
14895485|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14895486|NCT01275911|Narcotics|narcotics|mesh-ancestor
14895487|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895488|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895489|NCT01275911|Analgesics|analgesics|mesh-ancestor
14895490|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
14895491|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895492|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14895493|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14895494|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14895495|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
14895496|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895497|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297155|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
14297156|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
14297157|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297158|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297159|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14297160|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297161|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
14297162|NCT04545008|Famotidine|famotidine|mesh-list
14297163|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14297164|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
14297165|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297166|NCT04545008|Expectorants|expectorants|mesh-ancestor
14297167|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
14297168|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14297169|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
14297170|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297171|NCT04545008|Protective Agents|protective agents|mesh-ancestor
14297172|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297173|NCT04545008|Antidotes|antidotes|mesh-ancestor
14297174|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14297175|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14297176|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14297177|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
14297178|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
14297179|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297180|NCT04527770|Dexamethasone|dexamethasone|mesh-list
14297181|NCT04527770|Midazolam|midazolam|mesh-list
14297182|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297183|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
14895498|NCT01275937|Esomeprazole|esomeprazole|mesh-list
14895499|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14297184|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
14297185|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297186|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297187|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14297188|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
14297189|NCT04527770|Hormones|hormones|mesh-ancestor
14895500|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895501|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14895502|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895503|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895504|NCT01275976|Complement C1s|complement c1s|mesh-list
14895505|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
15216940|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15216941|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15216942|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15216943|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15216944|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216945|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
15216946|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
15216947|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216948|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
15216949|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297190|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895506|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14895507|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
14895508|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895509|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14895510|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895511|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
14895512|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14895513|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14895514|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14895515|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895516|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895517|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14895518|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895519|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895520|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14895521|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895522|NCT01276067|Donepezil|donepezil|mesh-list
14895523|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14895524|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895525|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895526|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
14895527|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895528|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895529|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
14895530|NCT01276080|Donepezil|donepezil|mesh-list
14895531|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14895532|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895533|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895534|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
14895535|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895536|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895537|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
14895538|NCT01276093|Amiodarone|amiodarone|mesh-list
14895539|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14895540|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
14895541|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14895542|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895543|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895544|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14895545|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14895546|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14895547|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895548|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14895549|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14895550|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14895551|NCT01276210|Sorafenib|sorafenib|mesh-list
14895552|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895553|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14895554|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895555|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895556|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
14895557|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14895558|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14895559|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
14895560|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14895561|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717846|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717847|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14717848|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14717849|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
14717850|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717851|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
14717852|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
14717853|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14717854|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717855|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717856|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
14717857|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14717858|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717859|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717860|NCT00469976|Gemcitabine|gemcitabine|mesh-list
14717861|NCT00469976|Bevacizumab|bevacizumab|mesh-list
14895562|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14895563|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14895564|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14895565|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14895566|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14895567|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14895568|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14895569|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14895570|NCT01276431|Buprenorphine|buprenorphine|mesh-list
14895571|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14717862|NCT00469976|Carboplatin|carboplatin|mesh-list
14717863|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14717864|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717865|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14717866|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14895572|NCT01276431|Narcotics|narcotics|mesh-ancestor
14895573|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895574|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895575|NCT01276431|Analgesics|analgesics|mesh-ancestor
14895576|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
14895577|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895578|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14895579|NCT01276496|Paclitaxel|paclitaxel|mesh-list
14895580|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14895581|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14895582|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895583|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
14895584|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
14895585|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
14895586|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895587|NCT01276548|Carboplatin|carboplatin|mesh-list
14717867|NCT00469976|Growth Substances|growth substances|mesh-ancestor
14717868|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717869|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717870|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717871|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
14717872|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717873|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
14717874|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717875|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717876|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717877|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
14717878|NCT00470015|Aldesleukin|aldesleukin|mesh-list
14717879|NCT00470015|Interleukin-2|interleukin-2|mesh-list
14717880|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717881|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14717882|NCT00470015|Analgesics|analgesics|mesh-ancestor
14717883|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
14717884|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717885|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717886|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14717887|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14717888|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
14717889|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717890|NCT00470041|Lamivudine|lamivudine|mesh-list
14717891|NCT00470041|Zidovudine|zidovudine|mesh-list
14717892|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
14717893|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14717894|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14717895|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717896|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216950|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216951|NCT04672460|Talazoparib|talazoparib|mesh-list
15216952|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14717897|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717898|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14717899|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14717900|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
14895588|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895589|NCT01276600|Tenofovir|tenofovir|mesh-list
14895590|NCT01276600|Emtricitabine|emtricitabine|mesh-list
14895591|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
14895592|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895593|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14895594|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14895595|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895596|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895597|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14895598|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895599|NCT01276613|Gemcitabine|gemcitabine|mesh-list
14895600|NCT01276613|Losartan|losartan|mesh-list
14895601|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14895602|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
14895603|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895604|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895605|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
14895606|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895607|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895608|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895609|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
14895610|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895611|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14895612|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15216953|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15216954|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216955|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216956|NCT04671875|Antibodies|antibodies|mesh-list
15216957|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15216958|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
15216959|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216960|NCT04663997|Docetaxel|docetaxel|mesh-list
15216961|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
14717901|NCT00470197|Cytarabine|cytarabine|mesh-list
14717902|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
14895613|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14895614|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14895615|NCT01276691|Aspirin|aspirin|mesh-list
14895616|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14895617|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14895618|NCT01276691|Analgesics|analgesics|mesh-ancestor
14297191|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14297192|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297193|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14297194|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14297195|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297196|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14297197|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14895619|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
14895620|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895621|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297198|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14297199|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14297200|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
14297201|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
14297202|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
14297203|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
14297204|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297205|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297206|NCT04514211|Propofol|propofol|mesh-list
14297207|NCT04514211|Sevoflurane|sevoflurane|mesh-list
14297208|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14297209|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717903|NCT00470197|Alvocidib|alvocidib|mesh-list
14717904|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717905|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
14717906|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717907|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717908|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
14717909|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717910|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717911|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
14895622|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895623|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14895624|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14895625|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14895626|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895627|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14895628|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14895629|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895630|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
14895631|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
14895632|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
14895633|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14895634|NCT01276704|Estrogens|estrogens|mesh-ancestor
14895635|NCT01276704|Hormones|hormones|mesh-ancestor
14717912|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717913|NCT00470197|Analgesics|analgesics|mesh-ancestor
14717914|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
14717915|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14717916|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14717917|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14717918|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717919|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
14717920|NCT00470197|Growth Substances|growth substances|mesh-ancestor
14895636|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895637|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895638|NCT01276717|Vorinostat|vorinostat|mesh-list
15216962|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15216963|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
15216964|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
15216965|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
15216966|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216967|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15216968|NCT04651348|Antibodies|antibodies|mesh-list
15216969|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15216970|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
15216971|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216972|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
15216973|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15216974|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216975|NCT04636086|Vitamins|vitamins|mesh-ancestor
15216976|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
14297210|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297211|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15216977|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14895639|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895640|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14895641|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895642|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895643|NCT01276730|Interferons|interferons|mesh-list
14895644|NCT01276730|Tretinoin|tretinoin|mesh-list
14895645|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895646|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
14895647|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895648|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
14895649|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
14895650|NCT01276769|Paclitaxel|paclitaxel|mesh-list
14895651|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14895652|NCT01276769|Carboplatin|carboplatin|mesh-list
14895653|NCT01276769|Epirubicin|epirubicin|mesh-list
14895654|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14895655|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895656|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
14895657|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
14895658|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
14895659|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895660|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14895661|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14895662|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14895663|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895664|NCT01276834|Everolimus|everolimus|mesh-list
14895665|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895666|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895667|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
14895668|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895669|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14895670|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895671|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
14895672|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14895673|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895674|NCT01276925|Bupivacaine|bupivacaine|mesh-list
14895675|NCT01276925|Ropivacaine|ropivacaine|mesh-list
14895676|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
14895677|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
14895678|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895679|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895680|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
14895681|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895682|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
14895683|NCT01276977|Eletriptan|eletriptan|mesh-list
14895684|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14895685|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14895686|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
14895687|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895688|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895689|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895690|NCT01277016|Melphalan|melphalan|mesh-list
14895691|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14895692|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
14895693|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895694|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895695|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14895696|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895697|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
15216978|NCT04623099|Citalopram|citalopram|mesh-list
15216979|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15216980|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15216981|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15216982|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15216983|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15216984|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
15216985|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216986|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15216987|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
15216988|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15216989|NCT04563247|Antibodies|antibodies|mesh-list
15216990|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
14895698|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895699|NCT01277107|Zaleplon|zaleplon|mesh-list
14895700|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
14895701|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14895702|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895703|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895704|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
14895705|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
14895706|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895707|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895708|NCT01277172|Rituximab|rituximab|mesh-list
14895709|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14895710|NCT01277172|Antibodies|antibodies|mesh-list
14895711|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
14895712|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14895713|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
14895714|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717921|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14717922|NCT00470210|Ribavirin|ribavirin|mesh-list
14717923|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14717924|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
14895715|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895716|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14895717|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
14895718|NCT01277185|Calcium|calcium|mesh-list
14895719|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14895720|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895721|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14895722|NCT01277289|Dexamethasone|dexamethasone|mesh-list
14895723|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895724|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
14895725|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
14895726|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895727|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895728|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895729|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
14895730|NCT01277289|Hormones|hormones|mesh-ancestor
14895731|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895732|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895733|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895734|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14895735|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14915995|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
14297212|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
14297213|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
14717925|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717926|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
14717927|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717928|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
14717929|NCT00470223|Doxorubicin|doxorubicin|mesh-list
14717930|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14717931|NCT00470223|Methotrexate|methotrexate|mesh-list
14717932|NCT00470223|Etoposide|etoposide|mesh-list
14717933|NCT00470223|Ifosfamide|ifosfamide|mesh-list
14717934|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717935|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14717936|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14915996|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
14717937|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14717938|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14915997|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14915998|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895736|NCT01277484|Decitabine|decitabine|mesh-list
14895737|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14895738|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
14895739|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895740|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895741|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895742|NCT01277497|Calcium|calcium|mesh-list
14895743|NCT01277497|Sevelamer|sevelamer|mesh-list
14895744|NCT01277497|Calcium acetate|calcium acetate|mesh-list
14895745|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14895746|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895747|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
14895748|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
14895749|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895750|NCT01277627|Efavirenz|efavirenz|mesh-list
14895751|NCT01277627|Nevirapine|nevirapine|mesh-list
14895752|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14895753|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
14895754|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14895755|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14895756|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895757|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895758|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
14895759|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895760|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14895761|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14895762|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14895763|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14895764|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14895765|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14895766|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14297214|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14297215|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14297216|NCT04507503|Futibatinib|futibatinib|mesh-list
14297217|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297218|NCT04507204|Methylphenidate|methylphenidate|mesh-list
14297219|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14297220|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297221|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14297222|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14297223|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297224|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297225|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
14297226|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297227|NCT04505566|Ketorolac|ketorolac|mesh-list
14297228|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14297229|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
14297230|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14297231|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14297232|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14297233|NCT04505566|Analgesics|analgesics|mesh-ancestor
14297234|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
14297235|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297236|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297237|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297238|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297239|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14297240|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297241|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297242|NCT04504331|Tamoxifen|tamoxifen|mesh-list
14297243|NCT04504331|Infigratinib|infigratinib|mesh-list
14297244|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14297245|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
14297246|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895767|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895768|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14895769|NCT01277640|Dapivirine|dapivirine|mesh-list
14895770|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14895771|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14895772|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
14895773|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895774|NCT01277705|Vaccines|vaccines|mesh-list
14895775|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
14895776|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895777|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
14895778|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14895779|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14895780|NCT01277731|Prednisolone|prednisolone|mesh-list
14895781|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
14895782|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14895783|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
14895784|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895785|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
14895786|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
14895787|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895788|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895789|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15216991|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15216992|NCT04552080|Amoxicillin|amoxicillin|mesh-list
15216993|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15216994|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15216995|NCT04551131|Dexamethasone|dexamethasone|mesh-list
15216996|NCT04551131|Etoposide|etoposide|mesh-list
15216997|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
15216998|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14717939|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717940|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14717941|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
14717942|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14717943|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717944|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717945|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
14717946|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
14717947|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14717948|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717949|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
14717950|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14717951|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14717952|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14895790|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
14895791|NCT01277731|Hormones|hormones|mesh-ancestor
15216999|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
15217000|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
14895792|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895793|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14895794|NCT01277731|Protective Agents|protective agents|mesh-ancestor
14895795|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895796|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895797|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
14895798|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14895799|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
14895800|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895801|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14895802|NCT01277835|Lidocaine|lidocaine|mesh-list
14895803|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
14895804|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
14895805|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895806|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895807|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
14895808|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895809|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14895810|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14895811|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14895812|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895813|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895814|NCT01277913|Vitamin D|vitamin d|mesh-list
14895815|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
14895816|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
14895817|NCT01277913|Vitamins|vitamins|mesh-list
14895818|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
14895819|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895820|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14895821|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14895822|NCT01278004|Ethosuximide|ethosuximide|mesh-list
14895823|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
14895824|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
14895825|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14895826|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895827|NCT01278056|Deferasirox|deferasirox|mesh-list
14895828|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14895829|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
14895830|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
14895831|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895832|NCT01278082|Budesonide|budesonide|mesh-list
14895833|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217001|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217002|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217003|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15217004|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
15217005|NCT04551131|Hormones|hormones|mesh-ancestor
15217006|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217007|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217008|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895834|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14895835|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
14895836|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895837|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895838|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14895839|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
14895840|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
14895841|NCT01278082|Hormones|hormones|mesh-ancestor
14895842|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895843|NCT01278186|Paclitaxel|paclitaxel|mesh-list
14895844|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14895845|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895846|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14895847|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14895848|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14895849|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895850|NCT01278238|Phenylephrine|phenylephrine|mesh-list
14895851|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
14895852|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14895853|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
14895854|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
14895855|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895856|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895857|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
14895858|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14895859|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
14895860|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
14895861|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14895862|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14895863|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14895864|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
14895865|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895866|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895867|NCT01278238|Protective Agents|protective agents|mesh-ancestor
14895868|NCT01278264|Ropivacaine|ropivacaine|mesh-list
14895869|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
14895870|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
14895871|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14717953|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14717954|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
14717955|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14717956|NCT00470249|Gemcitabine|gemcitabine|mesh-list
14717957|NCT00470249|Carboplatin|carboplatin|mesh-list
14717958|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717959|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717960|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
14728996|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14895872|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895873|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
14895874|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895875|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14895876|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14895877|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
14895878|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14895879|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
14895880|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14895881|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895882|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15217009|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15217010|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15217011|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15217012|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217013|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217014|NCT04508855|Heparin|heparin|mesh-list
15217015|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15217016|NCT04508855|Tinzaparin|tinzaparin|mesh-list
15217017|NCT04508855|Dalteparin|dalteparin|mesh-list
14297247|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217018|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
14895883|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895884|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297248|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14297249|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297250|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14297251|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14297252|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14297253|NCT04497298|Vaccines|vaccines|mesh-list
14297254|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
14297255|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297256|NCT04483102|Liver Extracts|liver extracts|mesh-list
14297257|NCT04483102|Hematinics|hematinics|mesh-ancestor
14297258|NCT04482244|Cannabidiol|cannabidiol|mesh-list
14297259|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
14297260|NCT04473482|Ethanol|ethanol|mesh-list
14297261|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14297262|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297263|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297264|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297265|NCT04459715|Cisplatin|cisplatin|mesh-list
14297266|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327569|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14327570|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14327571|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14327572|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327573|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14327574|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
14327575|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
14327576|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14327577|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14327578|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
14327579|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
14327580|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14327581|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327582|NCT00803049|Teriflunomide|teriflunomide|mesh-list
14327583|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14327584|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14327585|NCT00803049|Analgesics|analgesics|mesh-ancestor
14717961|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717962|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
14717963|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14717964|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14717965|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717966|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
14717967|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717968|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
14717969|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14717970|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14717971|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14717972|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717973|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717974|NCT00470340|Gemcitabine|gemcitabine|mesh-list
14717975|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
14895885|NCT01278290|Hormones|hormones|mesh-ancestor
14297267|NCT04459117|Acetaminophen|acetaminophen|mesh-list
14297268|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14297269|NCT04459117|Analgesics|analgesics|mesh-ancestor
14297270|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
14297271|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297272|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895886|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895887|NCT01278446|Caseins|caseins|mesh-list
14895888|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
14895889|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
14895890|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895891|NCT01278459|Atorvastatin|atorvastatin|mesh-list
14895892|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14895893|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14895894|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
14895895|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895896|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14895897|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14895898|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895899|NCT01278498|Citalopram|citalopram|mesh-list
14895900|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14895901|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14895902|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895903|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895904|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895905|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
14895906|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895907|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14895908|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
14895909|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14895910|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
14895911|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14895912|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14895913|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14895914|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14895915|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895916|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
14895917|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895918|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895919|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14895920|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895921|NCT01278602|Rituximab|rituximab|mesh-list
14895922|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14895923|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895924|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
14717976|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
14717977|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14717978|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717979|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
14717980|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717981|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
14717982|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895925|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895926|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14895927|NCT01278758|Vadimezan|vadimezan|mesh-list
14895928|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895929|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
14895930|NCT01278784|Chitosan|chitosan|mesh-list
14895931|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14895932|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14895933|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14717983|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895934|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
14895935|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14895936|NCT01278784|Expectorants|expectorants|mesh-ancestor
14895937|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
14895938|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14895939|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
14895940|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895941|NCT01278784|Protective Agents|protective agents|mesh-ancestor
14895942|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895943|NCT01278784|Antidotes|antidotes|mesh-ancestor
14895944|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14895945|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14895946|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
14895947|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14895948|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
14895949|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
14895950|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
14895951|NCT01278784|Coagulants|coagulants|mesh-ancestor
14895952|NCT01278849|Vadimezan|vadimezan|mesh-list
14895953|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14915999|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916000|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
15217019|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15217020|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15217021|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217022|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
15217023|NCT04499950|Naltrexone|naltrexone|mesh-list
15217024|NCT04499950|Bupropion|bupropion|mesh-list
15217025|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15217026|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15217027|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217028|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
15217029|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217030|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15217031|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
14916001|NCT01390012|Hormones|hormones|mesh-ancestor
14916002|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916003|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14916004|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916005|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
14916006|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916007|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916008|NCT01390051|Tinzaparin|tinzaparin|mesh-list
14916009|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14916010|NCT01390051|Dalteparin|dalteparin|mesh-list
14916011|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
14916012|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14916013|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14916014|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916015|NCT01390311|Azacitidine|azacitidine|mesh-list
14916016|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14916017|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
14916018|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916019|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916020|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916021|NCT01390324|Naproxen|naproxen|mesh-list
14916022|NCT01390324|Naratriptan|naratriptan|mesh-list
14916023|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14916024|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14895954|NCT01279083|Timolol|timolol|mesh-list
14895955|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14895956|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14895957|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14895958|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
14895959|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14895960|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895961|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895962|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14895963|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14895964|NCT01279096|Dexamethasone|dexamethasone|mesh-list
14895965|NCT01279096|Etoposide|etoposide|mesh-list
14895966|NCT01279096|Asparaginase|asparaginase|mesh-list
14895967|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
14895968|NCT01279096|Clofarabine|clofarabine|mesh-list
14895969|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14895970|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
14895971|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
14895972|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14895973|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895974|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14895975|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
14895976|NCT01279096|Hormones|hormones|mesh-ancestor
14895977|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14895978|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14895979|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14895980|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14895981|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14895982|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14895983|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14895984|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14895985|NCT01279096|Analgesics|analgesics|mesh-ancestor
14895986|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
14895987|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14895988|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
14895989|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14895990|NCT01279213|Clozapine|clozapine|mesh-list
14895991|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14895992|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14895993|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14895994|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14895995|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14895996|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14895997|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14895998|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
14895999|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896000|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896001|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14896002|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14896003|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
14896004|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
14896005|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
14896006|NCT01279252|Metronidazole|metronidazole|mesh-list
14297273|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
14297274|NCT04457557|Ropivacaine|ropivacaine|mesh-list
14297275|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
14297276|NCT04457557|Anesthetics|anesthetics|mesh-list
14297277|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297278|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297279|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
14297280|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297281|NCT04427072|Docetaxel|docetaxel|mesh-list
14297282|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297283|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
14297284|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
14297285|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
14297286|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297287|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15217032|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15217033|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14896007|NCT01279252|Clarithromycin|clarithromycin|mesh-list
14896008|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
14896009|NCT01279252|Lansoprazole|lansoprazole|mesh-list
14896010|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
14896011|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217034|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14896012|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896013|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14896014|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14896015|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14896016|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896017|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896018|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14717984|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14717985|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
15217035|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217036|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896019|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14896020|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14896021|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14896022|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896023|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14896024|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896025|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896026|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14896027|NCT01279291|Gemcitabine|gemcitabine|mesh-list
14896028|NCT01279291|Paclitaxel|paclitaxel|mesh-list
14896029|NCT01279291|Carboplatin|carboplatin|mesh-list
14896030|NCT01279291|Doxorubicin|doxorubicin|mesh-list
14896031|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14896032|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14896033|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896034|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14896035|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14896036|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14896037|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896038|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14717986|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717987|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
14717988|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
14717989|NCT00470353|Calcium|calcium|mesh-list
14717990|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14717991|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14717992|NCT00470353|Vitamins|vitamins|mesh-ancestor
14717993|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
14717994|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14717995|NCT00470353|Antacids|antacids|mesh-ancestor
14717996|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14717997|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14717998|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
14717999|NCT00470405|Pemetrexed|pemetrexed|mesh-list
14718000|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718001|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718002|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718003|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14718004|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14896039|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
15217037|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
14896040|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
15217038|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217039|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15217040|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15217041|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217042|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14718005|NCT00470483|Paroxetine|paroxetine|mesh-list
14728997|NCT00521092|Growth Substances|growth substances|mesh-ancestor
14896041|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896042|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896043|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896044|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
14896045|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896046|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896047|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14896048|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14896049|NCT01279434|Vitamins|vitamins|mesh-list
14896050|NCT01279434|Vitamin E|vitamin e|mesh-list
14896051|NCT01279434|Tocopherols|tocopherols|mesh-list
14896052|NCT01279434|Tocotrienols|tocotrienols|mesh-list
14896053|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
14896054|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
14896055|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896056|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
14896057|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896058|NCT01279434|Protective Agents|protective agents|mesh-ancestor
14896059|NCT01279499|Remifentanil|remifentanil|mesh-list
14896060|NCT01279499|Propofol|propofol|mesh-list
14896061|NCT01279499|Sevoflurane|sevoflurane|mesh-list
14896062|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14896063|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896064|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896065|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14896066|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
14896067|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
14896068|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14896069|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14896070|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14718006|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14718007|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14718008|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14718009|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718010|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718011|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
14718012|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718013|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14718014|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
14718015|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14718016|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14718017|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14718018|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896071|NCT01279499|Narcotics|narcotics|mesh-ancestor
14896072|NCT01279499|Analgesics|analgesics|mesh-ancestor
14896073|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
14896074|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896075|NCT01279512|Metformin|metformin|mesh-list
14896076|NCT01279512|Acarbose|acarbose|mesh-list
14896077|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14896078|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896079|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14896080|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217043|NCT04495621|Cetuximab|cetuximab|mesh-list
15217044|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217045|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217046|NCT04463394|Vasopressins|vasopressins|mesh-list
15217047|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
15217048|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
15217049|NCT04463394|Coagulants|coagulants|mesh-ancestor
15217050|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15217051|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15217052|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
15217053|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217054|NCT04454476|Trametinib|trametinib|mesh-list
15217055|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217056|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15217057|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217058|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217059|NCT04454411|Naltrexone|naltrexone|mesh-list
15217060|NCT04454411|Buprenorphine|buprenorphine|mesh-list
15217061|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15217062|NCT04454411|Narcotics|narcotics|mesh-ancestor
15217063|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15217064|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217065|NCT04454411|Analgesics|analgesics|mesh-ancestor
15217066|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
14896081|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896082|NCT01279551|Lidocaine|lidocaine|mesh-list
14896083|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
14896084|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
14896085|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
14896086|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896087|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896088|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
14896089|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896090|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14896091|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14896092|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14896093|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14896094|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896095|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
14896096|NCT01279629|Tazarotene|tazarotene|mesh-list
14896097|NCT01279629|Calcipotriene|calcipotriene|mesh-list
14896098|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14896099|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
14896100|NCT01279668|Montelukast|montelukast|mesh-list
14896101|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14896102|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
14896103|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14896104|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
14896105|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896106|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896107|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14896108|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14896109|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896110|NCT01279694|Prednisone|prednisone|mesh-list
14896111|NCT01279694|Melphalan|melphalan|mesh-list
14896112|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896113|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
14896114|NCT01279694|Hormones|hormones|mesh-ancestor
14896115|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896116|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896117|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14896118|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896119|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14896120|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
14896121|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896122|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14896123|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896124|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
14896125|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14896126|NCT01279707|Epratuzumab|epratuzumab|mesh-list
14896127|NCT01279707|Veltuzumab|veltuzumab|mesh-list
14896128|NCT01279707|Antibodies|antibodies|mesh-list
14896129|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
14718019|NCT00470509|Adalimumab|adalimumab|mesh-list
14718020|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896130|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14718021|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718022|NCT00470522|Folic Acid|folic acid|mesh-list
14718023|NCT00470522|Methotrexate|methotrexate|mesh-list
14718024|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14718025|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
14718026|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718027|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718028|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14718029|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
14728998|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896131|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
14896132|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718030|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718031|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718032|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718033|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718034|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14718035|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14718036|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
14718037|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718038|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14718039|NCT00470522|Hematinics|hematinics|mesh-ancestor
14718040|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
14718041|NCT00470522|Vitamins|vitamins|mesh-ancestor
14718042|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
14718043|NCT00470561|Aspirin|aspirin|mesh-list
14896133|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896134|NCT01279811|Dopamine|dopamine|mesh-list
14896135|NCT01279811|Norepinephrine|norepinephrine|mesh-list
14896136|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14896137|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14718044|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718045|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14718046|NCT00470561|Analgesics|analgesics|mesh-ancestor
14718047|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
14718048|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718049|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718050|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896138|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14896139|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
14896140|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896141|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896142|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896143|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
14896144|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
14896145|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896146|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14896147|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
14896148|NCT01279811|Protective Agents|protective agents|mesh-ancestor
14896149|NCT01279876|Melatonin|melatonin|mesh-list
14896150|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
14896151|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896152|NCT01279876|Protective Agents|protective agents|mesh-ancestor
14896153|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896154|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896155|NCT01279902|Rituximab|rituximab|mesh-list
14896156|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14896157|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896158|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
14896159|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896160|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896161|NCT01279915|Linaclotide|linaclotide|mesh-list
14896162|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14896163|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
14896164|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896165|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896166|NCT01279980|Anesthetics|anesthetics|mesh-list
14896167|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
14896168|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896169|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896170|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
14896171|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896172|NCT01280006|Celecoxib|celecoxib|mesh-list
14896173|NCT01280006|Indomethacin|indomethacin|mesh-list
14718051|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718052|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14896174|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14896175|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14896176|NCT01280006|Analgesics|analgesics|mesh-ancestor
14896177|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
14896178|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896179|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896180|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896181|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896182|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14896183|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14896184|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896185|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896186|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
14896187|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
14896188|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14896189|NCT01280071|Aminophylline|aminophylline|mesh-list
14896190|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14896191|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
14896192|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896193|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896194|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14896195|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
14896196|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14896197|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14896198|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896199|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896200|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14896201|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14896202|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
14896203|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896204|NCT01280071|Protective Agents|protective agents|mesh-ancestor
14896205|NCT01280149|Substance P|substance p|mesh-list
14896206|NCT01280149|Neurokinin A|neurokinin a|mesh-list
14896207|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896208|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896209|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896210|NCT01280162|Piperaquine|piperaquine|mesh-list
14896211|NCT01280162|Artenimol|artenimol|mesh-list
14896212|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
14896213|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14896214|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14896215|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896216|NCT01280175|Charcoal|charcoal|mesh-list
14896217|NCT01280175|Antidotes|antidotes|mesh-ancestor
14896218|NCT01280175|Protective Agents|protective agents|mesh-ancestor
14896219|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896220|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14896221|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
14896222|NCT01280188|Coagulants|coagulants|mesh-ancestor
14896223|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14896224|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
14896225|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896226|NCT01280214|Triamcinolone|triamcinolone|mesh-list
14896227|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896228|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
14297288|NCT04417569|Estradiol|estradiol|mesh-list
14896229|NCT01280214|Hormones|hormones|mesh-ancestor
15217067|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217068|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15217069|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15217070|NCT04447846|Cannabidiol|cannabidiol|mesh-list
15217071|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
15225394|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15225395|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15225396|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225397|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225398|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14896230|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896231|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896232|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14896233|NCT01280240|Hematinics|hematinics|mesh-ancestor
14896234|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14896235|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14896236|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
14896237|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896238|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896239|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14896240|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14896241|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14896242|NCT01280526|Romidepsin|romidepsin|mesh-list
14896243|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896244|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896245|NCT01280669|Sirolimus|sirolimus|mesh-list
14896246|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896247|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896248|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896249|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896250|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
14896251|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896252|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
14896253|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896254|NCT01280682|Rituximab|rituximab|mesh-list
14896255|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14896256|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896257|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
14896258|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896259|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896260|NCT01280734|Melatonin|melatonin|mesh-list
14896261|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
14896262|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896263|NCT01280734|Protective Agents|protective agents|mesh-ancestor
14896264|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896265|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916025|NCT01390324|Analgesics|analgesics|mesh-ancestor
14916026|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
14916027|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225399|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15225400|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14896266|NCT01280929|Ranibizumab|ranibizumab|mesh-list
14896267|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14896268|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14896269|NCT01280929|Growth Substances|growth substances|mesh-ancestor
14896270|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896271|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
14896272|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896273|NCT01280994|Xenon|xenon|mesh-list
14896274|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14896275|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
14896276|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
14896277|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896278|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896279|NCT01281111|Aspirin|aspirin|mesh-list
14896280|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14896281|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14896282|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14896283|NCT01281111|Analgesics|analgesics|mesh-ancestor
14896284|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
14896285|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896286|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896287|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896288|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896289|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14896290|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14896291|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896292|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14896293|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14896294|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896295|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
14896296|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
14896297|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896298|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
14896299|NCT01281150|Paclitaxel|paclitaxel|mesh-list
14896300|NCT01281150|Carboplatin|carboplatin|mesh-list
14896301|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14896302|NCT01281150|Veliparib|veliparib|mesh-list
14896303|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14896304|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896305|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
14896306|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
14718053|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14718054|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718055|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14718056|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718057|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718058|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
14718059|NCT00470665|Sirolimus|sirolimus|mesh-list
14718060|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14718061|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718062|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14718063|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718064|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
14718065|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14718066|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
14718067|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718068|NCT00470678|Ranibizumab|ranibizumab|mesh-list
14896307|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
14896308|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896309|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14896310|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896311|NCT01281163|Lapatinib|lapatinib|mesh-list
14896312|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896313|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14896314|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896315|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896316|NCT01281228|Exenatide|exenatide|mesh-list
14896317|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14896318|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896319|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14896320|NCT01281228|Incretins|incretins|mesh-ancestor
14896321|NCT01281228|Hormones|hormones|mesh-ancestor
14896322|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896323|NCT01281514|Carboplatin|carboplatin|mesh-list
14896324|NCT01281514|Doxorubicin|doxorubicin|mesh-list
14896325|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14896326|NCT01281514|Everolimus|everolimus|mesh-list
14896327|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896328|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896329|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14896330|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14896331|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896332|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896333|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896334|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
14896335|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896336|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14896337|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14896338|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14896339|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896340|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896341|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14896342|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14896343|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14896344|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
14896345|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896346|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896347|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14896348|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14896349|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
14896350|NCT01281540|Cisapride|cisapride|mesh-list
14896351|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896352|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896353|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14896354|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
14896355|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896356|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896357|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896358|NCT01281553|Cisapride|cisapride|mesh-list
14896359|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896360|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896361|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14896362|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
14896363|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896364|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896365|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896366|NCT01281566|Cisapride|cisapride|mesh-list
14896367|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896368|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896369|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14896370|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
14896371|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896372|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896373|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896374|NCT01281579|Canagliflozin|canagliflozin|mesh-list
14896375|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14896376|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896377|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14896378|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718069|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14718070|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14718071|NCT00470678|Growth Substances|growth substances|mesh-ancestor
14718072|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718073|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
14718074|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718075|NCT00470743|Ibuprofen|ibuprofen|mesh-list
14718076|NCT00470743|Indomethacin|indomethacin|mesh-list
14718077|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718078|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14896379|NCT01281605|Insulin|insulin|mesh-list
14896380|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14896381|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
14718079|NCT00470743|Analgesics|analgesics|mesh-ancestor
14896382|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14896383|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896384|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14896385|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14896386|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896387|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896388|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
14896389|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896390|NCT01281696|Bevacizumab|bevacizumab|mesh-list
14896391|NCT01281696|Methotrexate|methotrexate|mesh-list
14896392|NCT01281696|Etoposide|etoposide|mesh-list
14896393|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14896394|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896395|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14896396|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14896397|NCT01281696|Growth Substances|growth substances|mesh-ancestor
14896398|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896399|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
14896400|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14896401|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
14896402|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14896403|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14896404|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
14896405|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896406|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
14896407|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896408|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14896409|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896410|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
14896411|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896412|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14896413|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14896414|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14896415|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14896416|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
14896417|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14896418|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14896419|NCT01281748|Prednisolone|prednisolone|mesh-list
14896420|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
14896421|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14896422|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
14896423|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896424|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
14896425|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
14896426|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896427|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896428|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896429|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
14896430|NCT01281748|Hormones|hormones|mesh-ancestor
14896431|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896432|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14896433|NCT01281748|Protective Agents|protective agents|mesh-ancestor
14297289|NCT04417569|Progesterone|progesterone|mesh-list
14896434|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14896435|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896436|NCT01281761|Irinotecan|irinotecan|mesh-list
14896437|NCT01281761|Cetuximab|cetuximab|mesh-list
14896438|NCT01281761|Simvastatin|simvastatin|mesh-list
14896439|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14896440|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14896441|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896442|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217072|NCT04436133|Vaccines|vaccines|mesh-list
15217073|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
15217074|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217075|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
15217076|NCT04424602|Dimethoate|dimethoate|mesh-list
15217077|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217078|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217079|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217080|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14297290|NCT04417569|Hormones|hormones|mesh-ancestor
14896443|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896444|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14896445|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14896446|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14896447|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
14896448|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14896449|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14896450|NCT01281787|Losartan|losartan|mesh-list
14896451|NCT01281787|Metoprolol|metoprolol|mesh-list
14896452|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14896453|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14896454|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14896455|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14896456|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896457|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
14896458|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
14896459|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896460|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896461|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14896462|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14896463|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14896464|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
14896465|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896466|NCT01281800|Gemcitabine|gemcitabine|mesh-list
14896467|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14896468|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
14896469|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896470|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896471|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
14896472|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896473|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896474|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896475|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
14896476|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896477|NCT01281813|Ritonavir|ritonavir|mesh-list
14896478|NCT01281813|Darunavir|darunavir|mesh-list
14896479|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14896480|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14896481|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
14896482|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896483|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896484|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14896485|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14896486|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
14896487|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896488|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14896489|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14896490|NCT01281852|Paclitaxel|paclitaxel|mesh-list
14297291|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14297292|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297293|NCT04417569|Estrogens|estrogens|mesh-ancestor
14297294|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14297295|NCT04417569|Progestins|progestins|mesh-ancestor
14297296|NCT04411680|Sargramostim|sargramostim|mesh-list
14297297|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
14297298|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297299|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14297300|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
14297301|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
14896491|NCT01281852|Cisplatin|cisplatin|mesh-list
15217081|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
15217082|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217083|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217084|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217085|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
15217086|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15217087|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217088|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
14896492|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14896493|NCT01281852|Veliparib|veliparib|mesh-list
14896494|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14896495|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896496|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14896497|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14896498|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14896499|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896500|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14896501|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896502|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
14896503|NCT01281878|Pyridoxal|pyridoxal|mesh-list
14896504|NCT01281878|Pyridoxine|pyridoxine|mesh-list
14896505|NCT01281878|Vitamins|vitamins|mesh-ancestor
14896506|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
14896507|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896508|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
14896509|NCT01281891|Morphine|morphine|mesh-list
14896510|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14896511|NCT01281891|Narcotics|narcotics|mesh-ancestor
14896512|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896513|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896514|NCT01281891|Analgesics|analgesics|mesh-ancestor
14896515|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
14896516|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896517|NCT01281943|Sirolimus|sirolimus|mesh-list
15217089|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15217090|NCT04398329|Bupivacaine|bupivacaine|mesh-list
15217091|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
15217092|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
14297302|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14297303|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
14297304|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297305|NCT04405908|Antacids|antacids|mesh-ancestor
14896518|NCT01281943|Doxorubicin|doxorubicin|mesh-list
14896519|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14896520|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896521|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896522|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14896523|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14896524|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896525|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896526|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896527|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896528|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
14896529|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896530|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
14896531|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896532|NCT01282047|Lenalidomide|lenalidomide|mesh-list
14896533|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
14896534|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896535|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14896536|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14896537|NCT01282047|Growth Substances|growth substances|mesh-ancestor
14896538|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
14896539|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896540|NCT01282073|Cyclosporine|cyclosporine|mesh-list
14896541|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
14896542|NCT01282073|Cyclosporins|cyclosporins|mesh-list
14896543|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896544|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896545|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896546|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
14896547|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896548|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
14896549|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896550|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14896551|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896552|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14896553|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896554|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896555|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15217093|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15217094|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217095|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
15217096|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217097|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
14896556|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
14896557|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896558|NCT01282151|Cisplatin|cisplatin|mesh-list
14896559|NCT01282151|Pemetrexed|pemetrexed|mesh-list
14896560|NCT01282151|Docetaxel|docetaxel|mesh-list
14896561|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896562|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896563|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896564|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14896565|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14896566|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
14896567|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
14896568|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
14896569|NCT01282333|Gemcitabine|gemcitabine|mesh-list
14718080|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
14896570|NCT01282333|Veliparib|veliparib|mesh-list
14896571|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896572|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14896573|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
14896574|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896575|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
14896576|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896577|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896578|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896579|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
14896580|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896581|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14896582|NCT01282385|Simvastatin|simvastatin|mesh-list
14896583|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14896584|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14896585|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
14896586|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896587|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14896588|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14896589|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896590|NCT01282398|Simvastatin|simvastatin|mesh-list
14896591|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14896592|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14896593|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
14718081|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718082|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718083|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718084|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718085|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718086|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718087|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718088|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
14718089|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
14718090|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718091|NCT00470821|Melatonin|melatonin|mesh-list
14718092|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
14718093|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718094|NCT00470821|Protective Agents|protective agents|mesh-ancestor
14896594|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896595|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14896596|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14896597|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896598|NCT01282502|Midostaurin|midostaurin|mesh-list
14896599|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896600|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14896601|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718095|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718096|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718097|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14718098|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
14718099|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14718100|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14718101|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718102|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718103|NCT00470873|Urological Agents|urological agents|mesh-ancestor
14718104|NCT00470886|Telmisartan|telmisartan|mesh-list
14718105|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14718106|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14896602|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896603|NCT01282515|Clobetasol|clobetasol|mesh-list
14896604|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896605|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
14896606|NCT01282515|Hormones|hormones|mesh-ancestor
14896607|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718107|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14718108|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718109|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
14718110|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14718111|NCT00470912|Protective Agents|protective agents|mesh-ancestor
14718112|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718113|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14728999|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
14729000|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14729001|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729002|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729003|NCT00521131|Levocetirizine|levocetirizine|mesh-list
14729004|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14729005|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14729006|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
14729007|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
14729008|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729009|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896608|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896609|NCT01282528|Infliximab|infliximab|mesh-list
14896610|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
14896611|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896612|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896613|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
14896614|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14896615|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14896616|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14896617|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14896618|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896619|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
14896620|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718114|NCT00470977|Ranibizumab|ranibizumab|mesh-list
14718115|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14718116|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14718117|NCT00470977|Growth Substances|growth substances|mesh-ancestor
14718118|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718119|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
14718120|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718121|NCT00470990|Acyline|acyline|mesh-list
14718122|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
14718123|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718124|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718125|NCT00471003|Telmisartan|telmisartan|mesh-list
14718126|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14896621|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896622|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14896623|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896624|NCT01282619|Huperzine A|huperzine a|mesh-list
14896625|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14896626|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896627|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896628|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
14896629|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896630|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217098|NCT04391855|Tramadol|tramadol|mesh-list
14718127|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14718128|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14718129|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718130|NCT00471029|Esomeprazole|esomeprazole|mesh-list
14718131|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14718132|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718133|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14718134|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718135|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718136|NCT00471042|Buprenorphine|buprenorphine|mesh-list
14718137|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15217099|NCT04391855|Ropivacaine|ropivacaine|mesh-list
14718138|NCT00471042|Narcotics|narcotics|mesh-ancestor
14896631|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15217100|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15217101|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15217102|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217103|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15217104|NCT04391855|Analgesics|analgesics|mesh-ancestor
15217105|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
14896632|NCT01282619|Protective Agents|protective agents|mesh-ancestor
14896633|NCT01282632|Olanzapine|olanzapine|mesh-list
14896634|NCT01282632|Risperidone|risperidone|mesh-list
14896635|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14896636|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
14896637|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896638|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217106|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896639|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896640|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14896641|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14896642|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896643|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14896644|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14896645|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
14896646|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
14896647|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
14896648|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896649|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14297306|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297307|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14297308|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14297309|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14297310|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14896650|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14896651|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14896652|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916028|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916029|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916030|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916031|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
14916032|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14916033|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916034|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916035|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14916036|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14916037|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14916038|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
14916039|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916040|NCT01390337|Cytarabine|cytarabine|mesh-list
14916041|NCT01390337|Daunorubicin|daunorubicin|mesh-list
14916042|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14916043|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
14916044|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916045|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916046|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
14916047|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916048|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916049|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
14916050|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916051|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14916052|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14916053|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14916054|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916055|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
14916056|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14297311|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896653|NCT01282697|Sirolimus|sirolimus|mesh-list
14896654|NCT01282697|Irinotecan|irinotecan|mesh-list
14896655|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14896656|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14896657|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896658|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896659|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896660|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896661|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896662|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896663|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
14896664|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896665|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
14896666|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896667|NCT01282762|Vaccines|vaccines|mesh-list
14896668|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
14896669|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896670|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14896671|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14896672|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14896673|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
14896674|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896675|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896676|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896677|NCT01282840|Urological Agents|urological agents|mesh-ancestor
14896678|NCT01282879|Itraconazole|itraconazole|mesh-list
14896679|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
14896680|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896681|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14896682|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14896683|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896684|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896685|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14896686|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
14896687|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896688|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896689|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14896690|NCT01283048|Bevacizumab|bevacizumab|mesh-list
14896691|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14896692|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896693|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14896694|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14297312|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
14896695|NCT01283048|Growth Substances|growth substances|mesh-ancestor
14896696|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896697|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
14896698|NCT01283061|Zafirlukast|zafirlukast|mesh-list
14896699|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14896700|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
14896701|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14896702|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
14896703|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896704|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896705|NCT01283100|Dolutegravir|dolutegravir|mesh-list
14896706|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14896707|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14896708|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896709|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896710|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14896711|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14896712|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
14896713|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896714|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14896715|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896716|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14896717|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14896718|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896719|NCT01283204|Leucovorin|leucovorin|mesh-list
14896720|NCT01283204|Paclitaxel|paclitaxel|mesh-list
14896721|NCT01283204|Docetaxel|docetaxel|mesh-list
14896722|NCT01283204|Cisplatin|cisplatin|mesh-list
14896723|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
14896724|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
14896725|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14896726|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896727|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
14896728|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
14896729|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
14896730|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896731|NCT01283204|Antidotes|antidotes|mesh-ancestor
14896732|NCT01283204|Protective Agents|protective agents|mesh-ancestor
14896733|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896734|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
14896735|NCT01283204|Vitamins|vitamins|mesh-ancestor
14896736|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
14896737|NCT01283217|Cisplatin|cisplatin|mesh-list
14896738|NCT01283217|Docetaxel|docetaxel|mesh-list
14896739|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896740|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14896741|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217107|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15217108|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15217109|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14896742|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14896743|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896744|NCT01283256|Zonisamide|zonisamide|mesh-list
15217110|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
15217111|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217112|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217113|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
14718139|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718140|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718141|NCT00471042|Analgesics|analgesics|mesh-ancestor
14718142|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
14718143|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718144|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14718145|NCT00471055|Capsaicin|capsaicin|mesh-list
14718146|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
14718147|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718148|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
14718149|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718150|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718151|NCT00471094|Lansoprazole|lansoprazole|mesh-list
14718152|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
14718153|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896745|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
14896746|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14896747|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14896748|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896749|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14896750|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896751|NCT01283360|Tenofovir|tenofovir|mesh-list
14896752|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
14896753|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896754|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14896755|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14896756|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896757|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896758|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14896759|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14896760|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
14896761|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14297313|NCT04363437|Colchicine|colchicine|mesh-list
14297314|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
14297315|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297316|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
14297317|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
14297318|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
14896762|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896763|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896764|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14896765|NCT01283412|Analgesics|analgesics|mesh-ancestor
14896766|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
14896767|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896768|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14896769|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14896770|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14896771|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
14896772|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896773|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896774|NCT01283646|Vitamins|vitamins|mesh-list
14896775|NCT01283646|Ascorbic Acid|ascorbic acid|mesh-list
14896776|NCT01283646|Folic Acid|folic acid|mesh-list
14896777|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
14896778|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
14896779|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896780|NCT01283646|Antioxidants|antioxidants|mesh-ancestor
14896781|NCT01283646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896782|NCT01283646|Protective Agents|protective agents|mesh-ancestor
14896783|NCT01283646|Hematinics|hematinics|mesh-ancestor
14896784|NCT01283724|Dienogest|dienogest|mesh-list
14896785|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14896786|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
14896787|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14896788|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896789|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14297319|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297320|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896790|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14896791|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14896792|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14896793|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
14896794|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896795|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14896796|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896797|NCT01283763|Imiquimod|imiquimod|mesh-list
14896798|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14896799|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
14896800|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896801|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896802|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
14896803|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
14896804|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896805|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
14896806|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896807|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896808|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217114|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
14718154|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718155|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14718156|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718157|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718158|NCT00471159|Docetaxel|docetaxel|mesh-list
14718159|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718160|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
14718161|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
14718162|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
14718163|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718164|NCT00471185|Acyline|acyline|mesh-list
14718165|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
14718166|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718167|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718168|NCT00471289|Paclitaxel|paclitaxel|mesh-list
14718169|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14718170|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217115|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15217116|NCT04391855|Narcotics|narcotics|mesh-ancestor
15217117|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
15217118|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15217119|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
15217120|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217121|NCT04381897|Expectorants|expectorants|mesh-ancestor
15217122|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
15217123|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15217124|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
15217125|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217126|NCT04381897|Protective Agents|protective agents|mesh-ancestor
15217127|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217128|NCT04381897|Antidotes|antidotes|mesh-ancestor
15217129|NCT04371380|Rilpivirine|rilpivirine|mesh-list
15217130|NCT04371380|Cabotegravir|cabotegravir|mesh-list
15217131|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15217132|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15217133|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217134|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217135|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
15217136|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217137|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15217138|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15217139|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15217140|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15217141|NCT04297618|Lifitegrast|lifitegrast|mesh-list
14718171|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
15217142|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15217143|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15217144|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
15217145|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15217146|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15217147|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217148|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14896809|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
14896810|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896811|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896812|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14896813|NCT01283789|Everolimus|everolimus|mesh-list
14896814|NCT01283789|Lapatinib|lapatinib|mesh-list
14896815|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896816|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896817|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
14896818|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896819|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14896820|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896821|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896822|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
14896823|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896824|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896825|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14896826|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
14896827|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896828|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896829|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896830|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896831|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
14896832|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896833|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896834|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14896835|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
14896836|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896837|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896838|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896839|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896840|NCT01283919|Pantoprazole|pantoprazole|mesh-list
14896841|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896842|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896843|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14896844|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896845|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896846|NCT01283932|Pantoprazole|pantoprazole|mesh-list
14896847|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896848|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896849|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14896850|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896851|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896852|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14896853|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14896854|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14896855|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14896856|NCT01284166|Timolol|timolol|mesh-list
14896857|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14896858|NCT01284166|Dorzolamide|dorzolamide|mesh-list
14896859|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14896860|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14896861|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14896862|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15217149|NCT04266665|Analgesics|analgesics|mesh-ancestor
15217150|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
15217151|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217152|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15217153|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15217154|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15217155|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
15217156|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217157|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217158|NCT04259749|Menthol|menthol|mesh-list
15217159|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
15217160|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14896863|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
14896864|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896865|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896866|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896867|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14896868|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14896869|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14896870|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14896871|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14896872|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14896873|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896874|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
14896875|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14896876|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
14896877|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896878|NCT01284309|Mirabegron|mirabegron|mesh-list
14896879|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14896880|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14896881|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14896882|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
14896883|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896884|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896885|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896886|NCT01284309|Urological Agents|urological agents|mesh-ancestor
14916057|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916058|NCT01390480|Vitamins|vitamins|mesh-ancestor
14916059|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
14916060|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14916061|NCT01390506|Selenious Acid|selenious acid|mesh-list
14916062|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
14916063|NCT01390506|Trace Elements|trace elements|mesh-ancestor
14916064|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
14916065|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916066|NCT01390519|Everolimus|everolimus|mesh-list
14916067|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916068|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916069|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
14916070|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718172|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
14718173|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
14718174|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718175|NCT00471341|Celecoxib|celecoxib|mesh-list
14718176|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718177|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14718178|NCT00471341|Analgesics|analgesics|mesh-ancestor
14718179|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
14916071|NCT01390571|Temozolomide|temozolomide|mesh-list
14916072|NCT01390571|Olaparib|olaparib|mesh-list
15217161|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15217162|NCT04250636|Antibodies|antibodies|mesh-list
15217163|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
15217164|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15217165|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
15217166|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217167|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217168|NCT04246996|Gentamicins|gentamicins|mesh-list
15217169|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15217170|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217171|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15217172|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217173|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718180|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718181|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718182|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217174|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14718183|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718184|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14718185|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718186|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718187|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718188|NCT00471393|Diclofenac|diclofenac|mesh-list
14718189|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14718190|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718191|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14718192|NCT00471393|Analgesics|analgesics|mesh-ancestor
14718193|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
14718194|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718195|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718196|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718197|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718198|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718199|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896887|NCT01284413|Gemcitabine|gemcitabine|mesh-list
14896888|NCT01284413|Cisplatin|cisplatin|mesh-list
14896889|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896890|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14896891|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
14896892|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896893|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
14896894|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896895|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896896|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14896897|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
14896898|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896899|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
14896900|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14896901|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
14896902|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896903|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
14896904|NCT01284439|Protective Agents|protective agents|mesh-ancestor
14896905|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
14896906|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896907|NCT01284478|Dexamethasone|dexamethasone|mesh-list
14896908|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14896909|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
14896910|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
14896911|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896912|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896913|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896914|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
14896915|NCT01284478|Hormones|hormones|mesh-ancestor
14896916|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14896917|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14896918|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896919|NCT01284556|Phenobarbital|phenobarbital|mesh-list
14896920|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
14896921|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14896922|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14896923|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896924|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14896925|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14896926|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896927|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896928|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
14896929|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
14896930|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14896931|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14896932|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14896933|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
14896934|NCT01284647|Sucralfate|sucralfate|mesh-list
14896935|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14896936|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896937|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896938|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
14896939|NCT01284725|Azathioprine|azathioprine|mesh-list
14896940|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14896941|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14896942|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14896943|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14896944|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
14896945|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14896946|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14896947|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14896948|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896949|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
14896950|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15217175|NCT04245748|Citalopram|citalopram|mesh-list
15217176|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15217177|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15217178|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14896951|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
14896952|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896953|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14896954|NCT01284764|Mosapride|mosapride|mesh-list
14896955|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14896956|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14896957|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
14896958|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896959|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896960|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896961|NCT01284855|Antivenins|antivenins|mesh-list
14896962|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
15217179|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217180|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217181|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
15217182|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896963|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896964|NCT01284868|Propranolol|propranolol|mesh-list
14896965|NCT01284868|Bisoprolol|bisoprolol|mesh-list
14896966|NCT01284868|Mirabegron|mirabegron|mesh-list
14896967|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14896968|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14896969|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
14896970|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14896971|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896972|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896973|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14896974|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14896975|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
14896976|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14896977|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14896978|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14896979|NCT01284868|Urological Agents|urological agents|mesh-ancestor
14896980|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
14896981|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
14896982|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14896983|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14896984|NCT01284907|Vitamin D|vitamin d|mesh-list
14896985|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
14896986|NCT01284907|Vitamins|vitamins|mesh-ancestor
14896987|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
14896988|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14896989|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14896990|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14896991|NCT01284946|Deferasirox|deferasirox|mesh-list
14896992|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14896993|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
14896994|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
14896995|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14896996|NCT01285037|Gemcitabine|gemcitabine|mesh-list
14896997|NCT01285037|Cetuximab|cetuximab|mesh-list
14896998|NCT01285037|Ramucirumab|ramucirumab|mesh-list
14896999|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897000|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14897001|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
14897002|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897003|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
14897004|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897005|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897006|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897007|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
14897008|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718200|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718201|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14718202|NCT00471393|Protective Agents|protective agents|mesh-ancestor
14718203|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14718204|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
14718205|NCT00471406|Verteporfin|verteporfin|mesh-list
14718206|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14718207|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
14897009|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897010|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
14897011|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14897012|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
14897013|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897014|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14897015|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897016|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
14897017|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897018|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
14897019|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14897020|NCT01285141|Protective Agents|protective agents|mesh-ancestor
14897021|NCT01285219|Lenograstim|lenograstim|mesh-list
14718208|NCT00471419|Rimexolone|rimexolone|mesh-list
14897022|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14897023|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
14897024|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897025|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14897026|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897027|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14897028|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897029|NCT01285271|Sevoflurane|sevoflurane|mesh-list
14897030|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14897031|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14897032|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
14897033|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
14897034|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897035|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897036|NCT01285375|Curcumin|curcumin|mesh-list
14897037|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14897038|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14897039|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897040|NCT01285375|Analgesics|analgesics|mesh-ancestor
14897041|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
14897042|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897043|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897044|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897045|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897046|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897047|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897048|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897049|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
14897050|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897051|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14897052|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14897053|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897054|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897055|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
14897056|NCT01285414|Temozolomide|temozolomide|mesh-list
14897057|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14897058|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
14897059|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897060|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897061|NCT01285453|Vadimezan|vadimezan|mesh-list
14897062|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897063|NCT01285466|Paclitaxel|paclitaxel|mesh-list
14897064|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14897065|NCT01285466|Trastuzumab|trastuzumab|mesh-list
14897066|NCT01285466|Dactolisib|dactolisib|mesh-list
14897067|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14897068|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897069|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
14897070|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
14897071|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
14897072|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897073|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897074|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14897075|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14897076|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897077|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897078|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
14897079|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897080|NCT01285505|Alprazolam|alprazolam|mesh-list
14897081|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14897082|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897083|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897084|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14897085|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14897086|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14897087|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
14897088|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
14897089|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897090|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897091|NCT01285544|Atorvastatin|atorvastatin|mesh-list
14897092|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14897093|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14897094|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
14897095|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897096|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14897097|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14897098|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897099|NCT01285557|Cisplatin|cisplatin|mesh-list
14897100|NCT01285557|Fluorouracil|fluorouracil|mesh-list
14897101|NCT01285557|Tegafur|tegafur|mesh-list
14897102|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897103|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
14897104|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897105|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15217183|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15217184|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
14718209|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
14718210|NCT00471419|Hormones|hormones|mesh-ancestor
14718211|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718212|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718213|NCT00471432|Docetaxel|docetaxel|mesh-list
14718214|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718215|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
14718216|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
14718217|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
14718218|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718219|NCT00471471|Sargramostim|sargramostim|mesh-list
14718220|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
14718221|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718222|NCT00471484|Interferons|interferons|mesh-list
14718223|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
14718224|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
14897106|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217185|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15217186|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217187|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15217188|NCT04245748|Analgesics|analgesics|mesh-ancestor
15217189|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
15217190|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
15217191|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15217192|NCT04245436|Citalopram|citalopram|mesh-list
15217193|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15217194|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15217195|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217196|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217197|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217198|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
15217199|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897107|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
14897108|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897109|NCT01285596|Mirabegron|mirabegron|mesh-list
14897110|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14897111|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14897112|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14897113|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14897114|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897115|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897116|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897117|NCT01285596|Urological Agents|urological agents|mesh-ancestor
14897118|NCT01285661|Vitamin K|vitamin k|mesh-list
14897119|NCT01285661|Warfarin|warfarin|mesh-list
14897120|NCT01285661|Anticoagulants|anticoagulants|mesh-list
14897121|NCT01285661|Vitamins|vitamins|mesh-ancestor
14897122|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
14897123|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897124|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14897125|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14897126|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897127|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
14897128|NCT01285661|Coagulants|coagulants|mesh-ancestor
14897129|NCT01285674|Cisplatin|cisplatin|mesh-list
14897130|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897131|NCT01285765|Rituximab|rituximab|mesh-list
14897132|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897133|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897134|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
14897135|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897136|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897137|NCT01285778|Panitumumab|panitumumab|mesh-list
14897138|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897139|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897140|NCT01285817|Celecoxib|celecoxib|mesh-list
14897141|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
14897142|NCT01285817|Methotrexate|methotrexate|mesh-list
14897143|NCT01285817|Vinblastine|vinblastine|mesh-list
14897144|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897145|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
14897146|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897147|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897148|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14897149|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
14897150|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897151|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897152|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14897153|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14897154|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
14897155|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14297321|NCT04362839|Nivolumab|nivolumab|mesh-list
14297322|NCT04362839|Ipilimumab|ipilimumab|mesh-list
14297323|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297324|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897156|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14897157|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
14897158|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
14897159|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897160|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14897161|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14897162|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14897163|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897164|NCT01285817|Analgesics|analgesics|mesh-ancestor
14897165|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
14897166|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897167|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897168|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14897169|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14297325|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14297326|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718225|NCT00471484|Doxorubicin|doxorubicin|mesh-list
14718226|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14718227|NCT00471484|Fluorouracil|fluorouracil|mesh-list
14718228|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
14718229|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14718230|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718231|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14897170|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14897171|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
14897172|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
14897173|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
14897174|NCT01285934|Insulin|insulin|mesh-list
14897175|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14897176|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897177|NCT01286051|Ganirelix|ganirelix|mesh-list
14718232|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14718233|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897178|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
14718234|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718235|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
14718236|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14718237|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14718238|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
14718239|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718240|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
14718241|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897179|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897180|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217200|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15217201|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
14897181|NCT01286090|Cisapride|cisapride|mesh-list
14897182|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14897183|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897184|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14897185|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
14897186|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897187|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897188|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897189|NCT01286103|Canagliflozin|canagliflozin|mesh-list
14897190|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14897191|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897192|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14897193|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916073|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14916074|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
14916075|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916076|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916077|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14916078|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916079|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
14916080|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14916081|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916082|NCT01390662|Vitamin D|vitamin d|mesh-list
14916083|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
14916084|NCT01390662|Vitamins|vitamins|mesh-ancestor
14916085|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
14916086|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916087|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14916088|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14916089|NCT01390766|Azathioprine|azathioprine|mesh-list
14916090|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
14916091|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916092|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14916093|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916094|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916095|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
14916096|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916097|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916098|NCT01390792|Zanamivir|zanamivir|mesh-list
14916099|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
14916100|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916101|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916102|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916103|NCT01390805|Valacyclovir|valacyclovir|mesh-list
14916104|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
14916105|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916106|NCT01390883|PENTA|penta|mesh-list
14916107|NCT01390883|Fondaparinux|fondaparinux|mesh-list
14916108|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14916109|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
14916110|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14916111|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
14916112|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916113|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916114|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
14916115|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15217202|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15217203|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217204|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15217205|NCT04245436|Analgesics|analgesics|mesh-ancestor
15217206|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
15217207|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
15217208|NCT04221997|Sertraline|sertraline|mesh-list
15217209|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
14897194|NCT01286194|Rabeprazole|rabeprazole|mesh-list
14897195|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14897196|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897197|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14897198|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897199|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897200|NCT01286233|Metformin|metformin|mesh-list
14897201|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14897202|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897203|NCT01286246|Progesterone|progesterone|mesh-list
14897204|NCT01286246|Progestins|progestins|mesh-ancestor
14897205|NCT01286246|Hormones|hormones|mesh-ancestor
14897206|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897207|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897208|NCT01286584|Varenicline|varenicline|mesh-list
14897209|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14897210|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14897211|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
14897212|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897213|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897214|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897215|NCT01286688|Terbinafine|terbinafine|mesh-list
14897216|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
14897217|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897218|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897219|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897220|NCT01286701|Terbinafine|terbinafine|mesh-list
14897221|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
14897222|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897223|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897224|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897225|NCT01286766|Cisplatin|cisplatin|mesh-list
14897226|NCT01286766|Docetaxel|docetaxel|mesh-list
14897227|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897228|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
14897229|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
14897230|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
14897231|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897232|NCT01286857|Silicon|silicon|mesh-list
15217210|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15217211|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15217212|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14897233|NCT01286857|Trace Elements|trace elements|mesh-ancestor
14897234|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
14897235|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897236|NCT01286896|Sunitinib|sunitinib|mesh-list
14897237|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217213|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217214|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217215|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217216|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
15217217|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217218|NCT04161989|Progesterone|progesterone|mesh-list
15217219|NCT04161989|Progestins|progestins|mesh-ancestor
15217220|NCT04161989|Hormones|hormones|mesh-ancestor
15217221|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217222|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217223|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
15217224|NCT04130828|Trace Elements|trace elements|mesh-ancestor
15217225|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
15217226|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217227|NCT03881059|Ustekinumab|ustekinumab|mesh-list
15217228|NCT03881059|BMS-986165|bms-986165|mesh-list
15217229|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
15217230|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14897238|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14897239|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14897240|NCT01286896|Growth Substances|growth substances|mesh-ancestor
14897241|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897242|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14897243|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14897244|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897245|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897246|NCT01286909|Lycopene|lycopene|mesh-list
14897247|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897248|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
14897249|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897250|NCT01286909|Protective Agents|protective agents|mesh-ancestor
14897251|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897252|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14897253|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14897254|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897255|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
14897256|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14897257|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
14897258|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14897259|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897260|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14897261|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14897262|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14897263|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
14897264|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14897265|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
14897266|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
14897267|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897268|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897269|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897270|NCT01287052|Analgesics|analgesics|mesh-ancestor
14897271|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
14897272|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897273|NCT01287091|Rabeprazole|rabeprazole|mesh-list
14897274|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14897275|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15217231|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217232|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217233|NCT03840967|Niraparib|niraparib|mesh-list
15217234|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15217235|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217236|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217237|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217238|NCT03837860|Oxycodone|oxycodone|mesh-list
15217239|NCT03837860|Risperidone|risperidone|mesh-list
15217240|NCT03837860|Ziprasidone|ziprasidone|mesh-list
15217241|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15217242|NCT03837860|Narcotics|narcotics|mesh-ancestor
15217243|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15217244|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217245|NCT03837860|Analgesics|analgesics|mesh-ancestor
15217246|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
14897276|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14897277|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897278|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897279|NCT01287130|Cetuximab|cetuximab|mesh-list
14897280|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217247|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217248|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15217249|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
15217250|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217251|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217252|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15217253|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15217254|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15217255|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15217256|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
15217257|NCT03817853|Prednisone|prednisone|mesh-list
15217258|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
15217259|NCT03817853|Prednisolone|prednisolone|mesh-list
15217260|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
14897281|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897282|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
14897283|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14897284|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14897285|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217261|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15217262|NCT03817853|Doxorubicin|doxorubicin|mesh-list
15217263|NCT03817853|Vincristine|vincristine|mesh-list
15217264|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
14897286|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897287|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
14897288|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897289|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897290|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14897291|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897292|NCT01287260|Nifedipine|nifedipine|mesh-list
14897293|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14897294|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14897295|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897296|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14897297|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217265|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217266|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
14718242|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14718243|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
14718244|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718245|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718246|NCT00471523|Metformin|metformin|mesh-list
14718247|NCT00471523|Clomiphene|clomiphene|mesh-list
14718248|NCT00471523|Enclomiphene|enclomiphene|mesh-list
14718249|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
14718250|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14718251|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718252|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14718253|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
14718254|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718255|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14718256|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
14718257|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14897298|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
14897299|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
14897300|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14897301|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14897302|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14897303|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897304|NCT01287338|Analgesics|analgesics|mesh-ancestor
14897305|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
14897306|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897307|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897308|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897309|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897310|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14897311|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14897312|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14897313|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
14897314|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
14897315|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897316|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897317|NCT01287351|Fluticasone|fluticasone|mesh-list
14897318|NCT01287351|Xhance|xhance|mesh-list
14897319|NCT01287351|Beclomethasone|beclomethasone|mesh-list
14897320|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897321|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14897322|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
14897323|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897324|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897325|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14897326|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
14897327|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
14897328|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14897329|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
14897330|NCT01287351|Hormones|hormones|mesh-ancestor
14897331|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897332|NCT01287455|Vitamin D|vitamin d|mesh-list
14897333|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
14897334|NCT01287455|Vitamins|vitamins|mesh-ancestor
14897335|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
14897336|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897337|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14897338|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14897339|NCT01287494|Sertraline|sertraline|mesh-list
14897340|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
14897341|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14897342|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14897343|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14897344|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14897345|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897346|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897347|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
14897348|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897349|NCT01287507|Lactoferrin|lactoferrin|mesh-list
14897350|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897351|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
14897352|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14897353|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897354|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14897355|NCT01287546|Trametinib|trametinib|mesh-list
14897356|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897357|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14897358|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897359|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897360|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
14897361|NCT01287598|Midazolam|midazolam|mesh-list
14897362|NCT01287598|Omeprazole|omeprazole|mesh-list
14897363|NCT01287598|Warfarin|warfarin|mesh-list
14897364|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14897365|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14897366|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897367|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897368|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14897369|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14897370|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14897371|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14897372|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
14897373|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
14897374|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
14897375|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
14897376|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897377|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897378|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
14897379|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14897380|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897381|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14897382|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897383|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14897384|NCT01287624|Gemcitabine|gemcitabine|mesh-list
14897385|NCT01287624|Paclitaxel|paclitaxel|mesh-list
14897386|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14897387|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897388|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
14897389|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
14897390|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
14897391|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897392|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14897393|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
14897394|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
14897395|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897396|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897397|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897398|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
14897399|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897400|NCT01287663|Permethrin|permethrin|mesh-list
14897401|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897402|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897403|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
14897404|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14897405|NCT01287689|Antibodies|antibodies|mesh-list
14897406|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
15217267|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897407|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
14897408|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897409|NCT01287715|Etanercept|etanercept|mesh-list
14897410|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14897411|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897412|NCT01287715|Analgesics|analgesics|mesh-ancestor
14897413|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
14897414|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897415|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897416|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897417|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897418|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897419|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897420|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
14897421|NCT01287741|Prednisone|prednisone|mesh-list
14897422|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
14897423|NCT01287741|Rituximab|rituximab|mesh-list
14897424|NCT01287741|Doxorubicin|doxorubicin|mesh-list
14897425|NCT01287741|Vincristine|vincristine|mesh-list
14897426|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
14897427|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897428|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
14897429|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897430|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897431|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14897432|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
14897433|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897434|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897435|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14897436|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897437|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14897438|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14897439|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14897440|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897441|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897442|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
14897443|NCT01287741|Hormones|hormones|mesh-ancestor
14897444|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897445|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14897446|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14897447|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
14897448|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217268|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15217269|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217270|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
15217271|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217272|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217273|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15217274|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15217275|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15217276|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15217277|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217278|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217279|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
14897449|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
14897450|NCT01287780|Gentamicins|gentamicins|mesh-list
14897451|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897452|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897453|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14897454|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897455|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897456|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
14897457|NCT01287793|Tigecycline|tigecycline|mesh-list
14897458|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897459|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897460|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14897461|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14897462|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897463|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897464|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897465|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14897466|NCT01287806|Urinastatin|urinastatin|mesh-list
14897467|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14897468|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14897469|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
14897470|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897471|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897472|NCT01287949|Vaccines|vaccines|mesh-list
14897473|NCT01287949|Immunologic Factors|immunologic factors|mesh-ancestor
14897474|NCT01287949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897475|NCT01287962|Apatinib|apatinib|mesh-list
14718258|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14718259|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14718260|NCT00471549|Simvastatin|simvastatin|mesh-list
14718261|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14718262|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14718263|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
14718264|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718265|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14718266|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14897476|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897477|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14897478|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897479|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916116|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14916117|NCT01390896|PENTA|penta|mesh-list
15217280|NCT03817853|Hormones|hormones|mesh-ancestor
15217281|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217282|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217283|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15217284|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
15217285|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217286|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
15217287|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
15217288|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
15217289|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718267|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718268|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14718269|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14718270|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
14718271|NCT00471588|Pramipexole|pramipexole|mesh-list
14718272|NCT00471588|Amisulpride|amisulpride|mesh-list
14718273|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
14718274|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718275|NCT00471588|Protective Agents|protective agents|mesh-ancestor
14916118|NCT01390896|Fondaparinux|fondaparinux|mesh-list
14916119|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14897480|NCT01288092|Dactolisib|dactolisib|mesh-list
14897481|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897482|NCT01288131|Cyclosporine|cyclosporine|mesh-list
14897483|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
14897484|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
14897485|NCT01288131|Cyclosporins|cyclosporins|mesh-list
14897486|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897487|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
14897488|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897489|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897490|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14897491|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
14897492|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897493|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897494|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14897495|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897496|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
14897497|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897498|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
14897499|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14897500|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14897501|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14897502|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
14897503|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897504|NCT01288157|Golimumab|golimumab|mesh-list
14897505|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14897506|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14897507|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718276|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718277|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14718278|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14718279|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
14718280|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
14718281|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718282|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14718283|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14897508|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897509|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
14897510|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897511|NCT01288170|Tobramycin|tobramycin|mesh-list
14897512|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897513|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897514|NCT01288261|Paclitaxel|paclitaxel|mesh-list
14897515|NCT01288261|Bavituximab|bavituximab|mesh-list
14897516|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15217290|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15217291|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15217292|NCT03817853|Protective Agents|protective agents|mesh-ancestor
15217293|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217294|NCT03697629|Daratumumab|daratumumab|mesh-list
15217295|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217296|NCT03677830|Acetaminophen|acetaminophen|mesh-list
15217297|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15217298|NCT03677830|Analgesics|analgesics|mesh-ancestor
15217299|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
15217300|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897517|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897518|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
14897519|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
14897520|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
14897521|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897522|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897523|NCT01288326|Liraglutide|liraglutide|mesh-list
14897524|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14897525|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897526|NCT01288326|Incretins|incretins|mesh-ancestor
14897527|NCT01288326|Hormones|hormones|mesh-ancestor
14897528|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897529|NCT01288339|Leucovorin|leucovorin|mesh-list
14897530|NCT01288339|Fluorouracil|fluorouracil|mesh-list
14897531|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
14897532|NCT01288339|Panitumumab|panitumumab|mesh-list
14897533|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
14897534|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897535|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14897536|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897537|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897538|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
14897539|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897540|NCT01288339|Antidotes|antidotes|mesh-ancestor
14897541|NCT01288339|Protective Agents|protective agents|mesh-ancestor
14897542|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
14897543|NCT01288339|Vitamins|vitamins|mesh-ancestor
14897544|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
14897545|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897546|NCT01288378|Caspofungin|caspofungin|mesh-list
14897547|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
14897548|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897549|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897550|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897551|NCT01288404|Fluorometholone|fluorometholone|mesh-list
14897552|NCT01288404|Bevacizumab|bevacizumab|mesh-list
14897553|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897554|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897555|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14897556|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14897557|NCT01288404|Growth Substances|growth substances|mesh-ancestor
14897558|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897559|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
14897560|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897561|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
14897562|NCT01288404|Hormones|hormones|mesh-ancestor
14897563|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897564|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14897565|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
14897566|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14897567|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14897568|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
14897569|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897570|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14897571|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14897572|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897573|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897574|NCT01288495|Psyllium|psyllium|mesh-list
14897575|NCT01288495|Cathartics|cathartics|mesh-ancestor
14897576|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897577|NCT01288508|Psyllium|psyllium|mesh-list
14897578|NCT01288508|Cathartics|cathartics|mesh-ancestor
14897579|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897580|NCT01288547|Theobromine|theobromine|mesh-list
14897581|NCT01288547|Caffeine|caffeine|mesh-list
14897582|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14897583|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897584|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14897585|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897586|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897587|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14897588|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14897589|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
14897590|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897591|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14897592|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
14897593|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897594|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14897595|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
14897596|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
14897597|NCT01288573|Plerixafor|plerixafor|mesh-list
14897598|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14897599|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14897600|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
14897601|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897602|NCT01288664|Tacrolimus|tacrolimus|mesh-list
14897603|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897604|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
14897605|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897606|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14897607|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897608|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897609|NCT01288716|Baclofen|baclofen|mesh-list
14897610|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14897611|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897612|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14897613|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897614|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14897615|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
14897616|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
14897617|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897618|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897619|NCT01288742|Simeprevir|simeprevir|mesh-list
14897620|NCT01288742|Digoxin|digoxin|mesh-list
14897621|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14897622|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14897623|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14897624|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
14897625|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897626|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14897627|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14897628|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897629|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14897630|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14897631|NCT01288742|Protective Agents|protective agents|mesh-ancestor
14897632|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897633|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
14897634|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897635|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
14897636|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
14897637|NCT01288755|Rilpivirine|rilpivirine|mesh-list
14897638|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14897639|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14897640|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
14897641|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897642|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14897643|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14897644|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897645|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897646|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14897647|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14897648|NCT01288794|Furosemide|furosemide|mesh-list
14897649|NCT01288794|Diuretics|diuretics|mesh-list
14897650|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
14897651|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897652|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14897653|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14897654|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897655|NCT01288820|Artesunate|artesunate|mesh-list
14897656|NCT01288820|Piperaquine|piperaquine|mesh-list
14897657|NCT01288820|Primaquine|primaquine|mesh-list
14897658|NCT01288820|Amodiaquine|amodiaquine|mesh-list
14897659|NCT01288820|Artenimol|artenimol|mesh-list
14897660|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
14897661|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14897662|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14897663|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897664|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897665|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
14897666|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
14897667|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14897668|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
14897669|NCT01288872|Praziquantel|praziquantel|mesh-list
14897670|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
14897671|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14897672|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897673|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
14897674|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14897675|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897676|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14897677|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897678|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
14897679|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14897680|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897681|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14897682|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897683|NCT01288924|Parecoxib|parecoxib|mesh-list
14897684|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14897685|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14897686|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897687|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897688|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14897689|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897690|NCT01288924|Analgesics|analgesics|mesh-ancestor
14897691|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
14297327|NCT04333459|Vaccines|vaccines|mesh-list
14718284|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897692|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897693|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897694|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897695|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897696|NCT01288950|Vitamin D|vitamin d|mesh-list
14897697|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
14897698|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
14897699|NCT01288950|Vitamins|vitamins|mesh-list
14897700|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
14897701|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897702|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14897703|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14718285|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14718286|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14718287|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14718288|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
14718289|NCT00471627|Pancrelipase|pancrelipase|mesh-list
14718290|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718291|NCT00471640|Dexamethasone|dexamethasone|mesh-list
14718292|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718293|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
14897704|NCT01288963|Aldesleukin|aldesleukin|mesh-list
14897705|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897706|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14897707|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14897708|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
14897709|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897710|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
14897711|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897712|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14897713|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897714|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897715|NCT01289132|Candesartan|candesartan|mesh-list
14897716|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
14897717|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14897718|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14897719|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14897720|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14897721|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897722|NCT01289171|Glycolic acid|glycolic acid|mesh-list
14897723|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
14897724|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
14897725|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14897726|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14897727|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
14897728|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897729|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897730|NCT01289236|Milnacipran|milnacipran|mesh-list
14897731|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
14897732|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14897733|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14897734|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14897735|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897736|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897737|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897738|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897739|NCT01289236|Analgesics|analgesics|mesh-ancestor
14897740|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
14897741|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897742|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
14897743|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14897744|NCT01289301|Cyclosporine|cyclosporine|mesh-list
14897745|NCT01289301|Sirolimus|sirolimus|mesh-list
14897746|NCT01289301|Everolimus|everolimus|mesh-list
14897747|NCT01289301|Tacrolimus|tacrolimus|mesh-list
14897748|NCT01289301|Cyclosporins|cyclosporins|mesh-list
14897749|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14897750|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897751|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
14897752|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897753|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897754|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297328|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
14297329|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297330|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14297331|NCT04304274|Morphine|morphine|mesh-list
14297332|NCT04304274|Ropivacaine|ropivacaine|mesh-list
14297333|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14297334|NCT04304274|Narcotics|narcotics|mesh-ancestor
14718294|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
14718295|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718296|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718297|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718298|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
14718299|NCT00471640|Hormones|hormones|mesh-ancestor
14718300|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718301|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14718302|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718303|NCT00471653|Temozolomide|temozolomide|mesh-list
14718304|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14718305|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
14718306|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718307|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718308|NCT00471679|Ethanol|ethanol|mesh-list
14718309|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14718310|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718311|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718312|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718313|NCT00471744|Levetiracetam|levetiracetam|mesh-list
14897755|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
14897756|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897757|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
14897758|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897759|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897760|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897761|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14897762|NCT01289327|Midazolam|midazolam|mesh-list
14897763|NCT01289327|Alfentanil|alfentanil|mesh-list
14897764|NCT01289327|Propofol|propofol|mesh-list
14897765|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14897766|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897767|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897768|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14897769|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
14897770|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
14897771|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14897772|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14897773|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14897774|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14897775|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
14897776|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
14897777|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297335|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297336|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297337|NCT04304274|Analgesics|analgesics|mesh-ancestor
14297338|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
14718314|NCT00471744|Sulthiame|sulthiame|mesh-list
14718315|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
14718316|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
14718317|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
14718318|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14718319|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718320|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
14718321|NCT00471809|Azithromycin|azithromycin|mesh-list
14718322|NCT00471809|Budesonide|budesonide|mesh-list
14718323|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14718324|NCT00471809|Montelukast|montelukast|mesh-list
14718325|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718326|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14718327|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
14718328|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718329|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718330|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14718331|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
14718332|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
14718333|NCT00471809|Hormones|hormones|mesh-ancestor
14718334|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718335|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897778|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897779|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14897780|NCT01289327|Narcotics|narcotics|mesh-ancestor
14897781|NCT01289327|Analgesics|analgesics|mesh-ancestor
14897782|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
14897783|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897784|NCT01289483|Fospropofol|fospropofol|mesh-list
14897785|NCT01289483|Propofol|propofol|mesh-list
14897786|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14897787|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897788|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897789|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14897790|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
14897791|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
14897792|NCT01289496|Interferons|interferons|mesh-list
14897793|NCT01289496|Ribavirin|ribavirin|mesh-list
14897794|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
14897795|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
14897796|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14897797|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897798|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
14897799|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897800|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
14897801|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897802|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
14897803|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897804|NCT01289561|Ethanol|ethanol|mesh-list
14897805|NCT01289561|Quinine|quinine|mesh-list
14897806|NCT01289561|Caffeine|caffeine|mesh-list
14897807|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14897808|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897809|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897810|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897811|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14897812|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14897813|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897814|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897815|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14897816|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14897817|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
14897818|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718336|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718337|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14897819|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
14897820|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14897821|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14897822|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14897823|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14897824|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897825|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897826|NCT01289561|Analgesics|analgesics|mesh-ancestor
14718338|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14718339|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14718340|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
14718341|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718342|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718343|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14718344|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
14718345|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14718346|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14718347|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14718348|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14718349|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
14718350|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718351|NCT00471952|Caffeine|caffeine|mesh-list
14718352|NCT00471952|Rizatriptan|rizatriptan|mesh-list
14718353|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14718354|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718355|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14718356|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897827|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
14897828|NCT01289730|Etanercept|etanercept|mesh-list
14729010|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897829|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14897830|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897831|NCT01289730|Analgesics|analgesics|mesh-ancestor
14897832|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
14297339|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718357|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718358|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14897833|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897834|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897835|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897836|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897837|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897838|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897839|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
14897840|NCT01289743|Etanercept|etanercept|mesh-list
14897841|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14897842|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897843|NCT01289743|Analgesics|analgesics|mesh-ancestor
14897844|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
14897845|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897846|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897847|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14897848|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897849|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897850|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14897851|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
14897852|NCT01289756|Clarithromycin|clarithromycin|mesh-list
14897853|NCT01289756|Paroxetine|paroxetine|mesh-list
14897854|NCT01289756|Clomiphene|clomiphene|mesh-list
14897855|NCT01289756|Enclomiphene|enclomiphene|mesh-list
14897856|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
14897857|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897858|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897859|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14897860|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718359|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14718360|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
14718361|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718362|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14718363|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
14718364|NCT00471965|Leucovorin|leucovorin|mesh-list
14718365|NCT00471965|Doxorubicin|doxorubicin|mesh-list
14897861|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916120|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
14897862|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14897863|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14897864|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14897865|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14897866|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14897867|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897868|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
14897869|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897870|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14897871|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
14897872|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14897873|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14897874|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14897875|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
14897876|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897877|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14897878|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
14897879|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14897880|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14897881|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14897882|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
14897883|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14897884|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897885|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897886|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14897887|NCT01289769|Analgesics|analgesics|mesh-ancestor
14897888|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
14897889|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897890|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14897891|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15217301|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217302|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
15217303|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
15217304|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
15217305|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217306|NCT03582137|Cannabidiol|cannabidiol|mesh-list
15217307|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
15217308|NCT03547999|Nivolumab|nivolumab|mesh-list
15217309|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217310|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718366|NCT00471965|Fluorouracil|fluorouracil|mesh-list
14718367|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
14718368|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14718369|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718370|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14718371|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14718372|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718373|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718374|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
14718375|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14718376|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14718377|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
14718378|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718379|NCT00471965|Antidotes|antidotes|mesh-ancestor
15217311|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15217312|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217313|NCT03528694|Durvalumab|durvalumab|mesh-list
15217314|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
15217315|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897892|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14897893|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
14897894|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897895|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916121|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14916122|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
14916123|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916124|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916125|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
14916126|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14916127|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14916128|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
14916129|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14916130|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14916131|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14916132|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916133|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916134|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
14916135|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916136|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916137|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14916138|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916139|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14916140|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
14916141|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916142|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916143|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14916144|NCT01390935|Diuretics|diuretics|mesh-ancestor
14916145|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
14916146|NCT01390961|Pheniramine|pheniramine|mesh-list
14916147|NCT01390961|Naphazoline|naphazoline|mesh-list
14916148|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916149|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14916150|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14916151|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14916152|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916153|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916154|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
14916155|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14916156|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
14916157|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14916158|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
14916159|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
14916160|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
14916161|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14916162|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15217316|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217317|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15217318|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
15217319|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217320|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15217321|NCT03526848|Antibodies|antibodies|mesh-list
15217322|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
15217323|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15217324|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
15217325|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217326|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217327|NCT03501381|Aldesleukin|aldesleukin|mesh-list
15217328|NCT03501381|Interleukin-2|interleukin-2|mesh-list
15217329|NCT03501381|Entinostat|entinostat|mesh-list
15217330|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897896|NCT01289925|Selenium|selenium|mesh-list
14897897|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
14897898|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897899|NCT01289925|Protective Agents|protective agents|mesh-ancestor
14897900|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897901|NCT01289925|Trace Elements|trace elements|mesh-ancestor
14897902|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
14897903|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
14897904|NCT01289938|Promethazine|promethazine|mesh-list
14897905|NCT01289938|Metoclopramide|metoclopramide|mesh-list
14897906|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14897907|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14897908|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14897909|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897910|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
14897911|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
14897912|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
14897913|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14897914|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
14897915|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
14897916|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14897917|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14897918|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
14897919|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
14897920|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897921|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897922|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14897923|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
14897924|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
14897925|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14897926|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14897927|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
14897928|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
14897929|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14897930|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14897931|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
14897932|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897933|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14897934|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14897935|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897936|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897937|NCT01290003|Tazobactam|tazobactam|mesh-list
14897938|NCT01290003|Piperacillin|piperacillin|mesh-list
14897939|NCT01290003|Amikacin|amikacin|mesh-list
14897940|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14897941|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14897942|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897943|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14897944|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897945|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897946|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14897947|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
14897948|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897949|NCT01290120|Rituximab|rituximab|mesh-list
14897950|NCT01290120|Doxorubicin|doxorubicin|mesh-list
14897951|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14897952|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14897953|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
14897954|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897955|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14897956|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14897957|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14897958|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14897959|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897960|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897961|NCT01290133|Vestipitant|vestipitant|mesh-list
14897962|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14897963|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14897964|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897965|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897966|NCT01290146|Simendan|simendan|mesh-list
14897967|NCT01290146|Diuretics|diuretics|mesh-list
14897968|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
14897969|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897970|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14897971|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
14897972|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14897973|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14897974|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897975|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897976|NCT01290146|Protective Agents|protective agents|mesh-ancestor
14897977|NCT01290172|Somatostatin|somatostatin|mesh-list
14897978|NCT01290172|Hormones|hormones|mesh-ancestor
14897979|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897980|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897981|NCT01290198|Fluconazole|fluconazole|mesh-list
14897982|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
14897983|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
14897984|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14897985|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14897986|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14897987|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14897988|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14897989|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14897990|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
14897991|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14897992|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14897993|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14897994|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14897995|NCT01290211|Ritonavir|ritonavir|mesh-list
14897996|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
14897997|NCT01290211|Maraviroc|maraviroc|mesh-list
14897998|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14897999|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14898000|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
14898001|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898002|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898003|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14898004|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14898005|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
14898006|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898007|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14898008|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14898009|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14898010|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15217331|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15217332|NCT03501381|Analgesics|analgesics|mesh-ancestor
15217333|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
15217334|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217335|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217336|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15217337|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15217338|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
15217339|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297340|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
14898011|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14898012|NCT01290276|Ondansetron|ondansetron|mesh-list
14898013|NCT01290276|Methylphenidate|methylphenidate|mesh-list
14898014|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14898015|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898016|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14898017|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14898018|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14898019|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898020|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
14898021|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898022|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
14898023|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
14898024|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898025|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14898026|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
14898027|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
14898028|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14898029|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
14898030|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14898031|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14898032|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898033|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14898034|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14898035|NCT01290302|Azacitidine|azacitidine|mesh-list
14898036|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14898037|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
14898038|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898039|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898040|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217340|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15217341|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217342|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898041|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
14898042|NCT01290328|Hematinics|hematinics|mesh-ancestor
14898043|NCT01290354|Lapatinib|lapatinib|mesh-list
14898044|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898045|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14898046|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898047|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898048|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
14898049|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14898050|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
14898051|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898052|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
14898053|NCT01290367|Protective Agents|protective agents|mesh-ancestor
14898054|NCT01290380|Vadimezan|vadimezan|mesh-list
14898055|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898056|NCT01290406|Dactolisib|dactolisib|mesh-list
14898057|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898058|NCT01290419|Vaccines|vaccines|mesh-list
14898059|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
14898060|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898061|NCT01290432|Folic Acid|folic acid|mesh-list
14898062|NCT01290432|Melatonin|melatonin|mesh-list
14898063|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
14898064|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898065|NCT01290432|Protective Agents|protective agents|mesh-ancestor
14898066|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898067|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898068|NCT01290432|Hematinics|hematinics|mesh-ancestor
14898069|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
14898070|NCT01290432|Vitamins|vitamins|mesh-ancestor
14898071|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
14898072|NCT01290458|Vitamins|vitamins|mesh-list
14898073|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
14898074|NCT01290458|Vitamin E|vitamin e|mesh-list
14898075|NCT01290458|Tocopherols|tocopherols|mesh-list
15217343|NCT03495973|Ustekinumab|ustekinumab|mesh-list
15217344|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
15217345|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14898076|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
14898077|NCT01290458|Antioxidants|antioxidants|mesh-list
14898078|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
14898079|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898080|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217346|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14898081|NCT01290458|Protective Agents|protective agents|mesh-ancestor
14898082|NCT01290471|U3-1565|u3-1565|mesh-list
14898083|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898084|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898085|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
14898086|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14718380|NCT00471965|Protective Agents|protective agents|mesh-ancestor
14718381|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
14718382|NCT00471965|Vitamins|vitamins|mesh-ancestor
14898087|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
14898088|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898089|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
14898090|NCT01290497|Protective Agents|protective agents|mesh-ancestor
14898091|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
14898092|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14898093|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
14898094|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898095|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
14898096|NCT01290510|Protective Agents|protective agents|mesh-ancestor
14898097|NCT01290549|Rituximab|rituximab|mesh-list
14898098|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898099|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898100|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
14898101|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898102|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14898103|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14898104|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
14898105|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898106|NCT01290744|Clofazimine|clofazimine|mesh-list
14898107|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898108|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
14898109|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898110|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898111|NCT01290783|Irinotecan|irinotecan|mesh-list
14898112|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14898113|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14898114|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898115|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898116|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898117|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
14898118|NCT01290900|Ceftazidime|ceftazidime|mesh-list
14898119|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14898120|NCT01290900|Avibactam|avibactam|mesh-list
14898121|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898122|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898123|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14898124|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14898125|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898126|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898127|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898128|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14898129|NCT01290926|Sorafenib|sorafenib|mesh-list
14898130|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898131|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14718383|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
14718384|NCT00471991|Dienogest|dienogest|mesh-list
14718385|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14718386|NCT00471991|Estradiol|estradiol|mesh-list
14718387|NCT00471991|Estrogens|estrogens|mesh-ancestor
14718388|NCT00471991|Hormones|hormones|mesh-ancestor
14718389|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718390|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718391|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14718392|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
14718393|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718394|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14718395|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14898132|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718396|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14729011|NCT00521157|Naltrexone|naltrexone|mesh-list
14898133|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898134|NCT01290939|Bevacizumab|bevacizumab|mesh-list
14898135|NCT01290939|Lomustine|lomustine|mesh-list
14898136|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898137|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898138|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14898139|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14898140|NCT01290939|Growth Substances|growth substances|mesh-ancestor
14898141|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898142|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14898143|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14898144|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
14898145|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898146|NCT01291069|Tadalafil|tadalafil|mesh-list
14898147|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898148|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898149|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14898150|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14898151|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898152|NCT01291069|Urological Agents|urological agents|mesh-ancestor
14898153|NCT01291095|Cisplatin|cisplatin|mesh-list
14898154|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898155|NCT01291121|Ranibizumab|ranibizumab|mesh-list
14898156|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14898157|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14898158|NCT01291121|Growth Substances|growth substances|mesh-ancestor
14898159|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898160|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14898161|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898162|NCT01291186|Epinephrine|epinephrine|mesh-list
14898163|NCT01291186|Racepinephrine|racepinephrine|mesh-list
14898164|NCT01291186|Bupivacaine|bupivacaine|mesh-list
14898165|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
14898166|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
14898167|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
14898168|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898169|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898170|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
14898171|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898172|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14898173|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14898174|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
14898175|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898176|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898177|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14898178|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14898179|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
14898180|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14898181|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
14898182|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
14898183|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
14898184|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14898185|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14898186|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898187|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14898188|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14898189|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898190|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898191|NCT01291199|Urological Agents|urological agents|mesh-ancestor
14898192|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
14898193|NCT01291212|Testosterone|testosterone|mesh-list
14898194|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
14898195|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
14898196|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14898197|NCT01291212|Androgens|androgens|mesh-ancestor
14898198|NCT01291212|Hormones|hormones|mesh-ancestor
14898199|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14898200|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898201|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14898202|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898203|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
14898204|NCT01291316|Clonazepam|clonazepam|mesh-list
14898205|NCT01291316|Clobazam|clobazam|mesh-list
14898206|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14898207|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14898208|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14898209|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
14898210|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898211|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898212|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898213|NCT01291316|Urological Agents|urological agents|mesh-ancestor
14898214|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
14898215|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
14898216|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
14898217|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14898218|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14898219|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898220|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14898221|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14898222|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
14898223|NCT01291420|Vaccines|vaccines|mesh-list
14898224|NCT01291420|Immunologic Factors|immunologic factors|mesh-ancestor
14898225|NCT01291420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898226|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
14898227|NCT01291433|Tocopherols|tocopherols|mesh-list
14898228|NCT01291433|Vitamin E|vitamin e|mesh-list
14898229|NCT01291433|Tocotrienols|tocotrienols|mesh-list
14898230|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
14898231|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
14898232|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14898233|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898234|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898235|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14898236|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14898237|NCT01291433|Protective Agents|protective agents|mesh-ancestor
14898238|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898239|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898240|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14898241|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
14898242|NCT01291433|Vitamins|vitamins|mesh-ancestor
14898243|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
14898244|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14898245|NCT01291459|Tenofovir|tenofovir|mesh-list
14898246|NCT01291459|Emtricitabine|emtricitabine|mesh-list
14898247|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
14898248|NCT01291459|Maraviroc|maraviroc|mesh-list
14898249|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
14898250|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898251|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14898252|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14898253|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898254|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898255|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14898256|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14898257|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14898258|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14898259|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14898260|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14898261|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14898262|NCT01291472|Ketorolac|ketorolac|mesh-list
14898263|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14898264|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14898265|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14898266|NCT01291472|Analgesics|analgesics|mesh-ancestor
14898267|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
14898268|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898269|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898270|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898271|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14898272|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14898273|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898274|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898275|NCT01291511|Iloperidone|iloperidone|mesh-list
14898276|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14898277|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14898278|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898279|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898280|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14898281|NCT01291524|Pregabalin|pregabalin|mesh-list
14898282|NCT01291524|Analgesics|analgesics|mesh-ancestor
14898283|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
14898284|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898285|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898286|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
14898287|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14898288|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14898289|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898290|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14898291|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14898292|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14898293|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898294|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14898295|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14898296|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14898297|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
14898298|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898299|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14898300|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14898301|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
14898302|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
14898303|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898304|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898305|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
14898306|NCT01291563|Bedaquiline|bedaquiline|mesh-list
14898307|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
15217347|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15217348|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217349|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15217350|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15217351|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15217352|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
14898308|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14898309|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898310|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898311|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14898312|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14898313|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898314|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898315|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898316|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14898317|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
14898318|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14898319|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898320|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14898321|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14898322|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14898323|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
14898324|NCT01291602|Avibactam|avibactam|mesh-list
14898325|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14898326|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898327|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898328|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898329|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898330|NCT01291615|Gemcitabine|gemcitabine|mesh-list
14898331|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14898332|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
14898333|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898334|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898335|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
14898336|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898337|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898338|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14898339|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
14898340|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898341|NCT01291628|Copper|copper|mesh-list
14898342|NCT01291628|Trace Elements|trace elements|mesh-ancestor
14898343|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
14898344|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898345|NCT01291641|Cilostazol|cilostazol|mesh-list
14898346|NCT01291641|Probucol|probucol|mesh-list
14898347|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14898348|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14898349|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
14898350|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898351|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898352|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14898353|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
15217353|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217354|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217355|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217356|NCT03448718|Olaparib|olaparib|mesh-list
15217357|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15217358|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217359|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217360|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217361|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
15217362|NCT03445858|Decitabine|decitabine|mesh-list
15217363|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898354|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14898355|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14898356|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898357|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14898358|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898359|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14898360|NCT01291641|Protective Agents|protective agents|mesh-ancestor
14898361|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14898362|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14898363|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898364|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14898365|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14898366|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
14898367|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14898368|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
14898369|NCT01291654|Acetaminophen|acetaminophen|mesh-list
14898370|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14898371|NCT01291654|Analgesics|analgesics|mesh-ancestor
14898372|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
14898373|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898374|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898375|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
14916163|NCT01391052|Norethindrone|norethindrone|mesh-list
14916164|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
14916165|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14916166|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14916167|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14916168|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
14916169|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14916170|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916171|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14916172|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14916173|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
14916174|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916175|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14916176|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14916177|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916178|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916179|NCT01391104|Urological Agents|urological agents|mesh-ancestor
14916180|NCT01391156|Minoxidil|minoxidil|mesh-list
14718397|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14718398|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
14718399|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14718400|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718401|NCT00472004|Tibolone|tibolone|mesh-list
14718402|NCT00472004|Estradiol|estradiol|mesh-list
14718403|NCT00472004|Estrogens|estrogens|mesh-ancestor
14718404|NCT00472004|Hormones|hormones|mesh-ancestor
14718405|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718406|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718407|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
14718408|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
14718409|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14718410|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14718411|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718412|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14916181|NCT01391156|Finasteride|finasteride|mesh-list
14916182|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14916183|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916184|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14916185|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14916186|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916187|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916188|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
14916189|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916190|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916191|NCT01391156|Urological Agents|urological agents|mesh-ancestor
14916192|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14916193|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14916194|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14916195|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14718413|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
14718414|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14898376|NCT01291719|Insulin|insulin|mesh-list
14898377|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14898378|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898379|NCT01291823|Gefitinib|gefitinib|mesh-list
14898380|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898381|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14898382|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898383|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898384|NCT01291927|Pancrelipase|pancrelipase|mesh-list
14898385|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14898386|NCT01291940|Petrolatum|petrolatum|mesh-list
14898387|NCT01291940|Emollients|emollients|mesh-ancestor
14898388|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
14898389|NCT01291979|Lidocaine|lidocaine|mesh-list
14898390|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
14898391|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
14898392|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898393|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898394|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
14898395|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898396|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14898397|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14898398|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14898399|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14898400|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898401|NCT01292031|Meropenem|meropenem|mesh-list
14898402|NCT01292031|Colistin|colistin|mesh-list
14898403|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898404|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898405|NCT01292083|Azacitidine|azacitidine|mesh-list
14898406|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14898407|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
14898408|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898409|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898410|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898411|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
14898412|NCT01292109|Cathartics|cathartics|mesh-ancestor
14898413|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14898414|NCT01292161|Silymarin|silymarin|mesh-list
14297341|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
14718415|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14718416|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718417|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14718418|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14718419|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718420|NCT00472134|Bupivacaine|bupivacaine|mesh-list
14718421|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
14718422|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
14718423|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718424|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898415|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
14898416|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898417|NCT01292161|Protective Agents|protective agents|mesh-ancestor
14898418|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898419|NCT01292174|Ibalizumab|ibalizumab|mesh-list
14898420|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14898421|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14898422|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14898423|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
14898424|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898425|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
14898426|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898427|NCT01292343|Listerine|listerine|mesh-list
14898428|NCT01292343|Triclosan|triclosan|mesh-list
15217364|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217365|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15217366|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
15217367|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217368|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217369|NCT03442413|Nicotine|nicotine|mesh-list
14898429|NCT01292343|Fluorides|fluorides|mesh-list
14898430|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
14898431|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
14898432|NCT01292343|Protective Agents|protective agents|mesh-ancestor
14898433|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898434|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14898435|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898436|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14898437|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14898438|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
14898439|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898440|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14898441|NCT01292356|Cetuximab|cetuximab|mesh-list
14898442|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898443|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898444|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
14898445|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
14898446|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14898447|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14898448|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898449|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898450|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898451|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14898452|NCT01292460|Timolol|timolol|mesh-list
14898453|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14898454|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14898455|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
14898456|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898457|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898458|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898459|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14898460|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14898461|NCT01292525|Tacrolimus|tacrolimus|mesh-list
14898462|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14898463|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
14898464|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898465|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14898466|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898467|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898468|NCT01292551|Bosentan|bosentan|mesh-list
14898469|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14898470|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14898471|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898472|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
14898473|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14898474|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14898475|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14898476|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
15217370|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15217371|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
15217372|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217373|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217374|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14898477|NCT01292694|Losartan|losartan|mesh-list
14898478|NCT01292694|Captopril|captopril|mesh-list
15217375|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14898479|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14898480|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14898481|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14898482|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14898483|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898484|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14898485|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14898486|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898487|NCT01292720|Vitamin D|vitamin d|mesh-list
14898488|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
15217376|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
15217377|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217378|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217379|NCT03439462|Sirolimus|sirolimus|mesh-list
15217380|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15217381|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217382|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15217383|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217384|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
15217385|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217386|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
15217387|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217388|NCT03386500|Manganese|manganese|mesh-list
15217389|NCT03386500|Trace Elements|trace elements|mesh-ancestor
15217390|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
15217391|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898489|NCT01292720|Vitamins|vitamins|mesh-ancestor
14898490|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
14898491|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898492|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14898493|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14898494|NCT01292785|Hormones|hormones|mesh-list
14898495|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14898496|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898497|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14898498|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
14898499|NCT01292993|Metformin|metformin|mesh-list
14898500|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14898501|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14898502|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898503|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14898504|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898505|NCT01293058|Naloxone|naloxone|mesh-list
14898506|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14898507|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898508|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
14898509|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898510|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14898511|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14898512|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898513|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
14898514|NCT01293097|Atorvastatin|atorvastatin|mesh-list
14898515|NCT01293097|Pravastatin|pravastatin|mesh-list
14898516|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14898517|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14898518|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
14898519|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898520|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14898521|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14898522|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898523|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
14898524|NCT01293136|Narcotics|narcotics|mesh-ancestor
14898525|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898526|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898527|NCT01293136|Analgesics|analgesics|mesh-ancestor
14898528|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
14898529|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898530|NCT01293149|Clonidine|clonidine|mesh-list
14898531|NCT01293149|Ropivacaine|ropivacaine|mesh-list
14898532|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
14898533|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
15217392|NCT03385655|Carboplatin|carboplatin|mesh-list
15217393|NCT03385655|Durvalumab|durvalumab|mesh-list
14297342|NCT04298853|Morphine|morphine|mesh-list
14297343|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14297344|NCT04298853|Narcotics|narcotics|mesh-ancestor
14718425|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
14718426|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718427|NCT00472173|Calcium|calcium|mesh-list
14718428|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14718429|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718430|NCT00472225|Rituximab|rituximab|mesh-list
14718431|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14718432|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718433|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
14718434|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718435|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718436|NCT00472329|Fludarabine|fludarabine|mesh-list
14718437|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718438|NCT00472355|Apomorphine|apomorphine|mesh-list
14718439|NCT00472355|Emetics|emetics|mesh-ancestor
14718440|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718441|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
14718442|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718443|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14297345|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898534|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898535|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898536|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
14898537|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898538|NCT01293149|Analgesics|analgesics|mesh-ancestor
14898539|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14898540|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
14898541|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
14898542|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14898543|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14898544|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14898545|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14898546|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898547|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898548|NCT01293162|Folic Acid|folic acid|mesh-list
14898549|NCT01293162|Policosanol|policosanol|mesh-list
14898550|NCT01293162|Hematinics|hematinics|mesh-ancestor
14718444|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
14718445|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
14718446|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718447|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718448|NCT00472368|Panobinostat|panobinostat|mesh-list
14718449|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718450|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14718451|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718452|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718453|NCT00472381|Insulin|insulin|mesh-list
14718454|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14718455|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718456|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
14718457|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14718458|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718459|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14898551|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
14898552|NCT01293162|Vitamins|vitamins|mesh-ancestor
14898553|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
14898554|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898555|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14898556|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14898557|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
14898558|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898559|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14898560|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14898561|NCT01293266|Propofol|propofol|mesh-list
14898562|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14898563|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898564|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898565|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14898566|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
14898567|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
14898568|NCT01293292|Teriparatide|teriparatide|mesh-list
14898569|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14898570|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898571|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14916196|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916197|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916198|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916199|NCT01391221|Analgesics|analgesics|mesh-ancestor
14916200|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
14916201|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916202|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
14916203|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14916204|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
14916205|NCT01391260|Gefitinib|gefitinib|mesh-list
14916206|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916207|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14916208|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916209|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916210|NCT01391377|Niacin|niacin|mesh-list
14916211|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14916212|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
14916213|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916214|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14916215|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916216|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
14916217|NCT01391377|Vitamins|vitamins|mesh-ancestor
14916218|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
14916219|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916220|NCT01391390|Melatonin|melatonin|mesh-list
14916221|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
14916222|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916223|NCT01391390|Protective Agents|protective agents|mesh-ancestor
14916224|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916225|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916226|NCT01391403|Artemisinins|artemisinins|mesh-list
14916227|NCT01391403|Artemisinin|artemisinin|mesh-list
14916228|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
14916229|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14916230|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14916231|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916232|NCT01391520|Deferiprone|deferiprone|mesh-list
14916233|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14916234|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
14916235|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
14916236|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916237|NCT01391572|Fluorouracil|fluorouracil|mesh-list
14916238|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916239|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
14916240|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916241|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14916242|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916243|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
14916244|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916245|NCT01391598|Lidocaine|lidocaine|mesh-list
14916246|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
14916247|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
14916248|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916249|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898572|NCT01293422|Rifampin|rifampin|mesh-list
14898573|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14898574|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
14898575|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898576|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898577|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
14898578|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14898579|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898580|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898581|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14898582|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14898583|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14898584|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14898585|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14898586|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14898587|NCT01293630|Paclitaxel|paclitaxel|mesh-list
14898588|NCT01293630|Carboplatin|carboplatin|mesh-list
14898589|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14898590|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898591|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
14898592|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
14898593|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
14898594|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898595|NCT01293643|Clindamycin|clindamycin|mesh-list
14898596|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
14898597|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
14898598|NCT01293643|Amphotericin B|amphotericin b|mesh-list
14898599|NCT01293643|Tetracycline|tetracycline|mesh-list
14898600|NCT01293643|Ketoconazole|ketoconazole|mesh-list
14898601|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14898602|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898603|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898604|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14898605|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898606|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898607|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
14898608|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14898609|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14898610|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14898611|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
14898612|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14898613|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898614|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14898615|NCT01293643|Amebicides|amebicides|mesh-ancestor
14898616|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14898617|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14898618|NCT01293734|Budesonide|budesonide|mesh-list
14898619|NCT01293734|Theophylline|theophylline|mesh-list
14718460|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14718461|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718462|NCT00472472|Paclitaxel|paclitaxel|mesh-list
14718463|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14718464|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718465|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14718466|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14718467|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14718468|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718469|NCT00472550|Esomeprazole|esomeprazole|mesh-list
14297346|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297347|NCT04298853|Analgesics|analgesics|mesh-ancestor
14297348|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
14297349|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297350|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14297351|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
14297352|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14898620|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898621|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14898622|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
14898623|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898624|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898625|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14898626|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14297353|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
14297354|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297355|NCT04233567|Infigratinib|infigratinib|mesh-list
14718470|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14718471|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718472|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14898627|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
14898628|NCT01293734|Hormones|hormones|mesh-ancestor
14898629|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14898630|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14898631|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898632|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898633|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898634|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14898635|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14898636|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
14898637|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898638|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14898639|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14898640|NCT01293747|Estradiol|estradiol|mesh-list
14898641|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14898642|NCT01293747|Progesterone|progesterone|mesh-list
14898643|NCT01293747|Estrogens|estrogens|mesh-ancestor
14898644|NCT01293747|Hormones|hormones|mesh-ancestor
14898645|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14898646|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898647|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14898648|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
14898649|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14898650|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14898651|NCT01293747|Progestins|progestins|mesh-ancestor
14898652|NCT01293838|Citalopram|citalopram|mesh-list
14898653|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14898654|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14898655|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14898656|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898657|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898658|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
14898659|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718473|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718474|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718475|NCT00472758|Sifalimumab|sifalimumab|mesh-list
14718476|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
14718477|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729012|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14729013|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14729014|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729015|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
14729016|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729017|NCT00521170|Levocetirizine|levocetirizine|mesh-list
14729018|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14729019|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14729020|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
14729021|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
14297356|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297357|NCT04224740|Cisplatin|cisplatin|mesh-list
14898660|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14898661|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
14898662|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14898663|NCT01293942|Bevacizumab|bevacizumab|mesh-list
14898664|NCT01293942|Capecitabine|capecitabine|mesh-list
14898665|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
14898666|NCT01293942|Irinotecan|irinotecan|mesh-list
14898667|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898668|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898669|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14898670|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14898671|NCT01293942|Growth Substances|growth substances|mesh-ancestor
14898672|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898673|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
14898674|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14898675|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
14898676|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898677|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14898678|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14898679|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898680|NCT01294059|Milnacipran|milnacipran|mesh-list
14898681|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
14898682|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14898683|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14898684|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14898685|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898686|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898687|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898688|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14898689|NCT01294059|Analgesics|analgesics|mesh-ancestor
14898690|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
14718478|NCT00472810|Mitomycins|mitomycins|mesh-list
14718479|NCT00472810|Mitomycin|mitomycin|mesh-list
14718480|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14718481|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718482|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
14718483|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718484|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14718485|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718486|NCT00472823|Vitamin D|vitamin d|mesh-list
14718487|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
14718488|NCT00472823|Calcium|calcium|mesh-list
14718489|NCT00472823|Vitamins|vitamins|mesh-ancestor
14898691|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898692|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
14898693|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14898694|NCT01294072|Curcumin|curcumin|mesh-list
14898695|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14898696|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14898697|NCT01294072|Analgesics|analgesics|mesh-ancestor
14898698|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
14898699|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898700|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898701|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898702|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14898703|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898704|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898705|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898706|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
14898707|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
14898708|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898709|NCT01294176|Protective Agents|protective agents|mesh-ancestor
14898710|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898711|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
14898712|NCT01294176|Vitamins|vitamins|mesh-ancestor
14898713|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
14898714|NCT01294215|Nifedipine|nifedipine|mesh-list
14898715|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14898716|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14898717|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898718|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14898719|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898720|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898721|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
14898722|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718490|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
14718491|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718492|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14718493|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14718494|NCT00472875|Glyburide|glyburide|mesh-list
14718495|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14898723|NCT01294293|Paclitaxel|paclitaxel|mesh-list
14898724|NCT01294293|Doxorubicin|doxorubicin|mesh-list
14898725|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14898726|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14898727|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898728|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
14898729|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
14898730|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
14898731|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898732|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14898733|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14898734|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14898735|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898736|NCT01294410|Antibodies|antibodies|mesh-list
14898737|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
14898738|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
14718496|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718497|NCT00472901|Afamelanotide|afamelanotide|mesh-list
14718498|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718499|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14718500|NCT00472927|Estrogens|estrogens|mesh-ancestor
14718501|NCT00472927|Hormones|hormones|mesh-ancestor
14718502|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718503|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718504|NCT00472953|Insulin|insulin|mesh-list
14898739|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898740|NCT01294605|Edetic Acid|edetic acid|mesh-list
14898741|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
14898742|NCT01294605|Antidotes|antidotes|mesh-ancestor
14898743|NCT01294605|Protective Agents|protective agents|mesh-ancestor
14898744|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898745|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
14898746|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
14898747|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898748|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14898749|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
14898750|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14898751|NCT01294618|Interferons|interferons|mesh-list
14898752|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898753|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
14898754|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898755|NCT01294631|Canagliflozin|canagliflozin|mesh-list
14898756|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14898757|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898758|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14898759|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898760|NCT01294735|Temozolomide|temozolomide|mesh-list
14898761|NCT01294735|Niraparib|niraparib|mesh-list
14898762|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14898763|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
14898764|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898765|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898766|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14898767|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898768|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
14898769|NCT01294761|Darunavir|darunavir|mesh-list
14898770|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14898771|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14898772|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
14898773|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898774|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14898775|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14898776|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898777|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898778|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14898779|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14898780|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14898781|NCT01294826|Cetuximab|cetuximab|mesh-list
14898782|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898783|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898784|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14898785|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
14898786|NCT01294878|Omalizumab|omalizumab|mesh-list
14898787|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14898788|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14898789|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
14898790|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14898791|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14898792|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
14898793|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14898794|NCT01294956|Laxatives|laxatives|mesh-ancestor
14898795|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14898796|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14898797|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14898798|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14898799|NCT01294969|Analgesics|analgesics|mesh-ancestor
14898800|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
14898801|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898802|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898803|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898804|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14898805|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14898806|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14898807|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14898808|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
14898809|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
14898810|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898811|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898812|NCT01295047|Atenolol|atenolol|mesh-list
14898813|NCT01295047|Verapamil|verapamil|mesh-list
14898814|NCT01295047|Perindopril|perindopril|mesh-list
14898815|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14898816|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14898817|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
14898818|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
14898819|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898820|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898821|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14898822|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14898823|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14898824|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
14898825|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898826|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898827|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14898828|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14898829|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14898830|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898831|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14898832|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
14898833|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898834|NCT01295073|Trientine|trientine|mesh-list
14898835|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
14898836|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
14898837|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898838|NCT01295086|Docetaxel|docetaxel|mesh-list
14898839|NCT01295086|Capecitabine|capecitabine|mesh-list
14898840|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
14898841|NCT01295086|Trastuzumab|trastuzumab|mesh-list
14898842|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898843|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
14898844|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
14898845|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14898846|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898847|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14898848|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
14898849|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898850|NCT01295099|Triamcinolone|triamcinolone|mesh-list
14898851|NCT01295099|Fluorouracil|fluorouracil|mesh-list
14898852|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
14898853|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898854|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14898855|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898856|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14898857|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
14898858|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898859|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898860|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
14898861|NCT01295099|Hormones|hormones|mesh-ancestor
14898862|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14898863|NCT01295138|Lactulose|lactulose|mesh-list
14898864|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14898865|NCT01295151|Adalimumab|adalimumab|mesh-list
14898866|NCT01295151|Etanercept|etanercept|mesh-list
14898867|NCT01295151|Golimumab|golimumab|mesh-list
14898868|NCT01295151|Rituximab|rituximab|mesh-list
14898869|NCT01295151|Abatacept|abatacept|mesh-list
14898870|NCT01295151|Infliximab|infliximab|mesh-list
14898871|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
14898872|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14898873|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898874|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
14898875|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898876|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14898877|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898878|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14898879|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14898880|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14898881|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14898882|NCT01295151|Analgesics|analgesics|mesh-ancestor
14898883|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
14898884|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898885|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14898886|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14898887|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898888|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14898889|NCT01295177|Insulin|insulin|mesh-list
14898890|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14898891|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14898892|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898893|NCT01295268|Emu Oil|emu oil|mesh-list
14898894|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898895|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
14898896|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
14898897|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
14898898|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
14898899|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14898900|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14898901|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898902|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
14898903|NCT01295294|Coagulants|coagulants|mesh-ancestor
14898904|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14898905|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
14898906|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14898907|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898908|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14898909|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14898910|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14898911|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14898912|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14898913|NCT01295294|Analgesics|analgesics|mesh-ancestor
14898914|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
14898915|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898916|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14898917|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14898918|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14898919|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898920|NCT01295307|Clofarabine|clofarabine|mesh-list
14898921|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14898922|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
14898923|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898924|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916250|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
14916251|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916252|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14916253|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14916254|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14916255|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916256|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916257|NCT01391624|Mineral Oil|mineral oil|mesh-list
14916258|NCT01391624|Emollients|emollients|mesh-ancestor
14916259|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
14916260|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14916261|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14898925|NCT01295372|Risperidone|risperidone|mesh-list
14898926|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14898927|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
14898928|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898929|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898930|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898931|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14898932|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14898933|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898934|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14898935|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14898936|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
14898937|NCT01295450|Vitamins|vitamins|mesh-list
14898938|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
14898939|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898940|NCT01295502|Paclitaxel|paclitaxel|mesh-list
14898941|NCT01295502|Cisplatin|cisplatin|mesh-list
14898942|NCT01295502|Carboplatin|carboplatin|mesh-list
14898943|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15217394|NCT03385655|Tremelimumab|tremelimumab|mesh-list
15217395|NCT03385655|Adavosertib|adavosertib|mesh-list
15217396|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217397|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14718505|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14898944|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14898945|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898946|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
14898947|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
14898948|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
14898949|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898950|NCT01295567|Dipyridamole|dipyridamole|mesh-list
14898951|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14898952|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898953|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898954|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14898955|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898956|NCT01295593|Cladribine|cladribine|mesh-list
14718506|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
14718507|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14718508|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718509|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14718510|NCT00472966|Tretinoin|tretinoin|mesh-list
14718511|NCT00472966|Glycolic acid|glycolic acid|mesh-list
14718512|NCT00472966|Hydroquinone|hydroquinone|mesh-list
14898957|NCT01295593|Valproic Acid|valproic acid|mesh-list
14898958|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
14898959|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898960|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898961|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
14898962|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14898963|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898964|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
14898965|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14898966|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14898967|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14718513|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217398|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217399|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217400|NCT03379727|Midostaurin|midostaurin|mesh-list
15217401|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217402|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15217403|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718514|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
14718515|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718516|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718517|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
14718518|NCT00472966|Hormones|hormones|mesh-ancestor
14718519|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718520|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718521|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
14718522|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898968|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14898969|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14898970|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
14898971|NCT01295606|Cefazolin|cefazolin|mesh-list
14898972|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14898973|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14898974|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
14898975|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14898976|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14898977|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14898978|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14898979|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898980|NCT01295736|Urological Agents|urological agents|mesh-ancestor
14898981|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14898982|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
14898983|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14898984|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
14898985|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14898986|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14898987|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14898988|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14898989|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14898990|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898991|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
14898992|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14898993|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
14898994|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14898995|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14898996|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14898997|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
14898998|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14898999|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
14899000|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899001|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899002|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14899003|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
14899004|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
14899005|NCT01295866|Protective Agents|protective agents|mesh-ancestor
14899006|NCT01295892|Estrogens|estrogens|mesh-list
14899007|NCT01295892|Hormones|hormones|mesh-ancestor
14899008|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899009|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899010|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14899011|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899012|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14899013|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899014|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
14899015|NCT01296074|Hormones|hormones|mesh-ancestor
14899016|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899017|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899018|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14899019|NCT01296074|Protective Agents|protective agents|mesh-ancestor
14899020|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899021|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899022|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14899023|NCT01296139|Hematinics|hematinics|mesh-ancestor
14899024|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14899025|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14899026|NCT01296178|Idarubicin|idarubicin|mesh-list
14899027|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14718523|NCT00472966|Protective Agents|protective agents|mesh-ancestor
14718524|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14718525|NCT00473005|Capecitabine|capecitabine|mesh-list
14718526|NCT00473005|Everolimus|everolimus|mesh-list
14718527|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14718528|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
14718529|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718530|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718531|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14718532|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
14718533|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718534|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14718535|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718536|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14718537|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718538|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
14718539|NCT00473070|Hormones|hormones|mesh-ancestor
14899028|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899029|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14899030|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14899031|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899032|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899033|NCT01296204|Antibodies|antibodies|mesh-list
14899034|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
14899035|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899036|NCT01296230|Hormones|hormones|mesh-list
14899037|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718540|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718541|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718542|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14718543|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14718544|NCT00473174|Ramipril|ramipril|mesh-list
14718545|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14718546|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
14718547|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899038|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899039|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14899040|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14899041|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
14899042|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899043|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899044|NCT01296269|Vasopressins|vasopressins|mesh-list
14899045|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
14899046|NCT01296269|Oxytocin|oxytocin|mesh-list
14899047|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
14899048|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14899049|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899050|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
14899051|NCT01296269|Coagulants|coagulants|mesh-ancestor
14899052|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14899053|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14899054|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
14899055|NCT01296334|Morphine|morphine|mesh-list
14899056|NCT01296334|Buprenorphine|buprenorphine|mesh-list
14899057|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14899058|NCT01296334|Narcotics|narcotics|mesh-ancestor
14899059|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899060|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899061|NCT01296334|Analgesics|analgesics|mesh-ancestor
14899062|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
14899063|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899064|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14899065|NCT01296438|Insulin|insulin|mesh-list
14899066|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14899067|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
14899068|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
14899069|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14899070|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899071|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899072|NCT01296464|Carbidopa|carbidopa|mesh-list
14899073|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14899074|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14899075|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
14899076|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899077|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899078|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899079|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14899080|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899081|NCT01296503|Thalidomide|thalidomide|mesh-list
14899082|NCT01296503|Dexamethasone|dexamethasone|mesh-list
14899083|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
14899084|NCT01296503|BB 1101|bb 1101|mesh-list
14899085|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899086|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
14899087|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
14899088|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899089|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899090|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899091|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
14899092|NCT01296503|Hormones|hormones|mesh-ancestor
14899093|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899094|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899095|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899096|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
14899097|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899098|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899099|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899100|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
14899101|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
14899102|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899103|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899104|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899105|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15217404|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225401|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15225402|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
15225403|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
15225404|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
15225405|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
14297358|NCT04224740|Carboplatin|carboplatin|mesh-list
14899106|NCT01296503|Growth Substances|growth substances|mesh-ancestor
14899107|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
14899108|NCT01296555|Letrozole|letrozole|mesh-list
14899109|NCT01296555|Fulvestrant|fulvestrant|mesh-list
14899110|NCT01296555|Midazolam|midazolam|mesh-list
14899111|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14899112|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14899113|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899114|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899115|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14899116|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14899117|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14899118|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14899119|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
14899120|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
14899121|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
14899122|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
14899123|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899124|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899125|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899126|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14899127|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14899128|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899129|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14899130|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
14899131|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899132|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899133|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14899134|NCT01296802|Fenfluramine|fenfluramine|mesh-list
14899135|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
14899136|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14718548|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718549|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14718550|NCT00473213|Interferons|interferons|mesh-list
14718551|NCT00473213|Interferon-beta|interferon-beta|mesh-list
14718552|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718553|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
14718554|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718555|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
14718556|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718557|NCT00473239|Vitamin D|vitamin d|mesh-list
14899137|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14899138|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899139|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899140|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899141|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
14899142|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899143|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14899144|NCT01296958|Niclosamide|niclosamide|mesh-list
14899145|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
14297359|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
14899146|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14899147|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
14718558|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
14899148|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14899149|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899150|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
14899151|NCT01296971|Ribavirin|ribavirin|mesh-list
14899152|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14899153|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
14899154|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899155|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
14899156|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899157|NCT01296997|Calcium|calcium|mesh-list
14899158|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14899159|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899160|NCT01297010|Dexamethasone|dexamethasone|mesh-list
14899161|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
14899162|NCT01297010|BB 1101|bb 1101|mesh-list
14899163|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899164|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
14899165|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
14899166|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899167|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899168|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899169|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
14899170|NCT01297010|Hormones|hormones|mesh-ancestor
14899171|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899172|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899173|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899174|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
14899175|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899176|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718559|NCT00473239|Vitamins|vitamins|mesh-ancestor
14718560|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
14718561|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718562|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14718563|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14718564|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14718565|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14718566|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
14899177|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
14899178|NCT01297023|Vitamin D|vitamin d|mesh-list
14899179|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
14899180|NCT01297023|Vitamins|vitamins|mesh-list
14899181|NCT01297023|Calcium|calcium|mesh-list
14899182|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
14899183|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899184|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14899185|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14899186|NCT01297036|Donepezil|donepezil|mesh-list
14899187|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14899188|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899189|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899190|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
14297360|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718567|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
14899191|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899192|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899193|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
14916262|NCT01391689|Protective Agents|protective agents|mesh-ancestor
14916263|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916264|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916265|NCT01391715|Rabeprazole|rabeprazole|mesh-list
14916266|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14916267|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916268|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14916269|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916270|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916271|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
14916272|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14916273|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
14916274|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14916275|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916276|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14917493|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917494|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14917495|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917496|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14917497|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
14917498|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14917499|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917500|NCT05060913|Lidocaine|lidocaine|mesh-list
14917501|NCT05060913|Prilocaine|prilocaine|mesh-list
14917502|NCT05060913|Benzocaine|benzocaine|mesh-list
14917503|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14917504|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
14917505|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
14917506|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917507|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917508|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
14917509|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917510|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14917511|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14917512|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14917513|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14917514|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917515|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14917516|NCT05054439|Paclitaxel|paclitaxel|mesh-list
14917517|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14917518|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917519|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
14917520|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
14917521|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
14917522|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917523|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14917524|NCT05038592|Decitabine|decitabine|mesh-list
14917525|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917526|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
14917527|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917528|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917529|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917530|NCT05011058|Valganciclovir|valganciclovir|mesh-list
14917531|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
14917532|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917533|NCT05009355|Ascorbic Acid|ascorbic acid|mesh-list
14917534|NCT05009355|Vitamins|vitamins|mesh-ancestor
14917535|NCT05009355|Micronutrients|micronutrients|mesh-ancestor
14917536|NCT05009355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917537|NCT05009355|Antioxidants|antioxidants|mesh-ancestor
14917538|NCT05009355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917539|NCT05009355|Protective Agents|protective agents|mesh-ancestor
14917540|NCT04998006|Ethanol|ethanol|mesh-list
14917541|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14917542|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917543|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917544|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899194|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14899195|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899196|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14899197|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899198|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899199|NCT01297166|Calcitriol|calcitriol|mesh-list
14899200|NCT01297166|Calcipotriene|calcipotriene|mesh-list
14899201|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
14899202|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14899203|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899204|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14899205|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899206|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899207|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14899208|NCT01297166|Vitamins|vitamins|mesh-ancestor
14899209|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
14899210|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14899211|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
14899212|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14899213|NCT01297179|Mirabegron|mirabegron|mesh-list
14899214|NCT01297179|Estradiol|estradiol|mesh-list
14899215|NCT01297179|Estrogens|estrogens|mesh-ancestor
14899216|NCT01297179|Hormones|hormones|mesh-ancestor
14899217|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899218|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899219|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14899220|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
14899221|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14899222|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14899223|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14899224|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14899225|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14899226|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14899227|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14899228|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14899229|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
14899230|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899231|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899232|NCT01297179|Urological Agents|urological agents|mesh-ancestor
14899233|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
14899234|NCT01297192|Mirabegron|mirabegron|mesh-list
14899235|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14899236|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14899237|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
14899238|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899239|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899240|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899241|NCT01297192|Urological Agents|urological agents|mesh-ancestor
14899242|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14899243|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14899244|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14899245|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
14899246|NCT01297452|Paclitaxel|paclitaxel|mesh-list
14899247|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14899248|NCT01297452|Carboplatin|carboplatin|mesh-list
14899249|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14899250|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899251|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
14899252|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217405|NCT03326492|Antivenins|antivenins|mesh-list
15217406|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
15217407|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217408|NCT03272217|Bevacizumab|bevacizumab|mesh-list
15217409|NCT03272217|Atezolizumab|atezolizumab|mesh-list
15217410|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217411|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217412|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899253|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
14899254|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899255|NCT01297569|Ranibizumab|ranibizumab|mesh-list
14916277|NCT01392014|Piperaquine|piperaquine|mesh-list
15217413|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14899256|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899257|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14899258|NCT01297569|Growth Substances|growth substances|mesh-ancestor
14899259|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899260|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
14899261|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217414|NCT03272217|Growth Substances|growth substances|mesh-ancestor
15217415|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217416|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
15217417|NCT03260023|Avelumab|avelumab|mesh-list
15217418|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217419|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217420|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15217421|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15217422|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
15217423|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718568|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14718569|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14718570|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718571|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14718572|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14718573|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718574|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718575|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718576|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14718577|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
14718578|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718579|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718580|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14718581|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14718582|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14718583|NCT00473486|Carboplatin|carboplatin|mesh-list
14718584|NCT00473486|Pemetrexed|pemetrexed|mesh-list
14718585|NCT00473486|Sorafenib|sorafenib|mesh-list
14718586|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718587|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729022|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899262|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
14899263|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14899264|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14899265|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14899266|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899267|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899268|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
14899269|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899270|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899271|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14899272|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899273|NCT01297686|Dexamethasone|dexamethasone|mesh-list
14899274|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899275|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
14899276|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
14899277|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899278|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899279|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899280|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
14899281|NCT01297686|Hormones|hormones|mesh-ancestor
14899282|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899283|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899284|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899285|NCT01297764|Dexamethasone|dexamethasone|mesh-list
14899286|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
14899287|NCT01297764|Lenalidomide|lenalidomide|mesh-list
14899288|NCT01297764|Vorinostat|vorinostat|mesh-list
14899289|NCT01297764|BB 1101|bb 1101|mesh-list
14899290|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899291|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
14899292|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
14899293|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899294|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899295|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899296|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
14899297|NCT01297764|Hormones|hormones|mesh-ancestor
14899298|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899299|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899300|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899301|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
14899302|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899303|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899304|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
14899305|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899306|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14899307|NCT01297764|Growth Substances|growth substances|mesh-ancestor
14899308|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
14899309|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14899310|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
14899311|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899312|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14899313|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899314|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899315|NCT01297803|Mitomycins|mitomycins|mesh-list
14899316|NCT01297803|Mitomycin|mitomycin|mesh-list
14899317|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14899318|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899319|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
14899320|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899321|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14899322|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899323|NCT01297816|Minocycline|minocycline|mesh-list
14899324|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899325|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899326|NCT01297829|Ibuprofen|ibuprofen|mesh-list
14899327|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14899328|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14899329|NCT01297829|Analgesics|analgesics|mesh-ancestor
14899330|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
14899331|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899332|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899333|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899334|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14899335|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14899336|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899337|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899338|NCT01297842|Meropenem|meropenem|mesh-list
14899339|NCT01297842|Imipenem|imipenem|mesh-list
14899340|NCT01297842|Ertapenem|ertapenem|mesh-list
14899341|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899342|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899343|NCT01297855|Rifampin|rifampin|mesh-list
14899344|NCT01297855|Colistin|colistin|mesh-list
14899345|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14899346|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
14899347|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899348|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899349|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
14899350|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14899351|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899352|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899353|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14899354|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14899355|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14899356|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14899357|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14899358|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14899359|NCT01297894|Colistin|colistin|mesh-list
14899360|NCT01297894|Fosfomycin|fosfomycin|mesh-list
14899361|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899362|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899363|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
14899364|NCT01297907|Miotics|miotics|mesh-ancestor
14899365|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
14899366|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899367|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899368|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14899369|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14899370|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
14899371|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14899372|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14899373|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
14899374|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899375|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899376|NCT01297946|Hormones|hormones|mesh-list
14899377|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899378|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899379|NCT01297998|Gemcitabine|gemcitabine|mesh-list
14899380|NCT01297998|Cisplatin|cisplatin|mesh-list
14899381|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718588|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718589|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14718590|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14718591|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14718592|NCT00473551|Vidarabine|vidarabine|mesh-list
14718593|NCT00473551|Sirolimus|sirolimus|mesh-list
14718594|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
14718595|NCT00473551|Rituximab|rituximab|mesh-list
14718596|NCT00473551|Fludarabine|fludarabine|mesh-list
14718597|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
14718598|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899382|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14899383|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
14899384|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899385|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
14899386|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899387|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899388|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899389|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
14899390|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899391|NCT01298011|Gemcitabine|gemcitabine|mesh-list
14899392|NCT01298011|Paclitaxel|paclitaxel|mesh-list
14899393|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14899394|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14899395|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899396|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14899397|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14899398|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14899399|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899400|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14899401|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
14899402|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
14899403|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899404|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899405|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899406|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
14899407|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899408|NCT01298076|Dexamethasone|dexamethasone|mesh-list
15217424|NCT03215524|Thalidomide|thalidomide|mesh-list
15217425|NCT03215524|Dexamethasone|dexamethasone|mesh-list
15217426|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
15217427|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
15217428|NCT03215524|Daratumumab|daratumumab|mesh-list
15217429|NCT03215524|Pomalidomide|pomalidomide|mesh-list
15217430|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15217431|NCT03215524|BB 1101|bb 1101|mesh-list
15217432|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217433|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
15217434|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217435|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15217436|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217437|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
15217438|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217439|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217440|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15217441|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899409|NCT01298076|Bevacizumab|bevacizumab|mesh-list
14718599|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
14899410|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14899411|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217442|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
14899412|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899413|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14899414|NCT01298076|Growth Substances|growth substances|mesh-ancestor
14899415|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899416|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14899417|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899418|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
14899419|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
14899420|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899421|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899422|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
14899423|NCT01298076|Hormones|hormones|mesh-ancestor
14899424|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899425|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899426|NCT01298180|Hormones|hormones|mesh-list
14899427|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899428|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899429|NCT01298271|Propranolol|propranolol|mesh-list
14899430|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14899431|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14899432|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14899433|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899434|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899435|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899436|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14899437|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14899438|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
14899439|NCT01298284|Propranolol|propranolol|mesh-list
14899440|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14899441|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14899442|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
14899443|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217443|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
15217444|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217445|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15217446|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
15217447|NCT03215524|Hormones|hormones|mesh-ancestor
15217448|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217449|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217450|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
15217451|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217452|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899444|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899445|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899446|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14899447|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14899448|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
14899449|NCT01298297|Morphine|morphine|mesh-list
14899450|NCT01298297|Buprenorphine|buprenorphine|mesh-list
14899451|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14899452|NCT01298297|Narcotics|narcotics|mesh-ancestor
14899453|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899454|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899455|NCT01298297|Analgesics|analgesics|mesh-ancestor
14899456|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
14899457|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899458|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14899459|NCT01298310|Lidocaine|lidocaine|mesh-list
14899460|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
14899461|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
14899462|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899463|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899464|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
14899465|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899466|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14899467|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14899468|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14899469|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899470|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899471|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
15217453|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15217454|NCT03215524|Growth Substances|growth substances|mesh-ancestor
15217455|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
14899472|NCT01298336|Clarithromycin|clarithromycin|mesh-list
14899473|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899474|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899475|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14899476|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14899477|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899478|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899479|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899480|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14899481|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14899482|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14899483|NCT01298401|Gemcitabine|gemcitabine|mesh-list
14899484|NCT01298401|Capecitabine|capecitabine|mesh-list
14899485|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14899486|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
14899487|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899488|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899489|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
14899490|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899491|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899492|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899493|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
14899494|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899495|NCT01298466|Pregabalin|pregabalin|mesh-list
14899496|NCT01298466|Analgesics|analgesics|mesh-ancestor
14899497|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
14899498|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899499|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899500|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
14899501|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14899502|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899503|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899504|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14899505|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14899506|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14899507|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899508|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14899509|NCT01298505|Fexofenadine|fexofenadine|mesh-list
14899510|NCT01298505|Terfenadine|terfenadine|mesh-list
14899511|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14899512|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14899513|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14899514|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
14899515|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
14899516|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899517|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217456|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
14899518|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899519|NCT01298713|Tamoxifen|tamoxifen|mesh-list
14899520|NCT01298713|Everolimus|everolimus|mesh-list
14899521|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899522|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899523|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
14899524|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899525|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14899526|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
14899527|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899528|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899529|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14899530|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14899531|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14899532|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14899533|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899534|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899535|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
14899536|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916278|NCT01392014|Primaquine|primaquine|mesh-list
14916279|NCT01392014|Artenimol|artenimol|mesh-list
14916280|NCT01392014|Artemisinins|artemisinins|mesh-list
14916281|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
14916282|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14916283|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14916284|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916285|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
14916286|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14916287|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916288|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
14916289|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14916290|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
14916291|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916292|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916293|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14916294|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
14916295|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14916296|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
14916297|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916298|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916299|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14916300|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916301|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
14916302|NCT01392144|Protective Agents|protective agents|mesh-ancestor
14916303|NCT01392157|Copper|copper|mesh-list
14916304|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
14916305|NCT01392157|Trace Elements|trace elements|mesh-ancestor
14916306|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
14916307|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916308|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14916309|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
14916310|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14916311|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14916312|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14916313|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14916314|NCT01392209|Bevacizumab|bevacizumab|mesh-list
14916315|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14916316|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916317|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14916318|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14916319|NCT01392209|Growth Substances|growth substances|mesh-ancestor
14916320|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916321|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
14916322|NCT01392287|Memantine|memantine|mesh-list
14916323|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14916324|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14899537|NCT01298934|Panobinostat|panobinostat|mesh-list
14899538|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899539|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14899540|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899541|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899542|NCT01299012|Liraglutide|liraglutide|mesh-list
14899543|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899544|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899545|NCT01299012|Incretins|incretins|mesh-ancestor
14899546|NCT01299012|Hormones|hormones|mesh-ancestor
14899547|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899548|NCT01299181|Atorvastatin|atorvastatin|mesh-list
14899549|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14899550|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14899551|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
14899552|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899553|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14899554|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14899555|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899556|NCT01299194|Atorvastatin|atorvastatin|mesh-list
14899557|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14899558|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14899559|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
14899560|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899561|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14899562|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14899563|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899564|NCT01299220|Acitretin|acitretin|mesh-list
14899565|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
14899566|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
14899567|NCT01299298|Mipomersen|mipomersen|mesh-list
14899568|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14899569|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14899570|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
14899571|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718600|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718601|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718602|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14899572|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14899573|NCT01299415|Vadimezan|vadimezan|mesh-list
14899574|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899575|NCT01299558|Fluticasone|fluticasone|mesh-list
14899576|NCT01299558|Xhance|xhance|mesh-list
14899577|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899578|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14899579|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
14899580|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899581|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899582|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14899583|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
14899584|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
14899585|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14899586|NCT01299597|Atorvastatin|atorvastatin|mesh-list
14899587|NCT01299597|Simvastatin|simvastatin|mesh-list
14899588|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14899589|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14899590|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
14899591|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899592|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14899593|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14899594|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899595|NCT01299662|Poly ICLC|poly iclc|mesh-list
14899596|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
14899597|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
14899598|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899599|NCT01299701|Vadimezan|vadimezan|mesh-list
14899600|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899601|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14899602|NCT01299779|Laxatives|laxatives|mesh-ancestor
14899603|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899604|NCT01299831|Hormones|hormones|mesh-list
14899605|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899606|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899607|NCT01299857|Rituximab|rituximab|mesh-list
14899608|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14899609|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899610|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
14899611|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899612|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14899613|NCT01299922|Cyclosporine|cyclosporine|mesh-list
14899614|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
14899615|NCT01299922|Cyclosporins|cyclosporins|mesh-list
14899616|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899617|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718603|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
14718604|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718605|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718606|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14899618|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899619|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
14899620|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899621|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
14899622|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899623|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
14899624|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14899625|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14899626|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14899627|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899628|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14899629|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
14899630|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899631|NCT01299948|Prednisolone|prednisolone|mesh-list
14899632|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899633|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
14899634|NCT01299948|Hormones|hormones|mesh-ancestor
14899635|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899636|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899637|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899638|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899639|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
14899640|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899641|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899642|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
14899643|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899644|NCT01300312|Diclofenac|diclofenac|mesh-list
14899645|NCT01300312|Eperisone|eperisone|mesh-list
14899646|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14899647|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14899648|NCT01300312|Analgesics|analgesics|mesh-ancestor
14899649|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
14899650|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899651|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899652|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899653|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14899654|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14899655|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899656|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899657|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
14899658|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14899659|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899660|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14899661|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14899662|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14899663|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
14899664|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
14899665|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
14899666|NCT01300364|Citalopram|citalopram|mesh-list
14899667|NCT01300364|Reboxetine|reboxetine|mesh-list
14899668|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14899669|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14899670|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899671|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899672|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899673|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
14899674|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899675|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14899676|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
14899677|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14899678|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14899679|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
15217457|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15217458|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217459|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
15217460|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217461|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217462|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
15217463|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217464|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899680|NCT01300377|Lidocaine|lidocaine|mesh-list
14899681|NCT01300377|Bupivacaine|bupivacaine|mesh-list
15217465|NCT03117309|Nivolumab|nivolumab|mesh-list
14899682|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
14899683|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
14899684|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899685|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899686|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
14899687|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899688|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14899689|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14899690|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14899691|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899692|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899693|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14899694|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14899695|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
14899696|NCT01300637|Metformin|metformin|mesh-list
14899697|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899698|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899699|NCT01300676|Estradiol|estradiol|mesh-list
14899700|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
14899701|NCT01300676|Estrogens|estrogens|mesh-ancestor
14899702|NCT01300676|Hormones|hormones|mesh-ancestor
14899703|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899704|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899705|NCT01300676|Progestins|progestins|mesh-ancestor
14899706|NCT01300754|Lidocaine|lidocaine|mesh-list
14899707|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
14899708|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
14899709|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899710|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899711|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
14899712|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899713|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14899714|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14899715|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14899716|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899717|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899718|NCT01300780|Etoricoxib|etoricoxib|mesh-list
14899719|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14899720|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14899721|NCT01300780|Analgesics|analgesics|mesh-ancestor
14899722|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
14899723|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899724|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899725|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899726|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14899727|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14899728|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14899729|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899730|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899731|NCT01300793|Rituximab|rituximab|mesh-list
14899732|NCT01300793|Carboplatin|carboplatin|mesh-list
14899733|NCT01300793|Etoposide|etoposide|mesh-list
14899734|NCT01300793|Bortezomib|bortezomib|mesh-list
14899735|NCT01300793|Ifosfamide|ifosfamide|mesh-list
14899736|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
14899737|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14899738|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899739|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
14899740|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899741|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14899742|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14899743|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14899744|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14899745|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899746|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899747|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14899748|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
14916325|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
14916326|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916327|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916328|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916329|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14916330|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14916331|NCT01392430|Azithromycin|azithromycin|mesh-list
14916332|NCT01392430|Dapsone|dapsone|mesh-list
14916333|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14916334|NCT01392430|Itraconazole|itraconazole|mesh-list
14916335|NCT01392430|Fluconazole|fluconazole|mesh-list
14916336|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14916337|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916338|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
14916339|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14916340|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14916341|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916342|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916343|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14916344|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
14916345|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916346|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916347|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15217466|NCT03117309|Ipilimumab|ipilimumab|mesh-list
15217467|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217468|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217469|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15217470|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217471|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
15217472|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
15217473|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217474|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
15217475|NCT03073785|Fluorouracil|fluorouracil|mesh-list
15217476|NCT03073785|Capecitabine|capecitabine|mesh-list
15217477|NCT03073785|Imidazole|imidazole|mesh-list
15217478|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
15217479|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217480|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15217481|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916348|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14916349|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14916350|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
14916351|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14916352|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14916353|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14916354|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
14916355|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14916356|NCT01392430|Renal Agents|renal agents|mesh-ancestor
14916357|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14916358|NCT01392534|Telmisartan|telmisartan|mesh-list
15217482|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217483|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
14899749|NCT01300962|Capecitabine|capecitabine|mesh-list
14899750|NCT01300962|Trastuzumab|trastuzumab|mesh-list
14899751|NCT01300962|Lapatinib|lapatinib|mesh-list
14899752|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14899753|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
14899754|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899755|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899756|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14899757|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14899758|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899759|NCT01300988|Aprepitant|aprepitant|mesh-list
14899760|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
14899761|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
14899762|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
14899763|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899764|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899765|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899766|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14899767|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899768|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899769|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
14899770|NCT01301040|Docetaxel|docetaxel|mesh-list
14899771|NCT01301040|Epirubicin|epirubicin|mesh-list
14899772|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899773|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
14899774|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899775|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14899776|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217484|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217485|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14899777|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
14899778|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899779|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899780|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14899781|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
14899782|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
14899783|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
14899784|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14899785|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14899786|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14899787|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899788|NCT01301053|Insulin|insulin|mesh-list
14899789|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14899790|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15217486|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217487|NCT03047135|Olaparib|olaparib|mesh-list
15217488|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15217489|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217490|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217491|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217492|NCT03035630|Sunitinib|sunitinib|mesh-list
15217493|NCT03035630|Avelumab|avelumab|mesh-list
15217494|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899791|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217495|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899792|NCT01301222|Octreotide|octreotide|mesh-list
14899793|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899794|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14899795|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899796|NCT01301248|Cisplatin|cisplatin|mesh-list
14899797|NCT01301248|Cetuximab|cetuximab|mesh-list
14899798|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899799|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14718607|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14718608|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14718609|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
14718610|NCT00473551|Antiviral Agents|antiviral agents|mesh-ancestor
14718611|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718612|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14718613|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14899800|NCT01301313|Simendan|simendan|mesh-list
14899801|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14899802|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
14899803|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14899804|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14899805|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899806|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899807|NCT01301313|Protective Agents|protective agents|mesh-ancestor
14899808|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899809|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14899810|NCT01301586|Doxycycline|doxycycline|mesh-list
14899811|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899812|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899813|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
14899814|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14899815|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14899816|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14899817|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
14899818|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14899819|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
14899820|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899821|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899822|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899823|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14899824|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899825|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
14899826|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899827|NCT01301612|Cisplatin|cisplatin|mesh-list
14899828|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
14899829|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899830|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14899831|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
14899832|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14899833|NCT01301716|Paclitaxel|paclitaxel|mesh-list
14899834|NCT01301716|Bevacizumab|bevacizumab|mesh-list
14899835|NCT01301716|Carboplatin|carboplatin|mesh-list
14899836|NCT01301716|Pemetrexed|pemetrexed|mesh-list
14899837|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14899838|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899839|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14899840|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14899841|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14899842|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899843|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14899844|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899845|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14899846|NCT01301716|Growth Substances|growth substances|mesh-ancestor
14899847|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899848|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
14899849|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899850|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14899851|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14899852|NCT01301807|Panobinostat|panobinostat|mesh-list
14899853|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899854|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14899855|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899856|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899857|NCT01301820|Lenalidomide|lenalidomide|mesh-list
14899858|NCT01301820|Azacitidine|azacitidine|mesh-list
14899859|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
14899860|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899861|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14899862|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14899863|NCT01301820|Growth Substances|growth substances|mesh-ancestor
14899864|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14899865|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899866|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14899867|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
14899868|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899869|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899870|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14899871|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14899872|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14899873|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899874|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14899875|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14899876|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14899877|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899878|NCT01302002|Metformin|metformin|mesh-list
14899879|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899880|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899881|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
14899882|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14899883|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899884|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899885|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899886|NCT01302093|Racecadotril|racecadotril|mesh-list
14899887|NCT01302093|Thiorphan|thiorphan|mesh-list
14899888|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
14899889|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14899890|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
14899891|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899892|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899893|NCT01302106|Clofarabine|clofarabine|mesh-list
14899894|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14899895|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
14899896|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899897|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899898|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
14899899|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14899900|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899901|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899902|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899903|NCT01302145|Metformin|metformin|mesh-list
14899904|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
14899905|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899906|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899907|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14899908|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899909|NCT01302158|Glimepiride|glimepiride|mesh-list
14899910|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
14899911|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14899912|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14899913|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899914|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14899915|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
14899916|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14899917|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899918|NCT01302171|Sargramostim|sargramostim|mesh-list
14899919|NCT01302171|Lenograstim|lenograstim|mesh-list
14899920|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
14899921|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899922|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14899923|NCT01302210|Mupirocin|mupirocin|mesh-list
14899924|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14899925|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14899926|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14899927|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899928|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899929|NCT01302236|Eplerenone|eplerenone|mesh-list
14899930|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14899931|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
14899932|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899933|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899934|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14899935|NCT01302236|Diuretics|diuretics|mesh-ancestor
14899936|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
14899937|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14899938|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
14899939|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
14917545|NCT04975269|Acetazolamide|acetazolamide|mesh-list
14718614|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
14718615|NCT00473603|Heparin|heparin|mesh-list
14718616|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
14718617|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14718618|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14718619|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718620|NCT00473616|Irinotecan|irinotecan|mesh-list
14718621|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14718622|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14718623|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14899940|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14718624|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718625|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718626|NCT00473707|Oxytocin|oxytocin|mesh-list
14718627|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
14899941|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14899942|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14899943|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899944|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14899945|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14899946|NCT01302340|Dronabinol|dronabinol|mesh-list
14899947|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
14899948|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899949|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14899950|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14899951|NCT01302340|Analgesics|analgesics|mesh-ancestor
14899952|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
14899953|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899954|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14899955|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14899956|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899957|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899958|NCT01302340|Hormones|hormones|mesh-ancestor
14899959|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14899960|NCT01302353|Isoflurane|isoflurane|mesh-list
14899961|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14899962|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
14899963|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
14899964|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14899965|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899966|NCT01302496|Ipilimumab|ipilimumab|mesh-list
14899967|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14899968|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899969|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14899970|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899971|NCT01302587|Albuterol|albuterol|mesh-list
14899972|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14718628|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718629|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718630|NCT00473720|Paclitaxel|paclitaxel|mesh-list
14718631|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14718632|NCT00473720|Satraplatin|satraplatin|mesh-list
14718633|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14718634|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718635|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14718636|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
14899973|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
14899974|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14899975|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899976|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14899977|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
14899978|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
14899979|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14899980|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14899981|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14899982|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14899983|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
15217496|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15217497|NCT03035630|Growth Substances|growth substances|mesh-ancestor
15217498|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217499|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
15217500|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14899984|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14899985|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916359|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
14916360|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14916361|NCT01392534|Diuretics|diuretics|mesh-ancestor
14916362|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
14916363|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916364|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14916365|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916366|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916367|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14916368|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14916369|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
14916370|NCT01392612|Hematinics|hematinics|mesh-ancestor
14916371|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
14916372|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916373|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14916374|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14916375|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916376|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916377|NCT01392638|Urological Agents|urological agents|mesh-ancestor
14916378|NCT01392716|Rituximab|rituximab|mesh-list
14916379|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14916380|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916381|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
14916382|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916383|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916384|NCT01392755|Ritonavir|ritonavir|mesh-list
14916385|NCT01392755|Omeprazole|omeprazole|mesh-list
14916386|NCT01392755|Ranitidine|ranitidine|mesh-list
15217501|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217502|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217503|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217504|NCT02962297|Vitamin E|vitamin e|mesh-list
15217505|NCT02962297|Vitamins|vitamins|mesh-ancestor
15217506|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
15217507|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916387|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14917546|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
15217508|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
15225406|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718637|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14718638|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718639|NCT00473915|Fluticasone|fluticasone|mesh-list
14718640|NCT00473915|Xhance|xhance|mesh-list
14718641|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718642|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14718643|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
14718644|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718645|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718646|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14718647|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
14899986|NCT01302613|Leucovorin|leucovorin|mesh-list
14899987|NCT01302613|Capecitabine|capecitabine|mesh-list
14899988|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
14899989|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14899990|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
14899991|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14899992|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14899993|NCT01302613|Antidotes|antidotes|mesh-ancestor
14899994|NCT01302613|Protective Agents|protective agents|mesh-ancestor
14899995|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14899996|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
14899997|NCT01302613|Vitamins|vitamins|mesh-ancestor
14718648|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
14718649|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14899998|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
14899999|NCT01302756|Folic Acid|folic acid|mesh-list
14900000|NCT01302756|Hematinics|hematinics|mesh-ancestor
14900001|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
14900002|NCT01302756|Vitamins|vitamins|mesh-ancestor
14900003|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
14900004|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900005|NCT01302821|Tryptophan|tryptophan|mesh-list
14900006|NCT01302821|Vaccines|vaccines|mesh-list
14900007|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
14900008|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900009|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14718650|NCT00473980|Celecoxib|celecoxib|mesh-list
14718651|NCT00473980|Indomethacin|indomethacin|mesh-list
14718652|NCT00473980|Esomeprazole|esomeprazole|mesh-list
14718653|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718654|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14718655|NCT00473980|Analgesics|analgesics|mesh-ancestor
14718656|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
14718657|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718658|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718659|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718660|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900010|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
14900011|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14900012|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
14900013|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14297361|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297362|NCT04220684|Cytarabine|cytarabine|mesh-list
14297363|NCT04220684|Fludarabine|fludarabine|mesh-list
14900014|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900015|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14900016|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14900017|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900018|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900019|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900020|NCT01303029|Gemcitabine|gemcitabine|mesh-list
14900021|NCT01303029|Capecitabine|capecitabine|mesh-list
14900022|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14900023|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14900024|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
14900025|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900026|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900027|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
14900028|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900029|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900030|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900031|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
14900032|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900033|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14900034|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
14900035|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
14900036|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14900037|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900038|NCT01303055|Metformin|metformin|mesh-list
14900039|NCT01303055|Alogliptin|alogliptin|mesh-list
14900040|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15217509|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217510|NCT02962297|Protective Agents|protective agents|mesh-ancestor
15217511|NCT02913664|Losartan|losartan|mesh-list
15217512|NCT02913664|Amlodipine|amlodipine|mesh-list
15217513|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
15217514|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
15217515|NCT02913664|Giapreza|giapreza|mesh-list
15217516|NCT02913664|Calcium|calcium|mesh-list
15217517|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15217518|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
15217519|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15217520|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217521|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217522|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217523|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217524|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
15217525|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217526|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217527|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15217528|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15217529|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
15217530|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217531|NCT02889133|Iron|iron|mesh-list
15217532|NCT02889133|Dextrans|dextrans|mesh-list
15217533|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
14900041|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217534|NCT02889133|Trace Elements|trace elements|mesh-ancestor
15217535|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
14297364|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900042|NCT01303055|Incretins|incretins|mesh-ancestor
15217536|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900043|NCT01303055|Hormones|hormones|mesh-ancestor
14900044|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900045|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14900046|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
14900047|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900048|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900049|NCT01303094|Trabectedin|trabectedin|mesh-list
14900050|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14900051|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
14900052|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900053|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900054|NCT01303107|Bupivacaine|bupivacaine|mesh-list
14900055|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900056|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
14900057|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900058|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900059|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
14900060|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900061|NCT01303237|Cetuximab|cetuximab|mesh-list
14900062|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900063|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900064|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14900065|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
14900066|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
14900067|NCT01303471|Remifentanil|remifentanil|mesh-list
14900068|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14900069|NCT01303471|Narcotics|narcotics|mesh-ancestor
14900070|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900071|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900072|NCT01303471|Analgesics|analgesics|mesh-ancestor
14900073|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
14900074|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900075|NCT01303497|Paclitaxel|paclitaxel|mesh-list
14900076|NCT01303497|Bevacizumab|bevacizumab|mesh-list
14900077|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14900078|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900079|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
14900080|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
14900081|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
14900082|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900083|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900084|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14900085|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14900086|NCT01303497|Growth Substances|growth substances|mesh-ancestor
14900087|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900088|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
14718661|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14718662|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718663|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718664|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718665|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14718666|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718667|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14718668|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
14718669|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
14718670|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718671|NCT00474006|Daunorubicin|daunorubicin|mesh-list
14718672|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14718673|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900089|NCT01303536|Ondansetron|ondansetron|mesh-list
14900090|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
14900091|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
14900092|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900093|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900094|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14900095|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
14900096|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14900097|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14900098|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
14900099|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900100|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900101|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14900102|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14900103|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900104|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14900105|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14900106|NCT01303549|Amphotericin B|amphotericin b|mesh-list
14900107|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14900108|NCT01303549|Anidulafungin|anidulafungin|mesh-list
14900109|NCT01303549|Amebicides|amebicides|mesh-ancestor
14900110|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14900111|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14900112|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900113|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14900114|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
14900115|NCT01303601|Olanzapine|olanzapine|mesh-list
14900116|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
14900117|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
14900118|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900119|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900120|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14900121|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14900122|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14900123|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900124|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14900125|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14900126|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14900127|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900128|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900129|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900130|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
14900131|NCT01303614|Lidocaine|lidocaine|mesh-list
14900132|NCT01303614|Prilocaine|prilocaine|mesh-list
14900133|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14900134|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900135|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
14900136|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900137|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900138|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
14900139|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900140|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14900141|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14900142|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14900143|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900144|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900145|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14900146|NCT01303640|Everolimus|everolimus|mesh-list
14900147|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900148|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900149|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
14900150|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900151|NCT01303679|Paclitaxel|paclitaxel|mesh-list
14900152|NCT01303679|Bevacizumab|bevacizumab|mesh-list
14900153|NCT01303679|Exemestane|exemestane|mesh-list
14900154|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14900155|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900156|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
14900157|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
14900158|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
14900159|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900160|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900161|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14900162|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14900163|NCT01303679|Growth Substances|growth substances|mesh-ancestor
14900164|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900165|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
14900166|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14900167|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14900168|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900169|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14900170|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
14900171|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900172|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
14900173|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900174|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
14900175|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900176|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900177|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14900178|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
14900179|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900180|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900181|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14900182|NCT01303731|Fentanyl|fentanyl|mesh-list
14900183|NCT01303731|Bupivacaine|bupivacaine|mesh-list
14900184|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900185|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
14900186|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900187|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900188|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
14900189|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900190|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14900191|NCT01303731|Narcotics|narcotics|mesh-ancestor
14900192|NCT01303731|Analgesics|analgesics|mesh-ancestor
14900193|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14900194|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14900195|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
14900196|NCT01303796|Decitabine|decitabine|mesh-list
14900197|NCT01303796|Sapacitabine|sapacitabine|mesh-list
14900198|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14900199|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
14900200|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900201|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718674|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14718675|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14718676|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718677|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718678|NCT00474019|Esomeprazole|esomeprazole|mesh-list
14718679|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14718680|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718681|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14718682|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718683|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718684|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
14718685|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14718686|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14718687|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718688|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
14718689|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718690|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718691|NCT00474071|Remifentanil|remifentanil|mesh-list
14900202|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900203|NCT01303874|Etanercept|etanercept|mesh-list
14900204|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14900205|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14900206|NCT01303874|Analgesics|analgesics|mesh-ancestor
14900207|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
14900208|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900209|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900210|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900211|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900212|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14900213|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900214|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
14900215|NCT01303887|Prednisolone|prednisolone|mesh-list
14900216|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
14900217|NCT01303887|Rituximab|rituximab|mesh-list
14900218|NCT01303887|Fludarabine|fludarabine|mesh-list
14900219|NCT01303887|Vincristine|vincristine|mesh-list
14900220|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900221|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
14900222|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900223|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900224|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14900225|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
14900226|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900227|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900228|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14900229|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900230|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14900231|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
14900232|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
14900233|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
14900234|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900235|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
14900236|NCT01303887|Hormones|hormones|mesh-ancestor
14900237|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900238|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14900239|NCT01303926|Paclitaxel|paclitaxel|mesh-list
14900240|NCT01303926|Bevacizumab|bevacizumab|mesh-list
14900241|NCT01303926|Carboplatin|carboplatin|mesh-list
14900242|NCT01303926|Pemetrexed|pemetrexed|mesh-list
14900243|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14900244|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900245|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
14900246|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
14900247|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
14900248|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900249|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900250|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14900251|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14900252|NCT01303926|Growth Substances|growth substances|mesh-ancestor
14900253|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900254|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
14900255|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900256|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14900257|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14900258|NCT01303952|Eculizumab|eculizumab|mesh-list
14900259|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14900260|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900261|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
14900262|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900263|NCT01304069|Etoricoxib|etoricoxib|mesh-list
14900264|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14900265|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14900266|NCT01304069|Analgesics|analgesics|mesh-ancestor
14900267|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
14900268|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900269|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900270|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900271|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900272|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14900273|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718692|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14718693|NCT00474071|Narcotics|narcotics|mesh-ancestor
14718694|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718695|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718696|NCT00474071|Analgesics|analgesics|mesh-ancestor
14718697|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
14718698|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718699|NCT00474110|Ketamine|ketamine|mesh-list
14718700|NCT00474110|Hydromorphone|hydromorphone|mesh-list
14718701|NCT00474110|Analgesics|analgesics|mesh-ancestor
14718702|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
14718703|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718704|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718705|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14718706|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14900274|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900275|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900276|NCT01304095|Ranolazine|ranolazine|mesh-list
14900277|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14900278|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900279|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900280|NCT01304134|Morphine|morphine|mesh-list
14900281|NCT01304134|Oxycodone|oxycodone|mesh-list
14900282|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14900283|NCT01304134|Narcotics|narcotics|mesh-ancestor
14900284|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900285|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900286|NCT01304134|Analgesics|analgesics|mesh-ancestor
14900287|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
14900288|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900289|NCT01304212|Ketorolac|ketorolac|mesh-list
14900290|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14900291|NCT01304212|Epinephrine|epinephrine|mesh-list
14900292|NCT01304212|Racepinephrine|racepinephrine|mesh-list
14900293|NCT01304212|Morphine|morphine|mesh-list
14900294|NCT01304212|Ropivacaine|ropivacaine|mesh-list
14900295|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
14900296|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14900297|NCT01304212|Narcotics|narcotics|mesh-ancestor
14900298|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900299|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900300|NCT01304212|Analgesics|analgesics|mesh-ancestor
14900301|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
14900302|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900303|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900304|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
14900305|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14900306|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14900307|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
14900308|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900309|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900310|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14900311|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14900312|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
14900313|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14900314|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
14900315|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
14900316|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
14900317|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14900318|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14900319|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14900320|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900321|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900322|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14900323|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900324|NCT01304264|Maleic acid|maleic acid|mesh-list
14900325|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900326|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900327|NCT01304316|Phenylephrine|phenylephrine|mesh-list
14900328|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
14900329|NCT01304316|Tetracaine|tetracaine|mesh-list
14900330|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900331|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
14900332|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900333|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900334|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
14900335|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900336|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14900337|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14900338|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
14900339|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900340|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900341|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
14900342|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
14900343|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
14900344|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14900345|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
14900346|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14900347|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
14900348|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14900349|NCT01304316|Protective Agents|protective agents|mesh-ancestor
14900350|NCT01304342|Fentanyl|fentanyl|mesh-list
14900351|NCT01304342|Remifentanil|remifentanil|mesh-list
14900352|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14900353|NCT01304342|Narcotics|narcotics|mesh-ancestor
14900354|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900355|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900356|NCT01304342|Analgesics|analgesics|mesh-ancestor
14900357|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
14900358|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900359|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14900360|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14900361|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
14900362|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
14916388|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14916389|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14916390|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
14916391|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916392|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916393|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14916394|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14916395|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
14916396|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916397|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14916398|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14916399|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14916400|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916401|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14916402|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14916403|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
14916404|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
14916405|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916406|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916407|NCT01392768|Levetiracetam|levetiracetam|mesh-list
14916408|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
14916409|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
14916410|NCT01392794|Ramosetron|ramosetron|mesh-list
14916411|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
14916412|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
14916413|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916414|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916415|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916416|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14916417|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
14916418|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916419|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916420|NCT01392807|Naloxegol|naloxegol|mesh-list
14916421|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14916422|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916423|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
14916424|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916425|NCT01392833|Prednisone|prednisone|mesh-list
14916426|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
14916427|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14916428|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14916429|NCT01392833|Prednisolone|prednisolone|mesh-list
14916430|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
14916431|NCT01392833|Azathioprine|azathioprine|mesh-list
14916432|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14916433|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
14916434|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916435|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
14916436|NCT01392833|Hormones|hormones|mesh-ancestor
14916437|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217537|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
15217538|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
15217539|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
15217540|NCT02889133|Hematinics|hematinics|mesh-ancestor
15217541|NCT02818582|Remdesivir|remdesivir|mesh-list
15217542|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
14900363|NCT01304472|Clopidogrel|clopidogrel|mesh-list
14900364|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15217543|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217544|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
14900365|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14900366|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14900367|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14900368|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14900369|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
14900370|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900371|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900372|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900373|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14900374|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
14900375|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14900376|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14900377|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
14900378|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900379|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900380|NCT01304563|Vaccines|vaccines|mesh-list
14900381|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
14900382|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900383|NCT01304602|Irinotecan|irinotecan|mesh-list
14900384|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14900385|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14900386|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900387|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900388|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900389|NCT01304784|Paclitaxel|paclitaxel|mesh-list
14900390|NCT01304784|Docetaxel|docetaxel|mesh-list
14900391|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14900392|NCT01304784|Capecitabine|capecitabine|mesh-list
14900393|NCT01304784|Trastuzumab|trastuzumab|mesh-list
14900394|NCT01304784|Lapatinib|lapatinib|mesh-list
14900395|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14900396|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14900397|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900398|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
14900399|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
14900400|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
14900401|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900402|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14900403|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
14900404|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900405|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14900406|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900407|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
14900408|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900409|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
14900410|NCT01304797|Trastuzumab|trastuzumab|mesh-list
14900411|NCT01304797|Doxorubicin|doxorubicin|mesh-list
14900412|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
14900413|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900414|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
14900415|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900416|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900417|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14900418|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
14900419|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900420|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900421|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14900422|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900423|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14900424|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14900425|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14900426|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900427|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
14900428|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
14900429|NCT01304836|Prednisolone|prednisolone|mesh-list
14900430|NCT01304836|Tacrolimus|tacrolimus|mesh-list
14900431|NCT01304836|Basiliximab|basiliximab|mesh-list
14900432|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900433|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
15217545|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900434|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217546|NCT02740985|Docetaxel|docetaxel|mesh-list
14900435|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14900436|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900437|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900438|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14900439|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900440|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14900441|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
14900442|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14900443|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900444|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900445|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
14900446|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
14900447|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900448|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14900449|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
14900450|NCT01304836|Hormones|hormones|mesh-ancestor
14900451|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900452|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14900453|NCT01304836|Protective Agents|protective agents|mesh-ancestor
14900454|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14900455|NCT01304901|Montelukast|montelukast|mesh-list
14900456|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14900457|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
14900458|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14900459|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
14900460|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900461|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900462|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14900463|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14900464|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900465|NCT01304927|Vitamin D|vitamin d|mesh-list
14900466|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
14900467|NCT01304927|Calcium|calcium|mesh-list
14900468|NCT01304927|Vitamins|vitamins|mesh-ancestor
14900469|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
14900470|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900471|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14900472|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14900473|NCT01305057|Pyridoxine|pyridoxine|mesh-list
14900474|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
14900475|NCT01305057|Vitamins|vitamins|mesh-ancestor
14900476|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
14900477|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900478|NCT01305083|Udenafil|udenafil|mesh-list
14900479|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15217547|NCT02740985|Durvalumab|durvalumab|mesh-list
15217548|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
15217549|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217550|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
15217551|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217552|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
15217553|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217554|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217555|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15217556|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217557|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
15217558|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217559|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217560|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15217561|NCT02703623|Prednisone|prednisone|mesh-list
15217562|NCT02703623|Cortisone|cortisone|mesh-list
15217563|NCT02703623|Carboplatin|carboplatin|mesh-list
15217564|NCT02703623|Ipilimumab|ipilimumab|mesh-list
15217565|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
15217566|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217567|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217568|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
15217569|NCT02703623|Hormones|hormones|mesh-ancestor
15217570|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900480|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14900481|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900482|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900483|NCT01305135|Azacitidine|azacitidine|mesh-list
14900484|NCT01305135|Idarubicin|idarubicin|mesh-list
14900485|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14900486|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
14900487|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900488|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900489|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900490|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14900491|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14900492|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14900493|NCT01305148|Warfarin|warfarin|mesh-list
14900494|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
14900495|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
14900496|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14900497|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
14900498|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900499|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
14900500|NCT01305187|Protective Agents|protective agents|mesh-ancestor
14297365|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297366|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
14297367|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297368|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297369|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
14297370|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297371|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
14900501|NCT01305226|Streptokinase|streptokinase|mesh-list
14900502|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14900503|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14900504|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900505|NCT01305317|Atorvastatin|atorvastatin|mesh-list
14900506|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14900507|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14900508|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
14900509|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900510|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14900511|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14900512|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900513|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14900514|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14900515|NCT01305395|Sirolimus|sirolimus|mesh-list
14900516|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14900517|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900518|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14900519|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900520|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
14900521|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900522|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
14900523|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900524|NCT01305551|Metformin|metformin|mesh-list
14900525|NCT01305551|Saxagliptin|saxagliptin|mesh-list
14900526|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14900527|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900528|NCT01305551|Incretins|incretins|mesh-ancestor
14900529|NCT01305551|Hormones|hormones|mesh-ancestor
14900530|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14297372|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900531|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14900532|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
14900533|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900534|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900535|NCT01305603|Bupivacaine|bupivacaine|mesh-list
14900536|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
14900537|NCT01305603|Anesthetics|anesthetics|mesh-list
14900538|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900539|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900540|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
14900541|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900542|NCT01305707|Diazepam|diazepam|mesh-list
14900543|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14900544|NCT01305707|Lorazepam|lorazepam|mesh-list
14297373|NCT04159974|Durvalumab|durvalumab|mesh-list
14297374|NCT04159974|Tremelimumab|tremelimumab|mesh-list
14297375|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297376|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297377|NCT04157725|Clomiphene|clomiphene|mesh-list
14718707|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
14718708|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
14718709|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718710|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14718711|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14900545|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
14900546|NCT01305707|Dexetimide|dexetimide|mesh-list
14900547|NCT01305707|Olanzapine|olanzapine|mesh-list
14900548|NCT01305707|Risperidone|risperidone|mesh-list
14900549|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14900550|NCT01305707|Aripiprazole|aripiprazole|mesh-list
14900551|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
14900552|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
14900553|NCT01305707|Mirtazapine|mirtazapine|mesh-list
14297378|NCT04157725|Enclomiphene|enclomiphene|mesh-list
14718712|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900554|NCT01305707|Citalopram|citalopram|mesh-list
14900555|NCT01305707|Sertraline|sertraline|mesh-list
14900556|NCT01305707|Fluoxetine|fluoxetine|mesh-list
14900557|NCT01305707|Paroxetine|paroxetine|mesh-list
14900558|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14900559|NCT01305707|Nortriptyline|nortriptyline|mesh-list
14900560|NCT01305707|Imipramine|imipramine|mesh-list
14900561|NCT01305707|Clomipramine|clomipramine|mesh-list
14900562|NCT01305707|Mianserin|mianserin|mesh-list
14900563|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
14900564|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14900565|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
14900566|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297379|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
14718713|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718714|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14718715|NCT00474110|Narcotics|narcotics|mesh-ancestor
14900567|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900568|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900569|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15217571|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900570|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900571|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14900572|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14900573|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
14900574|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14900575|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14900576|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900577|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14900578|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14900579|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14900580|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
14900581|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
14900582|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900583|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14900584|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14900585|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
14900586|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
14900587|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14900588|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
14900589|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14900590|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14900591|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14900592|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14900593|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14900594|NCT01305707|Analgesics|analgesics|mesh-ancestor
14900595|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
14900596|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14900597|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14900598|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900599|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
14900600|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
14900601|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14900602|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14900603|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
14900604|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
14900605|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14900606|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
14900607|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
14900608|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14900609|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14900610|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14900611|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
14900612|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14900613|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14900614|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14900615|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14900616|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14900617|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
14900618|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
14900619|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14900620|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14900621|NCT01305733|Ketorolac|ketorolac|mesh-list
14900622|NCT01305733|Epinephrine|epinephrine|mesh-list
14900623|NCT01305733|Racepinephrine|racepinephrine|mesh-list
14900624|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
14900625|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
15217572|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217573|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217574|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15217575|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217576|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15217577|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217578|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
15217579|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15217580|NCT02684032|Letrozole|letrozole|mesh-list
15217581|NCT02684032|Fulvestrant|fulvestrant|mesh-list
14900626|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14900627|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14900628|NCT01305733|Analgesics|analgesics|mesh-ancestor
14900629|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
14900630|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900631|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900632|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900633|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900634|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14900635|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900636|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900637|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900638|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
14900639|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900640|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14900641|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14900642|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
14900643|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900644|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14900645|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14900646|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
14900647|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14900648|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
14900649|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
14900650|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
14900651|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14900652|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
14900653|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14900654|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14900655|NCT01305837|Prednisolone|prednisolone|mesh-list
14900656|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
14900657|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14900658|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
14900659|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900660|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
14900661|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
14900662|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900663|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900664|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14900665|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
14900666|NCT01305837|Hormones|hormones|mesh-ancestor
14900667|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900668|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14900669|NCT01305837|Protective Agents|protective agents|mesh-ancestor
14900670|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14900671|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900672|NCT01305850|Losartan|losartan|mesh-list
14900673|NCT01305850|Enalapril|enalapril|mesh-list
14900674|NCT01305850|Enalaprilat|enalaprilat|mesh-list
14900675|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14900676|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14900677|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14900678|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14900679|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900680|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14900681|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
14900682|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900683|NCT01305889|Sertraline|sertraline|mesh-list
14900684|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
14900685|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14900686|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14900687|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14900688|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900689|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900690|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718716|NCT00474136|Diclofenac|diclofenac|mesh-list
14718717|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718718|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14718719|NCT00474136|Analgesics|analgesics|mesh-ancestor
14718720|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
14718721|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718722|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900691|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
14900692|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900693|NCT01306006|Vaccines|vaccines|mesh-list
14900694|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
14900695|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900696|NCT01306097|Zinc|zinc|mesh-list
14900697|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
14900698|NCT01306097|Trace Elements|trace elements|mesh-ancestor
14900699|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
14900700|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900701|NCT01306097|Astringents|astringents|mesh-ancestor
14900702|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
14916438|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916439|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14916440|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916441|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
14916442|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
14297380|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14297381|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
14297382|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14297383|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718723|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718724|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718725|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718726|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729432|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14916443|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916444|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916445|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14718727|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900703|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
14900704|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
14900705|NCT01306123|Vitamins|vitamins|mesh-ancestor
14900706|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
14900707|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900708|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
14900709|NCT01306123|Hematinics|hematinics|mesh-ancestor
14900710|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14900711|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
14900712|NCT01306266|Rizatriptan|rizatriptan|mesh-list
14900713|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14900714|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
14900715|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900716|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900717|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900718|NCT01306318|Diclofenac|diclofenac|mesh-list
14900719|NCT01306318|Eperisone|eperisone|mesh-list
14900720|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14900721|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14900722|NCT01306318|Analgesics|analgesics|mesh-ancestor
14900723|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
14900724|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900725|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900726|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14900727|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900728|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14900729|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900730|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900731|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
14900732|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14900733|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900734|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14900735|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14900736|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14900737|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
14900738|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
14900739|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
14900740|NCT01306357|Hormones|hormones|mesh-list
14900741|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14900742|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900743|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
14900744|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14900745|NCT01306370|Hemostatics|hemostatics|mesh-list
14900746|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14900747|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14900748|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900749|NCT01306370|Coagulants|coagulants|mesh-ancestor
14718728|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14718729|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
14718730|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
14718731|NCT00474279|Hormones|hormones|mesh-list
14718732|NCT00474279|Secretagogues|secretagogues|mesh-list
14718733|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718734|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718735|NCT00474435|Tenofovir|tenofovir|mesh-list
14718736|NCT00474435|Emtricitabine|emtricitabine|mesh-list
14718737|NCT00474435|Efavirenz|efavirenz|mesh-list
14718738|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
14718739|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718740|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14718741|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14718742|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718743|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718744|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14718745|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14718746|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14900750|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
14900751|NCT01306409|Hematinics|hematinics|mesh-ancestor
14900752|NCT01306461|Timolol|timolol|mesh-list
14900753|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14900754|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14900755|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
14900756|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900757|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900758|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900759|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14900760|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14900761|NCT01306565|Atorvastatin|atorvastatin|mesh-list
14900762|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14900763|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14900764|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
14900765|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900766|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14900767|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14900768|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900769|NCT01306591|Bevacizumab|bevacizumab|mesh-list
14900770|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900771|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900772|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14900773|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14900774|NCT01306591|Growth Substances|growth substances|mesh-ancestor
14900775|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900776|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
14900777|NCT01306630|Capecitabine|capecitabine|mesh-list
14900778|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14900779|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
14900780|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900781|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900782|NCT01306708|Amitriptyline|amitriptyline|mesh-list
14900783|NCT01306708|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14900784|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14900785|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
14900786|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14900787|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14900788|NCT01306708|Analgesics|analgesics|mesh-ancestor
14900789|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
14900790|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900791|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900792|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14900793|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14900794|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900795|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900796|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
14900797|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900798|NCT01306708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14900799|NCT01306708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14900800|NCT01306708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900801|NCT01306721|Fexofenadine|fexofenadine|mesh-list
14900802|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
14900803|NCT01306721|Ephedrine|ephedrine|mesh-list
14900804|NCT01306721|Terfenadine|terfenadine|mesh-list
14900805|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14900806|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
14900807|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900808|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900809|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14900810|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
14900811|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
14900812|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14900813|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14900814|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
14900815|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14900816|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900817|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900818|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14900819|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14900820|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14900821|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
14900822|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
14900823|NCT01306760|Ketamine|ketamine|mesh-list
14900824|NCT01306760|Propofol|propofol|mesh-list
14900825|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14900826|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900827|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900828|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14900829|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
14900830|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
14900831|NCT01306760|Analgesics|analgesics|mesh-ancestor
14900832|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
14900833|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900834|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14900835|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14900836|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14900837|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900838|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900839|NCT01306773|Oseltamivir|oseltamivir|mesh-list
14900840|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
14900841|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900842|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900843|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900844|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14900845|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
14900846|NCT01306851|Coagulants|coagulants|mesh-ancestor
14900847|NCT01306864|Hemostatics|hemostatics|mesh-list
14900848|NCT01306864|Coagulants|coagulants|mesh-ancestor
14900849|NCT01306981|Ranibizumab|ranibizumab|mesh-list
14900850|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14900851|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14900852|NCT01306981|Growth Substances|growth substances|mesh-ancestor
14900853|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900854|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
14900855|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900856|NCT01306994|Adenosine|adenosine|mesh-list
14900857|NCT01306994|Analgesics|analgesics|mesh-ancestor
14900858|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
14900859|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900860|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900861|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14900862|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
14900863|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14900864|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
14900865|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
15217582|NCT02684032|Palbociclib|palbociclib|mesh-list
15217583|NCT02684032|Gedatolisib|gedatolisib|mesh-list
15217584|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217585|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15217586|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14900866|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900867|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900868|NCT01307124|Lopinavir|lopinavir|mesh-list
14900869|NCT01307124|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15217587|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900870|NCT01307124|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14900871|NCT01307124|Protease Inhibitors|protease inhibitors|mesh-ancestor
14900872|NCT01307124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900873|NCT01307124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900874|NCT01307124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14900875|NCT01307124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14900876|NCT01307124|Antiviral Agents|antiviral agents|mesh-ancestor
14900877|NCT01307124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900878|NCT01307124|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14900879|NCT01307124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14900880|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
14900881|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14900882|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
14900883|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900884|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900885|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14900886|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
14900887|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
14900888|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14900889|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
14900890|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900891|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900892|NCT01307202|Gabapentin|gabapentin|mesh-list
14900893|NCT01307202|Analgesics|analgesics|mesh-ancestor
14900894|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
14900895|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900896|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900897|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
14900898|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14900899|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14900900|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900901|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14900902|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14900903|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14900904|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900905|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900906|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
14900907|NCT01307215|Ropivacaine|ropivacaine|mesh-list
14900908|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900909|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
14900910|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900911|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900912|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
14900913|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900914|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
14900915|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900916|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900917|NCT01307475|Adenosine|adenosine|mesh-list
14900918|NCT01307475|Analgesics|analgesics|mesh-ancestor
14900919|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
14900920|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14900921|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900922|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14900923|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
14900924|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14900925|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
14900926|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
14900927|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14900928|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900929|NCT01307488|Ritonavir|ritonavir|mesh-list
14900930|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14900931|NCT01307488|Lamivudine|lamivudine|mesh-list
14900932|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14900933|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14900934|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
14900935|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900936|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900937|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14900938|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14900939|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
14900940|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900941|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14900942|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14900943|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14900944|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14900945|NCT01307527|Riboflavin|riboflavin|mesh-list
14900946|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
14900947|NCT01307527|Vitamins|vitamins|mesh-ancestor
14900948|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
14900949|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900950|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14900951|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
14900952|NCT01307592|Gemcitabine|gemcitabine|mesh-list
14900953|NCT01307592|Rituximab|rituximab|mesh-list
14900954|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
14900955|NCT01307592|Lenalidomide|lenalidomide|mesh-list
14900956|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900957|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900958|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
14900959|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900960|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900961|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14900962|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
14900963|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14900964|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
14900965|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14900966|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14900967|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14900968|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14718747|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14718748|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14718749|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14718750|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14718751|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14718752|NCT00474591|PENTA|penta|mesh-list
14718753|NCT00474591|Fondaparinux|fondaparinux|mesh-list
14718754|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14718755|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
14718756|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14718757|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
14900969|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14900970|NCT01307592|Growth Substances|growth substances|mesh-ancestor
14900971|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
14900972|NCT01307605|Rituximab|rituximab|mesh-list
14900973|NCT01307605|Lenalidomide|lenalidomide|mesh-list
14900974|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14900975|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14900976|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
14900977|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900978|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14900979|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14718758|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718759|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718760|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
14718761|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14718762|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14729023|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729024|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729025|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
14729026|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
14729027|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729028|NCT00521222|Fluticasone|fluticasone|mesh-list
14729029|NCT00521222|Xhance|xhance|mesh-list
14729030|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14729031|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14729032|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729033|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14729034|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
14900980|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14900981|NCT01307605|Growth Substances|growth substances|mesh-ancestor
14900982|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
14900983|NCT01307839|Lidocaine|lidocaine|mesh-list
14900984|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
14900985|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
14900986|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14900987|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14900988|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
14900989|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217588|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217589|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14900990|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14900991|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14900992|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14900993|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14900994|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217590|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
15217591|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217592|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217593|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217594|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15217595|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15217596|NCT02668770|Ipilimumab|ipilimumab|mesh-list
15217597|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217598|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217599|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15217600|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217601|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
15217602|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15217603|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
14900995|NCT01307865|Mannitol|mannitol|mesh-list
14900996|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14900997|NCT01307865|Diuretics|diuretics|mesh-ancestor
14900998|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
14900999|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916446|NCT01392833|Protective Agents|protective agents|mesh-ancestor
14916447|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
14901000|NCT01307969|Lidocaine|lidocaine|mesh-list
14901001|NCT01307969|Epinephrine|epinephrine|mesh-list
14901002|NCT01307969|Racepinephrine|racepinephrine|mesh-list
14901003|NCT01307969|Ropivacaine|ropivacaine|mesh-list
14901004|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
14901005|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
14901006|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
14901007|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901008|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901009|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
14901010|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901011|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14901012|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14901013|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14901014|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14901015|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901016|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14901017|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14901018|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
14901019|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901020|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14901021|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14901022|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
14901023|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14901024|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
14901025|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
14901026|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
14901027|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14901028|NCT01308047|Bupivacaine|bupivacaine|mesh-list
14901029|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
14901030|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
14901031|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901032|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901033|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
14901034|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901035|NCT01308086|Leucovorin|leucovorin|mesh-list
14901036|NCT01308086|Fluorouracil|fluorouracil|mesh-list
14901037|NCT01308086|Capecitabine|capecitabine|mesh-list
14901038|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
14901039|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
14901040|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
14901041|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901042|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14901043|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901044|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901045|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
14901046|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901047|NCT01308086|Antidotes|antidotes|mesh-ancestor
14901048|NCT01308086|Protective Agents|protective agents|mesh-ancestor
14901049|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
14901050|NCT01308086|Vitamins|vitamins|mesh-ancestor
14901051|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
14901052|NCT01308177|Ecabet|ecabet|mesh-list
14901053|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901054|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14901055|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901056|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
14901057|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901058|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217604|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217605|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217606|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15217607|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
15217608|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15217609|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
15217610|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217611|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217612|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15217613|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
15217614|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
15217615|NCT02652429|Protective Agents|protective agents|mesh-ancestor
15217616|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
15217617|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217618|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
14901059|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14901060|NCT01308177|Protective Agents|protective agents|mesh-ancestor
14901061|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901062|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901063|NCT01308203|Niacin|niacin|mesh-list
14901064|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14901065|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
14901066|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901067|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14901068|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
14901069|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
14901070|NCT01308203|Vitamins|vitamins|mesh-ancestor
14901071|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
14901072|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901073|NCT01308229|Paclitaxel|paclitaxel|mesh-list
14901074|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14901075|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901076|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901077|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901078|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901079|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901080|NCT01308242|Sevelamer|sevelamer|mesh-list
14901081|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
14901082|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
14901083|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901084|NCT01308255|Vitamins|vitamins|mesh-list
14901085|NCT01308255|Folic Acid|folic acid|mesh-list
14901086|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
14901087|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14901088|NCT01308255|Methotrexate|methotrexate|mesh-list
14901089|NCT01308255|Infliximab|infliximab|mesh-list
14901090|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
14901091|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901092|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14901093|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
14901094|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14901095|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14901096|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
14901097|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901098|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901099|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14901100|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901101|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14901102|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901103|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
14901104|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901105|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14901106|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14901107|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
14901108|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
14901109|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901110|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901111|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
14901112|NCT01308255|Hormones|hormones|mesh-ancestor
14901113|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14901114|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14901115|NCT01308255|Protective Agents|protective agents|mesh-ancestor
14901116|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14901117|NCT01308255|Hematinics|hematinics|mesh-ancestor
14901118|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
14901119|NCT01308268|Ivermectin|ivermectin|mesh-list
14901120|NCT01308268|Albendazole|albendazole|mesh-list
14901121|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14901122|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901123|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
14901124|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
14901125|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15217619|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217620|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15217621|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217622|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
15217623|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217624|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217625|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15217626|NCT02649764|Cytarabine|cytarabine|mesh-list
15217627|NCT02649764|Fludarabine|fludarabine|mesh-list
14901126|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14901127|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901128|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901129|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901130|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901131|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901132|NCT01308320|Fentanyl|fentanyl|mesh-list
14901133|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14901134|NCT01308320|Narcotics|narcotics|mesh-ancestor
14901135|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901136|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901137|NCT01308320|Analgesics|analgesics|mesh-ancestor
14901138|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
14901139|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901140|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14901141|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14901142|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
14901143|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
14901144|NCT01308346|Everolimus|everolimus|mesh-list
14901145|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901146|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901147|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
14901148|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901149|NCT01308437|Insulin|insulin|mesh-list
14901150|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14901151|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
14901152|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14901153|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901154|NCT01308528|Enoxaparin|enoxaparin|mesh-list
14901155|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
14901156|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
14901157|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14901158|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14917547|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14901159|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901160|NCT01308541|Propofol|propofol|mesh-list
14901161|NCT01308541|Fospropofol|fospropofol|mesh-list
14901162|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14901163|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15217628|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
15217629|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217630|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15217631|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
15217632|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901164|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901165|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14901166|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
14901167|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
14901168|NCT01308554|Bupivacaine|bupivacaine|mesh-list
14901169|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
14901170|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
14901171|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901172|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901173|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
14901174|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901175|NCT01308606|Simeprevir|simeprevir|mesh-list
14718763|NCT00474669|Docetaxel|docetaxel|mesh-list
14718764|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901176|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
15217633|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217634|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
14297384|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14297385|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
14297386|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14297387|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14297388|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14297389|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
14297390|NCT04142502|Propofol|propofol|mesh-list
14297391|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14297392|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297393|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297394|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14297395|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
14297396|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
14297397|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14297398|NCT04142502|Analgesics|analgesics|mesh-ancestor
14297399|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
14297400|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297401|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14297402|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14297403|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14297404|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
14718765|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
15217635|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217636|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
15217637|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217638|NCT02629419|Amphotericin B|amphotericin b|mesh-list
15217639|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15217640|NCT02629419|Amebicides|amebicides|mesh-ancestor
15217641|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15217642|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15217643|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217644|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15217645|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
15217646|NCT02596503|Cefixime|cefixime|mesh-list
15217647|NCT02596503|Irinotecan|irinotecan|mesh-list
15217648|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14718766|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14718767|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14718768|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718769|NCT00474695|Ranibizumab|ranibizumab|mesh-list
14718770|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14718771|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14718772|NCT00474695|Growth Substances|growth substances|mesh-ancestor
14718773|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718774|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
14718775|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718776|NCT00474721|Acetaminophen|acetaminophen|mesh-list
14718777|NCT00474721|Ibuprofen|ibuprofen|mesh-list
15217649|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15217650|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901177|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901178|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
14901179|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901180|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901181|NCT01308632|Irinotecan|irinotecan|mesh-list
14901182|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14901183|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14901184|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901185|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901186|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901187|NCT01308658|Ritonavir|ritonavir|mesh-list
14901188|NCT01308658|Darunavir|darunavir|mesh-list
14901189|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14901190|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14901191|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
14901192|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901193|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901194|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14901195|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14901196|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
14901197|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901198|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14901199|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14901200|NCT01308671|Varenicline|varenicline|mesh-list
14901201|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14901202|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14901203|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
14901204|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901205|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901206|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901207|NCT01308684|Bevacizumab|bevacizumab|mesh-list
14901208|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901209|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901210|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14901211|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14901212|NCT01308684|Growth Substances|growth substances|mesh-ancestor
14901213|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901214|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14901215|NCT01308723|Sorafenib|sorafenib|mesh-list
14901216|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14718778|NCT00474721|Codeine|codeine|mesh-list
14718779|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14718780|NCT00474721|Analgesics|analgesics|mesh-ancestor
14718781|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
14718782|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718783|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718784|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
14718785|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718786|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718787|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14718788|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14901217|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901218|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14901219|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901220|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901221|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
14901222|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901223|NCT01308944|Propranolol|propranolol|mesh-list
14901224|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14901225|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14901226|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
14901227|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901228|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901229|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901230|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14901231|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14901232|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
14901233|NCT01308983|Amiloride|amiloride|mesh-list
14901234|NCT01308983|Diuretics|diuretics|mesh-ancestor
14901235|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
14901236|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901237|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14901238|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14901239|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14901240|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901241|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14901242|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14901243|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14901244|NCT01309009|MEN 11420|men 11420|mesh-list
14901245|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14901246|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
14901247|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901248|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901249|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14901250|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14901251|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
14901252|NCT01309022|Sirolimus|sirolimus|mesh-list
14901253|NCT01309022|Tacrolimus|tacrolimus|mesh-list
14901254|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901255|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
14901256|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901257|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14901258|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901259|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901260|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14901261|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901262|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14901263|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
14901264|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14901265|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901266|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
14901267|NCT01309074|Pregabalin|pregabalin|mesh-list
14901268|NCT01309074|Sertraline|sertraline|mesh-list
14901269|NCT01309074|Analgesics|analgesics|mesh-ancestor
14901270|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
14901271|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901272|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901273|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
14901274|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14901275|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14901276|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901277|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14901278|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14901279|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14901280|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901281|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14901282|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
14901283|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14901284|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14901285|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901286|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
14901287|NCT01309126|Cetuximab|cetuximab|mesh-list
14901288|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901289|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297405|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297406|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297407|NCT04118166|Nivolumab|nivolumab|mesh-list
14901290|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
14901291|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14901292|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
14901293|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901294|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901295|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15217651|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217652|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217653|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15217654|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217655|NCT02581215|Ramucirumab|ramucirumab|mesh-list
15217656|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217657|NCT02554253|Ketamine|ketamine|mesh-list
15217658|NCT02554253|Propofol|propofol|mesh-list
14901296|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
14901297|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
14901298|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14901299|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
14901300|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901301|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901302|NCT01309178|Mannitol|mannitol|mesh-list
14901303|NCT01309178|Amitriptyline|amitriptyline|mesh-list
14901304|NCT01309178|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14901305|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14901306|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
14901307|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14901308|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14901309|NCT01309178|Analgesics|analgesics|mesh-ancestor
14901310|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
14901311|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901312|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901313|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14901314|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14901315|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14901316|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901317|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
14901318|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901319|NCT01309178|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14901320|NCT01309178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14901321|NCT01309178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901322|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14901323|NCT01309178|Diuretics|diuretics|mesh-ancestor
14901324|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
15217659|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14901325|NCT01309399|Teriparatide|teriparatide|mesh-list
14901326|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14901327|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901328|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14901329|NCT01309412|Siltuximab|siltuximab|mesh-list
14901330|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901331|NCT01309425|Tapentadol|tapentadol|mesh-list
14901332|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14901333|NCT01309425|Narcotics|narcotics|mesh-ancestor
14718789|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718790|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718791|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14718792|NCT00474721|Narcotics|narcotics|mesh-ancestor
14718793|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718794|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
14718795|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
14718796|NCT00474773|Celecoxib|celecoxib|mesh-list
14718797|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14718798|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14718799|NCT00474773|Analgesics|analgesics|mesh-ancestor
14718800|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
14718801|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718802|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718803|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14718804|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901334|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297408|NCT04118166|Ipilimumab|ipilimumab|mesh-list
14297409|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297410|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297411|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14297412|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297413|NCT04117581|Vitamin D|vitamin d|mesh-list
14901335|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901336|NCT01309425|Analgesics|analgesics|mesh-ancestor
14297414|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
14297415|NCT04117581|Vitamins|vitamins|mesh-ancestor
14297416|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
14297417|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297418|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14901337|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
14901338|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901339|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14901340|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14901341|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14901342|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901343|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
14901344|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901345|NCT01309438|Erythromycin|erythromycin|mesh-list
14901346|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
14901347|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14901348|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
14901349|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
14901350|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14901351|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
14901352|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14901353|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
14901354|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901355|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901356|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
14901357|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14901358|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901359|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901360|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14901361|NCT01309477|Tacrolimus|tacrolimus|mesh-list
14901362|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901363|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
14901364|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901365|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14901366|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901367|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901368|NCT01309490|Ribavirin|ribavirin|mesh-list
14901369|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
14901370|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901371|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
14901372|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901373|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14901374|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14901375|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14901376|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14901377|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901378|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901379|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901380|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
14901381|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14901382|NCT01309607|Paclitaxel|paclitaxel|mesh-list
14901383|NCT01309607|Carboplatin|carboplatin|mesh-list
14901384|NCT01309607|Lapatinib|lapatinib|mesh-list
14901385|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14901386|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901387|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901388|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901389|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901390|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901391|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14901392|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901393|NCT01309620|Zinc|zinc|mesh-list
14901394|NCT01309620|Trace Elements|trace elements|mesh-ancestor
14901395|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
14901396|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901397|NCT01309633|Gemcitabine|gemcitabine|mesh-list
14901398|NCT01309633|Bevacizumab|bevacizumab|mesh-list
14901399|NCT01309633|Sunitinib|sunitinib|mesh-list
14901400|NCT01309633|Cisplatin|cisplatin|mesh-list
14901401|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901402|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901403|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14901404|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14901405|NCT01309633|Growth Substances|growth substances|mesh-ancestor
14901406|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901407|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
14901408|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14901409|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
14901410|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901411|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
15217660|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15217661|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217662|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15217663|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
15217664|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
15217665|NCT02554253|Analgesics|analgesics|mesh-ancestor
15217666|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
14901412|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901413|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901414|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901415|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
14901416|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14901417|NCT01309685|Varenicline|varenicline|mesh-list
14901418|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14901419|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14901420|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
14901421|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901422|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901423|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901424|NCT01309698|Inositol|inositol|mesh-list
14901425|NCT01309698|Vildagliptin|vildagliptin|mesh-list
14901426|NCT01309698|Voglibose|voglibose|mesh-list
14901427|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14901428|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901429|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14901430|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14901431|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901432|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901433|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14901434|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
14901435|NCT01309698|Vitamins|vitamins|mesh-ancestor
14901436|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
14916448|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916449|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14916450|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916451|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
14718805|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14718806|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14718807|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718808|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718809|NCT00474838|Metformin|metformin|mesh-list
14718810|NCT00474838|Glimepiride|glimepiride|mesh-list
14718811|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14718812|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217667|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217668|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15217669|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15217670|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15217671|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217672|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217673|NCT02535091|Cenobamate|cenobamate|mesh-list
14916452|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916453|NCT01392898|Liraglutide|liraglutide|mesh-list
14901437|NCT01309776|Citalopram|citalopram|mesh-list
14901438|NCT01309776|Tianeptine|tianeptine|mesh-list
14901439|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14901440|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14901441|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14901442|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901443|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901444|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
14901445|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901446|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14901447|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
14901448|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14901449|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14901450|NCT01309789|Prednisone|prednisone|mesh-list
14901451|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
14901452|NCT01309789|Doxorubicin|doxorubicin|mesh-list
14901453|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14901454|NCT01309789|Vincristine|vincristine|mesh-list
14901455|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14901456|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14901457|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901458|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
14901459|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901460|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901461|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14901462|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
14901463|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901464|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901465|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14901466|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14901467|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14901468|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14901469|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901470|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14901471|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
14901472|NCT01309789|Hormones|hormones|mesh-ancestor
14901473|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14901474|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14901475|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14901476|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901477|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901478|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901479|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901480|NCT01309854|Pioglitazone|pioglitazone|mesh-list
14901481|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14901482|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901483|NCT01309984|Propofol|propofol|mesh-list
14901484|NCT01309984|Fospropofol|fospropofol|mesh-list
14901485|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14901486|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901487|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901488|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14901489|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
14901490|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
14901491|NCT01310101|Dexamethasone|dexamethasone|mesh-list
14901492|NCT01310101|Ofatumumab|ofatumumab|mesh-list
14901493|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14901494|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
14901495|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
14901496|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901497|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901498|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901499|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
14901500|NCT01310101|Hormones|hormones|mesh-ancestor
14901501|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14901502|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14901503|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901504|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14901505|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14901506|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901507|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901508|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
14901509|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901510|NCT01310192|Choline|choline|mesh-list
14901511|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
14901512|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14901513|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
14901514|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901515|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901516|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14901517|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
14901518|NCT01310244|Paclitaxel|paclitaxel|mesh-list
14901519|NCT01310244|Carboplatin|carboplatin|mesh-list
14901520|NCT01310244|Belinostat|belinostat|mesh-list
14901521|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14901522|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901523|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901524|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901525|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901526|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901527|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14901528|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901529|NCT01310283|Fluorides|fluorides|mesh-list
14901530|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
14901531|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
14901532|NCT01310283|Protective Agents|protective agents|mesh-ancestor
14901533|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901534|NCT01310296|Lofexidine|lofexidine|mesh-list
14901535|NCT01310296|Clonidine|clonidine|mesh-list
14901536|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14901537|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14901538|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901539|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
14901540|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901541|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14901542|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14901543|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14901544|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
14901545|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901546|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217674|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
15217675|NCT02513563|Paclitaxel|paclitaxel|mesh-list
15217676|NCT02513563|Carboplatin|carboplatin|mesh-list
15217677|NCT02513563|Adavosertib|adavosertib|mesh-list
15217678|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15217679|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217680|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
15217681|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217682|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
15217683|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901547|NCT01310296|Analgesics|analgesics|mesh-ancestor
14901548|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
14901549|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
14901550|NCT01310361|Amoxicillin|amoxicillin|mesh-list
14901551|NCT01310361|Penicillins|penicillins|mesh-list
14901552|NCT01310361|Penicillin G|penicillin g|mesh-list
14901553|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14901554|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
14901555|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15217684|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901556|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901557|NCT01310452|Insulin|insulin|mesh-list
14901558|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14901559|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
14901560|NCT01310452|Protamines|protamines|mesh-list
14901561|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14901562|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901563|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
14901564|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901565|NCT01310452|Coagulants|coagulants|mesh-ancestor
14901566|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
14901567|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14901568|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901569|NCT01310478|Endostatins|endostatins|mesh-list
14901570|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14901571|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14901572|NCT01310478|Growth Substances|growth substances|mesh-ancestor
14901573|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901574|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
14901575|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718813|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14718814|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14718815|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
14718816|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
14901576|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14901577|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
14718817|NCT00474890|Ephedrine|ephedrine|mesh-list
14718818|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14718819|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
14718820|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718821|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718822|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14718823|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
14718824|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
14718825|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14718826|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14718827|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
14718828|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
14718829|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718830|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718831|NCT00474916|KRN 5500|krn 5500|mesh-list
14718832|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901578|NCT01310647|Estradiol|estradiol|mesh-list
14901579|NCT01310647|Testosterone|testosterone|mesh-list
14901580|NCT01310647|Estrogens|estrogens|mesh-ancestor
14901581|NCT01310647|Hormones|hormones|mesh-ancestor
14901582|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14901583|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901584|NCT01310647|Androgens|androgens|mesh-ancestor
14901585|NCT01310673|Allopurinol|allopurinol|mesh-list
14901586|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
14901587|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901588|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901589|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
14901590|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901591|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14901592|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
14901593|NCT01310673|Protective Agents|protective agents|mesh-ancestor
14901594|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901595|NCT01310712|Oxybutynin|oxybutynin|mesh-list
14901596|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
14901597|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
14901598|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901599|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901600|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14297419|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14297420|NCT04113616|Cytarabine|cytarabine|mesh-list
14297421|NCT04113616|Decitabine|decitabine|mesh-list
14297422|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297423|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
14297424|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297425|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297426|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
14297427|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901601|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14901602|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
14901603|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901604|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901605|NCT01310712|Urological Agents|urological agents|mesh-ancestor
14901606|NCT01310738|Amphotericin B|amphotericin b|mesh-list
14901607|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14297428|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916454|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14718833|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14718834|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718835|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718836|NCT00475059|Cimetidine|cimetidine|mesh-list
14718837|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15217685|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
15217686|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15217687|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217688|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217689|NCT02498600|Nivolumab|nivolumab|mesh-list
15217690|NCT02498600|Ipilimumab|ipilimumab|mesh-list
15217691|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217692|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217693|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15217694|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217695|NCT02441686|Dexamethasone|dexamethasone|mesh-list
15217696|NCT02441686|Lenalidomide|lenalidomide|mesh-list
15217697|NCT02441686|Bortezomib|bortezomib|mesh-list
15217698|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217699|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
15217700|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
15217701|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217702|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217703|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718838|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901608|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14901609|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14901610|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
14901611|NCT01310738|Amebicides|amebicides|mesh-ancestor
15217704|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
14718839|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14718840|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
14718841|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
14718842|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718843|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718844|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718845|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14718846|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15217705|NCT02441686|Hormones|hormones|mesh-ancestor
15225715|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901612|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14901613|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14718847|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718848|NCT00475072|Ribavirin|ribavirin|mesh-list
14901614|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901615|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14901616|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
14901617|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14901618|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901619|NCT01310751|Iloprost|iloprost|mesh-list
14901620|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14901621|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
14718849|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14718850|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
14718851|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718852|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
14718853|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718854|NCT00475098|Tinzaparin|tinzaparin|mesh-list
14718855|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14718856|NCT00475098|Dalteparin|dalteparin|mesh-list
14718857|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
14718858|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14718859|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14718860|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718861|NCT00475137|Lamotrigine|lamotrigine|mesh-list
14718862|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
14718863|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14718864|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14718865|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718866|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14718867|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901622|NCT01310842|Nicotine|nicotine|mesh-list
14901623|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15217706|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217707|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217708|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217709|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
15217710|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15217711|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15217712|NCT02441686|Growth Substances|growth substances|mesh-ancestor
15217713|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
15217714|NCT02382406|Paclitaxel|paclitaxel|mesh-list
15217715|NCT02382406|Carboplatin|carboplatin|mesh-list
15217716|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
15217717|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15217718|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217719|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
15217720|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217721|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
15217722|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217723|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217724|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
14718868|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14718869|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14718870|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14718871|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14718872|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14718873|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14718874|NCT00475189|Norinyl|norinyl|mesh-list
14718875|NCT00475189|Mestranol|mestranol|mesh-list
14718876|NCT00475189|Norethindrone|norethindrone|mesh-list
14718877|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14718878|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14718879|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14718880|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
14718881|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718882|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718883|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14297429|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
14718884|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14718885|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14718886|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14718887|NCT00475189|Estrogens|estrogens|mesh-ancestor
14718888|NCT00475189|Hormones|hormones|mesh-ancestor
14718889|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718890|NCT00475293|Panitumumab|panitumumab|mesh-list
14718891|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718892|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901624|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
14901625|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901626|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901627|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14297430|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297431|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297432|NCT04066725|Aspirin|aspirin|mesh-list
14297433|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14297434|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14297435|NCT04066725|Analgesics|analgesics|mesh-ancestor
14297436|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
14297437|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297438|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718893|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14901628|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14901629|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
14901630|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901631|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901632|NCT01310985|Capecitabine|capecitabine|mesh-list
14901633|NCT01310985|Cetuximab|cetuximab|mesh-list
14901634|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14901635|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
14901636|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901637|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901638|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901639|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14901640|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14901641|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901642|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901643|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14901644|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
14901645|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14901646|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901647|NCT01311050|Bevacizumab|bevacizumab|mesh-list
14901648|NCT01311050|Capecitabine|capecitabine|mesh-list
14901649|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
14901650|NCT01311050|Irinotecan|irinotecan|mesh-list
14901651|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901652|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901653|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14901654|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14901655|NCT01311050|Growth Substances|growth substances|mesh-ancestor
14901656|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901657|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
14901658|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14901659|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
14901660|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718894|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14718895|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14718896|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14718897|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718898|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718899|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718900|NCT00475358|Analgesics|analgesics|mesh-ancestor
14718901|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
14718902|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718903|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
14901661|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14901662|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14901663|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901664|NCT01311076|Insulin|insulin|mesh-list
14901665|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14901666|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
14297439|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297440|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901667|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14901668|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901669|NCT01311141|Doripenem|doripenem|mesh-list
14901670|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14901671|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901672|NCT01311167|Dexamethasone|dexamethasone|mesh-list
14901673|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14901674|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
14901675|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
14901676|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901677|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901678|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14901679|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
14901680|NCT01311167|Hormones|hormones|mesh-ancestor
14718904|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14718905|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
14718906|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14718907|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14718908|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14718909|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14718910|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718911|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718912|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718913|NCT00475397|Analgesics|analgesics|mesh-ancestor
14718914|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
14718915|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901681|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14901682|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14297441|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14901683|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901684|NCT01311336|Loratadine|loratadine|mesh-list
14901685|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
14901686|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14901687|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14901688|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14901689|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14901690|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
14901691|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
14901692|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901693|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901694|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901695|NCT01311414|Urapidil|urapidil|mesh-list
14901696|NCT01311414|Cafedrine|cafedrine|mesh-list
14297442|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14297443|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297444|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14297445|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14297446|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297447|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
14297448|NCT04062032|Aspirin|aspirin|mesh-list
14297449|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14297450|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14297451|NCT04062032|Analgesics|analgesics|mesh-ancestor
14297452|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
14297453|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297454|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297455|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297456|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297457|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14297458|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14297459|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217725|NCT02308527|Temozolomide|temozolomide|mesh-list
15217726|NCT02308527|Bevacizumab|bevacizumab|mesh-list
15217727|NCT02308527|Irinotecan|irinotecan|mesh-list
14901697|NCT01311414|Theodrenaline|theodrenaline|mesh-list
14901698|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14901699|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
14901700|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14901701|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
14901702|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901703|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901704|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901705|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14901706|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14901707|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14901708|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
14916455|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916456|NCT01392898|Incretins|incretins|mesh-ancestor
14916457|NCT01392898|Hormones|hormones|mesh-ancestor
14916458|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916459|NCT01392911|Rifampin|rifampin|mesh-list
15217728|NCT02308527|Topotecan|topotecan|mesh-list
14916460|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14916461|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
14916462|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15217729|NCT02308527|Dinutuximab|dinutuximab|mesh-list
15217730|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217731|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
15217732|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217733|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225716|NCT03873675|Hormones|hormones|mesh-list
14901709|NCT01311570|Buprenorphine|buprenorphine|mesh-list
14901710|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14718916|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
14718917|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14718918|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
14718919|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14718920|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
14718921|NCT00475410|Coagulants|coagulants|mesh-ancestor
14901711|NCT01311570|Narcotics|narcotics|mesh-ancestor
14901712|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901713|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901714|NCT01311570|Analgesics|analgesics|mesh-ancestor
14901715|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
14901716|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901717|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14901718|NCT01311622|Warfarin|warfarin|mesh-list
14901719|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
14901720|NCT01311700|Metoprolol|metoprolol|mesh-list
14901721|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14901722|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14901723|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
14901724|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
14901725|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901726|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901727|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14901728|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14718922|NCT00475462|Metoprolol|metoprolol|mesh-list
14901729|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14901730|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
14901731|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901732|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901733|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
14901734|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
14901735|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
14901736|NCT01311739|Vitamins|vitamins|mesh-ancestor
14901737|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
14901738|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901739|NCT01311739|Hematinics|hematinics|mesh-ancestor
14718923|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14901740|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14901741|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901742|NCT01311778|Fentanyl|fentanyl|mesh-list
14901743|NCT01311778|Cannabidiol|cannabidiol|mesh-list
14901744|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14901745|NCT01311778|Narcotics|narcotics|mesh-ancestor
14901746|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901747|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901748|NCT01311778|Analgesics|analgesics|mesh-ancestor
14901749|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
14901750|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901751|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14901752|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14901753|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
14901754|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
14901755|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
14901756|NCT01311804|Parecoxib|parecoxib|mesh-list
15217734|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217735|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
15217736|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217737|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217738|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15217739|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217740|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15217741|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15217742|NCT02308527|Growth Substances|growth substances|mesh-ancestor
14718924|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14718925|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
14718926|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
14718927|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718928|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718929|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14901757|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14901758|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14901759|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916463|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718930|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14718931|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14718932|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
14718933|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718934|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901760|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901761|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15217743|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
15217744|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15217745|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15217746|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718935|NCT00475514|Frovatriptan|frovatriptan|mesh-list
14901762|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14901763|NCT01311804|Analgesics|analgesics|mesh-ancestor
14901764|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
14901765|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901766|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901767|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14901768|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901769|NCT01311882|Zopiclone|zopiclone|mesh-list
14718936|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14718937|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
14718938|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718939|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718940|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718941|NCT00475527|Amoxicillin|amoxicillin|mesh-list
14718942|NCT00475527|Metronidazole|metronidazole|mesh-list
14718943|NCT00475527|Clarithromycin|clarithromycin|mesh-list
14718944|NCT00475527|Omeprazole|omeprazole|mesh-list
14718945|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14718946|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14718947|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14718948|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14718949|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14718950|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14718951|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14718952|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14718953|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718954|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14718955|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14718956|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14718957|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14718958|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14718959|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14718960|NCT00475553|Etonogestrel|etonogestrel|mesh-list
14901770|NCT01311882|Suvorexant|suvorexant|mesh-list
14901771|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14901772|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901773|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901774|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14901775|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14901776|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901777|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901778|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14901779|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
14901780|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901781|NCT01311960|Bevacizumab|bevacizumab|mesh-list
14901782|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14901783|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901784|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901785|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14901786|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14901787|NCT01311960|Growth Substances|growth substances|mesh-ancestor
14901788|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901789|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
14901790|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15217747|NCT02121184|Oxytocin|oxytocin|mesh-list
15217748|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
15217749|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15217750|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217751|NCT01972919|Gemcitabine|gemcitabine|mesh-list
14718961|NCT00475553|Desogestrel|desogestrel|mesh-list
14718962|NCT00475553|NuvaRing|nuvaring|mesh-list
14901791|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
14901792|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901793|NCT01312064|Rituximab|rituximab|mesh-list
14901794|NCT01312064|Everolimus|everolimus|mesh-list
14901795|NCT01312064|Tacrolimus|tacrolimus|mesh-list
14901796|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
14901797|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901798|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901799|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
14901800|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901801|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901802|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901803|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14901804|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901805|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901806|NCT01312077|Morphine|morphine|mesh-list
14901807|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
14901808|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14901809|NCT01312077|Narcotics|narcotics|mesh-ancestor
14901810|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901811|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901812|NCT01312077|Analgesics|analgesics|mesh-ancestor
14901813|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
14901814|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901815|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
14901816|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
14901817|NCT01312298|Bupivacaine|bupivacaine|mesh-list
14901818|NCT01312298|Anesthetics|anesthetics|mesh-list
14901819|NCT01312298|Propofol|propofol|mesh-list
14901820|NCT01312298|Succinylcholine|succinylcholine|mesh-list
14901821|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
14901822|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901823|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901824|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
14901825|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901826|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14901827|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14901828|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
14901829|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14901830|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14901831|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14901832|NCT01312311|Docetaxel|docetaxel|mesh-list
14901833|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901834|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901835|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901836|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901837|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901838|NCT01312324|Docetaxel|docetaxel|mesh-list
14901839|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901840|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901841|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901842|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901843|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901844|NCT01312337|Gefitinib|gefitinib|mesh-list
14901845|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901846|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14901847|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901848|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901849|NCT01312350|Docetaxel|docetaxel|mesh-list
14901850|NCT01312350|Fluorouracil|fluorouracil|mesh-list
14901851|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901852|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901853|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901854|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901855|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901856|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
14901857|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14901858|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901859|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
14901860|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901861|NCT01312363|Rivastigmine|rivastigmine|mesh-list
14901862|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14901863|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901864|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901865|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
14901866|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901867|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901868|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14901869|NCT01312363|Protective Agents|protective agents|mesh-ancestor
14901870|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
14901871|NCT01312376|Bevacizumab|bevacizumab|mesh-list
14901872|NCT01312376|Fludarabine|fludarabine|mesh-list
14901873|NCT01312376|Vaccines|vaccines|mesh-list
14901874|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
14901875|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901876|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901877|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901878|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14901879|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
14901880|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901881|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901882|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14901883|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901884|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14901885|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14901886|NCT01312376|Growth Substances|growth substances|mesh-ancestor
14901887|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
14901888|NCT01312402|Brinzolamide|brinzolamide|mesh-list
14901889|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14901890|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901891|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901892|NCT01312415|Morphine|morphine|mesh-list
14901893|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
14901894|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14901895|NCT01312415|Narcotics|narcotics|mesh-ancestor
14901896|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901897|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901898|NCT01312415|Analgesics|analgesics|mesh-ancestor
14901899|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
14901900|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901901|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
14901902|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
14901903|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
14901904|NCT01312441|Vitamin D|vitamin d|mesh-list
14901905|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14901906|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901907|NCT01312441|Vitamins|vitamins|mesh-ancestor
14901908|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
14901909|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14901910|NCT01312493|Panitumumab|panitumumab|mesh-list
14901911|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14901912|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718963|NCT00475553|Estradiol|estradiol|mesh-list
14718964|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14718965|NCT00475553|Estrogens|estrogens|mesh-ancestor
14718966|NCT00475553|Hormones|hormones|mesh-ancestor
14718967|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14718968|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718969|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14718970|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
14718971|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14718972|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14718973|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14718974|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14718975|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14901913|NCT01312714|Vitamin D|vitamin d|mesh-list
14901914|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
14901915|NCT01312714|Vitamins|vitamins|mesh-ancestor
14901916|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
14901917|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901918|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14901919|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14901920|NCT01312792|Ampicillin|ampicillin|mesh-list
14901921|NCT01312792|Cephradine|cephradine|mesh-list
14901922|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14901923|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297460|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14297461|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14297462|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901924|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
14901925|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
14901926|NCT01312831|Vitamins|vitamins|mesh-ancestor
14901927|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
14901928|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901929|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
14901930|NCT01312831|Hematinics|hematinics|mesh-ancestor
14901931|NCT01313143|Esmolol|esmolol|mesh-list
14901932|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14901933|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14901934|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14901935|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
14901936|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14901937|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901938|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297463|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
14297464|NCT04055844|Decitabine|decitabine|mesh-list
14901939|NCT01313247|Acetaminophen|acetaminophen|mesh-list
14901940|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14901941|NCT01313247|Analgesics|analgesics|mesh-ancestor
14901942|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
14901943|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901944|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901945|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
14916464|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
14916465|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14916466|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916467|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916468|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14916469|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14916470|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14916471|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14916472|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14916473|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14916474|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
14916475|NCT01393080|Cisplatin|cisplatin|mesh-list
14916476|NCT01393080|Paclitaxel|paclitaxel|mesh-list
14916477|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14916478|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916479|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14916480|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
14916481|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
14916482|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
14916483|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916484|NCT01393145|Fluticasone|fluticasone|mesh-list
14916485|NCT01393145|Xhance|xhance|mesh-list
14916486|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
14916487|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14916488|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14916489|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916490|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15217752|NCT01972919|Capecitabine|capecitabine|mesh-list
15217753|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15217754|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
15217755|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916491|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
14916492|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916493|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916494|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14916495|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
14916496|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14916497|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14916498|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14916499|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14916500|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14916501|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
14916502|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916503|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916504|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
14916505|NCT01393145|Hormones|hormones|mesh-ancestor
14916506|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916507|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
14916508|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
14916509|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14916510|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916511|NCT01393288|Lorazepam|lorazepam|mesh-list
14916512|NCT01393288|Ondansetron|ondansetron|mesh-list
14916513|NCT01393288|Aprepitant|aprepitant|mesh-list
14916514|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
14916515|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
14916516|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916517|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916518|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916519|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
14916520|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
14916521|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14916522|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
14916523|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916524|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916525|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14916526|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14916527|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14901946|NCT01313377|Gemcitabine|gemcitabine|mesh-list
14901947|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
14901948|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14901949|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
14901950|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901951|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901952|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
14901953|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14901954|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901955|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901956|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
14901957|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901958|NCT01313390|Docetaxel|docetaxel|mesh-list
14901959|NCT01313390|Everolimus|everolimus|mesh-list
14901960|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901961|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
14901962|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
14901963|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
14901964|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718976|NCT00475553|Progestins|progestins|mesh-ancestor
14718977|NCT00475566|Everolimus|everolimus|mesh-list
14718978|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14718979|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901965|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901966|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
14901967|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901968|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
14901969|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14901970|NCT01313429|Celecoxib|celecoxib|mesh-list
14901971|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
14901972|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14901973|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
14901974|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14901975|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14901976|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14901977|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
14901978|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14901979|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14901980|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14901981|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14901982|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14901983|NCT01313429|Analgesics|analgesics|mesh-ancestor
14901984|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
14901985|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901986|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14901987|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14901988|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14901989|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14901990|NCT01313585|Beclomethasone|beclomethasone|mesh-list
14901991|NCT01313585|Albuterol|albuterol|mesh-list
14901992|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14901993|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
14901994|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14901995|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718980|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
14718981|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718982|NCT00475618|Fluorides|fluorides|mesh-list
14718983|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
14718984|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
14718985|NCT00475618|Protective Agents|protective agents|mesh-ancestor
14718986|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718987|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14718988|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14718989|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14901996|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14901997|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
14901998|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
14901999|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14902000|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14902001|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14902002|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14902003|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
14902004|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902005|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902006|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14902007|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
14902008|NCT01313585|Hormones|hormones|mesh-ancestor
14902009|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902010|NCT01313611|Rituximab|rituximab|mesh-list
14902011|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14902012|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14902013|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902014|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
14902015|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902016|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14902017|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14902018|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
14902019|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902020|NCT01313689|Ofatumumab|ofatumumab|mesh-list
14902021|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902022|NCT01313702|Atenolol|atenolol|mesh-list
14902023|NCT01313702|Lisinopril|lisinopril|mesh-list
14902024|NCT01313702|Simvastatin|simvastatin|mesh-list
14902025|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14902026|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14902027|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
14902028|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902029|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14902030|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14902031|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902032|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14902033|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
14902034|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14902035|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14902036|NCT01313702|Protective Agents|protective agents|mesh-ancestor
14902037|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902038|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14902039|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
14902040|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
14902041|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902042|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14902043|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14902044|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14902045|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
14902046|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902047|NCT01313819|Amantadine|amantadine|mesh-list
14902048|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14902049|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14902050|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
14902051|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902052|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
14902053|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902054|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902055|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902056|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902057|NCT01313819|Analgesics|analgesics|mesh-ancestor
14902058|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
14902059|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902060|NCT01313845|Amantadine|amantadine|mesh-list
14902061|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14902062|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14902063|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
14902064|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902065|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
14902066|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902067|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902068|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902069|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902070|NCT01313845|Analgesics|analgesics|mesh-ancestor
14902071|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
14902072|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902073|NCT01314027|Gemcitabine|gemcitabine|mesh-list
14902074|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
14902075|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14902076|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
14902077|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902078|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902079|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
14902080|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902081|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902082|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902083|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
14902084|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902085|NCT01314066|Bevacizumab|bevacizumab|mesh-list
14902086|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14902087|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902088|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14902089|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14902090|NCT01314066|Growth Substances|growth substances|mesh-ancestor
14902091|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902092|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
14902093|NCT01314144|Bupivacaine|bupivacaine|mesh-list
14902094|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
14902095|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
14902096|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902097|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902098|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
14902099|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902100|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
15217756|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217757|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
15217758|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902101|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14902102|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902103|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902104|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902105|NCT01314209|Analgesics|analgesics|mesh-ancestor
14902106|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
14902107|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902108|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14902109|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14902110|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14902111|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14902112|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902113|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902114|NCT01314274|Bevacizumab|bevacizumab|mesh-list
14902115|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14902116|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902117|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14902118|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14902119|NCT01314274|Growth Substances|growth substances|mesh-ancestor
14902120|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217759|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217760|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15217761|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
15217762|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217763|NCT01524536|Prednisone|prednisone|mesh-list
14902121|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
14902122|NCT01314300|Lidocaine|lidocaine|mesh-list
14902123|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
14902124|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
14902125|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902126|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902127|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
14902128|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902129|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14902130|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14902131|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14297465|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297466|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
14297467|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297468|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297469|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297470|NCT04052698|Factor VIII|factor viii|mesh-list
14902132|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14902133|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902134|NCT01314339|Desloratadine|desloratadine|mesh-list
14902135|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14902136|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
14902137|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902138|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902139|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902140|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14902141|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14902142|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
14902143|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
14902144|NCT01314352|Desloratadine|desloratadine|mesh-list
14902145|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14902146|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
14902147|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902148|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902149|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902150|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14902151|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14902152|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
14902153|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
14902154|NCT01314482|Minocycline|minocycline|mesh-list
14902155|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14902156|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902157|NCT01314495|Abatacept|abatacept|mesh-list
14902158|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14902159|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902160|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902161|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902162|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
14902163|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902164|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14902165|NCT01314508|Mecasermin|mecasermin|mesh-list
14902166|NCT01314508|Growth Substances|growth substances|mesh-ancestor
14902167|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902168|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
14902169|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
14902170|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14902171|NCT01314586|Estrogens|estrogens|mesh-ancestor
14902172|NCT01314586|Hormones|hormones|mesh-ancestor
14902173|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902174|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902175|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14902176|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14902177|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14902178|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902179|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
14902180|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14902181|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14902182|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
14902183|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902184|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902185|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902186|NCT01314781|Urological Agents|urological agents|mesh-ancestor
14902187|NCT01314833|Paclitaxel|paclitaxel|mesh-list
14902188|NCT01314833|Docetaxel|docetaxel|mesh-list
14902189|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
14902190|NCT01314833|Fluorouracil|fluorouracil|mesh-list
14902191|NCT01314833|Epirubicin|epirubicin|mesh-list
14902192|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14902193|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902194|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
14902195|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
14902196|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
14902197|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902198|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902199|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
14902200|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902201|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14902202|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14902203|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
14902204|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14902205|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
14902206|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14902207|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14902208|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14902209|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14902210|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902211|NCT01314859|Nifedipine|nifedipine|mesh-list
14902212|NCT01314859|Atosiban|atosiban|mesh-list
14902213|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14902214|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14902215|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902216|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14902217|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902218|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
14902219|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
14902220|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14902221|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
14902222|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902223|NCT01314898|Spironolactone|spironolactone|mesh-list
14902224|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14902225|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
14902226|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902227|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902228|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14902229|NCT01314898|Diuretics|diuretics|mesh-ancestor
14902230|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
14297471|NCT04052698|Coagulants|coagulants|mesh-ancestor
14297472|NCT04033991|Sunitinib|sunitinib|mesh-list
14297473|NCT04033991|Axitinib|axitinib|mesh-list
14297474|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297475|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14297476|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14297477|NCT04033991|Growth Substances|growth substances|mesh-ancestor
14297478|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297479|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
14297480|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14902231|NCT01314937|Mebendazole|mebendazole|mesh-list
14902232|NCT01314937|Piperazine|piperazine|mesh-list
14902233|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
14902234|NCT01314937|DMP 777|dmp 777|mesh-list
14902235|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
14902236|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
14902237|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14902238|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902239|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14902240|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14902241|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14902242|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902243|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902244|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902245|NCT01314976|Metronidazole|metronidazole|mesh-list
14902246|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902247|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14902248|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14902249|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14902250|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
14902251|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
14902252|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
14902253|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14902254|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14902255|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
14902256|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
14902257|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902258|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902259|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902260|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14902261|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
14902262|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14902263|NCT01315093|Heparin|heparin|mesh-list
14902264|NCT01315093|Calcium heparin|calcium heparin|mesh-list
14902265|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14902266|NCT01315093|Tinzaparin|tinzaparin|mesh-list
14902267|NCT01315093|Dalteparin|dalteparin|mesh-list
14902268|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
14902269|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14902270|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14902271|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916528|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14916529|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14916530|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14916531|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
14916532|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14916533|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
14916534|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
14916535|NCT01393340|Omalizumab|omalizumab|mesh-list
14916536|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14916537|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14902272|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
14902273|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
14902274|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14902275|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14902276|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902277|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902278|NCT01315262|Urological Agents|urological agents|mesh-ancestor
14902279|NCT01315275|Ranibizumab|ranibizumab|mesh-list
14902280|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14902281|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14902282|NCT01315275|Growth Substances|growth substances|mesh-ancestor
14902283|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902284|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
14902285|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902286|NCT01315431|Capecitabine|capecitabine|mesh-list
14902287|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14902288|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
14902289|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902290|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902291|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
14902292|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14902293|NCT01315496|Antibodies|antibodies|mesh-list
14902294|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
14902295|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
14902296|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902297|NCT01315691|Amikacin|amikacin|mesh-list
14902298|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14902299|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902300|NCT01315704|Vitamin D|vitamin d|mesh-list
14902301|NCT01315704|Vitamins|vitamins|mesh-ancestor
14902302|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
14902303|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902304|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14902305|NCT01315795|Lanreotide|lanreotide|mesh-list
14902306|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902307|NCT01315886|Fentanyl|fentanyl|mesh-list
14902308|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14902309|NCT01315886|Narcotics|narcotics|mesh-ancestor
14902310|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902311|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902312|NCT01315886|Analgesics|analgesics|mesh-ancestor
14902313|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
14902314|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902315|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14902316|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14902317|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
14902318|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
14902319|NCT01315912|Letrozole|letrozole|mesh-list
14902320|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902321|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14902322|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14902323|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902324|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902325|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14902326|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
14902327|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902328|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902329|NCT01315938|Abatacept|abatacept|mesh-list
14902330|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14902331|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902332|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902333|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902334|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
14902335|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902336|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14902337|NCT01315951|Petrolatum|petrolatum|mesh-list
14902338|NCT01315951|Emollients|emollients|mesh-ancestor
14902339|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
14902340|NCT01315990|Cetuximab|cetuximab|mesh-list
14902341|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14902342|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902343|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14902344|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
14902345|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14902346|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
14902347|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902348|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14902349|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14902350|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14902351|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15217764|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217765|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
15217766|NCT01524536|Hormones|hormones|mesh-ancestor
15217767|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217768|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217769|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217770|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217771|NCT01485874|Doxorubicin|doxorubicin|mesh-list
15217772|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15217773|NCT01485874|Nintedanib|nintedanib|mesh-list
15217774|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15217775|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217776|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15217777|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15217778|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217779|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217780|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15217781|NCT01424982|Cytarabine|cytarabine|mesh-list
15217782|NCT01424982|Dexamethasone|dexamethasone|mesh-list
14902352|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902353|NCT01316081|Vitamins|vitamins|mesh-list
14902354|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
14902355|NCT01316081|Vitamin E|vitamin e|mesh-list
14902356|NCT01316081|Tocopherols|tocopherols|mesh-list
14902357|NCT01316081|Tocotrienols|tocotrienols|mesh-list
14902358|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
14902359|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
14902360|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902361|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
14902362|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902363|NCT01316081|Protective Agents|protective agents|mesh-ancestor
14902364|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
14902365|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14902366|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902367|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15217783|NCT01424982|Prednisone|prednisone|mesh-list
15217784|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
14902368|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902369|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
14902370|NCT01316107|Nateglinide|nateglinide|mesh-list
14902371|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14902372|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902373|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14902374|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902375|NCT01316133|Tacrolimus|tacrolimus|mesh-list
14902376|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902377|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
14902378|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902379|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14902380|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902381|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297481|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902382|NCT01316445|Midazolam|midazolam|mesh-list
14902383|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14902384|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14902385|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902386|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902387|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14902388|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14902389|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14902390|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15217785|NCT01424982|Cortisone|cortisone|mesh-list
15217786|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
15217787|NCT01424982|Rituximab|rituximab|mesh-list
15217788|NCT01424982|Doxorubicin|doxorubicin|mesh-list
15217789|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15217790|NCT01424982|Methotrexate|methotrexate|mesh-list
15217791|NCT01424982|Vincristine|vincristine|mesh-list
15217792|NCT01424982|Daunorubicin|daunorubicin|mesh-list
15217793|NCT01424982|Ponatinib|ponatinib|mesh-list
15217794|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15217795|NCT01424982|Antibodies|antibodies|mesh-list
15217796|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
15217797|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15217798|NCT01424982|BB 1101|bb 1101|mesh-list
15217799|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902391|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
14902392|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
14902393|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
14902394|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
14902395|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902396|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902397|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
14902398|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902399|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14902400|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902401|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902402|NCT01316549|Fludarabine|fludarabine|mesh-list
14902403|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902404|NCT01316718|Mesalamine|mesalamine|mesh-list
14902405|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14902406|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902407|NCT01316718|Analgesics|analgesics|mesh-ancestor
14902408|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
14902409|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902410|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902411|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14902412|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14902413|NCT01316744|Ketamine|ketamine|mesh-list
14902414|NCT01316744|Analgesics|analgesics|mesh-ancestor
14902415|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
14902416|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902417|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902418|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14902419|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14902420|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
14902421|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
14902422|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902423|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14902424|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14902425|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902426|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902427|NCT01316757|Paclitaxel|paclitaxel|mesh-list
14902428|NCT01316757|Carboplatin|carboplatin|mesh-list
14902429|NCT01316757|Cetuximab|cetuximab|mesh-list
14902430|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14902431|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14902432|NCT01316757|Antibodies|antibodies|mesh-list
14902433|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
14902434|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14902435|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14902436|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902437|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
14902438|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
14902439|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
14902440|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902441|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
14902442|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902443|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14902444|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902445|NCT01316861|Acarbose|acarbose|mesh-list
14902446|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14902447|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902448|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902449|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14902450|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902451|NCT01316874|Valrubicin|valrubicin|mesh-list
14902452|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902453|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14902454|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14902455|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902456|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718990|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14902457|NCT01316952|Carvedilol|carvedilol|mesh-list
14902458|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14902459|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
14902460|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14902461|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902462|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902463|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902464|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14902465|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
14902466|NCT01316952|Protective Agents|protective agents|mesh-ancestor
14902467|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14902468|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14902469|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14902470|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
14718991|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14718992|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14718993|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14718994|NCT00475696|Analgesics|analgesics|mesh-ancestor
14718995|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
14718996|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14718997|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
14718998|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14718999|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
14719000|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
14719001|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14719002|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14719003|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729035|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902471|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14902472|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14902473|NCT01316978|Ibuprofen|ibuprofen|mesh-list
14902474|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14902475|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902476|NCT01316978|Analgesics|analgesics|mesh-ancestor
14902477|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
14902478|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902479|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902480|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14902481|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14902482|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14902483|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719004|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719005|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14719006|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14719007|NCT00475800|Analgesics|analgesics|mesh-ancestor
14719008|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
14719009|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719010|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719011|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719012|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719013|NCT00475813|Fluticasone|fluticasone|mesh-list
14719014|NCT00475813|Xhance|xhance|mesh-list
14902484|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916538|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
14916539|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
14916540|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916541|NCT01393522|Milnacipran|milnacipran|mesh-list
14916542|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
14916543|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14916544|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14916545|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916546|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916547|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916548|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916549|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14916550|NCT01393522|Analgesics|analgesics|mesh-ancestor
14916551|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
14916552|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916553|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
14916554|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917548|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917549|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917550|NCT04975269|Diuretics|diuretics|mesh-ancestor
14917551|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
14917552|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917553|NCT04971720|Valsartan|valsartan|mesh-list
14917554|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14917555|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14917556|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14917557|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14917558|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917559|NCT04968106|Doxorubicin|doxorubicin|mesh-list
14917560|NCT04968106|Ifosfamide|ifosfamide|mesh-list
14917561|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14917562|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917563|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14917564|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14917565|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917566|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917567|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14917568|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
14917569|NCT04965870|Trifluridine|trifluridine|mesh-list
14719015|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
14902485|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
14902486|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
14902487|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902488|NCT01317069|Fluorouracil|fluorouracil|mesh-list
14902489|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
14902490|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902491|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14902492|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902493|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902494|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
14902495|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902496|NCT01317212|Carboplatin|carboplatin|mesh-list
14902497|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902498|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14902499|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14902500|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14902501|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
14902502|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902503|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902504|NCT01317225|Progestins|progestins|mesh-ancestor
14902505|NCT01317225|Hormones|hormones|mesh-ancestor
14902506|NCT01317368|Ropivacaine|ropivacaine|mesh-list
14902507|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
14902508|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
14902509|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902510|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902511|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
14902512|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902513|NCT01317433|Doxycycline|doxycycline|mesh-list
14902514|NCT01317433|Cetuximab|cetuximab|mesh-list
14902515|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14902516|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902517|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14902518|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902519|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
14902520|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14902521|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14902522|NCT01317446|Fluorides|fluorides|mesh-list
14297482|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297483|NCT04027361|Amphetamine|amphetamine|mesh-list
14297484|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14902523|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
14902524|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
14902525|NCT01317446|Protective Agents|protective agents|mesh-ancestor
14902526|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902527|NCT01317511|Caseins|caseins|mesh-list
14902528|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
14902529|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
14902530|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902531|NCT01317563|Vitamin A|vitamin a|mesh-list
14902532|NCT01317563|Selenium|selenium|mesh-list
14902533|NCT01317563|Vitamins|vitamins|mesh-ancestor
14902534|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
14902535|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902536|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
14902537|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902538|NCT01317563|Protective Agents|protective agents|mesh-ancestor
14902539|NCT01317563|Trace Elements|trace elements|mesh-ancestor
14902540|NCT01317589|Fentanyl|fentanyl|mesh-list
14902541|NCT01317589|Methadone|methadone|mesh-list
14902542|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14902543|NCT01317589|Narcotics|narcotics|mesh-ancestor
14902544|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902545|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902546|NCT01317589|Analgesics|analgesics|mesh-ancestor
14902547|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
14902548|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902549|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14902550|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14902551|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
14902552|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
14902553|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
14916555|NCT01393548|Brompheniramine|brompheniramine|mesh-list
14902554|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
14902555|NCT01317784|Antibodies|antibodies|mesh-list
14902556|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
14902557|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
14902558|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
14902559|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902560|NCT01317849|Vitamins|vitamins|mesh-list
14902561|NCT01317849|Folic Acid|folic acid|mesh-list
14902562|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
14902563|NCT01317849|Hydroxocobalamin|hydroxocobalamin|mesh-list
14902564|NCT01317849|Pyridoxine|pyridoxine|mesh-list
14902565|NCT01317849|Pyridoxal|pyridoxal|mesh-list
14902566|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
14902567|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
14902568|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
14902569|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902570|NCT01317849|Hematinics|hematinics|mesh-ancestor
14902571|NCT01317927|Belinostat|belinostat|mesh-list
14902572|NCT01317927|Warfarin|warfarin|mesh-list
14902573|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
14902574|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902575|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14902576|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902577|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902578|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14902579|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
14902580|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902581|NCT01317953|Protective Agents|protective agents|mesh-ancestor
14902582|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902583|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14902584|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14902585|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902586|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14902587|NCT01317966|Rituximab|rituximab|mesh-list
14902588|NCT01317966|Oprelvekin|oprelvekin|mesh-list
14902589|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14902590|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902591|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
14902592|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902593|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14902594|NCT01317992|Ibudilast|ibudilast|mesh-list
14902595|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14902596|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
14902597|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902598|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902599|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14902600|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
14902601|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14902602|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902603|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902604|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14902605|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
14902606|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
14902607|NCT01318005|Norinyl|norinyl|mesh-list
14902608|NCT01318005|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14902609|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
14902610|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14902611|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902612|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14902613|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14902614|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14902615|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14902616|NCT01318005|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14902617|NCT01318005|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14902618|NCT01318044|Thiopental|thiopental|mesh-list
14902619|NCT01318044|Propofol|propofol|mesh-list
14902620|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14902621|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902622|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902623|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14902624|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
14902625|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
14902626|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
14902627|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
14902628|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
14902629|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902630|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902631|NCT01318096|Tenofovir|tenofovir|mesh-list
14902632|NCT01318096|Lamivudine|lamivudine|mesh-list
14902633|NCT01318096|Efavirenz|efavirenz|mesh-list
14902634|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
14902635|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
14902636|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902637|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14902638|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14902639|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902640|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902641|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14902642|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14902643|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14902644|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14902645|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14902646|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14902647|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14902648|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14902649|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14902650|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14902651|NCT01318148|Caspofungin|caspofungin|mesh-list
14902652|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
14902653|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902654|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902655|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902656|NCT01318161|Morphine|morphine|mesh-list
14902657|NCT01318161|Ropivacaine|ropivacaine|mesh-list
14902658|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14902659|NCT01318161|Narcotics|narcotics|mesh-ancestor
14902660|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902661|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902662|NCT01318161|Analgesics|analgesics|mesh-ancestor
14902663|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
14902664|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902665|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
14902666|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
14902667|NCT01318187|Acetaminophen|acetaminophen|mesh-list
14902668|NCT01318187|Morphine|morphine|mesh-list
14902669|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14902670|NCT01318187|Narcotics|narcotics|mesh-ancestor
14902671|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916556|NCT01393548|Phenylephrine|phenylephrine|mesh-list
14902672|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902673|NCT01318187|Analgesics|analgesics|mesh-ancestor
14902674|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
14902675|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902676|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902677|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
14902678|NCT01318265|Ketoconazole|ketoconazole|mesh-list
14902679|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
14902680|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902681|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14902682|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14902683|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902684|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902685|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14902686|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
14902687|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902688|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902689|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14902690|NCT01318369|Diazepam|diazepam|mesh-list
14297485|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297486|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
14902691|NCT01318369|Dronabinol|dronabinol|mesh-list
14902692|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
14902693|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902694|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14902695|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902696|NCT01318369|Analgesics|analgesics|mesh-ancestor
14902697|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
14902698|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902699|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14902700|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14902701|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902702|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902703|NCT01318369|Hormones|hormones|mesh-ancestor
14902704|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902705|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14902706|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
14902707|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
14902708|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
14902709|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14902710|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14902711|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902712|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14902713|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14902714|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14902715|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14902716|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14902717|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
14902718|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
14902719|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
14902720|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
14902721|NCT01318460|Simendan|simendan|mesh-list
14902722|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14902723|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
14902724|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14902725|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14297487|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
14902726|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902727|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902728|NCT01318460|Protective Agents|protective agents|mesh-ancestor
14902729|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902730|NCT01318564|Metformin|metformin|mesh-list
14902731|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14902732|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902733|NCT01318590|Triamcinolone|triamcinolone|mesh-list
14902734|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14902735|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14902736|NCT01318590|Bupivacaine|bupivacaine|mesh-list
14902737|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14902738|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
14902739|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
14902740|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902741|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902742|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
14902743|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902744|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14902745|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
14902746|NCT01318590|Hormones|hormones|mesh-ancestor
14902747|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902748|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14902749|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
14902750|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902751|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902752|NCT01318655|Naloxegol|naloxegol|mesh-list
14902753|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14902754|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902755|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
14902756|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902757|NCT01318668|Vaccines|vaccines|mesh-list
14902758|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
14902759|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902760|NCT01318681|Fluticasone|fluticasone|mesh-list
14902761|NCT01318681|Xhance|xhance|mesh-list
14902762|NCT01318681|Cetirizine|cetirizine|mesh-list
14902763|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14902764|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14902765|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
14902766|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902767|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902768|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14902769|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
14902770|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
14902771|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14902772|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14902773|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14902774|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
14902775|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
14902776|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902777|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916557|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
14916558|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
14916559|NCT01393548|Ephedrine|ephedrine|mesh-list
14916560|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14916561|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
14916562|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
14916563|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916564|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916565|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
14916566|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14916567|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
14916568|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
14916569|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14916570|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14916571|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14916572|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
14916573|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916574|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916575|NCT01393548|Protective Agents|protective agents|mesh-ancestor
14916576|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14916577|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14916578|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14916579|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14916580|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
14916581|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
14916582|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14916583|NCT01393574|Melatonin|melatonin|mesh-list
14916584|NCT01393574|Methylphenidate|methylphenidate|mesh-list
14916585|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
14916586|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916587|NCT01393574|Protective Agents|protective agents|mesh-ancestor
14916588|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916589|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916590|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14916591|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14916592|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14916593|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14902778|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
14902779|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14902780|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14902781|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
14902782|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902783|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902784|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902785|NCT01318837|Urological Agents|urological agents|mesh-ancestor
14902786|NCT01318928|Metronidazole|metronidazole|mesh-list
14902787|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902788|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14902789|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14902790|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14902791|NCT01318941|Ranibizumab|ranibizumab|mesh-list
14902792|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14902793|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14902794|NCT01318941|Growth Substances|growth substances|mesh-ancestor
14902795|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902796|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
14902797|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902798|NCT01319006|Glycine|glycine|mesh-list
14902799|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
14902800|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902801|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902802|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902803|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14902804|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14902805|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
14902806|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902807|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902808|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14902809|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
14902810|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14902811|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14902812|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14902813|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14902814|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902815|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902816|NCT01319188|Ranibizumab|ranibizumab|mesh-list
14902817|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14297488|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297489|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
14297490|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297491|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297492|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
14297493|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14297494|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14297495|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297496|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14297497|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
14297498|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
14297499|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
14297500|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297501|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297502|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
14902818|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14902819|NCT01319188|Growth Substances|growth substances|mesh-ancestor
14902820|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902821|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
14902822|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902823|NCT01319214|Propranolol|propranolol|mesh-list
14902824|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14902825|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14902826|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
14902827|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902828|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902829|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902830|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14902831|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14902832|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
14902833|NCT01319240|Insulin|insulin|mesh-list
14902834|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14902835|NCT01319240|Liraglutide|liraglutide|mesh-list
14902836|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
14902837|NCT01319240|Xultophy|xultophy|mesh-list
14902838|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14902839|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902840|NCT01319240|Incretins|incretins|mesh-ancestor
14902841|NCT01319240|Hormones|hormones|mesh-ancestor
14902842|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902843|NCT01319266|Hydrocodone|hydrocodone|mesh-list
14902844|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14902845|NCT01319266|Narcotics|narcotics|mesh-ancestor
14902846|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902847|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902848|NCT01319266|Analgesics|analgesics|mesh-ancestor
14902849|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
14297503|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902850|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902851|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
14902852|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
14902853|NCT01319279|Hydrocodone|hydrocodone|mesh-list
14902854|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14902855|NCT01319279|Narcotics|narcotics|mesh-ancestor
14902856|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902857|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902858|NCT01319279|Analgesics|analgesics|mesh-ancestor
14902859|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
14902860|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902861|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
14902862|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
14902863|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14902864|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
14902865|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14902866|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14902867|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
14902868|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902869|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719016|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719017|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14719018|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
14719019|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719020|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719021|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14719022|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
14902870|NCT01319344|Eplerenone|eplerenone|mesh-list
14902871|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14902872|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
14902873|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902874|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902875|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14902876|NCT01319344|Diuretics|diuretics|mesh-ancestor
14902877|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
14902878|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14902879|NCT01319357|Saxagliptin|saxagliptin|mesh-list
14902880|NCT01319357|Incretins|incretins|mesh-ancestor
14902881|NCT01319357|Hormones|hormones|mesh-ancestor
14902882|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902883|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902884|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14902885|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
14902886|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719023|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14297504|NCT03991091|Oxytocin|oxytocin|mesh-list
14719024|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14902887|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902888|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14902889|NCT01319370|Minoxidil|minoxidil|mesh-list
14902890|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14902891|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
14902892|NCT01319448|Artesunate|artesunate|mesh-list
14902893|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
14902894|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
14902895|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14902896|NCT01319448|Amodiaquine|amodiaquine|mesh-list
14902897|NCT01319448|Mefloquine|mefloquine|mesh-list
14902898|NCT01319448|Proguanil|proguanil|mesh-list
14902899|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
14902900|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14902901|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14902902|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902903|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902904|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
14902905|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
14902906|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14902907|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
14902908|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14902909|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902910|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902911|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14902912|NCT01319448|Renal Agents|renal agents|mesh-ancestor
14902913|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
14902914|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
14902915|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14902916|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
14902917|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902918|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
14902919|NCT01319461|Protective Agents|protective agents|mesh-ancestor
14902920|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14902921|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14902922|NCT01319682|Lidocaine|lidocaine|mesh-list
14902923|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
14902924|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
14902925|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14902926|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902927|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
14902928|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902929|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14902930|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14719025|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14719026|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14719027|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14719028|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
14719029|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719030|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719031|NCT00475826|Ezetimibe|ezetimibe|mesh-list
14719032|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14297505|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
14902931|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14902932|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14902933|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297506|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14297507|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297508|NCT03973229|Estradiol|estradiol|mesh-list
14297509|NCT03973229|Estrogens|estrogens|mesh-ancestor
14297510|NCT03973229|Hormones|hormones|mesh-ancestor
14297511|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14297512|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297513|NCT03934840|Prednisone|prednisone|mesh-list
14297514|NCT03934840|Carboplatin|carboplatin|mesh-list
14902934|NCT01319695|Hormones|hormones|mesh-list
14902935|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14902936|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14902937|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902938|NCT01319734|Ascorbic Acid|ascorbic acid|mesh-list
14902939|NCT01319734|Glyburide|glyburide|mesh-list
14902940|NCT01319734|Vitamins|vitamins|mesh-ancestor
14902941|NCT01319734|Micronutrients|micronutrients|mesh-ancestor
14902942|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902943|NCT01319734|Antioxidants|antioxidants|mesh-ancestor
14902944|NCT01319734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902945|NCT01319734|Protective Agents|protective agents|mesh-ancestor
14902946|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14902947|NCT01319825|Milnacipran|milnacipran|mesh-list
14902948|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
14902949|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14902950|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14902951|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14902952|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902953|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14902954|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902955|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14902956|NCT01319825|Analgesics|analgesics|mesh-ancestor
14902957|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
14902958|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14902959|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
14902960|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14902961|NCT01319838|Isotretinoin|isotretinoin|mesh-list
14902962|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14902963|NCT01319864|Plerixafor|plerixafor|mesh-list
14902964|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14902965|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14902966|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
14902967|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14902968|NCT01319903|Antibodies|antibodies|mesh-list
14902969|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14902970|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
14902971|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902972|NCT01319942|Sorafenib|sorafenib|mesh-list
14902973|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902974|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14902975|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14902976|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902977|NCT01319981|Cytarabine|cytarabine|mesh-list
14902978|NCT01319981|Dexamethasone|dexamethasone|mesh-list
14902979|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
14902980|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14902981|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14902982|NCT01319981|Prednisolone|prednisolone|mesh-list
14902983|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
14902984|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
14902985|NCT01319981|Rituximab|rituximab|mesh-list
14902986|NCT01319981|Doxorubicin|doxorubicin|mesh-list
14902987|NCT01319981|Methotrexate|methotrexate|mesh-list
14902988|NCT01319981|Vincristine|vincristine|mesh-list
14902989|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
14902990|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14902991|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
14902992|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297515|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14902993|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
14902994|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14902995|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916594|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
14902996|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14902997|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
14902998|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14902999|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903000|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14903001|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903002|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
14903003|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
14903004|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903005|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903006|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
14903007|NCT01319981|Hormones|hormones|mesh-ancestor
14903008|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903009|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14903010|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14903011|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14903012|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14903013|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903014|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903015|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14903016|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
14903017|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14903018|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903019|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
14903020|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
14903021|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14903022|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14903023|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
14903024|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903025|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14903026|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
14903027|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
14903028|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
14903029|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14903030|NCT01319981|Protective Agents|protective agents|mesh-ancestor
14903031|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903032|NCT01320007|Furosemide|furosemide|mesh-list
14903033|NCT01320007|Diuretics|diuretics|mesh-ancestor
14903034|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
14903035|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903036|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14903037|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14903038|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903039|NCT01320020|Catumaxomab|catumaxomab|mesh-list
14903040|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903041|NCT01320111|Paclitaxel|paclitaxel|mesh-list
14903042|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14903043|NCT01320111|Sorafenib|sorafenib|mesh-list
14903044|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14903045|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903046|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14903047|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14903048|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14903049|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903050|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903051|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903052|NCT01320176|Vaccines|vaccines|mesh-list
14903053|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
14903054|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903055|NCT01320254|Gemcitabine|gemcitabine|mesh-list
14903056|NCT01320254|Cisplatin|cisplatin|mesh-list
14903057|NCT01320254|Panitumumab|panitumumab|mesh-list
14903058|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14903059|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903060|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903061|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
14903062|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903063|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
14903064|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903065|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903066|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903067|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
14903068|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903069|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297516|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297517|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
14297518|NCT03934840|Hormones|hormones|mesh-ancestor
14297519|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903070|NCT01320280|Afatinib|afatinib|mesh-list
14903071|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903072|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903073|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903074|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903075|NCT01320345|Fenofibrate|fenofibrate|mesh-list
14903076|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14903077|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
14903078|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903079|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14903080|NCT01320397|Losartan|losartan|mesh-list
14903081|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14903082|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14903083|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14903084|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14903085|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903086|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14903087|NCT01320436|Curcumin|curcumin|mesh-list
14903088|NCT01320436|Mesalamine|mesalamine|mesh-list
14903089|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14903090|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14903091|NCT01320436|Analgesics|analgesics|mesh-ancestor
14903092|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
14903093|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903094|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903095|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903096|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903097|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903098|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903099|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903100|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
14903101|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903102|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15217800|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
15217801|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217802|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15217803|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15217804|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
15217805|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217806|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217807|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15217808|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903103|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
14903104|NCT01320449|Hematinics|hematinics|mesh-ancestor
14903105|NCT01320475|Sufentanil|sufentanil|mesh-list
14903106|NCT01320475|Ketamine|ketamine|mesh-list
14903107|NCT01320475|Analgesics|analgesics|mesh-ancestor
14903108|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
14903109|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903110|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903111|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14903112|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14903113|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
14903114|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
14903115|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903116|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14903117|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14903118|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903119|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903120|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14903121|NCT01320475|Narcotics|narcotics|mesh-ancestor
14903122|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14903123|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14903124|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903125|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903126|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903127|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903128|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14903129|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
14903130|NCT01320514|Coagulants|coagulants|mesh-ancestor
14916595|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916596|NCT01393756|Lenalidomide|lenalidomide|mesh-list
14916597|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
14297520|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916598|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916599|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14917570|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
14903131|NCT01320579|Tacrolimus|tacrolimus|mesh-list
14903132|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903133|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
14903134|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903135|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14903136|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903137|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903138|NCT01320592|Paclitaxel|paclitaxel|mesh-list
14903139|NCT01320592|Palbociclib|palbociclib|mesh-list
14903140|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14903141|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903142|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
14903143|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
14903144|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
14903145|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903146|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903147|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903148|NCT01320709|Piroxicam|piroxicam|mesh-list
14903149|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14903150|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14903151|NCT01320709|Analgesics|analgesics|mesh-ancestor
14903152|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
14903153|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903154|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903155|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903156|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903157|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14903158|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903159|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903160|NCT01320878|Iloprost|iloprost|mesh-list
14903161|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14903162|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14903163|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
14903164|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
14903165|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14903166|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
14903167|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14903168|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903169|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14903170|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14903171|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14903172|NCT01320982|Aspirin|aspirin|mesh-list
14903173|NCT01320982|Minocycline|minocycline|mesh-list
14903174|NCT01320982|Pramipexole|pramipexole|mesh-list
14903175|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14903176|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14903177|NCT01320982|Analgesics|analgesics|mesh-ancestor
14903178|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
14903179|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903180|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903181|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903182|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903183|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14903184|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14903185|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903186|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14903187|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14903188|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903189|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
14903190|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903191|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903192|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
14903193|NCT01320982|Protective Agents|protective agents|mesh-ancestor
14903194|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14903195|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14903196|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
14903197|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
14903198|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719033|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14719034|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
14719035|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719036|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14719037|NCT00475917|Gemcitabine|gemcitabine|mesh-list
14719038|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719039|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
14719040|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903199|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
14903200|NCT01321021|Promethazine|promethazine|mesh-list
14903201|NCT01321021|Losartan|losartan|mesh-list
14903202|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14903203|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14903204|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14903205|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14903206|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903207|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14903208|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14903209|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903210|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903211|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
14903212|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
14719041|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719042|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
14903213|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
14903214|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903215|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
14903216|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
14903217|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903218|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14903219|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
14903220|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
14903221|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903222|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14903223|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
14903224|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
14903225|NCT01321034|Niacin|niacin|mesh-list
14903226|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14903227|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
14903228|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903229|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14903230|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
14903231|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
14903232|NCT01321034|Vitamins|vitamins|mesh-ancestor
14903233|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
14903234|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903235|NCT01321047|Propofol|propofol|mesh-list
14903236|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14903237|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903238|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903239|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14903240|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
14903241|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
14903242|NCT01321099|Ascorbic Acid|ascorbic acid|mesh-list
14903243|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
14903244|NCT01321099|Vitamins|vitamins|mesh-ancestor
14903245|NCT01321099|Micronutrients|micronutrients|mesh-ancestor
14903246|NCT01321099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903247|NCT01321099|Antioxidants|antioxidants|mesh-ancestor
14903248|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903249|NCT01321099|Protective Agents|protective agents|mesh-ancestor
14903250|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14903251|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
14903252|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
14903253|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
14903254|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14903255|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
14903256|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14903257|NCT01321125|Povidone|povidone|mesh-list
14903258|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903259|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
14903260|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
14903261|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
14903262|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
14903263|NCT01321138|Morphine|morphine|mesh-list
14903264|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14903265|NCT01321138|Narcotics|narcotics|mesh-ancestor
14903266|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903267|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903268|NCT01321138|Analgesics|analgesics|mesh-ancestor
14903269|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
14903270|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903271|NCT01321255|Aspirin|aspirin|mesh-list
14903272|NCT01321255|Ramipril|ramipril|mesh-list
14903273|NCT01321255|Simvastatin|simvastatin|mesh-list
14903274|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14903275|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14903276|NCT01321255|Analgesics|analgesics|mesh-ancestor
14903277|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
14903278|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903279|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903280|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903281|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903282|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14903283|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14903284|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903285|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14903286|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15217809|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
15217810|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
15217811|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903287|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903288|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
14903289|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14903290|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14903291|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
14903292|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14903293|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14903294|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14903295|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
14903296|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14903297|NCT01321268|Beta Carotene|beta carotene|mesh-list
14903298|NCT01321268|Lycopene|lycopene|mesh-list
14903299|NCT01321268|Resveratrol|resveratrol|mesh-list
14903300|NCT01321268|Carotenoids|carotenoids|mesh-list
14903301|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
14903302|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903303|NCT01321268|Protective Agents|protective agents|mesh-ancestor
14903304|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903305|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903306|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14903307|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903308|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14903309|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14903310|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903311|NCT01321268|Provitamins|provitamins|mesh-ancestor
14903312|NCT01321268|Vitamins|vitamins|mesh-ancestor
14903313|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
14903314|NCT01321346|Cytarabine|cytarabine|mesh-list
14903315|NCT01321346|Panobinostat|panobinostat|mesh-list
14903316|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903317|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
14903318|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903319|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903320|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
14903321|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903322|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903323|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
14903324|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903325|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14903326|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903327|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
14903328|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903329|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
14903330|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14903331|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14903332|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903333|NCT01321489|Urological Agents|urological agents|mesh-ancestor
14903334|NCT01321502|Famciclovir|famciclovir|mesh-list
14903335|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
14903336|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903337|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14903338|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903339|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903340|NCT01321515|Famciclovir|famciclovir|mesh-list
14903341|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
14903342|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903343|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14903344|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903345|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903346|NCT01321567|Rabeprazole|rabeprazole|mesh-list
14903347|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14903348|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903349|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14903350|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903351|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903352|NCT01321671|Pregabalin|pregabalin|mesh-list
14903353|NCT01321671|Analgesics|analgesics|mesh-ancestor
14903354|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
14903355|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903356|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903357|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
14903358|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14903359|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14903360|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903361|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14903362|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14903363|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14903364|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903365|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14903366|NCT01321775|Paclitaxel|paclitaxel|mesh-list
14903367|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
14903368|NCT01321775|Bevacizumab|bevacizumab|mesh-list
14903369|NCT01321775|Trastuzumab|trastuzumab|mesh-list
14903370|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14903371|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903372|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
14903373|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
14903374|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
14903375|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903376|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903377|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
14903378|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903379|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903380|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14903381|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
14903382|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14903383|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14903384|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14903385|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14903386|NCT01321775|Growth Substances|growth substances|mesh-ancestor
14903387|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
14903388|NCT01321788|Tinzaparin|tinzaparin|mesh-list
14903389|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14903390|NCT01321788|Dalteparin|dalteparin|mesh-list
14903391|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
14903392|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14903393|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14903394|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903395|NCT01321801|Pregabalin|pregabalin|mesh-list
14903396|NCT01321801|Analgesics|analgesics|mesh-ancestor
14903397|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
14903398|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903399|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903400|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
14903401|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14903402|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14903403|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903404|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14903405|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14903406|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14903407|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903408|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14903409|NCT01321827|Itraconazole|itraconazole|mesh-list
14903410|NCT01321827|Prednisolone|prednisolone|mesh-list
14903411|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
14903412|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903413|NCT01321827|Hormones|hormones|mesh-ancestor
14903414|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903415|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903416|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14903417|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903418|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
14903419|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903420|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14903421|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14903422|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903423|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903424|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14903425|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
14903426|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14903427|NCT01321905|Vitamin D|vitamin d|mesh-list
14903428|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
14903429|NCT01321905|Vitamins|vitamins|mesh-ancestor
14903430|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
14903431|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903432|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14903433|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14903434|NCT01321931|Nicotine|nicotine|mesh-list
14903435|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14903436|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
14903437|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903438|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903439|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14903440|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14903441|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
14719043|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719044|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903442|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903443|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903444|NCT01321944|Nicotine|nicotine|mesh-list
14903445|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14297521|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14297522|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
14297523|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14903446|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
14903447|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903448|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903449|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14903450|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14903451|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14903452|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903453|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903454|NCT01321957|Bevacizumab|bevacizumab|mesh-list
14903455|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
14903456|NCT01321957|Irinotecan|irinotecan|mesh-list
14903457|NCT01321957|Fluorouracil|fluorouracil|mesh-list
14903458|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217812|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14719045|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719046|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
14719047|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297524|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719048|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
14719049|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14719050|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14719051|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719052|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
14719053|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
14719054|NCT00475956|Cediranib|cediranib|mesh-list
14719055|NCT00475956|Saracatinib|saracatinib|mesh-list
14719056|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719057|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903459|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217813|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
15217814|NCT01424982|Hormones|hormones|mesh-ancestor
15217815|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15217816|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217817|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15217818|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15217819|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15217820|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217821|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15217822|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
15217823|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15217824|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15217825|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
15217826|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
15217827|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15217828|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14903460|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14903461|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14903462|NCT01321957|Growth Substances|growth substances|mesh-ancestor
14903463|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903464|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
14903465|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14903466|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903467|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217829|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
15217830|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903468|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903469|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
14903470|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903471|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903472|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
14903473|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
14903474|NCT01322061|Vitamins|vitamins|mesh-ancestor
14903475|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
14903476|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903477|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
14903478|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903479|NCT01322061|Protective Agents|protective agents|mesh-ancestor
14903480|NCT01322100|Bleomycin|bleomycin|mesh-list
14903481|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14903482|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916600|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14916601|NCT01393756|Growth Substances|growth substances|mesh-ancestor
14916602|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
15217831|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15217832|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
15217833|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
15217834|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
15217835|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
15217836|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15225407|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225408|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15225409|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15225410|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
15225411|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225412|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15225413|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15225414|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
15225415|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225416|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14903483|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
14903484|NCT01322139|Nabiximols|nabiximols|mesh-list
14903485|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14903486|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903487|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903488|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14903489|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903490|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903491|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903492|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903493|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14903494|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
14903495|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14903496|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903497|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14903498|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14903499|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14903500|NCT01322139|Analgesics|analgesics|mesh-ancestor
14903501|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
14903502|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903503|NCT01322152|Capecitabine|capecitabine|mesh-list
14903504|NCT01322152|Irinotecan|irinotecan|mesh-list
14903505|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903506|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
14903507|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903508|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903509|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14903510|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903511|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903512|NCT01322178|Cetuximab|cetuximab|mesh-list
14903513|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14903514|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903515|NCT01322191|Morphine|morphine|mesh-list
14903516|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14903517|NCT01322191|Narcotics|narcotics|mesh-ancestor
14903518|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903519|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217837|NCT01307046|Losartan|losartan|mesh-list
15217838|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217839|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217840|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217841|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15217842|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217843|NCT01307033|Losartan|losartan|mesh-list
15217844|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217845|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14719058|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719059|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719060|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14719061|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14719062|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14719063|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14719064|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903520|NCT01322191|Analgesics|analgesics|mesh-ancestor
14903521|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
15217846|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217847|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15217848|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217849|NCT01041807|Losartan|losartan|mesh-list
15217850|NCT01041807|Amlodipine|amlodipine|mesh-list
15217851|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217852|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14903522|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903523|NCT01322204|Codeine|codeine|mesh-list
14903524|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14903525|NCT01322204|Narcotics|narcotics|mesh-ancestor
14903526|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903527|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903528|NCT01322204|Analgesics|analgesics|mesh-ancestor
14903529|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
14903530|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903531|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
14903532|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
14903533|NCT01322282|Cetirizine|cetirizine|mesh-list
14903534|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14903535|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14903536|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14903537|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
14903538|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
14903539|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903540|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903541|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903542|NCT01322308|Pioglitazone|pioglitazone|mesh-list
14903543|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14719065|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719066|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719067|NCT00475969|Analgesics|analgesics|mesh-ancestor
14719068|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
14719069|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719070|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
14719071|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14719072|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
14719073|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
14903544|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903545|NCT01322438|Rifampin|rifampin|mesh-list
14903546|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14903547|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
14903548|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903549|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903550|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
14903551|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14903552|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719074|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15217853|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217854|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217855|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15217856|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217857|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
15217858|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217859|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217860|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14903553|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217861|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15217862|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217863|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15217864|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217865|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217866|NCT00739674|Losartan|losartan|mesh-list
15217867|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15217868|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
14903554|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14903555|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14903556|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14903557|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14903558|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14903559|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14903560|NCT01322464|Nabiximols|nabiximols|mesh-list
14903561|NCT01322464|Analgesics|analgesics|mesh-ancestor
14903562|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
14903563|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903564|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903565|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14903566|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14903567|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903568|NCT01322711|Atorvastatin|atorvastatin|mesh-list
14903569|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14903570|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14903571|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
14903572|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903573|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14903574|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14903575|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903576|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
14903577|NCT01322776|Fludarabine|fludarabine|mesh-list
14903578|NCT01322776|Bortezomib|bortezomib|mesh-list
14903579|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903580|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
14903581|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903582|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903583|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14903584|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
15217869|NCT00739674|Calcium|calcium|mesh-list
15217870|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15217871|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217872|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217873|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217874|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14903585|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903586|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903587|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14903588|NCT01322867|Alprazolam|alprazolam|mesh-list
14903589|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14903590|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903591|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903592|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14903593|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14903594|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14903595|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
14903596|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
14903597|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903598|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903599|NCT01323062|Bavituximab|bavituximab|mesh-list
14903600|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14903601|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903602|NCT01323101|Doxycycline|doxycycline|mesh-list
14719075|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14719076|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719077|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719078|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14719079|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14719080|NCT00476034|Analgesics|analgesics|mesh-ancestor
14719081|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
14903603|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903604|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903605|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
14903606|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14903607|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14903608|NCT01323218|Vitamin D|vitamin d|mesh-list
14903609|NCT01323218|Vitamins|vitamins|mesh-ancestor
14903610|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
14719082|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719083|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719084|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719085|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719086|NCT00476073|Fluticasone|fluticasone|mesh-list
14719087|NCT00476073|Xhance|xhance|mesh-list
14719088|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
14903611|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903612|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14903613|NCT01323244|Simeprevir|simeprevir|mesh-list
14903614|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
14903615|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903616|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
14903617|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903618|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903619|NCT01323257|Ritonavir|ritonavir|mesh-list
14903620|NCT01323257|Darunavir|darunavir|mesh-list
14903621|NCT01323257|Erythromycin|erythromycin|mesh-list
14903622|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
14903623|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14903624|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
14903625|NCT01323257|Simeprevir|simeprevir|mesh-list
14903626|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14903627|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14903628|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
14903629|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903630|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903631|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14903632|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14903633|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
14903634|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903635|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14903636|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14903637|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903638|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903639|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14903640|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14903641|NCT01323296|Hematinics|hematinics|mesh-ancestor
14903642|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14903643|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14903644|NCT01323335|Rasburicase|rasburicase|mesh-list
14903645|NCT01323335|Uric Acid|uric acid|mesh-list
14903646|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
14903647|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903648|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
14903649|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903650|NCT01323335|Protective Agents|protective agents|mesh-ancestor
14903651|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903652|NCT01323374|Carbidopa|carbidopa|mesh-list
14719089|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719090|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14903653|NCT01323374|Droxidopa|droxidopa|mesh-list
14903654|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14903655|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14903656|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
14903657|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916603|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903658|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903659|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903660|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14903661|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903662|NCT01323452|Entecavir|entecavir|mesh-list
14903663|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
14903664|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903665|NCT01323465|Rifampin|rifampin|mesh-list
14903666|NCT01323465|Ketoconazole|ketoconazole|mesh-list
14903667|NCT01323465|Nabiximols|nabiximols|mesh-list
14903668|NCT01323465|Omeprazole|omeprazole|mesh-list
14903669|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14903670|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903671|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14903672|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903673|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903674|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14903675|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
14903676|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903677|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903678|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
14903679|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14903680|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14903681|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14903682|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14903683|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14903684|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14903685|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14903686|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
14903687|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14903688|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14903689|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14903690|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
14903691|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903692|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903693|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14903694|NCT01323465|Analgesics|analgesics|mesh-ancestor
14903695|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
14903696|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903697|NCT01323491|Nicotine|nicotine|mesh-list
14903698|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14903699|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
14903700|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903701|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903702|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14903703|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14903704|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
14903705|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903706|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903707|NCT01323569|Nabiximols|nabiximols|mesh-list
14903708|NCT01323569|Dronabinol|dronabinol|mesh-list
14903709|NCT01323569|Analgesics|analgesics|mesh-ancestor
14903710|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
14903711|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916604|NCT01393769|Melphalan|melphalan|mesh-list
14903712|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903713|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
14903714|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14903715|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14903716|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14903717|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14903718|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903719|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903720|NCT01323569|Hormones|hormones|mesh-ancestor
14903721|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903722|NCT01323608|Vitamin D|vitamin d|mesh-list
14903723|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
14903724|NCT01323608|Vitamins|vitamins|mesh-ancestor
14903725|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
14903726|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903727|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14903728|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14903729|NCT01323712|Vitamin D|vitamin d|mesh-list
14903730|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
14903731|NCT01323712|Vitamins|vitamins|mesh-ancestor
14903732|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
14903733|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903734|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14903735|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14903736|NCT01323751|Ricolinostat|ricolinostat|mesh-list
14903737|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903738|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14903739|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903740|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916605|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14916606|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
14916607|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916608|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916609|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14916610|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916611|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
14916612|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916613|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
14916614|NCT01393782|Giapreza|giapreza|mesh-list
14916615|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
14916616|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14916617|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14916618|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
14916619|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903741|NCT01324063|Cytarabine|cytarabine|mesh-list
14903742|NCT01324063|Daunorubicin|daunorubicin|mesh-list
14903743|NCT01324063|Amsacrine|amsacrine|mesh-list
14903744|NCT01324063|Sargramostim|sargramostim|mesh-list
14903745|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903746|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
14903747|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903748|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903749|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
14903750|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903751|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903752|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
14903753|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903754|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14903755|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14903756|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903757|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903758|NCT01324076|Doxorubicin|doxorubicin|mesh-list
14903759|NCT01324076|Sorafenib|sorafenib|mesh-list
14903760|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14903761|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903762|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14903763|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903764|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903765|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903766|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903767|NCT01324089|Resveratrol|resveratrol|mesh-list
14903768|NCT01324089|Piperine|piperine|mesh-list
14903769|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
14903770|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903771|NCT01324089|Protective Agents|protective agents|mesh-ancestor
14903772|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903773|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903774|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14903775|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14903776|NCT01324115|Nitroarginine|nitroarginine|mesh-list
14903777|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903778|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903779|NCT01324180|Metformin|metformin|mesh-list
14903780|NCT01324180|Dexamethasone|dexamethasone|mesh-list
14903781|NCT01324180|Doxorubicin|doxorubicin|mesh-list
14903782|NCT01324180|Vincristine|vincristine|mesh-list
14903783|NCT01324180|Asparaginase|asparaginase|mesh-list
14903784|NCT01324180|Pegaspargase|pegaspargase|mesh-list
14903785|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903786|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
14903787|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
14903788|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903789|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903790|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903791|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
14903792|NCT01324180|Hormones|hormones|mesh-ancestor
15217875|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15217876|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217877|NCT00739674|Diuretics|diuretics|mesh-ancestor
15217878|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
15217879|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15217880|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217881|NCT00731757|Adalimumab|adalimumab|mesh-list
15217882|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217883|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15217884|NCT00730717|Adalimumab|adalimumab|mesh-list
15217885|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15217886|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15217887|NCT00546754|Losartan|losartan|mesh-list
15217888|NCT00546754|Valsartan|valsartan|mesh-list
15217889|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15217890|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217891|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14903793|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903794|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14903795|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903796|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14903797|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14903798|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14903799|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903800|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903801|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903802|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14903803|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
14903804|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
14903805|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
14903806|NCT01324245|Fenoldopam|fenoldopam|mesh-list
14903807|NCT01324245|Enalaprilat|enalaprilat|mesh-list
14903808|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14903809|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
14903810|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
14903811|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
14903812|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903813|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903814|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903815|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14903816|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
14903817|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903818|NCT01324258|Gemcitabine|gemcitabine|mesh-list
14903819|NCT01324258|Trametinib|trametinib|mesh-list
14903820|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903821|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
14903822|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903823|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903824|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
14903825|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903826|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903827|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903828|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
14903829|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903830|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14903831|NCT01324284|Lubiprostone|lubiprostone|mesh-list
14903832|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14903833|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14903834|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903835|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
14903836|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
14903837|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903838|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903839|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903840|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903841|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
14903842|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903843|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14903844|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903845|NCT01324492|Everolimus|everolimus|mesh-list
14903846|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903847|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903848|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
14903849|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903850|NCT01324544|Buprenorphine|buprenorphine|mesh-list
14903851|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14903852|NCT01324544|Narcotics|narcotics|mesh-ancestor
14903853|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903854|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903855|NCT01324544|Analgesics|analgesics|mesh-ancestor
14903856|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
14903857|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903858|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14903859|NCT01324583|Prednisolone|prednisolone|mesh-list
14903860|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903861|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
14903862|NCT01324583|Hormones|hormones|mesh-ancestor
14903863|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903864|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217892|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15217893|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217894|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217895|NCT00546754|Diuretics|diuretics|mesh-ancestor
15217896|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
15217897|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217898|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15217899|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217900|NCT00480805|Losartan|losartan|mesh-list
15217901|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15217902|NCT00480805|Ramipril|ramipril|mesh-list
15217903|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217904|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217905|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217906|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15217907|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217908|NCT00480805|Diuretics|diuretics|mesh-ancestor
15217909|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
14903865|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14903866|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903867|NCT01324596|Prednisolone|prednisolone|mesh-list
14903868|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14903869|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
14903870|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14903871|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
14903872|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
14903873|NCT01324596|Rituximab|rituximab|mesh-list
14903874|NCT01324596|Doxorubicin|doxorubicin|mesh-list
14903875|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14903876|NCT01324596|Vincristine|vincristine|mesh-list
14903877|NCT01324596|Bortezomib|bortezomib|mesh-list
14903878|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14903879|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
14903880|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903881|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
14903882|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903883|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14903884|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14903885|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
14903886|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903887|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903888|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14903889|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15217910|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217911|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14903890|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14719091|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
14719092|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719093|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719094|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14719095|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
14719096|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14903891|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14903892|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903893|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903894|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14903895|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
14903896|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
14903897|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14903898|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14903899|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
14903900|NCT01324596|Hormones|hormones|mesh-ancestor
14903901|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14903902|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14903903|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
14903904|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
14903905|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903906|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14903907|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14903908|NCT01324596|Protective Agents|protective agents|mesh-ancestor
14903909|NCT01324635|Panobinostat|panobinostat|mesh-list
14903910|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14903911|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903912|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719097|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14719098|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14719099|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14719100|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14719101|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
14719102|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719103|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719104|NCT00476099|Budesonide|budesonide|mesh-list
14719105|NCT00476099|Beclomethasone|beclomethasone|mesh-list
14719106|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
14719107|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719108|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14903913|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719109|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
14719110|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903914|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14903915|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
14903916|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903917|NCT01324752|Losartan|losartan|mesh-list
14903918|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14903919|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14903920|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14903921|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14903922|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903923|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14903924|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
14903925|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
14903926|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14903927|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903928|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
14903929|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903930|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14903931|NCT01324960|Aldesleukin|aldesleukin|mesh-list
14903932|NCT01324960|Azacitidine|azacitidine|mesh-list
14903933|NCT01324960|Histamine|histamine|mesh-list
14903934|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903935|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
14903936|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903937|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903938|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903939|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903940|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14903941|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14903942|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
14903943|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903944|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
14903945|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
14903946|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903947|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
14903948|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14903949|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14719111|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719112|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14719113|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
14719114|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
14719115|NCT00476099|Hormones|hormones|mesh-ancestor
14719116|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719117|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14719118|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14719119|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14719120|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
14719121|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719122|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903950|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
14903951|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903952|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14903953|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14903954|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903955|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903956|NCT01325168|Oxytocin|oxytocin|mesh-list
14903957|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
14903958|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14719123|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14719124|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
14719125|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719126|NCT00476138|Protective Agents|protective agents|mesh-ancestor
14719127|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719128|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14719129|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14903959|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903960|NCT01325194|Cytarabine|cytarabine|mesh-list
14903961|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14903962|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
14903963|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903964|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903965|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
14903966|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903967|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14903968|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
14903969|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903970|NCT01325220|Baclofen|baclofen|mesh-list
14903971|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14903972|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903973|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14903974|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14903975|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14903976|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
14903977|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
14903978|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14903979|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903980|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14903981|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14903982|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903983|NCT01325298|Riboflavin|riboflavin|mesh-list
14903984|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
14903985|NCT01325298|Vitamins|vitamins|mesh-ancestor
14903986|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
14903987|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14903988|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14903989|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
14903990|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
14903991|NCT01325415|Naloxegol|naloxegol|mesh-list
14903992|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14903993|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14903994|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14903995|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14903996|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14903997|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14903998|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14903999|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904000|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14904001|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
14904002|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904003|NCT01325558|Gemcitabine|gemcitabine|mesh-list
14904004|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14904005|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
14904006|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904007|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904008|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
14904009|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904010|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904011|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904012|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
14904013|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904014|NCT01325571|Tacrolimus|tacrolimus|mesh-list
14904015|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904016|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
14904017|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904018|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14904019|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904020|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904021|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
14904022|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14904023|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904024|NCT01325610|Vitamins|vitamins|mesh-ancestor
14904025|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
14904026|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14904027|NCT01325779|Heparin|heparin|mesh-list
14904028|NCT01325779|Enoxaparin|enoxaparin|mesh-list
14904029|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
14904030|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14904031|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14904032|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916620|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916621|NCT01393795|Capsaicin|capsaicin|mesh-list
14916622|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
14916623|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
14916624|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
14916625|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916626|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916627|NCT01393912|Crenolanib|crenolanib|mesh-list
14916628|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916629|NCT01393925|Parecoxib|parecoxib|mesh-list
14916630|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14916631|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14916632|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916633|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916634|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14916635|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14916636|NCT01393925|Analgesics|analgesics|mesh-ancestor
14916637|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
14916638|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916639|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916640|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916641|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916642|NCT01394016|Fulvestrant|fulvestrant|mesh-list
14916643|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14916644|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916645|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14916646|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14916647|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
14916648|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916649|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916650|NCT01394029|Deferasirox|deferasirox|mesh-list
14916651|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14916652|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
14916653|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
15217912|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217913|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14904033|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14904034|NCT01325818|Pravastatin|pravastatin|mesh-list
14904035|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14904036|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14904037|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
14904038|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904039|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14904040|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14904041|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904042|NCT01325844|Anesthetics|anesthetics|mesh-list
14904043|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904044|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904045|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14904046|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
14904047|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904048|NCT01325935|Clopidogrel|clopidogrel|mesh-list
14904049|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14904050|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14904051|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14904052|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14904053|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
14904054|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904055|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904056|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904057|NCT01325987|Vitamin D|vitamin d|mesh-list
14904058|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
14904059|NCT01325987|Vitamins|vitamins|mesh-list
14904060|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
14904061|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904062|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14904063|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14904064|NCT01326000|Cetuximab|cetuximab|mesh-list
14904065|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904066|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904067|NCT01326039|Bupivacaine|bupivacaine|mesh-list
14904068|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
14904069|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
14904070|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297525|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297526|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297527|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14297528|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
14297529|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297530|NCT03879629|Carvedilol|carvedilol|mesh-list
14297531|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14297532|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14297533|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
14297534|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904071|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217914|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
15217915|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15217916|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15217917|NCT00479713|Simvastatin|simvastatin|mesh-list
14904072|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
14904073|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904074|NCT01326078|Propofol|propofol|mesh-list
14904075|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14904076|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904077|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904078|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14904079|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
15217918|NCT00479713|Ezetimibe|ezetimibe|mesh-list
15217919|NCT00479713|Calcium|calcium|mesh-list
15217920|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15217921|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217922|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15217923|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15217924|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
15217925|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217926|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15217927|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15217928|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904080|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
14904081|NCT01326117|Tadalafil|tadalafil|mesh-list
14904082|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
14297535|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297536|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297537|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14904083|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14904084|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14904085|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904086|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904087|NCT01326117|Urological Agents|urological agents|mesh-ancestor
14904088|NCT01326221|Tenofovir|tenofovir|mesh-list
14297538|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
14297539|NCT03879629|Protective Agents|protective agents|mesh-ancestor
14297540|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14297541|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297542|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14904089|NCT01326221|Emtricitabine|emtricitabine|mesh-list
14904090|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
14904091|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904092|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14904093|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14904094|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904095|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904096|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14904097|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14904098|NCT01326312|Leuprolide|leuprolide|mesh-list
14904099|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14904100|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
14904101|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14904102|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904103|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14904104|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904105|NCT01326325|Ketamine|ketamine|mesh-list
14904106|NCT01326325|Analgesics|analgesics|mesh-ancestor
14904107|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
14904108|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904109|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904110|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14904111|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14904112|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
14904113|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
14904114|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904115|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14904116|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14297543|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14904117|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904118|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904119|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
14904120|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14904121|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904122|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
14904123|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14904124|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14904125|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904126|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
14904127|NCT01326403|Coagulants|coagulants|mesh-ancestor
14904128|NCT01326442|Vitamin D|vitamin d|mesh-list
14904129|NCT01326442|Vitamins|vitamins|mesh-ancestor
14904130|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
15217929|NCT00457275|Ezetimibe|ezetimibe|mesh-list
15217930|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15217931|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15217932|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
15217933|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217934|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14904131|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904132|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14904133|NCT01326468|Sirolimus|sirolimus|mesh-list
14904134|NCT01326468|Cisplatin|cisplatin|mesh-list
14904135|NCT01326468|Cetuximab|cetuximab|mesh-list
14904136|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904137|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904138|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14904139|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904140|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14904141|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
14904142|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904143|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
14904144|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904145|NCT01326494|Prednisone|prednisone|mesh-list
14904146|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904147|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
14904148|NCT01326494|Hormones|hormones|mesh-ancestor
14904149|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904150|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904151|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15217935|NCT00449111|Losartan|losartan|mesh-list
15217936|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217937|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217938|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217939|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14904152|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904153|NCT01326559|Docetaxel|docetaxel|mesh-list
14904154|NCT01326559|Cetuximab|cetuximab|mesh-list
14904155|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904156|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
14904157|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
14904158|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
14904159|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904160|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904161|NCT01326585|Dexamethasone|dexamethasone|mesh-list
15217940|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217941|NCT00406783|Desloratadine|desloratadine|mesh-list
15217942|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15217943|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
15217944|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217945|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217946|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225417|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14904162|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
14904163|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14904164|NCT01326585|BB 1101|bb 1101|mesh-list
14904165|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904166|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
14904167|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
14904168|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904169|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904170|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14904171|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
14904172|NCT01326585|Hormones|hormones|mesh-ancestor
14904173|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904174|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14904175|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904176|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
14904177|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904178|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904179|NCT01326611|Clarithromycin|clarithromycin|mesh-list
14904180|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14904181|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904182|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14904183|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904184|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904185|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14904186|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14904187|NCT01326650|Vitamin D|vitamin d|mesh-list
14904188|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
14904189|NCT01326650|Vitamins|vitamins|mesh-list
14904190|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14904191|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
14904192|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904193|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14904194|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14904195|NCT01326754|Artesunate|artesunate|mesh-list
14904196|NCT01326754|Lumefantrine|lumefantrine|mesh-list
14904197|NCT01326754|Artemether|artemether|mesh-list
14904198|NCT01326754|Piperaquine|piperaquine|mesh-list
14904199|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14904200|NCT01326754|Amodiaquine|amodiaquine|mesh-list
14904201|NCT01326754|Artenimol|artenimol|mesh-list
14904202|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
14904203|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
15217947|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15217948|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15217949|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
15217950|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
15217951|NCT00405964|Desloratadine|desloratadine|mesh-list
15217952|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15217953|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
15217954|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217955|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217956|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217957|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15217958|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15217959|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
15217960|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
15217961|NCT00400218|Losartan|losartan|mesh-list
15217962|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15217963|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217964|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217965|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217966|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15217967|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217968|NCT00400218|Diuretics|diuretics|mesh-ancestor
15217969|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
15217970|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904204|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14904205|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14904206|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904207|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904208|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
14904209|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
14904210|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14904211|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
14904212|NCT01326767|Paclitaxel|paclitaxel|mesh-list
14904213|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14904214|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14904215|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904216|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
14904217|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
14904218|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
14904219|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904220|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14904221|NCT01326858|Ketotifen|ketotifen|mesh-list
14904222|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14904223|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14904224|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14904225|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14904226|NCT01326858|Analgesics|analgesics|mesh-ancestor
14904227|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
14904228|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904229|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904230|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904231|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14904232|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14904233|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14904234|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14904235|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
14904236|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
14904237|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904238|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904239|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
15217971|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15225418|NCT05007873|Decitabine|decitabine|mesh-list
14904240|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
14904241|NCT01326871|Gemcitabine|gemcitabine|mesh-list
14904242|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15217972|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217973|NCT00398541|Losartan|losartan|mesh-list
15217974|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15217975|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15217976|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15217977|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15217978|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15217979|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904243|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14904244|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
14904245|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904246|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
14904247|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904248|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904249|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904250|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
14904251|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904252|NCT01326988|Anesthetics|anesthetics|mesh-list
14904253|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904254|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904255|NCT01327027|Vasopressins|vasopressins|mesh-list
14904256|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
14904257|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
14904258|NCT01327027|Coagulants|coagulants|mesh-ancestor
14904259|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14904260|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14904261|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
14904262|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904263|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
14904264|NCT01327066|Droxidopa|droxidopa|mesh-list
14904265|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14904266|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904267|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14904268|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904269|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904270|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904271|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904272|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14904273|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14904274|NCT01327079|Methadone|methadone|mesh-list
14904275|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14904276|NCT01327079|Narcotics|narcotics|mesh-ancestor
14904277|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904278|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904279|NCT01327079|Analgesics|analgesics|mesh-ancestor
14904280|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
14904281|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904282|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
14904283|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
14904284|NCT01327118|Dinoprost|dinoprost|mesh-list
14904285|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
14904286|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14904287|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
14904288|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14904289|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904290|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
14904291|NCT01327144|Acyclovir|acyclovir|mesh-list
14904292|NCT01327144|Famciclovir|famciclovir|mesh-list
14904293|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
14904294|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904295|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14904296|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904297|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904298|NCT01327222|Bevacizumab|bevacizumab|mesh-list
15217980|NCT00398541|Diuretics|diuretics|mesh-ancestor
15217981|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
14904299|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904300|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904301|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14904302|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14904303|NCT01327222|Growth Substances|growth substances|mesh-ancestor
14904304|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904305|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14904306|NCT01327235|Cisplatin|cisplatin|mesh-list
14904307|NCT01327235|Endostar protein|endostar protein|mesh-list
14904308|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904309|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14904310|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14904311|NCT01327235|Growth Substances|growth substances|mesh-ancestor
14904312|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904313|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
14904314|NCT01327261|Levodopa|levodopa|mesh-list
14904315|NCT01327261|Benserazide|benserazide|mesh-list
14904316|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14904317|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14904318|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
14904319|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904320|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904321|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904322|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904323|NCT01327326|Naltrexone|naltrexone|mesh-list
14904324|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14904325|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14904326|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904327|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
14904328|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916654|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916655|NCT01394094|Calcium|calcium|mesh-list
14916656|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14916657|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916658|NCT01394133|Ritonavir|ritonavir|mesh-list
14916659|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14916660|NCT01394133|Tenofovir|tenofovir|mesh-list
14916661|NCT01394133|Emtricitabine|emtricitabine|mesh-list
14916662|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14916663|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14916664|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
14916665|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916666|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916667|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14916668|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14916669|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
14916670|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916671|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14916672|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14916673|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14916674|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14916675|NCT01394224|Levetiracetam|levetiracetam|mesh-list
14719130|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719131|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14719132|NCT00476164|Rituximab|rituximab|mesh-list
14719133|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14719134|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719135|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
14719136|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719137|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719138|NCT00476190|Cytarabine|cytarabine|mesh-list
14904329|NCT01327469|Albendazole|albendazole|mesh-list
14904330|NCT01327469|Mebendazole|mebendazole|mesh-list
14904331|NCT01327469|Piperazine|piperazine|mesh-list
14904332|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
14904333|NCT01327469|Pyrantel|pyrantel|mesh-list
14904334|NCT01327469|Oxantel|oxantel|mesh-list
14904335|NCT01327469|DMP 777|dmp 777|mesh-list
14904336|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
14904337|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14904338|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904339|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
14904340|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14904341|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14904342|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
14904343|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
14904344|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
14904345|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904346|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904347|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
14904348|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904349|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14904350|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14904351|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14719139|NCT00476190|Dexamethasone|dexamethasone|mesh-list
14719140|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
14719141|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14719142|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14719143|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14719144|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
14904352|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904353|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904354|NCT01327521|Gemcitabine|gemcitabine|mesh-list
14904355|NCT01327521|Cisplatin|cisplatin|mesh-list
14904356|NCT01327521|Doxorubicin|doxorubicin|mesh-list
14904357|NCT01327521|Fluorouracil|fluorouracil|mesh-list
14904358|NCT01327521|Epirubicin|epirubicin|mesh-list
14904359|NCT01327521|Mitomycins|mitomycins|mesh-list
15217982|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15217983|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15217984|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15217985|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
15217986|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
15217987|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15217988|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
15217989|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15217990|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719145|NCT00476190|Doxorubicin|doxorubicin|mesh-list
14719146|NCT00476190|Methotrexate|methotrexate|mesh-list
14719147|NCT00476190|Etoposide|etoposide|mesh-list
14719148|NCT00476190|Vincristine|vincristine|mesh-list
14719149|NCT00476190|Asparaginase|asparaginase|mesh-list
14719150|NCT00476190|Pegaspargase|pegaspargase|mesh-list
14719151|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719152|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
14719153|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719154|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719155|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14719156|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
14719157|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719158|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904360|NCT01327521|Mitomycin|mitomycin|mesh-list
14904361|NCT01327521|Maleic acid|maleic acid|mesh-list
14904362|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904363|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14904364|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
14904365|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904366|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
14904367|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904368|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904369|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904370|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
14904371|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904372|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14904373|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14904374|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904375|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
14904376|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14904377|NCT01327534|Clopidogrel|clopidogrel|mesh-list
14904378|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14904379|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14904380|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14904381|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14904382|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14904383|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
14904384|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904385|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904386|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904387|NCT01327625|Azithromycin|azithromycin|mesh-list
14904388|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14904389|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904390|NCT01327729|Interferons|interferons|mesh-list
14904391|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
14904392|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
14904393|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14904394|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904395|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
14904396|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904397|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
14904398|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904399|NCT01327755|Selenium|selenium|mesh-list
14904400|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
14904401|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904402|NCT01327755|Protective Agents|protective agents|mesh-ancestor
14904403|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904404|NCT01327755|Trace Elements|trace elements|mesh-ancestor
14904405|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
14904406|NCT01327859|Donepezil|donepezil|mesh-list
14904407|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14904408|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904409|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904410|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
14904411|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904412|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719159|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14719160|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719161|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
14719162|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
14719163|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719164|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14719165|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
14719166|NCT00476190|Hormones|hormones|mesh-ancestor
14719167|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719168|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14719169|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14719170|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14719171|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904413|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
14904414|NCT01328015|Oxybutynin|oxybutynin|mesh-list
14904415|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14904416|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
14904417|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
14904418|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904419|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904420|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14904421|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14904422|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904423|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904424|NCT01328015|Urological Agents|urological agents|mesh-ancestor
14904425|NCT01328106|Trametinib|trametinib|mesh-list
14904426|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904427|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14904428|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904429|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904430|NCT01328145|Aspirin|aspirin|mesh-list
14904431|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14904432|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14904433|NCT01328145|Analgesics|analgesics|mesh-ancestor
14904434|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
14904435|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904436|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904437|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904438|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14904439|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14904440|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14904441|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904442|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14904443|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14904444|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904445|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
14904446|NCT01328171|Folic Acid|folic acid|mesh-list
14904447|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
14904448|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
14904449|NCT01328171|Irinotecan|irinotecan|mesh-list
14904450|NCT01328171|Panitumumab|panitumumab|mesh-list
14904451|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904452|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14904453|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904454|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904455|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904456|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904457|NCT01328171|Hematinics|hematinics|mesh-ancestor
14904458|NCT01328171|Vitamins|vitamins|mesh-ancestor
14904459|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
14719172|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904460|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904461|NCT01328223|Sorafenib|sorafenib|mesh-list
14904462|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904463|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14904464|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904465|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904466|NCT01328236|Dexamethasone|dexamethasone|mesh-list
14904467|NCT01328236|Doxorubicin|doxorubicin|mesh-list
14904468|NCT01328236|Bortezomib|bortezomib|mesh-list
14904469|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904470|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
14904471|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
14904472|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719173|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14719174|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
14719175|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14719176|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719177|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
14719178|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
14719179|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14719180|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14904473|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904474|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14904475|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
14904476|NCT01328236|Hormones|hormones|mesh-ancestor
14904477|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904478|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14904479|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904480|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14904481|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14904482|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904483|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904484|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904485|NCT01328301|Methamphetamine|methamphetamine|mesh-list
14904486|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14904487|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904488|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
14904489|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
14904490|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904491|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
14904492|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904493|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904494|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
14904495|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14904496|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14904497|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14904498|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14904499|NCT01328340|Methamphetamine|methamphetamine|mesh-list
14904500|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14719181|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14719182|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
14719183|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719184|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
14719185|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
14719186|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
14719187|NCT00476216|Fondaparinux|fondaparinux|mesh-list
14719188|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14904501|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719189|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
14904502|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
14904503|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
14904504|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719190|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14719191|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
14719192|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719193|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719194|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
14719195|NCT00476268|Beclomethasone|beclomethasone|mesh-list
14719196|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
14719197|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14904505|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
14904506|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904507|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904508|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
14904509|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14904510|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14904511|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14904512|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14904513|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
14904514|NCT01328392|Lansoprazole|lansoprazole|mesh-list
14904515|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14904516|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14904517|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14904518|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904519|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904520|NCT01328457|Paromomycin|paromomycin|mesh-list
14904521|NCT01328457|Neomycin|neomycin|mesh-list
14719198|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
14904522|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14904523|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904524|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14904525|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14904526|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14904527|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904528|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904529|NCT01328470|Cilostazol|cilostazol|mesh-list
14904530|NCT01328470|Clopidogrel|clopidogrel|mesh-list
14904531|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14904532|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14904533|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14904534|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14904535|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
14904536|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904537|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904538|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904539|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14904540|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
14904541|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904542|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14904543|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
14904544|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14904545|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14904546|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
14904547|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14904548|NCT01328470|Protective Agents|protective agents|mesh-ancestor
14904549|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14916676|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
15217991|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15217992|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
15217993|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15217994|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15217995|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15217996|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
15217997|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15217998|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15217999|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218000|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
15218001|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15218002|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
15218003|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
15218004|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218005|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
15218006|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904550|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14904551|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904552|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
14904553|NCT01328652|Lansoprazole|lansoprazole|mesh-list
14904554|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14904555|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904556|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904557|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14904558|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14904559|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
14904560|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14904561|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904562|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904563|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14904564|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14904565|NCT01328821|Protective Agents|protective agents|mesh-ancestor
14904566|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904567|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
14904568|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14904569|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
14904570|NCT01328834|Tacrolimus|tacrolimus|mesh-list
14904571|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904572|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
14904573|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904574|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14904575|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904576|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904577|NCT01328886|Omalizumab|omalizumab|mesh-list
14904578|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14904579|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14904580|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
14904581|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
14904582|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14719199|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904583|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904584|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
14904585|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
14904586|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14904587|NCT01328990|Amodiaquine|amodiaquine|mesh-list
14904588|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
14904589|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14904590|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14904591|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904592|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14904593|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904594|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904595|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14719200|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719201|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14719202|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
14719203|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14719204|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14719205|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14719206|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
14904596|NCT01328990|Renal Agents|renal agents|mesh-ancestor
14904597|NCT01329016|Metformin|metformin|mesh-list
14904598|NCT01329016|Glyburide|glyburide|mesh-list
14904599|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14916677|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
14719207|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719208|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719209|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719210|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
14719211|NCT00476268|Hormones|hormones|mesh-ancestor
14719212|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719213|NCT00476346|Vitamin D|vitamin d|mesh-list
14719214|NCT00476346|Calcium|calcium|mesh-list
14904600|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904601|NCT01329042|Citric Acid|citric acid|mesh-list
14904602|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
14904603|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
14904604|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14719215|NCT00476346|Vitamins|vitamins|mesh-ancestor
14719216|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
14719217|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719218|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14719219|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14719220|NCT00476359|Lopinavir|lopinavir|mesh-list
14719221|NCT00476359|Saquinavir|saquinavir|mesh-list
14719222|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14719223|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14719224|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
14719225|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719226|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719227|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14719228|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14719229|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
14719230|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719231|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14719232|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14904605|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
14904606|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
14904607|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904608|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
14904609|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14904610|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904611|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14904612|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904613|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904614|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904615|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904616|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14904617|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14904618|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
14904619|NCT01329289|Dexamethasone|dexamethasone|mesh-list
14904620|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
14904621|NCT01329289|Bortezomib|bortezomib|mesh-list
14904622|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14904623|NCT01329289|Pasireotide|pasireotide|mesh-list
14904624|NCT01329289|BB 1101|bb 1101|mesh-list
14904625|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904626|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
14904627|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
14904628|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904629|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904630|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14904631|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
14904632|NCT01329289|Hormones|hormones|mesh-ancestor
14904633|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904634|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14904635|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904636|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
14904637|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904638|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904639|NCT01329367|Antioxidants|antioxidants|mesh-list
14904640|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904641|NCT01329367|Protective Agents|protective agents|mesh-ancestor
14904642|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904643|NCT01329406|Milnacipran|milnacipran|mesh-list
14904644|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
14904645|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14904646|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14904647|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14904648|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904649|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904650|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904651|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14904652|NCT01329406|Analgesics|analgesics|mesh-ancestor
14904653|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
14904654|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904655|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
14904656|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14916678|NCT01394263|Goserelin|goserelin|mesh-list
14916679|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14916680|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916681|NCT01394341|Liraglutide|liraglutide|mesh-list
14916682|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14916683|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916684|NCT01394341|Incretins|incretins|mesh-ancestor
14916685|NCT01394341|Hormones|hormones|mesh-ancestor
14916686|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916687|NCT01394354|Dexamethasone|dexamethasone|mesh-list
14916688|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
14916689|NCT01394354|Doxorubicin|doxorubicin|mesh-list
14916690|NCT01394354|Bortezomib|bortezomib|mesh-list
14916691|NCT01394354|Vorinostat|vorinostat|mesh-list
14916692|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916693|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
14916694|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
14916695|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916696|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916697|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916698|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
14916699|NCT01394354|Hormones|hormones|mesh-ancestor
14916700|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916701|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14916702|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916703|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14916704|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14916705|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14916706|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916707|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916708|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14916709|NCT01394406|Ketamine|ketamine|mesh-list
14916710|NCT01394406|Analgesics|analgesics|mesh-ancestor
14916711|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
14916712|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916713|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916714|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14916715|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14916716|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
14916717|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
14916718|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916719|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14916720|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14916721|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904657|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15218007|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218008|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218009|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
14904658|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904659|NCT01329614|Nicotine|nicotine|mesh-list
14904660|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14904661|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
14904662|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904663|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904664|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14904665|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14904666|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
14904667|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904668|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904669|NCT01329627|Paclitaxel|paclitaxel|mesh-list
14904670|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14904671|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
14904672|NCT01329627|Doxorubicin|doxorubicin|mesh-list
14904673|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14904674|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14904675|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218010|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15218011|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15218012|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14904676|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
14904677|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
14904678|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
14904679|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904680|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904681|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
14904682|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904683|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14904684|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14904685|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
14904686|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14904687|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14904688|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14904689|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904690|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904691|NCT01329640|Paclitaxel|paclitaxel|mesh-list
15218013|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218014|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225419|NCT05007873|Dasatinib|dasatinib|mesh-list
14719233|NCT00476424|Efavirenz|efavirenz|mesh-list
14719234|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14719235|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14719236|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719237|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719238|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
14719239|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719240|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14719241|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14719242|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14719243|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14904692|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
14904693|NCT01329640|Trastuzumab|trastuzumab|mesh-list
14904694|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14904695|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904696|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
14904697|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
14904698|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
14904699|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904700|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904701|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
14904702|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904703|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14904704|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14904705|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
14904706|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14904707|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904708|NCT01329666|Vitamin D|vitamin d|mesh-list
14904709|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
14904710|NCT01329666|Vitamins|vitamins|mesh-ancestor
14904711|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
14904712|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904713|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14904714|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14904715|NCT01329731|Olaflur|olaflur|mesh-list
14904716|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
14904717|NCT01329731|Protective Agents|protective agents|mesh-ancestor
14904718|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904719|NCT01329744|Mecasermin|mecasermin|mesh-list
14904720|NCT01329744|Growth Substances|growth substances|mesh-ancestor
14904721|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904722|NCT01329770|Vitamins|vitamins|mesh-list
14904723|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
14904724|NCT01329770|Vitamin E|vitamin e|mesh-list
14904725|NCT01329770|Tocopherols|tocopherols|mesh-list
14904726|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
14904727|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
14904728|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904729|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
14904730|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904731|NCT01329770|Protective Agents|protective agents|mesh-ancestor
14904732|NCT01329783|Maraviroc|maraviroc|mesh-list
14904733|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14904734|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14904735|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904736|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14904737|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14904738|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
14904739|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904740|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14904741|NCT01329796|Lidocaine|lidocaine|mesh-list
14904742|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
14904743|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
14904744|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904745|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904746|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
14904747|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904748|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14904749|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14904750|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14904751|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14904752|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904753|NCT01329809|Molgramostim|molgramostim|mesh-list
14904754|NCT01329809|Sargramostim|sargramostim|mesh-list
14904755|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
14904756|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904757|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904758|NCT01329887|Ketanserin|ketanserin|mesh-list
14904759|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14904760|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14904761|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14904762|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
14904763|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904764|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904765|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904766|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
14904767|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
14904768|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
14904769|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14904770|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904771|NCT01330472|Alprazolam|alprazolam|mesh-list
14719244|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14719245|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14719246|NCT00476437|Insulin|insulin|mesh-list
14719247|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14719248|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
14719249|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
14719250|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14719251|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719252|NCT00476463|Emtricitabine|emtricitabine|mesh-list
14719253|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
14719254|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719255|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14719256|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14904772|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14904773|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904774|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904775|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14904776|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14904777|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14904778|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
14904779|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
14904780|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904781|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904782|NCT01330524|Triamcinolone|triamcinolone|mesh-list
14904783|NCT01330524|Bevacizumab|bevacizumab|mesh-list
15225717|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
14719257|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719258|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719259|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15225718|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225719|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225720|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15225721|NCT03826992|Cytarabine|cytarabine|mesh-list
15225722|NCT03826992|Daunorubicin|daunorubicin|mesh-list
15225723|NCT03826992|Venetoclax|venetoclax|mesh-list
15225724|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15225725|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
15225726|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904784|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904785|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904786|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14904787|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14904788|NCT01330524|Growth Substances|growth substances|mesh-ancestor
14904789|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904790|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
14904791|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904792|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
14904793|NCT01330524|Hormones|hormones|mesh-ancestor
14904794|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904795|NCT01330563|Ketoconazole|ketoconazole|mesh-list
14904796|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
14904797|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904798|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14904799|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14904800|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719260|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14719261|NCT00476515|Rituximab|rituximab|mesh-list
14719262|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14719263|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719264|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
14719265|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719266|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719267|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
14904801|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904802|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14904803|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
14904804|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904805|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904806|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14904807|NCT01330615|Lidocaine|lidocaine|mesh-list
14904808|NCT01330615|Prilocaine|prilocaine|mesh-list
14904809|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14904810|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
14904811|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
14904812|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14904813|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904814|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
14904815|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904816|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14904817|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14904818|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14904819|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14904820|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904821|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14904822|NCT01330654|Metoprolol|metoprolol|mesh-list
14904823|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14904824|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14904825|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
14904826|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
14904827|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904828|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904829|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14904830|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14904831|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14904832|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14904833|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904834|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904835|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14904836|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14904837|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14904838|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14904839|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904840|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
14904841|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904842|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904843|NCT01330706|Polihexanide|polihexanide|mesh-list
14904844|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
14904845|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904846|NCT01330810|Curcumin|curcumin|mesh-list
14904847|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14904848|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14904849|NCT01330810|Analgesics|analgesics|mesh-ancestor
14904850|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
14904851|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904852|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218015|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719268|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14719269|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729036|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729037|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14729038|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
14729039|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
14729040|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14729041|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14729042|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14729043|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14729044|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14729045|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218016|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218017|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
15218018|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15218019|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
15218020|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
15218021|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218022|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
15218023|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218024|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218025|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218026|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218027|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14904853|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904854|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14904855|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904856|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904857|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904858|NCT01330901|Ustekinumab|ustekinumab|mesh-list
14904859|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14904860|NCT01331122|Droxidopa|droxidopa|mesh-list
14719270|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
14719271|NCT00476619|Hematinics|hematinics|mesh-ancestor
14719272|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14904861|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14904862|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14904863|NCT01331135|Sirolimus|sirolimus|mesh-list
14904864|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14904865|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14904866|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14904867|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904868|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
14904869|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904870|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
14904871|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904872|NCT01331148|Vitamin D|vitamin d|mesh-list
14904873|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
14297544|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14719273|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14719274|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14719275|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
14719276|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719277|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14904874|NCT01331148|Vitamins|vitamins|mesh-ancestor
14904875|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
14904876|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719278|NCT00476853|Nevirapine|nevirapine|mesh-list
14904877|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14904878|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14916722|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916723|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
14916724|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14916725|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
14916726|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916727|NCT01394419|Expectorants|expectorants|mesh-ancestor
14916728|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
14916729|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14916730|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
14916731|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916732|NCT01394419|Protective Agents|protective agents|mesh-ancestor
14916733|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916734|NCT01394419|Antidotes|antidotes|mesh-ancestor
14916735|NCT01394445|Physostigmine|physostigmine|mesh-list
14916736|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14916737|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916738|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916739|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
14916740|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916741|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719279|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14719280|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14719281|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916742|NCT01394445|Miotics|miotics|mesh-ancestor
14916743|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
14916744|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916745|NCT01394458|Ethanol|ethanol|mesh-list
14916746|NCT01394458|Heparin|heparin|mesh-list
14916747|NCT01394458|Citric Acid|citric acid|mesh-list
14916748|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
14916749|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
14916750|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14916751|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
14916752|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
14916753|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719282|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916754|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14916755|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14916756|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14916757|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916758|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916759|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916760|NCT01394471|Oxytocin|oxytocin|mesh-list
14719283|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
14719284|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719285|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14719286|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14719287|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14916761|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
14916762|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14904879|NCT01331382|Resveratrol|resveratrol|mesh-list
14904880|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
14904881|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904882|NCT01331382|Protective Agents|protective agents|mesh-ancestor
14904883|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904884|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904885|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14904886|NCT01331421|Exemestane|exemestane|mesh-list
14904887|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904888|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14904889|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14904890|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904891|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904892|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14904893|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
14904894|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904895|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904896|NCT01331434|Exemestane|exemestane|mesh-list
14904897|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904898|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14904899|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14904900|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904901|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904902|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14904903|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
14904904|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904905|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904906|NCT01331447|Exemestane|exemestane|mesh-list
14904907|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904908|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14904909|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14904910|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904911|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904912|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14904913|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
14904914|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904915|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904916|NCT01331525|Ipilimumab|ipilimumab|mesh-list
14904917|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14904918|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904919|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14904920|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904921|NCT01331590|Dexamethasone|dexamethasone|mesh-list
14904922|NCT01331590|Etoposide|etoposide|mesh-list
14904923|NCT01331590|Ifosfamide|ifosfamide|mesh-list
14904924|NCT01331590|Lenograstim|lenograstim|mesh-list
14904925|NCT01331590|Sargramostim|sargramostim|mesh-list
14904926|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14904927|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
14904928|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
14904929|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904930|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904931|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14904932|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
14904933|NCT01331590|Hormones|hormones|mesh-ancestor
14904934|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904935|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14904936|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904937|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14904938|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14904939|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14904940|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14904941|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904942|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14904943|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
14904944|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14904945|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
14904946|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
14904947|NCT01331655|Drospirenone|drospirenone|mesh-list
14904948|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14904949|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
14904950|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14904951|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904952|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14904953|NCT01331655|Diuretics|diuretics|mesh-ancestor
14904954|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
14904955|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
14904956|NCT01331655|Vitamins|vitamins|mesh-ancestor
14904957|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
14904958|NCT01331707|Everolimus|everolimus|mesh-list
14904959|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904960|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14904961|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
14904962|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904963|NCT01331785|Midodrine|midodrine|mesh-list
14904964|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
14904965|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
14904966|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904967|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904968|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14904969|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14904970|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14904971|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14904972|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
14904973|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904974|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218028|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15218029|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15218030|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218031|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218032|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218033|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218034|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
15218035|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15218036|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
15218037|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
15218038|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218039|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
14904975|NCT01331902|Nicorandil|nicorandil|mesh-list
14904976|NCT01331902|Adenosine|adenosine|mesh-list
14904977|NCT01331902|Analgesics|analgesics|mesh-ancestor
14904978|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
14904979|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904980|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904981|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14904982|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
14904983|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14904984|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
14904985|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
14904986|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14904987|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14904988|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14904989|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
14904990|NCT01331902|Vitamins|vitamins|mesh-ancestor
15218040|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14904991|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
14904992|NCT01331928|Docetaxel|docetaxel|mesh-list
14904993|NCT01331928|Capecitabine|capecitabine|mesh-list
15218041|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14904994|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
14904995|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14904996|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
14904997|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
14904998|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
14904999|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905000|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905001|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
14905002|NCT01331941|Paclitaxel|paclitaxel|mesh-list
14905003|NCT01331941|Trebananib|trebananib|mesh-list
14719288|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14719289|NCT00476918|Triamcinolone|triamcinolone|mesh-list
14719290|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14719291|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14719292|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14719293|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719294|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
14719295|NCT00476918|Hormones|hormones|mesh-ancestor
14719296|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719297|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719298|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719299|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
14905004|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14905005|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905006|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
14905007|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905008|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
14905009|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905010|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14905011|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14905012|NCT01331941|Growth Substances|growth substances|mesh-ancestor
14905013|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905014|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
14905015|NCT01331967|Pioglitazone|pioglitazone|mesh-list
14905016|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905017|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905018|NCT01331993|Naproxen|naproxen|mesh-list
14905019|NCT01331993|Esomeprazole|esomeprazole|mesh-list
14905020|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14905021|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14905022|NCT01331993|Analgesics|analgesics|mesh-ancestor
14905023|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
14905024|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905025|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905026|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905027|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14905028|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
14905029|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14905030|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905031|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905032|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14905033|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14905034|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14905035|NCT01332097|Prednisone|prednisone|mesh-list
14905036|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905037|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
14905038|NCT01332097|Hormones|hormones|mesh-ancestor
14905039|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905040|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905041|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14905042|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905043|NCT01332201|Tacrolimus|tacrolimus|mesh-list
14905044|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905045|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
14905046|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905047|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14905048|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905049|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905050|NCT01332279|Everolimus|everolimus|mesh-list
14905051|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14905052|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905053|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905054|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
14905055|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905056|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905057|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905058|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905059|NCT01332344|Fluticasone|fluticasone|mesh-list
14905060|NCT01332344|Xhance|xhance|mesh-list
14905061|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14905062|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905063|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14905064|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
14905065|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905066|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905067|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14905068|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
14905069|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
14905070|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14905071|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14905072|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14905073|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14905074|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
14905075|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905076|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905077|NCT01332370|Metformin|metformin|mesh-list
14905078|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14905079|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
14905080|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905081|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905082|NCT01332370|Incretins|incretins|mesh-ancestor
14905083|NCT01332370|Hormones|hormones|mesh-ancestor
14905084|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905085|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15218042|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218043|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218044|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15218045|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15218046|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14905086|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
14905087|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905088|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905089|NCT01332383|Naratriptan|naratriptan|mesh-list
14905090|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15218047|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218048|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905091|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14905092|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14905093|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
14905094|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905095|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905096|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905097|NCT01332396|Lapatinib|lapatinib|mesh-list
14905098|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905099|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905100|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905101|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905102|NCT01332409|Fluticasone|fluticasone|mesh-list
14905103|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14905104|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14905105|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905106|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14905107|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
15218049|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218050|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218051|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
15218052|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14905108|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905109|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905110|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14905111|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
14905112|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14905113|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14905114|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14905115|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14905116|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14905117|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
14905118|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905119|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905120|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
14905121|NCT01332409|Hormones|hormones|mesh-ancestor
14905122|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905123|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
14905124|NCT01332422|Fluticasone|fluticasone|mesh-list
15218053|NCT00379288|Fluticasone|fluticasone|mesh-list
15218054|NCT00379288|Xhance|xhance|mesh-list
14719300|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719301|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719302|NCT00476983|Ritonavir|ritonavir|mesh-list
14719303|NCT00476983|Saquinavir|saquinavir|mesh-list
14719304|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14719305|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14719306|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14719307|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
14719308|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719309|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719310|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14719311|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14719312|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
14719313|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719314|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14719315|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14719316|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14719317|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14719318|NCT00477035|Gemcitabine|gemcitabine|mesh-list
14719319|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
14719320|NCT00477035|Melphalan|melphalan|mesh-list
14719321|NCT00477035|Carmustine|carmustine|mesh-list
14719322|NCT00477035|Etoposide|etoposide|mesh-list
14719323|NCT00477035|Vinorelbine|vinorelbine|mesh-list
14719324|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719325|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
14719326|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719327|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719328|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14719329|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
14719330|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719331|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719332|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14719333|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719334|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
14719335|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
14719336|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719337|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719338|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14719339|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14719340|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14719341|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
14719342|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
14719343|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
14719344|NCT00477048|Saquinavir|saquinavir|mesh-list
15218055|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
15218056|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15218057|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15218058|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218059|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218060|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
14719345|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14719346|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14719347|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
14905125|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14905126|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14905127|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905128|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14905129|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
14905130|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905131|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905132|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14905133|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14905134|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
14905135|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14905136|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14905137|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14719348|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719349|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719350|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14719351|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14905138|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14905139|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
14905140|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905141|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905142|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
14905143|NCT01332422|Hormones|hormones|mesh-ancestor
14905144|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905145|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
14905146|NCT01332448|Orlistat|orlistat|mesh-list
14905147|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905148|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905149|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14905150|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14905151|NCT01332552|Ritonavir|ritonavir|mesh-list
14719352|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
14719353|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719354|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14719355|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14719356|NCT00477061|Morphine|morphine|mesh-list
14719357|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14905152|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14905153|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14905154|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
14905155|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905156|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905157|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14905158|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14905159|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
14905160|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905161|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14905162|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14905163|NCT01332565|Dolutegravir|dolutegravir|mesh-list
14905164|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14905165|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14905166|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905167|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905168|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14905169|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14905170|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
14905171|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905172|NCT01332604|Bevacizumab|bevacizumab|mesh-list
14905173|NCT01332604|Capecitabine|capecitabine|mesh-list
14905174|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14905175|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905176|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14905177|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14905178|NCT01332604|Growth Substances|growth substances|mesh-ancestor
14905179|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905180|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
14905181|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905182|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
14905183|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905184|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
14905185|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
14905186|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14905187|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14905188|NCT01332617|Prednisolone|prednisolone|mesh-list
14905189|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
14905190|NCT01332617|Diclofenac|diclofenac|mesh-list
14905191|NCT01332617|Bortezomib|bortezomib|mesh-list
14905192|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14905193|NCT01332617|Simvastatin|simvastatin|mesh-list
14905194|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14905195|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
14905196|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905197|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905198|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
14905199|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
14905200|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905201|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905202|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14905203|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
14905204|NCT01332617|Hormones|hormones|mesh-ancestor
14905205|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905206|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14905207|NCT01332617|Protective Agents|protective agents|mesh-ancestor
14905208|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14905209|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14905210|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14905211|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
14905212|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905213|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14905214|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14905215|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905216|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14905217|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14905218|NCT01332617|Analgesics|analgesics|mesh-ancestor
14905219|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
14905220|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14905221|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14905222|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14905223|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
14905224|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14905225|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
14905226|NCT01332734|Analgesics|analgesics|mesh-ancestor
14905227|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
14905228|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905229|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905230|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
14905231|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14905232|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14905233|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
14905234|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14905235|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14905236|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905237|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14905238|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
14905239|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14905240|NCT01332747|Atorvastatin|atorvastatin|mesh-list
14905241|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14905242|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14905243|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
14905244|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905245|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14905246|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14905247|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905248|NCT01332786|Tigecycline|tigecycline|mesh-list
14905249|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14905250|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905251|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14905252|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905253|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905254|NCT01332929|Bevacizumab|bevacizumab|mesh-list
14905255|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14905256|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905257|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14297545|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14297546|NCT03793439|Prednisone|prednisone|mesh-list
14297547|NCT03793439|Tofacitinib|tofacitinib|mesh-list
14297548|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297549|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
14297550|NCT03793439|Hormones|hormones|mesh-ancestor
14297551|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14297552|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297553|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14905258|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14905259|NCT01332929|Growth Substances|growth substances|mesh-ancestor
14905260|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905261|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
14905262|NCT01332955|Ribavirin|ribavirin|mesh-list
14905263|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14905264|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
14905265|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905266|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
14905267|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905268|NCT01333085|Paclitaxel|paclitaxel|mesh-list
14905269|NCT01333085|Carboplatin|carboplatin|mesh-list
14905270|NCT01333085|Everolimus|everolimus|mesh-list
14905271|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14905272|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905273|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
14905274|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905275|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
14905276|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905277|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905278|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
14905279|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905280|NCT01333124|Gemcitabine|gemcitabine|mesh-list
14905281|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905282|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
14905283|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905284|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905285|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
14905286|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905287|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905288|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905289|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
14905290|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905291|NCT01333137|Gemcitabine|gemcitabine|mesh-list
14905292|NCT01333137|Carboplatin|carboplatin|mesh-list
14905293|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905294|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905295|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
14905296|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905297|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
14905298|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905299|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905300|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905301|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
14905302|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905303|NCT01333150|Propranolol|propranolol|mesh-list
14905304|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14905305|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15218061|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218062|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218063|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218064|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218065|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
15218066|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15218067|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15218068|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15218069|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15218070|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218071|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218072|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218073|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
15218074|NCT00379288|Hormones|hormones|mesh-ancestor
15218075|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218076|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
14905306|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
14905307|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905308|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905309|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905310|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14905311|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14905312|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916763|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916764|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
14916765|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
14916766|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916767|NCT01394497|Expectorants|expectorants|mesh-ancestor
14916768|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
14916769|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14916770|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
14916771|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916772|NCT01394497|Protective Agents|protective agents|mesh-ancestor
14916773|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916774|NCT01394640|Vaccines|vaccines|mesh-list
14916775|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
14916776|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916777|NCT01394653|Ramosetron|ramosetron|mesh-list
14916778|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
14916779|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
14916780|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916781|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916782|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15218077|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
15218078|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218079|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
14905313|NCT01333267|Hormones|hormones|mesh-list
14905314|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
14905315|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
14905316|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14905317|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
14905318|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905319|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905320|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14905321|NCT01333332|Capecitabine|capecitabine|mesh-list
14905322|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905323|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
14905324|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905325|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905326|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
14905327|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14905328|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905329|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
14905330|NCT01333410|Tacrolimus|tacrolimus|mesh-list
14905331|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905332|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
14905333|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905334|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14905335|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905336|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905337|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905338|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
14905339|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14905340|NCT01333423|Roscovitine|roscovitine|mesh-list
14905341|NCT01333423|Doxorubicin|doxorubicin|mesh-list
14905342|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14905343|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14905344|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905345|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14905346|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14905347|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905348|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905349|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
14905350|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905351|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905352|NCT01333449|Decitabine|decitabine|mesh-list
14905353|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905354|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
14905355|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905356|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905357|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905358|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
14905359|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
14905360|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14905361|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905362|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905363|NCT01333631|Valproic Acid|valproic acid|mesh-list
14905364|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
14905365|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905366|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905367|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
14905368|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905369|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218080|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15218081|NCT00338260|Atenolol|atenolol|mesh-list
15218082|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218083|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218084|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218085|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218086|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
15218087|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218088|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15218089|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218090|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
14905370|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
14905371|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14905372|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14905373|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14905374|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14905375|NCT01333696|Pemetrexed|pemetrexed|mesh-list
14905376|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905377|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905378|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905379|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14905380|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14905381|NCT01333709|Folfirinox|folfirinox|mesh-list
14905382|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905383|NCT01333774|Acarbose|acarbose|mesh-list
14905384|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14905385|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905386|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905387|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905388|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905389|NCT01333800|Ciclesonide|ciclesonide|mesh-list
14905390|NCT01333800|Beclomethasone|beclomethasone|mesh-list
14905391|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905392|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
14905393|NCT01333800|Hormones|hormones|mesh-ancestor
14905394|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905395|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905396|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14905397|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
14905398|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14905399|NCT01333852|Metformin|metformin|mesh-list
14905400|NCT01333852|Paclitaxel|paclitaxel|mesh-list
14905401|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14905402|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905403|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14905404|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905405|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14905406|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905407|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905408|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905409|NCT01333878|Abatacept|abatacept|mesh-list
14905410|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14905411|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905412|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905413|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905414|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
14905415|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905416|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14905417|NCT01333891|Nitroprusside|nitroprusside|mesh-list
14905418|NCT01333891|Phenylephrine|phenylephrine|mesh-list
14905419|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
14905420|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14905421|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
14905422|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
14905423|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905424|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905425|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
14905426|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14905427|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
14905428|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
14905429|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14905430|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14905431|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14905432|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14905433|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905434|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905435|NCT01333891|Protective Agents|protective agents|mesh-ancestor
14905436|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14905437|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
14905438|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14905439|NCT01333917|Curcumin|curcumin|mesh-list
15218091|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15218092|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15218093|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15218094|NCT00308347|Losartan|losartan|mesh-list
14905440|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14905441|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14905442|NCT01333917|Analgesics|analgesics|mesh-ancestor
14905443|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
14297554|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297555|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905444|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905445|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905446|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905447|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14905448|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905449|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905450|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905451|NCT01333982|Amoxicillin|amoxicillin|mesh-list
14905452|NCT01333982|Gentamicins|gentamicins|mesh-list
14905453|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14905454|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905455|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14905456|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905457|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905458|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
14905459|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905460|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218095|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15218096|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218097|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15218098|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15218099|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218100|NCT00307060|Losartan|losartan|mesh-list
15218101|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15218102|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14297556|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297557|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327586|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
14719358|NCT00477061|Narcotics|narcotics|mesh-ancestor
14719359|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719360|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719361|NCT00477061|Analgesics|analgesics|mesh-ancestor
14719362|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
14719363|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719364|NCT00477126|Ritonavir|ritonavir|mesh-list
14719365|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14719366|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14719367|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
14719368|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719369|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719370|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14719371|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14719372|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
14719373|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719374|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14719375|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14719376|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
14719377|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14719378|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719379|NCT00477282|Topotecan|topotecan|mesh-list
14719380|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14719381|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14719382|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719383|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719384|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719385|NCT00477347|Anesthetics|anesthetics|mesh-list
14905461|NCT01334047|Vaccines|vaccines|mesh-list
15218103|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218104|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15218105|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15218106|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218107|NCT00307060|Diuretics|diuretics|mesh-ancestor
15218108|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
15218109|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218110|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14905462|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
14905463|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905464|NCT01334060|Vaccines|vaccines|mesh-list
14905465|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
14905466|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905467|NCT01334073|Everolimus|everolimus|mesh-list
14905468|NCT01334073|Axitinib|axitinib|mesh-list
14905469|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905470|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905471|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
14905472|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905473|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905474|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905475|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905476|NCT01334099|Tremelimumab|tremelimumab|mesh-list
14905477|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905478|NCT01334112|Axitinib|axitinib|mesh-list
14905479|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905480|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905481|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905482|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905483|NCT01334151|Insulin|insulin|mesh-list
14905484|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14905485|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
14905486|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905487|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905488|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14905489|NCT01334177|Cetuximab|cetuximab|mesh-list
14905490|NCT01334177|Antibodies|antibodies|mesh-list
14905491|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
14905492|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14905493|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
14905494|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905495|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905496|NCT01334203|Ranolazine|ranolazine|mesh-list
14905497|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14905498|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14905499|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905500|NCT01334268|Paclitaxel|paclitaxel|mesh-list
14297558|NCT03755518|Luspatercept|luspatercept|mesh-list
14905501|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14905502|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905503|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
14905504|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905505|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
14905506|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905507|NCT01334333|Tacrolimus|tacrolimus|mesh-list
14905508|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905509|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
14905510|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905511|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14905512|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905513|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905514|NCT01334424|Propofol|propofol|mesh-list
14905515|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14905516|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14905517|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905518|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14905519|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
14905520|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
14905521|NCT01334502|Prednisone|prednisone|mesh-list
14905522|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
14905523|NCT01334502|Rituximab|rituximab|mesh-list
14905524|NCT01334502|Doxorubicin|doxorubicin|mesh-list
14905525|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14905526|NCT01334502|Vincristine|vincristine|mesh-list
14905527|NCT01334502|Everolimus|everolimus|mesh-list
14905528|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905529|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
14905530|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905531|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14905532|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14905533|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
14905534|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905535|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905536|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14905537|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14905538|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14905539|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14905540|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14905541|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905542|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905543|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
14905544|NCT01334502|Hormones|hormones|mesh-ancestor
14905545|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905546|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14905547|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14905548|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
14905549|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905550|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
14905551|NCT01334567|Tenofovir|tenofovir|mesh-list
14905552|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
14905553|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905554|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14905555|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14905556|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905557|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905558|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14905559|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14905560|NCT01334580|Methadone|methadone|mesh-list
14905561|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14905562|NCT01334580|Narcotics|narcotics|mesh-ancestor
14905563|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14905564|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905565|NCT01334580|Analgesics|analgesics|mesh-ancestor
14905566|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
14905567|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905568|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
14905569|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
14905570|NCT01334619|Ropivacaine|ropivacaine|mesh-list
14905571|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
14905572|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
14905573|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14905574|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905575|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
14905576|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905577|NCT01334632|Morphine|morphine|mesh-list
15218111|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14905578|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14905579|NCT01334632|Narcotics|narcotics|mesh-ancestor
14905580|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14905581|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905582|NCT01334632|Analgesics|analgesics|mesh-ancestor
14905583|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
14905584|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905585|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
14905586|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
14905587|NCT01334645|Coagulants|coagulants|mesh-ancestor
14905588|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14719386|NCT00477347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719387|NCT00477347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719388|NCT00477373|Valproic Acid|valproic acid|mesh-list
14719389|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
14719390|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719391|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719392|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
14719393|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905589|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14905590|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
14905591|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905592|NCT01334671|Atorvastatin|atorvastatin|mesh-list
14905593|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14905594|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14905595|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
14905596|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905597|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14905598|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14905599|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905600|NCT01334684|Metformin|metformin|mesh-list
14905601|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905602|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905603|NCT01334762|Letrozole|letrozole|mesh-list
14905604|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905605|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14297559|NCT03755518|Hematinics|hematinics|mesh-ancestor
14297560|NCT03729401|Aspirin|aspirin|mesh-list
14297561|NCT03729401|Clopidogrel|clopidogrel|mesh-list
14297562|NCT03729401|Ticagrelor|ticagrelor|mesh-list
14297563|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14297564|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14719394|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905606|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14905607|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905608|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905609|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14905610|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
14905611|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905612|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916783|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14916784|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
14916785|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297565|NCT03729401|Analgesics|analgesics|mesh-ancestor
14719395|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
14719396|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14719397|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719398|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14719399|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
14719400|NCT00477503|Gallium citrate|gallium citrate|mesh-list
15218112|NCT00157963|Losartan|losartan|mesh-list
14719401|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
14719402|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
14719403|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719404|NCT00477503|Antidotes|antidotes|mesh-ancestor
14916786|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218113|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15218114|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15218115|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218116|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15218117|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15218118|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218119|NCT00157963|Diuretics|diuretics|mesh-ancestor
14297566|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
14719405|NCT00477503|Protective Agents|protective agents|mesh-ancestor
15218120|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
14719406|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719407|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14719408|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14719409|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
14719410|NCT00477516|Calcium|calcium|mesh-list
14719411|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14719412|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719413|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14719414|NCT00477542|Clofarabine|clofarabine|mesh-list
14719415|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15218121|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218122|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15218123|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15218124|NCT00151424|Olanzapine|olanzapine|mesh-list
15218125|NCT00151424|Asenapine|asenapine|mesh-list
15218126|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
15218127|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
15218128|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218129|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218130|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15218131|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14719416|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
14719417|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719418|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218132|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14905613|NCT01334879|Ranibizumab|ranibizumab|mesh-list
14905614|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14905615|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14905616|NCT01334879|Growth Substances|growth substances|mesh-ancestor
14905617|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905618|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
14905619|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905620|NCT01334892|Cyclosporine|cyclosporine|mesh-list
14905621|NCT01334892|Cyclosporins|cyclosporins|mesh-list
14905622|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905623|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905624|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905625|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
14905626|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905627|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
14905628|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905629|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
14905630|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14905631|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14905632|NCT01334905|Mirabegron|mirabegron|mesh-list
14905633|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14905634|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14905635|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14905636|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
14905637|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905638|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905639|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905640|NCT01334905|Urological Agents|urological agents|mesh-ancestor
14905641|NCT01335035|Deferasirox|deferasirox|mesh-list
14905642|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14905643|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
14905644|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
14905645|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905646|NCT01335048|Clopidogrel|clopidogrel|mesh-list
14905647|NCT01335048|Atorvastatin|atorvastatin|mesh-list
14905648|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14905649|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14905650|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
14905651|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905652|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14905653|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14905654|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905655|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14905656|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14905657|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14905658|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14905659|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
14905660|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905661|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905662|NCT01335074|Sirolimus|sirolimus|mesh-list
14905663|NCT01335074|Sorafenib|sorafenib|mesh-list
14905664|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905665|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905666|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905667|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905668|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14905669|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905670|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14905671|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
14905672|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905673|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
14905674|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905675|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
14905676|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14905677|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14905678|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
14905679|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218133|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15218134|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15218135|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15218136|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15218137|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15218138|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218139|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218140|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
15218141|NCT00092690|Atorvastatin|atorvastatin|mesh-list
15218142|NCT00092690|Simvastatin|simvastatin|mesh-list
14719419|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14719420|NCT00477581|Exenatide|exenatide|mesh-list
14719421|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14719422|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719423|NCT00477581|Incretins|incretins|mesh-ancestor
14719424|NCT00477581|Hormones|hormones|mesh-ancestor
14719425|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719426|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14719427|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
14719428|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719429|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719430|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14719431|NCT00477711|Capecitabine|capecitabine|mesh-list
14905680|NCT01335321|Triamcinolone|triamcinolone|mesh-list
14719432|NCT00477711|Cetuximab|cetuximab|mesh-list
14905681|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
14905682|NCT01335321|Hylan|hylan|mesh-list
14905683|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905684|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
14905685|NCT01335321|Hormones|hormones|mesh-ancestor
14905686|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905687|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905688|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
14905689|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
14905690|NCT01335321|Protective Agents|protective agents|mesh-ancestor
14905691|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14905692|NCT01335334|Metronidazole|metronidazole|mesh-list
14905693|NCT01335334|Tetracycline|tetracycline|mesh-list
14905694|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14905695|NCT01335334|Omeprazole|omeprazole|mesh-list
14905696|NCT01335334|Bismuth|bismuth|mesh-list
14905697|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905698|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14905699|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14905700|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14905701|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14905702|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14905703|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14905704|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905705|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905706|NCT01335334|Antacids|antacids|mesh-ancestor
14905707|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14905708|NCT01335360|Nevirapine|nevirapine|mesh-list
14905709|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14905710|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14905711|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905712|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905713|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
14905714|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905715|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14905716|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14905717|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14905718|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14905719|NCT01335373|Metronidazole|metronidazole|mesh-list
14905720|NCT01335373|Miconazole|miconazole|mesh-list
14719433|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719434|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719435|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
14719436|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719437|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14719438|NCT00477737|Propofol|propofol|mesh-list
14719439|NCT00477737|Sevoflurane|sevoflurane|mesh-list
14719440|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14719441|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719442|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719443|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14905721|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905722|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14905723|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14905724|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14905725|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
14719444|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
14719445|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
14719446|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14905726|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14905727|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14905728|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905729|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905730|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14905731|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
14905732|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905733|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905734|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14905735|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14905736|NCT01335386|Glycerol|glycerol|mesh-list
14905737|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14905738|NCT01335386|Protective Agents|protective agents|mesh-ancestor
14905739|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905740|NCT01335516|Terlipressin|terlipressin|mesh-list
14905741|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14905742|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14905743|NCT01335529|Interferons|interferons|mesh-list
14905744|NCT01335529|Ribavirin|ribavirin|mesh-list
14905745|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
14905746|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
14905747|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14905748|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905749|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
14905750|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905751|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
14905752|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905753|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
14905754|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905755|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14905756|NCT01335646|Analgesics|analgesics|mesh-list
14905757|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
14905758|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905759|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905760|NCT01335685|Prednisone|prednisone|mesh-list
14905761|NCT01335685|Melphalan|melphalan|mesh-list
14905762|NCT01335685|Ixazomib|ixazomib|mesh-list
14905763|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905764|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
14905765|NCT01335685|Hormones|hormones|mesh-ancestor
14905766|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905767|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905768|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14905769|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905770|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14905771|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
14905772|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905773|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14905774|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905775|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
14905776|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
14905777|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905778|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
14905779|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905780|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905781|NCT01336010|Ribavirin|ribavirin|mesh-list
14905782|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14905783|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
14905784|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905785|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
14905786|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905787|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
14905788|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14905789|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719447|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15218143|NCT00092690|Ezetimibe|ezetimibe|mesh-list
15218144|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218145|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218146|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
15218147|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218148|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218149|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15218150|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218151|NCT00092664|Simvastatin|simvastatin|mesh-list
15218152|NCT00092664|Ezetimibe|ezetimibe|mesh-list
15218153|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218154|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14719448|NCT00477763|Cyclosporine|cyclosporine|mesh-list
14719449|NCT00477763|Cyclosporins|cyclosporins|mesh-list
14719450|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719451|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719452|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719453|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
14719454|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719455|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
14719456|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719457|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
14719458|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719459|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14719460|NCT00477776|Metoclopramide|metoclopramide|mesh-list
14719461|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
14719462|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
14719463|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905790|NCT01336062|Paclitaxel|paclitaxel|mesh-list
14905791|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14905792|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14905793|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905794|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14905795|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905796|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14905797|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905798|NCT01336166|Vaccines|vaccines|mesh-list
14905799|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
14905800|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905801|NCT01336192|Gemcitabine|gemcitabine|mesh-list
14905802|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905803|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
14905804|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905805|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905806|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
14905807|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905808|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905809|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14905810|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
14905811|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905812|NCT01336218|Rifampin|rifampin|mesh-list
14905813|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14905814|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
14905815|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14905816|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905817|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
14905818|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14905819|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905820|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905821|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14905822|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14905823|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14905824|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14905825|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14905826|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14905827|NCT01336322|Metformin|metformin|mesh-list
14905828|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14905829|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905830|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905831|NCT01336322|Incretins|incretins|mesh-ancestor
14905832|NCT01336322|Hormones|hormones|mesh-ancestor
14905833|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905834|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14905835|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
14905836|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905837|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905838|NCT01336348|Tirofiban|tirofiban|mesh-list
14905839|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14905840|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14905841|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14905842|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14905843|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905844|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
14905845|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14905846|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14905847|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14905848|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14905849|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905850|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14905851|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14905852|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905853|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14905854|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905855|NCT01336543|Gemcitabine|gemcitabine|mesh-list
14905856|NCT01336543|Cisplatin|cisplatin|mesh-list
14905857|NCT01336543|Etoposide|etoposide|mesh-list
14905858|NCT01336543|Pemetrexed|pemetrexed|mesh-list
14905859|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905860|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14905861|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
14905862|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905863|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
14905864|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905865|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905866|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297567|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297568|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297569|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297570|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297571|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14297572|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14297573|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297574|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14297575|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14297576|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297577|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
14905867|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
14905868|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905869|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14905870|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14905871|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14905872|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14905873|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14916787|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
14916788|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916789|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
14916790|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
14916791|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905874|NCT01336582|Docetaxel|docetaxel|mesh-list
14905875|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905876|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14905877|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905878|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14905879|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905880|NCT01336595|Cobalt|cobalt|mesh-list
14905881|NCT01336595|Triamcinolone|triamcinolone|mesh-list
14905882|NCT01336595|Trace Elements|trace elements|mesh-ancestor
14905883|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
14905884|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905885|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905886|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
14905887|NCT01336595|Hormones|hormones|mesh-ancestor
14905888|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905889|NCT01336621|Ezogabine|ezogabine|mesh-list
14905890|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
14905891|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14905892|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905893|NCT01336660|Antivenins|antivenins|mesh-list
14905894|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
14905895|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905896|NCT01336751|Insulin|insulin|mesh-list
14905897|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14905898|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
14905899|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
14905900|NCT01336751|Protamines|protamines|mesh-list
14905901|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905902|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905903|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
14905904|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905905|NCT01336751|Coagulants|coagulants|mesh-ancestor
14905906|NCT01336829|Rilpivirine|rilpivirine|mesh-list
14905907|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14905908|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14905909|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905910|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905911|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
14905912|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905913|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14905914|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14905915|NCT01336842|Pemetrexed|pemetrexed|mesh-list
14905916|NCT01336842|Panobinostat|panobinostat|mesh-list
14905917|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905918|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905919|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905920|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14905921|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14719464|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719465|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14719466|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14719467|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14719468|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
14719469|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719470|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719471|NCT00477789|Allopurinol|allopurinol|mesh-list
14719472|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
14719473|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719474|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719475|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
14719476|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14905922|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14905923|NCT01336985|Irinotecan|irinotecan|mesh-list
14905924|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14905925|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14905926|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297578|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14297579|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14297580|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14297581|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
14297582|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297583|NCT03725436|Paclitaxel|paclitaxel|mesh-list
14297584|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14297585|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14297586|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905927|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905928|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905929|NCT01337219|Tobramycin|tobramycin|mesh-list
14905930|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14905931|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905932|NCT01337258|Dutasteride|dutasteride|mesh-list
14905933|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14905934|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14905935|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905936|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905937|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
14905938|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905939|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905940|NCT01337323|Fluticasone|fluticasone|mesh-list
14905941|NCT01337323|Xhance|xhance|mesh-list
14905942|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14905943|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14905944|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
14905945|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14905946|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905947|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14905948|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14905949|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14905950|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14905951|NCT01337362|Insulin|insulin|mesh-list
14905952|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14905953|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14905954|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905955|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14905956|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
14905957|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
14905958|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905959|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
14905960|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905961|NCT01337401|Cediranib|cediranib|mesh-list
14297587|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14297588|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14905962|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905963|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905964|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905965|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905966|NCT01337427|Interferons|interferons|mesh-list
14905967|NCT01337427|Interferon-beta|interferon-beta|mesh-list
14905968|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
14905969|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905970|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
14905971|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905972|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
14905973|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14905974|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14905975|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14905976|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14905977|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14916792|NCT01394731|Acetaminophen|acetaminophen|mesh-list
14905978|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218155|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
15218156|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719477|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14719478|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
14719479|NCT00477789|Protective Agents|protective agents|mesh-ancestor
14719480|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719481|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
14719482|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14719483|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14719484|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14719485|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14905979|NCT01337440|Incretins|incretins|mesh-ancestor
14905980|NCT01337440|Hormones|hormones|mesh-ancestor
14905981|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14905982|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14905983|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
14905984|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905985|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905986|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14905987|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14905988|NCT01337466|Fialuridine|fialuridine|mesh-list
14905989|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
14905990|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14905991|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14905992|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905993|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905994|NCT01337492|Sorafenib|sorafenib|mesh-list
15218157|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218158|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15218159|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218160|NCT00092651|Simvastatin|simvastatin|mesh-list
15218161|NCT00092651|Ezetimibe|ezetimibe|mesh-list
15218162|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
15218163|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218164|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218165|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
15218166|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218167|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218168|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15218169|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218170|NCT00092638|Ezetimibe|ezetimibe|mesh-list
15218171|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218172|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218173|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
15218174|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218175|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218176|NCT00092625|Ezetimibe|ezetimibe|mesh-list
15218177|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218178|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218179|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
15218180|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218181|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218182|NCT00092612|Ezetimibe|ezetimibe|mesh-list
15218183|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218184|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218185|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
15218186|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905995|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14905996|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14905997|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14905998|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14905999|NCT01337518|Androgens|androgens|mesh-list
15218187|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218188|NCT00092599|Ezetimibe|ezetimibe|mesh-list
15218189|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218190|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218191|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
15218192|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218193|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218194|NCT00092586|Ezetimibe|ezetimibe|mesh-list
15218195|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14297589|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
14297590|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297591|NCT03722966|Nicotine|nicotine|mesh-list
14297592|NCT03722966|Varenicline|varenicline|mesh-list
14297593|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14297594|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
14906000|NCT01337518|Hormones|hormones|mesh-ancestor
14906001|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906002|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906003|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
14906004|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14906005|NCT01337570|Dapivirine|dapivirine|mesh-list
14906006|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14906007|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14906008|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
14906009|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906010|NCT01337583|Dapivirine|dapivirine|mesh-list
14906011|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14906012|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14906013|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
14906014|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906015|NCT01337765|Dactolisib|dactolisib|mesh-list
14906016|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906017|NCT01337791|Telbivudine|telbivudine|mesh-list
14906018|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
14906019|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906020|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14906021|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906022|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906023|NCT01337804|Omeprazole|omeprazole|mesh-list
14906024|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14906025|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14906026|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14906027|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906028|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906029|NCT01338077|Omeprazole|omeprazole|mesh-list
14906030|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14906031|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14906032|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14906033|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906034|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906035|NCT01338090|Bevacizumab|bevacizumab|mesh-list
14906036|NCT01338090|Everolimus|everolimus|mesh-list
14906037|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
14906038|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14906039|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906040|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14906041|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14906042|NCT01338090|Growth Substances|growth substances|mesh-ancestor
14906043|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906044|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
14906045|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906046|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
14906047|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14906048|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906049|NCT01338103|Rituximab|rituximab|mesh-list
14906050|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14906051|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297595|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297596|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906052|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
14906053|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906054|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906055|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14906056|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297597|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14719486|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719487|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
14719488|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719489|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719490|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14719491|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906057|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
14906058|NCT01338129|Vitamins|vitamins|mesh-ancestor
14906059|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
14719492|NCT00477815|Rituximab|rituximab|mesh-list
14719493|NCT00477815|Melphalan|melphalan|mesh-list
14719494|NCT00477815|Sargramostim|sargramostim|mesh-list
14719495|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14719496|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14906060|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906061|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
14906062|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906063|NCT01338129|Protective Agents|protective agents|mesh-ancestor
14719497|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719498|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
14719499|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719500|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906064|NCT01338311|Albuterol|albuterol|mesh-list
14906065|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14906066|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
14906067|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906068|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906069|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14906070|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
14906071|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
14906072|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14906073|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14906074|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14906075|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14906076|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
14906077|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906078|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906079|NCT01338324|Simvastatin|simvastatin|mesh-list
14906080|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14906081|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14906082|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
14906083|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906084|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14906085|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14906086|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906087|NCT01338337|Azacitidine|azacitidine|mesh-list
15218196|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218197|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
15218198|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218199|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218200|NCT00092573|Ezetimibe|ezetimibe|mesh-list
15218201|NCT00092573|Fenofibrate|fenofibrate|mesh-list
15218202|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218203|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218204|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
15218205|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218206|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218207|NCT00092560|Ezetimibe|ezetimibe|mesh-list
15218208|NCT00092560|Fenofibrate|fenofibrate|mesh-list
15218209|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218210|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218211|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
14297598|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15218212|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218213|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218214|NCT00092209|Losartan|losartan|mesh-list
15218215|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15218216|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15218217|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14906088|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14906089|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
14906090|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906091|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906092|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906093|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14906094|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
14906095|NCT01338441|Erythromycin|erythromycin|mesh-list
14906096|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
14906097|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14906098|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
14906099|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906100|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906101|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14906102|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14906103|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906104|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906105|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
14906106|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14906107|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14906108|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906109|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
14906110|NCT01338454|Coagulants|coagulants|mesh-ancestor
14916793|NCT01394731|Meperidine|meperidine|mesh-list
14916794|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14916795|NCT01394731|Analgesics|analgesics|mesh-ancestor
14916796|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
14916797|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916798|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218218|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15218219|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15218220|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218221|NCT00092209|Diuretics|diuretics|mesh-ancestor
15218222|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
15218223|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218224|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15218225|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15218226|NCT00092157|Simvastatin|simvastatin|mesh-list
15218227|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218228|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14916799|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
14916800|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15218229|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
14916801|NCT01394731|Narcotics|narcotics|mesh-ancestor
15225420|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14906111|NCT01338558|Bevacizumab|bevacizumab|mesh-list
14906112|NCT01338558|Cetuximab|cetuximab|mesh-list
14906113|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14906114|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906115|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14906116|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14906117|NCT01338558|Growth Substances|growth substances|mesh-ancestor
14906118|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906119|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
14906120|NCT01338675|Busulfan|busulfan|mesh-list
14906121|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
14906122|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906123|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906124|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
14906125|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906126|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906127|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906128|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906129|NCT01338740|Adalimumab|adalimumab|mesh-list
14906130|NCT01338740|Infliximab|infliximab|mesh-list
14906131|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906132|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906133|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
14906134|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14906135|NCT01338753|Bevacizumab|bevacizumab|mesh-list
14906136|NCT01338753|Docetaxel|docetaxel|mesh-list
14906137|NCT01338753|Doxorubicin|doxorubicin|mesh-list
14906138|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14906139|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906140|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14906141|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14906142|NCT01338753|Growth Substances|growth substances|mesh-ancestor
14906143|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906144|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
14906145|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
14906146|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
14906147|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
14906148|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906149|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14906150|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14906151|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14906152|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906153|NCT01338844|Inositol|inositol|mesh-list
14906154|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
14906155|NCT01338844|Vitamins|vitamins|mesh-ancestor
14906156|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
14906157|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906158|NCT01338896|Rotigotine|rotigotine|mesh-list
14906159|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
14906160|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
14906161|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906162|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906163|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906164|NCT01338909|Clopidogrel|clopidogrel|mesh-list
14906165|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14906166|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14906167|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14906168|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14906169|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14906170|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
14906171|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906172|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906173|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906174|NCT01338922|Insulin|insulin|mesh-list
15218230|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218231|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218232|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15218233|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218234|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15218235|NCT00090298|Simvastatin|simvastatin|mesh-list
15218236|NCT00090298|Ezetimibe|ezetimibe|mesh-list
15218237|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14906175|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15218238|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218239|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
15225421|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
14906176|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906177|NCT01339026|Clopidogrel|clopidogrel|mesh-list
14906178|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14906179|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14906180|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14906181|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14906182|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14906183|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
14906184|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906185|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906186|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906187|NCT01339039|Plerixafor|plerixafor|mesh-list
14297599|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
15218240|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218241|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218242|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15218243|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218244|NCT00090181|Diclofenac|diclofenac|mesh-list
15218245|NCT00090181|Etoricoxib|etoricoxib|mesh-list
15218246|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15218247|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15218248|NCT00090181|Analgesics|analgesics|mesh-ancestor
15218249|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
15218250|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218251|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218252|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218253|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297600|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906188|NCT01339039|Bevacizumab|bevacizumab|mesh-list
14906189|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14906190|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906191|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14906192|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14906193|NCT01339039|Growth Substances|growth substances|mesh-ancestor
14906194|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906195|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14906196|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14906197|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14906198|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
14906199|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906200|NCT01339065|Ketamine|ketamine|mesh-list
14906201|NCT01339065|Analgesics|analgesics|mesh-ancestor
14906202|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
14906203|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906204|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906205|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14906206|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14906207|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
14906208|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
14906209|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15218254|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14297601|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297602|NCT03708354|Tocotrienols|tocotrienols|mesh-list
14906210|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14906211|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14906212|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906213|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906214|NCT01339143|Pioglitazone|pioglitazone|mesh-list
14906215|NCT01339143|Vildagliptin|vildagliptin|mesh-list
15218255|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906216|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14719501|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14719502|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
14719503|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719504|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906217|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906218|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14906219|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
14906220|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906221|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906222|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14906223|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14906224|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14906225|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14906226|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906227|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
14906228|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906229|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906230|NCT01339312|Vaccines|vaccines|mesh-list
14906231|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
14906232|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906233|NCT01339442|Fulvestrant|fulvestrant|mesh-list
14906234|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14906235|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906236|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14906237|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14906238|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
14906239|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719505|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719506|NCT00477854|Chromium|chromium|mesh-list
14719507|NCT00477854|Picolinic acid|picolinic acid|mesh-list
14719508|NCT00477854|Trace Elements|trace elements|mesh-ancestor
14719509|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
14719510|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218256|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218257|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15218258|NCT00090168|Atorvastatin|atorvastatin|mesh-list
15218259|NCT00090168|Simvastatin|simvastatin|mesh-list
15218260|NCT00090168|Ezetimibe|ezetimibe|mesh-list
15218261|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218262|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218263|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
15218264|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218265|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218266|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15218267|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218268|NCT00089895|Eptifibatide|eptifibatide|mesh-list
15218269|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15218270|NCT02765854|Dexamethasone|dexamethasone|mesh-list
15218271|NCT02765854|Lenalidomide|lenalidomide|mesh-list
15218272|NCT02765854|Ixazomib|ixazomib|mesh-list
15218273|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218274|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
14906240|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906241|NCT01339468|Tacrolimus|tacrolimus|mesh-list
14906242|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906243|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
14906244|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906245|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14906246|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906247|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906248|NCT01339481|Abatacept|abatacept|mesh-list
14906249|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14906250|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906251|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906252|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906253|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
14906254|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906255|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906256|NCT01339572|Plerixafor|plerixafor|mesh-list
14906257|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14906258|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14906259|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
14906260|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906261|NCT01339624|Ketorolac|ketorolac|mesh-list
14906262|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14906263|NCT01339624|Fentanyl|fentanyl|mesh-list
14906264|NCT01339624|Morphine|morphine|mesh-list
14906265|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14906266|NCT01339624|Narcotics|narcotics|mesh-ancestor
14906267|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906268|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906269|NCT01339624|Analgesics|analgesics|mesh-ancestor
14906270|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
14906271|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906272|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14906273|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14906274|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
15218275|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
14719511|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14719512|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
14906275|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
14906276|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14906277|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14906278|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906279|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906280|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14906281|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906282|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906283|NCT01339663|Aldesleukin|aldesleukin|mesh-list
14906284|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
14906285|NCT01339663|Interleukin-2|interleukin-2|mesh-list
14906286|NCT01339663|Vaccines|vaccines|mesh-list
14906287|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
14906288|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906289|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906290|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906291|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906292|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
14906293|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906294|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906295|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906296|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14906297|NCT01339663|Analgesics|analgesics|mesh-ancestor
14906298|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
14906299|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906300|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14906301|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14906302|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
14906303|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906304|NCT01339676|Vitamin D|vitamin d|mesh-list
14906305|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
14906306|NCT01339676|Vitamins|vitamins|mesh-ancestor
14906307|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
14906308|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906309|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14906310|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14906311|NCT01339741|Vitamin D|vitamin d|mesh-list
14906312|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
14906313|NCT01339741|Vitamins|vitamins|mesh-ancestor
14906314|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
14906315|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906316|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14906317|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14906318|NCT01339754|Trabectedin|trabectedin|mesh-list
14906319|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906320|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
14906321|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906322|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906323|NCT01339819|Dabigatran|dabigatran|mesh-list
14906324|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
14906325|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
14906326|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14906327|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
14906328|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719513|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
14719514|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719515|NCT00477880|Cetuximab|cetuximab|mesh-list
14719516|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14719517|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719518|NCT00477893|Adalimumab|adalimumab|mesh-list
14719519|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719520|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719521|NCT00477945|Clofarabine|clofarabine|mesh-list
14719522|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719523|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
14719524|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719525|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719526|NCT00477984|Ethanol|ethanol|mesh-list
14719527|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14719528|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906329|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719529|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906330|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
14906331|NCT01339871|Vorinostat|vorinostat|mesh-list
14906332|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906333|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15218276|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218277|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218278|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15218279|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
15218280|NCT02765854|Hormones|hormones|mesh-ancestor
14906334|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906335|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906336|NCT01339884|Resveratrol|resveratrol|mesh-list
14906337|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
14906338|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906339|NCT01339884|Protective Agents|protective agents|mesh-ancestor
14906340|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906341|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906342|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14906343|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
14906344|NCT01339988|Busulfan|busulfan|mesh-list
14906345|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906346|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
14906347|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906348|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906349|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906350|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
14906351|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906352|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906353|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906354|NCT01340118|Budesonide|budesonide|mesh-list
14906355|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906356|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14906357|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
14906358|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906359|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906360|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14906361|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
14906362|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
14906363|NCT01340118|Hormones|hormones|mesh-ancestor
14906364|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906365|NCT01340235|Erythromycin|erythromycin|mesh-list
14906366|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
14906367|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14906368|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
14906369|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906370|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906371|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14906372|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14906373|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906374|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906375|NCT01340248|Carvedilol|carvedilol|mesh-list
14906376|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14906377|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14906378|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
14906379|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906380|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906381|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906382|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14906383|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
14906384|NCT01340248|Protective Agents|protective agents|mesh-ancestor
14906385|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14906386|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14906387|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14906388|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
15218281|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218282|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218283|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218284|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
15218285|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14906389|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14906390|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14906391|NCT01340326|Valsartan|valsartan|mesh-list
14906392|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14906393|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14906394|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14906395|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916802|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916803|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14916804|NCT01394757|Ketamine|ketamine|mesh-list
14916805|NCT01394757|Esketamine|esketamine|mesh-list
14916806|NCT01394757|Analgesics|analgesics|mesh-ancestor
14916807|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
14916808|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916809|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916810|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14916811|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14916812|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
14916813|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
14916814|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916815|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14916816|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14916817|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916818|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916819|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
14916820|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14916821|NCT01394770|Amlodipine|amlodipine|mesh-list
14916822|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14916823|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14916824|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916825|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719530|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719531|NCT00477997|Hormones|hormones|mesh-list
14719532|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719533|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719534|NCT00478049|Docetaxel|docetaxel|mesh-list
14719535|NCT00478049|Gefitinib|gefitinib|mesh-list
14719536|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719537|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14719538|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
14719539|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
14719540|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719541|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14916826|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14916827|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916828|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916829|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14916830|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
14916831|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218286|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15218287|NCT02765854|Growth Substances|growth substances|mesh-ancestor
15218288|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
15218289|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218290|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
15218291|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218292|NCT02761057|Sunitinib|sunitinib|mesh-list
15218293|NCT02761057|Crizotinib|crizotinib|mesh-list
15218294|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719542|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719543|NCT00478075|Bortezomib|bortezomib|mesh-list
14719544|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14719545|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719546|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14719547|NCT00478075|Analgesics|analgesics|mesh-ancestor
15218295|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14906396|NCT01340417|Melatonin|melatonin|mesh-list
14906397|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
14906398|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906399|NCT01340417|Protective Agents|protective agents|mesh-ancestor
14906400|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906401|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906402|NCT01340430|Trastuzumab|trastuzumab|mesh-list
14906403|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14906404|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906405|NCT01340456|Rifampin|rifampin|mesh-list
14906406|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14906407|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
14906408|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906409|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906410|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
14906411|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14906412|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906413|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906414|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14906415|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14906416|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14906417|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14906418|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14906419|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14906420|NCT01340521|Clomiphene|clomiphene|mesh-list
14906421|NCT01340521|Enclomiphene|enclomiphene|mesh-list
14906422|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
14906423|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14906424|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
14906425|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906426|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906427|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14906428|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
14906429|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14906430|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14906431|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14906432|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
14906433|NCT01340547|Ifosfamide|ifosfamide|mesh-list
14906434|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906435|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
14906436|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906437|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906438|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14906439|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
14906440|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906441|NCT01340599|Protective Agents|protective agents|mesh-ancestor
14906442|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906443|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14906444|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14906445|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297603|NCT03708354|Vitamin E|vitamin e|mesh-list
14297604|NCT03708354|Tocopherols|tocopherols|mesh-list
14297605|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
14297606|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297607|NCT03708354|Protective Agents|protective agents|mesh-ancestor
14906446|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14906447|NCT01340677|Canagliflozin|canagliflozin|mesh-list
14906448|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14906449|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906450|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906451|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906452|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
14906453|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14906454|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
14906455|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906456|NCT01340833|Dabrafenib|dabrafenib|mesh-list
14906457|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906458|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14906459|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906460|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906461|NCT01340846|Ketoconazole|ketoconazole|mesh-list
14906462|NCT01340846|Dabrafenib|dabrafenib|mesh-list
14906463|NCT01340846|Warfarin|warfarin|mesh-list
14906464|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
14906465|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
14906466|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
14906467|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906468|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14906469|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14906470|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906471|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906472|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14906473|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
14906474|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906475|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906476|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14906477|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906478|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14906479|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14906480|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
14906481|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14906482|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14906483|NCT01340950|Tenofovir|tenofovir|mesh-list
14906484|NCT01340950|Lamivudine|lamivudine|mesh-list
14906485|NCT01340950|Zidovudine|zidovudine|mesh-list
14906486|NCT01340950|Efavirenz|efavirenz|mesh-list
14906487|NCT01340950|Nevirapine|nevirapine|mesh-list
14906488|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14906489|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
14906490|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906491|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14906492|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14906493|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218296|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15218297|NCT02761057|Growth Substances|growth substances|mesh-ancestor
15218298|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218299|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
15218300|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15218301|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218302|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218303|NCT02750540|Tenofovir|tenofovir|mesh-list
15218304|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
15218305|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218306|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14906494|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906495|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14906496|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14906497|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
14906498|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14906499|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14906500|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14906501|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14906502|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14906503|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14906504|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
14906505|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
14906506|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
14906507|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906508|NCT01341080|Varenicline|varenicline|mesh-list
14906509|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14906510|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14906511|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
14906512|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906513|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906514|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906515|NCT01341106|Entecavir|entecavir|mesh-list
14906516|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
14906517|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906518|NCT01341158|Interferons|interferons|mesh-list
14906519|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906520|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
14906521|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906522|NCT01341184|Rifampin|rifampin|mesh-list
14906523|NCT01341184|Rifabutin|rifabutin|mesh-list
14906524|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14906525|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
14906526|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906527|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906528|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
14906529|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14906530|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906531|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906532|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14906533|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14906534|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14906535|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14906536|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14906537|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14906538|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
14906539|NCT01341262|Thalidomide|thalidomide|mesh-list
14906540|NCT01341262|Dexamethasone|dexamethasone|mesh-list
14906541|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
14906542|NCT01341262|Melphalan|melphalan|mesh-list
14906543|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906544|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
14906545|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906546|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906547|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906548|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
14906549|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906550|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906551|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906552|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906553|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
14906554|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
14906555|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906556|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14906557|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
14906558|NCT01341262|Hormones|hormones|mesh-ancestor
14906559|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218307|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15218308|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218309|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218310|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15218311|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15218312|NCT02520791|Antibodies|antibodies|mesh-list
15218313|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14906560|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14906561|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
14906562|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906563|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906564|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14719548|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
14719549|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719550|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906565|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14906566|NCT01341262|Growth Substances|growth substances|mesh-ancestor
14906567|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
14906568|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14906569|NCT01341275|Vaccines|vaccines|mesh-list
14906570|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
14906571|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906572|NCT01341340|Everolimus|everolimus|mesh-list
14906573|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906574|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906575|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
14906576|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906577|NCT01341353|Amiodarone|amiodarone|mesh-list
14906578|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
14906579|NCT01341353|Calcium|calcium|mesh-list
14906580|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14906581|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906582|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14906583|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
14906584|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14906585|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14906586|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906587|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14906588|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14906589|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14906590|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906591|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14906592|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14906593|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14906594|NCT01341392|Amlodipine|amlodipine|mesh-list
14906595|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14906596|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14906597|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14906598|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906599|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14906600|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906601|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
14906602|NCT01341405|Celecoxib|celecoxib|mesh-list
14906603|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14906604|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14906605|NCT01341405|Analgesics|analgesics|mesh-ancestor
14906606|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
14906607|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906608|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906609|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906610|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906611|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14906612|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14906613|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906614|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719551|NCT00478101|Fentanyl|fentanyl|mesh-list
14719552|NCT00478101|Oxycodone|oxycodone|mesh-list
14719553|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14719554|NCT00478101|Narcotics|narcotics|mesh-ancestor
14719555|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719556|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719557|NCT00478101|Analgesics|analgesics|mesh-ancestor
14719558|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
14719559|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719560|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14719561|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14719562|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
14719563|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
14719564|NCT00478114|Sorafenib|sorafenib|mesh-list
14719565|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906615|NCT01341496|Celecoxib|celecoxib|mesh-list
14906616|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
14906617|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906618|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
14906619|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906620|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906621|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906622|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
14906623|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906624|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906625|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906626|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14906627|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14906628|NCT01341496|Analgesics|analgesics|mesh-ancestor
14906629|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
14906630|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906631|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906632|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14906633|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14906634|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906635|NCT01341717|Metformin|metformin|mesh-list
14906636|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14906637|NCT01341717|Glimepiride|glimepiride|mesh-list
14906638|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906639|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906640|NCT01341717|Incretins|incretins|mesh-ancestor
14906641|NCT01341717|Hormones|hormones|mesh-ancestor
15218314|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
15218315|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218316|NCT02474173|Paclitaxel|paclitaxel|mesh-list
15218317|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15218318|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218319|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218320|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218321|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218322|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218323|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218324|NCT02207504|Crizotinib|crizotinib|mesh-list
15218325|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906642|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906643|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14906644|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
14906645|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906646|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906647|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14906648|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906649|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
14906650|NCT01341743|Entecavir|entecavir|mesh-list
14906651|NCT01341743|Adefovir|adefovir|mesh-list
14906652|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14906653|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
14906654|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906655|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14906656|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14906657|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906658|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906659|NCT01341834|Everolimus|everolimus|mesh-list
14906660|NCT01341834|Panobinostat|panobinostat|mesh-list
14906661|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906662|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906663|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
14906664|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906665|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14906666|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906667|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906668|NCT01341886|Metformin|metformin|mesh-list
14906669|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906670|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906671|NCT01341938|Nicotine|nicotine|mesh-list
14906672|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14906673|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
14906674|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906675|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906676|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14906677|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14906678|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
14906679|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906680|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906681|NCT01341951|Sargramostim|sargramostim|mesh-list
14906682|NCT01341951|Lenograstim|lenograstim|mesh-list
14906683|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
14906684|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906685|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14906686|NCT01341964|Aspirin|aspirin|mesh-list
14906687|NCT01341964|Clopidogrel|clopidogrel|mesh-list
14906688|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14906689|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14719566|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14719567|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719568|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719569|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
14719570|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14719571|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719572|NCT00478374|Doxorubicin|doxorubicin|mesh-list
14719573|NCT00478374|Sorafenib|sorafenib|mesh-list
14719574|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14719575|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719576|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14906690|NCT01341964|Analgesics|analgesics|mesh-ancestor
14906691|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
14916832|NCT01394796|Protective Agents|protective agents|mesh-ancestor
14906692|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906693|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906694|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906695|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906696|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14906697|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14906698|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906699|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14906700|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14906701|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906702|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
14906703|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14906704|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14906705|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14906706|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
14906707|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906708|NCT01342016|Prednisone|prednisone|mesh-list
14906709|NCT01342016|Tacrolimus|tacrolimus|mesh-list
14906710|NCT01342016|Leflunomide|leflunomide|mesh-list
14906711|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906712|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
14906713|NCT01342016|Hormones|hormones|mesh-ancestor
14906714|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906715|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906716|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14906717|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906718|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906719|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
14906720|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14906721|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906722|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916833|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916834|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14916835|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14916836|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916837|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14916838|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14916839|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
14916840|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14916841|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14916842|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
14916843|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916844|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916845|NCT01394848|Everolimus|everolimus|mesh-list
14906723|NCT01342146|Hormones|hormones|mesh-list
14906724|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906725|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906726|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
14906727|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906728|NCT01342198|Erythromycin|erythromycin|mesh-list
14906729|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
14906730|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14906731|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
14906732|NCT01342198|Pregabalin|pregabalin|mesh-list
14906733|NCT01342198|Analgesics|analgesics|mesh-ancestor
14906734|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
14906735|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906736|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906737|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
14906738|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14906739|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14906740|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906741|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14906742|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14906743|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14906744|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719577|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14719578|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719579|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719580|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14719581|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
14719582|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719583|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
14719584|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719585|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719586|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14719587|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
14719588|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719589|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719590|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14719591|NCT00478465|Valganciclovir|valganciclovir|mesh-list
14719592|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
14719593|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719594|NCT00478504|Letrozole|letrozole|mesh-list
14719595|NCT00478504|Clomiphene|clomiphene|mesh-list
14719596|NCT00478504|Enclomiphene|enclomiphene|mesh-list
14719597|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
14906745|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14906746|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906747|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906748|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14906749|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14906750|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906751|NCT01342224|Gemcitabine|gemcitabine|mesh-list
14906752|NCT01342224|Tadalafil|tadalafil|mesh-list
14906753|NCT01342224|Sargramostim|sargramostim|mesh-list
14906754|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
14906755|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906756|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14906757|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
14906758|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906759|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906760|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
14906761|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906762|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906763|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906764|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
14906765|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14906766|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14906767|NCT01342224|Urological Agents|urological agents|mesh-ancestor
14906768|NCT01342237|Carboplatin|carboplatin|mesh-list
14906769|NCT01342237|Etoposide|etoposide|mesh-list
14906770|NCT01342237|Melphalan|melphalan|mesh-list
14906771|NCT01342237|Topotecan|topotecan|mesh-list
14906772|NCT01342237|Thiotepa|thiotepa|mesh-list
14719598|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906773|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916846|NCT01394848|Clopidogrel|clopidogrel|mesh-list
14906774|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14906775|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14906776|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14906777|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906778|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906779|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906780|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
14906781|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906782|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906783|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
14906784|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906785|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14906786|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
14906787|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
14906788|NCT01342289|Fludarabine|fludarabine|mesh-list
14906789|NCT01342289|Tacrolimus|tacrolimus|mesh-list
14906790|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906791|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
14906792|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906793|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14906794|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14906795|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
14906796|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906797|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906798|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14906799|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14906800|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906801|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14906802|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14906803|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
14906804|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906805|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906806|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
14906807|NCT01342328|Propofol|propofol|mesh-list
14906808|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14906809|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906810|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906811|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14906812|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
14906813|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
14906814|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14906815|NCT01342328|Analgesics|analgesics|mesh-ancestor
14906816|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
14906817|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906818|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14906819|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14906820|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14906821|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
14906822|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906823|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906824|NCT01342562|Anesthetics|anesthetics|mesh-list
14906825|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906826|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906827|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14906828|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14906829|NCT01342614|Metformin|metformin|mesh-list
14906830|NCT01342614|Fosinopril|fosinopril|mesh-list
14906831|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906832|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906833|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14906834|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
14906835|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906836|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906837|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14906838|NCT01342627|Sorafenib|sorafenib|mesh-list
14906839|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906840|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14906841|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906842|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906843|NCT01342679|Dasatinib|dasatinib|mesh-list
14906844|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906845|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14906846|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906847|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906848|NCT01342692|Lenalidomide|lenalidomide|mesh-list
14906849|NCT01342692|Azacitidine|azacitidine|mesh-list
14906850|NCT01342692|Idarubicin|idarubicin|mesh-list
14906851|NCT01342692|Valproic Acid|valproic acid|mesh-list
14906852|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
14906853|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218326|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15218327|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218328|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218329|NCT02196961|Nivolumab|nivolumab|mesh-list
15218330|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15218331|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218332|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14906854|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14906855|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14906856|NCT01342692|Growth Substances|growth substances|mesh-ancestor
14906857|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
14906858|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906859|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14906860|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
14906861|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906862|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906863|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
14906864|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
14906865|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906866|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
14906867|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14906868|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906869|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14906870|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14906871|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14906872|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14906873|NCT01342731|Tigecycline|tigecycline|mesh-list
14906874|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14906875|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906876|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14906877|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906878|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906879|NCT01342744|Metformin|metformin|mesh-list
14906880|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906881|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906882|NCT01342835|Propofol|propofol|mesh-list
14906883|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14906884|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906885|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906886|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14906887|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
14906888|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
14906889|NCT01342874|Inositol|inositol|mesh-list
14906890|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
14906891|NCT01342874|Vitamins|vitamins|mesh-ancestor
14906892|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
14906893|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906894|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14906895|NCT01342939|Incretins|incretins|mesh-list
14906896|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906897|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906898|NCT01342939|Hormones|hormones|mesh-ancestor
14906899|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906900|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14906901|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14906902|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719599|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719600|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14719601|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14719602|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719603|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14719604|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
14719605|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719606|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719607|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14719608|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
14719609|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14719610|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14719611|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14719612|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
14719613|NCT00478517|Hematinics|hematinics|mesh-ancestor
14719614|NCT00478543|Furosemide|furosemide|mesh-list
14719615|NCT00478543|Diuretics|diuretics|mesh-ancestor
14719616|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
14719617|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719618|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14719619|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14719620|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906903|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906904|NCT05251584|Gentamicins|gentamicins|mesh-list
14906905|NCT05251584|Mupirocin|mupirocin|mesh-list
14906906|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14719621|NCT00478621|Vaccines|vaccines|mesh-list
14719622|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
14719623|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719624|NCT00478634|Irinotecan|irinotecan|mesh-list
14719625|NCT00478634|Cetuximab|cetuximab|mesh-list
14719626|NCT00478634|Everolimus|everolimus|mesh-list
14719627|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14719628|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14719629|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719630|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719631|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719632|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14719633|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719634|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
14719635|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729046|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729047|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
14729048|NCT00521222|Hormones|hormones|mesh-ancestor
14729049|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729050|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
14729051|NCT00521248|Morphine|morphine|mesh-list
14729052|NCT00521248|Buprenorphine|buprenorphine|mesh-list
14729053|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14906907|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906908|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14906909|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906910|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906911|NCT05251493|Iron|iron|mesh-list
14906912|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14906913|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14906914|NCT05251493|Trace Elements|trace elements|mesh-ancestor
14906915|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
14906916|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906917|NCT05251493|Hematinics|hematinics|mesh-ancestor
14906918|NCT05251038|Leucovorin|leucovorin|mesh-list
14906919|NCT05251038|Gemcitabine|gemcitabine|mesh-list
14906920|NCT05251038|Paclitaxel|paclitaxel|mesh-list
14906921|NCT05251038|Fluorouracil|fluorouracil|mesh-list
14906922|NCT05251038|Irinotecan|irinotecan|mesh-list
14906923|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14906924|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906925|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14906926|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14906927|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218333|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218334|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
15218335|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15218336|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218337|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15218338|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15218339|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218340|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15218341|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218342|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15218343|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14729054|NCT00521248|Narcotics|narcotics|mesh-ancestor
14906928|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906929|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14906930|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
14906931|NCT05251038|Antiviral Agents|antiviral agents|mesh-ancestor
14906932|NCT05251038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14906933|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906934|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14906935|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
14906936|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906937|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14906938|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14906939|NCT05251038|Antidotes|antidotes|mesh-ancestor
14906940|NCT05251038|Protective Agents|protective agents|mesh-ancestor
14906941|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
14906942|NCT05251038|Vitamins|vitamins|mesh-ancestor
14906943|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
14906944|NCT05250843|Lenvatinib|lenvatinib|mesh-list
14906945|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14906946|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14906947|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14906948|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906949|NCT05250791|Lidocaine|lidocaine|mesh-list
14906950|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
14906951|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
14906952|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14906953|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906954|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
14906955|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14906956|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14906957|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14906958|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14906959|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14906960|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906961|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
14906962|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14906963|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906964|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906965|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906966|NCT05250661|Propolis|propolis|mesh-list
14906967|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916847|NCT01394848|Atorvastatin|atorvastatin|mesh-list
14916848|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14916849|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14916850|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
14916851|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916852|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14916853|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14916854|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916855|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916856|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916857|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
14916858|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916859|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14916860|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14916861|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14916862|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14916863|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
14916864|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916865|NCT01394887|Metformin|metformin|mesh-list
14916866|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14916867|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916868|NCT01394913|Etanercept|etanercept|mesh-list
14916869|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14906968|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14906969|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14906970|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14906971|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
14906972|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14906973|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906974|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906975|NCT05250245|Urological Agents|urological agents|mesh-ancestor
14906976|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
14906977|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14906978|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14906979|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14906980|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906981|NCT05249972|Calcitriol|calcitriol|mesh-list
14906982|NCT05249972|Betamethasone|betamethasone|mesh-list
14906983|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
14906984|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14906985|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
14906986|NCT05249972|Calcipotriene|calcipotriene|mesh-list
14906987|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14906988|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14906989|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
14906990|NCT05249972|Hormones|hormones|mesh-ancestor
14906991|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14906992|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14906993|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14906994|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
14906995|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
14906996|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14906997|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14906998|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14906999|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907000|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14907001|NCT05249972|Vitamins|vitamins|mesh-ancestor
14907002|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
14907003|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14907004|NCT05249933|Benzocaine|benzocaine|mesh-list
14907005|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
14907006|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
14907007|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907008|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907009|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
14907010|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907011|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
14907012|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
14907013|NCT05249751|Coagulants|coagulants|mesh-ancestor
14907014|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14907015|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14907016|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
14907017|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907018|NCT05249712|Androgens|androgens|mesh-list
14907019|NCT05249712|Hormones|hormones|mesh-ancestor
14907020|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907021|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907022|NCT05246046|Bromides|bromides|mesh-list
14907023|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
14907024|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14907025|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
15218344|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15218345|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15218346|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15218347|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
15218348|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218349|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218350|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15218351|NCT02118610|Analgesics|analgesics|mesh-ancestor
15218352|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
15218353|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218354|NCT02083250|Fludarabine|fludarabine|mesh-list
15218355|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
14907026|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907027|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907028|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14907029|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
14907030|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
14907031|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14907032|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
14907033|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907034|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907035|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
14907036|NCT05227612|Psilocybin|psilocybin|mesh-list
14907037|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
14907038|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907039|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14907040|NCT05227456|Etonogestrel|etonogestrel|mesh-list
14907041|NCT05227456|Desogestrel|desogestrel|mesh-list
14907042|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14907043|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
14907044|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14907045|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907046|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14907047|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14907048|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14907049|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14907050|NCT05227456|Progestins|progestins|mesh-ancestor
14907051|NCT05227456|Hormones|hormones|mesh-ancestor
14907052|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907053|NCT05226442|Heparin|heparin|mesh-list
14907054|NCT05226442|Calcium heparin|calcium heparin|mesh-list
15218356|NCT02083250|Busulfan|busulfan|mesh-list
15218357|NCT02083250|Vorinostat|vorinostat|mesh-list
15218358|NCT02083250|Clofarabine|clofarabine|mesh-list
15218359|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
15218360|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15218361|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218362|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15218363|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
15218364|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218365|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14907055|NCT05226442|Argatroban|argatroban|mesh-list
14907056|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
14907057|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14907058|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14907059|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907060|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
14907061|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14907062|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
14907063|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907064|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14907065|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
14907066|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14907067|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14907068|NCT05220319|Prednisolone|prednisolone|mesh-list
14907069|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
14907070|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14907071|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
14907072|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907073|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
14907074|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
14907075|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907076|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907077|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14907078|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
14907079|NCT05220319|Hormones|hormones|mesh-ancestor
14907080|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907081|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14907082|NCT05220319|Protective Agents|protective agents|mesh-ancestor
14907083|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14907084|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907085|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
14907086|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
14907087|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907088|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14907089|NCT05211024|Penicillins|penicillins|mesh-list
14907090|NCT05211024|Penicillin G|penicillin g|mesh-list
14907091|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14907092|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
14907093|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14907094|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907095|NCT05206266|Turmeric extract|turmeric extract|mesh-list
14907096|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
14907097|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907098|NCT05206266|Protective Agents|protective agents|mesh-ancestor
14907099|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907100|NCT05198128|Calcium|calcium|mesh-list
14907101|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14907102|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907103|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
14907104|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907105|NCT05178888|Palbociclib|palbociclib|mesh-list
14907106|NCT05178888|Adagrasib|adagrasib|mesh-list
14907107|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907108|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14297608|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907109|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907110|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907111|NCT05170334|Belinostat|belinostat|mesh-list
14907112|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907113|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14907114|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907115|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907116|NCT05164549|Buprenorphine|buprenorphine|mesh-list
14907117|NCT05164549|Methadone|methadone|mesh-list
14907118|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14907119|NCT05164549|Narcotics|narcotics|mesh-ancestor
14907120|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907121|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907122|NCT05164549|Analgesics|analgesics|mesh-ancestor
14907123|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
14907124|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907125|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14907126|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
14907127|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
14907128|NCT05162274|Lazertinib|lazertinib|mesh-list
14907129|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14907130|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907131|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907132|NCT05157698|Naltrexone|naltrexone|mesh-list
14907133|NCT05157698|Bupropion|bupropion|mesh-list
14907134|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14907135|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14907136|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907137|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
14907138|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907139|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14907140|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
14907141|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14907142|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14907143|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14907144|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14907145|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907146|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
14907147|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907148|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14907149|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14907150|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907151|NCT05154279|Terlipressin|terlipressin|mesh-list
15218366|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
15218367|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218368|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
15218369|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218370|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218371|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15218372|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218373|NCT01857934|Aldesleukin|aldesleukin|mesh-list
15218374|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
15218375|NCT01857934|Melphalan|melphalan|mesh-list
15218376|NCT01857934|Busulfan|busulfan|mesh-list
15218377|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
15218378|NCT01857934|Doxorubicin|doxorubicin|mesh-list
15218379|NCT01857934|Etoposide|etoposide|mesh-list
15218380|NCT01857934|Vincristine|vincristine|mesh-list
15218381|NCT01857934|Topotecan|topotecan|mesh-list
15218382|NCT01857934|Interleukin-2|interleukin-2|mesh-list
15218383|NCT01857934|Molgramostim|molgramostim|mesh-list
15218384|NCT01857934|Dinutuximab|dinutuximab|mesh-list
15218385|NCT01857934|Levetiracetam|levetiracetam|mesh-list
15218386|NCT01857934|Isotretinoin|isotretinoin|mesh-list
15218387|NCT01857934|Antibodies|antibodies|mesh-list
15218388|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
15218389|NCT01857934|Sargramostim|sargramostim|mesh-list
15218390|NCT01857934|Lenograstim|lenograstim|mesh-list
15218391|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218392|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
15218393|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218394|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218395|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218396|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
14907152|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14907153|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14907154|NCT05148312|Budesonide|budesonide|mesh-list
14907155|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907156|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14907157|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
14907158|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907159|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907160|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14907161|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14907162|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
14907163|NCT05148312|Hormones|hormones|mesh-ancestor
14907164|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907165|NCT05124691|Ivermectin|ivermectin|mesh-list
14907166|NCT05124691|Albendazole|albendazole|mesh-list
14907167|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14907168|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907169|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
14907170|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
14907171|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14907172|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14907173|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
14907174|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
14907175|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
14907176|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907177|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907178|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
14907179|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907180|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907181|NCT05119101|Analgesics|analgesics|mesh-ancestor
14719636|NCT00478660|Adalimumab|adalimumab|mesh-list
14719637|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719638|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719639|NCT00478699|Gemcitabine|gemcitabine|mesh-list
15218397|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218398|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218399|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218400|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15218401|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15218402|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15218403|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719640|NCT00478699|Cisplatin|cisplatin|mesh-list
14719641|NCT00478699|Docetaxel|docetaxel|mesh-list
14719642|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719643|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719644|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
14719645|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719646|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
14719647|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719648|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719649|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218404|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218405|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218406|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218407|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218408|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15218409|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15218410|NCT01857934|Analgesics|analgesics|mesh-ancestor
15218411|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
15218412|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218413|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15218414|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15218415|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
15218416|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218417|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15218418|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
14297609|NCT03708354|Vitamins|vitamins|mesh-ancestor
14907182|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
14907183|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218419|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
15218420|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
14297610|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
14719650|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
14907184|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907185|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
14907186|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14907187|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
14907188|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14907189|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14907190|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14907191|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
14907192|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14907193|NCT05118477|Caffeine|caffeine|mesh-list
14907194|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14907195|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907196|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14907197|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907198|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907199|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14907200|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14907201|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
14907202|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916870|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14916871|NCT01394913|Analgesics|analgesics|mesh-ancestor
14916872|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
14916873|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916874|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916875|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916876|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916877|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14916878|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14916879|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
14916880|NCT01395069|Ketorolac|ketorolac|mesh-list
14916881|NCT01395069|Nepafenac|nepafenac|mesh-list
14916882|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14916883|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14916884|NCT01395069|Analgesics|analgesics|mesh-ancestor
14916885|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
14916886|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916887|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916888|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916889|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14916890|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14916891|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916892|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916893|NCT01395147|Vortioxetine|vortioxetine|mesh-list
14916894|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
14916895|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14916896|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14916897|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14916898|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14916899|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916900|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14916901|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14916902|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916903|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916904|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916905|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
14916906|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14916907|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14916908|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14916909|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14916910|NCT01395199|Amlodipine|amlodipine|mesh-list
14916911|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14916912|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14916913|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916914|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916915|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14916916|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916917|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
14916918|NCT01395251|Prednisolone|prednisolone|mesh-list
14916919|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
14297611|NCT03656536|Gemcitabine|gemcitabine|mesh-list
14297612|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916920|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14916921|NCT01395251|Hormones|hormones|mesh-ancestor
14907203|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
14907204|NCT05109455|Procyanidin|procyanidin|mesh-list
14907205|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
14907206|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719651|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719652|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
14719653|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
14907207|NCT05109455|Protective Agents|protective agents|mesh-ancestor
14907208|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907209|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14907210|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14907211|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907212|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
14907213|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14907214|NCT05090657|Methylene Blue|methylene blue|mesh-list
14719654|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
14719655|NCT00478764|Triamcinolone|triamcinolone|mesh-list
14719656|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719657|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
14719658|NCT00478764|Hormones|hormones|mesh-ancestor
14719659|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719660|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907215|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14907216|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907217|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
14907218|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
14907219|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907220|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907221|NCT05073250|Rituximab|rituximab|mesh-list
14719661|NCT00478816|Vaccines|vaccines|mesh-list
14719662|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
14907222|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907223|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907224|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
14907225|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907226|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907227|NCT05070403|Afatinib|afatinib|mesh-list
14907228|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907229|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14907230|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907231|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907232|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
14719663|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719664|NCT00478855|Piperacillin|piperacillin|mesh-list
14907233|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14907234|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
14907235|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907236|NCT05034562|Edetic Acid|edetic acid|mesh-list
14907237|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14907238|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
14907239|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
14907240|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907241|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
14907242|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14907243|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14907244|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
14907245|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14907246|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907247|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218421|NCT01841177|Milrinone|milrinone|mesh-list
15218422|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15218423|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15218424|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
15218425|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15218426|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15218427|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218428|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218429|NCT01841177|Protective Agents|protective agents|mesh-ancestor
15218430|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218431|NCT01697527|Aldesleukin|aldesleukin|mesh-list
15218432|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
15218433|NCT01697527|Fludarabine|fludarabine|mesh-list
15218434|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
14907248|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15218435|NCT01697527|Interleukin-2|interleukin-2|mesh-list
15218436|NCT01697527|Vaccines|vaccines|mesh-list
15218437|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14907249|NCT05031026|Analgesics|analgesics|mesh-ancestor
14907250|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
14907251|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907252|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14907253|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14907254|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14907255|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
14907256|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907257|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907258|NCT05027919|Lofexidine|lofexidine|mesh-list
14907259|NCT05027919|Clonidine|clonidine|mesh-list
14907260|NCT05027919|Morphine|morphine|mesh-list
14907261|NCT05027919|Naloxone|naloxone|mesh-list
14907262|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14907263|NCT05027919|Narcotics|narcotics|mesh-ancestor
14907264|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907265|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907266|NCT05027919|Analgesics|analgesics|mesh-ancestor
14907267|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
14907268|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907269|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14907270|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14907271|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14907272|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14907273|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14907274|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14907275|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907276|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907277|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
14907278|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
14907279|NCT05027048|Calcium|calcium|mesh-list
14907280|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14907281|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907282|NCT04999228|Mesalamine|mesalamine|mesh-list
14907283|NCT04999228|Infliximab|infliximab|mesh-list
14907284|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
14907285|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14907286|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907287|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14907288|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14907289|NCT04999228|Analgesics|analgesics|mesh-ancestor
14907290|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
14907291|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907292|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907293|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907294|NCT04983407|Gemcitabine|gemcitabine|mesh-list
14907295|NCT04983407|Paclitaxel|paclitaxel|mesh-list
14907296|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14907297|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907298|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
14907299|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
14907300|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
14907301|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907302|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14907303|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
14907304|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
14907305|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907306|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907307|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14907308|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
14907309|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907310|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
14907311|NCT04955743|Lenvatinib|lenvatinib|mesh-list
14907312|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907313|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907314|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14907315|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907316|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907317|NCT04944134|Vaccines|vaccines|mesh-list
14907318|NCT04944134|Immunologic Factors|immunologic factors|mesh-ancestor
14907319|NCT04944134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907320|NCT04920331|Erenumab|erenumab|mesh-list
14907321|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14907322|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907323|NCT04920331|Analgesics|analgesics|mesh-ancestor
14907324|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
14907325|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907326|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907327|NCT04863885|Nivolumab|nivolumab|mesh-list
14907328|NCT04863885|Ipilimumab|ipilimumab|mesh-list
14907329|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907330|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907331|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14907332|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907333|NCT04861987|Capecitabine|capecitabine|mesh-list
14907334|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14907335|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
14907336|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907337|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907338|NCT04832438|Carboplatin|carboplatin|mesh-list
14907339|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907340|NCT04832087|Teduglutide|teduglutide|mesh-list
14907341|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14907342|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14907343|NCT04832087|Protective Agents|protective agents|mesh-ancestor
14907344|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907345|NCT04831398|Melatonin|melatonin|mesh-list
14907346|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
14907347|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907348|NCT04831398|Protective Agents|protective agents|mesh-ancestor
14907349|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907350|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907351|NCT04763343|Ketamine|ketamine|mesh-list
14907352|NCT04763343|Analgesics|analgesics|mesh-ancestor
14907353|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
14907354|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907355|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907356|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14907357|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14907358|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
14907359|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
14907360|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907361|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14907362|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14907363|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907364|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907365|NCT04761848|Cilostazol|cilostazol|mesh-list
14719665|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14719666|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14719667|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719668|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14907366|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14907367|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
14907368|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907369|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907370|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14907371|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
14907372|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14907373|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14907374|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907375|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14907376|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
14907377|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14907378|NCT04761848|Protective Agents|protective agents|mesh-ancestor
14297613|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719669|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719670|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719671|NCT00478907|Ketamine|ketamine|mesh-list
14719672|NCT00478907|Thiopental|thiopental|mesh-list
14719673|NCT00478907|Propofol|propofol|mesh-list
14719674|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14719675|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719676|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719677|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14719678|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
14907379|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14907380|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14907381|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907382|NCT04757571|Paroxetine|paroxetine|mesh-list
14907383|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14907384|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14907385|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14907386|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907387|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907388|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
14907389|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907390|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14907391|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14907392|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14907393|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14907394|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14907395|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907396|NCT04753957|Progesterone|progesterone|mesh-list
14907397|NCT04753957|Progestins|progestins|mesh-ancestor
14907398|NCT04753957|Hormones|hormones|mesh-ancestor
14907399|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907400|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907401|NCT04736394|Epirubicin|epirubicin|mesh-list
14907402|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14907403|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907404|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14907405|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14907406|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907407|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907408|NCT04721132|Bevacizumab|bevacizumab|mesh-list
14907409|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14907410|NCT04721132|Atezolizumab|atezolizumab|mesh-list
14907411|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
14907412|NCT04721132|Antibodies|antibodies|mesh-list
14907413|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
14907414|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14907415|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
14907416|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907417|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14907418|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14907419|NCT04721132|Growth Substances|growth substances|mesh-ancestor
14907420|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907421|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14907422|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
14907423|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14907424|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
14907425|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14907426|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907427|NCT04718155|Atorvastatin|atorvastatin|mesh-list
14719679|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
14719680|NCT00478907|Analgesics|analgesics|mesh-ancestor
14719681|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
14719682|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719683|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14719684|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14907428|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14907429|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14907430|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
14907431|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907432|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14907433|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14907434|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907435|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14907436|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14907437|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
14907438|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907439|NCT04693689|Vaccines|vaccines|mesh-list
14907440|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
14907441|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907442|NCT04661514|Psilocybin|psilocybin|mesh-list
14907443|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
14907444|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907445|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14916922|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14916923|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916924|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14916925|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916926|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
14916927|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14916928|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916929|NCT01395290|Vitamins|vitamins|mesh-ancestor
14916930|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
14916931|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14917571|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917572|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
14917573|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917574|NCT04941937|Thalidomide|thalidomide|mesh-list
14917575|NCT04941937|Dexamethasone|dexamethasone|mesh-list
14719685|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14719686|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719687|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719688|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
14719689|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
14917576|NCT04941937|Lenalidomide|lenalidomide|mesh-list
14917577|NCT04941937|Pomalidomide|pomalidomide|mesh-list
14917578|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917579|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
14917580|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
14917581|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917582|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917583|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917584|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
14917585|NCT04941937|Hormones|hormones|mesh-ancestor
14917586|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917587|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14917588|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917589|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
14917590|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15218438|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218439|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
15218440|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218441|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218442|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218443|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
15218444|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218445|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218446|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218447|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15218448|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
15218449|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15218450|NCT01697527|Analgesics|analgesics|mesh-ancestor
15218451|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
14907446|NCT04588545|Trastuzumab|trastuzumab|mesh-list
14907447|NCT04588545|Pertuzumab|pertuzumab|mesh-list
14907448|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907449|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218452|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218453|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15218454|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15218455|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
14907450|NCT04577755|Pomalidomide|pomalidomide|mesh-list
14907451|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
14907452|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907453|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14907454|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14907455|NCT04577755|Growth Substances|growth substances|mesh-ancestor
14907456|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
14907457|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907458|NCT04563273|Vaccines|vaccines|mesh-list
14907459|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
14907460|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
14907461|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907462|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14907463|NCT04541108|Paclitaxel|paclitaxel|mesh-list
14907464|NCT04541108|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14907465|NCT04541108|Carboplatin|carboplatin|mesh-list
14907466|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
14907467|NCT04541108|Fluorouracil|fluorouracil|mesh-list
14907468|NCT04541108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14907469|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907470|NCT04541108|Tubulin Modulators|tubulin modulators|mesh-ancestor
14907471|NCT04541108|Antimitotic Agents|antimitotic agents|mesh-ancestor
14907472|NCT04541108|Mitosis Modulators|mitosis modulators|mesh-ancestor
14907473|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907474|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907475|NCT04541108|Antimetabolites|antimetabolites|mesh-ancestor
14907476|NCT04541108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14907477|NCT04541108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14907478|NCT04541108|Immunologic Factors|immunologic factors|mesh-ancestor
14907479|NCT04541108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907480|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
14907481|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14907482|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907483|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14907484|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907485|NCT04490993|Epirubicin|epirubicin|mesh-list
14907486|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14907487|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907488|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14907489|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14907490|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907491|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907492|NCT04449861|Durvalumab|durvalumab|mesh-list
14907493|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907494|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907495|NCT04420624|Colchicine|colchicine|mesh-list
14907496|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
14907497|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907498|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
14907499|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
14907500|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
14907501|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907502|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907503|NCT04409964|Lidocaine|lidocaine|mesh-list
15218456|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218457|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15218458|NCT01591577|Temozolomide|temozolomide|mesh-list
15218459|NCT01591577|Lapatinib|lapatinib|mesh-list
15218460|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14907504|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
15218461|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
14907505|NCT04409964|Remifentanil|remifentanil|mesh-list
14907506|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
14907507|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
14907508|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907509|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907510|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
14907511|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907512|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14907513|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14907514|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14907515|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14907516|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907517|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14907518|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14907519|NCT04409964|Analgesics|analgesics|mesh-ancestor
14907520|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14907521|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14907522|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14907523|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14907524|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907525|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14907526|NCT04409964|Narcotics|narcotics|mesh-ancestor
14907527|NCT04377997|Heparin|heparin|mesh-list
14907528|NCT04377997|Calcium heparin|calcium heparin|mesh-list
14907529|NCT04377997|Enoxaparin|enoxaparin|mesh-list
14907530|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14907531|NCT04377997|Tinzaparin|tinzaparin|mesh-list
14907532|NCT04377997|Dalteparin|dalteparin|mesh-list
14907533|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
14907534|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14907535|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14907536|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907537|NCT04346394|Yohimbine|yohimbine|mesh-list
14907538|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
14907539|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
14907540|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907541|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907542|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14907543|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14297614|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
14907544|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14907545|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
14907546|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907547|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907548|NCT04346394|Urological Agents|urological agents|mesh-ancestor
14907549|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
14907550|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907551|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14907552|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907553|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907554|NCT04300140|Nivolumab|nivolumab|mesh-list
14907555|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907556|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907557|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14916932|NCT01395381|Albendazole|albendazole|mesh-list
14719690|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
14719691|NCT00478946|Leucovorin|leucovorin|mesh-list
14719692|NCT00478946|Antidotes|antidotes|mesh-ancestor
14719693|NCT00478946|Protective Agents|protective agents|mesh-ancestor
14719694|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719695|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
14719696|NCT00478946|Vitamins|vitamins|mesh-ancestor
14719697|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
14719698|NCT00478959|Lenalidomide|lenalidomide|mesh-list
14719699|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
15218462|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218463|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907558|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907559|NCT04258488|Vitamin K|vitamin k|mesh-list
14907560|NCT04258488|Warfarin|warfarin|mesh-list
14907561|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
14907562|NCT04258488|Vitamins|vitamins|mesh-ancestor
14907563|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
14907564|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907565|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
14907566|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14907567|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
14907568|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14907569|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
14907570|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907571|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907572|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14907573|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14907574|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
14907575|NCT04258488|Coagulants|coagulants|mesh-ancestor
14907576|NCT04216134|Edetic Acid|edetic acid|mesh-list
14907577|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14907578|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
14907579|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
14907580|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907581|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
14907582|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14907583|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14907584|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
14907585|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14907586|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907587|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14907588|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907589|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
14907590|NCT04179110|Ramucirumab|ramucirumab|mesh-list
14907591|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907592|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907593|NCT04101461|Iron|iron|mesh-list
14907594|NCT04101461|Hepcidins|hepcidins|mesh-list
14907595|NCT04101461|Trace Elements|trace elements|mesh-ancestor
14907596|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
14907597|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297615|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297616|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
14297617|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719700|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719701|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15218464|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14719702|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14907598|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907599|NCT04091022|Eflornithine|eflornithine|mesh-list
14907600|NCT04091022|Diclofenac|diclofenac|mesh-list
14907601|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14907602|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14907603|NCT04091022|Analgesics|analgesics|mesh-ancestor
14907604|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
14907605|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907606|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907607|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907608|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907609|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14907610|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907611|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907612|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907613|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14907614|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14719703|NCT00478959|Growth Substances|growth substances|mesh-ancestor
14719704|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
14719705|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719706|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
14719707|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218465|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719708|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14907615|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14907616|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907617|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14907618|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
14907619|NCT04090775|Nivolumab|nivolumab|mesh-list
14907620|NCT04090775|Ipilimumab|ipilimumab|mesh-list
14907621|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14907622|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
14907623|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907624|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907625|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14907626|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
14907627|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907628|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907629|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14907630|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907631|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14907632|NCT04068753|Niraparib|niraparib|mesh-list
14907633|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15218466|NCT01512888|Busulfan|busulfan|mesh-list
15218467|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
15218468|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218469|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218470|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
15218471|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218472|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218473|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218474|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218475|NCT01453946|Budesonide|budesonide|mesh-list
15218476|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218477|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218478|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
15218479|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218480|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218481|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218482|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218483|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
15218484|NCT01453946|Hormones|hormones|mesh-ancestor
15218485|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218486|NCT01444092|Budesonide|budesonide|mesh-list
15218487|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218488|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218489|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
15218490|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218491|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218492|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14907634|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907635|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907636|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907637|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
14907638|NCT04052334|Fludarabine|fludarabine|mesh-list
14907639|NCT04052334|Interleukin-2|interleukin-2|mesh-list
14907640|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14907641|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
14907642|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907643|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907644|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14907645|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
14907646|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907647|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907648|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14907649|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14907650|NCT04052334|Analgesics|analgesics|mesh-ancestor
14907651|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
14907652|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907653|NCT03981614|Trifluridine|trifluridine|mesh-list
14907654|NCT03981614|Palbociclib|palbociclib|mesh-list
14907655|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907656|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14907657|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907658|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907659|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
14907660|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
14907661|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907662|NCT03951649|Acetaminophen|acetaminophen|mesh-list
14907663|NCT03951649|Caffeine|caffeine|mesh-list
14907664|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14907665|NCT03951649|Analgesics|analgesics|mesh-ancestor
14907666|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
14907667|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907668|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907669|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
14907670|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14907671|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14907672|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907673|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907674|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14719709|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719710|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719711|NCT00478998|Tamsulosin|tamsulosin|mesh-list
14907675|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14907676|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
14907677|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907678|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
14907679|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14907680|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14907681|NCT03875690|Prednisolone|prednisolone|mesh-list
14907682|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
14907683|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14907684|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
14907685|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907686|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
14907687|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
14907688|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907689|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907690|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14907691|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
14907692|NCT03875690|Hormones|hormones|mesh-ancestor
14907693|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907694|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14907695|NCT03875690|Protective Agents|protective agents|mesh-ancestor
14907696|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14719712|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14719713|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14719714|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14719715|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
14719716|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719717|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719718|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907697|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907698|NCT03860038|Dexamethasone|dexamethasone|mesh-list
14907699|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907700|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
14907701|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
14907702|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907703|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907704|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14719719|NCT00478998|Urological Agents|urological agents|mesh-ancestor
14719720|NCT00479076|Aflibercept|aflibercept|mesh-list
14719721|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14719722|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14719723|NCT00479076|Growth Substances|growth substances|mesh-ancestor
14719724|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719725|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14719726|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719727|NCT00479128|Gemcitabine|gemcitabine|mesh-list
14719728|NCT00479128|Doxorubicin|doxorubicin|mesh-list
14719729|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14719730|NCT00479128|Bortezomib|bortezomib|mesh-list
14719731|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719732|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
14907705|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
14907706|NCT03860038|Hormones|hormones|mesh-ancestor
14907707|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907708|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14907709|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907710|NCT03845296|Rucaparib|rucaparib|mesh-list
14907711|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14907712|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907713|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907714|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916933|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
14916934|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14916935|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916936|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
14916937|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14916938|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14916939|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
14916940|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218493|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218494|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
15218495|NCT01444092|Hormones|hormones|mesh-ancestor
14916941|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
14916942|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916943|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14916944|NCT01395420|Ceftazidime|ceftazidime|mesh-list
14916945|NCT01395420|Avibactam|avibactam|mesh-list
14916946|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14916947|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916948|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14916949|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916950|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916951|NCT01395433|Dexetimide|dexetimide|mesh-list
14916952|NCT01395433|Citalopram|citalopram|mesh-list
14916953|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14916954|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14916955|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14916956|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916957|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916958|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
15218496|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218497|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15218498|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15218499|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218500|NCT01332968|Prednisone|prednisone|mesh-list
15218501|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
15218502|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15218503|NCT01332968|Rituximab|rituximab|mesh-list
15218504|NCT01332968|Doxorubicin|doxorubicin|mesh-list
15218505|NCT01332968|Vincristine|vincristine|mesh-list
15218506|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
15218507|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218508|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
15218509|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218510|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218511|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218512|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
15218513|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719733|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218514|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218515|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14907715|NCT03809013|Trastuzumab|trastuzumab|mesh-list
14907716|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907717|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907718|NCT03807765|Nivolumab|nivolumab|mesh-list
14907719|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907720|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907721|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14907722|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907723|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
14907724|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
14907725|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
14907726|NCT03785249|Cetuximab|cetuximab|mesh-list
14907727|NCT03785249|Afatinib|afatinib|mesh-list
14907728|NCT03785249|Adagrasib|adagrasib|mesh-list
15218516|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15218517|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15218518|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15218519|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15218520|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218521|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218522|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
15218523|NCT01332968|Hormones|hormones|mesh-ancestor
14907729|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907730|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907731|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14907732|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907733|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907734|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
14297618|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719734|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719735|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
14719736|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719737|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719738|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719739|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
14719740|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719741|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14719742|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15218524|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907735|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14907736|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
14907737|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14907738|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
14907739|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907740|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
14907741|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14907742|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
14907743|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14907744|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
14907745|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907746|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907747|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
14907748|NCT03740958|Argatroban|argatroban|mesh-list
14907749|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
14907750|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14907751|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
14907752|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907753|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907754|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
14907755|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14907756|NCT03711318|Buprenorphine|buprenorphine|mesh-list
14907757|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14907758|NCT03711318|Naloxone|naloxone|mesh-list
14907759|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14907760|NCT03711318|Narcotics|narcotics|mesh-ancestor
14907761|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907762|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907763|NCT03711318|Analgesics|analgesics|mesh-ancestor
14907764|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
14907765|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907766|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14907767|NCT03686488|Ramucirumab|ramucirumab|mesh-list
14907768|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907769|NCT03685188|Sufentanil|sufentanil|mesh-list
14907770|NCT03685188|Oxycodone|oxycodone|mesh-list
14907771|NCT03685188|Dsuvia|dsuvia|mesh-list
14907772|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14907773|NCT03685188|Narcotics|narcotics|mesh-ancestor
14907774|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907775|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907776|NCT03685188|Analgesics|analgesics|mesh-ancestor
14907777|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
14907778|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907779|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14907780|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14907781|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
14907782|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
14907783|NCT03649880|Misonidazole|misonidazole|mesh-list
14907784|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907785|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14907786|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14907787|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907788|NCT03635749|Aspirin|aspirin|mesh-list
14907789|NCT03635749|Atorvastatin|atorvastatin|mesh-list
14907790|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14907791|NCT03635749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14907792|NCT03635749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14907793|NCT03635749|Analgesics|analgesics|mesh-ancestor
14907794|NCT03635749|Sensory System Agents|sensory system agents|mesh-ancestor
14907795|NCT03635749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907796|NCT03635749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907797|NCT03635749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907798|NCT03635749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907799|NCT03635749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14907800|NCT03635749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14907801|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907802|NCT03635749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14907803|NCT03635749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14907804|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907805|NCT03635749|Antipyretics|antipyretics|mesh-ancestor
14907806|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14907807|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14907808|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
14907809|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14907810|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
14907811|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907812|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907813|NCT03599791|Fluticasone|fluticasone|mesh-list
14907814|NCT03599791|Xhance|xhance|mesh-list
14907815|NCT03599791|Azelastine|azelastine|mesh-list
14907816|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907817|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14907818|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
14907819|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907820|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907821|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14907822|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
14907823|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
14907824|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14907825|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14907826|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907827|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907828|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14907829|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14907830|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
14907831|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
14907832|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907833|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
14907834|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
14907835|NCT03526432|Bevacizumab|bevacizumab|mesh-list
14907836|NCT03526432|Atezolizumab|atezolizumab|mesh-list
14907837|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907838|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907839|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14907840|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14907841|NCT03526432|Growth Substances|growth substances|mesh-ancestor
14907842|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907843|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
14907844|NCT03502330|Nivolumab|nivolumab|mesh-list
14907845|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907846|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907847|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14907848|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907849|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
14719743|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14719744|NCT00479193|Bacitracin|bacitracin|mesh-list
14719745|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14907850|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14907851|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
14907852|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907853|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
14907854|NCT03429140|Protective Agents|protective agents|mesh-ancestor
14907855|NCT03363035|Enoxaparin|enoxaparin|mesh-list
14907856|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
14907857|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14907858|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
14719746|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719747|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14719748|NCT00479206|Artesunate|artesunate|mesh-list
14719749|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
14719750|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14719751|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14719752|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719753|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719754|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
14719755|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
14719756|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14907859|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14719757|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
14719758|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14907860|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
14907861|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907862|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907863|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
14907864|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14907865|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14907866|NCT03327805|Choline|choline|mesh-list
14907867|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
14907868|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14907869|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
14907870|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907871|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14907872|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14907873|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
14907874|NCT03246958|Nivolumab|nivolumab|mesh-list
14907875|NCT03246958|Ipilimumab|ipilimumab|mesh-list
14907876|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907877|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907878|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14907879|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907880|NCT03192345|Cemiplimab|cemiplimab|mesh-list
14907881|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907882|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907883|NCT03160521|Risperidone|risperidone|mesh-list
14907884|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14907885|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
14907886|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907887|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907888|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907889|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14907890|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14907891|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907892|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14907893|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14907894|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
14907895|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
14907896|NCT03150329|Vorinostat|vorinostat|mesh-list
14907897|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907898|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907899|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14907900|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907901|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907902|NCT03143816|Insulin|insulin|mesh-list
14907903|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14907904|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907905|NCT03133988|Margetuximab|margetuximab|mesh-list
14907906|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907907|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
14907908|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14907909|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14907910|NCT03122847|Prednisolone|prednisolone|mesh-list
14907911|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
14907912|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14907913|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
14907914|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907915|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
14907916|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
14907917|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907918|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907919|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14907920|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
14907921|NCT03122847|Hormones|hormones|mesh-ancestor
14907922|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907923|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14907924|NCT03122847|Protective Agents|protective agents|mesh-ancestor
15218525|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218526|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218527|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218528|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218529|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218530|NCT01265784|Ertapenem|ertapenem|mesh-list
15218531|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14907925|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14907926|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907927|NCT03078192|Xenon|xenon|mesh-list
14907928|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14907929|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
14907930|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
14907931|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14907932|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907933|NCT03004131|Fluticasone|fluticasone|mesh-list
14907934|NCT03004131|Xhance|xhance|mesh-list
14907935|NCT03004131|Loratadine|loratadine|mesh-list
14907936|NCT03004131|Azelastine|azelastine|mesh-list
14907937|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907938|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14907939|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
14907940|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907941|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907942|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14907943|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
14907944|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
14907945|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14907946|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
14907947|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14907948|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14907949|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
14907950|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
14907951|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907952|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907953|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14907954|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907955|NCT02959944|Prednisone|prednisone|mesh-list
14907956|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14907957|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
14907958|NCT02959944|Hormones|hormones|mesh-ancestor
14907959|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14907960|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218532|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14907961|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218533|NCT00719966|Letrozole|letrozole|mesh-list
14907962|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907963|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
14907964|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14907965|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907966|NCT02903823|Baclofen|baclofen|mesh-list
14907967|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14907968|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907969|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14907970|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14907971|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14907972|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
14907973|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
14907974|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14907975|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907976|NCT02876302|Paclitaxel|paclitaxel|mesh-list
14907977|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
14907978|NCT02876302|Doxorubicin|doxorubicin|mesh-list
14907979|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14907980|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907981|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14907982|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
14907983|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
14907984|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14907985|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14907986|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
14907987|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14907988|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14907989|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14907990|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
14907991|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218534|NCT00719966|Anastrozole|anastrozole|mesh-list
15218535|NCT00719966|Exemestane|exemestane|mesh-list
15218536|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14907992|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14907993|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14907994|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14907995|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14907996|NCT02869009|Aspirin|aspirin|mesh-list
14907997|NCT02869009|Clopidogrel|clopidogrel|mesh-list
14907998|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14907999|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908000|NCT02869009|Analgesics|analgesics|mesh-ancestor
14908001|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
14908002|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908003|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908004|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908005|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908006|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14908007|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14908008|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908009|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14908010|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14908011|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908012|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
14908013|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14908014|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14908015|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14908016|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
14908017|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908018|NCT02855697|Olaparib|olaparib|mesh-list
14908019|NCT02855697|Cediranib|cediranib|mesh-list
14908020|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14908021|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908022|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908023|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218537|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15218538|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15218539|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218540|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218541|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15218542|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
14908024|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14908025|NCT02710097|Ethanol|ethanol|mesh-list
14908026|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14908027|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719759|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
14719760|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719761|NCT00479362|Aspirin|aspirin|mesh-list
14719762|NCT00479362|Warfarin|warfarin|mesh-list
14719763|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14719764|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14719765|NCT00479362|Analgesics|analgesics|mesh-ancestor
14719766|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
14719767|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719768|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719769|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719770|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719771|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14719772|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14719773|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719774|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14719775|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14719776|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719777|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
14908028|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908029|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908030|NCT02709954|Ethanol|ethanol|mesh-list
14908031|NCT02709954|Dronabinol|dronabinol|mesh-list
14908032|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14908033|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908034|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908035|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719778|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
14297619|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719779|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
14719780|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
14719781|NCT00479479|Vitamins|vitamins|mesh-ancestor
14719782|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
14719783|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719784|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
14719785|NCT00479479|Hematinics|hematinics|mesh-ancestor
14719786|NCT00479609|Testosterone|testosterone|mesh-list
14908036|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
14908037|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14908038|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908039|NCT02709954|Analgesics|analgesics|mesh-ancestor
14908040|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
14908041|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908042|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14908043|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14908044|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908045|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908046|NCT02709954|Hormones|hormones|mesh-ancestor
14908047|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908048|NCT02681549|Bevacizumab|bevacizumab|mesh-list
14908049|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
14908050|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14908051|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908052|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14908053|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14908054|NCT02681549|Growth Substances|growth substances|mesh-ancestor
14908055|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908056|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
14719787|NCT00479609|Androgens|androgens|mesh-ancestor
14719788|NCT00479609|Hormones|hormones|mesh-ancestor
14908057|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
14908058|NCT02616302|Lansoprazole|lansoprazole|mesh-list
14908059|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14908060|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908061|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14908062|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908063|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908064|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
14908065|NCT02615184|Lansoprazole|lansoprazole|mesh-list
15218543|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218544|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218545|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218546|NCT00637832|Prednisolone|prednisolone|mesh-list
15218547|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
15218548|NCT00637832|Rituximab|rituximab|mesh-list
15218549|NCT00637832|Doxorubicin|doxorubicin|mesh-list
15218550|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14908066|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14908067|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908068|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14908069|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908070|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908071|NCT02607319|Bemiparin|bemiparin|mesh-list
14908072|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
14908073|NCT02576574|Gemcitabine|gemcitabine|mesh-list
14908074|NCT02576574|Paclitaxel|paclitaxel|mesh-list
14908075|NCT02576574|Carboplatin|carboplatin|mesh-list
14908076|NCT02576574|Pemetrexed|pemetrexed|mesh-list
14908077|NCT02576574|Avelumab|avelumab|mesh-list
14908078|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14908079|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14908080|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908081|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
14908082|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
14908083|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
14908084|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908085|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14908086|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
14908087|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
14908088|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908089|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908090|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14908091|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
14908092|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908093|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14908094|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14908095|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14908096|NCT02562599|Raltitrexed|raltitrexed|mesh-list
14908097|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908098|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14908099|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
14908100|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908101|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14908102|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908103|NCT02489448|Durvalumab|durvalumab|mesh-list
14908104|NCT02489448|Tremelimumab|tremelimumab|mesh-list
14908105|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14908106|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218551|NCT00637832|Vincristine|vincristine|mesh-list
15218552|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218553|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
15218554|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218555|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218556|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218557|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
14908107|NCT02456012|Esomeprazole|esomeprazole|mesh-list
14908108|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14908109|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908110|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15218558|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908111|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908112|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908113|NCT02250157|Irinotecan|irinotecan|mesh-list
14908114|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14908115|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14908116|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908117|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908118|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908119|NCT02225405|Cisplatin|cisplatin|mesh-list
14908120|NCT02225405|Docetaxel|docetaxel|mesh-list
14908121|NCT02225405|Nintedanib|nintedanib|mesh-list
14908122|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908123|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
14908124|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
14908125|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
14908126|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908127|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14908128|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916959|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916960|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14916961|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
14916962|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14916963|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14916964|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14916965|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
14916966|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
14916967|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14916968|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14916969|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14916970|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
14916971|NCT01395485|Brodalumab|brodalumab|mesh-list
14916972|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
14916973|NCT01395589|Vitamin D|vitamin d|mesh-list
14916974|NCT01395589|Vitamins|vitamins|mesh-ancestor
14916975|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
14916976|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916977|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14916978|NCT01395602|Cabergoline|cabergoline|mesh-list
14916979|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14916980|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14916981|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
14916982|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
14916983|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14916984|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916985|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14916986|NCT01395654|Rifampin|rifampin|mesh-list
14916987|NCT01395654|Isoniazid|isoniazid|mesh-list
14916988|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
14916989|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14916990|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
14916991|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14916992|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14916993|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
14916994|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14916995|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14916996|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916997|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14908129|NCT02087865|Donepezil|donepezil|mesh-list
14908130|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14908131|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908132|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297620|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
14297621|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908133|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
14908134|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908135|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908136|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
14908137|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14908138|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14908139|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908140|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
14908141|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
14908142|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908143|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
14908144|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908145|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908146|NCT01431508|Losartan|losartan|mesh-list
14908147|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14908148|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14908149|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14908150|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14908151|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908152|NCT00871351|Atorvastatin|atorvastatin|mesh-list
14908153|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14908154|NCT00871351|Ezetimibe|ezetimibe|mesh-list
14908155|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14908156|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14908157|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
14908158|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908159|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14908160|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14908161|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908162|NCT00832455|Montelukast|montelukast|mesh-list
14908163|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14908164|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
14908165|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14908166|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
14908167|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908168|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908169|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14908170|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14908171|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908172|NCT00812006|Rizatriptan|rizatriptan|mesh-list
14908173|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14908174|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
14908175|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908176|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908177|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908178|NCT00777582|Olaparib|olaparib|mesh-list
14908179|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14908180|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908181|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908182|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908183|NCT00739050|Simvastatin|simvastatin|mesh-list
14908184|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14908185|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14908186|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
14908187|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297622|NCT03571191|Denosumab|denosumab|mesh-list
14297623|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14297624|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297625|NCT03527472|Memantine|memantine|mesh-list
14297626|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14908188|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14908189|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14908190|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908191|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
14908192|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908193|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
14908194|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14908195|NCT00654628|Simvastatin|simvastatin|mesh-list
14908196|NCT00654628|Ezetimibe|ezetimibe|mesh-list
14908197|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14908198|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14908199|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
14908200|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218559|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218560|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218561|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15218562|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15218563|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15218564|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15218565|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218566|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218567|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218568|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218569|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218570|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218571|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
15218572|NCT00637832|Hormones|hormones|mesh-ancestor
14297627|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14297628|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
14908201|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14908202|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14908203|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908204|NCT00604812|Rizatriptan|rizatriptan|mesh-list
14908205|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14908206|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
14908207|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908208|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908209|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908210|NCT00536380|Loratadine|loratadine|mesh-list
14908211|NCT00536380|Desloratadine|desloratadine|mesh-list
14908212|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14908213|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
14908214|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908215|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908216|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908217|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14908218|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14908219|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
14908220|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
14908221|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
14908222|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
14908223|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14908224|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
15225727|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908225|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908226|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
14908227|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14908228|NCT00496834|Losartan|losartan|mesh-list
14908229|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14908230|NCT00496834|Carvedilol|carvedilol|mesh-list
15218573|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218574|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218575|NCT00392327|Vitamin A|vitamin a|mesh-list
14908231|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14908232|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14908233|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14908234|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14908235|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908236|NCT00496834|Diuretics|diuretics|mesh-ancestor
14908237|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
14908238|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908239|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14908240|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14908241|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14908242|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14908243|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14908244|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908245|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
14908246|NCT00496834|Protective Agents|protective agents|mesh-ancestor
14908247|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14908248|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14297629|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719789|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719790|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719791|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
14719792|NCT00479661|Propofol|propofol|mesh-list
14719793|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14719794|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719795|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719796|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14719797|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
14719798|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
14719799|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14719800|NCT00479661|Analgesics|analgesics|mesh-ancestor
14719801|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
14719802|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218576|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
15218577|NCT00392327|Cisplatin|cisplatin|mesh-list
15218578|NCT00392327|Carboplatin|carboplatin|mesh-list
15218579|NCT00392327|Vincristine|vincristine|mesh-list
15218580|NCT00392327|Tretinoin|tretinoin|mesh-list
15218581|NCT00392327|Isotretinoin|isotretinoin|mesh-list
15218582|NCT00392327|Lenograstim|lenograstim|mesh-list
15218583|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218584|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
15218585|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218586|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218587|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218588|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
14327587|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719803|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15218589|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908249|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
14908250|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14908251|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14908252|NCT00442897|Atorvastatin|atorvastatin|mesh-list
14908253|NCT00442897|Simvastatin|simvastatin|mesh-list
14908254|NCT00442897|Ezetimibe|ezetimibe|mesh-list
14908255|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14908256|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14908257|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
14908258|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908259|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14908260|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14908261|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908262|NCT00423579|Simvastatin|simvastatin|mesh-list
14908263|NCT00423579|Ezetimibe|ezetimibe|mesh-list
14908264|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14908265|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14908266|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14908267|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
14908268|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908269|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14908270|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14908271|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908272|NCT00394355|Fluticasone|fluticasone|mesh-list
14908273|NCT00394355|Xhance|xhance|mesh-list
14908274|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
14908275|NCT00394355|Montelukast|montelukast|mesh-list
14908276|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908277|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14908278|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
14908279|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908280|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908281|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14908282|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
14908283|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
14908284|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14908285|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14908286|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
14908287|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908288|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14908289|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14908290|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908291|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
14908292|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908293|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
14908294|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14908295|NCT00189280|Imiquimod|imiquimod|mesh-list
14908296|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14908297|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
14908298|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908299|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908300|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
14908301|NCT00166504|Atorvastatin|atorvastatin|mesh-list
14908302|NCT00166504|Simvastatin|simvastatin|mesh-list
14908303|NCT00166504|Ezetimibe|ezetimibe|mesh-list
14908304|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14908305|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14908306|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
14908307|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908308|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14908309|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14908310|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719804|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14719805|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14908311|NCT00101972|Antibodies|antibodies|mesh-list
14908312|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14908313|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
14908314|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908315|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
14908316|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908317|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14908318|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908319|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908320|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14908321|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
14908322|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
14908323|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908324|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
14908325|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908326|NCT01343225|Ritonavir|ritonavir|mesh-list
14908327|NCT01343225|Darunavir|darunavir|mesh-list
14908328|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
14908329|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14908330|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15218590|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719806|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
14719807|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719808|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719809|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14719810|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14719811|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14719812|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14719813|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719814|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719815|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719816|NCT00479726|Analgesics|analgesics|mesh-ancestor
14719817|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
14719818|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719819|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
14719820|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14719821|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
14908331|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15218591|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218592|NCT00392327|Vitamins|vitamins|mesh-ancestor
15218593|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
15218594|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15218595|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218596|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218597|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218598|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218599|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
15218600|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
15225422|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225423|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908332|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
14908333|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908334|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908335|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14908336|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14908337|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
14908338|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908339|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14908340|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14908341|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14908342|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14908343|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14908344|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14908345|NCT01343290|Canagliflozin|canagliflozin|mesh-list
14908346|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14908347|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908348|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14908349|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908350|NCT01343303|Naproxen|naproxen|mesh-list
14908351|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908352|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908353|NCT01343303|Analgesics|analgesics|mesh-ancestor
14297630|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719822|NCT00479739|Fluticasone|fluticasone|mesh-list
14719823|NCT00479739|Xhance|xhance|mesh-list
14719824|NCT00479739|Budesonide|budesonide|mesh-list
14719825|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
14719826|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14719827|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719828|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14719829|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
14719830|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719831|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719832|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14719833|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
14719834|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
14719835|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14719836|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
14719837|NCT00479739|Hormones|hormones|mesh-ancestor
14719838|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719839|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14719840|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14719841|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14719842|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
14719843|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719844|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719845|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
14719846|NCT00479752|Cetuximab|cetuximab|mesh-list
14719847|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719848|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14719849|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
14719850|NCT00479778|Estrogens|estrogens|mesh-list
14719851|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14719852|NCT00479778|Hormones|hormones|mesh-ancestor
14908354|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
14908355|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908356|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908357|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908358|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908359|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
14908360|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14908361|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908362|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908363|NCT01343329|Propranolol|propranolol|mesh-list
14908364|NCT01343329|Esmolol|esmolol|mesh-list
14908365|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14908366|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14908367|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
14908368|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908369|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908370|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908371|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14719853|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719854|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719855|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14719856|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14719857|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
14719858|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14719859|NCT00479895|HBOC 201|hboc 201|mesh-list
14297631|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297632|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14297633|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14297634|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14297635|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14297636|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14297637|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297638|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297639|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297640|NCT03497975|Nalbuphine|nalbuphine|mesh-list
14297641|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14719860|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
15218601|NCT00116220|Goserelin|goserelin|mesh-list
15218602|NCT00116220|Flutamide|flutamide|mesh-list
15218603|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218604|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218605|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218606|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
15218607|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
15218608|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218609|NCT00099086|Docetaxel|docetaxel|mesh-list
15218610|NCT00099086|Leuprolide|leuprolide|mesh-list
15218611|NCT00099086|Goserelin|goserelin|mesh-list
15218612|NCT00099086|Bicalutamide|bicalutamide|mesh-list
15218613|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218614|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218615|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218616|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218617|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908372|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14908373|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
14908374|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14908375|NCT01343381|Heparin|heparin|mesh-list
14908376|NCT01343381|Calcium heparin|calcium heparin|mesh-list
14908377|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
14908378|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14908379|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14908380|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908381|NCT01343498|Dactolisib|dactolisib|mesh-list
14908382|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908383|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14908384|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14908385|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14908386|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14908387|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908388|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
14908389|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908390|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908391|NCT01343680|Heparin|heparin|mesh-list
14908392|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
14908393|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14908394|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14908395|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908396|NCT01343706|BI 409306|bi 409306|mesh-list
14908397|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14908398|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719861|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
14719862|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
14719863|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719864|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
14719865|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14719866|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14719867|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719868|NCT00479908|Urological Agents|urological agents|mesh-ancestor
14719869|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
14908399|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908400|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
14908401|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14908402|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
14908403|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908404|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719870|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719871|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14719872|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908405|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14908406|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
14908407|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14908408|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14908409|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14908410|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
14908411|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908412|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908413|NCT01343862|Cycloserine|cycloserine|mesh-list
14908414|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14908415|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908416|NCT01343862|Renal Agents|renal agents|mesh-ancestor
14908417|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14908418|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
14908419|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14908420|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
14908421|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908422|NCT01344031|Fulvestrant|fulvestrant|mesh-list
14908423|NCT01344031|Anastrozole|anastrozole|mesh-list
14908424|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14908425|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908426|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14908427|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14908428|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
14908429|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908430|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908431|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14908432|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14908433|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908434|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719873|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719874|NCT00479986|Pioglitazone|pioglitazone|mesh-list
14719875|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14719876|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719877|NCT00480064|Cytarabine|cytarabine|mesh-list
14719878|NCT00480064|Lomustine|lomustine|mesh-list
14719879|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719880|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
14719881|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908435|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14908436|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908437|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908438|NCT01344083|Analgesics|analgesics|mesh-ancestor
15218618|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15218619|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
15218620|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14908439|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
14908440|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908441|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908442|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908443|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908444|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14908445|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14908446|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14908447|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
14908448|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
14908449|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908450|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908451|NCT01344174|Lamivudine|lamivudine|mesh-list
14908452|NCT01344174|Dexamethasone|dexamethasone|mesh-list
14908453|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218621|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218622|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218623|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
15218624|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
15218625|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218626|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
15218627|NCT00085202|Vincristine|vincristine|mesh-list
15218628|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218629|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
15218630|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218631|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218632|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218633|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
15218634|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719882|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719883|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
14719884|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719885|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719886|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
14719887|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719888|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14719889|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
14719890|NCT00480090|Cytarabine|cytarabine|mesh-list
14719891|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14719892|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
14719893|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719894|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719895|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
14719896|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719897|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14719898|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
14719899|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719900|NCT00480103|Mineral Oil|mineral oil|mesh-list
14719901|NCT00480103|Emollients|emollients|mesh-ancestor
14719902|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
14719903|NCT00480116|Vaccines|vaccines|mesh-list
14719904|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
14719905|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719906|NCT00480142|Oxycodone|oxycodone|mesh-list
14719907|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14719908|NCT00480142|Narcotics|narcotics|mesh-ancestor
14719909|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719910|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908454|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
14719911|NCT00480142|Analgesics|analgesics|mesh-ancestor
14719912|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
14719913|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719914|NCT00480181|Nabilone|nabilone|mesh-list
14908455|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
14908456|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908457|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908458|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908459|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
14908460|NCT01344174|Hormones|hormones|mesh-ancestor
14908461|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908462|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14908463|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908464|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14908465|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14908466|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908467|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908468|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
14908469|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908470|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14908471|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14908472|NCT01344200|Celecoxib|celecoxib|mesh-list
14908473|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908474|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908475|NCT01344200|Analgesics|analgesics|mesh-ancestor
14908476|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
14908477|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908478|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908479|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908480|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908481|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14908482|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15218635|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218636|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15218637|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218638|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218639|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218640|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
14297642|NCT03497975|Narcotics|narcotics|mesh-ancestor
14297643|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297644|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297645|NCT03497975|Analgesics|analgesics|mesh-ancestor
14719915|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
14719916|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
14719917|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719918|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719919|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14719920|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14719921|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14719922|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719923|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14719924|NCT00480194|Xylometazoline|xylometazoline|mesh-list
14719925|NCT00480194|Bromides|bromides|mesh-list
14719926|NCT00480194|Ipratropium|ipratropium|mesh-list
14719927|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
14719928|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218641|NCT05187507|Theobromine|theobromine|mesh-list
15218642|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218643|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
15218644|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719929|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
14719930|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908483|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218645|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218646|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218647|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218648|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
15218649|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15218650|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
15218651|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
14719931|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719932|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14719933|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
14719934|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14719935|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
14719936|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719937|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908484|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908485|NCT01344213|Celecoxib|celecoxib|mesh-list
14908486|NCT01344213|Pregabalin|pregabalin|mesh-list
14908487|NCT01344213|Analgesics|analgesics|mesh-ancestor
14908488|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
14908489|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908490|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908491|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
14908492|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14908493|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14908494|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908495|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14908496|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14908497|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14908498|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908499|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14908500|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908501|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908502|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908503|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218652|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15218653|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218654|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
14297646|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
14908504|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14908505|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14908506|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908507|NCT01344252|Lidocaine|lidocaine|mesh-list
14297647|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297648|NCT03480971|Tempol|tempol|mesh-list
14297649|NCT03480971|TEMPO|tempo|mesh-list
14297650|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
14297651|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297652|NCT03480971|Protective Agents|protective agents|mesh-ancestor
14297653|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297654|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14297655|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297656|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14297657|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14297658|NCT03433833|Digoxin|digoxin|mesh-list
14297659|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14297660|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14297661|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297662|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297663|NCT03433833|Protective Agents|protective agents|mesh-ancestor
14297664|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297665|NCT03376646|Paclitaxel|paclitaxel|mesh-list
14297666|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14297667|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297668|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
14297669|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
14297670|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
14297671|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297672|NCT03375307|Olaparib|olaparib|mesh-list
14297673|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14297674|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719938|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
14719939|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14719940|NCT00480207|Folic Acid|folic acid|mesh-list
14719941|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
14719942|NCT00480207|Hematinics|hematinics|mesh-ancestor
14908508|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
14908509|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
14908510|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908511|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908512|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
14908513|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908514|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14908515|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14908516|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14908517|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14908518|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14916998|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14916999|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14917000|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14917001|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14917002|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14917003|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14917004|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14917005|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
14917006|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14917007|NCT01395667|Leucovorin|leucovorin|mesh-list
14917008|NCT01395667|Fluorouracil|fluorouracil|mesh-list
14917009|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
14917010|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917011|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917012|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
14917013|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917014|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917015|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917016|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
14917017|NCT01395667|Antidotes|antidotes|mesh-ancestor
14917018|NCT01395667|Protective Agents|protective agents|mesh-ancestor
14917019|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
14917020|NCT01395667|Vitamins|vitamins|mesh-ancestor
14917021|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
14917022|NCT01395732|Bosentan|bosentan|mesh-list
14917023|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14917024|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14917025|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917026|NCT01395849|Fluticasone|fluticasone|mesh-list
14917027|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14917028|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14917029|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917030|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14917031|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
14917032|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917033|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917034|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14917035|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
14917036|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
14917037|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15218655|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218656|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15218657|NCT05187429|Nivolumab|nivolumab|mesh-list
15218658|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15218659|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218660|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15218661|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218662|NCT05186675|Epinephrine|epinephrine|mesh-list
15218663|NCT05186675|Racepinephrine|racepinephrine|mesh-list
15218664|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
15225424|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14719943|NCT00480207|Vitamins|vitamins|mesh-ancestor
14719944|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
14719945|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719946|NCT00480246|Perphenazine|perphenazine|mesh-list
14719947|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14719948|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14719949|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14719950|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719951|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14719952|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14719953|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
14908519|NCT01344291|Curcumin|curcumin|mesh-list
14908520|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908521|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908522|NCT01344291|Analgesics|analgesics|mesh-ancestor
14908523|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
14908524|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908525|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908526|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908527|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908528|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908529|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908530|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908531|NCT01344304|Aprepitant|aprepitant|mesh-list
14908532|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
14908533|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
14908534|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
14908535|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908536|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908537|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908538|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14908539|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908540|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908541|NCT01344395|Ketorolac|ketorolac|mesh-list
14908542|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14908543|NCT01344395|Ropivacaine|ropivacaine|mesh-list
14908544|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
14908545|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
14908546|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908547|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908548|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
14908549|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908550|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908551|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908552|NCT01344395|Analgesics|analgesics|mesh-ancestor
14908553|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908554|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908555|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14908556|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908557|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908558|NCT01344473|Caseins|caseins|mesh-list
14908559|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
14908560|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
14908561|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908562|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
14908563|NCT01344512|Ceftazidime|ceftazidime|mesh-list
14908564|NCT01344512|Voriconazole|voriconazole|mesh-list
14908565|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14908566|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908567|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14908568|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14908569|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908570|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908571|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908572|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14908573|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14908574|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
14908575|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14908576|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14908577|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
14908578|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908579|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908580|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14908581|NCT01344564|Leuprolide|leuprolide|mesh-list
14908582|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14908583|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
14908584|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14908585|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908586|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14908587|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908588|NCT01344590|Ethanol|ethanol|mesh-list
14908589|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14908590|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908591|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908592|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908593|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14908594|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14908595|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
14908596|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908597|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908598|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14908599|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
14908600|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14908601|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14908602|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14908603|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14908604|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908605|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908606|NCT01344681|Itraconazole|itraconazole|mesh-list
14908607|NCT01344681|Micafungin|micafungin|mesh-list
14908608|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
14908609|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908610|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14908611|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14908612|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908613|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908614|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14908615|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
14908616|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908617|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908618|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14908619|NCT01344720|Etoricoxib|etoricoxib|mesh-list
14908620|NCT01344720|Oxycodone|oxycodone|mesh-list
14908621|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14908622|NCT01344720|Narcotics|narcotics|mesh-ancestor
14908623|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908624|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908625|NCT01344720|Analgesics|analgesics|mesh-ancestor
14908626|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
14908627|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908628|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908629|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908630|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908631|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908632|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14908633|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14908634|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908635|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908636|NCT01344863|Trastuzumab|trastuzumab|mesh-list
14908637|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14908638|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908639|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
14908640|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14908641|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14908642|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
14908643|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14908644|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
14908645|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908646|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908647|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
14908648|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
14908649|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908650|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
14908651|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14908652|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908653|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
14908654|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908655|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14908656|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14719954|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14719955|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14719956|NCT00480272|Prednisone|prednisone|mesh-list
14719957|NCT00480272|Adalimumab|adalimumab|mesh-list
14719958|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719959|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
14908657|NCT01345175|Metronidazole|metronidazole|mesh-list
14908658|NCT01345175|Rifaximin|rifaximin|mesh-list
14908659|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14908660|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908661|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
14908662|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14908663|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14908664|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908665|NCT01345240|Vaccines|vaccines|mesh-list
14908666|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
14908667|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908668|NCT01345279|Paclitaxel|paclitaxel|mesh-list
14908669|NCT01345279|Topotecan|topotecan|mesh-list
14908670|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14908671|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908672|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218665|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15218666|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15218667|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218668|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218669|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218670|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218671|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15218672|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15218673|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
15218674|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218675|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218676|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218677|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
15218678|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
15218679|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15218680|NCT05186649|Warfarin|warfarin|mesh-list
15218681|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
15218682|NCT05186545|Fulvestrant|fulvestrant|mesh-list
15218683|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218684|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218685|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15218686|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15218687|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
15218688|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225728|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
14719960|NCT00480272|Hormones|hormones|mesh-ancestor
14908673|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
14908674|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
14908675|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908676|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14908677|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14908678|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908679|NCT01345357|Gemcitabine|gemcitabine|mesh-list
14908680|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908681|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14908682|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
14908683|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908684|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
14908685|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14719961|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719962|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719963|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14719964|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719965|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14719966|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
14908686|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908687|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14908688|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
14908689|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908690|NCT01345370|Temozolomide|temozolomide|mesh-list
14908691|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14908692|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
14908693|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908694|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908695|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14908696|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14908697|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14908698|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14908699|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14908700|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
14908701|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908702|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908703|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908704|NCT01345604|Ropivacaine|ropivacaine|mesh-list
14908705|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
14908706|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
14297675|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297676|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297677|NCT03359811|Bupivacaine|bupivacaine|mesh-list
14908707|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908708|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908709|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
14908710|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908711|NCT01345708|Prednisone|prednisone|mesh-list
14908712|NCT01345708|Rituximab|rituximab|mesh-list
14297678|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
14297679|NCT03359811|Anesthetics|anesthetics|mesh-list
14297680|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297681|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297682|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
14297683|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297684|NCT03297684|Aflibercept|aflibercept|mesh-list
14297685|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14297686|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14908713|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14908714|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908715|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
14908716|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908717|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908718|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908719|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
14908720|NCT01345708|Hormones|hormones|mesh-ancestor
14908721|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908722|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14297687|NCT03297684|Growth Substances|growth substances|mesh-ancestor
14297688|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297689|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14297690|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297691|NCT03262662|Varenicline|varenicline|mesh-list
14297692|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14908723|NCT01345734|Liraglutide|liraglutide|mesh-list
14908724|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14908725|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908726|NCT01345734|Incretins|incretins|mesh-ancestor
14908727|NCT01345734|Hormones|hormones|mesh-ancestor
14908728|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908729|NCT01345851|Paclitaxel|paclitaxel|mesh-list
14908730|NCT01345851|Carboplatin|carboplatin|mesh-list
15218689|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218690|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
15218691|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
15218692|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15218693|NCT05186363|Amodiaquine|amodiaquine|mesh-list
15218694|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
15218695|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15218696|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15218697|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218698|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14297693|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14297694|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
14908731|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218699|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908732|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908733|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
14908734|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
14908735|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
14908736|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908737|NCT01345864|Scopolamine|scopolamine|mesh-list
14297695|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297696|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908738|NCT01345864|Donepezil|donepezil|mesh-list
14908739|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14908740|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14908741|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908742|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908743|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
14908744|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908745|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908746|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
14719967|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14719968|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14719969|NCT00480298|Prednisolone|prednisolone|mesh-list
14719970|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
14719971|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14719972|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
14719973|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719974|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
14719975|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
14719976|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908747|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14908748|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
14908749|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
14908750|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908751|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908752|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
14908753|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14908754|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14908755|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
14908756|NCT01345981|Lidocaine|lidocaine|mesh-list
14908757|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
14908758|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
14908759|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15218700|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218701|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15218702|NCT05186363|Renal Agents|renal agents|mesh-ancestor
15218703|NCT05186194|Vitamin D|vitamin d|mesh-list
15218704|NCT05186194|Calcium|calcium|mesh-list
15218705|NCT05186194|Vitamins|vitamins|mesh-ancestor
14908760|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908761|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
14908762|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908763|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14908764|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14908765|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14908766|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14908767|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908768|NCT01346007|Vaccines|vaccines|mesh-list
14908769|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14908770|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
14908771|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917038|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14917039|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14917040|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14917041|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
14917042|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917043|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917044|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
14917045|NCT01395849|Hormones|hormones|mesh-ancestor
14917046|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917047|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
14917048|NCT01395862|Fluticasone|fluticasone|mesh-list
14917049|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14917050|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14297697|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297703|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14917051|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917052|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14917053|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
14917054|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917055|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917056|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14917057|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14917058|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
15218706|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
15218707|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218708|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14297704|NCT03179163|Enalapril|enalapril|mesh-list
14297705|NCT03179163|Captopril|captopril|mesh-list
14297706|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14297707|NCT03179163|Diuretics|diuretics|mesh-ancestor
14297708|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
14297709|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297710|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15218709|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14297711|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297712|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917059|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14908772|NCT01346137|Meloxicam|meloxicam|mesh-list
14908773|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908774|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908775|NCT01346137|Analgesics|analgesics|mesh-ancestor
14908776|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
14908777|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908778|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908779|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908780|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908781|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14908782|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14908783|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908784|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908785|NCT01346215|Heparin|heparin|mesh-list
14908786|NCT01346215|Calcium heparin|calcium heparin|mesh-list
14908787|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
14908788|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14908789|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14908790|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908791|NCT01346254|Pioglitazone|pioglitazone|mesh-list
14908792|NCT01346254|Vildagliptin|vildagliptin|mesh-list
14908793|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14908794|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908795|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14908796|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
14908797|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908798|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908799|NCT01346670|Lovastatin|lovastatin|mesh-list
14908800|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14908801|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14908802|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
15218710|NCT05185999|Icodextrin|icodextrin|mesh-list
15218711|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
15218712|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15218713|NCT05185869|Gemcitabine|gemcitabine|mesh-list
15218714|NCT05185869|Paclitaxel|paclitaxel|mesh-list
15218715|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15218716|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297713|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14297714|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
14297715|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297716|NCT03177122|Inositol|inositol|mesh-list
14719977|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719978|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14719979|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
14719980|NCT00480298|Hormones|hormones|mesh-ancestor
14719981|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719982|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14719983|NCT00480298|Protective Agents|protective agents|mesh-ancestor
14297717|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
14297718|NCT03177122|Vitamins|vitamins|mesh-ancestor
14297719|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
14297720|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297721|NCT03004443|Infliximab|infliximab|mesh-list
14297722|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
14297723|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14297724|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297725|NCT02959775|Vaccines|vaccines|mesh-list
14297726|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
14297727|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297728|NCT02954406|Gemcitabine|gemcitabine|mesh-list
14297729|NCT02954406|Rituximab|rituximab|mesh-list
14297730|NCT02954406|Lenalidomide|lenalidomide|mesh-list
15218717|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218718|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218719|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
14297731|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14297732|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297733|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719984|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14719985|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719986|NCT00480363|Dexamethasone|dexamethasone|mesh-list
14719987|NCT00480363|Lenalidomide|lenalidomide|mesh-list
14719988|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14719989|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
14719990|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
14719991|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14719992|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14719993|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14719994|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
14297734|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
14297735|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297736|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297737|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297738|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
14297739|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297740|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
14297741|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297742|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297743|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297744|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14297745|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14719995|NCT00480363|Hormones|hormones|mesh-ancestor
14719996|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14719997|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14719998|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14719999|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
14720000|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720001|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720002|NCT00480363|Growth Substances|growth substances|mesh-ancestor
14720003|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720004|NCT00480376|Gentamicins|gentamicins|mesh-list
14720005|NCT00480376|Ofloxacin|ofloxacin|mesh-list
14720006|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14908803|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908804|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14908805|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14908806|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908807|NCT01346800|Ritonavir|ritonavir|mesh-list
14908808|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14908809|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14908810|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14908811|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
14908812|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908813|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908814|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14908815|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14908816|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
14908817|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908818|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14908819|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14908820|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14908821|NCT01346826|Infliximab|infliximab|mesh-list
14908822|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
14908823|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908824|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908825|NCT01346865|Cilostazol|cilostazol|mesh-list
14908826|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14908827|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
14908828|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908829|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908830|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14908831|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
14908832|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14908833|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14908834|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908835|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14908836|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
14908837|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14908838|NCT01346865|Protective Agents|protective agents|mesh-ancestor
14908839|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14908840|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14908841|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908842|NCT01346917|Lidocaine|lidocaine|mesh-list
14908843|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
14908844|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
14297746|NCT02954406|Growth Substances|growth substances|mesh-ancestor
14297747|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
14297748|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15218720|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720007|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297749|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
15218721|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15218722|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
15218723|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
15218724|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218725|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218726|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218727|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
15218728|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218729|NCT05185804|Enoxaparin|enoxaparin|mesh-list
15218730|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
15218731|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
15218732|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15218733|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15218734|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297755|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
14297756|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297757|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14297758|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297759|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297760|NCT02910583|Venetoclax|venetoclax|mesh-list
14297761|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297762|NCT02829268|Dantrolene|dantrolene|mesh-list
14297763|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14297764|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297765|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14297766|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297767|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14297768|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14297769|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14297770|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297771|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297772|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
14297773|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297774|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297775|NCT02776605|Prednisone|prednisone|mesh-list
14297776|NCT02776605|Methotrexate|methotrexate|mesh-list
14297777|NCT02776605|Vincristine|vincristine|mesh-list
14297778|NCT02776605|Daunorubicin|daunorubicin|mesh-list
14297779|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
14297780|NCT02776605|Ponatinib|ponatinib|mesh-list
14720008|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14720009|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720010|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720011|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14720012|NCT00480376|Renal Agents|renal agents|mesh-ancestor
14720013|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14720014|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14720015|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720016|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14720017|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14720018|NCT00480389|Sorafenib|sorafenib|mesh-list
14720019|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720020|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14720021|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720022|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720023|NCT00480402|Progesterone|progesterone|mesh-list
14720024|NCT00480402|Progestins|progestins|mesh-ancestor
14720025|NCT00480402|Hormones|hormones|mesh-ancestor
14720026|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720027|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720028|NCT00480454|Vaccines|vaccines|mesh-list
14720029|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
14720030|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729055|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729056|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729057|NCT00521248|Analgesics|analgesics|mesh-ancestor
14729058|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
14729059|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729060|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14729061|NCT00521261|Antibodies|antibodies|mesh-list
14729062|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14729063|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
15218735|NCT05185544|Pemetrexed|pemetrexed|mesh-list
14729064|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720031|NCT00480558|Vaccines|vaccines|mesh-list
14720032|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
14720033|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720034|NCT00480571|Perphenazine|perphenazine|mesh-list
14720035|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
14720036|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
14720037|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720038|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720039|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720040|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14720041|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14720042|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720043|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14720044|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14908845|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908846|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908847|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
14908848|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908849|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14908850|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14908851|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14908852|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14908853|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908854|NCT01346930|Macitentan|macitentan|mesh-list
14908855|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14908856|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14908857|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908858|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14908859|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14908860|NCT01347268|Hormones|hormones|mesh-ancestor
14908861|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14908862|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908863|NCT01347294|Bleomycin|bleomycin|mesh-list
14908864|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14908865|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908866|NCT01347424|Paclitaxel|paclitaxel|mesh-list
14908867|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14908868|NCT01347424|Carboplatin|carboplatin|mesh-list
14908869|NCT01347424|Endostatins|endostatins|mesh-list
14908870|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14908871|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908872|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
14908873|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
14908874|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
14908875|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908876|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14908877|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14908878|NCT01347424|Growth Substances|growth substances|mesh-ancestor
14908879|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908880|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
14908881|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
14908882|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14908883|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908884|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14908885|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
14908886|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14908887|NCT01347814|Domperidone|domperidone|mesh-list
14908888|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
14908889|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
14908890|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908891|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908892|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14908893|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14908894|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
14908895|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908896|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908897|NCT01347853|Ketorolac|ketorolac|mesh-list
14908898|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14908899|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14908900|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908901|NCT01347853|Analgesics|analgesics|mesh-ancestor
14908902|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
14720045|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
15218736|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218737|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218738|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218739|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14908903|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908904|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908905|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14908906|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908907|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14908908|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908909|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917060|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14917061|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14917062|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14297781|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14297782|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
14297783|NCT02776605|Hormones|hormones|mesh-ancestor
14297784|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14297785|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297786|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14297787|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297788|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14297789|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
14297790|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14297791|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917063|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
14917064|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917065|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917066|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
14917067|NCT01395862|Hormones|hormones|mesh-ancestor
14917068|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917069|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
14917070|NCT01395875|Fluticasone|fluticasone|mesh-list
14917071|NCT01395875|Xhance|xhance|mesh-list
14917072|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14917073|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14917074|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917075|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14917076|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
14917077|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917078|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917079|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218740|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15218741|NCT05185518|Insulin|insulin|mesh-list
15218742|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15218743|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218744|NCT05185505|Bevacizumab|bevacizumab|mesh-list
15218745|NCT05185505|Atezolizumab|atezolizumab|mesh-list
15218746|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297792|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
14720046|NCT00480584|Gemcitabine|gemcitabine|mesh-list
14720047|NCT00480584|Capecitabine|capecitabine|mesh-list
14720048|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14720049|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720050|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
14720051|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720052|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720053|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
14720054|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720055|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720056|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720057|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
14720058|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720059|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14720060|NCT00480597|Gemcitabine|gemcitabine|mesh-list
14720061|NCT00480597|Capecitabine|capecitabine|mesh-list
14720062|NCT00480597|Vinorelbine|vinorelbine|mesh-list
14720063|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720064|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720065|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
14720066|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720067|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
14720068|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14908910|NCT01347944|Lenalidomide|lenalidomide|mesh-list
14908911|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
14908912|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908913|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14908914|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14908915|NCT01347944|Growth Substances|growth substances|mesh-ancestor
14908916|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
14908917|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908918|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
14908919|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14297793|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297794|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
14297795|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297796|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14297797|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297798|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
14297799|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297800|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14297801|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14297802|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
14297803|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
14297804|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
14297805|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14297806|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14297807|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14297808|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14908920|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
14297809|NCT02721537|Niacinamide|niacinamide|mesh-list
14720069|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720070|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720071|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
14720072|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297810|NCT02721537|Niacin|niacin|mesh-list
14297811|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
14297812|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
14720073|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14720074|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
14720075|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
14720076|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
14720077|NCT00480610|Tacrolimus|tacrolimus|mesh-list
14297813|NCT02721537|Vitamins|vitamins|mesh-ancestor
14297814|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
14297815|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297816|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14297817|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
14297818|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720078|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720079|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
14720080|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720081|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14720082|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720083|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720084|NCT00480623|Satraplatin|satraplatin|mesh-list
14720085|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720086|NCT00480649|Fluticasone|fluticasone|mesh-list
14720087|NCT00480649|Xhance|xhance|mesh-list
14720088|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14297819|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14297820|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
14297821|NCT02697227|Nicotine|nicotine|mesh-list
14297822|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14297823|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
14297824|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297825|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297826|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14297827|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14297828|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
14297829|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908921|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297830|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720089|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720090|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14908922|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908923|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14908924|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
14908925|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14908926|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
14908927|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908928|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908929|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14908930|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
14908931|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
14908932|NCT01347957|Protective Agents|protective agents|mesh-ancestor
14908933|NCT01347983|Methotrexate|methotrexate|mesh-list
14908934|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14908935|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
14908936|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14908937|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908938|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14908939|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
14908940|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908941|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908942|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
14908943|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908944|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14908945|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14908946|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
14908947|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14908948|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14908949|NCT01347996|Interleukin-2|interleukin-2|mesh-list
14908950|NCT01347996|Histamine|histamine|mesh-list
14908951|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
14908952|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908953|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14908954|NCT01347996|Analgesics|analgesics|mesh-ancestor
14908955|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
14908956|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908957|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908958|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
14908959|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
14908960|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14908961|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908962|NCT01348009|Cisplatin|cisplatin|mesh-list
14908963|NCT01348009|Capecitabine|capecitabine|mesh-list
14908964|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908965|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14908966|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
14908967|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908968|NCT01348126|Docetaxel|docetaxel|mesh-list
14908969|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14908970|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14908971|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14908972|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14908973|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908974|NCT01348204|Quercetin|quercetin|mesh-list
14908975|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
14908976|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908977|NCT01348204|Protective Agents|protective agents|mesh-ancestor
14908978|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908979|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
14908980|NCT01348243|Lidocaine|lidocaine|mesh-list
14908981|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
14908982|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
14908983|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14908984|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908985|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
14908986|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14908987|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14908988|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14908989|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14908990|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14908991|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908992|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14908993|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
14908994|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14908995|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14908996|NCT01348282|Rivastigmine|rivastigmine|mesh-list
14908997|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14908998|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14908999|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909000|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14909001|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
14297831|NCT02664155|Vitamin K|vitamin k|mesh-list
14297832|NCT02664155|Heparin|heparin|mesh-list
14297833|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
14297834|NCT02664155|Apixaban|apixaban|mesh-list
14297835|NCT02664155|Vitamins|vitamins|mesh-ancestor
14297836|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
14297837|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297838|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
14297839|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14720091|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
14720092|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720093|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720094|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14720095|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720096|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
14720097|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14720098|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14909002|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909003|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14297840|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14720099|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14720100|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14720101|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14720102|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720103|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720104|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14720105|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
14720106|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14297841|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297842|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14297843|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
14297844|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14720107|NCT00480675|Prednisolone|prednisolone|mesh-list
14720108|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
14720109|NCT00480675|Bupivacaine|bupivacaine|mesh-list
14720110|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14720111|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
14720112|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
14720113|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
14720114|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720115|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720116|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
14909004|NCT01348282|Protective Agents|protective agents|mesh-ancestor
14297845|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
14297846|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297847|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14297848|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
14297849|NCT02664155|Coagulants|coagulants|mesh-ancestor
14297850|NCT02592356|Lenvatinib|lenvatinib|mesh-list
14297851|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297852|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14297853|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297854|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720117|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909005|NCT01348308|Maraviroc|maraviroc|mesh-list
14297855|NCT02506933|Vaccines|vaccines|mesh-list
15218747|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218748|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15218749|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15218750|NCT05185505|Growth Substances|growth substances|mesh-ancestor
15218751|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909006|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14909007|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14909008|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909009|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14909010|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14909011|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
14909012|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909013|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14909014|NCT01348321|Levamisole|levamisole|mesh-list
14909015|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14909016|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
14909017|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909018|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
14909019|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
14909020|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14909021|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909022|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14909023|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
14909024|NCT01348412|Raltitrexed|raltitrexed|mesh-list
14909025|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218752|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
14297856|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
14297857|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297858|NCT02493751|Avelumab|avelumab|mesh-list
14297859|NCT02493751|Axitinib|axitinib|mesh-list
14297860|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297861|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297862|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14297863|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297864|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297865|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
14297866|NCT02461537|Analgesics|analgesics|mesh-ancestor
14297867|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
14297868|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297869|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297870|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297871|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14297872|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14297873|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909026|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14909027|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
14909028|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909029|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14909030|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909031|NCT01348503|Lenalidomide|lenalidomide|mesh-list
14909032|NCT01348503|Sorafenib|sorafenib|mesh-list
15218753|NCT05185284|Remdesivir|remdesivir|mesh-list
15218754|NCT05185284|Favipiravir|favipiravir|mesh-list
15218755|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
15218756|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218757|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
15218758|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225425|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15225426|NCT04933149|Ketamine|ketamine|mesh-list
15225427|NCT04933149|Analgesics|analgesics|mesh-ancestor
14297874|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909033|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
15225428|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
15225429|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909034|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909035|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14909036|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14909037|NCT01348503|Growth Substances|growth substances|mesh-ancestor
14909038|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
14909039|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909040|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14909041|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909042|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909043|NCT01348724|Naloxegol|naloxegol|mesh-list
14909044|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14909045|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909046|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
14909047|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909048|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14909049|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
14909050|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14909051|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14909052|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909053|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909054|NCT01348880|Urological Agents|urological agents|mesh-ancestor
14909055|NCT01348984|Fentanyl|fentanyl|mesh-list
14909056|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14909057|NCT01348984|Narcotics|narcotics|mesh-ancestor
14909058|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909059|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909060|NCT01348984|Analgesics|analgesics|mesh-ancestor
14909061|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
14909062|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14297875|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
14297876|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
14297877|NCT02446964|Fludarabine|fludarabine|mesh-list
14297878|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
14297879|NCT02446964|Tacrolimus|tacrolimus|mesh-list
14297880|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297881|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
14297882|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297883|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14297884|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14297885|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
14297886|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297887|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297888|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14297889|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297890|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
14297891|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14297892|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297893|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14297894|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14297895|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
14297896|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14909063|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14297897|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909064|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14909065|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
14909066|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
14909067|NCT01349010|Probucol|probucol|mesh-list
14909068|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14909069|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14909070|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
14909071|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909072|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14909073|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
14909074|NCT01349010|Protective Agents|protective agents|mesh-ancestor
14909075|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909076|NCT01349088|Niacinamide|niacinamide|mesh-list
14909077|NCT01349088|Capecitabine|capecitabine|mesh-list
14909078|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
14909079|NCT01349088|Imetelstat|imetelstat|mesh-list
14909080|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14909081|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
14909082|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909083|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909084|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14909085|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909086|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
14909087|NCT01349088|Vitamins|vitamins|mesh-ancestor
14909088|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
14909089|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909090|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
14909091|NCT01349127|Vitamin D|vitamin d|mesh-list
14909092|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
14909093|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
14909094|NCT01349127|Vitamins|vitamins|mesh-list
14909095|NCT01349127|Calcium|calcium|mesh-list
14909096|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
14909097|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909098|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14909099|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14909100|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
14909101|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
14909102|NCT01349205|Caffeine|caffeine|mesh-list
14909103|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14909104|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909105|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14909106|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909107|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909108|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14909109|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14909110|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
14909111|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909112|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
14909113|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909114|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14909115|NCT01349205|Protective Agents|protective agents|mesh-ancestor
14909116|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14909117|NCT01349205|Analgesics|analgesics|mesh-ancestor
14909118|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
14909119|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909120|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
14909121|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14909122|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
14909123|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909124|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909125|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14909126|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
14909127|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14909128|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14297898|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
14297899|NCT02394834|Leucovorin|leucovorin|mesh-list
14909129|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14909130|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909131|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14297900|NCT02394834|Bevacizumab|bevacizumab|mesh-list
14909132|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909133|NCT01349270|Prednisone|prednisone|mesh-list
14297901|NCT02394834|Panitumumab|panitumumab|mesh-list
14297902|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
14909134|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
14909135|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14909136|NCT01349270|Antibodies|antibodies|mesh-list
14909137|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14909138|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
14909139|NCT01349270|Hormones|hormones|mesh-ancestor
14909140|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14909141|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909142|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14909143|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909144|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
14909145|NCT01349296|Everolimus|everolimus|mesh-list
14909146|NCT01349296|Nintedanib|nintedanib|mesh-list
14909147|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909148|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297903|NCT02394834|Fluorouracil|fluorouracil|mesh-list
14297904|NCT02394834|Calcium|calcium|mesh-list
14297905|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
14297906|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297907|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297908|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720118|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720119|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
14720120|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
14720121|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720122|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
14297909|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14297910|NCT02394834|Growth Substances|growth substances|mesh-ancestor
14297911|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297912|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
14297913|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14297914|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14297915|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
14297916|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297917|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297918|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297919|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
14297920|NCT02394834|Antidotes|antidotes|mesh-ancestor
14720123|NCT00480675|Hormones|hormones|mesh-ancestor
14720124|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720125|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14720126|NCT00480675|Protective Agents|protective agents|mesh-ancestor
14720127|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14720128|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909149|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
14909150|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297921|NCT02394834|Protective Agents|protective agents|mesh-ancestor
14720129|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
14909151|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14909152|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909153|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909154|NCT01349335|Tolvaptan|tolvaptan|mesh-list
14909155|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14909156|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909157|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
14909158|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909159|NCT01349348|Tolvaptan|tolvaptan|mesh-list
14909160|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14909161|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909162|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
14909163|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909164|NCT01349387|Metformin|metformin|mesh-list
14909165|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15218759|NCT05184816|Deferoxamine|deferoxamine|mesh-list
15218760|NCT05184816|Siderophores|siderophores|mesh-ancestor
14720130|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
14720131|NCT00480844|Risperidone|risperidone|mesh-list
14297922|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
14297923|NCT02394834|Vitamins|vitamins|mesh-ancestor
14297924|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
14297925|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
14297926|NCT02394795|Leucovorin|leucovorin|mesh-list
14297927|NCT02394795|Bevacizumab|bevacizumab|mesh-list
14297928|NCT02394795|Panitumumab|panitumumab|mesh-list
14297929|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
14297930|NCT02394795|Fluorouracil|fluorouracil|mesh-list
14297931|NCT02394795|Calcium|calcium|mesh-list
14297932|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
14297933|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14297934|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297935|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720132|NCT00480844|Sertindole|sertindole|mesh-list
14720133|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14297936|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14297937|NCT02394795|Growth Substances|growth substances|mesh-ancestor
14720134|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
15218761|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15218762|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
15218763|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
15218764|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218765|NCT05184803|Docetaxel|docetaxel|mesh-list
15218766|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
15218767|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218768|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
15218769|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
15218770|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
15218771|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218772|NCT05184712|Carboplatin|carboplatin|mesh-list
15218773|NCT05184712|Pemetrexed|pemetrexed|mesh-list
15218774|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218775|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218776|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218777|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15218778|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15218779|NCT05184530|Evolocumab|evolocumab|mesh-list
15218780|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218781|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14297938|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720135|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720136|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297939|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720137|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720138|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15218782|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
14909166|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909167|NCT01349413|Esomeprazole|esomeprazole|mesh-list
14909168|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14909169|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14909170|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14909171|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909172|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909173|NCT01349439|Propranolol|propranolol|mesh-list
14909174|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14909175|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14909176|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909177|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909178|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909179|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909180|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14909181|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14909182|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
14909183|NCT01349452|Ganciclovir|ganciclovir|mesh-list
14909184|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14909185|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
14909186|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
14909187|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909188|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14909189|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909190|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909191|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14909192|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14909193|NCT01349556|Tretinoin|tretinoin|mesh-list
14909194|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909195|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
14909196|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
14917080|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
14917081|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
14917082|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14917083|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14917084|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14917085|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14720139|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14720140|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297940|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14297941|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14297942|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
14327588|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720141|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14720142|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14720143|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
14720144|NCT00480870|Donepezil|donepezil|mesh-list
14720145|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14720146|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720147|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720148|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
14720149|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720150|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720151|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
14720152|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14720153|NCT00480883|Allopurinol|allopurinol|mesh-list
14720154|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
14720155|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720156|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720157|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
14720158|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14720159|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14720160|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
14720161|NCT00480883|Protective Agents|protective agents|mesh-ancestor
14917086|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
14720162|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720163|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14720164|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14720165|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720166|NCT00480896|Tacrolimus|tacrolimus|mesh-list
14720167|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720168|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
14720169|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720170|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14720171|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720172|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720173|NCT00480935|Sunitinib|sunitinib|mesh-list
14720174|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720175|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720176|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720177|NCT00480935|Growth Substances|growth substances|mesh-ancestor
14720178|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720179|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720180|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14720181|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909197|NCT01349647|Vaccines|vaccines|mesh-list
14909198|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
14909199|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909200|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14909201|NCT01349699|Deferasirox|deferasirox|mesh-list
14909202|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14909203|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
14909204|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
14909205|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909206|NCT01349699|Hematinics|hematinics|mesh-ancestor
14909207|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14909208|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
14909209|NCT01349738|Levofloxacin|levofloxacin|mesh-list
14909210|NCT01349738|Ofloxacin|ofloxacin|mesh-list
14909211|NCT01349738|Gentamicins|gentamicins|mesh-list
14909212|NCT01349738|Cefazolin|cefazolin|mesh-list
14909213|NCT01349738|Tobramycin|tobramycin|mesh-list
14909214|NCT01349738|Ampicillin|ampicillin|mesh-list
14909215|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14909216|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
14909217|NCT01349738|Sulbactam|sulbactam|mesh-list
14909218|NCT01349738|Trimethoprim|trimethoprim|mesh-list
14909219|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
14909220|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909221|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14909222|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14909223|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909224|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909225|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909226|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14909227|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14909228|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14909229|NCT01349738|Renal Agents|renal agents|mesh-ancestor
14909230|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14909231|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
14909232|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14297943|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297944|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720182|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720183|NCT00481013|Valproic Acid|valproic acid|mesh-list
14720184|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
14720185|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720186|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720187|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
14297945|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297946|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
14297947|NCT02394795|Antidotes|antidotes|mesh-ancestor
14297948|NCT02394795|Protective Agents|protective agents|mesh-ancestor
14720188|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720189|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720190|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
14720191|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14909233|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14909234|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14909235|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14909236|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14909237|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14909238|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
14909239|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
14909240|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
14909241|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909242|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909243|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
14909244|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909245|NCT01349764|Vitamin D|vitamin d|mesh-list
14909246|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
14909247|NCT01349764|Vitamins|vitamins|mesh-ancestor
14909248|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
14909249|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909250|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14909251|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14909252|NCT01349777|Clopidogrel|clopidogrel|mesh-list
14909253|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14909254|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14909255|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14909256|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14909257|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
14909258|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909259|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909260|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909261|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
14909262|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14909263|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909264|NCT01350024|Lidocaine|lidocaine|mesh-list
14909265|NCT01350024|Epinephrine|epinephrine|mesh-list
14909266|NCT01350024|Racepinephrine|racepinephrine|mesh-list
14909267|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
14909268|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
14909269|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
14909270|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909271|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909272|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
14909273|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909274|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14909275|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14909276|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14909277|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14909278|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909279|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14909280|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14909281|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909282|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720192|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720193|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14720194|NCT00481091|Navitoclax|navitoclax|mesh-list
14720195|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720196|NCT00481143|Deferasirox|deferasirox|mesh-list
14720197|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14720198|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
14720199|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
14720200|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720201|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
14297949|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
14297950|NCT02394795|Vitamins|vitamins|mesh-ancestor
14297951|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
14297952|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
15218783|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218784|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15218785|NCT05184517|Cyclosporine|cyclosporine|mesh-list
15218786|NCT05184517|Cyclosporins|cyclosporins|mesh-list
15218787|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218788|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218789|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218790|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
15218791|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218792|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
14297953|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
14909283|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14720202|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14909284|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14909285|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
14909286|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14909287|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
14909288|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
14909289|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
14909290|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14909291|NCT01350037|Remifentanil|remifentanil|mesh-list
14909292|NCT01350037|Alfentanil|alfentanil|mesh-list
14909293|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14909294|NCT01350037|Narcotics|narcotics|mesh-ancestor
14909295|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909296|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909297|NCT01350037|Analgesics|analgesics|mesh-ancestor
14909298|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
14909299|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909300|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14909301|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
14909302|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
14909303|NCT01350050|Carticaine|carticaine|mesh-list
14297954|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720203|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14720204|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
14720205|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720206|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720207|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14720208|NCT00481182|Ritonavir|ritonavir|mesh-list
14720209|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
14297955|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14297956|NCT02278120|Tamoxifen|tamoxifen|mesh-list
14297957|NCT02278120|Letrozole|letrozole|mesh-list
14297958|NCT02278120|Anastrozole|anastrozole|mesh-list
14297959|NCT02278120|Goserelin|goserelin|mesh-list
14297960|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297961|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14297962|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14297963|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297964|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297965|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14297966|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
14297967|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14297968|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297969|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14297970|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14297971|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14297972|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14720210|NCT00481182|Methadone|methadone|mesh-list
14720211|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14720212|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14720213|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
14720214|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720215|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909304|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
14297973|NCT02202772|Gemcitabine|gemcitabine|mesh-list
14297974|NCT02202772|Cisplatin|cisplatin|mesh-list
14297975|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297976|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14297977|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
14297978|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297979|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
14297980|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14297981|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297982|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14297983|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
14297984|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297985|NCT02192359|Irinotecan|irinotecan|mesh-list
14297986|NCT02192359|Camptothecin|camptothecin|mesh-list
14297987|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14297988|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14297989|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14297990|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14297991|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14297992|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14909305|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
14909306|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909307|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909308|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
14909309|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909310|NCT01350063|Troclosene|troclosene|mesh-list
14909311|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
14909312|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909313|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
14909314|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
14909315|NCT01350089|Ethanol|ethanol|mesh-list
14909316|NCT01350089|Caffeine|caffeine|mesh-list
14909317|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15218793|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218794|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
15218795|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218796|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15218797|NCT05184465|Anesthetics|anesthetics|mesh-list
15218798|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15218799|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218800|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15218801|NCT05184374|Hormones|hormones|mesh-ancestor
15218802|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218803|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14297993|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14720216|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14720217|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15218804|NCT05184179|Olmesartan|olmesartan|mesh-list
15218805|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15218806|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15218807|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15218808|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14720218|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
14720219|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720220|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14720221|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14720222|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14720223|NCT00481182|Narcotics|narcotics|mesh-ancestor
14720224|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720225|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720226|NCT00481182|Analgesics|analgesics|mesh-ancestor
14720227|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
15218809|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
15218810|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218811|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15225430|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720228|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720229|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
14720230|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720231|NCT00481273|Azacitidine|azacitidine|mesh-list
14720232|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720233|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
14720234|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720235|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720236|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909318|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909319|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720237|NCT00481312|Midazolam|midazolam|mesh-list
14909320|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909321|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14909322|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14909323|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909324|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909325|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14909326|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14909327|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
15218812|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15218813|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218814|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218815|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15218816|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15218817|NCT05184101|Heparin|heparin|mesh-list
15218818|NCT05184101|Calcium heparin|calcium heparin|mesh-list
15218819|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
15218820|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15218821|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15218822|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218823|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
14720238|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
14720239|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14720240|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14297994|NCT02174822|Paroxetine|paroxetine|mesh-list
14297995|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14297996|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14297997|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297998|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720241|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218824|NCT05184049|Epalrestat|epalrestat|mesh-list
15218825|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
15218826|NCT05184049|Vitamins|vitamins|mesh-ancestor
15218827|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
15218828|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218829|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218830|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218831|NCT05183997|Verapamil|verapamil|mesh-list
15218832|NCT05183997|Thrombin|thrombin|mesh-list
15218833|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15218834|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14720242|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14720243|NCT00481312|Analgesics|analgesics|mesh-ancestor
14720244|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
14720245|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720246|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14720247|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14720248|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14720249|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
14720250|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720251|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720252|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14909328|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909329|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
14909330|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
14909331|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14909332|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14909333|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909334|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218835|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14297999|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298000|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298001|NCT02174822|Analgesics|analgesics|mesh-ancestor
14298002|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
14298003|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298004|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
14298005|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14298006|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
14298007|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14298008|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
14298009|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14298010|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14298011|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14298012|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218836|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218837|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15218838|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218839|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
15218840|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
15218841|NCT05183997|Coagulants|coagulants|mesh-ancestor
15218842|NCT05183880|Vitamins|vitamins|mesh-list
15218843|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
15218844|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
15218845|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720253|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14720254|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14720255|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14720256|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14720257|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
14720258|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
14720259|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
14327589|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720260|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
14720261|NCT00481364|Atorvastatin|atorvastatin|mesh-list
14720262|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14720263|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15218846|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
15218847|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218848|NCT05183880|Protective Agents|protective agents|mesh-ancestor
15218849|NCT05183841|Fenoterol|fenoterol|mesh-list
15218850|NCT05183841|Ipratropium|ipratropium|mesh-list
15218851|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
15218852|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
15218853|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218854|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218855|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15218856|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
15218857|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15218858|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
15218859|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218860|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218861|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
15218862|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
15218863|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15218864|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15218865|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15218866|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15218867|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218868|NCT05183737|Propolis|propolis|mesh-list
14720264|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
14327590|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14720265|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218869|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218870|NCT05183555|Edotreotide|edotreotide|mesh-list
14909335|NCT01350154|Urological Agents|urological agents|mesh-ancestor
14909336|NCT01350323|Bevacizumab|bevacizumab|mesh-list
14909337|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14298023|NCT01961063|Busulfan|busulfan|mesh-list
14298024|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
14298025|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298026|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298027|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
14298028|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298029|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14298030|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298031|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14298032|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14298033|NCT01909245|Gastrins|gastrins|mesh-list
14298034|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
14298035|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298036|NCT01909245|Hormones|hormones|mesh-ancestor
14298037|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720266|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14720267|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14720268|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720269|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
14720270|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14720271|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720272|NCT00481442|Phenylephrine|phenylephrine|mesh-list
14720273|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
14720274|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14720275|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
14720276|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
14720277|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720278|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720279|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
14720280|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14720281|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
14720282|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720283|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14720284|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14720285|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14720286|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14720287|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720288|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720289|NCT00481442|Protective Agents|protective agents|mesh-ancestor
14720290|NCT00481455|Temozolomide|temozolomide|mesh-list
14720291|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
14720292|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14720293|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
14720294|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720295|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720296|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
14720297|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
14720298|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
14720299|NCT00481481|Tacrolimus|tacrolimus|mesh-list
14720300|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720301|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
14720302|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720303|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14720304|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720305|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720306|NCT00481533|Oxytocin|oxytocin|mesh-list
14720307|NCT00481533|Ergonovine|ergonovine|mesh-list
14720308|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
14720309|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14720310|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720311|NCT00481572|Terlipressin|terlipressin|mesh-list
14720312|NCT00481572|Vasopressins|vasopressins|mesh-list
14720313|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
14720314|NCT00481572|Norepinephrine|norepinephrine|mesh-list
14720315|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14909338|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720316|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14909339|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14909340|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14909341|NCT01350323|Growth Substances|growth substances|mesh-ancestor
14909342|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720317|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
14720318|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720319|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720320|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298038|NCT01885689|Sirolimus|sirolimus|mesh-list
14298039|NCT01885689|Melphalan|melphalan|mesh-list
14298040|NCT01885689|Clofarabine|clofarabine|mesh-list
14298041|NCT01885689|Tacrolimus|tacrolimus|mesh-list
14298042|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298043|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
14298044|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298045|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14298046|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720321|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
14720322|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
14720323|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720324|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14720325|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
14720326|NCT00481572|Coagulants|coagulants|mesh-ancestor
14720327|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14720328|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
14720329|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218871|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15218872|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218873|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
14720330|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
14720331|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
14720332|NCT00481624|Hematinics|hematinics|mesh-ancestor
14720333|NCT00481663|Metformin|metformin|mesh-list
14720334|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14720335|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14720336|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720337|NCT00481663|Incretins|incretins|mesh-ancestor
14720338|NCT00481663|Hormones|hormones|mesh-ancestor
14720339|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720340|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14720341|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
14720342|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909343|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
15218874|NCT05183334|Tramadol|tramadol|mesh-list
15218875|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
15218876|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15218877|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15218878|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218879|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218880|NCT05183334|Urological Agents|urological agents|mesh-ancestor
15218881|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15218882|NCT05183334|Narcotics|narcotics|mesh-ancestor
14298047|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909344|NCT01350570|Loperamide|loperamide|mesh-list
14909345|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
14909346|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720343|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720344|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
14909347|NCT01350596|Ibuprofen|ibuprofen|mesh-list
14298048|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14298049|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14298050|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14298051|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298052|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
14720345|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14720346|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720347|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15218883|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720348|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14720349|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720350|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720351|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720352|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14720353|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14720354|NCT00481702|Metronidazole|metronidazole|mesh-list
14298053|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14298054|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
14298055|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14298056|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14298057|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
14298058|NCT01872260|Letrozole|letrozole|mesh-list
14298059|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298060|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14298061|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14298062|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298063|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298064|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14298065|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
14298066|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720355|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
14720356|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720357|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14720358|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14720359|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14720360|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14720361|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14720362|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14720363|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
14720364|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720365|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720366|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720367|NCT00481728|Urological Agents|urological agents|mesh-ancestor
14720368|NCT00481741|Hemostatics|hemostatics|mesh-list
14720369|NCT00481741|Coagulants|coagulants|mesh-ancestor
14720370|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
14720371|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
14720372|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14720373|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14720374|NCT00481819|Prednisolone|prednisolone|mesh-list
14720375|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
14720376|NCT00481819|Tacrolimus|tacrolimus|mesh-list
14720377|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14720378|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
14720379|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720380|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
14720381|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720382|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14720383|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720384|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720385|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14720386|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298067|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298068|NCT01740648|Fluorouracil|fluorouracil|mesh-list
14298069|NCT01740648|Trametinib|trametinib|mesh-list
14720387|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15218884|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218885|NCT05183334|Analgesics|analgesics|mesh-ancestor
15218886|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
15218887|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218888|NCT05183204|Metformin|metformin|mesh-list
15218889|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15218890|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218891|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14298070|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
14720388|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
14720389|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14909348|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14909349|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14909350|NCT01350596|Analgesics|analgesics|mesh-ancestor
14909351|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
14909352|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909353|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909354|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14909355|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14909356|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14909357|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909358|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909359|NCT01350609|Candesartan|candesartan|mesh-list
14909360|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
15218892|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218893|NCT05183139|Dexamethasone|dexamethasone|mesh-list
15218894|NCT05183139|Lenalidomide|lenalidomide|mesh-list
15218895|NCT05183139|Pomalidomide|pomalidomide|mesh-list
15218896|NCT05183139|Ixazomib|ixazomib|mesh-list
15218897|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218898|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
15218899|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
15218900|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218901|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218902|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15218903|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
15218904|NCT05183139|Hormones|hormones|mesh-ancestor
15218905|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15218906|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15218907|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218908|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
15218909|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15218910|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15218911|NCT05183139|Growth Substances|growth substances|mesh-ancestor
15218912|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
15218913|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
14909361|NCT01350609|Nifedipine|nifedipine|mesh-list
15218914|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218915|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218916|NCT05182970|Metformin|metformin|mesh-list
15218917|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15218918|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218919|NCT05182957|Lenalidomide|lenalidomide|mesh-list
14720390|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720391|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720392|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
14720393|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
14720394|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720395|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720396|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
14720397|NCT00481819|Hormones|hormones|mesh-ancestor
14720398|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14909362|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14298071|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298072|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14298073|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298074|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298075|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
14298076|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298077|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14298078|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298079|NCT01685424|Etoricoxib|etoricoxib|mesh-list
14298080|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298081|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298082|NCT01685424|Analgesics|analgesics|mesh-ancestor
14720399|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14720400|NCT00481819|Protective Agents|protective agents|mesh-ancestor
14720401|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14720402|NCT00481884|Petrolatum|petrolatum|mesh-list
14720403|NCT00481884|Emollients|emollients|mesh-ancestor
14720404|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14720405|NCT00481923|Rimonabant|rimonabant|mesh-list
14720406|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14720407|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14720408|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14720409|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720410|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720411|NCT00481923|Hormones|hormones|mesh-ancestor
14720412|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720413|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298083|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
14298084|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298085|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298086|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218920|NCT05182957|Azacitidine|azacitidine|mesh-list
15218921|NCT05182957|Antibodies|antibodies|mesh-list
15218922|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
15218923|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15218924|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
15218925|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909363|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15218926|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15218927|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15218928|NCT05182957|Growth Substances|growth substances|mesh-ancestor
15218929|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
15218930|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218931|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14909364|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14909365|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909366|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14909367|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14909368|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14909369|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909370|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
14909371|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
14909372|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14909373|NCT01350622|Diclofenac|diclofenac|mesh-list
14909374|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14909375|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14909376|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298087|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298088|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14298089|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298090|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298091|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298092|NCT01587235|Simvastatin|simvastatin|mesh-list
14298093|NCT01587235|Ezetimibe|ezetimibe|mesh-list
14298094|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14298095|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14720414|NCT00481962|Tigecycline|tigecycline|mesh-list
14720415|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14720416|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720417|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14720418|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720419|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720420|NCT00481975|Rimonabant|rimonabant|mesh-list
14720421|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14720422|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14720423|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14720424|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720425|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720426|NCT00481975|Hormones|hormones|mesh-ancestor
14720427|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720428|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720429|NCT00482027|Vaccines|vaccines|mesh-list
14720430|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
14720431|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720432|NCT00482066|Abatacept|abatacept|mesh-list
14720433|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14298096|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298097|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
14298098|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298099|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298100|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298101|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298102|NCT01583322|Nintedanib|nintedanib|mesh-list
14298103|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298104|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14298105|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298106|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729065|NCT00521274|Docetaxel|docetaxel|mesh-list
14909377|NCT01350622|Analgesics|analgesics|mesh-ancestor
14909378|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
14909379|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909380|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909381|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14909382|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14909383|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14720434|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720435|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720436|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720437|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
14720438|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720439|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14720440|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14720441|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14720442|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720443|NCT00482079|Incretins|incretins|mesh-ancestor
14720444|NCT00482079|Hormones|hormones|mesh-ancestor
14720445|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720446|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14720447|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
14720448|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720449|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720450|NCT00482183|Pioglitazone|pioglitazone|mesh-list
14720451|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14298107|NCT01571128|Tenofovir|tenofovir|mesh-list
14298108|NCT01571128|Emtricitabine|emtricitabine|mesh-list
14298109|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
14298110|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14298111|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14298112|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14298113|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298114|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298115|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14298116|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14298117|NCT01429168|Etoricoxib|etoricoxib|mesh-list
14720452|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720453|NCT00482209|Misoprostol|misoprostol|mesh-list
14720454|NCT00482209|Mifepristone|mifepristone|mesh-list
14720455|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14720456|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
14720457|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14720458|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720459|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14720460|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720461|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
14720462|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14720463|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14720464|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14720465|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14720466|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
14720467|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14720468|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14909384|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909385|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909386|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
14909387|NCT01350713|Povidone|povidone|mesh-list
14909388|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
14909389|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
14909390|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15218932|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
15218933|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218934|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218935|NCT05182710|Vaccines|vaccines|mesh-list
15218936|NCT05182710|Immunologic Factors|immunologic factors|mesh-ancestor
15218937|NCT05182710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225431|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15225432|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15225433|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
15225434|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
15225435|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225436|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14909391|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909392|NCT01350817|Docetaxel|docetaxel|mesh-list
14327591|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298118|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14720469|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
14720470|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720471|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
14720472|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14720473|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14298119|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298120|NCT01429168|Analgesics|analgesics|mesh-ancestor
14298121|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
14298122|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298123|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298124|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298125|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298126|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14298127|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298128|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298129|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298130|NCT01327638|Etoricoxib|etoricoxib|mesh-list
14298131|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14298132|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298133|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298134|NCT01327638|Analgesics|analgesics|mesh-ancestor
14298135|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
14298136|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298137|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298138|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298139|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298140|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298141|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298142|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298143|NCT01077843|Etoricoxib|etoricoxib|mesh-list
14298144|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14298145|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14298146|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298147|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298148|NCT01077843|Analgesics|analgesics|mesh-ancestor
14298149|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
14720474|NCT00482222|Leucovorin|leucovorin|mesh-list
15218938|NCT05182385|Venetoclax|venetoclax|mesh-list
15218939|NCT05182385|Blinatumomab|blinatumomab|mesh-list
15218940|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218941|NCT05182151|Istradefylline|istradefylline|mesh-list
15218942|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14720475|NCT00482222|Fluorouracil|fluorouracil|mesh-list
14720476|NCT00482222|Capecitabine|capecitabine|mesh-list
14720477|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
14720478|NCT00482222|Cetuximab|cetuximab|mesh-list
14720479|NCT00482222|Calcium|calcium|mesh-list
14720480|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
15218943|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15218944|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14720481|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14720482|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720483|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
14720484|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720485|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720486|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218945|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
15218946|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218947|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218948|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218949|NCT05182138|Zinc|zinc|mesh-list
15218950|NCT05182138|Trace Elements|trace elements|mesh-ancestor
15218951|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
14298150|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298151|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298152|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298153|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298154|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298155|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298156|NCT00771160|Montelukast|montelukast|mesh-list
14298157|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14298158|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
14298159|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14298160|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
14298161|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298162|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298163|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14298164|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14298165|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298166|NCT00756418|Theophylline|theophylline|mesh-list
14298167|NCT00756418|Montelukast|montelukast|mesh-list
15218952|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218953|NCT05182112|Gemcitabine|gemcitabine|mesh-list
15218954|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15218955|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15218956|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
15218957|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218958|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
15218959|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15218960|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15218961|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15218962|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
15218963|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218964|NCT05181969|Dextrans|dextrans|mesh-list
14298168|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14298169|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
14298170|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14298171|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
14298172|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720487|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720488|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
14720489|NCT00482222|Antidotes|antidotes|mesh-ancestor
14720490|NCT00482222|Protective Agents|protective agents|mesh-ancestor
14720491|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
14720492|NCT00482222|Vitamins|vitamins|mesh-ancestor
14720493|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
14720494|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14720495|NCT00482248|Omalizumab|omalizumab|mesh-list
14720496|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14720497|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14720498|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720499|NCT00482261|Aspirin|aspirin|mesh-list
14720500|NCT00482261|Dexamethasone|dexamethasone|mesh-list
14720501|NCT00482261|Lenalidomide|lenalidomide|mesh-list
14298173|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298174|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14298175|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14720502|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720503|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
14720504|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
14298176|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298177|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14298178|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
14298179|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298180|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14298181|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298182|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
14720505|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720506|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720507|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720508|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
14720509|NCT00482261|Hormones|hormones|mesh-ancestor
14720510|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720511|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14720512|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720513|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14720514|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14720515|NCT00482261|Analgesics|analgesics|mesh-ancestor
14720516|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
15218965|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
15218966|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
15218967|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
15218968|NCT05180292|Carvedilol|carvedilol|mesh-list
15218969|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15218970|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15218971|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
15218972|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15218973|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15218974|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15218975|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15218976|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
15218977|NCT05180292|Protective Agents|protective agents|mesh-ancestor
15218978|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15218979|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15218980|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15218981|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
15218982|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15218983|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15218984|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
15218985|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15218986|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15218987|NCT05177939|Prednisolone|prednisolone|mesh-list
14720517|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15218988|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
14720518|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14720519|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14720520|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720521|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14720522|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14720523|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720524|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
14720525|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
14720526|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720527|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720528|NCT00482261|Growth Substances|growth substances|mesh-ancestor
14720529|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14729066|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298183|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14298184|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14729067|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
14729068|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729069|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
14909393|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15218989|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15218990|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
15218991|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
15218992|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15218993|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
15218994|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15218995|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15218996|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
15218997|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
15218998|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15218999|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219000|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219001|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
15219002|NCT05177939|Hormones|hormones|mesh-ancestor
15219003|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219004|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15219005|NCT05177939|Protective Agents|protective agents|mesh-ancestor
15219006|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219007|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219008|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
15219009|NCT05177718|Natalizumab|natalizumab|mesh-list
15219010|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
15219011|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219012|NCT05172908|Dexamethasone|dexamethasone|mesh-list
15219013|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219014|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
15219015|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
15219016|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219017|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219018|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219019|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
15219020|NCT05172908|Hormones|hormones|mesh-ancestor
15219021|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219022|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14298185|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
14298186|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219023|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219024|NCT05171166|Leucovorin|leucovorin|mesh-list
14720530|NCT00482313|Methylphenidate|methylphenidate|mesh-list
14720531|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14720532|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720533|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14720534|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14720535|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14720536|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720537|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
14720538|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720539|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
14720540|NCT00482378|Pamidronate|pamidronate|mesh-list
14720541|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14720542|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720543|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
14720544|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14720545|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
14720546|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
14720547|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720548|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720549|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14720550|NCT00482456|Analgesics|analgesics|mesh-ancestor
14720551|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
14720552|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720553|NCT00482495|Bevacizumab|bevacizumab|mesh-list
14720554|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14720555|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720556|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720557|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720558|NCT00482495|Growth Substances|growth substances|mesh-ancestor
14720559|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720560|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720561|NCT00482508|Omalizumab|omalizumab|mesh-list
15219025|NCT05171166|Fluorouracil|fluorouracil|mesh-list
15219026|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
15219027|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
15219028|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
15219029|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219030|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15219031|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219032|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219033|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
15219034|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219035|NCT05171166|Antidotes|antidotes|mesh-ancestor
15219036|NCT05171166|Protective Agents|protective agents|mesh-ancestor
15219037|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
15219038|NCT05171166|Vitamins|vitamins|mesh-ancestor
15219039|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
15219040|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15219041|NCT05171166|Estrogens|estrogens|mesh-ancestor
15219042|NCT05171166|Hormones|hormones|mesh-ancestor
15219043|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219044|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219045|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
15219046|NCT05170711|Anesthetics|anesthetics|mesh-list
15219047|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219048|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219049|NCT05170139|Caffeine|caffeine|mesh-list
15219050|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15219051|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219052|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15219053|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219054|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219055|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15219056|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15219057|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
15219058|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219059|NCT05168423|Cyclophosphamide|cyclophosphamide|mesh-list
15219060|NCT05168423|Fludarabine|fludarabine|mesh-list
15219061|NCT05168423|Isotretinoin|isotretinoin|mesh-list
15219062|NCT05168423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219063|NCT05168423|Immunologic Factors|immunologic factors|mesh-ancestor
15219064|NCT05168423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720562|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15219065|NCT05168423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14720563|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14720564|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720565|NCT00482521|Pomalidomide|pomalidomide|mesh-list
14720566|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
14720567|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720568|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720569|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720570|NCT00482521|Growth Substances|growth substances|mesh-ancestor
14720571|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720572|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720573|NCT00482573|Epinephrine|epinephrine|mesh-list
14720574|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14720575|NCT00482573|Anesthetics|anesthetics|mesh-list
14720576|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219066|NCT05168423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15219067|NCT05168423|Alkylating Agents|alkylating agents|mesh-ancestor
15219068|NCT05168423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219069|NCT05168423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219070|NCT05168423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15219071|NCT05168423|Dermatologic Agents|dermatologic agents|mesh-ancestor
15219072|NCT05166291|Anesthetics|anesthetics|mesh-list
15219073|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219074|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219075|NCT05163561|Vaccines|vaccines|mesh-list
15219076|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
15219077|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219078|NCT05163496|Psilocybin|psilocybin|mesh-list
15219079|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
15219080|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219081|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15219082|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
15219083|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15219084|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219085|NCT05159752|Afamelanotide|afamelanotide|mesh-list
15219086|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
15219087|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
15219088|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219089|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
15219090|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219091|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15219092|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15219093|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
14298187|NCT00755794|Montelukast|montelukast|mesh-list
14720577|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720578|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14720579|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14720580|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
14720581|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720582|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720583|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14720584|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14720585|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
14720586|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720587|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14720588|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720589|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
14720590|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
14720591|NCT00482690|Nicotine|nicotine|mesh-list
14720592|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14720593|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
14720594|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720595|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720596|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14720597|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14720598|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
14720599|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720600|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720601|NCT00482716|Iron|iron|mesh-list
14720602|NCT00482716|Dextrans|dextrans|mesh-list
14720603|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
14720604|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14720605|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
14298188|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14298189|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
14298190|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14298191|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
15219094|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219095|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219096|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14298192|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298193|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298194|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14298195|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14298196|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720606|NCT00482716|Trace Elements|trace elements|mesh-ancestor
14720607|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
15219097|NCT05153772|Octreotide|octreotide|mesh-list
15219098|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219099|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219100|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219101|NCT05152862|Bevacizumab|bevacizumab|mesh-list
15219102|NCT05152862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219103|NCT05152862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219104|NCT05152862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15219105|NCT05152862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15219106|NCT05152862|Growth Substances|growth substances|mesh-ancestor
15219107|NCT05152862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219108|NCT05152862|Growth Inhibitors|growth inhibitors|mesh-ancestor
15219109|NCT05151159|Antibodies|antibodies|mesh-list
15219110|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
15219111|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219112|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
15219113|NCT05150782|Curcumin|curcumin|mesh-list
15219114|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
15219115|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219116|NCT05150782|Protective Agents|protective agents|mesh-ancestor
15219117|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219118|NCT05150782|Vitamins|vitamins|mesh-ancestor
15219119|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
15219120|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15219121|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15219122|NCT05150782|Analgesics|analgesics|mesh-ancestor
15219123|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
15219124|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219125|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219126|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15219127|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909394|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219128|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298197|NCT00700661|Montelukast|montelukast|mesh-list
14298198|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15219129|NCT05149560|Ticagrelor|ticagrelor|mesh-list
14720608|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720609|NCT00482716|Hematinics|hematinics|mesh-ancestor
14720610|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
14720611|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
15219130|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15219131|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15219132|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15219133|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15219134|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
15219135|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219136|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219137|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219138|NCT05146674|Tadalafil|tadalafil|mesh-list
15219139|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
15219140|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15219141|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15219142|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219143|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219144|NCT05146674|Urological Agents|urological agents|mesh-ancestor
15225437|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15225438|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225439|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225440|NCT04893161|Belimumab|belimumab|mesh-list
15225441|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225442|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
15225443|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225444|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
15225445|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15225446|NCT04871165|Antibodies|antibodies|mesh-list
14720612|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
14720613|NCT00482755|Sunitinib|sunitinib|mesh-list
14720614|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225447|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
15225448|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225449|NCT04857385|Hemostatics|hemostatics|mesh-list
15225450|NCT04857385|Coagulants|coagulants|mesh-ancestor
15225451|NCT04735185|Anesthetics|anesthetics|mesh-list
15225452|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
15225453|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225454|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225455|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
15225456|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225457|NCT04666389|Atorvastatin|atorvastatin|mesh-list
15225458|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15225459|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15225460|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
15225461|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225462|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15225463|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15225464|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225465|NCT04635631|Talazoparib|talazoparib|mesh-list
15225466|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15225467|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225468|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225469|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225470|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15225471|NCT04614168|Glycerol|glycerol|mesh-list
15225472|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225473|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15225474|NCT04614168|Protective Agents|protective agents|mesh-ancestor
15225475|NCT04559139|Gemcitabine|gemcitabine|mesh-list
15225476|NCT04559139|Cisplatin|cisplatin|mesh-list
15225477|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225478|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15225479|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
15225480|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225481|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
15225482|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720615|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15225483|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298199|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
14909395|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
14298200|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14298201|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
14298202|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298203|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298204|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14298205|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14298206|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298207|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14720616|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720617|NCT00482755|Growth Substances|growth substances|mesh-ancestor
14720618|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720619|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720620|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14720621|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720622|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720623|NCT00482807|Docetaxel|docetaxel|mesh-list
14720624|NCT00482807|Goserelin|goserelin|mesh-list
14720625|NCT00482807|Bicalutamide|bicalutamide|mesh-list
14720626|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720627|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14720628|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14720629|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14720630|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219145|NCT05146635|Epirubicin|epirubicin|mesh-list
15219146|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15219147|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219148|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15219149|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15219150|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219151|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219152|NCT05145569|Paclitaxel|paclitaxel|mesh-list
15219153|NCT05145569|Carboplatin|carboplatin|mesh-list
15219154|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15219155|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219156|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
15219157|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
15219158|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
15219159|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219160|NCT05133518|Midazolam|midazolam|mesh-list
15219161|NCT05133518|Ketamine|ketamine|mesh-list
15219162|NCT05133518|Analgesics|analgesics|mesh-ancestor
15219163|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
15219164|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219165|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219166|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15219167|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15219168|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
15219169|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
15219170|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219171|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15219172|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15219173|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219174|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219175|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15219176|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15219177|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15219178|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15219179|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15219180|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
15219181|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
15219182|NCT05130060|Trifluridine|trifluridine|mesh-list
15219183|NCT05130060|Vaccines|vaccines|mesh-list
14298208|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14720631|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219184|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
15219185|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219186|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
15219187|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219188|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
15219189|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219190|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
14720632|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
15219191|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14298209|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298210|NCT00659711|Incretins|incretins|mesh-ancestor
14298211|NCT00659711|Hormones|hormones|mesh-ancestor
14298212|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219192|NCT05124899|Protective Agents|protective agents|mesh-ancestor
14298213|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14298214|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
15219193|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219194|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
15219195|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
15219196|NCT05119140|Mesalamine|mesalamine|mesh-list
15219197|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
15219198|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15219199|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15219200|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219201|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219202|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219203|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15219204|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15219205|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15219206|NCT05119140|Analgesics|analgesics|mesh-ancestor
15219207|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
15219208|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219209|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219210|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219211|NCT05119075|Dopamine|dopamine|mesh-list
15219212|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
15219213|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15219214|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
15219215|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
15219216|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219217|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219218|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
15219219|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219220|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219221|NCT05119075|Protective Agents|protective agents|mesh-ancestor
15219222|NCT05111262|Budesonide|budesonide|mesh-list
15219223|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
15219224|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219225|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15219226|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
15219227|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219228|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219229|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15219230|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
15219231|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
15219232|NCT05111262|Hormones|hormones|mesh-ancestor
15219233|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219234|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15219235|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15219236|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15219237|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
15219238|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219239|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219240|NCT05099107|Albuterol|albuterol|mesh-list
15219241|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15219242|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
15219243|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219244|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219245|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15219246|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
15219247|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
15219248|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15219249|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15219250|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15219251|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15219252|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
15219253|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720633|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
15219254|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298215|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298216|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720634|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720635|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720636|NCT00482846|Melphalan|melphalan|mesh-list
14720637|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14720638|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
14720639|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720640|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720641|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14720642|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720643|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
14720644|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720645|NCT00482963|Efavirenz|efavirenz|mesh-list
14720646|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
14720647|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14720648|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14720649|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720650|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720651|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
14720652|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720653|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14720654|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14720655|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14720656|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14720657|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14720658|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14909396|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
14298217|NCT00653276|Cyclosporine|cyclosporine|mesh-list
14298218|NCT00653276|Ezetimibe|ezetimibe|mesh-list
14298219|NCT00653276|Cyclosporins|cyclosporins|mesh-list
14298220|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298221|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909397|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
14909398|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219255|NCT05089643|Capecitabine|capecitabine|mesh-list
15219256|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15219257|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
15219258|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219259|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219260|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
15219261|NCT05073627|Dabigatran|dabigatran|mesh-list
15219262|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
15219263|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15219264|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
15219265|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219266|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219267|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
15219268|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15219269|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219270|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
15219271|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15219272|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219273|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219274|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219275|NCT05064488|Metformin|metformin|mesh-list
15219276|NCT05064488|Digoxin|digoxin|mesh-list
15219277|NCT05064488|Sumatriptan|sumatriptan|mesh-list
15219278|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15219279|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15219280|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219281|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15219282|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15219283|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
14909399|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14909400|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909401|NCT01350856|Artesunate|artesunate|mesh-list
14909402|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
14909403|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14298222|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298223|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
14298224|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298225|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
14298226|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219284|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219285|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15219286|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15219287|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219288|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15219289|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15219290|NCT05064488|Protective Agents|protective agents|mesh-ancestor
15219291|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15219292|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15219293|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15219294|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
15219295|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219296|NCT05061524|Omalizumab|omalizumab|mesh-list
15219297|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15219298|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15219299|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
15219300|NCT05060627|Dexamethasone|dexamethasone|mesh-list
15219301|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219302|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
15219303|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
15219304|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219305|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219306|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219307|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
15219308|NCT05060627|Hormones|hormones|mesh-ancestor
15219309|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219310|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219311|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219312|NCT05031494|Gemcitabine|gemcitabine|mesh-list
15219313|NCT05031494|Paclitaxel|paclitaxel|mesh-list
15219314|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15219315|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219316|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
15219317|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
15219318|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
15219319|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219320|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15219321|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
15219322|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
15219323|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219324|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219325|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219326|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
15219327|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219328|NCT05027633|Carboplatin|carboplatin|mesh-list
15219329|NCT05027633|Docetaxel|docetaxel|mesh-list
15219330|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
15219331|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219332|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
15219333|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
15219334|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
15219335|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219336|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219337|NCT05008484|Vitamin D|vitamin d|mesh-list
15219338|NCT05008484|Vitamins|vitamins|mesh-ancestor
15219339|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
15219340|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219341|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15225484|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225485|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
15225486|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225487|NCT04553419|Cephalexin|cephalexin|mesh-list
15225488|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15225489|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225490|NCT04528108|Hemostatics|hemostatics|mesh-list
15225491|NCT04528108|Coagulants|coagulants|mesh-ancestor
15225492|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
15225493|NCT04527549|Trametinib|trametinib|mesh-list
15225494|NCT04527549|Dabrafenib|dabrafenib|mesh-list
14298227|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
14298228|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298229|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14298230|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298231|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298232|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
15219342|NCT05000710|Durvalumab|durvalumab|mesh-list
15219343|NCT05000710|Tremelimumab|tremelimumab|mesh-list
15219344|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219345|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219346|NCT04967248|Fulvestrant|fulvestrant|mesh-list
15219347|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219348|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219349|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15219350|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15219351|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
15219352|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219353|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219354|NCT04965519|Trastuzumab|trastuzumab|mesh-list
14298233|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298234|NCT00652847|Ezetimibe|ezetimibe|mesh-list
14909404|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14909405|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909406|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909407|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
14909408|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
14909409|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14909410|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
14909411|NCT01350882|Rituximab|rituximab|mesh-list
14909412|NCT01350882|Citric Acid|citric acid|mesh-list
14909413|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
14909414|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14909415|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909416|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
14909417|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909418|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14909419|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
14909420|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14909421|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
14909422|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
14909423|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909424|NCT01350921|Ticagrelor|ticagrelor|mesh-list
14909425|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14909426|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14909427|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14909428|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14909429|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
14909430|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909431|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225495|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14909432|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298235|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15219355|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219356|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298236|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298237|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
14298238|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909433|NCT01351038|Capecitabine|capecitabine|mesh-list
15219357|NCT04952389|Budesonide|budesonide|mesh-list
15219358|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219359|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15219360|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
15219361|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219362|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219363|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15219364|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
15219365|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
15219366|NCT04952389|Hormones|hormones|mesh-ancestor
14909434|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
14909435|NCT01351038|Panitumumab|panitumumab|mesh-list
15219367|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219368|NCT04943549|Bupivacaine|bupivacaine|mesh-list
15219369|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
15219370|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
15219371|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219372|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219373|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
15219374|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219375|NCT04931667|Lorecivivint|lorecivivint|mesh-list
15219376|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219377|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
15219378|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
15219379|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15219380|NCT04902131|Menotropins|menotropins|mesh-list
15219381|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15219382|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
15219383|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15219384|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219385|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
15219386|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15219387|NCT04893291|Sirolimus|sirolimus|mesh-list
15219388|NCT04893291|Everolimus|everolimus|mesh-list
15219389|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219390|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219391|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
15219392|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219393|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15219394|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219395|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15219396|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
15219397|NCT04889599|Docetaxel|docetaxel|mesh-list
15219398|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219399|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
15219400|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
15219401|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
15219402|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298239|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14909436|NCT01351038|Epirubicin|epirubicin|mesh-list
14909437|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14909438|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
14909439|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909440|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909441|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14909442|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14909443|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14909444|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14909445|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909446|NCT01351168|Levodopa|levodopa|mesh-list
14909447|NCT01351168|Zolpidem|zolpidem|mesh-list
14909448|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14909449|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15219403|NCT04877587|Gemcitabine|gemcitabine|mesh-list
14298240|NCT00652717|Simvastatin|simvastatin|mesh-list
14298241|NCT00652717|Ezetimibe|ezetimibe|mesh-list
14298242|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298243|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298244|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
14298245|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298246|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298247|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15219404|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219405|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15219406|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
15219407|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219408|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219409|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
15219410|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219411|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219412|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219413|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
15219414|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
15219415|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
15219416|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219417|NCT04842422|Imiquimod|imiquimod|mesh-list
15219418|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15219419|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
15219420|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219421|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219422|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
15219423|NCT04840641|Efavirenz|efavirenz|mesh-list
15219424|NCT04840641|Floxacillin|floxacillin|mesh-list
15219425|NCT04840641|Losartan|losartan|mesh-list
15219426|NCT04840641|Metoprolol|metoprolol|mesh-list
15219427|NCT04840641|Midazolam|midazolam|mesh-list
15219428|NCT04840641|Caffeine|caffeine|mesh-list
15219429|NCT04840641|Omeprazole|omeprazole|mesh-list
15219430|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15219431|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15219432|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219433|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219434|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15219435|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15219436|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15219437|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15219438|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
15219439|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
15219440|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
14720659|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14720660|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
14720661|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14720662|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720663|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14720664|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14720665|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14720666|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
14909450|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
15219441|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
15219442|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219443|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219444|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15219445|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15219446|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14909451|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909452|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909453|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909454|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14909455|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14909456|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909457|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14909458|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
14909459|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
14909460|NCT01351272|Methylphenidate|methylphenidate|mesh-list
14909461|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14909462|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219447|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15219448|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15219449|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15225496|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
14298248|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298249|NCT00652444|Simvastatin|simvastatin|mesh-list
15219450|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15219451|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219452|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15219453|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15219454|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15219455|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15219456|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
15219457|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15219458|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15219459|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
15219460|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219461|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15219462|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15219463|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15219464|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15219465|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15219466|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15219467|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
15219468|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
15219469|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219470|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15219471|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15219472|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15219473|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
15219474|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15219475|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
15219476|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
15219477|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
15219478|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219479|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219480|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
15219481|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219482|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
15219483|NCT04827992|Narcotics|narcotics|mesh-ancestor
15219484|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219485|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219486|NCT04827992|Analgesics|analgesics|mesh-ancestor
15219487|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
15219488|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219489|NCT04802863|Imipenem|imipenem|mesh-list
15219490|NCT04802863|Cilastatin|cilastatin|mesh-list
15219491|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15219492|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219493|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
15219494|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219495|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219496|NCT04802746|Alprazolam|alprazolam|mesh-list
15219497|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15219498|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219499|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219500|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15219501|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15219502|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15219503|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
15219504|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
15219505|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219506|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219507|NCT04801043|Imipenem|imipenem|mesh-list
14298250|NCT00652444|Ezetimibe|ezetimibe|mesh-list
14298251|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298252|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298253|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
14720667|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219508|NCT04801043|Cilastatin|cilastatin|mesh-list
15219509|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15219510|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219511|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
14327592|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
14298254|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298255|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298256|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298257|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298258|NCT00652301|Simvastatin|simvastatin|mesh-list
14298259|NCT00652301|Ezetimibe|ezetimibe|mesh-list
14298260|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14720668|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720669|NCT00482989|Sifalimumab|sifalimumab|mesh-list
14720670|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
14720671|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720672|NCT00483028|Donepezil|donepezil|mesh-list
14298261|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14909463|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15219512|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219513|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219514|NCT04794569|Tinzaparin|tinzaparin|mesh-list
15219515|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15219516|NCT04794569|Dalteparin|dalteparin|mesh-list
15219517|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
15219518|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15219519|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
15219520|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15219521|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
15219522|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219523|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219524|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
15219525|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15219526|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15219527|NCT04791176|Lenvatinib|lenvatinib|mesh-list
15219528|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219529|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15219530|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219531|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219532|NCT04787562|Imipenem|imipenem|mesh-list
15219533|NCT04787562|Cilastatin|cilastatin|mesh-list
15219534|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15219535|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219536|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
15219537|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219538|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219539|NCT04786756|Bupivacaine|bupivacaine|mesh-list
15219540|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
15219541|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
15219542|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219543|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219544|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
15219545|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219546|NCT04784715|Trastuzumab|trastuzumab|mesh-list
15219547|NCT04784715|Pertuzumab|pertuzumab|mesh-list
15219548|NCT04784715|Taxane|taxane|mesh-list
15219549|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219550|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225497|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15225498|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15225499|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225500|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225501|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225502|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225503|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225504|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15225505|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15225506|NCT04527549|Protective Agents|protective agents|mesh-ancestor
14720673|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14720674|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720675|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909464|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14909465|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14909466|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909467|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
14909468|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225507|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225508|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15225509|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
14298262|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
14298263|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298264|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298265|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298266|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219551|NCT04782791|Nivolumab|nivolumab|mesh-list
15219552|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219553|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219554|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15219555|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219556|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
15219557|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
15219558|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219559|NCT04777643|Cannabidiol|cannabidiol|mesh-list
15219560|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
15219561|NCT04776018|Daratumumab|daratumumab|mesh-list
15219562|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219563|NCT04768426|Capecitabine|capecitabine|mesh-list
15219564|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15219565|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
15219566|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219567|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219568|NCT04766086|Vaccines|vaccines|mesh-list
15219569|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
15219570|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219571|NCT04762836|Cycloserine|cycloserine|mesh-list
15219572|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15219573|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219574|NCT04762836|Renal Agents|renal agents|mesh-ancestor
15219575|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15219576|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
15219577|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15219578|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
15219579|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219580|NCT04758949|Nivolumab|nivolumab|mesh-list
15219581|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219582|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219583|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15219584|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219585|NCT04750395|Haloperidol|haloperidol|mesh-list
15219586|NCT04750395|Olanzapine|olanzapine|mesh-list
15219587|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
15219588|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
15219589|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
15219590|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219591|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219592|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219593|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15219594|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15219595|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219596|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15219597|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15219598|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15219599|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15219600|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219601|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219602|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
15219603|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15219604|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
15219605|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15219606|NCT04739735|Anesthetics|anesthetics|mesh-list
15219607|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219608|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219609|NCT04735965|Meperidine|meperidine|mesh-list
14298267|NCT00651963|Ezetimibe|ezetimibe|mesh-list
14298268|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298269|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298270|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
15219610|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
15219611|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15219612|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219613|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219614|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15219615|NCT04735965|Analgesics|analgesics|mesh-ancestor
15219616|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
15219617|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219618|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15219619|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15219620|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15219621|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
15219622|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219623|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219624|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15219625|NCT04735965|Narcotics|narcotics|mesh-ancestor
15219626|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15219627|NCT04734535|Thrombin|thrombin|mesh-list
15219628|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
15219629|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
15219630|NCT04734535|Coagulants|coagulants|mesh-ancestor
15219631|NCT04734379|Fasudil|fasudil|mesh-list
15219632|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15219633|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15219634|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219635|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15219636|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219637|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
15219638|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15219639|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219640|NCT04731272|Dulaglutide|dulaglutide|mesh-list
15219641|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15219642|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219643|NCT04730037|Warfarin|warfarin|mesh-list
15219644|NCT04730037|Edoxaban|edoxaban|mesh-list
15219645|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
15219646|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15219647|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
15219648|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15219649|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
15219650|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219651|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219652|NCT04714190|Paclitaxel|paclitaxel|mesh-list
15219653|NCT04714190|Irinotecan|irinotecan|mesh-list
15219654|NCT04714190|Apatinib|apatinib|mesh-list
15219655|NCT04714190|Trastuzumab|trastuzumab|mesh-list
15219656|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15219657|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219658|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
15219659|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
15219660|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
15219661|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219662|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15219663|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15219664|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219665|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15219666|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219667|NCT04704999|Chloroquine|chloroquine|mesh-list
15219668|NCT04704999|Lumefantrine|lumefantrine|mesh-list
15219669|NCT04704999|Artemether|artemether|mesh-list
15219670|NCT04704999|Tafenoquine|tafenoquine|mesh-list
15219671|NCT04704999|Amebicides|amebicides|mesh-ancestor
15219672|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15219673|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15219674|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219675|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
15219676|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15219677|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
15219678|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15219679|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
14298271|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219680|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219681|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
15219682|NCT04702802|Protective Agents|protective agents|mesh-ancestor
15219683|NCT04702789|Timolol|timolol|mesh-list
14298272|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298273|NCT00651560|Simvastatin|simvastatin|mesh-list
14298274|NCT00651560|Ezetimibe|ezetimibe|mesh-list
14298275|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298276|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298277|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
14298278|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298279|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14720676|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
14720677|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720678|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720679|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
14720680|NCT00483054|Efavirenz|efavirenz|mesh-list
14720681|NCT00483054|Nevirapine|nevirapine|mesh-list
14298280|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298281|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219684|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15219685|NCT04702789|Dorzolamide|dorzolamide|mesh-list
15219686|NCT04702789|Latanoprost|latanoprost|mesh-list
15219687|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15219688|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15219689|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
15219690|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219691|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219692|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720682|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14720683|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14720684|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720685|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909469|NCT01351285|Remifentanil|remifentanil|mesh-list
14909470|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14909471|NCT01351285|Narcotics|narcotics|mesh-ancestor
14909472|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909473|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909474|NCT01351285|Analgesics|analgesics|mesh-ancestor
14909475|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
14909476|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219693|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14720686|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
15219694|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15219695|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15219696|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15219697|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15219698|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15219699|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15219700|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14720687|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720688|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14720689|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14720690|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14720691|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14720692|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14720693|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14720694|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15219701|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219702|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
15219703|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14720695|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15219704|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
14720696|NCT00483067|Cytarabine|cytarabine|mesh-list
14909477|NCT01351298|Lidocaine|lidocaine|mesh-list
14909478|NCT01351298|Xylometazoline|xylometazoline|mesh-list
15219705|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219706|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
15219707|NCT04702776|Protective Agents|protective agents|mesh-ancestor
15219708|NCT04699422|Pirinitramide|pirinitramide|mesh-list
15219709|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15219710|NCT04699422|Narcotics|narcotics|mesh-ancestor
15219711|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298301|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
14298302|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298303|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
14298304|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14298305|NCT00551876|Simvastatin|simvastatin|mesh-list
14298306|NCT00551876|Ezetimibe|ezetimibe|mesh-list
14298307|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14720697|NCT00483067|Cladribine|cladribine|mesh-list
14720698|NCT00483067|Sargramostim|sargramostim|mesh-list
14720699|NCT00483067|Lenograstim|lenograstim|mesh-list
14720700|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720701|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
14720702|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720703|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720704|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
14720705|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720706|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720707|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
14720708|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720709|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14720710|NCT00483093|Cisplatin|cisplatin|mesh-list
14298308|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298309|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
14298310|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298311|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298312|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298313|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298314|NCT00551447|Simvastatin|simvastatin|mesh-list
14298315|NCT00551447|Ezetimibe|ezetimibe|mesh-list
14298316|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298317|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298318|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
14298319|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298320|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14720711|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298321|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15219712|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219713|NCT04699422|Analgesics|analgesics|mesh-ancestor
15219714|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
15219715|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219716|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
15219717|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15219718|NCT04686773|Vaccines|vaccines|mesh-list
15219719|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
15219720|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219721|NCT04684953|Hormones|hormones|mesh-list
15219722|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298322|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298323|NCT00542087|Diclofenac|diclofenac|mesh-list
14720712|NCT00483106|Methylphenidate|methylphenidate|mesh-list
14720713|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14720714|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298324|NCT00542087|Etoricoxib|etoricoxib|mesh-list
14298325|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298326|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298327|NCT00542087|Analgesics|analgesics|mesh-ancestor
14298328|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
14298329|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298330|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298331|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298332|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298333|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298334|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298335|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298336|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14298337|NCT00541697|Atorvastatin|atorvastatin|mesh-list
14298338|NCT00541697|Simvastatin|simvastatin|mesh-list
14298339|NCT00541697|Ezetimibe|ezetimibe|mesh-list
14298340|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298341|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298342|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
14298343|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298344|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298345|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298346|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298347|NCT00489346|Fluticasone|fluticasone|mesh-list
14298348|NCT00489346|Xhance|xhance|mesh-list
14298349|NCT00489346|Montelukast|montelukast|mesh-list
14298350|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298351|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14298352|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
14298353|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298354|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298355|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14298356|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
14298357|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
14298358|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14298359|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298360|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14298361|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
14298362|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298363|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14298364|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14298365|NCT00395603|Atorvastatin|atorvastatin|mesh-list
14298366|NCT00395603|Simvastatin|simvastatin|mesh-list
14298367|NCT00395603|Ezetimibe|ezetimibe|mesh-list
14298368|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298369|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298370|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
14298371|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298372|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298373|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298374|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298375|NCT00395473|Ezetimibe|ezetimibe|mesh-list
14298376|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14909479|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
14298377|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298378|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
14298379|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298380|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298381|NCT00393354|Etoricoxib|etoricoxib|mesh-list
14298382|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298383|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298384|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298385|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298386|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298387|NCT00393354|Analgesics|analgesics|mesh-ancestor
14298388|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
14298389|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298390|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298391|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14298392|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298393|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298394|NCT00393211|Etoricoxib|etoricoxib|mesh-list
14298395|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298396|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298397|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298398|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298399|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298400|NCT00393211|Analgesics|analgesics|mesh-ancestor
14298401|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
14298402|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298403|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298404|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14720715|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14720716|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14720717|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14720718|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298405|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298406|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298407|NCT00328523|Ezetimibe|ezetimibe|mesh-list
14909480|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
14909481|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909482|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909483|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
14909484|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298408|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14720719|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
14720720|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720721|NCT00483132|Interferons|interferons|mesh-list
14720722|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
14720723|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
14720724|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720725|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
14720726|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720727|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
14720728|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720729|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14720730|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14720731|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14720732|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14720733|NCT00483158|Finafloxacin|finafloxacin|mesh-list
14720734|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15219723|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219724|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15219725|NCT04674020|Erenumab|erenumab|mesh-list
15219726|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
15219727|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219728|NCT04674020|Analgesics|analgesics|mesh-ancestor
15219729|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
15225510|NCT04521114|Leronlimab|leronlimab|mesh-list
14298409|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14909485|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14909486|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14909487|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14909488|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14909489|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909490|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
14909491|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14909492|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
14909493|NCT01351428|Nifedipine|nifedipine|mesh-list
14909494|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14909495|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14917087|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298410|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
14298411|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298412|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298413|NCT00269191|Ibuprofen|ibuprofen|mesh-list
14298414|NCT00269191|Etoricoxib|etoricoxib|mesh-list
14298415|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298416|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298417|NCT00269191|Analgesics|analgesics|mesh-ancestor
14298418|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
14298419|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298420|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298421|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298422|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298423|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298424|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298425|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298426|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14298427|NCT00251576|Heparin|heparin|mesh-list
14298428|NCT00251576|Calcium heparin|calcium heparin|mesh-list
14298429|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14298430|NCT00251576|Tinzaparin|tinzaparin|mesh-list
14298431|NCT00251576|Dalteparin|dalteparin|mesh-list
14298432|NCT00251576|Tirofiban|tirofiban|mesh-list
14298433|NCT00251576|Simvastatin|simvastatin|mesh-list
14298434|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
14298435|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14298436|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14298437|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720735|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720736|NCT00483158|Renal Agents|renal agents|mesh-ancestor
14720737|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14298438|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298439|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14720738|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14720739|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14720740|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720741|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720742|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720743|NCT00483210|Fenofibrate|fenofibrate|mesh-list
14720744|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14720745|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
14720746|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720747|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14720748|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
14720749|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
15219730|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219731|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219732|NCT04673786|Ustekinumab|ustekinumab|mesh-list
15219733|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
15219734|NCT04667637|Edaravone|edaravone|mesh-list
15219735|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15219736|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
15219737|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219738|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15219739|NCT04667637|Protective Agents|protective agents|mesh-ancestor
15219740|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298440|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
14298441|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14720750|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14720751|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720752|NCT00483275|Vitamins|vitamins|mesh-ancestor
14720753|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
14720754|NCT00483301|Sorafenib|sorafenib|mesh-list
14720755|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14720756|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720757|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14720758|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720759|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720760|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
14720761|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14720762|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
14720763|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720764|NCT00483314|Expectorants|expectorants|mesh-ancestor
14720765|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720766|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14720767|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
14720768|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720769|NCT00483314|Protective Agents|protective agents|mesh-ancestor
14720770|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720771|NCT00483314|Antidotes|antidotes|mesh-ancestor
14720772|NCT00483366|Gemcitabine|gemcitabine|mesh-list
14720773|NCT00483366|Capecitabine|capecitabine|mesh-list
14720774|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
14720775|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720776|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
14720777|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720778|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720779|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
14720780|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720781|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720782|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720783|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
14720784|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720785|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14720786|NCT00483392|Metformin|metformin|mesh-list
14720787|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
14720788|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14298442|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298443|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298444|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14298445|NCT00250445|Diclofenac|diclofenac|mesh-list
14298446|NCT00250445|Etoricoxib|etoricoxib|mesh-list
14298447|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298448|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298449|NCT00250445|Analgesics|analgesics|mesh-ancestor
14720789|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720790|NCT00483431|Vitamin MK 7|vitamin mk 7|mesh-list
14720791|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
14720792|NCT00483431|Coagulants|coagulants|mesh-ancestor
14720793|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14720794|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720795|NCT00483470|Vaccines|vaccines|mesh-list
14720796|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
14720797|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720798|NCT00483600|PENTA|penta|mesh-list
14720799|NCT00483600|Fondaparinux|fondaparinux|mesh-list
14909496|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298450|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
14298451|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298452|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298453|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298454|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298455|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298456|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298457|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298458|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14298459|NCT00242489|Diclofenac|diclofenac|mesh-list
14298460|NCT00242489|Etoricoxib|etoricoxib|mesh-list
14298461|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298462|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298463|NCT00242489|Analgesics|analgesics|mesh-ancestor
14720800|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14720801|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
14720802|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14720803|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
14298464|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
14298465|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298466|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298467|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298468|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298469|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298470|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298471|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298472|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14298473|NCT00166530|Atorvastatin|atorvastatin|mesh-list
14298474|NCT00166530|Simvastatin|simvastatin|mesh-list
14298475|NCT00166530|Ezetimibe|ezetimibe|mesh-list
14298476|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298477|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298478|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
14298479|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298480|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298481|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298482|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298483|NCT00092833|Ezetimibe|ezetimibe|mesh-list
14298484|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298485|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298486|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
14298487|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298488|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14720804|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720805|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720806|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
14720807|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14720808|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14720809|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
14720810|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
14720811|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14298489|NCT00092716|Atorvastatin|atorvastatin|mesh-list
14298490|NCT00092716|Ezetimibe|ezetimibe|mesh-list
14298491|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14298492|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14298493|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
14298494|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720812|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14720813|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720814|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720815|NCT00483626|Urological Agents|urological agents|mesh-ancestor
14720816|NCT00483730|Actovegin|actovegin|mesh-list
14720817|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14720818|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720819|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14720820|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720821|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
14298495|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298496|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14298497|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298498|NCT00588094|Rituximab|rituximab|mesh-list
14720822|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720823|NCT00483730|Protective Agents|protective agents|mesh-ancestor
14720824|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14720825|NCT00483743|Budesonide|budesonide|mesh-list
14720826|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720827|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14720828|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
14720829|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720830|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720831|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14720832|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
14720833|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
14298499|NCT00588094|Carboplatin|carboplatin|mesh-list
14298500|NCT00588094|Etoposide|etoposide|mesh-list
14298501|NCT00588094|Ifosfamide|ifosfamide|mesh-list
14298502|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14298503|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298504|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
14298505|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298506|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298507|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14298508|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14298509|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14720834|NCT00483743|Hormones|hormones|mesh-ancestor
14720835|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720836|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
14298510|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298511|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298512|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14298513|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
14298514|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
14298515|NCT00588159|Promethazine|promethazine|mesh-list
14298516|NCT00588159|Gabapentin|gabapentin|mesh-list
14298517|NCT00588159|Analgesics|analgesics|mesh-ancestor
14720837|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14720838|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720839|NCT00483782|Paclitaxel|paclitaxel|mesh-list
14720840|NCT00483782|Bevacizumab|bevacizumab|mesh-list
14720841|NCT00483782|Carboplatin|carboplatin|mesh-list
14720842|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14720843|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720844|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
14720845|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
14720846|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
14720847|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720848|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14720849|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720850|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720851|NCT00483782|Growth Substances|growth substances|mesh-ancestor
14720852|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298518|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
14298519|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298520|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298521|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
14298522|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14298523|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14298524|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298525|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14298526|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14298527|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14298528|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219741|NCT04659317|Oxycodone|oxycodone|mesh-list
15219742|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15219743|NCT04659317|Narcotics|narcotics|mesh-ancestor
15219744|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219745|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219746|NCT04659317|Analgesics|analgesics|mesh-ancestor
15219747|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
14298529|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298530|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
14298531|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14298532|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14298533|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
14298534|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
14298535|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
14298536|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
14298537|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14298538|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14298539|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
14298540|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
14298541|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14298542|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
14298543|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14298544|NCT00588237|Paclitaxel|paclitaxel|mesh-list
14298545|NCT00588237|Bevacizumab|bevacizumab|mesh-list
14298546|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14298547|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298548|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14298549|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14298550|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14298551|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298552|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14298553|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14720853|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720854|NCT00483795|Citric Acid|citric acid|mesh-list
14720855|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
14720856|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
14720857|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14720858|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
14720859|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
14720860|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720861|NCT00483834|Bevacizumab|bevacizumab|mesh-list
14720862|NCT00483834|Capecitabine|capecitabine|mesh-list
14720863|NCT00483834|Irinotecan|irinotecan|mesh-list
14720864|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14720865|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720866|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14298554|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14298555|NCT00588237|Growth Substances|growth substances|mesh-ancestor
14298556|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298557|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
14298558|NCT00588341|Temozolomide|temozolomide|mesh-list
14298559|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14298560|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
14298561|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298562|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298563|NCT00588354|Triamcinolone|triamcinolone|mesh-list
14298564|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14720867|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14720868|NCT00483834|Growth Substances|growth substances|mesh-ancestor
14720869|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720870|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
14720871|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14720872|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
14720873|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219748|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720874|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14720875|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14720876|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720877|NCT00483860|Topotecan|topotecan|mesh-list
14720878|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14720879|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14720880|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720881|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720882|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720883|NCT00483886|Prucalopride|prucalopride|mesh-list
14720884|NCT00483886|Laxatives|laxatives|mesh-ancestor
14720885|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720886|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14720887|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14720888|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
14720889|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720890|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720891|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720892|NCT00483964|Olanzapine|olanzapine|mesh-list
14720893|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
14720894|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
14720895|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720896|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720897|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720898|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14720899|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14720900|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720901|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14720902|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14298565|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14298566|NCT00588354|Lidocaine|lidocaine|mesh-list
14298567|NCT00588354|Clonidine|clonidine|mesh-list
14298568|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14298569|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
14298570|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
14298571|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298572|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298573|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
14298574|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298575|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14298576|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14720903|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14720904|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14720905|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720906|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720907|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
14720908|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14720909|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
14720910|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
14720911|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14720912|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720913|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
14720914|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720915|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14720916|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
14720917|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14720918|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14720919|NCT00484003|Analgesics|analgesics|mesh-ancestor
14720920|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
14720921|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720922|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720923|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720924|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14720925|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
14720926|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720927|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
14720928|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14720929|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909497|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14909498|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909499|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
14298577|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14298578|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327593|NCT00803062|Paclitaxel|paclitaxel|mesh-list
14720930|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720931|NCT00484055|Gentamicins|gentamicins|mesh-list
14720932|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14720933|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720934|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14720935|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219749|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
15219750|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15219751|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219752|NCT04641312|Dulaglutide|dulaglutide|mesh-list
14720936|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720937|NCT00484068|Enalapril|enalapril|mesh-list
14720938|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14720939|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
14720940|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720941|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219753|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15219754|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219755|NCT04635423|Vaccines|vaccines|mesh-list
14298579|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298580|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298581|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
14298582|NCT00588354|Hormones|hormones|mesh-ancestor
14298583|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298584|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298585|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
14298586|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298587|NCT00588354|Analgesics|analgesics|mesh-ancestor
15219756|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
15219757|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219758|NCT04611802|Vaccines|vaccines|mesh-list
14298588|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14298589|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
14298590|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
14298591|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15219759|NCT04611802|Immunologic Factors|immunologic factors|mesh-ancestor
15219760|NCT04611802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219761|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
15219762|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
15219763|NCT04611763|Analgesics|analgesics|mesh-ancestor
15219764|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
15219765|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219766|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219767|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14298592|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14298593|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14298594|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
14298595|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298596|NCT00588406|Prednisone|prednisone|mesh-list
14298597|NCT00588406|Budesonide|budesonide|mesh-list
14298598|NCT00588406|Bromides|bromides|mesh-list
14298599|NCT00588406|Albuterol|albuterol|mesh-list
14298600|NCT00588406|Ipratropium|ipratropium|mesh-list
14298601|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298602|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
14298603|NCT00588406|Hormones|hormones|mesh-ancestor
14298604|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298605|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298606|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14298607|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298608|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14720942|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14729070|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729071|NCT00521300|Octreotide|octreotide|mesh-list
14729072|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729073|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14729074|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729075|NCT00521430|Cyclosporine|cyclosporine|mesh-list
14729076|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
14729077|NCT00521430|Methotrexate|methotrexate|mesh-list
15219768|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15219769|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219770|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15219771|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14298609|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
14729078|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
14729079|NCT00521430|Fludarabine|fludarabine|mesh-list
14298610|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729080|NCT00521430|Busulfan|busulfan|mesh-list
14729081|NCT00521430|Cyclosporins|cyclosporins|mesh-list
14729082|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14729083|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14729084|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
14729085|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14729086|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729087|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729088|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
14729089|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729090|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729091|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
14729092|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729093|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14729094|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729095|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
14729096|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729097|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14729098|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
14729099|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729100|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14729101|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729102|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
14729103|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
14729104|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729105|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729106|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
14729107|NCT00521430|Hormones|hormones|mesh-ancestor
14729108|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729109|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14729110|NCT00521430|Protective Agents|protective agents|mesh-ancestor
14729111|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
14729112|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15219772|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219773|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219774|NCT04608786|Capecitabine|capecitabine|mesh-list
15219775|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15219776|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
14298611|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14327594|NCT00803062|Bevacizumab|bevacizumab|mesh-list
14729113|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14729114|NCT00521482|Thalidomide|thalidomide|mesh-list
14720943|NCT00484107|Estrogens|estrogens|mesh-list
14720944|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14720945|NCT00484107|Hormones|hormones|mesh-ancestor
14720946|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14720947|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720948|NCT00484120|Diclofenac|diclofenac|mesh-list
14298612|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
14298613|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
14298614|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
14298615|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14298616|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14298617|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14298618|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14298619|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
14298620|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298621|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298622|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14298623|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
14720949|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14720950|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14720951|NCT00484120|Analgesics|analgesics|mesh-ancestor
14720952|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
14298624|NCT00588445|Gefitinib|gefitinib|mesh-list
14298625|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14720953|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720954|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720955|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720956|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14720957|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14720958|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720959|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720960|NCT00484133|Dobutamine|dobutamine|mesh-list
14720961|NCT00484133|Dopamine|dopamine|mesh-list
14720962|NCT00484133|Enoximone|enoximone|mesh-list
14720963|NCT00484133|Norepinephrine|norepinephrine|mesh-list
14720964|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
14720965|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
14720966|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14720967|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
14720968|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
14720969|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720970|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720971|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14720972|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14720973|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14720974|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
14720975|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14720976|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14720977|NCT00484133|Protective Agents|protective agents|mesh-ancestor
14720978|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
14720979|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14720980|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14720981|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14720982|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14720983|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14720984|NCT00484237|Etanercept|etanercept|mesh-list
14720985|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14720986|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14720987|NCT00484237|Analgesics|analgesics|mesh-ancestor
14720988|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
14720989|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14720990|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14720991|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14720992|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14720993|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14720994|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14720995|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
14909500|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
14720996|NCT00484250|Metronidazole|metronidazole|mesh-list
14720997|NCT00484250|Doxycycline|doxycycline|mesh-list
14909501|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14909502|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
14909503|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14327595|NCT00803062|Cisplatin|cisplatin|mesh-list
14720998|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14720999|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14909504|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
14721000|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14721001|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14721002|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
14721003|NCT00484328|Ribavirin|ribavirin|mesh-list
14721004|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
14721005|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721006|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
14721007|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721008|NCT00484341|Doxorubicin|doxorubicin|mesh-list
14721009|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721010|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721011|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14721012|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721013|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721014|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721015|NCT00484432|Doxorubicin|doxorubicin|mesh-list
14721016|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721017|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721018|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14721019|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14298626|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14298627|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298628|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298629|NCT00588536|Leucovorin|leucovorin|mesh-list
14298630|NCT00588536|Methotrexate|methotrexate|mesh-list
14298631|NCT00588536|Thioguanine|thioguanine|mesh-list
14298632|NCT00588536|Calcium|calcium|mesh-list
14298633|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
14298634|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14298635|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298636|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14298637|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
14298638|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14721020|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721021|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721022|NCT00484484|Ketamine|ketamine|mesh-list
14721023|NCT00484484|Analgesics|analgesics|mesh-ancestor
14721024|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
14721025|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721026|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721027|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14721028|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14721029|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
14721030|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
14721031|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721032|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14721033|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14721034|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721035|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721036|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
14721037|NCT00484510|Vitamins|vitamins|mesh-ancestor
14721038|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
14721039|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721040|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
14721041|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721042|NCT00484510|Protective Agents|protective agents|mesh-ancestor
14721043|NCT00484575|Propofol|propofol|mesh-list
14298639|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14298640|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
14298641|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298642|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298643|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14298644|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721044|NCT00484575|Sevoflurane|sevoflurane|mesh-list
14721045|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14721046|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721047|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721048|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14721049|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
14721050|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
14721051|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14721052|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14721053|NCT00484601|Doxorubicin|doxorubicin|mesh-list
14721054|NCT00484601|Ifosfamide|ifosfamide|mesh-list
14721055|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721056|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721057|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14721058|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721059|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721060|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721061|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14298645|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14298646|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298647|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
14298648|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298649|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14298650|NCT00588536|Antidotes|antidotes|mesh-ancestor
14298651|NCT00588536|Protective Agents|protective agents|mesh-ancestor
14721062|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
14721063|NCT00484640|Warfarin|warfarin|mesh-list
14721064|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
14721065|NCT00484692|Bupropion|bupropion|mesh-list
14721066|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14721067|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721068|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721069|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14721070|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721071|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721072|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721073|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
14721074|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721075|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721076|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14721077|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14721078|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721079|NCT00484731|Bupivacaine|bupivacaine|mesh-list
14721080|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
14721081|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
14721082|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721083|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721084|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
14721085|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721086|NCT00484744|Acetaminophen|acetaminophen|mesh-list
14721087|NCT00484744|Ibuprofen|ibuprofen|mesh-list
14721088|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721089|NCT00484744|Analgesics|analgesics|mesh-ancestor
14721090|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
14721091|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298652|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
14298653|NCT00588536|Vitamins|vitamins|mesh-ancestor
14721092|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721093|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
14721094|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14721095|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721096|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721097|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14721098|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721099|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721100|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14721101|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
14721102|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721103|NCT00484809|Etanercept|etanercept|mesh-list
14721104|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14721105|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721106|NCT00484809|Analgesics|analgesics|mesh-ancestor
14721107|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
14721108|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298654|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
14298655|NCT00588640|Methadone|methadone|mesh-list
14298656|NCT00588640|D-methadone|d-methadone|mesh-list
14298657|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14298658|NCT00588640|Narcotics|narcotics|mesh-ancestor
14298659|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298660|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298661|NCT00588640|Analgesics|analgesics|mesh-ancestor
14298662|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
14298663|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298664|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
14298665|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
14298666|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14298667|NCT00588666|Gemcitabine|gemcitabine|mesh-list
14298668|NCT00588666|Bevacizumab|bevacizumab|mesh-list
14298669|NCT00588666|Carboplatin|carboplatin|mesh-list
14298670|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14298671|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298672|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14298673|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14298674|NCT00588666|Growth Substances|growth substances|mesh-ancestor
14298675|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219777|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219778|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225511|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15225512|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15225513|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225514|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15225515|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15225516|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
15225517|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225729|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219779|NCT04603911|Dexamethasone|dexamethasone|mesh-list
15219780|NCT04603911|Clonidine|clonidine|mesh-list
15219781|NCT04603911|Epinephrine|epinephrine|mesh-list
14298676|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
14298677|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14298678|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
14298679|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298680|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
14298681|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14298682|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298683|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298684|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
14298685|NCT00588731|Cannabidiol|cannabidiol|mesh-list
14298686|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
14298687|NCT00588822|Rituximab|rituximab|mesh-list
14298688|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14298689|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298690|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
14721109|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721110|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721111|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721112|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721113|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721114|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
14721115|NCT00484822|Heparin|heparin|mesh-list
14721116|NCT00484822|Calcium heparin|calcium heparin|mesh-list
14721117|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
14721118|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14721119|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14721120|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721121|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14721122|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
14721123|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14721124|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14721125|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721126|NCT00484926|Aspirin|aspirin|mesh-list
14721127|NCT00484926|Clopidogrel|clopidogrel|mesh-list
14721128|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14721129|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721130|NCT00484926|Analgesics|analgesics|mesh-ancestor
14721131|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
14721132|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721133|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721134|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721135|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721136|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14721137|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14721138|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721139|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14721140|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14721141|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721142|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
14721143|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14721144|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14721145|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14721146|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
14721147|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721148|NCT00484991|Verapamil|verapamil|mesh-list
14721149|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14721150|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14721151|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721152|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729115|NCT00521482|Temozolomide|temozolomide|mesh-list
14298691|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298692|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298693|NCT00588900|Irinotecan|irinotecan|mesh-list
14298694|NCT00588900|Cediranib|cediranib|mesh-list
14298695|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14298696|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14298697|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298698|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298699|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298700|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15219782|NCT04603911|Bupivacaine|bupivacaine|mesh-list
14298701|NCT00588952|Ketamine|ketamine|mesh-list
14298702|NCT00588952|Analgesics|analgesics|mesh-ancestor
14298703|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
14298704|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721153|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14721154|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298705|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298706|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14298707|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14298708|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
14721155|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
14721156|NCT00485004|Sirolimus|sirolimus|mesh-list
14721157|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14721158|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721159|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721160|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721161|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
14721162|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721163|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
14721164|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721165|NCT00485030|Sirolimus|sirolimus|mesh-list
14721166|NCT00485030|Everolimus|everolimus|mesh-list
14721167|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721168|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721169|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
14721170|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721171|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14909505|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909506|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298709|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
14298710|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298711|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14721172|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721173|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721174|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
14721175|NCT00485056|Pioglitazone|pioglitazone|mesh-list
14721176|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14298712|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14298713|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298714|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298715|NCT00588965|Propranolol|propranolol|mesh-list
14298716|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14298717|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14298718|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
14298719|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298720|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298721|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298722|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14298723|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14298724|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
14298725|NCT00589056|Nelfinavir|nelfinavir|mesh-list
14298726|NCT00589056|Etoposide|etoposide|mesh-list
14298727|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298728|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14298729|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14298730|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14298731|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298732|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298733|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14298734|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14298735|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
14298736|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14721177|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721178|NCT00485108|Prednisolone|prednisolone|mesh-list
14721179|NCT00485108|Ketorolac|ketorolac|mesh-list
14721180|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
14298737|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14298738|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
14298739|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721181|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721182|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
14721183|NCT00485108|Hormones|hormones|mesh-ancestor
14721184|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14721185|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298740|NCT00589290|Belinostat|belinostat|mesh-list
14298741|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298742|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14298743|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298744|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298745|NCT00589303|Metoprolol|metoprolol|mesh-list
14298746|NCT00589303|Amiodarone|amiodarone|mesh-list
14298747|NCT00589303|Verapamil|verapamil|mesh-list
14298748|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14721186|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14721187|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721188|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721189|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14721190|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721191|NCT00485108|Analgesics|analgesics|mesh-ancestor
14721192|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
14721193|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721194|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14721195|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721196|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721197|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14721198|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14721199|NCT00485121|Ezetimibe|ezetimibe|mesh-list
14721200|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15219783|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219784|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
15219785|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
15219786|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219787|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219788|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219789|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
15219790|NCT04603911|Hormones|hormones|mesh-ancestor
15219791|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14721201|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14721202|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
14721203|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721204|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14298749|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14298750|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
14298751|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
14298752|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298753|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298754|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14298755|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14298756|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14298757|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
14298758|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298759|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298760|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
14298761|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14298762|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721205|NCT00485160|Ibuprofen|ibuprofen|mesh-list
14721206|NCT00485160|Indomethacin|indomethacin|mesh-list
14721207|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14721208|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721209|NCT00485160|Analgesics|analgesics|mesh-ancestor
14721210|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
14721211|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721212|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721213|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721214|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721215|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14721216|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721217|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721218|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
14721219|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
14721220|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14721221|NCT00485238|Acetazolamide|acetazolamide|mesh-list
14721222|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
15219792|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219793|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219794|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
15219795|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
15219796|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219797|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
15219798|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15219799|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15219800|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
15219801|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219802|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219803|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15219804|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15219805|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15219806|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
15219807|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
15219808|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
15219809|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15219810|NCT04603911|Analgesics|analgesics|mesh-ancestor
15219811|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15219812|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
15219813|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15219814|NCT04595266|Leucovorin|leucovorin|mesh-list
15219815|NCT04595266|Bevacizumab|bevacizumab|mesh-list
15219816|NCT04595266|Fluorouracil|fluorouracil|mesh-list
15219817|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
14298763|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14298764|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14298765|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14298766|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298767|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14298768|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14298769|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14298770|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14298771|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14298772|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14298773|NCT00589329|Metronidazole|metronidazole|mesh-list
14298774|NCT00589329|Erythromycin|erythromycin|mesh-list
14721223|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14721224|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721225|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721226|NCT00485238|Diuretics|diuretics|mesh-ancestor
14721227|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
14721228|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721229|NCT00485342|Interferons|interferons|mesh-list
14721230|NCT00485342|Ribavirin|ribavirin|mesh-list
14721231|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
14721232|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
14721233|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14721234|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721235|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
14721236|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721237|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
14721238|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721239|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
14721240|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721241|NCT00485368|Perindopril|perindopril|mesh-list
14721242|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14721243|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
14721244|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721245|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721246|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14721247|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14721248|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721249|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721250|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721251|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721252|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721253|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721254|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721255|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14721256|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721257|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721258|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721259|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721260|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721261|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721262|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721263|NCT00485498|Olanzapine|olanzapine|mesh-list
14721264|NCT00485498|Risperidone|risperidone|mesh-list
14721265|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14721266|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
14721267|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298775|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
15219818|NCT04595266|Irinotecan|irinotecan|mesh-list
15219819|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219820|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219821|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15219822|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15219823|NCT04595266|Growth Substances|growth substances|mesh-ancestor
14721268|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721269|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721270|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14721271|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14721272|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721273|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721274|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14721275|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
14721276|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
14721277|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
14721278|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721279|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219824|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219825|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
15219826|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
15219827|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219828|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15219829|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219830|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
14298776|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14298777|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
14298778|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721280|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721281|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721282|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721283|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
14298779|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14298780|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14298781|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14298782|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14298783|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721284|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298784|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298785|NCT00589472|Vorinostat|vorinostat|mesh-list
14721285|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
14721286|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721287|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721288|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14721289|NCT00485550|Methylphenidate|methylphenidate|mesh-list
14298786|NCT00589472|Leuprolide|leuprolide|mesh-list
15219831|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14298787|NCT00589472|Goserelin|goserelin|mesh-list
15219832|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15219833|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219834|NCT04595266|Antidotes|antidotes|mesh-ancestor
15219835|NCT04595266|Protective Agents|protective agents|mesh-ancestor
15219836|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
15219837|NCT04595266|Vitamins|vitamins|mesh-ancestor
15219838|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
15219839|NCT04594798|Prednisone|prednisone|mesh-list
15219840|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
15219841|NCT04594798|Rituximab|rituximab|mesh-list
14298788|NCT00589472|Bicalutamide|bicalutamide|mesh-list
14298789|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298790|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14298791|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298792|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298793|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14298794|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
14298795|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14298796|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298797|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14298798|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
14298799|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
15219842|NCT04594798|Doxorubicin|doxorubicin|mesh-list
15219843|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219844|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
15219845|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219846|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15219847|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15219848|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
15219849|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219850|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219851|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15219852|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15219853|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15219854|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15219855|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15219856|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219857|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298800|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14298801|NCT00589563|Sirolimus|sirolimus|mesh-list
14298802|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
14298803|NCT00589563|Melphalan|melphalan|mesh-list
14298804|NCT00589563|Methotrexate|methotrexate|mesh-list
14298805|NCT00589563|Fludarabine|fludarabine|mesh-list
14721290|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14721291|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15219858|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
14298806|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
14298807|NCT00589563|Etoposide|etoposide|mesh-list
14298808|NCT00589563|Tacrolimus|tacrolimus|mesh-list
14298809|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14298810|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298811|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
14298812|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298813|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298814|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14298815|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
14298816|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298817|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219859|NCT04594798|Hormones|hormones|mesh-ancestor
14721292|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721293|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14721294|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721295|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721296|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721297|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
14721298|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721299|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721300|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721301|NCT00485576|Eculizumab|eculizumab|mesh-list
14721302|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14721303|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721304|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
14721305|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721306|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14298818|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14298819|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14298820|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
14721307|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721308|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721309|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721310|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721311|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
14298821|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14298822|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14298823|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
14298824|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
14298825|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298826|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14298827|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14298828|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14298829|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14298830|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14298831|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14298832|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14298833|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14298834|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14298835|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
14298836|NCT00589628|Infliximab|infliximab|mesh-list
14298837|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
14721312|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721313|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721314|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
14721315|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14721316|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721317|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14721318|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721319|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721320|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721321|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298838|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14298839|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14298840|NCT00589667|Gemcitabine|gemcitabine|mesh-list
14298841|NCT00589667|Pemetrexed|pemetrexed|mesh-list
14298842|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14298843|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
14298844|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298845|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298846|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
14298847|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14298848|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298849|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14298850|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
14298851|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298852|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14298853|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14298854|NCT00589693|Imipenem|imipenem|mesh-list
14298855|NCT00589693|Doripenem|doripenem|mesh-list
14298856|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14298857|NCT00589693|Cilastatin|cilastatin|mesh-list
14298858|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14298859|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14298860|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
14298861|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298862|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721322|NCT00485680|Olanzapine|olanzapine|mesh-list
14721323|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
14721324|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
14721325|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
14721326|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721327|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721328|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721329|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14298863|NCT00589784|Sunitinib|sunitinib|mesh-list
14298864|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
14298865|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298866|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14298867|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14298868|NCT00589784|Growth Substances|growth substances|mesh-ancestor
14298869|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298870|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
14298871|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14298872|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298873|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298874|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14298875|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14298876|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14298877|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14298878|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14327596|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14327597|NCT00803062|Topotecan|topotecan|mesh-list
14327598|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14327599|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
14327600|NCT00803062|Antibodies|antibodies|mesh-list
14327601|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
14327602|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14327603|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
14327604|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14327605|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327606|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14327607|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14327608|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14327609|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721330|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14721331|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721332|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721333|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721334|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721335|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721336|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721337|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721338|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
14721339|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721340|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721341|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
14721342|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
14721343|NCT00485706|Calcium|calcium|mesh-list
14721344|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14721345|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721346|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14729116|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14729117|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
14729118|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729119|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729120|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729121|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
14729122|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729123|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
14729124|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14298879|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14298880|NCT00589914|Risperidone|risperidone|mesh-list
14298881|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14298882|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14298883|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298884|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298885|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14298886|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14729125|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729126|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14729127|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14729128|NCT00521482|Growth Substances|growth substances|mesh-ancestor
14729129|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
14729130|NCT00521521|Docetaxel|docetaxel|mesh-list
14729131|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729132|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
14729133|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729134|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
14298887|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14298888|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
14298889|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298890|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298891|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14298892|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14298893|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
14298894|NCT00589979|Lidocaine|lidocaine|mesh-list
14298895|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
14298896|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
14298897|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298898|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298899|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
14298900|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298901|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14298902|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14298903|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14298904|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14298905|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298906|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
14298907|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14298908|NCT00590031|Irinotecan|irinotecan|mesh-list
14298909|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298910|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14729135|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729136|NCT00521612|Sevoflurane|sevoflurane|mesh-list
14729137|NCT00521612|Isoflurane|isoflurane|mesh-list
14729138|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14729139|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14729140|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
14721347|NCT00485771|Lamotrigine|lamotrigine|mesh-list
14721348|NCT00485771|Olanzapine|olanzapine|mesh-list
14721349|NCT00485771|Fluoxetine|fluoxetine|mesh-list
14298911|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14298912|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298913|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298914|NCT00590044|Insulin|insulin|mesh-list
14298915|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14298916|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
14298917|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
14298918|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14298919|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298920|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
14298921|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14298922|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14298923|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298924|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14298925|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14298926|NCT00590161|Protective Agents|protective agents|mesh-ancestor
14298927|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298928|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
14298929|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14298930|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
14298931|NCT00590226|Insulin|insulin|mesh-list
14298932|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14298933|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
14298934|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
14298935|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
14298936|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
14721350|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
14721351|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
14298937|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14298938|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298939|NCT00590317|Ondansetron|ondansetron|mesh-list
14298940|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
14298941|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
14298942|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
14298943|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14298944|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298945|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14298946|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
14298947|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
14298948|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14298949|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
14298950|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298951|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298952|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14298953|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14298954|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298955|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14298956|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14298957|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14298958|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
14298959|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14298960|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14298961|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298962|NCT00590460|Fludarabine|fludarabine|mesh-list
14298963|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
14298964|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14298965|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14298966|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14298967|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15219860|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219861|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219862|NCT04592536|Alprazolam|alprazolam|mesh-list
15219863|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15219864|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219865|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219866|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15219867|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15219868|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15219869|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
15219870|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
15219871|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219872|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219873|NCT04552535|Afatinib|afatinib|mesh-list
15219874|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219875|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15219876|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219877|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219878|NCT04541797|Empagliflozin|empagliflozin|mesh-list
15219879|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15219880|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298968|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14298969|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298970|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298971|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14298972|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14298973|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14298974|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
14298975|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298976|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298977|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14298978|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14298979|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
14298980|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
14298981|NCT00590590|Promethazine|promethazine|mesh-list
14298982|NCT00590590|Lidocaine|lidocaine|mesh-list
14298983|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
14298984|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
14298985|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14298986|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14298987|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
14298988|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721352|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721353|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721354|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721355|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14721356|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14721357|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721358|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721359|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15219881|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15219882|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219883|NCT04531553|Bupivacaine|bupivacaine|mesh-list
15219884|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
14298989|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14298990|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14298991|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14298992|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721360|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721361|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721362|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721363|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14298993|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14298994|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14298995|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14721364|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
14721365|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14721366|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721367|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14721368|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14721369|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721370|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
14721371|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14721372|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14721373|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14721374|NCT00485797|Methylphenidate|methylphenidate|mesh-list
14721375|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14721376|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721377|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14721378|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14729141|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
15219885|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
15219886|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219887|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219888|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
15219889|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219890|NCT04529265|Methylene Blue|methylene blue|mesh-list
15219891|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219892|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219893|NCT04528680|Paclitaxel|paclitaxel|mesh-list
14298996|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
14298997|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
14298998|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14298999|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14299000|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
14299001|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
14299002|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299003|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14299004|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
14299005|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
14299006|NCT00590681|Bevacizumab|bevacizumab|mesh-list
14299007|NCT00590681|Temozolomide|temozolomide|mesh-list
14721379|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721380|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721381|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
14299008|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299009|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299010|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14299011|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299012|NCT00590681|Growth Substances|growth substances|mesh-ancestor
14299013|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299014|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
14299015|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299016|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
14299017|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721382|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721383|NCT00485810|Olanzapine|olanzapine|mesh-list
14721384|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
14721385|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
14721386|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721387|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721388|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721389|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14721390|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14721391|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721392|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721393|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721394|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14299018|NCT00590772|Montelukast|montelukast|mesh-list
14299019|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14299020|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
14299021|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14299022|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
14299023|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14909507|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14909508|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
14909509|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14909510|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
14909511|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909512|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909513|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14909514|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
14299024|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299025|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14299026|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14299027|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721395|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721396|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721397|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721398|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
14721399|NCT00485823|Olanzapine|olanzapine|mesh-list
14721400|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
14299028|NCT00590824|Interleukin-2|interleukin-2|mesh-list
14299029|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299030|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14299031|NCT00590824|Analgesics|analgesics|mesh-ancestor
14299032|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
14299033|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299034|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299035|NCT00590863|Dexetimide|dexetimide|mesh-list
14299036|NCT00590863|Mirtazapine|mirtazapine|mesh-list
14299037|NCT00590863|Citalopram|citalopram|mesh-list
14721401|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
14909515|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
14909516|NCT01351493|Protective Agents|protective agents|mesh-ancestor
14299038|NCT00590863|Bupropion|bupropion|mesh-list
14299039|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14299040|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14299041|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14299042|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299043|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299044|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299045|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
14299046|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299047|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14299048|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
14299049|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721402|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721403|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721404|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721405|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14721406|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14721407|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721408|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721409|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721410|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721411|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721412|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721413|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721414|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
14721415|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14299050|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14299051|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14299052|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
14299053|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
14299054|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299055|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14299056|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14299057|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
14299058|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14299059|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
14299060|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14299061|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14299062|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299063|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14299064|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14299065|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
14299066|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
14299067|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14299068|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299069|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299070|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14299071|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14721416|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721417|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721418|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721419|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721420|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721421|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721422|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721423|NCT00485862|Sertraline|sertraline|mesh-list
14721424|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14299072|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14299073|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
14299074|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14299075|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14299076|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14299077|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14299078|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299079|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14299080|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299081|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299082|NCT00590967|Cisplatin|cisplatin|mesh-list
14299083|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299084|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
14299085|NCT00591006|Phenytoin|phenytoin|mesh-list
14299086|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14299087|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
14299088|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14299089|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14299090|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299091|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299092|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14299093|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14299094|NCT00591019|Modafinil|modafinil|mesh-list
14299095|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14299096|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299097|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14299098|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14299099|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14299100|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299101|NCT00591123|Leucovorin|leucovorin|mesh-list
14909517|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14909518|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14299102|NCT00591123|Fluorouracil|fluorouracil|mesh-list
14299103|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
14299104|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14299105|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
14299106|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299107|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
14299108|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299109|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14299110|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299111|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299112|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
14299113|NCT00591123|Antidotes|antidotes|mesh-ancestor
14721425|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721426|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721427|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721428|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721429|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721430|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721431|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721432|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
14721433|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721434|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14909519|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
14299114|NCT00591123|Protective Agents|protective agents|mesh-ancestor
14299115|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
14721435|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
15219894|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15219895|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15219896|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299116|NCT00591123|Vitamins|vitamins|mesh-ancestor
14299117|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
14721436|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14721437|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14299118|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14299119|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299120|NCT00591149|Docetaxel|docetaxel|mesh-list
14299121|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
14299122|NCT00591149|Cetuximab|cetuximab|mesh-list
14299123|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299124|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
14299125|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
14299126|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
14299127|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721438|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721439|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721440|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721441|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721442|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721443|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721444|NCT00485888|Citalopram|citalopram|mesh-list
14721445|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721446|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721447|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721448|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721449|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721450|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
14721451|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721452|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14721453|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721454|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721455|NCT00485901|Haloperidol|haloperidol|mesh-list
14721456|NCT00485901|Olanzapine|olanzapine|mesh-list
14721457|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
14721458|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
14721459|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
14721460|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721461|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721462|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14299128|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299129|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14299130|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14299131|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14299132|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299133|NCT00591266|Amlodipine|amlodipine|mesh-list
14299134|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14299135|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14299136|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14299137|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299138|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299139|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14299140|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299141|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
15219897|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
15219898|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
15219899|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
15219900|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219901|NCT04520685|Cannabidiol|cannabidiol|mesh-list
15219902|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
15219903|NCT04515329|Cyclosporine|cyclosporine|mesh-list
15219904|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
15219905|NCT04515329|Cyclosporins|cyclosporins|mesh-list
15219906|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219907|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219908|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219909|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
15219910|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299142|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14299143|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14299144|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14299145|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14299146|NCT00591305|Protective Agents|protective agents|mesh-ancestor
14299147|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299148|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299149|NCT00591370|Temozolomide|temozolomide|mesh-list
14299150|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299151|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
14299152|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299153|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299154|NCT00591565|Acamprosate|acamprosate|mesh-list
14299155|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14299156|NCT00591578|Valsartan|valsartan|mesh-list
14299157|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14299158|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14299159|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14299160|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14299161|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299162|NCT00591630|Cytarabine|cytarabine|mesh-list
14299163|NCT00591630|Rituximab|rituximab|mesh-list
14299164|NCT00591630|Etoposide|etoposide|mesh-list
14299165|NCT00591630|Melphalan|melphalan|mesh-list
14299166|NCT00591630|Carmustine|carmustine|mesh-list
14299167|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299168|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299169|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
14299170|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299171|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299172|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14299173|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14299174|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14299175|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299176|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299177|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14299178|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
14299179|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
14299180|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299181|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299182|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299183|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
14299184|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14299185|NCT00591734|Bevacizumab|bevacizumab|mesh-list
14299186|NCT00591734|Everolimus|everolimus|mesh-list
14299187|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299188|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299189|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14299190|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299191|NCT00591734|Growth Substances|growth substances|mesh-ancestor
14299192|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299193|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14299194|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299195|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
14299196|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
14299197|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14721463|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14721464|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14721465|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721466|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721467|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721468|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721469|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721470|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721471|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721472|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
14721473|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14721474|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
14721475|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14299198|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14299199|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14299200|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299201|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14721476|NCT00485940|Prucalopride|prucalopride|mesh-list
14721477|NCT00485940|Laxatives|laxatives|mesh-ancestor
14721478|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721479|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14721480|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14721481|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
14721482|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721483|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721484|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721485|NCT00485979|Docetaxel|docetaxel|mesh-list
14299202|NCT00591773|Diuretics|diuretics|mesh-ancestor
14721486|NCT00485979|Trastuzumab|trastuzumab|mesh-list
14721487|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299203|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
14299204|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299205|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14299206|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299207|NCT00591825|Cycloserine|cycloserine|mesh-list
14299208|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14299209|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299210|NCT00591825|Renal Agents|renal agents|mesh-ancestor
14299211|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14299212|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
14299213|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14299214|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
14299215|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299216|NCT00591851|Paclitaxel|paclitaxel|mesh-list
14299217|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
14299218|NCT00591851|Doxorubicin|doxorubicin|mesh-list
14299219|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14299220|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14299221|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299222|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
14299223|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
14299224|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
14299225|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299226|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299227|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
14721488|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14721489|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14721490|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14721491|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721492|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14721493|NCT00486005|Olanzapine|olanzapine|mesh-list
14721494|NCT00486005|Nizatidine|nizatidine|mesh-list
14721495|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
14721496|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
14721497|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721498|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721499|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721500|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14721501|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299228|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299229|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299230|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299231|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
14299232|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14299233|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14299234|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14299235|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721502|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721503|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721504|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14721505|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721506|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721507|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721508|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721509|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
14721510|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14721511|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14721512|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
14721513|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
14299236|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299237|NCT00592072|Decanoic acid|decanoic acid|mesh-list
14299238|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
14299239|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299240|NCT00592124|Tenofovir|tenofovir|mesh-list
14299241|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
14299242|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299243|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14299244|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14299245|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299246|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299247|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14299248|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14299249|NCT00592176|Bevacizumab|bevacizumab|mesh-list
14299250|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299251|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299252|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14299253|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299254|NCT00592176|Growth Substances|growth substances|mesh-ancestor
14299255|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299256|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
14299257|NCT00592319|Celecoxib|celecoxib|mesh-list
14299258|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14299259|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14299260|NCT00592319|Analgesics|analgesics|mesh-ancestor
14299261|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
14299262|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721514|NCT00486083|Methylphenidate|methylphenidate|mesh-list
14721515|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14721516|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14721517|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219911|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
15219912|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15219913|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
14721518|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14721519|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721520|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721521|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721522|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
14721523|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721524|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721525|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721526|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14721527|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721528|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721529|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721530|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721531|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721532|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721533|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721534|NCT00486174|Methylene Blue|methylene blue|mesh-list
14721535|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721536|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721537|NCT00486187|Metformin|metformin|mesh-list
14721538|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
14721539|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14721540|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721541|NCT00486213|Pyridoxine|pyridoxine|mesh-list
14721542|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
14721543|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
14721544|NCT00486213|Vitamins|vitamins|mesh-ancestor
14721545|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
14721546|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721547|NCT00486317|Calcitonin|calcitonin|mesh-list
14721548|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
14721549|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14721550|NCT00486317|Katacalcin|katacalcin|mesh-list
14721551|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14721552|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721553|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15219914|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15219915|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14299263|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299264|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219916|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14721554|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
14721555|NCT00486343|Zileuton|zileuton|mesh-list
14299265|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299266|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14299267|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14299268|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299269|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299270|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14299271|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14299272|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299273|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299274|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299275|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299276|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14299277|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14299278|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
14299279|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299280|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299281|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14299282|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14299283|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
14721556|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14721557|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721558|NCT00486343|Analgesics|analgesics|mesh-ancestor
14721559|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
14721560|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721561|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721562|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721563|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721564|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14721565|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721566|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721567|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14721568|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
15219917|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15219918|NCT04508790|Dexamethasone|dexamethasone|mesh-list
15219919|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
15219920|NCT04508790|Pomalidomide|pomalidomide|mesh-list
15219921|NCT04508790|Ichthammol|ichthammol|mesh-list
15219922|NCT04508790|BB 1101|bb 1101|mesh-list
15219923|NCT04508790|Leflunomide|leflunomide|mesh-list
15219924|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219925|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
15219926|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
15219927|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219928|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219929|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219930|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
14721569|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14721570|NCT00486356|Carboplatin|carboplatin|mesh-list
14721571|NCT00486356|Capecitabine|capecitabine|mesh-list
14721572|NCT00486356|Epirubicin|epirubicin|mesh-list
14721573|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219931|NCT04508790|Hormones|hormones|mesh-ancestor
15219932|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219933|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219934|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299284|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14299285|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14299286|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14299287|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299288|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721574|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14299289|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299290|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299291|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14299292|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
14299293|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299294|NCT00592475|Conivaptan|conivaptan|mesh-list
14721575|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
14721576|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721577|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721578|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14721579|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721580|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721581|NCT00486369|Calcitonin|calcitonin|mesh-list
14721582|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
14721583|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14721584|NCT00486369|Katacalcin|katacalcin|mesh-list
14721585|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14721586|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721587|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14909520|NCT01351597|Docetaxel|docetaxel|mesh-list
14909521|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
14909522|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909523|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
14909524|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
14909525|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
14909526|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909527|NCT01351636|Arotinolol|arotinolol|mesh-list
14909528|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14721588|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
14721589|NCT00486421|Prednisone|prednisone|mesh-list
14721590|NCT00486421|Rituximab|rituximab|mesh-list
14721591|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14721592|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721593|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
14721594|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219935|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
14299295|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14299296|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299297|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
14299298|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299299|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
14299300|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
14299301|NCT00592488|Vitamins|vitamins|mesh-ancestor
14299302|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
14299303|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299304|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
14299305|NCT00592501|Fluorouracil|fluorouracil|mesh-list
14299306|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299307|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
14299308|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299309|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14299310|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721595|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14909529|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15219936|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15219937|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219938|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
15219939|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14299311|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
14299312|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721596|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721597|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
14721598|NCT00486421|Hormones|hormones|mesh-ancestor
14721599|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219940|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15219941|NCT04508790|Growth Substances|growth substances|mesh-ancestor
15219942|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
15219943|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
15219944|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15219945|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15219946|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15219947|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219948|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
15219949|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
15219950|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15219951|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15219952|NCT04503668|Dexamethasone|dexamethasone|mesh-list
14721600|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14721601|NCT00486460|Gemcitabine|gemcitabine|mesh-list
14299313|NCT00592683|Aripiprazole|aripiprazole|mesh-list
14299314|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
14299315|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299316|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14299317|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299318|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299319|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299320|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
14299321|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
14299322|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299323|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299324|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14299325|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14299326|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
14299327|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14299328|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14299329|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14299330|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14299331|NCT00592839|Estrogens|estrogens|mesh-list
14299332|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14299333|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
14299334|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
14299335|NCT00592839|Hormones|hormones|mesh-ancestor
14299336|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14299337|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299338|NCT00592852|Fluoxetine|fluoxetine|mesh-list
14299339|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14299340|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14299341|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721602|NCT00486460|Curcumin|curcumin|mesh-list
14721603|NCT00486460|Celecoxib|celecoxib|mesh-list
14721604|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14721605|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
14721606|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299342|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299343|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299344|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
14299345|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299346|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14721607|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721608|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
14721609|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299347|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721610|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721611|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721612|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
14721613|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721614|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14721615|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721616|NCT00486460|Analgesics|analgesics|mesh-ancestor
14721617|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
14721618|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721619|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721620|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721621|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14721622|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14721623|NCT00486486|Timolol|timolol|mesh-list
14721624|NCT00486486|Bimatoprost|bimatoprost|mesh-list
14721625|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14721626|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14721627|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721628|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721629|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721630|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721631|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14721632|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14721633|NCT00486564|Nifurtimox|nifurtimox|mesh-list
14721634|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14299348|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299349|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14299350|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14299351|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299352|NCT00592943|Modafinil|modafinil|mesh-list
14299353|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14299354|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299355|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14299356|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14299357|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14299358|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299359|NCT00593112|Methylphenidate|methylphenidate|mesh-list
14299360|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14299361|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299362|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14299363|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14299364|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299365|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299366|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
14299367|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299368|NCT00593450|Bevacizumab|bevacizumab|mesh-list
14299369|NCT00593450|Ranibizumab|ranibizumab|mesh-list
14299370|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299371|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299372|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14299373|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299374|NCT00593450|Growth Substances|growth substances|mesh-ancestor
14299375|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299376|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14299377|NCT00593489|Insulin|insulin|mesh-list
14299378|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14299379|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721635|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14721636|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14721637|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721638|NCT00486668|Paclitaxel|paclitaxel|mesh-list
14721639|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
14721640|NCT00486668|Doxorubicin|doxorubicin|mesh-list
14721641|NCT00486668|Trastuzumab|trastuzumab|mesh-list
14721642|NCT00486668|Lapatinib|lapatinib|mesh-list
14721643|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14721644|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721645|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
14721646|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
14721647|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
14721648|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721649|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721650|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
14721651|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721652|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721653|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14721654|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
14721655|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14721656|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721657|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14721658|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721659|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721660|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14721661|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14721662|NCT00486694|Artesunate|artesunate|mesh-list
14721663|NCT00486694|Chloroquine|chloroquine|mesh-list
14721664|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
14721665|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
14721666|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14721667|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
14721668|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14721669|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14721670|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721671|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721672|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
14721673|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
14721674|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14721675|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
14721676|NCT00486694|Amebicides|amebicides|mesh-ancestor
14721677|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721678|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14721679|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721680|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721681|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14721682|NCT00486694|Renal Agents|renal agents|mesh-ancestor
14721683|NCT00486772|Calcium|calcium|mesh-list
14721684|NCT00486772|Sevelamer|sevelamer|mesh-list
14721685|NCT00486772|Calcium acetate|calcium acetate|mesh-list
14721686|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14721687|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721688|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
14721689|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
14721690|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721691|NCT00486785|Alfuzosin|alfuzosin|mesh-list
14721692|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14721693|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14721694|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14721695|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721696|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721697|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721698|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721699|NCT00486785|Urological Agents|urological agents|mesh-ancestor
14721700|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14721701|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721702|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721703|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14721704|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14721705|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721706|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299380|NCT00593554|Fludarabine|fludarabine|mesh-list
14299381|NCT00593554|Thiotepa|thiotepa|mesh-list
14299382|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
14721707|NCT00486876|Tofisopam|tofisopam|mesh-list
14721708|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721709|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721710|NCT00486980|Peramivir|peramivir|mesh-list
14721711|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
14721712|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721713|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721714|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721715|NCT00487032|Fluticasone|fluticasone|mesh-list
14721716|NCT00487032|Xhance|xhance|mesh-list
14721717|NCT00487032|Prazosin|prazosin|mesh-list
14299383|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14299384|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299385|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299386|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721718|NCT00487032|Phenylephrine|phenylephrine|mesh-list
14721719|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
14299387|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
14299388|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299389|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299390|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
14299391|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14299392|NCT00593606|Rotigotine|rotigotine|mesh-list
14299393|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
14721720|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721721|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14299394|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
14299395|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299396|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299397|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299398|NCT00593645|Cytarabine|cytarabine|mesh-list
14299399|NCT00593645|Clofarabine|clofarabine|mesh-list
14299400|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
14299401|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14299402|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14299403|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
14299404|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299405|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299406|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
14299407|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299408|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721722|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
14721723|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721724|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721725|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14721726|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
14721727|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
14721728|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14721729|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14721730|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14721731|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14721732|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14721733|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721734|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721735|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721736|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14721737|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14721738|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
14721739|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
14721740|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14721741|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14721742|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
14721743|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15219953|NCT04503668|Ondansetron|ondansetron|mesh-list
15219954|NCT04503668|Olanzapine|olanzapine|mesh-list
14721744|NCT00487032|Protective Agents|protective agents|mesh-ancestor
15219955|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
15219956|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
15219957|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
15219958|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15219959|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
15219960|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
15219961|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219962|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219963|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15219964|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
15219965|NCT04503668|Hormones|hormones|mesh-ancestor
15219966|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15219967|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15219968|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15219969|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
15219970|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
14721745|NCT00487110|Acetaminophen|acetaminophen|mesh-list
14721746|NCT00487110|Tropisetron|tropisetron|mesh-list
14721747|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721748|NCT00487110|Analgesics|analgesics|mesh-ancestor
14721749|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
14721750|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721751|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721752|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
14721753|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
14721754|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
14721755|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721756|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14721757|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14721758|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
14721759|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721760|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721761|NCT00487123|Valsartan|valsartan|mesh-list
14721762|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14721763|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14721764|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14721765|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14721766|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721767|NCT00487123|Diuretics|diuretics|mesh-ancestor
14721768|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
14721769|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721770|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14721771|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721772|NCT00487136|Warfarin|warfarin|mesh-list
14721773|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14721774|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
14721775|NCT00487136|Fenofibrate|fenofibrate|mesh-list
14721776|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14721777|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14721778|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
14721779|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721780|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14721781|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14721782|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721783|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
14721784|NCT00487175|Tramadol|tramadol|mesh-list
14721785|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14721786|NCT00487175|Narcotics|narcotics|mesh-ancestor
14721787|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721788|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721789|NCT00487175|Analgesics|analgesics|mesh-ancestor
14721790|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
14721791|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721792|NCT00487227|Caffeine|caffeine|mesh-list
14721793|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14721794|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721795|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14721796|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721797|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721798|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14721799|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15219971|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14299409|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
14299410|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299411|NCT00593827|Epothilones|epothilones|mesh-list
14299412|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
14299413|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
14299414|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
14299415|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299416|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299417|NCT00593866|Gemcitabine|gemcitabine|mesh-list
14299418|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14299419|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
14299420|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299421|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299422|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
14299423|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721800|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
14721801|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721802|NCT00487253|Miltefosine|miltefosine|mesh-list
14721803|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14299424|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299425|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299426|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
14299427|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219972|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
15219973|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15219974|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15219975|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15219976|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15219977|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219978|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15219979|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15219980|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15219981|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15219982|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15219983|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15219984|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
15219985|NCT04502550|Propofol|propofol|mesh-list
15219986|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15219987|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15219988|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219989|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15219990|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
15219991|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
15219992|NCT04502407|Cisplatin|cisplatin|mesh-list
14299428|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
14299429|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
14299430|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
14721804|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
14909530|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909531|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909532|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909533|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219993|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299431|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14721805|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721806|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721807|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14721808|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14721809|NCT00487422|Prucalopride|prucalopride|mesh-list
14721810|NCT00487422|Laxatives|laxatives|mesh-ancestor
14721811|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721812|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14721813|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14721814|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
14909534|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14909535|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14909536|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14909537|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
14909538|NCT01351818|Hormones|hormones|mesh-list
14299432|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14299433|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299434|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299435|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299436|NCT00594165|Rotigotine|rotigotine|mesh-list
14299437|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
14299438|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
14299439|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299440|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299441|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299442|NCT00594204|Varenicline|varenicline|mesh-list
14299443|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14299444|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14299445|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
14299446|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299447|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299448|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299449|NCT00594230|Panobinostat|panobinostat|mesh-list
14299450|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299451|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14299452|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299453|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299454|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
14299455|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14299456|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14299457|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
14299458|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
14299459|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299460|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299461|NCT00594308|Cyclosporine|cyclosporine|mesh-list
14299462|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
14299463|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
14299464|NCT00594308|Fludarabine|fludarabine|mesh-list
14299465|NCT00594308|Cyclosporins|cyclosporins|mesh-list
14299466|NCT00594308|Basiliximab|basiliximab|mesh-list
14299467|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299468|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
14299469|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299470|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299471|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299472|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
14299473|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299474|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299475|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14299476|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299477|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
14299478|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299479|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
14299480|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14299481|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14299482|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14299483|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
14299484|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14327610|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14327611|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14327612|NCT00803062|Growth Substances|growth substances|mesh-ancestor
14327613|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327614|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
14327615|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
14327616|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14327617|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14327618|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327619|NCT00803101|Protein C|protein c|mesh-list
14327620|NCT00803101|Protein S|protein s|mesh-list
14327621|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
14327622|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14327623|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14327624|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327625|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14327626|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14327627|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327628|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327629|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327630|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327631|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327632|NCT00803361|Analgesics|analgesics|mesh-ancestor
14327633|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
14327634|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327635|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
14327636|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14327637|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
14327638|NCT00803400|Alprazolam|alprazolam|mesh-list
14327639|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14327640|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14327641|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327642|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14327643|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14327644|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14327645|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
14327646|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
14327647|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327648|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327649|NCT00803452|Azithromycin|azithromycin|mesh-list
14327650|NCT00803452|Doxycycline|doxycycline|mesh-list
14327651|NCT00803452|Minocycline|minocycline|mesh-list
14721815|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299485|NCT00594386|Rotigotine|rotigotine|mesh-list
14299486|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
14299487|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
14299488|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299489|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299490|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299491|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14299492|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14299493|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15219994|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
15219995|NCT04481672|Analgesics|analgesics|mesh-ancestor
15219996|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
15219997|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15219998|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15219999|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
14299494|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
14299495|NCT00594464|Rotigotine|rotigotine|mesh-list
14299496|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
14299497|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
14299498|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299499|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299500|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299501|NCT00594516|Tapentadol|tapentadol|mesh-list
14299502|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14299503|NCT00594516|Narcotics|narcotics|mesh-ancestor
14909539|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14909540|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220000|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220001|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15220002|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
15220003|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15220004|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220005|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909541|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14909542|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14909543|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
14909544|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909545|NCT01351948|Antacids|antacids|mesh-ancestor
15220006|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14299504|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299505|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299506|NCT00594516|Analgesics|analgesics|mesh-ancestor
14299507|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
14299508|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299509|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14299510|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14299511|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299512|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299513|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
14299514|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299515|NCT00594646|Tenofovir|tenofovir|mesh-list
14299516|NCT00594646|Emtricitabine|emtricitabine|mesh-list
14299517|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
14299518|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14721816|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721817|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721818|NCT00487448|Cytarabine|cytarabine|mesh-list
14721819|NCT00487448|Fludarabine|fludarabine|mesh-list
14721820|NCT00487448|Idarubicin|idarubicin|mesh-list
14721821|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721822|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14721823|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
14721824|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299519|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
14299520|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299521|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14299522|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14299523|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299524|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299525|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14299526|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14299527|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14299528|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14299529|NCT00594815|Leucovorin|leucovorin|mesh-list
14299530|NCT00594815|Cytarabine|cytarabine|mesh-list
14299531|NCT00594815|Rituximab|rituximab|mesh-list
14299532|NCT00594815|Methotrexate|methotrexate|mesh-list
14299533|NCT00594815|Vincristine|vincristine|mesh-list
14299534|NCT00594815|Procarbazine|procarbazine|mesh-list
14299535|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299536|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299537|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
14299538|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299539|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299540|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14299541|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
14299542|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14299543|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14299544|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
14299545|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299546|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14299547|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299548|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14299549|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299550|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14299551|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
14299552|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299553|NCT00594815|Antidotes|antidotes|mesh-ancestor
14299554|NCT00594815|Protective Agents|protective agents|mesh-ancestor
14299555|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
14299556|NCT00594815|Vitamins|vitamins|mesh-ancestor
14299557|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
14299558|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14299559|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14299560|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14299561|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14299562|NCT00594854|Diclofenac|diclofenac|mesh-list
14299563|NCT00594854|Arthrotec|arthrotec|mesh-list
14299564|NCT00594854|Misoprostol|misoprostol|mesh-list
14299565|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14299566|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
14299567|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14299568|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299569|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14299570|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14299571|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
14299572|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14299573|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14299574|NCT00594854|Analgesics|analgesics|mesh-ancestor
14299575|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
14299576|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299577|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14299578|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299579|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14299580|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299581|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299582|NCT00594880|Interferons|interferons|mesh-list
14299583|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
14299584|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
14299585|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14299586|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299587|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
14299588|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299589|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
14299590|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299591|NCT00594906|Teriparatide|teriparatide|mesh-list
14299592|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14299593|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299594|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14299595|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
14299596|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14299597|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299598|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14299599|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
14299600|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14299601|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299602|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299603|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299604|NCT00594945|Clonazepam|clonazepam|mesh-list
14299605|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
14299606|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
14299607|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
14299608|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721825|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14721826|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
14721827|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721828|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
14721829|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721830|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14721831|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14721832|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721833|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721834|NCT00487591|Simvastatin|simvastatin|mesh-list
14721835|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14721836|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14299609|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299610|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299611|NCT00594958|Vaccines|vaccines|mesh-list
14299612|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
14721837|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
14721838|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721839|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14721840|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14721841|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729142|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220007|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
14299613|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299614|NCT00595101|Latanoprost|latanoprost|mesh-list
14299615|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14299616|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14299617|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
15220008|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14721842|NCT00487682|Valacyclovir|valacyclovir|mesh-list
14721843|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
14721844|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721845|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
14721846|NCT00487734|Testosterone|testosterone|mesh-list
14721847|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
14721848|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
14721849|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14721850|NCT00487734|Androgens|androgens|mesh-ancestor
14721851|NCT00487734|Hormones|hormones|mesh-ancestor
14909546|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909547|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14909548|NCT01352026|Metformin|metformin|mesh-list
14909549|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14909550|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909551|NCT01352039|Heparin|heparin|mesh-list
14909552|NCT01352039|Calcium heparin|calcium heparin|mesh-list
14909553|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
14909554|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14909555|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14909556|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909557|NCT01352065|Bosentan|bosentan|mesh-list
14909558|NCT01352065|Ambrisentan|ambrisentan|mesh-list
14909559|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14909560|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14909561|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909562|NCT01352091|Goserelin|goserelin|mesh-list
14909563|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14909564|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220009|NCT04470778|Famotidine|famotidine|mesh-list
15220010|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15220011|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15220012|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15220013|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
15220014|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
15220015|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220016|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299618|NCT00595127|Fludarabine|fludarabine|mesh-list
14299619|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299620|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
14299621|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299622|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299623|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299624|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
14299625|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299626|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299627|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14299628|NCT00595153|Budesonide|budesonide|mesh-list
14299629|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14299630|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14299631|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
14299632|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299633|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299634|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14299635|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
14299636|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
14299637|NCT00595153|Hormones|hormones|mesh-ancestor
14299638|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14299639|NCT00595231|Rufinamide|rufinamide|mesh-list
14299640|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
14299641|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14299642|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14299643|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299644|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299645|NCT00595270|Vaccines|vaccines|mesh-list
14299646|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
14299647|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299648|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
14299649|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14299650|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14299651|NCT00595335|Prednisolone|prednisolone|mesh-list
14299652|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
14299653|NCT00595335|Rituximab|rituximab|mesh-list
14909565|NCT01352130|Ondansetron|ondansetron|mesh-list
14909566|NCT01352130|Granisetron|granisetron|mesh-list
14721852|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14299654|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14299655|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
14299656|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299657|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299658|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
14299659|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299660|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299661|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14299662|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
14299663|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
14299664|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299665|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14299666|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
14299667|NCT00595335|Hormones|hormones|mesh-ancestor
14299668|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14299669|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14299670|NCT00595335|Protective Agents|protective agents|mesh-ancestor
14299671|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14299672|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14299673|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14299674|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
14299675|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299676|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299677|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14299678|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
15220017|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220018|NCT04464798|Rituximab|rituximab|mesh-list
15220019|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
15220020|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220021|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220022|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
15220023|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220024|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220025|NCT04418427|Aflibercept|aflibercept|mesh-list
14299679|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14299680|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14299681|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14299682|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
14299683|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299684|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299685|NCT00595413|Adalimumab|adalimumab|mesh-list
14299686|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14299687|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299688|NCT00595517|Esomeprazole|esomeprazole|mesh-list
14299689|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14299690|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14299691|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14299692|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299693|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299694|NCT00595530|Ketamine|ketamine|mesh-list
14299695|NCT00595530|Analgesics|analgesics|mesh-ancestor
14299696|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
14299697|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299698|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299699|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14299700|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14299701|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
14299702|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
14299703|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299704|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14299705|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14299706|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299707|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299708|NCT00595556|Zonisamide|zonisamide|mesh-list
14299709|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
14299710|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14299711|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299712|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299713|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14299714|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299715|NCT00595790|Vaccines|vaccines|mesh-list
14721853|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220026|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15220027|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299716|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
14299717|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299718|NCT00595868|Varenicline|varenicline|mesh-list
14721854|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14721855|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721856|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
14721857|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
14721858|NCT00487773|Budesonide|budesonide|mesh-list
14721859|NCT00487773|Albuterol|albuterol|mesh-list
14721860|NCT00487773|Montelukast|montelukast|mesh-list
14299719|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14299720|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14299721|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
14299722|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299723|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299724|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299725|NCT00595946|Lubiprostone|lubiprostone|mesh-list
14299726|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14299727|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299728|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299729|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14299730|NCT00596167|Vancomycin|vancomycin|mesh-list
14299731|NCT00596167|Levofloxacin|levofloxacin|mesh-list
14299732|NCT00596167|Gentamicins|gentamicins|mesh-list
14299733|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299734|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14299735|NCT00596167|Renal Agents|renal agents|mesh-ancestor
14299736|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14299737|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14299738|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299739|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299740|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299741|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14299742|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14299743|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14299744|NCT00596271|Vaccines|vaccines|mesh-list
14299745|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
14299746|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299747|NCT00596362|Bevacizumab|bevacizumab|mesh-list
14299748|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299749|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299750|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15220028|NCT04418427|Growth Substances|growth substances|mesh-ancestor
15220029|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220030|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
15220031|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225518|NCT04504942|Leronlimab|leronlimab|mesh-list
15225519|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15225520|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15225521|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225522|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15225523|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15225524|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
15225525|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721861|NCT00487773|Vitamins|vitamins|mesh-ancestor
14721862|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
15225526|NCT04485039|Sevelamer|sevelamer|mesh-list
14299751|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299752|NCT00596362|Growth Substances|growth substances|mesh-ancestor
14299753|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299754|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
14299755|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14299756|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14299757|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14299758|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
14299759|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299760|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14299761|NCT00596440|Nicotine|nicotine|mesh-list
14299762|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14299763|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
14299764|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299765|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299766|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14299767|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14299768|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
14721863|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721864|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14721865|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14721866|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
14721867|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721868|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14721869|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14721870|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
14721871|NCT00487773|Hormones|hormones|mesh-ancestor
14721872|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14721873|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14721874|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14721875|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14721876|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14721877|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299769|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299770|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299771|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
14299772|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14299773|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14299774|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14299775|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14299776|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299777|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299778|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299779|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14299780|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14299781|NCT00596466|Pregabalin|pregabalin|mesh-list
14299782|NCT00596466|Analgesics|analgesics|mesh-ancestor
14299783|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
14299784|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299785|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299786|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
14299787|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14299788|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299789|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299790|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14299791|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14299792|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299793|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299794|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299795|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
14299796|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
14299797|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299798|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299799|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299800|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
14299801|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299802|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299803|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299804|NCT00596687|Insulin|insulin|mesh-list
14299805|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14299806|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
14299807|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
14299808|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14299809|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299810|NCT00596752|Alprostadil|alprostadil|mesh-list
14299811|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14299812|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
14299813|NCT00596752|Urological Agents|urological agents|mesh-ancestor
14299814|NCT00596817|Vortioxetine|vortioxetine|mesh-list
14299815|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
14299816|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299817|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14299818|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299819|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299820|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299821|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14299822|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14299823|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299824|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299825|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299826|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
14299827|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14299828|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14299829|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14299830|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14299831|NCT00596830|Paclitaxel|paclitaxel|mesh-list
15220032|NCT04412863|Interferons|interferons|mesh-list
15220033|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
15220034|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
15220035|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15220036|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220037|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
15220038|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220039|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
15220040|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220041|NCT04412785|Cyclosporine|cyclosporine|mesh-list
14299832|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14299833|NCT00596830|Carboplatin|carboplatin|mesh-list
14299834|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14299835|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299836|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
14299837|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
14299838|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
14299839|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299840|NCT00597038|Dasatinib|dasatinib|mesh-list
14299841|NCT00597038|Dacarbazine|dacarbazine|mesh-list
14299842|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220042|NCT04412785|Cyclosporins|cyclosporins|mesh-list
15220043|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299843|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14299844|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299845|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299846|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299847|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
14299848|NCT00597116|Vinorelbine|vinorelbine|mesh-list
14299849|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14299850|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299851|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
14299852|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14299853|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14299854|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299855|NCT00597402|Bevacizumab|bevacizumab|mesh-list
14299856|NCT00597402|Irinotecan|irinotecan|mesh-list
14299857|NCT00597402|Temozolomide|temozolomide|mesh-list
14299858|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299859|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299860|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14299861|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299862|NCT00597402|Growth Substances|growth substances|mesh-ancestor
14299863|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299864|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
14299865|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14299866|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14299867|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299868|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299869|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299870|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
14299871|NCT00597428|Lubiprostone|lubiprostone|mesh-list
14299872|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14299873|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299874|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299875|NCT00597493|Temozolomide|temozolomide|mesh-list
14299876|NCT00597493|Sorafenib|sorafenib|mesh-list
14299877|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299878|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
14299879|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299880|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299881|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14299882|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299883|NCT00597506|Bevacizumab|bevacizumab|mesh-list
14299884|NCT00597506|Everolimus|everolimus|mesh-list
14299885|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14299886|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299887|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14299888|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14299889|NCT00597506|Growth Substances|growth substances|mesh-ancestor
14299890|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299891|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
14299892|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299893|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
14299894|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
14299895|NCT00597519|Fludarabine|fludarabine|mesh-list
14299896|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299897|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
14299898|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299899|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14721878|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
14299900|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299901|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
14299902|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299903|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299904|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14299905|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
14299906|NCT00597584|Hematinics|hematinics|mesh-ancestor
14299907|NCT00597701|Lorazepam|lorazepam|mesh-list
14299908|NCT00597701|Baclofen|baclofen|mesh-list
14299909|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14299910|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299911|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14299912|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299913|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14299914|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
14721879|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14721880|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14721881|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14299915|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
14299916|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299917|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299918|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
14299919|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
14299920|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
14299921|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14299922|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14299923|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299924|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14299925|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14299926|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14299927|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
14299928|NCT00597727|Glycerol|glycerol|mesh-list
14299929|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14299930|NCT00597727|Protective Agents|protective agents|mesh-ancestor
14299931|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299932|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
14299933|NCT00597753|Hematinics|hematinics|mesh-ancestor
14299934|NCT00597766|Triamcinolone|triamcinolone|mesh-list
14299935|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14299936|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14299937|NCT00597766|Lidocaine|lidocaine|mesh-list
14299938|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14299939|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
14299940|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
14299941|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299942|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299943|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
14299944|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299945|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14299946|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14299947|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14299948|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14299949|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299950|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14299951|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
14299952|NCT00597766|Hormones|hormones|mesh-ancestor
14299953|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14299954|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299955|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
14299956|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14299957|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14299958|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14299959|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14299960|NCT00597818|Analgesics|analgesics|mesh-ancestor
14299961|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
14299962|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14299963|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299964|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14299965|NCT00597896|Pramipexole|pramipexole|mesh-list
14299966|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
14299967|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299968|NCT00597896|Protective Agents|protective agents|mesh-ancestor
14721882|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14299969|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721883|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721884|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721885|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14721886|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14299970|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14299971|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14299972|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
14299973|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
14299974|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14299975|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
14299976|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14299977|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14299978|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
14299979|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
14299980|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14299981|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299982|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
14299983|NCT00598273|Hematinics|hematinics|mesh-ancestor
14299984|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
14299985|NCT00598442|Hematinics|hematinics|mesh-ancestor
14721887|NCT00487786|Docetaxel|docetaxel|mesh-list
14721888|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299986|NCT00598481|Busulfan|busulfan|mesh-list
14299987|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
14299988|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299989|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14299990|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
14299991|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14299992|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14299993|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299994|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14299995|NCT00598507|Sagopilone|sagopilone|mesh-list
14299996|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14299997|NCT00598559|Acetaminophen|acetaminophen|mesh-list
14299998|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14721889|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
14721890|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
14721891|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
14721892|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14299999|NCT00598559|Analgesics|analgesics|mesh-ancestor
14300000|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
14300001|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300002|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300003|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
14721893|NCT00487799|Ularitide|ularitide|mesh-list
14721894|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14721895|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
14721896|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721897|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721898|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14721899|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14721900|NCT00487799|Diuretics|diuretics|mesh-ancestor
14721901|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
14721902|NCT00487812|Dobutamine|dobutamine|mesh-list
14721903|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14721904|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
14721905|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
14721906|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721907|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721908|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14721909|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14721910|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14300004|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
14300005|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
14300006|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14721911|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721912|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721913|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721914|NCT00487812|Protective Agents|protective agents|mesh-ancestor
14721915|NCT00487994|Atorvastatin|atorvastatin|mesh-list
14300007|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14300008|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300009|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300010|NCT00598585|Urological Agents|urological agents|mesh-ancestor
14300011|NCT00598650|Donepezil|donepezil|mesh-list
14300012|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14300013|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300014|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300015|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
14300016|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300017|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300018|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
14300019|NCT00598663|Insulin|insulin|mesh-list
14300020|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14300021|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14300022|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300023|NCT00598702|Acetaminophen|acetaminophen|mesh-list
14300024|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14300025|NCT00598702|Analgesics|analgesics|mesh-ancestor
14300026|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
14300027|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300028|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300029|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
14300030|NCT00598806|Apaziquone|apaziquone|mesh-list
14300031|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300032|NCT00598832|Adapalene|adapalene|mesh-list
14300033|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14300034|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14300035|NCT00598832|Analgesics|analgesics|mesh-ancestor
14300036|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
14300037|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300038|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300039|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300040|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300041|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
14300042|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14300043|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14300044|NCT00598975|Irinotecan|irinotecan|mesh-list
14721916|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14721917|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14721918|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
14721919|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721920|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14721921|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14721922|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721923|NCT00488072|Mirtazapine|mirtazapine|mesh-list
14300045|NCT00598975|Cetuximab|cetuximab|mesh-list
14300046|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
14300047|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14300048|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14300049|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300050|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300051|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300052|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300053|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14327652|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14327653|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327654|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
14327655|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14327656|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14327657|NCT00803543|Valacyclovir|valacyclovir|mesh-list
14327658|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
14327659|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327660|NCT00803569|Sargramostim|sargramostim|mesh-list
14327661|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
14327662|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327663|NCT00803595|Oseltamivir|oseltamivir|mesh-list
14327664|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
14327665|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327666|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327667|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327668|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
14327669|NCT00803634|Diltiazem|diltiazem|mesh-list
14721924|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
14721925|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14721926|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14327670|NCT00803634|Nitroprusside|nitroprusside|mesh-list
14327671|NCT00803634|Nicardipine|nicardipine|mesh-list
14327672|NCT00803634|Clevidipine|clevidipine|mesh-list
14327673|NCT00803634|Isosorbide|isosorbide|mesh-list
14327674|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14327675|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
14327676|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
14327677|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14327678|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327679|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327680|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14327681|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327682|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14327683|NCT00803634|Diuretics|diuretics|mesh-ancestor
14327684|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
14327685|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14328583|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14328584|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
14328585|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14328586|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328587|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14328588|NCT00810069|Analgesics|analgesics|mesh-ancestor
14328589|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
14328590|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
14328591|NCT00810108|Ritonavir|ritonavir|mesh-list
14328592|NCT00810108|Lopinavir|lopinavir|mesh-list
14328593|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14328594|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14328595|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328596|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328597|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328598|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14328599|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14328600|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
14328601|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328602|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14328603|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14328604|NCT00810199|Methotrexate|methotrexate|mesh-list
14300054|NCT00599053|Azithromycin|azithromycin|mesh-list
14300055|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14300056|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300057|NCT00599196|Rotigotine|rotigotine|mesh-list
14300058|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
14300059|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
14300060|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300061|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300062|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300063|NCT00599313|Sunitinib|sunitinib|mesh-list
14300064|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300065|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300066|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300067|NCT00599313|Growth Substances|growth substances|mesh-ancestor
14300068|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300069|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300070|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14300071|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300072|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300073|NCT00599326|Deferasirox|deferasirox|mesh-list
14300074|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14300075|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
14300076|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
14300077|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220044|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220045|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220046|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
15220047|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300078|NCT00599521|Adapalene|adapalene|mesh-list
14300079|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14300080|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14300081|NCT00599521|Analgesics|analgesics|mesh-ancestor
14300082|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
14300083|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300084|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300085|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300086|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300087|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
14300088|NCT00599638|Pregabalin|pregabalin|mesh-list
14300089|NCT00599638|Analgesics|analgesics|mesh-ancestor
14300090|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
14300091|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300092|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300093|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
14300094|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14300095|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300096|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300097|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14300098|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14300099|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300100|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300101|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300102|NCT00599755|Gemcitabine|gemcitabine|mesh-list
14300103|NCT00599755|Carboplatin|carboplatin|mesh-list
14300104|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300105|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14300106|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
14300107|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300108|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
14300109|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300110|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300111|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300112|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
14300113|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300114|NCT00599924|Leucovorin|leucovorin|mesh-list
14300115|NCT00599924|Sunitinib|sunitinib|mesh-list
14300116|NCT00599924|Fluorouracil|fluorouracil|mesh-list
14300117|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
14909567|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
14909568|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
14909569|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
14909570|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909571|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300118|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300119|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300120|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300121|NCT00599924|Growth Substances|growth substances|mesh-ancestor
14300122|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300123|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300124|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14300125|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300126|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300127|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
14300128|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14300129|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300130|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
14300131|NCT00599924|Antidotes|antidotes|mesh-ancestor
14300132|NCT00599924|Protective Agents|protective agents|mesh-ancestor
14300133|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
14300134|NCT00599924|Vitamins|vitamins|mesh-ancestor
14300135|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
14300136|NCT00600028|Thalidomide|thalidomide|mesh-list
14300137|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300138|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
14300139|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300140|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
14300141|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14300142|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300143|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300144|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300145|NCT00600028|Growth Substances|growth substances|mesh-ancestor
14300146|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300147|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300148|NCT00600067|Topiramate|topiramate|mesh-list
14300149|NCT00600067|Phentermine|phentermine|mesh-list
14300150|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
14300151|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14300152|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300153|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14300154|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
14300155|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14300156|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
14300157|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
14300158|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300159|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
14300160|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300161|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300162|NCT00600119|Naloxegol|naloxegol|mesh-list
14300163|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14300164|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300165|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
14300166|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300167|NCT00600340|Paclitaxel|paclitaxel|mesh-list
14300168|NCT00600340|Bevacizumab|bevacizumab|mesh-list
14300169|NCT00600340|Capecitabine|capecitabine|mesh-list
14300170|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14300171|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300172|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
14300173|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
14300174|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
14300175|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300176|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300177|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300178|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300179|NCT00600340|Growth Substances|growth substances|mesh-ancestor
14300180|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909572|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14909573|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
14300181|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300182|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14300183|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
14300184|NCT00600353|Dexamethasone|dexamethasone|mesh-list
14300185|NCT00600353|Aprepitant|aprepitant|mesh-list
14300186|NCT00600353|Palonosetron|palonosetron|mesh-list
14300187|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300188|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
14300189|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
14300190|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300191|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300192|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14300193|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
14300194|NCT00600353|Hormones|hormones|mesh-ancestor
14300195|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300196|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14300197|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300198|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14300199|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300200|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300201|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14300202|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14300203|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
14300204|NCT00600756|Risperidone|risperidone|mesh-list
14300205|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14300206|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14300207|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
14300208|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300209|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300210|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300211|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14300212|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300213|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300214|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300215|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14300216|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
14300217|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300218|NCT00600821|Paclitaxel|paclitaxel|mesh-list
14300219|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14300220|NCT00600821|Bevacizumab|bevacizumab|mesh-list
14300221|NCT00600821|Carboplatin|carboplatin|mesh-list
14300222|NCT00600821|Axitinib|axitinib|mesh-list
14300223|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14300224|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300225|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
14300226|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
14300227|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
14300228|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300229|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300230|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300231|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300232|NCT00600821|Growth Substances|growth substances|mesh-ancestor
14300233|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300234|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300235|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14300236|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300237|NCT00600886|Octreotide|octreotide|mesh-list
14300238|NCT00600886|Pasireotide|pasireotide|mesh-list
14300239|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14300240|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14300241|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300242|NCT00600886|Hormones|hormones|mesh-ancestor
14300243|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300244|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721927|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
14721928|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
14721929|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721930|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721931|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721932|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14721933|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300245|NCT00600925|Gentamicins|gentamicins|mesh-list
14300246|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14300247|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300248|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14300249|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300250|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300251|NCT00600938|Deferasirox|deferasirox|mesh-list
14300252|NCT00600938|Deferoxamine|deferoxamine|mesh-list
14300253|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14300254|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
14300255|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
14300256|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300257|NCT00600938|Siderophores|siderophores|mesh-ancestor
14300258|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14300259|NCT00601107|Vitamins|vitamins|mesh-ancestor
14300260|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
14300261|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300262|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14300263|NCT00601172|Dexamethasone|dexamethasone|mesh-list
14300264|NCT00601172|Ondansetron|ondansetron|mesh-list
14300265|NCT00601172|Casopitant|casopitant|mesh-list
14300266|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300267|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
14300268|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
14300269|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300270|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300271|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14300272|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
14300273|NCT00601172|Hormones|hormones|mesh-ancestor
14300274|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300275|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14300276|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300277|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
14300278|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
14300279|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14300280|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
14300281|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300282|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300283|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14300284|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300285|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300286|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300287|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14300288|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14300289|NCT00601250|Linagliptin|linagliptin|mesh-list
14300290|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14300291|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300292|NCT00601250|Incretins|incretins|mesh-ancestor
14300293|NCT00601250|Hormones|hormones|mesh-ancestor
14300294|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300295|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14300296|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
14300297|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300298|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300299|NCT00601354|Orlistat|orlistat|mesh-list
14300300|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300301|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300302|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14300303|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14300304|NCT00601458|Naproxen|naproxen|mesh-list
14300305|NCT00601458|Pregabalin|pregabalin|mesh-list
14300306|NCT00601458|Analgesics|analgesics|mesh-ancestor
14300307|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
14300308|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300309|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300310|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
14300311|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14909574|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
14300312|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721934|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300313|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300314|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14300315|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14300316|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300317|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14721935|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14300318|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300319|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14300320|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14300321|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300322|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300323|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
14300324|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14300325|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300326|NCT00601484|Tanezumab|tanezumab|mesh-list
14300327|NCT00601484|Analgesics|analgesics|mesh-ancestor
14300328|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
14300329|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300330|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300331|NCT00601523|Pramipexole|pramipexole|mesh-list
14300332|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
14300333|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300334|NCT00601523|Protective Agents|protective agents|mesh-ancestor
14300335|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300336|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14300337|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14300338|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
14300339|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
14300340|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300341|NCT00601627|Gemcitabine|gemcitabine|mesh-list
14300342|NCT00601627|Fluorouracil|fluorouracil|mesh-list
14300343|NCT00601627|Capecitabine|capecitabine|mesh-list
14300344|NCT00601627|Panitumumab|panitumumab|mesh-list
14300345|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14300346|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
14300347|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721936|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14721937|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14909575|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14300348|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300349|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
14300350|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300351|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300352|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300353|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
14300354|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721938|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721939|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14721940|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14721941|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
14721942|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14721943|NCT00488137|Prucalopride|prucalopride|mesh-list
14721944|NCT00488137|Laxatives|laxatives|mesh-ancestor
14721945|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14300355|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300356|NCT00601640|Eflornithine|eflornithine|mesh-list
14300357|NCT00601640|Diclofenac|diclofenac|mesh-list
14300358|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14300359|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14300360|NCT00601640|Analgesics|analgesics|mesh-ancestor
14300361|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
14300362|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300363|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300364|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300365|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300366|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14300367|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300368|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300369|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300370|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14300371|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14300372|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14300373|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300374|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14300375|NCT00601705|Fluorouracil|fluorouracil|mesh-list
14300376|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
14300377|NCT00601705|Epirubicin|epirubicin|mesh-list
14300378|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300379|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
14300380|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300381|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14300382|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300383|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
14300384|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300385|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14300386|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14300387|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14300388|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300389|NCT00601718|Rituximab|rituximab|mesh-list
14300390|NCT00601718|Carboplatin|carboplatin|mesh-list
14300391|NCT00601718|Etoposide|etoposide|mesh-list
14300392|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
14300393|NCT00601718|Ifosfamide|ifosfamide|mesh-list
14300394|NCT00601718|Vorinostat|vorinostat|mesh-list
14300395|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300396|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300397|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
14300398|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300399|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300400|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14300401|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14300402|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14300403|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721946|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14909576|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
14300404|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300405|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14300406|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
14300407|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14300408|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
14300409|NCT00601796|Tretinoin|tretinoin|mesh-list
14300410|NCT00601796|Vaccines|vaccines|mesh-list
14300411|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
14300412|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300413|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300414|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300415|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14300416|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
14300417|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300418|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300419|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14300420|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
14300421|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
14300422|NCT00601835|Vaccines|vaccines|mesh-list
14300423|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
14300424|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300425|NCT00601926|Bevacizumab|bevacizumab|mesh-list
14300426|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300427|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300428|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300429|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14721947|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14721948|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
14300430|NCT00601926|Growth Substances|growth substances|mesh-ancestor
14300431|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300432|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300433|NCT00601965|Citalopram|citalopram|mesh-list
14300434|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14300435|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300436|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300437|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300438|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300439|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
14300440|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300441|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14300442|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300443|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300444|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14300445|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14300446|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300447|NCT00602225|Cytarabine|cytarabine|mesh-list
14300448|NCT00602225|Clofarabine|clofarabine|mesh-list
14300449|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14300450|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
14300451|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300452|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300453|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
14300454|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300455|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300456|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
14300457|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300458|NCT00602290|Methylphenidate|methylphenidate|mesh-list
14300459|NCT00602290|Citalopram|citalopram|mesh-list
14300460|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14300461|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300462|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14300463|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300464|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300465|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300466|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
14300467|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300468|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14300469|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
14300470|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14300471|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300472|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300473|NCT00602355|Sertraline|sertraline|mesh-list
14300474|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300475|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300476|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14300477|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300478|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300479|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300480|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300481|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
14300482|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300483|NCT00602420|Naproxen|naproxen|mesh-list
14300484|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14300485|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14300486|NCT00602420|Analgesics|analgesics|mesh-ancestor
14300487|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
14300488|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300489|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300490|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300491|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300492|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
14300493|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14300494|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300495|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300496|NCT00602446|Deferasirox|deferasirox|mesh-list
14300497|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14300498|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
14300499|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
14300500|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300501|NCT00602472|Linagliptin|linagliptin|mesh-list
14300502|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14300503|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300504|NCT00602472|Incretins|incretins|mesh-ancestor
14300505|NCT00602472|Hormones|hormones|mesh-ancestor
14300506|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300507|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14300508|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
14300509|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300510|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300511|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
14300512|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14300513|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300514|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300515|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300516|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300517|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
14300518|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300519|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300520|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300521|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14300522|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300523|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300524|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300525|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14300526|NCT00602771|Etoposide|etoposide|mesh-list
14300527|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
14300528|NCT00602771|Tipifarnib|tipifarnib|mesh-list
14300529|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14300530|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300531|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14300532|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14721949|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721950|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721951|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721952|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14721953|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14721954|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14721955|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14721956|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300533|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300534|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300535|NCT00602797|Paclitaxel|paclitaxel|mesh-list
14300536|NCT00602797|Vinorelbine|vinorelbine|mesh-list
14300537|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14300538|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14300539|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300540|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
14300541|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
14300542|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
14300543|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300544|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
14300545|NCT00602836|Rituximab|rituximab|mesh-list
14300546|NCT00602836|Lenalidomide|lenalidomide|mesh-list
14300547|NCT00602836|Pentostatin|pentostatin|mesh-list
14300548|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300549|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
14300550|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300551|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300552|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14300553|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
14300554|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300555|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300556|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14300557|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300558|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300559|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300560|NCT00602836|Growth Substances|growth substances|mesh-ancestor
14300561|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300562|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14300563|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300564|NCT00602927|Varenicline|varenicline|mesh-list
14300565|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14300566|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14300567|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
14300568|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300569|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300570|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300571|NCT00603018|Fluoxetine|fluoxetine|mesh-list
14300572|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14300573|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300574|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300575|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300576|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300577|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
14300578|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300579|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14300580|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300581|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300582|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14300583|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14300584|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300585|NCT00603044|Fluticasone|fluticasone|mesh-list
14300586|NCT00603044|Xhance|xhance|mesh-list
14300587|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300588|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14300589|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
14300590|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300591|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300592|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14300593|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
14300594|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
14300595|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14300596|NCT00603187|Acyline|acyline|mesh-list
14300597|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
14300598|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300599|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300600|NCT00603239|Exenatide|exenatide|mesh-list
14300601|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14300602|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300603|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14300604|NCT00603239|Incretins|incretins|mesh-ancestor
14300605|NCT00603239|Hormones|hormones|mesh-ancestor
14300606|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300607|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14300608|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14300609|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300610|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300611|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300612|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300613|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300614|NCT00603265|Analgesics|analgesics|mesh-ancestor
14300615|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
14300616|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300617|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300618|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300619|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
14300620|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
14300621|NCT00603304|Urological Agents|urological agents|mesh-ancestor
14300622|NCT00603408|Cisplatin|cisplatin|mesh-list
14300623|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300624|NCT00603447|Dexamethasone|dexamethasone|mesh-list
14300625|NCT00603447|Lenalidomide|lenalidomide|mesh-list
14300626|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300627|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
14300628|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
14300629|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300630|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300631|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14300632|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
14300633|NCT00603447|Hormones|hormones|mesh-ancestor
14300634|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300635|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14300636|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300637|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
15220048|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
15220049|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300638|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300639|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300640|NCT00603447|Growth Substances|growth substances|mesh-ancestor
14300641|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300642|NCT00603473|Gabapentin|gabapentin|mesh-list
14300643|NCT00603473|Analgesics|analgesics|mesh-ancestor
14300644|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
14300645|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300646|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300647|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
14300648|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14300649|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300650|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300651|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300652|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14300653|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14300654|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300655|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220050|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
15220051|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220052|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15220053|NCT04385433|Pravastatin|pravastatin|mesh-list
15220054|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15220055|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15220056|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
15220057|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220058|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15220059|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15220060|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220061|NCT04377711|Ciclesonide|ciclesonide|mesh-list
14721957|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
14721958|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721959|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721960|NCT00488176|Cetirizine|cetirizine|mesh-list
14721961|NCT00488176|Montelukast|montelukast|mesh-list
14721962|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14721963|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
14721964|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14300656|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
14300657|NCT00603512|Tofacitinib|tofacitinib|mesh-list
14300658|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14300659|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300660|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300661|NCT00603525|Ofatumumab|ofatumumab|mesh-list
14300662|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300663|NCT00603538|Paclitaxel|paclitaxel|mesh-list
14300664|NCT00603538|Carboplatin|carboplatin|mesh-list
14300665|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14300666|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300667|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
14300668|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
14300669|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
14300670|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300671|NCT00603720|Phenylephrine|phenylephrine|mesh-list
14300672|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
14300673|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
14300674|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14300675|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
14300676|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
14300677|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300678|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300679|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
14300680|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14300681|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
14300682|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
14300683|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14300684|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14300685|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14300686|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
14300687|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300688|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300689|NCT00603720|Protective Agents|protective agents|mesh-ancestor
14300690|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300691|NCT00603733|Mesalamine|mesalamine|mesh-list
14300692|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14300693|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14300694|NCT00603733|Analgesics|analgesics|mesh-ancestor
14300695|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
14300696|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300697|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300698|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300699|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300700|NCT00603798|Imiquimod|imiquimod|mesh-list
14300701|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14300702|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
14300703|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300704|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300705|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
14300706|NCT00603915|Gemcitabine|gemcitabine|mesh-list
14300707|NCT00603915|Carboplatin|carboplatin|mesh-list
14300708|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14300709|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300710|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14300711|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
14300712|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300713|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
14721965|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
14300714|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300715|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300716|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300717|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
14300718|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300719|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14300720|NCT00603941|Paclitaxel|paclitaxel|mesh-list
14300721|NCT00603941|Efatutazone|efatutazone|mesh-list
14300722|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14721966|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14721967|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300723|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14721968|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14721969|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14721970|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300724|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
14300725|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
14300726|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
14300727|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300728|NCT00603980|Alprazolam|alprazolam|mesh-list
14300729|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14300730|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300731|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300732|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14300733|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300734|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300735|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
14300736|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
14300737|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300738|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300739|NCT00603993|Adalimumab|adalimumab|mesh-list
14300740|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300741|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300742|NCT00604019|Dopamine|dopamine|mesh-list
14300743|NCT00604019|Norepinephrine|norepinephrine|mesh-list
14300744|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14300745|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14300746|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14300747|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300748|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300749|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300750|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
14300751|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
14721971|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14721972|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14909577|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300752|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14721973|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14721974|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
14721975|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
14721976|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721977|NCT00488189|Tazobactam|tazobactam|mesh-list
14721978|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14721979|NCT00488189|Piperacillin|piperacillin|mesh-list
14721980|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14721981|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14721982|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14721983|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14721984|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721985|NCT00488215|Prucalopride|prucalopride|mesh-list
15220062|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
15220063|NCT04377711|Hormones|hormones|mesh-ancestor
15220064|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220065|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220066|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15220067|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15220068|NCT04369560|Hematinics|hematinics|mesh-ancestor
14721986|NCT00488215|Laxatives|laxatives|mesh-ancestor
14721987|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14721988|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14721989|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14721990|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
14721991|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14721992|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14721993|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14721994|NCT00488306|Tigecycline|tigecycline|mesh-list
14721995|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14300753|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14721996|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300754|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14300755|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
14300756|NCT00604019|Protective Agents|protective agents|mesh-ancestor
14300757|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14300758|NCT00604188|Buprenorphine|buprenorphine|mesh-list
14300759|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14300760|NCT00604188|Narcotics|narcotics|mesh-ancestor
14300761|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300762|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300763|NCT00604188|Analgesics|analgesics|mesh-ancestor
14300764|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
14300765|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300766|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14300767|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14300768|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300769|NCT00604279|Risperidone|risperidone|mesh-list
14300770|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14300771|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14300772|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
14300773|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300774|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300775|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300776|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14300777|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300778|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300779|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300780|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14300781|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
14300782|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14300783|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14300784|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
14300785|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300786|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300787|NCT00604461|Bevacizumab|bevacizumab|mesh-list
14300788|NCT00604461|Carboplatin|carboplatin|mesh-list
14300789|NCT00604461|Pemetrexed|pemetrexed|mesh-list
14300790|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300791|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300792|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14721997|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15220069|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14300793|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14721998|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220070|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15220071|NCT04356690|Etoposide|etoposide|mesh-list
15220072|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15220073|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220074|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15220075|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15220076|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220077|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220078|NCT04356209|Pravastatin|pravastatin|mesh-list
15220079|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15220080|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15220081|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
15220082|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300794|NCT00604461|Growth Substances|growth substances|mesh-ancestor
14300795|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300796|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300797|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300798|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300799|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14300800|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14327686|NCT00803647|Leucovorin|leucovorin|mesh-list
14327687|NCT00803647|Fluorouracil|fluorouracil|mesh-list
14327688|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
14327689|NCT00803647|Cetuximab|cetuximab|mesh-list
14327690|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
14327691|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327692|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14327693|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327694|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327695|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
14327696|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327697|NCT00803647|Antidotes|antidotes|mesh-ancestor
14909578|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909579|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14909580|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14909581|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909582|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14909583|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14909584|NCT01352143|Thrombin|thrombin|mesh-list
14909585|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
14909586|NCT01352143|Coagulants|coagulants|mesh-ancestor
14909587|NCT01352234|Aspirin|aspirin|mesh-list
14327698|NCT00803647|Protective Agents|protective agents|mesh-ancestor
14327699|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
14327700|NCT00803647|Vitamins|vitamins|mesh-ancestor
14327701|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
14327702|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14327703|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
14327704|NCT00803686|Calcitonin|calcitonin|mesh-list
14327705|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14327706|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327707|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14327708|NCT00803712|Vitamin D|vitamin d|mesh-list
14327709|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
14327710|NCT00803712|Vitamins|vitamins|mesh-list
14327711|NCT00803712|Cinacalcet|cinacalcet|mesh-list
14327712|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
14327713|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327714|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14327715|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14327716|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14327717|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
14327718|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327719|NCT00803738|Terconazole|terconazole|mesh-list
14327720|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
14327721|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909588|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14300801|NCT00604695|Tenecteplase|tenecteplase|mesh-list
14300802|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14300803|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14300804|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300805|NCT00604708|Vaccines|vaccines|mesh-list
14300806|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
14300807|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300808|NCT00604786|Omalizumab|omalizumab|mesh-list
14300809|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14300810|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14300811|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
14300812|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14300813|NCT00604825|Estrogens|estrogens|mesh-ancestor
14300814|NCT00604825|Hormones|hormones|mesh-ancestor
14300815|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300816|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300817|NCT00604968|Doxorubicin|doxorubicin|mesh-list
14300818|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14300819|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14300820|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300821|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14300822|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14300823|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300824|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300825|NCT00605033|Buprenorphine|buprenorphine|mesh-list
14300826|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14300827|NCT00605033|Naloxone|naloxone|mesh-list
14300828|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14300829|NCT00605033|Narcotics|narcotics|mesh-ancestor
14300830|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300831|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300832|NCT00605033|Analgesics|analgesics|mesh-ancestor
14300833|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
15220083|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15220084|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15220085|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220086|NCT04354025|Cytarabine|cytarabine|mesh-list
15220087|NCT04354025|Fludarabine|fludarabine|mesh-list
15220088|NCT04354025|Interleukin-2|interleukin-2|mesh-list
15220089|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220090|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15220091|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
15220092|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220093|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300834|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300835|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14300836|NCT00605072|Metoprolol|metoprolol|mesh-list
14300837|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14300838|NCT00605072|Candesartan|candesartan|mesh-list
14300839|NCT00605072|Lisinopril|lisinopril|mesh-list
14300840|NCT00605072|Nifedipine|nifedipine|mesh-list
14300841|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14300842|NCT00605072|Diuretics|diuretics|mesh-ancestor
14300843|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
14300844|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300845|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14300846|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300847|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300848|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14300849|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
14300850|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
14300851|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300852|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14300853|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14300854|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15220094|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
15220095|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220096|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
15220097|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220098|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220099|NCT04354025|Analgesics|analgesics|mesh-ancestor
15220100|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
15220101|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14300855|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14300856|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300857|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14300858|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14300859|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14300860|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14300861|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
14300862|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
14300863|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14300864|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14300865|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
14300866|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300867|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14300868|NCT00605072|Protective Agents|protective agents|mesh-ancestor
14300869|NCT00605176|Imiquimod|imiquimod|mesh-list
14300870|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14300871|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
14300872|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300873|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300874|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
14300875|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14300876|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14300877|NCT00605202|Diuretics|diuretics|mesh-ancestor
14300878|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
14300879|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300880|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14300881|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300882|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300883|NCT00605267|Tamoxifen|tamoxifen|mesh-list
14300884|NCT00605267|Goserelin|goserelin|mesh-list
14300885|NCT00605267|Anastrozole|anastrozole|mesh-list
14300886|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14300887|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
14300888|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14300889|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300890|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14300891|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300892|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14300893|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14300894|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14300895|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15220102|NCT04352101|Citalopram|citalopram|mesh-list
15220103|NCT04352101|Bupropion|bupropion|mesh-list
14300896|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14300897|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300898|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300899|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
14300900|NCT00605293|Hematinics|hematinics|mesh-ancestor
14300901|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
14300902|NCT00605306|Maleic acid|maleic acid|mesh-list
14300903|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300904|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300905|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300906|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14300907|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14300908|NCT00605319|Fesoterodine|fesoterodine|mesh-list
14300909|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15220104|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15220105|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15220106|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220107|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220108|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220109|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
15220110|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300910|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14300911|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
14300912|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300913|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300914|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300915|NCT00605319|Urological Agents|urological agents|mesh-ancestor
14300916|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
14300917|NCT00605345|Hematinics|hematinics|mesh-ancestor
14300918|NCT00605384|Tenofovir|tenofovir|mesh-list
14300919|NCT00605384|Lamivudine|lamivudine|mesh-list
14300920|NCT00605384|Entecavir|entecavir|mesh-list
14300921|NCT00605384|Adefovir|adefovir|mesh-list
14300922|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
14300923|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14300924|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14300925|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14300926|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300927|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300928|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14300929|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14300930|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14300931|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14300932|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
14909589|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14909590|NCT01352234|Analgesics|analgesics|mesh-ancestor
14300933|NCT00605423|Hormones|hormones|mesh-ancestor
14300934|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14721999|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722000|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14722001|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
14722002|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722003|NCT00488384|Acitretin|acitretin|mesh-list
14722004|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
14722005|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
14722006|NCT00488436|Cyclosporine|cyclosporine|mesh-list
14300935|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300936|NCT00605475|Metformin|metformin|mesh-list
14300937|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14300938|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300939|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
14300940|NCT00605566|Sorafenib|sorafenib|mesh-list
14300941|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300942|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
14300943|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300944|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14300945|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14300946|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
14300947|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300948|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300949|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14300950|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14300951|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300952|NCT00605657|Valproic Acid|valproic acid|mesh-list
14300953|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
14300954|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300955|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300956|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
14300957|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300958|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300959|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
14300960|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14300961|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14300962|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300963|NCT00605696|Insulin|insulin|mesh-list
14300964|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14300965|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300966|NCT00605722|Bevacizumab|bevacizumab|mesh-list
14300967|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14300968|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14300969|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14300970|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14300971|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14300972|NCT00605722|Growth Substances|growth substances|mesh-ancestor
14300973|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300974|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
14300975|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14300976|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14300977|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300978|NCT00605813|Sertraline|sertraline|mesh-list
14300979|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300980|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300981|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14300982|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300983|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300984|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300985|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14300986|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
14722007|NCT00488436|Cyclosporins|cyclosporins|mesh-list
14722008|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14300987|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300988|NCT00605865|Sertraline|sertraline|mesh-list
14300989|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
14300990|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14300991|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14300992|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14300993|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14300994|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14300995|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722009|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722010|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722011|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14300996|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
14300997|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14300998|NCT00605904|Acamprosate|acamprosate|mesh-list
14300999|NCT00605904|Yohimbine|yohimbine|mesh-list
14301000|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14301001|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
14301002|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
14301003|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301004|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301005|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14301006|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14301007|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14301008|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
14301009|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301010|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301011|NCT00605904|Urological Agents|urological agents|mesh-ancestor
14301012|NCT00605917|Sertraline|sertraline|mesh-list
14301013|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301014|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301015|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14301016|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14301017|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722012|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
14722013|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722014|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
14722015|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722016|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
14722017|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722018|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14722019|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
14301018|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301019|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301020|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
14301021|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301022|NCT00606008|Sunitinib|sunitinib|mesh-list
15220111|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15220112|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301023|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301024|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14301025|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14301026|NCT00606008|Growth Substances|growth substances|mesh-ancestor
14722020|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15220113|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301027|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301028|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
14301029|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14301030|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301031|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301032|NCT00606021|Pemetrexed|pemetrexed|mesh-list
14301033|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722021|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722022|NCT00488540|Acetaminophen|acetaminophen|mesh-list
15220114|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15220115|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
15220116|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15220117|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15220118|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220119|NCT04350463|Nivolumab|nivolumab|mesh-list
15220120|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
15220121|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220122|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301034|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909591|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
14909592|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909593|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909594|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14909595|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14909596|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15220123|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15220124|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301035|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220125|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220126|NCT04347408|Antibodies|antibodies|mesh-list
15220127|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
14301036|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14301037|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14301038|NCT00606034|Insulin|insulin|mesh-list
14301039|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14301040|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301041|NCT00606086|Interferons|interferons|mesh-list
14301042|NCT00606086|Ribavirin|ribavirin|mesh-list
14301043|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14301044|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
14301045|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301046|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
14301047|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301048|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
14301049|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301050|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
14301051|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301052|NCT00606138|Ranibizumab|ranibizumab|mesh-list
14301053|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14301054|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14301055|NCT00606138|Growth Substances|growth substances|mesh-ancestor
14301056|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301057|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
14301058|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301059|NCT00606177|Aripiprazole|aripiprazole|mesh-list
14301060|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301061|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301062|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14301063|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301064|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301065|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722023|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14722024|NCT00488540|Analgesics|analgesics|mesh-ancestor
14722025|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
14722026|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722027|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722028|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
14722029|NCT00488566|Lamotrigine|lamotrigine|mesh-list
14722030|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
14301066|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
14301067|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
14301068|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301069|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301070|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15220128|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220129|NCT04336943|Durvalumab|durvalumab|mesh-list
15220130|NCT04336943|Olaparib|olaparib|mesh-list
15220131|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15220132|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
15220133|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14722031|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14909597|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14909598|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220134|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
15220135|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220136|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220137|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
15220138|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220139|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220140|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220141|NCT04296942|Trastuzumab|trastuzumab|mesh-list
15220142|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15220143|NCT04296942|Maytansine|maytansine|mesh-list
15220144|NCT04296942|Entinostat|entinostat|mesh-list
14909599|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14909600|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14909601|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909602|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
14909603|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
14909604|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
14909605|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
14909606|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14909607|NCT01352312|Ofatumumab|ofatumumab|mesh-list
14909608|NCT01352312|Pentostatin|pentostatin|mesh-list
14909609|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14909610|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
14909611|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909612|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909613|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14909614|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909615|NCT01352338|Prednisone|prednisone|mesh-list
14909616|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
14301071|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14301072|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
14301073|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14301074|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14301075|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14301076|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14301077|NCT00606229|Aripiprazole|aripiprazole|mesh-list
14301078|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301079|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301080|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14301081|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301082|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301083|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301084|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
14301085|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
14301086|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301087|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301088|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15220145|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220146|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220147|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15220148|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
15220149|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
15220150|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
15220151|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220152|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15220153|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220154|NCT04291599|Ketorolac|ketorolac|mesh-list
15220155|NCT04291599|Morphine|morphine|mesh-list
15220156|NCT04291599|Hydromorphone|hydromorphone|mesh-list
15220157|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15220158|NCT04291599|Narcotics|narcotics|mesh-ancestor
14301089|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14301090|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
14301091|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14301092|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14301093|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14301094|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14301095|NCT00606281|Aripiprazole|aripiprazole|mesh-list
14301096|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301097|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301098|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14301099|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301100|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301101|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301102|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
14301103|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
14301104|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909617|NCT01352338|Lenalidomide|lenalidomide|mesh-list
14301105|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301106|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14301107|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14301108|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
14301109|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14301110|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14301111|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14301112|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14301113|NCT00606294|Misonidazole|misonidazole|mesh-list
14301114|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301115|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14301116|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14301117|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301118|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14301119|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14301120|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301121|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301122|NCT00606320|Aripiprazole|aripiprazole|mesh-list
14301123|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301124|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301125|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14301126|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301127|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301128|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301129|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
14301130|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
14301131|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301132|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301133|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14301134|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14301135|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
14301136|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14301137|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14301138|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14301139|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14301140|NCT00606489|Ibuprofen|ibuprofen|mesh-list
14301141|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14301142|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14301143|NCT00606489|Analgesics|analgesics|mesh-ancestor
14301144|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
14301145|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301146|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301147|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301148|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301149|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15220159|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220160|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220161|NCT04291599|Analgesics|analgesics|mesh-ancestor
15220162|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
14301150|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301151|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220163|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301152|NCT00606502|Vitamins|vitamins|mesh-list
14301153|NCT00606502|Folic Acid|folic acid|mesh-list
14301154|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
14301155|NCT00606502|Hydroxocobalamin|hydroxocobalamin|mesh-list
14301156|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
14301157|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15220164|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15220165|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220166|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220167|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220168|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15220169|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220170|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220171|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
15220172|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
15220173|NCT04269356|Antacids|antacids|mesh-ancestor
15220174|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220175|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15220176|NCT04266249|Paclitaxel|paclitaxel|mesh-list
15220177|NCT04266249|Maytansine|maytansine|mesh-list
15220178|NCT04266249|Docetaxel|docetaxel|mesh-list
15220179|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15220180|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14301158|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14301159|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
14301160|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301161|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301162|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14722032|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722033|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722034|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14722035|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722036|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14722037|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14722038|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722039|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722040|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14722041|NCT00488605|Leucovorin|leucovorin|mesh-list
14722042|NCT00488605|Prednisone|prednisone|mesh-list
14722043|NCT00488605|Methotrexate|methotrexate|mesh-list
14722044|NCT00488605|Vinblastine|vinblastine|mesh-list
14722045|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
14722046|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722047|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
14722048|NCT00488605|Hormones|hormones|mesh-ancestor
14722049|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722050|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722051|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14722052|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722053|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14722054|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
14722055|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14722056|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722057|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
14722058|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722059|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
14722060|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722061|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14301163|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301164|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301165|NCT00606502|Hematinics|hematinics|mesh-ancestor
14301166|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14301167|NCT00606580|Paromomycin|paromomycin|mesh-list
14301168|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14301169|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301170|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14301171|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14301172|NCT00606801|Galantamine|galantamine|mesh-list
14301173|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14301174|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301175|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301176|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
14301177|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301178|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301179|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14301180|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
14301181|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301182|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
14301183|NCT00606892|Nicotine|nicotine|mesh-list
14301184|NCT00606892|Varenicline|varenicline|mesh-list
14301185|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14301186|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
14301187|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301188|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301189|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14301190|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14301191|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
14301192|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301193|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301194|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
14301195|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
14722062|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301196|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14722063|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
14301197|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15220181|NCT04266249|Trastuzumab|trastuzumab|mesh-list
15220182|NCT04266249|Pertuzumab|pertuzumab|mesh-list
14301198|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
14301199|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301200|NCT00607048|Paclitaxel|paclitaxel|mesh-list
14301201|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14301202|NCT00607048|Carboplatin|carboplatin|mesh-list
14301203|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14301204|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14301205|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301206|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
14301207|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
14301208|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
14301209|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301210|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
14301211|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301212|NCT00607087|Insulin|insulin|mesh-list
14301213|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14301214|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
14301215|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
14301216|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
14301217|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14909618|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14909619|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
15220183|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14301218|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301219|NCT00607113|Bevacizumab|bevacizumab|mesh-list
14301220|NCT00607113|Everolimus|everolimus|mesh-list
14301221|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14301222|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301223|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14301224|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14301225|NCT00607113|Growth Substances|growth substances|mesh-ancestor
14301226|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301227|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
14301228|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301229|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
14301230|NCT00607373|Mipomersen|mipomersen|mesh-list
14301231|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14301232|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14301233|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
14301234|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301235|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14301236|NCT00607594|Saracatinib|saracatinib|mesh-list
14301237|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301238|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909620|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220184|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15220185|NCT04266249|Antibodies|antibodies|mesh-list
15220186|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
15220187|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15220188|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
15220189|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15220190|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220191|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
14301239|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301240|NCT00607672|Candesartan|candesartan|mesh-list
14301241|NCT00607672|Ramipril|ramipril|mesh-list
14909621|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220192|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
15220193|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
14301242|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14301243|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14301244|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14301245|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301246|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15220194|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220195|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
15220196|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220197|NCT04222504|Tenofovir|tenofovir|mesh-list
15220198|NCT04222504|Emtricitabine|emtricitabine|mesh-list
14301247|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
14301248|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301249|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14301250|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14301251|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14301252|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14301253|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301254|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301255|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301256|NCT00607789|Analgesics|analgesics|mesh-ancestor
14301257|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
14301258|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301259|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301260|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301261|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
14301262|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14301263|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15220199|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
15220200|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220201|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15220202|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15220203|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220204|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220205|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15220206|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14301264|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14301265|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14301266|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301267|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14301268|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301269|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301270|NCT00608062|Estradiol|estradiol|mesh-list
14301271|NCT00608062|Ganirelix|ganirelix|mesh-list
14301272|NCT00608062|Estrogens|estrogens|mesh-ancestor
14301273|NCT00608062|Hormones|hormones|mesh-ancestor
14301274|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301275|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301276|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
14301277|NCT00608205|Fluorouracil|fluorouracil|mesh-list
14301278|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301279|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
14301280|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301281|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301282|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301283|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
14301284|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301285|NCT00608244|Tacrolimus|tacrolimus|mesh-list
14722064|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722065|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14722066|NCT00488605|Antidotes|antidotes|mesh-ancestor
14722067|NCT00488605|Protective Agents|protective agents|mesh-ancestor
14722068|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
14722069|NCT00488605|Vitamins|vitamins|mesh-ancestor
14722070|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
14722071|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14722072|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
14301286|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301287|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
14301288|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301289|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14301290|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301291|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722073|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
14722074|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
14722075|NCT00488670|Citalopram|citalopram|mesh-list
14722076|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14722077|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14722078|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722079|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722080|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722081|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
14722082|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722083|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14301292|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
14301293|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14301294|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
14301295|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301296|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722084|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
14722085|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722086|NCT00488709|Cytarabine|cytarabine|mesh-list
14722087|NCT00488709|Fludarabine|fludarabine|mesh-list
15220207|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
14301297|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14301298|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
14301299|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14301300|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
14301301|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301302|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301303|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14301304|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
14301305|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
14301306|NCT00608322|Protective Agents|protective agents|mesh-ancestor
14301307|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
14301308|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
14301309|NCT00608517|Fludarabine|fludarabine|mesh-list
14301310|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
14301311|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14301312|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301313|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
14301314|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301315|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301316|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14301317|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
14301318|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301319|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301320|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14301321|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301322|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
14722088|NCT00488709|Topotecan|topotecan|mesh-list
14722089|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220208|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15220209|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
15220210|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
15220211|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220212|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220213|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220214|NCT04177706|Ketamine|ketamine|mesh-list
14301323|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301324|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
14301325|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
15220215|NCT04177706|Analgesics|analgesics|mesh-ancestor
14301326|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301327|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301328|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
14301329|NCT00608517|Hormones|hormones|mesh-ancestor
14301330|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301331|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14301332|NCT00608517|Protective Agents|protective agents|mesh-ancestor
14301333|NCT00608543|Aripiprazole|aripiprazole|mesh-list
14301334|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301335|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301336|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14301337|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301338|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301339|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301340|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
14301341|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
14301342|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301343|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301344|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14301345|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14301346|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
14301347|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14301348|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14301349|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14301350|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14301351|NCT00608569|Ritonavir|ritonavir|mesh-list
14301352|NCT00608569|Lopinavir|lopinavir|mesh-list
14301353|NCT00608569|Tenofovir|tenofovir|mesh-list
14301354|NCT00608569|Zidovudine|zidovudine|mesh-list
14301355|NCT00608569|Emtricitabine|emtricitabine|mesh-list
14301356|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14301357|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14301358|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14301359|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
14301360|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301361|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301362|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14301363|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14301364|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
14301365|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301366|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14722090|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722091|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
14722092|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722093|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722094|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
15225527|NCT04485039|Calcium acetate|calcium acetate|mesh-list
14301367|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15225528|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
15225529|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
15225530|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225531|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
15225532|NCT04477837|Apixaban|apixaban|mesh-list
15225533|NCT04477837|Edoxaban|edoxaban|mesh-list
15225534|NCT04477837|Dabigatran|dabigatran|mesh-list
15225535|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15225536|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
15225537|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15225538|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
14722095|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301368|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14301369|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14301370|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
14301371|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
14722096|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
14722097|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722098|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14722099|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14722100|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722101|NCT00488722|Goserelin|goserelin|mesh-list
14722102|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14722103|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301372|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301373|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301374|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301375|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
14301376|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14301377|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301378|NCT00608868|Gefitinib|gefitinib|mesh-list
14301379|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301380|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14301381|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301382|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301383|NCT00608881|Ubiquinone|ubiquinone|mesh-list
14301384|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
14301385|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
14301386|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301387|NCT00608881|Vitamins|vitamins|mesh-ancestor
14301388|NCT00608894|Prednisone|prednisone|mesh-list
14301389|NCT00608894|Azathioprine|azathioprine|mesh-list
14301390|NCT00608894|Tacrolimus|tacrolimus|mesh-list
14301391|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301392|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
14301393|NCT00608894|Hormones|hormones|mesh-ancestor
14301394|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301395|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301396|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14301397|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301398|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301399|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
14301400|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14301401|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301402|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301403|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
14301404|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301405|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327722|NCT00804141|Bromides|bromides|mesh-list
14327723|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
14327724|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
14327725|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14327726|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327727|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
14327728|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327729|NCT00804193|Ciclopirox|ciclopirox|mesh-list
14327730|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
14327731|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327732|NCT00804609|Lidocaine|lidocaine|mesh-list
14327733|NCT00804609|Morphine|morphine|mesh-list
14327734|NCT00804609|Anesthetics|anesthetics|mesh-list
14327735|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
14722104|NCT00488761|Tigecycline|tigecycline|mesh-list
15220216|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
15220217|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220218|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220219|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15220220|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15220221|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
15220222|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
15220223|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220224|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15220225|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15220226|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220227|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220228|NCT04173247|Mineral Oil|mineral oil|mesh-list
15220229|NCT04173247|Emollients|emollients|mesh-ancestor
15220230|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
15220231|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15220232|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15220233|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15220234|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220235|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220236|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15220237|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220238|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220239|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
14301406|NCT00608907|Rifampin|rifampin|mesh-list
14301407|NCT00608907|Dexamethasone|dexamethasone|mesh-list
14301408|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
14301409|NCT00608907|Bortezomib|bortezomib|mesh-list
14301410|NCT00608907|BB 1101|bb 1101|mesh-list
14301411|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301412|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
14722105|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722106|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722107|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14722108|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722109|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722110|NCT00488787|Ketamine|ketamine|mesh-list
14722111|NCT00488787|Analgesics|analgesics|mesh-ancestor
14301413|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
14301414|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301415|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301416|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301417|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
14301418|NCT00608907|Hormones|hormones|mesh-ancestor
14301419|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301420|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14301421|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301422|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14301423|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301424|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301425|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14301426|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
14301427|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14301428|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301429|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
14301430|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14301431|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14301432|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14722112|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
14722113|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909622|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14301433|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15220240|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220241|NCT04166331|Dobutamine|dobutamine|mesh-list
15220242|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14301434|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14301435|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14301436|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14722114|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722115|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15220243|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
14301437|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
14301438|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14301439|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301440|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
14301441|NCT00608985|Zolpidem|zolpidem|mesh-list
14301442|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14301443|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14301444|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301445|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301446|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14301447|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
14301448|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
14301449|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301450|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301451|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14301452|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14301453|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14301454|NCT00609128|Analgesics|analgesics|mesh-ancestor
14301455|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
14301456|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301457|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301458|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301459|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301460|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14301461|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14301462|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14301463|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
14301464|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
14301465|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301466|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301467|NCT00609167|Dexamethasone|dexamethasone|mesh-list
14301468|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
14301469|NCT00609167|Bortezomib|bortezomib|mesh-list
14301470|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301471|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
14301472|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301473|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301474|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14301475|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
14301476|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301477|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301478|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14301479|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301480|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
14301481|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
14301482|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301483|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301484|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
14301485|NCT00609167|Hormones|hormones|mesh-ancestor
14301486|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301487|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14301488|NCT00609245|Valproic Acid|valproic acid|mesh-list
14301489|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
14301490|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301491|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301492|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
14722116|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15220244|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
15220245|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220246|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220247|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15220248|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15220249|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14301493|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301494|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301495|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
14301496|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301497|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301498|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301499|NCT00609336|Gemcitabine|gemcitabine|mesh-list
14301500|NCT00609336|Capecitabine|capecitabine|mesh-list
14301501|NCT00609336|Docetaxel|docetaxel|mesh-list
14301502|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
14301503|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301504|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
14301505|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301506|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301507|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
14301508|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301509|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722117|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
14722118|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
14722119|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722120|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14301510|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301511|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
14301512|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301513|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
14301514|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
14301515|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
14301516|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
14301517|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14301518|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301519|NCT00609466|Morphine|morphine|mesh-list
14301520|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14301521|NCT00609466|Narcotics|narcotics|mesh-ancestor
14301522|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301523|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301524|NCT00609466|Analgesics|analgesics|mesh-ancestor
14301525|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
14301526|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301527|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14301528|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
14301529|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301530|NCT00609518|Folic Acid|folic acid|mesh-list
14301531|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
14301532|NCT00609518|Hydroxocobalamin|hydroxocobalamin|mesh-list
14301533|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
14301534|NCT00609518|Dexamethasone|dexamethasone|mesh-list
14301535|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
14301536|NCT00609518|Pemetrexed|pemetrexed|mesh-list
14301537|NCT00609518|BB 1101|bb 1101|mesh-list
14301538|NCT00609518|Vitamins|vitamins|mesh-ancestor
14301539|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
14301540|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301541|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301542|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
14301543|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
14301544|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722121|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14722122|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722123|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301545|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301546|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
14301547|NCT00609518|Hormones|hormones|mesh-ancestor
14301548|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301549|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14301550|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301551|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
14301552|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301553|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301554|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14301555|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14301556|NCT00609518|Hematinics|hematinics|mesh-ancestor
14301557|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
14301558|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14301559|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14301560|NCT00609609|Prednisolone|prednisolone|mesh-list
14301561|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
14301562|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14301563|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
14301564|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301565|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
14301566|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
14301567|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301568|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301569|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301570|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
14729143|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301571|NCT00609609|Hormones|hormones|mesh-ancestor
14301572|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301573|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14301574|NCT00609609|Protective Agents|protective agents|mesh-ancestor
14301575|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14301576|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301577|NCT00609622|Bevacizumab|bevacizumab|mesh-list
14301578|NCT00609622|Sunitinib|sunitinib|mesh-list
14301579|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14301580|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301581|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14301582|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14301583|NCT00609622|Growth Substances|growth substances|mesh-ancestor
14301584|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301585|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
14301586|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14301587|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301588|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301589|NCT00609674|Fluticasone|fluticasone|mesh-list
14301590|NCT00609674|Xhance|xhance|mesh-list
14301591|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301592|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14301593|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
14301594|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301595|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301596|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14301597|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
14301598|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
14301599|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14301600|NCT00609739|Cytarabine|cytarabine|mesh-list
14301601|NCT00609739|Cyclosporine|cyclosporine|mesh-list
14301602|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
14301603|NCT00609739|Methotrexate|methotrexate|mesh-list
14301604|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
14301605|NCT00609739|Tretinoin|tretinoin|mesh-list
14301606|NCT00609739|Isotretinoin|isotretinoin|mesh-list
14301607|NCT00609739|Cyclosporins|cyclosporins|mesh-list
14301608|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14301609|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
14301610|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14301611|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301612|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301613|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
14301614|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301615|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301616|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
14301617|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301618|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14301619|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14909623|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
14909624|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909625|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909626|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14909627|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14909628|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
14909629|NCT01352338|Hormones|hormones|mesh-ancestor
15220250|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
15220251|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220252|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220253|NCT04166331|Protective Agents|protective agents|mesh-ancestor
14722124|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14722125|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
14722126|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722127|NCT00488813|Cephalosporins|cephalosporins|mesh-list
14722128|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722129|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220254|NCT04166071|Naltrexone|naltrexone|mesh-list
15220255|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15220256|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15220257|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301620|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
14301621|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301622|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14301623|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
14301624|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301625|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
14301626|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14301627|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301628|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
14301629|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
14301630|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301631|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301632|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
14301633|NCT00609739|Hormones|hormones|mesh-ancestor
14301634|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301635|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14301636|NCT00609739|Protective Agents|protective agents|mesh-ancestor
14301637|NCT00609739|Analgesics|analgesics|mesh-ancestor
15220258|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
15220259|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220260|NCT04163874|Pramlintide|pramlintide|mesh-list
15220261|NCT04163874|Pancrelipase|pancrelipase|mesh-list
15220262|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15220263|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14301638|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
14301639|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14301640|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14301641|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
14722130|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14301642|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14722131|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
14722132|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14722133|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722134|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722135|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722136|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14722137|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14301643|NCT00609804|Sorafenib|sorafenib|mesh-list
14301644|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301645|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14301646|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301647|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301648|NCT00609869|Rituximab|rituximab|mesh-list
14301649|NCT00609869|Lenalidomide|lenalidomide|mesh-list
14301650|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14301651|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301652|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
14301653|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301654|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301655|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14301656|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14301657|NCT00609869|Growth Substances|growth substances|mesh-ancestor
14301658|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
14301659|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
14301660|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14301661|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301662|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14301663|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14301664|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301665|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301666|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301667|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14301668|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14301669|NCT00609986|Insulin|insulin|mesh-list
14301670|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14301671|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
14301672|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
14301673|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
14301674|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
14301675|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14301676|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301677|NCT00610155|Pregabalin|pregabalin|mesh-list
14301678|NCT00610155|Tramadol|tramadol|mesh-list
14301679|NCT00610155|Analgesics|analgesics|mesh-ancestor
14301680|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
14301681|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301682|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301683|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
14301684|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14301685|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14301686|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301687|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14301688|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14301689|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301690|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301691|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301692|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14301693|NCT00610155|Narcotics|narcotics|mesh-ancestor
14301694|NCT00610168|Vaccines|vaccines|mesh-list
14301695|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
14301696|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301697|NCT00610311|Aldesleukin|aldesleukin|mesh-list
14301698|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
14301699|NCT00610311|Fludarabine|fludarabine|mesh-list
14301700|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
14301701|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301702|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
14301703|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301704|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301705|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14301706|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
14301707|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301708|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301709|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14301710|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301711|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
14301712|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14301713|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14301714|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
14301715|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301716|NCT00610363|Rilonacept|rilonacept|mesh-list
14301717|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14301718|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
14301719|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
14301720|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
14301721|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301722|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301723|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301724|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14301725|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301726|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301727|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301728|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14301729|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
14301730|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722138|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
14722139|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722140|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301731|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301732|NCT00610675|Mirtazapine|mirtazapine|mesh-list
14301733|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
14301734|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301735|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14722141|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14722142|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14722143|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
14722144|NCT00488969|Morphine|morphine|mesh-list
14722145|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14722146|NCT00488969|Narcotics|narcotics|mesh-ancestor
14722147|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722148|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722149|NCT00488969|Analgesics|analgesics|mesh-ancestor
14722150|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
14722151|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722152|NCT00488995|Tremelimumab|tremelimumab|mesh-list
14722153|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722154|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14722155|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14722156|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14722157|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722158|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722159|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722160|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722161|NCT00489073|Analgesics|analgesics|mesh-ancestor
14722162|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
14722163|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301736|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
14722164|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
14722165|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301737|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
14301738|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301739|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301740|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301741|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14301742|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301743|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301744|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14301745|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14301746|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14301747|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
14301748|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14722166|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
14722167|NCT00489099|Vaccines|vaccines|mesh-list
15220264|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220265|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
15220266|NCT04140526|Osimertinib|osimertinib|mesh-list
14301749|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15225539|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301750|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
14301751|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14301752|NCT00610688|Vitamin D|vitamin d|mesh-list
14301753|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
14301754|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
14301755|NCT00610688|Vitamins|vitamins|mesh-list
14301756|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
14301757|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301758|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14301759|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14301760|NCT00610714|Paclitaxel|paclitaxel|mesh-list
14301761|NCT00610714|Carboplatin|carboplatin|mesh-list
14301762|NCT00610714|Saracatinib|saracatinib|mesh-list
14301763|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14301764|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301765|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
14301766|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
14301767|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
14301768|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301769|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301770|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
14301771|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
14301772|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
14301773|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301774|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301775|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14301776|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14301777|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14301778|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301779|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14301780|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14301781|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
14301782|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301783|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301784|NCT00610740|Gemcitabine|gemcitabine|mesh-list
14301785|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301786|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
14301787|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301788|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301789|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
14301790|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301791|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301792|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301793|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
14301794|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301795|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14301796|NCT00610857|Antibodies|antibodies|mesh-list
14301797|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
14301798|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14909630|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14909631|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14301799|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
14301800|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301801|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301802|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
14301803|NCT00610883|Methotrexate|methotrexate|mesh-list
14301804|NCT00610883|Asparaginase|asparaginase|mesh-list
14301805|NCT00610883|Daunorubicin|daunorubicin|mesh-list
14301806|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301807|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
14301808|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301809|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301810|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14301811|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
14301812|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220267|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220268|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220269|NCT04140526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14301813|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301814|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14301815|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14301816|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
14301817|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14301818|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14301819|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
14301820|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
14301821|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301822|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14301823|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15220270|NCT04140526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220271|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301824|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14301825|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14301826|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14301827|NCT00610935|Peramivir|peramivir|mesh-list
14301828|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
14301829|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301830|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301831|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301832|NCT00610987|Cefazolin|cefazolin|mesh-list
14301833|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14301834|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301835|NCT00611026|Fesoterodine|fesoterodine|mesh-list
14301836|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14301837|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14301838|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14301839|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
14301840|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301841|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301842|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301843|NCT00611026|Urological Agents|urological agents|mesh-ancestor
14301844|NCT00611130|Vigabatrin|vigabatrin|mesh-list
14301845|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
14301846|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301847|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301848|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
14301849|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301850|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301851|NCT00611247|Temozolomide|temozolomide|mesh-list
14301852|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14301853|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
14301854|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301855|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722168|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
14722169|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722170|NCT00489138|Ertapenem|ertapenem|mesh-list
14722171|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722172|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722173|NCT00489151|Lamivudine|lamivudine|mesh-list
14722174|NCT00489151|Adefovir|adefovir|mesh-list
14722175|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14722176|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14301856|NCT00611325|Bevacizumab|bevacizumab|mesh-list
15220272|NCT04129996|Paclitaxel|paclitaxel|mesh-list
15220273|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15220274|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220275|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
15220276|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729144|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
14301857|NCT00611325|Bortezomib|bortezomib|mesh-list
14301858|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14301859|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220277|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
15220278|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220279|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15220280|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
15220281|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15220282|NCT04120766|Nicorandil|nicorandil|mesh-list
14301860|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14301861|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14301862|NCT00611325|Growth Substances|growth substances|mesh-ancestor
14301863|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301864|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
14301865|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
14301866|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
14301867|NCT00611351|Busulfan|busulfan|mesh-list
14301868|NCT00611351|Tacrolimus|tacrolimus|mesh-list
14301869|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14301870|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301871|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
14301872|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301873|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301874|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14301875|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
14301876|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301877|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301878|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14301879|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14301880|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301881|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14301882|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14301883|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
14301884|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14301885|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301886|NCT00611403|Cyclosporine|cyclosporine|mesh-list
14301887|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
14301888|NCT00611403|Cyclosporins|cyclosporins|mesh-list
14301889|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301890|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301891|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301892|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
14301893|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301894|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
14722177|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14722178|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722179|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722180|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
14722181|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722182|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14722183|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14722184|NCT00489164|Sirolimus|sirolimus|mesh-list
14301895|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301896|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14301897|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14301898|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14301899|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14301900|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14301901|NCT00611442|Lubiprostone|lubiprostone|mesh-list
14301902|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14301903|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14301904|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301905|NCT00611455|Ofatumumab|ofatumumab|mesh-list
14301906|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301907|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14301908|NCT00611468|Topotecan|topotecan|mesh-list
14301909|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301910|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14301911|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301912|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301913|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14301914|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14301915|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14722185|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722186|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301916|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14301917|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14301918|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14301919|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301920|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
14301921|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301922|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301923|NCT00611559|PENTA|penta|mesh-list
14722187|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14722188|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722189|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
14722190|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722191|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
14722192|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722193|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
14722194|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15220283|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14301924|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
14301925|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14301926|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14301927|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301928|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14301929|NCT00611715|Letrozole|letrozole|mesh-list
14301930|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301931|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14301932|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14301933|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301934|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14301935|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14301936|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14301937|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
14301938|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14301939|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301940|NCT00611767|Thiopental|thiopental|mesh-list
14301941|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
14301942|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14301943|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301944|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301945|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14301946|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
14301947|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
14301948|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
14301949|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
14301950|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301951|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301952|NCT00611806|Folic Acid|folic acid|mesh-list
14301953|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
14301954|NCT00611806|Hematinics|hematinics|mesh-ancestor
15220284|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15220285|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
14301955|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
14301956|NCT00611806|Vitamins|vitamins|mesh-ancestor
14301957|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
14301958|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301959|NCT00611858|Fluorouracil|fluorouracil|mesh-list
14301960|NCT00611858|Cetuximab|cetuximab|mesh-list
14301961|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
15220286|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
15220287|NCT04120766|Vitamins|vitamins|mesh-ancestor
14301962|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220288|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
15220289|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220290|NCT04105998|Oxytocin|oxytocin|mesh-list
15220291|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
15220292|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15220293|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301963|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15220294|NCT04075136|Triamcinolone|triamcinolone|mesh-list
15220295|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14301964|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14301965|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14301966|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
14301967|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301968|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14301969|NCT00611884|Insulin|insulin|mesh-list
14301970|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14301971|NCT00611884|Metformin|metformin|mesh-list
14301972|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
14301973|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
14301974|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14301975|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301976|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
14301977|NCT00611897|Ketamine|ketamine|mesh-list
14301978|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14301979|NCT00611897|Analgesics|analgesics|mesh-ancestor
14301980|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
14301981|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14301982|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14301983|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15220296|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14301984|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15220297|NCT04075136|Ranibizumab|ranibizumab|mesh-list
15220298|NCT04075136|Verteporfin|verteporfin|mesh-list
15220299|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15220300|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15220301|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15220302|NCT04075136|Growth Substances|growth substances|mesh-ancestor
15220303|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220304|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
15220305|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220306|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220307|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
15220308|NCT04075136|Hormones|hormones|mesh-ancestor
14301985|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
14301986|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
14301987|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14301988|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14301989|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14301990|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14301991|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14301992|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
14301993|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14301994|NCT00611897|Expectorants|expectorants|mesh-ancestor
14301995|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
14301996|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14301997|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
14301998|NCT00611897|Protective Agents|protective agents|mesh-ancestor
14301999|NCT00611897|Antidotes|antidotes|mesh-ancestor
14302000|NCT00611923|Flutamide|flutamide|mesh-list
14302001|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
14302002|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
14302003|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302004|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302005|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14302006|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302007|NCT00611975|Bupropion|bupropion|mesh-list
14722195|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722196|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
14722197|NCT00489229|Ramipril|ramipril|mesh-list
14722198|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302008|NCT00611975|Fluoxetine|fluoxetine|mesh-list
14302009|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14302010|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
14302011|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302012|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14302013|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302014|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302015|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302016|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
14302017|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220309|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220310|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302018|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722199|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722200|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15220311|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
15220312|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220313|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220314|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15220315|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
15220316|NCT04074967|Nivolumab|nivolumab|mesh-list
15220317|NCT04074967|Ipilimumab|ipilimumab|mesh-list
15220318|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220319|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220320|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15220321|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220322|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
15220323|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220324|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302019|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14302020|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14302021|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302022|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14302023|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
14302024|NCT00612040|Insulin|insulin|mesh-list
14302025|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14302026|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
14302027|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
14722201|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
14722202|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722203|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722204|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14722205|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
14722206|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14722207|NCT00489372|Protective Agents|protective agents|mesh-ancestor
14722208|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722209|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722210|NCT00489385|Ribavirin|ribavirin|mesh-list
14722211|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
14722212|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302028|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
14302029|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302030|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302031|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
14302032|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302033|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302034|NCT00612105|Ezogabine|ezogabine|mesh-list
14302035|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
14302036|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302037|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302038|NCT00612222|Aldesleukin|aldesleukin|mesh-list
14302039|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
14302040|NCT00612222|Fludarabine|fludarabine|mesh-list
14302041|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
14302042|NCT00612222|Interleukin-2|interleukin-2|mesh-list
14302043|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302044|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
14302045|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302046|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302047|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14302048|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
14302049|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302050|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302051|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14302052|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14302053|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
14302054|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14302055|NCT00612222|Analgesics|analgesics|mesh-ancestor
14302056|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
14302057|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302058|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14302059|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14302060|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
14302061|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302062|NCT00612235|Lamotrigine|lamotrigine|mesh-list
14722213|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
15220325|NCT04074174|Acetaminophen|acetaminophen|mesh-list
15220326|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
15220327|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
15220328|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220329|NCT04074174|Analgesics|analgesics|mesh-ancestor
15220330|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
15220331|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220332|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722214|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220333|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
15220334|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14302063|NCT00612235|Carbamazepine|carbamazepine|mesh-list
14302064|NCT00612235|Levetiracetam|levetiracetam|mesh-list
14302065|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
14302066|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
14302067|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14302068|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302069|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302070|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14302071|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302072|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14302073|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14302074|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302075|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302076|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14302077|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
14302078|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14302079|NCT00612235|Analgesics|analgesics|mesh-ancestor
14302080|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
14302081|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302082|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14302083|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14302084|NCT00612313|Fluoxetine|fluoxetine|mesh-list
14302085|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14302086|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302087|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302088|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302089|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302090|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
14302091|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302092|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14302093|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
14302094|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302095|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14302096|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14302097|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302098|NCT00612339|Bevacizumab|bevacizumab|mesh-list
14302099|NCT00612339|Temozolomide|temozolomide|mesh-list
14302100|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14302101|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302102|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14722215|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14722216|NCT00489398|Epinastine|epinastine|mesh-list
14302103|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302104|NCT00612339|Growth Substances|growth substances|mesh-ancestor
14302105|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302106|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
14302107|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14722217|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14722218|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14722219|NCT00489398|Analgesics|analgesics|mesh-ancestor
14302108|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
14302109|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302110|NCT00612352|Ethanol|ethanol|mesh-list
14302111|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14302112|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302113|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302114|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302115|NCT00612430|Bevacizumab|bevacizumab|mesh-list
14302116|NCT00612430|Etoposide|etoposide|mesh-list
14302117|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
14302118|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14302119|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302120|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302121|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302122|NCT00612430|Growth Substances|growth substances|mesh-ancestor
14302123|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302124|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
14302125|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14302126|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14302127|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14722220|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
15220335|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15220336|NCT04068831|Avelumab|avelumab|mesh-list
15220337|NCT04068831|Talazoparib|talazoparib|mesh-list
14722221|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722222|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722223|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722224|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722225|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14722226|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14722227|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14722228|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
14722229|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
14722230|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722231|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220338|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220339|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220340|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15220341|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302128|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302129|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302130|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15220342|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220343|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15220344|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
15220345|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220346|NCT04061421|Decitabine|decitabine|mesh-list
15220347|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15220348|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
14302131|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14302132|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14302133|NCT00612508|Etonogestrel|etonogestrel|mesh-list
14302134|NCT00612508|Desogestrel|desogestrel|mesh-list
14302135|NCT00612508|NuvaRing|nuvaring|mesh-list
14302136|NCT00612508|Estradiol|estradiol|mesh-list
14302137|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14302138|NCT00612508|Estrogens|estrogens|mesh-ancestor
14302139|NCT00612508|Hormones|hormones|mesh-ancestor
14302140|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302141|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302142|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14302143|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
14302144|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14302145|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14302146|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14302147|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14302148|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14302149|NCT00612508|Progestins|progestins|mesh-ancestor
14302150|NCT00612534|Sufentanil|sufentanil|mesh-list
14302151|NCT00612534|Dsuvia|dsuvia|mesh-list
14302152|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14909632|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14909633|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15220349|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220350|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220351|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220352|NCT04054713|Acetic Acid|acetic acid|mesh-list
15220353|NCT04054713|Retinol acetate|retinol acetate|mesh-list
15220354|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15220355|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220356|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14302153|NCT00612534|Narcotics|narcotics|mesh-ancestor
14302154|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909634|NCT01352338|Growth Substances|growth substances|mesh-ancestor
14909635|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
14909636|NCT01352494|Gemcitabine|gemcitabine|mesh-list
14909637|NCT01352494|Docetaxel|docetaxel|mesh-list
14909638|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14909639|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
14909640|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909641|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909642|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
14909643|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220357|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
15220358|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220359|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15220360|NCT04054713|Protective Agents|protective agents|mesh-ancestor
15220361|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220362|NCT04044469|Vaccines|vaccines|mesh-list
15220363|NCT04044469|Immunologic Factors|immunologic factors|mesh-ancestor
15220364|NCT04044469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220365|NCT04040959|Niacinamide|niacinamide|mesh-list
15220366|NCT04040959|Niacin|niacin|mesh-list
15220367|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
15220368|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
14909644|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909645|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14909646|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
14909647|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220369|NCT04040959|Vitamins|vitamins|mesh-ancestor
15220370|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
15220371|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220372|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15220373|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
15220374|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220375|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15220376|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
14909648|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
14909649|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
14909650|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
14909651|NCT01352559|Milnacipran|milnacipran|mesh-list
14909652|NCT01352559|Mirtazapine|mirtazapine|mesh-list
14909653|NCT01352559|Sertraline|sertraline|mesh-list
14909654|NCT01352559|Fluoxetine|fluoxetine|mesh-list
14909655|NCT01352559|Paroxetine|paroxetine|mesh-list
15220377|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
14302155|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302156|NCT00612534|Analgesics|analgesics|mesh-ancestor
14302157|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
14302158|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302159|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14302160|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14302161|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
14302162|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
14302163|NCT00612560|Anastrozole|anastrozole|mesh-list
14302164|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14302165|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302166|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14302167|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14302168|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302169|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302170|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14302171|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
14302172|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302173|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302174|NCT00612573|Doxycycline|doxycycline|mesh-list
14302175|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14909656|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14909657|NCT01352559|Nortriptyline|nortriptyline|mesh-list
14909658|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
15220378|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14302176|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302177|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
14302178|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14302179|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14302180|NCT00612586|Leucovorin|leucovorin|mesh-list
14302181|NCT00612586|Bevacizumab|bevacizumab|mesh-list
14302182|NCT00612586|Fluorouracil|fluorouracil|mesh-list
14302183|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14302184|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302185|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302186|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302187|NCT00612586|Growth Substances|growth substances|mesh-ancestor
14302188|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302189|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
14302190|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
14302191|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302192|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14302193|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302194|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
14302195|NCT00612586|Antidotes|antidotes|mesh-ancestor
14302196|NCT00612586|Protective Agents|protective agents|mesh-ancestor
14302197|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
14302198|NCT00612586|Vitamins|vitamins|mesh-ancestor
14302199|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
14302200|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
14302201|NCT00612716|Busulfan|busulfan|mesh-list
14302202|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302203|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
14302204|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302205|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302206|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14302207|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
14302208|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302209|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302210|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14302211|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
14302212|NCT00612807|Bupropion|bupropion|mesh-list
14302213|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14302214|NCT00612807|Sertraline|sertraline|mesh-list
14302215|NCT00612807|Nortriptyline|nortriptyline|mesh-list
15220379|NCT04023071|Rituximab|rituximab|mesh-list
15220380|NCT04023071|Fludarabine|fludarabine|mesh-list
15220381|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
15220382|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220383|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
15220384|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220385|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220386|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15220387|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
15220388|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220389|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220390|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15220391|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220392|NCT04019262|Temozolomide|temozolomide|mesh-list
15220393|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15220394|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
15220395|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220396|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220397|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
15220398|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15220399|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
15220400|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
15220401|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220402|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220403|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220404|NCT04008628|Analgesics|analgesics|mesh-ancestor
15220405|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
15220406|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220407|NCT04001894|Clopidogrel|clopidogrel|mesh-list
15220408|NCT04001894|Ticagrelor|ticagrelor|mesh-list
15220409|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15220410|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15220411|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14302216|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14722232|NCT00489437|Heparin|heparin|mesh-list
14302217|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
14302218|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302219|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14302220|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302221|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302222|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302223|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
14302224|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302225|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302226|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14302227|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14302228|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302229|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14302230|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
15220412|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15220413|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
15220414|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220415|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220416|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220417|NCT03988920|Sevelamer|sevelamer|mesh-list
15220418|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
15220419|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
15220420|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220421|NCT03982485|Paclitaxel|paclitaxel|mesh-list
15220422|NCT03982485|Apatinib|apatinib|mesh-list
15220423|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15220424|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220425|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
15220426|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
15220427|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
15220428|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220429|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15220430|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225540|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225541|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
15225542|NCT04473807|Sotalol|sotalol|mesh-list
14302231|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14302232|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302233|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14302234|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14302235|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14302236|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
14302237|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14302238|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14302239|NCT00613015|Guanfacine|guanfacine|mesh-list
14302240|NCT00613015|Modafinil|modafinil|mesh-list
14302241|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14302242|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302243|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14302244|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14302245|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14302246|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302247|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14302248|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14302249|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14302250|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14302251|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
14302252|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302253|NCT00613028|Bevacizumab|bevacizumab|mesh-list
14302254|NCT00613028|Etoposide|etoposide|mesh-list
14302255|NCT00613028|Temozolomide|temozolomide|mesh-list
14302256|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14302257|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302258|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302259|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302260|NCT00613028|Growth Substances|growth substances|mesh-ancestor
14302261|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225543|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14302262|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14302263|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14302264|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15225544|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15225545|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
15225546|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225547|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302265|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14302266|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302267|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302268|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14302269|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
14302270|NCT00613080|Leucovorin|leucovorin|mesh-list
14302271|NCT00613080|Fluorouracil|fluorouracil|mesh-list
14302272|NCT00613080|Capecitabine|capecitabine|mesh-list
15225548|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225549|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15225550|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
15225551|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
15225552|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225553|NCT04452344|Analgesics|analgesics|mesh-list
15225554|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225555|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
15225556|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225557|NCT04436744|Palbociclib|palbociclib|mesh-list
15225558|NCT04436744|Anastrozole|anastrozole|mesh-list
15225559|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225560|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15225561|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302273|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
14302274|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
14302275|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302276|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14302277|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302278|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722233|NCT00489437|Antibodies|antibodies|mesh-list
14722234|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
14722235|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722236|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
14722237|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14722238|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14722239|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729145|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729146|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729147|NCT00521703|Lidocaine|lidocaine|mesh-list
14729148|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
14729149|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
14729150|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729151|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729152|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
14729153|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729154|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14729155|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14729156|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14729157|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729158|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729159|NCT00521742|Pioglitazone|pioglitazone|mesh-list
14729160|NCT00521742|Glyburide|glyburide|mesh-list
15220431|NCT03969121|Palbociclib|palbociclib|mesh-list
15220432|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220433|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15220434|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220435|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220436|NCT03966339|Hormones|hormones|mesh-list
15220437|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220438|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729161|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729162|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729163|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14729164|NCT00521781|Leuprolide|leuprolide|mesh-list
15220439|NCT03948022|Progesterone|progesterone|mesh-list
14729165|NCT00521781|Bicalutamide|bicalutamide|mesh-list
14729166|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
14722240|NCT00489528|Hormones|hormones|mesh-list
14722241|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722242|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722243|NCT00489593|Olanzapine|olanzapine|mesh-list
14722244|NCT00489593|Fluoxetine|fluoxetine|mesh-list
14722245|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
14722246|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
14302279|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
14302280|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302281|NCT00613080|Antidotes|antidotes|mesh-ancestor
14302282|NCT00613080|Protective Agents|protective agents|mesh-ancestor
14302283|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
14302284|NCT00613080|Vitamins|vitamins|mesh-ancestor
14302285|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
14302286|NCT00613106|Ibuprofen|ibuprofen|mesh-list
14302287|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14302288|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14302289|NCT00613106|Analgesics|analgesics|mesh-ancestor
14302290|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
14302291|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302292|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302293|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14302294|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302295|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14302296|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302297|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302298|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
14302299|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302300|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14302301|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302302|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302303|NCT00613327|Oxybutynin|oxybutynin|mesh-list
14302304|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
14302305|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
14302306|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302307|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302308|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14302309|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14302310|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
14302311|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302312|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302313|NCT00613327|Urological Agents|urological agents|mesh-ancestor
14722247|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722248|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302314|NCT00613366|Misoprostol|misoprostol|mesh-list
14302315|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
14302316|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14302317|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
14302318|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14302319|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302320|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14302321|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14302322|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
14302323|NCT00613366|Antacids|antacids|mesh-ancestor
14302324|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302325|NCT00613379|Leronlimab|leronlimab|mesh-list
14302326|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
14302327|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14302328|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14302329|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302330|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14302331|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14302332|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
14302333|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302334|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
14302335|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302336|NCT00613509|Interferons|interferons|mesh-list
14302337|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
14302338|NCT00613509|Vaccines|vaccines|mesh-list
14302339|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302340|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
14302341|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722249|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14722250|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14722251|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14722252|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722253|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722254|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15220440|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
14302342|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
14302343|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302344|NCT00613574|Bromides|bromides|mesh-list
14302345|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
14302346|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14302347|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
14302348|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302349|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302350|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14302351|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
14302352|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
14302353|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15220441|NCT03948022|Progestins|progestins|mesh-ancestor
15220442|NCT03948022|Hormones|hormones|mesh-ancestor
15220443|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220444|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220445|NCT03946111|Naltrexone|naltrexone|mesh-list
15220446|NCT03946111|Bupropion|bupropion|mesh-list
15220447|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15220448|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15220449|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220450|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
15220451|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220452|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15220453|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
15220454|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15220455|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14302354|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
14302355|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302356|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302357|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
14302358|NCT00613626|Etoposide|etoposide|mesh-list
14302359|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302360|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14302361|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14302362|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14302363|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302364|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302365|NCT00613821|Lidocaine|lidocaine|mesh-list
14302366|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
14302367|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
14302368|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302369|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302370|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
14302371|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302372|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14302373|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14302374|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14302375|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302376|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302377|NCT00613834|Lidocaine|lidocaine|mesh-list
14302378|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
14302379|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
14302380|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302381|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302382|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
14302383|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302384|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14302385|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14302386|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14302387|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302388|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302389|NCT00613938|Oxycodone|oxycodone|mesh-list
14302390|NCT00613938|Tapentadol|tapentadol|mesh-list
14302391|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14302392|NCT00613938|Narcotics|narcotics|mesh-ancestor
14302393|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302394|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302395|NCT00613938|Analgesics|analgesics|mesh-ancestor
14302396|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
14302397|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302398|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14302399|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302400|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302401|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302402|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
14302403|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327736|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14327737|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327738|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
14327739|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327740|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14327741|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14327742|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14327743|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327744|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327745|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14327746|NCT00804609|Narcotics|narcotics|mesh-ancestor
14327747|NCT00804609|Analgesics|analgesics|mesh-ancestor
14327748|NCT00804648|Timolol|timolol|mesh-list
14722255|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14722256|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327749|NCT00804648|Maleic acid|maleic acid|mesh-list
14327750|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14327751|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14327752|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
14327753|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722257|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302404|NCT00613951|Insulin|insulin|mesh-list
14302405|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14302406|NCT00613951|Metformin|metformin|mesh-list
14722258|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722259|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
14722260|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14722261|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
14722262|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14722263|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14722264|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722265|NCT00489645|Pramlintide|pramlintide|mesh-list
14722266|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14302407|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
14302408|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
14302409|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14302410|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
14302411|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302412|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302413|NCT00614055|Insulin|insulin|mesh-list
14302414|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14302415|NCT00614055|Metformin|metformin|mesh-list
14302416|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
14302417|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
14302418|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
14302419|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14302420|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302421|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302422|NCT00614120|Metformin|metformin|mesh-list
14302423|NCT00614120|Liraglutide|liraglutide|mesh-list
14302424|NCT00614120|Glimepiride|glimepiride|mesh-list
14302425|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302426|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302427|NCT00614120|Incretins|incretins|mesh-ancestor
14302428|NCT00614120|Hormones|hormones|mesh-ancestor
14302429|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302430|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14302431|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302432|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
14302433|NCT00614198|Caseins|caseins|mesh-list
14302434|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
14302435|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
14302436|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302437|NCT00614380|Amlodipine|amlodipine|mesh-list
14302438|NCT00614380|Telmisartan|telmisartan|mesh-list
14302439|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14302440|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14302441|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14302442|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302443|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302444|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14302445|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302446|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
14302447|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14302448|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14302449|NCT00614393|Irinotecan|irinotecan|mesh-list
14302450|NCT00614393|Cetuximab|cetuximab|mesh-list
14302451|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14302452|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14302453|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14302454|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302455|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302456|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302457|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220456|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15220457|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220458|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220459|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
15220460|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302458|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
14302459|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302460|NCT00614406|Celecoxib|celecoxib|mesh-list
14302461|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14302462|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14302463|NCT00614406|Analgesics|analgesics|mesh-ancestor
14302464|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
14302465|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302466|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302467|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14302468|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302469|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14302470|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14302471|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302472|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302473|NCT00614445|Pyridoxine|pyridoxine|mesh-list
14302474|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
14302475|NCT00614445|Doxylamine|doxylamine|mesh-list
14302476|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
14302477|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
14302478|NCT00614445|Vitamins|vitamins|mesh-ancestor
14302479|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
15220461|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15220462|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15220463|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220464|NCT03937596|Cycloserine|cycloserine|mesh-list
15220465|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15220466|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220467|NCT03937596|Renal Agents|renal agents|mesh-ancestor
14302480|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302481|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14302482|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
14302483|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
14302484|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302485|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302486|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
14302487|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
14302488|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302489|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14302490|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
15220468|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15220469|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
15220470|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15220471|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
15220472|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220473|NCT03928158|Valsartan|valsartan|mesh-list
15220474|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15220475|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15220476|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15220477|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15220478|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220479|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14302491|NCT00614458|Valproic Acid|valproic acid|mesh-list
14302492|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14302493|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14722267|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14722268|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220480|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15220481|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220482|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14302494|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
14722269|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
14722270|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14722271|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14722272|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722273|NCT00489658|Eflornithine|eflornithine|mesh-list
14722274|NCT00489658|Nifurtimox|nifurtimox|mesh-list
14722275|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722276|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14722277|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14722278|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14722279|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302495|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302496|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14302497|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15220483|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15220484|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220485|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220486|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
15220487|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220488|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15220489|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15220490|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220491|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15220492|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302498|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302499|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302500|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
14302501|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
14302502|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302503|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302504|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
14302505|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14302506|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302507|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302508|NCT00614484|Paclitaxel|paclitaxel|mesh-list
14302509|NCT00614484|Carboplatin|carboplatin|mesh-list
14302510|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14302511|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302512|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
14302513|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
14302514|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
14302515|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302516|NCT00614614|Vaccines|vaccines|mesh-list
14302517|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
14302518|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302519|NCT00614822|Bevacizumab|bevacizumab|mesh-list
14302520|NCT00614822|Carboplatin|carboplatin|mesh-list
14302521|NCT00614822|Pemetrexed|pemetrexed|mesh-list
14302522|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14302523|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302524|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302525|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302526|NCT00614822|Growth Substances|growth substances|mesh-ancestor
14302527|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722280|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
15220493|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220494|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220495|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
15220496|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220497|NCT03922880|Nivolumab|nivolumab|mesh-list
15220498|NCT03922880|Ipilimumab|ipilimumab|mesh-list
15220499|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220500|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220501|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14302528|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
14302529|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302530|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302531|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15220502|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220503|NCT03920722|Rituximab|rituximab|mesh-list
15220504|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220505|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220506|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
15220507|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220508|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220509|NCT03902314|Lidocaine|lidocaine|mesh-list
15220510|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14302532|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14302533|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
14302534|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302535|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302536|NCT00614926|Modafinil|modafinil|mesh-list
14302537|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14302538|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302539|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14302540|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14302541|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14302542|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302543|NCT00614939|Saxagliptin|saxagliptin|mesh-list
14302544|NCT00614939|Incretins|incretins|mesh-ancestor
14302545|NCT00614939|Hormones|hormones|mesh-ancestor
14302546|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302547|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302548|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14302549|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14302550|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302551|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302552|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302553|NCT00614991|Ritonavir|ritonavir|mesh-list
14302554|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
14302555|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
14302556|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14302557|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14302558|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
14302559|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302560|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302561|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14302562|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14302563|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
14302564|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302565|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14302566|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14302567|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14302568|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14302569|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14302570|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14302571|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
14302572|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302573|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302574|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14302575|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
14302576|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14302577|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14302578|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14302579|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
14302580|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302581|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302582|NCT00615056|Leucovorin|leucovorin|mesh-list
14302583|NCT00615056|Bevacizumab|bevacizumab|mesh-list
14302584|NCT00615056|Fluorouracil|fluorouracil|mesh-list
14302585|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
14302586|NCT00615056|Irinotecan|irinotecan|mesh-list
14302587|NCT00615056|Axitinib|axitinib|mesh-list
14302588|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
14302589|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14302590|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302591|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302592|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302593|NCT00615056|Growth Substances|growth substances|mesh-ancestor
15220511|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
14302594|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302595|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
14302596|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
14302597|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302598|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14302599|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302600|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
14302601|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14302602|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14302603|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302604|NCT00615056|Antidotes|antidotes|mesh-ancestor
14302605|NCT00615056|Protective Agents|protective agents|mesh-ancestor
14302606|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
14302607|NCT00615056|Vitamins|vitamins|mesh-ancestor
14302608|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
14302609|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14302610|NCT00615199|Tofacitinib|tofacitinib|mesh-list
14302611|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14302612|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302613|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302614|NCT00615290|Tipranavir|tipranavir|mesh-list
14302615|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14302616|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14302617|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
14302618|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302619|NCT00615433|Olanzapine|olanzapine|mesh-list
14302620|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14302621|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
14302622|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
14302623|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302624|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302625|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14302626|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14302627|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14302628|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302629|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302630|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14302631|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302632|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302633|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302634|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302635|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
14302636|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14302637|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14302638|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14722281|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722282|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722283|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14722284|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722285|NCT00489723|Tamsulosin|tamsulosin|mesh-list
14722286|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14722287|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15220512|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220513|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220514|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
15220515|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220516|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15220517|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15220518|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14722288|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14722289|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
14722290|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722291|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722292|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722293|NCT00489723|Urological Agents|urological agents|mesh-ancestor
14302639|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
14302640|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14302641|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14302642|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14302643|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14302644|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
14302645|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
14302646|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14302647|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
14302648|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302649|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302650|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14302651|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
14302652|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
14302653|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14302654|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
14302655|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302656|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302657|NCT00615472|Remifentanil|remifentanil|mesh-list
14302658|NCT00615472|Propofol|propofol|mesh-list
14302659|NCT00615472|Isoflurane|isoflurane|mesh-list
14302660|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14302661|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302662|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302663|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14302664|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
14302665|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
14302666|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14302667|NCT00615472|Narcotics|narcotics|mesh-ancestor
14722294|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14722295|NCT00489775|Paroxetine|paroxetine|mesh-list
14302668|NCT00615472|Analgesics|analgesics|mesh-ancestor
14302669|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
14302670|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302671|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14302672|NCT00615550|Progesterone|progesterone|mesh-list
14302673|NCT00615550|Progestins|progestins|mesh-ancestor
14302674|NCT00615550|Hormones|hormones|mesh-ancestor
14302675|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302676|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302677|NCT00615589|Fludarabine|fludarabine|mesh-list
14302678|NCT00615589|Busulfan|busulfan|mesh-list
14302679|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302680|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722296|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14722297|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302681|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302682|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
14302683|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302684|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
14722298|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722299|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722300|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722301|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722302|NCT00489775|Analgesics|analgesics|mesh-ancestor
14722303|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
14722304|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722305|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
14722306|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302685|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14302686|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14302687|NCT00615784|Bexarotene|bexarotene|mesh-list
14302688|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302689|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14302690|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
14302691|NCT00615836|Coagulants|coagulants|mesh-ancestor
14302692|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14302693|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
14722307|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
14302694|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302695|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
14302696|NCT00615901|Fluorouracil|fluorouracil|mesh-list
14302697|NCT00615901|Methotrexate|methotrexate|mesh-list
14302698|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220519|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220520|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302699|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
14302700|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302701|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302702|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14302703|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
14302704|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302705|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302706|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14302707|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
14302708|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14302709|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14302710|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
14302711|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15220521|NCT03900715|Luspatercept|luspatercept|mesh-list
15220522|NCT03900715|Hematinics|hematinics|mesh-ancestor
15220523|NCT03899467|Androgens|androgens|mesh-list
15220524|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
15220525|NCT03899467|Hormones|hormones|mesh-ancestor
15220526|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220527|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220528|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
15220529|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
15220530|NCT03898037|Metformin|metformin|mesh-list
15220531|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15220532|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302712|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
15220533|NCT03894501|Methadone|methadone|mesh-list
15220534|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15220535|NCT03894501|Narcotics|narcotics|mesh-ancestor
15220536|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220537|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220538|NCT03894501|Analgesics|analgesics|mesh-ancestor
15220539|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
15220540|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220541|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
14302713|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302714|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14302715|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14302716|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
14302717|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
14302718|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302719|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14302720|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302721|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302722|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
14302723|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14302724|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
14302725|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14302726|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
14302727|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302728|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302729|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14302730|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
14302731|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
14302732|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14302733|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
14302734|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302735|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302736|NCT00616018|Acetaminophen|acetaminophen|mesh-list
14302737|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14302738|NCT00616018|Analgesics|analgesics|mesh-ancestor
14302739|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
15220542|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
15220543|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
14302740|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302741|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302742|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
14302743|NCT00616109|Sunitinib|sunitinib|mesh-list
14302744|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302745|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302746|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302747|NCT00616109|Growth Substances|growth substances|mesh-ancestor
14302748|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302749|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
14302750|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14302751|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302752|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302753|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
14302754|NCT00616122|Methotrexate|methotrexate|mesh-list
14302755|NCT00616122|Sunitinib|sunitinib|mesh-list
14302756|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302757|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
14302758|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302759|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302760|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14302761|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
14302762|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302763|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302764|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14302765|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14302766|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
14302767|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14302768|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14302769|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
14302770|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
14909659|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302771|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302772|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14302773|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14302774|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302775|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302776|NCT00616122|Growth Substances|growth substances|mesh-ancestor
14302777|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
15220544|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15220545|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
15220546|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
15220547|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220548|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220549|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220550|NCT03879538|Analgesics|analgesics|mesh-ancestor
15220551|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
15220552|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302778|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14302779|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
14302780|NCT00616239|Salicylates|salicylates|mesh-list
14302781|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302782|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
14302783|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
14302784|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14302785|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14302786|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14302787|NCT00616239|Analgesics|analgesics|mesh-ancestor
14302788|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
14302789|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302790|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302791|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14302792|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302793|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14302794|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302795|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302796|NCT00616434|Interferons|interferons|mesh-list
14302797|NCT00616434|Interferon-beta|interferon-beta|mesh-list
14302798|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
14302799|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302800|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
14302801|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302802|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
14302803|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302804|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14302805|NCT00616655|Eszopiclone|eszopiclone|mesh-list
14302806|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14302807|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302808|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302809|NCT00616772|Choline|choline|mesh-list
14302810|NCT00616772|Atorvastatin|atorvastatin|mesh-list
15220553|NCT03874325|Letrozole|letrozole|mesh-list
15220554|NCT03874325|Durvalumab|durvalumab|mesh-list
15220555|NCT03874325|Anastrozole|anastrozole|mesh-list
15220556|NCT03874325|Exemestane|exemestane|mesh-list
15220557|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220558|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15220559|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15220560|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220561|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302811|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
14302812|NCT00616772|Fenofibrate|fenofibrate|mesh-list
15220562|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15220563|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
14302813|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14302814|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14302815|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
14302816|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302817|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14302818|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14302819|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302820|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
14302821|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14302822|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
14302823|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
14302824|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14302825|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302826|NCT00616902|Vitamins|vitamins|mesh-ancestor
14302827|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
15220564|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220565|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220566|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220567|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15220568|NCT03853317|Avelumab|avelumab|mesh-list
15220569|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220570|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220571|NCT03834688|Rituximab|rituximab|mesh-list
15220572|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15220573|NCT03834688|Venetoclax|venetoclax|mesh-list
15220574|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220575|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220576|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
15220577|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220578|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220579|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15220580|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
14302828|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14302829|NCT00616941|Poly ICLC|poly iclc|mesh-list
14302830|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
14302831|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
14302832|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302833|NCT00617058|Metformin|metformin|mesh-list
14302834|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302835|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302836|NCT00617084|Everolimus|everolimus|mesh-list
14302837|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302838|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302839|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
14302840|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302841|NCT00617097|Ketorolac|ketorolac|mesh-list
14302842|NCT00617097|Lidocaine|lidocaine|mesh-list
14302843|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
14302844|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
14302845|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302846|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220581|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220582|NCT03831165|Acyclovir|acyclovir|mesh-list
15220583|NCT03831165|Melatonin|melatonin|mesh-list
15220584|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
15220585|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220586|NCT03831165|Protective Agents|protective agents|mesh-ancestor
15220587|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220588|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302847|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
14302848|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302849|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14302850|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14302851|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14302852|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302853|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302854|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14302855|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14302856|NCT00617097|Analgesics|analgesics|mesh-ancestor
14302857|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14302858|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14302859|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14722308|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14722309|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
14722310|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14722311|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14722312|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14302860|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302861|NCT00617123|Vorapaxar|vorapaxar|mesh-list
14302862|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14302863|NCT00617188|Fulvestrant|fulvestrant|mesh-list
14302864|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14302865|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302866|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14302867|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14302868|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
14302869|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302870|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302871|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14302872|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14302873|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14302874|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14302875|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302876|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
14302877|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302878|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302879|NCT00617240|Metformin|metformin|mesh-list
14302880|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14302881|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302882|NCT00617305|Ambrisentan|ambrisentan|mesh-list
14302883|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
14302884|NCT00617305|Tadalafil|tadalafil|mesh-list
14302885|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
14302886|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14302887|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14302888|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302889|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302890|NCT00617305|Urological Agents|urological agents|mesh-ancestor
14302891|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14302892|NCT00617344|Vaccines|vaccines|mesh-list
14302893|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
14302894|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722313|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722314|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
14722315|NCT00489840|Anecortave|anecortave|mesh-list
14302895|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14302896|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
14302897|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302898|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14302899|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14302900|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302901|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302902|NCT00617409|Paclitaxel|paclitaxel|mesh-list
14302903|NCT00617409|Tretinoin|tretinoin|mesh-list
14302904|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14302905|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302906|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
14302907|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
14302908|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
14302909|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302910|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
14302911|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14302912|NCT00617461|Gabapentin|gabapentin|mesh-list
14302913|NCT00617461|Analgesics|analgesics|mesh-ancestor
14302914|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
14302915|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302916|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302917|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
14302918|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14302919|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14302920|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14302921|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14302922|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15220589|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
15220590|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220591|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15220592|NCT03830723|Hormones|hormones|mesh-ancestor
15220593|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220594|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220595|NCT03829007|Durvalumab|durvalumab|mesh-list
15220596|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15220597|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220598|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220599|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
15220600|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220601|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15220602|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220603|NCT03801863|Ropivacaine|ropivacaine|mesh-list
15220604|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
15220605|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
15220606|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220607|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302923|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14302924|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14302925|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302926|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
14302927|NCT00617539|Irinotecan|irinotecan|mesh-list
14302928|NCT00617539|Temozolomide|temozolomide|mesh-list
14302929|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14302930|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14302931|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220608|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
15220609|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302932|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722316|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14722317|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14722318|NCT00489840|Growth Substances|growth substances|mesh-ancestor
15220610|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
14302933|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302934|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14722319|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722320|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
14722321|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722322|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722323|NCT00489892|Modafinil|modafinil|mesh-list
14722324|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14722325|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302935|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
14302936|NCT00617591|Dexamethasone|dexamethasone|mesh-list
14302937|NCT00617591|Doxorubicin|doxorubicin|mesh-list
14302938|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14302939|NCT00617591|Lenalidomide|lenalidomide|mesh-list
14302940|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14302941|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
14302942|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
14302943|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14302944|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302945|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14302946|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
14302947|NCT00617591|Hormones|hormones|mesh-ancestor
14302948|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14302949|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14302950|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302951|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14302952|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14302953|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14302954|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14302955|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302956|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
14302957|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14302958|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14302959|NCT00617591|Growth Substances|growth substances|mesh-ancestor
14302960|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
15220611|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15220612|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220613|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220614|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14722326|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14722327|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14722328|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15220615|NCT03800641|Analgesics|analgesics|mesh-ancestor
14302961|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
14302962|NCT00617604|Alefacept|alefacept|mesh-list
14302963|NCT00617604|Tacrolimus|tacrolimus|mesh-list
14302964|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14302965|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
14302966|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302967|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14302968|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220616|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
15220617|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220618|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14302969|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302970|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14302971|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302972|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14302973|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
14302974|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14302975|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14302976|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14302977|NCT00617669|Docetaxel|docetaxel|mesh-list
14302978|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302979|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14302980|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14302981|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14302982|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14302983|NCT00617734|Cetuximab|cetuximab|mesh-list
14302984|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14302985|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14302986|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302987|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
14302988|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302989|NCT00617851|Vaccines|vaccines|mesh-list
14302990|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
14302991|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302992|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14302993|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
14302994|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14302995|NCT00617903|Azelaic acid|azelaic acid|mesh-list
14302996|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14302997|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14302998|NCT00617929|Rituximab|rituximab|mesh-list
14302999|NCT00617929|Clofarabine|clofarabine|mesh-list
15220619|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15220620|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14303000|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
14303001|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14303002|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303003|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303004|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
14303005|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303006|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14303007|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303008|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303009|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
14303010|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303011|NCT00617942|Paclitaxel|paclitaxel|mesh-list
14303012|NCT00617942|Carboplatin|carboplatin|mesh-list
14303013|NCT00617942|Trastuzumab|trastuzumab|mesh-list
14303014|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14303015|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303016|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
14303017|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
14303018|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
14303019|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220621|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
15220622|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303020|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303021|NCT00618072|Metformin|metformin|mesh-list
14303022|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
14303023|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14303024|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303025|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
14303026|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14303027|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
14303028|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14303029|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
14303030|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14303031|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14303032|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
14303033|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303034|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14722329|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722330|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
14722331|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14722332|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722333|NCT00489944|Tamoxifen|tamoxifen|mesh-list
14722334|NCT00489944|Sunitinib|sunitinib|mesh-list
15220623|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220624|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
14303035|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14303036|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303037|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303038|NCT00618436|Phenytoin|phenytoin|mesh-list
14303039|NCT00618436|Levetiracetam|levetiracetam|mesh-list
14303040|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
14303041|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
14303042|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14303043|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14303044|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303045|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303046|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14303047|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14722335|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722336|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722337|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14722338|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14722339|NCT00489944|Growth Substances|growth substances|mesh-ancestor
14722340|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722341|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
14722342|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14722343|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303048|NCT00618449|Azithromycin|azithromycin|mesh-list
14303049|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303050|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303051|NCT00618540|Fludarabine|fludarabine|mesh-list
14303052|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
14303053|NCT00618540|Melphalan|melphalan|mesh-list
14303054|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
14303055|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909660|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14909661|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14303056|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303057|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
14303058|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303059|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303060|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
14303061|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303062|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14303063|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
14303064|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14303065|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303066|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
14303067|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14303068|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303069|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
14303070|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14303071|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303072|NCT00618748|Olanzapine|olanzapine|mesh-list
14303073|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
14303074|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
14303075|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303076|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303077|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303078|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14303079|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303080|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303081|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303082|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14303083|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14722344|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14722345|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
14722346|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722347|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14909662|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14909663|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909664|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909665|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
14909666|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909667|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14303084|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303085|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303086|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303087|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
14303088|NCT00618774|Amlodipine|amlodipine|mesh-list
14303089|NCT00618774|Telmisartan|telmisartan|mesh-list
14303090|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14303091|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14303092|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303093|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303094|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14303095|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303096|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
14722348|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14722349|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14722350|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15220625|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14303097|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14303098|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14303099|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
14303100|NCT00618813|Ifosfamide|ifosfamide|mesh-list
14303101|NCT00618813|Doxorubicin|doxorubicin|mesh-list
14303102|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14303103|NCT00618813|Etoposide|etoposide|mesh-list
14303104|NCT00618813|Vincristine|vincristine|mesh-list
14303105|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
14303106|NCT00618813|Topotecan|topotecan|mesh-list
14303107|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303108|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
14303109|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303110|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14303111|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14303112|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
14303113|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303114|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303115|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14303116|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14303117|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14303118|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14303119|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303120|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14303121|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
14303122|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
14303123|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
14303124|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14303125|NCT00618826|Gemcitabine|gemcitabine|mesh-list
14303126|NCT00618826|Paclitaxel|paclitaxel|mesh-list
14303127|NCT00618826|Bevacizumab|bevacizumab|mesh-list
14303128|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14303129|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303130|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14303131|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14303132|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
14328605|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15220626|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15220627|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220628|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
15220629|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
15220630|NCT03772951|Clozapine|clozapine|mesh-list
15220631|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15220632|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
15220633|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220634|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220635|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909668|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15220636|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15220637|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15220638|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220639|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303133|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303134|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303135|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
14303136|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
14303137|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303138|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303139|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303140|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
14303141|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303142|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303143|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303144|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303145|NCT00618826|Growth Substances|growth substances|mesh-ancestor
14303146|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14303147|NCT00618917|Manganese|manganese|mesh-list
14303148|NCT00618917|Paclitaxel|paclitaxel|mesh-list
14303149|NCT00618917|Carboplatin|carboplatin|mesh-list
14303150|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
14303151|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14303152|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303153|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
14303154|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
14303155|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
14303156|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303157|NCT00618917|Trace Elements|trace elements|mesh-ancestor
14303158|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
14303159|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303160|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14303161|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
14303162|NCT00618917|Protective Agents|protective agents|mesh-ancestor
14327754|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327755|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327756|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14327757|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14327758|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327759|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
14327760|NCT00804687|Ephedrine|ephedrine|mesh-list
14327761|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14327762|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
14327763|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722351|NCT00489983|Gemcitabine|gemcitabine|mesh-list
14722352|NCT00489983|Pemetrexed|pemetrexed|mesh-list
14722353|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722354|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
14722355|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722356|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722357|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
14722358|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722359|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722360|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722361|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
14722362|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722363|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14722364|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14722365|NCT00489996|Gemcitabine|gemcitabine|mesh-list
14909669|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14909670|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909671|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14909672|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14909673|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
14909674|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
14909675|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15220640|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
15220641|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
15220642|NCT03771612|Naproxen|naproxen|mesh-list
15220643|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15220644|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220645|NCT03771612|Analgesics|analgesics|mesh-ancestor
14722366|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328606|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
14303163|NCT00618956|Milnacipran|milnacipran|mesh-list
14303164|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
14303165|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14303166|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15220646|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
15220647|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220648|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220649|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220650|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220651|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
15220652|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15220653|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303167|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303168|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303169|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303170|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303171|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14303172|NCT00618956|Analgesics|analgesics|mesh-ancestor
14303173|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
14303174|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303175|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303176|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303177|NCT00618982|Sorafenib|sorafenib|mesh-list
14303178|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303179|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14303180|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303181|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303182|NCT00618995|Niacin|niacin|mesh-list
14303183|NCT00618995|Niacinamide|niacinamide|mesh-list
14303184|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
14303185|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14303186|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
14303187|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303188|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14303189|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
14303190|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
14303191|NCT00618995|Vitamins|vitamins|mesh-ancestor
14303192|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
14303193|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303194|NCT00619060|Niacin|niacin|mesh-list
14303195|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
14303196|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14303197|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
14303198|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303199|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14303200|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
14303201|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
14303202|NCT00619060|Vitamins|vitamins|mesh-ancestor
14303203|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
14303204|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303205|NCT00619073|Aspirin|aspirin|mesh-list
14303206|NCT00619073|Clopidogrel|clopidogrel|mesh-list
14303207|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14303208|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14303209|NCT00619073|Analgesics|analgesics|mesh-ancestor
14303210|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
14303211|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303212|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303213|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14303214|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14303215|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14303216|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14303217|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303218|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14303219|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14303220|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303221|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
14303222|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14303223|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14303224|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14303225|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
14303226|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303227|NCT00619099|Decitabine|decitabine|mesh-list
14303228|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303229|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
14303230|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303231|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303232|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303233|NCT00619112|Temozolomide|temozolomide|mesh-list
14303234|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14303235|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
14303236|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303237|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303238|NCT00619190|Aripiprazole|aripiprazole|mesh-list
14303239|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303240|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303241|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14303242|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303243|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303244|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303245|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
14303246|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
14303247|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303248|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303249|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14303250|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14303251|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
14303252|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14303253|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14303254|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14303255|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14303256|NCT00619229|Alprostadil|alprostadil|mesh-list
14303257|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14303258|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
14303259|NCT00619229|Urological Agents|urological agents|mesh-ancestor
14303260|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
14303261|NCT00619307|Ibuprofen|ibuprofen|mesh-list
14303262|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14303263|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14303264|NCT00619307|Analgesics|analgesics|mesh-ancestor
14722367|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722368|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
14722369|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722370|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
14722371|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722372|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722373|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722374|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
14303265|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
14303266|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303267|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303268|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14303269|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14303270|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14303271|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303272|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303273|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14303274|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
14303275|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303276|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
14303277|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303278|NCT00619359|Dexamethasone|dexamethasone|mesh-list
14303279|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
14722375|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220654|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220655|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
15220656|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220657|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220658|NCT03753087|Empagliflozin|empagliflozin|mesh-list
15220659|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15220660|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220661|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15220662|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220663|NCT03735420|Xanthohumol|xanthohumol|mesh-list
14303280|NCT00619359|Ondansetron|ondansetron|mesh-list
14303281|NCT00619359|Aprepitant|aprepitant|mesh-list
14303282|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
14303283|NCT00619359|BB 1101|bb 1101|mesh-list
14303284|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14303285|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
14303286|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
14303287|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303288|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303289|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303290|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
14303291|NCT00619359|Hormones|hormones|mesh-ancestor
14303292|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14303293|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14303294|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303295|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
14303296|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303297|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303298|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
14303299|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14303300|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14303301|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
14303302|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303303|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14303304|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303305|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303306|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303307|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14303308|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14303309|NCT00619476|Gabapentin|gabapentin|mesh-list
14303310|NCT00619476|Analgesics|analgesics|mesh-ancestor
14303311|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
14303312|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303313|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303314|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
14303315|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14303316|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303317|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303318|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303319|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14303320|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14303321|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303322|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303323|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
14303324|NCT00619489|Vedolizumab|vedolizumab|mesh-list
14303325|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303326|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14303327|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14303328|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14303329|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303330|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303331|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303332|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303333|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303334|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303335|NCT00619645|Cyclosporine|cyclosporine|mesh-list
14303336|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
14303337|NCT00619645|Fludarabine|fludarabine|mesh-list
14303338|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
14303339|NCT00619645|Busulfan|busulfan|mesh-list
14303340|NCT00619645|Cyclosporins|cyclosporins|mesh-list
14303341|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303342|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303343|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
14303344|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303345|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303346|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
14303347|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303348|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303349|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
14303350|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303351|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
14303352|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14303353|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14303354|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14303355|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14303356|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
14303357|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303358|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
14303359|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14303360|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14303361|NCT00619684|Lenalidomide|lenalidomide|mesh-list
14303362|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
14303363|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303364|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303365|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303366|NCT00619684|Growth Substances|growth substances|mesh-ancestor
14303367|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
15220664|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220665|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15220666|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303368|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303369|NCT00619723|Choline|choline|mesh-list
14303370|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14303371|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
14303372|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14303373|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
14303374|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303375|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303376|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14303377|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
14303378|NCT00619801|Levocetirizine|levocetirizine|mesh-list
14303379|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14303380|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14303381|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
14303382|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
14303383|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303384|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303385|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303386|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14303387|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303388|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303389|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14303390|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303391|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303392|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303393|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
14303394|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14303395|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303396|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303397|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14303398|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303399|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14303400|NCT00619970|Rifaximin|rifaximin|mesh-list
14303401|NCT00619970|Lactulose|lactulose|mesh-list
14303402|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303403|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303404|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303405|NCT00619983|Gabapentin|gabapentin|mesh-list
14303406|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14303407|NCT00619983|Donepezil|donepezil|mesh-list
14303408|NCT00619983|Analgesics|analgesics|mesh-ancestor
14303409|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
14303410|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303411|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303412|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
14303413|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14303414|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14722376|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
14722377|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14722378|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
14722379|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14722380|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722381|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14722382|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14722383|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14722384|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
15220667|NCT03735420|Growth Substances|growth substances|mesh-ancestor
15220668|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220669|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
15220670|NCT03734237|Vaccines|vaccines|mesh-list
15220671|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
15220672|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220673|NCT03730337|Nivolumab|nivolumab|mesh-list
15220674|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220675|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220676|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15220677|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220678|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
15220679|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
15220680|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
15220681|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220682|NCT03727776|Hormones|hormones|mesh-list
14722385|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
14722386|NCT00490113|Vitamins|vitamins|mesh-ancestor
14722387|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
14722388|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722389|NCT00490178|Metformin|metformin|mesh-list
14722390|NCT00490178|Fenofibrate|fenofibrate|mesh-list
14722391|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14722392|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722393|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14303415|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303416|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303417|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14303418|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14303419|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722394|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
14722395|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303420|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303421|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
14303422|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14303423|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14303424|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303425|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303426|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
14303427|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14303428|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303429|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
14303430|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
14303431|NCT00620061|Lubiprostone|lubiprostone|mesh-list
14303432|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14303433|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303434|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303435|NCT00620074|Voriconazole|voriconazole|mesh-list
14303436|NCT00620074|Anidulafungin|anidulafungin|mesh-list
14303437|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
14303438|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303439|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14303440|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14303441|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303442|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303443|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14303444|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
14303445|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14303446|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303447|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14303448|NCT00620113|Vitamin D|vitamin d|mesh-list
14303449|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
14303450|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
14303451|NCT00620113|Calcium|calcium|mesh-list
14303452|NCT00620113|Vitamins|vitamins|mesh-ancestor
14303453|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
14303454|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303455|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14303456|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14303457|NCT00620113|Antacids|antacids|mesh-ancestor
14303458|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303459|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303460|NCT00620191|Metformin|metformin|mesh-list
14303461|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14303462|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303463|NCT00620282|Liraglutide|liraglutide|mesh-list
14303464|NCT00620282|Glimepiride|glimepiride|mesh-list
14303465|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14303466|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303467|NCT00620282|Incretins|incretins|mesh-ancestor
14303468|NCT00620282|Hormones|hormones|mesh-ancestor
14303469|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14303470|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14303471|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303472|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
14303473|NCT00620321|Cytarabine|cytarabine|mesh-list
14722396|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14722397|NCT00490204|Cetirizine|cetirizine|mesh-list
14303474|NCT00620321|Idarubicin|idarubicin|mesh-list
14303475|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303476|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
14303477|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303478|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303479|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
14303480|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303481|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303482|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
14303483|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303484|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14303485|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14303486|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14303487|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303488|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14303489|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14722398|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14303490|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303491|NCT00620425|Sumatriptan|sumatriptan|mesh-list
14303492|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14303493|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14303494|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14303495|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
14303496|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303497|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303498|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303499|NCT00620542|Atorvastatin|atorvastatin|mesh-list
14303500|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14303501|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14303502|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14303503|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
14303504|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303505|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14303506|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14303507|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303508|NCT00620555|Gabapentin|gabapentin|mesh-list
14303509|NCT00620555|Analgesics|analgesics|mesh-ancestor
14303510|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
14303511|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303512|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303513|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
14303514|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14303515|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303516|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303517|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303518|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14303519|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14303520|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303521|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303522|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
14303523|NCT00620659|Modafinil|modafinil|mesh-list
14303524|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14303525|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303526|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14909676|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14909677|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909678|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14909679|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14909680|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14909681|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909682|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14909683|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14909684|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14909685|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14909686|NCT01352559|Analgesics|analgesics|mesh-ancestor
14909687|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
14303527|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14303528|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14303529|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303530|NCT00620750|Naltrexone|naltrexone|mesh-list
14303531|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14303532|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14303533|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303534|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
14303535|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303536|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14303537|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14303538|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14303539|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303540|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303541|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729167|NCT00521781|Androgens|androgens|mesh-list
14303542|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303543|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14303544|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303545|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303546|NCT00620815|Vaccines|vaccines|mesh-list
14303547|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14303548|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
14303549|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303550|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14303551|NCT00620854|Calcitonin|calcitonin|mesh-list
14303552|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
14303553|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14303554|NCT00620854|Katacalcin|katacalcin|mesh-list
14303555|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14303556|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303557|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14303558|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
14303559|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
14303560|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14303561|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14303562|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
14303563|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303564|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303565|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303566|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14303567|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
14303568|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
14303569|NCT00621023|Decitabine|decitabine|mesh-list
14303570|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
14303571|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303572|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
14303573|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303574|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303575|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303576|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
14303577|NCT00621023|Protective Agents|protective agents|mesh-ancestor
14303578|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303579|NCT00621023|Vitamins|vitamins|mesh-ancestor
14303580|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
14303581|NCT00621049|Bevacizumab|bevacizumab|mesh-list
14303582|NCT00621049|Carboplatin|carboplatin|mesh-list
14303583|NCT00621049|Docetaxel|docetaxel|mesh-list
14303584|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14303585|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303586|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303587|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303588|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303589|NCT00621049|Growth Substances|growth substances|mesh-ancestor
14303590|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303591|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
14303592|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14303593|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
14303594|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
14303595|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303596|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14303597|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303598|NCT00621140|Linagliptin|linagliptin|mesh-list
14303599|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14303600|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303601|NCT00621140|Incretins|incretins|mesh-ancestor
14303602|NCT00621140|Hormones|hormones|mesh-ancestor
14303603|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14303604|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14303605|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
14303606|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303607|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303608|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14303609|NCT00621153|Candesartan|candesartan|mesh-list
14303610|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
14303611|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14303612|NCT00621153|Diuretics|diuretics|mesh-ancestor
14303613|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
14303614|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303615|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14303616|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303617|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303618|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14303619|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14303620|NCT00621179|Leuprolide|leuprolide|mesh-list
14303621|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14303622|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
14303623|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14303624|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303625|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14303626|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303627|NCT00621192|Meropenem|meropenem|mesh-list
14303628|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303629|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303630|NCT00621244|Panobinostat|panobinostat|mesh-list
14303631|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303632|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14303633|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303634|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303635|NCT00621257|Vitamin D|vitamin d|mesh-list
14303636|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
14303637|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
14303638|NCT00621257|Vitamins|vitamins|mesh-list
14303639|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
14303640|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303641|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14303642|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14303643|NCT00621309|Rifampin|rifampin|mesh-list
14303644|NCT00621309|Rifamycins|rifamycins|mesh-list
14303645|NCT00621309|Sulforaphane|sulforaphane|mesh-list
14303646|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14303647|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
14303648|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303649|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303650|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
14303651|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14303652|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303653|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303654|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14303655|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14303656|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14303657|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14303658|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14303659|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14303660|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14303661|NCT00621309|Protective Agents|protective agents|mesh-ancestor
14303662|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303663|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303664|NCT00621322|Vaccines|vaccines|mesh-list
14303665|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
14303666|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303667|NCT00621504|Clarithromycin|clarithromycin|mesh-list
14303668|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
14303669|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14303670|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303671|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303672|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14303673|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303674|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303675|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14303676|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14303677|NCT00621517|Bupropion|bupropion|mesh-list
14303678|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14303679|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303680|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303681|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14729168|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303682|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14303683|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303684|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303685|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
14303686|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303687|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303688|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14303689|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14303690|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303691|NCT00621530|Ketorolac|ketorolac|mesh-list
14303692|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14303693|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14303694|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14303695|NCT00621530|Analgesics|analgesics|mesh-ancestor
14303696|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
14303697|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303698|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303699|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14303700|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14303701|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14303702|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303703|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303704|NCT00621543|Copper|copper|mesh-list
14303705|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
14303706|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14303707|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
14303708|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14303709|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303710|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14303711|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14303712|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14303713|NCT00621543|Trace Elements|trace elements|mesh-ancestor
14303714|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
14303715|NCT00621686|Bevacizumab|bevacizumab|mesh-list
14303716|NCT00621686|Sorafenib|sorafenib|mesh-list
14303717|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303718|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303719|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303720|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303721|NCT00621686|Growth Substances|growth substances|mesh-ancestor
14303722|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303723|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
14303724|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14303725|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303726|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303727|NCT00621764|Vaccines|vaccines|mesh-list
14303728|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
14303729|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303730|NCT00621777|Varenicline|varenicline|mesh-list
14303731|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14303732|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14303733|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
14303734|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303735|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303736|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303737|NCT00621842|Lamotrigine|lamotrigine|mesh-list
14303738|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
14303739|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14303740|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303741|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303742|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14303743|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303744|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14303745|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303746|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14303747|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303748|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14303749|NCT00621855|Dabigatran|dabigatran|mesh-list
14303750|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
14303751|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14303752|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14303753|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722399|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14722400|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14722401|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
14722402|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
14722403|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722404|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722405|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303754|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303755|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
14303756|NCT00621946|Dexetimide|dexetimide|mesh-list
14303757|NCT00621946|Citalopram|citalopram|mesh-list
14303758|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14303759|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14303760|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14303761|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303762|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303763|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
14303764|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303765|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14303766|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
14303767|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303768|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14303769|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14303770|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
14303771|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
14303772|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303773|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14303774|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14303775|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
14303776|NCT00621959|Levocetirizine|levocetirizine|mesh-list
14303777|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14303778|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14303779|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
14303780|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
14303781|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303782|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303783|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303784|NCT00621985|Dexamethasone|dexamethasone|mesh-list
14303785|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
14303786|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14303787|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
14303788|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
14303789|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303790|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303791|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14303792|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
14303793|NCT00621985|Hormones|hormones|mesh-ancestor
14303794|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14303795|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14303796|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303797|NCT00622284|Glimepiride|glimepiride|mesh-list
14303798|NCT00622284|Linagliptin|linagliptin|mesh-list
15220683|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15220684|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15220685|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
15220686|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220687|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220688|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220689|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225562|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225563|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14303799|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14303800|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14303801|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303802|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303803|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
14303804|NCT00622284|Incretins|incretins|mesh-ancestor
14303805|NCT00622284|Hormones|hormones|mesh-ancestor
14303806|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14303807|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14303808|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
14303809|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303810|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303811|NCT00622336|Lenalidomide|lenalidomide|mesh-list
14303812|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
14303813|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303814|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303815|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303816|NCT00622336|Growth Substances|growth substances|mesh-ancestor
14303817|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
14303818|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303819|NCT00622388|Ofatumumab|ofatumumab|mesh-list
14303820|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303821|NCT00622401|Interleukin-12|interleukin-12|mesh-list
14909688|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909689|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14303822|NCT00622401|Vaccines|vaccines|mesh-list
14303823|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
14303824|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303825|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14303826|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303827|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303828|NCT00622401|Growth Substances|growth substances|mesh-ancestor
14303829|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
14303830|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303831|NCT00622466|Paclitaxel|paclitaxel|mesh-list
14303832|NCT00622466|Sorafenib|sorafenib|mesh-list
14303833|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14303834|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303835|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
14303836|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
14303837|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
14303838|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303839|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14303840|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303841|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
14303842|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14303843|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303844|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14303845|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14303846|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
14303847|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303848|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303849|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14722406|NCT00490243|Budesonide|budesonide|mesh-list
14722407|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
14722408|NCT00490243|Montelukast|montelukast|mesh-list
14722409|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722410|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14722411|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
14722412|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722413|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722414|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14722415|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
14722416|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
14722417|NCT00490243|Hormones|hormones|mesh-ancestor
14303850|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
14303851|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14303852|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14303853|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14303854|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
14303855|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303856|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303857|NCT00622700|Teriflunomide|teriflunomide|mesh-list
14303858|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14303859|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14303860|NCT00622700|Analgesics|analgesics|mesh-ancestor
14303861|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
14303862|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14303863|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303864|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14303865|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14303866|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303867|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
14303868|NCT00622713|Rivastigmine|rivastigmine|mesh-list
14303869|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14303870|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303871|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303872|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
14303873|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303874|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303875|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14303876|NCT00622713|Protective Agents|protective agents|mesh-ancestor
14303877|NCT00622726|Bevacizumab|bevacizumab|mesh-list
14303878|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303879|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303880|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303881|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303882|NCT00622726|Growth Substances|growth substances|mesh-ancestor
14303883|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303884|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
14303885|NCT00622739|Ziprasidone|ziprasidone|mesh-list
14303886|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14303887|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
14303888|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303889|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303890|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303891|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14303892|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14303893|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909690|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14303894|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14303895|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14303896|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
14303897|NCT00622869|Everolimus|everolimus|mesh-list
14303898|NCT00622869|Tacrolimus|tacrolimus|mesh-list
14303899|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303900|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
14303901|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303902|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14303903|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303904|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303905|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303906|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
14303907|NCT00622895|Fludarabine|fludarabine|mesh-list
14303908|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
14303909|NCT00622895|Tacrolimus|tacrolimus|mesh-list
14303910|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303911|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303912|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
14303913|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303914|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303915|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
14303916|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303917|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14303918|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303919|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14303920|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14303921|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
14303922|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303923|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303924|NCT00622908|Besifloxacin|besifloxacin|mesh-list
14303925|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303926|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303927|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14303928|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14303929|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303930|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303931|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303932|NCT00623012|Sirolimus|sirolimus|mesh-list
14303933|NCT00623012|Tacrolimus|tacrolimus|mesh-list
14303934|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303935|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
14303936|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303937|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14303938|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303939|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303940|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14303941|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303942|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14722418|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722419|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14722420|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15220690|NCT03721328|Vancomycin|vancomycin|mesh-list
15220691|NCT03721328|Tobramycin|tobramycin|mesh-list
15220692|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15220693|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220694|NCT03715153|Bumetanide|bumetanide|mesh-list
15220695|NCT03715153|Diuretics|diuretics|mesh-ancestor
15220696|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
15220697|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220698|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15220699|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220700|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220701|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
15220702|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15220703|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
14303943|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303944|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
14327764|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909691|NCT01352572|Milnacipran|milnacipran|mesh-list
14303945|NCT00623103|Rivastigmine|rivastigmine|mesh-list
14303946|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14303947|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303948|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303949|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
14303950|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303951|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303952|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14303953|NCT00623103|Protective Agents|protective agents|mesh-ancestor
14303954|NCT00623181|Vaccines|vaccines|mesh-list
14303955|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
14303956|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303957|NCT00623194|Insulin|insulin|mesh-list
14303958|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14303959|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
14303960|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
14303961|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14303962|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303963|NCT00623233|Gemcitabine|gemcitabine|mesh-list
14303964|NCT00623233|Bevacizumab|bevacizumab|mesh-list
14303965|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14303966|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14303967|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14303968|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14303969|NCT00623233|Growth Substances|growth substances|mesh-ancestor
14303970|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303971|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
14303972|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14303973|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
14303974|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303975|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
14303976|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303977|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14303978|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14303979|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
14303980|NCT00623363|Piclozotan|piclozotan|mesh-list
14303981|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14303982|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14303983|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
14303984|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14303985|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303986|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303987|NCT00623428|Ribavirin|ribavirin|mesh-list
14303988|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14303989|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
14303990|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14303991|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
14303992|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14303993|NCT00623480|Factor VIII|factor viii|mesh-list
14303994|NCT00623480|Coagulants|coagulants|mesh-ancestor
14303995|NCT00623545|Exenatide|exenatide|mesh-list
14303996|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14303997|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14303998|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14303999|NCT00623545|Incretins|incretins|mesh-ancestor
14304000|NCT00623545|Hormones|hormones|mesh-ancestor
14304001|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304002|NCT00623597|Ritonavir|ritonavir|mesh-list
14304003|NCT00623597|Saquinavir|saquinavir|mesh-list
14304004|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14304005|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14304006|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
14304007|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304008|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304009|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14304010|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14304011|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
14304012|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722421|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14304013|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14722422|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304014|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14304015|NCT00623623|Enoxaparin|enoxaparin|mesh-list
14304016|NCT00623623|Tenecteplase|tenecteplase|mesh-list
14304017|NCT00623623|Clopidogrel|clopidogrel|mesh-list
14304018|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14304019|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14304020|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14304021|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14304022|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
14304023|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304024|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304025|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304026|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
14304027|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14304028|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14304029|NCT00623714|Fluticasone|fluticasone|mesh-list
14304030|NCT00623714|Xhance|xhance|mesh-list
14304031|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304032|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304033|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
14304034|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304035|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304036|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304037|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304038|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14304039|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14304040|NCT00623727|Factor VIII|factor viii|mesh-list
14304041|NCT00623727|Coagulants|coagulants|mesh-ancestor
14304042|NCT00623766|Dexamethasone|dexamethasone|mesh-list
14304043|NCT00623766|Prednisone|prednisone|mesh-list
14304044|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
14304045|NCT00623766|Prednisolone|prednisolone|mesh-list
14304046|NCT00623766|Triamcinolone|triamcinolone|mesh-list
14304047|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
14304048|NCT00623766|Betamethasone|betamethasone|mesh-list
14304049|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
14304050|NCT00623766|Ipilimumab|ipilimumab|mesh-list
14304051|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304052|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
14304053|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
14304054|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304055|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304056|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304057|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
14304058|NCT00623766|Hormones|hormones|mesh-ancestor
14304059|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304060|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14304061|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304062|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304063|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14304064|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304065|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14304066|NCT00623766|Protective Agents|protective agents|mesh-ancestor
14304067|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304068|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304069|NCT00623779|Aspirin|aspirin|mesh-list
14304070|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14304071|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14304072|NCT00623779|Analgesics|analgesics|mesh-ancestor
14304073|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
14304074|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304075|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304076|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304077|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304078|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14304079|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14304080|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304081|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14909692|NCT01352572|Mirtazapine|mirtazapine|mesh-list
14304082|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14304083|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304084|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
14304085|NCT00623805|Bevacizumab|bevacizumab|mesh-list
14304086|NCT00623805|Capecitabine|capecitabine|mesh-list
14304087|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
14304088|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304089|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304090|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14304091|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14304092|NCT00623805|Growth Substances|growth substances|mesh-ancestor
14304093|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304094|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
14304095|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304096|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
14304097|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304098|NCT00623935|Fludarabine|fludarabine|mesh-list
14304099|NCT00623935|Busulfan|busulfan|mesh-list
14304100|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304101|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304102|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304103|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
14304104|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304105|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
14304106|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304107|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14304108|NCT00624013|Sertraline|sertraline|mesh-list
14304109|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
14304110|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14304111|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14304112|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14304113|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722423|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722424|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722425|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14304114|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304115|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304116|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
14304117|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304118|NCT00624052|Amlodipine|amlodipine|mesh-list
14304119|NCT00624052|Telmisartan|telmisartan|mesh-list
14722426|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
14722427|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14722428|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14722429|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14722430|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14722431|NCT00490308|Estradiol|estradiol|mesh-list
14304120|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14304121|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14304122|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304123|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304124|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14304125|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304126|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
14304127|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14304128|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14304129|NCT00624065|Carvedilol|carvedilol|mesh-list
14722432|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14722433|NCT00490308|Estrogens|estrogens|mesh-ancestor
14722434|NCT00490308|Hormones|hormones|mesh-ancestor
14722435|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722436|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722437|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14722438|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
14304130|NCT00624065|Lisinopril|lisinopril|mesh-list
14304131|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14304132|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14304133|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304134|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304135|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304136|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304137|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14304138|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
14304139|NCT00624065|Protective Agents|protective agents|mesh-ancestor
14304140|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14304141|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304142|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14304143|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
14304144|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14304145|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14304146|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14304147|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
14304148|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304149|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14304150|NCT00624195|Etravirine|etravirine|mesh-list
14304151|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14304152|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14304153|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14304154|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304155|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304156|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
14304157|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304158|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
14304159|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304160|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
14304161|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304162|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304163|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304164|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304165|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
14304166|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14304167|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14304168|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304169|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304170|NCT00624416|Prednisolone|prednisolone|mesh-list
14304171|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14304172|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
14304173|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14304174|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
14304175|NCT00624416|Cortisone|cortisone|mesh-list
14304176|NCT00624416|Isoproterenol|isoproterenol|mesh-list
14304177|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14304178|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
14304179|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304180|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
14304181|NCT00624416|Hormones|hormones|mesh-ancestor
14304182|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304183|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304184|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14304185|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304186|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
14304187|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
14304188|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304189|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304190|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14304191|NCT00624416|Protective Agents|protective agents|mesh-ancestor
14304192|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14304193|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14304194|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304195|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304196|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304197|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304198|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304199|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304200|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14304201|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
14304202|NCT00624559|Celecoxib|celecoxib|mesh-list
14304203|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14304204|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14304205|NCT00624559|Analgesics|analgesics|mesh-ancestor
14304206|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
14304207|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304208|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304209|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304210|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304211|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14304212|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14304213|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909693|NCT01352572|Sertraline|sertraline|mesh-list
14304214|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304215|NCT00624585|Dasatinib|dasatinib|mesh-list
14304216|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304217|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14304218|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304219|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304220|NCT00624780|Pregabalin|pregabalin|mesh-list
14304221|NCT00624780|Lorazepam|lorazepam|mesh-list
14304222|NCT00624780|Analgesics|analgesics|mesh-ancestor
14304223|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
14304224|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304225|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304226|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
14304227|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14304228|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304229|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304230|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14304231|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14304232|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14304233|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14304234|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14304235|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
14304236|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
14304237|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304238|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14304239|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
14304240|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
14304241|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304242|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14304243|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
14304244|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304245|NCT00624832|Omalizumab|omalizumab|mesh-list
14304246|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14304247|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304248|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304249|NCT00624910|Bupivacaine|bupivacaine|mesh-list
14304250|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
14304251|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
14304252|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14304253|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304254|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
14304255|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304256|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14304257|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
14304258|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14304259|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14304260|NCT00624923|Analgesics|analgesics|mesh-ancestor
14304261|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
14304262|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304263|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304264|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304265|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304266|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14304267|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304268|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304269|NCT00625131|Bupropion|bupropion|mesh-list
14304270|NCT00625131|Nicotine|nicotine|mesh-list
14304271|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14304272|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
14304273|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304274|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304275|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14304276|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14304277|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
14304278|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304279|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304280|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14304281|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
14304282|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14304283|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14304284|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14304285|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304286|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
14304287|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14304288|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14304289|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304290|NCT00625183|Selenium|selenium|mesh-list
14304291|NCT00625183|Capecitabine|capecitabine|mesh-list
14304292|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
14304293|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304294|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
14304295|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304296|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304297|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
14304298|NCT00625183|Protective Agents|protective agents|mesh-ancestor
14304299|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304300|NCT00625183|Trace Elements|trace elements|mesh-ancestor
14304301|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
14304302|NCT00625404|Tenofovir|tenofovir|mesh-list
14304303|NCT00625404|Emtricitabine|emtricitabine|mesh-list
14304304|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14304305|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
14304306|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304307|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14304308|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14304309|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304310|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304311|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14304312|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14304313|NCT00625729|Aldesleukin|aldesleukin|mesh-list
14304314|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
14304315|NCT00625729|Rituximab|rituximab|mesh-list
14304316|NCT00625729|Fludarabine|fludarabine|mesh-list
14304317|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
14304318|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304319|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
14304320|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304321|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304322|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304323|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
14304324|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304325|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304326|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14304327|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304328|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304329|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
14304330|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14304331|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14304332|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
14304333|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304334|NCT00625820|Ascorbic Acid|ascorbic acid|mesh-list
14304335|NCT00625820|Vitamins|vitamins|mesh-ancestor
15220704|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220705|NCT03711838|Expectorants|expectorants|mesh-ancestor
15220706|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
15220707|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14304336|NCT00625820|Micronutrients|micronutrients|mesh-ancestor
14304337|NCT00625820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304338|NCT00625820|Antioxidants|antioxidants|mesh-ancestor
14304339|NCT00625820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304340|NCT00625820|Protective Agents|protective agents|mesh-ancestor
14304341|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
14304342|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304343|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
14304344|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304345|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304346|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304347|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304348|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14304349|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
14304350|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304351|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304352|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14304353|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
14304354|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
14304355|NCT00626028|Protective Agents|protective agents|mesh-ancestor
14304356|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
14304357|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
14304358|NCT00626197|Azathioprine|azathioprine|mesh-list
14304359|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
14304360|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304361|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
14304362|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304363|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304364|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304365|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
14304366|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304367|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304368|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14304369|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14304370|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14304371|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
14304372|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14304373|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304374|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304375|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
15220708|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
15220709|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220710|NCT03711838|Protective Agents|protective agents|mesh-ancestor
15220711|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220712|NCT03711838|Antidotes|antidotes|mesh-ancestor
15220713|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
15220714|NCT03706898|Dolutegravir|dolutegravir|mesh-list
15220715|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
15220716|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
15220717|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220718|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15220719|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15220720|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220721|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220722|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14304376|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304377|NCT00626210|Modafinil|modafinil|mesh-list
14304378|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14304379|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304380|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14304381|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14304382|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14304383|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304384|NCT00626275|Naproxen|naproxen|mesh-list
14304385|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14304386|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14304387|NCT00626275|Analgesics|analgesics|mesh-ancestor
14304388|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
14304389|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304390|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304391|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304392|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304393|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
14304394|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14304395|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304396|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304397|NCT00626340|Fluoxetine|fluoxetine|mesh-list
14304398|NCT00626340|Estrogens|estrogens|mesh-list
14304399|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14304400|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14304401|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304402|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304403|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304404|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
14304405|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304406|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14304407|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
14304408|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14304409|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14304410|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14304411|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304412|NCT00626340|Hormones|hormones|mesh-ancestor
14304413|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304414|NCT00626392|Aspirin|aspirin|mesh-list
14304415|NCT00626392|Niacin|niacin|mesh-list
14304416|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14304417|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14304418|NCT00626392|Analgesics|analgesics|mesh-ancestor
14304419|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
14304420|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304421|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304422|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304423|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304424|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14304425|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14304426|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304427|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14304428|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14304429|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304430|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
14304431|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14304432|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
15220723|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15220724|NCT03694002|Paclitaxel|paclitaxel|mesh-list
15220725|NCT03694002|Carboplatin|carboplatin|mesh-list
15220726|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15220727|NCT03694002|Ramucirumab|ramucirumab|mesh-list
15220728|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15220729|NCT03694002|Antibodies|antibodies|mesh-list
15220730|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
15220731|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15220732|NCT03694002|Lexatumumab|lexatumumab|mesh-list
15220733|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15220734|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304433|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14304434|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
14304435|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
14304436|NCT00626392|Vitamins|vitamins|mesh-ancestor
14304437|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
14304438|NCT00626405|Paclitaxel|paclitaxel|mesh-list
14304439|NCT00626405|Bevacizumab|bevacizumab|mesh-list
14304440|NCT00626405|Carboplatin|carboplatin|mesh-list
14304441|NCT00626405|Temozolomide|temozolomide|mesh-list
14304442|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14304443|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14304444|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304445|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
14304446|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
14304447|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
14304448|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304449|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304450|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14304451|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14304452|NCT00626405|Growth Substances|growth substances|mesh-ancestor
14304453|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220735|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
15220736|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
14304454|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14304455|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304456|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
14304457|NCT00626431|Leuprolide|leuprolide|mesh-list
14304458|NCT00626431|Hormones|hormones|mesh-list
14304459|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14304460|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304461|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304462|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14304463|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
14304464|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14304465|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14304466|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304467|NCT00626522|Bromides|bromides|mesh-list
14304468|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
14304469|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304470|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
14304471|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304472|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304473|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304474|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304475|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14304476|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14722439|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14722440|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14722441|NCT00490360|Gemcitabine|gemcitabine|mesh-list
14722442|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722443|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304477|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14304478|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304479|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304480|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304481|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
14304482|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
14304483|NCT00626574|Hematinics|hematinics|mesh-ancestor
14304484|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
14304485|NCT00626626|Clofarabine|clofarabine|mesh-list
14304486|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
14304487|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304488|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304489|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304490|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
14304491|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722444|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
14722445|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220737|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
15220738|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220739|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
15220740|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220741|NCT03691727|Tirofiban|tirofiban|mesh-list
14304492|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722446|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
14304493|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
14304494|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304495|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304496|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304497|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
14304498|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14304499|NCT00626639|Cisplatin|cisplatin|mesh-list
14304500|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304501|NCT00626743|Amlodipine|amlodipine|mesh-list
14304502|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14304503|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14304504|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304505|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304506|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14304507|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304508|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
14304509|NCT00626782|Ranibizumab|ranibizumab|mesh-list
14304510|NCT00626782|Mitomycins|mitomycins|mesh-list
14304511|NCT00626782|Mitomycin|mitomycin|mesh-list
14304512|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14304513|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14304514|NCT00626782|Growth Substances|growth substances|mesh-ancestor
14304515|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304516|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
14304517|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304518|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14304519|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
14304520|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304521|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14304522|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304523|NCT00626795|Mupirocin|mupirocin|mesh-list
14304524|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14304525|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304526|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14304527|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304528|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722447|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304529|NCT00626886|Bupivacaine|bupivacaine|mesh-list
14304530|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
14304531|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
14304532|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14304533|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304534|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
14304535|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304536|NCT00626925|Topiramate|topiramate|mesh-list
14304537|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
14304538|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14304539|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304540|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
14304541|NCT00627016|Lansoprazole|lansoprazole|mesh-list
14304542|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14304543|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304544|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14304545|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304546|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304547|NCT00627042|Ramucirumab|ramucirumab|mesh-list
14304548|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14304549|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304550|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
14304551|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304552|NCT00627367|Hydromorphone|hydromorphone|mesh-list
14304553|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14304554|NCT00627367|Narcotics|narcotics|mesh-ancestor
14304555|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14304556|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304557|NCT00627367|Analgesics|analgesics|mesh-ancestor
14304558|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
14304559|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304560|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
14304561|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14304562|NCT00627393|Dexamethasone|dexamethasone|mesh-list
14304563|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304564|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
14304565|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
14304566|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304567|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304568|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304569|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
14304570|NCT00627393|Hormones|hormones|mesh-ancestor
14304571|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304572|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14304573|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304574|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14304575|NCT00627406|Buserelin|buserelin|mesh-list
14304576|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14304577|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304578|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14304579|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
14304580|NCT00627445|Insulin|insulin|mesh-list
14304581|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14304582|NCT00627445|Metformin|metformin|mesh-list
14304583|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
14304584|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
14304585|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14304586|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
14304587|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14304588|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14304589|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304590|NCT00627458|Vaccines|vaccines|mesh-list
14304591|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
14304592|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304593|NCT00627679|Budesonide|budesonide|mesh-list
14304594|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304595|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304596|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
14304597|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304598|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304599|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304600|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304601|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
14304602|NCT00627679|Hormones|hormones|mesh-ancestor
14304603|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304604|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
14304605|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14304606|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
14304607|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304608|NCT00627705|Expectorants|expectorants|mesh-ancestor
14304609|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304610|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14304611|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
14304612|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304613|NCT00627705|Protective Agents|protective agents|mesh-ancestor
14304614|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722448|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304615|NCT00627705|Antidotes|antidotes|mesh-ancestor
14304616|NCT00627861|Metoprolol|metoprolol|mesh-list
14304617|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14304618|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14304619|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
14304620|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
14304621|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304622|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304623|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14304624|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14304625|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14304626|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304627|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304628|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304629|NCT00627926|Interferons|interferons|mesh-list
14304630|NCT00627926|Ribavirin|ribavirin|mesh-list
14304631|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
14304632|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
14304633|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14304634|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304635|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
14304636|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304637|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
14304638|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304639|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
14304640|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304641|NCT00628108|Levocetirizine|levocetirizine|mesh-list
14304642|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14304643|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14304644|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
14304645|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
14304646|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304647|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304648|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304649|NCT00628134|Calfactant|calfactant|mesh-list
14304650|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14304651|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304652|NCT00628251|Doxorubicin|doxorubicin|mesh-list
14304653|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14304654|NCT00628251|Olaparib|olaparib|mesh-list
14304655|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14304656|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304657|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14304658|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14304659|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304660|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304661|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14304662|NCT00628355|Lidocaine|lidocaine|mesh-list
14304663|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
14304664|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
14304665|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722449|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304666|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304667|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
14304668|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304669|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14304670|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14304671|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14304672|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304673|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327765|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14327766|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14327767|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
14327768|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14327769|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14327770|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
14327771|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
14327772|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722450|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
14722451|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327773|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327774|NCT00804843|Niacin|niacin|mesh-list
14327775|NCT00804843|Atorvastatin|atorvastatin|mesh-list
14327776|NCT00804843|Simvastatin|simvastatin|mesh-list
14327777|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14327778|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14327779|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
14327780|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327781|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14327782|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14327783|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327784|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
14327785|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
14327786|NCT00804843|Vitamins|vitamins|mesh-ancestor
14327787|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
14327788|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327789|NCT00804908|Temozolomide|temozolomide|mesh-list
14327790|NCT00804908|Veliparib|veliparib|mesh-list
14327791|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14327792|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
14327793|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722452|NCT00490373|Pemetrexed|pemetrexed|mesh-list
14304674|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14304675|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14304676|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14304677|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304678|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304679|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304680|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304681|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722453|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722454|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722455|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722456|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14722457|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14722458|NCT00490399|Gemcitabine|gemcitabine|mesh-list
14722459|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722460|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722461|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
14722462|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722463|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
14722464|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909694|NCT01352572|Fluoxetine|fluoxetine|mesh-list
14909695|NCT01352572|Paroxetine|paroxetine|mesh-list
14304682|NCT00628498|Defibrotide|defibrotide|mesh-list
14304683|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14304684|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14304685|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304686|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14304687|NCT00628589|Loxapine|loxapine|mesh-list
14304688|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14304689|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14304690|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14304691|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304692|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14304693|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14304694|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
14304695|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304696|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304697|NCT00628628|Rasburicase|rasburicase|mesh-list
14304698|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
14304699|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304700|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14304701|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
14304702|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15220742|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15220743|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15220744|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220745|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14304703|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304704|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304705|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304706|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
14304707|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304708|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304709|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14304710|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14304711|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14304712|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304713|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304714|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304715|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
14304716|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14304717|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
14304718|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304719|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304720|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14304721|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14304722|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14909696|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14909697|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
14909698|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
14909699|NCT01352572|Nortriptyline|nortriptyline|mesh-list
14909700|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14909701|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14909702|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14909703|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14909704|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909705|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909706|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
15220746|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
15220747|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15220748|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15220749|NCT03647852|Prednisolone|prednisolone|mesh-list
14304723|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14304724|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14304725|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
14304726|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304727|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304728|NCT00629122|Clotrimazole|clotrimazole|mesh-list
14304729|NCT00629122|Miconazole|miconazole|mesh-list
14304730|NCT00629122|Nystatin|nystatin|mesh-list
14304731|NCT00629122|Tacrolimus|tacrolimus|mesh-list
14304732|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304733|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
14304734|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304735|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14304736|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304737|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304738|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14304739|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304740|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
14304741|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14304742|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14304743|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14304744|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
14304745|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304746|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14304747|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14304748|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14304749|NCT00629122|Ionophores|ionophores|mesh-ancestor
14304750|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14304751|NCT00629499|Paclitaxel|paclitaxel|mesh-list
14304752|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
14304753|NCT00629499|Trastuzumab|trastuzumab|mesh-list
14304754|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14304755|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304756|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14304757|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14304758|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14304759|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304760|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304761|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
14304762|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304763|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304764|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304765|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
14304766|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14304767|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304768|NCT00629525|Everolimus|everolimus|mesh-list
14304769|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304770|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304771|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
14304772|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304773|NCT00629772|Infliximab|infliximab|mesh-list
14304774|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
14304775|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304776|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304777|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
14304778|NCT00630032|Docetaxel|docetaxel|mesh-list
14304779|NCT00630032|Fluorouracil|fluorouracil|mesh-list
14304780|NCT00630032|Epirubicin|epirubicin|mesh-list
14304781|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304782|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
14304783|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304784|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304785|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304786|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
14304787|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304788|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304789|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14304790|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
14304791|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
14304792|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
14304793|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
14304794|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304795|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14304796|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14304797|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14304798|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304799|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
14304800|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
14304801|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14304802|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14304803|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
14304804|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304805|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
14304806|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304807|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304808|NCT00630253|Cyclosporine|cyclosporine|mesh-list
14304809|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
14304810|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
14304811|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
14304812|NCT00630253|Fludarabine|fludarabine|mesh-list
14304813|NCT00630253|Cyclosporins|cyclosporins|mesh-list
14304814|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14304815|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304816|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
14304817|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304818|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304819|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14304820|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
14304821|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304822|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304823|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14304824|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304825|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
14304826|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304827|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
14304828|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14304829|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14304830|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14304831|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
14722465|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304832|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14304833|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304834|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
14304835|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
14304836|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304837|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304838|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
14909707|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909708|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15220750|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
14304839|NCT00630253|Hormones|hormones|mesh-ancestor
14304840|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304841|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14304842|NCT00630253|Protective Agents|protective agents|mesh-ancestor
14304843|NCT00630331|Vaccines|vaccines|mesh-list
14304844|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
14304845|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304846|NCT00630344|Everolimus|everolimus|mesh-list
14304847|NCT00630344|Bicalutamide|bicalutamide|mesh-list
14304848|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304849|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304850|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
14304851|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304852|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
14304853|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
14304854|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722466|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722467|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
14722468|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722469|NCT00490412|Vitamin D|vitamin d|mesh-list
14722470|NCT00490412|Vitamins|vitamins|mesh-ancestor
14722471|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
14722472|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722473|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14722474|NCT00490464|Nicardipine|nicardipine|mesh-list
14722475|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15220751|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15220752|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
15220753|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220754|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
15220755|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
14304855|NCT00630396|Minocycline|minocycline|mesh-list
14304856|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14304857|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304858|NCT00630409|Gemcitabine|gemcitabine|mesh-list
14304859|NCT00630409|Doxorubicin|doxorubicin|mesh-list
14304860|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304861|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
14304862|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304863|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304864|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
14304865|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304866|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304867|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14304868|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
14304869|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304870|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14304871|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14304872|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14304873|NCT00630539|Tamoxifen|tamoxifen|mesh-list
14304874|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14304875|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
14304876|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304877|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304878|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14304879|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304880|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14304881|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14304882|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14304883|NCT00630734|Ritonavir|ritonavir|mesh-list
14304884|NCT00630734|Darunavir|darunavir|mesh-list
14304885|NCT00630734|Pravastatin|pravastatin|mesh-list
14304886|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14304887|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14304888|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
15220756|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304889|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722476|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14722477|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15225564|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14304890|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304891|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14304892|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14304893|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
14304894|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14304895|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14304896|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14304897|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14304898|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14304899|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
14304900|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14304901|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14304902|NCT00630786|Panitumumab|panitumumab|mesh-list
14304903|NCT00630786|Conatumumab|conatumumab|mesh-list
14304904|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304905|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304906|NCT00630812|Mannitol|mannitol|mesh-list
14304907|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14304908|NCT00630812|Diuretics|diuretics|mesh-ancestor
14304909|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
14304910|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304911|NCT00630825|Dulaglutide|dulaglutide|mesh-list
14304912|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14304913|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304914|NCT00630877|Aspirin|aspirin|mesh-list
14304915|NCT00630877|Niacin|niacin|mesh-list
14304916|NCT00630877|Niacinamide|niacinamide|mesh-list
14909709|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14909710|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14909711|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909712|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14909713|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14909714|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
14909715|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
14909716|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14909717|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14909718|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909719|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15220757|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304917|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
14304918|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14304919|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14304920|NCT00630877|Analgesics|analgesics|mesh-ancestor
14304921|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
14304922|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304923|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304924|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304925|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14304926|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14304927|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14304928|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304929|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14304930|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14304931|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304932|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
14304933|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14304934|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
14304935|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14304936|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
14304937|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
14304938|NCT00630877|Vitamins|vitamins|mesh-ancestor
14304939|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
14304940|NCT00630955|Memantine|memantine|mesh-list
14304941|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14304942|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14304943|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
14304944|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14304945|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304946|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304947|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14304948|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14304949|NCT00630994|Decitabine|decitabine|mesh-list
14304950|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14304951|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
14304952|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304953|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304954|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304955|NCT00631007|Pioglitazone|pioglitazone|mesh-list
14304956|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14304957|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304958|NCT00631163|Deferasirox|deferasirox|mesh-list
14304959|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14304960|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
14304961|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
15220758|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15220759|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
14304962|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304963|NCT00631189|Atorvastatin|atorvastatin|mesh-list
14304964|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14304965|NCT00631189|Pravastatin|pravastatin|mesh-list
14304966|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14304967|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14304968|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
14304969|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14304970|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14304971|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14304972|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14304973|NCT00631319|Hydromorphone|hydromorphone|mesh-list
14304974|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14304975|NCT00631319|Narcotics|narcotics|mesh-ancestor
14304976|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14304977|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304978|NCT00631319|Analgesics|analgesics|mesh-ancestor
14304979|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
14304980|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304981|NCT00631358|Dexamethasone|dexamethasone|mesh-list
14304982|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14304983|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
14304984|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
14304985|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14304986|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14304987|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14304988|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
14304989|NCT00631358|Hormones|hormones|mesh-ancestor
14304990|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14304991|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14304992|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304993|NCT00631371|Interferons|interferons|mesh-list
14304994|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
14304995|NCT00631371|Sirolimus|sirolimus|mesh-list
14722478|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722479|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14722480|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722481|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
14722482|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
14722483|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722484|NCT00490633|Ethanol|ethanol|mesh-list
14304996|NCT00631371|Bevacizumab|bevacizumab|mesh-list
14304997|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14304998|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14304999|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305000|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305001|NCT00631371|Growth Substances|growth substances|mesh-ancestor
14305002|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305003|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305004|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
14305005|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305006|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
14305007|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305008|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14305009|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
14305010|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305011|NCT00631410|Sunitinib|sunitinib|mesh-list
14305012|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305013|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305014|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305015|NCT00631410|Growth Substances|growth substances|mesh-ancestor
14305016|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305017|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305018|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14305019|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305020|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305021|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
14305022|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14305023|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14305024|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
14305025|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305026|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14305027|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14305028|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305029|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305030|NCT00631475|Bosentan|bosentan|mesh-list
14305031|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14305032|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14305033|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305034|NCT00631488|Metformin|metformin|mesh-list
14305035|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14305036|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14305037|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305038|NCT00631488|Incretins|incretins|mesh-ancestor
14305039|NCT00631488|Hormones|hormones|mesh-ancestor
14305040|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305041|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14305042|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
14305043|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305044|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305045|NCT00631566|Mupirocin|mupirocin|mesh-list
14305046|NCT00631566|Triclosan|triclosan|mesh-list
14305047|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
14305048|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305049|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305050|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14305051|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305052|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305053|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14722485|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
14722486|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14305054|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14305055|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14305056|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
14305057|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14305058|NCT00631657|Mirtazapine|mirtazapine|mesh-list
14305059|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
14305060|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305061|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14305062|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
14305063|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
14305064|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305065|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305066|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305067|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14305068|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305069|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305070|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14305071|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14305072|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14305073|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
14305074|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14305075|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14305076|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
14305077|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14305078|NCT00631696|Pregabalin|pregabalin|mesh-list
14305079|NCT00631696|Analgesics|analgesics|mesh-ancestor
14305080|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
14305081|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305082|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305083|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
14305084|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14305085|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722487|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722488|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722489|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722490|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
14722491|NCT00490659|Gemcitabine|gemcitabine|mesh-list
14722492|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722493|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722494|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
14722495|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722496|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
14305086|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722497|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305087|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14305088|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14305089|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305090|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305091|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305092|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14305093|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
14305094|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305095|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14305096|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305097|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305098|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305099|NCT00631917|Ramipril|ramipril|mesh-list
14305100|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14305101|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
14305102|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305103|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305104|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14305105|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14305106|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
14305107|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14305108|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14305109|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305110|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305111|NCT00631969|Urological Agents|urological agents|mesh-ancestor
14305112|NCT00632099|Progesterone|progesterone|mesh-list
14305113|NCT00632099|Progestins|progestins|mesh-ancestor
14305114|NCT00632099|Hormones|hormones|mesh-ancestor
14305115|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305116|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305117|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
14305118|NCT00632125|Hematinics|hematinics|mesh-ancestor
14305119|NCT00632203|Temozolomide|temozolomide|mesh-list
14305120|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14305121|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
14305122|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305123|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305124|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14305125|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14305126|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305127|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305128|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305129|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305130|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14305131|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14305132|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
14305133|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305134|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305135|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14305136|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14305137|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
14305138|NCT00632359|Lenalidomide|lenalidomide|mesh-list
14305139|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
14305140|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305141|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305142|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305143|NCT00632359|Growth Substances|growth substances|mesh-ancestor
14305144|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305145|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220760|NCT03647852|Hormones|hormones|mesh-ancestor
15220761|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220762|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15220763|NCT03647852|Protective Agents|protective agents|mesh-ancestor
15220764|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305146|NCT00632411|Nicotine|nicotine|mesh-list
14305147|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14305148|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
14305149|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305150|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305151|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14305152|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14305153|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
14305154|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305155|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305156|NCT00632489|Capecitabine|capecitabine|mesh-list
14305157|NCT00632489|Lapatinib|lapatinib|mesh-list
14305158|NCT00632489|Panobinostat|panobinostat|mesh-list
14305159|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305160|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
14305161|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305162|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305163|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14305164|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305165|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14305166|NCT00632541|Bevacizumab|bevacizumab|mesh-list
14305167|NCT00632541|Sorafenib|sorafenib|mesh-list
14305168|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305169|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305170|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305171|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305172|NCT00632541|Growth Substances|growth substances|mesh-ancestor
14305173|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305174|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305175|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14305176|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305177|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305178|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
14305179|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305180|NCT00632632|Cycloserine|cycloserine|mesh-list
14305181|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14305182|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305183|NCT00632632|Renal Agents|renal agents|mesh-ancestor
14909720|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14909721|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14909722|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909723|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14909724|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14909725|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14909726|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14909727|NCT01352572|Analgesics|analgesics|mesh-ancestor
14909728|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
14909729|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909730|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14909731|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14909732|NCT01352611|Baclofen|baclofen|mesh-list
14909733|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14909734|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305184|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14305185|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
14305186|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305187|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
14305188|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305189|NCT00632736|Ropinirole|ropinirole|mesh-list
14305190|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14305191|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14305192|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
14305193|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
14305194|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305195|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909735|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14305196|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305197|NCT00632749|Cytarabine|cytarabine|mesh-list
14305198|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305199|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
14305200|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305201|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305202|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
14305203|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305204|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305205|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
14305206|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305207|NCT00632814|Factor VIII|factor viii|mesh-list
14305208|NCT00632814|Coagulants|coagulants|mesh-ancestor
14305209|NCT00632827|Leucovorin|leucovorin|mesh-list
14305210|NCT00632827|Gemcitabine|gemcitabine|mesh-list
14305211|NCT00632827|Cytarabine|cytarabine|mesh-list
14305212|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
14305213|NCT00632827|Carmustine|carmustine|mesh-list
14305214|NCT00632827|Doxorubicin|doxorubicin|mesh-list
14305215|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14305216|NCT00632827|Methotrexate|methotrexate|mesh-list
14305217|NCT00632827|Etoposide|etoposide|mesh-list
14305218|NCT00632827|Vincristine|vincristine|mesh-list
14305219|NCT00632827|Vinorelbine|vinorelbine|mesh-list
14305220|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
14305221|NCT00632827|Lenograstim|lenograstim|mesh-list
14305222|NCT00632827|Sargramostim|sargramostim|mesh-list
14305223|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305224|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
14305225|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305226|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305227|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14305228|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
14305229|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305230|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305231|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14305232|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305233|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
14305234|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
14305235|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305236|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305237|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14305238|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14305239|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14305240|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14305241|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
14305242|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305243|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14305244|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14305245|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14305246|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14305247|NCT00632827|Antidotes|antidotes|mesh-ancestor
14305248|NCT00632827|Protective Agents|protective agents|mesh-ancestor
14305249|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
14305250|NCT00632827|Vitamins|vitamins|mesh-ancestor
14305251|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
14305252|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
15220765|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220766|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
15220767|NCT03630211|Thiotepa|thiotepa|mesh-list
15220768|NCT03630211|Rituximab|rituximab|mesh-list
15220769|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
15220770|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
15220771|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15220772|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
15220773|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14305253|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
14305254|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
14305255|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14305256|NCT00632931|Vorinostat|vorinostat|mesh-list
14305257|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305258|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14305259|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220774|NCT03630211|Antibodies|antibodies|mesh-list
14722498|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220775|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
14305260|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305261|NCT00632970|Ritonavir|ritonavir|mesh-list
14305262|NCT00632970|Lopinavir|lopinavir|mesh-list
15220776|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15220777|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220778|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
15220779|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220780|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220781|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15220782|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
15220783|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220784|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220785|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15220786|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220787|NCT03629327|Aspirin|aspirin|mesh-list
15220788|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15220789|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220790|NCT03629327|Analgesics|analgesics|mesh-ancestor
15220791|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
15220792|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220793|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220794|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220795|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220796|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15220797|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15220798|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305263|NCT00632970|Tenofovir|tenofovir|mesh-list
14305264|NCT00632970|Emtricitabine|emtricitabine|mesh-list
14305265|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
14305266|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14305267|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14305268|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14305269|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
14305270|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305271|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305272|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14305273|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14305274|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
14305275|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305276|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14305277|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14305278|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14305279|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14305280|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14305281|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14305282|NCT00633074|Vaccines|vaccines|mesh-list
14305283|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
14305284|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305285|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14305286|NCT00633126|Cephalosporins|cephalosporins|mesh-list
14305287|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305288|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305289|NCT00633152|Linezolid|linezolid|mesh-list
14305290|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14305291|NCT00633152|Cephalosporins|cephalosporins|mesh-list
14305292|NCT00633152|Aztreonam|aztreonam|mesh-list
14305293|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305294|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305295|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14305296|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305297|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305298|NCT00633217|Fluticasone|fluticasone|mesh-list
14305299|NCT00633217|Xhance|xhance|mesh-list
14305300|NCT00633217|Norflurane|norflurane|mesh-list
14305301|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14305302|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14305303|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305304|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14305305|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
14305306|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305307|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305308|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14305309|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
14305310|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
14305311|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14305312|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14305313|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14305314|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14305315|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
14305316|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305317|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305318|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
14305319|NCT00633217|Hormones|hormones|mesh-ancestor
14305320|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305321|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
14305322|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
14305323|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305324|NCT00633256|Isoniazid|isoniazid|mesh-list
14305325|NCT00633256|Cycloserine|cycloserine|mesh-list
14305326|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
14305327|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305328|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305329|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14305330|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14305331|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
14305332|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305333|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14305334|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14305335|NCT00633256|Renal Agents|renal agents|mesh-ancestor
14305336|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14722499|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722500|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
14722501|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722502|NCT00490685|Sorafenib|sorafenib|mesh-list
14722503|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722504|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14722505|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722506|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722507|NCT00490711|Gemcitabine|gemcitabine|mesh-list
14722508|NCT00490711|Paclitaxel|paclitaxel|mesh-list
14722509|NCT00490711|Carboplatin|carboplatin|mesh-list
14722510|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14722511|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722512|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14305337|NCT00633360|Drospirenone|drospirenone|mesh-list
14305338|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14305339|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14305340|NCT00633360|Estradiol|estradiol|mesh-list
14305341|NCT00633360|Estrogens|estrogens|mesh-ancestor
14305342|NCT00633360|Hormones|hormones|mesh-ancestor
14305343|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305344|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305345|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14305346|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
14305347|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305348|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14305349|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15220799|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15220800|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15220801|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220802|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
15220803|NCT03604159|Buprenorphine|buprenorphine|mesh-list
15220804|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15220805|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15220806|NCT03604159|Narcotics|narcotics|mesh-ancestor
14305350|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14722513|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14722514|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
15220807|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220808|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220809|NCT03604159|Analgesics|analgesics|mesh-ancestor
15220810|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
15220811|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220812|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15220813|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
15220814|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
15220815|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220816|NCT03592693|Vitamins|vitamins|mesh-list
15220817|NCT03592693|Ascorbic Acid|ascorbic acid|mesh-list
15220818|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
15220819|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
15220820|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305351|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14305352|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
14305353|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14305354|NCT00633360|Diuretics|diuretics|mesh-ancestor
14305355|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
14305356|NCT00633399|Ziprasidone|ziprasidone|mesh-list
14305357|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14305358|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
14305359|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305360|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305361|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305362|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14305363|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305364|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305365|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305366|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14305367|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
14305368|NCT00633464|Cetuximab|cetuximab|mesh-list
14305369|NCT00633464|Epothilones|epothilones|mesh-list
14305370|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305371|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305372|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
14305373|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
14305374|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
14305375|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305376|NCT00633594|Rituximab|rituximab|mesh-list
14305377|NCT00633594|Lenalidomide|lenalidomide|mesh-list
14305378|NCT00633594|Bortezomib|bortezomib|mesh-list
14305379|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305380|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305381|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
14305382|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305383|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305384|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305385|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305386|NCT00633594|Growth Substances|growth substances|mesh-ancestor
14305387|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305388|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14305389|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305390|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14305391|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305392|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305393|NCT00633880|Droxidopa|droxidopa|mesh-list
14305394|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15220821|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305395|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14305396|NCT00633893|Apixaban|apixaban|mesh-list
14305397|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14305398|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
14305399|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14305400|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
14305401|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305402|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305403|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
14305404|NCT00633919|Prednisone|prednisone|mesh-list
14305405|NCT00633919|Budesonide|budesonide|mesh-list
14305406|NCT00633919|Albuterol|albuterol|mesh-list
14305407|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
14305408|NCT00633919|Desloratadine|desloratadine|mesh-list
14305409|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305410|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
14305411|NCT00633919|Hormones|hormones|mesh-ancestor
14305412|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305413|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305414|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305415|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305416|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14305417|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
14305418|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305419|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14305420|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
14305421|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14305422|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14305423|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14305424|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14305425|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220822|NCT03592693|Antioxidants|antioxidants|mesh-ancestor
15220823|NCT03592693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220824|NCT03592693|Protective Agents|protective agents|mesh-ancestor
14305426|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305427|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
14305428|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305429|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14305430|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
14305431|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14305432|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14305433|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
14305434|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
14305435|NCT00633932|Esomeprazole|esomeprazole|mesh-list
14305436|NCT00633932|Omeprazole|omeprazole|mesh-list
14305437|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14305438|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14305439|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14305440|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305441|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305442|NCT00633945|Lenalidomide|lenalidomide|mesh-list
14305443|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
14305444|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305445|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305446|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305447|NCT00633945|Growth Substances|growth substances|mesh-ancestor
15220825|NCT03591380|Belimumab|belimumab|mesh-list
15220826|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220827|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
15220828|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220829|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
15220830|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
15220831|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220832|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15220833|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220834|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305448|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305449|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220835|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14327794|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328607|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305450|NCT00633984|Cycloserine|cycloserine|mesh-list
14305451|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14305452|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305453|NCT00633984|Renal Agents|renal agents|mesh-ancestor
14305454|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14305455|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
14305456|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305457|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
14305458|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305459|NCT00634036|Pioglitazone|pioglitazone|mesh-list
14305460|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14305461|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305462|NCT00634049|Isavuconazole|isavuconazole|mesh-list
14305463|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
14305464|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305465|NCT00634088|Capecitabine|capecitabine|mesh-list
14305466|NCT00634088|Lapatinib|lapatinib|mesh-list
14305467|NCT00634088|Epothilones|epothilones|mesh-list
14305468|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305469|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
14305470|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305471|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305472|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14305473|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305474|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14305475|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14305476|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14305477|NCT00634114|Esomeprazole|esomeprazole|mesh-list
14305478|NCT00634114|Omeprazole|omeprazole|mesh-list
14305479|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14305480|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15220836|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14305481|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14909736|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220837|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
15220838|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220839|NCT03578172|Menotropins|menotropins|mesh-list
15220840|NCT03578172|Hormones|hormones|mesh-list
15220841|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220842|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220843|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14909737|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14909738|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
14909739|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
14909740|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909741|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909742|NCT01352650|Plerixafor|plerixafor|mesh-list
14909743|NCT01352650|Decitabine|decitabine|mesh-list
14909744|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14909745|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
14909746|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305482|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909747|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305483|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722515|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722516|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722517|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
14722518|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
14722519|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722520|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722521|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722522|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
14722523|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722524|NCT00490737|Daptomycin|daptomycin|mesh-list
14909748|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909749|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14909750|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14909751|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
14909752|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909753|NCT01352663|Insulin|insulin|mesh-list
14909754|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
14909755|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14909756|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909757|NCT01352702|Dabigatran|dabigatran|mesh-list
14909758|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
14722525|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722526|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722527|NCT00490789|Sirolimus|sirolimus|mesh-list
14722528|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722529|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722530|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14722531|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722532|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
14722533|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722534|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
14722535|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722536|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
14722537|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14722538|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14722539|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14722540|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722541|NCT00490854|Insulin|insulin|mesh-list
14722542|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14305484|NCT00634166|Vancomycin|vancomycin|mesh-list
14305485|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14305486|NCT00634166|Cefazolin|cefazolin|mesh-list
14305487|NCT00634166|Tazobactam|tazobactam|mesh-list
14305488|NCT00634166|Piperacillin|piperacillin|mesh-list
14305489|NCT00634166|Amphotericin B|amphotericin b|mesh-list
14305490|NCT00634166|Nystatin|nystatin|mesh-list
14305491|NCT00634166|Bacitracin|bacitracin|mesh-list
14305492|NCT00634166|Sulfadiazine|sulfadiazine|mesh-list
14305493|NCT00634166|Mafenide|mafenide|mesh-list
14305494|NCT00634166|Fluconazole|fluconazole|mesh-list
14305495|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
14305496|NCT00634166|Clotrimazole|clotrimazole|mesh-list
14305497|NCT00634166|Miconazole|miconazole|mesh-list
14305498|NCT00634166|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14305499|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
14305500|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14305501|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14305502|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305503|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305504|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14305505|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
14305506|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305507|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305508|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14305509|NCT00634166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14305510|NCT00634166|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14305511|NCT00634166|Amebicides|amebicides|mesh-ancestor
14305512|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14305513|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14305514|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14722543|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
14305515|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14909759|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
14909760|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14909761|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
14305516|NCT00634166|Ionophores|ionophores|mesh-ancestor
14305517|NCT00634166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14305518|NCT00634166|Coccidiostats|coccidiostats|mesh-ancestor
14305519|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14305520|NCT00634179|Prednisone|prednisone|mesh-list
14305521|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
14305522|NCT00634179|Rituximab|rituximab|mesh-list
14305523|NCT00634179|Doxorubicin|doxorubicin|mesh-list
14305524|NCT00634179|Vincristine|vincristine|mesh-list
14305525|NCT00634179|Bortezomib|bortezomib|mesh-list
14305526|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305527|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
14305528|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305529|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305530|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14305531|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
14305532|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305533|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305534|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14305535|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305536|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14305537|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14305538|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14305539|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305540|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305541|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
14305542|NCT00634179|Hormones|hormones|mesh-ancestor
14305543|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305544|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305545|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14305546|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
14305547|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
14305548|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
14305549|NCT00634244|Cytarabine|cytarabine|mesh-list
14305550|NCT00634244|Sirolimus|sirolimus|mesh-list
14305551|NCT00634244|Carboplatin|carboplatin|mesh-list
14305552|NCT00634244|Etoposide|etoposide|mesh-list
14305553|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
14305554|NCT00634244|Topotecan|topotecan|mesh-list
14305555|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
14305556|NCT00634244|Alvocidib|alvocidib|mesh-list
14305557|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305558|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14305559|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14305560|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14305561|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305562|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305563|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305564|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
14305565|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
14305566|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305567|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305568|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
14305569|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305570|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305571|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14305572|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
14305573|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14305574|NCT00634244|Analgesics|analgesics|mesh-ancestor
14305575|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
14305576|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305577|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305578|NCT00634244|Growth Substances|growth substances|mesh-ancestor
14305579|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14305580|NCT00634270|Sirolimus|sirolimus|mesh-list
14305581|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305582|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305583|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14305584|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305585|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
14305586|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305587|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
14305588|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305589|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14305590|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14305591|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14909762|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305592|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14305593|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305594|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305595|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305596|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14305597|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
14305598|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305599|NCT00634504|Leucovorin|leucovorin|mesh-list
14305600|NCT00634504|Methotrexate|methotrexate|mesh-list
14305601|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
14305602|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14305603|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
14305604|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305605|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305606|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305607|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
15220844|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
15220845|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15220846|NCT03578081|Dexamethasone|dexamethasone|mesh-list
15220847|NCT03578081|Ondansetron|ondansetron|mesh-list
15220848|NCT03578081|Olanzapine|olanzapine|mesh-list
15220849|NCT03578081|Palonosetron|palonosetron|mesh-list
15220850|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
15220851|NCT03578081|Aprepitant|aprepitant|mesh-list
15220852|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220853|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
15220854|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
15220855|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305608|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305609|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305610|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
14305611|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305612|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14305613|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305614|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
14305615|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305616|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14305617|NCT00634504|Antidotes|antidotes|mesh-ancestor
14305618|NCT00634504|Protective Agents|protective agents|mesh-ancestor
14305619|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
14305620|NCT00634504|Vitamins|vitamins|mesh-ancestor
14305621|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
14305622|NCT00634543|Acetaminophen|acetaminophen|mesh-list
14305623|NCT00634543|Gabapentin|gabapentin|mesh-list
14305624|NCT00634543|Tramadol|tramadol|mesh-list
14305625|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14305626|NCT00634543|Analgesics|analgesics|mesh-ancestor
14305627|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
14305628|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305629|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305630|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
14305631|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
14305632|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14305633|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305634|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305635|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305636|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14305637|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15220856|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220857|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14305638|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305639|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305640|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
14305641|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14305642|NCT00634543|Narcotics|narcotics|mesh-ancestor
14305643|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
14305644|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14305645|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14305646|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
14305647|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305648|NCT00634647|Prednisone|prednisone|mesh-list
14305649|NCT00634647|Satraplatin|satraplatin|mesh-list
15220858|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
15220859|NCT03578081|Hormones|hormones|mesh-ancestor
15220860|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220861|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15220862|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220863|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
15220864|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
15220865|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15220866|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
15220867|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220868|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220869|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15220870|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15220871|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220872|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15220873|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15220874|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15220875|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15220876|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15220877|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15220878|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15220879|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15220880|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220881|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220882|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220883|NCT03561259|Vorinostat|vorinostat|mesh-list
15220884|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15220885|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220886|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15220887|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220888|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220889|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15220890|NCT03551522|Seladelpar|seladelpar|mesh-list
15220891|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15220892|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
15220893|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220894|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15220895|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
15220896|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
15220897|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
15220898|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220899|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15220900|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220901|NCT03539601|Analgesics|analgesics|mesh-ancestor
15220902|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
15220903|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305650|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305651|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
14305652|NCT00634647|Hormones|hormones|mesh-ancestor
14305653|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305654|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305655|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305656|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305657|NCT00634751|Capecitabine|capecitabine|mesh-list
14305658|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
14305659|NCT00634751|Sorafenib|sorafenib|mesh-list
14305660|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305661|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
14305662|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305663|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220904|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220905|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305664|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14305665|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305666|NCT00634803|Buprenorphine|buprenorphine|mesh-list
14305667|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14305668|NCT00634803|Narcotics|narcotics|mesh-ancestor
14305669|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305670|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305671|NCT00634803|Analgesics|analgesics|mesh-ancestor
14305672|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
14305673|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305674|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14305675|NCT00634842|Insulin|insulin|mesh-list
14305676|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14305677|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
14305678|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14305679|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305680|NCT00634907|Warfarin|warfarin|mesh-list
14305681|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
14305682|NCT00634920|Cyclosporine|cyclosporine|mesh-list
14305683|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
14305684|NCT00634920|Prednisolone|prednisolone|mesh-list
14305685|NCT00634920|Everolimus|everolimus|mesh-list
14305686|NCT00634920|Cyclosporins|cyclosporins|mesh-list
14305687|NCT00634920|Basiliximab|basiliximab|mesh-list
14305688|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305689|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305690|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305691|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
14305692|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305693|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
14305694|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305695|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
14305696|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305697|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14305698|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305699|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14305700|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14305701|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
14305702|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305703|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305704|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
14305705|NCT00634920|Hormones|hormones|mesh-ancestor
14305706|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305707|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305708|NCT00634933|Prednisone|prednisone|mesh-list
14305709|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
14305710|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14305711|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14305712|NCT00634933|Prednisolone|prednisolone|mesh-list
14305713|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
14305714|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14305715|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
14305716|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305717|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
14305718|NCT00634933|Hormones|hormones|mesh-ancestor
14305719|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305720|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305721|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305722|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305723|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
14305724|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
14305725|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305726|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14305727|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14305728|NCT00634933|Protective Agents|protective agents|mesh-ancestor
14305729|NCT00635024|Melphalan|melphalan|mesh-list
14305730|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14305731|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14305732|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
14305733|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305734|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305735|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14305736|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305737|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
14305738|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305739|NCT00635050|Paclitaxel|paclitaxel|mesh-list
14305740|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
14305741|NCT00635050|Bevacizumab|bevacizumab|mesh-list
14305742|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14305743|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305744|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
14305745|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
14305746|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
14305747|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305748|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305749|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
14305750|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305751|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305752|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14305753|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
14305754|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14305755|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305756|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305757|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305758|NCT00635050|Growth Substances|growth substances|mesh-ancestor
14305759|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305760|NCT00635089|Reslizumab|reslizumab|mesh-list
14305761|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14305762|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
14305763|NCT00635102|Cycloserine|cycloserine|mesh-list
14305764|NCT00635102|Glycine|glycine|mesh-list
14305765|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14305766|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305767|NCT00635102|Renal Agents|renal agents|mesh-ancestor
14305768|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14305769|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
14305770|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305771|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
14305772|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305773|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
14305774|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305775|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305776|NCT00635154|Dexamethasone|dexamethasone|mesh-list
14305777|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
14305778|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14305779|NCT00635154|BB 1101|bb 1101|mesh-list
14305780|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305781|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
14305782|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
14305783|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220906|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
15220907|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220908|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
15220909|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15220910|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220911|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220912|NCT03535688|Cycloserine|cycloserine|mesh-list
14305784|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305785|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14305786|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
14305787|NCT00635154|Hormones|hormones|mesh-ancestor
14305788|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305789|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305790|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305791|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305792|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14305793|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305794|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305795|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14305796|NCT00635219|Vortioxetine|vortioxetine|mesh-list
14305797|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14305798|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14305799|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14305800|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305801|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305802|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305803|NCT00635219|Analgesics|analgesics|mesh-ancestor
14305804|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
14305805|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305806|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
14305807|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722544|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
14722545|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
14722546|NCT00490854|Protamines|protamines|mesh-list
14722547|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14722548|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722549|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
14722550|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305808|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
14305809|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14305810|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305811|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305812|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14305813|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
14305814|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14305815|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14305816|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14305817|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14722551|NCT00490854|Coagulants|coagulants|mesh-ancestor
14722552|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
14722553|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
14729169|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14305818|NCT00635232|Irbesartan|irbesartan|mesh-list
14305819|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14305820|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14305821|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14305822|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305823|NCT00635349|Acetaminophen|acetaminophen|mesh-list
14305824|NCT00635349|Meloxicam|meloxicam|mesh-list
14305825|NCT00635349|Aceclofenac|aceclofenac|mesh-list
14305826|NCT00635349|Tramadol|tramadol|mesh-list
14305827|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14305828|NCT00635349|Analgesics|analgesics|mesh-ancestor
14305829|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
14305830|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14305831|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305832|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
14305833|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14305834|NCT00635349|Narcotics|narcotics|mesh-ancestor
14305835|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305836|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14305837|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14305838|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305839|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14305840|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14305841|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305842|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305843|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
14305844|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14305845|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
14305846|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305847|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305848|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14305849|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14305850|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14305851|NCT00635492|Insulin|insulin|mesh-list
14305852|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14305853|NCT00635492|Exenatide|exenatide|mesh-list
14305854|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14305855|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305856|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14305857|NCT00635492|Incretins|incretins|mesh-ancestor
14305858|NCT00635492|Hormones|hormones|mesh-ancestor
14305859|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305860|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
14305861|NCT00635570|NuvaRing|nuvaring|mesh-list
14305862|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14305863|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14305864|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
14305865|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305866|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305867|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14305868|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14305869|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14305870|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305871|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305872|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14305873|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14305874|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305875|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305876|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305877|NCT00635609|Doxycycline|doxycycline|mesh-list
14305878|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14305879|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305880|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
15220913|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15220914|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220915|NCT03535688|Renal Agents|renal agents|mesh-ancestor
15220916|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15220917|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
14305881|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14305882|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14305883|NCT00635648|Caspofungin|caspofungin|mesh-list
14305884|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
14305885|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14305886|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305887|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305888|NCT00635700|Ziprasidone|ziprasidone|mesh-list
14305889|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14305890|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
14305891|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305892|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305893|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305894|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14305895|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305896|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305897|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305898|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14305899|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
14305900|NCT00635817|Leuprolide|leuprolide|mesh-list
14305901|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15220918|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15220919|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
15220920|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220921|NCT03535350|Temozolomide|temozolomide|mesh-list
14305902|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
14722554|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722555|NCT00490867|Protective Agents|protective agents|mesh-ancestor
14722556|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722557|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
14722558|NCT00490867|Vitamins|vitamins|mesh-ancestor
14722559|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
14722560|NCT00490880|Gemcitabine|gemcitabine|mesh-list
14722561|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722562|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14305903|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14305904|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305905|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14305906|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305907|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
14305908|NCT00636155|Rituximab|rituximab|mesh-list
14305909|NCT00636155|Fludarabine|fludarabine|mesh-list
14305910|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305911|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
14305912|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305913|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305914|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14305915|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
14305916|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305917|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305918|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14305919|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305920|NCT00636168|Ipilimumab|ipilimumab|mesh-list
14305921|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305922|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305923|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14305924|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305925|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14305926|NCT00636207|Montelukast|montelukast|mesh-list
14305927|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14305928|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
14305929|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14305930|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
14305931|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14305932|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305933|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14305934|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14305935|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305936|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14722563|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
14305937|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
14305938|NCT00636441|Docetaxel|docetaxel|mesh-list
14305939|NCT00636441|Doxorubicin|doxorubicin|mesh-list
14305940|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14305941|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14305942|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
14305943|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305944|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305945|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14305946|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
14305947|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305948|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305949|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14305950|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
14305951|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
14305952|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
14305953|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14305954|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14305955|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14305956|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14305957|NCT00636610|Bevacizumab|bevacizumab|mesh-list
14305958|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305959|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305960|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14305961|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14305962|NCT00636610|Growth Substances|growth substances|mesh-ancestor
14305963|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305964|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
14305965|NCT00636636|Gabapentin|gabapentin|mesh-list
14305966|NCT00636636|Analgesics|analgesics|mesh-ancestor
14305967|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
14305968|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722564|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305969|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305970|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
14305971|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14305972|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14305973|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14305974|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305975|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14305976|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14305977|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305978|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305979|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
14305980|NCT00636649|Citalopram|citalopram|mesh-list
14305981|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14305982|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14305983|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14305984|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14305985|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14305986|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
14305987|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305988|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14305989|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
14305990|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14305991|NCT00636792|Rituximab|rituximab|mesh-list
14305992|NCT00636792|Bortezomib|bortezomib|mesh-list
14305993|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14305994|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14305995|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14305996|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
14305997|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14305998|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14305999|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14306000|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
14306001|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306002|NCT00636805|Dexamethasone|dexamethasone|mesh-list
14722565|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
14722566|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722567|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722568|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722569|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
14306003|NCT00636805|Palonosetron|palonosetron|mesh-list
14306004|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306005|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
14306006|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
14306007|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306008|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306009|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306010|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
14306011|NCT00636805|Hormones|hormones|mesh-ancestor
14306012|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306013|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14306014|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306015|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14306016|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14306017|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
14306018|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306019|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306020|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14306021|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14306022|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14722570|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306023|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306024|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306025|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
14306026|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306027|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306028|NCT00637000|Buprenorphine|buprenorphine|mesh-list
14306029|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14306030|NCT00637000|Naloxone|naloxone|mesh-list
14306031|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14306032|NCT00637000|Narcotics|narcotics|mesh-ancestor
14306033|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306034|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306035|NCT00637000|Analgesics|analgesics|mesh-ancestor
14306036|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
14306037|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306038|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14306039|NCT00637195|Vaccines|vaccines|mesh-list
14306040|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
14306041|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306042|NCT00637247|Gemcitabine|gemcitabine|mesh-list
14306043|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14306044|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
14306045|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306046|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306047|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
14306048|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306049|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306050|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14306051|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
14306052|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306053|NCT00637273|Pioglitazone|pioglitazone|mesh-list
14306054|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14306055|NCT00637273|Exenatide|exenatide|mesh-list
14306056|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306057|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306058|NCT00637273|Incretins|incretins|mesh-ancestor
14306059|NCT00637273|Hormones|hormones|mesh-ancestor
14306060|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306061|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14306062|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
14306063|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306064|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306065|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14306066|NCT00637377|Ranibizumab|ranibizumab|mesh-list
14306067|NCT00637377|Aflibercept|aflibercept|mesh-list
14306068|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14306069|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14306070|NCT00637377|Growth Substances|growth substances|mesh-ancestor
14306071|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306072|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
14306073|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306074|NCT00637494|Mifepristone|mifepristone|mesh-list
14306075|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14306076|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
14306077|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14306078|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306079|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14306080|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14306081|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14306082|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
14306083|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14306084|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14306085|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
14306086|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306087|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
14306088|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14306089|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14306090|NCT00637572|Megestrol|megestrol|mesh-list
14306091|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
14306092|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14306093|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14306094|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14306095|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
14306096|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14306097|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306098|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14306099|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14306100|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14306101|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306102|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
14306103|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14306104|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
14306105|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306106|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14306107|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14306108|NCT00637780|Analgesics|analgesics|mesh-ancestor
14306109|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
15220922|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15220923|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
15220924|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220925|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220926|NCT03532451|Nivolumab|nivolumab|mesh-list
15220927|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220928|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220929|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15220930|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220931|NCT03522844|Citalopram|citalopram|mesh-list
15220932|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15220933|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14306110|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306111|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306112|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306113|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14306114|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306115|NCT00637923|Ribavirin|ribavirin|mesh-list
14306116|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14306117|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
14306118|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
14306119|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306120|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
14306121|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306122|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14306123|NCT00638027|Memantine|memantine|mesh-list
14306124|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14306125|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14722571|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
14722572|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14722573|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722574|NCT00490906|Interferons|interferons|mesh-list
14722575|NCT00490906|Interferon-beta|interferon-beta|mesh-list
14722576|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
14722577|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
14722578|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
14306126|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
14306127|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306128|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306129|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306130|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14306131|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14306132|NCT00638157|Gentamicins|gentamicins|mesh-list
14306133|NCT00638157|Daptomycin|daptomycin|mesh-list
14306134|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14306135|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306136|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14306137|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306138|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306139|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
14306140|NCT00638443|Promethazine|promethazine|mesh-list
14306141|NCT00638443|Pregabalin|pregabalin|mesh-list
14306142|NCT00638443|Analgesics|analgesics|mesh-ancestor
14306143|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
14306144|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306145|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306146|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
14306147|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14306148|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306149|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306150|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14306151|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14306152|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306153|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306154|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722579|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
14722580|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722581|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
14306155|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14306156|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14306157|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
14306158|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
14306159|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
14306160|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
14306161|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306162|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14306163|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
14306164|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
14306165|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306166|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14306167|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
14306168|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
14306169|NCT00638456|Budesonide|budesonide|mesh-list
14306170|NCT00638456|Lansoprazole|lansoprazole|mesh-list
14306171|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
14306172|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306173|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14306174|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
14306175|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722582|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722583|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
14722584|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722585|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14722586|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722587|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722588|NCT00490958|Telmisartan|telmisartan|mesh-list
14722589|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14722590|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14722591|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14722592|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722593|NCT00490997|Ketamine|ketamine|mesh-list
14306176|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306177|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14306178|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
14306179|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
14306180|NCT00638456|Hormones|hormones|mesh-ancestor
14306181|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306182|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14306183|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14722594|NCT00490997|Propofol|propofol|mesh-list
14722595|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14306184|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14306185|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306186|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306187|NCT00638508|Ketorolac|ketorolac|mesh-list
14306188|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14306189|NCT00638508|Ropivacaine|ropivacaine|mesh-list
14306190|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
14306191|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
14306192|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306193|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306194|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
14306195|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306196|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14306197|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14306198|NCT00638508|Analgesics|analgesics|mesh-ancestor
14306199|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306200|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722596|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722597|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722598|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14722599|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
14722600|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
14722601|NCT00490997|Analgesics|analgesics|mesh-ancestor
14722602|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
14722603|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722604|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14722605|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14722606|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14306201|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14306202|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306203|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306204|NCT00638651|Imiquimod|imiquimod|mesh-list
14306205|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14306206|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
14306207|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306208|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306209|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
14306210|NCT00638690|Prednisone|prednisone|mesh-list
14306211|NCT00638690|Prednisolone|prednisolone|mesh-list
14306212|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
14306213|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306214|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
14306215|NCT00638690|Hormones|hormones|mesh-ancestor
14306216|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306217|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306218|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14306219|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306220|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14306221|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306222|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306223|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
14306224|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14306225|NCT00638820|Busulfan|busulfan|mesh-list
14306226|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
14306227|NCT00638820|Clofarabine|clofarabine|mesh-list
14306228|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
14306229|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306230|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14306231|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
14306232|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306233|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14306234|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306235|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14306236|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14306237|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14306238|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
14306239|NCT00638937|Saracatinib|saracatinib|mesh-list
14306240|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306241|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306242|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306243|NCT00638963|Temozolomide|temozolomide|mesh-list
14722607|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909763|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909764|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
14909765|NCT01352728|Axitinib|axitinib|mesh-list
14909766|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909767|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14909768|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909769|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909770|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14909771|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
14306244|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14306245|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
14306246|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306247|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327795|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14327796|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327797|NCT00804973|Sumatriptan|sumatriptan|mesh-list
14327798|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14327799|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14327800|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14327801|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
14327802|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327803|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327804|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327805|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14327806|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14327807|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327808|NCT00805142|Tapentadol|tapentadol|mesh-list
14327809|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14327810|NCT00805142|Narcotics|narcotics|mesh-ancestor
14327811|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722608|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722609|NCT00491049|Levofloxacin|levofloxacin|mesh-list
14722610|NCT00491049|Ofloxacin|ofloxacin|mesh-list
14722611|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14327812|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327813|NCT00805142|Analgesics|analgesics|mesh-ancestor
14327814|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
14327815|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327816|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14327817|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327818|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327819|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327820|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
14327821|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327822|NCT00805194|Docetaxel|docetaxel|mesh-list
14327823|NCT00805194|Nintedanib|nintedanib|mesh-list
14327824|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327825|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
14327826|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
14327827|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
14327828|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327829|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14327830|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327831|NCT00805207|Estradiol|estradiol|mesh-list
14327832|NCT00805207|Estrogens|estrogens|mesh-list
14327833|NCT00805207|Testosterone|testosterone|mesh-list
14327834|NCT00805207|Progesterone|progesterone|mesh-list
14327835|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
14327836|NCT00805207|Hormones|hormones|mesh-ancestor
14327837|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327838|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327839|NCT00805207|Androgens|androgens|mesh-ancestor
14327840|NCT00805207|Progestins|progestins|mesh-ancestor
14327841|NCT00805285|Budesonide|budesonide|mesh-list
14327842|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
14327843|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327844|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14722612|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14722613|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14722614|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722615|NCT00491049|Renal Agents|renal agents|mesh-ancestor
14722616|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722617|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14306248|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14306249|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
14306250|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306251|NCT00639002|Dexamethasone|dexamethasone|mesh-list
14306252|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306253|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
14306254|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
14306255|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306256|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306257|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306258|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
14306259|NCT00639002|Hormones|hormones|mesh-ancestor
14306260|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306261|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14306262|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306263|NCT00639158|Choline|choline|mesh-list
14306264|NCT00639158|Atorvastatin|atorvastatin|mesh-list
14306265|NCT00639158|Ezetimibe|ezetimibe|mesh-list
14306266|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
14306267|NCT00639158|Fenofibrate|fenofibrate|mesh-list
14306268|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14306269|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14306270|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
14306271|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306272|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14306273|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14306274|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306275|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
14306276|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306277|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
14306278|NCT00639223|Pravastatin|pravastatin|mesh-list
14306279|NCT00639223|Red yeast rice|red yeast rice|mesh-list
14306280|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14306281|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14306282|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
14306283|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306284|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14306285|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14306286|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306287|NCT00639418|Vaccines|vaccines|mesh-list
14306288|NCT00639418|Immunologic Factors|immunologic factors|mesh-ancestor
14306289|NCT00639418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306290|NCT00639457|Pioglitazone|pioglitazone|mesh-list
14306291|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306292|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306293|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14306294|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
14306295|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306296|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14306297|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
14306298|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306299|NCT00639717|Etanercept|etanercept|mesh-list
14306300|NCT00639717|Methoxsalen|methoxsalen|mesh-list
14306301|NCT00639717|Tacrolimus|tacrolimus|mesh-list
14306302|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14306303|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
14306304|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306305|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14306306|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306307|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306308|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14306309|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14306310|NCT00639717|Analgesics|analgesics|mesh-ancestor
14306311|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
14722618|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14327845|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
14306312|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306313|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306314|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14306315|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306316|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14306317|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14306318|NCT00639769|Cisplatin|cisplatin|mesh-list
14306319|NCT00639769|Irinotecan|irinotecan|mesh-list
14306320|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306321|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14722619|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722620|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722621|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722622|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14722623|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14722624|NCT00491114|Gemcitabine|gemcitabine|mesh-list
15220934|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306322|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14306323|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306324|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306325|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14306326|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
14306327|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306328|NCT00640042|Morphine|morphine|mesh-list
14306329|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14306330|NCT00640042|Narcotics|narcotics|mesh-ancestor
14306331|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306332|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306333|NCT00640042|Analgesics|analgesics|mesh-ancestor
14306334|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
15220935|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306335|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306336|NCT00640146|Bromides|bromides|mesh-list
15220936|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220937|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
15220938|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220939|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15220940|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
15220941|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15220942|NCT03514719|Avelumab|avelumab|mesh-list
15220943|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15220944|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15220945|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220946|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
15220947|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220948|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
14306337|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
14306338|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
14306339|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14306340|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306341|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
14306342|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306343|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
14306344|NCT00640224|Drospirenone|drospirenone|mesh-list
14306345|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14306346|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14306347|NCT00640224|Estradiol|estradiol|mesh-list
14306348|NCT00640224|Estrogens|estrogens|mesh-ancestor
14306349|NCT00640224|Hormones|hormones|mesh-ancestor
14306350|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306351|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306352|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14306353|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
14306354|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14306355|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14306356|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306357|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14306358|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14306359|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14306360|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
14306361|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14306362|NCT00640224|Diuretics|diuretics|mesh-ancestor
14306363|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
14306364|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
14306365|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14306366|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14306367|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306368|NCT00640315|Riociguat|riociguat|mesh-list
14306369|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
14306370|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722625|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722626|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
14722627|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722628|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722629|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
15220949|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14306371|NCT00640328|Ofatumumab|ofatumumab|mesh-list
14306372|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14306373|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306374|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
14306375|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306376|NCT00640393|Etanercept|etanercept|mesh-list
14722630|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15220950|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220951|NCT03513770|Ketorolac|ketorolac|mesh-list
15220952|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15220953|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15220954|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15220955|NCT03513770|Analgesics|analgesics|mesh-ancestor
15220956|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
15220957|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220958|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306377|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14306378|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14306379|NCT00640393|Analgesics|analgesics|mesh-ancestor
14306380|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
14306381|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306382|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306383|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306384|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14306385|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306386|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220959|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15220960|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15220961|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15220962|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15220963|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220964|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
14306387|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
14306388|NCT00640510|Olanzapine|olanzapine|mesh-list
14306389|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
14306390|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
14306391|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306392|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306393|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306394|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14306395|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306396|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306397|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306398|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14306399|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14306400|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306401|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306402|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306403|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
14306404|NCT00640562|Risperidone|risperidone|mesh-list
14306405|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14306406|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14722631|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306407|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
14306408|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306409|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306410|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722632|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722633|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
14722634|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722635|NCT00491127|Gemcitabine|gemcitabine|mesh-list
14722636|NCT00491127|Dexamethasone|dexamethasone|mesh-list
14722637|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722638|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722639|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
14722640|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
14306411|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14306412|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306413|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306414|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306415|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14306416|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
14306417|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
14306418|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14306419|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
14306420|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306421|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14722641|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909772|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15220965|NCT03492112|Velpatasvir|velpatasvir|mesh-list
15220966|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
15220967|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306422|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306423|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306424|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306425|NCT00640822|Calcitriol|calcitriol|mesh-list
14306426|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
14722642|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722643|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14722644|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
14722645|NCT00491127|Hormones|hormones|mesh-ancestor
14722646|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722647|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14306427|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14306428|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14306429|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14306430|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
14306431|NCT00640822|Calcipotriene|calcipotriene|mesh-list
14306432|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306433|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
14306434|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14306435|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306436|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14306437|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306438|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306439|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14722648|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14722649|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
14722650|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722651|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
14722652|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722653|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722654|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14306440|NCT00640822|Vitamins|vitamins|mesh-ancestor
14306441|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
14306442|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14306443|NCT00640835|Buprenorphine|buprenorphine|mesh-list
14306444|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14306445|NCT00640835|Naloxone|naloxone|mesh-list
14306446|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14306447|NCT00640835|Narcotics|narcotics|mesh-ancestor
14306448|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306449|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306450|NCT00640835|Analgesics|analgesics|mesh-ancestor
14306451|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
14306452|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306453|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14306454|NCT00640926|Radezolid|radezolid|mesh-list
14306455|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
14306456|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14306457|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306458|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14306459|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306460|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306461|NCT00640978|Everolimus|everolimus|mesh-list
14306462|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14306463|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306464|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14306465|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
14306466|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306467|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14306468|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306469|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306470|NCT00641043|Pioglitazone|pioglitazone|mesh-list
14306471|NCT00641043|Linagliptin|linagliptin|mesh-list
14306472|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306473|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306474|NCT00641043|Incretins|incretins|mesh-ancestor
14306475|NCT00641043|Hormones|hormones|mesh-ancestor
14306476|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306477|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14306478|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
14306479|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306480|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306481|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
14306482|NCT00641056|Exenatide|exenatide|mesh-list
14306483|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306484|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306485|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14306486|NCT00641056|Incretins|incretins|mesh-ancestor
14306487|NCT00641056|Hormones|hormones|mesh-ancestor
14306488|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15220968|NCT03484520|Venetoclax|venetoclax|mesh-list
15220969|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15220970|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15220971|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14306489|NCT00641147|Curcumin|curcumin|mesh-list
14306490|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14306491|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14722655|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
14722656|NCT00491166|Bromfenac|bromfenac|mesh-list
14722657|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14722658|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14722659|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14722660|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14722661|NCT00491166|Analgesics|analgesics|mesh-ancestor
14722662|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
15220972|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14306492|NCT00641147|Analgesics|analgesics|mesh-ancestor
14306493|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
14306494|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306495|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306496|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306497|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14306498|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306499|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306500|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306501|NCT00641563|Midazolam|midazolam|mesh-list
14306502|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
14306503|NCT00641563|Remifentanil|remifentanil|mesh-list
14306504|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14306505|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306506|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306507|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14306508|NCT00641563|Analgesics|analgesics|mesh-ancestor
14306509|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
14306510|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306511|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14306512|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14306513|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14306514|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
14306515|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306516|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306517|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14306518|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14306519|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306520|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306521|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14306522|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
14306523|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
14306524|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
14306525|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
14306526|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14306527|NCT00641563|Narcotics|narcotics|mesh-ancestor
14722663|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220973|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15220974|NCT03476642|Epinephrine|epinephrine|mesh-list
15220975|NCT03476642|Ropivacaine|ropivacaine|mesh-list
15220976|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
15220977|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
15220978|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15220979|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15220980|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
15220981|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15220982|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15220983|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15220984|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
15220985|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15220986|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15220987|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15220988|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15220989|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
15220990|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14306528|NCT00641641|Tenofovir|tenofovir|mesh-list
14306529|NCT00641641|Emtricitabine|emtricitabine|mesh-list
14306530|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
14306531|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
14306532|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306533|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14306534|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14306535|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306536|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306537|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14306538|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14306539|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14306540|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14306541|NCT00641667|Fentanyl|fentanyl|mesh-list
14306542|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14306543|NCT00641667|Narcotics|narcotics|mesh-ancestor
14306544|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306545|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306546|NCT00641667|Analgesics|analgesics|mesh-ancestor
14306547|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
14306548|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306549|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14306550|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14306551|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
14306552|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
14306553|NCT00641706|Bortezomib|bortezomib|mesh-list
14306554|NCT00641706|Vorinostat|vorinostat|mesh-list
14306555|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306556|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14306557|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306558|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306559|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14306560|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14306561|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14306562|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306563|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306564|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306565|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306566|NCT00641719|Analgesics|analgesics|mesh-ancestor
14306567|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
14306568|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306569|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
14306570|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306571|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
14306572|NCT00641745|Risperidone|risperidone|mesh-list
14306573|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14306574|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14306575|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
14306576|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306577|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306578|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306579|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14306580|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306581|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306582|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306583|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14306584|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
14306585|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14306586|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14306587|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14306588|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
14306589|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14306590|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14306591|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
14306592|NCT00641797|Promethazine|promethazine|mesh-list
14306593|NCT00641797|Meclizine|meclizine|mesh-list
14306594|NCT00641797|Lorazepam|lorazepam|mesh-list
14306595|NCT00641797|Ondansetron|ondansetron|mesh-list
14306596|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
14306597|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
14306598|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306599|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306600|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306601|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
14306602|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
14306603|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14306604|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
14306605|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306606|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306607|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14306608|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306609|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306610|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306611|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14306612|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14306613|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14306614|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
14306615|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
14306616|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
14306617|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14306618|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
14306619|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
14306620|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14306621|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
14306622|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
14306623|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
14306624|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
14306625|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
14306626|NCT00641862|Vitamins|vitamins|mesh-ancestor
14722664|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722665|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722666|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722667|NCT00491192|Diclofenac|diclofenac|mesh-list
14722668|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14722669|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14722670|NCT00491192|Analgesics|analgesics|mesh-ancestor
14306627|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
14306628|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306629|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
14306630|NCT00641862|Hematinics|hematinics|mesh-ancestor
14306631|NCT00642018|Prednisone|prednisone|mesh-list
14306632|NCT00642018|Docetaxel|docetaxel|mesh-list
14306633|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306634|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14306635|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14306636|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14306637|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306638|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306639|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
14306640|NCT00642018|Hormones|hormones|mesh-ancestor
14306641|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306642|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306643|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14306644|NCT00642174|Clopidogrel|clopidogrel|mesh-list
14722671|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
14306645|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14306646|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14306647|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14306648|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14306649|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14306650|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
14306651|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306652|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306653|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306654|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14306655|NCT00642278|Canagliflozin|canagliflozin|mesh-list
14306656|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306657|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306658|NCT00642278|Incretins|incretins|mesh-ancestor
14306659|NCT00642278|Hormones|hormones|mesh-ancestor
14306660|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306661|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14306662|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
14306663|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306664|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306665|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14306666|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
14306667|NCT00642304|Hematinics|hematinics|mesh-ancestor
14306668|NCT00642356|Levodopa|levodopa|mesh-list
14306669|NCT00642356|Carbidopa|carbidopa|mesh-list
14306670|NCT00642356|Entacapone|entacapone|mesh-list
14306671|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14306672|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14306673|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14306674|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
14306675|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306676|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306677|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306678|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14306679|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306680|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14306681|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14306682|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
14306683|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
14306684|NCT00642369|Haloperidol|haloperidol|mesh-list
14306685|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14306686|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
14306687|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
14306688|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306689|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14306690|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306691|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306692|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306693|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
14306694|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
14306695|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306696|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306697|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14306698|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
14306699|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306700|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306701|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14306702|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14306703|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14306704|NCT00642460|Methotrexate|methotrexate|mesh-list
14306705|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14306706|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
14306707|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14306708|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306709|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14306710|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
14306711|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306712|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306713|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
14306714|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306715|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14306716|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14306717|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
14306718|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14306719|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14306720|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14306721|NCT00642460|Analgesics|analgesics|mesh-ancestor
14306722|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
14306723|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306724|NCT00642473|Metronidazole|metronidazole|mesh-list
14306725|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14306726|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306727|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14306728|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306729|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306730|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306731|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14306732|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14306733|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14306734|NCT00642616|Insulin|insulin|mesh-list
14306735|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306736|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306737|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
14306738|NCT00642668|Hematinics|hematinics|mesh-ancestor
14306739|NCT00642694|Dexetimide|dexetimide|mesh-list
14722672|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722673|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722674|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722675|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722676|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14306740|NCT00642694|Citalopram|citalopram|mesh-list
14306741|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14722677|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722678|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729170|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
14729171|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14729172|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729173|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14729174|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
14729175|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729176|NCT00521781|Hormones|hormones|mesh-ancestor
14306742|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14306743|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306744|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722679|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14722680|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14722681|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14306745|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306746|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
14306747|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306748|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14306749|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
14306750|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306751|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14306752|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14306753|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
14306754|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
14306755|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306756|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14306757|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14306758|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14306759|NCT00642707|Leronlimab|leronlimab|mesh-list
14306760|NCT00642707|Antibodies|antibodies|mesh-list
14306761|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14306762|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
14306763|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306764|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14306765|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14306766|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306767|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14306768|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14306769|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
14306770|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306771|NCT00642746|Leucovorin|leucovorin|mesh-list
14306772|NCT00642746|Fluorouracil|fluorouracil|mesh-list
14306773|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
14306774|NCT00642746|Irinotecan|irinotecan|mesh-list
14306775|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14306776|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
14306777|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306778|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14306779|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306780|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14306781|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
14306782|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306783|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14306784|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14306785|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306786|NCT00642746|Antidotes|antidotes|mesh-ancestor
14722682|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722683|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722684|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722685|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722686|NCT00491348|Analgesics|analgesics|mesh-ancestor
14722687|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
14729177|NCT00521820|Pioglitazone|pioglitazone|mesh-list
15220991|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
15220992|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
15220993|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
15220994|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15220995|NCT03465280|Interferons|interferons|mesh-list
15220996|NCT03465280|Acyclovir|acyclovir|mesh-list
15220997|NCT03465280|Cidofovir|cidofovir|mesh-list
15220998|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
15220999|NCT03465280|Artemisinins|artemisinins|mesh-list
15221000|NCT03465280|Artemisinin|artemisinin|mesh-list
15221001|NCT03465280|Celecoxib|celecoxib|mesh-list
14306787|NCT00642746|Protective Agents|protective agents|mesh-ancestor
15221002|NCT03465280|Bevacizumab|bevacizumab|mesh-list
15221003|NCT03465280|Methotrexate|methotrexate|mesh-list
14306788|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
14306789|NCT00642746|Vitamins|vitamins|mesh-ancestor
14306790|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
14306791|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14306792|NCT00642759|Paclitaxel|paclitaxel|mesh-list
14306793|NCT00642759|Bevacizumab|bevacizumab|mesh-list
14306794|NCT00642759|Carboplatin|carboplatin|mesh-list
14306795|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14306796|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306797|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
14306798|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
14306799|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
14306800|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306801|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14306802|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14306803|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14306804|NCT00642759|Growth Substances|growth substances|mesh-ancestor
14306805|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306806|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
14306807|NCT00642811|Aspirin|aspirin|mesh-list
14306808|NCT00642811|Clopidogrel|clopidogrel|mesh-list
14306809|NCT00642811|Ticagrelor|ticagrelor|mesh-list
14306810|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14306811|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14306812|NCT00642811|Analgesics|analgesics|mesh-ancestor
14306813|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
14306814|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306815|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306816|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306817|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14306818|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14306819|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14306820|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306821|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14306822|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14306823|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306824|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
14306825|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14306826|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14306827|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14306828|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
14306829|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306830|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
14306831|NCT00642850|Hematinics|hematinics|mesh-ancestor
14306832|NCT00642954|Dexamethasone|dexamethasone|mesh-list
14306833|NCT00642954|Lenalidomide|lenalidomide|mesh-list
14306834|NCT00642954|Vorinostat|vorinostat|mesh-list
14306835|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14306836|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
14306837|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
14306838|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306839|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306840|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14306841|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
14306842|NCT00642954|Hormones|hormones|mesh-ancestor
14306843|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14306844|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14306845|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306846|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
14306847|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14306848|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14306849|NCT00642954|Growth Substances|growth substances|mesh-ancestor
14306850|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
14306851|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14306852|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306853|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306854|NCT00643097|Temozolomide|temozolomide|mesh-list
14306855|NCT00643097|Sargramostim|sargramostim|mesh-list
14306856|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14722688|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722689|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14722690|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722691|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
14722692|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
14722693|NCT00491413|Hematinics|hematinics|mesh-ancestor
14722694|NCT00491426|Metronidazole|metronidazole|mesh-list
14306857|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
14306858|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306859|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306860|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
14306861|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306862|NCT00643123|Allopurinol|allopurinol|mesh-list
14306863|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
14306864|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306865|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306866|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
14306867|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14306868|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14306869|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
14306870|NCT00643123|Protective Agents|protective agents|mesh-ancestor
14306871|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306872|NCT00643162|Citalopram|citalopram|mesh-list
14306873|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14306874|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14306875|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306876|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306877|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306878|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
14306879|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306880|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14306881|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
14306882|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306883|NCT00643201|Enoxaparin|enoxaparin|mesh-list
14306884|NCT00643201|Warfarin|warfarin|mesh-list
14306885|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
14306886|NCT00643201|Apixaban|apixaban|mesh-list
14306887|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
14306888|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14306889|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14306890|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306891|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14306892|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
14306893|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14306894|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
14306895|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14306896|NCT00643565|Bevacizumab|bevacizumab|mesh-list
14306897|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14306898|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306899|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14306900|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14306901|NCT00643565|Growth Substances|growth substances|mesh-ancestor
14306902|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306903|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
14306904|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
14306905|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14306906|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
14306907|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306908|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306909|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14306910|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
14306911|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14306912|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14306913|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14722695|NCT00491426|Tazobactam|tazobactam|mesh-list
14722696|NCT00491426|Piperacillin|piperacillin|mesh-list
14306914|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
14306915|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306916|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306917|NCT00643604|Treprostinil|treprostinil|mesh-list
14306918|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14306919|NCT00643760|Pregabalin|pregabalin|mesh-list
14306920|NCT00643760|Gabapentin|gabapentin|mesh-list
14306921|NCT00643760|Analgesics|analgesics|mesh-ancestor
14306922|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
14306923|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306924|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306925|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
14306926|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14306927|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306928|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306929|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14306930|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14306931|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14306932|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306933|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306934|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14306935|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14306936|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306937|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
14306938|NCT00643851|Metformin|metformin|mesh-list
14306939|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
14306940|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14306941|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306942|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14306943|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306944|NCT00644059|Vaccines|vaccines|mesh-list
14306945|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
14306946|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306947|NCT00644189|Clofarabine|clofarabine|mesh-list
14306948|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14306949|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
14306950|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306951|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306952|NCT00644280|Ranibizumab|ranibizumab|mesh-list
14306953|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14306954|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14722697|NCT00491426|Amphotericin B|amphotericin b|mesh-list
14722698|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14722699|NCT00491426|Acyclovir|acyclovir|mesh-list
14722700|NCT00491426|Ampicillin|ampicillin|mesh-list
14722701|NCT00491426|Caspofungin|caspofungin|mesh-list
14722702|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14722703|NCT00491426|Anidulafungin|anidulafungin|mesh-list
14722704|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221004|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
15221005|NCT03465280|Isotretinoin|isotretinoin|mesh-list
15221006|NCT03465280|Cimetidine|cimetidine|mesh-list
15221007|NCT03465280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221008|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221009|NCT03465280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15221010|NCT03465280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15221011|NCT03465280|Growth Substances|growth substances|mesh-ancestor
15221012|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221013|NCT03465280|Growth Inhibitors|growth inhibitors|mesh-ancestor
15221014|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15221015|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
15221016|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15221017|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221018|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
15221019|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221020|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
15221021|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221022|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15221023|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221024|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
15221025|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221026|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15221027|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
15221028|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14306955|NCT00644280|Growth Substances|growth substances|mesh-ancestor
14722705|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15221029|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15221030|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15221031|NCT03465280|Analgesics|analgesics|mesh-ancestor
15221032|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
15221033|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221034|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221035|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15221036|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15221037|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15221038|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15221039|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15221040|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
15221041|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
15221042|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221043|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15221044|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15221045|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
14722706|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14722707|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14722708|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14722709|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909773|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
14306956|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306957|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
14306958|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14306959|NCT00644332|Ranolazine|ranolazine|mesh-list
14306960|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14306961|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306962|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306963|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14306964|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
14306965|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14306966|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14306967|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14306968|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14306969|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306970|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306971|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
14306972|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306973|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14306974|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14306975|NCT00644592|Fenofibrate|fenofibrate|mesh-list
14306976|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14306977|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
14306978|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306979|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14306980|NCT00644657|Clopidogrel|clopidogrel|mesh-list
14306981|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14306982|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14306983|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14306984|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14306985|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
14306986|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14306987|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14306988|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306989|NCT00644787|Fentanyl|fentanyl|mesh-list
14306990|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14306991|NCT00644787|Narcotics|narcotics|mesh-ancestor
14306992|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14306993|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14306994|NCT00644787|Analgesics|analgesics|mesh-ancestor
14306995|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
14306996|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14306997|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14306998|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14306999|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
14307000|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
14307001|NCT00644969|Varenicline|varenicline|mesh-list
14307002|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14307003|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14307004|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
14729178|NCT00521820|Glyburide|glyburide|mesh-list
14307005|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307006|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307007|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307008|NCT00645099|Olanzapine|olanzapine|mesh-list
14307009|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14307010|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
14307011|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
14307012|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307013|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307014|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14307015|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14307016|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14307017|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307018|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14307019|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14307020|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14307021|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307022|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307023|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307024|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
14307025|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14307026|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14307027|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14307028|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14307029|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
14307030|NCT00645333|Docetaxel|docetaxel|mesh-list
14307031|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307032|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14307033|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14307034|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14307035|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307036|NCT00645411|Vaccines|vaccines|mesh-list
14307037|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
14307038|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307039|NCT00645450|Propranolol|propranolol|mesh-list
14307040|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14307041|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14307042|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
14307043|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307044|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307045|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307046|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14307047|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14307048|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
14327846|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327847|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327848|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14327849|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
14327850|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
14327851|NCT00805285|Hormones|hormones|mesh-ancestor
14327852|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327853|NCT00805493|Riluzole|riluzole|mesh-list
14327854|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
14327855|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14327856|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14327857|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307049|NCT00645528|Insulin|insulin|mesh-list
14307050|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14307051|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307052|NCT00645593|Gemcitabine|gemcitabine|mesh-list
14307053|NCT00645593|Cetuximab|cetuximab|mesh-list
14307054|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307055|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307056|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
14307057|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307058|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
14307059|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307060|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307061|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307062|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
14307063|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307064|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14307065|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14307066|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14307067|NCT00645710|Gemcitabine|gemcitabine|mesh-list
14307068|NCT00645710|Floxuridine|floxuridine|mesh-list
14307069|NCT00645710|Antibodies|antibodies|mesh-list
14307070|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14307071|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
14307072|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307073|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307074|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
14307075|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307076|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307077|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
14307078|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307079|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307080|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307081|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
14307082|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14307083|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307084|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14307085|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14307086|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307087|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307088|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307089|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14307090|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14307091|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14307092|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307093|NCT00645853|Warfarin|warfarin|mesh-list
14307094|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
14307095|NCT00645944|Eszopiclone|eszopiclone|mesh-list
14307096|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14307097|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307098|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307099|NCT00646451|Pregabalin|pregabalin|mesh-list
14307100|NCT00646451|Analgesics|analgesics|mesh-ancestor
14307101|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
14307102|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307103|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307104|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
14307105|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14307106|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307107|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307108|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14307109|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14307110|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14307111|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307112|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14307113|NCT00646581|Insulin|insulin|mesh-list
14307114|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14307115|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14307116|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307117|NCT00646646|Midazolam|midazolam|mesh-list
14307118|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
14307119|NCT00646646|Propofol|propofol|mesh-list
14307120|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14307121|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307122|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307123|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14307124|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
14307125|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
14307126|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307127|NCT00646646|Analgesics|analgesics|mesh-ancestor
14307128|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
14307129|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307130|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14307131|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14307132|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14307133|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
14307134|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307135|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307136|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14307137|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14307138|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14307139|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14307140|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
14307141|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
14307142|NCT00646763|Lenograstim|lenograstim|mesh-list
14307143|NCT00646763|Sargramostim|sargramostim|mesh-list
14307144|NCT00646763|Mitogens|mitogens|mesh-list
14307145|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14307146|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
14307147|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307148|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
14307149|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307150|NCT00646776|Ritonavir|ritonavir|mesh-list
14307151|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14307152|NCT00646776|Rifabutin|rifabutin|mesh-list
14307153|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14307154|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14307155|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
14307156|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307157|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307158|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14307159|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14307160|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
14307161|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307162|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14307163|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14307164|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14307165|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14307166|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
14307167|NCT00646906|Aspirin|aspirin|mesh-list
14307168|NCT00646906|Acetaminophen|acetaminophen|mesh-list
14307169|NCT00646906|Ibuprofen|ibuprofen|mesh-list
14307170|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14307171|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307172|NCT00646906|Analgesics|analgesics|mesh-ancestor
14307173|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
14307174|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307175|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307176|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221046|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15221047|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14307177|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221048|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15221049|NCT03465280|Protective Agents|protective agents|mesh-ancestor
15221050|NCT03464136|Adalimumab|adalimumab|mesh-list
15221051|NCT03464136|Ustekinumab|ustekinumab|mesh-list
15221052|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221053|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221054|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
15225565|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15225566|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15225567|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
15225568|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225569|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307178|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14307179|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14307180|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307181|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14307182|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14307183|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307184|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
14307185|NCT00646958|Linezolid|linezolid|mesh-list
14307186|NCT00646958|Radezolid|radezolid|mesh-list
14307187|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
14307188|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14307189|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307190|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14307191|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307192|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307193|NCT00647270|Adalimumab|adalimumab|mesh-list
14307194|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307195|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307196|NCT00647296|Pramipexole|pramipexole|mesh-list
14307197|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
14307198|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307199|NCT00647296|Protective Agents|protective agents|mesh-ancestor
14307200|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307201|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14307202|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14307203|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
14307204|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
14307205|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307206|NCT00647348|Simvastatin|simvastatin|mesh-list
14307207|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14307208|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14307209|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
14307210|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307211|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14307212|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14307213|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307214|NCT00647400|Adalimumab|adalimumab|mesh-list
14307215|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307216|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307217|NCT00647556|Adapalene|adapalene|mesh-list
14307218|NCT00647556|Tretinoin|tretinoin|mesh-list
14307219|NCT00647556|Emollients|emollients|mesh-list
14307220|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14307221|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307222|NCT00647556|Analgesics|analgesics|mesh-ancestor
14307223|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
14307224|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307225|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307226|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307227|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307228|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
14307229|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307230|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
14307231|NCT00647699|Riboflavin|riboflavin|mesh-list
14307232|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14307233|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14307234|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
14307235|NCT00647699|Vitamins|vitamins|mesh-ancestor
14307236|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
14307237|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307238|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14307239|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
14307240|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
14307241|NCT00647998|Hematinics|hematinics|mesh-ancestor
14307242|NCT00648037|Rituximab|rituximab|mesh-list
14307243|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14307244|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307245|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
14307246|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307247|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307248|NCT00648375|Propranolol|propranolol|mesh-list
14307249|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14307250|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14307251|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
14307252|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307253|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307254|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307255|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14307256|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14307257|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
14307258|NCT00648648|Gemcitabine|gemcitabine|mesh-list
14307259|NCT00648648|Carboplatin|carboplatin|mesh-list
14307260|NCT00648648|Adavosertib|adavosertib|mesh-list
14307261|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307262|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307263|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
14307264|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307265|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
14307266|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307267|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307268|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722710|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307269|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
14307270|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307271|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
14307272|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14307273|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307274|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307275|NCT00649220|Memantine|memantine|mesh-list
14307276|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14307277|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14307278|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
14307279|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307280|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307281|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307282|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14307283|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15221055|NCT03454035|Palbociclib|palbociclib|mesh-list
15221056|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307284|NCT00649389|Amlodipine|amlodipine|mesh-list
14307285|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14307286|NCT00649389|Olmesartan|olmesartan|mesh-list
14307287|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14307288|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14307289|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14307290|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307291|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221057|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221058|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221059|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221060|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15221061|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
15221062|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307292|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14307293|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307294|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
14307295|NCT00649389|Diuretics|diuretics|mesh-ancestor
14307296|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
14307297|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14307298|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14307299|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14307300|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
14307301|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14307302|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307303|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307304|NCT00649961|Melatonin|melatonin|mesh-list
14307305|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
14307306|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307307|NCT00649961|Protective Agents|protective agents|mesh-ancestor
14307308|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307309|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307310|NCT00650078|Prednisone|prednisone|mesh-list
14307311|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307312|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
14307313|NCT00650078|Hormones|hormones|mesh-ancestor
14307314|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14307315|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307316|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14307317|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307318|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
14307319|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14307320|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
14307321|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307322|NCT00650091|Expectorants|expectorants|mesh-ancestor
14307323|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
14307324|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14307325|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
14307326|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307327|NCT00650091|Protective Agents|protective agents|mesh-ancestor
14307328|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307329|NCT00650091|Antidotes|antidotes|mesh-ancestor
14307330|NCT00650104|Ropinirole|ropinirole|mesh-list
14307331|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14307332|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14307333|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
14307334|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
14307335|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307336|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307337|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307338|NCT00650546|Exenatide|exenatide|mesh-list
14307339|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14307340|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307341|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14307342|NCT00650546|Incretins|incretins|mesh-ancestor
14307343|NCT00650546|Hormones|hormones|mesh-ancestor
14307344|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14307345|NCT00650806|Canagliflozin|canagliflozin|mesh-list
14307346|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14307347|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307348|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14307349|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307350|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14307351|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
14307352|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
14307353|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307354|NCT00650858|Plasminogen|plasminogen|mesh-list
14307355|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14307356|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14307357|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14307358|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307359|NCT00651040|Prednisone|prednisone|mesh-list
14307360|NCT00651040|Prednisolone|prednisolone|mesh-list
14307361|NCT00651040|Methotrexate|methotrexate|mesh-list
14307362|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307363|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
14307364|NCT00651040|Hormones|hormones|mesh-ancestor
14307365|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14307366|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307367|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14307368|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307369|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14307370|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
14307371|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14307372|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307373|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
14307374|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307375|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
14307376|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307377|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14307378|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307379|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
14307380|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307381|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14307382|NCT00651118|Fluticasone|fluticasone|mesh-list
14307383|NCT00651118|Xhance|xhance|mesh-list
14307384|NCT00651118|Azelastine|azelastine|mesh-list
14307385|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307386|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14307387|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
14307388|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307389|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307390|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14307391|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
14307392|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
14307393|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14307394|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14307395|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307396|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307397|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14307398|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14307399|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
14307400|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
14307401|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722711|NCT00491426|Amebicides|amebicides|mesh-ancestor
14722712|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
14722713|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
14722714|NCT00491478|Sertraline|sertraline|mesh-list
14307402|NCT00651183|Pramipexole|pramipexole|mesh-list
14307403|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
14307404|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307405|NCT00651183|Protective Agents|protective agents|mesh-ancestor
14307406|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307407|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14307408|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14307409|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
14307410|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
14307411|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307412|NCT00651261|Cytarabine|cytarabine|mesh-list
14307413|NCT00651261|Dexamethasone|dexamethasone|mesh-list
14307414|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
14307415|NCT00651261|Daunorubicin|daunorubicin|mesh-list
14307416|NCT00651261|Midostaurin|midostaurin|mesh-list
14307417|NCT00651261|BB 1101|bb 1101|mesh-list
14307418|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307419|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
14307420|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
14307421|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307422|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307423|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14307424|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
14307425|NCT00651261|Hormones|hormones|mesh-ancestor
14307426|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14307427|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14307428|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307429|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307430|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
14307431|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307432|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
14307433|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909774|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307434|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307435|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
14307436|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14722715|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
14307437|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14307438|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14307439|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307440|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14307441|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
14307442|NCT00651313|Lidocaine|lidocaine|mesh-list
14307443|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
14307444|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
14307445|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307446|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307447|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
14307448|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307449|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14307450|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14307451|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14307452|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307453|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307454|NCT00651482|Bevacizumab|bevacizumab|mesh-list
14307455|NCT00651482|Everolimus|everolimus|mesh-list
14307456|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14307457|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307458|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14307459|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14307460|NCT00651482|Growth Substances|growth substances|mesh-ancestor
14307461|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307462|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
14307463|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307464|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
14307465|NCT00651755|Prednisone|prednisone|mesh-list
14307466|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
14307467|NCT00651755|Rituximab|rituximab|mesh-list
14307468|NCT00651755|Doxorubicin|doxorubicin|mesh-list
14307469|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14307470|NCT00651755|Vincristine|vincristine|mesh-list
14307471|NCT00651755|Ondansetron|ondansetron|mesh-list
14722716|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722717|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14722718|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14722719|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722720|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722721|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722722|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
14722723|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722724|NCT00491517|Sirolimus|sirolimus|mesh-list
14722725|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14722726|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722727|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14722728|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307472|NCT00651755|Aprepitant|aprepitant|mesh-list
14307473|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307474|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
14307475|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307476|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307477|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14307478|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
14307479|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307480|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307481|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14307482|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14307483|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14307484|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14307485|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14307486|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307487|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307488|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
14307489|NCT00651755|Hormones|hormones|mesh-ancestor
14307490|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14307491|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14307492|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14307493|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
14307494|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
14307495|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
14307496|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
14307497|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
14307498|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307499|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14307500|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
14307501|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14307502|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14307503|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
14307504|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307505|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14307506|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14307507|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307508|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14307509|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14307510|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14307511|NCT00651937|Melphalan|melphalan|mesh-list
14307512|NCT00651937|Sargramostim|sargramostim|mesh-list
14307513|NCT00651937|Lenograstim|lenograstim|mesh-list
14307514|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14307515|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
14307516|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307517|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307518|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14307519|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307520|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
14307521|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307522|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14307523|NCT00652028|Fentanyl|fentanyl|mesh-list
14307524|NCT00652028|Midazolam|midazolam|mesh-list
14307525|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
14307526|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14307527|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307528|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307529|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307530|NCT00652028|Analgesics|analgesics|mesh-ancestor
14307531|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
14307532|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307533|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14307534|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14307535|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14307536|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
14307537|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307538|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307539|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14307540|NCT00652028|Narcotics|narcotics|mesh-ancestor
14307541|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14307542|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14307543|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
14307544|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
14307545|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14307546|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14307547|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14307548|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
14307549|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
14307550|NCT00652093|Acetaminophen|acetaminophen|mesh-list
14307551|NCT00652093|Oxymorphone|oxymorphone|mesh-list
14307552|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
14307553|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
14307554|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
14307555|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307556|NCT00652093|Analgesics|analgesics|mesh-ancestor
14307557|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
14307558|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307559|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307560|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
14307561|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14307562|NCT00652093|Narcotics|narcotics|mesh-ancestor
14307563|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307564|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14307565|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
14307566|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
14307567|NCT00652145|Mesalamine|mesalamine|mesh-list
14307568|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14307569|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307570|NCT00652145|Analgesics|analgesics|mesh-ancestor
14307571|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
14307572|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307573|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307574|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307575|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307576|NCT00652314|Thrombin|thrombin|mesh-list
14307577|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
14307578|NCT00652314|Coagulants|coagulants|mesh-ancestor
14307579|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14307580|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307581|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14307582|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307583|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307584|NCT00652366|Gemcitabine|gemcitabine|mesh-list
14307585|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14307586|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307587|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
14307588|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307589|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307590|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
14307591|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307592|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307593|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307594|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
14307595|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307596|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14307597|NCT00652626|Azacitidine|azacitidine|mesh-list
14307598|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307599|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
14307600|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307601|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307602|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307603|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
14307604|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14307605|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307606|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14307607|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
14307608|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14307609|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307610|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307611|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307612|NCT00652899|Vidarabine|vidarabine|mesh-list
14307613|NCT00652899|Aldesleukin|aldesleukin|mesh-list
14307614|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
14307615|NCT00652899|Fludarabine|fludarabine|mesh-list
14307616|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
14307617|NCT00652899|Interleukin-2|interleukin-2|mesh-list
14307618|NCT00652899|Allopurinol|allopurinol|mesh-list
14307619|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307620|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
14307621|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307622|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307623|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14307624|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
14307625|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307626|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307627|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14307628|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307629|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
14307630|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
14307631|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307632|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307633|NCT00652899|Analgesics|analgesics|mesh-ancestor
14307634|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
14307635|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307636|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14307637|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14307638|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307639|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
14307640|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14307641|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
14307642|NCT00652899|Protective Agents|protective agents|mesh-ancestor
14307643|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14307644|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
14307645|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307646|NCT00653159|Copper|copper|mesh-list
14307647|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
14307648|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14307649|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
14307650|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14307651|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307652|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14307653|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14307654|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14307655|NCT00653159|Trace Elements|trace elements|mesh-ancestor
14307656|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
14307657|NCT00653224|Levocetirizine|levocetirizine|mesh-list
14307658|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14307659|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15221063|NCT03421041|Dexamethasone|dexamethasone|mesh-list
15221064|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221065|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
15221066|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
15221067|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221068|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221069|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15221070|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
15221071|NCT03421041|Hormones|hormones|mesh-ancestor
15221072|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221073|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15221074|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307660|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
14307661|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
15221075|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14307662|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221076|NCT03377790|Cantharidin|cantharidin|mesh-list
14307663|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307664|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307665|NCT00653328|Doxorubicin|doxorubicin|mesh-list
14307666|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14307667|NCT00653328|Atrasentan|atrasentan|mesh-list
14307668|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14307669|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307670|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14307671|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14307672|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307673|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307674|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14307675|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14307676|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
14307677|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14307678|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
14307679|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307680|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
14307681|NCT00653432|Protective Agents|protective agents|mesh-ancestor
14307682|NCT00653861|Lidocaine|lidocaine|mesh-list
14307683|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
14307684|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
14307685|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307686|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307687|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
14307688|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307689|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14307690|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14307691|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14307692|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307693|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307694|NCT00653939|Paclitaxel|paclitaxel|mesh-list
14307695|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
14307696|NCT00653939|Combretastatin|combretastatin|mesh-list
14307697|NCT00653939|Bevacizumab|bevacizumab|mesh-list
14307698|NCT00653939|Carboplatin|carboplatin|mesh-list
14307699|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14307700|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307701|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14307702|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14307703|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14307704|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307705|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14307706|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14307707|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14307708|NCT00653939|Growth Substances|growth substances|mesh-ancestor
14307709|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307710|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14307711|NCT00654030|Vaccines|vaccines|mesh-list
14307712|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
14307713|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307714|NCT00654069|Niacin|niacin|mesh-list
14307715|NCT00654069|Niacinamide|niacinamide|mesh-list
14307716|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
14722729|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
14722730|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722731|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
14722732|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722733|NCT00491582|Hormones|hormones|mesh-list
14722734|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722735|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722736|NCT00491634|Treosulfan|treosulfan|mesh-list
14722737|NCT00491634|Busulfan|busulfan|mesh-list
14722738|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14722739|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
14722740|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722741|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722742|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14722743|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
14307717|NCT00654069|Oxycodone|oxycodone|mesh-list
14307718|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14722744|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722745|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14722746|NCT00491712|Triamcinolone|triamcinolone|mesh-list
14722747|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722748|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
14722749|NCT00491712|Hormones|hormones|mesh-ancestor
14722750|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14307719|NCT00654069|Narcotics|narcotics|mesh-ancestor
14307720|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307721|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307722|NCT00654069|Analgesics|analgesics|mesh-ancestor
14307723|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
14307724|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307725|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14307726|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
14307727|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307728|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14307729|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
14307730|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
14307731|NCT00654069|Vitamins|vitamins|mesh-ancestor
14307732|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
14307733|NCT00654147|Ritonavir|ritonavir|mesh-list
14307734|NCT00654147|Lopinavir|lopinavir|mesh-list
14307735|NCT00654147|Tenofovir|tenofovir|mesh-list
14307736|NCT00654147|Emtricitabine|emtricitabine|mesh-list
14307737|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
14307738|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14307739|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14307740|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14307741|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307742|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307743|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14307744|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14307745|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
14307746|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14307747|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14307748|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14307749|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14307750|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14307751|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14307752|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14307753|NCT00654186|Lenalidomide|lenalidomide|mesh-list
14307754|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
14307755|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307756|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14307757|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14307758|NCT00654186|Growth Substances|growth substances|mesh-ancestor
14307759|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14307760|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307761|NCT00654238|Sorafenib|sorafenib|mesh-list
14307762|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307763|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221077|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221078|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221079|NCT03376477|Lenalidomide|lenalidomide|mesh-list
15221080|NCT03376477|Molgramostim|molgramostim|mesh-list
15221081|NCT03376477|Vaccines|vaccines|mesh-list
15221082|NCT03376477|Sargramostim|sargramostim|mesh-list
15221083|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15221084|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
15221085|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221086|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14307764|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221087|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14307765|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307766|NCT00654329|Fentanyl|fentanyl|mesh-list
14307767|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
14307768|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14307769|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307770|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307771|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307772|NCT00654329|Analgesics|analgesics|mesh-ancestor
14307773|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
14307774|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307775|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14307776|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14307777|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14307778|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
14307779|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307780|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307781|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14307782|NCT00654329|Narcotics|narcotics|mesh-ancestor
14307783|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14307784|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14307785|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
14307786|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
14307787|NCT00654355|Tacrolimus|tacrolimus|mesh-list
14307788|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307789|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
14307790|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307791|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14307792|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307793|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307794|NCT00654368|Etanercept|etanercept|mesh-list
14307795|NCT00654368|Methotrexate|methotrexate|mesh-list
14307796|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14307797|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
14307798|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14307799|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307800|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14307801|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
14307802|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307803|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722751|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722752|NCT00491725|Metformin|metformin|mesh-list
14722753|NCT00491725|Repaglinide|repaglinide|mesh-list
14722754|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14722755|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307804|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14307805|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307806|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14307807|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14307808|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
14307809|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307810|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14307811|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14307812|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307813|NCT00654368|Analgesics|analgesics|mesh-ancestor
14307814|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
14307815|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307816|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14307817|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14307818|NCT00654381|Inositol|inositol|mesh-list
14307819|NCT00654381|Linagliptin|linagliptin|mesh-list
14307820|NCT00654381|Voglibose|voglibose|mesh-list
14307821|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14307822|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307823|NCT00654381|Incretins|incretins|mesh-ancestor
14307824|NCT00654381|Hormones|hormones|mesh-ancestor
14307825|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14307826|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14722756|NCT00491790|Montelukast|montelukast|mesh-list
14722757|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14307827|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
14307828|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307829|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307830|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14307831|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
14307832|NCT00654381|Vitamins|vitamins|mesh-ancestor
14307833|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
14307834|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14307835|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307836|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14307837|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307838|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307839|NCT00654498|Pramipexole|pramipexole|mesh-list
14307840|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
14307841|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307842|NCT00654498|Protective Agents|protective agents|mesh-ancestor
14307843|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307844|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14307845|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14307846|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
14307847|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
14307848|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327858|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327859|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327860|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14327861|NCT00805493|Protective Agents|protective agents|mesh-ancestor
14327862|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14327863|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14327864|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327865|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
14327866|NCT00805675|Tenofovir|tenofovir|mesh-list
14327867|NCT00805675|Telbivudine|telbivudine|mesh-list
14327868|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
14327869|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327870|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14327871|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14327872|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327873|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327874|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14327875|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14327876|NCT00805740|Caspofungin|caspofungin|mesh-list
14327877|NCT00805740|Anidulafungin|anidulafungin|mesh-list
14327878|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
14327879|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327880|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327881|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327882|NCT00805766|Infliximab|infliximab|mesh-list
14327883|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
14327884|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327885|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327886|NCT00805792|Donepezil|donepezil|mesh-list
14327887|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14327888|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327889|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327890|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
14327891|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327892|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327893|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
14327894|NCT00805935|Leuprolide|leuprolide|mesh-list
14327895|NCT00805935|Menotropins|menotropins|mesh-list
14722758|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14327896|NCT00805935|Progesterone|progesterone|mesh-list
14307849|NCT00654511|Fentanyl|fentanyl|mesh-list
14307850|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
14307851|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14307852|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307853|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307854|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14307855|NCT00654511|Analgesics|analgesics|mesh-ancestor
14307856|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
14307857|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307858|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14307859|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14307860|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14307861|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
14307862|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307863|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307864|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14307865|NCT00654511|Narcotics|narcotics|mesh-ancestor
14307866|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14307867|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14307868|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
14307869|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
14307870|NCT00654732|Rituximab|rituximab|mesh-list
14307871|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14307872|NCT00654732|Doxorubicin|doxorubicin|mesh-list
14307873|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14307874|NCT00654732|Dacarbazine|dacarbazine|mesh-list
15221088|NCT03376477|Growth Substances|growth substances|mesh-ancestor
15221089|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
15221090|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221091|NCT03367871|Paclitaxel|paclitaxel|mesh-list
15221092|NCT03367871|Bevacizumab|bevacizumab|mesh-list
15221093|NCT03367871|Carboplatin|carboplatin|mesh-list
15221094|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
15221095|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15221096|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221097|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
15221098|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
15221099|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
15221100|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221101|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221102|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15221103|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15221104|NCT03367871|Growth Substances|growth substances|mesh-ancestor
15221105|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307875|NCT00654732|Bleomycin|bleomycin|mesh-list
14307876|NCT00654732|Vinblastine|vinblastine|mesh-list
14307877|NCT00654732|Antibodies|antibodies|mesh-list
14307878|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
15221106|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
15221107|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15221108|NCT03365882|Trastuzumab|trastuzumab|mesh-list
14307879|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14307880|NCT00654732|Imidazole|imidazole|mesh-list
14307881|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
14307882|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307883|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307884|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14307885|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14307886|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14307887|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14307888|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307889|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307890|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14307891|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
14307892|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14307893|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
14307894|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
14307895|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
14307896|NCT00654745|Amlodipine|amlodipine|mesh-list
14307897|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14307898|NCT00654745|Olmesartan|olmesartan|mesh-list
15221109|NCT03365882|Cetuximab|cetuximab|mesh-list
15221110|NCT03365882|Pertuzumab|pertuzumab|mesh-list
15221111|NCT03365882|Irinotecan|irinotecan|mesh-list
14307899|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14307900|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14307901|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14307902|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307903|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307904|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14307905|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307906|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
14307907|NCT00654745|Diuretics|diuretics|mesh-ancestor
14307908|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
14307909|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14307910|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14307911|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14307912|NCT00654784|Idebenone|idebenone|mesh-list
14307913|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
14307914|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307915|NCT00654784|Protective Agents|protective agents|mesh-ancestor
14307916|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307917|NCT00654836|Bevacizumab|bevacizumab|mesh-list
14307918|NCT00654836|Carboplatin|carboplatin|mesh-list
14307919|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14307920|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14307921|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307922|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14307923|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14307924|NCT00654836|Growth Substances|growth substances|mesh-ancestor
14307925|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307926|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
14307927|NCT00654901|Vaccines|vaccines|mesh-list
14307928|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
14307929|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307930|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
14307931|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14307932|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307933|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307934|NCT00654940|Pregabalin|pregabalin|mesh-list
14307935|NCT00654940|Analgesics|analgesics|mesh-ancestor
14307936|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
14307937|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307938|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307939|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
14307940|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14307941|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307942|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307943|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14307944|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14307945|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14307946|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307947|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14307948|NCT00654953|Gabapentin|gabapentin|mesh-list
14307949|NCT00654953|Sertraline|sertraline|mesh-list
14307950|NCT00654953|Analgesics|analgesics|mesh-ancestor
14307951|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
14307952|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307953|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307954|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
14307955|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14307956|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14307957|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14307958|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14307959|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14307960|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14307961|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14307962|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307963|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
14307964|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
14307965|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14307966|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14307967|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307968|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
14307969|NCT00655083|MEN 11420|men 11420|mesh-list
14307970|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14307971|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
14307972|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14307973|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14307974|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14307975|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
14307976|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
14307977|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14307978|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14307979|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
14307980|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307981|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14307982|NCT00655486|Lacosamide|lacosamide|mesh-list
14307983|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
14307984|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14307985|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14307986|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14307987|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307988|NCT00655499|Irinotecan|irinotecan|mesh-list
14307989|NCT00655499|Panitumumab|panitumumab|mesh-list
14307990|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14307991|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14307992|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14307993|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14307994|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14307995|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14307996|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
14307997|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14307998|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14307999|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
14308000|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308001|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14308002|NCT00655551|Lacosamide|lacosamide|mesh-list
14308003|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
14308004|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14308005|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14308006|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14308007|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308008|NCT00655564|Alefacept|alefacept|mesh-list
14308009|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308010|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
14308011|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308012|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14308013|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14308014|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14308015|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14308016|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308017|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308018|NCT00655629|Urological Agents|urological agents|mesh-ancestor
14308019|NCT00655642|Promethazine|promethazine|mesh-list
14308020|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
14308021|NCT00655642|Ondansetron|ondansetron|mesh-list
14308022|NCT00655642|Metoclopramide|metoclopramide|mesh-list
14308023|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
14308024|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
14722759|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14722760|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
14722761|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308025|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729179|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308026|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308027|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308028|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
14308029|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308030|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14308031|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
14308032|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308033|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308034|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14308035|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14308036|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722762|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722763|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14722764|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14722765|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722766|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
14722767|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
14722768|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14308037|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14308038|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14308039|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14308040|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14308041|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
14308042|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14308043|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
14308044|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
14308045|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14308046|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14308047|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14308048|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
14308049|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
14308050|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
14308051|NCT00655668|Lenalidomide|lenalidomide|mesh-list
14308052|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
14308053|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308054|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14308055|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14308056|NCT00655668|Growth Substances|growth substances|mesh-ancestor
14308057|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
14308058|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308059|NCT00655746|Dasatinib|dasatinib|mesh-list
14308060|NCT00655746|Omeprazole|omeprazole|mesh-list
14308061|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14308062|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308063|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14308064|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308065|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308066|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308067|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14308068|NCT00655811|Capsaicin|capsaicin|mesh-list
14308069|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
14308070|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308071|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
14308072|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308073|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308074|NCT00655850|Gemcitabine|gemcitabine|mesh-list
14308075|NCT00655850|Paclitaxel|paclitaxel|mesh-list
14308076|NCT00655850|Bevacizumab|bevacizumab|mesh-list
14308077|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14722769|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14722770|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722771|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722772|NCT00491803|Urological Agents|urological agents|mesh-ancestor
14722773|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14722774|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722775|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14722776|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722777|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722778|NCT00491855|Paclitaxel|paclitaxel|mesh-list
14722779|NCT00491855|Bevacizumab|bevacizumab|mesh-list
14722780|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
14308078|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308079|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308080|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308081|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308082|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308083|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14308084|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
14308085|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
14308086|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308087|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308088|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308089|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
14308090|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308091|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308092|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14308093|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14308094|NCT00655850|Growth Substances|growth substances|mesh-ancestor
14308095|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
14308096|NCT00655863|Pioglitazone|pioglitazone|mesh-list
14308097|NCT00655863|Alogliptin|alogliptin|mesh-list
14308098|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308099|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308100|NCT00655863|Incretins|incretins|mesh-ancestor
14308101|NCT00655863|Hormones|hormones|mesh-ancestor
14308102|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308103|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14308104|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
14308105|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308106|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308107|NCT00655876|Paclitaxel|paclitaxel|mesh-list
14308108|NCT00655876|Cetuximab|cetuximab|mesh-list
14308109|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14308110|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308111|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308112|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308113|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308114|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308115|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308116|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
14308117|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14308118|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
14308119|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308120|NCT00655928|Expectorants|expectorants|mesh-ancestor
14308121|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
14308122|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14308123|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
14308124|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308125|NCT00655928|Protective Agents|protective agents|mesh-ancestor
14308126|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308127|NCT00655928|Antidotes|antidotes|mesh-ancestor
14308128|NCT00655980|Folic Acid|folic acid|mesh-list
14308129|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
14308130|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
14308131|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
14308132|NCT00655980|Vitamins|vitamins|mesh-ancestor
14722781|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14722782|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722783|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
14722784|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
14722785|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
14722786|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722787|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14722788|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14722789|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14722790|NCT00491855|Growth Substances|growth substances|mesh-ancestor
14308133|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
14308134|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308135|NCT00655980|Hematinics|hematinics|mesh-ancestor
14308136|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
14308137|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14308138|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
14308139|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
14308140|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308141|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14308142|NCT00655980|Analgesics|analgesics|mesh-ancestor
14308143|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
14308144|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308145|NCT00656019|Vitamin D|vitamin d|mesh-list
14308146|NCT00656019|Calcipotriene|calcipotriene|mesh-list
14308147|NCT00656019|Vitamins|vitamins|mesh-ancestor
14308148|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
14308149|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308150|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14308151|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308152|NCT00656058|Montelukast|montelukast|mesh-list
14308153|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14308154|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
14308155|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14308156|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
14308157|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308158|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308159|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14308160|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14308161|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308162|NCT00656084|Gemcitabine|gemcitabine|mesh-list
14308163|NCT00656084|Rituximab|rituximab|mesh-list
14308164|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
14308165|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308166|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308167|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
14308168|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308169|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14308170|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14308171|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
14308172|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308173|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
14308174|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308175|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308176|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308177|NCT00656084|Analgesics|analgesics|mesh-ancestor
14308178|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
14308179|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308180|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14308181|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14308182|NCT00656136|Afatinib|afatinib|mesh-list
14308183|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308184|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14308185|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308186|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308187|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
14308188|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14308189|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14308190|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
14308191|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308192|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14308193|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14308194|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308195|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308196|NCT00656201|Progesterone|progesterone|mesh-list
14308197|NCT00656201|Progestins|progestins|mesh-ancestor
14308198|NCT00656201|Hormones|hormones|mesh-ancestor
14308199|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308200|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308201|NCT00656292|Simvastatin|simvastatin|mesh-list
14308202|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14308203|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14308204|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
14308205|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308206|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14308207|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14308208|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308209|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
14308210|NCT00656448|Hematinics|hematinics|mesh-ancestor
14308211|NCT00656487|Rimonabant|rimonabant|mesh-list
14308212|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14308213|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14308214|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14308215|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308216|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308217|NCT00656487|Hormones|hormones|mesh-ancestor
14308218|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308219|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308220|NCT00656513|Pilocarpine|pilocarpine|mesh-list
14308221|NCT00656513|Miotics|miotics|mesh-ancestor
14308222|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
14308223|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308224|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308225|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14308226|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14308227|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
14308228|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308229|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308230|NCT00656617|Cytarabine|cytarabine|mesh-list
14308231|NCT00656617|Vorinostat|vorinostat|mesh-list
14308232|NCT00656617|Idarubicin|idarubicin|mesh-list
14308233|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14308234|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
14308235|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308236|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308237|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
14308238|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308239|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308240|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
14308241|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308242|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14308243|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308244|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14308245|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14308246|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14308247|NCT00656630|Naltrexone|naltrexone|mesh-list
14308248|NCT00656630|Acamprosate|acamprosate|mesh-list
14308249|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14308250|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14308251|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308252|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
14308253|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308254|NCT00656656|Dexamethasone|dexamethasone|mesh-list
14308255|NCT00656656|Rituximab|rituximab|mesh-list
14308256|NCT00656656|Azathioprine|azathioprine|mesh-list
14308257|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14308258|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
14308259|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
14308260|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308261|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308262|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308263|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
14308264|NCT00656656|Hormones|hormones|mesh-ancestor
14308265|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308266|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14308267|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308268|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308269|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
14308270|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14308271|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
14308272|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308273|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14308274|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308275|NCT00656669|Paclitaxel|paclitaxel|mesh-list
14308276|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
14308277|NCT00656669|Doxorubicin|doxorubicin|mesh-list
14308278|NCT00656669|Sunitinib|sunitinib|mesh-list
14308279|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14308280|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308281|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308282|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308283|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308284|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308285|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308286|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
14308287|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308288|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14308289|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14308290|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
14308291|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14308292|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14308293|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14308294|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14308295|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308296|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14308297|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14308298|NCT00656669|Growth Substances|growth substances|mesh-ancestor
14308299|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
14308300|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14308301|NCT00656799|Bromides|bromides|mesh-list
14308302|NCT00656799|Rocuronium|rocuronium|mesh-list
14308303|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
14308304|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14308305|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14308306|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14308307|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308308|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308309|NCT00656851|Pioglitazone|pioglitazone|mesh-list
14308310|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308311|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308312|NCT00656968|Esomeprazole|esomeprazole|mesh-list
14308313|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14308314|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308315|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14308316|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308317|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308318|NCT00657020|Nicotine|nicotine|mesh-list
14308319|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14308320|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
14308321|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308322|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308323|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14308324|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14308325|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
14308326|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308327|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308328|NCT00657046|Droxidopa|droxidopa|mesh-list
14308329|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14308330|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14308331|NCT00657150|Enoxaparin|enoxaparin|mesh-list
14308332|NCT00657150|Dabigatran|dabigatran|mesh-list
14909775|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
15221112|NCT03365882|Camptothecin|camptothecin|mesh-list
15221113|NCT03365882|Antibodies|antibodies|mesh-list
15221114|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
15221115|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15221116|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
15221117|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221118|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221119|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15221120|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221121|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221122|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221123|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14308333|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
14308334|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15221124|NCT03365609|Bismuth|bismuth|mesh-list
14308335|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14308336|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308337|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
14308338|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14308339|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
14308340|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308341|NCT00657267|Temozolomide|temozolomide|mesh-list
14308342|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14308343|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
14308344|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308345|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308346|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14308347|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308348|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308349|NCT00657280|Incretins|incretins|mesh-ancestor
14308350|NCT00657280|Hormones|hormones|mesh-ancestor
14308351|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308352|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14308353|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
14308354|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308355|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308356|NCT00657358|Lidocaine|lidocaine|mesh-list
14308357|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
14308358|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
14308359|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308360|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308361|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
14308362|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308363|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14308364|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14308365|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14308366|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14308367|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308368|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14308369|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14308370|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14308371|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308372|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
14308373|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14308374|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
14308375|NCT00657709|Vaccines|vaccines|mesh-list
14308376|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14308377|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
14308378|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308379|NCT00657917|Gentamicins|gentamicins|mesh-list
14308380|NCT00657917|Paromomycin|paromomycin|mesh-list
14308381|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14308382|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308383|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14308384|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308385|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308386|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14308387|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14308388|NCT00658021|Exenatide|exenatide|mesh-list
14308389|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308390|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308391|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14308392|NCT00658021|Incretins|incretins|mesh-ancestor
14308393|NCT00658021|Hormones|hormones|mesh-ancestor
14308394|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308395|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14308396|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308397|NCT00658320|Cyclosporine|cyclosporine|mesh-list
14308398|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
14308399|NCT00658320|Everolimus|everolimus|mesh-list
14308400|NCT00658320|Cyclosporins|cyclosporins|mesh-list
14308401|NCT00658320|Basiliximab|basiliximab|mesh-list
14308402|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308403|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308404|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308405|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
14308406|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308407|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
14308408|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308409|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308410|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14308411|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14308412|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308413|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14308414|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14308415|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
14308416|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14308417|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
14308418|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14308419|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308420|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14308421|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
14308422|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14308423|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308424|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308425|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308426|NCT00658359|Cyclosporine|cyclosporine|mesh-list
14308427|NCT00658359|Cyclosporins|cyclosporins|mesh-list
14308428|NCT00658359|Tofacitinib|tofacitinib|mesh-list
14308429|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308430|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308431|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308432|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
14308433|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308434|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
14308435|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308436|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14722791|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722792|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
14722793|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
14909776|NCT01353170|Calcium|calcium|mesh-list
14308437|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14308438|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14308439|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14308440|NCT00658411|Deferoxamine|deferoxamine|mesh-list
14308441|NCT00658411|Siderophores|siderophores|mesh-ancestor
14308442|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14308443|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
14308444|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
14308445|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308446|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
14308447|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14308448|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14308449|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
14308450|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308451|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14308452|NCT00658528|Esomeprazole|esomeprazole|mesh-list
14308453|NCT00658528|Rabeprazole|rabeprazole|mesh-list
14308454|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14308455|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308456|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14308457|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327897|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14722794|NCT00491868|Hematinics|hematinics|mesh-ancestor
15221125|NCT03365609|Antacids|antacids|mesh-ancestor
15221126|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221127|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15221128|NCT03353675|Nivolumab|nivolumab|mesh-list
15221129|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221130|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221131|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221132|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221133|NCT03341156|Thrombin|thrombin|mesh-list
15221134|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
15221135|NCT03341156|Coagulants|coagulants|mesh-ancestor
15221136|NCT03341078|Ibudilast|ibudilast|mesh-list
15221137|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15221138|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
15225570|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
14308458|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308459|NCT00658541|Zolpidem|zolpidem|mesh-list
14308460|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14308461|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14308462|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308463|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308464|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14308465|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
14308466|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
14308467|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308468|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308469|NCT00658567|Pimavanserin|pimavanserin|mesh-list
14308470|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14308471|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14308472|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14308473|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14308474|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308475|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308476|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14308477|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14308478|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14308479|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
14308480|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308481|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308482|NCT00658606|Alefacept|alefacept|mesh-list
14308483|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308484|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
14308485|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308486|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14308487|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14308488|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14308489|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14308490|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14308491|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
14308492|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308493|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308494|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308495|NCT00658632|Esomeprazole|esomeprazole|mesh-list
14308496|NCT00658632|Rabeprazole|rabeprazole|mesh-list
14308497|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14308498|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308499|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14308500|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308501|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308502|NCT00658658|Panitumumab|panitumumab|mesh-list
14308503|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308504|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308505|NCT00658684|Fesoterodine|fesoterodine|mesh-list
14308506|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14308507|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14308508|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
14308509|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308510|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308511|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308512|NCT00658684|Urological Agents|urological agents|mesh-ancestor
14308513|NCT00658697|Bevacizumab|bevacizumab|mesh-list
14308514|NCT00658697|Docetaxel|docetaxel|mesh-list
14308515|NCT00658697|Bicalutamide|bicalutamide|mesh-list
14308516|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308517|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308518|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14308519|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14308520|NCT00658697|Growth Substances|growth substances|mesh-ancestor
14308521|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308522|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
14308523|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308524|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308525|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308526|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308527|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
14308528|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
14308529|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308530|NCT00658736|Triamcinolone|triamcinolone|mesh-list
14308531|NCT00658736|Bupivacaine|bupivacaine|mesh-list
15221139|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221140|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308532|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
14308533|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
14308534|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308535|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308536|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
14308537|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308538|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14308539|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
14308540|NCT00658736|Hormones|hormones|mesh-ancestor
14308541|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308542|NCT00658775|Esomeprazole|esomeprazole|mesh-list
14308543|NCT00658775|Rabeprazole|rabeprazole|mesh-list
14308544|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14308545|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308546|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14308547|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308548|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308549|NCT00658788|Calcitriol|calcitriol|mesh-list
14308550|NCT00658788|Clobetasol|clobetasol|mesh-list
14308551|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14308552|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308553|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14308554|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14308555|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308556|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14308557|NCT00658788|Vitamins|vitamins|mesh-ancestor
14308558|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
14308559|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14308560|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14308561|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
14308562|NCT00658788|Hormones|hormones|mesh-ancestor
14308563|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308564|NCT00659165|Insulin|insulin|mesh-list
14308565|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14308566|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
14308567|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
14308568|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308569|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308570|NCT00659230|Dopamine|dopamine|mesh-list
14308571|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14308572|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
14308573|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
14308574|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308575|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221141|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15221142|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
15221143|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15221144|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221145|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221146|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15221147|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
15221148|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
15221149|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
15221150|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
15221151|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221152|NCT03319316|Durvalumab|durvalumab|mesh-list
15221153|NCT03319316|Tremelimumab|tremelimumab|mesh-list
14308576|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
14308577|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308578|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308579|NCT00659230|Protective Agents|protective agents|mesh-ancestor
14308580|NCT00659269|Vitamins|vitamins|mesh-list
14308581|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
14308582|NCT00659269|Hydroxocobalamin|hydroxocobalamin|mesh-list
14308583|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
14308584|NCT00659269|Pyridoxal|pyridoxal|mesh-list
14308585|NCT00659269|Pyridoxine|pyridoxine|mesh-list
14308586|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
14308587|NCT00659269|Paclitaxel|paclitaxel|mesh-list
14308588|NCT00659269|Vincristine|vincristine|mesh-list
14308589|NCT00659269|Vinorelbine|vinorelbine|mesh-list
14308590|NCT00659269|Docetaxel|docetaxel|mesh-list
14308591|NCT00659269|Cisplatin|cisplatin|mesh-list
14308592|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
14308593|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14308594|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308595|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308596|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308597|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308598|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308599|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
14308600|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308601|NCT00659269|Hematinics|hematinics|mesh-ancestor
14308602|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
14308603|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308604|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308605|NCT00659360|Saracatinib|saracatinib|mesh-list
14308606|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308607|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308608|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308609|NCT00659373|Tamoxifen|tamoxifen|mesh-list
14308610|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14308611|NCT00659373|Exemestane|exemestane|mesh-list
14308612|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14308613|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
14308614|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308615|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308616|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14308617|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308618|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14308619|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14308620|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14308621|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14308622|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14308623|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308624|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308625|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
14308626|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14308627|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
14308628|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14308629|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14308630|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
14308631|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308632|NCT00659438|Bicalutamide|bicalutamide|mesh-list
14308633|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
14308634|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
14308635|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308636|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308637|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327898|NCT00805935|Progestins|progestins|mesh-ancestor
14327899|NCT00805935|Hormones|hormones|mesh-ancestor
14327900|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327901|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327902|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14327903|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
14327904|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14327905|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14327906|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327907|NCT00806026|Pregabalin|pregabalin|mesh-list
14327908|NCT00806026|Pramipexole|pramipexole|mesh-list
14327909|NCT00806026|Analgesics|analgesics|mesh-ancestor
14327910|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
14327911|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327912|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327913|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
14327914|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14308638|NCT00659490|Naproxen|naproxen|mesh-list
14308639|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14308640|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14308641|NCT00659490|Analgesics|analgesics|mesh-ancestor
14308642|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
14308643|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308644|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308645|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14308646|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14308647|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
14308648|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14308649|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308650|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308651|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
14308652|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
14308653|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14308654|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14308655|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308656|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308657|NCT00659529|Urological Agents|urological agents|mesh-ancestor
14308658|NCT00659581|Telmisartan|telmisartan|mesh-list
14308659|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14308660|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14308661|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14308662|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308663|NCT00659633|Lidocaine|lidocaine|mesh-list
14308664|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
14308665|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
14308666|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308667|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308668|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
14308669|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308670|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14308671|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14308672|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14308673|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15221154|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221155|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221156|NCT03317496|Gemcitabine|gemcitabine|mesh-list
15221157|NCT03317496|Cisplatin|cisplatin|mesh-list
15221158|NCT03317496|Carboplatin|carboplatin|mesh-list
15221159|NCT03317496|Pemetrexed|pemetrexed|mesh-list
15221160|NCT03317496|Avelumab|avelumab|mesh-list
15221161|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15221162|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221163|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14308674|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308675|NCT00659737|Scopolamine|scopolamine|mesh-list
14308676|NCT00659737|Aprepitant|aprepitant|mesh-list
14308677|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
14308678|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14308679|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
14308680|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
14308681|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308682|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308683|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308684|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14308685|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308686|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308687|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14308688|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
14308689|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14308690|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
14308691|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14308692|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
14308693|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14308694|NCT00659945|Ondansetron|ondansetron|mesh-list
14308695|NCT00659945|Aprepitant|aprepitant|mesh-list
14308696|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
14722795|NCT00491907|Folic Acid|folic acid|mesh-list
14722796|NCT00491907|Hematinics|hematinics|mesh-ancestor
14722797|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
14722798|NCT00491907|Vitamins|vitamins|mesh-ancestor
14722799|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
14722800|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722801|NCT00491920|Vitamin D|vitamin d|mesh-list
14722802|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
14722803|NCT00491920|Vitamins|vitamins|mesh-ancestor
14722804|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
14909777|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14308697|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
14308698|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308699|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308700|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308701|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
14308702|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308703|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14308704|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
14308705|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308706|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308707|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14308708|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14308709|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308710|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14909778|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909779|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14308711|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14308712|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14308713|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14308714|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308715|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308716|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308717|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14308718|NCT00660010|Leuprolide|leuprolide|mesh-list
14308719|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14308720|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
14308721|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14308722|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308723|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14308724|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308725|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
14308726|NCT00660023|Hematinics|hematinics|mesh-ancestor
14308727|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14308728|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308729|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308730|NCT00660075|Incretins|incretins|mesh-ancestor
14308731|NCT00660075|Hormones|hormones|mesh-ancestor
14308732|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308733|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14308734|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
14722805|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722806|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14909780|NCT01353209|Letrozole|letrozole|mesh-list
14308735|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308736|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308737|NCT00660179|Macitentan|macitentan|mesh-list
14308738|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14308739|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14308740|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308741|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14308742|NCT00660309|Irbesartan|irbesartan|mesh-list
14308743|NCT00660309|Captopril|captopril|mesh-list
14308744|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14308745|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14308746|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14308747|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308748|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14308749|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
14308750|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308751|NCT00660387|Levodopa|levodopa|mesh-list
14308752|NCT00660387|Carbidopa|carbidopa|mesh-list
14308753|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14308754|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14308755|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14308756|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
14308757|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308758|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308759|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308760|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14308761|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308762|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14308763|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
14308764|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
14308765|NCT00660400|Azacitidine|azacitidine|mesh-list
14308766|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14308767|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
14308768|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308769|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308770|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308771|NCT00660504|Etoposide|etoposide|mesh-list
14308772|NCT00660504|Amrubicin|amrubicin|mesh-list
14308773|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308774|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14308775|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14308776|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14308777|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308778|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308779|NCT00660517|Fluticasone|fluticasone|mesh-list
14308780|NCT00660517|Xhance|xhance|mesh-list
14308781|NCT00660517|Azelastine|azelastine|mesh-list
14308782|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14308783|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14308784|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
14308785|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308786|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308787|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14308788|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
14308789|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308790|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14308791|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14308792|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308793|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308794|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14308795|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14308796|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
14308797|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
14308798|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308799|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14308800|NCT00660543|Hematinics|hematinics|mesh-ancestor
14308801|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14308802|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14308803|NCT00660660|Esomeprazole|esomeprazole|mesh-list
14308804|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14308805|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14308806|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14308807|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308808|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308809|NCT00660699|Gemcitabine|gemcitabine|mesh-list
14308810|NCT00660699|Docetaxel|docetaxel|mesh-list
14308811|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14308812|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
14308813|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722807|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14722808|NCT00491946|Dactinomycin|dactinomycin|mesh-list
14722809|NCT00491946|Vincristine|vincristine|mesh-list
14722810|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14722811|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722812|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
14722813|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
14722814|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308814|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308815|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
14308816|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308817|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308818|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14308819|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
14308820|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308821|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308822|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308823|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308824|NCT00660816|Docetaxel|docetaxel|mesh-list
14308825|NCT00660816|Pemetrexed|pemetrexed|mesh-list
14308826|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14308827|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308828|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308829|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308830|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308831|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308832|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308833|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14308834|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14308835|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14308836|NCT00660829|Azelastine|azelastine|mesh-list
14308837|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14308838|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
14308839|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308840|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308841|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14308842|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
14308843|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14308844|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308845|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308846|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14308847|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14308848|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14308849|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
14308850|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
14308851|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308852|NCT00660907|Metformin|metformin|mesh-list
14308853|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
14308854|NCT00660907|Glipizide|glipizide|mesh-list
14308855|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308856|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308857|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14308858|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308859|NCT00660985|Adapalene|adapalene|mesh-list
14308860|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14308861|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14308862|NCT00660985|Analgesics|analgesics|mesh-ancestor
15221164|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
14308863|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
14308864|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308865|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308866|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14308867|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14308868|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
14308869|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
14308870|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14308871|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14308872|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14308873|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14308874|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308875|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
14308876|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308877|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308878|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14308879|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308880|NCT00661141|Ethanol|ethanol|mesh-list
14308881|NCT00661141|Fomepizole|fomepizole|mesh-list
14308882|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14308883|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14308884|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308885|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308886|NCT00661141|Antidotes|antidotes|mesh-ancestor
14308887|NCT00661141|Protective Agents|protective agents|mesh-ancestor
14308888|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308889|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308890|NCT00661193|Paclitaxel|paclitaxel|mesh-list
14308891|NCT00661193|Carboplatin|carboplatin|mesh-list
14308892|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14308893|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14308894|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308895|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14308896|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14308897|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14308898|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308899|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14308900|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308901|NCT00661362|Metformin|metformin|mesh-list
14308902|NCT00661362|Saxagliptin|saxagliptin|mesh-list
14308903|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14308904|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308905|NCT00661362|Incretins|incretins|mesh-ancestor
14308906|NCT00661362|Hormones|hormones|mesh-ancestor
14308907|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308908|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14308909|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
14308910|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308911|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308912|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
14308913|NCT00661388|Hematinics|hematinics|mesh-ancestor
14308914|NCT00661427|Cetuximab|cetuximab|mesh-list
14308915|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308916|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308917|NCT00661453|Valproic Acid|valproic acid|mesh-list
14308918|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
14308919|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308920|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308921|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
14308922|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308923|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308924|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
14308925|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14722815|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722816|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15221165|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308926|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14308927|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14308928|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14308929|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14308930|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14308931|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14308932|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14308933|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
14308934|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14308935|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308936|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308937|NCT00661492|Cetuximab|cetuximab|mesh-list
15221166|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
15221167|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221168|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221169|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221170|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
14308938|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
14308939|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14308940|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308941|NCT00661492|Analgesics|analgesics|mesh-ancestor
14308942|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
14308943|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14308944|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308945|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14308946|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14308947|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308948|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308949|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
14308950|NCT00661505|Hematinics|hematinics|mesh-ancestor
14308951|NCT00661531|Anastrozole|anastrozole|mesh-list
14308952|NCT00661531|Estradiol|estradiol|mesh-list
14308953|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14308954|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308955|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14308956|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14308957|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308958|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308959|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14308960|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
14308961|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14308962|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308963|NCT00661531|Estrogens|estrogens|mesh-ancestor
14308964|NCT00661531|Hormones|hormones|mesh-ancestor
14308965|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
14308966|NCT00661544|Melphalan|melphalan|mesh-list
14308967|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
14308968|NCT00661544|Vitamins|vitamins|mesh-ancestor
14308969|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
14308970|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308971|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14308972|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
14308973|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308974|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308975|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14308976|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221171|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221172|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15221173|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15221174|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221175|NCT03315832|Valsartan|valsartan|mesh-list
15221176|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14308977|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
14308978|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
14308979|NCT00661544|Protective Agents|protective agents|mesh-ancestor
14308980|NCT00661583|Ranibizumab|ranibizumab|mesh-list
14722817|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722818|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14722819|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14722820|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722821|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14722822|NCT00491985|Vaccines|vaccines|mesh-list
14308981|NCT00661583|Mitomycins|mitomycins|mesh-list
14308982|NCT00661583|Mitomycin|mitomycin|mesh-list
14308983|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14308984|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14308985|NCT00661583|Growth Substances|growth substances|mesh-ancestor
14308986|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308987|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
14308988|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308989|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14308990|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
14308991|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14308992|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14308993|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14308994|NCT00661622|Molgramostim|molgramostim|mesh-list
14308995|NCT00661622|Sargramostim|sargramostim|mesh-list
14308996|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
14308997|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14308998|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14308999|NCT00661661|Tofacitinib|tofacitinib|mesh-list
14309000|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14309001|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309002|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309003|NCT00661674|Palonosetron|palonosetron|mesh-list
14309004|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
14309005|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
14309006|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
14309007|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309008|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309009|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309010|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14309011|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14309012|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
14309013|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309014|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309015|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
14309016|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
14722823|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
14722824|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722825|NCT00491998|Entacapone|entacapone|mesh-list
14722826|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14722827|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14309017|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14309018|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
15221177|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15221178|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15221179|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221180|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15221181|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15221182|NCT03300518|Estradiol|estradiol|mesh-list
15221183|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15221184|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15221185|NCT03300518|Ganirelix|ganirelix|mesh-list
14722828|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14722829|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722830|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309019|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
14309020|NCT00661713|Vaccines|vaccines|mesh-list
14309021|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
14309022|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309023|NCT00661726|Decitabine|decitabine|mesh-list
14309024|NCT00661726|Azacitidine|azacitidine|mesh-list
14309025|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309026|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
14309027|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309028|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309029|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309030|NCT00661778|Bevacizumab|bevacizumab|mesh-list
14309031|NCT00661778|Docetaxel|docetaxel|mesh-list
14309032|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309033|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309034|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14309035|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14309036|NCT00661778|Growth Substances|growth substances|mesh-ancestor
14309037|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309038|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
14309039|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
14309040|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
14309041|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14309042|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722831|NCT00492037|Conivaptan|conivaptan|mesh-list
14309043|NCT00661830|Gemcitabine|gemcitabine|mesh-list
14309044|NCT00661830|Sorafenib|sorafenib|mesh-list
14309045|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309046|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
14309047|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309048|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309049|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
14309050|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309051|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309052|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309053|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
14309054|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309055|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14309056|NCT00661895|Metoprolol|metoprolol|mesh-list
14309057|NCT00661895|Atenolol|atenolol|mesh-list
14309058|NCT00661895|Amlodipine|amlodipine|mesh-list
14309059|NCT00661895|Valsartan|valsartan|mesh-list
14309060|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14309061|NCT00661895|Clonidine|clonidine|mesh-list
14309062|NCT00661895|Lisinopril|lisinopril|mesh-list
14309063|NCT00661895|Doxazosin|doxazosin|mesh-list
14309064|NCT00661895|Hydralazine|hydralazine|mesh-list
14309065|NCT00661895|Nifedipine|nifedipine|mesh-list
14309066|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14309067|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14309068|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309069|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309070|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14309071|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309072|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
14309073|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14309074|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14309075|NCT00661895|Diuretics|diuretics|mesh-ancestor
14309076|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
14309077|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14309078|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14309079|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
14309080|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
14309081|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309082|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14309083|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14309084|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14309085|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
14309086|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309087|NCT00661895|Analgesics|analgesics|mesh-ancestor
14309088|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
14309089|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14309090|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14309091|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14309092|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
15221186|NCT03300518|Estrogens|estrogens|mesh-ancestor
15221187|NCT03300518|Hormones|hormones|mesh-ancestor
15221188|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221189|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221190|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15221191|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
15221192|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15221193|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15221194|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
15221195|NCT03299309|Vaccines|vaccines|mesh-list
15221196|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
15221197|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221198|NCT03294109|Bupivacaine|bupivacaine|mesh-list
15221199|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
15221200|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
15221201|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15221202|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221203|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
15221204|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221205|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
14309093|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14309094|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14309095|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
15221206|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221207|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221208|NCT03277196|Ivacaftor|ivacaftor|mesh-list
15221209|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15221210|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15221211|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221212|NCT03273413|Pravastatin|pravastatin|mesh-list
15221213|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15221214|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15221215|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
15221216|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221217|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14309096|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309097|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14309098|NCT00661895|Protective Agents|protective agents|mesh-ancestor
14309099|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14309100|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14309101|NCT00661960|Efavirenz|efavirenz|mesh-list
14309102|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
14309103|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14309104|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14309105|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309106|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309107|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
14309108|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309109|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14309110|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14309111|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14309112|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14309113|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14309114|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14309115|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14309116|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14309117|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14309118|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14309119|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
14309120|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
14309121|NCT00661999|Hematinics|hematinics|mesh-ancestor
14309122|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14309123|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14309124|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14309125|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309126|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
14309127|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14309128|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
14309129|NCT00662025|Capecitabine|capecitabine|mesh-list
14309130|NCT00662025|Sunitinib|sunitinib|mesh-list
14309131|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309132|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
14309133|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309134|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309135|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14309136|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14309137|NCT00662025|Growth Substances|growth substances|mesh-ancestor
14309138|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309139|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
14309140|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14309141|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309142|NCT00662038|Pirfenidone|pirfenidone|mesh-list
14309143|NCT00662038|Analgesics|analgesics|mesh-ancestor
14309144|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
14309145|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309146|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309147|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14309148|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14309149|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309150|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309151|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309152|NCT00662129|Gemcitabine|gemcitabine|mesh-list
14309153|NCT00662129|Paclitaxel|paclitaxel|mesh-list
14309154|NCT00662129|Bevacizumab|bevacizumab|mesh-list
14309155|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14309156|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14309157|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309158|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
14309159|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
14309160|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
14309161|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722832|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14722833|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722834|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
14309162|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309163|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14309164|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14309165|NCT00662129|Growth Substances|growth substances|mesh-ancestor
14309166|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309167|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
14309168|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309169|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
14309170|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
14309171|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309172|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309173|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309174|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
14309175|NCT00662155|Zolpidem|zolpidem|mesh-list
14309176|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14309177|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14309178|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14309179|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309180|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14309181|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
14309182|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
14309183|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309184|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309185|NCT00662259|Alprazolam|alprazolam|mesh-list
14309186|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14309187|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14309188|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309189|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14309190|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14309191|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14309192|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
14309193|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
14309194|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309195|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309196|NCT00662298|Prednisolone|prednisolone|mesh-list
14309197|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309198|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
14309199|NCT00662298|Hormones|hormones|mesh-ancestor
14309200|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309201|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309202|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14309203|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309204|NCT00662311|Paclitaxel|paclitaxel|mesh-list
14309205|NCT00662311|Vorinostat|vorinostat|mesh-list
14309206|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14309207|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309208|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14309209|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14309210|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14309211|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309212|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14309213|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309214|NCT00662363|Lubiprostone|lubiprostone|mesh-list
14309215|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14309216|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309217|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309218|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14309219|NCT00662532|Minocycline|minocycline|mesh-list
14309220|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309221|NCT00662545|Tenofovir|tenofovir|mesh-list
14309222|NCT00662545|Lamivudine|lamivudine|mesh-list
14309223|NCT00662545|Emtricitabine|emtricitabine|mesh-list
14309224|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14309225|NCT00662545|Entecavir|entecavir|mesh-list
14309226|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14309227|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
14309228|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309229|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14309230|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14309231|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309232|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309233|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14309234|NCT00662558|Celecoxib|celecoxib|mesh-list
14309235|NCT00662558|Tramadol|tramadol|mesh-list
14309236|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14309237|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14309238|NCT00662558|Analgesics|analgesics|mesh-ancestor
14309239|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
14309240|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309241|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309242|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309243|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309244|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14309245|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14309246|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309247|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309248|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14309249|NCT00662558|Narcotics|narcotics|mesh-ancestor
14309250|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14309251|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14309252|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14309253|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309254|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309255|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
14309256|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309257|NCT00662675|Pancrelipase|pancrelipase|mesh-list
14309258|NCT00662675|Pancreatin|pancreatin|mesh-list
14309259|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309260|NCT00662818|Acetaminophen|acetaminophen|mesh-list
14309261|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14309262|NCT00662818|Analgesics|analgesics|mesh-ancestor
14309263|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
14309264|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309265|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309266|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
14309267|NCT00662831|Dalteparin|dalteparin|mesh-list
14309268|NCT00662831|Tinzaparin|tinzaparin|mesh-list
14309269|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14309270|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
14722835|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722836|NCT00492050|Valacyclovir|valacyclovir|mesh-list
14722837|NCT00492050|Rituximab|rituximab|mesh-list
14722838|NCT00492050|Bortezomib|bortezomib|mesh-list
14722839|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14722840|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722841|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
14722842|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722843|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309271|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14309272|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14309273|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309274|NCT00662857|Insulin|insulin|mesh-list
14722844|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
14722845|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722846|NCT00492102|Montelukast|montelukast|mesh-list
14722847|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14722848|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
14722849|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14722850|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
14722851|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722852|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722853|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14722854|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14722855|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722856|NCT00492128|Losartan|losartan|mesh-list
14722857|NCT00492128|Amlodipine|amlodipine|mesh-list
14722858|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14722859|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14722860|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14722861|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722862|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722863|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14909781|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909782|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14909783|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14909784|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909785|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909786|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14909787|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
14909788|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309275|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14309276|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309277|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309278|NCT00662909|Mirabegron|mirabegron|mesh-list
14309279|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14309280|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14309281|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14309282|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
14722864|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722865|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
14722866|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14722867|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14722868|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14722869|NCT00492128|Diuretics|diuretics|mesh-ancestor
14909789|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909790|NCT01353235|Prednisolone|prednisolone|mesh-list
14909791|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14909792|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
14309283|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309284|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909793|NCT01353235|Hormones|hormones|mesh-ancestor
14909794|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14909795|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221218|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15221219|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309285|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722870|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
14909796|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14909797|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221220|NCT03269409|Coal Tar|coal tar|mesh-list
14722871|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14722872|NCT00492141|Temozolomide|temozolomide|mesh-list
14722873|NCT00492141|Camptothecin|camptothecin|mesh-list
14722874|NCT00492141|Rubitecan|rubitecan|mesh-list
14722875|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14722876|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
14309286|NCT00662909|Urological Agents|urological agents|mesh-ancestor
14309287|NCT00663039|Oxytocin|oxytocin|mesh-list
14309288|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
14309289|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14309290|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309291|NCT00663117|Naltrexone|naltrexone|mesh-list
14309292|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14309293|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14309294|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309295|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
14309296|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722877|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722878|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722879|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14722880|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14722881|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14722882|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722883|NCT00492219|Cimetidine|cimetidine|mesh-list
14722884|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14722885|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14722886|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14722887|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
14722888|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
14722889|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722890|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722891|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722892|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14722893|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14722894|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722895|NCT00492245|Mitomycins|mitomycins|mesh-list
14722896|NCT00492245|Mitomycin|mitomycin|mesh-list
14722897|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14722898|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722899|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
14722900|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722901|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14309297|NCT00663169|Dexamethasone|dexamethasone|mesh-list
14309298|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
14309299|NCT00663169|BB 1101|bb 1101|mesh-list
14309300|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14309301|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309302|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
14309303|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
14309304|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722902|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722903|NCT00492258|Sorafenib|sorafenib|mesh-list
14722904|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909798|NCT01353339|Levofloxacin|levofloxacin|mesh-list
14909799|NCT01353339|Ofloxacin|ofloxacin|mesh-list
14909800|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14309305|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309306|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309307|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
14309308|NCT00663169|Hormones|hormones|mesh-ancestor
14309309|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221221|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
15221222|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
15221223|NCT03268005|Insulin|insulin|mesh-list
14309310|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14722905|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14722906|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909801|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909802|NCT01353339|Renal Agents|renal agents|mesh-ancestor
14909803|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14309311|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309312|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
14909804|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14909805|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221224|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14309313|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309314|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309315|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
14309316|NCT00663234|Atorvastatin|atorvastatin|mesh-list
14309317|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14309318|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14309319|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
14309320|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309321|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14309322|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14309323|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309324|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
14309325|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14309326|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309327|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309328|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221225|NCT03268005|Metformin|metformin|mesh-list
15221226|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
15221227|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
15221228|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15221229|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15221230|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221231|NCT03257618|Temozolomide|temozolomide|mesh-list
15221232|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221233|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
15221234|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309329|NCT00663403|Daptomycin|daptomycin|mesh-list
14309330|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14309331|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309332|NCT00663702|Abatacept|abatacept|mesh-list
14309333|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14309334|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309335|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309336|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309337|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
14309338|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309339|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309340|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
14309341|NCT00663793|Finasteride|finasteride|mesh-list
14309342|NCT00663793|Testosterone|testosterone|mesh-list
14309343|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
14309344|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
14309345|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14309346|NCT00663793|Acyline|acyline|mesh-list
14309347|NCT00663793|Androgens|androgens|mesh-ancestor
14309348|NCT00663793|Hormones|hormones|mesh-ancestor
14309349|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309350|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309351|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14722907|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722908|NCT00492388|Ketamine|ketamine|mesh-list
14722909|NCT00492388|Analgesics|analgesics|mesh-ancestor
14909806|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309352|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309353|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
14309354|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14309355|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14309356|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309357|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309358|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
14309359|NCT00663793|Urological Agents|urological agents|mesh-ancestor
14309360|NCT00663858|Cetrorelix|cetrorelix|mesh-list
14309361|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14309362|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
14309363|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14309364|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309365|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
14309366|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309367|NCT00663962|Pregabalin|pregabalin|mesh-list
14309368|NCT00663962|Analgesics|analgesics|mesh-ancestor
14309369|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
14309370|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309371|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309372|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
14309373|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14309374|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309375|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309376|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14309377|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14309378|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14309379|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14309380|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14309381|NCT00664105|Carboplatin|carboplatin|mesh-list
14309382|NCT00664105|Docetaxel|docetaxel|mesh-list
14309383|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309384|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
14309385|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
14309386|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
14309387|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309388|NCT00664209|Amoxicillin|amoxicillin|mesh-list
14309389|NCT00664209|Omeprazole|omeprazole|mesh-list
14309390|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14309391|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309392|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14309393|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309394|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14309395|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309396|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327915|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327916|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327917|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14327918|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14327919|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14309397|NCT00664430|Calcitriol|calcitriol|mesh-list
14309398|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14309399|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309400|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14309401|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309402|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309403|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14309404|NCT00664430|Vitamins|vitamins|mesh-ancestor
15221235|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221236|NCT03228186|Docetaxel|docetaxel|mesh-list
15221237|NCT03228186|Pevonedistat|pevonedistat|mesh-list
14909807|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909808|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909809|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14909810|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14909811|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
14909812|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14909813|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909814|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909815|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14909816|NCT01353378|Analgesics|analgesics|mesh-ancestor
14909817|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
14909818|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909819|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14909820|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14909821|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14909822|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
15221238|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221239|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14722910|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
14722911|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722912|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722913|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14722914|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15221240|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
15221241|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
15221242|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221243|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221244|NCT03226756|Nivolumab|nivolumab|mesh-list
15221245|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221246|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309405|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
14309406|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14309407|NCT00664521|Rituximab|rituximab|mesh-list
14309408|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309409|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309410|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
14722915|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
14722916|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
14722917|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14722918|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14722919|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14722920|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722921|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221247|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14722922|NCT00492414|Paroxetine|paroxetine|mesh-list
14722923|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14722924|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14722925|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14722926|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722927|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14722928|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
14722929|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722930|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14722931|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
14722932|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14722933|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14722934|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14722935|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722936|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
14722937|NCT00492427|Hematinics|hematinics|mesh-ancestor
14722938|NCT00492466|Interferons|interferons|mesh-list
14722939|NCT00492466|Interferon-beta|interferon-beta|mesh-list
14722940|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
14722941|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
14722942|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722943|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
14722944|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722945|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309411|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309412|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14722946|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
14722947|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
14722948|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722949|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722950|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14722951|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
14722952|NCT00492466|Hormones|hormones|mesh-ancestor
14722953|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722954|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14722955|NCT00492466|Protective Agents|protective agents|mesh-ancestor
14722956|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
14722957|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14722958|NCT00492479|Kinetin|kinetin|mesh-list
14722959|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14722960|NCT00492479|Growth Substances|growth substances|mesh-ancestor
14722961|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722962|NCT00492505|Tamoxifen|tamoxifen|mesh-list
14722963|NCT00492505|Sorafenib|sorafenib|mesh-list
14722964|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14722965|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722966|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14722967|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722968|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14722969|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
14722970|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14722971|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722972|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14722973|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14309413|NCT00664534|Insulin|insulin|mesh-list
14309414|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14309415|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
14309416|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
14309417|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309418|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309419|NCT00664560|Celecoxib|celecoxib|mesh-list
14309420|NCT00664560|Antacids|antacids|mesh-list
14309421|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14722974|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14722975|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14309422|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14309423|NCT00664560|Analgesics|analgesics|mesh-ancestor
14309424|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
14309425|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309426|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309427|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14722976|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
14722977|NCT00492518|Theophylline|theophylline|mesh-list
14722978|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14722979|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
14309428|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309429|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14309430|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14309431|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309432|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309433|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309434|NCT00664755|Nicotine|nicotine|mesh-list
14309435|NCT00664755|Varenicline|varenicline|mesh-list
14722980|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14722981|NCT00492518|Expectorants|expectorants|mesh-ancestor
14722982|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
14309436|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14309437|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
14309438|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722983|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14722984|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
14722985|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14722986|NCT00492518|Protective Agents|protective agents|mesh-ancestor
14722987|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14722988|NCT00492518|Antidotes|antidotes|mesh-ancestor
14722989|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14722990|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
14722991|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14722992|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14722993|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14722994|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14722995|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
14722996|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14722997|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14722998|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
14722999|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723000|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14723001|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
14723002|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14723003|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14723004|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723005|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723006|NCT00492635|Urological Agents|urological agents|mesh-ancestor
14723007|NCT00492661|Tacrolimus|tacrolimus|mesh-list
14723008|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723009|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
14723010|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723011|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14723012|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309439|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309440|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14309441|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14309442|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
14723013|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723014|NCT00492687|Tamoxifen|tamoxifen|mesh-list
14723015|NCT00492687|Carboplatin|carboplatin|mesh-list
14309443|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309444|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309445|NCT00664859|Atorvastatin|atorvastatin|mesh-list
14309446|NCT00664859|Fenofibrate|fenofibrate|mesh-list
14309447|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14309448|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14309449|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
14309450|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309451|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14309452|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14309453|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309454|NCT00665002|Sargramostim|sargramostim|mesh-list
14309455|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
14309456|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309457|NCT00665353|Pioglitazone|pioglitazone|mesh-list
14309458|NCT00665353|Ribavirin|ribavirin|mesh-list
14309459|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
14309460|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309461|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
14309462|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723016|NCT00492687|Temozolomide|temozolomide|mesh-list
14723017|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309463|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309464|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309465|NCT00665366|Valproic Acid|valproic acid|mesh-list
14309466|NCT00665366|Aripiprazole|aripiprazole|mesh-list
14309467|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
14309468|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14309469|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14309470|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14309471|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14309472|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309473|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
14309474|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
14309475|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309476|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309477|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14309478|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14309479|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
14309480|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14309481|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14309482|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14309483|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14309484|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309485|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
14309486|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
14309487|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
14309488|NCT00665392|Docetaxel|docetaxel|mesh-list
14309489|NCT00665392|Fluorouracil|fluorouracil|mesh-list
14309490|NCT00665392|Cetuximab|cetuximab|mesh-list
14309491|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309492|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
14309493|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
14309494|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
14723018|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723019|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14723020|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
14723021|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14723022|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
14723023|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723024|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723025|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14723026|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14723027|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14723028|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14723029|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
14723030|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309495|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723031|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723032|NCT00492739|Vaccines|vaccines|mesh-list
14723033|NCT00492739|Immunologic Factors|immunologic factors|mesh-ancestor
14723034|NCT00492739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723035|NCT00492765|Interferons|interferons|mesh-list
14723036|NCT00492765|Interferon-beta|interferon-beta|mesh-list
14723037|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
14723038|NCT00492765|Simvastatin|simvastatin|mesh-list
14723039|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723040|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
14723041|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723042|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14723043|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14723044|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
14723045|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723046|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14723047|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14723048|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723049|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
14723050|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723051|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14723052|NCT00492778|Cisplatin|cisplatin|mesh-list
14723053|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723054|NCT00492830|Antibodies|antibodies|mesh-list
14723055|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14723056|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
14723057|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723058|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
14723059|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14723060|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723061|NCT00492934|Menotropins|menotropins|mesh-list
14723062|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14723063|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
14309496|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
14309497|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309498|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309499|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
14309500|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309501|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309502|NCT00665431|Celecoxib|celecoxib|mesh-list
14309503|NCT00665431|Antacids|antacids|mesh-list
14309504|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14309505|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14309506|NCT00665431|Analgesics|analgesics|mesh-ancestor
14309507|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
14309508|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309509|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309510|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309511|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309512|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14309513|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14309514|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309515|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309516|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309517|NCT00665457|Celecoxib|celecoxib|mesh-list
14309518|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
14309519|NCT00665457|Docetaxel|docetaxel|mesh-list
14309520|NCT00665457|Doxorubicin|doxorubicin|mesh-list
14309521|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14309522|NCT00665457|Capecitabine|capecitabine|mesh-list
14723064|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14723065|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309523|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309524|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
14309525|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309526|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309527|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14309528|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
14309529|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309530|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309531|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14309532|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14309533|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
14309534|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14309535|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14309536|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14309537|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14309538|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309539|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309540|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
14309541|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14309542|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14309543|NCT00665457|Analgesics|analgesics|mesh-ancestor
14723066|NCT00492986|Sorafenib|sorafenib|mesh-list
14723067|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723068|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14723069|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723070|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723071|NCT00493077|Interferons|interferons|mesh-list
14723072|NCT00493077|Interferon-beta|interferon-beta|mesh-list
14723073|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
14909823|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909824|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909825|NCT01353391|Metformin|metformin|mesh-list
14909826|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14909827|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917088|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917089|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
14917090|NCT01395927|Canagliflozin|canagliflozin|mesh-list
14917091|NCT01395927|Rifampin|rifampin|mesh-list
14917092|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14917093|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
14917094|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14917095|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917096|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
14309544|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
14309545|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309546|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309547|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14309548|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14309549|NCT00665470|Aldesleukin|aldesleukin|mesh-list
14309550|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309551|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14309552|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14309553|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
14309554|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309555|NCT00665561|Maraviroc|maraviroc|mesh-list
14309556|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14309557|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14309558|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14723074|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723075|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
14917097|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14723076|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309559|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309560|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14309561|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
14309562|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309563|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14309564|NCT00665652|Lenalidomide|lenalidomide|mesh-list
14309565|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
14309566|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309567|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14309568|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14309569|NCT00665652|Growth Substances|growth substances|mesh-ancestor
14309570|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
14309571|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309572|NCT00665847|Etravirine|etravirine|mesh-list
14723077|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
14723078|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723079|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14723080|NCT00493116|Interferons|interferons|mesh-list
14723081|NCT00493116|Interferon-beta|interferon-beta|mesh-list
14723082|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
14723083|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
14723084|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723085|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
14723086|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723087|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14723088|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
14723089|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
14723090|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909828|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
14309573|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14309574|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14309575|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309576|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309577|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
14309578|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309579|NCT00666029|Atorvastatin|atorvastatin|mesh-list
14309580|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14309581|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14309582|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
14309583|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309584|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14309585|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14309586|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309587|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
14309588|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
14309589|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14309590|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14309591|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309592|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309593|NCT00666198|Urological Agents|urological agents|mesh-ancestor
14309594|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
14309595|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
14309596|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14309597|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
14309598|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309599|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309600|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309601|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14309602|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
14309603|NCT00666263|Antibodies|antibodies|mesh-list
14309604|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
14309605|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14309606|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14309607|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
14309608|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309609|NCT00666276|Linezolid|linezolid|mesh-list
14309610|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14309611|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909829|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14917098|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309612|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14309613|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309614|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221248|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221249|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15221250|NCT03220854|Antibodies|antibodies|mesh-list
15221251|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
15221252|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15221253|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
15221254|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309615|NCT00666328|Clevidipine|clevidipine|mesh-list
14309616|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14309617|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309618|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309619|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14309620|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309621|NCT00666406|Factor VIII|factor viii|mesh-list
14309622|NCT00666406|Coagulants|coagulants|mesh-ancestor
14309623|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14309624|NCT00666458|Saxagliptin|saxagliptin|mesh-list
14309625|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309626|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309627|NCT00666458|Incretins|incretins|mesh-ancestor
14309628|NCT00666458|Hormones|hormones|mesh-ancestor
14309629|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309630|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14309631|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
14723091|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723092|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14723093|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
15221255|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221256|NCT03187769|Olanzapine|olanzapine|mesh-list
15221257|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
15221258|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
15221259|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221260|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723094|NCT00493116|Hormones|hormones|mesh-ancestor
14723095|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723096|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14723097|NCT00493116|Protective Agents|protective agents|mesh-ancestor
14723098|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
14723099|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14723100|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
14723101|NCT00493129|Interleukin-2|interleukin-2|mesh-list
14723102|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723103|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14723104|NCT00493129|Analgesics|analgesics|mesh-ancestor
14723105|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
14309632|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723106|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723107|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723108|NCT00493194|Cyclosporine|cyclosporine|mesh-list
14723109|NCT00493194|Sirolimus|sirolimus|mesh-list
14723110|NCT00493194|Cyclosporins|cyclosporins|mesh-list
14723111|NCT00493194|Daclizumab|daclizumab|mesh-list
14723112|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723113|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723114|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723115|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
14723116|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723117|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
14723118|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723119|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
14723120|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723121|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14723122|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14723123|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14723124|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723125|NCT00493233|Olanzapine|olanzapine|mesh-list
14723126|NCT00493233|Risperidone|risperidone|mesh-list
14723127|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14723128|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
14723129|NCT00493233|Clozapine|clozapine|mesh-list
14723130|NCT00493233|Perphenazine|perphenazine|mesh-list
14723131|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14723132|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
14723133|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723134|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723135|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723136|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14723137|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723138|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14723139|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14723140|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
14723141|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
14723142|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
14723143|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723144|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14723145|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14723146|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14723147|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723148|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
14723149|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
14723150|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
14723151|NCT00493298|Natalizumab|natalizumab|mesh-list
14723152|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
14723153|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729180|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729181|NCT00521859|Vidarabine|vidarabine|mesh-list
14729182|NCT00521859|Fludarabine|fludarabine|mesh-list
14729183|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
14729184|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729185|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723154|NCT00493324|Alefacept|alefacept|mesh-list
14723155|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14723156|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
14909830|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14909831|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909832|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14909833|NCT01353456|Analgesics|analgesics|mesh-ancestor
14909834|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
14909835|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309633|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309634|NCT00666536|Amlodipine|amlodipine|mesh-list
14309635|NCT00666536|Valsartan|valsartan|mesh-list
14309636|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14309637|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14309638|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14309639|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309640|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309641|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14309642|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309643|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
14309644|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14309645|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14309646|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14309647|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
14909836|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14909837|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14909838|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14909839|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909840|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909841|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909842|NCT01353469|Insulin|insulin|mesh-list
14909843|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14909844|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14909845|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909846|NCT01353482|Pemetrexed|pemetrexed|mesh-list
14909847|NCT01353482|Vorinostat|vorinostat|mesh-list
14909848|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909849|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909850|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909851|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14909852|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14909853|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14909854|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
14909855|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309648|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909856|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
14909857|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14909858|NCT01353716|Dolutegravir|dolutegravir|mesh-list
14909859|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14909860|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14909861|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909862|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309649|NCT00666562|Protective Agents|protective agents|mesh-ancestor
14309650|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309651|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14309652|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14309653|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309654|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14309655|NCT00666588|Cytarabine|cytarabine|mesh-list
14309656|NCT00666588|Etoposide|etoposide|mesh-list
14309657|NCT00666588|Idarubicin|idarubicin|mesh-list
14309658|NCT00666588|Bortezomib|bortezomib|mesh-list
14309659|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
14309660|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14309661|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309662|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14309663|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14723157|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723158|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
14723159|NCT00493363|Artesunate|artesunate|mesh-list
14723160|NCT00493363|Mefloquine|mefloquine|mesh-list
14723161|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
14309664|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723162|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14309665|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309666|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309667|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
14309668|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
14309669|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309670|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309671|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
14309672|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309673|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14309674|NCT00666666|Acetic Acid|acetic acid|mesh-list
14309675|NCT00666666|Bicalutamide|bicalutamide|mesh-list
14309676|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
14309677|NCT00666666|Gossypol|gossypol|mesh-list
14309678|NCT00666666|Hormones|hormones|mesh-list
14309679|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309680|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309681|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
14309682|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
14309683|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309684|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14309685|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309686|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14309687|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14309688|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
14309689|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14309690|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14309691|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14309692|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14309693|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
14309694|NCT00666679|Montelukast|montelukast|mesh-list
14309695|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14309696|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
14309697|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14309698|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
14327920|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723163|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14723164|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723165|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723166|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
14723167|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
14723168|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14723169|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
14309699|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309700|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309701|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14309702|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14309703|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309704|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309705|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
14309706|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14309707|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
14309708|NCT00666705|Maraviroc|maraviroc|mesh-list
14309709|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14309710|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14309711|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
14309712|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309713|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14309714|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14309715|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309716|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309717|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14309718|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14309719|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14309720|NCT00666718|Insulin|insulin|mesh-list
14309721|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14309722|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
14309723|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
14309724|NCT00666718|Protamines|protamines|mesh-list
14309725|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309726|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309727|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
14309728|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309729|NCT00666718|Coagulants|coagulants|mesh-ancestor
14309730|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14309731|NCT00666757|Sertraline|sertraline|mesh-list
14309732|NCT00666757|Fluoxetine|fluoxetine|mesh-list
14309733|NCT00666757|Paroxetine|paroxetine|mesh-list
14309734|NCT00666757|Citalopram|citalopram|mesh-list
14309735|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14309736|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14309737|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309738|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723170|NCT00493389|Hormones|hormones|mesh-list
14723171|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14723172|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723173|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723174|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
14723175|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14723176|NCT00493402|Estrogens|estrogens|mesh-ancestor
14723177|NCT00493402|Hormones|hormones|mesh-ancestor
14723178|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723179|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723180|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14723181|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309739|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309740|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309741|NCT00666757|Analgesics|analgesics|mesh-ancestor
14309742|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
14309743|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309744|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
14723182|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
14723183|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
14723184|NCT00493428|Baclofen|baclofen|mesh-list
14723185|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14723186|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723187|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14723188|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723189|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14723190|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
14723191|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
14723192|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309745|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14309746|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
14309747|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14723193|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723194|NCT00493480|Propranolol|propranolol|mesh-list
14309748|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
14309749|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14309750|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14309751|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14309752|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309753|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
14309754|NCT00666835|Hematinics|hematinics|mesh-ancestor
14309755|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14309756|NCT00666848|Enalapril|enalapril|mesh-list
14309757|NCT00666848|Enalaprilat|enalaprilat|mesh-list
14309758|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309759|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309760|NCT00666848|Incretins|incretins|mesh-ancestor
14309761|NCT00666848|Hormones|hormones|mesh-ancestor
14309762|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309763|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14309764|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
14309765|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309766|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309767|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14309768|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14309769|NCT00666965|Rotigotine|rotigotine|mesh-list
14309770|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
14309771|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
14309772|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309773|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309774|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309775|NCT00666978|Bupropion|bupropion|mesh-list
14309776|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14309777|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
14309778|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14309779|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14309780|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14309781|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309782|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309783|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
14309784|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309785|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309786|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14309787|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14309788|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309789|NCT00667004|Ecabet|ecabet|mesh-list
14309790|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14309791|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14309792|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309793|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14309794|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309795|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
14309796|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309797|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309798|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14309799|NCT00667004|Protective Agents|protective agents|mesh-ancestor
14309800|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309801|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309802|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14309803|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14309804|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14309805|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309806|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909863|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14909864|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14723195|NCT00493480|Carvedilol|carvedilol|mesh-list
14723196|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14723197|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14723198|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
14723199|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723200|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723201|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723202|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14723203|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14723204|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
14723205|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
14723206|NCT00493480|Protective Agents|protective agents|mesh-ancestor
14723207|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14723208|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723209|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14723210|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14723211|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14723212|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
14723213|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14723214|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723215|NCT00493545|Poly ICLC|poly iclc|mesh-list
14723216|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
14309807|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14309808|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309809|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309810|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
14309811|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309812|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14309813|NCT00667095|Protective Agents|protective agents|mesh-ancestor
14309814|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14309815|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
14309816|NCT00667225|Cantharidin|cantharidin|mesh-list
14723217|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
14723218|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309817|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221261|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14309818|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309819|NCT00667277|Bevacizumab|bevacizumab|mesh-list
14309820|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309821|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309822|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14309823|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14309824|NCT00667277|Growth Substances|growth substances|mesh-ancestor
14309825|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309826|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
14309827|NCT00667342|Bevacizumab|bevacizumab|mesh-list
14309828|NCT00667342|Doxorubicin|doxorubicin|mesh-list
14309829|NCT00667342|Methotrexate|methotrexate|mesh-list
14723219|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
15221262|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15221263|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15221264|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15221265|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15221266|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15221267|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15221268|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15221269|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221270|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221271|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
15221272|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
14309830|NCT00667342|Etoposide|etoposide|mesh-list
14309831|NCT00667342|Ifosfamide|ifosfamide|mesh-list
14309832|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309833|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309834|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14309835|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14309836|NCT00667342|Growth Substances|growth substances|mesh-ancestor
14309837|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309838|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
14309839|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14309840|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14309841|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14309842|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309843|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909865|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
14909866|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909867|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
14909868|NCT01353729|Zanamivir|zanamivir|mesh-list
14909869|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14909870|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14909871|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909872|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14909873|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14909874|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909875|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909876|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909877|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14909878|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
14909879|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14909880|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909881|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14309844|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14309845|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
14309846|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14309847|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14309848|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
14309849|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
14309850|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14309851|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309852|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
14309853|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309854|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14309855|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14309856|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14309857|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
14309858|NCT00667355|Adalimumab|adalimumab|mesh-list
14309859|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309860|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309861|NCT00667368|Metronidazole|metronidazole|mesh-list
14309862|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14309863|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14309864|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14309865|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14309866|NCT00667394|Bevacizumab|bevacizumab|mesh-list
14309867|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309868|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309869|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14309870|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14723220|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14723221|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
14723222|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723223|NCT00493610|Expectorants|expectorants|mesh-ancestor
14723224|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
14723225|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14723226|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
14723227|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723228|NCT00493610|Protective Agents|protective agents|mesh-ancestor
14723229|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309871|NCT00667394|Growth Substances|growth substances|mesh-ancestor
14309872|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309873|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
14309874|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
14309875|NCT00667420|Epirubicin|epirubicin|mesh-list
14723230|NCT00493610|Antidotes|antidotes|mesh-ancestor
14309876|NCT00667420|Panitumumab|panitumumab|mesh-list
14723231|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
14309877|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309878|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309879|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14309880|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14309881|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14309882|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309883|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14309884|NCT00667446|Leuprolide|leuprolide|mesh-list
14309885|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14309886|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
14309887|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14309888|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309889|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14309890|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309891|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
14309892|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309893|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
14309894|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14309895|NCT00667576|Protective Agents|protective agents|mesh-ancestor
14309896|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309897|NCT00667589|Fluocinonide|fluocinonide|mesh-list
14309898|NCT00667589|Tazarotene|tazarotene|mesh-list
14309899|NCT00667589|Emollients|emollients|mesh-list
14309900|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14309901|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
14309902|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309903|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
14309904|NCT00667589|Hormones|hormones|mesh-ancestor
14309905|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309906|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309907|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14309908|NCT00667615|Prednisone|prednisone|mesh-list
14309909|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
14723232|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14723233|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723234|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
14309910|NCT00667615|Rituximab|rituximab|mesh-list
14309911|NCT00667615|Etoposide|etoposide|mesh-list
14309912|NCT00667615|Vorinostat|vorinostat|mesh-list
14309913|NCT00667615|Lenograstim|lenograstim|mesh-list
14309914|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14309915|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
14309916|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309917|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14309918|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14309919|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
14309920|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309921|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309922|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14309923|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14909882|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14909883|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14909884|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
14909885|NCT01353742|Lamivudine|lamivudine|mesh-list
14909886|NCT01353742|Adefovir|adefovir|mesh-list
14909887|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14909888|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14909889|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14909890|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309924|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309925|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
14309926|NCT00667615|Hormones|hormones|mesh-ancestor
14309927|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309928|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14723235|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14723236|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
14723237|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723238|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
14723239|NCT00493662|Protective Agents|protective agents|mesh-ancestor
14723240|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
14309929|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14723241|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14909891|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309930|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14723242|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
14723243|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723244|NCT00493727|Expectorants|expectorants|mesh-ancestor
14723245|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
14723246|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14723247|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
14723248|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723249|NCT00493727|Protective Agents|protective agents|mesh-ancestor
14723250|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723251|NCT00493727|Antidotes|antidotes|mesh-ancestor
14723252|NCT00493766|Panobinostat|panobinostat|mesh-list
14723253|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723254|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14723255|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723256|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723257|NCT00493831|Nicotine|nicotine|mesh-list
14723258|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14723259|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
14723260|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723261|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723262|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14909892|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
14909893|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909894|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14309931|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14309932|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309933|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14309934|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14909895|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14909896|NCT01353794|Sorafenib|sorafenib|mesh-list
14909897|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909898|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14909899|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909900|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909901|NCT01353833|Aldesleukin|aldesleukin|mesh-list
14909902|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909903|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14909904|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14909905|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
14909906|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909907|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14309935|NCT00667719|Amlodipine|amlodipine|mesh-list
14309936|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14309937|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14309938|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14309939|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14309940|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309941|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14309942|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309943|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
14309944|NCT00667719|Diuretics|diuretics|mesh-ancestor
14309945|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
14309946|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14309947|NCT00667732|Exenatide|exenatide|mesh-list
14309948|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14309949|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909908|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14909909|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14909910|NCT01353846|Estradiol|estradiol|mesh-list
14909911|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14909912|NCT01353846|Progesterone|progesterone|mesh-list
14909913|NCT01353846|Estrogens|estrogens|mesh-ancestor
14909914|NCT01353846|Hormones|hormones|mesh-ancestor
14723263|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14723264|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
14723265|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909915|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309950|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14309951|NCT00667732|Incretins|incretins|mesh-ancestor
14309952|NCT00667732|Hormones|hormones|mesh-ancestor
14309953|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14309954|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
14723266|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723267|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
14909916|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909917|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14309955|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
14309956|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14309957|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309958|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309959|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
14309960|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14309961|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14309962|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309963|NCT00667862|Panobinostat|panobinostat|mesh-list
14309964|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14309965|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14309966|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14309967|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309968|NCT00667875|Naltrexone|naltrexone|mesh-list
14309969|NCT00667875|Aripiprazole|aripiprazole|mesh-list
14309970|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14309971|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14309972|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309973|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
14309974|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309975|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
14309976|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14309977|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14309978|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14309979|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14309980|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
14309981|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
14309982|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14309983|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14309984|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14309985|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14309986|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
14309987|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14309988|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14309989|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14309990|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14309991|NCT00667992|Budesonide|budesonide|mesh-list
14309992|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14309993|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14309994|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
14309995|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14309996|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14309997|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14309998|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
14309999|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
14310000|NCT00667992|Hormones|hormones|mesh-ancestor
14310001|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310002|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14723268|NCT00493857|Antibodies|antibodies|mesh-list
14723269|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14723270|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
14723271|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723272|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14723273|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723274|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
14909918|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
14723275|NCT00493870|Docetaxel|docetaxel|mesh-list
14723276|NCT00493870|Doxorubicin|doxorubicin|mesh-list
14723277|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723278|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
14723279|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723280|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723281|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14310003|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
14310004|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310005|NCT00668200|Vitamin D|vitamin d|mesh-list
14310006|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
14310007|NCT00668200|Calcium|calcium|mesh-list
14310008|NCT00668200|Vitamins|vitamins|mesh-ancestor
14310009|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
14310010|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310011|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14310012|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14310013|NCT00668317|Omeprazole|omeprazole|mesh-list
14310014|NCT00668317|Ranitidine|ranitidine|mesh-list
14310015|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14310016|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14310017|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14310018|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14310019|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909919|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14909920|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14909921|NCT01353846|Progestins|progestins|mesh-ancestor
14909922|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
14909923|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14909924|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909925|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
14909926|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14909927|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
14909928|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909929|NCT01353937|Plerixafor|plerixafor|mesh-list
14310020|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723282|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
14723283|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723284|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723285|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14723286|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723287|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310021|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14310022|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
14310023|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
14310024|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310025|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310026|NCT00668395|Efavirenz|efavirenz|mesh-list
14310027|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14310028|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14310029|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310030|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310031|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
14310032|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310033|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14310034|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14310035|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14310036|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14310037|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14310038|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14310039|NCT00668434|Prednisone|prednisone|mesh-list
14310040|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310041|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
14723288|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
14723289|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14909930|NCT01353937|Becaplermin|becaplermin|mesh-list
14310042|NCT00668434|Hormones|hormones|mesh-ancestor
14310043|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310044|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310045|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14310046|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310047|NCT00668525|Dexetimide|dexetimide|mesh-list
14310048|NCT00668525|Citalopram|citalopram|mesh-list
14310049|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14310050|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14310051|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310052|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310053|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310054|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
14310055|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909931|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14909932|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14909933|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
14909934|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909935|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
14909936|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
15221273|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
15221274|NCT03168438|Fludarabine|fludarabine|mesh-list
15221275|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221276|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
15221277|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221278|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221279|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221280|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
15221281|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221282|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221283|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14310056|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14310057|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
14310058|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14310059|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14310060|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14310061|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
14310062|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
14310063|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310064|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14310065|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14310066|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
14310067|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
14310068|NCT00668564|Busulfan|busulfan|mesh-list
14310069|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
14310070|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310071|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
14310072|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310073|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310074|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14310075|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
14310076|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310077|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310078|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14310079|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310080|NCT00668707|Melatonin|melatonin|mesh-list
14310081|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
14310082|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310083|NCT00668707|Protective Agents|protective agents|mesh-ancestor
14310084|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310085|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310086|NCT00668746|Minocycline|minocycline|mesh-list
14310087|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14310088|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310089|NCT00668811|Sunitinib|sunitinib|mesh-list
14310090|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310091|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14310092|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310093|NCT00668811|Growth Substances|growth substances|mesh-ancestor
14310094|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310095|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
14310096|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310097|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310098|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310099|NCT00668863|Leucovorin|leucovorin|mesh-list
14310100|NCT00668863|Fluorouracil|fluorouracil|mesh-list
14310101|NCT00668863|Irinotecan|irinotecan|mesh-list
14310102|NCT00668863|Sunitinib|sunitinib|mesh-list
14310103|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
14310104|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
14310105|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310106|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14310107|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310108|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310109|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
14723290|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14723291|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14723292|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723293|NCT00493961|Hormones|hormones|mesh-list
14723294|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723295|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723296|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
14723297|NCT00493987|Testosterone|testosterone|mesh-list
14310110|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723298|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
14723299|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
14723300|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14723301|NCT00493987|Dutasteride|dutasteride|mesh-list
14723302|NCT00493987|Androgens|androgens|mesh-ancestor
14723303|NCT00493987|Hormones|hormones|mesh-ancestor
14723304|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310111|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14310112|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14310113|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310114|NCT00668863|Antidotes|antidotes|mesh-ancestor
14310115|NCT00668863|Protective Agents|protective agents|mesh-ancestor
14310116|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
14310117|NCT00668863|Vitamins|vitamins|mesh-ancestor
14310118|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
14310119|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14310120|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310121|NCT00668863|Growth Substances|growth substances|mesh-ancestor
14310122|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
14310123|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310124|NCT00668902|Pantoprazole|pantoprazole|mesh-list
14310125|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14310126|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14310127|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15221284|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221285|NCT03154996|Topotecan|topotecan|mesh-list
15221286|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14310128|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310129|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310130|NCT00669019|Saracatinib|saracatinib|mesh-list
14310131|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310132|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310133|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310134|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
14310135|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14310136|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
14723305|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723306|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14723307|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723308|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
14723309|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14723310|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14723311|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221287|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221288|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221289|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221290|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221291|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
15221292|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221293|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221294|NCT03141034|Irinotecan|irinotecan|mesh-list
15221295|NCT03141034|Ramucirumab|ramucirumab|mesh-list
15221296|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15221297|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221298|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221299|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221300|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221301|NCT03132038|Nivolumab|nivolumab|mesh-list
15221302|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221303|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221304|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221305|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221306|NCT03128021|Milnacipran|milnacipran|mesh-list
15221307|NCT03128021|Citalopram|citalopram|mesh-list
15221308|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
15221309|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15221310|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15221311|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15221312|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221313|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310137|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723312|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723313|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
14310138|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
14310139|NCT00669032|Protective Agents|protective agents|mesh-ancestor
14310140|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14310141|NCT00669071|Tretinoin|tretinoin|mesh-list
14310142|NCT00669071|Hydroquinone|hydroquinone|mesh-list
14310143|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310144|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
14310145|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
14310146|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310147|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
14310148|NCT00669071|Hormones|hormones|mesh-ancestor
14310149|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14909937|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14909938|NCT01353937|Growth Substances|growth substances|mesh-ancestor
14909939|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909940|NCT01354158|Droxidopa|droxidopa|mesh-list
14909941|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14909942|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14909943|NCT01354262|Vitamin D|vitamin d|mesh-list
14909944|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
14909945|NCT01354262|Vitamins|vitamins|mesh-list
14909946|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
14909947|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310150|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310151|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
14310152|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310153|NCT00669071|Protective Agents|protective agents|mesh-ancestor
14310154|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14310155|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14310156|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14723314|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
14723315|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
14723316|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14723317|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14723318|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310157|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14723319|NCT00494104|Vitamin D|vitamin d|mesh-list
14723320|NCT00494104|Vitamins|vitamins|mesh-ancestor
14723321|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
14723322|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723323|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14723324|NCT00494156|Aspirin|aspirin|mesh-list
14723325|NCT00494156|Heparin|heparin|mesh-list
14723326|NCT00494156|Clopidogrel|clopidogrel|mesh-list
14723327|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14723328|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14723329|NCT00494156|Analgesics|analgesics|mesh-ancestor
14723330|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
14723331|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221314|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
15221315|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221316|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15221317|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
15221318|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15221319|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221320|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15221321|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15221322|NCT03128021|Analgesics|analgesics|mesh-ancestor
15221323|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
15221324|NCT03120624|Iodine|iodine|mesh-list
15221325|NCT03120624|Interferons|interferons|mesh-list
15221326|NCT03120624|Interferon-beta|interferon-beta|mesh-list
15221327|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15221328|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
14310158|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310159|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310160|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310161|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310162|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
14310163|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14310164|NCT00669162|Docetaxel|docetaxel|mesh-list
14909948|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14909949|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14909950|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14310165|NCT00669162|Leuprolide|leuprolide|mesh-list
14310166|NCT00669162|Goserelin|goserelin|mesh-list
14310167|NCT00669162|Bicalutamide|bicalutamide|mesh-list
14310168|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310169|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
14310170|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310171|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
14310172|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310173|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14310174|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
14310175|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14310176|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310177|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14310178|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
14310179|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
14310180|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310181|NCT00669240|Varenicline|varenicline|mesh-list
14310182|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14310183|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14310184|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
14310185|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310186|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310187|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310188|NCT00669279|Atenolol|atenolol|mesh-list
14909951|NCT01354275|Hormones|hormones|mesh-ancestor
14909952|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723332|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723333|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14723334|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723335|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14723336|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14310189|NCT00669279|Carvedilol|carvedilol|mesh-list
14310190|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14310191|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14310192|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
14310193|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310194|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310195|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310196|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14310197|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
14310198|NCT00669279|Protective Agents|protective agents|mesh-ancestor
14310199|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14310200|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310201|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14310202|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
14310203|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14723337|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723338|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14723339|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14310204|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14310205|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14310206|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
14310207|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
14310208|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310209|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14310210|NCT00669318|Rituximab|rituximab|mesh-list
14310211|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
14310212|NCT00669318|Pentostatin|pentostatin|mesh-list
14310213|NCT00669318|Sargramostim|sargramostim|mesh-list
14310214|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310215|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310216|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
14310217|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310218|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310219|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14310220|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310221|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310222|NCT00669331|Mannitol|mannitol|mesh-list
14310223|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14310224|NCT00669331|Diuretics|diuretics|mesh-ancestor
14310225|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
14310226|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723340|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723341|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
14723342|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14310227|NCT00669383|Betamethasone|betamethasone|mesh-list
14310228|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310229|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
14310230|NCT00669383|Hormones|hormones|mesh-ancestor
14310231|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310232|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310233|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14310234|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
14310235|NCT00669396|Copper|copper|mesh-list
14310236|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
14310237|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14310238|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
14729186|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
14310239|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14310240|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310241|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14310242|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14310243|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14310244|NCT00669396|Trace Elements|trace elements|mesh-ancestor
14310245|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
14310246|NCT00669409|Tanezumab|tanezumab|mesh-list
14310247|NCT00669409|Analgesics|analgesics|mesh-ancestor
14310248|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
14310249|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310250|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327921|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14327922|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
14327923|NCT00806026|Protective Agents|protective agents|mesh-ancestor
14327924|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14327925|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14327926|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
14327927|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
14327928|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327929|NCT00806078|Quinine|quinine|mesh-list
14327930|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
14327931|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14327932|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14327933|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909953|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909954|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
14909955|NCT01354301|Everolimus|everolimus|mesh-list
14909956|NCT01354301|Tacrolimus|tacrolimus|mesh-list
14909957|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
14909958|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14909959|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
14909960|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909961|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14723343|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14723344|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14723345|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
14723346|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723347|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
14723348|NCT00494208|Testosterone|testosterone|mesh-list
14723349|NCT00494208|Androgens|androgens|mesh-ancestor
14723350|NCT00494208|Hormones|hormones|mesh-ancestor
14723351|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723352|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723353|NCT00494247|Antibodies|antibodies|mesh-list
14723354|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
14909962|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14909963|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909964|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909965|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14909966|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14909967|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
14909968|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14909969|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14909970|NCT01354405|Lanreotide|lanreotide|mesh-list
14327934|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14327935|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327936|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14327937|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909971|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909972|NCT01354418|Phenylephrine|phenylephrine|mesh-list
14909973|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
14909974|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14327938|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14327939|NCT00806078|Analgesics|analgesics|mesh-ancestor
14723355|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909975|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
14909976|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
14909977|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14909978|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909979|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
14909980|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14909981|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
14909982|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
14909983|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14909984|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14310251|NCT00669578|Pomalidomide|pomalidomide|mesh-list
14310252|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
14310253|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310254|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14310255|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310256|NCT00669578|Growth Substances|growth substances|mesh-ancestor
14310257|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
14310258|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14909985|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14909986|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
14909987|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14909988|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14909989|NCT01354418|Protective Agents|protective agents|mesh-ancestor
14909990|NCT01354457|Epratuzumab|epratuzumab|mesh-list
14310259|NCT00669617|Fluticasone|fluticasone|mesh-list
14310260|NCT00669617|Xhance|xhance|mesh-list
14310261|NCT00669617|Albuterol|albuterol|mesh-list
14310262|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14310263|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310264|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14310265|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
14310266|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310267|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310268|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14310269|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
14310270|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
14310271|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14310272|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14310273|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14310274|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14310275|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
14310276|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310277|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310278|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
14310279|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14310280|NCT00669864|Metformin|metformin|mesh-list
14310281|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
14310282|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
14310283|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14310284|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310285|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310286|NCT00669877|Cytarabine|cytarabine|mesh-list
14310287|NCT00669877|Dexamethasone|dexamethasone|mesh-list
14310288|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
14310289|NCT00669877|Rituximab|rituximab|mesh-list
14310290|NCT00669877|Doxorubicin|doxorubicin|mesh-list
14310291|NCT00669877|Methotrexate|methotrexate|mesh-list
14310292|NCT00669877|Vincristine|vincristine|mesh-list
14310293|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310294|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
14310295|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310296|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310297|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14310298|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
14310299|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310300|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310301|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14310302|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310303|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
14310304|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
14310305|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310306|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14310307|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
14310308|NCT00669877|Hormones|hormones|mesh-ancestor
14310309|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310310|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14310311|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14723356|NCT00494312|Pioglitazone|pioglitazone|mesh-list
14723357|NCT00494312|Glyburide|glyburide|mesh-list
14723358|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14723359|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723360|NCT00494338|Docetaxel|docetaxel|mesh-list
14723361|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723362|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723363|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
14723364|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
14723365|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723366|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14723367|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14723368|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14723369|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723370|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723371|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723372|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723373|NCT00494377|Analgesics|analgesics|mesh-ancestor
14723374|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
14723375|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723376|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
14723377|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14723378|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
14723379|NCT00494429|Morphine|morphine|mesh-list
14909991|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14909992|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310312|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14310313|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14310314|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14310315|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310316|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14310317|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
14310318|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14310319|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14310320|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
14310321|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
14310322|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14310323|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14310324|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
14310325|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310326|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14310327|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
14310328|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310329|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
14310330|NCT00669955|Amoxicillin|amoxicillin|mesh-list
14723380|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14909993|NCT01354470|Modafinil|modafinil|mesh-list
14310331|NCT00669955|Metronidazole|metronidazole|mesh-list
14723381|NCT00494429|Narcotics|narcotics|mesh-ancestor
14723382|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723383|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723384|NCT00494429|Analgesics|analgesics|mesh-ancestor
14723385|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
14723386|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310332|NCT00669955|Clarithromycin|clarithromycin|mesh-list
14310333|NCT00669955|Tetracycline|tetracycline|mesh-list
14310334|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14310335|NCT00669955|Omeprazole|omeprazole|mesh-list
14310336|NCT00669955|Bismuth|bismuth|mesh-list
14310337|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14723387|NCT00494468|Zolpidem|zolpidem|mesh-list
14723388|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14723389|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14723390|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723391|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723392|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14723393|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
14723394|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
14723395|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723396|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723397|NCT00494533|Treprostinil|treprostinil|mesh-list
14723398|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14723399|NCT00494559|Pioglitazone|pioglitazone|mesh-list
14909994|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14909995|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14909996|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14909997|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14909998|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14310338|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310339|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14909999|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910000|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
14910001|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14910002|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14910003|NCT01354483|Prednisolone|prednisolone|mesh-list
14910004|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
15221329|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221330|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
15221331|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310340|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14310341|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14310342|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14310343|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15221332|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
15221333|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221334|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15221335|NCT03120624|Trace Elements|trace elements|mesh-ancestor
15221336|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
15221337|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221338|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221339|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221340|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15221341|NCT03110380|Dolutegravir|dolutegravir|mesh-list
15221342|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14310344|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310345|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723400|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310346|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14310347|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14310348|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14310349|NCT00669955|Antacids|antacids|mesh-ancestor
14723401|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723402|NCT00494572|Montelukast|montelukast|mesh-list
14723403|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14723404|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
14723405|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14310350|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
14310351|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14310352|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310353|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310354|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14310355|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14310356|NCT00670046|Valproic Acid|valproic acid|mesh-list
14310357|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
14310358|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310359|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310360|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
14310361|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310362|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310363|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
14310364|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14310365|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310366|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14723406|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
14723407|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910005|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
14310367|NCT00670202|Fasudil|fasudil|mesh-list
14310368|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14310369|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310370|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310371|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14310372|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310373|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
14310374|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310375|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310376|NCT00670228|Insulin|insulin|mesh-list
14310377|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14910006|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14910007|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
14910008|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910009|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
14910010|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
14910011|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910012|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910013|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910014|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
14310378|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
14310379|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
14310380|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310381|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310382|NCT00670241|Betamethasone|betamethasone|mesh-list
14310383|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
14310384|NCT00670241|Calcipotriene|calcipotriene|mesh-list
14310385|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310386|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
14723408|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723409|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14723410|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14723411|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723412|NCT00494598|Sufentanil|sufentanil|mesh-list
14723413|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14723414|NCT00494598|Narcotics|narcotics|mesh-ancestor
14310387|NCT00670241|Hormones|hormones|mesh-ancestor
14310388|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310389|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310390|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14310391|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
14310392|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
14310393|NCT00670267|Nadolol|nadolol|mesh-list
14310394|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14310395|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14310396|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
14310397|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310398|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310399|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310400|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14310401|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14723415|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723416|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723417|NCT00494598|Analgesics|analgesics|mesh-ancestor
14723418|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
14723419|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723420|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14310402|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
14310403|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
14310404|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310405|NCT00670306|Cetrorelix|cetrorelix|mesh-list
14310406|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14310407|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
14310408|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14310409|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310410|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
14310411|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310412|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14310413|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14310414|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310415|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310416|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
14310417|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310418|NCT00670748|Aldesleukin|aldesleukin|mesh-list
14310419|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
14310420|NCT00670748|Fludarabine|fludarabine|mesh-list
14310421|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
14310422|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310423|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
14310424|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310425|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310426|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14310427|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
14310428|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310429|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310430|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14310431|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723421|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14723422|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
14310432|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
14310433|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14310434|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14310435|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
14310436|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310437|NCT00670774|Eculizumab|eculizumab|mesh-list
14310438|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14310439|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310440|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
14310441|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310442|NCT00670800|Metformin|metformin|mesh-list
14310443|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310444|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310445|NCT00670930|Omalizumab|omalizumab|mesh-list
14310446|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14310447|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14310448|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
14310449|NCT00670956|Betamethasone|betamethasone|mesh-list
14723423|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
14723424|NCT00494611|Cetuximab|cetuximab|mesh-list
14723425|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14723426|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723427|NCT00494624|Prednisolone|prednisolone|mesh-list
14723428|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14723429|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
14723430|NCT00494624|Hormones|hormones|mesh-ancestor
14723431|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723432|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723433|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14310450|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310451|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
14310452|NCT00670956|Hormones|hormones|mesh-ancestor
14310453|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310454|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310455|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14310456|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
14310457|NCT00670982|Bevacizumab|bevacizumab|mesh-list
14310458|NCT00670982|Trastuzumab|trastuzumab|mesh-list
14310459|NCT00670982|Vinorelbine|vinorelbine|mesh-list
14310460|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310461|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723434|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910015|NCT01354483|Hormones|hormones|mesh-ancestor
14910016|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910017|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14910018|NCT01354483|Protective Agents|protective agents|mesh-ancestor
14910019|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14910020|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910021|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
14910022|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910023|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910024|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723435|NCT00494663|Ketoconazole|ketoconazole|mesh-list
14723436|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
14723437|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723438|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14723439|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14723440|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723441|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723442|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14723443|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
14723444|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723445|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723446|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14723447|NCT00494715|Valsartan|valsartan|mesh-list
14910025|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
14310462|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14310463|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14723448|NCT00494715|Benazepril|benazepril|mesh-list
14310464|NCT00670982|Growth Substances|growth substances|mesh-ancestor
14910026|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910027|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910028|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
14910029|NCT01354522|Docetaxel|docetaxel|mesh-list
14910030|NCT01354522|Doxorubicin|doxorubicin|mesh-list
14910031|NCT01354522|Capecitabine|capecitabine|mesh-list
14910032|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14910033|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
14910034|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910035|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14910036|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14910037|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
15221343|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15221344|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15221345|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310465|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310466|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
14310467|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14310468|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14310469|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310470|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14310471|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310472|NCT00671034|Cytarabine|cytarabine|mesh-list
14310473|NCT00671034|Dexamethasone|dexamethasone|mesh-list
14310474|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
14310475|NCT00671034|Prednisone|prednisone|mesh-list
14310476|NCT00671034|Cortisone|cortisone|mesh-list
14310477|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
14310478|NCT00671034|Doxorubicin|doxorubicin|mesh-list
14310479|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14310480|NCT00671034|Methotrexate|methotrexate|mesh-list
14310481|NCT00671034|Vincristine|vincristine|mesh-list
14310482|NCT00671034|Daunorubicin|daunorubicin|mesh-list
14310483|NCT00671034|Asparaginase|asparaginase|mesh-list
14310484|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
14310485|NCT00671034|Pegaspargase|pegaspargase|mesh-list
14310486|NCT00671034|Thioguanine|thioguanine|mesh-list
14310487|NCT00671034|BB 1101|bb 1101|mesh-list
14723449|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14723450|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14723451|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14723452|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723453|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14723454|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
14723455|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221346|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310488|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
14310489|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221347|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15221348|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15221349|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
15221350|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310490|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
14723456|NCT00494728|Nicotine|nicotine|mesh-list
14723457|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14723458|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
14723459|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917591|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310491|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310492|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310493|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14310494|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
14310495|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221351|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15221352|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15221353|NCT03078478|Insulin|insulin|mesh-list
15221354|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15221355|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
15221356|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15221357|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225571|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15225572|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225573|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
15225574|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15225575|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
15225576|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
15225577|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225578|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225579|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225580|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15225581|NCT04406649|Analgesics|analgesics|mesh-ancestor
14310496|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310497|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14910038|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910039|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910040|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14910041|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
14910042|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310498|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310499|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
14310500|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
14310501|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310502|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14310503|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
14310504|NCT00671034|Hormones|hormones|mesh-ancestor
14310505|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310506|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14310507|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
14310508|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310509|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14310510|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14310511|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14310512|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14310513|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
14310514|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14310515|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14310516|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
14723460|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723461|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14723462|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14723463|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
14723464|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723465|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723466|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
14723467|NCT00494741|Azathioprine|azathioprine|mesh-list
14723468|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14910043|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
14910044|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14910045|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14910046|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14910047|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910048|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14910049|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
14910050|NCT01354613|Amlodipine|amlodipine|mesh-list
14910051|NCT01354613|Dobutamine|dobutamine|mesh-list
14910052|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15225582|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
15225583|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225584|NCT04388475|Temozolomide|temozolomide|mesh-list
15225585|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225586|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
15225587|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910053|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14723469|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723470|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14723471|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
14723472|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14723473|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723474|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723475|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723476|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
14723477|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723478|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723479|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
14310517|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14310518|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14310519|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14310520|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
14310521|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310522|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14310523|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
14310524|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310525|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
14310526|NCT00671060|Misoprostol|misoprostol|mesh-list
14310527|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14310528|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
14310529|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14910054|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910055|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910056|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910057|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910058|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
14910059|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14310530|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310531|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14310532|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14310533|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
14310534|NCT00671437|Cetuximab|cetuximab|mesh-list
14310535|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310536|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310537|NCT00671502|Carisoprodol|carisoprodol|mesh-list
14310538|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14310539|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310540|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14310541|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910060|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
14910061|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
14910062|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910063|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14910064|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14910065|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14910066|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
14910067|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910068|NCT01354613|Protective Agents|protective agents|mesh-ancestor
14910069|NCT01354665|Interferons|interferons|mesh-list
14910070|NCT01354665|Interferon-beta|interferon-beta|mesh-list
14910071|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
14910072|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910073|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
14910074|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910075|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
14910076|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910077|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14310542|NCT00671515|Pioglitazone|pioglitazone|mesh-list
14310543|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310544|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310545|NCT00671658|Cytarabine|cytarabine|mesh-list
14310546|NCT00671658|Dexamethasone|dexamethasone|mesh-list
14310547|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
14310548|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14310549|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14310550|NCT00671658|Prednisolone|prednisolone|mesh-list
14310551|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
14910078|NCT01354704|Enoxaparin|enoxaparin|mesh-list
14910079|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
14310552|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
14310553|NCT00671658|Rituximab|rituximab|mesh-list
14723480|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723481|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723482|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
14310554|NCT00671658|Doxorubicin|doxorubicin|mesh-list
14310555|NCT00671658|Methotrexate|methotrexate|mesh-list
14310556|NCT00671658|Vincristine|vincristine|mesh-list
14310557|NCT00671658|Asparaginase|asparaginase|mesh-list
14310558|NCT00671658|Pegaspargase|pegaspargase|mesh-list
14310559|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14310560|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
14310561|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14910080|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14910081|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14910082|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221358|NCT03061539|Nivolumab|nivolumab|mesh-list
14723483|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14723484|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723485|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723486|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14723487|NCT00494832|Analgesics|analgesics|mesh-ancestor
14310562|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
14310563|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310564|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310565|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14310566|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
14310567|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310568|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723488|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
14723489|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310569|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14310570|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310571|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
14310572|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
14310573|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310574|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14310575|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
14310576|NCT00671658|Hormones|hormones|mesh-ancestor
14310577|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310578|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14310579|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310580|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14310581|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14310582|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14310583|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310584|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14310585|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
14310586|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14310587|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14310588|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
14310589|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
14310590|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14310591|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14310592|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
14310593|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723490|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15221359|NCT03061539|Ipilimumab|ipilimumab|mesh-list
15221360|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221361|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221362|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221363|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221364|NCT03046927|Vitamin D|vitamin d|mesh-list
15221365|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
15221366|NCT03046927|Vitamins|vitamins|mesh-ancestor
14310594|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14310595|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
14310596|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310597|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
14310598|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14310599|NCT00671658|Protective Agents|protective agents|mesh-ancestor
14310600|NCT00671749|Clindamycin|clindamycin|mesh-list
14310601|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
14310602|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
14310603|NCT00671749|Adapalene|adapalene|mesh-list
14310604|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14723491|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14723492|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14723493|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
14723494|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723495|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723496|NCT00494884|Vildagliptin|vildagliptin|mesh-list
14723497|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14723498|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723499|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14723500|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
14723501|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310605|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14310606|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310607|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14310608|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310609|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310610|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14310611|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14310612|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14310613|NCT00671749|Analgesics|analgesics|mesh-ancestor
14310614|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
14310615|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310616|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310617|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310618|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310619|NCT00671788|Dasatinib|dasatinib|mesh-list
14310620|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310621|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310622|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310623|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310624|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14310625|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
14310626|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14310627|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14310628|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14310629|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310630|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310631|NCT00671879|Carisoprodol|carisoprodol|mesh-list
14310632|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14310633|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310634|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14310635|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310636|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
14310637|NCT00671931|Propofol|propofol|mesh-list
14310638|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14310639|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310640|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310641|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14310642|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
14310643|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
14310644|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14310645|NCT00671931|Analgesics|analgesics|mesh-ancestor
14310646|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
14910083|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15221367|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
15221368|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221369|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15221370|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15221371|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
15221372|NCT03016377|Fludarabine|fludarabine|mesh-list
15221373|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221374|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
15221375|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310647|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910084|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14910085|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910086|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221376|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310648|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14310649|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14310650|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14310651|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
14310652|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310653|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310654|NCT00671970|Bevacizumab|bevacizumab|mesh-list
14310655|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14310656|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310657|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310658|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14310659|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310660|NCT00671970|Growth Substances|growth substances|mesh-ancestor
14310661|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310662|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
14310663|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310664|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310665|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310666|NCT00672100|Ropivacaine|ropivacaine|mesh-list
14310667|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
14310668|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
14310669|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310670|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723502|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723503|NCT00494897|Cytarabine|cytarabine|mesh-list
14723504|NCT00494897|Prednisone|prednisone|mesh-list
14723505|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
14723506|NCT00494897|Methotrexate|methotrexate|mesh-list
14723507|NCT00494897|Vincristine|vincristine|mesh-list
14723508|NCT00494897|Daunorubicin|daunorubicin|mesh-list
14723509|NCT00494897|Asparaginase|asparaginase|mesh-list
14723510|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
14723511|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310671|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
14310672|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310673|NCT00672139|Bromides|bromides|mesh-list
14310674|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
14310675|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
14310676|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14310677|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310678|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
14310679|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310680|NCT00672204|Sirolimus|sirolimus|mesh-list
14310681|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
14310682|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14310683|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14310684|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310685|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14310686|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310687|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
14723512|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
14910087|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
14910088|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910089|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910090|NCT01354860|Lobeline|lobeline|mesh-list
14910091|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15221377|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221378|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
15221379|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221380|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221381|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15221382|NCT03009487|Amlodipine|amlodipine|mesh-list
15221383|NCT03009487|Olmesartan|olmesartan|mesh-list
15221384|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15221385|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
15221386|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15221387|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15221388|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15221389|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723513|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225588|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310688|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310689|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
14310690|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310691|NCT00672243|Sirolimus|sirolimus|mesh-list
14310692|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14310693|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310694|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310695|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310696|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310697|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14310698|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310699|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14310700|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
14310701|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310702|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
14310703|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310704|NCT00672438|Alfentanil|alfentanil|mesh-list
14310705|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14310706|NCT00672438|Narcotics|narcotics|mesh-ancestor
14310707|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310708|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310709|NCT00672438|Analgesics|analgesics|mesh-ancestor
14310710|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
14310711|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310712|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14310713|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
14310714|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
14310715|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
15221390|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221391|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15221392|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221393|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
15221394|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15221395|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15221396|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
15221397|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15221398|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15221399|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221400|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15221401|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15221402|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
15221403|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
15221404|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15221405|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221406|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221407|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
15221408|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15221409|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15221410|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221411|NCT02966782|Azacitidine|azacitidine|mesh-list
15221412|NCT02966782|Venetoclax|venetoclax|mesh-list
15221413|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221414|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
15221415|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221416|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221417|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221418|NCT02961881|Blinatumomab|blinatumomab|mesh-list
15221419|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221420|NCT02954523|Dasatinib|dasatinib|mesh-list
15221421|NCT02954523|Osimertinib|osimertinib|mesh-list
15221422|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221423|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221424|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221425|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221426|NCT02936102|Spartalizumab|spartalizumab|mesh-list
15221427|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221428|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221429|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221430|NCT02927249|Aspirin|aspirin|mesh-list
15221431|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15221432|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15221433|NCT02927249|Analgesics|analgesics|mesh-ancestor
15221434|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
14310716|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14310717|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310718|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
14310719|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310720|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14310721|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
14310722|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14310723|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14310724|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14310725|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310726|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310727|NCT00672594|Sunitinib|sunitinib|mesh-list
14310728|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310729|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14310730|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310731|NCT00672594|Growth Substances|growth substances|mesh-ancestor
14310732|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310733|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14310734|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310735|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310736|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310737|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14310738|NCT00672620|Vortioxetine|vortioxetine|mesh-list
14310739|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14310740|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14310741|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310742|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310743|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310744|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310745|NCT00672620|Analgesics|analgesics|mesh-ancestor
14310746|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
14310747|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310748|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
14310749|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14310750|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
14310751|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14310752|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14310753|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310754|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14310755|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
14310756|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14310757|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14310758|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14310759|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14310760|NCT00672646|Naproxen|naproxen|mesh-list
14310761|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14310762|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14310763|NCT00672646|Analgesics|analgesics|mesh-ancestor
14310764|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
14310765|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310766|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310767|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310768|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14310769|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
14310770|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14310771|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310772|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310773|NCT00672737|Remifentanil|remifentanil|mesh-list
14310774|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14310775|NCT00672737|Narcotics|narcotics|mesh-ancestor
14310776|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310777|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310778|NCT00672737|Analgesics|analgesics|mesh-ancestor
14310779|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
14310780|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310781|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
14310782|NCT00672841|Clotrimazole|clotrimazole|mesh-list
14310783|NCT00672841|Miconazole|miconazole|mesh-list
14310784|NCT00672841|Anidulafungin|anidulafungin|mesh-list
14723514|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723515|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14723516|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
14723517|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723518|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723519|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14723520|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14723521|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
14723522|NCT00494897|Hormones|hormones|mesh-ancestor
14723523|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14723524|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14723525|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14723526|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
14723527|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14723528|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221435|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221436|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310785|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310786|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14310787|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14310788|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14310789|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310790|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310791|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14910092|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
14310792|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
14310793|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310794|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310795|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14310796|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14310797|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14310798|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14310799|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14310800|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14310801|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
14310802|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14310803|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14310804|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
14310805|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310806|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14310807|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14310808|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310809|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310810|NCT00672958|Vortioxetine|vortioxetine|mesh-list
14310811|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
14310812|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14310813|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14310814|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14310815|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723529|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
14910093|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910094|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910095|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14910096|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14910097|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
14910098|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910099|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910100|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
14917592|NCT04941937|Growth Substances|growth substances|mesh-ancestor
14910101|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14910102|NCT01354886|Hormones|hormones|mesh-ancestor
14910103|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910104|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910105|NCT01354925|Insulin|insulin|mesh-list
14910106|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14910107|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310816|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310817|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14310818|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14723530|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
14723531|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723532|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14723533|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14723534|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
14723535|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310819|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310820|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310821|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310822|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
14310823|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14310824|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14310825|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14310826|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14310827|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
14310828|NCT00672984|Guanfacine|guanfacine|mesh-list
14310829|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14310830|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310831|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14310832|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14310833|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310834|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310835|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310836|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310837|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14310838|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14310839|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14310840|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14310841|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
14310842|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310843|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14310844|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310845|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14310846|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310847|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310848|NCT00673075|Carvedilol|carvedilol|mesh-list
14310849|NCT00673075|Nebivolol|nebivolol|mesh-list
14310850|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14310851|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14310852|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
14310853|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723536|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14723537|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723538|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
14910108|NCT01355120|Ipilimumab|ipilimumab|mesh-list
14910109|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14910110|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723539|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
14723540|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14723541|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14723542|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14723543|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14723544|NCT00494988|Insulin|insulin|mesh-list
14723545|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14723546|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
14910111|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14917593|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
14910112|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910113|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
14910114|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14910115|NCT01355198|Glycine|glycine|mesh-list
14910116|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
14910117|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910118|NCT01355198|Expectorants|expectorants|mesh-ancestor
14910119|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
14310854|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310855|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310856|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14310857|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
14310858|NCT00673075|Protective Agents|protective agents|mesh-ancestor
14310859|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14310860|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310861|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14310862|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
14310863|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14310864|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14310865|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14310866|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14310867|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14310868|NCT00673127|Ketoconazole|ketoconazole|mesh-list
14310869|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
14310870|NCT00673127|Dutasteride|dutasteride|mesh-list
14310871|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14310872|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
14310873|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14310874|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14310875|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14910120|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14910121|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
14910122|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910123|NCT01355198|Protective Agents|protective agents|mesh-ancestor
14910124|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910125|NCT01355198|Antidotes|antidotes|mesh-ancestor
14910126|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
14910127|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917099|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917100|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14917101|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14917102|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14917103|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14917104|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14917105|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14917106|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14917107|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14723547|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
14723548|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
14917108|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917109|NCT01395953|Buspirone|buspirone|mesh-list
14723549|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
14723550|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14723551|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729187|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729188|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729189|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
14729190|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729191|NCT00521859|Antiviral Agents|antiviral agents|mesh-ancestor
14723552|NCT00495027|Vaccines|vaccines|mesh-list
14723553|NCT00495027|Immunologic Factors|immunologic factors|mesh-ancestor
14723554|NCT00495027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723555|NCT00495066|Ipilimumab|ipilimumab|mesh-list
14723556|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14723557|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723558|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14723559|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723560|NCT00495092|Biperiden|biperiden|mesh-list
14723561|NCT00495092|Caffeine|caffeine|mesh-list
14723562|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14723563|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723564|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14723565|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723566|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723567|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14723568|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14310876|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310877|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310878|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14310879|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
14310880|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14310881|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310882|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14310883|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14310884|NCT00673153|Vorinostat|vorinostat|mesh-list
14310885|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
14310886|NCT00673153|Calicheamicins|calicheamicins|mesh-list
14310887|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310888|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14310889|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310890|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310891|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310892|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14310893|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
14310894|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14310895|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310896|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310897|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310898|NCT00673244|Furosemide|furosemide|mesh-list
14310899|NCT00673244|Diuretics|diuretics|mesh-ancestor
14310900|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
14310901|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310902|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14310903|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723569|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
14723570|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14310904|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310905|NCT00673387|Pramlintide|pramlintide|mesh-list
14310906|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14310907|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310908|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310909|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
14310910|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14310911|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14310912|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310913|NCT00673439|PENTA|penta|mesh-list
14310914|NCT00673439|Warfarin|warfarin|mesh-list
14910128|NCT01355263|Vitamin A|vitamin a|mesh-list
14910129|NCT01355263|Vitamins|vitamins|mesh-ancestor
14910130|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
15221437|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221438|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221439|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15221440|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15221441|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221442|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14310915|NCT00673439|Fondaparinux|fondaparinux|mesh-list
14310916|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
14310917|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14310918|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
14310919|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14310920|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
14310921|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310922|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310923|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14310924|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14310925|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15221443|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15221444|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221445|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
15221446|NCT02924272|Ixazomib|ixazomib|mesh-list
15221447|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221448|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
15221449|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221450|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310926|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14310927|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14310928|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14310929|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310930|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221451|NCT02908087|Liraglutide|liraglutide|mesh-list
15221452|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15221453|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221454|NCT02908087|Incretins|incretins|mesh-ancestor
15221455|NCT02908087|Hormones|hormones|mesh-ancestor
14310931|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310932|NCT00673452|Analgesics|analgesics|mesh-ancestor
14310933|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
14310934|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310935|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
14910131|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910132|NCT01355276|Domperidone|domperidone|mesh-list
14910133|NCT01355276|Cinitapride|cinitapride|mesh-list
14910134|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
14910135|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
14910136|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310936|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14310937|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
14310938|NCT00673465|Metformin|metformin|mesh-list
14310939|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14310940|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310941|NCT00673673|Bevacizumab|bevacizumab|mesh-list
14310942|NCT00673673|Fluorouracil|fluorouracil|mesh-list
14310943|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310944|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310945|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15221456|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221457|NCT02901483|Cisplatin|cisplatin|mesh-list
14910137|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310946|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310947|NCT00673673|Growth Substances|growth substances|mesh-ancestor
14310948|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310949|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14310950|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
14310951|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310952|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14310953|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14310954|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
15221458|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221459|NCT02874651|Apatinib|apatinib|mesh-list
15221460|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221461|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221462|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310955|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
14310956|NCT00673712|Narcotics|narcotics|mesh-ancestor
14310957|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14310958|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310959|NCT00673712|Analgesics|analgesics|mesh-ancestor
14310960|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
14310961|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14310962|NCT00673738|Docetaxel|docetaxel|mesh-list
14310963|NCT00673738|Cetuximab|cetuximab|mesh-list
14310964|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310965|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
14310966|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
14310967|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
14310968|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14310969|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14310970|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14310971|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
14310972|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14310973|NCT00673790|Losartan|losartan|mesh-list
14310974|NCT00673790|Lisinopril|lisinopril|mesh-list
14723571|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14723572|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14723573|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
14723574|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
14723575|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723576|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14723577|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14723578|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
14723579|NCT00495118|Risperidone|risperidone|mesh-list
14723580|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14723581|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
14723582|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723583|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723584|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723585|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14723586|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14723587|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723588|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14723589|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14723590|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
14723591|NCT00495183|Biperiden|biperiden|mesh-list
14723592|NCT00495183|Caffeine|caffeine|mesh-list
14723593|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14723594|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723595|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14723596|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723597|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723598|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14723599|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14723600|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
14723601|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723602|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14310975|NCT00673790|Nebivolol|nebivolol|mesh-list
14310976|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15221463|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723603|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14723604|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
14723605|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
14723606|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723607|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14723608|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14723609|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
14723610|NCT00495287|Cytarabine|cytarabine|mesh-list
14723611|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723612|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
14723613|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723614|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723615|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
14723616|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221464|NCT02873195|Bevacizumab|bevacizumab|mesh-list
15221465|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15221466|NCT02873195|Capecitabine|capecitabine|mesh-list
15221467|NCT02873195|Atezolizumab|atezolizumab|mesh-list
15221468|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
15221469|NCT02873195|Antibodies|antibodies|mesh-list
15221470|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
15221471|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15221472|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
15221473|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221474|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15221475|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15221476|NCT02873195|Growth Substances|growth substances|mesh-ancestor
15221477|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221478|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
14723617|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723618|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
14723619|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723620|NCT00495313|Metronidazole|metronidazole|mesh-list
14723621|NCT00495313|Doxycycline|doxycycline|mesh-list
14723622|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723623|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14723624|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14723625|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14723626|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
14723627|NCT00495326|Efavirenz|efavirenz|mesh-list
14310977|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14310978|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14310979|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14310980|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723628|NCT00495326|Nevirapine|nevirapine|mesh-list
14723629|NCT00495326|Rifampin|rifampin|mesh-list
15221479|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
14723630|NCT00495326|Isoniazid|isoniazid|mesh-list
14723631|NCT00495326|Ethambutol|ethambutol|mesh-list
15221480|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723632|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14723633|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14723634|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310981|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14310982|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
14310983|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14310984|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14310985|NCT00673790|Protective Agents|protective agents|mesh-ancestor
14310986|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310987|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
14310988|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14310989|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14310990|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14310991|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
14310992|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723635|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723636|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
14723637|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723638|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14723639|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14723640|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14723641|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14723642|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14723643|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14723644|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14723645|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15221481|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
14310993|NCT00673816|Sunitinib|sunitinib|mesh-list
14310994|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14310995|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14310996|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14310997|NCT00673816|Growth Substances|growth substances|mesh-ancestor
14310998|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14310999|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311000|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14311001|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311002|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311003|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14311004|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
14311005|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14311006|NCT00673881|Choline|choline|mesh-list
14311007|NCT00673881|Fenofibrate|fenofibrate|mesh-list
14311008|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14311009|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
14311010|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311011|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14311012|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
14311013|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14311014|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
14311015|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14311016|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14311017|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311018|NCT00673894|Incretins|incretins|mesh-ancestor
14311019|NCT00673894|Hormones|hormones|mesh-ancestor
14311020|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311021|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14311022|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
14311023|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311024|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311025|NCT00673920|Methotrexate|methotrexate|mesh-list
14311026|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
14311027|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14311028|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
14311029|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14311030|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311031|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14311032|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
14311033|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311034|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311035|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
14311036|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311037|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14311038|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311039|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
14311040|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311041|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14311042|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14311043|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14311044|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14311045|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
14311046|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14311047|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
14311048|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14311049|NCT00674115|Omeprazole|omeprazole|mesh-list
14311050|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14311051|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14311052|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14311053|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311054|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311055|NCT00674154|Vitamin D|vitamin d|mesh-list
14311056|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
14311057|NCT00674154|Vitamins|vitamins|mesh-ancestor
14311058|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
14311059|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311060|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14311061|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14311062|NCT00674206|Gemcitabine|gemcitabine|mesh-list
14311063|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
14311064|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14311065|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
14311066|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311067|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311068|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
14311069|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311070|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311071|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723646|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14723647|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
14723648|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14723649|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
14723650|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14723651|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14723652|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14723653|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14723654|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14723655|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
14723656|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14723657|NCT00495339|Levofloxacin|levofloxacin|mesh-list
14723658|NCT00495339|Ofloxacin|ofloxacin|mesh-list
14723659|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14723660|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723661|NCT00495339|Renal Agents|renal agents|mesh-ancestor
14723662|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14723663|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14723664|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14723665|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311072|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
14311073|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311074|NCT00674219|Memantine|memantine|mesh-list
14311075|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14723666|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723667|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723668|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14723669|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14723670|NCT00495352|Bupropion|bupropion|mesh-list
14723671|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14311076|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14311077|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
14311078|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311079|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311080|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311081|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14311082|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14311083|NCT00674323|Ranibizumab|ranibizumab|mesh-list
14311084|NCT00674323|Verteporfin|verteporfin|mesh-list
14311085|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311086|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311087|NCT00674323|Growth Substances|growth substances|mesh-ancestor
14311088|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311089|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311090|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311091|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14311092|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14327940|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
14327941|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
14327942|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327943|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14327944|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14327945|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327946|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327947|NCT00806195|Vaccines|vaccines|mesh-list
14327948|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14723672|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
14723673|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14723674|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14723675|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14723676|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723677|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723678|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
14723679|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723680|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723681|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14723682|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14723683|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723684|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
14723685|NCT00495365|Hematinics|hematinics|mesh-ancestor
14723686|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
14723687|NCT00495378|Hematinics|hematinics|mesh-ancestor
14327949|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
14327950|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327951|NCT00806221|Emollients|emollients|mesh-list
14327952|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
14327953|NCT00806234|Metformin|metformin|mesh-list
14327954|NCT00806234|Olanzapine|olanzapine|mesh-list
14327955|NCT00806234|Risperidone|risperidone|mesh-list
14327956|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14327957|NCT00806234|Aripiprazole|aripiprazole|mesh-list
14723688|NCT00495508|Lumefantrine|lumefantrine|mesh-list
14723689|NCT00495508|Artemether|artemether|mesh-list
14327958|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14327959|NCT00806234|Ziprasidone|ziprasidone|mesh-list
14327960|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14327961|NCT00806234|Asenapine|asenapine|mesh-list
14311093|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
14311094|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311095|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
14311096|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311097|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311098|NCT00674570|Cycloserine|cycloserine|mesh-list
14311099|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
14311100|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311101|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14311102|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311103|NCT00674570|Renal Agents|renal agents|mesh-ancestor
14311104|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14311105|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
14311106|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311107|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
14311108|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311109|NCT00674583|Vaccines|vaccines|mesh-list
14311110|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
14311111|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311112|NCT00674609|Nabiximols|nabiximols|mesh-list
14311113|NCT00674609|Analgesics|analgesics|mesh-ancestor
14311114|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
14311115|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311116|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311117|NCT00674661|Riboflavin|riboflavin|mesh-list
14311118|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14311119|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14311120|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
14311121|NCT00674661|Vitamins|vitamins|mesh-ancestor
14311122|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
14311123|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311124|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14311125|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
14311126|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
14311127|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311128|NCT00674739|Imiquimod|imiquimod|mesh-list
14311129|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14311130|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
14311131|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311132|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311133|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
14311134|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14311135|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
14311136|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14311137|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14311138|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14311139|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311140|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311141|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14311142|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311143|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14311144|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311145|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311146|NCT00675025|Donepezil|donepezil|mesh-list
14311147|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14311148|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311149|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311150|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
14311151|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311152|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311153|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
14311154|NCT00675259|Paclitaxel|paclitaxel|mesh-list
14723690|NCT00495508|Quinine|quinine|mesh-list
14311155|NCT00675259|Bevacizumab|bevacizumab|mesh-list
14917110|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14311156|NCT00675259|Carboplatin|carboplatin|mesh-list
14311157|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14311158|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311159|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
14311160|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
14311161|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
14311162|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311163|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311164|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311165|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311166|NCT00675259|Growth Substances|growth substances|mesh-ancestor
14311167|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311168|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311169|NCT00675428|Natalizumab|natalizumab|mesh-list
14311170|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
14311171|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311172|NCT00675441|Lenalidomide|lenalidomide|mesh-list
14311173|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
14311174|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311175|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311176|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311177|NCT00675441|Growth Substances|growth substances|mesh-ancestor
14311178|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311179|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311180|NCT00675506|Hormones|hormones|mesh-list
14311181|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14311182|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311183|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311184|NCT00675584|Budesonide|budesonide|mesh-list
14311185|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311186|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14311187|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
14311188|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311189|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311190|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14311191|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
14311192|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
14311193|NCT00675584|Hormones|hormones|mesh-ancestor
14311194|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311195|NCT00675597|Bevacizumab|bevacizumab|mesh-list
14311196|NCT00675597|Docetaxel|docetaxel|mesh-list
14311197|NCT00675597|Vinorelbine|vinorelbine|mesh-list
14311198|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311199|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311200|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311201|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311202|NCT00675597|Growth Substances|growth substances|mesh-ancestor
14311203|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311204|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311205|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
14311206|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
14311207|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
14311208|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311209|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14311210|NCT00675792|Bromides|bromides|mesh-list
14311211|NCT00675792|Rocuronium|rocuronium|mesh-list
14311212|NCT00675792|Neostigmine|neostigmine|mesh-list
14311213|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
14311214|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14311215|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14311216|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14311217|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311218|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311219|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14311220|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311221|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311222|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
14311223|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311224|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14311225|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
14311226|NCT00675909|Midazolam|midazolam|mesh-list
14311227|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14311228|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14311229|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311230|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311231|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14311232|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14311233|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14311234|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14311235|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
14311236|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
14311237|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
14311238|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
14311239|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311240|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311241|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
14311242|NCT00675922|Mafenide|mafenide|mesh-list
14311243|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14311244|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311245|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311246|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14311247|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311248|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311249|NCT00675948|Nabiximols|nabiximols|mesh-list
14311250|NCT00675948|Analgesics|analgesics|mesh-ancestor
14311251|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
14311252|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311253|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311254|NCT00675987|Losartan|losartan|mesh-list
14311255|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14311256|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14311257|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14311258|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14311259|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311260|NCT00676091|Vaccines|vaccines|mesh-list
14311261|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14311262|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
14311263|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311264|NCT00676130|Trimethoprim|trimethoprim|mesh-list
14723691|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14723692|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
14723693|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14723694|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14723695|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723696|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14723697|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723698|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14723699|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723700|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14723701|NCT00495508|Analgesics|analgesics|mesh-ancestor
14723702|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
14723703|NCT00495547|Azacitidine|azacitidine|mesh-list
14723704|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
14723705|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723706|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
14723707|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221482|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311265|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14311266|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
14311267|NCT00676130|Cephalexin|cephalexin|mesh-list
14311268|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14311269|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311270|NCT00676130|Renal Agents|renal agents|mesh-ancestor
14311271|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
14311272|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14311273|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14311274|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14311275|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311276|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311277|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14311278|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14311279|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14311280|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311281|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
14311282|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14311283|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
14311284|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311285|NCT00676195|Expectorants|expectorants|mesh-ancestor
14311286|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
14311287|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14311288|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
14311289|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311290|NCT00676195|Protective Agents|protective agents|mesh-ancestor
14311291|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311292|NCT00676195|Antidotes|antidotes|mesh-ancestor
14311293|NCT00676338|Metformin|metformin|mesh-list
14311294|NCT00676338|Pioglitazone|pioglitazone|mesh-list
14311295|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14311296|NCT00676338|Exenatide|exenatide|mesh-list
14311297|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14311298|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311299|NCT00676338|Incretins|incretins|mesh-ancestor
15221483|NCT02851056|Sargramostim|sargramostim|mesh-list
15221484|NCT02851056|Lenograstim|lenograstim|mesh-list
15221485|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
14311300|NCT00676338|Hormones|hormones|mesh-ancestor
14311301|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311302|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14311303|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
14311304|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311305|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221486|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221487|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15221488|NCT02834975|Paclitaxel|paclitaxel|mesh-list
15221489|NCT02834975|Carboplatin|carboplatin|mesh-list
15221490|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
14311306|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14311307|NCT00676364|Lidocaine|lidocaine|mesh-list
14311308|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
14311309|NCT00676364|Anesthetics|anesthetics|mesh-list
14311310|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311311|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311312|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
14311313|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311314|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14311315|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14311316|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14311317|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14311318|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311319|NCT00676403|Pregabalin|pregabalin|mesh-list
14311320|NCT00676403|Analgesics|analgesics|mesh-ancestor
14311321|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
14311322|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311323|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311324|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
14311325|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14311326|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14311327|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311328|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14311329|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14311330|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14311331|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311332|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14311333|NCT00676520|Everolimus|everolimus|mesh-list
14311334|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311335|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311336|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
14311337|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311338|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
14311339|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311340|NCT00676650|Prednisone|prednisone|mesh-list
14311341|NCT00676650|Sunitinib|sunitinib|mesh-list
14311342|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311343|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
14311344|NCT00676650|Hormones|hormones|mesh-ancestor
14311345|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311346|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311347|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14311348|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311349|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311350|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311351|NCT00676650|Growth Substances|growth substances|mesh-ancestor
14311352|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311353|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14311354|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311355|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311356|NCT00676663|Exemestane|exemestane|mesh-list
14311357|NCT00676663|Entinostat|entinostat|mesh-list
14311358|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311359|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14311360|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14311361|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311362|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311363|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14311364|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
14311365|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311366|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311367|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14311368|NCT00676676|Testosterone|testosterone|mesh-list
14311369|NCT00676676|Androgens|androgens|mesh-ancestor
14311370|NCT00676676|Hormones|hormones|mesh-ancestor
14311371|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311372|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311373|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
14311374|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311375|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
14311376|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311377|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311378|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14311379|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
14311380|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311381|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311382|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14311383|NCT00676897|Simvastatin|simvastatin|mesh-list
14311384|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14311385|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14311386|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
14311387|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311388|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14311389|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14311390|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311391|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
14311392|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311393|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14311394|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311395|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311396|NCT00677352|Sertraline|sertraline|mesh-list
14311397|NCT00677352|Paroxetine|paroxetine|mesh-list
14311398|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
14311399|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14311400|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14311401|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14311402|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14311403|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311404|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311405|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
14311406|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311407|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14311408|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14311409|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14311410|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311411|NCT00677365|Levofloxacin|levofloxacin|mesh-list
14311412|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14311413|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311414|NCT00677365|Renal Agents|renal agents|mesh-ancestor
14311415|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311416|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14311417|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14311418|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311419|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311420|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311421|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14311422|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14311423|NCT00677534|Vitamin D|vitamin d|mesh-list
14311424|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
14311425|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
14311426|NCT00677534|Vitamins|vitamins|mesh-ancestor
14311427|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
14311428|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311429|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14311430|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14311431|NCT00677833|Azithromycin|azithromycin|mesh-list
14311432|NCT00677833|Chloroquine|chloroquine|mesh-list
14311433|NCT00677833|Lumefantrine|lumefantrine|mesh-list
14311434|NCT00677833|Artemether|artemether|mesh-list
14311435|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14311436|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311437|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311438|NCT00677833|Amebicides|amebicides|mesh-ancestor
14311439|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14311440|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14311441|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
14311442|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311443|NCT00677924|Zalutumumab|zalutumumab|mesh-list
14311444|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311445|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311446|NCT00678015|Masoprocol|masoprocol|mesh-list
14311447|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
14311448|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311449|NCT00678015|Protective Agents|protective agents|mesh-ancestor
14311450|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311451|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14311452|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311453|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14311454|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14311455|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14311456|NCT00678015|Analgesics|analgesics|mesh-ancestor
14311457|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
14311458|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311459|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311460|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311461|NCT00678080|Metformin|metformin|mesh-list
14311462|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14311463|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311464|NCT00678210|Tofacitinib|tofacitinib|mesh-list
14311465|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14311466|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311467|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311468|NCT00678301|Vaccines|vaccines|mesh-list
14311469|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
14311470|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311471|NCT00678379|Lidocaine|lidocaine|mesh-list
14311472|NCT00678379|Clonidine|clonidine|mesh-list
14311473|NCT00678379|Bupivacaine|bupivacaine|mesh-list
14311474|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
14311475|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
14311476|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311477|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311478|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
14311479|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311480|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14311481|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14311482|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14311483|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14311484|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311485|NCT00678379|Analgesics|analgesics|mesh-ancestor
14311486|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14311487|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
14311488|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
14327962|NCT00806234|Iloperidone|iloperidone|mesh-list
14311489|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14311490|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14311491|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14311492|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
14311493|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311494|NCT00678392|Sorafenib|sorafenib|mesh-list
14311495|NCT00678392|Axitinib|axitinib|mesh-list
14311496|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311497|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14311498|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311499|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311500|NCT00678418|Naltrexone|naltrexone|mesh-list
14311501|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14311502|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14311503|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311504|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
14311505|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311506|NCT00678470|Alefacept|alefacept|mesh-list
14311507|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
14311508|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
14311509|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311510|NCT00678535|Capecitabine|capecitabine|mesh-list
14311511|NCT00678535|Cetuximab|cetuximab|mesh-list
14311512|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311513|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14311514|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
14311515|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311516|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311517|NCT00678561|Tofacitinib|tofacitinib|mesh-list
14311518|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221491|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15221492|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221493|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
15221494|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
15221495|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
15221496|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221497|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221498|NCT02818868|Apixaban|apixaban|mesh-list
15221499|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15221500|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
15221501|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15221502|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
15221503|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221504|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311519|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311520|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311521|NCT00678652|Vaccines|vaccines|mesh-list
14311522|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
14311523|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311524|NCT00678691|Modafinil|modafinil|mesh-list
14311525|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14311526|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311527|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14311528|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14311529|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14311530|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311531|NCT00678795|Nabiximols|nabiximols|mesh-list
14311532|NCT00678795|Analgesics|analgesics|mesh-ancestor
14311533|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
14311534|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311535|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311536|NCT00678834|Tocopherols|tocopherols|mesh-list
14311537|NCT00678834|Vitamin E|vitamin e|mesh-list
14311538|NCT00678834|Tocotrienols|tocotrienols|mesh-list
14311539|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
14311540|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
14311541|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311542|NCT00678834|Protective Agents|protective agents|mesh-ancestor
14311543|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311544|NCT00678834|Vitamins|vitamins|mesh-ancestor
14311545|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
14311546|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
14311547|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
14311548|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723708|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221505|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
14311549|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311550|NCT00679029|Gemcitabine|gemcitabine|mesh-list
14311551|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
14311552|NCT00679029|Bevacizumab|bevacizumab|mesh-list
14311553|NCT00679029|Doxorubicin|doxorubicin|mesh-list
14311554|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14311555|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14311556|NCT00679029|Antibodies|antibodies|mesh-list
14311557|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
14311558|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14311559|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311560|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311561|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311562|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
14311563|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311564|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311565|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14311566|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
14311567|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14311568|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311569|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311570|NCT00679029|Growth Substances|growth substances|mesh-ancestor
14311571|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311572|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14311573|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
14311574|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
14311575|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311576|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311577|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14311578|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14311579|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14311580|NCT00679042|Exenatide|exenatide|mesh-list
14311581|NCT00679042|Sirolimus|sirolimus|mesh-list
14311582|NCT00679042|Etanercept|etanercept|mesh-list
14311583|NCT00679042|Tacrolimus|tacrolimus|mesh-list
14311584|NCT00679042|Basiliximab|basiliximab|mesh-list
14311585|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311586|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
14311587|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311588|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14311589|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311590|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311591|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311592|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311593|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14311594|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311595|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
14311596|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14311597|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14311598|NCT00679042|Analgesics|analgesics|mesh-ancestor
14311599|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
14311600|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311601|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311602|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311603|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14311604|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14311605|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14311606|NCT00679042|Incretins|incretins|mesh-ancestor
14311607|NCT00679042|Hormones|hormones|mesh-ancestor
14327963|NCT00806234|Perphenazine|perphenazine|mesh-list
14311608|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311609|NCT00679211|Trastuzumab|trastuzumab|mesh-list
14311610|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14311611|NCT00679211|Maytansine|maytansine|mesh-list
14311612|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311613|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311614|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14311615|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
14311616|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
14311617|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
14311618|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311619|NCT00679289|Interferons|interferons|mesh-list
14311620|NCT00679289|Ecromeximab|ecromeximab|mesh-list
14311621|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311622|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
14311623|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311624|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311625|NCT00679302|Trimethoprim|trimethoprim|mesh-list
14311626|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14311627|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
14311628|NCT00679302|Simethicone|simethicone|mesh-list
14311629|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14311630|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311631|NCT00679302|Renal Agents|renal agents|mesh-ancestor
14311632|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
14311633|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14311634|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14311635|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14311636|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311637|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311638|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14311639|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14311640|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14311641|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
14311642|NCT00679302|Emollients|emollients|mesh-ancestor
14311643|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
14311644|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311645|NCT00679341|Docetaxel|docetaxel|mesh-list
14311646|NCT00679341|Trastuzumab|trastuzumab|mesh-list
14311647|NCT00679341|Maytansine|maytansine|mesh-list
14311648|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14311649|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311650|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
14311651|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
14311652|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
14311653|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311654|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311655|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14311656|NCT00679367|Dexamethasone|dexamethasone|mesh-list
14311657|NCT00679367|Lenalidomide|lenalidomide|mesh-list
14311658|NCT00679367|Melphalan|melphalan|mesh-list
14311659|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221506|NCT02809131|Levofloxacin|levofloxacin|mesh-list
15221507|NCT02809131|Ofloxacin|ofloxacin|mesh-list
15221508|NCT02809131|Clindamycin|clindamycin|mesh-list
15221509|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
15221510|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
15221511|NCT02809131|Cephalexin|cephalexin|mesh-list
15221512|NCT02809131|Polymyxins|polymyxins|mesh-list
15221513|NCT02809131|Bacitracin|bacitracin|mesh-list
15221514|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15221515|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221516|NCT02809131|Renal Agents|renal agents|mesh-ancestor
15221517|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311660|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
14311661|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
14311662|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311663|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311664|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14311665|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
14311666|NCT00679367|Hormones|hormones|mesh-ancestor
14311667|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311668|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14311669|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311670|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
14311671|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311672|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311673|NCT00679367|Growth Substances|growth substances|mesh-ancestor
14311674|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311675|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14311676|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
14311677|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311678|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14311679|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327964|NCT00806234|Fluoxetine|fluoxetine|mesh-list
14327965|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14327966|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327967|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14327968|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
14327969|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327970|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327971|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14327972|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14327973|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14327974|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14327975|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14327976|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
14327977|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
14327978|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
14327979|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327980|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327981|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14327982|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327983|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327984|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
14327985|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
14327986|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14327987|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14327988|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14327989|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14327990|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14327991|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14327992|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15221518|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15221519|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221520|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311680|NCT00679380|Budesonide|budesonide|mesh-list
14311681|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311682|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14311683|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
14311684|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311685|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311686|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14311687|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
14311688|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
14311689|NCT00679380|Hormones|hormones|mesh-ancestor
14311690|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311691|NCT00679432|Budesonide|budesonide|mesh-list
14311692|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311693|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14311694|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
14311695|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311696|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311697|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14311698|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
14311699|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
14311700|NCT00679432|Hormones|hormones|mesh-ancestor
14311701|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311702|NCT00679627|Galantamine|galantamine|mesh-list
14311703|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14311704|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311705|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311706|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
14311707|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311708|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311709|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14311710|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
14311711|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311712|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
14311713|NCT00679939|Metformin|metformin|mesh-list
14311714|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
14311715|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14311716|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311717|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14311718|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
14311719|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14311720|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14311721|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
14311722|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311723|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14311724|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14311725|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311726|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
14311727|NCT00680043|Hematinics|hematinics|mesh-ancestor
14311728|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
14311729|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
14311730|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14311731|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
14311732|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311733|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311734|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14311735|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
14311736|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14311737|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14311738|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14311739|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
14311740|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311741|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311742|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
14311743|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14311744|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
14311745|NCT00680121|Benphothiamine|benphothiamine|mesh-list
14311746|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14311747|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
14311748|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311749|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
14311750|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
14311751|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311752|NCT00680186|Warfarin|warfarin|mesh-list
14311753|NCT00680186|Dabigatran|dabigatran|mesh-list
14311754|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
14311755|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
14311756|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14311757|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
14311758|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311759|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311760|NCT00680225|Ranibizumab|ranibizumab|mesh-list
14311761|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311762|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311763|NCT00680225|Growth Substances|growth substances|mesh-ancestor
14311764|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311765|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311766|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311767|NCT00680407|Silymarin|silymarin|mesh-list
14311768|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
14311769|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311770|NCT00680407|Protective Agents|protective agents|mesh-ancestor
14311771|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311772|NCT00680459|Ethanol|ethanol|mesh-list
14311773|NCT00680459|Heparin|heparin|mesh-list
14311774|NCT00680459|Anticoagulants|anticoagulants|mesh-list
14311775|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14311776|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14311777|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311778|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14311779|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311780|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311781|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311782|NCT00680628|Enoxaparin|enoxaparin|mesh-list
14311783|NCT00680628|Tenecteplase|tenecteplase|mesh-list
14311784|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
14311785|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
14311786|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14311787|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14311788|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311789|NCT00680706|Thiamine|thiamine|mesh-list
14311790|NCT00680706|Vitamins|vitamins|mesh-ancestor
14311791|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
14311792|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311793|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
14311794|NCT00680745|Metformin|metformin|mesh-list
14311795|NCT00680745|Pioglitazone|pioglitazone|mesh-list
14311796|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
14311797|NCT00680745|Glimepiride|glimepiride|mesh-list
14311798|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
14311799|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14311800|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723709|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723710|NCT00495547|Hematinics|hematinics|mesh-ancestor
14723711|NCT00495560|Misoprostol|misoprostol|mesh-list
14723712|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15221521|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221522|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311801|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14311802|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311803|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14311804|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14311805|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
14311806|NCT00680797|Testosterone|testosterone|mesh-list
14311807|NCT00680797|Estrogens|estrogens|mesh-list
14311808|NCT00680797|Androgens|androgens|mesh-ancestor
14311809|NCT00680797|Hormones|hormones|mesh-ancestor
14311810|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221523|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15221524|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15221525|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15221526|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15221527|NCT02798471|Heparin|heparin|mesh-list
15221528|NCT02798471|Enoxaparin|enoxaparin|mesh-list
15221529|NCT02798471|Warfarin|warfarin|mesh-list
15221530|NCT02798471|Edoxaban|edoxaban|mesh-list
15221531|NCT02798471|Fondaparinux|fondaparinux|mesh-list
14311811|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311812|NCT00680823|Ropivacaine|ropivacaine|mesh-list
14311813|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
15221532|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
14311814|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
14311815|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311816|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311817|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
14311818|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221533|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15221534|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15221535|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221536|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15221537|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
15221538|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15221539|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
15221540|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221541|NCT02785952|Nivolumab|nivolumab|mesh-list
15221542|NCT02785952|Ipilimumab|ipilimumab|mesh-list
15221543|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221544|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221545|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221546|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221547|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
15221548|NCT02784171|Pemetrexed|pemetrexed|mesh-list
15221549|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221550|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311819|NCT00680836|Rifaximin|rifaximin|mesh-list
14311820|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14311821|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14311822|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910138|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910139|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14910140|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
14910141|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910142|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910143|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14910144|NCT01355354|Digoxin|digoxin|mesh-list
14910145|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14910146|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14910147|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910148|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910149|NCT01355354|Protective Agents|protective agents|mesh-ancestor
14910150|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910151|NCT01355367|Nifedipine|nifedipine|mesh-list
14311823|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14311824|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
14311825|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311826|NCT00680953|Denosumab|denosumab|mesh-list
14311827|NCT00680953|Alendronate|alendronate|mesh-list
14311828|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14311829|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311830|NCT00680992|Denosumab|denosumab|mesh-list
14910152|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15221551|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311831|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
14311832|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
14723713|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
14723714|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14723715|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723716|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14723717|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14723718|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
14723719|NCT00495573|Acyclovir|acyclovir|mesh-list
14723720|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
14311833|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
14311834|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311835|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14311836|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14311837|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
14311838|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14311839|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14311840|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14311841|NCT00681187|Lanreotide|lanreotide|mesh-list
14311842|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311843|NCT00681265|Glycerol|glycerol|mesh-list
14311844|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14311845|NCT00681265|Protective Agents|protective agents|mesh-ancestor
14311846|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311847|NCT00681538|Nabiximols|nabiximols|mesh-list
14311848|NCT00681538|Analgesics|analgesics|mesh-ancestor
14311849|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
14311850|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311851|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311852|NCT00681590|Vitamin D|vitamin d|mesh-list
14311853|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
14311854|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
14311855|NCT00681590|Vitamins|vitamins|mesh-list
14311856|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
14311857|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311858|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14311859|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14311860|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14311861|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
14311862|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14311863|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14723721|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723722|NCT00495651|Isoniazid|isoniazid|mesh-list
15221552|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221553|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15221554|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15221555|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15221556|NCT02758717|Nivolumab|nivolumab|mesh-list
15221557|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15221558|NCT02758717|Antibodies|antibodies|mesh-list
15221559|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
15221560|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15221561|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
15221562|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
15221563|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311864|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14311865|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311866|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311867|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14311868|NCT00681824|Thrombin|thrombin|mesh-list
14311869|NCT00681824|Aprotinin|aprotinin|mesh-list
14311870|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
14311871|NCT00681824|Coagulants|coagulants|mesh-ancestor
14311872|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14311873|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14311874|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
14311875|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14311876|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311877|NCT00681863|Pramipexole|pramipexole|mesh-list
14311878|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
14311879|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311880|NCT00681863|Protective Agents|protective agents|mesh-ancestor
14311881|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311882|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14311883|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14311884|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
14723723|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14723724|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
14723725|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14723726|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723727|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14311885|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
14311886|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311887|NCT00681889|Ranibizumab|ranibizumab|mesh-list
14311888|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311889|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311890|NCT00681889|Growth Substances|growth substances|mesh-ancestor
14311891|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311892|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311893|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311894|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
14311895|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14311896|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14311897|NCT00682357|Prednisolone|prednisolone|mesh-list
14311898|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
14311899|NCT00682357|Lidocaine|lidocaine|mesh-list
14311900|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14311901|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
14311902|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
14311903|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
14311904|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311905|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311906|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
14311907|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311908|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14311909|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14311910|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14311911|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14311912|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311913|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311914|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
14311915|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
14311916|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14723728|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14723729|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
14723730|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910153|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910154|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910155|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15221564|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221565|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221566|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221567|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15221568|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15221569|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15221570|NCT02738866|Fulvestrant|fulvestrant|mesh-list
14311917|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
14311918|NCT00682357|Hormones|hormones|mesh-ancestor
14311919|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311920|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14311921|NCT00682357|Protective Agents|protective agents|mesh-ancestor
14311922|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14311923|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311924|NCT00682435|Hydromorphone|hydromorphone|mesh-list
14311925|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14311926|NCT00682435|Narcotics|narcotics|mesh-ancestor
14311927|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311928|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311929|NCT00682435|Analgesics|analgesics|mesh-ancestor
14311930|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
14311931|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311932|NCT00682448|Metformin|metformin|mesh-list
14311933|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14311934|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311935|NCT00682461|Nicotine|nicotine|mesh-list
14311936|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14311937|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
14311938|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311939|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311940|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14311941|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14311942|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
14311943|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311944|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311945|NCT00682539|Triamcinolone|triamcinolone|mesh-list
14910156|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221571|NCT02738866|Palbociclib|palbociclib|mesh-list
15221572|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14723731|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14723732|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
15221573|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221574|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15221575|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15221576|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
15221577|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221578|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221579|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221580|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221581|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221582|NCT02730429|Letrozole|letrozole|mesh-list
15221583|NCT02730429|Palbociclib|palbociclib|mesh-list
15221584|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311946|NCT00682539|Bevacizumab|bevacizumab|mesh-list
14311947|NCT00682539|Ranibizumab|ranibizumab|mesh-list
14311948|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14311949|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14311950|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14311951|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14311952|NCT00682539|Growth Substances|growth substances|mesh-ancestor
14311953|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311954|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
14311955|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311956|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
14311957|NCT00682539|Hormones|hormones|mesh-ancestor
14311958|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14311959|NCT00682643|Fluticasone|fluticasone|mesh-list
14311960|NCT00682643|Xhance|xhance|mesh-list
14311961|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14311962|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14311963|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
14311964|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311965|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311966|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14311967|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
14311968|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
14311969|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14311970|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
14311971|NCT00682734|Promethazine|promethazine|mesh-list
14311972|NCT00682734|Metoclopramide|metoclopramide|mesh-list
14311973|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14311974|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14311975|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14311976|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14311977|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
14311978|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
14311979|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
14311980|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14311981|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
14311982|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
14311983|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14311984|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14311985|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
14311986|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
14311987|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14311988|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311989|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14311990|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
14311991|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
14311992|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14311993|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14311994|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
14311995|NCT00682786|Fluorouracil|fluorouracil|mesh-list
14311996|NCT00682786|Irinotecan|irinotecan|mesh-list
14311997|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
14311998|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14311999|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14312000|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312001|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312002|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
14312003|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312004|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14312005|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14312006|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221585|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15221586|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15221587|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221588|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221589|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15221590|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
15221591|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312007|NCT00682890|Metformin|metformin|mesh-list
14723733|NCT00495729|Simvastatin|simvastatin|mesh-list
14723734|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14723735|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14723736|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
14723737|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723738|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14312008|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312009|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312010|NCT00682929|Dronabinol|dronabinol|mesh-list
14312011|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
14312012|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312013|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14312014|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312015|NCT00682929|Analgesics|analgesics|mesh-ancestor
14312016|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
14312017|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312018|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14312019|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14312020|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312021|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312022|NCT00682929|Hormones|hormones|mesh-ancestor
14312023|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312024|NCT00683046|Fludarabine|fludarabine|mesh-list
14312025|NCT00683046|Melphalan|melphalan|mesh-list
14312026|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
14312027|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312028|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312029|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312030|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
14312031|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312032|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14312033|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
14312034|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14312035|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14312036|NCT00683085|Vaccines|vaccines|mesh-list
14312037|NCT00683085|Immunologic Factors|immunologic factors|mesh-ancestor
14312038|NCT00683085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312039|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
14312040|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
14312041|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14312042|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312043|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14312044|NCT00683332|Tigecycline|tigecycline|mesh-list
14312045|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14312046|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312047|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14312048|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312049|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312050|NCT00683384|Etanercept|etanercept|mesh-list
14312051|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312052|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312053|NCT00683384|Analgesics|analgesics|mesh-ancestor
14312054|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
14312055|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312056|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312057|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312058|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312059|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312060|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312061|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
14312062|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14312063|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
14312064|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312065|NCT00683475|Prednisone|prednisone|mesh-list
14312066|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
14312067|NCT00683475|Ramucirumab|ramucirumab|mesh-list
14312068|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14312069|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312070|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
14312071|NCT00683475|Hormones|hormones|mesh-ancestor
14312072|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312073|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312074|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14312075|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312076|NCT00683475|Analgesics|analgesics|mesh-ancestor
14312077|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
14312078|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221592|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221593|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221594|NCT02730416|Paclitaxel|paclitaxel|mesh-list
15221595|NCT02730416|Carboplatin|carboplatin|mesh-list
14312079|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14312080|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14312081|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312082|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312083|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
14312084|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14312085|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
14312086|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14312087|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14312088|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14312089|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312090|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312091|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312092|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
14312093|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312094|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14312095|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14312096|NCT00683618|Atorvastatin|atorvastatin|mesh-list
14312097|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14312098|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14312099|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14312100|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
14312101|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312102|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14312103|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14312104|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312105|NCT00683644|Zinc|zinc|mesh-list
14312106|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
14312107|NCT00683644|Trace Elements|trace elements|mesh-ancestor
14312108|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
14312109|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312110|NCT00683644|Astringents|astringents|mesh-ancestor
14312111|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312112|NCT00683657|Saxagliptin|saxagliptin|mesh-list
14312113|NCT00683657|Incretins|incretins|mesh-ancestor
15221596|NCT02730416|Nintedanib|nintedanib|mesh-list
14312114|NCT00683657|Hormones|hormones|mesh-ancestor
14327993|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221597|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15221598|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312115|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312116|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312117|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14312118|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
14312119|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312120|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312121|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312122|NCT00683774|Diazoxide|diazoxide|mesh-list
14312123|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14312124|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
14312125|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15221599|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
15221600|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
14312126|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14312127|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14312128|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312129|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312130|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312131|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312132|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
14312133|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14312134|NCT00683852|Aripiprazole|aripiprazole|mesh-list
14312135|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
14312136|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14312137|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14312138|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14312139|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312140|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312141|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
14312142|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
14312143|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312144|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312145|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14312146|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14312147|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
14312148|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14312149|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14312150|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14312151|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14312152|NCT00683878|Pioglitazone|pioglitazone|mesh-list
14312153|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
14312154|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14312155|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312156|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312157|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14312158|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312159|NCT00683904|Carboplatin|carboplatin|mesh-list
14312160|NCT00683904|Epothilones|epothilones|mesh-list
14312161|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312162|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
14312163|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
14312164|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14312165|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312166|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
14312167|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14312168|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312169|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14312170|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
14312171|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14312172|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312173|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312174|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221601|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
14312175|NCT00684073|Buprenorphine|buprenorphine|mesh-list
14312176|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14312177|NCT00684073|Naloxone|naloxone|mesh-list
14312178|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14312179|NCT00684073|Narcotics|narcotics|mesh-ancestor
14312180|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312181|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312182|NCT00684073|Analgesics|analgesics|mesh-ancestor
14312183|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
14312184|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312185|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14312186|NCT00684177|Retapamulin|retapamulin|mesh-list
14312187|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14312188|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312189|NCT00684203|Aspirin|aspirin|mesh-list
14312190|NCT00684203|Clopidogrel|clopidogrel|mesh-list
14312191|NCT00684203|Vorapaxar|vorapaxar|mesh-list
14312192|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312193|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312194|NCT00684203|Analgesics|analgesics|mesh-ancestor
14312195|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
14312196|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312197|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312198|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312199|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312200|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14312201|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14312202|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312203|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14312204|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14312205|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312206|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
14312207|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14312208|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14312209|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14312210|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
14312211|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312212|NCT00684242|Lenalidomide|lenalidomide|mesh-list
14312213|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
14312214|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312215|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14723739|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14723740|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723741|NCT00495781|Iron|iron|mesh-list
14723742|NCT00495781|Trace Elements|trace elements|mesh-ancestor
14723743|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
14723744|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723745|NCT00495846|Octreotide|octreotide|mesh-list
14723746|NCT00495846|Lanreotide|lanreotide|mesh-list
14723747|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14723748|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14312216|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14312217|NCT00684242|Growth Substances|growth substances|mesh-ancestor
14723749|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312218|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14312219|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312220|NCT00684307|Vitamin K|vitamin k|mesh-list
14312221|NCT00684307|Warfarin|warfarin|mesh-list
14312222|NCT00684307|Vitamins|vitamins|mesh-ancestor
14312223|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
14312224|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312225|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
14312226|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14312227|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14312228|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312229|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
14312230|NCT00684307|Coagulants|coagulants|mesh-ancestor
14312231|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
14312232|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312233|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14312234|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312235|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312236|NCT00684515|Aspirin|aspirin|mesh-list
14312237|NCT00684515|Vorapaxar|vorapaxar|mesh-list
14312238|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312239|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312240|NCT00684515|Analgesics|analgesics|mesh-ancestor
14312241|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
14312242|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312243|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312244|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312245|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312246|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14312247|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14312248|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312249|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14312250|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14312251|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312252|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
14312253|NCT00684554|Buprenorphine|buprenorphine|mesh-list
14312254|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14312255|NCT00684554|Narcotics|narcotics|mesh-ancestor
14312256|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312257|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312258|NCT00684554|Analgesics|analgesics|mesh-ancestor
14312259|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
14312260|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312261|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14312262|NCT00684567|Temozolomide|temozolomide|mesh-list
14312263|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14312264|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
14312265|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910157|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
14910158|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
14910159|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14910160|NCT01355380|Iloprost|iloprost|mesh-list
14910161|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14910162|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
14312266|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312267|NCT00684645|Sunitinib|sunitinib|mesh-list
14312268|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312269|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14312270|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14312271|NCT00684645|Growth Substances|growth substances|mesh-ancestor
14312272|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312273|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
14312274|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14312275|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312276|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312277|NCT00684723|Lovastatin|lovastatin|mesh-list
14312278|NCT00684723|L 647318|l 647318|mesh-list
14312279|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
14312280|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14312281|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14312282|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
14312283|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312284|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14312285|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14312286|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910163|NCT01355445|Irinotecan|irinotecan|mesh-list
14910164|NCT01355445|Vincristine|vincristine|mesh-list
14312287|NCT00684762|Cilostazol|cilostazol|mesh-list
14312288|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14312289|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
14312290|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312291|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312292|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14312293|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
14312294|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14312295|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14312296|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312297|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14312298|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
14312299|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14312300|NCT00684762|Protective Agents|protective agents|mesh-ancestor
14312301|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14312302|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14312303|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312304|NCT00684775|Naltrexone|naltrexone|mesh-list
14312305|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14312306|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14312307|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312308|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
14312309|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312310|NCT00684814|Zolpidem|zolpidem|mesh-list
14312311|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14312312|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14312313|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312314|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312315|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14312316|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
14312317|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
14312318|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312319|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312320|NCT00684983|Capecitabine|capecitabine|mesh-list
14312321|NCT00684983|Lapatinib|lapatinib|mesh-list
14312322|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14312323|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14312324|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
14312325|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312326|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312327|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14312328|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312329|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
14312330|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312331|NCT00684996|Bevacizumab|bevacizumab|mesh-list
14312332|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14312333|NCT00684996|Antibodies|antibodies|mesh-list
14312334|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
14312335|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14312336|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312337|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14312338|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14312339|NCT00684996|Growth Substances|growth substances|mesh-ancestor
14312340|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312341|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
14312342|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
14723750|NCT00495872|Lenalidomide|lenalidomide|mesh-list
14312343|NCT00685139|Zonisamide|zonisamide|mesh-list
14312344|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
14312345|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14312346|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312347|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312348|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14312349|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312350|NCT00685165|Primidone|primidone|mesh-list
14312351|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
14312352|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
14312353|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
14312354|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312355|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312356|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723751|NCT00495872|Sunitinib|sunitinib|mesh-list
14723752|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14723753|NCT00495872|Sorafenib|sorafenib|mesh-list
14723754|NCT00495872|Dasatinib|dasatinib|mesh-list
14723755|NCT00495872|Lapatinib|lapatinib|mesh-list
14723756|NCT00495872|Valproic Acid|valproic acid|mesh-list
14312357|NCT00685178|Topiramate|topiramate|mesh-list
14723757|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
14723758|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312358|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
14312359|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312360|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312361|NCT00685295|Fentanyl|fentanyl|mesh-list
14312362|NCT00685295|Oxycodone|oxycodone|mesh-list
14312363|NCT00685295|Lansoprazole|lansoprazole|mesh-list
14312364|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
14312365|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14312366|NCT00685295|Narcotics|narcotics|mesh-ancestor
14312367|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312368|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312369|NCT00685295|Analgesics|analgesics|mesh-ancestor
14312370|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
14312371|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312372|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14312373|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14312374|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
14312375|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
14312376|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14312377|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312378|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14312379|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312380|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312381|NCT00685334|Olanzapine|olanzapine|mesh-list
14312382|NCT00685334|Aripiprazole|aripiprazole|mesh-list
14312383|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
14312384|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
14312385|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312386|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312387|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312388|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14312389|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14312390|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312391|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14312392|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14312393|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14312394|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312395|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312396|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312397|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
14312398|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
14312399|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
14312400|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
14312401|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14312402|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14312403|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14312404|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14312405|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14312406|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14312407|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14312408|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
14312409|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312410|NCT00685685|Lovastatin|lovastatin|mesh-list
14312411|NCT00685685|L 647318|l 647318|mesh-list
14312412|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
14723759|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14723760|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14723761|NCT00495872|Growth Substances|growth substances|mesh-ancestor
14312413|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14312414|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14312415|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
14312416|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312417|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14312418|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14312419|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312420|NCT00685763|Gemcitabine|gemcitabine|mesh-list
14723762|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
14723763|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312421|NCT00685763|Capecitabine|capecitabine|mesh-list
14312422|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14312423|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
14312424|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312425|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312426|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
14312427|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312428|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312429|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312430|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
14312431|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312432|NCT00685802|Cilostazol|cilostazol|mesh-list
14312433|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14312434|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
14312435|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312436|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312437|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14312438|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
14312439|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14312440|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15221602|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221603|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15221604|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312441|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312442|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14312443|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
14910165|NCT01355445|Temozolomide|temozolomide|mesh-list
15221605|NCT02693821|Gabapentin|gabapentin|mesh-list
15221606|NCT02693821|Analgesics|analgesics|mesh-ancestor
15221607|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
15221608|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221609|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221610|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
15221611|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15221612|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14312444|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14312445|NCT00685802|Protective Agents|protective agents|mesh-ancestor
14312446|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14312447|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14312448|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312449|NCT00685945|Isosorbide|isosorbide|mesh-list
14723764|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14723765|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723766|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723767|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
14723768|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
14723769|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723770|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
14723771|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14723772|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723773|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14723774|NCT00495898|Sirolimus|sirolimus|mesh-list
14723775|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14312450|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14312451|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14312452|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
14312453|NCT00685945|Bradykinin|bradykinin|mesh-list
14312454|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14312455|NCT00685945|Kininogens|kininogens|mesh-list
14312456|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
14312457|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14312458|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14312459|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312460|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312461|NCT00685945|Urological Agents|urological agents|mesh-ancestor
14312462|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14312463|NCT00685945|Diuretics|diuretics|mesh-ancestor
14312464|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
14312465|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312466|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14312467|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14312468|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
14312469|NCT00686127|Lidocaine|lidocaine|mesh-list
14312470|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
14312471|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
14312472|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312473|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723776|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312474|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
14312475|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312476|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14312477|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14312478|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14312479|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312480|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312481|NCT00686166|Capecitabine|capecitabine|mesh-list
14312482|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
14312483|NCT00686166|Cetuximab|cetuximab|mesh-list
14312484|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14312485|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
14312486|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312487|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312488|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14312489|NCT00686231|Lidocaine|lidocaine|mesh-list
14312490|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
14312491|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
14312492|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
14312493|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312494|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312495|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
14312496|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312497|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14312498|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14723777|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14312499|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14312500|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312501|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312502|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
14312503|NCT00686335|Prednisone|prednisone|mesh-list
14312504|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312505|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
14312506|NCT00686335|Hormones|hormones|mesh-ancestor
14312507|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312508|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312509|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14312510|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312511|NCT00686517|Interferons|interferons|mesh-list
14312512|NCT00686517|Ribavirin|ribavirin|mesh-list
14312513|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
14312514|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
14312515|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14312516|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312517|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
14312518|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312519|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
14312520|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312521|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
14312522|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312523|NCT00686543|Posaconazole|posaconazole|mesh-list
14312524|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
14312525|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312526|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14312527|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14312528|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14312529|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14312530|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14312531|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312532|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312533|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14312534|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
14312535|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312536|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312537|NCT00686595|Infliximab|infliximab|mesh-list
14312538|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312539|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312540|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312541|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14723778|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723779|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
14723780|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221613|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15221614|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14312542|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312543|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312544|NCT00686634|Incretins|incretins|mesh-ancestor
14723781|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
14723782|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723783|NCT00496002|Adefovir|adefovir|mesh-list
15221615|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14312545|NCT00686634|Hormones|hormones|mesh-ancestor
14312546|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312547|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14312548|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
14312549|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312550|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312551|NCT00686686|Infliximab|infliximab|mesh-list
14312552|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312553|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312554|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312555|NCT00686712|Insulin|insulin|mesh-list
14312556|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14312557|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
14312558|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
14312559|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
14312560|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
14723784|NCT00496002|Clevudine|clevudine|mesh-list
15221616|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15221617|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312561|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312562|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312563|NCT00686725|Temozolomide|temozolomide|mesh-list
14312564|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14312565|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
14312566|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312567|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312568|NCT00686777|Interferons|interferons|mesh-list
14312569|NCT00686777|Ribavirin|ribavirin|mesh-list
14312570|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
14312571|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
14312572|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14312573|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312574|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
14312575|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312576|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
14312577|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312578|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
14312579|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312580|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14312581|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
14312582|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
14312583|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312584|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
14312585|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312586|NCT00686829|Maleic acid|maleic acid|mesh-list
14312587|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312588|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312589|NCT00686855|Dexamethasone|dexamethasone|mesh-list
14312590|NCT00686855|Tacrolimus|tacrolimus|mesh-list
14312591|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312592|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
14312593|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
14312594|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312595|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312596|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312597|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
14312598|NCT00686855|Hormones|hormones|mesh-ancestor
14312599|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312600|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14312601|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312602|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312603|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
14312604|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14312605|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312606|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312607|NCT00686881|Interferons|interferons|mesh-list
14312608|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
14312609|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
14312610|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14312611|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312612|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
14312613|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312614|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
14312615|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312616|NCT00686894|Infliximab|infliximab|mesh-list
14312617|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312618|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312619|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312620|NCT00686920|Rifaximin|rifaximin|mesh-list
14312621|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14312622|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312623|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312624|NCT00686959|Paclitaxel|paclitaxel|mesh-list
14312625|NCT00686959|Etoposide|etoposide|mesh-list
14312626|NCT00686959|Vinorelbine|vinorelbine|mesh-list
14312627|NCT00686959|Carboplatin|carboplatin|mesh-list
14312628|NCT00686959|Pemetrexed|pemetrexed|mesh-list
14312629|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14312630|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312631|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
14312632|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
14312633|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
14312634|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312635|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14312636|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14312637|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312638|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14312639|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14312640|NCT00686998|Olanzapine|olanzapine|mesh-list
14312641|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
14312642|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
14312643|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312644|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312645|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312646|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14312647|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14312648|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14312649|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14312650|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14312651|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14312652|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312653|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312654|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312655|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
14312656|NCT00687076|Aspirin|aspirin|mesh-list
14312657|NCT00687076|Niacin|niacin|mesh-list
14312658|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
14312659|NCT00687076|Clopidogrel|clopidogrel|mesh-list
14312660|NCT00687076|Ezetimibe|ezetimibe|mesh-list
14312661|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312662|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312663|NCT00687076|Analgesics|analgesics|mesh-ancestor
14312664|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
14312665|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312666|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312667|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312668|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312669|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14312670|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14312671|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312672|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14312673|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14312674|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312675|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
14312676|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14723785|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
14723786|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723787|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14723788|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14723789|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312677|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14312678|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14312679|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
14312680|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312681|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14312682|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14312683|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
14312684|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14312685|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
14312686|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
14312687|NCT00687076|Vitamins|vitamins|mesh-ancestor
14312688|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
14312689|NCT00687102|Tamoxifen|tamoxifen|mesh-list
14312690|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14723790|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723791|NCT00496028|Paclitaxel|paclitaxel|mesh-list
14723792|NCT00496028|Carboplatin|carboplatin|mesh-list
14723793|NCT00496028|Saracatinib|saracatinib|mesh-list
14723794|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14723795|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723796|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723797|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14723798|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14723799|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723800|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723801|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14723802|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
14723803|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723804|NCT00496158|Adefovir|adefovir|mesh-list
14723805|NCT00496158|Clevudine|clevudine|mesh-list
14723806|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
14723807|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723808|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14723809|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14723810|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723811|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723812|NCT00496184|Nifedipine|nifedipine|mesh-list
14723813|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14723814|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723815|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723816|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14723817|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723818|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
14723819|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
14723820|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14723821|NCT00496223|Sunitinib|sunitinib|mesh-list
14723822|NCT00496223|Dacarbazine|dacarbazine|mesh-list
14312691|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14312692|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
14723823|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312693|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312694|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221618|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221619|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
15221620|NCT02671890|Gemcitabine|gemcitabine|mesh-list
15221621|NCT02671890|Disulfiram|disulfiram|mesh-list
15221622|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221623|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
15221624|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221625|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221626|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
15221627|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221628|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221629|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221630|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
14312695|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14312696|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312697|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14312698|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14312699|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14312700|NCT00687167|Zonisamide|zonisamide|mesh-list
14312701|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
14312702|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14312703|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312704|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312705|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14312706|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312707|NCT00687193|Tofacitinib|tofacitinib|mesh-list
14312708|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14312709|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312710|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312711|NCT00687219|Ribavirin|ribavirin|mesh-list
14312712|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14723824|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14723825|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14723826|NCT00496223|Growth Substances|growth substances|mesh-ancestor
14723827|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723828|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
14723829|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14723830|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312713|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
14312714|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312715|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
14312716|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312717|NCT00687271|Atorvastatin|atorvastatin|mesh-list
14723831|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723832|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14723833|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
14723834|NCT00496275|Gemcitabine|gemcitabine|mesh-list
14723835|NCT00496275|Cisplatin|cisplatin|mesh-list
14723836|NCT00496275|Vinorelbine|vinorelbine|mesh-list
14312718|NCT00687271|Calcium|calcium|mesh-list
14312719|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14312720|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312721|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14312722|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14312723|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
14312724|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312725|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14312726|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14312727|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312728|NCT00687297|Carboplatin|carboplatin|mesh-list
14312729|NCT00687297|Docetaxel|docetaxel|mesh-list
14312730|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312731|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723837|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225589|NCT04347239|Leronlimab|leronlimab|mesh-list
14312732|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
14312733|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
14312734|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312735|NCT00687323|Temozolomide|temozolomide|mesh-list
14312736|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14312737|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
14312738|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312739|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312740|NCT00687362|Infliximab|infliximab|mesh-list
14312741|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312742|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312743|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312744|NCT00687401|Infliximab|infliximab|mesh-list
14312745|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312746|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312747|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312748|NCT00687440|Docetaxel|docetaxel|mesh-list
14312749|NCT00687440|Doxorubicin|doxorubicin|mesh-list
14312750|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14312751|NCT00687440|Trastuzumab|trastuzumab|mesh-list
14312752|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312753|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
14312754|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
14312755|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
14312756|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312757|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14312758|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14312759|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14312760|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312761|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14312762|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
14312763|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312764|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312765|NCT00687544|Ribavirin|ribavirin|mesh-list
14312766|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14312767|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
14312768|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312769|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
14312770|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312771|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14312772|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14312773|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14312774|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312775|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312776|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14312777|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312778|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312779|NCT00687674|Dexamethasone|dexamethasone|mesh-list
14312780|NCT00687674|Lenalidomide|lenalidomide|mesh-list
14312781|NCT00687674|Sorafenib|sorafenib|mesh-list
14312782|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312783|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
14312784|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
14312785|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312786|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312787|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312788|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
14312789|NCT00687674|Hormones|hormones|mesh-ancestor
14312790|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312791|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14312792|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312793|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
14312794|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14312795|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14312796|NCT00687674|Growth Substances|growth substances|mesh-ancestor
14312797|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
14312798|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14312799|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312800|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312801|NCT00687713|Bupropion|bupropion|mesh-list
14312802|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14312803|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
14312804|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917111|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14312805|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14312806|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14312807|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312808|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312809|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
14312810|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312811|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312812|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14312813|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14312814|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312815|NCT00687739|Leuprolide|leuprolide|mesh-list
14312816|NCT00687739|Estradiol|estradiol|mesh-list
14312817|NCT00687739|Estrogens|estrogens|mesh-ancestor
14312818|NCT00687739|Hormones|hormones|mesh-ancestor
14312819|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312820|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312821|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14312822|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14312823|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
14312824|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14312825|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312826|NCT00687804|Ranibizumab|ranibizumab|mesh-list
14312827|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14312828|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14312829|NCT00687804|Growth Substances|growth substances|mesh-ancestor
14312830|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312831|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
14312832|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312833|NCT00687908|Adapalene|adapalene|mesh-list
14312834|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14312835|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312836|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312837|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312838|NCT00687908|Analgesics|analgesics|mesh-ancestor
14312839|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
14312840|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312841|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312842|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312843|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312844|NCT00687973|Atenolol|atenolol|mesh-list
14312845|NCT00687973|Amlodipine|amlodipine|mesh-list
14312846|NCT00687973|Valsartan|valsartan|mesh-list
14312847|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14312848|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14312849|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312850|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312851|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14312852|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312853|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
14312854|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14312855|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14312856|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14312857|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
14312858|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
14312859|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312860|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14312861|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14312862|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14312863|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
14312864|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312865|NCT00688064|Doxycycline|doxycycline|mesh-list
14312866|NCT00688064|Adapalene|adapalene|mesh-list
14312867|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14312868|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312869|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
14312870|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14312871|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14312872|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312873|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312874|NCT00688064|Analgesics|analgesics|mesh-ancestor
14312875|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
14312876|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312877|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312878|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312879|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312880|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312881|NCT00688103|Etanercept|etanercept|mesh-list
14312882|NCT00688103|Methotrexate|methotrexate|mesh-list
14312883|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14312884|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
14312885|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14312886|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312887|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14312888|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
14312889|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312890|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312891|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312892|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312893|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14312894|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312895|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
14312896|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312897|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14312898|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312899|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14723838|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723839|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
14723840|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723841|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
14723842|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723843|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312900|NCT00688103|Analgesics|analgesics|mesh-ancestor
14312901|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
14312902|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312903|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312904|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312905|NCT00688324|Acamprosate|acamprosate|mesh-list
14312906|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14312907|NCT00688545|Celecoxib|celecoxib|mesh-list
14723844|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723845|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
14723846|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723847|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14312908|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14312909|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14312910|NCT00688545|Analgesics|analgesics|mesh-ancestor
14312911|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
14312912|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14312913|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312914|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14312915|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312916|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14312917|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14312918|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312919|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312920|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
14312921|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
14312922|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14312923|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312924|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312925|NCT00688623|Everolimus|everolimus|mesh-list
14312926|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312927|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312928|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
14312929|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312930|NCT00688636|Infliximab|infliximab|mesh-list
14312931|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14312932|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14312933|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312934|NCT00688688|Mirabegron|mirabegron|mesh-list
14312935|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14312936|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14312937|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14312938|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14312939|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14312940|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14312941|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312942|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312943|NCT00688688|Urological Agents|urological agents|mesh-ancestor
14312944|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14312945|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14312946|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
14312947|NCT00688701|Lixisenatide|lixisenatide|mesh-list
14312948|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14312949|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312950|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
14312951|NCT00688740|Docetaxel|docetaxel|mesh-list
14312952|NCT00688740|Doxorubicin|doxorubicin|mesh-list
14312953|NCT00688740|Fluorouracil|fluorouracil|mesh-list
14312954|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312955|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
14312956|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312957|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14312958|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14312959|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
14312960|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312961|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312962|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14312963|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14312964|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14312965|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14312966|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14312967|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14312968|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14312969|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312970|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
14312971|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14312972|NCT00688753|Everolimus|everolimus|mesh-list
14312973|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312974|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14312975|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
14312976|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312977|NCT00688870|Vaccines|vaccines|mesh-list
14312978|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14312979|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
14312980|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312981|NCT00688909|Letrozole|letrozole|mesh-list
14312982|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14312983|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14312984|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14312985|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14312986|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312987|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14312988|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
14312989|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14312990|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14312991|NCT00689026|Lubiprostone|lubiprostone|mesh-list
14312992|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14312993|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14312994|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14312995|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14312996|NCT00689078|Prednisolone|prednisolone|mesh-list
14312997|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14312998|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
14312999|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14313000|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
14313001|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
14313002|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14313003|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
14313004|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313005|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
14313006|NCT00689078|Hormones|hormones|mesh-ancestor
14313007|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313008|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313009|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14313010|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313011|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
14313012|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
14313013|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313014|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313015|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14313016|NCT00689078|Protective Agents|protective agents|mesh-ancestor
14313017|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14313018|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14313019|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14313020|NCT00689104|Mirabegron|mirabegron|mesh-list
14313021|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14313022|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14313023|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14313024|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14313025|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14313026|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313027|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313028|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221631|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221632|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15221633|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14313029|NCT00689104|Urological Agents|urological agents|mesh-ancestor
14313030|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14313031|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14313032|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
14313033|NCT00689117|Clindamycin|clindamycin|mesh-list
15221634|NCT02664181|Nivolumab|nivolumab|mesh-list
15221635|NCT02664181|Decitabine|decitabine|mesh-list
15221636|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
15221637|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221638|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221639|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14313034|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
14313035|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
14313036|NCT00689117|Tretinoin|tretinoin|mesh-list
14313037|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14313038|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313039|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14313040|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313041|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313042|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313043|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
14313044|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313045|NCT00689221|Temozolomide|temozolomide|mesh-list
14313046|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14313047|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
14313048|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313049|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327994|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14327995|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14327996|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14327997|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14327998|NCT00806260|Ethanol|ethanol|mesh-list
14327999|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14328000|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328001|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328002|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328003|NCT00806286|Paclitaxel|paclitaxel|mesh-list
14328004|NCT00806286|Carboplatin|carboplatin|mesh-list
14328005|NCT00806286|Efatutazone|efatutazone|mesh-list
14328006|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14328007|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328008|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
14328009|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
14328010|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
14328011|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328012|NCT00806351|Caspofungin|caspofungin|mesh-list
14328013|NCT00806351|Anidulafungin|anidulafungin|mesh-list
14328014|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
14328015|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328016|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328017|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328018|NCT00806442|Borage oil|borage oil|mesh-list
14328019|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328020|NCT00806494|Fesoterodine|fesoterodine|mesh-list
14328021|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14328022|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14328023|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
14910166|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14328024|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910167|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14910168|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328025|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328026|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328027|NCT00806494|Urological Agents|urological agents|mesh-ancestor
14328028|NCT00806598|Cyclosporine|cyclosporine|mesh-list
14328029|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
14328030|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14328031|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14328032|NCT00806598|Prednisolone|prednisolone|mesh-list
14328033|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
14328034|NCT00806598|Cyclosporins|cyclosporins|mesh-list
14723848|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723849|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
14328035|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
14328036|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14723850|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
14723851|NCT00496301|Gemcitabine|gemcitabine|mesh-list
14723852|NCT00496301|Capecitabine|capecitabine|mesh-list
14723853|NCT00496301|Sorafenib|sorafenib|mesh-list
14723854|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723855|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
14723856|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723857|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723858|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
14723859|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221640|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221641|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221642|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
14723860|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723861|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221643|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313050|NCT00689338|Fluconazole|fluconazole|mesh-list
14313051|NCT00689338|Voriconazole|voriconazole|mesh-list
14313052|NCT00689338|Anidulafungin|anidulafungin|mesh-list
14313053|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
15221644|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15221645|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221646|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221647|NCT02633397|Riociguat|riociguat|mesh-list
15221648|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
15221649|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221650|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
15221651|NCT02633241|Propofol|propofol|mesh-list
15221652|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15221653|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15221654|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221655|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14313054|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723862|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
14313055|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14313056|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14313057|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313058|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313059|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14313060|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
14313061|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313062|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313063|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14313064|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14313065|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14313066|NCT00689351|Vaccines|vaccines|mesh-list
14313067|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14313068|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
14313069|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313070|NCT00689390|Ribavirin|ribavirin|mesh-list
14910169|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313071|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14910170|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910171|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14910172|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
14910173|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
14910174|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
14910175|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14910176|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
14313072|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
14313073|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313074|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
14313075|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313076|NCT00689572|Ondansetron|ondansetron|mesh-list
14313077|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
14313078|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
14313079|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313080|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313081|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313082|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
14313083|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14723863|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723864|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14723865|NCT00496392|Fentanyl|fentanyl|mesh-list
14723866|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14723867|NCT00496392|Narcotics|narcotics|mesh-ancestor
14723868|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723869|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723870|NCT00496392|Analgesics|analgesics|mesh-ancestor
14723871|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
14723872|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723873|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14910177|NCT01355562|Interleukin-2|interleukin-2|mesh-list
14723874|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14723875|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
14723876|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
14723877|NCT00496405|Bevacizumab|bevacizumab|mesh-list
14723878|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14723879|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723880|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14723881|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14723882|NCT00496405|Growth Substances|growth substances|mesh-ancestor
14723883|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723884|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14723885|NCT00496444|Azacitidine|azacitidine|mesh-list
14723886|NCT00496444|Valproic Acid|valproic acid|mesh-list
14723887|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723888|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
14723889|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723890|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723891|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221656|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
15221657|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
14313084|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14313085|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
14313086|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313087|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313088|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14313089|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313090|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313091|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15221658|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15221659|NCT02633241|Analgesics|analgesics|mesh-ancestor
15221660|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
15221661|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221662|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15221663|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15221664|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14313092|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14313093|NCT00689611|Bupropion|bupropion|mesh-list
14313094|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14313095|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
14313096|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313097|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14313098|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14313099|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313100|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313101|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
14313102|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313103|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313104|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14313105|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14313106|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313107|NCT00689793|Iron|iron|mesh-list
14313108|NCT00689793|Trace Elements|trace elements|mesh-ancestor
14313109|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
14313110|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313111|NCT00689936|Thalidomide|thalidomide|mesh-list
14313112|NCT00689936|Dexamethasone|dexamethasone|mesh-list
14313113|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
15221665|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
15221666|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313114|NCT00689936|Prednisone|prednisone|mesh-list
14313115|NCT00689936|Lenalidomide|lenalidomide|mesh-list
14313116|NCT00689936|Melphalan|melphalan|mesh-list
14313117|NCT00689936|BB 1101|bb 1101|mesh-list
14313118|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910178|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221667|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221668|NCT02626715|Vidarabine|vidarabine|mesh-list
15221669|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
15221670|NCT02626715|Fludarabine|fludarabine|mesh-list
15221671|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
15221672|NCT02626715|Thiotepa|thiotepa|mesh-list
15221673|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221674|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
15221675|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313119|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
14313120|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
14313121|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313122|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313123|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313124|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
14313125|NCT00689936|Hormones|hormones|mesh-ancestor
14313126|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313127|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14313128|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313129|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
14313130|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313131|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313132|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
14313133|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14313134|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14313135|NCT00689936|Growth Substances|growth substances|mesh-ancestor
14313136|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
14313137|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14313138|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
14313139|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14313140|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313141|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
14313142|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14313143|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313144|NCT00690235|Pramlintide|pramlintide|mesh-list
14313145|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14313146|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313147|NCT00690378|Imipenem|imipenem|mesh-list
14313148|NCT00690378|Ceftazidime|ceftazidime|mesh-list
14313149|NCT00690378|Avibactam|avibactam|mesh-list
14313150|NCT00690378|Cilastatin|cilastatin|mesh-list
14313151|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14313152|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313153|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
14313154|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313155|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313156|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14723892|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
14723893|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
14723894|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14723895|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723896|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
14723897|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14723898|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14723899|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14723900|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
14723901|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723902|NCT00496600|Everolimus|everolimus|mesh-list
14723903|NCT00496600|Epothilone B|epothilone b|mesh-list
14723904|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723905|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723906|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
14723907|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723908|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723909|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
14723910|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
14313157|NCT00690430|Octreotide|octreotide|mesh-list
15221676|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313158|NCT00690430|Pasireotide|pasireotide|mesh-list
14313159|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313160|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14313161|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313162|NCT00690430|Hormones|hormones|mesh-ancestor
14313163|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313164|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313165|NCT00690443|Atorvastatin|atorvastatin|mesh-list
14313166|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14313167|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14313168|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
14313169|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313170|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14313171|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14313172|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313173|NCT00690495|Propofol|propofol|mesh-list
14313174|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14313175|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313176|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313177|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14313178|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
14313179|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
14313180|NCT00690573|Adalimumab|adalimumab|mesh-list
14313181|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313182|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313183|NCT00690612|Candesartan|candesartan|mesh-list
14313184|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
14313185|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313186|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14313187|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14313188|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313189|NCT00690794|Travoprost|travoprost|mesh-list
14313190|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14313191|NCT00690794|Latanoprost|latanoprost|mesh-list
14313192|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14313193|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313194|NCT00690820|Pancrelipase|pancrelipase|mesh-list
14313195|NCT00690820|Pancreatin|pancreatin|mesh-list
14313196|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313197|NCT00690833|Desonide|desonide|mesh-list
14910179|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910180|NCT01355562|Analgesics|analgesics|mesh-ancestor
15221677|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221678|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
15221679|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221680|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
14313198|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313199|NCT00690898|Lanreotide|lanreotide|mesh-list
14313200|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313201|NCT00690924|Calcitriol|calcitriol|mesh-list
14313202|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14313203|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313204|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14313205|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313206|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313207|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14313208|NCT00690924|Vitamins|vitamins|mesh-ancestor
14313209|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
14313210|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14313211|NCT00691002|Calcitriol|calcitriol|mesh-list
14313212|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
14313213|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14313214|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14313215|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14313216|NCT00691002|Calcipotriene|calcipotriene|mesh-list
14313217|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313218|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
14723911|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723912|NCT00496652|Zalutumumab|zalutumumab|mesh-list
14723913|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14723914|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723915|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
14723916|NCT00496665|Methotrexate|methotrexate|mesh-list
14723917|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221681|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221682|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221683|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221684|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
15221685|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15221686|NCT02589860|Melphalan|melphalan|mesh-list
15221687|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221688|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
15221689|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221690|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313219|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14313220|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313221|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14313222|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313223|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313224|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14313225|NCT00691002|Vitamins|vitamins|mesh-ancestor
14313226|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
14313227|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14313228|NCT00691015|Cytarabine|cytarabine|mesh-list
14313229|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
14313230|NCT00691015|Melphalan|melphalan|mesh-list
14313231|NCT00691015|Busulfan|busulfan|mesh-list
14723918|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
14313232|NCT00691015|Carmustine|carmustine|mesh-list
14313233|NCT00691015|Rituximab|rituximab|mesh-list
14723919|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723920|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723921|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14723922|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
14723923|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313234|NCT00691015|Fludarabine|fludarabine|mesh-list
14313235|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
14313236|NCT00691015|Etoposide|etoposide|mesh-list
14313237|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
14313238|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15221691|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15221692|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221693|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
15221694|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313239|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313240|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
14313241|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313242|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313243|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14313244|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
15221695|NCT02583789|Treprostinil|treprostinil|mesh-list
15221696|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15221697|NCT02556606|Midazolam|midazolam|mesh-list
15221698|NCT02556606|Ketamine|ketamine|mesh-list
15221699|NCT02556606|Analgesics|analgesics|mesh-ancestor
15221700|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
15221701|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221702|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221703|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15221704|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15221705|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
15221706|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
15221707|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15221708|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15221709|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15221710|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221711|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221712|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15221713|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15221714|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15221715|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313245|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313246|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313247|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14313248|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14313249|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14313250|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
14313251|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14313252|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14313253|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14313254|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313255|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
14313256|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313257|NCT00691028|Infliximab|infliximab|mesh-list
14313258|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313259|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313260|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313261|NCT00691054|Paclitaxel|paclitaxel|mesh-list
14313262|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14313263|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14313264|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313265|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
14313266|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
14910181|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
14313267|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
14328037|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14313268|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313269|NCT00691093|Fesoterodine|fesoterodine|mesh-list
14313270|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14313271|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14313272|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
14313273|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313274|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313275|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313276|NCT00691093|Urological Agents|urological agents|mesh-ancestor
14313277|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
14313278|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313279|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313280|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14313281|NCT00691132|Protective Agents|protective agents|mesh-ancestor
14313282|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313283|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313284|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14313285|NCT00691197|Glycerol|glycerol|mesh-list
14313286|NCT00691197|Laxatives|laxatives|mesh-ancestor
14313287|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313288|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14313289|NCT00691197|Protective Agents|protective agents|mesh-ancestor
14313290|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313291|NCT00691210|Niacinamide|niacinamide|mesh-list
14313292|NCT00691210|Niacin|niacin|mesh-list
14313293|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
14313294|NCT00691210|Etoposide|etoposide|mesh-list
14313295|NCT00691210|Vorinostat|vorinostat|mesh-list
14313296|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14313297|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313298|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14313299|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14313300|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313301|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313302|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14313303|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
14313304|NCT00691210|Vitamins|vitamins|mesh-ancestor
14313305|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
14313306|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313307|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14313308|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
14313309|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14313310|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
14313311|NCT00691301|Pemetrexed|pemetrexed|mesh-list
14313312|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313313|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313314|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313315|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14313316|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14313317|NCT00691483|Varenicline|varenicline|mesh-list
14313318|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14313319|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14313320|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
15221716|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15221717|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
15221718|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
15221719|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
15221720|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15221721|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15221722|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15221723|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221724|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
15221725|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221726|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221727|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15221728|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221729|NCT02545283|Cytarabine|cytarabine|mesh-list
15221730|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14313321|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313322|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313323|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313324|NCT00691600|Trimethoprim|trimethoprim|mesh-list
14313325|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
14313326|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14313327|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313328|NCT00691600|Renal Agents|renal agents|mesh-ancestor
14313329|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
14313330|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14313331|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14313332|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14313333|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313334|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313335|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14313336|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14313337|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14313338|NCT00691665|Fluticasone|fluticasone|mesh-list
14313339|NCT00691665|Xhance|xhance|mesh-list
14313340|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14313341|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313342|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14313343|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
14313344|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313345|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313346|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14313347|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
14313348|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313349|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14313350|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14313351|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14313352|NCT00691665|Analgesics|analgesics|mesh-ancestor
14313353|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
14313354|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313355|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14313356|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14313357|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
14723924|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221731|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
14313358|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
14313359|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313360|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313361|NCT00691704|Aspirin|aspirin|mesh-list
14313362|NCT00691704|Prednisone|prednisone|mesh-list
14313363|NCT00691704|Lenalidomide|lenalidomide|mesh-list
14313364|NCT00691704|Bortezomib|bortezomib|mesh-list
14313365|NCT00691704|Melphalan|melphalan|mesh-list
14313366|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313367|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
14313368|NCT00691704|Hormones|hormones|mesh-ancestor
14313369|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313370|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313371|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14313372|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313373|NCT00691704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14313374|NCT00691704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14313375|NCT00691704|Analgesics|analgesics|mesh-ancestor
14313376|NCT00691704|Sensory System Agents|sensory system agents|mesh-ancestor
14313377|NCT00691704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313378|NCT00691704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313379|NCT00691704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14313380|NCT00691704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14313381|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313382|NCT00691704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14313383|NCT00691704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14313384|NCT00691704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313385|NCT00691704|Antipyretics|antipyretics|mesh-ancestor
14313386|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
14313387|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14313388|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14313389|NCT00691704|Growth Substances|growth substances|mesh-ancestor
14313390|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14313391|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14313392|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
14313393|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14313394|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313395|NCT00691938|Decitabine|decitabine|mesh-list
14313396|NCT00691938|Panobinostat|panobinostat|mesh-list
14313397|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14313398|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
14313399|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313400|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313401|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723925|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14723926|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14723927|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
14313402|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14313403|NCT00692185|Olanzapine|olanzapine|mesh-list
14313404|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
14313405|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
14313406|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313407|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313408|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313409|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14313410|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313411|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313412|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313413|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14313414|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14313415|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328038|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
14313416|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313417|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313418|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
14313419|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
14313420|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
14313421|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14313422|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14313423|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313424|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313425|NCT00692237|Urological Agents|urological agents|mesh-ancestor
14313426|NCT00692341|Axitinib|axitinib|mesh-list
14313427|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313428|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14313429|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313430|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313431|NCT00692770|Sorafenib|sorafenib|mesh-list
14313432|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313433|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14313434|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313435|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313436|NCT00692978|Fluticasone|fluticasone|mesh-list
14723928|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14910182|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313437|NCT00692978|Xhance|xhance|mesh-list
14313438|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313439|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14313440|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
14313441|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313442|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313443|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14313444|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
14313445|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313446|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14313447|NCT00693160|Ketorolac|ketorolac|mesh-list
14313448|NCT00693160|Remifentanil|remifentanil|mesh-list
14313449|NCT00693160|Capsaicin|capsaicin|mesh-list
14313450|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14313451|NCT00693160|Narcotics|narcotics|mesh-ancestor
14313452|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313453|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313454|NCT00693160|Analgesics|analgesics|mesh-ancestor
14313455|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
14313456|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313457|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14313458|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14313459|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313460|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313461|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14313462|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313463|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313464|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
14313465|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313466|NCT00693225|Omeprazole|omeprazole|mesh-list
14313467|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14313468|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313469|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14313470|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313471|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313472|NCT00693420|Bimatoprost|bimatoprost|mesh-list
14313473|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14313474|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313475|NCT00693472|Propranolol|propranolol|mesh-list
14313476|NCT00693472|Haloperidol|haloperidol|mesh-list
15221732|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221733|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221734|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
15221735|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221736|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221737|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
15221738|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313477|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
14313478|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14313479|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
14313480|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
14328039|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221739|NCT02532231|Nivolumab|nivolumab|mesh-list
15221740|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221741|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221742|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221743|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221744|NCT02531126|Ozanimod|ozanimod|mesh-list
15221745|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15221746|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723929|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723930|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
14723931|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
14723932|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723933|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14723934|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14723935|NCT00496704|Gemcitabine|gemcitabine|mesh-list
14723936|NCT00496704|Capecitabine|capecitabine|mesh-list
14723937|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
14723938|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723939|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
14723940|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723941|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723942|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
14723943|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723944|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14723945|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14723946|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
14723947|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723948|NCT00496795|Docetaxel|docetaxel|mesh-list
14723949|NCT00496795|Epirubicin|epirubicin|mesh-list
14723950|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221747|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221748|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
14313481|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313482|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313483|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313484|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14313485|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313486|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313487|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313488|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14313489|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
14313490|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313491|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313492|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14313493|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
14313494|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14313495|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14313496|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
14313497|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14313498|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313499|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
14313500|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14313501|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313502|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14313503|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14313504|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14313505|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
14313506|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313507|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313508|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313509|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
14313510|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14313511|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14313512|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15221749|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221750|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
15221751|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
15221752|NCT02510300|Ledipasvir|ledipasvir|mesh-list
15221753|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15221754|NCT02510300|Velpatasvir|velpatasvir|mesh-list
15221755|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
14723951|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
14723952|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
14313513|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
14313514|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313515|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313516|NCT00693719|Irinotecan|irinotecan|mesh-list
14313517|NCT00693719|Etoposide|etoposide|mesh-list
14313518|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14313519|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14313520|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313521|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313522|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313523|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14313524|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14313525|NCT00693992|Sunitinib|sunitinib|mesh-list
14313526|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313527|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14313528|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14313529|NCT00693992|Growth Substances|growth substances|mesh-ancestor
14313530|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313531|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
14313532|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14313533|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313534|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313535|NCT00694096|Sunitinib|sunitinib|mesh-list
14313536|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313537|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14313538|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14313539|NCT00694096|Growth Substances|growth substances|mesh-ancestor
14313540|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313541|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
14313542|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14313543|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313544|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313545|NCT00694109|Mipomersen|mipomersen|mesh-list
14313546|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14313547|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14313548|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
14313549|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313550|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14313551|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
14313552|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14313553|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313554|NCT00694304|Vortioxetine|vortioxetine|mesh-list
14313555|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
14313556|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313557|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14313558|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313559|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313560|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313561|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14313562|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14313563|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313564|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313565|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313566|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
14313567|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15221756|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221757|NCT02507505|Anesthetics|anesthetics|mesh-list
15221758|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15221759|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221760|NCT02476968|Olaparib|olaparib|mesh-list
15221761|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15221762|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221763|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221764|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313568|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14313569|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14313570|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14313571|NCT00694551|Poly I-C|poly i-c|mesh-list
14313572|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14313573|NCT00694551|Vaccines|vaccines|mesh-list
14313574|NCT00694551|Poly ICLC|poly iclc|mesh-list
14313575|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
14313576|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313577|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
14313578|NCT00694551|Laxatives|laxatives|mesh-ancestor
14313579|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313580|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
14313581|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313582|NCT00694603|Cetuximab|cetuximab|mesh-list
14313583|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14313584|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313585|NCT00694707|Risperidone|risperidone|mesh-list
14313586|NCT00694707|Cariprazine|cariprazine|mesh-list
14313587|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14313588|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
14313589|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313590|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313591|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313592|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14313593|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313594|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313595|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313596|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14313597|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
14313598|NCT00695019|Interferons|interferons|mesh-list
14313599|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
14313600|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
14313601|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14313602|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313603|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
14313604|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313605|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
14313606|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313607|NCT00695097|Rituximab|rituximab|mesh-list
14313608|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14313609|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313610|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
14313611|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313612|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221765|NCT02465593|Fluorouracil|fluorouracil|mesh-list
15221766|NCT02465593|Capecitabine|capecitabine|mesh-list
15221767|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
15221768|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221769|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221770|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221771|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221772|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
15221773|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221774|NCT02465268|Molgramostim|molgramostim|mesh-list
15221775|NCT02465268|Sargramostim|sargramostim|mesh-list
15221776|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
15221777|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221778|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221779|NCT02436707|Gemcitabine|gemcitabine|mesh-list
15221780|NCT02436707|Dexamethasone|dexamethasone|mesh-list
15221781|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
14313613|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
14313614|NCT00695110|Testosterone|testosterone|mesh-list
15221782|NCT02436707|Rituximab|rituximab|mesh-list
14313615|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
14313616|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
14313617|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14313618|NCT00695110|Androgens|androgens|mesh-ancestor
14313619|NCT00695110|Hormones|hormones|mesh-ancestor
14313620|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313621|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313622|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14313623|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313624|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
14313625|NCT00695136|Donepezil|donepezil|mesh-list
14313626|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14313627|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313628|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313629|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
14313630|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313631|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313632|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
14313633|NCT00695188|Methotrexate|methotrexate|mesh-list
14313634|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14313635|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
14313636|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14313637|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313638|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14313639|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
14313640|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313641|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313642|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313643|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313644|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14313645|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313646|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
14313647|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313648|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14313649|NCT00695292|Carboplatin|carboplatin|mesh-list
14313650|NCT00695292|Irinotecan|irinotecan|mesh-list
14723953|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
14723954|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723955|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14723956|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14723957|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14723958|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729192|NCT00521859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729193|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
14729194|NCT00521950|Azathioprine|azathioprine|mesh-list
14729195|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
14729196|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729197|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729198|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729199|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729200|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
14313651|NCT00695292|Sunitinib|sunitinib|mesh-list
14313652|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313653|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14723959|NCT00497003|Metoprolol|metoprolol|mesh-list
14723960|NCT00497003|Carvedilol|carvedilol|mesh-list
14723961|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14723962|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14723963|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
15221783|NCT02436707|Etoposide|etoposide|mesh-list
15221784|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221785|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
15221786|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221787|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723964|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
14723965|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14723966|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313654|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14313655|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313656|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313657|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14313658|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14313659|NCT00695292|Growth Substances|growth substances|mesh-ancestor
14313660|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313661|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
14313662|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14313663|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14313664|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313665|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
14313666|NCT00695318|Hormones|hormones|mesh-ancestor
14313667|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313668|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313669|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
14313670|NCT00695396|Hematinics|hematinics|mesh-ancestor
14313671|NCT00695409|Cytarabine|cytarabine|mesh-list
14313672|NCT00695409|Rituximab|rituximab|mesh-list
14313673|NCT00695409|Etoposide|etoposide|mesh-list
14313674|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
14313675|NCT00695409|Melphalan|melphalan|mesh-list
14313676|NCT00695409|Carmustine|carmustine|mesh-list
14313677|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14313678|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14313679|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313680|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
14313681|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313682|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313683|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14313684|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14313685|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14313686|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313687|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313688|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14313689|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
14313690|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
14313691|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313692|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313693|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14313694|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
14313695|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14313696|NCT00695435|Tobramycin|tobramycin|mesh-list
15221788|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221789|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
15221790|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221791|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221792|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15221793|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221794|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
15221795|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
15221796|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221797|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14723967|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14313697|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14313698|NCT00695435|Dexamethasone|dexamethasone|mesh-list
14313699|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14313700|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313701|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
14313702|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
14313703|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313704|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313705|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313706|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
14313707|NCT00695435|Hormones|hormones|mesh-ancestor
14313708|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313709|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14313710|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313711|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14313712|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14313713|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313714|NCT00695500|Varenicline|varenicline|mesh-list
14313715|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14313716|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14313717|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
14313718|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313719|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313720|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313721|NCT00695565|Clonidine|clonidine|mesh-list
14313722|NCT00695565|Analgesics|analgesics|mesh-ancestor
14313723|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
14313724|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313725|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313726|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313727|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
14313728|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
14313729|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14313730|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14313731|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14313732|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
14313733|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313734|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313735|NCT00695578|Bacitracin|bacitracin|mesh-list
14313736|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14313737|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313738|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14313739|NCT00695786|Rituximab|rituximab|mesh-list
14313740|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14313741|NCT00695786|Lenalidomide|lenalidomide|mesh-list
14313742|NCT00695786|Antibodies|antibodies|mesh-list
14313743|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
14313744|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15221798|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
15221799|NCT02436707|Hormones|hormones|mesh-ancestor
15221800|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221801|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14313745|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
14313746|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313747|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313748|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313749|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14313750|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14313751|NCT00695786|Growth Substances|growth substances|mesh-ancestor
14313752|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14328040|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328041|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328042|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
14723968|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14723969|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14723970|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
14723971|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221802|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221803|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221804|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
15221805|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
14328043|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328044|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
14313753|NCT00695864|Ondansetron|ondansetron|mesh-list
14313754|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
14313755|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
14313756|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313757|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313758|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14313759|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
14313760|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313761|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14313762|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
14313763|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313764|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313765|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14313766|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313767|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313768|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313769|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14313770|NCT00695903|Vancomycin|vancomycin|mesh-list
14313771|NCT00695903|Daptomycin|daptomycin|mesh-list
14313772|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14313773|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313774|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14313775|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
14313776|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14313777|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313778|NCT00695955|Diuretics|diuretics|mesh-ancestor
14313779|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
14313780|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313781|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14313782|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313783|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313784|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14313785|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14313786|NCT00696020|Bromides|bromides|mesh-list
14313787|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
14313788|NCT00696020|Olodaterol|olodaterol|mesh-list
14313789|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14313790|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
14313791|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313792|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313793|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14313794|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
14313795|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
14313796|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14313797|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
14313798|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313799|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313800|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
14313801|NCT00696072|Letrozole|letrozole|mesh-list
14313802|NCT00696072|Dasatinib|dasatinib|mesh-list
14313803|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313804|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14313805|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14313806|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221806|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221807|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221808|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15221809|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15221810|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221811|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
15221812|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221813|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
15221814|NCT02424019|Hormones|hormones|mesh-ancestor
15221815|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221816|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221817|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
15221818|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15221819|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15221820|NCT02422368|Prednisolone|prednisolone|mesh-list
15221821|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
14313807|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313808|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14313809|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
14313810|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313811|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313812|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14313813|NCT00696137|Fentanyl|fentanyl|mesh-list
14313814|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14313815|NCT00696137|Narcotics|narcotics|mesh-ancestor
14313816|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313817|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313818|NCT00696137|Analgesics|analgesics|mesh-ancestor
14313819|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
15221822|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15221823|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
15221824|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221825|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
15221826|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
15221827|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221828|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313820|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313821|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14313822|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14313823|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
14313824|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
14313825|NCT00696241|Olmesartan|olmesartan|mesh-list
14313826|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14313827|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14313828|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313829|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14313830|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14313831|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313832|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14313833|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14313834|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14313835|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313836|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313837|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313838|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313839|NCT00696293|Analgesics|analgesics|mesh-ancestor
14313840|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
14313841|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313842|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
14313843|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313844|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
14313845|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
14313846|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
14313847|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14313848|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14313849|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14313850|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313851|NCT00696384|Diuretics|diuretics|mesh-ancestor
15221829|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15221830|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
15221831|NCT02422368|Hormones|hormones|mesh-ancestor
15221832|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221833|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15221834|NCT02422368|Protective Agents|protective agents|mesh-ancestor
14313852|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
14313853|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313854|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14313855|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313856|NCT00696410|Zinc|zinc|mesh-list
14313857|NCT00696410|Trace Elements|trace elements|mesh-ancestor
14313858|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
14313859|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313860|NCT00696436|Valsartan|valsartan|mesh-list
14313861|NCT00696436|Olmesartan|olmesartan|mesh-list
14313862|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14313863|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313864|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14313865|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14313866|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313867|NCT00696449|Adapalene|adapalene|mesh-list
14313868|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14313869|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15221835|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15221836|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313870|NCT00696449|Analgesics|analgesics|mesh-ancestor
14313871|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
14313872|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313873|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313874|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14313875|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14313876|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
14313877|NCT00696488|Fluorouracil|fluorouracil|mesh-list
14313878|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
14313879|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313880|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14313881|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313882|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313883|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
14313884|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313885|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
14313886|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14313887|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14313888|NCT00696657|Liraglutide|liraglutide|mesh-list
14313889|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14313890|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313891|NCT00696657|Incretins|incretins|mesh-ancestor
14313892|NCT00696657|Hormones|hormones|mesh-ancestor
14328045|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14723972|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723973|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
14723974|NCT00497003|Protective Agents|protective agents|mesh-ancestor
15221837|NCT02420847|Gemcitabine|gemcitabine|mesh-list
15221838|NCT02420847|Doxorubicin|doxorubicin|mesh-list
15221839|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15221840|NCT02420847|Ixazomib|ixazomib|mesh-list
15221841|NCT02420847|Glycine|glycine|mesh-list
15221842|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221843|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
15221844|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221845|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221846|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
14313893|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14313894|NCT00696696|Gemcitabine|gemcitabine|mesh-list
14313895|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14313896|NCT00696696|Sorafenib|sorafenib|mesh-list
14313897|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14313898|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
14723975|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14723976|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14723977|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14723978|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
14723979|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14723980|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14723981|NCT00497016|Atorvastatin|atorvastatin|mesh-list
14910183|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313899|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313900|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313901|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
14313902|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313903|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313904|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313905|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
14313906|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313907|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14313908|NCT00696761|Alfuzosin|alfuzosin|mesh-list
14313909|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14313910|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14313911|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14313912|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
14313913|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313914|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313915|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910184|NCT01355614|Infliximab|infliximab|mesh-list
14910185|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
14910186|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910187|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14910188|NCT01355718|Repaglinide|repaglinide|mesh-list
15221847|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313916|NCT00696761|Urological Agents|urological agents|mesh-ancestor
14313917|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14313918|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14313919|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14313920|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313921|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313922|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313923|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313924|NCT00696774|Analgesics|analgesics|mesh-ancestor
14313925|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
14313926|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313927|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
14313928|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14313929|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
14313930|NCT00696787|Pregabalin|pregabalin|mesh-list
14313931|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14313932|NCT00696787|Analgesics|analgesics|mesh-ancestor
14313933|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
14313934|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14313935|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313936|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
14313937|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14313938|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14313939|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313940|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14313941|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14313942|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14313943|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313944|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910189|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15221848|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221849|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221850|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
15221851|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221852|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14313945|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14313946|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14313947|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313948|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
14313949|NCT00697073|Idebenone|idebenone|mesh-list
14313950|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
14313951|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313952|NCT00697073|Protective Agents|protective agents|mesh-ancestor
14313953|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313954|NCT00697112|Sirolimus|sirolimus|mesh-list
14313955|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14313956|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14313957|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14313958|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14313959|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
14313960|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14313961|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
14313962|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313963|NCT00697203|Pravastatin|pravastatin|mesh-list
14313964|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
14313965|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14313966|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14313967|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
14313968|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313969|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14313970|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14313971|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14313972|NCT00697463|Teriparatide|teriparatide|mesh-list
14313973|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14313974|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313975|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14313976|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14313977|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14313978|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14313979|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14313980|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14313981|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14313982|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14313983|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
14313984|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14313985|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14313986|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313987|NCT00697593|Antibodies|antibodies|mesh-list
14313988|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14313989|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
14313990|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313991|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
14313992|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14313993|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313994|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
14313995|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14313996|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14313997|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14313998|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14313999|NCT00697788|Analgesics|analgesics|mesh-ancestor
14314000|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
14314001|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314002|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14314003|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14314004|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14314005|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
14314006|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314007|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314008|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
14314009|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14314010|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14314011|NCT00698035|Testosterone|testosterone|mesh-list
14314012|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
14314013|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
14314014|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14314015|NCT00698035|Estradiol|estradiol|mesh-list
14314016|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14314017|NCT00698035|Androgens|androgens|mesh-ancestor
14314018|NCT00698035|Hormones|hormones|mesh-ancestor
14314019|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314020|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314021|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14314022|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314023|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
14314024|NCT00698035|Estrogens|estrogens|mesh-ancestor
14314025|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14314026|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
14314027|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14314028|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14314029|NCT00698204|Celecoxib|celecoxib|mesh-list
14314030|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14314031|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14314032|NCT00698204|Analgesics|analgesics|mesh-ancestor
14314033|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
14314034|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221853|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15221854|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221855|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
15221856|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
15221857|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15221858|NCT02400242|Dexamethasone|dexamethasone|mesh-list
15221859|NCT02400242|Pomalidomide|pomalidomide|mesh-list
15221860|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14314035|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314036|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314037|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314038|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14314039|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14314040|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314041|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314042|NCT00698451|Bevacizumab|bevacizumab|mesh-list
14314043|NCT00698451|Carboplatin|carboplatin|mesh-list
14314044|NCT00698451|Doxorubicin|doxorubicin|mesh-list
14314045|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14314046|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314047|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314048|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314049|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14314050|NCT00698451|Growth Substances|growth substances|mesh-ancestor
14314051|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314052|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314053|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14314054|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14314055|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14314056|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314057|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314058|NCT00698516|Bevacizumab|bevacizumab|mesh-list
14314059|NCT00698516|Topotecan|topotecan|mesh-list
14314060|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314061|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314062|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314063|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14314064|NCT00698516|Growth Substances|growth substances|mesh-ancestor
15221861|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221862|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
14314065|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314066|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314067|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14314068|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14314069|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314070|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314071|NCT00698581|Brivaracetam|brivaracetam|mesh-list
14314072|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
14314073|NCT00698646|Valsartan|valsartan|mesh-list
14314074|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14314075|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14314076|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14314077|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14314078|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314079|NCT00698646|Diuretics|diuretics|mesh-ancestor
14314080|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
14314081|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314082|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14314083|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314084|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
14314085|NCT00698685|Pentostatin|pentostatin|mesh-list
14314086|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314087|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314088|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14314089|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314090|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314091|NCT00698841|Cetuximab|cetuximab|mesh-list
14314092|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314093|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314094|NCT00698932|Saxagliptin|saxagliptin|mesh-list
14314095|NCT00698932|Incretins|incretins|mesh-ancestor
14314096|NCT00698932|Hormones|hormones|mesh-ancestor
14314097|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314098|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314099|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14314100|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
14314101|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314102|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314103|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314104|NCT00699010|Oxycodone|oxycodone|mesh-list
14314105|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14314106|NCT00699010|Narcotics|narcotics|mesh-ancestor
14314107|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14314108|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314109|NCT00699010|Analgesics|analgesics|mesh-ancestor
14314110|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
14314111|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314112|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14314113|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15221863|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
15221864|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221865|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221866|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15221867|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
15221868|NCT02400242|Hormones|hormones|mesh-ancestor
15221869|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221870|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15221871|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221872|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
15221873|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15221874|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15221875|NCT02400242|Growth Substances|growth substances|mesh-ancestor
15221876|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314114|NCT00699192|Amlodipine|amlodipine|mesh-list
15221877|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221878|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221879|NCT02393183|Selenium|selenium|mesh-list
15221880|NCT02393183|Antioxidants|antioxidants|mesh-list
14314115|NCT00699192|Valsartan|valsartan|mesh-list
15225590|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15221881|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221882|NCT02393183|Protective Agents|protective agents|mesh-ancestor
15221883|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221884|NCT02393183|Trace Elements|trace elements|mesh-ancestor
14314116|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14314117|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14314118|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314119|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314120|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14314121|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314122|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
14314123|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14314124|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14314125|NCT00699283|Brivaracetam|brivaracetam|mesh-list
14314126|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
14314127|NCT00699335|Fentanyl|fentanyl|mesh-list
14314128|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14314129|NCT00699335|Narcotics|narcotics|mesh-ancestor
14314130|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14314131|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314132|NCT00699335|Analgesics|analgesics|mesh-ancestor
14314133|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
14314134|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314135|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14314136|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14314137|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
14314138|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
14314139|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
14314140|NCT00699348|Hematinics|hematinics|mesh-ancestor
14314141|NCT00699374|Sorafenib|sorafenib|mesh-list
14314142|NCT00699374|Sunitinib|sunitinib|mesh-list
14314143|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314144|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14314145|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314146|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314147|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314148|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14723982|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14723983|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14723984|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
14723985|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14723986|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14723987|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14723988|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221885|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
14314149|NCT00699374|Growth Substances|growth substances|mesh-ancestor
14314150|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314151|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314152|NCT00699491|Sirolimus|sirolimus|mesh-list
14314153|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14314154|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14314155|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314156|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14314157|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314158|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
15221886|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
15221887|NCT02379520|Nivolumab|nivolumab|mesh-list
15221888|NCT02379520|Fludarabine|fludarabine|mesh-list
15221889|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221890|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
15221891|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221892|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221893|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221894|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
15221895|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328046|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14314159|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314160|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
14314161|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314162|NCT00699556|Nicotine|nicotine|mesh-list
14314163|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14314164|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
14314165|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314166|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314167|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14314168|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14314169|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
14314170|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314171|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314172|NCT00699608|Zopiclone|zopiclone|mesh-list
14314173|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14314174|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14314175|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314176|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14314177|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314178|NCT00699803|Prednisone|prednisone|mesh-list
14314179|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
14314180|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14314181|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
14314182|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14314183|NCT00699803|Prednisolone|prednisolone|mesh-list
14314184|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14314185|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
14314186|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314187|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
14314188|NCT00699803|Hormones|hormones|mesh-ancestor
14314189|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314190|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314191|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14314192|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314193|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
14314194|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
14314195|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314196|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14314197|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14314198|NCT00699803|Protective Agents|protective agents|mesh-ancestor
14314199|NCT00699907|Flutamide|flutamide|mesh-list
14314200|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
14314201|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
14314202|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314203|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314204|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14314205|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314206|NCT00699998|Aspirin|aspirin|mesh-list
14314207|NCT00699998|Clopidogrel|clopidogrel|mesh-list
14314208|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14314209|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14314210|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14314211|NCT00699998|Analgesics|analgesics|mesh-ancestor
14314212|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
14314213|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314214|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314215|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314216|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314217|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14314218|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14314219|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314220|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14314221|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14314222|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314223|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
14314224|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14314225|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14314226|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14314227|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
14314228|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314229|NCT00700011|Clofarabine|clofarabine|mesh-list
14314230|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14314231|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
14314232|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314233|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314234|NCT00700102|Bevacizumab|bevacizumab|mesh-list
14314235|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314236|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314237|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314238|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14314239|NCT00700102|Growth Substances|growth substances|mesh-ancestor
14314240|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314241|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314242|NCT00700115|Ritonavir|ritonavir|mesh-list
14314243|NCT00700115|Lopinavir|lopinavir|mesh-list
14314244|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
14314245|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14314246|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14314247|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14314248|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
14314249|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314250|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221896|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221897|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15221898|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221899|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15221900|NCT02354131|Bevacizumab|bevacizumab|mesh-list
15221901|NCT02354131|Niraparib|niraparib|mesh-list
15221902|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15221903|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221904|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15221905|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15221906|NCT02354131|Growth Substances|growth substances|mesh-ancestor
14314251|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14314252|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
14314253|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314254|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14314255|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14314256|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14314257|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14314258|NCT00700180|Bevacizumab|bevacizumab|mesh-list
14314259|NCT00700180|Carboplatin|carboplatin|mesh-list
14314260|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314261|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314262|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314263|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14314264|NCT00700180|Growth Substances|growth substances|mesh-ancestor
14314265|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314266|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314267|NCT00700271|Amlodipine|amlodipine|mesh-list
14314268|NCT00700271|Valsartan|valsartan|mesh-list
14314269|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14314270|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14314271|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314272|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314273|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14314274|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314275|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
14314276|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14314277|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14314278|NCT00700336|Cisplatin|cisplatin|mesh-list
14314279|NCT00700336|Pemetrexed|pemetrexed|mesh-list
14314280|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314281|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314282|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314283|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14314284|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14314285|NCT00700401|Ribavirin|ribavirin|mesh-list
14314286|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14314287|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
14314288|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314289|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
14314290|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314291|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14314292|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14314293|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14314294|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314295|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314296|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
14314297|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314298|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314299|NCT00700440|Cetuximab|cetuximab|mesh-list
14314300|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314301|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314302|NCT00700570|Bevacizumab|bevacizumab|mesh-list
14314303|NCT00700570|Capecitabine|capecitabine|mesh-list
14314304|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
14314305|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314306|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314307|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314308|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14314309|NCT00700570|Growth Substances|growth substances|mesh-ancestor
14314310|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314311|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314312|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14314313|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
15221907|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221908|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
15221909|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15221910|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221911|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221912|NCT02335944|Nazartinib|nazartinib|mesh-list
15221913|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221914|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
15221915|NCT02333162|Fludarabine|fludarabine|mesh-list
15221916|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
15221917|NCT02333162|Melphalan|melphalan|mesh-list
14314314|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314315|NCT00700622|Insulin|insulin|mesh-list
14314316|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14314317|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
14314318|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
14314319|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314320|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314321|NCT00700817|Metformin|metformin|mesh-list
14314322|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14314323|NCT00700817|Liraglutide|liraglutide|mesh-list
14314324|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314325|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314326|NCT00700817|Incretins|incretins|mesh-ancestor
14314327|NCT00700817|Hormones|hormones|mesh-ancestor
14314328|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314329|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14314330|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
14314331|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314332|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314333|NCT00700882|Dasatinib|dasatinib|mesh-list
14314334|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314335|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14314336|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314337|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314338|NCT00700999|Paroxetine|paroxetine|mesh-list
14314339|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14314340|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14314341|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314342|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314343|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314344|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
14314345|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314346|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14314347|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
14314348|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314349|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14314350|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14314351|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314352|NCT00701090|Metformin|metformin|mesh-list
14314353|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14314354|NCT00701090|Glimepiride|glimepiride|mesh-list
14314355|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314356|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314357|NCT00701090|Incretins|incretins|mesh-ancestor
14314358|NCT00701090|Hormones|hormones|mesh-ancestor
14314359|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314360|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14314361|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
14314362|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314363|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314364|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14314365|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314366|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
14314367|NCT00701129|Rituximab|rituximab|mesh-list
14314368|NCT00701129|Methotrexate|methotrexate|mesh-list
14314369|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314370|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14723989|NCT00497029|Fluorides|fluorides|mesh-list
14723990|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
14723991|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
15221918|NCT02333162|Tacrolimus|tacrolimus|mesh-list
15221919|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221920|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14723992|NCT00497029|Protective Agents|protective agents|mesh-ancestor
15221921|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
15221922|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221923|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221924|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
15221925|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221926|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15221927|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221928|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15221929|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15221930|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
15221931|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15221932|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221933|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221934|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
15221935|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15221936|NCT02318342|Warfarin|warfarin|mesh-list
15221937|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
15221938|NCT02304991|Glycerol|glycerol|mesh-list
15221939|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15221940|NCT02304991|Protective Agents|protective agents|mesh-ancestor
14314371|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
14314372|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314373|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314374|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14314375|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
14314376|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14314377|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14314378|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
14314379|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221941|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221942|NCT02303821|Cytarabine|cytarabine|mesh-list
15221943|NCT02303821|Dexamethasone|dexamethasone|mesh-list
15221944|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
15221945|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
15221946|NCT02303821|Methotrexate|methotrexate|mesh-list
15221947|NCT02303821|Vincristine|vincristine|mesh-list
15221948|NCT02303821|Daunorubicin|daunorubicin|mesh-list
14314380|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14314381|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314382|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14314383|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314384|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14314385|NCT00701311|Apremilast|apremilast|mesh-list
14314386|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14314387|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14314388|NCT00701311|Analgesics|analgesics|mesh-ancestor
14314389|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
14328047|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221949|NCT02303821|Asparaginase|asparaginase|mesh-list
15221950|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
15221951|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
14314390|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314391|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314392|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314393|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14723993|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14723994|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
14910190|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314394|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14314395|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14314396|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314397|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328048|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14328049|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328050|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
14328051|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
14328052|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328053|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14328054|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
14328055|NCT00806598|Hormones|hormones|mesh-ancestor
14328056|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328057|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14328058|NCT00806598|Protective Agents|protective agents|mesh-ancestor
14328059|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14328060|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328061|NCT00806624|Warfarin|warfarin|mesh-list
14328062|NCT00806624|Edoxaban|edoxaban|mesh-list
14328063|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
14328064|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14328065|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
15221952|NCT02303821|Pegaspargase|pegaspargase|mesh-list
15221953|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15221954|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
15221955|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15221956|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221957|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14328066|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14328067|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328068|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328069|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328070|NCT00806676|Vaccines|vaccines|mesh-list
14328071|NCT00806676|Immunologic Factors|immunologic factors|mesh-ancestor
14328072|NCT00806676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328073|NCT00806819|Folic Acid|folic acid|mesh-list
14328074|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
14328075|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
14328076|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
14328077|NCT00806819|Dexamethasone|dexamethasone|mesh-list
14328078|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
14328079|NCT00806819|Pemetrexed|pemetrexed|mesh-list
14328080|NCT00806819|Nintedanib|nintedanib|mesh-list
14328081|NCT00806819|BB 1101|bb 1101|mesh-list
14328082|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328083|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
14328084|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
14328085|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328086|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328087|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14328088|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
14328089|NCT00806819|Hormones|hormones|mesh-ancestor
14328090|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328091|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14328092|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328093|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328094|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328095|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328096|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14328097|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14910191|NCT01355757|Anesthetics|anesthetics|mesh-list
14910192|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
15221958|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
15221959|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15221960|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15221961|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15221962|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15221963|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
14328098|NCT00806819|Hematinics|hematinics|mesh-ancestor
14328099|NCT00806819|Vitamins|vitamins|mesh-ancestor
15221964|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
15221965|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221966|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15221967|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
15221968|NCT02303821|Hormones|hormones|mesh-ancestor
15221969|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15221970|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14314398|NCT00701363|Lanreotide|lanreotide|mesh-list
14314399|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314400|NCT00701376|Liver Extracts|liver extracts|mesh-list
14314401|NCT00701376|Hematinics|hematinics|mesh-ancestor
14314402|NCT00701389|Sumatriptan|sumatriptan|mesh-list
14314403|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14314404|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14314405|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14314406|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
14314407|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314408|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314409|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314410|NCT00701558|Gemcitabine|gemcitabine|mesh-list
14314411|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14314412|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14314413|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
14314414|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314415|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314416|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
14314417|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314418|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314419|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314420|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
14314421|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314422|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14314423|NCT00701636|Daptomycin|daptomycin|mesh-list
14314424|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14314425|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314426|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
14314427|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
14314428|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314429|NCT00701675|Sertraline|sertraline|mesh-list
14314430|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
14314431|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314432|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14314433|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14314434|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314435|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314436|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314437|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
14314438|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314439|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
14314440|NCT00701714|Hematinics|hematinics|mesh-ancestor
14314441|NCT00701727|Ezetimibe|ezetimibe|mesh-list
14314442|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14314443|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14314444|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
14314445|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314446|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14314447|NCT00701779|Tamsulosin|tamsulosin|mesh-list
14314448|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14314449|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14314450|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14314451|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14314452|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314453|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314454|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314455|NCT00701779|Urological Agents|urological agents|mesh-ancestor
14314456|NCT00701896|Nicotine|nicotine|mesh-list
14314457|NCT00701896|Varenicline|varenicline|mesh-list
14314458|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14314459|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
14314460|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314461|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314462|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14314463|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14314464|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14314465|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314466|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314467|NCT00701935|Exenatide|exenatide|mesh-list
14314468|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314469|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314470|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14314471|NCT00701935|Incretins|incretins|mesh-ancestor
14314472|NCT00701935|Hormones|hormones|mesh-ancestor
14314473|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314474|NCT00702052|Everolimus|everolimus|mesh-list
14314475|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314476|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314477|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
14314478|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314479|NCT00702221|Vaccines|vaccines|mesh-list
14314480|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
14314481|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314482|NCT00702299|Paclitaxel|paclitaxel|mesh-list
14314483|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14314484|NCT00702299|Cisplatin|cisplatin|mesh-list
14314485|NCT00702299|Pemetrexed|pemetrexed|mesh-list
15221971|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15221972|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
15221973|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14314486|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14314487|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314488|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
14314489|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
14314490|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
14314491|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314492|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314493|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14314494|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14314495|NCT00702325|Budesonide|budesonide|mesh-list
14314496|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
14314497|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14314498|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314499|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14314500|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
14314501|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15221974|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15221975|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
15221976|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
15221977|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15221978|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15221979|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15221980|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
14314502|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314503|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14314504|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
14314505|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
14314506|NCT00702325|Hormones|hormones|mesh-ancestor
14314507|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314508|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14314509|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14314510|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14314511|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
14314512|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314513|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314514|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14314515|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14314516|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14314517|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314518|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314519|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
14314520|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314521|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314522|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
14314523|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314524|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14314525|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314526|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314527|NCT00702468|Nabiximols|nabiximols|mesh-list
14314528|NCT00702468|Analgesics|analgesics|mesh-ancestor
14314529|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
14314530|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314531|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314532|NCT00702507|Miconazole|miconazole|mesh-list
14314533|NCT00702507|Clotrimazole|clotrimazole|mesh-list
14314534|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
14314535|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314536|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14314537|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14314538|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314539|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314540|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14314541|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
14314542|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314543|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314544|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14314545|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14723995|NCT00497107|Leucovorin|leucovorin|mesh-list
14723996|NCT00497107|Calcium|calcium|mesh-list
14723997|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
14723998|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14723999|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314546|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14314547|NCT00702650|Testosterone|testosterone|mesh-list
14314548|NCT00702650|Androgens|androgens|mesh-ancestor
14314549|NCT00702650|Hormones|hormones|mesh-ancestor
14314550|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314551|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724000|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14314552|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
14314553|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314554|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14314555|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314556|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314557|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14314558|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
14314559|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14314560|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14314561|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14314562|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314563|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314564|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
14314565|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314566|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314567|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14314568|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314569|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14314570|NCT00702780|Citalopram|citalopram|mesh-list
14314571|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14314572|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14314573|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314574|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314575|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314576|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
14314577|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314578|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14314579|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
15221981|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15221982|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15221983|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
15221984|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
14314580|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314581|NCT00702884|Sunitinib|sunitinib|mesh-list
14314582|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314583|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314584|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14314585|NCT00702884|Growth Substances|growth substances|mesh-ancestor
14314586|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314587|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314588|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14314589|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314590|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314591|NCT00702923|Tremelimumab|tremelimumab|mesh-list
15221985|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
15221986|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15221987|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15221988|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15221989|NCT02303821|Analgesics|analgesics|mesh-ancestor
15221990|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
15221991|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
15221992|NCT02287311|Fludarabine|fludarabine|mesh-list
14314592|NCT00702923|Bicalutamide|bicalutamide|mesh-list
14314593|NCT00702923|Ipilimumab|ipilimumab|mesh-list
14314594|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14314595|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314596|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
14314597|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314598|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
14314599|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
14314600|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314601|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314602|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14314603|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314604|NCT00702949|Pregabalin|pregabalin|mesh-list
14314605|NCT00702949|Analgesics|analgesics|mesh-ancestor
14314606|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
15221993|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314607|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314608|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314609|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
14314610|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14314611|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314612|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314613|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14314614|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14314615|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14314616|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14314617|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314618|NCT00703118|Ribavirin|ribavirin|mesh-list
14314619|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
14314620|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14314621|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
14314622|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314623|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
14314624|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314625|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910193|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910194|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910195|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
14910196|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910197|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
14910198|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
14910199|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
14314626|NCT00703261|Atorvastatin|atorvastatin|mesh-list
14314627|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14314628|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14314629|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
14314630|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314631|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14314632|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14314633|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314634|NCT00703508|Metformin|metformin|mesh-list
14314635|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314636|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314637|NCT00703664|Bortezomib|bortezomib|mesh-list
14314638|NCT00703664|Vorinostat|vorinostat|mesh-list
14314639|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314640|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14314641|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314642|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314643|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
14314644|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
14314645|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314646|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724001|NCT00497107|Antidotes|antidotes|mesh-ancestor
14314647|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724002|NCT00497107|Protective Agents|protective agents|mesh-ancestor
14724003|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
14724004|NCT00497107|Vitamins|vitamins|mesh-ancestor
14724005|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
14724006|NCT00497120|Acetazolamide|acetazolamide|mesh-list
14724007|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
14724008|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14724009|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724010|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724011|NCT00497120|Diuretics|diuretics|mesh-ancestor
14724012|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
14724013|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724014|NCT00497172|Sirolimus|sirolimus|mesh-list
14724015|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724016|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724017|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14724018|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724019|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
14314648|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
14314649|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14314650|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14314651|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314652|NCT00703781|Bromfenac|bromfenac|mesh-list
14314653|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14314654|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14314655|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14314656|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14314657|NCT00703781|Analgesics|analgesics|mesh-ancestor
14314658|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
14314659|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314660|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314661|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14724020|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724021|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
14724022|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724023|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14724024|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724025|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14724026|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314662|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314663|NCT00703820|Cytarabine|cytarabine|mesh-list
14314664|NCT00703820|Etoposide|etoposide|mesh-list
14314665|NCT00703820|Daunorubicin|daunorubicin|mesh-list
14314666|NCT00703820|Clofarabine|clofarabine|mesh-list
14724027|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724028|NCT00497237|Fluticasone|fluticasone|mesh-list
14724029|NCT00497237|Beclomethasone|beclomethasone|mesh-list
14328100|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
14724030|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
14314667|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14314668|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314669|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14314670|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14314671|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314672|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314673|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14314674|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
14314675|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
14314676|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314677|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314678|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
14314679|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314680|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14314681|NCT00703846|Ketoconazole|ketoconazole|mesh-list
14314682|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
14314683|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314684|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14314685|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14314686|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314687|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314688|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14314689|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
14314690|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314691|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314692|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14314693|NCT00703924|Paromomycin|paromomycin|mesh-list
14314694|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14314695|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314696|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14314697|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14314698|NCT00703976|Bevacizumab|bevacizumab|mesh-list
14314699|NCT00703976|Cetuximab|cetuximab|mesh-list
14314700|NCT00703976|Pemetrexed|pemetrexed|mesh-list
14314701|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314702|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314703|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14314704|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14314705|NCT00703976|Growth Substances|growth substances|mesh-ancestor
14314706|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314707|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
14314708|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314709|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314710|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14314711|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14314712|NCT00704028|Dextrans|dextrans|mesh-list
14314713|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
14314714|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
14314715|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
14314716|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
14314717|NCT00704028|Hematinics|hematinics|mesh-ancestor
14314718|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14314719|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314720|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314721|NCT00704132|Incretins|incretins|mesh-ancestor
14314722|NCT00704132|Hormones|hormones|mesh-ancestor
14314723|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14314724|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14314725|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
14724031|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14724032|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14724033|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14724034|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
14724035|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724036|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724037|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14724038|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
14314726|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314727|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314728|NCT00704184|Interferons|interferons|mesh-list
14314729|NCT00704184|Ribavirin|ribavirin|mesh-list
14314730|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314731|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
14314732|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314733|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
14314734|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314735|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
14314736|NCT00704262|Calcipotriene|calcipotriene|mesh-list
14314737|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314738|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
14314739|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
14314740|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
14314741|NCT00704353|Hematinics|hematinics|mesh-ancestor
14314742|NCT00704379|Sertraline|sertraline|mesh-list
14314743|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
14314744|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314745|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14314746|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14314747|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314748|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314749|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314750|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
14314751|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314752|NCT00704405|Interferons|interferons|mesh-list
14314753|NCT00704405|Ribavirin|ribavirin|mesh-list
14314754|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314755|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
14314756|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314757|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
14314758|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314759|NCT00704418|Bromfenac|bromfenac|mesh-list
14314760|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14314761|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14314762|NCT00704418|Analgesics|analgesics|mesh-ancestor
14314763|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
14314764|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314765|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314766|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314767|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314768|NCT00704522|Ribavirin|ribavirin|mesh-list
14314769|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14314770|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
14314771|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314772|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
14314773|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314774|NCT00704717|Ribavirin|ribavirin|mesh-list
14314775|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14314776|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
14314777|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
14314778|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314779|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
14314780|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314781|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
14314782|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314783|NCT00704808|Temozolomide|temozolomide|mesh-list
14314784|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14314785|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
14314786|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314787|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314788|NCT00704847|Calcitonin|calcitonin|mesh-list
14314789|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
15221994|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
15221995|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314790|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14314791|NCT00704847|Katacalcin|katacalcin|mesh-list
14314792|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14314793|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314794|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14314795|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
14314796|NCT00704912|Orlistat|orlistat|mesh-list
14314797|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
14314798|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14314799|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
14314800|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14314801|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314802|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14314803|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314804|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314805|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14314806|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14314807|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14314808|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14314809|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14314810|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14314811|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14314812|NCT00704938|Aldesleukin|aldesleukin|mesh-list
14314813|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
14314814|NCT00704938|Fludarabine|fludarabine|mesh-list
14314815|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
14314816|NCT00704938|Sargramostim|sargramostim|mesh-list
14314817|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314818|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
14314819|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314820|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314821|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14314822|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
14314823|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314824|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314825|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14314826|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14314827|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
14314828|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14314829|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14314830|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
14314831|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314832|NCT00704964|Ribavirin|ribavirin|mesh-list
14314833|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14314834|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
14314835|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
14314836|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314837|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
14314838|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314839|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
14314840|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314841|NCT00705003|Melatonin|melatonin|mesh-list
14314842|NCT00705003|Buspirone|buspirone|mesh-list
15221996|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15221997|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15221998|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
15221999|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222000|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222001|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15222002|NCT02271919|Nicotine|nicotine|mesh-list
15222003|NCT02271919|Varenicline|varenicline|mesh-list
15222004|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15222005|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
15222006|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314843|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
15222007|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314844|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314845|NCT00705003|Protective Agents|protective agents|mesh-ancestor
14314846|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314847|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14314848|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14314849|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14314850|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314851|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14314852|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
14314853|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314854|NCT00705016|Fluorouracil|fluorouracil|mesh-list
14314855|NCT00705016|Cetuximab|cetuximab|mesh-list
14314856|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314857|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
14314858|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314859|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14314860|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314861|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
14314862|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314863|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14314864|NCT00705107|Ribavirin|ribavirin|mesh-list
14314865|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14314866|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
14314867|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
14314868|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314869|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
14314870|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314871|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
14314872|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314873|NCT00705133|Treprostinil|treprostinil|mesh-list
14314874|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14314875|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14314876|NCT00705159|Tobramycin|tobramycin|mesh-list
14314877|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14314878|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314879|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14314880|NCT00705224|Interferons|interferons|mesh-list
14314881|NCT00705224|Ribavirin|ribavirin|mesh-list
14314882|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314883|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
14314884|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314885|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
14314886|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314887|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14314888|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14314889|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
15222008|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15222009|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15222010|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
15222011|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222012|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222013|NCT02263729|Losartan|losartan|mesh-list
15222014|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15222015|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15222016|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15222017|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15222018|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222019|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
15222020|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15222021|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14314890|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314891|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314892|NCT00705263|Ribavirin|ribavirin|mesh-list
14314893|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14314894|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
14314895|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314896|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
14314897|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314898|NCT00705289|Infliximab|infliximab|mesh-list
14314899|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
14314900|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14314901|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314902|NCT00705341|Fluticasone|fluticasone|mesh-list
14314903|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14314904|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14314905|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
14314906|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14314907|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314908|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14314909|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
14314910|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
14314911|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14314912|NCT00705367|Abatacept|abatacept|mesh-list
14314913|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14314914|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314915|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14314916|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14314917|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
14314918|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314919|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314920|NCT00705406|Peramivir|peramivir|mesh-list
14314921|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
14314922|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314923|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314924|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314925|NCT00705432|Ribavirin|ribavirin|mesh-list
14314926|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14314927|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
14314928|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314929|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
14314930|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314931|NCT00705484|Infliximab|infliximab|mesh-list
14314932|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14314933|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14314934|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314935|NCT00705523|Varenicline|varenicline|mesh-list
14314936|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14314937|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14314938|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
14314939|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314940|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314941|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314942|NCT00705536|Insulin|insulin|mesh-list
14314943|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14314944|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
14314945|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14314946|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314947|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14314948|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14314949|NCT00705575|Diuretics|diuretics|mesh-ancestor
14314950|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
14314951|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314952|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14314953|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14314954|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314955|NCT00705614|Infliximab|infliximab|mesh-list
14314956|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
14724039|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
14314957|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14314958|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14314959|NCT00705666|Ribavirin|ribavirin|mesh-list
14314960|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14314961|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
14314962|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314963|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
14314964|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314965|NCT00705679|Tenofovir|tenofovir|mesh-list
14314966|NCT00705679|Emtricitabine|emtricitabine|mesh-list
14314967|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14314968|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
14314969|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14314970|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14314971|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14314972|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14314973|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314974|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14314975|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14314976|NCT00705757|Bimatoprost|bimatoprost|mesh-list
14314977|NCT00705757|Travoprost|travoprost|mesh-list
14314978|NCT00705757|Latanoprost|latanoprost|mesh-list
14724040|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14724041|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14314979|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14314980|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14314981|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14314982|NCT00705783|Aripiprazole|aripiprazole|mesh-list
14314983|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
14314984|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14314985|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14314986|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14314987|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14314988|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14314989|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
14314990|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
14314991|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14314992|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14314993|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14314994|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14314995|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
14314996|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14314997|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14314998|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14314999|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14315000|NCT00705874|Leucovorin|leucovorin|mesh-list
14315001|NCT00705874|Gemcitabine|gemcitabine|mesh-list
14315002|NCT00705874|Bevacizumab|bevacizumab|mesh-list
14315003|NCT00705874|Sunitinib|sunitinib|mesh-list
14315004|NCT00705874|Docetaxel|docetaxel|mesh-list
14315005|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14315006|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14315007|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315008|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14315009|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14315010|NCT00705874|Growth Substances|growth substances|mesh-ancestor
14724042|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14724043|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14315011|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315012|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
14724044|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
14315013|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14315014|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
14315015|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315016|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
14315017|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315018|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315019|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315020|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
14315021|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
14315022|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
14315023|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
14315024|NCT00705874|Antidotes|antidotes|mesh-ancestor
14315025|NCT00705874|Protective Agents|protective agents|mesh-ancestor
14315026|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
14315027|NCT00705874|Vitamins|vitamins|mesh-ancestor
14315028|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
14315029|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315030|NCT00706004|Lubiprostone|lubiprostone|mesh-list
14315031|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14315032|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14315033|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315034|NCT00706030|Vinorelbine|vinorelbine|mesh-list
14315035|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14315036|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315037|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14315038|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14315039|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14315040|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328101|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14328102|NCT00807014|Adapalene|adapalene|mesh-list
14328103|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14328104|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328105|NCT00807014|Analgesics|analgesics|mesh-ancestor
14328106|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
14328107|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328108|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328109|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328110|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328111|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
14328112|NCT00807092|Insulin|insulin|mesh-list
14328113|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14328114|NCT00807092|Metformin|metformin|mesh-list
14328115|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
14328116|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
14328117|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14328118|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14328119|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328120|NCT00807144|Tacrolimus|tacrolimus|mesh-list
14328121|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328122|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
14328123|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328124|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14328125|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328126|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328127|NCT00807209|Fentanyl|fentanyl|mesh-list
14315041|NCT00706121|Vitamins|vitamins|mesh-list
14315042|NCT00706121|Vitamin E|vitamin e|mesh-list
14315043|NCT00706121|Tocopherols|tocopherols|mesh-list
14315044|NCT00706121|Tocotrienols|tocotrienols|mesh-list
14315045|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
14315046|NCT00706121|Selenium|selenium|mesh-list
14315047|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
14315048|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315049|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
14315050|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315051|NCT00706121|Protective Agents|protective agents|mesh-ancestor
14315052|NCT00706121|Trace Elements|trace elements|mesh-ancestor
14315053|NCT00706264|Silicon|silicon|mesh-list
14315054|NCT00706264|Trace Elements|trace elements|mesh-ancestor
14315055|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
14315056|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315057|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14315058|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14315059|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14315060|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14315061|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14315062|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
14315063|NCT00706446|Fluticasone|fluticasone|mesh-list
14315064|NCT00706446|Xhance|xhance|mesh-list
14315065|NCT00706446|Budesonide|budesonide|mesh-list
14315066|NCT00706446|Bromides|bromides|mesh-list
14315067|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
14315068|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
14315069|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14315070|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315071|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14315072|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
14315073|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315074|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315075|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14315076|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
14315077|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
14315078|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14315079|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
14315080|NCT00706446|Hormones|hormones|mesh-ancestor
14315081|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315082|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14910200|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14910201|NCT01355939|Protective Agents|protective agents|mesh-ancestor
14910202|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315083|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14315084|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14315085|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
14315086|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315087|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315088|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
14315089|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14315090|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
14315091|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
14315092|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14315093|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
14315094|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315095|NCT00706589|Aripiprazole|aripiprazole|mesh-list
14315096|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
14315097|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315098|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14315099|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14315100|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315101|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315102|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
14315103|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
14315104|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315105|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315106|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14315107|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14315108|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
14315109|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14315110|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14315111|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14315112|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14315113|NCT00706628|Nintedanib|nintedanib|mesh-list
14315114|NCT00706628|Afatinib|afatinib|mesh-list
14315115|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315116|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14724045|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724046|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724047|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
14724048|NCT00497237|Hormones|hormones|mesh-ancestor
15222022|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222023|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
15222024|NCT02261415|Coagulants|coagulants|mesh-ancestor
15222025|NCT02256696|Rifampin|rifampin|mesh-list
15222026|NCT02256696|Rifabutin|rifabutin|mesh-list
15222027|NCT02256696|Isoniazid|isoniazid|mesh-list
15222028|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
15222029|NCT02256696|Ethambutol|ethambutol|mesh-list
15222030|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15222031|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
15222032|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315117|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222033|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222034|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
14724049|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724050|NCT00497250|Gefitinib|gefitinib|mesh-list
14724051|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222035|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15222036|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222037|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222038|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15222039|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15222040|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15222041|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15222042|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15222043|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15222044|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15222045|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15222046|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
15222047|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15222048|NCT02225600|Oxytocin|oxytocin|mesh-list
15222049|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
15222050|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724052|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14724053|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724054|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724055|NCT00497315|Pemetrexed|pemetrexed|mesh-list
14724056|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724057|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724058|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724059|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14724060|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14315118|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315119|NCT00706641|Dasatinib|dasatinib|mesh-list
14315120|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315121|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315122|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315123|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315124|NCT00706654|Aripiprazole|aripiprazole|mesh-list
14315125|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
14315126|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315127|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14315128|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14315129|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315130|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315131|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
14315132|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
14315133|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315134|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315135|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14315136|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14315137|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
14315138|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14315139|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14315140|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14315141|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14315142|NCT00706706|Sunitinib|sunitinib|mesh-list
14315143|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315144|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14315145|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14315146|NCT00706706|Growth Substances|growth substances|mesh-ancestor
14315147|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315148|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
14315149|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315150|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315151|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315152|NCT00706719|Enclomiphene|enclomiphene|mesh-list
14315153|NCT00706719|Clomiphene|clomiphene|mesh-list
14315154|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
14315155|NCT00706719|Testosterone|testosterone|mesh-list
14315156|NCT00706719|Androgens|androgens|mesh-ancestor
14315157|NCT00706719|Hormones|hormones|mesh-ancestor
14315158|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315159|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315160|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14315161|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
14315162|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14315163|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
14315164|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14315165|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14315166|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14315167|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
14315168|NCT00706810|Verapamil|verapamil|mesh-list
14315169|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315170|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
14315171|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315172|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315173|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14315174|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14315175|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14315176|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14315177|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14315178|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315179|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
14315180|NCT00706836|Pregabalin|pregabalin|mesh-list
14315181|NCT00706836|Analgesics|analgesics|mesh-ancestor
14315182|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
14315183|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315184|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315185|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
14315186|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14315187|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14315188|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315189|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14315190|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14315191|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14315192|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315193|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315194|NCT00706849|Mipomersen|mipomersen|mesh-list
14315195|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14315196|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14315197|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
14315198|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315199|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14315200|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
14315201|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14315202|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
14315203|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315204|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315205|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14315206|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
14315207|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14315208|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14315209|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14315210|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
14315211|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315212|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315213|NCT00706966|Dutasteride|dutasteride|mesh-list
14315214|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14315215|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14315216|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315217|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315218|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
14315219|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315220|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315221|NCT00706979|Nicotine|nicotine|mesh-list
14315222|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14315223|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
14315224|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315225|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315226|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14315227|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14315228|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
14315229|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315230|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315231|NCT00706992|Aldesleukin|aldesleukin|mesh-list
14315232|NCT00706992|Vaccines|vaccines|mesh-list
14315233|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
14315234|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
14315235|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315236|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315237|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14315238|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14315239|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
14315240|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315241|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14315242|NCT00707031|Metformin|metformin|mesh-list
14315243|NCT00707031|Exenatide|exenatide|mesh-list
14315244|NCT00707031|Lixisenatide|lixisenatide|mesh-list
14315245|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14315246|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315247|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14315248|NCT00707031|Incretins|incretins|mesh-ancestor
14315249|NCT00707031|Hormones|hormones|mesh-ancestor
14315250|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315251|NCT00707057|Ibuprofen|ibuprofen|mesh-list
15222051|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222052|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
15222053|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15222054|NCT02223520|Mupirocin|mupirocin|mesh-list
15222055|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15222056|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315252|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14315253|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14315254|NCT00707057|Analgesics|analgesics|mesh-ancestor
14315255|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
15222057|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
15222058|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
15222059|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15222060|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15222061|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222062|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222063|NCT02220309|Pramipexole|pramipexole|mesh-list
14315256|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315257|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315258|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315259|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14315260|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14315261|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315262|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315263|NCT00707174|Imiquimod|imiquimod|mesh-list
14315264|NCT00707174|Tazarotene|tazarotene|mesh-list
14315265|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14315266|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
14315267|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315268|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315269|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
14315270|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
14315271|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
14315272|NCT00707239|Imipenem|imipenem|mesh-list
14315273|NCT00707239|Tigecycline|tigecycline|mesh-list
14315274|NCT00707239|Cilastatin|cilastatin|mesh-list
14315275|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315276|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315277|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14315278|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315279|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315280|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
14315281|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14315282|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
14315283|NCT00707486|Coagulants|coagulants|mesh-ancestor
14315284|NCT00707655|Zalutumumab|zalutumumab|mesh-list
14315285|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14315286|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315287|NCT00707746|Mipomersen|mipomersen|mesh-list
14315288|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14315289|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14315290|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
14315291|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315292|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14315293|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
14315294|NCT00707759|Prednisone|prednisone|mesh-list
14315295|NCT00707759|Prednisolone|prednisolone|mesh-list
14315296|NCT00707759|Tacrolimus|tacrolimus|mesh-list
14315297|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315298|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
14315299|NCT00707759|Hormones|hormones|mesh-ancestor
14315300|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315301|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315302|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14315303|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315304|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315305|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
14315306|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14315307|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222064|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
15222065|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222066|NCT02220309|Protective Agents|protective agents|mesh-ancestor
15222067|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222068|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15222069|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15222070|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
15222071|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
15222072|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222073|NCT02143401|Sorafenib|sorafenib|mesh-list
14315308|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315309|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14315310|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14315311|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
14315312|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315313|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315314|NCT00707863|Citalopram|citalopram|mesh-list
14315315|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14315316|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14315317|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14315318|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315319|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315320|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
14315321|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315322|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14315323|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
14315324|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315325|NCT00707967|Vaccines|vaccines|mesh-list
14315326|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
14315327|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315328|NCT00707980|Vortioxetine|vortioxetine|mesh-list
14315329|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
14315330|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315331|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14315332|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14315333|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315334|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315335|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14315336|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14315337|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14315338|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315339|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315340|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
14315341|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14315342|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14315343|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14315344|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14315345|NCT00707993|Alogliptin|alogliptin|mesh-list
14315346|NCT00707993|Glipizide|glipizide|mesh-list
14315347|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14315348|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315349|NCT00707993|Incretins|incretins|mesh-ancestor
14315350|NCT00707993|Hormones|hormones|mesh-ancestor
14315351|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315352|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14315353|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
14315354|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315355|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315356|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14315357|NCT00708071|Thrombin|thrombin|mesh-list
14315358|NCT00708071|Aprotinin|aprotinin|mesh-list
14315359|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
14315360|NCT00708071|Coagulants|coagulants|mesh-ancestor
14315361|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14315362|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14315363|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
14315364|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315365|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315366|NCT00708097|Fluorides|fluorides|mesh-list
14315367|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
14315368|NCT00708097|Protective Agents|protective agents|mesh-ancestor
14315369|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315370|NCT00708110|Dolutegravir|dolutegravir|mesh-list
14315371|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14315372|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14315373|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315374|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315375|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14315376|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14315377|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
14315378|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315379|NCT00708123|Listerine|listerine|mesh-list
14315380|NCT00708123|Fluorides|fluorides|mesh-list
14315381|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
14315382|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
14315383|NCT00708123|Protective Agents|protective agents|mesh-ancestor
14315384|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315385|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14315386|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315387|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
14315388|NCT00708162|Elvitegravir|elvitegravir|mesh-list
14315389|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14724061|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
14724062|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14724063|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
14315390|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14315391|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
14315392|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315393|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14315394|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14315395|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315396|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315397|NCT00708175|Pioglitazone|pioglitazone|mesh-list
14315398|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14315399|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315400|NCT00708201|Alvimopan|alvimopan|mesh-list
14315401|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14315402|NCT00708214|Letrozole|letrozole|mesh-list
14315403|NCT00708214|Afatinib|afatinib|mesh-list
14315404|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315405|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14328128|NCT00807209|Bupivacaine|bupivacaine|mesh-list
14724064|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724065|NCT00497328|Expectorants|expectorants|mesh-ancestor
14724066|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
14724067|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14724068|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
14724069|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724070|NCT00497328|Protective Agents|protective agents|mesh-ancestor
14724071|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724072|NCT00497328|Antidotes|antidotes|mesh-ancestor
14724073|NCT00497341|Cefuroxime|cefuroxime|mesh-list
14724074|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
14724075|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724076|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724077|NCT00497354|Anesthetics|anesthetics|mesh-list
14724078|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
15222074|NCT02143401|Navitoclax|navitoclax|mesh-list
15222075|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222076|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15222077|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222078|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222079|NCT02141282|Venetoclax|venetoclax|mesh-list
15222080|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222081|NCT02126553|Lenalidomide|lenalidomide|mesh-list
15222082|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
15222083|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315406|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14315407|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315408|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315409|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14315410|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
14315411|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315412|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315413|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315414|NCT00708305|Listerine|listerine|mesh-list
14315415|NCT00708305|Fluorides|fluorides|mesh-list
14315416|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
14315417|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
14315418|NCT00708305|Protective Agents|protective agents|mesh-ancestor
14315419|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315420|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14315421|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315422|NCT00708422|Travoprost|travoprost|mesh-list
14315423|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14315424|NCT00708422|Latanoprost|latanoprost|mesh-list
14315425|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14315426|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14315427|NCT00708435|Protein C|protein c|mesh-list
14315428|NCT00708435|Protein S|protein s|mesh-list
14315429|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
14315430|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14315431|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14315432|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315433|NCT00708500|Interferons|interferons|mesh-list
14315434|NCT00708500|Ribavirin|ribavirin|mesh-list
14315435|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
14315436|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
14315437|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14315438|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315439|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
14315440|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315441|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
14315442|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315443|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
14315444|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315445|NCT00708526|Anesthetics|anesthetics|mesh-list
14315446|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315447|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315448|NCT00708552|Donepezil|donepezil|mesh-list
14315449|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14315450|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315451|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315452|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
14315453|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315454|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315455|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
14315456|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14315457|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
14315458|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315459|NCT00708708|Etanercept|etanercept|mesh-list
14315460|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14315461|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14315462|NCT00708708|Analgesics|analgesics|mesh-ancestor
14315463|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
14315464|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315465|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315466|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315467|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14315468|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14315469|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315470|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
14315471|NCT00708721|Clofarabine|clofarabine|mesh-list
14315472|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14315473|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
14315474|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315475|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315476|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14315477|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14315478|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14315479|NCT00709059|Ribavirin|ribavirin|mesh-list
14315480|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14315481|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
14315482|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
14315483|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315484|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
14315485|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315486|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
14315487|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315488|NCT00709098|Iloprost|iloprost|mesh-list
14315489|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14315490|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
14315491|NCT00709111|Maraviroc|maraviroc|mesh-list
14315492|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14315493|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14315494|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315495|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14315496|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14315497|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
14315498|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315499|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14315500|NCT00709202|Betahistine|betahistine|mesh-list
14315501|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
14315502|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
14315503|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
14315504|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315505|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315506|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315507|NCT00709228|Ribavirin|ribavirin|mesh-list
14315508|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14315509|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
14315510|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315511|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
14315512|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315513|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
14315514|NCT00709592|Tacrolimus|tacrolimus|mesh-list
14315515|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
14315516|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14315517|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315518|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
14315519|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315520|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14315521|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315522|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315523|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14315524|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315525|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14315526|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
14315527|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315528|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315529|NCT00709618|Vinorelbine|vinorelbine|mesh-list
14315530|NCT00709618|Lapatinib|lapatinib|mesh-list
14315531|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14315532|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315533|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
14315534|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
14315535|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
14315536|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315537|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315538|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315539|NCT00709696|Varenicline|varenicline|mesh-list
15222084|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222085|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222086|NCT02126553|Growth Substances|growth substances|mesh-ancestor
15222087|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222088|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222089|NCT02122198|Leuprolide|leuprolide|mesh-list
15222090|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15222091|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
15222092|NCT02122198|Estradiol|estradiol|mesh-list
15222093|NCT02122198|Estrogens|estrogens|mesh-ancestor
15222094|NCT02122198|Hormones|hormones|mesh-ancestor
15222095|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222096|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222097|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14315540|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14315541|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14315542|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
15222098|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
14315543|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315544|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315545|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315546|NCT00709722|Gusperimus|gusperimus|mesh-list
14315547|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14315548|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315549|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14315550|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724079|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724080|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724081|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
14724082|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724083|NCT00497458|Testosterone|testosterone|mesh-list
14724084|NCT00497458|Androgens|androgens|mesh-ancestor
14724085|NCT00497458|Hormones|hormones|mesh-ancestor
14724086|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724087|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724088|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
14724089|NCT00497471|Dapsone|dapsone|mesh-list
14724090|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
14724091|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14724092|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14724093|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724094|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14724095|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724096|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724097|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
14724098|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724099|NCT00497497|Bevacizumab|bevacizumab|mesh-list
14724100|NCT00497497|Cetuximab|cetuximab|mesh-list
14724101|NCT00497497|Irinotecan|irinotecan|mesh-list
14724102|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724103|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724104|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14724105|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222099|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15222100|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15222101|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15222102|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
15222103|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222104|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222105|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15222106|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15222107|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15222108|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15222109|NCT02079948|Folic Acid|folic acid|mesh-list
15222110|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
15222111|NCT02079948|Methotrexate|methotrexate|mesh-list
15222112|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15222113|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
15222114|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15222115|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222116|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724106|NCT00497497|Growth Substances|growth substances|mesh-ancestor
15222117|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
15222118|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222119|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222120|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
15222121|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222122|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14315551|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315552|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
14315553|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14315554|NCT00709722|Protective Agents|protective agents|mesh-ancestor
14315555|NCT00709735|Propranolol|propranolol|mesh-list
14315556|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14315557|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14315558|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
14315559|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315560|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315561|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315562|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14315563|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14315564|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
14315565|NCT00709761|Paclitaxel|paclitaxel|mesh-list
14315566|NCT00709761|Lapatinib|lapatinib|mesh-list
14315567|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14315568|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315569|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14315570|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14315571|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14315572|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315573|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315574|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315575|NCT00709826|Gemcitabine|gemcitabine|mesh-list
14315576|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14315577|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14315578|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
14315579|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315580|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315581|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
14315582|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315583|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315584|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315585|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
14315586|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315587|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315588|NCT00709956|Iloprost|iloprost|mesh-list
14315589|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14315590|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
14315591|NCT00709995|Sunitinib|sunitinib|mesh-list
14315592|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315593|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14315594|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14315595|NCT00709995|Growth Substances|growth substances|mesh-ancestor
14315596|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315597|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
14315598|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315599|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315600|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315601|NCT00710021|Vitamin D|vitamin d|mesh-list
14315602|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
14315603|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
14315604|NCT00710021|Vitamins|vitamins|mesh-list
14315605|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
14315606|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315607|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14315608|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14315609|NCT00710034|Nicotine|nicotine|mesh-list
14315610|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14315611|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
14315612|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315613|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315614|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14315615|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14315616|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
14315617|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315618|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222123|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724107|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315619|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14315620|NCT00710385|Buprenorphine|buprenorphine|mesh-list
14315621|NCT00710385|Heroin|heroin|mesh-list
14315622|NCT00710385|Naloxone|naloxone|mesh-list
14315623|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14315624|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315625|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
14315626|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315627|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14315628|NCT00710385|Narcotics|narcotics|mesh-ancestor
14315629|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315630|NCT00710385|Analgesics|analgesics|mesh-ancestor
14315631|NCT00710424|Nabiximols|nabiximols|mesh-list
14315632|NCT00710424|Analgesics|analgesics|mesh-ancestor
14315633|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
14315634|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315635|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315636|NCT00710554|Nabiximols|nabiximols|mesh-list
14315637|NCT00710554|Analgesics|analgesics|mesh-ancestor
14315638|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
14315639|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315640|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328129|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
14328130|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
14328131|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328132|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328133|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
14328134|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328135|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14328136|NCT00807209|Narcotics|narcotics|mesh-ancestor
14328137|NCT00807209|Analgesics|analgesics|mesh-ancestor
14328138|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14328139|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14328140|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
14328141|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14328142|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
14328143|NCT00807248|Gaboxadol|gaboxadol|mesh-list
14328144|NCT00807248|Dexetimide|dexetimide|mesh-list
14328145|NCT00807248|Citalopram|citalopram|mesh-list
14724108|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
14724109|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14724110|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14724111|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724112|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724113|NCT00497523|Beclomethasone|beclomethasone|mesh-list
14724114|NCT00497523|Albuterol|albuterol|mesh-list
14724115|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14724116|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
14724117|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724118|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724119|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14724120|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
14315641|NCT00710606|NuvaRing|nuvaring|mesh-list
14724121|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
14724122|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724123|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14724124|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14724125|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14724126|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14724127|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315642|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14315643|NCT00710606|Desogestrel|desogestrel|mesh-list
14315644|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14315645|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
14315646|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14315647|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315648|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14315649|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14315650|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14315651|NCT00710606|Estrogens|estrogens|mesh-ancestor
14315652|NCT00710606|Hormones|hormones|mesh-ancestor
14315653|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315654|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14315655|NCT00710606|Progestins|progestins|mesh-ancestor
14315656|NCT00710684|Donepezil|donepezil|mesh-list
14315657|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14315658|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315659|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315660|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
14315661|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315662|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315663|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
14315664|NCT00710762|Nintedanib|nintedanib|mesh-list
14315665|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315666|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315667|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315668|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315669|NCT00711009|Ritonavir|ritonavir|mesh-list
14315670|NCT00711009|Lopinavir|lopinavir|mesh-list
14315671|NCT00711009|Tenofovir|tenofovir|mesh-list
14315672|NCT00711009|Emtricitabine|emtricitabine|mesh-list
14315673|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
14315674|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14315675|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14315676|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14315677|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
14315678|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315679|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315680|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14315681|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14315682|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
14315683|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315684|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14315685|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14315686|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14315687|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14315688|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14315689|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14315690|NCT00711191|Antibodies|antibodies|mesh-list
14315691|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14315692|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
14315693|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315694|NCT00711243|Docetaxel|docetaxel|mesh-list
14315695|NCT00711243|Fluorouracil|fluorouracil|mesh-list
14315696|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
14315697|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315698|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14315699|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14315700|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14315701|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315702|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
14315703|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14315704|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315705|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
14315706|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315707|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
14315708|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14315709|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
14315710|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315711|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
14315712|NCT00711347|Protective Agents|protective agents|mesh-ancestor
14315713|NCT00711412|Capecitabine|capecitabine|mesh-list
14315714|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
14315715|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14315716|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
14315717|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315718|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315719|NCT00711464|Modafinil|modafinil|mesh-list
14315720|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14315721|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315722|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14315723|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14315724|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14315725|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315726|NCT00711477|Naltrexone|naltrexone|mesh-list
14315727|NCT00711477|Bupropion|bupropion|mesh-list
14315728|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14315729|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14315730|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315731|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
14315732|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315733|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14315734|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
14315735|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315736|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14315737|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14315738|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14315739|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315740|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
14315741|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315742|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14315743|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14315744|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315745|NCT00711490|Sirolimus|sirolimus|mesh-list
14315746|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315747|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315748|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14315749|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315750|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
14315751|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315752|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
14315753|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315754|NCT00711516|Modafinil|modafinil|mesh-list
14315755|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14315756|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315757|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14315758|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14315759|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14315760|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315761|NCT00711529|Gabapentin|gabapentin|mesh-list
14315762|NCT00711529|Analgesics|analgesics|mesh-ancestor
14315763|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
14315764|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315765|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315766|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
14315767|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14315768|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14315769|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315770|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315771|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14315772|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14315773|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315774|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315775|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
14315776|NCT00711594|Afatinib|afatinib|mesh-list
14315777|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315778|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315779|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315780|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315781|NCT00711646|Nabiximols|nabiximols|mesh-list
14315782|NCT00711646|Analgesics|analgesics|mesh-ancestor
14315783|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
14315784|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315785|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315786|NCT00711802|Daptomycin|daptomycin|mesh-list
14315787|NCT00711802|Cloxacillin|cloxacillin|mesh-list
14315788|NCT00711802|Oxacillin|oxacillin|mesh-list
14315789|NCT00711802|Nafcillin|nafcillin|mesh-list
14315790|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315791|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315792|NCT00711828|Dexamethasone|dexamethasone|mesh-list
14315793|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
14315794|NCT00711828|Rituximab|rituximab|mesh-list
14315795|NCT00711828|Bortezomib|bortezomib|mesh-list
14315796|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315797|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
14315798|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315799|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14315800|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14315801|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
14315802|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315803|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315804|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14315805|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315806|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
14315807|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
14315808|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315809|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14315810|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
14315811|NCT00711828|Hormones|hormones|mesh-ancestor
14315812|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315813|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14315814|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14315815|NCT00711880|Nabiximols|nabiximols|mesh-list
14315816|NCT00711880|Analgesics|analgesics|mesh-ancestor
14315817|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
14315818|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315819|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315820|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14315821|NCT00712010|Caseins|caseins|mesh-list
14315822|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
14315823|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
14315824|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724128|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315825|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
14315826|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14315827|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
14315828|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315829|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
14315830|NCT00712244|Protective Agents|protective agents|mesh-ancestor
14315831|NCT00712270|Risperidone|risperidone|mesh-list
14315832|NCT00712270|Aripiprazole|aripiprazole|mesh-list
14315833|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14315834|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
14315835|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315836|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315837|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315838|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14315839|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14315840|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315841|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14315842|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15222124|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
15222125|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15222126|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15222127|NCT02079948|Hematinics|hematinics|mesh-ancestor
15222128|NCT02079948|Vitamins|vitamins|mesh-ancestor
15222129|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
14910203|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
14910204|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
14910205|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910206|NCT01355952|Protective Agents|protective agents|mesh-ancestor
14910207|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910208|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
14315843|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
14315844|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
14315845|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
14315846|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14315847|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14315848|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14315849|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14315850|NCT00712335|Fluticasone|fluticasone|mesh-list
14315851|NCT00712335|Xhance|xhance|mesh-list
14315852|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14315853|NCT00712335|Montelukast|montelukast|mesh-list
14315854|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14315855|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315856|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14315857|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
14315858|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315859|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315860|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14315861|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
14315862|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
14315863|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14315864|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14910209|NCT01355952|Vitamins|vitamins|mesh-ancestor
15222130|NCT02060188|Nivolumab|nivolumab|mesh-list
15222131|NCT02060188|Ipilimumab|ipilimumab|mesh-list
15222132|NCT02060188|Daratumumab|daratumumab|mesh-list
15222133|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222134|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222135|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15222136|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222137|NCT02055053|Bupivacaine|bupivacaine|mesh-list
15222138|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
15222139|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
15222140|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15222141|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315865|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14315866|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14315867|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
14315868|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315869|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315870|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
14315871|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14315872|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14315873|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14315874|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14315875|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
14315876|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315877|NCT00712543|Lactulose|lactulose|mesh-list
14315878|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14315879|NCT00712673|Metformin|metformin|mesh-list
14315880|NCT00712673|Lixisenatide|lixisenatide|mesh-list
14315881|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14315882|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315883|NCT00712712|Acetaminophen|acetaminophen|mesh-list
14315884|NCT00712712|Morphine|morphine|mesh-list
14315885|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14315886|NCT00712712|Narcotics|narcotics|mesh-ancestor
14315887|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14315888|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315889|NCT00712712|Analgesics|analgesics|mesh-ancestor
14315890|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
14315891|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315892|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14315893|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
15222142|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
15222143|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222144|NCT02034110|Trametinib|trametinib|mesh-list
15222145|NCT02034110|Dabrafenib|dabrafenib|mesh-list
15222146|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222147|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14315894|NCT00712920|Azelastine|azelastine|mesh-list
14315895|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14315896|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
14315897|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315898|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315899|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14315900|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
14315901|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14315902|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315903|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315904|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14315905|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14315906|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14315907|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
14315908|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
14315909|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315910|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
14315911|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14315912|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315913|NCT00713219|Docetaxel|docetaxel|mesh-list
14315914|NCT00713219|Cetuximab|cetuximab|mesh-list
14315915|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14315916|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
14315917|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
14315918|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
14315919|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315920|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14315921|NCT00713284|Sirolimus|sirolimus|mesh-list
14315922|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315923|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315924|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14315925|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222148|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222149|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222150|NCT02004275|Dexamethasone|dexamethasone|mesh-list
15222151|NCT02004275|Pomalidomide|pomalidomide|mesh-list
14315926|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
14315927|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315928|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
14315929|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315930|NCT00713310|Mesalamine|mesalamine|mesh-list
14315931|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14315932|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14315933|NCT00713310|Analgesics|analgesics|mesh-ancestor
14315934|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
14315935|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315936|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315937|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315938|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14315939|NCT00713323|Nabiximols|nabiximols|mesh-list
14315940|NCT00713323|Analgesics|analgesics|mesh-ancestor
14315941|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
14315942|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315943|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315944|NCT00713479|Varenicline|varenicline|mesh-list
14315945|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14315946|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14315947|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
14315948|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315949|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315950|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315951|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14315952|NCT00713544|Etanercept|etanercept|mesh-list
14315953|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14315954|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14315955|NCT00713544|Analgesics|analgesics|mesh-ancestor
14315956|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
14315957|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315958|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315959|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14315960|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14315961|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14315962|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14315963|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
14315964|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14315965|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315966|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14315967|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14315968|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
14315969|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315970|NCT00713583|Levodopa|levodopa|mesh-list
14315971|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14315972|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14315973|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
14315974|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14315975|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315976|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315977|NCT00713609|Clindamycin|clindamycin|mesh-list
14315978|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
14315979|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
14910210|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
14315980|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14315981|NCT00713609|Tazarotene|tazarotene|mesh-list
14315982|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14315983|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14315984|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14315985|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14315986|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14315987|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
14315988|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
14315989|NCT00713817|Nabiximols|nabiximols|mesh-list
14315990|NCT00713817|Analgesics|analgesics|mesh-ancestor
14315991|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
14315992|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14315993|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315994|NCT00713830|Metformin|metformin|mesh-list
14315995|NCT00713830|Lixisenatide|lixisenatide|mesh-list
14315996|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14315997|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14315998|NCT00714233|Metformin|metformin|mesh-list
14315999|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
14316000|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
14316001|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14316002|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14316003|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14316004|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316005|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14316006|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14316007|NCT00714259|Fludarabine|fludarabine|mesh-list
14316008|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316009|NCT00714285|Vaccines|vaccines|mesh-list
14316010|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
14316011|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316012|NCT00714493|Infliximab|infliximab|mesh-list
14316013|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316014|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14316015|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316016|NCT00714688|Methylphenidate|methylphenidate|mesh-list
14316017|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14316018|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316019|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14316020|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14316021|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316022|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316023|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
14316024|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316025|NCT00714714|Adapalene|adapalene|mesh-list
14316026|NCT00714714|Tretinoin|tretinoin|mesh-list
14316027|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14316028|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14316029|NCT00714714|Analgesics|analgesics|mesh-ancestor
14316030|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
14316031|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910211|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
14910212|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14316032|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316033|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316034|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316035|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316036|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316037|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
14316038|NCT00715117|Naltrexone|naltrexone|mesh-list
14316039|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14316040|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14316041|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316042|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
14316043|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316044|NCT00715208|Prednisone|prednisone|mesh-list
14316045|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
14316046|NCT00715208|Rituximab|rituximab|mesh-list
14316047|NCT00715208|Doxorubicin|doxorubicin|mesh-list
14316048|NCT00715208|Bortezomib|bortezomib|mesh-list
14316049|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316050|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
14316051|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316052|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316053|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14316054|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
14910213|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14316055|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316056|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316057|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14316058|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316059|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14316060|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14316061|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14316062|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316063|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316064|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
14316065|NCT00715208|Hormones|hormones|mesh-ancestor
14316066|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14316067|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14316068|NCT00715403|Nintedanib|nintedanib|mesh-list
14316069|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316070|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316071|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316072|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316073|NCT00715429|Vitamin D|vitamin d|mesh-list
14316074|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
14316075|NCT00715429|Vitamins|vitamins|mesh-ancestor
14316076|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
14316077|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316078|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14316079|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14316080|NCT00715520|Levodopa|levodopa|mesh-list
14316081|NCT00715520|Carbidopa|carbidopa|mesh-list
14316082|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14316083|NCT00715520|Methylphenidate|methylphenidate|mesh-list
14316084|NCT00715520|Amphetamine|amphetamine|mesh-list
14316085|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14316086|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316087|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14316088|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14316089|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316090|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316091|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
14316092|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316093|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14316094|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14316095|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14316096|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316097|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
14316098|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
14316099|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316100|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
14316101|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14316102|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14316103|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
14316104|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
14316105|NCT00715559|Cysteamine|cysteamine|mesh-list
14316106|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14316107|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316108|NCT00715624|Metformin|metformin|mesh-list
14316109|NCT00715624|Lixisenatide|lixisenatide|mesh-list
14316110|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14316111|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316112|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14316113|NCT00715676|Vitamins|vitamins|mesh-ancestor
14316114|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
14316115|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316116|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14328146|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14328147|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14328148|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328149|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328150|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328151|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
14328152|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328153|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14328154|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
14328155|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724129|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316117|NCT00715793|Temozolomide|temozolomide|mesh-list
14316118|NCT00715793|Decitabine|decitabine|mesh-list
14316119|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14316120|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
14316121|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316122|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316123|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14316124|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
14316125|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316126|NCT00715884|Sirolimus|sirolimus|mesh-list
14316127|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316128|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316129|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14316130|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316131|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
14316132|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316133|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
14316134|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316135|NCT00715910|Vaccines|vaccines|mesh-list
14316136|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
14316137|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316138|NCT00716079|Metoprolol|metoprolol|mesh-list
14316139|NCT00716079|Clonidine|clonidine|mesh-list
14316140|NCT00716079|Hydralazine|hydralazine|mesh-list
14316141|NCT00716079|Labetalol|labetalol|mesh-list
14316142|NCT00716079|Nicardipine|nicardipine|mesh-list
14316143|NCT00716079|Phentolamine|phentolamine|mesh-list
14316144|NCT00716079|Urapidil|urapidil|mesh-list
14316145|NCT00716079|Enalaprilat|enalaprilat|mesh-list
14316146|NCT00716079|Esmolol|esmolol|mesh-list
14316147|NCT00716079|Glycerol|glycerol|mesh-list
14316148|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14316149|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14316150|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
14316151|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
14316152|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316153|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316154|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14316155|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14316156|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14316157|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
14316158|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316159|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316160|NCT00716079|Analgesics|analgesics|mesh-ancestor
14316161|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
14316162|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14316163|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14316164|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14316165|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14316166|NCT00716079|Protective Agents|protective agents|mesh-ancestor
14316167|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
14316168|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
14316169|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14316170|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14316171|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14316172|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316173|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14316174|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14316175|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
14316176|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14316177|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
14316178|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316179|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14316180|NCT00716092|Linagliptin|linagliptin|mesh-list
14316181|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15222152|NCT02004275|Ixazomib|ixazomib|mesh-list
15222153|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15222154|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
15222155|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
15222156|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316182|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316183|NCT00716092|Incretins|incretins|mesh-ancestor
14316184|NCT00716092|Hormones|hormones|mesh-ancestor
14316185|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14316186|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14316187|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
14316188|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316189|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316190|NCT00716144|R 115866|r 115866|mesh-list
14316191|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14316192|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316193|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316194|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15222157|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222158|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15222159|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
15222160|NCT02004275|Hormones|hormones|mesh-ancestor
15222161|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222162|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222163|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222164|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
15222165|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222166|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222167|NCT02004275|Growth Substances|growth substances|mesh-ancestor
15222168|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222169|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
14910214|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
14910215|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910216|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910217|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14910218|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
14910219|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
14910220|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14910221|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
14910222|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316195|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14316196|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14316197|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316198|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316199|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
14316200|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316201|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316202|NCT00716417|Afatinib|afatinib|mesh-list
14316203|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316204|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316205|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316206|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316207|NCT00716443|Lidocaine|lidocaine|mesh-list
14316208|NCT00716443|Tetracaine|tetracaine|mesh-list
14316209|NCT00716443|Benzocaine|benzocaine|mesh-list
14316210|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
14316211|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
14316212|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14316213|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316214|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
14316215|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316216|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14316217|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14316218|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14910223|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316219|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316220|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316221|NCT00716456|Cetuximab|cetuximab|mesh-list
14316222|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14316223|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316224|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316225|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316226|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316227|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316228|NCT00716586|Dorzolamide|dorzolamide|mesh-list
14316229|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14316230|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14316231|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316232|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316233|NCT00716625|Sunitinib|sunitinib|mesh-list
14316234|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316235|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316236|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14316237|NCT00716625|Growth Substances|growth substances|mesh-ancestor
14316238|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316239|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316240|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316241|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316242|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316243|NCT00716742|Bimatoprost|bimatoprost|mesh-list
14316244|NCT00716742|Travoprost|travoprost|mesh-list
14316245|NCT00716742|Latanoprost|latanoprost|mesh-list
14316246|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14316247|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14316248|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14316249|NCT00716820|Sunitinib|sunitinib|mesh-list
14316250|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316251|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316252|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14316253|NCT00716820|Growth Substances|growth substances|mesh-ancestor
14316254|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316255|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316256|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316257|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316258|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316259|NCT00716859|Timolol|timolol|mesh-list
14316260|NCT00716859|Latanoprost|latanoprost|mesh-list
14316261|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14316262|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14316263|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
14316264|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316265|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316266|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316267|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14316268|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14316269|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14316270|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14316271|NCT00716963|Fluticasone|fluticasone|mesh-list
14316272|NCT00716963|Xhance|xhance|mesh-list
14316273|NCT00716963|Budesonide|budesonide|mesh-list
14316274|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316275|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14316276|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
14316277|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316278|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316279|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14316280|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
14316281|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316282|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14316283|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
14316284|NCT00716963|Hormones|hormones|mesh-ancestor
14316285|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14316286|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
14316287|NCT00716976|Antidotes|antidotes|mesh-ancestor
14316288|NCT00716976|Protective Agents|protective agents|mesh-ancestor
14316289|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316290|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
14316291|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316292|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
14316293|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316294|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316295|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
14316296|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
14316297|NCT00717054|Scopolamine|scopolamine|mesh-list
14316298|NCT00717054|Aprepitant|aprepitant|mesh-list
14316299|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14316300|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
14316301|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
14316302|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316303|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316304|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14316305|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14316306|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316307|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316308|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14316309|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
14316310|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14316311|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
14316312|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14316313|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
14316314|NCT00717067|Ritonavir|ritonavir|mesh-list
14316315|NCT00717067|Saquinavir|saquinavir|mesh-list
14316316|NCT00717067|Maraviroc|maraviroc|mesh-list
14316317|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14316318|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14316319|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
14316320|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222170|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222171|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222172|NCT01978938|Levofloxacin|levofloxacin|mesh-list
15222173|NCT01978938|Ofloxacin|ofloxacin|mesh-list
15222174|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15222175|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222176|NCT01978938|Renal Agents|renal agents|mesh-ancestor
15222177|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15222178|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222179|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14316321|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316322|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14316323|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15222180|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316324|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
14316325|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316326|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14316327|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14316328|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14316329|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14316330|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14316331|NCT00717093|Varenicline|varenicline|mesh-list
14316332|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14316333|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14316334|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
14316335|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316336|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316337|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316338|NCT00717197|Capecitabine|capecitabine|mesh-list
14316339|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14910224|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14910225|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14910226|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14910227|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
14910228|NCT01356017|Amlodipine|amlodipine|mesh-list
14910229|NCT01356017|Telmisartan|telmisartan|mesh-list
14910230|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14910231|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14910232|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910233|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910234|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910235|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910236|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
14910237|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14910238|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14910239|NCT01356043|Niacin|niacin|mesh-list
14910240|NCT01356043|Amlodipine|amlodipine|mesh-list
14910241|NCT01356043|Telmisartan|telmisartan|mesh-list
14910242|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14910243|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14316340|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
14316341|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316342|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316343|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
14316344|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316345|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
14316346|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316347|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316348|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
14316349|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14316350|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316351|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
14316352|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14316353|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316354|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14316355|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
14316356|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316357|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316358|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316359|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316360|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
14316361|NCT00717366|Hematinics|hematinics|mesh-ancestor
14316362|NCT00717405|Bevacizumab|bevacizumab|mesh-list
14316363|NCT00717405|Trastuzumab|trastuzumab|mesh-list
14316364|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316365|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316366|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316367|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14316368|NCT00717405|Growth Substances|growth substances|mesh-ancestor
14316369|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316370|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316371|NCT00717418|Cyclosporine|cyclosporine|mesh-list
14316372|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
14316373|NCT00717418|Cyclosporins|cyclosporins|mesh-list
14316374|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316375|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316376|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316377|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
14316378|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316379|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
14316380|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316381|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316382|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316383|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14316384|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14316385|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14316386|NCT00717522|Pomalidomide|pomalidomide|mesh-list
14316387|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
14316388|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316389|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316390|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14316391|NCT00717522|Growth Substances|growth substances|mesh-ancestor
14316392|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316393|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316394|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
14316395|NCT00717574|Propofol|propofol|mesh-list
14316396|NCT00717574|Sevoflurane|sevoflurane|mesh-list
14316397|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14316398|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14316399|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316400|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14316401|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
14316402|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
14316403|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14316404|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14316405|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14316406|NCT00717574|Analgesics|analgesics|mesh-ancestor
14316407|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
14316408|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316409|NCT00717626|Factor VIII|factor viii|mesh-list
14316410|NCT00717626|Coagulants|coagulants|mesh-ancestor
14316411|NCT00717756|Lenalidomide|lenalidomide|mesh-list
14316412|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
14316413|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316414|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316415|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14316416|NCT00717756|Growth Substances|growth substances|mesh-ancestor
14316417|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316418|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316419|NCT00717860|Caspofungin|caspofungin|mesh-list
14316420|NCT00717860|Micafungin|micafungin|mesh-list
14316421|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
14316422|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724130|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
14724131|NCT00497523|Hormones|hormones|mesh-ancestor
14724132|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724133|NCT00497536|Insulin|insulin|mesh-list
14724134|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14724135|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
14724136|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
15222181|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222182|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222183|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15222184|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15222185|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15222186|NCT01976065|Metronidazole|metronidazole|mesh-list
15222187|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
14316423|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316424|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724137|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14316425|NCT00718081|Sufentanil|sufentanil|mesh-list
14724138|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14316426|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14316427|NCT00718081|Narcotics|narcotics|mesh-ancestor
14316428|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14316429|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316430|NCT00718081|Analgesics|analgesics|mesh-ancestor
14316431|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
14316432|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316433|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14316434|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14316435|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
14316436|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
14316437|NCT00718315|Erythromycin|erythromycin|mesh-list
14316438|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
14316439|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14316440|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
14316441|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
14316442|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14316443|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316444|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316445|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316446|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316447|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316448|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316449|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14316450|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14316451|NCT00718328|Simvastatin|simvastatin|mesh-list
14316452|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14316453|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14316454|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
14316455|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316456|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14316457|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15222188|NCT01976065|Minocycline|minocycline|mesh-list
15222189|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724139|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724140|NCT00497562|Tramadol|tramadol|mesh-list
14724141|NCT00497562|Amitriptyline|amitriptyline|mesh-list
14316458|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316459|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14316460|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
14316461|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316462|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
14316463|NCT00718549|Rituximab|rituximab|mesh-list
14316464|NCT00718549|Cladribine|cladribine|mesh-list
14316465|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316466|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
14316467|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316468|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316469|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14316470|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
14316471|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316472|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316473|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14316474|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316475|NCT00718718|Methotrexate|methotrexate|mesh-list
14316476|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14316477|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14316478|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
14316479|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14316480|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222190|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14316481|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724142|NCT00497562|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15222191|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15222192|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222193|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222194|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225591|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14316482|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
14328156|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14316483|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316484|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316485|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316486|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316487|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14316488|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316489|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
14316490|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316491|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14316492|NCT00718770|Bexarotene|bexarotene|mesh-list
14316493|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316494|NCT00718809|Saracatinib|saracatinib|mesh-list
14316495|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316496|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316497|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316498|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
14316499|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14316500|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316501|NCT00718887|Entecavir|entecavir|mesh-list
14316502|NCT00718887|Adefovir|adefovir|mesh-list
14316503|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
14316504|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316505|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14316506|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14316507|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316508|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316509|NCT00719043|Vaccines|vaccines|mesh-list
14316510|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
14316511|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316512|NCT00719134|Rizatriptan|rizatriptan|mesh-list
14316513|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14316514|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
14316515|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316516|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316517|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316518|NCT00719160|Esomeprazole|esomeprazole|mesh-list
14316519|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14316520|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14316521|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14316522|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316523|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316524|NCT00719186|Letrozole|letrozole|mesh-list
15222195|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222196|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222197|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15222198|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15222199|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
15222200|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15222201|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
15222202|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222203|NCT01878669|Expectorants|expectorants|mesh-ancestor
15222204|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
15222205|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15222206|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
15222207|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222208|NCT01878669|Protective Agents|protective agents|mesh-ancestor
15222209|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316525|NCT00719186|Clomiphene|clomiphene|mesh-list
14316526|NCT00719186|Enclomiphene|enclomiphene|mesh-list
14316527|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
14316528|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316529|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316530|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14316531|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14316532|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316533|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14316534|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
14316535|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14316536|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316537|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14316538|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
14316539|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14316540|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14316541|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14316542|NCT00719264|Interferons|interferons|mesh-list
14316543|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
14316544|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
14316545|NCT00719264|Bevacizumab|bevacizumab|mesh-list
14316546|NCT00719264|Everolimus|everolimus|mesh-list
14316547|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316548|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316549|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316550|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14316551|NCT00719264|Growth Substances|growth substances|mesh-ancestor
14316552|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316553|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316554|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
14316555|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316556|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316557|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
14316558|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
14316559|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14316560|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316561|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
14316562|NCT00719472|Antipyretics|antipyretics|mesh-list
14316563|NCT00719472|Prednisone|prednisone|mesh-list
14316564|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
14316565|NCT00719472|Rituximab|rituximab|mesh-list
14316566|NCT00719472|Doxorubicin|doxorubicin|mesh-list
14316567|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14316568|NCT00719472|Vincristine|vincristine|mesh-list
14316569|NCT00719472|Analgesics|analgesics|mesh-list
14910244|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15222210|NCT01878669|Antidotes|antidotes|mesh-ancestor
15222211|NCT01854385|Sumatriptan|sumatriptan|mesh-list
15222212|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15222213|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15222214|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15222215|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
15222216|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222217|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222218|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222219|NCT01844856|Ertapenem|ertapenem|mesh-list
14316570|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
14910245|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910246|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910247|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910248|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
14910249|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14910250|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14910251|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14910252|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
14910253|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15222220|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316571|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14316572|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316573|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
14316574|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316575|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316576|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14316577|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
14316578|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316579|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316580|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14316581|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316582|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14316583|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14316584|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14316585|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316586|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316587|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
14316588|NCT00719472|Hormones|hormones|mesh-ancestor
14316589|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14316590|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14316591|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14316592|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14316593|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14316594|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14316595|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
14316596|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316597|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
14316598|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316599|NCT00719537|Aspirin|aspirin|mesh-list
14316600|NCT00719537|Progesterone|progesterone|mesh-list
14316601|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14316602|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14316603|NCT00719537|Analgesics|analgesics|mesh-ancestor
14316604|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
14316605|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316606|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316607|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316608|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316609|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14316610|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14316611|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316612|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14316613|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14316614|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316615|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
14316616|NCT00719537|Progestins|progestins|mesh-ancestor
14316617|NCT00719537|Hormones|hormones|mesh-ancestor
14316618|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14316619|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
14316620|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
14316621|NCT00719706|Vitamins|vitamins|mesh-ancestor
14316622|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
14316623|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316624|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
14316625|NCT00719810|Tigecycline|tigecycline|mesh-list
14316626|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
14316627|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316628|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316629|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14316630|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316631|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316632|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14316633|NCT00719849|Cyclosporine|cyclosporine|mesh-list
14316634|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
14316635|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
14316636|NCT00719849|Fludarabine|fludarabine|mesh-list
14316637|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
14316638|NCT00719849|Cyclosporins|cyclosporins|mesh-list
14316639|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14316640|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316641|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
14316642|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724143|NCT00497562|Fluoxetine|fluoxetine|mesh-list
14724144|NCT00497562|Hormones|hormones|mesh-list
14316643|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316644|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14316645|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
14316646|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316647|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316648|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14316649|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14316650|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
14316651|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316652|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
14316653|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316654|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316655|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14316656|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14316657|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14316658|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
14316659|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316660|NCT00719862|Azelastine|azelastine|mesh-list
14316661|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14316662|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
14316663|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316664|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316665|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14316666|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14316667|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14316668|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316669|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316670|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14316671|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14316672|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14316673|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
14316674|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
14316675|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316676|NCT00719901|Bortezomib|bortezomib|mesh-list
14316677|NCT00719901|Obatoclax|obatoclax|mesh-list
14316678|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316679|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316680|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316681|NCT00720057|Naproxen|naproxen|mesh-list
14316682|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14316683|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14316684|NCT00720057|Analgesics|analgesics|mesh-ancestor
14316685|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
14316686|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316687|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316688|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316689|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316690|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
14316691|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14316692|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316693|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316694|NCT00720096|Doxorubicin|doxorubicin|mesh-list
14316695|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14316696|NCT00720096|Topotecan|topotecan|mesh-list
14316697|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14316698|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316699|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14316700|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14316701|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316702|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316703|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14316704|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
14316705|NCT00720109|Leucovorin|leucovorin|mesh-list
14316706|NCT00720109|Folic Acid|folic acid|mesh-list
14316707|NCT00720109|Cytarabine|cytarabine|mesh-list
14316708|NCT00720109|Dexamethasone|dexamethasone|mesh-list
14316709|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
14316710|NCT00720109|Prednisone|prednisone|mesh-list
14724145|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724146|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724147|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14724148|NCT00497562|Narcotics|narcotics|mesh-ancestor
14724149|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724150|NCT00497562|Analgesics|analgesics|mesh-ancestor
14724151|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
14724152|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724153|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14724154|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14724155|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14724156|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724157|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724158|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
14724159|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14724160|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
14724161|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724162|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14724163|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14724164|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724165|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14724166|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14316711|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
14316712|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14316713|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14316714|NCT00720109|Prednisolone|prednisolone|mesh-list
14316715|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
14316716|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
14316717|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14316718|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14316719|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14316720|NCT00720109|Cortisone|cortisone|mesh-list
14316721|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
14316722|NCT00720109|Ifosfamide|ifosfamide|mesh-list
14316723|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
14316724|NCT00720109|Methotrexate|methotrexate|mesh-list
14316725|NCT00720109|Etoposide|etoposide|mesh-list
14316726|NCT00720109|Vincristine|vincristine|mesh-list
14316727|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
14316728|NCT00720109|Daunorubicin|daunorubicin|mesh-list
14316729|NCT00720109|Asparaginase|asparaginase|mesh-list
14316730|NCT00720109|Dasatinib|dasatinib|mesh-list
14316731|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
14316732|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
14316733|NCT00720109|Pegaspargase|pegaspargase|mesh-list
14316734|NCT00720109|Lenograstim|lenograstim|mesh-list
14316735|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14316736|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
14316737|NCT00720109|BB 1101|bb 1101|mesh-list
14316738|NCT00720109|Calcium|calcium|mesh-list
14316739|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
14316740|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316741|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
14316742|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316743|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316744|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14316745|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
14316746|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316747|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316748|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14316749|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316750|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
14316751|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
14316752|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316753|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14316754|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
14316755|NCT00720109|Hormones|hormones|mesh-ancestor
14316756|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14316757|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14316758|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
14316759|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316760|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14316761|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14316762|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14316763|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
14316764|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14316765|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14316766|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
14316767|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316768|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14316769|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14316770|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14316771|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14316772|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14910254|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
14910255|NCT01356043|Vitamins|vitamins|mesh-ancestor
14910256|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
14910257|NCT01356121|Midazolam|midazolam|mesh-list
14910258|NCT01356121|Propofol|propofol|mesh-list
14910259|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14910260|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910261|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910262|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14316773|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
14316774|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316775|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14316776|NCT00720109|Antidotes|antidotes|mesh-ancestor
14316777|NCT00720109|Protective Agents|protective agents|mesh-ancestor
14316778|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
14316779|NCT00720109|Vitamins|vitamins|mesh-ancestor
14316780|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
14316781|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
14316782|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
14316783|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
14316784|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14316785|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14316786|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316787|NCT00720109|Hematinics|hematinics|mesh-ancestor
14316788|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
14316789|NCT00720122|Insulin|insulin|mesh-list
14316790|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14316791|NCT00720122|Mitogens|mitogens|mesh-list
14316792|NCT00720122|Mecasermin|mecasermin|mesh-list
14316793|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14316794|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316795|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
14316796|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316797|NCT00720122|Growth Substances|growth substances|mesh-ancestor
14316798|NCT00720226|Losartan|losartan|mesh-list
14316799|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14316800|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14316801|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14316802|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14316803|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316804|NCT00720278|Azelastine|azelastine|mesh-list
14316805|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14316806|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
14316807|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316808|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316809|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14316810|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
14316811|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14316812|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316813|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316814|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14316815|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14316816|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14316817|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
14316818|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
14316819|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316820|NCT00720330|Lidocaine|lidocaine|mesh-list
14316821|NCT00720330|Ketamine|ketamine|mesh-list
14316822|NCT00720330|Ropivacaine|ropivacaine|mesh-list
14316823|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
14724167|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14724168|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
14724169|NCT00497562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14724170|NCT00497562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14724171|NCT00497601|Amphotericin B|amphotericin b|mesh-list
14724172|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14724173|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14316824|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
14316825|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14316826|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316827|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
14316828|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316829|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14316830|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14316831|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14316832|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316833|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316834|NCT00720330|Analgesics|analgesics|mesh-ancestor
14316835|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14316836|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14316837|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
14316838|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14316839|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14316840|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316841|NCT00720356|Bevacizumab|bevacizumab|mesh-list
14316842|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14316843|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316844|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316845|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316846|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14724174|NCT00497601|Amebicides|amebicides|mesh-ancestor
14724175|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14316847|NCT00720356|Growth Substances|growth substances|mesh-ancestor
14316848|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316849|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316850|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316851|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316852|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316853|NCT00720369|Ubiquinone|ubiquinone|mesh-list
14316854|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
14316855|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
14316856|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316857|NCT00720369|Vitamins|vitamins|mesh-ancestor
14316858|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
14316859|NCT00720382|Azelastine|azelastine|mesh-list
14316860|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316861|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14316862|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14316863|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14316864|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
14316865|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316866|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316867|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14316868|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
14316869|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14316870|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316871|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316872|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14316873|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14316874|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
14316875|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
14316876|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316877|NCT00720473|Lamotrigine|lamotrigine|mesh-list
14316878|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
14316879|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14316880|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316881|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316882|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14316883|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316884|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14316885|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14316886|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14316887|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14316888|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14316889|NCT00720499|Bromides|bromides|mesh-list
14316890|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
14316891|NCT00720499|Olodaterol|olodaterol|mesh-list
14316892|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14316893|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
14316894|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316895|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316896|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14316897|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14316898|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
14316899|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14316900|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14316901|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316902|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316903|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
14316904|NCT00720629|Methotrexate|methotrexate|mesh-list
14316905|NCT00720629|Tacrolimus|tacrolimus|mesh-list
14316906|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
14316907|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14316908|NCT00720629|Visilizumab|visilizumab|mesh-list
14316909|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14316910|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
14316911|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14316912|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316913|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14316914|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
14910263|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
14316915|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316916|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316917|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14910264|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
14316918|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316919|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14910265|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15222221|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316920|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14316921|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
14316922|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316923|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14316924|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14316925|NCT00720759|Cycloserine|cycloserine|mesh-list
14316926|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14316927|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14316928|NCT00720759|Renal Agents|renal agents|mesh-ancestor
14316929|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14316930|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
14316931|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14316932|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
14316933|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316934|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14316935|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14316936|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
14316937|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14316938|NCT00720798|Analgesics|analgesics|mesh-ancestor
14316939|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
14316940|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316941|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328157|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14328158|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
14328159|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
14328160|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328161|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14328162|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14328163|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
14328164|NCT00807248|Analgesics|analgesics|mesh-ancestor
14328165|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
14328166|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
14328167|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
14328168|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
14328169|NCT00807573|Paclitaxel|paclitaxel|mesh-list
14328170|NCT00807573|Bevacizumab|bevacizumab|mesh-list
14328171|NCT00807573|Pemetrexed|pemetrexed|mesh-list
14328172|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14328173|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328174|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
14328175|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
14724176|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14724177|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724178|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724179|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
14724180|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15222222|NCT01817166|Vitamin D|vitamin d|mesh-list
15222223|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
15222224|NCT01817166|Vitamins|vitamins|mesh-ancestor
15222225|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
15222226|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222227|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15222228|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15222229|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
15222230|NCT01783535|Carboplatin|carboplatin|mesh-list
15222231|NCT01783535|Doxorubicin|doxorubicin|mesh-list
15222232|NCT01783535|Etoposide|etoposide|mesh-list
15222233|NCT01783535|Vincristine|vincristine|mesh-list
15222234|NCT01783535|Topotecan|topotecan|mesh-list
15222235|NCT01783535|Lenograstim|lenograstim|mesh-list
15222236|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222237|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
15222238|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222239|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328176|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
14724181|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14724182|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15222240|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15222241|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
14724183|NCT00497614|Adalimumab|adalimumab|mesh-list
14724184|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14316942|NCT00720876|Rituximab|rituximab|mesh-list
14316943|NCT00720876|Vorinostat|vorinostat|mesh-list
14316944|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14316945|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316946|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
14316947|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316948|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14316949|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14316950|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316951|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316952|NCT00720941|Sunitinib|sunitinib|mesh-list
14316953|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316954|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14316955|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14316956|NCT00720941|Growth Substances|growth substances|mesh-ancestor
14316957|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316958|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
14316959|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14316960|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316961|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316962|NCT00721110|Lidocaine|lidocaine|mesh-list
14316963|NCT00721110|Ketamine|ketamine|mesh-list
14316964|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
14316965|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
14316966|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14316967|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14316968|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
14316969|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14316970|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14316971|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14316972|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14316973|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14316974|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316975|NCT00721110|Analgesics|analgesics|mesh-ancestor
14316976|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14316977|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14316978|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
14316979|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14316980|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14316981|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14316982|NCT00721136|Heparin|heparin|mesh-list
14316983|NCT00721136|Warfarin|warfarin|mesh-list
14316984|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
14316985|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14316986|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14316987|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316988|NCT00721162|Ramucirumab|ramucirumab|mesh-list
14316989|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316990|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14316991|NCT00721188|Hematinics|hematinics|mesh-ancestor
14316992|NCT00721214|Azacitidine|azacitidine|mesh-list
14316993|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14316994|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
14316995|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14316996|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14316997|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14316998|NCT00721279|Pramipexole|pramipexole|mesh-list
14316999|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
14317000|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317001|NCT00721279|Protective Agents|protective agents|mesh-ancestor
14317002|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317003|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15222242|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222243|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222244|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15222245|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15222246|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222247|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222248|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222249|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222250|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15222251|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222252|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222253|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222254|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14317004|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14317005|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
14317006|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
14317007|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317008|NCT00721396|Vaccines|vaccines|mesh-list
14317009|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14317010|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
14317011|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317012|NCT00721409|Letrozole|letrozole|mesh-list
14317013|NCT00721409|Palbociclib|palbociclib|mesh-list
14317014|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317015|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14317016|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14317017|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317018|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317019|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14317020|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317021|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317022|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317023|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14317024|NCT00721513|Docetaxel|docetaxel|mesh-list
14317025|NCT00721513|Fluorouracil|fluorouracil|mesh-list
14317026|NCT00721513|Cetuximab|cetuximab|mesh-list
14317027|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317028|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
14317029|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
14317030|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
14317031|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317032|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
14317033|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14317034|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317035|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
14317036|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317037|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14317038|NCT00721578|Voriconazole|voriconazole|mesh-list
14317039|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
14317040|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317041|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14317042|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14317043|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317044|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317045|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14317046|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317047|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317048|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317049|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14317050|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14317051|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14317052|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14317053|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14724185|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317054|NCT00721630|Capecitabine|capecitabine|mesh-list
14317055|NCT00721630|Lapatinib|lapatinib|mesh-list
14317056|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14317057|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
14317058|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317059|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317060|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14317061|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317062|NCT00721955|Loxapine|loxapine|mesh-list
14317063|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14317064|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14317065|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317066|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317067|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14317068|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14317069|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
14724186|NCT00497744|Cefepime|cefepime|mesh-list
14317070|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317071|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317072|NCT00722072|Sorafenib|sorafenib|mesh-list
14317073|NCT00722072|Fulvestrant|fulvestrant|mesh-list
14317074|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317075|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14317076|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317077|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317078|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14317079|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14317080|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14317081|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317082|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317083|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317084|NCT00722137|Prednisone|prednisone|mesh-list
14317085|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
14317086|NCT00722137|Rituximab|rituximab|mesh-list
14317087|NCT00722137|Doxorubicin|doxorubicin|mesh-list
14317088|NCT00722137|Vincristine|vincristine|mesh-list
14317089|NCT00722137|Bortezomib|bortezomib|mesh-list
14317090|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317091|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
14317092|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317093|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317094|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14317095|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
14317096|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317097|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317098|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14317099|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14317100|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14317101|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14317102|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14317103|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317104|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317105|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
14317106|NCT00722137|Hormones|hormones|mesh-ancestor
14317107|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317108|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14317109|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14317110|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14317111|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14317112|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14317113|NCT00722371|Metformin|metformin|mesh-list
14317114|NCT00722371|Pioglitazone|pioglitazone|mesh-list
14317115|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14317116|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14317117|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317118|NCT00722371|Incretins|incretins|mesh-ancestor
14317119|NCT00722371|Hormones|hormones|mesh-ancestor
14317120|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317121|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14317122|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
14317123|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317124|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317125|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
14317126|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14317127|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14317128|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317129|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
14317130|NCT00722436|Coagulants|coagulants|mesh-ancestor
14317131|NCT00722553|Vitamins|vitamins|mesh-list
14317132|NCT00722553|Folic Acid|folic acid|mesh-list
14910266|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14910267|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910268|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910269|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
14910270|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
14910271|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910272|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910273|NCT01356212|Ketorolac|ketorolac|mesh-list
14317133|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
14910274|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14910275|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14910276|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910277|NCT01356212|Analgesics|analgesics|mesh-ancestor
14910278|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
14910279|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910280|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910281|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910282|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724187|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724188|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724189|NCT00497809|Lenograstim|lenograstim|mesh-list
14724190|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14724191|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
14724192|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724193|NCT00497900|Vitamin D|vitamin d|mesh-list
14724194|NCT00497900|Vitamins|vitamins|mesh-ancestor
14724195|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
14724196|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724197|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14724198|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
14724199|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14724200|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14724201|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14317134|NCT00722553|Hydroxocobalamin|hydroxocobalamin|mesh-list
14317135|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
14317136|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14317137|NCT00722553|Aminopterin|aminopterin|mesh-list
14317138|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
14317139|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317140|NCT00722553|Hematinics|hematinics|mesh-ancestor
14317141|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14317142|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317143|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317144|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317145|NCT00722566|Bortezomib|bortezomib|mesh-list
14317146|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317147|NCT00722722|Bortezomib|bortezomib|mesh-list
14317148|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317149|NCT00722761|Drospirenone|drospirenone|mesh-list
14317150|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14317151|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14317152|NCT00722761|Estradiol|estradiol|mesh-list
14317153|NCT00722761|Estrogens|estrogens|mesh-ancestor
14317154|NCT00722761|Hormones|hormones|mesh-ancestor
14317155|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910283|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14910284|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910285|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910286|NCT01356225|Ketorolac|ketorolac|mesh-list
14317156|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317157|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14317158|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
14317159|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14317160|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14317161|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14317162|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14317163|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14317164|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317165|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14317166|NCT00722761|Diuretics|diuretics|mesh-ancestor
14724202|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14724203|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724204|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
14724205|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724206|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724207|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14724208|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910287|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14910288|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14317167|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
14317168|NCT00722800|Drospirenone|drospirenone|mesh-list
14317169|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14317170|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14317171|NCT00722800|Estradiol|estradiol|mesh-list
14317172|NCT00722800|Estrogens|estrogens|mesh-ancestor
14317173|NCT00722800|Hormones|hormones|mesh-ancestor
14317174|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317175|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317176|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14317177|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
14317178|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14317179|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14317180|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14317181|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14317182|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14724209|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
14724210|NCT00497939|Urological Agents|urological agents|mesh-ancestor
14317183|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317184|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14317185|NCT00722800|Diuretics|diuretics|mesh-ancestor
14317186|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
14317187|NCT00722865|Bevacizumab|bevacizumab|mesh-list
14317188|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14317189|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317190|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14317191|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14317192|NCT00722865|Growth Substances|growth substances|mesh-ancestor
14317193|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317194|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
14317195|NCT00723021|Zileuton|zileuton|mesh-list
14317196|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14317197|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317198|NCT00723021|Analgesics|analgesics|mesh-ancestor
14317199|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
14317200|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317201|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317202|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317203|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317204|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14317205|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317206|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317207|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14317208|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317209|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317210|NCT00723099|Cyclosporine|cyclosporine|mesh-list
14317211|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
14317212|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
14317213|NCT00723099|Fludarabine|fludarabine|mesh-list
14317214|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
14317215|NCT00723099|Cyclosporins|cyclosporins|mesh-list
14317216|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317217|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
14317218|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317219|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317220|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14317221|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
14317222|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317223|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317224|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14317225|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14317226|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
14317227|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317228|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
14317229|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317230|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317231|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14724211|NCT00498004|Risperidone|risperidone|mesh-list
14724212|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14724213|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14724214|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
14724215|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724216|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724217|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724218|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14724219|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14724220|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724221|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724222|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14724223|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
14317232|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14317233|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14317234|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
14317235|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14317236|NCT00723125|Paclitaxel|paclitaxel|mesh-list
14317237|NCT00723125|Bevacizumab|bevacizumab|mesh-list
14317238|NCT00723125|Carboplatin|carboplatin|mesh-list
14317239|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14317240|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14317241|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317242|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14317243|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14317244|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14317245|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317246|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14317247|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14317248|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14317249|NCT00723125|Growth Substances|growth substances|mesh-ancestor
14317250|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317251|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
14317252|NCT00723177|Ibudilast|ibudilast|mesh-list
14317253|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14317254|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
14317255|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317256|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317257|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14317258|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
14724224|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
14317259|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14317260|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317261|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317262|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14317263|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
14317264|NCT00723190|Clonidine|clonidine|mesh-list
14317265|NCT00723190|Analgesics|analgesics|mesh-ancestor
14317266|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
14317267|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317268|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317269|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14317270|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
14317271|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
14317272|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14317273|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14317274|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14317275|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14317276|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317277|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317278|NCT00723203|Panobinostat|panobinostat|mesh-list
14317279|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317280|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14317281|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317282|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317283|NCT00723229|Acyclovir|acyclovir|mesh-list
14317284|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
14317285|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317286|NCT00723255|Sirolimus|sirolimus|mesh-list
14317287|NCT00723255|Bevacizumab|bevacizumab|mesh-list
14317288|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14317289|NCT00723255|Antibodies|antibodies|mesh-list
14317290|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
14317291|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14317292|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317293|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14317294|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14317295|NCT00723255|Growth Substances|growth substances|mesh-ancestor
14317296|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317297|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
14317298|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
14317299|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14317300|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317301|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14317302|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
14317303|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317304|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14317305|NCT00723398|Pitavastatin|pitavastatin|mesh-list
14317306|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14317307|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14317308|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14317309|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
14317310|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317311|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317312|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14317313|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14317314|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317315|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317316|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317317|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14317318|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14317319|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14317320|NCT00723450|Lamotrigine|lamotrigine|mesh-list
14317321|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
14317322|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14317323|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14317324|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317325|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14317326|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317327|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14317328|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14317329|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317330|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14317331|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14317332|NCT00723528|Ustekinumab|ustekinumab|mesh-list
14317333|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317334|NCT00723554|Iloprost|iloprost|mesh-list
14317335|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14317336|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
14317337|NCT00723580|Risperidone|risperidone|mesh-list
14317338|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14910289|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910290|NCT01356225|Analgesics|analgesics|mesh-ancestor
14910291|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
14317339|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
14317340|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317341|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317342|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317343|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14317344|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14317345|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15222255|NCT01726452|Leucovorin|leucovorin|mesh-list
15222256|NCT01726452|Paclitaxel|paclitaxel|mesh-list
15222257|NCT01726452|Docetaxel|docetaxel|mesh-list
15222258|NCT01726452|Carboplatin|carboplatin|mesh-list
15222259|NCT01726452|Fluorouracil|fluorouracil|mesh-list
14317346|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14317347|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14317348|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
14317349|NCT00723606|Haloperidol|haloperidol|mesh-list
14317350|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
14317351|NCT00723606|Ziprasidone|ziprasidone|mesh-list
14317352|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
14317353|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
14317354|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317355|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317356|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317357|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14317358|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14317359|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317360|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14317361|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14317362|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
14317363|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317364|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317365|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14317366|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14317367|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
14317368|NCT00723632|Ribavirin|ribavirin|mesh-list
14317369|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317370|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
14317371|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317372|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
14317373|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317374|NCT00723697|Buprenorphine|buprenorphine|mesh-list
14317375|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14317376|NCT00723697|Narcotics|narcotics|mesh-ancestor
14910292|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910293|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910294|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910295|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14910296|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14910297|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910298|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910299|NCT01356303|Docetaxel|docetaxel|mesh-list
14910300|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910301|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
14910302|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
14910303|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222260|NCT01726452|Capecitabine|capecitabine|mesh-list
15222261|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
15222262|NCT01726452|Epirubicin|epirubicin|mesh-list
15222263|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222264|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222265|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222266|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222267|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
14317377|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317378|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222268|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222269|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
15222270|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14317379|NCT00723697|Analgesics|analgesics|mesh-ancestor
14317380|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
14317381|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317382|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14317383|NCT00723710|Interferons|interferons|mesh-list
14317384|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
14317385|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
14317386|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317387|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
14317388|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317389|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
14317390|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317391|NCT00723749|Buprenorphine|buprenorphine|mesh-list
14317392|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14317393|NCT00723749|Naloxone|naloxone|mesh-list
14317394|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14317395|NCT00723749|Narcotics|narcotics|mesh-ancestor
14317396|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317397|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317398|NCT00723749|Analgesics|analgesics|mesh-ancestor
14317399|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
14317400|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317401|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14317402|NCT00723801|Losartan|losartan|mesh-list
14317403|NCT00723801|Atenolol|atenolol|mesh-list
14317404|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14317405|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14317406|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14317407|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14317408|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317409|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
14317410|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
14317411|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317412|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317413|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14317414|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14317415|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14317416|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14317417|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317418|NCT00723827|Temozolomide|temozolomide|mesh-list
14317419|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14317420|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
14317421|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317422|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317423|NCT00723892|Ribavirin|ribavirin|mesh-list
14317424|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317425|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
14317426|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
14317427|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317428|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
14317429|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317430|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
14317431|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317432|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317433|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
14317434|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317435|NCT00723957|Paclitaxel|paclitaxel|mesh-list
14317436|NCT00723957|Carboplatin|carboplatin|mesh-list
14317437|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14317438|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317439|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
14317440|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
14317441|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
14317442|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317443|NCT00724009|Clofarabine|clofarabine|mesh-list
14317444|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14317445|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
14317446|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317447|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317448|NCT00724061|Interferons|interferons|mesh-list
14317449|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
14317450|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
14317451|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317452|NCT00724061|Furocoumarins|furocoumarins|mesh-list
14317453|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317454|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
14317455|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317456|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
14317457|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317458|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317459|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14317460|NCT00724126|Rifaximin|rifaximin|mesh-list
14317461|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14317462|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317463|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317464|NCT00724243|Infliximab|infliximab|mesh-list
14317465|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317466|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317467|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317468|NCT00724373|Ribavirin|ribavirin|mesh-list
14317469|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317470|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
14317471|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317472|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
14317473|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317474|NCT00724451|Ribavirin|ribavirin|mesh-list
14317475|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14317476|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317477|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
14317478|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317479|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
14317480|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317481|NCT00724464|Interferons|interferons|mesh-list
15222271|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222272|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
15222273|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222274|NCT01726452|Antidotes|antidotes|mesh-ancestor
15222275|NCT01726452|Protective Agents|protective agents|mesh-ancestor
15222276|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
15222277|NCT01726452|Vitamins|vitamins|mesh-ancestor
15222278|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
15222279|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14317482|NCT00724464|Ribavirin|ribavirin|mesh-list
14317483|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
14317484|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
14317485|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317486|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317487|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
14317488|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317489|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
14317490|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317491|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
14317492|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317493|NCT00724568|Dexamethasone|dexamethasone|mesh-list
14317494|NCT00724568|Lenalidomide|lenalidomide|mesh-list
14317495|NCT00724568|Bortezomib|bortezomib|mesh-list
14317496|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317497|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
14317498|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
14317499|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317500|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317501|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317502|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
14317503|NCT00724568|Hormones|hormones|mesh-ancestor
14317504|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317505|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14317506|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317507|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
14317508|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14317509|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14317510|NCT00724568|Growth Substances|growth substances|mesh-ancestor
14317511|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
14317512|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
14317513|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14317514|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
14317515|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317516|NCT00724594|Expectorants|expectorants|mesh-ancestor
14317517|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
14317518|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14317519|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
14317520|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317521|NCT00724594|Protective Agents|protective agents|mesh-ancestor
14317522|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317523|NCT00724594|Antidotes|antidotes|mesh-ancestor
14317524|NCT00724711|Tenofovir|tenofovir|mesh-list
14317525|NCT00724711|Lamivudine|lamivudine|mesh-list
14317526|NCT00724711|Emtricitabine|emtricitabine|mesh-list
14317527|NCT00724711|Abacavir|abacavir|mesh-list
14317528|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
14317529|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317530|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14317531|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14317532|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317533|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317534|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14317535|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14317536|NCT00724815|Sumatriptan|sumatriptan|mesh-list
14317537|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14317538|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14317539|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14317540|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
14317541|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317542|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317543|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317544|NCT00724854|Ribavirin|ribavirin|mesh-list
14317545|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317546|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
14317547|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
14910304|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317548|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317549|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
14317550|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317551|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
14317552|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317553|NCT00724867|Belimumab|belimumab|mesh-list
15222280|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222281|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222282|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222283|NCT01712789|Dexamethasone|dexamethasone|mesh-list
15222284|NCT01712789|Pomalidomide|pomalidomide|mesh-list
15222285|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15222286|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
15222287|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
15222288|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222289|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222290|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15222291|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
15222292|NCT01712789|Hormones|hormones|mesh-ancestor
15222293|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222294|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222295|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222296|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
15222297|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222298|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222299|NCT01712789|Growth Substances|growth substances|mesh-ancestor
15222300|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222301|NCT01665794|Dexamethasone|dexamethasone|mesh-list
15222302|NCT01665794|Daratumumab|daratumumab|mesh-list
15222303|NCT01665794|Pomalidomide|pomalidomide|mesh-list
15222304|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317554|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317555|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
14317556|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317557|NCT00724893|Interferons|interferons|mesh-list
14317558|NCT00724893|Ribavirin|ribavirin|mesh-list
14317559|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
14317560|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
14317561|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317562|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317563|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
14317564|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317565|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
14317566|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317567|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
14317568|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317569|NCT00724932|Atropine|atropine|mesh-list
14317570|NCT00724932|Bromides|bromides|mesh-list
14317571|NCT00724932|Rocuronium|rocuronium|mesh-list
14317572|NCT00724932|Neostigmine|neostigmine|mesh-list
14317573|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
14317574|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14317575|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14317576|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14317577|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317578|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317579|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14317580|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14317581|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14317582|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
14317583|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14317584|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
14317585|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
14317586|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
14317587|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14317588|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14317589|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
14317590|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222305|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
15222306|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
14317591|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317592|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14317593|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317594|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14317595|NCT00724958|Infliximab|infliximab|mesh-list
14317596|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317597|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317598|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317599|NCT00724971|Rituximab|rituximab|mesh-list
14317600|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14317601|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14317602|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317603|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
14724225|NCT00498108|Rotigotine|rotigotine|mesh-list
14724226|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
14724227|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
14317604|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317605|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317606|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14317607|NCT00724984|Abexinostat|abexinostat|mesh-list
14317608|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14317609|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317610|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317611|NCT00725010|Temozolomide|temozolomide|mesh-list
14317612|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14317613|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
14317614|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317615|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317616|NCT00725205|Ribavirin|ribavirin|mesh-list
14317617|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317618|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
14317619|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
14317620|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317621|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
14317622|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317623|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
14317624|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328177|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328178|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14328179|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14328180|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14328181|NCT00807573|Growth Substances|growth substances|mesh-ancestor
14328182|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328183|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
14328184|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328185|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14328186|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14328187|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14724228|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910305|NCT01356329|Heparin|heparin|mesh-list
14317625|NCT00725270|Mifepristone|mifepristone|mesh-list
14317626|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14317627|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
14317628|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14317629|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317630|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14317631|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14317632|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14317633|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
14317634|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14317635|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14317636|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317637|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317638|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
14317639|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14317640|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14317641|NCT00725296|Infliximab|infliximab|mesh-list
14317642|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317643|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317644|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317645|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
14317646|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14317647|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14317648|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14317649|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14317650|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317651|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
14317652|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317653|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317654|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14317655|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317656|NCT00725361|Ambrisentan|ambrisentan|mesh-list
14317657|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14317658|NCT00725452|Infliximab|infliximab|mesh-list
14317659|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317660|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317661|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317662|NCT00725504|Lidocaine|lidocaine|mesh-list
14317663|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
14317664|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
14317665|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317666|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317667|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
14317668|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317669|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14317670|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14317671|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14317672|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14317673|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317674|NCT00725543|Infliximab|infliximab|mesh-list
14317675|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317676|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317677|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317678|NCT00725608|Buprenorphine|buprenorphine|mesh-list
14317679|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14317680|NCT00725608|Naloxone|naloxone|mesh-list
14317681|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14317682|NCT00725608|Narcotics|narcotics|mesh-ancestor
14910306|NCT01356329|Enoxaparin|enoxaparin|mesh-list
14910307|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
14910308|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14910309|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14910310|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910311|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14910312|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14910313|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14910314|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
14910315|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910316|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910317|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317683|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317684|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317685|NCT00725608|Analgesics|analgesics|mesh-ancestor
14317686|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
14317687|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317688|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14317689|NCT00725621|Infliximab|infliximab|mesh-list
14317690|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317691|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317692|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317693|NCT00725751|Interferons|interferons|mesh-list
14317694|NCT00725751|Ribavirin|ribavirin|mesh-list
14317695|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
14317696|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
14317697|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317698|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317699|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
14317700|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317701|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
14317702|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317703|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
14317704|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317705|NCT00725842|Ribavirin|ribavirin|mesh-list
14724229|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724230|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724231|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14724232|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14724233|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724234|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724235|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14724236|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14724237|NCT00498134|Analgesics|analgesics|mesh-ancestor
14724238|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
14724239|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724240|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724241|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14724242|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317706|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
14317707|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317708|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
14317709|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317710|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
14317711|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317712|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317713|NCT00725920|Topiramate|topiramate|mesh-list
14317714|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
14317715|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14317716|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317717|NCT00726375|Etanercept|etanercept|mesh-list
14724243|NCT00498225|Gemcitabine|gemcitabine|mesh-list
14910318|NCT01356355|Urological Agents|urological agents|mesh-ancestor
14317718|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14317719|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317720|NCT00726375|Analgesics|analgesics|mesh-ancestor
14317721|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
14317722|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317723|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317724|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317725|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317726|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317727|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317728|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
14317729|NCT00726388|Diclofenac|diclofenac|mesh-list
14317730|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14317731|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317732|NCT00726388|Analgesics|analgesics|mesh-ancestor
14317733|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
14317734|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317735|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317736|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317737|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317738|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14317739|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317740|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317741|NCT00726414|Quinine|quinine|mesh-list
14317742|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
14317743|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14317744|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14317745|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317746|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14317747|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317748|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14317749|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317750|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317751|NCT00726414|Analgesics|analgesics|mesh-ancestor
14317752|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
14317753|NCT00726557|Interferons|interferons|mesh-list
14317754|NCT00726557|Ribavirin|ribavirin|mesh-list
14317755|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
14317756|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
14317757|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317758|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317759|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
14317760|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317761|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
14317762|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317763|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
14317764|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317765|NCT00726609|Posaconazole|posaconazole|mesh-list
14317766|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
14317767|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317768|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14317769|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14317770|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14317771|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14317772|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14317773|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317774|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317775|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14317776|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
14317777|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14317778|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317779|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
14317780|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
14317781|NCT00726713|Vitamins|vitamins|mesh-ancestor
14317782|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
14317783|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317784|NCT00726739|Aldesleukin|aldesleukin|mesh-list
14317785|NCT00726739|Interleukin-2|interleukin-2|mesh-list
14317786|NCT00726739|Vaccines|vaccines|mesh-list
14317787|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
14317788|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317789|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317790|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317791|NCT00726739|Analgesics|analgesics|mesh-ancestor
14317792|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
14317793|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317794|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14317795|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14317796|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
14317797|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317798|NCT00726752|Axitinib|axitinib|mesh-list
14317799|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317800|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14317801|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317802|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317803|NCT00726895|Quinine|quinine|mesh-list
14317804|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
14317805|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14317806|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14317807|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317808|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14317809|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317810|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14317811|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317812|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317813|NCT00726895|Analgesics|analgesics|mesh-ancestor
14317814|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
14317815|NCT00726986|Etoposide|etoposide|mesh-list
14317816|NCT00726986|Sorafenib|sorafenib|mesh-list
14317817|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317818|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14317819|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14317820|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14317821|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317822|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317823|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14317824|NCT00726999|Morphine|morphine|mesh-list
14317825|NCT00726999|Gabapentin|gabapentin|mesh-list
14317826|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14317827|NCT00726999|Narcotics|narcotics|mesh-ancestor
14317828|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14317829|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222307|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222308|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222309|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15222310|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
15222311|NCT01665794|Hormones|hormones|mesh-ancestor
15222312|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222313|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222314|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222315|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
14317830|NCT00726999|Analgesics|analgesics|mesh-ancestor
14317831|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
14317832|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317833|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
14317834|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14317835|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14317836|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14317837|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14317838|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14317839|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14317840|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317841|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
14317842|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14317843|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14317844|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14317845|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14317846|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14317847|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317848|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222316|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222317|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222318|NCT01665794|Growth Substances|growth substances|mesh-ancestor
15222319|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222320|NCT01651403|Tenofovir|tenofovir|mesh-list
15222321|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
15222322|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317849|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317850|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14317851|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
14317852|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14317853|NCT00727194|Eculizumab|eculizumab|mesh-list
14317854|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14317855|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317856|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
14317857|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317858|NCT00727246|Choline|choline|mesh-list
14317859|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14317860|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
14317861|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14724244|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724245|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
14724246|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724247|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724248|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
15222323|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14317862|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
14317863|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317864|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317865|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14317866|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
14317867|NCT00727259|Ribavirin|ribavirin|mesh-list
14317868|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317869|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
14317870|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317871|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
14317872|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317873|NCT00727272|Quinine|quinine|mesh-list
14317874|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
14317875|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14317876|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14317877|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317878|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15222324|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14317879|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317880|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15222325|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222326|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222327|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14317881|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317882|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317883|NCT00727272|Analgesics|analgesics|mesh-ancestor
14317884|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
14317885|NCT00727298|Infliximab|infliximab|mesh-list
14317886|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
14317887|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317888|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724249|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724250|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724251|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724252|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
14317889|NCT00727311|Ribavirin|ribavirin|mesh-list
14317890|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14317891|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
14317892|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
14724253|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222328|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15222329|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
15222330|NCT01560572|Prednisolone|prednisolone|mesh-list
15222331|NCT01560572|Tacrolimus|tacrolimus|mesh-list
15222332|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222333|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
15222334|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222335|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15222336|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222337|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724254|NCT00498251|Albuterol|albuterol|mesh-list
14724255|NCT00498251|Ipratropium|ipratropium|mesh-list
15222338|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317893|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317894|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
14317895|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317896|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
14317897|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317898|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
14317899|NCT00727415|Fludarabine|fludarabine|mesh-list
14317900|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
14317901|NCT00727415|Lenalidomide|lenalidomide|mesh-list
14317902|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317903|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
14317904|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317905|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317906|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14317907|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
14317908|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317909|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317910|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14317911|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14317912|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
14317913|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14317914|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14317915|NCT00727415|Growth Substances|growth substances|mesh-ancestor
14317916|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
14317917|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
14317918|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14317919|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
14317920|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317921|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317922|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14317923|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
14317924|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317925|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317926|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14317927|NCT00727506|Afatinib|afatinib|mesh-list
14317928|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317929|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14317930|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317931|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317932|NCT00727532|Sorafenib|sorafenib|mesh-list
14317933|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317934|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14317935|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317936|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317937|NCT00727597|Efavirenz|efavirenz|mesh-list
14317938|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
14910319|NCT01356368|Docetaxel|docetaxel|mesh-list
14317939|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14317940|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14317941|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317942|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317943|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
14317944|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317945|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14317946|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14317947|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14317948|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14317949|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14317950|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14317951|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14317952|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14317953|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
14317954|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14317955|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14317956|NCT00727636|Vaccines|vaccines|mesh-list
14317957|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
14317958|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317959|NCT00727649|Loperamide|loperamide|mesh-list
14317960|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
14317961|NCT00727649|Psyllium|psyllium|mesh-list
14317962|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14317963|NCT00727649|Cathartics|cathartics|mesh-ancestor
14317964|NCT00727740|Indomethacin|indomethacin|mesh-list
14317965|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14317966|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14317967|NCT00727740|Analgesics|analgesics|mesh-ancestor
14317968|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
14317969|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14317970|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317971|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14317972|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14317973|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
14317974|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
14317975|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14317976|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14317977|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317978|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317979|NCT00727844|Linezolid|linezolid|mesh-list
14317980|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14317981|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14317982|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14317983|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317984|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317985|NCT00727857|Metformin|metformin|mesh-list
14317986|NCT00727857|Pioglitazone|pioglitazone|mesh-list
14317987|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14317988|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14317989|NCT00727961|Doxorubicin|doxorubicin|mesh-list
14317990|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14317991|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14317992|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14317993|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14317994|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14317995|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14317996|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14317997|NCT00728481|Budesonide|budesonide|mesh-list
14317998|NCT00728481|Esomeprazole|esomeprazole|mesh-list
14317999|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318000|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14318001|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
14318002|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318003|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318004|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14318005|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
14318006|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
14318007|NCT00728481|Hormones|hormones|mesh-ancestor
14318008|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318009|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14318010|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318011|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14318012|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222339|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
14318013|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318014|NCT00728494|Ribavirin|ribavirin|mesh-list
14318015|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14318016|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
14318017|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
14318018|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318019|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
14318020|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318021|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
14318022|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318023|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
14318024|NCT00728507|Rifampin|rifampin|mesh-list
14318025|NCT00728507|Isoniazid|isoniazid|mesh-list
14318026|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
14318027|NCT00728507|Ethambutol|ethambutol|mesh-list
14318028|NCT00728507|Rifapentine|rifapentine|mesh-list
14318029|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14318030|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318031|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14318032|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14318033|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318034|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318035|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318036|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14318037|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
14318038|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
14318039|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14318040|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14318041|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14318042|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14318043|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14318044|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14318045|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14724256|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14724257|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
14724258|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724259|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724260|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14724261|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
14724262|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
14318046|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14318047|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14318048|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
14318049|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14318050|NCT00728910|Niacin|niacin|mesh-list
14318051|NCT00728910|Atorvastatin|atorvastatin|mesh-list
14318052|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14318053|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14318054|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
14318055|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318056|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14318057|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14318058|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318059|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
14318060|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
14318061|NCT00728910|Vitamins|vitamins|mesh-ancestor
14318062|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
14318063|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318064|NCT00728949|Tamoxifen|tamoxifen|mesh-list
14318065|NCT00728949|Letrozole|letrozole|mesh-list
14318066|NCT00728949|Fulvestrant|fulvestrant|mesh-list
14318067|NCT00728949|Anastrozole|anastrozole|mesh-list
14318068|NCT00728949|Exemestane|exemestane|mesh-list
14318069|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14318070|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318071|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14318072|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14318073|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318074|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318075|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14318076|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
14318077|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318078|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318079|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14318080|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14318081|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14318082|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14318083|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14318084|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
14318085|NCT00728988|Atorvastatin|atorvastatin|mesh-list
14318086|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14318087|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14318088|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
14318089|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318090|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14318091|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14318092|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318093|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
14318094|NCT00729157|Aflibercept|aflibercept|mesh-list
14318095|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
14318096|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14318097|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222340|NCT01560572|Hormones|hormones|mesh-ancestor
15222341|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222342|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222343|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222344|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15222345|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15222346|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
15222347|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15222348|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222349|NCT01543633|Propofol|propofol|mesh-list
15222350|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15222351|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15222352|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222353|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15222354|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
15222355|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
15222356|NCT01542736|Carboplatin|carboplatin|mesh-list
15222357|NCT01542736|Vincristine|vincristine|mesh-list
15222358|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222359|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222360|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222361|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222362|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
14318098|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14318099|NCT00729157|Growth Substances|growth substances|mesh-ancestor
14318100|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318101|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
14318102|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318103|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318104|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14318105|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
14318106|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
14318107|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318108|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
14318109|NCT00729183|Vitamin D|vitamin d|mesh-list
14318110|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
14318111|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
14318112|NCT00729183|Calcium|calcium|mesh-list
14318113|NCT00729183|Vitamins|vitamins|mesh-ancestor
14318114|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
14318115|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318116|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14318117|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14318118|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318119|NCT00729183|Antacids|antacids|mesh-ancestor
14318120|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318121|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14318122|NCT00729326|Exenatide|exenatide|mesh-list
14318123|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14318124|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318125|NCT00729326|Incretins|incretins|mesh-ancestor
14318126|NCT00729326|Hormones|hormones|mesh-ancestor
14318127|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318128|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14318129|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
14318130|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318131|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318132|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14318133|NCT00729482|Everolimus|everolimus|mesh-list
14318134|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318135|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222363|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222364|NCT01481974|Treprostinil|treprostinil|mesh-list
15222365|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15222366|NCT01465100|Liver Extracts|liver extracts|mesh-list
15222367|NCT01465100|Hematinics|hematinics|mesh-ancestor
15222368|NCT01442649|Leucovorin|leucovorin|mesh-list
15222369|NCT01442649|Folic Acid|folic acid|mesh-list
15222370|NCT01442649|Bevacizumab|bevacizumab|mesh-list
15222371|NCT01442649|Cetuximab|cetuximab|mesh-list
15222372|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
14318136|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
14318137|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724263|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724264|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14724265|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14318138|NCT00729586|Tamoxifen|tamoxifen|mesh-list
15222373|NCT01442649|Irinotecan|irinotecan|mesh-list
15222374|NCT01442649|Fluorouracil|fluorouracil|mesh-list
15222375|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
14318139|NCT00729586|Sirolimus|sirolimus|mesh-list
14318140|NCT00729586|Megestrol|megestrol|mesh-list
14318141|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
14318142|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14318143|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222376|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222377|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222378|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14318144|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14318145|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318146|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
14318147|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318148|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
14318149|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318150|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14318151|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
14318152|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318153|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14318154|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14318155|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14318156|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14318157|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14318158|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14318159|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14318160|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
14318161|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14318162|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14318163|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14318164|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
14318165|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14318166|NCT00729612|Paclitaxel|paclitaxel|mesh-list
14318167|NCT00729612|Carboplatin|carboplatin|mesh-list
14318168|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14318169|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14318170|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318171|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14318172|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
14318173|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
14318174|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318175|NCT00729690|Pregabalin|pregabalin|mesh-list
14318176|NCT00729690|Analgesics|analgesics|mesh-ancestor
14318177|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
14318178|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318179|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318180|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
14318181|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14318182|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14318183|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318184|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14318185|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14318186|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14318187|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318188|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14318189|NCT00729807|Pentamidine|pentamidine|mesh-list
14318190|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
14318191|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318192|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14318193|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14318194|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14318195|NCT00729833|Sunitinib|sunitinib|mesh-list
14318196|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318197|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14318198|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14318199|NCT00729833|Growth Substances|growth substances|mesh-ancestor
14318200|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318201|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
14318202|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14318203|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318204|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318205|NCT00729846|Bevacizumab|bevacizumab|mesh-list
14318206|NCT00729846|Verteporfin|verteporfin|mesh-list
14318207|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724266|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14724267|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
14724268|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724269|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724270|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14724271|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
14724272|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
14724273|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
14724274|NCT00498316|Melphalan|melphalan|mesh-list
14724275|NCT00498316|Busulfan|busulfan|mesh-list
14318208|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318209|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14318210|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14318211|NCT00729846|Growth Substances|growth substances|mesh-ancestor
14318212|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318213|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
14318214|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14318215|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
14318216|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
14318217|NCT00729859|Anastrozole|anastrozole|mesh-list
14318218|NCT00729859|Testosterone|testosterone|mesh-list
14318219|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
14318220|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
14318221|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14318222|NCT00729859|Acyline|acyline|mesh-list
14318223|NCT00729859|Androgens|androgens|mesh-ancestor
14318224|NCT00729859|Hormones|hormones|mesh-ancestor
14318225|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724276|NCT00498316|Rituximab|rituximab|mesh-list
14724277|NCT00498316|Fludarabine|fludarabine|mesh-list
14724278|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
14724279|NCT00498316|Clofarabine|clofarabine|mesh-list
14724280|NCT00498316|Tacrolimus|tacrolimus|mesh-list
14724281|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
14724282|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14318226|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318227|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14318228|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724283|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724284|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
15222379|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222380|NCT01442649|Growth Substances|growth substances|mesh-ancestor
15222381|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222382|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222383|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15222384|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222385|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222386|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222387|NCT01442649|Antidotes|antidotes|mesh-ancestor
15222388|NCT01442649|Protective Agents|protective agents|mesh-ancestor
15222389|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
15222390|NCT01442649|Vitamins|vitamins|mesh-ancestor
15222391|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
15222392|NCT01442649|Hematinics|hematinics|mesh-ancestor
15222393|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
15222394|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15222395|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222396|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
14318229|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
15222397|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
15222398|NCT01147666|Hematinics|hematinics|mesh-ancestor
15222399|NCT00982111|Pemetrexed|pemetrexed|mesh-list
14724285|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724286|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724287|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14318230|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14318231|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14318232|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318233|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318234|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14318235|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
14318236|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
14318237|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14318238|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14318239|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
14318240|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318241|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14318242|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14318243|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318244|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318245|NCT00729937|Clindamycin|clindamycin|mesh-list
14318246|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
14318247|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
14318248|NCT00729937|Cephalexin|cephalexin|mesh-list
14318249|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14318250|NCT00729937|Trimethoprim|trimethoprim|mesh-list
14318251|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
14318252|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14318253|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318254|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14318255|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318256|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318257|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14318258|NCT00729937|Renal Agents|renal agents|mesh-ancestor
14318259|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
14318260|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14318261|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14318262|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14318263|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14318264|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14318265|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14318266|NCT00730015|Linaclotide|linaclotide|mesh-list
14318267|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14318268|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
14318269|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318270|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318271|NCT00730028|Clindamycin|clindamycin|mesh-list
14318272|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
14318273|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
14318274|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14318275|NCT00730028|Trimethoprim|trimethoprim|mesh-list
14318276|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
14318277|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14318278|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318279|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14318280|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724288|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
14318281|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318282|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14318283|NCT00730028|Renal Agents|renal agents|mesh-ancestor
14318284|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
14318285|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14318286|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14318287|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14318288|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14318289|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14318290|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14328188|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14328189|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
14328190|NCT00807586|Prednisolone|prednisolone|mesh-list
14328191|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
14328192|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14328193|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
14328194|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328195|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
14328196|NCT00807586|Hormones|hormones|mesh-ancestor
14328197|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328198|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328199|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14328200|NCT00807586|Protective Agents|protective agents|mesh-ancestor
14328201|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14328202|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328203|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
14328204|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
14328205|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328206|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14328207|NCT00807599|Dexamethasone|dexamethasone|mesh-list
14328208|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
14328209|NCT00807599|Lenalidomide|lenalidomide|mesh-list
14328210|NCT00807599|Melphalan|melphalan|mesh-list
14328211|NCT00807599|BB 1101|bb 1101|mesh-list
14328212|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328213|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
14328214|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
14328215|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328216|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328217|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14328218|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
14328219|NCT00807599|Hormones|hormones|mesh-ancestor
14328220|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328221|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14328222|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328223|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328224|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328225|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328226|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
14328227|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14328228|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14328229|NCT00807599|Growth Substances|growth substances|mesh-ancestor
14328230|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
14328231|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14328232|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
14328233|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14328234|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328235|NCT00807742|Nicotine|nicotine|mesh-list
14328236|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14328237|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
14328238|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328239|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328240|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14328241|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14328242|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
14724289|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724290|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328243|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328244|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724291|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14724292|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724293|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724294|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
14724295|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724296|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14724297|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724298|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14724299|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14724300|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
14724301|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724302|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
14318291|NCT00730158|Irinotecan|irinotecan|mesh-list
14318292|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14318293|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14318294|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318295|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318296|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222400|NCT00982111|Necitumumab|necitumumab|mesh-list
15222401|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222402|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222403|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222404|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15222405|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15222406|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222407|NCT00670358|Prednisone|prednisone|mesh-list
15222408|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
15222409|NCT00670358|Rituximab|rituximab|mesh-list
15222410|NCT00670358|Doxorubicin|doxorubicin|mesh-list
14318297|NCT00730171|Linaclotide|linaclotide|mesh-list
14318298|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14318299|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
14318300|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318301|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318302|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14318303|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14318304|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318305|NCT00730275|Incretins|incretins|mesh-ancestor
14318306|NCT00730275|Hormones|hormones|mesh-ancestor
14318307|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318308|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14318309|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
14318310|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318311|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318312|NCT00730353|Paclitaxel|paclitaxel|mesh-list
14318313|NCT00730353|Sunitinib|sunitinib|mesh-list
14318314|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14318315|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724303|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14724304|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
14724305|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724306|NCT00498342|Expectorants|expectorants|mesh-ancestor
14318316|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
14318317|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
14318318|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
14318319|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318320|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14318321|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14318322|NCT00730353|Growth Substances|growth substances|mesh-ancestor
14318323|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318324|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
14318325|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14318326|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318327|NCT00730405|Albaconazole|albaconazole|mesh-list
14724307|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
14724308|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14724309|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
15222411|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15222412|NCT00670358|Vincristine|vincristine|mesh-list
14724310|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724311|NCT00498342|Protective Agents|protective agents|mesh-ancestor
14318328|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
14318329|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318330|NCT00730483|Doxorubicin|doxorubicin|mesh-list
14318331|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14318332|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14318333|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318334|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14318335|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14318336|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318337|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318338|NCT00730522|Vigabatrin|vigabatrin|mesh-list
14318339|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
14318340|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318341|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318342|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
14318343|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318344|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318345|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14318346|NCT00730691|Vortioxetine|vortioxetine|mesh-list
14318347|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14318348|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14318349|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14318350|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318351|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318352|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318353|NCT00730691|Analgesics|analgesics|mesh-ancestor
14318354|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
14318355|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318356|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
14318357|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14318358|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
14318359|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14318360|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14318361|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318362|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14318363|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
14318364|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14318365|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14318366|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14910320|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910321|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14910322|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222413|NCT00670358|Lenalidomide|lenalidomide|mesh-list
14318367|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14318368|NCT00730756|Fluticasone|fluticasone|mesh-list
14318369|NCT00730756|Xhance|xhance|mesh-list
14318370|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318371|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14318372|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
14318373|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318374|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318375|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14318376|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
14318377|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14318378|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14318379|NCT00730847|Vaccines|vaccines|mesh-list
14318380|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
14318381|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318382|NCT00730912|Loratadine|loratadine|mesh-list
14318383|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
14318384|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14318385|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14318386|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14318387|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14318388|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
14318389|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
15222414|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222415|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
14724312|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910323|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222416|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222417|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15222418|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15222419|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
15222420|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222421|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318390|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318391|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318392|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318393|NCT00730925|Paclitaxel|paclitaxel|mesh-list
14318394|NCT00730925|Afatinib|afatinib|mesh-list
14318395|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14318396|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318397|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
14318398|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
14318399|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
14318400|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318401|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14318402|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318403|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14318404|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14318405|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318406|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14318407|NCT00731055|Varenicline|varenicline|mesh-list
14318408|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14318409|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14318410|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
14318411|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318412|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318413|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318414|NCT00731120|Vortioxetine|vortioxetine|mesh-list
14318415|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
14318416|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14318417|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14318418|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14318419|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318420|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318421|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14318422|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14318423|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14318424|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318425|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318426|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
14318427|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14318428|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14318429|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14318430|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14318431|NCT00731133|Disulfiram|disulfiram|mesh-list
14318432|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14318433|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14318434|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318435|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318436|NCT00731198|Drotaverin|drotaverin|mesh-list
14318437|NCT00731198|Scopolamine|scopolamine|mesh-list
14318438|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14318439|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15222422|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15222423|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222424|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15222425|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222426|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222427|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222428|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15222429|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
14318440|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
14318441|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
14318442|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318443|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318444|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318445|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
14318446|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14318447|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
14318448|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318449|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318450|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14318451|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
14318452|NCT00731198|Analgesics|analgesics|mesh-ancestor
14318453|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
14318454|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
14318455|NCT00731549|Aripiprazole|aripiprazole|mesh-list
14318456|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
14318457|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14318458|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14318459|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14318460|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318461|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318462|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
14318463|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
14318464|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318465|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318466|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14318467|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14318468|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
14318469|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14318470|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14318471|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14318472|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14318473|NCT00731588|Biotin|biotin|mesh-list
14318474|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
14318475|NCT00731588|Vitamins|vitamins|mesh-ancestor
14318476|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
14318477|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318478|NCT00731679|Rifaximin|rifaximin|mesh-list
14318479|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14318480|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318481|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318482|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14318483|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14318484|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318485|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318486|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
14318487|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318488|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
14318489|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14318490|NCT00731783|Mupirocin|mupirocin|mesh-list
15222430|NCT00670358|Hormones|hormones|mesh-ancestor
15222431|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222432|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222433|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222434|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222435|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222436|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14318491|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14328245|NCT00807768|Paclitaxel|paclitaxel|mesh-list
14318492|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318493|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
14318494|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
14318495|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14318496|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14318497|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318498|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318499|NCT00731874|Tacrolimus|tacrolimus|mesh-list
14318500|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318501|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
14318502|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318503|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14318504|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318505|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318506|NCT00732069|Valsartan|valsartan|mesh-list
14318507|NCT00732069|Ramipril|ramipril|mesh-list
14318508|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14318509|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14318510|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14318511|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318512|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14318513|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
14318514|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318515|NCT00732212|Hemostatics|hemostatics|mesh-list
14318516|NCT00732212|Coagulants|coagulants|mesh-ancestor
14318517|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
14318518|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14318519|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
14318520|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318521|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
14318522|NCT00732225|Protective Agents|protective agents|mesh-ancestor
14318523|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14318524|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318525|NCT00732251|Allopurinol|allopurinol|mesh-list
14318526|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
14318527|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318528|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318529|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
14318530|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14318531|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14318532|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
14318533|NCT00732251|Protective Agents|protective agents|mesh-ancestor
14318534|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318535|NCT00732303|Pemetrexed|pemetrexed|mesh-list
14318536|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318537|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318538|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318539|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14318540|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14318541|NCT00732498|Cytarabine|cytarabine|mesh-list
14318542|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
14318543|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14318544|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14318545|NCT00732498|Prednisolone|prednisolone|mesh-list
14318546|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
14318547|NCT00732498|Rituximab|rituximab|mesh-list
14318548|NCT00732498|Etoposide|etoposide|mesh-list
14318549|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14318550|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14318551|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
14318552|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318553|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14318554|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
14318555|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318556|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14318557|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14318558|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14318559|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14318560|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318561|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318562|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14318563|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
14318564|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
14318565|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318566|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318567|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318568|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
14318569|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
14318570|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318571|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318572|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
14318573|NCT00732498|Hormones|hormones|mesh-ancestor
14318574|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318575|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14318576|NCT00732498|Protective Agents|protective agents|mesh-ancestor
14318577|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14318578|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
14318579|NCT00732654|Caseins|caseins|mesh-list
14318580|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318581|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
14318582|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
14318583|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318584|NCT00732758|Vitamin D|vitamin d|mesh-list
14318585|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
14318586|NCT00732758|Vitamins|vitamins|mesh-ancestor
14318587|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
14318588|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318589|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14318590|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14318591|NCT00732875|Methotrexate|methotrexate|mesh-list
14318592|NCT00732875|Infliximab|infliximab|mesh-list
14318593|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14318594|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
14318595|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14318596|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318597|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14318598|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
14318599|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318600|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318601|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
14318602|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318603|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14318604|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318605|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
14318606|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14318607|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14318608|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318609|NCT00732901|Citalopram|citalopram|mesh-list
14318610|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14318611|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14318612|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15222437|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222438|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222439|NCT00670358|Growth Substances|growth substances|mesh-ancestor
15222440|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222441|NCT00193219|Leucovorin|leucovorin|mesh-list
15222442|NCT00193219|Bevacizumab|bevacizumab|mesh-list
15222443|NCT00193219|Cetuximab|cetuximab|mesh-list
15222444|NCT00193219|Fluorouracil|fluorouracil|mesh-list
15222445|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
15222446|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222447|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222448|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222449|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222450|NCT00193219|Growth Substances|growth substances|mesh-ancestor
15222451|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318613|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318614|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318615|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
14318616|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318617|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14318618|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
14318619|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14318620|NCT00732940|Belimumab|belimumab|mesh-list
14318621|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318622|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
14318623|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318624|NCT00732992|Pemetrexed|pemetrexed|mesh-list
14318625|NCT00732992|Sunitinib|sunitinib|mesh-list
14318626|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318627|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318628|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318629|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14318630|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14318631|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14318632|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14318633|NCT00732992|Growth Substances|growth substances|mesh-ancestor
14318634|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318635|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
14318636|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14318637|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
14318638|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14318639|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14318640|NCT00733096|Prednisolone|prednisolone|mesh-list
14318641|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
14318642|NCT00733096|Etanercept|etanercept|mesh-list
14318643|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14318644|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
14318645|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318646|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
14318647|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
14318648|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318649|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318650|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318651|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
14318652|NCT00733096|Hormones|hormones|mesh-ancestor
14318653|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318654|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14318655|NCT00733096|Protective Agents|protective agents|mesh-ancestor
14318656|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14318657|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318658|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14318659|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14318660|NCT00733096|Analgesics|analgesics|mesh-ancestor
14318661|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
15222452|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
14318662|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14318663|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318664|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
14318665|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
14318666|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14318667|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
14318668|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318669|NCT00733278|Copper|copper|mesh-list
14318670|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
14318671|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14318672|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318673|NCT00733278|Trace Elements|trace elements|mesh-ancestor
14318674|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
14318675|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14318676|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14318677|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14318678|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318679|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14318680|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14318681|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14318682|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318683|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
14318684|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318685|NCT00733408|Paclitaxel|paclitaxel|mesh-list
14318686|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14318687|NCT00733408|Bevacizumab|bevacizumab|mesh-list
14318688|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14318689|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14318690|NCT00733408|Antibodies|antibodies|mesh-list
14318691|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
14318692|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14318693|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14318694|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318695|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14318696|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14318697|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14318698|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318699|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14318700|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14318701|NCT00733408|Growth Substances|growth substances|mesh-ancestor
14318702|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318703|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
14724313|NCT00498342|Antidotes|antidotes|mesh-ancestor
14729201|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729202|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14729203|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729204|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729205|NCT00521963|Infliximab|infliximab|mesh-list
14729206|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
14729207|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729208|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729209|NCT00522015|Rivastigmine|rivastigmine|mesh-list
14729210|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14729211|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729212|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729213|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14729214|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729215|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729216|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14729217|NCT00522015|Protective Agents|protective agents|mesh-ancestor
14729218|NCT00522132|Artesunate|artesunate|mesh-list
14729219|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
14318704|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
14729220|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14729221|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15222453|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
14318705|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14318706|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318707|NCT00733421|Etoricoxib|etoricoxib|mesh-list
14318708|NCT00733421|Tramadol|tramadol|mesh-list
14318709|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14318710|NCT00733421|Narcotics|narcotics|mesh-ancestor
14318711|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318712|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318713|NCT00733421|Analgesics|analgesics|mesh-ancestor
14318714|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
14318715|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318716|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14318717|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14318718|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318719|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14318720|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14318721|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14318722|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318723|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318724|NCT00733746|Gemcitabine|gemcitabine|mesh-list
15222454|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222455|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15222456|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222457|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
15222458|NCT00193219|Antidotes|antidotes|mesh-ancestor
15222459|NCT00193219|Protective Agents|protective agents|mesh-ancestor
15222460|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
15222461|NCT00193219|Vitamins|vitamins|mesh-ancestor
15222462|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
15222463|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
15222464|NCT00116142|Docetaxel|docetaxel|mesh-list
14318725|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15222465|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
15222466|NCT00116142|Androgens|androgens|mesh-list
15222467|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15222468|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222469|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222470|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222471|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222472|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222473|NCT00116142|Hormones|hormones|mesh-ancestor
15222474|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222475|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222476|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
15222477|NCT00116142|Protective Agents|protective agents|mesh-ancestor
15222478|NCT00116142|Vitamins|vitamins|mesh-ancestor
15222479|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
15222480|NCT00116142|Estrogens|estrogens|mesh-ancestor
14318726|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15222481|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222482|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
14318727|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
14318728|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318729|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318730|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
14318731|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318732|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318733|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318734|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
14318735|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318736|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14318737|NCT00733824|Plerixafor|plerixafor|mesh-list
14318738|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14318739|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14318740|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
14318741|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318742|NCT00733902|Tanezumab|tanezumab|mesh-list
14318743|NCT00733902|Analgesics|analgesics|mesh-ancestor
14318744|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
14318745|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318746|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318747|NCT00733954|Clobetasol|clobetasol|mesh-list
14318748|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318749|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
14318750|NCT00733954|Hormones|hormones|mesh-ancestor
14318751|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318752|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318753|NCT00733993|Caffeine|caffeine|mesh-list
14318754|NCT00733993|Amphetamine|amphetamine|mesh-list
14318755|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14318756|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318757|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15222483|NCT00070018|Prednisone|prednisone|mesh-list
15222484|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
15222485|NCT00070018|Rituximab|rituximab|mesh-list
15222486|NCT00070018|Doxorubicin|doxorubicin|mesh-list
15222487|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15222488|NCT00070018|Vincristine|vincristine|mesh-list
15222489|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15222490|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222491|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
15222492|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222493|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15222494|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15222495|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
15222496|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222497|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318758|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318759|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318760|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14318761|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14318762|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
14318763|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318764|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
14318765|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
14318766|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318767|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
14318768|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
14318769|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14318770|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14318771|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14318772|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14318773|NCT00734032|Darapladib|darapladib|mesh-list
14318774|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14318775|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318776|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318777|NCT00734071|Vortioxetine|vortioxetine|mesh-list
14318778|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
14318779|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14318780|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14318781|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14318782|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318783|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318784|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14318785|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14318786|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14318787|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318788|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318789|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
14318790|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14318791|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14318792|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14318793|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14318794|NCT00734097|Esomeprazole|esomeprazole|mesh-list
14318795|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14318796|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318797|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14318798|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318799|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318800|NCT00734149|Prednisone|prednisone|mesh-list
14318801|NCT00734149|Bortezomib|bortezomib|mesh-list
14318802|NCT00734149|Melphalan|melphalan|mesh-list
14318803|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318804|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
14318805|NCT00734149|Hormones|hormones|mesh-ancestor
14318806|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318807|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318808|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14318809|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318810|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14318811|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
14318812|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318813|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14318814|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14318815|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
14318816|NCT00734162|Tenofovir|tenofovir|mesh-list
14318817|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
14318818|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724314|NCT00498537|Spironolactone|spironolactone|mesh-list
14724315|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14724316|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
14724317|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724318|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724319|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14724320|NCT00498537|Diuretics|diuretics|mesh-ancestor
14724321|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
14724322|NCT00498589|Methotrexate|methotrexate|mesh-list
14724323|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14724324|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
14318819|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14318820|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14318821|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318822|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318823|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14724325|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724326|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724327|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724328|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
14318824|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14318825|NCT00734344|Tenofovir|tenofovir|mesh-list
14318826|NCT00734344|Efavirenz|efavirenz|mesh-list
14318827|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
14318828|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
14318829|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318830|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14318831|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14318832|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318833|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318834|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14318835|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14318836|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14318837|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14318838|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14318839|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14318840|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14318841|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14318842|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14318843|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14318844|NCT00734474|Metformin|metformin|mesh-list
14724329|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724330|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724331|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14724332|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724333|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14724334|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724335|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
14724336|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14318845|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14318846|NCT00734474|Dulaglutide|dulaglutide|mesh-list
14318847|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14318848|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318849|NCT00734474|Incretins|incretins|mesh-ancestor
14318850|NCT00734474|Hormones|hormones|mesh-ancestor
14318851|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318852|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14318853|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
14318854|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318855|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318856|NCT00734500|Anidulafungin|anidulafungin|mesh-list
14318857|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
14318858|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318859|NCT00734539|Fluconazole|fluconazole|mesh-list
14318860|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
14318861|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318862|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14318863|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14318864|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318865|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318866|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14724337|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14724338|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
14724339|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14724340|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
14724341|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14724342|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14724343|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724344|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724345|NCT00498680|Urological Agents|urological agents|mesh-ancestor
14724346|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
14318867|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
14318868|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318869|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318870|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14318871|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14318872|NCT00734578|Guanfacine|guanfacine|mesh-list
14318873|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14318874|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14318875|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14318876|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14318877|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
14318878|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318879|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318880|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318881|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
14318882|NCT00734604|Tadalafil|tadalafil|mesh-list
14318883|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318884|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
14318885|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14318886|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14318887|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318888|NCT00734604|Urological Agents|urological agents|mesh-ancestor
14318889|NCT00734617|Nicotine|nicotine|mesh-list
14318890|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14318891|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
14318892|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318893|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318894|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14318895|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14318896|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
14318897|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318898|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318899|NCT00734630|Losartan|losartan|mesh-list
14318900|NCT00734630|Lisinopril|lisinopril|mesh-list
14318901|NCT00734630|Nebivolol|nebivolol|mesh-list
14318902|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14318903|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14318904|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14318905|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14318906|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318907|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14318908|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
14318909|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318910|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14724347|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14318911|NCT00734630|Protective Agents|protective agents|mesh-ancestor
14318912|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318913|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
14318914|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14318915|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14318916|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14318917|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
14318918|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318919|NCT00734656|Ethanol|ethanol|mesh-list
14318920|NCT00734656|Dutasteride|dutasteride|mesh-list
14318921|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14318922|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318923|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318924|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318925|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14318926|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14318927|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318928|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318929|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
14318930|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318931|NCT00734851|Docetaxel|docetaxel|mesh-list
14318932|NCT00734851|Sunitinib|sunitinib|mesh-list
14318933|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318934|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
14318935|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
14318936|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
14318937|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318938|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14318939|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14318940|NCT00734851|Growth Substances|growth substances|mesh-ancestor
14318941|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318942|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
14318943|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14318944|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318945|NCT00734929|Dexamethasone|dexamethasone|mesh-list
14318946|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
14318947|NCT00734929|Ondansetron|ondansetron|mesh-list
14318948|NCT00734929|Aprepitant|aprepitant|mesh-list
14318949|NCT00734929|BB 1101|bb 1101|mesh-list
14318950|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14318951|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
14318952|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
14318953|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14318954|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14318955|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14318956|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
14318957|NCT00734929|Hormones|hormones|mesh-ancestor
14318958|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14318959|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14318960|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318961|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
14318962|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318963|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318964|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
14318965|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
14318966|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14318967|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
14318968|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14318969|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14318970|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14318971|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14318972|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14318973|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14318974|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14328246|NCT00807768|Carboplatin|carboplatin|mesh-list
14328247|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14328248|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14328249|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328250|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
14328251|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
14328252|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
14328253|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328254|NCT00807846|Celecoxib|celecoxib|mesh-list
14328255|NCT00807846|Naproxen|naproxen|mesh-list
14724348|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
14318975|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
14318976|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14318977|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318978|NCT00734968|Renal Agents|renal agents|mesh-ancestor
14318979|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14318980|NCT00734994|Mitomycins|mitomycins|mesh-list
14318981|NCT00734994|Mitomycin|mitomycin|mesh-list
14318982|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14318983|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14318984|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
14318985|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318986|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14318987|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14318988|NCT00735072|Maraviroc|maraviroc|mesh-list
14318989|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14318990|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14318991|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14318992|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14318993|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14318994|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
14318995|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14318996|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14318997|NCT00735306|Bevacizumab|bevacizumab|mesh-list
14318998|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14318999|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319000|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319001|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14319002|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14319003|NCT00735306|Growth Substances|growth substances|mesh-ancestor
14319004|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319005|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
14319006|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14319007|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319008|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319009|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14319010|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14319011|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319012|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14319013|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14319014|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319015|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319016|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
14319017|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319018|NCT00735436|Bevacizumab|bevacizumab|mesh-list
14319019|NCT00735436|Irinotecan|irinotecan|mesh-list
14319020|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319021|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319022|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14319023|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14319024|NCT00735436|Growth Substances|growth substances|mesh-ancestor
14319025|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319026|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
14319027|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14319028|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14319029|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319030|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319031|NCT00735449|Timolol|timolol|mesh-list
14319032|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14319033|NCT00735449|Latanoprost|latanoprost|mesh-list
14319034|NCT00735449|Maleic acid|maleic acid|mesh-list
14319035|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14319036|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14319037|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
14319038|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319039|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319040|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319041|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14319042|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14319043|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319044|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14319045|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14319046|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14319047|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14319048|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14319049|NCT00735462|Imiquimod|imiquimod|mesh-list
14319050|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14319051|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
14319052|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319053|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319054|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
14319055|NCT00735475|Vaccines|vaccines|mesh-list
14319056|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
14319057|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319058|NCT00735644|Vaccines|vaccines|mesh-list
14319059|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
14319060|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319061|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14319062|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14319063|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14319064|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319065|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319066|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319067|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319068|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14319069|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
14319070|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724349|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724350|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319071|NCT00735696|Paclitaxel|paclitaxel|mesh-list
14319072|NCT00735696|Carboplatin|carboplatin|mesh-list
14319073|NCT00735696|Ramucirumab|ramucirumab|mesh-list
14319074|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14319075|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319076|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14319077|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14319078|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14319079|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319080|NCT00735709|Vortioxetine|vortioxetine|mesh-list
14319081|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
14319082|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14319083|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14319084|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14319085|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319086|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319087|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14319088|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14319089|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319090|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319091|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319092|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
14319093|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14319094|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14319095|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14319096|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14319097|NCT00735787|Adalimumab|adalimumab|mesh-list
14319098|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14319099|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319100|NCT00735826|Vorinostat|vorinostat|mesh-list
14319101|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319102|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14319103|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319104|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319105|NCT00735878|Carboplatin|carboplatin|mesh-list
14319106|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319107|NCT00735904|Gemcitabine|gemcitabine|mesh-list
14319108|NCT00735904|Axitinib|axitinib|mesh-list
14319109|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319110|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14319111|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
14319112|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319113|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
14319114|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319115|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319116|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319117|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
14319118|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724351|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14724352|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14724353|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14724354|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14724355|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14724356|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15222498|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14319119|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14319120|NCT00735917|Saracatinib|saracatinib|mesh-list
14319121|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14319122|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14319123|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319124|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319125|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319126|NCT00735969|Ribavirin|ribavirin|mesh-list
14319127|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
14319128|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319129|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
14319130|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319131|NCT00736073|Aprepitant|aprepitant|mesh-list
14319132|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
14319133|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
14319134|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319135|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319136|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14319137|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14319138|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319139|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319140|NCT00736099|Pioglitazone|pioglitazone|mesh-list
14319141|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14319142|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319143|NCT00736190|Tenofovir|tenofovir|mesh-list
14319144|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
14319145|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319146|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14319147|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14319148|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319149|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319150|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14724357|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
15222499|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222500|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15222501|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222502|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222503|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222504|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15222505|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
15222506|NCT00070018|Hormones|hormones|mesh-ancestor
15222507|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222508|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14319151|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14319152|NCT00736229|Exenatide|exenatide|mesh-list
14319153|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14319154|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319155|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14319156|NCT00736229|Incretins|incretins|mesh-ancestor
14319157|NCT00736229|Hormones|hormones|mesh-ancestor
14319158|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319159|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14319160|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
14319161|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
14319162|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319163|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319164|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14319165|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
14319166|NCT00736255|Nicotine|nicotine|mesh-list
14319167|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14319168|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
14319169|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319170|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319171|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14319172|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14319173|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
14319174|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319175|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319176|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14319177|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14319178|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14319179|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319180|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
14319181|NCT00736333|Doxorubicin|doxorubicin|mesh-list
14319182|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14319183|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14319184|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319185|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14319186|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14319187|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319188|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319189|NCT00736450|Prednisone|prednisone|mesh-list
14319190|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
14319191|NCT00736450|Rituximab|rituximab|mesh-list
14319192|NCT00736450|Doxorubicin|doxorubicin|mesh-list
14319193|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14319194|NCT00736450|Vincristine|vincristine|mesh-list
14319195|NCT00736450|Oblimersen|oblimersen|mesh-list
14319196|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319197|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
14319198|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319199|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319200|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14319201|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
14319202|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319203|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319204|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14319205|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319206|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14319207|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14319208|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14319209|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319210|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14319211|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
14319212|NCT00736450|Hormones|hormones|mesh-ancestor
14319213|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319214|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14319215|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14319216|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
14319217|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
14724358|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724359|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319218|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
14319219|NCT00736476|Vaccines|vaccines|mesh-list
14319220|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
14319221|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319222|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
14910324|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910325|NCT01356381|Vildagliptin|vildagliptin|mesh-list
14910326|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14910327|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910328|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14910329|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
14910330|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910331|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910332|NCT01356433|Vitamins|vitamins|mesh-list
14910333|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
14910334|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
14910335|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910336|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
14910337|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910338|NCT01356433|Protective Agents|protective agents|mesh-ancestor
14910339|NCT01356472|Imipenem|imipenem|mesh-list
14910340|NCT01356472|Cilastatin|cilastatin|mesh-list
14910341|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14319223|NCT00736489|AZD-3199|azd-3199|mesh-list
14319224|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14319225|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
14319226|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319227|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319228|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14319229|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
14319230|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14319231|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14319232|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14319233|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
14319234|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319235|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319236|NCT00736632|Vitamin D|vitamin d|mesh-list
14319237|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
14319238|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
14724360|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724361|NCT00498888|Urological Agents|urological agents|mesh-ancestor
14724362|NCT00498901|Letrozole|letrozole|mesh-list
14724363|NCT00498901|Leuprolide|leuprolide|mesh-list
14724364|NCT00498901|Goserelin|goserelin|mesh-list
14724365|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724366|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14724367|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14724368|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724369|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724370|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14724371|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
14724372|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724373|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724374|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15222509|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222510|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14319239|NCT00736632|Vitamins|vitamins|mesh-list
14319240|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
14319241|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319242|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14319243|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14319244|NCT00736645|Selenium|selenium|mesh-list
14319245|NCT00736645|Finasteride|finasteride|mesh-list
14319246|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14319247|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14319248|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319249|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724375|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
14724376|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724377|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222511|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222512|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222513|NCT05189535|Paclitaxel|paclitaxel|mesh-list
15222514|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
15222515|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222516|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319250|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
15222517|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222518|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222519|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222520|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222521|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15222522|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222523|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14319251|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319252|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319253|NCT00736645|Urological Agents|urological agents|mesh-ancestor
14319254|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
14319255|NCT00736645|Protective Agents|protective agents|mesh-ancestor
14319256|NCT00736645|Trace Elements|trace elements|mesh-ancestor
14319257|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
14319258|NCT00736853|Acetaminophen|acetaminophen|mesh-list
14319259|NCT00736853|Tramadol|tramadol|mesh-list
14319260|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14319261|NCT00736853|Analgesics|analgesics|mesh-ancestor
14319262|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
14319263|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319264|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319265|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
14319266|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14319267|NCT00736853|Narcotics|narcotics|mesh-ancestor
14319268|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319269|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
14319270|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14319271|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319272|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14319273|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319274|NCT00736944|Cisplatin|cisplatin|mesh-list
14319275|NCT00736944|Cetuximab|cetuximab|mesh-list
14319276|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14319277|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319278|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319279|NCT00736957|Acetaminophen|acetaminophen|mesh-list
14319280|NCT00736957|Tramadol|tramadol|mesh-list
14319281|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14319282|NCT00736957|Analgesics|analgesics|mesh-ancestor
14319283|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
14319284|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222524|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15222525|NCT05189535|Protective Agents|protective agents|mesh-ancestor
15222526|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222527|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
15222528|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15222529|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
15222530|NCT05189223|Buprenorphine|buprenorphine|mesh-list
15222531|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15222532|NCT05189223|Narcotics|narcotics|mesh-ancestor
15222533|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319285|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319286|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
14319287|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14319288|NCT00736957|Narcotics|narcotics|mesh-ancestor
14319289|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319290|NCT00736996|Pioglitazone|pioglitazone|mesh-list
14319291|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14319292|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319293|NCT00737048|Acetaminophen|acetaminophen|mesh-list
14319294|NCT00737048|Tramadol|tramadol|mesh-list
14319295|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14319296|NCT00737048|Analgesics|analgesics|mesh-ancestor
14319297|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
14319298|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319299|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319300|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
14319301|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14319302|NCT00737048|Narcotics|narcotics|mesh-ancestor
14319303|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319304|NCT00737100|Bromides|bromides|mesh-list
14319305|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
14319306|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14319307|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
14319308|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319309|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319310|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14319311|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
14319312|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
14319313|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14319314|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
14319315|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319316|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319317|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
14319318|NCT00737178|Copper|copper|mesh-list
15222534|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222535|NCT05189223|Analgesics|analgesics|mesh-ancestor
14319319|NCT00737178|Trace Elements|trace elements|mesh-ancestor
14319320|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
14319321|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319322|NCT00737204|Modafinil|modafinil|mesh-list
14319323|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14319324|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319325|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14319326|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14319327|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14319328|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319329|NCT00737243|Paclitaxel|paclitaxel|mesh-list
14319330|NCT00737243|Bevacizumab|bevacizumab|mesh-list
14319331|NCT00737243|Carboplatin|carboplatin|mesh-list
14319332|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14319333|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14319334|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319335|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14319336|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14319337|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14319338|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319339|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319340|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14319341|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14319342|NCT00737243|Growth Substances|growth substances|mesh-ancestor
14319343|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319344|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
14319345|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14319346|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319347|NCT00737438|Bevacizumab|bevacizumab|mesh-list
14319348|NCT00737438|Docetaxel|docetaxel|mesh-list
14319349|NCT00737438|Capecitabine|capecitabine|mesh-list
14319350|NCT00737438|Irinotecan|irinotecan|mesh-list
14319351|NCT00737438|Epirubicin|epirubicin|mesh-list
14319352|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319353|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319354|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14319355|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14319356|NCT00737438|Growth Substances|growth substances|mesh-ancestor
14319357|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319358|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
14319359|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
14319360|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
14319361|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
14319362|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319363|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14319364|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
14319365|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14319366|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14319367|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319368|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14319369|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14319370|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
14319371|NCT00737464|Hematinics|hematinics|mesh-ancestor
14319372|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
14319373|NCT00737477|Hematinics|hematinics|mesh-ancestor
14319374|NCT00737529|Lenalidomide|lenalidomide|mesh-list
14319375|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
15222536|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
15222537|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222538|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15222539|NCT05189184|Paclitaxel|paclitaxel|mesh-list
14319376|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222540|NCT05189184|Apatinib|apatinib|mesh-list
14319377|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14319378|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14319379|NCT00737529|Growth Substances|growth substances|mesh-ancestor
14319380|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
14319381|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319382|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14319383|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14319384|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14319385|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319386|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319387|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
14319388|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319389|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14319390|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14319391|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
14319392|NCT00737711|Hematinics|hematinics|mesh-ancestor
14319393|NCT00737737|Morphine|morphine|mesh-list
14724378|NCT00498953|Carboplatin|carboplatin|mesh-list
14724379|NCT00498953|Docetaxel|docetaxel|mesh-list
14724380|NCT00498953|Fluorouracil|fluorouracil|mesh-list
14724381|NCT00498953|Lapatinib|lapatinib|mesh-list
14724382|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14724383|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724384|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14724385|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14724386|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14724387|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724388|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
14724389|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724390|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724391|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
14724392|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724393|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14724394|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724395|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14319394|NCT00737737|Oxycodone|oxycodone|mesh-list
14319395|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14319396|NCT00737737|Narcotics|narcotics|mesh-ancestor
14319397|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319398|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319399|NCT00737737|Analgesics|analgesics|mesh-ancestor
14319400|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
14319401|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319402|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
14319403|NCT00737893|Hematinics|hematinics|mesh-ancestor
14319404|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
14319405|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14319406|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14319407|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319408|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14319409|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14319410|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14319411|NCT00738049|Darusentan|darusentan|mesh-list
14319412|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14319413|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319414|NCT00738062|Droxidopa|droxidopa|mesh-list
14319415|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14910342|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910343|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
14910344|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910345|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910346|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14910347|NCT01356511|Dexamethasone|dexamethasone|mesh-list
14910348|NCT01356511|Prednisone|prednisone|mesh-list
14910349|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910350|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
14724396|NCT00498979|Interferons|interferons|mesh-list
14319416|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14319417|NCT00738361|Paclitaxel|paclitaxel|mesh-list
14724397|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
14910351|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
14910352|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222541|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15222542|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222543|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222544|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
14319418|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14319419|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14319420|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319421|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
14319422|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
14319423|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
14319424|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319425|NCT00738374|Rituximab|rituximab|mesh-list
14319426|NCT00738374|Chlorambucil|chlorambucil|mesh-list
14319427|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319428|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319429|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
14319430|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319431|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319432|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14319433|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
14319434|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319435|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14319436|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
14319437|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14319438|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14319439|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319440|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319441|NCT00738400|Urological Agents|urological agents|mesh-ancestor
14319442|NCT00738530|Interferons|interferons|mesh-list
14319443|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
14319444|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
14319445|NCT00738530|Bevacizumab|bevacizumab|mesh-list
14319446|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319447|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319448|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14319449|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14319450|NCT00738530|Growth Substances|growth substances|mesh-ancestor
14319451|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319452|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
14319453|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
14319454|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319455|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
14319456|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
14319457|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14319458|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319459|NCT00738699|Paclitaxel|paclitaxel|mesh-list
14319460|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14319461|NCT00738699|Farletuzumab|farletuzumab|mesh-list
14319462|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14319463|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319464|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222545|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222546|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222547|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319465|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
14319466|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
14319467|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319468|NCT00738881|Pemetrexed|pemetrexed|mesh-list
14319469|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14724398|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
14724399|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14724400|NCT00498979|Dacarbazine|dacarbazine|mesh-list
14724401|NCT00498979|Vinblastine|vinblastine|mesh-list
15222548|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15222549|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222550|NCT05189093|Antibodies|antibodies|mesh-list
15222551|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15222552|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
15222553|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319470|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319471|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319472|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319473|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14319474|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14319475|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14319476|NCT00738894|Aspirin|aspirin|mesh-list
14319477|NCT00738894|Dipyridamole|dipyridamole|mesh-list
14319478|NCT00738894|Clopidogrel|clopidogrel|mesh-list
14319479|NCT00738894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14319480|NCT00738894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14319481|NCT00738894|Analgesics|analgesics|mesh-ancestor
14319482|NCT00738894|Sensory System Agents|sensory system agents|mesh-ancestor
14319483|NCT00738894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319484|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319485|NCT00738894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14319486|NCT00738894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319487|NCT00738894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14319488|NCT00738894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15222554|NCT05189067|Paclitaxel|paclitaxel|mesh-list
15222555|NCT05189067|Docetaxel|docetaxel|mesh-list
15222556|NCT05189067|Trastuzumab|trastuzumab|mesh-list
14319489|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319490|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14319491|NCT00738894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14319492|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319493|NCT00738894|Antipyretics|antipyretics|mesh-ancestor
14319494|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14319495|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14319496|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14319497|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
14319498|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319499|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14319500|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
14319501|NCT00739297|Montelukast|montelukast|mesh-list
14319502|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14319503|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
14319504|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14319505|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
14319506|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319507|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319508|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14319509|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14319510|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319511|NCT00739596|Amlodipine|amlodipine|mesh-list
14319512|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14319513|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14319514|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14319515|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319516|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319517|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14319518|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319519|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
14319520|NCT00739596|Diuretics|diuretics|mesh-ancestor
14319521|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
14319522|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14319523|NCT00739648|Levofloxacin|levofloxacin|mesh-list
14319524|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14319525|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319526|NCT00739648|Renal Agents|renal agents|mesh-ancestor
14319527|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14319528|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14319529|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14319530|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319531|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319532|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319533|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14319534|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14319535|NCT00739934|Voriconazole|voriconazole|mesh-list
14319536|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
14319537|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319538|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14319539|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14319540|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319541|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319542|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14319543|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
14319544|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319545|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319546|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14319547|NCT00739960|Abatacept|abatacept|mesh-list
14319548|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14319549|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319550|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319551|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319552|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
14319553|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319554|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319555|NCT00739973|Amlodipine|amlodipine|mesh-list
14319556|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14319557|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14319558|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319559|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319560|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14319561|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319562|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
14319563|NCT00739999|Atorvastatin|atorvastatin|mesh-list
14319564|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14319565|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14319566|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
14319567|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319568|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14319569|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14319570|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319571|NCT00740051|Glimepiride|glimepiride|mesh-list
14319572|NCT00740051|Linagliptin|linagliptin|mesh-list
14319573|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14319574|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724402|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319575|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724403|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
14724404|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724405|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
14724406|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724407|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14724408|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
14724409|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724410|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14724411|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14724412|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14724413|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14724414|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14724415|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14724416|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
14724417|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14319576|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319577|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
14319578|NCT00740051|Incretins|incretins|mesh-ancestor
14319579|NCT00740051|Hormones|hormones|mesh-ancestor
14319580|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319581|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14319582|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
14319583|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319584|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319585|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
14319586|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14319587|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724418|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
14724419|NCT00498992|Vitamin E|vitamin e|mesh-list
14319588|NCT00740636|Temozolomide|temozolomide|mesh-list
14319589|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14319590|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
14319591|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319592|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319593|NCT00740714|Vitamins|vitamins|mesh-list
14319594|NCT00740714|Vitamin E|vitamin e|mesh-list
14319595|NCT00740714|Tocopherols|tocopherols|mesh-list
14319596|NCT00740714|Tocotrienols|tocotrienols|mesh-list
14319597|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
14319598|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
14319599|NCT00740714|Ubiquinone|ubiquinone|mesh-list
14319600|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
14319601|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319602|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
14319603|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319604|NCT00740714|Protective Agents|protective agents|mesh-ancestor
15222557|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222558|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222559|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222560|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
14724420|NCT00498992|Lidocaine|lidocaine|mesh-list
14724421|NCT00498992|Vitamins|vitamins|mesh-ancestor
14724422|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
14724423|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724424|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
14724425|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
14724426|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724427|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
15222561|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222562|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222563|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14319605|NCT00740779|Silodosin|silodosin|mesh-list
14319606|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14319607|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14319608|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14319609|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14319610|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319611|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319612|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319613|NCT00740779|Urological Agents|urological agents|mesh-ancestor
14319614|NCT00740792|Fluticasone|fluticasone|mesh-list
14319615|NCT00740792|Xhance|xhance|mesh-list
14319616|NCT00740792|Azelastine|azelastine|mesh-list
14319617|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14319618|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14319619|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
14319620|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319621|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319622|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14319623|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
14319624|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14319625|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14319626|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14319627|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319628|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319629|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15222564|NCT05189015|Olmesartan|olmesartan|mesh-list
15222565|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15222566|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15222567|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15222568|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15222569|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222570|NCT05189002|Dalteparin|dalteparin|mesh-list
15222571|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
15222572|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15222573|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14319630|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14724428|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222574|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222575|NCT05188911|Prednisone|prednisone|mesh-list
15222576|NCT05188911|Androgens|androgens|mesh-list
15222577|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15222578|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
15222579|NCT05188911|Hormones|hormones|mesh-ancestor
15222580|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222581|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222582|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222583|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222584|NCT05188859|Pemetrexed|pemetrexed|mesh-list
14319631|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
14319632|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
14319633|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319634|NCT00740831|Leuprolide|leuprolide|mesh-list
14319635|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
14319636|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14319637|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
14319638|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14319639|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319640|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14319641|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319642|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14319643|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
14319644|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14319645|NCT00740857|Ibuprofen|ibuprofen|mesh-list
14319646|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14319647|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14319648|NCT00740857|Analgesics|analgesics|mesh-ancestor
14319649|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
14319650|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319651|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319652|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14319653|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724429|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14724430|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14910353|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910354|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14910355|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
14910356|NCT01356511|Hormones|hormones|mesh-ancestor
14910357|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724431|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14724432|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14724433|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724434|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
14724435|NCT00498992|Protective Agents|protective agents|mesh-ancestor
14724436|NCT00499005|Carbetocin|carbetocin|mesh-list
14319654|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14319655|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319656|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319657|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14319658|NCT00741013|Protein C|protein c|mesh-list
14319659|NCT00741013|Lovastatin|lovastatin|mesh-list
14319660|NCT00741013|L 647318|l 647318|mesh-list
14319661|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
14319662|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14319663|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14319664|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
14724437|NCT00499005|Oxytocin|oxytocin|mesh-list
14319665|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319666|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14319667|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14319668|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319669|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
14319670|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14319671|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14319672|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319673|NCT00741026|Olanzapine|olanzapine|mesh-list
14319674|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
14319675|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
14319676|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319677|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319678|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14319679|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14319680|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14319681|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319682|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14319683|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14319684|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14319685|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319686|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319687|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319688|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
14319689|NCT00741039|Vaccines|vaccines|mesh-list
14319690|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14319691|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
14319692|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319693|NCT00741104|Infliximab|infliximab|mesh-list
14319694|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
14319695|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14319696|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319697|NCT00741156|Enalaprilat|enalaprilat|mesh-list
14319698|NCT00741156|Enalapril|enalapril|mesh-list
14319699|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14319700|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
14319701|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319702|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319703|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14319704|NCT00741260|Capecitabine|capecitabine|mesh-list
14319705|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14319706|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
14319707|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319708|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319709|NCT00741286|Aspirin|aspirin|mesh-list
14319710|NCT00741286|Cilostazol|cilostazol|mesh-list
14319711|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14319712|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910358|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14910359|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724438|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
14724439|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724440|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724441|NCT00499018|Cytarabine|cytarabine|mesh-list
14724442|NCT00499018|Prednisone|prednisone|mesh-list
14724443|NCT00499018|Rituximab|rituximab|mesh-list
14724444|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
14724445|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
14319713|NCT00741286|Analgesics|analgesics|mesh-ancestor
14319714|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
14319715|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319716|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319717|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14319718|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319719|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14319720|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14724446|NCT00499018|Vincristine|vincristine|mesh-list
14724447|NCT00499018|Doxorubicin|doxorubicin|mesh-list
14724448|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14319721|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319722|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14319723|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14319724|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319725|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
14319726|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14319727|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
15222585|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222586|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222587|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222588|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15222589|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15222590|NCT05188833|Paroxetine|paroxetine|mesh-list
15222591|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15222592|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14319728|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14319729|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
14319730|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14319731|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14319732|NCT00741286|Protective Agents|protective agents|mesh-ancestor
14319733|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14319734|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14319735|NCT00741338|Cyclosporine|cyclosporine|mesh-list
14319736|NCT00741338|Azathioprine|azathioprine|mesh-list
14319737|NCT00741338|Cyclosporins|cyclosporins|mesh-list
14319738|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319739|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319740|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319741|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
14319742|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319743|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
14319744|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319745|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
14319746|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319747|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14319748|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
14319749|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14319750|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319751|NCT00741455|Cyclosporine|cyclosporine|mesh-list
14319752|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
14319753|NCT00741455|Methotrexate|methotrexate|mesh-list
14319754|NCT00741455|Fludarabine|fludarabine|mesh-list
14319755|NCT00741455|Cyclosporins|cyclosporins|mesh-list
14319756|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319757|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
14319758|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319759|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319760|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14319761|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
14319762|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319763|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319764|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14319765|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14319766|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
14319767|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14319768|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14319769|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
14319770|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
14319771|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319772|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14319773|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14319774|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
14319775|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319776|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14319777|NCT00741468|Tolbutamide|tolbutamide|mesh-list
14319778|NCT00741468|Midazolam|midazolam|mesh-list
14319779|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
14319780|NCT00741468|Caffeine|caffeine|mesh-list
14319781|NCT00741468|Omeprazole|omeprazole|mesh-list
14319782|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14319783|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14319784|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319785|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319786|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14319787|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14319788|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14319789|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14319790|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
14319791|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
14319792|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
14319793|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
14319794|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319795|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319796|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14319797|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14319798|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14319799|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724449|NCT00499018|Lenograstim|lenograstim|mesh-list
14724450|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724451|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319800|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14319801|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14724452|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
14319802|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14319803|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14319804|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
14319805|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
14319806|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
14319807|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14319808|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14319809|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14319810|NCT00741598|Galantamine|galantamine|mesh-list
14319811|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14319812|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319813|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319814|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
14319815|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319816|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319817|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14319818|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
14319819|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319820|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
14319821|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14319822|NCT00741819|Treprostinil|treprostinil|mesh-list
14319823|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14319824|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14319825|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14319826|NCT00741858|Estradiol|estradiol|mesh-list
14319827|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14319828|NCT00741858|Estrogens|estrogens|mesh-ancestor
14319829|NCT00741858|Hormones|hormones|mesh-ancestor
14319830|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319831|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319832|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14319833|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
14319834|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14319835|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14319836|NCT00742027|Panobinostat|panobinostat|mesh-list
14319837|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319838|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14319839|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319840|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319841|NCT00742079|Cycloserine|cycloserine|mesh-list
14319842|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14319843|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319844|NCT00742079|Renal Agents|renal agents|mesh-ancestor
14319845|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14319846|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
14319847|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14319848|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
14319849|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319850|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14319851|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14319852|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319853|NCT00742235|Vitamin D|vitamin d|mesh-list
14319854|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
14319855|NCT00742235|Vitamins|vitamins|mesh-ancestor
14319856|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
14319857|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319858|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14319859|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14319860|NCT00742313|Hemostatics|hemostatics|mesh-list
14319861|NCT00742313|Coagulants|coagulants|mesh-ancestor
14319862|NCT00742326|Pioglitazone|pioglitazone|mesh-list
14319863|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14319864|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319865|NCT00742469|Rifaximin|rifaximin|mesh-list
14319866|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14910360|NCT01356524|Progesterone|progesterone|mesh-list
14910361|NCT01356524|Progestins|progestins|mesh-ancestor
14910362|NCT01356524|Hormones|hormones|mesh-ancestor
14910363|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910364|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319867|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319868|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14319869|NCT00742508|Carvedilol|carvedilol|mesh-list
14319870|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14319871|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14319872|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
14319873|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319874|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319875|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319876|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14319877|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
14724453|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724454|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319878|NCT00742508|Protective Agents|protective agents|mesh-ancestor
14319879|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14319880|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319881|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14319882|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
14319883|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14319884|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14319885|NCT00742560|Dexamethasone|dexamethasone|mesh-list
14319886|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
14319887|NCT00742560|Lenalidomide|lenalidomide|mesh-list
14319888|NCT00742560|Elotuzumab|elotuzumab|mesh-list
14319889|NCT00742560|BB 1101|bb 1101|mesh-list
14319890|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14319891|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
14319892|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
14319893|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319894|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319895|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14319896|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
14319897|NCT00742560|Hormones|hormones|mesh-ancestor
14319898|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14319899|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14319900|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724455|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14724456|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
14724457|NCT00499018|Hormones|hormones|mesh-ancestor
14724458|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724459|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14724460|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724461|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
14729222|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14319901|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
14319902|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319903|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319904|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
14319905|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14319906|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14319907|NCT00742560|Growth Substances|growth substances|mesh-ancestor
14319908|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
14319909|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
14319910|NCT00742573|Bupropion|bupropion|mesh-list
14319911|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14319912|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14319913|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14319914|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319915|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319916|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910365|NCT01356615|Heparin|heparin|mesh-list
14910366|NCT01356615|Calcium heparin|calcium heparin|mesh-list
14910367|NCT01356615|Enoxaparin|enoxaparin|mesh-list
14910368|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14910369|NCT01356615|Tinzaparin|tinzaparin|mesh-list
14910370|NCT01356615|Dalteparin|dalteparin|mesh-list
14910371|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
14910372|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
14910373|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14910374|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14910375|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910376|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14910377|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910378|NCT01356680|Prednisone|prednisone|mesh-list
14910379|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
14910380|NCT01356680|Dacarbazine|dacarbazine|mesh-list
14910381|NCT01356680|Etoposide|etoposide|mesh-list
14910382|NCT01356680|Vincristine|vincristine|mesh-list
14910383|NCT01356680|Doxorubicin|doxorubicin|mesh-list
14910384|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14910385|NCT01356680|Bleomycin|bleomycin|mesh-list
14910386|NCT01356680|Vinblastine|vinblastine|mesh-list
14910387|NCT01356680|Procarbazine|procarbazine|mesh-list
14724462|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724463|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
14724464|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724465|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724466|NCT00499018|Analgesics|analgesics|mesh-ancestor
14724467|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
14724468|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14319917|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14319918|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
14319919|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14319920|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14319921|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14319922|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319923|NCT00742625|Cytarabine|cytarabine|mesh-list
14319924|NCT00742625|Bortezomib|bortezomib|mesh-list
14319925|NCT00742625|Daunorubicin|daunorubicin|mesh-list
14319926|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14319927|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
14319928|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319929|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319930|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
14319931|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724469|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14910388|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14910389|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
14910390|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910391|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319932|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319933|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
14319934|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319935|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14319936|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14319937|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14319938|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319939|NCT00742781|Vitamin D|vitamin d|mesh-list
14319940|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
14319941|NCT00742781|Vitamins|vitamins|mesh-ancestor
14319942|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
14319943|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319944|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14319945|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14319946|NCT00742859|Warfarin|warfarin|mesh-list
14319947|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
14319948|NCT00742859|Betrixaban|betrixaban|mesh-list
14319949|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
14319950|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14319951|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
14319952|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14319953|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
14319954|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319955|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319956|NCT00742872|Mosapride|mosapride|mesh-list
14319957|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319958|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14319959|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14319960|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
14319961|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14319962|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319963|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
14319964|NCT00742924|Leucovorin|leucovorin|mesh-list
14319965|NCT00742924|Cisplatin|cisplatin|mesh-list
14319966|NCT00742924|Doxorubicin|doxorubicin|mesh-list
14319967|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14319968|NCT00742924|Methotrexate|methotrexate|mesh-list
14319969|NCT00742924|Etoposide|etoposide|mesh-list
14319970|NCT00742924|Ifosfamide|ifosfamide|mesh-list
14319971|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
14319972|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
14319973|NCT00742924|Razoxane|razoxane|mesh-list
14319974|NCT00742924|Imidazole|imidazole|mesh-list
14319975|NCT00742924|Lenograstim|lenograstim|mesh-list
14319976|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
14319977|NCT00742924|Mesna|mesna|mesh-list
14319978|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14319979|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14319980|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14319981|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14319982|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14319983|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14319984|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14319985|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14910392|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14910393|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
14917112|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14319986|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
14319987|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14319988|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14319989|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
14319990|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14319991|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14319992|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14319993|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
14319994|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14319995|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14319996|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14319997|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14319998|NCT00742924|Antidotes|antidotes|mesh-ancestor
14319999|NCT00742924|Protective Agents|protective agents|mesh-ancestor
14320000|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
14320001|NCT00742924|Vitamins|vitamins|mesh-ancestor
14320002|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
14320003|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14320004|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
14724470|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14320005|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14320006|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14320007|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
14320008|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
14320009|NCT00743093|Acetaminophen|acetaminophen|mesh-list
14320010|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14320011|NCT00743093|Analgesics|analgesics|mesh-ancestor
14320012|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
14320013|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320014|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320015|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
14320016|NCT00743106|Fenoldopam|fenoldopam|mesh-list
14320017|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14320018|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14320019|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
14320020|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
14320021|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320022|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320023|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320024|NCT00743119|Dronabinol|dronabinol|mesh-list
14320025|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
14320026|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320027|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320028|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14320029|NCT00743119|Analgesics|analgesics|mesh-ancestor
14320030|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
14320031|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320032|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14320033|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14320034|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320035|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320036|NCT00743119|Hormones|hormones|mesh-ancestor
14320037|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320038|NCT00743145|Naltrexone|naltrexone|mesh-list
14320039|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14320040|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14320041|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320042|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
14320043|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320044|NCT00743288|Melphalan|melphalan|mesh-list
14320045|NCT00743288|Panobinostat|panobinostat|mesh-list
14320046|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14320047|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
14320048|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320049|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320050|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14320051|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14320052|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
14320053|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320054|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14320055|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320056|NCT00743340|Emtricitabine|emtricitabine|mesh-list
14320057|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
14320058|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320059|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14320060|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14320061|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320062|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320063|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14320064|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14320065|NCT00743366|Riboflavin|riboflavin|mesh-list
14320066|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14320067|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
14320068|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320069|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14320070|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320071|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320072|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320073|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
14320074|NCT00743366|Vitamins|vitamins|mesh-ancestor
14320075|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
14320076|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14320077|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
14320078|NCT00743431|Doxorubicin|doxorubicin|mesh-list
14320079|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14320080|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320081|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14320082|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14320083|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320084|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320085|NCT00743444|Lesogaberan|lesogaberan|mesh-list
14320086|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320087|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14320088|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
14320089|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
14320090|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320091|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320092|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320093|NCT00743509|Sirolimus|sirolimus|mesh-list
14320094|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
14320095|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14320096|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
14320097|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320098|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320099|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14320100|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
14320101|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320102|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320103|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14320104|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14320105|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320106|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14320107|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
14320108|NCT00743574|Vitamin D|vitamin d|mesh-list
15222593|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15222594|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222595|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222596|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
15222597|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320109|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
14320110|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
14320111|NCT00743574|Vitamins|vitamins|mesh-list
14320112|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14320113|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
14320114|NCT00743574|Calcium|calcium|mesh-list
14320115|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
14320116|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320117|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14320118|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14320119|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14320120|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14320121|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14320122|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
14320123|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15222598|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15222599|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
15222600|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320124|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14320125|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14320126|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14320127|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14320128|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320129|NCT00743652|Vaccines|vaccines|mesh-list
14320130|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14320131|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
14320132|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320133|NCT00743717|Cobalt|cobalt|mesh-list
15222601|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15222602|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15222603|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222604|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
15222605|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222606|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320134|NCT00743717|Trace Elements|trace elements|mesh-ancestor
14320135|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
14320136|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320137|NCT00743730|Morphine|morphine|mesh-list
14320138|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14320139|NCT00743730|Narcotics|narcotics|mesh-ancestor
14320140|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320141|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320142|NCT00743730|Analgesics|analgesics|mesh-ancestor
14320143|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
14320144|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320145|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
14320146|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
14320147|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320148|NCT00744055|Prazosin|prazosin|mesh-list
14320149|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14320150|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14320151|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14320152|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14320153|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
14320154|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320155|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320156|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320157|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
14320158|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14320159|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320160|NCT00744237|Metoprolol|metoprolol|mesh-list
14320161|NCT00744237|Nebivolol|nebivolol|mesh-list
14320162|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14320163|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14320164|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
14320165|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
14320166|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320167|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320168|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14320169|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14320170|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14320171|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
14320172|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320173|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320174|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
14320175|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14320176|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14320177|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14320178|NCT00744263|Vaccines|vaccines|mesh-list
14320179|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14320180|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
14320181|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320182|NCT00744328|Sertraline|sertraline|mesh-list
14320183|NCT00744328|Estradiol|estradiol|mesh-list
14320184|NCT00744328|Estrogens|estrogens|mesh-ancestor
14320185|NCT00744328|Hormones|hormones|mesh-ancestor
14320186|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320187|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320188|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
14320189|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320190|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14320191|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14724471|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320192|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14320193|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320194|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320195|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
14320196|NCT00744380|Midazolam|midazolam|mesh-list
14320197|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
14320198|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14320199|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320200|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320201|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14320202|NCT00744380|Analgesics|analgesics|mesh-ancestor
14320203|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
14320204|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320205|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14320206|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14320207|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14320208|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
14320209|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320210|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320211|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14320212|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14320213|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320214|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320215|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14320216|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
14320217|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
14320218|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
14320219|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
14320220|NCT00744471|Tanezumab|tanezumab|mesh-list
14320221|NCT00744471|Analgesics|analgesics|mesh-ancestor
14320222|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
14320223|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320224|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320225|NCT00744497|Prednisone|prednisone|mesh-list
14320226|NCT00744497|Docetaxel|docetaxel|mesh-list
14320227|NCT00744497|Dasatinib|dasatinib|mesh-list
14320228|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320229|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
14320230|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
14320231|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
14320232|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320233|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320234|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
14320235|NCT00744497|Hormones|hormones|mesh-ancestor
14320236|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320237|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320238|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14320239|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14320240|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320241|NCT00744627|Vortioxetine|vortioxetine|mesh-list
14320242|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
14320243|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320244|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14320245|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320246|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320247|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320248|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14320249|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14320250|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14320251|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320252|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320253|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
14320254|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14320255|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14320256|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14320257|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14320258|NCT00744653|Bleomycin|bleomycin|mesh-list
14320259|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14320260|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320261|NCT00744692|Fludarabine|fludarabine|mesh-list
14320262|NCT00744692|Melphalan|melphalan|mesh-list
14320263|NCT00744692|Thiotepa|thiotepa|mesh-list
14320264|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
14320265|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320266|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320267|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14320268|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
14320269|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320270|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14320271|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
14320272|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14320273|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
14320274|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320275|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14320276|NCT00744757|Decitabine|decitabine|mesh-list
14320277|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14320278|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
14320279|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320280|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320281|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320282|NCT00744848|Epinephrine|epinephrine|mesh-list
14320283|NCT00744848|Bupivacaine|bupivacaine|mesh-list
14320284|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
14320285|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
14320286|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320287|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320288|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
14320289|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320290|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14320291|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14320292|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
14320293|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320294|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320295|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14320296|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14320297|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
14320298|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14320299|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
14320300|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
14320301|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
14320302|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14320303|NCT00744965|Glyburide|glyburide|mesh-list
14320304|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14320305|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320306|NCT00744978|Varenicline|varenicline|mesh-list
14320307|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14320308|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14320309|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
14320310|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320311|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724472|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14724473|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
14724474|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14724475|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14724476|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14320312|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320313|NCT00745095|Neostigmine|neostigmine|mesh-list
14320314|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14320315|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320316|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320317|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
14320318|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320319|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320320|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14320321|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
14320322|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320323|NCT00745290|Bupivacaine|bupivacaine|mesh-list
14320324|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
14320325|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
14320326|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320327|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320328|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
14320329|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320330|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
14320331|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14320332|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14320333|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
14320334|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320335|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14320336|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14320337|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320338|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320339|NCT00745498|Bevacizumab|bevacizumab|mesh-list
14320340|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14320341|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320342|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14320343|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14320344|NCT00745498|Growth Substances|growth substances|mesh-ancestor
14724477|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14724478|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14320345|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320346|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
14320347|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
14320348|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14320349|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14320350|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14320351|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
14320352|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320353|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14320354|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14320355|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320356|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320357|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14320358|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14724479|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14724480|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14724481|NCT00499135|Alovudine|alovudine|mesh-list
14724482|NCT00499135|Sunitinib|sunitinib|mesh-list
14724483|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724484|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14724485|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14320359|NCT00745849|Esomeprazole|esomeprazole|mesh-list
14320360|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14320361|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320362|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14320363|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320364|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328256|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14328257|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328258|NCT00807846|Analgesics|analgesics|mesh-ancestor
14328259|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
14328260|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328261|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328262|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328263|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328264|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14328265|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14328266|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328267|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328268|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
14328269|NCT00807937|Lorazepam|lorazepam|mesh-list
14328270|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
14328271|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
14328272|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
14328273|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328274|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328275|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14328276|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14328277|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328278|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14328279|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14328280|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14328281|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
14328282|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
14328283|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328284|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724486|NCT00499135|Growth Substances|growth substances|mesh-ancestor
14320365|NCT00745875|Pemetrexed|pemetrexed|mesh-list
14320366|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320367|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320368|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320369|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14320370|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14320371|NCT00745901|Drospirenone|drospirenone|mesh-list
14320372|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14320373|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14320374|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14320375|NCT00745901|Norgestimate|norgestimate|mesh-list
14320376|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14320377|NCT00745901|Estradiol|estradiol|mesh-list
14320378|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14320379|NCT00745901|Estrogens|estrogens|mesh-ancestor
14320380|NCT00745901|Hormones|hormones|mesh-ancestor
14320381|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320382|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320383|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14320384|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
14320385|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14320386|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14320387|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14320388|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14320389|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15222607|NCT05188768|Mitogens|mitogens|mesh-list
15222608|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222609|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222610|NCT05188742|Mirabegron|mirabegron|mesh-list
15222611|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15222612|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15222613|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15222614|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
15222615|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222616|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320390|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
14320391|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14320392|NCT00745901|Diuretics|diuretics|mesh-ancestor
14320393|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
14320394|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14320395|NCT00746252|Risperidone|risperidone|mesh-list
14320396|NCT00746252|Aripiprazole|aripiprazole|mesh-list
14320397|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14320398|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
14320399|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320400|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320401|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320402|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14320403|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320404|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320405|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320406|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14320407|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
14320408|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
14320409|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
14320410|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14320411|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14320412|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14320413|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14320414|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
14320415|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
14320416|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14320417|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
14724487|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724488|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
14724489|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15222617|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320418|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320419|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320420|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14320421|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
14320422|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14320423|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14320424|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14320425|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
14320426|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320427|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320428|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320429|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
14320430|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14320431|NCT00746395|Lubiprostone|lubiprostone|mesh-list
14320432|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14320433|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14320434|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320435|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14320436|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
14910394|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910395|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910396|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14910397|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910398|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
14910399|NCT01356680|Hormones|hormones|mesh-ancestor
14917113|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320437|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320438|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14320439|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320440|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320441|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320442|NCT00746512|Prednisone|prednisone|mesh-list
14320443|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320444|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
14320445|NCT00746512|Hormones|hormones|mesh-ancestor
14320446|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320447|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320448|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14320449|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320450|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14320451|NCT00746551|Hematinics|hematinics|mesh-ancestor
14320452|NCT00746733|Amphetamine|amphetamine|mesh-list
14320453|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14320454|NCT00746733|Adderall|adderall|mesh-list
14320455|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14320456|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320457|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
14320458|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
14320459|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320460|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
14320461|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320462|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320463|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
14320464|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14320465|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14320466|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14320467|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14320468|NCT00746785|Olanzapine|olanzapine|mesh-list
14320469|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
14320470|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
14320471|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320472|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320473|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320474|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14320475|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320476|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320477|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320478|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14320479|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14320480|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14320481|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320482|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320483|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
14320484|NCT00746798|Vaccines|vaccines|mesh-list
14320485|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
14320486|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320487|NCT00746863|Bupivacaine|bupivacaine|mesh-list
14320488|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
14320489|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
14320490|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320491|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320492|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
14320493|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320494|NCT00746889|Triamcinolone|triamcinolone|mesh-list
14320495|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14320496|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14320497|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14320498|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320499|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
14320500|NCT00746889|Hormones|hormones|mesh-ancestor
14320501|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320502|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320503|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14320504|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
14320505|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320506|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320507|NCT00746941|Mefloquine|mefloquine|mesh-list
14320508|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
14320509|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14320510|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14320511|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320512|NCT00746954|Acetazolamide|acetazolamide|mesh-list
14320513|NCT00746954|Buspirone|buspirone|mesh-list
14320514|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
14320515|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14320516|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320517|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320518|NCT00746954|Diuretics|diuretics|mesh-ancestor
14320519|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
14320520|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222618|NCT05188742|Urological Agents|urological agents|mesh-ancestor
15222619|NCT05188495|Trastuzumab|trastuzumab|mesh-list
15222620|NCT05188495|Pertuzumab|pertuzumab|mesh-list
15222621|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724490|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724491|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320521|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14320522|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320523|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320524|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320525|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14320526|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
14320527|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320528|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
14320529|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14320530|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320531|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14320532|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14320533|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14320534|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
14320535|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320536|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14320537|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14320538|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320539|NCT00747214|Prednisolone|prednisolone|mesh-list
14320540|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
14320541|NCT00747214|Dipyridamole|dipyridamole|mesh-list
14320542|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14724492|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
14320543|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
14320544|NCT00747214|Hormones|hormones|mesh-ancestor
14328285|NCT00807989|Lamotrigine|lamotrigine|mesh-list
14328286|NCT00807989|Carbamazepine|carbamazepine|mesh-list
15222622|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225592|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225593|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14320545|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320546|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320547|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14320548|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320549|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14320550|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320551|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320552|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14320553|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
14320554|NCT00747344|Ustekinumab|ustekinumab|mesh-list
14320555|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
14320556|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14320557|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14320558|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320559|NCT00747643|Varenicline|varenicline|mesh-list
14320560|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14724493|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724494|NCT00499265|Gemcitabine|gemcitabine|mesh-list
14724495|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
14724496|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
14724497|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724498|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
14724499|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724500|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724501|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
14724502|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724503|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724504|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724505|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
14724506|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724507|NCT00499291|Paclitaxel|paclitaxel|mesh-list
14724508|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14724509|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14724510|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724511|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14724512|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14724513|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14320561|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14724514|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724515|NCT00499525|Paclitaxel|paclitaxel|mesh-list
15225594|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15225595|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
15225596|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225597|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15225598|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225599|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225600|NCT04285086|Anagrelide|anagrelide|mesh-list
15225601|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15225602|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15225603|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225604|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15225605|NCT04249167|Paclitaxel|paclitaxel|mesh-list
15225606|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15225607|NCT04249167|Atezolizumab|atezolizumab|mesh-list
14724516|NCT00499525|Sorafenib|sorafenib|mesh-list
14724517|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14724518|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320562|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
14320563|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320564|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320565|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320566|NCT00748072|Vasopressins|vasopressins|mesh-list
14320567|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
14320568|NCT00748072|Coagulants|coagulants|mesh-ancestor
14320569|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14320570|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14320571|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
14320572|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320573|NCT00748098|Gabapentin|gabapentin|mesh-list
14320574|NCT00748098|Analgesics|analgesics|mesh-ancestor
14320575|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
14320576|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320577|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320578|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
14320579|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14320580|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320581|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320582|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320583|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14320584|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14320585|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320586|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320587|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
14320588|NCT00748189|Ofatumumab|ofatumumab|mesh-list
14320589|NCT00748189|Chlorambucil|chlorambucil|mesh-list
14320590|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320591|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14320592|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
14320593|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320594|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
14320595|NCT00748215|Loperamide|loperamide|mesh-list
14724519|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
14724520|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
14724521|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
14724522|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724523|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14724524|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724525|NCT00499577|Vaccines|vaccines|mesh-list
14724526|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14724527|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
14724528|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724529|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
14724530|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724531|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724532|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14724533|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14724534|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724535|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724536|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724537|NCT00499668|Ondansetron|ondansetron|mesh-list
14724538|NCT00499668|Aprepitant|aprepitant|mesh-list
14724539|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
14724540|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
15222623|NCT05188339|Citric Acid|citric acid|mesh-list
15222624|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
15222625|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
15222626|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15222627|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
14724541|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724542|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724543|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14724544|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
15222628|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
15222629|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222630|NCT05188313|Paclitaxel|paclitaxel|mesh-list
15222631|NCT05188313|Carboplatin|carboplatin|mesh-list
15222632|NCT05188313|Trastuzumab|trastuzumab|mesh-list
14320596|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
14724545|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
14724546|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15222633|NCT05188313|Pertuzumab|pertuzumab|mesh-list
15222634|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14724547|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
14724548|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724549|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724550|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14320597|NCT00748215|Calcium|calcium|mesh-list
14320598|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14320599|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320600|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320601|NCT00748553|Paclitaxel|paclitaxel|mesh-list
14320602|NCT00748553|Azacitidine|azacitidine|mesh-list
14320603|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14320604|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14320605|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320606|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
14320607|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
14320608|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
14320609|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320610|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14320611|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
14320612|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320613|NCT00748566|Ziprasidone|ziprasidone|mesh-list
14320614|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14320615|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
14320616|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910400|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910401|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222635|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320617|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320618|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320619|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14320620|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320621|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320622|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320623|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14320624|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
14320625|NCT00748657|Bevacizumab|bevacizumab|mesh-list
14320626|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14320627|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
14320628|NCT00748657|Antibodies|antibodies|mesh-list
14320629|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
14724551|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14724552|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724553|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724554|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14724555|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14724556|NCT00499707|Metformin|metformin|mesh-list
14724557|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
15222636|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
14320630|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14320631|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
14320632|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320633|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14320634|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14320635|NCT00748657|Growth Substances|growth substances|mesh-ancestor
14320636|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320637|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222637|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222638|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222639|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222640|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222641|NCT05188131|Diclofenac|diclofenac|mesh-list
15222642|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15222643|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15222644|NCT05188131|Analgesics|analgesics|mesh-ancestor
15222645|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
15222646|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222647|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222648|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15222649|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320638|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
14320639|NCT00748709|Afatinib|afatinib|mesh-list
14320640|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320641|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14320642|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328287|NCT00807989|Valproic Acid|valproic acid|mesh-list
14320643|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320644|NCT00748826|Infliximab|infliximab|mesh-list
14320645|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
14320646|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320647|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320648|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14320649|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
14320650|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14320651|NCT00749125|Citalopram|citalopram|mesh-list
14320652|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14320653|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14320654|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14320655|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320656|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320657|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
14320658|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320659|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14320660|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
14320661|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320662|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14320663|NCT00749190|Empagliflozin|empagliflozin|mesh-list
14320664|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14320665|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320666|NCT00749190|Incretins|incretins|mesh-ancestor
14320667|NCT00749190|Hormones|hormones|mesh-ancestor
14320668|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320669|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14320670|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
14320671|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320672|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320673|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14320674|NCT00749203|Midazolam|midazolam|mesh-list
14320675|NCT00749203|Ketamine|ketamine|mesh-list
14320676|NCT00749203|Analgesics|analgesics|mesh-ancestor
14320677|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
14320678|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320679|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320680|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14320681|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14320682|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
14320683|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
14320684|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320685|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14320686|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14320687|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320688|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320689|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14320690|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14320691|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14320692|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320693|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320694|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
14320695|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
14320696|NCT00749398|Infliximab|infliximab|mesh-list
14320697|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
14320698|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320699|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320700|NCT00749463|Nicotine|nicotine|mesh-list
14320701|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14320702|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
14320703|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320704|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320705|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14320706|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14320707|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
14320708|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320709|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320710|NCT00749515|Deferasirox|deferasirox|mesh-list
14724558|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724559|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724560|NCT00499720|Aztreonam|aztreonam|mesh-list
14724561|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14724562|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320711|NCT00749515|Deferoxamine|deferoxamine|mesh-list
14320712|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14320713|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
14320714|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
14320715|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320716|NCT00749515|Siderophores|siderophores|mesh-ancestor
14320717|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
14320718|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14320719|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14320720|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
14320721|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320722|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14320723|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14320724|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320725|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320726|NCT00749684|Interferons|interferons|mesh-list
14320727|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320728|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
14320729|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320730|NCT00749749|Bupivacaine|bupivacaine|mesh-list
14320731|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
14320732|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
14320733|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320734|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320735|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
14320736|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320737|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14320738|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320739|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14320740|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320741|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320742|NCT00749944|Varenicline|varenicline|mesh-list
14320743|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14320744|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14320745|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14320746|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320747|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320748|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320749|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
14320750|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
14320751|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320752|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320753|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320754|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
14320755|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320756|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320757|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320758|NCT00750308|Ramipril|ramipril|mesh-list
14320759|NCT00750308|Tadalafil|tadalafil|mesh-list
14320760|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
14320761|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14320762|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14320763|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320764|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320765|NCT00750308|Urological Agents|urological agents|mesh-ancestor
14320766|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14320767|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
14320768|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14320769|NCT00750737|Amphotericin B|amphotericin b|mesh-list
14320770|NCT00750737|Posaconazole|posaconazole|mesh-list
14320771|NCT00750737|Amebicides|amebicides|mesh-ancestor
14320772|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14320773|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14320774|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320775|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15222650|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15222651|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222652|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222653|NCT05188118|Nivolumab|nivolumab|mesh-list
15222654|NCT05188118|Ipilimumab|ipilimumab|mesh-list
15222655|NCT05188118|Everolimus|everolimus|mesh-list
15222656|NCT05188118|Lenvatinib|lenvatinib|mesh-list
15222657|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222658|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222659|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15222660|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222661|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222662|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
15222663|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222664|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15222665|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222666|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
15222667|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15222668|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222669|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
15222670|NCT05169424|Fluticasone|fluticasone|mesh-list
15222671|NCT05169424|Xhance|xhance|mesh-list
15222672|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
14320776|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
14320777|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14320778|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14320779|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14320780|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320781|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320782|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14320783|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
14320784|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320785|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320786|NCT00750815|Dexamethasone|dexamethasone|mesh-list
14320787|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
14320788|NCT00750815|Doxorubicin|doxorubicin|mesh-list
14320789|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14320790|NCT00750815|Bortezomib|bortezomib|mesh-list
14320791|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14320792|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
14320793|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320794|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320795|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14320796|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
14320797|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320798|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320799|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14320800|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320801|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
14320802|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
15222673|NCT05169424|Olodaterol|olodaterol|mesh-list
15222674|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320803|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320804|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320805|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
14320806|NCT00750815|Hormones|hormones|mesh-ancestor
14320807|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320808|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14320809|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14320810|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14320811|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14320812|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320813|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
14320814|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14320815|NCT00750867|Antibodies|antibodies|mesh-list
14320816|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
14320817|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14320818|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
14320819|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320820|NCT00750919|Mirtazapine|mirtazapine|mesh-list
14320821|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14320822|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14320823|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14320824|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
14320825|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
14320826|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320827|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320828|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320829|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14320830|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14320831|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14320832|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14320833|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14320834|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14320835|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14320836|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14320837|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14320838|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
14320839|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14320840|NCT00751023|Modafinil|modafinil|mesh-list
14320841|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14320842|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320843|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14320844|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14320845|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14320846|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320847|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
14320848|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320849|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14320850|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320851|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320852|NCT00751101|Nicotine|nicotine|mesh-list
14320853|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14320854|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
14320855|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320856|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320857|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14320858|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14320859|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
14320860|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14320861|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724563|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
14320862|NCT00751114|Metformin|metformin|mesh-list
14320863|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
14320864|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14320865|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14320866|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320867|NCT00751114|Incretins|incretins|mesh-ancestor
14320868|NCT00751114|Hormones|hormones|mesh-ancestor
14320869|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14320870|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14320871|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
14320872|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320873|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320874|NCT00751179|Bromides|bromides|mesh-list
14320875|NCT00751179|Rocuronium|rocuronium|mesh-list
14320876|NCT00751179|Succinylcholine|succinylcholine|mesh-list
14320877|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
14320878|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14320879|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14320880|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14320881|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320882|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320883|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14320884|NCT00751296|Lenalidomide|lenalidomide|mesh-list
14320885|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
14320886|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320887|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14320888|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14320889|NCT00751296|Growth Substances|growth substances|mesh-ancestor
14320890|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
14320891|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320892|NCT00751400|Naproxen|naproxen|mesh-list
14320893|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14320894|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14320895|NCT00751400|Analgesics|analgesics|mesh-ancestor
14320896|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
14320897|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320898|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320899|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320900|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320901|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
14320902|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14320903|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320904|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328288|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
14328289|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14328290|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328291|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328292|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14328293|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328294|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14328295|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14328296|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328297|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14328298|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14328299|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328300|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
14328301|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328302|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
14328303|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328304|NCT00807989|Analgesics|analgesics|mesh-ancestor
14328305|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
14328306|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328307|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14328308|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14328309|NCT00808015|Varenicline|varenicline|mesh-list
14328310|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14328311|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14320905|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
14320906|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14320907|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14320908|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
14320909|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910402|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14910403|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14910404|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14910405|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14910406|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
14910407|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
14320910|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14320911|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14320912|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320913|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320914|NCT00751777|Vaccines|vaccines|mesh-list
14320915|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
14320916|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320917|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14320918|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
14320919|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14320920|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
14320921|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15222675|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15222676|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
15222677|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222678|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910408|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
14320922|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320923|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14320924|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14320925|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14320926|NCT00751881|Teriflunomide|teriflunomide|mesh-list
14320927|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14320928|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14320929|NCT00751881|Analgesics|analgesics|mesh-ancestor
14320930|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
14320931|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14320932|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320933|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14320934|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320935|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14320936|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
14320937|NCT00752102|Calcitriol|calcitriol|mesh-list
14320938|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14320939|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320940|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14320941|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14320942|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320943|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14320944|NCT00752102|Vitamins|vitamins|mesh-ancestor
14320945|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
14320946|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14320947|NCT00752206|Saracatinib|saracatinib|mesh-list
14910409|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14910410|NCT01356732|Sufentanil|sufentanil|mesh-list
14910411|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14910412|NCT01356732|Narcotics|narcotics|mesh-ancestor
14910413|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910414|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910415|NCT01356732|Analgesics|analgesics|mesh-ancestor
14910416|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
14910417|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910418|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14910419|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14910420|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
15222679|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15222680|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
15222681|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
14320948|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222682|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14320949|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320950|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320951|NCT00752219|Metronidazole|metronidazole|mesh-list
14320952|NCT00752219|Meropenem|meropenem|mesh-list
14320953|NCT00752219|Ceftazidime|ceftazidime|mesh-list
14320954|NCT00752219|Avibactam|avibactam|mesh-list
14320955|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14320956|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14320957|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14320958|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14320959|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14320960|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320961|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320962|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
14320963|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14320964|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
15222683|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
15222684|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15222685|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
14724564|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724565|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
14724566|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320965|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320966|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
14320967|NCT00752557|Vitamin D|vitamin d|mesh-list
14320968|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
14320969|NCT00752557|Diphosphonates|diphosphonates|mesh-list
14320970|NCT00752557|Vitamins|vitamins|mesh-list
14320971|NCT00752557|Calcium|calcium|mesh-list
14320972|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
14320973|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14320974|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14320975|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14320976|NCT00752622|Infliximab|infliximab|mesh-list
14724567|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724568|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14724569|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
14724570|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724571|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724572|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14724573|NCT00499811|Vorinostat|vorinostat|mesh-list
14724574|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724575|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14724576|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724577|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724578|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14724579|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
14724580|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14724581|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14724582|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
15222686|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222687|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222688|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
15222689|NCT05165225|Docetaxel|docetaxel|mesh-list
15222690|NCT05165225|Epirubicin|epirubicin|mesh-list
15222691|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222692|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
15222693|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222694|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15222695|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15222696|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
15222697|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320977|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14320978|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14320979|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14320980|NCT00752726|Orlistat|orlistat|mesh-list
14320981|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320982|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320983|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14320984|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14320985|NCT00752856|Ritonavir|ritonavir|mesh-list
14320986|NCT00752856|Lopinavir|lopinavir|mesh-list
14320987|NCT00752856|Tenofovir|tenofovir|mesh-list
14320988|NCT00752856|Emtricitabine|emtricitabine|mesh-list
14320989|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
14320990|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14320991|NCT00752856|Efavirenz|efavirenz|mesh-list
14320992|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14320993|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14320994|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
14320995|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14320996|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14320997|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14320998|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14320999|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
14321000|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321001|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14321002|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14321003|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14321004|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14321005|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14321006|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14321007|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14321008|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14321009|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14321010|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14321011|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14321012|NCT00752973|Malathion|malathion|mesh-list
14321013|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14321014|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321015|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321016|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
14321017|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321018|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321019|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14321020|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14321021|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321022|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14321023|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14321024|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321025|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321026|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
14321027|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321028|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14321029|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14910421|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
14910422|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
14910423|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14910424|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
14910425|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
14910426|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910427|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321030|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14321031|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14321032|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
14321033|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321034|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
14321035|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321036|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14910428|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910429|NCT01356745|Analgesics|analgesics|mesh-ancestor
14321037|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14321038|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
14321039|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321040|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321041|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14321042|NCT00753337|Cobalt|cobalt|mesh-list
14321043|NCT00753337|Trace Elements|trace elements|mesh-ancestor
14321044|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
14321045|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321046|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
14321047|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321048|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
14321049|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321050|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321051|NCT00753506|Artemisinins|artemisinins|mesh-list
14321052|NCT00753506|Artemisinin|artemisinin|mesh-list
14321053|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
14321054|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14321055|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14321056|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321057|NCT00753636|Isradipine|isradipine|mesh-list
14321058|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14321059|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14321060|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321061|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321062|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14321063|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321064|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
14321065|NCT00753675|Gemcitabine|gemcitabine|mesh-list
14321066|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321067|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
14321068|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321069|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321070|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
14321071|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321072|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321073|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321074|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
14321075|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321076|NCT00753714|Gemcitabine|gemcitabine|mesh-list
14321077|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321078|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
14321079|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321080|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321081|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
14321082|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321083|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321084|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321085|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
14321086|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321087|NCT00753896|Exenatide|exenatide|mesh-list
14321088|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14321089|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321090|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14321091|NCT00753896|Incretins|incretins|mesh-ancestor
14321092|NCT00753896|Hormones|hormones|mesh-ancestor
14321093|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321094|NCT00753935|Aspirin|aspirin|mesh-list
14724583|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328312|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14321095|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14321096|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321097|NCT00753935|Analgesics|analgesics|mesh-ancestor
14321098|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
14321099|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321100|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321101|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321102|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724584|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724585|NCT00499850|Leucovorin|leucovorin|mesh-list
14724586|NCT00499850|Fluorouracil|fluorouracil|mesh-list
14724587|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
14724588|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
14724589|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724590|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321103|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14321104|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14321105|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321106|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14321107|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14321108|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321109|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
14321110|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
14321111|NCT00754065|Dienogest|dienogest|mesh-list
14321112|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14321113|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14321114|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14321115|NCT00754065|Estradiol|estradiol|mesh-list
14321116|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14321117|NCT00754065|Estrogens|estrogens|mesh-ancestor
14321118|NCT00754065|Hormones|hormones|mesh-ancestor
14321119|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321120|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321121|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14321122|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
14321123|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14321124|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14321125|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14321126|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14321127|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14321128|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
14321129|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14321130|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321131|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14321132|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14321133|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321134|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14321135|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14321136|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321137|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321138|NCT00754208|Methylphenidate|methylphenidate|mesh-list
14321139|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14321140|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321141|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14321142|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14321143|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321144|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321145|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
14321146|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321147|NCT00754247|Vitamin E|vitamin e|mesh-list
14321148|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
14321149|NCT00754247|Vitamins|vitamins|mesh-ancestor
14321150|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
14321151|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321152|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321153|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
14321154|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321155|NCT00754247|Protective Agents|protective agents|mesh-ancestor
14321156|NCT00754325|Dasatinib|dasatinib|mesh-list
14321157|NCT00754325|Fulvestrant|fulvestrant|mesh-list
14321158|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321159|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14321160|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321161|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321162|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14321163|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14321164|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14321165|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
14321166|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321167|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321168|NCT00754338|Dipivefrin|dipivefrin|mesh-list
14321169|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14321170|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
14321171|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321172|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321173|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321174|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
14321175|NCT00754390|Calcium|calcium|mesh-list
14321176|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14321177|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321178|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14321179|NCT00754442|Teriparatide|teriparatide|mesh-list
14321180|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14321181|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321182|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14321183|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15222698|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222699|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15222700|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222701|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
15222702|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222703|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15222704|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222705|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14321184|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321185|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14321186|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321187|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321188|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
14321189|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14321190|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
14321191|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321192|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321193|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14321194|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
14321195|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14321196|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14321197|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14321198|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
14321199|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321200|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321201|NCT00754572|Methotrexate|methotrexate|mesh-list
14321202|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14321203|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
14321204|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14321205|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321206|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321207|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
14321208|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321209|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321210|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14321211|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321212|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14321213|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321214|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
14321215|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321216|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14321217|NCT00754624|Insulin|insulin|mesh-list
14321218|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14321219|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321220|NCT00754650|Bevacizumab|bevacizumab|mesh-list
14321221|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14321222|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321223|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14321224|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14321225|NCT00754650|Growth Substances|growth substances|mesh-ancestor
14321226|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321227|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
14321228|NCT00754845|Letrozole|letrozole|mesh-list
14321229|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321230|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14321231|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14321232|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321233|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321234|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14321235|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
14321236|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321237|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321238|NCT00754923|Sorafenib|sorafenib|mesh-list
14321239|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321240|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14321241|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321242|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321243|NCT00754936|Citalopram|citalopram|mesh-list
14321244|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14321245|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14321246|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321247|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321248|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321249|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
14321250|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321251|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14321252|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
14321253|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321254|NCT00755040|Cyclosporine|cyclosporine|mesh-list
14321255|NCT00755040|Cyclosporins|cyclosporins|mesh-list
14321256|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321257|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321258|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321259|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
14321260|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321261|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
14321262|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321263|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
14321264|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321265|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14321266|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
14321267|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
14321268|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321269|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321270|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724591|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724592|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724593|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
14724594|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724595|NCT00499850|Antidotes|antidotes|mesh-ancestor
14724596|NCT00499850|Protective Agents|protective agents|mesh-ancestor
14724597|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
14724598|NCT00499850|Vitamins|vitamins|mesh-ancestor
14724599|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
14724600|NCT00499876|Mefloquine|mefloquine|mesh-list
14724601|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
14724602|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14724603|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14724604|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724605|NCT00499993|Lanreotide|lanreotide|mesh-list
14724606|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321271|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
14321272|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14321273|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14321274|NCT00755183|Testosterone|testosterone|mesh-list
14321275|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
14321276|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
14321277|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14321278|NCT00755183|Androgens|androgens|mesh-ancestor
14321279|NCT00755183|Hormones|hormones|mesh-ancestor
14321280|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321281|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321282|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14321283|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321284|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
14321285|NCT00755274|Vaccines|vaccines|mesh-list
14321286|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
14321287|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321288|NCT00755417|Gabapentin|gabapentin|mesh-list
14321289|NCT00755417|Analgesics|analgesics|mesh-ancestor
14321290|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
14321291|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321292|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321293|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
14321294|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14321295|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14321296|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321297|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321298|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14321299|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14321300|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321301|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321302|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
14321303|NCT00755716|Topiramate|topiramate|mesh-list
14321304|NCT00755716|Nicotine|nicotine|mesh-list
14321305|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14321306|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
14321307|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321308|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321309|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14321310|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14321311|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
14321312|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321313|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321314|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
14321315|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14321316|NCT00755755|Iron|iron|mesh-list
14321317|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
14724607|NCT00500006|Dasatinib|dasatinib|mesh-list
14321318|NCT00755755|Trace Elements|trace elements|mesh-ancestor
14321319|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
14724608|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724609|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14321320|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321321|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14321322|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
14321323|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14321324|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14321325|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14321326|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14321327|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14321328|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321329|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321330|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321331|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321332|NCT00755807|Analgesics|analgesics|mesh-ancestor
14321333|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
14321334|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321335|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
14321336|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321337|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
14321338|NCT00755846|Alogliptin|alogliptin|mesh-list
14321339|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14321340|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321341|NCT00755846|Incretins|incretins|mesh-ancestor
14321342|NCT00755846|Hormones|hormones|mesh-ancestor
14321343|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321344|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14321345|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
14321346|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321347|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321348|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14321349|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
14321350|NCT00755911|Coagulants|coagulants|mesh-ancestor
14321351|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14321352|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
14321353|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14321354|NCT00756106|Temozolomide|temozolomide|mesh-list
14321355|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14321356|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
14724610|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724611|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724612|NCT00500058|Rituximab|rituximab|mesh-list
14724613|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222706|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321357|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321358|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321359|NCT00756236|Metoprolol|metoprolol|mesh-list
14321360|NCT00756236|Esmolol|esmolol|mesh-list
14321361|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14321362|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14321363|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
14321364|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
14321365|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321366|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321367|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14321368|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14321369|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14321370|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
14321371|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321372|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321373|NCT00756275|Nicotine|nicotine|mesh-list
14321374|NCT00756275|Varenicline|varenicline|mesh-list
14321375|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14321376|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
15222707|NCT05162222|Itraconazole|itraconazole|mesh-list
15222708|NCT05162222|Diltiazem|diltiazem|mesh-list
15222709|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
15222710|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222711|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15222712|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15222713|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222714|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222715|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15222716|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
15222717|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321377|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321378|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321379|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14321380|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14321381|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
14321382|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321383|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321384|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
14321385|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14321386|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321387|NCT00756444|Panitumumab|panitumumab|mesh-list
14321388|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321389|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14321390|NCT00756470|Paclitaxel|paclitaxel|mesh-list
14321391|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
14321392|NCT00756470|Fluorouracil|fluorouracil|mesh-list
14321393|NCT00756470|Epirubicin|epirubicin|mesh-list
14321394|NCT00756470|Lapatinib|lapatinib|mesh-list
14321395|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14321396|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321397|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14321398|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14321399|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14321400|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321401|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321402|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
14321403|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321404|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321405|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14321406|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
14321407|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14724614|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724615|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
14724616|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724617|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724618|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14724619|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
14724620|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14724621|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14724622|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
14724623|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321408|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
14321409|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321410|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14321411|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14321412|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14724624|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321413|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321414|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14321415|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14321416|NCT00756548|Laxatives|laxatives|mesh-ancestor
14321417|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14321418|NCT00756600|Anesthetics|anesthetics|mesh-list
14321419|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321420|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328313|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328314|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328315|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328316|NCT00808028|Vaccines|vaccines|mesh-list
14328317|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
14328318|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328319|NCT00808067|Dabigatran|dabigatran|mesh-list
14328320|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
14328321|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14328322|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328323|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328324|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328325|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
14328326|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
14328327|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14328328|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
14328329|NCT00808132|Estrogens|estrogens|mesh-list
14328330|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14328331|NCT00808132|Hormones|hormones|mesh-ancestor
14328332|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328333|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328334|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14328335|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14328336|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14328337|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
14328338|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14328339|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14328340|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14328341|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14328342|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14328343|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328344|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14328345|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14328346|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
14328347|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14328348|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
14328349|NCT00808210|Methotrexate|methotrexate|mesh-list
14328350|NCT00808210|Infliximab|infliximab|mesh-list
14328351|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
14328352|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14328353|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
14328354|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14328355|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328356|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14328357|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
14328358|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328359|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328360|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
14328361|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328362|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14724625|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
14724626|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724627|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14724628|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724629|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724630|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
14724631|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
14724632|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14724633|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
14321421|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14321422|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
14321423|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14321424|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14321425|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14321426|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14321427|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
14321428|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321429|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321430|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14321431|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14321432|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
14321433|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321434|NCT00756886|Atorvastatin|atorvastatin|mesh-list
14321435|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14321436|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14321437|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
14321438|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321439|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14321440|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14321441|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321442|NCT00756964|Rasburicase|rasburicase|mesh-list
14321443|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
14321444|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321445|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14321446|NCT00756977|Laxatives|laxatives|mesh-ancestor
14321447|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14321448|NCT00757172|Docetaxel|docetaxel|mesh-list
14321449|NCT00757172|Panitumumab|panitumumab|mesh-list
14321450|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321451|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
14321452|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
14321453|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14724634|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724635|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724636|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14724637|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
14724638|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14724639|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
14724640|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321454|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321455|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14321456|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14321457|NCT00757237|Tobramycin|tobramycin|mesh-list
14321458|NCT00757237|Aztreonam|aztreonam|mesh-list
14321459|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14321460|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14321461|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321462|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
14321463|NCT00757588|Insulin|insulin|mesh-list
14321464|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14321465|NCT00757588|Saxagliptin|saxagliptin|mesh-list
14321466|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14321467|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321468|NCT00757588|Incretins|incretins|mesh-ancestor
14321469|NCT00757588|Hormones|hormones|mesh-ancestor
14910430|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
14910431|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724641|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910432|NCT01356758|Adalimumab|adalimumab|mesh-list
14321470|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321471|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14321472|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
14321473|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321474|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321475|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14321476|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14321477|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14321478|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321479|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321480|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321481|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14321482|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14321483|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
14321484|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321485|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321486|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14321487|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14321488|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
14321489|NCT00757783|Ritonavir|ritonavir|mesh-list
14321490|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14321491|NCT00757783|Darunavir|darunavir|mesh-list
14321492|NCT00757783|Tenofovir|tenofovir|mesh-list
14321493|NCT00757783|Emtricitabine|emtricitabine|mesh-list
14321494|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14321495|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14321496|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14321497|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321498|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321499|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14321500|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14321501|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
14321502|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321503|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14321504|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14321505|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14321506|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14321507|NCT00757822|Dronabinol|dronabinol|mesh-list
14321508|NCT00757822|Ondansetron|ondansetron|mesh-list
14321509|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
14321510|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
14321511|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321512|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321513|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14321514|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
14321515|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
14321516|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14321517|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
14321518|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321519|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321520|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14321521|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14321522|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321523|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321524|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14321525|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
14321526|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321527|NCT00757822|Analgesics|analgesics|mesh-ancestor
14321528|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
14321529|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14321530|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14321531|NCT00757822|Hormones|hormones|mesh-ancestor
14321532|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321533|NCT00758043|Ribavirin|ribavirin|mesh-list
14321534|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14321535|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
14321536|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321537|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
14321538|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321539|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14321540|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14321541|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321542|NCT00758069|Incretins|incretins|mesh-ancestor
14321543|NCT00758069|Hormones|hormones|mesh-ancestor
14321544|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321545|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14321546|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
14321547|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321548|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321549|NCT00758160|Methylphenidate|methylphenidate|mesh-list
14321550|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14321551|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321552|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14321553|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14321554|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321555|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321556|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
14321557|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321558|NCT00758264|Vaccines|vaccines|mesh-list
14321559|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14321560|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
14321561|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321562|NCT00758342|Travoprost|travoprost|mesh-list
14321563|NCT00758342|Brinzolamide|brinzolamide|mesh-list
14321564|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14321565|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14321566|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321567|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321568|NCT00758394|Listerine|listerine|mesh-list
14321569|NCT00758394|Triclosan|triclosan|mesh-list
14321570|NCT00758394|Fluorides|fluorides|mesh-list
14321571|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
14321572|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
14321573|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
14321574|NCT00758394|Protective Agents|protective agents|mesh-ancestor
14321575|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321576|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14724642|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14724643|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14724644|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
14724645|NCT00500253|Protective Agents|protective agents|mesh-ancestor
14724646|NCT00500253|Miotics|miotics|mesh-ancestor
14724647|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14724648|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14724649|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14724650|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14724651|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
14724652|NCT00500279|Celecoxib|celecoxib|mesh-list
14321577|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321578|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14321579|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14321580|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
14321581|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321582|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14321583|NCT00758420|Polidocanol|polidocanol|mesh-list
14321584|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14321585|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14321586|NCT00758498|Modafinil|modafinil|mesh-list
14321587|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14321588|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321589|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14321590|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14321591|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14321592|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321593|NCT00758524|Eplerenone|eplerenone|mesh-list
14321594|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14321595|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
14321596|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14321597|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321598|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14321599|NCT00758524|Diuretics|diuretics|mesh-ancestor
14321600|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
14724653|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14724654|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321601|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14321602|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
14321603|NCT00758602|Tacrolimus|tacrolimus|mesh-list
14321604|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321605|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
14321606|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321607|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14321608|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321609|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321610|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14321611|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321612|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14321613|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
14321614|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14321615|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321616|NCT00758667|Mesna|mesna|mesh-list
14321617|NCT00758667|Protective Agents|protective agents|mesh-ancestor
14321618|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321619|NCT00758784|Bromfenac|bromfenac|mesh-list
14321620|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14321621|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14321622|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14321623|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321624|NCT00758784|Analgesics|analgesics|mesh-ancestor
14321625|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
14321626|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321627|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321628|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321629|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321630|NCT00758836|Acetaminophen|acetaminophen|mesh-list
14321631|NCT00758836|Ibuprofen|ibuprofen|mesh-list
14321632|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14321633|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321634|NCT00758836|Analgesics|analgesics|mesh-ancestor
14321635|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
14321636|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321637|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321638|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321639|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321640|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14321641|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321642|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321643|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
14321644|NCT00759031|Listerine|listerine|mesh-list
14321645|NCT00759031|Triclosan|triclosan|mesh-list
14321646|NCT00759031|Fluorides|fluorides|mesh-list
14321647|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
14321648|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
14321649|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
14321650|NCT00759031|Protective Agents|protective agents|mesh-ancestor
14321651|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321652|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14321653|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321654|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14321655|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14321656|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
14321657|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321658|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14321659|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14321660|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
14321661|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321662|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
14321663|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14321664|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14321665|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14321666|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14321667|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14910433|NCT01356758|Etanercept|etanercept|mesh-list
14910434|NCT01356758|Infliximab|infliximab|mesh-list
15222718|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222719|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15222720|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15222721|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15225608|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14321668|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14910435|NCT01356758|Ustekinumab|ustekinumab|mesh-list
14917114|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321669|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14724655|NCT00500279|Analgesics|analgesics|mesh-ancestor
14724656|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
14724657|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724658|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724659|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321670|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321671|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321672|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321673|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14321674|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
14321675|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14321676|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321677|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14321678|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14321679|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14321680|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
14321681|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14321682|NCT00759187|Triclosan|triclosan|mesh-list
14321683|NCT00759187|Fluorides|fluorides|mesh-list
14321684|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
14321685|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
14321686|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
14321687|NCT00759187|Protective Agents|protective agents|mesh-ancestor
14321688|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321689|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14321690|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321691|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
14321692|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
14321693|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14321694|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14321695|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
14321696|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321697|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14321698|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
14321699|NCT00759330|Analgesics|analgesics|mesh-ancestor
14321700|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
14321701|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321702|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321703|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14321704|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321705|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321706|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321707|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14321708|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321709|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321710|NCT00759356|Morphine|morphine|mesh-list
14321711|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14321712|NCT00759356|Narcotics|narcotics|mesh-ancestor
14321713|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321714|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321715|NCT00759356|Analgesics|analgesics|mesh-ancestor
14321716|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
14321717|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321718|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14321719|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14321720|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14321721|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321722|NCT00759473|Cycloserine|cycloserine|mesh-list
14321723|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14321724|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321725|NCT00759473|Renal Agents|renal agents|mesh-ancestor
14321726|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14321727|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
14321728|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14321729|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
14321730|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321731|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
14321732|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321733|NCT00759564|Lactams|lactams|mesh-list
14321734|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14321735|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321736|NCT00759603|Rituximab|rituximab|mesh-list
14321737|NCT00759603|Lenalidomide|lenalidomide|mesh-list
14321738|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14321739|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321740|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
14321741|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321742|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321743|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14321744|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14321745|NCT00759603|Growth Substances|growth substances|mesh-ancestor
14321746|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
14321747|NCT00759642|Lapatinib|lapatinib|mesh-list
14321748|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321749|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14321750|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321751|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321752|NCT00759655|Factor VIII|factor viii|mesh-list
14321753|NCT00759655|Coagulants|coagulants|mesh-ancestor
14321754|NCT00759681|Thrombin|thrombin|mesh-list
14321755|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14321756|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
14321757|NCT00759681|Coagulants|coagulants|mesh-ancestor
14321758|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14321759|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321760|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321761|NCT00759759|Morphine|morphine|mesh-list
14321762|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14321763|NCT00759759|Narcotics|narcotics|mesh-ancestor
14724660|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321764|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321765|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321766|NCT00759759|Analgesics|analgesics|mesh-ancestor
14321767|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
14321768|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321769|NCT00759772|Teriparatide|teriparatide|mesh-list
14321770|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14321771|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321772|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14321773|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14321774|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
14321775|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321776|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
14321777|NCT00759798|Rituximab|rituximab|mesh-list
14321778|NCT00759798|Fludarabine|fludarabine|mesh-list
14321779|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321780|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
14321781|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321782|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321783|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14321784|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
14321785|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321786|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321787|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14321788|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14321789|NCT00759811|Methotrexate|methotrexate|mesh-list
14321790|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14321791|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
14321792|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14321793|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321794|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321795|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
14321796|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321797|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321798|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14321799|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321800|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14321801|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321802|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
14321803|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321804|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14321805|NCT00759902|Morphine|morphine|mesh-list
14321806|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14321807|NCT00759902|Narcotics|narcotics|mesh-ancestor
14321808|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321809|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321810|NCT00759902|Analgesics|analgesics|mesh-ancestor
14321811|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
14321812|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321813|NCT00759915|Morphine|morphine|mesh-list
14321814|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14321815|NCT00759915|Narcotics|narcotics|mesh-ancestor
14321816|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321817|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321818|NCT00759915|Analgesics|analgesics|mesh-ancestor
14321819|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
14321820|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321821|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14321822|NCT00759941|Latanoprost|latanoprost|mesh-list
15222722|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15222723|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15222724|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
15222725|NCT05160896|Bevacizumab|bevacizumab|mesh-list
15222726|NCT05160896|Cetuximab|cetuximab|mesh-list
15222727|NCT05160896|Irinotecan|irinotecan|mesh-list
15222728|NCT05160896|Raltitrexed|raltitrexed|mesh-list
15222729|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222730|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222731|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222732|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222733|NCT05160896|Growth Substances|growth substances|mesh-ancestor
15222734|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724661|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14321823|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14321824|NCT00759941|Brinzolamide|brinzolamide|mesh-list
14321825|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14321826|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321827|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321828|NCT00759954|Morphine|morphine|mesh-list
14321829|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14321830|NCT00759954|Narcotics|narcotics|mesh-ancestor
14321831|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321832|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321833|NCT00759954|Analgesics|analgesics|mesh-ancestor
14321834|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
14321835|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321836|NCT00760006|Ampicillin|ampicillin|mesh-list
14321837|NCT00760006|Sulbactam|sulbactam|mesh-list
14321838|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14321839|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14321840|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321841|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14321842|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321843|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321844|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14321845|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14321846|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321847|NCT00760019|Analgesics|analgesics|mesh-ancestor
14321848|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
14321849|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321850|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321851|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14321852|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321853|NCT00760084|Decitabine|decitabine|mesh-list
14321854|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321855|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
14321856|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321857|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321858|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321859|NCT00760214|Ramipril|ramipril|mesh-list
14321860|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14321861|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14321862|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
14321863|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321864|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321865|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14321866|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14321867|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14321868|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14321869|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14321870|NCT00760266|Diuretics|diuretics|mesh-ancestor
14321871|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
14321872|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321873|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14321874|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321875|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321876|NCT00760435|Infliximab|infliximab|mesh-list
14321877|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14321878|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14321879|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321880|NCT00760474|Pregabalin|pregabalin|mesh-list
14321881|NCT00760474|Analgesics|analgesics|mesh-ancestor
14321882|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
14321883|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321884|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321885|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
14321886|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14321887|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321888|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321889|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14321890|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14321891|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14321892|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321893|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321894|NCT00760578|Pioglitazone|pioglitazone|mesh-list
14321895|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14321896|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321897|NCT00760669|Methotrexate|methotrexate|mesh-list
14321898|NCT00760669|Infliximab|infliximab|mesh-list
14321899|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14321900|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
14321901|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14321902|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321903|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14321904|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
14321905|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321906|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321907|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
14321908|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321909|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14321910|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14321911|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
14321912|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14321913|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14321914|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14321915|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14321916|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14321917|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14321918|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14321919|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321920|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
14321921|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321922|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321923|NCT00760838|Azithromycin|azithromycin|mesh-list
14321924|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14321925|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14321926|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
14321927|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321928|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14321929|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321930|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321931|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14321932|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14321933|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14321934|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15222735|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222736|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15222737|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222738|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222739|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222740|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15222741|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
15222742|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15222743|NCT05152004|Amoxicillin|amoxicillin|mesh-list
15222744|NCT05152004|Metronidazole|metronidazole|mesh-list
15222745|NCT05152004|Clarithromycin|clarithromycin|mesh-list
15222746|NCT05152004|Rabeprazole|rabeprazole|mesh-list
15222747|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15222748|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222749|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15222750|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15222751|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15222752|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222753|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222754|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15222755|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14321935|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14321936|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321937|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
14321938|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321939|NCT00761085|Morphine|morphine|mesh-list
14321940|NCT00761085|Methadone|methadone|mesh-list
14321941|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14321942|NCT00761085|Narcotics|narcotics|mesh-ancestor
14321943|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321944|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321945|NCT00761085|Analgesics|analgesics|mesh-ancestor
14321946|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
14321947|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321948|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
14321949|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
14321950|NCT00761137|Tropicamide|tropicamide|mesh-list
14321951|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
14321952|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
14321953|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321954|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321955|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14321956|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14321957|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
14321958|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321959|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321960|NCT00761150|Acetaminophen|acetaminophen|mesh-list
14321961|NCT00761150|Hydrocodone|hydrocodone|mesh-list
14321962|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14321963|NCT00761150|Analgesics|analgesics|mesh-ancestor
14321964|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
14321965|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14321966|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321967|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
14321968|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14321969|NCT00761150|Narcotics|narcotics|mesh-ancestor
14321970|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321971|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
14321972|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
14321973|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14321974|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14321975|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14321976|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14321977|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321978|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14321979|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14321980|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14321981|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
14321982|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14321983|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14321984|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14321985|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14321986|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
14321987|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14724662|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14724663|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724664|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724665|NCT00500344|Ranibizumab|ranibizumab|mesh-list
14724666|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14724667|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14724668|NCT00500344|Growth Substances|growth substances|mesh-ancestor
14724669|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724670|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
14724671|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724672|NCT00500409|Vitamin D|vitamin d|mesh-list
14724673|NCT00500409|Vitamins|vitamins|mesh-ancestor
14724674|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
15222756|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15222757|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15222758|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15222759|NCT05124509|Vaccines|vaccines|mesh-list
15222760|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
14724675|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724676|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14724677|NCT00500422|Gemcitabine|gemcitabine|mesh-list
14321988|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
14321989|NCT00761202|Glycerol|glycerol|mesh-list
14321990|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14321991|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
14321992|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14321993|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
14321994|NCT00761202|Protective Agents|protective agents|mesh-ancestor
14321995|NCT00761202|Laxatives|laxatives|mesh-ancestor
14321996|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14321997|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14321998|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
14321999|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14322000|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328363|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328364|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
14328365|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328366|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14328367|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328368|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
14328369|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
14328370|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328371|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14328372|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
14328373|NCT00808210|Hormones|hormones|mesh-ancestor
14328374|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328375|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14328376|NCT00808210|Protective Agents|protective agents|mesh-ancestor
14328377|NCT00808405|Acyclovir|acyclovir|mesh-list
14910436|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14910437|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328378|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
14328379|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328380|NCT00808444|Vaccines|vaccines|mesh-list
14328381|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14328382|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
14724678|NCT00500422|Doxorubicin|doxorubicin|mesh-list
14724679|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14724680|NCT00500422|Bortezomib|bortezomib|mesh-list
14724681|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724682|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
14729223|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322001|NCT00761267|Fluconazole|fluconazole|mesh-list
14322002|NCT00761267|Anidulafungin|anidulafungin|mesh-list
14322003|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
14322004|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322005|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14322006|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14322007|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322008|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322009|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14322010|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
14322011|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322012|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322013|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14322014|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14322015|NCT00761280|Temozolomide|temozolomide|mesh-list
14322016|NCT00761280|Carmustine|carmustine|mesh-list
14322017|NCT00761280|Lomustine|lomustine|mesh-list
14322018|NCT00761280|Trabedersen|trabedersen|mesh-list
14322019|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14322020|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
14322021|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724683|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724684|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222761|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222762|NCT05076409|Fluconazole|fluconazole|mesh-list
14724685|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
14724686|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724687|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724688|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724689|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
14724690|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724691|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14724692|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222763|NCT05076409|BI 425809|bi 425809|mesh-list
15222764|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
15222765|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222766|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15222767|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15222768|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222769|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222770|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15222771|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
15222772|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222773|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222774|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15222775|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15222776|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
15222777|NCT05060068|Ketamine|ketamine|mesh-list
15222778|NCT05060068|Esketamine|esketamine|mesh-list
15222779|NCT05060068|Analgesics|analgesics|mesh-ancestor
15222780|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
15222781|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222782|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222783|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15222784|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15222785|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
15222786|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
15222787|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15222788|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15222789|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15222790|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222791|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222792|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
15222793|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15222794|NCT05038982|Abrocitinib|abrocitinib|mesh-list
15222795|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15222796|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222797|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222798|NCT05028062|Naltrexone|naltrexone|mesh-list
15222799|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15222800|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15222801|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222802|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
15222803|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222804|NCT05022342|Fulvestrant|fulvestrant|mesh-list
15222805|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222806|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222807|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15222808|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15222809|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
14322022|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322023|NCT00761306|Vortioxetine|vortioxetine|mesh-list
14322024|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
14322025|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14322026|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14322027|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14322028|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322029|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322030|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14322031|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14322032|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322033|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322034|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322035|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
14322036|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14322037|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14322038|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14322039|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14322040|NCT00761319|Travoprost|travoprost|mesh-list
14322041|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14322042|NCT00761319|Latanoprost|latanoprost|mesh-list
14322043|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14322044|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14322045|NCT00761345|Gemcitabine|gemcitabine|mesh-list
14322046|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14724693|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14729224|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
14729225|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
14729226|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14729227|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
14729228|NCT00522158|Atorvastatin|atorvastatin|mesh-list
14729229|NCT00522158|Simvastatin|simvastatin|mesh-list
14729230|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14729231|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14729232|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
14322047|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14322048|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
14322049|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322050|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322051|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
14322052|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322053|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322054|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322055|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
14322056|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322057|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14322058|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14322059|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
14322060|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322061|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14322062|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14322063|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322064|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322065|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322066|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14729233|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729234|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14729235|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14729236|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322067|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14322068|NCT00761514|Adalimumab|adalimumab|mesh-list
14322069|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322070|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322071|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14322072|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14322073|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14322074|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322075|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322076|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14322077|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14322078|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14322079|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
14322080|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322081|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322082|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14322083|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14322084|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
14322085|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
14322086|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14322087|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14322088|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14322089|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322090|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322091|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
14322092|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322093|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322094|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14322095|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322096|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14322097|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14322098|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14322099|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322100|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322101|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14322102|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14322103|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14322104|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
14322105|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322106|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322107|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14322108|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14322109|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
14322110|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14322111|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
14322112|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322113|NCT00761735|Ribavirin|ribavirin|mesh-list
14322114|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14322115|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
14322116|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322117|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
14322118|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322119|NCT00761774|Brivaracetam|brivaracetam|mesh-list
14322120|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
14322121|NCT00761891|Aspirin|aspirin|mesh-list
14322122|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14322123|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322124|NCT00761891|Analgesics|analgesics|mesh-ancestor
14322125|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
14322126|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322127|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322128|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322129|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322130|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14322131|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14322132|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322133|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14322134|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14322135|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322136|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
14322137|NCT00761930|Listerine|listerine|mesh-list
14322138|NCT00761930|Triclosan|triclosan|mesh-list
14322139|NCT00761930|Fluorides|fluorides|mesh-list
14322140|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
14322141|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322142|NCT00761930|Protective Agents|protective agents|mesh-ancestor
14322143|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322144|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322145|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322146|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322147|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322148|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
14322149|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322150|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322151|NCT00762034|Paclitaxel|paclitaxel|mesh-list
14322152|NCT00762034|Bevacizumab|bevacizumab|mesh-list
14322153|NCT00762034|Carboplatin|carboplatin|mesh-list
14322154|NCT00762034|Pemetrexed|pemetrexed|mesh-list
14322155|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14322156|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322157|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
14322158|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
14322159|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
14322160|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322161|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14322162|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14322163|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14322164|NCT00762034|Growth Substances|growth substances|mesh-ancestor
14322165|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322166|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
14322167|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322168|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14322169|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14322170|NCT00762073|Budesonide|budesonide|mesh-list
14322171|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322172|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14322173|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
14322174|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322175|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322176|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14322177|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
14322178|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
14322179|NCT00762073|Hormones|hormones|mesh-ancestor
14322180|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322181|NCT00762164|Simvastatin|simvastatin|mesh-list
14322182|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14322183|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14322184|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322185|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
14322186|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322187|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322188|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14322189|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322190|NCT00762177|Triclosan|triclosan|mesh-list
14322191|NCT00762177|Fluorides|fluorides|mesh-list
14322192|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
14322193|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322194|NCT00762177|Protective Agents|protective agents|mesh-ancestor
14322195|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322196|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322197|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322198|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322199|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322200|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
14322201|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322202|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322203|NCT00762229|Ezetimibe|ezetimibe|mesh-list
14322204|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14322205|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322206|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
14322207|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322208|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322209|NCT00762320|Ritonavir|ritonavir|mesh-list
14322210|NCT00762320|Lopinavir|lopinavir|mesh-list
14322211|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14322212|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14322213|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
14322214|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322215|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322216|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14322217|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14322218|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
14322219|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322220|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14322221|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14322222|NCT00762359|Lansoprazole|lansoprazole|mesh-list
14322223|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
14322224|NCT00762359|Gefarnate|gefarnate|mesh-list
14322225|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14322226|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14322227|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14322228|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322229|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322230|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
14322231|NCT00762372|Sevoflurane|sevoflurane|mesh-list
14322232|NCT00762372|Desflurane|desflurane|mesh-list
14322233|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14322234|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14322235|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
14322236|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
14322237|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322238|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322239|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322240|NCT00762372|Analgesics|analgesics|mesh-ancestor
14322241|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
14322242|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322243|NCT00762450|Triclosan|triclosan|mesh-list
14322244|NCT00762450|Fluorides|fluorides|mesh-list
14322245|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322246|NCT00762450|Protective Agents|protective agents|mesh-ancestor
14322247|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322248|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322249|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322250|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322251|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322252|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
14322253|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322254|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322255|NCT00762463|Celecoxib|celecoxib|mesh-list
14322256|NCT00762463|Diclofenac|diclofenac|mesh-list
14322257|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14322258|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322259|NCT00762463|Analgesics|analgesics|mesh-ancestor
14322260|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
14322261|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322262|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322263|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322264|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322265|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14322266|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14322267|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322268|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322269|NCT00762515|Triclosan|triclosan|mesh-list
14322270|NCT00762515|Fluorides|fluorides|mesh-list
14322271|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322272|NCT00762515|Protective Agents|protective agents|mesh-ancestor
14322273|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322274|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322275|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322276|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322277|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322278|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
14322279|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322280|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322281|NCT00762528|Triclosan|triclosan|mesh-list
14322282|NCT00762528|Fluorides|fluorides|mesh-list
14322283|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
14322284|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322285|NCT00762528|Protective Agents|protective agents|mesh-ancestor
14724694|NCT00500552|Perhexiline|perhexiline|mesh-list
14724695|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14724696|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14724697|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322286|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322287|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322288|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322289|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14724698|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14322290|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322291|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
14322292|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322293|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322294|NCT00762619|Triclosan|triclosan|mesh-list
14322295|NCT00762619|Fluorides|fluorides|mesh-list
14322296|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322297|NCT00762619|Protective Agents|protective agents|mesh-ancestor
14322298|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322299|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322300|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322301|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322302|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322303|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
14322304|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322305|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322306|NCT00762645|Travoprost|travoprost|mesh-list
14322307|NCT00762645|Pilocarpine|pilocarpine|mesh-list
14322308|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14322309|NCT00762645|Miotics|miotics|mesh-ancestor
14322310|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
14322311|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322312|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322313|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14322314|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14322315|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
14322316|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322317|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322318|NCT00762710|Prazosin|prazosin|mesh-list
14322319|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14322320|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14322321|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14322322|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14322323|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
14322324|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322325|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322326|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322327|NCT00762762|Triclosan|triclosan|mesh-list
14322328|NCT00762762|Fluorides|fluorides|mesh-list
14724699|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724700|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
14724701|NCT00500565|Bupivacaine|bupivacaine|mesh-list
14322329|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322330|NCT00762762|Protective Agents|protective agents|mesh-ancestor
14322331|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322332|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322333|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322334|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322335|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322336|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
14322337|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322338|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322339|NCT00762853|Triclosan|triclosan|mesh-list
14322340|NCT00762853|Fluorides|fluorides|mesh-list
14322341|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322342|NCT00762853|Protective Agents|protective agents|mesh-ancestor
14724702|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
14724703|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
14724704|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724705|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724706|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
14724707|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724708|NCT00500604|Valsartan|valsartan|mesh-list
14724709|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14724710|NCT00500604|Irbesartan|irbesartan|mesh-list
14724711|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14724712|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14724713|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14724714|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724715|NCT00500604|Diuretics|diuretics|mesh-ancestor
14724716|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
14724717|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724718|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14724719|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14724720|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
15222810|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222811|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222812|NCT05017545|Abatacept|abatacept|mesh-list
15222813|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15222814|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222815|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222816|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222817|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
15222818|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222819|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15222820|NCT05008575|Fludarabine|fludarabine|mesh-list
15222821|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
15222822|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222823|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222824|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222825|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
15222826|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222827|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15222828|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15222829|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
15222830|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15222831|NCT04988074|Cemiplimab|cemiplimab|mesh-list
15222832|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222833|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222834|NCT04984369|Cetuximab|cetuximab|mesh-list
15222835|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222836|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222837|NCT04971473|Hormones|hormones|mesh-list
15222838|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322343|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322344|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322345|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322346|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322347|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322348|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
14322349|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322350|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322351|NCT00762892|Tenofovir|tenofovir|mesh-list
14322352|NCT00762892|Emtricitabine|emtricitabine|mesh-list
14322353|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
14322354|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14322355|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14322356|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
14724721|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14724722|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724723|NCT00500721|Desipramine|desipramine|mesh-list
14724724|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14724725|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
14724726|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724727|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729237|NCT00522184|Etanercept|etanercept|mesh-list
14322357|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322358|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14322359|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14322360|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322361|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322362|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14322363|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14322364|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14322365|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14322366|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14322367|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14322368|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
14322369|NCT00763035|Dobutamine|dobutamine|mesh-list
14322370|NCT00763035|Regadenoson|regadenoson|mesh-list
14322371|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14322372|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
14322373|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
14322374|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322375|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322376|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14322377|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14322378|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14322379|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
14322380|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322381|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322382|NCT00763035|Protective Agents|protective agents|mesh-ancestor
14322383|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14322384|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14322385|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
14322386|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
14322387|NCT00763048|Triclosan|triclosan|mesh-list
14322388|NCT00763048|Fluorides|fluorides|mesh-list
14322389|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322390|NCT00763048|Protective Agents|protective agents|mesh-ancestor
14322391|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322392|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322393|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322394|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322395|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322396|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
14322397|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322398|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322399|NCT00763061|Timolol|timolol|mesh-list
14322400|NCT00763061|Travoprost|travoprost|mesh-list
14322401|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14322402|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14322403|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14322404|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14322405|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
14322406|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322407|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322408|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322409|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14322410|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14322411|NCT00763139|Pioglitazone|pioglitazone|mesh-list
14322412|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14322413|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322414|NCT00763256|Triclosan|triclosan|mesh-list
14322415|NCT00763256|Fluorides|fluorides|mesh-list
14322416|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322417|NCT00763256|Protective Agents|protective agents|mesh-ancestor
14322418|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322419|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322420|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322421|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322422|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322423|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
14322424|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322425|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322426|NCT00763269|Silicon|silicon|mesh-list
14322427|NCT00763269|Triclosan|triclosan|mesh-list
14322428|NCT00763269|Fluorides|fluorides|mesh-list
14322429|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
14322430|NCT00763269|Protective Agents|protective agents|mesh-ancestor
14322431|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322432|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322433|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322434|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322435|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322436|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
14322437|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322438|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322439|NCT00763269|Trace Elements|trace elements|mesh-ancestor
14724728|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724729|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14724730|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14724731|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14724732|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14322440|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
14322441|NCT00763321|Acetaminophen|acetaminophen|mesh-list
14322442|NCT00763321|Hydrocodone|hydrocodone|mesh-list
14322443|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322444|NCT00763321|Analgesics|analgesics|mesh-ancestor
14322445|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
14322446|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322447|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322448|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
14322449|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14322450|NCT00763321|Narcotics|narcotics|mesh-ancestor
14322451|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322452|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
14322453|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
14322454|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
14322455|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14322456|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
14322457|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322458|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
14322459|NCT00763360|Protective Agents|protective agents|mesh-ancestor
14322460|NCT00763412|Repaglinide|repaglinide|mesh-list
14322461|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14322462|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322463|NCT00763451|Metformin|metformin|mesh-list
14322464|NCT00763451|Lixisenatide|lixisenatide|mesh-list
14322465|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14322466|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322467|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
14322468|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14322469|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322470|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14322471|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
14322472|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14322473|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322474|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322475|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322476|NCT00763815|Metformin|metformin|mesh-list
14322477|NCT00763815|Pioglitazone|pioglitazone|mesh-list
14322478|NCT00763815|Lixisenatide|lixisenatide|mesh-list
14322479|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14322480|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724733|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724734|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724735|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
14724736|NCT00500864|Analgesics|analgesics|mesh-ancestor
14724737|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
14724738|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724739|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724740|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
14322481|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
14322482|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
14322483|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14724741|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322484|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14322485|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322486|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322487|NCT00763867|Urological Agents|urological agents|mesh-ancestor
14322488|NCT00763958|Buprenorphine|buprenorphine|mesh-list
14322489|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14322490|NCT00763958|Narcotics|narcotics|mesh-ancestor
15222839|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225609|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225610|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225611|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225612|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225613|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225614|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225615|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
15225616|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225617|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
15225618|NCT04245423|Narcotics|narcotics|mesh-ancestor
14322491|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322492|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322493|NCT00763958|Analgesics|analgesics|mesh-ancestor
14322494|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
14322495|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322496|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14322497|NCT00763971|Methylphenidate|methylphenidate|mesh-list
14322498|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14322499|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14322500|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322501|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14910438|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
15225619|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225620|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225621|NCT04245423|Analgesics|analgesics|mesh-ancestor
15225622|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
15225623|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225624|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
15225625|NCT04230265|Fludarabine|fludarabine|mesh-list
15225626|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222840|NCT04964284|Hormones|hormones|mesh-list
15222841|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322502|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14322503|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322504|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322505|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
14322506|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322507|NCT00764309|Dasatinib|dasatinib|mesh-list
14322508|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322509|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14322510|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322511|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222842|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222843|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
15222844|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14322512|NCT00764322|Tamoxifen|tamoxifen|mesh-list
14322513|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14322514|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
14322515|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322516|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322517|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14322518|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322519|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14322520|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14322521|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14322522|NCT00764361|Doxycycline|doxycycline|mesh-list
14322523|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14322524|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322525|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
14322526|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14322527|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14322528|NCT00764465|Ritonavir|ritonavir|mesh-list
14322529|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
14322530|NCT00764465|Maraviroc|maraviroc|mesh-list
14322531|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15222845|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15222846|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222847|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15222848|NCT04946396|Analgesics|analgesics|mesh-ancestor
15222849|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
15222850|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222851|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15222852|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15222853|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15222854|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
15222855|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322532|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14322533|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
14322534|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322535|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322536|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14322537|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14322538|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
14322539|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322540|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14322541|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14322542|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14322543|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14322544|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14322545|NCT00764517|Rituximab|rituximab|mesh-list
14322546|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14322547|NCT00764517|Vorinostat|vorinostat|mesh-list
14322548|NCT00764517|Cladribine|cladribine|mesh-list
14322549|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14322550|NCT00764517|Antibodies|antibodies|mesh-list
14322551|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
14322552|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14322553|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
14322554|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322555|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322556|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322557|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14322558|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322559|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322560|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322561|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14322562|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
14322563|NCT00764738|Ranibizumab|ranibizumab|mesh-list
14322564|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14322565|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14322566|NCT00764738|Growth Substances|growth substances|mesh-ancestor
14322567|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322568|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
14322569|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322570|NCT00764751|Calcipotriene|calcipotriene|mesh-list
14322571|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
14322572|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14322573|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14322574|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322575|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14322576|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14322577|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322578|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322579|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
14322580|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322581|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14322582|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14322583|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14322584|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
14322585|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14322586|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322587|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14322588|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14322589|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14322590|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14322591|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14322592|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14322593|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14322594|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14322595|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
14322596|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14322597|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14322598|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
15222856|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222857|NCT04933344|Daptomycin|daptomycin|mesh-list
15222858|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15222859|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222860|NCT04925193|Dexamethasone|dexamethasone|mesh-list
15222861|NCT04925193|Daratumumab|daratumumab|mesh-list
15222862|NCT04925193|Pomalidomide|pomalidomide|mesh-list
15222863|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15222864|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
15222865|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
15222866|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222867|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222868|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15222869|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
14322599|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322600|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14322601|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14322602|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322603|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322604|NCT00765063|Dalteparin|dalteparin|mesh-list
14322605|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
14322606|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14322607|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14322608|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322609|NCT00765102|Bortezomib|bortezomib|mesh-list
14322610|NCT00765102|Romidepsin|romidepsin|mesh-list
14322611|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322612|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14322613|NCT00765128|Ketorolac|ketorolac|mesh-list
14322614|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14322615|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322616|NCT00765128|Analgesics|analgesics|mesh-ancestor
14322617|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
14322618|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322619|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322620|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322621|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322622|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14322623|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322624|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322625|NCT00765206|Omeprazole|omeprazole|mesh-list
14322626|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14322627|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14322628|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14322629|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322630|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322631|NCT00765232|Ketorolac|ketorolac|mesh-list
14322632|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14322633|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322634|NCT00765232|Analgesics|analgesics|mesh-ancestor
14322635|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
14322636|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322637|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322638|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322639|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322640|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14322641|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322642|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322643|NCT00765245|Rituximab|rituximab|mesh-list
15222870|NCT04925193|Hormones|hormones|mesh-ancestor
15225627|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
14724742|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14724743|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
14724744|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14724745|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14724746|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724747|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14322644|NCT00765245|Lenalidomide|lenalidomide|mesh-list
14322645|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14322646|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322647|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
14322648|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322649|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322650|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14322651|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14322652|NCT00765245|Growth Substances|growth substances|mesh-ancestor
14322653|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
14328383|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328384|NCT00808470|Ascorbic Acid|ascorbic acid|mesh-list
14328385|NCT00808470|Beta Carotene|beta carotene|mesh-list
14328386|NCT00808470|Carotenoids|carotenoids|mesh-list
14328387|NCT00808470|Vitamins|vitamins|mesh-ancestor
14328388|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
14328389|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328390|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
14328391|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328392|NCT00808470|Protective Agents|protective agents|mesh-ancestor
14328393|NCT00808470|Provitamins|provitamins|mesh-ancestor
14328394|NCT00808509|Adalimumab|adalimumab|mesh-list
14328395|NCT00808509|Methotrexate|methotrexate|mesh-list
14328396|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14328397|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
14328398|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14328399|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328400|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14328401|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
14328402|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328403|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328404|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
14328405|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322654|NCT00765336|Minocycline|minocycline|mesh-list
14322655|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14322656|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322657|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
14322658|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14322659|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14322660|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14322661|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322662|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322663|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
14322664|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322665|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222871|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222872|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222873|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222874|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
15222875|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15222876|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15222877|NCT04925193|Growth Substances|growth substances|mesh-ancestor
14322666|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14322667|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322668|NCT00765648|Labetalol|labetalol|mesh-list
14322669|NCT00765648|Nicardipine|nicardipine|mesh-list
14322670|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14322671|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14322672|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
14322673|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322674|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322675|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322676|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14322677|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
14322678|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
14322679|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322680|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14322681|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14322682|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14322683|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322684|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14322685|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
14322686|NCT00765661|Tacrolimus|tacrolimus|mesh-list
14322687|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322688|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
14322689|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322690|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14322691|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322692|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322693|NCT00765674|Amlodipine|amlodipine|mesh-list
14322694|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14322695|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14322696|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14322697|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322698|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322699|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14322700|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322701|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
14322702|NCT00765674|Diuretics|diuretics|mesh-ancestor
14322703|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
14322704|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14322705|NCT00765726|Factor VIII|factor viii|mesh-list
14322706|NCT00765726|Coagulants|coagulants|mesh-ancestor
14322707|NCT00765817|Exenatide|exenatide|mesh-list
14322708|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14322709|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322710|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14322711|NCT00765817|Incretins|incretins|mesh-ancestor
14322712|NCT00765817|Hormones|hormones|mesh-ancestor
14322713|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322714|NCT00765856|Oxymorphone|oxymorphone|mesh-list
14322715|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14322716|NCT00765856|Narcotics|narcotics|mesh-ancestor
14322717|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322718|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322719|NCT00765856|Analgesics|analgesics|mesh-ancestor
14322720|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
14322721|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322722|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14322723|NCT00765882|Linaclotide|linaclotide|mesh-list
14322724|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14322725|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
14322726|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322727|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14322728|NCT00765895|Nortriptyline|nortriptyline|mesh-list
14322729|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14322730|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
14322731|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14322732|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14322733|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14322734|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322735|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322736|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
14322737|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322738|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322739|NCT00765947|Amlodipine|amlodipine|mesh-list
14322740|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14322741|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14322742|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14322743|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322744|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322745|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14322746|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222878|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
15222879|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
15222880|NCT04925180|Cyproterone|cyproterone|mesh-list
15222881|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
15222882|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
15222883|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222884|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222885|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222886|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15222887|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
15222888|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15222889|NCT04886531|Trastuzumab|trastuzumab|mesh-list
15222890|NCT04886531|Letrozole|letrozole|mesh-list
14322747|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
14322748|NCT00765947|Diuretics|diuretics|mesh-ancestor
14322749|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
14322750|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14322751|NCT00765999|Linaclotide|linaclotide|mesh-list
14322752|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14322753|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
14322754|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322755|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14322756|NCT00766038|Hormones|hormones|mesh-list
14322757|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322758|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322759|NCT00766116|Azacitidine|azacitidine|mesh-list
14322760|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
14322761|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14322762|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
14322763|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322764|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322765|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322766|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14322767|NCT00766142|Leucovorin|leucovorin|mesh-list
14322768|NCT00766142|Fluorouracil|fluorouracil|mesh-list
14322769|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
14322770|NCT00766142|Cetuximab|cetuximab|mesh-list
14322771|NCT00766142|Calcium|calcium|mesh-list
14322772|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
14322773|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14322774|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322775|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
14322776|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322777|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14322778|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322779|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322780|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
14322781|NCT00766142|Antidotes|antidotes|mesh-ancestor
14322782|NCT00766142|Protective Agents|protective agents|mesh-ancestor
14322783|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
14322784|NCT00766142|Vitamins|vitamins|mesh-ancestor
14322785|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
14322786|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14322787|NCT00766363|Rivastigmine|rivastigmine|mesh-list
14322788|NCT00766363|Donepezil|donepezil|mesh-list
14322789|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14322790|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322791|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322792|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
14322793|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322794|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322795|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
14322796|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14322797|NCT00766363|Protective Agents|protective agents|mesh-ancestor
14322798|NCT00766467|Modafinil|modafinil|mesh-list
14322799|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14322800|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322801|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14322802|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14322803|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14322804|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322805|NCT00766506|Fentanyl|fentanyl|mesh-list
14322806|NCT00766506|Morphine|morphine|mesh-list
14322807|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14322808|NCT00766506|Narcotics|narcotics|mesh-ancestor
14322809|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322810|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322811|NCT00766506|Analgesics|analgesics|mesh-ancestor
14322812|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
14322813|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322814|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14322815|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14322816|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
14322817|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
14322818|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14322819|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14322820|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322821|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322822|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14322823|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
14322824|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322825|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322826|NCT00766649|Sirolimus|sirolimus|mesh-list
14322827|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14322828|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322829|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14322830|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322831|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
14322832|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322833|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
14322834|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322835|NCT00766675|Acetaminophen|acetaminophen|mesh-list
14322836|NCT00766675|Tramadol|tramadol|mesh-list
14322837|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322838|NCT00766675|Analgesics|analgesics|mesh-ancestor
14322839|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
14322840|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322841|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322842|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
14322843|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14322844|NCT00766675|Narcotics|narcotics|mesh-ancestor
14322845|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322846|NCT00766753|Vaccines|vaccines|mesh-list
14322847|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
14322848|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322849|NCT00766831|Hydromorphone|hydromorphone|mesh-list
14322850|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14322851|NCT00766831|Narcotics|narcotics|mesh-ancestor
14322852|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322853|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322854|NCT00766831|Analgesics|analgesics|mesh-ancestor
14322855|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
14322856|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322857|NCT00767000|Metformin|metformin|mesh-list
14322858|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
14322859|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14322860|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322861|NCT00767039|Poractant alfa|poractant alfa|mesh-list
14322862|NCT00767039|Beractant|beractant|mesh-list
14322863|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14322864|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14322865|NCT00767325|Methotrexate|methotrexate|mesh-list
14322866|NCT00767325|Abatacept|abatacept|mesh-list
14322867|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14322868|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
14322869|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14322870|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322871|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14322872|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
14322873|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322874|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322875|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
14322876|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322877|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14322878|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322879|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
14322880|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322881|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14322882|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14322883|NCT00767364|Vaccines|vaccines|mesh-list
14322884|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
14322885|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322886|NCT00767507|Cangrelor|cangrelor|mesh-list
14322887|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14322888|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14322889|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14322890|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14322891|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
14322892|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322893|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322894|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322895|NCT00767520|Dasatinib|dasatinib|mesh-list
14322896|NCT00767520|Exemestane|exemestane|mesh-list
14322897|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322898|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14322899|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322900|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322901|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14322902|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14322903|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14322904|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
14322905|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14322906|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322907|NCT00767572|Atorvastatin|atorvastatin|mesh-list
14322908|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14322909|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322910|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
14322911|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322912|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322913|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14322914|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322915|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
14322916|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14322917|NCT00767767|Thiopental|thiopental|mesh-list
14322918|NCT00767767|Propofol|propofol|mesh-list
14322919|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14322920|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14322921|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322922|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14322923|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
14322924|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
14322925|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
14322926|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
14322927|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
14322928|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322929|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322930|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14322931|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14322932|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14322933|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14322934|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322935|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14322936|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322937|NCT00767806|Analgesics|analgesics|mesh-ancestor
14322938|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
14322939|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322940|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
14322941|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14322942|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
14322943|NCT00767819|Everolimus|everolimus|mesh-list
14322944|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322945|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322946|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
14322947|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322948|NCT00768053|Etanercept|etanercept|mesh-list
14322949|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14322950|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322951|NCT00768053|Analgesics|analgesics|mesh-ancestor
14322952|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
14322953|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322954|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322955|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322956|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322957|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14322958|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14322959|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
14322960|NCT00768079|Benralizumab|benralizumab|mesh-list
15222891|NCT04886531|Anastrozole|anastrozole|mesh-list
15222892|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222893|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322961|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14322962|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
14322963|NCT00768118|Curcumin|curcumin|mesh-list
14322964|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14322965|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14322966|NCT00768118|Analgesics|analgesics|mesh-ancestor
14322967|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
14322968|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14322969|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322970|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14322971|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14322972|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322973|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322974|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322975|NCT00768144|Sunitinib|sunitinib|mesh-list
14322976|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14322977|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14322978|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14322979|NCT00768144|Growth Substances|growth substances|mesh-ancestor
14322980|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14322981|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
14322982|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14322983|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322984|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322985|NCT00768222|Triclosan|triclosan|mesh-list
14322986|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14322987|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14322988|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14322989|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14322990|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
14322991|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322992|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14322993|NCT00768261|Memantine|memantine|mesh-list
14322994|NCT00768261|Donepezil|donepezil|mesh-list
14322995|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14322996|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14322997|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14322998|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
14322999|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323000|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323001|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
14323002|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14323003|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14323004|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
15222894|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15222895|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15222896|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222897|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222898|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15222899|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
15222900|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222901|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222902|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222903|NCT04786067|Abatacept|abatacept|mesh-list
14323005|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14323006|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14323007|NCT00768300|Ambrisentan|ambrisentan|mesh-list
14323008|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14323009|NCT00768430|Midazolam|midazolam|mesh-list
14323010|NCT00768430|Ketamine|ketamine|mesh-list
14323011|NCT00768430|Analgesics|analgesics|mesh-ancestor
14323012|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
14323013|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323014|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323015|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14323016|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14323017|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
14323018|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
14323019|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14323020|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14323021|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14323022|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323023|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323024|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14323025|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14323026|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14323027|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14323028|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14323029|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
14323030|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
14323031|NCT00768469|Paclitaxel|paclitaxel|mesh-list
14323032|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14323033|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323034|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
14323035|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
14323036|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
14323037|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323038|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14323039|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14323040|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14323041|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
14323042|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323043|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323044|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323045|NCT00768521|Urological Agents|urological agents|mesh-ancestor
14323046|NCT00768560|Nifedipine|nifedipine|mesh-list
14323047|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14323048|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323049|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323050|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14323051|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323052|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
14323053|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
14323054|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14323055|NCT00768599|Econazole|econazole|mesh-list
14323056|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
14323057|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323058|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14323059|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14323060|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328406|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14323061|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323062|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14323063|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
14323064|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323065|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323066|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14323067|NCT00768651|Pantoprazole|pantoprazole|mesh-list
14323068|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14323069|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323070|NCT00768651|Incretins|incretins|mesh-ancestor
14323071|NCT00768651|Hormones|hormones|mesh-ancestor
14323072|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323073|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14323074|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
14323075|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323076|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323077|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14323078|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14724748|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
14724749|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14323079|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14323080|NCT00768716|Acetaminophen|acetaminophen|mesh-list
14323081|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14323082|NCT00768716|Analgesics|analgesics|mesh-ancestor
14323083|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
14323084|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323085|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323086|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
14323087|NCT00768755|Pemetrexed|pemetrexed|mesh-list
14323088|NCT00768755|Axitinib|axitinib|mesh-list
14323089|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323090|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323091|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323092|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14323093|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14323094|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14323095|NCT00768989|Ritonavir|ritonavir|mesh-list
14323096|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15222904|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15222905|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222906|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222907|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222908|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
14323097|NCT00768989|Tenofovir|tenofovir|mesh-list
14323098|NCT00768989|Emtricitabine|emtricitabine|mesh-list
14323099|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
14323100|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14323101|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14323102|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
14323103|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323104|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323105|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14323106|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14323107|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
14323108|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222909|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222910|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15222911|NCT04775680|Antibodies|antibodies|mesh-list
15222912|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
15222913|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222914|NCT04760613|Cannabidiol|cannabidiol|mesh-list
15222915|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
14323109|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15222916|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
14323110|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14323111|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14323112|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14323113|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14323114|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14323115|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14323116|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323117|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14323118|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323119|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323120|NCT00769132|Niacin|niacin|mesh-list
15222917|NCT04757363|Nivolumab|nivolumab|mesh-list
15222918|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222919|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222920|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15222921|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222922|NCT04738292|Fulvestrant|fulvestrant|mesh-list
15222923|NCT04738292|Onapristone|onapristone|mesh-list
15222924|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15222925|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222926|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15222927|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15222928|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
15222929|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15222930|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222931|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14323121|NCT00769132|Niacinamide|niacinamide|mesh-list
14323122|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
14323123|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14323124|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
14323125|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323126|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14323127|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
14323128|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
14323129|NCT00769132|Vitamins|vitamins|mesh-ancestor
14323130|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
14323131|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323132|NCT00769184|Clobetasol|clobetasol|mesh-list
14323133|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323134|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
14323135|NCT00769184|Hormones|hormones|mesh-ancestor
14323136|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323137|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323138|NCT00769314|Acyclovir|acyclovir|mesh-list
14323139|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
14323140|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323141|NCT00769392|Lidocaine|lidocaine|mesh-list
14323142|NCT00769392|Tetracaine|tetracaine|mesh-list
14323143|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
14323144|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
14323145|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
14323146|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14323147|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323148|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
14323149|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323150|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14323151|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14323152|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14323153|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323154|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323155|NCT00769483|Gemcitabine|gemcitabine|mesh-list
14323156|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14323157|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14323158|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
14323159|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323160|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323161|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
14323162|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323163|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323164|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323165|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
14323166|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323167|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14323168|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
14323169|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323170|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
14323171|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
14323172|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
14323173|NCT00769600|Itraconazole|itraconazole|mesh-list
14323174|NCT00769600|Pemetrexed|pemetrexed|mesh-list
14323175|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323176|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323177|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323178|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14323179|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14323180|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
14323181|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323182|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14323183|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14323184|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14323185|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
14323186|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323187|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323188|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14323189|NCT00769704|Molgramostim|molgramostim|mesh-list
14323190|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14323191|NCT00769704|Sargramostim|sargramostim|mesh-list
14323192|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
14323193|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323194|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323195|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14323196|NCT00769886|Ketotifen|ketotifen|mesh-list
14323197|NCT00769886|Naphazoline|naphazoline|mesh-list
14323198|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
14323199|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
14323200|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14323201|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
14323202|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
14323203|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323204|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323205|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323206|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14323207|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14323208|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14323209|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14323210|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
14323211|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14323212|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
14323213|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
14323214|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14323215|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14323216|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14323217|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14323218|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323219|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323220|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
14323221|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323222|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323223|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14323224|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323225|NCT00770120|Everolimus|everolimus|mesh-list
14323226|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323227|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323228|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
14323229|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323230|NCT00770133|Ketotifen|ketotifen|mesh-list
14323231|NCT00770133|Naphazoline|naphazoline|mesh-list
14323232|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
14323233|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
14323234|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14323235|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
14323236|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
14323237|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323238|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323239|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323240|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14323241|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14323242|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14323243|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
14323244|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
14323245|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14323246|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
14323247|NCT00770146|Mipomersen|mipomersen|mesh-list
14323248|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14323249|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14323250|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
14323251|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323252|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14323253|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
14323254|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14323255|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14323256|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14323257|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14323258|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323259|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323260|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
14323261|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323262|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323263|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14323264|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323265|NCT00770224|Prednisone|prednisone|mesh-list
14323266|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
14323267|NCT00770224|Rituximab|rituximab|mesh-list
14323268|NCT00770224|Doxorubicin|doxorubicin|mesh-list
14323269|NCT00770224|Vincristine|vincristine|mesh-list
14323270|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
14323271|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323272|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
14323273|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323274|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323275|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14323276|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
14323277|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323278|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323279|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14724750|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
14724751|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724752|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724753|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
14724754|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724755|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724756|NCT00501098|Caspofungin|caspofungin|mesh-list
14910439|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323280|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724757|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
14724758|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724759|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724760|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724761|NCT00501111|Donepezil|donepezil|mesh-list
14323281|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14323282|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14323283|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14323284|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323285|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323286|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
14323287|NCT00770224|Hormones|hormones|mesh-ancestor
14724762|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14724763|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724764|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724765|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
14724766|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724767|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724768|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
14724769|NCT00501124|Clevudine|clevudine|mesh-list
14724770|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
14724771|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724772|NCT00501137|Vaccines|vaccines|mesh-list
14724773|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
14724774|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724775|NCT00501150|Linezolid|linezolid|mesh-list
14724776|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14323288|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323289|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323290|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14323291|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
14323292|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
14323293|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
14323294|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
14323295|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14323296|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323297|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323298|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14323299|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14323300|NCT00770328|Protective Agents|protective agents|mesh-ancestor
14323301|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323302|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
14323303|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14323304|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
14323305|NCT00770341|Vancomycin|vancomycin|mesh-list
14323306|NCT00770341|Daptomycin|daptomycin|mesh-list
14323307|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14323308|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323309|NCT00770367|Pioglitazone|pioglitazone|mesh-list
14323310|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14323311|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323312|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14323313|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14323314|NCT00770432|Laxatives|laxatives|mesh-ancestor
14323315|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323316|NCT00770484|Propranolol|propranolol|mesh-list
14323317|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14323318|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14323319|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
14724777|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222932|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
15222933|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15222934|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
15222935|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15222936|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222937|NCT04681417|Carboplatin|carboplatin|mesh-list
15222938|NCT04681417|Etoposide|etoposide|mesh-list
15222939|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
15222940|NCT04681417|Vincristine|vincristine|mesh-list
15222941|NCT04681417|Melphalan|melphalan|mesh-list
15222942|NCT04681417|Topotecan|topotecan|mesh-list
15222943|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222944|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15222945|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15222946|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15222947|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222948|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222949|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
15222950|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14323320|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323321|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323322|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323323|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14323324|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14323325|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
14323326|NCT00770510|Zolpidem|zolpidem|mesh-list
14323327|NCT00770510|Eszopiclone|eszopiclone|mesh-list
14323328|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14323329|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14323330|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14323331|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323332|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14323333|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
14323334|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
14323335|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323336|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323337|NCT00770562|Dexamethasone|dexamethasone|mesh-list
14323338|NCT00770562|Rituximab|rituximab|mesh-list
14323339|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323340|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
14323341|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
14323342|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323343|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323344|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323345|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
14323346|NCT00770562|Hormones|hormones|mesh-ancestor
14323347|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323348|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323349|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323350|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14323351|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
14323352|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323353|NCT00770588|Gefitinib|gefitinib|mesh-list
14323354|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323355|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14323356|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323357|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328407|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328408|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
14328409|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328410|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14328411|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328412|NCT00808639|Doxorubicin|doxorubicin|mesh-list
14328413|NCT00808639|Methotrexate|methotrexate|mesh-list
14328414|NCT00808639|Vinblastine|vinblastine|mesh-list
14328415|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328416|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14328417|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14328418|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14328419|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328420|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328421|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14328422|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
14328423|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14328424|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328425|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14328426|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
14328427|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
14328428|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14328429|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328430|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
14328431|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328432|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14328433|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14328434|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
14328435|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
14328436|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
14328437|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
14328438|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14328439|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328440|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328441|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328442|NCT00808665|Analgesics|analgesics|mesh-ancestor
14323358|NCT00770653|Metformin|metformin|mesh-list
14323359|NCT00770653|Pioglitazone|pioglitazone|mesh-list
14323360|NCT00770653|Glimepiride|glimepiride|mesh-list
14323361|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14323362|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323363|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14323364|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323365|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
14323366|NCT00770679|Atorvastatin|atorvastatin|mesh-list
14323367|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14323368|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14323369|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
14323370|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323371|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14323372|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14323373|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323374|NCT00770692|Eszopiclone|eszopiclone|mesh-list
14323375|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14323376|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14323377|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323378|NCT00770757|Pomalidomide|pomalidomide|mesh-list
14323379|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
14323380|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323381|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14323382|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14323383|NCT00770757|Growth Substances|growth substances|mesh-ancestor
14323384|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
14323385|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323386|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14323387|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323388|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
14323389|NCT00770770|Hormones|hormones|mesh-ancestor
14323390|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323391|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323392|NCT00770861|Nebivolol|nebivolol|mesh-list
14724778|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14724779|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724780|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323393|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14323394|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
14724781|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
14724782|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14323395|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14323396|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14323397|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14323398|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
14323399|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323400|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323401|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323402|NCT00770874|Cisplatin|cisplatin|mesh-list
14323403|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323404|NCT00770913|Rabeprazole|rabeprazole|mesh-list
14323405|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14323406|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323407|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14323408|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323409|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323410|NCT00771030|Brodalumab|brodalumab|mesh-list
14323411|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14323412|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
14323413|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
14323414|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14323415|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14323416|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323417|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323418|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323419|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323420|NCT00771472|Vorinostat|vorinostat|mesh-list
14323421|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323422|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14323423|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323424|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323425|NCT00771667|Ustekinumab|ustekinumab|mesh-list
14323426|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
14323427|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
14323428|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14323429|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
14323430|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323431|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323432|NCT00771758|Oxycodone|oxycodone|mesh-list
14323433|NCT00771758|Tapentadol|tapentadol|mesh-list
14323434|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14323435|NCT00771758|Narcotics|narcotics|mesh-ancestor
14323436|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14323437|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323438|NCT00771758|Analgesics|analgesics|mesh-ancestor
14724783|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323439|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
14323440|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323441|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14323442|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14323443|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323444|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323445|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14323446|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323447|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14323448|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14323449|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
14323450|NCT00771875|Acetaminophen|acetaminophen|mesh-list
14323451|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
14323452|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
14323453|NCT00771875|Rituximab|rituximab|mesh-list
14323454|NCT00771875|Bortezomib|bortezomib|mesh-list
14323455|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
14323456|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14323457|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14323458|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
14323459|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14323460|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323461|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
14323462|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323463|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323464|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14323465|NCT00771875|Analgesics|analgesics|mesh-ancestor
14323466|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
14323467|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323468|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
14323469|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323470|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
14323471|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
14323472|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323473|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
14323474|NCT00771875|Hormones|hormones|mesh-ancestor
14323475|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323476|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14323477|NCT00771875|Protective Agents|protective agents|mesh-ancestor
14323478|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323479|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14323480|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14323481|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14323482|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
14323483|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
14323484|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
14323485|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323486|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323487|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14323488|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14323489|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14323490|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323491|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
14323492|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323493|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14323494|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323495|NCT00771914|Aspirin|aspirin|mesh-list
14323496|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14323497|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14323498|NCT00771914|Analgesics|analgesics|mesh-ancestor
14323499|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
14323500|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15222951|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
15222952|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15222953|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
14323501|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222954|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15222955|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222956|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
15222957|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222958|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15222959|NCT04657640|Iron|iron|mesh-list
15222960|NCT04657640|Trace Elements|trace elements|mesh-list
14323502|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323503|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323504|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14323505|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14323506|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323507|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14323508|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14323509|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323510|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
14323511|NCT00771927|Lacosamide|lacosamide|mesh-list
14323512|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
14323513|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14323514|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14323515|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323516|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222961|NCT04657640|Folic Acid|folic acid|mesh-list
15222962|NCT04657640|Micronutrients|micronutrients|mesh-list
15222963|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
15222964|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222965|NCT04657640|Hematinics|hematinics|mesh-ancestor
15222966|NCT04657640|Vitamins|vitamins|mesh-ancestor
14323517|NCT00771953|Docetaxel|docetaxel|mesh-list
14323518|NCT00771953|Pemetrexed|pemetrexed|mesh-list
14323519|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323520|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14323521|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14323522|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14323523|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323524|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323525|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14323526|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14323527|NCT00772005|Modafinil|modafinil|mesh-list
14323528|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14323529|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323530|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14323531|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14323532|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14323533|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323534|NCT00772031|Topiramate|topiramate|mesh-list
14323535|NCT00772031|Propranolol|propranolol|mesh-list
14323536|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14323537|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14323538|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
14323539|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323540|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724784|NCT00501241|ATI 7505|ati 7505|mesh-list
14724785|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14724786|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14724787|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
14724788|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724789|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724790|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724791|NCT00501254|Aspirin|aspirin|mesh-list
14724792|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
14724793|NCT00501254|Salicylates|salicylates|mesh-list
14724794|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724795|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
14910440|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14910441|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910442|NCT01356758|Analgesics|analgesics|mesh-ancestor
14910443|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
14910444|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910445|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910446|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14910447|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
14910448|NCT01356797|Fentanyl|fentanyl|mesh-list
14910449|NCT01356797|Bupivacaine|bupivacaine|mesh-list
14910450|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
14910451|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
14910452|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
14910453|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910454|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910455|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
14910456|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910457|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14910458|NCT01356797|Narcotics|narcotics|mesh-ancestor
14910459|NCT01356797|Analgesics|analgesics|mesh-ancestor
15222967|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
14323541|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323542|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14323543|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14323544|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
14323545|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
14323546|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14323547|NCT00772070|Vaccines|vaccines|mesh-list
14323548|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
14323549|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323550|NCT00772109|Vaccines|vaccines|mesh-list
14323551|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
14323552|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323553|NCT00772148|Tacrolimus|tacrolimus|mesh-list
14323554|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323555|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
14323556|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323557|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14323558|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323559|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323560|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14323561|NCT00772304|Azelastine|azelastine|mesh-list
14323562|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14323563|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14323564|NCT00772304|Analgesics|analgesics|mesh-ancestor
14323565|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
14323566|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323567|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323568|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323569|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323570|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14323571|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14323572|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14323573|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
14323574|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
14323575|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323576|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323577|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14323578|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
14323579|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14323580|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14323581|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14323582|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323583|NCT00772447|Vancomycin|vancomycin|mesh-list
14323584|NCT00772447|Daptomycin|daptomycin|mesh-list
14323585|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14323586|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323587|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
14323588|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14323589|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
14323590|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323591|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323592|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14323593|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
14323594|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
14323595|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14323596|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
14323597|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323598|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323599|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14323600|NCT00772577|Ramipril|ramipril|mesh-list
14724796|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
14323601|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14323602|NCT00772577|Diuretics|diuretics|mesh-ancestor
14323603|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
14323604|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323605|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14323606|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323607|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323608|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14323609|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
14323610|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323611|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
14323612|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14323613|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14323614|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
14323615|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323616|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14323617|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14323618|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323619|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323620|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
14323621|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
14323622|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14323623|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14323624|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323625|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323626|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14323627|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14323628|NCT00772668|Prednisone|prednisone|mesh-list
14323629|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
14323630|NCT00772668|Rituximab|rituximab|mesh-list
14323631|NCT00772668|Bortezomib|bortezomib|mesh-list
14323632|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323633|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
14323634|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323635|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323636|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14323637|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
14323638|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323639|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323640|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14323641|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14323642|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323643|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
14323644|NCT00772668|Hormones|hormones|mesh-ancestor
14323645|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323646|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323647|NCT00772772|Vitamin D|vitamin d|mesh-list
14323648|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
14323649|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
14323650|NCT00772772|Vitamins|vitamins|mesh-list
14323651|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
14323652|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323653|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14323654|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14323655|NCT00772915|Dexamethasone|dexamethasone|mesh-list
14323656|NCT00772915|Lenalidomide|lenalidomide|mesh-list
14323657|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323658|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
14323659|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
14323660|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323661|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323662|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323663|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
14323664|NCT00772915|Hormones|hormones|mesh-ancestor
14323665|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323666|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323667|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323668|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
14323669|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14323670|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14323671|NCT00772915|Growth Substances|growth substances|mesh-ancestor
14323672|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
14323673|NCT00772928|Vaccines|vaccines|mesh-list
14323674|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14323675|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
14323676|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323677|NCT00772941|Varenicline|varenicline|mesh-list
14323678|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14323679|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14323680|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
14323681|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323682|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323683|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323684|NCT00772954|Vaccines|vaccines|mesh-list
14323685|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
14323686|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323687|NCT00772967|Naproxen|naproxen|mesh-list
14323688|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14323689|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14323690|NCT00772967|Analgesics|analgesics|mesh-ancestor
14323691|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
14323692|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323693|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323694|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323695|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323696|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
14323697|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14323698|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323699|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323700|NCT00773097|Poly ICLC|poly iclc|mesh-list
14323701|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
14323702|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
14323703|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323704|NCT00773136|Bimatoprost|bimatoprost|mesh-list
14323705|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14724797|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
14724798|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14724799|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14724800|NCT00501254|Analgesics|analgesics|mesh-ancestor
14724801|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
14724802|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724803|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323706|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
14323707|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14323708|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14323709|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14323710|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323711|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323712|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
14323713|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323714|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724804|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14724805|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724806|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14724807|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724808|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724809|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14724810|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14724811|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14724812|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
14724813|NCT00501267|Oxybutynin|oxybutynin|mesh-list
14724814|NCT00501267|Solabegron|solabegron|mesh-list
14724815|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
14724816|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
14724817|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724818|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724819|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14724820|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14910460|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14910461|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14323715|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14323716|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323717|NCT00773292|Cyclosporine|cyclosporine|mesh-list
14323718|NCT00773292|Cyclosporins|cyclosporins|mesh-list
14323719|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323720|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323721|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323722|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
14323723|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323724|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
14323725|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323726|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
14323727|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323728|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14323729|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14323730|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323731|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14323732|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323733|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323734|NCT00773422|Naltrexone|naltrexone|mesh-list
14323735|NCT00773422|Varenicline|varenicline|mesh-list
14323736|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14323737|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14323738|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910462|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
14910463|NCT01356862|Pasireotide|pasireotide|mesh-list
14910464|NCT01356862|Hormones|hormones|mesh-ancestor
14910465|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14910466|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917115|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14917116|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
15222968|NCT04651088|Diuretics|diuretics|mesh-ancestor
14917117|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15222969|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
15222970|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222971|NCT04651088|Expectorants|expectorants|mesh-ancestor
15222972|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
15222973|NCT04595513|Sirolimus|sirolimus|mesh-list
15222974|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15222975|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15222976|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15222977|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222978|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
14323739|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
14323740|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323741|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14323742|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14323743|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
14323744|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323745|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323746|NCT00773474|Lonafarnib|lonafarnib|mesh-list
14323747|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323748|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323749|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
14323750|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
14323751|NCT00773513|Hematinics|hematinics|mesh-ancestor
14323752|NCT00773734|Thalidomide|thalidomide|mesh-list
14323753|NCT00773734|Apremilast|apremilast|mesh-list
14323754|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14323755|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14323756|NCT00773734|Analgesics|analgesics|mesh-ancestor
14323757|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
14323758|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323759|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323760|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323761|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323762|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14323763|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14323764|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323765|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910467|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14910468|NCT01356927|Etonogestrel|etonogestrel|mesh-list
14910469|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14910470|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
14910471|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14910472|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910473|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14323766|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323767|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
14323768|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
14323769|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14323770|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323771|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14323772|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14323773|NCT00773734|Growth Substances|growth substances|mesh-ancestor
14323774|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14323775|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323776|NCT00773747|Bortezomib|bortezomib|mesh-list
14323777|NCT00773747|Vorinostat|vorinostat|mesh-list
14323778|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323779|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14323780|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323781|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323782|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
14323783|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14323784|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
14323785|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323786|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910474|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14910475|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14910476|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323787|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14323788|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
14323789|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14323790|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14323791|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14323792|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14323793|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323794|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323795|NCT00773838|Dexamethasone|dexamethasone|mesh-list
14323796|NCT00773838|Bortezomib|bortezomib|mesh-list
14323797|NCT00773838|Vorinostat|vorinostat|mesh-list
14323798|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323799|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
14323800|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
14323801|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323802|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323803|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323804|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
14323805|NCT00773838|Hormones|hormones|mesh-ancestor
14323806|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323807|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323808|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323809|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14323810|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323811|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323812|NCT00773955|Acetic Acid|acetic acid|mesh-list
14323813|NCT00773955|Retinol acetate|retinol acetate|mesh-list
14323814|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
14323815|NCT00773955|Gossypol|gossypol|mesh-list
14323816|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14323817|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323818|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14323819|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
14724821|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
14724822|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724823|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724824|NCT00501267|Urological Agents|urological agents|mesh-ancestor
14323820|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323821|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14323822|NCT00773955|Protective Agents|protective agents|mesh-ancestor
14323823|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323824|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14323825|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
14323826|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14323827|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14323828|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14323829|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14323830|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14323831|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
14323832|NCT00773968|Hematinics|hematinics|mesh-ancestor
14323833|NCT00774046|Cytarabine|cytarabine|mesh-list
14323834|NCT00774046|Etoposide|etoposide|mesh-list
14323835|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
14323836|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14323837|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323838|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14323839|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14323840|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323841|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323842|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14323843|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
14323844|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
14323845|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323846|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323847|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
14323848|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323849|NCT00774046|Analgesics|analgesics|mesh-ancestor
14323850|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
14323851|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323852|NCT00774202|Prednisone|prednisone|mesh-list
14323853|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
14323854|NCT00774202|Rituximab|rituximab|mesh-list
14323855|NCT00774202|Vincristine|vincristine|mesh-list
14323856|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323857|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
14323858|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323859|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323860|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14323861|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
14323862|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323863|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323864|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14323865|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14323866|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323867|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
14323868|NCT00774202|Hormones|hormones|mesh-ancestor
14323869|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323870|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323871|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14323872|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
14323873|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
14323874|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
14323875|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14323876|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14323877|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
14323878|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323879|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323880|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14323881|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14323882|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14323883|NCT00774787|Imiquimod|imiquimod|mesh-list
14323884|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14323885|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
14323886|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323887|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323888|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
14323889|NCT00774800|Insulin|insulin|mesh-list
14323890|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14323891|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
14323892|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14323893|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323894|NCT00774852|Prednisone|prednisone|mesh-list
14323895|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
14323896|NCT00774852|Abatacept|abatacept|mesh-list
14323897|NCT00774852|Azathioprine|azathioprine|mesh-list
14323898|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323899|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
14323900|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323901|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323902|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14323903|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
14323904|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323905|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323906|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14323907|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323908|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
14323909|NCT00774852|Hormones|hormones|mesh-ancestor
14323910|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323911|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323912|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14323913|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
14323914|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14323915|NCT00774930|Lanreotide|lanreotide|mesh-list
14323916|NCT00774930|Somatostatin|somatostatin|mesh-list
14323917|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323918|NCT00774930|Hormones|hormones|mesh-ancestor
14323919|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323920|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323921|NCT00775138|Amikacin|amikacin|mesh-list
14323922|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14323923|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323924|NCT00775203|Trazodone|trazodone|mesh-list
14323925|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14323926|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14323927|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14323928|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323929|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14323930|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14323931|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14323932|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14323933|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323934|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14323935|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
14323936|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14323937|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
14323938|NCT00775229|Naltrexone|naltrexone|mesh-list
14323939|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14323940|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14323941|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323942|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
14323943|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323944|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14323945|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14323946|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323947|NCT00775411|Dexamethasone|dexamethasone|mesh-list
14323948|NCT00775411|Ranibizumab|ranibizumab|mesh-list
14323949|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323950|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
14323951|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
14323952|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14323953|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323954|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323955|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
14323956|NCT00775411|Hormones|hormones|mesh-ancestor
14323957|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14323958|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14323959|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323960|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14323961|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14323962|NCT00775411|Growth Substances|growth substances|mesh-ancestor
14724825|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14724826|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14724827|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14724828|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
14724829|NCT00501384|Satavaptan|satavaptan|mesh-list
14323963|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
14323964|NCT00775437|Adalimumab|adalimumab|mesh-list
14323965|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14323966|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14323967|NCT00775450|Vaccines|vaccines|mesh-list
14323968|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
14323969|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323970|NCT00775463|Treprostinil|treprostinil|mesh-list
14323971|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14323972|NCT00775528|Pancrelipase|pancrelipase|mesh-list
14323973|NCT00775528|Pancreatin|pancreatin|mesh-list
14323974|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14323975|NCT00775593|Sirolimus|sirolimus|mesh-list
14323976|NCT00775593|Clofarabine|clofarabine|mesh-list
14323977|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14323978|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14323979|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14323980|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14323981|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
14323982|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14323983|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
14323984|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14323985|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14323986|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
14323987|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323988|NCT00775606|Ritonavir|ritonavir|mesh-list
14323989|NCT00775606|Lopinavir|lopinavir|mesh-list
14323990|NCT00775606|Efavirenz|efavirenz|mesh-list
14323991|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14323992|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14323993|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
14323994|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14323995|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14323996|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14323997|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14323998|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
14323999|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324000|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14324001|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14324002|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14324003|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14324004|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14324005|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14324006|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14324007|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14324008|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14324009|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
14324010|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
14324011|NCT00775645|Vitamins|vitamins|mesh-ancestor
14324012|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
14324013|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324014|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
14324015|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14324016|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14324017|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14324018|NCT00775658|Analgesics|analgesics|mesh-ancestor
14324019|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
14324020|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324021|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324022|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14324023|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324024|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14910477|NCT01356992|Enoxaparin|enoxaparin|mesh-list
14324025|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14324026|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14324027|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
14324028|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
14324029|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324030|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328443|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
14328444|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328445|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14328446|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14328447|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14328448|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
14328449|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328450|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328451|NCT00809055|Caffeine|caffeine|mesh-list
14328452|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
14328453|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328454|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14328455|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328456|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14328457|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328458|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14328459|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14328460|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
14724830|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14910478|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
15222979|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15222980|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
15222981|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222982|NCT04589832|Entrectinib|entrectinib|mesh-list
15222983|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15222984|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15222985|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222986|NCT04575181|Insulin|insulin|mesh-list
15222987|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15222988|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
15222989|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324031|NCT00775671|Metoprolol|metoprolol|mesh-list
14324032|NCT00775671|Nebivolol|nebivolol|mesh-list
14324033|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14324034|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14324035|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
14324036|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
14324037|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324038|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324039|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14324040|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14324041|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14324042|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
14324043|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324044|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324045|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324046|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14324047|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14324048|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14324049|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14324050|NCT00775684|Exenatide|exenatide|mesh-list
14324051|NCT00775684|Glimepiride|glimepiride|mesh-list
14324052|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324053|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324054|NCT00775684|Incretins|incretins|mesh-ancestor
14324055|NCT00775684|Hormones|hormones|mesh-ancestor
14324056|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324057|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14324058|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
14324059|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324060|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324061|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14324062|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15222990|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222991|NCT04560881|Vaccines|vaccines|mesh-list
15222992|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
15222993|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15222994|NCT04501120|Azacitidine|azacitidine|mesh-list
15222995|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15222996|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
15222997|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15222998|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15222999|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223000|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
15223001|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15223002|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223003|NCT04497961|Lenalidomide|lenalidomide|mesh-list
15223004|NCT04497961|Daratumumab|daratumumab|mesh-list
14324063|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324064|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
14324065|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
14324066|NCT00775931|Busulfan|busulfan|mesh-list
14324067|NCT00775931|Fludarabine|fludarabine|mesh-list
14324068|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
14324069|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
14324070|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324071|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
14324072|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324073|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324074|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14324075|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
14910479|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14910480|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14910481|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910482|NCT01357031|Amitriptyline|amitriptyline|mesh-list
14910483|NCT01357031|Melatonin|melatonin|mesh-list
14910484|NCT01357031|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14910485|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
14910486|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223005|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
14910487|NCT01357031|Protective Agents|protective agents|mesh-ancestor
14324076|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324077|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324078|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14324079|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324080|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
14324081|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324082|NCT00775944|Nicotine|nicotine|mesh-list
14324083|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14324084|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
14324085|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324086|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324087|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14324088|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14324089|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14324090|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324091|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324092|NCT00776009|Methylphenidate|methylphenidate|mesh-list
14324093|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14324094|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14324095|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324096|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14324097|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14324098|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324099|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324100|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
14324101|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324102|NCT00776230|Vaccines|vaccines|mesh-list
14324103|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
14324104|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324105|NCT00776594|Bevacizumab|bevacizumab|mesh-list
14324106|NCT00776594|Bicalutamide|bicalutamide|mesh-list
14324107|NCT00776594|Androgens|androgens|mesh-list
14324108|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324109|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324110|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14324111|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14324112|NCT00776594|Growth Substances|growth substances|mesh-ancestor
14324113|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324114|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
15223006|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223007|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15223008|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15223009|NCT04497961|Growth Substances|growth substances|mesh-ancestor
15223010|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
14324115|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
14324116|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
14324117|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324118|NCT00776594|Hormones|hormones|mesh-ancestor
14324119|NCT00776659|Exemestane|exemestane|mesh-list
14324120|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324121|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14324122|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14324123|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324124|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324125|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14324126|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
14324127|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324128|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724831|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724832|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
14724833|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724834|NCT00501397|Ketoconazole|ketoconazole|mesh-list
14724835|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
14724836|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724837|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14324129|NCT00776919|Clindamycin|clindamycin|mesh-list
14724838|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14724839|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724840|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724841|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14724842|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
14724843|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724844|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724845|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14324130|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
14324131|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
14324132|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14910488|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910489|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14910490|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14324133|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14324134|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324135|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14324136|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324137|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324138|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
14324139|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
14324140|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14724846|NCT00501410|Leucovorin|leucovorin|mesh-list
14724847|NCT00501410|Fluorouracil|fluorouracil|mesh-list
14724848|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
14724849|NCT00501410|Cetuximab|cetuximab|mesh-list
14910491|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
15223011|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223012|NCT04483583|Clopidogrel|clopidogrel|mesh-list
15223013|NCT04483583|Ticagrelor|ticagrelor|mesh-list
14724850|NCT00501410|Dasatinib|dasatinib|mesh-list
14324141|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
14324142|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324143|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324144|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324145|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324146|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
14324147|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14324148|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
14324149|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324150|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324151|NCT00777023|Gabapentin|gabapentin|mesh-list
14324152|NCT00777023|Analgesics|analgesics|mesh-ancestor
14324153|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
14324154|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324155|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324156|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
14324157|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14324158|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14324159|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14324160|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14324161|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14324162|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14324163|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324164|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324165|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
14324166|NCT00777049|Panobinostat|panobinostat|mesh-list
14324167|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324168|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14324169|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324170|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324171|NCT00777062|Naltrexone|naltrexone|mesh-list
14324172|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14324173|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14324174|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324175|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
14324176|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324177|NCT00777101|Capecitabine|capecitabine|mesh-list
14324178|NCT00777101|Lapatinib|lapatinib|mesh-list
14324179|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324180|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
14324181|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324182|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324183|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324184|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724851|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
14724852|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724853|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14724854|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324185|NCT00777153|Cediranib|cediranib|mesh-list
14324186|NCT00777153|Lomustine|lomustine|mesh-list
14324187|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324188|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324189|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324190|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324191|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14324192|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
14324193|NCT00777296|Amikacin|amikacin|mesh-list
14324194|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14324195|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324196|NCT00777335|Panobinostat|panobinostat|mesh-list
14324197|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324198|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14324199|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324200|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324201|NCT00777491|Gemcitabine|gemcitabine|mesh-list
14324202|NCT00777491|Cisplatin|cisplatin|mesh-list
14324203|NCT00777491|Fluorouracil|fluorouracil|mesh-list
14324204|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324205|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324206|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
14324207|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324208|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
14324209|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324210|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324211|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324212|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
14324213|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324214|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
14324215|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14324216|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
14324217|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14324218|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324219|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14324220|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14324221|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14324222|NCT00777608|Donepezil|donepezil|mesh-list
14324223|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14324224|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324225|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324226|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
14324227|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324228|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324229|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
14324230|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
14324231|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14324232|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14324233|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14324234|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14324235|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324236|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324237|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
14324238|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324239|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324240|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14324241|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324242|NCT00777829|Zolpidem|zolpidem|mesh-list
14324243|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14324244|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14324245|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724855|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14724856|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
14724857|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724858|NCT00501410|Antidotes|antidotes|mesh-ancestor
14724859|NCT00501410|Protective Agents|protective agents|mesh-ancestor
14724860|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
14724861|NCT00501410|Vitamins|vitamins|mesh-ancestor
14724862|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
14724863|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724864|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14724865|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324246|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324247|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14324248|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
14324249|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
15223014|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14324250|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324251|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324252|NCT00777855|Rifampin|rifampin|mesh-list
14324253|NCT00777855|Warfarin|warfarin|mesh-list
14324254|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
14324255|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14324256|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
14324257|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14324258|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324259|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
14324260|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14324261|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324262|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324263|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14324264|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14324265|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15223015|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15223016|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15223017|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15223018|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
15223019|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223020|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324266|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14324267|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14324268|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14324269|NCT00777920|Ambrisentan|ambrisentan|mesh-list
14324270|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14324271|NCT00777946|Amlodipine|amlodipine|mesh-list
14324272|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14324273|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14324274|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324275|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324276|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14724866|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
14724867|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724868|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724869|NCT00501514|Hormones|hormones|mesh-list
14724870|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324277|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324278|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324279|NCT00778102|Leucovorin|leucovorin|mesh-list
14324280|NCT00778102|Bevacizumab|bevacizumab|mesh-list
14324281|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
14324282|NCT00778102|Irinotecan|irinotecan|mesh-list
14324283|NCT00778102|Fluorouracil|fluorouracil|mesh-list
14324284|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
14324285|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324286|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324287|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14324288|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14324289|NCT00778102|Growth Substances|growth substances|mesh-ancestor
14324290|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324291|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14324292|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14324293|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14324294|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724871|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324295|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324296|NCT00778102|Antidotes|antidotes|mesh-ancestor
14324297|NCT00778102|Protective Agents|protective agents|mesh-ancestor
14324298|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
14324299|NCT00778102|Vitamins|vitamins|mesh-ancestor
14324300|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
14324301|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
14324302|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324303|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324304|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
14324305|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14324306|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14324307|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324308|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324309|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324310|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324311|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
14324312|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324313|NCT00778310|Methylphenidate|methylphenidate|mesh-list
14324314|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14324315|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324316|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14324317|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14324318|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324319|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324320|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
14324321|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324322|NCT00778375|Cytarabine|cytarabine|mesh-list
14324323|NCT00778375|Decitabine|decitabine|mesh-list
14324324|NCT00778375|Clofarabine|clofarabine|mesh-list
14324325|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324326|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
14324327|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324328|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324329|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
14324330|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324331|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324332|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
14324333|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324334|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324335|NCT00778622|Metformin|metformin|mesh-list
14324336|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324337|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324338|NCT00778817|Mitotane|mitotane|mesh-list
14324339|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14324340|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324341|NCT00778830|Cetuximab|cetuximab|mesh-list
14324342|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324343|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324344|NCT00778869|Infliximab|infliximab|mesh-list
14324345|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
14324346|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324347|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324348|NCT00778921|Amlodipine|amlodipine|mesh-list
14324349|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14324350|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14324351|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324352|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324353|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14324354|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324355|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324356|NCT00779142|Methotrexate|methotrexate|mesh-list
14324357|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14324358|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
14324359|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14324360|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324361|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324362|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
14324363|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324364|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324365|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14324366|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324367|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14324368|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324369|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
14324370|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324371|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14324372|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
14324373|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14324374|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14324375|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324376|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
14324377|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
14324378|NCT00779259|Quinine|quinine|mesh-list
14324379|NCT00779259|Theophylline|theophylline|mesh-list
14324380|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14324381|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
14324382|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324383|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324384|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324385|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324386|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14324387|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324388|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324389|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324390|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14324391|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14324392|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
14324393|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324394|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
14324395|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14324396|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14324397|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324398|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14324399|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14324400|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14324401|NCT00779259|Analgesics|analgesics|mesh-ancestor
14324402|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
14324403|NCT00779285|Doxorubicin|doxorubicin|mesh-list
14324404|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14324405|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14324406|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324407|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14324408|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14324409|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324410|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324411|NCT00779311|Bevacizumab|bevacizumab|mesh-list
14324412|NCT00779311|Sorafenib|sorafenib|mesh-list
14324413|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324414|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324415|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14324416|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14324417|NCT00779311|Growth Substances|growth substances|mesh-ancestor
14324418|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324419|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
14324420|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324421|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223021|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223022|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
15223023|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15223024|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
15223025|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223026|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223027|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324422|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324423|NCT00779324|Amantadine|amantadine|mesh-list
14324424|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14324425|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14324426|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
14324427|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324428|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
14324429|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324430|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324431|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324432|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14324433|NCT00779324|Analgesics|analgesics|mesh-ancestor
14324434|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
14324435|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324436|NCT00779467|Fentanyl|fentanyl|mesh-list
14324437|NCT00779467|Bupivacaine|bupivacaine|mesh-list
14324438|NCT00779467|Neostigmine|neostigmine|mesh-list
14324439|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
14324440|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
14324441|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14324442|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324443|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
14324444|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324445|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14324446|NCT00779467|Narcotics|narcotics|mesh-ancestor
14324447|NCT00779467|Analgesics|analgesics|mesh-ancestor
14324448|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14324449|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14324450|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
14324451|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14324452|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324453|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324454|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
14324455|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324456|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14324457|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
14324458|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14324459|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
14724872|NCT00501566|Satavaptan|satavaptan|mesh-list
14724873|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14724874|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223028|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
15223029|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15223030|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
15223031|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223032|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324460|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724875|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
14724876|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724877|NCT00501579|Prednisolone|prednisolone|mesh-list
14724878|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14324461|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14324462|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14324463|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14324464|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324465|NCT00779558|Heparin|heparin|mesh-list
14324466|NCT00779558|Calcium heparin|calcium heparin|mesh-list
14324467|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
14324468|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14324469|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14324470|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324471|NCT00779584|Gemcitabine|gemcitabine|mesh-list
14324472|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324473|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
14324474|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324475|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724879|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
14724880|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14724881|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
14724882|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14724883|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
14724884|NCT00501579|Difluprednate|difluprednate|mesh-list
14724885|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14724886|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
14724887|NCT00501579|Hormones|hormones|mesh-ancestor
14724888|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724889|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724890|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14724891|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324476|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
14324477|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724892|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
14724893|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
14324478|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324479|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324480|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
14324481|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724894|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724895|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223033|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15223034|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
15223035|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
15223036|NCT04460183|Protective Agents|protective agents|mesh-ancestor
15223037|NCT04447287|Buprenorphine|buprenorphine|mesh-list
15223038|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15223039|NCT04447287|Naloxone|naloxone|mesh-list
15223040|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15223041|NCT04447287|Narcotics|narcotics|mesh-ancestor
15223042|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223043|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724896|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15223044|NCT04447287|Analgesics|analgesics|mesh-ancestor
15223045|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
14324482|NCT00779675|Infliximab|infliximab|mesh-list
14324483|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
14324484|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324485|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324486|NCT00779701|Insulin|insulin|mesh-list
14324487|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324488|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324489|NCT00779909|Vitamin D|vitamin d|mesh-list
14324490|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
14324491|NCT00779909|Vitamins|vitamins|mesh-ancestor
14324492|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
14324493|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324494|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14324495|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14324496|NCT00780026|Insulin|insulin|mesh-list
14324497|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324498|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324499|NCT00780143|Cytarabine|cytarabine|mesh-list
14324500|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324501|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
14324502|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324503|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324504|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
14324505|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324506|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324507|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
14324508|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324509|NCT00780208|Methylphenidate|methylphenidate|mesh-list
14324510|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14324511|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324512|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14324513|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14324514|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324515|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324516|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
14324517|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324518|NCT00780234|Pioglitazone|pioglitazone|mesh-list
14324519|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324520|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324521|NCT00780273|Cimetidine|cimetidine|mesh-list
14324522|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14324523|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324524|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14324525|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
14324526|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
14324527|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324528|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324529|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324530|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14324531|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14324532|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324533|NCT00780416|Ribavirin|ribavirin|mesh-list
14324534|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14324535|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
14324536|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
14324537|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324538|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
14324539|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324540|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
14324541|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324542|NCT00780442|Cycloserine|cycloserine|mesh-list
14324543|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14324544|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324545|NCT00780442|Renal Agents|renal agents|mesh-ancestor
14324546|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14324547|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
14324548|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14324549|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
14324550|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324551|NCT00780494|Bevacizumab|bevacizumab|mesh-list
14324552|NCT00780494|Carboplatin|carboplatin|mesh-list
14324553|NCT00780494|Capecitabine|capecitabine|mesh-list
14324554|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324555|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324556|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14324557|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14324558|NCT00780494|Growth Substances|growth substances|mesh-ancestor
14324559|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324560|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
14324561|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324562|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
14324563|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324564|NCT00780676|Dasatinib|dasatinib|mesh-list
14324565|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324566|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324567|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324568|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324569|NCT00780715|Metformin|metformin|mesh-list
14324570|NCT00780715|Pioglitazone|pioglitazone|mesh-list
14324571|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14324572|NCT00780715|Gliclazide|gliclazide|mesh-list
14324573|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324574|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324575|NCT00780715|Incretins|incretins|mesh-ancestor
14324576|NCT00780715|Hormones|hormones|mesh-ancestor
14324577|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324578|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14324579|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
14324580|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324581|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324582|NCT00780910|Ribavirin|ribavirin|mesh-list
14324583|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14324584|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
14324585|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324586|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
14324587|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324588|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
14324589|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14324590|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
14324591|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324592|NCT00780962|Expectorants|expectorants|mesh-ancestor
14324593|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324594|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14324595|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
14324596|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324597|NCT00780962|Protective Agents|protective agents|mesh-ancestor
14324598|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324599|NCT00780962|Antidotes|antidotes|mesh-ancestor
14724897|NCT00501579|Protective Agents|protective agents|mesh-ancestor
15223046|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223047|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15223048|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
15223049|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15223050|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
15223051|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15223052|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
15223053|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324600|NCT00781274|Ribavirin|ribavirin|mesh-list
14324601|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15225628|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223054|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223055|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
15223056|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
15223057|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
15223058|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15223059|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15223060|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223061|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223062|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223063|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15223064|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
15223065|NCT04393350|Lenvatinib|lenvatinib|mesh-list
14324602|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
14324603|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324604|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
14324605|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324606|NCT00781326|Nimodipine|nimodipine|mesh-list
14324607|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14324608|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14324609|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324610|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324611|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14324612|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324613|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324614|NCT00781391|Warfarin|warfarin|mesh-list
14324615|NCT00781391|Edoxaban|edoxaban|mesh-list
14324616|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
14324617|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14324618|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
14324619|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14324620|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
15223066|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324621|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223067|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324622|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324623|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
14324624|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
14324625|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
14324626|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14324627|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324628|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14324629|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14324630|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14324631|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
14324632|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324633|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14324634|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14324635|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324636|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324637|NCT00781508|Urological Agents|urological agents|mesh-ancestor
14324638|NCT00781599|Varenicline|varenicline|mesh-list
14324639|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14324640|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14324641|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
14324642|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324643|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324644|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324645|NCT00781768|Ondansetron|ondansetron|mesh-list
14324646|NCT00781768|Aprepitant|aprepitant|mesh-list
14324647|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
14324648|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
14324649|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324650|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324651|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324652|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
14324653|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
14324654|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14324655|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
14324656|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324657|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324658|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14324659|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14324660|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14324661|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14324662|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14324663|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14324664|NCT00781859|Plasminogen|plasminogen|mesh-list
14324665|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14324666|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14324667|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324668|NCT00781885|Beraprost|beraprost|mesh-list
14324669|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14324670|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324671|NCT00781898|Naltrexone|naltrexone|mesh-list
14324672|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14324673|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14324674|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324675|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
14324676|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324677|NCT00781911|Octreotide|octreotide|mesh-list
14324678|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324679|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14324680|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324681|NCT00781937|Liraglutide|liraglutide|mesh-list
14324682|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324683|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324684|NCT00781937|Incretins|incretins|mesh-ancestor
14324685|NCT00781937|Hormones|hormones|mesh-ancestor
14324686|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324687|NCT00782067|Midostaurin|midostaurin|mesh-list
14324688|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324689|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324690|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223068|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223069|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223070|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223071|NCT04336735|Vaccines|vaccines|mesh-list
15223072|NCT04336735|Immunologic Factors|immunologic factors|mesh-ancestor
15223073|NCT04336735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223074|NCT04300647|Atezolizumab|atezolizumab|mesh-list
14324691|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324692|NCT00782210|Olodaterol|olodaterol|mesh-list
14324693|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14324694|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
14324695|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324696|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324697|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324698|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324699|NCT00782275|Sirolimus|sirolimus|mesh-list
14324700|NCT00782275|Bevacizumab|bevacizumab|mesh-list
14324701|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324702|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324703|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14324704|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14324705|NCT00782275|Growth Substances|growth substances|mesh-ancestor
14324706|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324707|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
14324708|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14324709|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324710|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14324711|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
14324712|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324713|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
14324714|NCT00782340|Droxidopa|droxidopa|mesh-list
14324715|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14324716|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14324717|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
14324718|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
14324719|NCT00782379|Busulfan|busulfan|mesh-list
14324720|NCT00782379|Fludarabine|fludarabine|mesh-list
14324721|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
14324722|NCT00782379|Tacrolimus|tacrolimus|mesh-list
15223075|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225629|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225630|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225631|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
15225632|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225633|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225634|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15225635|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
15225636|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15225637|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
15225638|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15225639|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
15225640|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324723|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324724|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
14324725|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324726|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324727|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14324728|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
14324729|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324730|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324731|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14324732|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14324733|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
14324734|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14324735|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324736|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14324737|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14324738|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
14324739|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14324740|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324741|NCT00782418|Exenatide|exenatide|mesh-list
14324742|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324743|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324744|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14324745|NCT00782418|Incretins|incretins|mesh-ancestor
14324746|NCT00782418|Hormones|hormones|mesh-ancestor
14324747|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324748|NCT00782509|Olodaterol|olodaterol|mesh-list
14324749|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14324750|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
14324751|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324752|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324753|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324754|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324755|NCT00782626|Everolimus|everolimus|mesh-list
14324756|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324757|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324758|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
14324759|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324760|NCT00782717|Prednisolone|prednisolone|mesh-list
14324761|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14324762|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
14324763|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14324764|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
14324765|NCT00782717|Nepafenac|nepafenac|mesh-list
14324766|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14324767|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
14324768|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14324769|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
14324770|NCT00782717|Hormones|hormones|mesh-ancestor
14324771|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324772|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324773|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14324774|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324775|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
14324776|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
14324777|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324778|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324779|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14324780|NCT00782717|Protective Agents|protective agents|mesh-ancestor
14324781|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14324782|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14324783|NCT00782717|Analgesics|analgesics|mesh-ancestor
14324784|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
14324785|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324786|NCT00782756|Bevacizumab|bevacizumab|mesh-list
14324787|NCT00782756|Temozolomide|temozolomide|mesh-list
14324788|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324789|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324790|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14324791|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14324792|NCT00782756|Growth Substances|growth substances|mesh-ancestor
14324793|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724898|NCT00501605|Cediranib|cediranib|mesh-list
14724899|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324794|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
14324795|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14324796|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
14324797|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324798|NCT00782795|Pioglitazone|pioglitazone|mesh-list
14324799|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14324800|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324801|NCT00782821|Rituximab|rituximab|mesh-list
14324802|NCT00782821|Bortezomib|bortezomib|mesh-list
14324803|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
14324804|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14324805|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324806|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324807|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
14324808|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324809|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324810|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324811|NCT00783094|Tadalafil|tadalafil|mesh-list
14324812|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
14324813|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14324814|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14324815|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324816|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324817|NCT00783094|Urological Agents|urological agents|mesh-ancestor
14324818|NCT00783289|Benralizumab|benralizumab|mesh-list
14324819|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324820|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324821|NCT00783367|Dexamethasone|dexamethasone|mesh-list
14324822|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
14324823|NCT00783367|Rituximab|rituximab|mesh-list
14324824|NCT00783367|Lenalidomide|lenalidomide|mesh-list
14324825|NCT00783367|BB 1101|bb 1101|mesh-list
14324826|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14324827|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
14324828|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
14324829|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324830|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324831|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324832|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
14324833|NCT00783367|Hormones|hormones|mesh-ancestor
14324834|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324835|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14324836|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324837|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
14324838|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324839|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324840|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14324841|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
14324842|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324843|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14324844|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14324845|NCT00783367|Growth Substances|growth substances|mesh-ancestor
14324846|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
15223076|NCT04283669|Crizotinib|crizotinib|mesh-list
15223077|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223078|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223079|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223080|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223081|NCT04262154|Prednisone|prednisone|mesh-list
15223082|NCT04262154|Atezolizumab|atezolizumab|mesh-list
14324847|NCT00783432|Azelastine|azelastine|mesh-list
14324848|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15223083|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223084|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
15223085|NCT04262154|Hormones|hormones|mesh-ancestor
15223086|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14324849|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
14324850|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324851|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324852|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324853|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324854|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14324855|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324856|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324857|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14324858|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14324859|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14324860|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
15223087|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223088|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223089|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324861|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
14324862|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324863|NCT00783614|Aspirin|aspirin|mesh-list
15223090|NCT04175964|Metformin|metformin|mesh-list
14324864|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14324865|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14324866|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14324867|NCT00783614|Analgesics|analgesics|mesh-ancestor
14324868|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
14324869|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324870|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324871|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14324872|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14324873|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14324874|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14324875|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324876|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14324877|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14324878|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324879|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
14324880|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
14324881|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324882|NCT00783692|Vedolizumab|vedolizumab|mesh-list
14324883|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324884|NCT00783705|Inositol|inositol|mesh-list
14324885|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
14324886|NCT00783705|Vitamins|vitamins|mesh-ancestor
14324887|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
14324888|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324889|NCT00783718|Vedolizumab|vedolizumab|mesh-list
14324890|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14324891|NCT00783796|Everolimus|everolimus|mesh-list
14324892|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324893|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324894|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
14324895|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324896|NCT00783835|Methylphenidate|methylphenidate|mesh-list
14324897|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14324898|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324899|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14324900|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14324901|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324902|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324903|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
14324904|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324905|NCT00783965|Tazarotene|tazarotene|mesh-list
14324906|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
14324907|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
14324908|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14324909|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14324910|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14324911|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324912|NCT00784147|Ibalizumab|ibalizumab|mesh-list
14324913|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14324914|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14324915|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14324916|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
14324917|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324918|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
14324919|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324920|NCT00784225|Vitamins|vitamins|mesh-list
14324921|NCT00784225|Vitamin E|vitamin e|mesh-list
14324922|NCT00784225|Tocopherols|tocopherols|mesh-list
14324923|NCT00784225|Tocotrienols|tocotrienols|mesh-list
14324924|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
14324925|NCT00784225|Selenium|selenium|mesh-list
14324926|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
14324927|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324928|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
14324929|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324930|NCT00784225|Protective Agents|protective agents|mesh-ancestor
14724900|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324931|NCT00784225|Trace Elements|trace elements|mesh-ancestor
14324932|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14324933|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14324934|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14324935|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14324936|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324937|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14324938|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15223091|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15223092|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223093|NCT04175834|Cetirizine|cetirizine|mesh-list
15223094|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
15223095|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15223096|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15223097|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15223098|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
15223099|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223100|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223101|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223102|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
15223103|NCT04157985|Nivolumab|nivolumab|mesh-list
15223104|NCT04157985|Ipilimumab|ipilimumab|mesh-list
15223105|NCT04157985|Cemiplimab|cemiplimab|mesh-list
15223106|NCT04157985|Atezolizumab|atezolizumab|mesh-list
15223107|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15223108|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223109|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324939|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14324940|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
14324941|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324942|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324943|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14910492|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14910493|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14910494|NCT01357031|Analgesics|analgesics|mesh-ancestor
14910495|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
14910496|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14910497|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14910498|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14910499|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14910500|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
14910501|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14910502|NCT01357031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14324944|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14910503|NCT01357031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14910504|NCT01357109|Bosentan|bosentan|mesh-list
14910505|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15223110|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223111|NCT04125745|CXA-10|cxa-10|mesh-list
15223112|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223113|NCT04070768|Venetoclax|venetoclax|mesh-list
15223114|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
15223115|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223116|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223117|NCT04058366|Ivacaftor|ivacaftor|mesh-list
15223118|NCT04058366|Elexacaftor|elexacaftor|mesh-list
15223119|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15223120|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15223121|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223122|NCT04042740|Ribavirin|ribavirin|mesh-list
14324945|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
14324946|NCT00784277|Oxycodone|oxycodone|mesh-list
14324947|NCT00784277|Tapentadol|tapentadol|mesh-list
14324948|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14324949|NCT00784277|Narcotics|narcotics|mesh-ancestor
14324950|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14324951|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324952|NCT00784277|Analgesics|analgesics|mesh-ancestor
14324953|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
14324954|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324955|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14324956|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14324957|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14324958|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324959|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
14324960|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14324961|NCT00784303|Lenvatinib|lenvatinib|mesh-list
14324962|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324963|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14324964|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14324965|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324966|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14324967|NCT00784459|Abatacept|abatacept|mesh-list
14324968|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14324969|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14324970|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324971|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14324972|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
14324973|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324974|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724901|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724902|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724903|NCT00501618|Clozapine|clozapine|mesh-list
14324975|NCT00784524|Aldesleukin|aldesleukin|mesh-list
14724904|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14724905|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
14724906|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724907|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724908|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223123|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
15223124|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223125|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
15223126|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223127|NCT04039503|Tirzepatide|tirzepatide|mesh-list
15223128|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15223129|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223130|NCT04039503|Incretins|incretins|mesh-ancestor
15223131|NCT04039503|Hormones|hormones|mesh-ancestor
15223132|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223133|NCT03913195|Ibalizumab|ibalizumab|mesh-list
14324976|NCT00784524|Interleukin-2|interleukin-2|mesh-list
15223134|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14324977|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14324978|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14324979|NCT00784524|Analgesics|analgesics|mesh-ancestor
14324980|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
14324981|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324982|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324983|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14324984|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14324985|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
14324986|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14324987|NCT00784550|Fluticasone|fluticasone|mesh-list
14324988|NCT00784550|Xhance|xhance|mesh-list
14324989|NCT00784550|Bromides|bromides|mesh-list
14324990|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
14324991|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14324992|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14324993|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14324994|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
14324995|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14324996|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14324997|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14324998|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
14324999|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14325000|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14325001|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
14325002|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14325003|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
14325004|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325005|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325006|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14325007|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14325008|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14325009|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
14325010|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
14325011|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14325012|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14325013|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325014|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14325015|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14325016|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325017|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325018|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
14325019|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325020|NCT00784693|Tanezumab|tanezumab|mesh-list
14325021|NCT00784693|Analgesics|analgesics|mesh-ancestor
14325022|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
14325023|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325024|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325025|NCT00784719|Cyclosporine|cyclosporine|mesh-list
14325026|NCT00784719|Cyclosporins|cyclosporins|mesh-list
14325027|NCT00784719|Tofacitinib|tofacitinib|mesh-list
14325028|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325029|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325030|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325031|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
14325032|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325033|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
14325034|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325035|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14325036|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325037|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14325038|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14325039|NCT00784784|Zanamivir|zanamivir|mesh-list
14325040|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
14325041|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325042|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325043|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325044|NCT00784810|Acetaminophen|acetaminophen|mesh-list
14325045|NCT00784810|Oxycodone|oxycodone|mesh-list
14325046|NCT00784810|Codeine|codeine|mesh-list
14325047|NCT00784810|Naloxone|naloxone|mesh-list
14325048|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325049|NCT00784810|Analgesics|analgesics|mesh-ancestor
14325050|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
14325051|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325052|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325053|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
14325054|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14325055|NCT00784810|Narcotics|narcotics|mesh-ancestor
14325056|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325057|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14325058|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
14325059|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
14325060|NCT00784836|Interferons|interferons|mesh-list
14325061|NCT00784836|Interferon-beta|interferon-beta|mesh-list
14325062|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
14325063|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325064|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
14325065|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325066|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
14325067|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325068|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14325069|NCT00784849|Methylene Blue|methylene blue|mesh-list
14325070|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325071|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325072|NCT00784875|Zolpidem|zolpidem|mesh-list
14325073|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14325074|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14325075|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325076|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325077|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14325078|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
14325079|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
14325080|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325081|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325082|NCT00784927|Dexamethasone|dexamethasone|mesh-list
14325083|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
14325084|NCT00784927|Rituximab|rituximab|mesh-list
14325085|NCT00784927|Lenalidomide|lenalidomide|mesh-list
14325086|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325087|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
14325088|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325089|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325090|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325091|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
14325092|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325093|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325094|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325095|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325096|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
14325097|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
14325098|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325099|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325100|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
14325101|NCT00784927|Hormones|hormones|mesh-ancestor
14325102|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325103|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14325104|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14325105|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14325106|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14325107|NCT00784927|Growth Substances|growth substances|mesh-ancestor
14325108|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
14325109|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
14325110|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
14325111|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325112|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
14325113|NCT00785213|Quinine|quinine|mesh-list
14325114|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14325115|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325116|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
14325117|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14325118|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14325119|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325120|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14325121|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14325122|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325123|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325124|NCT00785213|Analgesics|analgesics|mesh-ancestor
14325125|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
14325126|NCT00785486|Quinine|quinine|mesh-list
14325127|NCT00785486|Midazolam|midazolam|mesh-list
14325128|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14325129|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14724909|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14724910|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14724911|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14724912|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14724913|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
14325130|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325131|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325132|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14325133|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325134|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325135|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14325136|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
14325137|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
14724914|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
14724915|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14724916|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724917|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724918|NCT00501657|Incretins|incretins|mesh-ancestor
14724919|NCT00501657|Hormones|hormones|mesh-ancestor
14724920|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724921|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14724922|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
14724923|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724924|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724925|NCT00501696|Naltrexone|naltrexone|mesh-list
14724926|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14724927|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14724928|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724929|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
14325138|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
14325139|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
14724930|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724931|NCT00501722|Satavaptan|satavaptan|mesh-list
14724932|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14724933|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724934|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
14724935|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724936|NCT00501748|Rituximab|rituximab|mesh-list
14724937|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14724938|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724939|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
14724940|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724941|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14724942|NCT00501787|Metformin|metformin|mesh-list
14724943|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724944|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724945|NCT00501839|Clomiphene|clomiphene|mesh-list
14724946|NCT00501839|Enclomiphene|enclomiphene|mesh-list
14724947|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
14724948|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14724949|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
14724950|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14724951|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325140|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325141|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325142|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
14325143|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14325144|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14325145|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325146|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14325147|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14724952|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14724953|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
14724954|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14724955|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14325148|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325149|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325150|NCT00785486|Analgesics|analgesics|mesh-ancestor
14325151|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
14325152|NCT00785512|Nebivolol|nebivolol|mesh-list
14325153|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14325154|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
14325155|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14325156|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14325157|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14325158|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
14325159|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325160|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325161|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325162|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14325163|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
14325164|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325165|NCT00785577|Pregabalin|pregabalin|mesh-list
14325166|NCT00785577|Analgesics|analgesics|mesh-ancestor
14325167|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
14325168|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325169|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325170|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
14325171|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14325172|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325173|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325174|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14325175|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14325176|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325177|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325178|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325179|NCT00785629|Calcium|calcium|mesh-list
14325180|NCT00785629|Sevelamer|sevelamer|mesh-list
14325181|NCT00785629|Calcium acetate|calcium acetate|mesh-list
14325182|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14325183|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325184|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
14325185|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
14325186|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325187|NCT00785772|Gabapentin|gabapentin|mesh-list
14325188|NCT00785772|Analgesics|analgesics|mesh-ancestor
14325189|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
14325190|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325191|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325192|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
14325193|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14325194|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325195|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325196|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325197|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14325198|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14325199|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325200|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325201|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
14325202|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
14325203|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325204|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14325205|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325206|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325207|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
14325208|NCT00785980|Quinine|quinine|mesh-list
14325209|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14325210|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325211|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14325212|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14724956|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14325213|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325214|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325215|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325216|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14325217|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14325218|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
14325219|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14325220|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14325221|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14325222|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325223|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14325224|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325225|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325226|NCT00785980|Analgesics|analgesics|mesh-ancestor
14325227|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
14325228|NCT00786019|Vitamins|vitamins|mesh-list
14325229|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
14325230|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
14325231|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325232|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
14325233|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325234|NCT00786019|Protective Agents|protective agents|mesh-ancestor
14325235|NCT00786188|Paroxetine|paroxetine|mesh-list
14325236|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14325237|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14325238|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325239|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325240|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325241|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
14325242|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325243|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14325244|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
14325245|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325246|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14325247|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14325248|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14724957|NCT00501878|Phenylephrine|phenylephrine|mesh-list
14724958|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
15223135|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15223136|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
15223137|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223138|NCT03878199|Cytarabine|cytarabine|mesh-list
15223139|NCT03878199|Daunorubicin|daunorubicin|mesh-list
15223140|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15223141|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223142|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
15223143|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223144|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223145|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
15223146|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325249|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
14325250|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14325251|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
14325252|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14325253|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
14325254|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325255|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325256|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
14325257|NCT00786474|Dalteparin|dalteparin|mesh-list
14325258|NCT00786474|Tinzaparin|tinzaparin|mesh-list
14325259|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14325260|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
14325261|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14325262|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14325263|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325264|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14325265|NCT00786487|Glycerol|glycerol|mesh-list
14325266|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14325267|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14325268|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14325269|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14325270|NCT00786487|Protective Agents|protective agents|mesh-ancestor
14325271|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325272|NCT00786643|Leucovorin|leucovorin|mesh-list
14325273|NCT00786643|Interferons|interferons|mesh-list
14325274|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
14325275|NCT00786643|Bevacizumab|bevacizumab|mesh-list
14325276|NCT00786643|Fluorouracil|fluorouracil|mesh-list
14325277|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
14325278|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14325279|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325280|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14325281|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14325282|NCT00786643|Growth Substances|growth substances|mesh-ancestor
14325283|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325284|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
14325285|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
14325286|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325287|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14325288|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325289|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
14325290|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
14325291|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325292|NCT00786643|Antidotes|antidotes|mesh-ancestor
14325293|NCT00786643|Protective Agents|protective agents|mesh-ancestor
14325294|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
14325295|NCT00786643|Vitamins|vitamins|mesh-ancestor
14325296|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
14325297|NCT00786825|Somatostatin|somatostatin|mesh-list
14325298|NCT00786825|Hormones|hormones|mesh-ancestor
14325299|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325300|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325301|NCT00786838|Trabectedin|trabectedin|mesh-list
14724959|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14724960|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
14724961|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
14724962|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724963|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724964|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
14724965|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14724966|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
14724967|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
14724968|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14325302|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325303|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
14325304|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325305|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325306|NCT00786916|Lidocaine|lidocaine|mesh-list
14325307|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
14325308|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
14325309|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325310|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325311|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
14325312|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325313|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14325314|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14325315|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14325316|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325317|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325318|NCT00786994|Petrolatum|petrolatum|mesh-list
14325319|NCT00786994|Emollients|emollients|mesh-ancestor
14325320|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
14325321|NCT00787150|Warfarin|warfarin|mesh-list
14325322|NCT00787150|Apixaban|apixaban|mesh-list
14325323|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
14325324|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14325325|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
14325326|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14325327|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
14325328|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325329|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325330|NCT00787254|Lansoprazole|lansoprazole|mesh-list
14724969|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14724970|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14724971|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
14325331|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
14325332|NCT00787254|Gefarnate|gefarnate|mesh-list
14325333|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14325334|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325335|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14325336|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325337|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325338|NCT00787267|Dasatinib|dasatinib|mesh-list
14325339|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325340|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14325341|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325342|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325343|NCT00787332|Desirudin|desirudin|mesh-list
14325344|NCT00787332|Argatroban|argatroban|mesh-list
14325345|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
14325346|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14325347|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
14325348|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325349|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325350|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
14325351|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14724972|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14724973|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724974|NCT00501878|Protective Agents|protective agents|mesh-ancestor
14724975|NCT00501904|Metformin|metformin|mesh-list
14724976|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14724977|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724978|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
14724979|NCT00501917|Hematinics|hematinics|mesh-ancestor
14724980|NCT00501982|Poractant alfa|poractant alfa|mesh-list
14724981|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14724982|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
14724983|NCT00502034|Interferons|interferons|mesh-list
14724984|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
14724985|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
14325352|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14325353|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14325354|NCT00787527|Prednisone|prednisone|mesh-list
14325355|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
14325356|NCT00787527|Doxorubicin|doxorubicin|mesh-list
14325357|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14325358|NCT00787527|Vincristine|vincristine|mesh-list
14325359|NCT00787527|Vorinostat|vorinostat|mesh-list
14325360|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325361|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
14325362|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325363|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325364|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325365|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
14325366|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14724986|NCT00502034|Interleukin-2|interleukin-2|mesh-list
14724987|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325367|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325368|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325369|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14325370|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14325371|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14325372|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325373|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325374|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
14325375|NCT00787527|Hormones|hormones|mesh-ancestor
14325376|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325377|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14325378|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14325379|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
14325380|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
14325381|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
14325382|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14325383|NCT00787566|Granisetron|granisetron|mesh-list
14325384|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
14325385|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
14325386|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325387|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325388|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325389|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14325390|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
14325391|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325392|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325393|NCT00787605|Amlodipine|amlodipine|mesh-list
14325394|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14325395|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14325396|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14325397|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325398|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325399|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14325400|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325401|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
14325402|NCT00787605|Diuretics|diuretics|mesh-ancestor
14325403|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
14325404|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14325405|NCT00787644|Pioglitazone|pioglitazone|mesh-list
14325406|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14325407|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325408|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
14325409|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14325410|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14325411|NCT00787722|Prednisolone|prednisolone|mesh-list
14325412|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
14325413|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
14325414|NCT00787722|Rituximab|rituximab|mesh-list
14325415|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
14325416|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14325417|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14325418|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
14325419|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325420|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
14325421|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325422|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325423|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325424|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
14325425|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325426|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325427|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325428|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14325429|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325430|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
14325431|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
14325432|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325433|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325434|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
14325435|NCT00787722|Hormones|hormones|mesh-ancestor
14325436|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325437|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14325438|NCT00787722|Protective Agents|protective agents|mesh-ancestor
14325439|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14328461|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328462|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
14328463|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14328464|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
14328465|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328466|NCT00809094|Expectorants|expectorants|mesh-ancestor
14328467|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
14328468|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14328469|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
14328470|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328471|NCT00809094|Protective Agents|protective agents|mesh-ancestor
14328472|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328473|NCT00809094|Antidotes|antidotes|mesh-ancestor
14328474|NCT00809133|Paclitaxel|paclitaxel|mesh-list
14328475|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14328476|NCT00809133|Bevacizumab|bevacizumab|mesh-list
14328477|NCT00809133|Carboplatin|carboplatin|mesh-list
14328478|NCT00809133|Afatinib|afatinib|mesh-list
14328479|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14328480|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328481|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
14328482|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
14328483|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
14328484|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328485|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14328486|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14328487|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14328488|NCT00809133|Growth Substances|growth substances|mesh-ancestor
14328489|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328490|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
14328491|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14328492|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328608|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325440|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
14325441|NCT00787761|Busulfan|busulfan|mesh-list
14325442|NCT00787761|Methotrexate|methotrexate|mesh-list
14325443|NCT00787761|Fludarabine|fludarabine|mesh-list
14325444|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
14325445|NCT00787761|Tacrolimus|tacrolimus|mesh-list
14325446|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
14325447|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14325448|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325449|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
14325450|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325451|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325452|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325453|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
14325454|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325455|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325456|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325457|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14325458|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
14325459|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14325460|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14325461|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
14325462|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14325463|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325464|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14325465|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14325466|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14325467|NCT00787787|Capecitabine|capecitabine|mesh-list
14325468|NCT00787787|Sunitinib|sunitinib|mesh-list
14325469|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14325470|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
14325471|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325472|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325473|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14325474|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14325475|NCT00787787|Growth Substances|growth substances|mesh-ancestor
14325476|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325477|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
14325478|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14325479|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325480|NCT00787852|Paclitaxel|paclitaxel|mesh-list
14325481|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14325482|NCT00787852|Dasatinib|dasatinib|mesh-list
14325483|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14325484|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325485|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14325486|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14325487|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14325488|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325489|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14325490|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325491|NCT00787891|Rabeprazole|rabeprazole|mesh-list
14325492|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14325493|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325494|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14325495|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325496|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325497|NCT00787930|Valproic Acid|valproic acid|mesh-list
14325498|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
14325499|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325500|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325501|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
14325502|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325503|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325504|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
14325505|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325506|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325507|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325508|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14325509|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
14325510|NCT00788008|Propofol|propofol|mesh-list
14325511|NCT00788008|Isoflurane|isoflurane|mesh-list
14325512|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
14325513|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325514|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325515|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14325516|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14325517|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
14325518|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14325519|NCT00788255|Oxytocin|oxytocin|mesh-list
14325520|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
14325521|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14325522|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325523|NCT00788372|Fentanyl|fentanyl|mesh-list
14325524|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14325525|NCT00788372|Narcotics|narcotics|mesh-ancestor
14325526|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325527|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325528|NCT00788372|Analgesics|analgesics|mesh-ancestor
14325529|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
14325530|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325531|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14325532|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14325533|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
14325534|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
14325535|NCT00788593|Pancreatin|pancreatin|mesh-list
14325536|NCT00788593|Pancrelipase|pancrelipase|mesh-list
14325537|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325538|NCT00788892|Cytarabine|cytarabine|mesh-list
14325539|NCT00788892|Daunorubicin|daunorubicin|mesh-list
14325540|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14325541|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
14325542|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325543|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325544|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
14325545|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325546|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325547|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
14325548|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325549|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14325550|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14325551|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14325552|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325553|NCT00788957|Panitumumab|panitumumab|mesh-list
14325554|NCT00788957|Rilotumumab|rilotumumab|mesh-list
14325555|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14325556|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325557|NCT00789035|Metformin|metformin|mesh-list
14325558|NCT00789035|Empagliflozin|empagliflozin|mesh-list
14325559|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14325560|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325561|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14325562|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325563|NCT00789074|Varenicline|varenicline|mesh-list
14325564|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14325565|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14325566|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
14325567|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325568|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325569|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325570|NCT00789113|Lamotrigine|lamotrigine|mesh-list
14325571|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
14325572|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14325573|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325574|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325575|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14325576|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325577|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14325578|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325579|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325580|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325581|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14325582|NCT00789191|Metformin|metformin|mesh-list
14325583|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14325584|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
14325585|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14910506|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14325586|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724988|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
14724989|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14724990|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
14724991|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14724992|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14724993|NCT00502034|Analgesics|analgesics|mesh-ancestor
14724994|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
14724995|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14724996|NCT00502060|Cediranib|cediranib|mesh-list
14724997|NCT00502060|Gefitinib|gefitinib|mesh-list
14724998|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14724999|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725000|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725001|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725002|NCT00502073|Cyclosporine|cyclosporine|mesh-list
14910507|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910508|NCT01357252|Vildagliptin|vildagliptin|mesh-list
14910509|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14910510|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910511|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14910512|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
14910513|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223147|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223148|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
14325587|NCT00789191|Incretins|incretins|mesh-ancestor
14325588|NCT00789191|Hormones|hormones|mesh-ancestor
14325589|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325590|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14325591|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
14325592|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325593|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325594|NCT00789256|Bortezomib|bortezomib|mesh-list
14325595|NCT00789256|Melphalan|melphalan|mesh-list
14325596|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325597|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325598|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
15223149|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223150|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15223151|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15223152|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15223153|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223154|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14325599|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325600|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325601|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325602|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
14325603|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325604|NCT00789321|Amlodipine|amlodipine|mesh-list
14325605|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14725003|NCT00502073|Cyclosporins|cyclosporins|mesh-list
15223155|NCT03778229|Osimertinib|osimertinib|mesh-list
14725004|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223156|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14910514|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223157|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14325606|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14325607|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325608|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325609|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14325610|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325611|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
14325612|NCT00789360|Loxapine|loxapine|mesh-list
14325613|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14325614|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325615|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325616|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325617|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325618|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14325619|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
14325620|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325621|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325622|NCT00789373|Pemetrexed|pemetrexed|mesh-list
14325623|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325624|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325625|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325626|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14325627|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14325628|NCT00789477|Aflibercept|aflibercept|mesh-list
14325629|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14325630|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14325631|NCT00789477|Growth Substances|growth substances|mesh-ancestor
14325632|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325633|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
14325634|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325635|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14325636|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14325637|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325638|NCT00789555|Analgesics|analgesics|mesh-ancestor
14325639|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
14325640|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325641|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325642|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325643|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325644|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14325645|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14325646|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14325647|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
14325648|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
14325649|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325650|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325651|NCT00789581|Paclitaxel|paclitaxel|mesh-list
14325652|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
14325653|NCT00789581|Doxorubicin|doxorubicin|mesh-list
14325654|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14325655|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14325656|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325657|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
14325658|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
14325659|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
14325660|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325661|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325662|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
14325663|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325664|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325665|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325666|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
14325667|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325668|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14325669|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14325670|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14325671|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325672|NCT00789672|Levodopa|levodopa|mesh-list
14325673|NCT00789672|Carbidopa|carbidopa|mesh-list
14325674|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14325675|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14325676|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
14325677|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325678|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325679|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325680|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14325681|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325682|NCT00789685|Interferons|interferons|mesh-list
14325683|NCT00789685|Interferon-beta|interferon-beta|mesh-list
14910515|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
14325684|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325685|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
14328493|NCT00809185|Everolimus|everolimus|mesh-list
14325686|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325687|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
14325688|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325689|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14325690|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14325691|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
14325692|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15223158|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223159|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223160|NCT03695172|Ropivacaine|ropivacaine|mesh-list
15223161|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
15223162|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
15223163|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223164|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725005|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725006|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725007|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
14725008|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223165|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
14325693|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14325694|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325695|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325696|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325697|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14325698|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14325699|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14325700|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14325701|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325702|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325703|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14325704|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14325705|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
14325706|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14325707|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14325708|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
14325709|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15223166|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223167|NCT03554044|Tamoxifen|tamoxifen|mesh-list
15223168|NCT03554044|Gemcitabine|gemcitabine|mesh-list
15223169|NCT03554044|Paclitaxel|paclitaxel|mesh-list
15223170|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15223171|NCT03554044|Carboplatin|carboplatin|mesh-list
14325710|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325711|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14325712|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14325713|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14325714|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
14325715|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325716|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14325717|NCT00789750|Pioglitazone|pioglitazone|mesh-list
14325718|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14325719|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14325720|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325721|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14325722|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14325723|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
14325724|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325725|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14325726|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
14325727|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
14325728|NCT00789776|Fludarabine|fludarabine|mesh-list
14325729|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
14325730|NCT00789776|Tacrolimus|tacrolimus|mesh-list
14325731|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325732|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
14325733|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325734|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325735|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325736|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
14325737|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325738|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325739|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325740|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14325741|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
14325742|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14325743|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325744|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14325745|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14325746|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
14325747|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14325748|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325749|NCT00789802|Naproxen|naproxen|mesh-list
14325750|NCT00789802|Estradiol|estradiol|mesh-list
14325751|NCT00789802|Estrogens|estrogens|mesh-ancestor
14325752|NCT00789802|Hormones|hormones|mesh-ancestor
14325753|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325754|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325755|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14325756|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325757|NCT00789802|Analgesics|analgesics|mesh-ancestor
14325758|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
14325759|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325760|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325761|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325762|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
14325763|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14325764|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325765|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325766|NCT00789815|Midazolam|midazolam|mesh-list
14325767|NCT00789815|Propofol|propofol|mesh-list
14325768|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14325769|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325770|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325771|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14325772|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
14325773|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
14325774|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14325775|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14325776|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325777|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325778|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
14325779|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
14325780|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325781|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325782|NCT00789828|Everolimus|everolimus|mesh-list
14325783|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325784|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325785|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
14725009|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
14725010|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325786|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325787|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14725011|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14725012|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725013|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14725014|NCT00502099|Interferons|interferons|mesh-list
14910516|NCT01357317|Calcium|calcium|mesh-list
14325788|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
14910517|NCT01357317|Calcium acetate|calcium acetate|mesh-list
14725015|NCT00502099|Ribavirin|ribavirin|mesh-list
14725016|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
14725017|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
14725018|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14325789|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14325790|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
14325791|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325792|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14325793|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325794|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325795|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325796|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325797|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325798|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
14325799|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14325800|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14325801|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325802|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325803|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14325804|NCT00789880|Vitamin D|vitamin d|mesh-list
14325805|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
14325806|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
14325807|NCT00789880|Vitamins|vitamins|mesh-list
14325808|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
14325809|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325810|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14325811|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14325812|NCT00789958|Gemcitabine|gemcitabine|mesh-list
14325813|NCT00789958|Capecitabine|capecitabine|mesh-list
14325814|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14325815|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
14325816|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325817|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325818|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
14325819|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325820|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325821|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325822|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
14325823|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325824|NCT00789997|Levofloxacin|levofloxacin|mesh-list
14325825|NCT00789997|Ofloxacin|ofloxacin|mesh-list
14325826|NCT00789997|Prednisone|prednisone|mesh-list
14325827|NCT00789997|Etanercept|etanercept|mesh-list
14325828|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325829|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
14325830|NCT00789997|Hormones|hormones|mesh-ancestor
14325831|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325832|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325833|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14325834|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325835|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14325836|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325837|NCT00789997|Analgesics|analgesics|mesh-ancestor
14325838|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
14325839|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325840|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325841|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325842|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325843|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
14325844|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14725019|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14725020|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725021|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
14725022|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325845|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14325846|NCT00789997|Renal Agents|renal agents|mesh-ancestor
14325847|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14325848|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14325849|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14325850|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325851|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325852|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14325853|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14325854|NCT00790023|Ciclesonide|ciclesonide|mesh-list
14325855|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
14325856|NCT00790023|Hormones|hormones|mesh-ancestor
14325857|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325858|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325859|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14325860|NCT00790036|Everolimus|everolimus|mesh-list
14325861|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325862|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325863|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
14325864|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223172|NCT03554044|Letrozole|letrozole|mesh-list
15223173|NCT03554044|Fulvestrant|fulvestrant|mesh-list
15223174|NCT03554044|Anastrozole|anastrozole|mesh-list
15223175|NCT03554044|Exemestane|exemestane|mesh-list
15223176|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15223177|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15223178|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223179|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
15223180|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
15223181|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
15223182|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223183|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14325865|NCT00790062|Oxytocin|oxytocin|mesh-list
14325866|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
14325867|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14325868|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325869|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14325870|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14910518|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14910519|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14910520|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14910521|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
14910522|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
14910523|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910524|NCT01357486|Sorafenib|sorafenib|mesh-list
14910525|NCT01357486|Pravastatin|pravastatin|mesh-list
14910526|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325871|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
14910527|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223184|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
14325872|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325873|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14325874|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325875|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325876|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325877|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14725023|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
14725024|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725025|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
14325878|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14325879|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14325880|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
14325881|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325882|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325883|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14325884|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14325885|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
14325886|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14325887|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14325888|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
14325889|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14325890|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14325891|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325892|NCT00790205|Incretins|incretins|mesh-ancestor
14325893|NCT00790205|Hormones|hormones|mesh-ancestor
14325894|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325895|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14325896|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
14325897|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325898|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325899|NCT00790218|Adenosine|adenosine|mesh-list
14325900|NCT00790218|Analgesics|analgesics|mesh-ancestor
14325901|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
14325902|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325903|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325904|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14325905|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14325906|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14325907|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
14325908|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
14325909|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325910|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325911|NCT00790270|Ibuprofen|ibuprofen|mesh-list
14325912|NCT00790270|Amitriptyline|amitriptyline|mesh-list
14325913|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
14325914|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14325915|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14325916|NCT00790270|Analgesics|analgesics|mesh-ancestor
14325917|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
14325918|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325919|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325920|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325921|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14325922|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14325923|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325924|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325925|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14325926|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
14325927|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325928|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14325929|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14725026|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725027|NCT00502112|Lenalidomide|lenalidomide|mesh-list
14325930|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325931|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325932|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14325933|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14325934|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14325935|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
14325936|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325937|NCT00790296|Hormones|hormones|mesh-list
14325938|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
14325939|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14325940|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325941|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14325942|NCT00790335|Plasminogen|plasminogen|mesh-list
14325943|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14325944|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14325945|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325946|NCT00790400|Everolimus|everolimus|mesh-list
14325947|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325948|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325949|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
14325950|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325951|NCT00790569|Nicotine|nicotine|mesh-list
14325952|NCT00790569|Varenicline|varenicline|mesh-list
14325953|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14325954|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
14325955|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325956|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325957|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14325958|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14325959|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
14725028|NCT00502112|Lintuzumab|lintuzumab|mesh-list
14725029|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
14725030|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725031|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14725032|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14725033|NCT00502112|Growth Substances|growth substances|mesh-ancestor
14725034|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
14325960|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14325961|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325962|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
14325963|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
14325964|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325965|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14325966|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325967|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
14325968|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14325969|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14325970|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325971|NCT00790647|Bortezomib|bortezomib|mesh-list
15223185|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
15223186|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223187|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223188|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223189|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
15223190|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223191|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15223192|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15223193|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15223194|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
15223195|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223196|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223197|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15223198|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15223199|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15223200|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15223201|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223202|NCT03552380|Nivolumab|nivolumab|mesh-list
15223203|NCT03552380|Ipilimumab|ipilimumab|mesh-list
15223204|NCT03552380|Entinostat|entinostat|mesh-list
15223205|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223206|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223207|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15223208|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223209|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15223210|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223211|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
15223212|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223213|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223214|NCT03491267|Tretinoin|tretinoin|mesh-list
15223215|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223216|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
15223217|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
15223218|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15223219|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
14325972|NCT00790647|Melphalan|melphalan|mesh-list
14325973|NCT00790647|Sargramostim|sargramostim|mesh-list
14325974|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
14325975|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325976|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14325977|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14325978|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
14325979|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14325980|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14325981|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14325982|NCT00790842|Aspirin|aspirin|mesh-list
14325983|NCT00790842|Dexamethasone|dexamethasone|mesh-list
14325984|NCT00790842|Lenalidomide|lenalidomide|mesh-list
14325985|NCT00790842|Heparin|heparin|mesh-list
14325986|NCT00790842|Calcium heparin|calcium heparin|mesh-list
14325987|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15223220|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223221|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14325988|NCT00790842|Tinzaparin|tinzaparin|mesh-list
14325989|NCT00790842|Dalteparin|dalteparin|mesh-list
14325990|NCT00790842|Anticoagulants|anticoagulants|mesh-list
14325991|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14325992|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
14325993|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
14325994|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14325995|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14325996|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14325997|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
14325998|NCT00790842|Hormones|hormones|mesh-ancestor
14325999|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326000|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14326001|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326002|NCT00790842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14326003|NCT00790842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326004|NCT00790842|Analgesics|analgesics|mesh-ancestor
14326005|NCT00790842|Sensory System Agents|sensory system agents|mesh-ancestor
14326006|NCT00790842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326007|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14326008|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14326009|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326010|NCT00790842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14326011|NCT00790842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14326012|NCT00790842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326013|NCT00790842|Antipyretics|antipyretics|mesh-ancestor
14326014|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
14326015|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14326016|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14326017|NCT00790842|Growth Substances|growth substances|mesh-ancestor
14326018|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326019|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14326020|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326021|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
14326022|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326023|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326024|NCT00790868|Cycloserine|cycloserine|mesh-list
14326025|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14326026|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326027|NCT00790868|Renal Agents|renal agents|mesh-ancestor
14326028|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14326029|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
14326030|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326031|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
14326032|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326033|NCT00790907|Heparin|heparin|mesh-list
14326034|NCT00790907|PENTA|penta|mesh-list
14326035|NCT00790907|Fondaparinux|fondaparinux|mesh-list
14326036|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
14326037|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14326038|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14910528|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223222|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
15223223|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223224|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223225|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15223226|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15223227|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15223228|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
15223229|NCT03470675|Ketamine|ketamine|mesh-list
15223230|NCT03470675|Morphine|morphine|mesh-list
14326039|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326040|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14326041|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
14326042|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14326043|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14326044|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326045|NCT00790933|Vedolizumab|vedolizumab|mesh-list
14326046|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326047|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
14326048|NCT00791037|Sargramostim|sargramostim|mesh-list
14326049|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326050|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
14326051|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326052|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326053|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326054|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
14326055|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326056|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326057|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14326058|NCT00791219|Itraconazole|itraconazole|mesh-list
14326059|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14326060|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
14326061|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326062|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14326063|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14326064|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326065|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326066|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15223231|NCT03470675|Analgesics|analgesics|mesh-ancestor
15223232|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
15223233|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223234|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223235|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15223236|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15223237|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
15223238|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
15223239|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223240|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15223241|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15223242|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223243|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223244|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15223245|NCT03470675|Narcotics|narcotics|mesh-ancestor
14326067|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
14326068|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326069|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326070|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14326071|NCT00791258|Amlodipine|amlodipine|mesh-list
14326072|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15223246|NCT03467360|Etoposide|etoposide|mesh-list
14326073|NCT00791258|Olmesartan|olmesartan|mesh-list
14326074|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14326075|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14326076|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14326077|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326078|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326079|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14326080|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326081|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
14326082|NCT00791258|Diuretics|diuretics|mesh-ancestor
14326083|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
14326084|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14326085|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14326086|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14326087|NCT00791323|Ketorolac|ketorolac|mesh-list
14326088|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14326089|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
14326090|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14326091|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14326092|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326093|NCT00791323|Analgesics|analgesics|mesh-ancestor
14326094|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
14326095|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326096|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326097|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14326098|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326099|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14326100|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326101|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326102|NCT00791479|Dulaglutide|dulaglutide|mesh-list
14326103|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326104|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326105|NCT00791557|Infliximab|infliximab|mesh-list
14326106|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
14326107|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326108|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326109|NCT00791648|Atorvastatin|atorvastatin|mesh-list
14326110|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14326111|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14326112|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
14326113|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326114|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14326115|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14326116|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326117|NCT00791700|Maraviroc|maraviroc|mesh-list
14326118|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14326119|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14326120|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326121|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14326122|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14326123|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
14326124|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326125|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14326126|NCT00791765|Etanercept|etanercept|mesh-list
14326127|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14326128|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326129|NCT00791765|Analgesics|analgesics|mesh-ancestor
14326130|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
14326131|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326132|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326133|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14326134|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326135|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326136|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326137|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
14326138|NCT00791778|Sorafenib|sorafenib|mesh-list
14326139|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326140|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14326141|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326142|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326143|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
14326144|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326145|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
14326146|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326147|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326148|NCT00791973|Fluticasone|fluticasone|mesh-list
14326149|NCT00791973|Xhance|xhance|mesh-list
14326150|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14326151|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14326152|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
14326153|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326154|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326155|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14326156|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
14326157|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
14326158|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14326159|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
14326160|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326161|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
14326162|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326163|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326164|NCT00792077|Lenalidomide|lenalidomide|mesh-list
14326165|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
14326166|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326167|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14326168|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14326169|NCT00792077|Growth Substances|growth substances|mesh-ancestor
14326170|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326171|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326172|NCT00792142|Thalidomide|thalidomide|mesh-list
14326173|NCT00792142|Dexamethasone|dexamethasone|mesh-list
14326174|NCT00792142|Bortezomib|bortezomib|mesh-list
14326175|NCT00792142|Melphalan|melphalan|mesh-list
14326176|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14326177|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
14326178|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
14326179|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326180|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326181|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326182|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
14326183|NCT00792142|Hormones|hormones|mesh-ancestor
14326184|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326185|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14326186|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326187|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326188|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
14326189|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326190|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14326191|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326192|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
14326193|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
14326194|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326195|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326196|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14326197|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14326198|NCT00792142|Growth Substances|growth substances|mesh-ancestor
14326199|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326200|NCT00792298|Suvorexant|suvorexant|mesh-list
14326201|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14326202|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14326203|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14326204|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326205|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14326206|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326207|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328494|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328495|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328496|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
14328497|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328498|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
14328499|NCT00809276|Busulfan|busulfan|mesh-list
14328500|NCT00809276|Fludarabine|fludarabine|mesh-list
14328501|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328502|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
14328503|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328504|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328505|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14328506|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
14328507|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328508|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328509|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14328510|NCT00809328|Azithromycin|azithromycin|mesh-list
14328511|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14328512|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328513|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14328514|NCT00809354|Tanezumab|tanezumab|mesh-list
14328515|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328516|NCT00809354|Analgesics|analgesics|mesh-ancestor
14328517|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
14328518|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328519|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328520|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328521|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328522|NCT00809757|Albuterol|albuterol|mesh-list
14328523|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14328524|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
14328525|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328526|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328527|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14328528|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
14328529|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
14328530|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14328531|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14328532|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14328533|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14328534|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
14328535|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328536|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328537|NCT00809783|Tanezumab|tanezumab|mesh-list
14328538|NCT00809783|Analgesics|analgesics|mesh-ancestor
14328539|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
14328540|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328541|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328542|NCT00809809|Zinc|zinc|mesh-list
14328543|NCT00809809|Trace Elements|trace elements|mesh-ancestor
14328544|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
14326208|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14326209|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14326210|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326211|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326212|NCT00792571|Epoprostenol|epoprostenol|mesh-list
14326213|NCT00792571|Beraprost|beraprost|mesh-list
14326214|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14326215|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
14326216|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14326217|NCT00792636|Naproxen|naproxen|mesh-list
14326218|NCT00792636|Sumatriptan|sumatriptan|mesh-list
14326219|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14326220|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326221|NCT00792636|Analgesics|analgesics|mesh-ancestor
14326222|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
14725035|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725036|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14725037|NCT00502138|Pramlintide|pramlintide|mesh-list
14725038|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14725039|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14725040|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725041|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
14725042|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14725043|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14326223|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326224|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326225|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14326226|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326227|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
14326228|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14326229|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326230|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326231|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14326232|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14326233|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14326234|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
14326235|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326236|NCT00792701|Gemcitabine|gemcitabine|mesh-list
14326237|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326238|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14326239|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
14326240|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326241|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
14326242|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326243|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326244|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326245|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
14326246|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326247|NCT00792909|Vaccines|vaccines|mesh-list
14326248|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14326249|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
14326250|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326251|NCT00792922|Azithromycin|azithromycin|mesh-list
14326252|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326253|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326254|NCT00792935|Metformin|metformin|mesh-list
14326255|NCT00792935|Glimepiride|glimepiride|mesh-list
14326256|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326257|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326258|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14326259|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326260|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
14326261|NCT00793546|Exemestane|exemestane|mesh-list
14326262|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326263|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14326264|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14326265|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326266|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326267|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14326268|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
14326269|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326270|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326271|NCT00793572|Cyclosporine|cyclosporine|mesh-list
14326272|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
14326273|NCT00793572|Fludarabine|fludarabine|mesh-list
14326274|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
14326275|NCT00793572|Bortezomib|bortezomib|mesh-list
14326276|NCT00793572|Melphalan|melphalan|mesh-list
14326277|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
14326278|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14326279|NCT00793572|Cyclosporins|cyclosporins|mesh-list
14326280|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326281|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14326282|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
14725044|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725045|NCT00502164|Cediranib|cediranib|mesh-list
14326283|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326284|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326285|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
14326286|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326287|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326288|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
14326289|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326290|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14326291|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326292|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14326293|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14326294|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14326295|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
14326296|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326297|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326298|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
14326299|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14326300|NCT00793585|Allopurinol|allopurinol|mesh-list
14326301|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
14326302|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326303|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326304|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
14326305|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326306|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14326307|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
14326308|NCT00793585|Protective Agents|protective agents|mesh-ancestor
14326309|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326310|NCT00793598|Brincidofovir|brincidofovir|mesh-list
14326311|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
14326312|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326313|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
14326314|NCT00793624|Olodaterol|olodaterol|mesh-list
14326315|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14326316|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
14326317|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326318|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326319|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14326320|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
14326321|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14326322|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14326323|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14326324|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
14326325|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326326|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326327|NCT00793650|Bortezomib|bortezomib|mesh-list
14725046|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326328|NCT00793650|Melphalan|melphalan|mesh-list
14326329|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223247|NCT03467360|Acetazolamide|acetazolamide|mesh-list
14326330|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326331|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
14326332|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326333|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14326334|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326335|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
14326336|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326337|NCT00793780|Naltrexone|naltrexone|mesh-list
14326338|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14725047|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725048|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223248|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14326339|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14326340|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326341|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
14326342|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326343|NCT00793819|Silodosin|silodosin|mesh-list
14326344|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14326345|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14326346|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14326347|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
14725049|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725050|NCT00502190|Silicon|silicon|mesh-list
14725051|NCT00502190|Trace Elements|trace elements|mesh-ancestor
14725052|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
14326348|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326349|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326350|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326351|NCT00793819|Urological Agents|urological agents|mesh-ancestor
14326352|NCT00793871|Sunitinib|sunitinib|mesh-list
14326353|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326354|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14326355|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14326356|NCT00793871|Growth Substances|growth substances|mesh-ancestor
14326357|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326358|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326359|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14326360|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326361|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326362|NCT00793910|Gabapentin|gabapentin|mesh-list
14326363|NCT00793910|Analgesics|analgesics|mesh-ancestor
14326364|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
14326365|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326366|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326367|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
14326368|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14326369|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14326370|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223249|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223250|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15223251|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725053|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725054|NCT00502229|Metformin|metformin|mesh-list
15223252|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223253|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223254|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
15223255|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15223256|NCT03467360|Diuretics|diuretics|mesh-ancestor
15223257|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
15223258|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223259|NCT03452072|Timolol|timolol|mesh-list
15223260|NCT03452072|Petrolatum|petrolatum|mesh-list
15223261|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14326371|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326372|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14326373|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14326374|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223262|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14326375|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326376|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
14326377|NCT00794040|Methylphenidate|methylphenidate|mesh-list
14326378|NCT00794040|Citalopram|citalopram|mesh-list
14326379|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14326380|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326381|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14326382|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14326383|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326384|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326385|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
14326386|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326387|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14326388|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
14326389|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14326390|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
14326391|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326392|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14326393|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14326394|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326395|NCT00794144|Analgesics|analgesics|mesh-ancestor
14326396|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
14326397|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326398|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326399|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14326400|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326401|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15223263|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
15223264|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223265|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223266|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223267|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15223268|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15223269|NCT03452072|Emollients|emollients|mesh-ancestor
15223270|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
15223271|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
15223272|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
15223273|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15223274|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
15223275|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223276|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223277|NCT03433040|Progestins|progestins|mesh-ancestor
15223278|NCT03433040|Hormones|hormones|mesh-ancestor
15223279|NCT03432065|Buspirone|buspirone|mesh-list
15223280|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15223281|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15223282|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223283|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326402|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14326403|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14326404|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
14326405|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
14326406|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326407|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326408|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
14326409|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326410|NCT00794313|Topiramate|topiramate|mesh-list
14326411|NCT00794313|Amantadine|amantadine|mesh-list
14326412|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
14326413|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326414|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223284|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15223285|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14326415|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14326416|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14326417|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
14326418|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326419|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
14326420|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326421|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326422|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326423|NCT00794313|Analgesics|analgesics|mesh-ancestor
14725055|NCT00502229|Clomiphene|clomiphene|mesh-list
15223286|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
14326424|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
14326425|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223287|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223288|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223289|NCT03412799|Gemcitabine|gemcitabine|mesh-list
15223290|NCT03412799|Paclitaxel|paclitaxel|mesh-list
15223291|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15223292|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15223293|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223294|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
15223295|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
15223296|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
15223297|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223298|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223299|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
15223300|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
15223301|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223302|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223303|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223304|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
15223305|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223306|NCT03405870|SMOFlipid|smoflipid|mesh-list
15223307|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15223308|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14326426|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14326427|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14326428|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326429|NCT00794365|Varenicline|varenicline|mesh-list
14326430|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14326431|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14326432|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
14326433|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326434|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326435|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326436|NCT00794417|Pemetrexed|pemetrexed|mesh-list
14326437|NCT00794417|Aflibercept|aflibercept|mesh-list
14326438|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223309|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14326439|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326440|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326441|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14326442|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14326443|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14326444|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14326445|NCT00794417|Growth Substances|growth substances|mesh-ancestor
14326446|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326447|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326448|NCT00794547|Calcitriol|calcitriol|mesh-list
14326449|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14326450|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326451|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14326452|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326453|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326454|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14326455|NCT00794547|Vitamins|vitamins|mesh-ancestor
14326456|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
14326457|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14326458|NCT00794573|Varenicline|varenicline|mesh-list
14326459|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14326460|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14326461|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
14326462|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326463|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725056|NCT00502229|Enclomiphene|enclomiphene|mesh-list
14326464|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326465|NCT00794664|Mipomersen|mipomersen|mesh-list
14326466|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14326467|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14326468|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
14326469|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326470|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14326471|NCT00794820|Vidarabine|vidarabine|mesh-list
14326472|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
14326473|NCT00794820|Rituximab|rituximab|mesh-list
14326474|NCT00794820|Fludarabine|fludarabine|mesh-list
14326475|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
14326476|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326477|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
14326478|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326479|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326480|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326481|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
14326482|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326483|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326484|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14326485|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14326486|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14326487|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
14326488|NCT00794820|Antiviral Agents|antiviral agents|mesh-ancestor
14326489|NCT00794820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326490|NCT00794950|Sunitinib|sunitinib|mesh-list
14326491|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326492|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14326493|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14326494|NCT00794950|Growth Substances|growth substances|mesh-ancestor
14326495|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326496|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326497|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14326498|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326499|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326500|NCT00794963|Metformin|metformin|mesh-list
14326501|NCT00794963|Orlistat|orlistat|mesh-list
14326502|NCT00794963|Irbesartan|irbesartan|mesh-list
14326503|NCT00794963|Fenofibrate|fenofibrate|mesh-list
14326504|NCT00794963|Pravastatin|pravastatin|mesh-list
14326505|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326506|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326507|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14326508|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
14326509|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326510|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14326511|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14326512|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14326513|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326514|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14326515|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14326516|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14326517|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14326518|NCT00795002|Cytarabine|cytarabine|mesh-list
14326519|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
14326520|NCT00795002|Alvocidib|alvocidib|mesh-list
14326521|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14326522|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
14326523|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223310|NCT03394027|TIC10 compound|tic10 compound|mesh-list
15223311|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225641|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225642|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
15225643|NCT04198363|Amoxicillin|amoxicillin|mesh-list
15225644|NCT04198363|Clarithromycin|clarithromycin|mesh-list
15225645|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
15225646|NCT04198363|Esomeprazole|esomeprazole|mesh-list
15225647|NCT04198363|Bismuth|bismuth|mesh-list
15225648|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225649|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15225650|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225651|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15225652|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15225653|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15225654|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225655|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15225656|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15225657|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15225658|NCT04198363|Antacids|antacids|mesh-ancestor
15225659|NCT04198363|Diuretics|diuretics|mesh-ancestor
15225660|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
15225661|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326524|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326525|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
14326526|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326527|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326528|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
14326529|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326530|NCT00795002|Analgesics|analgesics|mesh-ancestor
14326531|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
14326532|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326533|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14326534|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14326535|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326536|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326537|NCT00795002|Growth Substances|growth substances|mesh-ancestor
14326538|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14326539|NCT00795132|Cyclosporine|cyclosporine|mesh-list
14326540|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
14326541|NCT00795132|Fludarabine|fludarabine|mesh-list
14326542|NCT00795132|Busulfan|busulfan|mesh-list
14326543|NCT00795132|Cyclosporins|cyclosporins|mesh-list
14326544|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
14326545|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14326546|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326547|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326548|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326549|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
14326550|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326551|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326552|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
14326553|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326554|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
14326555|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326556|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14326557|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14326558|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14326559|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
14326560|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326561|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
14326562|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326563|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14326564|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
14326565|NCT00795145|Linezolid|linezolid|mesh-list
14326566|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326567|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326568|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14326569|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14326570|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326571|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326572|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326573|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14326574|NCT00795210|Hormones|hormones|mesh-list
14326575|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14326576|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326577|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326578|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14326579|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326580|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326581|NCT00795275|Incretins|incretins|mesh-ancestor
14326582|NCT00795275|Hormones|hormones|mesh-ancestor
14326583|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326584|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14326585|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
14326586|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326587|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326588|NCT00795288|Simvastatin|simvastatin|mesh-list
14326589|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14326590|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14326591|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
14326592|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326593|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14326594|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14725057|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
14725058|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326595|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326596|NCT00795340|Paclitaxel|paclitaxel|mesh-list
14326597|NCT00795340|Carboplatin|carboplatin|mesh-list
14326598|NCT00795340|Cediranib|cediranib|mesh-list
14725059|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725060|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14725061|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
14725062|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725063|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14725064|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
14725065|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14725066|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14326599|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14326600|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326601|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
14326602|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
14326603|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
14326604|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326605|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326606|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14326607|NCT00795366|Vasopressins|vasopressins|mesh-list
14326608|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
14326609|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
14326610|NCT00795366|Coagulants|coagulants|mesh-ancestor
14326611|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14326612|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14326613|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
14326614|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326615|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14326616|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14326617|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14326618|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
14326619|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326620|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326621|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326622|NCT00795509|Urological Agents|urological agents|mesh-ancestor
14326623|NCT00795600|Insulin|insulin|mesh-list
14326624|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14326625|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
14326626|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
14326627|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
14326628|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
14326629|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326630|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326631|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
14326632|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14326633|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326634|NCT00795769|Ondansetron|ondansetron|mesh-list
14326635|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
14326636|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
14326637|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326638|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326639|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326640|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
14326641|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
14326642|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14326643|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
14326644|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326645|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326646|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14326647|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14326648|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14326649|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326650|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14326651|NCT00795886|Sirolimus|sirolimus|mesh-list
14326652|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326653|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326654|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14326655|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326656|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
14326657|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326658|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
14326659|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326660|NCT00796003|Decitabine|decitabine|mesh-list
14326661|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14326662|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
14326663|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326664|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326665|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326666|NCT00796120|Doxorubicin|doxorubicin|mesh-list
14326667|NCT00796120|Ifosfamide|ifosfamide|mesh-list
14326668|NCT00796120|Trabectedin|trabectedin|mesh-list
14326669|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14326670|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326671|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14326672|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14326673|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326674|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326675|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326676|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
14326677|NCT00796224|Azithromycin|azithromycin|mesh-list
14326678|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326679|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326680|NCT00796302|Risperidone|risperidone|mesh-list
14326681|NCT00796302|Methylphenidate|methylphenidate|mesh-list
14326682|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14326683|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
14326684|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326685|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326686|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326687|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14326688|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14326689|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14326690|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326691|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14326692|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
14326693|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14326694|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14326695|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14326696|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326697|NCT00796315|Doxylamine|doxylamine|mesh-list
14326698|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
14326699|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14326700|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
14326701|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
14326702|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326703|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326704|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326705|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
14326706|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
14326707|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326708|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326709|NCT00796328|Phenylephrine|phenylephrine|mesh-list
14326710|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
14326711|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14326712|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
14326713|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
14326714|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326715|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326716|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
14326717|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14326718|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
14326719|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
14326720|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14326721|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14326722|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14326723|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
14326724|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326725|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326726|NCT00796328|Protective Agents|protective agents|mesh-ancestor
14326727|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14326728|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
14326729|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
14326730|NCT00796549|Afatinib|afatinib|mesh-list
14326731|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326732|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14326733|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326734|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326735|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
14326736|NCT00796562|Busulfan|busulfan|mesh-list
14326737|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326738|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
14326739|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326740|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326741|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326742|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
14326743|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326744|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326745|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14326746|NCT00796614|Tamsulosin|tamsulosin|mesh-list
14326747|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14326748|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14326749|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14326750|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14326751|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326752|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326753|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326754|NCT00796614|Urological Agents|urological agents|mesh-ancestor
14326755|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
14326756|NCT00796653|Olodaterol|olodaterol|mesh-list
14326757|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14326758|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
14326759|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326760|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326761|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14326762|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
14326763|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14326764|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14326765|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14326766|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
14326767|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326768|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326769|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
14326770|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
14326771|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
14326772|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14326773|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14326774|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326775|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326776|NCT00796666|Urological Agents|urological agents|mesh-ancestor
14326777|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14326778|NCT00796705|Adalimumab|adalimumab|mesh-list
14326779|NCT00796705|Etanercept|etanercept|mesh-list
14326780|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14326781|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14326782|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14326783|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326784|NCT00796705|Analgesics|analgesics|mesh-ancestor
14326785|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
14326786|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223312|NCT03391882|Apomorphine|apomorphine|mesh-list
15223313|NCT03391882|Emetics|emetics|mesh-ancestor
15223314|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223315|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
15223316|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223317|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223318|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
15223319|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
14326787|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326788|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223320|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326789|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326790|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
14326791|NCT00796718|Capecitabine|capecitabine|mesh-list
14326792|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14326793|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
14326794|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326795|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326796|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14326797|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14326798|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
14326799|NCT00796757|Interferons|interferons|mesh-list
14326800|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
14326801|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
14326802|NCT00796757|Bevacizumab|bevacizumab|mesh-list
14326803|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14326804|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223321|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223322|NCT03382574|Denosumab|denosumab|mesh-list
15223323|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15223324|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223325|NCT03357952|Daratumumab|daratumumab|mesh-list
15223326|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223327|NCT03323463|Carboplatin|carboplatin|mesh-list
15223328|NCT03323463|Fluorouracil|fluorouracil|mesh-list
15223329|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223330|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
15223331|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223332|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223333|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223334|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
15223335|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326805|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14326806|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14326807|NCT00796757|Growth Substances|growth substances|mesh-ancestor
14326808|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326809|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
14326810|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
14326811|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326812|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
14326813|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
14326814|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14326815|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326816|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326817|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14326818|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14326819|NCT00796822|Protective Agents|protective agents|mesh-ancestor
14326820|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326821|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
14326822|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14326823|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
14725067|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14725068|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14725069|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
14725070|NCT00502268|Vitamins|vitamins|mesh-ancestor
14725071|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
14725072|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725073|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14725074|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14729238|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14729239|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14729240|NCT00522184|Analgesics|analgesics|mesh-ancestor
14729241|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
14729242|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729243|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326824|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14326825|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14326826|NCT00796978|Trastuzumab|trastuzumab|mesh-list
14326827|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14326828|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326829|NCT00796991|Paclitaxel|paclitaxel|mesh-list
14326830|NCT00796991|Carboplatin|carboplatin|mesh-list
14326831|NCT00796991|Ipilimumab|ipilimumab|mesh-list
14326832|NCT00796991|Dacarbazine|dacarbazine|mesh-list
14326833|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14326834|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326835|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14326836|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14326837|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
14729244|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729245|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729246|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729247|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14326838|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725075|NCT00502294|Visilizumab|visilizumab|mesh-list
15223336|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14326839|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14326840|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14326841|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14326842|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
14326843|NCT00797108|Amoxicillin|amoxicillin|mesh-list
14326844|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
14326845|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
14326846|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
14326847|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14326848|NCT00797108|Lactams|lactams|mesh-list
14326849|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14326850|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326851|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14326852|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326853|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326854|NCT00797225|Leuprolide|leuprolide|mesh-list
14326855|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14326856|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
14326857|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14326858|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326859|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14326860|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14326861|NCT00797277|Lorazepam|lorazepam|mesh-list
14326862|NCT00797277|Haloperidol|haloperidol|mesh-list
14326863|NCT00797277|Olanzapine|olanzapine|mesh-list
14326864|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
14326865|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
14326866|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
14326867|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326868|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326869|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326870|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14326871|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14326872|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14326873|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326874|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14326875|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14326876|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326877|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326878|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326879|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
14326880|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14326881|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
14326882|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14326883|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
14326884|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14326885|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14326886|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
14326887|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
14326888|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14326889|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14326890|NCT00797316|Diuretics|diuretics|mesh-ancestor
14326891|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
14326892|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326893|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15223337|NCT03286556|Autoantibodies|autoantibodies|mesh-list
15223338|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223339|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
15223340|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223341|NCT03241186|Nivolumab|nivolumab|mesh-list
15223342|NCT03241186|Ipilimumab|ipilimumab|mesh-list
15223343|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223344|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223345|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15223346|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326894|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326895|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326896|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
14326897|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14326898|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
14326899|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326900|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
14326901|NCT00797459|Protective Agents|protective agents|mesh-ancestor
14326902|NCT00797797|Milnacipran|milnacipran|mesh-list
14326903|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
14326904|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14326905|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14326906|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326907|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326908|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326909|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326910|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14326911|NCT00797797|Analgesics|analgesics|mesh-ancestor
14326912|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
14326913|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326914|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
14326915|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14328545|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328546|NCT00809835|Galantamine|galantamine|mesh-list
14328547|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14328548|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725076|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
14725077|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725078|NCT00502385|Cediranib|cediranib|mesh-list
14725079|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725080|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725081|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725082|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328549|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328550|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
14328551|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328552|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328553|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14328554|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
14328555|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328556|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
14328557|NCT00809848|Bimatoprost|bimatoprost|mesh-list
14328558|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14328559|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14328560|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14328561|NCT00809926|Valsartan|valsartan|mesh-list
14328562|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14328563|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14328564|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14328565|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328566|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
14328567|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14328568|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
14328569|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14328570|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328571|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328572|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328573|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
14328574|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14328575|NCT00810069|Citalopram|citalopram|mesh-list
14328576|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14328577|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14328578|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328579|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328580|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328581|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
14328582|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725083|NCT00502411|Doxorubicin|doxorubicin|mesh-list
15223347|NCT03194542|Luspatercept|luspatercept|mesh-list
15223348|NCT03194542|Hematinics|hematinics|mesh-ancestor
15223349|NCT03113422|Venetoclax|venetoclax|mesh-list
15223350|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223351|NCT03066622|Olanzapine|olanzapine|mesh-list
15223352|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
14326916|NCT00797823|Insulin|insulin|mesh-list
14326917|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14326918|NCT00797823|Glucagon|glucagon|mesh-list
14326919|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326920|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326921|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14326922|NCT00797823|Hormones|hormones|mesh-ancestor
14326923|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326924|NCT00797862|Amlodipine|amlodipine|mesh-list
14326925|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14326926|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14326927|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14326928|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326929|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326930|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14326931|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326932|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
14326933|NCT00797862|Diuretics|diuretics|mesh-ancestor
14326934|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
14326935|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14326936|NCT00797966|Citalopram|citalopram|mesh-list
14326937|NCT00797966|Fluoxetine|fluoxetine|mesh-list
14326938|NCT00797966|Paroxetine|paroxetine|mesh-list
14326939|NCT00797966|Sertraline|sertraline|mesh-list
14326940|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14326941|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
14326942|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14326943|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14326944|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326945|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326946|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14326947|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
14326948|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326949|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14326950|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
14326951|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326952|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14326953|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14326954|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326955|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14326956|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
14326957|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
14326958|NCT00798018|Lidocaine|lidocaine|mesh-list
14326959|NCT00798018|Tetracaine|tetracaine|mesh-list
14326960|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
14326961|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
14326962|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14326963|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326964|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
14326965|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14326966|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14326967|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14326968|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14326969|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14326970|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326971|NCT00798135|Itraconazole|itraconazole|mesh-list
14326972|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
15223353|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
15223354|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223355|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223356|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223357|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15223358|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15223359|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15223360|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14326973|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14326974|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14326975|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14326976|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326977|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326978|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14326979|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
14326980|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14326981|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326982|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14326983|NCT00798161|Metformin|metformin|mesh-list
14326984|NCT00798161|Linagliptin|linagliptin|mesh-list
14326985|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14326986|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326987|NCT00798161|Incretins|incretins|mesh-ancestor
14326988|NCT00798161|Hormones|hormones|mesh-ancestor
14326989|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725084|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14725085|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14725086|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223361|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15223362|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15223363|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15223364|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223365|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15223366|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
15223367|NCT03029598|Carboplatin|carboplatin|mesh-list
15223368|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
15223369|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223370|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15223371|NCT03020030|Leucovorin|leucovorin|mesh-list
15223372|NCT03020030|Cytarabine|cytarabine|mesh-list
15223373|NCT03020030|Dexamethasone|dexamethasone|mesh-list
15223374|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
15223375|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
15223376|NCT03020030|Doxorubicin|doxorubicin|mesh-list
15223377|NCT03020030|Methotrexate|methotrexate|mesh-list
15223378|NCT03020030|Etoposide|etoposide|mesh-list
15223379|NCT03020030|Vincristine|vincristine|mesh-list
15223380|NCT03020030|Asparaginase|asparaginase|mesh-list
15223381|NCT03020030|Dasatinib|dasatinib|mesh-list
14326990|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14326991|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
14326992|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14326993|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14326994|NCT00798304|Vaccines|vaccines|mesh-list
14326995|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
14326996|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14326997|NCT00798317|Plasminogen|plasminogen|mesh-list
14326998|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14326999|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14327000|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327001|NCT00798369|Triamcinolone|triamcinolone|mesh-list
14327002|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14327003|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14327004|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14327005|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14327006|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327007|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
14327008|NCT00798369|Hormones|hormones|mesh-ancestor
14327009|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327010|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327011|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327012|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
14327013|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327014|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327015|NCT00798434|Fesoterodine|fesoterodine|mesh-list
14327016|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14327017|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14327018|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
14327019|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327020|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327021|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327022|NCT00798434|Urological Agents|urological agents|mesh-ancestor
14327023|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14327024|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14327025|NCT00798603|Bevacizumab|bevacizumab|mesh-list
14327026|NCT00798603|Carboplatin|carboplatin|mesh-list
14327027|NCT00798603|Pemetrexed|pemetrexed|mesh-list
14327028|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14327029|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327030|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14327031|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14327032|NCT00798603|Growth Substances|growth substances|mesh-ancestor
14327033|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327034|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
14327035|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327036|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327037|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14327038|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14327039|NCT00798655|Cisplatin|cisplatin|mesh-list
14327040|NCT00798655|Panitumumab|panitumumab|mesh-list
14327041|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327042|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14327043|NCT00798694|Travoprost|travoprost|mesh-list
14327044|NCT00798694|Latanoprost|latanoprost|mesh-list
14327045|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14327046|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14327047|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15223382|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
15223383|NCT03020030|Pegaspargase|pegaspargase|mesh-list
15223384|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
15223385|NCT03020030|Razoxane|razoxane|mesh-list
15223386|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
15223387|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15223388|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
15223389|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223390|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15223391|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15223392|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
15223393|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223394|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223395|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15223396|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223397|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
14327048|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15223398|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
14327049|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14327050|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327051|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327052|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327053|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327054|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327055|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
14327056|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14327057|NCT00798720|Bortezomib|bortezomib|mesh-list
14327058|NCT00798720|Vorinostat|vorinostat|mesh-list
14725087|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14725088|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725089|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725090|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725091|NCT00502437|Granisetron|granisetron|mesh-list
14327059|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327060|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14327061|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327062|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327063|NCT00798759|Travoprost|travoprost|mesh-list
14327064|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14327065|NCT00798759|Latanoprost|latanoprost|mesh-list
14327066|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14327067|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14327068|NCT00798889|Sunitinib|sunitinib|mesh-list
14327069|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327070|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14327071|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14327072|NCT00798889|Growth Substances|growth substances|mesh-ancestor
14327073|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327074|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14327075|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14327076|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327077|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327078|NCT00798967|Teduglutide|teduglutide|mesh-list
14327079|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327080|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14327081|NCT00798967|Protective Agents|protective agents|mesh-ancestor
14327082|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327083|NCT00799227|Dexamethasone|dexamethasone|mesh-list
14327084|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327085|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
14327086|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
14327087|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327088|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327089|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327090|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
14327091|NCT00799227|Hormones|hormones|mesh-ancestor
14327092|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327093|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14327094|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327095|NCT00799383|Vitamin D|vitamin d|mesh-list
14327096|NCT00799383|Calcium|calcium|mesh-list
14327097|NCT00799383|Vitamins|vitamins|mesh-ancestor
14327098|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
14327099|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725092|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
14327100|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14327101|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14327102|NCT00799409|Methylphenidate|methylphenidate|mesh-list
14327103|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14327104|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327105|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14327106|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327107|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327108|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327109|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
14327110|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327111|NCT00799435|Exenatide|exenatide|mesh-list
14327112|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14327113|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327114|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14327115|NCT00799435|Incretins|incretins|mesh-ancestor
14327116|NCT00799435|Hormones|hormones|mesh-ancestor
14327117|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327118|NCT00799487|Methylphenidate|methylphenidate|mesh-list
14327119|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14725093|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
14725094|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725095|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725096|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14725097|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14725098|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
14725099|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725100|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725101|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
15223399|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223400|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15223401|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
15223402|NCT03020030|Hormones|hormones|mesh-ancestor
15223403|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223404|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15223405|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15223406|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15223407|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15223408|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223409|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15223410|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
15223411|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14327120|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327121|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14327122|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327123|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327124|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327125|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
14327126|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327127|NCT00799578|Cysteamine|cysteamine|mesh-list
14327128|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14327129|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327130|NCT00799604|Clevidipine|clevidipine|mesh-list
14327131|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14327132|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327133|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327134|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14327135|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327136|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
14327137|NCT00799617|Testosterone|testosterone|mesh-list
14327138|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
14327139|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
14327140|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14327141|NCT00799617|Androgens|androgens|mesh-ancestor
14327142|NCT00799617|Hormones|hormones|mesh-ancestor
14327143|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327144|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327145|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14327146|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327147|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
14327148|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14327149|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
14327150|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14327151|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14327152|NCT00799643|Analgesics|analgesics|mesh-ancestor
14327153|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
14327154|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327155|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327156|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327157|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327158|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14327159|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327160|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327161|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14327162|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14327163|NCT00799708|Estradiol|estradiol|mesh-list
14327164|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14327165|NCT00799708|Estrogens|estrogens|mesh-ancestor
14327166|NCT00799708|Hormones|hormones|mesh-ancestor
14327167|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327168|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327169|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14327170|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
14327171|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14327172|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14327173|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14327174|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14327175|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327176|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
14327177|NCT00799903|Darapladib|darapladib|mesh-list
14327178|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14327179|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327180|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327181|NCT00800202|Paclitaxel|paclitaxel|mesh-list
14327182|NCT00800202|Bevacizumab|bevacizumab|mesh-list
14327183|NCT00800202|Carboplatin|carboplatin|mesh-list
14327184|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14327185|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14327186|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327187|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
14327188|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
14327189|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
14327190|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327191|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14327192|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14327193|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14327194|NCT00800202|Growth Substances|growth substances|mesh-ancestor
14327195|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327196|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
14327197|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14327198|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327199|NCT00800345|Topotecan|topotecan|mesh-list
14327200|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14327201|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14327202|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327203|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327204|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327205|NCT00800436|Trastuzumab|trastuzumab|mesh-list
14327206|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14327207|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327208|NCT00800540|Timolol|timolol|mesh-list
14327209|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14327210|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14327211|NCT00800540|Brinzolamide|brinzolamide|mesh-list
14327212|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14327213|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14327214|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14327215|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14327216|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327217|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327218|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327219|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14327220|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14327221|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14327222|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14327223|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14327224|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14327225|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327226|NCT00800683|Linagliptin|linagliptin|mesh-list
14327227|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14327228|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327229|NCT00800683|Incretins|incretins|mesh-ancestor
14327230|NCT00800683|Hormones|hormones|mesh-ancestor
14327231|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327232|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14327233|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
15223412|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223413|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
15223414|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
15223415|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15223416|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15223417|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15223418|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
15223419|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223420|NCT03020030|Antidotes|antidotes|mesh-ancestor
15223421|NCT03020030|Protective Agents|protective agents|mesh-ancestor
15223422|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
15223423|NCT03020030|Vitamins|vitamins|mesh-ancestor
15223424|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
14327234|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327235|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327236|NCT00800735|Interferons|interferons|mesh-list
14327237|NCT00800735|Ribavirin|ribavirin|mesh-list
14327238|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
14327239|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
14327240|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14327241|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327242|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
14327243|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725102|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14725103|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14725104|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
14725105|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14725106|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14725107|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14725108|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725109|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14725110|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14725111|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
14725112|NCT00502541|Hormones|hormones|mesh-ancestor
14725113|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14725114|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725115|NCT00502567|Leucovorin|leucovorin|mesh-list
14725116|NCT00502567|Docetaxel|docetaxel|mesh-list
14725117|NCT00502567|Fluorouracil|fluorouracil|mesh-list
14725118|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
14725119|NCT00502567|Irinotecan|irinotecan|mesh-list
14725120|NCT00502567|Pemetrexed|pemetrexed|mesh-list
14725121|NCT00502567|Cetuximab|cetuximab|mesh-list
14725122|NCT00502567|Cediranib|cediranib|mesh-list
14725123|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14725124|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
14725125|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
14725126|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
14725127|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725128|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
14725129|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725130|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14725131|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
14725132|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725133|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14725134|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14725135|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14725136|NCT00502567|Antidotes|antidotes|mesh-ancestor
14725137|NCT00502567|Protective Agents|protective agents|mesh-ancestor
14725138|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
14725139|NCT00502567|Vitamins|vitamins|mesh-ancestor
14327244|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
14327245|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725140|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
14725141|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14725142|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14725143|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14725144|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14725145|NCT00502658|Vitamins|vitamins|mesh-list
14327246|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
14327247|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327248|NCT00800839|Vidarabine|vidarabine|mesh-list
14327249|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
14327250|NCT00800839|Busulfan|busulfan|mesh-list
14327251|NCT00800839|Fludarabine|fludarabine|mesh-list
14327252|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
14327253|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327254|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
14327255|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327256|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327257|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14327258|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
14327259|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327260|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327261|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15223425|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14327262|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14725146|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
14725147|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725148|NCT00502684|Etodolac|etodolac|mesh-list
14725149|NCT00502684|Propranolol|propranolol|mesh-list
14327263|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
14327264|NCT00800839|Antiviral Agents|antiviral agents|mesh-ancestor
14327265|NCT00800839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327266|NCT00800982|Etanercept|etanercept|mesh-list
14327267|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14327268|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14327269|NCT00800982|Analgesics|analgesics|mesh-ancestor
14327270|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
14327271|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327272|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327273|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327274|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327275|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327276|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327277|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
14327278|NCT00801099|Amoxicillin|amoxicillin|mesh-list
14327279|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14327280|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
14327281|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
14327282|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14327283|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327284|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14327285|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327286|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327287|NCT00801138|Dexamethasone|dexamethasone|mesh-list
14327288|NCT00801138|Bupivacaine|bupivacaine|mesh-list
14327289|NCT00801138|Ropivacaine|ropivacaine|mesh-list
14327290|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327291|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
14327292|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
14327293|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327294|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327295|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327296|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
14327297|NCT00801138|Hormones|hormones|mesh-ancestor
14327298|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327299|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14327300|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327301|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
14327302|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
14327303|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14327304|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
14327305|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14327306|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14327307|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327308|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14327309|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327310|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327311|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327312|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
14327313|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327314|NCT00801398|Oxymorphone|oxymorphone|mesh-list
14327315|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14327316|NCT00801398|Narcotics|narcotics|mesh-ancestor
14327317|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14725150|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14725151|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14725152|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
14725153|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14725154|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14725155|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14725156|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14327318|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327319|NCT00801398|Analgesics|analgesics|mesh-ancestor
14327320|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
14327321|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327322|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14327323|NCT00801632|Prednisone|prednisone|mesh-list
14327324|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
14327325|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
14327326|NCT00801632|Rituximab|rituximab|mesh-list
14327327|NCT00801632|Tacrolimus|tacrolimus|mesh-list
14327328|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327329|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
14327330|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327331|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14327332|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14327333|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
14327334|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327335|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327336|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14327337|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14327338|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327339|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
14327340|NCT00801632|Hormones|hormones|mesh-ancestor
14327341|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327342|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14327343|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14327344|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327345|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
14910529|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14910530|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14910531|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14910532|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
14910533|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14910534|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14910535|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
14910536|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15223426|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
15223427|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14327346|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
14327347|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327348|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327349|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14327350|NCT00801632|Protective Agents|protective agents|mesh-ancestor
14327351|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14327352|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
14327353|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14327354|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
14327355|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327356|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327357|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14327358|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
14327359|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14327360|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14327361|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14327362|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
14327363|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327364|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327365|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
14327366|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14327367|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
14327368|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14327369|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14327370|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14327371|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223428|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15223429|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15223430|NCT03016312|Atezolizumab|atezolizumab|mesh-list
15223431|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223432|NCT02799212|Somatostatin|somatostatin|mesh-list
15223433|NCT02799212|Hormones|hormones|mesh-ancestor
15223434|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15223435|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223436|NCT02553941|Azacitidine|azacitidine|mesh-list
15223437|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15223438|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
15223439|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223440|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223441|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223442|NCT02482753|Exemestane|exemestane|mesh-list
15223443|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223444|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15223445|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14327372|NCT00801723|Budesonide|budesonide|mesh-list
14327373|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327374|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14327375|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
14327376|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327377|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327378|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14327379|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
14327380|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
14327381|NCT00801723|Hormones|hormones|mesh-ancestor
14327382|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327383|NCT00801801|Docetaxel|docetaxel|mesh-list
14327384|NCT00801801|Sorafenib|sorafenib|mesh-list
14327385|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327386|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
14327387|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
14327388|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
14327389|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327390|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14327391|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327392|NCT00801827|Fallypride|fallypride|mesh-list
14327393|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14327394|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14327395|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
14327396|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327397|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327398|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327399|NCT00802074|Ritonavir|ritonavir|mesh-list
14327400|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
14327401|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
14725157|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14725158|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
14725159|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15223446|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327402|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14327403|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14327404|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
14327405|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327406|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327407|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14327408|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14327409|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
14327410|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327411|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14327412|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14327413|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14327414|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14327415|NCT00802100|Metformin|metformin|mesh-list
14327416|NCT00802100|Benztropine|benztropine|mesh-list
14327417|NCT00802100|Olanzapine|olanzapine|mesh-list
14327418|NCT00802100|Aripiprazole|aripiprazole|mesh-list
14327419|NCT00802100|Perphenazine|perphenazine|mesh-list
14327420|NCT00802100|Simvastatin|simvastatin|mesh-list
14327421|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14327422|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327423|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14327424|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14327425|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
14327426|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225662|NCT04198363|Expectorants|expectorants|mesh-ancestor
14327427|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14327428|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14327429|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327430|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
14327431|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
14327432|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327433|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327434|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14327435|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14327436|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14327437|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14327438|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14327439|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14327440|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14327441|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14327442|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
15223447|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223448|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15223449|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
15223450|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327443|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
14327444|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
14327445|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
14327446|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14327447|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14327448|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14327449|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14327450|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14327451|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14327452|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14327453|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14327454|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
14327455|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14327456|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14327457|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
14327458|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14327459|NCT00802113|Fludarabine|fludarabine|mesh-list
14327460|NCT00802113|Busulfan|busulfan|mesh-list
14327461|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14327462|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327463|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327464|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14327465|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
14725160|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14725161|NCT00502684|Analgesics|analgesics|mesh-ancestor
14725162|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
14725163|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14725164|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327466|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327467|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
14327468|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14327469|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14327470|NCT00802360|Menotropins|menotropins|mesh-list
14327471|NCT00802360|Progesterone|progesterone|mesh-list
14327472|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14327473|NCT00802360|Ganirelix|ganirelix|mesh-list
14327474|NCT00802360|Progestins|progestins|mesh-ancestor
14327475|NCT00802360|Hormones|hormones|mesh-ancestor
14327476|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327477|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327478|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
15223451|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223452|NCT02420574|Albendazole|albendazole|mesh-list
15223453|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
15223454|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15223455|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15223456|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
15223457|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15223458|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14327479|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15223459|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
15223460|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
14327480|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
15223461|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
15223462|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223463|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223464|NCT02403193|Spartalizumab|spartalizumab|mesh-list
15223465|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15223466|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223467|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15223468|NCT02358681|Ketorolac|ketorolac|mesh-list
15223469|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15223470|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15223471|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15223472|NCT02358681|Analgesics|analgesics|mesh-ancestor
15223473|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
15223474|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15223475|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223476|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15223477|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15223478|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15223479|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15223480|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15223481|NCT02339168|Metformin|metformin|mesh-list
15223482|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15223483|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223484|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
15223485|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
15223486|NCT02269267|Protective Agents|protective agents|mesh-ancestor
15223487|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15223488|NCT02101788|Tamoxifen|tamoxifen|mesh-list
15223489|NCT02101788|Paclitaxel|paclitaxel|mesh-list
15223490|NCT02101788|Doxorubicin|doxorubicin|mesh-list
15223491|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15223492|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15223493|NCT02101788|Letrozole|letrozole|mesh-list
15223494|NCT02101788|Topotecan|topotecan|mesh-list
15223495|NCT02101788|Trametinib|trametinib|mesh-list
14725165|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14725166|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14327481|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14327482|NCT00802412|Topiramate|topiramate|mesh-list
14327483|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
14327484|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14327485|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327486|NCT00802529|Gentamicins|gentamicins|mesh-list
14327487|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
14327488|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14327489|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14327490|NCT00802529|Prednisolone|prednisolone|mesh-list
14327491|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
14327492|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14327493|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
14327494|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14327495|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
14327496|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
14327497|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14327498|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14327499|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14327500|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
14327501|NCT00802529|Hormones|hormones|mesh-ancestor
14327502|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14327503|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14327504|NCT00802529|Protective Agents|protective agents|mesh-ancestor
14327505|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14327506|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14327507|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14327508|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327509|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14327510|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14327511|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14327512|NCT00802672|Ciclopirox|ciclopirox|mesh-list
14327513|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
14327514|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14327515|NCT00802685|Ibuprofen|ibuprofen|mesh-list
15223496|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14327516|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14327517|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15223497|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15223498|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328611|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328612|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328613|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
14328614|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328615|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14328616|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328617|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
14328618|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328619|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14328620|NCT00810303|Efavirenz|efavirenz|mesh-list
14328621|NCT00810303|Ezetimibe|ezetimibe|mesh-list
14328622|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14328623|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14328624|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
14328625|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328626|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14328627|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14328628|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14328629|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328630|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
14328631|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328632|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14328633|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14328634|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14328635|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14328636|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14328637|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14328638|NCT00810394|Sorafenib|sorafenib|mesh-list
14328639|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328640|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14328641|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328642|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328643|NCT00810407|Rifabutin|rifabutin|mesh-list
14328644|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14328645|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328646|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14328647|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
14328648|NCT00810576|Bortezomib|bortezomib|mesh-list
14328649|NCT00810576|Vorinostat|vorinostat|mesh-list
14328650|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328651|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14328652|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328653|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328654|NCT00810602|Vorinostat|vorinostat|mesh-list
14328655|NCT00810602|Tacrolimus|tacrolimus|mesh-list
14328656|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328657|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
14328658|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328659|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14328660|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328661|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328662|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328663|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14328664|NCT00810693|Riociguat|riociguat|mesh-list
14328665|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
14328666|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328667|NCT00810719|Gemcitabine|gemcitabine|mesh-list
14328668|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14328669|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14328670|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
14328671|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328672|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328673|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
14328674|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328675|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328676|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328677|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
14328678|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328679|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14328680|NCT00810797|Exemestane|exemestane|mesh-list
14328681|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328682|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14328683|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14328684|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328685|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328686|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14328687|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
14328688|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328689|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328690|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
14328691|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14328692|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328693|NCT00811057|Indomethacin|indomethacin|mesh-list
14328694|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
14328695|NCT00811057|Nifedipine|nifedipine|mesh-list
14328696|NCT00811057|Analgesics|analgesics|mesh-ancestor
14328697|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
14328698|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328699|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328700|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
14328701|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328702|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14328703|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
14328704|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14328705|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328706|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328707|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14328708|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
14328709|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14328710|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
14328711|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14328712|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328713|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328714|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328715|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
14328716|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14328717|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328718|NCT00811135|Bevacizumab|bevacizumab|mesh-list
14328719|NCT00811135|Trastuzumab|trastuzumab|mesh-list
14328720|NCT00811135|Capecitabine|capecitabine|mesh-list
14328721|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14328722|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328723|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14328724|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14328725|NCT00811135|Growth Substances|growth substances|mesh-ancestor
14328726|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328727|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
14328728|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15225732|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225733|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15225734|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15225735|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15225736|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328729|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
14328730|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328731|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
14328732|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14328733|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14729483|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729484|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729485|NCT00523458|Efavirenz|efavirenz|mesh-list
14729486|NCT00523458|Nevirapine|nevirapine|mesh-list
14729487|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14328734|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
14328735|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328736|NCT00811187|Lidocaine|lidocaine|mesh-list
14328737|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
14328738|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
14328739|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328740|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328741|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
14328742|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328743|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14328744|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14328745|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14328746|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328747|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328748|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14328749|NCT00811252|Vortioxetine|vortioxetine|mesh-list
14328750|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14328751|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14328752|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328753|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328754|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328755|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328756|NCT00811252|Analgesics|analgesics|mesh-ancestor
14328757|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
14328758|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328759|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
14328760|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14328761|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
14328762|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14328763|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14328764|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328765|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14328766|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
14328767|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14328768|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14328769|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14328770|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14328771|NCT00811395|Interferons|interferons|mesh-list
15225737|NCT03809767|Antibodies|antibodies|mesh-list
15225738|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15225739|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
14328772|NCT00811395|Interferon-beta|interferon-beta|mesh-list
14328773|NCT00811395|Teriflunomide|teriflunomide|mesh-list
14328774|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
14328775|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
14328776|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
14328777|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729488|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15225740|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225741|NCT03740529|Rituximab|rituximab|mesh-list
15225742|NCT03740529|Venetoclax|venetoclax|mesh-list
15225743|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225744|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225745|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
15225746|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225747|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225748|NCT03728179|Aspirin|aspirin|mesh-list
15225749|NCT03728179|Celecoxib|celecoxib|mesh-list
15225750|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
15225751|NCT03728179|Nivolumab|nivolumab|mesh-list
15225752|NCT03728179|Ipilimumab|ipilimumab|mesh-list
15225753|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225754|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
15225755|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225756|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225757|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225758|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
15225759|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225760|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917624|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14917625|NCT04835129|Growth Substances|growth substances|mesh-ancestor
14917626|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
15225761|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14328778|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
14328779|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328780|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14328781|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
14328782|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328783|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14328784|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14328785|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14328786|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328787|NCT00811395|Analgesics|analgesics|mesh-ancestor
14328788|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
14328789|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328790|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14328791|NCT00811434|Lactulose|lactulose|mesh-list
14328792|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14328793|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14328794|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
14328795|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14328796|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14328797|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14328798|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328799|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328800|NCT00811564|Timolol|timolol|mesh-list
14328801|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14328802|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14328803|NCT00811564|Latanoprost|latanoprost|mesh-list
14328804|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14328805|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14328806|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14328807|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
14328808|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328809|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328810|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328811|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14328812|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14328813|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14328814|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14328815|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14328816|NCT00811642|Posaconazole|posaconazole|mesh-list
14328817|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
14328818|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328819|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14328820|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14328821|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14328822|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14328823|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14328824|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328825|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328826|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14328827|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
14328828|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328829|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328830|NCT00811720|Nalmefene|nalmefene|mesh-list
14328831|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14328832|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328833|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
14328834|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328835|NCT00811733|Ofatumumab|ofatumumab|mesh-list
14328836|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917627|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14917628|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
15225762|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14328837|NCT00811850|Timolol|timolol|mesh-list
14328838|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14328839|NCT00811850|Dorzolamide|dorzolamide|mesh-list
14328840|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14328841|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14328842|NCT00811850|Maleic acid|maleic acid|mesh-list
14328843|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14328844|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14328845|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
14328846|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328847|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328848|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328849|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14328850|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14328851|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328852|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14328853|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14328854|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14328855|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14328856|NCT00811928|Fluconazole|fluconazole|mesh-list
14328857|NCT00811928|Posaconazole|posaconazole|mesh-list
14328858|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
14328859|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328860|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14328861|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14328862|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328863|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328864|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14328865|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
14328866|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14328867|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328868|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14328869|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14328870|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14328871|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14328872|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14328873|NCT00811941|Nalmefene|nalmefene|mesh-list
14328874|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14328875|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328876|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
14328877|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328878|NCT00811954|Ritonavir|ritonavir|mesh-list
14328879|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14328880|NCT00811954|Darunavir|darunavir|mesh-list
14328881|NCT00811954|Tenofovir|tenofovir|mesh-list
14328882|NCT00811954|Emtricitabine|emtricitabine|mesh-list
14328883|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
14328884|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14328885|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14328886|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14328887|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328888|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328889|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328890|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14328891|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14328892|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
14328893|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328894|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14328895|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14328896|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14328897|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14729489|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729490|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729491|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
14729492|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225763|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14328898|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14328899|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14328900|NCT00812253|Insulin|insulin|mesh-list
14328901|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14328902|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14328903|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328904|NCT00812331|Simeprevir|simeprevir|mesh-list
14328905|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
14328906|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14328907|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
14328908|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328909|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328910|NCT00812461|Nalmefene|nalmefene|mesh-list
14328911|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14328912|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328913|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
14328914|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328915|NCT00812487|Insulin|insulin|mesh-list
14328916|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14328917|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14328918|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328919|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
14328920|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14328921|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14328922|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
14328923|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328924|NCT00812604|Analgesics|analgesics|mesh-list
14328925|NCT00812604|Petrolatum|petrolatum|mesh-list
14328926|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
14328927|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917629|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917630|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14917631|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14917632|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917633|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917634|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14917635|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14917636|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
14917637|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15225764|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15225765|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14328928|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225766|NCT03728179|Analgesics|analgesics|mesh-ancestor
15225767|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
15225768|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225769|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15225770|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15225771|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15225772|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14917638|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
14328929|NCT00812604|Emollients|emollients|mesh-ancestor
14328930|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14328931|NCT00812812|Paroxetine|paroxetine|mesh-list
14328932|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14328933|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14328934|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328935|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328936|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328937|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
14328938|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328939|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14328940|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
14328941|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14328942|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14328943|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14328944|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328945|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
14328946|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14328947|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14328948|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14328949|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14328950|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328951|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
14328952|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328953|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328954|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14328955|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328956|NCT00812877|Calcium|calcium|mesh-list
14328957|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14328958|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328959|NCT00812955|Simvastatin|simvastatin|mesh-list
14328960|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14328961|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14328962|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
14328963|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328964|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14917639|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14917640|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
14917641|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917642|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917643|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
15225773|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15225774|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328965|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14328966|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14328967|NCT00812968|Lenalidomide|lenalidomide|mesh-list
14328968|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
14328969|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328970|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14328971|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14328972|NCT00812968|Growth Substances|growth substances|mesh-ancestor
14328973|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
14328974|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14328975|NCT00813111|Epinephrine|epinephrine|mesh-list
14328976|NCT00813111|Bupivacaine|bupivacaine|mesh-list
14328977|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
14328978|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
14328979|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14328980|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14328981|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
14328982|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14328983|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14328984|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14328985|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14328986|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14328987|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14328988|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14328989|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14328990|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
14328991|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14328992|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
14328993|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
14328994|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
15225775|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
15225776|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14328995|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14328996|NCT00813124|Vidarabine|vidarabine|mesh-list
14328997|NCT00813124|Fludarabine|fludarabine|mesh-list
14328998|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
14328999|NCT00813124|Azacitidine|azacitidine|mesh-list
14329000|NCT00813124|Busulfan|busulfan|mesh-list
14329001|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
14329002|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14329003|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329004|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14329005|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
14329006|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329007|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329008|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
15225777|NCT03626376|Valacyclovir|valacyclovir|mesh-list
15225778|NCT03626376|Acyclovir|acyclovir|mesh-list
15225779|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15225780|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15225781|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
15225782|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329009|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329010|NCT00813124|Antiviral Agents|antiviral agents|mesh-ancestor
14329011|NCT00813124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329012|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329013|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
14329014|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14329015|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14329016|NCT00813150|Dexamethasone|dexamethasone|mesh-list
14329017|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
14329018|NCT00813150|Bortezomib|bortezomib|mesh-list
14329019|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329020|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
14329021|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329022|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329023|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14329024|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
14329025|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329026|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329027|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14329028|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329029|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
14329030|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
14329031|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329032|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329033|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
14329034|NCT00813150|Hormones|hormones|mesh-ancestor
14329035|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329036|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14329037|NCT00813293|Sorafenib|sorafenib|mesh-list
14329038|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329039|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14329040|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329041|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329042|NCT00813488|Fentanyl|fentanyl|mesh-list
14329043|NCT00813488|Oxycodone|oxycodone|mesh-list
14329044|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14329045|NCT00813488|Narcotics|narcotics|mesh-ancestor
14329046|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329047|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329048|NCT00813488|Analgesics|analgesics|mesh-ancestor
14329049|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
14329050|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329051|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14329052|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14329053|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
14329054|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
14329055|NCT00813592|Pasireotide|pasireotide|mesh-list
14329056|NCT00813592|Hormones|hormones|mesh-ancestor
14917644|NCT04700176|Dexamethasone|dexamethasone|mesh-list
14329057|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225783|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
14329058|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329059|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
14329060|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14329061|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
14329062|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329063|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329064|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
14329065|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329066|NCT00813748|Omalizumab|omalizumab|mesh-list
14329067|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14329068|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14329069|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14329070|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14329071|NCT00813800|Varenicline|varenicline|mesh-list
14329072|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14329073|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14329074|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
14329075|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329076|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329077|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329078|NCT00813917|Varenicline|varenicline|mesh-list
14329079|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15225784|NCT03624036|Fludarabine|fludarabine|mesh-list
15225785|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225786|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
15225787|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329080|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14329081|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
14329082|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329083|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329084|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464193|NCT02206685|Narcotics|narcotics|mesh-ancestor
14464194|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464195|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464196|NCT02206685|Analgesics|analgesics|mesh-ancestor
14464197|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
14464198|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464199|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
14464200|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
14464201|NCT02206776|Midazolam|midazolam|mesh-list
14464202|NCT02206776|Ketamine|ketamine|mesh-list
14464203|NCT02206776|Analgesics|analgesics|mesh-ancestor
14464204|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
14464205|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464206|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464207|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14464208|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14464209|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
15225788|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225789|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225790|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
15225791|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225792|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464210|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
14464211|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464212|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14329085|NCT00813943|Temozolomide|temozolomide|mesh-list
14329086|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14329087|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
14329088|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329089|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329090|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14329091|NCT00813995|Metformin|metformin|mesh-list
14329092|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329093|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329094|NCT00813995|Incretins|incretins|mesh-ancestor
14329095|NCT00813995|Hormones|hormones|mesh-ancestor
14329096|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329097|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14329098|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
15225793|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15225794|NCT03556358|Paclitaxel|paclitaxel|mesh-list
15225795|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
15225796|NCT03556358|Trastuzumab|trastuzumab|mesh-list
15225797|NCT03556358|Epirubicin|epirubicin|mesh-list
15225798|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225799|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225800|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225801|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225802|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225803|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329099|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329100|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329101|NCT00814138|Methotrexate|methotrexate|mesh-list
14329102|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14329103|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
14329104|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14329105|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329106|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14329107|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
14329108|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329109|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917645|NCT04700176|Daratumumab|daratumumab|mesh-list
14917646|NCT04700176|Pomalidomide|pomalidomide|mesh-list
14917647|NCT04700176|Tretinoin|tretinoin|mesh-list
14917648|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14917649|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
14917650|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
14917651|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329110|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329111|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329112|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14329113|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329114|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
14329115|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329116|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14329117|NCT00814164|Daunorubicin|daunorubicin|mesh-list
14329118|NCT00814164|Clofarabine|clofarabine|mesh-list
14729493|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14729494|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14729495|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14729496|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14729497|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14729498|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14729499|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14917652|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729500|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14729501|NCT00523666|Galantamine|galantamine|mesh-list
14729502|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14729503|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729504|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917653|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917654|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
14917655|NCT04700176|Hormones|hormones|mesh-ancestor
14917656|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225804|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729505|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
14729506|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729507|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729508|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14729509|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
14729510|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729511|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
14729512|NCT00523692|Etanercept|etanercept|mesh-list
14329119|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14329120|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329121|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14329122|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14329123|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329124|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329125|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729513|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14729514|NCT00523692|Methotrexate|methotrexate|mesh-list
14729515|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14729516|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
14729517|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14329126|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
14329127|NCT00814177|Warfarin|warfarin|mesh-list
14329128|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
14329129|NCT00814255|Adalimumab|adalimumab|mesh-list
14329130|NCT00814255|Losartan|losartan|mesh-list
14329131|NCT00814255|Lisinopril|lisinopril|mesh-list
14329132|NCT00814255|Atorvastatin|atorvastatin|mesh-list
14329133|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14329134|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14329135|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
14329136|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329137|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14329138|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14329139|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329140|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329141|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329142|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14729518|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729519|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729520|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
14329143|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329144|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14752950|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329145|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14329146|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14329147|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
14329148|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14329149|NCT00814255|Protective Agents|protective agents|mesh-ancestor
14329150|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329151|NCT00814307|Tofacitinib|tofacitinib|mesh-list
14329152|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14329153|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329154|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329155|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
14329156|NCT00814320|Antibodies|antibodies|mesh-list
15225805|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
15225806|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225807|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225808|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225809|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
15225810|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15225811|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225812|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15225813|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15225814|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15225815|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225816|NCT03555578|Leuprolide|leuprolide|mesh-list
14729521|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729522|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329157|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
14329158|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14329159|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14329160|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
14329161|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
14329162|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329163|NCT00814502|Zolpidem|zolpidem|mesh-list
14329164|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14329165|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14329166|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329167|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329168|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14329169|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
14329170|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
14329171|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329172|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329173|NCT00814580|Oxycodone|oxycodone|mesh-list
14329174|NCT00814580|Tapentadol|tapentadol|mesh-list
14329175|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14329176|NCT00814580|Narcotics|narcotics|mesh-ancestor
14329177|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329178|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329179|NCT00814580|Analgesics|analgesics|mesh-ancestor
14329180|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
14329181|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329182|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14329183|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14329184|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14329185|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329186|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
14329187|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329188|NCT00814632|Apremilast|apremilast|mesh-list
14329189|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14329190|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14329191|NCT00814632|Analgesics|analgesics|mesh-ancestor
14329192|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
14329193|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729523|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329194|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329195|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329196|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329197|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14329198|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14329199|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329200|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329201|NCT00814658|Nimodipine|nimodipine|mesh-list
14329202|NCT00814658|Galantamine|galantamine|mesh-list
14329203|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14329204|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329205|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329206|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
14329207|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329208|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329209|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14329210|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
14329211|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329212|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
14329213|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329214|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14329215|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14329216|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14329217|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
14329218|NCT00814671|Rifampin|rifampin|mesh-list
14329219|NCT00814671|Rifapentine|rifapentine|mesh-list
14329220|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14329221|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
14329222|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14329223|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329224|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
14329225|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14329226|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329227|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329228|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14329229|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14329230|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14329231|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14329232|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14329233|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14329234|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14329235|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
14329236|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329237|NCT00814788|Everolimus|everolimus|mesh-list
14329238|NCT00814788|Bicalutamide|bicalutamide|mesh-list
14329239|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329240|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329241|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
14329242|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329243|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
14329244|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
14329245|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329246|NCT00814801|Galantamine|galantamine|mesh-list
14329247|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14329248|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329249|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329250|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
14329251|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329252|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225817|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15225818|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
15225819|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15225820|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225821|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15225822|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225823|NCT03539302|Flecainide|flecainide|mesh-list
15225824|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15225825|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15225826|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15225827|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15225828|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225829|NCT03520790|Gemcitabine|gemcitabine|mesh-list
14329253|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14329254|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
14329255|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329256|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
14329257|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
14329258|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14329259|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14329260|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14329261|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
14329262|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329263|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14329264|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14329265|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329266|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329267|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14329268|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14329269|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
14329270|NCT00815295|Cetuximab|cetuximab|mesh-list
14329271|NCT00815295|Sorafenib|sorafenib|mesh-list
14329272|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329273|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329274|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14329275|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329276|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329277|NCT00815308|Paclitaxel|paclitaxel|mesh-list
14329278|NCT00815308|Cetuximab|cetuximab|mesh-list
14329279|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14329280|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329281|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
14329282|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
14329283|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
14329284|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329285|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329286|NCT00815347|Bosentan|bosentan|mesh-list
14329287|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329288|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14329289|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329290|NCT00815360|Triamcinolone|triamcinolone|mesh-list
14329291|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14329292|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14329293|NCT00815360|Ranibizumab|ranibizumab|mesh-list
14329294|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14329295|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14329296|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14329297|NCT00815360|Growth Substances|growth substances|mesh-ancestor
14329298|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329299|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
14329300|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329301|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329302|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
14329303|NCT00815360|Hormones|hormones|mesh-ancestor
14329304|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329305|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329306|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
14329307|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329308|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329309|NCT00815516|Amphotericin B|amphotericin b|mesh-list
14329310|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14329311|NCT00815516|Micafungin|micafungin|mesh-list
14329312|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14329313|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
14329314|NCT00815516|Amebicides|amebicides|mesh-ancestor
14329315|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14329316|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14329317|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329318|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14329319|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
14329320|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14329321|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329322|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14329323|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14329324|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14329325|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
14329326|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329327|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14329328|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14329329|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329330|NCT00815919|Prednisone|prednisone|mesh-list
14329331|NCT00815919|Bortezomib|bortezomib|mesh-list
14329332|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329333|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
14329334|NCT00815919|Hormones|hormones|mesh-ancestor
14329335|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329336|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329337|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14329338|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329339|NCT00816023|Ecallantide|ecallantide|mesh-list
14329340|NCT00816023|Analgesics|analgesics|mesh-ancestor
14329341|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
14329342|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329343|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329344|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14329345|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14329346|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329347|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329348|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
14329349|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14329350|NCT00816166|Aspirin|aspirin|mesh-list
14329351|NCT00816166|Clopidogrel|clopidogrel|mesh-list
14329352|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14329353|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14329354|NCT00816166|Analgesics|analgesics|mesh-ancestor
14329355|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
14329356|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329357|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329358|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329359|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329360|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14329361|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14917657|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14917658|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917659|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
14917660|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14917661|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14917662|NCT04700176|Growth Substances|growth substances|mesh-ancestor
14917663|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
14917664|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
14917665|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329362|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917666|NCT04699240|Clotrimazole|clotrimazole|mesh-list
14917667|NCT04699240|Miconazole|miconazole|mesh-list
15225830|NCT03520790|Paclitaxel|paclitaxel|mesh-list
14917668|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14917669|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225831|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225832|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225833|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225834|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
14917670|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
14917671|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14917672|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14917673|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917674|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917675|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15225835|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225836|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225837|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14329363|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14329364|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14329365|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329366|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
14329367|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14329368|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14329369|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14329370|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
14329371|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329372|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14329373|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14329374|NCT00816556|Estradiol|estradiol|mesh-list
14329375|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14329376|NCT00816556|Estrogens|estrogens|mesh-ancestor
14329377|NCT00816556|Hormones|hormones|mesh-ancestor
14329378|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329379|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329380|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14329381|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
14329382|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14329383|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14329384|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
14329385|NCT00816595|Bevacizumab|bevacizumab|mesh-list
14329386|NCT00816595|Rituximab|rituximab|mesh-list
14329387|NCT00816595|Pentostatin|pentostatin|mesh-list
14329388|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329389|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
14329390|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329391|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329392|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14329393|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
14329394|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329395|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329396|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14329397|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329398|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14329399|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14329400|NCT00816595|Growth Substances|growth substances|mesh-ancestor
14329401|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
14329402|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14329403|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329404|NCT00816751|Lidocaine|lidocaine|mesh-list
14329405|NCT00816751|Vasopressins|vasopressins|mesh-list
14329406|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
14329407|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
14329408|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
14329409|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329410|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329411|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
14329412|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329413|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14329414|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14329415|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14329416|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14329417|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329418|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
14329419|NCT00816751|Coagulants|coagulants|mesh-ancestor
14329420|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14329421|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14329422|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
14329423|NCT00816829|Fenofibrate|fenofibrate|mesh-list
14329424|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14329425|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
14329426|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329427|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14329428|NCT00816907|Metformin|metformin|mesh-list
14329429|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329430|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329431|NCT00817063|Alitretinoin|alitretinoin|mesh-list
14329432|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329433|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329434|NCT00817089|Naltrexone|naltrexone|mesh-list
14329435|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14329436|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14329437|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329438|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
14329439|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329440|NCT00817206|Tacrolimus|tacrolimus|mesh-list
14329441|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329442|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
14329443|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329444|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14329445|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329446|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329447|NCT00817219|Betamethasone|betamethasone|mesh-list
14329448|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
14329449|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14329450|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
14329451|NCT00817219|Calcipotriene|calcipotriene|mesh-list
14329452|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14329453|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329454|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
14329455|NCT00817219|Hormones|hormones|mesh-ancestor
14329456|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329457|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329458|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14329459|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
14329460|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
14729524|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329461|NCT00817479|Dexamethasone|dexamethasone|mesh-list
14329462|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329463|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
14329464|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
14329465|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329466|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329467|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329468|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
14329469|NCT00817479|Hormones|hormones|mesh-ancestor
14329470|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329471|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14329472|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329473|NCT00817531|Dasatinib|dasatinib|mesh-list
14329474|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329475|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14329476|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329477|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329478|NCT00817635|Eplerenone|eplerenone|mesh-list
14329479|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14329480|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
14329481|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329482|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329483|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14329484|NCT00817635|Diuretics|diuretics|mesh-ancestor
14329485|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
14329486|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329487|NCT00817843|Simvastatin|simvastatin|mesh-list
14329488|NCT00817843|Ezetimibe|ezetimibe|mesh-list
14329489|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14329490|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14329491|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
14329492|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329493|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14329494|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14329495|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329496|NCT00817999|Clopidogrel|clopidogrel|mesh-list
14329497|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14917676|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
15225838|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
15225839|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
15225840|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15225841|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225842|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225843|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
15225844|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225845|NCT03490760|Durvalumab|durvalumab|mesh-list
15225846|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225847|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225848|NCT03436108|Bisphenol A|bisphenol a|mesh-list
15225849|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15225850|NCT03436108|Estrogens|estrogens|mesh-ancestor
15225851|NCT03436108|Hormones|hormones|mesh-ancestor
15225852|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225853|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225854|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15225855|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
15225856|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225857|NCT03436108|Protective Agents|protective agents|mesh-ancestor
15225858|NCT03433248|Empagliflozin|empagliflozin|mesh-list
15225859|NCT03433248|Gliclazide|gliclazide|mesh-list
15225860|NCT03433248|Linagliptin|linagliptin|mesh-list
15225861|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15225862|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225863|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15225864|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225865|NCT03433248|Incretins|incretins|mesh-ancestor
15225866|NCT03433248|Hormones|hormones|mesh-ancestor
15225867|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225868|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15225869|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
15225870|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225871|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
15225872|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15225873|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329498|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14329499|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14329500|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14329501|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
14329502|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329503|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329504|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329505|NCT00818168|Infliximab|infliximab|mesh-list
14329506|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329507|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329508|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329509|NCT00818259|Dexamethasone|dexamethasone|mesh-list
14329510|NCT00818259|Ondansetron|ondansetron|mesh-list
14329511|NCT00818259|Aprepitant|aprepitant|mesh-list
14329512|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
14329513|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329514|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
14329515|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
14329516|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329517|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329518|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329519|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
14329520|NCT00818259|Hormones|hormones|mesh-ancestor
14329521|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329522|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14329523|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329524|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
14329525|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329526|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14329527|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
14329528|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329529|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329530|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14329531|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14329532|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329533|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14329534|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14329535|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14329536|NCT00818272|Infliximab|infliximab|mesh-list
14329537|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329538|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329539|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329540|NCT00818324|Rebamipide|rebamipide|mesh-list
14329541|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14329542|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329543|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
14329544|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329545|NCT00818324|Protective Agents|protective agents|mesh-ancestor
14329546|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329547|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329548|NCT00818337|Aspirin|aspirin|mesh-list
14329549|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14729525|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15225874|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225875|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15225876|NCT03417999|Analgesics|analgesics|mesh-ancestor
15225877|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
15225878|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225879|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15225880|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15225881|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15225882|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
15225883|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329550|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14329551|NCT00818337|Analgesics|analgesics|mesh-ancestor
15225884|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225885|NCT03348670|BCG Vaccine|bcg vaccine|mesh-list
14329552|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
14329553|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329554|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329555|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329556|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329557|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14329558|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14329559|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329560|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14329561|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14329562|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329563|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
14329564|NCT00818363|Bupivacaine|bupivacaine|mesh-list
14329565|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
14329566|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
14329567|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329568|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329569|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
14329570|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329571|NCT00818389|Riluzole|riluzole|mesh-list
14329572|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
14917677|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917678|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917679|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14917680|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14917681|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14917682|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
14917683|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
14917684|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917685|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917686|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
14329573|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
14329574|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14329575|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329576|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329577|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
14329578|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14329579|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329580|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329581|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
14329582|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14329583|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14329584|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329585|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14329586|NCT00818389|Protective Agents|protective agents|mesh-ancestor
14329587|NCT00818454|Albuterol|albuterol|mesh-list
14329588|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14329589|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
14329590|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329591|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329592|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14329593|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
14329594|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
14329595|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14329596|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14329597|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14329598|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14329599|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
14329600|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329601|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329602|NCT00818519|Drospirenone|drospirenone|mesh-list
14329603|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14329604|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
14329605|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329606|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329607|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14329608|NCT00818519|Diuretics|diuretics|mesh-ancestor
14329609|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
14329610|NCT00818649|Bortezomib|bortezomib|mesh-list
14329611|NCT00818649|Vorinostat|vorinostat|mesh-list
14329612|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329613|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14329614|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329615|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329616|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14329617|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
14329618|NCT00818662|Antibodies|antibodies|mesh-list
14329619|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
14329620|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14329621|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14329622|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
14329623|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
14329624|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329625|NCT00818753|Heparin|heparin|mesh-list
14329626|NCT00818753|Calcium heparin|calcium heparin|mesh-list
14329627|NCT00818753|Dabigatran|dabigatran|mesh-list
14329628|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
14329629|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14329630|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14329631|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329632|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
14329633|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14329634|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
14329635|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329636|NCT00818766|Vancomycin|vancomycin|mesh-list
14329637|NCT00818766|Cefazolin|cefazolin|mesh-list
14329638|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14329639|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329640|NCT00818779|Amlodipine|amlodipine|mesh-list
14329641|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329642|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14329643|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14329644|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329645|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14329646|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329647|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
14329648|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14329649|NCT00818805|Tranilast|tranilast|mesh-list
14329650|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14329651|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14329652|NCT00818805|Analgesics|analgesics|mesh-ancestor
14329653|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
14329654|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329655|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329656|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329657|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329658|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14329659|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14329660|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14329661|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
14329662|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
14329663|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329664|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329665|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14329666|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14329667|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14329668|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14329669|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14329670|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
14329671|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14329672|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329673|NCT00818883|Diuretics|diuretics|mesh-ancestor
14329674|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
14329675|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329676|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14329677|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14329678|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329679|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14329680|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14329681|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
14329682|NCT00818961|Busulfan|busulfan|mesh-list
14329683|NCT00818961|Rituximab|rituximab|mesh-list
14329684|NCT00818961|Methotrexate|methotrexate|mesh-list
14329685|NCT00818961|Fludarabine|fludarabine|mesh-list
14329686|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
14329687|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
14329688|NCT00818961|Tacrolimus|tacrolimus|mesh-list
14329689|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329690|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
14329691|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329692|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329693|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14329694|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
14329695|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329696|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225886|NCT03348670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15225887|NCT03348670|Immunologic Factors|immunologic factors|mesh-ancestor
14329697|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14329698|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329699|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14329700|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
14329701|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14329702|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14329703|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
14329704|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329705|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329706|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14329707|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14329708|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14329709|NCT00819013|Vaccines|vaccines|mesh-list
14329710|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
14329711|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329712|NCT00819039|Ondansetron|ondansetron|mesh-list
14329713|NCT00819039|Aprepitant|aprepitant|mesh-list
14329714|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
14329715|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
14329716|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329717|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329718|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329719|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
14329720|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
14329721|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14329722|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
14329723|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329724|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329725|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14329726|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15225888|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329727|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329728|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14329729|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14329730|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14329731|NCT00819052|Nevirapine|nevirapine|mesh-list
14329732|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14329733|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14329734|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329735|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329736|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
14329737|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329738|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14329739|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14329740|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14329741|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14329742|NCT00819091|Linagliptin|linagliptin|mesh-list
14329743|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329744|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329745|NCT00819091|Incretins|incretins|mesh-ancestor
14329746|NCT00819091|Hormones|hormones|mesh-ancestor
14329747|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329748|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14329749|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14329750|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329751|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329752|NCT00819234|Pramlintide|pramlintide|mesh-list
14329753|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329754|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329755|NCT00819390|Chloroquine|chloroquine|mesh-list
14329756|NCT00819390|Amebicides|amebicides|mesh-ancestor
14329757|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14329758|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14329759|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329760|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
14329761|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329762|NCT00819403|Simvastatin|simvastatin|mesh-list
14329763|NCT00819403|Ezetimibe|ezetimibe|mesh-list
14329764|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
15225889|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
15225890|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225891|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329765|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14329766|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14329767|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
14329768|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329769|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14329770|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14329771|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464213|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14464214|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225892|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
15225893|NCT03263559|Thiotepa|thiotepa|mesh-list
15225894|NCT03263559|Fludarabine|fludarabine|mesh-list
15225895|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
15225896|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
15225897|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225898|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
15225899|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225900|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464215|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225901|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15225902|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
14329772|NCT00819507|Fluocinonide|fluocinonide|mesh-list
14329773|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329774|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
14329775|NCT00819507|Hormones|hormones|mesh-ancestor
14329776|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329777|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329778|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14329779|NCT00819585|Colchicine|colchicine|mesh-list
14329780|NCT00819585|Allopurinol|allopurinol|mesh-list
14329781|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14329782|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
14329783|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329784|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14329785|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225903|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225904|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225905|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15225906|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
15225907|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225908|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15225909|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15225910|NCT03228680|Hormones|hormones|mesh-ancestor
14329786|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14329787|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329788|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329789|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
14329790|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329791|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14329792|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
14329793|NCT00819585|Protective Agents|protective agents|mesh-ancestor
14329794|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329795|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
14329796|NCT00819637|Albuterol|albuterol|mesh-list
14329797|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
14329798|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14329799|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
14329800|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329801|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329802|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14329803|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
14329804|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14329805|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14329806|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14329807|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
14329808|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329809|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329810|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
14329811|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14917687|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917688|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14930813|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14930814|NCT01435395|Bevacizumab|bevacizumab|mesh-list
14930815|NCT01435395|Temozolomide|temozolomide|mesh-list
14930816|NCT01435395|Bortezomib|bortezomib|mesh-list
15225911|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225912|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930817|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14930818|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930819|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14930820|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14930821|NCT01435395|Growth Substances|growth substances|mesh-ancestor
14930822|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930823|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
14930824|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14930825|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
14930826|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930827|NCT01435486|Caffeine|caffeine|mesh-list
14930828|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
14930829|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930830|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14930831|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930832|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14329812|NCT00819741|Metformin|metformin|mesh-list
14329813|NCT00819741|Repaglinide|repaglinide|mesh-list
14329814|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329815|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329816|NCT00819767|Valsartan|valsartan|mesh-list
14329817|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14329818|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14329819|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14329820|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329821|NCT00819780|Bevacizumab|bevacizumab|mesh-list
14917689|NCT04604353|Calcium|calcium|mesh-list
14917690|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15225913|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
14329822|NCT00819780|Panitumumab|panitumumab|mesh-list
14329823|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329824|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329825|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14329826|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14329827|NCT00819780|Growth Substances|growth substances|mesh-ancestor
14329828|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329829|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
14329830|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
14329831|NCT00819910|Fenofibrate|fenofibrate|mesh-list
14329832|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329833|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329834|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14329835|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
14329836|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329837|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14329838|NCT00820170|Paclitaxel|paclitaxel|mesh-list
14329839|NCT00820170|Dasatinib|dasatinib|mesh-list
14329840|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14329841|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329842|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14329843|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14329844|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14329845|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329846|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14329847|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329848|NCT00820222|Capecitabine|capecitabine|mesh-list
14329849|NCT00820222|Trastuzumab|trastuzumab|mesh-list
14329850|NCT00820222|Lapatinib|lapatinib|mesh-list
14329851|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14329852|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
14329853|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329854|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329855|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15225914|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
15225915|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15225916|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
14329856|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14917691|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917692|NCT04598815|Sirolimus|sirolimus|mesh-list
14917693|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14917694|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917695|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14917696|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917697|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
14917698|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917699|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
14917700|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917701|NCT04593940|Remdesivir|remdesivir|mesh-list
14917702|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
14917703|NCT04593940|Abatacept|abatacept|mesh-list
14917704|NCT04593940|Infliximab|infliximab|mesh-list
14917705|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
14917706|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917707|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917708|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14917709|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917710|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329857|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329858|NCT00820248|Panitumumab|panitumumab|mesh-list
14917711|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917712|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
14329859|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329860|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329861|NCT00820534|Penciclovir|penciclovir|mesh-list
14329862|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
14729526|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225917|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225918|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15225919|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225920|NCT03112174|Venetoclax|venetoclax|mesh-list
15225921|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225922|NCT03082729|Apremilast|apremilast|mesh-list
14729527|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
14729528|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729529|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14729530|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14729531|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14329863|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329864|NCT00820573|Metformin|metformin|mesh-list
14329865|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14329866|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329867|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329868|NCT00820573|Incretins|incretins|mesh-ancestor
14329869|NCT00820573|Hormones|hormones|mesh-ancestor
14329870|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329871|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14329872|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
14329873|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329874|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329875|NCT00820612|Indomethacin|indomethacin|mesh-list
14329876|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14329877|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14329878|NCT00820612|Analgesics|analgesics|mesh-ancestor
14329879|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
14329880|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329881|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329882|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329883|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14329884|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
14329885|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
14329886|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14329887|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14329888|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329889|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329890|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14329891|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14329892|NCT00820664|Estradiol|estradiol|mesh-list
14329893|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14329894|NCT00820664|Estrogens|estrogens|mesh-ancestor
14329895|NCT00820664|Hormones|hormones|mesh-ancestor
14329896|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329897|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729532|NCT00523692|Analgesics|analgesics|mesh-ancestor
14729533|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
14729534|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329898|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14329899|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
14329900|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14329901|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14329902|NCT00820755|Cetuximab|cetuximab|mesh-list
14329903|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329904|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329905|NCT00820872|Carboplatin|carboplatin|mesh-list
14329906|NCT00820872|Docetaxel|docetaxel|mesh-list
14329907|NCT00820872|Trastuzumab|trastuzumab|mesh-list
14329908|NCT00820872|Lapatinib|lapatinib|mesh-list
14329909|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329910|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
14329911|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
14329912|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
14329913|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329914|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14329915|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14329916|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329917|NCT00820898|Gemcitabine|gemcitabine|mesh-list
14729535|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14329918|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14329919|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
14329920|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329921|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329922|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
14329923|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329924|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329925|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14329926|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
14329927|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329928|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14329929|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14329930|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
14329931|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14329932|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329933|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14329934|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
14329935|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14329936|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14329937|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14329938|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
14329939|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329940|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329941|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
14329942|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14329943|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14329944|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
14329945|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329946|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329947|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329948|NCT00821184|Urological Agents|urological agents|mesh-ancestor
14329949|NCT05237115|Amoxicillin|amoxicillin|mesh-list
14329950|NCT05237115|Clarithromycin|clarithromycin|mesh-list
14329951|NCT05237115|Esomeprazole|esomeprazole|mesh-list
14329952|NCT05237115|Bismuth|bismuth|mesh-list
14329953|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14329954|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14329955|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14329956|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14329957|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14329958|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329959|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329960|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14329961|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14329962|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14329963|NCT05237115|Antacids|antacids|mesh-ancestor
14329964|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14329965|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
14329966|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14329967|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329968|NCT05236998|Incretins|incretins|mesh-ancestor
14329969|NCT05236998|Hormones|hormones|mesh-ancestor
14329970|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14329971|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14329972|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
14329973|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14329974|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329975|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14329976|NCT05236972|Capecitabine|capecitabine|mesh-list
14329977|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
14329978|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14329979|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
14329980|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14329981|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14329982|NCT05236907|Midazolam|midazolam|mesh-list
14329983|NCT05236907|Melatonin|melatonin|mesh-list
14329984|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14329985|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14329986|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14329987|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14329988|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14329989|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14329990|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14329991|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14329992|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
14329993|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
14329994|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
14329995|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
14329996|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14329997|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917713|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225923|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14329998|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
14329999|NCT05236907|Protective Agents|protective agents|mesh-ancestor
14330000|NCT05236842|Sulthiame|sulthiame|mesh-list
14330001|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
14330002|NCT05236777|Natalizumab|natalizumab|mesh-list
14330003|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
14330004|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729536|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729537|NCT00523757|Spironolactone|spironolactone|mesh-list
14729538|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14729539|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
14729540|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729541|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225924|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15225925|NCT03082729|Analgesics|analgesics|mesh-ancestor
15225926|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
15225927|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225928|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729542|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14729543|NCT00523757|Diuretics|diuretics|mesh-ancestor
15225929|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15225930|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225931|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15225932|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15225933|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225934|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225935|NCT03062826|Aspirin|aspirin|mesh-list
15225936|NCT03062826|Clopidogrel|clopidogrel|mesh-list
15225937|NCT03062826|Ticagrelor|ticagrelor|mesh-list
15225938|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15225939|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15225940|NCT03062826|Analgesics|analgesics|mesh-ancestor
15225941|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
15225942|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225943|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225944|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15225945|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15225946|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15225947|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15225948|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225949|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15225950|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15225951|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225952|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
15225953|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15225954|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15225955|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14330018|NCT05236634|Tadalafil|tadalafil|mesh-list
14330019|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14330020|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14330021|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
14330022|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14330023|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330024|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330025|NCT05236634|Urological Agents|urological agents|mesh-ancestor
14330026|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14330027|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14330028|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330029|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330030|NCT05236621|Dexamethasone|dexamethasone|mesh-list
14330031|NCT05236621|Pomalidomide|pomalidomide|mesh-list
14330032|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330033|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
14330034|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
14330035|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330036|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330037|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14330038|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
14330039|NCT05236621|Hormones|hormones|mesh-ancestor
14330040|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330041|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14330042|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330043|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
14330044|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14330045|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14330046|NCT05236621|Growth Substances|growth substances|mesh-ancestor
14330047|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
14330048|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
14330049|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14330050|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14330051|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330052|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
14330053|NCT05236569|Coagulants|coagulants|mesh-ancestor
14330054|NCT05236504|Melatonin|melatonin|mesh-list
14330055|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
15225956|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
15225957|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15225958|NCT03029611|Paclitaxel|paclitaxel|mesh-list
15225959|NCT03029611|Carboplatin|carboplatin|mesh-list
15225960|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15225961|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15225962|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225963|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
15225964|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
15225965|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225966|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225967|NCT03024996|Atezolizumab|atezolizumab|mesh-list
15225968|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225969|NCT02914977|Daunorubicin|daunorubicin|mesh-list
15225970|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14330056|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225971|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330057|NCT05236504|Protective Agents|protective agents|mesh-ancestor
14330058|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330059|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330060|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
14464216|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14464217|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14464218|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14464219|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14464220|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464221|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
14464222|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
14464223|NCT02207088|Ritonavir|ritonavir|mesh-list
14464224|NCT02207088|Ribavirin|ribavirin|mesh-list
14464225|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14464226|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14464227|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
14464228|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464229|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464230|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14464231|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464232|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
14464233|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464234|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14464235|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14464236|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
14464237|NCT02207231|Adalimumab|adalimumab|mesh-list
14464238|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14464239|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14464240|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464241|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
14464242|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464243|NCT02207244|Adalimumab|adalimumab|mesh-list
14464244|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14464245|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14464246|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464247|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
14464248|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464249|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14464250|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
14464251|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464252|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464253|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15225972|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15225973|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15225974|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225975|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225976|NCT02891798|Dexamethasone|dexamethasone|mesh-list
15225977|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
15225978|NCT02891798|Clonidine|clonidine|mesh-list
15225979|NCT02891798|Buprenorphine|buprenorphine|mesh-list
15225980|NCT02891798|Bupivacaine|bupivacaine|mesh-list
14330061|NCT05235542|Paclitaxel|paclitaxel|mesh-list
14330062|NCT05235542|Docetaxel|docetaxel|mesh-list
14330063|NCT05235542|Capecitabine|capecitabine|mesh-list
14330064|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
14330065|NCT05235542|Irinotecan|irinotecan|mesh-list
14330066|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14330067|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330068|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14330069|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14330070|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
15225981|NCT02891798|BB 1101|bb 1101|mesh-list
15225982|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15225983|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
15225984|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
15225985|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15225986|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225987|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15225988|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
15225989|NCT02891798|Hormones|hormones|mesh-ancestor
15225990|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15225991|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14330071|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330072|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14330073|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
14330074|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14330075|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14330076|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330077|NCT05235516|Cisplatin|cisplatin|mesh-list
14330078|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330079|NCT05235256|Dexamethasone|dexamethasone|mesh-list
14330080|NCT05235256|Lidocaine|lidocaine|mesh-list
14330081|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330082|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
14330083|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
14330084|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330085|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330086|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14330087|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
14330088|NCT05235256|Hormones|hormones|mesh-ancestor
14330089|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330090|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14330091|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330092|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
14330093|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
14330094|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330095|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
14330096|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14330097|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14330098|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14330099|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14330100|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330101|NCT05235191|Methadone|methadone|mesh-list
14330102|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330103|NCT05235191|Narcotics|narcotics|mesh-ancestor
14330104|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330105|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330106|NCT05235191|Analgesics|analgesics|mesh-ancestor
14330107|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
14330108|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330109|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
14330110|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
14330111|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
14330112|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14330113|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330114|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15225992|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15225993|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
15225994|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15225995|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15225996|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
15225997|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
15225998|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15225999|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
15226000|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15226001|NCT02891798|Narcotics|narcotics|mesh-ancestor
15226002|NCT02891798|Analgesics|analgesics|mesh-ancestor
15226003|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15226004|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15226005|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
15226006|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15226007|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15226008|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15226009|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
15226010|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226011|NCT02870218|Nicotine|nicotine|mesh-list
15226012|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14330115|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14330116|NCT05215158|Analgesics|analgesics|mesh-ancestor
14330117|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
14330118|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330119|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14330120|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14330121|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14330122|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14330123|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330124|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330125|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
14330126|NCT05214196|Povidone|povidone|mesh-list
14330127|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
14330128|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
14330129|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14330130|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330131|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
14330132|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
14330133|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330134|NCT05209620|Pemetrexed|pemetrexed|mesh-list
14330135|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330136|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330137|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330138|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14330139|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14330140|NCT05209308|Rituximab|rituximab|mesh-list
14330141|NCT05209308|Venetoclax|venetoclax|mesh-list
14330142|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330143|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330144|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
14330145|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330146|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330147|NCT05206812|Durvalumab|durvalumab|mesh-list
14729544|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
14729545|NCT00523887|Fentanyl|fentanyl|mesh-list
14729546|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14729547|NCT00523887|Narcotics|narcotics|mesh-ancestor
14729548|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729549|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729550|NCT00523887|Analgesics|analgesics|mesh-ancestor
15226013|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
14330148|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330149|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330150|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
14330151|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
14330152|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14330153|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14330154|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330155|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330156|NCT05201144|Urological Agents|urological agents|mesh-ancestor
14330157|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
14729551|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
15226014|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226015|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226016|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15226017|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15226018|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
15226019|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226020|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226021|NCT02864992|Tepotinib|tepotinib|mesh-list
15226022|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226023|NCT02859961|Leronlimab|leronlimab|mesh-list
15226024|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
15226025|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15226026|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15226027|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226028|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15226029|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15226030|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
15226031|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226032|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
15226033|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226034|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
14330158|NCT05198232|TEMPO|tempo|mesh-list
14330159|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
14330160|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330161|NCT05198232|Protective Agents|protective agents|mesh-ancestor
14330162|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330163|NCT05198232|Antacids|antacids|mesh-ancestor
14330164|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464254|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464255|NCT02207400|Listerine|listerine|mesh-list
14464256|NCT02207400|Fluorides|fluorides|mesh-list
14464257|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
15226035|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226036|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226037|NCT02679781|Midazolam|midazolam|mesh-list
15226038|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15226039|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15226040|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226041|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226042|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15226043|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15226044|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15226045|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15226046|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
15226047|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
14464258|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
14917714|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
14917715|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
14464259|NCT02207400|Protective Agents|protective agents|mesh-ancestor
14464260|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464261|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14464262|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464263|NCT02207413|Vaccines|vaccines|mesh-list
14464264|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
14464265|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464266|NCT02207491|Timolol|timolol|mesh-list
14464267|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14464268|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14464269|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14464270|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14464271|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
14464272|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464273|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464274|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464275|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14464276|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14464277|NCT02207530|Durvalumab|durvalumab|mesh-list
14464278|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464279|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464280|NCT02207556|Doxycycline|doxycycline|mesh-list
14464281|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15226048|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
15226049|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
14917716|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917717|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14917718|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14917719|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14917720|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
14917721|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
14917722|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14917723|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14464282|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226050|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226051|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226052|NCT02624869|Evolocumab|evolocumab|mesh-list
15226053|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15226054|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15226055|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
14464283|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
15226056|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226057|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15226058|NCT02614690|Calpastatin|calpastatin|mesh-list
14330165|NCT05177198|Clindamycin|clindamycin|mesh-list
14330166|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
14330167|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
14330168|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14330169|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330170|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14330171|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330172|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330173|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14330174|NCT05170841|Tramadol|tramadol|mesh-list
14330175|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330176|NCT05170841|Narcotics|narcotics|mesh-ancestor
14330177|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330178|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330179|NCT05170841|Analgesics|analgesics|mesh-ancestor
14330180|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
14330181|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330182|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14330183|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14330184|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330185|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226059|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
15226060|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
15226061|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226062|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226063|NCT02595424|Carboplatin|carboplatin|mesh-list
15226064|NCT02595424|Capecitabine|capecitabine|mesh-list
15226065|NCT02595424|Etoposide|etoposide|mesh-list
15226066|NCT02595424|Temozolomide|temozolomide|mesh-list
15226067|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226068|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15226069|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
15226070|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226071|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15226072|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14330186|NCT05157685|Azithromycin|azithromycin|mesh-list
14330187|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14330188|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226073|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15226074|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226075|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14930833|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226076|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
15226077|NCT02569242|Paclitaxel|paclitaxel|mesh-list
15226078|NCT02569242|Docetaxel|docetaxel|mesh-list
15226079|NCT02569242|Nivolumab|nivolumab|mesh-list
15226080|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15226081|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226082|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
15226083|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
15226084|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
15226085|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226086|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226087|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14330198|NCT05131152|Cyclosporine|cyclosporine|mesh-list
14330199|NCT05131152|Cyclosporins|cyclosporins|mesh-list
14330200|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330201|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226088|NCT02435433|Ramucirumab|ramucirumab|mesh-list
15226089|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226090|NCT02426125|Docetaxel|docetaxel|mesh-list
15226091|NCT02426125|Ramucirumab|ramucirumab|mesh-list
15226092|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226093|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14330202|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330203|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
14330204|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330205|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
14464284|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14464285|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14464286|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
14464287|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14464288|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
14464289|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464290|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
14464291|NCT02207608|Protective Agents|protective agents|mesh-ancestor
15226094|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
15226095|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
15226096|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226097|NCT02417142|Exenatide|exenatide|mesh-list
15226098|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226099|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226100|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15226101|NCT02417142|Incretins|incretins|mesh-ancestor
15226102|NCT02417142|Hormones|hormones|mesh-ancestor
15226103|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330206|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330207|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14330208|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330209|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14330210|NCT05126784|Denosumab|denosumab|mesh-list
14330211|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14330212|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330213|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
14729552|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330214|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14330215|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14330216|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330217|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
14330218|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330219|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330220|NCT05124704|Ropivacaine|ropivacaine|mesh-list
14330221|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
14330222|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
14330223|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330224|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330225|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
14330226|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330227|NCT05120505|Metformin|metformin|mesh-list
14330228|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14330229|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330230|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
14330231|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330232|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330233|NCT05076110|Acetaminophen|acetaminophen|mesh-list
14330234|NCT05076110|Ibuprofen|ibuprofen|mesh-list
14330235|NCT05076110|Oxycodone|oxycodone|mesh-list
14330236|NCT05076110|Gabapentin|gabapentin|mesh-list
14330237|NCT05076110|Methocarbamol|methocarbamol|mesh-list
14330238|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14330239|NCT05076110|Analgesics|analgesics|mesh-ancestor
14330240|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
14330241|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330242|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330243|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
14330244|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14330245|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330246|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330247|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14330248|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330249|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330250|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330251|NCT05076110|Narcotics|narcotics|mesh-ancestor
14330252|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330253|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
14330254|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14330255|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14330256|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14330257|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14330258|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14330259|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330260|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
15226104|NCT02368886|Clobetasol|clobetasol|mesh-list
15226105|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226106|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
15226107|NCT02368886|Hormones|hormones|mesh-ancestor
15226108|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226109|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226110|NCT02354703|Ondansetron|ondansetron|mesh-list
14330261|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14330262|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15226111|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
15226112|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
15226113|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226114|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226115|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15226116|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
14330263|NCT05063201|Cariprazine|cariprazine|mesh-list
14330264|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14330265|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14330266|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330267|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330268|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14330269|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14330270|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14330271|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14330272|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330273|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330274|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
14330275|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330276|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14330277|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464292|NCT02207621|Timolol|timolol|mesh-list
14464293|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14464294|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14464295|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14464296|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14464297|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14464298|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464299|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464300|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464301|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14464302|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14464303|NCT02207634|Evolocumab|evolocumab|mesh-list
14464304|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14464305|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14464306|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
14464307|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464308|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14464309|NCT02207816|Vaccines|vaccines|mesh-list
14464310|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
14464311|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464312|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
14464313|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14464314|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
14464315|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464316|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464317|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14464318|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
14464319|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
14464320|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14464321|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
14464322|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464323|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464324|NCT02207907|Listerine|listerine|mesh-list
14464325|NCT02207907|Fluorides|fluorides|mesh-list
14464326|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
14917724|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917725|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917726|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917727|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917728|NCT04510194|Metformin|metformin|mesh-list
14464327|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
14464328|NCT02207907|Protective Agents|protective agents|mesh-ancestor
14917729|NCT04510194|Ivermectin|ivermectin|mesh-list
14917730|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
14917731|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14917732|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917733|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14917734|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917735|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14917736|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917737|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917738|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917739|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14917740|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14330278|NCT05039736|Nivolumab|nivolumab|mesh-list
14330279|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330280|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330281|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14330282|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330283|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14330284|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330285|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330286|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330287|NCT05028075|Cobalt|cobalt|mesh-list
14330288|NCT05028075|Trace Elements|trace elements|mesh-ancestor
14330289|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
14330290|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330291|NCT05003089|Prednisolone|prednisolone|mesh-list
14330292|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330293|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
14330294|NCT05003089|Hormones|hormones|mesh-ancestor
14330295|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330296|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330297|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14330298|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330299|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
14330300|NCT05000450|Fludarabine|fludarabine|mesh-list
14330301|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330302|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
14330303|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330304|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330305|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14330306|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
14330307|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330308|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330309|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14330310|NCT04994431|Tamsulosin|tamsulosin|mesh-list
14330311|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14330312|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14330313|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14330314|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
14330315|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330316|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330317|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330318|NCT04994431|Urological Agents|urological agents|mesh-ancestor
14330319|NCT04964947|Tobramycin|tobramycin|mesh-list
14330320|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14330321|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330322|NCT04926324|Niraparib|niraparib|mesh-list
14330323|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14330324|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330325|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330326|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330327|NCT04918407|Empagliflozin|empagliflozin|mesh-list
14330328|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226117|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
15226118|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15226119|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
15226120|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226121|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226122|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15226123|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15226124|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226125|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15226126|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15226127|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15226128|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15226129|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226130|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226131|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
15226132|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226133|NCT00796068|Cyclosporine|cyclosporine|mesh-list
15226134|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
15226135|NCT00796068|Fludarabine|fludarabine|mesh-list
15226136|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
15226137|NCT00796068|Treosulfan|treosulfan|mesh-list
15226138|NCT00796068|Busulfan|busulfan|mesh-list
15226139|NCT00796068|Cyclosporins|cyclosporins|mesh-list
14330329|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330330|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14330331|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917741|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14917742|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917743|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917744|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
14917745|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14917746|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
14917747|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14917748|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14917749|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917750|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14917751|NCT04500756|Metformin|metformin|mesh-list
14917752|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14917753|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917754|NCT04472416|Analgesics|analgesics|mesh-list
14330332|NCT04900116|Bupivacaine|bupivacaine|mesh-list
15226140|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226141|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15226142|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
15226143|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226144|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226145|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
15226146|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226147|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226148|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
15226149|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226150|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
15226151|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330333|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
14330334|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
14330335|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917755|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
15226152|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15226153|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15226154|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15226155|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
15226156|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15226157|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15226158|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
15226159|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15226160|NCT00468130|Aripiprazole|aripiprazole|mesh-list
15226161|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
15226162|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15226163|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15226164|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917756|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917757|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917758|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
14917759|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
14917760|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14917761|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14917762|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917763|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917764|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226165|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226166|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226167|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
15226168|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
15226169|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226170|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226171|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14917765|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917766|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
14917767|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226172|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15226173|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
15226174|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14330336|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330337|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
14330338|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330339|NCT04894123|Trifluridine|trifluridine|mesh-list
14330340|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
14330341|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330342|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
14330343|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330344|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
14330345|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330346|NCT04857684|Bevacizumab|bevacizumab|mesh-list
14330347|NCT04857684|Atezolizumab|atezolizumab|mesh-list
14330348|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330349|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330350|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14330351|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14330352|NCT04857684|Growth Substances|growth substances|mesh-ancestor
14330353|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330354|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14330355|NCT04825275|Posaconazole|posaconazole|mesh-list
14330356|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
14330357|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330358|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14330359|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14330360|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14330361|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14330362|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14330363|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226175|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15226176|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15226177|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15226178|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15226179|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15226180|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
15226181|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226182|NCT05197751|Antacids|antacids|mesh-ancestor
15226183|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226184|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15226185|NCT05197621|Vaccines|vaccines|mesh-list
15226186|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
15226187|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226188|NCT05197504|Bevacizumab|bevacizumab|mesh-list
15226189|NCT05197504|Atezolizumab|atezolizumab|mesh-list
15226190|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226191|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226192|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15226193|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15226194|NCT05197504|Growth Substances|growth substances|mesh-ancestor
15226195|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226196|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
15226197|NCT05197192|Venetoclax|venetoclax|mesh-list
15226198|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
15226199|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
15226200|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226201|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226202|NCT05197101|Oxytocin|oxytocin|mesh-list
15226203|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
14330364|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226204|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14729553|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14729554|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14330365|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14330366|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
15226205|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226206|NCT05197088|Tamsulosin|tamsulosin|mesh-list
15226207|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15226208|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15226209|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15226210|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
15226211|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226212|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226213|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226214|NCT05197088|Urological Agents|urological agents|mesh-ancestor
15226215|NCT05196815|Dobutamine|dobutamine|mesh-list
15226216|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15226217|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
15226218|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
15226219|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226220|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226221|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15226222|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15226223|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15226224|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
15226225|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226226|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226227|NCT05196815|Protective Agents|protective agents|mesh-ancestor
15226228|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
15226229|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15226230|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226231|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226232|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226233|NCT05196256|Sufentanil|sufentanil|mesh-list
15226234|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
15226235|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
15226236|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
15226237|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226238|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226239|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
15226240|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226241|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14729555|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
14729556|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
14729557|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
14729558|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729559|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729560|NCT00523926|Bedaquiline|bedaquiline|mesh-list
14729561|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
14729562|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14729563|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729564|NCT00523952|Tacrolimus|tacrolimus|mesh-list
14729565|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729566|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
14729567|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917768|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
14917769|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
14917770|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
14917771|NCT04453449|Midazolam|midazolam|mesh-list
14917772|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14917773|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14917774|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729568|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14729569|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917775|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917776|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14330367|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330368|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330369|NCT04787744|Prednisone|prednisone|mesh-list
14330370|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
14330371|NCT04787744|Docetaxel|docetaxel|mesh-list
14330372|NCT04787744|Leuprolide|leuprolide|mesh-list
14330373|NCT04787744|Goserelin|goserelin|mesh-list
14330374|NCT04787744|Bicalutamide|bicalutamide|mesh-list
14330375|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14330376|NCT04787744|Flutamide|flutamide|mesh-list
14330377|NCT04787744|Nilutamide|nilutamide|mesh-list
14330378|NCT04787744|Relugolix|relugolix|mesh-list
14330379|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330380|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14330381|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14330382|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14330383|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330384|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330385|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
14330386|NCT04787744|Hormones|hormones|mesh-ancestor
14330387|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330388|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330389|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14330390|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
14330391|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
14330392|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330393|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14330394|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14330395|NCT04787744|Protective Agents|protective agents|mesh-ancestor
14330396|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14330397|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
14330398|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14330399|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
14330400|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
14330401|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
14330402|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14330403|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
14330404|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14330405|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
15226242|NCT05196256|Narcotics|narcotics|mesh-ancestor
15226243|NCT05196256|Analgesics|analgesics|mesh-ancestor
15226244|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15226245|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15226246|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
15226247|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15226248|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15226249|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226250|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14917777|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917778|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917779|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14917780|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
14917781|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
14917782|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
14917783|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
14917784|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917785|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330406|NCT04767984|Atorvastatin|atorvastatin|mesh-list
14330407|NCT04767984|Calcium|calcium|mesh-list
14330408|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14330409|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330410|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14330411|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14330412|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14330413|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
14330414|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330415|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14330416|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14330417|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330418|NCT04760275|Fluoxetine|fluoxetine|mesh-list
14330419|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14330420|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14330421|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14330422|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330423|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330424|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
14330425|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330426|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14330427|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
14330428|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15226251|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15226252|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226253|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226254|NCT05195944|Incretins|incretins|mesh-ancestor
15226255|NCT05195944|Hormones|hormones|mesh-ancestor
15226256|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226257|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15226258|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
15226259|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226260|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226261|NCT05195645|Abatacept|abatacept|mesh-list
15226262|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15226263|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226264|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226265|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226266|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
15226267|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226268|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226269|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
15226270|NCT05195619|Vaccines|vaccines|mesh-list
15226271|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
15226272|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226273|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226274|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226275|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15226276|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
15226277|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226278|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226279|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15226280|NCT05195294|Lenvatinib|lenvatinib|mesh-list
15226281|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226282|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15226283|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226284|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226285|NCT05195177|Anesthetics|anesthetics|mesh-list
15226286|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
14330429|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15226287|NCT05195177|Histamine|histamine|mesh-list
14330430|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14330431|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330432|NCT04742283|Timolol|timolol|mesh-list
14330433|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14330434|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14330435|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14330436|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14330437|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
14330438|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330439|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330440|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330441|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14330442|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14330443|NCT04729725|Cemiplimab|cemiplimab|mesh-list
14330444|NCT04729725|Antibodies|antibodies|mesh-list
14330445|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14330446|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
14330447|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330448|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330449|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330450|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
14330451|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14330452|NCT04694976|Vitamin D|vitamin d|mesh-list
14330453|NCT04694976|Vitamins|vitamins|mesh-ancestor
15226288|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
15226289|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15226290|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226291|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226292|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
15226293|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226294|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
15226295|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
15226296|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226297|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917786|NCT04415333|Butyric Acid|butyric acid|mesh-list
14917787|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
14917788|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
14917789|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729570|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729571|NCT00523965|Amphotericin B|amphotericin b|mesh-list
14729572|NCT00523965|Paromomycin|paromomycin|mesh-list
14729573|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14729574|NCT00523965|Miltefosine|miltefosine|mesh-list
14729575|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14729576|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
14729577|NCT00523965|Amebicides|amebicides|mesh-ancestor
14917790|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917791|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330454|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
14330455|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330456|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14330457|NCT04661280|Donepezil|donepezil|mesh-list
14330458|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14330459|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330460|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330461|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
14330462|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330463|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330464|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
14330465|NCT04645550|Aspirin|aspirin|mesh-list
14330466|NCT04645550|Heparin|heparin|mesh-list
14917792|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14917793|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14917794|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330467|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14330468|NCT04645550|Tinzaparin|tinzaparin|mesh-list
14729578|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14330469|NCT04645550|Dalteparin|dalteparin|mesh-list
14330470|NCT04645550|Dipyridamole|dipyridamole|mesh-list
14330471|NCT04645550|Warfarin|warfarin|mesh-list
14330472|NCT04645550|Apixaban|apixaban|mesh-list
14330473|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14330474|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14330475|NCT04645550|Analgesics|analgesics|mesh-ancestor
14330476|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
14330477|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330478|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330479|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330480|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330481|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15226298|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
15226299|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
15226300|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226301|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
15226302|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226303|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226304|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15226305|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
15226306|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226307|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226308|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15226309|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15226310|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15226311|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
15226312|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15226313|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226314|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226315|NCT05194904|Ketorolac|ketorolac|mesh-list
15226316|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
15226317|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15226318|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226319|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226320|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15226321|NCT05194904|Analgesics|analgesics|mesh-ancestor
15226322|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
15226323|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226324|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15226325|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15226326|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15226327|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
15226328|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226329|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226330|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15226331|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330482|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14330483|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330484|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14330485|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14330486|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330487|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
14330488|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
14330489|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14330490|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
14330491|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14330492|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
14330493|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14330494|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
14464329|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464330|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14464331|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464332|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
14464333|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14464334|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14464335|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14464336|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14464337|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464338|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464339|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
14464340|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464341|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464342|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14464343|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729579|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15226332|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226333|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15226334|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226335|NCT05194852|Anesthetics|anesthetics|mesh-list
15226336|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
15226337|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226338|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226339|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
15226340|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226341|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15226342|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226343|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226344|NCT05194046|Amoxicillin|amoxicillin|mesh-list
15226345|NCT05194046|Clarithromycin|clarithromycin|mesh-list
15226346|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15226347|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226348|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15226349|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226350|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226351|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15226352|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15226353|NCT05193994|Lamivudine|lamivudine|mesh-list
15226354|NCT05193994|Abacavir|abacavir|mesh-list
15226355|NCT05193994|Dolutegravir|dolutegravir|mesh-list
15226356|NCT05193994|Triumeq|triumeq|mesh-list
15226357|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15226358|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15226359|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226360|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226361|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
15226362|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226363|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15226364|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15226365|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15226366|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15226367|NCT05193838|Allopurinol|allopurinol|mesh-list
15226368|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
15226369|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226370|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226371|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
15226372|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226373|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15226374|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
14464344|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
14729580|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226375|NCT05193838|Protective Agents|protective agents|mesh-ancestor
15226376|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226377|NCT05193747|Anesthetics|anesthetics|mesh-list
15226378|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226379|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226380|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
15226381|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
15226382|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
15226383|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226384|NCT05193604|Gemcitabine|gemcitabine|mesh-list
15226385|NCT05193604|Paclitaxel|paclitaxel|mesh-list
15226386|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15226387|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226388|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
15226389|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
15226390|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
15226391|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226392|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15226393|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
15226394|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
15226395|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226396|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226397|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226398|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
15226399|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226400|NCT05193253|Liver Extracts|liver extracts|mesh-list
15226401|NCT05193253|Hematinics|hematinics|mesh-ancestor
14330495|NCT04634071|Bupropion|bupropion|mesh-list
14330496|NCT04634071|Nicotine|nicotine|mesh-list
14330497|NCT04634071|Varenicline|varenicline|mesh-list
14330498|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14330499|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
14330500|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729581|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14729582|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
15226402|NCT05190445|Paclitaxel|paclitaxel|mesh-list
15226403|NCT05190445|Ramucirumab|ramucirumab|mesh-list
15226404|NCT05190445|Tucatinib|tucatinib|mesh-list
15226405|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15226406|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226407|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
15226408|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
15226409|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
15226410|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226411|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15226412|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226413|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15226414|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15226415|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14729583|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729584|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14729585|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729586|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
14729587|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
14729588|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729589|NCT00524069|Gemcitabine|gemcitabine|mesh-list
14729590|NCT00524069|Bevacizumab|bevacizumab|mesh-list
15226416|NCT05176158|Analgesics|analgesics|mesh-ancestor
15226417|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
15226418|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226419|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226420|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226421|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226422|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15226423|NCT05173597|Hormones|hormones|mesh-ancestor
15226424|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226425|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226426|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
15226427|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15226428|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
15226429|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15226430|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226431|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15226432|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15226433|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15226434|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15226435|NCT05170464|Caffeine|caffeine|mesh-list
15226436|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15226437|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226438|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15226439|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226440|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226441|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14330501|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729591|NCT00524069|Capecitabine|capecitabine|mesh-list
14330502|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14330503|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14330504|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
14330505|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330506|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330507|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14330508|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
14729592|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226442|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15226443|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
15226444|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226445|NCT05170438|Paclitaxel|paclitaxel|mesh-list
15226446|NCT05170438|Lenvatinib|lenvatinib|mesh-list
15226447|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15226448|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226449|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
15226450|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
15226451|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
14729593|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729594|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14729595|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14729596|NCT00524069|Growth Substances|growth substances|mesh-ancestor
14729597|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729598|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
14729599|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729600|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
14729601|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917795|NCT04248829|Gefitinib|gefitinib|mesh-list
14917796|NCT04248829|Lazertinib|lazertinib|mesh-list
14917797|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917798|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14917799|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917800|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226452|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226453|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15226454|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226455|NCT05165251|Amlodipine|amlodipine|mesh-list
14330509|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14330510|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14330511|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14330512|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14330513|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
14330514|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14330515|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14330516|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330517|NCT04609514|Nicotine|nicotine|mesh-list
14330518|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14330519|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
14330520|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330521|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330522|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14330523|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14330524|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
14330525|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330526|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330527|NCT04608201|Nicotine|nicotine|mesh-list
14330528|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14330529|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
14330530|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330531|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330532|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14330533|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14330534|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
14330535|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330536|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330537|NCT04603248|Nivolumab|nivolumab|mesh-list
14330538|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330539|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330540|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14330541|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330542|NCT04591925|Insulin|insulin|mesh-list
14330543|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14330544|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14330545|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330546|NCT04572256|Montelukast|montelukast|mesh-list
14330547|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14330548|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14330549|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14330550|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
14330551|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330552|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330553|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14330554|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14330555|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330556|NCT04565730|Anesthetics|anesthetics|mesh-list
14330557|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330558|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330559|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14330560|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14330561|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14330562|NCT04550481|Lisinopril|lisinopril|mesh-list
14330563|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14330564|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
14330565|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330566|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330567|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14330568|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14330569|NCT04550481|Protective Agents|protective agents|mesh-ancestor
14330570|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330571|NCT04537156|Vaccines|vaccines|mesh-list
14330572|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
14330573|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330574|NCT04526691|Carboplatin|carboplatin|mesh-list
14330575|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
14330576|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330577|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330578|NCT04524689|Carboplatin|carboplatin|mesh-list
14330579|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
14330580|NCT04524689|Pemetrexed|pemetrexed|mesh-list
14330581|NCT04524689|Maytansine|maytansine|mesh-list
14330582|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330583|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330584|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330585|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330586|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14330587|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14330588|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14330589|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
14330590|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
14330591|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
14330592|NCT04501718|Etoposide|etoposide|mesh-list
14330593|NCT04501718|Temozolomide|temozolomide|mesh-list
14330594|NCT04501718|Apatinib|apatinib|mesh-list
14330595|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14330596|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330597|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14330598|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14330599|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330600|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330601|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14330602|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
14330603|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14330604|NCT04501705|Apatinib|apatinib|mesh-list
14330605|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330606|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14330607|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330608|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330609|NCT04490018|Vaccines|vaccines|mesh-list
14330610|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
14330611|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226456|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
15226457|NCT05165251|Atorvastatin|atorvastatin|mesh-list
15226458|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15226459|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15226460|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
15226461|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226462|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15226463|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15226464|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226465|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15226466|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14330623|NCT04410406|Ivermectin|ivermectin|mesh-list
14330624|NCT04410406|Albendazole|albendazole|mesh-list
14330625|NCT04410406|Moxidectin|moxidectin|mesh-list
14330626|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
14330627|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330628|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14330629|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330630|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
14330631|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
14330632|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14330633|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14330634|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
14330635|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
14330636|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
15226467|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15226468|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15226469|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226470|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
15226471|NCT05154669|Nicotine|nicotine|mesh-list
15226472|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15226473|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
15226474|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729602|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
15226475|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226476|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15226477|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15226478|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
15226479|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226480|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226481|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14330637|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330638|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
14330639|NCT04410406|Filaricides|filaricides|mesh-ancestor
14330640|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14330641|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330642|NCT04342975|Niacinamide|niacinamide|mesh-list
14330643|NCT04342975|Niacin|niacin|mesh-list
14330644|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
14330645|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
14330646|NCT04342975|Vitamins|vitamins|mesh-ancestor
14330647|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
14330648|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330649|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14330650|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
14330651|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330652|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14330653|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
14330654|NCT04329494|Leucovorin|leucovorin|mesh-list
14330655|NCT04329494|Cisplatin|cisplatin|mesh-list
14330656|NCT04329494|Doxorubicin|doxorubicin|mesh-list
14330657|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14330658|NCT04329494|Fluorouracil|fluorouracil|mesh-list
14330659|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
14330660|NCT04329494|Irinotecan|irinotecan|mesh-list
14330661|NCT04329494|Daunorubicin|daunorubicin|mesh-list
14330662|NCT04329494|Mitomycins|mitomycins|mesh-list
14330663|NCT04329494|Mitomycin|mitomycin|mesh-list
14330664|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330665|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14330666|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14330667|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14330668|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330669|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330670|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
14330671|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14330672|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330673|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
14330674|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330675|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14330676|NCT04329494|Antidotes|antidotes|mesh-ancestor
14330677|NCT04329494|Protective Agents|protective agents|mesh-ancestor
14330678|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
14330679|NCT04329494|Vitamins|vitamins|mesh-ancestor
14330680|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
14729603|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226482|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
15226483|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15226484|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
15226485|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15226486|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330681|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
14330682|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14330683|NCT04294069|Azithromycin|azithromycin|mesh-list
14330684|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14729604|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330685|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330686|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
14330687|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14330688|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14330689|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14330690|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14330691|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330692|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
14330693|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330694|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330695|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14330696|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330697|NCT04271904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14330698|NCT04270747|Aflibercept|aflibercept|mesh-list
14330699|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14330700|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14330701|NCT04270747|Growth Substances|growth substances|mesh-ancestor
14330702|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330703|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
14330704|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226487|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15226488|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15226489|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15226490|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15226491|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15226492|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
15226493|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15226494|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15226495|NCT05151146|Metformin|metformin|mesh-list
15226496|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226497|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226498|NCT05150652|Tamoxifen|tamoxifen|mesh-list
15226499|NCT05150652|Letrozole|letrozole|mesh-list
15226500|NCT05150652|Anastrozole|anastrozole|mesh-list
15226501|NCT05150652|Exemestane|exemestane|mesh-list
15226502|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226503|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15226504|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14330723|NCT04267978|Irinotecan|irinotecan|mesh-list
14330724|NCT04267978|Temozolomide|temozolomide|mesh-list
14330725|NCT04267978|Endostatins|endostatins|mesh-list
14330726|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14330727|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14330728|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330729|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330730|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330731|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14330732|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
14330733|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14330734|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14330735|NCT04267978|Growth Substances|growth substances|mesh-ancestor
14330736|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226505|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226506|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226507|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15226508|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
15226509|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330737|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14330738|NCT04261075|Durvalumab|durvalumab|mesh-list
14330739|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330740|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330741|NCT04260022|Blinatumomab|blinatumomab|mesh-list
14330742|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330743|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14330744|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330745|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14330746|NCT04203901|Nivolumab|nivolumab|mesh-list
14330747|NCT04203901|Ipilimumab|ipilimumab|mesh-list
14330748|NCT04203901|Everolimus|everolimus|mesh-list
14330749|NCT04203901|Lenvatinib|lenvatinib|mesh-list
14330750|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330751|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330752|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14330753|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330754|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330755|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
14330756|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330757|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14330758|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330759|NCT04178005|Cladribine|cladribine|mesh-list
14330760|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330761|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330762|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
14330763|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330764|NCT04173494|Danazol|danazol|mesh-list
15226510|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226511|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15226512|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15226513|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15226514|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15226515|NCT05143489|Lidocaine|lidocaine|mesh-list
14917801|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14917802|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917803|NCT04215146|Paclitaxel|paclitaxel|mesh-list
15226516|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
15226517|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
15226518|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226519|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226520|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
15226521|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226522|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15226523|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15226524|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15226525|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15226526|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226527|NCT05143073|Ethanol|ethanol|mesh-list
15226528|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14917804|NCT04215146|Avelumab|avelumab|mesh-list
14330765|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
14330766|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14330767|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
14330768|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330769|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330770|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14330771|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330772|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330773|NCT04155164|Metformin|metformin|mesh-list
14330774|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14330775|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330776|NCT04138316|Candesartan|candesartan|mesh-list
14330777|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14330778|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14330779|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14330780|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330781|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14330782|NCT04134663|Oxytocin|oxytocin|mesh-list
14330783|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
14330784|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14330785|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330786|NCT04131504|Adalimumab|adalimumab|mesh-list
14330787|NCT04131504|Infliximab|infliximab|mesh-list
14330788|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330789|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330790|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
14330791|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14330792|NCT04126031|Ceftazidime|ceftazidime|mesh-list
14330793|NCT04126031|Avibactam|avibactam|mesh-list
14330794|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14330795|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14330796|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330797|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14330798|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330799|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464345|NCT02208037|Maraviroc|maraviroc|mesh-list
14464346|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
14464347|NCT02208037|Methotrexate|methotrexate|mesh-list
14464348|NCT02208037|Bortezomib|bortezomib|mesh-list
14464349|NCT02208037|Tacrolimus|tacrolimus|mesh-list
14464350|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14464351|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
14464352|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464353|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464354|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14464355|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
14464356|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464357|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464358|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14464359|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14464360|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
14464361|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14464362|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14464363|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
14464364|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
14464365|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464366|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14464367|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14464368|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14464369|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14464370|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14464371|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
14464372|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464373|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330800|NCT04095221|Irinotecan|irinotecan|mesh-list
14330801|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14330802|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14330803|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330804|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330805|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330806|NCT04072952|Palbociclib|palbociclib|mesh-list
14330807|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330808|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14330809|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330810|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330811|NCT04037683|Misoprostol|misoprostol|mesh-list
14330812|NCT04037683|Oxytocin|oxytocin|mesh-list
14330813|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
14330814|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14330815|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330816|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14330817|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
14330818|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14330819|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14330820|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14330821|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14330822|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330823|NCT03969004|Cemiplimab|cemiplimab|mesh-list
14330824|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330825|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330826|NCT03958474|Remifentanil|remifentanil|mesh-list
14917805|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14917806|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917807|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14917808|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14917809|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14917810|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917811|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917812|NCT04182373|Antithrombins|antithrombins|mesh-list
15226529|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330827|NCT03958474|Oxycodone|oxycodone|mesh-list
14330828|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330829|NCT03958474|Narcotics|narcotics|mesh-ancestor
14330830|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330831|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330832|NCT03958474|Analgesics|analgesics|mesh-ancestor
14330833|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
14330834|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330835|NCT03936270|Letrozole|letrozole|mesh-list
14330836|NCT03936270|Palbociclib|palbociclib|mesh-list
14330837|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330838|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14330839|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14330840|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330841|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330842|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14330843|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
14330844|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14330845|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330846|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14330847|NCT03934905|Sulforaphane|sulforaphane|mesh-list
14330848|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14330849|NCT03934905|Protective Agents|protective agents|mesh-ancestor
14330850|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330851|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330852|NCT03918850|Buprenorphine|buprenorphine|mesh-list
14330853|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330854|NCT03918850|Narcotics|narcotics|mesh-ancestor
14330855|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330856|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330857|NCT03918850|Analgesics|analgesics|mesh-ancestor
14330858|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
14330859|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330860|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14330861|NCT03911739|Buprenorphine|buprenorphine|mesh-list
14330862|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330863|NCT03911739|Narcotics|narcotics|mesh-ancestor
14330864|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330865|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330866|NCT03911739|Analgesics|analgesics|mesh-ancestor
14330867|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
14330868|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330869|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14330870|NCT03911466|Buprenorphine|buprenorphine|mesh-list
14330871|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330872|NCT03911466|Narcotics|narcotics|mesh-ancestor
14330873|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330874|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330875|NCT03911466|Analgesics|analgesics|mesh-ancestor
14330876|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
14330877|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330878|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14330879|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14330880|NCT03872180|Venetoclax|venetoclax|mesh-list
14330881|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
14330882|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14330883|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
14330884|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330885|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330886|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330887|NCT03857321|Insulin|insulin|mesh-list
15226530|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729605|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729606|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
14330888|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14330889|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
14330890|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14330891|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330892|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
14330893|NCT03846219|Calcium|calcium|mesh-list
15226531|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226532|NCT05139875|Triamcinolone|triamcinolone|mesh-list
15226533|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15226534|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15226535|NCT05139875|Betamethasone|betamethasone|mesh-list
15226536|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
14330894|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14330895|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330896|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14330897|NCT03839446|Etoposide|etoposide|mesh-list
14330898|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
14330899|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
14330900|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14330901|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330902|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14330903|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14330904|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330905|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330906|NCT03839446|Analgesics|analgesics|mesh-ancestor
14330907|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
14330908|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330909|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330910|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330911|NCT03781986|Carboplatin|carboplatin|mesh-list
14330912|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330913|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
14330914|NCT03781934|Lenvatinib|lenvatinib|mesh-list
14330915|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330916|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330917|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14330918|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330919|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330920|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
14330921|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729607|NCT00524095|Fluticasone|fluticasone|mesh-list
15226537|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15226538|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
15226539|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15226540|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14330922|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
14330923|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330924|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330925|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14330926|NCT03713645|Tacrolimus|tacrolimus|mesh-list
14729608|NCT00524095|Xhance|xhance|mesh-list
14330927|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330928|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
14330929|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330930|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14330931|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330932|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330933|NCT03690869|Cemiplimab|cemiplimab|mesh-list
14330934|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14330935|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330936|NCT03641001|Micronutrients|micronutrients|mesh-list
14330937|NCT03641001|Trace Elements|trace elements|mesh-list
14330938|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330939|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
14330940|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
14330941|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14330942|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330943|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330944|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
14330945|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
14330946|NCT03608696|Buprenorphine|buprenorphine|mesh-list
14330947|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14330948|NCT03608696|Narcotics|narcotics|mesh-ancestor
14330949|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330950|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330951|NCT03608696|Analgesics|analgesics|mesh-ancestor
14330952|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
14330953|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330954|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14330955|NCT03587636|Bupivacaine|bupivacaine|mesh-list
14330956|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
14330957|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
14330958|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14330959|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330960|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
14729609|NCT00524095|Azithromycin|azithromycin|mesh-list
15226541|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14330961|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14330962|NCT03541486|Gemcitabine|gemcitabine|mesh-list
14330963|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330964|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14330965|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
14330966|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330967|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330968|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
14330969|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330970|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330971|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330972|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
14330973|NCT03500731|Rituximab|rituximab|mesh-list
14330974|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
14330975|NCT03500731|Fludarabine|fludarabine|mesh-list
14330976|NCT03500731|Thiotepa|thiotepa|mesh-list
14330977|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
14330978|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14729610|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226542|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
15226543|NCT05139875|Hormones|hormones|mesh-ancestor
15226544|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226545|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226546|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226547|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
15226548|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226549|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226550|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15226551|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
15226552|NCT05137860|Bortezomib|bortezomib|mesh-list
14330979|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14330980|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
14330981|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14330982|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14330983|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14330984|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14330985|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14330986|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
14330987|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14330988|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
14330989|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14330990|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14330991|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
14330992|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14330993|NCT03493178|Glycine|glycine|mesh-list
14330994|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
14330995|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14330996|NCT03493178|Expectorants|expectorants|mesh-ancestor
14330997|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
14330998|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14330999|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
14331000|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331001|NCT03493178|Protective Agents|protective agents|mesh-ancestor
14331002|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331003|NCT03493178|Antidotes|antidotes|mesh-ancestor
14331004|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
14331005|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331006|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
14331007|NCT03417193|Anesthetics|anesthetics|mesh-list
14331008|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14331009|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331010|NCT03417193|Narcotics|narcotics|mesh-ancestor
14331011|NCT03417193|Analgesics|analgesics|mesh-ancestor
14331012|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
14331013|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331014|NCT03414112|Oxytocin|oxytocin|mesh-list
14331015|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
14331016|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14331017|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331018|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
14331019|NCT03410030|Gemcitabine|gemcitabine|mesh-list
14331020|NCT03410030|Paclitaxel|paclitaxel|mesh-list
14331021|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14331022|NCT03410030|Cisplatin|cisplatin|mesh-list
14331023|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14331024|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331025|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14331026|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14331027|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14331028|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331029|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14331030|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
14331031|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
14331032|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331033|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331034|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331035|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
14331036|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331037|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
14331038|NCT03410030|Protective Agents|protective agents|mesh-ancestor
14331039|NCT03410030|Vitamins|vitamins|mesh-ancestor
14331040|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
14331041|NCT03386240|Triclosan|triclosan|mesh-list
14331042|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14331043|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331044|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14331045|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14331046|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
14331047|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331048|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14331049|NCT03343197|Ivosidenib|ivosidenib|mesh-list
14331050|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331051|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331052|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331053|NCT03334305|Vaccines|vaccines|mesh-list
14331054|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
14331055|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464374|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14464375|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14331056|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14331057|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14331058|NCT03298802|Diuretics|diuretics|mesh-ancestor
14331059|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
14331060|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331061|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14331062|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331063|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331064|NCT03240861|Aldesleukin|aldesleukin|mesh-list
14331065|NCT03240861|Plerixafor|plerixafor|mesh-list
14331066|NCT03240861|Fludarabine|fludarabine|mesh-list
14331067|NCT03240861|Busulfan|busulfan|mesh-list
14331068|NCT03240861|Interleukin-2|interleukin-2|mesh-list
14331069|NCT03240861|Lenograstim|lenograstim|mesh-list
14331070|NCT03240861|Sargramostim|sargramostim|mesh-list
14331071|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331072|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331073|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331074|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
14331075|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331076|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14331077|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
14331078|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331079|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14331080|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14331081|NCT03240861|Analgesics|analgesics|mesh-ancestor
14331082|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
14331083|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331084|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14331085|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14331086|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
14331087|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331088|NCT03151057|Idelalisib|idelalisib|mesh-list
14331089|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331090|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331091|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331092|NCT03149770|Naloxone|naloxone|mesh-list
14331093|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14331094|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331095|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
14331096|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331097|NCT03088930|Crizotinib|crizotinib|mesh-list
14331098|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331099|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14331100|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331101|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331102|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
14331103|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331104|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14331105|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331106|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331107|NCT03032172|Risdiplam|risdiplam|mesh-list
14331108|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14331109|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331110|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331111|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
14331112|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
14331113|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
15226553|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226554|NCT05136898|Mitomycins|mitomycins|mesh-list
15226555|NCT05136898|Mitomycin|mitomycin|mesh-list
15226556|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15226557|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226558|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
15226559|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331121|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
14331122|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331123|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331124|NCT02845596|Cyclosporine|cyclosporine|mesh-list
14331125|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
14331126|NCT02845596|Methotrexate|methotrexate|mesh-list
14331127|NCT02845596|Fludarabine|fludarabine|mesh-list
14331128|NCT02845596|Cyclosporins|cyclosporins|mesh-list
14331129|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
14331130|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14331131|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14331132|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
14331133|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331134|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14331135|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331136|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
14331137|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331138|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331139|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14331140|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14331141|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
14331142|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14331143|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14331144|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
14331145|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
14331146|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331147|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14331148|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14331149|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
14331150|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331151|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14331152|NCT02815995|Durvalumab|durvalumab|mesh-list
14331153|NCT02815995|Tremelimumab|tremelimumab|mesh-list
14331154|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331155|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331156|NCT02812615|Micronutrients|micronutrients|mesh-list
14331157|NCT02812615|Trace Elements|trace elements|mesh-list
14331158|NCT02812615|Albendazole|albendazole|mesh-list
14331159|NCT02812615|Pyrantel|pyrantel|mesh-list
14331160|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
14331161|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
14331162|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14331163|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331164|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
14331165|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14331166|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14331167|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14331168|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14331169|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14331170|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331171|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331172|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331173|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
14331174|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15226560|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15226561|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226562|NCT05131997|Atorvastatin|atorvastatin|mesh-list
15226563|NCT05131997|Ezetimibe|ezetimibe|mesh-list
15226564|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15226565|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15226566|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
15226567|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226568|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14331175|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14331176|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14331177|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331178|NCT02807883|Blinatumomab|blinatumomab|mesh-list
14331179|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331180|NCT02807363|Leuprolide|leuprolide|mesh-list
14331181|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14331182|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
14331183|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14331184|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331185|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14331186|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331187|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14331188|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14331189|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331190|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331191|NCT02756403|Azithromycin|azithromycin|mesh-list
14331192|NCT02756403|Metronidazole|metronidazole|mesh-list
14331193|NCT02756403|Doxycycline|doxycycline|mesh-list
14331194|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14331195|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331196|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14331197|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14729611|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14729612|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
14729613|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331198|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
14331199|NCT02739035|Dexamethasone|dexamethasone|mesh-list
14331200|NCT02739035|Celecoxib|celecoxib|mesh-list
14331201|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14331202|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
14331203|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
14331204|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331205|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331206|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14331207|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
14331208|NCT02739035|Hormones|hormones|mesh-ancestor
14331209|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331210|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14331211|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331212|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14729614|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331213|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14331214|NCT02739035|Analgesics|analgesics|mesh-ancestor
14331215|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
14331216|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14331217|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14331218|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14331219|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331220|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331221|NCT02710851|Vaccines|vaccines|mesh-list
14331222|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
14331223|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331224|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
14331225|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331226|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331227|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331228|NCT02682888|Oxytocin|oxytocin|mesh-list
14331229|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
14331230|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14331231|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331232|NCT02675452|Itraconazole|itraconazole|mesh-list
14331233|NCT02675452|Azacitidine|azacitidine|mesh-list
14331234|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14331235|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
14331236|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331237|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331238|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331239|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
14331240|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331241|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14331242|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14331243|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14331244|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
14331245|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331246|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331247|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14331248|NCT02669186|Fentanyl|fentanyl|mesh-list
14331249|NCT02669186|Bupivacaine|bupivacaine|mesh-list
14331250|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
14331251|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
14331252|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14331253|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331254|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
14331255|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331256|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14331257|NCT02669186|Narcotics|narcotics|mesh-ancestor
14331258|NCT02669186|Analgesics|analgesics|mesh-ancestor
14331259|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14331260|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14331261|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
14331262|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
14331263|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
14331264|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331265|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14331266|NCT02665117|Diuretics|diuretics|mesh-ancestor
14331267|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
14331268|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331269|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14331270|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331271|NCT02665117|Cathartics|cathartics|mesh-ancestor
14331272|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14331273|NCT02646839|Biotin|biotin|mesh-list
14331274|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
14331275|NCT02646839|Vitamins|vitamins|mesh-ancestor
14331276|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
14331277|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331278|NCT02641236|Vancomycin|vancomycin|mesh-list
14331279|NCT02641236|Polymyxins|polymyxins|mesh-list
14331280|NCT02641236|Polymyxin B|polymyxin b|mesh-list
14331281|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14331282|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331283|NCT02487797|Oxytocin|oxytocin|mesh-list
14331284|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
14331285|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14331286|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331287|NCT02476786|Tamoxifen|tamoxifen|mesh-list
14331288|NCT02476786|Fulvestrant|fulvestrant|mesh-list
14331289|NCT02476786|Anastrozole|anastrozole|mesh-list
14331290|NCT02476786|Goserelin|goserelin|mesh-list
14331291|NCT02476786|Exemestane|exemestane|mesh-list
14331292|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14331293|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
14331294|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331295|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331296|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14331297|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331298|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14331299|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14331300|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14331301|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14331302|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14331303|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14331304|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331305|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331306|NCT02405520|Vaccines|vaccines|mesh-list
14729615|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14729616|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
14729617|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
14331307|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
14331308|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331309|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
14331310|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14331311|NCT02348762|Glycine|glycine|mesh-list
14331312|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
14331313|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331314|NCT02348762|Expectorants|expectorants|mesh-ancestor
14331315|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
14331316|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14331317|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
14331318|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331319|NCT02348762|Protective Agents|protective agents|mesh-ancestor
14331320|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331321|NCT02348762|Antidotes|antidotes|mesh-ancestor
14331322|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
14331323|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331324|NCT02348359|Bevacizumab|bevacizumab|mesh-list
14331325|NCT02348359|Ranibizumab|ranibizumab|mesh-list
14331326|NCT02348359|Aflibercept|aflibercept|mesh-list
14331327|NCT02348359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331328|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331329|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14331330|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14331331|NCT02348359|Growth Substances|growth substances|mesh-ancestor
14331332|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331333|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
14331334|NCT02285062|Prednisone|prednisone|mesh-list
14331335|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
14331336|NCT02285062|Rituximab|rituximab|mesh-list
14331337|NCT02285062|Doxorubicin|doxorubicin|mesh-list
14331338|NCT02285062|Vincristine|vincristine|mesh-list
14331339|NCT02285062|Lenalidomide|lenalidomide|mesh-list
14331340|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331341|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
14331342|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331343|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14331344|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331345|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
14331346|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331347|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331348|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14331349|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331350|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14331351|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14331352|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14331353|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331354|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14331355|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
14331356|NCT02285062|Hormones|hormones|mesh-ancestor
14331357|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331358|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14331359|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14331360|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14331361|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14331362|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14331363|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14331364|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14331365|NCT02285062|Growth Substances|growth substances|mesh-ancestor
14331366|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
14331367|NCT02252432|Ketamine|ketamine|mesh-list
14331368|NCT02252432|Methadone|methadone|mesh-list
14331369|NCT02252432|Analgesics|analgesics|mesh-ancestor
14331370|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
14331371|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331372|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331373|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14331374|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14331375|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
14331376|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
14331377|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14331378|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14331379|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14331380|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331381|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331382|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14331383|NCT02252432|Narcotics|narcotics|mesh-ancestor
14331384|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
14331385|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
14331386|NCT02230969|Interferons|interferons|mesh-list
14331387|NCT02230969|Interferon-beta|interferon-beta|mesh-list
14331388|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
14331389|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331390|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
14331391|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331392|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
14331393|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331394|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14331395|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
14331396|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
14331397|NCT02224872|Fludarabine|fludarabine|mesh-list
14331398|NCT02224872|Tacrolimus|tacrolimus|mesh-list
14331399|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
14331400|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331401|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
14331402|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331403|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14331404|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331405|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
14331406|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331407|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331408|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14331409|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14331410|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331411|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14331412|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14331413|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
14331414|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14331415|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331416|NCT02187224|Progesterone|progesterone|mesh-list
14331417|NCT02187224|Progestins|progestins|mesh-ancestor
14331418|NCT02187224|Hormones|hormones|mesh-ancestor
14331419|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331420|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331421|NCT02059499|Fluorouracil|fluorouracil|mesh-list
14331422|NCT02059499|Imiquimod|imiquimod|mesh-list
14331423|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
14331424|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331425|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14331426|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331427|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331428|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
14331429|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331430|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14331431|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
14331432|NCT01995669|Lenalidomide|lenalidomide|mesh-list
14331433|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
14331434|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
14331435|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331436|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14331437|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14331438|NCT01995669|Growth Substances|growth substances|mesh-ancestor
14331439|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
14331440|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331441|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331442|NCT01968109|Nivolumab|nivolumab|mesh-list
14331443|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331444|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331445|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14331446|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331447|NCT01962415|Fludarabine|fludarabine|mesh-list
14331448|NCT01962415|Melphalan|melphalan|mesh-list
14331449|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
14331450|NCT01962415|Thiotepa|thiotepa|mesh-list
14331451|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
14331452|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331453|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331454|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331455|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
14331456|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331457|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331458|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
14331459|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14331460|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331461|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
14331462|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331463|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14331464|NCT01935336|Ponatinib|ponatinib|mesh-list
14331465|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331466|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14331467|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331468|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331469|NCT01905436|Ivermectin|ivermectin|mesh-list
14331470|NCT01905436|Albendazole|albendazole|mesh-list
14331471|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14331472|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331473|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
14331474|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
14331475|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14331476|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14331477|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14331478|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14331479|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
14331480|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331481|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331482|NCT01885702|Vaccines|vaccines|mesh-list
14331483|NCT01885702|Immunologic Factors|immunologic factors|mesh-ancestor
14331484|NCT01885702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464376|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14464377|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464378|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
14464379|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14464380|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
14464381|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14464382|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464383|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464384|NCT02208063|Vancomycin|vancomycin|mesh-list
14464385|NCT02208063|Cefazolin|cefazolin|mesh-list
14464386|NCT02208063|Daptomycin|daptomycin|mesh-list
14464387|NCT02208063|Penicillins|penicillins|mesh-list
14464388|NCT02208063|Cloxacillin|cloxacillin|mesh-list
14464389|NCT02208063|Oxacillin|oxacillin|mesh-list
14464390|NCT02208063|Telavancin|telavancin|mesh-list
14464391|NCT02208063|Nafcillin|nafcillin|mesh-list
14464392|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464393|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464394|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14464395|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14469844|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469845|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
14469846|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14469847|NCT02300103|Velpatasvir|velpatasvir|mesh-list
14469848|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
14469849|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469850|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
14469851|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14469852|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469853|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14469854|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14469855|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469856|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469857|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469858|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14469859|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14469860|NCT02300259|Itraconazole|itraconazole|mesh-list
14469861|NCT02300259|Diltiazem|diltiazem|mesh-list
14469862|NCT02300259|Tadalafil|tadalafil|mesh-list
14469863|NCT02300259|Simvastatin|simvastatin|mesh-list
14469864|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14917813|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
14469865|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14469866|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
14331485|NCT01797523|Metformin|metformin|mesh-list
14331486|NCT01797523|Everolimus|everolimus|mesh-list
14331487|NCT01797523|Letrozole|letrozole|mesh-list
14331488|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14331489|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331490|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331491|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331492|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
14331493|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14331494|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14331495|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729618|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14729619|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14729620|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729621|NCT00524160|Fentanyl|fentanyl|mesh-list
14729622|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14729623|NCT00524160|Narcotics|narcotics|mesh-ancestor
14729624|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729625|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729626|NCT00524160|Analgesics|analgesics|mesh-ancestor
14729627|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
14729628|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729629|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14729630|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14729631|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
14729632|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
14729633|NCT00524186|Leucovorin|leucovorin|mesh-list
14729634|NCT00524186|Fluorouracil|fluorouracil|mesh-list
14729635|NCT00524186|Irinotecan|irinotecan|mesh-list
14729636|NCT00524186|Sunitinib|sunitinib|mesh-list
14729637|NCT00524186|Calcium|calcium|mesh-list
14729638|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
14729639|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14729640|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729641|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
14729642|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729643|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729644|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729645|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729646|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
14729647|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14729648|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14729649|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729650|NCT00524186|Antidotes|antidotes|mesh-ancestor
14729651|NCT00524186|Protective Agents|protective agents|mesh-ancestor
14331496|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331497|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14331498|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
14331499|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331500|NCT01733693|Buprenorphine|buprenorphine|mesh-list
14331501|NCT01733693|Methadone|methadone|mesh-list
14331502|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14331503|NCT01733693|Narcotics|narcotics|mesh-ancestor
14331504|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14331505|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331506|NCT01733693|Analgesics|analgesics|mesh-ancestor
14331507|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
14729652|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
14331508|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331509|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14331510|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
14729653|NCT00524186|Vitamins|vitamins|mesh-ancestor
14729654|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
14729655|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14729656|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14331511|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
14331512|NCT01712490|Doxorubicin|doxorubicin|mesh-list
14331513|NCT01712490|Bleomycin|bleomycin|mesh-list
14331514|NCT01712490|Dacarbazine|dacarbazine|mesh-list
14331515|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14331516|NCT01712490|Vinblastine|vinblastine|mesh-list
14331517|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14331518|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331519|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14331520|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14331521|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331522|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331523|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331524|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
14331525|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331526|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14331527|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14331528|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
14331529|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14331530|NCT01499160|Everolimus|everolimus|mesh-list
14331531|NCT01499160|Letrozole|letrozole|mesh-list
14331532|NCT01499160|Lapatinib|lapatinib|mesh-list
14331533|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331534|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331535|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
14331536|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331537|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14331538|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14331539|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331540|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331541|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14331542|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
14331543|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331544|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14331545|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
14331546|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14331547|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
14331548|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331549|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331550|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14331551|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
14331552|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14331553|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14331554|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14331555|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
14331556|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331557|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729657|NCT00524186|Growth Substances|growth substances|mesh-ancestor
15226569|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15226570|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226571|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15226572|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
15226573|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226574|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
15226575|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226576|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226577|NCT05123170|Lidocaine|lidocaine|mesh-list
15226578|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
15226579|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
15226580|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
15226581|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226582|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226583|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
15226584|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226585|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14729658|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14729659|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14729660|NCT00524199|Mesna|mesna|mesh-list
14729661|NCT00524199|Protective Agents|protective agents|mesh-ancestor
14729662|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752951|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14331558|NCT01149850|Bevacizumab|bevacizumab|mesh-list
14331559|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14331560|NCT01149850|Temozolomide|temozolomide|mesh-list
15226586|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15226587|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15226588|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15226589|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226590|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15226591|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15226592|NCT05123170|Analgesics|analgesics|mesh-ancestor
15226593|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15226594|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15226595|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15226596|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
15226597|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226598|NCT05123131|Dexamethasone|dexamethasone|mesh-list
15226599|NCT05123131|Lenalidomide|lenalidomide|mesh-list
15226600|NCT05123131|Bortezomib|bortezomib|mesh-list
15226601|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226602|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
15226603|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
15226604|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226605|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226606|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14331561|NCT01149850|Antibodies|antibodies|mesh-list
14331562|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
14331563|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14331564|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331565|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14331566|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14331567|NCT01149850|Growth Substances|growth substances|mesh-ancestor
14331568|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752952|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14752953|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331569|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
15226607|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
14331570|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
15226608|NCT05123131|Hormones|hormones|mesh-ancestor
14331571|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331572|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
14331573|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331574|NCT01090089|Dexamethasone|dexamethasone|mesh-list
14331575|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
14331576|NCT01090089|Lenalidomide|lenalidomide|mesh-list
14331577|NCT01090089|BB 1101|bb 1101|mesh-list
14331578|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14331579|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
14331580|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
14331581|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331582|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331583|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14331584|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
14331585|NCT01090089|Hormones|hormones|mesh-ancestor
14331586|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331587|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14331588|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331589|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
14331590|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331591|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331592|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
14331593|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14331594|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14331595|NCT01090089|Growth Substances|growth substances|mesh-ancestor
14331596|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14331597|NCT01061151|Ritonavir|ritonavir|mesh-list
14331598|NCT01061151|Lopinavir|lopinavir|mesh-list
14331599|NCT01061151|Tenofovir|tenofovir|mesh-list
14331600|NCT01061151|Lamivudine|lamivudine|mesh-list
14331601|NCT01061151|Zidovudine|zidovudine|mesh-list
14331602|NCT01061151|Emtricitabine|emtricitabine|mesh-list
14331603|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14331604|NCT01061151|Nevirapine|nevirapine|mesh-list
14331605|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14331606|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14331607|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14331608|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
14331609|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331610|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331611|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14331612|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14331613|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
14331614|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331615|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14331616|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14331617|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14331618|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14331619|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
14331620|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14331621|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14331622|NCT00981058|Gemcitabine|gemcitabine|mesh-list
14331623|NCT00981058|Necitumumab|necitumumab|mesh-list
14331624|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331625|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14331626|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
14331627|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331628|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
14331629|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331630|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331631|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331632|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
14331633|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331634|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331635|NCT00885495|Ritonavir|ritonavir|mesh-list
14331636|NCT00885495|Darunavir|darunavir|mesh-list
14331637|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14331638|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15226609|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331639|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14331640|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
14331641|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331642|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331643|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15226610|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15226611|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226612|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
14331644|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14331645|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
14331646|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331647|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14331648|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14331649|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14331650|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14331651|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
14331652|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14331653|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14331654|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
14331655|NCT00692939|Melphalan|melphalan|mesh-list
14331656|NCT00692939|Thiotepa|thiotepa|mesh-list
14331657|NCT00692939|Rituximab|rituximab|mesh-list
14331658|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
14331659|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
14331660|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14331661|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331662|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
14331663|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331664|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14331665|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331666|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
14331667|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331668|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331669|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14331670|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331671|NCT00388921|Vitamin A|vitamin a|mesh-list
14331672|NCT00388921|Vitamins|vitamins|mesh-ancestor
14331673|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
14331674|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331675|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
14331676|NCT00142285|Astringents|astringents|mesh-ancestor
14331677|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331678|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
14331679|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
14331680|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14331681|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331682|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14331683|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14331684|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331685|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331686|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331687|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14331688|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14331689|NCT00084799|Antibodies|antibodies|mesh-list
14331690|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14331691|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
14331692|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331693|NCT00821327|Gemcitabine|gemcitabine|mesh-list
14331694|NCT00821327|Sunitinib|sunitinib|mesh-list
14331695|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331696|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14331697|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
14331698|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331699|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
14331700|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331701|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331702|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331703|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
14331704|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331705|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14331706|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14331707|NCT00821327|Growth Substances|growth substances|mesh-ancestor
14331708|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
14331709|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14331710|NCT00821509|Disinfectants|disinfectants|mesh-list
14331711|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331712|NCT00821795|Insulin|insulin|mesh-list
14331713|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
15226613|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14331714|NCT00821795|Protamines|protamines|mesh-list
14331715|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14331716|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331717|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
14331718|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331719|NCT00821795|Coagulants|coagulants|mesh-ancestor
14331720|NCT00821821|Edaravone|edaravone|mesh-list
14331721|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14331722|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
14331723|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331724|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14331725|NCT00821821|Protective Agents|protective agents|mesh-ancestor
14331726|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331727|NCT00821886|Carboplatin|carboplatin|mesh-list
14331728|NCT00821886|Trastuzumab|trastuzumab|mesh-list
14331729|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331730|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14331731|NCT00821951|Vorinostat|vorinostat|mesh-list
14331732|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331733|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14331734|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331735|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331736|NCT00821964|Paclitaxel|paclitaxel|mesh-list
14331737|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14331738|NCT00821964|Imiquimod|imiquimod|mesh-list
14331739|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14331740|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331741|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
14331742|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
14331743|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
14331744|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331745|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14331746|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
14331747|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331748|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
14331749|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14331750|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14331751|NCT00822107|Diuretics|diuretics|mesh-ancestor
14331752|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
14331753|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331754|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14331755|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331756|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331757|NCT00822172|Cilostazol|cilostazol|mesh-list
14331758|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14331759|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
14331760|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331761|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331762|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14331763|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
14331764|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14331765|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14331766|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331767|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14331768|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
14331769|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14331770|NCT00822172|Protective Agents|protective agents|mesh-ancestor
14331771|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14331772|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14331773|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331774|NCT00822237|Vaccines|vaccines|mesh-list
14331775|NCT00822237|Immunoglobulins|immunoglobulins|mesh-list
14331776|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
14331777|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331778|NCT00822354|Tadalafil|tadalafil|mesh-list
14331779|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
14331780|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14331781|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14331782|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331783|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331784|NCT00822354|Urological Agents|urological agents|mesh-ancestor
14331785|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
14331786|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14331787|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14331788|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14331789|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331790|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331791|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
14331792|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331793|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331794|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14331795|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331796|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14331797|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14331798|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331799|NCT00822692|Renal Agents|renal agents|mesh-ancestor
14729663|NCT00524251|Esomeprazole|esomeprazole|mesh-list
14729664|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14729665|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729666|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14729667|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729668|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729669|NCT00524381|Etanercept|etanercept|mesh-list
14729670|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14331800|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14331801|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
14331802|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14331803|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14331804|NCT00822770|Vidarabine|vidarabine|mesh-list
14729671|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14729672|NCT00524381|Analgesics|analgesics|mesh-ancestor
14729673|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
14729674|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729675|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729676|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729677|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729678|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729679|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729680|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
14729681|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
14729682|NCT00524407|Hematinics|hematinics|mesh-ancestor
14729683|NCT00524433|Tezosentan|tezosentan|mesh-list
14729684|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
14729685|NCT00524498|Cisplatin|cisplatin|mesh-list
14729686|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226614|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15226615|NCT05123131|Growth Substances|growth substances|mesh-ancestor
15226616|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
15226617|NCT05116241|Vaccines|vaccines|mesh-list
15226618|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
15226619|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226620|NCT05105750|Aspirin|aspirin|mesh-list
15226621|NCT05105750|Indobufen|indobufen|mesh-list
15226622|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15226623|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15226624|NCT05105750|Analgesics|analgesics|mesh-ancestor
15226625|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
15226626|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226627|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226628|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226629|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226630|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15226631|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15226632|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331805|NCT00822770|Plerixafor|plerixafor|mesh-list
14729687|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
14729688|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729689|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14729690|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14729691|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729692|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729693|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
14729694|NCT00524615|Spironolactone|spironolactone|mesh-list
14331806|NCT00822770|Fludarabine|fludarabine|mesh-list
14331807|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
14331808|NCT00822770|Busulfan|busulfan|mesh-list
14331809|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
14331810|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14331811|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331812|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14331813|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
14331814|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331815|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331816|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
14331817|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331818|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
14331819|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331820|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
14331821|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331822|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14331823|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14331824|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14331825|NCT00822900|Progesterone|progesterone|mesh-list
14331826|NCT00822900|Progestins|progestins|mesh-ancestor
14331827|NCT00822900|Hormones|hormones|mesh-ancestor
14331828|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331829|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331830|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
14331831|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14331832|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14331833|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14331834|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331835|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331836|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
14331837|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331838|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331839|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14331840|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331841|NCT00823043|Timolol|timolol|mesh-list
14331842|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14331843|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14331844|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14331845|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331846|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331847|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331848|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14331849|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14331850|NCT00823082|Antithrombins|antithrombins|mesh-list
14331851|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
14331852|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14331853|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
14331854|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331855|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331856|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
14331857|NCT00823212|Aspirin|aspirin|mesh-list
14331858|NCT00823212|Ticlopidine|ticlopidine|mesh-list
14917814|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14331859|NCT00823212|Clopidogrel|clopidogrel|mesh-list
14331860|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14331861|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14331862|NCT00823212|Analgesics|analgesics|mesh-ancestor
14331863|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
14331864|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14331865|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331866|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14331867|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14331868|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14331869|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14331870|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331871|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14331872|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14331873|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331874|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
14331875|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14331876|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14331877|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14331878|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
14331879|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331880|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14331881|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14331882|NCT00823264|Charcoal|charcoal|mesh-list
14331883|NCT00823264|Antidotes|antidotes|mesh-ancestor
14331884|NCT00823264|Protective Agents|protective agents|mesh-ancestor
14331885|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331886|NCT00823303|Calcitriol|calcitriol|mesh-list
14331887|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14331888|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331889|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14331890|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331891|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331892|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14331893|NCT00823303|Vitamins|vitamins|mesh-ancestor
14331894|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
14331895|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14331896|NCT00823459|Everolimus|everolimus|mesh-list
14331897|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331898|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14331899|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
14331900|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331901|NCT00823472|Ganirelix|ganirelix|mesh-list
14331902|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
14331903|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14331904|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331905|NCT00823719|Ofatumumab|ofatumumab|mesh-list
14331906|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14331907|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331908|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
14331909|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331910|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14331911|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14331912|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
14331913|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331914|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331915|NCT00823823|Calpastatin|calpastatin|mesh-list
14331916|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14331917|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
14331918|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331919|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331920|NCT00823836|Ropinirole|ropinirole|mesh-list
14331921|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14331922|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14331923|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
14331924|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
14331925|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464396|NCT02208310|Vitamin D|vitamin d|mesh-list
14917815|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
14331926|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331927|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331928|NCT00823901|Clindamycin|clindamycin|mesh-list
14331929|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
14331930|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
14331931|NCT00823901|Tretinoin|tretinoin|mesh-list
14331932|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14331933|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331934|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14331935|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331936|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331937|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331938|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
14331939|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14331940|NCT00823966|Delavirdine|delavirdine|mesh-list
14331941|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14331942|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14331943|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331944|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331945|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
14331946|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331947|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14331948|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14331949|NCT00823979|Etravirine|etravirine|mesh-list
14331950|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14331951|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14331952|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331953|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331954|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
14331955|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331956|NCT00824044|Citalopram|citalopram|mesh-list
14331957|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14331958|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14331959|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331960|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331961|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331962|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
14331963|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331964|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14331965|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
14331966|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14331967|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
14331968|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
14331969|NCT00824070|Besifloxacin|besifloxacin|mesh-list
14331970|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14331971|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14331972|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14331973|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14331974|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14331975|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14331976|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331977|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14331978|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14331979|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
14331980|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14331981|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331982|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14331983|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14331984|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14331985|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14331986|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14331987|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15226633|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15226634|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15226635|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226636|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
15226637|NCT05081089|Lumefantrine|lumefantrine|mesh-list
15226638|NCT05081089|Artemether|artemether|mesh-list
15226639|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
15226640|NCT05081089|Primaquine|primaquine|mesh-list
15226641|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
15226642|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15226643|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14917816|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917817|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331988|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14331989|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14331990|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14331991|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14331992|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14331993|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14331994|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
14331995|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14331996|NCT00824382|Olodaterol|olodaterol|mesh-list
14331997|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14331998|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
14331999|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332000|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332001|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14332002|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
14332003|NCT00824408|Pemetrexed|pemetrexed|mesh-list
14332004|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332005|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332006|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332007|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14332008|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14332009|NCT00824460|Iron|iron|mesh-list
14332010|NCT00824460|Sevelamer|sevelamer|mesh-list
14332011|NCT00824460|Trace Elements|trace elements|mesh-ancestor
14332012|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
14332013|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332014|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
14917818|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
14917819|NCT04104672|Gemcitabine|gemcitabine|mesh-list
14917820|NCT04104672|Paclitaxel|paclitaxel|mesh-list
14917821|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14917822|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917823|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
14917824|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
15226644|NCT05081089|Amodiaquine|amodiaquine|mesh-list
15226645|NCT05081089|Tafenoquine|tafenoquine|mesh-list
15226646|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
15226647|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15226648|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15226649|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226650|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15226651|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226652|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226653|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15226654|NCT05081089|Renal Agents|renal agents|mesh-ancestor
14917825|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
14917826|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917827|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917828|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
14917829|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
14917830|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917831|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917832|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917833|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
14917834|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917835|NCT04099888|Gemcitabine|gemcitabine|mesh-list
14917836|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917837|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14332015|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
14332016|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332017|NCT00824473|Azelastine|azelastine|mesh-list
14332018|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14332019|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
14332020|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332021|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332022|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14332023|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
14332024|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14332025|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332026|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332027|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14332028|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14332029|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14332030|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
14332031|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
14332032|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332033|NCT00824538|Sunitinib|sunitinib|mesh-list
14332034|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332035|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332036|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332037|NCT00824538|Growth Substances|growth substances|mesh-ancestor
14332038|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332039|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332040|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332041|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332042|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332043|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
14332044|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14332045|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14332046|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332047|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
14332048|NCT00824564|Coagulants|coagulants|mesh-ancestor
14332049|NCT00824616|Insulin|insulin|mesh-list
14332050|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14332051|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332052|NCT00824733|Trastuzumab|trastuzumab|mesh-list
14332053|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14332054|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332055|NCT00824746|Gefitinib|gefitinib|mesh-list
14332056|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332057|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332058|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332059|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332060|NCT00824824|Timolol|timolol|mesh-list
14332061|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14332062|NCT00824824|Dorzolamide|dorzolamide|mesh-list
14332063|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14332064|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14332065|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14332066|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332067|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332068|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332069|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14332070|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14332071|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14332072|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14332073|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14332074|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14332075|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332076|NCT00824850|Vaccines|vaccines|mesh-list
14332077|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14332078|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
14332079|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464397|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
14464398|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
14464399|NCT02208310|Vitamins|vitamins|mesh-list
14464400|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
14464401|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464402|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14464403|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14464404|NCT02208466|Fluoxetine|fluoxetine|mesh-list
14464405|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14464406|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14464407|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464408|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464409|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464410|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
14464411|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464412|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14464413|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
14464414|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464415|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14332080|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
14332081|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332082|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14332083|NCT00825162|Vaccines|vaccines|mesh-list
14332084|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
14332085|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332086|NCT00825266|Pioglitazone|pioglitazone|mesh-list
14332087|NCT00825266|Bosentan|bosentan|mesh-list
14332088|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14332089|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332090|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14332091|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14332092|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332093|NCT00825305|Vaccines|vaccines|mesh-list
14332094|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
14332095|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332096|NCT00825344|Etanercept|etanercept|mesh-list
14332097|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14332098|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14332099|NCT00825344|Analgesics|analgesics|mesh-ancestor
14332100|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
14332101|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332102|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332103|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332104|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14332105|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332106|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332107|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
14332108|NCT00825370|Hydromorphone|hydromorphone|mesh-list
14332109|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14332110|NCT00825370|Narcotics|narcotics|mesh-ancestor
14332111|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332112|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332113|NCT00825370|Analgesics|analgesics|mesh-ancestor
14332114|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
14332115|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332116|NCT00825500|Loxapine|loxapine|mesh-list
14332117|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14332118|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14332119|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332120|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332121|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14332122|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14332123|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
14332124|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332125|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332126|NCT00825565|Allantoin|allantoin|mesh-list
14332127|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14332128|NCT00825630|Esomeprazole|esomeprazole|mesh-list
14332129|NCT00825630|Pantoprazole|pantoprazole|mesh-list
14332130|NCT00825630|Lansoprazole|lansoprazole|mesh-list
14332131|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
14332132|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14332133|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332134|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14332135|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332136|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332137|NCT00825734|Sorafenib|sorafenib|mesh-list
14332138|NCT00825734|Epothilones|epothilones|mesh-list
14332139|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332140|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332141|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332142|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332143|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14332144|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14332145|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14332146|NCT00825786|Ropivacaine|ropivacaine|mesh-list
14332147|NCT00825786|Mepivacaine|mepivacaine|mesh-list
14332148|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
14332149|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
14332150|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332151|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332152|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
14332153|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332154|NCT00825812|Atropine|atropine|mesh-list
14332155|NCT00825812|Neostigmine|neostigmine|mesh-list
14332156|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14332157|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14332158|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14332159|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
14332160|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332161|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332162|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14332163|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14332164|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
14332165|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
14332166|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14332167|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14332168|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
14332169|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332170|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332171|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14332172|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332173|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14332174|NCT00825825|Citalopram|citalopram|mesh-list
14332175|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14332176|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14332177|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14332178|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729695|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14917838|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
14917839|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917840|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
15226655|NCT05068661|Fentanyl|fentanyl|mesh-list
15226656|NCT05068661|Bupivacaine|bupivacaine|mesh-list
15226657|NCT05068661|Ropivacaine|ropivacaine|mesh-list
15226658|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15226659|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
15226660|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
15226661|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332179|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729696|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
14729697|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729698|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332180|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
14332181|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332182|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14332183|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
14332184|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14332185|NCT00826111|Eszopiclone|eszopiclone|mesh-list
14332186|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14332187|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332188|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332189|NCT00826228|Teriparatide|teriparatide|mesh-list
14332190|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14332191|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332192|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14332193|NCT00826241|Temozolomide|temozolomide|mesh-list
14332194|NCT00826241|Lapatinib|lapatinib|mesh-list
14332195|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14332196|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
14332197|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332198|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332199|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332200|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332201|NCT00826267|Trastuzumab|trastuzumab|mesh-list
14332202|NCT00826267|Lapatinib|lapatinib|mesh-list
14332203|NCT00826267|Afatinib|afatinib|mesh-list
14332204|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14332205|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332206|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332207|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332208|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332209|NCT00826280|Caffeine|caffeine|mesh-list
14332210|NCT00826280|Regadenoson|regadenoson|mesh-list
14332211|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14332212|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332213|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14332214|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332215|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332216|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14332217|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14332218|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
14332219|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332220|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14332221|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14332222|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
14332223|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14332224|NCT00826449|Dasatinib|dasatinib|mesh-list
14332225|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332226|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332227|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332228|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332229|NCT00826514|Tanezumab|tanezumab|mesh-list
14332230|NCT00826514|Analgesics|analgesics|mesh-ancestor
14332231|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
14332232|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332233|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332234|NCT00826540|Bevacizumab|bevacizumab|mesh-list
14332235|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14332236|NCT00826540|Sorafenib|sorafenib|mesh-list
14332237|NCT00826540|Antibodies|antibodies|mesh-list
14332238|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
14332239|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14332240|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332241|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332242|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332243|NCT00826540|Growth Substances|growth substances|mesh-ancestor
14332244|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332245|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332246|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
14332247|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332248|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332249|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332250|NCT00826618|Ranibizumab|ranibizumab|mesh-list
14917841|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917842|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332251|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332252|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332253|NCT00826618|Growth Substances|growth substances|mesh-ancestor
14332254|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332255|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332256|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332257|NCT00826748|Beclomethasone|beclomethasone|mesh-list
14332258|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332259|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
14332260|NCT00826748|Hormones|hormones|mesh-ancestor
14332261|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332262|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332263|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14332264|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14332265|NCT00826800|Bevacizumab|bevacizumab|mesh-list
14332266|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14332267|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332268|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332269|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332270|NCT00826800|Growth Substances|growth substances|mesh-ancestor
14332271|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332272|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332273|NCT00826943|Cetirizine|cetirizine|mesh-list
14332274|NCT00826943|Levocetirizine|levocetirizine|mesh-list
14332275|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14332276|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14332277|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14332278|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
14332279|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
14332280|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332281|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332282|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332283|NCT00827073|Lidocaine|lidocaine|mesh-list
14332284|NCT00827073|Tetracaine|tetracaine|mesh-list
14332285|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
14332286|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
14332287|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332288|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332289|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
14332290|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332291|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14332292|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14332293|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14332294|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14332295|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332296|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
14332297|NCT00827099|Fludarabine|fludarabine|mesh-list
14332298|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
14332299|NCT00827099|Melphalan|melphalan|mesh-list
14332300|NCT00827099|Tacrolimus|tacrolimus|mesh-list
14332301|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14332302|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332303|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14332304|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
14332305|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729699|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14729700|NCT00524615|Diuretics|diuretics|mesh-ancestor
14729701|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
14729702|NCT00524667|Fludarabine|fludarabine|mesh-list
14729703|NCT00524667|Valproic Acid|valproic acid|mesh-list
14729704|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729705|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729706|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729707|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
14729708|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729709|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
14729710|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729711|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
14332306|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729712|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14729713|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729714|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14332307|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
14332308|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332309|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14332310|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332311|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14332312|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14332313|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
14332314|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14332315|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332316|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14332317|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
14332318|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14332319|NCT00827112|Ritonavir|ritonavir|mesh-list
14332320|NCT00827112|Lopinavir|lopinavir|mesh-list
14332321|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14332322|NCT00827112|Darunavir|darunavir|mesh-list
14332323|NCT00827112|Tenofovir|tenofovir|mesh-list
14332324|NCT00827112|Emtricitabine|emtricitabine|mesh-list
14332325|NCT00827112|Maraviroc|maraviroc|mesh-list
14332326|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14332327|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14332328|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
14332329|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332330|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332331|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14332332|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14332333|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
14729715|NCT00524693|Montelukast|montelukast|mesh-list
14729716|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14332334|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332335|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14332336|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14332337|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14332338|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14332339|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14332340|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14332341|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14332342|NCT00827242|Tadalafil|tadalafil|mesh-list
14332343|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
14332344|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14332345|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14332346|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332347|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332348|NCT00827242|Urological Agents|urological agents|mesh-ancestor
14332349|NCT00827255|Cyclosporine|cyclosporine|mesh-list
14332350|NCT00827255|Cyclosporins|cyclosporins|mesh-list
14332351|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332352|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332353|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332354|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
14332355|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332356|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
14332357|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332358|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14752954|NCT05321043|Riboflavin|riboflavin|mesh-list
14332359|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14332360|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14332361|NCT00827359|Everolimus|everolimus|mesh-list
14332362|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332363|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332364|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
14332365|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332366|NCT00827541|Tigecycline|tigecycline|mesh-list
14332367|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14332368|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332369|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14332370|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332371|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332372|NCT00827606|Atorvastatin|atorvastatin|mesh-list
14332373|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14332374|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14332375|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
14332376|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332377|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14332378|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14332379|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332380|NCT00827775|Carvedilol|carvedilol|mesh-list
14332381|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14332382|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14332383|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14332384|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332385|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332386|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332387|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14332388|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
14332389|NCT00827775|Protective Agents|protective agents|mesh-ancestor
14332390|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14332391|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14332392|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14332393|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
14332394|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14332395|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14332396|NCT00827918|Olanzapine|olanzapine|mesh-list
14332397|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
14332398|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
14332399|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332400|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332401|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332402|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14332403|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14332404|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332405|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14332406|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14332407|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14332408|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14332409|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332410|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332411|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
14332412|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
14332413|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14332414|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14332415|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332416|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
14332417|NCT00827931|Coagulants|coagulants|mesh-ancestor
14332418|NCT00827983|Progesterone|progesterone|mesh-list
14332419|NCT00827983|Progestins|progestins|mesh-ancestor
14332420|NCT00827983|Hormones|hormones|mesh-ancestor
14332421|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332422|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332423|NCT00828009|Paclitaxel|paclitaxel|mesh-list
14332424|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
14332425|NCT00828009|Bevacizumab|bevacizumab|mesh-list
14332426|NCT00828009|Carboplatin|carboplatin|mesh-list
14332427|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14332428|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332429|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14332430|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14332431|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14332432|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332433|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332434|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
14332435|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332436|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14332437|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14332438|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
14332439|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14332440|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14332441|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332442|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332443|NCT00828009|Growth Substances|growth substances|mesh-ancestor
14332444|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332445|NCT00828061|Prednisone|prednisone|mesh-list
14332446|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332447|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
14332448|NCT00828061|Hormones|hormones|mesh-ancestor
14332449|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332450|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332451|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14332452|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332453|NCT00828074|Sorafenib|sorafenib|mesh-list
14332454|NCT00828074|Vinorelbine|vinorelbine|mesh-list
14332455|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332456|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332457|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332458|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332459|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14332460|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
14332461|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
14332462|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
14332463|NCT00828113|Varenicline|varenicline|mesh-list
14332464|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14332465|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14332466|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
14332467|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332468|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332469|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332470|NCT00828139|Aflibercept|aflibercept|mesh-list
14332471|NCT00828139|Topotecan|topotecan|mesh-list
14332472|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
14332473|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332474|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332475|NCT00828139|Growth Substances|growth substances|mesh-ancestor
14332476|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332477|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332478|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332479|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14332480|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14332481|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332482|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332483|NCT00828191|Progesterone|progesterone|mesh-list
14332484|NCT00828191|Progestins|progestins|mesh-ancestor
14332485|NCT00828191|Hormones|hormones|mesh-ancestor
14332486|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332487|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332488|NCT00828204|Interferons|interferons|mesh-list
14332489|NCT00828204|Interferon-beta|interferon-beta|mesh-list
14332490|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
14332491|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332492|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
14332493|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332494|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
14332495|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752955|NCT05321043|Vitamins|vitamins|mesh-ancestor
14332496|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14332497|NCT00828295|Palonosetron|palonosetron|mesh-list
14332498|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
14332499|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
14332500|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332501|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332502|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332503|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14332504|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14729717|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
14729718|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14729719|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
14729720|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729721|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729722|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14729723|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14729724|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729725|NCT00524706|Leucovorin|leucovorin|mesh-list
14729726|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
14729727|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729728|NCT00524706|Antidotes|antidotes|mesh-ancestor
14729729|NCT00524706|Protective Agents|protective agents|mesh-ancestor
14729730|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729731|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
14729732|NCT00524706|Vitamins|vitamins|mesh-ancestor
14332505|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
14332506|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332507|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332508|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
14332509|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14332510|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14332511|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332512|NCT00828347|Vitamins|vitamins|mesh-ancestor
14332513|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
14332514|NCT00828412|Desonide|desonide|mesh-list
14332515|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332516|NCT00828464|Clobetasol|clobetasol|mesh-list
14332517|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332518|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
14332519|NCT00828464|Hormones|hormones|mesh-ancestor
14332520|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332521|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332522|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14332523|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
14332524|NCT00828542|Desogestrel|desogestrel|mesh-list
14332525|NCT00828542|Etonogestrel|etonogestrel|mesh-list
14332526|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14332527|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14332528|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14332529|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
14332530|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14332531|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332532|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14332533|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14332534|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14332535|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14332536|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332537|NCT00828542|Progestins|progestins|mesh-ancestor
14332538|NCT00828542|Hormones|hormones|mesh-ancestor
14332539|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332540|NCT00828568|Imiquimod|imiquimod|mesh-list
14332541|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14332542|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
14332543|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729733|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
14917843|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332544|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332545|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
14729734|NCT00524810|Docetaxel|docetaxel|mesh-list
14332546|NCT00828672|Bevacizumab|bevacizumab|mesh-list
14332547|NCT00828672|Capecitabine|capecitabine|mesh-list
14332548|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
14332549|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14332550|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332551|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332552|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332553|NCT00828672|Growth Substances|growth substances|mesh-ancestor
14332554|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332555|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332556|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14332557|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
14332558|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332559|NCT00828841|Gemcitabine|gemcitabine|mesh-list
14332560|NCT00828841|Paclitaxel|paclitaxel|mesh-list
14332561|NCT00828841|Carboplatin|carboplatin|mesh-list
14332562|NCT00828841|Cetuximab|cetuximab|mesh-list
14332563|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14332564|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332565|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
14332566|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
14332567|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
14332568|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332569|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14332570|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
14332571|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
14332572|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332573|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332574|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332575|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
14332576|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332577|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14332578|NCT00828984|Laxatives|laxatives|mesh-list
14332579|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14332580|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332581|NCT00829010|Vaccines|vaccines|mesh-list
14332582|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14332583|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
14332584|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332585|NCT00829049|Adapalene|adapalene|mesh-list
14332586|NCT00829049|Tazarotene|tazarotene|mesh-list
14332587|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14332588|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14332589|NCT00829049|Analgesics|analgesics|mesh-ancestor
14332590|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
14332591|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917844|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
14332592|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332593|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332594|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14332595|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
14332596|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
14332597|NCT00829166|Capecitabine|capecitabine|mesh-list
14332598|NCT00829166|Trastuzumab|trastuzumab|mesh-list
14332599|NCT00829166|Lapatinib|lapatinib|mesh-list
14332600|NCT00829166|Maytansine|maytansine|mesh-list
14332601|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14332602|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14332603|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
14332604|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332605|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332606|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14332607|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332608|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332609|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14332610|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
14332611|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
14332612|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
14332613|NCT00829179|Omalizumab|omalizumab|mesh-list
14332614|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14332615|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14332616|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
14332617|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14332618|NCT00829244|Hormones|hormones|mesh-ancestor
14332619|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332620|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332621|NCT00829283|Orlistat|orlistat|mesh-list
14332622|NCT00829283|Sibutramine|sibutramine|mesh-list
14332623|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332624|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332625|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14332626|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14332627|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
14332628|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14332629|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
14332630|NCT00829296|Metoprolol|metoprolol|mesh-list
14332631|NCT00829296|Nebivolol|nebivolol|mesh-list
14332632|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14332633|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14332634|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
14332635|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
14332636|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332637|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332638|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14332639|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14332640|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14332641|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
14332642|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332643|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332644|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
14332645|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14332646|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14332647|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14332648|NCT00829439|Levodopa|levodopa|mesh-list
14332649|NCT00829439|Carbidopa|carbidopa|mesh-list
14332650|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14332651|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14332652|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
14332653|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332654|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332655|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332656|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14332657|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332658|NCT00829738|Pantoprazole|pantoprazole|mesh-list
14332659|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14332660|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332661|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14332662|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332663|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332664|NCT00829829|Rilonacept|rilonacept|mesh-list
14332665|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332666|NCT00829933|Warfarin|warfarin|mesh-list
14332667|NCT00829933|Edoxaban|edoxaban|mesh-list
14332668|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
15226662|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226663|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
15226664|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226665|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15226666|NCT05068661|Narcotics|narcotics|mesh-ancestor
15226667|NCT05068661|Analgesics|analgesics|mesh-ancestor
15226668|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15226669|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15226670|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
14332669|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14332670|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
14332671|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14332672|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
14332673|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332674|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332675|NCT00830063|Naproxen|naproxen|mesh-list
14332676|NCT00830063|Tanezumab|tanezumab|mesh-list
14332677|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14332678|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14332679|NCT00830063|Analgesics|analgesics|mesh-ancestor
14332680|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
14332681|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332682|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332683|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332684|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14332685|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
14332686|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14332687|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332688|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332689|NCT00830076|Metformin|metformin|mesh-list
14332690|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14332691|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14332692|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332693|NCT00830076|Incretins|incretins|mesh-ancestor
14332694|NCT00830076|Hormones|hormones|mesh-ancestor
14332695|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332696|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14332697|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
14332698|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332699|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332700|NCT00830115|Pantoprazole|pantoprazole|mesh-list
14332701|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14332702|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332703|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14332704|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332705|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332706|NCT00830128|Pregabalin|pregabalin|mesh-list
14332707|NCT00830128|Analgesics|analgesics|mesh-ancestor
14332708|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
14332709|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332710|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332711|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
14332712|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14332713|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14917845|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917846|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
14917847|NCT04093596|Fludarabine|fludarabine|mesh-list
14917848|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917849|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
14917850|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226671|NCT05064800|Ritonavir|ritonavir|mesh-list
15226672|NCT05064800|Dabigatran|dabigatran|mesh-list
15226673|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15226674|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15226675|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
15226676|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226677|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226678|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15226679|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15226680|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
15226681|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226682|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14332714|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332715|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14332716|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14332717|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14332718|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332719|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14332720|NCT00830167|Pregabalin|pregabalin|mesh-list
14332721|NCT00830167|Analgesics|analgesics|mesh-ancestor
14332722|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
14332723|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332724|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332725|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
14332726|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14332727|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14332728|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332729|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14332730|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14332731|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14332732|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332733|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464416|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14464417|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464418|NCT02208843|Afatinib|afatinib|mesh-list
14464419|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464420|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14464421|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464422|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464423|NCT02209181|Acetaminophen|acetaminophen|mesh-list
14464424|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14464425|NCT02209181|Analgesics|analgesics|mesh-ancestor
14464426|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
14464427|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464428|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464429|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
14464430|NCT02209272|Lidocaine|lidocaine|mesh-list
14464431|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
14464432|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
14464433|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
14464434|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464435|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464436|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
14464437|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464438|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14464439|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14464440|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14464441|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464442|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464443|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14464444|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14464445|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14464446|NCT02209454|Analgesics|analgesics|mesh-ancestor
14464447|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
14464448|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464449|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464450|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14464451|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917851|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917852|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14917853|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
14917854|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917855|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917856|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14917857|NCT04059484|Tamoxifen|tamoxifen|mesh-list
14917858|NCT04059484|Letrozole|letrozole|mesh-list
14917859|NCT04059484|Fulvestrant|fulvestrant|mesh-list
14917860|NCT04059484|Anastrozole|anastrozole|mesh-list
14917861|NCT04059484|Exemestane|exemestane|mesh-list
14917862|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917863|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14917864|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14917865|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226683|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14917866|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332734|NCT00830362|Propranolol|propranolol|mesh-list
14332735|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14332736|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14332737|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
14332738|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332739|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332740|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332741|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14332742|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14332743|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
14332744|NCT00830375|Memantine|memantine|mesh-list
14332745|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14332746|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14332747|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
14332748|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332749|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332750|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332751|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14332752|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14332753|NCT00830388|Ketoconazole|ketoconazole|mesh-list
14332754|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
14332755|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332756|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14332757|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14332758|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332759|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332760|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14332761|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
14332762|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332763|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332764|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14332765|NCT00830765|Progesterone|progesterone|mesh-list
14332766|NCT00830765|Progestins|progestins|mesh-ancestor
14332767|NCT00830765|Hormones|hormones|mesh-ancestor
14332768|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332769|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332770|NCT00830804|Ritonavir|ritonavir|mesh-list
14332771|NCT00830804|Darunavir|darunavir|mesh-list
14332772|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
14332773|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14332774|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14332775|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
14332776|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332777|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332778|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14332779|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14332780|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
14332781|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332782|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14332783|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14332784|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14332785|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14332786|NCT00830869|Ixazomib|ixazomib|mesh-list
14332787|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332788|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
14332789|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332790|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332791|NCT00830960|Clopidogrel|clopidogrel|mesh-list
15226684|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
15226685|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15226686|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
15226687|NCT05062889|Leucovorin|leucovorin|mesh-list
15226688|NCT05062889|Trifluridine|trifluridine|mesh-list
15226689|NCT05062889|Fluorouracil|fluorouracil|mesh-list
15226690|NCT05062889|Capecitabine|capecitabine|mesh-list
15226691|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
15226692|NCT05062889|Irinotecan|irinotecan|mesh-list
15226693|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
15226694|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
14332792|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14332793|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14332794|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14332795|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14332796|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14332797|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
14332798|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332799|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332800|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332801|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
14332802|NCT00831129|Simvastatin|simvastatin|mesh-list
14332803|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14332804|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14332805|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
14332806|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332807|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14332808|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14332809|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332810|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14332811|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332812|NCT00831181|Leucovorin|leucovorin|mesh-list
14332813|NCT00831181|Fluorouracil|fluorouracil|mesh-list
14332814|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
14332815|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
14332816|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332817|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14332818|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332819|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332820|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
14332821|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332822|NCT00831181|Antidotes|antidotes|mesh-ancestor
14332823|NCT00831181|Protective Agents|protective agents|mesh-ancestor
14332824|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
14332825|NCT00831181|Vitamins|vitamins|mesh-ancestor
14332826|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
14332827|NCT00831233|Goserelin|goserelin|mesh-list
14332828|NCT00831233|Bicalutamide|bicalutamide|mesh-list
14332829|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14332830|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332831|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
14332832|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
14332833|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332834|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332835|NCT00831272|Naltrexone|naltrexone|mesh-list
14332836|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14332837|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14332838|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332839|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
14332840|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332841|NCT00831311|Vaccines|vaccines|mesh-list
14332842|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
14332843|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332844|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14332845|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14332846|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14332847|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14332848|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332849|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332850|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332851|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
14332852|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14332853|NCT00831441|Apixaban|apixaban|mesh-list
14332854|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14332855|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
14332856|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14332857|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
14332858|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332859|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332860|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
14332861|NCT00831480|Everolimus|everolimus|mesh-list
14332862|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332863|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332864|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
14332865|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332866|NCT00831493|Vorinostat|vorinostat|mesh-list
14332867|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332868|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14332869|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332870|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332871|NCT00831675|Vaccines|vaccines|mesh-list
14332872|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
14332873|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332874|NCT00831701|Tamsulosin|tamsulosin|mesh-list
14332875|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14332876|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14332877|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14332878|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
14332879|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332880|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332881|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332882|NCT00831701|Urological Agents|urological agents|mesh-ancestor
14332883|NCT00831766|Cytarabine|cytarabine|mesh-list
14332884|NCT00831766|Lenalidomide|lenalidomide|mesh-list
14332885|NCT00831766|Idarubicin|idarubicin|mesh-list
14332886|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
14332887|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14332888|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
14332889|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226695|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226696|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15226697|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226698|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226699|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
15226700|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226701|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15226702|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15226703|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226704|NCT05062889|Antidotes|antidotes|mesh-ancestor
15226705|NCT05062889|Protective Agents|protective agents|mesh-ancestor
15226706|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
15226707|NCT05062889|Vitamins|vitamins|mesh-ancestor
14332890|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
14332891|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332892|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332893|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
14332894|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332895|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14332896|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14332897|NCT00831766|Growth Substances|growth substances|mesh-ancestor
14332898|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
14332899|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14332900|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14332901|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14332902|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332903|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
14332904|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14332905|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332906|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14332907|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332908|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14332909|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
14332910|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332911|NCT00831987|Vaccines|vaccines|mesh-list
14332912|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
14332913|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332914|NCT00832000|Mexiletine|mexiletine|mesh-list
14332915|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14332916|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14332917|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14332918|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14332919|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332920|NCT00832117|Cisplatin|cisplatin|mesh-list
14332921|NCT00832117|Epothilones|epothilones|mesh-list
14332922|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332923|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14332924|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14332925|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14332926|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332927|NCT00832338|Dexamethasone|dexamethasone|mesh-list
14332928|NCT00832338|Docetaxel|docetaxel|mesh-list
14332929|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
14332930|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14332931|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
14332932|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
14332933|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332934|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332935|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14332936|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
14332937|NCT00832338|Hormones|hormones|mesh-ancestor
14332938|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332939|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14464452|NCT02209519|Metronidazole|metronidazole|mesh-list
14332940|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332941|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
14332942|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
14332943|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
14332944|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332945|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332946|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
14332947|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14332948|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14332949|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
14332950|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14332951|NCT00832377|Timolol|timolol|mesh-list
14332952|NCT00832377|Dorzolamide|dorzolamide|mesh-list
14332953|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14332954|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14332955|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
14332956|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14332957|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332958|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332959|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14332960|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14332961|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14332962|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332963|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14332964|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14332965|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332966|NCT00832390|Incretins|incretins|mesh-ancestor
14332967|NCT00832390|Hormones|hormones|mesh-ancestor
14332968|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332969|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14332970|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
14332971|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332972|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332973|NCT00832416|Tramadol|tramadol|mesh-list
14332974|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14332975|NCT00832416|Narcotics|narcotics|mesh-ancestor
14332976|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14332977|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332978|NCT00832416|Analgesics|analgesics|mesh-ancestor
14332979|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
14332980|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14332981|NCT00832585|Alefacept|alefacept|mesh-list
14332982|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14332983|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
14332984|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332985|NCT00832637|Gemcitabine|gemcitabine|mesh-list
14332986|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14332987|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14332988|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14917867|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14917868|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
14917869|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14332989|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
14332990|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14332991|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
14332992|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14332993|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14332994|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14332995|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
14332996|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14332997|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14332998|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
14332999|NCT00832650|Fesoterodine|fesoterodine|mesh-list
14333000|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14333001|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14333002|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
14333003|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333004|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333005|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333006|NCT00832650|Urological Agents|urological agents|mesh-ancestor
14333007|NCT00832819|Paclitaxel|paclitaxel|mesh-list
14333008|NCT00832819|Carboplatin|carboplatin|mesh-list
14333009|NCT00832819|Lenvatinib|lenvatinib|mesh-list
14333010|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14333011|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333012|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
14333013|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
14333014|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
14333015|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333016|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14333017|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333018|NCT00832871|Mifepristone|mifepristone|mesh-list
14333019|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14333020|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
14333021|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14333022|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333023|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14333024|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14333025|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14333026|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
14333027|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14333028|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14333029|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
14333030|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333031|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
14333032|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14333033|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14333034|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14333035|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333036|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333037|NCT00833027|Incretins|incretins|mesh-ancestor
14333038|NCT00833027|Hormones|hormones|mesh-ancestor
14333039|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333040|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14333041|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
14333042|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333043|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333044|NCT00833040|Sufentanil|sufentanil|mesh-list
14333045|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14333046|NCT00833040|Narcotics|narcotics|mesh-ancestor
14333047|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333048|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333049|NCT00833040|Analgesics|analgesics|mesh-ancestor
14333050|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
14333051|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333052|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14333053|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14333054|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
14333055|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
14333056|NCT00833053|Methotrexate|methotrexate|mesh-list
14333057|NCT00833053|Infliximab|infliximab|mesh-list
14333058|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14729735|NCT00524810|Doxorubicin|doxorubicin|mesh-list
14729736|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14729737|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729738|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14729739|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729740|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14729741|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729742|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14729743|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14333059|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
14333060|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14333061|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333062|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14333063|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
14333064|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333065|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333066|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
14333067|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333068|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14917870|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917871|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14917872|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15226708|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
15226709|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
15226710|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226711|NCT05057806|Empagliflozin|empagliflozin|mesh-list
15226712|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15226713|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226714|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226715|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226716|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14333069|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917873|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14917874|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14917875|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14930834|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15226717|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
14333070|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
14333071|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333072|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14333073|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333074|NCT00833248|Goserelin|goserelin|mesh-list
14333075|NCT00833248|Bicalutamide|bicalutamide|mesh-list
14333076|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14333077|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333078|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
14333079|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
14333080|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333081|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333082|NCT00833261|Paclitaxel|paclitaxel|mesh-list
14333083|NCT00833261|Cetuximab|cetuximab|mesh-list
14333084|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14333085|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333086|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
14333087|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
14333088|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
14333089|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333090|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14333091|NCT00833365|Ibuprofen|ibuprofen|mesh-list
14333092|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14333093|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14333094|NCT00833365|Analgesics|analgesics|mesh-ancestor
14333095|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
14333096|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333097|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333098|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14333099|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333100|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14333101|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333102|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333103|NCT00833443|Bupropion|bupropion|mesh-list
14333104|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14333105|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
14333106|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14333107|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14333108|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14333109|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333110|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333111|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
14333112|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333113|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752956|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
14333114|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14333115|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14333116|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333117|NCT00833469|Citalopram|citalopram|mesh-list
14333118|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14333119|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14333120|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333121|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333122|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333123|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
14333124|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333125|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14333126|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
14333127|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14333128|NCT00833482|Ritonavir|ritonavir|mesh-list
14333129|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14333130|NCT00833482|Voriconazole|voriconazole|mesh-list
14333131|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14333132|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14333133|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
14333134|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333135|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333136|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14333137|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14333138|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
14333139|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333140|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14333141|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14333142|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
14333143|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14333144|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14333145|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
15226718|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226719|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226720|NCT05042505|Incretins|incretins|mesh-ancestor
15226721|NCT05042505|Hormones|hormones|mesh-ancestor
15226722|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226723|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15226724|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
15226725|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226726|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226727|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15226728|NCT05041673|Metformin|metformin|mesh-list
14333146|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333147|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333148|NCT00833547|Eszopiclone|eszopiclone|mesh-list
14333149|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14333150|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333151|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333152|NCT00833560|Dexamethasone|dexamethasone|mesh-list
14333153|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
14333154|NCT00833560|Bortezomib|bortezomib|mesh-list
14333155|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333156|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
14333157|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333158|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333159|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14333160|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
14333161|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333162|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333163|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14333164|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14333165|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
14333166|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
14333167|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333168|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333169|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
14333170|NCT00833560|Hormones|hormones|mesh-ancestor
14333171|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333172|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14333173|NCT00833638|Tadalafil|tadalafil|mesh-list
14333174|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
14333175|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14333176|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14333177|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333178|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333179|NCT00833638|Urological Agents|urological agents|mesh-ancestor
14333180|NCT00833703|Clopidogrel|clopidogrel|mesh-list
14333181|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14333182|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14333183|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14333184|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14333185|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
14333186|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333187|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333188|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729744|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14729745|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729746|NCT00524836|Levocetirizine|levocetirizine|mesh-list
14729747|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14729748|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14729749|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
14729750|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
14729751|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729752|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729753|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729754|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
14729755|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14729756|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333189|NCT00833755|Ketamine|ketamine|mesh-list
14333190|NCT00833755|Analgesics|analgesics|mesh-ancestor
14333191|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
14333192|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333193|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333194|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14333195|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14333196|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
14333197|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
14333198|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333199|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14333200|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14333201|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333202|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333203|NCT00833794|Tramadol|tramadol|mesh-list
14333204|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14333205|NCT00833794|Narcotics|narcotics|mesh-ancestor
14333206|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333207|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333208|NCT00833794|Analgesics|analgesics|mesh-ancestor
14333209|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
14333210|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333211|NCT00833833|Aspirin|aspirin|mesh-list
14333212|NCT00833833|Dexamethasone|dexamethasone|mesh-list
14333213|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
14333214|NCT00833833|Pomalidomide|pomalidomide|mesh-list
14333215|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14333216|NCT00833833|BB 1101|bb 1101|mesh-list
14333217|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14333218|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
14333219|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
14333220|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333221|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333222|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333223|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
14333224|NCT00833833|Hormones|hormones|mesh-ancestor
14333225|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333226|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14333227|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333228|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
15226729|NCT05041673|Liraglutide|liraglutide|mesh-list
15226730|NCT05041673|Empagliflozin|empagliflozin|mesh-list
15226731|NCT05041673|Vildagliptin|vildagliptin|mesh-list
15226732|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226733|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226734|NCT05041673|Incretins|incretins|mesh-ancestor
15226735|NCT05041673|Hormones|hormones|mesh-ancestor
15226736|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226737|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15226738|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226739|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15226740|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
14333229|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333230|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333231|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14333232|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14333233|NCT00833833|Analgesics|analgesics|mesh-ancestor
14333234|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
14333235|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333236|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14333237|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14333238|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14333239|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14333240|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
14333241|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
14333242|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14333243|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14333244|NCT00833833|Growth Substances|growth substances|mesh-ancestor
14333245|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
14333246|NCT00833911|Tramadol|tramadol|mesh-list
14333247|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14333248|NCT00833911|Narcotics|narcotics|mesh-ancestor
14333249|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333250|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333251|NCT00833911|Analgesics|analgesics|mesh-ancestor
14333252|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
14333253|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333254|NCT00834080|Naltrexone|naltrexone|mesh-list
14333255|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14333256|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14333257|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333258|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
14333259|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333260|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14333261|NCT00834171|Tobramycin|tobramycin|mesh-list
14333262|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14333263|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333264|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14333265|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
14333266|NCT00834210|Dapsone|dapsone|mesh-list
14333267|NCT00834210|Tazarotene|tazarotene|mesh-list
14333268|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729757|NCT00524875|Bevacizumab|bevacizumab|mesh-list
14729758|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14729759|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729760|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14729761|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14729762|NCT00524875|Growth Substances|growth substances|mesh-ancestor
14729763|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729764|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
14333269|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
14333270|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14333271|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14333272|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14333273|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333274|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333275|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
14333276|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14333277|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
14333278|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
14333279|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
14333280|NCT00834210|Vitamins|vitamins|mesh-ancestor
14333281|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
14333282|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333283|NCT00834288|Tramadol|tramadol|mesh-list
14333284|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14333285|NCT00834288|Narcotics|narcotics|mesh-ancestor
14333286|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333287|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333288|NCT00834288|Analgesics|analgesics|mesh-ancestor
14333289|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
14333290|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333291|NCT00834366|Tramadol|tramadol|mesh-list
14333292|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14333293|NCT00834366|Narcotics|narcotics|mesh-ancestor
14333294|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333295|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333296|NCT00834366|Analgesics|analgesics|mesh-ancestor
14333297|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
14333298|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333299|NCT00834652|Metformin|metformin|mesh-list
14333300|NCT00834652|Sertraline|sertraline|mesh-list
14333301|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333302|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333303|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
14333304|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14333305|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14333306|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14333307|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333308|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333309|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333310|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
14333311|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14333312|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14333313|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333314|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14333315|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333316|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333317|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14333318|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
14333319|NCT00834808|Tramadol|tramadol|mesh-list
14333320|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14333321|NCT00834808|Narcotics|narcotics|mesh-ancestor
14333322|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333323|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333324|NCT00834808|Analgesics|analgesics|mesh-ancestor
14333325|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
14333326|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333327|NCT00834834|Fluoxetine|fluoxetine|mesh-list
14333328|NCT00834834|Citalopram|citalopram|mesh-list
14333329|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14333330|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14333331|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333332|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333333|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333334|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
14333335|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333336|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14333337|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
14333338|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14333339|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14333340|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14333341|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333342|NCT00834886|Melatonin|melatonin|mesh-list
14333343|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
14333344|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333345|NCT00834886|Protective Agents|protective agents|mesh-ancestor
14333346|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333347|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333348|NCT00834899|Eptifibatide|eptifibatide|mesh-list
14333349|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14333350|NCT00834912|Tramadol|tramadol|mesh-list
14333351|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14333352|NCT00834912|Narcotics|narcotics|mesh-ancestor
14333353|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333354|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333355|NCT00834912|Analgesics|analgesics|mesh-ancestor
14333356|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
14333357|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333358|NCT00835120|Pioglitazone|pioglitazone|mesh-list
14333359|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333360|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333361|NCT00835159|Rivastigmine|rivastigmine|mesh-list
14333362|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14333363|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333364|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333365|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
14333366|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333367|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333368|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14333369|NCT00835159|Protective Agents|protective agents|mesh-ancestor
14333370|NCT00835185|Leucovorin|leucovorin|mesh-list
14333371|NCT00835185|Folic Acid|folic acid|mesh-list
14333372|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
14333373|NCT00835185|Necitumumab|necitumumab|mesh-list
14333374|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
14333375|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14333376|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333377|NCT00835185|Antidotes|antidotes|mesh-ancestor
14333378|NCT00835185|Protective Agents|protective agents|mesh-ancestor
14333379|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333380|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
14333381|NCT00835185|Vitamins|vitamins|mesh-ancestor
14333382|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
14333383|NCT00835185|Hematinics|hematinics|mesh-ancestor
14333384|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14333385|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
14333386|NCT00835198|Dapsone|dapsone|mesh-list
14333387|NCT00835198|Tretinoin|tretinoin|mesh-list
15226741|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226742|NCT05032950|Ritonavir|ritonavir|mesh-list
15226743|NCT05032950|Midazolam|midazolam|mesh-list
15226744|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14333388|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333389|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
14333390|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
14333391|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333392|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
14333393|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14333394|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14333395|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14333396|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333397|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333398|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
15226745|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15226746|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226747|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226748|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15226749|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15226750|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15226751|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15226752|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
15226753|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
15226754|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
15226755|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
15226756|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333399|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15226757|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333400|NCT00835224|Midodrine|midodrine|mesh-list
14333401|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
14333402|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
14333403|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333404|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226758|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14333405|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14333406|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14333407|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14333408|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14333409|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
14333410|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333411|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464453|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464454|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464455|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14464456|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14464457|NCT02209597|Bupropion|bupropion|mesh-list
14464458|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14464459|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
14464460|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464461|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14464462|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14464463|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464464|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464465|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
14464466|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464467|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464468|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14464469|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14464470|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464471|NCT02209610|Fentanyl|fentanyl|mesh-list
14464472|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14464473|NCT02209610|Narcotics|narcotics|mesh-ancestor
14464474|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464475|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464476|NCT02209610|Analgesics|analgesics|mesh-ancestor
14464477|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
14464478|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464479|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14464480|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14464481|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
14464482|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
14464483|NCT02209948|Temozolomide|temozolomide|mesh-list
14464484|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14464485|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
14464486|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464487|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464488|NCT02210091|Factor VIII|factor viii|mesh-list
14464489|NCT02210091|BAX 855|bax 855|mesh-list
14464490|NCT02210091|Coagulants|coagulants|mesh-ancestor
14464491|NCT02210195|Aprepitant|aprepitant|mesh-list
14464492|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
14464493|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
14464494|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464495|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333412|NCT00835510|Butenafine|butenafine|mesh-list
14333413|NCT00835510|Clotrimazole|clotrimazole|mesh-list
14333414|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
14333415|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333416|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14333417|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14333418|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14333419|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333420|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333421|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14333422|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
15226759|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15226760|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
15226761|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226762|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15226763|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15226764|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
15226765|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226766|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15226767|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15226768|NCT05026320|Diclofenac|diclofenac|mesh-list
15226769|NCT05026320|Naproxen|naproxen|mesh-list
14333423|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333424|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333425|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
14333426|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
14333427|NCT00835731|Misoprostol|misoprostol|mesh-list
14333428|NCT00835731|Vitamins|vitamins|mesh-ancestor
14333429|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
14333430|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333431|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14333432|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
14333433|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14333434|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14333435|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333436|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
14333437|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
14333438|NCT00835731|Hematinics|hematinics|mesh-ancestor
14333439|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14333440|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
14333441|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333442|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
14333443|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333444|NCT00835861|Insulin|insulin|mesh-list
14333445|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14333446|NCT00835861|Metformin|metformin|mesh-list
14333447|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
14333448|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
14333449|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333450|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333451|NCT00835900|Varenicline|varenicline|mesh-list
14333452|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14333453|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14333454|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
14333455|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333456|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333457|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333458|NCT00835926|Vaccines|vaccines|mesh-list
15226770|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14333459|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
14333460|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333461|NCT00835978|Axitinib|axitinib|mesh-list
14333462|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333463|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14333464|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333465|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333466|NCT00836277|Irinotecan|irinotecan|mesh-list
14333467|NCT00836277|Panitumumab|panitumumab|mesh-list
14333468|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14333469|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14333470|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333471|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333472|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333473|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14333474|NCT00836407|Ipilimumab|ipilimumab|mesh-list
14333475|NCT00836407|Vaccines|vaccines|mesh-list
14333476|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
14333477|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333478|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14333479|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333480|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14333481|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333482|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14333483|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
14333484|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333485|NCT00836693|Tadalafil|tadalafil|mesh-list
14333486|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
14333487|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14333488|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14333489|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333490|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333491|NCT00836693|Urological Agents|urological agents|mesh-ancestor
14333492|NCT00836810|Prednisone|prednisone|mesh-list
14333493|NCT00836810|Prednisolone|prednisolone|mesh-list
14333494|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14333495|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
14333496|NCT00836810|Hormones|hormones|mesh-ancestor
14333497|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333498|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333499|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14333500|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333501|NCT00836875|Voriconazole|voriconazole|mesh-list
14333502|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
14333503|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333504|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14729765|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
14333505|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14333506|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333507|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333508|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14333509|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
14333510|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333511|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333512|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14333513|NCT00836888|Nivolumab|nivolumab|mesh-list
14333514|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14333515|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333516|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14333517|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333518|NCT00836927|Sirolimus|sirolimus|mesh-list
14333519|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14333520|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333521|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14333522|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333523|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
14333524|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333525|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
14333526|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333527|NCT00837031|Gemcitabine|gemcitabine|mesh-list
14333528|NCT00837031|Lenalidomide|lenalidomide|mesh-list
14333529|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14333530|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
14333531|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333532|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333533|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
14333534|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333535|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333536|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333537|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
14333538|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729766|NCT00524901|Hematinics|hematinics|mesh-ancestor
14333539|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14333540|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14333541|NCT00837031|Growth Substances|growth substances|mesh-ancestor
14333542|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14333543|NCT00837148|Sorafenib|sorafenib|mesh-list
14333544|NCT00837148|Dacarbazine|dacarbazine|mesh-list
14333545|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333546|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14333547|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333548|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333549|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14333550|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
14333551|NCT00837200|Doxorubicin|doxorubicin|mesh-list
14333552|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14333553|NCT00837200|Asparaginase|asparaginase|mesh-list
14333554|NCT00837200|Pegaspargase|pegaspargase|mesh-list
14333555|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14729767|NCT00524914|Apomorphine|apomorphine|mesh-list
14729768|NCT00524914|Emetics|emetics|mesh-ancestor
14333556|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333557|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14333558|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14333559|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333560|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333561|NCT00837213|Doxycycline|doxycycline|mesh-list
14333562|NCT00837213|Clindamycin|clindamycin|mesh-list
14333563|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
14333564|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
14333565|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14333566|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15226771|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15226772|NCT05026320|Analgesics|analgesics|mesh-ancestor
15226773|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
15226774|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226775|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226776|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226777|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226778|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15226779|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226780|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226781|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
15226782|NCT05022927|Bevacizumab|bevacizumab|mesh-list
14333567|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333568|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
14333569|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14333570|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14333571|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14333572|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333573|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333574|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
14333575|NCT00837252|Finasteride|finasteride|mesh-list
14333576|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14333577|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14333578|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333579|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333580|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
14333581|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333582|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333583|NCT00837252|Urological Agents|urological agents|mesh-ancestor
14333584|NCT00837330|Ranibizumab|ranibizumab|mesh-list
14333585|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14333586|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14333587|NCT00837330|Growth Substances|growth substances|mesh-ancestor
14333588|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333589|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14333590|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333591|NCT00837434|Adalimumab|adalimumab|mesh-list
14333592|NCT00837434|Etanercept|etanercept|mesh-list
14333593|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14333594|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333595|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14333596|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14333597|NCT00837434|Analgesics|analgesics|mesh-ancestor
14333598|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
14333599|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333600|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333601|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333602|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333603|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
14333604|NCT00837512|Insulin|insulin|mesh-list
14333605|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14333606|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333607|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333608|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14333609|NCT00837577|Voglibose|voglibose|mesh-list
14333610|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333611|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333612|NCT00837577|Incretins|incretins|mesh-ancestor
14333613|NCT00837577|Hormones|hormones|mesh-ancestor
14333614|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333615|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14333616|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
14333617|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333618|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333619|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14333620|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14333621|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
14333622|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14333623|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14333624|NCT00837590|Analgesics|analgesics|mesh-ancestor
14333625|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
14333626|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333627|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333628|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14333629|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333630|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14333631|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333632|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333633|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14333634|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14333635|NCT00837616|Estradiol|estradiol|mesh-list
14729769|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729770|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
14729771|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729772|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15226783|NCT05022927|Atezolizumab|atezolizumab|mesh-list
14729773|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
14729774|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
14729775|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729776|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729777|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
14729778|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14729779|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
14729780|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
14333636|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14333637|NCT00837616|Estrogens|estrogens|mesh-ancestor
14333638|NCT00837616|Hormones|hormones|mesh-ancestor
14333639|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333640|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333641|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14333642|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
14333643|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14729781|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14729782|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729783|NCT00524966|Hemostatics|hemostatics|mesh-list
14729784|NCT00524966|Coagulants|coagulants|mesh-ancestor
14729785|NCT00525005|Docetaxel|docetaxel|mesh-list
15226784|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226785|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226786|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15226787|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14917876|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
14917877|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917878|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333644|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14333645|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14333646|NCT00837759|Lansoprazole|lansoprazole|mesh-list
14333647|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
14333648|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333649|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333650|NCT00837759|Incretins|incretins|mesh-ancestor
14333651|NCT00837759|Hormones|hormones|mesh-ancestor
14333652|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333653|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14333654|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
14333655|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226788|NCT05022927|Growth Substances|growth substances|mesh-ancestor
15226789|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226790|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
15226791|NCT05008276|Dextrans|dextrans|mesh-list
15226792|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
14333656|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333657|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14333658|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333659|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14333660|NCT00837876|Sorafenib|sorafenib|mesh-list
14333661|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333662|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14333663|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333664|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333665|NCT00837902|Atenolol|atenolol|mesh-list
14333666|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14333667|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14333668|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
14333669|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
14333670|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333671|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729786|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
14729787|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729788|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14729789|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729790|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14729791|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729792|NCT00525096|Celecoxib|celecoxib|mesh-list
14729793|NCT00525096|Exemestane|exemestane|mesh-list
15226793|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
15226794|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
14333672|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14333673|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14333674|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14333675|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
14333676|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333677|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333678|NCT00837967|Terbutaline|terbutaline|mesh-list
14333679|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14729794|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14917879|NCT03982693|Edetic Acid|edetic acid|mesh-list
14917880|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
14917881|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
14917882|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14917883|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
15226795|NCT05005312|Ritonavir|ritonavir|mesh-list
15226796|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15226797|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15226798|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
15226799|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226800|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226801|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15226802|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15226803|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
15226804|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226805|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15226806|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15226807|NCT04995120|Paclitaxel|paclitaxel|mesh-list
15226808|NCT04995120|Cisplatin|cisplatin|mesh-list
15226809|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15226810|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226811|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
15226812|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
14333680|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14333681|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
15226813|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
15226814|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226815|NCT04989946|Nivolumab|nivolumab|mesh-list
15226816|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14729795|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14729796|NCT00525096|Analgesics|analgesics|mesh-ancestor
14729797|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
14729798|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729799|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729800|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729801|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333682|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14333683|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
14729802|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14729803|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14729804|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729805|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729806|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333684|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333685|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333686|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
14333687|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
14333688|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14333689|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14729807|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14729808|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14333690|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14333691|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14333692|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
14333693|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333694|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333695|NCT00838162|Ritonavir|ritonavir|mesh-list
14333696|NCT00838162|TMC-310911|tmc-310911|mesh-list
14333697|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14333698|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14333699|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
14333700|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729809|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14729810|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
14729811|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729812|NCT00525200|Docetaxel|docetaxel|mesh-list
14729813|NCT00525200|Cisplatin|cisplatin|mesh-list
14729814|NCT00525200|Fluorouracil|fluorouracil|mesh-list
15226817|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333701|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333702|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14333703|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14333704|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
14333705|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333706|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14333707|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14333708|NCT00838201|Denosumab|denosumab|mesh-list
14333709|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14333710|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333711|NCT00838435|Verapamil|verapamil|mesh-list
14333712|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14333713|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14333714|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333715|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333716|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14333717|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333718|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
14333719|NCT00838513|Eculizumab|eculizumab|mesh-list
14333720|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14333721|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917884|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
14930835|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15226818|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15226819|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226820|NCT04971837|Cannabidiol|cannabidiol|mesh-list
15226821|NCT04971837|Sorbitol|sorbitol|mesh-list
15226822|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
15226823|NCT04971837|Cathartics|cathartics|mesh-ancestor
15226824|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15226825|NCT04964960|Paclitaxel|paclitaxel|mesh-list
14333722|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
14333723|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333724|NCT00838539|Sirolimus|sirolimus|mesh-list
14333725|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14333726|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333727|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14333728|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729815|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729816|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
15226826|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15226827|NCT04964960|Carboplatin|carboplatin|mesh-list
15226828|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
15226829|NCT04964960|Pemetrexed|pemetrexed|mesh-list
15226830|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15226831|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226832|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
15226833|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
15226834|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
15226835|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226836|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15226837|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226838|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15226839|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15226840|NCT04958044|Calcium|calcium|mesh-list
15226841|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14729817|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729818|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14729819|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729820|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
14333729|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
14333730|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333731|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
14333732|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333733|NCT00838578|Irinotecan|irinotecan|mesh-list
14333734|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14333735|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14333736|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333737|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333738|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333739|NCT00838682|Omeprazole|omeprazole|mesh-list
14333740|NCT00838682|Rabeprazole|rabeprazole|mesh-list
14333741|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14333742|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333743|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14333744|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333745|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333746|NCT00838695|Phenylephrine|phenylephrine|mesh-list
14333747|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
14333748|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14333749|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
14333750|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
14333751|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333752|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333753|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
14333754|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14333755|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
14333756|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
14333757|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14333758|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14333759|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14333760|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
14333761|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333762|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333763|NCT00838695|Protective Agents|protective agents|mesh-ancestor
14333764|NCT00838903|Metformin|metformin|mesh-list
14333765|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14333766|NCT00838903|Glimepiride|glimepiride|mesh-list
14333767|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
14333768|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14333769|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333770|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333771|NCT00838903|Incretins|incretins|mesh-ancestor
14333772|NCT00838903|Hormones|hormones|mesh-ancestor
14333773|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333774|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14333775|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
14333776|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333777|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333778|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14333779|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333780|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
14333781|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
14333782|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
14333783|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333784|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333785|NCT00838916|Incretins|incretins|mesh-ancestor
14333786|NCT00838916|Hormones|hormones|mesh-ancestor
14333787|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333788|NCT00838929|Vorinostat|vorinostat|mesh-list
14333789|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333790|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14333791|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333792|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333793|NCT00839072|Trazodone|trazodone|mesh-list
14333794|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14333795|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14333796|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333797|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333798|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14333799|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14333800|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14333801|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333802|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333803|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333804|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
14333805|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14333806|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
14333807|NCT00839254|Vaccines|vaccines|mesh-list
14333808|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14333809|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
14333810|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333811|NCT00839306|Rabeprazole|rabeprazole|mesh-list
14333812|NCT00839306|Ranitidine|ranitidine|mesh-list
14333813|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14333814|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14333815|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14333816|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14333817|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333818|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333819|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14333820|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
14333821|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
14333822|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333823|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333824|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14333825|NCT00839319|Testosterone|testosterone|mesh-list
14333826|NCT00839319|Acyline|acyline|mesh-list
14333827|NCT00839319|Androgens|androgens|mesh-ancestor
14333828|NCT00839319|Hormones|hormones|mesh-ancestor
14333829|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333830|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333831|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14333832|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
14333833|NCT00839332|Gemcitabine|gemcitabine|mesh-list
14333834|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14333835|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
14333836|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333837|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333838|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
14333839|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333840|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333841|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333842|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
14333843|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333844|NCT00839423|Vortioxetine|vortioxetine|mesh-list
14333845|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14333846|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14333847|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14333848|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333849|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333850|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333851|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333852|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14333853|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
14333854|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14333855|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14333856|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14333857|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333858|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14333859|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
14333860|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14333861|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14333862|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14333863|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14333864|NCT00839527|Metformin|metformin|mesh-list
14333865|NCT00839527|Pioglitazone|pioglitazone|mesh-list
14333866|NCT00839527|Glimepiride|glimepiride|mesh-list
14333867|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
14333868|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14333869|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14729821|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729822|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729823|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
14729824|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729825|NCT00525239|Ritonavir|ritonavir|mesh-list
14333870|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333871|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14333872|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333873|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
14333874|NCT00839527|Incretins|incretins|mesh-ancestor
14333875|NCT00839527|Hormones|hormones|mesh-ancestor
14333876|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14333877|NCT00839540|Caspofungin|caspofungin|mesh-list
14333878|NCT00839540|Micafungin|micafungin|mesh-list
14333879|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
14333880|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333881|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333882|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333883|NCT00839800|Terbutaline|terbutaline|mesh-list
14333884|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14333885|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14333886|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
14333887|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14333888|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
14333889|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333890|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333891|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
14333892|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
14333893|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14333894|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14333895|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14333896|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14333897|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
14333898|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14333899|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333900|NCT00839852|Cariprazine|cariprazine|mesh-list
14333901|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14333902|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14333903|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333904|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333905|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14333906|NCT00839956|Bortezomib|bortezomib|mesh-list
14333907|NCT00839956|Vorinostat|vorinostat|mesh-list
14333908|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333909|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14333910|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333911|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333912|NCT00839982|Cytarabine|cytarabine|mesh-list
14333913|NCT00839982|Clofarabine|clofarabine|mesh-list
14333914|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14333915|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
14333916|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333917|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333918|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
14333919|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333920|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14333921|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
14333922|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333923|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
14333924|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14333925|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14333926|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14333927|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14333928|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333929|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333930|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333931|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14333932|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14333933|NCT00840450|Paclitaxel|paclitaxel|mesh-list
14333934|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14333935|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
14333936|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14333937|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333938|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
14333939|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
14333940|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
14333941|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333942|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14333943|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333944|NCT00840463|Ambrisentan|ambrisentan|mesh-list
14333945|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14333946|NCT00840996|Lidocaine|lidocaine|mesh-list
14333947|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
14333948|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
14333949|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14333950|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333951|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
14333952|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333953|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14333954|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14333955|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14333956|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14333957|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333958|NCT00841087|Insulin|insulin|mesh-list
14333959|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14333960|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
14333961|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
14333962|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14333963|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333964|NCT00841204|Sulindac|sulindac|mesh-list
14333965|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14333966|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14333967|NCT00841204|Analgesics|analgesics|mesh-ancestor
14333968|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
14333969|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14333970|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333971|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14333972|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14333973|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333974|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14333975|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14333976|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464496|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464497|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14464498|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464499|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464500|NCT02210247|Bupivacaine|bupivacaine|mesh-list
14464501|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
14464502|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
14464503|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464504|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464505|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
14464506|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464507|NCT02210689|Clindamycin|clindamycin|mesh-list
14464508|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
14464509|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
14464510|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464511|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464512|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14464513|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464514|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464515|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
14464516|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464517|NCT02211638|Candesartan|candesartan|mesh-list
14464518|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
14464519|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14464520|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14464521|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14464522|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464523|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14464524|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14464525|NCT02212106|Vaccines|vaccines|mesh-list
14464526|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
14464527|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464528|NCT02212197|Leuprolide|leuprolide|mesh-list
14464529|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14333977|NCT00841555|Temozolomide|temozolomide|mesh-list
14333978|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14333979|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
14333980|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333981|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14333982|NCT00841568|Tolvaptan|tolvaptan|mesh-list
14333983|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14333984|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333985|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
14333986|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333987|NCT00841672|Amlodipine|amlodipine|mesh-list
14333988|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14333989|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14333990|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729826|NCT00525239|Lopinavir|lopinavir|mesh-list
14729827|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14729828|NCT00525239|Efavirenz|efavirenz|mesh-list
14729829|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14729830|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14729831|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
14729832|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729833|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729834|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14729835|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14729836|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
14729837|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729838|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14729839|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14729840|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15226842|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333991|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14333992|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14333993|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333994|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
14333995|NCT00841763|Vaccines|vaccines|mesh-list
14333996|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
14333997|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14333998|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
14333999|NCT00841828|Docetaxel|docetaxel|mesh-list
14334000|NCT00841828|Trastuzumab|trastuzumab|mesh-list
14334001|NCT00841828|Epirubicin|epirubicin|mesh-list
14334002|NCT00841828|Lapatinib|lapatinib|mesh-list
14334003|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334004|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
14334005|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334006|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334007|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14334008|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
14334009|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334010|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334011|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14334012|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
14334013|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14334014|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
14334015|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334016|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14334017|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14334018|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14334019|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334020|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14729841|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14729842|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14729843|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14729844|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14729845|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15226843|NCT04954196|Amlodipine|amlodipine|mesh-list
15226844|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15226845|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15226846|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15226847|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729846|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14729847|NCT00525252|Baclofen|baclofen|mesh-list
14334021|NCT00841971|Fluconazole|fluconazole|mesh-list
14334022|NCT00841971|Anidulafungin|anidulafungin|mesh-list
14334023|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
14334024|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334025|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14729848|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14729849|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729850|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14729851|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729852|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14729853|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
14729854|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
14729855|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729856|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729857|NCT00525278|Levocetirizine|levocetirizine|mesh-list
14334026|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14334027|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334028|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334029|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14334030|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
14334031|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334032|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334033|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14334034|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14334035|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14334036|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
14334037|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
14334038|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
14334039|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334040|NCT00842075|Pramlintide|pramlintide|mesh-list
14334041|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14334042|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334043|NCT00842153|Clobetasol|clobetasol|mesh-list
14334044|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334045|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
14334046|NCT00842153|Hormones|hormones|mesh-ancestor
14334047|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334048|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334049|NCT00842244|Capecitabine|capecitabine|mesh-list
14334050|NCT00842244|Axitinib|axitinib|mesh-list
14334051|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334052|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334053|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
14729858|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14729859|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15226848|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15226849|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226850|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
15226851|NCT04891809|Dexamethasone|dexamethasone|mesh-list
15226852|NCT04891809|Lenalidomide|lenalidomide|mesh-list
15226853|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226854|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
14729860|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
14729861|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
14729862|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729863|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729864|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729865|NCT00525382|Levocetirizine|levocetirizine|mesh-list
14729866|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14729867|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14729868|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
14729869|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
14729870|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729871|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226855|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
14729872|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729873|NCT00525408|Docetaxel|docetaxel|mesh-list
14729874|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729875|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14729876|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729877|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14729878|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729879|NCT00525447|Dexamethasone|dexamethasone|mesh-list
14729880|NCT00525447|Lenalidomide|lenalidomide|mesh-list
14729881|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
14729882|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14729883|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
14729884|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
14729885|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729886|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729887|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14729888|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
14334054|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334055|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14334056|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334057|NCT00842257|Panitumumab|panitumumab|mesh-list
14334058|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334059|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334060|NCT00842309|Cycloserine|cycloserine|mesh-list
14334061|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14334062|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334063|NCT00842309|Renal Agents|renal agents|mesh-ancestor
14334064|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14334065|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
14334066|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14334067|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
14334068|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334069|NCT00842348|Lanreotide|lanreotide|mesh-list
14334070|NCT00842348|Somatostatin|somatostatin|mesh-list
14334071|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334072|NCT00842348|Hormones|hormones|mesh-ancestor
14334073|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334074|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334075|NCT00842361|Insulin|insulin|mesh-list
14334076|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14334077|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
14334078|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
14729889|NCT00525447|Hormones|hormones|mesh-ancestor
14729890|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14729891|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15226856|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226857|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226858|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15226859|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
15226860|NCT04891809|Hormones|hormones|mesh-ancestor
15226861|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226862|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15226863|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226864|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
15226865|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15226866|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15226867|NCT04891809|Growth Substances|growth substances|mesh-ancestor
15226868|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
15226869|NCT04890106|Bimatoprost|bimatoprost|mesh-list
14334079|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14334080|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
14334081|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14334082|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14334083|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334084|NCT00842608|Haloperidol|haloperidol|mesh-list
14334085|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
14334086|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14334087|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
14334088|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
14334089|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334090|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334091|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334092|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14334093|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14334094|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14334095|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14334096|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14334097|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
14334098|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334099|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334100|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14334101|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
14334102|NCT00842712|Gemcitabine|gemcitabine|mesh-list
14334103|NCT00842712|Cisplatin|cisplatin|mesh-list
14334104|NCT00842712|Cetuximab|cetuximab|mesh-list
14334105|NCT00842712|Vinorelbine|vinorelbine|mesh-list
14334106|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334107|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334108|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
14334109|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334110|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
14334111|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334112|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334113|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334114|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
14334115|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334116|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334117|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14334118|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
14334119|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
14334120|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
14334121|NCT00842751|Finasteride|finasteride|mesh-list
14334122|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14729892|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226870|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15226871|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15226872|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15226873|NCT04885881|Lidocaine|lidocaine|mesh-list
15226874|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
15226875|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
14334123|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14334124|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334125|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334126|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
14334127|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334128|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334129|NCT00842751|Urological Agents|urological agents|mesh-ancestor
14334130|NCT00842829|Fentanyl|fentanyl|mesh-list
14334131|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14334132|NCT00842829|Narcotics|narcotics|mesh-ancestor
14334133|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14334134|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334135|NCT00842829|Analgesics|analgesics|mesh-ancestor
14334136|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
14334137|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334138|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14334139|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14334140|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
14334141|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
14334142|NCT00842985|Dronabinol|dronabinol|mesh-list
14334143|NCT00842985|Modafinil|modafinil|mesh-list
15226876|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226877|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226878|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
15226879|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226880|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15226881|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14334144|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14334145|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334146|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14334147|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14334148|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14334149|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334150|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
14334151|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14334152|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14334153|NCT00842985|Analgesics|analgesics|mesh-ancestor
14334154|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
14334155|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334156|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14334157|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14334158|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729893|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
14729894|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14729895|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14729896|NCT00525447|Growth Substances|growth substances|mesh-ancestor
14729897|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
14729898|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14729899|NCT00525473|Azathioprine|azathioprine|mesh-list
15226882|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15226883|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15226884|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226885|NCT04885257|Methylphenidate|methylphenidate|mesh-list
15226886|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15226887|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226888|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15226889|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15226890|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15226891|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226892|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
15226893|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226894|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
14334159|NCT00842985|Hormones|hormones|mesh-ancestor
14334160|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334161|NCT00843024|Naproxen|naproxen|mesh-list
14334162|NCT00843024|Sumatriptan|sumatriptan|mesh-list
14334163|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14334164|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14334165|NCT00843024|Analgesics|analgesics|mesh-ancestor
14334166|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
14334167|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334168|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334169|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334170|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334171|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
14334172|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14334173|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334174|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334175|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14334176|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14334177|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14334178|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
14334179|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334180|NCT00843115|Donepezil|donepezil|mesh-list
14334181|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14334182|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334183|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334184|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
14334185|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334186|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334187|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
14334188|NCT00843193|Fluticasone|fluticasone|mesh-list
14334189|NCT00843193|Xhance|xhance|mesh-list
14334190|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334191|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14334192|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
14334193|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334194|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334195|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14334196|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334197|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
14334198|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14334199|NCT00843284|Pregabalin|pregabalin|mesh-list
14334200|NCT00843284|Analgesics|analgesics|mesh-ancestor
14334201|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
14334202|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334203|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334204|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
14334205|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14334206|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334207|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334208|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14334209|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14334210|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14334211|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14334212|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14334213|NCT00843492|PENTA|penta|mesh-list
14334214|NCT00843492|Nadroparin|nadroparin|mesh-list
14334215|NCT00843492|Fondaparinux|fondaparinux|mesh-list
14334216|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14334217|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
14334218|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14334219|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
14334220|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334221|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334222|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
14334223|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14334224|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14334225|NCT00843531|Everolimus|everolimus|mesh-list
14334226|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14334227|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334228|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334229|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
14334230|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334231|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14334232|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334233|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334234|NCT00843635|Tadalafil|tadalafil|mesh-list
14334235|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
14334236|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14334237|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14334238|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334239|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334240|NCT00843635|Urological Agents|urological agents|mesh-ancestor
14334241|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
14334242|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14334243|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14334244|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
14334245|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334246|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14334247|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14334248|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334249|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334250|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
14334251|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334252|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
14334253|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334254|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334255|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
14334256|NCT00843856|Tacrolimus|tacrolimus|mesh-list
14334257|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334258|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
14334259|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334260|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14334261|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334262|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334263|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14334264|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334265|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14334266|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
14334267|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14334268|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334269|NCT00844051|Vaccines|vaccines|mesh-list
14334270|NCT00844051|Immunologic Factors|immunologic factors|mesh-ancestor
14334271|NCT00844051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334272|NCT00844090|Methylphenidate|methylphenidate|mesh-list
14334273|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14334274|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334275|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14334276|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14334277|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334278|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334279|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
14334280|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334281|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14334282|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14334283|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14334284|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334285|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334286|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334287|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334288|NCT00844194|Analgesics|analgesics|mesh-ancestor
14334289|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
14334290|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334291|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
14334292|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14334293|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
14334294|NCT00844298|Cytarabine|cytarabine|mesh-list
14334295|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334296|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
14334297|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334298|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334299|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
14334300|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334301|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334302|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
14334303|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334304|NCT00844376|Atorvastatin|atorvastatin|mesh-list
14334305|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14334306|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14334307|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
14334308|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334309|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14334310|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14334311|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334312|NCT00844415|Dabigatran|dabigatran|mesh-list
14334313|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
14334314|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14334315|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
14334316|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334317|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334318|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
14334319|NCT00844428|Eculizumab|eculizumab|mesh-list
14334320|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14334321|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334322|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
14334323|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334324|NCT00844519|Maraviroc|maraviroc|mesh-list
14334325|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14334326|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14334327|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334328|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14334329|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14334330|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
14334331|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334332|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14334333|NCT00844545|Eculizumab|eculizumab|mesh-list
14334334|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14334335|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334336|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
14334337|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334338|NCT00844649|Gemcitabine|gemcitabine|mesh-list
14334339|NCT00844649|Paclitaxel|paclitaxel|mesh-list
14334340|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14334341|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14334342|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334343|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
14334344|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
14334345|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
14334346|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334347|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334348|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
14334349|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
14334350|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334351|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334352|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334353|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
14334354|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334355|NCT00844714|Rituximab|rituximab|mesh-list
14334356|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334357|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334358|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
14334359|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334360|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334361|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14334362|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14334363|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14334364|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334365|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334366|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
14334367|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334368|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334369|NCT00844805|Naproxen|naproxen|mesh-list
14334370|NCT00844805|Infliximab|infliximab|mesh-list
14334371|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
14334372|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334373|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334374|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14334375|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14334376|NCT00844805|Analgesics|analgesics|mesh-ancestor
14334377|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
14334378|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334379|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334380|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334381|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
14334382|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14729900|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
14334383|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334384|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334385|NCT00844831|Lubiprostone|lubiprostone|mesh-list
14334386|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14334387|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334388|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334389|NCT00844844|Eculizumab|eculizumab|mesh-list
14334390|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14334391|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334392|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
14334393|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334394|NCT00844857|Olanzapine|olanzapine|mesh-list
14334395|NCT00844857|Fluoxetine|fluoxetine|mesh-list
14334396|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
14334397|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
14917885|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917886|NCT03982693|Antidotes|antidotes|mesh-ancestor
14917887|NCT03982693|Protective Agents|protective agents|mesh-ancestor
14917888|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917889|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14917890|NCT03972488|Octreotide|octreotide|mesh-list
14917891|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14917892|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917893|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14917894|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334398|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334399|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334400|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334401|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14334402|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14334403|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14334404|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14334405|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14334406|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14334407|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334408|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334409|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334410|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
14334411|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14334412|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
14334413|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14334414|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14334415|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334416|NCT00844883|Sorafenib|sorafenib|mesh-list
14334417|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334418|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14334419|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334420|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334421|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
14334422|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334423|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334424|NCT00845000|Levodopa|levodopa|mesh-list
14334425|NCT00845000|Carbidopa|carbidopa|mesh-list
14334426|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14334427|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14334428|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
14334429|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334430|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334431|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334432|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14334433|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334434|NCT00845039|Irinotecan|irinotecan|mesh-list
14334435|NCT00845039|Cetuximab|cetuximab|mesh-list
14334436|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14334437|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14334438|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14334439|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334440|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464530|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
14334441|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917895|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14334442|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334443|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
14334444|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334445|NCT00845065|Ribavirin|ribavirin|mesh-list
14334446|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14334447|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
14334448|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334449|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
14334450|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334451|NCT00845130|Vitamins|vitamins|mesh-list
14334452|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
14334453|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
14334454|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334455|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
14334456|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334457|NCT00845130|Protective Agents|protective agents|mesh-ancestor
14334458|NCT00845182|Pioglitazone|pioglitazone|mesh-list
14334459|NCT00845182|Exenatide|exenatide|mesh-list
14334460|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14334461|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334462|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14334463|NCT00845182|Incretins|incretins|mesh-ancestor
14334464|NCT00845182|Hormones|hormones|mesh-ancestor
14334465|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334466|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14334467|NCT00845195|Azelastine|azelastine|mesh-list
14334468|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14334469|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14334470|NCT00845195|Analgesics|analgesics|mesh-ancestor
14334471|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
14334472|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334473|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334474|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334475|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334476|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14334477|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14334478|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14334479|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
14334480|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
14334481|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334482|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334483|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14334484|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
14334485|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14334486|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334487|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14334488|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334489|NCT00845429|Vaccines|vaccines|mesh-list
14334490|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
14334491|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334492|NCT00845481|Calcitriol|calcitriol|mesh-list
14334493|NCT00845481|Betamethasone|betamethasone|mesh-list
14334494|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334495|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
14334496|NCT00845481|Hormones|hormones|mesh-ancestor
14334497|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334498|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334499|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14334500|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334501|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14334502|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14334503|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334504|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334505|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14334506|NCT00845481|Vitamins|vitamins|mesh-ancestor
14334507|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
14334508|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14334509|NCT00845507|Exenatide|exenatide|mesh-list
14334510|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14334511|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334512|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14334513|NCT00845507|Incretins|incretins|mesh-ancestor
14334514|NCT00845507|Hormones|hormones|mesh-ancestor
14464531|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15226895|NCT04872595|Melphalan|melphalan|mesh-list
15226896|NCT04872595|Busulfan|busulfan|mesh-list
15226897|NCT04872595|Thiotepa|thiotepa|mesh-list
14334515|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334516|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
14334517|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
14334518|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14334519|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14334520|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
14334521|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334522|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
14334523|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334524|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
14334525|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334526|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334527|NCT00845676|Interferons|interferons|mesh-list
14334528|NCT00845676|Ribavirin|ribavirin|mesh-list
14334529|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
14334530|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
14334531|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14334532|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334533|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
14334534|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334535|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
14334536|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334537|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
14334538|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334539|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
14334540|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14334541|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
14334542|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334543|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334544|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14334545|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334546|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
14334547|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14334548|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
14334549|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334550|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334551|NCT00845832|Rituximab|rituximab|mesh-list
14334552|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334553|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334554|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
14334555|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334556|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334557|NCT00845858|Metoclopramide|metoclopramide|mesh-list
14334558|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
14334559|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
14334560|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334561|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334562|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334563|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14334564|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14334565|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
14334566|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334567|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334568|NCT00845871|Deferasirox|deferasirox|mesh-list
14334569|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14334570|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
14334571|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
14334572|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334573|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
14334574|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14334575|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334576|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334577|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
14334578|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334579|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729901|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226898|NCT04872595|Fludarabine|fludarabine|mesh-list
15226899|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729902|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14729903|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226900|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
14334580|NCT00846027|Gemcitabine|gemcitabine|mesh-list
14334581|NCT00846027|Paclitaxel|paclitaxel|mesh-list
14334582|NCT00846027|Bevacizumab|bevacizumab|mesh-list
14334583|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14334584|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334585|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
14334586|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
14334587|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
14334588|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334589|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334590|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14334591|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14334592|NCT00846027|Growth Substances|growth substances|mesh-ancestor
14334593|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334594|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
14334595|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334596|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
14334597|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
14334598|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334599|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334600|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334601|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
14334602|NCT00846040|Fallypride|fallypride|mesh-list
14334603|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14334604|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14334605|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
14334606|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334607|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334608|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334609|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14334610|NCT00846365|Olmesartan|olmesartan|mesh-list
14334611|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14334612|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
14334613|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14334614|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14334615|NCT00846365|Diuretics|diuretics|mesh-ancestor
14334616|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
14334617|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334618|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14334619|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334620|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334621|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15226901|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226902|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226903|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15226904|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
15226905|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226906|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226907|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14334622|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14334623|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
14334624|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334625|NCT00846495|Topiramate|topiramate|mesh-list
14334626|NCT00846495|Frovatriptan|frovatriptan|mesh-list
14334627|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
14334628|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14334629|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334630|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14334631|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
14334632|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334633|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334634|NCT00846521|Acarbose|acarbose|mesh-list
14334635|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14334636|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334637|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334638|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15226908|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14334639|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334640|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
14334641|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14334642|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
14334643|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334644|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334645|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14334646|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334647|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
15226909|NCT04871360|Laxatives|laxatives|mesh-ancestor
15226910|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15226911|NCT04860804|Aspirin|aspirin|mesh-list
15226912|NCT04860804|Ketamine|ketamine|mesh-list
15226913|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15226914|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15226915|NCT04860804|Analgesics|analgesics|mesh-ancestor
15226916|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
15226917|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15226918|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226919|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226920|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226921|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15226922|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15226923|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226924|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15226925|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15226926|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226927|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
14334648|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14334649|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
14334650|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334651|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334652|NCT00846651|Phenylephrine|phenylephrine|mesh-list
14334653|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
14334654|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14334655|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
14334656|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
14334657|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334658|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334659|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
14334660|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14334661|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
14334662|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334663|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14334664|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14334665|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14334666|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14334667|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334668|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334669|NCT00846651|Protective Agents|protective agents|mesh-ancestor
14464532|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464533|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14464534|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464535|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
14464536|NCT02212379|Etravirine|etravirine|mesh-list
14464537|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14464538|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464539|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
14464540|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334670|NCT00846768|Olodaterol|olodaterol|mesh-list
14334671|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14334672|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
14334673|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334674|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334675|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14334676|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334677|NCT00847015|Gemcitabine|gemcitabine|mesh-list
14334678|NCT00847015|Sunitinib|sunitinib|mesh-list
14334679|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334680|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334681|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
14334682|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334683|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
14334684|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334685|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334686|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334687|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
14334688|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334689|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14334690|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14334691|NCT00847015|Growth Substances|growth substances|mesh-ancestor
14334692|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
14334693|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14334694|NCT00847145|Vaccines|vaccines|mesh-list
14334695|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
14334696|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334697|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
14334698|NCT00847171|Trastuzumab|trastuzumab|mesh-list
14334699|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334700|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
14334701|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334702|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334703|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14334704|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
14334705|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334706|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334707|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14334708|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334709|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
14334710|NCT00847210|Lansoprazole|lansoprazole|mesh-list
14334711|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14334712|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334713|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14334714|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334715|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729904|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729905|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
14729906|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334716|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
14334717|NCT00847587|Etonogestrel|etonogestrel|mesh-list
14334718|NCT00847587|Desogestrel|desogestrel|mesh-list
14334719|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14334720|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334721|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14334722|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14334723|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14334724|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14334725|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14334726|NCT00847587|Progestins|progestins|mesh-ancestor
14334727|NCT00847587|Hormones|hormones|mesh-ancestor
14334728|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334729|NCT00847613|Tofacitinib|tofacitinib|mesh-list
14334730|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14334731|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334732|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729907|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334733|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
14334734|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14334735|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14334736|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14334737|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334738|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14334739|NCT00847626|Diuretics|diuretics|mesh-ancestor
14334740|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
14334741|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334742|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14334743|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334744|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
14334745|NCT00847808|Lansoprazole|lansoprazole|mesh-list
14334746|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14334747|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334748|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14334749|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729908|NCT00525486|Nifedipine|nifedipine|mesh-list
14729909|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14729910|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14729911|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729912|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14729913|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729914|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
14334750|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334751|NCT00847886|Methotrexate|methotrexate|mesh-list
14334752|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14334753|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
14334754|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14334755|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334756|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334757|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
14334758|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334759|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334760|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
14334761|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334762|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14334763|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334764|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
14334765|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334766|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14334767|NCT00847912|Fluorouracil|fluorouracil|mesh-list
14334768|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
14334769|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334770|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334771|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729915|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
14729916|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14334772|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334773|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
14334774|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334775|NCT00847938|Neostigmine|neostigmine|mesh-list
14334776|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14334777|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334778|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334779|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
14334780|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334781|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334782|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14334783|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
14334784|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334785|NCT00848016|Acetic Acid|acetic acid|mesh-list
14334786|NCT00848016|Retinol acetate|retinol acetate|mesh-list
14334787|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
14334788|NCT00848016|Gossypol|gossypol|mesh-list
14334789|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14334790|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14334791|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14334792|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
14334793|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334794|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14334795|NCT00848016|Protective Agents|protective agents|mesh-ancestor
14334796|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334797|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14334798|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
14334799|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14334800|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14334801|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14334802|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14334803|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14334804|NCT00848081|Tadalafil|tadalafil|mesh-list
14334805|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
14334806|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14334807|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14334808|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334809|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334810|NCT00848081|Urological Agents|urological agents|mesh-ancestor
14334811|NCT00848107|Treprostinil|treprostinil|mesh-list
14334812|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14334813|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14334814|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14334815|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
14334816|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334817|NCT00848354|Etanercept|etanercept|mesh-list
14334818|NCT00848354|Methotrexate|methotrexate|mesh-list
14334819|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14334820|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
14334821|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14334822|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334823|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334824|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
14334825|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334826|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334827|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
14334828|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334829|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15226928|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14334830|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334831|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
14334832|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334833|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14334834|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14334835|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14334836|NCT00848354|Analgesics|analgesics|mesh-ancestor
14334837|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
14334838|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334839|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334840|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334841|NCT00848393|Fentanyl|fentanyl|mesh-list
14334842|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
14334843|NCT00848393|Citric Acid|citric acid|mesh-list
14334844|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
14334845|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14334846|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14334847|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334848|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14334849|NCT00848393|Analgesics|analgesics|mesh-ancestor
14334850|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
14334851|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334852|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14334853|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14334854|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14334855|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
14334856|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14334857|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334858|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14334859|NCT00848393|Narcotics|narcotics|mesh-ancestor
14334860|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14334861|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14334862|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
14729917|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
14729918|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14729919|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
14729920|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729921|NCT00525551|Expectorants|expectorants|mesh-ancestor
14334863|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
14334864|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
14334865|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14334866|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
14334867|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
14334868|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
14334869|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
14334870|NCT00848497|Testosterone|testosterone|mesh-list
14334871|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
14334872|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
14334873|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14334874|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334875|NCT00848497|Androgens|androgens|mesh-ancestor
14334876|NCT00848497|Hormones|hormones|mesh-ancestor
14334877|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334878|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334879|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14334880|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334881|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
14334882|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
14334883|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14334884|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14334885|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334886|NCT00848497|Urological Agents|urological agents|mesh-ancestor
14334887|NCT00848536|Travoprost|travoprost|mesh-list
14334888|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14334889|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14334890|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14334891|NCT00848549|Carbamazepine|carbamazepine|mesh-list
14334892|NCT00848549|Zonisamide|zonisamide|mesh-list
14334893|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
14334894|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
14334895|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14334896|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14334897|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334898|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14334899|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14334900|NCT00848549|Analgesics|analgesics|mesh-ancestor
14334901|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
14334902|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334903|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14334904|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14334905|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334906|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14334907|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14334908|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14334909|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14334910|NCT00848718|Paclitaxel|paclitaxel|mesh-list
14334911|NCT00848718|Docetaxel|docetaxel|mesh-list
14334912|NCT00848718|Carboplatin|carboplatin|mesh-list
14334913|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14729922|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334914|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14334915|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334916|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
14334917|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
14334918|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
14334919|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334920|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15226929|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15226930|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
15226931|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
14334921|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334922|NCT00848783|Capecitabine|capecitabine|mesh-list
14334923|NCT00848783|Irinotecan|irinotecan|mesh-list
14334924|NCT00848783|Floxuridine|floxuridine|mesh-list
14334925|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334926|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14334927|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
14334928|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334929|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14334930|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14334931|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334932|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14334933|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14334934|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334935|NCT00848965|Fluticasone|fluticasone|mesh-list
14334936|NCT00848965|Xhance|xhance|mesh-list
14334937|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334938|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14334939|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
14334940|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334941|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334942|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14334943|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
14334944|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
14334945|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14334946|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
14334947|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14334948|NCT00849017|Incretins|incretins|mesh-ancestor
14334949|NCT00849017|Hormones|hormones|mesh-ancestor
14334950|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334951|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226932|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15226933|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15226934|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15226935|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15226936|NCT04856904|Trifarotene|trifarotene|mesh-list
15226937|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
15226938|NCT04856488|Lugol's solution|lugol's solution|mesh-list
15226939|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15226940|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
15226941|NCT04856488|Coagulants|coagulants|mesh-ancestor
14334952|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
14334953|NCT00849056|Incretins|incretins|mesh-ancestor
14334954|NCT00849056|Hormones|hormones|mesh-ancestor
14334955|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334956|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334957|NCT00849121|Vaccines|vaccines|mesh-list
14334958|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
14334959|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334960|NCT00849186|Sunitinib|sunitinib|mesh-list
14334961|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334962|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14334963|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14334964|NCT00849186|Growth Substances|growth substances|mesh-ancestor
14334965|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334966|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14334967|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14334968|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334969|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334970|NCT00849251|Dexamethasone|dexamethasone|mesh-list
14334971|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
14334972|NCT00849251|Doxorubicin|doxorubicin|mesh-list
14334973|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14334974|NCT00849251|Bortezomib|bortezomib|mesh-list
14334975|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14334976|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
14334977|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14334978|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14334979|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15226942|NCT04796948|Leucovorin|leucovorin|mesh-list
15226943|NCT04796948|Fluorouracil|fluorouracil|mesh-list
15226944|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
15226945|NCT04796948|Irinotecan|irinotecan|mesh-list
15226946|NCT04796948|Calcium|calcium|mesh-list
14334980|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
14334981|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14334982|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14334983|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14334984|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14334985|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
14334986|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
14334987|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14334988|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14334989|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
14334990|NCT00849251|Hormones|hormones|mesh-ancestor
14334991|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14334992|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14334993|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14334994|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14334995|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14334996|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14334997|NCT00849472|Paclitaxel|paclitaxel|mesh-list
14334998|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
14334999|NCT00849472|Doxorubicin|doxorubicin|mesh-list
14335000|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14335001|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335002|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14335003|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14335004|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14335005|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335006|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335007|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
14335008|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335009|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15226947|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
15226948|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15226949|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226950|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
14335010|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14335011|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
14930836|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
15226951|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335012|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14335013|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14335014|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14335015|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14335016|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335017|NCT00849680|Vaccines|vaccines|mesh-list
14335018|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
14335019|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335020|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14335021|NCT00849693|Fluoxetine|fluoxetine|mesh-list
14335022|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14335023|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14335024|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14335025|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335026|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335027|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335028|NCT00849693|Analgesics|analgesics|mesh-ancestor
14335029|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
14335030|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335031|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
14335032|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335033|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
14335034|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14335035|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
14335036|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14335037|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14335038|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14335039|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335040|NCT00849810|Metoprolol|metoprolol|mesh-list
14335041|NCT00849810|Nebivolol|nebivolol|mesh-list
14335042|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14335043|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14335044|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
14335045|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
14335046|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335047|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335048|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14335049|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14335050|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14335051|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
14335052|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335053|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335054|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335055|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14335056|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14335057|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14335058|NCT00849875|Dacarbazine|dacarbazine|mesh-list
14335059|NCT00849875|Imidazole|imidazole|mesh-list
14335060|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14335061|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
14335062|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335063|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335064|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335065|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14335066|NCT00849901|Fluoxetine|fluoxetine|mesh-list
14335067|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14335068|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14335069|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15226952|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15226953|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226954|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226955|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
15226956|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14335070|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335071|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335072|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226957|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15226958|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226959|NCT04796948|Antidotes|antidotes|mesh-ancestor
15226960|NCT04796948|Protective Agents|protective agents|mesh-ancestor
15226961|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
15226962|NCT04796948|Vitamins|vitamins|mesh-ancestor
15226963|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
15226964|NCT04792567|Siponimod|siponimod|mesh-list
15226965|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15226966|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226967|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15226968|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
14335073|NCT00849901|Analgesics|analgesics|mesh-ancestor
14335074|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
14335075|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335076|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
14335077|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335078|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
14335079|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14335080|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
14335081|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14335082|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14335083|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14335084|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335085|NCT00850096|Insulin|insulin|mesh-list
14335086|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335087|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335088|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
14335089|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335090|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
15226969|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226970|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
15226971|NCT04774107|Ribavirin|ribavirin|mesh-list
15226972|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
14335091|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335092|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335093|NCT00850395|Maraviroc|maraviroc|mesh-list
14335094|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14335095|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14335096|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335097|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335098|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335099|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
14335100|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335101|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14335102|NCT00850460|Atorvastatin|atorvastatin|mesh-list
14335103|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14335104|NCT00850460|Simvastatin|simvastatin|mesh-list
14335105|NCT00850460|Pravastatin|pravastatin|mesh-list
14335106|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14335107|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14335108|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
14335109|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335110|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14335111|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14335112|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335113|NCT00850499|Rituximab|rituximab|mesh-list
14335114|NCT00850499|Fludarabine|fludarabine|mesh-list
14335115|NCT00850499|Bortezomib|bortezomib|mesh-list
14335116|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335117|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335118|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
14335119|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335120|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335121|NCT00850564|Hormones|hormones|mesh-list
14335122|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14335123|NCT00850564|Tesamorelin|tesamorelin|mesh-list
14335124|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335125|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335126|NCT00850564|Growth Substances|growth substances|mesh-ancestor
14335127|NCT00850889|Lidocaine|lidocaine|mesh-list
14335128|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
14335129|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
14335130|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
14335131|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335132|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335133|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
14335134|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335135|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14335136|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14335137|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14335138|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14335139|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335140|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14335141|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
14335142|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
14335143|NCT00850889|Protective Agents|protective agents|mesh-ancestor
14335144|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14335145|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335146|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335147|NCT00851084|Leucovorin|leucovorin|mesh-list
14335148|NCT00851084|Folic Acid|folic acid|mesh-list
14335149|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
14335150|NCT00851084|Aflibercept|aflibercept|mesh-list
14335151|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
14335152|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335153|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14335154|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335155|NCT00851084|Growth Substances|growth substances|mesh-ancestor
14335156|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335157|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
14335158|NCT00851084|Antidotes|antidotes|mesh-ancestor
14335159|NCT00851084|Protective Agents|protective agents|mesh-ancestor
14335160|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
14335161|NCT00851084|Vitamins|vitamins|mesh-ancestor
14335162|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
14335163|NCT00851084|Hematinics|hematinics|mesh-ancestor
14335164|NCT00851318|Methotrexate|methotrexate|mesh-list
14335165|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
14335166|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14335167|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
14335168|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14335169|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335170|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14335171|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
14335172|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335173|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335174|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
14335175|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335176|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14335177|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335178|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
14335179|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335180|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14335181|NCT00851357|Nicotine|nicotine|mesh-list
14335182|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14335183|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
14335184|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335185|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335186|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14335187|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14335188|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
14335189|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335190|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335191|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14335192|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14335193|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335194|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
14335195|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335196|NCT00851630|Lamivudine|lamivudine|mesh-list
14335197|NCT00851630|Zidovudine|zidovudine|mesh-list
14335198|NCT00851630|Abacavir|abacavir|mesh-list
14335199|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14335200|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14335201|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335202|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335203|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
14335204|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335205|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335206|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335207|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
14335208|NCT00851721|Factor VIII|factor viii|mesh-list
14335209|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14335210|NCT00851721|Coagulants|coagulants|mesh-ancestor
14335211|NCT00851799|Ritonavir|ritonavir|mesh-list
14335212|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14335213|NCT00851799|Darunavir|darunavir|mesh-list
14335214|NCT00851799|Tenofovir|tenofovir|mesh-list
14335215|NCT00851799|Emtricitabine|emtricitabine|mesh-list
14335216|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
14335217|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14335218|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14335219|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14335220|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335221|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335222|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335223|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335224|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335225|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
14335226|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335227|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14335228|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14335229|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14335230|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14335231|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14335232|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14335233|NCT00851877|Paclitaxel|paclitaxel|mesh-list
14335234|NCT00851877|Cetuximab|cetuximab|mesh-list
14335235|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14335236|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335237|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
14335238|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
14335239|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
14335240|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335241|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335242|NCT00851890|Interferons|interferons|mesh-list
14335243|NCT00851890|Ribavirin|ribavirin|mesh-list
14335244|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335245|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
14335246|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335247|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
14335248|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335249|NCT00851903|Metformin|metformin|mesh-list
14335250|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
14335251|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14335252|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335253|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335254|NCT00851903|Incretins|incretins|mesh-ancestor
14335255|NCT00851903|Hormones|hormones|mesh-ancestor
14335256|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335257|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14335258|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335259|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335260|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464541|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14464542|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14464543|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464544|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464545|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14464546|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14464547|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
14464548|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14464549|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
14464550|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464551|NCT02212678|Expectorants|expectorants|mesh-ancestor
14464552|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
14464553|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14464554|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
14464555|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464556|NCT02212678|Protective Agents|protective agents|mesh-ancestor
14464557|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464558|NCT02212678|Antidotes|antidotes|mesh-ancestor
14464559|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
14464560|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464561|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335261|NCT00852202|Cariprazine|cariprazine|mesh-list
14335262|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14335263|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14335264|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335265|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335266|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335267|NCT00852397|Apixaban|apixaban|mesh-list
14335268|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14335269|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
14335270|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14335271|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335272|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335273|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335274|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
14335275|NCT00852540|Linezolid|linezolid|mesh-list
14335276|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15226973|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917896|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917897|NCT03937713|Eszopiclone|eszopiclone|mesh-list
14917898|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14917899|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335277|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335278|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14335279|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335280|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335281|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14335282|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
14335283|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335284|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14335285|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14335286|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335287|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335288|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14335289|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14335290|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335291|NCT00852761|Clobetasol|clobetasol|mesh-list
14335292|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335293|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
14335294|NCT00852761|Hormones|hormones|mesh-ancestor
14335295|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335296|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335297|NCT00852917|Tramadol|tramadol|mesh-list
14335298|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14335299|NCT00852917|Narcotics|narcotics|mesh-ancestor
14335300|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335301|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335302|NCT00852917|Analgesics|analgesics|mesh-ancestor
14335303|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
14335304|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335305|NCT00852969|Niacin|niacin|mesh-list
14335306|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14335307|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
14335308|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335309|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14335310|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335311|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
14335312|NCT00852969|Vitamins|vitamins|mesh-ancestor
14335313|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
14335314|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335315|NCT00853021|Aldesleukin|aldesleukin|mesh-list
14335316|NCT00853021|Bevacizumab|bevacizumab|mesh-list
14335317|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335318|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335319|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14335320|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335321|NCT00853021|Growth Substances|growth substances|mesh-ancestor
14335322|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335323|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14917900|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917901|NCT03817502|Cariprazine|cariprazine|mesh-list
14917902|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14917903|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917904|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335324|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335325|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335326|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
14335327|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335328|NCT00853047|Octreotide|octreotide|mesh-list
14335329|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14335330|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14335331|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335332|NCT00853073|Bevacizumab|bevacizumab|mesh-list
14335333|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335334|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335335|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14335336|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335337|NCT00853073|Growth Substances|growth substances|mesh-ancestor
14335338|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335339|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
14335340|NCT00853099|Adalimumab|adalimumab|mesh-list
14335341|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335342|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335343|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
14335344|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335345|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14335346|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14335347|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335348|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335349|NCT00853112|Urological Agents|urological agents|mesh-ancestor
14335350|NCT00853125|Sunitinib|sunitinib|mesh-list
14335351|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335352|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14335353|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335354|NCT00853125|Growth Substances|growth substances|mesh-ancestor
14335355|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729923|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14729924|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
14729925|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729926|NCT00525551|Protective Agents|protective agents|mesh-ancestor
14729927|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729928|NCT00525551|Antidotes|antidotes|mesh-ancestor
14729929|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14729930|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14335356|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
14335357|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335358|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335359|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335360|NCT00853242|Sevelamer|sevelamer|mesh-list
14335361|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
14335362|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
14335363|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335364|NCT00853333|Midazolam|midazolam|mesh-list
14335365|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
14335366|NCT00853333|Propofol|propofol|mesh-list
14335367|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14335368|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335369|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335370|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14335371|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
14335372|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
14335373|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14335374|NCT00853333|Analgesics|analgesics|mesh-ancestor
14335375|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
14335376|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335377|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14335378|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14335379|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14335380|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
14335381|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335382|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335383|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14335384|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14335385|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14335386|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335387|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
14335388|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
14335389|NCT00853372|Sunitinib|sunitinib|mesh-list
14335390|NCT00853372|Trebananib|trebananib|mesh-list
14335391|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14335392|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335393|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335394|NCT00853372|Growth Substances|growth substances|mesh-ancestor
14335395|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335396|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
14335397|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335398|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335399|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335400|NCT00853385|Adalimumab|adalimumab|mesh-list
14335401|NCT00853385|Tofacitinib|tofacitinib|mesh-list
14335402|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335403|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335404|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335405|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335406|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335407|NCT00853580|Lovastatin|lovastatin|mesh-list
14335408|NCT00853580|L 647318|l 647318|mesh-list
14335409|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
14335410|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14335411|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14335412|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
14335413|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335414|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14335415|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14335416|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335417|NCT00853658|Enalapril|enalapril|mesh-list
14335418|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14335419|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335420|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335421|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335422|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14335423|NCT00853671|Adenosine|adenosine|mesh-list
14729931|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
14335424|NCT00853671|Analgesics|analgesics|mesh-ancestor
14335425|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
14335426|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335427|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335428|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14335429|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335430|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14335431|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
14335432|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
14335433|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335434|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335435|NCT00853723|Teriparatide|teriparatide|mesh-list
14335436|NCT00853723|Hormones|hormones|mesh-list
14335437|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
14335438|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14335439|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14917905|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917906|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917907|NCT03800602|Metformin|metformin|mesh-list
14917908|NCT03800602|Nivolumab|nivolumab|mesh-list
14917909|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14917910|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917911|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917912|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917913|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14917914|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917915|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
14917916|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917917|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917918|NCT03703297|Durvalumab|durvalumab|mesh-list
14917919|NCT03703297|Tremelimumab|tremelimumab|mesh-list
14335440|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335441|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14917920|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14917921|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917922|NCT03623321|Pimavanserin|pimavanserin|mesh-list
14335442|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14335443|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14335444|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
14335445|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335446|NCT00853840|Maraviroc|maraviroc|mesh-list
14335447|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14335448|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14335449|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14335450|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335451|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335452|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335453|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
14335454|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335455|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14335456|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335457|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14335458|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14729932|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14729933|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335459|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335460|NCT00853840|Urological Agents|urological agents|mesh-ancestor
14335461|NCT00853905|Triamcinolone|triamcinolone|mesh-list
14335462|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14335463|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14335464|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14335465|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14335466|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335467|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
14335468|NCT00853905|Hormones|hormones|mesh-ancestor
14335469|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335470|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335471|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335472|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
14335473|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335474|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335475|NCT00853957|Amlodipine|amlodipine|mesh-list
14335476|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14335477|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14335478|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14335479|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335480|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14335481|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335482|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335483|NCT00853970|Bromfenac|bromfenac|mesh-list
14335484|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14335485|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14335486|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14335487|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14335488|NCT00853970|Analgesics|analgesics|mesh-ancestor
14335489|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
14335490|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335491|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335492|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335493|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335494|NCT00854061|Prednisone|prednisone|mesh-list
14335495|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
14335496|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14335497|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
14335498|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14335499|NCT00854061|Prednisolone|prednisolone|mesh-list
14335500|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14335501|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
14335502|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335503|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
14335504|NCT00854061|Hormones|hormones|mesh-ancestor
14335505|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335506|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335507|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14335508|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335509|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
14335510|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
14335511|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335512|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14335513|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14335514|NCT00854061|Protective Agents|protective agents|mesh-ancestor
14335515|NCT00854100|Cariprazine|cariprazine|mesh-list
14335516|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
14335517|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335518|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14335519|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14335520|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335521|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335522|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14335523|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729934|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14335524|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335525|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335526|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14335527|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335528|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335529|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335530|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335531|NCT00854360|Beclomethasone|beclomethasone|mesh-list
14335532|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335533|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
14335534|NCT00854360|Hormones|hormones|mesh-ancestor
14335535|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335536|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335537|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14335538|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
14335539|NCT00854373|Hormones|hormones|mesh-list
14335540|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14335541|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335542|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335543|NCT00854581|Interferons|interferons|mesh-list
14335544|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
14335545|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
14335546|NCT00854581|Zidovudine|zidovudine|mesh-list
14335547|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14335548|NCT00854581|Valproic Acid|valproic acid|mesh-list
14335549|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335550|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
14335551|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335552|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
14335553|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335554|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
14335555|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335556|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14335557|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14335558|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335559|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335560|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335561|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
14335562|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
14335563|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335564|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
14335565|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14335566|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335567|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335568|NCT00854620|Sorafenib|sorafenib|mesh-list
14335569|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335570|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335571|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335572|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335573|NCT00854724|Puerarin|puerarin|mesh-list
14335574|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335575|NCT00855010|Pioglitazone|pioglitazone|mesh-list
14335576|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335577|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335578|NCT00855062|Minocycline|minocycline|mesh-list
14335579|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14335580|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335581|NCT00855166|Metformin|metformin|mesh-list
14335582|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14335583|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
14335584|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335585|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335586|NCT00855166|Incretins|incretins|mesh-ancestor
14335587|NCT00855166|Hormones|hormones|mesh-ancestor
14335588|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335589|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14335590|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335591|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335592|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335593|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14335594|NCT00855218|Sorafenib|sorafenib|mesh-list
14335595|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335596|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335597|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335598|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335599|NCT00855309|Acyclovir|acyclovir|mesh-list
14335600|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
14335601|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335602|NCT00855335|Ritonavir|ritonavir|mesh-list
14335603|NCT00855335|Darunavir|darunavir|mesh-list
14335604|NCT00855335|Cobicistat|cobicistat|mesh-list
14335605|NCT00855335|Rilpivirine|rilpivirine|mesh-list
14335606|NCT00855335|Etravirine|etravirine|mesh-list
14335607|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14335608|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14335609|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335610|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335611|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335612|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335613|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335614|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
14335615|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335616|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14335617|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14335618|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14335619|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14335620|NCT00855413|Ritonavir|ritonavir|mesh-list
14335621|NCT00855413|Darunavir|darunavir|mesh-list
14335622|NCT00855413|Etravirine|etravirine|mesh-list
14335623|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14335624|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14335625|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335626|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335627|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335628|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335629|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335630|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
14335631|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335632|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14335633|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14335634|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14335635|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14335636|NCT00855439|Exenatide|exenatide|mesh-list
14335637|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335638|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335639|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14335640|NCT00855439|Incretins|incretins|mesh-ancestor
14335641|NCT00855439|Hormones|hormones|mesh-ancestor
14335642|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335643|NCT00855465|Riociguat|riociguat|mesh-list
14335644|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
14335645|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335646|NCT00855582|Tadalafil|tadalafil|mesh-list
14335647|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
14335648|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14335649|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14335650|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335651|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335652|NCT00855582|Urological Agents|urological agents|mesh-ancestor
14335653|NCT00855595|Metronidazole|metronidazole|mesh-list
14335654|NCT00855595|Doxycycline|doxycycline|mesh-list
14335655|NCT00855595|Azelaic acid|azelaic acid|mesh-list
14335656|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335657|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14335658|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14335659|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14335660|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
14335661|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335662|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
14335663|NCT00855738|Topiramate|topiramate|mesh-list
14335664|NCT00855738|Pregabalin|pregabalin|mesh-list
14335665|NCT00855738|Lamotrigine|lamotrigine|mesh-list
14335666|NCT00855738|Zonisamide|zonisamide|mesh-list
14335667|NCT00855738|Gabapentin|gabapentin|mesh-list
14729935|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
14729936|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14729937|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14729938|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14729939|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
14729940|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335668|NCT00855738|Levetiracetam|levetiracetam|mesh-list
14335669|NCT00855738|Tiagabine|tiagabine|mesh-list
14335670|NCT00855738|Analgesics|analgesics|mesh-ancestor
14335671|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
14335672|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335673|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335674|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
14335675|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14335676|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14335677|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335678|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14335679|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14335680|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14335681|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335682|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14729941|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729942|NCT00525577|Probucol|probucol|mesh-list
14335683|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14335684|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14335685|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335686|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
14335687|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335688|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
14335689|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14335690|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14335691|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14335692|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14335693|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
14335694|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14335695|NCT00855894|Pertuzumab|pertuzumab|mesh-list
14335696|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335697|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335698|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335699|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226974|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
15226975|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15226976|NCT04763577|Bradykinin|bradykinin|mesh-list
15226977|NCT04763577|Kininogens|kininogens|mesh-list
15226978|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
15226979|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
15226980|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335700|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335701|NCT00855920|Indomethacin|indomethacin|mesh-list
14335702|NCT00855920|Rilonacept|rilonacept|mesh-list
14729943|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14729944|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14335703|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14335704|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14335705|NCT00855920|Analgesics|analgesics|mesh-ancestor
14335706|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
14335707|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335708|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335709|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335710|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335711|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
14335712|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
14335713|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14335714|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14335715|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335716|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335717|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
14335718|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14335719|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335720|NCT00855959|Budesonide|budesonide|mesh-list
14335721|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335722|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14335723|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
14335724|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335725|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226981|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226982|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226983|NCT04750824|Afatinib|afatinib|mesh-list
14335726|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14335727|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
14335728|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
14335729|NCT00855959|Hormones|hormones|mesh-ancestor
14335730|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335731|NCT00856024|Ribavirin|ribavirin|mesh-list
14335732|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14335733|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
14335734|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335735|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
14335736|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335737|NCT00856050|Letrozole|letrozole|mesh-list
14335738|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335739|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14335740|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14335741|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335742|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335743|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14335744|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
14335745|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335746|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335747|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
14335748|NCT00856180|Bevacizumab|bevacizumab|mesh-list
14335749|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335750|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
14335751|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335752|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335753|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14335754|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
14335755|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335756|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335757|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14335758|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335759|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14335760|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335761|NCT00856180|Growth Substances|growth substances|mesh-ancestor
14335762|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
14335763|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
14335764|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14335765|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14335766|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14335767|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
14335768|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335769|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335770|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335771|NCT00856206|Rilonacept|rilonacept|mesh-list
14335772|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14335773|NCT00856245|Rituximab|rituximab|mesh-list
14335774|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335775|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335776|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
14335777|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917923|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14917924|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14917925|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14917926|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917927|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917928|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917929|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917930|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14335778|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335779|NCT00856284|Metformin|metformin|mesh-list
14335780|NCT00856284|Alogliptin|alogliptin|mesh-list
14335781|NCT00856284|Glipizide|glipizide|mesh-list
14335782|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335783|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335784|NCT00856284|Incretins|incretins|mesh-ancestor
14335785|NCT00856284|Hormones|hormones|mesh-ancestor
14335786|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335787|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14335788|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
14335789|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335790|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335791|NCT00856297|Vaccines|vaccines|mesh-list
14335792|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
14335793|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335794|NCT00856323|Tenofovir|tenofovir|mesh-list
14335795|NCT00856323|Emtricitabine|emtricitabine|mesh-list
14335796|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14335797|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
14335798|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14335799|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14335800|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14335801|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335802|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335803|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14335804|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14335805|NCT00856375|Irinotecan|irinotecan|mesh-list
14335806|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
14335807|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14335808|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14335809|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335810|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335811|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335812|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14335813|NCT00856388|Fludarabine|fludarabine|mesh-list
14335814|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
14335815|NCT00856388|Melphalan|melphalan|mesh-list
14335816|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
14335817|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14335818|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
14335819|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335820|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14335821|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
14335822|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335823|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335824|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
14335825|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335826|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14335827|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
14335828|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14335829|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
14335830|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14335831|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14335832|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14335833|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14335834|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335835|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
14335836|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335837|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335838|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14335839|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14335840|NCT00856492|Paclitaxel|paclitaxel|mesh-list
14335841|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
14335842|NCT00856492|Bevacizumab|bevacizumab|mesh-list
14335843|NCT00856492|Doxorubicin|doxorubicin|mesh-list
14335844|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14335845|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14335846|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14335847|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335848|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
14335849|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
14335850|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
14335851|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335852|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335853|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
14335854|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335855|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335856|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14335857|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
14335858|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14335859|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335860|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14335861|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335862|NCT00856492|Growth Substances|growth substances|mesh-ancestor
14335863|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
14335864|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14335865|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14335866|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14335867|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335868|NCT00856544|Tofacitinib|tofacitinib|mesh-list
14335869|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335870|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335871|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335872|NCT00856583|Risperidone|risperidone|mesh-list
14335873|NCT00856583|Sertindole|sertindole|mesh-list
14335874|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14335875|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
14335876|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335877|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335878|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335879|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14335880|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14335881|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335882|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14335883|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14335884|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
14335885|NCT00856609|Exenatide|exenatide|mesh-list
14335886|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335887|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335888|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14335889|NCT00856609|Incretins|incretins|mesh-ancestor
14335890|NCT00856609|Hormones|hormones|mesh-ancestor
14335891|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335892|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
14335893|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
14335894|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14335895|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
14335896|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335897|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335898|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14335899|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
14335900|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14335901|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14335902|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335903|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
14335904|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14335905|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335906|NCT00856791|ON 01910|on 01910|mesh-list
14335907|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335908|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14335909|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335910|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335911|NCT00856830|Carboplatin|carboplatin|mesh-list
14335912|NCT00856830|Irinotecan|irinotecan|mesh-list
14335913|NCT00856830|Etoposide|etoposide|mesh-list
14335914|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14335915|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335916|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14335917|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14335918|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335919|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335920|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14335921|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14335922|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14335923|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
14464562|NCT02213042|Trastuzumab|trastuzumab|mesh-list
14464563|NCT02213042|Lapatinib|lapatinib|mesh-list
14464564|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14464565|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464566|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464567|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14464568|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464569|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464570|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14464571|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14464572|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
14464573|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14464574|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464575|NCT02213055|Permethrin|permethrin|mesh-list
14464576|NCT02213055|Malathion|malathion|mesh-list
14464577|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464578|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464579|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14464580|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
14464581|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464582|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464583|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
14464584|NCT02213068|Abatacept|abatacept|mesh-list
14464585|NCT02213068|Tacrolimus|tacrolimus|mesh-list
14464586|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14464587|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
14464588|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464589|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14464590|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464591|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464592|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14464593|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464594|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14464595|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
14464596|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464597|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464598|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14464599|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464600|NCT02213094|Vitamins|vitamins|mesh-list
14464601|NCT02213094|Niacinamide|niacinamide|mesh-list
14464602|NCT02213094|Niacin|niacin|mesh-list
14464603|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
14464604|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
14464605|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
14464606|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464607|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14464608|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
14464609|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464610|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14464611|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
14464612|NCT02213263|Rituximab|rituximab|mesh-list
14464613|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464614|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464615|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
14464616|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464617|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464618|NCT02213289|Nivolumab|nivolumab|mesh-list
14464619|NCT02213289|Trastuzumab|trastuzumab|mesh-list
15226984|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15226985|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15226986|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15226987|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226988|NCT04731233|Triamcinolone|triamcinolone|mesh-list
15226989|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15226990|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15226991|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15226992|NCT04731233|Mitogens|mitogens|mesh-list
14464620|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
14464621|NCT02213289|Ramucirumab|ramucirumab|mesh-list
14729945|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
14335924|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14335925|NCT00856843|Laxatives|laxatives|mesh-ancestor
14335926|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14335927|NCT00856856|Everolimus|everolimus|mesh-list
14335928|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335929|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335930|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
14335931|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335932|NCT00856973|Eszopiclone|eszopiclone|mesh-list
14335933|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14335934|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335935|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335936|NCT00856986|Metformin|metformin|mesh-list
14335937|NCT00856986|Liraglutide|liraglutide|mesh-list
14335938|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
14335939|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14335940|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335941|NCT00856986|Incretins|incretins|mesh-ancestor
14335942|NCT00856986|Hormones|hormones|mesh-ancestor
14335943|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14335944|NCT00857220|Eszopiclone|eszopiclone|mesh-list
14335945|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14335946|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14335947|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335948|NCT00857233|Memantine|memantine|mesh-list
14335949|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14335950|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14335951|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
14335952|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14335953|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335954|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335955|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14335956|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14335957|NCT00857246|Irinotecan|irinotecan|mesh-list
14335958|NCT00857246|Cetuximab|cetuximab|mesh-list
14335959|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335960|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14335961|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14335962|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14335963|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335964|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14335965|NCT00857259|Everolimus|everolimus|mesh-list
14335966|NCT00857259|Ranibizumab|ranibizumab|mesh-list
14335967|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335968|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335969|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
14335970|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729946|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729947|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14729948|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
14729949|NCT00525577|Protective Agents|protective agents|mesh-ancestor
14335971|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14335972|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14335973|NCT00857259|Growth Substances|growth substances|mesh-ancestor
14335974|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
14335975|NCT00857272|Bisacodyl|bisacodyl|mesh-list
14335976|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14335977|NCT00857272|Cathartics|cathartics|mesh-ancestor
14335978|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14335979|NCT00857272|Laxatives|laxatives|mesh-ancestor
14335980|NCT00857311|Vaccines|vaccines|mesh-list
14335981|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
14335982|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335983|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
14335984|NCT00857389|Busulfan|busulfan|mesh-list
14335985|NCT00857389|Thiotepa|thiotepa|mesh-list
14335986|NCT00857389|Methotrexate|methotrexate|mesh-list
14335987|NCT00857389|Clofarabine|clofarabine|mesh-list
14335988|NCT00857389|Tacrolimus|tacrolimus|mesh-list
14335989|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
14335990|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14335991|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14335992|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
14335993|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14335994|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729950|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729951|NCT00525616|Rituximab|rituximab|mesh-list
14335995|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14335996|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
14335997|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14335998|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14335999|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14336000|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14336001|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
14336002|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14336003|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336004|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
14336005|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
14336006|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336007|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14336008|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336009|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14336010|NCT00857454|Testosterone|testosterone|mesh-list
14336011|NCT00857454|Androgens|androgens|mesh-ancestor
14336012|NCT00857454|Hormones|hormones|mesh-ancestor
14336013|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336014|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336015|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14336016|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
14336017|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336018|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14336019|NCT00857584|Sertraline|sertraline|mesh-list
14336020|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14336021|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14336022|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14336023|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14336024|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336025|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729952|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14729953|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729954|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
14729955|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729956|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14729957|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
14729958|NCT00525642|Docetaxel|docetaxel|mesh-list
14917931|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14336026|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14336027|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14917932|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
14336028|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336029|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336030|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336031|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
14336032|NCT00857649|Memantine|memantine|mesh-list
14336033|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14336034|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14336035|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
14336036|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336037|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336038|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336039|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14336040|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14336041|NCT00857714|Lapatinib|lapatinib|mesh-list
14336042|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336043|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336044|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336045|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336046|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
14336047|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14336048|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336049|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336050|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14336051|NCT00857727|Analgesics|analgesics|mesh-ancestor
14336052|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
14336053|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336054|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14336055|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14336056|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14336057|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
14336058|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336059|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336060|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14336061|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14336062|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
14336063|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336064|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336065|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14336066|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
14336067|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
14336068|NCT00857766|Hormones|hormones|mesh-ancestor
14336069|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336070|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
14336071|NCT00857792|Regadenoson|regadenoson|mesh-list
14336072|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14336073|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14336074|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
14336075|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
14336076|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14729959|NCT00525642|Doxorubicin|doxorubicin|mesh-list
14729960|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14729961|NCT00525642|Epirubicin|epirubicin|mesh-list
14729962|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729963|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
14729964|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729965|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336077|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336078|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336079|NCT00857818|Risperidone|risperidone|mesh-list
14336080|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14336081|NCT00857818|Aripiprazole|aripiprazole|mesh-list
14336082|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14336083|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
14336084|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336085|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336086|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336087|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14336088|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14336089|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336090|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14336091|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14336092|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
14336093|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
14336094|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
14336095|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14336096|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14336097|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14336098|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14336099|NCT00857896|Fesoterodine|fesoterodine|mesh-list
14336100|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14336101|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14336102|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14336103|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336104|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729966|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14729967|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
14729968|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729969|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729970|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14729971|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
14729972|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
14729973|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
14729974|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14729975|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14729976|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14729977|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729978|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14917933|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336105|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336106|NCT00857896|Urological Agents|urological agents|mesh-ancestor
14336107|NCT00857948|Ivermectin|ivermectin|mesh-list
14336108|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14336109|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336110|NCT00857961|Testosterone|testosterone|mesh-list
14336111|NCT00857961|Androgens|androgens|mesh-ancestor
14336112|NCT00857961|Hormones|hormones|mesh-ancestor
14336113|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336114|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336115|NCT00858013|Glimepiride|glimepiride|mesh-list
14336116|NCT00858013|Nateglinide|nateglinide|mesh-list
14336117|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14336118|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14336119|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336120|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336121|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
14336122|NCT00858117|Rituximab|rituximab|mesh-list
14336123|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
14336124|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14336125|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336126|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
14336127|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336128|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336129|NCT00858234|Bortezomib|bortezomib|mesh-list
14336130|NCT00858234|Vorinostat|vorinostat|mesh-list
14336131|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336132|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14336133|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336134|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336135|NCT00858247|Vitamin D|vitamin d|mesh-list
14336136|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
14336137|NCT00858247|Vitamins|vitamins|mesh-ancestor
14336138|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
14336139|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336140|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14336141|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14336142|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
14336143|NCT00858364|Hematinics|hematinics|mesh-ancestor
14336144|NCT00858403|Dasatinib|dasatinib|mesh-list
14336145|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336146|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336147|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336148|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336149|NCT00858468|Vaccines|vaccines|mesh-list
14336150|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
14336151|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336152|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
14336153|NCT00858637|Simvastatin|simvastatin|mesh-list
14336154|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14336155|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14336156|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
14336157|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336158|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14336159|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14336160|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336161|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14336162|NCT00858689|Minocycline|minocycline|mesh-list
14336163|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14336164|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336165|NCT00858780|Etanercept|etanercept|mesh-list
14336166|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14336167|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14336168|NCT00858780|Analgesics|analgesics|mesh-ancestor
14336169|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
14336170|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336171|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336172|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336173|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336174|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14336175|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336176|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
14336177|NCT00858832|Methylergonovine|methylergonovine|mesh-list
14336178|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
14336179|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14336180|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336181|NCT00858845|Clonidine|clonidine|mesh-list
14336182|NCT00858845|Analgesics|analgesics|mesh-ancestor
14336183|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
14336184|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336185|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336186|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14336187|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
14336188|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
14336189|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14336190|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14336191|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14336192|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
14336193|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336194|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336195|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14336196|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14336197|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14336198|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
14336199|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14336200|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14336201|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
14336202|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336203|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14336204|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14336205|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336206|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336207|NCT00858988|Rifaximin|rifaximin|mesh-list
14336208|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14336209|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336210|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14336211|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
14336212|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
14336213|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14336214|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336215|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336216|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14336217|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336218|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14336219|NCT00859040|Pasireotide|pasireotide|mesh-list
14336220|NCT00859040|Hormones|hormones|mesh-ancestor
14336221|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336222|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336223|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
14336224|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14336225|NCT00859131|Daclizumab|daclizumab|mesh-list
14336226|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
14336227|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729979|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
14729980|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729981|NCT00525668|Protective Agents|protective agents|mesh-ancestor
14336228|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336229|NCT00859222|Bevacizumab|bevacizumab|mesh-list
14336230|NCT00859222|Panobinostat|panobinostat|mesh-list
14336231|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14336232|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336233|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14336234|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14336235|NCT00859222|Growth Substances|growth substances|mesh-ancestor
14336236|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336237|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14336238|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14336239|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729982|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729983|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14729984|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14729985|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336240|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15226993|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15226994|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
15226995|NCT04731233|Hormones|hormones|mesh-ancestor
15226996|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15226997|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15226998|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336241|NCT00859313|Sufentanil|sufentanil|mesh-list
14336242|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14336243|NCT00859313|Narcotics|narcotics|mesh-ancestor
14336244|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336245|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336246|NCT00859313|Analgesics|analgesics|mesh-ancestor
14336247|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
14336248|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336249|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14336250|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14336251|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
14336252|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
14336253|NCT00859339|Gemcitabine|gemcitabine|mesh-list
14336254|NCT00859339|Sunitinib|sunitinib|mesh-list
14336255|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336256|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336257|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
14336258|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336259|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
14336260|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336261|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336262|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336263|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
14336264|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336265|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14336266|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14336267|NCT00859339|Growth Substances|growth substances|mesh-ancestor
14336268|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
14336269|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336270|NCT00859456|Sunitinib|sunitinib|mesh-list
14336271|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336272|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14336273|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14336274|NCT00859456|Growth Substances|growth substances|mesh-ancestor
14336275|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336276|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
14336277|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336278|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336279|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336280|NCT00859469|Gemcitabine|gemcitabine|mesh-list
14336281|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
14336282|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336283|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
14336284|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336285|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336286|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
14336287|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336288|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336289|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336290|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
14336291|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336292|NCT00859495|Doxorubicin|doxorubicin|mesh-list
15226999|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
15227000|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227001|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336293|NCT00859495|Pemetrexed|pemetrexed|mesh-list
14336294|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336295|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14336296|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14336297|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14336298|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336299|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729986|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14729987|NCT00525681|Cyclosporine|cyclosporine|mesh-list
14729988|NCT00525681|Tacrolimus|tacrolimus|mesh-list
14336300|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14336301|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336302|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14336303|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14336304|NCT00859508|Estradiol|estradiol|mesh-list
14336305|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14336306|NCT00859508|Estrogens|estrogens|mesh-ancestor
14336307|NCT00859508|Hormones|hormones|mesh-ancestor
14336308|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336309|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336310|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14336311|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
14336312|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14336313|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14336314|NCT00859573|Modafinil|modafinil|mesh-list
14336315|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14336316|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336317|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14336318|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14336319|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14336320|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336321|NCT00859651|Vitamin D|vitamin d|mesh-list
14336322|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
14336323|NCT00859651|Vitamins|vitamins|mesh-ancestor
14336324|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
14336325|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336326|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14336327|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14336328|NCT00859833|Adenosine|adenosine|mesh-list
15227002|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
15227003|NCT04726618|Xenon|xenon|mesh-list
15227004|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15227005|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
15227006|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
15227007|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336329|NCT00859833|Regadenoson|regadenoson|mesh-list
14336330|NCT00859833|Analgesics|analgesics|mesh-ancestor
14336331|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
14336332|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336333|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336334|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14336335|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
14336336|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14336337|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
14336338|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
14336339|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336340|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336341|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14336342|NCT00859898|Metformin|metformin|mesh-list
14336343|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
14336344|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14336345|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336346|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14336347|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336348|NCT00859937|Dasatinib|dasatinib|mesh-list
14336349|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14729989|NCT00525681|Cyclosporins|cyclosporins|mesh-list
15227008|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227009|NCT04726475|Cannabidiol|cannabidiol|mesh-list
15227010|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
15227011|NCT04721613|Melatonin|melatonin|mesh-list
15227012|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
14336350|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336351|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336352|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336353|NCT00860015|Gemcitabine|gemcitabine|mesh-list
14336354|NCT00860015|Pemetrexed|pemetrexed|mesh-list
14336355|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336356|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
14336357|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336358|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336359|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
14336360|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227013|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227014|NCT04721613|Protective Agents|protective agents|mesh-ancestor
14336361|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336362|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336363|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
14336364|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917934|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917935|NCT03602859|Niraparib|niraparib|mesh-list
14917936|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14917937|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917938|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336365|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14336366|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336367|NCT00860028|Varenicline|varenicline|mesh-list
14336368|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14336369|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14336370|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
14336371|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336372|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336373|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336374|NCT00860171|Iodine|iodine|mesh-list
14336375|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
14336376|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14336377|NCT00860171|Antibodies|antibodies|mesh-list
14336378|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
14917939|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227015|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227016|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227017|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
15227018|NCT04720976|Osimertinib|osimertinib|mesh-list
15227019|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227020|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227021|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227022|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917940|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
14917941|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
14917942|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
14917943|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14917944|NCT03600883|Midazolam|midazolam|mesh-list
14917945|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14917946|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14917947|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14917948|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227023|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227024|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
15227025|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15227026|NCT04717362|Testosterone|testosterone|mesh-list
15227027|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
15227028|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
15227029|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15227030|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227031|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
14336379|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15227032|NCT04717362|Hormones|hormones|mesh-ancestor
15227033|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227034|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729990|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14729991|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
14729992|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14729993|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15227035|NCT04717362|Androgens|androgens|mesh-ancestor
14336380|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
14336381|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336382|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336383|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14336384|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336385|NCT00860171|Trace Elements|trace elements|mesh-ancestor
14336386|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
14336387|NCT00860262|Amlodipine|amlodipine|mesh-list
14336388|NCT00860262|Telmisartan|telmisartan|mesh-list
14336389|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14336390|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14336391|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14336392|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336393|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336394|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14336395|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336396|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
14336397|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14336398|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14336399|NCT00860379|Selenium|selenium|mesh-list
14336400|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
14336401|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336402|NCT00860379|Protective Agents|protective agents|mesh-ancestor
14336403|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336404|NCT00860379|Trace Elements|trace elements|mesh-ancestor
14336405|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
14336406|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14336407|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
14336408|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
14336409|NCT00860457|Rituximab|rituximab|mesh-list
14336410|NCT00860457|Fludarabine|fludarabine|mesh-list
14336411|NCT00860457|Lenalidomide|lenalidomide|mesh-list
14336412|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14336413|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336414|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
15227036|NCT04707326|Lamivudine|lamivudine|mesh-list
15227037|NCT04707326|Dolutegravir|dolutegravir|mesh-list
14336415|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336416|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336417|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14336418|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14336419|NCT00860457|Growth Substances|growth substances|mesh-ancestor
14336420|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
14336421|NCT00860470|Iron|iron|mesh-list
14336422|NCT00860470|Trace Elements|trace elements|mesh-list
14729994|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14729995|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14729996|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
14729997|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14729998|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
14729999|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730000|NCT00525694|Cocaine|cocaine|mesh-list
14730001|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
14730002|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
14730003|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730004|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730005|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
14730006|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730007|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14730008|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14730009|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14730010|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14730011|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730012|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
14730013|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730014|NCT00525707|Tezosentan|tezosentan|mesh-list
14730015|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
14730016|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
15227038|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15227039|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336423|NCT00860470|Folic Acid|folic acid|mesh-list
14336424|NCT00860470|Micronutrients|micronutrients|mesh-list
14336425|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336426|NCT00860470|Hematinics|hematinics|mesh-ancestor
14336427|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
14336428|NCT00860470|Vitamins|vitamins|mesh-ancestor
14336429|NCT00860574|Methotrexate|methotrexate|mesh-list
14336430|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
14336431|NCT00860574|Fludarabine|fludarabine|mesh-list
14336432|NCT00860574|Treosulfan|treosulfan|mesh-list
14336433|NCT00860574|Tacrolimus|tacrolimus|mesh-list
14336434|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14336435|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
14336436|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14336437|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336438|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336439|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
14336440|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336441|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336442|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
15227040|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227041|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227042|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
15227043|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227044|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15227045|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15227046|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14336443|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336444|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14336445|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730017|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
14730018|NCT00525759|Docetaxel|docetaxel|mesh-list
14730019|NCT00525759|Fluorouracil|fluorouracil|mesh-list
14730020|NCT00525759|Epirubicin|epirubicin|mesh-list
14336446|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
14336447|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336448|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336449|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14336450|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14336451|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
14336452|NCT00860743|Antioxidants|antioxidants|mesh-list
14336453|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336454|NCT00860743|Protective Agents|protective agents|mesh-ancestor
14336455|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336456|NCT00860847|Ubiquinone|ubiquinone|mesh-list
14336457|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
14336458|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
14336459|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336460|NCT00860847|Vitamins|vitamins|mesh-ancestor
14336461|NCT00860938|Budesonide|budesonide|mesh-list
14336462|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336463|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14336464|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
14336465|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336466|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336467|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14336468|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
14336469|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
14336470|NCT00860938|Hormones|hormones|mesh-ancestor
14336471|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336472|NCT00861341|Aspirin|aspirin|mesh-list
14336473|NCT00861341|Pioglitazone|pioglitazone|mesh-list
14336474|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14336475|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14336476|NCT00861341|Analgesics|analgesics|mesh-ancestor
14336477|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
14336478|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336479|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336480|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336481|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336482|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14336483|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14336484|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730021|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336485|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14336486|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14336487|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336488|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
14336489|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14336490|NCT00861380|Vaccines|vaccines|mesh-list
14336491|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14336492|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
14336493|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336494|NCT00861471|Docetaxel|docetaxel|mesh-list
14336495|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
14336496|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336497|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14336498|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14336499|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14336500|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336501|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336502|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464622|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464623|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464624|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14464625|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464626|NCT02213380|Anesthetics|anesthetics|mesh-list
14464627|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464628|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464629|NCT02213900|Haloperidol|haloperidol|mesh-list
14464630|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
14464631|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
14464632|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
14464633|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227047|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15227048|NCT04703101|Leucovorin|leucovorin|mesh-list
15227049|NCT04703101|Fluorouracil|fluorouracil|mesh-list
15227050|NCT04703101|Capecitabine|capecitabine|mesh-list
14464634|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464635|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464636|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14464637|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14464638|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464639|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464640|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14464641|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
14464642|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464643|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464644|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14464645|NCT02214121|Ticagrelor|ticagrelor|mesh-list
14464646|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14464647|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14464648|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14464649|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14464650|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
14464651|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464652|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464653|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464654|NCT02214225|Vaccines|vaccines|mesh-list
14464655|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
14464656|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464657|NCT02214290|Caffeine|caffeine|mesh-list
14464658|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14464659|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464660|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14464661|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464662|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464663|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14464664|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14464665|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
14464666|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464667|NCT02214420|Ribavirin|ribavirin|mesh-list
14464668|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
14464669|NCT02214420|Simeprevir|simeprevir|mesh-list
14730022|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
14730023|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917949|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14464670|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
15227051|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
15227052|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
14730024|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730025|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14730026|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
14730027|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336503|NCT00861614|Ipilimumab|ipilimumab|mesh-list
14336504|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227053|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227054|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227055|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227056|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227057|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
15227058|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227059|NCT04703101|Antidotes|antidotes|mesh-ancestor
14336505|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336506|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14336507|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336508|NCT00861692|Argatroban|argatroban|mesh-list
14336509|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
14336510|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14336511|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
14336512|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336513|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336514|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
14336515|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14336516|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14336517|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
14336518|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336519|NCT00861757|Tadalafil|tadalafil|mesh-list
14336520|NCT00861757|Tamsulosin|tamsulosin|mesh-list
14336521|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
14336522|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14336523|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14336524|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336525|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336526|NCT00861757|Urological Agents|urological agents|mesh-ancestor
14336527|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14336528|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14336529|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14336530|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
14336531|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336532|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336533|NCT00862082|Sorafenib|sorafenib|mesh-list
14336534|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14336535|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336536|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336537|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336538|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336539|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14336540|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
14336541|NCT00862121|Mesalamine|mesalamine|mesh-list
14336542|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14336543|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14336544|NCT00862121|Analgesics|analgesics|mesh-ancestor
14336545|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
14336546|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336547|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336548|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336549|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336550|NCT00862134|Docetaxel|docetaxel|mesh-list
14336551|NCT00862134|Sargramostim|sargramostim|mesh-list
14336552|NCT00862134|Lenograstim|lenograstim|mesh-list
14336553|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227060|NCT04703101|Protective Agents|protective agents|mesh-ancestor
15227061|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
15227062|NCT04703101|Vitamins|vitamins|mesh-ancestor
15227063|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
15227064|NCT04690023|Ropivacaine|ropivacaine|mesh-list
15227065|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
15227066|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
15227067|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227068|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227069|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
15227070|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227071|NCT04678895|Naltrexone|naltrexone|mesh-list
14336554|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
14730028|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730029|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14336555|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
14336556|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
14336557|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336558|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
14336559|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336560|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14336561|NCT00862563|Topiramate|topiramate|mesh-list
14336562|NCT00862563|Zonisamide|zonisamide|mesh-list
14336563|NCT00862563|Levetiracetam|levetiracetam|mesh-list
14336564|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
14336565|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14336566|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336567|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
14336568|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14336569|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336570|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336571|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14336572|NCT00862641|Regadenoson|regadenoson|mesh-list
14336573|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14336574|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14336575|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
14336576|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
14336577|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336578|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336579|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336580|NCT00862654|Ketoconazole|ketoconazole|mesh-list
14336581|NCT00862654|Clobetasol|clobetasol|mesh-list
14336582|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
14336583|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336584|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14336585|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14336586|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336587|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336588|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14336589|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
14336590|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336591|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336592|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14336593|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336594|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
14336595|NCT00862654|Hormones|hormones|mesh-ancestor
14336596|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14336597|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14336598|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336599|NCT00862719|Incretins|incretins|mesh-ancestor
14336600|NCT00862719|Hormones|hormones|mesh-ancestor
14336601|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336602|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14730030|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
15227072|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15227073|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15227074|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227075|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
15227076|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227077|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
15227078|NCT04653818|Velpatasvir|velpatasvir|mesh-list
15227079|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
15227080|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227081|NCT04646590|Vaccines|vaccines|mesh-list
14730031|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730032|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
14730033|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
14730034|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227082|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
15227083|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227084|NCT04645667|Tacrolimus|tacrolimus|mesh-list
15227085|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227086|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
15227087|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227088|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15227089|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227090|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227091|NCT04638309|Azacitidine|azacitidine|mesh-list
15227092|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336603|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14336604|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336605|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336606|NCT00862745|Fesoterodine|fesoterodine|mesh-list
14336607|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14336608|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14336609|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
14336610|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336611|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336612|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227093|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
15227094|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227095|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227096|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227097|NCT04635254|Histamine|histamine|mesh-list
15227098|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
15227099|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
15227100|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227101|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227102|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227103|NCT04625946|Metformin|metformin|mesh-list
14336613|NCT00862745|Urological Agents|urological agents|mesh-ancestor
14336614|NCT00862784|Leucovorin|leucovorin|mesh-list
14336615|NCT00862784|Folic Acid|folic acid|mesh-list
15227104|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15227105|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227106|NCT04608344|Atorvastatin|atorvastatin|mesh-list
14336616|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
14336617|NCT00862784|Fluorouracil|fluorouracil|mesh-list
14336618|NCT00862784|Ramucirumab|ramucirumab|mesh-list
14336619|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14336620|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
14336621|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336622|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
14336623|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336624|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336625|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227107|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14336626|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
14336627|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336628|NCT00862784|Antidotes|antidotes|mesh-ancestor
14336629|NCT00862784|Protective Agents|protective agents|mesh-ancestor
15227108|NCT04608344|Pravastatin|pravastatin|mesh-list
15227109|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14336630|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
14336631|NCT00862784|Vitamins|vitamins|mesh-ancestor
14336632|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
14336633|NCT00862784|Hematinics|hematinics|mesh-ancestor
14336634|NCT00862810|Vaccines|vaccines|mesh-list
14336635|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
14336636|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336637|NCT00862823|Tenofovir|tenofovir|mesh-list
14336638|NCT00862823|Emtricitabine|emtricitabine|mesh-list
14336639|NCT00862823|Efavirenz|efavirenz|mesh-list
14336640|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
14336641|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336642|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14336643|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336644|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336645|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336646|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14336647|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14336648|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14336649|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14336650|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14336651|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14336652|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14336653|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14336654|NCT00862849|Insulin|insulin|mesh-list
14336655|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14336656|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
14336657|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14336658|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336659|NCT00862940|Memantine|memantine|mesh-list
14336660|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14336661|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14336662|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
14336663|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336664|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336665|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336666|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14336667|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14336668|NCT00862979|Cyclosporine|cyclosporine|mesh-list
14336669|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
14336670|NCT00862979|Everolimus|everolimus|mesh-list
14336671|NCT00862979|Tacrolimus|tacrolimus|mesh-list
14336672|NCT00862979|Cyclosporins|cyclosporins|mesh-list
14336673|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336674|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
14336675|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336676|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14336677|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336678|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336679|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
14336680|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336681|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
14336682|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336683|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336684|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14336685|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14336686|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
14336687|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14336688|NCT00862992|Cariprazine|cariprazine|mesh-list
14336689|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14336690|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14336691|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336692|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336693|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14336694|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14336695|NCT00863057|Methadone|methadone|mesh-list
14336696|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14336697|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14336698|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336699|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336700|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730035|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14730036|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730037|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730038|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730039|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14730040|NCT00525772|Ciclesonide|ciclesonide|mesh-list
14730041|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
14336701|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336702|NCT00863057|Analgesics|analgesics|mesh-ancestor
14336703|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
14336704|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336705|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
14336706|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14336707|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
14336708|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14336709|NCT00863057|Narcotics|narcotics|mesh-ancestor
14336710|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336711|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
14336712|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
14336713|NCT00863109|Ribavirin|ribavirin|mesh-list
14336714|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14336715|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
14336716|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336717|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
14336718|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336719|NCT00863122|Lapatinib|lapatinib|mesh-list
14336720|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336721|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336722|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336723|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336724|NCT00863265|Ezetimibe|ezetimibe|mesh-list
14336725|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14336726|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14336727|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
14336728|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336729|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14336730|NCT00863304|Naproxen|naproxen|mesh-list
14336731|NCT00863304|Tanezumab|tanezumab|mesh-list
14336732|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15227110|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15227111|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
15227112|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227113|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15227114|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15227115|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227116|NCT04591002|Osimertinib|osimertinib|mesh-list
15227117|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227118|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227119|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227120|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336733|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14336734|NCT00863304|Analgesics|analgesics|mesh-ancestor
14336735|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
14336736|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336737|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336738|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336739|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336740|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
14336741|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14336742|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336743|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336744|NCT00863317|Montelukast|montelukast|mesh-list
14336745|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14336746|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
14336747|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14336748|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
14336749|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336750|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336751|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14336752|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14336753|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336754|NCT00863356|Hemostatics|hemostatics|mesh-list
14730042|NCT00525772|Hormones|hormones|mesh-ancestor
14336755|NCT00863356|Chitosan|chitosan|mesh-list
14336756|NCT00863356|Coagulants|coagulants|mesh-ancestor
14336757|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14336758|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14336759|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
14336760|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336761|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14336762|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
15227121|NCT04589351|Ezetimibe|ezetimibe|mesh-list
15227122|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15227123|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15227124|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
15227125|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227126|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14336763|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
14336764|NCT00863434|Cytarabine|cytarabine|mesh-list
14336765|NCT00863434|Clofarabine|clofarabine|mesh-list
14336766|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336767|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
14336768|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336769|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336770|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
14336771|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336772|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336773|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
14336774|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336775|NCT00863551|Trospium chloride|trospium chloride|mesh-list
14336776|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
14336777|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
14336778|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336779|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336780|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14336781|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14336782|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
14336783|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336784|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336785|NCT00863551|Urological Agents|urological agents|mesh-ancestor
14336786|NCT00863655|Everolimus|everolimus|mesh-list
14336787|NCT00863655|Exemestane|exemestane|mesh-list
14336788|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336789|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336790|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
14336791|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336792|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14336793|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14336794|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336795|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336796|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14917950|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14917951|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14917952|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14917953|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
14917954|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
14917955|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
14917956|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
14917957|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14917958|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917959|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
14917960|NCT03580473|Dexamethasone|dexamethasone|mesh-list
14917961|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14917962|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336797|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
14917963|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
14336798|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730043|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730044|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730045|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14730046|NCT00525889|Sirolimus|sirolimus|mesh-list
14730047|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730048|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336799|NCT00863681|Riociguat|riociguat|mesh-list
14336800|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
14336801|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336802|NCT00863707|Regadenoson|regadenoson|mesh-list
14336803|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14336804|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14336805|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
14336806|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
14336807|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336808|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336809|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336810|NCT00863746|Sorafenib|sorafenib|mesh-list
14336811|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336812|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336813|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336814|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336815|NCT00863772|Tanezumab|tanezumab|mesh-list
14336816|NCT00863772|Analgesics|analgesics|mesh-ancestor
14336817|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
14336818|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336819|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336820|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14336821|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14336822|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14336823|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336824|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336825|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336826|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336827|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
14336828|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14336829|NCT00864032|Sorafenib|sorafenib|mesh-list
14336830|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336831|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336832|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336833|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336834|NCT00864097|Diclofenac|diclofenac|mesh-list
14336835|NCT00864097|Tanezumab|tanezumab|mesh-list
14336836|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14336837|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14336838|NCT00864097|Analgesics|analgesics|mesh-ancestor
14336839|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
14336840|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336841|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336842|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14336843|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14336844|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14336845|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730049|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14730050|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730051|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
14730052|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730053|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
14730054|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227127|NCT04583592|Gabexate|gabexate|mesh-list
15227128|NCT04583592|Camostat|camostat|mesh-list
15227129|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
15227130|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227131|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227132|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14336846|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336847|NCT00864123|Cycloserine|cycloserine|mesh-list
14336848|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14336849|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336850|NCT00864123|Renal Agents|renal agents|mesh-ancestor
14336851|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14336852|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
14336853|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14336854|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
14336855|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336856|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14336857|NCT00864253|Dacarbazine|dacarbazine|mesh-list
14336858|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336859|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14336860|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
14336861|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336862|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
14336863|NCT00864383|Rifampin|rifampin|mesh-list
14336864|NCT00864383|Isoniazid|isoniazid|mesh-list
14336865|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
14336866|NCT00864383|Ethambutol|ethambutol|mesh-list
14336867|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14336868|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336869|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14336870|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14336871|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336872|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336873|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336874|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14336875|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
14336876|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
14336877|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336878|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14336879|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14730055|NCT00525928|Varenicline|varenicline|mesh-list
14730056|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15227133|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14336880|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14336881|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14730057|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15227134|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
15227135|NCT04570904|Vaccines|vaccines|mesh-list
15227136|NCT04570904|Immunologic Factors|immunologic factors|mesh-ancestor
15227137|NCT04570904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227138|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
15227139|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
15227140|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730058|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
14730059|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14336882|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14336883|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14336884|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14336885|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14336886|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
14336887|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14336888|NCT00864513|Pemetrexed|pemetrexed|mesh-list
14336889|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336890|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336891|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336892|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14336893|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14336894|NCT00864539|Vitamin D|vitamin d|mesh-list
14336895|NCT00864539|Calcium|calcium|mesh-list
14336896|NCT00864539|Vitamins|vitamins|mesh-ancestor
14336897|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
14336898|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336899|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14336900|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14336901|NCT00864682|Lidocaine|lidocaine|mesh-list
14336902|NCT00864682|Propofol|propofol|mesh-list
14336903|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
14336904|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
14336905|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14336906|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336907|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
14336908|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14336909|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14336910|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14336911|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14336912|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336913|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336914|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14336915|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14336916|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
14336917|NCT00864721|Sunitinib|sunitinib|mesh-list
14336918|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336919|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14336920|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14336921|NCT00864721|Growth Substances|growth substances|mesh-ancestor
14336922|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336923|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
14336924|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14336925|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336926|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336927|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14336928|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
14336929|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14336930|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336931|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336932|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14336933|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14336934|NCT00864916|Protective Agents|protective agents|mesh-ancestor
14336935|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336936|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
14336937|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14336938|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
14336939|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
14336940|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336941|NCT00865020|Telmisartan|telmisartan|mesh-list
14336942|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14336943|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15227141|NCT04529850|Protective Agents|protective agents|mesh-ancestor
15227142|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227143|NCT04523961|Lidocaine|lidocaine|mesh-list
15227144|NCT04523961|Tetracaine|tetracaine|mesh-list
15227145|NCT04523961|Prilocaine|prilocaine|mesh-list
15227146|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15227147|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
15227148|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
15227149|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227150|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336944|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15227151|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
15227152|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227153|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15227154|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15227155|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15227156|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15227157|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227158|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15227159|NCT04500509|Diclofenac|diclofenac|mesh-list
15227160|NCT04500509|Dinoprostone|dinoprostone|mesh-list
15227161|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15227162|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15227163|NCT04500509|Analgesics|analgesics|mesh-ancestor
14336945|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336946|NCT00865098|Cetuximab|cetuximab|mesh-list
14336947|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14336948|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336949|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14336950|NCT00865124|Spironolactone|spironolactone|mesh-list
14336951|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14336952|NCT00865124|Diuretics|diuretics|mesh-ancestor
14336953|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
14336954|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336955|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14336956|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14336957|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336958|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14336959|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14336960|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14336961|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14336962|NCT00865189|Leucovorin|leucovorin|mesh-list
14336963|NCT00865189|Folic Acid|folic acid|mesh-list
14336964|NCT00865189|Bevacizumab|bevacizumab|mesh-list
14336965|NCT00865189|Fluorouracil|fluorouracil|mesh-list
14336966|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
14336967|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
14336968|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14336969|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336970|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14336971|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14336972|NCT00865189|Growth Substances|growth substances|mesh-ancestor
14336973|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14336974|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14336975|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
14336976|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336977|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14336978|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14336979|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
14336980|NCT00865189|Antidotes|antidotes|mesh-ancestor
14336981|NCT00865189|Protective Agents|protective agents|mesh-ancestor
14336982|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
14336983|NCT00865189|Vitamins|vitamins|mesh-ancestor
14336984|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
14336985|NCT00865189|Hematinics|hematinics|mesh-ancestor
14336986|NCT00865202|Tryptophan|tryptophan|mesh-list
14336987|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14730060|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730061|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730062|NCT00525967|Acetaminophen|acetaminophen|mesh-list
14730063|NCT00525967|Methadone|methadone|mesh-list
14730064|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730065|NCT00525967|Analgesics|analgesics|mesh-ancestor
14730066|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
14730067|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730068|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730069|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
14730070|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14730071|NCT00525967|Narcotics|narcotics|mesh-ancestor
14730072|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730073|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
14336988|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
14336989|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14336990|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
14336991|NCT00865280|Linezolid|linezolid|mesh-list
14336992|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14336993|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14336994|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14336995|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14336996|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14336997|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14336998|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14336999|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14730074|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
14730075|NCT00525993|Etoricoxib|etoricoxib|mesh-list
14730076|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14730077|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730078|NCT00525993|Analgesics|analgesics|mesh-ancestor
14337000|NCT00865566|Vaccines|vaccines|mesh-list
14730079|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
14337001|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
14337002|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337003|NCT00865709|Leucovorin|leucovorin|mesh-list
14337004|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
14337005|NCT00865709|Fluorouracil|fluorouracil|mesh-list
14337006|NCT00865709|Sorafenib|sorafenib|mesh-list
14337007|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
14337008|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337009|NCT00865709|Antidotes|antidotes|mesh-ancestor
14337010|NCT00865709|Protective Agents|protective agents|mesh-ancestor
14337011|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337012|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
14337013|NCT00865709|Vitamins|vitamins|mesh-ancestor
14337014|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
14337015|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
14337016|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337017|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14337018|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337019|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
14337020|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14337021|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337022|NCT00865969|Belinostat|belinostat|mesh-list
14337023|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337024|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14337025|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337026|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337027|NCT00866034|Cetrorelix|cetrorelix|mesh-list
14337028|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14337029|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
14337030|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14337031|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337032|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
14337033|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337034|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14337035|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337036|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337037|NCT00866281|Midostaurin|midostaurin|mesh-list
14337038|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337039|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14337040|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337041|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337042|NCT00866294|Paroxetine|paroxetine|mesh-list
14337043|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14337044|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14337045|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14337046|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337047|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337048|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
14337049|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337050|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14337051|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
14337052|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337053|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14337054|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14337055|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337056|NCT00866307|Cytarabine|cytarabine|mesh-list
14337057|NCT00866307|Dexamethasone|dexamethasone|mesh-list
14337058|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
14917964|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
14337059|NCT00866307|Prednisone|prednisone|mesh-list
14337060|NCT00866307|Cortisone|cortisone|mesh-list
14337061|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
14337062|NCT00866307|Doxorubicin|doxorubicin|mesh-list
14337063|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14337064|NCT00866307|Methotrexate|methotrexate|mesh-list
14337065|NCT00866307|Vincristine|vincristine|mesh-list
14337066|NCT00866307|Daunorubicin|daunorubicin|mesh-list
14337067|NCT00866307|Asparaginase|asparaginase|mesh-list
14337068|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
14337069|NCT00866307|Pegaspargase|pegaspargase|mesh-list
15227164|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
15227165|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227166|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227167|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15227168|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15227169|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15227170|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227171|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227172|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
15227173|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15227174|NCT04500470|Ketoprofen|ketoprofen|mesh-list
15227175|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15227176|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15227177|NCT04500470|Analgesics|analgesics|mesh-ancestor
15227178|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
15227179|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227180|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227181|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15227182|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337070|NCT00866307|Thioguanine|thioguanine|mesh-list
14337071|NCT00866307|BB 1101|bb 1101|mesh-list
14337072|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
14337073|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337074|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
14337075|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337076|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337077|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14337078|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
14337079|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337080|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337081|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14337082|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14337083|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
14337084|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
14337085|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337086|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14337087|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
14337088|NCT00866307|Hormones|hormones|mesh-ancestor
14337089|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337090|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14337091|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
14337092|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337093|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14337094|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730080|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730081|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730082|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730083|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337095|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14337096|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14730084|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14730085|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14730086|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730087|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730088|NCT00526006|Esomeprazole|esomeprazole|mesh-list
14730089|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14730090|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14730091|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14730092|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337097|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
14337098|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14337099|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14337100|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
14337101|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
14337102|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730093|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337103|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337104|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
14337105|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337106|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14337107|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
14337108|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
14337109|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
14917965|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14917966|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917967|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14917968|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
14917969|NCT03580473|Hormones|hormones|mesh-ancestor
14917970|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337110|NCT00866320|Sorafenib|sorafenib|mesh-list
14337111|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337112|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14337113|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337114|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337115|NCT00866333|Entinostat|entinostat|mesh-list
14337116|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337117|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14337118|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337119|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337120|NCT00866359|Apremilast|apremilast|mesh-list
14337121|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14337122|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14337123|NCT00866359|Analgesics|analgesics|mesh-ancestor
14337124|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
14917971|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14337125|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337126|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337127|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14337128|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337129|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14337130|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14337131|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337132|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337133|NCT00866619|Vaccines|vaccines|mesh-list
14337134|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
14337135|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337136|NCT00866658|Lixisenatide|lixisenatide|mesh-list
14337137|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14337138|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337139|NCT00866723|Bevacizumab|bevacizumab|mesh-list
14917972|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337140|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337141|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337142|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14337143|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14337144|NCT00866723|Growth Substances|growth substances|mesh-ancestor
14730094|NCT00526175|Cytarabine|cytarabine|mesh-list
14730095|NCT00526175|Prednisone|prednisone|mesh-list
14730096|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
14730097|NCT00526175|Methotrexate|methotrexate|mesh-list
14730098|NCT00526175|Vincristine|vincristine|mesh-list
14730099|NCT00526175|Daunorubicin|daunorubicin|mesh-list
14730100|NCT00526175|Asparaginase|asparaginase|mesh-list
14730101|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
14730102|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14917973|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14917974|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917975|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14917976|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227183|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15227184|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227185|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227186|NCT04461015|Insulin|insulin|mesh-list
15227187|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15227188|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15227189|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227190|NCT04457297|Trifluridine|trifluridine|mesh-list
15227191|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
15227192|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227193|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
14730103|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
14337145|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337146|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14337147|NCT00866749|Cytarabine|cytarabine|mesh-list
14337148|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
14337149|NCT00866749|Doxorubicin|doxorubicin|mesh-list
14337150|NCT00866749|Methotrexate|methotrexate|mesh-list
14337151|NCT00866749|Vincristine|vincristine|mesh-list
14337152|NCT00866749|Daunorubicin|daunorubicin|mesh-list
14337153|NCT00866749|Asparaginase|asparaginase|mesh-list
14337154|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
14337155|NCT00866749|Thioguanine|thioguanine|mesh-list
14337156|NCT00866749|Pegaspargase|pegaspargase|mesh-list
14337157|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337158|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
14337159|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337160|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337161|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14337162|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
14337163|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337164|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337165|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14337166|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14337167|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14337168|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14337169|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337170|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14337171|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
14337172|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14337173|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14337174|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
14730104|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730105|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730106|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14730107|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
14752957|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337175|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14337176|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14337177|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337178|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
14337179|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337180|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14337181|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
14337182|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
14337183|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
14337184|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14337185|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
14337186|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14337187|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14337188|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14337189|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337190|NCT00866788|Omalizumab|omalizumab|mesh-list
14337191|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
14337192|NCT00866788|Promethazine|promethazine|mesh-list
14337193|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14337194|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
14337195|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14337196|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14337197|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
14337198|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14337199|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14337200|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337201|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337202|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
14337203|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
14337204|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
14337205|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337206|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
15227194|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227195|NCT04441073|Lidocaine|lidocaine|mesh-list
15227196|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
15227197|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
15227198|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227199|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227200|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
14337207|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
14337208|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14337209|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
14337210|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337211|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337212|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
14337213|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
14337214|NCT00866879|Sirolimus|sirolimus|mesh-list
14337215|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14337216|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337217|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14337218|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337219|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
14337220|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337221|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
14337222|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337223|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
14337224|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337225|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
14337226|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337227|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337228|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14337229|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
14337230|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337231|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227201|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227202|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15227203|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15227204|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15227205|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15227206|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227207|NCT04409665|Ketamine|ketamine|mesh-list
15227208|NCT04409665|Analgesics|analgesics|mesh-ancestor
15227209|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
15227210|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337232|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14337233|NCT00867009|Pemetrexed|pemetrexed|mesh-list
14337234|NCT00867009|Cetuximab|cetuximab|mesh-list
14337235|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337236|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337237|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337238|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14337239|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337240|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337241|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
14337242|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14337243|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
14337244|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14337245|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337246|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
14337247|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
14337248|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
14337249|NCT00867087|Rituximab|rituximab|mesh-list
14337250|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14337251|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337252|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337253|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
14337254|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337255|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337256|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14337257|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
14337258|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337259|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14337260|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337261|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337262|NCT00867139|Oseltamivir|oseltamivir|mesh-list
14337263|NCT00867139|Ribavirin|ribavirin|mesh-list
14337264|NCT00867139|Zanamivir|zanamivir|mesh-list
14337265|NCT00867139|Amantadine|amantadine|mesh-list
14337266|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
14337267|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
14337268|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337269|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337270|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337271|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
14337272|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14337273|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14337274|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
14337275|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337276|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337277|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14337278|NCT00867139|Analgesics|analgesics|mesh-ancestor
14337279|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
14337280|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337281|NCT00867217|Vitamin D|vitamin d|mesh-list
14337282|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
14337283|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
14337284|NCT00867217|Vitamins|vitamins|mesh-list
14337285|NCT00867217|Letrozole|letrozole|mesh-list
14337286|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
14337287|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337288|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14337289|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14337290|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337291|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14337292|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14337293|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337294|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337295|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14337296|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
14337297|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337298|NCT00867308|Lenalidomide|lenalidomide|mesh-list
14337299|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
14337300|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337301|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14337302|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14337303|NCT00867308|Growth Substances|growth substances|mesh-ancestor
14337304|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
14337305|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337306|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
14337307|NCT00867334|Panitumumab|panitumumab|mesh-list
14337308|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337309|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14337310|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337311|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337312|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337313|NCT00867360|Mifepristone|mifepristone|mesh-list
14337314|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14337315|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
14337316|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14337317|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337318|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14337319|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14337320|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14337321|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
14337322|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14337323|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14337324|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
14337325|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337326|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
14337327|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14337328|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14337329|NCT00867451|Melatonin|melatonin|mesh-list
14337330|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
14337331|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337332|NCT00867451|Protective Agents|protective agents|mesh-ancestor
14337333|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337334|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464671|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464672|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
14464673|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464674|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
14464675|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464676|NCT02214615|Carbamazepine|carbamazepine|mesh-list
14464677|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
14464678|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
14464679|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14464680|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464681|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464682|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464683|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14464684|NCT02214615|Analgesics|analgesics|mesh-ancestor
14464685|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
14464686|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464687|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14464688|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464689|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227211|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227212|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15227213|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15227214|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
15227215|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
15227216|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227217|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15227218|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15227219|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227220|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337335|NCT00867490|Amlodipine|amlodipine|mesh-list
14337336|NCT00867490|Candesartan|candesartan|mesh-list
14337337|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14337338|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14337339|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14337340|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14337341|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337342|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14337343|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337344|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
14337345|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14337346|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14337347|NCT00867490|Diuretics|diuretics|mesh-ancestor
14337348|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
14337349|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14337350|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14337351|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14337352|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
14337353|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337354|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337355|NCT00867529|Rituximab|rituximab|mesh-list
14337356|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337357|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337358|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
14337359|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337360|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337361|NCT00867659|Cetrorelix|cetrorelix|mesh-list
14337362|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14337363|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
14337364|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14337365|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337366|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
14752958|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
15227221|NCT04382937|Ribavirin|ribavirin|mesh-list
15227222|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15227223|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
15227224|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227225|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
15227226|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227227|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
15227228|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15227229|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
15227230|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
15227231|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227232|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337367|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337368|NCT00867789|Trimethoprim|trimethoprim|mesh-list
14337369|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14337370|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
14337371|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14337372|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337373|NCT00867789|Renal Agents|renal agents|mesh-ancestor
14337374|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
14337375|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14337376|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14337377|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14337378|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337379|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337380|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14337381|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14337382|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14337383|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14337384|NCT00867932|Eculizumab|eculizumab|mesh-list
14337385|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14337386|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337387|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
14337388|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337389|NCT00868140|Pioglitazone|pioglitazone|mesh-list
14337390|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14337391|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337392|NCT00868166|Riluzole|riluzole|mesh-list
14337393|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
14337394|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14337395|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14337396|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337397|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337398|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337399|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14337400|NCT00868166|Protective Agents|protective agents|mesh-ancestor
14337401|NCT00868192|Bevacizumab|bevacizumab|mesh-list
14337402|NCT00868192|Pemetrexed|pemetrexed|mesh-list
14337403|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337404|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337405|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14337406|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14337407|NCT00868192|Growth Substances|growth substances|mesh-ancestor
14337408|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337409|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
14337410|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337411|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337412|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14337413|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337414|NCT00868231|Bromides|bromides|mesh-list
14337415|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
14337416|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14337417|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
14337418|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337419|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337420|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14337421|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
14337422|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
14337423|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14337424|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
14337425|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337426|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337427|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
14337428|NCT00868296|Pantoprazole|pantoprazole|mesh-list
14337429|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14337430|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14730108|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730109|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730110|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14730111|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730112|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
14730113|NCT00526175|Hormones|hormones|mesh-ancestor
14730114|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730115|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14730116|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14730117|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
14337431|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14337432|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337433|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337434|NCT00868309|Antivenins|antivenins|mesh-list
14337435|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
14337436|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337437|NCT00868348|Ketorolac|ketorolac|mesh-list
14337438|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14337439|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14337440|NCT00868348|Analgesics|analgesics|mesh-ancestor
14337441|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
14337442|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337443|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337444|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14337445|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337446|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14337447|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337448|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337449|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14337450|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
14337451|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337452|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14337453|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14337454|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337455|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337456|NCT00868452|Valproic Acid|valproic acid|mesh-list
14337457|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
14337458|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14337459|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
14337460|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337461|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337462|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337463|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
14337464|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14337465|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337466|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337467|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
14337468|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
14337469|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337470|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14337471|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14337472|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14337473|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14337474|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
14337475|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14337476|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14337477|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
14337478|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14337479|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14337480|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
14730118|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14337481|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14337482|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337483|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337484|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14337485|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14337486|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14337487|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14337488|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337489|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337490|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337491|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14337492|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14337493|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14337494|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
14337495|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337496|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337497|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14337498|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14337499|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
14337500|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14337501|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14337502|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
14337503|NCT00868790|Metformin|metformin|mesh-list
14337504|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14337505|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337506|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14337507|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14337508|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14337509|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337510|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337511|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337512|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14337513|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14337514|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14337515|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14337516|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337517|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337518|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14337519|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14337520|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
14337521|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14337522|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14337523|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
14337524|NCT00869050|Capecitabine|capecitabine|mesh-list
14337525|NCT00869050|Temozolomide|temozolomide|mesh-list
14337526|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14337527|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
14337528|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337529|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337530|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14337531|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
14337532|NCT00869089|Apremilast|apremilast|mesh-list
14337533|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14337534|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14337535|NCT00869089|Analgesics|analgesics|mesh-ancestor
14337536|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
14337537|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227233|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227234|NCT04351698|Montelukast|montelukast|mesh-list
15227235|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15227236|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
15227237|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15227238|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
15227239|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227240|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227241|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15227242|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14337538|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337539|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14337540|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337541|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14337542|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14337543|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337544|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337545|NCT00869141|Timolol|timolol|mesh-list
14337546|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14337547|NCT00869141|Dorzolamide|dorzolamide|mesh-list
14337548|NCT00869141|Brinzolamide|brinzolamide|mesh-list
14337549|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14337550|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14337551|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
14337552|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337553|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337554|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337555|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14337556|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14337557|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14337558|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14337559|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14337560|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14337561|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337562|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
14337563|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14337564|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337565|NCT00869323|Rituximab|rituximab|mesh-list
14337566|NCT00869323|Bortezomib|bortezomib|mesh-list
14337567|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337568|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337569|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
14337570|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337571|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337572|NCT00869401|Temozolomide|temozolomide|mesh-list
14337573|NCT00869401|Dasatinib|dasatinib|mesh-list
14337574|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14337575|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
14337576|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337577|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337578|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14337579|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337580|NCT00869440|Midazolam|midazolam|mesh-list
14337581|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14337582|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14337583|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337584|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730119|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14730120|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
15227243|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227244|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15227245|NCT04319627|Calcium|calcium|mesh-list
15227246|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15227247|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730121|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
14337585|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14337586|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14337587|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337588|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14337589|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
14337590|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
14337591|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
14337592|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
14337593|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337594|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337595|NCT00869518|Trimethoprim|trimethoprim|mesh-list
14337596|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14337597|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
14337598|NCT00869518|Rifabutin|rifabutin|mesh-list
14337599|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14337600|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337601|NCT00869518|Renal Agents|renal agents|mesh-ancestor
15227248|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15227249|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15227250|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
15227251|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227252|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15227253|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15227254|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227255|NCT04233879|Tenofovir|tenofovir|mesh-list
15227256|NCT04233879|Emtricitabine|emtricitabine|mesh-list
15227257|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14337602|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
14337603|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14337604|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14337605|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14337606|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337607|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337608|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14337609|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14337610|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14337611|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14337612|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15227258|NCT04233879|Islatravir|islatravir|mesh-list
15227259|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
15227260|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227261|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14337613|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
14337614|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14730122|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730123|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730124|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14730125|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14337615|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14337616|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14337617|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337618|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337619|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337620|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
14337621|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337622|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14337623|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14337624|NCT00869622|Vitamin D|vitamin d|mesh-list
14337625|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
14337626|NCT00869622|Calcium|calcium|mesh-list
14337627|NCT00869622|Vitamins|vitamins|mesh-ancestor
14337628|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
14337629|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337630|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14337631|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14337632|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14337633|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14337634|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337635|NCT00869778|Vaccines|vaccines|mesh-list
14337636|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
14337637|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337638|NCT00869791|Levodopa|levodopa|mesh-list
14337639|NCT00869791|Carbidopa|carbidopa|mesh-list
14337640|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14337641|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14337642|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14337643|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
14337644|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337645|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337646|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337647|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14337648|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337649|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14337650|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
14337651|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
14337652|NCT00869960|Ritonavir|ritonavir|mesh-list
14337653|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14337654|NCT00869960|Tenofovir|tenofovir|mesh-list
14337655|NCT00869960|Emtricitabine|emtricitabine|mesh-list
14337656|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14337657|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14337658|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
14337659|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337660|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337661|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14337662|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14337663|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
14337664|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337665|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14337666|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14337667|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14337668|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337669|NCT00869999|Rituximab|rituximab|mesh-list
14337670|NCT00869999|Everolimus|everolimus|mesh-list
14337671|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337672|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337673|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
14337674|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337675|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337676|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337677|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
14337678|NCT00870103|Dexamethasone|dexamethasone|mesh-list
14337679|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14337680|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14337681|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
14337682|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
14337683|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337684|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337685|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14337686|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
14337687|NCT00870103|Hormones|hormones|mesh-ancestor
14337688|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337689|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14337690|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337691|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14337692|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337693|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14337694|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14337695|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337696|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337697|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14337698|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14337699|NCT00870194|Exenatide|exenatide|mesh-list
14337700|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14337701|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337702|NCT00870194|Incretins|incretins|mesh-ancestor
14337703|NCT00870194|Hormones|hormones|mesh-ancestor
14730126|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
14730127|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730128|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
14730129|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
14730130|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337704|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730131|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14337705|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14730132|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730133|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14337706|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
14337707|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337708|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337709|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14337710|NCT00870363|Efavirenz|efavirenz|mesh-list
14337711|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14337712|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
14337713|NCT00870363|Maraviroc|maraviroc|mesh-list
14337714|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337715|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337716|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337717|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
14337718|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337719|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14337720|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14337721|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14337722|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14337723|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14730134|NCT00526214|Celecoxib|celecoxib|mesh-list
14730135|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14730136|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730137|NCT00526214|Analgesics|analgesics|mesh-ancestor
14730138|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
14730139|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730140|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730141|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730142|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730143|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14730144|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14730145|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730146|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752959|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14752960|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
14752961|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14752962|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752963|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
14752964|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14752965|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14752966|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752967|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
14752968|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
14752969|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
14752970|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14752971|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752972|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
14752973|NCT05311176|Paclitaxel|paclitaxel|mesh-list
14752974|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
14752975|NCT05311176|Irinotecan|irinotecan|mesh-list
14752976|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15227262|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15227263|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227264|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227265|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15227266|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14337724|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14337725|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14337726|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14337727|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14337728|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14337729|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14337730|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14337731|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14337732|NCT00870467|Adalimumab|adalimumab|mesh-list
14337733|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14337734|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337735|NCT00870584|Omalizumab|omalizumab|mesh-list
14337736|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14337737|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14337738|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
14337739|NCT00870727|Aripiprazole|aripiprazole|mesh-list
14337740|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
14337741|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337742|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14337743|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14337744|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337745|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337746|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
14337747|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
14337748|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337749|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337750|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14337751|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14337752|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
14337753|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14337754|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14337755|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14337756|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14337757|NCT00870740|Daclizumab|daclizumab|mesh-list
14337758|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337759|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
14337760|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337761|NCT00870870|Gemcitabine|gemcitabine|mesh-list
14337762|NCT00870870|Carboplatin|carboplatin|mesh-list
14337763|NCT00870870|Cetuximab|cetuximab|mesh-list
14337764|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14337765|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337766|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227267|NCT04226833|Entrectinib|entrectinib|mesh-list
15227268|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227269|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227270|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227271|NCT04214860|Azacitidine|azacitidine|mesh-list
15227272|NCT04214860|Venetoclax|venetoclax|mesh-list
14337767|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
14337768|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337769|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
14337770|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337771|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337772|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337773|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
14917977|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730147|NCT00526305|Cytarabine|cytarabine|mesh-list
15227273|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227274|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
14337774|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337775|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337776|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
14337777|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14337778|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
14337779|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337780|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337781|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14337782|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
15227275|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227276|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227277|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227278|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15227279|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14337783|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
14337784|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14337785|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14337786|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337787|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337788|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
14337789|NCT00871000|Antidotes|antidotes|mesh-ancestor
14337790|NCT00871000|Protective Agents|protective agents|mesh-ancestor
14337791|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337792|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
14337793|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
14337794|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337795|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14337796|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
14337797|NCT00871169|Irinotecan|irinotecan|mesh-list
14337798|NCT00871169|Cetuximab|cetuximab|mesh-list
14337799|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337800|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14337801|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14337802|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337803|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337804|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14337805|NCT00871234|Etravirine|etravirine|mesh-list
14337806|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14337807|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337808|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337809|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337810|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
14337811|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337812|NCT00871260|Regadenoson|regadenoson|mesh-list
14337813|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14337814|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14337815|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
14337816|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
14337817|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227280|NCT04205994|Tolcapone|tolcapone|mesh-list
15227281|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15227282|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15227283|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15227284|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227285|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227286|NCT04200313|Pancrelipase|pancrelipase|mesh-list
15227287|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15227288|NCT04197310|Nivolumab|nivolumab|mesh-list
15227289|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227290|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227291|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15227292|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337818|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227293|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
15227294|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337819|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337820|NCT00871338|Vaccines|vaccines|mesh-list
14337821|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14337822|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
14337823|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337824|NCT00871403|Pemetrexed|pemetrexed|mesh-list
14337825|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227295|NCT04176848|Durvalumab|durvalumab|mesh-list
15227296|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227297|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730148|NCT00526305|Dexamethasone|dexamethasone|mesh-list
14730149|NCT00526305|Prednisone|prednisone|mesh-list
14730150|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
14730151|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
14730152|NCT00526305|Vincristine|vincristine|mesh-list
14730153|NCT00526305|Daunorubicin|daunorubicin|mesh-list
14730154|NCT00526305|Asparaginase|asparaginase|mesh-list
14730155|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
14730156|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
14730157|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337826|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337827|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337828|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14337829|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14337830|NCT00871494|Azithromycin|azithromycin|mesh-list
14337831|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14337832|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337833|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
14337834|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14337835|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14337836|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337837|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15227298|NCT04168112|Dexamethasone|dexamethasone|mesh-list
15227299|NCT04168112|Prednisolone|prednisolone|mesh-list
15227300|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15227301|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
15227302|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15227303|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
15227304|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15227305|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
14337838|NCT00871624|Analgesics|analgesics|mesh-ancestor
14337839|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
14337840|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337841|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14337842|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14337843|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14337844|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
14337845|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337846|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337847|NCT00871689|Vidarabine|vidarabine|mesh-list
14337848|NCT00871689|Aldesleukin|aldesleukin|mesh-list
14337849|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
14337850|NCT00871689|Fludarabine|fludarabine|mesh-list
14337851|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
14337852|NCT00871689|Interleukin-2|interleukin-2|mesh-list
14337853|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14337854|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
14337855|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337856|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337857|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14730158|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
14730159|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14917978|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730160|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15227306|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15227307|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
14337858|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
14337859|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337860|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337861|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14337862|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14337863|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
14337864|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
14337865|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337866|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14337867|NCT00871689|Analgesics|analgesics|mesh-ancestor
14337868|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
14337869|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337870|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14337871|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14337872|NCT00871728|Itraconazole|itraconazole|mesh-list
14337873|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
14337874|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14337875|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14337876|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14917979|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14917980|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
14917981|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14917982|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14917983|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15227308|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
14337877|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337878|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337879|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14337880|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
14337881|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337882|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337883|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14337884|NCT00871780|Natalizumab|natalizumab|mesh-list
14337885|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
14337886|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337887|NCT00871858|Fulvestrant|fulvestrant|mesh-list
14337888|NCT00871858|Anastrozole|anastrozole|mesh-list
14337889|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14337890|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337891|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14337892|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14337893|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
14337894|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14337895|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337896|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14337897|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14337898|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337899|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337900|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15227309|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227310|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227311|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15227312|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
15227313|NCT04168112|Hormones|hormones|mesh-ancestor
15227314|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227315|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15227316|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227317|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15227318|NCT04168112|Protective Agents|protective agents|mesh-ancestor
15227319|NCT04165122|Valacyclovir|valacyclovir|mesh-list
14337901|NCT00871871|Isosorbide|isosorbide|mesh-list
14337902|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14337903|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14337904|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14337905|NCT00871871|Diuretics|diuretics|mesh-ancestor
14337906|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
14337907|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337908|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14337909|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14337910|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227320|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
15227321|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730161|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15227322|NCT04103554|Valsartan|valsartan|mesh-list
15227323|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15227324|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15227325|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15227326|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15227327|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227328|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
15227329|NCT04088890|Fludarabine|fludarabine|mesh-list
15227330|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227331|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
15227332|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227333|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15227334|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15227335|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
14337911|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14337912|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
14337913|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14337914|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14337915|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337916|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14337917|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337918|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337919|NCT00872027|Citalopram|citalopram|mesh-list
14337920|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14337921|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14337922|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14337923|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337924|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337925|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
14337926|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337927|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14337928|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
14337929|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14337930|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
14337931|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
15227336|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227337|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227338|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14337932|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14337933|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14337934|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464690|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14464691|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14464692|NCT02214628|Bevacizumab|bevacizumab|mesh-list
14464693|NCT02214628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464694|NCT02214628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464695|NCT02214628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14464696|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14464697|NCT02214628|Growth Substances|growth substances|mesh-ancestor
14464698|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464699|NCT02214628|Growth Inhibitors|growth inhibitors|mesh-ancestor
14464700|NCT02215070|Pasireotide|pasireotide|mesh-list
14464701|NCT02215070|Hormones|hormones|mesh-ancestor
14464702|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14464703|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464704|NCT02215200|Sargramostim|sargramostim|mesh-list
14464705|NCT02215200|Lenograstim|lenograstim|mesh-list
14464706|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
14337935|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337936|NCT00872170|Urological Agents|urological agents|mesh-ancestor
14337937|NCT00872534|Aspirin|aspirin|mesh-list
14337938|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14337939|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14337940|NCT00872534|Analgesics|analgesics|mesh-ancestor
14337941|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
14337942|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14337943|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14337944|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14337945|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14337946|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14337947|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14337948|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337949|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14337950|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14337951|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14337952|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
14337953|NCT00872599|Fenofibrate|fenofibrate|mesh-list
14337954|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14337955|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
14337956|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337957|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14337958|NCT00872729|Cysteamine|cysteamine|mesh-list
14337959|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14337960|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337961|NCT00872898|Memantine|memantine|mesh-list
14337962|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14337963|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14337964|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
14337965|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14337966|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337967|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227339|NCT04080843|Capecitabine|capecitabine|mesh-list
15227340|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
15227341|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227342|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
15227343|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227344|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227345|NCT04073147|Venetoclax|venetoclax|mesh-list
15227346|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
15227347|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227348|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227349|NCT04054375|Prednisone|prednisone|mesh-list
14337968|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14337969|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14337970|NCT00872989|Docetaxel|docetaxel|mesh-list
14337971|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14337972|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
14337973|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
14337974|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
15227350|NCT04054375|Prednisolone|prednisolone|mesh-list
15227351|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15227352|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
15227353|NCT04054375|Hormones|hormones|mesh-ancestor
14730162|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
14730163|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730164|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730165|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14730166|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730167|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
14730168|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
14730169|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730170|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14730171|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
14730172|NCT00526305|Hormones|hormones|mesh-ancestor
14730173|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730174|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14730175|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14337975|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337976|NCT00873041|Deferasirox|deferasirox|mesh-list
14337977|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14337978|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
14337979|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
14337980|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14337981|NCT00873093|Leucovorin|leucovorin|mesh-list
14337982|NCT00873093|Cytarabine|cytarabine|mesh-list
14337983|NCT00873093|Prednisone|prednisone|mesh-list
14337984|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
14337985|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14337986|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14337987|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14337988|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
14337989|NCT00873093|Doxorubicin|doxorubicin|mesh-list
14337990|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14337991|NCT00873093|Methotrexate|methotrexate|mesh-list
14337992|NCT00873093|Etoposide|etoposide|mesh-list
14337993|NCT00873093|Vincristine|vincristine|mesh-list
14337994|NCT00873093|Bortezomib|bortezomib|mesh-list
14337995|NCT00873093|Asparaginase|asparaginase|mesh-list
14337996|NCT00873093|Pegaspargase|pegaspargase|mesh-list
14337997|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
14337998|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
14337999|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338000|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
14338001|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338002|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14338003|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14338004|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
14338005|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338006|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338007|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15227354|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227355|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227356|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15227357|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227358|NCT04052139|Naltrexone|naltrexone|mesh-list
15227359|NCT04052139|Gabapentin|gabapentin|mesh-list
15227360|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15227361|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14730176|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
14730177|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730178|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
14730179|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14730180|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
14730181|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
15227362|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227363|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
15227364|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227365|NCT04052139|Analgesics|analgesics|mesh-ancestor
15227366|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
15227367|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15227368|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15227369|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338008|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338009|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15227370|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15227371|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15227372|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15227373|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227374|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227375|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
15227376|NCT04032301|Ketamine|ketamine|mesh-list
15227377|NCT04032301|Analgesics|analgesics|mesh-ancestor
15227378|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
15227379|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227380|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227381|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14338010|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338011|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338012|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338013|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
14338014|NCT00873093|Hormones|hormones|mesh-ancestor
14338015|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227382|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15227383|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
14338016|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14338017|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14338018|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
14338019|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14338020|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227384|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
14730182|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730183|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15227385|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227386|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15227387|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15227388|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227389|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338021|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
14730184|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15227390|NCT03998319|Tenecteplase|tenecteplase|mesh-list
14338022|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
14338023|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14338024|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14338025|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338026|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
14338027|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338028|NCT00873093|Antidotes|antidotes|mesh-ancestor
14338029|NCT00873093|Protective Agents|protective agents|mesh-ancestor
14338030|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
14338031|NCT00873093|Vitamins|vitamins|mesh-ancestor
14338032|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
14338033|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338034|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338035|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338036|NCT00873119|Paclitaxel|paclitaxel|mesh-list
14338037|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14338038|NCT00873119|Carboplatin|carboplatin|mesh-list
14730185|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730186|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730187|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14917984|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14917985|NCT03524170|Atezolizumab|atezolizumab|mesh-list
14917986|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14917987|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
14917988|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14917989|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14917990|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
15227391|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15227392|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15227393|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227394|NCT03984214|Dronabinol|dronabinol|mesh-list
15227395|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
15227396|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227397|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15227398|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14338039|NCT00873119|Belinostat|belinostat|mesh-list
14730188|NCT00526305|Analgesics|analgesics|mesh-ancestor
14730189|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
14730190|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
14730191|NCT00526318|Melphalan|melphalan|mesh-list
14730192|NCT00526318|Ifosfamide|ifosfamide|mesh-list
14917991|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227399|NCT03984214|Analgesics|analgesics|mesh-ancestor
14338040|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14730193|NCT00526318|Dacarbazine|dacarbazine|mesh-list
14730194|NCT00526318|Carboplatin|carboplatin|mesh-list
14917992|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
14730195|NCT00526318|Doxorubicin|doxorubicin|mesh-list
14730196|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14730197|NCT00526318|Etoposide|etoposide|mesh-list
14338041|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338042|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338043|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338044|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338045|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338046|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14338047|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464707|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14464708|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
14464709|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464710|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14464711|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14464712|NCT02215252|Pregabalin|pregabalin|mesh-list
14464713|NCT02215252|Analgesics|analgesics|mesh-ancestor
14464714|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
14464715|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464716|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464717|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
14464718|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14464719|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464720|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464721|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14464722|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14464723|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14464724|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464725|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464726|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
14464727|NCT02215967|Fludarabine|fludarabine|mesh-list
14464728|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14464729|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
14464730|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464731|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464732|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14464733|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
14464734|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464735|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464736|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14464737|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
14464738|NCT02216071|Dexamethasone|dexamethasone|mesh-list
14464739|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
14464740|NCT02216071|BB 1101|bb 1101|mesh-list
14464741|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14464742|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
14464743|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
14464744|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464745|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464746|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464747|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
14464748|NCT02216071|Hormones|hormones|mesh-ancestor
14730198|NCT00526318|Vincristine|vincristine|mesh-list
14730199|NCT00526318|Topotecan|topotecan|mesh-list
14730200|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
14730201|NCT00526318|Vindesine|vindesine|mesh-list
14730202|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14730203|NCT00526318|Isotretinoin|isotretinoin|mesh-list
14730204|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730205|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
14730206|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227400|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
15227401|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227402|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15227403|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15227404|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227405|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227406|NCT03984214|Hormones|hormones|mesh-ancestor
15227407|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227408|NCT03976323|Cisplatin|cisplatin|mesh-list
15227409|NCT03976323|Carboplatin|carboplatin|mesh-list
15227410|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
15227411|NCT03976323|Pemetrexed|pemetrexed|mesh-list
15227412|NCT03976323|Olaparib|olaparib|mesh-list
15227413|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227414|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227415|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227416|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338048|NCT00873327|Tazobactam|tazobactam|mesh-list
14338049|NCT00873327|Piperacillin|piperacillin|mesh-list
14338050|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14338051|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730207|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730208|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14730209|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
14338052|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338053|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14338054|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338055|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338056|NCT00873730|Etanercept|etanercept|mesh-list
14338057|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14338058|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14338059|NCT00873730|Analgesics|analgesics|mesh-ancestor
14338060|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
14338061|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338062|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338063|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338064|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14338065|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14338066|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338067|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
14338068|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14338069|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
14338070|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338071|NCT00874120|Phenylephrine|phenylephrine|mesh-list
14338072|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
14338073|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14338074|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
14338075|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
14338076|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338077|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338078|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
14338079|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14338080|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
14338081|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
14338082|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14338083|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14338084|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14338085|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
14338086|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338087|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338088|NCT00874120|Protective Agents|protective agents|mesh-ancestor
14338089|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
14338090|NCT00874237|Loxapine|loxapine|mesh-list
14338091|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14338092|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730210|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227417|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14338093|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338094|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338095|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338096|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338097|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338098|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338099|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14338100|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338101|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338102|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338103|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14338104|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
14338105|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338106|NCT00874432|Lisinopril|lisinopril|mesh-list
14338107|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14338108|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14338109|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
14338110|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338111|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14338112|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14338113|NCT00874432|Protective Agents|protective agents|mesh-ancestor
14338114|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338115|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14338116|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338117|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338118|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338119|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14338120|NCT00874731|Sirolimus|sirolimus|mesh-list
14338121|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14338122|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338123|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338124|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338125|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
14338126|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338127|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
14338128|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338129|NCT00874770|Ribavirin|ribavirin|mesh-list
14338130|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14338131|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
14338132|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338133|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
14338134|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338135|NCT00874848|Paclitaxel|paclitaxel|mesh-list
14338136|NCT00874848|Carboplatin|carboplatin|mesh-list
14338137|NCT00874848|Cetuximab|cetuximab|mesh-list
14338138|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14338139|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338140|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338141|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338142|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338143|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338144|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338145|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338146|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
14338147|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
14338148|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14338149|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14338150|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14338151|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227418|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15227419|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15227420|NCT03965130|Glucagon|glucagon|mesh-list
15227421|NCT03965130|Hormones|hormones|mesh-ancestor
15227422|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227423|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227424|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15227425|NCT03958383|Nivolumab|nivolumab|mesh-list
15227426|NCT03958383|Ipilimumab|ipilimumab|mesh-list
14338152|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338153|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338154|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338155|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338156|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338157|NCT00875017|Sevelamer|sevelamer|mesh-list
14338158|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
14730211|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730212|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14730213|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15227427|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14730214|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730215|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730216|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730217|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14730218|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14730219|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730220|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14730221|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14730222|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
14730223|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14730224|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
14730225|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14730226|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15227428|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227429|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15227430|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227431|NCT03953079|Sunitinib|sunitinib|mesh-list
15227432|NCT03953079|Aflibercept|aflibercept|mesh-list
15227433|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338159|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
14338160|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338161|NCT00875056|Vorinostat|vorinostat|mesh-list
14338162|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338163|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14338164|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338165|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338166|NCT00875212|Calcium|calcium|mesh-list
14338167|NCT00875212|Fluorides|fluorides|mesh-list
14338168|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
14338169|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14338170|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338171|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
15227434|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15227435|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15227436|NCT03953079|Growth Substances|growth substances|mesh-ancestor
15227437|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227438|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
15227439|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227440|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227441|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227442|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
15227443|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15227444|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15227445|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15227446|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15227447|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227448|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
15227449|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227450|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227451|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15227452|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227453|NCT03944577|Evolocumab|evolocumab|mesh-list
15227454|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15227455|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15227456|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
15227457|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227458|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15227459|NCT03931291|Azacitidine|azacitidine|mesh-list
15227460|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227461|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
15227462|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227463|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227464|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227465|NCT03922750|Insulin|insulin|mesh-list
15227466|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15227467|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
15227468|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15227469|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227470|NCT03910673|Fosfomycin|fosfomycin|mesh-list
15227471|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15227472|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338172|NCT00875212|Protective Agents|protective agents|mesh-ancestor
15227473|NCT03882970|Tirzepatide|tirzepatide|mesh-list
15227474|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15227475|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227476|NCT03882970|Incretins|incretins|mesh-ancestor
15227477|NCT03882970|Hormones|hormones|mesh-ancestor
15227478|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227479|NCT03867734|Aztreonam|aztreonam|mesh-list
15227480|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14338173|NCT00875277|Betamethasone|betamethasone|mesh-list
14338174|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
14338175|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14338176|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
14338177|NCT00875277|Calcipotriene|calcipotriene|mesh-list
14338178|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14338179|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338180|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
14338181|NCT00875277|Hormones|hormones|mesh-ancestor
14338182|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338183|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338184|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14338185|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
14338186|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
14338187|NCT00875433|Afatinib|afatinib|mesh-list
14338188|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338189|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14338190|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338191|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338192|NCT00875550|Fentanyl|fentanyl|mesh-list
14338193|NCT00875550|Midazolam|midazolam|mesh-list
14338194|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
14338195|NCT00875550|Morphine|morphine|mesh-list
14338196|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14338197|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338198|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338199|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14338200|NCT00875550|Analgesics|analgesics|mesh-ancestor
14338201|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
14338202|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338203|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14338204|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14338205|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14338206|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
14338207|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338208|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338209|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14338210|NCT00875550|Narcotics|narcotics|mesh-ancestor
14338211|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14338212|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14338213|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
14338214|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
14338215|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14338216|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338217|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338218|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
14338219|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
14338220|NCT00875615|Carboplatin|carboplatin|mesh-list
14338221|NCT00875615|Sorafenib|sorafenib|mesh-list
14338222|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338223|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14730227|NCT00526396|Cisplatin|cisplatin|mesh-list
15227481|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730228|NCT00526396|Etoposide|etoposide|mesh-list
15227482|NCT03854903|Fulvestrant|fulvestrant|mesh-list
15227483|NCT03854903|Palbociclib|palbociclib|mesh-list
14338224|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338225|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338226|NCT00875667|Fludarabine|fludarabine|mesh-list
14338227|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
14338228|NCT00875667|Lenalidomide|lenalidomide|mesh-list
14338229|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338230|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14338231|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
14338232|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338233|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338234|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
14338235|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338236|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14338237|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14338238|NCT00875667|Growth Substances|growth substances|mesh-ancestor
14338239|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
14338240|NCT00875836|Buspirone|buspirone|mesh-list
14338241|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14338242|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338243|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338244|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338245|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338246|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14338247|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
14338248|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338249|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338250|NCT00875979|Trastuzumab|trastuzumab|mesh-list
14338251|NCT00875979|Pertuzumab|pertuzumab|mesh-list
14338252|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14338253|NCT00875979|Maytansine|maytansine|mesh-list
14338254|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338255|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338256|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338257|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338258|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338259|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338260|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338261|NCT00876187|Naproxen|naproxen|mesh-list
14338262|NCT00876187|Tanezumab|tanezumab|mesh-list
14338263|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14338264|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14338265|NCT00876187|Analgesics|analgesics|mesh-ancestor
14338266|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
14338267|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338268|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338269|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338270|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14338271|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
14338272|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14338273|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730229|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
14730230|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730231|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14730232|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730233|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730234|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730235|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338274|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338275|NCT00876200|Minoxidil|minoxidil|mesh-list
14338276|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14338277|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
14338278|NCT00876343|Aripiprazole|aripiprazole|mesh-list
14338279|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
14338280|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338281|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14338282|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338283|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730236|NCT00526409|Cytarabine|cytarabine|mesh-list
14338284|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338285|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
14338286|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
14338287|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338288|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730237|NCT00526409|Prednisolone|prednisolone|mesh-list
15227484|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15227485|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227486|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15227487|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14338289|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14338290|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14338291|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
14338292|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14338293|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14338294|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14338295|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14338296|NCT00876395|Paclitaxel|paclitaxel|mesh-list
14338297|NCT00876395|Trastuzumab|trastuzumab|mesh-list
14338298|NCT00876395|Everolimus|everolimus|mesh-list
14338299|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338300|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338301|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338302|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338303|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338304|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338305|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338306|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338307|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
15227488|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
14338308|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227489|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227490|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227491|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227492|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227493|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227494|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
15227495|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15227496|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227497|NCT03829410|Bevacizumab|bevacizumab|mesh-list
15227498|NCT03829410|Onvansertib|onvansertib|mesh-list
15227499|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227500|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227501|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15227502|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15227503|NCT03829410|Growth Substances|growth substances|mesh-ancestor
15227504|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227505|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
15227506|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227507|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227508|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227509|NCT03818802|Niacinamide|niacinamide|mesh-list
15227510|NCT03818802|Niacin|niacin|mesh-list
15227511|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
15227512|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
15227513|NCT03818802|Vitamins|vitamins|mesh-ancestor
15227514|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
15227515|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338309|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
14338310|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14338311|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14338312|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14338313|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14338314|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338315|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
14338316|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338317|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338318|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14338319|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338320|NCT00876460|Docetaxel|docetaxel|mesh-list
14338321|NCT00876460|Nintedanib|nintedanib|mesh-list
14338322|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338323|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338324|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338325|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338326|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338327|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14338328|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227516|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15227517|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
14338329|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14338330|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14338331|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
14338332|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338333|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227518|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227519|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15227520|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
15227521|NCT03810313|Aflibercept|aflibercept|mesh-list
15227522|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15227523|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15227524|NCT03810313|Growth Substances|growth substances|mesh-ancestor
15227525|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227526|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
15227527|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227528|NCT03806335|Anesthetics|anesthetics|mesh-list
15227529|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227530|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227531|NCT03802630|Aflibercept|aflibercept|mesh-list
15227532|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15227533|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14338334|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15227534|NCT03802630|Growth Substances|growth substances|mesh-ancestor
15227535|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227536|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
15227537|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338335|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
14338336|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14338337|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14338338|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14338339|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
14338340|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338341|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338342|NCT00876915|Dalteparin|dalteparin|mesh-list
14338343|NCT00876915|Tinzaparin|tinzaparin|mesh-list
14338344|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14338345|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
14338346|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14338347|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14338348|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338349|NCT00876928|Vitamin D|vitamin d|mesh-list
14338350|NCT00876928|Vitamins|vitamins|mesh-ancestor
14338351|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
14338352|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338353|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14338354|NCT00876993|Bevacizumab|bevacizumab|mesh-list
14338355|NCT00876993|Irinotecan|irinotecan|mesh-list
14338356|NCT00876993|Temozolomide|temozolomide|mesh-list
14338357|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338358|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338359|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14338360|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14338361|NCT00876993|Growth Substances|growth substances|mesh-ancestor
14338362|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338363|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
14338364|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14338365|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338366|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338367|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338368|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14338369|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
14338370|NCT00877006|Prednisone|prednisone|mesh-list
14338371|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
14338372|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14338373|NCT00877006|Rituximab|rituximab|mesh-list
14338374|NCT00877006|Doxorubicin|doxorubicin|mesh-list
14338375|NCT00877006|Vincristine|vincristine|mesh-list
14338376|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338377|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
14338378|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338379|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14917993|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15227538|NCT03796156|Aspirin|aspirin|mesh-list
15227539|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15227540|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15227541|NCT03796156|Analgesics|analgesics|mesh-ancestor
15227542|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
15227543|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227544|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227545|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15227546|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15227547|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15227548|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15227549|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227550|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15227551|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15227552|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227553|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
15227554|NCT03794427|Anesthetics|anesthetics|mesh-list
15227555|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227556|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730238|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
14730239|NCT00526409|Methotrexate|methotrexate|mesh-list
14730240|NCT00526409|Vincristine|vincristine|mesh-list
14730241|NCT00526409|Daunorubicin|daunorubicin|mesh-list
14730242|NCT00526409|Asparaginase|asparaginase|mesh-list
14730243|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730244|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
14730245|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730246|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730247|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14730248|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
14730249|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730250|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730251|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14730252|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14730253|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
14730254|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14730255|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14338380|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14338381|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
14338382|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338383|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338384|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14338385|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338386|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338387|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338388|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338389|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338390|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338391|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
14338392|NCT00877006|Hormones|hormones|mesh-ancestor
14338393|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338394|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14338395|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338396|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338397|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338398|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
14917994|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14917995|NCT03481556|Dexamethasone|dexamethasone|mesh-list
14917996|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
14917997|NCT03481556|Bortezomib|bortezomib|mesh-list
14917998|NCT03481556|Melphalan|melphalan|mesh-list
14917999|NCT03481556|Daratumumab|daratumumab|mesh-list
14918000|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918001|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
14918002|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
15227557|NCT03770676|Selenium|selenium|mesh-list
14338399|NCT00877370|Ertapenem|ertapenem|mesh-list
14338400|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730256|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
14730257|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14730258|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730259|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730260|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14730261|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14730262|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
15227558|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
15227559|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227560|NCT03770676|Protective Agents|protective agents|mesh-ancestor
15227561|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227562|NCT03770676|Trace Elements|trace elements|mesh-ancestor
15227563|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
15227564|NCT03770455|Avelumab|avelumab|mesh-list
15227565|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14730263|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
14918003|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918004|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730264|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
14730265|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730266|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
14730267|NCT00526409|Hormones|hormones|mesh-ancestor
14730268|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730269|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14730270|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
14730271|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730272|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338401|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338402|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
14338403|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14338404|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
14338405|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338406|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338407|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14338408|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
14338409|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
14338410|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14338411|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
14338412|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338413|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338414|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14338415|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14338416|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338417|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14338418|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14338419|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14338420|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338421|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
14338422|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338423|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14338424|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14338425|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14338426|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
14338427|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338428|NCT00877773|Sirolimus|sirolimus|mesh-list
14338429|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14338430|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338431|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338432|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338433|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
14338434|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338435|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
14338436|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338437|NCT00877890|Exenatide|exenatide|mesh-list
14338438|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14338439|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338440|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14338441|NCT00877890|Incretins|incretins|mesh-ancestor
14338442|NCT00877890|Hormones|hormones|mesh-ancestor
14338443|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338444|NCT00877929|Amlodipine|amlodipine|mesh-list
14338445|NCT00877929|Telmisartan|telmisartan|mesh-list
14338446|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14338447|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14338448|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14338449|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338450|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14338451|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338452|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
14338453|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14338454|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14730273|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338455|NCT00878072|Famciclovir|famciclovir|mesh-list
14338456|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
14338457|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338458|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14338459|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338460|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338461|NCT00878215|Liver Extracts|liver extracts|mesh-list
14338462|NCT00878215|Hematinics|hematinics|mesh-ancestor
14338463|NCT00878228|Ondansetron|ondansetron|mesh-list
14338464|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
14338465|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
14338466|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338467|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338468|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14338469|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
14338470|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
14338471|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14338472|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
14338473|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338474|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338475|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14338476|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338477|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338478|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338479|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14338480|NCT00878436|Bicalutamide|bicalutamide|mesh-list
14338481|NCT00878436|Panobinostat|panobinostat|mesh-list
15227566|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227567|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
15227568|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15227569|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227570|NCT03760458|Lamivudine|lamivudine|mesh-list
14338482|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
14338483|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
14338484|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338485|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338486|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338487|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14338488|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338489|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338490|NCT00878553|Zaleplon|zaleplon|mesh-list
14338491|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
14338492|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15227571|NCT03760458|Abacavir|abacavir|mesh-list
15227572|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
15227573|NCT03760458|Dolutegravir|dolutegravir|mesh-list
15227574|NCT03760458|Triumeq|triumeq|mesh-list
15227575|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15227576|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15227577|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338493|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338494|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338495|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
14338496|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
14338497|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338498|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338499|NCT00878722|Idarubicin|idarubicin|mesh-list
14338500|NCT00878722|Belinostat|belinostat|mesh-list
14338501|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338502|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338503|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338504|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338505|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338506|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338507|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14338508|NCT00878800|Doxorubicin|doxorubicin|mesh-list
14338509|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14338510|NCT00878800|Belinostat|belinostat|mesh-list
14338511|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338512|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338513|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338514|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338515|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338516|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338517|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14338518|NCT00878826|Enoxaparin|enoxaparin|mesh-list
14338519|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
14338520|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14338521|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14338522|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338523|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
14338524|NCT00878995|Testosterone|testosterone|mesh-list
14338525|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
14338526|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
14338527|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14338528|NCT00878995|Androgens|androgens|mesh-ancestor
14338529|NCT00878995|Hormones|hormones|mesh-ancestor
14338530|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338531|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338532|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14338533|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338534|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
14338535|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
14338536|NCT00879034|Pravastatin|pravastatin|mesh-list
14338537|NCT00879034|Lonafarnib|lonafarnib|mesh-list
14338538|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14338539|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338540|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14338541|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14338542|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
14338543|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338544|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14730274|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730275|NCT00526448|Ribavirin|ribavirin|mesh-list
14730276|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14730277|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
14730278|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730279|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
14730280|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730281|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
14730282|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14730283|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227578|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227579|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
15227580|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227581|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14338545|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14338546|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338547|NCT00879060|Spironolactone|spironolactone|mesh-list
14338548|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14338549|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
14338550|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338551|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338552|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14338553|NCT00879060|Diuretics|diuretics|mesh-ancestor
14338554|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
14338555|NCT00879190|Gentamicins|gentamicins|mesh-list
14338556|NCT00879190|Ampicillin|ampicillin|mesh-list
14338557|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14338558|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338559|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15227582|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15227583|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
15227584|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15227585|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14338560|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338561|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338562|NCT00879229|Ambrisentan|ambrisentan|mesh-list
14338563|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14338564|NCT00879333|Everolimus|everolimus|mesh-list
14338565|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227586|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14338566|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338567|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
14338568|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338569|NCT00879359|Paclitaxel|paclitaxel|mesh-list
14338570|NCT00879359|Bevacizumab|bevacizumab|mesh-list
14338571|NCT00879359|Carboplatin|carboplatin|mesh-list
14338572|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338573|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338574|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338575|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338576|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338577|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730284|NCT00526617|Temozolomide|temozolomide|mesh-list
14730285|NCT00526617|Veliparib|veliparib|mesh-list
14338578|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338579|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14338580|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14338581|NCT00879359|Growth Substances|growth substances|mesh-ancestor
14730286|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14730287|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
14730288|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730289|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730290|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14338582|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338583|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
14338584|NCT00879398|Fesoterodine|fesoterodine|mesh-list
14338585|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14338586|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14338587|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
14338588|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338589|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338590|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338591|NCT00879398|Urological Agents|urological agents|mesh-ancestor
14338592|NCT00879411|Telmisartan|telmisartan|mesh-list
14338593|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14338594|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14338595|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14338596|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338597|NCT00879437|Bevacizumab|bevacizumab|mesh-list
14338598|NCT00879437|Valproic Acid|valproic acid|mesh-list
14338599|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338600|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338601|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14338602|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14918005|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918006|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
14918007|NCT03481556|Hormones|hormones|mesh-ancestor
14918008|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918009|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918010|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918011|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14338603|NCT00879437|Growth Substances|growth substances|mesh-ancestor
14338604|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338605|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
14338606|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
14338607|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338608|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338609|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
14338610|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338611|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
14338612|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338613|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338614|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338615|NCT00879658|Siponimod|siponimod|mesh-list
14338616|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14338617|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338618|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338619|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
14338620|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730291|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730292|NCT00526643|Gemcitabine|gemcitabine|mesh-list
14730293|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730294|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14730295|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
14918012|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
15227587|NCT03739996|Cabotegravir|cabotegravir|mesh-list
15227588|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15227589|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227590|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227591|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
15227592|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227593|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15227594|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14338621|NCT00879710|Simvastatin|simvastatin|mesh-list
14338622|NCT00879710|Ezetimibe|ezetimibe|mesh-list
14338623|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14338624|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14338625|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
14338626|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338627|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14338628|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14338629|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338630|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
14338631|NCT00879775|Caffeine|caffeine|mesh-list
14338632|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14338633|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338634|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14338635|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338636|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338637|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14730296|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730297|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
14730298|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730299|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730300|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730301|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
14730302|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730303|NCT00526695|Sevoflurane|sevoflurane|mesh-list
14730304|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14730305|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14730306|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
14338638|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14338639|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
14338640|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338641|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
14338642|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464749|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14464750|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14464751|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464752|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
14464753|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464754|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464755|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464756|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464757|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730307|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
14730308|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730309|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730310|NCT00526734|Melphalan|melphalan|mesh-list
14730311|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
14730312|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730313|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14918013|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918014|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14918015|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918016|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
14918017|NCT03462342|Olaparib|olaparib|mesh-list
14918018|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14918019|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918020|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918021|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918022|NCT03412747|Adalimumab|adalimumab|mesh-list
14918023|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918024|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918025|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
14918026|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14918027|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918028|NCT03308578|Atorvastatin|atorvastatin|mesh-list
14918029|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14918030|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14918031|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
14730314|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
14730315|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730316|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227595|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15227596|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15227597|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
15227598|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
15227599|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918032|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338643|NCT00879814|Vaccines|vaccines|mesh-list
14338644|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
14338645|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338646|NCT00879879|Losartan|losartan|mesh-list
14338647|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14338648|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14338649|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14338650|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14338651|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338652|NCT00879970|Vitamin D|vitamin d|mesh-list
14338653|NCT00879970|Pioglitazone|pioglitazone|mesh-list
14338654|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
14338655|NCT00879970|Vitamins|vitamins|mesh-ancestor
14338656|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
14338657|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338658|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14338659|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14338660|NCT00879996|Buprenorphine|buprenorphine|mesh-list
14338661|NCT00879996|Methadone|methadone|mesh-list
14338662|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14338663|NCT00879996|Naloxone|naloxone|mesh-list
14338664|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14338665|NCT00879996|Narcotics|narcotics|mesh-ancestor
14338666|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338667|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338668|NCT00879996|Analgesics|analgesics|mesh-ancestor
14338669|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
14918033|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14918034|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14918035|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918036|NCT03283813|Inositol|inositol|mesh-list
14918037|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
14918038|NCT03283813|Vitamins|vitamins|mesh-ancestor
15227600|NCT03689712|Protective Agents|protective agents|mesh-ancestor
15227601|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227602|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
15227603|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
15227604|NCT03631446|Citric Acid|citric acid|mesh-list
14338670|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227605|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
14338671|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14338672|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
15227606|NCT03631446|Cathartics|cathartics|mesh-ancestor
15227607|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15227608|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
15227609|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15227610|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
14730317|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15227611|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
14730318|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730319|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
14338673|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
14338674|NCT00880009|Letrozole|letrozole|mesh-list
14338675|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338676|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14338677|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14338678|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338679|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338680|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14338681|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
14338682|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338683|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338684|NCT00880100|Pancrelipase|pancrelipase|mesh-list
14338685|NCT00880100|Pancreatin|pancreatin|mesh-list
14338686|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14338687|NCT00880191|Dexamethasone|dexamethasone|mesh-list
14338688|NCT00880191|Gabapentin|gabapentin|mesh-list
14338689|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338690|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
14338691|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
14338692|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338693|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338694|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14338695|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
15227612|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227613|NCT03631446|Antacids|antacids|mesh-ancestor
15227614|NCT03630640|Nivolumab|nivolumab|mesh-list
15227615|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227616|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227617|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15227618|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227619|NCT03625388|Dasatinib|dasatinib|mesh-list
14338696|NCT00880191|Hormones|hormones|mesh-ancestor
14338697|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338698|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14338699|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338700|NCT00880191|Analgesics|analgesics|mesh-ancestor
14338701|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
14338702|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
14338703|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14338704|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338705|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338706|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338707|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14338708|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14338709|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338710|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338711|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
14338712|NCT00880269|Panobinostat|panobinostat|mesh-list
14338713|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338714|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14338715|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338716|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338717|NCT00880334|Docetaxel|docetaxel|mesh-list
14338718|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338719|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338720|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338721|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338722|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338723|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
14338724|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338725|NCT00880607|Morphine|morphine|mesh-list
14338726|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14338727|NCT00880607|Narcotics|narcotics|mesh-ancestor
14338728|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338729|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338730|NCT00880607|Analgesics|analgesics|mesh-ancestor
14338731|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
14338732|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338733|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14338734|NCT00880620|Carbidopa|carbidopa|mesh-list
14338735|NCT00880620|Levodopa|levodopa|mesh-list
14338736|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14338737|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
14338738|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338739|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14338740|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14338741|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
14338742|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
14338743|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338744|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338745|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14338746|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338747|NCT00880685|Memantine|memantine|mesh-list
14338748|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14338749|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14730320|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14730321|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338750|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
14338751|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338752|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338753|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338754|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14338755|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14338756|NCT00880763|Interferons|interferons|mesh-list
14338757|NCT00880763|Ribavirin|ribavirin|mesh-list
14338758|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338759|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
14338760|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338761|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
14338762|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338763|NCT00880906|Fluticasone|fluticasone|mesh-list
14338764|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14338765|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338766|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14730322|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730323|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730324|NCT00526760|Analgesics|analgesics|mesh-ancestor
14730325|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
14730326|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730327|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14730328|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14730329|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14730330|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
14730331|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730332|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730333|NCT00526877|Risperidone|risperidone|mesh-list
14730334|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14730335|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
14730336|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730337|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730338|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730339|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15227620|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227621|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227622|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227623|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227624|NCT03577704|Gemcitabine|gemcitabine|mesh-list
15227625|NCT03577704|Paclitaxel|paclitaxel|mesh-list
14730340|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14730341|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730342|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14730343|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14730344|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
14730345|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
14730346|NCT00526929|Hematinics|hematinics|mesh-ancestor
14730347|NCT00527020|Nicotine|nicotine|mesh-list
14730348|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14730349|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
14338767|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
14338768|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338769|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338770|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14338771|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
14338772|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14338773|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14338774|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338775|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338776|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14338777|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14338778|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338779|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14338780|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338781|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338782|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338783|NCT00880997|Doxazosin|doxazosin|mesh-list
14338784|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14338785|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14338786|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14338787|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14338788|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
14338789|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338790|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730350|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730351|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730352|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14730353|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14730354|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
14338791|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338792|NCT00881504|Bevacizumab|bevacizumab|mesh-list
14338793|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338794|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338795|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14338796|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14338797|NCT00881504|Growth Substances|growth substances|mesh-ancestor
14338798|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338799|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14338800|NCT00881530|Metformin|metformin|mesh-list
14338801|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14338802|NCT00881530|Empagliflozin|empagliflozin|mesh-list
14338803|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14338804|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338805|NCT00881530|Incretins|incretins|mesh-ancestor
14338806|NCT00881530|Hormones|hormones|mesh-ancestor
14338807|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338808|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14338809|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
14338810|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338811|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338812|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14338813|NCT00881569|Efatutazone|efatutazone|mesh-list
14338814|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338815|NCT00881621|Capecitabine|capecitabine|mesh-list
14730355|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730356|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227626|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15227627|NCT03577704|Cisplatin|cisplatin|mesh-list
14730357|NCT00527033|Mirabegron|mirabegron|mesh-list
14730358|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14730359|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15227628|NCT03577704|Carboplatin|carboplatin|mesh-list
15227629|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
15227630|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15227631|NCT03577704|Antibodies|antibodies|mesh-list
15227632|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
14338816|NCT00881621|Lapatinib|lapatinib|mesh-list
14730360|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14730361|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
14730362|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730363|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730364|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730365|NCT00527033|Urological Agents|urological agents|mesh-ancestor
14730366|NCT00527059|Simendan|simendan|mesh-list
14730367|NCT00527059|Spironolactone|spironolactone|mesh-list
14338817|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14338818|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
14338819|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338820|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338821|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14338822|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338823|NCT00881751|Bevacizumab|bevacizumab|mesh-list
14338824|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14338825|NCT00881751|Sorafenib|sorafenib|mesh-list
14338826|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338827|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338828|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14338829|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14338830|NCT00881751|Growth Substances|growth substances|mesh-ancestor
14338831|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338832|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
14338833|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14338834|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338835|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338836|NCT00881868|Clobetasol|clobetasol|mesh-list
14338837|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338838|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
14338839|NCT00881868|Hormones|hormones|mesh-ancestor
14338840|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338841|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338842|NCT00881894|Rotigotine|rotigotine|mesh-list
14338843|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
14338844|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
14338845|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338846|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338847|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338848|NCT00882102|Decitabine|decitabine|mesh-list
14338849|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
14338850|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14338851|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
14338852|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338853|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338854|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338855|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338856|NCT00882115|Sulforaphane|sulforaphane|mesh-list
14338857|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14338858|NCT00882115|Protective Agents|protective agents|mesh-ancestor
14338859|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338860|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338861|NCT00882206|Cytarabine|cytarabine|mesh-list
14338862|NCT00882206|Prednisone|prednisone|mesh-list
14338863|NCT00882206|Doxorubicin|doxorubicin|mesh-list
14338864|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14338865|NCT00882206|Methotrexate|methotrexate|mesh-list
14338866|NCT00882206|Vincristine|vincristine|mesh-list
14338867|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
14338868|NCT00882206|Decitabine|decitabine|mesh-list
14338869|NCT00882206|Asparaginase|asparaginase|mesh-list
14338870|NCT00882206|Vorinostat|vorinostat|mesh-list
14338871|NCT00882206|Pegaspargase|pegaspargase|mesh-list
14338872|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15227633|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14338873|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338874|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338875|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730368|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14338876|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338877|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338878|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14338879|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
14338880|NCT00882206|Hormones|hormones|mesh-ancestor
14338881|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14338882|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338883|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14338884|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15227634|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15227635|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227636|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
15227637|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
15227638|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
15227639|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227640|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
14338885|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
14338886|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14338887|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14338888|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
14338889|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
14338890|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14338891|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338892|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
14338893|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14338894|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14338895|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
14338896|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338897|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338898|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338899|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338900|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338901|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227641|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227642|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227643|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
15227644|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
15227645|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227646|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227647|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227648|NCT03567057|Amantadine|amantadine|mesh-list
15227649|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15227650|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15227651|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
15227652|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227653|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
15227654|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338902|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14338903|NCT00882362|Aripiprazole|aripiprazole|mesh-list
14338904|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
14338905|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338906|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14338907|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338908|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338909|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227655|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227656|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227657|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15227658|NCT03567057|Analgesics|analgesics|mesh-ancestor
15227659|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
15227660|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227661|NCT03566511|Diazoxide|diazoxide|mesh-list
14338910|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
14338911|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
14338912|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338913|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338914|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14338915|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14338916|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
14338917|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14338918|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14338919|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14338920|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14338921|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
14338922|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14338923|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
14338924|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14338925|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14338926|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14338927|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338928|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338929|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
14338930|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
14338931|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338932|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14338933|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14338934|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
14338935|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338936|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338937|NCT00882557|Daptomycin|daptomycin|mesh-list
14338938|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14338939|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14338940|NCT00882583|Cisplatin|cisplatin|mesh-list
14338941|NCT00882583|Cetuximab|cetuximab|mesh-list
14338942|NCT00882583|Dasatinib|dasatinib|mesh-list
14338943|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338944|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14338945|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14338946|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338947|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338948|NCT00882687|Lifitegrast|lifitegrast|mesh-list
14338949|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14338950|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14338951|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
14338952|NCT00882713|Hematinics|hematinics|mesh-ancestor
14338953|NCT00882908|Ribavirin|ribavirin|mesh-list
14338954|NCT00882908|Simeprevir|simeprevir|mesh-list
14338955|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
14338956|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338957|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
14338958|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227662|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15227663|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
15227664|NCT03553563|Esomeprazole|esomeprazole|mesh-list
15227665|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15227666|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14338959|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
14338960|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338961|NCT00883051|Lasmiditan|lasmiditan|mesh-list
14338962|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14338963|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
14338964|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14338965|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338966|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338967|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
14338968|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14338969|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14338970|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338971|NCT00883103|Lidocaine|lidocaine|mesh-list
14338972|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
14338973|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
14338974|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14338975|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14338976|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
14338977|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14338978|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14338979|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14338980|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14338981|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14338982|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338983|NCT00883116|Paclitaxel|paclitaxel|mesh-list
14338984|NCT00883116|Doxorubicin|doxorubicin|mesh-list
14338985|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14338986|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14338987|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14338988|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
14338989|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14338990|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14338991|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14338992|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14338993|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14338994|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14338995|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14338996|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
14338997|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
14338998|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14338999|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
14339000|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339001|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339002|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14339003|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
14339004|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339005|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339006|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14339007|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15227667|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15227668|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227669|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227670|NCT03552068|Clonidine|clonidine|mesh-list
15227671|NCT03552068|Analgesics|analgesics|mesh-ancestor
15227672|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
15227673|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227674|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227675|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15227676|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
15227677|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
15227678|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15227679|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15227680|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15227681|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
15227682|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227683|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227684|NCT03548064|Vaccines|vaccines|mesh-list
14339008|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14339009|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
14339010|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14339011|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339012|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339013|NCT00883168|Fluticasone|fluticasone|mesh-list
14339014|NCT00883168|Xhance|xhance|mesh-list
14339015|NCT00883168|Azelastine|azelastine|mesh-list
14339016|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339017|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14339018|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
14339019|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339020|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339021|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14339022|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
14339023|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339024|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14339025|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14339026|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339027|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339028|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14339029|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14339030|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
14339031|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
14339032|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339033|NCT00883233|Adapalene|adapalene|mesh-list
14339034|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14339035|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918039|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
14339036|NCT00883233|Analgesics|analgesics|mesh-ancestor
14339037|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
15227685|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
14339038|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339039|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339040|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339041|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339042|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339043|NCT00883337|Interferons|interferons|mesh-list
14339044|NCT00883337|Interferon-beta|interferon-beta|mesh-list
14339045|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
14339046|NCT00883337|Teriflunomide|teriflunomide|mesh-list
14339047|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339048|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
14339049|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339050|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14339051|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14339052|NCT00883337|Analgesics|analgesics|mesh-ancestor
14339053|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
14339054|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339055|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339056|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339057|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339058|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339059|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
14339060|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14339061|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
14339062|NCT00883415|Hematinics|hematinics|mesh-ancestor
14339063|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14339064|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
14339065|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
14339066|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14339067|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14339068|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14339069|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14339070|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339071|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339072|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339073|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
14339074|NCT00883558|Insulin|insulin|mesh-list
14339075|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14339076|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
14339077|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
14339078|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14339079|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339080|NCT00883675|Carboplatin|carboplatin|mesh-list
14339081|NCT00883675|Docetaxel|docetaxel|mesh-list
14339082|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339083|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339084|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339085|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339086|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339087|NCT00883688|Bevacizumab|bevacizumab|mesh-list
14339088|NCT00883688|Lapatinib|lapatinib|mesh-list
14339089|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14339090|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339091|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339092|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339093|NCT00883688|Growth Substances|growth substances|mesh-ancestor
14339094|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339095|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339096|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14339097|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339098|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339099|NCT00883740|Pregabalin|pregabalin|mesh-list
14339100|NCT00883740|Analgesics|analgesics|mesh-ancestor
15227686|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227687|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
15227688|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227689|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227690|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15227691|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
15227692|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227693|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15227694|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
15227695|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227696|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227697|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14339101|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
14339102|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339103|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339104|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
14339105|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14339106|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14339107|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339108|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14339109|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14339110|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14339111|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14339112|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14339113|NCT00883779|Gemcitabine|gemcitabine|mesh-list
14339114|NCT00883779|Carboplatin|carboplatin|mesh-list
14339115|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14339116|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339117|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339118|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
14339119|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339120|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
14339121|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339122|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339123|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227698|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15227699|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15227700|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
15227701|NCT03526679|Lenvatinib|lenvatinib|mesh-list
15227702|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339124|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
14339125|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339126|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14339127|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
14339128|NCT00884039|Anecortave|anecortave|mesh-list
14339129|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339130|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339131|NCT00884039|Growth Substances|growth substances|mesh-ancestor
14339132|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339133|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339134|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339135|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339136|NCT00884052|Levetiracetam|levetiracetam|mesh-list
14339137|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
14339138|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
14339139|NCT00884117|Oseltamivir|oseltamivir|mesh-list
14339140|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
14339141|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339142|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339143|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339144|NCT00884221|Menotropins|menotropins|mesh-list
14339145|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14339146|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
14339147|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14339148|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339149|NCT00884273|Goserelin|goserelin|mesh-list
14339150|NCT00884273|Bicalutamide|bicalutamide|mesh-list
14339151|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14339152|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339153|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
15227703|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227704|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227705|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227706|NCT03521232|Niclosamide|niclosamide|mesh-list
15227707|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
14730369|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14730370|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
15227708|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14339154|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
14339155|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339156|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339157|NCT00884325|Levocetirizine|levocetirizine|mesh-list
14339158|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14339159|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14339160|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
14752977|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339161|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
14339162|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339163|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339164|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339165|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14339166|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14339167|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14339168|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730371|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339169|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
14339170|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14339171|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
14339172|NCT00884390|Factor VIII|factor viii|mesh-list
14339173|NCT00884390|Coagulants|coagulants|mesh-ancestor
14339174|NCT00884585|Cyclosporine|cyclosporine|mesh-list
14339175|NCT00884585|Cyclosporins|cyclosporins|mesh-list
14339176|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339177|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339178|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339179|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
14339180|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339181|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
14339182|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339183|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339184|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339185|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14339186|NCT00884650|Analgesics|analgesics|mesh-list
14339187|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
14339188|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730372|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339189|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339190|NCT00884741|Bevacizumab|bevacizumab|mesh-list
14339191|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14339192|NCT00884741|Temozolomide|temozolomide|mesh-list
14339193|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
14339194|NCT00884741|Antibodies|antibodies|mesh-list
14339195|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
14339196|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14339197|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
14339198|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339199|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339200|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339201|NCT00884741|Growth Substances|growth substances|mesh-ancestor
14339202|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339203|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339204|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
14339205|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14339206|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
14339207|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339208|NCT00884793|Ritonavir|ritonavir|mesh-list
14339209|NCT00884793|Lopinavir|lopinavir|mesh-list
14339210|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14339211|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
14339212|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
14339213|NCT00884793|Efavirenz|efavirenz|mesh-list
14339214|NCT00884793|Etravirine|etravirine|mesh-list
14339215|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14339216|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14339217|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
14339218|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339219|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339220|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14339221|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14339222|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
14339223|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339224|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14339225|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14339226|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14339227|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14339228|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14339229|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14339230|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14339231|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14339232|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14339233|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14339234|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14339235|NCT00884832|Clonidine|clonidine|mesh-list
14339236|NCT00884832|Analgesics|analgesics|mesh-ancestor
14339237|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
14339238|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339239|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339240|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14339241|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
14339242|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
14339243|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14339244|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14339245|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14339246|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
14339247|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339248|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339249|NCT00884897|Oxytocin|oxytocin|mesh-list
14339250|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
14339251|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14339252|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339253|NCT00885079|Rebamipide|rebamipide|mesh-list
14339254|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14339255|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14339256|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14339257|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339258|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
14752978|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339259|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730373|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14730374|NCT00527059|Diuretics|diuretics|mesh-ancestor
14730375|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
14730376|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14730377|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14730378|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730379|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730380|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14339260|NCT00885079|Protective Agents|protective agents|mesh-ancestor
14339261|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339262|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464758|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14464759|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14464760|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14464761|NCT02216123|Chloroquine|chloroquine|mesh-list
14464762|NCT02216123|Primaquine|primaquine|mesh-list
14464763|NCT02216123|Tafenoquine|tafenoquine|mesh-list
14464764|NCT02216123|Amebicides|amebicides|mesh-ancestor
14464765|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14464766|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14464767|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464768|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
14464769|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464770|NCT02216214|Mirabegron|mirabegron|mesh-list
14464771|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14464772|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14464773|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14464774|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
14464775|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464776|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464777|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464778|NCT02216214|Urological Agents|urological agents|mesh-ancestor
14464779|NCT02216357|Ifetroban|ifetroban|mesh-list
14464780|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14464781|NCT02216422|Ritonavir|ritonavir|mesh-list
14464782|NCT02216422|Ribavirin|ribavirin|mesh-list
14464783|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14464784|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14464785|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
14464786|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464787|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464788|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14464789|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464790|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
14464791|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464792|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14464793|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14464794|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
14464795|NCT02216812|Ascorbic Acid|ascorbic acid|mesh-list
14464796|NCT02216812|Vitamins|vitamins|mesh-ancestor
14464797|NCT02216812|Micronutrients|micronutrients|mesh-ancestor
14464798|NCT02216812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464799|NCT02216812|Antioxidants|antioxidants|mesh-ancestor
14464800|NCT02216812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464801|NCT02216812|Protective Agents|protective agents|mesh-ancestor
14464802|NCT02217332|Pramipexole|pramipexole|mesh-list
14464803|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
14464804|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464805|NCT02217332|Protective Agents|protective agents|mesh-ancestor
14339263|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14339264|NCT00885105|Vaccines|vaccines|mesh-list
14339265|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
14339266|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339267|NCT00885118|Empagliflozin|empagliflozin|mesh-list
14339268|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14339269|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339270|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14339271|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339272|NCT00885170|Vitamin D|vitamin d|mesh-list
14339273|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
14339274|NCT00885170|Calcium|calcium|mesh-list
14339275|NCT00885170|Vitamins|vitamins|mesh-ancestor
14339276|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
14339277|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339278|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14339279|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14339280|NCT00885352|Metformin|metformin|mesh-list
14339281|NCT00885352|Pioglitazone|pioglitazone|mesh-list
14339282|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14339283|NCT00885352|Glipizide|glipizide|mesh-list
14339284|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14339285|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339286|NCT00885352|Incretins|incretins|mesh-ancestor
14339287|NCT00885352|Hormones|hormones|mesh-ancestor
14339288|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339289|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14339290|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
14730381|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
14730382|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14730383|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14339291|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339292|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339293|NCT00885365|Tobramycin|tobramycin|mesh-list
14339294|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14339295|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339296|NCT00885378|Metformin|metformin|mesh-list
14339297|NCT00885378|Saxagliptin|saxagliptin|mesh-list
14339298|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14339299|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339300|NCT00885378|Incretins|incretins|mesh-ancestor
14339301|NCT00885378|Hormones|hormones|mesh-ancestor
14339302|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339303|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14339304|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
14339305|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339306|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339307|NCT00885482|Ritonavir|ritonavir|mesh-list
14339308|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14339309|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14339310|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14339311|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
14339312|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339313|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339314|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14339315|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14339316|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
14339317|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339318|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14339319|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15227709|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
15227710|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15227711|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227712|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
15227713|NCT03511963|Bevacizumab|bevacizumab|mesh-list
15227714|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227715|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730384|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227716|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14730385|NCT00527059|Protective Agents|protective agents|mesh-ancestor
14730386|NCT00527085|Cinacalcet|cinacalcet|mesh-list
14730387|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14730388|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227717|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15227718|NCT03511963|Growth Substances|growth substances|mesh-ancestor
15227719|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227720|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
15227721|NCT03502785|Atezolizumab|atezolizumab|mesh-list
15227722|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339320|NCT00885534|Temozolomide|temozolomide|mesh-list
14339321|NCT00885534|Vinblastine|vinblastine|mesh-list
14339322|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339323|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14339324|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
14339325|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339326|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14339327|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339328|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339329|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339330|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14339331|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14339332|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339333|NCT00885638|Incretins|incretins|mesh-ancestor
14339334|NCT00885638|Hormones|hormones|mesh-ancestor
14339335|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339336|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14339337|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
14730389|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14730390|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
14730391|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730392|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
14730393|NCT00527137|Hematinics|hematinics|mesh-ancestor
14730394|NCT00527150|Varenicline|varenicline|mesh-list
14730395|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14339338|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339339|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339340|NCT00885703|Fluconazole|fluconazole|mesh-list
14730396|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14730397|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
14339341|NCT00885703|Amphotericin B|amphotericin b|mesh-list
14339342|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14730398|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730399|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730400|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730401|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
14730402|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14730403|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14730404|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14730405|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14730406|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730407|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
14730408|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227723|NCT03502668|Decitabine|decitabine|mesh-list
15227724|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227725|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
14339343|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14339344|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
14339345|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
14339346|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339347|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14339348|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14339349|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339350|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339351|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14339352|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
14339353|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339354|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730409|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227726|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227727|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227728|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227729|NCT03496610|Bupivacaine|bupivacaine|mesh-list
15227730|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
15227731|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
15227732|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227733|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227734|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
15227735|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227736|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15227737|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
15227738|NCT03461406|Coagulants|coagulants|mesh-ancestor
15227739|NCT03446456|Vasopressins|vasopressins|mesh-list
15227740|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
15227741|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
15227742|NCT03446456|Coagulants|coagulants|mesh-ancestor
15227743|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15227744|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15227745|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
15227746|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730410|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14730411|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730412|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
14730413|NCT00527215|Hematinics|hematinics|mesh-ancestor
14730414|NCT00527228|Deflazacort|deflazacort|mesh-list
14730415|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730416|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730417|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
14730418|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730419|NCT00527267|Cinacalcet|cinacalcet|mesh-list
14730420|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14730421|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730422|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14730423|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
14730424|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730425|NCT00527449|Carboplatin|carboplatin|mesh-list
14730426|NCT00527449|Docetaxel|docetaxel|mesh-list
14730427|NCT00527449|Epirubicin|epirubicin|mesh-list
14730428|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730429|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14730430|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730431|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14730432|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730433|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14730434|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730435|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730436|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730437|NCT00527501|Travoprost|travoprost|mesh-list
14730438|NCT00527501|Brinzolamide|brinzolamide|mesh-list
14730439|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14730440|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14730441|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730442|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730443|NCT00527540|Interferons|interferons|mesh-list
14730444|NCT00527540|Ribavirin|ribavirin|mesh-list
15227747|NCT03396692|Morphine|morphine|mesh-list
15227748|NCT03396692|Ropivacaine|ropivacaine|mesh-list
14339355|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14339356|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14339357|NCT00885703|Amebicides|amebicides|mesh-ancestor
14339358|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14339359|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14339360|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14339361|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14339362|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339363|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
14339364|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14339365|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14339366|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339367|NCT00885755|Capecitabine|capecitabine|mesh-list
14339368|NCT00885755|Trastuzumab|trastuzumab|mesh-list
14339369|NCT00885755|Taxane|taxane|mesh-list
14339370|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339371|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
14339372|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339373|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339374|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14339375|NCT00886236|Gabapentin|gabapentin|mesh-list
14339376|NCT00886236|Analgesics|analgesics|mesh-ancestor
14339377|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
14339378|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339379|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339380|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
14339381|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14339382|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14339383|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730445|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
14730446|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
14730447|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14730448|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730449|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
15227749|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15227750|NCT03396692|Narcotics|narcotics|mesh-ancestor
15227751|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227752|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227753|NCT03396692|Analgesics|analgesics|mesh-ancestor
15227754|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
15227755|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227756|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
15227757|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
15227758|NCT03395639|Heparin|heparin|mesh-list
15227759|NCT03395639|Enoxaparin|enoxaparin|mesh-list
15227760|NCT03395639|Warfarin|warfarin|mesh-list
15227761|NCT03395639|Edoxaban|edoxaban|mesh-list
15227762|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
15227763|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15227764|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15227765|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227766|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15227767|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
15227768|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14339384|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14730450|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227769|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
14730451|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
14730452|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730453|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
14730454|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730455|NCT00527657|Thalidomide|thalidomide|mesh-list
14730456|NCT00527657|Temozolomide|temozolomide|mesh-list
14730457|NCT00527657|Lomustine|lomustine|mesh-list
14730458|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14730459|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
14339385|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14339386|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14339387|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339388|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339389|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
14339390|NCT00886262|Vasopressins|vasopressins|mesh-list
14339391|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
14339392|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
14339393|NCT00886262|Coagulants|coagulants|mesh-ancestor
14339394|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14339395|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14339396|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
14339397|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339398|NCT00886379|Vitamin D|vitamin d|mesh-list
14752979|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
15227770|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227771|NCT03388190|Leucovorin|leucovorin|mesh-list
15227772|NCT03388190|Fluorouracil|fluorouracil|mesh-list
15227773|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
15227774|NCT03388190|Nivolumab|nivolumab|mesh-list
15227775|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
15227776|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
15227777|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227778|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227779|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227780|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227781|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
15227782|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227783|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227784|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15227785|NCT03388190|Antidotes|antidotes|mesh-ancestor
15227786|NCT03388190|Protective Agents|protective agents|mesh-ancestor
15227787|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
15227788|NCT03388190|Vitamins|vitamins|mesh-ancestor
15227789|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
15227790|NCT03382834|Tamoxifen|tamoxifen|mesh-list
15227791|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15227792|NCT03382834|Vorinostat|vorinostat|mesh-list
15227793|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15227794|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
15227795|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227796|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227797|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14339399|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
14339400|NCT00886379|Vitamins|vitamins|mesh-list
14339401|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
14339402|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339403|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14339404|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14339405|NCT00886613|Vaccines|vaccines|mesh-list
14339406|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
14339407|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339408|NCT00886626|Exenatide|exenatide|mesh-list
14339409|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14339410|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339411|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14339412|NCT00886626|Incretins|incretins|mesh-ancestor
14339413|NCT00886626|Hormones|hormones|mesh-ancestor
14339414|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339415|NCT00886743|Oprelvekin|oprelvekin|mesh-list
14339416|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339417|NCT00886795|Abatacept|abatacept|mesh-list
14339418|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14339419|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339420|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339421|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339422|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
14730460|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730461|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730462|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730463|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
14730464|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730465|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
14730466|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730467|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730468|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14730469|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14730470|NCT00527657|Growth Substances|growth substances|mesh-ancestor
14730471|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14730472|NCT00527683|Vigabatrin|vigabatrin|mesh-list
14730473|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
14339423|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339424|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339425|NCT00886834|Misoprostol|misoprostol|mesh-list
14339426|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14339427|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
14339428|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14339429|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339430|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14339431|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339432|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
14339433|NCT00887068|Azacitidine|azacitidine|mesh-list
14730474|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339434|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339435|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
14339436|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339437|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339438|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339439|NCT00887159|Cisplatin|cisplatin|mesh-list
14339440|NCT00887159|Etoposide|etoposide|mesh-list
14339441|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
14339442|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
14339443|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14339444|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339445|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14339446|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14339447|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14339448|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339449|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339450|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
14339451|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339452|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339453|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339454|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339455|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
14339456|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339457|NCT00887198|Prednisone|prednisone|mesh-list
15227798|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227799|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15227800|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15227801|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15227802|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15227803|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227804|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227805|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
15227806|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227807|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
15227808|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15227809|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227810|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
15227811|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15227812|NCT03326193|Bevacizumab|bevacizumab|mesh-list
15227813|NCT03326193|Niraparib|niraparib|mesh-list
15227814|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227815|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339458|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
15227816|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15227817|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15227818|NCT03326193|Growth Substances|growth substances|mesh-ancestor
15227819|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227820|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
15227821|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15227822|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339459|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339460|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
14339461|NCT00887198|Hormones|hormones|mesh-ancestor
14339462|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339463|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339464|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14339465|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339466|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14339467|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339468|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339469|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
14339470|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14339471|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14339472|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14339473|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14339474|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14339475|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339476|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339477|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339478|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
14339479|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14339480|NCT00887354|Vitamin D|vitamin d|mesh-list
14339481|NCT00887354|Teriparatide|teriparatide|mesh-list
14339482|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
14339483|NCT00887354|Calcium|calcium|mesh-list
14339484|NCT00887354|Vitamins|vitamins|mesh-ancestor
14339485|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
14339486|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339487|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14339488|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14339489|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14339490|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14339491|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339492|NCT00887432|Vitamin D|vitamin d|mesh-list
14339493|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
14339494|NCT00887432|Vitamins|vitamins|mesh-ancestor
14339495|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
14339496|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339497|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14339498|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14339499|NCT00887458|Itraconazole|itraconazole|mesh-list
14339500|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14339501|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
14339502|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339503|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14339504|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14339505|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339506|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339507|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14339508|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
14339509|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339510|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339511|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14339512|NCT00887484|Clindamycin|clindamycin|mesh-list
14339513|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
14339514|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
14339515|NCT00887484|Adapalene|adapalene|mesh-list
14339516|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14339517|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14918040|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918041|NCT03283384|Letrozole|letrozole|mesh-list
14339518|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339519|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14339520|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339521|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339522|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339523|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14918042|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339524|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14339525|NCT00887484|Analgesics|analgesics|mesh-ancestor
14339526|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
14339527|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339528|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339529|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339530|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339531|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14339532|NCT00887510|Trandolapril|trandolapril|mesh-list
14339533|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14339534|NCT00887510|Diuretics|diuretics|mesh-ancestor
14339535|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
14339536|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339537|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14339538|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14339539|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339540|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14339541|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
14339542|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339543|NCT00887549|Pemetrexed|pemetrexed|mesh-list
14339544|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918043|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14918044|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14918045|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930837|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339545|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730475|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730476|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
14730477|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730478|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730479|NCT00527761|Cisplatin|cisplatin|mesh-list
14730480|NCT00527761|Docetaxel|docetaxel|mesh-list
14339546|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339547|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14339548|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15227823|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227824|NCT03310905|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15227825|NCT03310905|Immunologic Factors|immunologic factors|mesh-ancestor
15227826|NCT03310905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227827|NCT03302286|Mannitol|mannitol|mesh-list
15227828|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15227829|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15227830|NCT03302286|Diuretics|diuretics|mesh-ancestor
15227831|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
15227832|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227833|NCT03271021|Minocycline|minocycline|mesh-list
15227834|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14339549|NCT00887562|Ubiquinone|ubiquinone|mesh-list
14339550|NCT00887562|Idebenone|idebenone|mesh-list
14339551|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
14339552|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339553|NCT00887562|Protective Agents|protective agents|mesh-ancestor
14339554|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339555|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
14339556|NCT00887575|Paclitaxel|paclitaxel|mesh-list
14339557|NCT00887575|Carboplatin|carboplatin|mesh-list
14339558|NCT00887575|Sunitinib|sunitinib|mesh-list
14339559|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14339560|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339561|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339562|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339563|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339564|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339565|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339566|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339567|NCT00887575|Growth Substances|growth substances|mesh-ancestor
14339568|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339569|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339570|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14339571|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339572|NCT00887588|Valsartan|valsartan|mesh-list
14339573|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14339574|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14339575|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14339576|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14339577|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339578|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
14339579|NCT00887640|Promethazine|promethazine|mesh-list
14339580|NCT00887640|Sirolimus|sirolimus|mesh-list
14339581|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14339582|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339583|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14339584|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339585|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
14339586|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339587|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
14339588|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339589|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14339590|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14339591|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14339592|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
14339593|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
14339594|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
14339595|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339596|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
14730481|NCT00527761|Temozolomide|temozolomide|mesh-list
14730482|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730483|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14730484|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730485|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339597|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
14339598|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339599|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14339600|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
14339601|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
14339602|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339603|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339604|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14339605|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
14339606|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339607|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
14339608|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14339609|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14339610|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
14339611|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339612|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14339613|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14339614|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339615|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339616|NCT00887679|Citalopram|citalopram|mesh-list
14339617|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14339618|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14339619|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14339620|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339621|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339622|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
14339623|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339624|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14339625|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
14339626|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14339627|NCT00887783|Vinorelbine|vinorelbine|mesh-list
14339628|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14339629|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339630|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339631|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730486|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730487|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15227835|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227836|NCT03264352|Amlodipine|amlodipine|mesh-list
15227837|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15227838|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15227839|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15227840|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227841|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15227842|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227843|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
15227844|NCT03255083|Osimertinib|osimertinib|mesh-list
15227845|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227846|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227847|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339632|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339633|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339634|NCT00887809|Gemcitabine|gemcitabine|mesh-list
14339635|NCT00887809|Bevacizumab|bevacizumab|mesh-list
14339636|NCT00887809|Docetaxel|docetaxel|mesh-list
14339637|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227848|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227849|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
15227850|NCT03253172|Diuretics|diuretics|mesh-ancestor
15227851|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
14730488|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
14730489|NCT00527800|Lumefantrine|lumefantrine|mesh-list
14730490|NCT00527800|Artemether|artemether|mesh-list
14730491|NCT00527800|Piperaquine|piperaquine|mesh-list
14730492|NCT00527800|Trimethoprim|trimethoprim|mesh-list
14730493|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14730494|NCT00527800|Artenimol|artenimol|mesh-list
14730495|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14730496|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
14730497|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
15227852|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227853|NCT03253172|Expectorants|expectorants|mesh-ancestor
15227854|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
14730498|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14730499|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14339638|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339639|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339640|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339641|NCT00887809|Growth Substances|growth substances|mesh-ancestor
14339642|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339643|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339644|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339645|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
14339646|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339647|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
14339648|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339649|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339650|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339651|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
14339652|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339653|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339654|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339655|NCT00887822|Bevacizumab|bevacizumab|mesh-list
14339656|NCT00887822|Capecitabine|capecitabine|mesh-list
14339657|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14339658|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339659|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339660|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339661|NCT00887822|Growth Substances|growth substances|mesh-ancestor
14339662|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339663|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339664|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339665|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
14339666|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339667|NCT00887965|Denosumab|denosumab|mesh-list
14339668|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14339669|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339670|NCT00887978|Treprostinil|treprostinil|mesh-list
14339671|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14339672|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14730500|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730501|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15227855|NCT03227471|Ivacaftor|ivacaftor|mesh-list
14730502|NCT00527800|Renal Agents|renal agents|mesh-ancestor
15227856|NCT03227471|Elexacaftor|elexacaftor|mesh-list
15227857|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15227858|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15227859|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227860|NCT03221842|Complement C1s|complement c1s|mesh-list
15227861|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
15227862|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
15227863|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
15227864|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227865|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15227866|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339673|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14339674|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339675|NCT00888238|Incretins|incretins|mesh-ancestor
14339676|NCT00888238|Hormones|hormones|mesh-ancestor
14730503|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730504|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730505|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730506|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14730507|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14730508|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14730509|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730510|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
14730511|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730512|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
14730513|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
14730514|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14730515|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14730516|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730517|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730518|NCT00527995|Urological Agents|urological agents|mesh-ancestor
15227867|NCT03195478|Nivolumab|nivolumab|mesh-list
15227868|NCT03195478|Ipilimumab|ipilimumab|mesh-list
15227869|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15227870|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227871|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15227872|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227873|NCT03194321|Tacrolimus|tacrolimus|mesh-list
14339677|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339678|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14339679|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
14339680|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918046|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918047|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14918048|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
14918049|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918050|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918051|NCT03268954|Azacitidine|azacitidine|mesh-list
14918052|NCT03268954|Pevonedistat|pevonedistat|mesh-list
14918053|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918054|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
14339681|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339682|NCT00888329|Aprepitant|aprepitant|mesh-list
14339683|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
14339684|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
14339685|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339686|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339687|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339688|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14339689|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339690|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339691|NCT00888381|Vaccines|vaccines|mesh-list
14339692|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
14339693|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339694|NCT00888459|Nicotine|nicotine|mesh-list
14339695|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14339696|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
14339697|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339698|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339699|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14339700|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14339701|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
14339702|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339703|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339704|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14339705|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339706|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14339707|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339708|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339709|NCT00888615|Paclitaxel|paclitaxel|mesh-list
14339710|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14918055|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918056|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918057|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918058|NCT03267836|Avelumab|avelumab|mesh-list
14918059|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918060|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918061|NCT03245827|Clomiphene|clomiphene|mesh-list
14918062|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14918063|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
14918064|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918065|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918066|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14918067|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
14918068|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14918069|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14918070|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14918071|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
14918072|NCT03164993|Doxorubicin|doxorubicin|mesh-list
15227874|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227875|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
15227876|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227877|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14339711|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14339712|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339713|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339714|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339715|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339716|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339717|NCT00888628|Etanercept|etanercept|mesh-list
14339718|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14339719|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14339720|NCT00888628|Analgesics|analgesics|mesh-ancestor
14339721|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
14339722|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339723|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339724|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339725|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339726|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339727|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339728|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
14339729|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14339730|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14339731|NCT00888654|Protective Agents|protective agents|mesh-ancestor
14339732|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339733|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339734|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
14339735|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339736|NCT00888940|Ecallantide|ecallantide|mesh-list
14339737|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
14918073|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14339738|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14339739|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14339740|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339741|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
14339742|NCT00888940|Coagulants|coagulants|mesh-ancestor
14339743|NCT00888940|Analgesics|analgesics|mesh-ancestor
14339744|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
14339745|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339746|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339747|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14339748|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14339749|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339750|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339751|NCT00888979|Nicotine|nicotine|mesh-list
14339752|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14339753|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
14339754|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339755|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339756|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14339757|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14339758|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
14339759|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339760|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339761|NCT00889187|Capecitabine|capecitabine|mesh-list
14339762|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339763|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
14339764|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339765|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339766|NCT00889200|Eszopiclone|eszopiclone|mesh-list
14339767|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14339768|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14339769|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339770|NCT00889226|Atorvastatin|atorvastatin|mesh-list
14339771|NCT00889226|Pitavastatin|pitavastatin|mesh-list
15227878|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227879|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227880|NCT03189693|Anesthetics|anesthetics|mesh-list
15227881|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227882|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227883|NCT03170206|Palbociclib|palbociclib|mesh-list
15227884|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227885|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14339772|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14339773|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14339774|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
14339775|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339776|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14339777|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14339778|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339779|NCT00889252|Ketotifen|ketotifen|mesh-list
14339780|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
14339781|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339782|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14339783|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
14339784|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
14339785|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339786|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339787|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339788|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14339789|NCT00889330|Alcaftadine|alcaftadine|mesh-list
14339790|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14339791|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
14339792|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
14730519|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
14730520|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14730521|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
14730522|NCT00528008|Povidone|povidone|mesh-list
14339793|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339794|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339795|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339796|NCT00889603|Donepezil|donepezil|mesh-list
14339797|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14339798|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339799|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339800|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
14339801|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339802|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339803|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
14339804|NCT00889720|Varenicline|varenicline|mesh-list
14339805|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14339806|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14339807|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
14339808|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730523|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14730524|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730525|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
14339809|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339810|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339811|NCT00889915|Methylphenidate|methylphenidate|mesh-list
14339812|NCT00889915|Amphetamine|amphetamine|mesh-list
14339813|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14339814|NCT00889915|Adderall|adderall|mesh-list
14339815|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14339816|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339817|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14339818|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14339819|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14339820|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339821|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
14339822|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339823|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
14339824|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
14339825|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339826|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
14339827|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14339828|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14339829|NCT00890084|Telmisartan|telmisartan|mesh-list
14339830|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
14339831|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14339832|NCT00890084|Diuretics|diuretics|mesh-ancestor
14339833|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
14339834|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339835|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14339836|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14339837|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730526|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
14730527|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
14730528|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
14339838|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14339839|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14339840|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14339841|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14339842|NCT00890162|Omalizumab|omalizumab|mesh-list
14339843|NCT00890162|Epinephrine|epinephrine|mesh-list
14339844|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14339845|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14339846|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
14339847|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14339848|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339849|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339850|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14339851|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14339852|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
14339853|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339854|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14339855|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
14339856|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
14339857|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
14339858|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14339859|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14464806|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464807|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14464808|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14464809|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
14464810|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
14464811|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464812|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
14464813|NCT02217410|Tacrolimus|tacrolimus|mesh-list
14464814|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14464815|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
14339860|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
14339861|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339862|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
14339863|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339864|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339865|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14339866|NCT00890552|Dexamethasone|dexamethasone|mesh-list
14339867|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
14339868|NCT00890552|Lenalidomide|lenalidomide|mesh-list
14339869|NCT00890552|Melphalan|melphalan|mesh-list
14339870|NCT00890552|BB 1101|bb 1101|mesh-list
14339871|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339872|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
14339873|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
14339874|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339875|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339876|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339877|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
14339878|NCT00890552|Hormones|hormones|mesh-ancestor
14339879|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339880|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14339881|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339882|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
14339883|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339884|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339885|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
14339886|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339887|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339888|NCT00890552|Growth Substances|growth substances|mesh-ancestor
14339889|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339890|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14339891|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
14339892|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14339893|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339894|NCT00890617|Prednisone|prednisone|mesh-list
14339895|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339896|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
14339897|NCT00890617|Hormones|hormones|mesh-ancestor
14339898|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339899|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339900|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14339901|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339902|NCT00890656|Dexamethasone|dexamethasone|mesh-list
14339903|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
14339904|NCT00890656|Doxorubicin|doxorubicin|mesh-list
14339905|NCT00890656|Methotrexate|methotrexate|mesh-list
14339906|NCT00890656|Vincristine|vincristine|mesh-list
14339907|NCT00890656|Asparaginase|asparaginase|mesh-list
14339908|NCT00890656|Pegaspargase|pegaspargase|mesh-list
14339909|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14339910|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
14339911|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339912|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14339913|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14339914|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
14339915|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339916|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339917|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14339918|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339919|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
14339920|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
14339921|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339922|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14339923|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
14339924|NCT00890656|Hormones|hormones|mesh-ancestor
14339925|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339926|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14339927|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339928|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14339929|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730529|NCT00528060|Ritonavir|ritonavir|mesh-list
14339930|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14339931|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14339932|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
14339933|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14339934|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339935|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
14339936|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339937|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730530|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14730531|NCT00528060|Tenofovir|tenofovir|mesh-list
14730532|NCT00528060|Emtricitabine|emtricitabine|mesh-list
14730533|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14730534|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14730535|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
14730536|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730537|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730538|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14730539|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14730540|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
14730541|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14339938|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14339939|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14339940|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339941|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339942|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339943|NCT00890825|Docetaxel|docetaxel|mesh-list
14339944|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339945|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14339946|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14339947|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14339948|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339949|NCT00890929|Lenalidomide|lenalidomide|mesh-list
14339950|NCT00890929|Azacitidine|azacitidine|mesh-list
14339951|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
14339952|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339953|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14339954|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14339955|NCT00890929|Growth Substances|growth substances|mesh-ancestor
14339956|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
14339957|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339958|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14339959|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
14339960|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339961|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339962|NCT00890981|Denosumab|denosumab|mesh-list
14339963|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14339964|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339965|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14339966|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
14339967|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339968|NCT00891202|Eliglustat|eliglustat|mesh-list
14339969|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14339970|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339971|NCT00891228|ST 1435|st 1435|mesh-list
14339972|NCT00891228|Testosterone|testosterone|mesh-list
14339973|NCT00891228|Androgens|androgens|mesh-ancestor
14339974|NCT00891228|Hormones|hormones|mesh-ancestor
14339975|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14339976|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339977|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14339978|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
14339979|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14339980|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14730542|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14730543|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14339981|NCT00891293|Fenofibrate|fenofibrate|mesh-list
14339982|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14339983|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
14339984|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14339985|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14339986|NCT00891371|Lanreotide|lanreotide|mesh-list
14339987|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14339988|NCT00891436|Fluticasone|fluticasone|mesh-list
14339989|NCT00891436|Xhance|xhance|mesh-list
14339990|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14339991|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14339992|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
14339993|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14339994|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14339995|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14339996|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
14339997|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
14339998|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14339999|NCT00891462|Bromides|bromides|mesh-list
14340000|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
14340001|NCT00891527|Bevacizumab|bevacizumab|mesh-list
14340002|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
14340003|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340004|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340005|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340006|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340007|NCT00891527|Growth Substances|growth substances|mesh-ancestor
14340008|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752980|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
14340009|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340010|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14340011|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340012|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340013|NCT00891735|Ranibizumab|ranibizumab|mesh-list
14340014|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340015|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340016|NCT00891735|Growth Substances|growth substances|mesh-ancestor
14340017|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340018|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340019|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340020|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
14340021|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14340022|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340023|NCT00891813|Vitamins|vitamins|mesh-ancestor
14340024|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
14340025|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14340026|NCT00891839|Rituximab|rituximab|mesh-list
14340027|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14340028|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340029|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340030|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
14340031|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340032|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340033|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14340034|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
14340035|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340036|NCT00891878|Capecitabine|capecitabine|mesh-list
14340037|NCT00891878|Sunitinib|sunitinib|mesh-list
14340038|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14340039|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
14340040|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340041|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340042|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340043|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340044|NCT00891878|Growth Substances|growth substances|mesh-ancestor
14340045|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340046|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340047|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14340048|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340049|NCT00891930|Irinotecan|irinotecan|mesh-list
14340050|NCT00891930|Panitumumab|panitumumab|mesh-list
14340051|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14340052|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14340053|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340054|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340055|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340056|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340057|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
14340058|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
14340059|NCT00891995|Insulin|insulin|mesh-list
14340060|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14340061|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340062|NCT00892008|Pregabalin|pregabalin|mesh-list
14340063|NCT00892008|Analgesics|analgesics|mesh-ancestor
14340064|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
14340065|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340066|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340067|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
14340068|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14340069|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340070|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340071|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14340072|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14340073|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14340074|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340075|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340076|NCT00892047|Aripiprazole|aripiprazole|mesh-list
14340077|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14340078|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
14340079|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340080|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14340081|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14340082|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340083|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340084|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
14340085|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
14340086|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340087|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340088|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14340089|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14340090|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
14340091|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14340092|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14340093|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14340094|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14340095|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14340096|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14340097|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340098|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14340099|NCT00892099|Vitamin D|vitamin d|mesh-list
14340100|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
14340101|NCT00892099|Vitamins|vitamins|mesh-list
14730544|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14730545|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14730546|NCT00528073|Rifaximin|rifaximin|mesh-list
14730547|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730548|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730549|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14752981|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752982|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752983|NCT05311176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14340102|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
14340103|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340104|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14340105|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14340106|NCT00892177|Bevacizumab|bevacizumab|mesh-list
14340107|NCT00892177|Dasatinib|dasatinib|mesh-list
14340108|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340109|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340110|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340111|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340112|NCT00892177|Growth Substances|growth substances|mesh-ancestor
14340113|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340114|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340115|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14340116|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340117|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340118|NCT00892281|Doxycycline|doxycycline|mesh-list
14340119|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14340120|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340121|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
14340122|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14340123|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14340124|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14340125|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14340126|NCT00892437|Cobicistat|cobicistat|mesh-list
14340127|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14340128|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14340129|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340130|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340131|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
14340132|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340133|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14752984|NCT05311176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14752985|NCT05311176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752986|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
14752987|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752988|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752989|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14752990|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14752991|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752992|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752993|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340134|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14340135|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14340136|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14340137|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
14340138|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14340139|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14340140|NCT00892606|Morphine|morphine|mesh-list
14340141|NCT00892606|Methadone|methadone|mesh-list
14340142|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14340143|NCT00892606|Narcotics|narcotics|mesh-ancestor
14340144|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340145|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340146|NCT00892606|Analgesics|analgesics|mesh-ancestor
14730550|NCT00528151|Curcumin|curcumin|mesh-list
14340147|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
14340148|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340149|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
14340150|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
14340151|NCT00892697|Ribavirin|ribavirin|mesh-list
14340152|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14340153|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
14730551|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14730552|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730553|NCT00528151|Analgesics|analgesics|mesh-ancestor
14730554|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
14730555|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730556|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730557|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340154|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340155|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
14340156|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340157|NCT00892710|Bevacizumab|bevacizumab|mesh-list
14340158|NCT00892710|Carboplatin|carboplatin|mesh-list
14340159|NCT00892710|Pemetrexed|pemetrexed|mesh-list
14340160|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340161|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340162|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340163|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340164|NCT00892710|Growth Substances|growth substances|mesh-ancestor
14340165|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340166|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340167|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340168|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340169|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14340170|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14340171|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14730558|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730559|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340172|NCT00892957|Thrombin|thrombin|mesh-list
14340173|NCT00892957|Aprotinin|aprotinin|mesh-list
14340174|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
14340175|NCT00892957|Coagulants|coagulants|mesh-ancestor
14340176|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14340177|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14340178|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
14340179|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340180|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340181|NCT00893074|Dronabinol|dronabinol|mesh-list
14340182|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
14340183|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340184|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340185|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15227886|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227887|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227888|NCT03150173|Buprenorphine|buprenorphine|mesh-list
14340186|NCT00893074|Analgesics|analgesics|mesh-ancestor
14340187|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
15227889|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15227890|NCT03150173|Narcotics|narcotics|mesh-ancestor
15227891|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227892|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227893|NCT03150173|Analgesics|analgesics|mesh-ancestor
15227894|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
15227895|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340188|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340189|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14340190|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14340191|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340192|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340193|NCT00893074|Hormones|hormones|mesh-ancestor
14340194|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340195|NCT00893113|Alfuzosin|alfuzosin|mesh-list
14340196|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14730560|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730561|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730562|NCT00528177|Morphine|morphine|mesh-list
14730563|NCT00528177|Oxycodone|oxycodone|mesh-list
14730564|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14730565|NCT00528177|Narcotics|narcotics|mesh-ancestor
14730566|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730567|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730568|NCT00528177|Analgesics|analgesics|mesh-ancestor
14730569|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
14730570|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730571|NCT00528216|Capsaicin|capsaicin|mesh-list
14730572|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
14730573|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
14730574|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
14730575|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730576|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730577|NCT00528255|Misoprostol|misoprostol|mesh-list
14730578|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14340197|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14340198|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15227896|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15227897|NCT03093922|Gemcitabine|gemcitabine|mesh-list
15227898|NCT03093922|Atezolizumab|atezolizumab|mesh-list
15227899|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340199|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
14340200|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340201|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340202|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340203|NCT00893113|Urological Agents|urological agents|mesh-ancestor
14340204|NCT00893464|Ixazomib|ixazomib|mesh-list
14340205|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340206|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
14340207|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340208|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730579|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
14730580|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14730581|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730582|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14730583|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14730584|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
14918074|NCT03164993|Atezolizumab|atezolizumab|mesh-list
14918075|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918076|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
14730585|NCT00528281|Pemetrexed|pemetrexed|mesh-list
14918077|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918078|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918079|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14918080|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
14918081|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918082|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227900|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227901|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
15227902|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227903|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
14918083|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14918084|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14918085|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14918086|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918087|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918088|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
14918089|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918090|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14918091|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14918092|NCT03129321|Econazole|econazole|mesh-list
14918093|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
14918094|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227904|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340209|NCT00893737|Naproxen|naproxen|mesh-list
14340210|NCT00893737|Sumatriptan|sumatriptan|mesh-list
14340211|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14340212|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14340213|NCT00893737|Analgesics|analgesics|mesh-ancestor
14340214|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
14340215|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340216|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340217|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340218|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340219|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
14340220|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14340221|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340222|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340223|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14340224|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14340225|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14340226|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
14340227|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340228|NCT00893984|Nebivolol|nebivolol|mesh-list
14340229|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14340230|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
14340231|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14340232|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14340233|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14730586|NCT00528281|Lapatinib|lapatinib|mesh-list
14730587|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730588|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752994|NCT05307198|Capecitabine|capecitabine|mesh-list
15227905|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227906|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15227907|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
15227908|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340234|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
14340235|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340236|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340237|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340238|NCT00893997|Vaccines|vaccines|mesh-list
14340239|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
14340240|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340241|NCT00894166|Bupropion|bupropion|mesh-list
14340242|NCT00894166|Nicotine|nicotine|mesh-list
14340243|NCT00894166|Varenicline|varenicline|mesh-list
14340244|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14340245|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
14340246|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340247|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340248|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14340249|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14340250|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
14340251|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340252|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340253|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14340254|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
14340255|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340256|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14340257|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14340258|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340259|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
14340260|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14340261|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14340262|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340263|NCT00894322|Exenatide|exenatide|mesh-list
14340264|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14340265|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340266|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14340267|NCT00894322|Incretins|incretins|mesh-ancestor
14340268|NCT00894322|Hormones|hormones|mesh-ancestor
14464816|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227909|NCT03085095|Leuprolide|leuprolide|mesh-list
15227910|NCT03085095|Relugolix|relugolix|mesh-list
15227911|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14464817|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14464818|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464819|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464820|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14340269|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340270|NCT00894413|Tadalafil|tadalafil|mesh-list
14340271|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
14340272|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14340273|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14340274|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340275|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340276|NCT00894413|Urological Agents|urological agents|mesh-ancestor
14340277|NCT00894465|Midazolam|midazolam|mesh-list
14340278|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14340279|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14340280|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340281|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730589|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340282|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14340283|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14340284|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340285|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14340286|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
14340287|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
14340288|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
14340289|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
14340290|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340291|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340292|NCT00894504|Gemcitabine|gemcitabine|mesh-list
14340293|NCT00894504|Carboplatin|carboplatin|mesh-list
14340294|NCT00894504|Panitumumab|panitumumab|mesh-list
14340295|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340296|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14340297|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
14340298|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340299|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
14340300|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340301|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340302|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14340303|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
14340304|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340305|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340306|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
14340307|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14340308|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14340309|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14340310|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340311|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340312|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
14340313|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340314|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340315|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14340316|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340317|NCT00894543|Citalopram|citalopram|mesh-list
14340318|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14340319|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14340320|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340321|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340322|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340323|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
14340324|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340325|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14340326|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
14340327|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340328|NCT00894647|Imiquimod|imiquimod|mesh-list
14340329|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14340330|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
14340331|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340332|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340333|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
14340334|NCT00894699|Sufentanil|sufentanil|mesh-list
14340335|NCT00894699|Triazolam|triazolam|mesh-list
14340336|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14340337|NCT00894699|Narcotics|narcotics|mesh-ancestor
14340338|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340339|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340340|NCT00894699|Analgesics|analgesics|mesh-ancestor
14340341|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
14340342|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340343|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14340344|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14340345|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
14340346|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
14340347|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14340348|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14340349|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340350|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
14340351|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
14340352|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340353|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340354|NCT00894803|Eptifibatide|eptifibatide|mesh-list
14340355|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14340356|NCT00895037|Factor VIII|factor viii|mesh-list
14340357|NCT00895037|Coagulants|coagulants|mesh-ancestor
14340358|NCT00895180|Ramucirumab|ramucirumab|mesh-list
14340359|NCT00895180|Olaratumab|olaratumab|mesh-list
14730590|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730591|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14730592|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14730593|NCT00528359|Olanzapine|olanzapine|mesh-list
14730594|NCT00528359|Risperidone|risperidone|mesh-list
14730595|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14340360|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340361|NCT00895193|Aspirin|aspirin|mesh-list
14340362|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14340363|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14340364|NCT00895193|Analgesics|analgesics|mesh-ancestor
14340365|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
14340366|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340367|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340368|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340369|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340370|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14730596|NCT00528359|Aripiprazole|aripiprazole|mesh-list
14730597|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15227912|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
14340371|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14340372|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340373|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14340374|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14340375|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340376|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
14340377|NCT00895232|Iron|iron|mesh-list
14340378|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15227913|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15227914|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340379|NCT00895232|Trace Elements|trace elements|mesh-ancestor
14340380|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
15227915|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15227916|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227917|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
15227918|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
15227919|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15227920|NCT03065062|Palbociclib|palbociclib|mesh-list
15227921|NCT03065062|Gedatolisib|gedatolisib|mesh-list
15227922|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227923|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15227924|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227925|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227926|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15227927|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15227928|NCT03057431|Diuretics|diuretics|mesh-ancestor
15227929|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
14340381|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340382|NCT00895232|Hematinics|hematinics|mesh-ancestor
14340383|NCT00895245|Dexamethasone|dexamethasone|mesh-list
14730598|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
14340384|NCT00895245|Palonosetron|palonosetron|mesh-list
14340385|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
14340386|NCT00895245|Aprepitant|aprepitant|mesh-list
14340387|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340388|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340389|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
14340390|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
14340391|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340392|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340393|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14340394|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
14340395|NCT00895245|Hormones|hormones|mesh-ancestor
14340396|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340397|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14340398|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14340399|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14340400|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
14340401|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340402|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340403|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14340404|NCT00895310|Ketoconazole|ketoconazole|mesh-list
14340405|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
14340406|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340407|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
14340408|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340409|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15227930|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227931|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15227932|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15227933|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227934|NCT03048422|Tenofovir|tenofovir|mesh-list
15227935|NCT03048422|Emtricitabine|emtricitabine|mesh-list
15227936|NCT03048422|Efavirenz|efavirenz|mesh-list
15227937|NCT03048422|Dolutegravir|dolutegravir|mesh-list
15227938|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14340410|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14340411|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340412|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340413|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14340414|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
14340415|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340416|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340417|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14340418|NCT00895414|Doxorubicin|doxorubicin|mesh-list
14340419|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14340420|NCT00895414|Enalapril|enalapril|mesh-list
14340421|NCT00895414|Enalaprilat|enalaprilat|mesh-list
14340422|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14340423|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340424|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14340425|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14340426|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340427|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340428|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14730599|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730600|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730601|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730602|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14730603|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14730604|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730605|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14730606|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14340429|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
14340430|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14340431|NCT00895453|Iron|iron|mesh-list
14340432|NCT00895453|Itraconazole|itraconazole|mesh-list
14340433|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
14340434|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340435|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14340436|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14730607|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
14730608|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
14730609|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
14730610|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730611|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14730612|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14730613|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14730614|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14730615|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
14730616|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
14730617|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14730618|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14340437|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340438|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340439|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14340440|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
14340441|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340442|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340443|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14340444|NCT00895453|Trace Elements|trace elements|mesh-ancestor
14340445|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
14340446|NCT00895531|Morphine|morphine|mesh-list
14340447|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14340448|NCT00895531|Narcotics|narcotics|mesh-ancestor
14340449|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340450|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340451|NCT00895531|Analgesics|analgesics|mesh-ancestor
14340452|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
14340453|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340454|NCT00895583|Sirolimus|sirolimus|mesh-list
14340455|NCT00895583|Tacrolimus|tacrolimus|mesh-list
14340456|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14340457|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
14340458|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340459|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14340460|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340461|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730619|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14752995|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
14340462|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14340463|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340464|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14340465|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340466|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
14340467|NCT00895661|Rituximab|rituximab|mesh-list
14340468|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340469|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340470|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
14340471|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340472|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340473|NCT00895752|Riluzole|riluzole|mesh-list
14340474|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
14340475|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14340476|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14340477|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340478|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340479|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340480|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14340481|NCT00895752|Protective Agents|protective agents|mesh-ancestor
14340482|NCT00895817|Fluticasone|fluticasone|mesh-list
14918095|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14918096|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14918097|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918098|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918099|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14340483|NCT00895817|Esomeprazole|esomeprazole|mesh-list
14340484|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340485|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14340486|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
14340487|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340488|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340489|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14340490|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
15227939|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15227940|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15227941|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
15227942|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15227943|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15227944|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15227945|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227946|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340491|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
14340492|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14340493|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14340494|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14340495|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14340496|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340497|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340498|NCT00895843|Ibuprofen|ibuprofen|mesh-list
14340499|NCT00895843|Epinephrine|epinephrine|mesh-list
14340500|NCT00895843|Bupivacaine|bupivacaine|mesh-list
14340501|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
14340502|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
14340503|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340504|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340505|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
14340506|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340507|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14340508|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14340509|NCT00895843|Analgesics|analgesics|mesh-ancestor
14340510|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918100|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
14918101|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918102|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340511|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340512|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14340513|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340514|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340515|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14340516|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14340517|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
14340518|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340519|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14340520|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14340521|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
14340522|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14340523|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14340524|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
14340525|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
14340526|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14340527|NCT00895895|Donepezil|donepezil|mesh-list
14340528|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14340529|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340530|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340531|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
14340532|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340533|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340534|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
14340535|NCT00895921|Olanzapine|olanzapine|mesh-list
14340536|NCT00895921|Aripiprazole|aripiprazole|mesh-list
14340537|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
14340538|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
14340539|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340540|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340541|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14340542|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14340543|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14340544|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340545|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340546|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14340547|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14340548|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340549|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340550|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918103|NCT03121534|Dexamethasone|dexamethasone|mesh-list
14918104|NCT03121534|Blinatumomab|blinatumomab|mesh-list
14918105|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918106|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
14918107|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
15227947|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15227948|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15227949|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15227950|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15227951|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15227952|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15227953|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15227954|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15227955|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15227956|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15227957|NCT03022279|Ropivacaine|ropivacaine|mesh-list
15227958|NCT03022279|Anesthetics, Local|anesthetics, local|mesh-ancestor
15227959|NCT03022279|Anesthetics|anesthetics|mesh-ancestor
15227960|NCT03022279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227961|NCT03022279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227962|NCT03022279|Sensory System Agents|sensory system agents|mesh-ancestor
15227963|NCT03022279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227964|NCT02984800|Anesthetics|anesthetics|mesh-list
15227965|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15227966|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227967|NCT02964884|Lovastatin|lovastatin|mesh-list
15227968|NCT02964884|L 647318|l 647318|mesh-list
14340551|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
14340552|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
14340553|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
14340554|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
14340555|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14340556|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14340557|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14730620|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14340558|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14340559|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14340560|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14340561|NCT00895934|Azacitidine|azacitidine|mesh-list
14340562|NCT00895934|Vorinostat|vorinostat|mesh-list
14340563|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
14340564|NCT00895934|Calicheamicins|calicheamicins|mesh-list
14340565|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14340566|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
14340567|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340568|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340569|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340570|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14340571|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340572|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14340573|NCT00895947|Interferons|interferons|mesh-list
14340574|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
14340575|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227969|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
14340576|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
14340577|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340578|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
14340579|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340580|NCT00896012|Sirolimus|sirolimus|mesh-list
14340581|NCT00896012|Tacrolimus|tacrolimus|mesh-list
14340582|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730621|NCT00528385|Spironolactone|spironolactone|mesh-list
14730622|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14730623|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
14730624|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730625|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340583|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
14340584|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340585|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14340586|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340587|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340588|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14340589|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730626|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14730627|NCT00528385|Diuretics|diuretics|mesh-ancestor
14730628|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
14730629|NCT00528502|Lidocaine|lidocaine|mesh-list
14730630|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
14730631|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
14730632|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730633|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730634|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
14730635|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730636|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14730637|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14730638|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14730639|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14730640|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730641|NCT00528515|Propofol|propofol|mesh-list
14730642|NCT00528515|Desflurane|desflurane|mesh-list
14730643|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14730644|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340590|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14340591|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340592|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
14340593|NCT00896038|Aprepitant|aprepitant|mesh-list
14340594|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
14340595|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
14340596|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340597|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340598|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14340599|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14730645|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730646|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14730647|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
14730648|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
14340600|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730649|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14340601|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340602|NCT00896051|Ritonavir|ritonavir|mesh-list
14340603|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14340604|NCT00896051|Tenofovir|tenofovir|mesh-list
14340605|NCT00896051|Etravirine|etravirine|mesh-list
14340606|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14340607|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14340608|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14340609|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
14340610|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340611|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340612|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14340613|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14340614|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
14340615|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340616|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14340617|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14340618|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14340619|NCT00896064|Vaccines|vaccines|mesh-list
14340620|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14340621|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
14340622|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340623|NCT00896168|Methotrexate|methotrexate|mesh-list
14340624|NCT00896168|Infliximab|infliximab|mesh-list
14340625|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14340626|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
14340627|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14340628|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340629|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14340630|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
14340631|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340632|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340633|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14340634|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340635|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14340636|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14340637|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
14340638|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340639|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14340640|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14340641|NCT00896181|Carboplatin|carboplatin|mesh-list
14340642|NCT00896181|Docetaxel|docetaxel|mesh-list
14340643|NCT00896181|Fluorouracil|fluorouracil|mesh-list
14340644|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340645|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14340646|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
14340647|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14340648|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340649|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
14340650|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14340651|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14340652|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
14340653|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464821|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464822|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14464823|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
14464824|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464825|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464826|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
14464827|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14464828|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464829|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14464830|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464831|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
14464832|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464833|NCT02217501|Aspirin|aspirin|mesh-list
14464834|NCT02217501|Clopidogrel|clopidogrel|mesh-list
14464835|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14464836|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14464837|NCT02217501|Analgesics|analgesics|mesh-ancestor
14918108|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918109|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918110|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464838|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
14464839|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227970|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15227971|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15227972|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
15227973|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340654|NCT00896441|Citalopram|citalopram|mesh-list
15227974|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15227975|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15227976|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15227977|NCT02925650|Phenserine|phenserine|mesh-list
15227978|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15227979|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730650|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
14730651|NCT00528593|Hematinics|hematinics|mesh-ancestor
14730652|NCT00528619|Carboplatin|carboplatin|mesh-list
14730653|NCT00528619|Pemetrexed|pemetrexed|mesh-list
14730654|NCT00528619|Sunitinib|sunitinib|mesh-list
14730655|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730656|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730657|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730658|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730659|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14730660|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14730661|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14730662|NCT00528619|Growth Substances|growth substances|mesh-ancestor
14730663|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730664|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
14730665|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14340655|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14340656|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14340657|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340658|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340659|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340660|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
14340661|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340662|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14340663|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
14730666|NCT00528658|Acetaminophen|acetaminophen|mesh-list
14730667|NCT00528658|Ibuprofen|ibuprofen|mesh-list
15227980|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227981|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
15227982|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15227983|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227984|NCT02910843|Capecitabine|capecitabine|mesh-list
14730668|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14730669|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730670|NCT00528658|Analgesics|analgesics|mesh-ancestor
14730671|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
14730672|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730673|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730674|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730675|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730676|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15227985|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15227986|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
15227987|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15227988|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15227989|NCT02891811|Thalidomide|thalidomide|mesh-list
15227990|NCT02891811|Dexamethasone|dexamethasone|mesh-list
15227991|NCT02891811|Lenalidomide|lenalidomide|mesh-list
15227992|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15227993|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
15227994|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
15227995|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15227996|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15227997|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15227998|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
15227999|NCT02891811|Hormones|hormones|mesh-ancestor
15228000|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228001|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15228002|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228003|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
15228004|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15228005|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15228006|NCT02891811|Growth Substances|growth substances|mesh-ancestor
15228007|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
15228008|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228009|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
15228010|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228011|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228012|NCT02876510|Vidarabine|vidarabine|mesh-list
15228013|NCT02876510|Aldesleukin|aldesleukin|mesh-list
15228014|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
14340664|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340665|NCT00896454|Denosumab|denosumab|mesh-list
14340666|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14340667|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340668|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
14340669|NCT00896532|Denosumab|denosumab|mesh-list
14340670|NCT00896532|Alendronate|alendronate|mesh-list
14340671|NCT00896532|Teriparatide|teriparatide|mesh-list
14340672|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14340673|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14340674|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340675|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14340676|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
14340677|NCT00896779|Ranibizumab|ranibizumab|mesh-list
14340678|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340679|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340680|NCT00896779|Growth Substances|growth substances|mesh-ancestor
14340681|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340682|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340683|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340684|NCT00897390|Metformin|metformin|mesh-list
14340685|NCT00897390|Saxagliptin|saxagliptin|mesh-list
14340686|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14340687|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340688|NCT00897390|Incretins|incretins|mesh-ancestor
14340689|NCT00897390|Hormones|hormones|mesh-ancestor
14340690|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340691|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14340692|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
14340693|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340694|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340695|NCT00897715|Rilonacept|rilonacept|mesh-list
14340696|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340697|NCT00898222|Aspirin|aspirin|mesh-list
14340698|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14340699|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14340700|NCT00898222|Analgesics|analgesics|mesh-ancestor
14340701|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
14340702|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340703|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340704|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228015|NCT02876510|Fludarabine|fludarabine|mesh-list
15228016|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
15228017|NCT02876510|Atezolizumab|atezolizumab|mesh-list
15228018|NCT02876510|Interleukin-2|interleukin-2|mesh-list
15228019|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228020|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
15228021|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228022|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228023|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15228024|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
15228025|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228026|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228027|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15228028|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15228029|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
15228030|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
15228031|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228032|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15228033|NCT02876510|Analgesics|analgesics|mesh-ancestor
15228034|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
14340705|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340706|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14340707|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14340708|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340709|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14340710|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14340711|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340712|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
14340713|NCT00898443|Anesthetics|anesthetics|mesh-list
14340714|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340715|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340716|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14340717|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
15228035|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228036|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15228037|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15228038|NCT02839915|Leucovorin|leucovorin|mesh-list
15228039|NCT02839915|Folic Acid|folic acid|mesh-list
15228040|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
15228041|NCT02839915|Antidotes|antidotes|mesh-ancestor
15228042|NCT02839915|Protective Agents|protective agents|mesh-ancestor
15228043|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228044|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
15228045|NCT02839915|Vitamins|vitamins|mesh-ancestor
15228046|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
15228047|NCT02839915|Hematinics|hematinics|mesh-ancestor
15228048|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
15228049|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14730677|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730678|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730679|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
14730680|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
14730681|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
14730682|NCT00528723|Albuterol|albuterol|mesh-list
14730683|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14730684|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
14730685|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730686|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730687|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14730688|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
14730689|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
14730690|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228050|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228051|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
14340718|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14340719|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14340720|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340721|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340722|NCT00898807|Citalopram|citalopram|mesh-list
14340723|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14340724|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14340725|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14730691|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14918111|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
14918112|NCT03121534|Hormones|hormones|mesh-ancestor
14730692|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14730693|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14730694|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
14730695|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730696|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730697|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
14730698|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14930838|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
15228052|NCT02828761|Calcium|calcium|mesh-list
15228053|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15228054|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228055|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14918113|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730699|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730700|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
14730701|NCT00528827|Nicardipine|nicardipine|mesh-list
14730702|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14730703|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14730704|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14730705|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918114|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15228056|NCT02815280|Minocycline|minocycline|mesh-list
14340726|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340727|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340728|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
14340729|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340730|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14340731|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
14340732|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14340733|NCT00899431|Vidarabine|vidarabine|mesh-list
14340734|NCT00899431|Rituximab|rituximab|mesh-list
14340735|NCT00899431|Fludarabine|fludarabine|mesh-list
14340736|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
14340737|NCT00899431|Lenalidomide|lenalidomide|mesh-list
14340738|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14340739|NCT00899431|Allopurinol|allopurinol|mesh-list
14340740|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
14340741|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14340742|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14340743|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340744|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
14340745|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340746|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340747|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14340748|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
14340749|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340750|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14340751|NCT00899431|Antiviral Agents|antiviral agents|mesh-ancestor
14340752|NCT00899431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340753|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340754|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340755|NCT00899431|Growth Substances|growth substances|mesh-ancestor
14340756|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340757|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15228057|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228058|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228059|NCT02815267|Minocycline|minocycline|mesh-list
14340758|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
14340759|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340760|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
14340761|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14340762|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
14340763|NCT00899431|Protective Agents|protective agents|mesh-ancestor
14340764|NCT00899470|Metformin|metformin|mesh-list
14340765|NCT00899470|Saxagliptin|saxagliptin|mesh-list
14340766|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14340767|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228060|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228061|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228062|NCT02811783|Naloxone|naloxone|mesh-list
15228063|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15228064|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228065|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
14340768|NCT00899470|Incretins|incretins|mesh-ancestor
14340769|NCT00899470|Hormones|hormones|mesh-ancestor
14730706|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15228066|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340770|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340771|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14340772|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
14340773|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340774|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340775|NCT00899574|Imiquimod|imiquimod|mesh-list
14340776|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14340777|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
14340778|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340779|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340780|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
14340781|NCT00899600|Ketamine|ketamine|mesh-list
14340782|NCT00899600|Analgesics|analgesics|mesh-ancestor
14340783|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
14340784|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340785|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340786|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14340787|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14340788|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
14340789|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
14340790|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340791|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14340792|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14340793|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340794|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340795|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
14340796|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14340797|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
14340798|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340799|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340800|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
14340801|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340802|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
14340803|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
14340804|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14340805|NCT00899847|Acetaminophen|acetaminophen|mesh-list
14340806|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
14340807|NCT00899847|Promethazine|promethazine|mesh-list
14340808|NCT00899847|Cyclosporine|cyclosporine|mesh-list
14340809|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
14340810|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
14340811|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14340812|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
14340813|NCT00899847|Melphalan|melphalan|mesh-list
15228067|NCT02802228|Ifetroban|ifetroban|mesh-list
15228068|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15228069|NCT02801448|Sulforaphane|sulforaphane|mesh-list
15228070|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15228071|NCT02801448|Protective Agents|protective agents|mesh-ancestor
15228072|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228073|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228074|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
15228075|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340814|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
14340815|NCT00899847|Cyclosporins|cyclosporins|mesh-list
14340816|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
15228076|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
15228077|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228078|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228079|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14340817|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14340818|NCT00899847|Lenograstim|lenograstim|mesh-list
14340819|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14340820|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
14340821|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340822|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340823|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14340824|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
14340825|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340826|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340827|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14340828|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14340829|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340830|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
14340831|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340832|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14340833|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14340834|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14340835|NCT00899847|Analgesics|analgesics|mesh-ancestor
14340836|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
14918115|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918116|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
14918117|NCT03116997|Neostigmine|neostigmine|mesh-list
14918118|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14918119|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918120|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918121|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
14918122|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918123|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340837|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340838|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
14340839|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14340840|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14340841|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
14340842|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14918124|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14340843|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340844|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14918125|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
14340845|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14340846|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340847|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
14340848|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
14340849|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
14340850|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
14340851|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14340852|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14340853|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
14340854|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
14340855|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340856|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14340857|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
14340858|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
14340859|NCT00899847|Hormones|hormones|mesh-ancestor
14340860|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340861|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14340862|NCT00899847|Protective Agents|protective agents|mesh-ancestor
14340863|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14340864|NCT00900146|Metformin|metformin|mesh-list
14340865|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14340866|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340867|NCT00900159|Eszopiclone|eszopiclone|mesh-list
14340868|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14340869|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340870|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340871|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14340872|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
14340873|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
14340874|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14340875|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14340876|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340877|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340878|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14340879|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14340880|NCT00900627|Paclitaxel|paclitaxel|mesh-list
14340881|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14340882|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228080|NCT02661022|Dexamethasone|dexamethasone|mesh-list
15228081|NCT02661022|Pomalidomide|pomalidomide|mesh-list
15228082|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228083|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
15228084|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
14340883|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
14340884|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
14730707|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730708|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
14340885|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
14340886|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340887|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
14340888|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14340889|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14340890|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14340891|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340892|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340893|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
15228085|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228086|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228087|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228088|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
15228089|NCT02661022|Hormones|hormones|mesh-ancestor
15228090|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14340894|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340895|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340896|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14340897|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340898|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
14340899|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14340900|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
14340901|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340902|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340903|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14340904|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
14340905|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
15228091|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15228092|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228093|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
15228094|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15228095|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15228096|NCT02661022|Growth Substances|growth substances|mesh-ancestor
15228097|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
14730709|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
14730710|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14730711|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14730712|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
14730713|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730714|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14730715|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14730716|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730717|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730718|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
14730719|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14730720|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730721|NCT00528983|Azacitidine|azacitidine|mesh-list
14730722|NCT00528983|Cc-486|cc-486|mesh-list
14730723|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14730724|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
14730725|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730726|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228098|NCT02655016|Niraparib|niraparib|mesh-list
15228099|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15228100|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228101|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228102|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228103|NCT02652195|Oxytocin|oxytocin|mesh-list
15228104|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
15228105|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228106|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228107|NCT02650271|Tenofovir|tenofovir|mesh-list
15228108|NCT02650271|Entecavir|entecavir|mesh-list
15228109|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
14730727|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340906|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14340907|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
14730728|NCT00529022|Carboplatin|carboplatin|mesh-list
15228110|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228111|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15228112|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228113|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228114|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228115|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15228116|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15228117|NCT02649855|Docetaxel|docetaxel|mesh-list
15228118|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228119|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
15228120|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
14340908|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340909|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340910|NCT00900757|Palonosetron|palonosetron|mesh-list
15228121|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
15228122|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228123|NCT02570984|Omalizumab|omalizumab|mesh-list
15228124|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15228125|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15228126|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
15228127|NCT02539693|Lidocaine|lidocaine|mesh-list
15228128|NCT02539693|Clonidine|clonidine|mesh-list
15228129|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
15228130|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
15228131|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15228132|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228133|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
14340911|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
14340912|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
14340913|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340914|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340915|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14340916|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14340917|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14340918|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
14340919|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340920|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340921|NCT00901186|Ranibizumab|ranibizumab|mesh-list
14340922|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14340923|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14340924|NCT00901186|Growth Substances|growth substances|mesh-ancestor
14340925|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340926|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14340927|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14340928|NCT00901199|Deferasirox|deferasirox|mesh-list
14340929|NCT00901199|Deferoxamine|deferoxamine|mesh-list
14340930|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14340931|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
14340932|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
14340933|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730729|NCT00529022|Azacitidine|azacitidine|mesh-list
14730730|NCT00529022|Valproic Acid|valproic acid|mesh-list
14730731|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730732|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14730733|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
14340934|NCT00901199|Siderophores|siderophores|mesh-ancestor
14340935|NCT00901225|Plerixafor|plerixafor|mesh-list
14340936|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14340937|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14340938|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
14340939|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14340940|NCT00901394|Folic Acid|folic acid|mesh-list
14340941|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
14340942|NCT00901394|Hematinics|hematinics|mesh-ancestor
14340943|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
14340944|NCT00901394|Vitamins|vitamins|mesh-ancestor
14340945|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
14340946|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340947|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14340948|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
14730734|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340949|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
14340950|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340951|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14340952|NCT00901394|Analgesics|analgesics|mesh-ancestor
14340953|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
15228134|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228135|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15228136|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15228137|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15228138|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15228139|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228140|NCT02539693|Analgesics|analgesics|mesh-ancestor
15228141|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15228142|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
15228143|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
15228144|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15228145|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15228146|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15228147|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
15228148|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228149|NCT02534012|Anesthetics|anesthetics|mesh-list
15228150|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15228151|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228152|NCT02505204|Clonidine|clonidine|mesh-list
15228153|NCT02505204|Analgesics|analgesics|mesh-ancestor
15228154|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
15228155|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340954|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14340955|NCT00901576|Methylphenidate|methylphenidate|mesh-list
14340956|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14340957|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340958|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14340959|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14340960|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14340961|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340962|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
14340963|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340964|NCT00901628|Cefuroxime|cefuroxime|mesh-list
14340965|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
14340966|NCT00901628|Ketorolac|ketorolac|mesh-list
14730735|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730736|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
14730737|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
14730738|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228156|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228157|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15228158|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
15228159|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
14730739|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340967|NCT00901628|Epinephrine|epinephrine|mesh-list
14340968|NCT00901628|Morphine|morphine|mesh-list
14340969|NCT00901628|Ropivacaine|ropivacaine|mesh-list
14340970|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14340971|NCT00901628|Narcotics|narcotics|mesh-ancestor
14730740|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
14730741|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14730742|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730743|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14730744|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
14730745|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14730746|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730747|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14730748|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
14730749|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730750|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730751|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730752|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730753|NCT00529295|Misoprostol|misoprostol|mesh-list
14730754|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14730755|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
14730756|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14752996|NCT05307198|Antibodies|antibodies|mesh-list
14340972|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14340973|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340974|NCT00901628|Analgesics|analgesics|mesh-ancestor
14340975|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
14340976|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730757|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14340977|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
14340978|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
14340979|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14340980|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14340981|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
14340982|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14340983|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14340984|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14340985|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14340986|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
14340987|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14340988|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
14340989|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
14340990|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
14340991|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14340992|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14340993|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14340994|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14340995|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14340996|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14340997|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14340998|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14340999|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341000|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14341001|NCT00901901|Sorafenib|sorafenib|mesh-list
14341002|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341003|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14341004|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341005|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341006|NCT00901927|Rituximab|rituximab|mesh-list
14341007|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14341008|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
14341009|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341010|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341011|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
14341012|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341013|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341014|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14341015|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
14464840|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464841|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14464842|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464843|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14464844|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14464845|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464846|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14464847|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14464848|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464849|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
14730758|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14730759|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14730760|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
14730761|NCT00529360|Clofarabine|clofarabine|mesh-list
14730762|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14730763|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
14730764|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730765|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730766|NCT00529425|Ropivacaine|ropivacaine|mesh-list
14341016|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341017|NCT00901927|Analgesics|analgesics|mesh-ancestor
14341018|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
14341019|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341020|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14341021|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14341022|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341023|NCT00902161|Propranolol|propranolol|mesh-list
14341024|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14341025|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14341026|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
14341027|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341028|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341029|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341030|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14341031|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341032|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
14730767|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
14730768|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
14730769|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730770|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730771|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
14730772|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730773|NCT00529594|Etoricoxib|etoricoxib|mesh-list
14730774|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14341033|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
14341034|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341035|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14341036|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341037|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730775|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730776|NCT00529594|Analgesics|analgesics|mesh-ancestor
14730777|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
14730778|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730779|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730780|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730781|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730782|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14730783|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14341038|NCT00902226|Citalopram|citalopram|mesh-list
14341039|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14341040|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14341041|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341042|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341043|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341044|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
14341045|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341046|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14341047|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
14341048|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14341049|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14341050|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
14341051|NCT00902265|Coagulants|coagulants|mesh-ancestor
14341052|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14341053|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
14341054|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341055|NCT00902304|Amlodipine|amlodipine|mesh-list
14341056|NCT00902304|Valsartan|valsartan|mesh-list
14341057|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14341058|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14341059|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341060|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14341061|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341062|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341063|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341064|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341065|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
14341066|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14341067|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14341068|NCT00902304|Diuretics|diuretics|mesh-ancestor
14341069|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
14341070|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14341071|NCT00902538|Amlodipine|amlodipine|mesh-list
14341072|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14341073|NCT00902538|Olmesartan|olmesartan|mesh-list
14341074|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14341075|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341076|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14341077|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341078|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341079|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341080|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341081|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
14341082|NCT00902538|Diuretics|diuretics|mesh-ancestor
14341083|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
14341084|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14341085|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14341086|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14341087|NCT00902564|Citalopram|citalopram|mesh-list
14341088|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14341089|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14341090|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341091|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341092|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341093|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
14730784|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730785|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730786|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
14730787|NCT00529620|Piperaquine|piperaquine|mesh-list
14730788|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
14730789|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14730790|NCT00529620|Amodiaquine|amodiaquine|mesh-list
14730791|NCT00529620|Artenimol|artenimol|mesh-list
14730792|NCT00529620|Sulfalene|sulfalene|mesh-list
14730793|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
14730794|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14730795|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14730796|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730797|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15228160|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14341094|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730798|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228161|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15228162|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14341095|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14341096|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
14341097|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14341098|NCT00902577|Misonidazole|misonidazole|mesh-list
14341099|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341100|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14341101|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14341102|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341103|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
14341104|NCT00903162|Letrozole|letrozole|mesh-list
14341105|NCT00903162|Leuprolide|leuprolide|mesh-list
14341106|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341107|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14341108|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14341109|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341110|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341111|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14341112|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
14341113|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341114|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341115|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14341116|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14341117|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
14341118|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14341119|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341120|NCT00903175|Everolimus|everolimus|mesh-list
14341121|NCT00903175|Sunitinib|sunitinib|mesh-list
14341122|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341123|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341124|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
14341125|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341126|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14341127|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14341128|NCT00903175|Growth Substances|growth substances|mesh-ancestor
14341129|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
14341130|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14341131|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341132|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341133|NCT00903331|Macitentan|macitentan|mesh-list
14341134|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14341135|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14341136|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341137|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14341138|NCT00903344|Vitamin D|vitamin d|mesh-list
14341139|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
14341140|NCT00903344|Vitamins|vitamins|mesh-ancestor
14341141|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
14341142|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341143|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14341144|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341145|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
14341146|NCT00903357|Montelukast|montelukast|mesh-list
14341147|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14341148|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14341149|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14341150|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
14341151|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228163|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
15228164|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228165|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228166|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
15228167|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
15228168|NCT02487979|Immunotoxins|immunotoxins|mesh-list
15228169|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15228170|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
15228171|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228172|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15228173|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228174|NCT02310867|Abatacept|abatacept|mesh-list
15228175|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15228176|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228177|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228178|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228179|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
15228180|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228181|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228182|NCT02303431|Edoxaban|edoxaban|mesh-list
15228183|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15228184|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
14341152|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341153|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14341154|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14341155|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341156|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
14341157|NCT00903357|Protective Agents|protective agents|mesh-ancestor
14918126|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918127|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14918128|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14918129|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14918130|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
14918131|NCT03107611|Tacrolimus|tacrolimus|mesh-list
14918132|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14918133|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918134|NCT03107611|Analgesics|analgesics|mesh-ancestor
14918135|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
14918136|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918137|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918138|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918139|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918140|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
14918141|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918142|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
15228185|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15228186|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
15228187|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228188|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228189|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
15228190|NCT02288897|Temozolomide|temozolomide|mesh-list
15228191|NCT02288897|Dacarbazine|dacarbazine|mesh-list
15228192|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15228193|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15228194|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
15228195|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228196|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228197|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15228198|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
15228199|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228200|NCT02022982|Palbociclib|palbociclib|mesh-list
15228201|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228202|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918143|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14918144|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918145|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918146|NCT03089866|Midazolam|midazolam|mesh-list
14918147|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14918148|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14918149|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918150|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918151|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14918152|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14918153|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14918154|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14918155|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
14918156|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
14918157|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
14918158|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
14918159|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918160|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918161|NCT03040726|Palonosetron|palonosetron|mesh-list
15228203|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228204|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228205|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15228206|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
15228207|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228208|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15228209|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
15228210|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228211|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228212|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15228213|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15228214|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15228215|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
15228216|NCT01898312|Mifepristone|mifepristone|mesh-list
14341158|NCT00903357|Vitamins|vitamins|mesh-ancestor
14341159|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
14341160|NCT00903409|Simvastatin|simvastatin|mesh-list
14341161|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14341162|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14341163|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
14341164|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341165|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14341166|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14341167|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341168|NCT00903448|Omeprazole|omeprazole|mesh-list
14341169|NCT00903448|Lansoprazole|lansoprazole|mesh-list
14341170|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14341171|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228217|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14341172|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15228218|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
15228219|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228220|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228221|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15228222|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14730799|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730800|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14730801|NCT00529620|Renal Agents|renal agents|mesh-ancestor
14730802|NCT00529646|APD791|apd791|mesh-list
14730803|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14730804|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14730805|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
14730806|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341173|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341174|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341175|NCT00903617|Niacin|niacin|mesh-list
14341176|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
14341177|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14341178|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
14341179|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341180|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14341181|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
14341182|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
14341183|NCT00903617|Vitamins|vitamins|mesh-ancestor
14341184|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
14341185|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341186|NCT00903630|Doxorubicin|doxorubicin|mesh-list
14341187|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14341188|NCT00903630|Lenalidomide|lenalidomide|mesh-list
14341189|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14341190|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341191|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14341192|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14341193|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341194|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341195|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
14752997|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14341196|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341197|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14341198|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14341199|NCT00903630|Growth Substances|growth substances|mesh-ancestor
14341200|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
14341201|NCT00903682|Efavirenz|efavirenz|mesh-list
14341202|NCT00903682|Etravirine|etravirine|mesh-list
14341203|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14341204|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14341205|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341206|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341207|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
14918162|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
14918163|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
14918164|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918165|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918166|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918167|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14918168|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14918169|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
14918170|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918171|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918172|NCT02871219|Lenalidomide|lenalidomide|mesh-list
14918173|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
14918174|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
14918175|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918176|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14918177|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14918178|NCT02871219|Growth Substances|growth substances|mesh-ancestor
14918179|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
14918180|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228223|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14341208|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228224|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
15228225|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15228226|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15228227|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
15228228|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228229|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
15228230|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15228231|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15228232|NCT01883804|Methyldopa|methyldopa|mesh-list
14341209|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14341210|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14341211|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14341212|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14341213|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14341214|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15228233|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341215|NCT00903760|Decitabine|decitabine|mesh-list
14341216|NCT00903760|Clofarabine|clofarabine|mesh-list
14341217|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14341218|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
14341219|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918181|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341220|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341221|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341222|NCT00903968|Plerixafor|plerixafor|mesh-list
14341223|NCT00903968|Dexamethasone|dexamethasone|mesh-list
14341224|NCT00903968|Bortezomib|bortezomib|mesh-list
14341225|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14341226|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
14341227|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
14341228|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341229|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341230|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14341231|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
14341232|NCT00903968|Hormones|hormones|mesh-ancestor
14341233|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341234|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341235|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341236|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14341237|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14341238|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
14341239|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341240|NCT00904033|Calcitriol|calcitriol|mesh-list
14341241|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341242|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341243|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14918182|NCT02607956|Dolutegravir|dolutegravir|mesh-list
14918183|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14918184|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14918185|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14918186|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918187|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918188|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14341244|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341245|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341246|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14341247|NCT00904033|Vitamins|vitamins|mesh-ancestor
14341248|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
14341249|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14341250|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14341251|NCT00904215|Telmisartan|telmisartan|mesh-list
14341252|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15228234|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
15228235|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
15228236|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228237|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228238|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14918189|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14918190|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
14918191|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14918192|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14918193|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14918194|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
14918195|NCT02501096|Lenvatinib|lenvatinib|mesh-list
14918196|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918197|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918198|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918199|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341253|NCT00904215|Diuretics|diuretics|mesh-ancestor
14341254|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
14341255|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341256|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14341257|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341258|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341259|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14341260|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15228239|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15228240|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15228241|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
14341261|NCT00904345|Cetuximab|cetuximab|mesh-list
14341262|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341263|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341264|NCT00904488|Metolazone|metolazone|mesh-list
14341265|NCT00904488|Furosemide|furosemide|mesh-list
14341266|NCT00904488|Diuretics|diuretics|mesh-ancestor
14341267|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
14341268|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341269|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14730807|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730808|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730809|NCT00529750|Atenolol|atenolol|mesh-list
14730810|NCT00529750|Irbesartan|irbesartan|mesh-list
14730811|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14730812|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14730813|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14730814|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730815|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15228242|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341270|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341271|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341272|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341273|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14341274|NCT00904618|Lidocaine|lidocaine|mesh-list
14341275|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
14341276|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
14341277|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14341278|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341279|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
14341280|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918200|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918201|NCT02499666|Clopidogrel|clopidogrel|mesh-list
14918202|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14918203|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14918204|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15228243|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341281|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14341282|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14341283|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14341284|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341285|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341286|NCT00904670|Methylphenidate|methylphenidate|mesh-list
14341287|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14341288|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228244|NCT01881048|Celecoxib|celecoxib|mesh-list
15228245|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15228246|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14341289|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14341290|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14341291|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341292|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341293|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
14341294|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341295|NCT00904722|Rituximab|rituximab|mesh-list
14341296|NCT00904722|Pidilizumab|pidilizumab|mesh-list
14341297|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15228247|NCT01881048|Analgesics|analgesics|mesh-ancestor
15228248|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
15228249|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228250|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228251|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228252|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228253|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15228254|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15228255|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228256|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228257|NCT01838187|Vorinostat|vorinostat|mesh-list
15228258|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14341298|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341299|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
14341300|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341301|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341302|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
14341303|NCT00904748|Citric Acid|citric acid|mesh-list
14341304|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
14341305|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
14341306|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14341307|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
14341308|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
14341309|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341310|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
14341311|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14341312|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14341313|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341314|NCT00904748|Urological Agents|urological agents|mesh-ancestor
14341315|NCT00904826|Eculizumab|eculizumab|mesh-list
14341316|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14341317|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341318|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
14341319|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341320|NCT00904839|Bevacizumab|bevacizumab|mesh-list
14341321|NCT00904839|Nintedanib|nintedanib|mesh-list
14341322|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341323|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341324|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14341325|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14341326|NCT00904839|Growth Substances|growth substances|mesh-ancestor
14341327|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341328|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
14341329|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14341330|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341331|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228259|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228260|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14918205|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14918206|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
14918207|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918208|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464850|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14464851|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14464852|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14464853|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
14464854|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469867|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469868|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15228261|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228262|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228263|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15228264|NCT01720147|Quercetin|quercetin|mesh-list
15228265|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
15228266|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228267|NCT01720147|Protective Agents|protective agents|mesh-ancestor
15228268|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228269|NCT01694004|Benzocaine|benzocaine|mesh-list
15228270|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
15228271|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
14341332|NCT00904995|Voriconazole|voriconazole|mesh-list
14341333|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
14341334|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228272|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15228273|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228274|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
15228275|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228276|NCT01566695|Azacitidine|azacitidine|mesh-list
15228277|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918209|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918210|NCT02456857|Bevacizumab|bevacizumab|mesh-list
14918211|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14918212|NCT02456857|Doxorubicin|doxorubicin|mesh-list
15228278|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
14341335|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14341336|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14341337|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341338|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341339|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15228279|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228280|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228281|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228282|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
15228283|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228284|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228285|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228286|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228287|NCT01376427|Dexamethasone|dexamethasone|mesh-list
15228288|NCT01376427|Methotrexate|methotrexate|mesh-list
15228289|NCT01376427|Vincristine|vincristine|mesh-list
15228290|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228291|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
15228292|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
15228293|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341340|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
14341341|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341342|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341343|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14341344|NCT00905021|Sunitinib|sunitinib|mesh-list
14341345|NCT00905021|Exemestane|exemestane|mesh-list
14730816|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
14730817|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
14730818|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730819|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730820|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14341346|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341347|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14341348|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14341349|NCT00905021|Growth Substances|growth substances|mesh-ancestor
14341350|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341351|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14341352|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14341353|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341354|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341355|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14341356|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14341357|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14341358|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
14341359|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730821|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14730822|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14918213|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14341360|NCT00905034|Dexamethasone|dexamethasone|mesh-list
14341361|NCT00905034|Rituximab|rituximab|mesh-list
14341362|NCT00905034|Methotrexate|methotrexate|mesh-list
14341363|NCT00905034|Vincristine|vincristine|mesh-list
14341364|NCT00905034|Asparaginase|asparaginase|mesh-list
14341365|NCT00905034|Pegaspargase|pegaspargase|mesh-list
14341366|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228294|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228295|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228296|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
15228297|NCT01376427|Hormones|hormones|mesh-ancestor
15228298|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918214|NCT02456857|Everolimus|everolimus|mesh-list
14918215|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
14918216|NCT02456857|Antibodies|antibodies|mesh-list
14918217|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
14918218|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14341367|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
14730823|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
14730824|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730825|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
14730826|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14730827|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730828|NCT00529867|Lumefantrine|lumefantrine|mesh-list
14730829|NCT00529867|Artemether|artemether|mesh-list
14730830|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14730831|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
14730832|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14730833|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14730834|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730835|NCT00529880|Cytarabine|cytarabine|mesh-list
15228299|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341368|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
14341369|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341370|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341371|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14341372|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
14341373|NCT00905034|Hormones|hormones|mesh-ancestor
14341374|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341375|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341376|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341377|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341378|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
14341379|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341380|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14341381|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
14341382|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14341383|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14341384|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
14341385|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341386|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14341387|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341388|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14341389|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730836|NCT00529880|Fludarabine|fludarabine|mesh-list
14730837|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228300|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228301|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15228302|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
15228303|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228304|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15228305|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
15228306|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228307|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
15228308|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228309|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14730838|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14730839|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
14918219|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
14341390|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14341391|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14341392|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
14341393|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
14341394|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
14341395|NCT00905060|Temozolomide|temozolomide|mesh-list
14341396|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14341397|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
14341398|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341399|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341400|NCT00905255|Lixisenatide|lixisenatide|mesh-list
14341401|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14341402|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341403|NCT00905268|Idebenone|idebenone|mesh-list
14341404|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
14341405|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341406|NCT00905268|Protective Agents|protective agents|mesh-ancestor
14341407|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341408|NCT00905307|Aripiprazole|aripiprazole|mesh-list
14341409|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
14341410|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14341411|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14341412|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14341413|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14341414|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341415|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
14341416|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
14341417|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341418|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341419|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14341420|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14341421|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
14341422|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14341423|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14730840|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730841|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14730842|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
14730843|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730844|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
14730845|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730846|NCT00530101|Doxorubicin|doxorubicin|mesh-list
14730847|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14730848|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341424|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14918220|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918221|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14918222|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14918223|NCT02456857|Growth Substances|growth substances|mesh-ancestor
14918224|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918225|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
14918226|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
14918227|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14918228|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14918229|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918230|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918231|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918232|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228310|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918233|NCT02420912|Nivolumab|nivolumab|mesh-list
14918234|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918235|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918236|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14918237|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918238|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
14918239|NCT02232152|Fluorouracil|fluorouracil|mesh-list
14918240|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
14918241|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918242|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918243|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918244|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918245|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
14918246|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918247|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
14918248|NCT02232152|Protective Agents|protective agents|mesh-ancestor
14918249|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
14918250|NCT02232152|Vitamins|vitamins|mesh-ancestor
14918251|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
14918252|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14918253|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14918254|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
14918255|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918256|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918257|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14918258|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
14918259|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
14918260|NCT02215122|Hormones|hormones|mesh-ancestor
14918261|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918262|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
14918263|NCT02112734|Vitamin D|vitamin d|mesh-list
14918264|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
14918265|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
14918266|NCT02112734|Vitamins|vitamins|mesh-list
14341425|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14341426|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14730849|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14730850|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730851|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730852|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730853|NCT00530127|Deferiprone|deferiprone|mesh-list
14730854|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14730855|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
14730856|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
14918267|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
14918268|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918269|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15228311|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
15228312|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228313|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228314|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14341427|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
14341428|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14730857|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341429|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14730858|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14730859|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
14730860|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752998|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
14752999|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753000|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753001|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
14753002|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753003|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753004|NCT05306379|Simvastatin|simvastatin|mesh-list
14753005|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14753006|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14753007|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
14753008|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753009|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14753010|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14753011|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753012|NCT05304663|Lomustine|lomustine|mesh-list
14753013|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14753014|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
14753015|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753016|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753017|NCT05303805|Sevoflurane|sevoflurane|mesh-list
14753018|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14753019|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14341430|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753020|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
14753021|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
14918270|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14918271|NCT02094716|Permethrin|permethrin|mesh-list
14918272|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918273|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341431|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14341432|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14341433|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341434|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918274|NCT02094261|Osimertinib|osimertinib|mesh-list
14918275|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918276|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918277|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918278|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918279|NCT01988493|Sorafenib|sorafenib|mesh-list
14918280|NCT01988493|Tepotinib|tepotinib|mesh-list
14918281|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228315|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
15228316|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
15228317|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14341435|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
14341436|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341437|NCT00905437|Pregabalin|pregabalin|mesh-list
14341438|NCT00905437|Analgesics|analgesics|mesh-ancestor
14341439|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
14341440|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341441|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341442|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
14464855|NCT02217566|Prednisone|prednisone|mesh-list
15228318|NCT01366898|Methotrexate|methotrexate|mesh-list
15228319|NCT01366898|Idarubicin|idarubicin|mesh-list
15228320|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15228321|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
15228322|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228323|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228324|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15228325|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
14464856|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
14464857|NCT02217566|Androgens|androgens|mesh-list
14464858|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14464859|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
14464860|NCT02217566|Hormones|hormones|mesh-ancestor
14464861|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14464862|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464863|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918282|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918283|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918284|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918285|NCT01953926|Trastuzumab|trastuzumab|mesh-list
14918286|NCT01953926|Fulvestrant|fulvestrant|mesh-list
14918287|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341443|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14341444|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341445|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341446|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341447|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14341448|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14341449|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14341450|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14341451|NCT00905489|Nevirapine|nevirapine|mesh-list
14341452|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14918288|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918289|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918290|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15228326|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341453|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14341454|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341455|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341456|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
14341457|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341458|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14341459|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14341460|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14341461|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14341462|NCT00905515|Cyclosporine|cyclosporine|mesh-list
14341463|NCT00905515|Tacrolimus|tacrolimus|mesh-list
14341464|NCT00905515|Cyclosporins|cyclosporins|mesh-list
14730861|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14730862|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
14730863|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341465|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341466|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
14341467|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341468|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14341469|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341470|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341471|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
14341472|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341473|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
14341474|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341475|NCT00905580|Pregabalin|pregabalin|mesh-list
14341476|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341477|NCT00905580|Analgesics|analgesics|mesh-ancestor
14341478|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
14341479|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341480|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
14341481|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14341482|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341483|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341484|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341485|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14341486|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14341487|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730864|NCT00530387|Ibuprofen|ibuprofen|mesh-list
14730865|NCT00530387|Diclofenac|diclofenac|mesh-list
15228327|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228328|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
15228329|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228330|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15228331|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228332|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
15228333|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228334|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228335|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15228336|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15228337|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14730866|NCT00530387|Ketoprofen|ketoprofen|mesh-list
14730867|NCT00530387|Piroxicam|piroxicam|mesh-list
14730868|NCT00530387|Salicylates|salicylates|mesh-list
14730869|NCT00530387|Etofenamate|etofenamate|mesh-list
14730870|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
14730871|NCT00530387|Homosalate|homosalate|mesh-list
14730872|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
14730873|NCT00530387|Benzophenone|benzophenone|mesh-list
14730874|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14730875|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14730876|NCT00530387|Analgesics|analgesics|mesh-ancestor
14730877|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
14341488|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14341489|NCT00906087|Timolol|timolol|mesh-list
14341490|NCT00906087|Dorzolamide|dorzolamide|mesh-list
14341491|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14341492|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14341493|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14341494|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
14341495|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341496|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341497|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341498|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14341499|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14918291|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14918292|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
14918293|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918294|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918295|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
14918296|NCT01798004|Melphalan|melphalan|mesh-list
14918297|NCT01798004|Busulfan|busulfan|mesh-list
14918298|NCT01798004|Doxorubicin|doxorubicin|mesh-list
14918299|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14918300|NCT01798004|Etoposide|etoposide|mesh-list
14730878|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14730879|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730880|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14730881|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14730882|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14918301|NCT01798004|Vincristine|vincristine|mesh-list
14918302|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
14918303|NCT01798004|Topotecan|topotecan|mesh-list
14918304|NCT01798004|Mesna|mesna|mesh-list
14918305|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918306|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
14918307|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918308|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918309|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14341500|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14341501|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341502|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14341503|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
14341504|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14341505|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
14341506|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341507|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341508|NCT00906282|Carboplatin|carboplatin|mesh-list
14730883|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730884|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730885|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14730886|NCT00530387|Protective Agents|protective agents|mesh-ancestor
14730887|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
14730888|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14730889|NCT00530400|Cefuroxime|cefuroxime|mesh-list
14730890|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
14730891|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14730892|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730893|NCT00530413|Phenobarbital|phenobarbital|mesh-list
14341509|NCT00906282|Pemetrexed|pemetrexed|mesh-list
14341510|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341511|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730894|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
14730895|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14730896|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918310|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
14918311|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730897|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730898|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14730899|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14730900|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730901|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730902|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
14730903|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
14730904|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14730905|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14730906|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14730907|NCT00530478|Donepezil|donepezil|mesh-list
14730908|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15228338|NCT01358201|Cytarabine|cytarabine|mesh-list
15228339|NCT01358201|Dexamethasone|dexamethasone|mesh-list
15228340|NCT01358201|Methotrexate|methotrexate|mesh-list
15228341|NCT01358201|Vincristine|vincristine|mesh-list
15228342|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228343|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
15228344|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
15228345|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228346|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228347|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228348|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
15228349|NCT01358201|Hormones|hormones|mesh-ancestor
15228350|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228351|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15228352|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228353|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15228354|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
15228355|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228356|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15228357|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
15228358|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228359|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
14730909|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730910|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730911|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
14730912|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730913|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730914|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
14730915|NCT00530517|Sumatriptan|sumatriptan|mesh-list
14730916|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14730917|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14730918|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14730919|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
14730920|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730921|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341512|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341513|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14341514|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14341515|NCT00906347|Misoprostol|misoprostol|mesh-list
14341516|NCT00906347|Oxytocin|oxytocin|mesh-list
14341517|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
14341518|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14341519|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341520|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14341521|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
15228360|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228361|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15228362|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228363|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
14341522|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15228364|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228365|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14341523|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14730922|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730923|NCT00530556|Zolpidem|zolpidem|mesh-list
15228366|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14341524|NCT00906373|Sorafenib|sorafenib|mesh-list
14341525|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14341526|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341527|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14341528|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341529|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730924|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14730925|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14730926|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730927|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730928|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14730929|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
14341530|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
14341531|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341532|NCT00906399|Interferons|interferons|mesh-list
14341533|NCT00906399|Interferon-beta|interferon-beta|mesh-list
14341534|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
14341535|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341536|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
14341537|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341538|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
14341539|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341540|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14730930|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
14918312|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918313|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14918314|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14918315|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14918316|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918317|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918318|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14918319|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14918320|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14918321|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14918322|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14918323|NCT01798004|Protective Agents|protective agents|mesh-ancestor
14918324|NCT01724606|Sorafenib|sorafenib|mesh-list
14918325|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918326|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918327|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918328|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918329|NCT01460810|Silicon|silicon|mesh-list
14918330|NCT01460810|Trace Elements|trace elements|mesh-ancestor
14918331|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
14918332|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918333|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
14918334|NCT01409200|Axitinib|axitinib|mesh-list
14918335|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
14918336|NCT01409200|Hormones|hormones|mesh-list
14918337|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14918338|NCT01409200|Androgens|androgens|mesh-list
14730931|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730932|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730933|NCT00530582|Progesterone|progesterone|mesh-list
14730934|NCT00530582|Progestins|progestins|mesh-ancestor
14730935|NCT00530582|Hormones|hormones|mesh-ancestor
14918339|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
14918340|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918341|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918342|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918343|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918344|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918345|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918346|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
14918347|NCT01409200|Protective Agents|protective agents|mesh-ancestor
14918348|NCT01409200|Vitamins|vitamins|mesh-ancestor
15228367|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
15228368|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
15228369|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
15228370|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
15228371|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228372|NCT01338636|Ambrisentan|ambrisentan|mesh-list
15228373|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15228374|NCT01308034|Sunitinib|sunitinib|mesh-list
15228375|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228376|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15228377|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15228378|NCT01308034|Growth Substances|growth substances|mesh-ancestor
15228379|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228380|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
14341541|NCT00906503|Dexamethasone|dexamethasone|mesh-list
14341542|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14341543|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14341544|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
14730936|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730937|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730938|NCT00530595|Losartan|losartan|mesh-list
14730939|NCT00530595|Valsartan|valsartan|mesh-list
14730940|NCT00530595|Candesartan|candesartan|mesh-list
14341545|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
14341546|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341547|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228381|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228382|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228383|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228384|NCT01149083|Carboplatin|carboplatin|mesh-list
15228385|NCT01149083|Veliparib|veliparib|mesh-list
15228386|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341548|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14341549|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
14341550|NCT00906503|Hormones|hormones|mesh-ancestor
14341551|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341552|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341553|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341554|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14341555|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341556|NCT00906698|Vinorelbine|vinorelbine|mesh-list
14341557|NCT00906698|Afatinib|afatinib|mesh-list
14341558|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14341559|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341560|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
14341561|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
14341562|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
14341563|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341564|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14341565|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341566|NCT00906945|Cytarabine|cytarabine|mesh-list
14341567|NCT00906945|Plerixafor|plerixafor|mesh-list
14341568|NCT00906945|Etoposide|etoposide|mesh-list
14341569|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
14341570|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14341571|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730941|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14730942|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14730943|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14730944|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730945|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14730946|NCT00530868|Bevacizumab|bevacizumab|mesh-list
14730947|NCT00530868|Letrozole|letrozole|mesh-list
14341572|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14341573|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14341574|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341575|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341576|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14341577|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
14341578|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
14341579|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341580|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341581|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
14730948|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14730949|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730950|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15228387|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15228388|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341582|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341583|NCT00906945|Analgesics|analgesics|mesh-ancestor
14341584|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
14341585|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918349|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
14918350|NCT01409200|Estrogens|estrogens|mesh-ancestor
14918351|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918352|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
14918353|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
14918354|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
14918355|NCT01175356|Melphalan|melphalan|mesh-list
14918356|NCT01175356|Busulfan|busulfan|mesh-list
14341586|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14341587|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14341588|NCT00907101|Adapalene|adapalene|mesh-list
15228389|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228390|NCT00938912|Lacosamide|lacosamide|mesh-list
15228391|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
15228392|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15228393|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14341589|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14341590|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14341591|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14341592|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14341593|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14341594|NCT00907101|Analgesics|analgesics|mesh-ancestor
14341595|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
14341596|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341597|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341598|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918357|NCT01175356|Doxorubicin|doxorubicin|mesh-list
14918358|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15228394|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15228395|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228396|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
15228397|NCT00925652|Bevacizumab|bevacizumab|mesh-list
15228398|NCT00925652|Methotrexate|methotrexate|mesh-list
15228399|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341599|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341600|NCT00907153|Vitamin D|vitamin d|mesh-list
14341601|NCT00907153|Vitamins|vitamins|mesh-ancestor
14341602|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
14730951|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14730952|NCT00530868|Growth Substances|growth substances|mesh-ancestor
14730953|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730954|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
14730955|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14730956|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14730957|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730958|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730959|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14730960|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
14753022|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14341603|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341604|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14341605|NCT00907257|Tretinoin|tretinoin|mesh-list
14341606|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14341607|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14341608|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341609|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
14341610|NCT00907335|Tretinoin|tretinoin|mesh-list
14341611|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14341612|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228400|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
15228401|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228402|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228403|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15228404|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
15228405|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228406|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228407|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15228408|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15228409|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15228410|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15228411|NCT00925652|Growth Substances|growth substances|mesh-ancestor
15228412|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
15228413|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15228414|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
15228415|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228416|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15228417|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
15228418|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
14341613|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
14341614|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
14341615|NCT00907374|Benazepril|benazepril|mesh-list
14918359|NCT01175356|Etoposide|etoposide|mesh-list
14918360|NCT01175356|Vincristine|vincristine|mesh-list
14918361|NCT01175356|Topotecan|topotecan|mesh-list
14918362|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
14918363|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15228419|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918364|NCT01175356|Isotretinoin|isotretinoin|mesh-list
14918365|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918366|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
15228420|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15228421|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228422|NCT00700258|Sirolimus|sirolimus|mesh-list
15228423|NCT00700258|Sunitinib|sunitinib|mesh-list
15228424|NCT00700258|Axitinib|axitinib|mesh-list
15228425|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228426|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14918367|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918368|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918369|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14918370|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
14918371|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918372|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918373|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14918374|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15228427|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15228428|NCT00700258|Growth Substances|growth substances|mesh-ancestor
15228429|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228430|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
15228431|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228432|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228433|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228434|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228435|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228436|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15228437|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
15228438|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228439|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
15228440|NCT00676715|Interferons|interferons|mesh-list
15228441|NCT00676715|Interferon-beta|interferon-beta|mesh-list
15228442|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
15228443|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228444|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
15228445|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228446|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
15228447|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228448|NCT00604617|Interferons|interferons|mesh-list
15228449|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
15228450|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228451|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
15228452|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341616|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14341617|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
14341618|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341619|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341620|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341621|NCT00907426|Bimatoprost|bimatoprost|mesh-list
14341622|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14341623|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341624|NCT00907517|Cytarabine|cytarabine|mesh-list
14341625|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14341626|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
14341627|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341628|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341629|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
14341630|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341631|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341632|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
14341633|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341634|NCT00907738|Vorinostat|vorinostat|mesh-list
14341635|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341636|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14341637|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341638|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341639|NCT00907777|Vaccines|vaccines|mesh-list
14341640|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14341641|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
14341642|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341643|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14341644|NCT00908011|Ezetimibe|ezetimibe|mesh-list
14341645|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14341646|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14341647|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
14341648|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341649|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14341650|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14341651|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341652|NCT00908076|Lubiprostone|lubiprostone|mesh-list
14341653|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14341654|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341655|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341656|NCT00908141|Sargramostim|sargramostim|mesh-list
14341657|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
14341658|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341659|NCT00908232|Dexamethasone|dexamethasone|mesh-list
14341660|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
14341661|NCT00908232|Lenalidomide|lenalidomide|mesh-list
14341662|NCT00908232|Bortezomib|bortezomib|mesh-list
14730961|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14730962|NCT00530907|Bevacizumab|bevacizumab|mesh-list
14730963|NCT00530907|Valproic Acid|valproic acid|mesh-list
14730964|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14730965|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730966|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14730967|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14730968|NCT00530907|Growth Substances|growth substances|mesh-ancestor
14730969|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730970|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
14730971|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
14730972|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14730973|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228453|NCT00579826|Letrozole|letrozole|mesh-list
15228454|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341663|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341664|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
14341665|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341666|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341667|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14341668|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
14341669|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341670|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341671|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14341672|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14341673|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
14341674|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
14341675|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341676|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14341677|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
14341678|NCT00908232|Hormones|hormones|mesh-ancestor
14341679|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341680|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341681|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14341682|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14341683|NCT00908232|Growth Substances|growth substances|mesh-ancestor
14341684|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
14341685|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
14341686|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
14341687|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14341688|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14918375|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14918376|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918377|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918378|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14918379|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
14918380|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
14918381|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
14918382|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14918383|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
14918384|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14918385|NCT00703222|Interleukin-2|interleukin-2|mesh-list
14918386|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918387|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918388|NCT00703222|Analgesics|analgesics|mesh-ancestor
14918389|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
14918390|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918391|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918392|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
14918393|NCT00667329|Rituximab|rituximab|mesh-list
14918394|NCT00667329|Cladribine|cladribine|mesh-list
14918395|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918396|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
14918397|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918398|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918399|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14918400|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
14918401|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918402|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918403|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14918404|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918405|NCT00492167|Antibodies|antibodies|mesh-list
14918406|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14918407|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
14918408|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918409|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14341689|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341690|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341691|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14341692|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14341693|NCT00908375|Pregabalin|pregabalin|mesh-list
14341694|NCT00908375|Analgesics|analgesics|mesh-ancestor
14918410|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14918411|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918412|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918413|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
14918414|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228455|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14341695|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
14341696|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341697|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341698|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
14341699|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14341700|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341701|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341702|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341703|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14341704|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14341705|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14341706|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14341707|NCT00908466|Sirolimus|sirolimus|mesh-list
14341708|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14341709|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341710|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14341711|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341712|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
14341713|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341714|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
14341715|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341716|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
14341717|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14341718|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14341719|NCT00908583|Prednisolone|prednisolone|mesh-list
14341720|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
14341721|NCT00908583|Rituximab|rituximab|mesh-list
14341722|NCT00908583|Bortezomib|bortezomib|mesh-list
14341723|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14341724|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
14730974|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
14918415|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918416|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
14918417|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14918418|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918419|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918420|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918421|NCT05274789|Analgesics|analgesics|mesh-ancestor
14918422|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
14918423|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918424|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14918425|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14730975|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730976|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
14730977|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14730978|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14730979|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14730980|NCT00530972|Ribavirin|ribavirin|mesh-list
14730981|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14730982|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
14730983|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14730984|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
14730985|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14730986|NCT00531024|Bevacizumab|bevacizumab|mesh-list
14730987|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14730988|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918426|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14918427|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
14918428|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14730989|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14730990|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14730991|NCT00531024|Growth Substances|growth substances|mesh-ancestor
14730992|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730993|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
14730994|NCT00531063|Everolimus|everolimus|mesh-list
14730995|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14730996|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918429|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918430|NCT05274633|Ravulizumab|ravulizumab|mesh-list
14918431|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14918432|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918433|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
14918434|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730997|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
14918435|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
14730998|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14730999|NCT00531076|Bevacizumab|bevacizumab|mesh-list
14731000|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731001|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731002|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14731003|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14731004|NCT00531076|Growth Substances|growth substances|mesh-ancestor
14731005|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731006|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14731007|NCT00531089|Rituximab|rituximab|mesh-list
14731008|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15228456|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15228457|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228458|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341725|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341726|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341727|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
14341728|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341729|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341730|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14341731|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
14341732|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
14341733|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341734|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731009|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341735|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
14341736|NCT00908583|Hormones|hormones|mesh-ancestor
14341737|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341738|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14341739|NCT00908583|Protective Agents|protective agents|mesh-ancestor
14341740|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341741|NCT00908960|Enoxaparin|enoxaparin|mesh-list
14341742|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
14341743|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14341744|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14341745|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341746|NCT00909064|PENTA|penta|mesh-list
14341747|NCT00909064|Fondaparinux|fondaparinux|mesh-list
14341748|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14341749|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
14341750|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14341751|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
14341752|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341753|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341754|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
14341755|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14341756|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14341757|NCT00909155|Fluoxetine|fluoxetine|mesh-list
14341758|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14341759|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14341760|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14341761|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341762|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341763|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341764|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
14341765|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341766|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14341767|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
14341768|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731010|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
14731011|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731012|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731013|NCT00531115|Cetuximab|cetuximab|mesh-list
14731014|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731015|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731016|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
14731017|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14731018|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
14731019|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731020|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14731021|NCT00531167|Lamivudine|lamivudine|mesh-list
14731022|NCT00531167|Adefovir|adefovir|mesh-list
14731023|NCT00531167|Entecavir|entecavir|mesh-list
14341769|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14341770|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14341771|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341772|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14341773|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
15228459|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15228460|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
15228461|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228462|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341774|NCT00909181|Oxybutynin|oxybutynin|mesh-list
14341775|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
14341776|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
14341777|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341778|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341779|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14341780|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14341781|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
14341782|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341783|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341784|NCT00909181|Urological Agents|urological agents|mesh-ancestor
14341785|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14918436|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14918437|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14918438|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918439|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
14918440|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918441|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918442|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918443|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918444|NCT05274269|Ivacaftor|ivacaftor|mesh-list
14918445|NCT05274269|Elexacaftor|elexacaftor|mesh-list
14918446|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14918447|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14918448|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228463|NCT00365157|Halichondrin B|halichondrin b|mesh-list
15228464|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
14341786|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341787|NCT00909181|Renal Agents|renal agents|mesh-ancestor
14731024|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14731025|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14731026|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731027|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731028|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
14731029|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731030|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14341788|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
14341789|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14341790|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14341791|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
14341792|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341793|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341794|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341795|NCT00909428|Urological Agents|urological agents|mesh-ancestor
14341796|NCT00909480|Insulin|insulin|mesh-list
14341797|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14341798|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
14341799|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
14341800|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14341801|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341802|NCT00909532|Ivacaftor|ivacaftor|mesh-list
15228465|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
15228466|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
15228467|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228468|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228469|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
15228470|NCT00186888|Carboplatin|carboplatin|mesh-list
15228471|NCT00186888|Doxorubicin|doxorubicin|mesh-list
15228472|NCT00186888|Etoposide|etoposide|mesh-list
15228473|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
15228474|NCT00186888|Vincristine|vincristine|mesh-list
15228475|NCT00186888|Topotecan|topotecan|mesh-list
15228476|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228477|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
15228478|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228479|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228480|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15228481|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
14731031|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15228482|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228483|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228484|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14341803|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14341804|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341805|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341806|NCT00909545|Isradipine|isradipine|mesh-list
14341807|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341808|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14341809|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341810|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341811|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14341812|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341813|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
14341814|NCT00909727|Ivacaftor|ivacaftor|mesh-list
14341815|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14341816|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341817|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341818|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
14341819|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14341820|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
14341821|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341822|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341823|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14341824|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
14341825|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14341826|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14341827|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14341828|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14341829|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341830|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341831|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14341832|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
15228485|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15228486|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15228487|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15228488|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228489|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15228490|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
15228491|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
15228492|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14341833|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14341834|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
14341835|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14341836|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918449|NCT05274191|Maleic acid|maleic acid|mesh-list
14918450|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918451|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918452|NCT05274139|Cytarabine|cytarabine|mesh-list
14918453|NCT05274139|Dexamethasone|dexamethasone|mesh-list
14918454|NCT05274139|Temozolomide|temozolomide|mesh-list
14918455|NCT05274139|Fotemustine|fotemustine|mesh-list
15228493|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15228494|NCT00001563|Rituximab|rituximab|mesh-list
15228495|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341837|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14341838|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341839|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341840|NCT00909857|Dienogest|dienogest|mesh-list
14341841|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14341842|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14341843|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
14341844|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14341845|NCT00909857|Estradiol|estradiol|mesh-list
14341846|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14341847|NCT00909857|Estrogens|estrogens|mesh-ancestor
14341848|NCT00909857|Hormones|hormones|mesh-ancestor
15228496|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228497|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
15228498|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228499|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341849|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14341850|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731032|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
14731033|NCT00531193|SCH 442416|sch 442416|mesh-list
14731034|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14731035|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14731036|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14731037|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
14731038|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731039|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918456|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14341851|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14341852|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
14341853|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14341854|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14341855|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14341856|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14341857|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14341858|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14341859|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14341860|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14341861|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341862|NCT00910000|Gemcitabine|gemcitabine|mesh-list
14341863|NCT00910000|Carboplatin|carboplatin|mesh-list
14341864|NCT00910000|Vorinostat|vorinostat|mesh-list
14341865|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341866|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14341867|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
14341868|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341869|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
14341870|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228500|NCT05200481|Carboplatin|carboplatin|mesh-list
15228501|NCT05200481|Pemetrexed|pemetrexed|mesh-list
15228502|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228503|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228504|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228505|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15228506|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228507|NCT05200442|Cetuximab|cetuximab|mesh-list
15228508|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15228509|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228510|NCT05200429|Ivacaftor|ivacaftor|mesh-list
15228511|NCT05200429|Elexacaftor|elexacaftor|mesh-list
15228512|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15228513|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15228514|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228515|NCT05200299|Leucovorin|leucovorin|mesh-list
15228516|NCT05200299|Fluorouracil|fluorouracil|mesh-list
15228517|NCT05200299|Capecitabine|capecitabine|mesh-list
15228518|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
15228519|NCT05200299|Irinotecan|irinotecan|mesh-list
14341871|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341872|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341873|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
14341874|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341875|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14341876|NCT00910039|Sunitinib|sunitinib|mesh-list
14341877|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341878|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14341879|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14341880|NCT00910039|Growth Substances|growth substances|mesh-ancestor
14341881|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341882|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14341883|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228520|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
15228521|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
15228522|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228523|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15228524|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228525|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228526|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
15228527|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228528|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15228529|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15228530|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228531|NCT05200299|Antidotes|antidotes|mesh-ancestor
14341884|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341885|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341886|NCT00910091|Megestrol|megestrol|mesh-list
14341887|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
14341888|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14341889|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14341890|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14341891|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
14341892|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14341893|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341894|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14341895|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14341896|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15228532|NCT05200299|Protective Agents|protective agents|mesh-ancestor
15228533|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
15228534|NCT05200299|Vitamins|vitamins|mesh-ancestor
15228535|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
15228536|NCT05200260|Niraparib|niraparib|mesh-list
15228537|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15228538|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228539|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341897|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341898|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
14341899|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14341900|NCT00910208|Morphine|morphine|mesh-list
14341901|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14341902|NCT00910208|Narcotics|narcotics|mesh-ancestor
14341903|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14341904|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341905|NCT00910208|Analgesics|analgesics|mesh-ancestor
15228540|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341906|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
15228541|NCT05200156|Choline|choline|mesh-list
15228542|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
14341907|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341908|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14341909|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
14341910|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15228543|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15228544|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
15228545|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341911|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14341912|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341913|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464864|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464865|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14464866|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464867|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464868|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
14464869|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14464870|NCT02217800|Octreotide|octreotide|mesh-list
14464871|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464872|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14464873|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464874|NCT02217878|Morphine|morphine|mesh-list
14464875|NCT02217878|Ticagrelor|ticagrelor|mesh-list
14464876|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14464877|NCT02217878|Narcotics|narcotics|mesh-ancestor
14464878|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464879|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464880|NCT02217878|Analgesics|analgesics|mesh-ancestor
14464881|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
14464882|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464883|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14464884|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14464885|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14464886|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14464887|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
14464888|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464889|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464890|NCT02217904|Islatravir|islatravir|mesh-list
14464891|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
14464892|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464893|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464894|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464895|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14464896|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14731040|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228546|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228547|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15228548|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
15228549|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
15228550|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228551|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14731041|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
14731042|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731043|NCT00531271|Docetaxel|docetaxel|mesh-list
14731044|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731045|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14731046|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
14731047|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
15228552|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228553|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228554|NCT05199727|Tadalafil|tadalafil|mesh-list
15228555|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
15228556|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15228557|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15228558|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228559|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228560|NCT05199727|Urological Agents|urological agents|mesh-ancestor
14341914|NCT00910273|Etanercept|etanercept|mesh-list
14341915|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14341916|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14341917|NCT00910273|Analgesics|analgesics|mesh-ancestor
14341918|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
14341919|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341920|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341921|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14341922|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14341923|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14341924|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14341925|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
14341926|NCT00910299|Clopidogrel|clopidogrel|mesh-list
14341927|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14341928|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14341929|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14341930|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14341931|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14341932|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
14341933|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341934|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341935|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341936|NCT00910429|Riociguat|riociguat|mesh-list
14731048|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918457|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
14918458|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
14918459|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918460|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918461|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918462|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
14731049|NCT00531310|Fludarabine|fludarabine|mesh-list
14731050|NCT00531310|Busulfan|busulfan|mesh-list
14731051|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731052|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918463|NCT05274139|Hormones|hormones|mesh-ancestor
15228561|NCT05199597|Atropine|atropine|mesh-list
15228562|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15228563|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15228564|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15228565|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
15228566|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228567|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228568|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15228569|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
15228570|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
15228571|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
15228572|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15228573|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15228574|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
15228575|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228576|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228577|NCT05199571|Ofatumumab|ofatumumab|mesh-list
15228578|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228579|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15228580|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
15228581|NCT05199324|Cefazolin|cefazolin|mesh-list
15228582|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
14918464|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918465|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918466|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918467|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918468|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918469|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
14918470|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
14918471|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14918472|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918473|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
14918474|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14918475|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
14918476|NCT05274113|Dexamethasone|dexamethasone|mesh-list
14918477|NCT05274113|Ropivacaine|ropivacaine|mesh-list
14918478|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918479|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
15228583|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14341937|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
14341938|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341939|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
14341940|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14341941|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14341942|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14341943|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341944|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731053|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731054|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
14731055|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731056|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
14731057|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14341945|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
14341946|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341947|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341948|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14341949|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341950|NCT00910624|Ribavirin|ribavirin|mesh-list
14341951|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14341952|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
14341953|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341954|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
14341955|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341956|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
14341957|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14341958|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14341959|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14341960|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
14341961|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14341962|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14341963|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14341964|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341965|NCT00910689|Propranolol|propranolol|mesh-list
14341966|NCT00910689|Nadolol|nadolol|mesh-list
14341967|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14341968|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14341969|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
14341970|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14341971|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14341972|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228584|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
15228585|NCT05199324|Trimethoprim|trimethoprim|mesh-list
14341973|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14341974|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14341975|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
14341976|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
14341977|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
14341978|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341979|NCT00910715|Doxycycline|doxycycline|mesh-list
14341980|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14341981|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731058|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14731059|NCT00531323|Etravirine|etravirine|mesh-list
14731060|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14731061|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228586|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
14918480|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
14918481|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918482|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918483|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918484|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
14918485|NCT05274113|Hormones|hormones|mesh-ancestor
14918486|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918487|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918488|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918489|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
14918490|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
14341982|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
14341983|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14341984|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14341985|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
14341986|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14341987|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14341988|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14341989|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14341990|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918491|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918492|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
15228587|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228588|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15228589|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15228590|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228591|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228592|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228593|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15228594|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14341991|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
14341992|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918493|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14918494|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
14918495|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918496|NCT05274048|Trastuzumab|trastuzumab|mesh-list
14918497|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14341993|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14341994|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14341995|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14341996|NCT00910858|Lenalidomide|lenalidomide|mesh-list
14341997|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
14341998|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
14341999|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342000|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342001|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14342002|NCT00910858|Growth Substances|growth substances|mesh-ancestor
14342003|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
15228595|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15228596|NCT05199324|Renal Agents|renal agents|mesh-ancestor
15228597|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
15228598|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15228599|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15228600|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15228601|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15228602|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15228603|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14342004|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342005|NCT00910858|Hematinics|hematinics|mesh-ancestor
14342006|NCT00910871|Bedaquiline|bedaquiline|mesh-list
14918498|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918499|NCT05273944|Doxorubicin|doxorubicin|mesh-list
14918500|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14918501|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14918502|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918503|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14918504|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918505|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918506|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228604|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14342007|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
14342008|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342009|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342010|NCT00910910|Lenalidomide|lenalidomide|mesh-list
14342011|NCT00910910|Chlorambucil|chlorambucil|mesh-list
14342012|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
14342013|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342014|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342015|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14342016|NCT00910910|Growth Substances|growth substances|mesh-ancestor
14342017|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342018|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342019|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14342020|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
14342021|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342022|NCT00910988|Olanzapine|olanzapine|mesh-list
14342023|NCT00910988|Ziprasidone|ziprasidone|mesh-list
14342024|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
14342025|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
14342026|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342027|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342028|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14342029|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14731062|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731063|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731064|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
14731065|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731066|NCT00531336|Bevacizumab|bevacizumab|mesh-list
14731067|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731068|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731069|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342030|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14342031|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342032|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14342033|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14342034|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14342035|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342036|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342037|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342038|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
14342039|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14342040|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14918507|NCT05273814|Bevacizumab|bevacizumab|mesh-list
14918508|NCT05273814|Pemetrexed|pemetrexed|mesh-list
14918509|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14918510|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342041|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
14342042|NCT00911144|Vaccines|vaccines|mesh-list
14342043|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14342044|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
14731070|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14731071|NCT00531336|Growth Substances|growth substances|mesh-ancestor
14731072|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731073|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
14731074|NCT00531349|Propofol|propofol|mesh-list
14731075|NCT00531349|Sevoflurane|sevoflurane|mesh-list
14731076|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
14731077|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731078|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918511|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918512|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14918513|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14918514|NCT05273814|Growth Substances|growth substances|mesh-ancestor
14918515|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918516|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342045|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342046|NCT00911157|Heparin|heparin|mesh-list
14342047|NCT00911157|Calcium heparin|calcium heparin|mesh-list
14342048|NCT00911157|PENTA|penta|mesh-list
14342049|NCT00911157|Fondaparinux|fondaparinux|mesh-list
14342050|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
14342051|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14918517|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918518|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918519|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14918520|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14342052|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14342053|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731079|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15228605|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
15228606|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
15228607|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228608|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228609|NCT05199038|Octreotide|octreotide|mesh-list
15228610|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228611|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15228612|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228613|NCT05198960|Aspirin|aspirin|mesh-list
14731080|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14731081|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
14731082|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14731083|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14731084|NCT00531362|Aspirin|aspirin|mesh-list
14731085|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14731086|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14731087|NCT00531362|Analgesics|analgesics|mesh-ancestor
14731088|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
14731089|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731090|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731091|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731092|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731093|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14731094|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14731095|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731096|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15228614|NCT05198960|Anticoagulants|anticoagulants|mesh-list
14731097|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14731098|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731099|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
14731100|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
15228615|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15228616|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15228617|NCT05198960|Analgesics|analgesics|mesh-ancestor
15228618|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
15228619|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342054|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14342055|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
14342056|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14342057|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342058|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342059|NCT00911170|Bevacizumab|bevacizumab|mesh-list
14342060|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342061|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342062|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342063|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14342064|NCT00911170|Growth Substances|growth substances|mesh-ancestor
14342065|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731101|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731102|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731103|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731104|NCT00531440|Everolimus|everolimus|mesh-list
14731105|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731106|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731107|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
14731108|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731109|NCT00531466|Tolperisone|tolperisone|mesh-list
14731110|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14731111|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731112|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14731113|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731114|NCT00531544|Sunitinib|sunitinib|mesh-list
14731115|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731116|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14731117|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14731118|NCT00531544|Growth Substances|growth substances|mesh-ancestor
14731119|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731120|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
14731121|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14731122|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731123|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731124|NCT00531557|Ritonavir|ritonavir|mesh-list
14731125|NCT00531557|Darunavir|darunavir|mesh-list
14731126|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14918521|NCT05273775|Vitamin K|vitamin k|mesh-list
14342066|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342067|NCT00911300|Vitamin K|vitamin k|mesh-list
14342068|NCT00911300|Heparin|heparin|mesh-list
14342069|NCT00911300|Calcium heparin|calcium heparin|mesh-list
14342070|NCT00911300|PENTA|penta|mesh-list
14342071|NCT00911300|Fondaparinux|fondaparinux|mesh-list
15228620|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228621|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228622|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228623|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15228624|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14342072|NCT00911300|Vitamins|vitamins|mesh-ancestor
14342073|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
14342074|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342075|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
14342076|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14342077|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14342078|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342079|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14342080|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
14342081|NCT00911300|Coagulants|coagulants|mesh-ancestor
14342082|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14342083|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
14342084|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14342085|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342086|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342087|NCT00911326|Dextrans|dextrans|mesh-list
14342088|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
14342089|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
14342090|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
14342091|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
14342092|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
14342093|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
14342094|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342095|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14342096|NCT00911534|Rabeprazole|rabeprazole|mesh-list
14342097|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14918522|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
14918523|NCT05273775|Digoxin|digoxin|mesh-list
14918524|NCT05273775|Midazolam|midazolam|mesh-list
14342098|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14342099|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15228625|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342100|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342101|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342102|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
14342103|NCT00911586|Testosterone|testosterone|mesh-list
14342104|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
14342105|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
14342106|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14731127|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14731128|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
14731129|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731130|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731131|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14731132|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14731133|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
14731134|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731135|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14731136|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14731137|NCT00531596|Selegiline|selegiline|mesh-list
14731138|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
14918525|NCT05273775|Omeprazole|omeprazole|mesh-list
15228626|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15228627|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15228628|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228629|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
15228630|NCT05198947|Ivermectin|ivermectin|mesh-list
15228631|NCT05198947|Permethrin|permethrin|mesh-list
15228632|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15228633|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228634|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228635|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342107|NCT00911586|Androgens|androgens|mesh-ancestor
14731139|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14918526|NCT05273775|Warfarin|warfarin|mesh-list
15228636|NCT05198856|Thalidomide|thalidomide|mesh-list
14342108|NCT00911586|Hormones|hormones|mesh-ancestor
14918527|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14918528|NCT05273775|Vitamins|vitamins|mesh-ancestor
14342109|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342110|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342111|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14342112|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342113|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
14342114|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14342115|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14342116|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14342117|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
14342118|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342119|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14342120|NCT00911625|Insulin|insulin|mesh-list
14342121|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14342122|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
14342123|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
14342124|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14342125|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342126|NCT00911742|Tramadol|tramadol|mesh-list
14342127|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14342128|NCT00911742|Narcotics|narcotics|mesh-ancestor
14342129|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342130|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342131|NCT00911742|Analgesics|analgesics|mesh-ancestor
14342132|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
14342133|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918529|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
14918530|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918531|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14918532|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14918533|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918534|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14918535|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14918536|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14918537|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14918538|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
14918539|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
14918540|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
14918541|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
14918542|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918543|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918544|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14918545|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14342134|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
14342135|NCT00911807|Donepezil|donepezil|mesh-list
14342136|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14342137|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342138|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342139|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
14342140|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342141|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342142|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
14342143|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14342144|NCT00911807|Protective Agents|protective agents|mesh-ancestor
14342145|NCT00911820|Bevacizumab|bevacizumab|mesh-list
14342146|NCT00911820|Cisplatin|cisplatin|mesh-list
14342147|NCT00911820|Docetaxel|docetaxel|mesh-list
14918546|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
14918547|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15228637|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228638|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
15228639|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228640|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
15228641|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228642|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228643|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15228644|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15228645|NCT05198856|Growth Substances|growth substances|mesh-ancestor
14342148|NCT00911820|Irinotecan|irinotecan|mesh-list
14342149|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342150|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342151|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342152|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14342153|NCT00911820|Growth Substances|growth substances|mesh-ancestor
14342154|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342155|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342156|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
14342157|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
14342158|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
14342159|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342160|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14342161|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14342162|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342163|NCT00911859|Prednisone|prednisone|mesh-list
14342164|NCT00911859|Bortezomib|bortezomib|mesh-list
14342165|NCT00911859|Melphalan|melphalan|mesh-list
14342166|NCT00911859|Siltuximab|siltuximab|mesh-list
14342167|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14342168|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342169|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
14731140|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14731141|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14731142|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14731143|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731144|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731145|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14731146|NCT00531596|Protective Agents|protective agents|mesh-ancestor
14731147|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731148|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
14918548|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14918549|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918550|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
14342170|NCT00911859|Hormones|hormones|mesh-ancestor
14342171|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342172|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342173|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14342174|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731149|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14731150|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731151|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14731152|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
14731153|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14731154|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731155|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731156|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731157|NCT00531674|Tocopherols|tocopherols|mesh-list
14731158|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
14731159|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731160|NCT00531674|Protective Agents|protective agents|mesh-ancestor
14731161|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918551|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14918552|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918553|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14918554|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14918555|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15228646|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
15228647|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228648|NCT05198609|Apatinib|apatinib|mesh-list
15228649|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228650|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228651|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228652|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228653|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15228654|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15228655|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15228656|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228657|NCT05198141|Letrozole|letrozole|mesh-list
15228658|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228659|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15228660|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15228661|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918556|NCT05273775|Protective Agents|protective agents|mesh-ancestor
14918557|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14918558|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14918559|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
14918560|NCT05273775|Coagulants|coagulants|mesh-ancestor
14918561|NCT05273710|Folic Acid|folic acid|mesh-list
14918562|NCT05273710|Hematinics|hematinics|mesh-ancestor
14918563|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
14918564|NCT05273710|Vitamins|vitamins|mesh-ancestor
14918565|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
14918566|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930839|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930840|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
14930841|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930842|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930843|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14930844|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
14930845|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930846|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930847|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14930848|NCT01435707|Triamcinolone|triamcinolone|mesh-list
15228662|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228663|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15228664|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
15228665|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228666|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228667|NCT05198050|Letrozole|letrozole|mesh-list
15228668|NCT05198050|Alprostadil|alprostadil|mesh-list
15228669|NCT05198050|Misoprostol|misoprostol|mesh-list
15228670|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228671|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15228672|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15228673|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228674|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228675|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14342175|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14342176|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
14731162|NCT00531674|Vitamins|vitamins|mesh-ancestor
15228676|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
14342177|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342178|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14342179|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342180|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
14342181|NCT00911937|Fesoterodine|fesoterodine|mesh-list
14731163|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
15228677|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228678|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731164|NCT00531687|Gemcitabine|gemcitabine|mesh-list
14731165|NCT00531687|Paclitaxel|paclitaxel|mesh-list
14731166|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14731167|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731168|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
14731169|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
14731170|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
14930849|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15228679|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15228680|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
15228681|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15228682|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14930850|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14731171|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731172|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14731173|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
14731174|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
14731175|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731176|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731177|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731178|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
14731179|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731180|NCT00531791|Prednisone|prednisone|mesh-list
14731181|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731182|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
14731183|NCT00531791|Hormones|hormones|mesh-ancestor
14731184|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228683|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228684|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
15228685|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15228686|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
15228687|NCT05198050|Urological Agents|urological agents|mesh-ancestor
14731185|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731186|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14731187|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731188|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
14731189|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
14731190|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731191|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
14731192|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731193|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731194|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14731195|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14731196|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14342182|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14342183|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14342184|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
14731197|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731198|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731199|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731200|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731201|NCT00531895|Analgesics|analgesics|mesh-ancestor
14731202|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
14731203|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731204|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
14918567|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
14731205|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731206|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
14731207|NCT00531908|Furosemide|furosemide|mesh-list
14731208|NCT00531908|Diuretics|diuretics|mesh-ancestor
14731209|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
14731210|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731211|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14731212|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731213|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731214|NCT00531973|Doxorubicin|doxorubicin|mesh-list
14731215|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14731216|NCT00531973|Epirubicin|epirubicin|mesh-list
14731217|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15228688|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15228689|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15228690|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15228691|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
15228692|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228693|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15228694|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15228695|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228696|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
15228697|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15228698|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
14342185|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342186|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342187|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342188|NCT00911937|Urological Agents|urological agents|mesh-ancestor
14342189|NCT00912015|Tramadol|tramadol|mesh-list
14342190|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14342191|NCT00912015|Narcotics|narcotics|mesh-ancestor
14342192|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342193|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342194|NCT00912015|Analgesics|analgesics|mesh-ancestor
14342195|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
14342196|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342197|NCT00912093|Icatibant|icatibant|mesh-list
14342198|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14342199|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14342200|NCT00912093|Analgesics|analgesics|mesh-ancestor
14342201|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
14342202|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342203|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342204|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342205|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342206|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14342207|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14342208|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342209|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14342210|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342211|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
14342212|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14342213|NCT00912301|Cathartics|cathartics|mesh-ancestor
14342214|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14342215|NCT00912340|Trastuzumab|trastuzumab|mesh-list
14342216|NCT00912340|Everolimus|everolimus|mesh-list
14342217|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342218|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731218|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228699|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342219|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342220|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
14342221|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342222|NCT00912509|Riboflavin|riboflavin|mesh-list
14342223|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
14342224|NCT00912509|Vitamins|vitamins|mesh-ancestor
15228700|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
15228701|NCT05188898|Protective Agents|protective agents|mesh-ancestor
15228702|NCT05184920|Nicotine|nicotine|mesh-list
15228703|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15228704|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
15228705|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228706|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228707|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14918568|NCT05273554|Lenvatinib|lenvatinib|mesh-list
15228708|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15228709|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
15228710|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228711|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228712|NCT05178225|Ubiquinone|ubiquinone|mesh-list
15228713|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
15228714|NCT05178225|Anticoagulants|anticoagulants|mesh-list
14918569|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918570|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918571|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14918572|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918573|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918574|NCT05273528|Vaccines|vaccines|mesh-list
14918575|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
14918576|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918577|NCT05273398|Diazepam|diazepam|mesh-list
14918578|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14918579|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
14342225|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
14342226|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342227|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14342228|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
14342229|NCT00912743|Olaparib|olaparib|mesh-list
14342230|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14342231|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342232|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342233|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342234|NCT00912782|Vitamin D|vitamin d|mesh-list
14342235|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
14342236|NCT00912782|Vitamins|vitamins|mesh-ancestor
14342237|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
14342238|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342239|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14342240|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14342241|NCT00912808|Donepezil|donepezil|mesh-list
14342242|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14918580|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
15228715|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
14342243|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342244|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342245|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
14342246|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342247|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342248|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
14342249|NCT00912873|Ropivacaine|ropivacaine|mesh-list
14342250|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
14342251|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
14342252|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342253|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342254|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
15228716|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228717|NCT05178225|Vitamins|vitamins|mesh-ancestor
14342255|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342256|NCT00912912|Sunitinib|sunitinib|mesh-list
14342257|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342258|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342259|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14342260|NCT00912912|Growth Substances|growth substances|mesh-ancestor
14342261|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342262|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342263|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14342264|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342265|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342266|NCT00912964|Mirabegron|mirabegron|mesh-list
14342267|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14342268|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14731219|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14731220|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14731221|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731222|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731223|NCT00531986|Lopinavir|lopinavir|mesh-list
15228718|NCT05178173|Ethanol|ethanol|mesh-list
15228719|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
15228720|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15228721|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228722|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15228723|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918581|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
14918582|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918583|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918584|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918585|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14918586|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918587|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14918588|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14918589|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14918590|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14918591|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14918592|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14918593|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
15228724|NCT05177484|Ferric maltol|ferric maltol|mesh-list
14731224|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14731225|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14731226|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
14731227|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731228|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731229|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14918594|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
14918595|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
14918596|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
14918597|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342269|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14342270|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14342271|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342272|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918598|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918599|NCT05273346|Analgesics|analgesics|mesh-list
14918600|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
14918601|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918602|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918603|NCT05272969|Vitamin D|vitamin d|mesh-list
14918604|NCT05272969|Calcium|calcium|mesh-list
14918605|NCT05272969|Vitamins|vitamins|mesh-ancestor
14918606|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
14918607|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918608|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14918609|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14731230|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14731231|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
14731232|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14918610|NCT05272930|Dienogest|dienogest|mesh-list
14342273|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342274|NCT00912964|Urological Agents|urological agents|mesh-ancestor
14342275|NCT00912990|Cisatracurium|cisatracurium|mesh-list
14342276|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14342277|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14342278|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342279|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342280|NCT00913003|Lidocaine|lidocaine|mesh-list
14342281|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
14342282|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
14342283|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342284|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342285|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
15228725|NCT05177484|Hematinics|hematinics|mesh-ancestor
15228726|NCT05162443|Adagrasib|adagrasib|mesh-list
15228727|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228728|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
14918611|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15228729|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
15228730|NCT05139849|Vasopressins|vasopressins|mesh-list
15228731|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
15228732|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228733|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
15228734|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
15228735|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228736|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228737|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228738|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
15228739|NCT05139849|Hormones|hormones|mesh-ancestor
14342286|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342287|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14342288|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14342289|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14342290|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731233|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14731234|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15228740|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228741|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15228742|NCT05139849|Protective Agents|protective agents|mesh-ancestor
15228743|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
15228744|NCT05139849|Coagulants|coagulants|mesh-ancestor
15228745|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14731235|NCT00531999|Ritonavir|ritonavir|mesh-list
14731236|NCT00531999|Lopinavir|lopinavir|mesh-list
14731237|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
14731238|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14731239|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14731240|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
14731241|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228746|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15228747|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
15228748|NCT05131698|Lenvatinib|lenvatinib|mesh-list
14731242|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731243|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14342291|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342292|NCT00913068|Lidocaine|lidocaine|mesh-list
14342293|NCT00913068|Ropivacaine|ropivacaine|mesh-list
14342294|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
14918612|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
14918613|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14918614|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918615|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14918616|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14918617|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14918618|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14918619|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
14918620|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228749|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228750|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228751|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228752|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228753|NCT05110781|Atezolizumab|atezolizumab|mesh-list
15228754|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15228755|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342295|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
14342296|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342297|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342298|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
14342299|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342300|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14342301|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14342302|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14342303|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342304|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342305|NCT00913081|Quercetin|quercetin|mesh-list
14342306|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
14342307|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342308|NCT00913081|Protective Agents|protective agents|mesh-ancestor
14342309|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342310|NCT00913133|Desirudin|desirudin|mesh-list
14342311|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
14342312|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14342313|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14342314|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342315|NCT00913263|Flutamide|flutamide|mesh-list
14918621|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918622|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918623|NCT05272878|Irbesartan|irbesartan|mesh-list
14918624|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14918625|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14918626|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14918627|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918628|NCT05272865|Dronabinol|dronabinol|mesh-list
14918629|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
14918630|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918631|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14918632|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918633|NCT05272865|Analgesics|analgesics|mesh-ancestor
14918634|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
14731244|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14731245|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
14731246|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228756|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
15228757|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228758|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
15228759|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14731247|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14731248|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14731249|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14731250|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14731251|NCT05319912|Molybdenum|molybdenum|mesh-list
14342316|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
15228760|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15228761|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918635|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918636|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14918637|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14918638|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918639|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918640|NCT05272865|Hormones|hormones|mesh-ancestor
14918641|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228762|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
14342317|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
14342318|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
14342319|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342320|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342321|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14342322|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342323|NCT00913458|Etanercept|etanercept|mesh-list
14342324|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14342325|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14342326|NCT00913458|Analgesics|analgesics|mesh-ancestor
14342327|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
14342328|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342329|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342330|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342331|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342332|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14342333|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342334|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
14342335|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14342336|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
14342337|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342338|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342339|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342340|NCT00913627|Ibuprofen|ibuprofen|mesh-list
14342341|NCT00913627|Naproxen|naproxen|mesh-list
14342342|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14342343|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14342344|NCT00913627|Analgesics|analgesics|mesh-ancestor
14342345|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
14342346|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342347|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342348|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342349|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342350|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14342351|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228763|NCT05099276|Coagulants|coagulants|mesh-ancestor
15228764|NCT05087212|Plerixafor|plerixafor|mesh-list
15228765|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15228766|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15228767|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
15228768|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14918642|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14918643|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918644|NCT05272696|Paclitaxel|paclitaxel|mesh-list
14918645|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
14918646|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14918647|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918648|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14918649|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14918650|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14918651|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918652|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918653|NCT05272605|Vaccines|vaccines|mesh-list
14918654|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
14918655|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918656|NCT05272462|Minoxidil|minoxidil|mesh-list
14918657|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14918658|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
14918659|NCT05272371|Dinutuximab|dinutuximab|mesh-list
14918660|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918661|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14342352|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342353|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
14342354|NCT00913770|Buprenorphine|buprenorphine|mesh-list
14342355|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14342356|NCT00913770|Narcotics|narcotics|mesh-ancestor
14342357|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342358|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342359|NCT00913770|Analgesics|analgesics|mesh-ancestor
14342360|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
14342361|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342362|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14918662|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342363|NCT00913835|Doxorubicin|doxorubicin|mesh-list
14342364|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14342365|NCT00913835|Olaratumab|olaratumab|mesh-list
14342366|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14342367|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342368|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14918663|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918664|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918665|NCT05271578|Nicotine|nicotine|mesh-list
14342369|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14342370|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342371|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342372|NCT00913913|Bevacizumab|bevacizumab|mesh-list
14342373|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342374|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342375|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342376|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14731252|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14731253|NCT05319912|Choline|choline|mesh-list
14731254|NCT05319912|Omeprazole|omeprazole|mesh-list
14731255|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14731256|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731257|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14731258|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731259|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731260|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
14731261|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14731262|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
14731263|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14731264|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
14731265|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
14731266|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
14731267|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342377|NCT00913913|Growth Substances|growth substances|mesh-ancestor
14342378|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342379|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342380|NCT00914316|Ranolazine|ranolazine|mesh-list
14342381|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14342382|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342383|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342384|NCT00914459|Factor VIII|factor viii|mesh-list
14342385|NCT00914459|Coagulants|coagulants|mesh-ancestor
14342386|NCT00914732|Vaccines|vaccines|mesh-list
14342387|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
14342388|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342389|NCT00914810|Vitamin D|vitamin d|mesh-list
14342390|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
14342391|NCT00914810|Vitamins|vitamins|mesh-ancestor
14342392|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
14342393|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342394|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14342395|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14342396|NCT00914849|Plerixafor|plerixafor|mesh-list
14342397|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14731268|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14731269|NCT05319912|Growth Substances|growth substances|mesh-ancestor
14731270|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731271|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342398|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14342399|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
14731272|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731273|NCT05319912|Trace Elements|trace elements|mesh-ancestor
15228769|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
15228770|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15228771|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
15228772|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731274|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
14731275|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14731276|NCT05319899|Choline|choline|mesh-list
14731277|NCT05319899|Omeprazole|omeprazole|mesh-list
14731278|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14731279|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731280|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14731281|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731282|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731283|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
14342400|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342401|NCT00914940|Fludarabine|fludarabine|mesh-list
14342402|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
14342403|NCT00914940|Thiotepa|thiotepa|mesh-list
14342404|NCT00914940|Tacrolimus|tacrolimus|mesh-list
14918666|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14918667|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
14918668|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918669|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918670|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14918671|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14918672|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
14918673|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918674|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918675|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
14918676|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14918677|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918678|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228773|NCT05081479|Expectorants|expectorants|mesh-ancestor
15228774|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
15228775|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15228776|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
15228777|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918679|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918680|NCT05271552|Analgesics|analgesics|mesh-ancestor
14342405|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731284|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14731285|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
14342406|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14342407|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
14342408|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342409|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342410|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
14342411|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342412|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14342413|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342414|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14342415|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
14342416|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14342417|NCT00914966|Complement C1s|complement c1s|mesh-list
14342418|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
15228778|NCT05081479|Protective Agents|protective agents|mesh-ancestor
15228779|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228780|NCT05081479|Antidotes|antidotes|mesh-ancestor
15228781|NCT05077449|Fulvestrant|fulvestrant|mesh-list
15228782|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15228783|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228784|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15228785|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15228786|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
14342419|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
15228787|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342420|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
14731286|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14731287|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
14342421|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342422|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14918681|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
14918682|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918683|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14918684|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14918685|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14918686|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
14918687|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918688|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918689|NCT05271539|Dexamethasone|dexamethasone|mesh-list
14918690|NCT05271539|Ranibizumab|ranibizumab|mesh-list
14918691|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918692|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
14918693|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
14918694|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918695|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918696|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918697|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
14918698|NCT05271539|Hormones|hormones|mesh-ancestor
14918699|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918700|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918701|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918702|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14918703|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14918704|NCT05271539|Growth Substances|growth substances|mesh-ancestor
14918705|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
14918706|NCT05271448|Losartan|losartan|mesh-list
14918707|NCT05271448|Valsartan|valsartan|mesh-list
14918708|NCT05271448|Candesartan|candesartan|mesh-list
14918709|NCT05271448|Ramipril|ramipril|mesh-list
14918710|NCT05271448|Enalapril|enalapril|mesh-list
14918711|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14918712|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14918713|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14918714|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14918715|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342423|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342424|NCT00915005|Paclitaxel|paclitaxel|mesh-list
14342425|NCT00915005|Carboplatin|carboplatin|mesh-list
14342426|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14342427|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342428|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14342429|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14342430|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14342431|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342432|NCT00915018|Paclitaxel|paclitaxel|mesh-list
14342433|NCT00915018|Trastuzumab|trastuzumab|mesh-list
14342434|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14342435|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14342436|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918716|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14918717|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
14918718|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930851|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14930852|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930853|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
14930854|NCT01435707|Hormones|hormones|mesh-ancestor
14930855|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930856|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930857|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930858|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
14930859|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931242|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918719|NCT05271370|Leronlimab|leronlimab|mesh-list
14918720|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
14918721|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14918722|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14918723|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918724|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14918725|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14342437|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14342438|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14342439|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14342440|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342441|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342442|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
14342443|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14342444|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14918726|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
14918727|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14918728|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
14918729|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918730|NCT05271331|Anesthetics|anesthetics|mesh-list
14918731|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
14918732|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918733|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918734|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
14918735|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918736|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
14918737|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918738|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918739|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
14918740|NCT05271253|Bupivacaine|bupivacaine|mesh-list
14918741|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
14918742|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
14918743|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918744|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918745|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
14918746|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918747|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14918748|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15228788|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228789|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14342445|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14342446|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342447|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
15228790|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228791|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
15228792|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15228793|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
15228794|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228795|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
14342448|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14342449|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14342450|NCT00915473|Prednisolone|prednisolone|mesh-list
14918749|NCT05271253|Analgesics|analgesics|mesh-ancestor
15228796|NCT05073575|Protective Agents|protective agents|mesh-ancestor
15228797|NCT05072093|Tenofovir|tenofovir|mesh-list
15228798|NCT05072093|Emtricitabine|emtricitabine|mesh-list
15228799|NCT05072093|Doxycycline|doxycycline|mesh-list
14342451|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
14342452|NCT00915473|Lidocaine|lidocaine|mesh-list
14342453|NCT00915473|Bupivacaine|bupivacaine|mesh-list
14342454|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14342455|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
14342456|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
14342457|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
14342458|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342459|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342460|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
14342461|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342462|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14342463|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14342464|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14342465|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731288|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
14731289|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
14731290|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14731291|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14731292|NCT05319899|Growth Substances|growth substances|mesh-ancestor
14731293|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731294|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
14731295|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731296|NCT05319873|Carboplatin|carboplatin|mesh-list
14731297|NCT05319873|Docetaxel|docetaxel|mesh-list
14731298|NCT05319873|Trastuzumab|trastuzumab|mesh-list
14731299|NCT05319873|Fulvestrant|fulvestrant|mesh-list
14731300|NCT05319873|Pertuzumab|pertuzumab|mesh-list
14731301|NCT05319873|Tucatinib|tucatinib|mesh-list
14731302|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14731303|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14342466|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342467|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342468|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
14342469|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
14342470|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14342471|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
14342472|NCT00915473|Hormones|hormones|mesh-ancestor
14342473|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342474|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14342475|NCT00915473|Protective Agents|protective agents|mesh-ancestor
14342476|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14342477|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342478|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
14342479|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14731304|NCT05319873|Antibodies|antibodies|mesh-list
14731305|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
14731306|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14731307|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
14731308|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731309|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731310|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
14731311|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
14731312|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
14731313|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731314|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14731315|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14731316|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14731317|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
14731318|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14731319|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14731320|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731321|NCT05319834|Aspirin|aspirin|mesh-list
14731322|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14731323|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14731324|NCT05319834|Analgesics|analgesics|mesh-ancestor
14731325|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
14731326|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731327|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731328|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731329|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342480|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14731330|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14731331|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14731332|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731333|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14731334|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14731335|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731336|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
14753023|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753024|NCT05303038|Bevacizumab|bevacizumab|mesh-list
14753025|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753026|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753027|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14753028|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14753029|NCT05303038|Growth Substances|growth substances|mesh-ancestor
14342481|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14342482|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342483|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342484|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
14342485|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918750|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14918751|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14918752|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14918753|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
14918754|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918755|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918756|NCT05271240|Bevacizumab|bevacizumab|mesh-list
14918757|NCT05271240|Temozolomide|temozolomide|mesh-list
14918758|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918759|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918760|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14918761|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14918762|NCT05271240|Growth Substances|growth substances|mesh-ancestor
14918763|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918764|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
14931243|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
14342486|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342487|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14342488|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342489|NCT00915538|Budesonide|budesonide|mesh-list
14342490|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14342491|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228800|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
15228801|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228802|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14731337|NCT05319756|Oxycodone|oxycodone|mesh-list
14731338|NCT05319756|Gabapentin|gabapentin|mesh-list
14731339|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14731340|NCT05319756|Narcotics|narcotics|mesh-ancestor
14731341|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731342|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731343|NCT05319756|Analgesics|analgesics|mesh-ancestor
14731344|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
14731345|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731346|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
14731347|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14731348|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14731349|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731350|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14731351|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14731352|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731353|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731354|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
15228803|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228804|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228805|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228806|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15228807|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15228808|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342492|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14342493|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
14342494|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342495|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342496|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14342497|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
14342498|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
14342499|NCT00915538|Hormones|hormones|mesh-ancestor
14342500|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342501|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14342502|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342503|NCT00915603|Paclitaxel|paclitaxel|mesh-list
14342504|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14731355|NCT05319730|Paclitaxel|paclitaxel|mesh-list
14342505|NCT00915603|Bevacizumab|bevacizumab|mesh-list
14342506|NCT00915603|Everolimus|everolimus|mesh-list
14342507|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14342508|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342509|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14342510|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14342511|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14342512|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342513|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342514|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14342515|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14342516|NCT00915603|Growth Substances|growth substances|mesh-ancestor
14342517|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342518|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
14342519|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342520|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
14342521|NCT00915655|Ritonavir|ritonavir|mesh-list
14342522|NCT00915655|Darunavir|darunavir|mesh-list
14342523|NCT00915655|Lamivudine|lamivudine|mesh-list
14342524|NCT00915655|Zidovudine|zidovudine|mesh-list
14342525|NCT00915655|Abacavir|abacavir|mesh-list
14342526|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14342527|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14342528|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342529|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342530|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342531|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14342532|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14342533|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
14342534|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228809|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
15228810|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15228811|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15228812|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
15228813|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15228814|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15228815|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15228816|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15228817|NCT05062135|Progesterone|progesterone|mesh-list
15228818|NCT05062135|Progestins|progestins|mesh-ancestor
15228819|NCT05062135|Hormones|hormones|mesh-ancestor
14918765|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14918766|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
14918767|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918768|NCT05271188|Anesthetics|anesthetics|mesh-list
14918769|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
14918770|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918771|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918772|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
14918773|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918774|NCT05271162|Empagliflozin|empagliflozin|mesh-list
14918775|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14918776|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918777|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15228820|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228821|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918778|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918779|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
14918780|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14918781|NCT05271136|Protective Agents|protective agents|mesh-ancestor
14918782|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918783|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
14918784|NCT05271058|Dexamethasone|dexamethasone|mesh-list
14918785|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
14918786|NCT05271058|Triamcinolone|triamcinolone|mesh-list
14918787|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14918788|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14918789|NCT05271058|BB 1101|bb 1101|mesh-list
14342535|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14342536|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14918790|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14918791|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918792|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
14918793|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
14918794|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918795|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342537|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14342538|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14342539|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
14342540|NCT00915772|Metformin|metformin|mesh-list
14342541|NCT00915772|Linagliptin|linagliptin|mesh-list
15228822|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
14342542|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14342543|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342544|NCT00915772|Incretins|incretins|mesh-ancestor
14342545|NCT00915772|Hormones|hormones|mesh-ancestor
14342546|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342547|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14342548|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342549|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342550|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464897|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464898|NCT02217982|Simethicone|simethicone|mesh-list
14464899|NCT02217982|Loperamide|loperamide|mesh-list
14918796|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14918797|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
14918798|NCT05271058|Hormones|hormones|mesh-ancestor
15228823|NCT05005182|Luspatercept|luspatercept|mesh-list
15228824|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15228825|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228826|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
15228827|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228828|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228829|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15228830|NCT05005182|Hematinics|hematinics|mesh-ancestor
15228831|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
15228832|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228833|NCT04997902|Tipifarnib|tipifarnib|mesh-list
15228834|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228835|NCT04996823|Ipilimumab|ipilimumab|mesh-list
15228836|NCT04996823|Axitinib|axitinib|mesh-list
14918799|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918800|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14918801|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918802|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
14918803|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228837|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14918804|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918805|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918806|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
14918807|NCT05271045|Vitamin D|vitamin d|mesh-list
14918808|NCT05271045|Vitamin A|vitamin a|mesh-list
14918809|NCT05271045|Vitamins|vitamins|mesh-ancestor
14918810|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
14918811|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918812|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14918813|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15228838|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228839|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15228840|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228841|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228842|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228843|NCT04945148|Metformin|metformin|mesh-list
15228844|NCT04945148|Temozolomide|temozolomide|mesh-list
15228845|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15228846|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228847|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15228848|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
15228849|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464900|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
14918814|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14918815|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918816|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14918817|NCT05270863|Carbachol|carbachol|mesh-list
14918818|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14918819|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14918820|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14918821|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14918822|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
14918823|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918824|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918825|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918826|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14342551|NCT00915928|Perindopril|perindopril|mesh-list
14342552|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14342553|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342554|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342555|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342556|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14342557|NCT00915967|Vancomycin|vancomycin|mesh-list
14342558|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342559|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342560|NCT00916032|Factor VIII|factor viii|mesh-list
14342561|NCT00916032|Coagulants|coagulants|mesh-ancestor
14342562|NCT00916058|Melphalan|melphalan|mesh-list
14342563|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14342564|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14342565|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
14342566|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918827|NCT05270863|Miotics|miotics|mesh-ancestor
14918828|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
14918829|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342567|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342568|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14342569|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342570|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
14342571|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342572|NCT00916149|Lamotrigine|lamotrigine|mesh-list
14918830|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14918831|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
14918832|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918833|NCT05270863|Analgesics|analgesics|mesh-ancestor
14918834|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
14918835|NCT05270863|Protective Agents|protective agents|mesh-ancestor
14918836|NCT05270733|Ustekinumab|ustekinumab|mesh-list
14342573|NCT00916149|Levetiracetam|levetiracetam|mesh-list
14342574|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
14342575|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
14342576|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14342577|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342578|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342579|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15228850|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342580|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342581|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14342582|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14342583|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342584|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14342585|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14342586|NCT00916279|Paclitaxel|paclitaxel|mesh-list
14342587|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14342588|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342589|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
14342590|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
14342591|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
14342592|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342593|NCT00916357|Insulin|insulin|mesh-list
14918837|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
14918838|NCT05270434|Dipyrone|dipyrone|mesh-list
14918839|NCT05270434|Meperidine|meperidine|mesh-list
14918840|NCT05270434|Morphine|morphine|mesh-list
15228851|NCT04937816|Empagliflozin|empagliflozin|mesh-list
15228852|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14918841|NCT05270434|Buprenorphine|buprenorphine|mesh-list
14918842|NCT05270434|Analgesics|analgesics|mesh-list
14918843|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14918844|NCT05270434|Narcotics|narcotics|mesh-ancestor
14918845|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918846|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918847|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
14918848|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918849|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14918850|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14918851|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14918852|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918853|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918854|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918855|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
15228853|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228854|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15228855|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228856|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
15228857|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731356|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
14731357|NCT05319730|Irinotecan|irinotecan|mesh-list
14731358|NCT05319730|Lenvatinib|lenvatinib|mesh-list
14731359|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
14731360|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14731361|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731362|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
14731363|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
15228858|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
14918856|NCT05270421|Furosemide|furosemide|mesh-list
14918857|NCT05270421|Diuretics|diuretics|mesh-ancestor
14918858|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
15228859|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
15228860|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
15228861|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
15228862|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342594|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14342595|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
14342596|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14342597|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342598|NCT00916383|Donepezil|donepezil|mesh-list
14342599|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14342600|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342601|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342602|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
14342603|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342604|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342605|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
14342606|NCT00916539|Calpastatin|calpastatin|mesh-list
14342607|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14342608|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342609|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342610|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342611|NCT00916578|Capecitabine|capecitabine|mesh-list
14342612|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14342613|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
14342614|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731364|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
14731365|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342615|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342616|NCT00916721|Propranolol|propranolol|mesh-list
14342617|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14731366|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731367|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14731368|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14731369|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731370|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
14731371|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342618|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14342619|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14918859|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918860|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14918861|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14918862|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918863|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
14918864|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14918865|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14918866|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
14918867|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14918868|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918869|NCT05270343|Vitamins|vitamins|mesh-ancestor
14918870|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
14918871|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14918872|NCT05270200|Azacitidine|azacitidine|mesh-list
14918873|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918874|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
14342620|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342621|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342622|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342623|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14342624|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14342625|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
14342626|NCT00917267|Exenatide|exenatide|mesh-list
14342627|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14342628|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342629|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14342630|NCT00917267|Incretins|incretins|mesh-ancestor
14342631|NCT00917267|Hormones|hormones|mesh-ancestor
14731372|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14731373|NCT05319639|Leucovorin|leucovorin|mesh-list
14731374|NCT05319639|Paclitaxel|paclitaxel|mesh-list
14918875|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342632|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342633|NCT00917384|Ramucirumab|ramucirumab|mesh-list
14342634|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342635|NCT00917462|Sorafenib|sorafenib|mesh-list
14342636|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342637|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14342638|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342639|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342640|NCT00917553|Doxycycline|doxycycline|mesh-list
14342641|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228863|NCT04878211|Interferons|interferons|mesh-list
15228864|NCT04878211|Ofatumumab|ofatumumab|mesh-list
15228865|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
15228866|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
15228867|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228868|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
15228869|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228870|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15228871|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
15228872|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228873|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228874|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15228875|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
15228876|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15228877|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228878|NCT04865731|Esomeprazole|esomeprazole|mesh-list
14342642|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342643|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
14731375|NCT05319639|Fluorouracil|fluorouracil|mesh-list
14918876|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918877|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918878|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
14918879|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14918880|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
15228879|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15228880|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15228881|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14342644|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14342645|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14342646|NCT00917579|Atorvastatin|atorvastatin|mesh-list
14342647|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14342648|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14342649|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
14918881|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918882|NCT05269849|Sirolimus|sirolimus|mesh-list
14731376|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
14731377|NCT05319639|Irinotecan|irinotecan|mesh-list
14731378|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
14731379|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14731380|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731381|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
14918883|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342650|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731382|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
14731383|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
14731384|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731385|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
14731386|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14731387|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731388|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
14731389|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228882|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228883|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342651|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14342652|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14342653|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342654|NCT00917644|Atorvastatin|atorvastatin|mesh-list
14342655|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14342656|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14342657|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
14342658|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342659|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14342660|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14342661|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342662|NCT00918138|Metformin|metformin|mesh-list
14342663|NCT00918138|Saxagliptin|saxagliptin|mesh-list
14342664|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14342665|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342666|NCT00918138|Incretins|incretins|mesh-ancestor
14342667|NCT00918138|Hormones|hormones|mesh-ancestor
15228884|NCT04856293|Crizotinib|crizotinib|mesh-list
15228885|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228886|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228887|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228888|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228889|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15228890|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14342668|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14731390|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14731391|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918884|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342669|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14342670|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342671|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342672|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342673|NCT00918203|Paclitaxel|paclitaxel|mesh-list
14342674|NCT00918203|Carboplatin|carboplatin|mesh-list
14342675|NCT00918203|Olaratumab|olaratumab|mesh-list
14342676|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14342677|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342678|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
14342679|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
14342680|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
14342681|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342682|NCT00918255|Adalimumab|adalimumab|mesh-list
14342683|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342684|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342685|NCT00918333|Everolimus|everolimus|mesh-list
14342686|NCT00918333|Panobinostat|panobinostat|mesh-list
14342687|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14342688|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342689|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342690|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
14342691|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342692|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342693|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342694|NCT00918385|Dasatinib|dasatinib|mesh-list
14342695|NCT00918385|Nilutamide|nilutamide|mesh-list
14342696|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342697|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14342698|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342699|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342700|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
14342701|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
14342702|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342703|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342704|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14342705|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14342706|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14918885|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14918886|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918887|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
14918888|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918889|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
14918890|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930860|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930861|NCT01435837|Caffeine|caffeine|mesh-list
14930862|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14930863|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930864|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14930865|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930866|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930867|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14930868|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14930869|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
14930870|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15228891|NCT04783233|Chitosan|chitosan|mesh-list
15228892|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
15228893|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15228894|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15228895|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
15228896|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228897|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15228898|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
15228899|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
15228900|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
15228901|NCT04783233|Coagulants|coagulants|mesh-ancestor
15228902|NCT04742036|Paclitaxel|paclitaxel|mesh-list
15228903|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15228904|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731392|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731393|NCT05319639|Antidotes|antidotes|mesh-ancestor
14731394|NCT05319639|Protective Agents|protective agents|mesh-ancestor
14342707|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731395|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
14731396|NCT05319639|Vitamins|vitamins|mesh-ancestor
14731397|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
14731398|NCT05319587|Cytarabine|cytarabine|mesh-list
14731399|NCT05319587|Annamycin|annamycin|mesh-list
14731400|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14731401|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
14731402|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731403|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731404|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
14731405|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731406|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731407|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
14731408|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342708|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342709|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14342710|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342711|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342712|NCT00918684|Citalopram|citalopram|mesh-list
14342713|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14342714|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14918891|NCT05269654|Mannitol|mannitol|mesh-list
14918892|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14918893|NCT05269654|Diuretics|diuretics|mesh-ancestor
14918894|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
14918895|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918896|NCT05269615|Valsartan|valsartan|mesh-list
14918897|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14918898|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14918899|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14918900|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918901|NCT05269459|Cannabidiol|cannabidiol|mesh-list
14342715|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342716|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342717|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342718|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
14342719|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342720|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14342721|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
14342722|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14342723|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
14342724|NCT00918723|Rituximab|rituximab|mesh-list
14342725|NCT00918723|Fludarabine|fludarabine|mesh-list
14731409|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14731410|NCT05319431|Lenvatinib|lenvatinib|mesh-list
14731411|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731412|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14731413|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731414|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731415|NCT05319340|Anticoagulants|anticoagulants|mesh-list
14731416|NCT05319301|Melatonin|melatonin|mesh-list
14731417|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
14731418|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731419|NCT05319301|Protective Agents|protective agents|mesh-ancestor
15228905|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
15228906|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
15228907|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
15228908|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228909|NCT04707183|Lidocaine|lidocaine|mesh-list
15228910|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
15228911|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
14731420|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731421|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15228912|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15228913|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228914|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
14342726|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
14342727|NCT00918723|Vorinostat|vorinostat|mesh-list
14342728|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342729|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
14342730|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918902|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
14342731|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342732|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14342733|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
14342734|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342735|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342736|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14342737|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342738|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14342739|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
14342740|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14342741|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342742|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
14342743|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14342744|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
14342745|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342746|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
14342747|NCT00918736|Protective Agents|protective agents|mesh-ancestor
14342748|NCT00918879|Saxagliptin|saxagliptin|mesh-list
14342749|NCT00918879|Incretins|incretins|mesh-ancestor
14342750|NCT00918879|Hormones|hormones|mesh-ancestor
14342751|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342752|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342753|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14342754|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342755|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342756|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342757|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14342758|NCT00918931|Obatoclax|obatoclax|mesh-list
14342759|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342760|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342761|NCT00918957|Tobramycin|tobramycin|mesh-list
14342762|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342763|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342764|NCT00919035|Sirolimus|sirolimus|mesh-list
14342765|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342766|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342767|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14342768|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342769|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
14342770|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342771|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
14918903|NCT05269355|Dacarbazine|dacarbazine|mesh-list
14731422|NCT05319249|Talazoparib|talazoparib|mesh-list
14731423|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14731424|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731425|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731426|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731427|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
14342772|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342773|NCT00919061|Gemcitabine|gemcitabine|mesh-list
14918904|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14918905|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
14918906|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918907|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918908|NCT05268003|Venetoclax|venetoclax|mesh-list
14918909|NCT05268003|Ponatinib|ponatinib|mesh-list
14918910|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918911|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14731428|NCT05319015|Lenvatinib|lenvatinib|mesh-list
14731429|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731430|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731431|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14731432|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731433|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731434|NCT05318794|Doxorubicin|doxorubicin|mesh-list
15228915|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228916|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15228917|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15228918|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14918912|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918913|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918914|NCT05261464|Metoprolol|metoprolol|mesh-list
14918915|NCT05261464|Diltiazem|diltiazem|mesh-list
14918916|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14342774|NCT00919061|Sorafenib|sorafenib|mesh-list
14342775|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342776|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14342777|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
14342778|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342779|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
14342780|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342781|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342782|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342783|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
14342784|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342785|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14342786|NCT00919126|Xenon|xenon|mesh-list
14342787|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15228919|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15228920|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228921|NCT04703205|Ivermectin|ivermectin|mesh-list
15228922|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15228923|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228924|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
14918917|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14918918|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
14918919|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
15228925|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228926|NCT04676334|Rucaparib|rucaparib|mesh-list
15228927|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14731435|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930871|NCT01435902|Fluticasone|fluticasone|mesh-list
14918920|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918921|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228928|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228929|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228930|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228931|NCT04639414|Empagliflozin|empagliflozin|mesh-list
15228932|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15228933|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731436|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14731437|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14731438|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15228934|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15228935|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228936|NCT04608903|Sulforaphane|sulforaphane|mesh-list
15228937|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15228938|NCT04608903|Protective Agents|protective agents|mesh-ancestor
15228939|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228940|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228941|NCT04560127|Apatinib|apatinib|mesh-list
14342788|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
14342789|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
14342790|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14342791|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342792|NCT00919191|Adapalene|adapalene|mesh-list
14342793|NCT00919191|Tretinoin|tretinoin|mesh-list
14342794|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14342795|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14342796|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14342797|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14342798|NCT00919191|Analgesics|analgesics|mesh-ancestor
14342799|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
15228942|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228943|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15228944|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228945|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228946|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15228947|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15228948|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228949|NCT04518345|Azacitidine|azacitidine|mesh-list
14342800|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731439|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731440|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731441|NCT05318755|Testosterone|testosterone|mesh-list
14731442|NCT05318755|Androgens|androgens|mesh-ancestor
14731443|NCT05318755|Hormones|hormones|mesh-ancestor
14731444|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14731445|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731446|NCT05318573|Gemcitabine|gemcitabine|mesh-list
14731447|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
14731448|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14731449|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
14731450|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731451|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731452|NCT05318573|Antiviral Agents|antiviral agents|mesh-ancestor
14731453|NCT05318573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731454|NCT05318573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731455|NCT05318573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731456|NCT05318573|Immunologic Factors|immunologic factors|mesh-ancestor
14930872|NCT01435902|Xhance|xhance|mesh-list
14918922|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14918923|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14918924|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14918925|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
14918926|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918927|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918928|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14918929|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14918930|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14918931|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
14918932|NCT05253846|Fluorouracil|fluorouracil|mesh-list
14918933|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
14918934|NCT05253846|Irinotecan|irinotecan|mesh-list
14918935|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
14731457|NCT05318573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731458|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731459|NCT05318560|Lidocaine|lidocaine|mesh-list
14731460|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
14731461|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
15228950|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15228951|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
15228952|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228953|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228954|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228955|NCT04515472|Hormones|hormones|mesh-list
15228956|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228957|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15228958|NCT04512079|Enoxaparin|enoxaparin|mesh-list
15228959|NCT04512079|Apixaban|apixaban|mesh-list
15228960|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
14918936|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918937|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918938|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918939|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228961|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15228962|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15228963|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15228964|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15228965|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
15228966|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15228967|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
15228968|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15228969|NCT04511247|Sirolimus|sirolimus|mesh-list
15228970|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228971|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228972|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15228973|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228974|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
15228975|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228976|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
15228977|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228978|NCT04511234|Sirolimus|sirolimus|mesh-list
15228979|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15228980|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15228981|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15228982|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15228983|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
15228984|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15228985|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
15228986|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228987|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
15228988|NCT04491617|Narcotics|narcotics|mesh-ancestor
14731462|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731463|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731464|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
14731465|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228989|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918940|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
14918941|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918942|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14918943|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918944|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918945|NCT05253495|Cytarabine|cytarabine|mesh-list
14918946|NCT05253495|Etoposide|etoposide|mesh-list
14918947|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14918948|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918949|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14918950|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14918951|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918952|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918953|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14918954|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
14918955|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
14918956|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14918957|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14918958|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
14918959|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918960|NCT05251714|Fulvestrant|fulvestrant|mesh-list
14918961|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14342801|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342802|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14342803|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14918962|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14918963|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14918964|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14918965|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
14918966|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14918967|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918968|NCT05251090|Factor VIII|factor viii|mesh-list
14918969|NCT05251090|Coagulants|coagulants|mesh-ancestor
14918970|NCT05250141|Levodopa|levodopa|mesh-list
14918971|NCT05250141|Carbidopa|carbidopa|mesh-list
14918972|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14342804|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342805|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
14342806|NCT00919503|Cyclosporine|cyclosporine|mesh-list
14342807|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
14918973|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14918974|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
14918975|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14918976|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918977|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918978|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14918979|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14918980|NCT05248724|Ketorolac|ketorolac|mesh-list
14918981|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14342808|NCT00919503|Methotrexate|methotrexate|mesh-list
14342809|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
14342810|NCT00919503|Fludarabine|fludarabine|mesh-list
14342811|NCT00919503|Treosulfan|treosulfan|mesh-list
14342812|NCT00919503|Busulfan|busulfan|mesh-list
14342813|NCT00919503|Tacrolimus|tacrolimus|mesh-list
14342814|NCT00919503|Cyclosporins|cyclosporins|mesh-list
14342815|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
14342816|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14342817|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14342818|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
14342819|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14342820|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342821|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14342822|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
14342823|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342824|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342825|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
14342826|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342827|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14342828|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342829|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
14342830|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14342831|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14342832|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14342833|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
14342834|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342835|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14342836|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14342837|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
14342838|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342839|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14342840|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
14342841|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14342842|NCT00919633|Interferons|interferons|mesh-list
14342843|NCT00919633|Ribavirin|ribavirin|mesh-list
14342844|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
14342845|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
14342846|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14342847|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228990|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731466|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14731467|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14731468|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14731469|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753030|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228991|NCT04491617|Analgesics|analgesics|mesh-ancestor
15228992|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
15228993|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15228994|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15228995|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
15228996|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15228997|NCT04437485|Norepinephrine|norepinephrine|mesh-list
15228998|NCT04437485|Bupropion|bupropion|mesh-list
15228999|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
15229000|NCT04437485|Serotonin|serotonin|mesh-list
15229001|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15229002|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14342848|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342849|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
14342850|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342851|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
14342852|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342853|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
14342854|NCT00919711|Denosumab|denosumab|mesh-list
14342855|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
14342856|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15229003|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15229004|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15229005|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15229006|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342857|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342858|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14342859|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342860|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342861|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14342862|NCT00919802|Oxytocin|oxytocin|mesh-list
14342863|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
14342864|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14342865|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342866|NCT00919854|Ritonavir|ritonavir|mesh-list
14342867|NCT00919854|Darunavir|darunavir|mesh-list
14342868|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14342869|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14342870|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
14342871|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342872|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14918982|NCT05248724|Epinephrine|epinephrine|mesh-list
14731470|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731471|NCT05318469|Ivermectin|ivermectin|mesh-list
14731472|NCT05318469|Pembrolizumab|pembrolizumab|mesh-list
14731473|NCT05318469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731474|NCT05318469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731475|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14731476|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731477|NCT05318248|Clonidine|clonidine|mesh-list
14731478|NCT05318248|Analgesics|analgesics|mesh-ancestor
14731479|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
14731480|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731481|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731482|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14731483|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
14731484|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
14731485|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14731486|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14731487|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14731488|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
14731489|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731490|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753031|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753032|NCT05296798|Paclitaxel|paclitaxel|mesh-list
14753033|NCT05296798|Docetaxel|docetaxel|mesh-list
14753034|NCT05296798|Trastuzumab|trastuzumab|mesh-list
14753035|NCT05296798|Pertuzumab|pertuzumab|mesh-list
14753036|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14753037|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753038|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14753039|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14918983|NCT05248724|Racepinephrine|racepinephrine|mesh-list
14918984|NCT05248724|Morphine|morphine|mesh-list
14918985|NCT05248724|Ropivacaine|ropivacaine|mesh-list
14753040|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753041|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753042|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753043|NCT05296577|Vinorelbine|vinorelbine|mesh-list
14753044|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14753045|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753046|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
14753047|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753048|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753049|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342873|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14753050|NCT05295212|Atezolizumab|atezolizumab|mesh-list
14918986|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
14731491|NCT05318105|Diuretics|diuretics|mesh-list
14731492|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14731493|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
14731494|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731495|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731496|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731497|NCT05318066|Norepinephrine|norepinephrine|mesh-list
14731498|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14731499|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14731500|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14731501|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731502|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731503|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731504|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
14731505|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
14731506|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731507|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14731508|NCT05317936|Venetoclax|venetoclax|mesh-list
14731509|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731510|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
14731511|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731512|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731513|NCT05317806|Metformin|metformin|mesh-list
14731514|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14731515|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731516|NCT05317767|Vaccines|vaccines|mesh-list
14731517|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
14731518|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731519|NCT05317689|Psilocybin|psilocybin|mesh-list
14731520|NCT05317689|Psilocin|psilocin|mesh-list
14731521|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
14731522|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731523|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731524|NCT05317676|Palmidrol|palmidrol|mesh-list
14731525|NCT05317676|Analgesics|analgesics|mesh-ancestor
14731526|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
14731527|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731528|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731529|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14731530|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14731531|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731532|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731533|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
14731534|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731535|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14731536|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14918987|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14918988|NCT05248724|Narcotics|narcotics|mesh-ancestor
14918989|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14918990|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14918991|NCT05248724|Analgesics|analgesics|mesh-ancestor
14918992|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
14918993|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14918994|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
14918995|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
14918996|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14918997|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14918998|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14918999|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919000|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14919001|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919002|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919003|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14342874|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14342875|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
14342876|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342877|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14342878|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14342879|NCT00919867|Guanfacine|guanfacine|mesh-list
14342880|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15229007|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229008|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
15229009|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919004|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14731537|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919005|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919006|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919007|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14919008|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14919009|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
14919010|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14919011|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
14919012|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
14919013|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
14919014|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15229010|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229011|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15229012|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15229013|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229014|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15229015|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15229016|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
15229017|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
15229018|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
14919015|NCT05248620|Amoxicillin|amoxicillin|mesh-list
14919016|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14919017|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919018|NCT05245760|Paclitaxel|paclitaxel|mesh-list
14919019|NCT05245760|Carboplatin|carboplatin|mesh-list
14919020|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14919021|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919022|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
14919023|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
14919024|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
14919025|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919026|NCT05243199|Valsartan|valsartan|mesh-list
14919027|NCT05243199|Irbesartan|irbesartan|mesh-list
14342881|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14342882|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342883|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15229019|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229020|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15229021|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14342884|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14342885|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14342886|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342887|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
14342888|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342889|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14342890|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14342891|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14342892|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919028|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14919029|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14919030|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14919031|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919032|NCT05242705|Cystatins|cystatins|mesh-list
14919033|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14919034|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
14919035|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919036|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919037|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
14919038|NCT05242692|Ketamine|ketamine|mesh-list
14919039|NCT05242692|Esketamine|esketamine|mesh-list
15229022|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
15229023|NCT04436224|Fentanyl|fentanyl|mesh-list
15229024|NCT04436224|Hydromorphone|hydromorphone|mesh-list
15229025|NCT04436224|Butorphanol|butorphanol|mesh-list
15229026|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15229027|NCT04436224|Narcotics|narcotics|mesh-ancestor
15229028|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919040|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15229029|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229030|NCT04436224|Analgesics|analgesics|mesh-ancestor
14919041|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919042|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919043|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14919044|NCT05242692|Analgesics|analgesics|mesh-ancestor
14919045|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
14919046|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919047|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14919048|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14919049|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919050|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919051|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919052|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919053|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14919054|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14919055|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
14919056|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
14919057|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14919058|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14919059|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
14919060|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14919061|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14919062|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14919063|NCT05238155|Antimetabolites|antimetabolites|mesh-list
14919064|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919065|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
14919066|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919067|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930873|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930874|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14930875|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
14930876|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930877|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930878|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14930879|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
14930880|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
14930881|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14342893|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
14342894|NCT00920075|Alendronate|alendronate|mesh-list
14342895|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14342896|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930882|NCT01435915|Ropinirole|ropinirole|mesh-list
14930883|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14930884|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14930885|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
14930886|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
14930887|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930888|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930889|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930890|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14930891|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14930892|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14930893|NCT01435941|Analgesics|analgesics|mesh-ancestor
14930894|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
14919068|NCT05233982|Olaparib|olaparib|mesh-list
14919069|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14919070|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919071|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919072|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919073|NCT05232006|Niraparib|niraparib|mesh-list
14919074|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14919075|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919076|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919077|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919078|NCT05226455|Azacitidine|azacitidine|mesh-list
14919079|NCT05226455|Venetoclax|venetoclax|mesh-list
14919080|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919081|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
14731538|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731539|NCT05317676|Hormones|hormones|mesh-ancestor
14731540|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14731541|NCT05317611|Ondansetron|ondansetron|mesh-list
14919082|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342897|NCT00920140|Trametinib|trametinib|mesh-list
14342898|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342899|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14342900|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919083|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919084|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919085|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
14919086|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14919087|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919088|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919089|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14919090|NCT05226325|Analgesics|analgesics|mesh-ancestor
14919091|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
14919092|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919093|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14919094|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14919095|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919096|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919097|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919098|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919099|NCT05219435|Nivolumab|nivolumab|mesh-list
14919100|NCT05219435|Ipilimumab|ipilimumab|mesh-list
14919101|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919102|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919103|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14919104|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919105|NCT05215418|Topiramate|topiramate|mesh-list
14919106|NCT05215418|Phentermine|phentermine|mesh-list
14919107|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
14919108|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14919109|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919110|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14919111|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
14464901|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14919112|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14919113|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
14919114|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
14342901|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342902|NCT00920218|Vaccines|vaccines|mesh-list
14342903|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
14342904|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342905|NCT00920426|Cabotegravir|cabotegravir|mesh-list
14342906|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14342907|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14342908|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342909|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342910|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14342911|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14342912|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
14342913|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342914|NCT00920556|Bortezomib|bortezomib|mesh-list
14342915|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342916|NCT00920686|Sumatriptan|sumatriptan|mesh-list
14342917|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14919115|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342918|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14342919|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14342920|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
14342921|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342922|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919116|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919117|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919118|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919119|NCT05209841|Heparin|heparin|mesh-list
14919120|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
14919121|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14919122|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14919123|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919124|NCT05209035|Trazodone|trazodone|mesh-list
14919125|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14919126|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14342923|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342924|NCT00920699|Ubiquinone|ubiquinone|mesh-list
14919127|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919128|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919129|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14919130|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14919131|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14919132|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229031|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
15229032|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229033|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15229034|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15229035|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
15229036|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
14919133|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342925|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
14342926|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
14342927|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342928|NCT00920699|Vitamins|vitamins|mesh-ancestor
14342929|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
14919134|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919135|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
15229037|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
15229038|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
15229039|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15229040|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
15229041|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15229042|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229043|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229044|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15229045|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15229046|NCT04433988|Protective Agents|protective agents|mesh-ancestor
15229047|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229048|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
15229049|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15229050|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
15229051|NCT04414722|Amoxicillin|amoxicillin|mesh-list
15229052|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
15229053|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
15229054|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15229055|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15229056|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229057|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15229058|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919136|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14919137|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
14919138|NCT05207280|Terlipressin|terlipressin|mesh-list
14919139|NCT05207280|Norepinephrine|norepinephrine|mesh-list
14919140|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14919141|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14919142|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14919143|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919144|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919145|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919146|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919147|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919148|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
14919149|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
14919150|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919151|NCT05205382|Nicotine|nicotine|mesh-list
14919152|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14919153|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
14919154|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919155|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919156|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14919157|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14919158|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
14919159|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919160|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919161|NCT05199714|Pramlintide|pramlintide|mesh-list
14919162|NCT05199714|Pancrelipase|pancrelipase|mesh-list
14919163|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14919164|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14919165|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919166|NCT05194397|Niacinamide|niacinamide|mesh-list
14919167|NCT05194397|Niacin|niacin|mesh-list
14919168|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
14919169|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
14919170|NCT05194397|Vitamins|vitamins|mesh-ancestor
14919171|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
14919172|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919173|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14919174|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
14919175|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919176|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14919177|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
14919178|NCT05190471|Decitabine|decitabine|mesh-list
14919179|NCT05190471|Oblimersen|oblimersen|mesh-list
14919180|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919181|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
14919182|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919183|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919184|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919185|NCT05180773|Bromocriptine|bromocriptine|mesh-list
14919186|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
14919187|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14919188|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
14919189|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14919190|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
14919191|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919192|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919193|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
14919194|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14919195|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14919196|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14919197|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919198|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919199|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
15229059|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342930|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342931|NCT00920816|Sorafenib|sorafenib|mesh-list
14342932|NCT00920816|Axitinib|axitinib|mesh-list
14342933|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342934|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14342935|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342936|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342937|NCT00920829|Naltrexone|naltrexone|mesh-list
14342938|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14342939|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14342940|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342941|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
14342942|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14342943|NCT00920855|Bortezomib|bortezomib|mesh-list
14342944|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14342945|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342946|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14342947|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
14342948|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342949|NCT00920907|Ipilimumab|ipilimumab|mesh-list
14342950|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14342951|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731542|NCT05317611|Bupivacaine|bupivacaine|mesh-list
15229060|NCT04410341|Vildagliptin|vildagliptin|mesh-list
15229061|NCT04410341|Citalopram|citalopram|mesh-list
15229062|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15229063|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15229064|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229065|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229066|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229067|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
15229068|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229069|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15229070|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
15229071|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731543|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
14731544|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
14731545|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731546|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731547|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
14731548|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731549|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
14731550|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
14731551|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731552|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
14731553|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
14731554|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14731555|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
14731556|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731557|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229072|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15229073|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15229074|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
15229075|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229076|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
15229077|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229078|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731558|NCT05317611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14731559|NCT05317611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14731560|NCT05317611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731561|NCT05317611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14731562|NCT05317572|Morphine|morphine|mesh-list
14731563|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14919200|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
14919201|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14342952|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14342953|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342954|NCT00921024|Ceftazidime|ceftazidime|mesh-list
14342955|NCT00921024|Ceftolozane|ceftolozane|mesh-list
14342956|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342957|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342958|NCT00921115|Fulvestrant|fulvestrant|mesh-list
14342959|NCT00921115|Anastrozole|anastrozole|mesh-list
14342960|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14342961|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342962|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14342963|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14342964|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
14342965|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14342966|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342967|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14342968|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14342969|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464902|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
14919202|NCT05180240|Cannabidiol|cannabidiol|mesh-list
14342970|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342971|NCT00921310|Sirolimus|sirolimus|mesh-list
14342972|NCT00921310|Pemetrexed|pemetrexed|mesh-list
14342973|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14342974|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14342975|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342976|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14342977|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14342978|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14342979|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14342980|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14342981|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
14342982|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14342983|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
14731564|NCT05317572|Narcotics|narcotics|mesh-ancestor
14731565|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731566|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731567|NCT05317572|Analgesics|analgesics|mesh-ancestor
14342984|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14342985|NCT00921557|Vitamin D|vitamin d|mesh-list
14342986|NCT00921557|Alendronate|alendronate|mesh-list
14342987|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
14342988|NCT00921557|Calcium|calcium|mesh-list
14342989|NCT00921557|Vitamins|vitamins|mesh-ancestor
14342990|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
14342991|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229079|NCT04374019|Artesunate|artesunate|mesh-list
15229080|NCT04374019|Ivermectin|ivermectin|mesh-list
15229081|NCT04374019|Camostat|camostat|mesh-list
14342992|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14342993|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14342994|NCT00921557|Antacids|antacids|mesh-ancestor
14342995|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14342996|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14342997|NCT00921843|Methadone|methadone|mesh-list
14342998|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14342999|NCT00921843|Narcotics|narcotics|mesh-ancestor
14343000|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919203|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
14919204|NCT05180097|Gemcitabine|gemcitabine|mesh-list
14919205|NCT05180097|Dexamethasone|dexamethasone|mesh-list
14919206|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
14919207|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14919208|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919209|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919210|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
14919211|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
14919212|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919213|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731568|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
14919214|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229082|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
15229083|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15229084|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15229085|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229086|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229087|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
15229088|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
15229089|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15229090|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
15229091|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
15229092|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229093|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229094|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15229095|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15229096|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15229097|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14343001|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343002|NCT00921843|Analgesics|analgesics|mesh-ancestor
14343003|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
14343004|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343005|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
14343006|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
15229098|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15229099|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229100|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
15229101|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229102|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
15229103|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14343007|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
14343008|NCT00922116|Hematinics|hematinics|mesh-ancestor
14343009|NCT00922194|Metformin|metformin|mesh-list
14919215|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
14919216|NCT05180097|Hormones|hormones|mesh-ancestor
14919217|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919218|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919219|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919220|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
14919221|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919222|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
14919223|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919224|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919225|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919226|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
14919227|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919228|NCT05173142|Gemcitabine|gemcitabine|mesh-list
14919229|NCT05173142|Docetaxel|docetaxel|mesh-list
14919230|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919231|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919232|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
14919233|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919234|NCT05173142|Antiviral Agents|antiviral agents|mesh-ancestor
14919235|NCT05173142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919236|NCT05173142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919237|NCT05173142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919238|NCT05173142|Immunologic Factors|immunologic factors|mesh-ancestor
14919239|NCT05173142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919240|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229104|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15229105|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229106|NCT04344678|Urological Agents|urological agents|mesh-ancestor
15229107|NCT04338399|Paclitaxel|paclitaxel|mesh-list
15229108|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229109|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229110|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229111|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229112|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229113|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229114|NCT04311463|Paroxetine|paroxetine|mesh-list
15229115|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14919241|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
14919242|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
14919243|NCT05170230|Terlipressin|terlipressin|mesh-list
14919244|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14919245|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14919246|NCT05168735|Ketamine|ketamine|mesh-list
14919247|NCT05168735|Analgesics|analgesics|mesh-ancestor
14919248|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
14919249|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919250|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919251|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14919252|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14919253|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
14919254|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
14919255|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919256|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14919257|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14919258|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919259|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919260|NCT05166746|Clindamycin|clindamycin|mesh-list
15229116|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14919261|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
14919262|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
14919263|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14919264|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919265|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14919266|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919267|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919268|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
14919269|NCT05165875|Lidocaine|lidocaine|mesh-list
14919270|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
14919271|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
14919272|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919273|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919274|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
14919275|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919276|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14919277|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14919278|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14919279|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14919280|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919281|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930895|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930896|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930897|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930898|NCT01435954|Doxazosin|doxazosin|mesh-list
14930899|NCT01435954|Tamsulosin|tamsulosin|mesh-list
14930900|NCT01435954|Finasteride|finasteride|mesh-list
14930901|NCT01435954|Silodosin|silodosin|mesh-list
14930902|NCT01435954|Terazosin|terazosin|mesh-list
14930903|NCT01435954|Alfuzosin|alfuzosin|mesh-list
14930904|NCT01435954|Dutasteride|dutasteride|mesh-list
14930905|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14930906|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14930907|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14930908|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930909|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930910|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930911|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930912|NCT01435954|Urological Agents|urological agents|mesh-ancestor
15229117|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229118|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229119|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229120|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
15229121|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229122|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15229123|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
15229124|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15229125|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15229126|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15229127|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229128|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15229129|NCT04295005|Empagliflozin|empagliflozin|mesh-list
14919282|NCT05162118|Nivolumab|nivolumab|mesh-list
14919283|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919284|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919285|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14919286|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919287|NCT05157971|Cytarabine|cytarabine|mesh-list
14919288|NCT05157971|Prednisone|prednisone|mesh-list
14919289|NCT05157971|Cortisone|cortisone|mesh-list
14919290|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
14919291|NCT05157971|Methotrexate|methotrexate|mesh-list
14919292|NCT05157971|Vincristine|vincristine|mesh-list
14919293|NCT05157971|Daunorubicin|daunorubicin|mesh-list
14919294|NCT05157971|Asparaginase|asparaginase|mesh-list
14919295|NCT05157971|Venetoclax|venetoclax|mesh-list
14919296|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
14919297|NCT05157971|Pegaspargase|pegaspargase|mesh-list
14919298|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919299|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
14919300|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919301|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919302|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14919303|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
14919304|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919305|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919306|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14343010|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14343011|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343012|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14343013|NCT00922207|Entecavir|entecavir|mesh-list
14919307|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919308|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
14919309|NCT05157971|Hormones|hormones|mesh-ancestor
14919310|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919311|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919312|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14919313|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
14919314|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14919315|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919316|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
14919317|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
14919318|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919319|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14919320|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14919321|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
14919322|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919323|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14919324|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
14919325|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
14919326|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
14919327|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14919328|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14919329|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14919330|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
14919331|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14919332|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919333|NCT05144542|Nicotine|nicotine|mesh-list
14919334|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14919335|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
15229130|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15229131|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229132|NCT04295005|Incretins|incretins|mesh-ancestor
15229133|NCT04295005|Hormones|hormones|mesh-ancestor
15229134|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229135|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15229136|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
15229137|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229138|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229139|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15229140|NCT04225988|Tacrolimus|tacrolimus|mesh-list
15229141|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229142|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
15229143|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919336|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919337|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919338|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14919339|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14919340|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
14919341|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919342|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919343|NCT05142267|Oxycodone|oxycodone|mesh-list
14919344|NCT05142267|Naloxone|naloxone|mesh-list
14919345|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14919346|NCT05142267|Narcotics|narcotics|mesh-ancestor
14919347|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919348|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919349|NCT05142267|Analgesics|analgesics|mesh-ancestor
14919350|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
14919351|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919352|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14919353|NCT05142072|Vitamin D|vitamin d|mesh-list
14919354|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
14919355|NCT05142072|Vitamins|vitamins|mesh-ancestor
14919356|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
14919357|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919358|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14919359|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14343014|NCT00922207|Adefovir|adefovir|mesh-list
14343015|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
14343016|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343017|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14343018|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14343019|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343020|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464903|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464904|NCT02217982|Emollients|emollients|mesh-ancestor
14464905|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
14464906|NCT02218164|Interferons|interferons|mesh-list
14464907|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
14464908|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
14464909|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14464910|NCT02218164|Fluorouracil|fluorouracil|mesh-list
14464911|NCT02218164|Capecitabine|capecitabine|mesh-list
14464912|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
14464913|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464914|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14464915|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464916|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14464917|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
14464918|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464919|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
14464920|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464921|NCT02218190|Alvimopan|alvimopan|mesh-list
14464922|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464923|NCT02218203|Lidocaine|lidocaine|mesh-list
14464924|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
14464925|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
14464926|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
14464927|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464928|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464929|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
14464930|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464931|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14464932|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14464933|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14464934|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464935|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464936|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
14464937|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
14919360|NCT05138029|Dexamethasone|dexamethasone|mesh-list
14919361|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
14343021|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
14343022|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14343023|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
14343024|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14731569|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731570|NCT05306470|Lidocaine|lidocaine|mesh-list
14731571|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
14731572|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
14731573|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
14731574|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731575|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731576|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
14731577|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731578|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14731579|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14731580|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14731581|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731582|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731583|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14731584|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
14731585|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14343025|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343026|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14343027|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14343028|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14343029|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14343030|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14343031|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343032|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14343033|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14343034|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343035|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343036|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
14343037|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343038|NCT00922441|Valsartan|valsartan|mesh-list
14343039|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14343040|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14343041|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14343042|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343043|NCT00922480|Losartan|losartan|mesh-list
14343044|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14919362|NCT05138029|Ranibizumab|ranibizumab|mesh-list
14919363|NCT05138029|BB 1101|bb 1101|mesh-list
14919364|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343045|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14343046|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14343047|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14343048|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343049|NCT00922636|Methylphenidate|methylphenidate|mesh-list
14343050|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14343051|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343052|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14343053|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14343054|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343055|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343056|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
14343057|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731586|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14919365|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
14919366|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
14343058|NCT00922766|Dalteparin|dalteparin|mesh-list
14343059|NCT00922766|Tinzaparin|tinzaparin|mesh-list
14343060|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14343061|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
14343062|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14343063|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14343064|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343065|NCT00922779|Ribavirin|ribavirin|mesh-list
14343066|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14343067|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
14343068|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343069|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
14343070|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343071|NCT00922987|Pregabalin|pregabalin|mesh-list
14343072|NCT00922987|Analgesics|analgesics|mesh-ancestor
14343073|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
14343074|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343075|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731587|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14731588|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919367|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343076|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
14343077|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14343078|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343079|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343080|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14343081|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14343082|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14343083|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343084|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14343085|NCT00923091|Amlodipine|amlodipine|mesh-list
14343086|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14343087|NCT00923091|Olmesartan|olmesartan|mesh-list
14343088|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14343089|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
14343090|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14343091|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14919368|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919369|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14919370|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
14919371|NCT05138029|Hormones|hormones|mesh-ancestor
14919372|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229144|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15229145|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229146|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229147|NCT04212364|Naloxone|naloxone|mesh-list
14343092|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343093|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343094|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14343095|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343096|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
14343097|NCT00923091|Diuretics|diuretics|mesh-ancestor
14343098|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
14343099|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14343100|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14343101|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14343102|NCT00923117|Sunitinib|sunitinib|mesh-list
14343103|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343104|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14343105|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14343106|NCT00923117|Growth Substances|growth substances|mesh-ancestor
14343107|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343108|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343109|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14343110|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731589|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731590|NCT05302804|Menthol|menthol|mesh-list
14731591|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
14731592|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
14731593|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
14731594|NCT05302388|Promethazine|promethazine|mesh-list
14731595|NCT05302388|Dexamethasone|dexamethasone|mesh-list
14731596|NCT05302388|Prednisolone|prednisolone|mesh-list
14731597|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15229148|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15229149|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229150|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
14919373|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919374|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919375|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
14919376|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919377|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343111|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343112|NCT00923130|Bevacizumab|bevacizumab|mesh-list
14343113|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343114|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343115|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14343116|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14343117|NCT00923130|Growth Substances|growth substances|mesh-ancestor
14343118|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343119|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343120|NCT00923156|Ramipril|ramipril|mesh-list
14343121|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14343122|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
14343123|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343124|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343125|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14343126|NCT00923195|Aldesleukin|aldesleukin|mesh-list
14343127|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
14343128|NCT00923195|Fludarabine|fludarabine|mesh-list
14919378|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14919379|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14919380|NCT05138029|Growth Substances|growth substances|mesh-ancestor
14919381|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
14919382|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14919383|NCT05137119|Vancomycin|vancomycin|mesh-list
14919384|NCT05137119|Clindamycin|clindamycin|mesh-list
14919385|NCT05137119|Cefazolin|cefazolin|mesh-list
14919386|NCT05137119|Daptomycin|daptomycin|mesh-list
14919387|NCT05137119|Penicillins|penicillins|mesh-list
14919388|NCT05137119|Penicillin G|penicillin g|mesh-list
14919389|NCT05137119|Lincomycin|lincomycin|mesh-list
14919390|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919391|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14919392|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919393|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919394|NCT05135039|Canagliflozin|canagliflozin|mesh-list
14919395|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14343129|NCT00923195|Interleukin-2|interleukin-2|mesh-list
14343130|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343131|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
14343132|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343133|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343134|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14343135|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
14343136|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343137|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343138|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14343139|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14343140|NCT00923195|Analgesics|analgesics|mesh-ancestor
14343141|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
14343142|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343143|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14343144|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14343145|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
14343146|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343147|NCT00923273|Folic Acid|folic acid|mesh-list
14343148|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
14343149|NCT00923273|Hydroxocobalamin|hydroxocobalamin|mesh-list
14343150|NCT00923273|Sirolimus|sirolimus|mesh-list
14343151|NCT00923273|Dexamethasone|dexamethasone|mesh-list
14343152|NCT00923273|Pemetrexed|pemetrexed|mesh-list
14343153|NCT00923273|Vitamins|vitamins|mesh-ancestor
14343154|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
14343155|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343156|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343157|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
14343158|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
14919396|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919397|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14343159|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343160|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14343161|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
14343162|NCT00923273|Hormones|hormones|mesh-ancestor
14343163|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14343164|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14343165|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343166|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343167|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343168|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14343169|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14343170|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14343171|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343172|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14343173|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
14343174|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343175|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
14343176|NCT00923273|Hematinics|hematinics|mesh-ancestor
14343177|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
14343178|NCT00923351|Vaccines|vaccines|mesh-list
14343179|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
14343180|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343181|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
14343182|NCT00923364|Fludarabine|fludarabine|mesh-list
14343183|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
14343184|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14343185|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343186|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
14343187|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343188|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343189|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14343190|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
14343191|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343192|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343193|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14343194|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14343195|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
14343196|NCT00923845|Sirolimus|sirolimus|mesh-list
14343197|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
14343198|NCT00923845|Pentostatin|pentostatin|mesh-list
14343199|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343200|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
14343201|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343202|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731598|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
14731599|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14731600|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
14731601|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14731602|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
14343203|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14343204|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
14343205|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343206|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343207|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14343208|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14343209|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343210|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14343211|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
14343212|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14343213|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343214|NCT00923910|Acetaminophen|acetaminophen|mesh-list
14343215|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
14731603|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731604|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
14731605|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
14919398|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919399|NCT05129332|Vitamin E|vitamin e|mesh-list
14919400|NCT05129332|Vitamins|vitamins|mesh-ancestor
14919401|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
14919402|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919403|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
14919404|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919405|NCT05129332|Protective Agents|protective agents|mesh-ancestor
14919406|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
14919407|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14731606|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919408|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
14343216|NCT00923910|Promethazine|promethazine|mesh-list
14343217|NCT00923910|Interleukin-4|interleukin-4|mesh-list
14343218|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14343219|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14343220|NCT00923910|Analgesics|analgesics|mesh-ancestor
14343221|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
14343222|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343223|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343224|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
14343225|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14343226|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14343227|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343228|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
14919409|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14919410|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
14919411|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919412|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229151|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229152|NCT04195750|Everolimus|everolimus|mesh-list
15229153|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229154|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229155|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
15229156|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229157|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
14343229|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
14343230|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
14343231|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
14343232|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14343233|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14343234|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
14919413|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
14919414|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
14919415|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15229158|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15229159|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
15229160|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15229161|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
15229162|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229163|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343235|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
14343236|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343237|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343238|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14343239|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
14343240|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14343241|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14343242|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
14343243|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343244|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343245|NCT00923936|Bevacizumab|bevacizumab|mesh-list
14343246|NCT00923936|Doxorubicin|doxorubicin|mesh-list
14343247|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14343248|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343249|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343250|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14343251|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14343252|NCT00923936|Growth Substances|growth substances|mesh-ancestor
14343253|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343254|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343255|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14343256|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14343257|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14343258|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343259|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343260|NCT00923949|Pioglitazone|pioglitazone|mesh-list
14731607|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731608|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731609|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
14731610|NCT05302388|Hormones|hormones|mesh-ancestor
14731611|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14731612|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14731613|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731614|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15229164|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
15229165|NCT04179890|Afatinib|afatinib|mesh-list
15229166|NCT04179890|Mitogens|mitogens|mesh-list
15229167|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229168|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229169|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229170|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229171|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229172|NCT04175509|Acetaminophen|acetaminophen|mesh-list
15229173|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15229174|NCT04175509|Analgesics|analgesics|mesh-ancestor
14731615|NCT05302388|Protective Agents|protective agents|mesh-ancestor
14731616|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14731617|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14731618|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731619|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
14731620|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
14731621|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
14731622|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14731623|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
14731624|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
15229175|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
15229176|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229177|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229178|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
15229179|NCT04148105|Cilostazol|cilostazol|mesh-list
15229180|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15229181|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
15229182|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229183|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229184|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15229185|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
15229186|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15229187|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14919416|NCT05112991|Lenvatinib|lenvatinib|mesh-list
14919417|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919418|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14919419|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919420|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919421|NCT05103358|Sirolimus|sirolimus|mesh-list
14919422|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14919423|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919424|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14919425|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229188|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919426|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
14919427|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919428|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
14919429|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919430|NCT05099471|Dexamethasone|dexamethasone|mesh-list
14919431|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
14919432|NCT05099471|Rituximab|rituximab|mesh-list
14919433|NCT05099471|Venetoclax|venetoclax|mesh-list
15229189|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14343261|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14343262|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343263|NCT00924001|Aldesleukin|aldesleukin|mesh-list
14343264|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
14343265|NCT00924001|Fludarabine|fludarabine|mesh-list
14343266|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343267|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
14343268|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343269|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731625|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229190|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
15229191|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15229192|NCT04148105|Protective Agents|protective agents|mesh-ancestor
15229193|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15229194|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15229195|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229196|NCT04147351|Bevacizumab|bevacizumab|mesh-list
15229197|NCT04147351|Atezolizumab|atezolizumab|mesh-list
15229198|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919434|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343270|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14343271|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
14343272|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343273|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343274|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14343275|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14343276|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14343277|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
14343278|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343279|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14343280|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343281|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14343282|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343283|NCT00924066|Epothilones|epothilones|mesh-list
14343284|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
14343285|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14343286|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14343287|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343288|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343289|NCT00924209|Gemcitabine|gemcitabine|mesh-list
14343290|NCT00924209|Bevacizumab|bevacizumab|mesh-list
15229199|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343291|NCT00924209|Etoposide|etoposide|mesh-list
14343292|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343293|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343294|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14343295|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14343296|NCT00924209|Growth Substances|growth substances|mesh-ancestor
14343297|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343298|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343299|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14343300|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
14343301|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343302|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
14343303|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343304|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343305|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919435|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
14919436|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919437|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919438|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14919439|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
14919440|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919441|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919442|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14919443|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919444|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
14919445|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
14919446|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343306|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
14343307|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14343308|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14343309|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14343310|NCT00924287|Aldesleukin|aldesleukin|mesh-list
14343311|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
14343312|NCT00924287|Fludarabine|fludarabine|mesh-list
14343313|NCT00924287|Interleukin-2|interleukin-2|mesh-list
14343314|NCT00924287|Mesna|mesna|mesh-list
14343315|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343316|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
14343317|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343318|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343319|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14343320|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
14343321|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343322|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343323|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14343324|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14343325|NCT00924287|Analgesics|analgesics|mesh-ancestor
14343326|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
14919447|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229200|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229201|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15229202|NCT04147351|Growth Substances|growth substances|mesh-ancestor
14343327|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343328|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14343329|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14343330|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
14343331|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343332|NCT00924287|Protective Agents|protective agents|mesh-ancestor
14343333|NCT00924352|Dasatinib|dasatinib|mesh-list
14343334|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343335|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14343336|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343337|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343338|NCT00924443|Clofarabine|clofarabine|mesh-list
14343339|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14343340|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
14343341|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343342|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919448|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
14919449|NCT05099471|Hormones|hormones|mesh-ancestor
14919450|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919451|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919452|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919453|NCT05092451|Vidarabine|vidarabine|mesh-list
14919454|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
14919455|NCT05092451|Fludarabine|fludarabine|mesh-list
14919456|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
14919457|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343343|NCT00924469|Prednisone|prednisone|mesh-list
14343344|NCT00924469|Leuprolide|leuprolide|mesh-list
14343345|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343346|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
14343347|NCT00924469|Hormones|hormones|mesh-ancestor
14919458|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
14919459|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919460|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919461|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14919462|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
14919463|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343348|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14343349|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343350|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14343351|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343352|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14343353|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
14343354|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14343355|NCT00924508|Triamcinolone|triamcinolone|mesh-list
14343356|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14343357|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14343358|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14343359|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343360|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
14343361|NCT00924508|Hormones|hormones|mesh-ancestor
14343362|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14343363|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343364|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343365|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
14343366|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343367|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343368|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14343369|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14343370|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
14343371|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14343372|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
14343373|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
14343374|NCT00924560|Estradiol|estradiol|mesh-list
14343375|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14343376|NCT00924560|Estrogens|estrogens|mesh-ancestor
14343377|NCT00924560|Hormones|hormones|mesh-ancestor
14343378|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919464|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919465|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14919466|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919467|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
14919468|NCT05092451|Antiviral Agents|antiviral agents|mesh-ancestor
14919469|NCT05092451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919470|NCT05090085|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14919471|NCT05090085|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14919472|NCT05090085|Protective Agents|protective agents|mesh-ancestor
14919473|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919474|NCT05090085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14919475|NCT05090085|Antioxidants|antioxidants|mesh-ancestor
14919476|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919477|NCT05090033|Ofatumumab|ofatumumab|mesh-list
14919478|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930913|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14930914|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14930915|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930916|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
14930917|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930918|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14931204|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931205|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931206|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931207|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931208|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
14731626|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731627|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14731628|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
14343379|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731629|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
14731630|NCT05279742|Valsartan|valsartan|mesh-list
14731631|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14731632|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14731633|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14731634|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731635|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
14731636|NCT05273671|Nalbuphine|nalbuphine|mesh-list
14731637|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14731638|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919479|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
14343380|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14343381|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14343382|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14343383|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14343384|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14919480|NCT05088928|Apixaban|apixaban|mesh-list
14919481|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14919482|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
14919483|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14919484|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
14919485|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343385|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
14343386|NCT00924612|Testosterone|testosterone|mesh-list
14919486|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919487|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
14919488|NCT05087771|Naltrexone|naltrexone|mesh-list
14919489|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14919490|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14919491|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919492|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
14919493|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919494|NCT05087030|Denosumab|denosumab|mesh-list
14919495|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14343387|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
14343388|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
14343389|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14343390|NCT00924612|Androgens|androgens|mesh-ancestor
14343391|NCT00924612|Hormones|hormones|mesh-ancestor
14464938|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14919496|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919497|NCT05084859|Prednisone|prednisone|mesh-list
14919498|NCT05084859|Docetaxel|docetaxel|mesh-list
14919499|NCT05084859|Panitumumab|panitumumab|mesh-list
14919500|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919501|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
14919502|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
14919503|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
14919504|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919505|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919506|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
14919507|NCT05084859|Hormones|hormones|mesh-ancestor
14919508|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919509|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919510|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919511|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919512|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
14919513|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14919514|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
15229203|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919515|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919516|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
14919517|NCT05082480|Protective Agents|protective agents|mesh-ancestor
14919518|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
14919519|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919520|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919521|NCT05080959|Ropivacaine|ropivacaine|mesh-list
14919522|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
14919523|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
14919524|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919525|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919526|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
14919527|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919528|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
14919529|NCT05075122|Sargramostim|sargramostim|mesh-list
14919530|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919531|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919532|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
14919533|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919534|NCT05074056|Ketorolac|ketorolac|mesh-list
14919535|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14919536|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14731639|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731640|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14731641|NCT05273671|Analgesics|analgesics|mesh-ancestor
14731642|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
14731643|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731644|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14731645|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14731646|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919537|NCT05074056|Analgesics|analgesics|mesh-ancestor
14919538|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
14919539|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919540|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229204|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343392|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229205|NCT04140396|Lidocaine|lidocaine|mesh-list
15229206|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
15229207|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
15229208|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15229209|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229210|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
15229211|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229212|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15229213|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15229214|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15229215|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343393|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343394|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14343395|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930919|NCT01435980|Exenatide|exenatide|mesh-list
14343396|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
14343397|NCT00924664|Tanezumab|tanezumab|mesh-list
14343398|NCT00924664|Analgesics|analgesics|mesh-ancestor
14343399|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
14343400|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343401|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343402|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
14343403|NCT00924729|Besifloxacin|besifloxacin|mesh-list
14343404|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14343405|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14343406|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14343407|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343408|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14343409|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14343410|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343411|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343412|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919541|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919542|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229216|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229217|NCT04075110|Montelukast|montelukast|mesh-list
15229218|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14919543|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14919544|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919545|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919546|NCT05071833|Peppermint oil|peppermint oil|mesh-list
14919547|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
14919548|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
14919549|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919550|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919551|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14919552|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
14919553|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
14919554|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919555|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919556|NCT05067439|Efavirenz|efavirenz|mesh-list
14919557|NCT05067439|Caffeine|caffeine|mesh-list
14919558|NCT05067439|Omeprazole|omeprazole|mesh-list
14919559|NCT05067439|Abrocitinib|abrocitinib|mesh-list
14919560|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14919561|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14919562|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14919563|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919564|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919565|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15229219|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
15229220|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15229221|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
15229222|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229223|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919566|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343413|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
14919567|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14919568|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14343414|NCT00924781|Hematinics|hematinics|mesh-ancestor
14343415|NCT00924820|Bevacizumab|bevacizumab|mesh-list
14343416|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343417|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343418|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14343419|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14343420|NCT00924820|Growth Substances|growth substances|mesh-ancestor
15229224|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15229225|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15229226|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229227|NCT04059003|Taxane|taxane|mesh-list
15229228|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229229|NCT04050410|Moxonidine|moxonidine|mesh-list
15229230|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15229231|NCT04046575|Paclitaxel|paclitaxel|mesh-list
15229232|NCT04046575|Carboplatin|carboplatin|mesh-list
15229233|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229234|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343421|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343422|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343423|NCT00924898|Tenofovir|tenofovir|mesh-list
14343424|NCT00924898|Emtricitabine|emtricitabine|mesh-list
14343425|NCT00924898|Efavirenz|efavirenz|mesh-list
14343426|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
14343427|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343428|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14343429|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14343430|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343431|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343432|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14343433|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14343434|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14343435|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14343436|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14343437|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14343438|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14343439|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14343440|NCT00924950|Calcitriol|calcitriol|mesh-list
14343441|NCT00924950|Betamethasone|betamethasone|mesh-list
14343442|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343443|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
14343444|NCT00924950|Hormones|hormones|mesh-ancestor
14343445|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14343446|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343447|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14343448|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
14343449|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14343450|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14343451|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731647|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
15229235|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
14343452|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343453|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14343454|NCT00924950|Vitamins|vitamins|mesh-ancestor
14343455|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
14343456|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14343457|NCT00925015|Irinotecan|irinotecan|mesh-list
14343458|NCT00925015|Cetuximab|cetuximab|mesh-list
14343459|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14343460|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14343461|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14343462|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343463|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343464|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343465|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343466|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
14343467|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343468|NCT00925119|Atenolol|atenolol|mesh-list
14343469|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14343470|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14343471|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
14343472|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
14343473|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343474|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343475|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15229236|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229237|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229238|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229239|NCT04044209|Nivolumab|nivolumab|mesh-list
15229240|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229241|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343476|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14919569|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14919570|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
14919571|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919572|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14919573|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14919574|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
14919575|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919576|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14919577|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14919578|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14919579|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14919580|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14919581|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14919582|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14919583|NCT05064319|Gabapentin|gabapentin|mesh-list
14919584|NCT05064319|Analgesics|analgesics|mesh-ancestor
14919585|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
14919586|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919587|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919588|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
14919589|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14919590|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14919591|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919592|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14919593|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14919594|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14919595|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919596|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919597|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
14919598|NCT05064137|Listerine|listerine|mesh-list
14919599|NCT05064137|Fluorides|fluorides|mesh-list
14919600|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
14919601|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
14919602|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
14919603|NCT05064137|Protective Agents|protective agents|mesh-ancestor
14919604|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919605|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14919606|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919607|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
14919608|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
14919609|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919610|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
14919611|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919612|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919613|NCT05055726|Benzydamine|benzydamine|mesh-list
14919614|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919615|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
15229242|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15229243|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229244|NCT03998813|Ropivacaine|ropivacaine|mesh-list
14343477|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14343478|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
14343479|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343480|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343481|NCT00925132|Temozolomide|temozolomide|mesh-list
14343482|NCT00925132|Decitabine|decitabine|mesh-list
14343483|NCT00925132|Panobinostat|panobinostat|mesh-list
14343484|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14343485|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
14343486|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343487|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343488|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14343489|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
14919616|NCT05052528|Rituximab|rituximab|mesh-list
14343490|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919617|NCT05052528|Fludarabine|fludarabine|mesh-list
14919618|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
14919619|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14919620|NCT05052528|Antibodies|antibodies|mesh-list
14919621|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
14919622|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14919623|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919624|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
14919625|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919626|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919627|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14919628|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
14919629|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919630|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343491|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14343492|NCT00925288|Vaccines|vaccines|mesh-list
14343493|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
14343494|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343495|NCT00925353|Lidocaine|lidocaine|mesh-list
14919631|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14919632|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919633|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
14919634|NCT05051150|Epinephrine|epinephrine|mesh-list
14919635|NCT05051150|Racepinephrine|racepinephrine|mesh-list
14919636|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
14919637|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14919638|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919639|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919640|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919641|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229245|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
15229246|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
15229247|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15229248|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229249|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
15229250|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229251|NCT03990363|Allopurinol|allopurinol|mesh-list
15229252|NCT03990363|Verinurad|verinurad|mesh-list
15229253|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
15229254|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229255|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229256|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
15229257|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229258|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15229259|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
15229260|NCT03990363|Protective Agents|protective agents|mesh-ancestor
15229261|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229262|NCT03930186|Apremilast|apremilast|mesh-list
15229263|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15229264|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15229265|NCT03930186|Analgesics|analgesics|mesh-ancestor
15229266|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
15229267|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229268|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229269|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229270|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229271|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
15229272|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15229273|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229274|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229275|NCT03911973|Talazoparib|talazoparib|mesh-list
15229276|NCT03911973|Gedatolisib|gedatolisib|mesh-list
15229277|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15229278|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343496|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
15229279|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229280|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919642|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919643|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14919644|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14919645|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
14919646|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919647|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14919648|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
14919649|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
14919650|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
14919651|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14919652|NCT05045313|Probenecid|probenecid|mesh-list
14919653|NCT05045313|Digoxin|digoxin|mesh-list
14343497|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
14343498|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343499|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343500|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
14343501|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343502|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14919654|NCT05045313|Warfarin|warfarin|mesh-list
14919655|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
14919656|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14919657|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14919658|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919659|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919660|NCT05045313|Protective Agents|protective agents|mesh-ancestor
14919661|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919662|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
14919663|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
14919664|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919665|NCT05045313|Renal Agents|renal agents|mesh-ancestor
14919666|NCT05032508|Lidocaine|lidocaine|mesh-list
14919667|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
14919668|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
14919669|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919670|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919671|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
14919672|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919673|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14919674|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14919675|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14919676|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14919677|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919678|NCT05030194|Nicotine|nicotine|mesh-list
14919679|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14919680|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
14919681|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919682|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919683|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14343503|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14343504|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14343505|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343506|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343507|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
14343508|NCT00925587|Hematinics|hematinics|mesh-ancestor
14731648|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731649|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731650|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14343509|NCT00925600|Denosumab|denosumab|mesh-list
14343510|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14343511|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343512|NCT00925704|Calcitriol|calcitriol|mesh-list
14343513|NCT00925704|Sevelamer|sevelamer|mesh-list
14343514|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14343515|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343516|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14343517|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343518|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229281|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229282|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15229283|NCT03910972|Vaccines|vaccines|mesh-list
15229284|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
15229285|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229286|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15229287|NCT03910972|Antacids|antacids|mesh-ancestor
15229288|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229289|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14343519|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14343520|NCT00925704|Vitamins|vitamins|mesh-ancestor
14343521|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
14343522|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14343523|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
14343524|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
14343525|NCT00925756|Maraviroc|maraviroc|mesh-list
14343526|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14343527|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14343528|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343529|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14343530|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14343531|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
14919684|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14919685|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
14919686|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919687|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919688|NCT05020574|Cephalexin|cephalexin|mesh-list
14919689|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14919690|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919691|NCT05018117|Nicotine|nicotine|mesh-list
14919692|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14919693|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
14919694|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919695|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343532|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731651|NCT05273671|Narcotics|narcotics|mesh-ancestor
14731652|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
14731653|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14731654|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731655|NCT05259696|Pembrolizumab|pembrolizumab|mesh-list
14731656|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731657|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731658|NCT05254002|Empagliflozin|empagliflozin|mesh-list
14919696|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14919697|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14919698|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
14919699|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229290|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
14343533|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14343534|NCT00925769|Bevacizumab|bevacizumab|mesh-list
14343535|NCT00925769|Capecitabine|capecitabine|mesh-list
14343536|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14343537|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343538|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343539|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14343540|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14343541|NCT00925769|Growth Substances|growth substances|mesh-ancestor
14343542|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343543|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343544|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919700|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919701|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
14919702|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
14919703|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14919704|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14919705|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919706|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919707|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919708|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919709|NCT05015439|Cannabidiol|cannabidiol|mesh-list
14919710|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
14919711|NCT05011123|Vaccines|vaccines|mesh-list
14919712|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
14919713|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919714|NCT05007561|Naltrexone|naltrexone|mesh-list
14919715|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14919716|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14919717|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919718|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
14919719|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343545|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
14343546|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343547|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14343548|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343549|NCT00925782|Melphalan|melphalan|mesh-list
14343550|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14343551|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
14343552|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343553|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343554|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14343555|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343556|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
14343557|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343558|NCT00925899|Melatonin|melatonin|mesh-list
14343559|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
14343560|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343561|NCT00925899|Protective Agents|protective agents|mesh-ancestor
14343562|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343563|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343564|NCT00925938|Misoprostol|misoprostol|mesh-list
14343565|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14343566|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
14343567|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14343568|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343569|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14343570|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14343571|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
14343572|NCT00925990|Ribavirin|ribavirin|mesh-list
14343573|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
14343574|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343575|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
14343576|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343577|NCT00926029|Listerine|listerine|mesh-list
14731659|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14731660|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731661|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14731662|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731663|NCT05251948|Capecitabine|capecitabine|mesh-list
14731664|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
14343578|NCT00926029|Triclosan|triclosan|mesh-list
14343579|NCT00926029|Fluorides|fluorides|mesh-list
14343580|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
14343581|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
14343582|NCT00926029|Protective Agents|protective agents|mesh-ancestor
14343583|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343584|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14343585|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343586|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14343587|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14343588|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
14343589|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343590|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14343591|NCT00926185|Lifitegrast|lifitegrast|mesh-list
14343592|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14343593|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14343594|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
14343595|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14343596|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14343597|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343598|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14343599|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14343600|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343601|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343602|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343603|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343604|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
14343605|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14343606|NCT00926289|Telmisartan|telmisartan|mesh-list
14343607|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14343608|NCT00926289|Diuretics|diuretics|mesh-ancestor
14919720|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14919721|NCT05002738|Desogestrel|desogestrel|mesh-list
14919722|NCT05002738|Estradiol|estradiol|mesh-list
14919723|NCT05002738|Estrogens|estrogens|mesh-ancestor
14919724|NCT05002738|Hormones|hormones|mesh-ancestor
14919725|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919726|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919727|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14919728|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
14919729|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14919730|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14919731|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14919732|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14919733|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14919734|NCT05002738|Progestins|progestins|mesh-ancestor
14919735|NCT05001724|Docetaxel|docetaxel|mesh-list
14919736|NCT05001724|Lenvatinib|lenvatinib|mesh-list
14919737|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919738|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
14919739|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
14919740|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
14919741|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919742|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14919743|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919744|NCT04997759|Neostigmine|neostigmine|mesh-list
14919745|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14919746|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919747|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919748|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
14919749|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919750|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919751|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14919752|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
14919753|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343609|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
14343610|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343611|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14343612|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343613|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343614|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14343615|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14343616|NCT00926328|Triclosan|triclosan|mesh-list
14343617|NCT00926328|Fluorides|fluorides|mesh-list
14343618|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
14343619|NCT00926328|Protective Agents|protective agents|mesh-ancestor
14343620|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343621|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14343622|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343623|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14343624|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14343625|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
14343626|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343627|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14343628|NCT00926367|Clindamycin|clindamycin|mesh-list
14343629|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
14343630|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
14919754|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
14919755|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919756|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930920|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14930921|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229291|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15229292|NCT03883828|Mupirocin|mupirocin|mesh-list
15229293|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15229294|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229295|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
14343631|NCT00926367|Adapalene|adapalene|mesh-list
14343632|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14343633|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14343634|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343635|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14731665|NCT05251948|Atezolizumab|atezolizumab|mesh-list
14731666|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14731667|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
15229296|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
14731668|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731669|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753051|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753788|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229297|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15229298|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15229299|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229300|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229301|NCT03854227|Docetaxel|docetaxel|mesh-list
15229302|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229303|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229304|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229305|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229306|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753789|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
14753790|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753791|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753792|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753793|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14753794|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14753795|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753796|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14753797|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14753798|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
14919757|NCT04990778|Venetoclax|venetoclax|mesh-list
14919758|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731670|NCT05242315|Tacrolimus|tacrolimus|mesh-list
14731671|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731672|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
14731673|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731674|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14731675|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731676|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731677|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
14731678|NCT05238233|Pilocarpine|pilocarpine|mesh-list
14731679|NCT05238233|Tropicamide|tropicamide|mesh-list
14731680|NCT05238233|Miotics|miotics|mesh-ancestor
14919759|NCT04981158|Anesthetics|anesthetics|mesh-list
14919760|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
14919761|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919762|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919763|NCT04972110|Olaparib|olaparib|mesh-list
14919764|NCT04972110|Niraparib|niraparib|mesh-list
14919765|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14919766|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919767|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919768|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919769|NCT04968522|Methylphenidate|methylphenidate|mesh-list
14919770|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
14919771|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14919772|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919773|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14919774|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14919775|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14919776|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919777|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
14919778|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919779|NCT04964934|Letrozole|letrozole|mesh-list
14919780|NCT04964934|Palbociclib|palbociclib|mesh-list
14919781|NCT04964934|Anastrozole|anastrozole|mesh-list
14919782|NCT04964934|Hormones|hormones|mesh-list
14919783|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14919784|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919785|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919786|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919787|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14919788|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14919789|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919790|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919791|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14919792|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
14919793|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14919794|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919795|NCT04961801|Methotrexate|methotrexate|mesh-list
14919796|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
14919797|NCT04961801|Tacrolimus|tacrolimus|mesh-list
14919798|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14919799|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
14919800|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14919801|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919802|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14919803|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
14919804|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919805|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919806|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14919807|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919808|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14919809|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919810|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
14919811|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919812|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14919813|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14919814|NCT04961281|Triamcinolone|triamcinolone|mesh-list
14919815|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
14919816|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14919817|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731681|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
14731682|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731683|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919818|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919819|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14919820|NCT04961281|Analgesics|analgesics|mesh-ancestor
14919821|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
14919822|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919823|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14919824|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14919825|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919826|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919827|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919828|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919829|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919830|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
14919831|NCT04961281|Hormones|hormones|mesh-ancestor
14919832|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919833|NCT04959799|Dalbavancin|dalbavancin|mesh-list
14919834|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14919835|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919836|NCT04949633|Oxytocin|oxytocin|mesh-list
14919837|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
14919838|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14919839|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919840|NCT04943900|Nivolumab|nivolumab|mesh-list
14919841|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919842|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919843|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14919844|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919845|NCT04942210|Vaccines|vaccines|mesh-list
14919846|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
14919847|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919848|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
14919849|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
14919850|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
14919851|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15229307|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
15229308|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229309|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229310|NCT03817463|Empagliflozin|empagliflozin|mesh-list
15229311|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15229312|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15229313|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229314|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14919852|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919853|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
14919854|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229315|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343636|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343637|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343638|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
14343639|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14343640|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14343641|NCT00926367|Analgesics|analgesics|mesh-ancestor
15229316|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
15229317|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229318|NCT03787849|Anesthetics|anesthetics|mesh-list
15229319|NCT03787849|Propofol|propofol|mesh-list
15229320|NCT03787849|Sevoflurane|sevoflurane|mesh-list
15229321|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15229322|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229323|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15229324|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15229325|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
15229326|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14343642|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
14343643|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343644|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343645|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343646|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343647|NCT00926380|Denosumab|denosumab|mesh-list
14343648|NCT00926380|Teriparatide|teriparatide|mesh-list
14343649|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14919855|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
14919856|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14919857|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919858|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14919859|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14919860|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14919861|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919862|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919863|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
14919864|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919865|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14919866|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14919867|NCT04919564|Furosemide|furosemide|mesh-list
14919868|NCT04919564|Diuretics|diuretics|mesh-ancestor
14919869|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
14919870|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919871|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14919872|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14919873|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919874|NCT04918823|Cyclosporine|cyclosporine|mesh-list
14919875|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14919876|NCT04918823|Cyclosporins|cyclosporins|mesh-list
14919877|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14919878|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919879|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14919880|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
14919881|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919882|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
14919883|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919884|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
14919885|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14919886|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14919887|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14343650|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343651|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14343652|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14343653|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
14343654|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14919888|NCT04918147|Acetaminophen|acetaminophen|mesh-list
14919889|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
14919890|NCT04918147|Promethazine|promethazine|mesh-list
14919891|NCT04918147|Prednisone|prednisone|mesh-list
14919892|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
14919893|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14919894|NCT04918147|Elotuzumab|elotuzumab|mesh-list
14919895|NCT04918147|Famotidine|famotidine|mesh-list
14919896|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14919897|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
14919898|NCT04918147|Hormones|hormones|mesh-ancestor
15229327|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15229328|NCT03781440|Lidocaine|lidocaine|mesh-list
15229329|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
15229330|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
15229331|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15229332|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229333|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
15229334|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343655|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14919899|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14919900|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919901|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919902|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919903|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14919904|NCT04918147|Analgesics|analgesics|mesh-ancestor
14919905|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
14919906|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919907|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
14919908|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
14919909|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
14919910|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731684|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14731685|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14731686|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
14919911|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14919912|NCT04918147|Protective Agents|protective agents|mesh-ancestor
14343656|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14343657|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343658|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343659|NCT00926588|Analgesics|analgesics|mesh-list
14343660|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
14343661|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343662|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343663|NCT00926796|Azithromycin|azithromycin|mesh-list
14343664|NCT00926796|Gentamicins|gentamicins|mesh-list
14343665|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
14343666|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14343667|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343668|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14343669|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343670|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343671|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14343672|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14343673|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343674|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14343675|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14919913|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14919914|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14919915|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919916|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
14919917|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
14919918|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14919919|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
14919920|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
14919921|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919922|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919923|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14919924|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
14919925|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
14919926|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14919927|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14919928|NCT04918069|Capsaicin|capsaicin|mesh-list
14919929|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
14919930|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14919931|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
14919932|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919933|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919934|NCT04917588|Lidocaine|lidocaine|mesh-list
14919935|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
14919936|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
14919937|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919938|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919939|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
14919940|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343676|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
14343677|NCT00927069|Adalimumab|adalimumab|mesh-list
14731687|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731688|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731689|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
14731690|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14731691|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14731692|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
14731693|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
14731694|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343678|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343679|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343680|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14343681|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
14919941|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14919942|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14919943|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14919944|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14919945|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14919946|NCT04908371|Lidocaine|lidocaine|mesh-list
14919947|NCT04908371|Epinephrine|epinephrine|mesh-list
14919948|NCT04908371|Racepinephrine|racepinephrine|mesh-list
14919949|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
14919950|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
14919951|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
14343682|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343683|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14343684|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14343685|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343686|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
14343687|NCT00927186|Teriparatide|teriparatide|mesh-list
14343688|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14343689|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343690|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14464939|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14464940|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464941|NCT02218307|Mupirocin|mupirocin|mesh-list
14464942|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14464943|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464944|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14464945|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464946|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464947|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
14464948|NCT02218320|Dolutegravir|dolutegravir|mesh-list
14464949|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14464950|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14464951|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
14464952|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464953|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14464954|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14464955|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464956|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464957|NCT02218372|Vancomycin|vancomycin|mesh-list
14464958|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
14464959|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14919952|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
14919953|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14919954|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919955|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
14919956|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464960|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14919957|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14919958|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14919959|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14919960|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14919961|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229335|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15229336|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15229337|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14919962|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14919963|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14919964|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14919965|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14919966|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14343691|NCT00927355|Pioglitazone|pioglitazone|mesh-list
14343692|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14343693|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343694|NCT00927394|Valsartan|valsartan|mesh-list
14343695|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14343696|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14343697|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14343698|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343699|NCT00927472|Permethrin|permethrin|mesh-list
14343700|NCT00927472|Malathion|malathion|mesh-list
14343701|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343702|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343703|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14343704|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
14919967|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14919968|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
14919969|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14919970|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
15229338|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229339|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229340|NCT03777319|Prednisolone|prednisolone|mesh-list
15229341|NCT03777319|Spironolactone|spironolactone|mesh-list
15229342|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229343|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
15229344|NCT03777319|Hormones|hormones|mesh-ancestor
15229345|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229346|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229347|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229348|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229349|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15229350|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
14919971|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
14919972|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
14919973|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14919974|NCT04907825|Warfarin|warfarin|mesh-list
14919975|NCT04907825|Anticoagulants|anticoagulants|mesh-list
14919976|NCT04897217|Megestrol|megestrol|mesh-list
14919977|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
14919978|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
14919979|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14919980|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
14919981|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14919982|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919983|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14919984|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14919985|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15229351|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15229352|NCT03777319|Diuretics|diuretics|mesh-ancestor
15229353|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
15229354|NCT03740100|Sirolimus|sirolimus|mesh-list
15229355|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14919986|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14919987|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14919988|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14919989|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
14919990|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14919991|NCT04896645|Albuterol|albuterol|mesh-list
14919992|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14919993|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
14919994|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14919995|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14919996|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14919997|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
14919998|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
14919999|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14920000|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14920001|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14920002|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14920003|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
14920004|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920005|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920006|NCT04895579|Durvalumab|durvalumab|mesh-list
14920007|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920008|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920009|NCT04894435|Vaccines|vaccines|mesh-list
14920010|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
14920011|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930922|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14930923|NCT01435980|Incretins|incretins|mesh-ancestor
14930924|NCT01435980|Hormones|hormones|mesh-ancestor
14930925|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930926|NCT01436123|Everolimus|everolimus|mesh-list
14930927|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930928|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930929|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
14930930|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930931|NCT01436188|Ibuprofen|ibuprofen|mesh-list
14930932|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15229356|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229357|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15229358|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930933|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14930934|NCT01436188|Analgesics|analgesics|mesh-ancestor
15229359|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
14920012|NCT04888858|Fentanyl|fentanyl|mesh-list
14920013|NCT04888858|Bupivacaine|bupivacaine|mesh-list
14920014|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
14920015|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
14920016|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920017|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920018|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
14920019|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920020|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14920021|NCT04888858|Narcotics|narcotics|mesh-ancestor
14920022|NCT04888858|Analgesics|analgesics|mesh-ancestor
15229360|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229361|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
15229362|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229363|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15229364|NCT03687814|Laxatives|laxatives|mesh-ancestor
15229365|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229366|NCT03635983|Nivolumab|nivolumab|mesh-list
15229367|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229368|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229369|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15229370|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229371|NCT03626337|Thiamine|thiamine|mesh-list
15229372|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
15229373|NCT03626337|Vitamins|vitamins|mesh-ancestor
15229374|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
15229375|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229376|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
15229377|NCT03600649|Topotecan|topotecan|mesh-list
15229378|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229379|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
15229380|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920023|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14920024|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14920025|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
14920026|NCT04886284|Ertapenem|ertapenem|mesh-list
14920027|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14920028|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920029|NCT04883281|Paclitaxel|paclitaxel|mesh-list
14920030|NCT04883281|Carboplatin|carboplatin|mesh-list
14920031|NCT04883281|Cetuximab|cetuximab|mesh-list
14920032|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14920033|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920034|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14920035|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
14920036|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14920037|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920038|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920039|NCT04879823|Acetaminophen|acetaminophen|mesh-list
14920040|NCT04879823|Dexamethasone|dexamethasone|mesh-list
14920041|NCT04879823|Ibuprofen|ibuprofen|mesh-list
14920042|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14920043|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
14920044|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
14920045|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920046|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920047|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14920048|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
14920049|NCT04879823|Hormones|hormones|mesh-ancestor
14920050|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920051|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920052|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920053|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14920054|NCT04879823|Analgesics|analgesics|mesh-ancestor
15229381|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229382|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15229383|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
15229384|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229385|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229386|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15229387|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15229388|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14920055|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
14920056|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
14930935|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
14920057|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14920058|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920059|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14920060|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920061|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920062|NCT04870333|Ciclesonide|ciclesonide|mesh-list
14920063|NCT04870333|Niclosamide|niclosamide|mesh-list
14920064|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
14920065|NCT04870333|Hormones|hormones|mesh-ancestor
14920066|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920067|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920068|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14920069|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
14920070|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14920071|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
14920072|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14920073|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920074|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
14920075|NCT04869449|Ketoconazole|ketoconazole|mesh-list
14920076|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
14920077|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920078|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14920079|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14920080|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920081|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920082|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14920083|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
14920084|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920085|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920086|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14920087|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
14920088|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14920089|NCT04859829|Antibodies|antibodies|mesh-list
14920090|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
14920091|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14920092|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
14920093|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920094|NCT04848480|Insulin|insulin|mesh-list
14920095|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14920096|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
14920097|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14920098|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920099|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
14920100|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920101|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920102|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14920103|NCT04818957|Vitamin D|vitamin d|mesh-list
14920104|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
14343705|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343706|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343707|NCT00927485|Curcumin|curcumin|mesh-list
14343708|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14343709|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14343710|NCT00927485|Analgesics|analgesics|mesh-ancestor
14343711|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
14343712|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343713|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343714|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343715|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343716|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343717|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343718|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343719|NCT00927563|Tolcapone|tolcapone|mesh-list
14343720|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14343721|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14343722|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14343723|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343724|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343725|NCT00927589|Carboplatin|carboplatin|mesh-list
14343726|NCT00927589|Docetaxel|docetaxel|mesh-list
14343727|NCT00927589|Trastuzumab|trastuzumab|mesh-list
14343728|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343729|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
14343730|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
14343731|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
14343732|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343733|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343734|NCT00927758|Fluticasone|fluticasone|mesh-list
14343735|NCT00927758|Xhance|xhance|mesh-list
14343736|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14343737|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14343738|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343739|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14343740|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
14343741|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229389|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343742|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343743|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14920105|NCT04818957|Vitamins|vitamins|mesh-ancestor
14343744|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14343745|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
14343746|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15229390|NCT03547115|Voruciclib|voruciclib|mesh-list
15229391|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229392|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229393|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229394|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229395|NCT03515304|Evolocumab|evolocumab|mesh-list
15229396|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15229397|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15229398|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
15229399|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343747|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14343748|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14343749|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14343750|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14343751|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343752|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343753|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
14343754|NCT00927758|Hormones|hormones|mesh-ancestor
14343755|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14343756|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
14343757|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
14343758|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
14343759|NCT00927849|Glycerol|glycerol|mesh-list
14343760|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14343761|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14343762|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343763|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
14343764|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343765|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343766|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14343767|NCT00927849|Protective Agents|protective agents|mesh-ancestor
14343768|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
14343769|NCT00927862|Warfarin|warfarin|mesh-list
14343770|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
14343771|NCT00927888|Bupivacaine|bupivacaine|mesh-list
14343772|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
14343773|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
14343774|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343775|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343776|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
14343777|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343778|NCT00927901|Maleic acid|maleic acid|mesh-list
14343779|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343780|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343781|NCT00928018|Cyclosporine|cyclosporine|mesh-list
14343782|NCT00928018|Sirolimus|sirolimus|mesh-list
14343783|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
14343784|NCT00928018|Methotrexate|methotrexate|mesh-list
14343785|NCT00928018|Tacrolimus|tacrolimus|mesh-list
14343786|NCT00928018|Cyclosporins|cyclosporins|mesh-list
14731695|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
14731696|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
14731697|NCT05225363|Fludarabine|fludarabine|mesh-list
14731698|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731699|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
14731700|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731701|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731702|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14731703|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
14731704|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731705|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343787|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14343788|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
14343789|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14343790|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343791|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14343792|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
14343793|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343794|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343795|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
14731706|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14731707|NCT05222750|Vaccines|vaccines|mesh-list
14731708|NCT05222750|Immunologic Factors|immunologic factors|mesh-ancestor
14731709|NCT05222750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229400|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15229401|NCT03501368|Trametinib|trametinib|mesh-list
15229402|NCT03501368|Ceritinib|ceritinib|mesh-list
15229403|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229404|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229405|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731710|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
14731711|NCT05220722|Nivolumab|nivolumab|mesh-list
14731712|NCT05220722|Ipilimumab|ipilimumab|mesh-list
14343796|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343797|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14343798|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343799|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
14343800|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343801|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14343802|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14343803|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
14343804|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343805|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14343806|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14343807|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
14343808|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14343809|NCT00928070|Fesoterodine|fesoterodine|mesh-list
14343810|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14343811|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14343812|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
14343813|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343814|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731713|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731714|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731715|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14731716|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731717|NCT05204927|Prednisone|prednisone|mesh-list
14731718|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731719|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
14731720|NCT05204927|Hormones|hormones|mesh-ancestor
15229406|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343815|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731721|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753052|NCT05289869|Oxytocin|oxytocin|mesh-list
15229407|NCT03490513|Anastrozole|anastrozole|mesh-list
15229408|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229409|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229410|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15229411|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15229412|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731722|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731723|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14731724|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731725|NCT05198934|Trifluridine|trifluridine|mesh-list
14731726|NCT05198934|Panitumumab|panitumumab|mesh-list
14731727|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731728|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731729|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
14731730|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731731|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
14731732|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731733|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14731734|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14343816|NCT00928070|Urological Agents|urological agents|mesh-ancestor
14343817|NCT00928083|Artefenomel|artefenomel|mesh-list
14343818|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
14343819|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14343820|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14343821|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343822|NCT00928174|Fluorides|fluorides|mesh-list
14343823|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
14343824|NCT00928174|Protective Agents|protective agents|mesh-ancestor
14343825|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343826|NCT00928187|Ritonavir|ritonavir|mesh-list
14343827|NCT00928187|Lopinavir|lopinavir|mesh-list
14343828|NCT00928187|Darunavir|darunavir|mesh-list
14343829|NCT00928187|Tenofovir|tenofovir|mesh-list
14343830|NCT00928187|Emtricitabine|emtricitabine|mesh-list
14343831|NCT00928187|Abacavir|abacavir|mesh-list
14343832|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14343833|NCT00928187|Didanosine|didanosine|mesh-list
14343834|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14343835|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14343836|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
14343837|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343838|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343839|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14343840|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14343841|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
14343842|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343843|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14343844|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14343845|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14343846|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14343847|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
14343848|NCT00928200|Cytarabine|cytarabine|mesh-list
14343849|NCT00928200|Dexamethasone|dexamethasone|mesh-list
14343850|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
14343851|NCT00928200|Doxorubicin|doxorubicin|mesh-list
14343852|NCT00928200|Methotrexate|methotrexate|mesh-list
14343853|NCT00928200|Vincristine|vincristine|mesh-list
14343854|NCT00928200|Asparaginase|asparaginase|mesh-list
14343855|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
14343856|NCT00928200|Razoxane|razoxane|mesh-list
14343857|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14343858|NCT00928200|BB 1101|bb 1101|mesh-list
14343859|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343860|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
14343861|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
14343862|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343863|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343864|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14343865|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
14343866|NCT00928200|Hormones|hormones|mesh-ancestor
14343867|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14343868|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14343869|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343870|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
14343871|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343872|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343873|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14343874|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14920106|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
14343875|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14343876|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14343877|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
14343878|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14343879|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14343880|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
14343881|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
14343882|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14343883|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343884|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
14343885|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14343886|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14343887|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
14343888|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343889|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14343890|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14343891|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14343892|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14343893|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14343894|NCT00928200|Protective Agents|protective agents|mesh-ancestor
14343895|NCT00928252|Fluorides|fluorides|mesh-list
14343896|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
14343897|NCT00928252|Protective Agents|protective agents|mesh-ancestor
14343898|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343899|NCT00928408|Cinacalcet|cinacalcet|mesh-list
14343900|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14343901|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343902|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15229413|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229414|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15229415|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
15229416|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229417|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229418|NCT03471728|Linaclotide|linaclotide|mesh-list
14343903|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
14343904|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14343905|NCT00928421|Polidocanol|polidocanol|mesh-list
14343906|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14343907|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14343908|NCT00928434|Leuprolide|leuprolide|mesh-list
14343909|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14343910|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
14343911|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14343912|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343913|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14343914|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343915|NCT00928486|Dexamethasone|dexamethasone|mesh-list
14343916|NCT00928486|Lenalidomide|lenalidomide|mesh-list
14343917|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14343918|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
14343919|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
14343920|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343921|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343922|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14343923|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
14343924|NCT00928486|Hormones|hormones|mesh-ancestor
14343925|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14464961|NCT02218463|Estradiol|estradiol|mesh-list
15229419|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15229420|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
15229421|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229422|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229423|NCT03463057|Atezolizumab|atezolizumab|mesh-list
15229424|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229425|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
14343926|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229426|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15229427|NCT03404596|Nicotine|nicotine|mesh-list
15229428|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15229429|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
15229430|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229431|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229432|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15229433|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15229434|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
15229435|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229436|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229437|NCT03342027|Bupropion|bupropion|mesh-list
15229438|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14920107|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920108|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14920109|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14920110|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
15229439|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
15229440|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15229441|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15229442|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15229443|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229444|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229445|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
15229446|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229447|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229448|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15229449|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15229450|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229451|NCT03321513|Bevacizumab|bevacizumab|mesh-list
14920111|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920112|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920113|NCT04803877|Nivolumab|nivolumab|mesh-list
14920114|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229452|NCT03321513|Aflibercept|aflibercept|mesh-list
15229453|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229454|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229455|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229456|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15229457|NCT03321513|Growth Substances|growth substances|mesh-ancestor
15229458|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229459|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
15229460|NCT03273023|Chromium|chromium|mesh-list
15229461|NCT03273023|Everolimus|everolimus|mesh-list
15229462|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229463|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229464|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
15229465|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229466|NCT03273023|Trace Elements|trace elements|mesh-ancestor
14343927|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343928|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
14343929|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14343930|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14343931|NCT00928486|Growth Substances|growth substances|mesh-ancestor
14343932|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
14343933|NCT00928564|Anesthetics|anesthetics|mesh-list
14343934|NCT00928564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343935|NCT00928564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343936|NCT00928642|Gemcitabine|gemcitabine|mesh-list
14343937|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
14343938|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14343939|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
14343940|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343941|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343942|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
14343943|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14343944|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343945|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14343946|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
14343947|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343948|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14343949|NCT00928668|Olodaterol|olodaterol|mesh-list
14343950|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14343951|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
14343952|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343953|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343954|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14343955|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
14343956|NCT00928694|Fenofibrate|fenofibrate|mesh-list
14343957|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14343958|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
14343959|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343960|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14343961|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
14343962|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14343963|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14343964|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
14343965|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14343966|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343967|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14343968|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14343969|NCT00928746|Bromides|bromides|mesh-list
14343970|NCT00928746|Ipratropium|ipratropium|mesh-list
14343971|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
14343972|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14343973|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
14343974|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14343975|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343976|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14343977|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
14343978|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14343979|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
14343980|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343981|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343982|NCT00928772|Midazolam|midazolam|mesh-list
15229467|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
15229468|NCT03125928|Paclitaxel|paclitaxel|mesh-list
15229469|NCT03125928|Trastuzumab|trastuzumab|mesh-list
15229470|NCT03125928|Atezolizumab|atezolizumab|mesh-list
15229471|NCT03125928|Pertuzumab|pertuzumab|mesh-list
15229472|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229473|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229474|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229475|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229476|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229477|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229478|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14343983|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14343984|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14343985|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14343986|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14343987|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14343988|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14343989|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14343990|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14343991|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
14343992|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
14343993|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
14343994|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
14343995|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14343996|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14343997|NCT00928889|Acarbose|acarbose|mesh-list
14343998|NCT00928889|Nateglinide|nateglinide|mesh-list
14343999|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14344000|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344001|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344002|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14344003|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344004|NCT00928954|Gabapentin|gabapentin|mesh-list
14344005|NCT00928954|Memantine|memantine|mesh-list
14344006|NCT00928954|Analgesics|analgesics|mesh-ancestor
14344007|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
14344008|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344009|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344010|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
14344011|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14344012|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14344013|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344014|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344015|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14344016|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14344017|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344018|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344019|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
14344020|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14344021|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14344022|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
14344023|NCT00929071|Lidocaine|lidocaine|mesh-list
14344024|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
14344025|NCT00929071|Anesthetics|anesthetics|mesh-list
15229479|NCT03086369|Gemcitabine|gemcitabine|mesh-list
15229480|NCT03086369|Paclitaxel|paclitaxel|mesh-list
15229481|NCT03086369|Olaratumab|olaratumab|mesh-list
15229482|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229483|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344026|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344027|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344028|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
14344029|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344030|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14344031|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14344032|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14344033|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14344034|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344035|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
14344036|NCT00929110|Bromides|bromides|mesh-list
14344037|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
14344038|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14344039|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
14344040|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344041|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344042|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14344043|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344044|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
14344045|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14344046|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
15229484|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229485|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229486|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229487|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344047|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229488|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14344048|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344049|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
14344050|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14344051|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14344052|NCT00929162|Paclitaxel|paclitaxel|mesh-list
14344053|NCT00929162|Carboplatin|carboplatin|mesh-list
14344054|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14344055|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344056|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344057|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344058|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344059|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344060|NCT00929201|Metformin|metformin|mesh-list
14344061|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14344062|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14344063|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344064|NCT00929201|Incretins|incretins|mesh-ancestor
14344065|NCT00929201|Hormones|hormones|mesh-ancestor
14344066|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344067|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14344068|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
14344069|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344070|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344071|NCT00929240|Bevacizumab|bevacizumab|mesh-list
14344072|NCT00929240|Capecitabine|capecitabine|mesh-list
14344073|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344074|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344075|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14344076|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14344077|NCT00929240|Growth Substances|growth substances|mesh-ancestor
14344078|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344079|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
14344080|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14344081|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
14344082|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344083|NCT00929344|Pregabalin|pregabalin|mesh-list
14344084|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14344085|NCT00929344|Analgesics|analgesics|mesh-ancestor
14344086|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
14344087|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344088|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344089|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
14344090|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14344091|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14344092|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344093|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14344094|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14344095|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14344096|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344097|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344098|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14344099|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14344100|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344101|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
14344102|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
14344103|NCT00929383|Hemostatics|hemostatics|mesh-list
14344104|NCT00929383|Coagulants|coagulants|mesh-ancestor
14344105|NCT00929578|Fluphenazine|fluphenazine|mesh-list
14344106|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
14344107|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14344108|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14344109|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14344110|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344111|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344112|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344113|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15229489|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
15229490|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
15229491|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229492|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229493|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229494|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
15229495|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344114|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
14344115|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344116|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344117|NCT00929669|Pasireotide|pasireotide|mesh-list
14344118|NCT00929669|Hormones|hormones|mesh-ancestor
14344119|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344120|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344121|NCT00929695|Prednisone|prednisone|mesh-list
14344122|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
14344123|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14344124|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14344125|NCT00929695|Prednisolone|prednisolone|mesh-list
14344126|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
14344127|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14344128|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
14344129|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344130|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
14344131|NCT00929695|Hormones|hormones|mesh-ancestor
14344132|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344133|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344134|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14344135|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344136|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
14344137|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
14344138|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344139|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14344140|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14344141|NCT00929695|Protective Agents|protective agents|mesh-ancestor
14344142|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
14344143|NCT00929708|AZD-3199|azd-3199|mesh-list
14344144|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14344145|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
14344146|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344147|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344148|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14344149|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344150|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14344151|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14344152|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14344153|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
14344154|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344155|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344156|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14344157|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14344158|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14344159|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14344160|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
14344161|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344162|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14344163|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344164|NCT00929864|Adalimumab|adalimumab|mesh-list
14344165|NCT00929864|Abatacept|abatacept|mesh-list
14344166|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229496|NCT03081910|Cyclophosphamide|cyclophosphamide|mesh-list
15229497|NCT03081910|Fludarabine|fludarabine|mesh-list
15229498|NCT03081910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229499|NCT03081910|Immunologic Factors|immunologic factors|mesh-ancestor
14344167|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344168|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14344169|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344170|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344171|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344172|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
14344173|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344174|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
14344175|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14344176|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14344177|NCT00929981|Prednisolone|prednisolone|mesh-list
14344178|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
14344179|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14920115|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920116|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14344180|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
14344181|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344182|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
14344183|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
14344184|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344185|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344186|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14344187|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
14344188|NCT00929981|Hormones|hormones|mesh-ancestor
14344189|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344190|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14344191|NCT00929981|Protective Agents|protective agents|mesh-ancestor
14344192|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14344193|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344194|NCT00930046|Ropivacaine|ropivacaine|mesh-list
14344195|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
14344196|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
14344197|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344198|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344199|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
14344200|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344201|NCT00930293|Dexetimide|dexetimide|mesh-list
14344202|NCT00930293|Citalopram|citalopram|mesh-list
14344203|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14344204|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14344205|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14344206|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344207|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344208|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
14344209|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344210|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14344211|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
14344212|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344213|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14920117|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229500|NCT03081910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229501|NCT03081910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229502|NCT03081910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15229503|NCT03081910|Alkylating Agents|alkylating agents|mesh-ancestor
15229504|NCT03081910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229505|NCT03081910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229506|NCT03081910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15229507|NCT03081858|Paclitaxel|paclitaxel|mesh-list
14344214|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14344215|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
14344216|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
14344217|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344218|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14344219|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14344220|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
14344221|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
14344222|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344223|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344224|NCT00930644|Teduglutide|teduglutide|mesh-list
14344225|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14344226|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14344227|NCT00930644|Protective Agents|protective agents|mesh-ancestor
14344228|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344229|NCT00930930|Paclitaxel|paclitaxel|mesh-list
14344230|NCT00930930|Everolimus|everolimus|mesh-list
14344231|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14344232|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344233|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344234|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344235|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344236|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344237|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344238|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
14344239|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344240|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
14344241|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14344242|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344243|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14344244|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14344245|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344246|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344247|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344248|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14344249|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14344250|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
14344251|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14344252|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14344253|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
14344254|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
14344255|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344256|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344257|NCT00931242|Thalidomide|thalidomide|mesh-list
14344258|NCT00931242|Apremilast|apremilast|mesh-list
14344259|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14344260|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14344261|NCT00931242|Analgesics|analgesics|mesh-ancestor
14344262|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
14344263|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344264|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344265|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344266|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344267|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14344268|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14344269|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344270|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344271|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344272|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
14344273|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
14344274|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14344275|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344276|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14344277|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14344278|NCT00931242|Growth Substances|growth substances|mesh-ancestor
14344279|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14344280|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344281|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
14344282|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14344283|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
14344284|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344285|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229508|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229509|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229510|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229511|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344286|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14344287|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344288|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14344289|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14344290|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14344291|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
14344292|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344293|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344294|NCT00931463|Ritonavir|ritonavir|mesh-list
14344295|NCT00931463|Lopinavir|lopinavir|mesh-list
14344296|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
14344297|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14344298|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14344299|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
14344300|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344301|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344302|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14344303|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14344304|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
14344305|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344306|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14344307|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15229512|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229513|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229514|NCT03053362|Vortioxetine|vortioxetine|mesh-list
15229515|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
15229516|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15229517|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15229518|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14344308|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14344309|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14344310|NCT00931489|Ranibizumab|ranibizumab|mesh-list
14344311|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14344312|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14344313|NCT00931489|Growth Substances|growth substances|mesh-ancestor
14344314|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344315|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
14344316|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344317|NCT00931528|Tadalafil|tadalafil|mesh-list
14344318|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
14344319|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14344320|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15229519|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15229520|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229521|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15229522|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15229523|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14344321|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344322|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344323|NCT00931528|Urological Agents|urological agents|mesh-ancestor
14344324|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
14344325|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14344326|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
14344327|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344328|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344329|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14344330|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344331|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14344332|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
14344333|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344334|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344335|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14344336|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
14344337|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
14344338|NCT00931632|Protective Agents|protective agents|mesh-ancestor
14344339|NCT00931710|Losartan|losartan|mesh-list
14344340|NCT00931710|Amlodipine|amlodipine|mesh-list
14344341|NCT00931710|Valsartan|valsartan|mesh-list
14344342|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14344343|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14344344|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14344345|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14344346|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344347|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14344348|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344349|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
14344350|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14344351|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14344352|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14344353|NCT00931710|Diuretics|diuretics|mesh-ancestor
14344354|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
14344355|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14344356|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14344357|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
14344358|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344359|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14344360|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14344361|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753053|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
15229524|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229525|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229526|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
15229527|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15229528|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14344362|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344363|NCT00931762|Panobinostat|panobinostat|mesh-list
14344364|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344365|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14344366|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344367|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344368|NCT00931801|Tenofovir|tenofovir|mesh-list
14344369|NCT00931801|Emtricitabine|emtricitabine|mesh-list
14344370|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
14344371|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14344372|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
14344373|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344374|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14344375|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14344376|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344377|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344378|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14344379|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14344380|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14344381|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14344382|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14344383|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14344384|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
14464962|NCT02218463|Estrogens|estrogens|mesh-ancestor
14464963|NCT02218463|Hormones|hormones|mesh-ancestor
14464964|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14464965|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464966|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14464967|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14464968|NCT02218736|Aticaprant|aticaprant|mesh-list
14464969|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
15229529|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15229530|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15229531|NCT02906332|Dexamethasone|dexamethasone|mesh-list
15229532|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
15229533|NCT02906332|Lenalidomide|lenalidomide|mesh-list
15229534|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229535|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
15229536|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
15229537|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229538|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464970|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464971|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
14464972|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464973|NCT02219009|Aripiprazole|aripiprazole|mesh-list
14464974|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
14464975|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464976|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14464977|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14464978|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464979|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464980|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
14464981|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
14464982|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464983|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464984|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14464985|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14464986|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
14464987|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14464988|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14464989|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14464990|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14344385|NCT00931918|Prednisone|prednisone|mesh-list
14344386|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
14344387|NCT00931918|Rituximab|rituximab|mesh-list
14344388|NCT00931918|Doxorubicin|doxorubicin|mesh-list
14344389|NCT00931918|Vincristine|vincristine|mesh-list
14344390|NCT00931918|Bortezomib|bortezomib|mesh-list
14344391|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344392|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
14344393|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344394|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344395|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14344396|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
14344397|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344398|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344399|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14344400|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344401|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14344402|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14344403|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14344404|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344405|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344406|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
15229539|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229540|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
15229541|NCT02906332|Hormones|hormones|mesh-ancestor
15229542|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229543|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229544|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229545|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229546|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
15229547|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229548|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14344407|NCT00931918|Hormones|hormones|mesh-ancestor
14344408|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344409|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14344410|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14344411|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344412|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344413|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344414|NCT00931944|Pramipexole|pramipexole|mesh-list
14344415|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
14344416|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344417|NCT00931944|Protective Agents|protective agents|mesh-ancestor
14344418|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344419|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14344420|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14344421|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
14344422|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
14344423|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344424|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
14344425|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14344426|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344427|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344428|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344429|NCT00932022|Trospium chloride|trospium chloride|mesh-list
15229549|NCT02906332|Growth Substances|growth substances|mesh-ancestor
14344430|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
14344431|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
14344432|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344433|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344434|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14344435|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14344436|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
14344437|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344438|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344439|NCT00932022|Urological Agents|urological agents|mesh-ancestor
14344440|NCT00932113|Folic Acid|folic acid|mesh-list
14344441|NCT00932113|Adalimumab|adalimumab|mesh-list
14344442|NCT00932113|Methotrexate|methotrexate|mesh-list
14344443|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14344444|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
14344445|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14344446|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344447|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14344448|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
14344449|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344450|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344451|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
14344452|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344453|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14344454|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344455|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
14344456|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344457|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14344458|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344459|NCT00932113|Hematinics|hematinics|mesh-ancestor
14344460|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
14344461|NCT00932113|Vitamins|vitamins|mesh-ancestor
14344462|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
14344463|NCT00932165|Exemestane|exemestane|mesh-list
14344464|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344465|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14344466|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14344467|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344468|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344469|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14344470|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
14344471|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344472|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344473|NCT00932282|Omalizumab|omalizumab|mesh-list
14344474|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14344475|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14344476|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344477|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14344478|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15229550|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
15229551|NCT02795988|Fluorouracil|fluorouracil|mesh-list
15229552|NCT02795988|Capecitabine|capecitabine|mesh-list
15229553|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
15229554|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229555|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
15229556|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229557|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15229558|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229559|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
15229560|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344479|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14344480|NCT00932321|Norethindrone|norethindrone|mesh-list
14344481|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
14344482|NCT00932321|Estradiol|estradiol|mesh-list
14344483|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14344484|NCT00932321|Estrogens|estrogens|mesh-ancestor
14344485|NCT00932321|Hormones|hormones|mesh-ancestor
15229561|NCT02786329|Lidocaine|lidocaine|mesh-list
15229562|NCT02786329|Sevoflurane|sevoflurane|mesh-list
15229563|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
15229564|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
15229565|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731735|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731736|NCT05185583|Methylphenidate|methylphenidate|mesh-list
14731737|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14344486|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344487|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344488|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14344489|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
14344490|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14344491|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14344492|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14344493|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14344494|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14344495|NCT00932373|Trastuzumab|trastuzumab|mesh-list
14344496|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14344497|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344498|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731738|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229566|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229567|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
15229568|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229569|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15229570|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15229571|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15229572|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229573|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229574|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14344499|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344500|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344501|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344502|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344503|NCT00932438|Leucovorin|leucovorin|mesh-list
14344504|NCT00932438|Bevacizumab|bevacizumab|mesh-list
14344505|NCT00932438|Fluorouracil|fluorouracil|mesh-list
14344506|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
14344507|NCT00932438|Irinotecan|irinotecan|mesh-list
14344508|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344509|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229575|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15229576|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
15229577|NCT02779855|Paclitaxel|paclitaxel|mesh-list
15229578|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15229579|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229580|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344510|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14344511|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14344512|NCT00932438|Growth Substances|growth substances|mesh-ancestor
14344513|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344514|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
14344515|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
14344516|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344517|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14344518|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229581|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229582|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229583|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229584|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229585|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229586|NCT02731352|Apatinib|apatinib|mesh-list
15229587|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229588|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229589|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344519|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
14344520|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14344521|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14344522|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344523|NCT00932438|Antidotes|antidotes|mesh-ancestor
14344524|NCT00932438|Protective Agents|protective agents|mesh-ancestor
14344525|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
14344526|NCT00932438|Vitamins|vitamins|mesh-ancestor
14344527|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
14344528|NCT00932451|Crizotinib|crizotinib|mesh-list
14344529|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344530|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14344531|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344532|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920118|NCT04801641|Nabilone|nabilone|mesh-list
14920119|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
14920120|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
14920121|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920122|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920123|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14920124|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14920125|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14920126|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920127|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14920128|NCT04800302|Morphine|morphine|mesh-list
14920129|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14920130|NCT04800302|Narcotics|narcotics|mesh-ancestor
14920131|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920132|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920133|NCT04800302|Analgesics|analgesics|mesh-ancestor
14920134|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
14931209|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
14344533|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14344534|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
14344535|NCT00932477|Glycerol|glycerol|mesh-list
14344536|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14344537|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14344538|NCT00932477|Laxatives|laxatives|mesh-ancestor
14344539|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14344540|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14344541|NCT00932477|Protective Agents|protective agents|mesh-ancestor
14344542|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344543|NCT00932620|Simvastatin|simvastatin|mesh-list
14344544|NCT00932620|Ezetimibe|ezetimibe|mesh-list
14344545|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14344546|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14344547|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
14344548|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344549|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14344550|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14344551|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344552|NCT00932646|Olodaterol|olodaterol|mesh-list
14344553|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
14344554|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14344555|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
14344556|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344557|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344558|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14344559|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344560|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14344561|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14344562|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14344563|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
14344564|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344565|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344566|NCT00932698|Ixazomib|ixazomib|mesh-list
14344567|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344568|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14344569|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344570|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344571|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
14344572|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344573|NCT00932893|Docetaxel|docetaxel|mesh-list
14344574|NCT00932893|Pemetrexed|pemetrexed|mesh-list
14344575|NCT00932893|Crizotinib|crizotinib|mesh-list
14344576|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344577|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344578|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344579|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344580|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344581|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344582|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14344583|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14344584|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14344585|NCT00933244|Vitamin D|vitamin d|mesh-list
14344586|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
14344587|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
14344588|NCT00933244|Vitamins|vitamins|mesh-list
14344589|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
14344590|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344591|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14344592|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14344593|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
14344594|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344595|NCT00933608|Memantine|memantine|mesh-list
14344596|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14344597|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14344598|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
14344599|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464991|NCT02219087|Bupivacaine|bupivacaine|mesh-list
14344600|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344601|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344602|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15229590|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229591|NCT02726659|Celecoxib|celecoxib|mesh-list
15229592|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15229593|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15229594|NCT02726659|Analgesics|analgesics|mesh-ancestor
15229595|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
15229596|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229597|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229598|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229599|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229600|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14731739|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14731740|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14731741|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731742|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344603|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14344604|NCT00934024|Varenicline|varenicline|mesh-list
14344605|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14344606|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14344607|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
14344608|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344609|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344610|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344611|NCT00934050|Inositol|inositol|mesh-list
14344612|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
14344613|NCT00934050|Vitamins|vitamins|mesh-ancestor
14344614|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
14344615|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344616|NCT00934089|Latanoprost|latanoprost|mesh-list
14344617|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14344618|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14344619|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14344620|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344621|NCT00934375|Donepezil|donepezil|mesh-list
14344622|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14344623|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344624|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344625|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
14344626|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344627|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731743|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
14731744|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731745|NCT05183646|Proxigermanium|proxigermanium|mesh-list
14731746|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731747|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
14731748|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
14731749|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731750|NCT05165212|Amoxicillin|amoxicillin|mesh-list
14731751|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14731752|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731753|NCT05147662|Factor VIII|factor viii|mesh-list
14731754|NCT05147662|Coagulants|coagulants|mesh-ancestor
14344628|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
14344629|NCT00934440|Bevacizumab|bevacizumab|mesh-list
14344630|NCT00934440|Azacitidine|azacitidine|mesh-list
14344631|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344632|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344633|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14344634|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14344635|NCT00934440|Growth Substances|growth substances|mesh-ancestor
14344636|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344637|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
14344638|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14344639|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
14344640|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344641|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344642|NCT00934635|Risperidone|risperidone|mesh-list
14344643|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14344644|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14344645|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
14344646|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344647|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344648|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344649|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14344650|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14344651|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344652|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344653|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14344654|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
14344655|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14344656|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14344657|NCT00934648|Rituximab|rituximab|mesh-list
14344658|NCT00934648|Methotrexate|methotrexate|mesh-list
14344659|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344660|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344661|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
14344662|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344663|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344664|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14344665|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
14344666|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14344667|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14344668|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
14344669|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344670|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
14344671|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344672|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14344673|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344674|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14344675|NCT00934661|Morphine|morphine|mesh-list
14344676|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14344677|NCT00934661|Narcotics|narcotics|mesh-ancestor
14344678|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344679|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344680|NCT00934661|Analgesics|analgesics|mesh-ancestor
14344681|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
14344682|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344683|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
14344684|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14344685|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14344686|NCT00934843|Prednisolone|prednisolone|mesh-list
14344687|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
14344688|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14344689|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
14344690|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
14344691|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344692|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
14344693|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
14344694|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344695|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344696|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14344697|NCT00934843|Hormones|hormones|mesh-ancestor
14344698|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344699|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14344700|NCT00934843|Protective Agents|protective agents|mesh-ancestor
14344701|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14344702|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344703|NCT00934856|Docetaxel|docetaxel|mesh-list
14344704|NCT00934856|Trastuzumab|trastuzumab|mesh-list
14344705|NCT00934856|Pertuzumab|pertuzumab|mesh-list
14344706|NCT00934856|Maytansine|maytansine|mesh-list
14344707|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14344708|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344709|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344710|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344711|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344712|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344713|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344714|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14344715|NCT00934934|Anidulafungin|anidulafungin|mesh-list
14344716|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
14344717|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344718|NCT00934947|Propranolol|propranolol|mesh-list
14344719|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14344720|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14344721|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
14344722|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344723|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344724|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344725|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14344726|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14344727|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
14344728|NCT00935220|Linagliptin|linagliptin|mesh-list
14344729|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14344730|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344731|NCT00935220|Incretins|incretins|mesh-ancestor
14344732|NCT00935220|Hormones|hormones|mesh-ancestor
14344733|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344734|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14344735|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
14344736|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344737|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344738|NCT00935259|Simvastatin|simvastatin|mesh-list
14344739|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14344740|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14344741|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
14344742|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344743|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14344744|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14344745|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344746|NCT00935311|Acetaminophen|acetaminophen|mesh-list
14344747|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14344748|NCT00935311|Hydrocodone|hydrocodone|mesh-list
14344749|NCT00935311|Oxycodone|oxycodone|mesh-list
14344750|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14344751|NCT00935311|Analgesics|analgesics|mesh-ancestor
14344752|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
14731755|NCT05145764|Suvorexant|suvorexant|mesh-list
14731756|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14731757|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14731758|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731759|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731760|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14731761|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229601|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14344753|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344754|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344755|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
14344756|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14344757|NCT00935311|Narcotics|narcotics|mesh-ancestor
14344758|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344759|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
14344760|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
14344761|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14731762|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731763|NCT05145413|Xanomeline|xanomeline|mesh-list
14344762|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344763|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344764|NCT00935493|Guanfacine|guanfacine|mesh-list
14344765|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14344766|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15229602|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229603|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229604|NCT02654132|Dexamethasone|dexamethasone|mesh-list
15229605|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
15229606|NCT02654132|Pomalidomide|pomalidomide|mesh-list
15229607|NCT02654132|Elotuzumab|elotuzumab|mesh-list
15229608|NCT02654132|BB 1101|bb 1101|mesh-list
15229609|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229610|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
15229611|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
15229612|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344767|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14344768|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14344769|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14344770|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344771|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344772|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344773|NCT00935532|Insulin|insulin|mesh-list
14344774|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14344775|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
14344776|NCT00935532|Exenatide|exenatide|mesh-list
14344777|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14344778|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344779|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14344780|NCT00935532|Incretins|incretins|mesh-ancestor
14344781|NCT00935532|Hormones|hormones|mesh-ancestor
14344782|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344783|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14344784|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
14344785|NCT00935792|Everolimus|everolimus|mesh-list
14344786|NCT00935792|Antibodies|antibodies|mesh-list
14344787|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
14344788|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14344789|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
14344790|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344791|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344792|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344793|NCT00935818|Bupropion|bupropion|mesh-list
14344794|NCT00935818|Varenicline|varenicline|mesh-list
14344795|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15229613|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229614|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229615|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
15229616|NCT02654132|Hormones|hormones|mesh-ancestor
15229617|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229618|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229619|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229620|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
15229621|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344796|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
14344797|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344798|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14344799|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14344800|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14344801|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344802|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
14344803|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344804|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344805|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14344806|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14344807|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344808|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14344809|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14344810|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
14344811|NCT00935883|Eculizumab|eculizumab|mesh-list
14344812|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14344813|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344814|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
14344815|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344816|NCT00936065|Etanercept|etanercept|mesh-list
14344817|NCT00936065|Acitretin|acitretin|mesh-list
14344818|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14344819|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14344820|NCT00936065|Analgesics|analgesics|mesh-ancestor
14344821|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
14344822|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344823|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344824|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14344825|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344826|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14344827|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344828|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
14344829|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
14344830|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
14344831|NCT00936117|Posaconazole|posaconazole|mesh-list
14344832|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
14344833|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344834|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14344835|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14344836|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14344837|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14344838|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14344839|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344840|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344841|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14344842|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
14344843|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344844|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344845|NCT00936221|Dacarbazine|dacarbazine|mesh-list
14344846|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14344847|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
14344848|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344849|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344850|NCT00936299|Bupropion|bupropion|mesh-list
14344851|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14344852|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
14344853|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14344854|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14344855|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14344856|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14344857|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344858|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
14344859|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344860|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344861|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14344862|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14344863|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344864|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
14344865|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14344866|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14344867|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344868|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14344869|NCT00936377|Analgesics|analgesics|mesh-ancestor
14344870|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
14344871|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344872|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14344873|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14344874|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14344875|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
14344876|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344877|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344878|NCT00936611|Panobinostat|panobinostat|mesh-list
14344879|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344880|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14344881|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344882|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344883|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14344884|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14344885|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344886|NCT00936663|Incretins|incretins|mesh-ancestor
14344887|NCT00936663|Hormones|hormones|mesh-ancestor
14344888|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344889|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14344890|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
14344891|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344892|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344893|NCT00936702|Paclitaxel|paclitaxel|mesh-list
14344894|NCT00936702|Carboplatin|carboplatin|mesh-list
14344895|NCT00936702|Everolimus|everolimus|mesh-list
14344896|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14344897|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344898|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344899|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344900|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344901|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344902|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344903|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
14344904|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344905|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14344906|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14344907|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14344908|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344909|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344910|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
14344911|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344912|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14344913|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14344914|NCT00936741|Mifepristone|mifepristone|mesh-list
14344915|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14344916|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
14344917|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14344918|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344919|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14344920|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14344921|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14344922|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
14344923|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14344924|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14344925|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
14344926|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14344927|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
14344928|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14344929|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14344930|NCT00936858|Everolimus|everolimus|mesh-list
14344931|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344932|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344933|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
14344934|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344935|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
14344936|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14344937|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344938|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
14344939|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14344940|NCT00936897|Denosumab|denosumab|mesh-list
14344941|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
14344942|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14344943|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344944|NCT00936910|Amphotericin B|amphotericin b|mesh-list
14344945|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14344946|NCT00936910|Amebicides|amebicides|mesh-ancestor
14344947|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14344948|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14344949|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344950|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14344951|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
14344952|NCT00936975|Listerine|listerine|mesh-list
14344953|NCT00936975|Fluorides|fluorides|mesh-list
14344954|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
14344955|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
14344956|NCT00936975|Protective Agents|protective agents|mesh-ancestor
14344957|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344958|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14344959|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14344960|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
14344961|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
14344962|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14920135|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920136|NCT04791761|Acetaminophen|acetaminophen|mesh-list
14920137|NCT04791761|Ibuprofen|ibuprofen|mesh-list
14920138|NCT04791761|Oxycodone|oxycodone|mesh-list
14920139|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
14920140|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14344963|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
14344964|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344965|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14344966|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14344967|NCT00937235|Varenicline|varenicline|mesh-list
14344968|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14344969|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14344970|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
14344971|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14344972|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344973|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344974|NCT00937495|Bortezomib|bortezomib|mesh-list
14344975|NCT00937495|Vorinostat|vorinostat|mesh-list
14344976|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344977|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14344978|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14344979|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344980|NCT00937521|Antipyretics|antipyretics|mesh-list
14344981|NCT00937521|Vaccines|vaccines|mesh-list
14344982|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
14344983|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14344984|NCT00937560|Paclitaxel|paclitaxel|mesh-list
14344985|NCT00937560|Bevacizumab|bevacizumab|mesh-list
14344986|NCT00937560|Carboplatin|carboplatin|mesh-list
14344987|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14344988|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14344989|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
14344990|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
14344991|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
14344992|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14344993|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14344994|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14344995|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14344996|NCT00937560|Growth Substances|growth substances|mesh-ancestor
14344997|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920141|NCT04791761|Analgesics|analgesics|mesh-ancestor
14920142|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
14344998|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
14464992|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
14464993|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
14464994|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464995|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464996|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
14464997|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464998|NCT02219321|Lidocaine|lidocaine|mesh-list
14464999|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
14465000|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
14465001|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465002|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465003|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
14465004|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465005|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14465006|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14465007|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14465008|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465009|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465010|NCT02219477|Ritonavir|ritonavir|mesh-list
14465011|NCT02219477|Ribavirin|ribavirin|mesh-list
14465012|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14465013|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14465014|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465015|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465016|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465017|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14465018|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14465019|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
14465020|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465021|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14344999|NCT00937768|Leuprolide|leuprolide|mesh-list
14345000|NCT00937768|Goserelin|goserelin|mesh-list
14345001|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14345002|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
14345003|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14345004|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345005|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14345006|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345007|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
14345008|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345009|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
14345010|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14345011|NCT00938314|Hematinics|hematinics|mesh-ancestor
14345012|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14345013|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345014|NCT00938366|Cladribine|cladribine|mesh-list
14345015|NCT00938366|Pantoprazole|pantoprazole|mesh-list
14345016|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14345017|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345018|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14345019|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345020|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345021|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345022|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345023|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
14345024|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345025|NCT00938392|Vaccines|vaccines|mesh-list
14345026|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
14345027|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345028|NCT00938431|Lacosamide|lacosamide|mesh-list
14345029|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
14345030|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14345031|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14345032|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14345033|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345034|NCT00938470|Docetaxel|docetaxel|mesh-list
14345035|NCT00938470|Fluorouracil|fluorouracil|mesh-list
14345036|NCT00938470|Capecitabine|capecitabine|mesh-list
14345037|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
14345038|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345039|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14345040|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14345041|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14345042|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345043|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
14345044|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345045|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345046|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
14345047|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345048|NCT00938548|Pregabalin|pregabalin|mesh-list
14345049|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345050|NCT00938548|Analgesics|analgesics|mesh-ancestor
14345051|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
14345052|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345053|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
14345054|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14345055|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14345056|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731764|NCT05145413|Trospium chloride|trospium chloride|mesh-list
14731765|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
14731766|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
14345057|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14345058|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14345059|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14345060|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14345061|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14345062|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14345063|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
14345064|NCT00938704|Glycerol|glycerol|mesh-list
14345065|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14345066|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
14345067|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345068|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
14345069|NCT00938704|Protective Agents|protective agents|mesh-ancestor
14345070|NCT00938704|Laxatives|laxatives|mesh-ancestor
14345071|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345072|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14345073|NCT00938717|Linaclotide|linaclotide|mesh-list
14345074|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14345075|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
14345076|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345077|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345078|NCT00938860|Cyclosporine|cyclosporine|mesh-list
14345079|NCT00938860|Tacrolimus|tacrolimus|mesh-list
14345080|NCT00938860|Cyclosporins|cyclosporins|mesh-list
14345081|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345082|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
14345083|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345084|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14345085|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345086|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345087|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
14345088|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345089|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
14345090|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345091|NCT00938886|Naltrexone|naltrexone|mesh-list
14345092|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14345093|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14345094|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345095|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
14345096|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345097|NCT00938964|Lidocaine|lidocaine|mesh-list
14345098|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
14345099|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
14345100|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14345101|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345102|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
14345103|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731767|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731768|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920143|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920144|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920145|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
14345104|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14345105|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14731769|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14731770|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14731771|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
14731772|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731773|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731774|NCT05145413|Urological Agents|urological agents|mesh-ancestor
14920146|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14920147|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14920148|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920149|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14920150|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920151|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920152|NCT04791761|Narcotics|narcotics|mesh-ancestor
14920153|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920154|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
14920155|NCT04789096|Trastuzumab|trastuzumab|mesh-list
14920156|NCT04789096|Capecitabine|capecitabine|mesh-list
14345106|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14345107|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14345108|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345109|NCT00939003|Adalimumab|adalimumab|mesh-list
14345110|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14345111|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345112|NCT00939029|Nicotine|nicotine|mesh-list
14345113|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14345114|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
14345115|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345116|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345117|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14345118|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14345119|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
14345120|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345121|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345122|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14345123|NCT00939120|Dutasteride|dutasteride|mesh-list
14345124|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14345125|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14345126|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345127|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345128|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
14345129|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14345130|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345131|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14345132|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14345133|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
14345134|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345135|NCT00939120|Urological Agents|urological agents|mesh-ancestor
14345136|NCT00939159|Panobinostat|panobinostat|mesh-list
14345137|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345138|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14345139|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345140|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345141|NCT00939185|Azithromycin|azithromycin|mesh-list
14345142|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14345143|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345144|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
14345145|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14345146|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
14345147|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345148|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345149|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14345150|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
14345151|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
14345152|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14345153|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
14345154|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345155|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345156|NCT00939341|Budesonide|budesonide|mesh-list
14345157|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
14345158|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14345159|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14345160|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14345161|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
14345162|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345163|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345164|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14345165|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
14345166|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
14345167|NCT00939341|Hormones|hormones|mesh-ancestor
14345168|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14345169|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14345170|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14345171|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14345172|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
14345173|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345174|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345175|NCT00939367|Zolpidem|zolpidem|mesh-list
14345176|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14345177|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14345178|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14345179|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345180|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14345181|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
14345182|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
14345183|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345184|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345185|NCT00939510|Lenalidomide|lenalidomide|mesh-list
14731775|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14731776|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731777|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14731778|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14731779|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
14731780|NCT05138614|Narcotics|narcotics|mesh-ancestor
14731781|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731782|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731783|NCT05138614|Analgesics|analgesics|mesh-ancestor
14731784|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
14731785|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731786|NCT05132660|Levodopa|levodopa|mesh-list
14731787|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14731788|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14345186|NCT00939510|Sargramostim|sargramostim|mesh-list
14345187|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
14345188|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345189|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14345190|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14345191|NCT00939510|Growth Substances|growth substances|mesh-ancestor
14345192|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
14345193|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345194|NCT00939523|Lapatinib|lapatinib|mesh-list
14345195|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345196|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345197|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345198|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345199|NCT00939536|Zolpidem|zolpidem|mesh-list
14345200|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14345201|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14345202|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14345203|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345204|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14345205|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
14345206|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
14345207|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345208|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345209|NCT00939562|Doxycycline|doxycycline|mesh-list
14345210|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14345211|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345212|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
14345213|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14731789|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14731790|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
14731791|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229622|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229623|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
15229624|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229625|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15229626|NCT02654132|Growth Substances|growth substances|mesh-ancestor
15229627|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
15229628|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15229629|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
14731792|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229630|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
14345214|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14345215|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14345216|NCT00939627|Cetuximab|cetuximab|mesh-list
14345217|NCT00939627|Sorafenib|sorafenib|mesh-list
14345218|NCT00939627|Antibodies|antibodies|mesh-list
14345219|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
14345220|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14345221|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
14345222|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345223|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345224|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345225|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345226|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345227|NCT00939653|Cytarabine|cytarabine|mesh-list
14345228|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
14345229|NCT00939653|Etoposide|etoposide|mesh-list
14345230|NCT00939653|Clofarabine|clofarabine|mesh-list
14345231|NCT00939653|Lenograstim|lenograstim|mesh-list
14345232|NCT00939653|Sargramostim|sargramostim|mesh-list
14345233|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345234|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
14345235|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345236|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345237|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345238|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
14345239|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345240|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345241|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14345242|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14345243|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14345244|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15229631|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15229632|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
15229633|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15229634|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15229635|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
15229636|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229637|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229638|NCT02603432|Avelumab|avelumab|mesh-list
15229639|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14345245|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345246|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345247|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
14345248|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
14345249|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345250|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14345251|NCT00939692|Topiramate|topiramate|mesh-list
14345252|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
14345253|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14345254|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345255|NCT00939705|Topiramate|topiramate|mesh-list
14345256|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
14345257|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14345258|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229640|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229641|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345259|NCT00939731|Crizotinib|crizotinib|mesh-list
14345260|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345261|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345262|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345263|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345264|NCT00939770|Crizotinib|crizotinib|mesh-list
14345265|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345266|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345267|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345268|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345269|NCT00939822|Simvastatin|simvastatin|mesh-list
14345270|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14345271|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14345272|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
14345273|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345274|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14345275|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14345276|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345277|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
14345278|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14345279|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14345280|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
14345281|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345282|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14345283|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14345284|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345285|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345286|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
14345287|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14345288|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345289|NCT00939952|Ertapenem|ertapenem|mesh-list
14345290|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14345291|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345292|NCT00939991|Bevacizumab|bevacizumab|mesh-list
14345293|NCT00939991|Temozolomide|temozolomide|mesh-list
14345294|NCT00939991|Vorinostat|vorinostat|mesh-list
14345295|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345296|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345297|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14345298|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14345299|NCT00939991|Growth Substances|growth substances|mesh-ancestor
14345300|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345301|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
14345302|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345303|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
14465022|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14345304|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345305|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14345306|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345307|NCT00940017|Voriconazole|voriconazole|mesh-list
14345308|NCT00940017|Anidulafungin|anidulafungin|mesh-list
14345309|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
14345310|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345311|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14345312|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14731793|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731794|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14345313|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345314|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345315|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14345316|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
14345317|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14345318|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345319|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14345320|NCT00940316|Irinotecan|irinotecan|mesh-list
14345321|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14345322|NCT00940316|Panitumumab|panitumumab|mesh-list
14345323|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14345324|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14345325|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345326|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345327|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345328|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345329|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345330|NCT00940342|Rituximab|rituximab|mesh-list
14345331|NCT00940342|Molgramostim|molgramostim|mesh-list
14345332|NCT00940342|Sargramostim|sargramostim|mesh-list
14345333|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345334|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345335|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
14345336|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345337|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345338|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14345339|NCT00940485|Entecavir|entecavir|mesh-list
14345340|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
14345341|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345342|NCT00940589|Melatonin|melatonin|mesh-list
14345343|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
14345344|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345345|NCT00940589|Protective Agents|protective agents|mesh-ancestor
14731795|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
14731796|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
14345346|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345347|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14345348|NCT00940602|Deferasirox|deferasirox|mesh-list
14345349|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14345350|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
14345351|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
14345352|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345353|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14345354|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14345355|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14345356|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
14345357|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345358|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345359|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14345360|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14345361|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
14345362|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345363|NCT00940875|Gemcitabine|gemcitabine|mesh-list
14345364|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14345365|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345366|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
14345367|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345368|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345369|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
14345370|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345371|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345372|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345373|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
14345374|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345375|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345376|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
14345377|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
14345378|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14345379|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14345380|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345381|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345382|NCT00940901|Urological Agents|urological agents|mesh-ancestor
14345383|NCT00940927|Albuterol|albuterol|mesh-list
14345384|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14345385|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
14345386|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345387|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345388|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14465023|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
14345389|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
14345390|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
14345391|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14345392|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14345393|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14345394|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14345395|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
14345396|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345397|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345398|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14345399|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
14345400|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345401|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14345402|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14345403|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345404|NCT00941304|Oxycodone|oxycodone|mesh-list
14345405|NCT00941304|Buprenorphine|buprenorphine|mesh-list
14345406|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14345407|NCT00941304|Narcotics|narcotics|mesh-ancestor
14345408|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14345409|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345410|NCT00941304|Analgesics|analgesics|mesh-ancestor
14345411|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
14345412|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345413|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14345414|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
14345415|NCT00941330|Docetaxel|docetaxel|mesh-list
14345416|NCT00941330|Exemestane|exemestane|mesh-list
14345417|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345418|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
14345419|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345420|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345421|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345422|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
14345423|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345424|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345425|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14345426|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
14345427|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
14345428|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
14345429|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14345430|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14345431|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345432|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14345433|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
14345434|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14345435|NCT00941655|Leucovorin|leucovorin|mesh-list
14345436|NCT00941655|Fluorouracil|fluorouracil|mesh-list
14345437|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
14345438|NCT00941655|Irinotecan|irinotecan|mesh-list
14345439|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
14345440|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345441|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345442|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345443|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345444|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
14345445|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345446|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14345447|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14345448|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345449|NCT00941655|Antidotes|antidotes|mesh-ancestor
14345450|NCT00941655|Protective Agents|protective agents|mesh-ancestor
14345451|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
14345452|NCT00941655|Vitamins|vitamins|mesh-ancestor
14345453|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
14345454|NCT00941668|Triclosan|triclosan|mesh-list
14345455|NCT00941668|Fluorides|fluorides|mesh-list
14345456|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
14345457|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
14345458|NCT00941668|Protective Agents|protective agents|mesh-ancestor
14345459|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345460|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14345461|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345462|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14345463|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14345464|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
14345465|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345466|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14345467|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
14345468|NCT00941720|Busulfan|busulfan|mesh-list
14345469|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345470|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
14345471|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345472|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345473|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345474|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
14345475|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345476|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345477|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14345478|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
14345479|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14345480|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14345481|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14345482|NCT00941863|Sorafenib|sorafenib|mesh-list
14345483|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345484|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345485|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345486|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345487|NCT00942084|Acyclovir|acyclovir|mesh-list
14345488|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
14345489|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345490|NCT00942149|Daptomycin|daptomycin|mesh-list
14345491|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14345492|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345493|NCT00942175|Esomeprazole|esomeprazole|mesh-list
14345494|NCT00942175|Omeprazole|omeprazole|mesh-list
14345495|NCT00942175|Lansoprazole|lansoprazole|mesh-list
14345496|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
14345497|NCT00942175|Clopidogrel|clopidogrel|mesh-list
14345498|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14345499|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14345500|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14345501|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14345502|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
14345503|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345504|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345505|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345506|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14345507|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345508|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14345509|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345510|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
14345511|NCT00942266|Leucovorin|leucovorin|mesh-list
14345512|NCT00942266|Fluorouracil|fluorouracil|mesh-list
14345513|NCT00942266|Vorinostat|vorinostat|mesh-list
14345514|NCT00942266|Calcium|calcium|mesh-list
14345515|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
14345516|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14345517|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345518|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14345519|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
14345520|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345521|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345522|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345523|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345524|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
14345525|NCT00942266|Antidotes|antidotes|mesh-ancestor
14345526|NCT00942266|Protective Agents|protective agents|mesh-ancestor
14345527|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
14345528|NCT00942266|Vitamins|vitamins|mesh-ancestor
14345529|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
14345530|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14345531|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345532|NCT00942305|Brincidofovir|brincidofovir|mesh-list
14345533|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
14345534|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345535|NCT00942357|Paclitaxel|paclitaxel|mesh-list
14345536|NCT00942357|Cisplatin|cisplatin|mesh-list
14345537|NCT00942357|Carboplatin|carboplatin|mesh-list
14345538|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14345539|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14345540|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345541|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
14345542|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
14345543|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
14345544|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345545|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14345546|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
14345547|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345548|NCT00942422|Protective Agents|protective agents|mesh-ancestor
14345549|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345550|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14345551|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14345552|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345553|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14345554|NCT00942448|Diclofenac|diclofenac|mesh-list
14345555|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14345556|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14345557|NCT00942448|Analgesics|analgesics|mesh-ancestor
14345558|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
14345559|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345560|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345561|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14345562|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345563|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14345564|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345565|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465024|NCT02219503|Ritonavir|ritonavir|mesh-list
14465025|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14345566|NCT00942578|Prednisone|prednisone|mesh-list
14345567|NCT00942578|Bevacizumab|bevacizumab|mesh-list
14345568|NCT00942578|Lenalidomide|lenalidomide|mesh-list
14345569|NCT00942578|Docetaxel|docetaxel|mesh-list
14345570|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345571|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345572|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14345573|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14345574|NCT00942578|Growth Substances|growth substances|mesh-ancestor
14345575|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345576|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
14345577|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
14345578|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
14345579|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
14345580|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345581|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14345582|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
14345583|NCT00942578|Hormones|hormones|mesh-ancestor
14345584|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14345585|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14345586|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
14345587|NCT00942708|Fluoxetine|fluoxetine|mesh-list
14345588|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14345589|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14345590|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14345591|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345592|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345593|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
14345594|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345595|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14345596|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
14345597|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14345598|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14345599|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14345600|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345601|NCT00942734|Everolimus|everolimus|mesh-list
14345602|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14345603|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345604|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345605|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
14345606|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345607|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345608|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345609|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345610|NCT00942825|Cisplatin|cisplatin|mesh-list
14345611|NCT00942825|Pemetrexed|pemetrexed|mesh-list
14345612|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345613|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345614|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345615|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14345616|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14345617|NCT00942968|Dalteparin|dalteparin|mesh-list
14345618|NCT00942968|Tinzaparin|tinzaparin|mesh-list
14345619|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14345620|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
14345621|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14345622|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14345623|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345624|NCT00942994|Amlodipine|amlodipine|mesh-list
14345625|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14345626|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14345627|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14345628|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14345629|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345630|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14345631|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345632|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
14345633|NCT00942994|Diuretics|diuretics|mesh-ancestor
14345634|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
14345635|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14345636|NCT00943072|Aflibercept|aflibercept|mesh-list
14345637|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229642|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
15229643|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345638|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14345639|NCT00943072|Growth Substances|growth substances|mesh-ancestor
14345640|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345641|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
14345642|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345643|NCT00943098|Diclofenac|diclofenac|mesh-list
14345644|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14345645|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14345646|NCT00943098|Analgesics|analgesics|mesh-ancestor
14345647|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
14345648|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345649|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345650|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14345651|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345652|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14345653|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345654|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345655|NCT00943111|Eliglustat|eliglustat|mesh-list
14345656|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345657|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345658|NCT00943124|Niacin|niacin|mesh-list
14345659|NCT00943124|Niacinamide|niacinamide|mesh-list
14345660|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
14345661|NCT00943124|Simvastatin|simvastatin|mesh-list
14345662|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14345663|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14345664|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
14345665|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345666|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14345667|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14345668|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345669|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
14345670|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
14345671|NCT00943124|Vitamins|vitamins|mesh-ancestor
14345672|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
14345673|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229644|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
15229645|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229646|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229647|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229648|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229649|NCT02600923|Letrozole|letrozole|mesh-list
15229650|NCT02600923|Palbociclib|palbociclib|mesh-list
15229651|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229652|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15229653|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15229654|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229655|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229656|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15229657|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
15229658|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229659|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229660|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14345674|NCT00943202|Vaccines|vaccines|mesh-list
14345675|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
14345676|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345677|NCT00943319|Fludarabine|fludarabine|mesh-list
14345678|NCT00943319|Busulfan|busulfan|mesh-list
14345679|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
14345680|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345681|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345682|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345683|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
14345684|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345685|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
14345686|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345687|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14345688|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345689|NCT00943592|Melphalan|melphalan|mesh-list
14345690|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
14345691|NCT00943592|Clofarabine|clofarabine|mesh-list
14345692|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345693|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
14345694|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345695|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345696|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14345697|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345698|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
14345699|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345700|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345701|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345702|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
14345703|NCT00943670|Trastuzumab|trastuzumab|mesh-list
14345704|NCT00943670|Pertuzumab|pertuzumab|mesh-list
14345705|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14345706|NCT00943670|Maytansine|maytansine|mesh-list
14345707|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345708|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345709|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14345710|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
14345711|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
14345712|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
14345713|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345714|NCT00943735|Fesoterodine|fesoterodine|mesh-list
14345715|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14345716|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14345717|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
14345718|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345719|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345720|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345721|NCT00943735|Urological Agents|urological agents|mesh-ancestor
14345722|NCT00943761|Interferons|interferons|mesh-list
14345723|NCT00943761|Ribavirin|ribavirin|mesh-list
14345724|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345725|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
14345726|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345727|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
14345728|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345729|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14345730|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345731|NCT00943800|Vidarabine|vidarabine|mesh-list
14345732|NCT00943800|Fludarabine|fludarabine|mesh-list
14345733|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
14345734|NCT00943800|Melphalan|melphalan|mesh-list
14345735|NCT00943800|Busulfan|busulfan|mesh-list
14345736|NCT00943800|Thiotepa|thiotepa|mesh-list
14345737|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14345738|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
14345739|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345740|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345741|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
14345742|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345743|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345744|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
14345745|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345746|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
14345747|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345748|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345749|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
14345750|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14345751|NCT00943826|Bevacizumab|bevacizumab|mesh-list
14345752|NCT00943826|Temozolomide|temozolomide|mesh-list
14345753|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345754|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345755|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14345756|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14345757|NCT00943826|Growth Substances|growth substances|mesh-ancestor
14345758|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345759|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14345760|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345761|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
14345762|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345763|NCT00943878|Vaccines|vaccines|mesh-list
14345764|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
14345765|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345766|NCT00943917|Exenatide|exenatide|mesh-list
14345767|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14345768|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345769|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14345770|NCT00943917|Incretins|incretins|mesh-ancestor
14345771|NCT00943917|Hormones|hormones|mesh-ancestor
14345772|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14345773|NCT00944034|Vaccines|vaccines|mesh-list
14345774|NCT00944034|Immunologic Factors|immunologic factors|mesh-ancestor
14345775|NCT00944034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345776|NCT00944047|Paclitaxel|paclitaxel|mesh-list
14345777|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
15229661|NCT02484664|Celecoxib|celecoxib|mesh-list
15229662|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15229663|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15229664|NCT02484664|Analgesics|analgesics|mesh-ancestor
15229665|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
15229666|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229667|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229668|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229669|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229670|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15229671|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15229672|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229673|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229674|NCT02460900|Varenicline|varenicline|mesh-list
15229675|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15229676|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15229677|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
15229678|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229679|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229680|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229681|NCT02428647|Zinc|zinc|mesh-list
15229682|NCT02428647|Trace Elements|trace elements|mesh-ancestor
14345778|NCT00944047|Doxorubicin|doxorubicin|mesh-list
15229683|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
15229684|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229685|NCT02371889|Topiramate|topiramate|mesh-list
15229686|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
15229687|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14345779|NCT00944047|Trastuzumab|trastuzumab|mesh-list
14345780|NCT00944047|Mitogens|mitogens|mesh-list
14345781|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14345782|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345783|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
14345784|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
14345785|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14345786|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345787|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345788|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
14345789|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345790|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345791|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14345792|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
14345793|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14345794|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14345795|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14345796|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14345797|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345798|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345799|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14345800|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14345801|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345802|NCT00944450|Incretins|incretins|mesh-ancestor
14345803|NCT00944450|Hormones|hormones|mesh-ancestor
14345804|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14345805|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14345806|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
14345807|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345808|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345809|NCT00944554|Varenicline|varenicline|mesh-list
14345810|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14345811|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14345812|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
14345813|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345814|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345815|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345816|NCT00944645|Niacin|niacin|mesh-list
14345817|NCT00944645|Niacinamide|niacinamide|mesh-list
14345818|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
14345819|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14345820|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
14345821|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345822|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14345823|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
14345824|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
14345825|NCT00944645|Vitamins|vitamins|mesh-ancestor
14345826|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
14345827|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345828|NCT00944658|Apremilast|apremilast|mesh-list
14345829|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14345830|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14345831|NCT00944658|Analgesics|analgesics|mesh-ancestor
14345832|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
14345833|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345834|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345835|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14345836|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345837|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14345838|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14345839|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345840|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345841|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
14345842|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
14345843|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14345844|NCT00944671|Famotidine|famotidine|mesh-list
14345845|NCT00944671|Calcium|calcium|mesh-list
14345846|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14345847|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345848|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14345849|NCT00944671|Antacids|antacids|mesh-ancestor
14345850|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345851|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345852|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14345853|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14345854|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
14345855|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
14345856|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345857|NCT00944697|Oxycodone|oxycodone|mesh-list
14731797|NCT05118854|Cisplatin|cisplatin|mesh-list
14731798|NCT05118854|Carboplatin|carboplatin|mesh-list
14731799|NCT05118854|Pemetrexed|pemetrexed|mesh-list
14345858|NCT00944697|Naloxone|naloxone|mesh-list
14345859|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14345860|NCT00944697|Narcotics|narcotics|mesh-ancestor
14345861|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14345862|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345863|NCT00944697|Analgesics|analgesics|mesh-ancestor
14345864|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
14345865|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345866|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14345867|NCT00944710|Atropine|atropine|mesh-list
14345868|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14345869|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14345870|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14345871|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
14345872|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345873|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345874|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14345875|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
14345876|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
14345877|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
14345878|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14345879|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14345880|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
14345881|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345882|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345883|NCT00944749|Cyclosporine|cyclosporine|mesh-list
14345884|NCT00944749|Cyclosporins|cyclosporins|mesh-list
14345885|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345886|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345887|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345888|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
14345889|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345890|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
14345891|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345892|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14345893|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14345894|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14345895|NCT00945139|Bevacizumab|bevacizumab|mesh-list
14345896|NCT00945139|Doxorubicin|doxorubicin|mesh-list
14345897|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345898|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345899|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14345900|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14345901|NCT00945139|Growth Substances|growth substances|mesh-ancestor
14345902|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345903|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
14345904|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14345905|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14345906|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14345907|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345908|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345909|NCT00945191|Paclitaxel|paclitaxel|mesh-list
14345910|NCT00945191|Carboplatin|carboplatin|mesh-list
14345911|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14345912|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345913|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
14345914|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
14345915|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
14345916|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345917|NCT00945256|Nitroprusside|nitroprusside|mesh-list
14345918|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14345919|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
14345920|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14345921|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345922|NCT00945282|Ritonavir|ritonavir|mesh-list
14345923|NCT00945282|Lopinavir|lopinavir|mesh-list
14345924|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14345925|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14345926|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
14731800|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345927|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345928|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731801|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345929|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14345930|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14345931|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
14345932|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345933|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14345934|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14345935|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
14345936|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14345937|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14345938|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14345939|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14345940|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345941|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
14345942|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345943|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345944|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14345945|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345946|NCT00945321|Aprepitant|aprepitant|mesh-list
14345947|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
14345948|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
14345949|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
14345950|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14345951|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345952|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345953|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14345954|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345955|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345956|NCT00945334|Rifaximin|rifaximin|mesh-list
14345957|NCT00945334|Neomycin|neomycin|mesh-list
14345958|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14345959|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345960|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345961|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14345962|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14345963|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345964|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14345965|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345966|NCT00945750|Famotidine|famotidine|mesh-list
14345967|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14345968|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14345969|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14345970|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
14345971|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
14345972|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345973|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345974|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345975|NCT00945815|Cytarabine|cytarabine|mesh-list
14345976|NCT00945815|Clofarabine|clofarabine|mesh-list
14345977|NCT00945815|Epratuzumab|epratuzumab|mesh-list
14345978|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14345979|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
14345980|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345981|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14345982|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
14345983|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14345984|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14345985|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
14345986|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345987|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14345988|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
14345989|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14345990|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14345991|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345992|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14345993|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14345994|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14345995|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14345996|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14345997|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14345998|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14345999|NCT00945945|Analgesics|analgesics|mesh-ancestor
14346000|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
14920157|NCT04789096|Tucatinib|tucatinib|mesh-list
14346001|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346002|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
14731802|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731803|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14731804|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14731805|NCT05113251|Paclitaxel|paclitaxel|mesh-list
14731806|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
14346003|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14346004|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
14346005|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
14346006|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
14346007|NCT00946023|Rituximab|rituximab|mesh-list
14346008|NCT00946023|Fludarabine|fludarabine|mesh-list
14346009|NCT00946023|Tacrolimus|tacrolimus|mesh-list
14346010|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346011|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
14346012|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346013|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346014|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14346015|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
14346016|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346017|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346018|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14346019|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346020|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14346021|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346022|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14346023|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14346024|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
14346025|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14346026|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346027|NCT00946088|Progesterone|progesterone|mesh-list
14346028|NCT00946088|Progestins|progestins|mesh-ancestor
14346029|NCT00946088|Hormones|hormones|mesh-ancestor
14346030|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346031|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346032|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
14346033|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
14346034|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14346035|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14346036|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346037|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346038|NCT00946114|Urological Agents|urological agents|mesh-ancestor
14346039|NCT00946153|Lenvatinib|lenvatinib|mesh-list
14346040|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346041|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346042|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346043|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346044|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14346045|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14346046|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14346047|NCT00946192|Desogestrel|desogestrel|mesh-list
14346048|NCT00946192|Estradiol|estradiol|mesh-list
14346049|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14346050|NCT00946192|Progesterone|progesterone|mesh-list
14346051|NCT00946192|Estrogens|estrogens|mesh-ancestor
14346052|NCT00946192|Hormones|hormones|mesh-ancestor
14346053|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346054|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346055|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14346056|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
14346057|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14346058|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14346059|NCT00946192|Progestins|progestins|mesh-ancestor
14346060|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14346061|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14346062|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14346063|NCT00946270|Thalidomide|thalidomide|mesh-list
14346064|NCT00946270|Prednisone|prednisone|mesh-list
14346065|NCT00946270|Pomalidomide|pomalidomide|mesh-list
14346066|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346067|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
14346068|NCT00946270|Hormones|hormones|mesh-ancestor
14346069|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346070|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346071|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14346072|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346073|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
14346074|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14346075|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14346076|NCT00946270|Growth Substances|growth substances|mesh-ancestor
14346077|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
14346078|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346079|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
14346080|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14346081|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346082|NCT00946309|Sulforaphane|sulforaphane|mesh-list
14346083|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14346084|NCT00946309|Protective Agents|protective agents|mesh-ancestor
14346085|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346086|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346087|NCT00946348|Dronabinol|dronabinol|mesh-list
14346088|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
14346089|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346090|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14346091|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14346092|NCT00946348|Analgesics|analgesics|mesh-ancestor
14346093|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
14346094|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346095|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14346096|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14346097|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346098|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346099|NCT00946348|Hormones|hormones|mesh-ancestor
14346100|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346101|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
14346102|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14346103|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14346104|NCT00946478|Analgesics|analgesics|mesh-ancestor
14346105|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
14346106|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346107|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346108|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346109|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346110|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14346111|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346112|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
14346113|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14346114|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346115|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346116|NCT00946647|Azacitidine|azacitidine|mesh-list
14346117|NCT00946647|Panobinostat|panobinostat|mesh-list
14346118|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14346119|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
14346120|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346121|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346122|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731807|NCT05113251|Doxorubicin|doxorubicin|mesh-list
14346123|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14346124|NCT00946712|Paclitaxel|paclitaxel|mesh-list
14346125|NCT00946712|Bevacizumab|bevacizumab|mesh-list
14346126|NCT00946712|Carboplatin|carboplatin|mesh-list
14346127|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14346128|NCT00946712|Cetuximab|cetuximab|mesh-list
14346129|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14346130|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
14346131|NCT00946712|Antibodies|antibodies|mesh-list
14346132|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
14346133|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14346134|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
14346135|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14346136|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346137|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
14346138|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
14346139|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
14346140|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346141|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14346142|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14346143|NCT00946712|Growth Substances|growth substances|mesh-ancestor
14346144|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346145|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
14346146|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
14346147|NCT00946920|Goserelin|goserelin|mesh-list
14346148|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14346149|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346150|NCT00946998|Sertraline|sertraline|mesh-list
14346151|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
14346152|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14346153|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14346154|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14346155|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346156|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346157|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346158|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
14346159|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346160|NCT00947154|Aripiprazole|aripiprazole|mesh-list
14346161|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
14346162|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14346163|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14346164|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14346165|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346166|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346167|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
14346168|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
14346169|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346170|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346171|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14346172|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14346173|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
14346174|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14346175|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14346176|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14346177|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14346178|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14346179|NCT00947167|Pertuzumab|pertuzumab|mesh-list
14346180|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346181|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346182|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346183|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346184|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346185|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14346186|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346187|NCT00947349|Interferons|interferons|mesh-list
14346188|NCT00947349|Ribavirin|ribavirin|mesh-list
14346189|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346190|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
14346191|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346192|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
14346193|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346194|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14346195|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
14346196|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346197|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
14346198|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14346199|NCT00947531|Protective Agents|protective agents|mesh-ancestor
14346200|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346201|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
14346202|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14346203|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465026|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14465027|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465028|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465029|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465030|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14465031|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14465032|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
14465033|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465034|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14465035|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14465036|NCT02219516|Verinurad|verinurad|mesh-list
14465037|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
14465038|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346204|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
14346205|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
14346206|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14346207|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
14346208|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346209|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346210|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346211|NCT00947765|Prednisolone|prednisolone|mesh-list
14346212|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14346213|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
14346214|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14346215|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
14346216|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14346217|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
14346218|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346219|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
14346220|NCT00947765|Hormones|hormones|mesh-ancestor
14346221|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346222|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346223|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14346224|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346225|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
14346226|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
14346227|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229688|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229689|NCT02272803|Dexamethasone|dexamethasone|mesh-list
15229690|NCT02272803|Lenalidomide|lenalidomide|mesh-list
15229691|NCT02272803|Elotuzumab|elotuzumab|mesh-list
15229692|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229693|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
15229694|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
15229695|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229696|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229697|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229698|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
14346228|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346229|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15229699|NCT02272803|Hormones|hormones|mesh-ancestor
14346230|NCT00947765|Protective Agents|protective agents|mesh-ancestor
14346231|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15229700|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346232|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346233|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346234|NCT00948064|Azacitidine|azacitidine|mesh-list
14346235|NCT00948064|Vorinostat|vorinostat|mesh-list
14346236|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14346237|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
14346238|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346239|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346240|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346241|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14346242|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
14346243|NCT00948090|Busulfan|busulfan|mesh-list
14346244|NCT00948090|Etoposide|etoposide|mesh-list
14346245|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346246|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
14346247|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346248|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346249|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14346250|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
14346251|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346252|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346253|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14346254|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14346255|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14346256|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14346257|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346258|NCT00948155|Varenicline|varenicline|mesh-list
14346259|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14346260|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14346261|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14346262|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346263|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346264|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346265|NCT00948298|Vitamin D|vitamin d|mesh-list
14346266|NCT00948298|Vitamins|vitamins|mesh-ancestor
14346267|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
14346268|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731808|NCT05113251|Trastuzumab|trastuzumab|mesh-list
14731809|NCT05113251|Pertuzumab|pertuzumab|mesh-list
14731810|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14731811|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731812|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14731813|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14731814|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14731815|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731816|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731817|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
14731818|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731819|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731820|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14731821|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
14731822|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15229701|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229702|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346269|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14346270|NCT00948389|Dasatinib|dasatinib|mesh-list
14346271|NCT00948389|Lomustine|lomustine|mesh-list
14346272|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346273|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346274|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346275|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346276|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14346277|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
14346278|NCT00948428|Imiquimod|imiquimod|mesh-list
14346279|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14346280|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
14346281|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346282|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346283|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
14346284|NCT00948441|Ethanol|ethanol|mesh-list
14346285|NCT00948441|Heparin|heparin|mesh-list
14346286|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
14346287|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14346288|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14346289|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346290|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14346291|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346292|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346293|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346294|NCT00948506|Cidofovir|cidofovir|mesh-list
14346295|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
14346296|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346297|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229703|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
15229704|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229705|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15229706|NCT02272803|Growth Substances|growth substances|mesh-ancestor
15229707|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
15229708|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
15229709|NCT02257424|Trametinib|trametinib|mesh-list
15229710|NCT02257424|Dabrafenib|dabrafenib|mesh-list
15229711|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
15229712|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15229713|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14346298|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346299|NCT00948610|Infliximab|infliximab|mesh-list
15229714|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346300|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
14346301|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346302|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346303|NCT00948675|Paclitaxel|paclitaxel|mesh-list
14346304|NCT00948675|Bevacizumab|bevacizumab|mesh-list
14346305|NCT00948675|Carboplatin|carboplatin|mesh-list
14346306|NCT00948675|Pemetrexed|pemetrexed|mesh-list
14346307|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14346308|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346309|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
14346310|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
14346311|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
14346312|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346313|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346314|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14346315|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14346316|NCT00948675|Growth Substances|growth substances|mesh-ancestor
14346317|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346318|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
14346319|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346320|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14346321|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14346322|NCT00948688|Vorinostat|vorinostat|mesh-list
14346323|NCT00948688|Fluorouracil|fluorouracil|mesh-list
14346324|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346325|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14346326|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346327|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346328|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
14346329|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14346330|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346331|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
14346332|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346333|NCT00948766|Rivastigmine|rivastigmine|mesh-list
14346334|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14346335|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346336|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346337|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
14346338|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346339|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346340|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14346341|NCT00948766|Protective Agents|protective agents|mesh-ancestor
14346342|NCT00948818|Linaclotide|linaclotide|mesh-list
14346343|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14346344|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
14346345|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346346|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346347|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14346348|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14346349|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
14346350|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346351|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
14346352|NCT00948896|Piperaquine|piperaquine|mesh-list
14346353|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
14346354|NCT00948896|Trimethoprim|trimethoprim|mesh-list
14346355|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14346356|NCT00948896|Artenimol|artenimol|mesh-list
14346357|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14346358|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
14346359|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
14346360|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14346361|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14346362|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346363|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14346364|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346365|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346366|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14346367|NCT00948896|Renal Agents|renal agents|mesh-ancestor
14346368|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14346369|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14346370|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14346371|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14346372|NCT00948922|Fludarabine|fludarabine|mesh-list
14346373|NCT00948922|Bortezomib|bortezomib|mesh-list
14346374|NCT00948922|Melphalan|melphalan|mesh-list
14346375|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346376|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346377|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346378|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
14346379|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346380|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14346381|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
14346382|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14346383|NCT00948935|Gemcitabine|gemcitabine|mesh-list
14346384|NCT00948935|Irinotecan|irinotecan|mesh-list
14346385|NCT00948935|Panitumumab|panitumumab|mesh-list
14346386|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14346387|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
14346388|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346389|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346390|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
14346391|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346392|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346393|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346394|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
14346395|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346396|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14346397|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14346398|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346399|NCT00949078|Omalizumab|omalizumab|mesh-list
14346400|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14346401|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14346402|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
14346403|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
14346404|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
14346405|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
14346406|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346407|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14346408|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
14346409|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
14346410|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346411|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346412|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346413|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14346414|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
14346415|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14346416|NCT00949234|Ritonavir|ritonavir|mesh-list
14346417|NCT00949234|Lopinavir|lopinavir|mesh-list
14346418|NCT00949234|Tenofovir|tenofovir|mesh-list
14346419|NCT00949234|Emtricitabine|emtricitabine|mesh-list
14346420|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14346421|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14346422|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
14346423|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346424|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346425|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14346426|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14346427|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
14346428|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346429|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14346430|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14346431|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14346432|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14346433|NCT00949325|Sirolimus|sirolimus|mesh-list
14346434|NCT00949325|Doxorubicin|doxorubicin|mesh-list
14346435|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14346436|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14346437|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346438|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14346439|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14346440|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346441|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346442|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14346443|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346444|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
14346445|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346446|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
14346447|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346448|NCT00949533|Oseltamivir|oseltamivir|mesh-list
14346449|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
14346450|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346451|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346452|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346453|NCT00949650|Pemetrexed|pemetrexed|mesh-list
14346454|NCT00949650|Afatinib|afatinib|mesh-list
14346455|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346456|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229715|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229716|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229717|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229718|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229719|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229720|NCT02186834|Dexamethasone|dexamethasone|mesh-list
15229721|NCT02186834|Doxorubicin|doxorubicin|mesh-list
15229722|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15229723|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229724|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
15229725|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
15229726|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346457|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229727|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229728|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229729|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
15229730|NCT02186834|Hormones|hormones|mesh-ancestor
15229731|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229732|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229733|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229734|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15229735|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15229736|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15229737|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229738|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229739|NCT02059265|Dasatinib|dasatinib|mesh-list
15229740|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229741|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15229742|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229743|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229744|NCT02034422|Antioxidants|antioxidants|mesh-list
15229745|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229746|NCT02034422|Protective Agents|protective agents|mesh-ancestor
15229747|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229748|NCT01988883|Propranolol|propranolol|mesh-list
15229749|NCT01988883|Modafinil|modafinil|mesh-list
15229750|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15229751|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15229752|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
15229753|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229754|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229755|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229756|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15229757|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15229758|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
15229759|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15229760|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15229761|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15229762|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15229763|NCT01945775|Talazoparib|talazoparib|mesh-list
15229764|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15229765|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229766|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229767|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229768|NCT01858922|Cytarabine|cytarabine|mesh-list
15229769|NCT01858922|Dexamethasone|dexamethasone|mesh-list
15229770|NCT01858922|Prednisone|prednisone|mesh-list
15229771|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
15229772|NCT01858922|Cisplatin|cisplatin|mesh-list
15229773|NCT01858922|Doxorubicin|doxorubicin|mesh-list
15229774|NCT01858922|Etoposide|etoposide|mesh-list
15229775|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
15229776|NCT01858922|Vincristine|vincristine|mesh-list
15229777|NCT01858922|Bleomycin|bleomycin|mesh-list
14346458|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14346459|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14346460|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346461|NCT00949702|Vemurafenib|vemurafenib|mesh-list
14346462|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346463|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346464|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346465|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346466|NCT00949884|Losartan|losartan|mesh-list
14346467|NCT00949884|Olmesartan|olmesartan|mesh-list
14346468|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14346469|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14346470|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14346471|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14346472|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15229778|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229779|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
14346473|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346474|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14346475|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346476|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346477|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346478|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920158|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346479|NCT00950170|Factor VIII|factor viii|mesh-list
14346480|NCT00950170|Coagulants|coagulants|mesh-ancestor
14346481|NCT00950248|Idebenone|idebenone|mesh-list
14346482|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
14346483|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346484|NCT00950248|Protective Agents|protective agents|mesh-ancestor
14346485|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346486|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
14346487|NCT00950300|Docetaxel|docetaxel|mesh-list
14346488|NCT00950300|Fluorouracil|fluorouracil|mesh-list
14346489|NCT00950300|Trastuzumab|trastuzumab|mesh-list
14346490|NCT00950300|Epirubicin|epirubicin|mesh-list
14346491|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14346492|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
14346493|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346494|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346495|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14346496|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
14346497|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346498|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346499|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14346500|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
14346501|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
14346502|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
14346503|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
14346504|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14346505|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346506|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14346507|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14346508|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14346509|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346510|NCT00950352|Choline|choline|mesh-list
14346511|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14346512|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
14346513|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14346514|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
14346515|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346516|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346517|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14346518|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
14346519|NCT00950365|Pemetrexed|pemetrexed|mesh-list
14346520|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14346521|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346522|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346523|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346524|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14346525|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14346526|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346527|NCT00950599|Saxagliptin|saxagliptin|mesh-list
14346528|NCT00950599|Incretins|incretins|mesh-ancestor
14346529|NCT00950599|Hormones|hormones|mesh-ancestor
14346530|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346531|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346532|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14346533|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
14346534|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346535|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346536|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14346537|NCT00950651|Tramadol|tramadol|mesh-list
14346538|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14346539|NCT00950651|Narcotics|narcotics|mesh-ancestor
14346540|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346541|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346542|NCT00950651|Analgesics|analgesics|mesh-ancestor
14346543|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
14346544|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346545|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14346546|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14346547|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14346548|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346549|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346550|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14346551|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346552|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346553|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
14346554|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346555|NCT00950742|Trastuzumab|trastuzumab|mesh-list
14346556|NCT00950742|Afatinib|afatinib|mesh-list
14346557|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346558|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346559|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346560|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346561|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346562|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
14346563|NCT00950755|Antibodies|antibodies|mesh-list
14346564|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
14346565|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346566|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346567|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
14346568|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14346569|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
15229780|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229781|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229782|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15229783|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
15229784|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229785|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229786|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15229787|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229788|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
15229789|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
15229790|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229791|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15229792|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
15229793|NCT01858922|Hormones|hormones|mesh-ancestor
15229794|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346570|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346571|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346572|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14346573|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
14346574|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
14346575|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14346576|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
14346577|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346578|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346579|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14346580|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
14346581|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346582|NCT00950859|Dolutegravir|dolutegravir|mesh-list
14346583|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14346584|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14346585|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346586|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346587|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14346588|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14346589|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
14346590|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346591|NCT00950911|Denosumab|denosumab|mesh-list
14346592|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14346593|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346594|NCT00951015|Efavirenz|efavirenz|mesh-list
14346595|NCT00951015|Dolutegravir|dolutegravir|mesh-list
14346596|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14346597|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14346598|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346599|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346600|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
14346601|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346602|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14346603|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14346604|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14346605|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14346606|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14346607|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14346608|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14346609|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14346610|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14346611|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14346612|NCT00951041|Vaccines|vaccines|mesh-list
14346613|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
14346614|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346615|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
14346616|NCT00951379|Pioglitazone|pioglitazone|mesh-list
14346617|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14346618|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731823|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14346619|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14346620|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
14346621|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14346622|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14346623|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14346624|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346625|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346626|NCT00951496|Paclitaxel|paclitaxel|mesh-list
14346627|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14346628|NCT00951496|Bevacizumab|bevacizumab|mesh-list
14346629|NCT00951496|Cisplatin|cisplatin|mesh-list
14346630|NCT00951496|Carboplatin|carboplatin|mesh-list
14346631|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14346632|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
14346633|NCT00951496|Antibodies|antibodies|mesh-list
14346634|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
14346635|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14346636|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
14346637|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14346638|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346639|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
14346640|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
14346641|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
14346642|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346643|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14346644|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14346645|NCT00951496|Growth Substances|growth substances|mesh-ancestor
14346646|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346647|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
14346648|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
14346649|NCT00951561|Ibuprofen|ibuprofen|mesh-list
14346650|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14346651|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14346652|NCT00951561|Analgesics|analgesics|mesh-ancestor
14346653|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
14346654|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346655|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346656|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346657|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346658|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14346659|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346660|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346661|NCT00951665|Paclitaxel|paclitaxel|mesh-list
14346662|NCT00951665|Maytansine|maytansine|mesh-list
14346663|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14346664|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14346665|NCT00951665|Trastuzumab|trastuzumab|mesh-list
14346666|NCT00951665|Pertuzumab|pertuzumab|mesh-list
14346667|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14346668|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346669|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
14346670|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
14346671|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14346672|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346673|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346674|NCT00951899|Metformin|metformin|mesh-list
14346675|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14346676|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14346677|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346678|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14346679|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14346680|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
14346681|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346682|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14346683|NCT00951912|Genistein|genistein|mesh-list
14346684|NCT00951912|Daidzein|daidzein|mesh-list
14346685|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14346686|NCT00951912|Protective Agents|protective agents|mesh-ancestor
14346687|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346688|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346689|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346690|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346691|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346692|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
14346693|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14346694|NCT00951912|Estrogens|estrogens|mesh-ancestor
14346695|NCT00951912|Hormones|hormones|mesh-ancestor
14346696|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346697|NCT00952068|Tramadol|tramadol|mesh-list
14346698|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14346699|NCT00952068|Narcotics|narcotics|mesh-ancestor
14346700|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346701|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346702|NCT00952068|Analgesics|analgesics|mesh-ancestor
14346703|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
14346704|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346705|NCT00952081|Clevidipine|clevidipine|mesh-list
14346706|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14346707|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346708|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346709|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14731824|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14731825|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14731826|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731827|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346710|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346711|NCT00952133|Dexamethasone|dexamethasone|mesh-list
14346712|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
14346713|NCT00952133|Palonosetron|palonosetron|mesh-list
14346714|NCT00952133|BB 1101|bb 1101|mesh-list
14346715|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346716|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
14346717|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
14346718|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346719|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346720|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346721|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
14346722|NCT00952133|Hormones|hormones|mesh-ancestor
14346723|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346724|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14346725|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346726|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
14346727|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346728|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346729|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14346730|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14346731|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
14346732|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346733|NCT00952276|Vaccines|vaccines|mesh-list
14346734|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
14346735|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346736|NCT00952341|Dexamethasone|dexamethasone|mesh-list
14346737|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
14346738|NCT00952341|Aprepitant|aprepitant|mesh-list
14346739|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
14346740|NCT00952341|Granisetron|granisetron|mesh-list
14346741|NCT00952341|BB 1101|bb 1101|mesh-list
14346742|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346743|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
14346744|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
14346745|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346746|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346747|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346748|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
14346749|NCT00952341|Hormones|hormones|mesh-ancestor
14346750|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346751|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14346752|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346753|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
14346754|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346755|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346756|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14346757|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346758|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14346759|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
14346760|NCT00952380|Dalteparin|dalteparin|mesh-list
14346761|NCT00952380|Tinzaparin|tinzaparin|mesh-list
14346762|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14346763|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
14346764|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14346765|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14346766|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346767|NCT00952419|Vaccines|vaccines|mesh-list
14346768|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
14346769|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346770|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
14346771|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
14346772|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346773|NCT00952523|Adapalene|adapalene|mesh-list
14346774|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14346775|NCT00952523|Tretinoin|tretinoin|mesh-list
14346776|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14346777|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14346778|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14346779|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14346780|NCT00952523|Analgesics|analgesics|mesh-ancestor
14346781|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
14346782|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346783|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346784|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346785|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346786|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346787|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
14346788|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14731828|NCT05109143|Indomethacin|indomethacin|mesh-list
14731829|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15229795|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229796|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229797|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15229798|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15229799|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14346789|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346790|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
14346791|NCT00952614|Hormones|hormones|mesh-ancestor
14346792|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229800|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229801|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15229802|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
14346793|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346794|NCT00952653|Midazolam|midazolam|mesh-list
15229803|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
15229804|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229805|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229806|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229807|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229808|NCT01781637|Omalizumab|omalizumab|mesh-list
15229809|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15229810|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14346795|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14346796|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14346797|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14465039|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
14465040|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14465041|NCT02219685|Ledipasvir|ledipasvir|mesh-list
14465042|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
14465043|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465044|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
14465045|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14465046|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465047|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465048|NCT02219997|Methamphetamine|methamphetamine|mesh-list
14346798|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346799|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346800|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14346801|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14346802|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14346803|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14346804|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
14346805|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
14346806|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
14346807|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
14346808|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346809|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346810|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14346811|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14346812|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346813|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
14346814|NCT00952731|Tamoxifen|tamoxifen|mesh-list
14346815|NCT00952731|Afimoxifene|afimoxifene|mesh-list
14346816|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14346817|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
14346818|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346819|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346820|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14346821|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346822|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14346823|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14346824|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14346825|NCT00952822|Factor VIII|factor viii|mesh-list
14346826|NCT00952822|Coagulants|coagulants|mesh-ancestor
14346827|NCT00953017|Bisacodyl|bisacodyl|mesh-list
14346828|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14346829|NCT00953017|Lubiprostone|lubiprostone|mesh-list
14731830|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14346830|NCT00953017|Cathartics|cathartics|mesh-ancestor
14346831|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14346832|NCT00953017|Laxatives|laxatives|mesh-ancestor
14346833|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14346834|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346835|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346836|NCT00953043|Lubiprostone|lubiprostone|mesh-list
14346837|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14346838|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346839|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346840|NCT00953056|Vaccines|vaccines|mesh-list
14346841|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
14346842|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346843|NCT00953121|Bevacizumab|bevacizumab|mesh-list
14346844|NCT00953121|Carboplatin|carboplatin|mesh-list
14346845|NCT00953121|Irinotecan|irinotecan|mesh-list
14346846|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14346847|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346848|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14346849|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14346850|NCT00953121|Growth Substances|growth substances|mesh-ancestor
14346851|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346852|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14346853|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14346854|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14346855|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346856|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465049|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
14465050|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14465051|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14465052|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14465053|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465054|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
14465055|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
14465056|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465057|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
14465058|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465059|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465060|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
14465061|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14465062|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14465063|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465064|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14465065|NCT02219997|Hormones|hormones|mesh-ancestor
14465066|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465067|NCT02220712|Aripiprazole|aripiprazole|mesh-list
14465068|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
14465069|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14465070|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14465071|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14465072|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465073|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465074|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
14465075|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
14465076|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465077|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465078|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14465079|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14465080|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
14465081|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14465082|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14465083|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14465084|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14465085|NCT02220907|Canagliflozin|canagliflozin|mesh-list
14465086|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465087|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346857|NCT00953147|Ciclesonide|ciclesonide|mesh-list
14346858|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
14346859|NCT00953147|Hormones|hormones|mesh-ancestor
14346860|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346861|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346862|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14346863|NCT00953199|Lidocaine|lidocaine|mesh-list
14346864|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
14346865|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
14346866|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346867|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346868|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
14346869|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346870|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14346871|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14346872|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14346873|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346874|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346875|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
14346876|NCT00953212|Amiodarone|amiodarone|mesh-list
14346877|NCT00953212|Metoprolol|metoprolol|mesh-list
14346878|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14346879|NCT00953212|Vitamins|vitamins|mesh-ancestor
14346880|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
14346881|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346882|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
14346883|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346884|NCT00953212|Protective Agents|protective agents|mesh-ancestor
14346885|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14346886|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
14346887|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14346888|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346889|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14346890|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14346891|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14346892|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346893|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14346894|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14346895|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14346896|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14346897|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
14346898|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346899|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14346900|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
14346901|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
14346902|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346903|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14346904|NCT00953225|Vitamin D|vitamin d|mesh-list
14346905|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
14346906|NCT00953225|Vitamins|vitamins|mesh-ancestor
14346907|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
14346908|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346909|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14346910|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14346911|NCT00953524|Vaccines|vaccines|mesh-list
14346912|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
14346913|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346914|NCT00953576|Ketoconazole|ketoconazole|mesh-list
14346915|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
14346916|NCT00953576|Lapatinib|lapatinib|mesh-list
14346917|NCT00953576|Dutasteride|dutasteride|mesh-list
14346918|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346919|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14346920|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14346921|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346922|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346923|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
14346924|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14346925|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14346926|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14346927|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14346928|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
14346929|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14346930|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346931|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14346932|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14346933|NCT00953667|Niacin|niacin|mesh-list
14346934|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14346935|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
14346936|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346937|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14346938|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
14346939|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
14346940|NCT00953667|Vitamins|vitamins|mesh-ancestor
14346941|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
14346942|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346943|NCT00953706|Ivacaftor|ivacaftor|mesh-list
14346944|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14346945|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346946|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346947|NCT00953745|Aripiprazole|aripiprazole|mesh-list
14346948|NCT00953745|Citalopram|citalopram|mesh-list
14346949|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14346950|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14346951|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346952|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346953|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14346954|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
14346955|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346956|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14346957|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
14346958|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14346959|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14346960|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14346961|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14346962|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
14346963|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
14346964|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14346965|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14346966|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14346967|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14346968|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14346969|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14346970|NCT00953849|Calcitriol|calcitriol|mesh-list
14346971|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14346972|NCT00953849|Vitamin D|vitamin d|mesh-list
15229811|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
15229812|NCT01773278|Antioxidants|antioxidants|mesh-list
14346973|NCT00953849|Celecoxib|celecoxib|mesh-list
14346974|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14346975|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14346976|NCT00953849|Analgesics|analgesics|mesh-ancestor
14346977|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
14346978|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14346979|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14346980|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14346981|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14346982|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14346983|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14346984|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14346985|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346986|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14346987|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14346988|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346989|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14346990|NCT00953849|Vitamins|vitamins|mesh-ancestor
14346991|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
14346992|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14346993|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14346994|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14346995|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14346996|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14346997|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14346998|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
14346999|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347000|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347001|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14347002|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
14347003|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347004|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14347005|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14347006|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347007|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347008|NCT00954174|Paclitaxel|paclitaxel|mesh-list
14347009|NCT00954174|Carboplatin|carboplatin|mesh-list
14347010|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14347011|NCT00954174|Ifosfamide|ifosfamide|mesh-list
14347012|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
14347013|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14347014|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347015|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229813|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229814|NCT01773278|Protective Agents|protective agents|mesh-ancestor
15229815|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229816|NCT01711541|Paclitaxel|paclitaxel|mesh-list
15229817|NCT01711541|Cisplatin|cisplatin|mesh-list
15229818|NCT01711541|Carboplatin|carboplatin|mesh-list
15229819|NCT01711541|Fluorouracil|fluorouracil|mesh-list
15229820|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14347016|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
15229821|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
15229822|NCT01711541|Veliparib|veliparib|mesh-list
15229823|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229824|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347017|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
14347018|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347019|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14347020|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
14347021|NCT00954447|Linagliptin|linagliptin|mesh-list
14347022|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14347023|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347024|NCT00954447|Incretins|incretins|mesh-ancestor
14347025|NCT00954447|Hormones|hormones|mesh-ancestor
14347026|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347027|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14347028|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
14347029|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347030|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347031|NCT00954512|Leucovorin|leucovorin|mesh-list
14347032|NCT00954512|Folic Acid|folic acid|mesh-list
14347033|NCT00954512|Gemcitabine|gemcitabine|mesh-list
14347034|NCT00954512|Carboplatin|carboplatin|mesh-list
14347035|NCT00954512|Trastuzumab|trastuzumab|mesh-list
14347036|NCT00954512|Irinotecan|irinotecan|mesh-list
14347037|NCT00954512|Cetuximab|cetuximab|mesh-list
14347038|NCT00954512|Everolimus|everolimus|mesh-list
14347039|NCT00954512|Epirubicin|epirubicin|mesh-list
14347040|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
14347041|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347042|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347043|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14347044|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
14347045|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
14347046|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347047|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347048|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347049|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
14347050|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347051|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14347052|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14347053|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14347054|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14347055|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14731831|NCT05109143|Analgesics|analgesics|mesh-ancestor
14731832|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
14731833|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731834|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731835|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731836|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731837|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
14731838|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
15229825|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
15229826|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
14347056|NCT00954512|Antidotes|antidotes|mesh-ancestor
14347057|NCT00954512|Protective Agents|protective agents|mesh-ancestor
14347058|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
14347059|NCT00954512|Vitamins|vitamins|mesh-ancestor
14347060|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
14347061|NCT00954512|Hematinics|hematinics|mesh-ancestor
14347062|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14347063|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
14347064|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347065|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14347066|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14347067|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347068|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347069|NCT00954707|Aspirin|aspirin|mesh-list
14347070|NCT00954707|Clopidogrel|clopidogrel|mesh-list
15229827|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
15229828|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229829|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
15229830|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15229831|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229832|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
14347071|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14347072|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14465088|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15229833|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347073|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14347074|NCT00954707|Analgesics|analgesics|mesh-ancestor
14347075|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
14347076|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347077|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347078|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347079|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347080|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14347081|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14347082|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347083|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14347084|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14347085|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347086|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
14347087|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14347088|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14347089|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14347090|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
14347091|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347092|NCT00954941|Ondansetron|ondansetron|mesh-list
14347093|NCT00954941|Aprepitant|aprepitant|mesh-list
14347094|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
14347095|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
14347096|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347097|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347098|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14347099|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
14347100|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
14347101|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14347102|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
14347103|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347104|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347105|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14347106|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14347107|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347108|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347109|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14347110|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14347111|NCT00955110|Oxymorphone|oxymorphone|mesh-list
14347112|NCT00955110|Oxycodone|oxycodone|mesh-list
14347113|NCT00955110|Hydromorphone|hydromorphone|mesh-list
14347114|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14347115|NCT00955110|Narcotics|narcotics|mesh-ancestor
14347116|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347117|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347118|NCT00955110|Analgesics|analgesics|mesh-ancestor
14347119|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
14347120|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347121|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14347122|NCT00955253|Guanfacine|guanfacine|mesh-list
14347123|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14347124|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14347125|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14347126|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14347127|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
14347128|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347129|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347130|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347131|NCT00955266|Calcium|calcium|mesh-list
14347132|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14347133|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347134|NCT00955279|Golimumab|golimumab|mesh-list
14347135|NCT00955279|Ustekinumab|ustekinumab|mesh-list
14347136|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
14347137|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14347138|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347139|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347140|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
14347141|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347142|NCT00955305|Paclitaxel|paclitaxel|mesh-list
14347143|NCT00955305|Bevacizumab|bevacizumab|mesh-list
14347144|NCT00955305|Carboplatin|carboplatin|mesh-list
14347145|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14347146|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347147|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
14347148|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
14347149|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
14347150|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347151|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14347152|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14347153|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14347154|NCT00955305|Growth Substances|growth substances|mesh-ancestor
14347155|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347156|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
14347157|NCT00955357|Lacosamide|lacosamide|mesh-list
14347158|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
14347159|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14347160|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14347161|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347162|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347163|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
14347164|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14347165|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
14347166|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347167|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14347168|NCT00955474|Citalopram|citalopram|mesh-list
14347169|NCT00955474|Sertraline|sertraline|mesh-list
14347170|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14347171|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14347172|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347173|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347174|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347175|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
14347176|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347177|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14347178|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
14347179|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347180|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14347181|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14347182|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347183|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
14347184|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14347185|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
14347186|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347187|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731839|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14731840|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14731841|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731842|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731843|NCT05108454|Micronutrients|micronutrients|mesh-list
14731844|NCT05108454|Trace Elements|trace elements|mesh-list
14731845|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731846|NCT05096702|Primaquine|primaquine|mesh-list
14731847|NCT05096702|Tafenoquine|tafenoquine|mesh-list
14731848|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
14731849|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14731850|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15229834|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
15229835|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229836|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15229837|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15229838|NCT01670539|Triamcinolone|triamcinolone|mesh-list
15229839|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229840|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
15229841|NCT01670539|Hormones|hormones|mesh-ancestor
15229842|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229843|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229844|NCT01552434|Sirolimus|sirolimus|mesh-list
15229845|NCT01552434|Bevacizumab|bevacizumab|mesh-list
14347188|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14347189|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
14347190|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14347191|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
14347192|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347193|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347194|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14347195|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
14347196|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
14347197|NCT00955487|Protective Agents|protective agents|mesh-ancestor
14347198|NCT00955513|Diclofenac|diclofenac|mesh-list
14347199|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14347200|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14347201|NCT00955513|Analgesics|analgesics|mesh-ancestor
14347202|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
14347203|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347204|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347205|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347206|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347207|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14731851|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731852|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14731853|NCT05085808|Trazodone|trazodone|mesh-list
14731854|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
14731855|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731856|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14731857|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14731858|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731859|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731860|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14731861|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14920159|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347208|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347209|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347210|NCT00955721|Gemcitabine|gemcitabine|mesh-list
14347211|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
14347212|NCT00955721|Sorafenib|sorafenib|mesh-list
14347213|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14347214|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
14347215|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731862|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14920160|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14347216|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347217|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
14347218|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347219|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347220|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347221|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
14347222|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347223|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14347224|NCT00955747|Tagatose|tagatose|mesh-list
14347225|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14347226|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
14347227|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
14347228|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347229|NCT00955877|Morphine|morphine|mesh-list
14347230|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14347231|NCT00955877|Narcotics|narcotics|mesh-ancestor
14347232|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347233|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347234|NCT00955877|Analgesics|analgesics|mesh-ancestor
14347235|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
14347236|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347237|NCT00955916|Cytarabine|cytarabine|mesh-list
14347238|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
14347239|NCT00955916|Cladribine|cladribine|mesh-list
14347240|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14347241|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
14347242|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347243|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347244|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
14347245|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347246|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229846|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15229847|NCT01552434|Cetuximab|cetuximab|mesh-list
15229848|NCT01552434|Valproic Acid|valproic acid|mesh-list
15229849|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
15229850|NCT01552434|Antibodies|antibodies|mesh-list
15229851|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
15229852|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15229853|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
15229854|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229855|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229856|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15229857|NCT01552434|Growth Substances|growth substances|mesh-ancestor
15229858|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229859|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
15229860|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
14347247|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
14347248|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347249|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14347250|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347251|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14347252|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
14347253|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347254|NCT00956085|Memantine|memantine|mesh-list
14347255|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14347256|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14347257|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
14347258|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347259|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347260|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347261|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14347262|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14347263|NCT00956254|Fentanyl|fentanyl|mesh-list
14347264|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14347265|NCT00956254|Narcotics|narcotics|mesh-ancestor
15229861|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14347266|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347267|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229862|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347268|NCT00956254|Analgesics|analgesics|mesh-ancestor
14347269|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
14347270|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347271|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14347272|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14347273|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
14347274|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
14347275|NCT00956293|Cyclosporine|cyclosporine|mesh-list
14347276|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
14347277|NCT00956293|Everolimus|everolimus|mesh-list
14347278|NCT00956293|Cyclosporins|cyclosporins|mesh-list
14347279|NCT00956293|Basiliximab|basiliximab|mesh-list
14347280|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347281|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347282|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347283|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
14347284|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347285|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
14347286|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347287|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
14347288|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347289|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14347290|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347291|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14347292|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14347293|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
14347294|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14347295|NCT00956709|Ropivacaine|ropivacaine|mesh-list
14347296|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
14347297|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
14347298|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
14347299|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347300|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347301|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
14347302|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347303|NCT00956839|Vitamin D|vitamin d|mesh-list
14347304|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
14347305|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
14347306|NCT00956839|Vitamins|vitamins|mesh-list
14347307|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
14347308|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347309|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14347310|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14347311|NCT00956930|Doxorubicin|doxorubicin|mesh-list
14347312|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14347313|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14347314|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229863|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15229864|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
15229865|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229866|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229867|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
15229868|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229869|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
15229870|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15229871|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
15229872|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15229873|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347315|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14347316|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14920161|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
14920162|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347317|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347318|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347319|NCT00956943|Nicotine|nicotine|mesh-list
14347320|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14347321|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
14347322|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347323|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347324|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14347325|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14347326|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
14347327|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347328|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347329|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14347330|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
14347331|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14347332|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14347333|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347334|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347335|NCT00957242|Warfarin|warfarin|mesh-list
14347336|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
14347337|NCT00957268|Alogliptin|alogliptin|mesh-list
14347338|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14347339|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347340|NCT00957268|Incretins|incretins|mesh-ancestor
14347341|NCT00957268|Hormones|hormones|mesh-ancestor
14347342|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347343|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14347344|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
14347345|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347346|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347347|NCT00957333|Ketamine|ketamine|mesh-list
14347348|NCT00957333|Analgesics|analgesics|mesh-ancestor
14347349|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
14347350|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347351|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347352|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14920163|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14920164|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920165|NCT04786093|Durvalumab|durvalumab|mesh-list
14920166|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920167|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347353|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14347354|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
14347355|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
14347356|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347357|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14347358|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14347359|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347360|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347361|NCT00957359|Niacin|niacin|mesh-list
14347362|NCT00957359|Psilocybin|psilocybin|mesh-list
14347363|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14347364|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347365|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
14347366|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347367|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347368|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
14347369|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
14347370|NCT00957359|Vitamins|vitamins|mesh-ancestor
14347371|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
14347372|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347373|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
14347374|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347375|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14347376|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
14920168|NCT04783376|Insulin|insulin|mesh-list
14920169|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14920170|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14920171|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920172|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
14347377|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347378|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14347379|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14347380|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
14347381|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14347382|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14347383|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347384|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347385|NCT00957424|Nicotine|nicotine|mesh-list
14347386|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14347387|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
14347388|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347389|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347390|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14347391|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14347392|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
14347393|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347394|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347395|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
14347396|NCT00957528|Testosterone|testosterone|mesh-list
14347397|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
14347398|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
14347399|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14347400|NCT00957528|Androgens|androgens|mesh-ancestor
14347401|NCT00957528|Hormones|hormones|mesh-ancestor
14347402|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347403|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347404|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920173|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14347405|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347406|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
14920174|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347407|NCT00957580|Niacinamide|niacinamide|mesh-list
14347408|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
14347409|NCT00957580|Vitamins|vitamins|mesh-ancestor
14347410|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
14347411|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347412|NCT00957593|Oxytocin|oxytocin|mesh-list
14347413|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
14347414|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14347415|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347416|NCT00957671|Hormones|hormones|mesh-list
14347417|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347418|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347419|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14347420|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
14347421|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14347422|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14347423|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347424|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347425|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
14347426|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14347427|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14347428|NCT00957801|Prednisolone|prednisolone|mesh-list
14347429|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
14347430|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
14347431|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14347432|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
14347433|NCT00957801|Testosterone|testosterone|mesh-list
14347434|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
14347435|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
14347436|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14347437|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347438|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
14347439|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
14347440|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347441|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347442|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14347443|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
14347444|NCT00957801|Hormones|hormones|mesh-ancestor
14347445|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347446|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14347447|NCT00957801|Protective Agents|protective agents|mesh-ancestor
14347448|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14347449|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347450|NCT00957801|Androgens|androgens|mesh-ancestor
14347451|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
14347452|NCT00957853|Cetuximab|cetuximab|mesh-list
14347453|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14347454|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347455|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
14347456|NCT00957905|Leucovorin|leucovorin|mesh-list
14347457|NCT00957905|Folic Acid|folic acid|mesh-list
14347458|NCT00957905|Fluorouracil|fluorouracil|mesh-list
14347459|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
14347460|NCT00957905|Alvocidib|alvocidib|mesh-list
14347461|NCT00957905|Calcium|calcium|mesh-list
14347462|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
14347463|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14347464|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347465|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14347466|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
14347467|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347468|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14347469|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347470|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347471|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
14347472|NCT00957905|Antidotes|antidotes|mesh-ancestor
14347473|NCT00957905|Protective Agents|protective agents|mesh-ancestor
14347474|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
14347475|NCT00957905|Vitamins|vitamins|mesh-ancestor
14347476|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
14347477|NCT00957905|Hematinics|hematinics|mesh-ancestor
14347478|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
14347479|NCT00957905|Growth Substances|growth substances|mesh-ancestor
14347480|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14347481|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347482|NCT00957944|Rotigotine|rotigotine|mesh-list
14347483|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
14347484|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
14347485|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347486|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347487|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347488|NCT00957996|Peramivir|peramivir|mesh-list
14347489|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
14347490|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347491|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347492|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347493|NCT00958035|Bimatoprost|bimatoprost|mesh-list
14347494|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14347495|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14347496|NCT00958074|Vorinostat|vorinostat|mesh-list
14347497|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347498|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14347499|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347500|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347501|NCT00958243|Vaccines|vaccines|mesh-list
14347502|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
14347503|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465089|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465090|NCT02220920|Canagliflozin|canagliflozin|mesh-list
14465091|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465092|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731863|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347504|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
14347505|NCT00958256|Rituximab|rituximab|mesh-list
14347506|NCT00958256|Bortezomib|bortezomib|mesh-list
14347507|NCT00958256|Sargramostim|sargramostim|mesh-list
14347508|NCT00958256|Lenograstim|lenograstim|mesh-list
14347509|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347510|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
14347511|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347512|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347513|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14347514|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
14347515|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347516|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347517|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14347518|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14347519|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14347520|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14347521|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14347522|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347523|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14347524|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14347525|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347526|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347527|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
14347528|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347529|NCT00958438|Rilonacept|rilonacept|mesh-list
15229874|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347530|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347531|NCT00958568|Olanzapine|olanzapine|mesh-list
14347532|NCT00958568|Fluoxetine|fluoxetine|mesh-list
14347533|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
14347534|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
14347535|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347536|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347537|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14347538|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14347539|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14347540|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14347541|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347542|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14347543|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14347544|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347545|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347546|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347547|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
14347548|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14347549|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
14347550|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14347551|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14347552|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347553|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
14347554|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
14347555|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14347556|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14347557|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347558|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
14347559|NCT00958581|Coagulants|coagulants|mesh-ancestor
14347560|NCT00958724|Vinorelbine|vinorelbine|mesh-list
14347561|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14347562|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347563|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
14347564|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
14347565|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
14347566|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347567|NCT00958776|Peramivir|peramivir|mesh-list
14347568|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
14347569|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347570|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347571|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347572|NCT00958841|Pasireotide|pasireotide|mesh-list
14347573|NCT00958841|Hormones|hormones|mesh-ancestor
14347574|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347575|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347576|NCT00958880|Yohimbine|yohimbine|mesh-list
14347577|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
14347578|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
14347579|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347580|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347581|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14347582|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14347583|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14347584|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
14347585|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347586|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347587|NCT00958880|Urological Agents|urological agents|mesh-ancestor
14347588|NCT00958919|Naloxone|naloxone|mesh-list
14347589|NCT00958919|Endorphins|endorphins|mesh-list
14347590|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14347591|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347592|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
14347593|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347594|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347595|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229875|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
15229876|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
15229877|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15229878|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15229879|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229880|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229881|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229882|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229883|NCT01416935|Amiodarone|amiodarone|mesh-list
15229884|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15229885|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
15229886|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15229887|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229888|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229889|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15229890|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15229891|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15229892|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229893|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15229894|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14347596|NCT00959049|Vaccines|vaccines|mesh-list
14347597|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
14347598|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347599|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
14347600|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14347601|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
14347602|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347603|NCT00959647|Bevacizumab|bevacizumab|mesh-list
14347604|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14347605|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347606|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14347607|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14347608|NCT00959647|Growth Substances|growth substances|mesh-ancestor
14347609|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347610|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
14347611|NCT00959699|Interferons|interferons|mesh-list
14347612|NCT00959699|Ribavirin|ribavirin|mesh-list
14347613|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
14347614|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
14347615|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14347616|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347617|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
14347618|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347619|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
14347620|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347621|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
14347622|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347623|NCT00959764|Calcitonin|calcitonin|mesh-list
14347624|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
14347625|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14347626|NCT00959764|Katacalcin|katacalcin|mesh-list
14347627|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14347628|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347629|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14731864|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347630|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
14347631|NCT00959894|Tenofovir|tenofovir|mesh-list
14347632|NCT00959894|Emtricitabine|emtricitabine|mesh-list
14347633|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14347634|NCT00959894|Etravirine|etravirine|mesh-list
14347635|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
14347636|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347637|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14347638|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14347639|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347640|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347641|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14347642|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14347643|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
14347644|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14347645|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14347646|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14347647|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14347648|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347649|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347650|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
14347651|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347652|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347653|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14347654|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347655|NCT00959946|Capecitabine|capecitabine|mesh-list
14347656|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14347657|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
14347658|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347659|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347660|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
14347661|NCT00960063|Temozolomide|temozolomide|mesh-list
14347662|NCT00960063|Ifosfamide|ifosfamide|mesh-list
14347663|NCT00960063|Doxorubicin|doxorubicin|mesh-list
14347664|NCT00960063|Irinotecan|irinotecan|mesh-list
14347665|NCT00960063|Etoposide|etoposide|mesh-list
14347666|NCT00960063|Vincristine|vincristine|mesh-list
14347667|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347668|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
14347669|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347670|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347671|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14347672|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
14347673|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347674|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347675|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14347676|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14347677|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14347678|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14347679|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347680|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14347681|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14347682|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
14347683|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
14347684|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
14347685|NCT00960076|Metformin|metformin|mesh-list
14347686|NCT00960076|Saxagliptin|saxagliptin|mesh-list
14347687|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14347688|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347689|NCT00960076|Incretins|incretins|mesh-ancestor
14347690|NCT00960076|Hormones|hormones|mesh-ancestor
14347691|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347692|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14347693|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
14347694|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347695|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347696|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
14347697|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
14347698|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347699|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14347700|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347701|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14347702|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
14347703|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347704|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347705|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14347706|NCT00960193|Colchicine|colchicine|mesh-list
14347707|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
14347708|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347709|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14347710|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14347711|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14347712|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347713|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347714|NCT00960323|Colchicine|colchicine|mesh-list
14347715|NCT00960323|Atorvastatin|atorvastatin|mesh-list
14347716|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14347717|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347718|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
14347719|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347720|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347721|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14347722|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347723|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
14347724|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347725|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
14347726|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
14347727|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
14347728|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347729|NCT00960440|Tofacitinib|tofacitinib|mesh-list
14347730|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14347731|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347732|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347733|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
14347734|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14347735|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
14347736|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347737|NCT00960570|Efavirenz|efavirenz|mesh-list
14347738|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
14347739|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14347740|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14347741|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347742|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347743|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
14347744|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347745|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14347746|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14347747|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14347748|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14347749|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14347750|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14347751|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14347752|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347753|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
14347754|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347755|NCT00960622|Tenofovir|tenofovir|mesh-list
14347756|NCT00960622|Lamivudine|lamivudine|mesh-list
14347757|NCT00960622|Zidovudine|zidovudine|mesh-list
14347758|NCT00960622|Emtricitabine|emtricitabine|mesh-list
14347759|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14347760|NCT00960622|Abacavir|abacavir|mesh-list
14347761|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
14347762|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14347763|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
14347764|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14347765|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14347766|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14731865|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731866|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
14731867|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14731868|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
14731869|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14731870|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
14731871|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731872|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
14731873|NCT05085067|Protective Agents|protective agents|mesh-ancestor
14731874|NCT05075980|Cisplatin|cisplatin|mesh-list
14731875|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347767|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347768|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347769|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14347770|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14347771|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
14347772|NCT00960661|Insulin|insulin|mesh-list
14347773|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14347774|NCT00960661|Metformin|metformin|mesh-list
14347775|NCT00960661|Exenatide|exenatide|mesh-list
14347776|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
14347777|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14347778|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347779|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14347780|NCT00960661|Incretins|incretins|mesh-ancestor
14347781|NCT00960661|Hormones|hormones|mesh-ancestor
14347782|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347783|NCT00960687|Fenofibrate|fenofibrate|mesh-list
14347784|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
14347785|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347786|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
14347787|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347788|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347789|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14920175|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14920176|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14347790|NCT00960778|Nicotine|nicotine|mesh-list
14347791|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14347792|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
14347793|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347794|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347795|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14347796|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14347797|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
14347798|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347799|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731876|NCT05069896|Mirikizumab|mirikizumab|mesh-list
14347800|NCT00960804|Tanezumab|tanezumab|mesh-list
14347801|NCT00960804|Analgesics|analgesics|mesh-ancestor
14731877|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14347802|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
14731878|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14347803|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347804|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347805|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
14347806|NCT00960856|Fenofibrate|fenofibrate|mesh-list
14347807|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14347808|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347809|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
14347810|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347811|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347812|NCT00960869|Aspirin|aspirin|mesh-list
14347813|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14347814|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14347815|NCT00960869|Analgesics|analgesics|mesh-ancestor
14347816|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
14347817|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347818|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347819|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347820|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347821|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14347822|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14347823|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347824|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14347825|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14347826|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347827|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
14347828|NCT00960934|Vitamin D|vitamin d|mesh-list
14347829|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
14347830|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
14347831|NCT00960934|Calcium|calcium|mesh-list
14347832|NCT00960934|Vitamins|vitamins|mesh-ancestor
14347833|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
14347834|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347835|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14347836|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14347837|NCT00960934|Antacids|antacids|mesh-ancestor
14347838|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347839|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14347840|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14347841|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14347842|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14347843|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347844|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347845|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347846|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347847|NCT00960986|Analgesics|analgesics|mesh-ancestor
14347848|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
14347849|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347850|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
14347851|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347852|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
14347853|NCT00961116|Fenofibrate|fenofibrate|mesh-list
14347854|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
14347855|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347856|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
14347857|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347858|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347859|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14347860|NCT00961181|Paclitaxel|paclitaxel|mesh-list
14347861|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14347862|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347863|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14347864|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
14347865|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14347866|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347867|NCT00961220|Carmustine|carmustine|mesh-list
14347868|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14347869|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14347870|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
14347871|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229895|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15229896|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
15229897|NCT01351909|Veliparib|veliparib|mesh-list
15229898|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229899|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
15229900|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229901|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15229902|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15229903|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
15229904|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229905|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229906|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15229907|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15229908|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229909|NCT01351896|Lenalidomide|lenalidomide|mesh-list
15229910|NCT01351896|Vaccines|vaccines|mesh-list
14347872|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229911|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14347873|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347874|NCT00961233|Budesonide|budesonide|mesh-list
14347875|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347876|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14347877|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
14347878|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347879|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347880|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14347881|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
14347882|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
14347883|NCT00961233|Hormones|hormones|mesh-ancestor
14347884|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14347885|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
14347886|NCT00961259|Fenofibrate|fenofibrate|mesh-list
14347887|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14347888|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347889|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
14347890|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347891|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347892|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14347893|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14347894|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14347895|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347896|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347897|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347898|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347899|NCT00961298|Analgesics|analgesics|mesh-ancestor
14347900|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
14347901|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347902|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
14347903|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347904|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
14347905|NCT00961350|Aspirin|aspirin|mesh-list
14347906|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14347907|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14347908|NCT00961350|Analgesics|analgesics|mesh-ancestor
14347909|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
14347910|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347911|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347912|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14347913|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347914|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14347915|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14347916|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347917|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14347918|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15229912|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
15229913|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229914|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15229915|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15229916|NCT01351896|Growth Substances|growth substances|mesh-ancestor
15229917|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14347919|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347920|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
14347921|NCT00961415|Bevacizumab|bevacizumab|mesh-list
14347922|NCT00961415|Pemetrexed|pemetrexed|mesh-list
14347923|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14347924|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347925|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14347926|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14347927|NCT00961415|Growth Substances|growth substances|mesh-ancestor
14347928|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229918|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229919|NCT01046825|Leucovorin|leucovorin|mesh-list
15229920|NCT01046825|Folic Acid|folic acid|mesh-list
15229921|NCT01046825|Cytarabine|cytarabine|mesh-list
15229922|NCT01046825|Prednisone|prednisone|mesh-list
15229923|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
15229924|NCT01046825|Doxorubicin|doxorubicin|mesh-list
14347929|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
14347930|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347931|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347932|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14347933|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14347934|NCT00961441|Levetiracetam|levetiracetam|mesh-list
14347935|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
14347936|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
14347937|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14347938|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
14347939|NCT00961532|Coagulants|coagulants|mesh-ancestor
14347940|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14347941|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
14347942|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347943|NCT00961571|Capecitabine|capecitabine|mesh-list
14347944|NCT00961571|Sunitinib|sunitinib|mesh-list
14731879|NCT05069896|Analgesics|analgesics|mesh-ancestor
14731880|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
14731881|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14347945|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14347946|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
14347947|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347948|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14347949|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14347950|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14347951|NCT00961571|Growth Substances|growth substances|mesh-ancestor
14347952|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347953|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
14347954|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14347955|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14347956|NCT00961636|Niacin|niacin|mesh-list
14347957|NCT00961636|Niacinamide|niacinamide|mesh-list
14347958|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
14347959|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14347960|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
14347961|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347962|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14347963|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
14347964|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
14347965|NCT00961636|Vitamins|vitamins|mesh-ancestor
14347966|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
14347967|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347968|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15229925|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15229926|NCT01046825|Rituximab|rituximab|mesh-list
15229927|NCT01046825|Rasburicase|rasburicase|mesh-list
14347969|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14347970|NCT00961649|Brinzolamide|brinzolamide|mesh-list
14347971|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14347972|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14347973|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14347974|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14347975|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14347976|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14347977|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347978|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731882|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229928|NCT01046825|Lenograstim|lenograstim|mesh-list
15229929|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
15229930|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229931|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
15229932|NCT01046825|Hormones|hormones|mesh-ancestor
15229933|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15229934|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229935|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15229936|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229937|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15229938|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
15229939|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15229940|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14347979|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347980|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14347981|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229941|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15229942|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
15229943|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229944|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15229945|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15229946|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15229947|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14347982|NCT00961662|Tagatose|tagatose|mesh-list
14347983|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14347984|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
14347985|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
14347986|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347987|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
14347988|NCT00961961|Fluoxetine|fluoxetine|mesh-list
14347989|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14347990|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14347991|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14347992|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14347993|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14347994|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
14347995|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14347996|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14347997|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
14347998|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14347999|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14348000|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14348001|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348002|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
14348003|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14348004|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348005|NCT00962039|Citalopram|citalopram|mesh-list
14348006|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14348007|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348008|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348009|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348010|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348011|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
14348012|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348013|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14348014|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
15229948|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229949|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229950|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15229951|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
15229952|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
15229953|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15229954|NCT01046825|Antidotes|antidotes|mesh-ancestor
15229955|NCT01046825|Protective Agents|protective agents|mesh-ancestor
15229956|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
15229957|NCT01046825|Vitamins|vitamins|mesh-ancestor
15229958|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
15229959|NCT01046825|Hematinics|hematinics|mesh-ancestor
15229960|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
15229961|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
15229962|NCT01019356|Acarbose|acarbose|mesh-list
15229963|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15229964|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229965|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15229966|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229967|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229968|NCT00576654|Irinotecan|irinotecan|mesh-list
15229969|NCT00576654|Camptothecin|camptothecin|mesh-list
15229970|NCT00576654|Veliparib|veliparib|mesh-list
15229971|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14348015|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348016|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14348017|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14348018|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348019|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14348020|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348021|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14348022|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14348023|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348024|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348025|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348026|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14348027|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348028|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348029|NCT00962390|Equol|equol|mesh-list
14348030|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
14348031|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14348032|NCT00962390|Estrogens|estrogens|mesh-ancestor
14348033|NCT00962390|Hormones|hormones|mesh-ancestor
14348034|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348035|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348036|NCT00962585|Equol|equol|mesh-list
14348037|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
14348038|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14348039|NCT00962585|Estrogens|estrogens|mesh-ancestor
14348040|NCT00962585|Hormones|hormones|mesh-ancestor
14348041|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348042|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348043|NCT00962741|Etanercept|etanercept|mesh-list
14348044|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14348045|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348046|NCT00962741|Analgesics|analgesics|mesh-ancestor
14348047|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
14348048|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348049|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348050|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15229972|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15229973|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15229974|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229975|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731883|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731884|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731885|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14348051|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348052|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14348053|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348054|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
14348055|NCT00962780|Vaccines|vaccines|mesh-list
14348056|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14348057|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
14348058|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348059|NCT00962871|Tenofovir|tenofovir|mesh-list
14348060|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14348061|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
14348062|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348063|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14348064|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14348065|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348066|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348067|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14731886|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14753054|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14753055|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229976|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15229977|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15229978|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
15229979|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15229980|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15229981|NCT05202730|Anesthetics|anesthetics|mesh-list
15229982|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
14348068|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14348069|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
14348070|NCT00962949|Giapreza|giapreza|mesh-list
14348071|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
14348072|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14348073|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14348074|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
14348075|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348076|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348077|NCT00963105|Lenalidomide|lenalidomide|mesh-list
14348078|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
14348079|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348080|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14348081|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14348082|NCT00963105|Growth Substances|growth substances|mesh-ancestor
14348083|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
14348084|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348085|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14348086|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
14348087|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348088|NCT00963508|Permethrin|permethrin|mesh-list
14348089|NCT00963508|Malathion|malathion|mesh-list
14348090|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348091|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348092|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14348093|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14348094|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348095|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348096|NCT00963547|Trastuzumab|trastuzumab|mesh-list
14348097|NCT00963547|Lapatinib|lapatinib|mesh-list
14348098|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348099|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348100|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14348101|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348102|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465093|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465094|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465095|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
14465096|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
14465097|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465098|NCT02221219|Indomethacin|indomethacin|mesh-list
14465099|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14465100|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14465101|NCT02221219|Analgesics|analgesics|mesh-ancestor
14465102|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
14465103|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465104|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465105|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465106|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465107|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
14465108|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
14465109|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14465110|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14465111|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465112|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465113|NCT02221284|Alogliptin|alogliptin|mesh-list
14465114|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465115|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465116|NCT02221284|Incretins|incretins|mesh-ancestor
14465117|NCT02221284|Hormones|hormones|mesh-ancestor
14465118|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14731887|NCT05061654|Tazobactam|tazobactam|mesh-list
14731888|NCT05061654|Ceftolozane|ceftolozane|mesh-list
15229983|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15229984|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229985|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
15229986|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15229987|NCT05202665|Fluorides|fluorides|mesh-list
15229988|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
15229989|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
15229990|NCT05202665|Protective Agents|protective agents|mesh-ancestor
15229991|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229992|NCT05202496|Calcitriol|calcitriol|mesh-list
15229993|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14348103|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
14348104|NCT00963807|Alovudine|alovudine|mesh-list
14348105|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
14348106|NCT00963807|Cisplatin|cisplatin|mesh-list
14348107|NCT00963807|Docetaxel|docetaxel|mesh-list
14348108|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14348109|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348110|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14348111|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14348112|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14348113|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348114|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14348115|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
14348116|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
14348117|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348118|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14348119|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14731889|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14731890|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14731891|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731892|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14731893|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731894|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731895|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14348120|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348121|NCT00963820|Ixazomib|ixazomib|mesh-list
14348122|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348123|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348124|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
14348125|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348126|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
14348127|NCT00963872|Fludarabine|fludarabine|mesh-list
14348128|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
14348129|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348130|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
14348131|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348132|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348133|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14348134|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
14348135|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348136|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348137|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14348138|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348139|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
14348140|NCT00963924|Cycloserine|cycloserine|mesh-list
14348141|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14348142|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348143|NCT00963924|Renal Agents|renal agents|mesh-ancestor
14348144|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14348145|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
14348146|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348147|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
14348148|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348149|NCT00963937|Sumatriptan|sumatriptan|mesh-list
14348150|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14348151|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14348152|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14348153|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
14348154|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348155|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348156|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348157|NCT00964223|Clindamycin|clindamycin|mesh-list
14348158|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
14348159|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
14348160|NCT00964223|Adapalene|adapalene|mesh-list
14348161|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14348162|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14348163|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348164|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348165|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14348166|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348167|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348168|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348169|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14348170|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348171|NCT00964223|Analgesics|analgesics|mesh-ancestor
14348172|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
14348173|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348174|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348175|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14348176|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348177|NCT00964353|Warfarin|warfarin|mesh-list
14348178|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
14348179|NCT00964366|Clindamycin|clindamycin|mesh-list
14348180|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
14348181|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
14348182|NCT00964366|Dapsone|dapsone|mesh-list
14348183|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14348184|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348185|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348186|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14348187|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348188|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348189|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348190|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
14348191|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14348192|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14348193|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14348194|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
14731896|NCT05061654|Renal Agents|renal agents|mesh-ancestor
14731897|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
14731898|NCT05049213|Povidone|povidone|mesh-list
14731899|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
14731900|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
14731901|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14731902|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14731903|NCT05045144|Vaccines|vaccines|mesh-list
14348195|NCT00964431|Celecoxib|celecoxib|mesh-list
14731904|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
14348196|NCT00964431|Indomethacin|indomethacin|mesh-list
14348197|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14348198|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348199|NCT00964431|Analgesics|analgesics|mesh-ancestor
14348200|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
14348201|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348202|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348203|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14348204|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348205|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14348206|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14348207|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348208|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348209|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
14348210|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
14348211|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14348212|NCT00964496|Thalidomide|thalidomide|mesh-list
14348213|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
14348214|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348215|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
14348216|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348217|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
14348218|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348219|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348220|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14348221|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14348222|NCT00964496|Growth Substances|growth substances|mesh-ancestor
14348223|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
14348224|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348225|NCT00964496|Hematinics|hematinics|mesh-ancestor
14348226|NCT00964548|Dantrolene|dantrolene|mesh-list
14731905|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229994|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15229995|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15229996|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15229997|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15229998|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15229999|NCT05202496|Vitamins|vitamins|mesh-ancestor
15230000|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
15230001|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15230002|NCT05202288|Vaccines|vaccines|mesh-list
15230003|NCT05202288|Immunologic Factors|immunologic factors|mesh-ancestor
15230004|NCT05202288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230005|NCT05202275|Olanzapine|olanzapine|mesh-list
15230006|NCT05202275|Aprepitant|aprepitant|mesh-list
15230007|NCT05202275|Palonosetron|palonosetron|mesh-list
15230008|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
15230009|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
15230010|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230011|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230012|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15230013|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15230014|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15230015|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230016|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15230017|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15230018|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15230019|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230020|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230021|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230022|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
15230023|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14348227|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14348228|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348229|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14348230|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348231|NCT00964678|Carvedilol|carvedilol|mesh-list
14348232|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14348233|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14348234|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
14348235|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348236|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348237|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348238|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14348239|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
14348240|NCT00964678|Protective Agents|protective agents|mesh-ancestor
14348241|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14348242|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348243|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14348244|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
14348245|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14348246|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14348247|NCT00964743|Cytarabine|cytarabine|mesh-list
14348248|NCT00964743|Sorafenib|sorafenib|mesh-list
14348249|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348250|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
14348251|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348252|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348253|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
14348254|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348255|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348256|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
14348257|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348258|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14348259|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348260|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
14348261|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
14348262|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14348263|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14348264|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348265|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348266|NCT00964782|Urological Agents|urological agents|mesh-ancestor
14348267|NCT00964795|Aflibercept|aflibercept|mesh-list
14348268|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14348269|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14348270|NCT00964795|Growth Substances|growth substances|mesh-ancestor
14348271|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348272|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14348273|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348274|NCT00964886|Benztropine|benztropine|mesh-list
14348275|NCT00964886|Desipramine|desipramine|mesh-list
14348276|NCT00964886|Clomipramine|clomipramine|mesh-list
14348277|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14348278|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
14348279|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348280|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348281|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348282|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14731906|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
14348283|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348284|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348285|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14348286|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348287|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348288|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14348289|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14348290|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
14348291|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
14348292|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920177|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348293|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14348294|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14348295|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
14348296|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14348297|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
14348298|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14348299|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
14348300|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14348301|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14348302|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348303|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348304|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348305|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348306|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348307|NCT00965081|Analgesics|analgesics|mesh-ancestor
14348308|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
14348309|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348310|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
14348311|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348312|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
14348313|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
14348314|NCT00965094|Everolimus|everolimus|mesh-list
14348315|NCT00965094|Tacrolimus|tacrolimus|mesh-list
14348316|NCT00965094|Basiliximab|basiliximab|mesh-list
14348317|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348318|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
14348319|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348320|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14348321|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348322|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348323|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348324|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14348325|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14348326|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
14348327|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348328|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230024|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15230025|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15230026|NCT05201859|Capecitabine|capecitabine|mesh-list
15230027|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230028|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
15230029|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230030|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348329|NCT00965185|Atorvastatin|atorvastatin|mesh-list
15230031|NCT05201560|Fentanyl|fentanyl|mesh-list
15230032|NCT05201560|Butorphanol|butorphanol|mesh-list
15230033|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15230034|NCT05201560|Narcotics|narcotics|mesh-ancestor
15230035|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348330|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14348331|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14348332|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
14348333|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348334|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14348335|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14348336|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348337|NCT00965263|Cocaine|cocaine|mesh-list
14348338|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
14348339|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
14348340|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348341|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348342|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
14348343|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348344|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14348345|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14348346|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348347|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348348|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348349|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
14348350|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348351|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
14348352|NCT00965341|Testosterone|testosterone|mesh-list
14348353|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
14348354|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
14348355|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14348356|NCT00965341|Androgens|androgens|mesh-ancestor
14348357|NCT00965341|Hormones|hormones|mesh-ancestor
14348358|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348359|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348360|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14348361|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348362|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
14348363|NCT00965458|Alefacept|alefacept|mesh-list
14348364|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348365|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
14348366|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348367|NCT00965497|Citalopram|citalopram|mesh-list
14348368|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14348369|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348370|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348371|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348372|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348373|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
14348374|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348375|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14348376|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
14348377|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348378|NCT00965562|Fluoxetine|fluoxetine|mesh-list
14348379|NCT00965562|Calcium|calcium|mesh-list
14348380|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14348381|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348382|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14348383|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348384|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348385|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348386|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348387|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
14348388|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14348389|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
14348390|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348391|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14348392|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14348393|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348394|NCT00965575|Melatonin|melatonin|mesh-list
14348395|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
14348396|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348397|NCT00965575|Protective Agents|protective agents|mesh-ancestor
14348398|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230036|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230037|NCT05201560|Analgesics|analgesics|mesh-ancestor
15230038|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
15230039|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230040|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15230041|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15230042|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
15230043|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
15230044|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
15230045|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
15230046|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15230047|NCT05201352|Trifluridine|trifluridine|mesh-list
15230048|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
15230049|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230050|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
15230051|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348399|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348400|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14348401|NCT00965731|Crizotinib|crizotinib|mesh-list
14348402|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348403|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14348404|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348405|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348406|NCT00965848|Doripenem|doripenem|mesh-list
14348407|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348408|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348409|NCT00966277|Dalteparin|dalteparin|mesh-list
14348410|NCT00966277|Tinzaparin|tinzaparin|mesh-list
14348411|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14348412|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
14348413|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14348414|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14348415|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348416|NCT00966355|Octreotide|octreotide|mesh-list
14348417|NCT00966355|Terlipressin|terlipressin|mesh-list
14348418|NCT00966355|Somatostatin|somatostatin|mesh-list
14348419|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14348420|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14348421|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348422|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14348423|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14348424|NCT00966355|Hormones|hormones|mesh-ancestor
14348425|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348426|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348427|NCT00966641|Naproxen|naproxen|mesh-list
14348428|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14348429|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348430|NCT00966641|Analgesics|analgesics|mesh-ancestor
14348431|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
14348432|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348433|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348434|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14348435|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348436|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
14348437|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14348438|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348439|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348440|NCT00966693|Thalidomide|thalidomide|mesh-list
14348441|NCT00966693|Dexamethasone|dexamethasone|mesh-list
14348442|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
14348443|NCT00966693|Lenalidomide|lenalidomide|mesh-list
14348444|NCT00966693|Ichthammol|ichthammol|mesh-list
14348445|NCT00966693|BB 1101|bb 1101|mesh-list
14348446|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14348447|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
14348448|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
14348449|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348450|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348451|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731907|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14731908|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
14731909|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731910|NCT05035316|Aspirin|aspirin|mesh-list
14731911|NCT05035316|Calcium|calcium|mesh-list
14731912|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14731913|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731914|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14731915|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14731916|NCT05035316|Analgesics|analgesics|mesh-ancestor
14731917|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
14731918|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731919|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731920|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348452|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
14348453|NCT00966693|Hormones|hormones|mesh-ancestor
14348454|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348455|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14348456|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348457|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
14348458|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14348459|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14348460|NCT00966693|Growth Substances|growth substances|mesh-ancestor
14348461|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
14348462|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348463|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
14348464|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348465|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348466|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
14920178|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920179|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920180|NCT04777071|Edetic Acid|edetic acid|mesh-list
14920181|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14920182|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
14920183|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
14348467|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348468|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348469|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348470|NCT00966875|Ixekizumab|ixekizumab|mesh-list
14348471|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348472|NCT00966940|Travoprost|travoprost|mesh-list
14348473|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14348474|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14348475|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14348476|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
14348477|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14348478|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
14348479|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348480|NCT00967005|Expectorants|expectorants|mesh-ancestor
14348481|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
14348482|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14348483|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
14348484|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348485|NCT00967005|Protective Agents|protective agents|mesh-ancestor
14348486|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348487|NCT00967005|Antidotes|antidotes|mesh-ancestor
14348488|NCT00967044|Everolimus|everolimus|mesh-list
14348489|NCT00967044|Panobinostat|panobinostat|mesh-list
14348490|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348491|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348492|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
14348493|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348494|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14348495|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348496|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920184|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920185|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
14920186|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14920187|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15230052|NCT05201326|Bevacizumab|bevacizumab|mesh-list
15230053|NCT05201326|Irinotecan|irinotecan|mesh-list
15230054|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348497|NCT00967226|Prednisolone|prednisolone|mesh-list
14348498|NCT00967226|Propranolol|propranolol|mesh-list
14348499|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
14348500|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14348501|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
14348502|NCT00967226|Hormones|hormones|mesh-ancestor
14348503|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348504|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348505|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14348506|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348507|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14348508|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14348509|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
14348510|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348511|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348512|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15230055|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230056|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15230057|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15230058|NCT05201326|Growth Substances|growth substances|mesh-ancestor
14348513|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14348514|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
14348515|NCT00967330|Bevacizumab|bevacizumab|mesh-list
14348516|NCT00967330|Irinotecan|irinotecan|mesh-list
14348517|NCT00967330|Temozolomide|temozolomide|mesh-list
14348518|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348519|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348520|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14348521|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14348522|NCT00967330|Growth Substances|growth substances|mesh-ancestor
14348523|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348524|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14348525|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14348526|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14348527|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348528|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348529|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14348530|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
14348531|NCT00967369|Carboplatin|carboplatin|mesh-list
14348532|NCT00967369|Etoposide|etoposide|mesh-list
14348533|NCT00967369|Bortezomib|bortezomib|mesh-list
14348534|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
14348535|NCT00967369|Ifosfamide|ifosfamide|mesh-list
14348536|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
14348537|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
14348538|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348539|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14348540|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14348541|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14348542|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348543|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348544|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14348545|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
14348546|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
14348547|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348548|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
14348549|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
14348550|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
14348551|NCT00967499|Ondansetron|ondansetron|mesh-list
14348552|NCT00967499|Palonosetron|palonosetron|mesh-list
14920188|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
14348553|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
14348554|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
14348555|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348556|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731921|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14731922|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14731923|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731924|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14731925|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14731926|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731927|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
14731928|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
14731929|NCT05034536|Infliximab|infliximab|mesh-list
14731930|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14731931|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731932|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14920189|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15230059|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230060|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
15230061|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15230062|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15230063|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348557|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14348558|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
14348559|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348560|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14348561|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
14348562|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348563|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348564|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14348565|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14348566|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348567|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348568|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14348569|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14348570|NCT00967551|Zinc|zinc|mesh-list
14348571|NCT00967551|Trace Elements|trace elements|mesh-list
14348572|NCT00967551|Micronutrients|micronutrients|mesh-list
14348573|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348574|NCT00967616|Leucovorin|leucovorin|mesh-list
14348575|NCT00967616|Fluorouracil|fluorouracil|mesh-list
14348576|NCT00967616|Irinotecan|irinotecan|mesh-list
14348577|NCT00967616|Efatutazone|efatutazone|mesh-list
14348578|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
14348579|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
14348580|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348581|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348582|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348583|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348584|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
14348585|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348586|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14348587|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14348588|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348589|NCT00967616|Antidotes|antidotes|mesh-ancestor
14348590|NCT00967616|Protective Agents|protective agents|mesh-ancestor
14348591|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
14348592|NCT00967616|Vitamins|vitamins|mesh-ancestor
14348593|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
14348594|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
14731933|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15230064|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230065|NCT05201313|Lidocaine|lidocaine|mesh-list
15230066|NCT05201313|Mepivacaine|mepivacaine|mesh-list
15230067|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
15230068|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
15230069|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230070|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230071|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
15230072|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230073|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14731934|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348595|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14348596|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
14348597|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
15230074|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15230075|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15230076|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230077|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348598|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348599|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348600|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348601|NCT00967694|Analgesics|analgesics|mesh-ancestor
14348602|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
14348603|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348604|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14348605|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14348606|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348607|NCT00967798|Incretins|incretins|mesh-ancestor
14348608|NCT00967798|Hormones|hormones|mesh-ancestor
14348609|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348610|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14348611|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
14348612|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348613|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348614|NCT00968071|Decitabine|decitabine|mesh-list
14348615|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
14348616|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348617|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
14348618|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348619|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348620|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348621|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348622|NCT00968253|Cytarabine|cytarabine|mesh-list
14348623|NCT00968253|Dexamethasone|dexamethasone|mesh-list
14348624|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
14348625|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14348626|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14348627|NCT00968253|Prednisolone|prednisolone|mesh-list
14348628|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
14348629|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
14348630|NCT00968253|Doxorubicin|doxorubicin|mesh-list
14348631|NCT00968253|Methotrexate|methotrexate|mesh-list
14348632|NCT00968253|Vincristine|vincristine|mesh-list
14348633|NCT00968253|Everolimus|everolimus|mesh-list
14348634|NCT00968253|Lenograstim|lenograstim|mesh-list
14348635|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14348636|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
14348637|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348638|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
14348639|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348640|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348641|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14348642|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
14348643|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348644|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348645|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14348646|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14348647|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
14348648|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
14348649|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348650|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14348651|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
15230078|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
14348652|NCT00968253|Hormones|hormones|mesh-ancestor
14348653|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348654|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14348655|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14348656|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14348657|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14731935|NCT05021978|Pramoxine|pramoxine|mesh-list
14731936|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
14731937|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
14731938|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731939|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230079|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348658|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348659|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14731940|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
15230080|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230081|NCT05201066|Azacitidine|azacitidine|mesh-list
15230082|NCT05201066|Decitabine|decitabine|mesh-list
15230083|NCT05201066|Venetoclax|venetoclax|mesh-list
15230084|NCT05201066|Spartalizumab|spartalizumab|mesh-list
15230085|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348660|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
14348661|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14348662|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348663|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
14348664|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
14348665|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14348666|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14348667|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
14348668|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348669|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14348670|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
14348671|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
14348672|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
14348673|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14348674|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14348675|NCT00968253|Protective Agents|protective agents|mesh-ancestor
14348676|NCT00968539|Vaccines|vaccines|mesh-list
14348677|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
15230086|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
15230087|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230088|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230089|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230090|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15230091|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15230092|NCT05200793|Metformin|metformin|mesh-list
15230093|NCT05200793|Empagliflozin|empagliflozin|mesh-list
14348678|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348679|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
14348680|NCT00968617|Hematinics|hematinics|mesh-ancestor
15230094|NCT05200793|Linagliptin|linagliptin|mesh-list
14348681|NCT00968708|Alogliptin|alogliptin|mesh-list
14348682|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15230095|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15230096|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230097|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15230098|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230099|NCT05200793|Incretins|incretins|mesh-ancestor
15230100|NCT05200793|Hormones|hormones|mesh-ancestor
15230101|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348683|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348684|NCT00968708|Incretins|incretins|mesh-ancestor
14348685|NCT00968708|Hormones|hormones|mesh-ancestor
14348686|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348687|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14348688|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
14348689|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348690|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348691|NCT00968799|Cisplatin|cisplatin|mesh-list
14348692|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348693|NCT00968812|Metformin|metformin|mesh-list
14348694|NCT00968812|Glimepiride|glimepiride|mesh-list
14348695|NCT00968812|Canagliflozin|canagliflozin|mesh-list
14348696|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14731941|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14731942|NCT05014919|Vortioxetine|vortioxetine|mesh-list
14731943|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14731944|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14731945|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14348697|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348698|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14348699|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348700|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
14348701|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14348702|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348703|NCT00968890|Vaccines|vaccines|mesh-list
14348704|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
14348705|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348706|NCT00968968|Trastuzumab|trastuzumab|mesh-list
14348707|NCT00968968|Lapatinib|lapatinib|mesh-list
14348708|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348709|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731946|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15230102|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15230103|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
14348710|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14348711|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348712|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348713|NCT00969150|Milnacipran|milnacipran|mesh-list
14348714|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
14348715|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14348716|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348717|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348718|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348719|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348720|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348721|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
14348722|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348723|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348724|NCT00969150|Analgesics|analgesics|mesh-ancestor
14348725|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
14348726|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465119|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14465120|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465121|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465122|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465123|NCT02221349|Listerine|listerine|mesh-list
14465124|NCT02221349|Fluorides|fluorides|mesh-list
14465125|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
14465126|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
14465127|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
14465128|NCT02221349|Protective Agents|protective agents|mesh-ancestor
14465129|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465130|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14465131|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465132|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14465133|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14465134|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14465135|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465136|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465137|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
14465138|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465139|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465140|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14465141|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465142|NCT02221674|Tapentadol|tapentadol|mesh-list
14465143|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14465144|NCT02221674|Narcotics|narcotics|mesh-ancestor
14465145|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465146|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465147|NCT02221674|Analgesics|analgesics|mesh-ancestor
14465148|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
14465149|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465150|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14465151|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14465152|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465153|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465154|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
14465155|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465156|NCT02221739|Ipilimumab|ipilimumab|mesh-list
14465157|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14465158|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465159|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14465160|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465161|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
14465162|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14465163|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
14465164|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465165|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465166|NCT02222129|Bupivacaine|bupivacaine|mesh-list
14465167|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
14465168|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
14465169|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465170|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465171|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
14465172|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465173|NCT02222207|Ranibizumab|ranibizumab|mesh-list
14465174|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14348727|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14348728|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14348729|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348730|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348731|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348732|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
14348733|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348734|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348735|NCT00969709|Milnacipran|milnacipran|mesh-list
14348736|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
14348737|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14348738|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348739|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348740|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348741|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348742|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348743|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
14348744|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348745|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348746|NCT00969709|Analgesics|analgesics|mesh-ancestor
14348747|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
14348748|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348749|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14348750|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14348751|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
14348752|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348753|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14348754|NCT00969878|Antacids|antacids|mesh-ancestor
14348755|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348756|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14348757|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
14348758|NCT00970073|Tacrolimus|tacrolimus|mesh-list
14348759|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
14348760|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14348761|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348762|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
14348763|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348764|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14348765|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348766|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348767|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14348768|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348769|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14348770|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
14731947|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14731948|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731949|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14348771|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348772|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348773|NCT00970203|Vaccines|vaccines|mesh-list
14348774|NCT00970203|Androgens|androgens|mesh-list
14348775|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
14348776|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348777|NCT00970203|Hormones|hormones|mesh-ancestor
14348778|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14348779|NCT00970216|Telbivudine|telbivudine|mesh-list
14348780|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
14348781|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348782|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14348783|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348784|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348785|NCT00970268|Bromides|bromides|mesh-list
14348786|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
14348787|NCT00970281|Olanzapine|olanzapine|mesh-list
14348788|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
14348789|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
14348790|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348791|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348792|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14348793|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14348794|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14348795|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348796|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15230104|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348797|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14348798|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14348799|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348800|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348801|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348802|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
14348803|NCT00970307|Vaccines|vaccines|mesh-list
14348804|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14348805|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
14348806|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348807|NCT00970502|Celecoxib|celecoxib|mesh-list
14348808|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14348809|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348810|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14348811|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348812|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348813|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14348814|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348815|NCT00970502|Analgesics|analgesics|mesh-ancestor
14348816|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
14348817|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348818|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348819|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14348820|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348821|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14348822|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14348823|NCT00970632|Tadalafil|tadalafil|mesh-list
14348824|NCT00970632|Tamsulosin|tamsulosin|mesh-list
14348825|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
14348826|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14348827|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14348828|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348829|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348830|NCT00970632|Urological Agents|urological agents|mesh-ancestor
14348831|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14348832|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14348833|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14348834|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
14920190|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348835|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348836|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348837|NCT00970684|Gemcitabine|gemcitabine|mesh-list
14348838|NCT00970684|Bevacizumab|bevacizumab|mesh-list
14348839|NCT00970684|Docetaxel|docetaxel|mesh-list
14348840|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348841|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348842|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15230105|NCT05200663|Tamoxifen|tamoxifen|mesh-list
15230106|NCT05200663|Vitamin E|vitamin e|mesh-list
15230107|NCT05200663|Vitamins|vitamins|mesh-ancestor
15230108|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
15230109|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230110|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15230111|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
15230112|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230113|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15230114|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230115|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15230116|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15230117|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15230118|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
15230119|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230120|NCT05200663|Protective Agents|protective agents|mesh-ancestor
15230121|NCT05198531|Gemcitabine|gemcitabine|mesh-list
15230122|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230123|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230124|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
15230125|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230126|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
15230127|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230128|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348843|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14348844|NCT00970684|Growth Substances|growth substances|mesh-ancestor
14348845|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348846|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14348847|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348848|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
14348849|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348850|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
14348851|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348852|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14348853|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230129|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348854|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
14348855|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
14348856|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
14348857|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
14348858|NCT00970814|Levetiracetam|levetiracetam|mesh-list
14348859|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
14348860|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
14348861|NCT00970944|Amantadine|amantadine|mesh-list
14348862|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14348863|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14348864|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
14348865|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348866|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
14348867|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348868|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348869|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348870|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348871|NCT00970944|Analgesics|analgesics|mesh-ancestor
14348872|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
14348873|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348874|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
14348875|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14348876|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348877|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348878|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14348879|NCT00971178|Analgesics|analgesics|mesh-ancestor
14348880|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
14348881|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348882|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14348883|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14348884|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14348885|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
14348886|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348887|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348888|NCT00971243|Metformin|metformin|mesh-list
14348889|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14348890|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348891|NCT00971295|Metformin|metformin|mesh-list
14348892|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14348893|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14348894|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348895|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
14348896|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14348897|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14348898|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348899|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348900|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
14348901|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14348902|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14348903|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14348904|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14348905|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348906|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
14348907|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348908|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348909|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14348910|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348911|NCT00971633|Ondansetron|ondansetron|mesh-list
14348912|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
14348913|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
14348914|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14348915|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348916|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14348917|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
14348918|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
14731950|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14731951|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14731952|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731953|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731954|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
14731955|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14731956|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14731957|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14731958|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14731959|NCT05013892|Memantine|memantine|mesh-list
14348919|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14348920|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
14348921|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14348922|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348923|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14348924|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14348925|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14348926|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14348927|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14348928|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
14348929|NCT00971737|Trastuzumab|trastuzumab|mesh-list
14348930|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348931|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
14348932|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348933|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14348934|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14348935|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
14348936|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348937|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348938|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14348939|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348940|NCT00971789|Sirolimus|sirolimus|mesh-list
14348941|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14348942|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14348943|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14348944|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14348945|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348946|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
14731960|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14731961|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14731962|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
14731963|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14731964|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731965|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731966|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14731967|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14731968|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
14731969|NCT04998240|Paraproteins|paraproteins|mesh-list
14731970|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
14348947|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348948|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
14348949|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348950|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14348951|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348952|NCT00971841|Paclitaxel|paclitaxel|mesh-list
14348953|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14348954|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348955|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
14348956|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
14348957|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
14348958|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348959|NCT00971932|Carboplatin|carboplatin|mesh-list
14348960|NCT00971932|Fluorouracil|fluorouracil|mesh-list
14348961|NCT00971932|Cetuximab|cetuximab|mesh-list
14348962|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348963|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
14348964|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348965|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14348966|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14348967|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
14348968|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348969|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14348970|NCT00971945|Paclitaxel|paclitaxel|mesh-list
14348971|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14348972|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348973|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14348974|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14348975|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14348976|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348977|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
14348978|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14348979|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348980|NCT00972205|Paclitaxel|paclitaxel|mesh-list
14348981|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14348982|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14348983|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14348984|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
14348985|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
14348986|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
14348987|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348988|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14348989|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
14348990|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14348991|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14348992|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14348993|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14348994|NCT00972283|Insulin|insulin|mesh-list
14348995|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14348996|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
14348997|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
14348998|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14348999|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349000|NCT00972335|Bevacizumab|bevacizumab|mesh-list
14349001|NCT00972335|Everolimus|everolimus|mesh-list
14349002|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349003|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349004|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349005|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349006|NCT00972335|Growth Substances|growth substances|mesh-ancestor
14349007|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349008|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349009|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349010|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
14349011|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14349012|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14349013|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14349014|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14349015|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14349016|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
14349017|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349018|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349019|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349020|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
14349021|NCT00972439|Norinyl|norinyl|mesh-list
14349022|NCT00972439|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14349023|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
14349024|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14349025|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349026|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14349027|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14349028|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14349029|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14349030|NCT00972439|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14349031|NCT00972439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14349032|NCT00972478|Prednisone|prednisone|mesh-list
14349033|NCT00972478|Cortisone|cortisone|mesh-list
14349034|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
14349035|NCT00972478|Rituximab|rituximab|mesh-list
14349036|NCT00972478|Doxorubicin|doxorubicin|mesh-list
14349037|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14349038|NCT00972478|Vincristine|vincristine|mesh-list
14349039|NCT00972478|Vorinostat|vorinostat|mesh-list
14349040|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14349041|NCT00972478|Antibodies|antibodies|mesh-list
14349042|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
14349043|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14349044|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349045|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
14349046|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349047|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349048|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14349049|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
14349050|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349051|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731971|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14731972|NCT04994132|Dactinomycin|dactinomycin|mesh-list
14731973|NCT04994132|Cactinomycin|cactinomycin|mesh-list
14349052|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14349053|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14349054|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14349055|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14349056|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349057|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349058|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
14349059|NCT00972478|Hormones|hormones|mesh-ancestor
14349060|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349061|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14349062|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14731974|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
14731975|NCT04994132|Vincristine|vincristine|mesh-list
14731976|NCT04994132|Vinorelbine|vinorelbine|mesh-list
14731977|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14731978|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
14731979|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349063|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
14349064|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349065|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349066|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14349067|NCT00972504|Cetirizine|cetirizine|mesh-list
14349068|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14731980|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14731981|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14731982|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
14920191|NCT04767022|Paclitaxel|paclitaxel|mesh-list
15230130|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
15230131|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349069|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14349070|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14349071|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
14349072|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
14349073|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349074|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349075|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349076|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14349077|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
14349078|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349079|NCT00972595|Ondansetron|ondansetron|mesh-list
14349080|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
14349081|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
14349082|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349083|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349084|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14349085|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
14349086|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
14731983|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14731984|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14731985|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14731986|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14731987|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
15230132|NCT05184192|Gabapentin|gabapentin|mesh-list
15230133|NCT05184192|Analgesics|analgesics|mesh-ancestor
15230134|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
15230135|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230136|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230137|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
14349087|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14349088|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
14349089|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349090|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349091|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14349092|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14349093|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349094|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14349095|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14349096|NCT00972725|Chloroquine|chloroquine|mesh-list
14349097|NCT00972725|Amebicides|amebicides|mesh-ancestor
14349098|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14349099|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14349100|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349101|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
15230138|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15230139|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15230140|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349102|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230141|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15230142|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14349103|NCT00972777|Besifloxacin|besifloxacin|mesh-list
14349104|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14349105|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349106|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14349107|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14349108|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349109|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349110|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349111|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
14349112|NCT00972959|Dexamethasone|dexamethasone|mesh-list
14349113|NCT00972959|Bortezomib|bortezomib|mesh-list
14349114|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349115|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
14349116|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
14349117|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349118|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349119|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14349120|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
14349121|NCT00972959|Hormones|hormones|mesh-ancestor
14349122|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349123|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14349124|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349125|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14349126|NCT00973102|Estrogens|estrogens|mesh-list
14349127|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14349128|NCT00973102|Hormones|hormones|mesh-ancestor
14349129|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349130|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349131|NCT00973479|Golimumab|golimumab|mesh-list
14349132|NCT00973479|Methotrexate|methotrexate|mesh-list
14349133|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14349134|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
14349135|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14349136|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349137|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14349138|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
14349139|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349140|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349141|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349142|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349143|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14349144|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349145|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
14349146|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349147|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14349148|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14349149|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349150|NCT00973674|Estrogens|estrogens|mesh-list
14349151|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14349152|NCT00973674|Hormones|hormones|mesh-ancestor
14349153|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349154|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349155|NCT00973739|Lapatinib|lapatinib|mesh-list
14349156|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349157|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349158|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731988|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
15230143|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15230144|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230145|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230146|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
15230147|NCT05180214|Ketorolac|ketorolac|mesh-list
15230148|NCT05180214|Bupivacaine|bupivacaine|mesh-list
14349159|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349160|NCT00973752|Cytarabine|cytarabine|mesh-list
14349161|NCT00973752|Prednisone|prednisone|mesh-list
14349162|NCT00973752|Doxorubicin|doxorubicin|mesh-list
14349163|NCT00973752|Methotrexate|methotrexate|mesh-list
14349164|NCT00973752|Vincristine|vincristine|mesh-list
14349165|NCT00973752|Asparaginase|asparaginase|mesh-list
14349166|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
14349167|NCT00973752|Clofarabine|clofarabine|mesh-list
14349168|NCT00973752|Pegaspargase|pegaspargase|mesh-list
14349169|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14349170|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349171|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14349172|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14349173|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230149|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
15230150|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
15230151|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230152|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230153|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
15230154|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349174|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349175|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349176|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
14349177|NCT00973752|Hormones|hormones|mesh-ancestor
14349178|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349179|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349180|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14349181|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14349182|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
14349183|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14349184|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14349185|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
14349186|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349187|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14349188|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349189|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
14349190|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349191|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14349192|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
14349193|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349194|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349195|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
14349196|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349197|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349198|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14349199|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14349200|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349201|NCT00973765|Renal Agents|renal agents|mesh-ancestor
14349202|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14349203|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
14349204|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14349205|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14349206|NCT00974051|Insulin|insulin|mesh-list
14349207|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14349208|NCT00974051|Terbutaline|terbutaline|mesh-list
14349209|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
14349210|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349211|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349212|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14349213|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
14349214|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349215|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14349216|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14349217|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
14349218|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
14349219|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14349220|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14349221|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14349222|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
14349223|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349224|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349225|NCT00974090|Glimepiride|glimepiride|mesh-list
14349226|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14349227|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349228|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349229|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349230|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
14349231|NCT00974142|Cyclosporine|cyclosporine|mesh-list
14349232|NCT00974142|Cyclosporins|cyclosporins|mesh-list
14349233|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349234|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349235|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349236|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
14349237|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349238|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
15230155|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15230156|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230157|NCT05180214|Analgesics|analgesics|mesh-ancestor
15230158|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230159|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230160|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15230161|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349239|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230162|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230163|NCT05179668|Empagliflozin|empagliflozin|mesh-list
15230164|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15230165|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230166|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15230167|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230168|NCT05170893|Ubiquinone|ubiquinone|mesh-list
15230169|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
15230170|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
15230171|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349240|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349241|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349242|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14349243|NCT00974220|Fentanyl|fentanyl|mesh-list
14349244|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14349245|NCT00974220|Narcotics|narcotics|mesh-ancestor
14349246|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349247|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349248|NCT00974220|Analgesics|analgesics|mesh-ancestor
14349249|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
14349250|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349251|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14349252|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14349253|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
14349254|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
14349255|NCT00974233|Rituximab|rituximab|mesh-list
14349256|NCT00974233|Lenalidomide|lenalidomide|mesh-list
14349257|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14349258|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349259|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349260|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
14349261|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349262|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349263|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349264|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349265|NCT00974233|Growth Substances|growth substances|mesh-ancestor
14349266|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349267|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14349268|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
14349269|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349270|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14349271|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14349272|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
14349273|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349274|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349275|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14349276|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
14349277|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
14349278|NCT00974246|Hormones|hormones|mesh-ancestor
14349279|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349280|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
14349281|NCT00974350|Bupivacaine|bupivacaine|mesh-list
14349282|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
14349283|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
14349284|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349285|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349286|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
14349287|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349288|NCT00974376|Gabapentin|gabapentin|mesh-list
14349289|NCT00974376|Analgesics|analgesics|mesh-ancestor
14349290|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
14349291|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349292|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349293|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
15230172|NCT05170893|Vitamins|vitamins|mesh-ancestor
15230173|NCT05158374|Aspirin|aspirin|mesh-list
15230174|NCT05158374|Metformin|metformin|mesh-list
15230175|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15230176|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349294|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15230177|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15230178|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230179|NCT05158374|Analgesics|analgesics|mesh-ancestor
15230180|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
15230181|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349295|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14349296|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349297|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14349298|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14349299|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14349300|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349301|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349302|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
14349303|NCT00974480|Tretinoin|tretinoin|mesh-list
14349304|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349305|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
14349306|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349307|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14349308|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14349309|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349310|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
14349311|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14349312|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
14349313|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349314|NCT00974818|Mitomycins|mitomycins|mesh-list
14349315|NCT00974818|Mitomycin|mitomycin|mesh-list
14349316|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
14349317|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14349318|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349319|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
14349320|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349321|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14349322|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731989|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349323|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14349324|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
14349325|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349326|NCT00974974|Levodopa|levodopa|mesh-list
14349327|NCT00974974|Carbidopa|carbidopa|mesh-list
14349328|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14349329|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14349330|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14349331|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
14349332|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349333|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349334|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349335|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14349336|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349337|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14349338|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
14349339|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
14349340|NCT00975000|Cinacalcet|cinacalcet|mesh-list
14349341|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14349342|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349343|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15230182|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230183|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230184|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15230185|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15230186|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230187|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15230188|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14349344|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
14349345|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349346|NCT00975130|Golimumab|golimumab|mesh-list
14349347|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14349348|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14349349|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349350|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349351|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
14349352|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349353|NCT00975143|Isotretinoin|isotretinoin|mesh-list
14349354|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349355|NCT00975195|Fluticasone|fluticasone|mesh-list
14349356|NCT00975195|Xhance|xhance|mesh-list
14349357|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
14731990|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14731991|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349358|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14349359|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14731992|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14731993|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14731994|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14731995|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14731996|NCT04992312|Glucagon|glucagon|mesh-list
14731997|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14731998|NCT04992312|Hormones|hormones|mesh-ancestor
14731999|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732000|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349360|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14349361|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
14349362|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349363|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349364|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14349365|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
14349366|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349367|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14349368|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
14349369|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14349370|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
14349371|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349372|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349373|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14349374|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14349375|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14349376|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
14349377|NCT00975221|Cinacalcet|cinacalcet|mesh-list
14349378|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14349379|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349380|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14349381|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
14349382|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349383|NCT00975286|Metformin|metformin|mesh-list
14349384|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
14349385|NCT00975286|Lixisenatide|lixisenatide|mesh-list
14349386|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14349387|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349388|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349389|NCT00975416|Oxytocin|oxytocin|mesh-list
14349390|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
14349391|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14349392|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349393|NCT00975481|Alprazolam|alprazolam|mesh-list
14349394|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14349395|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349396|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349397|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14732001|NCT04988685|Sirolimus|sirolimus|mesh-list
14732002|NCT04988685|Paclitaxel|paclitaxel|mesh-list
14732003|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349398|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14349399|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14349400|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
14349401|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
14349402|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349403|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465175|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14465176|NCT02222207|Growth Substances|growth substances|mesh-ancestor
14465177|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465178|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
14465179|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465180|NCT02222246|Morphine|morphine|mesh-list
14465181|NCT02222246|Hydromorphone|hydromorphone|mesh-list
14465182|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14732004|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465183|NCT02222246|Narcotics|narcotics|mesh-ancestor
14349404|NCT00975637|Brodalumab|brodalumab|mesh-list
14349405|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14349406|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349407|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
14349408|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349409|NCT00975650|Testosterone|testosterone|mesh-list
14349410|NCT00975650|Androgens|androgens|mesh-ancestor
14349411|NCT00975650|Hormones|hormones|mesh-ancestor
14349412|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349413|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349414|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
14349415|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14349416|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
14349417|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349418|NCT00975689|Expectorants|expectorants|mesh-ancestor
14349419|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
14349420|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14349421|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
14349422|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349423|NCT00975689|Protective Agents|protective agents|mesh-ancestor
14349424|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349425|NCT00975689|Antidotes|antidotes|mesh-ancestor
14349426|NCT00975806|Lenalidomide|lenalidomide|mesh-list
14349427|NCT00975806|Sunitinib|sunitinib|mesh-list
14349428|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
14349429|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349430|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349431|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349432|NCT00975806|Growth Substances|growth substances|mesh-ancestor
14349433|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349434|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349435|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349436|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349437|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349438|NCT00975975|Basiliximab|basiliximab|mesh-list
14349439|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349440|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
14349441|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349442|NCT00976027|Vaccines|vaccines|mesh-list
14349443|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
14349444|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349445|NCT00976183|Vorinostat|vorinostat|mesh-list
14349446|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349447|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14349448|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349449|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349450|NCT00976209|Phenylephrine|phenylephrine|mesh-list
14349451|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
14349452|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14349453|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
14349454|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
14349455|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349456|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349457|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
14349458|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14349459|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
14349460|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14349461|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14349462|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14349463|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14349464|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14349465|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349466|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349467|NCT00976209|Protective Agents|protective agents|mesh-ancestor
14349468|NCT00976248|Everolimus|everolimus|mesh-list
14349469|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349470|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349471|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
14349472|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349473|NCT00976391|Insulin|insulin|mesh-list
14349474|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14349475|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
14349476|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
14349477|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
14349478|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349479|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349480|NCT00976391|Incretins|incretins|mesh-ancestor
14349481|NCT00976391|Hormones|hormones|mesh-ancestor
14349482|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349483|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
14349484|NCT00976404|Maraviroc|maraviroc|mesh-list
14349485|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14349486|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14349487|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
14349488|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349489|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14349490|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14349491|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349492|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349493|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14349494|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14349495|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14349496|NCT00976456|Bevacizumab|bevacizumab|mesh-list
14349497|NCT00976456|Carboplatin|carboplatin|mesh-list
14349498|NCT00976456|Pemetrexed|pemetrexed|mesh-list
14349499|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349500|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349501|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349502|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349503|NCT00976456|Growth Substances|growth substances|mesh-ancestor
14349504|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349505|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349506|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349507|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349508|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14349509|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14349510|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
14349511|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14349512|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14349513|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349514|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349515|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349516|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14349517|NCT00976495|Diuretics|diuretics|mesh-ancestor
14349518|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
14349519|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14349520|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14349521|NCT00976521|Abciximab|abciximab|mesh-list
14349522|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
14349523|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14349524|NCT00976573|Paclitaxel|paclitaxel|mesh-list
14349525|NCT00976573|Bevacizumab|bevacizumab|mesh-list
14349526|NCT00976573|Carboplatin|carboplatin|mesh-list
14349527|NCT00976573|Everolimus|everolimus|mesh-list
15230189|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230190|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
15230191|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
15230192|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15230193|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
15230194|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230195|NCT05074121|Expectorants|expectorants|mesh-ancestor
15230196|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
15230197|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14349528|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349529|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349530|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
14349531|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349532|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349533|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349534|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349535|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349536|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349537|NCT00976573|Growth Substances|growth substances|mesh-ancestor
14349538|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349539|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349540|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349541|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
14349542|NCT00976599|Methotrexate|methotrexate|mesh-list
14349543|NCT00976599|Tofacitinib|tofacitinib|mesh-list
14349544|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14732005|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732006|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
14732007|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732008|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732009|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14732010|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732011|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14732012|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
14349545|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
14732013|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349546|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14349547|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349548|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14349549|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
15230198|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
15230199|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732014|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
15230200|NCT05074121|Protective Agents|protective agents|mesh-ancestor
15230201|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230202|NCT05074121|Antidotes|antidotes|mesh-ancestor
14349550|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349551|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349552|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349553|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349554|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14349555|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349556|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
14349557|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349558|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14349559|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349560|NCT00976677|Paclitaxel|paclitaxel|mesh-list
14349561|NCT00976677|Bevacizumab|bevacizumab|mesh-list
14349562|NCT00976677|Carboplatin|carboplatin|mesh-list
14349563|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14349564|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14349565|NCT00976677|Antibodies|antibodies|mesh-list
14349566|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
14349567|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14349568|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349569|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349570|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14349571|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349572|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349573|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349574|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349575|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349576|NCT00976677|Growth Substances|growth substances|mesh-ancestor
14349577|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349578|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349579|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
14349580|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349581|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349582|NCT00976716|Celecoxib|celecoxib|mesh-list
14349583|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14349584|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14349585|NCT00976716|Analgesics|analgesics|mesh-ancestor
14349586|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
14349587|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349588|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349589|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349590|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349591|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14349592|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14349593|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349594|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349595|NCT00976911|Paclitaxel|paclitaxel|mesh-list
14349596|NCT00976911|Bevacizumab|bevacizumab|mesh-list
14349597|NCT00976911|Doxorubicin|doxorubicin|mesh-list
14349598|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14349599|NCT00976911|Topotecan|topotecan|mesh-list
14349600|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349601|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349602|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14349603|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349604|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349605|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349606|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349607|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349608|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349609|NCT00976911|Growth Substances|growth substances|mesh-ancestor
14349610|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349611|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349612|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14349613|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14349614|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14349615|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349616|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14349617|NCT00976937|Metformin|metformin|mesh-list
14349618|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14349619|NCT00976937|Lixisenatide|lixisenatide|mesh-list
14349620|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349621|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349622|NCT00976937|Incretins|incretins|mesh-ancestor
14349623|NCT00976937|Hormones|hormones|mesh-ancestor
14349624|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349625|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14349626|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
14349627|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349628|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349629|NCT00976950|Ritonavir|ritonavir|mesh-list
14349630|NCT00976950|Tipranavir|tipranavir|mesh-list
14349631|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14349632|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14349633|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
14349634|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349635|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349636|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14349637|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14349638|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
14349639|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349640|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14349641|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14349642|NCT00976989|Docetaxel|docetaxel|mesh-list
14349643|NCT00976989|Trastuzumab|trastuzumab|mesh-list
14349644|NCT00976989|Pertuzumab|pertuzumab|mesh-list
14349645|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349646|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
14349647|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349648|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349649|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349650|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349651|NCT00977080|Cinacalcet|cinacalcet|mesh-list
14349652|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14349653|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349654|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14349655|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
14349656|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14349657|NCT00977171|Droxidopa|droxidopa|mesh-list
14349658|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14349659|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14349660|NCT00977197|Pregabalin|pregabalin|mesh-list
14349661|NCT00977197|Analgesics|analgesics|mesh-ancestor
14349662|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
14349663|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349664|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732015|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732016|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
14732017|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14732018|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
14732019|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732020|NCT04987775|Expectorants|expectorants|mesh-ancestor
14732021|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14732022|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14732023|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
14732024|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732025|NCT04987775|Protective Agents|protective agents|mesh-ancestor
14732026|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732027|NCT04987775|Antidotes|antidotes|mesh-ancestor
14732028|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
14732029|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14732030|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
14732031|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732032|NCT04982146|Expectorants|expectorants|mesh-ancestor
14732033|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
14732034|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14349665|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
14349666|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14349667|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14349668|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349669|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14349670|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14349671|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14349672|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349673|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14349674|NCT00977379|Capecitabine|capecitabine|mesh-list
14349675|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14349676|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
14349677|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349678|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732035|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
15230203|NCT05069012|Morphine|morphine|mesh-list
15230204|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15230205|NCT05069012|Narcotics|narcotics|mesh-ancestor
15230206|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230207|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230208|NCT05069012|Analgesics|analgesics|mesh-ancestor
15230209|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
15230210|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230211|NCT05049343|Ketamine|ketamine|mesh-list
15230212|NCT05049343|Analgesics|analgesics|mesh-ancestor
15230213|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
15230214|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230215|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230216|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15230217|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15230218|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
15230219|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
15230220|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349679|NCT00977431|Temozolomide|temozolomide|mesh-list
14349680|NCT00977431|Afatinib|afatinib|mesh-list
14349681|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14349682|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
14349683|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349684|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349685|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349686|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349687|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
14349688|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14349689|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349690|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349691|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349692|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349693|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
14349694|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14349695|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14349696|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349697|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349698|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14349699|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349700|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349701|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349702|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349703|NCT00977561|Cisplatin|cisplatin|mesh-list
14349704|NCT00977561|Carboplatin|carboplatin|mesh-list
14349705|NCT00977561|Etoposide|etoposide|mesh-list
14349706|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
14349707|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349708|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349709|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14349710|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15230221|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15230222|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14349711|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349712|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349713|NCT00977665|Rasagiline|rasagiline|mesh-list
14349714|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14349715|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349716|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349717|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14349718|NCT00977665|Protective Agents|protective agents|mesh-ancestor
14349719|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349720|NCT00977691|Sirolimus|sirolimus|mesh-list
14349721|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
14349722|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
14349723|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349724|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
14349725|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349726|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349727|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14349728|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
14349729|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349730|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349731|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14349732|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14349733|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349734|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14349735|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
14349736|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349737|NCT00977769|Oxytocin|oxytocin|mesh-list
14349738|NCT00977769|Carbetocin|carbetocin|mesh-list
14349739|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
14349740|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14349741|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349742|NCT00977938|Aspirin|aspirin|mesh-list
14349743|NCT00977938|Clopidogrel|clopidogrel|mesh-list
14349744|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14349745|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14349746|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14349747|NCT00977938|Analgesics|analgesics|mesh-ancestor
14349748|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
14349749|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349750|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349751|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349752|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349753|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14349754|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14349755|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349756|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15230223|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230224|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230225|NCT05041322|Buspirone|buspirone|mesh-list
15230226|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15230227|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15230228|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230229|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230230|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15230231|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15230232|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
15230233|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230234|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230235|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15230236|NCT05028673|Antacids|antacids|mesh-list
14349757|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14349758|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230237|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
15230238|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15230239|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
15230240|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230241|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230242|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15230243|NCT05023512|Vaccines|vaccines|mesh-list
15230244|NCT05023512|Immunologic Factors|immunologic factors|mesh-ancestor
15230245|NCT05023512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230246|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15230247|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14349759|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
14349760|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14349761|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14349762|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14349763|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
14349764|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349765|NCT00978068|Ritonavir|ritonavir|mesh-list
14732036|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732037|NCT04982146|Protective Agents|protective agents|mesh-ancestor
14732038|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349766|NCT00978068|Lopinavir|lopinavir|mesh-list
14349767|NCT00978068|Nevirapine|nevirapine|mesh-list
14349768|NCT00978068|Efavirenz|efavirenz|mesh-list
14349769|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14349770|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14349771|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14349772|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
15230248|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230249|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230250|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15230251|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230252|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230253|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
15230254|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230255|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
15230256|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15230257|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15230258|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230259|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
15230260|NCT04996368|Coagulants|coagulants|mesh-ancestor
15230261|NCT04941755|Famotidine|famotidine|mesh-list
15230262|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15230263|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14349773|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349774|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349775|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14349776|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14349777|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
14349778|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349779|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14349780|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14349781|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14349782|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14349783|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14349784|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14349785|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14349786|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14732039|NCT04982146|Antidotes|antidotes|mesh-ancestor
14349787|NCT00978120|Vaccines|vaccines|mesh-list
14349788|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
14349789|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349790|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
14349791|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
14349792|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349793|NCT00978341|Pregabalin|pregabalin|mesh-list
14349794|NCT00978341|Analgesics|analgesics|mesh-ancestor
14349795|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
14349796|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349797|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349798|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
14349799|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14349800|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14349801|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349802|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14349803|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14349804|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14732040|NCT04974684|Apixaban|apixaban|mesh-list
14732041|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14732042|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
14732043|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14349805|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349806|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14349807|NCT00978432|Everolimus|everolimus|mesh-list
14349808|NCT00978432|Panobinostat|panobinostat|mesh-list
14349809|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349810|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14349811|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
14349812|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349813|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14349814|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349815|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349816|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14349817|NCT00978562|Hematinics|hematinics|mesh-ancestor
14349818|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14349819|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14349820|NCT00978627|Insulin|insulin|mesh-list
14349821|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14349822|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
14349823|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
14349824|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14349825|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
14349826|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349827|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349828|NCT00978731|Dasatinib|dasatinib|mesh-list
14349829|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349830|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349831|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349832|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349833|NCT00978757|Ketamine|ketamine|mesh-list
14349834|NCT00978757|Analgesics|analgesics|mesh-ancestor
14349835|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
14349836|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349837|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349838|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14349839|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14349840|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
14349841|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
14349842|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349843|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14349844|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14349845|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349846|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349847|NCT00979017|Bevacizumab|bevacizumab|mesh-list
14349848|NCT00979017|Irinotecan|irinotecan|mesh-list
14349849|NCT00979017|Temozolomide|temozolomide|mesh-list
14349850|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349851|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349852|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349853|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349854|NCT00979017|Growth Substances|growth substances|mesh-ancestor
14349855|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349856|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349857|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14349858|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14349859|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349860|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349861|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14349862|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
14349863|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14349864|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14349865|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14349866|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
14349867|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349868|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14349869|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14349870|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349871|NCT00979212|Paclitaxel|paclitaxel|mesh-list
14349872|NCT00979212|Carboplatin|carboplatin|mesh-list
14349873|NCT00979212|Panitumumab|panitumumab|mesh-list
14349874|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349875|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349876|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
14349877|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349878|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
14349879|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349880|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349881|NCT00979407|Vaccines|vaccines|mesh-list
14349882|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
14349883|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349884|NCT00979576|Pemetrexed|pemetrexed|mesh-list
14349885|NCT00979576|Nintedanib|nintedanib|mesh-list
14349886|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349887|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349888|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349889|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14349890|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14349891|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14349892|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14349893|NCT00979615|Azelastine|azelastine|mesh-list
14349894|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14349895|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14349896|NCT00979615|Analgesics|analgesics|mesh-ancestor
14349897|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
14349898|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349899|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349900|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14349901|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14349902|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14349903|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14349904|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14349905|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
14349906|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
14349907|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14349908|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349909|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14349910|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
14349911|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14349912|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
14349913|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14349914|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349915|NCT00979628|Insulin|insulin|mesh-list
14349916|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14349917|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
14349918|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
14349919|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349920|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349921|NCT00979654|Sifalimumab|sifalimumab|mesh-list
14349922|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
14349923|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349924|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
14349925|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14349926|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349927|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
14349928|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349929|NCT00979732|Protective Agents|protective agents|mesh-ancestor
14349930|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349931|NCT00979745|Afamelanotide|afamelanotide|mesh-list
14349932|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
14349933|NCT00979875|Insulin|insulin|mesh-list
14349934|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14349935|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
14349936|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
14349937|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
14349938|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14349939|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349940|NCT00979940|Atorvastatin|atorvastatin|mesh-list
14349941|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14349942|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14349943|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
14349944|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349945|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14349946|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14349947|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349948|NCT00979953|Oxycodone|oxycodone|mesh-list
14349949|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14349950|NCT00979953|Narcotics|narcotics|mesh-ancestor
14349951|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349952|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349953|NCT00979953|Analgesics|analgesics|mesh-ancestor
14349954|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
14349955|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349956|NCT00979992|Sunitinib|sunitinib|mesh-list
14349957|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349958|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14349959|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14349960|NCT00979992|Growth Substances|growth substances|mesh-ancestor
14349961|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349962|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
14349963|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14732044|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
14732045|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732046|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732047|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
14732048|NCT04958785|Paclitaxel|paclitaxel|mesh-list
14732049|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14732050|NCT04958785|Magrolimab|magrolimab|mesh-list
14732051|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732052|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732053|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732054|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
14349964|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349965|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349966|NCT00980044|Tramadol|tramadol|mesh-list
14349967|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15230264|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15230265|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
15230266|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
15230267|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230268|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230269|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230270|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
15230271|NCT04931641|Trace Elements|trace elements|mesh-ancestor
15230272|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
15230273|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230274|NCT04878627|Cannabidiol|cannabidiol|mesh-list
15230275|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
14349968|NCT00980044|Narcotics|narcotics|mesh-ancestor
14349969|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14349970|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349971|NCT00980044|Analgesics|analgesics|mesh-ancestor
14349972|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
14349973|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14349974|NCT00980148|Azithromycin|azithromycin|mesh-list
14349975|NCT00980148|Doxycycline|doxycycline|mesh-list
14349976|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14349977|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349978|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
14349979|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14349980|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14349981|NCT00980174|Denosumab|denosumab|mesh-list
14349982|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14349983|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14349984|NCT00980330|Ribavirin|ribavirin|mesh-list
14349985|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14349986|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
14349987|NCT00980330|Simeprevir|simeprevir|mesh-list
14349988|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
14349989|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14349990|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
14349991|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14349992|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14349993|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
14349994|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14349995|NCT00980395|Rituximab|rituximab|mesh-list
14349996|NCT00980395|Bortezomib|bortezomib|mesh-list
14349997|NCT00980395|Cladribine|cladribine|mesh-list
14349998|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14349999|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350000|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
14350001|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350002|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350003|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14465184|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465185|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465186|NCT02222246|Analgesics|analgesics|mesh-ancestor
14465187|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
14465188|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465189|NCT02222493|Infliximab|infliximab|mesh-list
14465190|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
14465191|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14465192|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465193|NCT02222558|Testosterone|testosterone|mesh-list
14465194|NCT02222558|Androgens|androgens|mesh-ancestor
14465195|NCT02222558|Hormones|hormones|mesh-ancestor
14465196|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465197|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465198|NCT02222610|Ranibizumab|ranibizumab|mesh-list
14465199|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14465200|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14465201|NCT02222610|Growth Substances|growth substances|mesh-ancestor
14465202|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465203|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
14465204|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465205|NCT02222714|Protein C|protein c|mesh-list
14465206|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
14465207|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14465208|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14465209|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465210|NCT02222870|Vaccines|vaccines|mesh-list
14465211|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
14465212|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465213|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
14465214|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14465215|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14465216|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465217|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
14465218|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
14465219|NCT02222922|Fluconazole|fluconazole|mesh-list
14465220|NCT02222922|Avelumab|avelumab|mesh-list
14465221|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14465222|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350004|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14350005|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
14350006|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
14350007|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350008|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14350009|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
14350010|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14350011|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14350012|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350013|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230276|NCT04872426|Insulin|insulin|mesh-list
15230277|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15230278|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350014|NCT00980785|Ramipril|ramipril|mesh-list
14350015|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14350016|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
14350017|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350018|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350019|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14350020|NCT00980798|Hydromorphone|hydromorphone|mesh-list
14350021|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14350022|NCT00980798|Narcotics|narcotics|mesh-ancestor
14350023|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350024|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350025|NCT00980798|Analgesics|analgesics|mesh-ancestor
14350026|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
14350027|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350028|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
14350029|NCT00980980|Mupirocin|mupirocin|mesh-list
14350030|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14350031|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350032|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
14350033|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350034|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14350035|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350036|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350037|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14350038|NCT00981045|Hematinics|hematinics|mesh-ancestor
14350039|NCT00981084|Modafinil|modafinil|mesh-list
14350040|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14350041|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350042|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14350043|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14350044|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14350045|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350046|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14350047|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14350048|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350049|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350050|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350051|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350052|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350053|NCT00981149|Analgesics|analgesics|mesh-ancestor
14350054|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
14350055|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350056|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
14350057|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14350058|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
14350059|NCT00981214|Pancrelipase|pancrelipase|mesh-list
14350060|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14350061|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14350062|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
14350063|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14350064|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14350065|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350066|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350067|NCT00981409|Heparin|heparin|mesh-list
14350068|NCT00981409|Calcium heparin|calcium heparin|mesh-list
14350069|NCT00981409|PENTA|penta|mesh-list
14350070|NCT00981409|Fondaparinux|fondaparinux|mesh-list
14350071|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
14350072|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14350073|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14350074|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350075|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14350076|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
14350077|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14350078|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
14350079|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350080|NCT00981435|Prednisolone|prednisolone|mesh-list
14350081|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
14350082|NCT00981435|Ketorolac|ketorolac|mesh-list
14350083|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
14350084|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14350085|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
14350086|NCT00981435|Hormones|hormones|mesh-ancestor
14350087|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14350088|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350089|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14350090|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350091|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350092|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14465223|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
14350093|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14350094|NCT00981435|Analgesics|analgesics|mesh-ancestor
14350095|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
14350096|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350097|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14350098|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350099|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350100|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14350101|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14350102|NCT00981526|Telmisartan|telmisartan|mesh-list
14350103|NCT00981526|Olanzapine|olanzapine|mesh-list
14350104|NCT00981526|Clozapine|clozapine|mesh-list
14350105|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
14350106|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
14350107|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350108|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350109|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14350110|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14350111|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14350112|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350113|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14350114|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14350115|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350116|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350117|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350118|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350119|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
14350120|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14350121|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14350122|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14350123|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14350124|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
14350125|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
14350126|NCT00981669|Vaccines|vaccines|mesh-list
14350127|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
14350128|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350129|NCT00981747|Losartan|losartan|mesh-list
14350130|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
14350131|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14350132|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14350133|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14350134|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14350135|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350136|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
14350137|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14350138|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14350139|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350140|NCT00981747|Urological Agents|urological agents|mesh-ancestor
14350141|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
14350142|NCT00981799|Methotrexate|methotrexate|mesh-list
14350143|NCT00981799|Etoposide|etoposide|mesh-list
14350144|NCT00981799|Lenograstim|lenograstim|mesh-list
14350145|NCT00981799|Sargramostim|sargramostim|mesh-list
14350146|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350147|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
14350148|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350149|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350150|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14350151|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
14350152|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350153|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350154|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14350155|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14350156|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
14350157|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14350158|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14350159|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
14350160|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14350161|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350162|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14350163|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14350164|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14350165|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14350166|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14350167|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14350168|NCT00981825|Listerine|listerine|mesh-list
14350169|NCT00981825|Triclosan|triclosan|mesh-list
14350170|NCT00981825|Fluorides|fluorides|mesh-list
14350171|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
14350172|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
14350173|NCT00981825|Protective Agents|protective agents|mesh-ancestor
14350174|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350175|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14350176|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350177|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14350178|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14350179|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
14350180|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350181|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14350182|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
14350183|NCT00982007|Hematinics|hematinics|mesh-ancestor
14350184|NCT00982020|Olanzapine|olanzapine|mesh-list
14350185|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
14350186|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
14350187|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350188|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350189|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14350190|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14350191|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14350192|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350193|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14350194|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14350195|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14732055|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732056|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732057|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14350196|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350197|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350198|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350199|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
14350200|NCT00982072|Prednisolone|prednisolone|mesh-list
14350201|NCT00982072|Tacrolimus|tacrolimus|mesh-list
14350202|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350203|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
14350204|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350205|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14350206|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350207|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350208|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14350209|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
14350210|NCT00982072|Hormones|hormones|mesh-ancestor
14350211|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14350212|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14350213|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350214|NCT00982189|Lisinopril|lisinopril|mesh-list
14350215|NCT00982189|Pravastatin|pravastatin|mesh-list
14350216|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14350217|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14350218|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
14350219|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350220|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14350221|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14350222|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350223|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14350224|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
14350225|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14350226|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14350227|NCT00982189|Protective Agents|protective agents|mesh-ancestor
14350228|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350229|NCT00982228|Insulin|insulin|mesh-list
14350230|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14350231|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
14350232|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
14350233|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14350234|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350235|NCT00982280|Tapentadol|tapentadol|mesh-list
14350236|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14732058|NCT04958226|Midazolam|midazolam|mesh-list
14350237|NCT00982280|Narcotics|narcotics|mesh-ancestor
14350238|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350239|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350240|NCT00982280|Analgesics|analgesics|mesh-ancestor
14350241|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
14350242|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350243|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14350244|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350245|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350246|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350247|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
14350248|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350249|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14350250|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
14350251|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14350252|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14350253|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14350254|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350255|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350256|NCT00982423|Furosemide|furosemide|mesh-list
14350257|NCT00982423|Diuretics|diuretics|mesh-ancestor
14350258|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
14350259|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350260|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14350261|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350262|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350263|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
14350264|NCT00982488|Dasatinib|dasatinib|mesh-list
14350265|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350266|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14350267|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350268|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350269|NCT00982553|Ribavirin|ribavirin|mesh-list
14350270|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
14350271|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
14350272|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350273|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
14350274|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350275|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14350276|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15230279|NCT04856176|Paclitaxel|paclitaxel|mesh-list
15230280|NCT04856176|Carboplatin|carboplatin|mesh-list
15230281|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
15230282|NCT04856176|Pemetrexed|pemetrexed|mesh-list
15230283|NCT04856176|Molgramostim|molgramostim|mesh-list
15230284|NCT04856176|Sargramostim|sargramostim|mesh-list
15230285|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15230286|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230287|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
15230288|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
15230289|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350277|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14350278|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14350279|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350280|NCT00982592|Leucovorin|leucovorin|mesh-list
14350281|NCT00982592|Fluorouracil|fluorouracil|mesh-list
14350282|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
15230290|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230291|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230292|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230293|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15230294|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15230295|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
15230296|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230297|NCT04853043|Cetuximab|cetuximab|mesh-list
15230298|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230299|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350283|NCT00982592|Calcium|calcium|mesh-list
14350284|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
14350285|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14350286|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350287|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
14350288|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350289|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14350290|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350291|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350292|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
14350293|NCT00982592|Antidotes|antidotes|mesh-ancestor
14350294|NCT00982592|Protective Agents|protective agents|mesh-ancestor
14350295|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
14350296|NCT00982592|Vitamins|vitamins|mesh-ancestor
14350297|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
14350298|NCT00982644|Insulin|insulin|mesh-list
14350299|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14350300|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
14350301|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14350302|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350303|NCT00982657|Sunitinib|sunitinib|mesh-list
14350304|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350305|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14350306|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14350307|NCT00982657|Growth Substances|growth substances|mesh-ancestor
14350308|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350309|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14350310|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14350311|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350312|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350313|NCT00982865|Niacinamide|niacinamide|mesh-list
14350314|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
14350315|NCT00982865|Vitamins|vitamins|mesh-ancestor
14350316|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
14350317|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350318|NCT00982878|Maraviroc|maraviroc|mesh-list
14350319|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14350320|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14350321|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350322|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14350323|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14350324|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
14350325|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350326|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14350327|NCT00982930|Tobramycin|tobramycin|mesh-list
14350328|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350329|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350330|NCT00983073|Tapentadol|tapentadol|mesh-list
14350331|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14350332|NCT00983073|Narcotics|narcotics|mesh-ancestor
14350333|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350334|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350335|NCT00983073|Analgesics|analgesics|mesh-ancestor
14350336|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
14350337|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350338|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14350339|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350340|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350341|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350342|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
14350343|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350344|NCT00983216|Ketoconazole|ketoconazole|mesh-list
14350345|NCT00983216|Colchicine|colchicine|mesh-list
14350346|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
14350347|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350348|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350349|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350350|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350351|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350352|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350353|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
14350354|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350355|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14350356|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14350357|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350358|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14350359|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
14350360|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14350361|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350362|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14350363|NCT00983242|Colchicine|colchicine|mesh-list
14350364|NCT00983242|Verapamil|verapamil|mesh-list
14350365|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
14350366|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350367|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350368|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350369|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350370|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350371|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350372|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14350373|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14350374|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350375|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14350376|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350377|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
14350378|NCT00983294|Azithromycin|azithromycin|mesh-list
14350379|NCT00983294|Colchicine|colchicine|mesh-list
14350380|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350381|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350382|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
14350383|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350384|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350385|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350386|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350387|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350388|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350389|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14350390|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350391|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14350392|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350393|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350394|NCT00983346|Bortezomib|bortezomib|mesh-list
14350395|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350396|NCT00983372|Colchicine|colchicine|mesh-list
14350397|NCT00983372|Diltiazem|diltiazem|mesh-list
15230300|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
14920192|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14350398|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
14350399|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350400|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350401|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350402|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350403|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350404|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350405|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14350406|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14350407|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350408|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14350409|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350410|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
14350411|NCT00983385|Tapentadol|tapentadol|mesh-list
14350412|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14350413|NCT00983385|Narcotics|narcotics|mesh-ancestor
14350414|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350415|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350416|NCT00983385|Analgesics|analgesics|mesh-ancestor
14350417|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
14350418|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350419|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14350420|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350421|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350422|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350423|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
14350424|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350425|NCT00983515|Ritonavir|ritonavir|mesh-list
14350426|NCT00983515|Colchicine|colchicine|mesh-list
14350427|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14350428|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14350429|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
14350430|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732059|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14732060|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14732061|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732062|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732063|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14732064|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14732065|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14732066|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14350431|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350432|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14350433|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14350434|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
14350435|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350436|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14350437|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14350438|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
15230301|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15230302|NCT04800627|Pevonedistat|pevonedistat|mesh-list
15230303|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230304|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230305|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230306|NCT04792073|Avelumab|avelumab|mesh-list
15230307|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230308|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350439|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350440|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350441|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350442|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350443|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350444|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
14350445|NCT00983528|Clofarabine|clofarabine|mesh-list
14350446|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14350447|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350448|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14350449|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
14350450|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350451|NCT00983541|Gemcitabine|gemcitabine|mesh-list
14350452|NCT00983541|Fluorouracil|fluorouracil|mesh-list
14350453|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14350454|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
14350455|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350456|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350457|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
14350458|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350459|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350460|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350461|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
14350462|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350463|NCT00983580|Aspirin|aspirin|mesh-list
14350464|NCT00983580|Eflornithine|eflornithine|mesh-list
14350465|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14350466|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14350467|NCT00983580|Analgesics|analgesics|mesh-ancestor
14350468|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
14350469|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350470|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350471|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14350472|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350473|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14350474|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14350475|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350476|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14350477|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14350478|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350479|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
14350480|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350481|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14350482|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14350483|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14732067|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
14732068|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
14732069|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
14732070|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
14732071|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732072|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732073|NCT04956692|Paclitaxel|paclitaxel|mesh-list
14732074|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14732075|NCT04956692|Carboplatin|carboplatin|mesh-list
14732076|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
14732077|NCT04956692|Pemetrexed|pemetrexed|mesh-list
14350484|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350485|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14732078|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732079|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732080|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732081|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
14732082|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732083|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732084|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732085|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350486|NCT00983619|Rituximab|rituximab|mesh-list
14350487|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732086|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15230309|NCT04782687|Dexamethasone|dexamethasone|mesh-list
15230310|NCT04782687|Lenalidomide|lenalidomide|mesh-list
15230311|NCT04782687|Daratumumab|daratumumab|mesh-list
15230312|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230313|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
15230314|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
15230315|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230316|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230317|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15230318|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
15230319|NCT04782687|Hormones|hormones|mesh-ancestor
15230320|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230321|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15230322|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230323|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
15230324|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15230325|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14350488|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350489|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
14350490|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350491|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350492|NCT00983853|Ribavirin|ribavirin|mesh-list
14350493|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14350494|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
14350495|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350496|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
14350497|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350498|NCT00983905|Colchicine|colchicine|mesh-list
14350499|NCT00983905|Theophylline|theophylline|mesh-list
14350500|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
14350501|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350502|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350503|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350504|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350505|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350506|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350507|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14350508|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
14350509|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350510|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350511|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14350512|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
14350513|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14350514|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350515|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
14350516|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14350517|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14920193|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14920194|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350518|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
14350519|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920195|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14920196|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350520|NCT00983918|Propofol|propofol|mesh-list
14350521|NCT00983918|Sevoflurane|sevoflurane|mesh-list
14350522|NCT00983918|Desflurane|desflurane|mesh-list
14350523|NCT00983918|Isoflurane|isoflurane|mesh-list
14350524|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14350525|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350526|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350527|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14350528|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
14350529|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
14350530|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14350531|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14350532|NCT00983931|Cyclosporine|cyclosporine|mesh-list
14350533|NCT00983931|Colchicine|colchicine|mesh-list
14350534|NCT00983931|Cyclosporins|cyclosporins|mesh-list
14350535|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350536|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350537|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350538|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
14350539|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350540|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
14920197|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350541|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350542|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
14350543|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930936|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350544|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14350545|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
14350546|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350547|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350548|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350549|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350550|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
14350551|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14350552|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14350553|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
14350554|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14350555|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350556|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14350557|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14350558|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14350559|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350560|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350561|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14350562|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14350563|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350564|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350565|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350566|NCT00984009|Colchicine|colchicine|mesh-list
14350567|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
14350568|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350569|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350570|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350571|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350572|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350573|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350574|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14350575|NCT00984022|Laxatives|laxatives|mesh-ancestor
14350576|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14350577|NCT00984061|Clarithromycin|clarithromycin|mesh-list
14350578|NCT00984061|Colchicine|colchicine|mesh-list
14350579|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350580|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350581|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14350582|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350583|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350584|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14350585|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14350586|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
14350587|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350588|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350589|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350590|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350591|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350592|NCT00984126|Factor VIII|factor viii|mesh-list
14350593|NCT00984126|Coagulants|coagulants|mesh-ancestor
14350594|NCT00984139|Vaccines|vaccines|mesh-list
14350595|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
14350596|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350597|NCT00984256|Atovaquone|atovaquone|mesh-list
14350598|NCT00984256|Proguanil|proguanil|mesh-list
14350599|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14350600|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350601|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
14350602|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14350603|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14350604|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350605|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350606|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
14350607|NCT00984282|Sorafenib|sorafenib|mesh-list
14350608|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350609|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14350610|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350611|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350612|NCT00984334|Naloxone|naloxone|mesh-list
14350613|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14350614|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350615|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
14350616|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350617|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15230326|NCT04782687|Growth Substances|growth substances|mesh-ancestor
15230327|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
15230328|NCT04742673|Guanfacine|guanfacine|mesh-list
15230329|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15230330|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15230331|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15230332|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15230333|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
15230334|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230335|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230336|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230337|NCT04734990|Azacitidine|azacitidine|mesh-list
15230338|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230339|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
14350618|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14350619|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
14350620|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350621|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350622|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14350623|NCT00984568|Prednisolone|prednisolone|mesh-list
14350624|NCT00984568|Mesalamine|mesalamine|mesh-list
14350625|NCT00984568|Azathioprine|azathioprine|mesh-list
14350626|NCT00984568|Infliximab|infliximab|mesh-list
14350627|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14350628|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
14350629|NCT00984568|Hormones|hormones|mesh-ancestor
14350630|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14350631|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350632|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14350633|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350634|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350635|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14350636|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
14350637|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350638|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
14350639|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350640|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14350641|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350642|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
14350643|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
14350644|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350645|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350646|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14350647|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14350648|NCT00984568|Analgesics|analgesics|mesh-ancestor
14350649|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
14350650|NCT00984620|Interferons|interferons|mesh-list
14350651|NCT00984620|Ribavirin|ribavirin|mesh-list
14350652|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
14350653|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350654|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
14350655|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350656|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
14350657|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350658|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
14350659|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350660|NCT00984659|Fluticasone|fluticasone|mesh-list
14350661|NCT00984659|Xhance|xhance|mesh-list
14350662|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14350663|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14350664|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14350665|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
14350666|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350667|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350668|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14350669|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
14350670|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
14350671|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14350672|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14350673|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14350674|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14350675|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
14350676|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350677|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350678|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
14350679|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14350680|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350681|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14350682|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350683|NCT00985192|Everolimus|everolimus|mesh-list
14350684|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350685|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350686|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
14350687|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350688|NCT00985426|Vaccines|vaccines|mesh-list
14350689|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
14350690|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350691|NCT00985439|Celecoxib|celecoxib|mesh-list
14350692|NCT00985439|Diclofenac|diclofenac|mesh-list
14350693|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14350694|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14350695|NCT00985439|Analgesics|analgesics|mesh-ancestor
14350696|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
14350697|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350698|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350699|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14350700|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350701|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14350702|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14350703|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350704|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350705|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14350706|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
14350707|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350708|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14350709|NCT00985504|Citalopram|citalopram|mesh-list
14350710|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14350711|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350712|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350713|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350714|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350715|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
14350716|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350717|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14350718|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
14350719|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14350720|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350721|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14350722|NCT00985504|Analgesics|analgesics|mesh-ancestor
14350723|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
14350724|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
14350725|NCT00985543|Ritonavir|ritonavir|mesh-list
14350726|NCT00985543|Lopinavir|lopinavir|mesh-list
14350727|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14350728|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14350729|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
14350730|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350731|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350732|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14350733|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14350734|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
14350735|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350736|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14350737|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14350738|NCT00985621|Oxycodone|oxycodone|mesh-list
14350739|NCT00985621|Tanezumab|tanezumab|mesh-list
14350740|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14350741|NCT00985621|Narcotics|narcotics|mesh-ancestor
14350742|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350743|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350744|NCT00985621|Analgesics|analgesics|mesh-ancestor
14920198|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920199|NCT04760912|Bromides|bromides|mesh-list
14920200|NCT04760912|Anesthetics|anesthetics|mesh-list
14920201|NCT04760912|Rocuronium|rocuronium|mesh-list
14920202|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920203|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920204|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
14920205|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14920206|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14920207|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14350745|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
14350746|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350747|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
14350748|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14350749|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350750|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14350751|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14350752|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350753|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14350754|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350755|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350756|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350757|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
14350758|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350759|NCT00985751|Vaccines|vaccines|mesh-list
14350760|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14350761|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
14350762|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350763|NCT00985907|Bortezomib|bortezomib|mesh-list
14350764|NCT00985907|Melphalan|melphalan|mesh-list
14350765|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14350766|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350767|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14350768|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
14350769|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350770|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15230340|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230341|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230342|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350771|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350772|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
14350773|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350774|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14350775|NCT00985946|Panobinostat|panobinostat|mesh-list
14350776|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350777|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14350778|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350779|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350780|NCT00985959|Prednisolone|prednisolone|mesh-list
14350781|NCT00985959|Bortezomib|bortezomib|mesh-list
14350782|NCT00985959|Melphalan|melphalan|mesh-list
15230343|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
15230344|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230345|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230346|NCT04704271|Dronabinol|dronabinol|mesh-list
15230347|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
15230348|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350783|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350784|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14350785|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
14350786|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350787|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14350788|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230349|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15230350|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230351|NCT04704271|Analgesics|analgesics|mesh-ancestor
15230352|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
15230353|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230354|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14350789|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
14350790|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350791|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14350792|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
14350793|NCT00985959|Hormones|hormones|mesh-ancestor
14350794|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14350795|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15230355|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15230356|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230357|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350796|NCT00985985|Nicotine|nicotine|mesh-list
14350797|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14350798|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
14350799|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350800|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350801|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14350802|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14350803|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
14350804|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350805|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350806|NCT00986102|Doripenem|doripenem|mesh-list
14350807|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350808|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350809|NCT00986154|Heparin|heparin|mesh-list
14350810|NCT00986154|Calcium heparin|calcium heparin|mesh-list
14350811|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14350812|NCT00986154|Tinzaparin|tinzaparin|mesh-list
14350813|NCT00986154|Dalteparin|dalteparin|mesh-list
14350814|NCT00986154|Warfarin|warfarin|mesh-list
14350815|NCT00986154|Edoxaban|edoxaban|mesh-list
14350816|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
14350817|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14350818|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14350819|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350820|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14350821|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
14350822|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14350823|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14350824|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350825|NCT00986180|Oxycodone|oxycodone|mesh-list
14350826|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14350827|NCT00986180|Narcotics|narcotics|mesh-ancestor
14350828|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350829|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350830|NCT00986180|Analgesics|analgesics|mesh-ancestor
14350831|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
14350832|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350833|NCT00986245|Ropinirole|ropinirole|mesh-list
14350834|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14350835|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14350836|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
14920208|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920209|NCT04760691|Tenofovir|tenofovir|mesh-list
14920210|NCT04760691|Emtricitabine|emtricitabine|mesh-list
14920211|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14920212|NCT04760691|Leuprolide|leuprolide|mesh-list
14350837|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
14350838|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350839|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350840|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350841|NCT00986258|Tapentadol|tapentadol|mesh-list
14350842|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14350843|NCT00986258|Narcotics|narcotics|mesh-ancestor
14350844|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350845|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350846|NCT00986258|Analgesics|analgesics|mesh-ancestor
14350847|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
14350848|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350849|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14350850|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14350851|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350852|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350853|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
14350854|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350855|NCT00986401|Metformin|metformin|mesh-list
14350856|NCT00986401|Trospium chloride|trospium chloride|mesh-list
14350857|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14350858|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350859|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
14350860|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
14350861|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350862|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14350863|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14350864|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
14350865|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14350866|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350867|NCT00986401|Urological Agents|urological agents|mesh-ancestor
14350868|NCT00986427|Cyclosporine|cyclosporine|mesh-list
14350869|NCT00986427|Cyclosporins|cyclosporins|mesh-list
14350870|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350871|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350872|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350873|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
14350874|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350875|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
14350876|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350877|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
14350878|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350879|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14350880|NCT00986440|Efatutazone|efatutazone|mesh-list
14350881|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350882|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
14350883|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14350884|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14350885|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14350886|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14350887|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350888|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
14350889|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230358|NCT04704271|Hormones|hormones|mesh-ancestor
15230359|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230360|NCT04604782|Regadenoson|regadenoson|mesh-list
15230361|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15230362|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14350890|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350891|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14350892|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350893|NCT00986583|Succinylcholine|succinylcholine|mesh-list
14350894|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14350895|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14350896|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14350897|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14350898|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350899|NCT00986674|Paclitaxel|paclitaxel|mesh-list
14350900|NCT00986674|Carboplatin|carboplatin|mesh-list
14350901|NCT00986674|Cetuximab|cetuximab|mesh-list
14350902|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14350903|NCT00986674|Antibodies|antibodies|mesh-list
14350904|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
14350905|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14350906|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14350907|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350908|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14350909|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14350910|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14350911|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350912|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
14350913|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350914|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
14350915|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14350916|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732087|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14732088|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
15230363|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
15230364|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
14350917|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14350918|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350919|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350920|NCT00986921|Mifepristone|mifepristone|mesh-list
14350921|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14350922|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
14350923|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14350924|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350925|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14350926|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14350927|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14350928|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
14350929|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14350930|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14350931|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
14350932|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14350933|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
14350934|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14350935|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14350936|NCT00986986|Niacin|niacin|mesh-list
14350937|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14350938|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
14350939|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350940|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14350941|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
14350942|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
14350943|NCT00986986|Vitamins|vitamins|mesh-ancestor
14350944|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
14350945|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350946|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
14350947|NCT00987389|Hormones|hormones|mesh-ancestor
14350948|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732089|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732090|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732091|NCT04924257|Esketamine|esketamine|mesh-list
14350949|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350950|NCT00987402|Ethanol|ethanol|mesh-list
14350951|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14350952|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350953|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14350954|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350955|NCT00987415|Allopurinol|allopurinol|mesh-list
14350956|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
14350957|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350958|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350959|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
14350960|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350961|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14350962|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
14350963|NCT00987415|Protective Agents|protective agents|mesh-ancestor
14350964|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350965|NCT00987467|Cyclosporine|cyclosporine|mesh-list
14350966|NCT00987467|Cyclosporins|cyclosporins|mesh-list
14350967|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350968|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350969|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350970|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
14350971|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350972|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
14350973|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350974|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
14350975|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350976|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14350977|NCT00987480|Cyclosporine|cyclosporine|mesh-list
14350978|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
14350979|NCT00987480|Busulfan|busulfan|mesh-list
14350980|NCT00987480|Fludarabine|fludarabine|mesh-list
14350981|NCT00987480|Cyclosporins|cyclosporins|mesh-list
14350982|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14350983|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
14350984|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14350985|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14350986|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14350987|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
14350988|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14350989|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14350990|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14350991|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14350992|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
14350993|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14350994|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
14350995|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14350996|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14350997|NCT00987558|Simvastatin|simvastatin|mesh-list
14350998|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14350999|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14351000|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
14351001|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351002|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14351003|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14351004|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351005|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
14351006|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14351007|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14351008|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351009|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14351010|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
14351011|NCT00987727|Glycerol|glycerol|mesh-list
14351012|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14351013|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
14351014|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351015|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
14351016|NCT00987727|Protective Agents|protective agents|mesh-ancestor
14351017|NCT00987727|Laxatives|laxatives|mesh-ancestor
14351018|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351019|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14351020|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
14351021|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14351022|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351023|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
14351024|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
14351025|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351026|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351027|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351028|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
14351029|NCT00987831|Hormones|hormones|mesh-ancestor
14351030|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351031|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14351032|NCT00987831|Protective Agents|protective agents|mesh-ancestor
14351033|NCT00987935|Sorafenib|sorafenib|mesh-list
14351034|NCT00987935|Nintedanib|nintedanib|mesh-list
14920213|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14920214|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14920215|NCT04760691|Estradiol|estradiol|mesh-list
14351035|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351036|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14351037|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351038|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351039|NCT00987948|Maraviroc|maraviroc|mesh-list
14351040|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14351041|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14351042|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351043|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14351044|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14351045|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
14351046|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351047|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14351048|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
14351049|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14351050|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
14351051|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351052|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
14351053|NCT00988091|Protective Agents|protective agents|mesh-ancestor
14351054|NCT00988117|Rivastigmine|rivastigmine|mesh-list
14351055|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14351056|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351057|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351058|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
14351059|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351060|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351061|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14351062|NCT00988117|Protective Agents|protective agents|mesh-ancestor
14351063|NCT00988143|Vaccines|vaccines|mesh-list
14351064|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
14351065|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351066|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14920216|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14920217|NCT04760691|Estrogens|estrogens|mesh-list
14351067|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
14351068|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14351069|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14351070|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351071|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351072|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14351073|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351074|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14732092|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
14732093|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14732094|NCT04924101|Cisplatin|cisplatin|mesh-list
14920218|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
14920219|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920220|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14351075|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351076|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351077|NCT00988208|Prednisone|prednisone|mesh-list
14351078|NCT00988208|Docetaxel|docetaxel|mesh-list
14351079|NCT00988208|Lenalidomide|lenalidomide|mesh-list
14351080|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351081|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
14351082|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
14351083|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
14351084|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351085|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351086|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
14351087|NCT00988208|Hormones|hormones|mesh-ancestor
14351088|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351089|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732095|NCT04924101|Carboplatin|carboplatin|mesh-list
14732096|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
14732097|NCT04924101|Etoposide|etoposide|mesh-list
14732098|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
14732099|NCT04924101|Lenvatinib|lenvatinib|mesh-list
14732100|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732101|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732102|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15230365|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230366|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230367|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230368|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
15230369|NCT04596033|Fludarabine|fludarabine|mesh-list
15230370|NCT04596033|Interleukin-2|interleukin-2|mesh-list
15230371|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230372|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
15230373|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230374|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230375|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15230376|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
15230377|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230378|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230379|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15230380|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230381|NCT04596033|Analgesics|analgesics|mesh-ancestor
15230382|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
15230383|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230384|NCT04537806|Pregnanolone|pregnanolone|mesh-list
15230385|NCT04537806|Brexanolone|brexanolone|mesh-list
15230386|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
15230387|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230388|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230389|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
15230390|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351090|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14351091|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
14351092|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14351093|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14351094|NCT00988208|Growth Substances|growth substances|mesh-ancestor
14351095|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732103|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14732104|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14732105|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732106|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732107|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14351096|NCT00988325|Oseltamivir|oseltamivir|mesh-list
14351097|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
14351098|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351099|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351100|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351101|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14351102|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
14351103|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14351104|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14351105|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351106|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351107|NCT00988533|Ivermectin|ivermectin|mesh-list
14351108|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14351109|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351110|NCT00988559|Imiquimod|imiquimod|mesh-list
14351111|NCT00988559|Vaccines|vaccines|mesh-list
14351112|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
14351113|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351114|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14351115|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351116|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
14351117|NCT00988637|Calcitriol|calcitriol|mesh-list
14351118|NCT00988637|Clobetasol|clobetasol|mesh-list
14351119|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14351120|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351121|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14351122|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351123|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351124|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14351125|NCT00988637|Vitamins|vitamins|mesh-ancestor
14351126|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
14351127|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14351128|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351129|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
14351130|NCT00988637|Hormones|hormones|mesh-ancestor
14351131|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351132|NCT00988832|Infliximab|infliximab|mesh-list
14351133|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
14351134|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351135|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351136|NCT00988858|Pemetrexed|pemetrexed|mesh-list
14351137|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351138|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351139|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351140|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14351141|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14351142|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
14351143|NCT00989092|Hematinics|hematinics|mesh-ancestor
14351144|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14351145|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14351146|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14351147|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351148|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351149|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351150|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351151|NCT00989157|Analgesics|analgesics|mesh-ancestor
14351152|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
14351153|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351154|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
14351155|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14351156|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
14351157|NCT00989196|Factor VIII|factor viii|mesh-list
14351158|NCT00989196|Coagulants|coagulants|mesh-ancestor
14351159|NCT00989235|Abatacept|abatacept|mesh-list
14351160|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14351161|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351162|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351163|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351164|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
14351165|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351166|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351167|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14351168|NCT00989586|Veltuzumab|veltuzumab|mesh-list
14351169|NCT00989586|Antibodies|antibodies|mesh-list
14351170|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
14351171|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14351172|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
14351173|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351174|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351175|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
14351176|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351177|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
14351178|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14351179|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14351180|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14351181|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351182|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351183|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
14351184|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351185|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351186|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14351187|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351188|NCT00989781|Dexamethasone|dexamethasone|mesh-list
14351189|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14351190|NCT00989781|Hormones|hormones|mesh-list
14351191|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14351192|NCT00989781|Cosyntropin|cosyntropin|mesh-list
14351193|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14351194|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14351195|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
14351196|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351197|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
14351198|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
14351199|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351200|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351201|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351202|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
14351203|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351204|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14351205|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351206|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14351207|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351208|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351209|NCT00989833|Budesonide|budesonide|mesh-list
14351210|NCT00989833|Terbutaline|terbutaline|mesh-list
14351211|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
14351212|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351213|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14351214|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
14351215|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351216|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351217|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14351218|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
14351219|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
14351220|NCT00989833|Hormones|hormones|mesh-ancestor
14351221|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351222|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14351223|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14351224|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14351225|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
14351226|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351227|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351228|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
14351229|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
14351230|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14351231|NCT00989911|Bosentan|bosentan|mesh-list
14351232|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14351233|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14351234|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351235|NCT00989950|Methylphenidate|methylphenidate|mesh-list
14351236|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14351237|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351238|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14351239|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14351240|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351241|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351242|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
14351243|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351244|NCT00989963|Beraprost|beraprost|mesh-list
14351245|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14351246|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
14351247|NCT00989989|Ranibizumab|ranibizumab|mesh-list
14351248|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14351249|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14351250|NCT00989989|Growth Substances|growth substances|mesh-ancestor
14351251|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351252|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
14351253|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465224|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465225|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14465226|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14465227|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465228|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465229|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14465230|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
14465231|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465232|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465233|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14465234|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14465235|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
14465236|NCT02223065|Saxagliptin|saxagliptin|mesh-list
14465237|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465238|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465239|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465240|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465241|NCT02223065|Incretins|incretins|mesh-ancestor
14465242|NCT02223065|Hormones|hormones|mesh-ancestor
14465243|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465244|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14465245|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465246|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465247|NCT02223260|Dabigatran|dabigatran|mesh-list
14465248|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
14465249|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14465250|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465251|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465252|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465253|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
14465254|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
14465255|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14465256|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465257|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14465258|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14465259|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465260|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465261|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465262|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14465263|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14465264|NCT02223351|Ritonavir|ritonavir|mesh-list
14465265|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14465266|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14465267|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465268|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465269|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465270|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14351254|NCT00990106|Prazosin|prazosin|mesh-list
14351255|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14351256|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14351257|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14351258|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14351259|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
14351260|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351261|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351262|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351263|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14351264|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14351265|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14351266|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
14351267|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351268|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14351269|NCT00990236|Enoxaparin|enoxaparin|mesh-list
14351270|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
14351271|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
14351272|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14351273|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14351274|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351275|NCT00990249|Busulfan|busulfan|mesh-list
14351276|NCT00990249|Clofarabine|clofarabine|mesh-list
14351277|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
14351278|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14351279|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
14351280|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351281|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351282|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
14351283|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351284|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14351285|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351286|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14351287|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14732108|NCT04913220|Cemiplimab|cemiplimab|mesh-list
14732109|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732110|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732111|NCT04906382|Paclitaxel|paclitaxel|mesh-list
14732112|NCT04906382|Carboplatin|carboplatin|mesh-list
14732113|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14732114|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732115|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732116|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732117|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
14920221|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14351288|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
14351289|NCT00990288|Thrombin|thrombin|mesh-list
14732118|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
14920222|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732119|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732120|NCT04892875|Cisplatin|cisplatin|mesh-list
14351290|NCT00990288|Hemostatics|hemostatics|mesh-list
14351291|NCT00990288|Coagulants|coagulants|mesh-ancestor
14351292|NCT00990314|Epoprostenol|epoprostenol|mesh-list
14351293|NCT00990314|Beraprost|beraprost|mesh-list
14351294|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14351295|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
14351296|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14351297|NCT00990561|Clobetasol|clobetasol|mesh-list
14351298|NCT00990561|Halobetasol|halobetasol|mesh-list
14351299|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14351300|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351301|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
14351302|NCT00990561|Hormones|hormones|mesh-ancestor
14351303|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351304|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351305|NCT00990652|Bortezomib|bortezomib|mesh-list
14351306|NCT00990652|Temozolomide|temozolomide|mesh-list
14351307|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351308|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14351309|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
14465271|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14465272|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
14465273|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351310|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351311|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14351312|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14351313|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
14351314|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14351315|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351316|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14351317|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14351318|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14351319|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
14351320|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351321|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
14351322|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14351323|NCT00990704|Protective Agents|protective agents|mesh-ancestor
14351324|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351325|NCT00990769|Anesthetics|anesthetics|mesh-list
14351326|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351327|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351328|NCT00990821|Midazolam|midazolam|mesh-list
14351329|NCT00990821|Aprepitant|aprepitant|mesh-list
14351330|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
14351331|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14351332|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14351333|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351334|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351335|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14351336|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14351337|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14351338|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14351339|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
14351340|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
14351341|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
14351342|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
14351343|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351344|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351345|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
14351346|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
14351347|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351348|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351349|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14351350|NCT00991029|Clopidogrel|clopidogrel|mesh-list
14351351|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14351352|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14351353|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14351354|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14351355|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
14351356|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351357|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351358|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351359|NCT00991081|Bupropion|bupropion|mesh-list
14351360|NCT00991081|Nicotine|nicotine|mesh-list
14351361|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14351362|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
14351363|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351364|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351365|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14351366|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14351367|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14351368|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351369|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351370|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14351371|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
14351372|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14351373|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14351374|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14351375|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351376|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
14351377|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14351378|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14351379|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930937|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351380|NCT00991276|Pregabalin|pregabalin|mesh-list
14351381|NCT00991276|Pramipexole|pramipexole|mesh-list
14351382|NCT00991276|Analgesics|analgesics|mesh-ancestor
14351383|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
14351384|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351385|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351386|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
14351387|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14351388|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351389|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351390|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14351391|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14351392|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14351393|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351394|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14351395|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
14351396|NCT00991276|Protective Agents|protective agents|mesh-ancestor
14351397|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14351398|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14351399|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
14351400|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
14351401|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351402|NCT00991289|Interferons|interferons|mesh-list
14351403|NCT00991289|Ribavirin|ribavirin|mesh-list
14351404|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
14351405|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
14351406|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14351407|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
14351408|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351409|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
14351410|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351411|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
14351412|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351413|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
14351414|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351415|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14351416|NCT00991458|Cyclosporine|cyclosporine|mesh-list
14351417|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14351418|NCT00991458|Cyclosporins|cyclosporins|mesh-list
14351419|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351420|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351421|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351422|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
14351423|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351424|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
14351425|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351426|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14351427|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351428|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14351429|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14351430|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
14351431|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14351432|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351433|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14351434|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
14351435|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14351436|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351437|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351438|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351439|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
14351440|NCT00991809|Promethazine|promethazine|mesh-list
14351441|NCT00991809|Alfentanil|alfentanil|mesh-list
14351442|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14351443|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14351444|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351445|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351446|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
14351447|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
14351448|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
14351449|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351450|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
14351451|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
14351452|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351453|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14351454|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
14351455|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
14351456|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351457|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351458|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14351459|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
14351460|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
14351461|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14351462|NCT00991809|Narcotics|narcotics|mesh-ancestor
14351463|NCT00991809|Analgesics|analgesics|mesh-ancestor
14351464|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14351465|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
14351466|NCT00991939|Dexamethasone|dexamethasone|mesh-list
14351467|NCT00991939|Prednisone|prednisone|mesh-list
14351468|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351469|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
14351470|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
14351471|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351472|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351473|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351474|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
14351475|NCT00991939|Hormones|hormones|mesh-ancestor
14351476|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351477|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15230391|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230392|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
15230393|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
15230394|NCT04467723|Pirfenidone|pirfenidone|mesh-list
15230395|NCT04467723|Atezolizumab|atezolizumab|mesh-list
15230396|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230397|NCT04467723|Analgesics|analgesics|mesh-ancestor
15230398|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
15230399|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230400|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230401|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15230402|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230403|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230404|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230405|NCT04400838|Vaccines|vaccines|mesh-list
14351478|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351479|NCT00991952|Irinotecan|irinotecan|mesh-list
14351480|NCT00991952|Alvocidib|alvocidib|mesh-list
14351481|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14351482|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14351483|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351484|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351485|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351486|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
15230406|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
15230407|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230408|NCT04378933|Methamphetamine|methamphetamine|mesh-list
15230409|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15230410|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230411|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
14351487|NCT00991952|Growth Substances|growth substances|mesh-ancestor
14351488|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351489|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14351490|NCT00992056|Metoprolol|metoprolol|mesh-list
14351491|NCT00992056|Nebivolol|nebivolol|mesh-list
14351492|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14351493|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14351494|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
14351495|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
14351496|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351497|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351498|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14351499|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14351500|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14351501|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
14351502|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351503|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351504|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
14351505|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14351506|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14351507|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14351508|NCT00992108|Lidocaine|lidocaine|mesh-list
14351509|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
14351510|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
14351511|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351512|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351513|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
14351514|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351515|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14351516|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14351517|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14351518|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351519|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351520|NCT00992394|Etanercept|etanercept|mesh-list
14351521|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14351522|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14351523|NCT00992394|Analgesics|analgesics|mesh-ancestor
14351524|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
14351525|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351526|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351527|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351528|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230412|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
15230413|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230414|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
15230415|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230416|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230417|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
15230418|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15230419|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14351529|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351530|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351531|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
14351532|NCT00992407|Risperidone|risperidone|mesh-list
14351533|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14351534|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
14351535|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351536|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351537|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351538|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14351539|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14351540|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351541|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14351542|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14351543|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
14351544|NCT00992446|Cytarabine|cytarabine|mesh-list
14351545|NCT00992446|Rituximab|rituximab|mesh-list
14351546|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14351547|NCT00992446|Etoposide|etoposide|mesh-list
14351548|NCT00992446|Bortezomib|bortezomib|mesh-list
14351549|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
14351550|NCT00992446|Melphalan|melphalan|mesh-list
14351551|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
14351552|NCT00992446|Vorinostat|vorinostat|mesh-list
14351553|NCT00992446|Carmustine|carmustine|mesh-list
14351554|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
14351555|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14351556|NCT00992446|Antibodies|antibodies|mesh-list
14351557|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
14351558|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14351559|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
14351560|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351561|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351562|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351563|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14351564|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14351565|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14351566|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351567|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351568|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14351569|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
14351570|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
14351571|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351572|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351573|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14351574|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
14351575|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14351576|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14351577|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
14351578|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
14351579|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
14351580|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
14351581|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
14351582|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14351583|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351584|NCT00992511|Vaccines|vaccines|mesh-list
14351585|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
14351586|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351587|NCT00992589|Rabeprazole|rabeprazole|mesh-list
14351588|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14351589|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351590|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14351591|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351592|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351593|NCT00992602|Cytarabine|cytarabine|mesh-list
14351594|NCT00992602|Methotrexate|methotrexate|mesh-list
14351595|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14351596|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
14351597|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14351598|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351599|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14351600|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
14351601|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351602|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351603|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
14351604|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351605|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14351606|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351607|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
14351608|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351609|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14351610|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
14351611|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351612|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
14351613|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351614|NCT00993031|Ritonavir|ritonavir|mesh-list
14351615|NCT00993031|Lopinavir|lopinavir|mesh-list
14351616|NCT00993031|Lamivudine|lamivudine|mesh-list
14351617|NCT00993031|Zidovudine|zidovudine|mesh-list
14351618|NCT00993031|Efavirenz|efavirenz|mesh-list
14351619|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14351620|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14351621|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
14351622|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351623|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351624|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14351625|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14351626|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
14351627|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351628|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14351629|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14351630|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14351631|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14351632|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
14351633|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14351634|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14351635|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14351636|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14351637|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14351638|NCT00993044|Bevacizumab|bevacizumab|mesh-list
14351639|NCT00993044|Irinotecan|irinotecan|mesh-list
14351640|NCT00993044|Vincristine|vincristine|mesh-list
14351641|NCT00993044|Temozolomide|temozolomide|mesh-list
14351642|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14351643|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351644|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14351645|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14351646|NCT00993044|Growth Substances|growth substances|mesh-ancestor
14351647|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351648|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
14351649|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14351650|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14351651|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351652|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351653|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14351654|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
14351655|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
14351656|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
14351657|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14351658|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
14351659|NCT00993148|Ritonavir|ritonavir|mesh-list
14351660|NCT00993148|Darunavir|darunavir|mesh-list
14351661|NCT00993148|Maraviroc|maraviroc|mesh-list
14351662|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14351663|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14351664|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
14351665|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351666|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351667|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14351668|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14351669|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
14351670|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351671|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14351672|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14351673|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14351674|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14351675|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14351676|NCT00993187|Metformin|metformin|mesh-list
14351677|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14351678|NCT00993187|Glimepiride|glimepiride|mesh-list
14351679|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14351680|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351681|NCT00993187|Incretins|incretins|mesh-ancestor
14351682|NCT00993187|Hormones|hormones|mesh-ancestor
14351683|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351684|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14351685|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
14351686|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351687|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351688|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14351689|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351690|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
14351691|NCT00993200|Warfarin|warfarin|mesh-list
14351692|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
14351693|NCT00993226|Bupivacaine|bupivacaine|mesh-list
14351694|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
14351695|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
14351696|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351697|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351698|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
14351699|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351700|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
14351701|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14351702|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
14351703|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351704|NCT00993265|Expectorants|expectorants|mesh-ancestor
14351705|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
14351706|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14351707|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
14351708|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351709|NCT00993265|Protective Agents|protective agents|mesh-ancestor
14351710|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351711|NCT00993265|Antidotes|antidotes|mesh-ancestor
14351712|NCT00993317|Methotrexate|methotrexate|mesh-list
15230420|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230421|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15230422|NCT04368559|Fluconazole|fluconazole|mesh-list
15230423|NCT04368559|Posaconazole|posaconazole|mesh-list
15230424|NCT04368559|Rezafungin|rezafungin|mesh-list
15230425|NCT04368559|Trimethoprim|trimethoprim|mesh-list
15230426|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
15230427|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15230428|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
15230429|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230430|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14351713|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
15230431|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14351714|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14351715|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
14351716|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14351717|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351718|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14351719|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
14351720|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351721|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351722|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
14920223|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920224|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14351723|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351724|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14351725|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351726|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
14351727|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351728|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14351729|NCT00993421|Sibutramine|sibutramine|mesh-list
14351730|NCT00993421|Metoprolol|metoprolol|mesh-list
14351731|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14351732|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14351733|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
14351734|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
14351735|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351736|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351737|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14351738|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14351739|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14351740|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
14351741|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351742|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351743|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
14351744|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14351745|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
14351746|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14351747|NCT00993473|Insulin|insulin|mesh-list
14351748|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14351749|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
14351750|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
14351751|NCT00993473|Protamines|protamines|mesh-list
14351752|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14351753|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351754|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
14351755|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351756|NCT00993473|Coagulants|coagulants|mesh-ancestor
14351757|NCT00993499|Sirolimus|sirolimus|mesh-list
14351758|NCT00993499|Afatinib|afatinib|mesh-list
14351759|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14351760|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351761|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14351762|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351763|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
14351764|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351765|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
14351766|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351767|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14351768|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351769|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351770|NCT00993616|Carboplatin|carboplatin|mesh-list
14351771|NCT00993616|Belinostat|belinostat|mesh-list
14351772|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351773|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14351774|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351775|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351776|NCT00993655|Paclitaxel|paclitaxel|mesh-list
14351777|NCT00993655|Carboplatin|carboplatin|mesh-list
14351778|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14351779|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351780|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14351781|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14351782|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14351783|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351784|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
14351785|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14351786|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
14351787|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351788|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351789|NCT00993798|Bupivacaine|bupivacaine|mesh-list
14351790|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
14351791|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
14351792|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351793|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351794|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
14351795|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351796|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14351797|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14351798|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14351799|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
14465274|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14351800|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351801|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14351802|NCT00993915|Atorvastatin|atorvastatin|mesh-list
14351803|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14351804|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14351805|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
14351806|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351807|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14351808|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14351809|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351810|NCT00993967|Idebenone|idebenone|mesh-list
14351811|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
14351812|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351813|NCT00993967|Protective Agents|protective agents|mesh-ancestor
14351814|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732121|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732122|NCT04886154|Vaccines|vaccines|mesh-list
14351815|NCT00994110|Pasireotide|pasireotide|mesh-list
14351816|NCT00994110|Hormones|hormones|mesh-ancestor
14351817|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14351818|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351819|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14351820|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351821|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14351822|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351823|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351824|NCT00994175|Pioglitazone|pioglitazone|mesh-list
14351825|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14351826|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351827|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
14351828|NCT00994318|Hematinics|hematinics|mesh-ancestor
14351829|NCT00994422|Ivermectin|ivermectin|mesh-list
14351830|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14351831|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351832|NCT00994448|Bupropion|bupropion|mesh-list
14351833|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14351834|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
14351835|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14351836|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14351837|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14351838|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14351839|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351840|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
14351841|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351842|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351843|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14351844|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14351845|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351846|NCT00994461|Celecoxib|celecoxib|mesh-list
14351847|NCT00994461|Loxoprofen|loxoprofen|mesh-list
14351848|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14351849|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14351850|NCT00994461|Analgesics|analgesics|mesh-ancestor
14351851|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
14351852|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351853|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351854|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351855|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351856|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14351857|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14351858|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351859|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351860|NCT00994643|Aldesleukin|aldesleukin|mesh-list
14351861|NCT00994643|Rituximab|rituximab|mesh-list
14351862|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14351863|NCT00994643|Interleukin-2|interleukin-2|mesh-list
14351864|NCT00994643|Antibodies|antibodies|mesh-list
14351865|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
14351866|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14732123|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
14732124|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732125|NCT04881799|Topiramate|topiramate|mesh-list
14351867|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
14351868|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351869|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351870|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14351871|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14351872|NCT00994643|Analgesics|analgesics|mesh-ancestor
14351873|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
14351874|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351875|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14351876|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14351877|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
14351878|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14351879|NCT00994682|Pioglitazone|pioglitazone|mesh-list
14351880|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14351881|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351882|NCT00994760|Fentanyl|fentanyl|mesh-list
14351883|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14351884|NCT00994760|Narcotics|narcotics|mesh-ancestor
14351885|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351886|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351887|NCT00994760|Analgesics|analgesics|mesh-ancestor
14351888|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
14351889|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351890|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14351891|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14351892|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
14351893|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
14351894|NCT00994890|Tanezumab|tanezumab|mesh-list
14732126|NCT04881799|Phentermine|phentermine|mesh-list
14351895|NCT00994890|Analgesics|analgesics|mesh-ancestor
14732127|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
14732128|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732129|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732130|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14351896|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
14351897|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351898|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351899|NCT00994929|Oprelvekin|oprelvekin|mesh-list
14351900|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351901|NCT00995007|Carboplatin|carboplatin|mesh-list
14351902|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351903|NCT00995072|Metoprolol|metoprolol|mesh-list
14732131|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
14732132|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14732133|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
14351904|NCT00995072|Nebivolol|nebivolol|mesh-list
14351905|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14351906|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14351907|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
14351908|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
14351909|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351910|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351911|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14351912|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14351913|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14351914|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14351915|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14351916|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351917|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
14351918|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14351919|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14351920|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14351921|NCT00995085|Pyridoxine|pyridoxine|mesh-list
14351922|NCT00995085|Metadoxine|metadoxine|mesh-list
14351923|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14351924|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
14351925|NCT00995085|Vitamins|vitamins|mesh-ancestor
14351926|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
14351927|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351928|NCT00995475|Fluticasone|fluticasone|mesh-list
14351929|NCT00995475|Xhance|xhance|mesh-list
14351930|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351931|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14351932|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
14351933|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351934|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351935|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14351936|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
14351937|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14351938|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14351939|NCT00995488|Paclitaxel|paclitaxel|mesh-list
14351940|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14351941|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14351942|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351943|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
14351944|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
14351945|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
14351946|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351947|NCT00995501|Insulin|insulin|mesh-list
14351948|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14732134|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
14732135|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732136|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
14732137|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732138|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230432|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230433|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230434|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15230435|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
15230436|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230437|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230438|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15230439|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15230440|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15230441|NCT04368559|Renal Agents|renal agents|mesh-ancestor
14351949|NCT00995501|Dexamethasone|dexamethasone|mesh-list
14351950|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
14732139|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
14351951|NCT00995501|Anesthetics|anesthetics|mesh-list
14351952|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
14351953|NCT00995501|BB 1101|bb 1101|mesh-list
14732140|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732141|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230442|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
14351954|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14351955|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351956|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351957|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
14920225|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14920226|NCT04760691|Hormones|hormones|mesh-ancestor
15230443|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15230444|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15230445|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15230446|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14351958|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
14351959|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14351960|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14351961|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
14351962|NCT00995501|Hormones|hormones|mesh-ancestor
14351963|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230447|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15230448|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15230449|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15230450|NCT04364048|Cisplatin|cisplatin|mesh-list
15230451|NCT04364048|Carboplatin|carboplatin|mesh-list
15230452|NCT04364048|Etoposide|etoposide|mesh-list
14351964|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14351965|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14351966|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
14351967|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351968|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351969|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351970|NCT00995501|Cathartics|cathartics|mesh-ancestor
14465275|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14465276|NCT02223364|Bupivacaine|bupivacaine|mesh-list
14465277|NCT02223364|Ropivacaine|ropivacaine|mesh-list
14465278|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
14465279|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
14465280|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465281|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465282|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
14465283|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465284|NCT02223429|Vasopressins|vasopressins|mesh-list
14465285|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
14920227|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920228|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920229|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14920230|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
14920231|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14920232|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14920233|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14920234|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
14920235|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920236|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920237|NCT04745299|Riluzole|riluzole|mesh-list
14920238|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
14920239|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14920240|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14920241|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920242|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230453|NCT04364048|Pemetrexed|pemetrexed|mesh-list
15230454|NCT04364048|Durvalumab|durvalumab|mesh-list
15230455|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15230456|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230457|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14920243|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920244|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14920245|NCT04745299|Protective Agents|protective agents|mesh-ancestor
14920246|NCT04742751|Metformin|metformin|mesh-list
14920247|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14920248|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230458|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14465286|NCT02223429|Oxytocin|oxytocin|mesh-list
14920249|NCT04710641|Sorafenib|sorafenib|mesh-list
14351971|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
14351972|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14351973|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351974|NCT00995670|Ascorbic Acid|ascorbic acid|mesh-list
14351975|NCT00995670|Sevoflurane|sevoflurane|mesh-list
14351976|NCT00995670|Simvastatin|simvastatin|mesh-list
14351977|NCT00995670|Vitamins|vitamins|mesh-ancestor
14351978|NCT00995670|Micronutrients|micronutrients|mesh-ancestor
14351979|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351980|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14351981|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14351982|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
14351983|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351984|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15230459|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15230460|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732142|NCT04865835|Metformin|metformin|mesh-list
14732143|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732144|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230461|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14351985|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14351986|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14351987|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14351988|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14351989|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
14351990|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
14351991|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14351992|NCT00995670|Antioxidants|antioxidants|mesh-ancestor
14351993|NCT00995670|Protective Agents|protective agents|mesh-ancestor
14351994|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15230462|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15230463|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15230464|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230465|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
15230466|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230467|NCT04344444|Azithromycin|azithromycin|mesh-list
15230468|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
15230469|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15230470|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230471|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
15230472|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15230473|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14351995|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
14732145|NCT04857307|Alprazolam|alprazolam|mesh-list
14732146|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14732147|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732148|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732149|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14351996|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14351997|NCT00995722|Prednisone|prednisone|mesh-list
14351998|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14351999|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
14352000|NCT00995722|Hormones|hormones|mesh-ancestor
14352001|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352002|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352003|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14352004|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352005|NCT00995761|Cisplatin|cisplatin|mesh-list
14352006|NCT00995761|Docetaxel|docetaxel|mesh-list
14352007|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352008|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14352009|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14352010|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14352011|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352012|NCT00996034|Nicotine|nicotine|mesh-list
14352013|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352014|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14352015|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
14352016|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352017|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14352018|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14352019|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
14352020|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352021|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352022|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
14352023|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
14352024|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352025|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14352026|NCT00996281|Olmesartan|olmesartan|mesh-list
14352027|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14352028|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
14352029|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14352030|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14352031|NCT00996281|Diuretics|diuretics|mesh-ancestor
14352032|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
15230474|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230475|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230476|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230477|NCT04342715|Paromomycin|paromomycin|mesh-list
15230478|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14352033|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352034|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14352035|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14352036|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352037|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14352038|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14352039|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14352040|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14352041|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
14352042|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230479|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15230480|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230481|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15230482|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15230483|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
15230484|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15230485|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
15230486|NCT04324606|Acetaminophen|acetaminophen|mesh-list
15230487|NCT04324606|Vaccines|vaccines|mesh-list
15230488|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
15230489|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230490|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230491|NCT04324606|Analgesics|analgesics|mesh-ancestor
15230492|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
15230493|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230494|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
15230495|NCT04320940|Phenobarbital|phenobarbital|mesh-list
15230496|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
15230497|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15230498|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352043|NCT00996346|Sirolimus|sirolimus|mesh-list
14352044|NCT00996346|Irinotecan|irinotecan|mesh-list
15230499|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230500|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15230501|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15230502|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230503|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230504|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
14352045|NCT00996346|Complement Factor H|complement factor h|mesh-list
14352046|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14352047|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14352048|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352049|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352050|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352051|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14352052|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352053|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14352054|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
14352055|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352056|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
14352057|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352058|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14352059|NCT00996437|Ranibizumab|ranibizumab|mesh-list
14352060|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14352061|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14352062|NCT00996437|Growth Substances|growth substances|mesh-ancestor
14352063|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352064|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
14352065|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352066|NCT00996476|Simeprevir|simeprevir|mesh-list
14352067|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
14352068|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352069|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
14352070|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352071|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352072|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
14732150|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14732151|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14732152|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
14732153|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
14732154|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732155|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352073|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14732156|NCT04840888|Itraconazole|itraconazole|mesh-list
14732157|NCT04840888|Carbamazepine|carbamazepine|mesh-list
14732158|NCT04840888|Omeprazole|omeprazole|mesh-list
14732159|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15230505|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
14352074|NCT00996580|Estradiol|estradiol|mesh-list
15230506|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15230507|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15230508|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14352075|NCT00996580|Estrogens|estrogens|mesh-ancestor
14352076|NCT00996580|Hormones|hormones|mesh-ancestor
14352077|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352078|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352079|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14352080|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
14352081|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14352082|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14352083|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14352084|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14352085|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14352086|NCT00996593|Iodine|iodine|mesh-list
14352087|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
14352088|NCT00996593|Antibodies|antibodies|mesh-list
14352089|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
14352090|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
14352091|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352092|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14732160|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14732161|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15230509|NCT04295577|Niraparib|niraparib|mesh-list
14352093|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352094|NCT00996593|Trace Elements|trace elements|mesh-ancestor
14732162|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352095|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
14352096|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352097|NCT00996658|Linagliptin|linagliptin|mesh-list
14352098|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14352099|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352100|NCT00996658|Incretins|incretins|mesh-ancestor
14352101|NCT00996658|Hormones|hormones|mesh-ancestor
14352102|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352103|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14352104|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
14352105|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352106|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352107|NCT00996736|Voriconazole|voriconazole|mesh-list
14352108|NCT00996736|Natamycin|natamycin|mesh-list
14352109|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
14352110|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352111|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14352112|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14352113|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352114|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352115|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15230510|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15230511|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230512|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230513|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230514|NCT04261218|Paclitaxel|paclitaxel|mesh-list
15230515|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15230516|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352116|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
14352117|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352118|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352119|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14352120|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14352121|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14352122|NCT00996801|Vitamin D|vitamin d|mesh-list
14352123|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
14352124|NCT00996801|Alendronate|alendronate|mesh-list
14352125|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
14352126|NCT00996801|Calcium|calcium|mesh-list
14352127|NCT00996801|Vitamins|vitamins|mesh-ancestor
14352128|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
14352129|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352130|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14352131|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14352132|NCT00996801|Antacids|antacids|mesh-ancestor
14352133|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352134|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14352135|NCT00996931|Lenalidomide|lenalidomide|mesh-list
14352136|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
14352137|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352138|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14352139|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14352140|NCT00996931|Growth Substances|growth substances|mesh-ancestor
14352141|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
14352142|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352143|NCT00996944|Ropinirole|ropinirole|mesh-list
14352144|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15230517|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
14352145|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14352146|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
14352147|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
14352148|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352149|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352150|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352151|NCT00996996|Iodine|iodine|mesh-list
14352152|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
14352153|NCT00996996|Antibodies|antibodies|mesh-list
14352154|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
14352155|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
14352156|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352157|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14352158|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352159|NCT00996996|Trace Elements|trace elements|mesh-ancestor
14352160|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
14352161|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352162|NCT00997035|Voriconazole|voriconazole|mesh-list
14352163|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
14352164|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352165|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14732163|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732164|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
14732165|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352166|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14352167|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352168|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352169|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14352170|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
14352171|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352172|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352173|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14352174|NCT00997113|Alfentanil|alfentanil|mesh-list
14352175|NCT00997113|Propofol|propofol|mesh-list
14352176|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14352177|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352178|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352179|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14352180|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
14352181|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
14352182|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14352183|NCT00997113|Narcotics|narcotics|mesh-ancestor
14352184|NCT00997113|Analgesics|analgesics|mesh-ancestor
14352185|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
14352186|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352187|NCT00997126|Alfentanil|alfentanil|mesh-list
14352188|NCT00997126|Propofol|propofol|mesh-list
14352189|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14352190|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352191|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352192|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14352193|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
14352194|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
14352195|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14352196|NCT00997126|Narcotics|narcotics|mesh-ancestor
14352197|NCT00997126|Analgesics|analgesics|mesh-ancestor
14352198|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
14352199|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352200|NCT00997139|Polymyxins|polymyxins|mesh-list
14352201|NCT00997139|Bacitracin|bacitracin|mesh-list
14352202|NCT00997139|Neomycin|neomycin|mesh-list
14352203|NCT00997139|Polymyxin B|polymyxin b|mesh-list
14352204|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
14352205|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14352206|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352207|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14352208|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14352209|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352210|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352211|NCT00997204|Icatibant|icatibant|mesh-list
14352212|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15230518|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
14352213|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352214|NCT00997204|Analgesics|analgesics|mesh-ancestor
14352215|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
14352216|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352217|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352218|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352219|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352220|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14352221|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14352222|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732166|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14732167|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14732168|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14732169|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
14732170|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732171|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352223|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14352224|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352225|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
14352226|NCT00997243|Azacitidine|azacitidine|mesh-list
14352227|NCT00997243|Lintuzumab|lintuzumab|mesh-list
14352228|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14352229|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
14352230|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352231|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352232|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352233|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14352234|NCT00997321|Ketamine|ketamine|mesh-list
14352235|NCT00997321|Propofol|propofol|mesh-list
14352236|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14352237|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352238|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352239|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14352240|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
14352241|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
14352242|NCT00997321|Analgesics|analgesics|mesh-ancestor
14352243|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
14352244|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352245|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14352246|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14352247|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14352248|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352249|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352250|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14352251|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352252|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14352253|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352254|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352255|NCT00997373|Letrozole|letrozole|mesh-list
14352256|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352257|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14352258|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14352259|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352260|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230519|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
15230520|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230521|NCT04251689|Mannitol|mannitol|mesh-list
14352261|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14352262|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
14352263|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352264|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352265|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
14352266|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
14352267|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352268|NCT00997438|Protective Agents|protective agents|mesh-ancestor
14352269|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352270|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
14352271|NCT00997438|Vitamins|vitamins|mesh-ancestor
14352272|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
14352273|NCT00997503|Aspirin|aspirin|mesh-list
14352274|NCT00997503|Paclitaxel|paclitaxel|mesh-list
14352275|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14352276|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732172|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15230522|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14352277|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352278|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
14352279|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
14352280|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
14352281|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352282|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14352283|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352284|NCT00997503|Analgesics|analgesics|mesh-ancestor
14352285|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
14352286|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352287|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352288|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352289|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352290|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14352291|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14352292|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14352293|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14352294|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352295|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
14352296|NCT00997620|Fluticasone|fluticasone|mesh-list
14352297|NCT00997620|Xhance|xhance|mesh-list
14352298|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352299|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14352300|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
14352301|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352302|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352303|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14352304|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
14352305|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
14352306|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14352307|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
14352308|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
14352309|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14352310|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352311|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352312|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
14352313|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14352314|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352315|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352316|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14352317|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14352318|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14352319|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
14352320|NCT00997893|Estradiol|estradiol|mesh-list
14352321|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14352322|NCT00997893|Estrogens|estrogens|mesh-list
14352323|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
14352324|NCT00997893|Hormones|hormones|mesh-ancestor
14352325|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352326|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352327|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14352328|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
14352329|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14352330|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14352331|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14352332|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14352333|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14352334|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14352335|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14352336|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352337|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14352338|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
14352339|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
14352340|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14352341|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352342|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14352343|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14352344|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14352345|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14352346|NCT00997984|Guanfacine|guanfacine|mesh-list
14352347|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14352348|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14352349|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14352350|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14352351|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
14352352|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352353|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352354|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352355|NCT00998010|Bortezomib|bortezomib|mesh-list
14352356|NCT00998010|Temozolomide|temozolomide|mesh-list
14920250|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920251|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14920252|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920253|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920254|NCT04707664|Sargramostim|sargramostim|mesh-list
14920255|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
14920256|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920257|NCT04706767|Lidocaine|lidocaine|mesh-list
14920258|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
14920259|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
14920260|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
14920261|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230523|NCT04251689|Diuretics|diuretics|mesh-ancestor
15230524|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
15230525|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230526|NCT04232423|Olanzapine|olanzapine|mesh-list
15230527|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
15230528|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
15230529|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230530|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230531|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15230532|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15230533|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14732173|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
14732174|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
15230534|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352357|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352358|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14920262|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920263|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
14920264|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920265|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14920266|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14920267|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15230535|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14352359|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
14352360|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352361|NCT00998049|Plerixafor|plerixafor|mesh-list
14352362|NCT00998049|Lenograstim|lenograstim|mesh-list
14352363|NCT00998049|Sargramostim|sargramostim|mesh-list
14352364|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14352365|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
14352366|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352367|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14352368|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14352369|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
14352370|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352371|NCT00998205|Atropine|atropine|mesh-list
14352372|NCT00998205|Dobutamine|dobutamine|mesh-list
14352373|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14352374|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14352375|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14352376|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
14352377|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352378|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352379|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14352380|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
14352381|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
14352382|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
14352383|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14352384|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14352385|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
14352386|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352387|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352388|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14352389|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
14352390|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14352391|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14352392|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14352393|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
14352394|NCT00998205|Protective Agents|protective agents|mesh-ancestor
14352395|NCT00998296|Nintedanib|nintedanib|mesh-list
14352396|NCT00998296|Afatinib|afatinib|mesh-list
14352397|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352398|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14352399|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352400|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352401|NCT00998309|Azithromycin|azithromycin|mesh-list
14352402|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14352403|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352404|NCT00998335|Insulin|insulin|mesh-list
14352405|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14920268|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14920269|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920270|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14920271|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14920272|NCT04706767|Analgesics|analgesics|mesh-ancestor
14920273|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14920274|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14920275|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14920276|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
15230536|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15230537|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15230538|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230539|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230540|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230541|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
15230542|NCT04196010|Cytarabine|cytarabine|mesh-list
14352406|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
14352407|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
14352408|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14352409|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
14732175|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14732176|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732177|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14732178|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230543|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14352410|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14352411|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352412|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
14352413|NCT00998426|Antibodies|antibodies|mesh-list
14352414|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
14352415|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14352416|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14352417|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
14352418|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
14352419|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352420|NCT00998582|Tenofovir|tenofovir|mesh-list
14352421|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
14352422|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352423|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14352424|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14352425|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352426|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352427|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14352428|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14352429|NCT00998946|Vitamins|vitamins|mesh-list
14352430|NCT00998946|Folic Acid|folic acid|mesh-list
14352431|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
14352432|NCT00998946|Hydroxocobalamin|hydroxocobalamin|mesh-list
15230544|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
15230545|NCT04196010|Cladribine|cladribine|mesh-list
15230546|NCT04196010|Sargramostim|sargramostim|mesh-list
15230547|NCT04196010|Lenograstim|lenograstim|mesh-list
15230548|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230549|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
15230550|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230551|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352433|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
14352434|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14352435|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
14352436|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352437|NCT00998946|Hematinics|hematinics|mesh-ancestor
14352438|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352439|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14352440|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352441|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352442|NCT00998985|Grazoprevir|grazoprevir|mesh-list
14352443|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
14352444|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352445|NCT00999037|Sevelamer|sevelamer|mesh-list
14352446|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
14352447|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
14352448|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352449|NCT00999102|Metoprolol|metoprolol|mesh-list
14352450|NCT00999102|Nebivolol|nebivolol|mesh-list
14352451|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14352452|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14352453|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
14352454|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
14352455|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732179|NCT04840888|Analgesics|analgesics|mesh-ancestor
14352456|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352457|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14920277|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352458|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15230552|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
14352459|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14352460|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
14352461|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352462|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352463|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
14352464|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14352465|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14352466|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14352467|NCT00999518|Tanezumab|tanezumab|mesh-list
14352468|NCT00999518|Analgesics|analgesics|mesh-ancestor
14352469|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
14352470|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352471|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352472|NCT00999544|Oxycodone|oxycodone|mesh-list
14352473|NCT00999544|Aprepitant|aprepitant|mesh-list
14352474|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
14352475|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14352476|NCT00999544|Narcotics|narcotics|mesh-ancestor
14352477|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352478|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352479|NCT00999544|Analgesics|analgesics|mesh-ancestor
14352480|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
14352481|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352482|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
14352483|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
14352484|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14352485|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14352486|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352487|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352488|NCT00999713|Calfactant|calfactant|mesh-list
14352489|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14352490|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
14352491|NCT00999804|Trastuzumab|trastuzumab|mesh-list
14352492|NCT00999804|Letrozole|letrozole|mesh-list
14352493|NCT00999804|Lapatinib|lapatinib|mesh-list
14352494|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14352495|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352496|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14352497|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14352498|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352499|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352500|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14352501|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
14352502|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352503|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352504|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14352505|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
14352506|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14352507|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
14352508|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352509|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352510|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14352511|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
14352512|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
14352513|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14352514|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
14352515|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352516|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352517|NCT00999921|Tamoxifen|tamoxifen|mesh-list
14352518|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
14352519|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14352520|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
14352521|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352522|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352523|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14352524|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352525|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14352526|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14352527|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14352528|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14352529|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352530|NCT00999921|Analgesics|analgesics|mesh-ancestor
14352531|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
14352532|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352533|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352534|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352535|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14352536|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
14352537|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352538|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14352539|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
14352540|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14352541|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14352542|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352543|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14352544|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14352545|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14352546|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352547|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
14352548|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352549|NCT01000155|Vorinostat|vorinostat|mesh-list
14352550|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352551|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14352552|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352553|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352554|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
14352555|NCT01000285|Prednisone|prednisone|mesh-list
14352556|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
14352557|NCT01000285|Doxorubicin|doxorubicin|mesh-list
14352558|NCT01000285|Etoposide|etoposide|mesh-list
15230553|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230554|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230555|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
15230556|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230557|NCT04196010|Analgesics|analgesics|mesh-ancestor
15230558|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
15230559|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352559|NCT01000285|Vincristine|vincristine|mesh-list
14352560|NCT01000285|Bortezomib|bortezomib|mesh-list
14352561|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352562|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
14352563|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352564|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352565|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14352566|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
14352567|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352568|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230560|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15230561|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15230562|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230563|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15230564|NCT04190433|Carvedilol|carvedilol|mesh-list
15230565|NCT04190433|Lisinopril|lisinopril|mesh-list
15230566|NCT04190433|Spironolactone|spironolactone|mesh-list
15230567|NCT04190433|Pravastatin|pravastatin|mesh-list
15230568|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15230569|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
15230570|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230571|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352569|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14352570|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14352571|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14352572|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14352573|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352574|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352575|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
14352576|NCT01000285|Hormones|hormones|mesh-ancestor
14352577|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352578|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14352579|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14352580|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
14352581|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14352582|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14352583|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14352584|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14352585|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
14352586|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352587|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14352588|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14352589|NCT01000311|Vaccines|vaccines|mesh-list
14352590|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14352591|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
14352592|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352593|NCT01000337|Propofol|propofol|mesh-list
14352594|NCT01000337|Sevoflurane|sevoflurane|mesh-list
14352595|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14352596|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352597|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352598|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14352599|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
14352600|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
14352601|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15230572|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15230573|NCT04190433|Diuretics|diuretics|mesh-ancestor
15230574|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
14352602|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14352603|NCT01000376|Ketoconazole|ketoconazole|mesh-list
14352604|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
14352605|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352606|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14352607|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14352608|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352609|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352610|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14352611|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
14352612|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352613|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352614|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14352615|NCT01000480|Pemetrexed|pemetrexed|mesh-list
14352616|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352617|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352618|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352619|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14352620|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14465287|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465288|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
14465289|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14465290|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
14465291|NCT02223429|Coagulants|coagulants|mesh-ancestor
15230575|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15230576|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15230577|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
15230578|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230579|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352621|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
14352622|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14352623|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14352624|NCT01000610|Prednisolone|prednisolone|mesh-list
14352625|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
14352626|NCT01000610|Rituximab|rituximab|mesh-list
14352627|NCT01000610|Methotrexate|methotrexate|mesh-list
14352628|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14352629|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
14352630|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14352631|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352632|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
14352633|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352634|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352635|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14352636|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
14352637|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14352638|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14352639|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
14352640|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352641|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
14352642|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352643|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14352644|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352645|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14352646|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352647|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
14352648|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
14352649|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352650|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14352651|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
14352652|NCT01000610|Hormones|hormones|mesh-ancestor
14352653|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352654|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14352655|NCT01000610|Protective Agents|protective agents|mesh-ancestor
14352656|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14352657|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14352658|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14352659|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14352660|NCT01000649|Vasopressins|vasopressins|mesh-list
14352661|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
14352662|NCT01000649|Coagulants|coagulants|mesh-ancestor
14352663|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14352664|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14352665|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
14352666|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352667|NCT01000727|Darapladib|darapladib|mesh-list
14352668|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14352669|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352670|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352671|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14352672|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14352673|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14352674|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465292|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14352675|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352676|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352677|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352678|NCT01000805|Analgesics|analgesics|mesh-ancestor
14352679|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
14352680|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352681|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
14352682|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14352683|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
14352684|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
14352685|NCT01000818|Omeprazole|omeprazole|mesh-list
14352686|NCT01000818|Famotidine|famotidine|mesh-list
14352687|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14352688|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14352689|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14352690|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352691|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352692|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14352693|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14352694|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
14352695|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352696|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14352697|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14352698|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14352699|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
14352700|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
14352701|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352702|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352703|NCT01000961|Cysteamine|cysteamine|mesh-list
14352704|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14352705|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352706|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14352707|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
14352708|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352709|NCT01000987|Varenicline|varenicline|mesh-list
14352710|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14352711|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14352712|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
14352713|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352714|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352715|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352716|NCT01001052|Colchicine|colchicine|mesh-list
14352717|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
14352718|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352719|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
14352720|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
14352721|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
14352722|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352723|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352724|NCT01001104|Dulaglutide|dulaglutide|mesh-list
14352725|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14352726|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352727|NCT01001195|Bimatoprost|bimatoprost|mesh-list
14352728|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14352729|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14352730|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14352731|NCT01001208|Etanercept|etanercept|mesh-list
14352732|NCT01001208|Methotrexate|methotrexate|mesh-list
14352733|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14352734|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
14352735|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14352736|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352737|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14352738|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
14352739|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352740|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352741|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
14352742|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352743|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14352744|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352745|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
14352746|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352747|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14352748|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14352749|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352750|NCT01001208|Analgesics|analgesics|mesh-ancestor
14352751|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
14352752|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352753|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352754|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14352755|NCT01001221|Gemcitabine|gemcitabine|mesh-list
14352756|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14352757|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
14352758|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352759|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352760|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
14352761|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352762|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352763|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352764|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
14352765|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352766|NCT01001377|Cetuximab|cetuximab|mesh-list
14352767|NCT01001377|Panitumumab|panitumumab|mesh-list
14352768|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14352769|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352770|NCT01001403|Nafamostat|nafamostat|mesh-list
14352771|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14352772|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352773|NCT01001403|Analgesics|analgesics|mesh-ancestor
14352774|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
14352775|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352776|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352777|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352778|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352779|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
14352780|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
14352781|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352782|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352783|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14352784|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14352785|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14352786|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352787|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
14352788|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
14352789|NCT01001429|Propofol|propofol|mesh-list
14352790|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14352791|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352792|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352793|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14352794|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
14352795|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
14352796|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352797|NCT01001429|Analgesics|analgesics|mesh-ancestor
14352798|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
14352799|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352800|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14352801|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14352802|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14352803|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14352804|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352805|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352806|NCT01001442|Maytansine|maytansine|mesh-list
14352807|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14352808|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352809|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14352810|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14352811|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14352812|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352813|NCT01001494|Bromides|bromides|mesh-list
14352814|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
14352815|NCT01001520|Tolcapone|tolcapone|mesh-list
14352816|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14352817|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14352818|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14352819|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352820|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352821|NCT01001559|Norepinephrine|norepinephrine|mesh-list
14352822|NCT01001559|Serotonin|serotonin|mesh-list
14352823|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14352824|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
14352825|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14352826|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14352827|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
14352828|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352829|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352830|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352831|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
14352832|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
14732180|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
14732181|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732182|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14732183|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14732184|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14352833|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352834|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14352835|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14352836|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
14352837|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14352838|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14352839|NCT01001572|Amlodipine|amlodipine|mesh-list
14352840|NCT01001572|Valsartan|valsartan|mesh-list
14352841|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14352842|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14352843|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14352844|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352845|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14352846|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352847|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
14352848|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14352849|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14352850|NCT01001598|Danazol|danazol|mesh-list
14352851|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14352852|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
14352853|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352854|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352855|NCT01001702|Aripiprazole|aripiprazole|mesh-list
14352856|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
14352857|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14352858|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14352859|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14352860|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14352861|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352862|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
14352863|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
14352864|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352865|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352866|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14352867|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14352868|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
14352869|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14352870|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14352871|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14352872|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14352873|NCT01001806|Ketorolac|ketorolac|mesh-list
14352874|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14352875|NCT01001806|Nepafenac|nepafenac|mesh-list
14352876|NCT01001806|Bromfenac|bromfenac|mesh-list
14352877|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14352878|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352879|NCT01001806|Analgesics|analgesics|mesh-ancestor
14352880|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
14352881|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352882|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352883|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352884|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352885|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14352886|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352887|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352888|NCT01001832|Abatacept|abatacept|mesh-list
14352889|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14352890|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352891|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352892|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352893|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
14352894|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352895|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352896|NCT01001910|Carboplatin|carboplatin|mesh-list
14352897|NCT01001910|Pemetrexed|pemetrexed|mesh-list
14352898|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352899|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352900|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352901|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14352902|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14352903|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
14352904|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14352905|NCT01001975|Protective Agents|protective agents|mesh-ancestor
14352906|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352907|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
14352908|NCT01002105|Baclofen|baclofen|mesh-list
14352909|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14352910|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352911|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14352912|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352913|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14352914|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
14352915|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
14352916|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14352917|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352918|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
14352919|NCT01002339|Cyclosporine|cyclosporine|mesh-list
14352920|NCT01002339|Prednisone|prednisone|mesh-list
14352921|NCT01002339|Tacrolimus|tacrolimus|mesh-list
14352922|NCT01002339|Basiliximab|basiliximab|mesh-list
14352923|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14352924|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
14352925|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352926|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14352927|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352928|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352929|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14352930|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352931|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14352932|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
14352933|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14352934|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352935|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352936|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
14352937|NCT01002339|Hormones|hormones|mesh-ancestor
14352938|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14352939|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14352940|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
14352941|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
14352942|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352943|NCT01002547|Vitamins|vitamins|mesh-list
14352944|NCT01002547|Vitamin E|vitamin e|mesh-list
14352945|NCT01002547|Tocopherols|tocopherols|mesh-list
14352946|NCT01002547|Tocotrienols|tocotrienols|mesh-list
14352947|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
14352948|NCT01002547|Pioglitazone|pioglitazone|mesh-list
14352949|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
14352950|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352951|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14352952|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
14352953|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352954|NCT01002547|Protective Agents|protective agents|mesh-ancestor
14352955|NCT01002573|Acetaminophen|acetaminophen|mesh-list
14732185|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14732186|NCT04836910|Metformin|metformin|mesh-list
14732187|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
14732188|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
14732189|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14920278|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
15230580|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15230581|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
15230582|NCT04190433|Protective Agents|protective agents|mesh-ancestor
15230583|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15230584|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230585|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15230586|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
15230587|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15230588|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15230589|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15230590|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14352956|NCT01002573|Ibuprofen|ibuprofen|mesh-list
14732190|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14352957|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14352958|NCT01002573|Analgesics|analgesics|mesh-ancestor
14352959|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
14732191|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732192|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15230591|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
15230592|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15230593|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14352960|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14352961|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352962|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
14352963|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14352964|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14352965|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14352966|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14352967|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352968|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352969|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
14352970|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14352971|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352972|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14352973|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
14352974|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14352975|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14352976|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14352977|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14352978|NCT01002755|Lenalidomide|lenalidomide|mesh-list
14352979|NCT01002755|Ofatumumab|ofatumumab|mesh-list
14352980|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14352981|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
14352982|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352983|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14352984|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14352985|NCT01002755|Growth Substances|growth substances|mesh-ancestor
14352986|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
14352987|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352988|NCT01003080|Hemostatics|hemostatics|mesh-list
14352989|NCT01003080|Coagulants|coagulants|mesh-ancestor
14352990|NCT01003106|Ranibizumab|ranibizumab|mesh-list
14352991|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14352992|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14352993|NCT01003106|Growth Substances|growth substances|mesh-ancestor
14352994|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14352995|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
14352996|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14352997|NCT01003184|Exenatide|exenatide|mesh-list
14352998|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
15230594|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230595|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15230596|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
15230597|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15230598|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15230599|NCT04178993|Methylphenidate|methylphenidate|mesh-list
15230600|NCT04178993|Methamphetamine|methamphetamine|mesh-list
15230601|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15230602|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230603|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15230604|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14352999|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14353000|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353001|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14353002|NCT01003184|Incretins|incretins|mesh-ancestor
14353003|NCT01003184|Hormones|hormones|mesh-ancestor
14353004|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353005|NCT01003249|Baclofen|baclofen|mesh-list
14353006|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14353007|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353008|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14353009|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353010|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14353011|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
14353012|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
14353013|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353014|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353015|NCT01003301|Omalizumab|omalizumab|mesh-list
14353016|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14353017|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14353018|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353019|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14353020|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
14353021|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353022|NCT01003639|Aspirin|aspirin|mesh-list
14353023|NCT01003639|Acetaminophen|acetaminophen|mesh-list
14353024|NCT01003639|Ibuprofen|ibuprofen|mesh-list
14353025|NCT01003639|Naproxen|naproxen|mesh-list
14353026|NCT01003639|Acetazolamide|acetazolamide|mesh-list
14353027|NCT01003639|Codeine|codeine|mesh-list
14353028|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14353029|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14353030|NCT01003639|Analgesics|analgesics|mesh-ancestor
14353031|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
14353032|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353033|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353034|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353035|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353036|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14353037|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14353038|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353039|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14353040|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14353041|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353042|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
14353043|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
14353044|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
14353045|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14353046|NCT01003639|Diuretics|diuretics|mesh-ancestor
14353047|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
14353048|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14353049|NCT01003639|Narcotics|narcotics|mesh-ancestor
14353050|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353051|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
14353052|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353053|NCT01003769|Acetic Acid|acetic acid|mesh-list
14353054|NCT01003769|Lenalidomide|lenalidomide|mesh-list
14353055|NCT01003769|Retinol acetate|retinol acetate|mesh-list
14353056|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
14353057|NCT01003769|Gossypol|gossypol|mesh-list
14353058|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
14353059|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353060|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14353061|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14353062|NCT01003769|Growth Substances|growth substances|mesh-ancestor
14353063|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
14353064|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353065|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14353066|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353067|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14353068|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14353069|NCT01003769|Protective Agents|protective agents|mesh-ancestor
14353070|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14353071|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
14353072|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14353073|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353074|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14353075|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14353076|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14353077|NCT01003886|Doxazosin|doxazosin|mesh-list
14353078|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14353079|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14353080|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14353081|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14353082|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14353083|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353084|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353085|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353086|NCT01003899|Afatinib|afatinib|mesh-list
14353087|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353088|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14353089|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353090|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353091|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14353092|NCT01003938|Topotecan|topotecan|mesh-list
14353093|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353094|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14353095|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353096|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353097|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14353098|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14353099|NCT01003990|Ritonavir|ritonavir|mesh-list
14353100|NCT01003990|Lopinavir|lopinavir|mesh-list
14353101|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14353102|NCT01003990|Tenofovir|tenofovir|mesh-list
14353103|NCT01003990|Emtricitabine|emtricitabine|mesh-list
14353104|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14353105|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14353106|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353107|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353108|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353109|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14353110|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14353111|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
14353112|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353113|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14353114|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14353115|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14353116|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14353117|NCT01004003|Sorafenib|sorafenib|mesh-list
14353118|NCT01004003|Nintedanib|nintedanib|mesh-list
14353119|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353120|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14353121|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353122|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353123|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14353124|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14353125|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14353126|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
14353127|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353128|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353129|NCT01004029|Progestins|progestins|mesh-ancestor
14353130|NCT01004029|Hormones|hormones|mesh-ancestor
14353131|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
14353132|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14353133|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14353134|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14353135|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14353136|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353137|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
14353138|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353139|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353140|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14353141|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353142|NCT01004159|Irinotecan|irinotecan|mesh-list
14353143|NCT01004159|Cetuximab|cetuximab|mesh-list
14353144|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14353145|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14353146|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353147|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353148|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353149|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353150|NCT01004172|Bevacizumab|bevacizumab|mesh-list
14353151|NCT01004172|Trastuzumab|trastuzumab|mesh-list
14353152|NCT01004172|Carboplatin|carboplatin|mesh-list
14353153|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353154|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353155|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14353156|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14353157|NCT01004172|Growth Substances|growth substances|mesh-ancestor
14353158|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353159|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
14353160|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14353161|NCT01004185|Mesalamine|mesalamine|mesh-list
14353162|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14353163|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14353164|NCT01004185|Analgesics|analgesics|mesh-ancestor
14353165|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
14353166|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353167|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353168|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353169|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353170|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
14353171|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14353172|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353173|NCT01004250|Bevacizumab|bevacizumab|mesh-list
14353174|NCT01004250|Pemetrexed|pemetrexed|mesh-list
14353175|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353176|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353177|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14353178|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14353179|NCT01004250|Growth Substances|growth substances|mesh-ancestor
14353180|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353181|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
14353182|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353183|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353184|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14353185|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14353186|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
14353187|NCT01004354|Vitamin D|vitamin d|mesh-list
14353188|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14353189|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353190|NCT01004354|Vitamins|vitamins|mesh-ancestor
14353191|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
14353192|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14353193|NCT01004393|Bromides|bromides|mesh-list
14353194|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
14353195|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
14353196|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14353197|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353198|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
14353199|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353200|NCT01004406|Atorvastatin|atorvastatin|mesh-list
14353201|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14353202|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14353203|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14353204|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
14353205|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353206|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14353207|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353208|NCT01004432|Golimumab|golimumab|mesh-list
14353209|NCT01004432|Methotrexate|methotrexate|mesh-list
14353210|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14353211|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14353212|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
14353213|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14353214|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353215|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14353216|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
14353217|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353218|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353219|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
14353220|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353221|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14353222|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353223|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
14353224|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353225|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14353226|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14353227|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353228|NCT01004614|Amlodipine|amlodipine|mesh-list
14353229|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14353230|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14353231|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14353232|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353233|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14353234|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353235|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
14353236|NCT01004705|Aspirin|aspirin|mesh-list
14353237|NCT01004705|Ramipril|ramipril|mesh-list
14353238|NCT01004705|Simvastatin|simvastatin|mesh-list
14353239|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14353240|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14353241|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
14353242|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353243|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14353244|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14353245|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353246|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14353247|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14353248|NCT01004705|Analgesics|analgesics|mesh-ancestor
14353249|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
14353250|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353251|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353252|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353253|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353254|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14353255|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14465293|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14353256|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14353257|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14353258|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
14353259|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14353260|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353261|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14353262|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
14353263|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14353264|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14353265|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353266|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
14353267|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
14353268|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353269|NCT01004744|Anastrozole|anastrozole|mesh-list
14353270|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14353271|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353272|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14353273|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14353274|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353275|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353276|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14353277|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
14353278|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353279|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353280|NCT01004939|PENTA|penta|mesh-list
14353281|NCT01004939|Fondaparinux|fondaparinux|mesh-list
14353282|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14353283|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
14353284|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14353285|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353286|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353287|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353288|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
14353289|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14353290|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14353291|NCT01004991|Prednisone|prednisone|mesh-list
14353292|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
14353293|NCT01004991|Rituximab|rituximab|mesh-list
14353294|NCT01004991|Doxorubicin|doxorubicin|mesh-list
14353295|NCT01004991|Vincristine|vincristine|mesh-list
14353296|NCT01004991|Azacitidine|azacitidine|mesh-list
14353297|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353298|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
14353299|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353300|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353301|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14353302|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
14353303|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353304|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353305|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14353306|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230605|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230606|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230607|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
15230608|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230609|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15230610|NCT04178993|Analgesics|analgesics|mesh-ancestor
15230611|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
15230612|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230613|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
15230614|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14353307|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14353308|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14353309|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14353310|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732193|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14732194|NCT04818450|Gabapentin|gabapentin|mesh-list
14732195|NCT04818450|Analgesics|analgesics|mesh-ancestor
14732196|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
14732197|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732198|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732199|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
14353311|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353312|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
14353313|NCT01004991|Hormones|hormones|mesh-ancestor
14353314|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353315|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14353316|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353317|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14353318|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14353319|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
14353320|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14353321|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
14353322|NCT01005251|Lesogaberan|lesogaberan|mesh-list
14353323|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14353324|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14353325|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
14353326|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
14353327|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353328|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353329|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353330|NCT01005290|Ramipril|ramipril|mesh-list
14353331|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14353332|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353333|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353334|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353335|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14353336|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
14353337|NCT01005316|Prednisone|prednisone|mesh-list
14353338|NCT01005316|Tacrolimus|tacrolimus|mesh-list
14353339|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
14353340|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14353341|NCT01005316|Antibodies|antibodies|mesh-list
14353342|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
14353343|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14353344|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353345|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
14353346|NCT01005316|Hormones|hormones|mesh-ancestor
14353347|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353348|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353349|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14353350|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353351|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353352|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
14353353|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14353354|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353355|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353356|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14353357|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14353358|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
14353359|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14353360|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353361|NCT01005329|Paclitaxel|paclitaxel|mesh-list
14353362|NCT01005329|Bevacizumab|bevacizumab|mesh-list
14353363|NCT01005329|Cisplatin|cisplatin|mesh-list
14353364|NCT01005329|Carboplatin|carboplatin|mesh-list
14353365|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14732200|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14732201|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14353366|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14353367|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
14353368|NCT01005329|Antibodies|antibodies|mesh-list
14353369|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
14353370|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14353371|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
14353372|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353373|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353374|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
14353375|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
14353376|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
14353377|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353378|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14353379|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14353380|NCT01005329|Growth Substances|growth substances|mesh-ancestor
14353381|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353382|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
14353383|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
14353384|NCT01005355|Ramucirumab|ramucirumab|mesh-list
14353385|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353386|NCT01005407|Vaccines|vaccines|mesh-list
14353387|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
14353388|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353389|NCT01005459|Bupivacaine|bupivacaine|mesh-list
14353390|NCT01005459|Tetracaine|tetracaine|mesh-list
14353391|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
14353392|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
14353393|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353394|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353395|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
14353396|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353397|NCT01005576|Fludarabine|fludarabine|mesh-list
14353398|NCT01005576|Melphalan|melphalan|mesh-list
14353399|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
14353400|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353401|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353402|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353403|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
14353404|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353405|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14353406|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
14353407|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14353408|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353409|NCT01005602|Digoxin|digoxin|mesh-list
14353410|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14353411|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14353412|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353413|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353414|NCT01005602|Protective Agents|protective agents|mesh-ancestor
14353415|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353416|NCT01005680|Gemcitabine|gemcitabine|mesh-list
14353417|NCT01005680|Pemetrexed|pemetrexed|mesh-list
14353418|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353419|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14353420|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
14353421|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353422|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
14353423|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353424|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353425|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353426|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
14353427|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353428|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14732202|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732203|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14920279|NCT04699383|Allopurinol|allopurinol|mesh-list
14353429|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14353430|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
14353431|NCT01005706|Sirolimus|sirolimus|mesh-list
14353432|NCT01005706|Tacrolimus|tacrolimus|mesh-list
14353433|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353434|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
14353435|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353436|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14353437|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353438|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353439|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14353440|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353441|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14353442|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
14353443|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14353444|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353445|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
14353446|NCT01005719|Omeprazole|omeprazole|mesh-list
14353447|NCT01005719|Lansoprazole|lansoprazole|mesh-list
14353448|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
14353449|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14353450|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14353451|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14353452|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353453|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465294|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
14465295|NCT02223702|Amoxicillin|amoxicillin|mesh-list
14465296|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
14465297|NCT02223702|Metronidazole|metronidazole|mesh-list
14465298|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14465299|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465300|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14465301|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14465302|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465303|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465304|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465305|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14465306|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14465307|NCT02223871|Lumefantrine|lumefantrine|mesh-list
14465308|NCT02223871|Artemether|artemether|mesh-list
14465309|NCT02223871|Primaquine|primaquine|mesh-list
14465310|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
14465311|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14465312|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14465313|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465314|NCT02224053|Osimertinib|osimertinib|mesh-list
14465315|NCT02224053|Omeprazole|omeprazole|mesh-list
14465316|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14465317|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14465318|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14465319|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465320|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465321|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465322|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14353454|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
14353455|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14353456|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
14353457|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353458|NCT01005810|Expectorants|expectorants|mesh-ancestor
14353459|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353460|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14353461|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
14353462|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353463|NCT01005810|Protective Agents|protective agents|mesh-ancestor
14353464|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353465|NCT01005810|Antidotes|antidotes|mesh-ancestor
14353466|NCT01005875|Sorafenib|sorafenib|mesh-list
14353467|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353468|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14353469|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353470|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353471|NCT01005888|Complement C1s|complement c1s|mesh-list
14353472|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14353473|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14353474|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
14353475|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353476|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14353477|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353478|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
14353479|NCT01005901|Bromides|bromides|mesh-list
14353480|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
14353481|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14353482|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14353483|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14353484|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
14353485|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353486|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353487|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353488|NCT01005966|Listerine|listerine|mesh-list
14353489|NCT01005966|Fluorides|fluorides|mesh-list
14353490|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
14353491|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
14353492|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
14353493|NCT01005966|Protective Agents|protective agents|mesh-ancestor
14353494|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353495|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14353496|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353497|NCT01006252|Paclitaxel|paclitaxel|mesh-list
14353498|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353499|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353500|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14353501|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14353502|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14353503|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353504|NCT01006291|Insulin|insulin|mesh-list
14353505|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14353506|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
14353507|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
14353508|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14353509|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353510|NCT01006356|Hydromorphone|hydromorphone|mesh-list
14353511|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14353512|NCT01006356|Narcotics|narcotics|mesh-ancestor
14353513|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353514|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353515|NCT01006356|Analgesics|analgesics|mesh-ancestor
14353516|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
14353517|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353518|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
14353519|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
14353520|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14353521|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14353522|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353523|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353524|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230615|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
15230616|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
15230617|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
15230618|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15230619|NCT04156828|Gemcitabine|gemcitabine|mesh-list
15230620|NCT04156828|Dexamethasone|dexamethasone|mesh-list
15230621|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
15230622|NCT04156828|Rituximab|rituximab|mesh-list
15230623|NCT04156828|Carboplatin|carboplatin|mesh-list
15230624|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15230625|NCT04156828|Antibodies|antibodies|mesh-list
15230626|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
15230627|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15230628|NCT04156828|Lenograstim|lenograstim|mesh-list
15230629|NCT04156828|BB 1101|bb 1101|mesh-list
15230630|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
15230631|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230632|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230633|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
15230634|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
15230635|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230636|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15230637|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
15230638|NCT04156828|Hormones|hormones|mesh-ancestor
15230639|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230640|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15230641|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353525|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353526|NCT01006538|Ranibizumab|ranibizumab|mesh-list
14353527|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14353528|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14353529|NCT01006538|Growth Substances|growth substances|mesh-ancestor
14353530|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353531|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
14353532|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353533|NCT01006590|Metformin|metformin|mesh-list
14353534|NCT01006590|Saxagliptin|saxagliptin|mesh-list
14353535|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14353536|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353537|NCT01006590|Incretins|incretins|mesh-ancestor
14353538|NCT01006590|Hormones|hormones|mesh-ancestor
14353539|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353540|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14353541|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353542|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353543|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353544|NCT01006603|Glimepiride|glimepiride|mesh-list
14353545|NCT01006603|Saxagliptin|saxagliptin|mesh-list
14732204|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14732205|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14732206|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353546|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14353547|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14353548|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353549|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353550|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
14353551|NCT01006603|Incretins|incretins|mesh-ancestor
14353552|NCT01006603|Hormones|hormones|mesh-ancestor
14353553|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353554|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14353555|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353556|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353557|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353558|NCT01006629|Palivizumab|palivizumab|mesh-list
14353559|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
14353560|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353561|NCT01006655|Beclomethasone|beclomethasone|mesh-list
14353562|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353563|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
14353564|NCT01006655|Hormones|hormones|mesh-ancestor
14353565|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353566|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353567|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14353568|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353569|NCT01006707|Ondansetron|ondansetron|mesh-list
14732207|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353570|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
14353571|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
14353572|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353573|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353574|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14353575|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
15230642|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230643|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230644|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
15230645|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230646|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
15230647|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230648|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230649|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230650|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15230651|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353576|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14353577|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14353578|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
14353579|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353580|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353581|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14353582|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14353583|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353584|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14353585|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14353586|NCT01006889|Exenatide|exenatide|mesh-list
14353587|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14353588|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353589|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14353590|NCT01006889|Incretins|incretins|mesh-ancestor
14353591|NCT01006889|Hormones|hormones|mesh-ancestor
14353592|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353593|NCT01006980|Dacarbazine|dacarbazine|mesh-list
14353594|NCT01006980|Vemurafenib|vemurafenib|mesh-list
14353595|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14353596|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
14353597|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353598|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353599|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14353600|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353601|NCT01007071|Hormones|hormones|mesh-list
14353602|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353603|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353604|NCT01007149|Omalizumab|omalizumab|mesh-list
14353605|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14353606|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14353607|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353608|NCT01007253|Fluticasone|fluticasone|mesh-list
14353609|NCT01007253|Xhance|xhance|mesh-list
14353610|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14353611|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14353612|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353613|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14353614|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
15230652|NCT04107727|Cytarabine|cytarabine|mesh-list
15230653|NCT04107727|Idarubicin|idarubicin|mesh-list
15230654|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230655|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
15230656|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230657|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230658|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
15230659|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353615|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353616|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353617|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14353618|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353619|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
14353620|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14353621|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14353622|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14353623|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14353624|NCT01007253|Analgesics|analgesics|mesh-ancestor
15230660|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230661|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
15230662|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230663|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15230664|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15230665|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15230666|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230667|NCT04107077|Mitomycins|mitomycins|mesh-list
15230668|NCT04107077|Mitomycin|mitomycin|mesh-list
15230669|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230670|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15230671|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
15230672|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230673|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15230674|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230675|NCT04065074|FX006|fx006|mesh-list
15230676|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230677|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
14353625|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
14732208|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
15230678|NCT04065074|Hormones|hormones|mesh-ancestor
14353626|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353627|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14353628|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14353629|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
14353630|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
14353631|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353632|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353633|NCT01007435|Methotrexate|methotrexate|mesh-list
14353634|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14353635|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
14353636|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14353637|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353638|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14353639|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
14353640|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353641|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353642|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14353643|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353644|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14353645|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353646|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
14353647|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353648|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14353649|NCT01007448|Bexarotene|bexarotene|mesh-list
14353650|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353651|NCT01007552|Gemcitabine|gemcitabine|mesh-list
14353652|NCT01007552|Bevacizumab|bevacizumab|mesh-list
14353653|NCT01007552|Capecitabine|capecitabine|mesh-list
14353654|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353655|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353656|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14353657|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14353658|NCT01007552|Growth Substances|growth substances|mesh-ancestor
14353659|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353660|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
14353661|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14353662|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
14353663|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353664|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
14353665|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353666|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353667|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353668|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
14353669|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
14353670|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353671|NCT01007942|Trastuzumab|trastuzumab|mesh-list
14353672|NCT01007942|Everolimus|everolimus|mesh-list
14353673|NCT01007942|Vinorelbine|vinorelbine|mesh-list
14353674|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353675|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353676|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353677|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
14353678|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353679|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353680|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
14353681|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
14353682|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
14353683|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353684|NCT01007994|Propranolol|propranolol|mesh-list
14353685|NCT01007994|Enalapril|enalapril|mesh-list
14353686|NCT01007994|Isradipine|isradipine|mesh-list
14353687|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14353688|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14353689|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
14353690|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353691|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353692|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353693|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14353694|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14353695|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
14353696|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14353697|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353698|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353699|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14353700|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14353701|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14353702|NCT01008059|Alfentanil|alfentanil|mesh-list
14353703|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14353704|NCT01008059|Narcotics|narcotics|mesh-ancestor
14353705|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353706|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353707|NCT01008059|Analgesics|analgesics|mesh-ancestor
14353708|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
14353709|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353710|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14353711|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
14353712|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
14353713|NCT01008150|Paclitaxel|paclitaxel|mesh-list
14353714|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
14353715|NCT01008150|Doxorubicin|doxorubicin|mesh-list
14353716|NCT01008150|Trastuzumab|trastuzumab|mesh-list
14353717|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353718|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353719|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
14353720|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
14353721|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
14353722|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353723|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353724|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
14353725|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353726|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353727|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14353728|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
14353729|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14353730|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14353731|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14353732|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14353733|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353734|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353735|NCT01008280|Baclofen|baclofen|mesh-list
14353736|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14353737|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353738|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14353739|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353740|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14353741|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
14353742|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
15230679|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230680|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230681|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230682|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
15230683|NCT04042116|Nivolumab|nivolumab|mesh-list
14353743|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353744|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353745|NCT01008319|Citric Acid|citric acid|mesh-list
14353746|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
14353747|NCT01008319|Clomiphene|clomiphene|mesh-list
14353748|NCT01008319|Enclomiphene|enclomiphene|mesh-list
14353749|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
14353750|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
14353751|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14353752|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
14353753|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
14353754|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353755|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14353756|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
14353757|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353758|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353759|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14353760|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
14353761|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14353762|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14353763|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14353764|NCT01008410|Budesonide|budesonide|mesh-list
14353765|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353766|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14353767|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
14353768|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353769|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353770|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14353771|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353772|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
14353773|NCT01008410|Hormones|hormones|mesh-ancestor
14353774|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353775|NCT01008423|Budesonide|budesonide|mesh-list
14353776|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14353777|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14353778|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
14353779|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353780|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353781|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14353782|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
14353783|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
14353784|NCT01008423|Hormones|hormones|mesh-ancestor
14353785|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14353786|NCT01008462|Cytarabine|cytarabine|mesh-list
14353787|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
14353788|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
15230684|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230685|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230686|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15230687|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230688|NCT04017390|Allantoin|allantoin|mesh-list
14353789|NCT01008462|Melphalan|melphalan|mesh-list
14353790|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
14353791|NCT01008462|Carmustine|carmustine|mesh-list
14353792|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14353793|NCT01008462|Fludarabine|fludarabine|mesh-list
14353794|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
14353795|NCT01008462|Etoposide|etoposide|mesh-list
14353796|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
14353797|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
14353798|NCT01008462|Tacrolimus|tacrolimus|mesh-list
14353799|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353800|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
14353801|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353802|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14353803|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14353804|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
14353805|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353806|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353807|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14353808|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14353809|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
14353810|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353811|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14353812|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14732209|NCT04817033|Midazolam|midazolam|mesh-list
14732210|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
14732211|NCT04817033|Anesthetics|anesthetics|mesh-list
14732212|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732213|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353813|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353814|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
14353815|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353816|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14353817|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14353818|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14353819|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
14353820|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14353821|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
14353822|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
14353823|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14353824|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14353825|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14353826|NCT01008475|Irinotecan|irinotecan|mesh-list
14353827|NCT01008475|Cetuximab|cetuximab|mesh-list
14353828|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14353829|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14353830|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353831|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353832|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353833|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353834|NCT01008553|Fentanyl|fentanyl|mesh-list
14732214|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14920280|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
14353835|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14353836|NCT01008553|Narcotics|narcotics|mesh-ancestor
14353837|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353838|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353839|NCT01008553|Analgesics|analgesics|mesh-ancestor
14353840|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
14353841|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353842|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14353843|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14353844|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
14353845|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
14353846|NCT01008618|Fentanyl|fentanyl|mesh-list
14353847|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14353848|NCT01008618|Narcotics|narcotics|mesh-ancestor
14353849|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353850|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353851|NCT01008618|Analgesics|analgesics|mesh-ancestor
14353852|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
14353853|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353854|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14353855|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14353856|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
14353857|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
14353858|NCT01008696|Rabeprazole|rabeprazole|mesh-list
14353859|NCT01008696|Lansoprazole|lansoprazole|mesh-list
14353860|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
14353861|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14353862|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14353863|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14353864|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353865|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353866|NCT01008748|Nicotine|nicotine|mesh-list
14353867|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14353868|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
14353869|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14353870|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353871|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14353872|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14353873|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
14353874|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353875|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353876|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
14353877|NCT01008904|Antacids|antacids|mesh-ancestor
14353878|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353879|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14353880|NCT01008995|Ustekinumab|ustekinumab|mesh-list
14353881|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
14353882|NCT01009047|Aripiprazole|aripiprazole|mesh-list
14353883|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14353884|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
14353885|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14353886|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14353887|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14353888|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14353889|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353890|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
14353891|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
14353892|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353893|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353894|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14353895|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14353896|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
14353897|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14353898|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14353899|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14353900|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14353901|NCT01009086|Ustekinumab|ustekinumab|mesh-list
14353902|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14353903|NCT01009203|Sirolimus|sirolimus|mesh-list
14353904|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14353905|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353906|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14353907|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353908|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353909|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14353910|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353911|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14353912|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
14353913|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353914|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
14353915|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353916|NCT01009346|Cisplatin|cisplatin|mesh-list
14353917|NCT01009346|Carboplatin|carboplatin|mesh-list
14353918|NCT01009346|Cetuximab|cetuximab|mesh-list
14353919|NCT01009346|Everolimus|everolimus|mesh-list
14353920|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353921|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14353922|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353923|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
14353924|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353925|NCT01009515|Paclitaxel|paclitaxel|mesh-list
14353926|NCT01009515|Carboplatin|carboplatin|mesh-list
14353927|NCT01009515|Temozolomide|temozolomide|mesh-list
14353928|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14353929|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353930|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
14353931|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
14353932|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
14353933|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353934|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14353935|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
14353936|NCT01009554|Listerine|listerine|mesh-list
14353937|NCT01009554|Fluorides|fluorides|mesh-list
14353938|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
14353939|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
14353940|NCT01009554|Protective Agents|protective agents|mesh-ancestor
14353941|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353942|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14353943|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353944|NCT01009580|Insulin|insulin|mesh-list
14353945|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14353946|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
14353947|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
14353948|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14353949|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
14353950|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14353951|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14353952|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353953|NCT01009619|Azithromycin|azithromycin|mesh-list
14353954|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14353955|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353956|NCT01009814|Ritonavir|ritonavir|mesh-list
14353957|NCT01009814|Fostemsavir|fostemsavir|mesh-list
14353958|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14353959|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14353960|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
14353961|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14353962|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230689|NCT04017390|Dermatologic Agents|dermatologic agents|mesh-ancestor
15230690|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
15230691|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
15230692|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15230693|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15230694|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230695|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230696|NCT03997097|Urological Agents|urological agents|mesh-ancestor
15230697|NCT03979885|Nicotine|nicotine|mesh-list
15230698|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15230699|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
15230700|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230701|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230702|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15230703|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15230704|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
15230705|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230706|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230707|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
15230708|NCT03970252|Leucovorin|leucovorin|mesh-list
15230709|NCT03970252|Folic Acid|folic acid|mesh-list
15230710|NCT03970252|Fluorouracil|fluorouracil|mesh-list
15230711|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
15230712|NCT03970252|Nivolumab|nivolumab|mesh-list
15230713|NCT03970252|Irinotecan|irinotecan|mesh-list
15230714|NCT03970252|Camptothecin|camptothecin|mesh-list
15230715|NCT03970252|Calcium|calcium|mesh-list
15230716|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
14353963|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14353964|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14353965|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
14353966|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14353967|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14353968|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14353969|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14353970|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14353971|NCT01009840|Bortezomib|bortezomib|mesh-list
14353972|NCT01009840|Busulfan|busulfan|mesh-list
14353973|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14353974|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
14353975|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353976|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14353977|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
14353978|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230717|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15230718|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465323|NCT02224157|Budesonide|budesonide|mesh-list
15230719|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14353979|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14353980|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14353981|NCT01009918|Carvedilol|carvedilol|mesh-list
14353982|NCT01009918|Lisinopril|lisinopril|mesh-list
14353983|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14353984|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14353985|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
14353986|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14353987|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14353988|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14353989|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14353990|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
14353991|NCT01009918|Protective Agents|protective agents|mesh-ancestor
14353992|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14353993|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14353994|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14353995|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
14353996|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14353997|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14353998|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14353999|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
14354000|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354001|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14354002|NCT01009983|Paclitaxel|paclitaxel|mesh-list
14354003|NCT01009983|Carboplatin|carboplatin|mesh-list
14354004|NCT01009983|Panitumumab|panitumumab|mesh-list
14354005|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14354006|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354007|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354008|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354009|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354010|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354011|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354012|NCT01010009|Resveratrol|resveratrol|mesh-list
14354013|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
14354014|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354015|NCT01010009|Protective Agents|protective agents|mesh-ancestor
14354016|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354017|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354018|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14354019|NCT01010061|Rituximab|rituximab|mesh-list
14354020|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
14354021|NCT01010061|Chlorambucil|chlorambucil|mesh-list
14354022|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354023|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354024|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
14732215|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14732216|NCT04817033|Analgesics|analgesics|mesh-ancestor
14732217|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
14732218|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732219|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14732220|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14732221|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14920281|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920282|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230720|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
14732222|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
14920283|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
14920284|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230721|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230722|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230723|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230724|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230725|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
15230726|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230727|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15230728|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15230729|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15230730|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230731|NCT03970252|Antidotes|antidotes|mesh-ancestor
15230732|NCT03970252|Protective Agents|protective agents|mesh-ancestor
15230733|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
15230734|NCT03970252|Vitamins|vitamins|mesh-ancestor
14354025|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354026|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354027|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14354028|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
14354029|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354030|NCT01010126|Sirolimus|sirolimus|mesh-list
14354031|NCT01010126|Bevacizumab|bevacizumab|mesh-list
14354032|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14354033|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
14354034|NCT01010126|Antibodies|antibodies|mesh-list
14354035|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
14354036|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14354037|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
14354038|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354039|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14354040|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14354041|NCT01010126|Growth Substances|growth substances|mesh-ancestor
14354042|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354043|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
14354044|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
14354045|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354046|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354047|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14354048|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
14354049|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354050|NCT01010204|Varenicline|varenicline|mesh-list
14354051|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14354052|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14354053|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
14354054|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354055|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354056|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354057|NCT01010217|Vidarabine|vidarabine|mesh-list
14354058|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
14354059|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
14354060|NCT01010217|Melphalan|melphalan|mesh-list
14354061|NCT01010217|Thiotepa|thiotepa|mesh-list
14354062|NCT01010217|Rituximab|rituximab|mesh-list
14354063|NCT01010217|Fludarabine|fludarabine|mesh-list
14354064|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
14354065|NCT01010217|Tacrolimus|tacrolimus|mesh-list
14354066|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354067|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
14354068|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354069|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354070|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14354071|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
14354072|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354073|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354074|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14354075|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354076|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14354077|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
14354078|NCT01010217|Antiviral Agents|antiviral agents|mesh-ancestor
14354079|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354080|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14354081|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920285|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14354082|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14354083|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14465324|NCT02224157|Terbutaline|terbutaline|mesh-list
15230735|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
15230736|NCT03970252|Hematinics|hematinics|mesh-ancestor
15230737|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15230738|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15230739|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230740|NCT03951961|Midostaurin|midostaurin|mesh-list
14354084|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
14354085|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354086|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14354087|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
14354088|NCT01010282|Glycerol|glycerol|mesh-list
14354089|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14354090|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14354091|NCT01010282|Laxatives|laxatives|mesh-ancestor
14354092|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14354093|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14354094|NCT01010282|Protective Agents|protective agents|mesh-ancestor
14354095|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354096|NCT01010399|Ritonavir|ritonavir|mesh-list
14354097|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
14354098|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14354099|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14354100|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
14354101|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354102|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354103|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14354104|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14354105|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
14354106|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354107|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14354108|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14354109|NCT01010477|Nicotine|nicotine|mesh-list
14732223|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732224|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732225|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14732226|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14732227|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14732228|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14732229|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14732230|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
14732231|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
14732232|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
14732233|NCT04813926|Riociguat|riociguat|mesh-list
14732234|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
14732235|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732236|NCT04778410|Cytarabine|cytarabine|mesh-list
14732237|NCT04778410|Etoposide|etoposide|mesh-list
14732238|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
14354110|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14354111|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
14354112|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354113|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354114|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14354115|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14354116|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
14354117|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354118|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354119|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14354120|NCT01010568|Ofatumumab|ofatumumab|mesh-list
14354121|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14354122|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14354123|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
14354124|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354125|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354126|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
14354127|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354128|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14354129|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14354130|NCT01010750|Amphetamine|amphetamine|mesh-list
14354131|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14354132|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14354133|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354134|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
14732239|NCT04778410|Azacitidine|azacitidine|mesh-list
14732240|NCT04778410|Venetoclax|venetoclax|mesh-list
14732241|NCT04778410|Cc-486|cc-486|mesh-list
15230741|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354135|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
14354136|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354137|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
14354138|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354139|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354140|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
14354141|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14354142|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14354143|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14354144|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14354145|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14354146|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14354147|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14354148|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14354149|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354150|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14354151|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14354152|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14354153|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
14354154|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354155|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354156|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14354157|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14354158|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
14465325|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
14465326|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465327|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14465328|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
14465329|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465330|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465331|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14465332|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
14465333|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
14465334|NCT02224157|Hormones|hormones|mesh-ancestor
14465335|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465336|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14465337|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14465338|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14465339|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14465340|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465341|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465342|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
14465343|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
14465344|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14465345|NCT02224274|Clopidogrel|clopidogrel|mesh-list
14465346|NCT02224274|Ticagrelor|ticagrelor|mesh-list
14465347|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14465348|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14465349|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14465350|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14465351|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
14732242|NCT04778410|Magrolimab|magrolimab|mesh-list
15230742|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15230743|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230744|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230745|NCT03949153|Nivolumab|nivolumab|mesh-list
15230746|NCT03949153|Ipilimumab|ipilimumab|mesh-list
15230747|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230748|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230749|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15230750|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230751|NCT03947216|Pimavanserin|pimavanserin|mesh-list
14465352|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465353|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354159|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14354160|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
14354161|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
14354162|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354163|NCT01010971|Ciclesonide|ciclesonide|mesh-list
14354164|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
14354165|NCT01010971|Hormones|hormones|mesh-ancestor
14354166|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354167|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354168|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14354169|NCT01010984|Doxorubicin|doxorubicin|mesh-list
14354170|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14354171|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354172|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14354173|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14354174|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354175|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354176|NCT01011049|Vaccines|vaccines|mesh-list
14354177|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
14354178|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354179|NCT01011075|Paclitaxel|paclitaxel|mesh-list
14354180|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
14354181|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14354182|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354183|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354184|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354185|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354186|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354187|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14354188|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354189|NCT01011218|Modafinil|modafinil|mesh-list
14354190|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14354191|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354192|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14354193|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14354194|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14354195|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354196|NCT01011283|Azacitidine|azacitidine|mesh-list
14354197|NCT01011283|Decitabine|decitabine|mesh-list
14354198|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14354199|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
14354200|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354201|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354202|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354203|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14354204|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14354205|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14354206|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354207|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
14354208|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14354209|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
14354210|NCT01011413|Efavirenz|efavirenz|mesh-list
14354211|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14354212|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14354213|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354214|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354215|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
14354216|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354217|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14354218|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14354219|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14354220|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14354221|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14354222|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14354223|NCT01011439|Maleic acid|maleic acid|mesh-list
14354224|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354225|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354226|NCT01011465|Oxytocin|oxytocin|mesh-list
14354227|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
14354228|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14354229|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354230|NCT01011556|Teriparatide|teriparatide|mesh-list
14354231|NCT01011556|Hormones|hormones|mesh-list
14354232|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
14354233|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354234|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354235|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14354236|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14354237|NCT01011673|Ketorolac|ketorolac|mesh-list
14354238|NCT01011673|Metoclopramide|metoclopramide|mesh-list
14354239|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14354240|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14354241|NCT01011673|Analgesics|analgesics|mesh-ancestor
14354242|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
14354243|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354244|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354245|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14354246|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354247|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14354248|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354249|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354250|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
14354251|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
14354252|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14354253|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14354254|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14354255|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
14354256|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354257|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14354258|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
14354259|NCT01011816|Coagulants|coagulants|mesh-ancestor
14354260|NCT01011829|Varenicline|varenicline|mesh-list
14354261|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14354262|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14354263|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
14354264|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354265|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354266|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354267|NCT01011868|Empagliflozin|empagliflozin|mesh-list
14732243|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14354268|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14354269|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354270|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14354271|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354272|NCT01011894|Lenalidomide|lenalidomide|mesh-list
14354273|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
14354274|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354275|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14354276|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14354277|NCT01011894|Growth Substances|growth substances|mesh-ancestor
14354278|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
14354279|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354280|NCT01011907|Varenicline|varenicline|mesh-list
14354281|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14354282|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14354283|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
14732244|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354284|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354285|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354286|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354287|NCT01012037|Linagliptin|linagliptin|mesh-list
14354288|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14354289|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354290|NCT01012037|Incretins|incretins|mesh-ancestor
14354291|NCT01012037|Hormones|hormones|mesh-ancestor
14354292|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354293|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14354294|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
14354295|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354296|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354297|NCT01012089|Daptomycin|daptomycin|mesh-list
14354298|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354299|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354300|NCT01012219|Aspirin|aspirin|mesh-list
14354301|NCT01012219|Niacin|niacin|mesh-list
14354302|NCT01012219|Clopidogrel|clopidogrel|mesh-list
14354303|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14354304|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14354305|NCT01012219|Analgesics|analgesics|mesh-ancestor
14354306|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
14354307|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354308|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354309|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14354310|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354311|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14354312|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14354313|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354314|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14354315|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14354316|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354317|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
14354318|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14354319|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14354320|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14354321|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
14354322|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354323|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14354324|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
14354325|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14354326|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
14354327|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
14354328|NCT01012219|Vitamins|vitamins|mesh-ancestor
14354329|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
14354330|NCT01012258|Cetuximab|cetuximab|mesh-list
14354331|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354332|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354333|NCT01012297|Gemcitabine|gemcitabine|mesh-list
14354334|NCT01012297|Bevacizumab|bevacizumab|mesh-list
14354335|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14354336|NCT01012297|Docetaxel|docetaxel|mesh-list
14354337|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
14354338|NCT01012297|Antibodies|antibodies|mesh-list
14354339|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
14354340|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14354341|NCT01012297|Lenograstim|lenograstim|mesh-list
14354342|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
14354343|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920286|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
14732245|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14354344|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14354345|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14354346|NCT01012297|Growth Substances|growth substances|mesh-ancestor
14354347|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354348|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
14354349|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
14354350|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14354351|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
14354352|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354353|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
14354354|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354355|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354356|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354357|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354358|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354359|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354360|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14354361|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
14354362|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
14354363|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354364|NCT01012336|Dexamethasone|dexamethasone|mesh-list
14354365|NCT01012336|Aprepitant|aprepitant|mesh-list
14354366|NCT01012336|Ramosetron|ramosetron|mesh-list
14354367|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14354368|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
14354369|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
14354370|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354371|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354372|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14354373|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
14354374|NCT01012336|Hormones|hormones|mesh-ancestor
14354375|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354376|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14354377|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354378|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14354379|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354380|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354381|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14354382|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
14354383|NCT01012492|Abatacept|abatacept|mesh-list
14354384|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14354385|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354386|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354387|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354388|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
14354389|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354390|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354391|NCT01012622|Methylphenidate|methylphenidate|mesh-list
14354392|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14354393|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354394|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14354395|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14354396|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14354397|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354398|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
14354399|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354400|NCT01012661|Lidocaine|lidocaine|mesh-list
14354401|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
14354402|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
14354403|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14354404|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354405|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
14354406|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354407|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14354408|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14354409|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14354410|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465354|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465355|NCT02224313|Estradiol|estradiol|mesh-list
14465356|NCT02224313|Progesterone|progesterone|mesh-list
14465357|NCT02224313|Estrogens|estrogens|mesh-ancestor
14465358|NCT02224313|Hormones|hormones|mesh-ancestor
14465359|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354411|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354412|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14354413|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
14354414|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
14354415|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354416|NCT01012713|Calcitriol|calcitriol|mesh-list
14354417|NCT01012713|Clobetasol|clobetasol|mesh-list
14354418|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14354419|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
14354420|NCT01012713|Hormones|hormones|mesh-ancestor
14354421|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354422|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732246|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14732247|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732248|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732249|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14732250|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
14732251|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
14732252|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732253|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732254|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
14732255|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732256|NCT04778410|Analgesics|analgesics|mesh-ancestor
14732257|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
15230752|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15230753|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15230754|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15230755|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15230756|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230757|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230758|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15230759|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15230760|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15230761|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
15230762|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354423|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14354424|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14354425|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14354426|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354427|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14354428|NCT01012713|Vitamins|vitamins|mesh-ancestor
14354429|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
14354430|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14354431|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
14354432|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14354433|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
14354434|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354435|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354436|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14354437|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
14354438|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
14354439|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14354440|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
14354441|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354442|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354443|NCT01012973|Aflibercept|aflibercept|mesh-list
14354444|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14354445|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14354446|NCT01012973|Growth Substances|growth substances|mesh-ancestor
14354447|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354448|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
14354449|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354450|NCT01012999|Sufentanil|sufentanil|mesh-list
14354451|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14354452|NCT01012999|Narcotics|narcotics|mesh-ancestor
14354453|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14354454|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354455|NCT01012999|Analgesics|analgesics|mesh-ancestor
14354456|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
14354457|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354458|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14354459|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14354460|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
14354461|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
14354462|NCT01013285|Bevacizumab|bevacizumab|mesh-list
14354463|NCT01013285|Temozolomide|temozolomide|mesh-list
14354464|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354465|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354466|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14354467|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14354468|NCT01013285|Growth Substances|growth substances|mesh-ancestor
14354469|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354470|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
14354471|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14354472|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
14354473|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354474|NCT01013597|Panobinostat|panobinostat|mesh-list
14354475|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920287|NCT04699383|Protective Agents|protective agents|mesh-ancestor
14732258|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732259|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732260|NCT04775082|Liraglutide|liraglutide|mesh-list
14732261|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732262|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354476|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14354477|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354478|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354479|NCT01013740|Capecitabine|capecitabine|mesh-list
14354480|NCT01013740|Vinorelbine|vinorelbine|mesh-list
14354481|NCT01013740|Lapatinib|lapatinib|mesh-list
14354482|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14354483|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
14354484|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354485|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354486|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14354487|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354488|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354489|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354490|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14354491|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354492|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
14354493|NCT01013753|Olodaterol|olodaterol|mesh-list
14354494|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14354495|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
14354496|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354497|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354498|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14354499|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
14354500|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14354501|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14354502|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14354503|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
14354504|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354505|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354506|NCT01013870|Atorvastatin|atorvastatin|mesh-list
14354507|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14354508|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14354509|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
14354510|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354511|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14354512|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14354513|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354514|NCT01013961|Rituximab|rituximab|mesh-list
14354515|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
14354516|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354517|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354518|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
14354519|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354520|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354521|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
14354522|NCT01014013|Ertapenem|ertapenem|mesh-list
14354523|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354524|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354525|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
14354526|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14354527|NCT01014143|Triclosan|triclosan|mesh-list
14354528|NCT01014143|Fluorides|fluorides|mesh-list
14354529|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
14354530|NCT01014143|Protective Agents|protective agents|mesh-ancestor
14354531|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354532|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14354533|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354534|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
14732263|NCT04775082|Incretins|incretins|mesh-ancestor
14732264|NCT04775082|Hormones|hormones|mesh-ancestor
14354535|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14354536|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14354537|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14354538|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
14354539|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354540|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14354541|NCT01014208|Rituximab|rituximab|mesh-list
14354542|NCT01014208|Ofatumumab|ofatumumab|mesh-list
14354543|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354544|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354545|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
14354546|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354547|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354548|NCT01014351|Paclitaxel|paclitaxel|mesh-list
14354549|NCT01014351|Carboplatin|carboplatin|mesh-list
14354550|NCT01014351|Everolimus|everolimus|mesh-list
14354551|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14354552|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354553|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354554|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354555|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354556|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354557|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354558|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
14354559|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354560|NCT01014403|Enoxaparin|enoxaparin|mesh-list
14354561|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
14354562|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14354563|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14354564|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354565|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
14354566|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14354567|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354568|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14354569|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
14354570|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354571|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354572|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354573|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354574|NCT01014533|Gabapentin|gabapentin|mesh-list
14354575|NCT01014533|Analgesics|analgesics|mesh-ancestor
14354576|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
14354577|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354578|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354579|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
14354580|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14354581|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14354582|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230763|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230764|NCT03939520|Pirfenidone|pirfenidone|mesh-list
15230765|NCT03939520|Nintedanib|nintedanib|mesh-list
15230766|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230767|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15230768|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230769|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230770|NCT03939520|Analgesics|analgesics|mesh-ancestor
15230771|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
15230772|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230773|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354583|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14354584|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14354585|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14354586|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354587|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354588|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
14354589|NCT01014585|Milnacipran|milnacipran|mesh-list
14354590|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
14354591|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14354592|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14354593|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14354594|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354595|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354596|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230774|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14354597|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14354598|NCT01014585|Analgesics|analgesics|mesh-ancestor
14354599|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
14354600|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354601|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
14354602|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14354603|NCT01014624|Clopidogrel|clopidogrel|mesh-list
14354604|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14354605|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14354606|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14354607|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14354608|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14354609|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
14354610|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354611|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354612|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354613|NCT01014689|Lymecycline|lymecycline|mesh-list
14354614|NCT01014689|Adapalene|adapalene|mesh-list
14354615|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14354616|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14354617|NCT01014689|Analgesics|analgesics|mesh-ancestor
14354618|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
14354619|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354620|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354621|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14354622|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354623|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
14354624|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354625|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354626|NCT01014728|Propofol|propofol|mesh-list
14354627|NCT01014728|Sevoflurane|sevoflurane|mesh-list
14354628|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14354629|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14354630|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354631|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14354632|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
14354633|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
14354634|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14354635|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14732265|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732266|NCT04759144|Insulin|insulin|mesh-list
14732267|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14732268|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
15230775|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15230776|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230777|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354636|NCT01014741|Ibutilide|ibutilide|mesh-list
15230778|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
15230779|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15230780|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230781|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
15230782|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
15230783|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230784|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
14354637|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14354638|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
14732269|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
14354639|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14354640|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14354641|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14354642|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14354643|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354644|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
14354645|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354646|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354647|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14354648|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354649|NCT01014936|Tepotinib|tepotinib|mesh-list
14354650|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354651|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
14354652|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14354653|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14354654|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354655|NCT01014988|Zanamivir|zanamivir|mesh-list
14354656|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
14354657|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354658|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354659|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354660|NCT01015118|Paclitaxel|paclitaxel|mesh-list
14354661|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14354662|NCT01015118|Carboplatin|carboplatin|mesh-list
14354663|NCT01015118|Nintedanib|nintedanib|mesh-list
14354664|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14354665|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354666|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354667|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354668|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354669|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354670|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14354671|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354672|NCT01015131|Alovudine|alovudine|mesh-list
14354673|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
14354674|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354675|NCT01015170|Bupropion|bupropion|mesh-list
14354676|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14354677|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
14354678|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14354679|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14354680|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14354681|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14354682|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354683|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
14354684|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354685|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354686|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14354687|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14354688|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354689|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14354690|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14354691|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
14354692|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354693|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
14354694|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354695|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354696|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14354697|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
14354698|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354699|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354700|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14354701|NCT01015534|Temozolomide|temozolomide|mesh-list
14354702|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14354703|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
14354704|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354705|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354706|NCT01015560|Antibodies|antibodies|mesh-list
14354707|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14354708|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
14354709|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354710|NCT01015586|Lamotrigine|lamotrigine|mesh-list
14354711|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
14354712|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14354713|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14354714|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354715|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14354716|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354717|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14354718|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14354719|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14354720|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14354721|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14354722|NCT01015638|Clindamycin|clindamycin|mesh-list
14354723|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
14354724|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
14354725|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14354726|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354727|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354728|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14354729|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354730|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354731|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
14354732|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14354733|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14354734|NCT01015677|Estradiol|estradiol|mesh-list
14354735|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14354736|NCT01015677|Estrogens|estrogens|mesh-ancestor
14354737|NCT01015677|Hormones|hormones|mesh-ancestor
14354738|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354739|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354740|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14354741|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
14354742|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14354743|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14354744|NCT01015807|Clonidine|clonidine|mesh-list
14354745|NCT01015807|Bupivacaine|bupivacaine|mesh-list
14354746|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
14354747|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
14354748|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732270|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14732271|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732272|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732273|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14732274|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14732275|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14732276|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732277|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
14732278|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354749|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354750|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
14354751|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354752|NCT01015807|Analgesics|analgesics|mesh-ancestor
14354753|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14354754|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
14354755|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
14354756|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14354757|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14354758|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14354759|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
14354760|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354761|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354762|NCT01016015|Sirolimus|sirolimus|mesh-list
14354763|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14732279|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732280|NCT04748172|Antibodies|antibodies|mesh-list
14732281|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
14732282|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732283|NCT04743661|Antipyretics|antipyretics|mesh-list
14732284|NCT04743661|Dexamethasone|dexamethasone|mesh-list
14732285|NCT04743661|Bevacizumab|bevacizumab|mesh-list
14732286|NCT04743661|Irinotecan|irinotecan|mesh-list
14732287|NCT04743661|Temozolomide|temozolomide|mesh-list
14732288|NCT04743661|Antiemetics|antiemetics|mesh-list
14732289|NCT04743661|Emetics|emetics|mesh-list
14732290|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
14732291|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14732292|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732293|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732294|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14732295|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14732296|NCT04743661|Growth Substances|growth substances|mesh-ancestor
14732297|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732298|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732299|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14354764|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14732300|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
14732301|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920288|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354765|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354766|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14354767|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354768|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
14354769|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354770|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
14354771|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465360|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465361|NCT02224313|Progestins|progestins|mesh-ancestor
14465362|NCT02224560|Cannabidiol|cannabidiol|mesh-list
14465363|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
14465364|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
14465365|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14465366|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14465367|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465368|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
14465369|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469869|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14469870|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469871|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
14469872|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469873|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14469874|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14469875|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14469876|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469877|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469878|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469879|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14469880|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
14469881|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14920289|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14920290|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14920291|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920292|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
14920293|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14920294|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
14920295|NCT04697719|Aspirin|aspirin|mesh-list
14920296|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14920297|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14920298|NCT04697719|Analgesics|analgesics|mesh-ancestor
14920299|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
14920300|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920301|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920302|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14920303|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920304|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14920305|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14920306|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920307|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15230785|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354772|NCT01016262|Mesalamine|mesalamine|mesh-list
14354773|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14354774|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14354775|NCT01016262|Analgesics|analgesics|mesh-ancestor
14354776|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
14354777|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354778|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354779|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230786|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230787|NCT03906292|Niacinamide|niacinamide|mesh-list
15230788|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
15230789|NCT03906292|Dasatinib|dasatinib|mesh-list
15230790|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230791|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14354780|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230792|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230793|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230794|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
15230795|NCT03906292|Vitamins|vitamins|mesh-ancestor
15230796|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
15230797|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230798|NCT03891901|Isoniazid|isoniazid|mesh-list
15230799|NCT03891901|Rifabutin|rifabutin|mesh-list
14354781|NCT01016483|Gemcitabine|gemcitabine|mesh-list
14354782|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230800|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
14354783|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
14354784|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354785|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354786|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
14354787|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354788|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354789|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354790|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
14354791|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354792|NCT01016600|Lenalidomide|lenalidomide|mesh-list
14354793|NCT01016600|Azacitidine|azacitidine|mesh-list
14354794|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
14354795|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354796|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14354797|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14354798|NCT01016600|Growth Substances|growth substances|mesh-ancestor
14354799|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
15230801|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230802|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15230803|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230804|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230805|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
15230806|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15230807|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230808|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15230809|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15230810|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
14354800|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354801|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14354802|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
14354803|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354804|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354805|NCT01016678|Naproxen|naproxen|mesh-list
14354806|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14354807|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14354808|NCT01016678|Analgesics|analgesics|mesh-ancestor
14354809|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
14354810|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354811|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354812|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14354813|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354814|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
14354815|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14354816|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354817|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354818|NCT01016691|Bimatoprost|bimatoprost|mesh-list
14354819|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14354820|NCT01016769|Sirolimus|sirolimus|mesh-list
14354821|NCT01016769|Paclitaxel|paclitaxel|mesh-list
14354822|NCT01016769|Carboplatin|carboplatin|mesh-list
14354823|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14354824|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354825|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354826|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354827|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354828|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354829|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354830|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354831|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14354832|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
14354833|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354834|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
14354835|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354836|NCT01016834|Sumatriptan|sumatriptan|mesh-list
14354837|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14354838|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14354839|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14354840|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
14354841|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354842|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354843|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354844|NCT01016912|Ribavirin|ribavirin|mesh-list
14354845|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14354846|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
14354847|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354848|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
14354849|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354850|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
14354851|NCT01016977|Clindamycin|clindamycin|mesh-list
14354852|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
14354853|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
14354854|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14354855|NCT01016977|Tazarotene|tazarotene|mesh-list
14354856|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354857|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354858|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14354859|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354860|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354861|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
14354862|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
14354863|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
14354864|NCT01016977|Vitamins|vitamins|mesh-ancestor
14354865|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
14354866|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354867|NCT01017003|Colchicine|colchicine|mesh-list
14354868|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
14354869|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354870|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354871|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354872|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354873|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354874|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354875|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
14354876|NCT01017029|Everolimus|everolimus|mesh-list
14354877|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354878|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14354879|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
14354880|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354881|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14354882|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14732302|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14732303|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
14354883|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
14354884|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14465370|NCT02224690|Cannabidiol|cannabidiol|mesh-list
14732304|NCT04743661|Hormones|hormones|mesh-ancestor
14354885|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354886|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354887|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354888|NCT01017042|Colchicine|colchicine|mesh-list
14354889|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
14354890|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14354891|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14354892|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14354893|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14354894|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354895|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354896|NCT01017120|Tazarotene|tazarotene|mesh-list
14354897|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
14354898|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
14354899|NCT01017146|Tazarotene|tazarotene|mesh-list
14732305|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14354900|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
14354901|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
14354902|NCT01017237|Midazolam|midazolam|mesh-list
14354903|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
14354904|NCT01017237|Ketamine|ketamine|mesh-list
14354905|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14354906|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14354907|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354908|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14354909|NCT01017237|Analgesics|analgesics|mesh-ancestor
14354910|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
14354911|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354912|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14354913|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14354914|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14354915|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
14354916|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354917|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354918|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14354919|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14354920|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
14354921|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
14354922|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14354923|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14354924|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14354925|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14354926|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14354927|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14354928|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
14354929|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
14354930|NCT01017250|Bevacizumab|bevacizumab|mesh-list
14354931|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354932|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354933|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14354934|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14354935|NCT01017250|Growth Substances|growth substances|mesh-ancestor
14354936|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354937|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
14354938|NCT01017575|Ribavirin|ribavirin|mesh-list
14354939|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14354940|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
14354941|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230811|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15230812|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15230813|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
15230814|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230815|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230816|NCT03793010|FX006|fx006|mesh-list
15230817|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230818|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
15230819|NCT03793010|Hormones|hormones|mesh-ancestor
15230820|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230821|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230822|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230823|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
15230824|NCT03781219|Vemurafenib|vemurafenib|mesh-list
15230825|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354942|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
15230826|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14354943|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354944|NCT01017653|Irinotecan|irinotecan|mesh-list
14354945|NCT01017653|Panitumumab|panitumumab|mesh-list
14354946|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14354947|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14354948|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354949|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354950|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354951|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14354952|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
14354953|NCT01017731|Promethazine|promethazine|mesh-list
14354954|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
14354955|NCT01017731|Ramucirumab|ramucirumab|mesh-list
14354956|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14354957|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14354958|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14354959|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14354960|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354961|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354962|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354963|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354964|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14354965|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14354966|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14354967|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
14354968|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
14732306|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14732307|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14732308|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14732309|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354969|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
14354970|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14354971|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
14354972|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
14354973|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14354974|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14354975|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
14354976|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
14354977|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15230827|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230828|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230829|NCT03728556|Antibodies|antibodies|mesh-list
15230830|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15230831|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
15230832|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230833|NCT03684980|Leucovorin|leucovorin|mesh-list
15230834|NCT03684980|Rituximab|rituximab|mesh-list
15230835|NCT03684980|Methotrexate|methotrexate|mesh-list
15230836|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230837|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230838|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
15230839|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230840|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230841|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15230842|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
15230843|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15230844|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230845|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
15230846|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230847|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
15230848|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230849|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14354978|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14354979|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
14354980|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
14354981|NCT01017874|Pemetrexed|pemetrexed|mesh-list
14354982|NCT01017874|Gefitinib|gefitinib|mesh-list
14354983|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14354984|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14354985|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354986|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14354987|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14354988|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14354989|NCT01018056|Riluzole|riluzole|mesh-list
14354990|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
14354991|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14354992|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14354993|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14354994|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14354995|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14354996|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14354997|NCT01018056|Protective Agents|protective agents|mesh-ancestor
14354998|NCT01018095|Metronidazole|metronidazole|mesh-list
14354999|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355000|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355001|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14355002|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14355003|NCT01018134|Desoximetasone|desoximetasone|mesh-list
14355004|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355005|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
14355006|NCT01018134|Hormones|hormones|mesh-ancestor
14355007|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355008|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355009|NCT01018186|Fluticasone|fluticasone|mesh-list
14355010|NCT01018186|Xhance|xhance|mesh-list
14355011|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355012|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14355013|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
14355014|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355015|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355016|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14355017|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
14355018|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
14355019|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14355020|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
14355021|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14355022|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14355023|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355024|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355025|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355026|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355027|NCT01018264|Urological Agents|urological agents|mesh-ancestor
14355028|NCT01018394|Nicotine|nicotine|mesh-list
14355029|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14355030|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
14355031|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355032|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355033|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14355034|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14355035|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355036|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355037|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355038|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
14355039|NCT01018420|Colchicine|colchicine|mesh-list
15230850|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230851|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15230852|NCT03684980|Antidotes|antidotes|mesh-ancestor
14355040|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355041|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355042|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14355043|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14355044|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355045|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355046|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355047|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
14355048|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355049|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732310|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732311|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15230853|NCT03684980|Protective Agents|protective agents|mesh-ancestor
15230854|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
14355050|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14355051|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14355052|NCT01018511|Tamsulosin|tamsulosin|mesh-list
14355053|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
14355054|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14355055|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14355056|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14355057|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
14355058|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355059|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355060|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355061|NCT01018511|Urological Agents|urological agents|mesh-ancestor
15230855|NCT03684980|Vitamins|vitamins|mesh-ancestor
15230856|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
15230857|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
15230858|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230859|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230860|NCT03596905|Plecanatide|plecanatide|mesh-list
15230861|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15230862|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
15230863|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230864|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15230865|NCT03560531|Palbociclib|palbociclib|mesh-list
15230866|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230867|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15230868|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355062|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14355063|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14732312|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
14920308|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14920309|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920310|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
14920311|NCT04690686|Paclitaxel|paclitaxel|mesh-list
14920312|NCT04690686|Atezolizumab|atezolizumab|mesh-list
14920313|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14920314|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920315|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
14920316|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
14920317|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
14920318|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920319|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
14920320|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14920321|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920322|NCT04682626|Vitamins|vitamins|mesh-ancestor
14920323|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
14920324|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14920325|NCT04679818|Fentanyl|fentanyl|mesh-list
14920326|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
14920327|NCT04679818|Narcotics|narcotics|mesh-ancestor
14920328|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920329|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920330|NCT04679818|Analgesics|analgesics|mesh-ancestor
14920331|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
14920332|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920333|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14920334|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14920335|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
14920336|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
14920337|NCT04674514|Dexamethasone|dexamethasone|mesh-list
14920338|NCT04674514|Lenalidomide|lenalidomide|mesh-list
14355064|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355065|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14355066|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14355067|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14355068|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14355069|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355070|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355071|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355072|NCT01018680|Analgesics|analgesics|mesh-ancestor
14355073|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
14355074|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355075|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
14355076|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355077|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
14355078|NCT01018732|Lactitol|lactitol|mesh-list
14355079|NCT01018732|Cathartics|cathartics|mesh-ancestor
14355080|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14355081|NCT01018862|Azelastine|azelastine|mesh-list
14355082|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14355083|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
14355084|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355085|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920339|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355086|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14355087|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14355088|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14355089|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355090|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355091|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14355092|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14355093|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14355094|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
14355095|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
14355096|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355097|NCT01019317|Vidarabine|vidarabine|mesh-list
14355098|NCT01019317|Cytarabine|cytarabine|mesh-list
14732313|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
15230869|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230870|NCT03529942|FX006|fx006|mesh-list
14355099|NCT01019317|Fludarabine|fludarabine|mesh-list
14355100|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
14355101|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355102|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14355103|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
14355104|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355105|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355106|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
14355107|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355108|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
14355109|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355110|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14355111|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
14355112|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14355113|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14355114|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14355115|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
14355116|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14355117|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355118|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14355119|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14355120|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14355121|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14355122|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355123|NCT01019486|Regadenoson|regadenoson|mesh-list
14355124|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14355125|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14355126|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14355127|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
14355128|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
14355129|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355130|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355131|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355132|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14355133|NCT01019694|Albuterol|albuterol|mesh-list
14355134|NCT01019694|Ipratropium|ipratropium|mesh-list
14355135|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15230871|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230872|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
15230873|NCT03529942|Hormones|hormones|mesh-ancestor
15230874|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15230875|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230876|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230877|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
15230878|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
14355136|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
14355137|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355138|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355139|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14355140|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
14355141|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
14355142|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14355143|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14355144|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14355145|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14355146|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
14355147|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355148|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355149|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14355150|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355151|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14355152|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14355153|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14355154|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14355155|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355156|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
14355157|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355158|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355159|NCT01020006|Gemcitabine|gemcitabine|mesh-list
14355160|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14355161|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
14355162|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355163|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355164|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
14355165|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355166|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355167|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355168|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
14355169|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355170|NCT01020019|Lofexidine|lofexidine|mesh-list
14355171|NCT01020019|Dronabinol|dronabinol|mesh-list
14355172|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
14355173|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355174|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355175|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14355176|NCT01020019|Analgesics|analgesics|mesh-ancestor
14355177|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
14355178|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355179|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14355180|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14355181|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355182|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355183|NCT01020019|Hormones|hormones|mesh-ancestor
14355184|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355185|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14355186|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14355187|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14355188|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14355189|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14355190|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14355191|NCT01020123|Glipizide|glipizide|mesh-list
14355192|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14355193|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355194|NCT01020305|Sirolimus|sirolimus|mesh-list
14355195|NCT01020305|Bicalutamide|bicalutamide|mesh-list
14355196|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355197|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355198|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355199|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230879|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15230880|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230881|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
15230882|NCT03501940|Fluorides|fluorides|mesh-list
15230883|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
15230884|NCT03501940|Protective Agents|protective agents|mesh-ancestor
15230885|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230886|NCT03471663|Palbociclib|palbociclib|mesh-list
15230887|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230888|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14355200|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
14355201|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355202|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
14355203|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355204|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
14355205|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
14355206|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355207|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14355208|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
14355209|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14355210|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
15230889|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230890|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230891|NCT03373760|Durvalumab|durvalumab|mesh-list
15230892|NCT03373760|Ipilimumab|ipilimumab|mesh-list
14355211|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14355212|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355213|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14355214|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14355215|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355216|NCT01020474|Pregabalin|pregabalin|mesh-list
14355217|NCT01020474|Analgesics|analgesics|mesh-ancestor
14355218|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
14355219|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355220|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355221|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
14355222|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14355223|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14355224|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355225|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14355226|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14355227|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14355228|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14355229|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355230|NCT01020526|Pregabalin|pregabalin|mesh-list
14355231|NCT01020526|Analgesics|analgesics|mesh-ancestor
14355232|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
14355233|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355234|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355235|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
14355236|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14355237|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14355238|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355239|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14355240|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14355241|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14355242|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14355243|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355244|NCT01020747|Bevacizumab|bevacizumab|mesh-list
14355245|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14355246|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230893|NCT03373760|Tremelimumab|tremelimumab|mesh-list
15230894|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
15230895|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15230896|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
15230897|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230898|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230899|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
15230900|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355247|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14355248|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14355249|NCT01020747|Growth Substances|growth substances|mesh-ancestor
14355250|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355251|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
14355252|NCT01020786|Carboplatin|carboplatin|mesh-list
14355253|NCT01020786|Pemetrexed|pemetrexed|mesh-list
14355254|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920340|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
14920341|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
14920342|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920343|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920344|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14920345|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
14920346|NCT04674514|Hormones|hormones|mesh-ancestor
14920347|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920348|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920349|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920350|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
14920351|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14920352|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14920353|NCT04674514|Growth Substances|growth substances|mesh-ancestor
14920354|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
14920355|NCT04672941|Bromides|bromides|mesh-list
14920356|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
14920357|NCT04672941|Olodaterol|olodaterol|mesh-list
14920358|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14920359|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
14920360|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355255|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355256|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920361|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920362|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14920363|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
14920364|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
14920365|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14920366|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
14920367|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920368|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920369|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
14930938|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930939|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930940|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14930941|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930942|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930943|NCT01436422|Vaccines|vaccines|mesh-list
14930944|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
14930945|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930946|NCT01436474|Varenicline|varenicline|mesh-list
14930947|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14930948|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14355257|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14930949|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355258|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14355259|NCT01020799|Citalopram|citalopram|mesh-list
14355260|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14355261|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14355262|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14355263|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355264|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355265|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
14355266|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355267|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14355268|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
14355269|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355270|NCT01020877|Metronidazole|metronidazole|mesh-list
14355271|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355272|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355273|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14355274|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14355275|NCT01021020|Colchicine|colchicine|mesh-list
14355276|NCT01021020|Probenecid|probenecid|mesh-list
14355277|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
14355278|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355279|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
14355280|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
14355281|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
14355282|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355283|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355284|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
14355285|NCT01021020|Renal Agents|renal agents|mesh-ancestor
14355286|NCT01021215|Celecoxib|celecoxib|mesh-list
14355287|NCT01021215|Zileuton|zileuton|mesh-list
14355288|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14355289|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14355290|NCT01021215|Analgesics|analgesics|mesh-ancestor
14732314|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732315|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
14355291|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
14355292|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355293|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355294|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355295|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355296|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14355297|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14920370|NCT04667572|Riboflavin|riboflavin|mesh-list
14355298|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732316|NCT04724044|Clarithromycin|clarithromycin|mesh-list
14355299|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355300|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14355301|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14355302|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
14355303|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355304|NCT01021332|Tamsulosin|tamsulosin|mesh-list
14355305|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
14355306|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14355307|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14355308|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14355309|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
14355310|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355311|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355312|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355313|NCT01021332|Urological Agents|urological agents|mesh-ancestor
14355314|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14355315|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14355316|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355317|NCT01021423|Lenalidomide|lenalidomide|mesh-list
14355318|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
14355319|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355320|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14355321|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14355322|NCT01021423|Growth Substances|growth substances|mesh-ancestor
14355323|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14355324|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355325|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
14355326|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355327|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355328|NCT01021618|Dipyridamole|dipyridamole|mesh-list
14355329|NCT01021618|Regadenoson|regadenoson|mesh-list
14355330|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14355331|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14355332|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
14355333|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
14355334|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355335|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355336|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355337|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14355338|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355339|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14355340|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
14355341|NCT01021683|Itraconazole|itraconazole|mesh-list
14355342|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
14355343|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355344|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14355345|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14355346|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355347|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355348|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14355349|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
14355350|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355351|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355352|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14355353|NCT01021761|Ketorolac|ketorolac|mesh-list
14355354|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14355355|NCT01021761|Nepafenac|nepafenac|mesh-list
14355356|NCT01021761|Bromfenac|bromfenac|mesh-list
14355357|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14355358|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14355359|NCT01021761|Analgesics|analgesics|mesh-ancestor
14355360|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
14355361|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732317|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
14355362|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732318|NCT04724044|Lactams|lactams|mesh-list
14355363|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355364|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355365|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14355366|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355367|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355368|NCT01021813|Suvorexant|suvorexant|mesh-list
14355369|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14355370|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14355371|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14355372|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355373|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14355374|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355375|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355376|NCT01021878|Icodextrin|icodextrin|mesh-list
14355377|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
14355378|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14355379|NCT01022190|Etoricoxib|etoricoxib|mesh-list
14355380|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14355381|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14355382|NCT01022190|Analgesics|analgesics|mesh-ancestor
14355383|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
14355384|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355385|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355386|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355387|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355388|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14355389|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14355390|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355391|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355392|NCT01022424|Tolvaptan|tolvaptan|mesh-list
14355393|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14355394|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355395|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
14355396|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465371|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
14465372|NCT02224703|Cannabidiol|cannabidiol|mesh-list
14465373|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
14465374|NCT02224729|Dexamethasone|dexamethasone|mesh-list
14465375|NCT02224729|Bortezomib|bortezomib|mesh-list
14465376|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14465377|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465378|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
14465379|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
14465380|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465381|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465382|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14465383|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
14465384|NCT02224729|Hormones|hormones|mesh-ancestor
14465385|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465386|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14465387|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465388|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14355397|NCT01022567|Ertapenem|ertapenem|mesh-list
14355398|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355399|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355400|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14355401|NCT01022580|Calfactant|calfactant|mesh-list
14355402|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
14355403|NCT01022762|Repaglinide|repaglinide|mesh-list
14355404|NCT01022762|Gliclazide|gliclazide|mesh-list
14355405|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14355406|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355407|NCT01022853|Nintedanib|nintedanib|mesh-list
14355408|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355409|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14355410|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355411|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355412|NCT01022996|Everolimus|everolimus|mesh-list
14355413|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355414|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355415|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
14355416|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355417|NCT01023035|Ribavirin|ribavirin|mesh-list
14355418|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14355419|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
14355420|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
14355421|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355422|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
14355423|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355424|NCT01023035|Hematinics|hematinics|mesh-ancestor
14355425|NCT01023061|Prednisone|prednisone|mesh-list
14355426|NCT01023061|Leuprolide|leuprolide|mesh-list
14355427|NCT01023061|Goserelin|goserelin|mesh-list
14355428|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
14355429|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355430|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
14355431|NCT01023061|Hormones|hormones|mesh-ancestor
14355432|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355433|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355434|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14355435|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355436|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14355437|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
14355438|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14355439|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14355440|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355441|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355442|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
14355443|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14355444|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14355445|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14355446|NCT01023178|Estradiol|estradiol|mesh-list
14355447|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14355448|NCT01023178|Estrogens|estrogens|mesh-list
14355449|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14355450|NCT01023178|Progesterone|progesterone|mesh-list
14355451|NCT01023178|Hormones|hormones|mesh-ancestor
14355452|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355453|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355454|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14355455|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
14355456|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14355457|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14355458|NCT01023178|Progestins|progestins|mesh-ancestor
14355459|NCT01023217|Lamivudine|lamivudine|mesh-list
14355460|NCT01023217|Adefovir|adefovir|mesh-list
14355461|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14355462|NCT01023217|Entecavir|entecavir|mesh-list
14355463|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14355464|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14355465|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355466|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355467|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
14355468|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355469|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14355470|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14355471|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14355472|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
14355473|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355474|NCT01023308|Dexamethasone|dexamethasone|mesh-list
14355475|NCT01023308|Bortezomib|bortezomib|mesh-list
14355476|NCT01023308|Panobinostat|panobinostat|mesh-list
14355477|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355478|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
14355479|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
14355480|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355481|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355482|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14355483|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
14355484|NCT01023308|Hormones|hormones|mesh-ancestor
14355485|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355486|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14355487|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355488|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14355489|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355490|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355491|NCT01023477|Chloroquine|chloroquine|mesh-list
14355492|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14355493|NCT01023477|Amebicides|amebicides|mesh-ancestor
14355494|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14355495|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14355496|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355497|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
14355498|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355499|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14355500|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14355501|NCT01023477|Analgesics|analgesics|mesh-ancestor
14355502|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
14355503|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355504|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355505|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355506|NCT01023477|Filaricides|filaricides|mesh-ancestor
14355507|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
14355508|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
14355509|NCT01023581|Metformin|metformin|mesh-list
14355510|NCT01023581|Alogliptin|alogliptin|mesh-list
14355511|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14355512|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355513|NCT01023581|Incretins|incretins|mesh-ancestor
14355514|NCT01023581|Hormones|hormones|mesh-ancestor
14355515|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355516|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14355517|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
14355518|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355519|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355520|NCT01023659|Bupropion|bupropion|mesh-list
14355521|NCT01023659|Varenicline|varenicline|mesh-list
14355522|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14355523|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
14355524|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355525|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14355526|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14355527|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14355528|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355529|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
14355530|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355531|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355532|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14465389|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
14355533|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14355534|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355535|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14355536|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14355537|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355538|NCT01023672|Modafinil|modafinil|mesh-list
14355539|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14355540|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355541|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14355542|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14355543|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14355544|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355545|NCT01023711|Vaccines|vaccines|mesh-list
14355546|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
14355547|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355548|NCT01023724|Ketorolac|ketorolac|mesh-list
14355549|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14355550|NCT01023724|Bromfenac|bromfenac|mesh-list
14355551|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14355552|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14355553|NCT01023724|Analgesics|analgesics|mesh-ancestor
14355554|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
14355555|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355556|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355557|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355558|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355559|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14355560|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355561|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355562|NCT01023776|Vaccines|vaccines|mesh-list
14355563|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
14355564|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355565|NCT01023815|Cyclosporine|cyclosporine|mesh-list
15230901|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14355566|NCT01023815|Everolimus|everolimus|mesh-list
14355567|NCT01023815|Cyclosporins|cyclosporins|mesh-list
14355568|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355569|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355570|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732319|NCT04724044|beta-Lactams|beta-lactams|mesh-list
14732320|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14732321|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14732322|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732323|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14732324|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14732325|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732326|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230902|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230903|NCT03349775|Metformin|metformin|mesh-list
15230904|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15230905|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230906|NCT03337724|Paclitaxel|paclitaxel|mesh-list
15230907|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15230908|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230909|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
15230910|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
15230911|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
14355571|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
14355572|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355573|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
14355574|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355575|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14355576|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355577|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14732327|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230912|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230913|NCT03263078|Propofol|propofol|mesh-list
14732328|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14732329|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
14732330|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14732331|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732332|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14732333|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15230914|NCT03263078|Sevoflurane|sevoflurane|mesh-list
15230915|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15230916|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14355578|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355579|NCT01023841|Bimatoprost|bimatoprost|mesh-list
14355580|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14355581|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14355582|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14355583|NCT01024010|Vidarabine|vidarabine|mesh-list
14355584|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
14355585|NCT01024010|Ofatumumab|ofatumumab|mesh-list
14355586|NCT01024010|Pentostatin|pentostatin|mesh-list
14355587|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14355588|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355589|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
14355590|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355591|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355592|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14355593|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
14355594|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355595|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355596|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14355597|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14355598|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355599|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
14355600|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
14355601|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355602|NCT01024036|Siltuximab|siltuximab|mesh-list
14355603|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355604|NCT01024231|Nivolumab|nivolumab|mesh-list
14355605|NCT01024231|Ipilimumab|ipilimumab|mesh-list
14355606|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14355607|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355608|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14355609|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355610|NCT01024335|Naltrexone|naltrexone|mesh-list
14355611|NCT01024335|Dronabinol|dronabinol|mesh-list
14355612|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14355613|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14355614|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355615|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
14355616|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355617|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
14355618|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355619|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14355620|NCT01024335|Analgesics|analgesics|mesh-ancestor
14355621|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14355622|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14355623|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355624|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355625|NCT01024335|Hormones|hormones|mesh-ancestor
14355626|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355627|NCT01024686|Vaccines|vaccines|mesh-list
15230917|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230918|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15230919|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
15230920|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
15230921|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14355628|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
14355629|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355630|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
14355631|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14355632|NCT01024738|Triclosan|triclosan|mesh-list
14355633|NCT01024738|Fluorides|fluorides|mesh-list
14355634|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
14355635|NCT01024738|Protective Agents|protective agents|mesh-ancestor
14355636|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355637|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15230922|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15230923|NCT03256344|Atezolizumab|atezolizumab|mesh-list
15230924|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15230925|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355638|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355639|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
14355640|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
14355641|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15230926|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14355642|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14355643|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
14355644|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355645|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14355646|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14355647|NCT01024920|Sunitinib|sunitinib|mesh-list
14355648|NCT01024920|Nintedanib|nintedanib|mesh-list
14355649|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355650|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14355651|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14355652|NCT01024920|Growth Substances|growth substances|mesh-ancestor
14355653|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355654|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
14355655|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14355656|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355657|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355658|NCT01024946|Everolimus|everolimus|mesh-list
14355659|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355660|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355661|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
14355662|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355663|NCT01024972|Mannitol|mannitol|mesh-list
14355664|NCT01024972|Dantrolene|dantrolene|mesh-list
14355665|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14355666|NCT01024972|Diuretics|diuretics|mesh-ancestor
14355667|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
14355668|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355669|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14355670|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14355671|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355672|NCT01025154|Cytarabine|cytarabine|mesh-list
14355673|NCT01025154|Clofarabine|clofarabine|mesh-list
14355674|NCT01025154|Idarubicin|idarubicin|mesh-list
14355675|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14355676|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
14355677|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355678|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355679|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
14355680|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355681|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355682|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
14355683|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355684|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355685|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14355686|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14355687|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355688|NCT01025193|Belimumab|belimumab|mesh-list
14355689|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355690|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
14355691|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355692|NCT01025232|Ranibizumab|ranibizumab|mesh-list
14355693|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14355694|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14355695|NCT01025232|Growth Substances|growth substances|mesh-ancestor
14732334|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14753066|NCT05288777|Capecitabine|capecitabine|mesh-list
14355696|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355697|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
14355698|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355699|NCT01025284|Sargramostim|sargramostim|mesh-list
14355700|NCT01025284|Lenograstim|lenograstim|mesh-list
14355701|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
14355702|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355703|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14355704|NCT01025427|Tenofovir|tenofovir|mesh-list
14355705|NCT01025427|Emtricitabine|emtricitabine|mesh-list
14355706|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
14355707|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
14355708|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355709|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14732335|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14732336|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14732337|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14355710|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14355711|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355712|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355713|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14355714|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14732338|NCT04707391|Vaccines|vaccines|mesh-list
14732339|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
14355715|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14355716|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14355717|NCT01025453|Sirolimus|sirolimus|mesh-list
14355718|NCT01025453|Sorafenib|sorafenib|mesh-list
14355719|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355720|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14355721|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355722|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355723|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355724|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355725|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355726|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
14355727|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355728|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
14355729|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732340|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732341|NCT04698187|Nivolumab|nivolumab|mesh-list
14732342|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732343|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355730|NCT01025635|Azelaic acid|azelaic acid|mesh-list
14355731|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732344|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14732345|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230927|NCT03216187|Pregabalin|pregabalin|mesh-list
14355732|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
14355733|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
14355734|NCT01025817|Everolimus|everolimus|mesh-list
14355735|NCT01025817|Tacrolimus|tacrolimus|mesh-list
14355736|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355737|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
14355738|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355739|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14355740|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355741|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355742|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355743|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355744|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14355745|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
14355746|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355747|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355748|NCT01025830|Lamivudine|lamivudine|mesh-list
14355749|NCT01025830|Nevirapine|nevirapine|mesh-list
14355750|NCT01025830|Stavudine|stavudine|mesh-list
14355751|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
15230928|NCT03216187|Analgesics|analgesics|mesh-ancestor
15230929|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
15230930|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15230931|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230932|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
15230933|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15230934|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15230935|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230936|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15230937|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15230938|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15230939|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15230940|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355752|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14355753|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14355754|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355755|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355756|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
14355757|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355758|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14355759|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14355760|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14355761|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14355762|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
14355763|NCT01025843|Candesartan|candesartan|mesh-list
14355764|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
14355765|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14355766|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14355767|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14355768|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355769|NCT01026012|Regadenoson|regadenoson|mesh-list
14355770|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14355771|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14355772|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
14355773|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
14355774|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355775|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355776|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355777|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14355778|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
14355779|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355780|NCT01026142|Capecitabine|capecitabine|mesh-list
14355781|NCT01026142|Trastuzumab|trastuzumab|mesh-list
14355782|NCT01026142|Pertuzumab|pertuzumab|mesh-list
14355783|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14355784|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
14355785|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355786|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355787|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14355788|NCT01026194|Pioglitazone|pioglitazone|mesh-list
14355789|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14355790|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355791|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
14355792|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14355793|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355794|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355795|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14355796|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
14355797|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
14355798|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355799|NCT01026454|Valacyclovir|valacyclovir|mesh-list
14355800|NCT01026454|Acyclovir|acyclovir|mesh-list
14355801|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
14355802|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355803|NCT01026493|Temozolomide|temozolomide|mesh-list
14355804|NCT01026493|Veliparib|veliparib|mesh-list
14355805|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14355806|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
14355807|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355808|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355809|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14355810|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355811|NCT01026623|Sirolimus|sirolimus|mesh-list
14355812|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14355813|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355814|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355815|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355816|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355817|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
14355818|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355819|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
14355820|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355821|NCT01026792|Sirolimus|sirolimus|mesh-list
14355822|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355823|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355824|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355825|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355826|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
14355827|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355828|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
14355829|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355830|NCT01026818|Tadalafil|tadalafil|mesh-list
14355831|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
14355832|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14355833|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14355834|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355835|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355836|NCT01026818|Urological Agents|urological agents|mesh-ancestor
14355837|NCT01026831|Timolol|timolol|mesh-list
14355838|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14355839|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14355840|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
14355841|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355842|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355843|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355844|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14355845|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14355846|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
14355847|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14355848|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355849|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14355850|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732346|NCT04695977|Nivolumab|nivolumab|mesh-list
14355851|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355852|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
14355853|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14355854|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14355855|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355856|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355857|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14355858|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355859|NCT01026948|Dinoprostone|dinoprostone|mesh-list
14355860|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
14355861|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14355862|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355863|NCT01027000|Sirolimus|sirolimus|mesh-list
14355864|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
14355865|NCT01027000|Busulfan|busulfan|mesh-list
14355866|NCT01027000|Rituximab|rituximab|mesh-list
14355867|NCT01027000|Methotrexate|methotrexate|mesh-list
14355868|NCT01027000|Fludarabine|fludarabine|mesh-list
14732347|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732348|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732349|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14753067|NCT05288777|Trastuzumab|trastuzumab|mesh-list
14920371|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
14355869|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
14355870|NCT01027000|Tacrolimus|tacrolimus|mesh-list
14355871|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355872|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
14355873|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355874|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14355875|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14355876|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
14355877|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230941|NCT03207815|Prednisone|prednisone|mesh-list
15230942|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15230943|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
14355878|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732350|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732351|NCT04686305|Carboplatin|carboplatin|mesh-list
14732352|NCT04686305|Trastuzumab|trastuzumab|mesh-list
14732353|NCT04686305|Pemetrexed|pemetrexed|mesh-list
14732354|NCT04686305|Durvalumab|durvalumab|mesh-list
15230944|NCT03207815|Hormones|hormones|mesh-ancestor
15230945|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355879|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14355880|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14355881|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14355882|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
14355883|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14355884|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14355885|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
14355886|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
14355887|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355888|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14355889|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14355890|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14355891|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355892|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14355893|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355894|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
15230946|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230947|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15230948|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230949|NCT03159936|Tofacitinib|tofacitinib|mesh-list
14355895|NCT01027351|Vaccines|vaccines|mesh-list
14732355|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355896|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
14355897|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355898|NCT01027416|Tamoxifen|tamoxifen|mesh-list
14355899|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14355900|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
14355901|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355902|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355903|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14355904|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355905|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14355906|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14355907|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14355908|NCT01027468|Bevacizumab|bevacizumab|mesh-list
14355909|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14355910|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355911|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14355912|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14355913|NCT01027468|Growth Substances|growth substances|mesh-ancestor
14355914|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355915|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
14355916|NCT01027559|Sertraline|sertraline|mesh-list
14355917|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
14355918|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14355919|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14355920|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14355921|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14355922|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355923|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355924|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
14355925|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355926|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14355927|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355928|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14355929|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355930|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355931|NCT01027650|Dexamethasone|dexamethasone|mesh-list
14355932|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14355933|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
14920372|NCT04667572|Vitamins|vitamins|mesh-ancestor
14920373|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
14920374|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920375|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14920376|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14920377|NCT04660240|Sirolimus|sirolimus|mesh-list
14920378|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14920379|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920380|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14920381|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920382|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
14920383|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14355934|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
14355935|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14355936|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355937|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14355938|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
14355939|NCT01027650|Hormones|hormones|mesh-ancestor
14355940|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355941|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14355942|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355943|NCT01027754|Varenicline|varenicline|mesh-list
14355944|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14355945|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14355946|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
14355947|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14355948|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355949|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355950|NCT01027793|Tretinoin|tretinoin|mesh-list
14355951|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355952|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
14355953|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
14355954|NCT01027806|Montelukast|montelukast|mesh-list
14355955|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14355956|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
14355957|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14355958|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
14355959|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14355960|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355961|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14355962|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14355963|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355964|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14355965|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
14355966|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355967|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
14355968|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14355969|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355970|NCT01027884|Idebenone|idebenone|mesh-list
14355971|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
14355972|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355973|NCT01027884|Protective Agents|protective agents|mesh-ancestor
14355974|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14355975|NCT01027897|Doripenem|doripenem|mesh-list
14355976|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14355977|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465390|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355978|NCT01027910|Doxorubicin|doxorubicin|mesh-list
14355979|NCT01027910|Abexinostat|abexinostat|mesh-list
14355980|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14355981|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14355982|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14355983|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14355984|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14355985|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14355986|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14355987|NCT01027949|Treprostinil|treprostinil|mesh-list
14355988|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14355989|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
14355990|NCT01028014|Ephedrine|ephedrine|mesh-list
14355991|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
14355992|NCT01028014|Imipramine|imipramine|mesh-list
14355993|NCT01028014|Tamsulosin|tamsulosin|mesh-list
14355994|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
14355995|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14355996|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14355997|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14355998|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
14355999|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356000|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356001|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356002|NCT01028014|Urological Agents|urological agents|mesh-ancestor
15230950|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230951|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15230952|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356003|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14356004|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14356005|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
14356006|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14732356|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732357|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732358|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230953|NCT03156816|Colchicine|colchicine|mesh-list
15230954|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
14356007|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
14356008|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356009|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14356010|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
14356011|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
14356012|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14356013|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14356014|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
14356015|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14356016|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
14356017|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356018|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14356019|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14356020|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14356021|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14356022|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14356023|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14356024|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356025|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15230955|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230956|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
15230957|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
15230958|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
15230959|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15230960|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230961|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15230962|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356026|NCT01028027|Tobramycin|tobramycin|mesh-list
14356027|NCT01028027|Dexamethasone|dexamethasone|mesh-list
14356028|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356029|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
14356030|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
14356031|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356032|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356033|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356034|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
14356035|NCT01028027|Hormones|hormones|mesh-ancestor
14356036|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356037|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14356038|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356039|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356040|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356041|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14356042|NCT01028053|Flutemetamol|flutemetamol|mesh-list
14356043|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14356044|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356045|NCT01028222|Dacarbazine|dacarbazine|mesh-list
14356046|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14356047|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
14356048|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356049|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356050|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14356051|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14356052|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14356053|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356054|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356055|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356056|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356057|NCT01028352|Analgesics|analgesics|mesh-ancestor
14356058|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
14356059|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356060|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
14356061|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356062|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
14356063|NCT01028391|Metformin|metformin|mesh-list
14356064|NCT01028391|Pioglitazone|pioglitazone|mesh-list
14356065|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14356066|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356067|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356068|NCT01028391|Incretins|incretins|mesh-ancestor
14356069|NCT01028391|Hormones|hormones|mesh-ancestor
14356070|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356071|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14356072|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
14356073|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356074|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356075|NCT01028651|Treprostinil|treprostinil|mesh-list
14356076|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14356077|NCT01028677|Oxytocin|oxytocin|mesh-list
14356078|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
14356079|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14356080|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356081|NCT01028820|Aripiprazole|aripiprazole|mesh-list
14356082|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
14356083|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356084|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14356085|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14356086|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14356087|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356088|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
14356089|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
14356090|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356091|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356092|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14356093|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14356094|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
14356095|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14356096|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14356097|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14356098|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14356099|NCT01029054|Dexamethasone|dexamethasone|mesh-list
14356100|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
14356101|NCT01029054|Lenalidomide|lenalidomide|mesh-list
14356102|NCT01029054|BB 1101|bb 1101|mesh-list
14356103|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356104|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
14356105|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
14356106|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356107|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356108|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356109|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
14356110|NCT01029054|Hormones|hormones|mesh-ancestor
14356111|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356112|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14356113|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356114|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
14356115|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356116|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356117|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
14356118|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14356119|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356120|NCT01029054|Growth Substances|growth substances|mesh-ancestor
14356121|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356122|NCT01029262|Lenalidomide|lenalidomide|mesh-list
14356123|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
14356124|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356125|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14356126|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356127|NCT01029262|Growth Substances|growth substances|mesh-ancestor
14356128|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356129|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356130|NCT01029340|Factor VIII|factor viii|mesh-list
14356131|NCT01029340|Coagulants|coagulants|mesh-ancestor
15230963|NCT03019640|Cytarabine|cytarabine|mesh-list
14356132|NCT01029392|Vitamin D|vitamin d|mesh-list
14356133|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
14356134|NCT01029392|Vitamins|vitamins|mesh-ancestor
14356135|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
14356136|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356137|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14356138|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14356139|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
14356140|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14356141|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
14356142|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356143|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
14356144|NCT01029535|Protective Agents|protective agents|mesh-ancestor
14356145|NCT01029587|Eculizumab|eculizumab|mesh-list
14356146|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14356147|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356148|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
14356149|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356150|NCT01029652|Triamcinolone|triamcinolone|mesh-list
14356151|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14356152|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14356153|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14356154|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14356155|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356156|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
14356157|NCT01029652|Hormones|hormones|mesh-ancestor
14356158|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356159|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356160|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356161|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
14356162|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230964|NCT03019640|Rituximab|rituximab|mesh-list
14356163|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356164|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14465391|NCT02224846|Tadalafil|tadalafil|mesh-list
14356165|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356166|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356167|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356168|NCT01029730|Rituximab|rituximab|mesh-list
14356169|NCT01029730|Bortezomib|bortezomib|mesh-list
14356170|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14356171|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14356172|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356173|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
14356174|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356175|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356176|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14356177|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
14356178|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356179|NCT01029782|Cefazolin|cefazolin|mesh-list
14356180|NCT01029782|Cephalexin|cephalexin|mesh-list
14356181|NCT01029782|Probenecid|probenecid|mesh-list
14356182|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356183|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732359|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14732360|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14732361|NCT04684420|Metformin|metformin|mesh-list
14732362|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732363|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356184|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
14356185|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
14356186|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356187|NCT01029782|Renal Agents|renal agents|mesh-ancestor
14356188|NCT01029795|Glyburide|glyburide|mesh-list
14732368|NCT04680052|Rituximab|rituximab|mesh-list
14356189|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356190|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356191|NCT01029886|Liraglutide|liraglutide|mesh-list
14356192|NCT01029886|Exenatide|exenatide|mesh-list
14356193|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356194|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356195|NCT01029886|Incretins|incretins|mesh-ancestor
14356196|NCT01029886|Hormones|hormones|mesh-ancestor
14356197|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356198|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14356199|NCT01030458|Amlodipine|amlodipine|mesh-list
14356200|NCT01030458|Valsartan|valsartan|mesh-list
14356201|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14356202|NCT01030458|Bisoprolol|bisoprolol|mesh-list
14356203|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14356204|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14356205|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356206|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356207|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14356208|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356209|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
14356210|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14356211|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14356212|NCT01030458|Diuretics|diuretics|mesh-ancestor
14356213|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
14356214|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14356215|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
14356216|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
14356217|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356218|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14356219|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14356220|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14356221|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
14356222|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356223|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
14356224|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356225|NCT01030653|Voriconazole|voriconazole|mesh-list
14920384|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
14356226|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
14356227|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356228|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14356229|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14356230|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356231|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356232|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14356233|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
14356234|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356235|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356236|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14356237|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
14356238|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14356239|NCT01030666|Doxycycline|doxycycline|mesh-list
14356240|NCT01030666|Ibuprofen|ibuprofen|mesh-list
14356241|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14356242|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14356243|NCT01030666|Analgesics|analgesics|mesh-ancestor
14356244|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
14356245|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356246|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356247|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356248|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356249|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14356250|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356251|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356252|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14356253|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356254|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
14356255|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356256|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356257|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
14356258|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14356259|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14356260|NCT01030718|Dasatinib|dasatinib|mesh-list
14356261|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356262|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356263|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356264|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356265|NCT01030783|Sorafenib|sorafenib|mesh-list
14356266|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356267|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356268|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356269|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356270|NCT01030822|Vaccines|vaccines|mesh-list
14356271|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14356272|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
14356273|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356274|NCT01030952|Acarbose|acarbose|mesh-list
14356275|NCT01030952|Nateglinide|nateglinide|mesh-list
14356276|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14356277|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356278|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356279|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356280|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356281|NCT01031043|Bethanechol|bethanechol|mesh-list
14356282|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14356283|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
14356284|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356285|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356286|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14356287|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14356288|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
14356289|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356290|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356291|NCT01031069|Vaccines|vaccines|mesh-list
14356292|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
14356293|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356294|NCT01031381|Bevacizumab|bevacizumab|mesh-list
14356295|NCT01031381|Everolimus|everolimus|mesh-list
14356296|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14356297|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356298|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14356299|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356300|NCT01031381|Growth Substances|growth substances|mesh-ancestor
14356301|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356302|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356303|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356304|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
14356305|NCT01031420|Doxorubicin|doxorubicin|mesh-list
14356306|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14356307|NCT01031420|Methotrexate|methotrexate|mesh-list
14356308|NCT01031420|Vinblastine|vinblastine|mesh-list
14356309|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14356310|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356311|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14356312|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14356313|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356314|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356315|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14356316|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
14356317|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14356318|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356319|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14356320|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
14356321|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356322|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14356323|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356324|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
14356325|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356326|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14356327|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14356328|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14356329|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14356330|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14356331|NCT01031446|Paclitaxel|paclitaxel|mesh-list
14356332|NCT01031446|Everolimus|everolimus|mesh-list
14356333|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14356334|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356335|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
14356336|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
14356337|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
14356338|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356339|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356340|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
14356341|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356342|NCT01031498|Ondansetron|ondansetron|mesh-list
14356343|NCT01031498|Palonosetron|palonosetron|mesh-list
14356344|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
14356345|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
14356346|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356347|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356348|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356349|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
14356350|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356351|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14356352|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
14356353|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356354|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356355|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14356356|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14356357|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14356358|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356359|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14356360|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14356361|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
14356362|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14356363|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356364|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356365|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356366|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
14356367|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
14356368|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356369|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14356370|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356371|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356372|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14356373|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14356374|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14356375|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356376|NCT01031836|Sifalimumab|sifalimumab|mesh-list
14356377|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14356378|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
14356379|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356380|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
14356381|NCT01031953|Aprepitant|aprepitant|mesh-list
15230965|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15230966|NCT03019640|Etoposide|etoposide|mesh-list
15230967|NCT03019640|Lenalidomide|lenalidomide|mesh-list
15230968|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
15230969|NCT03019640|Melphalan|melphalan|mesh-list
15230970|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
15230971|NCT03019640|Carmustine|carmustine|mesh-list
15230972|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
15230973|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15230974|NCT03019640|Antibodies|antibodies|mesh-list
15230975|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
15230976|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15230977|NCT03019640|Lenograstim|lenograstim|mesh-list
15230978|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
14356382|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
14356383|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
14356384|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356385|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356386|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356387|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14356388|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356389|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356390|NCT01031979|Yohimbine|yohimbine|mesh-list
14356391|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
14356392|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
14732369|NCT04680052|Lenalidomide|lenalidomide|mesh-list
14732370|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15230979|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15230980|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15230981|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15230982|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15230983|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15230984|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15230985|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15230986|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356393|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356394|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356395|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14465392|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
15230987|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15230988|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
15230989|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
14465393|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14465394|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14465395|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465396|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465397|NCT02224846|Urological Agents|urological agents|mesh-ancestor
14465398|NCT02225106|Methylphenidate|methylphenidate|mesh-list
14465399|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14356396|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14356397|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14356398|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
14356399|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356400|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356401|NCT01031979|Urological Agents|urological agents|mesh-ancestor
14356402|NCT01032018|Bupropion|bupropion|mesh-list
14356403|NCT01032018|Citalopram|citalopram|mesh-list
14356404|NCT01032018|Sertraline|sertraline|mesh-list
14356405|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14356406|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
14356407|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356408|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14356409|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14356410|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356411|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356412|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
14356413|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356414|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356415|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14356416|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14356417|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356418|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14356419|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
14356420|NCT01032070|Etoposide|etoposide|mesh-list
14356421|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14356422|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14356423|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356424|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14356425|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14356426|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356427|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356428|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356429|NCT01032174|Azithromycin|azithromycin|mesh-list
14356430|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356431|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356432|NCT01032200|Modafinil|modafinil|mesh-list
14356433|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14356434|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356435|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14356436|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14356437|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14356438|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356439|NCT01032239|Baclofen|baclofen|mesh-list
14356440|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14356441|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356442|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14356443|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356444|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14356445|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
14356446|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
14356447|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356448|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356449|NCT01032291|Lenalidomide|lenalidomide|mesh-list
14356450|NCT01032291|Cetuximab|cetuximab|mesh-list
14356451|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
14356452|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356453|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14356454|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356455|NCT01032291|Growth Substances|growth substances|mesh-ancestor
14356456|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356457|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356458|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14356459|NCT01032382|Gentamicins|gentamicins|mesh-list
14356460|NCT01032382|Paromomycin|paromomycin|mesh-list
14356461|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356462|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356463|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14356464|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356465|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356466|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14356467|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14356468|NCT01032629|Canagliflozin|canagliflozin|mesh-list
14356469|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14356470|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356471|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356472|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356473|NCT01032694|Azithromycin|azithromycin|mesh-list
14356474|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356475|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356476|NCT01032759|Memantine|memantine|mesh-list
14356477|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14356478|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14356479|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
14356480|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356481|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356482|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356483|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14356484|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14356485|NCT01032837|Oseltamivir|oseltamivir|mesh-list
14356486|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
14356487|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356488|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356489|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356490|NCT01032850|Capecitabine|capecitabine|mesh-list
14356491|NCT01032850|Sorafenib|sorafenib|mesh-list
14356492|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14356493|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
14356494|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356495|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356496|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356497|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356498|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
14356499|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14356500|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356501|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14356502|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
14732371|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732372|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
15230990|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15230991|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15230992|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15230993|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15230994|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15230995|NCT03019640|Growth Substances|growth substances|mesh-ancestor
14732373|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732374|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732375|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15230996|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356503|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356504|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
14356505|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14356506|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356507|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356508|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
14356509|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356510|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356511|NCT01032993|Ubiquinone|ubiquinone|mesh-list
14356512|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
14356513|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
14356514|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356515|NCT01032993|Vitamins|vitamins|mesh-ancestor
14356516|NCT01033032|Amrubicin|amrubicin|mesh-list
14356517|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356518|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14356519|NCT01033071|Olmesartan|olmesartan|mesh-list
14356520|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15230997|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15230998|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
15230999|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15231000|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
15231001|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356521|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
14732376|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356522|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14356523|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14356524|NCT01033071|Diuretics|diuretics|mesh-ancestor
14356525|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
14356526|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356527|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14356528|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356529|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356530|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14356531|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14356532|NCT01033240|Sorafenib|sorafenib|mesh-list
14356533|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356534|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356535|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356536|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356537|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14356538|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
14356539|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356540|NCT01033565|Melatonin|melatonin|mesh-list
14356541|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
14356542|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356543|NCT01033565|Protective Agents|protective agents|mesh-ancestor
14356544|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356545|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465400|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465401|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14465402|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14465403|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465404|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465405|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
14465406|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465407|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
14465408|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465409|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
14465410|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465411|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465412|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14465413|NCT02225353|Progesterone|progesterone|mesh-list
14465414|NCT02225353|Progestins|progestins|mesh-ancestor
14465415|NCT02225353|Hormones|hormones|mesh-ancestor
14465416|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465417|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465418|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14465419|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
14465420|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465421|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
14465422|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14465423|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
14465424|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465425|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465426|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14465427|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
14465428|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465429|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465430|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14465431|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14465432|NCT02226003|Glimepiride|glimepiride|mesh-list
14465433|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
14465434|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465435|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465436|NCT02226003|Incretins|incretins|mesh-ancestor
14465437|NCT02226003|Hormones|hormones|mesh-ancestor
14465438|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465439|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14465440|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465441|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465442|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465443|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14465444|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14465445|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
14465446|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465447|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14465448|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14356546|NCT01033734|Oseltamivir|oseltamivir|mesh-list
15231002|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231003|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
15231004|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
15231005|NCT02991937|Tazobactam|tazobactam|mesh-list
15231006|NCT02991937|Piperacillin|piperacillin|mesh-list
15231007|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15231008|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356547|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
14356548|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356549|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356550|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356551|NCT01033747|Deferasirox|deferasirox|mesh-list
14356552|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14356553|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
14356554|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
14356555|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356556|NCT01033773|Metformin|metformin|mesh-list
14356557|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14356558|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356559|NCT01033825|Ciclesonide|ciclesonide|mesh-list
14356560|NCT01033825|Dexamethasone|dexamethasone|mesh-list
14356561|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
14356562|NCT01033825|BB 1101|bb 1101|mesh-list
14356563|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356564|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
14356565|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
14356566|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356567|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356568|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356569|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
14356570|NCT01033825|Hormones|hormones|mesh-ancestor
14356571|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356572|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14356573|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356574|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
14356575|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732377|NCT04680052|Growth Substances|growth substances|mesh-ancestor
14732378|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732379|NCT04666610|Brivaracetam|brivaracetam|mesh-list
14732380|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
14732381|NCT04659044|Rituximab|rituximab|mesh-list
14732382|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14732383|NCT04659044|Venetoclax|venetoclax|mesh-list
14732384|NCT04659044|Antibodies|antibodies|mesh-list
14732385|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
14732386|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14732387|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
15231009|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231010|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14356576|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356577|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14356578|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
14356579|NCT01033864|Prednisone|prednisone|mesh-list
14356580|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356581|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
14356582|NCT01033864|Hormones|hormones|mesh-ancestor
14356583|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231011|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231012|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231013|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
15231014|NCT02968563|Idelalisib|idelalisib|mesh-list
15231015|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231016|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231017|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231018|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231019|NCT02931890|Paclitaxel|paclitaxel|mesh-list
14356584|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732388|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
14732389|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732390|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732391|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732392|NCT04642378|Insulin|insulin|mesh-list
14356585|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14356586|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356587|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14356588|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14356589|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
14356590|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356591|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356592|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356593|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356594|NCT01033942|Tenofovir|tenofovir|mesh-list
14356595|NCT01033942|Emtricitabine|emtricitabine|mesh-list
14356596|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
14356597|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356598|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14356599|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14356600|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356601|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356602|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14356603|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14356604|NCT01034111|Metformin|metformin|mesh-list
14356605|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14356606|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14356607|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356608|NCT01034111|Incretins|incretins|mesh-ancestor
14356609|NCT01034111|Hormones|hormones|mesh-ancestor
14356610|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356611|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14356612|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
14356613|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356614|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356615|NCT01034137|Methotrexate|methotrexate|mesh-list
14356616|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14356617|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
14356618|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14356619|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356620|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14356621|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
14356622|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356623|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356624|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356625|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356626|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14356627|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356628|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
14356629|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356630|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14356631|NCT01034163|Panobinostat|panobinostat|mesh-list
14356632|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356633|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14356634|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356635|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356636|NCT01034176|Levofloxacin|levofloxacin|mesh-list
14356637|NCT01034176|Ofloxacin|ofloxacin|mesh-list
14356638|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14356639|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356640|NCT01034176|Renal Agents|renal agents|mesh-ancestor
14356641|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356642|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14356643|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14356644|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356645|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356646|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356647|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14732393|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15231020|NCT02931890|Docetaxel|docetaxel|mesh-list
15231021|NCT02931890|Carboplatin|carboplatin|mesh-list
15231022|NCT02931890|Capecitabine|capecitabine|mesh-list
14356648|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14356649|NCT01034462|Milnacipran|milnacipran|mesh-list
14356650|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
14356651|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14356652|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14356653|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356654|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356655|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356656|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356657|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
14356658|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356659|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14356660|NCT01034462|Analgesics|analgesics|mesh-ancestor
14356661|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
14356662|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356663|NCT01034553|Bortezomib|bortezomib|mesh-list
14356664|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356665|NCT01034592|Lenalidomide|lenalidomide|mesh-list
14356666|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
14356667|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356668|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14356669|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356670|NCT01034592|Growth Substances|growth substances|mesh-ancestor
14356671|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356672|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356673|NCT01034631|Everolimus|everolimus|mesh-list
14356674|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356675|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356676|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
14356677|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356678|NCT01034657|Panobinostat|panobinostat|mesh-list
14356679|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
14356680|NCT01034657|Hematinics|hematinics|mesh-ancestor
14356681|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356682|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14356683|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356684|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356685|NCT01035099|Letrozole|letrozole|mesh-list
14356686|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356687|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14356688|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14356689|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356690|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356691|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14356692|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
14356693|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356694|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231023|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
15231024|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15231025|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231026|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231027|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
15231028|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
15231029|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356695|NCT01035229|Everolimus|everolimus|mesh-list
14356696|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356697|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356698|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
14356699|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356700|NCT01035255|Enalapril|enalapril|mesh-list
14356701|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14356702|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14356703|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
14356704|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356705|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356706|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14356707|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14356708|NCT01035333|Orlistat|orlistat|mesh-list
14356709|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356710|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356711|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14356712|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14356713|NCT01035346|Ibuprofen|ibuprofen|mesh-list
14356714|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14356715|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14356716|NCT01035346|Analgesics|analgesics|mesh-ancestor
14356717|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
14356718|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356719|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356720|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356721|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356722|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14356723|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356724|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356725|NCT01035463|Cytarabine|cytarabine|mesh-list
14356726|NCT01035463|Rituximab|rituximab|mesh-list
14356727|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14356728|NCT01035463|Etoposide|etoposide|mesh-list
14356729|NCT01035463|Lenalidomide|lenalidomide|mesh-list
14356730|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
14356731|NCT01035463|Melphalan|melphalan|mesh-list
14356732|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
14356733|NCT01035463|Carmustine|carmustine|mesh-list
14356734|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
14356735|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14356736|NCT01035463|Antibodies|antibodies|mesh-list
14356737|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
14356738|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14356739|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
14356740|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356741|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356742|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356743|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14356744|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14356745|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14356746|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356747|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356748|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14356749|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
15231030|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15231031|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
15231032|NCT02915783|Everolimus|everolimus|mesh-list
15231033|NCT02915783|Lenvatinib|lenvatinib|mesh-list
15231034|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231035|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231036|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
15231037|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356750|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
15231038|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356751|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356752|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356753|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14356754|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356755|NCT01035463|Growth Substances|growth substances|mesh-ancestor
14356756|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356757|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14356758|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
14356759|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14356760|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
14356761|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356762|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231039|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231040|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231041|NCT02913482|Risdiplam|risdiplam|mesh-list
15231042|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15231043|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231044|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231045|NCT02897648|Lactams|lactams|mesh-list
15231046|NCT02897648|beta-Lactams|beta-lactams|mesh-list
15231047|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15231048|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231049|NCT02817659|Glucagon|glucagon|mesh-list
15231050|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231051|NCT02817659|Hormones|hormones|mesh-ancestor
15231052|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356763|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
14356764|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
14356765|NCT01035658|Doxorubicin|doxorubicin|mesh-list
14356766|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14356767|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14356768|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356769|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14356770|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14356771|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356772|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356773|NCT01035749|Vaccines|vaccines|mesh-list
14356774|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
14356775|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356776|NCT01036594|Ketoconazole|ketoconazole|mesh-list
14356777|NCT01036594|Dexamethasone|dexamethasone|mesh-list
14356778|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
14356779|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
14356780|NCT01036594|BB 1101|bb 1101|mesh-list
14356781|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356782|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
14356783|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
14356784|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356785|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356786|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356787|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
14356788|NCT01036594|Hormones|hormones|mesh-ancestor
14356789|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14356790|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14356791|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356792|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
14356793|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356794|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356795|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
14356796|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356797|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14356798|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14356799|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14356800|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
14356801|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14356802|NCT01036802|Warfarin|warfarin|mesh-list
14356803|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
14356804|NCT01037127|Trametinib|trametinib|mesh-list
14356805|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356806|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356807|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356808|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356809|NCT01037192|Vancomycin|vancomycin|mesh-list
14356810|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14356811|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356812|NCT01037218|Udenafil|udenafil|mesh-list
14356813|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14356814|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14356815|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356816|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356817|NCT01037244|Udenafil|udenafil|mesh-list
14356818|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14356819|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14356820|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356821|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356822|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
14356823|NCT01037452|Lansoprazole|lansoprazole|mesh-list
14356824|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
14356825|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
14356826|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14356827|NCT01037452|Calcium|calcium|mesh-list
14356828|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14356829|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356830|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14356831|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14356832|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356833|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14356834|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356835|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356836|NCT01037452|Antacids|antacids|mesh-ancestor
14356837|NCT01037790|Palbociclib|palbociclib|mesh-list
14356838|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356839|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356840|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356841|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356842|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
14356843|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14356844|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14356845|NCT01037881|Analgesics|analgesics|mesh-ancestor
14356846|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
14356847|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356848|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356849|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356850|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356851|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356852|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14356853|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
14356854|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14356855|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356856|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356857|NCT01038128|Memantine|memantine|mesh-list
14356858|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14356859|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14356860|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
14356861|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356862|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356863|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356864|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14356865|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14356866|NCT01038323|Milnacipran|milnacipran|mesh-list
14356867|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
14356868|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14356869|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14356870|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14356871|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356872|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356873|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356874|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14356875|NCT01038323|Analgesics|analgesics|mesh-ancestor
14356876|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
14356877|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356878|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
14356879|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14356880|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
14356881|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356882|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356883|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14356884|NCT01038609|Acetaminophen|acetaminophen|mesh-list
14356885|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14356886|NCT01038609|Morphine|morphine|mesh-list
14356887|NCT01038609|Hydrocodone|hydrocodone|mesh-list
14356888|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14356889|NCT01038609|Narcotics|narcotics|mesh-ancestor
14356890|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14356891|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356892|NCT01038609|Analgesics|analgesics|mesh-ancestor
14356893|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
14356894|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356895|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14356896|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
14356897|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
14356898|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
14356899|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14356900|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14356901|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14356902|NCT01038635|Lenalidomide|lenalidomide|mesh-list
14356903|NCT01038635|Azacitidine|azacitidine|mesh-list
14356904|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
14356905|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356906|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14356907|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14356908|NCT01038635|Growth Substances|growth substances|mesh-ancestor
14356909|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
14356910|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356911|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14356912|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
14356913|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356914|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356915|NCT01038778|Aldesleukin|aldesleukin|mesh-list
14356916|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
14356917|NCT01038778|Interleukin-2|interleukin-2|mesh-list
15231053|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231054|NCT02811510|Dronabinol|dronabinol|mesh-list
15231055|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
15231056|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231057|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15231058|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15231059|NCT02811510|Analgesics|analgesics|mesh-ancestor
15231060|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
15231061|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231062|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15231063|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15231064|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356918|NCT01038778|Entinostat|entinostat|mesh-list
14356919|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14356920|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14356921|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356922|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14356923|NCT01038778|Analgesics|analgesics|mesh-ancestor
14356924|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
14356925|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356926|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356927|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14356928|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14356929|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
14356930|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356931|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14356932|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356933|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356934|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
14356935|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14356936|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356937|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356938|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356939|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356940|NCT01038869|Azelaic acid|azelaic acid|mesh-list
14356941|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356942|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
14356943|NCT01038921|Melatonin|melatonin|mesh-list
14356944|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
14356945|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356946|NCT01038921|Protective Agents|protective agents|mesh-ancestor
14356947|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356948|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14356949|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14356950|NCT01039207|Rilotumumab|rilotumumab|mesh-list
14356951|NCT01039207|Antibodies|antibodies|mesh-list
14356952|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
14356953|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14356954|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
14356955|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356956|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356957|NCT01039376|Ofatumumab|ofatumumab|mesh-list
14356958|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14356959|NCT01039584|Butoconazole|butoconazole|mesh-list
14356960|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
14356961|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356962|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
14356963|NCT01039688|Tofacitinib|tofacitinib|mesh-list
14356964|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14356965|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14356966|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356967|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
14356968|NCT01039792|Vitamins|vitamins|mesh-ancestor
14356969|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
14356970|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356971|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
14356972|NCT01040130|Olodaterol|olodaterol|mesh-list
14356973|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15231065|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231066|NCT02811510|Hormones|hormones|mesh-ancestor
15231067|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231068|NCT02796261|Eflornithine|eflornithine|mesh-list
15231069|NCT02796261|Lomustine|lomustine|mesh-list
15231070|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15231071|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
14356974|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
14356975|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356976|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356977|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14356978|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
14356979|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
14356980|NCT01040169|Calcium|calcium|mesh-list
14356981|NCT01040169|Fluorides|fluorides|mesh-list
14356982|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14356983|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356984|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
14356985|NCT01040169|Protective Agents|protective agents|mesh-ancestor
14356986|NCT01040169|Antacids|antacids|mesh-ancestor
15231072|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231073|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231074|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15231075|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15231076|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15231077|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14356987|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356988|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14356989|NCT01040260|Nicotine|nicotine|mesh-list
14356990|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14356991|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
14356992|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14356993|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14356994|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14356995|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14356996|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
14356997|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14356998|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14356999|NCT01040403|Bromides|bromides|mesh-list
14357000|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
14357001|NCT01040403|Olodaterol|olodaterol|mesh-list
14357002|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357003|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
14357004|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357005|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357006|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357007|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357008|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
14357009|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14357010|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
14357011|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357012|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357013|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
14357014|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
14357015|NCT01040689|Olodaterol|olodaterol|mesh-list
14357016|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357017|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
14357018|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357019|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357020|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357021|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357022|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
14357023|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14357024|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
14357025|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357026|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357027|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
14357028|NCT01040728|Olodaterol|olodaterol|mesh-list
14357029|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357030|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
14357031|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357032|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357033|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357034|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357035|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
14357036|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14357037|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
14357038|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357039|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357040|NCT01040780|Gefitinib|gefitinib|mesh-list
14357041|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357042|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14357043|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732394|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732395|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732396|NCT04630886|Lidocaine|lidocaine|mesh-list
14357044|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357045|NCT01040793|Olodaterol|olodaterol|mesh-list
14357046|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357047|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
14357048|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357049|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357050|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357051|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357052|NCT01040819|Pioglitazone|pioglitazone|mesh-list
14357053|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732397|NCT04630886|Epinephrine|epinephrine|mesh-list
14732398|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
14732399|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
14732400|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
14732401|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732402|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920385|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920386|NCT04655391|Decitabine|decitabine|mesh-list
14357054|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357055|NCT01040832|Cetuximab|cetuximab|mesh-list
14357056|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357057|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357058|NCT01040845|Colchicine|colchicine|mesh-list
14357059|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14357060|NCT01040845|Norethindrone|norethindrone|mesh-list
14357061|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
14357062|NCT01040845|Estradiol|estradiol|mesh-list
14357063|NCT01040845|Estrogens|estrogens|mesh-ancestor
14357064|NCT01040845|Hormones|hormones|mesh-ancestor
14357065|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920387|NCT04655391|Venetoclax|venetoclax|mesh-list
14920388|NCT04655391|Ivosidenib|ivosidenib|mesh-list
14357066|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357067|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14357068|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
14357069|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14357070|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14357071|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
14357072|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357073|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14357074|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14357075|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14357076|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357077|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357078|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14357079|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14357080|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14357081|NCT01040871|Prednisone|prednisone|mesh-list
14357082|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
14357083|NCT01040871|Rituximab|rituximab|mesh-list
14357084|NCT01040871|Doxorubicin|doxorubicin|mesh-list
14357085|NCT01040871|Vincristine|vincristine|mesh-list
14357086|NCT01040871|Bortezomib|bortezomib|mesh-list
14357087|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14357088|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
14357089|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357090|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357091|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14357092|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
14357093|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357094|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920389|NCT04655391|Maleic acid|maleic acid|mesh-list
14920390|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14920391|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
14920392|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920393|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920394|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920395|NCT04652414|Prednisone|prednisone|mesh-list
14920396|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231078|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
15231079|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231080|NCT02787044|Vaccines|vaccines|mesh-list
15231081|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
15231082|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357095|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14357096|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920397|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
14920398|NCT04652414|Hormones|hormones|mesh-ancestor
14920399|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920400|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920401|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920402|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920403|NCT04641702|Atropine|atropine|mesh-list
14920404|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14920405|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14920406|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14920407|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
14920408|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920409|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920410|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14920411|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357097|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14357098|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14357099|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14357100|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357101|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357102|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
14357103|NCT01040871|Hormones|hormones|mesh-ancestor
14357104|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357105|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14357106|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14357107|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
14357108|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
14357109|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
14357110|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14357111|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465449|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465450|NCT02226159|Dexamethasone|dexamethasone|mesh-list
14465451|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
14465452|NCT02226159|Lidocaine|lidocaine|mesh-list
14465453|NCT02226159|BB 1101|bb 1101|mesh-list
14465454|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465455|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
14465456|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
14465457|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465458|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465459|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14465460|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
14465461|NCT02226159|Hormones|hormones|mesh-ancestor
14465462|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465463|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14465464|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465465|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
14465466|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465467|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465468|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
14465469|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
14465470|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465471|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
14465472|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14465473|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14465474|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14357112|NCT01041274|Citalopram|citalopram|mesh-list
14357113|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14357114|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14357115|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14357116|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357117|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357118|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
14357119|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357120|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14357121|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
14357122|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14357123|NCT01041287|Metoprolol|metoprolol|mesh-list
14357124|NCT01041287|Nebivolol|nebivolol|mesh-list
14357125|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14357126|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14357127|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
14357128|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
14357129|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357130|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357131|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14357132|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14357133|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14357134|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
14732403|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
14732404|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732405|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14732406|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14732407|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14732408|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14732409|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357135|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357136|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357137|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
14357138|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14357139|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14357140|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357141|NCT01041404|Fluorouracil|fluorouracil|mesh-list
14357142|NCT01041404|Capecitabine|capecitabine|mesh-list
14357143|NCT01041404|Trastuzumab|trastuzumab|mesh-list
14357144|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357145|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
14357146|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357147|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14357148|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14357149|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
14920412|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
14357150|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357151|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357152|NCT01041417|Molgramostim|molgramostim|mesh-list
14357153|NCT01041417|Sargramostim|sargramostim|mesh-list
14357154|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
14357155|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357156|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357157|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
14357158|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14357159|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
14357160|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14357161|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14357162|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357163|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14357164|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357165|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14357166|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357167|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14357168|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
14357169|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357170|NCT01041638|Vitamin A|vitamin a|mesh-list
14357171|NCT01041638|Aldesleukin|aldesleukin|mesh-list
14357172|NCT01041638|Interleukin-2|interleukin-2|mesh-list
14357173|NCT01041638|Tretinoin|tretinoin|mesh-list
14357174|NCT01041638|Dinutuximab|dinutuximab|mesh-list
14357175|NCT01041638|Isotretinoin|isotretinoin|mesh-list
14357176|NCT01041638|Sargramostim|sargramostim|mesh-list
14357177|NCT01041638|Vitamins|vitamins|mesh-ancestor
14357178|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
14357179|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357180|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357181|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357182|NCT01041638|Analgesics|analgesics|mesh-ancestor
14357183|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
14357184|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357185|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
14357186|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14357187|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14357188|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
14357189|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357190|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
14357191|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
14357192|NCT01041781|Gemcitabine|gemcitabine|mesh-list
14357193|NCT01041781|Celecoxib|celecoxib|mesh-list
14357194|NCT01041781|Carboplatin|carboplatin|mesh-list
14357195|NCT01041781|Pemetrexed|pemetrexed|mesh-list
14357196|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357197|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14357198|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
14357199|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357200|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
14357201|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357202|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357203|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14357204|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
14357205|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357206|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14357207|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14357208|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357209|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357210|NCT01041781|Analgesics|analgesics|mesh-ancestor
14357211|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
14357212|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357213|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357214|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357215|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14357216|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14357217|NCT01041859|Tapentadol|tapentadol|mesh-list
14357218|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14357219|NCT01041859|Narcotics|narcotics|mesh-ancestor
14357220|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357221|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357222|NCT01041859|Analgesics|analgesics|mesh-ancestor
14357223|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
14357224|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357225|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14357226|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14357227|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14357228|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357229|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357230|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357231|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14357232|NCT01042093|Clonidine|clonidine|mesh-list
14357233|NCT01042093|Epinephrine|epinephrine|mesh-list
14357234|NCT01042093|Ropivacaine|ropivacaine|mesh-list
14357235|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
14357236|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
14357237|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357238|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357239|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
14357240|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357241|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14357242|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357243|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357244|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357245|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357246|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14357247|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357248|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
14357249|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357250|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357251|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
14357252|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
15231083|NCT02781519|Dronabinol|dronabinol|mesh-list
15231084|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
15231085|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231086|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15231087|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15231088|NCT02781519|Analgesics|analgesics|mesh-ancestor
15231089|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
15231090|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231091|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14357253|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14357254|NCT01042093|Analgesics|analgesics|mesh-ancestor
14357255|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14357256|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
14357257|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14357258|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357259|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357260|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357261|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357262|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14357263|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357264|NCT01042145|Dexamethasone|dexamethasone|mesh-list
14357265|NCT01042145|Prednisone|prednisone|mesh-list
14357266|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357267|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
14357268|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
14357269|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357270|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357271|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14357272|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
14357273|NCT01042145|Hormones|hormones|mesh-ancestor
14357274|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357275|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14357276|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357277|NCT01042158|Ambrisentan|ambrisentan|mesh-list
14357278|NCT01042158|Tadalafil|tadalafil|mesh-list
14357279|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
14357280|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14357281|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14357282|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357283|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357284|NCT01042158|Urological Agents|urological agents|mesh-ancestor
14357285|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14357286|NCT01042236|Fesoterodine|fesoterodine|mesh-list
14357287|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14357288|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14357289|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
14357290|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357291|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357292|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357293|NCT01042236|Urological Agents|urological agents|mesh-ancestor
14357294|NCT01042288|Carboplatin|carboplatin|mesh-list
15231092|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14357295|NCT01042288|Pemetrexed|pemetrexed|mesh-list
14357296|NCT01042288|Panitumumab|panitumumab|mesh-list
14357297|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357298|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357299|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357300|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14357301|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14357302|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357303|NCT01042366|Vaccines|vaccines|mesh-list
14357304|NCT01042366|Immunologic Factors|immunologic factors|mesh-ancestor
14357305|NCT01042366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357306|NCT01042392|Ramipril|ramipril|mesh-list
14357307|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14357308|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
14357309|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357310|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357311|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14357312|NCT01042496|Lamotrigine|lamotrigine|mesh-list
14357313|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
14357314|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14357315|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14357316|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357317|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14357318|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357319|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14357320|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14357321|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357322|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14357323|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14357324|NCT01042509|Rituximab|rituximab|mesh-list
14357325|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
14357326|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357327|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357328|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
14357329|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357330|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357331|NCT01042535|Tryptophan|tryptophan|mesh-list
14357332|NCT01042535|Vaccines|vaccines|mesh-list
14357333|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
14357334|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357335|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14357336|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
14357337|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14357338|NCT01042795|Sunitinib|sunitinib|mesh-list
14357339|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357340|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14357341|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14732410|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14357342|NCT01042795|Growth Substances|growth substances|mesh-ancestor
14357343|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357344|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14357345|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14357346|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357347|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357348|NCT01042938|Curcumin|curcumin|mesh-list
14357349|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357350|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357351|NCT01042938|Analgesics|analgesics|mesh-ancestor
14357352|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
14357353|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357354|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357355|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357356|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357357|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357358|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357359|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357360|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
14357361|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14357362|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357363|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14357364|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357365|NCT01043094|Pitavastatin|pitavastatin|mesh-list
14357366|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14357367|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14357368|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14357369|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
14357370|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357371|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357372|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14357373|NCT01043185|Lesogaberan|lesogaberan|mesh-list
14357374|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14357375|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14357376|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
14357377|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
14357378|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357379|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357380|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357381|NCT01043393|Desoximetasone|desoximetasone|mesh-list
14357382|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357383|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
14357384|NCT01043393|Hormones|hormones|mesh-ancestor
14357385|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357386|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231093|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231094|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231095|NCT02781519|Hormones|hormones|mesh-ancestor
15231096|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231097|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
15231098|NCT02773732|Etoposide|etoposide|mesh-list
15231099|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15231100|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231101|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15231102|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15231103|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231104|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231105|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15231106|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231107|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15231108|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15231109|NCT02764489|Thrombin|thrombin|mesh-list
15231110|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
15231111|NCT02764489|Coagulants|coagulants|mesh-list
15231112|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
15231113|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14732411|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357387|NCT01043640|Cyclosporine|cyclosporine|mesh-list
14357388|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
14357389|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
14357390|NCT01043640|Busulfan|busulfan|mesh-list
14357391|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
14357392|NCT01043640|Cyclosporins|cyclosporins|mesh-list
14357393|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14357394|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
14357395|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357396|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357397|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14357398|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
14357399|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357400|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357401|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14357402|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357403|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
14357404|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357405|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
14357406|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14357407|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14357408|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14357409|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
14357410|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14357411|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357412|NCT01043926|Suvorexant|suvorexant|mesh-list
14357413|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14357414|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14357415|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357416|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357417|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14357418|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231114|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231115|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231116|NCT02586675|Tamoxifen|tamoxifen|mesh-list
15231117|NCT02586675|Goserelin|goserelin|mesh-list
15231118|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15231119|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
15231120|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357419|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732412|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14732413|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732414|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14732415|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14732416|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
14732417|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357420|NCT01044212|Psyllium|psyllium|mesh-list
14357421|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14357422|NCT01044212|Cathartics|cathartics|mesh-ancestor
14357423|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14357424|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
14357425|NCT01044264|Clindamycin|clindamycin|mesh-list
14357426|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
14357427|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
14357428|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14357429|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14357430|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357431|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14357432|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732418|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357433|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732419|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
14732420|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
14357434|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
14357435|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
14357436|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14357437|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357438|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14357439|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
14357440|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14357441|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357442|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357443|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357444|NCT01044433|Capecitabine|capecitabine|mesh-list
14357445|NCT01044433|Lapatinib|lapatinib|mesh-list
14357446|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14357447|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
14357448|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357449|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357450|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14357451|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357452|NCT01044459|Bromides|bromides|mesh-list
14357453|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
14357454|NCT01044498|Norinyl|norinyl|mesh-list
14357455|NCT01044498|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14357456|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14357457|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14357458|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14357459|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
14357460|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14357461|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357462|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14357463|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14357464|NCT01044498|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14357465|NCT01044498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14357466|NCT01044693|Metoprolol|metoprolol|mesh-list
14357467|NCT01044693|Nebivolol|nebivolol|mesh-list
14357468|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
14357469|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
14357470|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14357471|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14357472|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357473|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357474|NCT01044693|Urological Agents|urological agents|mesh-ancestor
14357475|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14357476|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14357477|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
14357478|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
14732421|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14732422|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14732423|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14732424|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
14732425|NCT04630886|Coagulants|coagulants|mesh-ancestor
14753068|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14753069|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753070|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
14357479|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357480|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357481|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14357482|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14357483|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14357484|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357485|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357486|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14357487|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14357488|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357489|NCT01044706|Bicalutamide|bicalutamide|mesh-list
14357490|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
14357491|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
14357492|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920413|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
14920414|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14920415|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14920416|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
14920417|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920418|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357493|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357494|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357495|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
14357496|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
14357497|NCT01044745|Busulfan|busulfan|mesh-list
14357498|NCT01044745|Rituximab|rituximab|mesh-list
14357499|NCT01044745|Fludarabine|fludarabine|mesh-list
14357500|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
14357501|NCT01044745|Tacrolimus|tacrolimus|mesh-list
14357502|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
14357503|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14357504|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14357505|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
14357506|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357507|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357508|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14357509|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
14357510|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357511|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357512|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14357513|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357514|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14357515|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
14357516|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14357517|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357518|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14357519|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14357520|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
14357521|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14357522|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357523|NCT01044758|Levetiracetam|levetiracetam|mesh-list
14357524|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
14920419|NCT04640636|Midazolam|midazolam|mesh-list
15231121|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231122|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920420|NCT04640636|Ketamine|ketamine|mesh-list
14920421|NCT04640636|Analgesics|analgesics|mesh-ancestor
14920422|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
15231123|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231124|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15231125|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15231126|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15231127|NCT02582905|Choline|choline|mesh-list
14920423|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357525|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
14357526|NCT01044771|Tenofovir|tenofovir|mesh-list
14357527|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
14357528|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
14357529|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357530|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14357531|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14357532|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357533|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357534|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14357535|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14357536|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14357537|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14357538|NCT01044862|Letrozole|letrozole|mesh-list
14357539|NCT01044862|Clomiphene|clomiphene|mesh-list
14357540|NCT01044862|Enclomiphene|enclomiphene|mesh-list
14357541|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
14357542|NCT01044862|Hormones|hormones|mesh-list
14357543|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14357544|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14357545|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357546|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357547|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357548|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357549|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14357550|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920424|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920425|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14920426|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14357551|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14357552|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
14357553|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14357554|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
14357555|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14357556|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14357557|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14357558|NCT01044966|Temozolomide|temozolomide|mesh-list
14357559|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14357560|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
14357561|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357562|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357563|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
14357564|NCT01045096|Lansoprazole|lansoprazole|mesh-list
14357565|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14920427|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
14920428|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
14357566|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14357567|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14357568|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357569|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357570|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
14357571|NCT01045122|Propofol|propofol|mesh-list
14357572|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14357573|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357574|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357575|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14357576|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
14357577|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
14357578|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357579|NCT01045122|Analgesics|analgesics|mesh-ancestor
14357580|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
14357581|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357582|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14357583|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14357584|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357585|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357586|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357587|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357588|NCT01045161|Bromides|bromides|mesh-list
14357589|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
14357590|NCT01045447|Insulin|insulin|mesh-list
14357591|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14357592|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
14357593|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
14357594|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14357595|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357596|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
14357597|NCT01045460|Melphalan|melphalan|mesh-list
14357598|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14357599|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
14357600|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357601|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357602|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14357603|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
14357604|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357605|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357606|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14357607|NCT01045551|Apremilast|apremilast|mesh-list
14357608|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357609|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357610|NCT01045551|Analgesics|analgesics|mesh-ancestor
14357611|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
14357612|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357613|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357614|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357615|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357616|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14357617|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14357618|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357619|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357620|NCT01045707|Insulin|insulin|mesh-list
14357621|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14357622|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
14357623|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
14357624|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14357625|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357626|NCT01045798|Caspofungin|caspofungin|mesh-list
14357627|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
14357628|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357629|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357630|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357631|NCT01045967|Lansoprazole|lansoprazole|mesh-list
14357632|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
14357633|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14357634|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14357635|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14357636|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732426|NCT04613492|Durvalumab|durvalumab|mesh-list
14357637|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357638|NCT01045993|Analgesics|analgesics|mesh-list
14357639|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
14357640|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357641|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357642|NCT01046084|Lansoprazole|lansoprazole|mesh-list
14357643|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
14920429|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920430|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14920431|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14920432|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920433|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357644|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14357645|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14357646|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14357647|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357648|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357649|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14357650|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14357651|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357652|NCT01046110|Incretins|incretins|mesh-ancestor
14357653|NCT01046110|Hormones|hormones|mesh-ancestor
14357654|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357655|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14357656|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
14357657|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357658|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357659|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
14357660|NCT01046136|Guaifenesin|guaifenesin|mesh-list
14357661|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14357662|NCT01046136|Expectorants|expectorants|mesh-ancestor
14357663|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357664|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14357665|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357666|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357667|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357668|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357669|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357670|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
14357671|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14357672|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
14357673|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
14357674|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357675|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
14357676|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14357677|NCT01046253|Lansoprazole|lansoprazole|mesh-list
14357678|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
14357679|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14357680|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14357681|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14357682|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357683|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357684|NCT01046396|Adapalene|adapalene|mesh-list
14357685|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357686|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357687|NCT01046396|Analgesics|analgesics|mesh-ancestor
14357688|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
14357689|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357690|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357691|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357692|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357693|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
14357694|NCT01046565|Adapalene|adapalene|mesh-list
14357695|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357696|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14920434|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14357697|NCT01046565|Analgesics|analgesics|mesh-ancestor
14920435|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14920436|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14920437|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14920438|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14920439|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
14732427|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732428|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732429|NCT04549168|Lemborexant|lemborexant|mesh-list
14732430|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14732431|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732432|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357698|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
14357699|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357700|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357701|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357702|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357703|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14357704|NCT01046643|Estradiol|estradiol|mesh-list
14920440|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
14920441|NCT04640376|Acetaminophen|acetaminophen|mesh-list
14920442|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357705|NCT01046643|Progesterone|progesterone|mesh-list
14357706|NCT01046643|Estrogens|estrogens|mesh-ancestor
14357707|NCT01046643|Hormones|hormones|mesh-ancestor
14357708|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357709|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357710|NCT01046643|Progestins|progestins|mesh-ancestor
14357711|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14357712|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357713|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357714|NCT01046682|Analgesics|analgesics|mesh-ancestor
14357715|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
14357716|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357717|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357718|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357719|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357720|NCT01046903|Dalteparin|dalteparin|mesh-list
14357721|NCT01046903|Tinzaparin|tinzaparin|mesh-list
14357722|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14357723|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
14357724|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14357725|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14357726|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357727|NCT01047007|Cisplatin|cisplatin|mesh-list
14357728|NCT01047007|Adavosertib|adavosertib|mesh-list
14357729|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357730|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732433|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14732434|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14732435|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732436|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732437|NCT04527380|Adalimumab|adalimumab|mesh-list
14732438|NCT04527380|Ixekizumab|ixekizumab|mesh-list
14357731|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357732|NCT01047189|Clindamycin|clindamycin|mesh-list
14357733|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
14920443|NCT04640376|Analgesics|analgesics|mesh-ancestor
14357734|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
14357735|NCT01047189|Tretinoin|tretinoin|mesh-list
14357736|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14357737|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357738|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14357739|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357740|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357741|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357742|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
14357743|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14357744|NCT01047241|Sufentanil|sufentanil|mesh-list
14357745|NCT01047241|Ketamine|ketamine|mesh-list
14357746|NCT01047241|Analgesics|analgesics|mesh-ancestor
14357747|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
14357748|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357749|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357750|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14357751|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14357752|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
14357753|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
14357754|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357755|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14357756|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14357757|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357758|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357759|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14357760|NCT01047241|Narcotics|narcotics|mesh-ancestor
14357761|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14357762|NCT01047293|Leucovorin|leucovorin|mesh-list
14357763|NCT01047293|Bevacizumab|bevacizumab|mesh-list
14357764|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
14357765|NCT01047293|Everolimus|everolimus|mesh-list
14357766|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357767|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357768|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14357769|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14357770|NCT01047293|Growth Substances|growth substances|mesh-ancestor
14357771|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357772|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
14357773|NCT01047293|Antidotes|antidotes|mesh-ancestor
14357774|NCT01047293|Protective Agents|protective agents|mesh-ancestor
14357775|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
14357776|NCT01047293|Vitamins|vitamins|mesh-ancestor
14357777|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
14357778|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14357779|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
14357780|NCT01047358|Exemestane|exemestane|mesh-list
14357781|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357782|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14357783|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14357784|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357785|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357786|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14357787|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
14357788|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357789|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357790|NCT01047436|Artemether|artemether|mesh-list
14357791|NCT01047436|Quinine|quinine|mesh-list
14357792|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
14357793|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14357794|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14357795|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357796|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14357797|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357798|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14357799|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357800|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357801|NCT01047436|Analgesics|analgesics|mesh-ancestor
14357802|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
14465475|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465476|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14465477|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14465478|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14465479|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
14465480|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465481|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14465482|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14465483|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465484|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
14732439|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14732440|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732441|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
14732442|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14732443|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
14732444|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732445|NCT04519619|Aflibercept|aflibercept|mesh-list
14465485|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14465486|NCT02226549|Ledipasvir|ledipasvir|mesh-list
14465487|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
14465488|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465489|NCT02226562|Listerine|listerine|mesh-list
14465490|NCT02226562|Fluorides|fluorides|mesh-list
14465491|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
14465492|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
14465493|NCT02226562|Protective Agents|protective agents|mesh-ancestor
14465494|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465495|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14465496|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465497|NCT02226653|Evacetrapib|evacetrapib|mesh-list
14465498|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14465499|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14465500|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
14465501|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465502|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14465503|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
14465504|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465505|NCT02227316|Acetaminophen|acetaminophen|mesh-list
14465506|NCT02227316|Ibuprofen|ibuprofen|mesh-list
14465507|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14920444|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
14465508|NCT02227316|Analgesics|analgesics|mesh-ancestor
14465509|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
14732446|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14357803|NCT01047527|Nicotine|nicotine|mesh-list
14357804|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14357805|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
14357806|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357807|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357808|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14357809|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14357810|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
14357811|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357812|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357813|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
14357814|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357815|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
14357816|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357817|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357818|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357819|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357820|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14357821|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14357822|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357823|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357824|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357825|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357826|NCT01048099|Trastuzumab|trastuzumab|mesh-list
14357827|NCT01048099|Pertuzumab|pertuzumab|mesh-list
14357828|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14357829|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14357830|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
14357831|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14357832|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357833|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
14357834|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357835|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357836|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357837|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357838|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14357839|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14357840|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357841|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357842|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357843|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357844|NCT01048502|Fenofibrate|fenofibrate|mesh-list
14357845|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14357846|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
14357847|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920445|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231128|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15231129|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
15231130|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15231131|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
15231132|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231133|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231134|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15231135|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
15231136|NCT02572843|Durvalumab|durvalumab|mesh-list
15231137|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231138|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231139|NCT02560805|Losartan|losartan|mesh-list
15231140|NCT02560805|Atenolol|atenolol|mesh-list
15231141|NCT02560805|Nitroprusside|nitroprusside|mesh-list
15231142|NCT02560805|Phenylephrine|phenylephrine|mesh-list
15231143|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
15231144|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15231145|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15231146|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15231147|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14357848|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14357849|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
14357850|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14357851|NCT01048606|Estrogens|estrogens|mesh-ancestor
14357852|NCT01048606|Hormones|hormones|mesh-ancestor
14357853|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357854|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357855|NCT01048658|Sevoflurane|sevoflurane|mesh-list
14357856|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14357857|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14357858|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
14357859|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
14357860|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357861|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357862|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
14357863|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14357864|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14357865|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
14357866|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357867|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14357868|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14357869|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357870|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357871|NCT01048697|Ethambutol|ethambutol|mesh-list
14357872|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
14357873|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14357874|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357875|NCT01048788|Tolvaptan|tolvaptan|mesh-list
14357876|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14920446|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920447|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
14920448|NCT04635683|Lenalidomide|lenalidomide|mesh-list
14920449|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
14920450|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920451|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14920452|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14920453|NCT04635683|Growth Substances|growth substances|mesh-ancestor
14920454|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
14920455|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920456|NCT04622735|Acetaminophen|acetaminophen|mesh-list
14920457|NCT04622735|Nefopam|nefopam|mesh-list
14357877|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357878|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
14357879|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357880|NCT01048866|Acetaminophen|acetaminophen|mesh-list
14357881|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
14357882|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357883|NCT01048866|Analgesics|analgesics|mesh-ancestor
14357884|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
14357885|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357886|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357887|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
14357888|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357889|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357890|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357891|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14357892|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357893|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357894|NCT01048879|Oseltamivir|oseltamivir|mesh-list
14357895|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
14357896|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14357897|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
14357898|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14357899|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357900|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357901|NCT01048944|Bupropion|bupropion|mesh-list
14357902|NCT01048944|Nicotine|nicotine|mesh-list
14357903|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14357904|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
14357905|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357906|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357907|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14357908|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14357909|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14357910|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920458|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357911|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357912|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14357913|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
14357914|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14357915|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14357916|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14357917|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14357918|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
14357919|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14357920|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14357921|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14357922|NCT01049009|Metoprolol|metoprolol|mesh-list
14920459|NCT04622735|Analgesics|analgesics|mesh-ancestor
14920460|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
14920461|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357923|NCT01049009|Nebivolol|nebivolol|mesh-list
14357924|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14357925|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14357926|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
14357927|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
14357928|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357929|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357930|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14357931|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14357932|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14357933|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357934|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357935|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357936|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
14357937|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14357938|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14357939|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357940|NCT01049217|Pregabalin|pregabalin|mesh-list
14357941|NCT01049217|Analgesics|analgesics|mesh-ancestor
14357942|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
14357943|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357944|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357945|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
14357946|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14357947|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14357948|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357949|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14357950|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14357951|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14357952|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14357953|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14357954|NCT01049243|Fluocinonide|fluocinonide|mesh-list
14357955|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357956|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
14357957|NCT01049243|Hormones|hormones|mesh-ancestor
14357958|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14357959|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357960|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14357961|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
14357962|NCT01049334|Analgesics|analgesics|mesh-ancestor
14357963|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
14357964|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357965|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357966|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14357967|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14357968|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357969|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14357970|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14357971|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465510|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231148|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231149|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15231150|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
15231151|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
15231152|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231153|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231154|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
15231155|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15231156|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
15231157|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
15231158|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15231159|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15231160|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15231161|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
15231162|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231163|NCT02560805|Protective Agents|protective agents|mesh-ancestor
15231164|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
15231165|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15231166|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15231167|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15231168|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
15231169|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15231170|NCT02557672|Thrombin|thrombin|mesh-list
15231171|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
15231172|NCT02557672|Coagulants|coagulants|mesh-ancestor
14357972|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357973|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
14357974|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14357975|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
14357976|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14357977|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357978|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14357979|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
14357980|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14357981|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14357982|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14357983|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
14357984|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14357985|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14357986|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
14357987|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14357988|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357989|NCT01049503|Fluorides|fluorides|mesh-list
14357990|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
14357991|NCT01049503|Protective Agents|protective agents|mesh-ancestor
14357992|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14357993|NCT01049945|Dexamethasone|dexamethasone|mesh-list
14357994|NCT01049945|Lenalidomide|lenalidomide|mesh-list
14357995|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14357996|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14357997|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
14357998|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
14357999|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358000|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358001|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358002|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
14358003|NCT01049945|Hormones|hormones|mesh-ancestor
14358004|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358005|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14358006|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358007|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
14358008|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14358009|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14358010|NCT01049945|Growth Substances|growth substances|mesh-ancestor
14358011|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
14920462|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920463|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
14920464|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14920465|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920466|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14920467|NCT04606264|Lidocaine|lidocaine|mesh-list
14920468|NCT04606264|Ketamine|ketamine|mesh-list
15231173|NCT02529930|Vaccines|vaccines|mesh-list
15231174|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
15231175|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231176|NCT02504151|Cannabidiol|cannabidiol|mesh-list
15231177|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
15231178|NCT02485418|Propofol|propofol|mesh-list
15231179|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15231180|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15231181|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231182|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15231183|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
15231184|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
15231185|NCT02367105|Testosterone|testosterone|mesh-list
15231186|NCT02367105|Androgens|androgens|mesh-ancestor
15231187|NCT02367105|Hormones|hormones|mesh-ancestor
15231188|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358012|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358013|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
14358014|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358015|NCT01049984|Rasagiline|rasagiline|mesh-list
14358016|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14358017|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358018|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358019|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14358020|NCT01049984|Protective Agents|protective agents|mesh-ancestor
14358021|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358022|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14358023|NCT01050062|Telmisartan|telmisartan|mesh-list
14358024|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14358025|NCT01050062|Diuretics|diuretics|mesh-ancestor
14358026|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
14358027|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358028|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14358029|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358030|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358031|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14358032|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14358033|NCT01050153|Aspirin|aspirin|mesh-list
14358034|NCT01050153|Dalteparin|dalteparin|mesh-list
14732447|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14732448|NCT04519619|Growth Substances|growth substances|mesh-ancestor
14358035|NCT01050153|Tinzaparin|tinzaparin|mesh-list
14358036|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14358037|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14358038|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14358039|NCT01050153|Analgesics|analgesics|mesh-ancestor
14358040|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
14358041|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358042|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358043|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358044|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358045|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14358046|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14358047|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358048|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14358049|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14358050|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358051|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
14358052|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
14358053|NCT01050257|Oseltamivir|oseltamivir|mesh-list
14358054|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
14358055|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358056|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358057|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358058|NCT01050530|Tolvaptan|tolvaptan|mesh-list
14358059|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14358060|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358061|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
14358062|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358063|NCT01050543|Neostigmine|neostigmine|mesh-list
14358064|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15231189|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231190|NCT02352948|Gemcitabine|gemcitabine|mesh-list
15231191|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15231192|NCT02352948|Durvalumab|durvalumab|mesh-list
15231193|NCT02352948|Vinorelbine|vinorelbine|mesh-list
15231194|NCT02352948|Tremelimumab|tremelimumab|mesh-list
15231195|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15231196|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15231197|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
15231198|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920469|NCT04606264|Morphine|morphine|mesh-list
14920470|NCT04606264|Gabapentin|gabapentin|mesh-list
14920471|NCT04606264|Hydromorphone|hydromorphone|mesh-list
14358065|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358066|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358067|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
14358068|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358069|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358070|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14358071|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
14358072|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358073|NCT01050569|Nicotine|nicotine|mesh-list
14358074|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14358075|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
14358076|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358077|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358078|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14358079|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14358080|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
14358081|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358082|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358083|NCT01050582|Risperidone|risperidone|mesh-list
14358084|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
14358085|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14358086|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
14358087|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358088|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358089|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358090|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14358091|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920472|NCT04606264|Aprepitant|aprepitant|mesh-list
14920473|NCT04606264|Anesthetics|anesthetics|mesh-list
14358092|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358093|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14358094|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
14358095|NCT01050634|Exemestane|exemestane|mesh-list
14358096|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358097|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14358098|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14358099|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358100|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358101|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14358102|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
14358103|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920474|NCT04606264|Perphenazine|perphenazine|mesh-list
14920475|NCT04606264|Anesthetics, Local|anesthetics, local|mesh-ancestor
14920476|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920477|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920478|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
14920479|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920480|NCT04606264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14920481|NCT04606264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14920482|NCT04606264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14920483|NCT04606264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14920484|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920485|NCT04606264|Analgesics|analgesics|mesh-ancestor
14920486|NCT04606264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14920487|NCT04606264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14358104|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358105|NCT01050647|Castor Oil|castor oil|mesh-list
14358106|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14358107|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14358108|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14358109|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
14358110|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358111|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358112|NCT01050647|Progestins|progestins|mesh-ancestor
14358113|NCT01050647|Hormones|hormones|mesh-ancestor
14358114|NCT01050647|Cathartics|cathartics|mesh-ancestor
14358115|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358116|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14358117|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
14358118|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14358119|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14358120|NCT01050764|Vidarabine|vidarabine|mesh-list
14358121|NCT01050764|Fludarabine|fludarabine|mesh-list
14358122|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
14358123|NCT01050764|Melphalan|melphalan|mesh-list
14358124|NCT01050764|Thiotepa|thiotepa|mesh-list
14358125|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
14358126|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14358127|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358128|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14358129|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
14358130|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358131|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358132|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
14358133|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358134|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
14358135|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358136|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358137|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
14358138|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14358139|NCT01050790|Lenalidomide|lenalidomide|mesh-list
14358140|NCT01050790|Azacitidine|azacitidine|mesh-list
14358141|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
14358142|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358143|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14358144|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14358145|NCT01050790|Growth Substances|growth substances|mesh-ancestor
14358146|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
14358147|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358148|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14358149|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
14358150|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358151|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358152|NCT01050907|Miltefosine|miltefosine|mesh-list
14358153|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
14358154|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358155|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358156|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14920488|NCT04606264|Anesthetics, General|anesthetics, general|mesh-ancestor
14920489|NCT04606264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14920490|NCT04606264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14920491|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920492|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14920493|NCT04606264|Narcotics|narcotics|mesh-ancestor
14920494|NCT04606264|Anticonvulsants|anticonvulsants|mesh-ancestor
14358157|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14732449|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732450|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732451|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732452|NCT04512066|Risperidone|risperidone|mesh-list
14732453|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14732454|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
14732455|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732456|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732457|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732458|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14358158|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
14358159|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14358160|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358161|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
14358162|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358163|NCT01051349|Daclizumab|daclizumab|mesh-list
14358164|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358165|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
14358166|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358167|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14358168|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14358169|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358170|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14358171|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14358172|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358173|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358174|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
14358175|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358176|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14732459|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14732460|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732461|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358177|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14358178|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14358179|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358180|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358181|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358182|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231199|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231200|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
15231201|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231202|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231203|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231204|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
15231205|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231206|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15231207|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231208|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14358183|NCT01051466|Analgesics|analgesics|mesh-ancestor
14358184|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
14358185|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358186|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
14358187|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358188|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
14358189|NCT01051557|Sirolimus|sirolimus|mesh-list
14358190|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14358191|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358192|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14358193|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358194|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
14358195|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358196|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
14358197|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358198|NCT01051570|Prednisone|prednisone|mesh-list
14358199|NCT01051570|Carboplatin|carboplatin|mesh-list
14358200|NCT01051570|Everolimus|everolimus|mesh-list
14358201|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358202|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358203|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
14358204|NCT01051570|Hormones|hormones|mesh-ancestor
14358205|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358206|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358207|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14358208|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358209|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
14358210|NCT01051596|Temozolomide|temozolomide|mesh-list
14358211|NCT01051596|Veliparib|veliparib|mesh-list
14358212|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358213|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
14358214|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358215|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358216|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14358217|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358218|NCT01051661|Vaccines|vaccines|mesh-list
14358219|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
14358220|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358221|NCT01051778|Aspirin|aspirin|mesh-list
14358222|NCT01051778|Heparin|heparin|mesh-list
14358223|NCT01051778|Enoxaparin|enoxaparin|mesh-list
14358224|NCT01051778|Calcium heparin|calcium heparin|mesh-list
14358225|NCT01051778|Calcium|calcium|mesh-list
14358226|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14358227|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358228|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14358229|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14358230|NCT01051778|Analgesics|analgesics|mesh-ancestor
14358231|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
14358232|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358233|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358234|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358235|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14358236|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14358237|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358238|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14358239|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14358240|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358241|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
14358242|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
14358243|NCT01051791|Everolimus|everolimus|mesh-list
14358244|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358245|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358246|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
14358247|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358248|NCT01051960|Ambrisentan|ambrisentan|mesh-list
14358249|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15231209|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231210|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
15231211|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
15231212|NCT02274571|Estrogens|estrogens|mesh-list
15231213|NCT02274571|Hormones|hormones|mesh-ancestor
14358250|NCT01052012|Bupivacaine|bupivacaine|mesh-list
14358251|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
14358252|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
14358253|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358254|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358255|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
14358256|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358257|NCT01052038|Dexamethasone|dexamethasone|mesh-list
14358258|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
14358259|NCT01052038|BB 1101|bb 1101|mesh-list
15231214|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231215|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231216|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
15231217|NCT02162420|Fludarabine|fludarabine|mesh-list
15231218|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
15231219|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15231220|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231221|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
15231222|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231223|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231224|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15231225|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
15231226|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231227|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231228|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15231229|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231230|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
14358260|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358261|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
14358262|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
14358263|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358264|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358265|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358266|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
14358267|NCT01052038|Hormones|hormones|mesh-ancestor
14358268|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358269|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14358270|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358271|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
14358272|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358273|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358274|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
14358275|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358276|NCT01052103|Olanzapine|olanzapine|mesh-list
14358277|NCT01052103|Antiemetics|antiemetics|mesh-ancestor
14358278|NCT01052103|Autonomic Agents|autonomic agents|mesh-ancestor
14358279|NCT01052103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358280|NCT01052103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358281|NCT01052103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358282|NCT01052103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14358283|NCT01052103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14358284|NCT01052103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358285|NCT01052103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358286|NCT01052103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14358287|NCT01052103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14358288|NCT01052103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358289|NCT01052103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358290|NCT01052103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358291|NCT01052103|Serotonin Agents|serotonin agents|mesh-ancestor
14358292|NCT01052272|Allopurinol|allopurinol|mesh-list
14358293|NCT01052272|Candesartan|candesartan|mesh-list
14358294|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
14358295|NCT01052272|Ramipril|ramipril|mesh-list
14358296|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14358297|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14358298|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14358299|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358300|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14358301|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
14358302|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358303|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
14358304|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
14358305|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358306|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14358307|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
14358308|NCT01052272|Protective Agents|protective agents|mesh-ancestor
14358309|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358310|NCT01052428|Metoprolol|metoprolol|mesh-list
14358311|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14358312|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14358313|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
14358314|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
14358315|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358316|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358317|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14358318|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14358319|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14358320|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
14358321|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358322|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358323|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
14358324|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358325|NCT01052493|Hormones|hormones|mesh-ancestor
14358326|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358327|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358328|NCT01052662|Memantine|memantine|mesh-list
14358329|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14358330|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14358331|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
14358332|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358333|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358334|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920495|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14920496|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14920497|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14920498|NCT04606264|Antimanic Agents|antimanic agents|mesh-ancestor
14920499|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
14920500|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
14920501|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14920502|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14920503|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14920504|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14920505|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
14358335|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14358336|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14358337|NCT01052701|Ribavirin|ribavirin|mesh-list
14358338|NCT01052701|Abacavir|abacavir|mesh-list
14358339|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
14358340|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358341|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
14358342|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358343|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14358344|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14358345|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358346|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14358347|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14920506|NCT04604691|Blinatumomab|blinatumomab|mesh-list
14358348|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14358349|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14358350|NCT01052779|Hematinics|hematinics|mesh-ancestor
14358351|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14358352|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14358353|NCT01052831|Naltrexone|naltrexone|mesh-list
14358354|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14358355|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14358356|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358357|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
14358358|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358359|NCT01052844|Gabapentin|gabapentin|mesh-list
14358360|NCT01052844|Analgesics|analgesics|mesh-ancestor
14358361|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
14358362|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358363|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358364|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
14358365|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14358366|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14358367|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358368|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358369|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14358370|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14358371|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358372|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358373|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
14358374|NCT01053000|Tazarotene|tazarotene|mesh-list
14358375|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
14358376|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
14358377|NCT01053078|Naltrexone|naltrexone|mesh-list
14358378|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14358379|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14358380|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358381|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
14358382|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358383|NCT01053156|Minocycline|minocycline|mesh-list
14358384|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14358385|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358386|NCT01053247|Tacrolimus|tacrolimus|mesh-list
14358387|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358388|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
14732462|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14732463|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
14732464|NCT04502667|Vitamin D|vitamin d|mesh-list
14732465|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
14358389|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358390|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14358391|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732466|NCT04502667|Vitamins|vitamins|mesh-ancestor
14732467|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
14732468|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732469|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14920507|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358392|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358393|NCT01053312|Flutemetamol|flutemetamol|mesh-list
14358394|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14358395|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358396|NCT01053429|Ziprasidone|ziprasidone|mesh-list
14358397|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14358398|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
14358399|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358400|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358401|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358402|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14358403|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14358404|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358405|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358406|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14358407|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
14358408|NCT01053507|Naproxen|naproxen|mesh-list
14358409|NCT01053507|Sumatriptan|sumatriptan|mesh-list
14358410|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14358411|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14358412|NCT01053507|Analgesics|analgesics|mesh-ancestor
14358413|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
14358414|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358415|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358416|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358417|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358418|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
14358419|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14358420|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358421|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358422|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14358423|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14358424|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14358425|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
14358426|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358427|NCT01053663|Oseltamivir|oseltamivir|mesh-list
14358428|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
14358429|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358430|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358431|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465511|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465512|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
14465513|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14465514|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465515|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465516|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14465517|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465518|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465519|NCT02227329|Ethanol|ethanol|mesh-list
14465520|NCT02227329|Heparin|heparin|mesh-list
14465521|NCT02227329|Calcium heparin|calcium heparin|mesh-list
14465522|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
14465523|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14465524|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14465525|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465526|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14465527|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465528|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465529|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465530|NCT02227368|Aspirin|aspirin|mesh-list
14465531|NCT02227368|Ticagrelor|ticagrelor|mesh-list
14465532|NCT02227368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14465533|NCT02227368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14465534|NCT02227368|Analgesics|analgesics|mesh-ancestor
14465535|NCT02227368|Sensory System Agents|sensory system agents|mesh-ancestor
14465536|NCT02227368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465537|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465538|NCT02227368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465539|NCT02227368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465540|NCT02227368|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14465541|NCT02227368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14465542|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465543|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14358432|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
14358433|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14358434|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14358435|NCT01053819|Etanercept|etanercept|mesh-list
14358436|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14358437|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14358438|NCT01053819|Analgesics|analgesics|mesh-ancestor
14358439|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
14358440|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358441|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358442|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358443|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358444|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358445|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358446|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
14358447|NCT01053962|Plecanatide|plecanatide|mesh-list
14358448|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14358449|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
14358450|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358451|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358452|NCT01054079|Cinacalcet|cinacalcet|mesh-list
14358453|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14358454|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358455|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14358456|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
14358457|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358458|NCT01054144|Dexamethasone|dexamethasone|mesh-list
14358459|NCT01054144|Prednisone|prednisone|mesh-list
14358460|NCT01054144|Lenalidomide|lenalidomide|mesh-list
14358461|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358462|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
14358463|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
14358464|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358465|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358466|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358467|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
14920508|NCT04604132|Paclitaxel|paclitaxel|mesh-list
14920509|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14920510|NCT04604132|Atezolizumab|atezolizumab|mesh-list
14920511|NCT04604132|Ramucirumab|ramucirumab|mesh-list
14920512|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14358468|NCT01054144|Hormones|hormones|mesh-ancestor
14358469|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358470|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14358471|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358472|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
14358473|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14920513|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14358474|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14358475|NCT01054144|Growth Substances|growth substances|mesh-ancestor
14358476|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
14358477|NCT01054222|Fesoterodine|fesoterodine|mesh-list
14358478|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14358479|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14358480|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
14358481|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358482|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358483|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358484|NCT01054222|Urological Agents|urological agents|mesh-ancestor
14358485|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
14358486|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14358487|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358488|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14358489|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358490|NCT01054404|Furosemide|furosemide|mesh-list
14358491|NCT01054404|Diuretics|diuretics|mesh-ancestor
14358492|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
14358493|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358494|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14358495|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358496|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358497|NCT01054573|Interferons|interferons|mesh-list
14358498|NCT01054573|Ribavirin|ribavirin|mesh-list
14358499|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358500|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
14358501|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358502|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
14358503|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358504|NCT01054599|Memantine|memantine|mesh-list
14358505|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14358506|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14358507|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
14358508|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358509|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732470|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14732471|NCT04497168|Citalopram|citalopram|mesh-list
14732472|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14732473|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14732474|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14732475|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732476|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732477|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
14732478|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732479|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14732480|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
14732481|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14732482|NCT04480502|Ipilimumab|ipilimumab|mesh-list
14732483|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732484|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732485|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14732486|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732487|NCT04472429|Paclitaxel|paclitaxel|mesh-list
14732488|NCT04472429|Carboplatin|carboplatin|mesh-list
14732489|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732490|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732491|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732492|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14732493|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732494|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358510|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231231|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231232|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
15231233|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
15231234|NCT01822652|Fludarabine|fludarabine|mesh-list
15231235|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
15231236|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231237|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
15231238|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231239|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231240|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15231241|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
15231242|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231243|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231244|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15231245|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231246|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15231247|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
15231248|NCT01821690|Buspirone|buspirone|mesh-list
15231249|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15231250|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15231251|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15231252|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231253|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15231254|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15231255|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
15231256|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231257|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231258|NCT01816165|Acipimox|acipimox|mesh-list
15231259|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15231260|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
15231261|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231262|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15231263|NCT01813929|Metformin|metformin|mesh-list
15231264|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15231265|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231266|NCT01693783|Ipilimumab|ipilimumab|mesh-list
15231267|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231268|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231269|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14358511|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14358512|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14358513|NCT01054625|Zalutumumab|zalutumumab|mesh-list
14358514|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358515|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358516|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
14358517|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
14358518|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358519|NCT01054742|Ribavirin|ribavirin|mesh-list
14358520|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14358521|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
14358522|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920514|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920515|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
14920516|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
14920517|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
14920518|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920519|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
14358523|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
14358524|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358525|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
14358526|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
14358527|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
14358528|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358529|NCT01054768|Protective Agents|protective agents|mesh-ancestor
14358530|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358531|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
14358532|NCT01054768|Vitamins|vitamins|mesh-ancestor
14358533|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
14358534|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
14358535|NCT01054820|Diclofenac|diclofenac|mesh-list
14358536|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14358537|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14358538|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14358539|NCT01054820|Analgesics|analgesics|mesh-ancestor
14358540|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
14358541|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358542|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358543|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358544|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358545|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14358546|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358547|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358548|NCT01054911|Sunitinib|sunitinib|mesh-list
14358549|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358550|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14358551|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14358552|NCT01054911|Growth Substances|growth substances|mesh-ancestor
14358553|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358554|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14358555|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14358556|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465544|NCT02227368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14358557|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358558|NCT01054976|Galantamine|galantamine|mesh-list
14358559|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14358560|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358561|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358562|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
14358563|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358564|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358565|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14358566|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
14358567|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358568|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
14358569|NCT01055028|Paclitaxel|paclitaxel|mesh-list
14358570|NCT01055028|Bevacizumab|bevacizumab|mesh-list
14358571|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14358572|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358573|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14358574|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14358575|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14358576|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358577|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358578|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14358579|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14358580|NCT01055028|Growth Substances|growth substances|mesh-ancestor
14358581|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358582|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14358583|NCT01055171|Propranolol|propranolol|mesh-list
14358584|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14358585|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14358586|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
14358587|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358588|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358589|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358590|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14358591|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14358592|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
14358593|NCT01055184|Vaccines|vaccines|mesh-list
14358594|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
14358595|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358596|NCT01055223|Troglitazone|troglitazone|mesh-list
14358597|NCT01055223|Amiloride|amiloride|mesh-list
14358598|NCT01055223|Spironolactone|spironolactone|mesh-list
14358599|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14358600|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
14358601|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358602|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358603|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14358604|NCT01055223|Diuretics|diuretics|mesh-ancestor
14358605|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
14358606|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14358607|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14358608|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358609|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358610|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14358611|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14358612|NCT01055314|Dactinomycin|dactinomycin|mesh-list
14358613|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
14358614|NCT01055314|Temozolomide|temozolomide|mesh-list
14358615|NCT01055314|Ifosfamide|ifosfamide|mesh-list
14358616|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
14358617|NCT01055314|Doxorubicin|doxorubicin|mesh-list
14358618|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14358619|NCT01055314|Irinotecan|irinotecan|mesh-list
14358620|NCT01055314|Etoposide|etoposide|mesh-list
14358621|NCT01055314|Vincristine|vincristine|mesh-list
14358622|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
14358623|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
14358624|NCT01055314|Camptothecin|camptothecin|mesh-list
14358625|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14358626|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358627|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
14358628|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358629|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358630|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358631|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
14358632|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358633|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358634|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14358635|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14358636|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14358637|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14358638|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358639|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14358640|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14358641|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
14358642|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
14358643|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
14358644|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
14358645|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
14358646|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14358647|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358648|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14358649|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14358650|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14358651|NCT01055496|Gemcitabine|gemcitabine|mesh-list
14358652|NCT01055496|Dexamethasone|dexamethasone|mesh-list
14358653|NCT01055496|Prednisone|prednisone|mesh-list
14358654|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
14358655|NCT01055496|Rituximab|rituximab|mesh-list
14358656|NCT01055496|Vincristine|vincristine|mesh-list
14358657|NCT01055496|Cisplatin|cisplatin|mesh-list
14358658|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14358659|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358660|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
14358661|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358662|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358663|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358664|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
14358665|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231270|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231271|NCT01555281|Nelfinavir|nelfinavir|mesh-list
15231272|NCT01555281|Dexamethasone|dexamethasone|mesh-list
15231273|NCT01555281|Lenalidomide|lenalidomide|mesh-list
15231274|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358666|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358667|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14358668|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358669|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
14358670|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
14358671|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358672|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358673|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
14358674|NCT01055496|Hormones|hormones|mesh-ancestor
14358675|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358676|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14358677|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358678|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14358679|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
14358680|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
14358681|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358682|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358683|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14358684|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231275|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
15231276|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
15231277|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231278|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358685|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
14358686|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
15231279|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358687|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14358688|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14358689|NCT01055704|Naltrexone|naltrexone|mesh-list
14358690|NCT01055704|Codeine|codeine|mesh-list
14358691|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
14358692|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14358693|NCT01055704|Narcotics|narcotics|mesh-ancestor
14358694|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358695|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358696|NCT01055704|Analgesics|analgesics|mesh-ancestor
14358697|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
14358698|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358699|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
14358700|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
14358701|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14358702|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14358703|NCT01055769|Linezolid|linezolid|mesh-list
14732495|NCT04460066|Paclitaxel|paclitaxel|mesh-list
14732496|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14358704|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14358705|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358706|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14358707|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358708|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358709|NCT01055834|Eszopiclone|eszopiclone|mesh-list
14358710|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14358711|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358712|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358713|NCT01055886|Nicotine|nicotine|mesh-list
14358714|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14358715|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
14358716|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358717|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358718|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14358719|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14358720|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
14358721|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358722|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358723|NCT01056107|Glucagon|glucagon|mesh-list
14358724|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14358725|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358726|NCT01056107|Hormones|hormones|mesh-ancestor
14358727|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358728|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358729|NCT01056107|Incretins|incretins|mesh-ancestor
14358730|NCT01056263|Axitinib|axitinib|mesh-list
14358731|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358732|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14358733|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358734|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358735|NCT01056276|Dexamethasone|dexamethasone|mesh-list
14358736|NCT01056276|Bortezomib|bortezomib|mesh-list
14358737|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14358738|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358739|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
14358740|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
14358741|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231280|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
15231281|NCT01555281|Hormones|hormones|mesh-ancestor
15231282|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231283|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15231284|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231285|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
15231286|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15231287|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15231288|NCT01555281|Growth Substances|growth substances|mesh-ancestor
15231289|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
14358742|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732497|NCT04460066|Antibodies|antibodies|mesh-list
14358743|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358744|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
14358745|NCT01056276|Hormones|hormones|mesh-ancestor
14358746|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358747|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14358748|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358749|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358750|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
14358751|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358752|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14358753|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14358754|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14358755|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358756|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358757|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358758|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358759|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
14358760|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358761|NCT01056341|Propranolol|propranolol|mesh-list
14358762|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14358763|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14358764|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
14358765|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358766|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358767|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358768|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14358769|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14358770|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
14358771|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
14358772|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14358773|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358774|NCT01056510|Rituximab|rituximab|mesh-list
14358775|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14358776|NCT01056510|Chlorambucil|chlorambucil|mesh-list
14358777|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358778|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358779|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
14358780|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358781|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358782|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358783|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
14358784|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358785|NCT01056523|Cytarabine|cytarabine|mesh-list
14358786|NCT01056523|Ribavirin|ribavirin|mesh-list
14358787|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14358788|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
14358789|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358790|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358791|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
14358792|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358793|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358794|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
14358795|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358796|NCT01056601|Bortezomib|bortezomib|mesh-list
14358797|NCT01056601|Panobinostat|panobinostat|mesh-list
14358798|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358799|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14358800|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358801|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358802|NCT01056718|Nebivolol|nebivolol|mesh-list
14358803|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14358804|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
14358805|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14358806|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14358807|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14358808|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
14358809|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358810|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358811|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358812|NCT01057017|Panitumumab|panitumumab|mesh-list
14358813|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358814|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358815|NCT01057225|Thalidomide|thalidomide|mesh-list
14358816|NCT01057225|Dexamethasone|dexamethasone|mesh-list
14358817|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
14358818|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358819|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
14358820|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358821|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358822|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14358823|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
14358824|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358825|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358826|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14358827|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14358828|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
14358829|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
14358830|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358831|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14358832|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
14358833|NCT01057225|Hormones|hormones|mesh-ancestor
14358834|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358835|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14358836|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
14358837|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14358838|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358839|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14358840|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15231290|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15231291|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15231292|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
15231293|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231294|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231295|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15231296|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15231297|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
15231298|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231299|NCT01502085|Dexamethasone|dexamethasone|mesh-list
15231300|NCT01502085|Vorinostat|vorinostat|mesh-list
15231301|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231302|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
15231303|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
14358841|NCT01057225|Growth Substances|growth substances|mesh-ancestor
14358842|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
14358843|NCT01057251|Nebivolol|nebivolol|mesh-list
14358844|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14358845|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
14358846|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14358847|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14358848|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14358849|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
14358850|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358851|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358852|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358853|NCT01057277|Everolimus|everolimus|mesh-list
14358854|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358855|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358856|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
14358857|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358858|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
14358859|NCT01057381|Morphine|morphine|mesh-list
14358860|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14732498|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732499|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732500|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732501|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14732502|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732503|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358861|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358862|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358863|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14358864|NCT01057381|Analgesics|analgesics|mesh-ancestor
14358865|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
14358866|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358867|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14358868|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14358869|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14358870|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
14358871|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14358872|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358873|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14358874|NCT01057381|Narcotics|narcotics|mesh-ancestor
14358875|NCT01057433|Ritonavir|ritonavir|mesh-list
14358876|NCT01057433|Lopinavir|lopinavir|mesh-list
14358877|NCT01057433|Pitavastatin|pitavastatin|mesh-list
14358878|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14358879|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14358880|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
14358881|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358882|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358883|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14358884|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14358885|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
14358886|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358887|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14358888|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14358889|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14358890|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14358891|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14358892|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
14358893|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14358894|NCT01057589|Folic Acid|folic acid|mesh-list
14358895|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
14358896|NCT01057589|Hydroxocobalamin|hydroxocobalamin|mesh-list
14358897|NCT01057589|Pemetrexed|pemetrexed|mesh-list
14358898|NCT01057589|Cetuximab|cetuximab|mesh-list
14358899|NCT01057589|Vitamins|vitamins|mesh-ancestor
14358900|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
14358901|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358902|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358903|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14358904|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358905|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14358906|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14358907|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358908|NCT01057589|Hematinics|hematinics|mesh-ancestor
14732504|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
14732505|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732506|NCT04459611|Paclitaxel|paclitaxel|mesh-list
15231304|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231305|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358909|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
14358910|NCT01057693|Pregabalin|pregabalin|mesh-list
14358911|NCT01057693|Analgesics|analgesics|mesh-ancestor
14358912|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
14358913|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358914|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358915|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
14358916|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14358917|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14358918|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358919|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14358920|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15231306|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231307|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
15231308|NCT01502085|Hormones|hormones|mesh-ancestor
15231309|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14358921|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14465545|NCT02227368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231310|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15231311|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231312|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15231313|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231314|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465546|NCT02227368|Antipyretics|antipyretics|mesh-ancestor
14465547|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14465548|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14358922|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358923|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358924|NCT01057810|Ipilimumab|ipilimumab|mesh-list
14358925|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358926|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358927|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14358928|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358929|NCT01057862|Naltrexone|naltrexone|mesh-list
14358930|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14358931|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14358932|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358933|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
14358934|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358935|NCT01058005|Interferons|interferons|mesh-list
14358936|NCT01058005|Interferon-beta|interferon-beta|mesh-list
14358937|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
14358938|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
14358939|NCT01058005|Natalizumab|natalizumab|mesh-list
14358940|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
14358941|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358942|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
14358943|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358944|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
14358945|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358946|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14358947|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358948|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358949|NCT01058096|Cariprazine|cariprazine|mesh-list
14358950|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14358951|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14358952|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358953|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358954|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15231315|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
15231316|NCT01413100|Plerixafor|plerixafor|mesh-list
15231317|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
15231318|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
15231319|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15231320|NCT01413100|Lenograstim|lenograstim|mesh-list
15231321|NCT01413100|Sargramostim|sargramostim|mesh-list
15231322|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231323|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
15231324|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231325|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231326|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15231327|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
15231328|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358955|NCT01058239|Rituximab|rituximab|mesh-list
15231329|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231330|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14358956|NCT01058239|Bortezomib|bortezomib|mesh-list
14358957|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14358958|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358959|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
14358960|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358961|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14358962|NCT01058395|Minocycline|minocycline|mesh-list
14358963|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14358964|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14358965|NCT01058655|Everolimus|everolimus|mesh-list
14358966|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14358967|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14358968|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
14358969|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358970|NCT01058668|Cariprazine|cariprazine|mesh-list
14358971|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14358972|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14358973|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14358974|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358975|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14358976|NCT01058863|Albuterol|albuterol|mesh-list
14358977|NCT01058863|Procaterol|procaterol|mesh-list
14358978|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14358979|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
14358980|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14358981|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358982|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14358983|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
14358984|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
14358985|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14358986|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14358987|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14358988|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14358989|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
14358990|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231331|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15231332|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15231333|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15231334|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
15231335|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14358991|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358992|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
14358993|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
14358994|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
14358995|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14358996|NCT01058941|Protective Agents|protective agents|mesh-ancestor
14358997|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14358998|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
14358999|NCT01058941|Vitamins|vitamins|mesh-ancestor
14359000|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
14359001|NCT01058993|Plerixafor|plerixafor|mesh-list
14359002|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14359003|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14359004|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
14359005|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359006|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14359007|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231336|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231337|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231338|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15231339|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15231340|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
15231341|NCT01178814|Lenalidomide|lenalidomide|mesh-list
15231342|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
15231343|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231344|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15231345|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15231346|NCT01178814|Growth Substances|growth substances|mesh-ancestor
14359008|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14359009|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359010|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359011|NCT01059318|Everolimus|everolimus|mesh-list
14359012|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359013|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359014|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
14359015|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465549|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14465550|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
14465551|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465552|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14465553|NCT02227446|Vancomycin|vancomycin|mesh-list
14465554|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465555|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
14465556|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14465557|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465558|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
14465559|NCT02227667|Durvalumab|durvalumab|mesh-list
14465560|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14465561|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465562|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14465563|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
14465564|NCT02227706|Coagulants|coagulants|mesh-ancestor
14465565|NCT02227784|Atorvastatin|atorvastatin|mesh-list
14465566|NCT02227784|Ezetimibe|ezetimibe|mesh-list
14465567|NCT02227784|Evacetrapib|evacetrapib|mesh-list
14465568|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14465569|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14465570|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
14465571|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465572|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14465573|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14465574|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465575|NCT02227849|Canagliflozin|canagliflozin|mesh-list
14465576|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465577|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465578|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465579|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465580|NCT02228408|Hydralazine|hydralazine|mesh-list
14465581|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15231347|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
15231348|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231349|NCT01125176|Thalidomide|thalidomide|mesh-list
15231350|NCT01125176|Rituximab|rituximab|mesh-list
15231351|NCT01125176|Lenalidomide|lenalidomide|mesh-list
15231352|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231353|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231354|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
15231355|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231356|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231357|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15231358|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15231359|NCT01125176|Growth Substances|growth substances|mesh-ancestor
15231360|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
15231361|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231362|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
14465582|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
14465583|NCT02228590|Apomorphine|apomorphine|mesh-list
14465584|NCT02228590|Emetics|emetics|mesh-ancestor
14359016|NCT01059526|Ecallantide|ecallantide|mesh-list
14359017|NCT01059526|Analgesics|analgesics|mesh-ancestor
14359018|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
14359019|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359020|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359021|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14359022|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14359023|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359024|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359025|NCT01059539|Cariprazine|cariprazine|mesh-list
14359026|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14359027|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14359028|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359029|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359030|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14359031|NCT01059617|Vaccines|vaccines|mesh-list
14359032|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
14359033|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359034|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14359035|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
14359036|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14359037|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
14359038|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359039|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359040|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14359041|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
14359042|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14359043|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14359044|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
14359045|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359046|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14359047|NCT01059773|Methotrexate|methotrexate|mesh-list
14359048|NCT01059773|Ustekinumab|ustekinumab|mesh-list
14732507|NCT04459611|Carboplatin|carboplatin|mesh-list
14359049|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14359050|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
14359051|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14359052|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359053|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14359054|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
14359055|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359056|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359057|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
14359058|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359059|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14359060|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359061|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
14359062|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359063|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14359064|NCT01059799|Insulin|insulin|mesh-list
14359065|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14359066|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
14359067|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359068|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359069|NCT01059812|Insulin|insulin|mesh-list
14359070|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14359071|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
14359072|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
14359073|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14359074|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
14359075|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14359076|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359077|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359078|NCT01059825|Metformin|metformin|mesh-list
14359079|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14359080|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
14359081|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359082|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359083|NCT01059825|Incretins|incretins|mesh-ancestor
14359084|NCT01059825|Hormones|hormones|mesh-ancestor
14359085|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359086|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14359087|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
14359088|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359089|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231363|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15231364|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231365|NCT00882050|Exenatide|exenatide|mesh-list
15231366|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15231367|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231368|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15231369|NCT00882050|Incretins|incretins|mesh-ancestor
15231370|NCT00882050|Hormones|hormones|mesh-ancestor
15231371|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231372|NCT00790829|Nicotine|nicotine|mesh-list
15231373|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15231374|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
15231375|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231376|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231377|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15231378|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15231379|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
15231380|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359090|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14359091|NCT01059851|Suvorexant|suvorexant|mesh-list
14359092|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14359093|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14359094|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359095|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359096|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14359097|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359098|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359099|NCT01059864|Atorvastatin|atorvastatin|mesh-list
14359100|NCT01059864|Tofacitinib|tofacitinib|mesh-list
14359101|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14359102|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14359103|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
14359104|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359105|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14359106|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14359107|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231381|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231382|NCT00070564|Paclitaxel|paclitaxel|mesh-list
15231383|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
15231384|NCT00070564|Doxorubicin|doxorubicin|mesh-list
15231385|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15231386|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15231387|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231388|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231389|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
15231390|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
15231391|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359108|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14359109|NCT01059903|Rotigotine|rotigotine|mesh-list
14359110|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
14359111|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
14359112|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359113|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359114|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359115|NCT01059929|Fentanyl|fentanyl|mesh-list
14359116|NCT01059929|Midazolam|midazolam|mesh-list
14359117|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
14359118|NCT01059929|Propofol|propofol|mesh-list
14359119|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14359120|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359121|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359122|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14359123|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
14359124|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
14359125|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14359126|NCT01059929|Analgesics|analgesics|mesh-ancestor
14359127|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
14359128|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359129|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14359130|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14359131|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14359132|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
14359133|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359134|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359135|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14359136|NCT01059929|Narcotics|narcotics|mesh-ancestor
14359137|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14359138|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14359139|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14359140|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14359141|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
14359142|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
15231392|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231393|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
15231394|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231395|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231396|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14359143|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
15231397|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
15231398|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14359144|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
14359145|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14359146|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14359147|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359148|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359149|NCT01059994|Urological Agents|urological agents|mesh-ancestor
14359150|NCT01060007|Leucovorin|leucovorin|mesh-list
14359151|NCT01060007|Fluorouracil|fluorouracil|mesh-list
14359152|NCT01060007|Capecitabine|capecitabine|mesh-list
14359153|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
14359154|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
14359155|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359156|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14359157|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359158|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359159|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
14359160|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359161|NCT01060007|Antidotes|antidotes|mesh-ancestor
14359162|NCT01060007|Protective Agents|protective agents|mesh-ancestor
14359163|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
14359164|NCT01060007|Vitamins|vitamins|mesh-ancestor
14359165|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
14359166|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
14359167|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
14359168|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14359169|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14359170|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359171|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359172|NCT01060020|Urological Agents|urological agents|mesh-ancestor
14359173|NCT01060059|Exenatide|exenatide|mesh-list
14359174|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359175|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359176|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14359177|NCT01060059|Incretins|incretins|mesh-ancestor
14359178|NCT01060059|Hormones|hormones|mesh-ancestor
14359179|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732508|NCT04459611|Pemetrexed|pemetrexed|mesh-list
15231399|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14359180|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14359181|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14359182|NCT01060098|Adalimumab|adalimumab|mesh-list
14359183|NCT01060098|Etanercept|etanercept|mesh-list
14359184|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359185|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359186|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14359187|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14359188|NCT01060098|Analgesics|analgesics|mesh-ancestor
14359189|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
14359190|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231400|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15231401|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15231402|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732509|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14359191|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359192|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14359193|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359194|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
14359195|NCT01060111|Topiramate|topiramate|mesh-list
14359196|NCT01060111|Propranolol|propranolol|mesh-list
14359197|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14359198|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14359199|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14359200|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359201|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359202|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359203|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14359204|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14359205|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
14359206|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
14359207|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15231403|NCT05206747|Methamphetamine|methamphetamine|mesh-list
15231404|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15231405|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359208|NCT01060124|Fentanyl|fentanyl|mesh-list
14732510|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732511|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732512|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732513|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
15231406|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
15231407|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
15231408|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231409|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
14359209|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14732514|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732515|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732516|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231410|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732517|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15231411|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231412|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
15231413|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15231414|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15231415|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15231416|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14359210|NCT01060124|Narcotics|narcotics|mesh-ancestor
14359211|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359212|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359213|NCT01060124|Analgesics|analgesics|mesh-ancestor
14359214|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
14359215|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359216|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14359217|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14359218|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
14359219|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
14359220|NCT01060150|Methylphenidate|methylphenidate|mesh-list
14359221|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14359222|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359223|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14359224|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14359225|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14359226|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359227|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
14359228|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359229|NCT01060384|Lenalidomide|lenalidomide|mesh-list
14359230|NCT01060384|Ofatumumab|ofatumumab|mesh-list
14359231|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
14359232|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359233|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14359234|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14359235|NCT01060384|Growth Substances|growth substances|mesh-ancestor
14359236|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
14359237|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359238|NCT01061034|Aspirin|aspirin|mesh-list
14359239|NCT01061034|Omeprazole|omeprazole|mesh-list
14359240|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14359241|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14359242|NCT01061034|Analgesics|analgesics|mesh-ancestor
14359243|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
14359244|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359245|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359246|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359247|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359248|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14359249|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14359250|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359251|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14359252|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14359253|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359254|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
14359255|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14359256|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14359257|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14359258|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
14359259|NCT01061333|Nedocromil|nedocromil|mesh-list
14359260|NCT01061333|Montelukast|montelukast|mesh-list
14359261|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14359262|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
14359263|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14359264|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
14465585|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231417|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
15231418|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15231419|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231420|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
14359265|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359266|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359267|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14359268|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14359269|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359270|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359271|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
14359272|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14359273|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14359274|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
14359275|NCT01061359|Epirubicin|epirubicin|mesh-list
14359276|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14359277|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359278|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14359279|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14359280|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359281|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359282|NCT01061528|Nicotine|nicotine|mesh-list
14359283|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14359284|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
14359285|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359286|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359287|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14359288|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14359289|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
14359290|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359291|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359292|NCT01061606|Sirolimus|sirolimus|mesh-list
14359293|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14359294|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465586|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
14465587|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732518|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14732519|NCT04447716|Rituximab|rituximab|mesh-list
14732520|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14732521|NCT04447716|Lenalidomide|lenalidomide|mesh-list
14732522|NCT04447716|Venetoclax|venetoclax|mesh-list
14732523|NCT04447716|Piperidine|piperidine|mesh-list
15231421|NCT05206682|Goserelin|goserelin|mesh-list
15231422|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15231423|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231424|NCT05206448|Letrozole|letrozole|mesh-list
15231425|NCT05206448|Clomiphene|clomiphene|mesh-list
15231426|NCT05206448|Enclomiphene|enclomiphene|mesh-list
15231427|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
15231428|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359295|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14359296|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359297|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
14732524|NCT04447716|Antibodies|antibodies|mesh-list
15231429|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231430|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15231431|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15231432|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231433|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15231434|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
15231435|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231436|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231437|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15231438|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
15231439|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15231440|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15231441|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15231442|NCT05206318|Cysteamine|cysteamine|mesh-list
14359298|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359299|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
14359300|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359301|NCT01061671|Simvastatin|simvastatin|mesh-list
14359302|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14359303|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14359304|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
14359305|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359306|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15231443|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14732525|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
14359307|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14359308|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359309|NCT01061710|Varenicline|varenicline|mesh-list
14359310|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14359311|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14359312|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
14359313|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359314|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359315|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359316|NCT01061736|Folic Acid|folic acid|mesh-list
14359317|NCT01061736|Methotrexate|methotrexate|mesh-list
14359318|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14359319|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
14359320|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14359321|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359322|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14359323|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
14359324|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359325|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359326|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14359327|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359328|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14359329|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359330|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
14359331|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359332|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14359333|NCT01061736|Hematinics|hematinics|mesh-ancestor
14359334|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
14359335|NCT01061736|Vitamins|vitamins|mesh-ancestor
14359336|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
14359337|NCT01061775|Exenatide|exenatide|mesh-list
14359338|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359339|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359340|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14359341|NCT01061775|Incretins|incretins|mesh-ancestor
14359342|NCT01061775|Hormones|hormones|mesh-ancestor
14359343|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359344|NCT01061866|Thalidomide|thalidomide|mesh-list
14359345|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359346|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
14359347|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359348|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
14359349|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14359350|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359351|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14359352|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14359353|NCT01061866|Growth Substances|growth substances|mesh-ancestor
14359354|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
14359355|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359356|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
14359357|NCT01062009|Astringents|astringents|mesh-ancestor
14359358|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732526|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14732527|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
14732528|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732529|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732530|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359359|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14359360|NCT01062113|Celecoxib|celecoxib|mesh-list
14359361|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14359362|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14359363|NCT01062113|Analgesics|analgesics|mesh-ancestor
14359364|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
14359365|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359366|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359367|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359368|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359369|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14359370|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14359371|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359372|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359373|NCT01062165|Caspofungin|caspofungin|mesh-list
14359374|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
14359375|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359376|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359377|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359378|NCT01062230|Bortezomib|bortezomib|mesh-list
14359379|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359380|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
14359381|NCT01062256|Guaifenesin|guaifenesin|mesh-list
14359382|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14359383|NCT01062256|Expectorants|expectorants|mesh-ancestor
14359384|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14359385|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14359386|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14359387|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14359388|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359389|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359390|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359391|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
14359392|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14359393|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
14359394|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
14359395|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359396|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
14359397|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14359398|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
14359399|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14359400|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14359401|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
14359402|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359403|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14359404|NCT01062399|Everolimus|everolimus|mesh-list
14359405|NCT01062399|Temozolomide|temozolomide|mesh-list
14359406|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359407|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359408|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
14359409|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359410|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14359411|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
14359412|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359413|NCT01062555|Cyclosporine|cyclosporine|mesh-list
14359414|NCT01062555|Sirolimus|sirolimus|mesh-list
14359415|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
14359416|NCT01062555|Tacrolimus|tacrolimus|mesh-list
14359417|NCT01062555|Cyclosporins|cyclosporins|mesh-list
14359418|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359419|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
14359420|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359421|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14359422|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359423|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359424|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
14359425|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359426|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
14359427|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732531|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14732532|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14359428|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14359429|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359430|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14359431|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
14359432|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14359433|NCT01062568|Dexamethasone|dexamethasone|mesh-list
14359434|NCT01062568|Cosyntropin|cosyntropin|mesh-list
14359435|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14359436|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14359437|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
14359438|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359439|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
14359440|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
14359441|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359442|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359443|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14359444|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
14359445|NCT01062568|Hormones|hormones|mesh-ancestor
14359446|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359447|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14359448|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359449|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359450|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359451|NCT01062763|Spironolactone|spironolactone|mesh-list
14359452|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14359453|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
14359454|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359455|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359456|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14732533|NCT04447716|Growth Substances|growth substances|mesh-ancestor
14732534|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732535|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920520|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359457|NCT01062763|Diuretics|diuretics|mesh-ancestor
14359458|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
14359459|NCT01062971|Timolol|timolol|mesh-list
14359460|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14359461|NCT01062971|Dorzolamide|dorzolamide|mesh-list
14359462|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14359463|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14359464|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
14359465|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359466|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359467|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359468|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14359469|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14359470|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14359471|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14359472|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14359473|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14359474|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359475|NCT01063036|Tenofovir|tenofovir|mesh-list
14359476|NCT01063036|Entecavir|entecavir|mesh-list
14359477|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
14359478|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359479|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14359480|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14359481|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359482|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359483|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14359484|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14359485|NCT01063049|Bisacodyl|bisacodyl|mesh-list
14359486|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14359487|NCT01063049|Cathartics|cathartics|mesh-ancestor
14359488|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14359489|NCT01063049|Laxatives|laxatives|mesh-ancestor
14359490|NCT01063062|Methotrexate|methotrexate|mesh-list
14359491|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14359492|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
14359493|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14359494|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359495|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14359496|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
14359497|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359498|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359499|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
14359500|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359501|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14359502|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359503|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
14359504|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359505|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14359506|NCT01063075|Carboplatin|carboplatin|mesh-list
14359507|NCT01063075|Cetuximab|cetuximab|mesh-list
14359508|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359509|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14359510|NCT01063153|Methylphenidate|methylphenidate|mesh-list
14359511|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14359512|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359513|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14359514|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14359515|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14359516|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359517|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
14359518|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359519|NCT01063283|Bevacizumab|bevacizumab|mesh-list
14359520|NCT01063283|Carboplatin|carboplatin|mesh-list
14359521|NCT01063283|Pemetrexed|pemetrexed|mesh-list
14359522|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14359523|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359524|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14359525|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14359526|NCT01063283|Growth Substances|growth substances|mesh-ancestor
14359527|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359528|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
14359529|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359530|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359531|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14359532|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14359533|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
14359534|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14359535|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
14359536|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359537|NCT01063348|Expectorants|expectorants|mesh-ancestor
14359538|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
14359539|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14359540|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
14359541|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359542|NCT01063348|Protective Agents|protective agents|mesh-ancestor
14359543|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359544|NCT01063348|Antidotes|antidotes|mesh-ancestor
14359545|NCT01063764|Levetiracetam|levetiracetam|mesh-list
14359546|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
14359547|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
14359548|NCT01063829|Letermovir|letermovir|mesh-list
14359549|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14359550|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359551|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359552|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732536|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14359553|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
14920521|NCT04602494|Varenicline|varenicline|mesh-list
14920522|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14920523|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14920524|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
14920525|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359554|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359555|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14359556|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14359557|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359558|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359559|NCT01063868|Oxycodone|oxycodone|mesh-list
14359560|NCT01063868|Tapentadol|tapentadol|mesh-list
14359561|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14359562|NCT01063868|Narcotics|narcotics|mesh-ancestor
14359563|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359564|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359565|NCT01063868|Analgesics|analgesics|mesh-ancestor
14359566|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
14359567|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359568|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14359569|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14359570|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14359571|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359572|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
14359573|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359574|NCT01063907|Bortezomib|bortezomib|mesh-list
14359575|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359576|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
14359577|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14359578|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14359579|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359580|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
14359581|NCT01064167|Coagulants|coagulants|mesh-ancestor
14359582|NCT01064284|Factor VIII|factor viii|mesh-list
14359583|NCT01064284|Coagulants|coagulants|mesh-ancestor
14359584|NCT01064297|Lamotrigine|lamotrigine|mesh-list
14359585|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
14359586|NCT01064297|Valproic Acid|valproic acid|mesh-list
14920526|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359587|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14359588|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14359589|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359590|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14359591|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359592|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14359593|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14359594|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359595|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14359596|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14359597|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359598|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
14359599|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359600|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
14359601|NCT01064310|Sunitinib|sunitinib|mesh-list
14359602|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359603|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14359604|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14359605|NCT01064310|Growth Substances|growth substances|mesh-ancestor
14359606|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359607|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
14359608|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14359609|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359610|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359611|NCT01064362|Heparin|heparin|mesh-list
14359612|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14359613|NCT01064362|Tinzaparin|tinzaparin|mesh-list
14359614|NCT01064362|Dalteparin|dalteparin|mesh-list
14359615|NCT01064362|PENTA|penta|mesh-list
14359616|NCT01064362|Fondaparinux|fondaparinux|mesh-list
14359617|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
14359618|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14359619|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15231444|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231445|NCT05206175|Methamphetamine|methamphetamine|mesh-list
15231446|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15231447|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359620|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359621|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14359622|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
14359623|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14359624|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
14359625|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359626|NCT01064401|Interferons|interferons|mesh-list
14359627|NCT01064401|Interferon-beta|interferon-beta|mesh-list
14359628|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
14359629|NCT01064401|Daclizumab|daclizumab|mesh-list
14359630|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359631|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
14359632|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359633|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
14359634|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359635|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15231448|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
15231449|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
15231450|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359636|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359637|NCT01064414|Canagliflozin|canagliflozin|mesh-list
14359638|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465588|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14359639|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359640|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359641|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359642|NCT01064622|Gemcitabine|gemcitabine|mesh-list
14359643|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
14359644|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14359645|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
14359646|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359647|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359648|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
14359649|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359650|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359651|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359652|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
14359653|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359654|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359655|NCT01064687|Metformin|metformin|mesh-list
14359656|NCT01064687|Pioglitazone|pioglitazone|mesh-list
14359657|NCT01064687|Exenatide|exenatide|mesh-list
14359658|NCT01064687|Dulaglutide|dulaglutide|mesh-list
14359659|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359660|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359661|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14359662|NCT01064687|Incretins|incretins|mesh-ancestor
14359663|NCT01064687|Hormones|hormones|mesh-ancestor
14359664|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359665|NCT01064830|Cyclosporine|cyclosporine|mesh-list
14359666|NCT01064830|Cyclosporins|cyclosporins|mesh-list
14359667|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359668|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359669|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359670|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
14359671|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359672|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
14359673|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359674|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
14359675|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359676|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14359677|NCT01064856|Adalimumab|adalimumab|mesh-list
14359678|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359679|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465589|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
14465590|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
14465591|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465592|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231451|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
15231452|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231453|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231454|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
15231455|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15231456|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15231457|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15231458|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15231459|NCT05205837|Letrozole|letrozole|mesh-list
15231460|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231461|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14465593|NCT02228681|Tamoxifen|tamoxifen|mesh-list
14465594|NCT02228681|Everolimus|everolimus|mesh-list
14465595|NCT02228681|Letrozole|letrozole|mesh-list
14465596|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14465597|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
14465598|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465599|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14465600|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
14465601|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465602|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14465603|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14359680|NCT01064882|Bimatoprost|bimatoprost|mesh-list
14359681|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14359682|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14359683|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14359684|NCT01064947|Retapamulin|retapamulin|mesh-list
14359685|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14359686|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359687|NCT01065350|Ketamine|ketamine|mesh-list
14359688|NCT01065350|Propofol|propofol|mesh-list
14359689|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14359690|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359691|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359692|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14359693|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
14359694|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
14359695|NCT01065350|Analgesics|analgesics|mesh-ancestor
14359696|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
14359697|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359698|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14359699|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14359700|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14359701|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359702|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359703|NCT01065506|Nicotine|nicotine|mesh-list
14359704|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14359705|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
14359706|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359707|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359708|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14359709|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15231462|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15231463|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231464|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231465|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15231466|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
15231467|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231468|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231469|NCT05205811|Zonisamide|zonisamide|mesh-list
15231470|NCT05205811|Bupropion|bupropion|mesh-list
15231471|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15231472|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
15231473|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15231474|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15231475|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15231476|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15231477|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231478|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
15231479|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231480|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231481|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15231482|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15231483|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231484|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
15231485|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15231486|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15231487|NCT05205720|Ropivacaine|ropivacaine|mesh-list
15231488|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
15231489|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
15231490|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15231491|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231492|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
15231493|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231494|NCT05205603|Mesalamine|mesalamine|mesh-list
15231495|NCT05205603|Infliximab|infliximab|mesh-list
15231496|NCT05205603|Vedolizumab|vedolizumab|mesh-list
15231497|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
15231498|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231499|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231500|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15231501|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15231502|NCT05205603|Analgesics|analgesics|mesh-ancestor
15231503|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
14359710|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
14359711|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231504|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231505|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231506|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231507|NCT05205577|Iodine|iodine|mesh-list
15231508|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15231509|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231510|NCT05205577|Trace Elements|trace elements|mesh-ancestor
15231511|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
15231512|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359712|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359713|NCT01065558|Ecopipam|ecopipam|mesh-list
14359714|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14359715|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14359716|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359717|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359718|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14359719|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14359720|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
14359721|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359722|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359723|NCT01065766|Metformin|metformin|mesh-list
14359724|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14359725|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359726|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359727|NCT01065766|Incretins|incretins|mesh-ancestor
14359728|NCT01065766|Hormones|hormones|mesh-ancestor
14359729|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359730|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14359731|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
14359732|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359733|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359734|NCT01065844|Nelfinavir|nelfinavir|mesh-list
14359735|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14359736|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14359737|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
14359738|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359739|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359740|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14359741|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14359742|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
14359743|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359744|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
15231513|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14359745|NCT01066000|Hematinics|hematinics|mesh-ancestor
14359746|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
14359747|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14359748|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
14359749|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359750|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
14359751|NCT01066026|Protective Agents|protective agents|mesh-ancestor
14359752|NCT01066039|Bisoprolol|bisoprolol|mesh-list
14359753|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14359754|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
14359755|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
14359756|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359757|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359758|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14359759|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14359760|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14359761|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
14359762|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359763|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359764|NCT01066104|Omalizumab|omalizumab|mesh-list
14359765|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14359766|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14359767|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14359768|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
14359769|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
15231514|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15231515|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231516|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
15231517|NCT05205317|Metformin|metformin|mesh-list
15231518|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15231519|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231520|NCT05205200|Paclitaxel|paclitaxel|mesh-list
15231521|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14359770|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359771|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14359772|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
14359773|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14359774|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14359775|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14359776|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359777|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359778|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14359779|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
14359780|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14359781|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14359782|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14359783|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359784|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359785|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14359786|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14359787|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14359788|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
14359789|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359790|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14359791|NCT01066520|Diclofenac|diclofenac|mesh-list
14359792|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14359793|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14359794|NCT01066520|Analgesics|analgesics|mesh-ancestor
14359795|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
14359796|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359797|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359798|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359799|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359800|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14359801|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359802|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359803|NCT01066585|Ivermectin|ivermectin|mesh-list
14359804|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14359805|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359806|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14359807|NCT01066624|Calcium|calcium|mesh-list
14359808|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14359809|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359810|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14359811|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14359812|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
14359813|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231522|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231523|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231524|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14359814|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14359815|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15231525|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14359816|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
14359817|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359818|NCT01066897|Pramipexole|pramipexole|mesh-list
14359819|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
14359820|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359821|NCT01066897|Protective Agents|protective agents|mesh-ancestor
14359822|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359823|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14359824|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14359825|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
14359826|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
14359827|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359828|NCT01066923|Aspirin|aspirin|mesh-list
14359829|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14359830|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14359831|NCT01066923|Analgesics|analgesics|mesh-ancestor
14359832|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
14359833|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359834|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359835|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14359836|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14359837|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14359838|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14359839|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359840|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14359841|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14359842|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231526|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231527|NCT05205122|Mitomycins|mitomycins|mesh-list
15231528|NCT05205122|Mitomycin|mitomycin|mesh-list
14359843|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
14359844|NCT01067105|Ciclesonide|ciclesonide|mesh-list
14359845|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
14359846|NCT01067105|Hormones|hormones|mesh-ancestor
14359847|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359848|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359849|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14359850|NCT01067144|Gabapentin|gabapentin|mesh-list
14359851|NCT01067144|Lorazepam|lorazepam|mesh-list
14359852|NCT01067144|Analgesics|analgesics|mesh-ancestor
14359853|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
14359854|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14359855|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359856|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
14359857|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14359858|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14359859|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14359860|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14359861|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14920527|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231529|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15231530|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231531|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
15231532|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231533|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15231534|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231535|NCT05204979|Misoprostol|misoprostol|mesh-list
14920528|NCT04598321|Talazoparib|talazoparib|mesh-list
14920529|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14920530|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920531|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920532|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920533|NCT04583501|Omalizumab|omalizumab|mesh-list
14920534|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14920535|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14920536|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
14920537|NCT04580381|Natalizumab|natalizumab|mesh-list
14920538|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
14920539|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920540|NCT04579848|Folic Acid|folic acid|mesh-list
14920541|NCT04579848|Methotrexate|methotrexate|mesh-list
14920542|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14920543|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
14920544|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14920545|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231536|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15231537|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
15231538|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15231539|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732537|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14732538|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14732539|NCT04447040|Acetaminophen|acetaminophen|mesh-list
15231540|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15231541|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14359862|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14359863|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14359864|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359865|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
14359866|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
14359867|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
14359868|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14359869|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14359870|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
14359871|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
14359872|NCT01067339|Darapladib|darapladib|mesh-list
14359873|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14359874|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359875|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359876|NCT01067352|Hormones|hormones|mesh-list
14359877|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359878|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359879|NCT01067469|Bevacizumab|bevacizumab|mesh-list
14359880|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14359881|NCT01067469|Lomustine|lomustine|mesh-list
14359882|NCT01067469|Antibodies|antibodies|mesh-list
14359883|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
14732540|NCT04447040|Naproxen|naproxen|mesh-list
14732541|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14732542|NCT04447040|Analgesics|analgesics|mesh-ancestor
14732543|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
14732544|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732545|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231542|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
15231543|NCT05204862|Antibodies|antibodies|mesh-list
15231544|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
15231545|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231546|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
15231547|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15231548|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231549|NCT05204667|Acetaminophen|acetaminophen|mesh-list
15231550|NCT05204667|Aspirin|aspirin|mesh-list
15231551|NCT05204667|Methocarbamol|methocarbamol|mesh-list
15231552|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15231553|NCT05204667|Analgesics|analgesics|mesh-ancestor
15231554|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
15231555|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231556|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231557|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
14359884|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14359885|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14359886|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14359887|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14359888|NCT01067469|Growth Substances|growth substances|mesh-ancestor
14359889|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359890|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
14359891|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
14359892|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14359893|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
14359894|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359895|NCT01067846|Cycloserine|cycloserine|mesh-list
14359896|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14359897|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359898|NCT01067846|Renal Agents|renal agents|mesh-ancestor
14359899|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14359900|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
14359901|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14359902|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
14359903|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359904|NCT01068158|Ivermectin|ivermectin|mesh-list
14359905|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14359906|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14359907|NCT01068418|Vitamin D|vitamin d|mesh-list
14359908|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
14359909|NCT01068418|Vitamins|vitamins|mesh-ancestor
14359910|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
14359911|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359912|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14359913|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14359914|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14359915|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14359916|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14359917|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
14359918|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359919|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14359920|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14359921|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359922|NCT01068652|Insulin|insulin|mesh-list
14359923|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14359924|NCT01068652|Metformin|metformin|mesh-list
14359925|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
14359926|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
14359927|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14359928|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
14359929|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
14359930|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14359931|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359932|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359933|NCT01068665|Insulin|insulin|mesh-list
14359934|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14359935|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
14359936|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359937|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359938|NCT01068678|Insulin|insulin|mesh-list
14359939|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14359940|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
14359941|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359942|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359943|NCT01068717|Metformin|metformin|mesh-list
14359944|NCT01068717|Saxagliptin|saxagliptin|mesh-list
14359945|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359946|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359947|NCT01068717|Incretins|incretins|mesh-ancestor
14359948|NCT01068717|Hormones|hormones|mesh-ancestor
14359949|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359950|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14359951|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
14359952|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359953|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359954|NCT01068730|Metformin|metformin|mesh-list
14359955|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359956|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359957|NCT01068743|Metformin|metformin|mesh-list
14359958|NCT01068743|Saxagliptin|saxagliptin|mesh-list
14359959|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359960|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359961|NCT01068743|Incretins|incretins|mesh-ancestor
14359962|NCT01068743|Hormones|hormones|mesh-ancestor
14359963|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14359964|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14359965|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
14359966|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359967|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359968|NCT01068860|Insulin|insulin|mesh-list
14359969|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14359970|NCT01068860|Metformin|metformin|mesh-list
14359971|NCT01068860|Glimepiride|glimepiride|mesh-list
14359972|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
14359973|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
14359974|NCT01068860|Glyburide|glyburide|mesh-list
14359975|NCT01068860|Glipizide|glipizide|mesh-list
14359976|NCT01068860|Troglitazone|troglitazone|mesh-list
14359977|NCT01068860|Tolbutamide|tolbutamide|mesh-list
14359978|NCT01068860|Acetohexamide|acetohexamide|mesh-list
14359979|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
14359980|NCT01068860|Tolazamide|tolazamide|mesh-list
14359981|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
14359982|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14359983|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14359984|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14359985|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14359986|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14359987|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
14359988|NCT01068873|Ritonavir|ritonavir|mesh-list
14359989|NCT01068873|Lopinavir|lopinavir|mesh-list
14359990|NCT01068873|Maraviroc|maraviroc|mesh-list
14359991|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14359992|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14359993|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
14359994|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14359995|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14359996|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14359997|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14359998|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
14359999|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360000|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360001|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360002|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14360003|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14360004|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14360005|NCT01068912|Favipiravir|favipiravir|mesh-list
14360006|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
14360007|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360008|NCT01068964|Timolol|timolol|mesh-list
14360009|NCT01068964|Bimatoprost|bimatoprost|mesh-list
14360010|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14360011|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14360012|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14360013|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14360014|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360015|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360016|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360017|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360018|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14360019|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14360020|NCT01069172|Dipivefrin|dipivefrin|mesh-list
14360021|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14360022|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360023|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360024|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360025|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360026|NCT01069289|Budesonide|budesonide|mesh-list
14360027|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
14360028|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14360029|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360030|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14920546|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14920547|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
14920548|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920549|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920550|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
14360031|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
14360032|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360033|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360034|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14360035|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
14360036|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
14360037|NCT01069289|Hormones|hormones|mesh-ancestor
14360038|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360039|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14360040|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14360041|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14360042|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360043|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360044|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360045|NCT01069341|Ranibizumab|ranibizumab|mesh-list
14360046|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14360047|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14360048|NCT01069341|Growth Substances|growth substances|mesh-ancestor
14360049|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360050|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
14360051|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360052|NCT01069354|Lidocaine|lidocaine|mesh-list
14360053|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
14360054|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
14360055|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14360056|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360057|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
14360058|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360059|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14360060|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14360061|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14360062|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14360063|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360064|NCT01069510|Spironolactone|spironolactone|mesh-list
14360065|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14360066|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
14360067|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360068|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360069|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14360070|NCT01069510|Diuretics|diuretics|mesh-ancestor
14360071|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
14360072|NCT01069523|Guanfacine|guanfacine|mesh-list
14360073|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14360074|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14360075|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14360076|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14360077|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360078|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360079|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360080|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360081|NCT01069627|Bevacizumab|bevacizumab|mesh-list
14360082|NCT01069627|Fotemustine|fotemustine|mesh-list
14360083|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14360084|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360085|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14465604|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231558|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15231559|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231560|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231561|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15231562|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15231563|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231564|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15231565|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15231566|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231567|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14360086|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14360087|NCT01069627|Growth Substances|growth substances|mesh-ancestor
14360088|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360089|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
14360090|NCT01069705|Tobramycin|tobramycin|mesh-list
14360091|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14360092|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360093|NCT01069900|Amoxicillin|amoxicillin|mesh-list
14360094|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
14360095|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
14360096|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
14360097|NCT01069900|Ertapenem|ertapenem|mesh-list
14360098|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14360099|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14360100|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14360101|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360102|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14360103|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14360104|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360105|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360106|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360107|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14360108|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
14360109|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14360110|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360111|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14732546|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
14732547|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14360112|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14360113|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14360114|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14360115|NCT01069939|Esomeprazole|esomeprazole|mesh-list
14360116|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14360117|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360118|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14360119|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360120|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360121|NCT01070043|Amlodipine|amlodipine|mesh-list
14360122|NCT01070043|Valsartan|valsartan|mesh-list
14360123|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14360124|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14360125|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14360126|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360127|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14360128|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360129|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
14360130|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14360131|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14360132|NCT01070303|Adalimumab|adalimumab|mesh-list
14360133|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360134|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14360135|NCT01070316|Everolimus|everolimus|mesh-list
14360136|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360137|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14360138|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
14360139|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360140|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14360141|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14360142|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14360143|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14360144|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360145|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360146|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360147|NCT01070329|Analgesics|analgesics|mesh-ancestor
14360148|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
14360149|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920551|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360150|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
14360151|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14360152|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
14360153|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14360154|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14360155|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360156|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14360157|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14360158|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14360159|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360160|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
14360161|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360162|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14360163|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
14360164|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360165|NCT01070784|Budesonide|budesonide|mesh-list
14360166|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
14360167|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14360168|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360169|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14360170|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
14360171|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360172|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360173|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14360174|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
14360175|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
14360176|NCT01070784|Hormones|hormones|mesh-ancestor
14360177|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360178|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14360179|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14360180|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14360181|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360182|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360183|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360184|NCT01070810|Thiamine|thiamine|mesh-list
14360185|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
14360186|NCT01070810|Vitamins|vitamins|mesh-ancestor
14360187|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
14360188|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360189|NCT01070888|Budesonide|budesonide|mesh-list
14360190|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
14360191|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360192|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14360193|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
14360194|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360195|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360196|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14360197|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
14360198|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
14360199|NCT01070888|Hormones|hormones|mesh-ancestor
14360200|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360201|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14360202|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14360203|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14360204|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360205|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360206|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360207|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14360208|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14360209|NCT01070979|Estradiol|estradiol|mesh-list
14360210|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14360211|NCT01070979|Estrogens|estrogens|mesh-list
14360212|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14360213|NCT01070979|Hormones|hormones|mesh-ancestor
14360214|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360215|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360216|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14360217|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
14360218|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14360219|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14360220|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14360221|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14360222|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360223|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14360224|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14360225|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15231568|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15231569|NCT05204641|Rifaximin|rifaximin|mesh-list
14360226|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360227|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
14360228|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360229|NCT01071083|Interferons|interferons|mesh-list
14360230|NCT01071083|Interferon-beta|interferon-beta|mesh-list
14360231|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
14360232|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
14360233|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
14360234|NCT01071083|Natalizumab|natalizumab|mesh-list
14360235|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
14360236|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360237|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
14360238|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360239|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360240|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
14360241|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
14360242|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360243|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920552|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15231570|NCT05204641|Levodopa|levodopa|mesh-list
15231571|NCT05204641|Benserazide|benserazide|mesh-list
15231572|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15231573|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15231574|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
15231575|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231576|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231577|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231578|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15231579|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231580|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231581|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920553|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14920554|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
14920555|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920556|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14920557|NCT04579848|Hematinics|hematinics|mesh-ancestor
14920558|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
14920559|NCT04579848|Vitamins|vitamins|mesh-ancestor
14920560|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
14920561|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
14920562|NCT04571632|Ipilimumab|ipilimumab|mesh-list
15231582|NCT05204628|Crizotinib|crizotinib|mesh-list
15231583|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360244|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360245|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
14360246|NCT01071083|Hormones|hormones|mesh-ancestor
14360247|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360248|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14360249|NCT01071083|Protective Agents|protective agents|mesh-ancestor
14360250|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
14360251|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14360252|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14360253|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14360254|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
14360255|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14360256|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14360257|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14360258|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14360259|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360260|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
14360261|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360262|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360263|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14360264|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360265|NCT01071200|Hormones|hormones|mesh-list
14360266|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14360267|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360268|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732548|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14732549|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732550|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
14732551|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14732552|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465605|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465606|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14732553|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732554|NCT04420598|Trastuzumab|trastuzumab|mesh-list
14732555|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231584|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14465607|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
14465608|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465609|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14465610|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14465611|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14465612|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14465613|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15231585|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231586|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231587|NCT05204550|Heparin|heparin|mesh-list
15231588|NCT05204550|Calcium heparin|calcium heparin|mesh-list
15231589|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
15231590|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15231591|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15231592|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231593|NCT05204524|Temozolomide|temozolomide|mesh-list
15231594|NCT05204524|Epirubicin|epirubicin|mesh-list
14360269|NCT01071317|Naproxen|naproxen|mesh-list
14360270|NCT01071317|Sumatriptan|sumatriptan|mesh-list
14360271|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14360272|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14360273|NCT01071317|Analgesics|analgesics|mesh-ancestor
14360274|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
14360275|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360276|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360277|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360278|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14360279|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
14360280|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14360281|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360282|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360283|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14360284|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14360285|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14360286|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
14360287|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360288|NCT01071395|Amantadine|amantadine|mesh-list
14360289|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14360290|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14360291|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
14360292|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360293|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
14360294|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360295|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360296|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360297|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14360298|NCT01071395|Analgesics|analgesics|mesh-ancestor
14360299|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
14360300|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360301|NCT01071512|Natalizumab|natalizumab|mesh-list
14360302|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
15231595|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15231596|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
15231597|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231598|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231599|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15231600|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15231601|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15231602|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360303|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360304|NCT01071538|Buprenorphine|buprenorphine|mesh-list
14360305|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14360306|NCT01071538|Narcotics|narcotics|mesh-ancestor
14360307|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14360308|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360309|NCT01071538|Analgesics|analgesics|mesh-ancestor
14360310|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
14360311|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360312|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14360313|NCT01071798|Rituximab|rituximab|mesh-list
14360314|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14360315|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360316|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
14360317|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360318|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14360319|NCT01072136|Azithromycin|azithromycin|mesh-list
14360320|NCT01072136|Cefixime|cefixime|mesh-list
14360321|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14360322|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360323|NCT01072149|Fluticasone|fluticasone|mesh-list
14360324|NCT01072149|Xhance|xhance|mesh-list
14360325|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360326|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14360327|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
14360328|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360329|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360330|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14360331|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14360332|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
14360333|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14360334|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
14360335|NCT01072188|Calcium|calcium|mesh-list
14360336|NCT01072188|Fluorides|fluorides|mesh-list
14360337|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14360338|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360339|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
14732556|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732557|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
14732558|NCT04416984|Fludarabine|fludarabine|mesh-list
14732559|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732560|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
14360340|NCT01072188|Protective Agents|protective agents|mesh-ancestor
14360341|NCT01072188|Antacids|antacids|mesh-ancestor
14360342|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360343|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360344|NCT01072201|Triclosan|triclosan|mesh-list
14360345|NCT01072201|Fluorides|fluorides|mesh-list
14360346|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
14360347|NCT01072201|Protective Agents|protective agents|mesh-ancestor
14360348|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360349|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14360350|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360351|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14360352|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14360353|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
14360354|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360355|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14360356|NCT01072357|Bevacizumab|bevacizumab|mesh-list
14360357|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14360358|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14360359|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360360|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14360361|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14360362|NCT01072357|Growth Substances|growth substances|mesh-ancestor
14360363|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732561|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360364|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732562|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14360365|NCT01072357|Laxatives|laxatives|mesh-ancestor
14360366|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14732563|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14360367|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
14360368|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14360369|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
14360370|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360371|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360372|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14360373|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
14360374|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
14360375|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14360376|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
14360377|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360378|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360379|NCT01072539|Tigecycline|tigecycline|mesh-list
14360380|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14360381|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360382|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14360383|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360384|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360385|NCT01072630|Modafinil|modafinil|mesh-list
14360386|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14360387|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360388|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14360389|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14360390|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14360391|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360392|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
14360393|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14360394|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14360395|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360396|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14360397|NCT01072643|Analgesics|analgesics|mesh-ancestor
14360398|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
14360399|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360400|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14360401|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14360402|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14360403|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360404|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360405|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360406|NCT01072669|Ambrisentan|ambrisentan|mesh-list
14360407|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14360408|NCT01072773|Dexamethasone|dexamethasone|mesh-list
14360409|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
14360410|NCT01072773|Bortezomib|bortezomib|mesh-list
14360411|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14360412|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
14360413|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360414|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14360415|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14360416|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
14360417|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360418|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360419|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14360420|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14360421|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
14360422|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
14360423|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360424|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360425|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
14360426|NCT01072773|Hormones|hormones|mesh-ancestor
14360427|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360428|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14360429|NCT01072877|Polidocanol|polidocanol|mesh-list
14360430|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14360431|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14360432|NCT01072929|Modafinil|modafinil|mesh-list
14360433|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14360434|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360435|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14360436|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14360437|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14360438|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360439|NCT01073163|Rituximab|rituximab|mesh-list
14360440|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14360441|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14360442|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360443|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
14360444|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360445|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920563|NCT04571632|Avelumab|avelumab|mesh-list
14920564|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920565|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920566|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14920567|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920568|NCT04564612|Itraconazole|itraconazole|mesh-list
14920569|NCT04564612|Rabeprazole|rabeprazole|mesh-list
14920570|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
14920571|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920572|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14360446|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14360447|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
14360448|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360449|NCT01073566|Insulin|insulin|mesh-list
14360450|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14360451|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14360452|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360453|NCT01073618|Voriconazole|voriconazole|mesh-list
14360454|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
14360455|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360456|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14360457|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360458|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360459|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360460|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14360461|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
14360462|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360463|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360464|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360465|NCT01073631|Voriconazole|voriconazole|mesh-list
14360466|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
14360467|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360468|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14360469|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360470|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360471|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360472|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14360473|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
14360474|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360475|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360476|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360477|NCT01073865|Goserelin|goserelin|mesh-list
14360478|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14360479|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360480|NCT01073930|Bisacodyl|bisacodyl|mesh-list
14360481|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
14360482|NCT01073930|Cathartics|cathartics|mesh-ancestor
14360483|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360484|NCT01073930|Laxatives|laxatives|mesh-ancestor
14360485|NCT01073943|Bisacodyl|bisacodyl|mesh-list
14360486|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
14360487|NCT01073943|Cathartics|cathartics|mesh-ancestor
14360488|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360489|NCT01073943|Laxatives|laxatives|mesh-ancestor
14360490|NCT01074008|Ritonavir|ritonavir|mesh-list
14360491|NCT01074008|Ribavirin|ribavirin|mesh-list
14360492|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14360493|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14360494|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14360495|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
14360496|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360497|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360498|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14360499|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14360500|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
14360501|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360502|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360503|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360504|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
14360505|NCT01074047|Azacitidine|azacitidine|mesh-list
14360506|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14360507|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
14360508|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360509|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360510|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360511|NCT01074177|Afatinib|afatinib|mesh-list
14360512|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360513|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14360514|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360515|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360516|NCT01074216|Vitamin D|vitamin d|mesh-list
14360517|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
14360518|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
14360519|NCT01074216|Vitamins|vitamins|mesh-list
14360520|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
14360521|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360522|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14360523|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14360524|NCT01074229|Ropivacaine|ropivacaine|mesh-list
14360525|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
14360526|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
14360527|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14360528|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360529|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
14360530|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360531|NCT01074255|Aprepitant|aprepitant|mesh-list
14360532|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
14360533|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
14360534|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360535|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360536|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360537|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14360538|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360539|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360540|NCT01074268|Insulin|insulin|mesh-list
14360541|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14360542|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
14360543|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
14360544|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14360545|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360546|NCT01074307|Bisoprolol|bisoprolol|mesh-list
14360547|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14360548|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
14360549|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
14360550|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360551|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360552|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14360553|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14360554|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14360555|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
14360556|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360557|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360558|NCT01074450|Pramipexole|pramipexole|mesh-list
14360559|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
14360560|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360561|NCT01074450|Protective Agents|protective agents|mesh-ancestor
14360562|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360563|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14360564|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14360565|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
14360566|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
14360567|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360568|NCT01074463|Pramipexole|pramipexole|mesh-list
14360569|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
14360570|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360571|NCT01074463|Protective Agents|protective agents|mesh-ancestor
14360572|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360573|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14360574|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14360575|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
14360576|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
14360577|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360578|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14360579|NCT01074554|Azithromycin|azithromycin|mesh-list
14360580|NCT01074554|Levofloxacin|levofloxacin|mesh-list
14360581|NCT01074554|Rifampin|rifampin|mesh-list
14360582|NCT01074554|Ethambutol|ethambutol|mesh-list
14360583|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360584|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14360585|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
14360586|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14360587|NCT01074554|Renal Agents|renal agents|mesh-ancestor
14360588|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14360589|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14360590|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360591|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360592|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360593|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14360594|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360595|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
14360596|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14360597|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14360598|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14360599|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14360600|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14360601|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14360602|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15231603|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15231604|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15231605|NCT05204173|Paclitaxel|paclitaxel|mesh-list
15231606|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15231607|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231608|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
14360603|NCT01074931|Ritonavir|ritonavir|mesh-list
14360604|NCT01074931|Lopinavir|lopinavir|mesh-list
14360605|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14360606|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14360607|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
14360608|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231609|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
15231610|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
15231611|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231612|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
15231613|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15231614|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15231615|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
15231616|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231617|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
15231618|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
15231619|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
15231620|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231621|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360609|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360610|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14360611|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14360612|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
14360613|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360614|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360615|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360616|NCT01074944|Eliglustat|eliglustat|mesh-list
14360617|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360618|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360619|NCT01075048|Irinotecan|irinotecan|mesh-list
14360620|NCT01075048|Cetuximab|cetuximab|mesh-list
14360621|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14360622|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14360623|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360624|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360625|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360626|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14360627|NCT01075087|Ropivacaine|ropivacaine|mesh-list
14360628|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
14360629|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
14360630|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14360631|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360632|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
14360633|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360634|NCT01075100|Carboplatin|carboplatin|mesh-list
14360635|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360636|NCT01075152|Lamivudine|lamivudine|mesh-list
14360637|NCT01075152|Zidovudine|zidovudine|mesh-list
14360638|NCT01075152|Efavirenz|efavirenz|mesh-list
14360639|NCT01075152|Stavudine|stavudine|mesh-list
14360640|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14360641|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14360642|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360643|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360644|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
14360645|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360646|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14360647|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14360648|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
14360649|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14360650|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360651|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14732564|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
14732565|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360652|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14360653|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14360654|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14360655|NCT01075204|Clarithromycin|clarithromycin|mesh-list
14360656|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14360657|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360658|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14360659|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360660|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360661|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360662|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360663|NCT01075243|Acetaminophen|acetaminophen|mesh-list
14360664|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14360665|NCT01075243|Analgesics|analgesics|mesh-ancestor
14360666|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
14360667|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360668|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360669|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
14360670|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
14360671|NCT01075256|Calcium|calcium|mesh-list
14360672|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14360673|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360674|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14360675|NCT01075282|Metformin|metformin|mesh-list
14360676|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
14360677|NCT01075282|Glimepiride|glimepiride|mesh-list
14360678|NCT01075282|Dulaglutide|dulaglutide|mesh-list
14360679|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465614|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14360680|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360681|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14360682|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14360683|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
14360684|NCT01075321|Lenalidomide|lenalidomide|mesh-list
14360685|NCT01075321|Everolimus|everolimus|mesh-list
14360686|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
14360687|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360688|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14360689|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14360690|NCT01075321|Growth Substances|growth substances|mesh-ancestor
14360691|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
14360692|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360693|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14360694|NCT01075399|Imidazole|imidazole|mesh-list
14360695|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360696|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360697|NCT01075646|Ropivacaine|ropivacaine|mesh-list
14360698|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14360699|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
14360700|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
14360701|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14360702|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360703|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
14360704|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360705|NCT01075763|Interferons|interferons|mesh-list
14360706|NCT01075763|Interferon-beta|interferon-beta|mesh-list
14360707|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
14360708|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360709|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
14360710|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360711|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
14360712|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360713|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14360714|NCT01075815|Hormones|hormones|mesh-list
14360715|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14360716|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360717|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360718|NCT01075971|Buprenorphine|buprenorphine|mesh-list
14360719|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14360720|NCT01075971|Narcotics|narcotics|mesh-ancestor
14360721|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14360722|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360723|NCT01075971|Analgesics|analgesics|mesh-ancestor
14360724|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
14360725|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360726|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14360727|NCT01075984|Posaconazole|posaconazole|mesh-list
14360728|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
14360729|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360730|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14360731|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14360732|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14360733|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14360734|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360735|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360736|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360737|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14360738|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
14360739|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360740|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360741|NCT01076010|Sorafenib|sorafenib|mesh-list
14360742|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360743|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14360744|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360745|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360746|NCT01076075|Metformin|metformin|mesh-list
14360747|NCT01076075|Pioglitazone|pioglitazone|mesh-list
14360748|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14360749|NCT01076075|Glimepiride|glimepiride|mesh-list
14360750|NCT01076075|Gliclazide|gliclazide|mesh-list
14360751|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14360752|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360753|NCT01076075|Incretins|incretins|mesh-ancestor
14360754|NCT01076075|Hormones|hormones|mesh-ancestor
14360755|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360756|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14360757|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
14360758|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360759|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360760|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14360761|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14360762|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
14360763|NCT01076088|Metformin|metformin|mesh-list
14360764|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14360765|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14360766|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360767|NCT01076088|Incretins|incretins|mesh-ancestor
14360768|NCT01076088|Hormones|hormones|mesh-ancestor
14360769|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360770|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14732566|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732567|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14732568|NCT04380740|Abatacept|abatacept|mesh-list
14732569|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14360771|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
14360772|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360773|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360774|NCT01076153|Clarithromycin|clarithromycin|mesh-list
14360775|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14360776|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360777|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14360778|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360779|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360780|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360781|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360782|NCT01076166|Clarithromycin|clarithromycin|mesh-list
14360783|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14360784|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360785|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14360786|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360787|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360788|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360789|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360790|NCT01076231|Etoposide|etoposide|mesh-list
14360791|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
14360792|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
14360793|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360794|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14360795|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14360796|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14360797|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360798|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360799|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
14360800|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
14360801|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
14360802|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
14360803|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
14465615|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14465616|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
14465617|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14753799|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360804|NCT01076270|Plerixafor|plerixafor|mesh-list
14360805|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14360806|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14360807|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
14360808|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360809|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
14360810|NCT01076283|Baclofen|baclofen|mesh-list
14360811|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14360812|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360813|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14360814|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360815|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14360816|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
14360817|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
14360818|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360819|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360820|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
14360821|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14360822|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360823|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14360824|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
14360825|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
14360826|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14360827|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
14360828|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14360829|NCT01076335|Docetaxel|docetaxel|mesh-list
14360830|NCT01076335|Leuprolide|leuprolide|mesh-list
14360831|NCT01076335|Goserelin|goserelin|mesh-list
14360832|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360833|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
14360834|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
14360835|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
14360836|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360837|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14360838|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
14360839|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14360840|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360841|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14360842|NCT01076400|Topotecan|topotecan|mesh-list
14360843|NCT01076400|Adavosertib|adavosertib|mesh-list
14360844|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360845|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14360846|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14360847|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360848|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360849|NCT01076504|Carboplatin|carboplatin|mesh-list
14360850|NCT01076504|Amrubicin|amrubicin|mesh-list
14360851|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360852|NCT01076543|Sirolimus|sirolimus|mesh-list
14360853|NCT01076543|Lenalidomide|lenalidomide|mesh-list
14360854|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
14732570|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732571|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732572|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732573|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
14360855|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360856|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14360857|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14360858|NCT01076543|Growth Substances|growth substances|mesh-ancestor
14360859|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
14360860|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360861|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14732574|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732575|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732576|NCT04351230|Trastuzumab|trastuzumab|mesh-list
14732577|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14732578|NCT04351230|Maytansine|maytansine|mesh-list
14732579|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
14732580|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732581|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360862|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360863|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14360864|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
14360865|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14360866|NCT01076647|Insulin|insulin|mesh-list
14360867|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14360868|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
14360869|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14360870|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360871|NCT01076972|Ritonavir|ritonavir|mesh-list
14360872|NCT01076972|Lopinavir|lopinavir|mesh-list
14360873|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14360874|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14360875|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
14360876|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360877|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360878|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14360879|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14360880|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
14360881|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360882|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360883|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360884|NCT01076985|Ritonavir|ritonavir|mesh-list
14360885|NCT01076985|Lopinavir|lopinavir|mesh-list
14360886|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14360887|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14360888|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
14360889|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360890|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360891|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14360892|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14360893|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
14360894|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360895|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14360896|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360897|NCT01077076|Omeprazole|omeprazole|mesh-list
14360898|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
14360899|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14732582|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14360900|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14360901|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14360902|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360903|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360904|NCT01077154|Denosumab|denosumab|mesh-list
14360905|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14360906|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360907|NCT01077284|Allopurinol|allopurinol|mesh-list
14360908|NCT01077284|Febuxostat|febuxostat|mesh-list
14360909|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
14360910|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360911|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360912|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
14360913|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14360914|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14360915|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
14360916|NCT01077284|Protective Agents|protective agents|mesh-ancestor
14360917|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732583|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732584|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14732585|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732586|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732587|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
14732588|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732589|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
14732590|NCT04348747|Vaccines|vaccines|mesh-list
14732591|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
14732592|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732593|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732594|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360918|NCT01077310|Naltrexone|naltrexone|mesh-list
14360919|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14360920|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14360921|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360922|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
14360923|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360924|NCT01077323|Exenatide|exenatide|mesh-list
14360925|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14360926|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732595|NCT04338061|Teriflunomide|teriflunomide|mesh-list
14360927|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14360928|NCT01077323|Incretins|incretins|mesh-ancestor
14360929|NCT01077323|Hormones|hormones|mesh-ancestor
14360930|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14360931|NCT01077362|Ustekinumab|ustekinumab|mesh-list
14360932|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
14360933|NCT01077375|Milnacipran|milnacipran|mesh-list
14360934|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
14360935|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14360936|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14360937|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14360938|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360939|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360940|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360941|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14360942|NCT01077375|Analgesics|analgesics|mesh-ancestor
14360943|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
14360944|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14360945|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
14360946|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14360947|NCT01077401|Ranibizumab|ranibizumab|mesh-list
14360948|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14360949|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14360950|NCT01077401|Growth Substances|growth substances|mesh-ancestor
14360951|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360952|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
14360953|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360954|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14360955|NCT01077518|Ofatumumab|ofatumumab|mesh-list
14360956|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14360957|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14360958|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
14360959|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360960|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360961|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
14360962|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360963|NCT01077596|Bupropion|bupropion|mesh-list
14360964|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
14360965|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14360966|NCT01077596|Serotonin|serotonin|mesh-list
14360967|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14360968|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14360969|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14360970|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14360971|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14360972|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14360973|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360974|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
14360975|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14360976|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360977|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14360978|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14360979|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753800|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
14360980|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14360981|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
14360982|NCT01077622|Ofatumumab|ofatumumab|mesh-list
14360983|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360984|NCT01077713|Gemcitabine|gemcitabine|mesh-list
14360985|NCT01077713|Bevacizumab|bevacizumab|mesh-list
14360986|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14360987|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14360988|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14360989|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14732596|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14732597|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14732598|NCT04338061|Analgesics|analgesics|mesh-ancestor
14732599|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
14732600|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732601|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732602|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14732603|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732604|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732605|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
14732606|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14732607|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732608|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
14732609|NCT04288323|Edetic Acid|edetic acid|mesh-list
14732610|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
15231622|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
14360990|NCT01077713|Growth Substances|growth substances|mesh-ancestor
14360991|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14360992|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
14360993|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14360994|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
14360995|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14360996|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
14360997|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14360998|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14360999|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361000|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
14361001|NCT01077739|Leucovorin|leucovorin|mesh-list
14361002|NCT01077739|Bevacizumab|bevacizumab|mesh-list
15231623|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15231624|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15231625|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
15231626|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231627|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231628|NCT05204056|Epinephrine|epinephrine|mesh-list
15231629|NCT05204056|Morphine|morphine|mesh-list
15231630|NCT05204056|Ropivacaine|ropivacaine|mesh-list
15231631|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
15231632|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15231633|NCT05204056|Narcotics|narcotics|mesh-ancestor
14361003|NCT01077739|Fluorouracil|fluorouracil|mesh-list
14732611|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15231634|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361004|NCT01077739|Capecitabine|capecitabine|mesh-list
14361005|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
14361006|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14361007|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361008|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14361009|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14361010|NCT01077739|Growth Substances|growth substances|mesh-ancestor
14361011|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361012|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
14361013|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
14361014|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361015|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14361016|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361017|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
14361018|NCT01077739|Antidotes|antidotes|mesh-ancestor
14361019|NCT01077739|Protective Agents|protective agents|mesh-ancestor
14361020|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
14361021|NCT01077739|Vitamins|vitamins|mesh-ancestor
14361022|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
14361023|NCT01077921|Propranolol|propranolol|mesh-list
14361024|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14361025|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14361026|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361027|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361028|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361029|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361030|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14361031|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14361032|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
14361033|NCT01077960|Hormones|hormones|mesh-list
14361034|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361035|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361036|NCT01077973|Ibuprofen|ibuprofen|mesh-list
14361037|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14361038|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14361039|NCT01077973|Analgesics|analgesics|mesh-ancestor
14361040|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
14361041|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361042|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361043|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361044|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361045|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14361046|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361047|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361048|NCT01078168|Acitretin|acitretin|mesh-list
14361049|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
14361050|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361051|NCT01078298|Varenicline|varenicline|mesh-list
14361052|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14361053|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14361054|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
14361055|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361056|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361057|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361058|NCT01078363|Ramipril|ramipril|mesh-list
14361059|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14361060|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
14361061|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361062|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361063|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14361064|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14361065|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14361066|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14361067|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361068|NCT01078389|Febuxostat|febuxostat|mesh-list
14361069|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
14361070|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361071|NCT01078441|Dexamethasone|dexamethasone|mesh-list
14361072|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
14361073|NCT01078441|Doxorubicin|doxorubicin|mesh-list
14361074|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14361075|NCT01078441|Bortezomib|bortezomib|mesh-list
14361076|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361077|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
14361078|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361079|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361080|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14361081|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
14361082|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361083|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361084|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14361085|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361086|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
14361087|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
14361088|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361089|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361090|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
14361091|NCT01078441|Hormones|hormones|mesh-ancestor
14361092|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732612|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732613|NCT04288323|Antidotes|antidotes|mesh-ancestor
14732614|NCT04288323|Protective Agents|protective agents|mesh-ancestor
14732615|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732616|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
14732617|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
14732618|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14732619|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
14732620|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14732621|NCT04283578|Oxytocin|oxytocin|mesh-list
14361093|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361094|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14361095|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14361096|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14361097|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361098|NCT01078545|Leuprolide|leuprolide|mesh-list
14361099|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14361100|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
14361101|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14361102|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361103|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361104|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361105|NCT01078571|Adalimumab|adalimumab|mesh-list
14361106|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361107|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361108|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
14361109|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14361110|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
14361111|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361112|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361113|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14361114|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361115|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14361116|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14361117|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15231635|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231636|NCT05204056|Analgesics|analgesics|mesh-ancestor
15231637|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
15231638|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231639|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
15231640|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
15231641|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15231642|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14361118|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361119|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361120|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361121|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
14361122|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14361123|NCT01078675|Calcium|calcium|mesh-list
14361124|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14361125|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361126|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14361127|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14361128|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14361129|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
14361130|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361131|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14361132|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14361133|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361134|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14361135|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
14361136|NCT01078753|Coagulants|coagulants|mesh-ancestor
14361137|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14361138|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
14361139|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361140|NCT01078805|Teriparatide|teriparatide|mesh-list
14361141|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14361142|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361143|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14361144|NCT01078922|Ofatumumab|ofatumumab|mesh-list
14361145|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732622|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
14732623|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15231643|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361146|NCT01078974|Dexamethasone|dexamethasone|mesh-list
14732624|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732625|NCT04279847|INCB057643|incb057643|mesh-list
14732626|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231644|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361147|NCT01078974|Rituximab|rituximab|mesh-list
14361148|NCT01078974|Pomalidomide|pomalidomide|mesh-list
14361149|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361150|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
14361151|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
14361152|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361153|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361154|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361155|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
14361156|NCT01078974|Hormones|hormones|mesh-ancestor
14361157|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361158|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361159|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361160|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14361161|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
14361162|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361163|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14361164|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14361165|NCT01078974|Growth Substances|growth substances|mesh-ancestor
14361166|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
14361167|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14361168|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14361169|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
14361170|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361171|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361172|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14361173|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361174|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14361175|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15231645|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231646|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15231647|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15231648|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
15231649|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15231650|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
15231651|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
15231652|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
15231653|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15231654|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15231655|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15231656|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
15231657|NCT05204056|Coagulants|coagulants|mesh-ancestor
14361176|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14732627|NCT04267939|Niraparib|niraparib|mesh-list
15231658|NCT05203913|Paclitaxel|paclitaxel|mesh-list
15231659|NCT05203913|Nivolumab|nivolumab|mesh-list
14361177|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361178|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361179|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361180|NCT01079143|Cyclosporine|cyclosporine|mesh-list
14361181|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
14361182|NCT01079143|Everolimus|everolimus|mesh-list
14361183|NCT01079143|Cyclosporins|cyclosporins|mesh-list
14361184|NCT01079143|Basiliximab|basiliximab|mesh-list
14361185|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361186|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361187|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361188|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
14361189|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361190|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
14361191|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361192|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361193|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361194|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14361195|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361196|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14361197|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14361198|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
14361199|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14361200|NCT01079234|Insulin|insulin|mesh-list
14361201|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14361202|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
14361203|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
14361204|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14361205|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361206|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
14361207|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14361208|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361209|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
14361210|NCT01079741|Poly I-C|poly i-c|mesh-list
14361211|NCT01079741|Mineral Oil|mineral oil|mesh-list
14361212|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14361213|NCT01079741|Poly ICLC|poly iclc|mesh-list
14361214|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
14361215|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
14361216|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
14361217|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361218|NCT01079741|Laxatives|laxatives|mesh-ancestor
14361219|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361220|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
14361221|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361222|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14361223|NCT01079741|Emollients|emollients|mesh-ancestor
14361224|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361225|NCT01079806|Entecavir|entecavir|mesh-list
14361226|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
14361227|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361228|NCT01079936|Lenalidomide|lenalidomide|mesh-list
14361229|NCT01079936|Melphalan|melphalan|mesh-list
14361230|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
14361231|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361232|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14361233|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14361234|NCT01079936|Growth Substances|growth substances|mesh-ancestor
14361235|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
14361236|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231660|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15231661|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231662|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
15231663|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
15231664|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
15231665|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231666|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231667|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15231668|NCT05203744|Tafenoquine|tafenoquine|mesh-list
15231669|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
15231670|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15231671|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15231672|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361237|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14361238|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
14361239|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361240|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15231673|NCT05203588|Vitamin D|vitamin d|mesh-list
15231674|NCT05203588|Denosumab|denosumab|mesh-list
14361241|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361242|NCT01079949|Cetrorelix|cetrorelix|mesh-list
14361243|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14361244|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14361245|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
14361246|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14361247|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361248|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
14361249|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361250|NCT01079962|Atenolol|atenolol|mesh-list
14361251|NCT01079962|Bisoprolol|bisoprolol|mesh-list
14361252|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14361253|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14361254|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
14361255|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
14361256|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231675|NCT05203588|Calcium|calcium|mesh-list
15231676|NCT05203588|Vitamins|vitamins|mesh-ancestor
15231677|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
15231678|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231679|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15231680|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15231681|NCT05203562|Letrozole|letrozole|mesh-list
15231682|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231683|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15231684|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15231685|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231686|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231687|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15231688|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
15231689|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231690|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231691|NCT05203510|Treprostinil|treprostinil|mesh-list
15231692|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15231693|NCT05203432|Atropine|atropine|mesh-list
15231694|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15231695|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15231696|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15231697|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
15231698|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231699|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231700|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15231701|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
15231702|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
15231703|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
15231704|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15231705|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15231706|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
15231707|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231708|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231709|NCT05203354|Acitretin|acitretin|mesh-list
15231710|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
15231711|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
15231712|NCT05203172|Cetuximab|cetuximab|mesh-list
15231713|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231714|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231715|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15231716|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
15231717|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
15231718|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231719|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
15231720|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231721|NCT05202821|Fluorides|fluorides|mesh-list
15231722|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
15231723|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
15231724|NCT05202821|Protective Agents|protective agents|mesh-ancestor
15231725|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231726|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
15231727|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231728|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15231729|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231730|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231731|NCT05198388|Endorphins|endorphins|mesh-list
15231732|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231733|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361257|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361258|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14361259|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14361260|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14361261|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361262|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361263|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361264|NCT01079988|Cyclosporine|cyclosporine|mesh-list
14361265|NCT01079988|Methotrexate|methotrexate|mesh-list
14361266|NCT01079988|Cyclosporins|cyclosporins|mesh-list
14361267|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14361268|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
14361269|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14361270|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361271|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14361272|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
14361273|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361274|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361275|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361276|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361277|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14361278|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361279|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
14361280|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361281|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14361282|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
14361283|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361284|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14361285|NCT01080131|Triamcinolone|triamcinolone|mesh-list
14361286|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14361287|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14361288|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14361289|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14361290|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361291|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
14361292|NCT01080131|Hormones|hormones|mesh-ancestor
14361293|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361294|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361295|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361296|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
14361297|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361298|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361299|NCT01080248|Gemcitabine|gemcitabine|mesh-list
14361300|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14361301|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
14361302|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361303|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361304|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
14361305|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361306|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361307|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361308|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
14361309|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361310|NCT01080300|Gabapentin|gabapentin|mesh-list
14361311|NCT01080300|Analgesics|analgesics|mesh-ancestor
14361312|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
14361313|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361314|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361315|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
14361316|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14361317|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14361318|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361319|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14361320|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14361321|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14361322|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361323|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361324|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
14361325|NCT01080391|Dexamethasone|dexamethasone|mesh-list
14361326|NCT01080391|Lenalidomide|lenalidomide|mesh-list
14361327|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361328|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
14361329|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
14361330|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361331|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361332|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361333|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
14361334|NCT01080391|Hormones|hormones|mesh-ancestor
14361335|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361336|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361337|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361338|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
14361339|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14361340|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14361341|NCT01080391|Growth Substances|growth substances|mesh-ancestor
14361342|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
14361343|NCT01080625|Phenylephrine|phenylephrine|mesh-list
14361344|NCT01080625|Epinephrine|epinephrine|mesh-list
14361345|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
14361346|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14361347|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14361348|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361349|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361350|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361351|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361352|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14361353|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14361354|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
14361355|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361356|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14361357|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361358|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
14361359|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
14361360|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14361361|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14361362|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
14361363|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14361364|NCT01080625|Protective Agents|protective agents|mesh-ancestor
14361365|NCT01080677|Propranolol|propranolol|mesh-list
14361366|NCT01080677|Caffeine|caffeine|mesh-list
14361367|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14361368|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361369|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14361370|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361371|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361372|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14361373|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14361374|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
14361375|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361376|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14361377|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14361378|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361379|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14361380|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14361381|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
14361382|NCT01080716|Vaccines|vaccines|mesh-list
14361383|NCT01080716|Complement Factor H|complement factor h|mesh-list
14361384|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
14361385|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361386|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14361387|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361388|NCT01080807|Modafinil|modafinil|mesh-list
14361389|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14361390|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361391|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14361392|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14361393|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14361394|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361395|NCT01081041|Carboplatin|carboplatin|mesh-list
14361396|NCT01081041|Fluorouracil|fluorouracil|mesh-list
14361397|NCT01081041|Cetuximab|cetuximab|mesh-list
14361398|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361399|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
14753801|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361400|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361401|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14361402|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361403|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
14361404|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361405|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14361406|NCT01081132|Guanfacine|guanfacine|mesh-list
14361407|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14361408|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14361409|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14732628|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15231734|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231735|NCT05180032|Denosumab|denosumab|mesh-list
15231736|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15231737|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361410|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14361411|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361412|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361413|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361414|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361415|NCT01081145|Guanfacine|guanfacine|mesh-list
14361416|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14361417|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14361418|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14361419|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14361420|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361421|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361422|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361423|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361424|NCT01081249|Oxytocin|oxytocin|mesh-list
14361425|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
14361426|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14361427|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465618|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14465619|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14465620|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14465621|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
14465622|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465623|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
14465624|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14465625|NCT02228824|Nicotine|nicotine|mesh-list
14465626|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14465627|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
14465628|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920573|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14920574|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920575|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920576|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14920577|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
14920578|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920579|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920580|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14920581|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14920582|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231738|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15231739|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15231740|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
15231741|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231742|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231743|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15231744|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15231745|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15231746|NCT05167370|Amifostine|amifostine|mesh-list
15231747|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15231748|NCT05167370|Protective Agents|protective agents|mesh-ancestor
15231749|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231750|NCT05156879|Aspirin|aspirin|mesh-list
15231751|NCT05156879|Drospirenone|drospirenone|mesh-list
15231752|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15231753|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15231754|NCT05156879|Estradiol|estradiol|mesh-list
15231755|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15231756|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15231757|NCT05156879|Analgesics|analgesics|mesh-ancestor
15231758|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
15231759|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231760|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231761|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231762|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231763|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15231764|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15231765|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231766|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15231767|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15231768|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231769|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
15231770|NCT05156879|Estrogens|estrogens|mesh-ancestor
15231771|NCT05156879|Hormones|hormones|mesh-ancestor
14361428|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14361429|NCT01081626|Hormones|hormones|mesh-ancestor
14361430|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361431|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361432|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14361433|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
14361434|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14361435|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361436|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361437|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14361438|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14361439|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14361440|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
14361441|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361442|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361443|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14361444|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14361445|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
14361446|NCT01081795|Topiramate|topiramate|mesh-list
14361447|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
14361448|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14361449|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361450|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14361451|NCT01081834|Canagliflozin|canagliflozin|mesh-list
14361452|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14732629|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231772|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231773|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15231774|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
15231775|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15231776|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15231777|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15231778|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15231779|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15231780|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
15231781|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15231782|NCT05156879|Diuretics|diuretics|mesh-ancestor
15231783|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
15231784|NCT05136560|Dexamethasone|dexamethasone|mesh-list
15231785|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
15231786|NCT05136560|BB 1101|bb 1101|mesh-list
15231787|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231788|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
15231789|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
15231790|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231791|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231792|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231793|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
15231794|NCT05136560|Hormones|hormones|mesh-ancestor
14920583|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14920584|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
14920585|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14920586|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920587|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
14920588|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920589|NCT04562597|Expectorants|expectorants|mesh-ancestor
15231795|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231796|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920590|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361453|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361454|NCT01081834|Incretins|incretins|mesh-ancestor
14361455|NCT01081834|Hormones|hormones|mesh-ancestor
14361456|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361457|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14361458|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
14361459|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361460|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361461|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14361462|NCT01081873|Leuprolide|leuprolide|mesh-list
14361463|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14361464|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
14361465|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14361466|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361467|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361468|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361469|NCT01081912|Hydrocodone|hydrocodone|mesh-list
14361470|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14361471|NCT01081912|Narcotics|narcotics|mesh-ancestor
14361472|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361473|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361474|NCT01081912|Analgesics|analgesics|mesh-ancestor
14361475|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
14361476|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361477|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
14361478|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361479|NCT01082081|Acetaminophen|acetaminophen|mesh-list
14361480|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14920591|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14920592|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
14920593|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920594|NCT04562597|Protective Agents|protective agents|mesh-ancestor
14920595|NCT04562597|Antidotes|antidotes|mesh-ancestor
14920596|NCT04561648|Heparin|heparin|mesh-list
14920597|NCT04561648|Calcium heparin|calcium heparin|mesh-list
15231797|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231798|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
15231799|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231800|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231801|NCT05125523|Sirolimus|sirolimus|mesh-list
15231802|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15231803|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231804|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14920598|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
14920599|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15231805|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231806|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
15231807|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231808|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
15231809|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231810|NCT05124678|Isoniazid|isoniazid|mesh-list
15231811|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
15231812|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15231813|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231814|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15231815|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15231816|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
15231817|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231818|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14361481|NCT01082081|Analgesics|analgesics|mesh-ancestor
14361482|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
14361483|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361484|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361485|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
14361486|NCT01082380|Crizotinib|crizotinib|mesh-list
14361487|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361488|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14361489|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361490|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361491|NCT01082588|Pravastatin|pravastatin|mesh-list
14361492|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14361493|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14361494|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
14361495|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361496|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15231819|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
15231820|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15231821|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
15231822|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231823|NCT05123365|Expectorants|expectorants|mesh-ancestor
15231824|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
15231825|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15231826|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
15231827|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231828|NCT05123365|Protective Agents|protective agents|mesh-ancestor
15231829|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231830|NCT05123365|Antidotes|antidotes|mesh-ancestor
15231831|NCT05106192|Triamcinolone|triamcinolone|mesh-list
15231832|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15231833|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15231834|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
15231835|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
15231836|NCT05106192|Bexarotene|bexarotene|mesh-list
15231837|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15231838|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231839|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
15231840|NCT05106192|Hormones|hormones|mesh-ancestor
15231841|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231842|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231843|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231844|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
15231845|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231846|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231847|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
15231848|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15231849|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231850|NCT05101564|Tamoxifen|tamoxifen|mesh-list
15231851|NCT05101564|Letrozole|letrozole|mesh-list
15231852|NCT05101564|Infigratinib|infigratinib|mesh-list
15231853|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231854|NCT05101564|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14361497|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14361498|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231855|NCT05101564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15231856|NCT05101564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361499|NCT01082640|Febuxostat|febuxostat|mesh-list
14361500|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
14361501|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361502|NCT01082874|Aspirin|aspirin|mesh-list
14361503|NCT01082874|Clonidine|clonidine|mesh-list
14361504|NCT01082874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14361505|NCT01082874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14361506|NCT01082874|Analgesics|analgesics|mesh-ancestor
14361507|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
14361508|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361509|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361510|NCT01082874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361511|NCT01082874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361512|NCT01082874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14361513|NCT01082874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14361514|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361515|NCT01082874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14361516|NCT01082874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14361517|NCT01082874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361518|NCT01082874|Antipyretics|antipyretics|mesh-ancestor
14361519|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14361520|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
14361521|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
14361522|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14361523|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14361524|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14361525|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361526|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361527|NCT01082939|Vidarabine|vidarabine|mesh-list
14361528|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
15231857|NCT05101564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231858|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15231859|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
15231860|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231861|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231862|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15231863|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15231864|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15231865|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15231866|NCT05083910|Misoprostol|misoprostol|mesh-list
15231867|NCT05083910|Oxytocin|oxytocin|mesh-list
15231868|NCT05083910|Carbetocin|carbetocin|mesh-list
15231869|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
15231870|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15231871|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231872|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15231873|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
15231874|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15231875|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231876|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
15231877|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
15231878|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
15231879|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15231880|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15231881|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231882|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231883|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231884|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15231885|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15231886|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231887|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15231888|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231889|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
15231890|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231891|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231892|NCT05079841|Oxytocin|oxytocin|mesh-list
15231893|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
15231894|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15231895|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231896|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
15231897|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15231898|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
14361529|NCT01082939|Rituximab|rituximab|mesh-list
14361530|NCT01082939|Fludarabine|fludarabine|mesh-list
14361531|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
14361532|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
14361533|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361534|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
14361535|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361536|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361537|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14361538|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
14361539|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361540|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361541|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14361542|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14361543|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14361544|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
14361545|NCT01082939|Antiviral Agents|antiviral agents|mesh-ancestor
14361546|NCT01082939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361547|NCT01082965|Donepezil|donepezil|mesh-list
14361548|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14361549|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231899|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231900|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15231901|NCT05055999|Atezolizumab|atezolizumab|mesh-list
15231902|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231903|NCT05055947|Atezolizumab|atezolizumab|mesh-list
15231904|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231905|NCT05055908|Atezolizumab|atezolizumab|mesh-list
15231906|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231907|NCT05050981|Hormones|hormones|mesh-list
15231908|NCT05050981|Serotonin|serotonin|mesh-list
15231909|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15231910|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231911|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231912|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15231913|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
15231914|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15231915|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231916|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15231917|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15231918|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
15231919|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15231920|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231921|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15231922|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361550|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361551|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
14361552|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361553|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361554|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
14361555|NCT01083316|Dexamethasone|dexamethasone|mesh-list
14361556|NCT01083316|Bortezomib|bortezomib|mesh-list
14361557|NCT01083316|Melphalan|melphalan|mesh-list
14361558|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361559|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
14361560|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
14361561|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361562|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361563|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361564|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
14361565|NCT01083316|Hormones|hormones|mesh-ancestor
14361566|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361567|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361568|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361569|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14361570|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
14361571|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361572|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14361573|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14361574|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
14361575|NCT01083368|Sirolimus|sirolimus|mesh-list
14361576|NCT01083368|Bevacizumab|bevacizumab|mesh-list
14361577|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14361578|NCT01083368|Antibodies|antibodies|mesh-list
14361579|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
14361580|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14361581|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361582|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14361583|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14361584|NCT01083368|Growth Substances|growth substances|mesh-ancestor
14361585|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361586|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
14361587|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
14361588|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14361589|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15231923|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
15231924|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15231925|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231926|NCT05017246|Lidocaine|lidocaine|mesh-list
15231927|NCT05017246|Morphine|morphine|mesh-list
15231928|NCT05017246|Bupivacaine|bupivacaine|mesh-list
15231929|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
15231930|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
15231931|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15231932|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231933|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
15231934|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231935|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15231936|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15231937|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15231938|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15231939|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231940|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15231941|NCT05017246|Narcotics|narcotics|mesh-ancestor
15231942|NCT05017246|Analgesics|analgesics|mesh-ancestor
14361590|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14361591|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
14361592|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15231943|NCT05014542|Analgesics|analgesics|mesh-list
15231944|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
15231945|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231946|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231947|NCT05013255|Pioglitazone|pioglitazone|mesh-list
15231948|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15231949|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231950|NCT05003076|Methamphetamine|methamphetamine|mesh-list
15231951|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15231952|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231953|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
15231954|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
15231955|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231956|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
15231957|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361593|NCT01083485|Oxycodone|oxycodone|mesh-list
14732630|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732631|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732632|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
14732633|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14732634|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
15231958|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231959|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
15231960|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15231961|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15231962|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15231963|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15231964|NCT04984330|Dexamethasone|dexamethasone|mesh-list
15231965|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15231966|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
15231967|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
15231968|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231969|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231970|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15231971|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
15231972|NCT04984330|Hormones|hormones|mesh-ancestor
15231973|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15231974|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15231975|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732635|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14361594|NCT01083485|Naloxone|naloxone|mesh-list
14361595|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14361596|NCT01083485|Narcotics|narcotics|mesh-ancestor
14361597|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361598|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361599|NCT01083485|Analgesics|analgesics|mesh-ancestor
14361600|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
14361601|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361602|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14361603|NCT01083576|Gentamicins|gentamicins|mesh-list
14361604|NCT01083576|Paromomycin|paromomycin|mesh-list
14361605|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14361606|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361607|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14361608|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361609|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361610|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14361611|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14361612|NCT01083602|Dexamethasone|dexamethasone|mesh-list
14361613|NCT01083602|Bortezomib|bortezomib|mesh-list
14361614|NCT01083602|Panobinostat|panobinostat|mesh-list
14361615|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361616|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
14361617|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
14361618|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15231976|NCT04953910|Decitabine|decitabine|mesh-list
15231977|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15231978|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
15231979|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231980|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231981|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231982|NCT04953897|Decitabine|decitabine|mesh-list
15231983|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15231984|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
15231985|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231986|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15231987|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15231988|NCT04949022|Insulin|insulin|mesh-list
15231989|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15231990|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15231991|NCT04929379|Fenofibrate|fenofibrate|mesh-list
15231992|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15231993|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
15231994|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15231995|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15231996|NCT04920292|Oxfendazole|oxfendazole|mesh-list
15231997|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
15231998|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15231999|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232000|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
15232001|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
15232002|NCT04917029|Bupivacaine|bupivacaine|mesh-list
15232003|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232004|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
15232005|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232006|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232007|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
15232008|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232009|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15232010|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15232011|NCT04917029|Analgesics|analgesics|mesh-ancestor
15232012|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15232013|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15232014|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15232015|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
15232016|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232017|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232018|NCT04914195|Leuprolide|leuprolide|mesh-list
15232019|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15232020|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
15232021|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15232022|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232023|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15232024|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232025|NCT04903119|Trametinib|trametinib|mesh-list
14361619|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232026|NCT04903119|Dabrafenib|dabrafenib|mesh-list
15232027|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361620|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361621|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
14361622|NCT01083602|Hormones|hormones|mesh-ancestor
14361623|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232028|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15232029|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232030|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232031|NCT04892420|Dexamethasone|dexamethasone|mesh-list
15232032|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
15232033|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
15232034|NCT04892420|Bupivacaine|bupivacaine|mesh-list
15232035|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232036|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
15232037|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
15232038|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232039|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232040|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232041|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
15232042|NCT04892420|Hormones|hormones|mesh-ancestor
15232043|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232044|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15232045|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232046|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232047|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
15232048|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232049|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
15232050|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15232051|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15232052|NCT04892420|Analgesics|analgesics|mesh-ancestor
15232053|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15232054|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15232055|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15232056|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
15232057|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232058|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232059|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15232060|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
15232061|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15232062|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232063|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15232064|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
15232065|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15232066|NCT04876677|Beclomethasone|beclomethasone|mesh-list
14361624|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361625|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361626|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14361627|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361628|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361629|NCT01083641|Estradiol|estradiol|mesh-list
14361630|NCT01083641|Estrogens|estrogens|mesh-ancestor
14361631|NCT01083641|Hormones|hormones|mesh-ancestor
14361632|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361633|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361634|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
14361635|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
15232067|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
15232068|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
14361636|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14361637|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14361638|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361639|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14361640|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361641|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361642|NCT01083706|Azacitidine|azacitidine|mesh-list
14361643|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14361644|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
14361645|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361646|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361647|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361648|NCT01083732|Dabigatran|dabigatran|mesh-list
14361649|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
14361650|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14361651|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
14361652|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361653|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361654|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
14361655|NCT01083810|Ritonavir|ritonavir|mesh-list
14361656|NCT01083810|Lopinavir|lopinavir|mesh-list
14361657|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14361658|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14361659|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
14361660|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361661|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361662|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14361663|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14361664|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
14361665|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361666|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14361667|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14361668|NCT01084005|Linagliptin|linagliptin|mesh-list
14361669|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14361670|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361671|NCT01084005|Incretins|incretins|mesh-ancestor
14361672|NCT01084005|Hormones|hormones|mesh-ancestor
14361673|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361674|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14361675|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
14361676|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361677|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361678|NCT01084083|Paclitaxel|paclitaxel|mesh-list
14361679|NCT01084083|Cetuximab|cetuximab|mesh-list
14361680|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14361681|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361682|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14361683|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14361684|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14361685|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361686|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14361687|NCT01084135|Rivastigmine|rivastigmine|mesh-list
15232069|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14361688|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14361689|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232070|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
15232071|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232072|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232073|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15232074|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
15232075|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15232076|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15232077|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15232078|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
14465629|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361690|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361691|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
14361692|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361693|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361694|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14361695|NCT01084135|Protective Agents|protective agents|mesh-ancestor
14361696|NCT01084148|V0034CR|v0034cr|mesh-list
14361697|NCT01084148|Emollients|emollients|mesh-ancestor
14361698|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361699|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14361700|NCT01084265|Hormones|hormones|mesh-list
14361701|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14361702|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361703|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361704|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14361705|NCT01084278|Colchicine|colchicine|mesh-list
14361706|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
14361707|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361708|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14361709|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14361710|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14361711|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361712|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361713|NCT01084499|Letrozole|letrozole|mesh-list
14361714|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361715|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14361716|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14361717|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232079|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232080|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232081|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232082|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
15232083|NCT04876677|Hormones|hormones|mesh-ancestor
15232084|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232085|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15232086|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15232087|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15232088|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
15232089|NCT04874194|Venetoclax|venetoclax|mesh-list
15232090|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
15232091|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232092|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15232093|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15232094|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232095|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232096|NCT04866602|Atovaquone|atovaquone|mesh-list
15232097|NCT04866602|Proguanil|proguanil|mesh-list
15232098|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14361718|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361719|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15232099|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232100|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
15232101|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15232102|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15232103|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232104|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232105|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
15232106|NCT04857398|Insulin|insulin|mesh-list
15232107|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15232108|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232109|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15232110|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15232111|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
15232112|NCT04843579|Clarithromycin|clarithromycin|mesh-list
15232113|NCT04843579|Dexamethasone|dexamethasone|mesh-list
15232114|NCT04843579|Pomalidomide|pomalidomide|mesh-list
15232115|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232116|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
15232117|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
15232118|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232119|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232120|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232121|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
15232122|NCT04843579|Hormones|hormones|mesh-ancestor
15232123|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232124|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15232125|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232126|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15232127|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232128|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15232129|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232130|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232131|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15232132|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15232133|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
15232134|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15232135|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15232136|NCT04843579|Growth Substances|growth substances|mesh-ancestor
15232137|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
15232138|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
15232139|NCT04821375|Estrogens|estrogens|mesh-list
15232140|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15232141|NCT04821375|Hormones|hormones|mesh-ancestor
15232142|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232143|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232144|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15232145|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15232146|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
15232147|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15232148|NCT04808505|Miglustat|miglustat|mesh-list
15232149|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232150|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232151|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15232152|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15232153|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
15232154|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232155|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15232156|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15232157|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232158|NCT04806919|Progesterone|progesterone|mesh-list
15232159|NCT04806919|Progestins|progestins|mesh-ancestor
15232160|NCT04806919|Hormones|hormones|mesh-ancestor
15232161|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232162|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232163|NCT04801797|Cytarabine|cytarabine|mesh-list
15232164|NCT04801797|Azacitidine|azacitidine|mesh-list
15232165|NCT04801797|Daunorubicin|daunorubicin|mesh-list
15232166|NCT04801797|Venetoclax|venetoclax|mesh-list
15232167|NCT04801797|Idarubicin|idarubicin|mesh-list
15232168|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15232169|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
15232170|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232171|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232172|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
15232173|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232174|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15232175|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
15232176|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232177|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232178|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15232179|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15232180|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15232181|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
15232182|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232183|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232184|NCT04785638|Bupivacaine|bupivacaine|mesh-list
15232185|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232186|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
15232187|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361720|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
14361721|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465630|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15232188|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232189|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
15232190|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232191|NCT04785625|Bupivacaine|bupivacaine|mesh-list
15232192|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232193|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
15232194|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232195|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232196|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
15232197|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232198|NCT04779307|Vedolizumab|vedolizumab|mesh-list
15232199|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232200|NCT04772079|BMS-986165|bms-986165|mesh-list
15232201|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
15232202|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15232203|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232204|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232205|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
15232206|NCT04756063|Vitamins|vitamins|mesh-ancestor
15232207|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
15232208|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232209|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
15232210|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232211|NCT04756063|Protective Agents|protective agents|mesh-ancestor
14732636|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
14732637|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465631|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14361722|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361723|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
14361724|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14361725|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361726|NCT01084538|Vitamins|vitamins|mesh-ancestor
14361727|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
14361728|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14361729|NCT01084603|Nicotine|nicotine|mesh-list
14361730|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14361731|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
14361732|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361733|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361734|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14361735|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14361736|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
14361737|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732638|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732639|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
14732640|NCT04259346|Ixekizumab|ixekizumab|mesh-list
14732641|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
14732642|NCT04255927|Triclosan|triclosan|mesh-list
14732643|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14732644|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732645|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14732646|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14361738|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361739|NCT01084655|Prednisone|prednisone|mesh-list
14361740|NCT01084655|Docetaxel|docetaxel|mesh-list
14361741|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361742|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14361743|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14361744|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14361745|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361746|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361747|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
14361748|NCT01084655|Hormones|hormones|mesh-ancestor
14361749|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361750|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361751|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361752|NCT01084707|Nicotine|nicotine|mesh-list
14361753|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14361754|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
14361755|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361756|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361757|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14361758|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14361759|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
14361760|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361761|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361762|NCT01084759|Etoposide|etoposide|mesh-list
14361763|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
14361764|NCT01084759|Testosterone|testosterone|mesh-list
14361765|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
14361766|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
14361767|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14361768|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14361769|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361770|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14361771|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14361772|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361773|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361774|NCT01084759|Androgens|androgens|mesh-ancestor
14361775|NCT01084759|Hormones|hormones|mesh-ancestor
14361776|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361777|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361778|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361779|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
14361780|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
14361781|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14361782|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14361783|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732647|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
14361784|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
14361785|NCT01085006|Coagulants|coagulants|mesh-ancestor
14361786|NCT01085045|Bromides|bromides|mesh-list
14361787|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
14361788|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
14361789|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14361790|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
15232212|NCT04739371|Insulin|insulin|mesh-list
15232213|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15232214|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15232215|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232216|NCT04725994|Irinotecan|irinotecan|mesh-list
15232217|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15232218|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15232219|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232220|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232221|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232222|NCT04716699|Lidocaine|lidocaine|mesh-list
15232223|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232224|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
15232225|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232226|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232227|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
15232228|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232229|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15232230|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15232231|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15232232|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232233|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232234|NCT04712942|Azacitidine|azacitidine|mesh-list
15232235|NCT04712942|Pevonedistat|pevonedistat|mesh-list
15232236|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15232237|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
15232238|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232239|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232240|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232241|NCT04708145|Aflibercept|aflibercept|mesh-list
15232242|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15232243|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15232244|NCT04708145|Growth Substances|growth substances|mesh-ancestor
15232245|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232246|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
15232247|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232248|NCT04688177|Nicotine|nicotine|mesh-list
15232249|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
15232250|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15232251|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
15232252|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232253|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232254|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15232255|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15232256|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
15232257|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232258|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232259|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
15232260|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
15232261|NCT04685590|Dasatinib|dasatinib|mesh-list
15232262|NCT04685590|Quercetin|quercetin|mesh-list
15232263|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232264|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15232265|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232266|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232267|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
15232268|NCT04685590|Protective Agents|protective agents|mesh-ancestor
15232269|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232270|NCT04680910|Propofol|propofol|mesh-list
15232271|NCT04680910|Anesthetics|anesthetics|mesh-list
15232272|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14361791|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361792|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232273|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361793|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14361794|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361795|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14361796|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14361797|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14361798|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
14361799|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361800|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361801|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
14361802|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14732648|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732649|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15232274|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232275|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15232276|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
15232277|NCT04671810|Eculizumab|eculizumab|mesh-list
15232278|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15232279|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15232280|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
15232281|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232282|NCT04671615|Palbociclib|palbociclib|mesh-list
15232283|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232284|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15232285|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232286|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232287|NCT04668365|Prednisone|prednisone|mesh-list
14361803|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
15232288|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
15232289|NCT04668365|Rituximab|rituximab|mesh-list
15232290|NCT04668365|Vincristine|vincristine|mesh-list
15232291|NCT04668365|Epirubicin|epirubicin|mesh-list
15232292|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
15232293|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15232294|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
15232295|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232296|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15232297|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15232298|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
15232299|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232300|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232301|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15232302|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232303|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232304|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
15232305|NCT04668365|Hormones|hormones|mesh-ancestor
15232306|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232307|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15232308|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15232309|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
15232310|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
15232311|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
15232312|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15232313|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15232314|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15232315|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232316|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15232317|NCT04667039|Ranibizumab|ranibizumab|mesh-list
15232318|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15232319|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15232320|NCT04667039|Growth Substances|growth substances|mesh-ancestor
15232321|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361804|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
14361805|NCT01085136|Afatinib|afatinib|mesh-list
14361806|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361807|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14361808|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361809|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361810|NCT01085201|Regadenoson|regadenoson|mesh-list
14361811|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14361812|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14361813|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
14361814|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
14361815|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361816|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361817|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232322|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
15232323|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232324|NCT04642820|Methamphetamine|methamphetamine|mesh-list
15232325|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15232326|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232327|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
15232328|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
15232329|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232330|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
15232331|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232332|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232333|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
15232334|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15232335|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15232336|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232337|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15232338|NCT04635735|Ipilimumab|ipilimumab|mesh-list
15232339|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232340|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232341|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15232342|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232343|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
15232344|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15232345|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
15232346|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232347|NCT04632069|Expectorants|expectorants|mesh-ancestor
15232348|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
15232349|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15232350|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
15232351|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232352|NCT04632069|Protective Agents|protective agents|mesh-ancestor
15232353|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232354|NCT04632069|Antidotes|antidotes|mesh-ancestor
15232355|NCT04629378|Amoxicillin|amoxicillin|mesh-list
15232356|NCT04629378|Meropenem|meropenem|mesh-list
15232357|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
15232358|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
15232359|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
15232360|NCT04629378|Bedaquiline|bedaquiline|mesh-list
15232361|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15232362|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15232363|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232364|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15232365|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232366|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232367|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
15232368|NCT04628572|Ceftazidime|ceftazidime|mesh-list
15232369|NCT04628572|Avibactam|avibactam|mesh-list
15232370|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
15232371|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15232372|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232373|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15232374|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232375|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232376|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15232377|NCT04616183|Cetuximab|cetuximab|mesh-list
15232378|NCT04616183|Antibodies|antibodies|mesh-list
14361818|NCT01085344|Factor VIII|factor viii|mesh-list
14361819|NCT01085344|Coagulants|coagulants|mesh-ancestor
14361820|NCT01085591|Vancomycin|vancomycin|mesh-list
14361821|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14361822|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361823|NCT01085630|Pemetrexed|pemetrexed|mesh-list
14361824|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361825|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361826|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361827|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14361828|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14361829|NCT01085734|Bevacizumab|bevacizumab|mesh-list
14361830|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14361831|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361832|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14361833|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14361834|NCT01085734|Growth Substances|growth substances|mesh-ancestor
14361835|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361836|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14361837|NCT01085760|Metronidazole|metronidazole|mesh-list
15232379|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
15232380|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15232381|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
15232382|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232383|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232384|NCT04608318|Venetoclax|venetoclax|mesh-list
15232385|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
15232386|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232387|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232388|NCT04606446|Letrozole|letrozole|mesh-list
15232389|NCT04606446|Fulvestrant|fulvestrant|mesh-list
15232390|NCT04606446|Palbociclib|palbociclib|mesh-list
15232391|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232392|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15232393|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15232394|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232395|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232396|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15232397|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
15232398|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232399|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232400|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15232401|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15232402|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15232403|NCT04606069|Regadenoson|regadenoson|mesh-list
15232404|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15232405|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15232406|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
15232407|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
15232408|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232409|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232410|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232411|NCT04603846|Paclitaxel|paclitaxel|mesh-list
15232412|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15232413|NCT04603846|Antibodies|antibodies|mesh-list
15232414|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15232415|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232416|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
15232417|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
15232418|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
15232419|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232420|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
15232421|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232422|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15232423|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15232424|NCT04591353|Lidocaine|lidocaine|mesh-list
15232425|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232426|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
15232427|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361838|NCT01085760|Vancomycin|vancomycin|mesh-list
15232428|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732657|NCT04249232|Abaloparatide|abaloparatide|mesh-list
14732658|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15232429|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
15232430|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232431|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15232432|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15232433|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15232434|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232435|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232436|NCT04581395|Rocuronium|rocuronium|mesh-list
15232437|NCT04581395|Succinylcholine|succinylcholine|mesh-list
15232438|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15232439|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15232440|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15232441|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232442|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232443|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15232444|NCT04578106|Trastuzumab|trastuzumab|mesh-list
15232445|NCT04578106|Pertuzumab|pertuzumab|mesh-list
15232446|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232447|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232448|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
15232449|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15232450|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
15232451|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232452|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232453|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732659|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753071|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753072|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753073|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232454|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
15232455|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
15232456|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15232457|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15232458|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
15232459|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232460|NCT04549376|Iodine|iodine|mesh-list
15232461|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
15232462|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
15232463|NCT04549376|Povidone|povidone|mesh-list
15232464|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15232465|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232466|NCT04549376|Trace Elements|trace elements|mesh-ancestor
15232467|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
15232468|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232469|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
15232470|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
15232471|NCT04545151|Verapamil|verapamil|mesh-list
15232472|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15232473|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15232474|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232475|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232476|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15232477|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232478|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
15232479|NCT04537598|Morphine|morphine|mesh-list
15232480|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15232481|NCT04537598|Narcotics|narcotics|mesh-ancestor
15232482|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232483|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232484|NCT04537598|Analgesics|analgesics|mesh-ancestor
15232485|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
15232486|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232487|NCT04528134|Listerine|listerine|mesh-list
15232488|NCT04528134|Fluorides|fluorides|mesh-list
15232489|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
15232490|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
15232491|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
14361839|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361840|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14361841|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14361842|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14361843|NCT01085786|Amoxicillin|amoxicillin|mesh-list
14361844|NCT01085786|Metronidazole|metronidazole|mesh-list
14361845|NCT01085786|Clarithromycin|clarithromycin|mesh-list
14361846|NCT01085786|Esomeprazole|esomeprazole|mesh-list
14361847|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14361848|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361849|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14361850|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15232492|NCT04528134|Protective Agents|protective agents|mesh-ancestor
15232493|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232494|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15232495|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232496|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
15232497|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232498|NCT04518046|Nivolumab|nivolumab|mesh-list
15232499|NCT04518046|Ipilimumab|ipilimumab|mesh-list
15232500|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232501|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232502|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15232503|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361851|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14361852|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361853|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14361854|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361855|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361856|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14361857|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14465632|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
15232504|NCT04502381|Amphotericin B|amphotericin b|mesh-list
15232505|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15232506|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
15232507|NCT04502381|Amebicides|amebicides|mesh-ancestor
15232508|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15232509|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15232510|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232511|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15232512|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
15232513|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15232514|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232515|NCT04472182|Calcium|calcium|mesh-list
15232516|NCT04472182|Fluorides|fluorides|mesh-list
15232517|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
15232518|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15232519|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232520|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
15232521|NCT04472182|Protective Agents|protective agents|mesh-ancestor
15232522|NCT04467905|Etripamil|etripamil|mesh-list
15232523|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15232524|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232525|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232526|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15232527|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232528|NCT04462965|Temozolomide|temozolomide|mesh-list
15232529|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15232530|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
15232531|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232532|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232533|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
15232534|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15232535|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232536|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15232537|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15232538|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232539|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232540|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232541|NCT04413123|Nivolumab|nivolumab|mesh-list
15232542|NCT04413123|Ipilimumab|ipilimumab|mesh-list
15232543|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232544|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232545|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15232546|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232547|NCT04409509|Antibodies|antibodies|mesh-list
15232548|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15232549|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
15232550|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232551|NCT04401865|Riboflavin|riboflavin|mesh-list
15232552|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
15232553|NCT04401865|Vitamins|vitamins|mesh-ancestor
15232554|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
15232555|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232556|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15232557|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
15232558|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
15232559|NCT04401150|Vitamins|vitamins|mesh-ancestor
15232560|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
15232561|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232562|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
15232563|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232564|NCT04401150|Protective Agents|protective agents|mesh-ancestor
15232565|NCT04388852|Ipilimumab|ipilimumab|mesh-list
15232566|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232567|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232568|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15232569|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232570|NCT04386811|Calcitriol|calcitriol|mesh-list
15232571|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15232572|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232573|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15232574|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232575|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232576|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15232577|NCT04386811|Vitamins|vitamins|mesh-ancestor
15232578|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
15232579|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15232580|NCT04381143|Aspirin|aspirin|mesh-list
15232581|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15232582|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15232583|NCT04381143|Analgesics|analgesics|mesh-ancestor
15232584|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
15232585|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232586|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232587|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232588|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15232589|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15232590|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15232591|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232592|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15232593|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15232594|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232595|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
15232596|NCT04369014|Anesthetics|anesthetics|mesh-list
15232597|NCT04369014|Propofol|propofol|mesh-list
15232598|NCT04369014|Etomidate|etomidate|mesh-list
15232599|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232600|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232601|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15232602|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15232603|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
15232604|NCT04358133|Morphine|morphine|mesh-list
15232605|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15232606|NCT04358133|Narcotics|narcotics|mesh-ancestor
15232607|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232608|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232609|NCT04358133|Analgesics|analgesics|mesh-ancestor
15232610|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
15232611|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232612|NCT04349371|Chloroquine|chloroquine|mesh-list
15232613|NCT04349371|Amebicides|amebicides|mesh-ancestor
15232614|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15232615|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15232616|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232617|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
15232618|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15232619|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
15232620|NCT04332211|Ephedrine|ephedrine|mesh-list
15232621|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15232622|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
15232623|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232624|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232625|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15232626|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
15232627|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
15232628|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15232629|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15232630|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
15232631|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
15232632|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232633|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232634|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15232635|NCT04309773|Bezafibrate|bezafibrate|mesh-list
15232636|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15232637|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232638|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15232639|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
15232640|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232641|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15232642|NCT04299867|Metronidazole|metronidazole|mesh-list
15232643|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232644|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15232645|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15232646|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15232647|NCT04294628|Trastuzumab|trastuzumab|mesh-list
15232648|NCT04294628|Camptothecin|camptothecin|mesh-list
15232649|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
15232650|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232651|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232652|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15232653|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15232654|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15232655|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232656|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232657|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
15232658|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232659|NCT04294459|Acetaminophen|acetaminophen|mesh-list
15232660|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
15232661|NCT04294459|Promethazine|promethazine|mesh-list
15232662|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
15232663|NCT04294459|Ranitidine|ranitidine|mesh-list
15232664|NCT04294459|Montelukast|montelukast|mesh-list
15232665|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15232666|NCT04294459|Analgesics|analgesics|mesh-ancestor
15232667|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
15232668|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232669|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232670|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
15232671|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232672|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
15232673|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
15232674|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232675|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
14361858|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14361859|NCT01085812|Milnacipran|milnacipran|mesh-list
14361860|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
14361861|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14361862|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14361863|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14361864|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361865|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361866|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361867|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
14361868|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14361869|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14361870|NCT01085812|Analgesics|analgesics|mesh-ancestor
14361871|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
14361872|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361873|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14361874|NCT01085903|Modafinil|modafinil|mesh-list
14361875|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14361876|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361877|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14361878|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14361879|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14361880|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361881|NCT01086150|Lidocaine|lidocaine|mesh-list
14732660|NCT04246086|Lenalidomide|lenalidomide|mesh-list
14732661|NCT04246086|Obinutuzumab|obinutuzumab|mesh-list
14732662|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
14732663|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732664|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14732665|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14732666|NCT04246086|Growth Substances|growth substances|mesh-ancestor
14732667|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732668|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732669|NCT04246086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732670|NCT04231968|Ziresovir|ziresovir|mesh-list
14732671|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
14361882|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
14361883|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
14361884|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361885|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361886|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
14361887|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361888|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14361889|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14361890|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14361891|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14361892|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361893|NCT01086358|Naproxen|naproxen|mesh-list
14732672|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732673|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
14732674|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732675|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
14732676|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361894|NCT01086358|Sumatriptan|sumatriptan|mesh-list
14361895|NCT01086358|Naratriptan|naratriptan|mesh-list
14361896|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
14361897|NCT01086358|Rizatriptan|rizatriptan|mesh-list
14361898|NCT01086358|Eletriptan|eletriptan|mesh-list
14361899|NCT01086358|Almotriptan|almotriptan|mesh-list
14465633|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732677|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
15232676|NCT04294459|Hormones|hormones|mesh-ancestor
15232677|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232678|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15232679|NCT04294459|Protective Agents|protective agents|mesh-ancestor
15232680|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15232681|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
15232682|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15232683|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
15232684|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15232685|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15232686|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361900|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14361901|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14361902|NCT01086358|Analgesics|analgesics|mesh-ancestor
14361903|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
14361904|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361905|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361906|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361907|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361908|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
14361909|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14361910|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361911|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361912|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14361913|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14361914|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14361915|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
14361916|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361917|NCT01086384|Fluticasone|fluticasone|mesh-list
14361918|NCT01086384|Xhance|xhance|mesh-list
14361919|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361920|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14361921|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
14361922|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361923|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361924|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14361925|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361926|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361927|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14361928|NCT01086410|Fluticasone|fluticasone|mesh-list
14361929|NCT01086410|Xhance|xhance|mesh-list
14361930|NCT01086410|Prednisolone|prednisolone|mesh-list
14361931|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361932|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14361933|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
14361934|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361935|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361936|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14361937|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
14361938|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361939|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14361940|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
14361941|NCT01086410|Hormones|hormones|mesh-ancestor
14361942|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361943|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361944|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361945|NCT01086475|Cycloserine|cycloserine|mesh-list
14361946|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14361947|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361948|NCT01086475|Renal Agents|renal agents|mesh-ancestor
14361949|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14361950|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
14361951|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15232687|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15232688|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15232689|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232690|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232691|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
15232692|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15232693|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
14361952|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
14361953|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361954|NCT01086540|Acetaminophen|acetaminophen|mesh-list
14361955|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
14361956|NCT01086540|Promethazine|promethazine|mesh-list
14361957|NCT01086540|Prednisone|prednisone|mesh-list
14361958|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
14361959|NCT01086540|Rituximab|rituximab|mesh-list
14361960|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14361961|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14361962|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
14361963|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14361964|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14361965|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14361966|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
14361967|NCT01086540|Hormones|hormones|mesh-ancestor
14361968|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14361969|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14361970|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14361971|NCT01086540|Analgesics|analgesics|mesh-ancestor
14361972|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
14361973|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14361974|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
14361975|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
14361976|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
14361977|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14361978|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14361979|NCT01086540|Protective Agents|protective agents|mesh-ancestor
14361980|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14361981|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14361982|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14361983|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
14361984|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
14361985|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14361986|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
14361987|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
14361988|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14361989|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361990|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14361991|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
14361992|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
14361993|NCT01086605|Pixantrone|pixantrone|mesh-list
14361994|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14361995|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14361996|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14361997|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14361998|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465634|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465635|NCT02228980|Vaccines|vaccines|mesh-list
14465636|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
14465637|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465638|NCT02229214|Topiramate|topiramate|mesh-list
14465639|NCT02229214|Phentermine|phentermine|mesh-list
14465640|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
14465641|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465642|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465643|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15232694|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
15232695|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232696|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15232697|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
15232698|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
15232699|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14465644|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
14465645|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14465646|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
15232700|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14732678|NCT04201457|Trametinib|trametinib|mesh-list
14732679|NCT04201457|Dabrafenib|dabrafenib|mesh-list
14732680|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14732681|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
14732682|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14732683|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14732684|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14361999|NCT01087489|Lidocaine|lidocaine|mesh-list
14362000|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
14362001|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
14362002|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362003|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362004|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
14362005|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362006|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14362007|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14362008|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15232701|NCT04291885|Avelumab|avelumab|mesh-list
15232702|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232703|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362009|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362010|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362011|NCT01087502|Glimepiride|glimepiride|mesh-list
14362012|NCT01087502|Linagliptin|linagliptin|mesh-list
14362013|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14362014|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362015|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362016|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362017|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
14362018|NCT01087502|Incretins|incretins|mesh-ancestor
14362019|NCT01087502|Hormones|hormones|mesh-ancestor
14362020|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362021|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14362022|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14362023|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362024|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362025|NCT01087723|Heparin|heparin|mesh-list
14362026|NCT01087723|Bivalirudin|bivalirudin|mesh-list
14362027|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
14362028|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14362029|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14362030|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732685|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732686|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732687|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362031|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
14362032|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14362033|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
14362034|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362035|NCT01087736|Topiramate|topiramate|mesh-list
14362036|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
14362037|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362038|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362039|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
14362040|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362041|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
14362042|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362043|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362044|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
14362045|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362046|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
14362047|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362048|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732688|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732689|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14920600|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15232704|NCT04289779|Atezolizumab|atezolizumab|mesh-list
15232705|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232706|NCT04286867|Ethanol|ethanol|mesh-list
15232707|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15232708|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232709|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232710|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362049|NCT01087814|Efavirenz|efavirenz|mesh-list
14362050|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14732690|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14732691|NCT04201457|Protective Agents|protective agents|mesh-ancestor
14732692|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362051|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14362052|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362053|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362054|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
14362055|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362056|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14362057|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14362058|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14362059|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14362060|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14362061|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14362062|NCT01087905|Nicotine|nicotine|mesh-list
14362063|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14362064|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
14362065|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362066|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362067|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14362068|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14362069|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
14362070|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362071|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362072|NCT01087931|Bupivacaine|bupivacaine|mesh-list
14362073|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
14362074|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
14362075|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362076|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362077|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
14362078|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362079|NCT01087970|Carboplatin|carboplatin|mesh-list
14362080|NCT01087970|Pemetrexed|pemetrexed|mesh-list
14362081|NCT01087970|Cetuximab|cetuximab|mesh-list
14362082|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362083|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362084|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362085|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14362086|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14362087|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362088|NCT01088048|Rituximab|rituximab|mesh-list
14362089|NCT01088048|Fludarabine|fludarabine|mesh-list
14362090|NCT01088048|Lenalidomide|lenalidomide|mesh-list
14362091|NCT01088048|Everolimus|everolimus|mesh-list
14362092|NCT01088048|Bortezomib|bortezomib|mesh-list
14362093|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14362094|NCT01088048|Ofatumumab|ofatumumab|mesh-list
14362095|NCT01088048|Idelalisib|idelalisib|mesh-list
14362096|NCT01088048|Chlorambucil|chlorambucil|mesh-list
14362097|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362098|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362099|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
14362100|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362101|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362102|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362103|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362104|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14362105|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14362106|NCT01088048|Growth Substances|growth substances|mesh-ancestor
14362107|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
14362108|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14362109|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
14732693|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14362110|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362111|NCT01088243|Mesalamine|mesalamine|mesh-list
14362112|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14362113|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14362114|NCT01088243|Analgesics|analgesics|mesh-ancestor
14362115|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
14362116|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362117|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362118|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362119|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362120|NCT01088295|Telmisartan|telmisartan|mesh-list
14362121|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14362122|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14362123|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14362124|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362125|NCT01088464|Necitumumab|necitumumab|mesh-list
14362126|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14362127|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362128|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362129|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
14362130|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362131|NCT01088529|Prednisone|prednisone|mesh-list
14362132|NCT01088529|Leuprolide|leuprolide|mesh-list
14362133|NCT01088529|Goserelin|goserelin|mesh-list
14362134|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
14362135|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362136|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
14362137|NCT01088529|Hormones|hormones|mesh-ancestor
14362138|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362139|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362140|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14362141|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362142|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14362143|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
14362144|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14362145|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14362146|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362147|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362148|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
14362149|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14362150|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14362151|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14362152|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
14362153|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362154|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362155|NCT01088997|Milrinone|milrinone|mesh-list
14362156|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14362157|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14362158|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
14362159|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14362160|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14362161|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362162|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362163|NCT01088997|Protective Agents|protective agents|mesh-ancestor
14362164|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362165|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
14362166|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14362167|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
14362168|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
15232711|NCT04284657|Citric Acid|citric acid|mesh-list
15232712|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
15232713|NCT04284657|Pravastatin|pravastatin|mesh-list
15232714|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
15232715|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15232716|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
15232717|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
15232718|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232719|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15232720|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15232721|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
15232722|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14362169|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362170|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362171|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362172|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14362173|NCT01089062|Analgesics|analgesics|mesh-ancestor
14362174|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
14362175|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362176|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14362177|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14362178|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
14362179|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362180|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362181|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14362182|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
14362183|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14362184|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14362185|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14362186|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
14362187|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362188|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362189|NCT01089361|Ketamine|ketamine|mesh-list
14362190|NCT01089361|Analgesics|analgesics|mesh-ancestor
14362191|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
14362192|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362193|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362194|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14362195|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14362196|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
14362197|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
14362198|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362199|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14362200|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14362201|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362202|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362203|NCT01089413|Bevacizumab|bevacizumab|mesh-list
14362204|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362205|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362206|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14362207|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14362208|NCT01089413|Growth Substances|growth substances|mesh-ancestor
14362209|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362210|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
14362211|NCT01089504|Phenobarbital|phenobarbital|mesh-list
14362212|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
14362213|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14732694|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
15232723|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15232724|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232725|NCT04263831|Aldesleukin|aldesleukin|mesh-list
15232726|NCT04263831|Interleukin-2|interleukin-2|mesh-list
15232727|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232728|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15232729|NCT04263831|Analgesics|analgesics|mesh-ancestor
15232730|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
15232731|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232732|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362214|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362215|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362216|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14362217|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14362218|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362219|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362220|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
14362221|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
14362222|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14362223|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14362224|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14362225|NCT01089517|Ranibizumab|ranibizumab|mesh-list
14362226|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14362227|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14362228|NCT01089517|Growth Substances|growth substances|mesh-ancestor
14362229|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362230|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
14362231|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362232|NCT01089543|Rabeprazole|rabeprazole|mesh-list
14362233|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14362234|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14362235|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14362236|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362237|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362238|NCT01089556|Pregabalin|pregabalin|mesh-list
14362239|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14362240|NCT01089556|Analgesics|analgesics|mesh-ancestor
14362241|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
14362242|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362243|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362244|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
14362245|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14362246|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362247|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362248|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14362249|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14362250|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14362251|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362252|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14362253|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14362254|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14362255|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362256|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
14362257|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
14362258|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
14362259|NCT01089569|Exenatide|exenatide|mesh-list
14362260|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362261|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362262|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14362263|NCT01089569|Incretins|incretins|mesh-ancestor
14362264|NCT01089569|Hormones|hormones|mesh-ancestor
14362265|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362266|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
14362267|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362268|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14362269|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362270|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362271|NCT01089608|Azithromycin|azithromycin|mesh-list
14362272|NCT01089608|Povidone|povidone|mesh-list
14362273|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14362274|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362275|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
14362276|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
14362277|NCT01089647|Budesonide|budesonide|mesh-list
14362278|NCT01089647|Montelukast|montelukast|mesh-list
14362279|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362280|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14362281|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
14362282|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362283|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232733|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15232734|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15232735|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
15232736|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232737|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
15232738|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
14362284|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14362285|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
14362286|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
14362287|NCT01089647|Hormones|hormones|mesh-ancestor
14362288|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362289|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14362290|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
14362291|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14362292|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14362293|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362294|NCT01089725|Tanezumab|tanezumab|mesh-list
14362295|NCT01089725|Analgesics|analgesics|mesh-ancestor
15232739|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
15232740|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15232741|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14362296|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
14362297|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362298|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362299|NCT01089751|Trospium chloride|trospium chloride|mesh-list
14362300|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
14362301|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
14362302|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362303|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362304|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14362305|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14362306|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
14362307|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362308|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362309|NCT01089751|Urological Agents|urological agents|mesh-ancestor
14362310|NCT01090011|Cetuximab|cetuximab|mesh-list
14362311|NCT01090011|Afatinib|afatinib|mesh-list
14362312|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362313|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362314|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14362315|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362316|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362317|NCT01090050|Naproxen|naproxen|mesh-list
14362318|NCT01090050|Sumatriptan|sumatriptan|mesh-list
14362319|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14362320|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14362321|NCT01090050|Analgesics|analgesics|mesh-ancestor
14362322|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
14732695|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
14732696|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362323|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732697|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
14732698|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732699|NCT04167163|Abaloparatide|abaloparatide|mesh-list
14732700|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14732701|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362324|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362325|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362326|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362327|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
14362328|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14362329|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362330|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362331|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14362332|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14362333|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14362334|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
14362335|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362336|NCT01090063|Ustekinumab|ustekinumab|mesh-list
14362337|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
14362338|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14362339|NCT01090102|Mesalamine|mesalamine|mesh-list
14465647|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
14465648|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465649|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
14465650|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362340|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14362341|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14362342|NCT01090102|Analgesics|analgesics|mesh-ancestor
14362343|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
14362344|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362345|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362346|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362347|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362348|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
14362349|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14362350|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362351|NCT01090180|Dexamethasone|dexamethasone|mesh-list
14362352|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362353|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
14362354|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
14362355|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362356|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362357|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14362358|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
14362359|NCT01090180|Hormones|hormones|mesh-ancestor
14362360|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362361|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14362362|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362363|NCT01090323|Deferasirox|deferasirox|mesh-list
14362364|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14362365|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
14362366|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
14362367|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362368|NCT01090414|Idelalisib|idelalisib|mesh-list
14362369|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362370|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362371|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362372|NCT01090427|Ustekinumab|ustekinumab|mesh-list
14362373|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
14362374|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14362375|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
14362376|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362377|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
14362378|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14362379|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362380|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
14362381|NCT01090752|Metformin|metformin|mesh-list
14362382|NCT01090752|Pioglitazone|pioglitazone|mesh-list
14362383|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362384|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362385|NCT01090921|Bortezomib|bortezomib|mesh-list
14362386|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362387|NCT01090973|Panobinostat|panobinostat|mesh-list
14362388|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14362389|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362390|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362391|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362392|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
14362393|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14362394|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14362395|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362396|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14362397|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362398|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
14362399|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362400|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
14362401|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362402|NCT01091259|Bevacizumab|bevacizumab|mesh-list
14362403|NCT01091259|Irinotecan|irinotecan|mesh-list
14362404|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362405|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362406|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14362407|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14362408|NCT01091259|Growth Substances|growth substances|mesh-ancestor
14362409|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362410|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
14362411|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14362412|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14362413|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362414|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362415|NCT01091428|Paclitaxel|paclitaxel|mesh-list
14362416|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14362417|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362418|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14362419|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
14362420|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14362421|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362422|NCT01091454|Cisplatin|cisplatin|mesh-list
14362423|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362424|NCT01091519|Fesoterodine|fesoterodine|mesh-list
14362425|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14362426|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14362427|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
14362428|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362429|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362430|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362431|NCT01091519|Urological Agents|urological agents|mesh-ancestor
14362432|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14362433|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
14362434|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14362435|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14362436|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362437|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362438|NCT01091675|Etoricoxib|etoricoxib|mesh-list
14362439|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14362440|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14362441|NCT01091675|Analgesics|analgesics|mesh-ancestor
14362442|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
14362443|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362444|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362445|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232742|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232743|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232744|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232745|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
15232746|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
15232747|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15232748|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232749|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232750|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
15232751|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15232752|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232753|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362446|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362447|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14362448|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14362449|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362450|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362451|NCT01091974|Modafinil|modafinil|mesh-list
14362452|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14362453|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362454|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14362455|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14362456|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14362457|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362458|NCT01092182|Prednisone|prednisone|mesh-list
14362459|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
14362460|NCT01092182|Rituximab|rituximab|mesh-list
14362461|NCT01092182|Doxorubicin|doxorubicin|mesh-list
14362462|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14362463|NCT01092182|Etoposide|etoposide|mesh-list
14362464|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
14362465|NCT01092182|Vincristine|vincristine|mesh-list
14362466|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362467|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
14362468|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362469|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362470|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14362471|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
14362472|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362473|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362474|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14362475|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362476|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14362477|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14362478|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14362479|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362480|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362481|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
14362482|NCT01092182|Hormones|hormones|mesh-ancestor
14362483|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362484|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14362485|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14362486|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
14362487|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
14362488|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
14362489|NCT01092338|Vitamin D|vitamin d|mesh-list
14362490|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
14362491|NCT01092338|Vitamins|vitamins|mesh-ancestor
14362492|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
14362493|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362494|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15232754|NCT04185311|Nivolumab|nivolumab|mesh-list
15232755|NCT04185311|Ipilimumab|ipilimumab|mesh-list
15232756|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15232757|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232758|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232759|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15232760|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232761|NCT04182334|TEMPO|tempo|mesh-list
15232762|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
15232763|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232764|NCT04182334|Protective Agents|protective agents|mesh-ancestor
15232765|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232766|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15232767|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15232768|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232769|NCT04161248|Gemcitabine|gemcitabine|mesh-list
15232770|NCT04161248|Dexamethasone|dexamethasone|mesh-list
14362495|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14362496|NCT01092507|Vaccines|vaccines|mesh-list
14362497|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
15232771|NCT04161248|Rituximab|rituximab|mesh-list
15232772|NCT04161248|Venetoclax|venetoclax|mesh-list
15232773|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232774|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232775|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
15232776|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
15232777|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232778|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232779|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232780|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
14362498|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362499|NCT01092546|Flutemetamol|flutemetamol|mesh-list
14362500|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14362501|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362502|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
14362503|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14362504|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
14362505|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362506|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362507|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14362508|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
14362509|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14362510|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
14362511|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362512|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362513|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14732702|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
14362514|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
14362515|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
14732703|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15232781|NCT04161248|Hormones|hormones|mesh-ancestor
14362516|NCT01092559|Protective Agents|protective agents|mesh-ancestor
14362517|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14362518|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14362519|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362520|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362521|NCT01092663|Incretins|incretins|mesh-ancestor
14362522|NCT01092663|Hormones|hormones|mesh-ancestor
14362523|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362524|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14362525|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
14362526|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362527|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362528|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14362529|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14362530|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
14362531|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14362532|NCT01092676|Ibuprofen|ibuprofen|mesh-list
14362533|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14362534|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14362535|NCT01092676|Analgesics|analgesics|mesh-ancestor
14362536|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
14362537|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362538|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362539|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362540|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362541|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14362542|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362543|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362544|NCT01092702|Varenicline|varenicline|mesh-list
14362545|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14362546|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14362547|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
14362548|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362549|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362550|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362551|NCT01092728|Dasatinib|dasatinib|mesh-list
14362552|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362553|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14362554|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362555|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362556|NCT01092780|Modafinil|modafinil|mesh-list
14362557|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14362558|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362559|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14362560|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14362561|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14362562|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362563|NCT01092832|Voriconazole|voriconazole|mesh-list
14362564|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
14362565|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753074|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
14362566|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14362567|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14362568|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362569|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362570|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14362571|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
14362572|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362573|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362574|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14362575|NCT01092923|Sevoflurane|sevoflurane|mesh-list
14362576|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14362577|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14362578|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
14362579|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
14362580|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362581|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465651|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465652|NCT02229227|Insulin|insulin|mesh-list
14465653|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
14465654|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
14465655|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
14465656|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465657|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465658|NCT02229227|Incretins|incretins|mesh-ancestor
14465659|NCT02229227|Hormones|hormones|mesh-ancestor
14465660|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465661|NCT02229383|Exenatide|exenatide|mesh-list
14465662|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465663|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465664|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14465665|NCT02229383|Incretins|incretins|mesh-ancestor
14465666|NCT02229383|Hormones|hormones|mesh-ancestor
14465667|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465668|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
14465669|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465670|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465671|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465672|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465673|NCT02229461|Aspirin|aspirin|mesh-list
14465674|NCT02229461|Naproxen|naproxen|mesh-list
14465675|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14465676|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14465677|NCT02229461|Analgesics|analgesics|mesh-ancestor
14465678|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
14465679|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465680|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465681|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465682|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465683|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14465684|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14465685|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465686|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14465687|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14465688|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465689|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
14465690|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
14465691|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
14465692|NCT02229539|Promethazine|promethazine|mesh-list
14465693|NCT02229539|Lidocaine|lidocaine|mesh-list
14465694|NCT02229539|Doxepin|doxepin|mesh-list
14465695|NCT02229539|Antacids|antacids|mesh-list
14465696|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
14465697|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
14465698|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465699|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465700|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
14465701|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465702|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14362582|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
14362583|NCT01093183|Lenalidomide|lenalidomide|mesh-list
14362584|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362585|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
14362586|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362587|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362588|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14362589|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
14362590|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362591|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362592|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14362593|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14362594|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14362595|NCT01093183|Growth Substances|growth substances|mesh-ancestor
14362596|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
14362597|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14362598|NCT01093222|Sorafenib|sorafenib|mesh-list
14362599|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362600|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14362601|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362602|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362603|NCT01093417|Vitamin D|vitamin d|mesh-list
14362604|NCT01093417|Vitamins|vitamins|mesh-ancestor
14362605|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
14362606|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362607|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14362608|NCT01093469|Decanoic acid|decanoic acid|mesh-list
14362609|NCT01093469|Petrolatum|petrolatum|mesh-list
14362610|NCT01093469|Emollients|emollients|mesh-ancestor
14362611|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
14362612|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
14362613|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362614|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
14362615|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14362616|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362617|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362618|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
14362619|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14362620|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14362621|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
14362622|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362623|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362624|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362625|NCT01093534|Urological Agents|urological agents|mesh-ancestor
14362626|NCT01093573|Azacitidine|azacitidine|mesh-list
14362627|NCT01093573|Midostaurin|midostaurin|mesh-list
14362628|NCT01093573|Staurosporine|staurosporine|mesh-list
14362629|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14362630|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
14362631|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362632|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362633|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362634|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14362635|NCT01093586|Cyclosporine|cyclosporine|mesh-list
14362636|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
14362637|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
14362638|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14362639|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15232782|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232783|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15232784|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232785|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
15232786|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362640|NCT01093586|Prednisolone|prednisolone|mesh-list
14362641|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
14362642|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
14362643|NCT01093586|Busulfan|busulfan|mesh-list
14362644|NCT01093586|Cyclosporins|cyclosporins|mesh-list
14362645|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
14362646|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14362647|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14362648|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
14362649|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362650|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
14362651|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362652|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362653|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14362654|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
14362655|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362656|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362657|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14362658|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362659|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
14362660|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362661|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
14362662|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14362663|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14362664|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14362665|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
14362666|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14362667|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14362668|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
15232787|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15232788|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
15232789|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232790|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
15232791|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232792|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232793|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362669|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
14362670|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362671|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14362672|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
14362673|NCT01093586|Hormones|hormones|mesh-ancestor
14362674|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362675|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14362676|NCT01093586|Protective Agents|protective agents|mesh-ancestor
14362677|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14362678|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14362679|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362680|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362681|NCT01093651|Incretins|incretins|mesh-ancestor
14362682|NCT01093651|Hormones|hormones|mesh-ancestor
14362683|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362684|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14362685|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
14362686|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362687|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362688|NCT01093690|Metoclopramide|metoclopramide|mesh-list
14362689|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
14362690|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
14362691|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362692|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920601|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930950|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930951|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930952|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362693|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14362694|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14362695|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14362696|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
14362697|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362698|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362699|NCT01093755|Omeprazole|omeprazole|mesh-list
14362700|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
14362701|NCT01093755|Lansoprazole|lansoprazole|mesh-list
14362702|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14362703|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14362704|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14362705|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362706|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362707|NCT01093794|Metformin|metformin|mesh-list
14362708|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14362709|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362710|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362711|NCT01093794|Incretins|incretins|mesh-ancestor
14362712|NCT01093794|Hormones|hormones|mesh-ancestor
14362713|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362714|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14362715|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
14362716|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362717|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362718|NCT01093885|Ambrisentan|ambrisentan|mesh-list
14362719|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14362720|NCT01093976|Dronabinol|dronabinol|mesh-list
14362721|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
14362722|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362723|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15232794|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
14362724|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14362725|NCT01093976|Analgesics|analgesics|mesh-ancestor
14362726|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
14362727|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362728|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14362729|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14362730|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362731|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362732|NCT01093976|Hormones|hormones|mesh-ancestor
14362733|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14362734|NCT01094106|Ropivacaine|ropivacaine|mesh-list
14362735|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
14362736|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
14362737|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362738|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362739|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
14362740|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362741|NCT01094184|Paclitaxel|paclitaxel|mesh-list
14362742|NCT01094184|Docetaxel|docetaxel|mesh-list
14362743|NCT01094184|Bevacizumab|bevacizumab|mesh-list
14362744|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14362745|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362746|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
14362747|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
14362748|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
14362749|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362750|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14362751|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14362752|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14362753|NCT01094184|Growth Substances|growth substances|mesh-ancestor
14362754|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362755|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
14362756|NCT01094288|Docetaxel|docetaxel|mesh-list
14362757|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362758|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
14362759|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
14362760|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
14362761|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362762|NCT01094522|Morphine|morphine|mesh-list
14362763|NCT01094522|Methadone|methadone|mesh-list
14362764|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14362765|NCT01094522|Narcotics|narcotics|mesh-ancestor
14362766|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362767|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232795|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15232796|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
15232797|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15232798|NCT04155580|Decitabine|decitabine|mesh-list
15232799|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15232800|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
15232801|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232802|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362768|NCT01094522|Analgesics|analgesics|mesh-ancestor
14362769|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
14753075|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753076|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
14362770|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362771|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
14362772|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
14362773|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
14362774|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362775|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
14362776|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362777|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14362778|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14362779|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
14362780|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362781|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362782|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14362783|NCT01094574|Propranolol|propranolol|mesh-list
14362784|NCT01094574|Alfentanil|alfentanil|mesh-list
14362785|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14362786|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14362787|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
14362788|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362789|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362790|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362791|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14362792|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14362793|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
14362794|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14362795|NCT01094574|Narcotics|narcotics|mesh-ancestor
14362796|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362797|NCT01094574|Analgesics|analgesics|mesh-ancestor
14362798|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
14362799|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362800|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14362801|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
14362802|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
14362803|NCT01094717|Tazarotene|tazarotene|mesh-list
14362804|NCT01094717|Acitretin|acitretin|mesh-list
14362805|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14362806|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
14362807|NCT01094808|Pregabalin|pregabalin|mesh-list
14362808|NCT01094808|Analgesics|analgesics|mesh-ancestor
14362809|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
14362810|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362811|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362812|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
14362813|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14362814|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362815|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362816|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14362817|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14362818|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14362819|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14362820|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14362821|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
14362822|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14362823|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
14362824|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14362825|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
14362826|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362827|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362828|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
15232803|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232804|NCT04149145|Niraparib|niraparib|mesh-list
15232805|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15232806|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232807|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362834|NCT01095094|Ritonavir|ritonavir|mesh-list
14362835|NCT01095094|Lopinavir|lopinavir|mesh-list
14362836|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14362837|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14362838|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
14362839|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362840|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362841|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14362842|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14362843|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
14362844|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732704|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14732705|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732706|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14732707|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732708|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14732709|NCT04151667|Dexamethasone|dexamethasone|mesh-list
14732710|NCT04151667|Lenalidomide|lenalidomide|mesh-list
14732711|NCT04151667|Bortezomib|bortezomib|mesh-list
14732712|NCT04151667|Daratumumab|daratumumab|mesh-list
14732713|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14732714|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
14362845|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14362846|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14362847|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14362848|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14362849|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362850|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
14362851|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362852|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14362853|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14362854|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362855|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
14362856|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362857|NCT01095653|Metformin|metformin|mesh-list
14362858|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
14362859|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362860|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362861|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14362862|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362863|NCT01095666|Metformin|metformin|mesh-list
14362864|NCT01095666|Pioglitazone|pioglitazone|mesh-list
14362865|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
14362866|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362867|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362868|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14362869|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362870|NCT01095757|Plerixafor|plerixafor|mesh-list
14362871|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14362872|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14732715|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
14362873|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
14732716|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362874|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232808|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232809|NCT04136548|Fentanyl|fentanyl|mesh-list
15232810|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15232811|NCT04136548|Narcotics|narcotics|mesh-ancestor
15232812|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232813|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232814|NCT04136548|Analgesics|analgesics|mesh-ancestor
14362875|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14362876|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14362877|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14362878|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14362879|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362880|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362881|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
14362882|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362883|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14362884|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14362885|NCT01095835|Interferons|interferons|mesh-list
14362886|NCT01095835|Lamivudine|lamivudine|mesh-list
14362887|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14362888|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
14362889|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14362890|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
14362891|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362892|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14362893|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14362894|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362895|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362896|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14362897|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14362898|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
14362899|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362900|NCT01095887|Eculizumab|eculizumab|mesh-list
14362901|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14362902|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14362903|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
14362904|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362905|NCT01095978|Clarithromycin|clarithromycin|mesh-list
14362906|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14362907|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362908|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14362909|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362910|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753077|NCT05285982|Nintedanib|nintedanib|mesh-list
14362911|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14362912|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14362913|NCT01096017|Albuterol|albuterol|mesh-list
14362914|NCT01096017|Terbutaline|terbutaline|mesh-list
14362915|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14362916|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
14362917|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362918|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362919|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14362920|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
14362921|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
14362922|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14362923|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14362924|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14362925|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14362926|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14362927|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362928|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362929|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
14362930|NCT01096056|Vaccines|vaccines|mesh-list
14362931|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
14362932|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362933|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14362934|NCT01096186|Carbidopa|carbidopa|mesh-list
14362935|NCT01096186|Levodopa|levodopa|mesh-list
14362936|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14362937|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
14362938|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362939|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14362940|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14362941|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
14362942|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
14362943|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362944|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362945|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14362946|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362947|NCT01096290|Lubiprostone|lubiprostone|mesh-list
14362948|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14362949|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362950|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362951|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
14362952|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14362953|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362954|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362955|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14362956|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
14362957|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14362958|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14362959|NCT01096589|Monensin|monensin|mesh-list
14362960|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
14362961|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14362962|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14362963|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14362964|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
14362965|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
14362966|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
14362967|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14362968|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362969|NCT01096589|Ionophores|ionophores|mesh-ancestor
14362970|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362971|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
14362972|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
14362973|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14362974|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14362975|NCT01096667|Diuretics|diuretics|mesh-ancestor
14362976|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
14362977|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362978|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14362979|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362980|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14362981|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14362982|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14362983|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14362984|NCT01096680|Modafinil|modafinil|mesh-list
14362985|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14362986|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14362987|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14362988|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14362989|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14362990|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232815|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
15232816|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232817|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15232818|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15232819|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
15232820|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
15232821|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15232822|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15232823|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15232824|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232825|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232826|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15232827|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232828|NCT04111627|Analgesics|analgesics|mesh-ancestor
15232829|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
15232830|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14362991|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
14362992|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14362993|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14362994|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14362995|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14362996|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14362997|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14362998|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14362999|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14363000|NCT01096784|Mecasermin|mecasermin|mesh-list
14363001|NCT01096784|Growth Substances|growth substances|mesh-ancestor
14363002|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363003|NCT01096849|Levofloxacin|levofloxacin|mesh-list
14363004|NCT01096849|Ofloxacin|ofloxacin|mesh-list
14363005|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14363006|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363007|NCT01096849|Renal Agents|renal agents|mesh-ancestor
14363008|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14363009|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14363010|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14363011|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363012|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363013|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363014|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14363015|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14363016|NCT01096875|Atorvastatin|atorvastatin|mesh-list
14363017|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14363018|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14363019|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
14363020|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363021|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14363022|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14363023|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363024|NCT01096992|Vidarabine|vidarabine|mesh-list
14363025|NCT01096992|Rituximab|rituximab|mesh-list
14363026|NCT01096992|Fludarabine|fludarabine|mesh-list
14363027|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
14363028|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14363029|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14363030|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363031|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
14363032|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363033|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363034|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14363035|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
14732717|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920602|NCT04551963|Clarithromycin|clarithromycin|mesh-list
14732718|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14732719|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
14732720|NCT04151667|Hormones|hormones|mesh-ancestor
14732721|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363036|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363037|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363038|NCT01096992|Antiviral Agents|antiviral agents|mesh-ancestor
14363039|NCT01096992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363040|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14363041|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
14363042|NCT01097044|Afamelanotide|afamelanotide|mesh-list
14363043|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
14363044|NCT01097057|Plerixafor|plerixafor|mesh-list
14363045|NCT01097057|Rituximab|rituximab|mesh-list
14363046|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14363047|NCT01097057|Carboplatin|carboplatin|mesh-list
14363048|NCT01097057|Etoposide|etoposide|mesh-list
14363049|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
14363050|NCT01097057|Ifosfamide|ifosfamide|mesh-list
14363051|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
14363052|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
14363053|NCT01097057|Antibodies|antibodies|mesh-list
14363054|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
14363055|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14363056|NCT01097057|Lenograstim|lenograstim|mesh-list
14363057|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
14363058|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363059|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363060|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363061|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14363062|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14363063|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14363064|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363065|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363066|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14363067|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14363068|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
14363069|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14363070|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14363071|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
14363072|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363073|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
14363074|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14363075|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14363076|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14363077|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14363078|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14363079|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14363080|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14363081|NCT01097330|Amiodarone|amiodarone|mesh-list
14363082|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14363083|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
14363084|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14363085|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363086|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363087|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14363088|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14920603|NCT04551963|Fluconazole|fluconazole|mesh-list
14363089|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14363090|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363091|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14363092|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14363093|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14363094|NCT01097343|Clopidogrel|clopidogrel|mesh-list
14363095|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14363096|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14363097|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14363098|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14363099|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
14363100|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363101|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363102|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363103|NCT01097395|Ribavirin|ribavirin|mesh-list
14363104|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
14363105|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363106|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
14732722|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14732723|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732724|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
14732725|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14363107|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363108|NCT01097421|Pramipexole|pramipexole|mesh-list
14363109|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
14363110|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363111|NCT01097421|Protective Agents|protective agents|mesh-ancestor
14363112|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363113|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14363114|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14363115|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
14363116|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
14363117|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363118|NCT01097460|Trastuzumab|trastuzumab|mesh-list
14363119|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14363120|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363121|NCT01097577|Pregabalin|pregabalin|mesh-list
14363122|NCT01097577|Analgesics|analgesics|mesh-ancestor
14363123|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
14363124|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363125|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363126|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
14363127|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14363128|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363129|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363130|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14363131|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14363132|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14363133|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363134|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14363135|NCT01097616|Suvorexant|suvorexant|mesh-list
14363136|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14363137|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14363138|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363139|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363140|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14363141|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363142|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363143|NCT01097629|Suvorexant|suvorexant|mesh-list
14363144|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14363145|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14363146|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363147|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363148|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14363149|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363150|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363151|NCT01097642|Cetuximab|cetuximab|mesh-list
14363152|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14363153|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363154|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
14363155|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363156|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14363157|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363158|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363159|NCT01097785|Simvastatin|simvastatin|mesh-list
14363160|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14363161|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14363162|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
14363163|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363164|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14363165|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14363166|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363167|NCT01098097|Ribavirin|ribavirin|mesh-list
14363168|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
14363169|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363170|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
14363171|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363172|NCT01098305|Varenicline|varenicline|mesh-list
14363173|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14363174|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14363175|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
14363176|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363177|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363178|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363179|NCT01098318|Sertraline|sertraline|mesh-list
14363180|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
14363181|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14363182|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14363183|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14363184|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363185|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363186|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363187|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
14363188|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363189|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
14363190|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14363191|NCT01098461|Incretins|incretins|mesh-ancestor
14363192|NCT01098461|Hormones|hormones|mesh-ancestor
14363193|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363194|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363195|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14363196|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
14363197|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363198|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14363199|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
14363200|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14363201|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363202|NCT01098539|Incretins|incretins|mesh-ancestor
14363203|NCT01098539|Hormones|hormones|mesh-ancestor
14363204|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732726|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14732727|NCT04151667|Growth Substances|growth substances|mesh-ancestor
14732728|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
14732729|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14732730|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732731|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
14732732|NCT04145349|Vinorelbine|vinorelbine|mesh-list
15232831|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
14363205|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14363206|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
14363207|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363208|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363209|NCT01098747|Ibuprofen|ibuprofen|mesh-list
14363210|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14363211|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14363212|NCT01098747|Analgesics|analgesics|mesh-ancestor
14363213|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
14363214|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363215|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363216|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14363217|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363218|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14363219|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363220|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465703|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14465704|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14465705|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465706|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465707|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14465708|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14465709|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
14465710|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
14465711|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14465712|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14465713|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
14465714|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
14732733|NCT04145349|Ramucirumab|ramucirumab|mesh-list
14732734|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14465715|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465716|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14465717|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
14465718|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
15232832|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15232833|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
15232834|NCT04087395|Lidocaine|lidocaine|mesh-list
15232835|NCT04087395|Anesthetics|anesthetics|mesh-list
15232836|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232837|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232838|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232839|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
15232840|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232841|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14363221|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
14363222|NCT01099202|Hematinics|hematinics|mesh-ancestor
14363223|NCT01099358|Fluorouracil|fluorouracil|mesh-list
14363224|NCT01099358|Cetuximab|cetuximab|mesh-list
14363225|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363226|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
14363227|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363228|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14363229|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363230|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
14363231|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363232|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14363233|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
14363234|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
14363235|NCT01099449|Calcium|calcium|mesh-list
14363236|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14363237|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363238|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363239|NCT01099449|Analgesics|analgesics|mesh-ancestor
14363240|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
14363241|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363242|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
14363243|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363244|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14363245|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
14363246|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14363247|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363248|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363249|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
14363250|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14363251|NCT01099579|Ritonavir|ritonavir|mesh-list
14363252|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14363253|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14363254|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14363255|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
15232842|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15232843|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15232844|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232845|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232846|NCT04085887|Panitumumab|panitumumab|mesh-list
15232847|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232848|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232849|NCT04074785|Bevacizumab|bevacizumab|mesh-list
15232850|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232851|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232852|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15232853|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15232854|NCT04074785|Growth Substances|growth substances|mesh-ancestor
15232855|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232856|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
15232857|NCT04069585|Lidocaine|lidocaine|mesh-list
15232858|NCT04069585|Anesthetics|anesthetics|mesh-list
15232859|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232860|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232861|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232862|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
15232863|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232864|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15232865|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15232866|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15232867|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232868|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232869|NCT04055753|Doxorubicin|doxorubicin|mesh-list
15232870|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15232871|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232872|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15232873|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15232874|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232875|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232876|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
15232877|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14363256|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732735|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
14732736|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363257|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363258|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14363259|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14363260|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
14363261|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363262|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14363263|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14363264|NCT01099618|Metformin|metformin|mesh-list
14363265|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14363266|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14363267|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363268|NCT01099618|Incretins|incretins|mesh-ancestor
14363269|NCT01099618|Hormones|hormones|mesh-ancestor
14363270|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732737|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363271|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14363272|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
14363273|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363274|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363275|NCT01099709|Oxycodone|oxycodone|mesh-list
14363276|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363277|NCT01099709|Narcotics|narcotics|mesh-ancestor
14363278|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363279|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363280|NCT01099709|Analgesics|analgesics|mesh-ancestor
14363281|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
14363282|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363283|NCT01099774|Bimatoprost|bimatoprost|mesh-list
14363284|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14363285|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14363286|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363287|NCT01100034|Etanercept|etanercept|mesh-list
14363288|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14363289|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14363290|NCT01100034|Analgesics|analgesics|mesh-ancestor
14363291|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
14363292|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363293|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363294|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14363295|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363296|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14363297|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363298|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
14363299|NCT01100086|Oxycodone|oxycodone|mesh-list
14363300|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363301|NCT01100086|Narcotics|narcotics|mesh-ancestor
14363302|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363303|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363304|NCT01100086|Analgesics|analgesics|mesh-ancestor
14363305|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
14363306|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363307|NCT01100112|Budesonide|budesonide|mesh-list
14363308|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14363309|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14363310|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
14363311|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363312|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363313|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14363314|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
14363315|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
14363316|NCT01100112|Hormones|hormones|mesh-ancestor
14920604|NCT04551963|Voriconazole|voriconazole|mesh-list
14920605|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
14920606|NCT04551963|Diltiazem|diltiazem|mesh-list
14920607|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14920608|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920609|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14920610|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920611|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920612|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14920613|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14920614|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
14920615|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14920616|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14920617|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
14920618|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920619|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920620|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14920621|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14363317|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363318|NCT01100242|Bortezomib|bortezomib|mesh-list
14363319|NCT01100242|Sorafenib|sorafenib|mesh-list
14363320|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363321|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14363322|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363323|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363324|NCT01100255|Ketamine|ketamine|mesh-list
14363325|NCT01100255|Analgesics|analgesics|mesh-ancestor
14363326|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
14363327|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363328|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363329|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14363330|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14363331|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
14363332|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
14363333|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363334|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14363335|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14363336|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363337|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363338|NCT01100268|Methylphenidate|methylphenidate|mesh-list
14363339|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14363340|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363341|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14363342|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14363343|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363344|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363345|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
14363346|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363347|NCT01100320|Oxycodone|oxycodone|mesh-list
14363348|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363349|NCT01100320|Narcotics|narcotics|mesh-ancestor
14363350|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363351|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363352|NCT01100320|Analgesics|analgesics|mesh-ancestor
14363353|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
14363354|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363355|NCT01100437|Naltrexone|naltrexone|mesh-list
14363356|NCT01100437|Morphine|morphine|mesh-list
14363357|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363358|NCT01100437|Narcotics|narcotics|mesh-ancestor
14363359|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363360|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363361|NCT01100437|Analgesics|analgesics|mesh-ancestor
14363362|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
14363363|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363364|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14363365|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14363366|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14363367|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14363368|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363369|NCT01100528|Interferons|interferons|mesh-list
14363370|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
14363371|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
14363372|NCT01100528|Dacarbazine|dacarbazine|mesh-list
14363373|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363374|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
14363375|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363376|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
14363377|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363378|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14363379|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
14363380|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363381|NCT01100606|Pancrelipase|pancrelipase|mesh-list
14363382|NCT01100606|Pancreatin|pancreatin|mesh-list
14363383|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14363384|NCT01100723|Vitamin D|vitamin d|mesh-list
14363385|NCT01100723|Calcitriol|calcitriol|mesh-list
14363386|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14363387|NCT01100723|Cinacalcet|cinacalcet|mesh-list
14363388|NCT01100723|Vitamins|vitamins|mesh-ancestor
14363389|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
14363390|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363391|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14363392|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14363393|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14363394|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363395|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363396|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14363397|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14363398|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
14363399|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363400|NCT01100853|Naltrexone|naltrexone|mesh-list
14363401|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14363402|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14363403|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363404|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
14363405|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363406|NCT01100931|Paclitaxel|paclitaxel|mesh-list
14363407|NCT01100931|Carboplatin|carboplatin|mesh-list
14363408|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14363409|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363410|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
14363411|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
14363412|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
14363413|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363414|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
14363415|NCT01100944|Doxorubicin|doxorubicin|mesh-list
14363416|NCT01100944|Belinostat|belinostat|mesh-list
14363417|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363418|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
14363419|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232878|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
14363420|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363421|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14363422|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
14363423|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363424|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363425|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14363426|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14363427|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14363428|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14363429|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363430|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14363431|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14363432|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14363433|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363434|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14363435|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14363436|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363437|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363438|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
14363439|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363440|NCT01101035|Allopurinol|allopurinol|mesh-list
14363441|NCT01101035|Febuxostat|febuxostat|mesh-list
14363442|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
14363443|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363444|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363445|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
14363446|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363447|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14363448|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
14363449|NCT01101035|Protective Agents|protective agents|mesh-ancestor
14363450|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363451|NCT01101100|Brodalumab|brodalumab|mesh-list
14363452|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
14363453|NCT01101165|Oxycodone|oxycodone|mesh-list
14363454|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363455|NCT01101165|Narcotics|narcotics|mesh-ancestor
14363456|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363457|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363458|NCT01101165|Analgesics|analgesics|mesh-ancestor
14363459|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
14363460|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363461|NCT01101178|Oxycodone|oxycodone|mesh-list
14363462|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363463|NCT01101178|Narcotics|narcotics|mesh-ancestor
14363464|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363465|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363466|NCT01101178|Analgesics|analgesics|mesh-ancestor
14363467|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
14363468|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363469|NCT01101191|Oxycodone|oxycodone|mesh-list
14363470|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363471|NCT01101191|Narcotics|narcotics|mesh-ancestor
15232879|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
15232880|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232881|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232882|NCT03968653|Carboplatin|carboplatin|mesh-list
15232883|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232884|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
14363472|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363473|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363474|NCT01101191|Analgesics|analgesics|mesh-ancestor
14363475|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
14363476|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363477|NCT01101308|Oxycodone|oxycodone|mesh-list
14363478|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363479|NCT01101308|Narcotics|narcotics|mesh-ancestor
14363480|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363481|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363482|NCT01101308|Analgesics|analgesics|mesh-ancestor
14363483|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
14363484|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363485|NCT01101321|Oxycodone|oxycodone|mesh-list
14363486|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14363487|NCT01101321|Narcotics|narcotics|mesh-ancestor
14363488|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363489|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363490|NCT01101321|Analgesics|analgesics|mesh-ancestor
14363491|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
14363492|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363493|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14363494|NCT01101334|Efatutazone|efatutazone|mesh-list
14363495|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363496|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14363497|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363498|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363499|NCT01101750|Vaccines|vaccines|mesh-list
14363500|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
14363501|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363502|NCT01101841|Paroxetine|paroxetine|mesh-list
14363503|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14363504|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14363505|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363506|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363507|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363508|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
14363509|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363510|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14363511|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
14363512|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14363513|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14363514|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14363515|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363516|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
14363517|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
14363518|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14363519|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14363520|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363521|NCT01101880|Cytarabine|cytarabine|mesh-list
14363522|NCT01101880|Clofarabine|clofarabine|mesh-list
14363523|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14363524|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
14363525|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363526|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363527|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
14363528|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363529|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363530|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
14363531|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363532|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
14363533|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
14363534|NCT01102218|Hematinics|hematinics|mesh-ancestor
14363535|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14363536|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363537|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363538|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14363539|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14363540|NCT01102218|Protective Agents|protective agents|mesh-ancestor
14363541|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363542|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14363543|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14363544|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
15232885|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15232886|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
14363545|NCT01102231|Cetuximab|cetuximab|mesh-list
14363546|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232887|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15232888|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
14363547|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363548|NCT01102270|Eszopiclone|eszopiclone|mesh-list
14363549|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14363550|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363551|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363552|NCT01102374|Vitamin D|vitamin d|mesh-list
14363553|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
14363554|NCT01102374|Vitamins|vitamins|mesh-list
14732738|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14732739|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
14732740|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732741|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732742|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14732743|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14732744|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
14732745|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
14732746|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
14732747|NCT04137770|Ketorolac|ketorolac|mesh-list
14732748|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14732749|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14732750|NCT04137770|Analgesics|analgesics|mesh-ancestor
14732751|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
14363555|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
14363556|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363557|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14363558|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14363559|NCT01102426|Dexamethasone|dexamethasone|mesh-list
14363560|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14363561|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
14363562|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
14363563|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363564|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363565|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14363566|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
14363567|NCT01102426|Hormones|hormones|mesh-ancestor
14363568|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363569|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14363570|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363571|NCT01102491|Ramosetron|ramosetron|mesh-list
14363572|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
14363573|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
14363574|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363575|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363576|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14363577|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14363578|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
14363579|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363580|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363581|NCT01102803|Cycloserine|cycloserine|mesh-list
14363582|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14363583|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363584|NCT01102803|Renal Agents|renal agents|mesh-ancestor
14363585|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14363586|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
14363587|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14363588|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
14363589|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363590|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14363591|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14363592|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14363593|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14363594|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363595|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363596|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
14363597|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363598|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14363599|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14363600|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14363601|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14363602|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
14363603|NCT01103063|Azithromycin|azithromycin|mesh-list
14363604|NCT01103063|Chloroquine|chloroquine|mesh-list
14363605|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
14363606|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
14363607|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14363608|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14363609|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363610|NCT01103063|Amebicides|amebicides|mesh-ancestor
14363611|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14363612|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14363613|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
14363614|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363615|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14363616|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363617|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363618|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14363619|NCT01103063|Renal Agents|renal agents|mesh-ancestor
14363620|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14363621|NCT01103245|Spironolactone|spironolactone|mesh-list
14363622|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363623|NCT01103245|Diuretics|diuretics|mesh-ancestor
14363624|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
14363625|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363626|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14363627|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363628|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363629|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14363630|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
14363631|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363632|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14363633|NCT01103414|Pioglitazone|pioglitazone|mesh-list
14363634|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14363635|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363636|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
14363637|NCT01103440|Tirofiban|tirofiban|mesh-list
14363638|NCT01103440|Ticlopidine|ticlopidine|mesh-list
14363639|NCT01103440|Abciximab|abciximab|mesh-list
14363640|NCT01103440|Clopidogrel|clopidogrel|mesh-list
14363641|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14363642|NCT01103440|Cangrelor|cangrelor|mesh-list
14363643|NCT01103440|Eptifibatide|eptifibatide|mesh-list
14363644|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14363645|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14363646|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14363647|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14363648|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
14363649|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363650|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363651|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363652|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
14363653|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15232889|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232890|NCT03911713|Ivacaftor|ivacaftor|mesh-list
15232891|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15232892|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232893|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232894|NCT03852459|Ibuprofen|ibuprofen|mesh-list
15232895|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14363654|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14363655|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15232896|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14363656|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
14363657|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14363658|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363659|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
14363660|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363661|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
14363662|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14363663|NCT01103440|Protective Agents|protective agents|mesh-ancestor
14363664|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14363665|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14363666|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363667|NCT01103713|Azithromycin|azithromycin|mesh-list
14363668|NCT01103713|Chloroquine|chloroquine|mesh-list
14363669|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14363670|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363671|NCT01103713|Amebicides|amebicides|mesh-ancestor
14363672|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14363673|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14363674|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
14363675|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363676|NCT01103778|Bortezomib|bortezomib|mesh-list
14363677|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363678|NCT01103934|Vitamin D|vitamin d|mesh-list
14363679|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
14363680|NCT01103934|Fluticasone|fluticasone|mesh-list
14363681|NCT01103934|Xhance|xhance|mesh-list
14363682|NCT01103934|Vitamins|vitamins|mesh-ancestor
14363683|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
14363684|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363685|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14363686|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14363687|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14363688|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
14363689|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363690|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14363691|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
14363692|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
14363693|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14363694|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14363695|NCT01103960|Amlodipine|amlodipine|mesh-list
14363696|NCT01103960|Telmisartan|telmisartan|mesh-list
14363697|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363698|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14363699|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363700|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363701|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14363702|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363703|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
14363704|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14363705|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14363706|NCT01104025|Dexamethasone|dexamethasone|mesh-list
14363707|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
14363708|NCT01104025|Methotrexate|methotrexate|mesh-list
14363709|NCT01104025|Etoposide|etoposide|mesh-list
14363710|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
14363711|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14363712|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
14363713|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
14363714|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363715|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363716|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14363717|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
14363718|NCT01104025|Hormones|hormones|mesh-ancestor
14363719|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363720|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14363721|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363722|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14363723|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
14363724|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14363725|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14363726|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
14363727|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363728|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
14363729|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363730|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14363731|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363732|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
14363733|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363734|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14363735|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14363736|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14363737|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14363738|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14363739|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363740|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14363741|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363742|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363743|NCT01104246|Testosterone|testosterone|mesh-list
14363744|NCT01104246|Androgens|androgens|mesh-ancestor
14363745|NCT01104246|Hormones|hormones|mesh-ancestor
14363746|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363747|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363748|NCT01104376|Efavirenz|efavirenz|mesh-list
14363749|NCT01104376|Voriconazole|voriconazole|mesh-list
14363750|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14363751|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14363752|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363753|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363754|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
14363755|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363756|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14363757|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14363758|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14363759|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14363760|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14363761|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14363762|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
14363763|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14363764|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14363765|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
14363766|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363767|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363768|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14465719|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14363769|NCT01104558|Bisoprolol|bisoprolol|mesh-list
14363770|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363771|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
14363772|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
14363773|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363774|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363775|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14363776|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14363777|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14363778|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
14363779|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363780|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363781|NCT01104636|Varenicline|varenicline|mesh-list
14363782|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14363783|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14363784|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14363785|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363786|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363787|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363788|NCT01104662|Vancomycin|vancomycin|mesh-list
14363789|NCT01104662|Daptomycin|daptomycin|mesh-list
14363790|NCT01104662|Penicillins|penicillins|mesh-list
14363791|NCT01104662|Cloxacillin|cloxacillin|mesh-list
14363792|NCT01104662|Oxacillin|oxacillin|mesh-list
14363793|NCT01104662|Nafcillin|nafcillin|mesh-list
14363794|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14363795|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363796|NCT01104701|Exenatide|exenatide|mesh-list
14363797|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14363798|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363799|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14363800|NCT01104701|Incretins|incretins|mesh-ancestor
14363801|NCT01104701|Hormones|hormones|mesh-ancestor
14363802|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363803|NCT01104766|Aripiprazole|aripiprazole|mesh-list
14363804|NCT01104766|Cariprazine|cariprazine|mesh-list
14363805|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
14363806|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14363807|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14363808|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14363809|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363810|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363811|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
14363812|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
14363813|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363814|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363815|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14363816|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15232897|NCT03852459|Analgesics|analgesics|mesh-ancestor
15232898|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
15232899|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232900|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232901|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232902|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15232903|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15232904|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232905|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232906|NCT03849768|Gefitinib|gefitinib|mesh-list
15232907|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232908|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15232909|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232910|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232911|NCT03828799|Folfirinox|folfirinox|mesh-list
15232912|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232913|NCT03824808|Lidocaine|lidocaine|mesh-list
15232914|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
15232915|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
15232916|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232917|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232918|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
15232919|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232920|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15232921|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14363817|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
14363818|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14363819|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14363820|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14363821|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14363822|NCT01104779|Cariprazine|cariprazine|mesh-list
14363823|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14363824|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14363825|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363826|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363827|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14363828|NCT01104792|Cariprazine|cariprazine|mesh-list
14363829|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14363830|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14363831|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363832|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363833|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14363834|NCT01104870|Treprostinil|treprostinil|mesh-list
14363835|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363836|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14363837|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363838|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14363839|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14363840|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14363841|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14363842|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363843|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363844|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363845|NCT01105091|Epoprostenol|epoprostenol|mesh-list
14363846|NCT01105091|Tezosentan|tezosentan|mesh-list
14363847|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363848|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14363849|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
14363850|NCT01105117|Epoprostenol|epoprostenol|mesh-list
14363851|NCT01105117|Tezosentan|tezosentan|mesh-list
14363852|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363853|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14363854|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
14363855|NCT01105312|Letrozole|letrozole|mesh-list
14363856|NCT01105312|Panobinostat|panobinostat|mesh-list
14363857|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363858|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14363859|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14363860|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363861|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363862|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14363863|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
14363864|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363865|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363866|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14363867|NCT01105377|Azacitidine|azacitidine|mesh-list
14363868|NCT01105377|Entinostat|entinostat|mesh-list
14363869|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14363870|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14363871|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
14363872|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363873|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363874|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363875|NCT01105650|Cyclosporine|cyclosporine|mesh-list
14363876|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
14363877|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14363878|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14732752|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732753|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732754|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14732755|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732756|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14732757|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732758|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732759|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14732760|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
15232922|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14363879|NCT01105650|Prednisolone|prednisolone|mesh-list
14363880|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
14363881|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
14363882|NCT01105650|Fludarabine|fludarabine|mesh-list
14363883|NCT01105650|Interleukin-2|interleukin-2|mesh-list
14363884|NCT01105650|Cyclosporins|cyclosporins|mesh-list
14363885|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14363886|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
14363887|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363888|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
14363889|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363890|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14363891|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14363892|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
14363893|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363894|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363895|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14363896|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363897|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
14363898|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363899|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
14363900|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14363901|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14363902|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
14363903|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
14363904|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363905|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232923|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232924|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363906|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
14363907|NCT01105650|Hormones|hormones|mesh-ancestor
14465720|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
14363908|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14363909|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14363910|NCT01105650|Protective Agents|protective agents|mesh-ancestor
14363911|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14363912|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14363913|NCT01105650|Analgesics|analgesics|mesh-ancestor
14363914|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
14363915|NCT01105702|Bevacizumab|bevacizumab|mesh-list
14363916|NCT01105702|Temozolomide|temozolomide|mesh-list
14363917|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
14363918|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14363919|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363920|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14363921|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14363922|NCT01105702|Growth Substances|growth substances|mesh-ancestor
14363923|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363924|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
14363925|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14363926|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
14363927|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363928|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
14363929|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14363930|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363931|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
14363932|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14363933|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14363934|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
14363935|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14363936|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14363937|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14363938|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
14363939|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14363940|NCT01105936|Acetaminophen|acetaminophen|mesh-list
14363941|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14363942|NCT01105936|Analgesics|analgesics|mesh-ancestor
14363943|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
14363944|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14363945|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363946|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
14363947|NCT01105975|Atorvastatin|atorvastatin|mesh-list
14363948|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14363949|NCT01105975|Simvastatin|simvastatin|mesh-list
14363950|NCT01105975|Evacetrapib|evacetrapib|mesh-list
14363951|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14363952|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14363953|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
14363954|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363955|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14363956|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14363957|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363958|NCT01106014|Selexipag|selexipag|mesh-list
14363959|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14363960|NCT01106027|Eculizumab|eculizumab|mesh-list
14363961|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14363962|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363963|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
14363964|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363965|NCT01106092|Vaccines|vaccines|mesh-list
14363966|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
14363967|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363968|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
14363969|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
14363970|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363971|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14363972|NCT01106352|Docetaxel|docetaxel|mesh-list
14363973|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14363974|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14363975|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
14363976|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
14363977|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
14363978|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363979|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14363980|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14363981|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14363982|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14363983|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14363984|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363985|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
14363986|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14363987|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14363988|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14363989|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14363990|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
14363991|NCT01106586|Ritonavir|ritonavir|mesh-list
14363992|NCT01106586|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14363993|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14363994|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14363995|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14363996|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
14363997|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14363998|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14363999|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14364000|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14364001|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
14364002|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364003|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14364004|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14364005|NCT01106586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14364006|NCT01106586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14364007|NCT01106625|Metformin|metformin|mesh-list
14364008|NCT01106625|Canagliflozin|canagliflozin|mesh-list
14364009|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364010|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364011|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14364012|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364013|NCT01106651|Canagliflozin|canagliflozin|mesh-list
14364014|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14364015|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14364016|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364017|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364018|NCT01106677|Metformin|metformin|mesh-list
14732761|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732762|NCT04107675|Cyclosporine|cyclosporine|mesh-list
14732763|NCT04107675|Cyclosporins|cyclosporins|mesh-list
14732764|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732765|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732766|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732767|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
14364019|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14364020|NCT01106677|Canagliflozin|canagliflozin|mesh-list
14364021|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364022|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364023|NCT01106677|Incretins|incretins|mesh-ancestor
14364024|NCT01106677|Hormones|hormones|mesh-ancestor
14364025|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364026|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14364027|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
14364028|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364029|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364030|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14364031|NCT01106690|Metformin|metformin|mesh-list
14364032|NCT01106690|Pioglitazone|pioglitazone|mesh-list
14364033|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14364034|NCT01106690|Canagliflozin|canagliflozin|mesh-list
14364035|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364036|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364037|NCT01106690|Incretins|incretins|mesh-ancestor
14364038|NCT01106690|Hormones|hormones|mesh-ancestor
14364039|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364040|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14364041|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
14364042|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364043|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364044|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14364045|NCT01106833|Sirolimus|sirolimus|mesh-list
14364046|NCT01106833|Prednisone|prednisone|mesh-list
14364047|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14364048|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14364049|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
14364050|NCT01106833|Hormones|hormones|mesh-ancestor
14364051|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364052|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364053|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14364054|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364055|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364056|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364057|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14364058|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
14364059|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14364060|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
14364061|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364062|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364063|NCT01106846|Ketamine|ketamine|mesh-list
14364064|NCT01106846|Analgesics|analgesics|mesh-ancestor
14364065|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
14364066|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232925|NCT03808610|Cytarabine|cytarabine|mesh-list
14364067|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364068|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14364069|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14364070|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
14364071|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
14364072|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364073|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14364074|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14364075|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364076|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364077|NCT01106859|Zolpidem|zolpidem|mesh-list
14364078|NCT01106859|Zopiclone|zopiclone|mesh-list
14364079|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14364080|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14364081|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364082|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364083|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14364084|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
14364085|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
14364086|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364087|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364088|NCT01106898|Paclitaxel|paclitaxel|mesh-list
14364089|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
14364090|NCT01106898|Trastuzumab|trastuzumab|mesh-list
14364091|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14364092|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364093|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14364094|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14364095|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14364096|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364097|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14364098|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
14364099|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364100|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14364101|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364102|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
14920622|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14364103|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14364104|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14364105|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
14364106|NCT01106950|Fludarabine|fludarabine|mesh-list
14364107|NCT01106950|Interleukin-2|interleukin-2|mesh-list
14364108|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
14364109|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14364110|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
14364111|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364112|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14364113|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364114|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
14364115|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364116|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364117|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14364118|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14364119|NCT01106950|Analgesics|analgesics|mesh-ancestor
14364120|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
14364121|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364122|NCT01107353|Imipramine|imipramine|mesh-list
14364123|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14364124|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14364125|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364126|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14364127|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14364128|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364129|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364130|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
14364131|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364132|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364133|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
14364134|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14364135|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14364136|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14364137|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364138|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364139|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
14364140|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364141|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364142|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14364143|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364144|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14364145|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14364146|NCT01107444|Docetaxel|docetaxel|mesh-list
14364147|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364148|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
14364149|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
14364150|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
14364151|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364152|NCT01107457|Ixekizumab|ixekizumab|mesh-list
14364153|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14364154|NCT01107535|Palivizumab|palivizumab|mesh-list
14364155|NCT01107535|Antibodies|antibodies|mesh-list
14364156|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14364157|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
14364158|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364159|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
14364160|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364161|NCT01107626|Paclitaxel|paclitaxel|mesh-list
14364162|NCT01107626|Bevacizumab|bevacizumab|mesh-list
14364163|NCT01107626|Carboplatin|carboplatin|mesh-list
14364164|NCT01107626|Pemetrexed|pemetrexed|mesh-list
14364165|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14364166|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364167|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14364168|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14364169|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14364170|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364171|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14364172|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14364173|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14364174|NCT01107626|Growth Substances|growth substances|mesh-ancestor
14364175|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364176|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
14364177|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364178|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14364179|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14364180|NCT01107665|Paclitaxel|paclitaxel|mesh-list
14364181|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14364182|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364183|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
14364184|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
14364185|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14364186|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364187|NCT01107730|Ascorbic Acid|ascorbic acid|mesh-list
14364188|NCT01107730|Vitamins|vitamins|mesh-ancestor
14732768|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232926|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
15232927|NCT03808610|Dexamethasone|dexamethasone|mesh-list
15232928|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
15232929|NCT03808610|Prednisone|prednisone|mesh-list
15232930|NCT03808610|Cortisone|cortisone|mesh-list
15232931|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
15232932|NCT03808610|Rituximab|rituximab|mesh-list
15232933|NCT03808610|Methotrexate|methotrexate|mesh-list
15232934|NCT03808610|Vincristine|vincristine|mesh-list
15232935|NCT03808610|Asparaginase|asparaginase|mesh-list
15232936|NCT03808610|Venetoclax|venetoclax|mesh-list
15232937|NCT03808610|Pegaspargase|pegaspargase|mesh-list
15232938|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15232939|NCT03808610|Antibodies|antibodies|mesh-list
14364189|NCT01107730|Micronutrients|micronutrients|mesh-ancestor
14364190|NCT01107730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364191|NCT01107730|Antioxidants|antioxidants|mesh-ancestor
14364192|NCT01107730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364193|NCT01107730|Protective Agents|protective agents|mesh-ancestor
14364194|NCT01107743|Amlodipine|amlodipine|mesh-list
14364195|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
14364196|NCT01107743|Atorvastatin|atorvastatin|mesh-list
14364197|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14364198|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14364199|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
14364200|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364201|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14364202|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14364203|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364204|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14364205|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14364206|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364207|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14364208|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364209|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
14364210|NCT01107886|Saxagliptin|saxagliptin|mesh-list
14364211|NCT01107886|Incretins|incretins|mesh-ancestor
14364212|NCT01107886|Hormones|hormones|mesh-ancestor
14364213|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364214|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364215|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14364216|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
14364217|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920623|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14920624|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14920625|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14920626|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
14920627|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920628|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14920629|NCT04551430|Nivolumab|nivolumab|mesh-list
14920630|NCT04551430|Ipilimumab|ipilimumab|mesh-list
14920631|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920632|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920633|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14364218|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364219|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364220|NCT01107899|Clopidogrel|clopidogrel|mesh-list
14364221|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14364222|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14364223|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14364224|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14364225|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14364226|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
14364227|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732769|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
14732770|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732771|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
14732772|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732773|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14732774|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
14732775|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732776|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732777|NCT04091217|Bevacizumab|bevacizumab|mesh-list
14732778|NCT04091217|Atezolizumab|atezolizumab|mesh-list
14732779|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232940|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
15232941|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15232942|NCT03808610|BB 1101|bb 1101|mesh-list
15232943|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15232944|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
15232945|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232946|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15232947|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364228|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364229|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364230|NCT01107912|Clopidogrel|clopidogrel|mesh-list
14364231|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14364232|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14364233|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14364234|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14364235|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14364236|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
14364237|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364238|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364239|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364240|NCT01107925|Clopidogrel|clopidogrel|mesh-list
14364241|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14364242|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14364243|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14364244|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14364245|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14364246|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
14364247|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364248|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364249|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364250|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
14364251|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364252|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
14364253|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364254|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364255|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
14364256|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14364257|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364258|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364259|NCT01108094|Itraconazole|itraconazole|mesh-list
14364260|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
14364261|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364262|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14364263|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14364264|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364265|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364266|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14364267|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
14364268|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364269|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364270|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14364271|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14364272|NCT01108341|Ofatumumab|ofatumumab|mesh-list
14364273|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364274|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
14364275|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364276|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364277|NCT01108445|Everolimus|everolimus|mesh-list
15232948|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
15232949|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232950|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15232951|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14364278|NCT01108445|Sunitinib|sunitinib|mesh-list
14364279|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364280|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15232952|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15232953|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
15232954|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
15232955|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232956|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15232957|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
15232958|NCT03808610|Hormones|hormones|mesh-ancestor
15232959|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15232960|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15232961|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
15232962|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15232963|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15232964|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
14732780|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732781|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14732782|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14732783|NCT04091217|Growth Substances|growth substances|mesh-ancestor
14732784|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732785|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
14364281|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
14364282|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364283|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14364284|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14364285|NCT01108445|Growth Substances|growth substances|mesh-ancestor
14732786|NCT04085458|Factor VIII|factor viii|mesh-list
14732787|NCT04085458|Coagulants|coagulants|mesh-ancestor
14732788|NCT04067726|Vitamin D|vitamin d|mesh-list
14732789|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
14732790|NCT04067726|Denosumab|denosumab|mesh-list
14732791|NCT04067726|Calcium|calcium|mesh-list
14732792|NCT04067726|Vitamins|vitamins|mesh-ancestor
14732793|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
14732794|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732795|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14732796|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15232965|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15232966|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15232967|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
15232968|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
15232969|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15232970|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15232971|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
15232972|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15232973|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15232974|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
15232975|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
15232976|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
15232977|NCT03797560|Pregabalin|pregabalin|mesh-list
15232978|NCT03797560|Analgesics|analgesics|mesh-ancestor
14364286|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
14364287|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14364288|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364289|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364290|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14364291|NCT01108458|Pertuzumab|pertuzumab|mesh-list
14364292|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364293|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14364294|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364295|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364296|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14364297|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14364298|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14364299|NCT01108510|Cobicistat|cobicistat|mesh-list
14364300|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14364301|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14364302|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364303|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364304|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
14364305|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364306|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14364307|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14364308|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14364309|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14364310|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
14364311|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14364312|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14364313|NCT01108731|Milnacipran|milnacipran|mesh-list
14364314|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
14465721|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14465722|NCT02230306|Vemurafenib|vemurafenib|mesh-list
15232979|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
14465723|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465724|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14465725|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465726|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465727|NCT02230332|Alendronate|alendronate|mesh-list
14465728|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14364315|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14364316|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14364317|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364318|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364319|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364320|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364321|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14364322|NCT01108731|Analgesics|analgesics|mesh-ancestor
14364323|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
14364324|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364325|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
14364326|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364327|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14364328|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14364329|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364330|NCT01108757|Renal Agents|renal agents|mesh-ancestor
14364331|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364332|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
14364333|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14364334|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14364335|NCT01108809|Telmisartan|telmisartan|mesh-list
14364336|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14364337|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14364338|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14364339|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364340|NCT01109056|Cyclosporine|cyclosporine|mesh-list
14364341|NCT01109056|Cyclosporins|cyclosporins|mesh-list
14364342|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364343|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364344|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14364345|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
14364346|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364347|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
14364348|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364349|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14364350|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15232980|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15232981|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232982|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
15232983|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15232984|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15232985|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15232986|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14364351|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14364352|NCT01109173|Nepafenac|nepafenac|mesh-list
14364353|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14364354|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14364355|NCT01109173|Analgesics|analgesics|mesh-ancestor
14364356|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
14364357|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364358|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364359|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14364360|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14364361|NCT01109316|Insulin|insulin|mesh-list
14364362|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14364363|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
14364364|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
14364365|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364366|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364367|NCT01109524|Cetuximab|cetuximab|mesh-list
14364368|NCT01109524|Vinorelbine|vinorelbine|mesh-list
14364369|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364370|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15232987|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15232988|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15232989|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15232990|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15232991|NCT03740919|Insulin|insulin|mesh-list
15232992|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15232993|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
15232994|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
15232995|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15232996|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15232997|NCT03737565|Tryptophan|tryptophan|mesh-list
15232998|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15232999|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
15233000|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15233001|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
15233002|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15233003|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233004|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233005|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15233006|NCT03708315|Analgesics|analgesics|mesh-ancestor
15233007|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
15233008|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233009|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15233010|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15233011|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15233012|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
15233013|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233014|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233015|NCT03700970|Bupivacaine|bupivacaine|mesh-list
15233016|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
15233017|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
15233018|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233019|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233020|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
15233021|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233022|NCT03686345|Midostaurin|midostaurin|mesh-list
15233023|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233024|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233025|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233026|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233027|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
15233028|NCT03684590|Narcotics|narcotics|mesh-ancestor
14364371|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14364372|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
14364373|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
14364374|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
14364375|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364376|NCT01109849|Methylphenidate|methylphenidate|mesh-list
14364377|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
14364378|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364379|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14364380|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14364381|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364382|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364383|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
14364384|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465729|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465730|NCT02230527|Clopidogrel|clopidogrel|mesh-list
14465731|NCT02230527|Ticagrelor|ticagrelor|mesh-list
14465732|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14465733|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14465734|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14465735|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14465736|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
14465737|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465738|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465739|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465740|NCT02230696|Fluticasone|fluticasone|mesh-list
14465741|NCT02230696|Xhance|xhance|mesh-list
14465742|NCT02230696|Azelastine|azelastine|mesh-list
14465743|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465744|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14465745|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
14465746|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465747|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465748|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14465749|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
14465750|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
14465751|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14465752|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14465753|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465754|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465755|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14465756|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14465757|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
14465758|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
14465759|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465760|NCT02230904|Rotigotine|rotigotine|mesh-list
14364385|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14364386|NCT01109979|Drospirenone|drospirenone|mesh-list
14364387|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14364388|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14364389|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
14364390|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14364391|NCT01109979|Estradiol|estradiol|mesh-list
14364392|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14364393|NCT01109979|Estrogens|estrogens|mesh-ancestor
14364394|NCT01109979|Hormones|hormones|mesh-ancestor
14364395|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364396|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364397|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14364398|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
14364399|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14364400|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14364401|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14364402|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14364403|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14364404|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14364405|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14364406|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364407|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14364408|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
14364409|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14364410|NCT01109979|Diuretics|diuretics|mesh-ancestor
14364411|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
14364412|NCT01109992|Regadenoson|regadenoson|mesh-list
14364413|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14364414|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14364415|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
14364416|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
14364417|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364418|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364419|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364420|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14364421|NCT01110135|Dexamethasone|dexamethasone|mesh-list
14364422|NCT01110135|Etoposide|etoposide|mesh-list
14364423|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
14364424|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14364425|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14364426|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
14364427|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
14364428|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364429|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364430|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14364431|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
14364432|NCT01110135|Hormones|hormones|mesh-ancestor
14364433|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364434|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14364435|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364436|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14364437|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14364438|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14364439|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364440|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364441|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364442|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
14364443|NCT01110187|Lacosamide|lacosamide|mesh-list
14364444|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
14364445|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
14364446|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14364447|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14364448|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364449|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364450|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14364451|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14364452|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14364453|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
14364454|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364455|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364456|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14364457|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
14364458|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14364459|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14364460|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14364461|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
14364462|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364463|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364464|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
14364465|NCT01110200|Hormones|hormones|mesh-ancestor
14364466|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364467|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
14364468|NCT01110330|Ketoconazole|ketoconazole|mesh-list
14364469|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
14364470|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364471|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14364472|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14364473|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364474|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364475|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14364476|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
14364477|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364478|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364479|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14364480|NCT01110382|Amoxicillin|amoxicillin|mesh-list
14364481|NCT01110382|Meropenem|meropenem|mesh-list
14364482|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
14364483|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
14364484|NCT01110382|Doripenem|doripenem|mesh-list
14465761|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
14364485|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14364486|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364487|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364488|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14364489|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364490|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364491|NCT01110408|Amoxicillin|amoxicillin|mesh-list
14364492|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
14364493|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
14364494|NCT01110408|Cefepime|cefepime|mesh-list
14364495|NCT01110408|Doripenem|doripenem|mesh-list
14364496|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14364497|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364498|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364499|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14364500|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364501|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364502|NCT01110421|Amoxicillin|amoxicillin|mesh-list
14364503|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
14364504|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
14920634|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233029|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364505|NCT01110421|Cefepime|cefepime|mesh-list
14364506|NCT01110421|Doripenem|doripenem|mesh-list
14364507|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14364508|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364509|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364510|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14364511|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364512|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233030|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233031|NCT03684590|Analgesics|analgesics|mesh-ancestor
15233032|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
15233033|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233034|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
15233035|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233036|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364513|NCT01110434|Topiramate|topiramate|mesh-list
14364514|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
14364515|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364516|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364517|NCT01110499|Bimatoprost|bimatoprost|mesh-list
14364518|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14364519|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14364520|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14364521|NCT01110707|Hormones|hormones|mesh-list
14364522|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14364523|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364524|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364525|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14364526|NCT01110876|Temozolomide|temozolomide|mesh-list
14364527|NCT01110876|Vorinostat|vorinostat|mesh-list
14364528|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364529|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14364530|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364531|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364532|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364533|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
14364534|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14920635|NCT04544475|Estrogens|estrogens|mesh-list
14920636|NCT04544475|Estradiol|estradiol|mesh-list
14920637|NCT04544475|Hormones|hormones|mesh-ancestor
14920638|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920639|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920640|NCT04543682|Iloprost|iloprost|mesh-list
14920641|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14920642|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
14920643|NCT04530981|Repaglinide|repaglinide|mesh-list
15233037|NCT03672643|Crizotinib|crizotinib|mesh-list
15233038|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920644|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14920645|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920646|NCT04530006|Amantadine|amantadine|mesh-list
14364535|NCT01111058|Everolimus|everolimus|mesh-list
14364536|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364537|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14364538|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
14364539|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364540|NCT01111123|Halobetasol|halobetasol|mesh-list
14364541|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14364542|NCT01111149|Bupropion|bupropion|mesh-list
14364543|NCT01111149|Varenicline|varenicline|mesh-list
14364544|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14364545|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
14364546|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364547|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14364548|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14364549|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364550|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364551|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
14364552|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364553|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364554|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14364555|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14364556|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364557|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14364558|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14364559|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
14364560|NCT01111162|Vaccines|vaccines|mesh-list
14364561|NCT01111162|Immunologic Factors|immunologic factors|mesh-ancestor
14364562|NCT01111162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364563|NCT01111292|Inositol|inositol|mesh-list
14364564|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
14364565|NCT01111292|Vitamins|vitamins|mesh-ancestor
14364566|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
14364567|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364568|NCT01111318|Empagliflozin|empagliflozin|mesh-list
14364569|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465762|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
15233039|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233040|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233041|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233042|NCT03647488|Docetaxel|docetaxel|mesh-list
15233043|NCT03647488|Spartalizumab|spartalizumab|mesh-list
15233044|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233045|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
15233046|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
15233047|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
15233048|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233049|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15233050|NCT03635164|Durvalumab|durvalumab|mesh-list
15233051|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233052|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233053|NCT03632759|Liraglutide|liraglutide|mesh-list
15233054|NCT03632759|Golimumab|golimumab|mesh-list
15233055|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233056|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233057|NCT03632759|Incretins|incretins|mesh-ancestor
14364570|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364571|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364572|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364573|NCT01111331|Empagliflozin|empagliflozin|mesh-list
14364574|NCT01111331|Warfarin|warfarin|mesh-list
14364575|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
14364576|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14364577|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364578|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364579|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364580|NCT01111461|Lenvatinib|lenvatinib|mesh-list
14364581|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364582|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14364583|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364584|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364585|NCT01111526|Panobinostat|panobinostat|mesh-list
14364586|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364587|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14364588|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364589|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364590|NCT01111539|Aripiprazole|aripiprazole|mesh-list
14364591|NCT01111539|Citalopram|citalopram|mesh-list
14364592|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14364593|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14364594|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364595|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364596|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364597|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
14364598|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364599|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14364600|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
14364601|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364602|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14364603|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14364604|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364605|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
14364606|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
14920647|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15233058|NCT03632759|Hormones|hormones|mesh-ancestor
15233059|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233060|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15233061|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233062|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233063|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
15233064|NCT03618537|Dexamethasone|dexamethasone|mesh-list
15233065|NCT03618537|Ixazomib|ixazomib|mesh-list
15233066|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233067|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
15233068|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
15233069|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233070|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233071|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14364607|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14364608|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14364609|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14364610|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14364611|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14364612|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14364613|NCT01111552|Aripiprazole|aripiprazole|mesh-list
14364614|NCT01111552|Citalopram|citalopram|mesh-list
14364615|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14364616|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14364617|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364618|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364619|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732797|NCT04050436|Cemiplimab|cemiplimab|mesh-list
14732798|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732799|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732800|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
14732801|NCT04049799|Narcotics|narcotics|mesh-ancestor
14732802|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732803|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732804|NCT04049799|Analgesics|analgesics|mesh-ancestor
14732805|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
14732806|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732807|NCT04049084|Adenosine|adenosine|mesh-list
14364620|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
14364621|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364622|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14364623|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
14364624|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364625|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14364626|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14364627|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364628|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
14364629|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
14364630|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14364631|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14364632|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14364633|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14364634|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14364635|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14364636|NCT01111604|Ramucirumab|ramucirumab|mesh-list
14364637|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364638|NCT01111825|Sirolimus|sirolimus|mesh-list
14364639|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364640|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364641|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14364642|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364643|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
14364644|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14364645|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
14364646|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364647|NCT01111851|Dexamethasone|dexamethasone|mesh-list
14364648|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
14364649|NCT01111851|Ondansetron|ondansetron|mesh-list
14364650|NCT01111851|Aprepitant|aprepitant|mesh-list
14364651|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
14364652|NCT01111851|BB 1101|bb 1101|mesh-list
14364653|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14364654|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
14364655|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
14364656|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364657|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364658|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14364659|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
14364660|NCT01111851|Hormones|hormones|mesh-ancestor
14364661|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364662|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14364663|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364664|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
14364665|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364666|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732808|NCT04049084|Analgesics|analgesics|mesh-ancestor
14732809|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
14364667|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
14732810|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364668|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
14364669|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14364670|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
14364671|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364672|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14364673|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14364674|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364675|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364676|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14364677|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14364678|NCT01112059|Doxycycline|doxycycline|mesh-list
14364679|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364680|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364681|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
14364682|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14364683|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14364684|NCT01112241|Albuterol|albuterol|mesh-list
14364685|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
14364686|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14364687|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
14364688|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364689|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364690|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14364691|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
14364692|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
14364693|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14364694|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
14364695|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364696|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364697|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
14364698|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14364699|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14364700|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14364701|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14364702|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
14364703|NCT01112267|Acetaminophen|acetaminophen|mesh-list
14364704|NCT01112267|Tramadol|tramadol|mesh-list
14364705|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14364706|NCT01112267|Analgesics|analgesics|mesh-ancestor
14364707|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
14364708|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364709|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364710|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
14364711|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14364712|NCT01112267|Narcotics|narcotics|mesh-ancestor
14364713|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364714|NCT01112358|Cetrorelix|cetrorelix|mesh-list
14364715|NCT01112358|Progesterone|progesterone|mesh-list
14364716|NCT01112358|Progestins|progestins|mesh-ancestor
14364717|NCT01112358|Hormones|hormones|mesh-ancestor
14364718|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732811|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732812|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14732813|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
14732814|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14732815|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
14732816|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
14732817|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364719|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364720|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14364721|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
14364722|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14364723|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
14364724|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14364725|NCT01112670|Atorvastatin|atorvastatin|mesh-list
14364726|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14364727|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14364728|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
14364729|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364730|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14364731|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14364732|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364733|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14364734|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364735|NCT01112670|Incretins|incretins|mesh-ancestor
14364736|NCT01112670|Hormones|hormones|mesh-ancestor
14364737|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364738|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14364739|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
14364740|NCT01112683|Memantine|memantine|mesh-list
14364741|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14364742|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14364743|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
14364744|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364745|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364746|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364747|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14364748|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14364749|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14364750|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
14364751|NCT01112735|Coagulants|coagulants|mesh-ancestor
14364752|NCT01112982|Colchicine|colchicine|mesh-list
14364753|NCT01112982|Febuxostat|febuxostat|mesh-list
14364754|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
14364755|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14364756|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14364757|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14364758|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14364759|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364760|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364761|NCT01113398|Bevacizumab|bevacizumab|mesh-list
14364762|NCT01113398|Rilotumumab|rilotumumab|mesh-list
14364763|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14364764|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364765|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14364766|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14364767|NCT01113398|Growth Substances|growth substances|mesh-ancestor
14364768|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364769|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
14364770|NCT01113541|Ziprasidone|ziprasidone|mesh-list
14364771|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14364772|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
14364773|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364774|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364775|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364776|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14364777|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14364778|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364779|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14364780|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14364781|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
14364782|NCT01113632|Ofatumumab|ofatumumab|mesh-list
14364783|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364784|NCT01113710|Rotigotine|rotigotine|mesh-list
14364785|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
14364786|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
14364787|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364788|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364789|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364790|NCT01113931|Doxycycline|doxycycline|mesh-list
14364791|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14364792|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364793|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
14364794|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14364795|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14364796|NCT01114360|Melatonin|melatonin|mesh-list
14364797|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
14364798|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364799|NCT01114360|Protective Agents|protective agents|mesh-ancestor
14364800|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364801|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364802|NCT01114373|Melatonin|melatonin|mesh-list
14364803|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
14364804|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364805|NCT01114373|Protective Agents|protective agents|mesh-ancestor
14364806|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364807|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364808|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
14364809|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14364810|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14364811|NCT01114503|Prednisolone|prednisolone|mesh-list
14364812|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
14364813|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14364814|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
14364815|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14364816|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
14364817|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
14364818|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364819|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364820|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14364821|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
14920648|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14920649|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
14920650|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364822|NCT01114503|Hormones|hormones|mesh-ancestor
14364823|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14364824|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14364825|NCT01114503|Protective Agents|protective agents|mesh-ancestor
14364826|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14364827|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364828|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14364829|NCT01114516|Clindamycin|clindamycin|mesh-list
14364830|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
14364831|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
14364832|NCT01114516|Cefazolin|cefazolin|mesh-list
14364833|NCT01114516|Indomethacin|indomethacin|mesh-list
14364834|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364835|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14364836|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364837|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364838|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14364839|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14364840|NCT01114516|Analgesics|analgesics|mesh-ancestor
14364841|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
14364842|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364843|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364844|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14364845|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14364846|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
14364847|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
14364848|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14364849|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14364850|NCT01114529|Cyclosporine|cyclosporine|mesh-list
14364851|NCT01114529|Everolimus|everolimus|mesh-list
14364852|NCT01114529|Tacrolimus|tacrolimus|mesh-list
14364853|NCT01114529|Cyclosporins|cyclosporins|mesh-list
14364854|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14364855|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
14364856|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364857|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14364858|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364859|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364860|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
14364861|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14364862|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
14364863|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14364864|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364865|NCT01114555|Bevacizumab|bevacizumab|mesh-list
14364866|NCT01114555|Irinotecan|irinotecan|mesh-list
14364867|NCT01114555|Temozolomide|temozolomide|mesh-list
14364868|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14364869|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364870|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14364871|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14364872|NCT01114555|Growth Substances|growth substances|mesh-ancestor
14364873|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364874|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
14364875|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14364876|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14364877|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14364878|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364879|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364880|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
14364881|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
14364882|NCT01114581|Guaifenesin|guaifenesin|mesh-list
14364883|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14364884|NCT01114581|Expectorants|expectorants|mesh-ancestor
14364885|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
14732818|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364886|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14364887|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14364888|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14364889|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732819|NCT04033419|Memantine|memantine|mesh-list
14732820|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14732821|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14364890|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364891|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364892|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
14364893|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14364894|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
14364895|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
14364896|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364897|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
14364898|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14364899|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
14364900|NCT01114672|Vitamin D|vitamin d|mesh-list
14364901|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14364902|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364903|NCT01114672|Vitamins|vitamins|mesh-ancestor
14364904|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
14364905|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14364906|NCT01114737|Verapamil|verapamil|mesh-list
14364907|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14364908|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14364909|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364910|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364911|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14364912|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364913|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
14364914|NCT01114828|Tolvaptan|tolvaptan|mesh-list
14364915|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14364916|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364917|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
14364918|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364919|NCT01114880|Adalimumab|adalimumab|mesh-list
14364920|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14364921|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14364922|NCT01114893|Travoprost|travoprost|mesh-list
14364923|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14364924|NCT01114971|Labetalol|labetalol|mesh-list
14364925|NCT01114971|Fentanyl|fentanyl|mesh-list
14364926|NCT01114971|Esmolol|esmolol|mesh-list
14364927|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14364928|NCT01114971|Narcotics|narcotics|mesh-ancestor
14364929|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364930|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364931|NCT01114971|Analgesics|analgesics|mesh-ancestor
14364932|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
14364933|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364934|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14364935|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14364936|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
14364937|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
14364938|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14364939|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14364940|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14364941|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
14732822|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
15233072|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
15233073|NCT03618537|Hormones|hormones|mesh-ancestor
15233074|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233075|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15233076|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233077|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
15233078|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233079|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732823|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732824|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364942|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364943|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364944|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14364945|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
14364946|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
14364947|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14364948|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14364949|NCT01114997|Lidocaine|lidocaine|mesh-list
14364950|NCT01114997|Esmolol|esmolol|mesh-list
14364951|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
14364952|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
14364953|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364954|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364955|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
14364956|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364957|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14364958|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14364959|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14364960|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14364961|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364962|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14364963|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14364964|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14364965|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
14364966|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14364967|NCT01115101|Pirinitramide|pirinitramide|mesh-list
14364968|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14364969|NCT01115101|Narcotics|narcotics|mesh-ancestor
14364970|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14364971|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364972|NCT01115101|Analgesics|analgesics|mesh-ancestor
14364973|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
14364974|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14364975|NCT01115491|Bevacizumab|bevacizumab|mesh-list
14364976|NCT01115491|Temozolomide|temozolomide|mesh-list
14364977|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14364978|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364979|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14364980|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14364981|NCT01115491|Growth Substances|growth substances|mesh-ancestor
14364982|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364983|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
14364984|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14364985|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
14364986|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14364987|NCT01115517|Bevacizumab|bevacizumab|mesh-list
14364988|NCT01115517|Mitomycins|mitomycins|mesh-list
14364989|NCT01115517|Mitomycin|mitomycin|mesh-list
14364990|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14364991|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14364992|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14364993|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14364994|NCT01115517|Growth Substances|growth substances|mesh-ancestor
14364995|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14364996|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
14364997|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14364998|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
14364999|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365000|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14365001|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365002|NCT01115556|Ranibizumab|ranibizumab|mesh-list
14365003|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14365004|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14365005|NCT01115556|Growth Substances|growth substances|mesh-ancestor
14365006|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365007|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
14365008|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365009|NCT01115569|Hydrocodone|hydrocodone|mesh-list
14365010|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14365011|NCT01115569|Narcotics|narcotics|mesh-ancestor
14365012|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365013|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365014|NCT01115569|Analgesics|analgesics|mesh-ancestor
14365015|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
14365016|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365017|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
14365018|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365019|NCT01115582|Cholic Acids|cholic acids|mesh-list
14365020|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365021|NCT01115673|Acetaminophen|acetaminophen|mesh-list
14365022|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14365023|NCT01115673|Analgesics|analgesics|mesh-ancestor
14365024|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
14365025|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365026|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365027|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
14365028|NCT01115738|Clopidogrel|clopidogrel|mesh-list
14365029|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14365030|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14365031|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14365032|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14365033|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14365034|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
14365035|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365036|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365037|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365038|NCT01115803|Everolimus|everolimus|mesh-list
14365039|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14365040|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365041|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365042|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
14365043|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365044|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14365045|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365046|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365047|NCT01115855|Eplerenone|eplerenone|mesh-list
14365048|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14365049|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
14365050|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365051|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365052|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14365053|NCT01115855|Diuretics|diuretics|mesh-ancestor
14365054|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
14365055|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14365056|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14365057|NCT01116401|Leuprolide|leuprolide|mesh-list
14365058|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14365059|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
14365060|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14365061|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365062|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14365063|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365064|NCT01116427|Abatacept|abatacept|mesh-list
14365065|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14365066|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365067|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365068|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365069|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
14365070|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365071|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365072|NCT01116687|R04929097|r04929097|mesh-list
14365073|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365074|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365075|NCT01116739|Fluorides|fluorides|mesh-list
14365076|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
14365077|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
14365078|NCT01116739|Protective Agents|protective agents|mesh-ancestor
14365079|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365080|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14365081|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365082|NCT01116986|Nicotine|nicotine|mesh-list
14365083|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14365084|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
14365085|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365086|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365087|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14365088|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14365089|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365090|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365091|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365092|NCT01117012|Ivacaftor|ivacaftor|mesh-list
14365093|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14365094|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365095|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365096|NCT01117051|Prucalopride|prucalopride|mesh-list
14365097|NCT01117051|Laxatives|laxatives|mesh-ancestor
14365098|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365099|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14365100|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14365101|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
14365102|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365103|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365104|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365105|NCT01117181|Methylphenidate|methylphenidate|mesh-list
14365106|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14365107|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365108|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14365109|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365110|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365111|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365112|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
14365113|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365114|NCT01117350|Metformin|metformin|mesh-list
14920651|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
14920652|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920653|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920654|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920655|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14732825|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732826|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14732827|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14732828|NCT04020172|Dobutamine|dobutamine|mesh-list
14732829|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14365115|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
14365116|NCT01117350|Liraglutide|liraglutide|mesh-list
14365117|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14365118|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365119|NCT01117350|Incretins|incretins|mesh-ancestor
14365120|NCT01117350|Hormones|hormones|mesh-ancestor
14365121|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365122|NCT01117454|Flecainide|flecainide|mesh-list
14365123|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14365124|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14365125|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
14365126|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365127|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365128|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365129|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14365130|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14365131|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14365132|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365133|NCT01117766|Pregabalin|pregabalin|mesh-list
14365134|NCT01117766|Analgesics|analgesics|mesh-ancestor
14365135|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
14365136|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365137|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365138|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
14365139|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14365140|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365141|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732830|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
14732831|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
14732832|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732833|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365142|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14365143|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14365144|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14365145|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365146|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365147|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14365148|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14365149|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365150|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365151|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365152|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365153|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365154|NCT01117857|Analgesics|analgesics|mesh-ancestor
14365155|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
14365156|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365157|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365158|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365159|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
14365160|NCT01117948|Lornoxicam|lornoxicam|mesh-list
14365161|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14365162|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14920656|NCT04530006|Analgesics|analgesics|mesh-ancestor
14920657|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
14920658|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365163|NCT01117948|Analgesics|analgesics|mesh-ancestor
14365164|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
14365165|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365166|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365167|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365168|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365169|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
14365170|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365171|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14365172|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365173|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365174|NCT01118091|Aldesleukin|aldesleukin|mesh-list
14365175|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365176|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14365177|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14365178|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
14365179|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365180|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
14365181|NCT01118273|Promethazine|promethazine|mesh-list
14365182|NCT01118273|Ibuprofen|ibuprofen|mesh-list
14365183|NCT01118273|Naproxen|naproxen|mesh-list
14365184|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365185|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15233080|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
15233081|NCT03615105|Melphalan|melphalan|mesh-list
15233082|NCT03615105|Busulfan|busulfan|mesh-list
15233083|NCT03615105|Thiotepa|thiotepa|mesh-list
14365186|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14365187|NCT01118273|Analgesics|analgesics|mesh-ancestor
14365188|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
14365189|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365190|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365191|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365192|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365193|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14365194|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920659|NCT04525755|Nicotine|nicotine|mesh-list
15233084|NCT03615105|Rituximab|rituximab|mesh-list
15233085|NCT03615105|Fludarabine|fludarabine|mesh-list
15233086|NCT03615105|Clofarabine|clofarabine|mesh-list
15233087|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15233088|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
15233089|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233090|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
15233091|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920660|NCT04525755|Varenicline|varenicline|mesh-list
15233092|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233093|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14365195|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
14365196|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14365197|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14365198|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365199|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
14365200|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
14365201|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
14365202|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
14365203|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365204|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14365205|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
14365206|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
14365207|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365208|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14365209|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
14365210|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
14365211|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
14365212|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365213|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14365214|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14365215|NCT01118325|Clopidogrel|clopidogrel|mesh-list
14365216|NCT01118325|Ticagrelor|ticagrelor|mesh-list
14365217|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14365218|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14365219|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14365220|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14365221|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
14365222|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365223|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365224|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365225|NCT01118351|Sunitinib|sunitinib|mesh-list
14365226|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365227|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14365228|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14365229|NCT01118351|Growth Substances|growth substances|mesh-ancestor
14365230|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365231|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
14365232|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14365233|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365234|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365235|NCT01118377|Capecitabine|capecitabine|mesh-list
14365236|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14365237|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
14920661|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14365238|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365239|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365240|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
14365241|NCT01118520|Amlodipine|amlodipine|mesh-list
14365242|NCT01118520|Perindopril|perindopril|mesh-list
14365243|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14365244|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14365245|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365246|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365247|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14365248|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365249|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
14365250|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14365251|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
14365252|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365253|NCT01118624|Vitamins|vitamins|mesh-list
14365254|NCT01118624|Folic Acid|folic acid|mesh-list
14365255|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
14365256|NCT01118624|Hydroxocobalamin|hydroxocobalamin|mesh-list
14365257|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
14365258|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14365259|NCT01118624|Aminopterin|aminopterin|mesh-list
14365260|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
14365261|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365262|NCT01118624|Hematinics|hematinics|mesh-ancestor
14365263|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14365264|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365265|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365266|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920662|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
14920663|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920664|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920665|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14920666|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14920667|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
14920668|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920669|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365267|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
14365268|NCT01118663|Edetic Acid|edetic acid|mesh-list
14365269|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14365270|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
14365271|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
14920670|NCT04516447|Gemcitabine|gemcitabine|mesh-list
15233094|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
15233095|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365272|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365273|NCT01118663|Expectorants|expectorants|mesh-ancestor
14365274|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365275|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14365276|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
14365277|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365278|NCT01118663|Protective Agents|protective agents|mesh-ancestor
14365279|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365280|NCT01118663|Antidotes|antidotes|mesh-ancestor
14365281|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
14365282|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14365283|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
14365284|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
14365285|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14365286|NCT01118741|Disulfiram|disulfiram|mesh-list
14732834|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14732835|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14732836|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14732837|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
14732838|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365287|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14365288|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14365289|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365290|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365291|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14365292|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14365293|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365294|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365295|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365296|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365297|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365298|NCT01118780|Analgesics|analgesics|mesh-ancestor
14732839|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732840|NCT04020172|Protective Agents|protective agents|mesh-ancestor
14732841|NCT04003103|Islatravir|islatravir|mesh-list
14732842|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
14732843|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920671|NCT04516447|Paclitaxel|paclitaxel|mesh-list
14920672|NCT04516447|Carboplatin|carboplatin|mesh-list
14365299|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
14365300|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365301|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365302|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365303|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
14365304|NCT01118845|Rituximab|rituximab|mesh-list
14365305|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14365306|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14365307|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365308|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
14365309|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365310|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732844|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920673|NCT04516447|Doxorubicin|doxorubicin|mesh-list
14920674|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14920675|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14920676|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233096|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233097|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233098|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233099|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233100|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
15233101|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
14920677|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
15233102|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14920678|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
14365311|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14365312|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
14365313|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365314|NCT01118949|Lacosamide|lacosamide|mesh-list
14365315|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
14365316|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14365317|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15233103|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
15233104|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15233105|NCT03613532|Fludarabine|fludarabine|mesh-list
15233106|NCT03613532|Azacitidine|azacitidine|mesh-list
15233107|NCT03613532|Busulfan|busulfan|mesh-list
15233108|NCT03613532|Decitabine|decitabine|mesh-list
15233109|NCT03613532|Venetoclax|venetoclax|mesh-list
15233110|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365318|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365319|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365320|NCT01118962|Lacosamide|lacosamide|mesh-list
14365321|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
14365322|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14365323|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14365324|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365325|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365326|NCT01118975|Lapatinib|lapatinib|mesh-list
14365327|NCT01118975|Vorinostat|vorinostat|mesh-list
14365328|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365329|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14365330|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365331|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365332|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14365333|NCT01119105|Vancomycin|vancomycin|mesh-list
14365334|NCT01119105|Lefamulin|lefamulin|mesh-list
14365335|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14365336|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365337|NCT01119131|Vitamin D|vitamin d|mesh-list
14365338|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
14365339|NCT01119131|Calcium|calcium|mesh-list
14365340|NCT01119131|Vitamins|vitamins|mesh-ancestor
14365341|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
14365342|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365343|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14365344|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14365345|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
14365346|NCT01119222|Promethazine|promethazine|mesh-list
14365347|NCT01119222|Morphine|morphine|mesh-list
14365348|NCT01119222|Gabapentin|gabapentin|mesh-list
14365349|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14365350|NCT01119222|Narcotics|narcotics|mesh-ancestor
14365351|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365352|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365353|NCT01119222|Analgesics|analgesics|mesh-ancestor
14365354|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
14365355|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365356|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
15233111|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14365357|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14365358|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14365359|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15233112|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
14365360|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14365361|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14365362|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365363|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365364|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
14365365|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14365366|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14365367|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
14365368|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
14365369|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
14365370|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
14365371|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365372|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14365373|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
14365374|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
14365375|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14365376|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
14365377|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
14365378|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14365379|NCT01119287|Dexamethasone|dexamethasone|mesh-list
14365380|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14365381|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365382|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
14365383|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
14365384|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365385|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365386|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365387|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
14365388|NCT01119287|Hormones|hormones|mesh-ancestor
14365389|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365390|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14365391|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365392|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14365393|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14365394|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14365395|NCT01119287|Analgesics|analgesics|mesh-ancestor
14365396|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
14365397|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365398|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14365399|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14365400|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14365401|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
14365402|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
14365403|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365404|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365405|NCT01119508|Temozolomide|temozolomide|mesh-list
14365406|NCT01119508|Ipilimumab|ipilimumab|mesh-list
14365407|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14365408|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
14365409|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365410|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365411|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14365412|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14365413|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14365414|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
14365415|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365416|NCT01119703|Vaccines|vaccines|mesh-list
14365417|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
14365418|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365419|NCT01119768|Esomeprazole|esomeprazole|mesh-list
14365420|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14365421|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365422|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14365423|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365424|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365425|NCT01119794|Bortezomib|bortezomib|mesh-list
14365426|NCT01119794|Ofatumumab|ofatumumab|mesh-list
14365427|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365428|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14365429|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14365430|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365431|NCT01119846|Incretins|incretins|mesh-ancestor
14365432|NCT01119846|Hormones|hormones|mesh-ancestor
14365433|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365434|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14365435|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
14365436|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365437|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365438|NCT01119859|Adalimumab|adalimumab|mesh-list
14365439|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365440|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365441|NCT01119898|Diclofenac|diclofenac|mesh-list
14365442|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14365443|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14365444|NCT01119898|Analgesics|analgesics|mesh-ancestor
14365445|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
14365446|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365447|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365448|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365449|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365450|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14365451|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365452|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365453|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
14365454|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
14365455|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14365456|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
14365457|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365458|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365459|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14365460|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365461|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
14365462|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14365463|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
14753078|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365464|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365465|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365466|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14365467|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14365468|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
14365469|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14365470|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14365471|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14365472|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365473|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365474|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365475|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365476|NCT01119963|Castor Oil|castor oil|mesh-list
14365477|NCT01119963|Progesterone|progesterone|mesh-list
14365478|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14365479|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14365480|NCT01119963|Progestins|progestins|mesh-ancestor
14365481|NCT01119963|Hormones|hormones|mesh-ancestor
14365482|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365483|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365484|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14365485|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
14365486|NCT01119963|Cathartics|cathartics|mesh-ancestor
14365487|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365488|NCT01120028|Sirolimus|sirolimus|mesh-list
14365489|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
14365490|NCT01120028|Tacrolimus|tacrolimus|mesh-list
14365491|NCT01120028|Basiliximab|basiliximab|mesh-list
14365492|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365493|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
14365494|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365495|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14365496|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365497|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365498|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14365499|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365500|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14365501|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365502|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
14365503|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14365504|NCT01120093|Bromides|bromides|mesh-list
14365505|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
14365506|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14365507|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
14365508|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365509|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365510|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14365511|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365512|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14365513|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14365514|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14365515|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
14365516|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365517|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365518|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
14365519|NCT01120184|Paclitaxel|paclitaxel|mesh-list
14365520|NCT01120184|Maytansine|maytansine|mesh-list
14365521|NCT01120184|Docetaxel|docetaxel|mesh-list
14365522|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14365523|NCT01120184|Trastuzumab|trastuzumab|mesh-list
14365524|NCT01120184|Pertuzumab|pertuzumab|mesh-list
14365525|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14365526|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365527|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
14365528|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
15233113|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365529|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
14365530|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365531|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14365532|NCT01120236|Leuprolide|leuprolide|mesh-list
14365533|NCT01120236|Goserelin|goserelin|mesh-list
14365534|NCT01120236|Bicalutamide|bicalutamide|mesh-list
14365535|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14920679|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
15233114|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365536|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14365537|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
14365538|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14365539|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365540|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14365541|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365542|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
14365543|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
14365544|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365545|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
14365546|NCT01120275|R04929097|r04929097|mesh-list
14365547|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365548|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365549|NCT01120405|Sevoflurane|sevoflurane|mesh-list
14365550|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14365551|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14365552|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
14365553|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
14365554|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365555|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365556|NCT01120600|Vitamin D|vitamin d|mesh-list
14365557|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
14365558|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
14365559|NCT01120600|Calcium|calcium|mesh-list
14365560|NCT01120600|Vitamins|vitamins|mesh-ancestor
14365561|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
14732845|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732846|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14732847|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14732848|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14732849|NCT04000854|Calcium|calcium|mesh-list
14732850|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14732851|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732852|NCT03997370|Carboplatin|carboplatin|mesh-list
14732853|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732854|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
14732855|NCT03981341|Estrogens|estrogens|mesh-list
14732856|NCT03981341|Hormones|hormones|mesh-ancestor
14732857|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732858|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732859|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14732860|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14732861|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
14732862|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14732863|NCT03971734|Regadenoson|regadenoson|mesh-list
14732864|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14365562|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365563|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14732865|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14732866|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
14732867|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
14732868|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14732869|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732870|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732871|NCT03970447|Temozolomide|temozolomide|mesh-list
14732872|NCT03970447|Lomustine|lomustine|mesh-list
14732873|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
14732874|NCT03970447|GDC-0084|gdc-0084|mesh-list
14732875|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14732876|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
14365564|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14365565|NCT01120600|Antacids|antacids|mesh-ancestor
14365566|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365567|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14465763|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465764|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465765|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465766|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
14465767|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14465768|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14465769|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14465770|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465771|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465772|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
14465773|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465774|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465775|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14465776|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465777|NCT02230995|Metformin|metformin|mesh-list
14465778|NCT02230995|Empagliflozin|empagliflozin|mesh-list
14465779|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14465780|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465781|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14465782|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465783|NCT02231086|Leucovorin|leucovorin|mesh-list
14465784|NCT02231086|Fluorouracil|fluorouracil|mesh-list
14465785|NCT02231086|Capecitabine|capecitabine|mesh-list
14465786|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
14465787|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
14465788|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233115|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
15233116|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233117|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233118|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
15233119|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233120|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233121|NCT03579160|Timolol|timolol|mesh-list
15233122|NCT03579160|Petrolatum|petrolatum|mesh-list
15233123|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15233124|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15233125|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
15233126|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233127|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233128|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233129|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15233130|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15233131|NCT03579160|Emollients|emollients|mesh-ancestor
15233132|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
15233133|NCT03556696|Remifentanil|remifentanil|mesh-list
15233134|NCT03556696|Propofol|propofol|mesh-list
15233135|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14365568|NCT01120626|Donepezil|donepezil|mesh-list
14365569|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14365570|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365571|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365572|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365573|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365574|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365575|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
14365576|NCT01120639|Temozolomide|temozolomide|mesh-list
14365577|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14365578|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
14365579|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365580|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365581|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
14365582|NCT01120691|Albuterol|albuterol|mesh-list
14365583|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
14365584|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14365585|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
14365586|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365587|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365588|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14365589|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365590|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
14365591|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14365592|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365593|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365594|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365595|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
14365596|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14365597|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15233136|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233137|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233138|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15233139|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
15233140|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
15233141|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14365598|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14365599|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14365600|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
14365601|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14365602|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14365603|NCT01120704|Nicotine|nicotine|mesh-list
14365604|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14365605|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
14365606|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233142|NCT03556696|Narcotics|narcotics|mesh-ancestor
15233143|NCT03556696|Analgesics|analgesics|mesh-ancestor
15233144|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
15233145|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233146|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
15233147|NCT03531736|Fludarabine|fludarabine|mesh-list
15233148|NCT03531736|Rituximab|rituximab|mesh-list
15233149|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15233150|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
15233151|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233152|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
15233153|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233154|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365607|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365608|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15233155|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233156|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
15233157|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233158|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233159|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233160|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233161|NCT03527537|Insulin|insulin|mesh-list
15233162|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233163|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233164|NCT03514069|Temozolomide|temozolomide|mesh-list
15233165|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233166|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
15233167|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233168|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233169|NCT03513445|Epinephrine|epinephrine|mesh-list
15233170|NCT03513445|Morphine|morphine|mesh-list
14732877|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732878|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732879|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732880|NCT03959423|Insulin|insulin|mesh-list
15233171|NCT03513445|Ropivacaine|ropivacaine|mesh-list
15233172|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15233173|NCT03513445|Narcotics|narcotics|mesh-ancestor
14365609|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14365610|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365611|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365612|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365613|NCT01120834|Azacitidine|azacitidine|mesh-list
14365614|NCT01120834|Vorinostat|vorinostat|mesh-list
14365615|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14365616|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
14365617|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365618|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365619|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365620|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14365621|NCT01120899|Minocycline|minocycline|mesh-list
14365622|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14365623|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365624|NCT01121211|Testosterone|testosterone|mesh-list
14365625|NCT01121211|Androgens|androgens|mesh-ancestor
14365626|NCT01121211|Hormones|hormones|mesh-ancestor
14365627|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365628|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365629|NCT01121224|Clopidogrel|clopidogrel|mesh-list
14365630|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14365631|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14365632|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14365633|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14365634|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
14365635|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365636|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365637|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365638|NCT01121393|Gemcitabine|gemcitabine|mesh-list
14365639|NCT01121393|Afatinib|afatinib|mesh-list
14365640|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365641|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14365642|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
14365643|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365644|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
14365645|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365646|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365647|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365648|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
14365649|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365650|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14365651|NCT01121406|Gemcitabine|gemcitabine|mesh-list
14365652|NCT01121406|Paclitaxel|paclitaxel|mesh-list
14365653|NCT01121406|Doxorubicin|doxorubicin|mesh-list
14365654|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14365655|NCT01121406|Topotecan|topotecan|mesh-list
14732881|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14365656|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14365657|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365658|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
14365659|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
14365660|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
14365661|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365662|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14365663|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
14365664|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
14365665|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365666|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365667|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365668|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
14365669|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365670|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14365671|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14365672|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14365673|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14365674|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14365675|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14365676|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365677|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365678|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365679|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365680|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365681|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365682|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365683|NCT01121536|Modafinil|modafinil|mesh-list
14365684|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14365685|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365686|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14365687|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14365688|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14365689|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365690|NCT01121549|Exemestane|exemestane|mesh-list
14365691|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365692|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14365693|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14365694|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365695|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365696|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14365697|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
14365698|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365699|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365700|NCT01121562|Sunitinib|sunitinib|mesh-list
14365701|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365702|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14365703|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14365704|NCT01121562|Growth Substances|growth substances|mesh-ancestor
14365705|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365706|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
14365707|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14365708|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365709|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365710|NCT01121575|Crizotinib|crizotinib|mesh-list
14365711|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365712|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14365713|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365714|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365715|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14365716|NCT01121666|Hormones|hormones|mesh-ancestor
14365717|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365718|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365719|NCT01121757|Lenalidomide|lenalidomide|mesh-list
14365720|NCT01121757|Azacitidine|azacitidine|mesh-list
14365721|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
14365722|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365723|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14365724|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14365725|NCT01121757|Growth Substances|growth substances|mesh-ancestor
14365726|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
14365727|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365728|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14365729|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
14365730|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365731|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365732|NCT01121900|Trazodone|trazodone|mesh-list
14365733|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14365734|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14365735|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365736|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365737|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365738|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14365739|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365740|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365741|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365742|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365743|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
14365744|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14365745|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365746|NCT01121913|Trazodone|trazodone|mesh-list
14365747|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14365748|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14365749|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365750|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365751|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365752|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14365753|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365754|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365755|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365756|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365757|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
14365758|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14365759|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365760|NCT01121926|Trazodone|trazodone|mesh-list
14365761|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14365762|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14365763|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365764|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365765|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365766|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14365767|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365768|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365769|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365770|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365771|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
14365772|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14365773|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365774|NCT01121939|Bevacizumab|bevacizumab|mesh-list
14365775|NCT01121939|Pertuzumab|pertuzumab|mesh-list
14365776|NCT01121939|Octreotide|octreotide|mesh-list
14365777|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14365778|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365779|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14365780|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14365781|NCT01121939|Growth Substances|growth substances|mesh-ancestor
14365782|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365783|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14365784|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365785|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14365786|NCT01121991|Hormones|hormones|mesh-list
14365787|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365788|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365789|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14365790|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
14365791|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14365792|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14365793|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
14365794|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365795|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14365796|NCT01122160|Omeprazole|omeprazole|mesh-list
14365797|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14365798|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365799|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14365800|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365801|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365802|NCT01122238|Nicotine|nicotine|mesh-list
14365803|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14365804|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
14365805|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365806|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365807|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14365808|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14365809|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365810|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365811|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365812|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
14365813|NCT01122264|Tadalafil|tadalafil|mesh-list
14365814|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365815|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
14365816|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14365817|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14365818|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365819|NCT01122264|Urological Agents|urological agents|mesh-ancestor
14365820|NCT01122316|Metformin|metformin|mesh-list
14365821|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14365822|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365823|NCT01122680|Bromides|bromides|mesh-list
14365824|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
14732882|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365825|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14365826|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
14365827|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365828|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365829|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14365830|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365831|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
14365832|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14365833|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365834|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365835|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365836|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
14365837|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
14365838|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14365839|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14365840|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
14365841|NCT01122901|R04929097|r04929097|mesh-list
14365842|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14365843|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365844|NCT01122927|Aripiprazole|aripiprazole|mesh-list
14365845|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365846|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365847|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14365848|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14365849|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365850|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365851|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
14365852|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
14365853|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365854|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365855|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14365856|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14365857|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
14365858|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14365859|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14365860|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14365861|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14365862|NCT01123070|Rituximab|rituximab|mesh-list
14365863|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14365864|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365865|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
14365866|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365867|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365868|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
14365869|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
14365870|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365871|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365872|NCT01123356|Lenalidomide|lenalidomide|mesh-list
14365873|NCT01123356|Ofatumumab|ofatumumab|mesh-list
14365874|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
14365875|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365876|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14365877|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14365878|NCT01123356|Growth Substances|growth substances|mesh-ancestor
14365879|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
14365880|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365881|NCT01123395|Colchicine|colchicine|mesh-list
14365882|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
14365883|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365884|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
14365885|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
14365886|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
14365887|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365888|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365889|NCT01123889|Lidocaine|lidocaine|mesh-list
14365890|NCT01123889|Ropivacaine|ropivacaine|mesh-list
14365891|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
14365892|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
14365893|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14365894|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365895|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
14365896|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365897|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14365898|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14365899|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14365900|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365901|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365902|NCT01123980|Insulin|insulin|mesh-list
14365903|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14365904|NCT01123980|Metformin|metformin|mesh-list
14365905|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
14365906|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
14365907|NCT01123980|Glimepiride|glimepiride|mesh-list
14365908|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
14365909|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14365910|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14365911|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365912|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14365913|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14365914|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
14365915|NCT01124045|Prednisolone|prednisolone|mesh-list
14365916|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14365917|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
14365918|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14365919|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
14365920|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15233174|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233175|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233176|NCT03513445|Analgesics|analgesics|mesh-ancestor
15233177|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
15233178|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233179|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15233180|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15233181|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
15233182|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233183|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233184|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15233185|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15233186|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
15233187|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15233188|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
15233189|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
15233190|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
14365921|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
14365922|NCT01124045|Difluprednate|difluprednate|mesh-list
15233191|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15233192|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
15233193|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
15233194|NCT03511118|Metformin|metformin|mesh-list
15233195|NCT03511118|Topiramate|topiramate|mesh-list
15233196|NCT03511118|Azithromycin|azithromycin|mesh-list
15233197|NCT03511118|Doxycycline|doxycycline|mesh-list
15233198|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
15233199|NCT03511118|Levofloxacin|levofloxacin|mesh-list
15233200|NCT03511118|Clindamycin|clindamycin|mesh-list
15233201|NCT03511118|Valganciclovir|valganciclovir|mesh-list
15233202|NCT03511118|Remdesivir|remdesivir|mesh-list
15233203|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
15233204|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14365923|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365924|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
14365925|NCT01124045|Hormones|hormones|mesh-ancestor
15233205|NCT03511118|Verapamil|verapamil|mesh-list
15233206|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15233207|NCT03511118|Labetalol|labetalol|mesh-list
14365926|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14365927|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365928|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14365929|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14365930|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
14365931|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
14365932|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365933|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14365934|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14365935|NCT01124045|Protective Agents|protective agents|mesh-ancestor
14365936|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14365937|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
14365938|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14365939|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14365940|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365941|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365942|NCT01124149|Mesalamine|mesalamine|mesh-list
14365943|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14365944|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14365945|NCT01124149|Analgesics|analgesics|mesh-ancestor
14365946|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
14365947|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365948|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365949|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14365950|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14365951|NCT01124162|Losartan|losartan|mesh-list
14365952|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14365953|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14365954|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14365955|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14365956|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365957|NCT01124175|Losartan|losartan|mesh-list
14365958|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14365959|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14365960|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14365961|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14465789|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233208|NCT03511118|Nifedipine|nifedipine|mesh-list
15233209|NCT03511118|Furosemide|furosemide|mesh-list
15233210|NCT03511118|Sumatriptan|sumatriptan|mesh-list
15233211|NCT03511118|Oxycodone|oxycodone|mesh-list
15233212|NCT03511118|Gabapentin|gabapentin|mesh-list
15233213|NCT03511118|Ondansetron|ondansetron|mesh-list
14365962|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365963|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14365964|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14365965|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14365966|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14365967|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365968|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365969|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365970|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14365971|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
14365972|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14365973|NCT01124422|Fluticasone|fluticasone|mesh-list
14365974|NCT01124422|Xhance|xhance|mesh-list
14365975|NCT01124422|Bromides|bromides|mesh-list
14365976|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
14365977|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14365978|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14732883|NCT03950817|Ketamine|ketamine|mesh-list
14732884|NCT03950817|Analgesics|analgesics|mesh-ancestor
14365979|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14365980|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
14365981|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14365982|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14365983|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14365984|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14365985|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
14365986|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14365987|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
14365988|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14365989|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
14365990|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14365991|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14365992|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14365993|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14365994|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14365995|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
14365996|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
14365997|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
14365998|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
14365999|NCT01124448|Growth Substances|growth substances|mesh-ancestor
14366000|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366001|NCT01124604|Tapentadol|tapentadol|mesh-list
14366002|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14366003|NCT01124604|Narcotics|narcotics|mesh-ancestor
14366004|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366005|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366006|NCT01124604|Analgesics|analgesics|mesh-ancestor
14366007|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
14366008|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732885|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
14732886|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366009|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14366010|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14366011|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366012|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366013|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
14366014|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366015|NCT01124617|Tapentadol|tapentadol|mesh-list
14366016|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14366017|NCT01124617|Narcotics|narcotics|mesh-ancestor
14366018|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366019|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366020|NCT01124617|Analgesics|analgesics|mesh-ancestor
14366021|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
14366022|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366023|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14366024|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14366025|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366026|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366027|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
14366028|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366029|NCT01124734|Temozolomide|temozolomide|mesh-list
14366030|NCT01124734|Interleukin-2|interleukin-2|mesh-list
14366031|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14366032|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
14366033|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366034|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366035|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14366036|NCT01124734|Analgesics|analgesics|mesh-ancestor
14366037|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
14366038|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366039|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366040|NCT01124786|Gemcitabine|gemcitabine|mesh-list
14366041|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14366042|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
14366043|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366044|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366045|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
14366046|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366047|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366048|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366049|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
14366050|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366051|NCT01124838|Prednisone|prednisone|mesh-list
14366052|NCT01124838|Adalimumab|adalimumab|mesh-list
14366053|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14366054|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
14366055|NCT01124838|Hormones|hormones|mesh-ancestor
14366056|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366057|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366058|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14366059|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366060|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14366061|NCT01125046|Bevacizumab|bevacizumab|mesh-list
14366062|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14366063|NCT01125046|Antibodies|antibodies|mesh-list
14366064|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
14366065|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14366066|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366067|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14366068|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14366069|NCT01125046|Growth Substances|growth substances|mesh-ancestor
14366070|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366071|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
14366072|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
14366073|NCT01125098|Amoxicillin|amoxicillin|mesh-list
14366074|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
14366075|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14366076|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14366077|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366078|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14366079|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366080|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366081|NCT01125163|Iron|iron|mesh-list
14366082|NCT01125163|Trace Elements|trace elements|mesh-ancestor
14366083|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
14366084|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366085|NCT01125189|Interferons|interferons|mesh-list
14366086|NCT01125189|Ribavirin|ribavirin|mesh-list
14366087|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
14366088|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
14366089|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14366090|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366091|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
14366092|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366093|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
14366094|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366095|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
14366096|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366097|NCT01125293|Rituximab|rituximab|mesh-list
14366098|NCT01125293|Everolimus|everolimus|mesh-list
14366099|NCT01125293|Bortezomib|bortezomib|mesh-list
14366100|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732887|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732888|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14732889|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14732890|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
14732891|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
14732892|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732893|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14732894|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14732895|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920680|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366101|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366102|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
14366103|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366104|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14366105|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366106|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
14366107|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14366108|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366109|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14366110|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366111|NCT05308056|Anesthetics|anesthetics|mesh-list
14366112|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366113|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465790|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465791|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14465792|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
14465793|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465794|NCT02231086|Antidotes|antidotes|mesh-ancestor
14465795|NCT02231086|Protective Agents|protective agents|mesh-ancestor
14465796|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
14465797|NCT02231086|Vitamins|vitamins|mesh-ancestor
15233214|NCT03511118|Trazodone|trazodone|mesh-list
14465798|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
14465799|NCT02231164|Docetaxel|docetaxel|mesh-list
14465800|NCT02231164|Nintedanib|nintedanib|mesh-list
14465801|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465802|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
14465803|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
14366114|NCT05307926|Lenvatinib|lenvatinib|mesh-list
14366115|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14366116|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366117|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14366118|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366119|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366120|NCT05307874|Aldesleukin|aldesleukin|mesh-list
14366121|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366122|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14366123|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14366124|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
14366125|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366126|NCT05307835|Molgramostim|molgramostim|mesh-list
14366127|NCT05307835|Sargramostim|sargramostim|mesh-list
14366128|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
14366129|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366130|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366131|NCT05307770|Melatonin|melatonin|mesh-list
14366132|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
14366133|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366134|NCT05307770|Protective Agents|protective agents|mesh-ancestor
14366135|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366136|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366137|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14366138|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14366139|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366140|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366141|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
14732896|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732897|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
14732898|NCT03925025|Nimodipine|nimodipine|mesh-list
14732899|NCT03925025|Analgesics|analgesics|mesh-ancestor
14732900|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
14366142|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366143|NCT05307718|Anticoagulants|anticoagulants|mesh-list
14366144|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
15233215|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
15233216|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
15233217|NCT03511118|Methylphenidate|methylphenidate|mesh-list
15233218|NCT03511118|Citalopram|citalopram|mesh-list
15233219|NCT03511118|Sertraline|sertraline|mesh-list
15233220|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15233221|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
15233222|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15233223|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233224|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233225|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15233226|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15233227|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
15233228|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233229|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15233230|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15233231|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233232|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14732901|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233233|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233234|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15233235|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15233236|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
15233237|NCT03511118|Coagulants|coagulants|mesh-ancestor
15233238|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15233239|NCT03511118|Narcotics|narcotics|mesh-ancestor
15233240|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233241|NCT03511118|Analgesics|analgesics|mesh-ancestor
14366145|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14366146|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14366147|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
14366148|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14366149|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14366150|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
14366151|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366152|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366153|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14366154|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14366155|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14366156|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
14366157|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366158|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366159|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
14366160|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14366161|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
15233242|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
15233243|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233244|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
15233245|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15233246|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15233247|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15233248|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15233249|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15233250|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233251|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
15233252|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15233253|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15233254|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15233255|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
15233256|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15233257|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
15233258|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
15233259|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15233260|NCT03511118|Diuretics|diuretics|mesh-ancestor
15233261|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
14366182|NCT05307627|Naltrexone|naltrexone|mesh-list
14366183|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14366184|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14366185|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366186|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
14366187|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366188|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
14366189|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14366190|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15233262|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14366191|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366192|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14366193|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14366194|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366195|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366196|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366197|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14366198|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
14366199|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14366200|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366201|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14366202|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14366203|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14366204|NCT05307458|Buprenorphine|buprenorphine|mesh-list
14366205|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14366206|NCT05307458|Naloxone|naloxone|mesh-list
14366207|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14366208|NCT05307458|Narcotics|narcotics|mesh-ancestor
14366209|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366210|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366211|NCT05307458|Analgesics|analgesics|mesh-ancestor
14366212|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
14366213|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366214|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14366215|NCT05307341|Sufentanil|sufentanil|mesh-list
14366216|NCT05307341|Dsuvia|dsuvia|mesh-list
14366217|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14366218|NCT05307341|Narcotics|narcotics|mesh-ancestor
14366219|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366220|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366221|NCT05307341|Analgesics|analgesics|mesh-ancestor
14366222|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
14366223|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366224|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14366225|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14366226|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
14366227|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
14366228|NCT05307042|Vasopressins|vasopressins|mesh-list
14366229|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
14366230|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14366231|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
14366232|NCT05307042|Coagulants|coagulants|mesh-ancestor
14366233|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14366234|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14366235|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
14366236|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366237|NCT05306990|Atorvastatin|atorvastatin|mesh-list
14366238|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14366239|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14366240|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14366241|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
14366242|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366243|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14366244|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14366245|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366246|NCT05306587|Daratumumab|daratumumab|mesh-list
14366247|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366248|NCT05306431|Biguanides|biguanides|mesh-list
14366249|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14366250|NCT05306431|Polihexanide|polihexanide|mesh-list
14366251|NCT05306431|Eusol|eusol|mesh-list
14366252|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
14366253|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366254|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14366255|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366256|NCT05306405|Misoprostol|misoprostol|mesh-list
14366257|NCT05306405|Estradiol|estradiol|mesh-list
14366258|NCT05306405|Estrogens|estrogens|mesh-ancestor
14366259|NCT05306405|Hormones|hormones|mesh-ancestor
14366260|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366261|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366262|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14366263|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14366264|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
14366265|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14366266|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14366267|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
14366268|NCT05306301|Ponatinib|ponatinib|mesh-list
14366269|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366270|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14366271|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366272|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366273|NCT05306223|Levofloxacin|levofloxacin|mesh-list
14366274|NCT05306223|Ofloxacin|ofloxacin|mesh-list
14366275|NCT05306223|Cycloserine|cycloserine|mesh-list
14366276|NCT05306223|Linezolid|linezolid|mesh-list
14366277|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
14366278|NCT05306223|Bedaquiline|bedaquiline|mesh-list
14366279|NCT05306223|Clofazimine|clofazimine|mesh-list
14366280|NCT05306223|Prothionamide|prothionamide|mesh-list
14366281|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14366282|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366283|NCT05306223|Renal Agents|renal agents|mesh-ancestor
14366284|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14366285|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14366286|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14366287|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366288|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366289|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366290|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14366291|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14366292|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14366293|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14366294|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
14732902|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366295|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
14366296|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14366297|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
14465804|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
14465805|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465806|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14465807|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465808|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
14465809|NCT02231177|Olodaterol|olodaterol|mesh-list
14465810|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14465811|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
14465812|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465813|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465814|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14465815|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
14465816|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
14465817|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14465818|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
14465819|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465820|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465821|NCT02231749|Nivolumab|nivolumab|mesh-list
14465822|NCT02231749|Ipilimumab|ipilimumab|mesh-list
14465823|NCT02231749|Sunitinib|sunitinib|mesh-list
14465824|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14465825|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465826|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14465827|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465828|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14465829|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14465830|NCT02231749|Growth Substances|growth substances|mesh-ancestor
14465831|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465832|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
14465833|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14465834|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465835|NCT02231918|Pramipexole|pramipexole|mesh-list
14465836|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
14465837|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465838|NCT02231918|Protective Agents|protective agents|mesh-ancestor
14465839|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465840|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14465841|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14465842|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
14465843|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
14465844|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465845|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15233263|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14465846|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14366298|NCT05305508|Mannitol|mannitol|mesh-list
14366299|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
14366300|NCT05305508|Calcium|calcium|mesh-list
14366301|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14366302|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366303|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14366304|NCT05305508|Diuretics|diuretics|mesh-ancestor
14366305|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
14366306|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
14366307|NCT05305508|Coagulants|coagulants|mesh-ancestor
14366308|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
14366309|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366310|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366311|NCT05303909|Gentamicins|gentamicins|mesh-list
14366312|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14366313|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366314|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14366315|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366316|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366317|NCT05299866|Ketamine|ketamine|mesh-list
14366318|NCT05299866|Esketamine|esketamine|mesh-list
14366319|NCT05299866|Analgesics|analgesics|mesh-ancestor
14366320|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
14366321|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366322|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366323|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14366324|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14366325|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
14366326|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
14366327|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366328|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14366329|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14366330|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366331|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366332|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14366333|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366334|NCT05296460|Dapsone|dapsone|mesh-list
15233264|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15233265|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
15233266|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
15233267|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233268|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
14366335|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366336|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
14366337|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14366338|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14366339|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14366340|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366341|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366342|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
14366343|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14366344|NCT05289856|Avelumab|avelumab|mesh-list
14366345|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366346|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366347|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
14366348|NCT05289167|Bortezomib|bortezomib|mesh-list
14366349|NCT05289167|Abatacept|abatacept|mesh-list
14366350|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366351|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
14366352|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366353|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14366354|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14366355|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
14366356|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366357|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233269|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
15233270|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15233271|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15233272|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
15233273|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15233274|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15233275|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15233276|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15233277|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366358|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14366359|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14366360|NCT05273320|Dronabinol|dronabinol|mesh-list
14366361|NCT05273320|Nabilone|nabilone|mesh-list
14366362|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
14366363|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
14366364|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366365|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366366|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14366367|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14366368|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14366369|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366370|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366371|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
14366372|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14366373|NCT05273320|Analgesics|analgesics|mesh-ancestor
14366374|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
14366375|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14366376|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14366377|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366378|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366379|NCT05273320|Hormones|hormones|mesh-ancestor
14366380|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366381|NCT05272683|Itraconazole|itraconazole|mesh-list
14732903|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
14732904|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14732905|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14366382|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
14732906|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
14366383|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366384|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14366385|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14366386|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366387|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366388|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14366389|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
14732907|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14732908|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14732909|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732910|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14732911|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
14732912|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14732913|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14732914|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
14732915|NCT03924440|Nonoxynol|nonoxynol|mesh-list
14732916|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14732917|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14732918|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732919|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14732920|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
14732921|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14732922|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14732923|NCT03914742|Temozolomide|temozolomide|mesh-list
14366390|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233278|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15233279|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14366391|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366392|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14366393|NCT05272397|Methylphenidate|methylphenidate|mesh-list
14366394|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14366395|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366396|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14366397|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14366398|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366399|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366400|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
14366401|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366402|NCT05269628|Dronabinol|dronabinol|mesh-list
14366403|NCT05269628|Cannabidiol|cannabidiol|mesh-list
14366404|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
14366405|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
14366406|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366407|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366408|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14366409|NCT05269628|Analgesics|analgesics|mesh-ancestor
14366410|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
14366411|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366412|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14366413|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14366414|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366415|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732924|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14732925|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14732926|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
15233280|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15233281|NCT03511118|Renal Agents|renal agents|mesh-ancestor
15233282|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15233283|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15233284|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14366416|NCT05269628|Hormones|hormones|mesh-ancestor
14366417|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366418|NCT05254418|Dulaglutide|dulaglutide|mesh-list
14366419|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14366420|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366421|NCT05243953|Cromakalim|cromakalim|mesh-list
14366422|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14366423|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14366424|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
14366425|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366426|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366427|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14366428|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
14366429|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
14366430|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
14366431|NCT05227742|Psilocybin|psilocybin|mesh-list
14366432|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
14366433|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366434|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366435|NCT05223335|Clopidogrel|clopidogrel|mesh-list
14366436|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14366437|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14366438|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14366439|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14366440|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14366441|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
14366442|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366443|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366444|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366445|NCT05215067|Docetaxel|docetaxel|mesh-list
14366446|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366447|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
14366448|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
14366449|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
14366450|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366451|NCT05205486|Cefazolin|cefazolin|mesh-list
14366452|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14366453|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366454|NCT05204134|Insulin|insulin|mesh-list
14366455|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14366456|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366457|NCT05183048|Panitumumab|panitumumab|mesh-list
14366458|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366459|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366460|NCT05179772|Olanzapine|olanzapine|mesh-list
14366461|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
14366462|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
14366463|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366464|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366465|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14366466|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14366467|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14366468|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366469|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366470|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14366471|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14366472|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366473|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366474|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366475|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
14366476|NCT05177510|Mifepristone|mifepristone|mesh-list
14366477|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14366478|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
14366479|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14366480|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366481|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14366482|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14366483|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14366484|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
14366485|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14366486|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14366487|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
14366488|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366489|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
14366490|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14366491|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14366492|NCT05160987|Midazolam|midazolam|mesh-list
14366493|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14366494|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14366495|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366496|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366497|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14366498|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14366499|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366500|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14366501|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
14366502|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
14366503|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
14366504|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
14366505|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366506|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366507|NCT05154136|Itraconazole|itraconazole|mesh-list
14366508|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
14366509|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366510|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14366511|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14366512|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366513|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366514|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14366515|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
14366516|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366517|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732927|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732928|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732929|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366518|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14366519|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
14366520|NCT05106296|Etoposide|etoposide|mesh-list
14366521|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366522|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
14366523|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366524|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14732930|NCT03869190|Gemcitabine|gemcitabine|mesh-list
14732931|NCT03869190|Atezolizumab|atezolizumab|mesh-list
15233285|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
15233286|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14366525|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14366526|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
14366527|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366528|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366529|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14366530|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14366531|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14366532|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14366533|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465847|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465848|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14465849|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
14465850|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465851|NCT02232087|Fluticasone|fluticasone|mesh-list
14465852|NCT02232087|Xhance|xhance|mesh-list
14465853|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14465854|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14465855|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465856|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14465857|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
14465858|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465859|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465860|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14465861|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14465862|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
14465863|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14465864|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14465865|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14465866|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14465867|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
14465868|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465869|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465870|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
14465871|NCT02232087|Hormones|hormones|mesh-ancestor
14465872|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465873|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
14465874|NCT02232178|Bupivacaine|bupivacaine|mesh-list
14465875|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
14465876|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
14465877|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465878|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465879|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
14465880|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465881|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
14465882|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
14465883|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14732932|NCT03869190|Niraparib|niraparib|mesh-list
14732933|NCT03869190|Magrolimab|magrolimab|mesh-list
15233287|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15233288|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15233289|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
15233290|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
15233291|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15233292|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14366534|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
14366535|NCT05068791|Psilocybin|psilocybin|mesh-list
14366536|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
14366537|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
14366538|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14366539|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14366540|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366541|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366542|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366543|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
14366544|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366545|NCT05065216|Kallikreins|kallikreins|mesh-list
14366546|NCT05065216|Coagulants|coagulants|mesh-ancestor
14366547|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14366548|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
14366549|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14366550|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366551|NCT05042648|Buprenorphine|buprenorphine|mesh-list
14366552|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14366553|NCT05042648|Narcotics|narcotics|mesh-ancestor
14366554|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366555|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366556|NCT05042648|Analgesics|analgesics|mesh-ancestor
14366557|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
14366558|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366559|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14366560|NCT05010590|Denosumab|denosumab|mesh-list
14366561|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14366562|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366563|NCT05004025|Nivolumab|nivolumab|mesh-list
14366564|NCT05004025|Ipilimumab|ipilimumab|mesh-list
14366565|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366566|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366567|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14366568|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366569|NCT04989816|Trastuzumab|trastuzumab|mesh-list
14366570|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366571|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366572|NCT04974151|Folic Acid|folic acid|mesh-list
14366573|NCT04974151|Amlodipine|amlodipine|mesh-list
14366574|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14366575|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14366576|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366577|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366578|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14366579|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366580|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
14366581|NCT04974151|Hematinics|hematinics|mesh-ancestor
14366582|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
14366583|NCT04974151|Vitamins|vitamins|mesh-ancestor
14366584|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
14366585|NCT04974138|Folic Acid|folic acid|mesh-list
14366586|NCT04974138|Amlodipine|amlodipine|mesh-list
14366587|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14366588|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14366589|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366590|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366591|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14366592|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366593|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
14366594|NCT04974138|Hematinics|hematinics|mesh-ancestor
14366595|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
14366596|NCT04974138|Vitamins|vitamins|mesh-ancestor
14366597|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
14366598|NCT04973982|Tacrolimus|tacrolimus|mesh-list
14366599|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366600|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
14366601|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366602|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14366603|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366604|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366605|NCT04969887|Nivolumab|nivolumab|mesh-list
14366606|NCT04969887|Ipilimumab|ipilimumab|mesh-list
14366607|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366608|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366609|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14366610|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366611|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
14366612|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366613|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366614|NCT04944771|Rabeprazole|rabeprazole|mesh-list
14366615|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14366616|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14366617|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14366618|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366619|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366620|NCT04944654|Emtricitabine|emtricitabine|mesh-list
14366621|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
14366622|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366623|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14366624|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14366625|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366626|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366627|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14366628|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15233293|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15233294|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15233295|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15233296|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
15233297|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15233298|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15233299|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15233300|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15233301|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
15233302|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
15233303|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15233304|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15233305|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15233306|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15233307|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14366644|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14366645|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14366646|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366647|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366648|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
14366649|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366650|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366651|NCT04928703|Ketamine|ketamine|mesh-list
14366652|NCT04928703|Analgesics|analgesics|mesh-ancestor
14366653|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
14366654|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366655|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366656|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14366657|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14366658|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
14366659|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
14366660|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366661|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14366662|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14366663|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366664|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366665|NCT04910815|Rifaximin|rifaximin|mesh-list
14366666|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14366667|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366668|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14366669|NCT04906395|Tamoxifen|tamoxifen|mesh-list
14366670|NCT04906395|Letrozole|letrozole|mesh-list
14366671|NCT04906395|Anastrozole|anastrozole|mesh-list
14366672|NCT04906395|Exemestane|exemestane|mesh-list
14366673|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366674|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14366675|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14366676|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366677|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366678|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14366679|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
14366680|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366681|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366682|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14366683|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14366684|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14366685|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14366686|NCT04902703|Molgramostim|molgramostim|mesh-list
14366687|NCT04902703|Sargramostim|sargramostim|mesh-list
14366688|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
14366689|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366690|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366691|NCT04880850|Insulin|insulin|mesh-list
14366692|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14366693|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
14366694|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
14366695|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14366696|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233308|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
15233309|NCT03498014|Narcotics|narcotics|mesh-ancestor
15233310|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366700|NCT04822363|Aspirin|aspirin|mesh-list
14366701|NCT04822363|Clopidogrel|clopidogrel|mesh-list
14366702|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14366703|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14366704|NCT04822363|Analgesics|analgesics|mesh-ancestor
14366705|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
14366706|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366707|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366708|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14366709|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14366710|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14366711|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14366712|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366713|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14366714|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14366715|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366716|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
14366717|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14366718|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15233311|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233312|NCT03498014|Analgesics|analgesics|mesh-ancestor
15233313|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
15233314|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233315|NCT03475004|Bevacizumab|bevacizumab|mesh-list
15233316|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
15233317|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233318|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366719|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14366720|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
14366721|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366722|NCT04766437|Ticagrelor|ticagrelor|mesh-list
14366723|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14366724|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14366725|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14366726|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14366727|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14366728|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
14366729|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366730|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366731|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366732|NCT04763408|Sorafenib|sorafenib|mesh-list
14366733|NCT04763408|Lenvatinib|lenvatinib|mesh-list
14366734|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366735|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14366736|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366737|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366738|NCT04762160|Rituximab|rituximab|mesh-list
14366739|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366740|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366741|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
14366742|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366743|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14366744|NCT04732065|Dopamine|dopamine|mesh-list
14366745|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14366746|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
14366747|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
14366748|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366749|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366750|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
14366751|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366752|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366753|NCT04732065|Protective Agents|protective agents|mesh-ancestor
14465884|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14465885|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14465886|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465887|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465888|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14465889|NCT02232802|Enoxaparin|enoxaparin|mesh-list
14465890|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
14465891|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
14465892|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14465893|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14465894|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469882|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14469883|NCT02300259|Urological Agents|urological agents|mesh-ancestor
15233319|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14732934|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233320|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15233321|NCT03475004|Growth Substances|growth substances|mesh-ancestor
15233322|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233323|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
15233324|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
14469884|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14469885|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14469886|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469887|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14469888|NCT02300298|Docetaxel|docetaxel|mesh-list
14469889|NCT02300298|Nintedanib|nintedanib|mesh-list
14469890|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469891|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
14469892|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
14469893|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
14469894|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469895|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469896|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469897|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
15233325|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233326|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14469898|NCT02300311|Capsaicin|capsaicin|mesh-list
14469899|NCT02300311|Nonivamide|nonivamide|mesh-list
15233327|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366754|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
14366755|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14366756|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
14366757|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366758|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
14366759|NCT04704531|Protective Agents|protective agents|mesh-ancestor
14366760|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
14366761|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366762|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366763|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14366764|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
14366765|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366766|NCT04573322|Protective Agents|protective agents|mesh-ancestor
14366767|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366768|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14366769|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366770|NCT04552288|Benralizumab|benralizumab|mesh-list
14366771|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14366772|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
14366773|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
14366774|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366775|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366776|NCT04513145|Ropivacaine|ropivacaine|mesh-list
14366777|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
14366778|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
14366779|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366780|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366781|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
14366782|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366783|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
14366784|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
14366785|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14366786|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366787|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366788|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14366789|NCT04498351|Analgesics|analgesics|mesh-ancestor
14366790|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
14366791|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366792|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14366793|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14366794|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14366795|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
14366796|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366797|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366798|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
14366799|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14366800|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
14366801|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14366802|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366803|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14366804|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
14366805|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14366806|NCT04497584|Prednisone|prednisone|mesh-list
14366807|NCT04497584|Afatinib|afatinib|mesh-list
14366808|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14366809|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
14366810|NCT04497584|Hormones|hormones|mesh-ancestor
14366811|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465895|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
14366812|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366813|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14366814|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366815|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14366816|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366817|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366818|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
14366819|NCT04485013|Cetuximab|cetuximab|mesh-list
14366820|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366821|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366822|NCT04478734|Thiamine|thiamine|mesh-list
14366823|NCT04478734|Biotin|biotin|mesh-list
14366824|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
14366825|NCT04478734|Vitamins|vitamins|mesh-ancestor
14366826|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
14366827|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366828|NCT04478084|Vaccines|vaccines|mesh-list
14366829|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
14366830|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14366831|NCT04478084|Antibodies|antibodies|mesh-list
14366832|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
14366833|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233328|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920681|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14920682|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
14920683|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
14920684|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920685|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920686|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14920687|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
14920688|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233329|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
15233330|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233331|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233332|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15233333|NCT03447262|Ivacaftor|ivacaftor|mesh-list
15233334|NCT03447262|VX-659|vx-659|mesh-list
15233335|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15233336|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15233337|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233338|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
15233339|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233340|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233341|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15233342|NCT03417180|Remifentanil|remifentanil|mesh-list
15233343|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15233344|NCT03417180|Narcotics|narcotics|mesh-ancestor
15233345|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233346|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233347|NCT03417180|Analgesics|analgesics|mesh-ancestor
15233348|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
15233349|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233350|NCT03365791|Spartalizumab|spartalizumab|mesh-list
15233351|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15233352|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233353|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233354|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
15233355|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15233356|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15233357|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233358|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
15233359|NCT03361345|Coagulants|coagulants|mesh-ancestor
15233360|NCT03342196|Fludarabine|fludarabine|mesh-list
15233361|NCT03342196|Melphalan|melphalan|mesh-list
15233362|NCT03342196|Thiotepa|thiotepa|mesh-list
15233363|NCT03342196|Mitogens|mitogens|mesh-list
15233364|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233365|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233366|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233367|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
15233368|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233369|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233370|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
14920689|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14366837|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
14366838|NCT04447534|Chloroquine|chloroquine|mesh-list
14366839|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14366840|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
14366841|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14366842|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14366843|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366844|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366845|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366846|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14366847|NCT04447534|Amebicides|amebicides|mesh-ancestor
14366848|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14366849|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14366850|NCT04447534|Analgesics|analgesics|mesh-ancestor
14366851|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
14366852|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366853|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366854|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14366855|NCT04447534|Filaricides|filaricides|mesh-ancestor
14366856|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
14366857|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
14366858|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14366859|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14366860|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14366861|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366862|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366863|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366864|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366865|NCT04395001|Analgesics|analgesics|mesh-ancestor
14366866|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
14366867|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366868|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
14366869|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14366870|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
14366871|NCT04394663|Omeprazole|omeprazole|mesh-list
14366872|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14366873|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14366874|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14366875|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366876|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366877|NCT04391309|Remdesivir|remdesivir|mesh-list
14366878|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
14366879|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366880|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
14366881|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366882|NCT04361656|Lubiprostone|lubiprostone|mesh-list
14366883|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14366884|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14366885|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366886|NCT04354155|Enoxaparin|enoxaparin|mesh-list
14366887|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
14366888|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14732935|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14732936|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
14732937|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732938|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
14732939|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732940|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732941|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14732942|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
14732943|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732944|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14732945|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732946|NCT03856515|Nicotine|nicotine|mesh-list
14732947|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14732948|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
14732949|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366889|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14366890|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366891|NCT04332341|Niacinamide|niacinamide|mesh-list
14366892|NCT04332341|Niacin|niacin|mesh-list
14366893|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
14366894|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
14366895|NCT04332341|Vitamins|vitamins|mesh-ancestor
14366896|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
14366897|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366898|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14366899|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
14366900|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366901|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14366902|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
14366903|NCT04312139|Lincomycin|lincomycin|mesh-list
14366904|NCT04312139|Calcium|calcium|mesh-list
14366905|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14366906|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366907|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14366908|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366909|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14366910|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366911|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366912|NCT04300309|Lumefantrine|lumefantrine|mesh-list
14366913|NCT04300309|Artemether|artemether|mesh-list
14366914|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
14366915|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14366916|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14366917|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366918|NCT04255602|Ticagrelor|ticagrelor|mesh-list
14366919|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14366920|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14366921|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14366922|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14366923|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
14366924|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366925|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366926|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366927|NCT04238637|Durvalumab|durvalumab|mesh-list
14366928|NCT04238637|Tremelimumab|tremelimumab|mesh-list
14366929|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14366930|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366931|NCT04224766|Bupivacaine|bupivacaine|mesh-list
14366932|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
14366933|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
14366934|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14366935|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366936|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
14366937|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14366938|NCT04187352|Cisplatin|cisplatin|mesh-list
14366939|NCT04187352|Fluorouracil|fluorouracil|mesh-list
14366940|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366941|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
14366942|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366943|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14366944|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366945|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
14366946|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366947|NCT04142892|Onapristone|onapristone|mesh-list
14366948|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366949|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14366950|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
14366951|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14366952|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366953|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
14366954|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14366955|NCT04071977|Antioxidants|antioxidants|mesh-list
14366956|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366957|NCT04071977|Protective Agents|protective agents|mesh-ancestor
14366958|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366959|NCT04055909|Nangibotide|nangibotide|mesh-list
14366960|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465896|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14465897|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14465898|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465899|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
14465900|NCT02233101|Coagulants|coagulants|mesh-ancestor
14465901|NCT02233296|Lasmiditan|lasmiditan|mesh-list
14465902|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14465903|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
14465904|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465905|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465906|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465907|NCT02233309|Anesthetics|anesthetics|mesh-list
14465908|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465909|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465910|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
14465911|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14465912|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14465913|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14465914|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
14465915|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465916|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465917|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465918|NCT02233647|Cocaine|cocaine|mesh-list
14465919|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
14465920|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
14465921|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14465922|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465923|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
14465924|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465925|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14465926|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14465927|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14465928|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465929|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465930|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
14465931|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465932|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
14465933|NCT02233751|Testosterone|testosterone|mesh-list
14465934|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
14465935|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
14465936|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14465937|NCT02233751|Androgens|androgens|mesh-ancestor
14465938|NCT02233751|Hormones|hormones|mesh-ancestor
14465939|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465940|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465941|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14465942|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465943|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
14465944|NCT02233803|Budesonide|budesonide|mesh-list
14465945|NCT02233803|Albuterol|albuterol|mesh-list
15233371|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14366961|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
14366962|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366963|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
14366964|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366965|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
14366966|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
14366967|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14366968|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366969|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14366970|NCT04037241|Leucovorin|leucovorin|mesh-list
14366971|NCT04037241|Gemcitabine|gemcitabine|mesh-list
14366972|NCT04037241|Paclitaxel|paclitaxel|mesh-list
14366973|NCT04037241|Capecitabine|capecitabine|mesh-list
14366974|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14366975|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14366976|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
14366977|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
14366978|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
14366979|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14366980|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14366981|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
14366982|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
14366983|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14366984|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14366985|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14366986|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
14366987|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14366988|NCT04037241|Antidotes|antidotes|mesh-ancestor
14366989|NCT04037241|Protective Agents|protective agents|mesh-ancestor
14366990|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
14366991|NCT04037241|Vitamins|vitamins|mesh-ancestor
14366992|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
14366993|NCT04025879|Paclitaxel|paclitaxel|mesh-list
14366994|NCT04025879|Docetaxel|docetaxel|mesh-list
14366995|NCT04025879|Carboplatin|carboplatin|mesh-list
14366996|NCT04025879|Nivolumab|nivolumab|mesh-list
14732950|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732951|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14732952|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14732953|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
14732954|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14366997|NCT04025879|Pemetrexed|pemetrexed|mesh-list
14366998|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14366999|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367000|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
14367001|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
14367002|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
14367003|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367004|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367005|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14367006|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367007|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14367008|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367009|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
14367010|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14367011|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367012|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14367013|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367014|NCT03983824|Cytarabine|cytarabine|mesh-list
14367015|NCT03983824|Etoposide|etoposide|mesh-list
14367016|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
14367017|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
14367018|NCT03983824|Peposertib|peposertib|mesh-list
14367019|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14367020|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367021|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14367022|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14367023|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367024|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367025|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367026|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
14367027|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
14367028|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753079|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14367029|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367030|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
14367031|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367032|NCT03983824|Analgesics|analgesics|mesh-ancestor
14367033|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
14367034|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367035|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14367036|NCT03971253|Peficitinib|peficitinib|mesh-list
14367037|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367038|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367039|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367040|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
14367041|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367042|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
14367043|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
14367044|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
14367045|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367046|NCT03886649|Venetoclax|venetoclax|mesh-list
14367047|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367048|NCT03880019|Temozolomide|temozolomide|mesh-list
14367049|NCT03880019|Olaparib|olaparib|mesh-list
14367050|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14367051|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14367052|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
14367053|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367054|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367055|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367056|NCT03877991|Cannabidiol|cannabidiol|mesh-list
14367057|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
14367058|NCT03872947|Leucovorin|leucovorin|mesh-list
14367059|NCT03872947|Gemcitabine|gemcitabine|mesh-list
14367060|NCT03872947|Bevacizumab|bevacizumab|mesh-list
14367061|NCT03872947|Carboplatin|carboplatin|mesh-list
14367062|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
14367063|NCT03872947|Nivolumab|nivolumab|mesh-list
14367064|NCT03872947|Irinotecan|irinotecan|mesh-list
14367065|NCT03872947|Topotecan|topotecan|mesh-list
14367066|NCT03872947|Imiquimod|imiquimod|mesh-list
14367067|NCT03872947|Ramucirumab|ramucirumab|mesh-list
14367068|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367069|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367070|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367071|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14367072|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14367073|NCT03872947|Growth Substances|growth substances|mesh-ancestor
14367074|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367075|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
14367076|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367077|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
14367078|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
14367079|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367080|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367081|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367082|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
14367083|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14367084|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14367085|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14367086|NCT03872947|Antidotes|antidotes|mesh-ancestor
14367087|NCT03872947|Protective Agents|protective agents|mesh-ancestor
14367088|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
14367089|NCT03872947|Vitamins|vitamins|mesh-ancestor
14367090|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
14367091|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14367092|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
14367093|NCT03872388|Capecitabine|capecitabine|mesh-list
14367094|NCT03872388|Atorvastatin|atorvastatin|mesh-list
14367095|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367096|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
14367097|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367098|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367099|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14732955|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367100|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14753080|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367101|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14367102|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14367103|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367104|NCT03846310|Carboplatin|carboplatin|mesh-list
14367105|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
14367106|NCT03846310|Pemetrexed|pemetrexed|mesh-list
14367107|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367108|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367109|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367110|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367111|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14367112|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367113|NCT03835949|Atezolizumab|atezolizumab|mesh-list
14367114|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367115|NCT03834519|Prednisone|prednisone|mesh-list
14367116|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
14367117|NCT03834519|Olaparib|olaparib|mesh-list
14367118|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
14367119|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367120|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367121|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367122|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
14367123|NCT03834519|Hormones|hormones|mesh-ancestor
14367124|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367125|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367126|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367127|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14367128|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367129|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367130|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14367131|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
14367132|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14367133|NCT03815890|Nivolumab|nivolumab|mesh-list
14367134|NCT03815890|Ipilimumab|ipilimumab|mesh-list
14367135|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367136|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367137|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14367138|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367139|NCT03809780|Dexamethasone|dexamethasone|mesh-list
14367140|NCT03809780|Lenalidomide|lenalidomide|mesh-list
14367141|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367142|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
14367143|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
14367144|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367145|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367146|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367147|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
14367148|NCT03809780|Hormones|hormones|mesh-ancestor
14367149|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367150|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367151|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367152|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
14367153|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14367154|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14367155|NCT03809780|Growth Substances|growth substances|mesh-ancestor
14367156|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
14367157|NCT03807856|Dabigatran|dabigatran|mesh-list
14367158|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
14367159|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14367160|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
14367161|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367162|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367163|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
15233372|NCT03342196|Mitosis Modulators|mitosis modulators|mesh-ancestor
15233373|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
14367166|NCT03780543|Tenofovir|tenofovir|mesh-list
14367167|NCT03780543|Entecavir|entecavir|mesh-list
15233374|NCT03331289|Exenatide|exenatide|mesh-list
15233375|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15233376|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233377|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233378|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233379|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15233380|NCT03331289|Incretins|incretins|mesh-ancestor
15233381|NCT03331289|Hormones|hormones|mesh-ancestor
15233382|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233383|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
15233384|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233385|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233386|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
15233387|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233388|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233389|NCT03321188|Paclitaxel|paclitaxel|mesh-list
14367168|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
14367169|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367170|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14367171|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367172|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367173|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367174|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14367175|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14367176|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14367177|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14367178|NCT03769025|Narcotics|narcotics|mesh-ancestor
14367179|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367180|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367181|NCT03769025|Analgesics|analgesics|mesh-ancestor
14367182|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
14367183|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367184|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14367185|NCT03715465|Melatonin|melatonin|mesh-list
14367186|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
14367187|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367188|NCT03715465|Protective Agents|protective agents|mesh-ancestor
14367189|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367190|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367191|NCT03713528|Vancomycin|vancomycin|mesh-list
14367192|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14367193|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367194|NCT03709459|Doxycycline|doxycycline|mesh-list
14367195|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14367196|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367197|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
14367198|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14367199|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14367200|NCT03702374|Antioxidants|antioxidants|mesh-list
14367201|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367202|NCT03702374|Protective Agents|protective agents|mesh-ancestor
14367203|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367204|NCT03697356|Dexamethasone|dexamethasone|mesh-list
14367205|NCT03697356|Rituximab|rituximab|mesh-list
14367206|NCT03697356|Lenalidomide|lenalidomide|mesh-list
14367207|NCT03697356|Bortezomib|bortezomib|mesh-list
14367208|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367209|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
14367210|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
14367211|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367212|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367213|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367214|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
14367215|NCT03697356|Hormones|hormones|mesh-ancestor
14367216|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367217|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367218|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367219|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367220|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
14367221|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367222|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14367223|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14367224|NCT03697356|Growth Substances|growth substances|mesh-ancestor
14367225|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
14367226|NCT03690544|Apremilast|apremilast|mesh-list
14367227|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14367228|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14367229|NCT03690544|Analgesics|analgesics|mesh-ancestor
14367230|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
14367231|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367232|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367233|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367234|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367235|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14367236|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14367237|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367238|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367239|NCT03683524|Darunavir|darunavir|mesh-list
14367240|NCT03683524|Dolutegravir|dolutegravir|mesh-list
14367241|NCT03683524|Cobicistat|cobicistat|mesh-list
14367242|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14367243|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14367244|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
14367245|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367246|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367247|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14367248|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14367249|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
14367250|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367251|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14367252|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14367253|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14367254|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14367255|NCT03672292|Voriconazole|voriconazole|mesh-list
14367256|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
14367257|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
14367258|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367259|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14367260|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14367261|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367262|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367263|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14367264|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
14367265|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367266|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367267|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14367268|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
14367269|NCT03660683|Saxagliptin|saxagliptin|mesh-list
14367270|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14367271|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367272|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14367273|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367274|NCT03660683|Incretins|incretins|mesh-ancestor
14367275|NCT03660683|Hormones|hormones|mesh-ancestor
14367276|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367277|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14367278|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
14367279|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367280|NCT03621696|Cisplatin|cisplatin|mesh-list
15233390|NCT03321188|Carboplatin|carboplatin|mesh-list
15233391|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15233392|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233393|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
15233394|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
15233395|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
15233396|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233397|NCT03315026|Siltuximab|siltuximab|mesh-list
15233398|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367281|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367282|NCT03616782|Ixazomib|ixazomib|mesh-list
14367283|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367284|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
14367285|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367286|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367289|NCT03574571|Docetaxel|docetaxel|mesh-list
14367290|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367291|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
14367292|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14367293|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
14367294|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367295|NCT03530995|Itraconazole|itraconazole|mesh-list
14367296|NCT03530995|Rifampin|rifampin|mesh-list
14367297|NCT03530995|Omeprazole|omeprazole|mesh-list
14367298|NCT03530995|Rabeprazole|rabeprazole|mesh-list
14367299|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14367300|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367301|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14367302|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367303|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367304|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
14367305|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367306|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14367307|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14367308|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14367309|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
14367310|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367311|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367312|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14367313|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14367314|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
14367315|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14367316|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
14367317|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367318|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14367319|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14367320|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14367321|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14367322|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14367323|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14367324|NCT03485677|Eliglustat|eliglustat|mesh-list
14367325|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367326|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367327|NCT03465527|Prednisolone|prednisolone|mesh-list
14367328|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367329|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
14367330|NCT03465527|Hormones|hormones|mesh-ancestor
14367331|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367332|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367333|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367334|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465946|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14465947|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14465948|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14465949|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
14465950|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14465951|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465952|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14465953|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
14732956|NCT03841565|Dexamethasone|dexamethasone|mesh-list
14920690|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14367335|NCT03450343|Azacitidine|azacitidine|mesh-list
14367336|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367337|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
14367338|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367339|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367340|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367341|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14367342|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
14367343|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367344|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14367345|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367346|NCT03418805|Ibuprofen|ibuprofen|mesh-list
14367347|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14367348|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14367349|NCT03418805|Analgesics|analgesics|mesh-ancestor
14367350|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
14367351|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367352|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367353|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367354|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367355|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14367356|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367357|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367358|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
14367359|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14367360|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367361|NCT03399981|Natalizumab|natalizumab|mesh-list
14367362|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
14367363|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367364|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
14367365|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14367366|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14367367|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367368|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
14367369|NCT03385928|Coagulants|coagulants|mesh-ancestor
14367370|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
14367371|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14367372|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14367373|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367374|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
14367375|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367376|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367377|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
14367378|NCT03375385|Propofol|propofol|mesh-list
14367379|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14367380|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367381|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367382|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14367383|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
14367384|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
14367385|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14367386|NCT03375385|Analgesics|analgesics|mesh-ancestor
14367387|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
14367388|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920691|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14367389|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14367390|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14920692|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14920693|NCT04515628|Branebrutinib|branebrutinib|mesh-list
14920694|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14920695|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14920696|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
14367391|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14367392|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
14367393|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367394|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367395|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
14367396|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14367397|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367398|NCT03358693|Infliximab|infliximab|mesh-list
14367399|NCT03358693|Upadacitinib|upadacitinib|mesh-list
14367400|NCT03358693|Ustekinumab|ustekinumab|mesh-list
14367401|NCT03358693|Ixekizumab|ixekizumab|mesh-list
14367402|NCT03358693|Brodalumab|brodalumab|mesh-list
14367403|NCT03358693|Abrocitinib|abrocitinib|mesh-list
14367404|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
14367405|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367406|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367407|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14367408|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14367409|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367410|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367411|NCT03340675|Ifetroban|ifetroban|mesh-list
14732957|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
14732958|NCT03841565|Daratumumab|daratumumab|mesh-list
14732959|NCT03841565|Pomalidomide|pomalidomide|mesh-list
14732960|NCT03841565|Ichthammol|ichthammol|mesh-list
14732961|NCT03841565|BB 1101|bb 1101|mesh-list
14732962|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14732963|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
14732964|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
14732965|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732966|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732967|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367412|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14732968|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
15233399|NCT03311308|Metformin|metformin|mesh-list
15233400|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
15233401|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233402|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233403|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233404|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233405|NCT03292133|Gefitinib|gefitinib|mesh-list
15233406|NCT03292133|Nazartinib|nazartinib|mesh-list
15233407|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233408|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14367413|NCT03329001|Niraparib|niraparib|mesh-list
14367414|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14367415|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367416|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367417|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367418|NCT03319667|Dexamethasone|dexamethasone|mesh-list
14367419|NCT03319667|Lenalidomide|lenalidomide|mesh-list
14367420|NCT03319667|Bortezomib|bortezomib|mesh-list
14367421|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367422|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
14367423|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
14367424|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367425|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367426|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367427|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
14367428|NCT03319667|Hormones|hormones|mesh-ancestor
14367429|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367430|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367431|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367432|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
14367433|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14367434|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14367435|NCT03319667|Growth Substances|growth substances|mesh-ancestor
14367436|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
14367437|NCT03270176|Avelumab|avelumab|mesh-list
14367438|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367439|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367440|NCT03245489|Aspirin|aspirin|mesh-list
14367441|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
14367442|NCT03245489|Clopidogrel|clopidogrel|mesh-list
14367443|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367444|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367445|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15233409|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233410|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233411|NCT03267589|Durvalumab|durvalumab|mesh-list
15233412|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233413|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233414|NCT03255096|Rituximab|rituximab|mesh-list
15233415|NCT03255096|Venetoclax|venetoclax|mesh-list
15233416|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233417|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233418|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
15233419|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233420|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233421|NCT03233139|Ipilimumab|ipilimumab|mesh-list
15233422|NCT03233139|Cemiplimab|cemiplimab|mesh-list
15233423|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233424|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233425|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15233426|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233427|NCT03221751|Prazosin|prazosin|mesh-list
15233428|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15233429|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15233430|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15233431|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15233432|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
15233433|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233434|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233435|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367446|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14732969|NCT03841565|Hormones|hormones|mesh-ancestor
14732970|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732971|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14732972|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732973|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
14732974|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14732975|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732976|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
14732977|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14732978|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14367447|NCT03245489|Analgesics|analgesics|mesh-ancestor
14367448|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
14367449|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367450|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367451|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367452|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367453|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14367454|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14367455|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367456|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14367457|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14367458|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367459|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
15233436|NCT03191084|Dronabinol|dronabinol|mesh-list
15233437|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
15233438|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233439|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15233440|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15233441|NCT03191084|Analgesics|analgesics|mesh-ancestor
15233442|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
15233443|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233444|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15233445|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15233446|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233447|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233448|NCT03191084|Hormones|hormones|mesh-ancestor
15233449|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367460|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14367461|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14367462|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14367463|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
14367464|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233450|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
15233451|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367467|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
14367468|NCT03199053|Saxagliptin|saxagliptin|mesh-list
14367469|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14367470|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367471|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14367472|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367473|NCT03199053|Incretins|incretins|mesh-ancestor
14367474|NCT03199053|Hormones|hormones|mesh-ancestor
14367475|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367476|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14367477|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
14367478|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367479|NCT03164057|Cytarabine|cytarabine|mesh-list
14367480|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
14367481|NCT03164057|Methotrexate|methotrexate|mesh-list
14367482|NCT03164057|Azacitidine|azacitidine|mesh-list
14367483|NCT03164057|Decitabine|decitabine|mesh-list
14367484|NCT03164057|Fludarabine|fludarabine|mesh-list
14367485|NCT03164057|Etoposide|etoposide|mesh-list
14367486|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
14367487|NCT03164057|Sorafenib|sorafenib|mesh-list
14367488|NCT03164057|Daunorubicin|daunorubicin|mesh-list
14367489|NCT03164057|Asparaginase|asparaginase|mesh-list
14367490|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
14367491|NCT03164057|Idarubicin|idarubicin|mesh-list
14367492|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
14367493|NCT03164057|Razoxane|razoxane|mesh-list
15233452|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367494|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15233453|NCT03184155|Nicardipine|nicardipine|mesh-list
14367495|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
14367496|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14367497|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367498|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367499|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
14367500|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367501|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367502|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14367503|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367504|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14367505|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367506|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
14367507|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367508|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367509|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14367510|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14367511|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14367512|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
14367513|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367514|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14367515|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367516|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14367517|NCT03164057|Analgesics|analgesics|mesh-ancestor
14367518|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
14367519|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367520|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14367521|NCT03164057|Protective Agents|protective agents|mesh-ancestor
14367522|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14367523|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14367524|NCT03112993|Neostigmine|neostigmine|mesh-list
14367525|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14367526|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367527|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367528|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
14367529|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367530|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367531|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14367532|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
14367533|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367534|NCT03110315|Suvorexant|suvorexant|mesh-list
14367535|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14367536|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14367537|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367538|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367539|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14367540|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367541|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367542|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14367543|NCT03088137|Hormones|hormones|mesh-ancestor
14367544|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233454|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15233455|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15233456|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15233457|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233458|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15233459|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367545|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367546|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
14367547|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
14367548|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367549|NCT02930044|Insulin|insulin|mesh-list
14367550|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14367551|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
14367552|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14367553|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367554|NCT02926222|Lomustine|lomustine|mesh-list
14367555|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14367556|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
14367557|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367558|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367559|NCT02926196|Avelumab|avelumab|mesh-list
14367560|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367561|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367562|NCT02819024|Alovudine|alovudine|mesh-list
14367563|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
14367564|NCT02819024|Dexamethasone|dexamethasone|mesh-list
14367565|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
14367566|NCT02819024|Ichthammol|ichthammol|mesh-list
14367567|NCT02819024|BB 1101|bb 1101|mesh-list
14367568|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367569|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
14367570|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
14367571|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367572|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367573|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367574|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
14367575|NCT02819024|Hormones|hormones|mesh-ancestor
14367576|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367577|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367578|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367579|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
14367580|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367581|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367582|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
14367583|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
14367584|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367585|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
14367586|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14367587|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367588|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14367589|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14367590|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367591|NCT02733185|Vitamins|vitamins|mesh-list
14367592|NCT02733185|Edetic Acid|edetic acid|mesh-list
14367593|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
14367594|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
14367595|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367596|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
14367597|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14367598|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
14367599|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
14367600|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367601|NCT02733185|Antidotes|antidotes|mesh-ancestor
14367602|NCT02733185|Protective Agents|protective agents|mesh-ancestor
14367603|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14367604|NCT02647437|Levetiracetam|levetiracetam|mesh-list
14367605|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
14367606|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
14367607|NCT02623426|Dexamethasone|dexamethasone|mesh-list
14367608|NCT02623426|Methotrexate|methotrexate|mesh-list
14367609|NCT02623426|Ranibizumab|ranibizumab|mesh-list
14367610|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367611|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
14367612|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
14367613|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367614|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367615|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367616|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
14367617|NCT02623426|Hormones|hormones|mesh-ancestor
14367618|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367619|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367620|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367621|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14367622|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
14367623|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14367624|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367625|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
14367626|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367627|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
14367628|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367629|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14367630|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367631|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
14367632|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367633|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367634|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14367635|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14367636|NCT02623426|Growth Substances|growth substances|mesh-ancestor
14367637|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
14367638|NCT02451943|Doxorubicin|doxorubicin|mesh-list
14367639|NCT02451943|Olaratumab|olaratumab|mesh-list
14367640|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14367641|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367642|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14367643|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14367644|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367645|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367646|NCT02436733|Pemetrexed|pemetrexed|mesh-list
14367647|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367648|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367649|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367650|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14367651|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14367652|NCT02410512|Atezolizumab|atezolizumab|mesh-list
14367653|NCT02410512|Antibodies|antibodies|mesh-list
14367654|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
14367655|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14367656|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
14367657|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367658|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367659|NCT02390427|Paclitaxel|paclitaxel|mesh-list
14367660|NCT02390427|Maytansine|maytansine|mesh-list
14367661|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14367662|NCT02390427|Trastuzumab|trastuzumab|mesh-list
14367663|NCT02390427|Pertuzumab|pertuzumab|mesh-list
14367664|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14367665|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367666|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
14367667|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
14367668|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14367669|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367670|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367671|NCT02312258|Ixazomib|ixazomib|mesh-list
14367672|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367673|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
14367674|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367675|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233460|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
15233461|NCT03161912|Aflibercept|aflibercept|mesh-list
15233462|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15233463|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15233464|NCT03161912|Growth Substances|growth substances|mesh-ancestor
15233465|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233466|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
15233467|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367684|NCT02242942|Venetoclax|venetoclax|mesh-list
14367685|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
14367686|NCT02242942|Chlorambucil|chlorambucil|mesh-list
14367687|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367688|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367689|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14367690|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
14367691|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465954|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
14465955|NCT02233803|Hormones|hormones|mesh-ancestor
14465956|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14465957|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
14465958|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14465959|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14465960|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14465961|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14465962|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
15233468|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
14367692|NCT02205047|Fluorouracil|fluorouracil|mesh-list
14367693|NCT02205047|Capecitabine|capecitabine|mesh-list
14367694|NCT02205047|Trastuzumab|trastuzumab|mesh-list
14367695|NCT02205047|Pertuzumab|pertuzumab|mesh-list
14367696|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367697|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
14367698|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367699|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367700|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367701|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
14367702|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233469|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15233470|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15233471|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
15233472|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233473|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233474|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233475|NCT03149809|Urological Agents|urological agents|mesh-ancestor
15233476|NCT03104400|Adalimumab|adalimumab|mesh-list
15233477|NCT03104400|Upadacitinib|upadacitinib|mesh-list
15233478|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233479|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367703|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367709|NCT02193191|Plerixafor|plerixafor|mesh-list
14367710|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14367711|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14367712|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
15233480|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15233481|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233482|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233483|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233484|NCT03104374|Upadacitinib|upadacitinib|mesh-list
15233485|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15233486|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233487|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233488|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233489|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233490|NCT03098654|Metformin|metformin|mesh-list
15233491|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233492|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233493|NCT03072043|Azacitidine|azacitidine|mesh-list
15233494|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233495|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
14367713|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367714|NCT02185209|Amoxicillin|amoxicillin|mesh-list
14367715|NCT02185209|Metronidazole|metronidazole|mesh-list
14367716|NCT02185209|Penicillin V|penicillin v|mesh-list
14367717|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14367718|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367719|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14367720|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14367721|NCT02121405|Capecitabine|capecitabine|mesh-list
14367722|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
14367723|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367724|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
14367725|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367726|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367727|NCT02066623|Everolimus|everolimus|mesh-list
14367728|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367729|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367730|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
14367731|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367732|NCT01989585|Trametinib|trametinib|mesh-list
14367733|NCT01989585|Dabrafenib|dabrafenib|mesh-list
14367734|NCT01989585|Navitoclax|navitoclax|mesh-list
14367735|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367736|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14367737|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367738|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367739|NCT01924819|Leucovorin|leucovorin|mesh-list
14367740|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14367741|NCT01924819|Cisplatin|cisplatin|mesh-list
14367742|NCT01924819|Docetaxel|docetaxel|mesh-list
14367743|NCT01924819|Fluorouracil|fluorouracil|mesh-list
14367744|NCT01924819|Capecitabine|capecitabine|mesh-list
14367745|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
14367746|NCT01924819|Epirubicin|epirubicin|mesh-list
14367747|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
14367748|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367749|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
14367750|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
14367751|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
14367752|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367753|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
14367754|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367755|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14367756|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
14367757|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367758|NCT01924819|Antidotes|antidotes|mesh-ancestor
14367759|NCT01924819|Protective Agents|protective agents|mesh-ancestor
14367760|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
14367761|NCT01924819|Vitamins|vitamins|mesh-ancestor
14367762|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
14367763|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14367764|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14367765|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14367766|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367767|NCT01861314|Bortezomib|bortezomib|mesh-list
14367768|NCT01861314|Sorafenib|sorafenib|mesh-list
14367769|NCT01861314|Decitabine|decitabine|mesh-list
14367770|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367771|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14920697|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367772|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367773|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367774|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367775|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
14367776|NCT01749969|Dexamethasone|dexamethasone|mesh-list
14920698|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14920699|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14920700|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920701|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233496|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233497|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233498|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233499|NCT03016013|Methotrexate|methotrexate|mesh-list
15233500|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14920702|NCT04501978|Remdesivir|remdesivir|mesh-list
14367777|NCT01749969|Lenalidomide|lenalidomide|mesh-list
14367778|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14367779|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
14367780|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
14367781|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367782|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367783|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14367784|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
14367785|NCT01749969|Hormones|hormones|mesh-ancestor
14367786|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367787|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367788|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367789|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
14367790|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14367791|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14367792|NCT01749969|Growth Substances|growth substances|mesh-ancestor
14367793|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
14367794|NCT01126255|Clobetasol|clobetasol|mesh-list
14367795|NCT01126255|Progesterone|progesterone|mesh-list
14367796|NCT01126255|Progestins|progestins|mesh-ancestor
14367797|NCT01126255|Hormones|hormones|mesh-ancestor
14367798|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14732979|NCT03841565|Growth Substances|growth substances|mesh-ancestor
14732980|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
14920703|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
15233501|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
14367799|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367800|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233502|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14732981|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14732982|NCT03836261|Venetoclax|venetoclax|mesh-list
14732983|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
14732984|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
14732985|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732986|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14732987|NCT03836040|Erenumab|erenumab|mesh-list
14367801|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
14367802|NCT00433589|Tamoxifen|tamoxifen|mesh-list
14367803|NCT00433589|Docetaxel|docetaxel|mesh-list
14367804|NCT00433589|Capecitabine|capecitabine|mesh-list
14367805|NCT00433589|Letrozole|letrozole|mesh-list
14367806|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367807|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
14367808|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
14367809|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
14367810|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367811|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14367812|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
14367813|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14367814|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14367815|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367816|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14367817|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
14367818|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14367819|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367820|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14367821|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14367822|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14367823|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14367824|NCT00308685|Albuterol|albuterol|mesh-list
14367825|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14367826|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
14367827|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367828|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367829|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14367830|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
14367831|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
14367832|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14367833|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14367834|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14367835|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14367836|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
14367837|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367838|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367839|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14367840|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14367841|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14367842|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14367843|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367844|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14367845|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367846|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367847|NCT01125514|Furosemide|furosemide|mesh-list
14367848|NCT01125514|Diuretics|diuretics|mesh-ancestor
14367849|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
14367850|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367851|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14367852|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14367853|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367854|NCT01125566|Trastuzumab|trastuzumab|mesh-list
14367855|NCT01125566|Vinorelbine|vinorelbine|mesh-list
14367856|NCT01125566|Afatinib|afatinib|mesh-list
14367857|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367858|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14732988|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14367859|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14367860|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
14367861|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
14367862|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
14367863|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367864|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14367865|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14367866|NCT01125748|Omalizumab|omalizumab|mesh-list
14367867|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14367868|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14367869|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14367870|NCT01125813|Factor VIII|factor viii|mesh-list
14367871|NCT01125813|Coagulants|coagulants|mesh-ancestor
14367872|NCT01125917|Buprenorphine|buprenorphine|mesh-list
14367873|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14367874|NCT01125917|Narcotics|narcotics|mesh-ancestor
14367875|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367876|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367877|NCT01125917|Analgesics|analgesics|mesh-ancestor
14367878|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
14367879|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367880|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14367881|NCT01125930|Tretinoin|tretinoin|mesh-list
14367882|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367883|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
14367884|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
14367885|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14367886|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
14367887|NCT01126060|Coagulants|coagulants|mesh-ancestor
14367888|NCT01126099|Prazosin|prazosin|mesh-list
14367889|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14367890|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14367891|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14367892|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14367893|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
14367894|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367895|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367896|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367897|NCT01126268|Retapamulin|retapamulin|mesh-list
14367898|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14367899|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14367900|NCT01126359|Lidocaine|lidocaine|mesh-list
14367901|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
14367902|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
14367903|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367904|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367905|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
14367906|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367907|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14732989|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14732990|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14732991|NCT03836040|Analgesics|analgesics|mesh-ancestor
14732992|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
14367908|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14367909|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14367910|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465963|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465964|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465965|NCT02233998|Listerine|listerine|mesh-list
14465966|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
14465967|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14465968|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14732993|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14732994|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14732995|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
14732996|NCT03832998|Erenumab|erenumab|mesh-list
14732997|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14732998|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14732999|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733000|NCT03832998|Analgesics|analgesics|mesh-ancestor
14733001|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
14733002|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733003|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920704|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920705|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
14367911|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367912|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
14367913|NCT01126424|Oxybutynin|oxybutynin|mesh-list
14367914|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14367915|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14367916|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
14367917|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367918|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367919|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367920|NCT01126424|Urological Agents|urological agents|mesh-ancestor
14367921|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
14367922|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
14367923|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367924|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
14367925|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14367926|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
14367927|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367928|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920706|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920707|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
14920708|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14367929|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14920709|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
14920710|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920711|NCT04484818|Leuprolide|leuprolide|mesh-list
14920712|NCT04484818|Goserelin|goserelin|mesh-list
14920713|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14920714|NCT04484818|Tryptophan|tryptophan|mesh-list
14920715|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
14920716|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14920717|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367930|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
14920718|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14367931|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
14367932|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14367933|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
14367934|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367935|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367936|NCT01126541|Rituximab|rituximab|mesh-list
14367937|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14367938|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14367939|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
14367940|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367941|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14367942|NCT01126580|Metformin|metformin|mesh-list
14367943|NCT01126580|Dulaglutide|dulaglutide|mesh-list
14367944|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14367945|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367946|NCT01126593|Bupivacaine|bupivacaine|mesh-list
14367947|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
14367948|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
14367949|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367950|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733004|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
14733005|NCT03816176|Isavuconazole|isavuconazole|mesh-list
14733006|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
14733007|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733008|NCT03768063|Atezolizumab|atezolizumab|mesh-list
14367951|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
14367952|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14367953|NCT01126671|Vitamin D|vitamin d|mesh-list
14367954|NCT01126671|Vitamins|vitamins|mesh-ancestor
14367955|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
14367956|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367957|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14367958|NCT01127165|Zonisamide|zonisamide|mesh-list
14367959|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
14733009|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733010|NCT03767348|Nivolumab|nivolumab|mesh-list
14733011|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733012|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733013|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14920719|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
14367960|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14367961|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14733014|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367962|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367963|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14367964|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367965|NCT01127438|Fospropofol|fospropofol|mesh-list
14367966|NCT01127438|Propofol|propofol|mesh-list
14367967|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14367968|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14367969|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367970|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14367971|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
14367972|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
14367973|NCT01127581|Dinoprostone|dinoprostone|mesh-list
14367974|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
14367975|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14367976|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367977|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14367978|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14367979|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367980|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14367981|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14367982|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14367983|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367984|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
14367985|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367986|NCT01127646|Methylphenidate|methylphenidate|mesh-list
14367987|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14367988|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14367989|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14367990|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14367991|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14367992|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14367993|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14367994|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
14367995|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14367996|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14367997|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
14367998|NCT01127659|Testosterone|testosterone|mesh-list
14367999|NCT01127659|Androgens|androgens|mesh-ancestor
14368000|NCT01127659|Hormones|hormones|mesh-ancestor
14368001|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368002|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368003|NCT01127763|Carboplatin|carboplatin|mesh-list
14368004|NCT01127763|Everolimus|everolimus|mesh-list
14368005|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368006|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368007|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
14368008|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368009|NCT01127893|Tanezumab|tanezumab|mesh-list
14368010|NCT01127893|Analgesics|analgesics|mesh-ancestor
14368011|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
14368012|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368013|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368014|NCT01128153|Saxagliptin|saxagliptin|mesh-list
14368015|NCT01128153|Incretins|incretins|mesh-ancestor
14368016|NCT01128153|Hormones|hormones|mesh-ancestor
14733015|NCT03741530|Glyburide|glyburide|mesh-list
14368017|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368018|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368019|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14368020|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
14368021|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368022|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368023|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368024|NCT01128192|Pasireotide|pasireotide|mesh-list
14368025|NCT01128192|Hormones|hormones|mesh-ancestor
14368026|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368027|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368028|NCT01128244|Pyridoxine|pyridoxine|mesh-list
14368029|NCT01128244|Pyridoxal|pyridoxal|mesh-list
14368030|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
14368031|NCT01128244|Vitamins|vitamins|mesh-ancestor
14368032|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
14368033|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368034|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
14368035|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
14368036|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14368037|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14368038|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368039|NCT01128296|Gemcitabine|gemcitabine|mesh-list
14368040|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
14368041|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14368042|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
14368043|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368044|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368045|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
14368046|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368047|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368048|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368049|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
14368050|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368051|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
14368052|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14368053|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14368054|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368055|NCT01128387|Panitumumab|panitumumab|mesh-list
14368056|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368057|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368058|NCT01128543|Vinorelbine|vinorelbine|mesh-list
14368059|NCT01128543|Lapatinib|lapatinib|mesh-list
14368060|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14368061|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368062|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14368063|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14368064|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14368065|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368066|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233503|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233504|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233505|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
15233506|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233507|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233508|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
15233509|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368067|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368068|NCT01128569|Fluticasone|fluticasone|mesh-list
14368069|NCT01128569|Xhance|xhance|mesh-list
14368070|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368071|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14368072|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
14368073|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368074|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368075|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14368076|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
14368077|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
14368078|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14368079|NCT01128595|Fluticasone|fluticasone|mesh-list
14368080|NCT01128595|Xhance|xhance|mesh-list
14368081|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368082|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14368083|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
14368084|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368085|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368086|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14368087|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
14368088|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
14368089|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14368090|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14368091|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368092|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368093|NCT01128621|Incretins|incretins|mesh-ancestor
14368094|NCT01128621|Hormones|hormones|mesh-ancestor
14368095|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368096|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14368097|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
14368098|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368099|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368100|NCT01128842|Capecitabine|capecitabine|mesh-list
14368101|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14368102|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
14368103|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368104|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368105|NCT01128894|Liraglutide|liraglutide|mesh-list
14368106|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
14368107|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368108|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368109|NCT01128894|Incretins|incretins|mesh-ancestor
14368110|NCT01128894|Hormones|hormones|mesh-ancestor
14368111|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368112|NCT01128959|Carbamazepine|carbamazepine|mesh-list
14368113|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
14368114|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
14368115|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14368116|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233510|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14368117|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368118|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14368119|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14368120|NCT01128959|Analgesics|analgesics|mesh-ancestor
14368121|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
14368122|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368123|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14368124|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368125|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368126|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14368127|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14368128|NCT01128972|Listerine|listerine|mesh-list
14368129|NCT01128972|Fluorides|fluorides|mesh-list
14368130|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
14368131|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
14368132|NCT01128972|Protective Agents|protective agents|mesh-ancestor
14368133|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368134|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14368135|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368136|NCT01129011|Naproxen|naproxen|mesh-list
14368137|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14368138|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14368139|NCT01129011|Analgesics|analgesics|mesh-ancestor
14368140|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
14368141|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368142|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368143|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368144|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368145|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
14368146|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14368147|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368148|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368149|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
14368150|NCT01129206|Docetaxel|docetaxel|mesh-list
14368151|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14368152|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368153|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14368154|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14368155|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14368156|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368157|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14368158|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
14368159|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
14368160|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368161|NCT01129245|Celecoxib|celecoxib|mesh-list
14368162|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14368163|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14368164|NCT01129245|Analgesics|analgesics|mesh-ancestor
14368165|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
14368166|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368167|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368168|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368169|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368170|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14368171|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14368172|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368173|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368174|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14368175|NCT01129284|Hormones|hormones|mesh-ancestor
14368176|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368177|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368178|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
14368179|NCT01129336|Diphosphonates|diphosphonates|mesh-list
14368180|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14368181|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368182|NCT01129440|Fluorides|fluorides|mesh-list
14368183|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
14368184|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
14368185|NCT01129440|Protective Agents|protective agents|mesh-ancestor
14368186|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465969|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
14465970|NCT02233998|Protective Agents|protective agents|mesh-ancestor
14465971|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465972|NCT02234115|Leuprolide|leuprolide|mesh-list
14465973|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14465974|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
14465975|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14465976|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465977|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14465978|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14465979|NCT02234141|Selonsertib|selonsertib|mesh-list
14465980|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14465981|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14465982|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465983|NCT02234362|Vortioxetine|vortioxetine|mesh-list
14465984|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
14465985|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14465986|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14368187|NCT01129557|Valsartan|valsartan|mesh-list
14368188|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14368189|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14368190|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14368191|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368192|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
14368193|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14368194|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14368195|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14368196|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368197|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368198|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
14368199|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368200|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368201|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14368202|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368203|NCT01129622|Letrozole|letrozole|mesh-list
14368204|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368205|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14368206|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14368207|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368208|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368209|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14368210|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
14368211|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368212|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368213|NCT01129778|Omeprazole|omeprazole|mesh-list
14368214|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14368215|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
14368216|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14368217|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14368218|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368219|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368220|NCT01129882|Aripiprazole|aripiprazole|mesh-list
14368221|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
14368222|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14368223|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14368224|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14368225|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14368226|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368227|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
14368228|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
14368229|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368230|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368231|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14368232|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14368233|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
14368234|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14368235|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14368236|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14368237|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14368238|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14368239|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
14465987|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15233511|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233512|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
15233513|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233514|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15233515|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
15233516|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
15233517|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15233518|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15233519|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233520|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368240|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14368241|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14368242|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368243|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368244|NCT01130051|Colchicine|colchicine|mesh-list
14368245|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
14368246|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368247|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
14368248|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
14368249|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
14368250|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368251|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368252|NCT01130103|Paroxetine|paroxetine|mesh-list
14368253|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14368254|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14368255|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368256|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368257|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368258|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
14368259|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368260|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14368261|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
14368262|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14368263|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14368264|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14368265|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368266|NCT01130168|Amlodipine|amlodipine|mesh-list
14368267|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14368268|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14368269|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465988|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733016|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14733017|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733018|NCT03724890|Avelumab|avelumab|mesh-list
15233521|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233522|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233523|NCT03011307|Oxytocin|oxytocin|mesh-list
15233524|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
15233525|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15233526|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733019|NCT03724890|Peposertib|peposertib|mesh-list
14733020|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733021|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733022|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368270|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368271|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14368272|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368273|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
14368274|NCT01130272|Eluxadoline|eluxadoline|mesh-list
14368275|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14368276|NCT01130337|Capecitabine|capecitabine|mesh-list
14368277|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
14368278|NCT01130337|Trastuzumab|trastuzumab|mesh-list
14368279|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14368280|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
14368281|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368282|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368283|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368284|NCT01130493|Levodopa|levodopa|mesh-list
14368285|NCT01130493|Carbidopa|carbidopa|mesh-list
14368286|NCT01130493|Entacapone|entacapone|mesh-list
14368287|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14368288|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14368289|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14368290|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
14368291|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368292|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368293|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368294|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14368295|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368296|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14368297|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14368298|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
14368299|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
14368300|NCT01130532|Tadalafil|tadalafil|mesh-list
14368301|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
14368302|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14368303|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14368304|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368305|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368306|NCT01130532|Urological Agents|urological agents|mesh-ancestor
14368307|NCT01130597|Spironolactone|spironolactone|mesh-list
14368308|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14368309|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
14368310|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368311|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368312|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14368313|NCT01130597|Diuretics|diuretics|mesh-ancestor
14368314|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
14368315|NCT01130844|Mesalamine|mesalamine|mesh-list
14368316|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14368317|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14368318|NCT01130844|Analgesics|analgesics|mesh-ancestor
14368319|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
14368320|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368321|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368322|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368323|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368324|NCT01131052|Insulin|insulin|mesh-list
14368325|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14368326|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
14368327|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
14368328|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368329|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368330|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
14368331|NCT01131065|Antibodies|antibodies|mesh-list
14368332|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
14368333|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14368334|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14368335|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
14368336|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368337|NCT01131078|Bevacizumab|bevacizumab|mesh-list
14368338|NCT01131078|Capecitabine|capecitabine|mesh-list
14368339|NCT01131078|Irinotecan|irinotecan|mesh-list
14368340|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368341|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368342|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368343|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368344|NCT01131078|Growth Substances|growth substances|mesh-ancestor
14368345|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368346|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
14368347|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14368348|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
14368349|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368350|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14368351|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14368352|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368353|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
14368354|NCT01131104|Tadalafil|tadalafil|mesh-list
14368355|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14368356|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14368357|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
14368358|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14368359|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368360|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368361|NCT01131104|Urological Agents|urological agents|mesh-ancestor
14368362|NCT01131182|Metformin|metformin|mesh-list
14368363|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14368364|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368365|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368366|NCT01131182|Incretins|incretins|mesh-ancestor
14368367|NCT01131182|Hormones|hormones|mesh-ancestor
14368368|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368369|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14368370|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
14368371|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368372|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368373|NCT01131507|Pancrelipase|pancrelipase|mesh-list
14368374|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14368375|NCT01131585|Ranibizumab|ranibizumab|mesh-list
14368376|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368377|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368378|NCT01131585|Growth Substances|growth substances|mesh-ancestor
14368379|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368380|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
14368381|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368382|NCT01131676|Empagliflozin|empagliflozin|mesh-list
14469900|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
14368383|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14368384|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368385|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368386|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368387|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
14368388|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
14368389|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14368390|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14368391|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368392|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368393|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368394|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368395|NCT01132313|Ribavirin|ribavirin|mesh-list
14368396|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
14368397|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368398|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
14368399|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368400|NCT01132326|Droxidopa|droxidopa|mesh-list
14368401|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14368402|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14368403|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
14368404|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
14368405|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14368406|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14368407|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368408|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368409|NCT01132482|Urological Agents|urological agents|mesh-ancestor
14368410|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
14368411|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
14368412|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
14368413|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14368414|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14368415|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
14368416|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
14368417|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368418|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368419|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368420|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14368421|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
14368422|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14368423|NCT01132664|Capecitabine|capecitabine|mesh-list
14368424|NCT01132664|Trastuzumab|trastuzumab|mesh-list
14368425|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14368426|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
14368427|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368428|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368429|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368430|NCT01132807|Prednisone|prednisone|mesh-list
14368431|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
14368432|NCT01132807|Dacarbazine|dacarbazine|mesh-list
14368433|NCT01132807|Doxorubicin|doxorubicin|mesh-list
14368434|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14368435|NCT01132807|Etoposide|etoposide|mesh-list
14368436|NCT01132807|Bleomycin|bleomycin|mesh-list
14368437|NCT01132807|Vinblastine|vinblastine|mesh-list
14368438|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
14368439|NCT01132807|Procarbazine|procarbazine|mesh-list
14368440|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14368441|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368442|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
14368443|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368444|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368445|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14368446|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
14368447|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368448|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368449|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14368450|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14368451|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14368452|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14368453|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368454|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368455|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
14368456|NCT01132807|Hormones|hormones|mesh-ancestor
14368457|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368458|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14368459|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14368460|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14368461|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14368462|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14368463|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14368464|NCT01132820|Cediranib|cediranib|mesh-list
14368465|NCT01132820|Maleic acid|maleic acid|mesh-list
14368466|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368467|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368468|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368469|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368470|NCT01132846|Dopamine|dopamine|mesh-list
14368471|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14368472|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14368473|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
15233527|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
15233528|NCT02981069|Exenatide|exenatide|mesh-list
15233529|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15233530|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233531|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233532|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233533|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15233534|NCT02981069|Incretins|incretins|mesh-ancestor
15233535|NCT02981069|Hormones|hormones|mesh-ancestor
15233536|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233537|NCT02970981|Nivolumab|nivolumab|mesh-list
15233538|NCT02970981|Ipilimumab|ipilimumab|mesh-list
15233539|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233540|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233541|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15233542|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233543|NCT02911935|Azithromycin|azithromycin|mesh-list
15233544|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15233545|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368474|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
14368475|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368476|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368477|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
14368478|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368479|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368480|NCT01132846|Protective Agents|protective agents|mesh-ancestor
14368481|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
14368482|NCT01133158|Dexamethasone|dexamethasone|mesh-list
14368483|NCT01133158|Rituximab|rituximab|mesh-list
14368484|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14368485|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
14368486|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368487|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
14368488|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
14368489|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368490|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368491|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233546|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
15233547|NCT02909452|Entinostat|entinostat|mesh-list
15233548|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233549|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233550|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15233551|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233552|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233553|NCT02909036|Melphalan|melphalan|mesh-list
15233554|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233555|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
15233556|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233557|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368492|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
14368493|NCT01133158|Hormones|hormones|mesh-ancestor
14368494|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368495|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14368496|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368497|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368498|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
14368499|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733023|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733024|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368500|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14368501|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
14368502|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368503|NCT01133158|Analgesics|analgesics|mesh-ancestor
14368504|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
14368505|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14368506|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14368507|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368508|NCT01133275|Prednisone|prednisone|mesh-list
14368509|NCT01133275|Lenalidomide|lenalidomide|mesh-list
14368510|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368511|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
14368512|NCT01133275|Hormones|hormones|mesh-ancestor
14368513|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368514|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368515|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14368516|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368517|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
14368518|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368519|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368520|NCT01133275|Growth Substances|growth substances|mesh-ancestor
14368521|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
14368522|NCT01133379|Fluorides|fluorides|mesh-list
14368523|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
14368524|NCT01133379|Protective Agents|protective agents|mesh-ancestor
14733025|NCT03721341|Hormones|hormones|mesh-list
14733026|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733027|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733028|NCT03713320|Vorinostat|vorinostat|mesh-list
14733029|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368525|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368526|NCT01133392|Insulin|insulin|mesh-list
14368527|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14368528|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
15233558|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233559|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368529|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368530|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368531|NCT01133522|Evolocumab|evolocumab|mesh-list
14368532|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14368533|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14368534|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
14368535|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368536|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14368537|NCT01133626|Prednisone|prednisone|mesh-list
14368538|NCT01133626|Beclomethasone|beclomethasone|mesh-list
14368539|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733030|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14733031|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733032|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733033|NCT03712228|Antibodies|antibodies|mesh-list
14733034|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14733035|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
14733036|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733037|NCT03673787|Atezolizumab|atezolizumab|mesh-list
14733038|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733039|NCT03571802|Simvastatin|simvastatin|mesh-list
14733040|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14733041|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14733042|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
14733043|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733044|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14733045|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14733046|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368540|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
14368541|NCT01133626|Hormones|hormones|mesh-ancestor
14368542|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368543|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368544|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14368545|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368546|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14368547|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
14368548|NCT01133665|Lenalidomide|lenalidomide|mesh-list
14368549|NCT01133665|Cetuximab|cetuximab|mesh-list
14368550|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
14368551|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368552|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368553|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14733047|NCT03568422|Paclitaxel|paclitaxel|mesh-list
15233560|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
15233561|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233562|NCT02898506|Liraglutide|liraglutide|mesh-list
15233563|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233564|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233565|NCT02898506|Incretins|incretins|mesh-ancestor
15233566|NCT02898506|Hormones|hormones|mesh-ancestor
15233567|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368554|NCT01133665|Growth Substances|growth substances|mesh-ancestor
14368555|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
15233568|NCT02880982|Vitamin D|vitamin d|mesh-list
14368556|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368557|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368558|NCT01133678|Paclitaxel|paclitaxel|mesh-list
14368559|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14368560|NCT01133678|Cisplatin|cisplatin|mesh-list
14368561|NCT01133678|Cetuximab|cetuximab|mesh-list
14368562|NCT01133678|Everolimus|everolimus|mesh-list
14368563|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14368564|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368565|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
14368566|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
14368567|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
14368568|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233569|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
14368569|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368570|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368571|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
14368572|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368573|NCT01133756|Gemcitabine|gemcitabine|mesh-list
14368574|NCT01133756|Carboplatin|carboplatin|mesh-list
14368575|NCT01133756|Lenvatinib|lenvatinib|mesh-list
14368576|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368577|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14368578|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
14368579|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368580|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
14368581|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368582|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368583|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368584|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
14368585|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368586|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368587|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14368588|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
14368589|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14368590|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14368591|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14368592|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14368593|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368594|NCT01133847|Guanfacine|guanfacine|mesh-list
14368595|NCT01133847|Methylphenidate|methylphenidate|mesh-list
14368596|NCT01133847|Amphetamine|amphetamine|mesh-list
14368597|NCT01133847|Adderall|adderall|mesh-list
14368598|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15233570|NCT02880982|Vitamins|vitamins|mesh-ancestor
14368599|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14368600|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233571|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
15233572|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233573|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15233574|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15233575|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
15233576|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
15233577|NCT02880293|Melphalan|melphalan|mesh-list
15233578|NCT02880293|Thiotepa|thiotepa|mesh-list
15233579|NCT02880293|Fludarabine|fludarabine|mesh-list
15233580|NCT02880293|Tacrolimus|tacrolimus|mesh-list
15233581|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233582|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
15233583|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233584|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233585|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233586|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
15233587|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233588|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233589|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14368601|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14368602|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14368603|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368604|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368605|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
14368606|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368607|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15233590|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15233591|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233592|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14368608|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
14368609|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
14368610|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
14368611|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368612|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14368613|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14368614|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14368615|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14368616|NCT01133977|Lenvatinib|lenvatinib|mesh-list
14368617|NCT01133977|Dacarbazine|dacarbazine|mesh-list
14368618|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368619|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368620|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368621|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368622|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14368623|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
14368624|NCT01134042|Fluticasone|fluticasone|mesh-list
14368625|NCT01134042|Xhance|xhance|mesh-list
14368626|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368627|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14368628|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
14368629|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368630|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368631|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14368632|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
14368633|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14368634|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14368635|NCT01134055|Ranibizumab|ranibizumab|mesh-list
14368636|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14368637|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368638|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368639|NCT01134055|Growth Substances|growth substances|mesh-ancestor
14368640|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368641|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
14368642|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368643|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14368644|NCT01134107|Insulin|insulin|mesh-list
14368645|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14368646|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
14368647|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
14368648|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368649|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368650|NCT01134198|Mifepristone|mifepristone|mesh-list
14368651|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14368652|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
14368653|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14368654|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368655|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14368656|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14368657|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14733048|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733049|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733050|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
14368658|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
14733051|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
15233593|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15233594|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
15233595|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15233596|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233597|NCT02853500|Doxorubicin|doxorubicin|mesh-list
15233598|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14733052|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
14733053|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733054|NCT03539614|Prazosin|prazosin|mesh-list
15233599|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233600|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15233601|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15233602|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233603|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233604|NCT02842827|Tretinoin|tretinoin|mesh-list
15233605|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233606|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
15233607|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
15233608|NCT02837029|Nivolumab|nivolumab|mesh-list
15233609|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233610|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233611|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14368659|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14733055|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14733056|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14733057|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14733058|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14733059|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14368660|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14368661|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
14368662|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368663|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
14368664|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14368665|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14368666|NCT01134263|Vaccines|vaccines|mesh-list
14368667|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
14368668|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368669|NCT01134315|Calcitriol|calcitriol|mesh-list
14368670|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14368671|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368672|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14368673|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368674|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368675|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14368676|NCT01134315|Vitamins|vitamins|mesh-ancestor
14368677|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
14368678|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14368679|NCT01134393|Amlodipine|amlodipine|mesh-list
14368680|NCT01134393|Telmisartan|telmisartan|mesh-list
14368681|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14368682|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14368683|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14368684|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368685|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368686|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14368687|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368688|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
14368689|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14368690|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14368691|NCT01134510|Complement C1s|complement c1s|mesh-list
14368692|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14368693|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14368694|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
14368695|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368696|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14368697|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368698|NCT01134575|Rituximab|rituximab|mesh-list
14368699|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14368700|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368701|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368702|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
14368703|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368704|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368705|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14733060|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733061|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733062|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733063|NCT03532022|Dexamethasone|dexamethasone|mesh-list
14733064|NCT03532022|Prednisone|prednisone|mesh-list
14733065|NCT03532022|Prednisolone|prednisolone|mesh-list
14733066|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
14733067|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14733068|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14733069|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14733070|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733071|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
14733072|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
14733073|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733074|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733075|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14733076|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
14733077|NCT03532022|Hormones|hormones|mesh-ancestor
14733078|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368714|NCT01134627|Minocycline|minocycline|mesh-list
14368715|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14368716|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368717|NCT01134705|Beclomethasone|beclomethasone|mesh-list
14368718|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368719|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
14368720|NCT01134705|Hormones|hormones|mesh-ancestor
14368721|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368722|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368723|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14368724|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
14368725|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14368726|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14368727|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368728|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14368729|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14368730|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368731|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14368732|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14368733|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14368734|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
14368735|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733079|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14368736|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14368737|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14733080|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733081|NCT03491683|Temozolomide|temozolomide|mesh-list
14733082|NCT03491683|Cemiplimab|cemiplimab|mesh-list
14368738|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
14368739|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
14368740|NCT01134952|Sirolimus|sirolimus|mesh-list
14368741|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14368742|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368743|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14733083|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733084|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
14733085|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368744|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
14368745|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14368746|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368747|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368748|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368749|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
14368750|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368751|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
14368752|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465989|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14465990|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14465991|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14465992|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14465993|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14465994|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14465995|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
14465996|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14465997|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14465998|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14465999|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14466000|NCT02234427|Aspirin|aspirin|mesh-list
14466001|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14466002|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466003|NCT02234427|Analgesics|analgesics|mesh-ancestor
14466004|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
14466005|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466006|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466007|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466008|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466009|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14466010|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14466011|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466012|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14466013|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14466014|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466015|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
14466016|NCT02234570|Oxfendazole|oxfendazole|mesh-list
14466017|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
14466018|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14466019|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466020|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
14466021|NCT02234596|Nintedanib|nintedanib|mesh-list
14466022|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466023|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14466024|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466025|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466026|NCT02234752|Memantine|memantine|mesh-list
14466027|NCT02234752|Galantamine|galantamine|mesh-list
14466028|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14466029|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14466030|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
14466031|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733086|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733087|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368753|NCT01135017|Dronedarone|dronedarone|mesh-list
14368754|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14368755|NCT01135069|Tretinoin|tretinoin|mesh-list
14368756|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368757|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
14368758|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14368759|NCT01135186|Verapamil|verapamil|mesh-list
14368760|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14368761|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14368762|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368763|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368764|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14368765|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368766|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
14368767|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
14368768|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
14368769|NCT01135329|Busulfan|busulfan|mesh-list
14368770|NCT01135329|Fludarabine|fludarabine|mesh-list
14368771|NCT01135329|Tacrolimus|tacrolimus|mesh-list
14368772|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368773|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
14368774|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368775|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14368776|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14368777|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
14368778|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368779|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368780|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14368781|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14368782|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368783|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14368784|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14368785|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
14368786|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14368787|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368788|NCT01135368|Lansoprazole|lansoprazole|mesh-list
14368789|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
14368790|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14368791|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14368792|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14368793|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368794|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368795|NCT01135394|Pioglitazone|pioglitazone|mesh-list
14368796|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368797|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368798|NCT01135498|Bevacizumab|bevacizumab|mesh-list
14368799|NCT01135498|Capecitabine|capecitabine|mesh-list
14368800|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14368801|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
14368802|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368803|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368804|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368805|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368806|NCT01135498|Growth Substances|growth substances|mesh-ancestor
14368807|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368808|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
14368809|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14368810|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
14368811|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368812|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368813|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368814|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14368815|NCT01135511|Tofacitinib|tofacitinib|mesh-list
14368816|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
14368817|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14368818|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368819|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368820|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368821|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14368822|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
14368823|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368824|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
14368825|NCT01135511|Protective Agents|protective agents|mesh-ancestor
14368826|NCT01135524|Buprenorphine|buprenorphine|mesh-list
14368827|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14368828|NCT01135524|Narcotics|narcotics|mesh-ancestor
14368829|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14368830|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368831|NCT01135524|Analgesics|analgesics|mesh-ancestor
14368832|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
14368833|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368834|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14368835|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
14368836|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14368837|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
14368838|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368839|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368840|NCT01135914|Ranibizumab|ranibizumab|mesh-list
14368841|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368842|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368843|NCT01135914|Growth Substances|growth substances|mesh-ancestor
14368844|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368845|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
14368846|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368847|NCT01135992|Insulin|insulin|mesh-list
14368848|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14368849|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
14368850|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368851|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368852|NCT01136174|Nintedanib|nintedanib|mesh-list
14368853|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368854|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368855|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368856|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368857|NCT01136226|Leuprolide|leuprolide|mesh-list
14368858|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14368859|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
14368860|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14368861|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368862|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14368863|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368864|NCT01136356|Morphine|morphine|mesh-list
14733088|NCT03481634|Aflibercept|aflibercept|mesh-list
14733089|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368865|NCT01136356|Buprenorphine|buprenorphine|mesh-list
14368866|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14368867|NCT01136356|Narcotics|narcotics|mesh-ancestor
14368868|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14368869|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368870|NCT01136356|Analgesics|analgesics|mesh-ancestor
14368871|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
14368872|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368873|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14368874|NCT01136382|Budesonide|budesonide|mesh-list
14368875|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368876|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14368877|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
14368878|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733090|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368879|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368880|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14368881|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
14368882|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
14368883|NCT01136382|Hormones|hormones|mesh-ancestor
14368884|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368885|NCT01136408|Warfarin|warfarin|mesh-list
14368886|NCT01136408|Dabigatran|dabigatran|mesh-list
14368887|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
14368888|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
14368889|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14368890|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
14368891|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368892|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368893|NCT01136655|Budesonide|budesonide|mesh-list
14368894|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
14368895|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14368896|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14368897|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14368898|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
14368899|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368900|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368901|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14368902|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
14368903|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
14368904|NCT01136655|Hormones|hormones|mesh-ancestor
14368905|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368906|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14368907|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14368908|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14368909|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14368910|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368911|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368912|NCT01136733|Everolimus|everolimus|mesh-list
14368913|NCT01136733|Lenvatinib|lenvatinib|mesh-list
14368914|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368915|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14368916|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
14368917|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368918|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14368919|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368920|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368921|NCT01136746|Insulin|insulin|mesh-list
14368922|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14368923|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
14368924|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
14368925|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368926|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368927|NCT01136772|Haloperidol|haloperidol|mesh-list
14368928|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14368929|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
14368930|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14368931|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14368932|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14368933|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368934|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14368935|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14368936|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14368937|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
14368938|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14368939|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368940|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14368941|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14368942|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
14368943|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
14368944|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
14368945|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14368946|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14368947|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14368948|NCT01136798|Exenatide|exenatide|mesh-list
14368949|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368950|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368951|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14368952|NCT01136798|Incretins|incretins|mesh-ancestor
14368953|NCT01136798|Hormones|hormones|mesh-ancestor
14368954|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368955|NCT01136954|Zonisamide|zonisamide|mesh-list
14368956|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
14368957|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14368958|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14368959|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368960|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14368961|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368962|NCT01137071|Antibodies|antibodies|mesh-list
14368963|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14368964|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
14368965|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368966|NCT01137292|Voriconazole|voriconazole|mesh-list
14368967|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
14368968|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14368969|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14368970|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14368971|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14368972|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368973|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14368974|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
14368975|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14368976|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368977|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14368978|NCT01137396|Modafinil|modafinil|mesh-list
14368979|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14368980|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368981|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14368982|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14368983|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14368984|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368985|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
14368986|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14368987|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14368988|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14368989|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368990|NCT01137604|Bevacizumab|bevacizumab|mesh-list
14368991|NCT01137604|Lenvatinib|lenvatinib|mesh-list
14368992|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14368993|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14368994|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14368995|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14368996|NCT01137604|Growth Substances|growth substances|mesh-ancestor
14368997|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14368998|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
14368999|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14369000|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369001|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369002|NCT01137682|Octreotide|octreotide|mesh-list
14369003|NCT01137682|Lanreotide|lanreotide|mesh-list
14369004|NCT01137682|Pasireotide|pasireotide|mesh-list
14369005|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14369006|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14369007|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369008|NCT01137682|Hormones|hormones|mesh-ancestor
14369009|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369010|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369011|NCT01137812|Metformin|metformin|mesh-list
14369012|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14369013|NCT01137812|Canagliflozin|canagliflozin|mesh-list
14369014|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14369015|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369016|NCT01137812|Incretins|incretins|mesh-ancestor
14369017|NCT01137812|Hormones|hormones|mesh-ancestor
14369018|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369019|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14369020|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
14369021|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369022|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369023|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14369024|NCT01137890|Zonisamide|zonisamide|mesh-list
14369025|NCT01137890|Cocaine|cocaine|mesh-list
14369026|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
14369027|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14369028|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369029|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369030|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14369031|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369032|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
14369033|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
14369034|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369035|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
14733091|NCT03481634|Growth Substances|growth substances|mesh-ancestor
14733092|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733093|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733094|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733095|NCT03472573|Dexamethasone|dexamethasone|mesh-list
14733096|NCT03472573|Palbociclib|palbociclib|mesh-list
14733097|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733098|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
14733099|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
14733100|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733101|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733102|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14733103|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
14733104|NCT03472573|Hormones|hormones|mesh-ancestor
14733105|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233612|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369036|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369037|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14369038|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14369039|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14369040|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
14369041|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369042|NCT01138046|Paclitaxel|paclitaxel|mesh-list
14369043|NCT01138046|Lapatinib|lapatinib|mesh-list
14369044|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14369045|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369046|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14369047|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14369048|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14369049|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369050|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14369051|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369052|NCT01138124|Gabapentin|gabapentin|mesh-list
14369053|NCT01138124|Analgesics|analgesics|mesh-ancestor
15233613|NCT02819635|Upadacitinib|upadacitinib|mesh-list
15233614|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15233615|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233616|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233617|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369054|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
14369055|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369056|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369057|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
14369058|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14369059|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369060|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369061|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369062|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14369063|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14369064|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369065|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369066|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
14369067|NCT01138150|Naproxen|naproxen|mesh-list
14369068|NCT01138150|Sumatriptan|sumatriptan|mesh-list
14369069|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14369070|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14369071|NCT01138150|Analgesics|analgesics|mesh-ancestor
14369072|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
14369073|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369074|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233618|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233619|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
15233620|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15233621|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14369075|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369076|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369077|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
14369078|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14369079|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369080|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369081|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14369082|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14369083|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14369084|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
14369085|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369086|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
14369087|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14369088|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369089|NCT01138475|Vitamins|vitamins|mesh-ancestor
14369090|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
14369091|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14369092|NCT01138501|Factor VIII|factor viii|mesh-list
14369093|NCT01138501|Coagulants|coagulants|mesh-ancestor
14369094|NCT01138514|Clindamycin|clindamycin|mesh-list
14369095|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
14369096|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
14369097|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14369098|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369099|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369100|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14369101|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369102|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369103|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369104|NCT01138657|Prednisone|prednisone|mesh-list
14369105|NCT01138657|Adalimumab|adalimumab|mesh-list
14369106|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369107|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
14369108|NCT01138657|Hormones|hormones|mesh-ancestor
14369109|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369110|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369111|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14369112|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369113|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369114|NCT01138735|Adapalene|adapalene|mesh-list
14369115|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14369116|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14369117|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369118|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14369119|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14369120|NCT01138735|Analgesics|analgesics|mesh-ancestor
14369121|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
14369122|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369123|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369124|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369125|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369126|NCT01138826|Amlodipine|amlodipine|mesh-list
14369127|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14369128|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14369129|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369130|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369131|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14369132|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369133|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
14369134|NCT01138969|Esomeprazole|esomeprazole|mesh-list
14369135|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14369136|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14369137|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14369138|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369139|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369140|NCT01139008|Metronidazole|metronidazole|mesh-list
14369141|NCT01139008|Azelaic acid|azelaic acid|mesh-list
14369142|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369143|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369144|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14369145|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14369146|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369147|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369148|NCT01139047|Metronidazole|metronidazole|mesh-list
14369149|NCT01139047|Azelaic acid|azelaic acid|mesh-list
14369150|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369151|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369152|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14369153|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14369154|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369155|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369156|NCT01139190|Naproxen|naproxen|mesh-list
14369157|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14369158|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14369159|NCT01139190|Analgesics|analgesics|mesh-ancestor
14369160|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
14369161|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369162|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369163|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369164|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369165|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
14369166|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14369167|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369168|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369169|NCT01139450|Tacrolimus|tacrolimus|mesh-list
14369170|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369171|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
14369172|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369173|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14369174|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369175|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369176|NCT01139515|Eletriptan|eletriptan|mesh-list
14369177|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14369178|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
14369179|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369180|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369181|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369182|NCT01139580|Calcipotriene|calcipotriene|mesh-list
14369183|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369184|NCT01139762|Tadalafil|tadalafil|mesh-list
14369185|NCT01139762|Finasteride|finasteride|mesh-list
14369186|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
14369187|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14369188|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14369189|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369190|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369191|NCT01139762|Urological Agents|urological agents|mesh-ancestor
14369192|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14369193|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14369194|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
14369195|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369196|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369197|NCT01139775|Pemetrexed|pemetrexed|mesh-list
14369198|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369199|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369200|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369201|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14369202|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369203|NCT01139801|Misoprostol|misoprostol|mesh-list
14369204|NCT01139801|Oxytocin|oxytocin|mesh-list
14369205|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
14369206|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14369207|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369208|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14369209|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
14369210|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14369211|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14369212|NCT01140061|MK 0873|mk 0873|mesh-list
14369213|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14369214|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14369215|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369216|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369217|NCT01140191|Gentamicins|gentamicins|mesh-list
14369218|NCT01140191|Paromomycin|paromomycin|mesh-list
14369219|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369220|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369221|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14369222|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369223|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369224|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14369225|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14369226|NCT01140347|Ramucirumab|ramucirumab|mesh-list
14369227|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369228|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
14369229|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369230|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14369231|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369232|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369233|NCT01140503|Apremilast|apremilast|mesh-list
14369234|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14369235|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14369236|NCT01140503|Analgesics|analgesics|mesh-ancestor
14369237|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
14369238|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369239|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369240|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369241|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369242|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14369243|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14369244|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369245|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369246|NCT01140880|Tenofovir|tenofovir|mesh-list
14369247|NCT01140880|Emtricitabine|emtricitabine|mesh-list
14369248|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14369249|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
14369250|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369251|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14369252|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369253|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369254|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733106|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14369255|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14369256|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14733107|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733108|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14733109|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733110|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733111|NCT03403569|Triptolide|triptolide|mesh-list
15233622|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
15233623|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15233624|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233625|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
15233626|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
15233627|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233628|NCT02740127|Dexamethasone|dexamethasone|mesh-list
15233629|NCT02740127|Clonidine|clonidine|mesh-list
14369257|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14369258|NCT01140906|Vortioxetine|vortioxetine|mesh-list
14369259|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14369260|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14369261|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369262|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369263|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369264|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369265|NCT01140906|Analgesics|analgesics|mesh-ancestor
14369266|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
14369267|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369268|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
14369269|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369270|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
14369271|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14369272|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369273|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369274|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14369275|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
14369276|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14369277|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14369278|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14369279|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14369280|NCT01141049|Gabapentin|gabapentin|mesh-list
14369281|NCT01141049|Analgesics|analgesics|mesh-ancestor
14369282|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
14369283|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369284|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369285|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
14369286|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14369287|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369288|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369289|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369290|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14369291|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14369292|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369293|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369294|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
14369295|NCT01141283|Buprenorphine|buprenorphine|mesh-list
14369296|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14369297|NCT01141283|Narcotics|narcotics|mesh-ancestor
14369298|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369299|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369300|NCT01141283|Analgesics|analgesics|mesh-ancestor
14369301|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
14369302|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369303|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14369304|NCT01141478|Sorafenib|sorafenib|mesh-list
14369305|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233630|NCT02740127|Epinephrine|epinephrine|mesh-list
14469901|NCT02300311|Vitamins|vitamins|mesh-ancestor
14469902|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
14469903|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469904|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
14469905|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469906|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
14469907|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469908|NCT02300610|Gemcitabine|gemcitabine|mesh-list
14469909|NCT02300610|Cisplatin|cisplatin|mesh-list
14469910|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469911|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14369306|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14369307|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369308|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369309|NCT01141491|Vaccines|vaccines|mesh-list
14369310|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14369311|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
14369312|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369313|NCT01141569|R04929097|r04929097|mesh-list
14369314|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369315|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369316|NCT01141595|Verapamil|verapamil|mesh-list
14369317|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14369318|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14369319|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369320|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369321|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14369322|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369323|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
14466032|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466033|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466034|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14466035|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14466036|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14466037|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466038|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
14466039|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14466040|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
14466041|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466042|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
14466043|NCT02235064|Sertraline|sertraline|mesh-list
14466044|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
14466045|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14466046|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14466047|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14466048|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466049|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466050|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466051|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
14466052|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466053|NCT02235077|Spironolactone|spironolactone|mesh-list
14466054|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15233631|NCT02740127|Propofol|propofol|mesh-list
14466055|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
14466056|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466057|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466058|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14466059|NCT02235077|Diuretics|diuretics|mesh-ancestor
14466060|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
14466061|NCT02235298|Metformin|metformin|mesh-list
14466062|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
14466063|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14466064|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466065|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14466066|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466067|NCT02235311|Pantoprazole|pantoprazole|mesh-list
14466068|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14466069|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233632|NCT02740127|Ropivacaine|ropivacaine|mesh-list
15233633|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233634|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
15233635|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
15233636|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233637|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233638|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233639|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
14369324|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14369325|NCT01141725|Idarubicin|idarubicin|mesh-list
14369326|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14369327|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
14369328|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369329|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369330|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14733112|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14733113|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369331|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14369332|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14369333|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369334|NCT01142089|Rifamycins|rifamycins|mesh-list
14369335|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
14369336|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369337|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369338|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369339|NCT01142193|Topiramate|topiramate|mesh-list
14369340|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
14369341|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14369342|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369343|NCT01142232|Lenalidomide|lenalidomide|mesh-list
14369344|NCT01142232|Melphalan|melphalan|mesh-list
14369345|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
14369346|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369347|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14469912|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
14469913|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469914|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
14469915|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469916|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469917|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469918|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
14469919|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469920|NCT02300727|Curcumin|curcumin|mesh-list
14369348|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14369349|NCT01142232|Growth Substances|growth substances|mesh-ancestor
14369350|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
14369351|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369352|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14369353|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
14369354|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369355|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14369356|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369357|NCT01142310|Lamotrigine|lamotrigine|mesh-list
14369358|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
14369359|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14369360|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369361|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369362|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14369363|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369364|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14369365|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369366|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369367|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369368|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14369369|NCT01142323|Fenofibrate|fenofibrate|mesh-list
14369370|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14369371|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
14369372|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369373|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14369374|NCT01142336|Simvastatin|simvastatin|mesh-list
14369375|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14369376|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14369377|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
14369378|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369379|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14369380|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14733114|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14733115|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
15233640|NCT02740127|Hormones|hormones|mesh-ancestor
15233641|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233642|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15233643|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233644|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233645|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15233646|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233647|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15233648|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
15233649|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
15233650|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
15233651|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
15233652|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15233653|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15233654|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
15233655|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233656|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15233657|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15233658|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15233659|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
15233660|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
15233661|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
15233662|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14369381|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369382|NCT01142466|Interferons|interferons|mesh-list
14369383|NCT01142466|Interferon-beta|interferon-beta|mesh-list
14369384|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
14369385|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369386|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
14369387|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369388|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
14369389|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369390|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14369391|NCT01142726|Methotrexate|methotrexate|mesh-list
14369392|NCT01142726|Abatacept|abatacept|mesh-list
14369393|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14369394|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
14369395|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14369396|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369397|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14369398|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
14369399|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369400|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369401|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369402|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369403|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14369404|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369405|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
14369406|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369407|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369408|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14369409|NCT01142947|Beclomethasone|beclomethasone|mesh-list
14369410|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369411|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
15233663|NCT02740127|Analgesics|analgesics|mesh-ancestor
15233664|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15233665|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
15233666|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15233667|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
15233668|NCT02737475|Nivolumab|nivolumab|mesh-list
15233669|NCT02737475|Ipilimumab|ipilimumab|mesh-list
15233670|NCT02737475|Vaccines|vaccines|mesh-list
15233671|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
15233672|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233673|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369412|NCT01142947|Hormones|hormones|mesh-ancestor
15233674|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369413|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369414|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369415|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14369416|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
14369417|NCT01143051|Epinephrine|epinephrine|mesh-list
14369418|NCT01143051|Racepinephrine|racepinephrine|mesh-list
14369419|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
14369420|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14369421|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14369422|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369423|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369424|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369425|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369426|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14369427|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14369428|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
14369429|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369430|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14369431|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14369432|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
14369433|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
14369434|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14369435|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14369436|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14369437|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369438|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369439|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369440|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369441|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14369442|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14369443|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14369444|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369445|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369446|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369447|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14369448|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14369449|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
14369450|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14369451|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14369452|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
14369453|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14369454|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14369455|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369456|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369457|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369458|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369459|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14369460|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14369461|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14369462|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369463|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369464|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369465|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14369466|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14369467|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
14369468|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14369469|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14369470|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
14369471|NCT01143181|Brincidofovir|brincidofovir|mesh-list
14369472|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
14369473|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369474|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14369475|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
14369476|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14369477|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14369478|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14369479|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
14369480|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14369481|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369482|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14369483|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14369484|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14369485|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14369486|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369487|NCT01143259|Alvimopan|alvimopan|mesh-list
14369488|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14369489|NCT01143337|Methotrexate|methotrexate|mesh-list
14369490|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14369491|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
14369492|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14369493|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369494|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14369495|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
14369496|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369497|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369498|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369499|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369500|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14369501|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369502|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
14369503|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233675|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233676|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
15233677|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233678|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233679|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233680|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233681|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15233682|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
15233683|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233684|NCT02709512|Cisplatin|cisplatin|mesh-list
15233685|NCT02709512|Pemetrexed|pemetrexed|mesh-list
15233686|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369504|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369505|NCT01143389|Riboflavin|riboflavin|mesh-list
14369506|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
14369507|NCT01143389|Vitamins|vitamins|mesh-ancestor
14369508|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
14369509|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369510|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14369511|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369512|NCT01143402|Temozolomide|temozolomide|mesh-list
14369513|NCT01143402|Dacarbazine|dacarbazine|mesh-list
14369514|NCT01143402|Imidazole|imidazole|mesh-list
14369515|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14369516|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
14369517|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369518|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369519|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369520|NCT01143688|Albuterol|albuterol|mesh-list
14369521|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14369522|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
14369523|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369524|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369525|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14369526|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
14369527|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
14369528|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14369529|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14369530|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14369531|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14369532|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369533|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369534|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369535|NCT01143714|Petrolatum|petrolatum|mesh-list
14369536|NCT01143714|Emollients|emollients|mesh-ancestor
14369537|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369538|NCT01143766|Gabapentin|gabapentin|mesh-list
14369539|NCT01143766|Analgesics|analgesics|mesh-ancestor
14369540|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
14369541|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369542|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369543|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
14369544|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14369545|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369546|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369547|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369548|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14369549|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14369550|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369551|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369552|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
14369553|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
14369554|NCT01143818|Testosterone|testosterone|mesh-list
14369555|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
14369556|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
14733116|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14733117|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733118|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
14733119|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733120|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
14733121|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733122|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733126|NCT03336203|Allopurinol|allopurinol|mesh-list
14733127|NCT03336203|Febuxostat|febuxostat|mesh-list
14733128|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
14733129|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369557|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14369558|NCT01143818|Androgens|androgens|mesh-ancestor
14369559|NCT01143818|Hormones|hormones|mesh-ancestor
14369560|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733130|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733131|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
14733132|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733133|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14733134|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
14733135|NCT03336203|Protective Agents|protective agents|mesh-ancestor
14733136|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733137|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
14733138|NCT03315897|Hematinics|hematinics|mesh-ancestor
14733139|NCT03288545|Gemcitabine|gemcitabine|mesh-list
14733140|NCT03288545|Carboplatin|carboplatin|mesh-list
14733141|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
14369561|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369562|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14369563|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369564|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
14369565|NCT01144052|Interferons|interferons|mesh-list
15233687|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233688|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233689|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15233690|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15233691|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
15233692|NCT02703714|Sargramostim|sargramostim|mesh-list
15233693|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233694|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233695|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
15233696|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233697|NCT02689440|Dasatinib|dasatinib|mesh-list
14369566|NCT01144052|Interferon-beta|interferon-beta|mesh-list
14369567|NCT01144052|Natalizumab|natalizumab|mesh-list
14369568|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
14733142|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733143|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14369569|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733144|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
14753802|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14369570|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
14369571|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369572|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
14369573|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369574|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14369575|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
14369576|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14369577|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14369578|NCT01144143|Prednisolone|prednisolone|mesh-list
14369579|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
14369580|NCT01144143|Infliximab|infliximab|mesh-list
14369581|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14369582|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
14369583|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369584|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
14369585|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
14369586|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369587|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369588|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14369589|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
14369590|NCT01144143|Hormones|hormones|mesh-ancestor
14369591|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369592|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14369593|NCT01144143|Protective Agents|protective agents|mesh-ancestor
14369594|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14369595|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369596|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14369597|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369598|NCT01144338|Exenatide|exenatide|mesh-list
14369599|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14369600|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369601|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14369602|NCT01144338|Incretins|incretins|mesh-ancestor
14369603|NCT01144338|Hormones|hormones|mesh-ancestor
14369604|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369605|NCT01144364|Rituximab|rituximab|mesh-list
14369606|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14369607|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369608|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
14369609|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369610|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369611|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
14369612|NCT01144403|Rituximab|rituximab|mesh-list
14369613|NCT01144403|Fludarabine|fludarabine|mesh-list
14369614|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
14369615|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369616|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
14369617|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369618|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369619|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14369620|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
14369621|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733145|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733146|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
14733147|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733148|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733149|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369622|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369623|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14369624|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733150|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
14369625|NCT01144403|Analgesics|analgesics|mesh-ancestor
14369626|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
14369627|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369628|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14369629|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14369630|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369631|NCT01144442|Paclitaxel|paclitaxel|mesh-list
14369632|NCT01144442|Carboplatin|carboplatin|mesh-list
14369633|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14369634|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369635|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14369636|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14369637|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14369638|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369639|NCT01144455|Gemcitabine|gemcitabine|mesh-list
14369640|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
14369641|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14369642|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
14369643|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369644|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369645|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
14369646|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369647|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369648|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369649|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
14369650|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369651|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14369652|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
14369653|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14369654|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
14369655|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14369656|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14369657|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14369658|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14369659|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369660|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369661|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369662|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369663|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14369664|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14369665|NCT01144949|Silodosin|silodosin|mesh-list
14369666|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14369667|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14369668|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14369669|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369670|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369671|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369672|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369673|NCT01144949|Urological Agents|urological agents|mesh-ancestor
14369674|NCT01145001|Nicotine|nicotine|mesh-list
14369675|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14369676|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
14369677|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369678|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369679|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14369680|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14369681|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
14369682|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369683|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369684|NCT01145066|Borage oil|borage oil|mesh-list
14369685|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369686|NCT01145183|Doxazosin|doxazosin|mesh-list
14369687|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14753803|NCT04975308|Fulvestrant|fulvestrant|mesh-list
14369688|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14369689|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14369690|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14369691|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369692|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369693|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369694|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369695|NCT01145222|Midazolam|midazolam|mesh-list
14369696|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14369697|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14369698|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369699|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369700|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14369701|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369702|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369703|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14369704|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
14369705|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
14369706|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
14369707|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
14369708|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369709|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369710|NCT01145352|Etanercept|etanercept|mesh-list
14369711|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14369712|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14369713|NCT01145352|Analgesics|analgesics|mesh-ancestor
14369714|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
14369715|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369716|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369717|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369718|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369719|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14369720|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369721|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
14733151|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733152|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733153|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
14733154|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
14733155|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14733156|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14733157|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369722|NCT01145417|Pregabalin|pregabalin|mesh-list
14369723|NCT01145417|Analgesics|analgesics|mesh-ancestor
14733158|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369724|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
14369725|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369726|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369727|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
14369728|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14369729|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369730|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369731|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14369732|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14369733|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14369734|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369735|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369736|NCT01145482|Insulin|insulin|mesh-list
14369737|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
14369738|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14369739|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369740|NCT01145508|Metronidazole|metronidazole|mesh-list
14369741|NCT01145508|Prednisone|prednisone|mesh-list
14369742|NCT01145508|Cortisone|cortisone|mesh-list
14369743|NCT01145508|Docetaxel|docetaxel|mesh-list
14369744|NCT01145508|Vaccines|vaccines|mesh-list
14369745|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
14369746|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369747|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369748|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
14369749|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
14369750|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
14369751|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369752|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369753|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
14369754|NCT01145508|Hormones|hormones|mesh-ancestor
14369755|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14369756|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14369757|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369758|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369759|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14369760|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14369761|NCT01145625|Minoxidil|minoxidil|mesh-list
14369762|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14369763|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
14369764|NCT01145638|Iron|iron|mesh-list
14369765|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14369766|NCT01145638|Trace Elements|trace elements|mesh-ancestor
14369767|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
14369768|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369769|NCT01145638|Hematinics|hematinics|mesh-ancestor
14369770|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14369771|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14369772|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14369773|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466070|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14369774|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369775|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369776|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369777|NCT01145755|Analgesics|analgesics|mesh-ancestor
14369778|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
14369779|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369780|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
14369781|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14369782|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
14369783|NCT01145898|Timolol|timolol|mesh-list
14369784|NCT01145898|Dorzolamide|dorzolamide|mesh-list
14369785|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14369786|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14369787|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
14369788|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14369789|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369790|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369791|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14369792|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14369793|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14369794|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369795|NCT01146054|Gemcitabine|gemcitabine|mesh-list
14369796|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14369797|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14369798|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
14369799|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369800|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369801|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
14369802|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369803|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369804|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369805|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
14369806|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369807|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14369808|NCT01146288|Furosemide|furosemide|mesh-list
14369809|NCT01146288|Acetazolamide|acetazolamide|mesh-list
14369810|NCT01146288|Diuretics|diuretics|mesh-ancestor
14369811|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
14369812|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369813|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14369814|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369815|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369816|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
14753804|NCT04975308|Exemestane|exemestane|mesh-list
14369817|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14733159|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733160|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733161|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14733162|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
14733163|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733164|NCT03278925|Protective Agents|protective agents|mesh-ancestor
14733165|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733166|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14733167|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14733168|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733169|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14733170|NCT03228693|Triamcinolone|triamcinolone|mesh-list
14369818|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369819|NCT01146457|Morphine|morphine|mesh-list
14369820|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14369821|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14369822|NCT01146457|Narcotics|narcotics|mesh-ancestor
14369823|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14369824|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369825|NCT01146457|Analgesics|analgesics|mesh-ancestor
14369826|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
14369827|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369828|NCT01146561|Tanezumab|tanezumab|mesh-list
14369829|NCT01146561|Analgesics|analgesics|mesh-ancestor
14369830|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
14369831|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369832|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369833|NCT01146600|Clarithromycin|clarithromycin|mesh-list
14369834|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369835|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369836|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14369837|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369838|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369839|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14369840|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14369841|NCT01146613|Varenicline|varenicline|mesh-list
14369842|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15233698|NCT02689440|Venetoclax|venetoclax|mesh-list
15233699|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233700|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233701|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233702|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369843|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14369844|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
14369845|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233703|NCT02684006|Sunitinib|sunitinib|mesh-list
15233704|NCT02684006|Avelumab|avelumab|mesh-list
15233705|NCT02684006|Axitinib|axitinib|mesh-list
15233706|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233707|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15233708|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15233709|NCT02684006|Growth Substances|growth substances|mesh-ancestor
15233710|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233711|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
15233712|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233713|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233714|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233715|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233716|NCT02642965|Cytarabine|cytarabine|mesh-list
14733171|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233717|NCT02642965|Fludarabine|fludarabine|mesh-list
14369846|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369847|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369848|NCT01146795|Paclitaxel|paclitaxel|mesh-list
14369849|NCT01146795|Bevacizumab|bevacizumab|mesh-list
14369850|NCT01146795|Carboplatin|carboplatin|mesh-list
14369851|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14369852|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369853|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
14369854|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
14369855|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
14369856|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369857|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14369858|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14369859|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14369860|NCT01146795|Growth Substances|growth substances|mesh-ancestor
14369861|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369862|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14369863|NCT01146808|Adefovir|adefovir|mesh-list
14369864|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14369865|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
14369866|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369867|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14369868|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369869|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369870|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369871|NCT01146834|Plerixafor|plerixafor|mesh-list
14369872|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
14369873|NCT01146834|Bortezomib|bortezomib|mesh-list
14369874|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369875|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
14369876|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369877|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369878|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14369879|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
14369880|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369881|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369882|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14369883|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14369884|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14369885|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
14369886|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369887|NCT01146873|Ritonavir|ritonavir|mesh-list
14369888|NCT01146873|Lopinavir|lopinavir|mesh-list
14369889|NCT01146873|Abacavir|abacavir|mesh-list
14369890|NCT01146873|Stavudine|stavudine|mesh-list
14369891|NCT01146873|Efavirenz|efavirenz|mesh-list
14369892|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14369893|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14369894|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
14369895|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369896|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369897|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14369898|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14369899|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
14369900|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369901|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14369902|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14369903|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14369904|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369905|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14369906|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14369907|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14369908|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14369909|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14369910|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
14369911|NCT01146951|Rufinamide|rufinamide|mesh-list
14369912|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
14369913|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14369914|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14466071|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369915|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14369916|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369917|NCT01147055|Rifampin|rifampin|mesh-list
14369918|NCT01147055|Crizotinib|crizotinib|mesh-list
14369919|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14369920|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
14369921|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14369922|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369923|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
14369924|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369925|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369926|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369927|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14369928|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14369929|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15233718|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
15233719|NCT02642965|Daunorubicin|daunorubicin|mesh-list
15233720|NCT02642965|Lenograstim|lenograstim|mesh-list
15233721|NCT02642965|Sargramostim|sargramostim|mesh-list
15233722|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233723|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233724|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
14369930|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14369931|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14369932|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14369933|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14369934|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14466072|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466073|NCT02235987|Octreotide|octreotide|mesh-list
14466074|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466075|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14466076|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466077|NCT02236130|Acetaminophen|acetaminophen|mesh-list
14466078|NCT02236130|Morphine|morphine|mesh-list
14466079|NCT02236130|Hydrocodone|hydrocodone|mesh-list
14466080|NCT02236130|Analgesics|analgesics|mesh-list
14466081|NCT02236130|Anesthetics|anesthetics|mesh-list
14466082|NCT02236130|Ropivacaine|ropivacaine|mesh-list
14466083|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
14466084|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466085|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466086|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14466087|NCT02236130|Narcotics|narcotics|mesh-ancestor
14466088|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
14466089|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466090|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466091|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
14466092|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
14466093|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
14466094|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
14466095|NCT02236520|Spironolactone|spironolactone|mesh-list
14466096|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14466097|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
14466098|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233725|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233726|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233727|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
15233728|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233729|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
15233730|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233731|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15233732|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14369935|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
14369936|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
14369937|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
14369938|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369939|NCT01147107|Efavirenz|efavirenz|mesh-list
14369940|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
14369941|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14369942|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14369943|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369944|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369945|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
14369946|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14369947|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14369948|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14369949|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14369950|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14369951|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14369952|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14369953|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14369954|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14369955|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14369956|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14369957|NCT01147250|Lixisenatide|lixisenatide|mesh-list
14369958|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14369959|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369960|NCT01147302|Complement C1s|complement c1s|mesh-list
14369961|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14369962|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14369963|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
14369964|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369965|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14369966|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369967|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
14369968|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14369969|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
14369970|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369971|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369972|NCT01147380|Vaccines|vaccines|mesh-list
14369973|NCT01147380|Immunologic Factors|immunologic factors|mesh-ancestor
14369974|NCT01147380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369975|NCT01147458|Naproxen|naproxen|mesh-list
14369976|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14369977|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14369978|NCT01147458|Analgesics|analgesics|mesh-ancestor
14369979|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
14369980|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14369981|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369982|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369983|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14369984|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
14369985|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14369986|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14369987|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14369988|NCT01147497|Misoprostol|misoprostol|mesh-list
14369989|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14369990|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
14369991|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14369992|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14369993|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14369994|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14369995|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
14369996|NCT01147601|Timolol|timolol|mesh-list
15233733|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15233734|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15233735|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233736|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
15233737|NCT02638090|Vorinostat|vorinostat|mesh-list
15233738|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233739|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233740|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15233741|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233742|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233743|NCT02632175|Adalimumab|adalimumab|mesh-list
15233744|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14369997|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14369998|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14369999|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
14370000|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370001|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370002|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370003|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14370004|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14370005|NCT01147627|Insulin|insulin|mesh-list
14370006|NCT01147627|Pioglitazone|pioglitazone|mesh-list
14370007|NCT01147627|Exenatide|exenatide|mesh-list
14370008|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
14370009|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14370010|NCT01147627|Protamines|protamines|mesh-list
14370011|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14370012|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370013|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14370014|NCT01147627|Incretins|incretins|mesh-ancestor
14370015|NCT01147627|Hormones|hormones|mesh-ancestor
14370016|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370017|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
14370018|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370019|NCT01147627|Coagulants|coagulants|mesh-ancestor
14370020|NCT01147640|Metronidazole|metronidazole|mesh-list
14370021|NCT01147640|Meropenem|meropenem|mesh-list
14370022|NCT01147640|Tazobactam|tazobactam|mesh-list
14370023|NCT01147640|Ceftolozane|ceftolozane|mesh-list
14370024|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370025|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370026|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14370027|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14370028|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14370029|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370030|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370031|NCT01147744|Fluticasone|fluticasone|mesh-list
14370032|NCT01147744|Xhance|xhance|mesh-list
14370033|NCT01147744|Montelukast|montelukast|mesh-list
14370034|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370035|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14370036|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
14370037|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370038|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370039|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14370040|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
14370041|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14370042|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14370043|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14370044|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370045|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370046|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14370047|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14370048|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370049|NCT01147848|Fluticasone|fluticasone|mesh-list
15233745|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14370050|NCT01147848|Xhance|xhance|mesh-list
14370051|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15233746|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
15233747|NCT02629809|Fludarabine|fludarabine|mesh-list
15233748|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
14370052|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370053|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14370054|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
14370055|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370056|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370057|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14370058|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
14370059|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
14370060|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14370061|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14370062|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14370063|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14370064|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
14370065|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15233749|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
15233750|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233751|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
15233752|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233753|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233754|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233755|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
15233756|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233757|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370066|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370067|NCT01147926|Prucalopride|prucalopride|mesh-list
14370068|NCT01147926|Laxatives|laxatives|mesh-ancestor
14370069|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370070|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14370071|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14370072|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
14370073|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370074|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370075|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370076|NCT01148225|Adalimumab|adalimumab|mesh-list
14370077|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370078|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14370079|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14370080|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
14370081|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14370082|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14370083|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14370084|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
14370085|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14370086|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370087|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14370088|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14370089|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14370090|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14370091|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370092|NCT01148459|Vaccines|vaccines|mesh-list
14920720|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14920721|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920722|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920723|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
14920724|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14920725|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
14370093|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
14370094|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370095|NCT01148511|Ranibizumab|ranibizumab|mesh-list
14370096|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14370097|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14370098|NCT01148511|Growth Substances|growth substances|mesh-ancestor
14370099|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370100|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
14370101|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370102|NCT01148524|Vaccines|vaccines|mesh-list
14370103|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
14370104|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370105|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
14370106|NCT01148537|Buprenorphine|buprenorphine|mesh-list
14370107|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14370108|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370109|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370110|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14370111|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14370112|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370113|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370114|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370115|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14370116|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
14370117|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14370118|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370119|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14370120|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14370121|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14370122|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14370123|NCT01148537|Narcotics|narcotics|mesh-ancestor
14370124|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370125|NCT01148537|Analgesics|analgesics|mesh-ancestor
14370126|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
14370127|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370128|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14370129|NCT01148693|Gentamicins|gentamicins|mesh-list
14370130|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370131|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370132|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14370133|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370134|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370135|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14370136|NCT01148745|Hematinics|hematinics|mesh-ancestor
14370137|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14370138|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14370139|NCT01148771|Ertapenem|ertapenem|mesh-list
14370140|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370141|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370142|NCT01148810|Siponimod|siponimod|mesh-list
14370143|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14370144|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370145|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370146|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
14370147|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370148|NCT01148836|Ubiquinone|ubiquinone|mesh-list
14370149|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
14370150|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
14370151|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370152|NCT01148836|Vitamins|vitamins|mesh-ancestor
14370153|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14370154|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14370155|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370156|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14370157|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14370158|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370159|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370160|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
14370161|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370162|NCT01149096|Lenograstim|lenograstim|mesh-list
14370163|NCT01149096|Sargramostim|sargramostim|mesh-list
14370164|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14370165|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
14370166|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370167|NCT01149369|Aprepitant|aprepitant|mesh-list
14370168|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
14370169|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
14370170|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370171|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370172|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370173|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14370174|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370175|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370176|NCT01149421|Dulaglutide|dulaglutide|mesh-list
14370177|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14370178|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370179|NCT01149434|Everolimus|everolimus|mesh-list
14920726|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14920727|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14920728|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
14920729|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14920730|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
14920731|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14920732|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14920733|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
14920734|NCT04482803|Hormones|hormones|mesh-ancestor
14920735|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370180|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370181|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370182|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
14370183|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370184|NCT01149460|Valacyclovir|valacyclovir|mesh-list
14370185|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
14370186|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370187|NCT01149473|Losartan|losartan|mesh-list
14370188|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14370189|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14370190|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14370191|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14370192|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14370193|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233758|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233759|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14370194|NCT01149473|Diuretics|diuretics|mesh-ancestor
15233760|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
15233761|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233762|NCT02629159|Adalimumab|adalimumab|mesh-list
15233763|NCT02629159|Upadacitinib|upadacitinib|mesh-list
15233764|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233765|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233766|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15233767|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233768|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233769|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370195|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
14370196|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370197|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14370198|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370199|NCT01149486|Losartan|losartan|mesh-list
14370200|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14370201|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14370202|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14370203|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14370204|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14370205|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233770|NCT02611232|Liraglutide|liraglutide|mesh-list
15233771|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14370206|NCT01149486|Diuretics|diuretics|mesh-ancestor
14370207|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
14370208|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370209|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14370210|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370211|NCT01149538|Choline|choline|mesh-list
14370212|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
14370213|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14370214|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
14370215|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370216|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370217|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14370218|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
14370219|NCT01149616|Dexamethasone|dexamethasone|mesh-list
14370220|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370221|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
14370222|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
14370223|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370224|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370225|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370226|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
14370227|NCT01149616|Hormones|hormones|mesh-ancestor
14370228|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370229|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14370230|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370231|NCT01149655|Aripiprazole|aripiprazole|mesh-list
14370232|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
14370233|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14370234|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14370235|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14370236|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370237|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370238|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
14370239|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
14370240|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370241|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370242|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14370243|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14370244|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
14370245|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14370246|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14370247|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14370248|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14370249|NCT01149733|Tamsulosin|tamsulosin|mesh-list
14370250|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14370251|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14370252|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14370253|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
14370254|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370255|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370256|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370257|NCT01149733|Urological Agents|urological agents|mesh-ancestor
14370258|NCT01149759|Cyclosporine|cyclosporine|mesh-list
14370259|NCT01149759|Cyclosporins|cyclosporins|mesh-list
14370260|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370261|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370262|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370263|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
14370264|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370265|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
14370266|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370267|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
14370268|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14370269|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14370270|NCT01149785|Ketoconazole|ketoconazole|mesh-list
14370271|NCT01149785|Crizotinib|crizotinib|mesh-list
14370272|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
14370273|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370274|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14370275|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14370276|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370277|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370278|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14370279|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370280|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370281|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370282|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14370283|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370284|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14370285|NCT01149863|Plerixafor|plerixafor|mesh-list
14370286|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14370287|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14370288|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
14370289|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370290|NCT01149876|Tretinoin|tretinoin|mesh-list
14370291|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370292|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
14370293|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
14370294|NCT01150097|Everolimus|everolimus|mesh-list
14370295|NCT01150097|Tacrolimus|tacrolimus|mesh-list
14370296|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370297|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
14370298|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370299|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14370300|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370301|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370302|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370303|NCT01150123|Vaccines|vaccines|mesh-list
14370304|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
14370305|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370306|NCT01150461|Losartan|losartan|mesh-list
14370307|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
14370308|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14370309|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14370310|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14370311|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14370312|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370313|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14370314|NCT01150500|Sirolimus|sirolimus|mesh-list
14370315|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370316|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370317|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14370318|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370319|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
14370320|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370321|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
14370322|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370323|NCT01150760|Alvimopan|alvimopan|mesh-list
14370324|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370325|NCT01150838|Propofol|propofol|mesh-list
14370326|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14370327|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370328|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370329|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14370330|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
14370331|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
14370332|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
14370333|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14370334|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370335|NCT01151046|Exemestane|exemestane|mesh-list
14370336|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370337|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14370338|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14370339|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370340|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370341|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14370342|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733172|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
14370343|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370344|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370345|NCT01151085|Voriconazole|voriconazole|mesh-list
14370346|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
14370347|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370348|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14370349|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14370350|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370351|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370352|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14370353|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370354|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370355|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370356|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14370357|NCT01151098|Buprenorphine|buprenorphine|mesh-list
14370358|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14370359|NCT01151098|Narcotics|narcotics|mesh-ancestor
14370360|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370361|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370362|NCT01151098|Analgesics|analgesics|mesh-ancestor
14370363|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
14370364|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370365|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14370366|NCT01151137|Dronedarone|dronedarone|mesh-list
14370367|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14370368|NCT01151215|Anastrozole|anastrozole|mesh-list
14370369|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14370370|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370371|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14370372|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14370373|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370374|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370375|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14370376|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370377|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370378|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370379|NCT01151410|Enalapril|enalapril|mesh-list
14370380|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14370381|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
14370382|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370383|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370384|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14370385|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
14370386|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14370387|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
14370388|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370389|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
14370390|NCT01151436|Protective Agents|protective agents|mesh-ancestor
14370391|NCT01151449|R04929097|r04929097|mesh-list
14370392|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370393|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370394|NCT01151540|Rufinamide|rufinamide|mesh-list
14370395|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
14370396|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14370397|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14370398|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370399|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370400|NCT01151579|Albuterol|albuterol|mesh-list
14370401|NCT01151579|Ipratropium|ipratropium|mesh-list
14370402|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14370403|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
14370404|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370405|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733173|NCT03228693|Hormones|hormones|mesh-ancestor
14733174|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733175|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733176|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
14370406|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14370407|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
14370408|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
14370409|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14370410|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14370411|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14370412|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14370413|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
14370414|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370415|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370416|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14370417|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
14370418|NCT01151761|Gemcitabine|gemcitabine|mesh-list
14370419|NCT01151761|Cisplatin|cisplatin|mesh-list
14370420|NCT01151761|Carboplatin|carboplatin|mesh-list
14370421|NCT01151761|Fluorouracil|fluorouracil|mesh-list
14370422|NCT01151761|Capecitabine|capecitabine|mesh-list
14370423|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370424|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14370425|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
14370426|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370427|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
14733177|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733178|NCT03178552|Gemcitabine|gemcitabine|mesh-list
14370428|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370429|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733179|NCT03178552|Bevacizumab|bevacizumab|mesh-list
14733180|NCT03178552|Carboplatin|carboplatin|mesh-list
15233772|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233773|NCT02611232|Incretins|incretins|mesh-ancestor
15233774|NCT02611232|Hormones|hormones|mesh-ancestor
15233775|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233776|NCT02604433|Luspatercept|luspatercept|mesh-list
15233777|NCT02604433|Hematinics|hematinics|mesh-ancestor
15233778|NCT02598895|Carboplatin|carboplatin|mesh-list
14733181|NCT03178552|Pemetrexed|pemetrexed|mesh-list
14733182|NCT03178552|Atezolizumab|atezolizumab|mesh-list
14733183|NCT03178552|Vemurafenib|vemurafenib|mesh-list
15233779|NCT02598895|Docetaxel|docetaxel|mesh-list
14370430|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370431|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
14370432|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370433|NCT01151813|Varenicline|varenicline|mesh-list
14370434|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14370435|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14370436|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
14370437|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370438|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370439|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370440|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
14370441|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370442|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14370443|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370444|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370445|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
14370446|NCT01152021|Propofol|propofol|mesh-list
14370447|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14370448|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370449|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370450|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14370451|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
14370452|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
14370453|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14370454|NCT01152021|Analgesics|analgesics|mesh-ancestor
14370455|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
14370456|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370457|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14370458|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14370459|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14370460|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14733184|NCT03178552|Entrectinib|entrectinib|mesh-list
15233780|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233781|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
15233782|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
15233783|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
15233784|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233785|NCT02582775|Vidarabine|vidarabine|mesh-list
15233786|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
15233787|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
14733185|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233788|NCT02582775|Busulfan|busulfan|mesh-list
14733186|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233789|NCT02582775|Fludarabine|fludarabine|mesh-list
15233790|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
15233791|NCT02582775|Tacrolimus|tacrolimus|mesh-list
14370461|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370462|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370463|NCT01152190|Tadalafil|tadalafil|mesh-list
14370464|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
14370465|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14370466|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14370467|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370468|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370469|NCT01152190|Urological Agents|urological agents|mesh-ancestor
14370470|NCT01152437|Cetuximab|cetuximab|mesh-list
14370471|NCT01152437|Afatinib|afatinib|mesh-list
14370472|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14370473|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370474|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14370475|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370476|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370477|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
14370478|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14370479|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
14370480|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370481|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370482|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14370483|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
14370484|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
14370485|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14370486|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
14370487|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370488|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370489|NCT01152515|Remifentanil|remifentanil|mesh-list
14370490|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14370491|NCT01152515|Narcotics|narcotics|mesh-ancestor
14370492|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370493|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370494|NCT01152515|Analgesics|analgesics|mesh-ancestor
14370495|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
14370496|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370497|NCT01152580|Melatonin|melatonin|mesh-list
14370498|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
14370499|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370500|NCT01152580|Protective Agents|protective agents|mesh-ancestor
14370501|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233792|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
15233793|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15233794|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233795|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
15233796|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233797|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233798|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233799|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
15233800|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233801|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233802|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233803|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233804|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
15233805|NCT02582775|Antiviral Agents|antiviral agents|mesh-ancestor
15233806|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233807|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15233808|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233809|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15233810|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15233811|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
15233812|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15233813|NCT02570542|Cytarabine|cytarabine|mesh-list
15233814|NCT02570542|Plerixafor|plerixafor|mesh-list
15233815|NCT02570542|Etoposide|etoposide|mesh-list
15233816|NCT02570542|Melphalan|melphalan|mesh-list
15233817|NCT02570542|Carmustine|carmustine|mesh-list
15233818|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15233819|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233820|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14370502|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370503|NCT01152697|Haloperidol|haloperidol|mesh-list
14370504|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
14370505|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
14370506|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
14370507|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370508|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370509|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370510|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14370511|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14370512|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370513|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14370514|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14370515|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
14370516|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370517|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370518|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14466099|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466100|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14466101|NCT02236520|Diuretics|diuretics|mesh-ancestor
14466102|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
14466103|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466104|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14466105|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466106|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466107|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
14466108|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14466109|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14466110|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14466111|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
14466112|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466113|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466114|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466115|NCT02236988|Thalidomide|thalidomide|mesh-list
14466116|NCT02236988|Apremilast|apremilast|mesh-list
14466117|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14466118|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466119|NCT02236988|Analgesics|analgesics|mesh-ancestor
14466120|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
14466121|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466122|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466123|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466124|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466125|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14466126|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14466127|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466128|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466129|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466130|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
14466131|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
14466132|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14466133|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466134|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14466135|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14466136|NCT02236988|Growth Substances|growth substances|mesh-ancestor
14466137|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
14466138|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466139|NCT02237157|Gemcitabine|gemcitabine|mesh-list
14466140|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14466141|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
14466142|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370519|NCT01152788|Dacarbazine|dacarbazine|mesh-list
14370520|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14370521|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
14370522|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370523|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370524|NCT01152996|Vortioxetine|vortioxetine|mesh-list
14370525|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
14370526|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14370527|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14370528|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14370529|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370530|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370531|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14370532|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14370533|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370534|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370535|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370536|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
14370537|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14370538|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14370539|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14370540|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14370541|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14370542|NCT01153009|Vortioxetine|vortioxetine|mesh-list
14370543|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14370544|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14370545|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370546|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370547|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370548|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370549|NCT01153009|Analgesics|analgesics|mesh-ancestor
14370550|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
14370551|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370552|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
14370553|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14370554|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
14370555|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14370556|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14370557|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733187|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14733188|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14733189|NCT03178552|Growth Substances|growth substances|mesh-ancestor
14733190|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733191|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733192|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733193|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
15233821|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15233822|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233823|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233824|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233825|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
15233826|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
15233827|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233828|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233829|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
14370558|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14370559|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
14370560|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14370561|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14370562|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14370563|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14370564|NCT01153269|Ritonavir|ritonavir|mesh-list
14370565|NCT01153269|Lopinavir|lopinavir|mesh-list
14370566|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14370567|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14370568|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
14370569|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370570|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370571|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14370572|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14370573|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
14370574|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370575|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14370576|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14370577|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
14370578|NCT01153425|Teriparatide|teriparatide|mesh-list
14370579|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14370580|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370581|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14370582|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14370583|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14370584|NCT01153581|Estradiol|estradiol|mesh-list
14370585|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14370586|NCT01153581|Progesterone|progesterone|mesh-list
14370587|NCT01153581|Ganirelix|ganirelix|mesh-list
14370588|NCT01153581|Estrogens|estrogens|mesh-ancestor
14370589|NCT01153581|Hormones|hormones|mesh-ancestor
14370590|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370591|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370592|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14370593|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
14370594|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14370595|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14370596|NCT01153581|Progestins|progestins|mesh-ancestor
14370597|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370598|NCT01153620|Polihexanide|polihexanide|mesh-list
14370599|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
14370600|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370601|NCT01153672|Letrozole|letrozole|mesh-list
14370602|NCT01153672|Vorinostat|vorinostat|mesh-list
14370603|NCT01153672|Anastrozole|anastrozole|mesh-list
14370604|NCT01153672|Exemestane|exemestane|mesh-list
14370605|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370606|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14370607|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14370608|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370609|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370610|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14370611|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370612|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370613|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370614|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14370615|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14370616|NCT01153698|Dabigatran|dabigatran|mesh-list
14370617|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
14370618|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14370619|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14370620|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370621|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370622|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
14370623|NCT01153711|Ketoconazole|ketoconazole|mesh-list
14370624|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
14370625|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370626|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14370627|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14370628|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370629|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370630|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14733194|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733195|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
14733196|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733197|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733198|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733199|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
14733200|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14733201|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14733202|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14733203|NCT03176134|Tedizolid|tedizolid|mesh-list
14370631|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370632|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370633|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370634|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14370635|NCT01153724|Fluconazole|fluconazole|mesh-list
14370636|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
14370637|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370638|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14370639|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14370640|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370641|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370642|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14370643|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370644|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370645|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370646|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14370647|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14370648|NCT01153763|Dabrafenib|dabrafenib|mesh-list
14370649|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370650|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14370651|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233830|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233831|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233832|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
15233833|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15233834|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15233835|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14370652|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370653|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
14370654|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14370655|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14370656|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14370657|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370658|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370659|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
14370660|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370661|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370662|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14370663|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370664|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14370665|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
14370666|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370667|NCT01153958|Metronidazole|metronidazole|mesh-list
14733204|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
14733205|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14733206|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733207|NCT03160638|Azithromycin|azithromycin|mesh-list
14733208|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14733209|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733210|NCT03153150|Warfarin|warfarin|mesh-list
14733211|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
14733212|NCT03153150|Dabigatran|dabigatran|mesh-list
14733213|NCT03153150|Apixaban|apixaban|mesh-list
14733214|NCT03153150|Edoxaban|edoxaban|mesh-list
14733215|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
14733216|NCT03153150|Phenindione|phenindione|mesh-list
14733217|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
14733218|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14733219|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
14733220|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14733221|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
14733222|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733223|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733224|NCT03126331|Nivolumab|nivolumab|mesh-list
14370668|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
14370669|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370670|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370671|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14370672|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14370673|NCT01153971|Rituximab|rituximab|mesh-list
14370674|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14370675|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370676|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
14370677|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370678|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14370679|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14370680|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370681|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14370682|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370683|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370684|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
14370685|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14370686|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14370687|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14370688|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
14370689|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370690|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370691|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370692|NCT01154153|Loratadine|loratadine|mesh-list
14370693|NCT01154153|Triamcinolone|triamcinolone|mesh-list
14370694|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14370695|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14370696|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14370697|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370698|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
14370699|NCT01154153|Hormones|hormones|mesh-ancestor
14370700|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370701|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370702|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370703|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
14370704|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370705|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370706|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
14370707|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
14370708|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14370709|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14370710|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14370711|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
14370712|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
14733225|NCT03126331|Ipilimumab|ipilimumab|mesh-list
14733226|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733227|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733228|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14753805|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14370713|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370714|NCT01154166|Ropinirole|ropinirole|mesh-list
14370715|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14370716|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14370717|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
14370718|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
14370719|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370720|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370721|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370722|NCT01154192|Dexamethasone|dexamethasone|mesh-list
14370723|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14370724|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370725|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
14370726|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
14370727|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370728|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370729|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370730|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
14370731|NCT01154192|Hormones|hormones|mesh-ancestor
14370732|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370733|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14370734|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370735|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14370736|NCT01154218|Crizotinib|crizotinib|mesh-list
14370737|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370738|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14370739|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370740|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370741|NCT01154335|Everolimus|everolimus|mesh-list
14370742|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233836|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
15233837|NCT02550652|Prednisone|prednisone|mesh-list
15233838|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
15233839|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
15233840|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370743|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370744|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
15233841|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
15233842|NCT02550652|Hormones|hormones|mesh-ancestor
15233843|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233844|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233845|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15233846|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233847|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15233848|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15233849|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
15233850|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15233851|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233852|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233853|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233854|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
15233855|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
14370745|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370746|NCT01154452|R04929097|r04929097|mesh-list
14370747|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370748|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370749|NCT01154673|Ritonavir|ritonavir|mesh-list
14370750|NCT01154673|Lopinavir|lopinavir|mesh-list
14370751|NCT01154673|Tenofovir|tenofovir|mesh-list
14370752|NCT01154673|Emtricitabine|emtricitabine|mesh-list
15233856|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233857|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233858|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15233859|NCT02550652|Protective Agents|protective agents|mesh-ancestor
15233860|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233861|NCT02537418|Durvalumab|durvalumab|mesh-list
15233862|NCT02537418|Tremelimumab|tremelimumab|mesh-list
15233863|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233864|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233865|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
15233866|NCT02519738|Triamcinolone|triamcinolone|mesh-list
14370753|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
14370754|NCT01154673|Maraviroc|maraviroc|mesh-list
14370755|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14370756|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14370757|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
14370758|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370759|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370760|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14370761|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14370762|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
14370763|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370764|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14370765|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14370766|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14370767|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14370768|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14370769|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14370770|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14370771|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14370772|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14370773|NCT01155063|Exemestane|exemestane|mesh-list
14370774|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370775|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14370776|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14370777|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370778|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370779|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14370780|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370781|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370782|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370783|NCT01155154|Clindamycin|clindamycin|mesh-list
14370784|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
14370785|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
14370786|NCT01155154|Cephalexin|cephalexin|mesh-list
14370787|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370788|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370789|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14370790|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233867|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14370791|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370792|NCT01155167|Lidocaine|lidocaine|mesh-list
14370793|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
14370794|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
14370795|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
14370796|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370797|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370798|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
14370799|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370800|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14370801|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14370802|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14370803|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370804|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370805|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
14370806|NCT01155219|Latanoprost|latanoprost|mesh-list
14370807|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14370808|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14370809|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14370810|NCT01155284|Lansoprazole|lansoprazole|mesh-list
14370811|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
14370812|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14370813|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370814|NCT01155284|Incretins|incretins|mesh-ancestor
14370815|NCT01155284|Hormones|hormones|mesh-ancestor
14370816|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370817|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14370818|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
14370819|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370820|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370821|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14370822|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370823|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14370824|NCT01155466|Rasagiline|rasagiline|mesh-list
14370825|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14370826|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370827|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370828|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14370829|NCT01155466|Protective Agents|protective agents|mesh-ancestor
14733229|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753081|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753082|NCT05284214|Ipilimumab|ipilimumab|mesh-list
14753083|NCT05284214|Sargramostim|sargramostim|mesh-list
14753084|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753085|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370830|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370831|NCT01155479|Rasagiline|rasagiline|mesh-list
14370832|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14370833|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370834|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753086|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14370835|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14370836|NCT01155479|Protective Agents|protective agents|mesh-ancestor
14370837|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370838|NCT01155531|Sertraline|sertraline|mesh-list
14370839|NCT01155531|Telenzepine|telenzepine|mesh-list
14370840|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
14370841|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14370842|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14370843|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14370844|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370845|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370846|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370847|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
14370848|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370849|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
14370850|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
14370851|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370852|NCT01155583|Dexamethasone|dexamethasone|mesh-list
14370853|NCT01155583|Lenalidomide|lenalidomide|mesh-list
14370854|NCT01155583|Azacitidine|azacitidine|mesh-list
14370855|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370856|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
14370857|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
14370858|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370859|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370860|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14370861|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
14370862|NCT01155583|Hormones|hormones|mesh-ancestor
14370863|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370864|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14370865|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233868|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15233869|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
15233870|NCT02519738|Hormones|hormones|mesh-ancestor
15233871|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233872|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233873|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233874|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
14370866|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
14370867|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14370868|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14370869|NCT01155583|Growth Substances|growth substances|mesh-ancestor
14733230|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14733231|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920736|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920737|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920738|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233875|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15233876|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233877|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
15233878|NCT02430077|Cathartics|cathartics|mesh-ancestor
15233879|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233880|NCT02420821|Bevacizumab|bevacizumab|mesh-list
15233881|NCT02420821|Sunitinib|sunitinib|mesh-list
15233882|NCT02420821|Atezolizumab|atezolizumab|mesh-list
15233883|NCT02420821|Antibodies|antibodies|mesh-list
15233884|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14370870|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733232|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733233|NCT03077685|Paclitaxel|paclitaxel|mesh-list
14733234|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733235|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733236|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
14733237|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
14733238|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
14920739|NCT04481412|Cetirizine|cetirizine|mesh-list
14920740|NCT04481412|Ethanol|ethanol|mesh-list
14920741|NCT04481412|Minoxidil|minoxidil|mesh-list
15233885|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15233886|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233887|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14370871|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14370872|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
14370873|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370874|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370875|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
14370876|NCT01155661|Serotonin|serotonin|mesh-list
14370877|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14370878|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14370879|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
14370880|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370881|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370882|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370883|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14370884|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14370885|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14370886|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370887|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
14370888|NCT01155869|Naltrexone|naltrexone|mesh-list
14370889|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14370890|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14370891|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370892|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
14370893|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370894|NCT01155999|Tobramycin|tobramycin|mesh-list
14370895|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14370896|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370897|NCT01156051|Guanfacine|guanfacine|mesh-list
14370898|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14370899|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14370900|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14370901|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14370902|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
14370903|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370904|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370905|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370906|NCT01156142|Doxepin|doxepin|mesh-list
14370907|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14370908|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14370909|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370910|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370911|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14370912|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
14370913|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14370914|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
14370915|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
14370916|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370917|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370918|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14370919|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14370920|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14370921|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
14370922|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370923|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
14370924|NCT01156363|Hematinics|hematinics|mesh-ancestor
14370925|NCT01156376|Listerine|listerine|mesh-list
14370926|NCT01156376|Fluorides|fluorides|mesh-list
14370927|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
14370928|NCT01156376|Protective Agents|protective agents|mesh-ancestor
14370929|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370930|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14370931|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370932|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
14370933|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14370934|NCT01156571|Clopidogrel|clopidogrel|mesh-list
14370935|NCT01156571|Cangrelor|cangrelor|mesh-list
14370936|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14370937|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14370938|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14370939|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14370940|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
14370941|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14370942|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370943|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370944|NCT01156597|Pioglitazone|pioglitazone|mesh-list
14370945|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14370946|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370947|NCT01156701|Zanamivir|zanamivir|mesh-list
14370948|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
14370949|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14370950|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14370951|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370952|NCT01156792|Montelukast|montelukast|mesh-list
14370953|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14370954|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
14370955|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14370956|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
14370957|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370958|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370959|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14370960|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14370961|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14370962|NCT01157065|Ranibizumab|ranibizumab|mesh-list
14370963|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14370964|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14370965|NCT01157065|Growth Substances|growth substances|mesh-ancestor
14370966|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370967|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
14370968|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14370969|NCT01157117|Omalizumab|omalizumab|mesh-list
14370970|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14370971|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14370972|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14370973|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
14370974|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
14370975|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370976|NCT01157169|Buprenorphine|buprenorphine|mesh-list
14370977|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14370978|NCT01157169|Narcotics|narcotics|mesh-ancestor
14370979|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14370980|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370981|NCT01157169|Analgesics|analgesics|mesh-ancestor
14370982|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
14370983|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14370984|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14370985|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14370986|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14370987|NCT01157182|Norethindrone|norethindrone|mesh-list
14370988|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
14370989|NCT01157182|Estradiol|estradiol|mesh-list
14370990|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14370991|NCT01157182|Estrogens|estrogens|mesh-ancestor
14370992|NCT01157182|Hormones|hormones|mesh-ancestor
14370993|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14370994|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14370995|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14370996|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
14370997|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14370998|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14370999|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14371000|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14371001|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14371002|NCT01157234|Metoprolol|metoprolol|mesh-list
14371003|NCT01157234|Nebivolol|nebivolol|mesh-list
14371004|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14371005|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14371006|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
14371007|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
14371008|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371009|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371010|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14371011|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14371012|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14733239|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733240|NCT03074539|Riociguat|riociguat|mesh-list
14371013|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14371014|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371015|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371016|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
14371017|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14371018|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14371019|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14371020|NCT01157351|Olanzapine|olanzapine|mesh-list
14371021|NCT01157351|Risperidone|risperidone|mesh-list
14371022|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14371023|NCT01157351|Aripiprazole|aripiprazole|mesh-list
14371024|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14371025|NCT01157351|Perphenazine|perphenazine|mesh-list
14371026|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14371027|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
14371028|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371029|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371030|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371031|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14371032|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14371033|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371034|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371035|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14371036|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
14371037|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
14371038|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
14371039|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371040|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14371041|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14371042|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14371043|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14371044|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
14371045|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
14371046|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14371047|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14371048|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14371049|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14371050|NCT01157364|Bimatoprost|bimatoprost|mesh-list
14371051|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14371052|NCT01157416|Cycloserine|cycloserine|mesh-list
14371053|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14371054|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371055|NCT01157416|Renal Agents|renal agents|mesh-ancestor
14371056|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14371057|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
14371058|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371059|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
14371060|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371061|NCT01157429|Cycloserine|cycloserine|mesh-list
14371062|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14371063|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371064|NCT01157429|Renal Agents|renal agents|mesh-ancestor
14371065|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14371066|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
14371067|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371068|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
14371069|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466143|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466144|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
14466145|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466146|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466147|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466148|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
14466149|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466150|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
14466151|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466152|NCT02237417|Aripiprazole|aripiprazole|mesh-list
14466153|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
14466154|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
14466155|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14466156|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14466157|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466158|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466159|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
14466160|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
14466161|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466162|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466163|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14466164|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14466165|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
14466166|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14466167|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14466168|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14466169|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14466170|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
14466171|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
14466172|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466173|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
14466174|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466175|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466176|NCT02237950|Metronidazole|metronidazole|mesh-list
14466177|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371070|NCT01158118|Plerixafor|plerixafor|mesh-list
14371071|NCT01158118|Sargramostim|sargramostim|mesh-list
14371072|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
14371073|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371074|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14371075|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14371076|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
14371077|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371078|NCT01158222|Sunitinib|sunitinib|mesh-list
14371079|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371080|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14371081|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14371082|NCT01158222|Growth Substances|growth substances|mesh-ancestor
14371083|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371084|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14371085|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14371086|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371087|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371088|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14371089|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
14371090|NCT01158261|Coagulants|coagulants|mesh-ancestor
14371091|NCT01158534|Interferons|interferons|mesh-list
14371092|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
14371093|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
14371094|NCT01158534|Celecoxib|celecoxib|mesh-list
14371095|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371096|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
14371097|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371098|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
14371099|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371100|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14371101|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371102|NCT01158534|Analgesics|analgesics|mesh-ancestor
14371103|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
14371104|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371105|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371106|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371107|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14371108|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14371109|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371110|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371111|NCT01158651|Everolimus|everolimus|mesh-list
14371112|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371113|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371114|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
14371115|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371116|NCT01158703|Aspirin|aspirin|mesh-list
14371117|NCT01158703|Clopidogrel|clopidogrel|mesh-list
14371118|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14371119|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371120|NCT01158703|Analgesics|analgesics|mesh-ancestor
14371121|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
14371122|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920742|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14920743|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920744|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920745|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920746|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15233888|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14371123|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371124|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371125|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233889|NCT02420821|Growth Substances|growth substances|mesh-ancestor
15233890|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233891|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
15233892|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
15233893|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15233894|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233895|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233896|NCT02412670|Gemcitabine|gemcitabine|mesh-list
14371126|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14371127|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14371128|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733241|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
14733242|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733243|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
14733244|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14733245|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733246|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371129|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14371130|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14371131|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371132|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
14371133|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14371134|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14371135|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14371136|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
14371137|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371138|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
14371139|NCT01158820|Fentanyl|fentanyl|mesh-list
14371140|NCT01158820|Midazolam|midazolam|mesh-list
14371141|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
14371142|NCT01158820|Ketamine|ketamine|mesh-list
14371143|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14371144|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371145|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371146|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371147|NCT01158820|Analgesics|analgesics|mesh-ancestor
14371148|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
14371149|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371150|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14733247|NCT03005782|Cemiplimab|cemiplimab|mesh-list
14733248|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733249|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371151|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14371152|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14371153|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
14371154|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371155|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371156|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14371157|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14371158|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
14371159|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
14733250|NCT02978391|Epinephrine|epinephrine|mesh-list
14733251|NCT02978391|Hemostatics|hemostatics|mesh-list
14733252|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14733253|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14733254|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
14733255|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733256|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733257|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733258|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14371160|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14371161|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14371162|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14371163|NCT01158820|Narcotics|narcotics|mesh-ancestor
14371164|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14371165|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14371166|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14371167|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371168|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
14371169|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
14371170|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14371171|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
14371172|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
14371173|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
14733259|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14371174|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14371175|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14371176|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
14371177|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
14371178|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14371179|NCT01158885|Cytarabine|cytarabine|mesh-list
14371180|NCT01158885|Methotrexate|methotrexate|mesh-list
14371181|NCT01158885|Clofarabine|clofarabine|mesh-list
14371182|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14371183|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
14371184|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14371185|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371186|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371187|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
14371188|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371189|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371190|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
14371191|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371192|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371193|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371194|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
14371195|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371196|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371197|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
14371198|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371199|NCT01158950|Tolcapone|tolcapone|mesh-list
14371200|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14371201|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14371202|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14371203|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371204|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371205|NCT01159054|Niacin|niacin|mesh-list
14371206|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
14371207|NCT01159054|Niacinamide|niacinamide|mesh-list
14371208|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14371209|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
14371210|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371211|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14371212|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
14371213|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
14371214|NCT01159054|Vitamins|vitamins|mesh-ancestor
14371215|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
14371216|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371217|NCT01159067|Deferasirox|deferasirox|mesh-list
14371218|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14371219|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
14371220|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
14371221|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371222|NCT01159171|Bevacizumab|bevacizumab|mesh-list
14371223|NCT01159171|Capecitabine|capecitabine|mesh-list
14371224|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
14371225|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371226|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371227|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14371228|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14371229|NCT01159171|Growth Substances|growth substances|mesh-ancestor
14371230|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371231|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733260|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
14371232|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371233|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
14371234|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371235|NCT01159262|Fentanyl|fentanyl|mesh-list
14371236|NCT01159262|Midazolam|midazolam|mesh-list
14371237|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
14371238|NCT01159262|Morphine|morphine|mesh-list
14371239|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14371240|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371241|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233897|NCT02412670|Cisplatin|cisplatin|mesh-list
15233898|NCT02412670|Carboplatin|carboplatin|mesh-list
15233899|NCT02412670|Doxorubicin|doxorubicin|mesh-list
15233900|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15233901|NCT02412670|Methotrexate|methotrexate|mesh-list
15233902|NCT02412670|Vinblastine|vinblastine|mesh-list
15233903|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233904|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233905|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
15233906|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15233907|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
15233908|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371242|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371243|NCT01159262|Analgesics|analgesics|mesh-ancestor
14371244|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
14371245|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371246|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14371247|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14371248|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14371249|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
14371250|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371251|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371252|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14371253|NCT01159262|Narcotics|narcotics|mesh-ancestor
14371254|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14371255|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14371256|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
14371257|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
14371258|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14371259|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15233909|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371260|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371261|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
15233910|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233911|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
14371262|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
14371263|NCT01159574|Clarithromycin|clarithromycin|mesh-list
14371264|NCT01159574|Dexamethasone|dexamethasone|mesh-list
14371265|NCT01159574|Pomalidomide|pomalidomide|mesh-list
14371266|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371267|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
14371268|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
14371269|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371270|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371271|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14371272|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
14371273|NCT01159574|Hormones|hormones|mesh-ancestor
14371274|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14371275|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14371276|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371277|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371278|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371279|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14371280|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371281|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371282|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14371283|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14371284|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
14371285|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14371286|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14371287|NCT01159574|Growth Substances|growth substances|mesh-ancestor
14371288|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
14371289|NCT01159600|Empagliflozin|empagliflozin|mesh-list
14371290|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14371291|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371292|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14371293|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233912|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233913|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15233914|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15233915|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15233916|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15233917|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
15233918|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15233919|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
15233920|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371294|NCT01159665|Plasminogen|plasminogen|mesh-list
14371295|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
14371296|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14371297|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14371298|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371299|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14371300|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14371301|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14371302|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14371303|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371304|NCT01159769|Analgesics|analgesics|mesh-ancestor
14371305|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
14371306|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371307|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371308|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371309|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15233921|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371310|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14371311|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14371312|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14371313|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
14371314|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
14371315|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371316|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371317|NCT01159912|Fluticasone|fluticasone|mesh-list
14371318|NCT01159912|Xhance|xhance|mesh-list
14371319|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371320|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14371321|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
14371322|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371323|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371324|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14371325|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
14371326|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14371327|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14371328|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
14371329|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14371330|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371331|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
14371332|NCT01160198|Chelating Agents|chelating agents|mesh-list
14371333|NCT01160198|Glycine|glycine|mesh-list
14371334|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
14371335|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371336|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
14371337|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371338|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371339|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
14371340|NCT01160198|Protective Agents|protective agents|mesh-ancestor
14371341|NCT01160198|Vitamins|vitamins|mesh-ancestor
14371342|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
14371343|NCT01160211|Trastuzumab|trastuzumab|mesh-list
14371344|NCT01160211|Lapatinib|lapatinib|mesh-list
14371345|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14371346|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371347|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371348|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14371349|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371350|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371351|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14371352|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14371353|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
14371354|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14371355|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371356|NCT01160289|Tadalafil|tadalafil|mesh-list
14371357|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
14371358|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14371359|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14371360|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466178|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371361|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371362|NCT01160289|Urological Agents|urological agents|mesh-ancestor
14371363|NCT01160354|Plerixafor|plerixafor|mesh-list
14371364|NCT01160354|Clofarabine|clofarabine|mesh-list
14371365|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371366|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
14371367|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371368|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233922|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14733261|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733262|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14733263|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
14930953|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15233923|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15233924|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
15233925|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
15233926|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
14371369|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14371370|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14371371|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
14371372|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371373|NCT01160380|Modafinil|modafinil|mesh-list
14371374|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14371375|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371376|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14371377|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14371378|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14371379|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371380|NCT01160445|Aldesleukin|aldesleukin|mesh-list
14371381|NCT01160445|Zanolimumab|zanolimumab|mesh-list
15233927|NCT02410343|Hormones|hormones|mesh-list
15233928|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233929|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233930|NCT02370329|Interferons|interferons|mesh-list
15233931|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
15233932|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
15233933|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
15233934|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15233935|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233936|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
15233937|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233938|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
15233939|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371382|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371383|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14371384|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14371385|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
14371386|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371387|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371388|NCT01160484|Lenalidomide|lenalidomide|mesh-list
14371389|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
14371390|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371391|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14371392|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14371393|NCT01160484|Growth Substances|growth substances|mesh-ancestor
15233940|NCT02343224|Interferons|interferons|mesh-list
14371394|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
14371395|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371396|NCT01160614|Oxycodone|oxycodone|mesh-list
14371397|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14371398|NCT01160614|Narcotics|narcotics|mesh-ancestor
14371399|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371400|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371401|NCT01160614|Analgesics|analgesics|mesh-ancestor
14371402|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
14371403|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371404|NCT01160640|Metronidazole|metronidazole|mesh-list
14371405|NCT01160640|Doxycycline|doxycycline|mesh-list
14371406|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
14371407|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371408|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371409|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14371410|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14371411|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
14371412|NCT01160744|Gemcitabine|gemcitabine|mesh-list
14371413|NCT01160744|Carboplatin|carboplatin|mesh-list
14371414|NCT01160744|Pemetrexed|pemetrexed|mesh-list
14371415|NCT01160744|Ramucirumab|ramucirumab|mesh-list
14371416|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14371417|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371418|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371419|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
14371420|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371421|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
14371422|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371423|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371424|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371425|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
14371426|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371427|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371428|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371429|NCT01160770|Clobazam|clobazam|mesh-list
14371430|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
14371431|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14371432|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14371433|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371434|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371435|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371436|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14371437|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
14371438|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
14371439|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371440|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371441|NCT01160822|Naproxen|naproxen|mesh-list
14371442|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14371443|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14371444|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371445|NCT01160822|Analgesics|analgesics|mesh-ancestor
14371446|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
14371447|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371448|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371449|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371450|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371451|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
14371452|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14371453|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371454|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371455|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
14371456|NCT01160848|Ethanol|ethanol|mesh-list
15233941|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
15233942|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
15233943|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15233944|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233945|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
15233946|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233947|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
15233948|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233949|NCT02339740|Vitamins|vitamins|mesh-list
14371457|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14371458|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233950|NCT02339740|Vitamin A|vitamin a|mesh-list
15233951|NCT02339740|Cytarabine|cytarabine|mesh-list
14371459|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371460|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371461|NCT01161121|Adenosine|adenosine|mesh-list
14371462|NCT01161121|Regadenoson|regadenoson|mesh-list
14371463|NCT01161121|Analgesics|analgesics|mesh-ancestor
14371464|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
14371465|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371466|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371467|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14371468|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
14371469|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14371470|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
14371471|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
14371472|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371473|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371474|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14371475|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14371476|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371477|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14371478|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371479|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371480|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
14371481|NCT01161407|Calcium|calcium|mesh-list
14371482|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14371483|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371484|NCT01161407|Antacids|antacids|mesh-ancestor
14371485|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371486|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14371487|NCT01161446|Antibodies|antibodies|mesh-list
14371488|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
14371489|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
14371490|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371491|NCT01161472|Alprazolam|alprazolam|mesh-list
14371492|NCT01161472|Fesoterodine|fesoterodine|mesh-list
14371493|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14371494|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371495|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371496|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14371497|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14371498|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371499|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
14371500|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
14371501|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371502|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371503|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14371504|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14371505|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
14371506|NCT01161472|Urological Agents|urological agents|mesh-ancestor
14371507|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14371508|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371509|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371510|NCT01161537|Ivacaftor|ivacaftor|mesh-list
14371511|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14733264|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
14371512|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14371513|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371514|NCT01161563|Leuprolide|leuprolide|mesh-list
14371515|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14733265|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
14733266|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14733267|NCT02978391|Coagulants|coagulants|mesh-ancestor
14733268|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
14733269|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733270|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733271|NCT02963766|Dulaglutide|dulaglutide|mesh-list
15233952|NCT02339740|Dexamethasone|dexamethasone|mesh-list
15233953|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
15233954|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
15233955|NCT02339740|Idarubicin|idarubicin|mesh-list
15233956|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
15233957|NCT02339740|Tretinoin|tretinoin|mesh-list
15233958|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
15233959|NCT02339740|BB 1101|bb 1101|mesh-list
15233960|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
15233961|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233962|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371516|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14371517|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
14371518|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14371519|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371520|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14371521|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371522|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
14371523|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14371524|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
14371525|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14371526|NCT01161628|Rituximab|rituximab|mesh-list
14371527|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371528|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371529|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
14371530|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371531|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371532|NCT01161862|Glucagon|glucagon|mesh-list
14371533|NCT01161862|Pancrelipase|pancrelipase|mesh-list
14371534|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371535|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14371536|NCT01161862|Hormones|hormones|mesh-ancestor
14371537|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14371538|NCT01162005|Tacrolimus|tacrolimus|mesh-list
14371539|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371540|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
14371541|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371542|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14371543|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371544|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371545|NCT01162122|Vaccines|vaccines|mesh-list
14371546|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
14371547|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371548|NCT01162135|Digoxin|digoxin|mesh-list
14371549|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14371550|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14371551|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371552|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371553|NCT01162135|Protective Agents|protective agents|mesh-ancestor
14371554|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371555|NCT01162239|Varenicline|varenicline|mesh-list
14371556|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14371557|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14371558|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
14371559|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371560|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371561|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371562|NCT01162421|Adalimumab|adalimumab|mesh-list
14371563|NCT01162421|Methotrexate|methotrexate|mesh-list
14371564|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14371565|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
14371566|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14371567|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371568|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371569|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
14371570|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371571|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371572|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
14371573|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371574|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371575|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371576|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
14371577|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371578|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371579|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371580|NCT01162473|Caseins|caseins|mesh-list
14371581|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
14371582|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
14371583|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733272|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15233963|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
15233964|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
14371584|NCT01162486|Rifampin|rifampin|mesh-list
14371585|NCT01162486|Rifapentine|rifapentine|mesh-list
14371586|NCT01162486|Midazolam|midazolam|mesh-list
14371587|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14371588|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14371589|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371590|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371591|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14371592|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14371593|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371594|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14371595|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
14371596|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
14371597|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
14371598|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
14371599|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371600|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371601|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14371602|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
14371603|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371604|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371605|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
14371606|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371607|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371608|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14371609|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14371610|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14371611|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14371612|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14371613|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14371614|NCT01162551|Sirolimus|sirolimus|mesh-list
14371615|NCT01162551|Methotrexate|methotrexate|mesh-list
14371616|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14371617|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
14371618|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14371619|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371620|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233965|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233966|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233967|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
15233968|NCT02339740|Hormones|hormones|mesh-ancestor
15233969|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15233970|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15233971|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15233972|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
15233973|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15233974|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371621|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
14466179|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14466180|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14466181|NCT02237989|Acetaminophen|acetaminophen|mesh-list
14466182|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466183|NCT02237989|Analgesics|analgesics|mesh-ancestor
14371622|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371623|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371624|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
14371625|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371626|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371627|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371628|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
14371629|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371630|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371631|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371632|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371633|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14371634|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
14371635|NCT01162733|Vancomycin|vancomycin|mesh-list
14371636|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371637|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371638|NCT01162863|Lubiprostone|lubiprostone|mesh-list
14371639|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14371640|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14371641|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371642|NCT01163097|Heparin|heparin|mesh-list
14371643|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
14371644|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14371645|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14371646|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371647|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
14371648|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
14371649|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371650|NCT01163214|Ropivacaine|ropivacaine|mesh-list
14371651|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
14371652|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
14371653|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733273|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733274|NCT02843230|Bevacizumab|bevacizumab|mesh-list
14733275|NCT02843230|Temozolomide|temozolomide|mesh-list
14733276|NCT02843230|Lomustine|lomustine|mesh-list
14733277|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733278|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733279|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14733280|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14371654|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371655|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
14371656|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371657|NCT01163253|Tofacitinib|tofacitinib|mesh-list
14371658|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14371659|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371660|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371661|NCT01163266|Vortioxetine|vortioxetine|mesh-list
14371662|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
14371663|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371664|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14371665|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14371666|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15233975|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15233976|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
15233977|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
15233978|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15233979|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15233980|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
15233981|NCT02339740|Analgesics|analgesics|mesh-ancestor
15233982|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
14733281|NCT02843230|Growth Substances|growth substances|mesh-ancestor
14930954|NCT01436513|Estrogens|estrogens|mesh-ancestor
14371667|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371668|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14371669|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14371670|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14371671|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371672|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371673|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
14371674|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14371675|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14371676|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14371677|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14371678|NCT01163604|Aspirin|aspirin|mesh-list
14371679|NCT01163604|Argatroban|argatroban|mesh-list
14371680|NCT01163604|Clopidogrel|clopidogrel|mesh-list
14371681|NCT01163604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14371682|NCT01163604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371683|NCT01163604|Analgesics|analgesics|mesh-ancestor
14371684|NCT01163604|Sensory System Agents|sensory system agents|mesh-ancestor
14371685|NCT01163604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371686|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371687|NCT01163604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371688|NCT01163604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371689|NCT01163604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14371690|NCT01163604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14371691|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371692|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14371693|NCT01163604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14371694|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371695|NCT01163604|Antipyretics|antipyretics|mesh-ancestor
14371696|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14371697|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14371698|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14371699|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
14371700|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371701|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
14371702|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14371703|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
14371704|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
14371705|NCT01163617|Adalimumab|adalimumab|mesh-list
14371706|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371707|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371708|NCT01163656|Cobalt|cobalt|mesh-list
14371709|NCT01163656|Trace Elements|trace elements|mesh-ancestor
14371710|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
14371711|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371712|NCT01163721|Ranolazine|ranolazine|mesh-list
14371713|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14371714|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466184|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
14371715|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371716|NCT01163747|Methotrexate|methotrexate|mesh-list
14371717|NCT01163747|Vaccines|vaccines|mesh-list
14371718|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14371719|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
14371720|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371721|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14371722|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
14371723|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14371724|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371725|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
14371726|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733282|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733283|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733284|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733285|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
14733286|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733287|NCT02712814|Estrogens|estrogens|mesh-list
14733288|NCT02712814|Hormones|hormones|mesh-ancestor
14733289|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733290|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733291|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
14733292|NCT02670252|Busulfan|busulfan|mesh-list
14733293|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733294|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
14733295|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371727|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371728|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
14733296|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733297|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733298|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
14733299|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733300|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733301|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14733302|NCT02665143|Nintedanib|nintedanib|mesh-list
14371729|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371730|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371731|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371732|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371733|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371734|NCT01163786|Bortezomib|bortezomib|mesh-list
14371735|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466185|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466186|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466187|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
14466188|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
14466189|NCT02238080|Hematinics|hematinics|mesh-ancestor
14466190|NCT02238379|Oxytocin|oxytocin|mesh-list
14920747|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14920748|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14920749|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
14920750|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
14920751|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920752|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920753|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14371736|NCT01163851|Bococizumab|bococizumab|mesh-list
14371737|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14371738|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14371739|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
14371740|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371741|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14371742|NCT01164007|Bevacizumab|bevacizumab|mesh-list
14371743|NCT01164007|Dacarbazine|dacarbazine|mesh-list
14371744|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371745|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371746|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14371747|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14371748|NCT01164007|Growth Substances|growth substances|mesh-ancestor
14371749|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371750|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
14371751|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14371752|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
14371753|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371754|NCT01164098|Rituximab|rituximab|mesh-list
14371755|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371756|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371757|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
14371758|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371759|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371760|NCT01164475|Plerixafor|plerixafor|mesh-list
14371761|NCT01164475|Sargramostim|sargramostim|mesh-list
14371762|NCT01164475|Lenograstim|lenograstim|mesh-list
14371763|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
14371764|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371765|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14371766|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14371767|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14371768|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
14371769|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371770|NCT01164501|Empagliflozin|empagliflozin|mesh-list
14371771|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14371772|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371773|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14371774|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371775|NCT01164579|Methotrexate|methotrexate|mesh-list
14371776|NCT01164579|Tofacitinib|tofacitinib|mesh-list
14920754|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
14371777|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14371778|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
14371779|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14371780|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371781|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371782|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
14371783|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371784|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371785|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
14371786|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371787|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371788|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371789|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
14371790|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371791|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371792|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14371793|NCT01164956|Methylphenidate|methylphenidate|mesh-list
14371794|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14371795|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371796|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14371797|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14371798|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14371799|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371800|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
14371801|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371802|NCT01165021|Folic Acid|folic acid|mesh-list
14371803|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
14371804|NCT01165021|Hydroxocobalamin|hydroxocobalamin|mesh-list
14371805|NCT01165021|Dexamethasone|dexamethasone|mesh-list
14371806|NCT01165021|Pemetrexed|pemetrexed|mesh-list
14371807|NCT01165021|Vitamins|vitamins|mesh-ancestor
14371808|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
14371809|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371810|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371811|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371812|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
14371813|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
14371814|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371815|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14371816|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
14371817|NCT01165021|Hormones|hormones|mesh-ancestor
14371818|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14371819|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14371820|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371821|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371822|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371823|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14371824|NCT01165021|Hematinics|hematinics|mesh-ancestor
14371825|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
14371826|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
14371827|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14371828|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
14371829|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371830|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371831|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14371832|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14371833|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14371834|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
14371835|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371836|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371837|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14371838|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
14371839|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
14371840|NCT01165047|Protective Agents|protective agents|mesh-ancestor
14371841|NCT01165112|Rituximab|rituximab|mesh-list
14371842|NCT01165112|Carboplatin|carboplatin|mesh-list
14371843|NCT01165112|Etoposide|etoposide|mesh-list
14371844|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14371845|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371846|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371847|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
14371848|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371849|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371850|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14371851|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14371852|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14371853|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371854|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371855|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14371856|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
14371857|NCT01165138|Fluticasone|fluticasone|mesh-list
14371858|NCT01165138|Xhance|xhance|mesh-list
14371859|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371860|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14371861|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
14371862|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371863|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371864|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14371865|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
14371866|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
14371867|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14371868|NCT01165203|Vaccines|vaccines|mesh-list
14371869|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
14371870|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371871|NCT01165216|Paclitaxel|paclitaxel|mesh-list
14371872|NCT01165216|Carboplatin|carboplatin|mesh-list
14371873|NCT01165216|Ipilimumab|ipilimumab|mesh-list
14371874|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14371875|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371876|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14371877|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14371878|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14371879|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371880|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14371881|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14371882|NCT01165281|Oxycodone|oxycodone|mesh-list
14371883|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14371884|NCT01165281|Narcotics|narcotics|mesh-ancestor
14371885|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371886|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371887|NCT01165281|Analgesics|analgesics|mesh-ancestor
14371888|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
14371889|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371890|NCT01165307|Naproxen|naproxen|mesh-list
14371891|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
14371892|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
14371893|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
14371894|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14371895|NCT01165307|Estradiol|estradiol|mesh-list
14371896|NCT01165307|Estrogens|estrogens|mesh-ancestor
14371897|NCT01165307|Hormones|hormones|mesh-ancestor
14371898|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14371899|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371900|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14371901|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14371902|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14371903|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14371904|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14371905|NCT01165307|Analgesics|analgesics|mesh-ancestor
14371906|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
14371907|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371908|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371909|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371910|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
14371911|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14371912|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371913|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371914|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14371915|NCT01165320|Caspofungin|caspofungin|mesh-list
14371916|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
14371917|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371918|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371919|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371920|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14371921|NCT01165541|Mirtazapine|mirtazapine|mesh-list
14371922|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
14371923|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14371924|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14371925|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14371926|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14371927|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371928|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14371929|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
14371930|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
14371931|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371932|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371933|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14371934|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14371935|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14371936|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14371937|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
14371938|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14371939|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14371940|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
14371941|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14371942|NCT01165554|Flutemetamol|flutemetamol|mesh-list
14371943|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14371944|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371945|NCT01165684|Insulin|insulin|mesh-list
14371946|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14371947|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
14371948|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
14371949|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14371950|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
14371951|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14371952|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371953|NCT01165840|Dapsone|dapsone|mesh-list
14371954|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371955|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
14371956|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14371957|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14371958|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14371959|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371960|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371961|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
14371962|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371963|NCT01165996|Decitabine|decitabine|mesh-list
14371964|NCT01165996|Azacitidine|azacitidine|mesh-list
14371965|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14371966|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
14371967|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371968|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371969|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14371970|NCT01166126|Sirolimus|sirolimus|mesh-list
14371971|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14371972|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14371973|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14371974|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14371975|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
14371976|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14371977|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
14371978|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371979|NCT01166282|Adalimumab|adalimumab|mesh-list
14371980|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14371981|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14371982|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
14371983|NCT01166438|Trospium chloride|trospium chloride|mesh-list
14371984|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
14371985|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14371986|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14371987|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14371988|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14371989|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14371990|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
14371991|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14371992|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14371993|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14371994|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14371995|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14371996|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14371997|NCT01166438|Urological Agents|urological agents|mesh-ancestor
14371998|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
14371999|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
14372000|NCT01166646|Clobetasol|clobetasol|mesh-list
14372001|NCT01166646|Halobetasol|halobetasol|mesh-list
14372002|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14372003|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372004|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
14372005|NCT01166646|Hormones|hormones|mesh-ancestor
14372006|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372007|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372008|NCT01166763|Vitamin D|vitamin d|mesh-list
14372009|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
14372010|NCT01166763|Vitamins|vitamins|mesh-ancestor
14372011|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
14372012|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372013|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14372014|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372015|NCT01166945|Amoxicillin|amoxicillin|mesh-list
14372016|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
14372017|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
14372018|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14372019|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372020|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372021|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14372022|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372023|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372024|NCT01166958|Teriparatide|teriparatide|mesh-list
14372025|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14372026|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372027|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372028|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14372029|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14372030|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
14372031|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372032|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14372033|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14372034|NCT01166997|Heparin|heparin|mesh-list
14372035|NCT01166997|Calcium heparin|calcium heparin|mesh-list
14372036|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
14372037|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14372038|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14372039|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372040|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14372041|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14372042|NCT01167153|Amlodipine|amlodipine|mesh-list
14372043|NCT01167153|Valsartan|valsartan|mesh-list
14372044|NCT01167153|Nifedipine|nifedipine|mesh-list
14372045|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14372046|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14372047|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372048|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372049|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372050|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920755|NCT04476745|Vitamin D|vitamin d|mesh-list
14920756|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
14920757|NCT04476745|Vitamins|vitamins|mesh-ancestor
14920758|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
14372051|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
14372052|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14372053|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14372054|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
14372055|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14372056|NCT01167192|Carboplatin|carboplatin|mesh-list
14372057|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372058|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
14920759|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372059|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14372060|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14372061|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14372062|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372063|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372064|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
14372065|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372066|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372067|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14372068|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372069|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
14372070|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
14372071|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14372072|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
14372073|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372074|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372075|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372076|NCT01167452|Trimethoprim|trimethoprim|mesh-list
14372077|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14372078|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
14372079|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14372080|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372081|NCT01167452|Renal Agents|renal agents|mesh-ancestor
14372082|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
14372083|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14372084|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14372085|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14372086|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372087|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372088|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14372089|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14372090|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14372091|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372092|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
14372093|NCT01167569|Vitamins|vitamins|mesh-ancestor
14372094|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
14372095|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372096|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
14372097|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372098|NCT01167569|Protective Agents|protective agents|mesh-ancestor
14372099|NCT01167712|Paclitaxel|paclitaxel|mesh-list
14372100|NCT01167712|Bevacizumab|bevacizumab|mesh-list
14372101|NCT01167712|Carboplatin|carboplatin|mesh-list
14372102|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14372103|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14372104|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
14372105|NCT01167712|Antibodies|antibodies|mesh-list
14372106|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
14372107|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14372108|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
14372109|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14372110|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372111|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
14733303|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733304|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14372112|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
14372113|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
14372114|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372115|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14372116|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14372117|NCT01167712|Growth Substances|growth substances|mesh-ancestor
14372118|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372119|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
14372120|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
14372121|NCT01167829|Testosterone|testosterone|mesh-list
14372122|NCT01167829|Acyline|acyline|mesh-list
14372123|NCT01167829|Androgens|androgens|mesh-ancestor
14372124|NCT01167829|Hormones|hormones|mesh-ancestor
14372125|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372126|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372127|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733305|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733306|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733307|NCT02663271|Bevacizumab|bevacizumab|mesh-list
14733308|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733309|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733310|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14372128|NCT01167881|Glimepiride|glimepiride|mesh-list
14372129|NCT01167881|Empagliflozin|empagliflozin|mesh-list
14372130|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14372131|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14372132|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372133|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372134|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
14372135|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14372136|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372137|NCT01167907|Ropivacaine|ropivacaine|mesh-list
14372138|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
14372139|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
14372140|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372141|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372142|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
14372143|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372144|NCT01168232|Epothilones|epothilones|mesh-list
14372145|NCT01168232|Epothilone B|epothilone b|mesh-list
14372146|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
14372147|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
14372148|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
14372149|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372150|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372151|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
14372152|NCT01168349|Hematinics|hematinics|mesh-ancestor
14372153|NCT01168596|Rasagiline|rasagiline|mesh-list
14372154|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14372155|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372156|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372157|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14372158|NCT01168596|Protective Agents|protective agents|mesh-ancestor
14372159|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372160|NCT01168674|Ziprasidone|ziprasidone|mesh-list
14372161|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14372162|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
14372163|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372164|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372165|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372166|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14372167|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14372168|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372169|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14372170|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14372171|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
14372172|NCT01168687|Levetiracetam|levetiracetam|mesh-list
14372173|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
14372174|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
14372175|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
14372176|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
14372177|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14372178|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14372179|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372180|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733311|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14733312|NCT02663271|Growth Substances|growth substances|mesh-ancestor
14733313|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733314|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733315|NCT02649790|Dexamethasone|dexamethasone|mesh-list
14733316|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372181|NCT01168908|Urological Agents|urological agents|mesh-ancestor
14372182|NCT01168934|Crizotinib|crizotinib|mesh-list
14372183|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372184|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14372185|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372186|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372187|NCT01168973|Docetaxel|docetaxel|mesh-list
14372188|NCT01168973|Ramucirumab|ramucirumab|mesh-list
14372189|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14372190|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372191|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
14372192|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
14372193|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
14372194|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372195|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
14372196|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372197|NCT01169038|Azithromycin|azithromycin|mesh-list
14372198|NCT01169038|Rifampin|rifampin|mesh-list
14372199|NCT01169038|Ethambutol|ethambutol|mesh-list
14372200|NCT01169038|Levofloxacin|levofloxacin|mesh-list
14372201|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372202|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372203|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14372204|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
14372205|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
14372206|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14372207|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372208|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372209|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14372210|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14372211|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14372212|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14372213|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14372214|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14372215|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14372216|NCT01169038|Renal Agents|renal agents|mesh-ancestor
14372217|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14372218|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14372219|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372220|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14372221|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14372222|NCT01169103|Hormones|hormones|mesh-list
14372223|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372224|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372225|NCT01169337|Lenalidomide|lenalidomide|mesh-list
14372226|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
14372227|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372228|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14372229|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14372230|NCT01169337|Growth Substances|growth substances|mesh-ancestor
14372231|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
14372232|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372233|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14372234|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14372235|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372236|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
14372237|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14372238|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372239|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372240|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14372241|NCT01169467|Analgesics|analgesics|mesh-ancestor
14372242|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
14372243|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372244|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14372245|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14372246|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14372247|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372248|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372249|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372250|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
14372251|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
14372252|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14372253|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14372254|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372255|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372256|NCT01169519|Urological Agents|urological agents|mesh-ancestor
14372257|NCT01169532|Vorinostat|vorinostat|mesh-list
14372258|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372259|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14372260|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372261|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372262|NCT01169558|Bevacizumab|bevacizumab|mesh-list
14372263|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14372264|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372265|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14372266|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14372267|NCT01169558|Growth Substances|growth substances|mesh-ancestor
14372268|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372269|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
14372270|NCT01169636|Carboplatin|carboplatin|mesh-list
14372271|NCT01169636|Etoposide|etoposide|mesh-list
14372272|NCT01169636|Ifosfamide|ifosfamide|mesh-list
14372273|NCT01169636|Panobinostat|panobinostat|mesh-list
14372274|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372275|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14372276|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14372277|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14372278|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372279|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372280|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14372281|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
14372282|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14733317|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
14733318|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
14733319|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733320|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733321|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14733322|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
14733323|NCT02649790|Hormones|hormones|mesh-ancestor
14733324|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733325|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733326|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733327|NCT02605538|Vaccines|vaccines|mesh-list
14733328|NCT02605538|Immunologic Factors|immunologic factors|mesh-ancestor
14733329|NCT02605538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733330|NCT02598661|Imetelstat|imetelstat|mesh-list
14733331|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
14733332|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733333|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733334|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14733335|NCT02566304|Vidarabine|vidarabine|mesh-list
14733336|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
14733337|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
14733338|NCT02566304|Fludarabine|fludarabine|mesh-list
14733339|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
14920760|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14920761|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372283|NCT01169675|Pemetrexed|pemetrexed|mesh-list
14372284|NCT01169675|Afatinib|afatinib|mesh-list
14372285|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372286|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372287|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372288|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14372289|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14372290|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14372291|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
14372292|NCT01169701|Everolimus|everolimus|mesh-list
14372293|NCT01169701|Tacrolimus|tacrolimus|mesh-list
14372294|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372295|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
14372296|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372297|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14372298|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372299|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372300|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372301|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14372302|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14372303|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
14733340|NCT02566304|Tacrolimus|tacrolimus|mesh-list
14733341|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733342|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
14920762|NCT04475991|Maraviroc|maraviroc|mesh-list
14733343|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733344|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733345|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15233983|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15233984|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14372304|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372305|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372306|NCT01169779|Metformin|metformin|mesh-list
14733346|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
15233985|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14372307|NCT01169779|Lixisenatide|lixisenatide|mesh-list
14372308|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14372309|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466191|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
14466192|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14466193|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15233986|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
15233987|NCT02339740|Protective Agents|protective agents|mesh-ancestor
15233988|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15233989|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
15233990|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
15233991|NCT02291445|Peppermint oil|peppermint oil|mesh-list
15233992|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
15233993|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
15233994|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15233995|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466194|NCT02238483|AZD7624|azd7624|mesh-list
14466195|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14466196|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466197|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466198|NCT02238626|Ibudilast|ibudilast|mesh-list
14466199|NCT02238626|Riluzole|riluzole|mesh-list
14466200|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
14466201|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14466202|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14466203|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466204|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466205|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466206|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14466207|NCT02238626|Protective Agents|protective agents|mesh-ancestor
14466208|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14466209|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
14466210|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466211|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14466212|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
14466213|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14466214|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466215|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14466216|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
14466217|NCT02238977|Bupropion|bupropion|mesh-list
14466218|NCT02238977|Fluoxetine|fluoxetine|mesh-list
14466219|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14466220|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
14466221|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14466222|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15233996|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15233997|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
15233998|NCT02262026|Saracatinib|saracatinib|mesh-list
15233999|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234000|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234001|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234002|NCT02159989|Aflibercept|aflibercept|mesh-list
15234003|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
15234004|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15234005|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15234006|NCT02159989|Growth Substances|growth substances|mesh-ancestor
15234007|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234008|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
15234009|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234010|NCT02124902|Carboplatin|carboplatin|mesh-list
15234011|NCT02124902|Docetaxel|docetaxel|mesh-list
15234012|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234013|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234014|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234015|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234016|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234017|NCT02113878|Cisplatin|cisplatin|mesh-list
15234018|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234019|NCT02097680|Letrozole|letrozole|mesh-list
15234020|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234021|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15234022|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14466223|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15234023|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234024|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372310|NCT01170039|Lubiprostone|lubiprostone|mesh-list
14372311|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14372312|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372313|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372314|NCT01170065|Nintedanib|nintedanib|mesh-list
14372315|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372316|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14372317|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372318|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372319|NCT01170117|Olanzapine|olanzapine|mesh-list
14372320|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
14372321|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
14372322|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372323|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372324|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14372325|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14372326|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14372327|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372328|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14372329|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14372330|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14372331|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372332|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372333|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372334|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
14372335|NCT01170208|Insulin|insulin|mesh-list
14372336|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14372337|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372338|NCT01170221|Linezolid|linezolid|mesh-list
14372339|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
14372340|NCT01170221|Tedizolid|tedizolid|mesh-list
14372341|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372342|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372343|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14372344|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372345|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372346|NCT01170247|Ketamine|ketamine|mesh-list
14372347|NCT01170247|Analgesics|analgesics|mesh-ancestor
14372348|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
14372349|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372350|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372351|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14372352|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14372353|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
14372354|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
14372355|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372356|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14372357|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14372358|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372359|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372360|NCT01170273|Vitamin D|vitamin d|mesh-list
14372361|NCT01170273|Vitamins|vitamins|mesh-ancestor
14372362|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
14372363|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372364|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14372365|NCT01170364|Sibutramine|sibutramine|mesh-list
14372366|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
14372367|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14372368|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
14372369|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14372370|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14372371|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14372372|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
14372373|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14372374|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14372375|NCT01170390|Estradiol|estradiol|mesh-list
14372376|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14372377|NCT01170390|Estrogens|estrogens|mesh-ancestor
14372378|NCT01170390|Hormones|hormones|mesh-ancestor
14372379|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372380|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372381|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14372382|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
14372383|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14372384|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14920763|NCT04475991|Favipiravir|favipiravir|mesh-list
14372385|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14372386|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14372387|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14372388|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14372389|NCT01170533|Omeprazole|omeprazole|mesh-list
14372390|NCT01170533|Pantoprazole|pantoprazole|mesh-list
14372391|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15234025|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15234026|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
15234027|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15234028|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234029|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15234030|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
15234031|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372392|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14372393|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14372394|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372395|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372396|NCT01170663|Paclitaxel|paclitaxel|mesh-list
14372397|NCT01170663|Ramucirumab|ramucirumab|mesh-list
14372398|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14372399|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372400|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
14372401|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
14372402|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
14372403|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372404|NCT01170715|Etanercept|etanercept|mesh-list
14372405|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14372406|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14372407|NCT01170715|Analgesics|analgesics|mesh-ancestor
14372408|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
14372409|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372410|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372411|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372412|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372413|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14372414|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372415|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
14372416|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14372417|NCT01170754|Laxatives|laxatives|mesh-ancestor
14372418|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14372419|NCT01170884|Timolol|timolol|mesh-list
14372420|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14372421|NCT01170884|Bimatoprost|bimatoprost|mesh-list
14372422|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14372423|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14372424|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14372425|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14372426|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372427|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372428|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372429|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372430|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14372431|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14372432|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14372433|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14372434|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14372435|NCT01170949|Miltefosine|miltefosine|mesh-list
14372436|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
14372437|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372438|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372439|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14372440|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14733347|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733348|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234032|NCT01995578|Azacitidine|azacitidine|mesh-list
15234033|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15234034|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
15234035|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372441|NCT01170962|Ribavirin|ribavirin|mesh-list
14733349|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14733350|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733351|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
14372442|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14372443|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
14372444|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372445|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
14372446|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372447|NCT01171118|Physostigmine|physostigmine|mesh-list
14372448|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14372449|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372450|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372451|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
14372452|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372453|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372454|NCT01171118|Miotics|miotics|mesh-ancestor
14372455|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
14372456|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372457|NCT01171183|Carvedilol|carvedilol|mesh-list
14372458|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14372459|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14372460|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372461|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372462|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372463|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372464|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14372465|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
14372466|NCT01171183|Protective Agents|protective agents|mesh-ancestor
14372467|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14372468|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372469|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372470|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
14372471|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14372472|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14372473|NCT01171690|Teriparatide|teriparatide|mesh-list
14372474|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372475|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372476|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14372477|NCT01171794|Ibuprofen|ibuprofen|mesh-list
14372478|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14372479|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14372480|NCT01171794|Analgesics|analgesics|mesh-ancestor
14372481|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
14372482|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372483|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372484|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372485|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372486|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14372487|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372488|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372489|NCT01171963|Vaccines|vaccines|mesh-list
14372490|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
14372491|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372492|NCT01171976|Ranibizumab|ranibizumab|mesh-list
14372493|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14372494|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14372495|NCT01171976|Growth Substances|growth substances|mesh-ancestor
14372496|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372497|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
14372498|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372499|NCT01172145|Modafinil|modafinil|mesh-list
14372500|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14372501|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372502|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14372503|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14372504|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14372505|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372506|NCT01172197|Ropivacaine|ropivacaine|mesh-list
14372507|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
14372508|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
14372509|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
14372510|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372511|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372512|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
14372513|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372514|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
14372515|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14372516|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
14372517|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372518|NCT01172275|Expectorants|expectorants|mesh-ancestor
14372519|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
14372520|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14372521|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
14372522|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372523|NCT01172275|Protective Agents|protective agents|mesh-ancestor
14372524|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372525|NCT01172275|Antidotes|antidotes|mesh-ancestor
14372526|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
14372527|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14372528|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
14372529|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372530|NCT01172288|Expectorants|expectorants|mesh-ancestor
14372531|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
14372532|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14372533|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
14372534|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372535|NCT01172288|Protective Agents|protective agents|mesh-ancestor
14372536|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372537|NCT01172288|Antidotes|antidotes|mesh-ancestor
14372538|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
14372539|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
14372540|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14372541|NCT01172418|Daclizumab|daclizumab|mesh-list
14372542|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
14372543|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372544|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372545|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14372546|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372547|NCT01172522|Fexofenadine|fexofenadine|mesh-list
14372548|NCT01172522|Terfenadine|terfenadine|mesh-list
14372549|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14372550|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14372551|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14372552|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
14372553|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
14372554|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372555|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372556|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372557|NCT01172535|Ritonavir|ritonavir|mesh-list
14372558|NCT01172535|Lopinavir|lopinavir|mesh-list
14372559|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14920764|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14920765|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14920766|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920767|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14372560|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14372561|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
14372562|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372563|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372564|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14372565|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14372566|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
14372567|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372568|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14372569|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14372570|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
14372571|NCT01172600|Entonox|entonox|mesh-list
14372572|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14372573|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
14372574|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
14372575|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372576|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372577|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14372578|NCT01172600|Analgesics|analgesics|mesh-ancestor
14372579|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
14372580|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733352|NCT02566304|Antiviral Agents|antiviral agents|mesh-ancestor
14733353|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733354|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14733355|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372581|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14372582|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
14372583|NCT01172639|Prednisone|prednisone|mesh-list
14930955|NCT01436513|Hormones|hormones|mesh-ancestor
14372584|NCT01172639|Methotrexate|methotrexate|mesh-list
14372585|NCT01172639|Leflunomide|leflunomide|mesh-list
14372586|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372587|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
14372588|NCT01172639|Hormones|hormones|mesh-ancestor
14372589|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372590|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372591|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733356|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14733357|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14733358|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
14733359|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14733360|NCT02550470|Sevoflurane|sevoflurane|mesh-list
14372592|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372593|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14372594|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
14372595|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14372596|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14372597|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
14372598|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372599|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
14372600|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372601|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14372602|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372603|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
14372604|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372605|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14372606|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372607|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14372608|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14372609|NCT01172639|Analgesics|analgesics|mesh-ancestor
14372610|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
14372611|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372612|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14372613|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
14372614|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14372615|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14372616|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
14372617|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372618|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372619|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14372620|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
14372621|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
14372622|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14372623|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
14372624|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372625|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372626|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14372627|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14372628|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14733361|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14733362|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14733363|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
14733364|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
14733365|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733366|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372629|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372630|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
14372631|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14372632|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14372633|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
14372634|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372635|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372636|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14372637|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
14372638|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
14372639|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14372640|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
14372641|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372642|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372643|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14372644|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14372645|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14372646|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372647|NCT01172847|Oseltamivir|oseltamivir|mesh-list
14372648|NCT01172847|Rimantadine|rimantadine|mesh-list
14372649|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
14372650|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372651|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372652|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372653|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14372654|NCT01172873|Cycloserine|cycloserine|mesh-list
14372655|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14372656|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372657|NCT01172873|Renal Agents|renal agents|mesh-ancestor
14372658|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14372659|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
14372660|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372661|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
14372662|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372663|NCT01172938|Thalidomide|thalidomide|mesh-list
14372664|NCT01172938|Apremilast|apremilast|mesh-list
14372665|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14372666|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14372667|NCT01172938|Analgesics|analgesics|mesh-ancestor
14372668|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
14372669|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372670|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372671|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372672|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372673|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14372674|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14372675|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372676|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372677|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372678|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
14372679|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
14372680|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372681|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372682|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14372683|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14372684|NCT01172938|Growth Substances|growth substances|mesh-ancestor
14372685|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733367|NCT02542696|Apomorphine|apomorphine|mesh-list
14733368|NCT02542696|Emetics|emetics|mesh-ancestor
14733369|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733370|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
14733371|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733372|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14733373|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
14372686|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372687|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
14372688|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
14372689|NCT01173029|Diuretics|diuretics|mesh-list
14372690|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15234036|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234037|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234038|NCT01986075|Amphetamine|amphetamine|mesh-list
15234039|NCT01986075|Adderall|adderall|mesh-list
14372691|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14372692|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14733374|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
15234040|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15234041|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234042|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
15234043|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
15234044|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372693|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14733375|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234045|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
14372694|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372695|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372696|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
14372697|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372698|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
14372699|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372700|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372701|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
14372702|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372703|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14372704|NCT01173055|Milnacipran|milnacipran|mesh-list
14372705|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
14372706|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14372707|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14372708|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372709|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372710|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372711|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372712|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14372713|NCT01173055|Analgesics|analgesics|mesh-ancestor
14372714|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
14372715|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372716|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
14372717|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14372718|NCT01173120|Abatacept|abatacept|mesh-list
14372719|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14372720|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372721|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372722|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372723|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
14372724|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372725|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372726|NCT01173211|Vaccines|vaccines|mesh-list
14372727|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
14372728|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372729|NCT01173471|Niacinamide|niacinamide|mesh-list
14372730|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
14372731|NCT01173471|Vitamins|vitamins|mesh-ancestor
14372732|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
14372733|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372734|NCT01173601|Serotonin|serotonin|mesh-list
14372735|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14372736|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14372737|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
14372738|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372739|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372740|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372741|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14372742|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372743|NCT01173679|Rituximab|rituximab|mesh-list
14372744|NCT01173679|Fludarabine|fludarabine|mesh-list
14372745|NCT01173679|Dasatinib|dasatinib|mesh-list
14372746|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14372747|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372748|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
14372749|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372750|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372751|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372752|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14372753|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372754|NCT01173692|Minocycline|minocycline|mesh-list
14372755|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372756|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372757|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
15234046|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234047|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234048|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
15234049|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15234050|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15234051|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15234052|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15234053|NCT01935466|Pioglitazone|pioglitazone|mesh-list
15234054|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15234055|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234056|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15234057|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14372758|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
14372759|NCT01173848|Vitamin D|vitamin d|mesh-list
14372760|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372761|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372762|NCT01173848|Vitamins|vitamins|mesh-ancestor
14372763|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
14372764|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14372765|NCT01174004|Pimavanserin|pimavanserin|mesh-list
14372766|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14372767|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14372768|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14372769|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14372770|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372771|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372772|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14372773|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14372774|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14372775|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
14372776|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372777|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372778|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14372779|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372780|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14372781|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234058|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234059|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234060|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234061|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14372782|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372783|NCT01174082|Vaccines|vaccines|mesh-list
14372784|NCT01174082|Sargramostim|sargramostim|mesh-list
14372785|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
14372786|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372787|NCT01174173|Ranolazine|ranolazine|mesh-list
14372788|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14372789|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372790|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372791|NCT01174186|Adalimumab|adalimumab|mesh-list
14372792|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372793|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372794|NCT01174238|Paclitaxel|paclitaxel|mesh-list
14372795|NCT01174238|Carboplatin|carboplatin|mesh-list
14372796|NCT01174238|Axitinib|axitinib|mesh-list
14372797|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14372798|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372799|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
14372800|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
14372801|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
14372802|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372803|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14372804|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372805|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
14372806|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14372807|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14372808|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14372809|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14372810|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372811|NCT01175135|Risperidone|risperidone|mesh-list
14372812|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14372813|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
14372814|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372815|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372816|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372817|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14372818|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14372819|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372820|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14372821|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14372822|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
14372823|NCT01175148|Atorvastatin|atorvastatin|mesh-list
14372824|NCT01175148|Calcium|calcium|mesh-list
14372825|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372826|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733376|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733377|NCT02523469|Nivolumab|nivolumab|mesh-list
14372827|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14372828|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14372829|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
14372830|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372831|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14372832|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14372833|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372834|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14372835|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
14372836|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14372837|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
14372838|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372839|NCT01175343|R04929097|r04929097|mesh-list
14372840|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234062|NCT01759836|Atorvastatin|atorvastatin|mesh-list
15234063|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15234064|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15234065|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
15234066|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234067|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15234068|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15234069|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234070|NCT01758328|Fludarabine|fludarabine|mesh-list
15234071|NCT01758328|Melphalan|melphalan|mesh-list
14372841|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372842|NCT01175382|Tamsulosin|tamsulosin|mesh-list
14372843|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14372844|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14372845|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14372846|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14372847|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372848|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372849|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372850|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372851|NCT01175382|Urological Agents|urological agents|mesh-ancestor
14372852|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14372853|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14372854|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
14372855|NCT01175395|Triamcinolone|triamcinolone|mesh-list
14372856|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14372857|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14920768|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14920769|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
14920770|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920771|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14920772|NCT04468360|Pregnanolone|pregnanolone|mesh-list
14920773|NCT04468360|Brexanolone|brexanolone|mesh-list
14920774|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
14920775|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920776|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372858|NCT01175395|Ranibizumab|ranibizumab|mesh-list
14372859|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14372860|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14372861|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
14372862|NCT01175395|Hormones|hormones|mesh-ancestor
14372863|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372864|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372865|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14372866|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
14372867|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372868|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372869|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14372870|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14372871|NCT01175395|Growth Substances|growth substances|mesh-ancestor
14372872|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
14372873|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372874|NCT01175473|Metformin|metformin|mesh-list
14372875|NCT01175473|Liraglutide|liraglutide|mesh-list
14372876|NCT01175473|Lixisenatide|lixisenatide|mesh-list
14372877|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14372878|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372879|NCT01175473|Incretins|incretins|mesh-ancestor
14920777|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
14920778|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234072|NCT01758328|Busulfan|busulfan|mesh-list
15234073|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15234074|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234075|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234076|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234077|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
15234078|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234079|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234080|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
15234081|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15234082|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
15234083|NCT01746849|Thiotepa|thiotepa|mesh-list
15234084|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234085|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
15234086|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234087|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14372880|NCT01175473|Hormones|hormones|mesh-ancestor
14372881|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372882|NCT01175590|Besifloxacin|besifloxacin|mesh-list
14372883|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372884|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372885|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14372886|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14372887|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372888|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372889|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372890|NCT01175668|Clonidine|clonidine|mesh-list
14372891|NCT01175668|Phenobarbital|phenobarbital|mesh-list
14372892|NCT01175668|Analgesics|analgesics|mesh-ancestor
14372893|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
14372894|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14372895|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372896|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14372897|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
14372898|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
14372899|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14372900|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14372901|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14372902|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372903|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372904|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372905|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
14372906|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14372907|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14372908|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14372909|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14372910|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
14372911|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
14372912|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14372913|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14372914|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14372915|NCT01175707|Vancomycin|vancomycin|mesh-list
14372916|NCT01175707|Daptomycin|daptomycin|mesh-list
14372917|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14372918|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372919|NCT01175798|Vitamin D|vitamin d|mesh-list
14372920|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
14372921|NCT01175798|Vitamins|vitamins|mesh-ancestor
14372922|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
14372923|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372924|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14372925|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14466224|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466225|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466226|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
14466227|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466228|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466229|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14466230|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14466231|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466232|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14466233|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
14466234|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14466235|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14466236|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14466237|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466238|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466239|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14466240|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14466241|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14466242|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14372926|NCT01175811|Insulin|insulin|mesh-list
14372927|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14372928|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
14372929|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
14372930|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
14372931|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
14372932|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
14372933|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14372934|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372935|NCT01175824|Insulin|insulin|mesh-list
14372936|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14372937|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
14372938|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
14372939|NCT01175824|Protamines|protamines|mesh-list
14372940|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14372941|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372942|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
14372943|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372944|NCT01175824|Coagulants|coagulants|mesh-ancestor
14372945|NCT01175902|Timolol|timolol|mesh-list
14372946|NCT01175902|Dorzolamide|dorzolamide|mesh-list
14372947|NCT01175902|Latanoprost|latanoprost|mesh-list
14372948|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14372949|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14372950|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
14372951|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14372952|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372953|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372954|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14372955|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14372956|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14372957|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14372958|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14372959|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372960|NCT01175980|Vorinostat|vorinostat|mesh-list
14372961|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14372962|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14372963|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733378|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733379|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234088|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234089|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
15234090|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234091|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234092|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15234093|NCT01745588|Clarithromycin|clarithromycin|mesh-list
15234094|NCT01745588|Dexamethasone|dexamethasone|mesh-list
15234095|NCT01745588|Pomalidomide|pomalidomide|mesh-list
15234096|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234097|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
15234098|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
15234099|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234100|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234101|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15234102|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
15234103|NCT01745588|Hormones|hormones|mesh-ancestor
14372964|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372965|NCT01176032|Losartan|losartan|mesh-list
14372966|NCT01176032|Amlodipine|amlodipine|mesh-list
14372967|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14372968|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14372969|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14372970|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14372971|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372972|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14372973|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234104|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15234105|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15234106|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234107|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15234108|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234109|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14372974|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
14372975|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14372976|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14372977|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14372978|NCT01176032|Diuretics|diuretics|mesh-ancestor
14372979|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
14372980|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14372981|NCT01176058|Fluconazole|fluconazole|mesh-list
14372982|NCT01176058|Anidulafungin|anidulafungin|mesh-list
14372983|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
14372984|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14372985|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14372986|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14372987|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14372988|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14372989|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14372990|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
14372991|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14372992|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14372993|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14372994|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14372995|NCT01176240|Mannitol|mannitol|mesh-list
14372996|NCT01176240|Droxidopa|droxidopa|mesh-list
14920779|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920780|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
14920781|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
14372997|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14372998|NCT01176240|Diuretics|diuretics|mesh-ancestor
14372999|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
14373000|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373001|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14373002|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14373003|NCT01176435|Levodopa|levodopa|mesh-list
14373004|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14373005|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14373006|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
14373007|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373008|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373009|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373010|NCT01176565|Nicardipine|nicardipine|mesh-list
14373011|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14373012|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14373013|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373014|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373015|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15234110|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234111|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234112|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15234113|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15234114|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
15234115|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15234116|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15234117|NCT01745588|Growth Substances|growth substances|mesh-ancestor
15234118|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
14373016|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373017|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
14373018|NCT01176591|Aprepitant|aprepitant|mesh-list
14373019|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
14373020|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
14373021|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
14373022|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373023|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373024|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14373025|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14373026|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373027|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373028|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
14373029|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14733380|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14733381|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733382|NCT02503839|Etoricoxib|etoricoxib|mesh-list
14920782|NCT04463680|Rifampin|rifampin|mesh-list
14373030|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
14373031|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373032|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
14373033|NCT01176773|Protective Agents|protective agents|mesh-ancestor
14373034|NCT01176916|Exemestane|exemestane|mesh-list
14373035|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373036|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14373037|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14373038|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373039|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373040|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14373041|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
14373042|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373043|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373044|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14373045|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
14373046|NCT01176968|Eplerenone|eplerenone|mesh-list
14373047|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14373048|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
14373049|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373050|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373051|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14920783|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14920784|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
14920785|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14920786|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920787|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
14920788|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14920789|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920790|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920791|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14373052|NCT01176968|Diuretics|diuretics|mesh-ancestor
14373053|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
14373054|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14373055|NCT01176981|Methotrexate|methotrexate|mesh-list
14373056|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14373057|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
14373058|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14373059|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373060|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14373061|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
14373062|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373063|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373064|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
14373065|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373066|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14373067|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373068|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
14373069|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373070|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14373071|NCT01177098|Timolol|timolol|mesh-list
14373072|NCT01177098|Bimatoprost|bimatoprost|mesh-list
14373073|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14373074|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14373075|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14373076|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14373077|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14373078|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373079|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373080|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373081|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14373082|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14373083|NCT01177189|Ascorbic Acid|ascorbic acid|mesh-list
14373084|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
14373085|NCT01177189|Vitamins|vitamins|mesh-ancestor
14373086|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
14373087|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373088|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
14373089|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373090|NCT01177189|Protective Agents|protective agents|mesh-ancestor
14373091|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
14373092|NCT01177228|Vedolizumab|vedolizumab|mesh-list
14373093|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14373094|NCT01177293|Amlodipine|amlodipine|mesh-list
14373095|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14373096|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14373097|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15234119|NCT01701674|Aldesleukin|aldesleukin|mesh-list
15234120|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
15234121|NCT01701674|Fludarabine|fludarabine|mesh-list
15234122|NCT01701674|Ipilimumab|ipilimumab|mesh-list
15234123|NCT01701674|Interleukin-2|interleukin-2|mesh-list
15234124|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234125|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
14373098|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373099|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14373100|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373101|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
14373102|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14373103|NCT01177384|Glimepiride|glimepiride|mesh-list
14373104|NCT01177384|Acarbose|acarbose|mesh-list
14373105|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373106|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373107|NCT01177384|Incretins|incretins|mesh-ancestor
14373108|NCT01177384|Hormones|hormones|mesh-ancestor
14373109|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373110|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14373111|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
14920792|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14920793|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14920794|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14920795|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14920796|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14920797|NCT04454203|Anesthetics|anesthetics|mesh-list
14920798|NCT04454203|Mepivacaine|mepivacaine|mesh-list
14920799|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
14920800|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920801|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920802|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
14920803|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920804|NCT04433390|Naloxegol|naloxegol|mesh-list
15234126|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234127|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234128|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234129|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
15234130|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234131|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234132|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15234133|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234134|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15234135|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15234136|NCT01701674|Analgesics|analgesics|mesh-ancestor
15234137|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
15234138|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234139|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15234140|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15234141|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
15234142|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234143|NCT01597388|Fulvestrant|fulvestrant|mesh-list
15234144|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15234145|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733383|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14373112|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373113|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373114|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14373115|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373116|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
14373117|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14373118|NCT01177410|Mesalamine|mesalamine|mesh-list
14373119|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14373120|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14373121|NCT01177410|Analgesics|analgesics|mesh-ancestor
14373122|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
14373123|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733384|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14733385|NCT02503839|Analgesics|analgesics|mesh-ancestor
14733386|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
14733387|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733388|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733389|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733390|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733391|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14733392|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14733393|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733394|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733395|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14733396|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14920805|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14920806|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920807|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
14920808|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920809|NCT04432610|Nebivolol|nebivolol|mesh-list
15234146|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14733397|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733398|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
14733399|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373124|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373125|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733400|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733401|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733402|NCT02428985|Riociguat|riociguat|mesh-list
14733403|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
14733404|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733405|NCT02384850|Leucovorin|leucovorin|mesh-list
14733406|NCT02384850|Folic Acid|folic acid|mesh-list
14373126|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733407|NCT02384850|Fluorouracil|fluorouracil|mesh-list
14733408|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
14733409|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
14733410|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
14733411|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733412|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733413|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733414|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733415|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
14733416|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234147|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15234148|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
15234149|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15234150|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234151|NCT01318486|Heparin|heparin|mesh-list
15234152|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
15234153|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14920810|NCT04432610|Bisoprolol|bisoprolol|mesh-list
14920811|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14920812|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
14920813|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15234154|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14733417|NCT02384850|Antidotes|antidotes|mesh-ancestor
14373127|NCT01177709|Metformin|metformin|mesh-list
14373128|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373129|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373130|NCT01177722|Vaccines|vaccines|mesh-list
14373131|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
14373132|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373133|NCT01177735|Pomalidomide|pomalidomide|mesh-list
14373134|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
14373135|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373136|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14373137|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14373138|NCT01177735|Growth Substances|growth substances|mesh-ancestor
14373139|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
14373140|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373141|NCT01177800|Infliximab|infliximab|mesh-list
14373142|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
15234155|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234156|NCT01116648|Olaparib|olaparib|mesh-list
15234157|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15234158|NCT01116648|Cediranib|cediranib|mesh-list
15234159|NCT01116648|Maleic acid|maleic acid|mesh-list
15234160|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234161|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234162|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234163|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15234164|NCT01064479|Cisplatin|cisplatin|mesh-list
15234165|NCT01064479|Carboplatin|carboplatin|mesh-list
15234166|NCT01064479|Docetaxel|docetaxel|mesh-list
15234167|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15234168|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234169|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234170|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234171|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234172|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234173|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15234174|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373143|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14373144|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373145|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14373146|NCT01177813|Empagliflozin|empagliflozin|mesh-list
14373147|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373148|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373149|NCT01177813|Incretins|incretins|mesh-ancestor
14373150|NCT01177813|Hormones|hormones|mesh-ancestor
14373151|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373152|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14373153|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
14373154|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373155|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373156|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14373157|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14373158|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14373159|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14373160|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373161|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373162|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
14373163|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373164|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373165|NCT01177956|Fluorouracil|fluorouracil|mesh-list
14373166|NCT01177956|Cetuximab|cetuximab|mesh-list
14373167|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373168|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
14373169|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373170|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14373171|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373172|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
14373173|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373174|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373175|NCT01178073|Ambrisentan|ambrisentan|mesh-list
14373176|NCT01178073|Tadalafil|tadalafil|mesh-list
14373177|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
14373178|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14373179|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14373180|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373181|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373182|NCT01178073|Urological Agents|urological agents|mesh-ancestor
14373183|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15234175|NCT01042522|Paclitaxel|paclitaxel|mesh-list
15234176|NCT01042522|Etoposide|etoposide|mesh-list
15234177|NCT01042522|Cisplatin|cisplatin|mesh-list
15234178|NCT01042522|Carboplatin|carboplatin|mesh-list
15234179|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15234180|NCT01042522|Bleomycin|bleomycin|mesh-list
15234181|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
15234182|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15234183|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234184|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234185|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234186|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234187|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234188|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15234189|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15234190|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373184|NCT01178086|Rituximab|rituximab|mesh-list
14373185|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373186|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373187|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
14373188|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373189|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373190|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14373191|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14373192|NCT01178138|Prazosin|prazosin|mesh-list
14373193|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14373194|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14373195|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14373196|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14373197|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14373198|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373199|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373200|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373201|NCT01178216|Rituximab|rituximab|mesh-list
14373202|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373203|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373204|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
14373205|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373206|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373207|NCT01178281|Thalidomide|thalidomide|mesh-list
14373208|NCT01178281|Pomalidomide|pomalidomide|mesh-list
14373209|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
14373210|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373211|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14373212|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14373213|NCT01178281|Growth Substances|growth substances|mesh-ancestor
14373214|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
15234191|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15234192|NCT00958737|Leucovorin|leucovorin|mesh-list
15234193|NCT00958737|Fluorouracil|fluorouracil|mesh-list
14920814|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14920815|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14920816|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
14920817|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920818|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920819|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920820|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
15234194|NCT00958737|Capecitabine|capecitabine|mesh-list
15234195|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
15234196|NCT00958737|Calcium|calcium|mesh-list
15234197|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
15234198|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15234199|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234200|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
14466243|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
15234201|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234202|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14373215|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373216|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373217|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
14373218|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14373219|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373220|NCT01178528|Carvedilol|carvedilol|mesh-list
14373221|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14373222|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14373223|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
14373224|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373225|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373226|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373227|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14373228|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
14373229|NCT01178528|Protective Agents|protective agents|mesh-ancestor
14373230|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14373231|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373232|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14373233|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
14373234|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14373235|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14373236|NCT01178671|Mirtazapine|mirtazapine|mesh-list
14373237|NCT01178671|Sertraline|sertraline|mesh-list
14373238|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
14373239|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14373240|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14373241|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14373242|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14733418|NCT02384850|Protective Agents|protective agents|mesh-ancestor
14733419|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
15234203|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234204|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234205|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
15234206|NCT00958737|Antidotes|antidotes|mesh-ancestor
15234207|NCT00958737|Protective Agents|protective agents|mesh-ancestor
15234208|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
15234209|NCT00958737|Vitamins|vitamins|mesh-ancestor
15234210|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
15234211|NCT00826462|Triamcinolone|triamcinolone|mesh-list
15234212|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15234213|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15234214|NCT00826462|Naproxen|naproxen|mesh-list
15234215|NCT00826462|Lidocaine|lidocaine|mesh-list
15234216|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15234217|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
15234218|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
15234219|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234220|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234221|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
15234222|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234223|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15234224|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15234225|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15234226|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15234227|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234228|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234229|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
14373243|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373244|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373245|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
14373246|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373247|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14733420|NCT02384850|Vitamins|vitamins|mesh-ancestor
14733421|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
14733422|NCT02384850|Hematinics|hematinics|mesh-ancestor
14733423|NCT02352090|Dienogest|dienogest|mesh-list
14733424|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14373248|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
14373249|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
14373250|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14373251|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14373252|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14373253|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14373254|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14373255|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14733425|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14733426|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14733427|NCT02352090|Estradiol|estradiol|mesh-list
14733428|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14733429|NCT02352090|Nandrolone|nandrolone|mesh-list
14733430|NCT02352090|Estrogens|estrogens|mesh-ancestor
14733431|NCT02352090|Hormones|hormones|mesh-ancestor
14733432|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373256|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
14373257|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14373258|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14373259|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14373260|NCT01178762|Azithromycin|azithromycin|mesh-list
14373261|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14373262|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373263|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
14373264|NCT01178827|Oxybutynin|oxybutynin|mesh-list
14373265|NCT01178827|Trospium chloride|trospium chloride|mesh-list
14373266|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
14373267|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
14733433|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733434|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14733435|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
14733436|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14733437|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14733438|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14733439|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14733440|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14733441|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733442|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733443|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733444|NCT02352090|Androgens|androgens|mesh-ancestor
14733445|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
14373268|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373269|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733446|NCT02298257|Doxorubicin|doxorubicin|mesh-list
15234230|NCT00826462|Hormones|hormones|mesh-ancestor
15234231|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15234232|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373270|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14373271|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14373272|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
14373273|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373274|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373275|NCT01178827|Urological Agents|urological agents|mesh-ancestor
14373276|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14373277|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373278|NCT01178827|Renal Agents|renal agents|mesh-ancestor
14373279|NCT01178853|Warfarin|warfarin|mesh-list
14373280|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14373281|NCT01178853|Pitavastatin|pitavastatin|mesh-list
14373282|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14373283|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14373284|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
14373285|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234233|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
15234234|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234235|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15234236|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15234237|NCT00826462|Analgesics|analgesics|mesh-ancestor
15234238|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234239|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
15234240|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15234241|NCT00710970|Tamoxifen|tamoxifen|mesh-list
15234242|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14373286|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14373287|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14373288|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373289|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
14373290|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
14373291|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14373292|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373293|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14373294|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373295|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373296|NCT01179048|Liraglutide|liraglutide|mesh-list
14373297|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373298|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733447|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14733448|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14733449|NCT02298257|Dacarbazine|dacarbazine|mesh-list
14733450|NCT02298257|Vinblastine|vinblastine|mesh-list
14733451|NCT02298257|Antibodies|antibodies|mesh-list
14733452|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
14373299|NCT01179048|Incretins|incretins|mesh-ancestor
14373300|NCT01179048|Hormones|hormones|mesh-ancestor
14373301|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373302|NCT01179113|Esmolol|esmolol|mesh-list
14373303|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14373304|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14373305|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14373306|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
14373307|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373308|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920821|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
14920822|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373309|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373310|NCT01179191|Naltrexone|naltrexone|mesh-list
14373311|NCT01179191|Morphine|morphine|mesh-list
14373312|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14920823|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14920824|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14920825|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14930956|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930957|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930958|NCT01436539|Adefovir|adefovir|mesh-list
14930959|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14930960|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
14930961|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
14373313|NCT01179191|Narcotics|narcotics|mesh-ancestor
14373314|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930962|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930963|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14930964|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14930965|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930966|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930967|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14930968|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
14930969|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14930970|NCT01436578|Posaconazole|posaconazole|mesh-list
14930971|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
14373315|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373316|NCT01179191|Analgesics|analgesics|mesh-ancestor
14373317|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
14373318|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373319|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14373320|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14373321|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
14373322|NCT01179334|Riociguat|riociguat|mesh-list
14373323|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
14733453|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14733454|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
14733455|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
14733456|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733457|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14733458|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733459|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14733460|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14373324|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14733461|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373325|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14373326|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373327|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373328|NCT01179334|Urological Agents|urological agents|mesh-ancestor
14373329|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
14373330|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
14373331|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14373332|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
14373333|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373334|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373335|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14373336|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
14373337|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
14373338|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14373339|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
14373340|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373341|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373342|NCT01179490|Prednisolone|prednisolone|mesh-list
14373343|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14373344|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
14373345|NCT01179490|Hormones|hormones|mesh-ancestor
14373346|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373347|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373348|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14373349|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373350|NCT01179516|Vortioxetine|vortioxetine|mesh-list
14373351|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
14373352|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14373353|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14373354|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14373355|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14373356|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373357|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14373358|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14373359|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373360|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373361|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373362|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
14373363|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14373364|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14373365|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14373366|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14373367|NCT01179568|Citalopram|citalopram|mesh-list
14373368|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14373369|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14373370|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373371|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373372|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373373|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
14373374|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373375|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14373376|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
14373377|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14920826|NCT04429685|Ketamine|ketamine|mesh-list
14920827|NCT04429685|Analgesics|analgesics|mesh-ancestor
14920828|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
14920829|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920830|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920831|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14920832|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14920833|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
14920834|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
14373378|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14373379|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14373380|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14373381|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373382|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373383|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373384|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373385|NCT01179672|Analgesics|analgesics|mesh-ancestor
14373386|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
14373387|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373388|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
14373389|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14373390|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
14373391|NCT01179919|Oseltamivir|oseltamivir|mesh-list
14373392|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
14373393|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373394|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373395|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373396|NCT01180036|Cyclosporine|cyclosporine|mesh-list
14373397|NCT01180036|Rituximab|rituximab|mesh-list
14373398|NCT01180036|Cyclosporins|cyclosporins|mesh-list
14373399|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373400|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373401|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
14373402|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373403|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373404|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373405|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373406|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373407|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
14373408|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373409|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
14373410|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14373411|NCT01180049|Sirolimus|sirolimus|mesh-list
14373412|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14373413|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373414|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14373415|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373416|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
14373417|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373418|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
14373419|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373420|NCT01180296|Progesterone|progesterone|mesh-list
14373421|NCT01180296|Progestins|progestins|mesh-ancestor
14373422|NCT01180296|Hormones|hormones|mesh-ancestor
14373423|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373424|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373425|NCT01180647|Naltrexone|naltrexone|mesh-list
14373426|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14373427|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14373428|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373429|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
14373430|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373431|NCT01180660|Lidocaine|lidocaine|mesh-list
14373432|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
14373433|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
14373434|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14373435|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373436|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
14373437|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373438|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14373439|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14373440|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14373441|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373442|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373443|NCT01180790|Interferons|interferons|mesh-list
14373444|NCT01180790|Ribavirin|ribavirin|mesh-list
14373445|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
14373446|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
14373447|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14373448|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373449|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
14373450|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373451|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
14373452|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373453|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
14373454|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234243|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15234244|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
15234245|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15234246|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234247|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15234248|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234249|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14373455|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14373456|NCT01180894|Hematinics|hematinics|mesh-ancestor
14373457|NCT01181011|Amlodipine|amlodipine|mesh-list
14373458|NCT01181011|Telmisartan|telmisartan|mesh-list
14373459|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14373460|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14373461|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14373462|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373463|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373464|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14373465|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373466|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
14373467|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14373468|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14373469|NCT01181102|Enoxaparin|enoxaparin|mesh-list
14373470|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
14373471|NCT01181102|Edoxaban|edoxaban|mesh-list
14373472|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
14373473|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14373474|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14373475|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373476|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14373477|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
14373478|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14373479|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
14373480|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373481|NCT01181128|Factor VIII|factor viii|mesh-list
14373482|NCT01181128|Coagulants|coagulants|mesh-ancestor
14373483|NCT01181141|Enoxaparin|enoxaparin|mesh-list
14373484|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
14373485|NCT01181141|Edoxaban|edoxaban|mesh-list
14373486|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
14373487|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14373488|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14373489|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373490|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14373491|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
14373492|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14373493|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
14373494|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373495|NCT01181167|Enoxaparin|enoxaparin|mesh-list
14373496|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
14373497|NCT01181167|Edoxaban|edoxaban|mesh-list
14373498|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
14373499|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14373500|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14373501|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373502|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14373503|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
14373504|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14373505|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
14373506|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373507|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
14373508|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
14373509|NCT01181258|Rituximab|rituximab|mesh-list
14373510|NCT01181258|Fludarabine|fludarabine|mesh-list
14373511|NCT01181258|Interleukin-2|interleukin-2|mesh-list
14373512|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373513|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
14373514|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373515|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373516|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14373517|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
14373518|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373519|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373520|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14373521|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373522|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14373523|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
15234250|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15234251|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15234252|NCT00685919|Carbidopa|carbidopa|mesh-list
15234253|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14733462|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373524|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
14373525|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373526|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14373527|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
14373528|NCT01181258|Hormones|hormones|mesh-ancestor
14373529|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373530|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14373531|NCT01181258|Protective Agents|protective agents|mesh-ancestor
14373532|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14373533|NCT01181258|Analgesics|analgesics|mesh-ancestor
14373534|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
14373535|NCT01181271|Sirolimus|sirolimus|mesh-list
14373536|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
14373537|NCT01181271|Busulfan|busulfan|mesh-list
14373538|NCT01181271|Methotrexate|methotrexate|mesh-list
14373539|NCT01181271|Fludarabine|fludarabine|mesh-list
14373540|NCT01181271|Etoposide|etoposide|mesh-list
14373541|NCT01181271|Tacrolimus|tacrolimus|mesh-list
14373542|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373543|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
14373544|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373545|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373546|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14373547|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
14373548|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373549|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373550|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14373551|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14373552|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
14373553|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14373554|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14373555|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
14373556|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
14373557|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373558|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14373559|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14373560|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14373561|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14373562|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14373563|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14373564|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14373565|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373566|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14373567|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
14373568|NCT01181323|Vaccines|vaccines|mesh-list
14373569|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
14373570|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373571|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
14373572|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14373573|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373574|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373575|NCT01181531|Vitamin D|vitamin d|mesh-list
14373576|NCT01181531|Cinacalcet|cinacalcet|mesh-list
14373577|NCT01181531|Vitamins|vitamins|mesh-ancestor
14373578|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
14373579|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373580|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14373581|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14373582|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14373583|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
14373584|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466244|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466245|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466246|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14466247|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14466248|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
14466249|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14466250|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14466251|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
14466252|NCT02239120|Dabigatran|dabigatran|mesh-list
14466253|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
14466254|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14466255|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
14466256|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466257|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466258|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
14466259|NCT02239380|Lorazepam|lorazepam|mesh-list
14466260|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
14466261|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
14466262|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
14466263|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466264|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466265|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466266|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14466267|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466268|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14466269|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14466270|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14466271|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
14466272|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
14466273|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466274|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466275|NCT02239510|Linaclotide|linaclotide|mesh-list
14466276|NCT02239510|Sennosides|sennosides|mesh-list
14466277|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14466278|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
14466279|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920835|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14373585|NCT01181609|Bevacizumab|bevacizumab|mesh-list
14373586|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373587|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373588|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14373589|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14373590|NCT01181609|Growth Substances|growth substances|mesh-ancestor
14373591|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373592|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
14373593|NCT01181674|Insulin|insulin|mesh-list
14373594|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14373595|NCT01181674|Metformin|metformin|mesh-list
14733463|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733464|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733465|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
14373596|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
14373597|NCT01181674|Acarbose|acarbose|mesh-list
14373598|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373599|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373600|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14373601|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373602|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373603|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15234254|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15234255|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
15234256|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234257|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234258|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234259|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15234260|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234261|NCT00574496|Gemcitabine|gemcitabine|mesh-list
15234262|NCT00574496|Cyclosporine|cyclosporine|mesh-list
15234263|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
15234264|NCT00574496|Prednisone|prednisone|mesh-list
15234265|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
15234266|NCT00574496|Melphalan|melphalan|mesh-list
15234267|NCT00574496|Ifosfamide|ifosfamide|mesh-list
15234268|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
14373604|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14373605|NCT01181726|Norethindrone|norethindrone|mesh-list
14373606|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
14373607|NCT01181726|Estradiol|estradiol|mesh-list
14733466|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733467|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
14373608|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14373609|NCT01181726|Estrogens|estrogens|mesh-ancestor
14373610|NCT01181726|Hormones|hormones|mesh-ancestor
14373611|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373612|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373613|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14373614|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
14373615|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14373616|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14373617|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14373618|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14373619|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14373620|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14373621|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14373622|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
14373623|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373624|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234269|NCT00574496|Methotrexate|methotrexate|mesh-list
15234270|NCT00574496|Fludarabine|fludarabine|mesh-list
14373625|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14373626|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
14373627|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14373628|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14373629|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14373630|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
14373631|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373632|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373633|NCT01181986|Exenatide|exenatide|mesh-list
14373634|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373635|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373636|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14373637|NCT01181986|Incretins|incretins|mesh-ancestor
14373638|NCT01181986|Hormones|hormones|mesh-ancestor
14373639|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373640|NCT01182181|Anastrozole|anastrozole|mesh-list
14373641|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14373642|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373643|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14373644|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15234271|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
15234272|NCT00574496|Vincristine|vincristine|mesh-list
15234273|NCT00574496|Vinorelbine|vinorelbine|mesh-list
15234274|NCT00574496|Procarbazine|procarbazine|mesh-list
15234275|NCT00574496|Cyclosporins|cyclosporins|mesh-list
15234276|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234277|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
15234278|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234279|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234280|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234281|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
15234282|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234283|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234284|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15234285|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15234286|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
15234287|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
15234288|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234289|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234290|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234291|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
14373645|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373646|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373647|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14373648|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
14466280|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15234292|NCT00574496|Hormones|hormones|mesh-ancestor
15234293|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373649|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373650|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373651|NCT01182194|Drospirenone|drospirenone|mesh-list
14373652|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14373653|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14373654|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14373655|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14373656|NCT01182194|Estradiol|estradiol|mesh-list
14373657|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14373658|NCT01182194|Estrogens|estrogens|mesh-ancestor
14373659|NCT01182194|Hormones|hormones|mesh-ancestor
14373660|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373661|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373662|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14373663|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
14373664|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14373665|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14373666|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14373667|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14373668|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14373669|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
14373670|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14373671|NCT01182194|Diuretics|diuretics|mesh-ancestor
14373672|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
14373673|NCT01182207|Drospirenone|drospirenone|mesh-list
14373674|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14373675|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14373676|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14373677|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14373678|NCT01182207|Estradiol|estradiol|mesh-list
14373679|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14373680|NCT01182207|Estrogens|estrogens|mesh-ancestor
14373681|NCT01182207|Hormones|hormones|mesh-ancestor
14373682|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373683|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373684|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14373685|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
14373686|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14373687|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14373688|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14373689|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14373690|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14373691|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
14373692|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14373693|NCT01182207|Diuretics|diuretics|mesh-ancestor
14373694|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
14373695|NCT01182285|Valproic Acid|valproic acid|mesh-list
14373696|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
14373697|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373698|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373699|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
14373700|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373701|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373702|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
14373703|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14373704|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14373705|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14373706|NCT01182350|Bevacizumab|bevacizumab|mesh-list
14373707|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14373708|NCT01182350|Temozolomide|temozolomide|mesh-list
14373709|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373710|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373711|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14373712|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14373713|NCT01182350|Growth Substances|growth substances|mesh-ancestor
14373714|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373715|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
14373716|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14373717|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373718|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373719|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14373720|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
14373721|NCT01182376|Dronedarone|dronedarone|mesh-list
14373722|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14373723|NCT01182441|Warfarin|warfarin|mesh-list
14373724|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
14373725|NCT01182493|Insulin|insulin|mesh-list
14373726|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373727|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373728|NCT01182675|Plerixafor|plerixafor|mesh-list
14373729|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
14373730|NCT01182675|Lenograstim|lenograstim|mesh-list
14373731|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14373732|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
14373733|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373734|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14373735|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373736|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14373737|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14373738|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
14373739|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373740|NCT01183013|Pioglitazone|pioglitazone|mesh-list
14373741|NCT01183013|Linagliptin|linagliptin|mesh-list
14373742|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373743|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373744|NCT01183013|Incretins|incretins|mesh-ancestor
14373745|NCT01183013|Hormones|hormones|mesh-ancestor
14373746|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373747|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14373748|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
14373749|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373750|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373751|NCT01183065|Folic Acid|folic acid|mesh-list
14373752|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
14373753|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
14373754|NCT01183065|Vitamins|vitamins|mesh-ancestor
14373755|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
14373756|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373757|NCT01183065|Hematinics|hematinics|mesh-ancestor
14373758|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
14373759|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14373760|NCT01183104|Glimepiride|glimepiride|mesh-list
14373761|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373762|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373763|NCT01183104|Incretins|incretins|mesh-ancestor
14373764|NCT01183104|Hormones|hormones|mesh-ancestor
14373765|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373766|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14373767|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
14373768|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373769|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373770|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14373771|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373772|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
14373773|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14373774|NCT01183143|Hormones|hormones|mesh-ancestor
14373775|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373776|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373777|NCT01183169|Ribavirin|ribavirin|mesh-list
14373778|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14373779|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
14373780|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373781|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
14373782|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373783|NCT01183234|Methylphenidate|methylphenidate|mesh-list
14373784|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14466281|NCT02239510|Laxatives|laxatives|mesh-ancestor
14373785|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373786|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14373787|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14373788|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14373789|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373790|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
14373791|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234294|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15234295|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15234296|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
15234297|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15234298|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
15234299|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15234300|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15234301|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14373792|NCT01183312|Flumazenil|flumazenil|mesh-list
14373793|NCT01183312|Antidotes|antidotes|mesh-ancestor
14373794|NCT01183312|Protective Agents|protective agents|mesh-ancestor
14373795|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373796|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
14373797|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
14373798|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373799|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373800|NCT01183390|Anastrozole|anastrozole|mesh-list
14373801|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733468|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
14733469|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
14733470|NCT02274779|Leuprolide|leuprolide|mesh-list
14733471|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14733472|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
14733473|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14733474|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733475|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733476|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733477|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
14733478|NCT02143830|Busulfan|busulfan|mesh-list
14733479|NCT02143830|Fludarabine|fludarabine|mesh-list
14733480|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
14733481|NCT02143830|Sargramostim|sargramostim|mesh-list
14733482|NCT02143830|Lenograstim|lenograstim|mesh-list
14733483|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733484|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
14733485|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733486|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733487|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733488|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
14733489|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733490|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733491|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14920836|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14920837|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15234302|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234303|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234304|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234305|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
15234306|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15234307|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15234308|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15234309|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
15234310|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15234311|NCT00344487|Ritonavir|ritonavir|mesh-list
15234312|NCT00344487|Lopinavir|lopinavir|mesh-list
15234313|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15234314|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15234315|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
14733492|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14733493|NCT02042287|Metronidazole|metronidazole|mesh-list
14373802|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373803|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14373804|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14373805|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373806|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373807|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14373808|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
14373809|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14373810|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373811|NCT01183481|Aprepitant|aprepitant|mesh-list
14373812|NCT01183481|Granisetron|granisetron|mesh-list
14373813|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
14373814|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
14373815|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373816|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373817|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14373818|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14373819|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373820|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373821|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14373822|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
14373823|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14373824|NCT01183533|Plasminogen|plasminogen|mesh-list
14373825|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14373826|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14373827|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373828|NCT01183559|Paclitaxel|paclitaxel|mesh-list
14373829|NCT01183559|Carboplatin|carboplatin|mesh-list
14373830|NCT01183559|Fluorouracil|fluorouracil|mesh-list
14373831|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14373832|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373833|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
14373834|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
14373835|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
14373836|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373837|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
14373838|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14373839|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373840|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
14373841|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373842|NCT01183650|Tadalafil|tadalafil|mesh-list
14373843|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
14373844|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14373845|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14373846|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373847|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373848|NCT01183650|Urological Agents|urological agents|mesh-ancestor
14373849|NCT01183780|Leucovorin|leucovorin|mesh-list
14373850|NCT01183780|Folic Acid|folic acid|mesh-list
14373851|NCT01183780|Fluorouracil|fluorouracil|mesh-list
14373852|NCT01183780|Irinotecan|irinotecan|mesh-list
14373853|NCT01183780|Ramucirumab|ramucirumab|mesh-list
14373854|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
14373855|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
14373856|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373857|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14373858|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373859|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373860|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
14373861|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373862|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14373863|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14373864|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373865|NCT01183780|Antidotes|antidotes|mesh-ancestor
14373866|NCT01183780|Protective Agents|protective agents|mesh-ancestor
14373867|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
14373868|NCT01183780|Vitamins|vitamins|mesh-ancestor
14373869|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
14373870|NCT01183780|Hematinics|hematinics|mesh-ancestor
14373871|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14373872|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373873|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14373874|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373875|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373876|NCT01184014|Insulin|insulin|mesh-list
14373877|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14373878|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
14373879|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
14373880|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
14373881|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
14373882|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
14373883|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14373884|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373885|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
14373886|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373887|NCT01184079|Vaccines|vaccines|mesh-list
14373888|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
14373889|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373890|NCT01184118|Fluticasone|fluticasone|mesh-list
14373891|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14373892|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14373893|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
14373894|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373895|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373896|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14373897|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
14373898|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
14373899|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14373900|NCT01184326|Everolimus|everolimus|mesh-list
14373901|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373902|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373903|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
14373904|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373905|NCT01184417|Phenobarbital|phenobarbital|mesh-list
14373906|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
14373907|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14373908|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14373909|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373910|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14373911|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14373912|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14373913|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373914|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
14373915|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
14373916|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14373917|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14373918|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14373919|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
14373920|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14373921|NCT01184846|Antibodies|antibodies|mesh-list
14373922|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
14373923|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373924|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14373925|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
14373926|NCT01184859|Coagulants|coagulants|mesh-ancestor
14373927|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14373928|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
14373929|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373930|NCT01184872|Vancomycin|vancomycin|mesh-list
14373931|NCT01184872|Daptomycin|daptomycin|mesh-list
14373932|NCT01184872|Penicillins|penicillins|mesh-list
14373933|NCT01184872|Floxacillin|floxacillin|mesh-list
14373934|NCT01184872|Cloxacillin|cloxacillin|mesh-list
14373935|NCT01184872|Oxacillin|oxacillin|mesh-list
14373936|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14373937|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373938|NCT01184885|Sirolimus|sirolimus|mesh-list
14373939|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
14373940|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14373941|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373942|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373943|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14373944|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234316|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373945|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
14373946|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373947|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
14373948|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373949|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14373950|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14373951|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
14373952|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14373953|NCT01184898|Cytarabine|cytarabine|mesh-list
14373954|NCT01184898|Sirolimus|sirolimus|mesh-list
14373955|NCT01184898|Etoposide|etoposide|mesh-list
14373956|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
14373957|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
14373958|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14373959|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373960|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14373961|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14373962|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373963|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373964|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14373965|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
14373966|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
14373967|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373968|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14373969|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
14373970|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373971|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14373972|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14373973|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
14373974|NCT01184898|Analgesics|analgesics|mesh-ancestor
14373975|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
14373976|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373977|NCT01184989|Dabigatran|dabigatran|mesh-list
14373978|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
14373979|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14373980|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
14373981|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14373982|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373983|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
14373984|NCT01185028|Interferons|interferons|mesh-list
14920838|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920839|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920840|NCT04423211|Leuprolide|leuprolide|mesh-list
14920841|NCT04423211|Goserelin|goserelin|mesh-list
14373985|NCT01185028|Ribavirin|ribavirin|mesh-list
14373986|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
14373987|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14373988|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
14373989|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14373990|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
14373991|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14373992|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14373993|NCT01185080|Adenosine|adenosine|mesh-list
14373994|NCT01185080|Analgesics|analgesics|mesh-ancestor
14373995|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
14373996|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14373997|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14373998|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14373999|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
14374000|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14374001|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
14374002|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
14374003|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374004|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374005|NCT01185171|Gefitinib|gefitinib|mesh-list
14374006|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374007|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14374008|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374009|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733494|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733495|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14374010|NCT01185288|Adalimumab|adalimumab|mesh-list
14374011|NCT01185288|Methotrexate|methotrexate|mesh-list
14374012|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14374013|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
14374014|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374015|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374016|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374017|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
14374018|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374019|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374020|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374021|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374022|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14374023|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374024|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
14374025|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374026|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14374027|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374028|NCT01185301|Adalimumab|adalimumab|mesh-list
14374029|NCT01185301|Methotrexate|methotrexate|mesh-list
14374030|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14374031|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
14374032|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14466282|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14374033|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374034|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374035|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
14374036|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374037|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374038|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374039|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374040|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14374041|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374042|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
14374043|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374044|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14374045|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374046|NCT01185340|Serotonin|serotonin|mesh-list
14374047|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14374048|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14374049|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
14374050|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374051|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374052|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374053|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14374054|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374055|NCT01185353|Methotrexate|methotrexate|mesh-list
14374056|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14374057|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
14374058|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374059|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374060|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374061|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
14374062|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374063|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374064|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374065|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374066|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14374067|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374068|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
14374069|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374070|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14374071|NCT01185366|Everolimus|everolimus|mesh-list
14374072|NCT01185366|Sunitinib|sunitinib|mesh-list
14374073|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374074|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374075|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
14374076|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374077|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14374078|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14374079|NCT01185366|Growth Substances|growth substances|mesh-ancestor
14374080|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
14374081|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14374082|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374083|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374084|NCT01185509|Trastuzumab|trastuzumab|mesh-list
14374085|NCT01185509|Vinorelbine|vinorelbine|mesh-list
14374086|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14374087|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374088|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14374089|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
14374090|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
14374091|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
14374092|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374093|NCT01185548|Tolbutamide|tolbutamide|mesh-list
14374094|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374095|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374096|NCT01185704|Cetrorelix|cetrorelix|mesh-list
14374097|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14374098|NCT01185704|Hormones|hormones|mesh-list
14374099|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14374100|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374101|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374102|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14374103|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
14374104|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374105|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
14374106|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
14374107|NCT01185782|Hormones|hormones|mesh-list
14374108|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14374109|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374110|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374111|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14374112|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
14374113|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374114|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14374115|NCT01185821|Siponimod|siponimod|mesh-list
14374116|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14374117|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374118|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374119|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
14374120|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374121|NCT01185964|Doxorubicin|doxorubicin|mesh-list
14374122|NCT01185964|Olaratumab|olaratumab|mesh-list
14374123|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14374124|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234317|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234318|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15234319|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15234320|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
15234321|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234322|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15234323|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15234324|NCT00281658|Paclitaxel|paclitaxel|mesh-list
15234325|NCT00281658|Lapatinib|lapatinib|mesh-list
15234326|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15234327|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234328|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
14374125|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14374126|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14374127|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374128|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374129|NCT01186250|Pioglitazone|pioglitazone|mesh-list
14374130|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374131|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374132|NCT01186328|Cytarabine|cytarabine|mesh-list
14374133|NCT01186328|Prednisone|prednisone|mesh-list
14374134|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
14374135|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14374136|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14374137|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14374138|NCT01186328|Cortisone|cortisone|mesh-list
14374139|NCT01186328|Doxorubicin|doxorubicin|mesh-list
14374140|NCT01186328|Methotrexate|methotrexate|mesh-list
14374141|NCT01186328|Vincristine|vincristine|mesh-list
14374142|NCT01186328|Asparaginase|asparaginase|mesh-list
14374143|NCT01186328|Pegaspargase|pegaspargase|mesh-list
14374144|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14374145|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374146|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14374147|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14374148|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920842|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14920843|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
14920844|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374149|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374150|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374151|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
14374152|NCT01186328|Hormones|hormones|mesh-ancestor
14374153|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374154|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374155|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14374156|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14374157|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
14374158|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374159|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374160|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
14374161|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374162|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14374163|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374164|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
14920845|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920846|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920847|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920848|NCT04418466|Risperidone|risperidone|mesh-list
14920849|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14920850|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
14920851|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920852|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920853|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920854|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14920855|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14374165|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374166|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14374167|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
14374168|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920856|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920857|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15234329|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234330|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234331|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234332|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15234333|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234334|NCT05209529|Durvalumab|durvalumab|mesh-list
15234335|NCT05209529|Olaparib|olaparib|mesh-list
15234336|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234337|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234338|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15234339|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234340|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374169|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14374170|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
14374171|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
14374172|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
14374173|NCT01186406|Bevacizumab|bevacizumab|mesh-list
14374174|NCT01186406|Temozolomide|temozolomide|mesh-list
14374175|NCT01186406|Carmustine|carmustine|mesh-list
15234341|NCT05209412|Aspirin|aspirin|mesh-list
15234342|NCT05209412|Paclitaxel|paclitaxel|mesh-list
15234343|NCT05209412|Clopidogrel|clopidogrel|mesh-list
15234344|NCT05209412|Ticagrelor|ticagrelor|mesh-list
15234345|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15234346|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234347|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234348|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234349|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234350|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234351|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15234352|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15234353|NCT05209412|Analgesics|analgesics|mesh-ancestor
15234354|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
15234355|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234356|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234357|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234358|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234359|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15234360|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15234361|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15234362|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15234363|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234364|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
15234365|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15234366|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15234367|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15234368|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
15234369|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234370|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
14374176|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14374177|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374178|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14374179|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14374180|NCT01186406|Growth Substances|growth substances|mesh-ancestor
14374181|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234371|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15234372|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234373|NCT05209295|Azacitidine|azacitidine|mesh-list
15234374|NCT05209295|Cc-486|cc-486|mesh-list
14374182|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
14374183|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14374184|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
14374185|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374186|NCT01186458|Rituximab|rituximab|mesh-list
14374187|NCT01186458|Fludarabine|fludarabine|mesh-list
14733496|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14733497|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14733498|NCT02037529|Paclitaxel|paclitaxel|mesh-list
14733499|NCT02037529|Halichondrin B|halichondrin b|mesh-list
14733500|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15234375|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15234376|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
15234377|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234378|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234379|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234380|NCT05209256|Pemetrexed|pemetrexed|mesh-list
15234381|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234382|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234383|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234384|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15234385|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15234386|NCT05209152|Azacitidine|azacitidine|mesh-list
15234387|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15234388|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
15234389|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234390|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733501|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733502|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733503|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
14733504|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
14733505|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
14733506|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234391|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374188|NCT01186458|Bortezomib|bortezomib|mesh-list
14374189|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14374190|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374191|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
14374192|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374193|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374194|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14374195|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374196|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234392|NCT05208983|Vaccines|vaccines|mesh-list
15234393|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
15234394|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234395|NCT05208944|Cemiplimab|cemiplimab|mesh-list
15234396|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234397|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234398|NCT05208931|Mitogens|mitogens|mesh-list
15234399|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
15234400|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234401|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234402|NCT05208931|Growth Substances|growth substances|mesh-ancestor
15234403|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234404|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
15234405|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14374197|NCT01186562|Incretins|incretins|mesh-ancestor
14374198|NCT01186562|Hormones|hormones|mesh-ancestor
14374199|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374200|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14374201|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
14374202|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374203|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374204|NCT01186744|Tofacitinib|tofacitinib|mesh-list
14374205|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15234406|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234407|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234408|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15234409|NCT05208892|Analgesics|analgesics|mesh-ancestor
15234410|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
15234411|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234412|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15234413|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15234414|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15234415|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
14374206|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374207|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234416|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374208|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
14374209|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14374210|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374211|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
14374212|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374213|NCT01186796|Fulvestrant|fulvestrant|mesh-list
14374214|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14374215|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374216|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14374217|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14374218|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733507|NCT01964560|Lacosamide|lacosamide|mesh-list
14733508|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
14733509|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14733510|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14733511|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14733512|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733513|NCT01840566|Cytarabine|cytarabine|mesh-list
14733514|NCT01840566|Etoposide|etoposide|mesh-list
14733515|NCT01840566|Melphalan|melphalan|mesh-list
14733516|NCT01840566|Carmustine|carmustine|mesh-list
14733517|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733518|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374219|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374220|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374221|NCT01186939|Azacitidine|azacitidine|mesh-list
14374222|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374223|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
14374224|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374225|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374226|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374227|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
14374228|NCT01187017|Fludarabine|fludarabine|mesh-list
14374229|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374230|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
14374231|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374232|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374233|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14374234|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
14374235|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374236|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374237|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14374238|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14374239|NCT01187381|Trastuzumab|trastuzumab|mesh-list
14374240|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14374241|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466283|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14466284|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
14466285|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
14466286|NCT02239692|Cathartics|cathartics|mesh-ancestor
14466287|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466288|NCT02239770|Nicotine|nicotine|mesh-list
14466289|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14466290|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
14466291|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733519|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14733520|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14733521|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374242|NCT01187407|Serotonin|serotonin|mesh-list
14374243|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14374244|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14374245|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
14374246|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374247|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374248|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374249|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14374250|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374251|NCT01187446|Vorinostat|vorinostat|mesh-list
14374252|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374253|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14374254|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374255|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374256|NCT01187498|Oxybutynin|oxybutynin|mesh-list
14374257|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
14374258|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
14374259|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374260|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374261|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14374262|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14374263|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
14374264|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374265|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374266|NCT01187498|Urological Agents|urological agents|mesh-ancestor
14374267|NCT01187550|Hormones|hormones|mesh-list
14374268|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374269|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374270|NCT01187901|Sulindac|sulindac|mesh-list
14374271|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14374272|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374273|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14374274|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374275|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374276|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14374277|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14374278|NCT01187901|Analgesics|analgesics|mesh-ancestor
14374279|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
14374280|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374281|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374282|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374283|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920858|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15234417|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234418|NCT05208879|Carotenoids|carotenoids|mesh-list
15234419|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
15234420|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234421|NCT05208879|Protective Agents|protective agents|mesh-ancestor
15234422|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234423|NCT05208827|Vitamin D|vitamin d|mesh-list
15234424|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
15234425|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
15234426|NCT05208827|Vitamins|vitamins|mesh-list
15234427|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
15234428|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234429|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15234430|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14374284|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14374285|NCT01187953|Tacrolimus|tacrolimus|mesh-list
14374286|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374287|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
14374288|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374289|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14374290|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374291|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374292|NCT01188109|Gemcitabine|gemcitabine|mesh-list
14374293|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374294|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374295|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
14374296|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374297|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
14374298|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374299|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374300|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374301|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
14374302|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374303|NCT01188369|Simendan|simendan|mesh-list
14374304|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14374305|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
14374306|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14374307|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14374308|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374309|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374310|NCT01188369|Protective Agents|protective agents|mesh-ancestor
14374311|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374312|NCT01188421|Clonidine|clonidine|mesh-list
14374313|NCT01188421|Buprenorphine|buprenorphine|mesh-list
14374314|NCT01188421|Tramadol|tramadol|mesh-list
14374315|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14374316|NCT01188421|Naloxone|naloxone|mesh-list
14374317|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14374318|NCT01188421|Narcotics|narcotics|mesh-ancestor
14374319|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374320|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374321|NCT01188421|Analgesics|analgesics|mesh-ancestor
14374322|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
14374323|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374324|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14374325|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14374326|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
14374327|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
14374328|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14374329|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14374330|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14374331|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
14374332|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374333|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374334|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14374335|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14374336|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14374337|NCT01188538|Analgesics|analgesics|mesh-ancestor
14374338|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
14374339|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374340|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374341|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14920859|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
14920860|NCT04416451|Rituximab|rituximab|mesh-list
14733522|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733523|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733524|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
14733525|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
14733526|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733527|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733528|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
14733529|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920861|NCT04416451|Venetoclax|venetoclax|mesh-list
14374342|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234431|NCT05208801|Morphine|morphine|mesh-list
15234432|NCT05208801|Bupivacaine|bupivacaine|mesh-list
15234433|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
15234434|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
15234435|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234436|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234437|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
15234438|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234439|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15234440|NCT05208801|Narcotics|narcotics|mesh-ancestor
15234441|NCT05208801|Analgesics|analgesics|mesh-ancestor
15234442|NCT05208398|Warfarin|warfarin|mesh-list
15234443|NCT05208398|Apixaban|apixaban|mesh-list
15234444|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
15234445|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15234446|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
15234447|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15234448|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
15234449|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234450|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234451|NCT05208294|Sulpiride|sulpiride|mesh-list
15234452|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15234453|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15234454|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234455|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234456|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15234457|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15234458|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
15234459|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234460|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234461|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15234462|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
15234463|NCT05208268|Rabeprazole|rabeprazole|mesh-list
14374343|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374344|NCT01188551|Fentanyl|fentanyl|mesh-list
14374345|NCT01188551|Midazolam|midazolam|mesh-list
14374346|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
14374347|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14374348|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374349|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374350|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14374351|NCT01188551|Analgesics|analgesics|mesh-ancestor
14374352|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
14374353|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374354|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14374355|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14374356|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14374357|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
14374358|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374359|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374360|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14374361|NCT01188551|Narcotics|narcotics|mesh-ancestor
14374362|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14374363|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14374364|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
14374365|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
14374366|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15234464|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15234465|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15234466|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15234467|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374367|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14374368|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14374369|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
14374370|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
14374371|NCT01188577|Epinephrine|epinephrine|mesh-list
14374372|NCT01188577|Racepinephrine|racepinephrine|mesh-list
14374373|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
14374374|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14374375|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14374376|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
14374377|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374378|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374379|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374380|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14374381|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14374382|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
14374383|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374384|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14374385|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
14374386|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
14374387|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
14374388|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14374389|NCT01188655|Etanercept|etanercept|mesh-list
14374390|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14374391|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14374392|NCT01188655|Analgesics|analgesics|mesh-ancestor
14374393|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
14374394|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374395|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374396|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374397|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374398|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14374399|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374400|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
14374401|NCT01188668|Aripiprazole|aripiprazole|mesh-list
14374402|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14374403|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
14374404|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14733530|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234468|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234469|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15234470|NCT05207904|Paclitaxel|paclitaxel|mesh-list
15234471|NCT05207904|Carboplatin|carboplatin|mesh-list
15234472|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15234473|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234474|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234475|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234476|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14374405|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14374406|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14374407|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374408|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234477|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234478|NCT05207774|Oxytocin|oxytocin|mesh-list
15234479|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
15234480|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15234481|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234482|NCT05207735|Capecitabine|capecitabine|mesh-list
15234483|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15234484|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
15234485|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234486|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234487|NCT05207683|Antibodies|antibodies|mesh-list
15234488|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
15234489|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
15234490|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234491|NCT05207514|Ethanol|ethanol|mesh-list
15234492|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
15234493|NCT05207514|Docetaxel|docetaxel|mesh-list
15234494|NCT05207514|Doxorubicin|doxorubicin|mesh-list
15234495|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234496|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
15234497|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234498|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234499|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234500|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
15234501|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234502|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234503|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15234504|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234505|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
14374409|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
14374410|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
14374411|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374412|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374413|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14374414|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14374415|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
14374416|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14374417|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14374418|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14374419|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14374420|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14374421|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14374422|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374423|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14374424|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
14374425|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14374426|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
14374427|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374428|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374429|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
14374430|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374431|NCT01188694|Methylene Blue|methylene blue|mesh-list
14374432|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374433|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374434|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
14374435|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
14374436|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374437|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
14374438|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
14374439|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374440|NCT01188811|Protective Agents|protective agents|mesh-ancestor
14374441|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374442|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
14374443|NCT01188811|Vitamins|vitamins|mesh-ancestor
14374444|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
14374445|NCT01188876|Folic Acid|folic acid|mesh-list
14374446|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
14374447|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
14374448|NCT01188876|Carboplatin|carboplatin|mesh-list
14374449|NCT01188876|Vitamins|vitamins|mesh-ancestor
14374450|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
14374451|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374452|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374453|NCT01188876|Hematinics|hematinics|mesh-ancestor
14374454|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
14374455|NCT01188928|Betamethasone|betamethasone|mesh-list
14374456|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
14374457|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14374458|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
14374459|NCT01188928|Calcipotriene|calcipotriene|mesh-list
14374460|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14374461|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374462|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
14733531|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
14374463|NCT01188928|Hormones|hormones|mesh-ancestor
14374464|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733532|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14733533|NCT01824537|Vaccines|vaccines|mesh-list
14733534|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
15234506|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234507|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15234508|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14374465|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374466|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14374467|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
14374468|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374469|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14374470|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14374471|NCT01189201|Linagliptin|linagliptin|mesh-list
14374472|NCT01189201|Empagliflozin|empagliflozin|mesh-list
14374473|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374474|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374475|NCT01189201|Incretins|incretins|mesh-ancestor
14733535|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733536|NCT01730937|Sorafenib|sorafenib|mesh-list
14374476|NCT01189201|Hormones|hormones|mesh-ancestor
14374477|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374478|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14374479|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
14374480|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374481|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374482|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14374483|NCT01189240|Bevacizumab|bevacizumab|mesh-list
14374484|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14374485|NCT01189240|Antibodies|antibodies|mesh-list
14374486|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
14374487|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14374488|NCT01189240|R04929097|r04929097|mesh-list
14374489|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374490|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14374491|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14374492|NCT01189240|Growth Substances|growth substances|mesh-ancestor
14374493|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374494|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
14374495|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
14374496|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374497|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374498|NCT01189266|Vorinostat|vorinostat|mesh-list
14374499|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374500|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14374501|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374502|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374503|NCT01189279|Bimatoprost|bimatoprost|mesh-list
14374504|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14374505|NCT01189292|Dexamethasone|dexamethasone|mesh-list
14374506|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374507|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
14374508|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
14374509|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374510|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374511|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14374512|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
14374513|NCT01189292|Hormones|hormones|mesh-ancestor
14374514|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374515|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14920862|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920863|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920864|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
14920865|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920866|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920867|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
14920868|NCT04399746|Azithromycin|azithromycin|mesh-list
14920869|NCT04399746|Ivermectin|ivermectin|mesh-list
14733537|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234509|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15234510|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234511|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15234512|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920870|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14920871|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920872|NCT04399746|Vitamins|vitamins|mesh-ancestor
14920873|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
14920874|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14920875|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14374516|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374517|NCT01189370|Sorafenib|sorafenib|mesh-list
14374518|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374519|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14374520|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374521|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374522|NCT01189409|Sennosides|sennosides|mesh-list
14374523|NCT01189409|Laxatives|laxatives|mesh-ancestor
14374524|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14374525|NCT01189487|Ampicillin|ampicillin|mesh-list
14374526|NCT01189487|Sulbactam|sulbactam|mesh-list
14374527|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14374528|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374529|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14374530|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733538|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14733539|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733540|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733541|NCT01655225|Pemetrexed|pemetrexed|mesh-list
14733542|NCT01655225|Letrozole|letrozole|mesh-list
14733543|NCT01655225|Fulvestrant|fulvestrant|mesh-list
14733544|NCT01655225|Midazolam|midazolam|mesh-list
14733545|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733546|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14733547|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14733548|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733549|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733550|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14733551|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14733552|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14733553|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14733554|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
14733555|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
14733556|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
14733557|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
14733558|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733559|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733560|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733561|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14374531|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374532|NCT01189500|Tamoxifen|tamoxifen|mesh-list
14374533|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14374534|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14374535|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
14374536|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374537|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374538|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14374539|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374540|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14374541|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14374542|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14374543|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14374544|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14374545|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374546|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374547|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374548|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
14374549|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14374550|NCT01189604|Propofol|propofol|mesh-list
14374551|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14374552|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374553|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374554|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14374555|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
14374556|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
14374557|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14374558|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14374559|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14374560|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374561|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374562|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14374563|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374564|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374565|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
14374566|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374567|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14374568|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14374569|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14374570|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374571|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374572|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14374573|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374574|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374575|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
14374576|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374577|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
14374578|NCT01189812|Citalopram|citalopram|mesh-list
14374579|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
14374580|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14374581|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374582|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374583|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
14374584|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14374585|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374586|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374587|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14374588|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14374589|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374590|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374591|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
14374592|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14374593|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14374594|NCT01189890|Glimepiride|glimepiride|mesh-list
14374595|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374596|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374597|NCT01189890|Incretins|incretins|mesh-ancestor
14374598|NCT01189890|Hormones|hormones|mesh-ancestor
14374599|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374600|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14374601|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
14374602|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374603|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374604|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14374605|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374606|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
14374607|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
14374608|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14374609|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14733562|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14733563|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15234513|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374610|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
14374611|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374612|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14374613|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14374614|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14733564|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14733565|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15234514|NCT05207436|Oxytocin|oxytocin|mesh-list
15234515|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
15234516|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15234517|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374615|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374616|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14374617|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374618|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14374619|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374620|NCT01190020|Lubiprostone|lubiprostone|mesh-list
14374621|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14374622|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374623|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374624|NCT01190098|Lacosamide|lacosamide|mesh-list
14374625|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
14374626|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14374627|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14374628|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374629|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374630|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
14374631|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14374632|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14374633|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374634|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
14374635|NCT01190150|Coagulants|coagulants|mesh-ancestor
14374636|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
14374637|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374638|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
14374639|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374640|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374641|NCT01190436|Bisoprolol|bisoprolol|mesh-list
14374642|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14374643|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
14374644|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
14374645|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374646|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374647|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14374648|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14374649|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14374650|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14374651|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374652|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374653|NCT01190449|Ofatumumab|ofatumumab|mesh-list
14374654|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374655|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14374656|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14374657|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14374658|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14374659|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374660|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374661|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374662|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
14374663|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14374664|NCT01190813|Levodopa|levodopa|mesh-list
14374665|NCT01190813|Carbidopa|carbidopa|mesh-list
14374666|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14374667|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14374668|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
14374669|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374670|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374671|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374672|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14374673|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374674|NCT01190839|Infliximab|infliximab|mesh-list
14374675|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374676|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14374677|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374678|NCT01190878|Bromfenac|bromfenac|mesh-list
14374679|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14374680|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14374681|NCT01190878|Analgesics|analgesics|mesh-ancestor
14374682|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
14374683|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374684|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374685|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374686|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374687|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
14374688|NCT01190930|Leucovorin|leucovorin|mesh-list
14374689|NCT01190930|Folic Acid|folic acid|mesh-list
14374690|NCT01190930|Cytarabine|cytarabine|mesh-list
14374691|NCT01190930|Dexamethasone|dexamethasone|mesh-list
14374692|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
14374693|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
14374694|NCT01190930|Doxorubicin|doxorubicin|mesh-list
14374695|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14374696|NCT01190930|Methotrexate|methotrexate|mesh-list
14374697|NCT01190930|Vincristine|vincristine|mesh-list
14374698|NCT01190930|Asparaginase|asparaginase|mesh-list
14374699|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
14374700|NCT01190930|Pegaspargase|pegaspargase|mesh-list
14374701|NCT01190930|Thioguanine|thioguanine|mesh-list
14374702|NCT01190930|BB 1101|bb 1101|mesh-list
14374703|NCT01190930|Calcium|calcium|mesh-list
14374704|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
14374705|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
14374706|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374707|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
14374708|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374709|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374710|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14374711|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
14374712|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374713|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374714|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14374715|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374716|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
14374717|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
14374718|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374719|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14374720|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
14374721|NCT01190930|Hormones|hormones|mesh-ancestor
14374722|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374723|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14374724|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
14374725|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374726|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14374727|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14374728|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14374729|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14374730|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14374731|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14374732|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
14374733|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374734|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374735|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
14374736|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374737|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14374738|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14374739|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
14374740|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374741|NCT01190930|Antidotes|antidotes|mesh-ancestor
14374742|NCT01190930|Protective Agents|protective agents|mesh-ancestor
14374743|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
14374744|NCT01190930|Vitamins|vitamins|mesh-ancestor
14374745|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
14374746|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14374747|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
14374748|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
14374749|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
14374750|NCT01190930|Hematinics|hematinics|mesh-ancestor
14374751|NCT01191008|Timolol|timolol|mesh-list
14374752|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14374753|NCT01191008|Latanoprost|latanoprost|mesh-list
14374754|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14374755|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14374756|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14374757|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
14374758|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374759|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374760|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374761|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14374762|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14374763|NCT01191086|Topiramate|topiramate|mesh-list
14374764|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
14374765|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374766|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374767|NCT01191190|Ofatumumab|ofatumumab|mesh-list
14374768|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374769|NCT01191255|Sevelamer|sevelamer|mesh-list
14374770|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
14374771|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
14374772|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374773|NCT01191268|Insulin|insulin|mesh-list
14374774|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14374775|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
14374776|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
14374777|NCT01191268|Dulaglutide|dulaglutide|mesh-list
14374778|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374779|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374780|NCT01191320|Enclomiphene|enclomiphene|mesh-list
14374781|NCT01191320|Clomiphene|clomiphene|mesh-list
14374782|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
14374783|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14374784|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
14374785|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374786|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374787|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14374788|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
14374789|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14374790|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14374791|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14374792|NCT01191398|Atropine|atropine|mesh-list
14374793|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
14374794|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14374795|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14374796|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14374797|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
14374798|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374799|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374800|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14374801|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
14374802|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
14374803|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
14374804|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14374805|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14374806|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
14374807|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374808|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374809|NCT01191476|Propofol|propofol|mesh-list
14374810|NCT01191476|Sevoflurane|sevoflurane|mesh-list
14374811|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14374812|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374813|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374814|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14374815|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
14374816|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
14374817|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14374818|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14374819|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
14374820|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14374821|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374822|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14374823|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14374824|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374825|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374826|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374827|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
14374828|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14374829|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374830|NCT01191762|Sevelamer|sevelamer|mesh-list
14374831|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
14374832|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
14374833|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374834|NCT01191801|Cytarabine|cytarabine|mesh-list
14374835|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14374836|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
14374837|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374838|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374839|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
14374840|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374841|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374842|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
14374843|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374844|NCT01191840|Vancomycin|vancomycin|mesh-list
14374845|NCT01191840|Cefazolin|cefazolin|mesh-list
14374846|NCT01191840|Daptomycin|daptomycin|mesh-list
14374847|NCT01191840|Cloxacillin|cloxacillin|mesh-list
14374848|NCT01191840|Oxacillin|oxacillin|mesh-list
14374849|NCT01191840|Nafcillin|nafcillin|mesh-list
14374850|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14374851|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374852|NCT01191944|Pramipexole|pramipexole|mesh-list
14374853|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
14374854|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374855|NCT01191944|Protective Agents|protective agents|mesh-ancestor
14374856|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374857|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14374858|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14374859|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
14374860|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
14374861|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374862|NCT01192139|Metformin|metformin|mesh-list
14374863|NCT01192139|Saxagliptin|saxagliptin|mesh-list
14374864|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374865|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374866|NCT01192139|Incretins|incretins|mesh-ancestor
14374867|NCT01192139|Hormones|hormones|mesh-ancestor
14374868|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374869|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14374870|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
14374871|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374872|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374873|NCT01192152|Metformin|metformin|mesh-list
14374874|NCT01192152|Saxagliptin|saxagliptin|mesh-list
14374875|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374876|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374877|NCT01192152|Incretins|incretins|mesh-ancestor
14374878|NCT01192152|Hormones|hormones|mesh-ancestor
14466292|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466293|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14466294|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14733566|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
14374879|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374880|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14374881|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
14374882|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374883|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374884|NCT01192178|Fluticasone|fluticasone|mesh-list
14374885|NCT01192178|Xhance|xhance|mesh-list
14374886|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14374887|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14374888|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374889|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14374890|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
14374891|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374892|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374893|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14374894|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
14374895|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374896|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14374897|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14374898|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14374899|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14374900|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
14374901|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374902|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374903|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
14374904|NCT01192178|Hormones|hormones|mesh-ancestor
14374905|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374906|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
14466295|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
14466296|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466297|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466298|NCT02240030|Levodopa|levodopa|mesh-list
14466299|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14466300|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14466301|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
14466302|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466303|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466304|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466305|NCT02240108|Rifaximin|rifaximin|mesh-list
14466306|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14466307|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733567|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733568|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733569|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14733570|NCT01614171|Hormones|hormones|mesh-list
14733571|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733572|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733573|NCT01582776|Lenalidomide|lenalidomide|mesh-list
14733574|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
14733575|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
14733576|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733577|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14733578|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15234518|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
14466308|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466309|NCT02240121|Rifaximin|rifaximin|mesh-list
15234519|NCT05187338|Ipilimumab|ipilimumab|mesh-list
15234520|NCT05187338|Durvalumab|durvalumab|mesh-list
15234521|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234522|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234523|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15234524|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234525|NCT05187208|Niraparib|niraparib|mesh-list
15234526|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15234527|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374907|NCT01192191|Fluticasone|fluticasone|mesh-list
14374908|NCT01192191|Xhance|xhance|mesh-list
14374909|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374910|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14374911|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
14374912|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374913|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374914|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14374915|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
14374916|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14374917|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14374918|NCT01192295|Oxycodone|oxycodone|mesh-list
14374919|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14374920|NCT01192295|Narcotics|narcotics|mesh-ancestor
14374921|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374922|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374923|NCT01192295|Analgesics|analgesics|mesh-ancestor
14374924|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
14374925|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374926|NCT01192399|Eculizumab|eculizumab|mesh-list
14374927|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14374928|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374929|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
14374930|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374931|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14374932|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374933|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14374934|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14374935|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374936|NCT01193049|Prednisone|prednisone|mesh-list
14374937|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374938|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
14374939|NCT01193049|Hormones|hormones|mesh-ancestor
14374940|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374941|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374942|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14374943|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374944|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14374945|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14374946|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374947|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14920876|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14374948|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14374949|NCT01193127|Mydriatics|mydriatics|mesh-list
14374950|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
14374951|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14374952|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374953|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14374954|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14374955|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14374956|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14374957|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374958|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14374959|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14374960|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14374961|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
14374962|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14374963|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374964|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14374965|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14374966|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
14374967|NCT01193218|Empagliflozin|empagliflozin|mesh-list
14374968|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14374969|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374970|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14374971|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374972|NCT01193244|Prednisone|prednisone|mesh-list
14374973|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374974|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
14374975|NCT01193244|Hormones|hormones|mesh-ancestor
14374976|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374977|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374978|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14374979|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374980|NCT01193257|Prednisone|prednisone|mesh-list
14374981|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14374982|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
14374983|NCT01193257|Hormones|hormones|mesh-ancestor
14374984|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14374985|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374986|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14374987|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374988|NCT01193283|Cyclosporine|cyclosporine|mesh-list
14374989|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
14374990|NCT01193283|Cyclosporins|cyclosporins|mesh-list
14374991|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14374992|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
14374993|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14374994|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14374995|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14374996|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
14374997|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14374998|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14374999|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14375000|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375001|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
14375002|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375003|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14375004|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14375005|NCT01193335|Vaccines|vaccines|mesh-list
14375006|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14375007|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
14375008|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234528|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234529|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234530|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
15234531|NCT05186467|Analgesics|analgesics|mesh-ancestor
15234532|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
15234533|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234534|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234535|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
15234536|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234537|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15234538|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
14375009|NCT01193348|Eculizumab|eculizumab|mesh-list
14375010|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14375011|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375012|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
14375013|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375014|NCT01193517|Capecitabine|capecitabine|mesh-list
14375015|NCT01193517|Azacitidine|azacitidine|mesh-list
14375016|NCT01193517|Decitabine|decitabine|mesh-list
14375017|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
14375018|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375019|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
14375020|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375021|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375022|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375023|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14375024|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
14375025|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375026|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
14375027|NCT01193660|Hematinics|hematinics|mesh-ancestor
14375028|NCT01193868|R04929097|r04929097|mesh-list
14375029|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375030|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375031|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14375032|NCT01193920|Vaccines|vaccines|mesh-list
14375033|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
14375034|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375035|NCT01194089|Nicotine|nicotine|mesh-list
14375036|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14375037|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
14375038|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375039|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375040|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14375041|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15234539|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15234540|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15234541|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234542|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15234543|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
15234544|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15234545|NCT05182892|Dopamine|dopamine|mesh-list
15234546|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
15234547|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15234548|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
14375042|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
14375043|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375044|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375045|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
14375046|NCT01194154|Hematinics|hematinics|mesh-ancestor
14375047|NCT01194245|Insulin|insulin|mesh-list
14375048|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14375049|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
14375050|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
14375051|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
14375052|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
14375053|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14375054|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375055|NCT01194258|Insulin|insulin|mesh-list
14375056|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14375057|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
14375058|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
14375059|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
14375060|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
14375061|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14375062|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375063|NCT01194271|Ipilimumab|ipilimumab|mesh-list
14375064|NCT01194271|Leuprolide|leuprolide|mesh-list
14375065|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375066|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375067|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14375068|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375069|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14375070|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
14375071|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14375072|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375073|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14375074|NCT01194297|Vaccines|vaccines|mesh-list
14375075|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
14375076|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375077|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
14375078|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
14375079|NCT01194440|Letrozole|letrozole|mesh-list
14375080|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375081|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14375082|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15234549|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
15234550|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234551|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234552|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
15234553|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234554|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234555|NCT05182892|Protective Agents|protective agents|mesh-ancestor
15234556|NCT05171673|Diclofenac|diclofenac|mesh-list
15234557|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
15234558|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15234559|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375083|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375084|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375085|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14375086|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
14466310|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14375087|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375088|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375089|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14375090|NCT01194453|Folic Acid|folic acid|mesh-list
14375091|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
14375092|NCT01194453|Hydroxocobalamin|hydroxocobalamin|mesh-list
14375093|NCT01194453|Gemcitabine|gemcitabine|mesh-list
14375094|NCT01194453|Dexamethasone|dexamethasone|mesh-list
14375095|NCT01194453|Cisplatin|cisplatin|mesh-list
14375096|NCT01194453|Vitamins|vitamins|mesh-ancestor
14375097|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
14375098|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375099|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375100|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375101|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
14375102|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
14375103|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375104|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14375105|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
14375106|NCT01194453|Hormones|hormones|mesh-ancestor
14375107|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375108|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14375109|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375110|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
14375111|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375112|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
14375113|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375114|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375115|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375116|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
14375117|NCT01194453|Hematinics|hematinics|mesh-ancestor
14375118|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
14375119|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
14375120|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14375121|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
14375122|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375123|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375124|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14375125|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
14375126|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14375127|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14375128|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14375129|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
14375130|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375131|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733579|NCT01582776|Growth Substances|growth substances|mesh-ancestor
14375132|NCT01194674|Plasminogen|plasminogen|mesh-list
14375133|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14375134|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14375135|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733580|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733581|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733582|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733583|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
15234560|NCT05171673|Analgesics|analgesics|mesh-ancestor
14375136|NCT01194804|Eculizumab|eculizumab|mesh-list
14375137|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14375138|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375139|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
14375140|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375141|NCT01194830|Linagliptin|linagliptin|mesh-list
14375142|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14375143|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375144|NCT01194830|Incretins|incretins|mesh-ancestor
14375145|NCT01194830|Hormones|hormones|mesh-ancestor
14920877|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15234561|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
15234562|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234563|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234564|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234565|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234566|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15234567|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375146|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375147|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14375148|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
14375149|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375150|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375151|NCT01194869|Paclitaxel|paclitaxel|mesh-list
14375152|NCT01194869|Cisplatin|cisplatin|mesh-list
14375153|NCT01194869|Sorafenib|sorafenib|mesh-list
14375154|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375155|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375156|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375157|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375158|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375159|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375160|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14375161|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375162|NCT01194973|Eculizumab|eculizumab|mesh-list
14375163|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14375164|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375165|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
14375166|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375167|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14375168|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
14375169|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
14375170|NCT01195090|Pioglitazone|pioglitazone|mesh-list
14375171|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14375172|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14375173|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375174|NCT01195090|Incretins|incretins|mesh-ancestor
14375175|NCT01195090|Hormones|hormones|mesh-ancestor
14375176|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375177|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14375178|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
14375179|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375180|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375181|NCT01195103|Fentanyl|fentanyl|mesh-list
14375182|NCT01195103|Midazolam|midazolam|mesh-list
14375183|NCT01195103|Propofol|propofol|mesh-list
14375184|NCT01195103|Fospropofol|fospropofol|mesh-list
15234568|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375185|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14375186|NCT01195103|Narcotics|narcotics|mesh-ancestor
14920878|NCT04397484|Lidocaine|lidocaine|mesh-list
15234569|NCT05167487|Cisplatin|cisplatin|mesh-list
15234570|NCT05167487|Carboplatin|carboplatin|mesh-list
15234571|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234572|NCT05166239|Lenvatinib|lenvatinib|mesh-list
15234573|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234574|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15234575|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234576|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234577|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
15234578|NCT05149287|Lidocaine|lidocaine|mesh-list
15234579|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
15234580|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
15234581|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234582|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234583|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
15234584|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234585|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14375187|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14375188|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375189|NCT01195103|Analgesics|analgesics|mesh-ancestor
14375190|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
14375191|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375192|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14375193|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14375194|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
14375195|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
14375196|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14375197|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14375198|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14375199|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14375200|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
14375201|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
14375202|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375203|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375204|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
14375205|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14375206|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14375207|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375208|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375209|NCT01195116|Analgesics|analgesics|mesh-ancestor
14375210|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
14375211|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375212|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14375213|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14375214|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14375215|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
14375216|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375217|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375218|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14375219|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
14375220|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14375221|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14375222|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14375223|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14375224|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375225|NCT01195415|Gemcitabine|gemcitabine|mesh-list
14375226|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375227|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
14375228|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375229|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375230|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
14375231|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234586|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15234587|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15234588|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15234589|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234590|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15234591|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234592|NCT05122130|Melatonin|melatonin|mesh-list
15234593|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
14375232|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375233|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375234|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
14375235|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375236|NCT01195467|Tenofovir|tenofovir|mesh-list
14375237|NCT01195467|Emtricitabine|emtricitabine|mesh-list
14375238|NCT01195467|Efavirenz|efavirenz|mesh-list
14375239|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
14375240|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14375241|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
14375242|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375243|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14375244|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14375245|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375246|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375247|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14375248|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14375249|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14375250|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14375251|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14375252|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14375253|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14375254|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14375255|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14375256|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14375257|NCT01195597|Nicotine|nicotine|mesh-list
14375258|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14375259|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
14375260|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375261|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375262|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14375263|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14375264|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
14375265|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375266|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375267|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
14375268|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14375269|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375270|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14375271|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375272|NCT01195675|Empagliflozin|empagliflozin|mesh-list
14375273|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
14375274|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14375275|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234594|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234595|NCT05122130|Protective Agents|protective agents|mesh-ancestor
15234596|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375276|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14375277|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14375278|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375279|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375280|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375281|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234597|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234598|NCT05119166|Niacinamide|niacinamide|mesh-list
15234599|NCT05119166|Azithromycin|azithromycin|mesh-list
15234600|NCT05119166|Vitamins|vitamins|mesh-ancestor
15234601|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
14375282|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14375283|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14375284|NCT01195779|Vaccines|vaccines|mesh-list
14375285|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
14375286|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375287|NCT01195831|Calcipotriene|calcipotriene|mesh-list
14375288|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
14375289|NCT01195922|Sirolimus|sirolimus|mesh-list
14375290|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14375291|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375292|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14375293|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733584|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733585|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
14375294|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
14375295|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234602|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375296|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
14733586|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733587|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733588|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234603|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14375297|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375298|NCT01196052|Trastuzumab|trastuzumab|mesh-list
14375299|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14375300|NCT01196052|Maytansine|maytansine|mesh-list
14375301|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375302|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375303|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375304|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375305|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375306|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375307|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375308|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14375309|NCT01196078|Vinorelbine|vinorelbine|mesh-list
14375310|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375311|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14375312|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375313|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375314|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375315|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375316|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375317|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375318|NCT01196091|Antimalarials|antimalarials|mesh-list
14375319|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14375320|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14375321|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14375322|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375323|NCT01196091|Analgesics|analgesics|mesh-ancestor
14375324|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
14375325|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375326|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375327|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375328|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
14375329|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14375330|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14375331|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375332|NCT01196104|Insulin|insulin|mesh-list
14375333|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14375334|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
14375335|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
14375336|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14375337|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375338|NCT01196377|Albuterol|albuterol|mesh-list
14375339|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14375340|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
14375341|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375342|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375343|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14375344|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
14375345|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
14375346|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14375347|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14375348|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14375349|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14375350|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
15234604|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234605|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
15234606|NCT05112848|Vaccines|vaccines|mesh-list
15234607|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
15234608|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234609|NCT05086250|Ketamine|ketamine|mesh-list
15234610|NCT05086250|Analgesics|analgesics|mesh-ancestor
15234611|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
15234612|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375351|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375352|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375353|NCT01196416|Cisplatin|cisplatin|mesh-list
14375354|NCT01196416|Temozolomide|temozolomide|mesh-list
14375355|NCT01196416|Vinblastine|vinblastine|mesh-list
14375356|NCT01196416|R04929097|r04929097|mesh-list
14375357|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375358|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14375359|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
14375360|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375361|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375362|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375363|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375364|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375365|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375366|NCT01196429|Sirolimus|sirolimus|mesh-list
14375367|NCT01196429|Paclitaxel|paclitaxel|mesh-list
14375368|NCT01196429|Docetaxel|docetaxel|mesh-list
14375369|NCT01196429|Carboplatin|carboplatin|mesh-list
14375370|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14375371|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375372|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375373|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375374|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375375|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375376|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375377|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14375378|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375379|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14375380|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
14375381|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375382|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
14375383|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375384|NCT01196741|Paclitaxel|paclitaxel|mesh-list
14375385|NCT01196741|Saracatinib|saracatinib|mesh-list
14375386|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375387|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375388|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375389|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375390|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375391|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375392|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375393|NCT01196975|Vaccines|vaccines|mesh-list
14375394|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
14375395|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375396|NCT01196988|Vaccines|vaccines|mesh-list
14375397|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
14375398|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375399|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
14375400|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14375401|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920879|NCT04397484|Epinephrine|epinephrine|mesh-list
14375402|NCT01197378|Cysteamine|cysteamine|mesh-list
14920880|NCT04397484|Racepinephrine|racepinephrine|mesh-list
14733589|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
14733590|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733591|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375403|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14375404|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375405|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
14375406|NCT01197417|Analgesics|analgesics|mesh-ancestor
14375407|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
14375408|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375409|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375410|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
14375411|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14375412|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14375413|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
14375414|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14375415|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14375416|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375417|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14375418|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
14375419|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14375420|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
14375421|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14375422|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
14375423|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375424|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
14733592|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14733593|NCT01356290|Cytarabine|cytarabine|mesh-list
14375425|NCT01197495|Protective Agents|protective agents|mesh-ancestor
14375426|NCT01197560|Gemcitabine|gemcitabine|mesh-list
14375427|NCT01197560|Rituximab|rituximab|mesh-list
14375428|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
14375429|NCT01197560|Etoposide|etoposide|mesh-list
14375430|NCT01197560|Lenalidomide|lenalidomide|mesh-list
14375431|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375432|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375433|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
14375434|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375435|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375436|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375437|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
14375438|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375439|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
14375440|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375441|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375442|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375443|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375444|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14375445|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14375446|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14375447|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14375448|NCT01197560|Growth Substances|growth substances|mesh-ancestor
14375449|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
14466311|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466312|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466313|NCT02240329|Capsaicin|capsaicin|mesh-list
14466314|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
14466315|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
14466316|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
14466317|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466318|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466319|NCT02240589|Memantine|memantine|mesh-list
14466320|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14920881|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
14920882|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
14920883|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
14920884|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
14920885|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920886|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920887|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
14920888|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920889|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14920890|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14920891|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14920892|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14920893|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920894|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14920895|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14920896|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
14920897|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14920898|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15234613|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234614|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15234615|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15234616|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
15234617|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
15234618|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234619|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15234620|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15234621|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234622|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234623|NCT05082688|Vaccines|vaccines|mesh-list
15234624|NCT05082688|Immunologic Factors|immunologic factors|mesh-ancestor
15234625|NCT05082688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234626|NCT05081206|Propofol|propofol|mesh-list
15234627|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15234628|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234629|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234630|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15234631|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
15234632|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
15234633|NCT05047939|Propofol|propofol|mesh-list
15234634|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15234635|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234636|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375450|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14375451|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14375452|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14375453|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375454|NCT01197612|Budesonide|budesonide|mesh-list
14375455|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375456|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14375457|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
14375458|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375459|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375460|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14375461|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
14375462|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
14375463|NCT01197612|Hormones|hormones|mesh-ancestor
14375464|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375465|NCT01197833|Polidocanol|polidocanol|mesh-list
14375466|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14375467|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14375468|NCT01198002|Methotrexate|methotrexate|mesh-list
14375469|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14375470|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
14375471|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14375472|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375473|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375474|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
14375475|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375476|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375477|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
14375478|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375479|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14375480|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375481|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
14375482|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375483|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14375484|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14375485|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375486|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14375487|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375488|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375489|NCT01198132|Vitamin D|vitamin d|mesh-list
14375490|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
14375491|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
14375492|NCT01198132|Vitamins|vitamins|mesh-list
14375493|NCT01198132|Interferons|interferons|mesh-list
14375494|NCT01198132|Interferon-beta|interferon-beta|mesh-list
14375495|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
14375496|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
14375497|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375498|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14375499|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15234637|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15234638|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
15234639|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
15234640|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
15234641|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
15234642|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14375500|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375501|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
14375502|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375503|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
14375504|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14375505|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
14375506|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375507|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14375508|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375509|NCT01198145|Analgesics|analgesics|mesh-ancestor
14375510|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
14375511|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375512|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375513|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375514|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375515|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14375516|NCT01198158|Bevacizumab|bevacizumab|mesh-list
14375517|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14375518|NCT01198158|Everolimus|everolimus|mesh-list
15234643|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234644|NCT05022329|Vaccines|vaccines|mesh-list
15234645|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
15234646|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234647|NCT05012254|Paclitaxel|paclitaxel|mesh-list
15234648|NCT05012254|Cisplatin|cisplatin|mesh-list
15234649|NCT05012254|Carboplatin|carboplatin|mesh-list
15234650|NCT05012254|Nivolumab|nivolumab|mesh-list
15234651|NCT05012254|Pemetrexed|pemetrexed|mesh-list
15234652|NCT05012254|Ipilimumab|ipilimumab|mesh-list
15234653|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15234654|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234655|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234656|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234657|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234658|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234659|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234660|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14375519|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
14375520|NCT01198158|Antibodies|antibodies|mesh-list
14375521|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
14375522|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14375523|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
14375524|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375525|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14375526|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14375527|NCT01198158|Growth Substances|growth substances|mesh-ancestor
14375528|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375529|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
14375530|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
14375531|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375532|NCT01198275|Amiodarone|amiodarone|mesh-list
14375533|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14375534|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
14375535|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14375536|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14375537|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375538|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14375539|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14375540|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14375541|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375542|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14375543|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14375544|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14375545|NCT01198327|Ranibizumab|ranibizumab|mesh-list
14375546|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14375547|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14375548|NCT01198327|Growth Substances|growth substances|mesh-ancestor
14375549|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375550|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
14375551|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375552|NCT01198509|Vancomycin|vancomycin|mesh-list
14375553|NCT01198509|Doxycycline|doxycycline|mesh-list
14375554|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14375555|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375556|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
14375557|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14375558|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14375559|NCT01198574|Vitamins|vitamins|mesh-list
14375560|NCT01198574|Folic Acid|folic acid|mesh-list
14375561|NCT01198574|Vitamin A|vitamin a|mesh-list
14375562|NCT01198574|Iron|iron|mesh-list
14375563|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
14375564|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
14375565|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375566|NCT01198574|Trace Elements|trace elements|mesh-ancestor
14375567|NCT01198574|Hematinics|hematinics|mesh-ancestor
14375568|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
14375569|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
14375570|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375571|NCT01198574|Protective Agents|protective agents|mesh-ancestor
14375572|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14375573|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375574|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
14375575|NCT01198587|Astringents|astringents|mesh-ancestor
14375576|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375577|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14375578|NCT01198756|Vaccines|vaccines|mesh-list
14375579|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
14375580|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375581|NCT01198795|Citalopram|citalopram|mesh-list
14375582|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14375583|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14375584|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14375585|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375586|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375587|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
14375588|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375589|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14375590|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
14375591|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14375592|NCT01198873|Dronedarone|dronedarone|mesh-list
14375593|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14375594|NCT01199055|Paclitaxel|paclitaxel|mesh-list
14375595|NCT01199055|Carboplatin|carboplatin|mesh-list
14375596|NCT01199055|Efatutazone|efatutazone|mesh-list
14375597|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375598|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375599|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375600|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375601|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375602|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375603|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14375604|NCT01199068|Efatutazone|efatutazone|mesh-list
14375605|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375606|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14375607|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375608|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375609|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
14375610|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375611|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14375612|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375613|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375614|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
14375615|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375616|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375617|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14375618|NCT01199198|Tolvaptan|tolvaptan|mesh-list
14375619|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14375620|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375621|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
14375622|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375623|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
14375624|NCT01199237|Sevoflurane|sevoflurane|mesh-list
14375625|NCT01199237|Desflurane|desflurane|mesh-list
14375626|NCT01199237|Rocuronium|rocuronium|mesh-list
14375627|NCT01199237|Neostigmine|neostigmine|mesh-list
14375628|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14375629|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14375630|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
14375631|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
14375632|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14375633|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375634|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14375635|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14375636|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14375637|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375638|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14375639|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375640|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375641|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
14920899|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14920900|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
14920901|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14920902|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
14920903|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
14920904|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
14920905|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14920906|NCT04394130|Ropivacaine|ropivacaine|mesh-list
14920907|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
14920908|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
14920909|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14920910|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375642|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375643|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14375644|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
14375645|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14375646|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14375647|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14375648|NCT01199263|Paclitaxel|paclitaxel|mesh-list
14375649|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14920911|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
14920912|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920913|NCT04391608|Tenofovir|tenofovir|mesh-list
14920914|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
14920915|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920916|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14920917|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14920918|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920919|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920920|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14920921|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14920922|NCT04389177|Paclitaxel|paclitaxel|mesh-list
14920923|NCT04389177|Cisplatin|cisplatin|mesh-list
14920924|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
14920925|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14920926|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920927|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
14920928|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
14920929|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
14920930|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920931|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920932|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
14920933|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14920934|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
14920935|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375650|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375651|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375652|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375653|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375654|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375655|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375656|NCT01199289|Brodalumab|brodalumab|mesh-list
14375657|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
14375658|NCT01199380|Nicotine|nicotine|mesh-list
14375659|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14375660|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
14920936|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375661|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375662|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375663|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14375664|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14375665|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
14375666|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375667|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375668|NCT01199575|Rituximab|rituximab|mesh-list
14375669|NCT01199575|Lenalidomide|lenalidomide|mesh-list
14375670|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375671|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375672|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
14375673|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375674|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375675|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14375676|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14375677|NCT01199575|Growth Substances|growth substances|mesh-ancestor
14375678|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
14375679|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
14375680|NCT01199705|Antibodies|antibodies|mesh-list
14375681|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
14375682|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14375683|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14375684|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
14375685|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375686|NCT01199731|Etravirine|etravirine|mesh-list
14375687|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14375688|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14375689|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375690|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375691|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
14375692|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375693|NCT01199744|Zanamivir|zanamivir|mesh-list
14375694|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
14375695|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14920937|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14920938|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
14920939|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920940|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920941|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14920942|NCT04368091|Sirolimus|sirolimus|mesh-list
14920943|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14920944|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234661|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234662|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15234663|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15234664|NCT04973800|Simvastatin|simvastatin|mesh-list
15234665|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15234666|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15234667|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
15234668|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375696|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733594|NCT01356290|Thalidomide|thalidomide|mesh-list
14733595|NCT01356290|Celecoxib|celecoxib|mesh-list
14733596|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
14733597|NCT01356290|Bevacizumab|bevacizumab|mesh-list
14733598|NCT01356290|Etoposide|etoposide|mesh-list
14733599|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
14733600|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
14733601|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733602|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
14733603|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733604|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733605|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733606|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
14733607|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733608|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733609|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14733610|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733611|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14733612|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14733613|NCT01356290|Growth Substances|growth substances|mesh-ancestor
14733614|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733615|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733616|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14375697|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375698|NCT01199822|Olaratumab|olaratumab|mesh-list
14375699|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375700|NCT01199861|Vaccines|vaccines|mesh-list
14375701|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14375702|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
14375703|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375704|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14375705|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375706|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375707|NCT01199926|Vitamin D|vitamin d|mesh-list
14375708|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
14375709|NCT01199926|Vitamins|vitamins|mesh-ancestor
14375710|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
14375711|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375712|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14375713|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14375714|NCT01199939|Ritonavir|ritonavir|mesh-list
14375715|NCT01199939|Darunavir|darunavir|mesh-list
14375716|NCT01199939|Etravirine|etravirine|mesh-list
14375717|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14375718|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14375719|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14375720|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375721|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375722|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14375723|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14375724|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
14375725|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375726|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14375727|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14375728|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14375729|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14375730|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
14375731|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14375732|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
14375733|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
14375734|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14375735|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375736|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375737|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375738|NCT01199965|Analgesics|analgesics|mesh-ancestor
14375739|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
14375740|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375741|NCT01200069|Ibuprofen|ibuprofen|mesh-list
14375742|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14375743|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375744|NCT01200069|Analgesics|analgesics|mesh-ancestor
14375745|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
14375746|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375747|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375748|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375749|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375750|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14375751|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733617|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14733618|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375752|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375753|NCT01200160|Niacin|niacin|mesh-list
14375754|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14375755|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
14375756|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375757|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14375758|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
14375759|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
14375760|NCT01200160|Vitamins|vitamins|mesh-ancestor
14375761|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
14375762|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375763|NCT01200329|Gemcitabine|gemcitabine|mesh-list
14375764|NCT01200329|Melphalan|melphalan|mesh-list
14375765|NCT01200329|Busulfan|busulfan|mesh-list
14375766|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375767|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
14375768|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375769|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234669|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14375770|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
14375771|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375772|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375773|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375774|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
14375775|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375776|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14375777|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
14375778|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14375779|NCT01200342|Paclitaxel|paclitaxel|mesh-list
14375780|NCT01200342|Carboplatin|carboplatin|mesh-list
14375781|NCT01200342|Oblimersen|oblimersen|mesh-list
14375782|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375783|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234670|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15234671|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234672|NCT04947059|Gemcitabine|gemcitabine|mesh-list
15234673|NCT04947059|Epirubicin|epirubicin|mesh-list
15234674|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15234675|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
15234676|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234677|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234678|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
15234679|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234680|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234681|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234682|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
15234683|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234684|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14375784|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375785|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
14375786|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375787|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375788|NCT01200355|Posaconazole|posaconazole|mesh-list
14375789|NCT01200355|Micafungin|micafungin|mesh-list
14375790|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
14375791|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375792|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14375793|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14375794|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14375795|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14375796|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14375797|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375798|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375799|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14920945|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14920946|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920947|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
14920948|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14920949|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
14920950|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920951|NCT04367883|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14375800|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
14375801|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375802|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234685|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14375803|NCT01200368|Vaccines|vaccines|mesh-list
14375804|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14375805|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
14375806|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375807|NCT01200407|Amlodipine|amlodipine|mesh-list
14375808|NCT01200407|Olmesartan|olmesartan|mesh-list
14375809|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14375810|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14375811|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14375812|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14375813|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375814|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14375815|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375816|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
14375817|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14375818|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14375819|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
14375820|NCT01200433|Propofol|propofol|mesh-list
14375821|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14375822|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14375823|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375824|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14375825|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
14375826|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
14375827|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375828|NCT01200433|Analgesics|analgesics|mesh-ancestor
14375829|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
14375830|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375831|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14375832|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14375833|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14375834|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
14375835|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466321|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14375836|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375837|NCT01200485|Allopurinol|allopurinol|mesh-list
14375838|NCT01200485|Rasburicase|rasburicase|mesh-list
14375839|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
14375840|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375841|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375842|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
14375843|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375844|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14375845|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
14375846|NCT01200485|Protective Agents|protective agents|mesh-ancestor
14375847|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375848|NCT01200589|Rituximab|rituximab|mesh-list
14375849|NCT01200589|Ofatumumab|ofatumumab|mesh-list
14375850|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14375851|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375852|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375853|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
14375854|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375855|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375856|NCT01200758|Prednisone|prednisone|mesh-list
14375857|NCT01200758|Prednisolone|prednisolone|mesh-list
14375858|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
14375859|NCT01200758|Rituximab|rituximab|mesh-list
14375860|NCT01200758|Doxorubicin|doxorubicin|mesh-list
14375861|NCT01200758|Vincristine|vincristine|mesh-list
14375862|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375863|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
14375864|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375865|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375866|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14375867|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
14375868|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375869|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375870|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14375871|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375872|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14375873|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14375874|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14375875|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375876|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375877|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
14375878|NCT01200758|Hormones|hormones|mesh-ancestor
14375879|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375880|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14375881|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14375882|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
14375883|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234686|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15234687|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
15234688|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234689|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234690|NCT04921735|Cisatracurium|cisatracurium|mesh-list
15234691|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15234692|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14375884|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
14375885|NCT01200810|Bicalutamide|bicalutamide|mesh-list
14375886|NCT01200810|R04929097|r04929097|mesh-list
14375887|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
14375888|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
14375889|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375890|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375891|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375892|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375893|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375894|NCT01200992|Mitomycins|mitomycins|mesh-list
14375895|NCT01200992|Mitomycin|mitomycin|mesh-list
14375896|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15234693|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234694|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375897|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375898|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
14375899|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375900|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14375901|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375902|NCT01201265|Gemcitabine|gemcitabine|mesh-list
14375903|NCT01201265|Bevacizumab|bevacizumab|mesh-list
14375904|NCT01201265|Carboplatin|carboplatin|mesh-list
14375905|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375906|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375907|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14375908|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14375909|NCT01201265|Growth Substances|growth substances|mesh-ancestor
14375910|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375911|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
14375912|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375913|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
14375914|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375915|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
14375916|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375917|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375918|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375919|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
14375920|NCT01201343|Interferons|interferons|mesh-list
14375921|NCT01201343|Interferon-beta|interferon-beta|mesh-list
14375922|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
14375923|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375924|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
14375925|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14375926|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
14375927|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375928|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14375929|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14375930|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14375931|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375932|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14375933|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
14375934|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375935|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14375936|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
14375937|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14375938|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375939|NCT01201759|Analgesics|analgesics|mesh-ancestor
14375940|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
14375941|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375942|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375943|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375944|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375945|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14375946|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375947|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375948|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14375949|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14375950|NCT01201785|Aspirin|aspirin|mesh-list
14375951|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14375952|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14375953|NCT01201785|Analgesics|analgesics|mesh-ancestor
14375954|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
14375955|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920952|NCT04367883|Protease Inhibitors|protease inhibitors|mesh-ancestor
14920953|NCT04367883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14920954|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920955|NCT04356950|Thrombin|thrombin|mesh-list
14920956|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
14920957|NCT04356950|Coagulants|coagulants|mesh-ancestor
14920958|NCT04341350|Analgesics|analgesics|mesh-list
14920959|NCT04341350|Propofol|propofol|mesh-list
14375956|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375957|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375958|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14375959|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14375960|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14466322|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
14920960|NCT04341350|Isoflurane|isoflurane|mesh-list
14920961|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14375961|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375962|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14375963|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14375964|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375965|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
14375966|NCT01201798|Prednisolone|prednisolone|mesh-list
14375967|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14375968|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
14375969|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14375970|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
14375971|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14375972|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
14375973|NCT01201798|Difluprednate|difluprednate|mesh-list
14375974|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14375975|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
14375976|NCT01201798|Hormones|hormones|mesh-ancestor
14375977|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14375978|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14375979|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14375980|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375981|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
14375982|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
14375983|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14375984|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14375985|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14375986|NCT01201798|Protective Agents|protective agents|mesh-ancestor
14375987|NCT01201811|Azacitidine|azacitidine|mesh-list
14375988|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14375989|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
14375990|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14375991|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733619|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733620|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
14733621|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
14375992|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14375993|NCT01201850|Bevacizumab|bevacizumab|mesh-list
14375994|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14375995|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14375996|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14375997|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14375998|NCT01201850|Growth Substances|growth substances|mesh-ancestor
14375999|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376000|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376001|NCT01201863|Testosterone|testosterone|mesh-list
14376002|NCT01201863|Androgens|androgens|mesh-ancestor
14376003|NCT01201863|Hormones|hormones|mesh-ancestor
14733622|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376004|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376005|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376006|NCT01202071|Rabeprazole|rabeprazole|mesh-list
14376007|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14376008|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14376009|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14376010|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376011|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376012|NCT01202162|Sevoflurane|sevoflurane|mesh-list
14376013|NCT01202162|Desflurane|desflurane|mesh-list
14376014|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14376015|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14376016|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
14376017|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
14376018|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376019|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376020|NCT01202175|Nebivolol|nebivolol|mesh-list
14733623|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14733624|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14733625|NCT01356290|Analgesics|analgesics|mesh-ancestor
14733626|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
14733627|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733628|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376021|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14376022|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
14376023|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14376024|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14376025|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14376026|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
14376027|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376028|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376029|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376030|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
14376031|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
14376032|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14376033|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
14376034|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376035|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376036|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14733629|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14376037|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
14376038|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
14376039|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14376040|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
14376041|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376042|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376043|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14376044|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14376045|NCT01202227|Pregabalin|pregabalin|mesh-list
14376046|NCT01202227|Analgesics|analgesics|mesh-ancestor
14376047|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
14376048|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376049|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376050|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
14376051|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14376052|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14376053|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376054|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14376055|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14376056|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14376057|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376058|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376059|NCT01202253|Anidulafungin|anidulafungin|mesh-list
14376060|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
14376061|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376062|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
14376063|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
14376064|NCT01202279|Guaifenesin|guaifenesin|mesh-list
14376065|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14376066|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14376067|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
14376068|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376069|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376070|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14376071|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
14376072|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
14376073|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14376074|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
14376075|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
14376076|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376077|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376078|NCT01202279|Expectorants|expectorants|mesh-ancestor
14376079|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14376080|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14376081|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
14376082|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14376083|NCT01202409|Panitumumab|panitumumab|mesh-list
14376084|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14376085|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376086|NCT01202591|Fulvestrant|fulvestrant|mesh-list
14376087|NCT01202591|Exemestane|exemestane|mesh-list
14376088|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14376089|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376090|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14376091|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14376092|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
14376093|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376094|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234695|NCT04908475|Apremilast|apremilast|mesh-list
15234696|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15234697|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15234698|NCT04908475|Analgesics|analgesics|mesh-ancestor
15234699|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
15234700|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234701|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376095|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14376096|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15234702|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234703|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234704|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14376097|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376098|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466323|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466324|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466325|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466326|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14466327|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14466328|NCT02240628|Lidocaine|lidocaine|mesh-list
14466329|NCT02240628|Tetracaine|tetracaine|mesh-list
14466330|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
14466331|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
14466332|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466333|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466334|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
14466335|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466336|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14466337|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14466338|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14466339|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466340|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466341|NCT02240667|Vitamin K|vitamin k|mesh-list
14466342|NCT02240667|Dabigatran|dabigatran|mesh-list
14466343|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
14466344|NCT02240667|Vitamins|vitamins|mesh-ancestor
14466345|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
14466346|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466347|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
14466348|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14466349|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
14466350|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466351|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466352|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
14466353|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14466354|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14466355|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
14466356|NCT02240667|Coagulants|coagulants|mesh-ancestor
14466357|NCT02240680|Linagliptin|linagliptin|mesh-list
14466358|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14466359|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466360|NCT02240680|Incretins|incretins|mesh-ancestor
14466361|NCT02240680|Hormones|hormones|mesh-ancestor
14466362|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466363|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14466364|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
14376099|NCT01202721|Atenolol|atenolol|mesh-list
14376100|NCT01202721|Telmisartan|telmisartan|mesh-list
14376101|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14376102|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14376103|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14376104|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376105|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15234705|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15234706|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234707|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234708|NCT04879368|Trifluridine|trifluridine|mesh-list
15234709|NCT04879368|Paclitaxel|paclitaxel|mesh-list
15234710|NCT04879368|Docetaxel|docetaxel|mesh-list
15234711|NCT04879368|Nivolumab|nivolumab|mesh-list
15234712|NCT04879368|Irinotecan|irinotecan|mesh-list
15234713|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15234714|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376106|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
14376107|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
14376108|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376109|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376110|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14376111|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14376112|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14376113|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14376114|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376115|NCT01202877|Azacitidine|azacitidine|mesh-list
14376116|NCT01202877|Midostaurin|midostaurin|mesh-list
14376117|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14376118|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
14376119|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376120|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376121|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376122|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376123|NCT01202903|Omalizumab|omalizumab|mesh-list
14376124|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14376125|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14376126|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
14376127|NCT01202955|Tolcapone|tolcapone|mesh-list
14376128|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14376129|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14376130|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14376131|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376132|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376133|NCT01202994|Flutemetamol|flutemetamol|mesh-list
14376134|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14376135|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376136|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14376137|NCT01203046|Ertapenem|ertapenem|mesh-list
14733630|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15234715|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14376138|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376139|NCT01203072|Edoxaban|edoxaban|mesh-list
14376140|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14376141|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
14376142|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14376143|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
14376144|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376145|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376146|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
14376147|NCT01203098|Enoxaparin|enoxaparin|mesh-list
14376148|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
14376149|NCT01203098|Edoxaban|edoxaban|mesh-list
14376150|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
14376151|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14376152|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14376153|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376154|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14376155|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
14376156|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14376157|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
14376158|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376159|NCT01203189|Ketoconazole|ketoconazole|mesh-list
14376160|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
14376161|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376162|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14376163|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14376164|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376165|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376166|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14376167|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
14376168|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376169|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376170|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14376171|NCT01203319|Vaccines|vaccines|mesh-list
14376172|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
14376173|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376174|NCT01203644|Bupivacaine|bupivacaine|mesh-list
14376175|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
14376176|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
14376177|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376178|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376179|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
14376180|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376181|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
14376182|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376183|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376184|NCT01203787|Sorafenib|sorafenib|mesh-list
14376185|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376186|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376187|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376188|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376189|NCT01203852|Metoprolol|metoprolol|mesh-list
14376190|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
14376191|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14376192|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14376193|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
14376194|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
14376195|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376196|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920962|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376197|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14376198|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14376199|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14376200|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
14376201|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376202|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376203|NCT01203852|Diuretics|diuretics|mesh-ancestor
14376204|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
14376205|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14376206|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14376207|NCT01203878|Imiquimod|imiquimod|mesh-list
14376208|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14376209|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14376210|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
14376211|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376212|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376213|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
14376214|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14376215|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
14376216|NCT01203917|Gefitinib|gefitinib|mesh-list
15234716|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
15234717|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
15234718|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234719|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234720|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15234721|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15234722|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15234723|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234724|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
15234725|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
15234726|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376217|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376218|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376219|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376220|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376221|NCT01203930|Rituximab|rituximab|mesh-list
14376222|NCT01203930|Idelalisib|idelalisib|mesh-list
14376223|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14376224|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376225|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
14733631|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
14733632|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14733633|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15234727|NCT04808245|Atezolizumab|atezolizumab|mesh-list
15234728|NCT04808245|Imiquimod|imiquimod|mesh-list
15234729|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234730|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15234731|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
15234732|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234733|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
15234734|NCT04776447|Carboplatin|carboplatin|mesh-list
14376226|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733634|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14733635|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14733636|NCT01342952|Ambrisentan|ambrisentan|mesh-list
14733637|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14733638|NCT01220583|Cisplatin|cisplatin|mesh-list
14733639|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733640|NCT01148849|Margetuximab|margetuximab|mesh-list
14733641|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733642|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
14920963|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920964|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14920965|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
15234735|NCT04776447|Atezolizumab|atezolizumab|mesh-list
15234736|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376227|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376228|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376229|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376230|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
14376231|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14376232|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920966|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
14920967|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
14920968|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14920969|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14920970|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
14920971|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15234737|NCT04739865|Psilocybin|psilocybin|mesh-list
15234738|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
15234739|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376233|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
14376234|NCT01204255|Promethazine|promethazine|mesh-list
14376235|NCT01204255|Lorazepam|lorazepam|mesh-list
14376236|NCT01204255|Haloperidol|haloperidol|mesh-list
14376237|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
14376238|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14376239|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14376240|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376241|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376242|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
14376243|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
14376244|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
14376245|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376246|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
14376247|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
14376248|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14376249|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14376250|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
14376251|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
14376252|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376253|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376254|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14376255|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
14376256|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14376257|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14376258|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15234740|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15234741|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
15234742|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15234743|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234744|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234745|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15234746|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15234747|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
15234748|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15234749|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234750|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234751|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15234752|NCT04720963|Analgesics|analgesics|mesh-ancestor
15234753|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
15234754|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234755|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15234756|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15234757|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15234758|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
15234759|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234760|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234761|NCT04699357|Atropine|atropine|mesh-list
15234762|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15234763|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15234764|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15234765|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
15234766|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234767|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234768|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15234769|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14920972|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14920973|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14920974|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
14920975|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14920976|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920977|NCT04302168|Choline|choline|mesh-list
14920978|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
14920979|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14920980|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
14920981|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920982|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15234770|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
15234771|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
15234772|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14376259|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376260|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14376261|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
14376262|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14376263|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
14376264|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14376265|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
14920983|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14920984|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
14920985|NCT04301271|Simvastatin|simvastatin|mesh-list
14920986|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14920987|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14920988|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
14920989|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14920990|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14920991|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14920992|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376266|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
14376267|NCT01204294|Metformin|metformin|mesh-list
14376268|NCT01204294|Linagliptin|linagliptin|mesh-list
14376269|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376270|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376271|NCT01204294|Incretins|incretins|mesh-ancestor
14376272|NCT01204294|Hormones|hormones|mesh-ancestor
14376273|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376274|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14376275|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
14376276|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376277|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376278|NCT01204398|Amlodipine|amlodipine|mesh-list
14376279|NCT01204398|Telmisartan|telmisartan|mesh-list
14376280|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14376281|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14376282|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14376283|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14376284|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376285|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14376286|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376287|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
14376288|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14376289|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14376290|NCT01204658|Vaccines|vaccines|mesh-list
14376291|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14376292|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
14376293|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376294|NCT01204671|Vaccines|vaccines|mesh-list
14376295|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
14376296|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376297|NCT01204697|Docetaxel|docetaxel|mesh-list
14376298|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14376299|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376300|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
14376301|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
14376302|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
14376303|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376304|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376305|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376306|NCT01204710|Prednisone|prednisone|mesh-list
14376307|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
14376308|NCT01204710|Olaratumab|olaratumab|mesh-list
14376309|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376310|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
14376311|NCT01204710|Hormones|hormones|mesh-ancestor
14376312|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376313|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376314|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14376315|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376316|NCT01204710|Analgesics|analgesics|mesh-ancestor
14376317|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
14376318|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376319|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14376320|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14376321|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376322|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376323|NCT01204775|Metformin|metformin|mesh-list
14376324|NCT01204775|Saxagliptin|saxagliptin|mesh-list
14376325|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376326|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376327|NCT01204775|Incretins|incretins|mesh-ancestor
14376328|NCT01204775|Hormones|hormones|mesh-ancestor
14376329|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376330|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14376331|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
14376332|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376333|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376334|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
14376335|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14376336|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376337|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
14376338|NCT01204905|Maraviroc|maraviroc|mesh-list
14376339|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14376340|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14376341|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
14376342|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234773|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15234774|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
15234775|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234776|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234777|NCT04690192|Gemcitabine|gemcitabine|mesh-list
15234778|NCT04690192|Melphalan|melphalan|mesh-list
15234779|NCT04690192|Busulfan|busulfan|mesh-list
15234780|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15234781|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
15234782|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376343|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14376344|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14376345|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376346|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376347|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14376348|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14376349|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14376350|NCT01204918|Riluzole|riluzole|mesh-list
14376351|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
14376352|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14376353|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14376354|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376355|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376356|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376357|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14376358|NCT01204918|Protective Agents|protective agents|mesh-ancestor
14376359|NCT01205035|Ranibizumab|ranibizumab|mesh-list
14376360|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376361|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376362|NCT01205035|Growth Substances|growth substances|mesh-ancestor
14376363|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376364|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376365|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376366|NCT01205126|Oxycodone|oxycodone|mesh-list
14376367|NCT01205126|Hydromorphone|hydromorphone|mesh-list
14376368|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14376369|NCT01205126|Narcotics|narcotics|mesh-ancestor
14376370|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376371|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376372|NCT01205126|Analgesics|analgesics|mesh-ancestor
14376373|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
14376374|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376375|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
14376376|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14376377|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14376378|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14376379|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14376380|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376381|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
14376382|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376383|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376384|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14376385|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376386|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
14376387|NCT01205503|Doxorubicin|doxorubicin|mesh-list
14376388|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14376389|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
14920993|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
14920994|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14376390|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376391|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376392|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14376393|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
14376394|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376395|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376396|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14376397|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14376398|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14376399|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14376400|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376401|NCT01205529|Procainamide|procainamide|mesh-list
14376402|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14376403|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14376404|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14376405|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14376406|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376407|NCT01205581|Vaccines|vaccines|mesh-list
14376408|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
14376409|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376410|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
14376411|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14376412|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376413|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14376414|NCT01205685|Letrozole|letrozole|mesh-list
14376415|NCT01205685|Goserelin|goserelin|mesh-list
14376416|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376417|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376418|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376419|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376420|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14376421|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14376422|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14376423|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
14376424|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466365|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733643|NCT01145209|Fludarabine|fludarabine|mesh-list
14376425|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376426|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14376427|NCT01205828|Temozolomide|temozolomide|mesh-list
14376428|NCT01205828|Veliparib|veliparib|mesh-list
14376429|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14376430|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
14376431|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376432|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376433|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14376434|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376435|NCT01206140|Sirolimus|sirolimus|mesh-list
14376436|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14376437|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376438|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14376439|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376440|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
14376441|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14376442|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
14376443|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376444|NCT01206322|Insulin|insulin|mesh-list
14376445|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376446|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376447|NCT01206387|Desoximetasone|desoximetasone|mesh-list
14376448|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376449|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
14376450|NCT01206387|Hormones|hormones|mesh-ancestor
15234783|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234784|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
15234785|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376451|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376452|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376453|NCT01206452|Prednisone|prednisone|mesh-list
14376454|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376455|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
14376456|NCT01206452|Hormones|hormones|mesh-ancestor
14376457|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376458|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376459|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14376460|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376461|NCT01206465|Fluorouracil|fluorouracil|mesh-list
14376462|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
14376463|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376464|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14376465|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376466|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14376467|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
14376468|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376469|NCT01206478|Megestrol|megestrol|mesh-list
15234786|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234787|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234788|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
14920995|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14920996|NCT04300127|Pioglitazone|pioglitazone|mesh-list
14920997|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14920998|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14920999|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
15234789|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234790|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234791|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
15234792|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15234793|NCT04661007|Lenalidomide|lenalidomide|mesh-list
15234794|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
15234795|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234796|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376470|NCT01206478|Amitriptyline|amitriptyline|mesh-list
14921000|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15234797|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376471|NCT01206478|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14376472|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14376473|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
14376474|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376475|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14376476|NCT01206478|Analgesics|analgesics|mesh-ancestor
14376477|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
14376478|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376479|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376480|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14376481|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14376482|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14376483|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376484|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
14376485|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376486|NCT01206478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14376487|NCT01206478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14376488|NCT01206478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376489|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14376490|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14376491|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14376492|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
14376493|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14376494|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14376495|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14376496|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14376497|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376498|NCT01206595|Bupivacaine|bupivacaine|mesh-list
14376499|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
14376500|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
14376501|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733644|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
14733645|NCT01145209|Ofatumumab|ofatumumab|mesh-list
14733646|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733647|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
14733648|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733649|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14733650|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14733651|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
14733652|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733653|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733654|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14733655|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733656|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
14733657|NCT01078662|Olaparib|olaparib|mesh-list
14733658|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14733659|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376502|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376503|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
14753806|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234798|NCT04661007|Growth Substances|growth substances|mesh-ancestor
15234799|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
15234800|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234801|NCT04629651|Captopril|captopril|mesh-list
15234802|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15234803|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
15234804|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234805|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234806|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15234807|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
14376504|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376505|NCT01206608|Bupivacaine|bupivacaine|mesh-list
14376506|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
14376507|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
14376508|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376509|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376510|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
14376511|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376512|NCT01206660|Desoximetasone|desoximetasone|mesh-list
14376513|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376514|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
14376515|NCT01206660|Hormones|hormones|mesh-ancestor
14376516|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376517|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376518|NCT01206764|Everolimus|everolimus|mesh-list
14376519|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376520|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14376521|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
14376522|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376523|NCT01206777|Rituximab|rituximab|mesh-list
14376524|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14376525|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376526|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
14376527|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376528|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376529|NCT01206816|Afatinib|afatinib|mesh-list
14376530|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376531|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376532|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376533|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376534|NCT01207388|Blinatumomab|blinatumomab|mesh-list
14376535|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376536|NCT01207401|Lidocaine|lidocaine|mesh-list
14376537|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
14376538|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
14376539|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376540|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376541|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
14376542|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376543|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14376544|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14376545|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14376546|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753807|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15234808|NCT04626024|Dasatinib|dasatinib|mesh-list
14376547|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376548|NCT01207414|Iloperidone|iloperidone|mesh-list
14376549|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14376550|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14376551|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376552|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376553|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376554|NCT01207440|Ponatinib|ponatinib|mesh-list
14376555|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376556|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376557|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376558|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376559|NCT01207453|Milnacipran|milnacipran|mesh-list
14376560|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
14376561|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14376562|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14376563|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14376564|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376565|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376566|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376567|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14376568|NCT01207453|Analgesics|analgesics|mesh-ancestor
14376569|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
14376570|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376571|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
14376572|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376573|NCT01207596|Hydromorphone|hydromorphone|mesh-list
14376574|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14376575|NCT01207596|Narcotics|narcotics|mesh-ancestor
14376576|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376577|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376578|NCT01207596|Analgesics|analgesics|mesh-ancestor
14376579|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
14376580|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376581|NCT01207687|Bevacizumab|bevacizumab|mesh-list
14376582|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14376583|NCT01207687|Antibodies|antibodies|mesh-list
14376584|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
14376585|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14376586|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376587|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376588|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376589|NCT01207687|Growth Substances|growth substances|mesh-ancestor
14376590|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376591|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376592|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
14376593|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14376594|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
14376595|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14376596|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14376597|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
14376598|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376599|NCT01207908|Mecasermin|mecasermin|mesh-list
14376600|NCT01207908|Growth Substances|growth substances|mesh-ancestor
14376601|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376602|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
14376603|NCT01208038|Testosterone|testosterone|mesh-list
14376604|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
14376605|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
14376606|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14376607|NCT01208038|Androgens|androgens|mesh-ancestor
14376608|NCT01208038|Hormones|hormones|mesh-ancestor
14376609|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376610|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376611|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14376612|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376613|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
14376614|NCT01208051|Lenalidomide|lenalidomide|mesh-list
14376615|NCT01208051|Cediranib|cediranib|mesh-list
14376616|NCT01208051|Maleic acid|maleic acid|mesh-list
14376617|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
14376618|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376619|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376620|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376621|NCT01208051|Growth Substances|growth substances|mesh-ancestor
14376622|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376623|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376624|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376625|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733660|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733661|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733662|NCT00971867|Paclitaxel|paclitaxel|mesh-list
14733663|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733664|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733665|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
14733666|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
14376626|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376627|NCT01208103|Bevacizumab|bevacizumab|mesh-list
14376628|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14376629|NCT01208103|Capecitabine|capecitabine|mesh-list
14376630|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
14376631|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
14376632|NCT01208103|Antibodies|antibodies|mesh-list
14376633|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
14376634|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14376635|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
14376636|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376637|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376638|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376639|NCT01208103|Growth Substances|growth substances|mesh-ancestor
14376640|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376641|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376642|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
14376643|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14376644|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
14376645|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376646|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
14376647|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14376648|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14376649|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376650|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376651|NCT01208324|Estrogens|estrogens|mesh-list
14376652|NCT01208324|Hormones|hormones|mesh-ancestor
14376653|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376654|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376655|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
14376656|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14376657|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376658|NCT01208402|Esmolol|esmolol|mesh-list
14376659|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14376660|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14376661|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14376662|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14376663|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376664|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376665|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376666|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
14376667|NCT01208922|Rifamycins|rifamycins|mesh-list
14376668|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
14376669|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14376670|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376671|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14376672|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14376673|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376674|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376675|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376676|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14376677|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14376678|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376679|NCT01209078|Linezolid|linezolid|mesh-list
14376680|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14376681|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376682|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14376683|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376684|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921001|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921002|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921003|NCT04293562|Cytarabine|cytarabine|mesh-list
14921004|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
14921005|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14921006|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14921007|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14921008|NCT04293562|Methotrexate|methotrexate|mesh-list
14376685|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
14376686|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14376687|NCT01209143|Norethindrone|norethindrone|mesh-list
14376688|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
14376689|NCT01209143|Estradiol|estradiol|mesh-list
14376690|NCT01209143|Estrogens|estrogens|mesh-ancestor
14376691|NCT01209143|Hormones|hormones|mesh-ancestor
14376692|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376693|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376694|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14376695|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
14376696|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14376697|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14376698|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376699|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14921009|NCT04293562|Etoposide|etoposide|mesh-list
15234809|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234810|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921010|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
14921011|NCT04293562|Daunorubicin|daunorubicin|mesh-list
14921012|NCT04293562|Asparaginase|asparaginase|mesh-list
15234811|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234812|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234813|NCT04616963|Tenofovir|tenofovir|mesh-list
15234814|NCT04616963|Emtricitabine|emtricitabine|mesh-list
15234815|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15234816|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
15234817|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234818|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15234819|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14733667|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
14733668|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753087|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753088|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
14753089|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753090|NCT05279963|Amitriptyline|amitriptyline|mesh-list
14753091|NCT05279963|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14753092|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14753093|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
14753094|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15234820|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234821|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234822|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15234823|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15234824|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
14921013|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
14733669|NCT00532025|Sorafenib|sorafenib|mesh-list
14733670|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733671|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14733672|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234825|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234826|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234827|NCT04589208|Ketamine|ketamine|mesh-list
15234828|NCT04589208|Analgesics|analgesics|mesh-ancestor
15234829|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
15234830|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234831|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234832|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14376700|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14376701|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14921014|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
15234833|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14376702|NCT01209195|Paclitaxel|paclitaxel|mesh-list
14376703|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14376704|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376705|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
14376706|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
14376707|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
14376708|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466366|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466367|NCT02240693|BI 409306|bi 409306|mesh-list
14466368|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14466369|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466370|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469921|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14469922|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14469923|NCT02300727|Analgesics|analgesics|mesh-ancestor
14469924|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
14469925|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469926|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469927|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469928|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469929|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469930|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733673|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234834|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
15234835|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
14733674|NCT00532090|R04929097|r04929097|mesh-list
14733675|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733676|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733677|NCT00532116|Selegiline|selegiline|mesh-list
14921015|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
14921016|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
15234836|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234837|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14733678|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
14733679|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14733680|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14733681|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14733682|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14733683|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733684|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733685|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14733686|NCT00532116|Protective Agents|protective agents|mesh-ancestor
14733687|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733688|NCT00532142|Triamcinolone|triamcinolone|mesh-list
14733689|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733690|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
14921017|NCT04293562|Razoxane|razoxane|mesh-list
14921018|NCT04293562|Calicheamicins|calicheamicins|mesh-list
14921019|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14921020|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
15234838|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15234839|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234840|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234841|NCT04577638|Nivolumab|nivolumab|mesh-list
15234842|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234843|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234844|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14376709|NCT01209286|Blinatumomab|blinatumomab|mesh-list
14376710|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376711|NCT01209442|Bevacizumab|bevacizumab|mesh-list
14376712|NCT01209442|Temozolomide|temozolomide|mesh-list
14376713|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14376714|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376715|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376716|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376717|NCT01209442|Growth Substances|growth substances|mesh-ancestor
14376718|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376719|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376720|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14376721|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
14376722|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376723|NCT01209598|Palbociclib|palbociclib|mesh-list
14376724|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376725|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376726|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376727|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376728|NCT01209832|Midazolam|midazolam|mesh-list
14376729|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14376730|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14376731|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376732|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376733|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14376734|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14376735|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376736|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14376737|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
14376738|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
14376739|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
14376740|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
14376741|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376742|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376743|NCT01209949|Adapalene|adapalene|mesh-list
14376744|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14376745|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
14376746|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14376747|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14376748|NCT01209949|Analgesics|analgesics|mesh-ancestor
14376749|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
14376750|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376751|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376752|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376753|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376754|NCT01210001|Empagliflozin|empagliflozin|mesh-list
14376755|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14376756|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376757|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376758|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376759|NCT01210079|Gabapentin|gabapentin|mesh-list
14376760|NCT01210079|Analgesics|analgesics|mesh-ancestor
14376761|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
14376762|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376763|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376764|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
14376765|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14376766|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14376767|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376768|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376769|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14376770|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14376771|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376772|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376773|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
14376774|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14376775|NCT01210144|Hormones|hormones|mesh-list
14376776|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14376777|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376778|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376779|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14376780|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
14376781|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376782|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
14376783|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14376784|NCT01210222|Trebananib|trebananib|mesh-list
14376785|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376786|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376787|NCT01210222|Growth Substances|growth substances|mesh-ancestor
14376788|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376789|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376790|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376791|NCT01210352|Oxymorphone|oxymorphone|mesh-list
14376792|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14376793|NCT01210352|Narcotics|narcotics|mesh-ancestor
14376794|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376795|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376796|NCT01210352|Analgesics|analgesics|mesh-ancestor
14376797|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
14376798|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376799|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14376800|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
14376801|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14376802|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376803|NCT01210495|Axitinib|axitinib|mesh-list
14376804|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376805|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376806|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376807|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376808|NCT01210560|Tolvaptan|tolvaptan|mesh-list
14376809|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14733691|NCT00532142|Hormones|hormones|mesh-ancestor
14466371|NCT02241486|Fentanyl|fentanyl|mesh-list
14753808|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14376810|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376811|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
14376812|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376813|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
14376814|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
14376815|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14376816|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14376817|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
14376818|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376819|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376820|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376821|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376822|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14376823|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376824|NCT01211197|Metformin|metformin|mesh-list
14376825|NCT01211197|Empagliflozin|empagliflozin|mesh-list
14376826|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376827|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376828|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14376829|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376830|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14376831|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376832|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14376833|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376834|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376835|NCT01211522|Haloperidol|haloperidol|mesh-list
14376836|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
14376837|NCT01211522|Ziprasidone|ziprasidone|mesh-list
14376838|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
14376839|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
14376840|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376841|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376842|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14376843|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14376844|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14376845|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14376846|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14376847|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14376848|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
14376849|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376850|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376851|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14376852|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14376853|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
14376854|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14376855|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
14376856|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14376857|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14376858|NCT01211665|Prednisolone|prednisolone|mesh-list
14921021|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14376859|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
14376860|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14921022|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921023|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921024|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
14921025|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921026|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921027|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
14921028|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921029|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14921030|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921031|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
14921032|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921033|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14921034|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921035|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14921036|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14921037|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
14921038|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376861|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
14376862|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376863|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
14376864|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
14376865|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376866|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376867|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14376868|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
14376869|NCT01211665|Hormones|hormones|mesh-ancestor
14376870|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376871|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14376872|NCT01211665|Protective Agents|protective agents|mesh-ancestor
14376873|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14376874|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376875|NCT01211730|Insulin|insulin|mesh-list
14376876|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14376877|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14376878|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376879|NCT01211769|Naltrexone|naltrexone|mesh-list
14376880|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14376881|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14376882|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376883|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
14376884|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376885|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14376886|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
14376887|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
14376888|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376889|NCT01212094|Rituximab|rituximab|mesh-list
14921039|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921040|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14921041|NCT04293562|Analgesics|analgesics|mesh-ancestor
14921042|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
14921043|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921044|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
14921045|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921046|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921047|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921048|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921049|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14376890|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14376891|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376892|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
14376893|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376894|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376895|NCT01212185|Oxytocin|oxytocin|mesh-list
14376896|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
14376897|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14376898|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376899|NCT01212302|Aspirin|aspirin|mesh-list
14376900|NCT01212302|Clopidogrel|clopidogrel|mesh-list
14376901|NCT01212302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14376902|NCT01212302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14376903|NCT01212302|Analgesics|analgesics|mesh-ancestor
14376904|NCT01212302|Sensory System Agents|sensory system agents|mesh-ancestor
14376905|NCT01212302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376906|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376907|NCT01212302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376908|NCT01212302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376909|NCT01212302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14376910|NCT01212302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14376911|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376912|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14376913|NCT01212302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14376914|NCT01212302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376915|NCT01212302|Antipyretics|antipyretics|mesh-ancestor
14376916|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14376917|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14376918|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14376919|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
14376920|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376921|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14376922|NCT01212445|Laxatives|laxatives|mesh-list
14376923|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14376924|NCT01212471|Bromfenac|bromfenac|mesh-list
14376925|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14921050|NCT04293562|Protective Agents|protective agents|mesh-ancestor
14376926|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14376927|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14376928|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14376929|NCT01212471|Analgesics|analgesics|mesh-ancestor
14376930|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
14376931|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376932|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376933|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376934|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376935|NCT01212484|Carbidopa|carbidopa|mesh-list
14376936|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14376937|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14376938|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
14376939|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14376940|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376941|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376942|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14376943|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376944|NCT01212588|Mifepristone|mifepristone|mesh-list
14376945|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14376946|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
14376947|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14376948|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376949|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14376950|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14376951|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14376952|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
14376953|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14376954|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14376955|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
14376956|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14376957|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
14376958|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14376959|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14376960|NCT01212757|Thalidomide|thalidomide|mesh-list
14376961|NCT01212757|Apremilast|apremilast|mesh-list
14376962|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14376963|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14376964|NCT01212757|Analgesics|analgesics|mesh-ancestor
14376965|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
14376966|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376967|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376968|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376969|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376970|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14376971|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14376972|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376973|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376974|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14376975|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
14376976|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
14376977|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14376978|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14376979|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14376980|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14376981|NCT01212757|Growth Substances|growth substances|mesh-ancestor
14376982|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
14376983|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14376984|NCT01212770|Thalidomide|thalidomide|mesh-list
14376985|NCT01212770|Apremilast|apremilast|mesh-list
14376986|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14376987|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14376988|NCT01212770|Analgesics|analgesics|mesh-ancestor
14376989|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
14376990|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14376991|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14376992|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14376993|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14376994|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14376995|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14376996|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14376997|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14376998|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14376999|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
14377000|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
14377001|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14377002|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377003|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377004|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377005|NCT01212770|Growth Substances|growth substances|mesh-ancestor
14377006|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377007|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377008|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
14377009|NCT01212874|Esmolol|esmolol|mesh-list
14377010|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
14377011|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14377012|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14377013|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14377014|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377015|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377016|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377017|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377018|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14377019|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14377020|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14377021|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
14377022|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377023|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377024|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14377025|NCT01212952|Dexamethasone|dexamethasone|mesh-list
14377026|NCT01212952|Bortezomib|bortezomib|mesh-list
14377027|NCT01212952|Pomalidomide|pomalidomide|mesh-list
14377028|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377029|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
14377030|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
14377031|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377032|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377033|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14377034|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
14377035|NCT01212952|Hormones|hormones|mesh-ancestor
14377036|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377037|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14377038|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377039|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
14377040|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377041|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377042|NCT01212952|Growth Substances|growth substances|mesh-ancestor
14377043|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377044|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
14377045|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14377046|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377047|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377048|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14377049|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14377050|NCT01213082|Bevacizumab|bevacizumab|mesh-list
14377051|NCT01213082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14377052|NCT01213082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377053|NCT01213082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377054|NCT01213082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377055|NCT01213082|Growth Substances|growth substances|mesh-ancestor
14377056|NCT01213082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377057|NCT01213082|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377058|NCT01213173|Metoprolol|metoprolol|mesh-list
14377059|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14377060|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14377061|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
14377062|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
14377063|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377064|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377065|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14377066|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14377067|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14377068|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377069|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377070|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377071|NCT01213199|Adapalene|adapalene|mesh-list
14377072|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14377073|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14377074|NCT01213199|Analgesics|analgesics|mesh-ancestor
14377075|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
14377076|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377077|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377078|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377079|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14377080|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377081|NCT01213264|Anesthetics|anesthetics|mesh-list
14377082|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377083|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377084|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
14377085|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14377086|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14377087|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
14377088|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377089|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14377090|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14377091|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377092|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377093|NCT01213524|Nicotine|nicotine|mesh-list
14377094|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14377095|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
14377096|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377097|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377098|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14377099|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14377100|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
14377101|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377102|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377103|NCT01213576|Ivermectin|ivermectin|mesh-list
14377104|NCT01213576|Albendazole|albendazole|mesh-list
14377105|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14377106|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377107|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
14377108|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
14377109|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14377110|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14377111|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
14377112|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
14377113|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14377114|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377115|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377116|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14377117|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
14377118|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14377119|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14377120|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14377121|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733692|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733693|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733694|NCT00532168|Ritonavir|ritonavir|mesh-list
14733695|NCT00532168|Lopinavir|lopinavir|mesh-list
14733696|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14377122|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377123|NCT01213966|Artefenomel|artefenomel|mesh-list
14377124|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
14377125|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14377126|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14377127|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377128|NCT01214044|Dexetimide|dexetimide|mesh-list
14377129|NCT01214044|Citalopram|citalopram|mesh-list
14377130|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14377131|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14733697|NCT00532168|Tenofovir|tenofovir|mesh-list
14733698|NCT00532168|Emtricitabine|emtricitabine|mesh-list
14377132|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14377133|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377134|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377135|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
14377136|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377137|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14377138|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
14377139|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14377140|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14377141|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14377142|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
14377143|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
14377144|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377145|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14377146|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14377147|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
14377148|NCT01214057|Remifentanil|remifentanil|mesh-list
14377149|NCT01214057|Propofol|propofol|mesh-list
14377150|NCT01214057|Sevoflurane|sevoflurane|mesh-list
14377151|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14377152|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377153|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377154|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14377155|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
14377156|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
14377157|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14377158|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14377159|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14377160|NCT01214057|Narcotics|narcotics|mesh-ancestor
14377161|NCT01214057|Analgesics|analgesics|mesh-ancestor
14377162|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
14377163|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377164|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
14377165|NCT01214083|Naltrexone|naltrexone|mesh-list
14377166|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14377167|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14377168|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14377169|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377170|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
14377171|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377172|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
14377173|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377174|NCT01214083|Expectorants|expectorants|mesh-ancestor
14377175|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
14377176|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14377177|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
14377178|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377179|NCT01214083|Protective Agents|protective agents|mesh-ancestor
14377180|NCT01214083|Antidotes|antidotes|mesh-ancestor
14377181|NCT01214109|Pramipexole|pramipexole|mesh-list
14377182|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
14377183|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377184|NCT01214109|Protective Agents|protective agents|mesh-ancestor
14377185|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377186|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14377187|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14377188|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
14377189|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
14377190|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733699|NCT00532168|Efavirenz|efavirenz|mesh-list
14733700|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14377191|NCT01214161|Lidocaine|lidocaine|mesh-list
14377192|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
14733701|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14377193|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
14466372|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14377194|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377195|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377196|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
14377197|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377198|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14377199|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14377200|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14377201|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14377202|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377203|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
14377204|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
14377205|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377206|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
14733702|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
14733703|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733704|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733705|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14733706|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14733707|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
14733708|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733709|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14733710|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14733711|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14377207|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377208|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377209|NCT01214239|Linagliptin|linagliptin|mesh-list
14377210|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377211|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377212|NCT01214239|Incretins|incretins|mesh-ancestor
14377213|NCT01214239|Hormones|hormones|mesh-ancestor
14377214|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377215|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14377216|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
14377217|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377218|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377219|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
14377220|NCT01214317|Analgesics|analgesics|mesh-ancestor
14377221|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
14377222|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377223|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377224|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377225|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14377226|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14377227|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377228|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377229|NCT01214356|Vitamin D|vitamin d|mesh-list
14377230|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
14377231|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
14377232|NCT01214356|Vitamins|vitamins|mesh-list
14377233|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
14377234|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377235|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14377236|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14377237|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
14377238|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14377239|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377240|NCT01214421|Tolvaptan|tolvaptan|mesh-list
14377241|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14377242|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377243|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
14377244|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377245|NCT01214434|Emollients|emollients|mesh-list
14377246|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377247|NCT01214616|Vinorelbine|vinorelbine|mesh-list
14377248|NCT01214616|Afatinib|afatinib|mesh-list
14377249|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14377250|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377251|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
14377252|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
14377253|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
14377254|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377255|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14377256|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377257|NCT01214668|Doxorubicin|doxorubicin|mesh-list
14377258|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14377259|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14377260|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377261|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14377262|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14377263|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377264|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466373|NCT02241486|Narcotics|narcotics|mesh-ancestor
14466374|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466375|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466376|NCT02241486|Analgesics|analgesics|mesh-ancestor
14466377|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
14466378|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466379|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14466380|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14466381|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
14466382|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
14466383|NCT02241512|Ibuprofen|ibuprofen|mesh-list
14466384|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14466385|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466386|NCT02241512|Analgesics|analgesics|mesh-ancestor
14466387|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
14466388|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466389|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466390|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466391|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466392|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14466393|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466394|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466395|NCT02241655|Anesthetics|anesthetics|mesh-list
14466396|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466397|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466398|NCT02241785|Natalizumab|natalizumab|mesh-list
14466399|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
14466400|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466401|NCT02241889|Pancrelipase|pancrelipase|mesh-list
14466402|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466403|NCT02242045|Idelalisib|idelalisib|mesh-list
14466404|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466405|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466406|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466407|NCT02242201|Ketorolac|ketorolac|mesh-list
14466408|NCT02242201|Epinephrine|epinephrine|mesh-list
14466409|NCT02242201|Bupivacaine|bupivacaine|mesh-list
14466410|NCT02242201|Ropivacaine|ropivacaine|mesh-list
14466411|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
14377265|NCT01214720|Bevacizumab|bevacizumab|mesh-list
14377266|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15234845|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377267|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377268|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377269|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377270|NCT01214720|Growth Substances|growth substances|mesh-ancestor
14377271|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377272|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377273|NCT01214759|Tenofovir|tenofovir|mesh-list
14377274|NCT01214759|Emtricitabine|emtricitabine|mesh-list
14377275|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
14377276|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14377277|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
14377278|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377279|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14377280|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14377281|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377282|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377283|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14377284|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14377285|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14377286|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14377287|NCT01214850|Vaccines|vaccines|mesh-list
14377288|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
14377289|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377290|NCT01214915|Anagrelide|anagrelide|mesh-list
14377291|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14377292|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14377293|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377294|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14377295|NCT01215032|Metformin|metformin|mesh-list
14377296|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377297|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377298|NCT01215097|Linagliptin|linagliptin|mesh-list
14377299|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377300|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377301|NCT01215097|Incretins|incretins|mesh-ancestor
14377302|NCT01215097|Hormones|hormones|mesh-ancestor
14377303|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377304|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14377305|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
14377306|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377307|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377308|NCT01215110|Bedaquiline|bedaquiline|mesh-list
14377309|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
14377310|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14377311|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377312|NCT01215123|Bevacizumab|bevacizumab|mesh-list
14377313|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14377314|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377315|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377316|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377317|NCT01215123|Growth Substances|growth substances|mesh-ancestor
14377318|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377319|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377320|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14377321|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
14377322|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377323|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14377324|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
14377325|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377326|NCT01215227|Rasagiline|rasagiline|mesh-list
14377327|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14377328|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377329|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377330|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14377331|NCT01215227|Protective Agents|protective agents|mesh-ancestor
14377332|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377333|NCT01215253|Ranolazine|ranolazine|mesh-list
14377334|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14377335|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466412|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
14377336|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377337|NCT01215292|Ketoconazole|ketoconazole|mesh-list
14377338|NCT01215292|Anastrozole|anastrozole|mesh-list
14377339|NCT01215292|Testosterone|testosterone|mesh-list
14377340|NCT01215292|Dutasteride|dutasteride|mesh-list
14377341|NCT01215292|Acyline|acyline|mesh-list
14377342|NCT01215292|Androgens|androgens|mesh-ancestor
14377343|NCT01215292|Hormones|hormones|mesh-ancestor
14377344|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377345|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377346|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14377347|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377348|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14377349|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14377350|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377351|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377352|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14377353|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
14377354|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
14377355|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377356|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14377357|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14377358|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14377359|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14377360|NCT01215318|Silicon|silicon|mesh-list
14377361|NCT01215318|Trace Elements|trace elements|mesh-ancestor
14377362|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
14377363|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377364|NCT01215344|Diphosphonates|diphosphonates|mesh-list
14377365|NCT01215344|Dexamethasone|dexamethasone|mesh-list
14377366|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
14377367|NCT01215344|Doxorubicin|doxorubicin|mesh-list
14377368|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14377369|NCT01215344|Lenalidomide|lenalidomide|mesh-list
14377370|NCT01215344|Bortezomib|bortezomib|mesh-list
14377371|NCT01215344|BB 1101|bb 1101|mesh-list
14377372|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377373|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
14377374|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
14377375|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377376|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377377|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14377378|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
14377379|NCT01215344|Hormones|hormones|mesh-ancestor
14377380|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377381|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14377382|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377383|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
14377384|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377385|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377386|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14377387|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14377388|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14377389|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
14377390|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377391|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377392|NCT01215344|Growth Substances|growth substances|mesh-ancestor
14377393|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377394|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14377395|NCT01215357|Ecopipam|ecopipam|mesh-list
14377396|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14377397|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14377398|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377399|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377400|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14377401|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14377402|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
14377403|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733712|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15234846|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
15234847|NCT04561557|Fludarabine|fludarabine|mesh-list
15234848|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234849|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
15234850|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234851|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234852|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234853|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
15234854|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234855|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234856|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15234857|NCT04540120|Dapansutrile|dapansutrile|mesh-list
15234858|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234859|NCT04513860|Cenobamate|cenobamate|mesh-list
15234860|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
15234861|NCT04503148|Propofol|propofol|mesh-list
15234862|NCT04503148|Anesthetics|anesthetics|mesh-list
15234863|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
15234864|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
15234865|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15234866|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234867|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234868|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15234869|NCT04498468|Dexamethasone|dexamethasone|mesh-list
15234870|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234871|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
15234872|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
15234873|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234874|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234875|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15234876|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
15234877|NCT04498468|Hormones|hormones|mesh-ancestor
15234878|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15234879|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15234880|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234881|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
15234882|NCT04477200|Temozolomide|temozolomide|mesh-list
15234883|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15234884|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234885|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15234886|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
15234887|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15234888|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234889|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15234890|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234891|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15234892|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
15234893|NCT04474223|Dexamethasone|dexamethasone|mesh-list
14733713|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14733714|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14733715|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14733716|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14733717|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14733718|NCT00532194|Cediranib|cediranib|mesh-list
14733719|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733720|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14733721|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753095|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15234894|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15234895|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
15234896|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
14377404|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377405|NCT01215435|Insulin|insulin|mesh-list
14377406|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14377407|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
14377408|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
14377409|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14377410|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
14377411|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14377412|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
14377413|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377414|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377415|NCT01215643|Ribavirin|ribavirin|mesh-list
14377416|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14377417|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
14377418|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377419|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
14377420|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377421|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
14377422|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14377423|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14377424|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
14377425|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377426|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377427|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377428|NCT01215721|Urological Agents|urological agents|mesh-ancestor
14377429|NCT01215734|Vaccines|vaccines|mesh-list
14377430|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
14377431|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377432|NCT01215786|Timolol|timolol|mesh-list
14377433|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14377434|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14377435|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14377436|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14377437|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377438|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377439|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377440|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377441|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14377442|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14377443|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
14377444|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
14377445|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14377446|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377447|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14377448|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14377449|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377450|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733722|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733723|NCT00532207|Teriparatide|teriparatide|mesh-list
14733724|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14733725|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733726|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14377451|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733727|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
14733728|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14733729|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733730|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14733731|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14733732|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733733|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733734|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377452|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
14377453|NCT01215916|Pemetrexed|pemetrexed|mesh-list
14377454|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377455|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377456|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377457|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14377458|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14377459|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
14377460|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14377461|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377462|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14377463|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14377464|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14377465|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377466|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
14377467|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377468|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
14377469|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377470|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377471|NCT01215968|Dulaglutide|dulaglutide|mesh-list
14377472|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377473|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377474|NCT01215981|Vaccines|vaccines|mesh-list
14377475|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
14377476|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377477|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14377478|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
14466413|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234897|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234898|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234899|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15234900|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
15234901|NCT04474223|Hormones|hormones|mesh-ancestor
15234902|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15234903|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15234904|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377479|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14377480|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377481|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14377482|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
14377483|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377484|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14377485|NCT01216163|Acetaminophen|acetaminophen|mesh-list
14377486|NCT01216163|Ibuprofen|ibuprofen|mesh-list
14377487|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14377488|NCT01216163|Analgesics|analgesics|mesh-ancestor
14377489|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
14377490|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377491|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377492|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
14377493|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14377494|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377495|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14377496|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14377497|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377498|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377499|NCT01216176|Anastrozole|anastrozole|mesh-list
14377500|NCT01216176|Saracatinib|saracatinib|mesh-list
15234905|NCT04405102|Ozanimod|ozanimod|mesh-list
15234906|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15234907|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234908|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15234909|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
15234910|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234911|NCT04400799|Enoxaparin|enoxaparin|mesh-list
15234912|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
15234913|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15234914|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14377501|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14377502|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377503|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14377504|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14377505|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377506|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377507|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14377508|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
14377509|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377510|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377511|NCT01216241|Daptomycin|daptomycin|mesh-list
14377512|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14377513|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377514|NCT01216332|Vaccines|vaccines|mesh-list
14377515|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
14377516|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377517|NCT01216397|Metformin|metformin|mesh-list
14377518|NCT01216397|Linagliptin|linagliptin|mesh-list
14377519|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15234915|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234916|NCT04368910|Artesunate|artesunate|mesh-list
15234917|NCT04368910|Chloroquine|chloroquine|mesh-list
15234918|NCT04368910|Pyronaridine|pyronaridine|mesh-list
15234919|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
15234920|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14753096|NCT05279963|Analgesics|analgesics|mesh-ancestor
15234921|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15234922|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15234923|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15234924|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
15234925|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
15234926|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15234927|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
15234928|NCT04368910|Amebicides|amebicides|mesh-ancestor
15234929|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15234930|NCT04365985|Naltrexone|naltrexone|mesh-list
15234931|NCT04365985|Ketamine|ketamine|mesh-list
15234932|NCT04365985|Analgesics|analgesics|mesh-ancestor
15234933|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
15234934|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234935|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234936|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15234937|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15234938|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
15234939|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
15234940|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377520|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377521|NCT01216397|Incretins|incretins|mesh-ancestor
14377522|NCT01216397|Hormones|hormones|mesh-ancestor
14377523|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377524|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14377525|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14377526|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377527|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377528|NCT01216410|Phenylephrine|phenylephrine|mesh-list
14377529|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
14377530|NCT01216410|Ondansetron|ondansetron|mesh-list
14377531|NCT01216410|Metoclopramide|metoclopramide|mesh-list
14377532|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
14377533|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
14377534|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377535|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377536|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14377537|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
14377538|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377539|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14377540|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
14377541|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377542|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377543|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14377544|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14377545|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377546|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14377547|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14377548|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14377549|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
14377550|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
14377551|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14377552|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
14377553|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
14377554|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14377555|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14377556|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14377557|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377558|NCT01216410|Protective Agents|protective agents|mesh-ancestor
14377559|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14377560|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14377561|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
14377562|NCT01216735|Fluticasone|fluticasone|mesh-list
14377563|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377564|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14377565|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
14377566|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377567|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377568|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14377569|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
14377570|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377571|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14377572|NCT01216761|Iodine|iodine|mesh-list
14377573|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
14377574|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14733735|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14733736|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14377575|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
14377576|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
14377577|NCT01216761|Povidone|povidone|mesh-list
14377578|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14377579|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377580|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
14733737|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14377581|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377582|NCT01216761|Trace Elements|trace elements|mesh-ancestor
14377583|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
14377584|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377585|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
14377586|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
14377587|NCT01216943|Timolol|timolol|mesh-list
14377588|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14377589|NCT01216943|Bimatoprost|bimatoprost|mesh-list
14377590|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14377591|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14377592|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14377593|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14377594|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377595|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377596|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377597|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377598|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14377599|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14377600|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14377601|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14377602|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14377603|NCT01217073|Metformin|metformin|mesh-list
14377604|NCT01217073|Pioglitazone|pioglitazone|mesh-list
14377605|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377606|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377607|NCT01217112|Cannabidiol|cannabidiol|mesh-list
14377608|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
14377609|NCT01217190|Ondansetron|ondansetron|mesh-list
14377610|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
14377611|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
14377612|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377613|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377614|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14377615|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
14377616|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377617|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14377618|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
14377619|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377620|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377621|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14377622|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14377623|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377624|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14377625|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14377626|NCT01217307|Metformin|metformin|mesh-list
14377627|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377628|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377629|NCT01217411|R04929097|r04929097|mesh-list
14377630|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377631|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377632|NCT01217437|Bevacizumab|bevacizumab|mesh-list
14377633|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14377634|NCT01217437|Irinotecan|irinotecan|mesh-list
14377635|NCT01217437|Temozolomide|temozolomide|mesh-list
14377636|NCT01217437|Camptothecin|camptothecin|mesh-list
14377637|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
14377638|NCT01217437|Antibodies|antibodies|mesh-list
14377639|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
14377640|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14377641|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
14377642|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377643|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377644|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377645|NCT01217437|Growth Substances|growth substances|mesh-ancestor
14377646|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377647|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377648|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
14377649|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14377650|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14377651|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377652|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377653|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14377654|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
14377655|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14377656|NCT01217515|Diltiazem|diltiazem|mesh-list
14377657|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14377658|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14377659|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14377660|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377661|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14377662|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377663|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
14377664|NCT01217606|Timolol|timolol|mesh-list
14377665|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14377666|NCT01217606|Bimatoprost|bimatoprost|mesh-list
14377667|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14377668|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14377669|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14377670|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14377671|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377672|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377673|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377674|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377675|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14377676|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14377677|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14377678|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14377679|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14377680|NCT01217749|Ofatumumab|ofatumumab|mesh-list
14377681|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377682|NCT01217801|Ondansetron|ondansetron|mesh-list
14377683|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
14377684|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
14377685|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377686|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377687|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14377688|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
14377689|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377690|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14377691|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
14377692|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377693|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377694|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14377695|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14377696|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377697|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14377698|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14377699|NCT01217814|Leucovorin|leucovorin|mesh-list
14377700|NCT01217814|Folic Acid|folic acid|mesh-list
14377701|NCT01217814|Golimumab|golimumab|mesh-list
14377702|NCT01217814|Methotrexate|methotrexate|mesh-list
14377703|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
14377704|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14377705|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
14377706|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14377707|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377708|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14377709|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
14377710|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377711|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377712|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377713|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377714|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14377715|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14377716|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
14377717|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14377718|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14377719|NCT01217814|Antidotes|antidotes|mesh-ancestor
14377720|NCT01217814|Protective Agents|protective agents|mesh-ancestor
14377721|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
14377722|NCT01217814|Vitamins|vitamins|mesh-ancestor
14377723|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
14377724|NCT01217814|Hematinics|hematinics|mesh-ancestor
14377725|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14377726|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377727|NCT01217840|Vitamin D|vitamin d|mesh-list
14377728|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
14377729|NCT01217840|Vitamins|vitamins|mesh-ancestor
14377730|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
14377731|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377732|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14377733|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14377734|NCT01217892|Metformin|metformin|mesh-list
14377735|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
14377736|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14377737|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377738|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14377739|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377740|NCT01217944|Ranibizumab|ranibizumab|mesh-list
14377741|NCT01217944|Verteporfin|verteporfin|mesh-list
14377742|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377743|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377744|NCT01217944|Growth Substances|growth substances|mesh-ancestor
14377745|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377746|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377747|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377748|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14377749|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
14377750|NCT01217957|Dexamethasone|dexamethasone|mesh-list
14377751|NCT01217957|Lenalidomide|lenalidomide|mesh-list
14377752|NCT01217957|Ixazomib|ixazomib|mesh-list
14377753|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377754|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
14733738|NCT00532272|Letrozole|letrozole|mesh-list
14733739|NCT00532272|Goserelin|goserelin|mesh-list
14733740|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733741|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14733742|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14377755|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
14733743|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733744|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733745|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15234941|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15234942|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15234943|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234944|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234945|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15234946|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15234947|NCT04249258|Dobutamine|dobutamine|mesh-list
15234948|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15234949|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
15234950|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
15234951|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234952|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234953|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15234954|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15234955|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14377756|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377757|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377758|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14377759|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
14377760|NCT01217957|Hormones|hormones|mesh-ancestor
14377761|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377762|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14377763|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377764|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
14377765|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377766|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377767|NCT01217957|Growth Substances|growth substances|mesh-ancestor
14377768|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377769|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
14377770|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377771|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377772|NCT01218009|Albuterol|albuterol|mesh-list
14377773|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14377774|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
14377775|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377776|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377777|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14377778|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14377779|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
14377780|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14377781|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14377782|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14377783|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14377784|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377785|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377786|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377787|NCT01218048|Carboplatin|carboplatin|mesh-list
14377788|NCT01218048|Cetuximab|cetuximab|mesh-list
14377789|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377790|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14377791|NCT01218100|Lisinopril|lisinopril|mesh-list
14377792|NCT01218100|Nebivolol|nebivolol|mesh-list
14377793|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14377794|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
14377795|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377796|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377797|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14377798|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14377799|NCT01218100|Protective Agents|protective agents|mesh-ancestor
14377800|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234956|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
15234957|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234958|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234959|NCT04249258|Protective Agents|protective agents|mesh-ancestor
15234960|NCT04235608|Propofol|propofol|mesh-list
14377801|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
14377802|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14377803|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14377804|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14377805|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
14377806|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14377807|NCT01218204|Atorvastatin|atorvastatin|mesh-list
14377808|NCT01218204|Ezetimibe|ezetimibe|mesh-list
14377809|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14377810|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14377811|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
14377812|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377813|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15234961|NCT04235608|Sevoflurane|sevoflurane|mesh-list
15234962|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15234963|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234964|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234965|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15234966|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
15234967|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
15234968|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15234969|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15234970|NCT04231838|Nicotine|nicotine|mesh-list
15234971|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15234972|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
15234973|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15234974|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234975|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14377814|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14377815|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377816|NCT01218308|Vaccines|vaccines|mesh-list
14377817|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
14377818|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377819|NCT01218399|Budesonide|budesonide|mesh-list
14377820|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14377821|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377822|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14377823|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
14377824|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377825|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377826|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14377827|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
14377828|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
14377829|NCT01218399|Hormones|hormones|mesh-ancestor
14377830|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377831|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14377832|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
14377833|NCT01218438|Antibodies|antibodies|mesh-list
14377834|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
14377835|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14377836|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14377837|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
14377838|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
14377839|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377840|NCT01218477|Dasatinib|dasatinib|mesh-list
14377841|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377842|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14377843|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377844|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377845|NCT01218516|Paclitaxel|paclitaxel|mesh-list
14377846|NCT01218516|Carboplatin|carboplatin|mesh-list
14377847|NCT01218516|Pemetrexed|pemetrexed|mesh-list
14377848|NCT01218516|Farletuzumab|farletuzumab|mesh-list
14377849|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14377850|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377851|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
14377852|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
14377853|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
14377854|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377855|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377856|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14377857|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14377858|NCT01218594|Endostatins|endostatins|mesh-list
14377859|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377860|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377861|NCT01218594|Growth Substances|growth substances|mesh-ancestor
14377862|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377863|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377864|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377865|NCT01218646|Vaccines|vaccines|mesh-list
14377866|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
14377867|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377868|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14377869|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14377870|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14377871|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
14377872|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377873|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14377874|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14377875|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14377876|NCT01218867|Aldesleukin|aldesleukin|mesh-list
14377877|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
14377878|NCT01218867|Fludarabine|fludarabine|mesh-list
14377879|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14377880|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
14377881|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377882|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14377883|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14377884|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
14377885|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377886|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377887|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14377888|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14377889|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14377890|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
14377891|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14377892|NCT01218958|Naltrexone|naltrexone|mesh-list
14377893|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14377894|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14377895|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377896|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
14377897|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377898|NCT01218971|Naltrexone|naltrexone|mesh-list
14377899|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14377900|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14377901|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377902|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
14377903|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377904|NCT01218984|Naltrexone|naltrexone|mesh-list
14377905|NCT01218984|Hydromorphone|hydromorphone|mesh-list
14377906|NCT01218984|Naloxone|naloxone|mesh-list
14377907|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14377908|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14377909|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377910|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
14377911|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377912|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14377913|NCT01218984|Narcotics|narcotics|mesh-ancestor
14377914|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377915|NCT01218984|Analgesics|analgesics|mesh-ancestor
14377916|NCT01218997|Naltrexone|naltrexone|mesh-list
14377917|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14377918|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14377919|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377920|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
14377921|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377922|NCT01219738|Budesonide|budesonide|mesh-list
14377923|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377924|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14377925|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
14377926|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377927|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377928|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14377929|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
14377930|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
15234976|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15234977|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
15234978|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15234979|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234980|NCT04176419|Acetaminophen|acetaminophen|mesh-list
15234981|NCT04176419|Celecoxib|celecoxib|mesh-list
15234982|NCT04176419|Lidocaine|lidocaine|mesh-list
15234983|NCT04176419|Ketamine|ketamine|mesh-list
15234984|NCT04176419|Gabapentin|gabapentin|mesh-list
15234985|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
15234986|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
15234987|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15234988|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234989|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
14377931|NCT01219738|Hormones|hormones|mesh-ancestor
14466414|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15234990|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377932|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377933|NCT01219777|Paclitaxel|paclitaxel|mesh-list
14377934|NCT01219777|Bevacizumab|bevacizumab|mesh-list
14377935|NCT01219777|Carboplatin|carboplatin|mesh-list
14377936|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14377937|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377938|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
15234991|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15234992|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15234993|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14377939|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
14377940|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
14377941|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14377942|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14377943|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14377944|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14377945|NCT01219777|Growth Substances|growth substances|mesh-ancestor
14377946|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377947|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
14377948|NCT01219881|Sevoflurane|sevoflurane|mesh-list
14377949|NCT01219881|Desflurane|desflurane|mesh-list
14377950|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14377951|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14377952|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
14377953|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
14377954|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377955|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377956|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
14377957|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15234994|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15234995|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15234996|NCT04176419|Analgesics|analgesics|mesh-ancestor
15234997|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15234998|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15234999|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
15235000|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15235001|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15235002|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235003|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14377958|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14377959|NCT01219933|Prednisolone|prednisolone|mesh-list
14377960|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
14377961|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14377962|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
14377963|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14377964|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
14377965|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
14377966|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377967|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377968|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14377969|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
14377970|NCT01219933|Hormones|hormones|mesh-ancestor
14377971|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14377972|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14377973|NCT01219933|Protective Agents|protective agents|mesh-ancestor
14377974|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14377975|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466415|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
14466416|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466417|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14466418|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14466419|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
14466420|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466421|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466422|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14466423|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14466424|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
14466425|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14466426|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
14466427|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
14466428|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
14466429|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14466430|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14466431|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466432|NCT02242201|Analgesics|analgesics|mesh-ancestor
14466433|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466434|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466435|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14466436|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466437|NCT02242305|Scopolamine|scopolamine|mesh-list
14466438|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14466439|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14466440|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
14466441|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
14466442|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466443|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466444|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466445|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
14466446|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14466447|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
14377976|NCT01219959|Icodextrin|icodextrin|mesh-list
14377977|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
14377978|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14377979|NCT01220024|Bupivacaine|bupivacaine|mesh-list
14377980|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
14377981|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
14377982|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14377983|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14377984|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
14377985|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14377986|NCT01220128|Paclitaxel|paclitaxel|mesh-list
14377987|NCT01220128|Docetaxel|docetaxel|mesh-list
14377988|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
14377989|NCT01220128|Carboplatin|carboplatin|mesh-list
14377990|NCT01220128|Doxorubicin|doxorubicin|mesh-list
14377991|NCT01220128|Fluorouracil|fluorouracil|mesh-list
14377992|NCT01220128|Trastuzumab|trastuzumab|mesh-list
14377993|NCT01220128|Epirubicin|epirubicin|mesh-list
14377994|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14377995|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14377996|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14377997|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14377998|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14377999|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
14378000|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378001|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378002|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
14378003|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378004|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14378005|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14378006|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
14378007|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14733746|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733747|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733748|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733749|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733750|NCT00532285|Gemcitabine|gemcitabine|mesh-list
14733751|NCT00532285|Paclitaxel|paclitaxel|mesh-list
14733752|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14733753|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733754|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733755|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
14733756|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14733757|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14733758|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733759|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14378008|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14378009|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14378010|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14378011|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378012|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
14378013|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14378014|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14378015|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14378016|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14378017|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
14378018|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14378019|NCT01220167|Ondansetron|ondansetron|mesh-list
14378020|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
14378021|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
14378022|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378023|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378024|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14378025|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
14378026|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
14378027|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14378028|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
14378029|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378030|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378031|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14378032|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14378033|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378034|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14378035|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14378036|NCT01220180|Pregabalin|pregabalin|mesh-list
14378037|NCT01220180|Analgesics|analgesics|mesh-ancestor
14378038|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
14378039|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378040|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378041|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
14378042|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14378043|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378044|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378045|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378046|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14378047|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14378048|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378049|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14378050|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
14378051|NCT01220297|Sirolimus|sirolimus|mesh-list
14378052|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
14378053|NCT01220297|Carmustine|carmustine|mesh-list
14378054|NCT01220297|Etoposide|etoposide|mesh-list
14378055|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
14378056|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378057|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
14378058|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378059|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14378060|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14378061|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
14378062|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378063|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378064|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14378065|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14378066|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14378067|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14378068|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378069|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14378070|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14378071|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
14378072|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14378073|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378074|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
14378075|NCT01220414|Naltrexone|naltrexone|mesh-list
14378076|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14378077|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14378078|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378079|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
14378080|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378081|NCT01220557|Insulin|insulin|mesh-list
14378082|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14378083|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378084|NCT01220609|Epothilones|epothilones|mesh-list
14378085|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
14378086|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
14378087|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
14378088|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378089|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378090|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
14378091|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14378092|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
14378093|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378094|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378095|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14378096|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14378097|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14378098|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
14378099|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378100|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378101|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14378102|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
14378103|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
14378104|NCT01220687|Protective Agents|protective agents|mesh-ancestor
14378105|NCT01220973|Celecoxib|celecoxib|mesh-list
14378106|NCT01220973|Atorvastatin|atorvastatin|mesh-list
14378107|NCT01220973|Calcium|calcium|mesh-list
14378108|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378109|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378110|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14378111|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14378112|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
14378113|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378114|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14378115|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14378116|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378117|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14378118|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14378119|NCT01220973|Analgesics|analgesics|mesh-ancestor
14378120|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
14378121|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378122|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14378123|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14378124|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14378125|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14378126|NCT01221181|Eculizumab|eculizumab|mesh-list
14378127|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14378128|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378129|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
14378130|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378131|NCT01221207|Calpastatin|calpastatin|mesh-list
14378132|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14378133|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
14378134|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378135|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378136|NCT01221272|Ranolazine|ranolazine|mesh-list
14378137|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14733760|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
15235004|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
15235005|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15235006|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235007|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235008|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15235009|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15235010|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235011|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
15235012|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14378138|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378139|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378140|NCT01221298|Ritonavir|ritonavir|mesh-list
14378141|NCT01221298|Ribavirin|ribavirin|mesh-list
14378142|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14378143|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14378144|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
14378145|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378146|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378147|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14378148|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14378149|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
14378150|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378151|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14378152|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14378153|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
14378154|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
14378155|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
14378156|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378157|NCT01221350|Protective Agents|protective agents|mesh-ancestor
14378158|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378159|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
14378160|NCT01221350|Vitamins|vitamins|mesh-ancestor
14378161|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
14378162|NCT01221727|Denosumab|denosumab|mesh-list
14378163|NCT01221727|Midazolam|midazolam|mesh-list
14378164|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14378165|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14378166|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378167|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378168|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14378169|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14378170|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14378171|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14378172|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
14378173|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
14378174|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
14378175|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
14378176|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378177|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378178|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378179|NCT01221753|Carboplatin|carboplatin|mesh-list
14378180|NCT01221753|Docetaxel|docetaxel|mesh-list
14378181|NCT01221753|Fluorouracil|fluorouracil|mesh-list
14378182|NCT01221753|Cetuximab|cetuximab|mesh-list
14378183|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378184|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
14378185|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
14378186|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
14378187|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378188|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
14378189|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14378190|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378191|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
14378192|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378193|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14378194|NCT01222091|Propranolol|propranolol|mesh-list
14378195|NCT01222091|Remifentanil|remifentanil|mesh-list
14378196|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14378197|NCT01222091|Narcotics|narcotics|mesh-ancestor
14378198|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378199|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378200|NCT01222091|Analgesics|analgesics|mesh-ancestor
14378201|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
14378202|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378203|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14378204|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14378205|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
14378206|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378207|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378208|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14378209|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378210|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
14378211|NCT01222117|Plasminogen|plasminogen|mesh-list
14378212|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14378213|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
14378214|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14378215|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14378216|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378217|NCT01222195|Lenalidomide|lenalidomide|mesh-list
14378218|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
14378219|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
14378220|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378221|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14378222|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14378223|NCT01222195|Growth Substances|growth substances|mesh-ancestor
14378224|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
14378225|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378226|NCT01222195|Hematinics|hematinics|mesh-ancestor
14378227|NCT01222234|Vitamin D|vitamin d|mesh-list
14378228|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
14378229|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
14378230|NCT01222234|Calcitriol|calcitriol|mesh-list
14378231|NCT01222234|Vitamins|vitamins|mesh-list
14378232|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
14378233|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378234|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378235|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378236|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14378237|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378238|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378239|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14378240|NCT01222260|Dexamethasone|dexamethasone|mesh-list
14378241|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14378242|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14378243|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
14378244|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
14378245|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378246|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378247|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14378248|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
14378249|NCT01222260|Hormones|hormones|mesh-ancestor
14378250|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14378251|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14378252|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378253|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14378254|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
14378255|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378256|NCT01222273|Vitamin D|vitamin d|mesh-list
14378257|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
14378258|NCT01222273|Vitamins|vitamins|mesh-ancestor
14378259|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
14378260|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378261|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378262|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378263|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
14378264|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14378265|NCT01222403|Vaccines|vaccines|mesh-list
14378266|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14378267|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
14378268|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378269|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14378270|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14733761|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
14378271|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378272|NCT01222520|Amlodipine|amlodipine|mesh-list
14378273|NCT01222520|Telmisartan|telmisartan|mesh-list
14378274|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14378275|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378276|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15235013|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15235014|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235015|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
14378277|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378278|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378279|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378280|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378281|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
14378282|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14378283|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14378284|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
14378285|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14378286|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
14378287|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378288|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378289|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14378290|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
14378291|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
14378292|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14378293|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
14378294|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378295|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378296|NCT01222572|Etoposide|etoposide|mesh-list
14378297|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378298|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14378299|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14378300|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14378301|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378302|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378303|NCT01222585|Metronidazole|metronidazole|mesh-list
14378304|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378305|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14378306|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14378307|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14378308|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14378309|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378310|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14378311|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378312|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378313|NCT01222715|Sirolimus|sirolimus|mesh-list
14378314|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
14378315|NCT01222715|Bevacizumab|bevacizumab|mesh-list
14378316|NCT01222715|Vinorelbine|vinorelbine|mesh-list
14378317|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14378318|NCT01222715|Antibodies|antibodies|mesh-list
14378319|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
14378320|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14378321|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
14378322|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
14378323|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378324|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
14378325|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378326|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14378327|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14378328|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
14378329|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378330|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378331|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14378332|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14378333|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14378334|NCT01222715|Growth Substances|growth substances|mesh-ancestor
14378335|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
14378336|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14378337|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378338|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14378339|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
14378340|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14378341|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
14378342|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
14378343|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
14378344|NCT01222832|Bacitracin|bacitracin|mesh-list
15235016|NCT04146324|Nivolumab|nivolumab|mesh-list
15235017|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235018|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235019|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14378345|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14378346|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378347|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14378348|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14378349|NCT01222884|Hematinics|hematinics|mesh-ancestor
14378350|NCT01223027|Sorafenib|sorafenib|mesh-list
14378351|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378352|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14378353|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378354|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378355|NCT01223196|Pioglitazone|pioglitazone|mesh-list
14378356|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14378357|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378358|NCT01223235|Bevacizumab|bevacizumab|mesh-list
14378359|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14378360|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378361|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14378362|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14378363|NCT01223235|Growth Substances|growth substances|mesh-ancestor
14378364|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378365|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
15235020|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235021|NCT04141579|Evolocumab|evolocumab|mesh-list
15235022|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15235023|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15235024|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
14378366|NCT01223352|Bosentan|bosentan|mesh-list
14378367|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378368|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14378369|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378370|NCT01223365|Hydrocodone|hydrocodone|mesh-list
14378371|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14921051|NCT04287049|Azithromycin|azithromycin|mesh-list
14921052|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14378372|NCT01223365|Narcotics|narcotics|mesh-ancestor
14378373|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378374|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378375|NCT01223365|Analgesics|analgesics|mesh-ancestor
14378376|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
14378377|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378378|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
14378379|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
14378380|NCT01223378|Latanoprost|latanoprost|mesh-list
14378381|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14378382|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14378383|NCT01223404|Mecamylamine|mecamylamine|mesh-list
14378384|NCT01223404|Nicotine|nicotine|mesh-list
14378385|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14378386|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
14378387|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378388|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378389|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14378390|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14733762|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733763|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733764|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733765|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
14733766|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378391|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14378392|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733767|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
14733768|NCT00532324|Mupirocin|mupirocin|mesh-list
14733769|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14733770|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733771|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
14733772|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14921053|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921054|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
14921055|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14921056|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14378393|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378394|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378395|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14378396|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14378397|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14378398|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14378399|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
14378400|NCT01223937|Coagulants|coagulants|mesh-ancestor
14378401|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14378402|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
14378403|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378404|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14378405|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14378406|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14378407|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378408|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378409|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14378410|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378411|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378412|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14378413|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378414|NCT01224145|Bupivacaine|bupivacaine|mesh-list
14378415|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
14921057|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921058|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
14921059|NCT04274335|Coagulants|coagulants|mesh-ancestor
14378416|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
14378417|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378418|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378419|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
14378420|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378421|NCT01224171|Vedolizumab|vedolizumab|mesh-list
14378422|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14378423|NCT01224210|Ambrisentan|ambrisentan|mesh-list
14378424|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378425|NCT01224431|Lidocaine|lidocaine|mesh-list
14378426|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
14378427|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
14378428|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378429|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378430|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
14378431|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378432|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14378433|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14378434|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14378435|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378436|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378437|NCT01224626|Linezolid|linezolid|mesh-list
14378438|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14378439|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378440|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14378441|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378442|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378443|NCT01224639|Vaccines|vaccines|mesh-list
14378444|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
14378445|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378446|NCT01224678|Vitamin D|vitamin d|mesh-list
14378447|NCT01224678|Vitamins|vitamins|mesh-ancestor
14378448|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
14378449|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378450|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378451|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
14378452|NCT01224821|Antibodies|antibodies|mesh-list
14378453|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
14378454|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378455|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378456|NCT01225055|Teriparatide|teriparatide|mesh-list
14378457|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378458|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378459|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378460|NCT01225068|Milnacipran|milnacipran|mesh-list
14378461|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
14466448|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378462|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14378463|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14378464|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378465|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378466|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378467|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378468|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14378469|NCT01225068|Analgesics|analgesics|mesh-ancestor
14378470|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
14378471|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378472|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
14378473|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14378474|NCT01225146|Ranibizumab|ranibizumab|mesh-list
14378475|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14378476|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14378477|NCT01225146|Growth Substances|growth substances|mesh-ancestor
14378478|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378479|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
14378480|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378481|NCT01225172|Letrozole|letrozole|mesh-list
14378482|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378483|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14378484|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14378485|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378486|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378487|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14378488|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
14378489|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14378490|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378491|NCT01225211|Ivacaftor|ivacaftor|mesh-list
14378492|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14378493|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378494|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378495|NCT01225263|Vitamin D|vitamin d|mesh-list
14378496|NCT01225263|Simvastatin|simvastatin|mesh-list
14378497|NCT01225263|Vitamins|vitamins|mesh-ancestor
14378498|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
14378499|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378500|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378501|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14378502|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14378503|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
14378504|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378505|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14378506|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14378507|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378508|NCT01225289|Vitamin A|vitamin a|mesh-list
14378509|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
14378510|NCT01225289|Vitamins|vitamins|mesh-ancestor
14378511|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
15235025|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235026|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15235027|NCT04094519|Digoxin|digoxin|mesh-list
15235028|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15235029|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15235030|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15235031|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
15235032|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235033|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15235034|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15235035|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235036|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15235037|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15235038|NCT04094519|Protective Agents|protective agents|mesh-ancestor
15235039|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235040|NCT04080531|Vaccines|vaccines|mesh-list
15235041|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
15235042|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235043|NCT04064359|Antibodies|antibodies|mesh-list
15235044|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
14378512|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378513|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
15235045|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
15235046|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378514|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378515|NCT01225289|Protective Agents|protective agents|mesh-ancestor
14378516|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14378517|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378518|NCT01225354|Calcium|calcium|mesh-list
14378519|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378520|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378521|NCT01225549|Budesonide|budesonide|mesh-list
14378522|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14378523|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14378524|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
14378525|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378526|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378527|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14378528|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
14378529|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
14378530|NCT01225549|Hormones|hormones|mesh-ancestor
14378531|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14378532|NCT01225562|Ticagrelor|ticagrelor|mesh-list
14378533|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14378534|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14378535|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14378536|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14378537|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
14378538|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378539|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378540|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466449|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466450|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14466451|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
14466452|NCT02242487|Levodopa|levodopa|mesh-list
14466453|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14466454|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14466455|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
14466456|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466457|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466458|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466459|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
14466460|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14466461|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15235047|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
15235048|NCT03938584|Vitamins|vitamins|mesh-ancestor
15235049|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
15235050|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235051|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
15235052|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235053|NCT03938584|Protective Agents|protective agents|mesh-ancestor
15235054|NCT03917381|Docetaxel|docetaxel|mesh-list
15235055|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
14378541|NCT01225822|Enoxaparin|enoxaparin|mesh-list
14378542|NCT01225822|Dabigatran|dabigatran|mesh-list
14378543|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
14378544|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14378545|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14378546|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378547|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
14378548|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14378549|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14378550|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378551|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14378552|NCT01225835|Cetrorelix|cetrorelix|mesh-list
14378553|NCT01225835|Menotropins|menotropins|mesh-list
14378554|NCT01225835|Progesterone|progesterone|mesh-list
14378555|NCT01225835|Progestins|progestins|mesh-ancestor
14378556|NCT01225835|Hormones|hormones|mesh-ancestor
14378557|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14378558|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378559|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14378560|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14378561|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
14378562|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
15235056|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378563|NCT01225887|Nintedanib|nintedanib|mesh-list
14378564|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378565|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14378566|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378567|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378568|NCT01225991|Milnacipran|milnacipran|mesh-list
14378569|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
14378570|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14378571|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14378572|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378573|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378574|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378575|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378576|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14378577|NCT01225991|Analgesics|analgesics|mesh-ancestor
14378578|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
14378579|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378580|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
14378581|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14378582|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
14378583|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14378584|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378585|NCT01226420|Alefacept|alefacept|mesh-list
14378586|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
14378587|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
14378588|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378589|NCT01226459|Minoxidil|minoxidil|mesh-list
14378590|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378591|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
14378592|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
14378593|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378594|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14378595|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14378596|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14378597|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378598|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378599|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378600|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235057|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235058|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235059|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
15235060|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235061|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235062|NCT03837873|Cytarabine|cytarabine|mesh-list
15235063|NCT03837873|Dexamethasone|dexamethasone|mesh-list
15235064|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
15235065|NCT03837873|Rituximab|rituximab|mesh-list
15235066|NCT03837873|Doxorubicin|doxorubicin|mesh-list
15235067|NCT03837873|Etoposide|etoposide|mesh-list
15235068|NCT03837873|Vincristine|vincristine|mesh-list
15235069|NCT03837873|Lenalidomide|lenalidomide|mesh-list
15235070|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378601|NCT01226511|Analgesics|analgesics|mesh-ancestor
14378602|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
14378603|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378604|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
14378605|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14378606|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
14378607|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
14378608|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14378609|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14378610|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14378611|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378612|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378613|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
14378614|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466462|NCT02242630|Prednisolone|prednisolone|mesh-list
15235071|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
15235072|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378615|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378616|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14378617|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378618|NCT01226719|Leucovorin|leucovorin|mesh-list
14378619|NCT01226719|Fluorouracil|fluorouracil|mesh-list
14378620|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
14378621|NCT01226719|Irinotecan|irinotecan|mesh-list
14378622|NCT01226719|Panitumumab|panitumumab|mesh-list
14378623|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
14378624|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378625|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14378626|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378627|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378628|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
14378629|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378630|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14378631|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14378632|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378633|NCT01226719|Antidotes|antidotes|mesh-ancestor
14378634|NCT01226719|Protective Agents|protective agents|mesh-ancestor
14378635|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
14378636|NCT01226719|Vitamins|vitamins|mesh-ancestor
14378637|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
14378638|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14378639|NCT01226745|Ceralifimod|ceralifimod|mesh-list
14378640|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14378641|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378642|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378643|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
14378644|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378645|NCT01227044|Naltrexone|naltrexone|mesh-list
14378646|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14378647|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14378648|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378649|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
14378650|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378651|NCT01227278|Benralizumab|benralizumab|mesh-list
14378652|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14378653|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
14378654|NCT01227395|Azithromycin|azithromycin|mesh-list
14378655|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14378656|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378657|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
14378658|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14378659|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378660|NCT01227434|Palbociclib|palbociclib|mesh-list
14378661|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378662|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14378663|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378664|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378665|NCT01227512|Tolvaptan|tolvaptan|mesh-list
14378666|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14378667|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378668|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
14378669|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378670|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
14378671|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14378672|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
14378673|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378674|NCT01227629|Warfarin|warfarin|mesh-list
14378675|NCT01227629|Dabigatran|dabigatran|mesh-list
14378676|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
14378677|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
14378678|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14378679|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
14378680|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378681|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378682|NCT01227655|Levodopa|levodopa|mesh-list
14378683|NCT01227655|Carbidopa|carbidopa|mesh-list
14378684|NCT01227655|Opicapone|opicapone|mesh-list
14378685|NCT01227655|Benserazide|benserazide|mesh-list
14378686|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14378687|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14378688|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
14378689|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378690|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378691|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378692|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14378693|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378694|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14378695|NCT01227668|Aripiprazole|aripiprazole|mesh-list
14378696|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
14378697|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14378698|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14378699|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14378700|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378701|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378702|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
14378703|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
14378704|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378705|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378706|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14378707|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14378708|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
14378709|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14378710|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14378711|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14378712|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14378713|NCT01227707|Leucovorin|leucovorin|mesh-list
14378714|NCT01227707|Bevacizumab|bevacizumab|mesh-list
14378715|NCT01227707|Fluorouracil|fluorouracil|mesh-list
14378716|NCT01227707|Capecitabine|capecitabine|mesh-list
14378717|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14378718|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378719|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14378720|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14378721|NCT01227707|Growth Substances|growth substances|mesh-ancestor
14378722|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378723|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14378724|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
14378725|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378726|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14378727|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378728|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
14378729|NCT01227707|Antidotes|antidotes|mesh-ancestor
14378730|NCT01227707|Protective Agents|protective agents|mesh-ancestor
14378731|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
14378732|NCT01227707|Vitamins|vitamins|mesh-ancestor
14378733|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
14378734|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
14378735|NCT01227824|Dolutegravir|dolutegravir|mesh-list
14378736|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14378737|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14378738|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
14378739|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378740|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14378741|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14378742|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378743|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378744|NCT01227889|Dacarbazine|dacarbazine|mesh-list
14378745|NCT01227889|Dabrafenib|dabrafenib|mesh-list
14378746|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14378747|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
14378748|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378749|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378750|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14378751|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378752|NCT01227902|Ezogabine|ezogabine|mesh-list
14378753|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
14378754|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378755|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378756|NCT01227967|Ribavirin|ribavirin|mesh-list
14378757|NCT01227967|Oseltamivir|oseltamivir|mesh-list
14378758|NCT01227967|Amantadine|amantadine|mesh-list
14378759|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
14378760|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378761|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
14378762|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14378763|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378764|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14378765|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14378766|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
14378767|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378768|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378769|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14378770|NCT01227967|Analgesics|analgesics|mesh-ancestor
14378771|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
14378772|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378773|NCT01227993|Finasteride|finasteride|mesh-list
14378774|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14378775|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14378776|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378777|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378778|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
14378779|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14378780|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378781|NCT01227993|Urological Agents|urological agents|mesh-ancestor
14378782|NCT01228019|Niacin|niacin|mesh-list
14378783|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14378784|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
14378785|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378786|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14378787|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
14378788|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
14378789|NCT01228019|Vitamins|vitamins|mesh-ancestor
14378790|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
14378791|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378792|NCT01228071|Testosterone|testosterone|mesh-list
14378793|NCT01228071|Androgens|androgens|mesh-ancestor
14378794|NCT01228071|Hormones|hormones|mesh-ancestor
14378795|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14378796|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378797|NCT01228084|Sulforaphane|sulforaphane|mesh-list
14378798|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14378799|NCT01228084|Protective Agents|protective agents|mesh-ancestor
14378800|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378801|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378802|NCT01228149|Acetazolamide|acetazolamide|mesh-list
15235073|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235074|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15235075|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
15235076|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235077|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235078|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15235079|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235080|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
14378803|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
14378804|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15235081|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
15235082|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235083|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14378805|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378806|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378807|NCT01228149|Diuretics|diuretics|mesh-ancestor
14378808|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
14378809|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378810|NCT01228175|Riboflavin|riboflavin|mesh-list
14378811|NCT01228175|Varenicline|varenicline|mesh-list
14378812|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14378813|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14378814|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
14378815|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378816|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378817|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378818|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
14378819|NCT01228175|Vitamins|vitamins|mesh-ancestor
14378820|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
14378821|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14378822|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
14378823|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
14378824|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378825|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378826|NCT01228734|Leucovorin|leucovorin|mesh-list
14378827|NCT01228734|Folic Acid|folic acid|mesh-list
14378828|NCT01228734|Fluorouracil|fluorouracil|mesh-list
14378829|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
14378830|NCT01228734|Cetuximab|cetuximab|mesh-list
14378831|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
14378832|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
14378833|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378834|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14378835|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378836|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378837|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
14378838|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378839|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14378840|NCT01228734|Antidotes|antidotes|mesh-ancestor
14378841|NCT01228734|Protective Agents|protective agents|mesh-ancestor
14378842|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
14378843|NCT01228734|Vitamins|vitamins|mesh-ancestor
14378844|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
14378845|NCT01228734|Hematinics|hematinics|mesh-ancestor
14378846|NCT01228747|Levetiracetam|levetiracetam|mesh-list
14378847|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
14378848|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
14378849|NCT01228903|Allopurinol|allopurinol|mesh-list
14378850|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
14733773|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14733774|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733775|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378851|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378852|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378853|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
14378854|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14378855|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14378856|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
15235084|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
15235085|NCT03837873|Hormones|hormones|mesh-ancestor
15235086|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235087|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15235088|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235089|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15235090|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15235091|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15235092|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378857|NCT01228903|Protective Agents|protective agents|mesh-ancestor
14378858|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378859|NCT01229111|Leucovorin|leucovorin|mesh-list
14378860|NCT01229111|Fluorouracil|fluorouracil|mesh-list
14378861|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
14378862|NCT01229111|Cediranib|cediranib|mesh-list
14378863|NCT01229111|Calcium|calcium|mesh-list
14378864|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
14378865|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378866|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378867|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
14378868|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378869|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14378870|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378871|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14378872|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
14378873|NCT01229111|Antidotes|antidotes|mesh-ancestor
14378874|NCT01229111|Protective Agents|protective agents|mesh-ancestor
14378875|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
14378876|NCT01229111|Vitamins|vitamins|mesh-ancestor
14378877|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
14378878|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378879|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14378880|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14378881|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14378882|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14378883|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378884|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378885|NCT01229176|Vaccines|vaccines|mesh-list
14378886|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14378887|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
14378888|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378889|NCT01229228|Naproxen|naproxen|mesh-list
14378890|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14378891|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14378892|NCT01229228|Analgesics|analgesics|mesh-ancestor
14378893|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
14378894|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378895|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378896|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14378897|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14378898|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
14733776|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
15235093|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14378899|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14378900|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378901|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378902|NCT01229254|Amiodarone|amiodarone|mesh-list
14378903|NCT01229254|Betrixaban|betrixaban|mesh-list
14378904|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14378905|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
14378906|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14378907|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14378908|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378909|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14378910|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14378911|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14378912|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378913|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14378914|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14378915|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14378916|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14378917|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
14378918|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14378919|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
14378920|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
14378921|NCT01229267|Vaccines|vaccines|mesh-list
14378922|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
14378923|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378924|NCT01229371|Vaccines|vaccines|mesh-list
14378925|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
14378926|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378927|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14378928|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378929|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14378930|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14378931|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14378932|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
14733777|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14733778|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
14733779|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733780|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733781|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14733782|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
14733783|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
14733784|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14378933|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378934|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378935|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378936|NCT01229423|Bimatoprost|bimatoprost|mesh-list
14378937|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378938|NCT01229449|Acetaminophen|acetaminophen|mesh-list
14378939|NCT01229449|Ibuprofen|ibuprofen|mesh-list
14378940|NCT01229449|Codeine|codeine|mesh-list
14378941|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14378942|NCT01229449|Analgesics|analgesics|mesh-ancestor
14378943|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
14378944|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378945|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378946|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
14378947|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14378948|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14378949|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14378950|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14378951|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14378952|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378953|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14378954|NCT01229449|Narcotics|narcotics|mesh-ancestor
14378955|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378956|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
14378957|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
14378958|NCT01229462|Timolol|timolol|mesh-list
14378959|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14378960|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14733785|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
14378961|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14378962|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14378963|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14378964|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
14378965|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14378966|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14378967|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378968|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14378969|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14378970|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14378971|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14378972|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14378973|NCT01229527|Meperidine|meperidine|mesh-list
14378974|NCT01229527|Remifentanil|remifentanil|mesh-list
14378975|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14378976|NCT01229527|Narcotics|narcotics|mesh-ancestor
14378977|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14378978|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378979|NCT01229527|Analgesics|analgesics|mesh-ancestor
14378980|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
14378981|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14378982|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14378983|NCT01229735|Topiramate|topiramate|mesh-list
14378984|NCT01229735|Levetiracetam|levetiracetam|mesh-list
14378985|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
14378986|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14378987|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378988|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
14378989|NCT01229891|Vitamin D|vitamin d|mesh-list
14378990|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
14378991|NCT01229891|Vitamins|vitamins|mesh-list
14378992|NCT01229891|Calcium|calcium|mesh-list
14378993|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
14378994|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14378995|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14378996|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14378997|NCT01230177|Etanercept|etanercept|mesh-list
14378998|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14378999|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14379000|NCT01230177|Analgesics|analgesics|mesh-ancestor
14379001|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
14379002|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379003|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379004|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379005|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379006|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14379007|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379008|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
14379009|NCT01230424|Triamcinolone|triamcinolone|mesh-list
14379010|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14379011|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14379012|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14379013|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379014|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
14379015|NCT01230424|Hormones|hormones|mesh-ancestor
14379016|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379017|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379018|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379019|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
14379020|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379021|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379022|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
14379023|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14379024|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379025|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14379026|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
14379027|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14379028|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379029|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379030|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379031|NCT01230593|Tobramycin|tobramycin|mesh-list
14379032|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14379033|NCT01230593|Dexamethasone|dexamethasone|mesh-list
14379034|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
14379035|NCT01230593|BB 1101|bb 1101|mesh-list
14379036|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379037|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
14379038|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
14379039|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379040|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379041|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14379042|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
14379043|NCT01230593|Hormones|hormones|mesh-ancestor
14379044|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379045|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14379046|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379047|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
14379048|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379049|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379050|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14379051|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379052|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14379053|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14379054|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14379055|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379056|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14379057|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379058|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379059|NCT01230749|Pioglitazone|pioglitazone|mesh-list
14379060|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14379061|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379062|NCT01230814|Metronidazole|metronidazole|mesh-list
14379063|NCT01230814|Miconazole|miconazole|mesh-list
14379064|NCT01230814|Clotrimazole|clotrimazole|mesh-list
14379065|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379066|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14379067|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14379068|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14379069|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
14379070|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14379071|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14379072|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379073|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379074|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14379075|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
14379076|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379077|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379078|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14379079|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14379080|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14379081|NCT01230827|Golimumab|golimumab|mesh-list
14379082|NCT01230827|Methotrexate|methotrexate|mesh-list
14379083|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14379084|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
14379085|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14379086|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379087|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379088|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
14379089|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379090|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379091|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379092|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379093|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14379094|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379095|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
14379096|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379097|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14379098|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14379099|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379100|NCT01230892|Atenolol|atenolol|mesh-list
14379101|NCT01230892|Nebivolol|nebivolol|mesh-list
14379102|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14379103|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14379104|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
14379105|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
14379106|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379107|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379108|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14379109|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14379110|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14379111|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
14379112|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379113|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379114|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
14379115|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14379116|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14379117|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14379118|NCT01231230|Fluticasone|fluticasone|mesh-list
14379119|NCT01231230|Xhance|xhance|mesh-list
14379120|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14379121|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14379122|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379123|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14379124|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
14379125|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379126|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379127|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14379128|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
14379129|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379130|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14379131|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14379132|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14379133|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14379134|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
14379135|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379136|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379137|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
14379138|NCT01231230|Hormones|hormones|mesh-ancestor
14379139|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379140|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
14379141|NCT01231321|Adalimumab|adalimumab|mesh-list
14379142|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379143|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379144|NCT01231334|Clindamycin|clindamycin|mesh-list
15235094|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235095|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
15235096|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
15235097|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235098|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235099|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235100|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
15235101|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14379145|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
14379146|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
15235102|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14379147|NCT01231334|Dapsone|dapsone|mesh-list
14379148|NCT01231334|Adapalene|adapalene|mesh-list
14379149|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14379150|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14379151|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379152|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14379153|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379154|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379155|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379156|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14379157|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14379158|NCT01231334|Analgesics|analgesics|mesh-ancestor
14379159|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
14379160|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379161|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379162|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379163|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379164|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
14379165|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14379166|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14379167|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14379168|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
14379169|NCT01231373|Polidocanol|polidocanol|mesh-list
14379170|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14379171|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14379172|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
14379173|NCT01231399|Leucovorin|leucovorin|mesh-list
14379174|NCT01231399|Fluorouracil|fluorouracil|mesh-list
14379175|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
14379176|NCT01231399|Everolimus|everolimus|mesh-list
14379177|NCT01231399|Calcium|calcium|mesh-list
14379178|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
14379179|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14379180|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379181|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14379182|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
14379183|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379184|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379185|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379186|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379187|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
14379188|NCT01231399|Antidotes|antidotes|mesh-ancestor
14379189|NCT01231399|Protective Agents|protective agents|mesh-ancestor
14379190|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
14379191|NCT01231399|Vitamins|vitamins|mesh-ancestor
14379192|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
14379193|NCT01231412|Cyclosporine|cyclosporine|mesh-list
14379194|NCT01231412|Sirolimus|sirolimus|mesh-list
14379195|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
14379196|NCT01231412|Fludarabine|fludarabine|mesh-list
14379197|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
14379198|NCT01231412|Cyclosporins|cyclosporins|mesh-list
14379199|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379200|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379201|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
15235103|NCT03837873|Growth Substances|growth substances|mesh-ancestor
15235104|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
15235105|NCT03836209|Cytarabine|cytarabine|mesh-list
15235106|NCT03836209|Daunorubicin|daunorubicin|mesh-list
15235107|NCT03836209|Midostaurin|midostaurin|mesh-list
15235108|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235109|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
15235110|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235111|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235112|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
15235113|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235114|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235115|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
15235116|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235117|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15235118|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15235119|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14379202|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379203|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379204|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
14379205|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235120|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379206|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379207|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
14379208|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379209|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379210|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379211|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14379212|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14379213|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14379214|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
14379215|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14466463|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
14466464|NCT02242630|Triamcinolone|triamcinolone|mesh-list
14466465|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14466466|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14466467|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14466468|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
14466469|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14466470|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466471|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
14466472|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
14466473|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466474|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466475|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466476|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
14466477|NCT02242630|Hormones|hormones|mesh-ancestor
14466478|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466479|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14466480|NCT02242630|Protective Agents|protective agents|mesh-ancestor
14466481|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14466482|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466483|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466484|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
14466485|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466486|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466487|NCT02243007|Gemcitabine|gemcitabine|mesh-list
14466488|NCT02243007|Paclitaxel|paclitaxel|mesh-list
14466489|NCT02243007|Capecitabine|capecitabine|mesh-list
14466490|NCT02243007|Folfirinox|folfirinox|mesh-list
14466491|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14466492|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466493|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
14466494|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
14466495|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
14466496|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466497|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14466498|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
14466499|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
14466500|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466501|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466502|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466503|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
14466504|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466505|NCT02243176|Saxagliptin|saxagliptin|mesh-list
14466506|NCT02243176|Acarbose|acarbose|mesh-list
14466507|NCT02243176|Incretins|incretins|mesh-ancestor
15235121|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235122|NCT03810495|Naltrexone|naltrexone|mesh-list
15235123|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15235124|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15235125|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235126|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
15235127|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235128|NCT03775200|Psilocybin|psilocybin|mesh-list
15235129|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
15235130|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379216|NCT01231464|Fluticasone|fluticasone|mesh-list
14379217|NCT01231464|Xhance|xhance|mesh-list
14379218|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379219|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14379220|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
14379221|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379222|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379223|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14379224|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14379225|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379226|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14379227|NCT01231503|Vaccines|vaccines|mesh-list
14379228|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
14379229|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379230|NCT01231555|Efavirenz|efavirenz|mesh-list
14379231|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14379232|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14379233|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379234|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379235|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
14379236|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379237|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14379238|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14379239|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14379240|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14379241|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14379242|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14379243|NCT01231581|Gemcitabine|gemcitabine|mesh-list
14379244|NCT01231581|Trametinib|trametinib|mesh-list
14379245|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379246|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
14379247|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379248|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379249|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
14379250|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379251|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379252|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379253|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
14379254|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379255|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14379256|NCT01231607|Finasteride|finasteride|mesh-list
14379257|NCT01231607|Dutasteride|dutasteride|mesh-list
14379258|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14379259|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14379260|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379261|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379262|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
14379263|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379264|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379265|NCT01231607|Urological Agents|urological agents|mesh-ancestor
14379266|NCT01231620|Oseltamivir|oseltamivir|mesh-list
14379267|NCT01231620|Zanamivir|zanamivir|mesh-list
14379268|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
14379269|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379270|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379271|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379272|NCT01231633|Dexamethasone|dexamethasone|mesh-list
14379273|NCT01231633|Bevacizumab|bevacizumab|mesh-list
14379274|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14379275|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379276|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14379277|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14379278|NCT01231633|Growth Substances|growth substances|mesh-ancestor
14379279|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379280|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
14379281|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379282|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
14379283|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
14379284|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379285|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14379286|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
14379287|NCT01231633|Hormones|hormones|mesh-ancestor
14379288|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379289|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14379290|NCT01231659|Everolimus|everolimus|mesh-list
14379291|NCT01231659|Letrozole|letrozole|mesh-list
14379292|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379293|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379294|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
14379295|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379296|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14379297|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14379298|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379299|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379300|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14379301|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
14379302|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379303|NCT01231841|Cyclosporine|cyclosporine|mesh-list
14379304|NCT01231841|Cyclosporins|cyclosporins|mesh-list
14379305|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
14379306|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14379307|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
14379308|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466508|NCT02243176|Hormones|hormones|mesh-ancestor
14733786|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733787|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733788|NCT00532389|Panobinostat|panobinostat|mesh-list
14733789|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733790|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14733791|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733792|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379309|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379310|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379311|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
14379312|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379313|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
14379314|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379315|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379316|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379317|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14379318|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
14379319|NCT01231906|Ifosfamide|ifosfamide|mesh-list
14379320|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
14379321|NCT01231906|Doxorubicin|doxorubicin|mesh-list
14379322|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14379323|NCT01231906|Etoposide|etoposide|mesh-list
14379324|NCT01231906|Vincristine|vincristine|mesh-list
14379325|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
14379326|NCT01231906|Topotecan|topotecan|mesh-list
14379327|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
14379328|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
14379329|NCT01231906|Razoxane|razoxane|mesh-list
14379330|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
14379331|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379332|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
14379333|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379334|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379335|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14379336|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
14379337|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379338|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379339|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14379340|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14379341|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14379342|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14379343|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379344|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14379345|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
14379346|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
14379347|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
14379348|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14379349|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
14379350|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379351|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14379352|NCT01231906|Protective Agents|protective agents|mesh-ancestor
14379353|NCT01232127|Ritonavir|ritonavir|mesh-list
14379354|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14379355|NCT01232127|Tenofovir|tenofovir|mesh-list
14379356|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14379357|NCT01232127|Famotidine|famotidine|mesh-list
14379358|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14379359|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14379360|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
14379361|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379362|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379363|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14379364|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14379365|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
14379366|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379367|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14379368|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14733793|NCT00532415|Triamcinolone|triamcinolone|mesh-list
14379369|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14379370|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14379371|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14379372|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14379373|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
14379374|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
14379375|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379376|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379377|NCT01232205|Micronutrients|micronutrients|mesh-list
14379378|NCT01232205|Trace Elements|trace elements|mesh-list
14379379|NCT01232205|Antioxidants|antioxidants|mesh-list
14379380|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379381|NCT01232205|Protective Agents|protective agents|mesh-ancestor
14379382|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379383|NCT01232296|Sorafenib|sorafenib|mesh-list
14379384|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379385|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14379386|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379387|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379388|NCT01232452|Pemetrexed|pemetrexed|mesh-list
14379389|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379390|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379391|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379392|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14379393|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14379394|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
14379395|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14379396|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379397|NCT01232504|Molgramostim|molgramostim|mesh-list
14379398|NCT01232504|Sargramostim|sargramostim|mesh-list
14379399|NCT01232504|Lenograstim|lenograstim|mesh-list
14379400|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
14379401|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379402|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14379403|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379404|NCT01232556|Gemcitabine|gemcitabine|mesh-list
14379405|NCT01232556|Rituximab|rituximab|mesh-list
14379406|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14379407|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14379408|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14379409|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379410|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
14379411|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379412|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379413|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379414|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
14379415|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379416|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
14379417|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379418|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379419|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379420|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14379421|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
14379422|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14379423|NCT01232738|Rasagiline|rasagiline|mesh-list
14379424|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14379425|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379426|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379427|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14379428|NCT01232738|Protective Agents|protective agents|mesh-ancestor
14379429|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379430|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
14379431|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14379432|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
14379433|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379434|NCT01232790|Expectorants|expectorants|mesh-ancestor
14379435|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14379436|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14379437|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
14379438|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379439|NCT01232790|Protective Agents|protective agents|mesh-ancestor
14379440|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379441|NCT01232790|Antidotes|antidotes|mesh-ancestor
14379442|NCT01232829|R04929097|r04929097|mesh-list
14379443|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379444|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379445|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
14379446|NCT01232920|Methotrexate|methotrexate|mesh-list
14379447|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14379448|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
14379449|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14379450|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379451|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379452|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
14379453|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379454|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379455|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379456|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379457|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14379458|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379459|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
14379460|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379461|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14379462|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14379463|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14379464|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
14379465|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14379466|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379467|NCT01232946|Insulin|insulin|mesh-list
14379468|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15235131|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235132|NCT03769766|Curcumin|curcumin|mesh-list
15235133|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15235134|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15235135|NCT03769766|Analgesics|analgesics|mesh-ancestor
15235136|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
15235137|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235138|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235139|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235140|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379469|NCT01232946|Liraglutide|liraglutide|mesh-list
14379470|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
14379471|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14379472|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379473|NCT01232946|Incretins|incretins|mesh-ancestor
14379474|NCT01232946|Hormones|hormones|mesh-ancestor
14379475|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379476|NCT01233050|Ethanol|ethanol|mesh-list
14379477|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
14379478|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14379479|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14379480|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379481|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14379482|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753809|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
15235141|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235142|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235143|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235144|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
15235145|NCT03753555|Atorvastatin|atorvastatin|mesh-list
15235146|NCT03753555|Probucol|probucol|mesh-list
15235147|NCT03753555|Calcium|calcium|mesh-list
15235148|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15235149|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235150|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15235151|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15235152|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15235153|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
15235154|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235155|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15235156|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15235157|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235158|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
15235159|NCT03753555|Protective Agents|protective agents|mesh-ancestor
15235160|NCT03734029|Gemcitabine|gemcitabine|mesh-list
15235161|NCT03734029|Paclitaxel|paclitaxel|mesh-list
15235162|NCT03734029|Camptothecin|camptothecin|mesh-list
15235163|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15235164|NCT03734029|Capecitabine|capecitabine|mesh-list
15235165|NCT03734029|Trastuzumab|trastuzumab|mesh-list
15235166|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
15235167|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15235168|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235169|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235170|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235171|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
15235172|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235173|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235174|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
15235175|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
15235176|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235177|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235178|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235179|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
14379483|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
15235180|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235181|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235182|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15235183|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15235184|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
15235185|NCT03716609|Citric Acid|citric acid|mesh-list
15235186|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
14379484|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379485|NCT01233258|Factor VIII|factor viii|mesh-list
14379486|NCT01233258|Coagulants|coagulants|mesh-ancestor
14379487|NCT01233284|Bromides|bromides|mesh-list
14379488|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
14379489|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14379490|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
14379491|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379492|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379493|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14379494|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
14379495|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
14379496|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14379497|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
14379498|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379499|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379500|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
14379501|NCT01233609|Valproic Acid|valproic acid|mesh-list
14379502|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
14379503|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379504|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379505|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
14379506|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379507|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379508|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
14379509|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14379510|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14379511|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14379512|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14379513|NCT01233687|Rilotumumab|rilotumumab|mesh-list
14379514|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379515|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14379516|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379517|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379518|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14379519|NCT01233921|Mitogens|mitogens|mesh-list
14379520|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
14379521|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379522|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
14379523|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15235187|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
15235188|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15235189|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
15235190|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
15235191|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235192|NCT03716609|Cathartics|cathartics|mesh-ancestor
15235193|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15235194|NCT03709355|Clarithromycin|clarithromycin|mesh-list
14379524|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15235195|NCT03709355|Rifampin|rifampin|mesh-list
14379525|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14379526|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379527|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379528|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
14379529|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379530|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379531|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14379532|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379533|NCT01234337|Capecitabine|capecitabine|mesh-list
14379534|NCT01234337|Sorafenib|sorafenib|mesh-list
14379535|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379536|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
14379537|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379538|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379539|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14379540|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379541|NCT01234402|Capecitabine|capecitabine|mesh-list
14379542|NCT01234402|Ramucirumab|ramucirumab|mesh-list
14379543|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379544|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
14379545|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379546|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379547|NCT01234467|Rituximab|rituximab|mesh-list
14379548|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14379549|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14379550|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379551|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
14379552|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379553|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379554|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14379555|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
14379556|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379557|NCT01234649|Metformin|metformin|mesh-list
14379558|NCT01234649|Liraglutide|liraglutide|mesh-list
14379559|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14379560|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379561|NCT01234649|Incretins|incretins|mesh-ancestor
14379562|NCT01234649|Hormones|hormones|mesh-ancestor
14379563|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379564|NCT01234675|Milnacipran|milnacipran|mesh-list
14379565|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
14379566|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14379567|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14379568|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379569|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379570|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379571|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379572|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14379573|NCT01234675|Analgesics|analgesics|mesh-ancestor
14379574|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
14379575|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379576|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
14379577|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14379578|NCT01234714|Liver Extracts|liver extracts|mesh-list
14379579|NCT01234714|Hematinics|hematinics|mesh-ancestor
14379580|NCT01234766|Rituximab|rituximab|mesh-list
14379581|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14379582|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14379583|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379584|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
14379585|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379586|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379587|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921060|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
14921061|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921062|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921063|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379588|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
14379589|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379590|NCT01234870|Adenosine|adenosine|mesh-list
14379591|NCT01234870|Analgesics|analgesics|mesh-ancestor
14379592|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
14379593|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379594|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379595|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14379596|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
14379597|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14379598|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
14379599|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
14379600|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379601|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379602|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
14379603|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14379604|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14379605|NCT01234922|Losartan|losartan|mesh-list
14379606|NCT01234922|Ramipril|ramipril|mesh-list
14379607|NCT01234922|Lisinopril|lisinopril|mesh-list
14379608|NCT01234922|Benazepril|benazepril|mesh-list
14379609|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14379610|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14379611|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14379612|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14379613|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379614|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14379615|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
14379616|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379617|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14379618|NCT01234922|Protective Agents|protective agents|mesh-ancestor
14379619|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379620|NCT01235195|Sertraline|sertraline|mesh-list
14379621|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
14379622|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14379623|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14379624|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14379625|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379626|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379627|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379628|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
14379629|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379630|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14379631|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14379632|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14379633|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14379634|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379635|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379636|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379637|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379638|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14379639|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
14379640|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14379641|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14379642|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14379643|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
14379644|NCT01235351|Clopidogrel|clopidogrel|mesh-list
14379645|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14921064|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921065|NCT04268277|Rituximab|rituximab|mesh-list
14921066|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
15235196|NCT03709355|Rifabutin|rifabutin|mesh-list
15235197|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
15235198|NCT03709355|Omeprazole|omeprazole|mesh-list
15235199|NCT03709355|Atorvastatin|atorvastatin|mesh-list
15235200|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
15235201|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14379646|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14379647|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14379648|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14379649|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
14379650|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379651|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379652|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379653|NCT01235403|Lacosamide|lacosamide|mesh-list
14379654|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
14379655|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14379656|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14379657|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379658|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379659|NCT01235442|Etanercept|etanercept|mesh-list
14379660|NCT01235442|Clobetasol|clobetasol|mesh-list
14379661|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14379662|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14379663|NCT01235442|Analgesics|analgesics|mesh-ancestor
14379664|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
14379665|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379666|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379667|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379668|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379669|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14379670|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379671|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
14379672|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
14379673|NCT01235442|Hormones|hormones|mesh-ancestor
14379674|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379675|NCT01235507|Methotrexate|methotrexate|mesh-list
14379676|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14379677|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
14379678|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14379679|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379680|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379681|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
14379682|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733794|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14733795|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14379683|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379684|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379685|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379686|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14379687|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379688|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
14379689|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379690|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14379691|NCT01235546|Azithromycin|azithromycin|mesh-list
14379692|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14379693|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379694|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
14379695|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379696|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
14379697|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379698|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379699|NCT01235689|Prednisone|prednisone|mesh-list
14379700|NCT01235689|Adalimumab|adalimumab|mesh-list
14379701|NCT01235689|Azathioprine|azathioprine|mesh-list
14379702|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379703|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
14379704|NCT01235689|Hormones|hormones|mesh-ancestor
14379705|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379706|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379707|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14379708|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379709|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379710|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
14379711|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379712|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379713|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379714|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
14379715|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14379716|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
14379717|NCT01235715|Coagulants|coagulants|mesh-ancestor
14379718|NCT01235728|Calcitriol|calcitriol|mesh-list
14379719|NCT01235728|MK 0873|mk 0873|mesh-list
14379720|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14379721|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379722|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14379723|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379724|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379725|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14379726|NCT01235728|Vitamins|vitamins|mesh-ancestor
14379727|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
14379728|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14379729|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14379730|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14379731|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379732|NCT01235741|Pramlintide|pramlintide|mesh-list
14379733|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14379734|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379735|NCT01235793|Temozolomide|temozolomide|mesh-list
14379736|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14379737|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
14379738|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379739|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379740|NCT01235897|Paclitaxel|paclitaxel|mesh-list
14379741|NCT01235897|Trastuzumab|trastuzumab|mesh-list
14379742|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14379743|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379744|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
14379745|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
14379746|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
14379747|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379748|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14379749|NCT01235910|Cyclosporine|cyclosporine|mesh-list
14379750|NCT01235910|Cyclosporins|cyclosporins|mesh-list
14379751|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379752|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379753|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379754|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
14379755|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379756|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
14379757|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379758|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379759|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379760|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14379761|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
14379762|NCT01235923|Hematinics|hematinics|mesh-ancestor
14379763|NCT01235949|Acetaminophen|acetaminophen|mesh-list
14379764|NCT01235949|Ibuprofen|ibuprofen|mesh-list
14379765|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14379766|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14379767|NCT01235949|Analgesics|analgesics|mesh-ancestor
14379768|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
14379769|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379770|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379771|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379772|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379773|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14379774|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379775|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379776|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
14379777|NCT01236001|Lacosamide|lacosamide|mesh-list
14379778|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
14379779|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14379780|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14379781|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379782|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379783|NCT01236053|Gabapentin|gabapentin|mesh-list
14379784|NCT01236053|Analgesics|analgesics|mesh-ancestor
14379785|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
14379786|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379787|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379788|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
14379789|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14379790|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14379791|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14379792|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14379793|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14379794|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14379795|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379796|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733796|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14733797|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733798|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
14379797|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
14379798|NCT01236105|Charcoal|charcoal|mesh-list
14379799|NCT01236105|Antidotes|antidotes|mesh-ancestor
14379800|NCT01236105|Protective Agents|protective agents|mesh-ancestor
14379801|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379802|NCT01236118|Ixekizumab|ixekizumab|mesh-list
14379803|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
14379804|NCT01236365|Atorvastatin|atorvastatin|mesh-list
14379805|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14379806|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14379807|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
14379808|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379809|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14379810|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14379811|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379812|NCT01236378|Sirolimus|sirolimus|mesh-list
14379813|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15235202|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15235203|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15235204|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15235205|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
15235206|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235207|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15235208|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15235209|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235210|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15235211|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15235212|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15235213|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15235214|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379814|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733799|NCT00532415|Hormones|hormones|mesh-ancestor
14733800|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733801|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733802|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733803|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
14733804|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733805|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379815|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14379816|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379817|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
14379818|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379819|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
14379820|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379821|NCT01236521|Analgesics|analgesics|mesh-list
14379822|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
14379823|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379824|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379825|NCT01236534|Lubiprostone|lubiprostone|mesh-list
14379826|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14379827|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379828|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379829|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
14379830|NCT01236573|Fludarabine|fludarabine|mesh-list
14379831|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379832|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
14733806|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14733807|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14733808|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733809|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733810|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733811|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14379833|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379834|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379835|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14379836|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
14379837|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379838|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379839|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14379840|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
14379841|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
14379842|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
14379843|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14379844|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733812|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15235215|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15235216|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15235217|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15235218|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15235219|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
15235220|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15235221|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235222|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15235223|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15235224|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15235225|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15235226|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
15235227|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
15235228|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15235229|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14379845|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14379846|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14379847|NCT01237041|Niacin|niacin|mesh-list
14379848|NCT01237041|Niacinamide|niacinamide|mesh-list
14379849|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
14379850|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14379851|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
14379852|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379853|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14379854|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
14379855|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
14379856|NCT01237041|Vitamins|vitamins|mesh-ancestor
14379857|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
14379858|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379859|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14379860|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14379861|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379862|NCT01237197|Exenatide|exenatide|mesh-list
14379863|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14379864|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379865|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14379866|NCT01237197|Incretins|incretins|mesh-ancestor
14379867|NCT01237197|Hormones|hormones|mesh-ancestor
14379868|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379869|NCT01237223|Amlodipine|amlodipine|mesh-list
14379870|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14379871|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14379872|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379873|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379874|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14379875|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379876|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
14466509|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466510|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466511|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14466512|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
14466513|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466514|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466515|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14466516|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14466517|NCT02243202|Canagliflozin|canagliflozin|mesh-list
14466518|NCT02243202|Phentermine|phentermine|mesh-list
14466519|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14466520|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466521|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14466522|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466523|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14466524|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
14466525|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14379877|NCT01237327|Exemestane|exemestane|mesh-list
14379878|NCT01237327|Megestrol|megestrol|mesh-list
14379879|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
14379880|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379881|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14379882|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14379883|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379884|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379885|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14379886|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
14921067|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921068|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921069|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
14921070|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921071|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930972|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930973|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14930974|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14930975|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14930976|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14379887|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379888|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379889|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14379890|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14379891|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14379892|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
14379893|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14379894|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14379895|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14379896|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14379897|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
14379898|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14379899|NCT01237353|Rabeprazole|rabeprazole|mesh-list
14379900|NCT01237353|Betaine|betaine|mesh-list
14379901|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14379902|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14379903|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14379904|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379905|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379906|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
14379907|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14379908|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
14379909|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14379910|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14379911|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14379912|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14379913|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14379914|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379915|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379916|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379917|NCT01237587|Analgesics|analgesics|mesh-ancestor
14379918|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
14379919|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379920|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
14379921|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14379922|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
14379923|NCT01237678|Carboplatin|carboplatin|mesh-list
14379924|NCT01237678|Etoposide|etoposide|mesh-list
14379925|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
14379926|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379927|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14379928|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14379929|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14379930|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379931|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379932|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14379933|NCT01237899|Eplerenone|eplerenone|mesh-list
14379934|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14379935|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
14379936|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930977|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14379937|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379938|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14379939|NCT01237899|Diuretics|diuretics|mesh-ancestor
14379940|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
14379941|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14379942|NCT01237951|Gemcitabine|gemcitabine|mesh-list
14379943|NCT01237951|Dexamethasone|dexamethasone|mesh-list
14379944|NCT01237951|Melphalan|melphalan|mesh-list
14379945|NCT01237951|Busulfan|busulfan|mesh-list
14379946|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379947|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
14379948|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
14379949|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379950|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379951|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14379952|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
14379953|NCT01237951|Hormones|hormones|mesh-ancestor
14379954|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14379955|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14379956|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14379957|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14379958|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
14379959|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379960|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
14379961|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14379962|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379963|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14379964|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
14379965|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14379966|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
14379967|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14379968|NCT01238120|Ibuprofen|ibuprofen|mesh-list
14379969|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14379970|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14379971|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14379972|NCT01238120|Analgesics|analgesics|mesh-ancestor
14379973|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
14379974|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14379975|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379976|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14379977|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14379978|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14379979|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379980|NCT01238471|Propranolol|propranolol|mesh-list
14379981|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14379982|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14379983|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
14379984|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14379985|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14379986|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14379987|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14379988|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14379989|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
14379990|NCT01238536|Dexamethasone|dexamethasone|mesh-list
14379991|NCT01238536|Betamethasone|betamethasone|mesh-list
14379992|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14379993|NCT01238536|Lidocaine|lidocaine|mesh-list
14379994|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
14379995|NCT01238536|Anesthetics|anesthetics|mesh-list
14379996|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14379997|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
14379998|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
14379999|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380000|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380001|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14380002|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
14380003|NCT01238536|Hormones|hormones|mesh-ancestor
14380004|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380005|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14380006|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380007|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380008|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380009|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
14380010|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14380011|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14380012|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14380013|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380014|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14380015|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
14380016|NCT01238575|Guanfacine|guanfacine|mesh-list
14380017|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14380018|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14380019|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14380020|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14380021|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
14380022|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380023|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380024|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380025|NCT01238588|Sevelamer|sevelamer|mesh-list
14380026|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
14380027|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
14380028|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380029|NCT01238640|Nicotine|nicotine|mesh-list
14380030|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14380031|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
14380032|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380033|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380034|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14380035|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14380036|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
14380037|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380038|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380039|NCT01238822|Methylphenidate|methylphenidate|mesh-list
14380040|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14380041|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380042|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14380043|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14380044|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380045|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380046|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
14380047|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380048|NCT01238861|Benralizumab|benralizumab|mesh-list
14380049|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14380050|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
14380051|NCT01239212|Levetiracetam|levetiracetam|mesh-list
14380052|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
14380053|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
14380054|NCT01239342|Everolimus|everolimus|mesh-list
14380055|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380056|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380057|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
14380058|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380059|NCT01239394|Ofatumumab|ofatumumab|mesh-list
14380060|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380061|NCT01239472|Everolimus|everolimus|mesh-list
14380062|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380063|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380064|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
14380065|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380066|NCT01239732|Paclitaxel|paclitaxel|mesh-list
14380067|NCT01239732|Bevacizumab|bevacizumab|mesh-list
14380068|NCT01239732|Carboplatin|carboplatin|mesh-list
14380069|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14380070|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380071|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
14380072|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
14380073|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
14380074|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380075|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14380076|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380077|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380078|NCT01239732|Growth Substances|growth substances|mesh-ancestor
14380079|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235230|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15235231|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15235232|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15235233|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15235234|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15235235|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15235236|NCT03709355|Estrogens|estrogens|mesh-ancestor
15235237|NCT03709355|Hormones|hormones|mesh-ancestor
15235238|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235239|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14380080|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380081|NCT01239745|Exemestane|exemestane|mesh-list
14466526|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
14380082|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380083|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14380084|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14380085|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380086|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380087|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14380088|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
14380089|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380090|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380091|NCT01239797|Dexamethasone|dexamethasone|mesh-list
14380092|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
14380093|NCT01239797|Lenalidomide|lenalidomide|mesh-list
14380094|NCT01239797|Elotuzumab|elotuzumab|mesh-list
14380095|NCT01239797|BB 1101|bb 1101|mesh-list
14380096|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380097|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
14380098|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
14380099|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380100|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380101|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14380102|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
14380103|NCT01239797|Hormones|hormones|mesh-ancestor
14380104|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380105|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14380106|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380107|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
14380108|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380109|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380110|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
14380111|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380112|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380113|NCT01239797|Growth Substances|growth substances|mesh-ancestor
14380114|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380115|NCT01239992|Niacin|niacin|mesh-list
14380116|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14380117|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
14380118|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380119|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14380120|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
14380121|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
14380122|NCT01239992|Vitamins|vitamins|mesh-ancestor
14380123|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
14380124|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380125|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14380126|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
14380127|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14380128|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380129|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14380130|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14380131|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
14380132|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14380133|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
14380134|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380135|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
15235240|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14380136|NCT01240382|Protective Agents|protective agents|mesh-ancestor
14380137|NCT01240590|Cisplatin|cisplatin|mesh-list
14380138|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380139|NCT01240746|Vaccines|vaccines|mesh-list
14380140|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
14380141|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380142|NCT01240785|Metformin|metformin|mesh-list
14380143|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14380144|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380145|NCT01240811|Copper|copper|mesh-list
14380146|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
15235241|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
15235242|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15235243|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15235244|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
15235245|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15235246|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15235247|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15235248|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
15235249|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15235250|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235251|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14380147|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14380148|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
14466527|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
14380149|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14380150|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380151|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14380152|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14380153|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14380154|NCT01240811|Trace Elements|trace elements|mesh-ancestor
14380155|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
14380156|NCT01240863|Hydrocodone|hydrocodone|mesh-list
14380157|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14380158|NCT01240863|Narcotics|narcotics|mesh-ancestor
14380159|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380160|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380161|NCT01240863|Analgesics|analgesics|mesh-ancestor
14380162|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
14380163|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380164|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
14380165|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
14380166|NCT01241240|Timolol|timolol|mesh-list
14380167|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14380168|NCT01241240|Bimatoprost|bimatoprost|mesh-list
14380169|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14380170|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14380171|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14380172|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14380173|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14380174|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380175|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380176|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380177|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14380178|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14380179|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14380180|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14380181|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14380182|NCT01241292|Elotuzumab|elotuzumab|mesh-list
14380183|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380184|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
14380185|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14380186|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14733813|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14733814|NCT00532454|Tamoxifen|tamoxifen|mesh-list
14733815|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14733816|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
14733817|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733818|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733819|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733820|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380187|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14380188|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
14733821|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14733822|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14733823|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14733824|NCT00532519|Citalopram|citalopram|mesh-list
14733825|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14733826|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14733827|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14733828|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380189|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
14380190|NCT01241344|Brincidofovir|brincidofovir|mesh-list
14380191|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
14380192|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235252|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15235253|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15235254|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15235255|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235256|NCT03698552|Epratuzumab|epratuzumab|mesh-list
15235257|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14380193|NCT01241539|Dabigatran|dabigatran|mesh-list
14380194|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
14380195|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14380196|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
14380197|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380198|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380199|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
14380200|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14380201|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
14380202|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380203|NCT01241591|Etanercept|etanercept|mesh-list
14380204|NCT01241591|Tofacitinib|tofacitinib|mesh-list
14380205|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14380206|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14380207|NCT01241591|Analgesics|analgesics|mesh-ancestor
14380208|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
14380209|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380210|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380211|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380212|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14380213|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14380214|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380215|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
14380216|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380217|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380218|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380219|NCT01241760|Interferons|interferons|mesh-list
14380220|NCT01241760|Ribavirin|ribavirin|mesh-list
14380221|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
14380222|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
14380223|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14380224|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380225|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
14380226|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14380227|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
14380228|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235258|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380229|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
15235259|NCT03669133|Vitamin E|vitamin e|mesh-list
14380230|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380231|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14380232|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14380233|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14380234|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
14380235|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380236|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14380237|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14380238|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380239|NCT01242176|Empagliflozin|empagliflozin|mesh-list
14380240|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14380241|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380242|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14380243|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380244|NCT01242241|Propofol|propofol|mesh-list
14380245|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14380246|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380247|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380248|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14380249|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
14380250|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
14380251|NCT01242644|Ketorolac|ketorolac|mesh-list
14380252|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14380253|NCT01242644|Morphine|morphine|mesh-list
14380254|NCT01242644|Ropivacaine|ropivacaine|mesh-list
14380255|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14380256|NCT01242644|Narcotics|narcotics|mesh-ancestor
14380257|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380258|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380259|NCT01242644|Analgesics|analgesics|mesh-ancestor
14380260|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
14380261|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380262|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
14380263|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
14380264|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14380265|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14380266|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380267|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14380268|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14380269|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380270|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380271|NCT01242748|Goserelin|goserelin|mesh-list
14380272|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14380273|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380274|NCT01243112|Lidocaine|lidocaine|mesh-list
14380275|NCT01243112|Epinephrine|epinephrine|mesh-list
14380276|NCT01243112|Racepinephrine|racepinephrine|mesh-list
14380277|NCT01243112|Bupivacaine|bupivacaine|mesh-list
14380278|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
14380279|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
14380280|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
14380281|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921072|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
14733829|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235260|NCT03669133|Vitamins|vitamins|mesh-ancestor
15235261|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
15235262|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235263|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
15235264|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235265|NCT03669133|Protective Agents|protective agents|mesh-ancestor
15235266|NCT03637491|Avelumab|avelumab|mesh-list
15235267|NCT03637491|Talazoparib|talazoparib|mesh-list
15235268|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235269|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235270|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15235271|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235272|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235273|NCT03582618|Sorafenib|sorafenib|mesh-list
15235274|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235275|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380282|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380283|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
14380284|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380285|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14380286|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14380287|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14380288|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380289|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380290|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14380291|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14380292|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
14380293|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380294|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14380295|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14380296|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
14380297|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14380298|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
14380299|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
14380300|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
14380301|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14380302|NCT01243151|Bococizumab|bococizumab|mesh-list
14380303|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14380304|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14380305|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
14380306|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380307|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14733830|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
14733831|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733832|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14733833|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
15235276|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380308|NCT01243177|Lacosamide|lacosamide|mesh-list
14380309|NCT01243177|Carbamazepine|carbamazepine|mesh-list
14380310|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
14380311|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14380312|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14380313|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380314|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380315|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
14380316|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14921073|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14380317|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380318|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380319|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14380320|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14380321|NCT01243177|Analgesics|analgesics|mesh-ancestor
14380322|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
14380323|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380324|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14380325|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14380326|NCT01243242|Metadoxine|metadoxine|mesh-list
14380327|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14380328|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14380329|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14380330|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14921074|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921075|NCT04245644|Aspirin|aspirin|mesh-list
14921076|NCT04245644|Metformin|metformin|mesh-list
14921077|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14921078|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14380331|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14380332|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380333|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
14380334|NCT01243333|Alovudine|alovudine|mesh-list
14380335|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
14380336|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14380337|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14380338|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380339|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
14380340|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
14380341|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14380342|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14380343|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14380344|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921079|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921080|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921081|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921082|NCT04245644|Analgesics|analgesics|mesh-ancestor
14380345|NCT01243424|Glimepiride|glimepiride|mesh-list
14380346|NCT01243424|Linagliptin|linagliptin|mesh-list
14380347|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14380348|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14380349|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380350|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380351|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
14380352|NCT01243424|Incretins|incretins|mesh-ancestor
14380353|NCT01243424|Hormones|hormones|mesh-ancestor
14380354|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380355|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14380356|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
14380357|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380358|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380359|NCT01243450|Tretinoin|tretinoin|mesh-list
14380360|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380361|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
14380362|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
14380363|NCT01243567|Timolol|timolol|mesh-list
14380364|NCT01243567|Bimatoprost|bimatoprost|mesh-list
14380365|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14380366|NCT01243567|Latanoprost|latanoprost|mesh-list
14380367|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14380368|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14380369|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14380370|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14380371|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380372|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380373|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380374|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14380375|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14380376|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
14380377|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
14380378|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14380379|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
14380380|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14380381|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380382|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14380383|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14380384|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14380385|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14380386|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14380387|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380388|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380389|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380390|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14380391|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14380392|NCT01243593|Anesthetics|anesthetics|mesh-list
14380393|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380394|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380395|NCT01243671|Adalimumab|adalimumab|mesh-list
14380396|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380397|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14380398|NCT01243775|Docetaxel|docetaxel|mesh-list
14380399|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
14380400|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380401|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
14380402|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
14380403|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
14380404|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380405|NCT01243944|Lenalidomide|lenalidomide|mesh-list
14380406|NCT01243944|Pomalidomide|pomalidomide|mesh-list
14380407|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
14380408|NCT01243944|Pipobroman|pipobroman|mesh-list
14380409|NCT01243944|Anagrelide|anagrelide|mesh-list
14380410|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
14380411|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380412|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380413|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380414|NCT01243944|Growth Substances|growth substances|mesh-ancestor
14380415|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380416|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380417|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
14380418|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380419|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380420|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14380421|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14380422|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15235277|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235278|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
15235279|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235280|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235281|NCT03498391|Ketamine|ketamine|mesh-list
15235282|NCT03498391|Propofol|propofol|mesh-list
14380423|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15235283|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15235284|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235285|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235286|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15235287|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
14380424|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14380425|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
14380426|NCT01243957|Fluoxetine|fluoxetine|mesh-list
14380427|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14380428|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14380429|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380430|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380431|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380432|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
14380433|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380434|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14380435|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
14380436|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14380437|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14380438|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14380439|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466528|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466529|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
14466530|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466531|NCT02243293|Ribavirin|ribavirin|mesh-list
14466532|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
14466533|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466534|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
14466535|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466536|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
14466537|NCT02243371|Nivolumab|nivolumab|mesh-list
14380440|NCT01244061|Varenicline|varenicline|mesh-list
14380441|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14380442|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14380443|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
14380444|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380445|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380446|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380447|NCT01244126|Fentanyl|fentanyl|mesh-list
14380448|NCT01244126|Morphine|morphine|mesh-list
14380449|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14380450|NCT01244126|Narcotics|narcotics|mesh-ancestor
14380451|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380452|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380453|NCT01244126|Analgesics|analgesics|mesh-ancestor
14380454|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
14380455|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380456|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14380457|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14380458|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
14380459|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
14380460|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14380461|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380462|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380463|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380464|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380465|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14380466|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
14380467|NCT01244425|Coagulants|coagulants|mesh-ancestor
14380468|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14380469|NCT01244451|Ofatumumab|ofatumumab|mesh-list
14380470|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14380471|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
14380472|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921083|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
14380473|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380474|NCT01244490|Guanfacine|guanfacine|mesh-list
14380475|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14380476|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14380477|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14380478|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380479|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380480|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
14380481|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380482|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380483|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14380484|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14380485|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14380486|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14380487|NCT01244633|Ecopipam|ecopipam|mesh-list
14380488|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14380489|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14380490|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380491|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380492|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14380493|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14380494|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
14380495|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380496|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380497|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14380498|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
14380499|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14380500|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14380501|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14380502|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380503|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380504|NCT01244724|Citalopram|citalopram|mesh-list
14380505|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14380506|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14380507|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380508|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380509|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380510|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
14380511|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380512|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14380513|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
14380514|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14380515|NCT01244984|Fluticasone|fluticasone|mesh-list
14380516|NCT01244984|Xhance|xhance|mesh-list
14380517|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380518|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14380519|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
14380520|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380521|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380522|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14380523|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
14380524|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
14380525|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14380526|NCT01245062|Trametinib|trametinib|mesh-list
14380527|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380528|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380529|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380530|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235288|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
15235289|NCT03498391|Analgesics|analgesics|mesh-ancestor
15235290|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
15235291|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235292|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15235293|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15235294|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15235295|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235296|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380531|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
14380532|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14380533|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14380534|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
14380535|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14380536|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14380537|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14380538|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380539|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380540|NCT01245140|Alitretinoin|alitretinoin|mesh-list
14380541|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380542|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
14380543|NCT01245595|Aminophylline|aminophylline|mesh-list
14380544|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14380545|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
14380546|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380547|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380548|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14380549|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
14380550|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14380551|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14380552|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380553|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380554|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14380555|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14380556|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
14380557|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380558|NCT01245595|Protective Agents|protective agents|mesh-ancestor
14380559|NCT01245647|Naltrexone|naltrexone|mesh-list
14380560|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14380561|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14380562|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380563|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
14380564|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380565|NCT01245673|Lenalidomide|lenalidomide|mesh-list
14380566|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14380567|NCT01245673|Poly ICLC|poly iclc|mesh-list
14380568|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
14380569|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380570|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380571|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380572|NCT01245673|Growth Substances|growth substances|mesh-ancestor
14380573|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380574|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380575|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
14380576|NCT01246063|Dexamethasone|dexamethasone|mesh-list
14380577|NCT01246063|Doxorubicin|doxorubicin|mesh-list
14380578|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14380579|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380580|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
14380581|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
14380582|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380583|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380584|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14380585|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
14380586|NCT01246063|Hormones|hormones|mesh-ancestor
14380587|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380588|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14380589|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380590|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14380591|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14380592|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14380593|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380594|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380595|NCT01246076|Lenalidomide|lenalidomide|mesh-list
14380596|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
14380597|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380598|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380599|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380600|NCT01246076|Growth Substances|growth substances|mesh-ancestor
14380601|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380602|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380603|NCT01246206|Tacrolimus|tacrolimus|mesh-list
14380604|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
14380605|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380606|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
14380607|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380608|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14380609|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380610|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380611|NCT01246401|Naltrexone|naltrexone|mesh-list
14380612|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14380613|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14380614|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380615|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
14380616|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380617|NCT01246583|Tofacitinib|tofacitinib|mesh-list
14380618|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380619|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380620|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380621|NCT01246713|Acetaminophen|acetaminophen|mesh-list
14380622|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14380623|NCT01246713|Analgesics|analgesics|mesh-ancestor
14380624|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
14380625|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380626|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380627|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
14380628|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14380629|NCT01246791|Norethindrone|norethindrone|mesh-list
14380630|NCT01246791|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14380631|NCT01246791|Norinyl|norinyl|mesh-list
14380632|NCT01246791|Estradiol|estradiol|mesh-list
14380633|NCT01246791|Estrogens|estrogens|mesh-ancestor
14380634|NCT01246791|Hormones|hormones|mesh-ancestor
14380635|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380636|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380637|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14380638|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
14380639|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14380640|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14380641|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14380642|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14380643|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14466538|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
14380644|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14380645|NCT01246791|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14380646|NCT01246960|Leucovorin|leucovorin|mesh-list
14380647|NCT01246960|Fluorouracil|fluorouracil|mesh-list
14733834|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14733835|NCT00532532|Tolperisone|tolperisone|mesh-list
14733836|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14733837|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733838|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14733839|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733840|NCT00532545|Teriparatide|teriparatide|mesh-list
14733841|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14733842|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380648|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
14380649|NCT01246960|Ramucirumab|ramucirumab|mesh-list
14380650|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
14380651|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380652|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14380653|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380654|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380655|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
14380656|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380657|NCT01246960|Antidotes|antidotes|mesh-ancestor
14380658|NCT01246960|Protective Agents|protective agents|mesh-ancestor
14380659|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
14380660|NCT01246960|Vitamins|vitamins|mesh-ancestor
14380661|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
14380662|NCT01246973|Curcumin|curcumin|mesh-list
14380663|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14380664|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14380665|NCT01246973|Analgesics|analgesics|mesh-ancestor
14380666|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
14380667|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380668|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380669|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380670|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14380671|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380672|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380673|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380674|NCT01246986|Sorafenib|sorafenib|mesh-list
14380675|NCT01246986|Ramucirumab|ramucirumab|mesh-list
14380676|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380677|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380678|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380679|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380680|NCT01246999|Vaccines|vaccines|mesh-list
14380681|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
14380682|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380683|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14380684|NCT01247090|Vasopressins|vasopressins|mesh-list
14380685|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
14380686|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
14380687|NCT01247090|Coagulants|coagulants|mesh-ancestor
14733843|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14733844|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
14733845|NCT00532571|Vitamins|vitamins|mesh-ancestor
14380688|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14380689|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14733846|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
14733847|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733848|NCT00532584|Beclomethasone|beclomethasone|mesh-list
14733849|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733850|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
14733851|NCT00532584|Hormones|hormones|mesh-ancestor
14733852|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733853|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733854|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14733855|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
14380690|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
14733856|NCT00532623|Gemcitabine|gemcitabine|mesh-list
14733857|NCT00532623|Vinorelbine|vinorelbine|mesh-list
14921084|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380691|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380692|NCT01247220|Ranibizumab|ranibizumab|mesh-list
14380693|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380694|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380695|NCT01247220|Growth Substances|growth substances|mesh-ancestor
14380696|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380697|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380698|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380699|NCT01247272|Fluoxetine|fluoxetine|mesh-list
14380700|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14380701|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14380702|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380703|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380704|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380705|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
14380706|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380707|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14380708|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
14380709|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14380710|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14380711|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14380712|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380713|NCT01247285|Fluoxetine|fluoxetine|mesh-list
14380714|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14380715|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14380716|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380717|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380718|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380719|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
14380720|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380721|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14380722|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
14380723|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14380724|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14380725|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14380726|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380727|NCT01247363|Globalagliatin|globalagliatin|mesh-list
14380728|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
14380729|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380730|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14380731|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380732|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380733|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380734|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380735|NCT01248065|Vitamin D|vitamin d|mesh-list
14380736|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
14380737|NCT01248065|Ciclesonide|ciclesonide|mesh-list
14380738|NCT01248065|Vitamins|vitamins|mesh-ancestor
14380739|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
14380740|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380741|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14380742|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14380743|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
14380744|NCT01248065|Hormones|hormones|mesh-ancestor
14733858|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14380745|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380746|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14380747|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
14380748|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
14380749|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14380750|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14380751|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380752|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
14380753|NCT01248104|Coagulants|coagulants|mesh-ancestor
14380754|NCT01248364|Empagliflozin|empagliflozin|mesh-list
14380755|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14380756|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380757|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14380758|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380759|NCT01248416|Letrozole|letrozole|mesh-list
14380760|NCT01248416|Anastrozole|anastrozole|mesh-list
14380761|NCT01248416|Hormones|hormones|mesh-list
14380762|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14380763|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380764|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380765|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380766|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14380767|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380768|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380769|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14380770|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
14380771|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14380772|NCT01248468|Aspirin|aspirin|mesh-list
14380773|NCT01248468|Acetaminophen|acetaminophen|mesh-list
14380774|NCT01248468|Sumatriptan|sumatriptan|mesh-list
14380775|NCT01248468|Caffeine|caffeine|mesh-list
14380776|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14380777|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14380778|NCT01248468|Analgesics|analgesics|mesh-ancestor
14380779|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
14380780|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380781|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380782|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380783|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14380784|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14380785|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14380786|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380787|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14380788|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14380789|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380790|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
14380791|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14380792|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14380793|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14380794|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14380795|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
14380796|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380797|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14380798|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14733859|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
14733860|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733861|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733862|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
14733863|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733864|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733865|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733866|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
14733867|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733868|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733869|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
14380799|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14380800|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
14380801|NCT01248585|Dexamethasone|dexamethasone|mesh-list
14380802|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380803|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
14380804|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
14380805|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380806|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380807|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14380808|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
14380809|NCT01248585|Hormones|hormones|mesh-ancestor
14380810|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380811|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14380812|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380813|NCT01248715|Oseltamivir|oseltamivir|mesh-list
14380814|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
14380815|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14380816|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380817|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380818|NCT01248780|Golimumab|golimumab|mesh-list
14380819|NCT01248780|Methotrexate|methotrexate|mesh-list
14380820|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14380821|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
14380822|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14380823|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380824|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14380825|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
14380826|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380827|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380828|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
14380829|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380830|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14380831|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380832|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
14380833|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14380834|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14380835|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14380836|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380837|NCT01248793|Golimumab|golimumab|mesh-list
14380838|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14380839|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14380840|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14380841|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380842|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
14380843|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380844|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14380845|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
14380846|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380847|NCT01248949|Paclitaxel|paclitaxel|mesh-list
14380848|NCT01248949|Bevacizumab|bevacizumab|mesh-list
14380849|NCT01248949|Carboplatin|carboplatin|mesh-list
14380850|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14380851|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380852|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
14380853|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
14380854|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
14380855|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380856|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733870|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
14733871|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
14380857|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380858|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380859|NCT01248949|Growth Substances|growth substances|mesh-ancestor
14380860|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380861|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380862|NCT01248962|Carboplatin|carboplatin|mesh-list
14380863|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380864|NCT01249027|Everolimus|everolimus|mesh-list
14380865|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380866|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14380867|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
14380868|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380869|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
14380870|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14380871|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921085|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921086|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921087|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14921088|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14921089|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380872|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380873|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14380874|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14380875|NCT01249092|Protective Agents|protective agents|mesh-ancestor
14380876|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380877|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
14380878|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14380879|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
14380880|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
14380881|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
14380882|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14380883|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380884|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380885|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14380886|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380887|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14380888|NCT01249274|Progesterone|progesterone|mesh-list
14380889|NCT01249274|Progestins|progestins|mesh-ancestor
14380890|NCT01249274|Hormones|hormones|mesh-ancestor
14380891|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380892|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380893|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
14921090|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14921091|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14921092|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921093|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
14921094|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
14380894|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14921095|NCT04238845|Vitamin A|vitamin a|mesh-list
14380895|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14921096|NCT04238845|Vitamins|vitamins|mesh-ancestor
14380896|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14380897|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380898|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380899|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14380900|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380901|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380902|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14380903|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380904|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
14380905|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14380906|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14380907|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14380908|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380909|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380910|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
14380911|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14380912|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380913|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14380914|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380915|NCT01249651|Esomeprazole|esomeprazole|mesh-list
14380916|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14380917|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14380918|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14380919|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380920|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380921|NCT01249664|Aflibercept|aflibercept|mesh-list
14380922|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380923|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14380924|NCT01249664|Growth Substances|growth substances|mesh-ancestor
14380925|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380926|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
14380927|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380928|NCT01249833|Oseltamivir|oseltamivir|mesh-list
14380929|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
14380930|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14380931|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380932|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380933|NCT01249872|Morphine|morphine|mesh-list
14380934|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
14380935|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14380936|NCT01249872|Narcotics|narcotics|mesh-ancestor
14380937|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380938|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380939|NCT01249872|Analgesics|analgesics|mesh-ancestor
14380940|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
14380941|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380942|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
14380943|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
14380944|NCT01250002|Lidocaine|lidocaine|mesh-list
14380945|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
14380946|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
14380947|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380948|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380949|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
14380950|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380951|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14380952|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14380953|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14380954|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14733872|NCT00532662|Ketamine|ketamine|mesh-list
14733873|NCT00532662|Analgesics|analgesics|mesh-ancestor
14380955|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466539|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466540|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466541|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466542|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14466543|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
14466544|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466545|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466546|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14466547|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14466548|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14466549|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
14466550|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14466551|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466552|NCT02243943|Neostigmine|neostigmine|mesh-list
14466553|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14466554|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466555|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466556|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
14466557|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466558|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466559|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14466560|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
14466561|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466562|NCT02244619|Acetaminophen|acetaminophen|mesh-list
14466563|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466564|NCT02244619|Analgesics|analgesics|mesh-ancestor
14466565|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
14466566|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466567|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466568|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
14466569|NCT02244918|Nicotine|nicotine|mesh-list
14466570|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14466571|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
14466572|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466573|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466574|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14466575|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14466576|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
14466577|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466578|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466579|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15235297|NCT03477162|Metformin|metformin|mesh-list
15235298|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15235299|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235300|NCT03461952|Nivolumab|nivolumab|mesh-list
15235301|NCT03461952|Ipilimumab|ipilimumab|mesh-list
15235302|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235303|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235304|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15235305|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235306|NCT03420508|Ensartinib|ensartinib|mesh-list
15235307|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235308|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235309|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235310|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235311|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15235312|NCT03390296|Avelumab|avelumab|mesh-list
15235313|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
14380956|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14380957|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380958|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14380959|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14380960|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380961|NCT01250145|Teriparatide|teriparatide|mesh-list
14380962|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14380963|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380964|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14380965|NCT01250184|Lidocaine|lidocaine|mesh-list
14380966|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
14380967|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
14380968|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14380969|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380970|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
14380971|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14380972|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14380973|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14380974|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14380975|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14380976|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14380977|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
14380978|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14380979|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14380980|NCT01250210|Estradiol|estradiol|mesh-list
14380981|NCT01250210|Estrogens|estrogens|mesh-ancestor
14380982|NCT01250210|Hormones|hormones|mesh-ancestor
14380983|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14380984|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14380985|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14733874|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
14733875|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733876|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733877|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14733878|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14733879|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
14380986|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
14380987|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14466580|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14733880|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
15235314|NCT03390296|Azacitidine|azacitidine|mesh-list
15235315|NCT03390296|Venetoclax|venetoclax|mesh-list
15235316|NCT03390296|Calicheamicins|calicheamicins|mesh-list
15235317|NCT03390296|Antibodies|antibodies|mesh-list
14380988|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14380989|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14380990|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14380991|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14380992|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14380993|NCT01250379|Bevacizumab|bevacizumab|mesh-list
14380994|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14380995|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14380996|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14380997|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15235318|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
15235319|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15235320|NCT03390296|Maleic acid|maleic acid|mesh-list
15235321|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
14380998|NCT01250379|Growth Substances|growth substances|mesh-ancestor
14380999|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381000|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
14381001|NCT01250418|Ketamine|ketamine|mesh-list
14381002|NCT01250418|Analgesics|analgesics|mesh-ancestor
14381003|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
14381004|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381005|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235322|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235323|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235324|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235325|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
15235326|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235327|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235328|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15235329|NCT03340727|Caffeine|caffeine|mesh-list
15235330|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
15235331|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235332|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15235333|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235334|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15235335|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235336|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15235337|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15235338|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
15235339|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235340|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15235341|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15235342|NCT03269344|Gabapentin|gabapentin|mesh-list
15235343|NCT03269344|Analgesics|analgesics|mesh-ancestor
15235344|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
15235345|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235346|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235347|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
15235348|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15235349|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15235350|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381006|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15235351|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235352|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14381007|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14381008|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
14381009|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
14381010|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381011|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14381012|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14381013|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733881|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921097|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
14921098|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921099|NCT04236609|Sirolimus|sirolimus|mesh-list
14921100|NCT04236609|Everolimus|everolimus|mesh-list
14921101|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921102|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921103|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
14921104|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235353|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15235354|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235355|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235356|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
15235357|NCT03215095|Durvalumab|durvalumab|mesh-list
15235358|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235359|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235360|NCT03201458|Atezolizumab|atezolizumab|mesh-list
15235361|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15235362|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235363|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
15235364|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235365|NCT03151746|Gabapentin|gabapentin|mesh-list
15235366|NCT03151746|Analgesics|analgesics|mesh-ancestor
15235367|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
15235368|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235369|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235370|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
15235371|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15235372|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15235373|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235374|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235375|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15235376|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14733882|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15235377|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235378|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235379|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
15235380|NCT03071406|Nivolumab|nivolumab|mesh-list
14733883|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14733884|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14733885|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733886|NCT00532675|Lenalidomide|lenalidomide|mesh-list
14733887|NCT00532675|Panobinostat|panobinostat|mesh-list
14733888|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
14733889|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733890|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14733891|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14733892|NCT00532675|Growth Substances|growth substances|mesh-ancestor
14733893|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733894|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733895|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14733896|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733897|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733898|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
14733899|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14733900|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
14733901|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733902|NCT00532688|Expectorants|expectorants|mesh-ancestor
14733903|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
14733904|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14733905|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
14733906|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733907|NCT00532688|Protective Agents|protective agents|mesh-ancestor
14733908|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921105|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14921106|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921107|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14921108|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
14381014|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381015|NCT01250717|Dexamethasone|dexamethasone|mesh-list
14381016|NCT01250717|Goserelin|goserelin|mesh-list
14381017|NCT01250717|Estramustine|estramustine|mesh-list
14381018|NCT01250717|Docetaxel|docetaxel|mesh-list
14921109|NCT04223037|Vaccines|vaccines|mesh-list
14921110|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
14921111|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921112|NCT04212013|Rituximab|rituximab|mesh-list
14921113|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921114|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921115|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
14921116|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921117|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921118|NCT04209855|Paclitaxel|paclitaxel|mesh-list
14921119|NCT04209855|Maytansine|maytansine|mesh-list
14921120|NCT04209855|Doxorubicin|doxorubicin|mesh-list
14381019|NCT01250717|Bicalutamide|bicalutamide|mesh-list
14381020|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14381021|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
14381022|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
14381023|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381024|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381025|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14381026|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
14381027|NCT01250717|Hormones|hormones|mesh-ancestor
14381028|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381029|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14381030|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381031|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14733909|NCT00532688|Antidotes|antidotes|mesh-ancestor
14733910|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14733911|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
14733912|NCT00532701|Ribavirin|ribavirin|mesh-list
14733913|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
15235381|NCT03071406|Ipilimumab|ipilimumab|mesh-list
15235382|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235383|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733914|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733915|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
14733916|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733917|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
14921121|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14921122|NCT04209855|Topotecan|topotecan|mesh-list
14921123|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921124|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235384|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15235385|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921125|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
14381032|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921126|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
14381033|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14381034|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381035|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
14381036|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
14381037|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14381038|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
14381039|NCT01250730|Crizotinib|crizotinib|mesh-list
14381040|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381041|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14381042|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381043|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381044|NCT01250756|Vaccines|vaccines|mesh-list
14381045|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14381046|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
14381047|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381048|NCT01250834|Dulaglutide|dulaglutide|mesh-list
14381049|NCT01250834|Atorvastatin|atorvastatin|mesh-list
14381050|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14381051|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14381052|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
14381053|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381054|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14381055|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14381056|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381057|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14381058|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381059|NCT01250873|Sertraline|sertraline|mesh-list
14381060|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
14381061|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381062|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14381063|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14381064|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381065|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381066|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381067|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
14381068|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381069|NCT01250899|Vitamin D|vitamin d|mesh-list
14381070|NCT01250899|Vitamins|vitamins|mesh-ancestor
14381071|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
14381072|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381073|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14381074|NCT01250977|Donepezil|donepezil|mesh-list
14381075|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14381076|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381077|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381078|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
14381079|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381080|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381081|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
14381082|NCT01250990|Niacin|niacin|mesh-list
14381083|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14381084|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
14381085|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381086|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14381087|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
14381088|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
14381089|NCT01250990|Vitamins|vitamins|mesh-ancestor
14381090|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
14381091|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381092|NCT01251146|Atenolol|atenolol|mesh-list
14381093|NCT01251146|Bisoprolol|bisoprolol|mesh-list
14381094|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14381095|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381096|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
14381097|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
14381098|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381099|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381100|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14381101|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14381102|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14381103|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
14381104|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381105|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381106|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
14381107|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14381108|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
14381109|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381110|NCT01251315|Expectorants|expectorants|mesh-ancestor
14381111|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
14381112|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14381113|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
14381114|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381115|NCT01251315|Protective Agents|protective agents|mesh-ancestor
14381116|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381117|NCT01251315|Antidotes|antidotes|mesh-ancestor
14381118|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
14381119|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14381120|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14381121|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14381122|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381123|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381124|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
14381125|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381126|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381127|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14381128|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381129|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
14381130|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14381131|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14381132|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14381133|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381134|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381135|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
14381136|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381137|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381138|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14381139|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381140|NCT01251393|Biperiden|biperiden|mesh-list
14381141|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14381142|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14381143|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
14381144|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
14381145|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381146|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381147|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14381148|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14381149|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
14381150|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381151|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381152|NCT01251536|Cetuximab|cetuximab|mesh-list
14381153|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14381154|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381155|NCT01251575|Cyclosporine|cyclosporine|mesh-list
14381156|NCT01251575|Sirolimus|sirolimus|mesh-list
14381157|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
14381158|NCT01251575|Fludarabine|fludarabine|mesh-list
14381159|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
14381160|NCT01251575|Cyclosporins|cyclosporins|mesh-list
14381161|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381162|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14381163|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
14381164|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381165|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381166|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
14381167|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381168|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381169|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
14381170|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381171|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
14381172|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381173|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14381174|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14381175|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14381176|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
14381177|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14381178|NCT01251614|Adalimumab|adalimumab|mesh-list
14381179|NCT01251614|Methotrexate|methotrexate|mesh-list
14381180|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14381181|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
14381182|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381183|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381184|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14381185|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
14381186|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381187|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381188|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
14381189|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381190|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14381191|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381192|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
14381193|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381194|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14381195|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14381196|NCT01251653|Gemcitabine|gemcitabine|mesh-list
14381197|NCT01251653|Docetaxel|docetaxel|mesh-list
14381198|NCT01251653|Afatinib|afatinib|mesh-list
14381199|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14381200|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
14381201|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381202|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381203|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
14381204|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381205|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381206|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381207|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
14381208|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381209|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
14381210|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
14381211|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
14381212|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14381213|NCT01251978|Ranibizumab|ranibizumab|mesh-list
14381214|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14381215|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14381216|NCT01251978|Growth Substances|growth substances|mesh-ancestor
14381217|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381218|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14381219|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381220|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14381221|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
14381222|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
14381223|NCT01252186|Desogestrel|desogestrel|mesh-list
14381224|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
14381225|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381226|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381227|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14381228|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14381229|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14381230|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14381231|NCT01252186|Progestins|progestins|mesh-ancestor
14381232|NCT01252186|Hormones|hormones|mesh-ancestor
14381233|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381234|NCT01252238|Amlodipine|amlodipine|mesh-list
14381235|NCT01252238|Valsartan|valsartan|mesh-list
14381236|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381237|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14381238|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381239|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381240|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14381241|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381242|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
14381243|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14381244|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14381245|NCT01252251|Everolimus|everolimus|mesh-list
14381246|NCT01252251|Pasireotide|pasireotide|mesh-list
14381247|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381248|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381249|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
14381250|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381251|NCT01252251|Hormones|hormones|mesh-ancestor
14381252|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381253|NCT01252355|Interferons|interferons|mesh-list
14381254|NCT01252355|Interferon-beta|interferon-beta|mesh-list
14381255|NCT01252355|Teriflunomide|teriflunomide|mesh-list
14381256|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381257|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
14381258|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381259|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
14381260|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381261|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14381262|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381263|NCT01252355|Analgesics|analgesics|mesh-ancestor
14381264|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
14381265|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381266|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14381267|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381268|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381269|NCT01252563|Amlodipine|amlodipine|mesh-list
14381270|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381271|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14381272|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381273|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381274|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14381275|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381276|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
14381277|NCT01252667|Cyclosporine|cyclosporine|mesh-list
14381278|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
14381279|NCT01252667|Clofarabine|clofarabine|mesh-list
14381280|NCT01252667|Cyclosporins|cyclosporins|mesh-list
14381281|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381282|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381283|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381284|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
14381285|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381286|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
14381287|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381288|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
14381289|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381290|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14381291|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14381292|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381293|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14381294|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
14381295|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14381296|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14381297|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
14381298|NCT01252732|Vancomycin|vancomycin|mesh-list
14381299|NCT01252732|Oritavancin|oritavancin|mesh-list
14381300|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14381301|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381302|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
14381303|NCT01252745|Testosterone|testosterone|mesh-list
14381304|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
14381305|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
14381306|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14381307|NCT01252745|Androgens|androgens|mesh-ancestor
14381308|NCT01252745|Hormones|hormones|mesh-ancestor
14381309|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381310|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381311|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14381312|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381313|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
14381314|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
14381315|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
14381316|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381317|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14381318|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14381319|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381320|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381321|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14381322|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14381323|NCT01253135|Petrolatum|petrolatum|mesh-list
14381324|NCT01253135|Emollients|emollients|mesh-ancestor
14381325|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
14381326|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
14381327|NCT01253174|Drospirenone|drospirenone|mesh-list
14381328|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14381329|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
14381330|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381331|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381332|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14381333|NCT01253174|Diuretics|diuretics|mesh-ancestor
14381334|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
14381335|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
14381336|NCT01253174|Vitamins|vitamins|mesh-ancestor
15235386|NCT03028857|Choline|choline|mesh-list
15235387|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
15235388|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15235389|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
15235390|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235391|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15235392|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15235393|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
15235394|NCT02971501|Bevacizumab|bevacizumab|mesh-list
15235395|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15235396|NCT02971501|Osimertinib|osimertinib|mesh-list
15235397|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
15235398|NCT02971501|Antibodies|antibodies|mesh-list
15235399|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
15235400|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15235401|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
15235402|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381337|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
14381338|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
14381339|NCT01253187|Drospirenone|drospirenone|mesh-list
15235403|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15235404|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14381340|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14381341|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
14381342|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381343|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381344|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14381345|NCT01253187|Diuretics|diuretics|mesh-ancestor
14381346|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
14381347|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
14381348|NCT01253187|Vitamins|vitamins|mesh-ancestor
14381349|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
14381350|NCT01253200|Acifluorfen|acifluorfen|mesh-list
14381351|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381352|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381353|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14381354|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
14381355|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381356|NCT01253265|Ixekizumab|ixekizumab|mesh-list
14381357|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
14381358|NCT01253304|Dulaglutide|dulaglutide|mesh-list
14381359|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14381360|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381361|NCT01253317|Mecasermin|mecasermin|mesh-list
14381362|NCT01253317|Growth Substances|growth substances|mesh-ancestor
14381363|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381364|NCT01253408|Dronabinol|dronabinol|mesh-list
14381365|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
14381366|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381367|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381368|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381369|NCT01253408|Analgesics|analgesics|mesh-ancestor
14381370|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
14381371|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753097|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
15235405|NCT02971501|Growth Substances|growth substances|mesh-ancestor
14381372|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14381373|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14381374|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381375|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381376|NCT01253408|Hormones|hormones|mesh-ancestor
14381377|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381378|NCT01253421|Amisulpride|amisulpride|mesh-list
14381379|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14381380|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14381381|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381382|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381383|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381384|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14381385|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
14381386|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381387|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381388|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14381389|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
14381390|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
14381391|NCT01253460|Rituximab|rituximab|mesh-list
14381392|NCT01253460|Sapacitabine|sapacitabine|mesh-list
14381393|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381394|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
14381395|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381396|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381397|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14381398|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
14381399|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381400|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381401|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14381402|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14381403|NCT01253525|Paclitaxel|paclitaxel|mesh-list
14381404|NCT01253525|Ramucirumab|ramucirumab|mesh-list
14381405|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14381406|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381407|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
14381408|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
14381409|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
14381410|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381411|NCT01253642|Docetaxel|docetaxel|mesh-list
14381412|NCT01253642|Phenelzine|phenelzine|mesh-list
14381413|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381414|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
14381415|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
14381416|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
14381417|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381418|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
14381419|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381420|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14381421|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381422|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14381423|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14381424|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14381425|NCT01253824|Norethindrone|norethindrone|mesh-list
14381426|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
14381427|NCT01253824|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14381428|NCT01253824|Norinyl|norinyl|mesh-list
14381429|NCT01253824|Mestranol|mestranol|mesh-list
14381430|NCT01253824|Estradiol|estradiol|mesh-list
14381431|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14381432|NCT01253824|Estrogens|estrogens|mesh-ancestor
14381433|NCT01253824|Hormones|hormones|mesh-ancestor
14381434|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381435|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381436|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14381437|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
14381438|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381439|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14381440|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14381441|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14381442|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14381443|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14381444|NCT01253824|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14381445|NCT01253902|Bimatoprost|bimatoprost|mesh-list
14381446|NCT01253902|Travoprost|travoprost|mesh-list
14381447|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14381448|NCT01253902|Latanoprost|latanoprost|mesh-list
14381449|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14381450|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381451|NCT01253980|Amoxicillin|amoxicillin|mesh-list
14381452|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14381453|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381454|NCT01254045|Oxytocin|oxytocin|mesh-list
14381455|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
14381456|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381457|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381458|NCT01254227|Deferasirox|deferasirox|mesh-list
14381459|NCT01254227|Deferoxamine|deferoxamine|mesh-list
14381460|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14381461|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
14733918|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733919|NCT00532714|Capecitabine|capecitabine|mesh-list
14733920|NCT00532714|Irinotecan|irinotecan|mesh-list
14733921|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733922|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
14733923|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733924|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733925|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14733926|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14733927|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381462|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
14381463|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381464|NCT01254227|Siderophores|siderophores|mesh-ancestor
14381465|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
14381466|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14381467|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
14381468|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381469|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381470|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14381471|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14381472|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14381473|NCT01254305|Milnacipran|milnacipran|mesh-list
14381474|NCT01254305|Sertraline|sertraline|mesh-list
14733928|NCT00532727|Carboplatin|carboplatin|mesh-list
14381475|NCT01254305|Fluoxetine|fluoxetine|mesh-list
14381476|NCT01254305|Paroxetine|paroxetine|mesh-list
14381477|NCT01254305|Citalopram|citalopram|mesh-list
14381478|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
14733929|NCT00532727|Docetaxel|docetaxel|mesh-list
14381479|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
14381480|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381481|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14381482|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14381483|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381484|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381485|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381486|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
14381487|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381488|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14381489|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14381490|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14381491|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381492|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381493|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14381494|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381495|NCT01254305|Analgesics|analgesics|mesh-ancestor
14381496|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
14381497|NCT01254344|Metronidazole|metronidazole|mesh-list
14381498|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
14381499|NCT01254344|Ertapenem|ertapenem|mesh-list
14381500|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381501|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14381502|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14381503|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14381504|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
14381505|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
14381506|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14381507|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14381508|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381509|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381510|NCT01254396|Urological Agents|urological agents|mesh-ancestor
14381511|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14381512|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
14381513|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
14381514|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381515|NCT01254604|Timolol|timolol|mesh-list
14381516|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14381517|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14381518|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
14381519|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381520|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381521|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381522|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14381523|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381524|NCT01254630|Vaccines|vaccines|mesh-list
14381525|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
14381526|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381527|NCT01254656|Efavirenz|efavirenz|mesh-list
14381528|NCT01254656|Etravirine|etravirine|mesh-list
14381529|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14381530|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14381531|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733930|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733931|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
14381532|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381533|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
14381534|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733932|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
14381535|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14381536|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14381537|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14381538|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14381539|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14381540|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14381541|NCT01254669|Vaccines|vaccines|mesh-list
14381542|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
14381543|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381544|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14381545|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
14381546|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381547|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14381548|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14381549|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381550|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466581|NCT02246218|Glycerol|glycerol|mesh-list
14466582|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14466583|NCT02246218|Protective Agents|protective agents|mesh-ancestor
14466584|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466585|NCT02246582|Insulin|insulin|mesh-list
14466586|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14466587|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466588|NCT02246647|Mannitol|mannitol|mesh-list
14466589|NCT02246647|Lactulose|lactulose|mesh-list
14466590|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14466591|NCT02246647|Diuretics|diuretics|mesh-ancestor
14466592|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
14466593|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466594|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14466595|NCT02246660|Resveratrol|resveratrol|mesh-list
14466596|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
14466597|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466598|NCT02246660|Protective Agents|protective agents|mesh-ancestor
14466599|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466600|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466601|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14466602|NCT02246673|Febuxostat|febuxostat|mesh-list
14466603|NCT02246673|Verinurad|verinurad|mesh-list
14466604|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
14466605|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466606|NCT02246764|Timolol|timolol|mesh-list
14466607|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14466608|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14466609|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14466610|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14466611|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
14733933|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
14733934|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733935|NCT00532818|Hydralazine|hydralazine|mesh-list
14733936|NCT00532818|Valproic Acid|valproic acid|mesh-list
14733937|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
14733938|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733939|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733940|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
14733941|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921127|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
14466612|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466613|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466614|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466615|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14466616|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466617|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14466618|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
15235406|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466619|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466620|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14466621|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15235407|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
15235408|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
15235409|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235410|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235411|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235412|NCT02970448|Temozolomide|temozolomide|mesh-list
14381551|NCT01254877|Ondansetron|ondansetron|mesh-list
14381552|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
14381553|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
14381554|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381555|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381556|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14381557|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
14381558|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
14381559|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14381560|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
14381561|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381562|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381563|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14381564|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14381565|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381566|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381567|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14381568|NCT01254890|Azacitidine|azacitidine|mesh-list
14381569|NCT01254890|Sorafenib|sorafenib|mesh-list
14381570|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14381571|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
14381572|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381573|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381574|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381575|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14381576|NCT01255137|Axitinib|axitinib|mesh-list
14381577|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381578|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14381579|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381580|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381581|NCT01255163|Exenatide|exenatide|mesh-list
14381582|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14381583|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381584|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14381585|NCT01255163|Incretins|incretins|mesh-ancestor
14381586|NCT01255163|Hormones|hormones|mesh-ancestor
14381587|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381588|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14381589|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381590|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14381591|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14381592|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14381593|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14381594|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381595|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381596|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381597|NCT01255423|Diclofenac|diclofenac|mesh-list
14381598|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14381599|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381600|NCT01255423|Analgesics|analgesics|mesh-ancestor
14381601|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
14381602|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381603|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381604|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14381605|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381606|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14381607|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381608|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381609|NCT01255449|Albuterol|albuterol|mesh-list
14381610|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14381611|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
14381612|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381613|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381614|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14381615|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
14381616|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
14381617|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381618|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14381619|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14381620|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14381621|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
14381622|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381623|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381624|NCT01255670|Metronidazole|metronidazole|mesh-list
14381625|NCT01255670|Penicillins|penicillins|mesh-list
14381626|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381627|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14381628|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14381629|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14381630|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
14381631|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381632|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
14381633|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381634|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381635|NCT01255787|Vortioxetine|vortioxetine|mesh-list
14381636|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
14381637|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381638|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14381639|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14381640|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381641|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381642|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14381643|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14381644|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381645|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381646|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381647|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
14381648|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14381649|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14381650|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14381651|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14381652|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
14381653|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
14381654|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14381655|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381656|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381657|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381658|NCT01255904|Analgesics|analgesics|mesh-ancestor
14381659|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
14381660|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381661|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14381662|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14381663|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14381664|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
14381665|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381666|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381667|NCT01256060|Oxytocin|oxytocin|mesh-list
14381668|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
14381669|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381670|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381671|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14381672|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14381673|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
14381674|NCT01256164|Coagulants|coagulants|mesh-ancestor
14381675|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14381676|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
14381677|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381678|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14381679|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14381680|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381681|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381682|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14381683|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
14381684|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
14381685|NCT01256190|Coagulants|coagulants|mesh-ancestor
14381686|NCT01256294|Tacrolimus|tacrolimus|mesh-list
14381687|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381688|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
15235413|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15235414|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
15235415|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381689|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381690|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14381691|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381692|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381693|NCT01256385|Sirolimus|sirolimus|mesh-list
14381694|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14381695|NCT01256385|Cetuximab|cetuximab|mesh-list
14381696|NCT01256385|Antibodies|antibodies|mesh-list
14381697|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
14381698|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14381699|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
14381700|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381701|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381702|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14381703|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381704|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14381705|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
14381706|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381707|NCT01256411|Amlodipine|amlodipine|mesh-list
14381708|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14381709|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14381710|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381711|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14381712|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381713|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381714|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14381715|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381716|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
14381717|NCT01256411|Diuretics|diuretics|mesh-ancestor
14381718|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
14381719|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14381720|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14381721|NCT01256450|Buprenorphine|buprenorphine|mesh-list
14381722|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14381723|NCT01256450|Narcotics|narcotics|mesh-ancestor
14381724|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381725|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381726|NCT01256450|Analgesics|analgesics|mesh-ancestor
14381727|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
14381728|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381729|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14381730|NCT01256476|Pravastatin|pravastatin|mesh-list
14381731|NCT01256476|Pitavastatin|pitavastatin|mesh-list
14381732|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14381733|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14381734|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
14381735|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381736|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14381737|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14381738|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381739|NCT01256567|Docetaxel|docetaxel|mesh-list
14381740|NCT01256567|Ramucirumab|ramucirumab|mesh-list
14381741|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381742|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
14381743|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
14381744|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
14381745|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381746|NCT01256593|Pregabalin|pregabalin|mesh-list
14381747|NCT01256593|Analgesics|analgesics|mesh-ancestor
14381748|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
14921128|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921129|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14921130|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14921131|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14921132|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235416|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381749|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381750|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381751|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
14381752|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14381753|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14381754|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381755|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14381756|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15235417|NCT02966093|Lenvatinib|lenvatinib|mesh-list
14381757|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14381758|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14381759|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14381760|NCT01256658|Lumefantrine|lumefantrine|mesh-list
14381761|NCT01256658|Artemether|artemether|mesh-list
14381762|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14381763|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
14381764|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14381765|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14381766|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381767|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14381768|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14381769|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
14381770|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381771|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14381772|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14381773|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
14381774|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381775|NCT01256879|Cimetidine|cimetidine|mesh-list
14381776|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14381777|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14381778|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14381779|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
14381780|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
14381781|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381782|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381783|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381784|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14381785|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14381786|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381787|NCT01257087|Insulin|insulin|mesh-list
14381788|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14381789|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
14381790|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14381791|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381792|NCT01257204|Interferons|interferons|mesh-list
14381793|NCT01257204|Ribavirin|ribavirin|mesh-list
14381794|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
14381795|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
14381796|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14381797|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381798|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
14381799|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381800|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
14381801|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381802|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
14381803|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381804|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
14381805|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14381806|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
14381807|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381808|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381809|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14381810|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
14381811|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
14381812|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14381813|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
14381814|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381815|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381816|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14381817|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
14381818|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14381819|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
14381820|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381821|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381822|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14381823|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14381824|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381825|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
14381826|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
14381827|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
14381828|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14381829|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14381830|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381831|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381832|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381833|NCT01257581|Tamoxifen|tamoxifen|mesh-list
14381834|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14381835|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
14381836|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381837|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381838|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14381839|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381840|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14381841|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14381842|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14381843|NCT01257698|Timolol|timolol|mesh-list
14381844|NCT01257698|Dorzolamide|dorzolamide|mesh-list
14381845|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14381846|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14381847|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14381848|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14381849|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14381850|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381851|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381852|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14733942|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381853|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14381854|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14381855|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381856|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14381857|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14381858|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381859|NCT01257802|Leuprolide|leuprolide|mesh-list
14381860|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14381861|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
14381862|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14381863|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381864|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14381865|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381866|NCT01258049|Artemether|artemether|mesh-list
14381867|NCT01258049|Quinine|quinine|mesh-list
14381868|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
14381869|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14381870|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14381871|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381872|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14381873|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381874|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14381875|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381876|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381877|NCT01258049|Analgesics|analgesics|mesh-ancestor
14381878|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
14381879|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14381880|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14381881|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14381882|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
14381883|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381884|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14381885|NCT01258101|Ribavirin|ribavirin|mesh-list
14381886|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14381887|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
14381888|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
14381889|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381890|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
14381891|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381892|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
14381893|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381894|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14381895|NCT01258153|MEN 11420|men 11420|mesh-list
14381896|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14381897|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
14381898|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381899|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381900|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14381901|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
14381902|NCT01258348|Sunitinib|sunitinib|mesh-list
14381903|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381904|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14381905|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14381906|NCT01258348|Growth Substances|growth substances|mesh-ancestor
14381907|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381908|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
14381909|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14381910|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381911|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381912|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
14381913|NCT01258374|Darunavir|darunavir|mesh-list
14381914|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14381915|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14381916|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
14381917|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381918|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14381919|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14381920|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381921|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381922|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14381923|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14381924|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
14381925|NCT01258387|Mitogens|mitogens|mesh-list
14381926|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14381927|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235418|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235419|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235420|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235421|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235422|NCT02953093|Acarbose|acarbose|mesh-list
15235423|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15235424|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235425|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235426|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15235427|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235428|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
15235429|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235430|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235431|NCT02921997|Vaccines|vaccines|mesh-list
15235432|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
15235433|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235434|NCT02879162|Durvalumab|durvalumab|mesh-list
15235435|NCT02879162|Tremelimumab|tremelimumab|mesh-list
15235436|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235437|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235438|NCT02822092|Risperidone|risperidone|mesh-list
14381928|NCT01258595|Vaccines|vaccines|mesh-list
14381929|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
14381930|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381931|NCT01258608|Sorafenib|sorafenib|mesh-list
14381932|NCT01258608|Mapatumumab|mapatumumab|mesh-list
14381933|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381934|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14381935|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381936|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381937|NCT01258660|Folic Acid|folic acid|mesh-list
14381938|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
14381939|NCT01258660|Drospirenone|drospirenone|mesh-list
15235439|NCT02822092|Aripiprazole|aripiprazole|mesh-list
15235440|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15235441|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
15235442|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235443|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235444|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381940|NCT01258660|Hematinics|hematinics|mesh-ancestor
14381941|NCT01258660|Vitamins|vitamins|mesh-ancestor
14381942|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
14381943|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381944|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14381945|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
14381946|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14381947|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14381948|NCT01258660|Diuretics|diuretics|mesh-ancestor
14381949|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
14381950|NCT01258738|Etanercept|etanercept|mesh-list
14381951|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14381952|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381953|NCT01258738|Analgesics|analgesics|mesh-ancestor
14381954|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
14381955|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381956|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381957|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14381958|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14381959|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14381960|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381961|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
14381962|NCT01258855|Aldesleukin|aldesleukin|mesh-list
14381963|NCT01258855|Aflibercept|aflibercept|mesh-list
14381964|NCT01258855|Interleukin-2|interleukin-2|mesh-list
14381965|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
14381966|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14381967|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14381968|NCT01258855|Growth Substances|growth substances|mesh-ancestor
14381969|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381970|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
14381971|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381972|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14381973|NCT01258855|Analgesics|analgesics|mesh-ancestor
14381974|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
14381975|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14381976|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14381977|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14381978|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
14381979|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381980|NCT01259063|Gemcitabine|gemcitabine|mesh-list
14381981|NCT01259063|Everolimus|everolimus|mesh-list
14381982|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14381983|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
14381984|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381985|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381986|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
14381987|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14381988|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381989|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14381990|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
14381991|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14381992|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14381993|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14381994|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921133|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14381995|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14381996|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14381997|NCT01259102|Buprenorphine|buprenorphine|mesh-list
14921134|NCT04195776|Tenofovir|tenofovir|mesh-list
14381998|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14381999|NCT01259102|Narcotics|narcotics|mesh-ancestor
14382000|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382001|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382002|NCT01259102|Analgesics|analgesics|mesh-ancestor
14382003|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
14382004|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382005|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14382006|NCT01259115|Ketoconazole|ketoconazole|mesh-list
14382007|NCT01259115|Buprenorphine|buprenorphine|mesh-list
14382008|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14382009|NCT01259115|Narcotics|narcotics|mesh-ancestor
14382010|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382011|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382012|NCT01259115|Analgesics|analgesics|mesh-ancestor
14382013|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
14382014|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382015|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14382016|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
14382017|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382018|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14382019|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14382020|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382021|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382022|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14382023|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
14382024|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382025|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14382026|NCT01259297|Amlodipine|amlodipine|mesh-list
14382027|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14382028|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14382029|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14382030|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382031|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382032|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14382033|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382034|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
14382035|NCT01259297|Diuretics|diuretics|mesh-ancestor
14382036|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
14382037|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14382038|NCT01259375|Amrubicin|amrubicin|mesh-list
14382039|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382040|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
14382041|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
14382042|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382043|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382044|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382045|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
14382046|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14382047|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382048|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382049|NCT01259466|Nicotine|nicotine|mesh-list
14382050|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14382051|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
14382052|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382053|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382054|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14382055|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14382056|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
14382057|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382058|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382059|NCT01259492|Methylphenidate|methylphenidate|mesh-list
14382060|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14382061|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382062|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14382063|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14382064|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382065|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382066|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
14382067|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382068|NCT01259713|Amphotericin B|amphotericin b|mesh-list
14382069|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14382070|NCT01259713|Amebicides|amebicides|mesh-ancestor
14382071|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14382072|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14382073|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382074|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14382075|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
14382076|NCT01259856|Aspirin|aspirin|mesh-list
14382077|NCT01259856|Interferons|interferons|mesh-list
14382078|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
14382079|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
14382080|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14382081|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
14382082|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382083|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
14382084|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382085|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14382086|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14382087|NCT01259856|Analgesics|analgesics|mesh-ancestor
15235445|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14382088|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
14382089|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382090|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382091|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382092|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382093|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14382094|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14382095|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382096|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14382097|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14382098|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382099|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
14382100|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
14382101|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
14382102|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14382103|NCT01260142|Propofol|propofol|mesh-list
14382104|NCT01260142|Fospropofol|fospropofol|mesh-list
14382105|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14382106|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382107|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382108|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14382109|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
14382110|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
14382111|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14382112|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382113|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14382114|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382115|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382116|NCT01260194|Trastuzumab|trastuzumab|mesh-list
14382117|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14382118|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382119|NCT01260311|Fesoterodine|fesoterodine|mesh-list
14382120|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14382121|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14382122|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14382123|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382124|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382125|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382126|NCT01260311|Urological Agents|urological agents|mesh-ancestor
14382127|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
14382128|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
14382129|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466622|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
14382130|NCT01260454|Capsaicin|capsaicin|mesh-list
14382131|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
14382132|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
14382133|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
14382134|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382135|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382136|NCT01260467|Memantine|memantine|mesh-list
14382137|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14382138|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14382139|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
14382140|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382141|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382142|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382143|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14382144|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14382145|NCT01260584|Clopidogrel|clopidogrel|mesh-list
14382146|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14382147|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14382148|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14382149|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14382150|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14382151|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
14921135|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
14921136|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921137|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14921138|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14921139|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921140|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921141|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14921142|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14382152|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382153|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382154|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382155|NCT01260649|Ketamine|ketamine|mesh-list
14382156|NCT01260649|Anesthetics|anesthetics|mesh-list
14382157|NCT01260649|Analgesics|analgesics|mesh-ancestor
14382158|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
14382159|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382160|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382161|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14382162|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14382163|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
14382164|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382165|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14382166|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14382167|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382168|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382169|NCT01260662|Ketamine|ketamine|mesh-list
14382170|NCT01260662|Propofol|propofol|mesh-list
14382171|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14382172|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382173|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382174|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14382175|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
14382176|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
14382177|NCT01260662|Analgesics|analgesics|mesh-ancestor
14382178|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
14382179|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382180|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14382181|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14382182|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14382183|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382184|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382185|NCT01260688|Dasatinib|dasatinib|mesh-list
14382186|NCT01260688|Cediranib|cediranib|mesh-list
14382187|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382188|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14382189|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382190|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382191|NCT01260883|Ketorolac|ketorolac|mesh-list
14382192|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14382193|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14382194|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14382195|NCT01260883|Analgesics|analgesics|mesh-ancestor
14382196|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
14382197|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382198|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382199|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382200|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382201|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14382202|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382203|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382204|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14382205|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14382206|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14382207|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382208|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382209|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382210|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382211|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14382212|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
14382213|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382214|NCT01260922|Donepezil|donepezil|mesh-list
14382215|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14382216|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382217|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382218|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
14382219|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382220|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382221|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
14382222|NCT01260948|Donepezil|donepezil|mesh-list
14382223|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14382224|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382225|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382226|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
14382227|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382228|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382229|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
14382230|NCT01261325|Brivaracetam|brivaracetam|mesh-list
14382231|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
14382232|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
14382233|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14382234|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14382235|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
14382236|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382237|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14382238|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
14382239|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14382240|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14382241|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14382242|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382243|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382244|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
14382245|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382246|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382247|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14382248|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382249|NCT01261793|Epratuzumab|epratuzumab|mesh-list
15235446|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15235447|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235448|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235449|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14382250|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14382251|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382252|NCT01262092|Buprenorphine|buprenorphine|mesh-list
14382253|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14382254|NCT01262092|Narcotics|narcotics|mesh-ancestor
14382255|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382256|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382257|NCT01262092|Analgesics|analgesics|mesh-ancestor
14382258|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
14382259|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382260|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14382261|NCT01262118|Tofacitinib|tofacitinib|mesh-list
14382262|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14382263|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382264|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382265|NCT01262287|Dutasteride|dutasteride|mesh-list
14382266|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14382267|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14382268|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382269|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382270|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
14382271|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382272|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382273|NCT01262352|Ivacaftor|ivacaftor|mesh-list
14382274|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14382275|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382276|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382277|NCT01262365|Epratuzumab|epratuzumab|mesh-list
14382278|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14382279|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382280|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14382281|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
14382282|NCT01262456|Coagulants|coagulants|mesh-ancestor
14382283|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14382284|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
14382285|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382286|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14382287|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14382288|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
14382289|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382290|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14382291|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382292|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14733943|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
15235450|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
15235451|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
14382293|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382294|NCT01262651|Nabiximols|nabiximols|mesh-list
14382295|NCT01262651|Analgesics|analgesics|mesh-ancestor
14382296|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
14382297|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382298|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382299|NCT01262677|Pregabalin|pregabalin|mesh-list
14382300|NCT01262677|Analgesics|analgesics|mesh-ancestor
14382301|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
14382302|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382303|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382304|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
14382305|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14382306|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382307|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382308|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14382309|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14382310|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14382311|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382312|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382313|NCT01262872|Vaccines|vaccines|mesh-list
14382314|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14382315|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
14382316|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382317|NCT01263015|Lamivudine|lamivudine|mesh-list
14382318|NCT01263015|Abacavir|abacavir|mesh-list
14382319|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
14382320|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14382321|NCT01263015|Dolutegravir|dolutegravir|mesh-list
14382322|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14382323|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14382324|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382325|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382326|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
14382327|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382328|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14382329|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14382330|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
14382331|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14382332|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14382333|NCT01263093|Clopidogrel|clopidogrel|mesh-list
14382334|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14382335|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14382336|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14382337|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14382338|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
14382339|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382340|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733944|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15235452|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
15235453|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15235454|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15235455|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15235456|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15235457|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
15235458|NCT02717416|Hemostatics|hemostatics|mesh-list
14382341|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382342|NCT01263106|Theophylline|theophylline|mesh-list
14382343|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14382344|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
14382345|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382346|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382347|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14382348|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
14382349|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14382350|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382351|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382352|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14382353|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14382354|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14382355|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
14382356|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382357|NCT01263119|Warfarin|warfarin|mesh-list
14382358|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
14382359|NCT01263132|Thiamine|thiamine|mesh-list
14382360|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
14382361|NCT01263132|Gabapentin|gabapentin|mesh-list
14382362|NCT01263132|Analgesics|analgesics|mesh-ancestor
14382363|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
14382364|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382365|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382366|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
14382367|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14382368|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14382369|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382370|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382371|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14382372|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14382373|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921143|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14921144|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14382374|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382375|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
14382376|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
14382377|NCT01263132|Vitamins|vitamins|mesh-ancestor
14921145|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382378|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
14382379|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
14382380|NCT01263197|Propranolol|propranolol|mesh-list
14382381|NCT01263197|Albuterol|albuterol|mesh-list
14382382|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14382383|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
14382384|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382385|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382386|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14382387|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
14921146|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921147|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14921148|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
14921149|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921150|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921151|NCT04186663|Fluorides|fluorides|mesh-list
14921152|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
14921153|NCT04186663|Protective Agents|protective agents|mesh-ancestor
15235459|NCT02717416|Coagulants|coagulants|mesh-ancestor
15235460|NCT02712905|Nivolumab|nivolumab|mesh-list
15235461|NCT02712905|Azacitidine|azacitidine|mesh-list
15235462|NCT02712905|Tretinoin|tretinoin|mesh-list
15235463|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235464|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921154|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921155|NCT04173338|Pemetrexed|pemetrexed|mesh-list
15235465|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15235466|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235467|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14382388|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
14921156|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382389|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14382390|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14382391|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14382392|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14382393|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
14382394|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382395|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382396|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14382397|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14382398|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14382399|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14382400|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
14382401|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14382402|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382403|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
14382404|NCT01263444|Timolol|timolol|mesh-list
14382405|NCT01263444|Bimatoprost|bimatoprost|mesh-list
14382406|NCT01263444|Travoprost|travoprost|mesh-list
14382407|NCT01263444|Latanoprost|latanoprost|mesh-list
14382408|NCT01263444|Brinzolamide|brinzolamide|mesh-list
14382409|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14382410|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14382411|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14382412|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382413|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382414|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382415|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14382416|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14382417|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14382418|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14382419|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14382420|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382421|NCT01263470|Alogliptin|alogliptin|mesh-list
14382422|NCT01263470|Voglibose|voglibose|mesh-list
14382423|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14382424|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382425|NCT01263470|Incretins|incretins|mesh-ancestor
14382426|NCT01263470|Hormones|hormones|mesh-ancestor
14382427|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382428|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14382429|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
14382430|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382431|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382432|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14382433|NCT01263483|Inositol|inositol|mesh-list
14382434|NCT01263483|Alogliptin|alogliptin|mesh-list
14382435|NCT01263483|Voglibose|voglibose|mesh-list
14382436|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14382437|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382438|NCT01263483|Incretins|incretins|mesh-ancestor
14382439|NCT01263483|Hormones|hormones|mesh-ancestor
14382440|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382441|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14382442|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
14382443|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382444|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382445|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14382446|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
14382447|NCT01263483|Vitamins|vitamins|mesh-ancestor
14382448|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
14382449|NCT01263496|Alogliptin|alogliptin|mesh-list
14382450|NCT01263496|Voglibose|voglibose|mesh-list
14382451|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14382452|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382453|NCT01263496|Incretins|incretins|mesh-ancestor
14382454|NCT01263496|Hormones|hormones|mesh-ancestor
14382455|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382456|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14382457|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
14382458|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382459|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382460|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14382461|NCT01263509|Inositol|inositol|mesh-list
14382462|NCT01263509|Alogliptin|alogliptin|mesh-list
14382463|NCT01263509|Voglibose|voglibose|mesh-list
14382464|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14382465|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382466|NCT01263509|Incretins|incretins|mesh-ancestor
14382467|NCT01263509|Hormones|hormones|mesh-ancestor
14382468|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382469|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14382470|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
14382471|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382472|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382473|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14382474|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
14382475|NCT01263509|Vitamins|vitamins|mesh-ancestor
14382476|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
14382477|NCT01263691|Vaccines|vaccines|mesh-list
14382478|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
14382479|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382480|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
14382481|NCT01263704|Rituximab|rituximab|mesh-list
14382482|NCT01263704|Fludarabine|fludarabine|mesh-list
14382483|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14382484|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
14382485|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382486|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382487|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15235468|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
15235469|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382488|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
14382489|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235470|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
15235471|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
15235472|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
15235473|NCT02675946|Cetuximab|cetuximab|mesh-list
15235474|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235475|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235476|NCT02660827|Insulin|insulin|mesh-list
15235477|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15235478|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382490|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382491|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14382492|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14382493|NCT01263717|Hormones|hormones|mesh-list
14382494|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14382495|NCT01263717|Tesamorelin|tesamorelin|mesh-list
14382496|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382497|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382498|NCT01263717|Growth Substances|growth substances|mesh-ancestor
14382499|NCT01263782|Bevacizumab|bevacizumab|mesh-list
14382500|NCT01263782|Carboplatin|carboplatin|mesh-list
14382501|NCT01263782|Pemetrexed|pemetrexed|mesh-list
14382502|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14382503|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382504|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14382505|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14382506|NCT01263782|Growth Substances|growth substances|mesh-ancestor
14382507|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382508|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
14382509|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382510|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382511|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14382512|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14382513|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
14382514|NCT01263925|Alprostadil|alprostadil|mesh-list
14382515|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14382516|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382517|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382518|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14733945|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14733946|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14733947|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14382519|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14382520|NCT01263925|Protective Agents|protective agents|mesh-ancestor
14382521|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382522|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
14382523|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14382524|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
14382525|NCT01263925|Urological Agents|urological agents|mesh-ancestor
14382526|NCT01263938|Atorvastatin|atorvastatin|mesh-list
14382527|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14382528|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14382529|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
14382530|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382531|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14382532|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14382533|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382534|NCT01264081|Lapatinib|lapatinib|mesh-list
14382535|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382536|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14382537|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382538|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382539|NCT01264705|Sorafenib|sorafenib|mesh-list
14382540|NCT01264705|Bavituximab|bavituximab|mesh-list
14382541|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14382542|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382543|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14382544|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382545|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382546|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733948|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
14733949|NCT00532857|Gemcitabine|gemcitabine|mesh-list
14733950|NCT00532857|Paclitaxel|paclitaxel|mesh-list
14733951|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15235479|NCT02627963|Sorafenib|sorafenib|mesh-list
15235480|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235481|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235482|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235483|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235484|NCT02520063|Everolimus|everolimus|mesh-list
15235485|NCT02520063|Letrozole|letrozole|mesh-list
15235486|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235487|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14382547|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
14382548|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382549|NCT01264770|Adalimumab|adalimumab|mesh-list
14382550|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382551|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382552|NCT01264887|Tapentadol|tapentadol|mesh-list
14382553|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14382554|NCT01264887|Narcotics|narcotics|mesh-ancestor
14382555|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382556|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382557|NCT01264887|Analgesics|analgesics|mesh-ancestor
14382558|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
14382559|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382560|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14382561|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14382562|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382563|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382564|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
14382565|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382566|NCT01264939|Omalizumab|omalizumab|mesh-list
14382567|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
15235488|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
14382568|NCT01264939|Promethazine|promethazine|mesh-list
14382569|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14382570|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14382571|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
14382572|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14382573|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14382574|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
14382575|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14382576|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14733952|NCT00532857|Trastuzumab|trastuzumab|mesh-list
14733953|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14733954|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235489|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921157|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921158|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921159|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14382577|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382578|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382579|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
14382580|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
14382581|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
14382582|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382583|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
14382584|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
14382585|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14382586|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
14382587|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382588|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382589|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
14382590|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
14382591|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
14382592|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382593|NCT01265056|Gabapentin|gabapentin|mesh-list
14382594|NCT01265056|Analgesics|analgesics|mesh-ancestor
14382595|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
14382596|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382597|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382598|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
14382599|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14382600|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14382601|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382602|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382603|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14382604|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14382605|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382606|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382607|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
14382608|NCT01265394|Flutemetamol|flutemetamol|mesh-list
14382609|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14382610|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382611|NCT01265446|Lidocaine|lidocaine|mesh-list
14382612|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
14382613|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
14382614|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382615|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382616|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
14382617|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382618|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14382619|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14382620|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14382621|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382622|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382623|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14382624|NCT01265498|Cathartics|cathartics|mesh-ancestor
14382625|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14382626|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14382627|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
14382628|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382629|NCT01265537|Tacrolimus|tacrolimus|mesh-list
14382630|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14382631|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
14382632|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382633|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14382634|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382635|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382636|NCT01265550|Baclofen|baclofen|mesh-list
14382637|NCT01265550|Desipramine|desipramine|mesh-list
14382638|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14382639|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382640|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14382641|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382642|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14382643|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
14733955|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
14733956|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
14733957|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921160|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14382644|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
14382645|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382646|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382647|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14382648|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
14382649|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382650|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382651|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14382652|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14382653|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382654|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
14382655|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
14382656|NCT01265563|Silybin|silybin|mesh-list
14382657|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14382658|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
14382659|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382660|NCT01265563|Expectorants|expectorants|mesh-ancestor
14382661|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
14382662|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14382663|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
14382664|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382665|NCT01265563|Protective Agents|protective agents|mesh-ancestor
14382666|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382667|NCT01265563|Antidotes|antidotes|mesh-ancestor
14382668|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14382669|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382670|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
14382671|NCT01265615|Calcitriol|calcitriol|mesh-list
14382672|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14382673|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382674|NCT01265615|Vitamins|vitamins|mesh-ancestor
14382675|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
14382676|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14382677|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14382678|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382679|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382680|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14466623|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14466624|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14466625|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14466626|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466627|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466628|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
14466629|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921161|NCT04167462|BMS-986165|bms-986165|mesh-list
14382681|NCT01265823|Adalimumab|adalimumab|mesh-list
14382682|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382683|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382684|NCT01265875|Secretin|secretin|mesh-list
14382685|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14382686|NCT01265875|Hormones|hormones|mesh-ancestor
14382687|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382688|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382689|NCT01265953|Sulforaphane|sulforaphane|mesh-list
14382690|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14382691|NCT01265953|Protective Agents|protective agents|mesh-ancestor
14382692|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382693|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382694|NCT01266148|Cyclosporine|cyclosporine|mesh-list
14382695|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
14382696|NCT01266148|Everolimus|everolimus|mesh-list
14382697|NCT01266148|Cyclosporins|cyclosporins|mesh-list
14382698|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14382699|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382700|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382701|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14382702|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
14382703|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382704|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
14382705|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382706|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
14382707|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382708|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14382709|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382710|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14382711|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14382712|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
14382713|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14382714|NCT01266161|Ibuprofen|ibuprofen|mesh-list
14382715|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14382716|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14382717|NCT01266161|Analgesics|analgesics|mesh-ancestor
14382718|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
14382719|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382720|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382721|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382722|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382723|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14382724|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382725|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382726|NCT01266265|Treprostinil|treprostinil|mesh-list
14382727|NCT01266265|Bosentan|bosentan|mesh-list
14382728|NCT01266265|Ambrisentan|ambrisentan|mesh-list
14382729|NCT01266265|Epoprostenol|epoprostenol|mesh-list
14382730|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
14382731|NCT01266265|Tadalafil|tadalafil|mesh-list
14382732|NCT01266265|Iloprost|iloprost|mesh-list
14382733|NCT01266265|Tezosentan|tezosentan|mesh-list
14382734|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14382735|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
14382736|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14382737|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382738|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382739|NCT01266265|Urological Agents|urological agents|mesh-ancestor
14382740|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14382741|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14382742|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14382743|NCT01266291|Vigabatrin|vigabatrin|mesh-list
14382744|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
14382745|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382746|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382747|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
14382748|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382749|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382750|NCT01266317|Rituximab|rituximab|mesh-list
14382751|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14382752|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382753|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
14382754|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382755|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382756|NCT01266447|Topotecan|topotecan|mesh-list
14382757|NCT01266447|Veliparib|veliparib|mesh-list
14382758|NCT01266447|Lenograstim|lenograstim|mesh-list
14382759|NCT01266447|Sargramostim|sargramostim|mesh-list
14382760|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14382761|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
14382762|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382763|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14382764|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14382765|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382766|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382767|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382768|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14382769|NCT01266460|Vaccines|vaccines|mesh-list
14382770|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
14382771|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382772|NCT01266590|Digoxin|digoxin|mesh-list
14382773|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14382774|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14382775|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382776|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382777|NCT01266590|Protective Agents|protective agents|mesh-ancestor
14382778|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382779|NCT01266603|Aldesleukin|aldesleukin|mesh-list
14382780|NCT01266603|Interleukin-2|interleukin-2|mesh-list
14382781|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382782|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14382783|NCT01266603|Analgesics|analgesics|mesh-ancestor
14382784|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
14382785|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235490|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15235491|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15235492|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235493|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235494|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15235495|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
15235496|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235497|NCT02496663|Osimertinib|osimertinib|mesh-list
15235498|NCT02496663|Necitumumab|necitumumab|mesh-list
15235499|NCT02496663|Cetuximab|cetuximab|mesh-list
15235500|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15235501|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235502|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235503|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235504|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235505|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235506|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
15235507|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235508|NCT02437370|Gemcitabine|gemcitabine|mesh-list
15235509|NCT02437370|Docetaxel|docetaxel|mesh-list
15235510|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
15235511|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235512|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
15235513|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235514|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235515|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
15235516|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382786|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382787|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14382788|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15235517|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382789|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
14382790|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382791|NCT01266902|Rilpivirine|rilpivirine|mesh-list
14382792|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14382793|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14382794|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382795|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382796|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
14382797|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14382798|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14382799|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14382800|NCT01266967|Dabrafenib|dabrafenib|mesh-list
14382801|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382802|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14382803|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382804|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382805|NCT01267136|Acetaminophen|acetaminophen|mesh-list
14382806|NCT01267136|Tramadol|tramadol|mesh-list
14382807|NCT01267136|Codeine|codeine|mesh-list
14382808|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14382809|NCT01267136|Analgesics|analgesics|mesh-ancestor
14382810|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
14382811|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382812|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382813|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
14382814|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14382815|NCT01267136|Narcotics|narcotics|mesh-ancestor
14382816|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382817|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
14382818|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
14382819|NCT01267175|Insulin|insulin|mesh-list
14382820|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14382821|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382822|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
14382823|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14382824|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14382825|NCT01267201|Prednisolone|prednisolone|mesh-list
14382826|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
14382827|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14382828|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
14382829|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382830|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
14382831|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
14382832|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382833|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235518|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235519|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
15235520|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235521|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235522|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235523|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
15235524|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235525|NCT02425644|Teriflunomide|teriflunomide|mesh-list
15235526|NCT02425644|Ponesimod|ponesimod|mesh-list
14382834|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14382835|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
14382836|NCT01267201|Hormones|hormones|mesh-ancestor
14382837|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382838|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14382839|NCT01267201|Protective Agents|protective agents|mesh-ancestor
14382840|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14382841|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733958|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733959|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733960|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
14733961|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
14382842|NCT01267240|Capecitabine|capecitabine|mesh-list
14382843|NCT01267240|Vorinostat|vorinostat|mesh-list
14382844|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14382845|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
14382846|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382847|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382848|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14382849|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382850|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
14382851|NCT01267266|Saracatinib|saracatinib|mesh-list
14382852|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382853|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382854|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382855|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382856|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
14382857|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14382858|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382859|NCT01267292|Buspirone|buspirone|mesh-list
14382860|NCT01267292|Methylphenidate|methylphenidate|mesh-list
14382861|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14382862|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382863|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14382864|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14382865|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14382866|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382867|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
14382868|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382869|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14382870|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14382871|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382872|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382873|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14382874|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
14382875|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14382876|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
14382877|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14382878|NCT01267864|Ketorolac|ketorolac|mesh-list
14382879|NCT01267864|Valproic Acid|valproic acid|mesh-list
14382880|NCT01267864|Metoclopramide|metoclopramide|mesh-list
14382881|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14382882|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14382883|NCT01267864|Analgesics|analgesics|mesh-ancestor
14382884|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
14382885|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382886|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382887|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14382888|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382889|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14382890|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382891|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382892|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
14382893|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
14382894|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382895|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
14382896|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14382897|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382898|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14382899|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
14382900|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
14382901|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14382902|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14382903|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14382904|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
14382905|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14382906|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382907|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14382908|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14382909|NCT01268046|Estradiol|estradiol|mesh-list
14382910|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14382911|NCT01268046|Estrogens|estrogens|mesh-list
14382912|NCT01268046|Hormones|hormones|mesh-ancestor
14382913|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382914|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382915|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14382916|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
14382917|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14382918|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14382919|NCT01268059|Paclitaxel|paclitaxel|mesh-list
14382920|NCT01268059|Carboplatin|carboplatin|mesh-list
14382921|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14382922|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235527|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15235528|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15235529|NCT02425644|Analgesics|analgesics|mesh-ancestor
15235530|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
15235531|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235532|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235533|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235534|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235535|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14382923|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14382924|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14382925|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14382926|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382927|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
14382928|NCT01268111|Vitamin D|vitamin d|mesh-list
14382929|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14382930|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382931|NCT01268111|Vitamins|vitamins|mesh-ancestor
14382932|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
14382933|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14382934|NCT01268293|Lenvatinib|lenvatinib|mesh-list
15235536|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
15235537|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14382935|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382936|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14382937|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382938|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382939|NCT01268527|Calcipotriene|calcipotriene|mesh-list
14382940|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
14382941|NCT01268553|Treprostinil|treprostinil|mesh-list
14382942|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14382943|NCT01268683|Glyburide|glyburide|mesh-list
14382944|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14382945|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382946|NCT01268891|Rasagiline|rasagiline|mesh-list
14382947|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14382948|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14382949|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382950|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14382951|NCT01268891|Protective Agents|protective agents|mesh-ancestor
14382952|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382953|NCT01268943|Capecitabine|capecitabine|mesh-list
14382954|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14382955|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
14382956|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382957|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382958|NCT01269047|Exenatide|exenatide|mesh-list
14382959|NCT01269047|Pramlintide|pramlintide|mesh-list
14382960|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14733962|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733963|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14733964|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14733965|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
14733966|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733967|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733968|NCT00532909|Bevacizumab|bevacizumab|mesh-list
15235538|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235539|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15235540|NCT02395614|Gentamicins|gentamicins|mesh-list
15235541|NCT02395614|Cefazolin|cefazolin|mesh-list
15235542|NCT02395614|Bacitracin|bacitracin|mesh-list
14733969|NCT00532909|Capecitabine|capecitabine|mesh-list
14733970|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
14733971|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14733972|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733973|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14733974|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15235543|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
15235544|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235545|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15235546|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
15235547|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15235548|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235549|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235550|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
15235551|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733975|NCT00532909|Growth Substances|growth substances|mesh-ancestor
14733976|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733977|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
14733978|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14733979|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
14733980|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14733981|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14733982|NCT00532961|Tobramycin|tobramycin|mesh-list
14733983|NCT00532961|Dexamethasone|dexamethasone|mesh-list
15235552|NCT02340221|Fulvestrant|fulvestrant|mesh-list
14382961|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382962|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14382963|NCT01269047|Incretins|incretins|mesh-ancestor
14382964|NCT01269047|Hormones|hormones|mesh-ancestor
14382965|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14382966|NCT01269125|Leuprolide|leuprolide|mesh-list
14382967|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14382968|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
14382969|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14382970|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382971|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14382972|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382973|NCT01269385|Rituximab|rituximab|mesh-list
14382974|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14382975|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
14382976|NCT01269385|Antibodies|antibodies|mesh-list
14382977|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
14382978|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14382979|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
14382980|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382981|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14382982|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14382983|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
14382984|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14382985|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14382986|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15235553|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15235554|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235555|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15235556|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15235557|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
15235558|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235559|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235560|NCT02270957|Abatacept|abatacept|mesh-list
14382987|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15235561|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15235562|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382988|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14382989|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
14382990|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14382991|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382992|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14382993|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14382994|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
14382995|NCT01269918|Remifentanil|remifentanil|mesh-list
14382996|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14382997|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14382998|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14382999|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14383000|NCT01269918|Analgesics|analgesics|mesh-ancestor
14733984|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14733985|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
14733986|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
14733987|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14733988|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14733989|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14733990|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
14733991|NCT00532961|Hormones|hormones|mesh-ancestor
14733992|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14733993|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14733994|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14733995|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14733996|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14733997|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14733998|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14733999|NCT00533026|Warfarin|warfarin|mesh-list
14734000|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
14734001|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14734002|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14734003|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734004|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734005|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734006|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734007|NCT00533026|Analgesics|analgesics|mesh-ancestor
14734008|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
14383001|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
14383002|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383003|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14383004|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14383005|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14383006|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
14383007|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383008|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383009|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14383010|NCT01269918|Narcotics|narcotics|mesh-ancestor
14383011|NCT01270256|Budesonide|budesonide|mesh-list
14383012|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383013|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14383014|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
14383015|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383016|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235563|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235564|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235565|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
15235566|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235567|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235568|NCT02237183|Iloprost|iloprost|mesh-list
15235569|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15235570|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
15235571|NCT02204085|Decitabine|decitabine|mesh-list
15235572|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235573|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
15235574|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235575|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235576|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235577|NCT02134925|Poly ICLC|poly iclc|mesh-list
15235578|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
15235579|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
15235580|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235581|NCT02133573|Progesterone|progesterone|mesh-list
14383017|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14383018|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14383019|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
14383020|NCT01270256|Hormones|hormones|mesh-ancestor
14383021|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383022|NCT01270321|Everolimus|everolimus|mesh-list
14383023|NCT01270321|Pasireotide|pasireotide|mesh-list
14383024|NCT01270321|Somatostatin|somatostatin|mesh-list
14383025|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383026|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383027|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
14383028|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383029|NCT01270321|Hormones|hormones|mesh-ancestor
14383030|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383031|NCT01270464|Reslizumab|reslizumab|mesh-list
14383032|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14383033|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14383034|NCT01270542|Bevacizumab|bevacizumab|mesh-list
14383035|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383036|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383037|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14383038|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14383039|NCT01270542|Growth Substances|growth substances|mesh-ancestor
14383040|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383041|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
14383042|NCT01270555|Bupropion|bupropion|mesh-list
14383043|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14383044|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
14383045|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14383046|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14383047|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14383048|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383049|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383050|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
14383051|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383052|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383053|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14383054|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14383055|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383056|NCT01270620|Propofol|propofol|mesh-list
14383057|NCT01270620|Desflurane|desflurane|mesh-list
14383058|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14383059|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383060|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383061|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14383062|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
14383063|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
14383064|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14383065|NCT01270659|Acetaminophen|acetaminophen|mesh-list
14383066|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14383067|NCT01270659|Fentanyl|fentanyl|mesh-list
14383068|NCT01270659|Oxycodone|oxycodone|mesh-list
14383069|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14383070|NCT01270659|Narcotics|narcotics|mesh-ancestor
14383071|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921162|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
14921163|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921164|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921165|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921166|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14921167|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14921168|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
14921169|NCT04164199|Capecitabine|capecitabine|mesh-list
14921170|NCT04164199|Pemetrexed|pemetrexed|mesh-list
14921171|NCT04164199|Temozolomide|temozolomide|mesh-list
15235582|NCT02133573|Progestins|progestins|mesh-ancestor
15235583|NCT02133573|Hormones|hormones|mesh-ancestor
14383072|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930978|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235584|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235585|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235586|NCT02054104|Celecoxib|celecoxib|mesh-list
15235587|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
15235588|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235589|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
15235590|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235591|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235592|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15235593|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
15235594|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383073|NCT01270659|Analgesics|analgesics|mesh-ancestor
14383074|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
14383075|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383076|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14383077|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14383078|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
14383079|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
14383080|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14383081|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
14383082|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14383083|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383084|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383085|NCT01270802|Tenofovir|tenofovir|mesh-list
14383086|NCT01270802|Emtricitabine|emtricitabine|mesh-list
14383087|NCT01270802|Efavirenz|efavirenz|mesh-list
14383088|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
14383089|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
14383090|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383091|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14383092|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14383093|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383094|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383095|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14383096|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14383097|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14383098|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14383099|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14383100|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14383101|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14383102|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14383103|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14383104|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14383105|NCT01270828|Pregabalin|pregabalin|mesh-list
14383106|NCT01270828|Analgesics|analgesics|mesh-ancestor
14383107|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
14383108|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383109|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383110|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
14383111|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14383112|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383113|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383114|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383115|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14383116|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14383117|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383118|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14383119|NCT01270841|Enclomiphene|enclomiphene|mesh-list
14383120|NCT01270841|Clomiphene|clomiphene|mesh-list
15235595|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235596|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15235597|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15235598|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15235599|NCT02054104|Analgesics|analgesics|mesh-ancestor
15235600|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
15235601|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235602|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235603|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15235604|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14383121|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
14734009|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734010|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
14383122|NCT01270841|Testosterone|testosterone|mesh-list
14383123|NCT01270841|Androgens|androgens|mesh-ancestor
14383124|NCT01270841|Hormones|hormones|mesh-ancestor
14383125|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383126|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383127|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14383128|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
14383129|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14383130|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
14383131|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14383132|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14734011|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734012|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
14734013|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
14734014|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14734015|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734016|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734017|NCT00533065|Donepezil|donepezil|mesh-list
14734018|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14734019|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734020|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734021|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
14734022|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734023|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734024|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
14734025|NCT00533091|Sifalimumab|sifalimumab|mesh-list
14734026|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
14734027|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383133|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14383134|NCT01270971|Tavaborole|tavaborole|mesh-list
14383135|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14383136|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
14383137|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383138|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
14383139|NCT01271010|Rituximab|rituximab|mesh-list
14383140|NCT01271010|Fludarabine|fludarabine|mesh-list
14383141|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383142|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
14383143|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383144|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383145|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14383146|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
14383147|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383148|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383149|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14383150|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383151|NCT01271244|Citalopram|citalopram|mesh-list
14383152|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14383153|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14383154|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734028|NCT00533169|Tretinoin|tretinoin|mesh-list
14734029|NCT00533169|Isotretinoin|isotretinoin|mesh-list
14921172|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921173|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
14921174|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921175|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921176|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921177|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14921178|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734030|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734031|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
14734032|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
14734033|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
14734034|NCT00533195|Methoxsalen|methoxsalen|mesh-list
14734035|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14734036|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
14734037|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14734038|NCT00533247|Celecoxib|celecoxib|mesh-list
14734039|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14734040|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14734041|NCT00533247|Analgesics|analgesics|mesh-ancestor
14921179|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921180|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
14921181|NCT04157075|Bupivacaine|bupivacaine|mesh-list
14383155|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383156|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383157|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
14383158|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383159|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14383160|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
14383161|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14383162|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
14383163|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14383164|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14383165|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14383166|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383167|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383168|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
14383169|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383170|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383171|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14921182|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
14921183|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
14921184|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235605|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383172|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383173|NCT01271504|Sorafenib|sorafenib|mesh-list
14383174|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383175|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14383176|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383177|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383178|NCT01271686|Bimatoprost|bimatoprost|mesh-list
14734042|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
14734043|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734044|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734045|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235606|NCT01954979|Abatacept|abatacept|mesh-list
15235607|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15235608|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235609|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235610|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235611|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
15235612|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235613|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235614|NCT01899144|Albuterol|albuterol|mesh-list
15235615|NCT01899144|Procaterol|procaterol|mesh-list
15235616|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15235617|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
15235618|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235619|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235620|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14734046|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734047|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15235621|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
15235622|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
15235623|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15235624|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15235625|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15235626|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15235627|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
15235628|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235629|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235630|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
15235631|NCT01853631|Cyclophosphamide|cyclophosphamide|mesh-list
15235632|NCT01853631|Fludarabine|fludarabine|mesh-list
15235633|NCT01853631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383179|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14383180|NCT01271725|Paclitaxel|paclitaxel|mesh-list
14383181|NCT01271725|Vinorelbine|vinorelbine|mesh-list
14383182|NCT01271725|Afatinib|afatinib|mesh-list
14383183|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14383184|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383185|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
14383186|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
14383187|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
14383188|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383189|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14383190|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383191|NCT01271803|Vemurafenib|vemurafenib|mesh-list
14383192|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383193|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14383194|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383195|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383196|NCT01271855|Glycerol|glycerol|mesh-list
14383197|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383198|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14383199|NCT01271855|Protective Agents|protective agents|mesh-ancestor
14466630|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466631|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14466632|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466633|NCT02247440|Interferons|interferons|mesh-list
14466634|NCT02247440|Ribavirin|ribavirin|mesh-list
14466635|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466636|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
14466637|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466638|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
14734048|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14734049|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734050|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734051|NCT00533299|Hydralazine|hydralazine|mesh-list
14734052|NCT00533299|Valproic Acid|valproic acid|mesh-list
14734053|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
14734054|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734055|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734056|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
14734057|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734058|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734059|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
14734060|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14734061|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734062|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734063|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14734064|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
14734065|NCT00533312|Niacin|niacin|mesh-list
14734066|NCT00533312|Niacinamide|niacinamide|mesh-list
14734067|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
14734068|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14734069|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
15235634|NCT01853631|Immunologic Factors|immunologic factors|mesh-ancestor
14734070|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383200|NCT01271907|Aldesleukin|aldesleukin|mesh-list
14383201|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
14383202|NCT01271907|Fludarabine|fludarabine|mesh-list
14383203|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383204|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
14383205|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383206|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383207|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14383208|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
14383209|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383210|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383211|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14383212|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14383213|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14383214|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
14383215|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383216|NCT01271933|Pregabalin|pregabalin|mesh-list
14383217|NCT01271933|Analgesics|analgesics|mesh-ancestor
14383218|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
14383219|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383220|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383221|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
14383222|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14383223|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383224|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383225|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383226|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14383227|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14383228|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235635|NCT01853631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235636|NCT01853631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235637|NCT01853631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15235638|NCT01853631|Alkylating Agents|alkylating agents|mesh-ancestor
15235639|NCT01853631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235640|NCT01853631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235641|NCT01853631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15235642|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15235643|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
15235644|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235645|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235646|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
15235647|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235648|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235649|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15235650|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15235651|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15235652|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
15235653|NCT01724879|Dasatinib|dasatinib|mesh-list
14383229|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14383230|NCT01272180|Vaccines|vaccines|mesh-list
14383231|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
14383232|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383233|NCT01272193|Insulin|insulin|mesh-list
14383234|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14383235|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
14383236|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
14383237|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383238|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383239|NCT01272219|Liraglutide|liraglutide|mesh-list
14383240|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383241|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383242|NCT01272219|Incretins|incretins|mesh-ancestor
14383243|NCT01272219|Hormones|hormones|mesh-ancestor
14383244|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383245|NCT01272232|Liraglutide|liraglutide|mesh-list
14383246|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383247|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383248|NCT01272232|Incretins|incretins|mesh-ancestor
14383249|NCT01272232|Hormones|hormones|mesh-ancestor
14383250|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383251|NCT01272245|Cytarabine|cytarabine|mesh-list
14383252|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
14383253|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14383254|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
14383255|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383256|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383257|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
14383258|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383259|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383260|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
14383261|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383262|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14383263|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14383264|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383265|NCT01272388|Tadalafil|tadalafil|mesh-list
14383266|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
14383267|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14383268|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14383269|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383270|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383271|NCT01272388|Urological Agents|urological agents|mesh-ancestor
14383272|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14383273|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383274|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383275|NCT01272583|Incretins|incretins|mesh-ancestor
14383276|NCT01272583|Hormones|hormones|mesh-ancestor
14383277|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383278|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14383279|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
14383280|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383281|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383282|NCT01272635|Azithromycin|azithromycin|mesh-list
14383283|NCT01272635|Prednisolone|prednisolone|mesh-list
14383284|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14383285|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
14383286|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14383287|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
14383288|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14383289|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
14383290|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383291|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
14383292|NCT01272635|Hormones|hormones|mesh-ancestor
14383293|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383294|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383295|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14921185|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921186|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
14921187|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921188|NCT04154189|Etoposide|etoposide|mesh-list
14921189|NCT04154189|Ifosfamide|ifosfamide|mesh-list
14921190|NCT04154189|Lenvatinib|lenvatinib|mesh-list
14921191|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921192|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921193|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14921194|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14921195|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921196|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921197|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921198|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
14921199|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921200|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
14921201|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921202|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235654|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383296|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383297|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
14383298|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
14383299|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383300|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383301|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14383302|NCT01272635|Protective Agents|protective agents|mesh-ancestor
15235655|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235656|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235657|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235658|NCT01468831|Minocycline|minocycline|mesh-list
15235659|NCT01468831|Bevacizumab|bevacizumab|mesh-list
15235660|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235661|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383303|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14383304|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383305|NCT01272908|Rituximab|rituximab|mesh-list
14383306|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383307|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383308|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
14383309|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383310|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383311|NCT01272921|Bupivacaine|bupivacaine|mesh-list
14383312|NCT01272921|Ropivacaine|ropivacaine|mesh-list
14383313|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
14383314|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
14383315|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383316|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383317|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
14383318|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383319|NCT01272934|Diclofenac|diclofenac|mesh-list
14383320|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14383321|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14383322|NCT01272934|Analgesics|analgesics|mesh-ancestor
14383323|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
14383324|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383325|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383326|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383327|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383328|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14383329|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383330|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383331|NCT01272947|Diclofenac|diclofenac|mesh-list
14383332|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14383333|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14383334|NCT01272947|Analgesics|analgesics|mesh-ancestor
14383335|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
14383336|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383337|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383338|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383339|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383340|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14383341|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383342|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383343|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
14383344|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14383345|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
14383346|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14383347|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383348|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14383349|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14383350|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14383351|NCT01273155|Belinostat|belinostat|mesh-list
14383352|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383353|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14383354|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383355|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383356|NCT01273181|Aldesleukin|aldesleukin|mesh-list
14383357|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
14383358|NCT01273181|Fludarabine|fludarabine|mesh-list
14383359|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383360|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
14921203|NCT04128956|Aspirin|aspirin|mesh-list
14383361|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383362|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383363|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921204|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921205|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921206|NCT04128956|Analgesics|analgesics|mesh-ancestor
14921207|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
14921208|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921209|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921210|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383364|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
14383365|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383366|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383367|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14383368|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14383369|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14383370|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
14383371|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383372|NCT01273207|Cyclosporine|cyclosporine|mesh-list
14383373|NCT01273207|Cyclosporins|cyclosporins|mesh-list
14383374|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383375|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383376|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383377|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
14921211|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921212|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14921213|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14383378|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383379|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
14383380|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383381|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
14383382|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383383|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14383384|NCT01273766|Deferasirox|deferasirox|mesh-list
14921214|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921215|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14921216|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14921217|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921218|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
14921219|NCT04108026|Durvalumab|durvalumab|mesh-list
14921220|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921221|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921222|NCT04100135|Clopidogrel|clopidogrel|mesh-list
14921223|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14921224|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14921225|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14921226|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14921227|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14734071|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14734072|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
14734073|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
14734074|NCT00533312|Vitamins|vitamins|mesh-ancestor
14734075|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
14734076|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734077|NCT00533390|Efavirenz|efavirenz|mesh-list
14734078|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14734079|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734080|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383385|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14383386|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
14383387|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
14383388|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383389|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
14383390|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
14383391|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14383392|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14383393|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383394|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383395|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383396|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383397|NCT01273818|Gentamicins|gentamicins|mesh-list
14383398|NCT01273818|Cefazolin|cefazolin|mesh-list
14383399|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14383400|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383401|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14383402|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383403|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921228|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
14921229|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921230|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921231|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930979|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930980|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14930981|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
14930982|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930983|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930984|NCT01436825|Factor VIII|factor viii|mesh-list
14930985|NCT01436825|Coagulants|coagulants|mesh-ancestor
14930986|NCT01436838|Interferons|interferons|mesh-list
14930987|NCT01436838|Interferon-beta|interferon-beta|mesh-list
14383404|NCT01274182|Rituximab|rituximab|mesh-list
14383405|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734081|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734082|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
14383406|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383407|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
14383408|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383409|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383410|NCT01274338|Interferons|interferons|mesh-list
14383411|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
14383412|NCT01274338|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14383413|NCT01274338|Ipilimumab|ipilimumab|mesh-list
14383414|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383415|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
14383416|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383417|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383418|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14383419|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921232|NCT04095104|Topiramate|topiramate|mesh-list
14921233|NCT04095104|Phentermine|phentermine|mesh-list
14921234|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
14921235|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14921236|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383420|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
14383421|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383422|NCT01274637|Dalteparin|dalteparin|mesh-list
14383423|NCT01274637|Tinzaparin|tinzaparin|mesh-list
14383424|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14383425|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
14383426|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14383427|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14383428|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383429|NCT01274897|Lactitol|lactitol|mesh-list
14383430|NCT01274897|Cathartics|cathartics|mesh-ancestor
14383431|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383432|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
14383433|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383434|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383435|NCT01275144|Lorazepam|lorazepam|mesh-list
14383436|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
14383437|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
14383438|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
14383439|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383440|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383441|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383442|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14383443|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383444|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14383445|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14383446|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14383447|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
14383448|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
14383449|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383450|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383451|NCT01275170|Imipenem|imipenem|mesh-list
14383452|NCT01275170|Relebactam|relebactam|mesh-list
14383453|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14921237|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14921238|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
14921239|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14921240|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
14383454|NCT01275170|Midazolam|midazolam|mesh-list
14383455|NCT01275170|Caffeine|caffeine|mesh-list
14383456|NCT01275170|Omeprazole|omeprazole|mesh-list
14383457|NCT01275170|Cilastatin|cilastatin|mesh-list
14383458|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14383459|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14383460|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383461|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383462|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14383463|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14383464|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14383465|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14383466|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
14383467|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
14383468|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
14383469|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
14383470|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383471|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383472|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14383473|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383474|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14383475|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383476|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14383477|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14383478|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14383479|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14383480|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
14383481|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14383482|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383483|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
14383484|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14383485|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
14383486|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383487|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14383488|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383489|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383490|NCT01275222|Everolimus|everolimus|mesh-list
14734083|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734084|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14734085|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14734086|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14734087|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14734088|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14734089|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14734090|NCT00533416|ON 01910|on 01910|mesh-list
14734091|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734092|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734093|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734094|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734095|NCT00533455|Gabapentin|gabapentin|mesh-list
14734096|NCT00533455|Analgesics|analgesics|mesh-ancestor
14921241|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
14383491|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
14921242|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921243|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14921244|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921245|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921246|NCT04074512|Copper|copper|mesh-list
14383492|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383493|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383494|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
14383495|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383496|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14383497|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383498|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383499|NCT01275300|Aspirin|aspirin|mesh-list
14383500|NCT01275300|Niacin|niacin|mesh-list
14383501|NCT01275300|Niacinamide|niacinamide|mesh-list
14383502|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
14383503|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14383504|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15235662|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15235663|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14383505|NCT01275300|Analgesics|analgesics|mesh-ancestor
14383506|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
14383507|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383508|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383509|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383510|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383511|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14383512|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14383513|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383514|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14383515|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14383516|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383517|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
14383518|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14383519|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
14383520|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14383521|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
14383522|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
14383523|NCT01275300|Vitamins|vitamins|mesh-ancestor
14383524|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
14383525|NCT01275339|Tadalafil|tadalafil|mesh-list
14921247|NCT04074512|Trace Elements|trace elements|mesh-ancestor
14921248|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
14921249|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921250|NCT04060342|Gemcitabine|gemcitabine|mesh-list
14921251|NCT04060342|Paclitaxel|paclitaxel|mesh-list
14921252|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
14921253|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921254|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921255|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235664|NCT01468831|Growth Substances|growth substances|mesh-ancestor
15235665|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235666|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
15235667|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15235668|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235669|NCT01383109|Pyronaridine|pyronaridine|mesh-list
15235670|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
15235671|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15235672|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14383526|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
14921256|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235673|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921257|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921258|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921259|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921260|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
14921261|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
14921262|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921263|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921264|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921265|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
14921266|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921267|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383527|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14383528|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14383529|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383530|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383531|NCT01275339|Urological Agents|urological agents|mesh-ancestor
14383532|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
14383533|NCT01275365|Testosterone|testosterone|mesh-list
14383534|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
14383535|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
14383536|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14383537|NCT01275365|Androgens|androgens|mesh-ancestor
14383538|NCT01275365|Hormones|hormones|mesh-ancestor
14921268|NCT04057131|Icatibant|icatibant|mesh-list
14921269|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921270|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921271|NCT04057131|Analgesics|analgesics|mesh-ancestor
14921272|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
14921273|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921274|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921275|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921276|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235674|NCT00822120|Prednisone|prednisone|mesh-list
15235675|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
15235676|NCT00822120|Dacarbazine|dacarbazine|mesh-list
15235677|NCT00822120|Doxorubicin|doxorubicin|mesh-list
15235678|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15235679|NCT00822120|Etoposide|etoposide|mesh-list
15235680|NCT00822120|Vincristine|vincristine|mesh-list
15235681|NCT00822120|Bleomycin|bleomycin|mesh-list
15235682|NCT00822120|Vinblastine|vinblastine|mesh-list
15235683|NCT00822120|Procarbazine|procarbazine|mesh-list
15235684|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235685|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
15235686|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235687|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235688|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15235689|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
15235690|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235691|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235692|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15235693|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15235694|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15235695|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15235696|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235697|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235698|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
15235699|NCT00822120|Hormones|hormones|mesh-ancestor
15235700|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235701|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15235702|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15235703|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235704|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235705|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
15235706|NCT00799110|Imiquimod|imiquimod|mesh-list
15235707|NCT00799110|Vaccines|vaccines|mesh-list
15235708|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
14921277|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
15235709|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383539|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383540|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383541|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15235710|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14383542|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235711|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235712|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
14383543|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
14383544|NCT01275625|Maraviroc|maraviroc|mesh-list
14383545|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14383546|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14383547|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383548|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14383549|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15235713|NCT00697684|Clofarabine|clofarabine|mesh-list
15235714|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15235715|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235716|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
15235717|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235718|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383550|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
14383551|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383552|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14383553|NCT01275664|Dexamethasone|dexamethasone|mesh-list
14383554|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
14383555|NCT01275664|Cisplatin|cisplatin|mesh-list
14383556|NCT01275664|Carboplatin|carboplatin|mesh-list
14383557|NCT01275664|Aprepitant|aprepitant|mesh-list
14383558|NCT01275664|Granisetron|granisetron|mesh-list
14383559|NCT01275664|Ichthammol|ichthammol|mesh-list
14921278|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14921279|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921280|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14921281|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921282|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
14921283|NCT04055389|Antithrombins|antithrombins|mesh-list
14921284|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
14921285|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14921286|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
14921287|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921288|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383560|NCT01275664|BB 1101|bb 1101|mesh-list
14383561|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383562|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383563|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
14383564|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
14383565|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383566|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383567|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383568|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
14383569|NCT01275664|Hormones|hormones|mesh-ancestor
14383570|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383571|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15235719|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
14383572|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
14383573|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383574|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383575|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14383576|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383577|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
14383578|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14383579|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
14383580|NCT01276041|Paclitaxel|paclitaxel|mesh-list
14383581|NCT01276041|Trastuzumab|trastuzumab|mesh-list
14383582|NCT01276041|Pertuzumab|pertuzumab|mesh-list
14383583|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14383584|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383585|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14383586|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14383587|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14383588|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383589|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383590|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
14383591|NCT01276223|Difluprednate|difluprednate|mesh-list
14383592|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
14383593|NCT01276223|Hormones|hormones|mesh-ancestor
14734097|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
14383594|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383595|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383596|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383597|NCT01276236|Maraviroc|maraviroc|mesh-list
14383598|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14383599|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14383600|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383601|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14383602|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14383603|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
14383604|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383605|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14383606|NCT01276288|Empagliflozin|empagliflozin|mesh-list
14383607|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14383608|NCT01276288|Torsemide|torsemide|mesh-list
14383609|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14383610|NCT01276288|Diuretics|diuretics|mesh-ancestor
14383611|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
14383612|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383613|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14383614|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383615|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383616|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14383617|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383618|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14383619|NCT01276301|Empagliflozin|empagliflozin|mesh-list
14383620|NCT01276301|Verapamil|verapamil|mesh-list
14383621|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14383622|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383623|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383624|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383625|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14383626|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14383627|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383628|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383629|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
14383630|NCT01276314|Prednisolone|prednisolone|mesh-list
14383631|NCT01276314|Etanercept|etanercept|mesh-list
14383632|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383633|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
14383634|NCT01276314|Hormones|hormones|mesh-ancestor
14383635|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383636|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383637|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14383638|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383639|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383640|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383641|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14383642|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14383643|NCT01276314|Analgesics|analgesics|mesh-ancestor
14383644|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
14383645|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383646|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383647|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
14921289|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
14921290|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
14921291|NCT04050540|Doxycycline|doxycycline|mesh-list
14921292|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14921293|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921294|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
14921295|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14921296|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14921297|NCT04044729|Cannabidiol|cannabidiol|mesh-list
14921298|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
14921299|NCT04040946|Choline|choline|mesh-list
14921300|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
14921301|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14921302|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
14921303|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921304|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14921305|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14921306|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
15235720|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235721|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235722|NCT00603954|Vidarabine|vidarabine|mesh-list
15235723|NCT00603954|Fludarabine|fludarabine|mesh-list
15235724|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
15235725|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15235726|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235727|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235728|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
15235729|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235730|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235731|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
15235732|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235733|NCT00603954|Antiviral Agents|antiviral agents|mesh-ancestor
15235734|NCT00603954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383648|NCT01276327|Pioglitazone|pioglitazone|mesh-list
14383649|NCT01276327|Linagliptin|linagliptin|mesh-list
14383650|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383651|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383652|NCT01276327|Incretins|incretins|mesh-ancestor
14383653|NCT01276327|Hormones|hormones|mesh-ancestor
14734098|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734099|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734100|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
14734101|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14734102|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14734103|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734104|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734105|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14734106|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14734107|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734108|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734109|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
14734110|NCT00533468|Lidocaine|lidocaine|mesh-list
14734111|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
14734112|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
14734113|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734114|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734115|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
14734116|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383654|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383655|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14383656|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
14383657|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383658|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383659|NCT01276353|Donepezil|donepezil|mesh-list
14383660|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14383661|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383662|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383663|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
14383664|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383665|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383666|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
14383667|NCT01276379|Leucovorin|leucovorin|mesh-list
14383668|NCT01276379|Folic Acid|folic acid|mesh-list
14383669|NCT01276379|Fluorouracil|fluorouracil|mesh-list
14734117|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14921307|NCT04037527|Gemcitabine|gemcitabine|mesh-list
14921308|NCT04037527|Docetaxel|docetaxel|mesh-list
14921309|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921310|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
14921311|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921312|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921313|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
14921314|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921315|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921316|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921317|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
14921318|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734118|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14734119|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14734120|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15235735|NCT00392353|Azacitidine|azacitidine|mesh-list
15235736|NCT00392353|Vorinostat|vorinostat|mesh-list
15235737|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235738|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
15235739|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235740|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235741|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235742|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14734121|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734122|NCT00533520|Ranibizumab|ranibizumab|mesh-list
14921319|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921320|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921321|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921322|NCT04020718|Nicotine|nicotine|mesh-list
14383670|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
15235743|NCT00003777|Fluorouracil|fluorouracil|mesh-list
15235744|NCT00003777|Amifostine|amifostine|mesh-list
15235745|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235746|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
15235747|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235748|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235749|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235750|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
15235751|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235752|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14734123|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734124|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734125|NCT00533520|Growth Substances|growth substances|mesh-ancestor
14734126|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734127|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734128|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734129|NCT00533533|Docetaxel|docetaxel|mesh-list
14734130|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
14734131|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734132|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
14734133|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
14734134|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
14734135|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734136|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14734137|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734138|NCT00533585|Paclitaxel|paclitaxel|mesh-list
14734139|NCT00533585|Bevacizumab|bevacizumab|mesh-list
14734140|NCT00533585|Carboplatin|carboplatin|mesh-list
14734141|NCT00533585|Sorafenib|sorafenib|mesh-list
14734142|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14734143|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734144|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14734145|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
14734146|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14734147|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734148|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734149|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734150|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734151|NCT00533585|Growth Substances|growth substances|mesh-ancestor
14734152|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734153|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734154|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734155|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753098|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753099|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753100|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14753101|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15235753|NCT00003777|Protective Agents|protective agents|mesh-ancestor
15235754|NCT05214599|Budesonide|budesonide|mesh-list
14921323|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14921324|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
14921325|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921326|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921327|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14921328|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14921329|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
14921330|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383671|NCT01276379|Irinotecan|irinotecan|mesh-list
14383672|NCT01276379|Cetuximab|cetuximab|mesh-list
14383673|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
14383674|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
14383675|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383676|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14383677|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383678|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383679|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
14383680|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383681|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14383682|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14383683|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383684|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383685|NCT01276379|Antidotes|antidotes|mesh-ancestor
14383686|NCT01276379|Protective Agents|protective agents|mesh-ancestor
14383687|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
14383688|NCT01276379|Vitamins|vitamins|mesh-ancestor
14383689|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
14383690|NCT01276379|Hematinics|hematinics|mesh-ancestor
15235755|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15235756|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14734156|NCT00533611|Niacin|niacin|mesh-list
14734157|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383691|NCT01276457|Cyclosporine|cyclosporine|mesh-list
14383692|NCT01276457|Everolimus|everolimus|mesh-list
14383693|NCT01276457|Cyclosporins|cyclosporins|mesh-list
14383694|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383695|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921331|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921332|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
14921333|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921334|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921335|NCT04011150|Fentanyl|fentanyl|mesh-list
14921336|NCT04011150|Ropivacaine|ropivacaine|mesh-list
14921337|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
14921338|NCT04011150|Anesthetics|anesthetics|mesh-list
14383696|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383697|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
14383698|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921339|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921340|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921341|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
14921342|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921343|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14921344|NCT04011150|Narcotics|narcotics|mesh-ancestor
14734158|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734159|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14734160|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
14734161|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14734162|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
15235757|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
15235758|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235759|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235760|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15235761|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
15235762|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
15235763|NCT05214599|Hormones|hormones|mesh-ancestor
15235764|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235765|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15235766|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14383699|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
14383700|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734163|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
14383701|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14383702|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235767|NCT05214573|Glucagon|glucagon|mesh-list
14921345|NCT04011150|Analgesics|analgesics|mesh-ancestor
14921346|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14921347|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14921348|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
14921349|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
14921350|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383703|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14383704|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383705|NCT01276639|Tofacitinib|tofacitinib|mesh-list
14921351|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921352|NCT04008082|Lenvatinib|lenvatinib|mesh-list
14921353|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921354|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921355|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383706|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14383707|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383708|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734164|NCT00533611|Vitamins|vitamins|mesh-ancestor
14921356|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921357|NCT04002180|Vedolizumab|vedolizumab|mesh-list
14921358|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14921359|NCT03997968|Gemcitabine|gemcitabine|mesh-list
14921360|NCT03997968|Rituximab|rituximab|mesh-list
14734165|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
14734166|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
14734167|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14734168|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734169|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14734170|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
14734171|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734172|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734173|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734174|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734175|NCT00533637|Cetirizine|cetirizine|mesh-list
14734176|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14921361|NCT03997968|Capecitabine|capecitabine|mesh-list
14921362|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14383709|NCT01276756|Interferons|interferons|mesh-list
14383710|NCT01276756|Ribavirin|ribavirin|mesh-list
14383711|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
14383712|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
14383713|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14383714|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
14383715|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383716|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
14383717|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383718|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
14383719|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383720|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
14383721|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383722|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14383723|NCT01276821|Epinephrine|epinephrine|mesh-list
14383724|NCT01276821|Racepinephrine|racepinephrine|mesh-list
14383725|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
14383726|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14383727|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14383728|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
14383729|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383730|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383731|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383732|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14383733|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14383734|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
14383735|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383736|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14383737|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
14383738|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
14383739|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
14383740|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14383741|NCT01276847|Etanercept|etanercept|mesh-list
14383742|NCT01276847|Ustekinumab|ustekinumab|mesh-list
14383743|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14383744|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14383745|NCT01276847|Analgesics|analgesics|mesh-ancestor
14383746|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
14383747|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383748|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383749|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383750|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383751|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383752|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383753|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
14383754|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14383755|NCT01277081|Acetaminophen|acetaminophen|mesh-list
14383756|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14383757|NCT01277081|Analgesics|analgesics|mesh-ancestor
14383758|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
14383759|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383760|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383761|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
14383762|NCT01277159|Dexamethasone|dexamethasone|mesh-list
14383763|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
14383764|NCT01277159|Buprenorphine|buprenorphine|mesh-list
14383765|NCT01277159|BB 1101|bb 1101|mesh-list
14383766|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383767|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
14383768|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
14383769|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383770|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383771|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14921363|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921364|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921365|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
14921366|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235768|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15235769|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15235770|NCT05214573|Hormones|hormones|mesh-ancestor
15235771|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235772|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235773|NCT05214573|Incretins|incretins|mesh-ancestor
15235774|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
14383772|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
14383773|NCT01277159|Hormones|hormones|mesh-ancestor
14383774|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383775|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14383776|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383777|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
14383778|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383779|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383780|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14734177|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14734178|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14734179|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
14734180|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
14734181|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734182|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734183|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734184|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
14734185|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14734186|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14734187|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
14734188|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734189|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734190|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734191|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
14734192|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
14734193|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734194|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
14734195|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14734196|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
14734197|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14734198|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14734199|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
14734200|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734201|NCT00533741|Antacids|antacids|mesh-ancestor
14734202|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734203|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14734204|NCT00533858|Losartan|losartan|mesh-list
14734205|NCT00533858|Lacidipine|lacidipine|mesh-list
14734206|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14734207|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14734208|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14734209|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14734210|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734211|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14734212|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734213|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14734214|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383781|NCT01277159|Narcotics|narcotics|mesh-ancestor
14383782|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383783|NCT01277159|Analgesics|analgesics|mesh-ancestor
14383784|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
14383785|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14383786|NCT01277302|Ranibizumab|ranibizumab|mesh-list
14383787|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14921367|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921368|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921369|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
14921370|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921371|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
14921372|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383788|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14383789|NCT01277302|Growth Substances|growth substances|mesh-ancestor
14383790|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383791|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
14383792|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383793|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
14383794|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14921373|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383795|NCT01277510|Cinacalcet|cinacalcet|mesh-list
14383796|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383797|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383798|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14383799|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
14383800|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14383801|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
14383802|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14383803|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
14383804|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383805|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383806|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14383807|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
14383808|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
14383809|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14383810|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
14383811|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383812|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383813|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14383814|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
14383815|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921374|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921375|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921376|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
14921377|NCT03997786|Etanercept|etanercept|mesh-list
14921378|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14921379|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921380|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921381|NCT03997786|Analgesics|analgesics|mesh-ancestor
14921382|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
14921383|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921384|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383816|NCT01277718|Rabeprazole|rabeprazole|mesh-list
14383817|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14383818|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383819|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14383820|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383821|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383822|NCT01277744|Cisplatin|cisplatin|mesh-list
14383823|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466639|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466640|NCT02247466|Rocuronium|rocuronium|mesh-list
14466641|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14466642|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14466643|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14466644|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466645|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466646|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14466647|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14466648|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466649|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
14466650|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466651|NCT02247804|Timolol|timolol|mesh-list
14383824|NCT01277861|Fentanyl|fentanyl|mesh-list
14383825|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14383826|NCT01277861|Narcotics|narcotics|mesh-ancestor
14383827|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383828|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383829|NCT01277861|Analgesics|analgesics|mesh-ancestor
14383830|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
14383831|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383832|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14383833|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14383834|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
14383835|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
14383836|NCT01278160|Insulin|insulin|mesh-list
14383837|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14383838|NCT01278160|Metformin|metformin|mesh-list
14383839|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
14383840|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
14383841|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14383842|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
14383843|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14383844|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
14383845|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383846|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383847|NCT01278173|Vigabatrin|vigabatrin|mesh-list
14383848|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
14383849|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383850|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383851|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
14383852|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383853|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383854|NCT01278342|Octreotide|octreotide|mesh-list
14383855|NCT01278342|Cabergoline|cabergoline|mesh-list
14383856|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383857|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14921385|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921386|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921387|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383858|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383859|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14383860|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14383861|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
14383862|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
14383863|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383864|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383865|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383866|NCT01278394|Tavaborole|tavaborole|mesh-list
14383867|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
14383868|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383869|NCT01278407|Donepezil|donepezil|mesh-list
14383870|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14383871|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383872|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921388|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383873|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
14383874|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14383875|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383876|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
14383877|NCT01278745|Rituximab|rituximab|mesh-list
14383878|NCT01278745|Tacrolimus|tacrolimus|mesh-list
14383879|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383880|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383881|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
14383882|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383883|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383884|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383885|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14383886|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14383887|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383888|NCT01278797|Amlodipine|amlodipine|mesh-list
14383889|NCT01278797|Telmisartan|telmisartan|mesh-list
14383890|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14383891|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14383892|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14383893|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383894|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383895|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383896|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383897|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
14383898|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14383899|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14383900|NCT01279057|Fluticasone|fluticasone|mesh-list
14383901|NCT01279057|Xhance|xhance|mesh-list
14383902|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14383903|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14383904|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
14921389|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
14921390|NCT03994874|Furosemide|furosemide|mesh-list
14921391|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
14921392|NCT03994874|Diuretics|diuretics|mesh-list
14921393|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14921394|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
14921395|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921396|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14921397|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921398|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14921399|NCT03980925|Carboplatin|carboplatin|mesh-list
14921400|NCT03980925|Nivolumab|nivolumab|mesh-list
14921401|NCT03980925|Etoposide|etoposide|mesh-list
14921402|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921403|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921404|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14383905|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383906|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383907|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14383908|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
14383909|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14383910|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14383911|NCT01279187|Teriparatide|teriparatide|mesh-list
14921405|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383912|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383913|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383914|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14383915|NCT01279317|Acetic Acid|acetic acid|mesh-list
14383916|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14383917|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14383918|NCT01279343|Misoprostol|misoprostol|mesh-list
14383919|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14383920|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
14383921|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14383922|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383923|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14383924|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383925|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
14383926|NCT01279447|Bupivacaine|bupivacaine|mesh-list
14383927|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
14383928|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
14383929|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383930|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383931|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
14383932|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383933|NCT01279681|Leucovorin|leucovorin|mesh-list
14383934|NCT01279681|Bevacizumab|bevacizumab|mesh-list
14383935|NCT01279681|Fluorouracil|fluorouracil|mesh-list
14383936|NCT01279681|Capecitabine|capecitabine|mesh-list
14383937|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
14383938|NCT01279681|Calcium|calcium|mesh-list
14383939|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
14383940|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14383941|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921406|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921407|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14921408|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14921409|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921410|NCT03980509|Curcumin|curcumin|mesh-list
14383942|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14383943|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14383944|NCT01279681|Growth Substances|growth substances|mesh-ancestor
14383945|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383946|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
14383947|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383948|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
14383949|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383950|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14383951|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383952|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
14383953|NCT01279681|Antidotes|antidotes|mesh-ancestor
14383954|NCT01279681|Protective Agents|protective agents|mesh-ancestor
14383955|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
14383956|NCT01279681|Vitamins|vitamins|mesh-ancestor
14383957|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
14383958|NCT01279850|Pregabalin|pregabalin|mesh-list
14383959|NCT01279850|Analgesics|analgesics|mesh-ancestor
14383960|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
14383961|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14383962|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383963|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
14383964|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14383965|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14383966|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383967|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14383968|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14383969|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14383970|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14383971|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14383972|NCT01279954|Abatacept|abatacept|mesh-list
14383973|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14383974|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921411|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921412|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921413|NCT03980509|Analgesics|analgesics|mesh-ancestor
14921414|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
14921415|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921416|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921417|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921418|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921419|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921420|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921421|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921422|NCT03974243|Chiauranib|chiauranib|mesh-list
14921423|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921424|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921425|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235775|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235776|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235777|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15235778|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
14383975|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383976|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14383977|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
14383978|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383979|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14383980|NCT01280058|Paclitaxel|paclitaxel|mesh-list
14383981|NCT01280058|Carboplatin|carboplatin|mesh-list
14383982|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14383983|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14383984|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14383985|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
14383986|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
14383987|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
14383988|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14383989|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14383990|NCT01280110|Laxatives|laxatives|mesh-ancestor
14383991|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14383992|NCT01280123|Pioglitazone|pioglitazone|mesh-list
14383993|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14383994|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14383995|NCT01280266|Amlodipine|amlodipine|mesh-list
14383996|NCT01280266|Udenafil|udenafil|mesh-list
14383997|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14383998|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14383999|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384000|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384001|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14384002|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384003|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
14384004|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14384005|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14384006|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384007|NCT01280409|Metformin|metformin|mesh-list
14384008|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15235779|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235780|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15235781|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235782|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235783|NCT05214339|Bevacizumab|bevacizumab|mesh-list
15235784|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235785|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235786|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14384009|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384010|NCT01280591|Naproxen|naproxen|mesh-list
14384011|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14384012|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384013|NCT01280591|Analgesics|analgesics|mesh-ancestor
14384014|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
14384015|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384016|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384017|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384018|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384019|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
14384020|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14384021|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384022|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384023|NCT01280604|Fenofibrate|fenofibrate|mesh-list
14384024|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14384025|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
14384026|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384027|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14384028|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
14384029|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14384030|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
14384031|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384032|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921426|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921427|NCT03972657|Cemiplimab|cemiplimab|mesh-list
14921428|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921429|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921430|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14921431|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14921432|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921433|NCT03967925|Prednisone|prednisone|mesh-list
14921434|NCT03967925|Prednisolone|prednisolone|mesh-list
14921435|NCT03967925|Rituximab|rituximab|mesh-list
14921436|NCT03967925|Belimumab|belimumab|mesh-list
14921437|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921438|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921439|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
14921440|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921441|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921442|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921443|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
14921444|NCT03967925|Hormones|hormones|mesh-ancestor
14921445|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15235787|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15235788|NCT05214339|Growth Substances|growth substances|mesh-ancestor
14921446|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14921447|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921448|NCT03955042|Pemetrexed|pemetrexed|mesh-list
14384033|NCT01280656|Interferons|interferons|mesh-list
14384034|NCT01280656|Ribavirin|ribavirin|mesh-list
14384035|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14384036|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14384037|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384038|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
14384039|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384040|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
14384041|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384042|NCT01280695|Pioglitazone|pioglitazone|mesh-list
14384043|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14384044|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921449|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921450|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235789|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921451|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921452|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15235790|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
15235791|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15235792|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235793|NCT05214222|Paclitaxel|paclitaxel|mesh-list
15235794|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15235795|NCT05214222|Cisplatin|cisplatin|mesh-list
15235796|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921453|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15235797|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384045|NCT01280721|Tolvaptan|tolvaptan|mesh-list
14384046|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14384047|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384048|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
14384049|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384050|NCT01280955|Plerixafor|plerixafor|mesh-list
14384051|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14384052|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14384053|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
14384054|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384055|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14384056|NCT01280968|Vaccines|vaccines|mesh-list
14384057|NCT01280968|Nicotine|nicotine|mesh-list
14384058|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
14384059|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384060|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14384061|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
14384062|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384063|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14384064|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14384065|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
14384066|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384067|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384068|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14384069|NCT01280968|Antacids|antacids|mesh-ancestor
14384070|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14384071|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
14384072|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14384073|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14384074|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384075|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
14384076|NCT01280981|Coagulants|coagulants|mesh-ancestor
14384077|NCT01281007|Acyclovir|acyclovir|mesh-list
14384078|NCT01281007|Famciclovir|famciclovir|mesh-list
14384079|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
14384080|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384081|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14384082|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384083|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384084|NCT01281189|Pramipexole|pramipexole|mesh-list
14384085|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
14384086|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384087|NCT01281189|Protective Agents|protective agents|mesh-ancestor
14384088|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384089|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14384090|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14384091|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
14384092|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
14384093|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384094|NCT01281202|Vigabatrin|vigabatrin|mesh-list
14734215|NCT00533923|Cyclosporine|cyclosporine|mesh-list
14734216|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
14734217|NCT00533923|Fludarabine|fludarabine|mesh-list
14734218|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
14734219|NCT00533923|Cyclosporins|cyclosporins|mesh-list
14734220|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734221|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
14734222|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734223|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734224|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14734225|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
14921454|NCT03954743|Vaccines|vaccines|mesh-list
14384095|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
14384096|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384097|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921455|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
14921456|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921457|NCT03947671|Acetaminophen|acetaminophen|mesh-list
14921458|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921459|NCT03947671|Analgesics|analgesics|mesh-ancestor
14921460|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
14921461|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921462|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921463|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
14921464|NCT03946969|Paclitaxel|paclitaxel|mesh-list
14921465|NCT03946969|Cisplatin|cisplatin|mesh-list
14921466|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921467|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921468|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921469|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921470|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921471|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921472|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
14921473|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
14384098|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
14384099|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384100|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384101|NCT01281306|Valsartan|valsartan|mesh-list
14384102|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14384103|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14384104|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14384105|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14384106|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384107|NCT01281475|Levodopa|levodopa|mesh-list
14384108|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14384109|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14384110|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
14921474|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14921475|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14921476|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921477|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921478|NCT03945643|Urological Agents|urological agents|mesh-ancestor
14921479|NCT03937219|Nivolumab|nivolumab|mesh-list
14921480|NCT03937219|Ipilimumab|ipilimumab|mesh-list
14921481|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921482|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921483|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14384111|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384112|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384113|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384114|NCT01281501|Scopolamine|scopolamine|mesh-list
14384115|NCT01281501|Pantoprazole|pantoprazole|mesh-list
14384116|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
14384117|NCT01281501|Antacids|antacids|mesh-list
14384118|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14384119|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14384120|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14384121|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384122|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384123|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14384124|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
14384125|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
14921484|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921485|NCT03932318|Azacitidine|azacitidine|mesh-list
14921486|NCT03932318|Venetoclax|venetoclax|mesh-list
14384126|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384127|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384128|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
14384129|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14384130|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
14384131|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384132|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14384133|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
14384134|NCT01281839|Ribavirin|ribavirin|mesh-list
14384135|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14384136|NCT01281839|Simeprevir|simeprevir|mesh-list
14384137|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
14384138|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384139|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
14384140|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384141|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
14384142|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384143|NCT01281865|Everolimus|everolimus|mesh-list
14384144|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
14384145|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384146|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384147|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
14384148|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384149|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921487|NCT03932318|Lintuzumab|lintuzumab|mesh-list
14921488|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921489|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
14921490|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921491|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921492|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921493|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14384150|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384151|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384152|NCT01281917|Sirolimus|sirolimus|mesh-list
14384153|NCT01281917|Bortezomib|bortezomib|mesh-list
14384154|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384155|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14384156|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384157|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14384158|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
14384159|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384160|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
14384161|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384162|NCT01281956|Naluzotan|naluzotan|mesh-list
14384163|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14384164|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14384165|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
14384166|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384167|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384168|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384169|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
14921494|NCT03913832|Sirolimus|sirolimus|mesh-list
14921495|NCT03913832|Paclitaxel|paclitaxel|mesh-list
14384170|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14921496|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921497|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921498|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921499|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921500|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921501|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921502|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14921503|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921504|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14384171|NCT01281969|Antibodies|antibodies|mesh-list
14384172|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
14384173|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14384174|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
14384175|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384176|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14384177|NCT01282138|Dextrans|dextrans|mesh-list
14384178|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14384179|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14384180|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
14384181|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
14384182|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
14384183|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14384184|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384185|NCT01282138|Analgesics|analgesics|mesh-ancestor
14384186|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
14921505|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
14921506|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921507|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
14921508|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921509|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14921510|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
14921511|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921512|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921513|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930988|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
14930989|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930990|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
14930991|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930992|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
14930993|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930994|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14930995|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
14930996|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14930997|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930998|NCT01436916|Vitamins|vitamins|mesh-ancestor
14930999|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
14931000|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14931001|NCT01436929|Silymarin|silymarin|mesh-list
14931002|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
14931003|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931004|NCT01436929|Protective Agents|protective agents|mesh-ancestor
14931005|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931006|NCT01436968|Valacyclovir|valacyclovir|mesh-list
14931007|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
14931008|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931009|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
14931010|NCT01436994|Carbimazole|carbimazole|mesh-list
14931011|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
14931012|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384187|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384188|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384189|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384190|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384191|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14384192|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14384193|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14384194|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
14384195|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
14384196|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384197|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384198|NCT01282164|Insulin|insulin|mesh-list
14384199|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14384200|NCT01282164|Glucagon|glucagon|mesh-list
14384201|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14921514|NCT03900793|Sunitinib|sunitinib|mesh-list
14921515|NCT03900793|Losartan|losartan|mesh-list
14921516|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921517|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14921518|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14921519|NCT03900793|Growth Substances|growth substances|mesh-ancestor
14921520|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921521|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
14384202|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14384203|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384204|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14384205|NCT01282164|Hormones|hormones|mesh-ancestor
14384206|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384207|NCT01282164|Incretins|incretins|mesh-ancestor
14384208|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14384209|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14384210|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14384211|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384212|NCT01282424|Idelalisib|idelalisib|mesh-list
14384213|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384214|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384215|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384216|NCT01282463|Docetaxel|docetaxel|mesh-list
14384217|NCT01282463|Ramucirumab|ramucirumab|mesh-list
14384218|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384219|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
14384220|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
14384221|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
14384222|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921522|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14921523|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921524|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921525|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14921526|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14921527|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14384223|NCT01282476|Rituximab|rituximab|mesh-list
14384224|NCT01282476|Panobinostat|panobinostat|mesh-list
14384225|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14384226|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384227|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
14384228|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384229|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384230|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14384231|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384232|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921528|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14921529|NCT03897439|Bupropion|bupropion|mesh-list
14921530|NCT03897439|Nicotine|nicotine|mesh-list
14921531|NCT03897439|Varenicline|varenicline|mesh-list
14921532|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15235798|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235799|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235800|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
15235801|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235802|NCT05214157|Bupivacaine|bupivacaine|mesh-list
15235803|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
15235804|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
15235805|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235806|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235807|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
15235808|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235809|NCT05214001|Almotriptan|almotriptan|mesh-list
14921533|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
14921534|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921535|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921536|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14921537|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14921538|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14921539|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921540|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921541|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14921542|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
14921543|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14384233|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14384234|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14384235|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14384236|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384237|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384238|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921544|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14921545|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14921546|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14921547|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
14921548|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14921549|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14921550|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921551|NCT03887624|Ethosuximide|ethosuximide|mesh-list
14921552|NCT03887624|Citalopram|citalopram|mesh-list
14921553|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14921554|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14921555|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14921556|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921557|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921558|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
14921559|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921560|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14921561|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
14921562|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14921563|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
14921564|NCT03883412|Liraglutide|liraglutide|mesh-list
14921565|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14921566|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921567|NCT03883412|Incretins|incretins|mesh-ancestor
14921568|NCT03883412|Hormones|hormones|mesh-ancestor
14921569|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921570|NCT03867682|Venetoclax|venetoclax|mesh-list
15235810|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15235811|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
15235812|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235813|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235814|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384239|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384240|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14384241|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
14384242|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14384243|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14384244|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14384245|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14384246|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384247|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384248|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384249|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384250|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14384251|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
14384252|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14384253|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
14384254|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14384255|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14384256|NCT01283009|Prednisolone|prednisolone|mesh-list
14384257|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
14384258|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14384259|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
14384260|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384261|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
14384262|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
14921571|NCT03867682|Lintuzumab|lintuzumab|mesh-list
14921572|NCT03867682|Spironolactone|spironolactone|mesh-list
14921573|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921574|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14921575|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
14921576|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921577|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921578|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14921579|NCT03867682|Diuretics|diuretics|mesh-ancestor
14921580|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
14921581|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921582|NCT03864419|Prednisone|prednisone|mesh-list
14921583|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
14384263|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384264|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384265|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14384266|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
14384267|NCT01283009|Hormones|hormones|mesh-ancestor
14384268|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384269|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14384270|NCT01283009|Protective Agents|protective agents|mesh-ancestor
14384271|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14384272|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384273|NCT01283139|Sifalimumab|sifalimumab|mesh-list
14384274|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14921584|NCT03864419|Rituximab|rituximab|mesh-list
14921585|NCT03864419|Doxorubicin|doxorubicin|mesh-list
14921586|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14921587|NCT03864419|Methotrexate|methotrexate|mesh-list
14921588|NCT03864419|Etoposide|etoposide|mesh-list
14921589|NCT03864419|Vincristine|vincristine|mesh-list
14921590|NCT03864419|Daunorubicin|daunorubicin|mesh-list
14921591|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
14921592|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14921593|NCT03864419|Antibodies|antibodies|mesh-list
14921594|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
14921595|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14921596|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921597|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
14921598|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921599|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921600|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921601|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
14921602|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921603|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921604|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14384275|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
14384276|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921605|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14921606|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14921607|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14384277|NCT01283152|Lactulose|lactulose|mesh-list
14384278|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14384279|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14384280|NCT01283152|Laxatives|laxatives|mesh-ancestor
14384281|NCT01283282|Clopidogrel|clopidogrel|mesh-list
14384282|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14384283|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14384284|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14384285|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14384286|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
14384287|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384288|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384289|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384290|NCT01283334|Carboplatin|carboplatin|mesh-list
14384291|NCT01283334|Cetuximab|cetuximab|mesh-list
14384292|NCT01283334|Everolimus|everolimus|mesh-list
14384293|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384294|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14384295|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384296|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
14384297|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384298|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
14384299|NCT01283386|Chlorambucil|chlorambucil|mesh-list
14384300|NCT01283386|Rituximab|rituximab|mesh-list
14384301|NCT01283386|Fludarabine|fludarabine|mesh-list
14921608|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921609|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921610|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
14921611|NCT03864419|Hormones|hormones|mesh-ancestor
14921612|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921613|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14921614|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14921615|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
14921616|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14921617|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921618|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
14921619|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
14921620|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14921621|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14921622|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921623|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921624|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921625|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921626|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
14921627|NCT03858621|Fentanyl|fentanyl|mesh-list
14384302|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384303|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
14384304|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384305|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384306|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921628|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14921629|NCT03858621|Narcotics|narcotics|mesh-ancestor
14921630|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921631|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921632|NCT03858621|Analgesics|analgesics|mesh-ancestor
14921633|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
14921634|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921635|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14384307|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
14921636|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14466652|NCT02247804|Bimatoprost|bimatoprost|mesh-list
14921637|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
14921638|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
14921639|NCT03845270|Docetaxel|docetaxel|mesh-list
14921640|NCT03845270|Trastuzumab|trastuzumab|mesh-list
14921641|NCT03845270|Pertuzumab|pertuzumab|mesh-list
14921642|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921643|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921644|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921645|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921646|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921647|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921648|NCT03836651|Antioxidants|antioxidants|mesh-list
14384308|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384309|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384310|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14384311|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14384312|NCT01283464|Vitamin A|vitamin a|mesh-list
14384313|NCT01283464|Tretinoin|tretinoin|mesh-list
14384314|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384315|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
14384316|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
14384317|NCT01283464|Vitamins|vitamins|mesh-ancestor
14384318|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
14384319|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384320|NCT01283516|Ceritinib|ceritinib|mesh-list
14384321|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384322|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14384323|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384324|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384325|NCT01283542|Pasireotide|pasireotide|mesh-list
14384326|NCT01283542|Hormones|hormones|mesh-ancestor
14921649|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921650|NCT03836651|Protective Agents|protective agents|mesh-ancestor
14921651|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921652|NCT03824938|Aspirin|aspirin|mesh-list
14384327|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921653|NCT03824938|Acetaminophen|acetaminophen|mesh-list
14921654|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921655|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384328|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384329|NCT01283555|Tenofovir|tenofovir|mesh-list
14384330|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
14384331|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384332|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14384333|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14384334|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384335|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384336|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14384337|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14384338|NCT01283581|Vancomycin|vancomycin|mesh-list
14384339|NCT01283581|Linezolid|linezolid|mesh-list
14384340|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14384341|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384342|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14384343|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384344|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384345|NCT01283971|Adalimumab|adalimumab|mesh-list
14384346|NCT01283971|Methotrexate|methotrexate|mesh-list
14384347|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14384348|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
14384349|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14384350|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921656|NCT03824938|Analgesics|analgesics|mesh-ancestor
14921657|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
14921658|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921659|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921660|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921661|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921662|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14921663|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14921664|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921665|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14921666|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14921667|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921668|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
14921669|NCT03813121|Midazolam|midazolam|mesh-list
14921670|NCT03813121|Ketamine|ketamine|mesh-list
14921671|NCT03813121|Analgesics|analgesics|mesh-ancestor
14921672|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
14921673|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235815|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
15235816|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15235817|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15235818|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
15235819|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235820|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15235821|NCT05213884|Cisplatin|cisplatin|mesh-list
15235822|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235823|NCT05213832|Isoflurane|isoflurane|mesh-list
15235824|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15235825|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
15235826|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
15235827|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235828|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235829|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
15235830|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15235831|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
15235832|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235833|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235834|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15235835|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
15235836|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14384351|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235837|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
14921674|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921675|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14921676|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14921677|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
14921678|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
14384352|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
14384353|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384354|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384355|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
14384356|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384357|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14384358|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384359|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
14384360|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384361|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14384362|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466653|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14466654|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14466655|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
14466656|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921679|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921680|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14921681|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14921682|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921683|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921684|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14921685|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14921686|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14921687|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14921688|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14921689|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
14921690|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
14921691|NCT03811886|Natalizumab|natalizumab|mesh-list
14921692|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
14921693|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921694|NCT03807921|Aspirin|aspirin|mesh-list
14466657|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466658|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466659|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14466660|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466661|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
14466662|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14466663|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466664|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14466665|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14466666|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466667|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466668|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466669|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14466670|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14466671|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14466672|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14466673|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14466674|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384363|NCT01284296|Lidocaine|lidocaine|mesh-list
14384364|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
14384365|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
14384366|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14384367|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384368|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
14384369|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384370|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14384371|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14384372|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14384373|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384374|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384375|NCT01284335|Gemcitabine|gemcitabine|mesh-list
14384376|NCT01284335|Docetaxel|docetaxel|mesh-list
14384377|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14384378|NCT01284335|Temozolomide|temozolomide|mesh-list
14384379|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384380|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14384381|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
14384382|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384383|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
14384384|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384385|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384386|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384387|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
14384388|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384389|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
14384390|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
14384391|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
14384392|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14384393|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14384394|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
14384395|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14921695|NCT03807921|Warfarin|warfarin|mesh-list
14921696|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921697|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921698|NCT03807921|Analgesics|analgesics|mesh-ancestor
14921699|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
14384396|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14384397|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14384398|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14384399|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384400|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14384401|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14384402|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14384403|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14384404|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
14384405|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384406|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384407|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14384408|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14384409|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
14931013|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
14921700|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921701|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384410|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14384411|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14384412|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
14384413|NCT01284621|Empagliflozin|empagliflozin|mesh-list
14384414|NCT01284621|Ramipril|ramipril|mesh-list
14384415|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14384416|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
14384417|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384418|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384419|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14384420|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14384421|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14384422|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921702|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921703|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921704|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14921705|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14921706|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921707|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14921708|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14921709|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921710|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
14921711|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
14921712|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
14921713|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14921714|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
14921715|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921716|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384423|NCT01284634|Cannabidiol|cannabidiol|mesh-list
14384424|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
14384425|NCT01284959|Risperidone|risperidone|mesh-list
14384426|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14384427|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14384428|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
14384429|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921717|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14921718|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
14921719|NCT03786783|Vitamin A|vitamin a|mesh-list
14921720|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
14921721|NCT03786783|Melphalan|melphalan|mesh-list
14921722|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
14921723|NCT03786783|Thiotepa|thiotepa|mesh-list
14921724|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14921725|NCT03786783|Cisplatin|cisplatin|mesh-list
14921726|NCT03786783|Carboplatin|carboplatin|mesh-list
14921727|NCT03786783|Doxorubicin|doxorubicin|mesh-list
14921728|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14921729|NCT03786783|Etoposide|etoposide|mesh-list
14921730|NCT03786783|Vincristine|vincristine|mesh-list
14921731|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
14921732|NCT03786783|Topotecan|topotecan|mesh-list
14921733|NCT03786783|Daunorubicin|daunorubicin|mesh-list
14921734|NCT03786783|Tretinoin|tretinoin|mesh-list
14921735|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
14921736|NCT03786783|Dinutuximab|dinutuximab|mesh-list
14921737|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
14921738|NCT03786783|Razoxane|razoxane|mesh-list
14921739|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
14921740|NCT03786783|Isotretinoin|isotretinoin|mesh-list
14921741|NCT03786783|Sargramostim|sargramostim|mesh-list
14921742|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921743|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
14384430|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921744|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921745|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921746|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14921747|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
14921748|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921749|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921750|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14384431|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384432|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14384433|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14384434|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14384435|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14921751|NCT03786783|Vitamins|vitamins|mesh-ancestor
14921752|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
14921753|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14921754|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14921755|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14384436|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14384437|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
14384438|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14384439|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14384440|NCT01285050|Tenofovir|tenofovir|mesh-list
14384441|NCT01285050|Emtricitabine|emtricitabine|mesh-list
14384442|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
14384443|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14384444|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
14384445|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384446|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14384447|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14384448|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384449|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384450|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14384451|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14384452|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14384453|NCT01285310|Thalidomide|thalidomide|mesh-list
14384454|NCT01285310|Apremilast|apremilast|mesh-list
14921756|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921757|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921758|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921759|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921760|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921761|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14921762|NCT03786783|Protective Agents|protective agents|mesh-ancestor
14921763|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
14921764|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
14921765|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14921766|NCT03778944|Dopamine|dopamine|mesh-list
14921767|NCT03778944|Mannitol|mannitol|mesh-list
14921768|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14921769|NCT03778944|Diuretics|diuretics|mesh-ancestor
14921770|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
14921771|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921772|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14921773|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
14384455|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921774|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
14921775|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384456|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921776|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
14921777|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384457|NCT01285310|Analgesics|analgesics|mesh-ancestor
14384458|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
14734226|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734227|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734228|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14734229|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235838|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384459|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921778|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921779|NCT03778944|Protective Agents|protective agents|mesh-ancestor
14921780|NCT03777462|Gemcitabine|gemcitabine|mesh-list
14921781|NCT03777462|Paclitaxel|paclitaxel|mesh-list
14921782|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14921783|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14921784|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921785|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14921786|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14921787|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14921788|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921789|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14921790|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
14921791|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
14921792|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921793|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235839|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235840|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15235841|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
15235842|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
15235843|NCT05213676|Protective Agents|protective agents|mesh-ancestor
15235844|NCT05213585|Ivermectin|ivermectin|mesh-list
15235845|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15235846|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235847|NCT05213312|Paclitaxel|paclitaxel|mesh-list
14384460|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384461|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384462|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384463|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14384464|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14384465|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384466|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384467|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384468|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
14734230|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
14734231|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734232|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
14734233|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14734234|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734235|NCT00533936|Paclitaxel|paclitaxel|mesh-list
14734236|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
14734237|NCT00533936|Doxorubicin|doxorubicin|mesh-list
14734238|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14734239|NCT00533936|Fluorouracil|fluorouracil|mesh-list
14734240|NCT00533936|Trastuzumab|trastuzumab|mesh-list
14734241|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14734242|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734243|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
14734244|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
14734245|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14734246|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734247|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734248|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
14734249|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734250|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734251|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14734252|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
14734253|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15235848|NCT05213312|Fluorouracil|fluorouracil|mesh-list
15235849|NCT05213312|Nivolumab|nivolumab|mesh-list
15235850|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15235851|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384469|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
14384470|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14384471|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384472|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14384473|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14384474|NCT01285310|Growth Substances|growth substances|mesh-ancestor
14384475|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
14384476|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384477|NCT01285323|Reslizumab|reslizumab|mesh-list
14921794|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921795|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
14921796|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921797|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
14921798|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
14921799|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
14921800|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921801|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921802|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
14921803|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921804|NCT03768440|Ropivacaine|ropivacaine|mesh-list
14921805|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
14921806|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
14921807|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921808|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921809|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
14921810|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921811|NCT03758170|Dexamethasone|dexamethasone|mesh-list
14921812|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921813|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
14921814|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
14921815|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921816|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734254|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14734255|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14734256|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14734257|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734258|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
14734259|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14734260|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921817|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14921818|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
14921819|NCT03758170|Hormones|hormones|mesh-ancestor
14921820|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921821|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14921822|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235852|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235853|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
15235854|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
14384478|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14384479|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14384480|NCT01285401|Interferons|interferons|mesh-list
14384481|NCT01285401|Interferon-beta|interferon-beta|mesh-list
14384482|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
14384483|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384484|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
14384485|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384486|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
14384487|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384488|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14384489|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
14384490|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14384491|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
15235855|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235856|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
15235857|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14384492|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734261|NCT00533962|Anecortave|anecortave|mesh-list
14921823|NCT03754049|Dexamethasone|dexamethasone|mesh-list
14921824|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
14384493|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384494|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14384495|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
14384496|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
14384497|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14384498|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
14384499|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384500|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384501|NCT01285609|Paclitaxel|paclitaxel|mesh-list
14384502|NCT01285609|Carboplatin|carboplatin|mesh-list
14384503|NCT01285609|Ipilimumab|ipilimumab|mesh-list
14384504|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14384505|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384506|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
14384507|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
14384508|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
14384509|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384510|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14384511|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14384512|NCT01285635|Docetaxel|docetaxel|mesh-list
14384513|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384514|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14384515|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14384516|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14384517|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384518|NCT01285908|Norepinephrine|norepinephrine|mesh-list
14384519|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14384520|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14384521|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
14384522|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384523|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384524|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384525|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
14384526|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
14384527|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384528|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14384529|NCT01286077|Bortezomib|bortezomib|mesh-list
14384530|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384531|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
14384532|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14921825|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14921826|NCT03754049|BB 1101|bb 1101|mesh-list
14921827|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921828|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
14921829|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
14921830|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921831|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921832|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14921833|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
14921834|NCT03754049|Hormones|hormones|mesh-ancestor
14921835|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921836|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14921837|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921838|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
14921839|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921840|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921841|NCT03749109|Quinagolide|quinagolide|mesh-list
14921842|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
14921843|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
14921844|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921845|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921846|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921847|NCT03733119|TIC10 compound|tic10 compound|mesh-list
14921848|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931014|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
14931015|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931016|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931017|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14931018|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
14384533|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14384534|NCT01286168|Eusol|eusol|mesh-list
14384535|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14384536|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14384537|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384538|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
14384539|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14384540|NCT01286259|Disulfiram|disulfiram|mesh-list
14384541|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14384542|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14384543|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384544|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384545|NCT01286402|Bupropion|bupropion|mesh-list
14384546|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14384547|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
14384548|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14384549|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14384550|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14384551|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384552|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384553|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
14384554|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384555|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931019|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931020|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14931021|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14384556|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14384557|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14384558|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384559|NCT01286454|Fesoterodine|fesoterodine|mesh-list
14384560|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14384561|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14384562|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
14384563|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384564|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931022|NCT01437046|Doxazosin|doxazosin|mesh-list
14931023|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14931024|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14931025|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14931026|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14931027|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
15235858|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235859|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
14921849|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14921850|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14921851|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921852|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
14921853|NCT03705962|Tobramycin|tobramycin|mesh-list
14921854|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14921855|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14921856|NCT03705338|Propofol|propofol|mesh-list
14921857|NCT03705338|Anesthetics|anesthetics|mesh-list
14921858|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
14921859|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14921860|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921861|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921862|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14921863|NCT03704285|Propofol|propofol|mesh-list
14921864|NCT03704285|Anesthetics|anesthetics|mesh-list
14921865|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
14921866|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14921867|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921868|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921869|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14921870|NCT03702179|Durvalumab|durvalumab|mesh-list
14921871|NCT03702179|Tremelimumab|tremelimumab|mesh-list
14921872|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921873|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384565|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384566|NCT01286454|Urological Agents|urological agents|mesh-ancestor
14384567|NCT01286558|Amlodipine|amlodipine|mesh-list
14384568|NCT01286558|Telmisartan|telmisartan|mesh-list
14384569|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14921874|NCT03696537|Fludarabine|fludarabine|mesh-list
14921875|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921876|NCT03695380|Atezolizumab|atezolizumab|mesh-list
14921877|NCT03695380|Niraparib|niraparib|mesh-list
14921878|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921879|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14921880|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921881|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921882|NCT03671330|Letrozole|letrozole|mesh-list
14921883|NCT03671330|Goserelin|goserelin|mesh-list
14921884|NCT03671330|Anastrozole|anastrozole|mesh-list
14921885|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921886|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14921887|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14384570|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14384571|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384572|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384573|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14921888|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921889|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921890|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14921891|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
14921892|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14921893|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921894|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14921895|NCT03669523|Denosumab|denosumab|mesh-list
14921896|NCT03669523|Nivolumab|nivolumab|mesh-list
14921897|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921898|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921899|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14921900|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921901|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14921902|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921903|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
14921904|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14921905|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921906|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921907|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14921908|NCT03668951|Analgesics|analgesics|mesh-ancestor
14921909|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
14734262|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734263|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734264|NCT00533962|Growth Substances|growth substances|mesh-ancestor
14734265|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921910|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734266|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734267|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734268|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
14734269|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14734270|NCT00534014|Ascorbic Acid|ascorbic acid|mesh-list
14734271|NCT00534014|Vitamins|vitamins|mesh-ancestor
14921911|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14921912|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14921913|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14921914|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
14921915|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921916|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921917|NCT03665207|Insulin|insulin|mesh-list
14921918|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14921919|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921920|NCT03663335|Tacrolimus|tacrolimus|mesh-list
14921921|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14921922|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
14921923|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921924|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14921925|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921926|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921927|NCT03661996|Lidocaine|lidocaine|mesh-list
14921928|NCT03661996|Epinephrine|epinephrine|mesh-list
14921929|NCT03661996|Capsaicin|capsaicin|mesh-list
14921930|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
14384574|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384575|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
14384576|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14384577|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14384578|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
14384579|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
14921931|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
14384580|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384581|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14384582|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14384583|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235860|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235861|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15235862|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15235863|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15235864|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15235865|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15235866|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14384584|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384585|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14384586|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14384587|NCT01286753|Vemurafenib|vemurafenib|mesh-list
14384588|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384589|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14384590|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384591|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384592|NCT01286805|Bupivacaine|bupivacaine|mesh-list
14384593|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
14384594|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
14734272|NCT00534014|Micronutrients|micronutrients|mesh-ancestor
15235867|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235868|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235869|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15235870|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15235871|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15235872|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
15235873|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235874|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734273|NCT00534014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734274|NCT00534014|Antioxidants|antioxidants|mesh-ancestor
14734275|NCT00534014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734276|NCT00534014|Protective Agents|protective agents|mesh-ancestor
14384595|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14384596|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384597|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
14384598|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384599|NCT01286818|Leucovorin|leucovorin|mesh-list
14384600|NCT01286818|Fluorouracil|fluorouracil|mesh-list
14384601|NCT01286818|Irinotecan|irinotecan|mesh-list
14384602|NCT01286818|Ramucirumab|ramucirumab|mesh-list
14384603|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14921932|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921933|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921934|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
14921935|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921936|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14921937|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14921938|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14921939|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14921940|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921941|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14921942|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14921943|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14921944|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14921945|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14921946|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14384604|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
14384605|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
14384606|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384607|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14384608|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384609|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384610|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
14384611|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384612|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14384613|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14384614|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384615|NCT01286818|Antidotes|antidotes|mesh-ancestor
14384616|NCT01286818|Protective Agents|protective agents|mesh-ancestor
14384617|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
14384618|NCT01286818|Vitamins|vitamins|mesh-ancestor
14384619|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
14384620|NCT01286987|Talazoparib|talazoparib|mesh-list
14921947|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
14921948|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14921949|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
14921950|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
15235875|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15235876|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15235877|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
15235878|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15235879|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15235880|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
15235881|NCT05213065|Bupivacaine|bupivacaine|mesh-list
15235882|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
15235883|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
15235884|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921951|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
14921952|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14921953|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
14921954|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
14921955|NCT03659799|Insulin|insulin|mesh-list
14921956|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14921957|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
14921958|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14921959|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921960|NCT03646058|Buprenorphine|buprenorphine|mesh-list
14921961|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14921962|NCT03646058|Narcotics|narcotics|mesh-ancestor
15235885|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384621|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14384622|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921963|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14921964|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921965|NCT03646058|Analgesics|analgesics|mesh-ancestor
14921966|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
14921967|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14921968|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14384623|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384624|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384625|NCT01287039|Reslizumab|reslizumab|mesh-list
14384626|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14384627|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14384628|NCT01287078|Cyclosporine|cyclosporine|mesh-list
14384629|NCT01287078|Cyclosporins|cyclosporins|mesh-list
14384630|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384631|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384632|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384633|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
14384634|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384635|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
14384636|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384637|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
14384638|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384639|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14384640|NCT01287117|Omalizumab|omalizumab|mesh-list
14384641|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14384642|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14384643|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
14384644|NCT01287195|Omeprazole|omeprazole|mesh-list
14921969|NCT03641755|Olaparib|olaparib|mesh-list
14921970|NCT03641755|Sapacitabine|sapacitabine|mesh-list
14921971|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14921972|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921973|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921974|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921975|NCT03638999|Ketorolac|ketorolac|mesh-list
14921976|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14921977|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14921978|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384645|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
14384646|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14384647|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14384648|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14384649|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384650|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384651|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
14384652|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384653|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384654|NCT01287221|Riboflavin|riboflavin|mesh-list
14384655|NCT01287221|Rifampin|rifampin|mesh-list
14384656|NCT01287221|Vitamins|vitamins|mesh-ancestor
14384657|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
14384658|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384659|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
14384660|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14921979|NCT03638999|Analgesics|analgesics|mesh-ancestor
14384661|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
14384662|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14384663|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384664|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
14384665|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15235886|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
15235887|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235888|NCT05212766|Vaccines|vaccines|mesh-list
15235889|NCT05212766|Immunologic Factors|immunologic factors|mesh-ancestor
15235890|NCT05212766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384666|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384667|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384668|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14384669|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14384670|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14384671|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14384672|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14384673|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14384674|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14384675|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
14384676|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
14384677|NCT01287364|Ciclesonide|ciclesonide|mesh-list
14384678|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384679|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
14384680|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14384681|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
14384682|NCT01287364|Hormones|hormones|mesh-ancestor
14384683|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384684|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384685|NCT01287377|Nicotine|nicotine|mesh-list
14921980|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
14921981|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235891|NCT05212662|Cysteamine|cysteamine|mesh-list
15235892|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
15235893|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235894|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
15235895|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15235896|NCT05212597|Losartan|losartan|mesh-list
15235897|NCT05212597|Amlodipine|amlodipine|mesh-list
15235898|NCT05212597|Valsartan|valsartan|mesh-list
14921982|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921983|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14921984|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14921985|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14921986|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14921987|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14921988|NCT03635021|Bevacizumab|bevacizumab|mesh-list
14384686|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14384687|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
14384688|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384689|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384690|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14384691|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14384692|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14384693|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384694|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384695|NCT01287520|Carboplatin|carboplatin|mesh-list
14384696|NCT01287520|Pemetrexed|pemetrexed|mesh-list
14384697|NCT01287520|Ranitidine|ranitidine|mesh-list
14384698|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14384699|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384700|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384701|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384702|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14384703|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14384704|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14384705|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14921989|NCT03635021|Panitumumab|panitumumab|mesh-list
14921990|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14921991|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14921992|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14921993|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14921994|NCT03635021|Growth Substances|growth substances|mesh-ancestor
14921995|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14921996|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14921997|NCT03628209|Nivolumab|nivolumab|mesh-list
14921998|NCT03628209|Azacitidine|azacitidine|mesh-list
14921999|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922000|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922001|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14922002|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384706|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14384707|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
14384708|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
14384709|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384710|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384711|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14384712|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384713|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14384714|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384715|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384716|NCT01287832|Vancomycin|vancomycin|mesh-list
14384717|NCT01287832|Daptomycin|daptomycin|mesh-list
14384718|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14384719|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922003|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922004|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
14922005|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922006|NCT03626922|Folic Acid|folic acid|mesh-list
14922007|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
14922008|NCT03626922|Hydroxocobalamin|hydroxocobalamin|mesh-list
14922009|NCT03626922|Dexamethasone|dexamethasone|mesh-list
14922010|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
14922011|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
14922012|NCT03626922|Pemetrexed|pemetrexed|mesh-list
14922013|NCT03626922|Vitamins|vitamins|mesh-ancestor
14922014|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
14922015|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922016|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922017|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
14922018|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
14922019|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384720|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14384721|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14384722|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14384723|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384724|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384725|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384726|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384727|NCT01288079|Analgesics|analgesics|mesh-ancestor
14384728|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
14384729|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384730|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
14384731|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14384732|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
14384733|NCT01288209|Ribavirin|ribavirin|mesh-list
14384734|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14384735|NCT01288209|Simeprevir|simeprevir|mesh-list
14384736|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
14384737|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384738|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
14384739|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384740|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
14384741|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384742|NCT01288443|Atorvastatin|atorvastatin|mesh-list
14384743|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14922020|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922021|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
14922022|NCT03626922|Hormones|hormones|mesh-ancestor
14922023|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922024|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14922025|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922026|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922027|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922028|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922029|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14922030|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14922031|NCT03626922|Hematinics|hematinics|mesh-ancestor
14922032|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
14922033|NCT03625141|Atezolizumab|atezolizumab|mesh-list
14922034|NCT03625141|Vemurafenib|vemurafenib|mesh-list
14922035|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922036|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14922037|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931028|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384744|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14384745|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14384746|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
14384747|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384748|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14384749|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14384750|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384751|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
14384752|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384753|NCT01288469|Atorvastatin|atorvastatin|mesh-list
14384754|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14384755|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14384756|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14384757|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
14384758|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384759|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14384760|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14384761|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384762|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
14384763|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384764|NCT01288521|Ketoconazole|ketoconazole|mesh-list
14384765|NCT01288521|Tacrolimus|tacrolimus|mesh-list
14384766|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384767|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
14384768|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235899|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15235900|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15235901|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15235902|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15235903|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235904|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15235905|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235906|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
15235907|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15235908|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15235909|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15235910|NCT05212337|Denosumab|denosumab|mesh-list
15235911|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15235912|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235913|NCT05212246|Imiquimod|imiquimod|mesh-list
15235914|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15235915|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
15235916|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235917|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235918|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
15235919|NCT05212025|Gemcitabine|gemcitabine|mesh-list
15235920|NCT05212025|Adavosertib|adavosertib|mesh-list
15235921|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15235922|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
15235923|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235924|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15235925|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
15235926|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235927|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15235928|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15235929|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
15235930|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235931|NCT05211791|Anesthetics|anesthetics|mesh-list
15235932|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15235933|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235934|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
15235935|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
15235936|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15235937|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15235938|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15235939|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235940|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
15235941|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14384769|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14384770|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384771|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384772|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
14384773|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384774|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14384775|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14384776|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14384777|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
14384778|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384779|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14384780|NCT01288781|Acetazolamide|acetazolamide|mesh-list
14384781|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
14384782|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14384783|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384784|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384785|NCT01288781|Diuretics|diuretics|mesh-ancestor
14384786|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
14384787|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384788|NCT01288807|Milnacipran|milnacipran|mesh-list
14384789|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14384790|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14384791|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384792|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384793|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384794|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384795|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384796|NCT01288807|Analgesics|analgesics|mesh-ancestor
14384797|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
14384798|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384799|NCT01288859|Curcumin|curcumin|mesh-list
14384800|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14384801|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384802|NCT01288859|Analgesics|analgesics|mesh-ancestor
14384803|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
14384804|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384805|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384806|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384807|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384808|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384809|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384810|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922038|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922039|NCT03620942|Phenylephrine|phenylephrine|mesh-list
14922040|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
14922041|NCT03620942|Ephedrine|ephedrine|mesh-list
14922042|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14922043|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14922044|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
14922045|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
14922046|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922047|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922048|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
14384811|NCT01288911|Bicalutamide|bicalutamide|mesh-list
14384812|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
14922049|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
14922050|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
14384813|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
14384814|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384815|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384816|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384817|NCT01288937|Milnacipran|milnacipran|mesh-list
14384818|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
14384819|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14384820|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14384821|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14384822|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384823|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384824|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922051|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14922052|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14922053|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14922054|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
14922055|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922056|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922057|NCT03620942|Protective Agents|protective agents|mesh-ancestor
14922058|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14922059|NCT03620903|Rituximab|rituximab|mesh-list
14922060|NCT03620903|Bortezomib|bortezomib|mesh-list
14384825|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384826|NCT01288937|Analgesics|analgesics|mesh-ancestor
14384827|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
14384828|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384829|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
14384830|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14384831|NCT01289067|Satraplatin|satraplatin|mesh-list
14384832|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384833|NCT01289119|Metformin|metformin|mesh-list
14384834|NCT01289119|Pioglitazone|pioglitazone|mesh-list
14384835|NCT01289119|Alogliptin|alogliptin|mesh-list
14384836|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14384837|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384838|NCT01289119|Incretins|incretins|mesh-ancestor
14384839|NCT01289119|Hormones|hormones|mesh-ancestor
14384840|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384841|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14384842|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
14384843|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384844|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384845|NCT01289275|Nicotine|nicotine|mesh-list
14384846|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14384847|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
14384848|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384849|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384850|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14384851|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14384852|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
14384853|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384854|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384855|NCT01289353|Carboplatin|carboplatin|mesh-list
14384856|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384857|NCT01289457|Cytarabine|cytarabine|mesh-list
14384858|NCT01289457|Fludarabine|fludarabine|mesh-list
14384859|NCT01289457|Idarubicin|idarubicin|mesh-list
14384860|NCT01289457|Clofarabine|clofarabine|mesh-list
14922061|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922062|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922063|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
14922064|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922065|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922066|NCT03618550|Gemcitabine|gemcitabine|mesh-list
14922067|NCT03618550|Doxorubicin|doxorubicin|mesh-list
14922068|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14922069|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
14922070|NCT03618550|Vinorelbine|vinorelbine|mesh-list
14922071|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922072|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
14922073|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922074|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922075|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
14922076|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922077|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922078|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384861|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384862|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14384863|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
14384864|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384865|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384866|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
14384867|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384868|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
14384869|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384870|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14384871|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14384872|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14384873|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384874|NCT01289522|Cetuximab|cetuximab|mesh-list
14384875|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14384876|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384877|NCT01289639|Pioglitazone|pioglitazone|mesh-list
14384878|NCT01289639|Fenofibrate|fenofibrate|mesh-list
14384879|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14384880|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384881|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14384882|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
14384883|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384884|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14466675|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466676|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466677|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466678|NCT02248480|Analgesics|analgesics|mesh-ancestor
14922079|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
14922080|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922081|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14466679|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
15235942|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
15235943|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235944|NCT05211622|Protective Agents|protective agents|mesh-ancestor
15235945|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235946|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
14922082|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14922083|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14922084|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922085|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14922086|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
14922087|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
14384885|NCT01289678|Interleukin-2|interleukin-2|mesh-list
14384886|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384887|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384888|NCT01289678|Analgesics|analgesics|mesh-ancestor
14384889|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
14922088|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
14922089|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
14922090|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922091|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922092|NCT03606967|Gemcitabine|gemcitabine|mesh-list
14922093|NCT03606967|Poly I-C|poly i-c|mesh-list
14922094|NCT03606967|Paclitaxel|paclitaxel|mesh-list
15235947|NCT05211622|Vitamins|vitamins|mesh-ancestor
15235948|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
14922095|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14922096|NCT03606967|Carboplatin|carboplatin|mesh-list
14922097|NCT03606967|Durvalumab|durvalumab|mesh-list
14922098|NCT03606967|Tremelimumab|tremelimumab|mesh-list
14922099|NCT03606967|Ipilimumab|ipilimumab|mesh-list
14922100|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14922101|NCT03606967|Vaccines|vaccines|mesh-list
14922102|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
14922103|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14922104|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
14922105|NCT03606967|Poly ICLC|poly iclc|mesh-list
15235949|NCT05211583|Progesterone|progesterone|mesh-list
14922106|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
15235950|NCT05211583|Progestins|progestins|mesh-ancestor
15235951|NCT05211583|Hormones|hormones|mesh-ancestor
15235952|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922107|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922108|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14922109|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922110|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
14922111|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
14922112|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
14922113|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922114|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922115|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
14384890|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384891|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384892|NCT01289782|Ribavirin|ribavirin|mesh-list
14384893|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14384894|NCT01289782|Simeprevir|simeprevir|mesh-list
14384895|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
14384896|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384897|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
14384898|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384899|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
14384900|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384901|NCT01289821|Leucovorin|leucovorin|mesh-list
14384902|NCT01289821|Folic Acid|folic acid|mesh-list
14384903|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
14384904|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
14384905|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384906|NCT01289821|Antidotes|antidotes|mesh-ancestor
14384907|NCT01289821|Protective Agents|protective agents|mesh-ancestor
14384908|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384909|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
14384910|NCT01289821|Vitamins|vitamins|mesh-ancestor
14922116|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
14922117|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922118|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922119|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922120|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922121|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14922122|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
14922123|NCT03606967|Laxatives|laxatives|mesh-ancestor
14922124|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14384911|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
14384912|NCT01289821|Hematinics|hematinics|mesh-ancestor
14384913|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
14384914|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14384915|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14384916|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
14384917|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384918|NCT01289912|Everolimus|everolimus|mesh-list
14384919|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922125|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
14922126|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922127|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922128|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
14922129|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922130|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922131|NCT03593434|Xenon|xenon|mesh-list
14922132|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14922133|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
14922134|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
14384920|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14384921|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
14384922|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384923|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14384924|NCT01289990|Empagliflozin|empagliflozin|mesh-list
14384925|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14384926|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922135|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14384927|NCT01289990|Incretins|incretins|mesh-ancestor
14384928|NCT01289990|Hormones|hormones|mesh-ancestor
14384929|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384930|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14384931|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
14384932|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384933|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384934|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14384935|NCT01290029|Cinacalcet|cinacalcet|mesh-list
14384936|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14384937|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384938|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14384939|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
14384940|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14384941|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
14384942|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14384943|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922136|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922137|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
14922138|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922139|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922140|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
14922141|NCT03589339|Nivolumab|nivolumab|mesh-list
14922142|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922143|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922144|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14922145|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922146|NCT03584516|Prednisone|prednisone|mesh-list
14922147|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
14922148|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14734277|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14734278|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
14734279|NCT00534144|Hematinics|hematinics|mesh-ancestor
14734280|NCT00534183|Haloperidol|haloperidol|mesh-list
14734281|NCT00534183|Olanzapine|olanzapine|mesh-list
14734282|NCT00534183|Risperidone|risperidone|mesh-list
14734283|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
14734284|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14734285|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
14734286|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922149|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14922150|NCT03584516|Prednisolone|prednisolone|mesh-list
14922151|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
14922152|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14922153|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
14922154|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922155|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
14922156|NCT03584516|Hormones|hormones|mesh-ancestor
14922157|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922158|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922159|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14922160|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922161|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
14922162|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
14384944|NCT01290237|Vancomycin|vancomycin|mesh-list
14384945|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14384946|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384947|NCT01290263|Bevacizumab|bevacizumab|mesh-list
14384948|NCT01290263|Trebananib|trebananib|mesh-list
14384949|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14384950|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14384951|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14384952|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14384953|NCT01290263|Growth Substances|growth substances|mesh-ancestor
14384954|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384955|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
14384956|NCT01290315|Dextrans|dextrans|mesh-list
14384957|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14734287|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734288|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922163|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922164|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922165|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14922166|NCT03584516|Protective Agents|protective agents|mesh-ancestor
14922167|NCT03580317|Carbamazepine|carbamazepine|mesh-list
14922168|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
14922169|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
14922170|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14922171|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14384958|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
14384959|NCT01290315|Hematinics|hematinics|mesh-ancestor
14384960|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
14922172|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922173|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14922174|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14922175|NCT03580317|Analgesics|analgesics|mesh-ancestor
14922176|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
14922177|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922178|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14922179|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922180|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922181|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14922182|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14922183|NCT03579966|Amifampridine|amifampridine|mesh-list
14922184|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14922185|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922186|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922187|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14922188|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922189|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922190|NCT03563690|Celecoxib|celecoxib|mesh-list
15235953|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384961|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
14384962|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
14384963|NCT01290341|Naftifine|naftifine|mesh-list
14384964|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
14384965|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384966|NCT01290445|Varenicline|varenicline|mesh-list
14384967|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14384968|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14384969|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
14384970|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14384971|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384972|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384973|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
14384974|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
14384975|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14384976|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14384977|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14384978|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14384979|NCT01290484|Urological Agents|urological agents|mesh-ancestor
14384980|NCT01290601|Chloroquine|chloroquine|mesh-list
14384981|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14922191|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14922192|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14922193|NCT03563690|Analgesics|analgesics|mesh-ancestor
14922194|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
14384982|NCT01290601|Primaquine|primaquine|mesh-list
14384983|NCT01290601|Tafenoquine|tafenoquine|mesh-list
14384984|NCT01290601|Amebicides|amebicides|mesh-ancestor
14384985|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14384986|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14384987|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14384988|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
14384989|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14384990|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14384991|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14384992|NCT01290601|Analgesics|analgesics|mesh-ancestor
14384993|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
14384994|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14384995|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14384996|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14384997|NCT01290601|Filaricides|filaricides|mesh-ancestor
14384998|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
14384999|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
14385000|NCT01290679|Ribavirin|ribavirin|mesh-list
14922195|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922196|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922197|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922198|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922199|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14922200|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14922201|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922202|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922203|NCT03555877|Letrozole|letrozole|mesh-list
14922204|NCT03555877|Fulvestrant|fulvestrant|mesh-list
14385001|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14922205|NCT03555877|Anastrozole|anastrozole|mesh-list
14922206|NCT03555877|Exemestane|exemestane|mesh-list
14922207|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922208|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14922209|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14922210|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922211|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922212|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14922213|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
14922214|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922215|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922216|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14922217|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14922218|NCT03527576|Dexamethasone|dexamethasone|mesh-list
14385002|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14385003|NCT01290679|Simeprevir|simeprevir|mesh-list
14385004|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
14385005|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385006|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
14385007|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385008|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
14385009|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385010|NCT01290731|Interferons|interferons|mesh-list
14385011|NCT01290731|Ribavirin|ribavirin|mesh-list
14385012|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14385013|NCT01290731|Simeprevir|simeprevir|mesh-list
14385014|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385015|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
14385016|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385017|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
14385018|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385019|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
14385020|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385021|NCT01290757|Dabigatran|dabigatran|mesh-list
14385022|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
14385023|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14385024|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
14385025|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385026|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385027|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
14922219|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922220|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
14922221|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
14922222|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922223|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922224|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922225|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
14922226|NCT03527576|Hormones|hormones|mesh-ancestor
14922227|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14734289|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14734290|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14734291|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734292|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734293|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14734294|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
14734295|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
14734296|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
14734297|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385028|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
14922228|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15235954|NCT05211050|Cromakalim|cromakalim|mesh-list
15235955|NCT05211050|Sumatriptan|sumatriptan|mesh-list
15235956|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15235957|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14922229|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385029|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
14385030|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14385031|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14385032|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
14385033|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385034|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385035|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14385036|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
14385037|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14385038|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14385039|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14385040|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14385041|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385042|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385043|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
14385044|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14385045|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
14385046|NCT01290887|Reslizumab|reslizumab|mesh-list
14385047|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14385048|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
14922230|NCT03523585|Capecitabine|capecitabine|mesh-list
14922231|NCT03523585|Trastuzumab|trastuzumab|mesh-list
14922232|NCT03523585|Lapatinib|lapatinib|mesh-list
14922233|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922234|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
14922235|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922236|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922237|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922238|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14922239|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922240|NCT03522584|Durvalumab|durvalumab|mesh-list
14922241|NCT03522584|Ipilimumab|ipilimumab|mesh-list
14922242|NCT03522584|Tremelimumab|tremelimumab|mesh-list
14922243|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
14922244|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14922245|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
14922246|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922247|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922248|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
14922249|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922250|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14922251|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922252|NCT03517722|Ustekinumab|ustekinumab|mesh-list
14922253|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
14385049|NCT01290913|Omalizumab|omalizumab|mesh-list
14385050|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14385051|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14931029|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931030|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931031|NCT01437189|Sertraline|sertraline|mesh-list
14931032|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
14931033|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14931034|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14931035|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15235958|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15235959|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
15235960|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15235961|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235962|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235963|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15235964|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15235965|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
15235966|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15235967|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14922254|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
14922255|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14922256|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14922257|NCT03511625|Prednisolone|prednisolone|mesh-list
14922258|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
14922259|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14922260|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
14922261|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14922262|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922263|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
14922264|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
14922265|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922266|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922267|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922268|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
14922269|NCT03511625|Hormones|hormones|mesh-ancestor
14922270|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922271|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14922272|NCT03511625|Protective Agents|protective agents|mesh-ancestor
14922273|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14922274|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922275|NCT03489018|Vaccines|vaccines|mesh-list
14922276|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14922277|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
14922278|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922279|NCT03479476|Metformin|metformin|mesh-list
14922280|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14922281|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922282|NCT03478488|Gemcitabine|gemcitabine|mesh-list
14922283|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
14922284|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922285|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
14922286|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922287|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922288|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
14922289|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922290|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922291|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922292|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
14922293|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922294|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
14922295|NCT03467386|Tacrolimus|tacrolimus|mesh-list
14922296|NCT03467386|Lenograstim|lenograstim|mesh-list
14922297|NCT03467386|Sargramostim|sargramostim|mesh-list
14922298|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922299|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
14922300|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922301|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922302|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14922303|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
14922304|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922305|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922306|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14922307|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14922308|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14922309|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922310|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14385052|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
14385053|NCT01291017|Palbociclib|palbociclib|mesh-list
14385054|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385055|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14922311|NCT03439254|Cathartics|cathartics|mesh-ancestor
14385056|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385057|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385058|NCT01291056|Clomiphene|clomiphene|mesh-list
14385059|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14385060|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
14922312|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385061|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385062|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385063|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14385064|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
14385065|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385066|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14385067|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14385068|NCT01291108|Bimatoprost|bimatoprost|mesh-list
14385069|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14385070|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14385071|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14385072|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385073|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14385074|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14385075|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14385076|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385077|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
14385078|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385079|NCT01291784|Antibodies|antibodies|mesh-list
14385080|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14385081|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
14734298|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14734299|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14734300|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14734301|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734302|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14734303|NCT00534261|Interferons|interferons|mesh-list
14734304|NCT00534261|Interferon-beta|interferon-beta|mesh-list
14734305|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
14734306|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734307|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
14385082|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385083|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
14385084|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14385085|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385086|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385087|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14385088|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14385089|NCT01292005|Protective Agents|protective agents|mesh-ancestor
14385090|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385091|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
14385092|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14385093|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
14385094|NCT01292057|Aripiprazole|aripiprazole|mesh-list
14385095|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
14385096|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14385097|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14385098|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14385099|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385100|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385101|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
14385102|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
14385103|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385104|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385105|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14385106|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14385107|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
14922313|NCT03439124|Cephalosporins|cephalosporins|mesh-list
14922314|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
14922315|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14922316|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14922317|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922318|NCT03436368|Anesthetics|anesthetics|mesh-list
14922319|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922320|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922321|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14922322|NCT03422536|Cetuximab|cetuximab|mesh-list
14922323|NCT03422536|Antibodies|antibodies|mesh-list
14922324|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
14922325|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14922326|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
14922327|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385108|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14385109|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14385110|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14385111|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14385112|NCT01292187|Calcitonin|calcitonin|mesh-list
14385113|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
14922328|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922329|NCT03410355|Cortisone|cortisone|mesh-list
14922330|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922331|NCT03406897|Vitamin D|vitamin d|mesh-list
14922332|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
14922333|NCT03406897|Vitamins|vitamins|mesh-ancestor
14385114|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14385115|NCT01292187|Katacalcin|katacalcin|mesh-list
14385116|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14385117|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385118|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14385119|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
14385120|NCT01292226|Cyclosporine|cyclosporine|mesh-list
14385121|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
14385122|NCT01292226|Antibodies|antibodies|mesh-list
14385123|NCT01292226|Cyclosporins|cyclosporins|mesh-list
14385124|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
14385125|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385126|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385127|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385128|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385129|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
14385130|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922334|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
14922335|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922336|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14922337|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14922338|NCT03399617|Micronutrients|micronutrients|mesh-list
14922339|NCT03399617|Trace Elements|trace elements|mesh-list
14922340|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922341|NCT03399552|Avelumab|avelumab|mesh-list
14922342|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922343|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922344|NCT03393884|Paclitaxel|paclitaxel|mesh-list
14922345|NCT03393884|Carboplatin|carboplatin|mesh-list
14922346|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14922347|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922348|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
15235968|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
15235969|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
15235970|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
15235971|NCT05211011|Fosfomycin|fosfomycin|mesh-list
15235972|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15235973|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15235974|NCT05210595|Clopidogrel|clopidogrel|mesh-list
15235975|NCT05210595|Ticagrelor|ticagrelor|mesh-list
15235976|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14922349|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14922350|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
14922351|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922352|NCT03386162|Fulvestrant|fulvestrant|mesh-list
14922353|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14922354|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922355|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14922356|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14922357|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
14922358|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922359|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922360|NCT03360214|Bupivacaine|bupivacaine|mesh-list
14922361|NCT03360214|Ropivacaine|ropivacaine|mesh-list
14922362|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
14922363|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
15235977|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14922364|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922365|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922366|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
14922367|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922368|NCT03359239|Atezolizumab|atezolizumab|mesh-list
14922369|NCT03359239|Poly ICLC|poly iclc|mesh-list
14922370|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922371|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
14922372|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
14922373|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922374|NCT03352765|Rituximab|rituximab|mesh-list
14385131|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
14385132|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385133|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14385134|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14385135|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385136|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14385137|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
14385138|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14385139|NCT01292239|Ribavirin|ribavirin|mesh-list
14385140|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14385141|NCT01292239|Simeprevir|simeprevir|mesh-list
14385142|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
14385143|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385144|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
14385145|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385146|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
14385147|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385148|NCT01292252|Teriparatide|teriparatide|mesh-list
14385149|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
14385150|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385151|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14385152|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14385153|NCT01292304|Tolvaptan|tolvaptan|mesh-list
14385154|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14385155|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385156|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
15235978|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15235979|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15235980|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
15235981|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385157|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385158|NCT01292447|Lidocaine|lidocaine|mesh-list
14385159|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
14385160|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
14385161|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385162|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385163|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
14385164|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385165|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15235982|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235983|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235984|NCT05210582|Afamelanotide|afamelanotide|mesh-list
15235985|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
15235986|NCT05210517|Empagliflozin|empagliflozin|mesh-list
15235987|NCT05210517|Benzbromarone|benzbromarone|mesh-list
15235988|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15235989|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15235990|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15235991|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15235992|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
15235993|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
15235994|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15235995|NCT05210517|Renal Agents|renal agents|mesh-ancestor
15235996|NCT05210465|Dobutamine|dobutamine|mesh-list
15235997|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15235998|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
14385166|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14922375|NCT03352765|Melphalan|melphalan|mesh-list
15235999|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
14385167|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14385168|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734308|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734309|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
14734310|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385169|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385170|NCT01292473|Omalizumab|omalizumab|mesh-list
14385171|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14385172|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14385173|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
14385174|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
14385175|NCT01292603|Rituximab|rituximab|mesh-list
14385176|NCT01292603|Fludarabine|fludarabine|mesh-list
14385177|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385178|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
14385179|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385180|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385181|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14385182|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
14385183|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385184|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385185|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14385186|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14385187|NCT01292642|Nicotine|nicotine|mesh-list
14385188|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14385189|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
14385190|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385191|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385192|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14385193|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14385194|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
14385195|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385196|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385197|NCT01292798|Ranibizumab|ranibizumab|mesh-list
14385198|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14385199|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14385200|NCT01292798|Growth Substances|growth substances|mesh-ancestor
14385201|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385202|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
14385203|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385204|NCT01292837|Levetiracetam|levetiracetam|mesh-list
14385205|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
14385206|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
14385207|NCT01293006|Suvorexant|suvorexant|mesh-list
14385208|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14385209|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14734311|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14734312|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
14734313|NCT00534287|Meropenem|meropenem|mesh-list
14734314|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14734315|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734316|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734317|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14734318|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14734319|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734320|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734321|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734322|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14734323|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
14734324|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14734325|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922376|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14922377|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14385210|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385211|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385212|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14385213|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385214|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385215|NCT01293032|Tamoxifen|tamoxifen|mesh-list
15236000|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236001|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236002|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15236003|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14385216|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14385217|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385218|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14385219|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
14385220|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385221|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385222|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14385223|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922378|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922379|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
14922380|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922381|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922382|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14922383|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
14922384|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922385|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14922386|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922387|NCT03343054|Talazoparib|talazoparib|mesh-list
14922388|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14922389|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922390|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236004|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15236005|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
15236006|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236007|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236008|NCT05210465|Protective Agents|protective agents|mesh-ancestor
15236009|NCT05210192|Lidocaine|lidocaine|mesh-list
15236010|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
15236011|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
15236012|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236013|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236014|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
15236015|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922391|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385224|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14385225|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14385226|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14385227|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14385228|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385229|NCT01293396|Insulin|insulin|mesh-list
14385230|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14385231|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
14385232|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
14385233|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14385234|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14385235|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14385236|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385237|NCT01293539|Melphalan|melphalan|mesh-list
14385238|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14385239|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
14922392|NCT03335163|Topiramate|topiramate|mesh-list
14922393|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
14922394|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14922395|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922396|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
14922397|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922398|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14922399|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922400|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922401|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
14922402|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14922403|NCT03328676|Protective Agents|protective agents|mesh-ancestor
14922404|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922405|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14922406|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14922407|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
14922408|NCT03317405|Tamoxifen|tamoxifen|mesh-list
14922409|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14922410|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
14922411|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922412|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922413|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14385240|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385241|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385242|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14385243|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385244|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
14385245|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385246|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14385247|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385248|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385249|NCT01293825|Ziprasidone|ziprasidone|mesh-list
14385250|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14385251|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
14385252|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922414|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922415|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14922416|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14922417|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14922418|NCT03315039|Annamycin|annamycin|mesh-list
14922419|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14922420|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922421|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14922422|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
14922423|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14922424|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
14922425|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922426|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922427|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922428|NCT03296813|Torsemide|torsemide|mesh-list
14922429|NCT03296813|Furosemide|furosemide|mesh-list
14922430|NCT03296813|Diuretics|diuretics|mesh-ancestor
14922431|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
14922432|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236016|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15236017|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15236018|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14734326|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14734327|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14734328|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14734329|NCT00534378|Midazolam|midazolam|mesh-list
14734330|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14734331|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14734332|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734333|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734334|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14734335|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15236019|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15236020|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236021|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
15236022|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
15236023|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236024|NCT05210166|Protective Agents|protective agents|mesh-ancestor
15236025|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734336|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734337|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14734338|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
14734339|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
14734340|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
14734341|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
14734342|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734343|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734344|NCT00534391|Polymyxins|polymyxins|mesh-list
14734345|NCT00534391|Neomycin|neomycin|mesh-list
14734346|NCT00534391|Polymyxin B|polymyxin b|mesh-list
14734347|NCT00534391|Gramicidin|gramicidin|mesh-list
14734348|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
14734349|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14734350|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14734351|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734352|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734353|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14734354|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922433|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14922434|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922435|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922436|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14922437|NCT03291847|Buprenorphine|buprenorphine|mesh-list
14922438|NCT03291847|Methadone|methadone|mesh-list
14922439|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14922440|NCT03291847|Naloxone|naloxone|mesh-list
14922441|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14922442|NCT03291847|Narcotics|narcotics|mesh-ancestor
14922443|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922444|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922445|NCT03291847|Analgesics|analgesics|mesh-ancestor
14922446|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
14922447|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922448|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14922449|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
15236026|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15236027|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734355|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734356|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14734357|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
14734358|NCT00534456|Hematinics|hematinics|mesh-ancestor
14734359|NCT00534508|Tacrolimus|tacrolimus|mesh-list
14734360|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734361|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
14734362|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734363|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14734364|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734365|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734366|NCT00534573|Amisulpride|amisulpride|mesh-list
14734367|NCT00534573|Moclobemide|moclobemide|mesh-list
14734368|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14734369|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14734370|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734371|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734372|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236028|NCT05210153|Sertraline|sertraline|mesh-list
15236029|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
14734373|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14734374|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
14734375|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734376|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734377|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14734378|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
14734379|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15236030|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734380|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734381|NCT00534586|Ketamine|ketamine|mesh-list
14734382|NCT00534586|Remifentanil|remifentanil|mesh-list
14734383|NCT00534586|Propofol|propofol|mesh-list
14734384|NCT00534586|Sevoflurane|sevoflurane|mesh-list
14734385|NCT00534586|Esketamine|esketamine|mesh-list
15236031|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15236032|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15236033|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15236034|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734386|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14922450|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
14922451|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
14922452|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14922453|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922454|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922455|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14922456|NCT03289325|Analgesics|analgesics|mesh-ancestor
14922457|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
14922458|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734387|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922459|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14922460|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14922461|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14922462|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
14922463|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922464|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922465|NCT03279289|Leucovorin|leucovorin|mesh-list
14922466|NCT03279289|Folic Acid|folic acid|mesh-list
14922467|NCT03279289|Fluorouracil|fluorouracil|mesh-list
14734388|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734389|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14734390|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
14734391|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
14734392|NCT00534586|Analgesics|analgesics|mesh-ancestor
14734393|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
14734394|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734395|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14734396|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14734397|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14734398|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734399|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734400|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14734401|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14734402|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14734403|NCT00534586|Narcotics|narcotics|mesh-ancestor
14734404|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
14734405|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734406|NCT00534625|Zileuton|zileuton|mesh-list
14734407|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
14734408|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14734409|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14734410|NCT00534625|Analgesics|analgesics|mesh-ancestor
14734411|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
14734412|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922468|NCT03279289|Irinotecan|irinotecan|mesh-list
15236035|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236036|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
14922469|NCT03279289|Aflibercept|aflibercept|mesh-list
14385253|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385254|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385255|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14385256|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14385257|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385258|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14385259|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14385260|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
14385261|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
14385262|NCT01293968|Promethazine|promethazine|mesh-list
14385263|NCT01293968|Ibuprofen|ibuprofen|mesh-list
14385264|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14385265|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15236037|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236038|NCT05210140|Citalopram|citalopram|mesh-list
15236039|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15236040|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15236041|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15236042|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236043|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236044|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
15236045|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385266|NCT01293968|Analgesics|analgesics|mesh-ancestor
14385267|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
14385268|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385269|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385270|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385271|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385272|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14385273|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385274|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385275|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14385276|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14385277|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385278|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
14385279|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
14385280|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
14385281|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
14385282|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385283|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14385284|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
14385285|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
14385286|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385287|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14385288|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
14385289|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
14385290|NCT01294098|Bupivacaine|bupivacaine|mesh-list
14385291|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
14385292|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
14385293|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385294|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385295|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
14385296|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385297|NCT01294163|Propofol|propofol|mesh-list
14385298|NCT01294163|Sevoflurane|sevoflurane|mesh-list
14385299|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14385300|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385301|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385302|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14385303|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
14922470|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
14922471|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
14922472|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922473|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922474|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922475|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922476|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
14922477|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236046|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15236047|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
15236048|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236049|NCT05209984|Topiramate|topiramate|mesh-list
15236050|NCT05209984|Sibutramine|sibutramine|mesh-list
15236051|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
15236052|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236053|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236054|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
15236055|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236056|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
15236057|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15236058|NCT05209906|Fentanyl|fentanyl|mesh-list
15236059|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15236060|NCT05209906|Narcotics|narcotics|mesh-ancestor
15236061|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236062|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922478|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14922479|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14922480|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922481|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14922482|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14922483|NCT03279289|Growth Substances|growth substances|mesh-ancestor
14922484|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
14922485|NCT03279289|Antidotes|antidotes|mesh-ancestor
14922486|NCT03279289|Protective Agents|protective agents|mesh-ancestor
14922487|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
14922488|NCT03279289|Vitamins|vitamins|mesh-ancestor
14922489|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
14922490|NCT03279289|Hematinics|hematinics|mesh-ancestor
14922491|NCT03276533|Lidocaine|lidocaine|mesh-list
14385304|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
14385305|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14385306|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14385307|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14385308|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922492|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
14922493|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
14922494|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
14922495|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922496|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922497|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
14922498|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922499|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14922500|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14922501|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14922502|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922503|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922504|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14922505|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14922506|NCT03276533|Analgesics|analgesics|mesh-ancestor
14922507|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14922508|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14922509|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14385309|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14385310|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922510|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
14922511|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922512|NCT03262935|Capecitabine|capecitabine|mesh-list
14922513|NCT03262935|Trastuzumab|trastuzumab|mesh-list
14922514|NCT03262935|Vinorelbine|vinorelbine|mesh-list
14922515|NCT03262935|Lapatinib|lapatinib|mesh-list
14922516|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922517|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
14922518|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922519|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922520|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922521|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14922522|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
14922523|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14922524|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
14922525|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14922526|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922527|NCT03254394|Lidocaine|lidocaine|mesh-list
14922528|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
15236063|NCT05209906|Analgesics|analgesics|mesh-ancestor
14385311|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385312|NCT01294319|Dexamethasone|dexamethasone|mesh-list
14385313|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
14385314|NCT01294319|Spironolactone|spironolactone|mesh-list
14385315|NCT01294319|Mifepristone|mifepristone|mesh-list
14385316|NCT01294319|BB 1101|bb 1101|mesh-list
14385317|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385318|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
14385319|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
14385320|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385321|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385322|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385323|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
14385324|NCT01294319|Hormones|hormones|mesh-ancestor
14385325|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385326|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14385327|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385328|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
14385329|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385330|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385331|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14385332|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
15236064|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
15236065|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236066|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15236067|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236068|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
15236069|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
15236070|NCT05209217|Ketamine|ketamine|mesh-list
15236071|NCT05209217|Analgesics|analgesics|mesh-ancestor
15236072|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
14385333|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14385334|NCT01294319|Diuretics|diuretics|mesh-ancestor
14385335|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
14385336|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14385337|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
14922529|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
14922530|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922531|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922532|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
14922533|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922534|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14922535|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14922536|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14922537|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922538|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922539|NCT03215940|Dronabinol|dronabinol|mesh-list
14922540|NCT03215940|Cannabidiol|cannabidiol|mesh-list
14922541|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
14922542|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
14922543|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922544|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14922545|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14922546|NCT03215940|Analgesics|analgesics|mesh-ancestor
14922547|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
14922548|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922549|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14922550|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14922551|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922552|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922553|NCT03215940|Hormones|hormones|mesh-ancestor
14922554|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385338|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385339|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14385340|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14385341|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14385342|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
14385343|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14385344|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14385345|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
14385346|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14385347|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14385348|NCT01294358|Gemcitabine|gemcitabine|mesh-list
14385349|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14385350|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
14385351|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734413|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734414|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14734415|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734416|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14734417|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734418|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734419|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14734420|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
14734421|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14734422|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734423|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
14734424|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734425|NCT00534651|Acetaminophen|acetaminophen|mesh-list
14734426|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14734427|NCT00534651|Analgesics|analgesics|mesh-ancestor
14734428|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
14922555|NCT03209687|Menotropins|menotropins|mesh-list
14922556|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14922557|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
14922558|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385352|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385353|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
14385354|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385355|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385356|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385357|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
14385358|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385359|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14385360|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14385361|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14922559|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922560|NCT03203876|Nivolumab|nivolumab|mesh-list
14922561|NCT03203876|Ipilimumab|ipilimumab|mesh-list
14922562|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922563|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385362|NCT01294384|Laxatives|laxatives|mesh-ancestor
14385363|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385364|NCT01294397|Denosumab|denosumab|mesh-list
14385365|NCT01294397|Etanercept|etanercept|mesh-list
14385366|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14385367|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14385368|NCT01294397|Analgesics|analgesics|mesh-ancestor
14385369|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
14385370|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385371|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385372|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385373|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385374|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385375|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385376|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
14922564|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14922565|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922566|NCT03203642|XL647|xl647|mesh-list
14922567|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922568|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14922569|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922570|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385377|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14922571|NCT03191240|Vasopressins|vasopressins|mesh-list
14922572|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
14922573|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
14922574|NCT03191240|Coagulants|coagulants|mesh-ancestor
14922575|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14922576|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14922577|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
14922578|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922579|NCT03180294|Bupropion|bupropion|mesh-list
14922580|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14922581|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
14922582|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14922583|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14922584|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14922585|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922586|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922587|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
15236073|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236074|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236075|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15236076|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236077|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
15236078|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
15236079|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236080|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15236081|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15236082|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385378|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
14385379|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14385380|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385381|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14385382|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385383|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
14385384|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14385385|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385386|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14385387|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385388|NCT01294449|Cytarabine|cytarabine|mesh-list
14385389|NCT01294449|Dexamethasone|dexamethasone|mesh-list
14385390|NCT01294449|Methotrexate|methotrexate|mesh-list
14385391|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14385392|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
14385393|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385394|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385395|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
14385396|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385397|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385398|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
14922588|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922589|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922590|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14922591|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14922592|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922593|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
14922594|NCT03179930|Entinostat|entinostat|mesh-list
14922595|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922596|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922597|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14922598|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922599|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922600|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
14922601|NCT03169881|Hematinics|hematinics|mesh-ancestor
14922602|NCT03151408|Azacitidine|azacitidine|mesh-list
14922603|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922604|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
14922605|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922606|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922607|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922608|NCT03141671|Prednisone|prednisone|mesh-list
14922609|NCT03141671|Bicalutamide|bicalutamide|mesh-list
14922610|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922611|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
14922612|NCT03141671|Hormones|hormones|mesh-ancestor
14922613|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922614|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922615|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14922616|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922617|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
14922618|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
14922619|NCT03137173|Vancomycin|vancomycin|mesh-list
14922620|NCT03137173|Aztreonam|aztreonam|mesh-list
14922621|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
14922622|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14922623|NCT03137173|Cephalosporins|cephalosporins|mesh-list
14922624|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14922625|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385399|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385400|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385401|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
14385402|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
14385403|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385404|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385405|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
14385406|NCT01294449|Hormones|hormones|mesh-ancestor
14385407|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385408|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14385409|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14385410|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
14385411|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385412|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
14385413|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922626|NCT03129828|Bortezomib|bortezomib|mesh-list
14922627|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922628|NCT03117751|Cytarabine|cytarabine|mesh-list
14922629|NCT03117751|Dexamethasone|dexamethasone|mesh-list
14922630|NCT03117751|Prednisone|prednisone|mesh-list
14922631|NCT03117751|Prednisolone|prednisolone|mesh-list
14922632|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
14922633|NCT03117751|Doxorubicin|doxorubicin|mesh-list
14922634|NCT03117751|Methotrexate|methotrexate|mesh-list
14922635|NCT03117751|Etoposide|etoposide|mesh-list
14922636|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
14922637|NCT03117751|Vincristine|vincristine|mesh-list
14922638|NCT03117751|Bortezomib|bortezomib|mesh-list
14385414|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14385415|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385416|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14385417|NCT01294462|Aspirin|aspirin|mesh-list
14385418|NCT01294462|Clopidogrel|clopidogrel|mesh-list
14385419|NCT01294462|Ticagrelor|ticagrelor|mesh-list
14385420|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14385421|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14385422|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14385423|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14385424|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
14385425|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385426|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385427|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385428|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14385429|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14385430|NCT01294462|Analgesics|analgesics|mesh-ancestor
14385431|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
14385432|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922639|NCT03117751|Daunorubicin|daunorubicin|mesh-list
14922640|NCT03117751|Asparaginase|asparaginase|mesh-list
14922641|NCT03117751|Dasatinib|dasatinib|mesh-list
14922642|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
14922643|NCT03117751|Vorinostat|vorinostat|mesh-list
14922644|NCT03117751|Idarubicin|idarubicin|mesh-list
14922645|NCT03117751|Clofarabine|clofarabine|mesh-list
14922646|NCT03117751|Pegaspargase|pegaspargase|mesh-list
14922647|NCT03117751|Thioguanine|thioguanine|mesh-list
14922648|NCT03117751|Blinatumomab|blinatumomab|mesh-list
14922649|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922650|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
14922651|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922652|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922653|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14922654|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
14922655|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734429|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734430|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734431|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
14734432|NCT00534677|Octreotide|octreotide|mesh-list
14734433|NCT00534677|Terlipressin|terlipressin|mesh-list
14734434|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14734435|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14734436|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734437|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14385433|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385434|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385435|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14385436|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14385437|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14385438|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734438|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14734439|NCT00534729|Carboplatin|carboplatin|mesh-list
14734440|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734441|NCT00534807|Rifampin|rifampin|mesh-list
14734442|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14734443|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
14734444|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734445|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734446|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
14734447|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734448|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734449|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734450|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14734451|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14734452|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14734453|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14734454|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14734455|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14734456|NCT00534846|Toremifene|toremifene|mesh-list
14734457|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14734458|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734459|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14734460|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14734461|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
14734462|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14734463|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734464|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14734465|NCT00534898|Fenretinide|fenretinide|mesh-list
14734466|NCT00534898|Bexarotene|bexarotene|mesh-list
14734467|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385439|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
14385440|NCT01294553|Metformin|metformin|mesh-list
14385441|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
14385442|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14385443|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385444|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14385445|NCT01294579|Ofatumumab|ofatumumab|mesh-list
14385446|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14385447|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
14385448|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385449|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385450|NCT01294592|Tamsulosin|tamsulosin|mesh-list
14385451|NCT01294592|Dutasteride|dutasteride|mesh-list
14385452|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14385453|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14385454|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14385455|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
14385456|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922656|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385457|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385458|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385459|NCT01294592|Urological Agents|urological agents|mesh-ancestor
14385460|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14385461|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14385462|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385463|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
14385464|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385465|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
14385466|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14385467|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922657|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14922658|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14922659|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
14922660|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
14922661|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922662|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922663|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
14922664|NCT03117751|Hormones|hormones|mesh-ancestor
14922665|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922666|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14385468|NCT01294683|Niacin|niacin|mesh-list
14385469|NCT01294683|Niacinamide|niacinamide|mesh-list
14385470|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
14385471|NCT01294683|Simvastatin|simvastatin|mesh-list
14385472|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14922667|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14922668|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14922669|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14922670|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922671|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14922672|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
14922673|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14922674|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922675|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
14922676|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
14922677|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14922678|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734468|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14734469|NCT00534898|Protective Agents|protective agents|mesh-ancestor
14734470|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734471|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14734472|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14734473|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14922679|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14922680|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
14922681|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922682|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
14922683|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
14922684|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
14385473|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14385474|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
14385475|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385476|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14385477|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14385478|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385479|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
14385480|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
14385481|NCT01294683|Vitamins|vitamins|mesh-ancestor
14385482|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
14385483|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922685|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14922686|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14922687|NCT03110107|Nivolumab|nivolumab|mesh-list
14922688|NCT03110107|Ipilimumab|ipilimumab|mesh-list
14385484|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
14734474|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
14734475|NCT00535119|Paclitaxel|paclitaxel|mesh-list
14734476|NCT00535119|Carboplatin|carboplatin|mesh-list
14734477|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14734478|NCT00535119|Veliparib|veliparib|mesh-list
14734479|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14922689|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922690|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922691|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14922692|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922693|NCT03092011|Clonidine|clonidine|mesh-list
14922694|NCT03092011|Morphine|morphine|mesh-list
14922695|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14922696|NCT03092011|Narcotics|narcotics|mesh-ancestor
14922697|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922698|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922699|NCT03092011|Analgesics|analgesics|mesh-ancestor
14922700|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
14922701|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922702|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14922703|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
14922704|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
14922705|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14922706|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14922707|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14922708|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
14922709|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922710|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922711|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14922712|NCT03091660|Vaccines|vaccines|mesh-list
14922713|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
14922714|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
14922715|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922716|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14922717|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
14922718|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14922719|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
14922720|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922721|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922722|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14922723|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14922724|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14922725|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
14922726|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385485|NCT01294787|Bromides|bromides|mesh-list
14385486|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
14385487|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14385488|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
14385489|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236083|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236084|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15236085|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
14385490|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385491|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14385492|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
14385493|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
14385494|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14385495|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
14385496|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385497|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385498|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
14385499|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14922727|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922728|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14922729|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
14922730|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
14922731|NCT03081052|Protective Agents|protective agents|mesh-ancestor
14922732|NCT03080935|Evolocumab|evolocumab|mesh-list
14922733|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14922734|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14922735|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
14922736|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922737|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15236086|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385500|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14922738|NCT03078855|Vitamin D|vitamin d|mesh-list
14922739|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
14922740|NCT03078855|Rituximab|rituximab|mesh-list
14922741|NCT03078855|Vitamins|vitamins|mesh-ancestor
14922742|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
14922743|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922744|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922745|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922746|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
14922747|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922748|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14922749|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14922750|NCT03071601|Lidocaine|lidocaine|mesh-list
14922751|NCT03071601|Epinephrine|epinephrine|mesh-list
14922752|NCT03071601|Prilocaine|prilocaine|mesh-list
14922753|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14922754|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
14922755|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
14922756|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922757|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922758|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
14922759|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922760|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14922761|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14922762|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14922763|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922764|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922765|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14922766|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14922767|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
14922768|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922769|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14922770|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14922771|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
14922772|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14922773|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
14922774|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
14922775|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
15236087|NCT05191264|Analgesics|analgesics|mesh-list
15236088|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
15236089|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236090|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236091|NCT05190627|Loratadine|loratadine|mesh-list
14922776|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14922777|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14922778|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
14922779|NCT03070327|Lenalidomide|lenalidomide|mesh-list
14385501|NCT01295034|Vitamin D|vitamin d|mesh-list
14385502|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
14385503|NCT01295034|Vitamins|vitamins|mesh-list
14385504|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
14385505|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385506|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14385507|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14466680|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922780|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922781|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
14922782|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922783|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922784|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14922785|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
14922786|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922787|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922788|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14922789|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14922790|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14922791|NCT03070327|Growth Substances|growth substances|mesh-ancestor
14922792|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
14922793|NCT03069326|Thalidomide|thalidomide|mesh-list
15236092|NCT05190627|Sirolimus|sirolimus|mesh-list
14466681|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
14466682|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236093|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15236094|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236095|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14466683|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
14466684|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14466685|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236096|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236097|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
14385508|NCT01295112|Dexamethasone|dexamethasone|mesh-list
14385509|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
14385510|NCT01295112|Bevacizumab|bevacizumab|mesh-list
14385511|NCT01295112|BB 1101|bb 1101|mesh-list
14385512|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14385513|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385514|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14385515|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14922794|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922795|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
14922796|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922797|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
14922798|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14385516|NCT01295112|Growth Substances|growth substances|mesh-ancestor
14385517|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385518|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
14385519|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385520|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
14385521|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
14922799|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922800|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14922801|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14922802|NCT03069326|Growth Substances|growth substances|mesh-ancestor
14922803|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
14922804|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922805|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14385522|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385523|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385524|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
14385525|NCT01295112|Hormones|hormones|mesh-ancestor
14385526|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385527|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14385528|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
14922806|NCT03061903|Laxatives|laxatives|mesh-ancestor
14922807|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922808|NCT03061643|Docetaxel|docetaxel|mesh-list
14922809|NCT03061643|Androgens|androgens|mesh-list
14922810|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922811|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
14922812|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
14922813|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
14922814|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922815|NCT03061643|Hormones|hormones|mesh-ancestor
14922816|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14922817|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922818|NCT03061630|Gemcitabine|gemcitabine|mesh-list
14922819|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922820|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922821|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
14922822|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922823|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
15236098|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236099|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
15236100|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236101|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
15236102|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
15236103|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15236104|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15236105|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15236106|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
15236107|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
15236108|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236109|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236110|NCT05188820|Cortisone|cortisone|mesh-list
15236111|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236112|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15236113|NCT05188417|Tirofiban|tirofiban|mesh-list
15236114|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14385529|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385530|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385531|NCT01295515|Interferons|interferons|mesh-list
14385532|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
14385533|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
14385534|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14385535|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385536|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
14922824|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922825|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922826|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922827|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
14922828|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922829|NCT03055390|Scopolamine|scopolamine|mesh-list
14922830|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14922831|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14922832|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
14922833|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
14922834|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922835|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922836|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14922837|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
14922838|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14922839|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
14922840|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922841|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922842|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14922843|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
14922844|NCT03038802|Vaccines|vaccines|mesh-list
14922845|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
14922846|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922847|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
14922848|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14922849|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922850|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14922851|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14922852|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
14922853|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922854|NCT03022097|Bromides|bromides|mesh-list
14922855|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
14922856|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14922857|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
14922858|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922859|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922860|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14922861|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
14922862|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14922863|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14922864|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14922865|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
14922866|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922867|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922868|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
14922869|NCT03012672|Cytarabine|cytarabine|mesh-list
14922870|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14922871|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
14922872|NCT03012672|Cladribine|cladribine|mesh-list
14922873|NCT03012672|Lenograstim|lenograstim|mesh-list
14922874|NCT03012672|Sargramostim|sargramostim|mesh-list
14922875|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922876|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
14922877|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922878|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922879|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
14922880|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922881|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922882|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
14922883|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922884|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14922885|NCT03012672|Analgesics|analgesics|mesh-ancestor
14922886|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
14922887|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922888|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14922889|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14922890|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922891|NCT03011775|Aspirin|aspirin|mesh-list
14922892|NCT03011775|Pioglitazone|pioglitazone|mesh-list
14922893|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14922894|NCT03011775|Ramipril|ramipril|mesh-list
14922895|NCT03011775|Bisoprolol|bisoprolol|mesh-list
14922896|NCT03011775|Isosorbide|isosorbide|mesh-list
14922897|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14922898|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14922899|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
14922900|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14922901|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14922902|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385537|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385538|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
14385539|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385540|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
14385541|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14385542|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
14385543|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385544|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385545|NCT01295814|Adalimumab|adalimumab|mesh-list
14385546|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385547|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385548|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
14385549|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14385550|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385551|NCT01295879|Vitamin D|vitamin d|mesh-list
14922903|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14385552|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
14385553|NCT01295879|Vitamins|vitamins|mesh-ancestor
14922904|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14385554|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
14385555|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385556|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14385557|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14385558|NCT01296035|Panitumumab|panitumumab|mesh-list
14385559|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14385560|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385561|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14385562|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
14385563|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14385564|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14385565|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14385566|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
14385567|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385568|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385569|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14385570|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14385571|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14922905|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
14922906|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922907|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14922908|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14922909|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922910|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14922911|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14922912|NCT03011775|Analgesics|analgesics|mesh-ancestor
14922913|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
14922914|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922915|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385572|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14385573|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385574|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
14385575|NCT01296191|Besifloxacin|besifloxacin|mesh-list
14385576|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14385577|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385578|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14385579|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14385580|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385581|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922916|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922917|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14385582|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922918|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14922919|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14922920|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
14922921|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14922922|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
14922923|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14922924|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
14922925|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
14922926|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14922927|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14922928|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14922929|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14922930|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14922931|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14385583|NCT01296347|Ketamine|ketamine|mesh-list
14385584|NCT01296347|Analgesics|analgesics|mesh-ancestor
14385585|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
14385586|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385587|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385588|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14922932|NCT03011775|Diuretics|diuretics|mesh-ancestor
14922933|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
14922934|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14922935|NCT02998047|Lintuzumab|lintuzumab|mesh-list
14922936|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922937|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922938|NCT02996110|Nivolumab|nivolumab|mesh-list
14922939|NCT02996110|Ipilimumab|ipilimumab|mesh-list
14922940|NCT02996110|Linrodostat|linrodostat|mesh-list
14922941|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922942|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922943|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14922944|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922945|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931036|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14931037|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385589|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14385590|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
14385591|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
14931038|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931039|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
14931040|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931041|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
14931042|NCT01437228|Povidone|povidone|mesh-list
14931043|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
15236115|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15236116|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236117|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15236118|NCT05188326|Azacitidine|azacitidine|mesh-list
15236119|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15236120|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
15236121|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236122|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385592|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385593|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14385594|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14385595|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734480|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734481|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14734482|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14734483|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14734484|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734485|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14734486|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734487|NCT00535158|Vitamin D|vitamin d|mesh-list
14734488|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
14734489|NCT00535158|Vitamins|vitamins|mesh-ancestor
14734490|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
14734491|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734492|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14734493|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14734494|NCT00535340|Amibegron|amibegron|mesh-list
14931044|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
14734495|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14385596|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385597|NCT01296412|Metformin|metformin|mesh-list
14385598|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14385599|NCT01296412|Liraglutide|liraglutide|mesh-list
14385600|NCT01296412|Glimepiride|glimepiride|mesh-list
14385601|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14385602|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385603|NCT01296412|Incretins|incretins|mesh-ancestor
15236123|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236124|NCT05187039|Anesthetics|anesthetics|mesh-list
15236125|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385604|NCT01296412|Hormones|hormones|mesh-ancestor
14385605|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385606|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14385607|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
14385608|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385609|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385610|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14385611|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385612|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
14385613|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
14385614|NCT01296542|Besifloxacin|besifloxacin|mesh-list
14385615|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14385616|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385617|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14385618|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14385619|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385620|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385621|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385622|NCT01296568|Gemcitabine|gemcitabine|mesh-list
14385623|NCT01296568|Pemetrexed|pemetrexed|mesh-list
14385624|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14922946|NCT02970318|Rituximab|rituximab|mesh-list
14922947|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14922948|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
14922949|NCT02970318|Idelalisib|idelalisib|mesh-list
14922950|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14922951|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922952|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
14922953|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922954|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14922955|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14922956|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
14922957|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922958|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14922959|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
14922960|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236126|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236127|NCT05186454|Dexamethasone|dexamethasone|mesh-list
15236128|NCT05186454|Midazolam|midazolam|mesh-list
15236129|NCT05186454|Morphine|morphine|mesh-list
15236130|NCT05186454|Bupivacaine|bupivacaine|mesh-list
15236131|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236132|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
15236133|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
15236134|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236135|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236136|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15236137|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
15236138|NCT05186454|Hormones|hormones|mesh-ancestor
15236139|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236140|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15236141|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236142|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
14922961|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922962|NCT02960997|Sirolimus|sirolimus|mesh-list
14922963|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14922964|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14922965|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14922966|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922967|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
14922968|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922969|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
14922970|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922971|NCT02949128|Ravulizumab|ravulizumab|mesh-list
14922972|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14922973|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14922974|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
14922975|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922976|NCT02944071|Paclitaxel|paclitaxel|mesh-list
14922977|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14385625|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
14385626|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385627|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385628|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
14385629|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385630|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385631|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385632|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
14922978|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14922979|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
14922980|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
14922981|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
14922982|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922983|NCT02924480|Lidocaine|lidocaine|mesh-list
14922984|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
14922985|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
14922986|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14922987|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922988|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
14922989|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14922990|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14922991|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14922992|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14922993|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14922994|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14922995|NCT02924064|Metformin|metformin|mesh-list
14922996|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14922997|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14922998|NCT02917993|Osimertinib|osimertinib|mesh-list
15236143|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
15236144|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236145|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
15236146|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15236147|NCT05186454|Narcotics|narcotics|mesh-ancestor
15236148|NCT05186454|Analgesics|analgesics|mesh-ancestor
15236149|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15236150|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15236151|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14734496|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14734497|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
14734498|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734499|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734500|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734501|NCT00535353|Irinotecan|irinotecan|mesh-list
14734502|NCT00535353|Olaparib|olaparib|mesh-list
14734503|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14734504|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14734505|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734506|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734507|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734508|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14734509|NCT00535379|Sunitinib|sunitinib|mesh-list
14734510|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734511|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734512|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734513|NCT00535379|Growth Substances|growth substances|mesh-ancestor
15236152|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15236153|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14922999|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923000|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923001|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923002|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923003|NCT02889900|Olaparib|olaparib|mesh-list
14923004|NCT02889900|Cediranib|cediranib|mesh-list
14923005|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14923006|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923007|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923008|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923009|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923010|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14923011|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14923012|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923013|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14923014|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
14923015|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923016|NCT02879942|Growth Substances|growth substances|mesh-ancestor
14923017|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923018|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923019|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923020|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
14923021|NCT02873819|Sargramostim|sargramostim|mesh-list
14923022|NCT02873819|Poly ICLC|poly iclc|mesh-list
14923023|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923024|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
14923025|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923026|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923027|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14385633|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385634|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14385635|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14385636|NCT01296646|Naltrexone|naltrexone|mesh-list
14385637|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14385638|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14385639|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385640|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
14385641|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385642|NCT01296672|Finasteride|finasteride|mesh-list
14385643|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14385644|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14385645|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385646|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385647|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
14385648|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385649|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385650|NCT01296672|Urological Agents|urological agents|mesh-ancestor
14385651|NCT01296698|Nicotine|nicotine|mesh-list
14385652|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14385653|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
14923028|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
14923029|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385654|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385655|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385656|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14385657|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14385658|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
14385659|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385660|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385661|NCT01296763|Irinotecan|irinotecan|mesh-list
14385662|NCT01296763|Olaparib|olaparib|mesh-list
14385663|NCT01296763|Mitomycins|mitomycins|mesh-list
14385664|NCT01296763|Mitomycin|mitomycin|mesh-list
14385665|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385666|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14385667|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14385668|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385669|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385670|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14385671|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14385672|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
14385673|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14385674|NCT01296815|Bevacizumab|bevacizumab|mesh-list
14923030|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923031|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14923032|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
14923033|NCT02872467|Oxytocin|oxytocin|mesh-list
14923034|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
14923035|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923036|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923037|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
14923038|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14923039|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
14923040|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923041|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923042|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14923043|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14923044|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14923045|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
14923046|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14385675|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14385676|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385677|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14385678|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14385679|NCT01296815|Growth Substances|growth substances|mesh-ancestor
14385680|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385681|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14385682|NCT01296932|BI 836826|bi 836826|mesh-list
14385683|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14385684|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385685|NCT01297062|Exenatide|exenatide|mesh-list
14385686|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
14385687|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14385688|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923047|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
14385689|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14385690|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14734514|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923048|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923049|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923050|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14923051|NCT02854436|Niraparib|niraparib|mesh-list
14923052|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14923053|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923054|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923055|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923056|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
14923057|NCT02811263|Hematinics|hematinics|mesh-ancestor
14923058|NCT02810457|Paclitaxel|paclitaxel|mesh-list
14923059|NCT02810457|Bevacizumab|bevacizumab|mesh-list
14923060|NCT02810457|Carboplatin|carboplatin|mesh-list
14923061|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923062|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923063|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923064|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923065|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14923066|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923067|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923068|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923069|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923070|NCT02810457|Growth Substances|growth substances|mesh-ancestor
14923071|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923072|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923073|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
14923074|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923075|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923076|NCT02754856|Durvalumab|durvalumab|mesh-list
14923077|NCT02754856|Ipilimumab|ipilimumab|mesh-list
14923078|NCT02754856|Tremelimumab|tremelimumab|mesh-list
14923079|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
14923080|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14923081|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
14923082|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923083|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923084|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
14923085|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923086|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14923087|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923088|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
14734515|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734516|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734517|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734518|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734519|NCT00535418|Letrozole|letrozole|mesh-list
14734520|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734521|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14734522|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14923089|NCT02745535|Velpatasvir|velpatasvir|mesh-list
14923090|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
14923091|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923092|NCT02740699|Atorvastatin|atorvastatin|mesh-list
14923093|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14923094|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14923095|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14923096|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
14923097|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923098|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14923099|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14923100|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923101|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
14923102|NCT02729701|Estrogens|estrogens|mesh-list
14923103|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14923104|NCT02729701|Hormones|hormones|mesh-ancestor
14923105|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923106|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923107|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14923108|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14923109|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
14923110|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14923111|NCT02723331|Gemcitabine|gemcitabine|mesh-list
14923112|NCT02723331|Paclitaxel|paclitaxel|mesh-list
14923113|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14923114|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923115|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923116|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923117|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923118|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
14923119|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923120|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14923121|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
14923122|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
14923123|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923124|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923125|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923126|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
14923127|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923128|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
14923129|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
14923130|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923131|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
14923132|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
14923133|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236154|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236155|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
15236156|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
15236157|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
15236158|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236159|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923134|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923135|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923136|NCT02719314|Hormones|hormones|mesh-ancestor
14923137|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923138|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14923139|NCT02719314|Protective Agents|protective agents|mesh-ancestor
15236160|NCT05176080|Fulvestrant|fulvestrant|mesh-list
15236161|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15236162|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236163|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15236164|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15236165|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
15236166|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236167|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236168|NCT05162898|Lenvatinib|lenvatinib|mesh-list
14385691|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923140|NCT02711826|Acetaminophen|acetaminophen|mesh-list
14923141|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
14923142|NCT02711826|Promethazine|promethazine|mesh-list
14923143|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
14923144|NCT02711826|Everolimus|everolimus|mesh-list
14923145|NCT02711826|Tacrolimus|tacrolimus|mesh-list
14923146|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923147|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
14923148|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923149|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14923150|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923151|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923152|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14923153|NCT02711826|Analgesics|analgesics|mesh-ancestor
14923154|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
14923155|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734523|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734524|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734525|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14923156|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
14923157|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923158|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14923159|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14923160|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
14923161|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14923162|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923163|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14923164|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14923165|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14923166|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
14923167|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
14385692|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385693|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385694|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385695|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14385696|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14385697|NCT01297062|Incretins|incretins|mesh-ancestor
14385698|NCT01297062|Hormones|hormones|mesh-ancestor
14385699|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385700|NCT01297335|Clonidine|clonidine|mesh-list
14385701|NCT01297335|Analgesics|analgesics|mesh-ancestor
14385702|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
14385703|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385704|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385705|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14734526|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
14734527|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385706|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
14385707|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
14385708|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14385709|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14385710|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14385711|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
14385712|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385713|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385714|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14385715|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14385716|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
14385717|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14385718|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14385719|NCT01297348|Norinyl|norinyl|mesh-list
14385720|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
14385721|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
14385722|NCT01297348|Estradiol|estradiol|mesh-list
14385723|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14385724|NCT01297348|Estrogens|estrogens|mesh-ancestor
14385725|NCT01297348|Hormones|hormones|mesh-ancestor
14734528|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753102|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753103|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753104|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
14753105|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753106|NCT05279963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14923168|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
14923169|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
14385726|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385727|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385728|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14385729|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385730|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14385731|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14385732|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14385733|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14385734|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14385735|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14385736|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14385737|NCT01297465|Hormones|hormones|mesh-ancestor
14385738|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385739|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385740|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385741|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14385742|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14385743|NCT01297517|Brinzolamide|brinzolamide|mesh-list
14385744|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14385745|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14385746|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14385747|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14385748|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14385749|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
14385750|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385751|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385752|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385753|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14385754|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385755|NCT01297595|Crizotinib|crizotinib|mesh-list
14385756|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385757|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14385758|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385759|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385760|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14385761|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14385762|NCT01297920|Brinzolamide|brinzolamide|mesh-list
14385763|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14385764|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14385765|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14385766|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14385767|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14385768|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
14385769|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385770|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385771|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385772|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14385773|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385774|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14385775|NCT01298063|Afatinib|afatinib|mesh-list
14385776|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385777|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14385778|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385779|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385780|NCT01298128|NuvaRing|nuvaring|mesh-list
14385781|NCT01298128|Desogestrel|desogestrel|mesh-list
14385782|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14385783|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
14385784|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15236169|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236170|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15236171|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923170|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923171|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14923172|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
14923173|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
14923174|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14923175|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15236172|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236173|NCT05155137|Amlodipine|amlodipine|mesh-list
14385785|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385786|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14385787|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14385788|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14385789|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14385790|NCT01298128|Progestins|progestins|mesh-ancestor
14385791|NCT01298128|Hormones|hormones|mesh-ancestor
14385792|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385793|NCT01298193|Phenothiazine|phenothiazine|mesh-list
14385794|NCT01298193|Droperidol|droperidol|mesh-list
14385795|NCT01298193|Haloperidol|haloperidol|mesh-list
14385796|NCT01298193|Aprepitant|aprepitant|mesh-list
14385797|NCT01298193|Metoclopramide|metoclopramide|mesh-list
14385798|NCT01298193|Domperidone|domperidone|mesh-list
14385799|NCT01298193|Alizapride|alizapride|mesh-list
14385800|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
14385801|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
14385802|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
14385803|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385804|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385805|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385806|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14385807|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385808|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385809|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14385810|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14385811|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385812|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14385813|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14385814|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
14385815|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14385816|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14385817|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14385818|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14385819|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
14385820|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14385821|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14385822|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385823|NCT01298219|Lubiprostone|lubiprostone|mesh-list
14385824|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14385825|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14385826|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385827|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14385828|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14385829|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385830|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385831|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14385832|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
14385833|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385834|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385835|NCT01298531|Etanercept|etanercept|mesh-list
14385836|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14385837|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14385838|NCT01298531|Analgesics|analgesics|mesh-ancestor
14385839|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
14385840|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385841|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385842|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14385843|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385844|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14385845|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385846|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
14385847|NCT01298570|Leucovorin|leucovorin|mesh-list
14385848|NCT01298570|Fluorouracil|fluorouracil|mesh-list
14385849|NCT01298570|Irinotecan|irinotecan|mesh-list
14385850|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
14385851|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
14385852|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385853|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14385854|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385855|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385856|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
14385857|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385858|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14385859|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14385860|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385861|NCT01298570|Antidotes|antidotes|mesh-ancestor
14385862|NCT01298570|Protective Agents|protective agents|mesh-ancestor
14385863|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
14385864|NCT01298570|Vitamins|vitamins|mesh-ancestor
14385865|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
14385866|NCT01298700|Bimatoprost|bimatoprost|mesh-list
14385867|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14385868|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14385869|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14385870|NCT01298765|Buprenorphine|buprenorphine|mesh-list
14385871|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14385872|NCT01298765|Narcotics|narcotics|mesh-ancestor
14385873|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385874|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385875|NCT01298765|Analgesics|analgesics|mesh-ancestor
14385876|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
14385877|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385878|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14385879|NCT01298778|Acetaminophen|acetaminophen|mesh-list
14385880|NCT01298778|Morphine|morphine|mesh-list
14385881|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14385882|NCT01298778|Analgesics|analgesics|mesh-ancestor
14385883|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
14385884|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385885|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385886|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
14385887|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14385888|NCT01298778|Narcotics|narcotics|mesh-ancestor
14385889|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385890|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14385891|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14385892|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14385893|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
14385894|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385895|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14385896|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14385897|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385898|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
14385899|NCT01299116|Etonogestrel|etonogestrel|mesh-list
14385900|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
14385901|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14385902|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385903|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14385904|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14385905|NCT01299272|Serotonin|serotonin|mesh-list
14385906|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14385907|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14385908|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
14385909|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385910|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385911|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385912|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14385913|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14385914|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14385915|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14385916|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14385917|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385918|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734529|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
14734530|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
14734531|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734532|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14734533|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734534|NCT00535509|Cisplatin|cisplatin|mesh-list
14734535|NCT00535509|Docetaxel|docetaxel|mesh-list
14734536|NCT00535509|Trastuzumab|trastuzumab|mesh-list
14734537|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734538|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
14734539|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
14385919|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14385920|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14385921|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14385922|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
14385923|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385924|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385925|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14385926|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14385927|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
14385928|NCT01299480|Vaccines|vaccines|mesh-list
14385929|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
14385930|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385931|NCT01299571|Dutasteride|dutasteride|mesh-list
14385932|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14385933|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14385934|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385935|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385936|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
14385937|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14385938|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385939|NCT01299584|Remifentanil|remifentanil|mesh-list
14734540|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
14385940|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14385941|NCT01299584|Narcotics|narcotics|mesh-ancestor
14385942|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385943|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385944|NCT01299584|Analgesics|analgesics|mesh-ancestor
14385945|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
14385946|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385947|NCT01299805|Vortioxetine|vortioxetine|mesh-list
14385948|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
14385949|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14385950|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14385951|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14385952|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14385953|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385954|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15236174|NCT05155137|Valsartan|valsartan|mesh-list
15236175|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15236176|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15236177|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15236178|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14385955|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14385956|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14385957|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385958|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385959|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
14385960|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14385961|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14385962|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14385963|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14385964|NCT01299896|Bupropion|bupropion|mesh-list
15236179|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236180|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15236181|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236182|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
14385965|NCT01299896|Nicotine|nicotine|mesh-list
14385966|NCT01299896|Varenicline|varenicline|mesh-list
14385967|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14385968|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
14385969|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14385970|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385971|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14385972|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14385973|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
14385974|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14385975|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385976|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14385977|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
14385978|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14385979|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14385980|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14385981|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14385982|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
14385983|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14385984|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14385985|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14385986|NCT01299961|Abatacept|abatacept|mesh-list
14385987|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14385988|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14385989|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14385990|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14385991|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
14385992|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14385993|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14385994|NCT01300234|Tenofovir|tenofovir|mesh-list
14385995|NCT01300234|Adefovir|adefovir|mesh-list
14385996|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14385997|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
14385998|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14385999|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14386000|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14386001|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386002|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386003|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14386004|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14386005|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
14386006|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14386007|NCT01300247|Fludarabine|fludarabine|mesh-list
14386008|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
14386009|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386010|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
14386011|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386012|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386013|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14386014|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
14386015|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386016|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386017|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14386018|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386019|NCT01300260|Dulaglutide|dulaglutide|mesh-list
14386020|NCT01300260|Glucagon|glucagon|mesh-list
14386021|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14386022|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386023|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386024|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14386025|NCT01300260|Hormones|hormones|mesh-ancestor
14386026|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386027|NCT01300260|Incretins|incretins|mesh-ancestor
14386028|NCT01300351|Fulvestrant|fulvestrant|mesh-list
14386029|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14386030|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386031|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14386032|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14386033|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
14386034|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386035|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386036|NCT01300455|Suvorexant|suvorexant|mesh-list
14386037|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14386038|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14386039|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386040|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386041|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14386042|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386043|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386044|NCT01300546|Naproxen|naproxen|mesh-list
14386045|NCT01300546|Sumatriptan|sumatriptan|mesh-list
14386046|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14386047|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14386048|NCT01300546|Analgesics|analgesics|mesh-ancestor
14386049|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
14386050|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386051|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386052|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386053|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386054|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
14386055|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14386056|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386057|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386058|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14386059|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14386060|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14386061|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
14386062|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386063|NCT01300572|Cyclosporine|cyclosporine|mesh-list
14386064|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
14386065|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14386066|NCT01300572|Fludarabine|fludarabine|mesh-list
14386067|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
14386068|NCT01300572|Antibodies|antibodies|mesh-list
14386069|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
14386070|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14386071|NCT01300572|Cyclosporins|cyclosporins|mesh-list
14386072|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
14386073|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923176|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
14923177|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
14386074|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923178|NCT02684253|Nivolumab|nivolumab|mesh-list
14923179|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386075|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14386076|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
14386077|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386078|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386079|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386080|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
14386081|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386082|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14386083|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386084|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14386085|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14386086|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14386087|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
14386088|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14466686|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466687|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14466688|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466689|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466690|NCT02248961|Losartan|losartan|mesh-list
14466691|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14466692|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466693|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14466694|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14466695|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466696|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14466697|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466698|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14466699|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14466700|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14466701|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14466702|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466703|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466704|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466705|NCT02249091|Cytarabine|cytarabine|mesh-list
14466706|NCT02249091|Idarubicin|idarubicin|mesh-list
14466707|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14466708|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
14466709|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466710|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466711|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
14466712|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466713|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466714|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
14466715|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466716|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14466717|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14466718|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14466719|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466720|NCT02249104|Adapalene|adapalene|mesh-list
14466721|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14466722|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14466723|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
14923180|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386089|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14386090|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386091|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
14386092|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
14386093|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386094|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
14386095|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
14386096|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386097|NCT01300819|Rotigotine|rotigotine|mesh-list
14386098|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
14386099|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
14386100|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386101|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386102|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386103|NCT01300923|Acamprosate|acamprosate|mesh-list
14386104|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14386105|NCT01301001|Gabapentin|gabapentin|mesh-list
14386106|NCT01301001|Analgesics|analgesics|mesh-ancestor
14386107|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
14386108|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386109|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386110|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
14386111|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14386112|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14386113|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386114|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14386115|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14386116|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14386117|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386118|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386119|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
14386120|NCT01301027|Pioglitazone|pioglitazone|mesh-list
14386121|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386122|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386123|NCT01301066|Pravastatin|pravastatin|mesh-list
14386124|NCT01301066|Pitavastatin|pitavastatin|mesh-list
14386125|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14386126|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14386127|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
14386128|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386129|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14386130|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14386131|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386132|NCT01301079|Ketamine|ketamine|mesh-list
14386133|NCT01301079|Analgesics|analgesics|mesh-ancestor
14386134|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
14386135|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386136|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386137|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14386138|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14386139|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
14386140|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
14386141|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386142|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14386143|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14386144|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386145|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386146|NCT01301092|Dulaglutide|dulaglutide|mesh-list
14386147|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386148|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386149|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14386150|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14386151|NCT01301183|Estradiol|estradiol|mesh-list
14386152|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14386153|NCT01301183|Mecasermin|mecasermin|mesh-list
14386154|NCT01301183|Estrogens|estrogens|mesh-ancestor
14386155|NCT01301183|Hormones|hormones|mesh-ancestor
14386156|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386157|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386158|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14386159|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
14386160|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14386161|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14386162|NCT01301183|Growth Substances|growth substances|mesh-ancestor
14386163|NCT01301391|Maleic acid|maleic acid|mesh-list
14386164|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386165|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386166|NCT01301729|Paclitaxel|paclitaxel|mesh-list
14386167|NCT01301729|Docetaxel|docetaxel|mesh-list
14386168|NCT01301729|Trastuzumab|trastuzumab|mesh-list
14386169|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14386170|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386171|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
14386172|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
14386173|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
14386174|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386175|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236183|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15236184|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15236185|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
15236186|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15236187|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15236188|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236189|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15236190|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15236191|NCT05153525|Cisatracurium|cisatracurium|mesh-list
15236192|NCT05153525|Atracurium|atracurium|mesh-list
15236193|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15236194|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15236195|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236196|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236197|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15236198|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15236199|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15236200|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
15236201|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236202|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236203|NCT05144295|Lactulose|lactulose|mesh-list
15236204|NCT05144295|Bisacodyl|bisacodyl|mesh-list
15236205|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
15236206|NCT05144295|Lubiprostone|lubiprostone|mesh-list
15236207|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15236208|NCT05144295|Cathartics|cathartics|mesh-ancestor
15236209|NCT05144295|Laxatives|laxatives|mesh-ancestor
15236210|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15236211|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15236212|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236213|NCT05134857|Zonisamide|zonisamide|mesh-list
14734541|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734542|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734543|NCT00535574|Bexarotene|bexarotene|mesh-list
14386176|NCT01301742|Empagliflozin|empagliflozin|mesh-list
14386177|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
14734544|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386178|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14386179|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386180|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14734545|NCT00535665|Vaccines|vaccines|mesh-list
14734546|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
14386181|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386182|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14386183|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
14386184|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14386185|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14386186|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14386187|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386188|NCT01301833|Biguanides|biguanides|mesh-list
14386189|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14386190|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386191|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386192|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386193|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386194|NCT01302054|Fesoterodine|fesoterodine|mesh-list
14386195|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14386196|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14386197|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
14386198|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386199|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386200|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386201|NCT01302054|Urological Agents|urological agents|mesh-ancestor
14386202|NCT01302067|Fesoterodine|fesoterodine|mesh-list
14386203|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14386204|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14386205|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
14386206|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386207|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386208|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386209|NCT01302067|Urological Agents|urological agents|mesh-ancestor
14386210|NCT01302080|Sertraline|sertraline|mesh-list
14386211|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
14386212|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14386213|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14386214|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14386215|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386216|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386217|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386218|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
14386219|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386220|NCT01302119|Tavaborole|tavaborole|mesh-list
14386221|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14386222|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
14386223|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386224|NCT01302379|Metformin|metformin|mesh-list
14386225|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386226|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386227|NCT01302483|Lidocaine|lidocaine|mesh-list
14386228|NCT01302483|Phenylephrine|phenylephrine|mesh-list
14386229|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
14386230|NCT01302483|Tetracaine|tetracaine|mesh-list
14386231|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
14386232|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
14386233|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734547|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734548|NCT00535691|Tacrolimus|tacrolimus|mesh-list
14386234|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386235|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
14386236|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386237|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14386238|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14386239|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14386240|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14923181|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14923182|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923183|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14923184|NCT02666794|Sufentanil|sufentanil|mesh-list
14923185|NCT02666794|Morphine|morphine|mesh-list
14923186|NCT02666794|Dsuvia|dsuvia|mesh-list
14923187|NCT02666794|Bupivacaine|bupivacaine|mesh-list
14923188|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
14923189|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
14923190|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14923191|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923192|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
14923193|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923194|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14923195|NCT02666794|Narcotics|narcotics|mesh-ancestor
14923196|NCT02666794|Analgesics|analgesics|mesh-ancestor
14923197|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14923198|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14386241|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386242|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14386243|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14386244|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
14386245|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386246|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
14386247|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
14386248|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
14386249|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14386250|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
14386251|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14386252|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
14386253|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14386254|NCT01302483|Protective Agents|protective agents|mesh-ancestor
14386255|NCT01302691|Losartan|losartan|mesh-list
14386256|NCT01302691|Amlodipine|amlodipine|mesh-list
14386257|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14386258|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14386259|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14386260|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386261|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386262|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14923199|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
14923200|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
14923201|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
14734549|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386263|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386264|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
14386265|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14386266|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14386267|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14386268|NCT01302691|Diuretics|diuretics|mesh-ancestor
14386269|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
14386270|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14386271|NCT01302743|Metformin|metformin|mesh-list
14386272|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386273|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386274|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14386275|NCT01302808|Romidepsin|romidepsin|mesh-list
14386276|NCT01302808|Antiemetics|antiemetics|mesh-list
14386277|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386278|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734550|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
14734551|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734552|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14734553|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923202|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923203|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734554|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734555|NCT00535808|Nitroprusside|nitroprusside|mesh-list
14734556|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
14386279|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386280|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923204|NCT02642094|Sirolimus|sirolimus|mesh-list
14923205|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14923206|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386281|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14386282|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
14386283|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386284|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386285|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14386286|NCT01302834|Cetuximab|cetuximab|mesh-list
14734557|NCT00535808|Sevoflurane|sevoflurane|mesh-list
15236214|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
15236215|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14386287|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386288|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386289|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14386290|NCT01302899|Ramipril|ramipril|mesh-list
14386291|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14386292|NCT01302899|Diuretics|diuretics|mesh-ancestor
14386293|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
14386294|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386295|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14386296|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386297|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386298|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14386299|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14386300|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386301|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14386302|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14386303|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14386304|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
14386305|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386306|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386307|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386308|NCT01302938|Urological Agents|urological agents|mesh-ancestor
14386309|NCT01302964|Mirtazapine|mirtazapine|mesh-list
14386310|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
14386311|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14386312|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14386313|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
14386314|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
14386315|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386316|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753107|NCT05279963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14923207|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14923208|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236216|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386317|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386318|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14386319|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14386320|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386321|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14386322|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14386323|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14386324|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14386325|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14386326|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14386327|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
14386328|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14386329|NCT01303172|Gemcitabine|gemcitabine|mesh-list
14386330|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14386331|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
14386332|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386333|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386334|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
14386335|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386336|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386337|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386338|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
14386339|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386340|NCT01303406|Idebenone|idebenone|mesh-list
14386341|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
14386342|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386343|NCT01303406|Protective Agents|protective agents|mesh-ancestor
14386344|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386345|NCT01303445|Omeprazole|omeprazole|mesh-list
14386346|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
14386347|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14386348|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14386349|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14386350|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386351|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236217|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236218|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15236219|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236220|NCT05113290|Sorafenib|sorafenib|mesh-list
15236221|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236222|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15236223|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236224|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236225|NCT05107778|Entecavir|entecavir|mesh-list
15236226|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
15236227|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386352|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14386353|NCT01303627|Remifentanil|remifentanil|mesh-list
14386354|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14386355|NCT01303627|Narcotics|narcotics|mesh-ancestor
14386356|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386357|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386358|NCT01303627|Analgesics|analgesics|mesh-ancestor
14386359|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
14386360|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386361|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
14386362|NCT01303744|Analgesics|analgesics|mesh-ancestor
14386363|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
14386364|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386365|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386366|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14386367|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14386368|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386369|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386370|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14386371|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386372|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386373|NCT01303835|Naltrexone|naltrexone|mesh-list
14386374|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14386375|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14386376|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386377|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
14386378|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386379|NCT01303861|Bupropion|bupropion|mesh-list
14386380|NCT01303861|Nicotine|nicotine|mesh-list
14386381|NCT01303861|Varenicline|varenicline|mesh-list
14386382|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14386383|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
14386384|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386385|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386386|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14386387|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14386388|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
14386389|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386390|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386391|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14386392|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
14386393|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14386394|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14386395|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14386396|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386397|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
14386398|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14386399|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14386400|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386401|NCT01303965|Sirolimus|sirolimus|mesh-list
14386402|NCT01303965|Lenalidomide|lenalidomide|mesh-list
14386403|NCT01303965|Tacrolimus|tacrolimus|mesh-list
14386404|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386405|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
14386406|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386407|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14386408|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386409|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386410|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14386411|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14386412|NCT01303965|Growth Substances|growth substances|mesh-ancestor
14386413|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
14386414|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386415|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14386416|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386417|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14386418|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
14386419|NCT01304082|Lidocaine|lidocaine|mesh-list
14386420|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
14386421|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
14386422|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386423|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386424|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
14386425|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386426|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14386427|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14386428|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14386429|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386430|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386431|NCT01304147|Ketamine|ketamine|mesh-list
14386432|NCT01304147|Analgesics|analgesics|mesh-ancestor
14386433|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
14386434|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386435|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386436|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14386437|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14386438|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
14386439|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
14386440|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386441|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14386442|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14386443|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386444|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386445|NCT01304238|PENTA|penta|mesh-list
14386446|NCT01304238|Lepirudin|lepirudin|mesh-list
14386447|NCT01304238|Danaparoid|danaparoid|mesh-list
14386448|NCT01304238|Fondaparinux|fondaparinux|mesh-list
14386449|NCT01304238|Argatroban|argatroban|mesh-list
14386450|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14386451|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
14386452|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14386453|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
14386454|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386455|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386456|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
14386457|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14386458|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14386459|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14386460|NCT01304329|Empagliflozin|empagliflozin|mesh-list
14386461|NCT01304329|Simvastatin|simvastatin|mesh-list
14386462|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14386463|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14386464|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
14386465|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386466|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14386467|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14386468|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386469|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14386470|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386471|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386472|NCT01304407|Calcium|calcium|mesh-list
14386473|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14386474|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386475|NCT01304498|Vaccines|vaccines|mesh-list
14386476|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
14386477|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386478|NCT01304589|Milnacipran|milnacipran|mesh-list
14386479|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
14386480|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14386481|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14386482|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14923209|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
14923210|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923211|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
14923212|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923213|NCT02636569|Diclofenac|diclofenac|mesh-list
14923214|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14734558|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14734559|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14734560|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
14734561|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
14734562|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734563|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734564|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
14734565|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14734566|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14734567|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734568|NCT00535860|Teriparatide|teriparatide|mesh-list
14923215|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14923216|NCT02636569|Analgesics|analgesics|mesh-ancestor
14923217|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
14923218|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734569|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14734570|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734571|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14734572|NCT00535951|Panobinostat|panobinostat|mesh-list
14734573|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734574|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14734575|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734576|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734577|NCT00536003|Progesterone|progesterone|mesh-list
14734578|NCT00536003|Progestins|progestins|mesh-ancestor
14734579|NCT00536003|Hormones|hormones|mesh-ancestor
14386483|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386484|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386485|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386486|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14386487|NCT01304589|Analgesics|analgesics|mesh-ancestor
14386488|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
14734580|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14734581|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734582|NCT00536042|Minocycline|minocycline|mesh-list
14734583|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734584|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734585|NCT00536068|Acetaminophen|acetaminophen|mesh-list
14734586|NCT00536068|Aspirin|aspirin|mesh-list
14734587|NCT00536068|Diclofenac|diclofenac|mesh-list
14734588|NCT00536068|Naproxen|naproxen|mesh-list
14734589|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14734590|NCT00536068|Analgesics|analgesics|mesh-ancestor
14386489|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386490|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
14386491|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14386492|NCT01304641|Atorvastatin|atorvastatin|mesh-list
14386493|NCT01304641|Simvastatin|simvastatin|mesh-list
14386494|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14386495|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14386496|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
14386497|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386498|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14386499|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14386500|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386501|NCT01304693|Ranibizumab|ranibizumab|mesh-list
14386502|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14386503|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14386504|NCT01304693|Growth Substances|growth substances|mesh-ancestor
14734591|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
14734592|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386505|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386506|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734593|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734594|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
14734595|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14734596|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14734597|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734598|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14386507|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386508|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14386509|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236228|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15236229|NCT05102409|Lifitegrast|lifitegrast|mesh-list
15236230|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15236231|NCT05097716|Tolbutamide|tolbutamide|mesh-list
15236232|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236233|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236234|NCT05095857|Ketamine|ketamine|mesh-list
15236235|NCT05095857|Esketamine|esketamine|mesh-list
14734599|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734600|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236236|NCT05095857|Analgesics|analgesics|mesh-ancestor
15236237|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
14386510|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
14386511|NCT01304706|Hormones|hormones|mesh-ancestor
14386512|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386513|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386514|NCT01305200|Calcium|calcium|mesh-list
14386515|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14386516|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386517|NCT01305213|Bevacizumab|bevacizumab|mesh-list
14386518|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14386519|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
14386520|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
14386521|NCT01305213|Antibodies|antibodies|mesh-list
14386522|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
14386523|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14386524|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
14386525|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386526|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14386527|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14386528|NCT01305213|Growth Substances|growth substances|mesh-ancestor
14386529|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386530|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
14386531|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
14386532|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14386533|NCT01305239|Exemestane|exemestane|mesh-list
14386534|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386535|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14386536|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14386537|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386538|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386539|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14386540|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
14386541|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386542|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386543|NCT01305252|Treprostinil|treprostinil|mesh-list
14386544|NCT01305252|Tadalafil|tadalafil|mesh-list
14386545|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
14386546|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14386547|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14386548|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386549|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386550|NCT01305252|Urological Agents|urological agents|mesh-ancestor
14386551|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14386552|NCT01305408|Modafinil|modafinil|mesh-list
14386553|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14386554|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386555|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14386556|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14386557|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14386558|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386559|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
15236238|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236239|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236240|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14386560|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14386561|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14386562|NCT01305772|Panitumumab|panitumumab|mesh-list
14386563|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386564|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386565|NCT01305941|Trastuzumab|trastuzumab|mesh-list
14386566|NCT01305941|Everolimus|everolimus|mesh-list
14386567|NCT01305941|Vinorelbine|vinorelbine|mesh-list
14386568|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386569|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386570|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386571|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
14386572|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386573|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14386574|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
14386575|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
14386576|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
14386577|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386578|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
14386579|NCT01306032|Veliparib|veliparib|mesh-list
15236241|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14734601|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
14386580|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386581|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
14386582|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386583|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386584|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14386585|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
14386586|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386587|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386588|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14386589|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14386590|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386591|NCT01306058|Sorafenib|sorafenib|mesh-list
14386592|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386593|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14386594|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386595|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386596|NCT01306162|Dronedarone|dronedarone|mesh-list
14386597|NCT01306162|Dabigatran|dabigatran|mesh-list
14386598|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
14386599|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14386600|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
14386601|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386602|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386603|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
14386604|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14386605|NCT01306175|Empagliflozin|empagliflozin|mesh-list
14386606|NCT01306175|Digoxin|digoxin|mesh-list
14386607|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14386608|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14386609|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386610|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386611|NCT01306175|Protective Agents|protective agents|mesh-ancestor
14386612|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386613|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14386614|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14734602|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14734603|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14734604|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14734605|NCT00536211|Metformin|metformin|mesh-list
14734606|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14734607|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386615|NCT01306214|Empagliflozin|empagliflozin|mesh-list
14386616|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14386617|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386618|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14386619|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386620|NCT01306331|Nonoxynol|nonoxynol|mesh-list
14386621|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14386622|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14386623|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386624|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14386625|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
15236242|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
15236243|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
15236244|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236245|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15236246|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15236247|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236248|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236249|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
15236250|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236251|NCT05076877|Metformin|metformin|mesh-list
15236252|NCT05076877|Midazolam|midazolam|mesh-list
15236253|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15236254|NCT05076877|Lazertinib|lazertinib|mesh-list
15236255|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236256|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236257|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14386626|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14734608|NCT00536237|Niacin|niacin|mesh-list
14734609|NCT00536237|Niacinamide|niacinamide|mesh-list
14386627|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14386628|NCT01306617|Ritonavir|ritonavir|mesh-list
14386629|NCT01306617|Ribavirin|ribavirin|mesh-list
14386630|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14386631|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14386632|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
14386633|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386634|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386635|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14386636|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14386637|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
14386638|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386639|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14386640|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14386641|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
14386642|NCT01306643|Idelalisib|idelalisib|mesh-list
14386643|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386644|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386645|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386646|NCT01306656|Vitamin D|vitamin d|mesh-list
14386647|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
14386648|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
14386649|NCT01306656|Vitamins|vitamins|mesh-list
14386650|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
14386651|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386652|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14386653|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14386654|NCT01306942|Paclitaxel|paclitaxel|mesh-list
14386655|NCT01306942|Trastuzumab|trastuzumab|mesh-list
14386656|NCT01306942|Dasatinib|dasatinib|mesh-list
14386657|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14386658|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386659|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
14386660|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
14386661|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
14386662|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386663|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386664|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14386665|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466724|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14466725|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466726|NCT02249104|Analgesics|analgesics|mesh-ancestor
14466727|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
14466728|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466729|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466730|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466731|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469931|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469932|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
15236258|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15236259|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236260|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15236261|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15236262|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236263|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236264|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
15236265|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
15236266|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
15236267|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
15236268|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236269|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469933|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236270|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14386666|NCT01307007|Dextrans|dextrans|mesh-list
14386667|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
14386668|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
14386669|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
14386670|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
14386671|NCT01307007|Hematinics|hematinics|mesh-ancestor
14386672|NCT01307020|Ibuprofen|ibuprofen|mesh-list
14386673|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14386674|NCT01307020|Ketoprofen|ketoprofen|mesh-list
14386675|NCT01307020|Tramadol|tramadol|mesh-list
14386676|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14386677|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14386678|NCT01307020|Analgesics|analgesics|mesh-ancestor
14386679|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
14386680|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386681|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386682|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386683|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386684|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14386685|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386686|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386687|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14386688|NCT01307020|Narcotics|narcotics|mesh-ancestor
14386689|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386690|NCT01307111|Misoprostol|misoprostol|mesh-list
14386691|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14386692|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
14386693|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14386694|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386695|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14734610|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
14734611|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734612|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734613|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14734614|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
14386696|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14386697|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
14386698|NCT01307267|Rituximab|rituximab|mesh-list
14386699|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14386700|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
14386701|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386702|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386703|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
14386704|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386705|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386706|NCT01307319|Beclomethasone|beclomethasone|mesh-list
14386707|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386708|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
14386709|NCT01307319|Hormones|hormones|mesh-ancestor
14386710|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386711|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386712|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14386713|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
14386714|NCT01307397|Vemurafenib|vemurafenib|mesh-list
14386715|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386716|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14386717|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386718|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386719|NCT01307423|Thalidomide|thalidomide|mesh-list
14386720|NCT01307423|Apremilast|apremilast|mesh-list
14386721|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14386722|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14386723|NCT01307423|Analgesics|analgesics|mesh-ancestor
14386724|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
14386725|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386726|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386727|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386728|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14386729|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14386730|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14386731|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386732|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386733|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386734|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
14386735|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
14386736|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14386737|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386738|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14386739|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15236271|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15236272|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
15236273|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15236274|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15236275|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236276|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15236277|NCT05076838|Diazepam|diazepam|mesh-list
15236278|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15236279|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
15236280|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
15236281|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
15236282|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236283|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236284|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14386740|NCT01307423|Growth Substances|growth substances|mesh-ancestor
14386741|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14386742|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386743|NCT01307449|Vaccines|vaccines|mesh-list
14386744|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14386745|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
14386746|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386747|NCT01307462|Fluticasone|fluticasone|mesh-list
14386748|NCT01307462|Xhance|xhance|mesh-list
14386749|NCT01307462|Azithromycin|azithromycin|mesh-list
14386750|NCT01307462|Montelukast|montelukast|mesh-list
14386751|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386752|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14386753|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
14386754|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386755|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236285|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15236286|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386756|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14466732|NCT02249182|Ribavirin|ribavirin|mesh-list
14386757|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
14386758|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
14386759|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14386760|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14386761|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386762|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14386763|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
14386764|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386765|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14386766|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14386767|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386768|NCT01307579|Fluconazole|fluconazole|mesh-list
14386769|NCT01307579|Caspofungin|caspofungin|mesh-list
14386770|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
14386771|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386772|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14386773|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14386774|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386775|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386776|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14386777|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
14386778|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386779|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386780|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14386781|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14386782|NCT01307618|Interleukin-12|interleukin-12|mesh-list
14386783|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14386784|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
14386785|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386786|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14386787|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14386788|NCT01307618|Growth Substances|growth substances|mesh-ancestor
14386789|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
14386790|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386791|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14386792|NCT01307891|Paclitaxel|paclitaxel|mesh-list
14386793|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386794|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14386795|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
14386796|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
14386797|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
14386798|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386799|NCT01307930|Anidulafungin|anidulafungin|mesh-list
14386800|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
14386801|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386802|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
14386803|NCT01307956|Leucovorin|leucovorin|mesh-list
14386804|NCT01307956|Folic Acid|folic acid|mesh-list
14386805|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14386806|NCT01307956|Panitumumab|panitumumab|mesh-list
14386807|NCT01307956|Fluorouracil|fluorouracil|mesh-list
14386808|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
14386809|NCT01307956|Antibodies|antibodies|mesh-list
14386810|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
14386811|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14386812|NCT01307956|Calcium|calcium|mesh-list
14386813|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
14386814|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
14386815|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386816|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386817|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14734615|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14734616|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
14734617|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
14734618|NCT00536237|Vitamins|vitamins|mesh-ancestor
14386818|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14734619|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
14386819|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
14386820|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386821|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14386822|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386823|NCT01307956|Antidotes|antidotes|mesh-ancestor
14386824|NCT01307956|Protective Agents|protective agents|mesh-ancestor
14386825|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
14386826|NCT01307956|Vitamins|vitamins|mesh-ancestor
14386827|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
14386828|NCT01307956|Hematinics|hematinics|mesh-ancestor
14386829|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
14386830|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14386831|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14386832|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14386833|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386834|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386835|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
14386836|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386837|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386838|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14386839|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386840|NCT01308294|Vaccines|vaccines|mesh-list
14386841|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
14386842|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386843|NCT01308567|Prednisone|prednisone|mesh-list
14386844|NCT01308567|Docetaxel|docetaxel|mesh-list
14386845|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386846|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
14386847|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
14386848|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
14386849|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386850|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386851|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
14923219|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923220|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923221|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923222|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14923223|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923224|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386852|NCT01308567|Hormones|hormones|mesh-ancestor
14386853|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386854|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386855|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14386856|NCT01308580|Prednisone|prednisone|mesh-list
14386857|NCT01308580|Prednisolone|prednisolone|mesh-list
14386858|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386859|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
14386860|NCT01308580|Hormones|hormones|mesh-ancestor
14386861|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386862|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386863|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14386864|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386865|NCT01308619|Doxycycline|doxycycline|mesh-list
14923225|NCT02636322|Prednisone|prednisone|mesh-list
14923226|NCT02636322|Cortisone|cortisone|mesh-list
14923227|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
14923228|NCT02636322|Rituximab|rituximab|mesh-list
14923229|NCT02636322|Doxorubicin|doxorubicin|mesh-list
14923230|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14923231|NCT02636322|Etoposide|etoposide|mesh-list
14923232|NCT02636322|Vincristine|vincristine|mesh-list
14923233|NCT02636322|Lenalidomide|lenalidomide|mesh-list
14386866|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14386867|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923234|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
14923235|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
14923236|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14923237|NCT02636322|Antibodies|antibodies|mesh-list
14386868|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
14386869|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14386870|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15236287|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15236288|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14734620|NCT00536276|Vitamin D|vitamin d|mesh-list
14734621|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
14734622|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
14386871|NCT01308736|Varenicline|varenicline|mesh-list
14386872|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14386873|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14734623|NCT00536276|Vitamins|vitamins|mesh-list
14734624|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
14734625|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734626|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14386874|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
14386875|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386876|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386877|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386878|NCT01308749|Oxytocin|oxytocin|mesh-list
14386879|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
14386880|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14386881|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386882|NCT01308814|Estradiol|estradiol|mesh-list
14386883|NCT01308814|Estrogens|estrogens|mesh-ancestor
14386884|NCT01308814|Hormones|hormones|mesh-ancestor
14734627|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14734628|NCT00536393|Doxorubicin|doxorubicin|mesh-list
14734629|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14734630|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14734631|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734632|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14734633|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14734634|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734635|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734636|NCT00536419|Methylphenidate|methylphenidate|mesh-list
14734637|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14734638|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734639|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14734640|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14386885|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386886|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386887|NCT01308840|Gemcitabine|gemcitabine|mesh-list
14386888|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
14386889|NCT01308840|Panitumumab|panitumumab|mesh-list
14386890|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14386891|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
14386892|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386893|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386894|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
14386895|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386896|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386897|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386898|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
14386899|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386900|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386901|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14386902|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14386903|NCT01309204|Brinzolamide|brinzolamide|mesh-list
14734641|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734642|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734643|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
14734644|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734645|NCT00536614|Cetuximab|cetuximab|mesh-list
14734646|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734647|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734648|NCT00536640|Gemcitabine|gemcitabine|mesh-list
14386904|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14386905|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15236289|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15236290|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15236291|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236292|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14734649|NCT00536640|Bevacizumab|bevacizumab|mesh-list
14734650|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14386906|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14386907|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14386908|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14386909|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
14386910|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386911|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386912|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386913|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14386914|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386915|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14386916|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14386917|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14386918|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386919|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386920|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
14386921|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14386922|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14386923|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14386924|NCT01309360|Midazolam|midazolam|mesh-list
14386925|NCT01309360|Prilocaine|prilocaine|mesh-list
14386926|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14386927|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14386928|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386929|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386930|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14386931|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14386932|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14386933|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236293|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
15236294|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
15236295|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
15236296|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
15236297|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236298|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236299|NCT05070039|Antibodies|antibodies|mesh-list
15236300|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
15236301|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386934|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
14386935|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
14386936|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
14386937|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
14386938|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386939|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386940|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
14386941|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
14386942|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386943|NCT01309386|Morphine|morphine|mesh-list
14386944|NCT01309386|Tapentadol|tapentadol|mesh-list
14386945|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14386946|NCT01309386|Narcotics|narcotics|mesh-ancestor
14386947|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14386948|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386949|NCT01309386|Analgesics|analgesics|mesh-ancestor
14386950|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
14386951|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386952|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14386953|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14386954|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386955|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386956|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
14386957|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386958|NCT01309451|Dexamethasone|dexamethasone|mesh-list
14386959|NCT01309451|Bevacizumab|bevacizumab|mesh-list
14386960|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14386961|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14386962|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14386963|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14386964|NCT01309451|Growth Substances|growth substances|mesh-ancestor
14386965|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386966|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
14386967|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14386968|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
14386969|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
14386970|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14386971|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14386972|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
14386973|NCT01309451|Hormones|hormones|mesh-ancestor
14386974|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14386975|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14386976|NCT01309659|Iron|iron|mesh-list
14386977|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14386978|NCT01309659|Trace Elements|trace elements|mesh-ancestor
14386979|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
14386980|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386981|NCT01309659|Hematinics|hematinics|mesh-ancestor
14386982|NCT01309737|Tofacitinib|tofacitinib|mesh-list
14386983|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14386984|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14386985|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386986|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
14386987|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14386988|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14923238|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
14923239|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14923240|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923241|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
14923242|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923243|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923244|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14923245|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
14923246|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923247|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923248|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14923249|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14923250|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14923251|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14923252|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923253|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923254|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
14923255|NCT02636322|Hormones|hormones|mesh-ancestor
14386989|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14466733|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
15236302|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
15236303|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15236304|NCT05058872|Estradiol|estradiol|mesh-list
15236305|NCT05058872|Estrogens|estrogens|mesh-ancestor
15236306|NCT05058872|Hormones|hormones|mesh-ancestor
14386990|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14386991|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14386992|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
14386993|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14386994|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14386995|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14386996|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734651|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734652|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734653|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734654|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734655|NCT00536640|Growth Substances|growth substances|mesh-ancestor
14734656|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734657|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734658|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14734659|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
14734660|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734661|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
14734662|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734663|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734664|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14386997|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14386998|NCT01309828|Olmesartan|olmesartan|mesh-list
14386999|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14387000|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
14387001|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14387002|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14387003|NCT01309828|Diuretics|diuretics|mesh-ancestor
14387004|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
14387005|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387006|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14387007|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387008|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387009|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14387010|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14387011|NCT01309841|Naloxegol|naloxegol|mesh-list
14387012|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14387013|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387014|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
14387015|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734665|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
14387016|NCT01309997|Rituximab|rituximab|mesh-list
14387017|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
14387018|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14387019|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387020|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
14387021|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387022|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387023|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14387024|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387025|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387026|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14387027|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387028|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14387029|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387030|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387031|NCT01310127|Nepafenac|nepafenac|mesh-list
14387032|NCT01310127|Bromfenac|bromfenac|mesh-list
14387033|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14387034|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14387035|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14387036|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14387037|NCT01310127|Analgesics|analgesics|mesh-ancestor
14387038|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
14387039|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387040|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387041|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387042|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387043|NCT01310179|Fludarabine|fludarabine|mesh-list
14387044|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
14387045|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387046|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15236307|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236308|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236309|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15236310|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
15236311|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15236312|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15236313|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15236314|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15236315|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15236316|NCT05041049|Anesthetics|anesthetics|mesh-list
15236317|NCT05041049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236318|NCT05041049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236319|NCT05020145|Vaccines|vaccines|mesh-list
15236320|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
15236321|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236322|NCT05004662|Nicotine|nicotine|mesh-list
15236323|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15236324|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
15236325|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236326|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236327|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14387047|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
14387048|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387049|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387050|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
14387051|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387052|NCT01310231|Metformin|metformin|mesh-list
14387053|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387054|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387055|NCT01310582|Sevoflurane|sevoflurane|mesh-list
14387056|NCT01310582|Desflurane|desflurane|mesh-list
14387057|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14387058|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14387059|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
14387060|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
14387061|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14387062|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387063|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14387064|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14387065|NCT01310777|Brinzolamide|brinzolamide|mesh-list
14387066|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14387067|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14387068|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14387069|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14387070|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14387071|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
14387072|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387073|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387074|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387075|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14387076|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387077|NCT01310855|Gefitinib|gefitinib|mesh-list
14387078|NCT01310855|Cediranib|cediranib|mesh-list
14387079|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387080|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387081|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387082|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14387083|NCT01310868|Carmustine|carmustine|mesh-list
14387084|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14387085|NCT01310868|Levulinic acid|levulinic acid|mesh-list
14387086|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14387087|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
14387088|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387089|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387090|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387091|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14387092|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387093|NCT01311024|Vaccines|vaccines|mesh-list
14387094|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
14387095|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387096|NCT01311102|Lidocaine|lidocaine|mesh-list
14387097|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
14387098|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
14387099|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14387100|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387101|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
14387102|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236328|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15236329|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
15236330|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236331|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236332|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15236333|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15236334|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
15236335|NCT04968366|Temozolomide|temozolomide|mesh-list
15236336|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14387103|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14387104|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14387105|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14387106|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387107|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387108|NCT01311505|Rifampin|rifampin|mesh-list
14387109|NCT01311505|Isoniazid|isoniazid|mesh-list
14387110|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14387111|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
14387112|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387113|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387114|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
14387115|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14387116|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387117|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387118|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14387119|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14387120|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14387121|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14387122|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14387123|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14387124|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14387125|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14387126|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
14387127|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14387128|NCT01311648|Factor VIII|factor viii|mesh-list
14387129|NCT01311648|Coagulants|coagulants|mesh-ancestor
14387130|NCT01311661|Olodaterol|olodaterol|mesh-list
14387131|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387132|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
14387133|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236337|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
15236338|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236339|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236340|NCT04964128|Insulin|insulin|mesh-list
15236341|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236342|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236343|NCT04901715|Albuterol|albuterol|mesh-list
15236344|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15236345|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
15236346|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236347|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236348|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387134|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387135|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387136|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
14387137|NCT01311674|Vaccines|vaccines|mesh-list
14387138|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
14387139|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387140|NCT01311687|Dexamethasone|dexamethasone|mesh-list
14387141|NCT01311687|Pomalidomide|pomalidomide|mesh-list
14387142|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387143|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
14387144|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
14387145|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387146|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387147|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387148|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
14387149|NCT01311687|Hormones|hormones|mesh-ancestor
14387150|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387151|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14387152|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923256|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923257|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14923258|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923259|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923260|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923261|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
14923262|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923263|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923264|NCT02636322|Growth Substances|growth substances|mesh-ancestor
14923265|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923266|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
14387153|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
14387154|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14387155|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14387156|NCT01311687|Growth Substances|growth substances|mesh-ancestor
14387157|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
14387158|NCT01311895|Hydromorphone|hydromorphone|mesh-list
14387159|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14387160|NCT01311895|Narcotics|narcotics|mesh-ancestor
14387161|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14387162|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387163|NCT01311895|Analgesics|analgesics|mesh-ancestor
14923267|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387164|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
14387165|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236349|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
15236350|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
15236351|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15236352|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15236353|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15236354|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15236355|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
15236356|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236357|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236358|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
15236359|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15236360|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
15236361|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236362|NCT04880707|Anesthetics|anesthetics|mesh-list
15236363|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
14387166|NCT01312038|Simethicone|simethicone|mesh-list
14387167|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
14387168|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387169|NCT01312038|Emollients|emollients|mesh-ancestor
14387170|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387171|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
14387172|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387173|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14387174|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14387175|NCT01312129|Analgesics|analgesics|mesh-ancestor
14387176|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
14387177|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387178|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387179|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387180|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387181|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387182|NCT01312272|Oxytocin|oxytocin|mesh-list
14387183|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
14387184|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14387185|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387186|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14387187|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
14387188|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387189|NCT01312467|Metformin|metformin|mesh-list
14387190|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14734666|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734667|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
14734668|NCT00536653|Vitamin D|vitamin d|mesh-list
14387191|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387192|NCT01312766|Menotropins|menotropins|mesh-list
14387193|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14387194|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
14387195|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14387196|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387197|NCT01312818|Dexamethasone|dexamethasone|mesh-list
14387198|NCT01312818|Methotrexate|methotrexate|mesh-list
14387199|NCT01312818|Bortezomib|bortezomib|mesh-list
14387200|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
14387201|NCT01312818|Vorinostat|vorinostat|mesh-list
14387202|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387203|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
14387204|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
14387205|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387206|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387207|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387208|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
14387209|NCT01312818|Hormones|hormones|mesh-ancestor
14387210|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387211|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14387212|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387213|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14387214|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
14387215|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14387216|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14387217|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
14387218|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387219|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387220|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387221|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14387222|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387223|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
14387224|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387225|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14387226|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14387227|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14387228|NCT01312844|Scopolamine|scopolamine|mesh-list
14387229|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14387230|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14387231|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
14387232|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
14387233|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387234|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387235|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387236|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
14387237|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14387238|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387239|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387240|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387241|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14387242|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
14387243|NCT01312909|Varenicline|varenicline|mesh-list
14387244|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14387245|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14387246|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387247|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387248|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387249|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387250|NCT01312961|Fluticasone|fluticasone|mesh-list
14387251|NCT01312961|Xhance|xhance|mesh-list
14387252|NCT01312961|Albuterol|albuterol|mesh-list
14387253|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14387254|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14387255|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14387256|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387257|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387258|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
14387259|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387260|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387261|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387262|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
14387263|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387264|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14387265|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14387266|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14387267|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14387268|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14387269|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387270|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387271|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
14387272|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14387273|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
14387274|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
14387275|NCT01312961|Hormones|hormones|mesh-ancestor
14387276|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387277|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
14387278|NCT01313078|Asparaginase|asparaginase|mesh-list
14387279|NCT01313078|Pegaspargase|pegaspargase|mesh-list
14387280|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387281|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
14387282|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
14387283|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387284|NCT01313117|Protective Agents|protective agents|mesh-ancestor
14387285|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387286|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
14387287|NCT01313117|Vitamins|vitamins|mesh-ancestor
14387288|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
14466734|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14466735|NCT02249182|Ledipasvir|ledipasvir|mesh-list
14466736|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
14466737|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466738|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
14466739|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466740|NCT02249585|Iodine|iodine|mesh-list
14466741|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14466742|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466743|NCT02249585|Trace Elements|trace elements|mesh-ancestor
14466744|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
14466745|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466746|NCT02249767|Tretinoin|tretinoin|mesh-list
14466747|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466748|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
14466749|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14466750|NCT02249949|Efatutazone|efatutazone|mesh-list
14466751|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466752|NCT02250612|Timolol|timolol|mesh-list
14466753|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14466754|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14466755|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14387289|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
14387290|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14387291|NCT01313182|Mupirocin|mupirocin|mesh-list
14387292|NCT01313182|Povidone|povidone|mesh-list
14387293|NCT01313182|Calcium|calcium|mesh-list
14387294|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14387295|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387296|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
14387297|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
14387298|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387299|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387300|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14387301|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387302|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387303|NCT01313208|Etanercept|etanercept|mesh-list
14387304|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14387305|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14387306|NCT01313208|Analgesics|analgesics|mesh-ancestor
14387307|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
14387308|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387309|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387310|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387311|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387312|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387313|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387314|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
14387315|NCT01313221|Etanercept|etanercept|mesh-list
14387316|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14387317|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14387318|NCT01313221|Analgesics|analgesics|mesh-ancestor
14387319|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
14387320|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387321|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387322|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387323|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387324|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387325|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387326|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
14387327|NCT01313286|Globalagliatin|globalagliatin|mesh-list
14387328|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
14387329|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387330|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
14387331|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14387332|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14387333|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14387334|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387335|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387336|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387337|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387338|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387339|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14387340|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387341|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
14387342|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14387343|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14387344|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14387345|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387346|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387347|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387348|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387349|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387350|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14387351|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387352|NCT01313494|Albuterol|albuterol|mesh-list
14387353|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387354|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
14387355|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387356|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387357|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387358|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
14387359|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
14387360|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14387361|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14387362|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14387363|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14387364|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
14387365|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387366|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387367|NCT01313520|Infliximab|infliximab|mesh-list
14387368|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387369|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387370|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387371|NCT01313559|Everolimus|everolimus|mesh-list
14387372|NCT01313559|Pasireotide|pasireotide|mesh-list
14387373|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387374|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387375|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
14387376|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387377|NCT01313559|Hormones|hormones|mesh-ancestor
14387378|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387379|NCT01313637|Bromides|bromides|mesh-list
14387380|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
14387381|NCT01313663|Pemetrexed|pemetrexed|mesh-list
14387382|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387383|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387384|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387385|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14387386|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14387387|NCT01313676|Fluticasone|fluticasone|mesh-list
14387388|NCT01313676|Xhance|xhance|mesh-list
14387389|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387390|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387391|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
14387392|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387393|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387394|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387395|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
14923268|NCT02619552|Prednisone|prednisone|mesh-list
14923269|NCT02619552|Budesonide|budesonide|mesh-list
14923270|NCT02619552|Adalimumab|adalimumab|mesh-list
14923271|NCT02619552|Infliximab|infliximab|mesh-list
14923272|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
14923273|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923274|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
14923275|NCT02619552|Hormones|hormones|mesh-ancestor
14923276|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923277|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923278|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14387396|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387397|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14387398|NCT01313728|Dapsone|dapsone|mesh-list
14387399|NCT01313728|Tretinoin|tretinoin|mesh-list
14387400|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387401|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
14387402|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387403|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387404|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
14387405|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14387406|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14387407|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14387408|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387409|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387410|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
14387411|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387412|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
14387413|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14387414|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14387415|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14387416|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387417|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387418|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387419|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387420|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387421|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14387422|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387423|NCT01313780|Oxycodone|oxycodone|mesh-list
14387424|NCT01313780|Naloxone|naloxone|mesh-list
14387425|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14387426|NCT01313780|Narcotics|narcotics|mesh-ancestor
15236364|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236365|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236366|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
15236367|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387427|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14387428|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387429|NCT01313780|Analgesics|analgesics|mesh-ancestor
14387430|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
14387431|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387432|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14387433|NCT01313858|Golimumab|golimumab|mesh-list
14387434|NCT01313858|Methotrexate|methotrexate|mesh-list
14387435|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14387436|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
15236368|NCT04874545|Propofol|propofol|mesh-list
15236369|NCT04874545|Sevoflurane|sevoflurane|mesh-list
15236370|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15236371|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236372|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387437|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14387438|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923279|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923280|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387439|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14387440|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
14387441|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387442|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387443|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387444|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387445|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14387446|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387447|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
14387448|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387449|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14387450|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14387451|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387452|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
14387453|NCT01313884|Temozolomide|temozolomide|mesh-list
14387454|NCT01313884|Doxorubicin|doxorubicin|mesh-list
15236373|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236374|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
15236375|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
14387455|NCT01313884|Irinotecan|irinotecan|mesh-list
15236376|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15236377|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15236378|NCT04864678|Vaccines|vaccines|mesh-list
15236379|NCT04864678|Immunologic Factors|immunologic factors|mesh-ancestor
15236380|NCT04864678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236381|NCT04851834|Cisplatin|cisplatin|mesh-list
15236382|NCT04851834|Carboplatin|carboplatin|mesh-list
15236383|NCT04851834|Temozolomide|temozolomide|mesh-list
15236384|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236385|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15236386|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
14387456|NCT01313884|Vincristine|vincristine|mesh-list
15236387|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236388|NCT04827979|Daratumumab|daratumumab|mesh-list
15236389|NCT04827979|Abatacept|abatacept|mesh-list
14387457|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387458|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
14387459|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387460|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387461|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14387462|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
14734669|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
14734670|NCT00536653|Vitamins|vitamins|mesh-list
14387463|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387464|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387465|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14387466|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14387467|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14387468|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14387469|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387470|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14387471|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14387472|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
14387473|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14387474|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
14387475|NCT01313897|Bortezomib|bortezomib|mesh-list
14387476|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387477|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14387478|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387479|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387480|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387481|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14387482|NCT01314001|Nicotine|nicotine|mesh-list
15236390|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
15236391|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
15236392|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
15236393|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236394|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236395|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15236396|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236397|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236398|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236399|NCT04824092|Prednisone|prednisone|mesh-list
15236400|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
15236401|NCT04824092|Rituximab|rituximab|mesh-list
15236402|NCT04824092|Doxorubicin|doxorubicin|mesh-list
15236403|NCT04824092|Vincristine|vincristine|mesh-list
15236404|NCT04824092|Lenalidomide|lenalidomide|mesh-list
15236405|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236406|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
15236407|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236408|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236409|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15236410|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
15236411|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236412|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236413|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14387483|NCT01314001|Varenicline|varenicline|mesh-list
14387484|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14387485|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
15236414|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14387486|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387487|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387488|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14387489|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14387490|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387491|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387492|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387493|NCT01314105|Carboplatin|carboplatin|mesh-list
14387494|NCT01314105|Nintedanib|nintedanib|mesh-list
14387495|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387496|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14387497|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387498|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387499|NCT01314261|Interferons|interferons|mesh-list
14387500|NCT01314261|Ribavirin|ribavirin|mesh-list
14387501|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387502|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
14387503|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387504|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
14387505|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387506|NCT01314417|Methotrexate|methotrexate|mesh-list
14387507|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14387508|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
14387509|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14387510|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387511|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14387512|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
14387513|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387514|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387515|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387516|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387517|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14387518|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387519|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
14387520|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387521|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15236415|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15236416|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15236417|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15236418|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236419|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236420|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
15236421|NCT04824092|Hormones|hormones|mesh-ancestor
15236422|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236423|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15236424|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15236425|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
15236426|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
15236427|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
15236428|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15236429|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15236430|NCT04824092|Growth Substances|growth substances|mesh-ancestor
15236431|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
14387522|NCT01314443|Vitamin E|vitamin e|mesh-list
14387523|NCT01314443|Tocopherols|tocopherols|mesh-list
14387524|NCT01314443|Tocotrienols|tocotrienols|mesh-list
14387525|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
14387526|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
14387527|NCT01314443|Nicotine|nicotine|mesh-list
14387528|NCT01314443|Vitamins|vitamins|mesh-ancestor
14387529|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
14387530|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387531|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14387532|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
14387533|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387534|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14387535|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14387536|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387537|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387538|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387539|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
14923281|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
14923282|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923283|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14923284|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
14923285|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387540|NCT01314443|Protective Agents|protective agents|mesh-ancestor
14387541|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14387542|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14387543|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14387544|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387545|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387546|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387547|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387548|NCT01314872|Urological Agents|urological agents|mesh-ancestor
14387549|NCT01314911|Oseltamivir|oseltamivir|mesh-list
14387550|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
14387551|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387552|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387553|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387554|NCT01315002|Nicotine|nicotine|mesh-list
14387555|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14387556|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
14387557|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387558|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387559|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14387560|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14387561|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387562|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387563|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387564|NCT01315158|Fentanyl|fentanyl|mesh-list
14387565|NCT01315158|Midazolam|midazolam|mesh-list
14387566|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
14387567|NCT01315158|Propofol|propofol|mesh-list
14387568|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14387569|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14387570|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387571|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14387572|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
14387573|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
14387574|NCT01315158|Narcotics|narcotics|mesh-ancestor
14387575|NCT01315158|Analgesics|analgesics|mesh-ancestor
15236432|NCT04814355|Celecoxib|celecoxib|mesh-list
15236433|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15236434|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15236435|NCT04814355|Analgesics|analgesics|mesh-ancestor
15236436|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
15236437|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236438|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236439|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387576|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
14387577|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387578|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14387579|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14387580|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14387581|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14387582|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
14387583|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
14387584|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387585|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387586|NCT01315236|Amikacin|amikacin|mesh-list
14387587|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387588|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387589|NCT01315249|Fluticasone|fluticasone|mesh-list
14387590|NCT01315249|Xhance|xhance|mesh-list
14387591|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
14387592|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14387593|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14387594|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387595|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387596|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
14387597|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387598|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387599|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387600|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
14387601|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387602|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14387603|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14387604|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14387605|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14387606|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
14387607|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387608|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387609|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14387610|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14387611|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14387612|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387613|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
14387614|NCT01315249|Hormones|hormones|mesh-ancestor
14387615|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387616|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
14387617|NCT01315574|Travoprost|travoprost|mesh-list
14387618|NCT01315574|Latanoprost|latanoprost|mesh-list
14387619|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14387620|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14387621|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14387622|NCT01315665|Sulforaphane|sulforaphane|mesh-list
14923286|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
14923287|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923288|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923289|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
14923290|NCT02617277|Durvalumab|durvalumab|mesh-list
14923291|NCT02617277|Adavosertib|adavosertib|mesh-list
14923292|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923293|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923294|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923295|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923296|NCT02603328|Atorvastatin|atorvastatin|mesh-list
14923297|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14923298|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14387623|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14923299|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
14923300|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923301|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14923302|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14923303|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387624|NCT01315665|Protective Agents|protective agents|mesh-ancestor
14387625|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387626|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387627|NCT01315678|Tobramycin|tobramycin|mesh-list
14387628|NCT01315678|Amikacin|amikacin|mesh-list
14387629|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387630|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387631|NCT01316042|Metformin|metformin|mesh-list
14387632|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387633|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387634|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
14387635|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14387636|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387637|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387638|NCT01316263|Olaratumab|olaratumab|mesh-list
14387639|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387640|NCT01316276|Amikacin|amikacin|mesh-list
14387641|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387642|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387643|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14466756|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387644|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14387645|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14387646|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387647|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387648|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387649|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387650|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
14387651|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14387652|NCT01316341|Empagliflozin|empagliflozin|mesh-list
14387653|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14387654|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387655|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387656|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387657|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
14387658|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387659|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
14387660|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387661|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387662|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387663|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
14387664|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
14387665|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14387666|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387667|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387668|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387669|NCT01316419|Amlodipine|amlodipine|mesh-list
14387670|NCT01316419|Telmisartan|telmisartan|mesh-list
14387671|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14387672|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14387673|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387674|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387675|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14387676|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387677|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
14387678|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14387679|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14387680|NCT01316770|Dexamethasone|dexamethasone|mesh-list
14387681|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387682|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
14387683|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
14387684|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387685|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387686|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387687|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
14387688|NCT01316770|Hormones|hormones|mesh-ancestor
14387689|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387690|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14387691|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387692|NCT01316900|Bromides|bromides|mesh-list
14387693|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
14387694|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387695|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
14387696|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387697|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387698|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387699|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
14387700|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
14387701|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14387702|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387703|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387704|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387705|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
14387706|NCT01316913|Bromides|bromides|mesh-list
14387707|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
14387708|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14387709|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
14387710|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387711|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387712|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14387713|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
14387714|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
14387715|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14387716|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
14387717|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387718|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387719|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
14387720|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14387721|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
14387722|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14387723|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387724|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387725|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
14387726|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387727|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14387728|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
14387729|NCT01317472|Lansoprazole|lansoprazole|mesh-list
14387730|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14387731|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387732|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14387733|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387734|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387735|NCT01317550|Minocycline|minocycline|mesh-list
14387736|NCT01317550|Modafinil|modafinil|mesh-list
14387737|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387738|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387739|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14387740|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387741|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14387742|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14387743|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14387744|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387745|NCT01317615|Paclitaxel|paclitaxel|mesh-list
14387746|NCT01317615|Carboplatin|carboplatin|mesh-list
14387747|NCT01317615|Everolimus|everolimus|mesh-list
14387748|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14387749|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387750|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14387751|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14387752|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14387753|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387754|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387755|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
14387756|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387757|NCT01317667|Vaccines|vaccines|mesh-list
14387758|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
14387759|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387760|NCT01317901|Rituximab|rituximab|mesh-list
14387761|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14387762|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14387763|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387764|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
14387765|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387766|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387767|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14387768|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
14387769|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387770|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
14387771|NCT01317940|Vitamin D|vitamin d|mesh-list
14387772|NCT01317940|Calcitriol|calcitriol|mesh-list
14387773|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14387774|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
15236440|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236441|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15236442|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15236443|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236444|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236445|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
15236446|NCT04798339|Hematinics|hematinics|mesh-ancestor
15236447|NCT04789304|Midazolam|midazolam|mesh-list
15236448|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15236449|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14387775|NCT01317940|Calcium|calcium|mesh-list
14387776|NCT01317940|Vitamins|vitamins|mesh-ancestor
14387777|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
14387778|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387779|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14387780|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14387781|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387782|NCT01317940|Antacids|antacids|mesh-ancestor
14387783|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387784|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14387785|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387786|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14387787|NCT01318070|Pioglitazone|pioglitazone|mesh-list
14387788|NCT01318070|Alogliptin|alogliptin|mesh-list
14387789|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387790|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387791|NCT01318070|Incretins|incretins|mesh-ancestor
14387792|NCT01318070|Hormones|hormones|mesh-ancestor
14387793|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387794|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15236450|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14387795|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14387796|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387797|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387798|NCT01318083|Glimepiride|glimepiride|mesh-list
14387799|NCT01318083|Alogliptin|alogliptin|mesh-list
14387800|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14387801|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387802|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387803|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387804|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
14387805|NCT01318083|Incretins|incretins|mesh-ancestor
14387806|NCT01318083|Hormones|hormones|mesh-ancestor
14387807|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387808|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14387809|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
14387810|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387811|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387812|NCT01318109|Metformin|metformin|mesh-list
14387813|NCT01318109|Alogliptin|alogliptin|mesh-list
14387814|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387815|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387816|NCT01318109|Incretins|incretins|mesh-ancestor
14387817|NCT01318109|Hormones|hormones|mesh-ancestor
14387818|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387819|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14387820|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
14387821|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387822|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387823|NCT01318122|Pioglitazone|pioglitazone|mesh-list
14387824|NCT01318122|Alogliptin|alogliptin|mesh-list
14387825|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387826|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387827|NCT01318122|Incretins|incretins|mesh-ancestor
14387828|NCT01318122|Hormones|hormones|mesh-ancestor
14387829|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387830|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14387831|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
14387832|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387833|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387834|NCT01318135|Metformin|metformin|mesh-list
14387835|NCT01318135|Glimepiride|glimepiride|mesh-list
14387836|NCT01318135|Alogliptin|alogliptin|mesh-list
14387837|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387838|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387839|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14387840|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387841|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
14387842|NCT01318135|Incretins|incretins|mesh-ancestor
14387843|NCT01318135|Hormones|hormones|mesh-ancestor
15236451|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387844|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236452|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15236453|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15236454|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236455|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236456|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
15236457|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
15236458|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
15236459|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
15236460|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236461|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387845|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15236462|NCT04784637|Insulin|insulin|mesh-list
15236463|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387846|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
14387847|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387848|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387849|NCT01318278|Dopamine|dopamine|mesh-list
14387850|NCT01318278|Vasopressins|vasopressins|mesh-list
14387851|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
14387852|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387853|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
14387854|NCT01318278|Coagulants|coagulants|mesh-ancestor
14387855|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14387856|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14387857|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
14387858|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14387859|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
14387860|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
14387861|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387862|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
14387863|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14387864|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387865|NCT01318278|Protective Agents|protective agents|mesh-ancestor
14387866|NCT01318356|Doxycycline|doxycycline|mesh-list
14387867|NCT01318356|Tetracycline|tetracycline|mesh-list
14387868|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387869|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387870|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
14387871|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14387872|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14387873|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14387874|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387875|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387876|NCT01318408|Levetiracetam|levetiracetam|mesh-list
14387877|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
14387878|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
14387879|NCT01318499|Nepafenac|nepafenac|mesh-list
14387880|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14387881|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14387882|NCT01318499|Analgesics|analgesics|mesh-ancestor
14387883|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
14387884|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387885|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387886|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387887|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387888|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14387889|NCT01318694|Ribavirin|ribavirin|mesh-list
14387890|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14387891|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
14387892|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387893|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
14387894|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387895|NCT01318811|Heparin|heparin|mesh-list
14387896|NCT01318811|Calcium heparin|calcium heparin|mesh-list
14387897|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
14387898|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14387899|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14387900|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466757|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466758|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466759|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14466760|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466761|NCT02250651|Timolol|timolol|mesh-list
14466762|NCT02250651|Bimatoprost|bimatoprost|mesh-list
14466763|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14466764|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14466765|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14466766|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466767|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466768|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466769|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14466770|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466771|NCT02250703|Midazolam|midazolam|mesh-list
14466772|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
14466773|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14387901|NCT01318902|Dexamethasone|dexamethasone|mesh-list
14387902|NCT01318902|Ixazomib|ixazomib|mesh-list
14387903|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14387904|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
14387905|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
14387906|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14387907|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387908|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14387909|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
14387910|NCT01318902|Hormones|hormones|mesh-ancestor
14387911|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14387912|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14387913|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387914|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
14387915|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387916|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387917|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
14387918|NCT01318915|Sirolimus|sirolimus|mesh-list
14387919|NCT01318915|Rituximab|rituximab|mesh-list
14387920|NCT01318915|Tacrolimus|tacrolimus|mesh-list
14387921|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
14387922|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14387923|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14387924|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387925|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
14387926|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387927|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387928|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387929|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14387930|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387931|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387932|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14387933|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14387934|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
14387935|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387936|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387937|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
14387938|NCT01318967|Furosemide|furosemide|mesh-list
14387939|NCT01318967|Diuretics|diuretics|mesh-ancestor
14387940|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
14387941|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387942|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14387943|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14387944|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387945|NCT01319045|Iloprost|iloprost|mesh-list
14387946|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14387947|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14387948|NCT01319110|Ubiquinone|ubiquinone|mesh-list
14387949|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
14387950|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
14387951|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387952|NCT01319110|Vitamins|vitamins|mesh-ancestor
14387953|NCT01319383|Vorinostat|vorinostat|mesh-list
14387954|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387955|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14387956|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387957|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387958|NCT01319422|Pomalidomide|pomalidomide|mesh-list
14387959|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
14387960|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387961|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14387962|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14387963|NCT01319422|Growth Substances|growth substances|mesh-ancestor
14387964|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734671|NCT00536653|Goserelin|goserelin|mesh-list
14734672|NCT00536653|Bicalutamide|bicalutamide|mesh-list
14734673|NCT00536653|Calcium|calcium|mesh-list
14387965|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923304|NCT02578368|Leucovorin|leucovorin|mesh-list
15236464|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236465|NCT04780724|Nitrox|nitrox|mesh-list
15236466|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15236467|NCT04780724|Protective Agents|protective agents|mesh-ancestor
15236468|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236469|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
15236470|NCT04774965|Promethazine|promethazine|mesh-list
14387966|NCT01319721|Mitomycins|mitomycins|mesh-list
14387967|NCT01319721|Mitomycin|mitomycin|mesh-list
14387968|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14387969|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14387970|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
14387971|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387972|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14387973|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14387974|NCT01319773|Cyclosporine|cyclosporine|mesh-list
14387975|NCT01319773|Cyclosporins|cyclosporins|mesh-list
14387976|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734674|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14734675|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
14734676|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734677|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14734678|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14734679|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14734680|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734681|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
14734682|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
14734683|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14734684|NCT00536653|Hormones|hormones|mesh-ancestor
15236471|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15236472|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15236473|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236474|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734685|NCT00536692|Mecamylamine|mecamylamine|mesh-list
14734686|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14734687|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14734688|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
14734689|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734690|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734691|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14734692|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14734693|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
14734694|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734695|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734696|NCT00536705|Montelukast|montelukast|mesh-list
14734697|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15236475|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
14387977|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734698|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
14734699|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14734700|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
14734701|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14734702|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734703|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14734704|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14734705|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14387978|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14387979|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
14387980|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387981|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
14387982|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387983|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
14387984|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14387985|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14387986|NCT01319851|Alefacept|alefacept|mesh-list
14387987|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
14734706|NCT00536770|Calcitriol|calcitriol|mesh-list
14734707|NCT00536770|Gemcitabine|gemcitabine|mesh-list
14734708|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14387988|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
14387989|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387990|NCT01319994|Metformin|metformin|mesh-list
14387991|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14387992|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14387993|NCT01320033|Doxycycline|doxycycline|mesh-list
14387994|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14387995|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14387996|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
14387997|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14387998|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14387999|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
14388000|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14388001|NCT01320293|Adalimumab|adalimumab|mesh-list
14388002|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388003|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388004|NCT01320722|Vitamin D|vitamin d|mesh-list
14388005|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
14388006|NCT01320722|Vitamins|vitamins|mesh-list
14388007|NCT01320722|Allopurinol|allopurinol|mesh-list
14388008|NCT01320722|Probenecid|probenecid|mesh-list
14388009|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
14388010|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388011|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14388012|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14388013|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
14388014|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388015|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388016|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
14734709|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388017|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388018|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14388019|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
14388020|NCT01320722|Protective Agents|protective agents|mesh-ancestor
14388021|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
14388022|NCT01320722|Renal Agents|renal agents|mesh-ancestor
14388023|NCT01321073|Treprostinil|treprostinil|mesh-list
14388024|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14388025|NCT01321151|Resveratrol|resveratrol|mesh-list
14388026|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
14388027|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388028|NCT01321151|Protective Agents|protective agents|mesh-ancestor
14388029|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388030|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388031|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14388032|NCT01321437|Axitinib|axitinib|mesh-list
14388033|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388034|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14388035|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388036|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388037|NCT01321541|Gemcitabine|gemcitabine|mesh-list
14388038|NCT01321541|Rituximab|rituximab|mesh-list
14388039|NCT01321541|Pixantrone|pixantrone|mesh-list
14388040|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14388041|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388042|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
14388043|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388044|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388045|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15236476|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
15236477|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
15236478|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236479|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
15236480|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
14388046|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
14388047|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236481|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15236482|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15236483|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
15236484|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
15236485|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236486|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236487|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15236488|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
15236489|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
15236490|NCT04742959|Paclitaxel|paclitaxel|mesh-list
15236491|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15236492|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236493|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
15236494|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
15236495|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
15236496|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236497|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
15236498|NCT04700007|Promethazine|promethazine|mesh-list
15236499|NCT04700007|Morphine|morphine|mesh-list
15236500|NCT04700007|Capsaicin|capsaicin|mesh-list
15236501|NCT04700007|Histamine|histamine|mesh-list
15236502|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15236503|NCT04700007|Narcotics|narcotics|mesh-ancestor
15236504|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236505|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236506|NCT04700007|Analgesics|analgesics|mesh-ancestor
15236507|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
15236508|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236509|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
15236510|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
15236511|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15236512|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15236513|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
15236514|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
15236515|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
15236516|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
14388048|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
15236517|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14388049|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388050|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236518|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15236519|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-ancestor
14388051|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14388052|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14388053|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14388054|NCT01321554|Lenvatinib|lenvatinib|mesh-list
14388055|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388056|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14388057|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388058|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388059|NCT01321710|Acetaminophen|acetaminophen|mesh-list
14388060|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14388061|NCT01321710|Analgesics|analgesics|mesh-ancestor
14388062|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
14388063|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388064|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388065|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
14388066|NCT01321723|Teriparatide|teriparatide|mesh-list
14388067|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14388068|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388069|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14388070|NCT01321879|Telavancin|telavancin|mesh-list
14388071|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14388072|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388073|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
14388074|NCT01322009|Probenecid|probenecid|mesh-list
14388075|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14388076|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
14388077|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388078|NCT01322009|Expectorants|expectorants|mesh-ancestor
14388079|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388080|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14388081|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
14388082|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388083|NCT01322009|Protective Agents|protective agents|mesh-ancestor
14388084|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388085|NCT01322009|Antidotes|antidotes|mesh-ancestor
14388086|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
14388087|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
14388088|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388089|NCT01322009|Renal Agents|renal agents|mesh-ancestor
14388090|NCT01322048|Propranolol|propranolol|mesh-list
14388091|NCT01322048|Clonidine|clonidine|mesh-list
14388092|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14388093|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14388094|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388095|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388096|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388097|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388098|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14388099|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14388100|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
14388101|NCT01322048|Analgesics|analgesics|mesh-ancestor
14388102|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
14388103|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388104|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
14388105|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
14388106|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14388107|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14388108|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14388109|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
14388110|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14388111|NCT01322360|Morphine|morphine|mesh-list
14388112|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14388113|NCT01322360|Narcotics|narcotics|mesh-ancestor
14388114|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388115|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388116|NCT01322360|Analgesics|analgesics|mesh-ancestor
14388117|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
14388118|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388119|NCT01322386|Vancomycin|vancomycin|mesh-list
14388120|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14388121|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388122|NCT01322490|Molgramostim|molgramostim|mesh-list
14388123|NCT01322490|Sargramostim|sargramostim|mesh-list
14388124|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
14388125|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388126|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388127|NCT01322815|Leucovorin|leucovorin|mesh-list
14388128|NCT01322815|Fluorouracil|fluorouracil|mesh-list
14388129|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
14388130|NCT01322815|Irinotecan|irinotecan|mesh-list
14388131|NCT01322815|Bevacizumab|bevacizumab|mesh-list
14388132|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
14388133|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
14388134|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388135|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388136|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388137|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14388138|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
14388139|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388140|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14388141|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14388142|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388143|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14388144|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14388145|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14388146|NCT01322815|Growth Substances|growth substances|mesh-ancestor
14388147|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14388148|NCT01322815|Antidotes|antidotes|mesh-ancestor
14388149|NCT01322815|Protective Agents|protective agents|mesh-ancestor
14388150|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
14388151|NCT01322815|Vitamins|vitamins|mesh-ancestor
14388152|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
15236520|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
15236521|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236522|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236523|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15236524|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
15236525|NCT04681079|Albuterol|albuterol|mesh-list
15236526|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15236527|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
14388153|NCT01323010|Albuterol|albuterol|mesh-list
15236528|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236529|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388154|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14388155|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
14388156|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388157|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388158|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14388159|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388160|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
14388161|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14388162|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14388163|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14388164|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14388165|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388166|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388167|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388168|NCT01323140|Testosterone|testosterone|mesh-list
14388169|NCT01323140|Androgens|androgens|mesh-ancestor
14388170|NCT01323140|Hormones|hormones|mesh-ancestor
14388171|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388172|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388173|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
14388174|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14388175|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14388176|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
14388177|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388178|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14388179|NCT01323478|Vortioxetine|vortioxetine|mesh-list
14388180|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
14388181|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14388182|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14388183|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14388184|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388185|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388186|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14388187|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14388188|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388189|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388190|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388191|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
14388192|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14388193|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14388194|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14388195|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14388196|NCT01323517|Dactinomycin|dactinomycin|mesh-list
14388197|NCT01323517|Ipilimumab|ipilimumab|mesh-list
14388198|NCT01323517|Melphalan|melphalan|mesh-list
14388199|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14388200|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388201|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14388202|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388203|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14388204|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
14388205|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14388206|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14388207|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
14388208|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388209|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14388210|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388211|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14388212|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14388213|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236530|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15236531|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
15236532|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
15236533|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15236534|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15236535|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15236536|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15236537|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
15236538|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236539|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236540|NCT04672382|Morphine|morphine|mesh-list
15236541|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15236542|NCT04672382|Narcotics|narcotics|mesh-ancestor
15236543|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236544|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388214|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14388215|NCT01323530|Capecitabine|capecitabine|mesh-list
14388216|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388217|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
14388218|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388219|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388220|NCT01323582|Azithromycin|azithromycin|mesh-list
14388221|NCT01323582|Erythromycin|erythromycin|mesh-list
14388222|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
14388223|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14388224|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
14388225|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14388226|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388227|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14388228|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14388229|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388230|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388231|NCT01323595|Celecoxib|celecoxib|mesh-list
14388232|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14734710|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
14734711|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923305|NCT02578368|Docetaxel|docetaxel|mesh-list
14923306|NCT02578368|Fluorouracil|fluorouracil|mesh-list
14923307|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
14388233|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14388234|NCT01323595|Analgesics|analgesics|mesh-ancestor
14388235|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
14388236|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388237|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388238|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388239|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388240|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14388241|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14388242|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388243|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388244|NCT01323621|Fluticasone|fluticasone|mesh-list
14388245|NCT01323621|Xhance|xhance|mesh-list
14388246|NCT01323621|Albuterol|albuterol|mesh-list
14388247|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14388248|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388249|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14388250|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
14388251|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388252|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388253|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14734712|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923308|NCT02578368|Trastuzumab|trastuzumab|mesh-list
14923309|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
14388254|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388255|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388256|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14388257|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14388258|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14388259|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14388260|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388261|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388262|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388263|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
14388264|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14388265|NCT01323634|Fluticasone|fluticasone|mesh-list
14388266|NCT01323634|Xhance|xhance|mesh-list
14388267|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14388268|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388269|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14388270|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
14388271|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388272|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388273|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14388274|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388275|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388276|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14388277|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14388278|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14388279|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14388280|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388281|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388282|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388283|NCT01323673|Clobetasol|clobetasol|mesh-list
14388284|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388285|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
15236545|NCT04672382|Analgesics|analgesics|mesh-ancestor
15236546|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
15236547|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236548|NCT04663282|Insulin|insulin|mesh-list
15236549|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236550|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236551|NCT04654689|Curcumin|curcumin|mesh-list
15236552|NCT04654689|Resveratrol|resveratrol|mesh-list
15236553|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15236554|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15236555|NCT04654689|Analgesics|analgesics|mesh-ancestor
15236556|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
15236557|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236558|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236559|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236560|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236561|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236562|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236563|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236564|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
15236565|NCT04654689|Protective Agents|protective agents|mesh-ancestor
15236566|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15236567|NCT04643405|Gemcitabine|gemcitabine|mesh-list
15236568|NCT04643405|Paclitaxel|paclitaxel|mesh-list
15236569|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15236570|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236571|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
15236572|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
15236573|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
15236574|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236575|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15236576|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
15236577|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
15236578|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236579|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236580|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236581|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
15236582|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236583|NCT04625803|Apatinib|apatinib|mesh-list
14388286|NCT01323673|Hormones|hormones|mesh-ancestor
15236584|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388287|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388288|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388289|NCT01323790|Naloxegol|naloxegol|mesh-list
14388290|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14388291|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388292|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
14388293|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388294|NCT01323920|Methotrexate|methotrexate|mesh-list
14388295|NCT01323920|Bortezomib|bortezomib|mesh-list
14388296|NCT01323920|Tacrolimus|tacrolimus|mesh-list
14388297|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14388298|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
14388299|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14388300|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388301|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388302|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
14388303|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388304|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388305|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388306|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388307|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14388308|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14388309|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
14388310|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388311|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14388312|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14388313|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14388314|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14388315|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388316|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14388317|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14388318|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734713|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
14734714|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734715|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734716|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734717|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
14734718|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734719|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734720|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14734721|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14388319|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388320|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
14388321|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388322|NCT01324128|Iron|iron|mesh-list
14388323|NCT01324128|Sevelamer|sevelamer|mesh-list
14388324|NCT01324128|Trace Elements|trace elements|mesh-ancestor
14388325|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
14388326|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388327|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
14388328|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
14388329|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388330|NCT01324141|Fluorouracil|fluorouracil|mesh-list
14388331|NCT01324141|Mitomycins|mitomycins|mesh-list
14388332|NCT01324141|Mitomycin|mitomycin|mesh-list
14388333|NCT01324141|Tempol|tempol|mesh-list
14388334|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
14388335|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388336|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388337|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388338|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14388339|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
14388340|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388341|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14388342|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
14388343|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14388344|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388345|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
14388346|NCT01324141|Protective Agents|protective agents|mesh-ancestor
14388347|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14388348|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14388349|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14388350|NCT01324232|Quinidine|quinidine|mesh-list
14388351|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
14388352|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
14388353|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388354|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14388355|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14388356|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388357|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388358|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388359|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14388360|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14388361|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388362|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14388363|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
14388364|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14388365|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14388366|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388367|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388368|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14388369|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14388370|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
14388371|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14388372|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14388373|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388374|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14388375|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14388376|NCT01324310|Ketoconazole|ketoconazole|mesh-list
14388377|NCT01324310|Romidepsin|romidepsin|mesh-list
14388378|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
14388379|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388380|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14388381|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14388382|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388383|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388384|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14388385|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
14388386|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388387|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388388|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14388389|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14388390|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388391|NCT01324323|Rifampin|rifampin|mesh-list
14388392|NCT01324323|Romidepsin|romidepsin|mesh-list
14388393|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14388394|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
14388395|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14388396|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388397|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
14388398|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14388399|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388400|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388401|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14388402|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14388403|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14388404|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14388405|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14388406|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14388407|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14388408|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388409|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14388410|NCT01324349|Hemostatics|hemostatics|mesh-list
14388411|NCT01324349|Coagulants|coagulants|mesh-ancestor
14388412|NCT01324388|Dulaglutide|dulaglutide|mesh-list
14388413|NCT01324388|Metoprolol|metoprolol|mesh-list
14388414|NCT01324388|Lisinopril|lisinopril|mesh-list
14388415|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14388416|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14388417|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
14388418|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
14388419|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388420|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388421|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14388422|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14388423|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14388424|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388425|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388426|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388427|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14388428|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
14388429|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388430|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14388431|NCT01324388|Protective Agents|protective agents|mesh-ancestor
14388432|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14388433|NCT01324570|Buprenorphine|buprenorphine|mesh-list
14388434|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14388435|NCT01324570|Narcotics|narcotics|mesh-ancestor
14388436|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388437|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388438|NCT01324570|Analgesics|analgesics|mesh-ancestor
14388439|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
14388440|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388441|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14388442|NCT01324700|Dexetimide|dexetimide|mesh-list
14388443|NCT01324700|Citalopram|citalopram|mesh-list
14388444|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14388445|NCT01324700|Serotonin|serotonin|mesh-list
14388446|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14388447|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388448|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388449|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388450|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
14388451|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388452|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14388453|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
14388454|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14388455|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14388456|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14388457|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
14388458|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
14388459|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388460|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14388461|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14388462|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
14388463|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14466774|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466775|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466776|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466777|NCT02250703|Analgesics|analgesics|mesh-ancestor
14466778|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
14466779|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466780|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14466781|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14466782|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14466783|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
15236585|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15236586|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236587|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388464|NCT01324947|Pomalidomide|pomalidomide|mesh-list
14388465|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
14388466|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388467|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14388468|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14388469|NCT01324947|Growth Substances|growth substances|mesh-ancestor
14388470|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
14388471|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388472|NCT01324999|Tadalafil|tadalafil|mesh-list
14388473|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
14388474|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14388475|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14388476|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388477|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388478|NCT01324999|Urological Agents|urological agents|mesh-ancestor
14388479|NCT01325181|Ranibizumab|ranibizumab|mesh-list
14388480|NCT01325181|Verteporfin|verteporfin|mesh-list
14388481|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14388482|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734722|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14734723|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14734724|NCT00536770|Vitamins|vitamins|mesh-ancestor
14734725|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
14734726|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14734727|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14734728|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
14734729|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14734730|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14734731|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15236588|NCT04623567|Metformin|metformin|mesh-list
14388483|NCT01325181|Growth Substances|growth substances|mesh-ancestor
14388484|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388485|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
14388486|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388487|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14388488|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388489|NCT01325207|Trastuzumab|trastuzumab|mesh-list
14388490|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14388491|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388492|NCT01325311|Vitamin D|vitamin d|mesh-list
14388493|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
14388494|NCT01325311|Genistein|genistein|mesh-list
14388495|NCT01325311|Vitamins|vitamins|mesh-ancestor
14388496|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
14388497|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388498|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14388499|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14388500|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15236589|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236590|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236591|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
15236592|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15236593|NCT04617821|Gemcitabine|gemcitabine|mesh-list
15236594|NCT04617821|Paclitaxel|paclitaxel|mesh-list
15236595|NCT04617821|Folfirinox|folfirinox|mesh-list
15236596|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15236597|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236598|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
15236599|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
15236600|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
15236601|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236602|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15236603|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
14388501|NCT01325311|Protective Agents|protective agents|mesh-ancestor
14923310|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236604|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
14388502|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388503|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14388504|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388505|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388506|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
14388507|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14388508|NCT01325311|Estrogens|estrogens|mesh-ancestor
14388509|NCT01325311|Hormones|hormones|mesh-ancestor
14388510|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388511|NCT01325337|Bimatoprost|bimatoprost|mesh-list
14388512|NCT01325337|Minoxidil|minoxidil|mesh-list
14388513|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14388514|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14388515|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
14388516|NCT01325350|Bimatoprost|bimatoprost|mesh-list
14388517|NCT01325350|Minoxidil|minoxidil|mesh-list
14388518|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14388519|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14388520|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
14388521|NCT01325428|Vinorelbine|vinorelbine|mesh-list
14388522|NCT01325428|Afatinib|afatinib|mesh-list
14388523|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14388524|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388525|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14388526|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
14388527|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14388528|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388529|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14388530|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388531|NCT01325493|Ketamine|ketamine|mesh-list
14388532|NCT01325493|Analgesics|analgesics|mesh-ancestor
14388533|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
14388534|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388535|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388536|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14388537|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14388538|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
14388539|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
14388540|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388541|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14388542|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14388543|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388544|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388545|NCT01326026|Insulin|insulin|mesh-list
14388546|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14388547|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
14388548|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14388549|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388550|NCT01326481|Capecitabine|capecitabine|mesh-list
14388551|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388552|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
14388553|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388554|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388555|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
14388556|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
14388557|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14388558|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14388559|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388560|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388561|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388562|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388563|NCT01326546|Entecavir|entecavir|mesh-list
14388564|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
14388565|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388566|NCT01326702|Rituximab|rituximab|mesh-list
14388567|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14388568|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14388569|NCT01326702|Veliparib|veliparib|mesh-list
14388570|NCT01326702|Antibodies|antibodies|mesh-list
14388571|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
14388572|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14388573|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
14388574|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388575|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388576|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388577|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14388578|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
14388579|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388580|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14388581|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388582|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
14388583|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388584|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
14388585|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
14388586|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388587|NCT01327300|Mesalamine|mesalamine|mesh-list
14388588|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14388589|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14388590|NCT01327300|Analgesics|analgesics|mesh-ancestor
14388591|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
14388592|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388593|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388594|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388595|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388596|NCT01327339|Ropinirole|ropinirole|mesh-list
14388597|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14388598|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14388599|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
14388600|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
14388601|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388602|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388603|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388604|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
14388605|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14388606|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14388607|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
14388608|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388609|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14388610|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14388611|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734732|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734733|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734734|NCT00536848|Metronidazole|metronidazole|mesh-list
14734735|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734736|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734737|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14734738|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14734739|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14734740|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734741|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734742|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388612|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388613|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
14388614|NCT01327495|Testosterone|testosterone|mesh-list
14388615|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
14388616|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
14388617|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14388618|NCT01327495|Acyline|acyline|mesh-list
14388619|NCT01327495|Androgens|androgens|mesh-ancestor
14388620|NCT01327495|Hormones|hormones|mesh-ancestor
14388621|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388622|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388623|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14388624|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388625|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
14388626|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
14388627|NCT01327547|Maraviroc|maraviroc|mesh-list
14388628|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14388629|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14388630|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388631|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14388632|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14388633|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
14388634|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388635|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14388636|NCT01327573|Eculizumab|eculizumab|mesh-list
14388637|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14388638|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14388639|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
14388640|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388641|NCT01327599|Timolol|timolol|mesh-list
14388642|NCT01327599|Travoprost|travoprost|mesh-list
14388643|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14388644|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14388645|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14388646|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15236605|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236606|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388647|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388648|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236607|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236608|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
15236609|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236610|NCT04610658|Nivolumab|nivolumab|mesh-list
15236611|NCT04610658|Ipilimumab|ipilimumab|mesh-list
15236612|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236613|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236614|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15236615|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236616|NCT04607980|Ustekinumab|ustekinumab|mesh-list
15236617|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388649|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388650|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388651|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14388652|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14388653|NCT01327612|Leucovorin|leucovorin|mesh-list
14388654|NCT01327612|Bevacizumab|bevacizumab|mesh-list
14388655|NCT01327612|Conatumumab|conatumumab|mesh-list
14388656|NCT01327612|Fluorouracil|fluorouracil|mesh-list
14388657|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
14388658|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734743|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734744|NCT00536887|Atorvastatin|atorvastatin|mesh-list
14734745|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14388659|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388660|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14388661|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14388662|NCT01327612|Growth Substances|growth substances|mesh-ancestor
14388663|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388664|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
14388665|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
14388666|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388667|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388668|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14388669|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
14388670|NCT01327612|Antidotes|antidotes|mesh-ancestor
14388671|NCT01327612|Protective Agents|protective agents|mesh-ancestor
14388672|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
14388673|NCT01327612|Vitamins|vitamins|mesh-ancestor
14388674|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
14388675|NCT01327651|Tenofovir|tenofovir|mesh-list
14388676|NCT01327651|Emtricitabine|emtricitabine|mesh-list
14388677|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
14388678|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388679|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14388680|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14388681|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388682|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388683|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14388684|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14388685|NCT01327677|Fentanyl|fentanyl|mesh-list
14388686|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14388687|NCT01327677|Narcotics|narcotics|mesh-ancestor
14388688|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388689|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388690|NCT01327677|Analgesics|analgesics|mesh-ancestor
14388691|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
14388692|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388693|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14388694|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14388695|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
14388696|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
14388697|NCT01327703|Pancreatin|pancreatin|mesh-list
14388698|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14388699|NCT01327885|Dacarbazine|dacarbazine|mesh-list
14388700|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14388701|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
14388702|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388703|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388704|NCT01328002|Milnacipran|milnacipran|mesh-list
14388705|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
14388706|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14388707|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14388708|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388709|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388710|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388711|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388712|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14388713|NCT01328002|Analgesics|analgesics|mesh-ancestor
14388714|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
14388715|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388716|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
14388717|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14388718|NCT01328041|Dolutegravir|dolutegravir|mesh-list
14388719|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14388720|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14388721|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388722|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388723|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14388724|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14388725|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
14388726|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388727|NCT01328054|Lapatinib|lapatinib|mesh-list
14388728|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388729|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14388730|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388731|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388732|NCT01328184|Empagliflozin|empagliflozin|mesh-list
14388733|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
14388734|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14388735|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14388736|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14388737|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14388738|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
14388739|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14388740|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388741|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14388742|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14388743|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14388744|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14388745|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388746|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14388747|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14388748|NCT01328184|Estrogens|estrogens|mesh-ancestor
14388749|NCT01328184|Hormones|hormones|mesh-ancestor
14388750|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388751|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14388752|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
15236618|NCT04601350|Anesthetics|anesthetics|mesh-list
15236619|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236620|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388753|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14388754|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14388755|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
14388756|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14388757|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388758|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388759|NCT01328535|Temozolomide|temozolomide|mesh-list
14388760|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14388761|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
14388762|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388763|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388764|NCT01328548|Vaccines|vaccines|mesh-list
14388765|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
14388766|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388767|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14388768|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14388769|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388770|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14388771|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14388772|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388773|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388774|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
14388775|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388776|NCT01328769|Febuxostat|febuxostat|mesh-list
14388777|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
14388778|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388779|NCT01328782|Acetaminophen|acetaminophen|mesh-list
14388780|NCT01328782|Oxycodone|oxycodone|mesh-list
14388781|NCT01328782|Bupivacaine|bupivacaine|mesh-list
14388782|NCT01328782|Ropivacaine|ropivacaine|mesh-list
14388783|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
14388784|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
14388785|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388786|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388787|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
14388788|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734746|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14734747|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
14734748|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734749|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14388789|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14388790|NCT01328782|Analgesics|analgesics|mesh-ancestor
14388791|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
14388792|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14388793|NCT01328782|Narcotics|narcotics|mesh-ancestor
14388794|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14388795|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388796|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14388797|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388798|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388799|NCT01328964|Fluticasone|fluticasone|mesh-list
14388800|NCT01328964|Xhance|xhance|mesh-list
14388801|NCT01328964|Budesonide|budesonide|mesh-list
14388802|NCT01328964|Montelukast|montelukast|mesh-list
14388803|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388804|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14388805|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
14388806|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388807|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388808|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14388809|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388810|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388811|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14388812|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
14388813|NCT01328964|Hormones|hormones|mesh-ancestor
14388814|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388815|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14388816|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
14388817|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14388818|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14388819|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388820|NCT01329185|Valganciclovir|valganciclovir|mesh-list
14734750|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14388821|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
14388822|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388823|NCT01329263|Menthol|menthol|mesh-list
14388824|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
14388825|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388826|NCT01329419|Adefovir|adefovir|mesh-list
14388827|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14388828|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
14388829|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388830|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14388831|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14388832|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388833|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388834|NCT01329562|Naproxen|naproxen|mesh-list
14388835|NCT01329562|Sumatriptan|sumatriptan|mesh-list
14388836|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14388837|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14388838|NCT01329562|Analgesics|analgesics|mesh-ancestor
14388839|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
14388840|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388841|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388842|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14388843|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14388844|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
14388845|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14388846|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388847|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388848|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14388849|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14388850|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14388851|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
14388852|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388853|NCT01329900|Etoposide|etoposide|mesh-list
14388854|NCT01329900|Ifosfamide|ifosfamide|mesh-list
14388855|NCT01329900|Ofatumumab|ofatumumab|mesh-list
14388856|NCT01329900|Sargramostim|sargramostim|mesh-list
14388857|NCT01329900|Lenograstim|lenograstim|mesh-list
14388858|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14388859|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388860|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14388861|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14388862|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388863|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388864|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14388865|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
14388866|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
14388867|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388868|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14388869|NCT01329939|Montelukast|montelukast|mesh-list
14388870|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14388871|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388872|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14388873|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
14388874|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14388875|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388876|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14388877|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14388878|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388879|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
14388880|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
14388881|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388882|NCT01330017|Loratadine|loratadine|mesh-list
14388883|NCT01330017|Phenylephrine|phenylephrine|mesh-list
14388884|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
14388885|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14388886|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
14388887|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
14388888|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388889|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388890|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
14388891|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14388892|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
14388893|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
14388894|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14388895|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14388896|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14388897|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14388898|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388899|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388900|NCT01330017|Protective Agents|protective agents|mesh-ancestor
14388901|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
14388902|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
14388903|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14388904|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14388905|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14388906|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
14388907|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
14388908|NCT01330030|Selegiline|selegiline|mesh-list
14388909|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
14388910|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14388911|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14388912|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14388913|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14923311|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923312|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14388914|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388915|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388916|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14388917|NCT01330030|Protective Agents|protective agents|mesh-ancestor
14388918|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388919|NCT01330043|Bupropion|bupropion|mesh-list
14388920|NCT01330043|Nicotine|nicotine|mesh-list
14388921|NCT01330043|Varenicline|varenicline|mesh-list
15236621|NCT04581148|Antibodies|antibodies|mesh-list
15236622|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
15236623|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
15236624|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236625|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
15236626|NCT04579367|Ezetimibe|ezetimibe|mesh-list
15236627|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15236628|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15236629|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
15236630|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236631|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14388922|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14388923|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
14388924|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388925|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388926|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14388927|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14388928|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
14388929|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388930|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388931|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14388932|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
14388933|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14388934|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14388935|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14388936|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388937|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
14388938|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14388939|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14388940|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388941|NCT01330108|Ambrisentan|ambrisentan|mesh-list
14388942|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14734751|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388943|NCT01330134|Lidocaine|lidocaine|mesh-list
14734752|NCT00537121|Leucovorin|leucovorin|mesh-list
14734753|NCT00537121|Fluorouracil|fluorouracil|mesh-list
14734754|NCT00537121|Irinotecan|irinotecan|mesh-list
14734755|NCT00537121|Vorinostat|vorinostat|mesh-list
14734756|NCT00537121|Calcium|calcium|mesh-list
14734757|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
14734758|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14388944|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
14388945|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
14388946|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388947|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388948|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
14388949|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388950|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14388951|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14388952|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14388953|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388954|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388955|NCT01330290|Rotigotine|rotigotine|mesh-list
14734759|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734760|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
14734761|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734762|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14388956|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
14388957|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
14388958|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388959|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388960|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388961|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
14388962|NCT01330355|Besifloxacin|besifloxacin|mesh-list
14388963|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14388964|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14388965|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14388966|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14388967|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14388968|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14388969|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14388970|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388971|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14388972|NCT01330381|Prucalopride|prucalopride|mesh-list
14388973|NCT01330381|Laxatives|laxatives|mesh-ancestor
14388974|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14388975|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14388976|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14388977|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
14388978|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14388979|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388980|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388981|NCT01330459|Acetaminophen|acetaminophen|mesh-list
14388982|NCT01330459|Ibuprofen|ibuprofen|mesh-list
14388983|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14388984|NCT01330459|Lidocaine|lidocaine|mesh-list
14388985|NCT01330459|Hydrocodone|hydrocodone|mesh-list
14388986|NCT01330459|Lorazepam|lorazepam|mesh-list
14388987|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
14388988|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
15236632|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236633|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236634|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388989|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14388990|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14388991|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
14388992|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14388993|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14388994|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14388995|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15236635|NCT04574232|Triamcinolone|triamcinolone|mesh-list
15236636|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15236637|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15236638|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15236639|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236640|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
14388996|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14388997|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14388998|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14388999|NCT01330459|Analgesics|analgesics|mesh-ancestor
14389000|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
14389001|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389002|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389003|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389004|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14389005|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389006|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14389007|NCT01330459|Narcotics|narcotics|mesh-ancestor
14389008|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
14389009|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389010|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
14389011|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
14389012|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
14389013|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14389014|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14389015|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14389016|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389017|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389018|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
14389019|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
14389020|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466784|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466785|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466786|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14466787|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14466788|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14466789|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14466790|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14466791|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
14466792|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
14466793|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
14466794|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
14466795|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
14466796|NCT02250807|Simeprevir|simeprevir|mesh-list
14466797|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
14466798|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466799|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
14466800|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466801|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466802|NCT02251236|Tenofovir|tenofovir|mesh-list
14466803|NCT02251236|Emtricitabine|emtricitabine|mesh-list
14466804|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14466805|NCT02251236|Cobicistat|cobicistat|mesh-list
14466806|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14469934|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389021|NCT01331005|Nepafenac|nepafenac|mesh-list
14389022|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389023|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389024|NCT01331005|Analgesics|analgesics|mesh-ancestor
14389025|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
14389026|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389027|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389028|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389029|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389030|NCT01331109|Milnacipran|milnacipran|mesh-list
14389031|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
14389032|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14389033|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14389034|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389035|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389036|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389037|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389038|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389039|NCT01331109|Analgesics|analgesics|mesh-ancestor
14389040|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
14389041|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389042|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
14389043|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389044|NCT01331161|Vaccines|vaccines|mesh-list
14389045|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
14389046|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389047|NCT01331213|Pregabalin|pregabalin|mesh-list
14389048|NCT01331213|Analgesics|analgesics|mesh-ancestor
14389049|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
14389050|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389051|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389052|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
14389053|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14389054|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389055|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389056|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14389057|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14389058|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389059|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389060|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389061|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14389062|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
14389063|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389064|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14389065|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389066|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389067|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389068|NCT01331681|Aflibercept|aflibercept|mesh-list
14389069|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14389070|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14389071|NCT01331681|Growth Substances|growth substances|mesh-ancestor
14389072|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389073|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
14389074|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389075|NCT01331694|Fluticasone|fluticasone|mesh-list
14389076|NCT01331694|Bromides|bromides|mesh-list
14389077|NCT01331694|Albuterol|albuterol|mesh-list
14389078|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
14389079|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14389080|NCT01331694|Ipratropium|ipratropium|mesh-list
14389081|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14389082|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389083|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14389084|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
14389085|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389086|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389087|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14389088|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389089|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389090|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389091|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
14389092|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14389093|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14389094|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389095|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389096|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14389097|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14389098|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14389099|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
14389100|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
14389101|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
14389102|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14389103|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
14389104|NCT01331694|Hormones|hormones|mesh-ancestor
14389105|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389106|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
14389107|NCT01331824|Amrubicin|amrubicin|mesh-list
14389108|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389109|NCT01331837|Etanercept|etanercept|mesh-list
14389110|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389111|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389112|NCT01331837|Analgesics|analgesics|mesh-ancestor
14389113|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
14389114|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389115|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389116|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389117|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389118|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14389119|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14389120|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
14389121|NCT01332019|Interferons|interferons|mesh-list
14389122|NCT01332019|Interferon-beta|interferon-beta|mesh-list
14389123|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
14389124|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389125|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
14389126|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389127|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
14389128|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389129|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14389130|NCT01332071|Metformin|metformin|mesh-list
14389131|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
14389132|NCT01332071|Maleic acid|maleic acid|mesh-list
14389133|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14389134|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389135|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389136|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389137|NCT01332149|Pregabalin|pregabalin|mesh-list
14389138|NCT01332149|Analgesics|analgesics|mesh-ancestor
14389139|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
14389140|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389141|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389142|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
14389143|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14389144|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389145|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389146|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14389147|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14389148|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389149|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389150|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389151|NCT01332188|Cetirizine|cetirizine|mesh-list
14389152|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389153|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14389154|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14389155|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
14389156|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
14389157|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389158|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389159|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389160|NCT01332227|Ritonavir|ritonavir|mesh-list
14389161|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14389162|NCT01332227|Tenofovir|tenofovir|mesh-list
14389163|NCT01332227|Emtricitabine|emtricitabine|mesh-list
14389164|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
14389165|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14389166|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14389167|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
14389168|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389169|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389170|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14389171|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14389172|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
14389173|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389174|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14389175|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14389176|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14389177|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14389178|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14389179|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14389180|NCT01332253|Ibuprofen|ibuprofen|mesh-list
14389181|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389182|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389183|NCT01332253|Analgesics|analgesics|mesh-ancestor
14389184|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
14389185|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389186|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389187|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389188|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389189|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14389190|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389191|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389192|NCT01332292|Fluticasone|fluticasone|mesh-list
14389193|NCT01332292|Xhance|xhance|mesh-list
14389194|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389195|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14389196|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
14389197|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389198|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389199|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14389200|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389201|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389202|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389203|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
14389204|NCT01332318|Promethazine|promethazine|mesh-list
14389205|NCT01332318|Gabapentin|gabapentin|mesh-list
14389206|NCT01332318|Analgesics|analgesics|mesh-ancestor
14389207|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
14389208|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389209|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389210|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
14389211|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14389212|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389213|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389214|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389215|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14389216|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14389217|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389218|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389219|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
14389220|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14389221|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14389222|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
14389223|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
14389224|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
14389225|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
14389226|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14389227|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14389228|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
14389229|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
14389230|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389231|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
14389232|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389233|NCT01332331|Ambrisentan|ambrisentan|mesh-list
14389234|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14389235|NCT01332357|Fluticasone|fluticasone|mesh-list
14389236|NCT01332357|Xhance|xhance|mesh-list
14389237|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14389238|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14389239|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389240|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14389241|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
14389242|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389243|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389244|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14389245|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389246|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389247|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389248|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14389249|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14389250|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14389251|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
14389252|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389253|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389254|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
14389255|NCT01332357|Hormones|hormones|mesh-ancestor
14389256|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389257|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
14389258|NCT01332461|Fluticasone|fluticasone|mesh-list
14389259|NCT01332461|Xhance|xhance|mesh-list
14389260|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14389261|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389262|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14389263|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
14389264|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389265|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389266|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14389267|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389268|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389269|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389270|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15236641|NCT04574232|Hormones|hormones|mesh-ancestor
15236642|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236643|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236644|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236645|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
15236646|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236647|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236648|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15236649|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
15236650|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236651|NCT04554888|Doxepin|doxepin|mesh-list
15236652|NCT04554888|Histamine|histamine|mesh-list
15236653|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
15236654|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
15236655|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389271|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14389272|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14389273|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
14389274|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389275|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389276|NCT01332500|Naproxen|naproxen|mesh-list
14389277|NCT01332500|Sumatriptan|sumatriptan|mesh-list
14389278|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389279|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389280|NCT01332500|Analgesics|analgesics|mesh-ancestor
14389281|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
14389282|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389283|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389284|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389285|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389286|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
14389287|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14389288|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389289|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389290|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14389291|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14389292|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14389293|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
14389294|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389295|NCT01332578|Acetaminophen|acetaminophen|mesh-list
14389296|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
14389297|NCT01332578|Phenylephrine|phenylephrine|mesh-list
14389298|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
14389299|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389300|NCT01332578|Analgesics|analgesics|mesh-ancestor
14389301|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
14389302|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389303|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389304|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
14389305|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
14389306|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389307|NCT01332578|Protective Agents|protective agents|mesh-ancestor
14389308|NCT01332578|Vitamins|vitamins|mesh-ancestor
14389309|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
14389310|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14389311|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
14389312|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
14389313|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
14389314|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14389315|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
14389316|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389317|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14389318|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14389319|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14389320|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
14389321|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389322|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
14389323|NCT01332630|Dexamethasone|dexamethasone|mesh-list
14389324|NCT01332630|Ranitidine|ranitidine|mesh-list
14389325|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14389326|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389327|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
14389328|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
14389329|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389330|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389331|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14389332|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
14389333|NCT01332630|Hormones|hormones|mesh-ancestor
14389334|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389335|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14389336|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389337|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14389338|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14389339|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389340|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
14389341|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
14389342|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
14389343|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14389344|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
14389345|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
14389346|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236656|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389347|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389348|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389349|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14389350|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14389351|NCT01332721|Bevacizumab|bevacizumab|mesh-list
14389352|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14389353|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389354|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14389355|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14389356|NCT01332721|Growth Substances|growth substances|mesh-ancestor
14389357|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389358|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
14389359|NCT01332994|Rituximab|rituximab|mesh-list
14389360|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14389361|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389362|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
14389363|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389364|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389365|NCT01333033|Leucovorin|leucovorin|mesh-list
14389366|NCT01333033|Paclitaxel|paclitaxel|mesh-list
14389367|NCT01333033|Carboplatin|carboplatin|mesh-list
14389368|NCT01333033|Fluorouracil|fluorouracil|mesh-list
14389369|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
14389370|NCT01333033|Calcium|calcium|mesh-list
14389371|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
14389372|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14389373|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389374|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
14389375|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
14389376|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
14389377|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389378|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14389379|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389380|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
14389381|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14389382|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14389383|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
14389384|NCT01333033|Antidotes|antidotes|mesh-ancestor
14389385|NCT01333033|Protective Agents|protective agents|mesh-ancestor
14389386|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
14389387|NCT01333033|Vitamins|vitamins|mesh-ancestor
14389388|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
14734763|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734764|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734765|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
14734766|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14734767|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14734768|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734769|NCT00537121|Antidotes|antidotes|mesh-ancestor
14734770|NCT00537121|Protective Agents|protective agents|mesh-ancestor
14734771|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
14734772|NCT00537121|Vitamins|vitamins|mesh-ancestor
14734773|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
14734774|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14389389|NCT01333059|Fentanyl|fentanyl|mesh-list
14389390|NCT01333059|Midazolam|midazolam|mesh-list
14389391|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14389392|NCT01333059|Narcotics|narcotics|mesh-ancestor
14389393|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389394|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389395|NCT01333059|Analgesics|analgesics|mesh-ancestor
14389396|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
14389397|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389398|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14734775|NCT00537173|Paclitaxel|paclitaxel|mesh-list
14734776|NCT00537173|Bevacizumab|bevacizumab|mesh-list
14734777|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14734778|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734779|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
14389399|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14389400|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
14389401|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
14389402|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14389403|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14734780|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
14734781|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
14389404|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14734782|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389405|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389406|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
14389407|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
14389408|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389409|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389410|NCT01333072|Risperidone|risperidone|mesh-list
14389411|NCT01333072|Aripiprazole|aripiprazole|mesh-list
14389412|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14389413|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
14389414|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389415|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389416|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389417|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14389418|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389419|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389420|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389421|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14389422|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
14389423|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
14389424|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
14389425|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14389426|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14389427|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14389428|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14389429|NCT01333098|Mifepristone|mifepristone|mesh-list
14389430|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14389431|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
14389432|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14389433|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389434|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14389435|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14389436|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14389437|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
14389438|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14389439|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14389440|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
14389441|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389442|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
14389443|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14389444|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14389445|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
14389446|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14389447|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14389448|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14389449|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389450|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389451|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
14389452|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389453|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389454|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14389455|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389456|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
14389457|NCT01333488|Analgesics|analgesics|mesh-ancestor
14389458|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
14389459|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389460|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389461|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
14389462|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389463|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14389464|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
14389465|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14389466|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389467|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389468|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14389469|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
14389470|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14389471|NCT01333501|Interferons|interferons|mesh-list
14389472|NCT01333501|Interferon-beta|interferon-beta|mesh-list
14389473|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14389474|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
14389475|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389476|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
14389477|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389478|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
14389479|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389480|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14389481|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389482|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14389483|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14389484|NCT01333592|Mitiglinide|mitiglinide|mesh-list
14389485|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14389486|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389487|NCT01333722|Acetaminophen|acetaminophen|mesh-list
14389488|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14389489|NCT01333722|Hydrocodone|hydrocodone|mesh-list
14389490|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389491|NCT01333722|Analgesics|analgesics|mesh-ancestor
14389492|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
14389493|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389494|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389495|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
14389496|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14389497|NCT01333722|Narcotics|narcotics|mesh-ancestor
14389498|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389499|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
14389500|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389501|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389502|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389503|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389504|NCT01333865|Memantine|memantine|mesh-list
14389505|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14389506|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14389507|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
14389508|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389509|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389510|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389511|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14389512|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14389513|NCT01333956|Pregabalin|pregabalin|mesh-list
14389514|NCT01333956|Analgesics|analgesics|mesh-ancestor
14389515|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
14389516|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389517|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389518|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
14389519|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14389520|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389521|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389522|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14389523|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14389524|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389525|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389526|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389527|NCT01334086|Aprepitant|aprepitant|mesh-list
14389528|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
14389529|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
14389530|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389531|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389532|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14389533|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14389534|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389535|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389536|NCT01334125|Metformin|metformin|mesh-list
14389537|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14389538|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389539|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14389540|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14389541|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389542|NCT01334229|Incretins|incretins|mesh-ancestor
14389543|NCT01334229|Hormones|hormones|mesh-ancestor
14389544|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389545|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14389546|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
14389547|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389548|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389549|NCT01334515|Isotretinoin|isotretinoin|mesh-list
14389550|NCT01334515|Sargramostim|sargramostim|mesh-list
14389551|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389552|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
14389553|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389554|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
14389555|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
14389556|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14389557|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14389558|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389559|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389560|NCT01334554|Urological Agents|urological agents|mesh-ancestor
14389561|NCT01334710|Sorafenib|sorafenib|mesh-list
14389562|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389563|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14389564|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389565|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389566|NCT01334723|Finasteride|finasteride|mesh-list
14389567|NCT01334723|Dutasteride|dutasteride|mesh-list
14389568|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
14389569|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14389570|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389571|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389572|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
14389573|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389574|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389575|NCT01334723|Urological Agents|urological agents|mesh-ancestor
14389576|NCT01334918|Regadenoson|regadenoson|mesh-list
14389577|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14389578|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14389579|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14389580|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
14389581|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
14389582|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389583|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389584|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389585|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14389586|NCT01334944|Ibuprofen|ibuprofen|mesh-list
14389587|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389588|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389589|NCT01334944|Analgesics|analgesics|mesh-ancestor
14389590|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
14389591|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389592|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389593|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389594|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389595|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14389596|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389597|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389598|NCT01334957|Ibuprofen|ibuprofen|mesh-list
14389599|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389600|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389601|NCT01334957|Analgesics|analgesics|mesh-ancestor
14389602|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
14389603|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389604|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389605|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389606|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389607|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14389608|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389609|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389610|NCT01335009|Antibodies|antibodies|mesh-list
14389611|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14389612|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
14389613|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389614|NCT01335204|Bavituximab|bavituximab|mesh-list
14469935|NCT02301143|Gemcitabine|gemcitabine|mesh-list
14389615|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14389616|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389617|NCT01335464|Nintedanib|nintedanib|mesh-list
14389618|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389619|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14389620|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389621|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389622|NCT01335477|Nintedanib|nintedanib|mesh-list
14389623|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389624|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14389625|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389626|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389627|NCT01335620|Tenofovir|tenofovir|mesh-list
14389628|NCT01335620|Emtricitabine|emtricitabine|mesh-list
14389629|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
14389630|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
14389631|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389632|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14389633|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14389634|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389635|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389636|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14389637|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14389638|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14389639|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14389640|NCT01335698|Ritonavir|ritonavir|mesh-list
14389641|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14389642|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14389643|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14389644|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14389645|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389646|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389647|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14389648|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14389649|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
14389650|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389651|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14389652|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14389653|NCT01335724|Diclofenac|diclofenac|mesh-list
14389654|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14389655|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389656|NCT01335724|Analgesics|analgesics|mesh-ancestor
14389657|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
14389658|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389659|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389660|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389661|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389662|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14389663|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389664|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389665|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14389666|NCT01335789|Oxytocin|oxytocin|mesh-list
14389667|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
14389668|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14389669|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389670|NCT01335867|Vigabatrin|vigabatrin|mesh-list
14389671|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
14389672|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389673|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389674|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
14389675|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389676|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389677|NCT01335932|Ganciclovir|ganciclovir|mesh-list
14389678|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14389679|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
14389680|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389681|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14389682|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389683|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389684|NCT01335971|Sulforaphane|sulforaphane|mesh-list
14389685|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14389686|NCT01335971|Protective Agents|protective agents|mesh-ancestor
14389687|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389688|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389689|NCT01336023|Insulin|insulin|mesh-list
14389690|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14389691|NCT01336023|Liraglutide|liraglutide|mesh-list
14389692|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
14389693|NCT01336023|Xultophy|xultophy|mesh-list
14389694|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14389695|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389696|NCT01336023|Incretins|incretins|mesh-ancestor
14389697|NCT01336023|Hormones|hormones|mesh-ancestor
14389698|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389699|NCT01336140|Aminophylline|aminophylline|mesh-list
14389700|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14389701|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
14389702|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389703|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389704|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14389705|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389706|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14389707|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14389708|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389709|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389710|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14389711|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14389712|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
14389713|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389714|NCT01336140|Protective Agents|protective agents|mesh-ancestor
14389715|NCT01336205|Naloxegol|naloxegol|mesh-list
14389716|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14389717|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389718|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
14389719|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389720|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
14389721|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14389722|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389723|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14389724|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
14389725|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14389726|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389727|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389728|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389729|NCT01336569|Timolol|timolol|mesh-list
14389730|NCT01336569|Travoprost|travoprost|mesh-list
14389731|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14389732|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14389733|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
14389734|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389735|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389736|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389737|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14389738|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14389739|NCT01336608|Fluticasone|fluticasone|mesh-list
14389740|NCT01336608|Xhance|xhance|mesh-list
14389741|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389742|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14389743|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
14389744|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389745|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389746|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14389747|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389748|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389749|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389750|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
14389751|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14389752|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14389753|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14389754|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389755|NCT01336738|Incretins|incretins|mesh-ancestor
14389756|NCT01336738|Hormones|hormones|mesh-ancestor
14389757|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389758|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14389759|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
14389760|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389761|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389762|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
14389763|NCT01336738|Vitamins|vitamins|mesh-ancestor
14389764|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
14389765|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14389766|NCT01336803|Hematinics|hematinics|mesh-ancestor
14389767|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14389768|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14389769|NCT01336933|Prednisone|prednisone|mesh-list
14389770|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
14389771|NCT01336933|Etoposide|etoposide|mesh-list
14389772|NCT01336933|Vincristine|vincristine|mesh-list
14389773|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
14389774|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14389775|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
14389776|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389777|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389778|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14389779|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
14389780|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389781|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389782|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14389783|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389784|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
14389785|NCT01336933|Hormones|hormones|mesh-ancestor
14389786|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389787|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14389788|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14389789|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14389790|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14389791|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389792|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
14389793|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
14389794|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
14389795|NCT01336972|Tolvaptan|tolvaptan|mesh-list
14389796|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14389797|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389798|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
14389799|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466807|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14466808|NCT02251236|Elvitegravir|elvitegravir|mesh-list
14466809|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
14466810|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466811|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14389800|NCT01337089|Nabiximols|nabiximols|mesh-list
14389801|NCT01337089|Analgesics|analgesics|mesh-ancestor
14389802|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
14389803|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389804|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389805|NCT01337115|Ropivacaine|ropivacaine|mesh-list
14389806|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
14389807|NCT01337115|Anesthetics|anesthetics|mesh-list
14389808|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389809|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389810|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
14389811|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389812|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14389813|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
14389814|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389815|NCT01337336|Fluticasone|fluticasone|mesh-list
14389816|NCT01337336|Xhance|xhance|mesh-list
14389817|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
14389818|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14389819|NCT01337336|Ipratropium|ipratropium|mesh-list
14389820|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14389821|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14389822|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14389823|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
14389824|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389825|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389826|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14389827|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
14389828|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389829|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14389830|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
14389831|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
14389832|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389833|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389834|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14389835|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14389836|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14389837|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
14389838|NCT01337635|Vitamin D|vitamin d|mesh-list
14389839|NCT01337635|Vitamins|vitamins|mesh-ancestor
14389840|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
14389841|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389842|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14389843|NCT01337674|Metoprolol|metoprolol|mesh-list
14389844|NCT01337674|Amlodipine|amlodipine|mesh-list
14389845|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14389846|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14389847|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389848|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389849|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14389850|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389851|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
14389852|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14389853|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
14389854|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
14389855|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389856|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14389857|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14389858|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14389859|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
14389860|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389861|NCT01337687|Oxytocin|oxytocin|mesh-list
14389862|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
14389863|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14389864|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389865|NCT01337700|Milnacipran|milnacipran|mesh-list
14389866|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
14389867|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14389868|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14389869|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389870|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389871|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389872|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389873|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14389874|NCT01337700|Analgesics|analgesics|mesh-ancestor
14389875|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
14389876|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14389877|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
14389878|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389879|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
14389880|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14389881|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389882|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389883|NCT01338025|Lamivudine|lamivudine|mesh-list
14389884|NCT01338025|Emtricitabine|emtricitabine|mesh-list
14389885|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14389886|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14389887|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389888|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389889|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
14389890|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389891|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14389892|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14389893|NCT01338298|Aripiprazole|aripiprazole|mesh-list
14389894|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
14389895|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14389896|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14389897|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14389898|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389899|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389900|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
14389901|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
14389902|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389903|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389904|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14389905|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14389906|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
14389907|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14389908|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14389909|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14389910|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14389911|NCT01338415|Bosentan|bosentan|mesh-list
14389912|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14389913|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14389914|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389915|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14389916|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14389917|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
14389918|NCT01338792|Pemetrexed|pemetrexed|mesh-list
14389919|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389920|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389921|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389922|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14389923|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14389924|NCT01338818|Methylphenidate|methylphenidate|mesh-list
14389925|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14389926|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389927|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14389928|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14389929|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14389930|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389931|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
14389932|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14389933|NCT01338857|Sorafenib|sorafenib|mesh-list
14389934|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389935|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14389936|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389937|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389938|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
14389939|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14389940|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14389941|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14389942|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389943|NCT01338870|Incretins|incretins|mesh-ancestor
14389944|NCT01338870|Hormones|hormones|mesh-ancestor
14389945|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14389946|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14389947|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
14389948|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389949|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389950|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
14389951|NCT01338870|Vitamins|vitamins|mesh-ancestor
14389952|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
14389953|NCT01338987|Alovudine|alovudine|mesh-list
14389954|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
14389955|NCT01338987|Busulfan|busulfan|mesh-list
14389956|NCT01338987|Methotrexate|methotrexate|mesh-list
14389957|NCT01338987|Fludarabine|fludarabine|mesh-list
14389958|NCT01338987|Leuprolide|leuprolide|mesh-list
14389959|NCT01338987|Tacrolimus|tacrolimus|mesh-list
14389960|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14389961|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
14389962|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389963|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14389964|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14389965|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
14389966|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389967|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14389968|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14389969|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14389970|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
14389971|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14389972|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14389973|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
14389974|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14389975|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389976|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14389977|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14389978|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14389979|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14389980|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
14389981|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14389982|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
14389983|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389984|NCT01339000|Vaccines|vaccines|mesh-list
14389985|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14389986|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
14389987|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389988|NCT01339013|Anesthetics|anesthetics|mesh-list
14389989|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14389990|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14389991|NCT01339091|Vancomycin|vancomycin|mesh-list
14389992|NCT01339091|Linezolid|linezolid|mesh-list
14389993|NCT01339091|Dalbavancin|dalbavancin|mesh-list
14389994|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14389995|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14389996|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14389997|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14389998|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14389999|NCT01339247|Halofantrine|halofantrine|mesh-list
14390000|NCT01339247|Paroxetine|paroxetine|mesh-list
14390001|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14390002|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14390003|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390004|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390005|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390006|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
14390007|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390008|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14390009|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
14390010|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14390011|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14390012|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14390013|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390014|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
14390015|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14390016|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14390017|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390018|NCT01339260|Dexamethasone|dexamethasone|mesh-list
14390019|NCT01339260|Palonosetron|palonosetron|mesh-list
14390020|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14390021|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
14390022|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
14390023|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390024|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390025|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14390026|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
14390027|NCT01339260|Hormones|hormones|mesh-ancestor
14390028|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390029|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14390030|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390031|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14390032|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14390033|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
14390034|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390035|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390036|NCT01339273|Anesthetics|anesthetics|mesh-list
14390037|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
14390038|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390039|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390040|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
14390041|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390042|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14390043|NCT01339299|Hormones|hormones|mesh-list
14390044|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390045|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390046|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14390047|NCT01339559|Brivaracetam|brivaracetam|mesh-list
14390048|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
14390049|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
14390050|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14390051|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
14390052|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390053|NCT01339858|Expectorants|expectorants|mesh-ancestor
14390054|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390055|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14390056|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
14390057|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390058|NCT01339858|Protective Agents|protective agents|mesh-ancestor
14390059|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390060|NCT01339858|Antidotes|antidotes|mesh-ancestor
14390061|NCT01339910|Vidarabine|vidarabine|mesh-list
14390062|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
14390063|NCT01339910|Melphalan|melphalan|mesh-list
14390064|NCT01339910|Busulfan|busulfan|mesh-list
14390065|NCT01339910|Fludarabine|fludarabine|mesh-list
14390066|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
14390067|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390068|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
14390069|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390070|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390071|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14390072|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
14390073|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390074|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390075|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14390076|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14390077|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
14390078|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
14390079|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390080|NCT01339923|Vaccines|vaccines|mesh-list
14390081|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
14390082|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390083|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14390084|NCT01339936|Glycerol|glycerol|mesh-list
14390085|NCT01339936|Laxatives|laxatives|mesh-ancestor
14390086|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14390087|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14390088|NCT01339936|Protective Agents|protective agents|mesh-ancestor
14390089|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390090|NCT01340014|Timolol|timolol|mesh-list
14390091|NCT01340014|Dorzolamide|dorzolamide|mesh-list
14390092|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14390093|NCT01340014|Brinzolamide|brinzolamide|mesh-list
14390094|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14390095|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14390096|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14390097|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390098|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390099|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390100|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390101|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14390102|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14390103|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14390104|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390105|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
14390106|NCT01340027|Mirabegron|mirabegron|mesh-list
14390107|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14390108|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14390109|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
14390110|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390111|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390112|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390113|NCT01340027|Urological Agents|urological agents|mesh-ancestor
14390114|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14390115|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14390116|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14390117|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390118|NCT01340196|Tenofovir|tenofovir|mesh-list
14923313|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
15236657|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236658|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15236659|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15236660|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236661|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15236662|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
15236663|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236664|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
15236665|NCT04548973|Esketamine|esketamine|mesh-list
15236666|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
15236667|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236668|NCT04547985|Naltrexone|naltrexone|mesh-list
15236669|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15236670|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15236671|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236672|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
15236673|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236674|NCT04544189|Fulvestrant|fulvestrant|mesh-list
15236675|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15236676|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236677|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15236678|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15236679|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
15236680|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236681|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236682|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
14390119|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
14390120|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390121|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14390122|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14390123|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390124|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390125|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14390126|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14390127|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
14390128|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14390129|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
14390130|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390131|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390132|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14390133|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390134|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
14390135|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14390136|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
14390137|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390138|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390139|NCT01340300|Metformin|metformin|mesh-list
14390140|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14390141|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390142|NCT01340586|Apixaban|apixaban|mesh-list
14390143|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14390144|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
14390145|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14390146|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
14390147|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390148|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390149|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
14390150|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14390151|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14390152|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14390153|NCT01340625|Norethindrone|norethindrone|mesh-list
14390154|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
14390155|NCT01340625|Estradiol|estradiol|mesh-list
14390156|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14390157|NCT01340625|Estrogens|estrogens|mesh-ancestor
14390158|NCT01340625|Hormones|hormones|mesh-ancestor
14390159|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390160|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390161|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14390162|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
14390163|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14390164|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14390165|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14390166|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14390167|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14390168|NCT01340664|Metformin|metformin|mesh-list
14390169|NCT01340664|Canagliflozin|canagliflozin|mesh-list
14390170|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14390171|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390172|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14390173|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390174|NCT01340768|Metformin|metformin|mesh-list
14390175|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15236683|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15236684|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390176|NCT01340768|Glimepiride|glimepiride|mesh-list
14390177|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14390178|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390179|NCT01340768|Incretins|incretins|mesh-ancestor
14390180|NCT01340768|Hormones|hormones|mesh-ancestor
14390181|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390182|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14390183|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
14390184|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390185|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390186|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14390187|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390188|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
14390189|NCT01340872|Ferric maltol|ferric maltol|mesh-list
14390190|NCT01340872|Hematinics|hematinics|mesh-ancestor
14390191|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14390192|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
14390193|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390194|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
14390195|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
14390196|NCT01341301|Tacrolimus|tacrolimus|mesh-list
14390197|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390198|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
14390199|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390200|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390201|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14390202|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
14390203|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390204|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390205|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14390206|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14390207|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390208|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14390209|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14390210|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
14390211|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14390212|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390213|NCT01341457|Gemcitabine|gemcitabine|mesh-list
14390214|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14390215|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
14390216|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390217|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390218|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
14390219|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390220|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390221|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390222|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
14390223|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390224|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14390225|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
14390226|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390227|NCT01341652|Molgramostim|molgramostim|mesh-list
14390228|NCT01341652|Sargramostim|sargramostim|mesh-list
14390229|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
14390230|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236685|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236686|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236687|NCT04539548|Prednisolone|prednisolone|mesh-list
15236688|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236689|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
15236690|NCT04539548|Hormones|hormones|mesh-ancestor
14390231|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390232|NCT01341730|Pioglitazone|pioglitazone|mesh-list
14390233|NCT01341730|Atorvastatin|atorvastatin|mesh-list
14390234|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14390235|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14390236|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
14390237|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390238|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14390239|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14390240|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390241|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14390242|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390243|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
14390244|NCT01341782|Calcitriol|calcitriol|mesh-list
14390245|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
14390246|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14390247|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390248|NCT01341782|Vitamins|vitamins|mesh-ancestor
14390249|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
14390250|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14390251|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390252|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390253|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14390254|NCT01341782|Protective Agents|protective agents|mesh-ancestor
14390255|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14390256|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390257|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390258|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14390259|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14390260|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14390261|NCT01342029|Ranolazine|ranolazine|mesh-list
14390262|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14390263|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390264|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390265|NCT01342081|Timolol|timolol|mesh-list
14390266|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14390267|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14390268|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14390269|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14390270|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390271|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390272|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390273|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390274|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14390275|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14390276|NCT01342094|Timolol|timolol|mesh-list
14390277|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14390278|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14390279|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14390280|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14390281|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390282|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390283|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390284|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390285|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14390286|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14390287|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14390288|NCT01342172|Lenalidomide|lenalidomide|mesh-list
14390289|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
14390290|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390291|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14390292|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14390293|NCT01342172|Growth Substances|growth substances|mesh-ancestor
14390294|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
14390295|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390296|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14390297|NCT01342211|Bococizumab|bococizumab|mesh-list
14390298|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14390299|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14390300|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
14390301|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390302|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390303|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14390304|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
14390305|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14390306|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390307|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14390308|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390309|NCT01342367|Bicalutamide|bicalutamide|mesh-list
14390310|NCT01342367|Finasteride|finasteride|mesh-list
14390311|NCT01342367|Dutasteride|dutasteride|mesh-list
14390312|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
14390313|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
14390314|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390315|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390316|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390317|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14390318|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14390319|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390320|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390321|NCT01342367|Urological Agents|urological agents|mesh-ancestor
14390322|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14390323|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14390324|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390325|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14390326|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14390327|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390328|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390329|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
14390330|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390331|NCT01342484|Linagliptin|linagliptin|mesh-list
14390332|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14390333|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236691|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236692|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236693|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15236694|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236695|NCT04538040|Tenofovir|tenofovir|mesh-list
14390334|NCT01342484|Incretins|incretins|mesh-ancestor
14390335|NCT01342484|Hormones|hormones|mesh-ancestor
14390336|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390337|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14390338|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
14390339|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390340|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390341|NCT01342510|Lidocaine|lidocaine|mesh-list
14390342|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
14390343|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
14390344|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
14390345|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390346|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390347|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
14390348|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390349|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14390350|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14390351|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14390352|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390353|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390354|NCT01342510|Analgesics|analgesics|mesh-ancestor
14390355|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
14390356|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14390357|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14390358|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
14390359|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14390360|NCT01342523|Nicotine|nicotine|mesh-list
14390361|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14390362|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
14390363|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390364|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390365|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14390366|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14390367|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
14390368|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390369|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236696|NCT04538040|Emtricitabine|emtricitabine|mesh-list
15236697|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15236698|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
15236699|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236700|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15236701|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15236702|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236703|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236704|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15236705|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15236706|NCT04530305|Upadacitinib|upadacitinib|mesh-list
14390370|NCT01342549|Naltrexone|naltrexone|mesh-list
14390371|NCT01342549|Valproic Acid|valproic acid|mesh-list
14390372|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14390373|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14390374|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390375|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
14390376|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390377|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
14390378|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390379|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390380|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
14390381|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390382|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
14390383|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14390384|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390385|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14390386|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
14390387|NCT01342640|Hematinics|hematinics|mesh-ancestor
14390388|NCT01342757|Temozolomide|temozolomide|mesh-list
14390389|NCT01342757|Vorinostat|vorinostat|mesh-list
14390390|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14390391|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
14390392|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236707|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15236708|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15236709|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390393|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390394|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14390395|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390396|NCT01342770|Pioglitazone|pioglitazone|mesh-list
14390397|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14390398|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390399|NCT01342796|Vaccines|vaccines|mesh-list
14390400|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
14390401|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390402|NCT01342887|Cyclosporine|cyclosporine|mesh-list
14390403|NCT01342887|Etoposide|etoposide|mesh-list
14390404|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
14390405|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
14390406|NCT01342887|Pravastatin|pravastatin|mesh-list
14390407|NCT01342887|Cyclosporins|cyclosporins|mesh-list
14390408|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14390409|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390410|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15236710|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236711|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236712|NCT04522804|Psilocybin|psilocybin|mesh-list
15236713|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
15236714|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236715|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236716|NCT04519645|Lacosamide|lacosamide|mesh-list
15236717|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
15236718|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15236719|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15236720|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390411|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14390412|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390413|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390414|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390415|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
14390416|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390417|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
14390418|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390419|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390420|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734783|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734784|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734785|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734786|NCT00537173|Growth Substances|growth substances|mesh-ancestor
14734787|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734788|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734789|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
14734790|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14734791|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734792|NCT00537355|Histamine|histamine|mesh-list
14390421|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14390422|NCT01342887|Analgesics|analgesics|mesh-ancestor
14390423|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
14390424|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390425|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14390426|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14390427|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
14390428|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14469936|NCT02301143|Paclitaxel|paclitaxel|mesh-list
14390429|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14466812|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14466813|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466814|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466815|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14466816|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14466817|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14466818|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14466819|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14466820|NCT02251275|Tolvaptan|tolvaptan|mesh-list
14466821|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14466822|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466823|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
14466824|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466825|NCT02251379|Fluticasone|fluticasone|mesh-list
14390430|NCT01342913|Fluticasone|fluticasone|mesh-list
14390431|NCT01342913|Xhance|xhance|mesh-list
14390432|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14390433|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14390434|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14390435|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
14390436|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390437|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390438|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14390439|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390440|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390441|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14390442|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14390443|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14390444|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14390445|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390446|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390447|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390448|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14390449|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390450|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14390451|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390452|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390453|NCT01343004|Teriparatide|teriparatide|mesh-list
14390454|NCT01343004|Abaloparatide|abaloparatide|mesh-list
14390455|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14390456|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390457|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14390458|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
14390459|NCT01343043|Fludarabine|fludarabine|mesh-list
14390460|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390461|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
14390462|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390463|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390464|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14390465|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
14390466|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390467|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390468|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14390469|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14390470|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14390471|NCT01343277|Dacarbazine|dacarbazine|mesh-list
14390472|NCT01343277|Trabectedin|trabectedin|mesh-list
14390473|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14390474|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
14390475|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390476|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390477|NCT01343368|Leuprolide|leuprolide|mesh-list
14390478|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14390479|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
14390480|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14390481|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466826|NCT02251379|Xhance|xhance|mesh-list
14390482|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14390483|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390484|NCT01343823|Ecallantide|ecallantide|mesh-list
14390485|NCT01343823|Analgesics|analgesics|mesh-ancestor
14390486|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
14390487|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390488|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390489|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14390490|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14390491|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14390492|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390493|NCT01343901|Bevacizumab|bevacizumab|mesh-list
14390494|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14390495|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390496|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14390497|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14390498|NCT01343901|Growth Substances|growth substances|mesh-ancestor
14390499|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390500|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
14390501|NCT01344161|Vitamin D|vitamin d|mesh-list
14390502|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
14390503|NCT01344161|Vitamins|vitamins|mesh-ancestor
14390504|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
14390505|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390506|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14390507|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14390508|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14390509|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14390510|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14390511|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14390512|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14390513|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14390514|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14390515|NCT01344369|Norethindrone|norethindrone|mesh-list
14390516|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
14390517|NCT01344369|Estradiol|estradiol|mesh-list
14390518|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14390519|NCT01344369|Estrogens|estrogens|mesh-ancestor
14390520|NCT01344369|Hormones|hormones|mesh-ancestor
14390521|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390522|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390523|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14390524|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
14390525|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14390526|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14390527|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14390528|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14390529|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14390530|NCT01344629|Telmisartan|telmisartan|mesh-list
14390531|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14390532|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14390533|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14390534|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390535|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
14390536|NCT01344759|Propofol|propofol|mesh-list
14390537|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14390538|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390539|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390540|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14390541|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
14390542|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
14390543|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14390544|NCT01344759|Analgesics|analgesics|mesh-ancestor
14390545|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
14390546|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390547|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14390548|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14390549|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14390550|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390551|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390552|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390553|NCT01344824|Bevacizumab|bevacizumab|mesh-list
14390554|NCT01344824|Carboplatin|carboplatin|mesh-list
14390555|NCT01344824|Pemetrexed|pemetrexed|mesh-list
14390556|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14390557|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14390558|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390559|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14390560|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14390561|NCT01344824|Growth Substances|growth substances|mesh-ancestor
14390562|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390563|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
14390564|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390565|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390566|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14390567|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14390568|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14390569|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
14390570|NCT01345019|Denosumab|denosumab|mesh-list
14390571|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14390572|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390573|NCT01345058|Lacosamide|lacosamide|mesh-list
14390574|NCT01345058|Levetiracetam|levetiracetam|mesh-list
14390575|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
14390576|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
14469937|NCT02301143|Capecitabine|capecitabine|mesh-list
15236721|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236722|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
15236723|NCT04512261|Trastuzumab|trastuzumab|mesh-list
15236724|NCT04512261|Tucatinib|tucatinib|mesh-list
15236725|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236726|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236727|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15236728|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236729|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236730|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
15236731|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15236732|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15236733|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
14390577|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14390578|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14390579|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390580|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390581|NCT01345162|Ketorolac|ketorolac|mesh-list
14390582|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14390583|NCT01345162|Tramadol|tramadol|mesh-list
14390584|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14390585|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14390586|NCT01345162|Analgesics|analgesics|mesh-ancestor
14390587|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
14390588|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390589|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390590|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14390591|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390592|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14390593|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390594|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390595|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14390596|NCT01345162|Narcotics|narcotics|mesh-ancestor
14390597|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390598|NCT01345188|Ranolazine|ranolazine|mesh-list
14390599|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14390600|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390601|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390602|NCT01345253|Belimumab|belimumab|mesh-list
14390603|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390604|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
14390605|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390606|NCT01345292|Listerine|listerine|mesh-list
14390607|NCT01345292|Fluorides|fluorides|mesh-list
14390608|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
14390609|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
14390610|NCT01345292|Protective Agents|protective agents|mesh-ancestor
14390611|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390612|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14390613|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390614|NCT01345630|Ritonavir|ritonavir|mesh-list
14390615|NCT01345630|Darunavir|darunavir|mesh-list
15236734|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236735|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236736|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236737|NCT04477265|Urological Agents|urological agents|mesh-ancestor
15236738|NCT04474847|Abatacept|abatacept|mesh-list
15236739|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14390616|NCT01345630|Tenofovir|tenofovir|mesh-list
14390617|NCT01345630|Emtricitabine|emtricitabine|mesh-list
14390618|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14390619|NCT01345630|Maraviroc|maraviroc|mesh-list
14390620|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15236740|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236741|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390621|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14390622|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
14390623|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390624|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390625|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14390626|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14390627|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
14390628|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390629|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14390630|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15236742|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236743|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
15236744|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236745|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236746|NCT04464070|Aspirin|aspirin|mesh-list
15236747|NCT04464070|Niacin|niacin|mesh-list
15236748|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15236749|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15236750|NCT04464070|Analgesics|analgesics|mesh-ancestor
15236751|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
15236752|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390631|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14390632|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14390633|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14390634|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14390635|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14390636|NCT01345669|Afatinib|afatinib|mesh-list
14390637|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390638|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14390639|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390640|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390641|NCT01345682|Methotrexate|methotrexate|mesh-list
14390642|NCT01345682|Afatinib|afatinib|mesh-list
14390643|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14390644|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
14390645|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14390646|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390647|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14390648|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
14390649|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390650|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390651|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390652|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390653|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14390654|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390655|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
14390656|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390657|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14390658|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14390659|NCT01345929|Levofloxacin|levofloxacin|mesh-list
14390660|NCT01345929|Ofloxacin|ofloxacin|mesh-list
14390661|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14390662|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390663|NCT01345929|Renal Agents|renal agents|mesh-ancestor
14390664|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14390665|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14390666|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14390667|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390668|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390669|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390670|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14390671|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15236753|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236754|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236755|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236756|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15236757|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15236758|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236759|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15236760|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15236761|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236762|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
15236763|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15236764|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
15236765|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15236766|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
15236767|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
15236768|NCT04464070|Vitamins|vitamins|mesh-ancestor
15236769|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
15236770|NCT04456517|Ranolazine|ranolazine|mesh-list
15236771|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15236772|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15236773|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236774|NCT04447768|Venetoclax|venetoclax|mesh-list
15236775|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
15236776|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236777|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14390672|NCT01346059|Vancomycin|vancomycin|mesh-list
14390673|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14390674|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390675|NCT01346072|Tolvaptan|tolvaptan|mesh-list
14390676|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14390677|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390678|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
14390679|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390680|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
14390681|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
14390682|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390683|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390684|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14390685|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
14390686|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14390687|NCT01346397|Cyclosporine|cyclosporine|mesh-list
14390688|NCT01346397|Tacrolimus|tacrolimus|mesh-list
14390689|NCT01346397|Cyclosporins|cyclosporins|mesh-list
14390690|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390691|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
14390692|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390693|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14390694|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390695|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390696|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
14390697|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390698|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390699|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390700|NCT01346475|Valacyclovir|valacyclovir|mesh-list
14390701|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
14390702|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390703|NCT01346540|Nintedanib|nintedanib|mesh-list
14390704|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390705|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14390706|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390707|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390708|NCT01346592|Vaccines|vaccines|mesh-list
14390709|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
14390710|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390711|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
14390712|NCT01347008|Citric Acid|citric acid|mesh-list
14390713|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
14390714|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
14390715|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14390716|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
14390717|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
14390718|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390719|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
14390720|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14390721|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14390722|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390723|NCT01347008|Urological Agents|urological agents|mesh-ancestor
14390724|NCT01347060|Fluticasone|fluticasone|mesh-list
14390725|NCT01347060|Xhance|xhance|mesh-list
14390726|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14390727|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14390728|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14390729|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
14390730|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390731|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390732|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14390733|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390734|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390735|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14390736|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14390737|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14390738|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14390739|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390740|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390741|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390742|NCT01347073|Glycerol|glycerol|mesh-list
14390743|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14390744|NCT01347073|Protective Agents|protective agents|mesh-ancestor
14390745|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390746|NCT01347112|Varenicline|varenicline|mesh-list
14390747|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14390748|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14390749|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
14390750|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390751|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390752|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390753|NCT01347255|Betamethasone|betamethasone|mesh-list
14390754|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
14390755|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14390756|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
14390757|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14390758|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14390759|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
14390760|NCT01347255|Hormones|hormones|mesh-ancestor
14390761|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390762|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390763|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14390764|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390765|NCT01347554|Everolimus|everolimus|mesh-list
14390766|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390767|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390768|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
14390769|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390770|NCT01347580|Ticagrelor|ticagrelor|mesh-list
14390771|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14390772|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14734793|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
14734794|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
14734795|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236778|NCT04442022|Gemcitabine|gemcitabine|mesh-list
15236779|NCT04442022|Dexamethasone|dexamethasone|mesh-list
15236780|NCT04442022|Rituximab|rituximab|mesh-list
15236781|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236782|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236783|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
15236784|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
14390773|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14390774|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15236785|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390775|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
15236786|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390776|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390777|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390778|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390779|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14390780|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
14390781|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14390782|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390783|NCT01347762|Nabilone|nabilone|mesh-list
14390784|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
14390785|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
14390786|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390787|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390788|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14390789|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14390790|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14390791|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390792|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14390793|NCT01347866|Irinotecan|irinotecan|mesh-list
14390794|NCT01347866|Gedatolisib|gedatolisib|mesh-list
14390795|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14390796|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14390797|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390798|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390799|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390800|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14390801|NCT01348100|Iloperidone|iloperidone|mesh-list
14390802|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14390803|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14390804|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390805|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390806|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14390807|NCT01348139|AZD-3199|azd-3199|mesh-list
14390808|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14390809|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14390810|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14390811|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390812|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390813|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390814|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390815|NCT01348542|Trazodone|trazodone|mesh-list
14390816|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14390817|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14390818|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390819|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390820|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14390821|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14390822|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14390823|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390824|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390825|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390826|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
14390827|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14390828|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
14390829|NCT01348607|Methylphenidate|methylphenidate|mesh-list
14390830|NCT01348607|Modafinil|modafinil|mesh-list
14390831|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14390832|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390833|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14390834|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14390835|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15236787|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15236788|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
15236789|NCT04442022|Hormones|hormones|mesh-ancestor
14390836|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390837|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
14390838|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390839|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14390840|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14390841|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14390842|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14390843|NCT01348763|Maraviroc|maraviroc|mesh-list
14390844|NCT01348763|Darunavir|darunavir|mesh-list
14390845|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14390846|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14390847|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390848|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923314|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923315|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236790|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236791|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14390849|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
14390850|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390851|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14734796|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734797|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734798|NCT00537420|Sibutramine|sibutramine|mesh-list
14390852|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14390853|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14390854|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14390855|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14390856|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14390857|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14390858|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
14466827|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14466828|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14466829|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
14466830|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466831|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466832|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14466833|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
14466834|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
14466835|NCT02251379|Hormones|hormones|mesh-ancestor
14466836|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466837|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
14466838|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466839|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
14466840|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14466841|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14466842|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14466843|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14466844|NCT02251613|Epinastine|epinastine|mesh-list
14466845|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14466846|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14466847|NCT02251613|Analgesics|analgesics|mesh-ancestor
14466848|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
14466849|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466850|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466851|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14466852|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236792|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236793|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
15236794|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236795|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15236796|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
14734799|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
14390859|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
14390860|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14390861|NCT01349192|Minocycline|minocycline|mesh-list
14390862|NCT01349192|Rifampin|rifampin|mesh-list
14390863|NCT01349192|Trimethoprim|trimethoprim|mesh-list
14390864|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
14390865|NCT01349192|Mupirocin|mupirocin|mesh-list
14390866|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14390867|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390868|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
14390869|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390870|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14390871|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14390872|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
14390873|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
14390874|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14390875|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390876|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734800|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14390877|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14734801|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
15236797|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236798|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
15236799|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236800|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390878|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14390879|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14390880|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14390881|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14390882|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14390883|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14390884|NCT01349192|Renal Agents|renal agents|mesh-ancestor
14390885|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
14390886|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14734802|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14923316|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
15236801|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390887|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14390888|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14390889|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14390890|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14390891|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14390892|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14390893|NCT01349231|Ketamine|ketamine|mesh-list
14390894|NCT01349231|Analgesics|analgesics|mesh-ancestor
14390895|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
14390896|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390897|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390898|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14390899|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14390900|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
14390901|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
14390902|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14390903|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14390904|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14390905|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390906|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390907|NCT01349491|Ranolazine|ranolazine|mesh-list
14390908|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14390909|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14390910|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390911|NCT01349569|Lenalidomide|lenalidomide|mesh-list
14390912|NCT01349569|Vaccines|vaccines|mesh-list
14390913|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
14390914|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390915|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14390916|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14390917|NCT01349569|Growth Substances|growth substances|mesh-ancestor
14390918|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
14390919|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390920|NCT01349660|Bevacizumab|bevacizumab|mesh-list
14923317|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14923318|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923319|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
14923320|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923321|NCT02578368|Antidotes|antidotes|mesh-ancestor
14923322|NCT02578368|Protective Agents|protective agents|mesh-ancestor
14923323|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
15236802|NCT04370054|Factor VIII|factor viii|mesh-list
15236803|NCT04370054|Coagulants|coagulants|mesh-ancestor
15236804|NCT04360980|Colchicine|colchicine|mesh-list
14390921|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14390922|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390923|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14390924|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14390925|NCT01349660|Growth Substances|growth substances|mesh-ancestor
14390926|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390927|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
14390928|NCT01349673|Budesonide|budesonide|mesh-list
14390929|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14390930|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14390931|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
14753108|NCT05279963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753109|NCT05275400|Insulin|insulin|mesh-list
14753110|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14753111|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390932|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390933|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390934|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14390935|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390936|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
14390937|NCT01349673|Hormones|hormones|mesh-ancestor
14390938|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14390939|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
14390940|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14390941|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
14390942|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390943|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390944|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14390945|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390946|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14390947|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14923324|NCT02578368|Vitamins|vitamins|mesh-ancestor
14923325|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
14923326|NCT02575963|Cytarabine|cytarabine|mesh-list
14923327|NCT02575963|Lintuzumab|lintuzumab|mesh-list
14923328|NCT02575963|Furosemide|furosemide|mesh-list
14923329|NCT02575963|Spironolactone|spironolactone|mesh-list
14923330|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14923331|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
14923332|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923333|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390948|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14390949|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
14390950|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14390951|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923334|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
14923335|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923336|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923337|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
14923338|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923339|NCT02575963|Diuretics|diuretics|mesh-ancestor
14923340|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
14923341|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14923342|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14923343|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14923344|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
14923345|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923346|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14923347|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923348|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14923349|NCT02568553|Lenalidomide|lenalidomide|mesh-list
14923350|NCT02568553|Blinatumomab|blinatumomab|mesh-list
15236805|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
14390952|NCT01349920|Infliximab|infliximab|mesh-list
14390953|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
14390954|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14390955|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14390956|NCT01349972|Cytarabine|cytarabine|mesh-list
14390957|NCT01349972|Daunorubicin|daunorubicin|mesh-list
14390958|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
14390959|NCT01349972|Alvocidib|alvocidib|mesh-list
14390960|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14390961|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
14390962|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390963|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14390964|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
15236806|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15236807|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
15236808|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
15236809|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
15236810|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236811|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236812|NCT04331704|Tenofovir|tenofovir|mesh-list
15236813|NCT04331704|Emtricitabine|emtricitabine|mesh-list
15236814|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
15236815|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236816|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15236817|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15236818|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236819|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236820|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15236821|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15236822|NCT04313075|Leronlimab|leronlimab|mesh-list
15236823|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15236824|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15236825|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236826|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15236827|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15236828|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
15236829|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236830|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
14390965|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390966|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14390967|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
14390968|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390969|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14390970|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14390971|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14390972|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14390973|NCT01349972|Analgesics|analgesics|mesh-ancestor
14390974|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
14390975|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390976|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
14390977|NCT01349972|Growth Substances|growth substances|mesh-ancestor
14390978|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14390979|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
14390980|NCT01350102|Bacitracin|bacitracin|mesh-list
14390981|NCT01350102|Vitamins|vitamins|mesh-ancestor
14390982|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
14390983|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390984|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
14390985|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14390986|NCT01350102|Protective Agents|protective agents|mesh-ancestor
14390987|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14390988|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14390989|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14390990|NCT01350128|Bromides|bromides|mesh-list
14390991|NCT01350128|Ipratropium|ipratropium|mesh-list
14390992|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
14390993|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14390994|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
14390995|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14390996|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14390997|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14390998|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
14390999|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14391000|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
14391001|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391002|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391003|NCT01350141|Bococizumab|bococizumab|mesh-list
14391004|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14391005|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14391006|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
14391007|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391008|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14391009|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
14391010|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
14391011|NCT01350245|Tacrolimus|tacrolimus|mesh-list
14391012|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391013|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
14391014|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391015|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391016|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14391017|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
14466853|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14391018|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391019|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391020|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14391021|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14391022|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391023|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14391024|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14391025|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
14391026|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14391027|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391028|NCT01350271|Mebendazole|mebendazole|mesh-list
14391029|NCT01350271|Piperazine|piperazine|mesh-list
14391030|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
14391031|NCT01350271|DMP 777|dmp 777|mesh-list
14391032|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
14391033|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
14391034|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14391035|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391036|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14391037|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
14391038|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
14391039|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391040|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391041|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391042|NCT01350388|Febuxostat|febuxostat|mesh-list
14391043|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
14391044|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391045|NCT01350804|Abatacept|abatacept|mesh-list
14391046|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14391047|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391048|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391049|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734803|NCT00537472|Bupivacaine|bupivacaine|mesh-list
14734804|NCT00537472|Anesthetics|anesthetics|mesh-list
14734805|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
14734806|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14734807|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391050|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
14391051|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391052|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734808|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
14734809|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14734810|NCT00537524|Vaccines|vaccines|mesh-list
14734811|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
14734812|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734813|NCT00537537|Telbivudine|telbivudine|mesh-list
14391053|NCT01350947|Azacitidine|azacitidine|mesh-list
14391054|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14391055|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
14391056|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391057|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391058|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391059|NCT01351025|Atorvastatin|atorvastatin|mesh-list
14391060|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14391061|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14391062|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
14391063|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391064|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14391065|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14391066|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391067|NCT01351090|Ketorolac|ketorolac|mesh-list
14391068|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14391069|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14391070|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14391071|NCT01351090|Analgesics|analgesics|mesh-ancestor
14391072|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
14391073|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391074|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391075|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391076|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391077|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14391078|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391079|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391080|NCT01351350|Paclitaxel|paclitaxel|mesh-list
14391081|NCT01351350|Trastuzumab|trastuzumab|mesh-list
14391082|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14391083|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391084|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
14391085|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
14391086|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
14391087|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391088|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14391089|NCT01351415|Bevacizumab|bevacizumab|mesh-list
14391090|NCT01351415|Docetaxel|docetaxel|mesh-list
14391091|NCT01351415|Pemetrexed|pemetrexed|mesh-list
14391092|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14391093|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14391094|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391095|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14391096|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14391097|NCT01351415|Growth Substances|growth substances|mesh-ancestor
14391098|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391099|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
14391100|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
14391101|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
14391102|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
14734814|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
14391103|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391104|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391105|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14391106|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14391107|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14391108|NCT01351480|Abatacept|abatacept|mesh-list
14391109|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14391110|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391111|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391112|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391113|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
14391114|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391115|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391116|NCT01351740|Ritonavir|ritonavir|mesh-list
14391117|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14391118|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14391119|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14391120|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
14391121|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391122|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391123|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14391124|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14391125|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
14391126|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391127|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14391128|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391129|NCT01351753|Metformin|metformin|mesh-list
14391130|NCT01351753|Topiramate|topiramate|mesh-list
14734815|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734816|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734817|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734818|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734819|NCT00537550|Methotrexate|methotrexate|mesh-list
14734820|NCT00537550|Vincristine|vincristine|mesh-list
14734821|NCT00537550|Asparaginase|asparaginase|mesh-list
14734822|NCT00537550|Daunorubicin|daunorubicin|mesh-list
14391131|NCT01351753|Orlistat|orlistat|mesh-list
14391132|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14391133|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391134|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
14391135|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391136|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391137|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14391138|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14391139|NCT01351766|Nicotine|nicotine|mesh-list
14391140|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14391141|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
14391142|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391143|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391144|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14391145|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14391146|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
14391147|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391148|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391149|NCT01351805|Vitamin D|vitamin d|mesh-list
14391150|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
14391151|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
14391152|NCT01351805|Vitamins|vitamins|mesh-list
14391153|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
14391154|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391155|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14734823|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14734824|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
14391156|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14391157|NCT01352117|Tenofovir|tenofovir|mesh-list
14391158|NCT01352117|Emtricitabine|emtricitabine|mesh-list
14391159|NCT01352117|Efavirenz|efavirenz|mesh-list
14391160|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14391161|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14391162|NCT01352117|Etoposide|etoposide|mesh-list
14391163|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14391164|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391165|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14734825|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14391166|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14391167|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391168|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391169|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
14391170|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391171|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14391172|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14391173|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14391174|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14391175|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14391176|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391177|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14391178|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14923351|NCT02568553|Antibodies|antibodies|mesh-list
14923352|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
14923353|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14923354|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
14923355|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14923356|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
14923357|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923358|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923359|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15236831|NCT04305795|Cemiplimab|cemiplimab|mesh-list
15236832|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236833|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236834|NCT04305756|Enoxaparin|enoxaparin|mesh-list
15236835|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
15236836|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15236837|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15236838|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236839|NCT04301934|Estradiol|estradiol|mesh-list
15236840|NCT04301934|Estrogens|estrogens|mesh-list
15236841|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15236842|NCT04301934|Hormones|hormones|mesh-ancestor
15236843|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236844|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236845|NCT04296305|Hydromorphone|hydromorphone|mesh-list
15236846|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14923360|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15236847|NCT04296305|Narcotics|narcotics|mesh-ancestor
15236848|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14923361|NCT02568553|Growth Substances|growth substances|mesh-ancestor
14923362|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
14391179|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14391180|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14391181|NCT01352182|Pioglitazone|pioglitazone|mesh-list
14391182|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14391183|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391184|NCT01352221|Ferric maltol|ferric maltol|mesh-list
14391185|NCT01352221|Hematinics|hematinics|mesh-ancestor
14391186|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
14391187|NCT01352507|Tadalafil|tadalafil|mesh-list
14391188|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
14391189|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14391190|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14391191|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391192|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391193|NCT01352507|Urological Agents|urological agents|mesh-ancestor
14391194|NCT01352585|Anagrelide|anagrelide|mesh-list
14391195|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14391196|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14391197|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391198|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14391199|NCT01352637|Cycloserine|cycloserine|mesh-list
14391200|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14391201|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391202|NCT01352637|Renal Agents|renal agents|mesh-ancestor
14391203|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14391204|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
14391205|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14391206|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
14391207|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391208|NCT01352715|Ritonavir|ritonavir|mesh-list
14391209|NCT01352715|Lopinavir|lopinavir|mesh-list
14391210|NCT01352715|Tenofovir|tenofovir|mesh-list
14391211|NCT01352715|Lamivudine|lamivudine|mesh-list
14391212|NCT01352715|Zidovudine|zidovudine|mesh-list
14391213|NCT01352715|Emtricitabine|emtricitabine|mesh-list
14391214|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
14391215|NCT01352715|Abacavir|abacavir|mesh-list
14391216|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14391217|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
14391218|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14391219|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14391220|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
14391221|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391222|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391223|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14391224|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14391225|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
14391226|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391227|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14391228|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391229|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14391230|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14391231|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
14391232|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14923363|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931045|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14931046|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931047|NCT01437293|Carbidopa|carbidopa|mesh-list
14391233|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14391234|NCT01352741|Pregabalin|pregabalin|mesh-list
14391235|NCT01352741|Tapentadol|tapentadol|mesh-list
14931048|NCT01437293|Entacapone|entacapone|mesh-list
14931049|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14931050|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14931051|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
14931052|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931053|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931054|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931055|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14931056|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931057|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14931058|NCT01437306|Lofexidine|lofexidine|mesh-list
14931059|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14931060|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14391236|NCT01352741|Analgesics|analgesics|mesh-ancestor
14391237|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
14391238|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236849|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391239|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391240|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
14391241|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14391242|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391243|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391244|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14391245|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14391246|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14391247|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391248|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391249|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14391250|NCT01352741|Narcotics|narcotics|mesh-ancestor
14391251|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14391252|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391253|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
14391254|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391255|NCT01353144|Aspirin|aspirin|mesh-list
14391256|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14391257|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14391258|NCT01353144|Analgesics|analgesics|mesh-ancestor
14391259|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
14391260|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391261|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391262|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391263|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391264|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14391265|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14391266|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391267|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14391268|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14391269|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391270|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
14391271|NCT01353508|Valsartan|valsartan|mesh-list
14391272|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14391273|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14391274|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15236850|NCT04296305|Analgesics|analgesics|mesh-ancestor
15236851|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
15236852|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391275|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14391276|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391277|NCT01353664|Romidepsin|romidepsin|mesh-list
14391278|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14391279|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391280|NCT01353859|Methotrexate|methotrexate|mesh-list
14391281|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14391282|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
14391283|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14391284|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391285|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14391286|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
14391287|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391288|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236853|NCT04278144|Nivolumab|nivolumab|mesh-list
15236854|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236855|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236856|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15236857|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236858|NCT04233840|Nivolumab|nivolumab|mesh-list
15236859|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236860|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236861|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15236862|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391289|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
14391290|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391291|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14391292|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391293|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
14391294|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391295|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14391296|NCT01353911|Interferons|interferons|mesh-list
14391297|NCT01353911|Ribavirin|ribavirin|mesh-list
14391298|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
14391299|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
14391300|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14391301|NCT01353911|Grazoprevir|grazoprevir|mesh-list
14391302|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391303|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
14391304|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391305|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
14391306|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391307|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
14391308|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391309|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14391310|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14391311|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391312|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391313|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391314|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391315|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391316|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391317|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391318|NCT01353976|Econazole|econazole|mesh-list
14391319|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
14391320|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391321|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14391322|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391323|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391324|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391325|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14391326|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469938|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14469939|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469940|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
14469941|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
14469942|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
14469943|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469944|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14469945|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
14734826|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734827|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14734828|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
14734829|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734830|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734831|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14734832|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236863|NCT04229290|Dolutegravir|dolutegravir|mesh-list
15236864|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15236865|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15236866|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236867|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236868|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15236869|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14391327|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236870|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
15236871|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15236872|NCT04223661|Dexamethasone|dexamethasone|mesh-list
15236873|NCT04223661|Lenalidomide|lenalidomide|mesh-list
15236874|NCT04223661|Daratumumab|daratumumab|mesh-list
15236875|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15236876|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
15236877|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
15236878|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236879|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391328|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391329|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
14391330|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14391331|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
14391332|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391333|NCT01354132|Expectorants|expectorants|mesh-ancestor
14391334|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
14391335|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14391336|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
14391337|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391338|NCT01354132|Protective Agents|protective agents|mesh-ancestor
14391339|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391340|NCT01354132|Antidotes|antidotes|mesh-ancestor
14391341|NCT01354145|Celecoxib|celecoxib|mesh-list
14391342|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14391343|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14391344|NCT01354145|Analgesics|analgesics|mesh-ancestor
14391345|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
14391346|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391347|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391348|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391349|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391350|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14391351|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14391352|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391353|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391354|NCT01354314|Fluconazole|fluconazole|mesh-list
14391355|NCT01354314|Paroxetine|paroxetine|mesh-list
14391356|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14391357|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391358|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391359|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391360|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391361|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
14391362|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391363|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14391364|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391365|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391366|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14391367|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391368|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391369|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
14391370|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391371|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14391372|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14391373|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
14391374|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391375|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14391376|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14391377|NCT01354353|Aripiprazole|aripiprazole|mesh-list
14391378|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391379|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391380|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14391381|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14391382|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391383|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391384|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
14391385|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
14391386|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391387|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391388|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14391389|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14391390|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
14391391|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15236880|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14391392|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14391393|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14391394|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14391395|NCT01354444|Carvedilol|carvedilol|mesh-list
14391396|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14391397|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14391398|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14391399|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391400|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391401|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391402|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14391403|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
14391404|NCT01354444|Protective Agents|protective agents|mesh-ancestor
14391405|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14391406|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391407|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14391408|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
14391409|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14391410|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14391411|NCT01354652|Lamivudine|lamivudine|mesh-list
14391412|NCT01354652|Entecavir|entecavir|mesh-list
14391413|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14391414|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14391415|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923364|NCT02551991|Leucovorin|leucovorin|mesh-list
14923365|NCT02551991|Fluorouracil|fluorouracil|mesh-list
14923366|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
14923367|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
15236881|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
14391416|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391417|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
14391418|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391419|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14391420|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15236882|NCT04223661|Hormones|hormones|mesh-ancestor
15236883|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236884|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15236885|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236886|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
15236887|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15236888|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15236889|NCT04223661|Growth Substances|growth substances|mesh-ancestor
15236890|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
15236891|NCT04218240|Lofexidine|lofexidine|mesh-list
15236892|NCT04218240|Pregabalin|pregabalin|mesh-list
15236893|NCT04218240|Analgesics|analgesics|mesh-ancestor
15236894|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
14391421|NCT01354938|Clarithromycin|clarithromycin|mesh-list
14923368|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236895|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391422|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14391423|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391424|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14391425|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391426|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391427|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14734833|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14734834|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391428|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391429|NCT01354964|Vitamin D|vitamin d|mesh-list
14391430|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
14391431|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
14391432|NCT01354964|Vitamins|vitamins|mesh-list
14391433|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
14391434|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391435|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14391436|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14466854|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14466855|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14466856|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
14466857|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
14466858|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466859|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466860|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
14466861|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14466862|NCT02251717|Ledipasvir|ledipasvir|mesh-list
14466863|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
14734835|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
14391437|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14391438|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14391439|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391440|NCT01354990|Incretins|incretins|mesh-ancestor
14391441|NCT01354990|Hormones|hormones|mesh-ancestor
14391442|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391443|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14391444|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
14391445|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391446|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391447|NCT01355068|Phenytoin|phenytoin|mesh-list
14391448|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
14391449|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14734836|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734837|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734838|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14391450|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14391451|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391452|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391453|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14391454|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14391455|NCT01355081|Vortioxetine|vortioxetine|mesh-list
14391456|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391457|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391458|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14391459|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14391460|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391461|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391462|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14391463|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391464|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391465|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391466|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391467|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
14391468|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14391469|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14391470|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14391471|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14391472|NCT01355159|Folic Acid|folic acid|mesh-list
14391473|NCT01355159|Hematinics|hematinics|mesh-ancestor
14391474|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
14391475|NCT01355159|Vitamins|vitamins|mesh-ancestor
14391476|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
14391477|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391478|NCT01355289|Interferons|interferons|mesh-list
14391479|NCT01355289|Ribavirin|ribavirin|mesh-list
14391480|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391481|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
14391482|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391483|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
14391484|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391485|NCT01355302|Capecitabine|capecitabine|mesh-list
14391486|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391487|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14391488|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
14391489|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391490|NCT01355523|Melatonin|melatonin|mesh-list
14391491|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
14391492|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391493|NCT01355523|Protective Agents|protective agents|mesh-ancestor
14391494|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391495|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391496|NCT01355575|Rifaximin|rifaximin|mesh-list
14734839|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
14734840|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
14734841|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
14734842|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14391497|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14391498|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391499|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14391500|NCT01355588|Ketorolac|ketorolac|mesh-list
14391501|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14391502|NCT01355588|Lidocaine|lidocaine|mesh-list
14391503|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
14391504|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
14391505|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391506|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391507|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
14391508|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391509|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14391510|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14734843|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14734844|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14734845|NCT00537563|Telithromycin|telithromycin|mesh-list
14734846|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734847|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923369|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14391511|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14391512|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391513|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391514|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14391515|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14391516|NCT01355588|Analgesics|analgesics|mesh-ancestor
14391517|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391518|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391519|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14391520|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391521|NCT01355705|Aspirin|aspirin|mesh-list
14391522|NCT01355705|Dexamethasone|dexamethasone|mesh-list
14391523|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
14391524|NCT01355705|Lenalidomide|lenalidomide|mesh-list
14391525|NCT01355705|Amrubicin|amrubicin|mesh-list
14391526|NCT01355705|BB 1101|bb 1101|mesh-list
14391527|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391528|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
14391529|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
14391530|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391531|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391532|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14391533|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
14391534|NCT01355705|Hormones|hormones|mesh-ancestor
14391535|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391536|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14391537|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391538|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
14391539|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391540|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391541|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14734848|NCT00537602|Miglustat|miglustat|mesh-list
14734849|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734850|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734851|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14734852|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14734853|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
14734854|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734855|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14734856|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14753112|NCT05267626|Aldesleukin|aldesleukin|mesh-list
14391542|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14391543|NCT01355705|Analgesics|analgesics|mesh-ancestor
14391544|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
14391545|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391546|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14391547|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14391548|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14391549|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14391550|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
14391551|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
14391552|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14391553|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14391554|NCT01355705|Growth Substances|growth substances|mesh-ancestor
14391555|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
14391556|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
14391557|NCT01356407|Cathartics|cathartics|mesh-ancestor
14391558|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14391559|NCT01356602|Triamcinolone|triamcinolone|mesh-list
14391560|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14391561|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14391562|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14391563|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14391564|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391565|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
14391566|NCT01356602|Hormones|hormones|mesh-ancestor
14391567|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391568|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391569|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391570|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
14391571|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391572|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391573|NCT01356628|Palbociclib|palbociclib|mesh-list
14391574|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391575|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14391576|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391577|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391578|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
14391579|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14391580|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391581|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391582|NCT01356966|Folic Acid|folic acid|mesh-list
14391583|NCT01356966|Hematinics|hematinics|mesh-ancestor
14391584|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
14391585|NCT01356966|Vitamins|vitamins|mesh-ancestor
14391586|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
14391587|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391588|NCT01357135|Metformin|metformin|mesh-list
14391589|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14391590|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14391591|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391592|NCT01357135|Incretins|incretins|mesh-ancestor
14391593|NCT01357135|Hormones|hormones|mesh-ancestor
14391594|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391595|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14391596|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
14734857|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734858|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14734859|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14734860|NCT00537732|Omeprazole|omeprazole|mesh-list
14734861|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14734862|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14734863|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14734864|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734865|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734866|NCT00537836|Estradiol|estradiol|mesh-list
14734867|NCT00537836|Estrogens|estrogens|mesh-ancestor
14734868|NCT00537836|Hormones|hormones|mesh-ancestor
14391597|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391598|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391599|NCT01357148|Metformin|metformin|mesh-list
14391600|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14391601|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14391602|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391603|NCT01357148|Incretins|incretins|mesh-ancestor
14391604|NCT01357148|Hormones|hormones|mesh-ancestor
14391605|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391606|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14391607|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
14391608|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391609|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391610|NCT01357161|Paclitaxel|paclitaxel|mesh-list
14391611|NCT01357161|Carboplatin|carboplatin|mesh-list
14391612|NCT01357161|Adavosertib|adavosertib|mesh-list
14391613|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14391614|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391615|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
14391616|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
14391617|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
14391618|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391619|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391620|NCT01357616|Timolol|timolol|mesh-list
14391621|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14391622|NCT01357616|Brinzolamide|brinzolamide|mesh-list
14391623|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14391624|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14391625|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14391626|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
14391627|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391628|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391629|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391630|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14391631|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14923370|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923371|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923372|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
14923373|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923374|NCT02551991|Antidotes|antidotes|mesh-ancestor
14923375|NCT02551991|Protective Agents|protective agents|mesh-ancestor
14923376|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
14923377|NCT02551991|Vitamins|vitamins|mesh-ancestor
14923378|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
14923379|NCT02539225|Paclitaxel|paclitaxel|mesh-list
14391632|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14391633|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391634|NCT01357655|Dasatinib|dasatinib|mesh-list
14391635|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391636|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14391637|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391638|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391639|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
14734869|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923380|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
14923381|NCT02539225|Ramucirumab|ramucirumab|mesh-list
14391640|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14923382|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14734870|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734871|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
14391641|NCT01357889|Incretins|incretins|mesh-ancestor
14391642|NCT01357889|Hormones|hormones|mesh-ancestor
14391643|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391644|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391645|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
14391646|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14391647|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14391648|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14391649|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391650|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391651|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
14391652|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391653|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391654|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14391655|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391656|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14391657|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
14391658|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391659|NCT01358266|Sirolimus|sirolimus|mesh-list
14391660|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14391661|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391662|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14391663|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391664|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
14391665|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391666|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
14391667|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391668|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14391669|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14391670|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14391671|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391672|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391673|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391674|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14391675|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14391676|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14391677|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
14391678|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236896|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236897|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
15236898|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15236899|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15236900|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391679|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391680|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14391681|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14391682|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
14391683|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14391684|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14391685|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
14391686|NCT01358526|Oxycodone|oxycodone|mesh-list
14391687|NCT01358526|Naloxone|naloxone|mesh-list
14391688|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14391689|NCT01358526|Narcotics|narcotics|mesh-ancestor
14391690|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391691|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391692|NCT01358526|Analgesics|analgesics|mesh-ancestor
14391693|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
14391694|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391695|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14391696|NCT01358578|Etanercept|etanercept|mesh-list
14391697|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14391698|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14391699|NCT01358578|Analgesics|analgesics|mesh-ancestor
14391700|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
14391701|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391702|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391703|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14734872|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14734873|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391704|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391705|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14391706|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391707|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
14391708|NCT01358721|Nivolumab|nivolumab|mesh-list
14391709|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14391710|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391711|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14391712|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391713|NCT01358734|Lenalidomide|lenalidomide|mesh-list
14391714|NCT01358734|Azacitidine|azacitidine|mesh-list
14923383|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923384|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923385|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923386|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14391715|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
14391716|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391717|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14391718|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14391719|NCT01358734|Growth Substances|growth substances|mesh-ancestor
14391720|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14391721|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391722|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14391723|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
14391724|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391725|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391726|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14391727|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14391728|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
14391729|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391730|NCT01358864|Interferons|interferons|mesh-list
14391731|NCT01358864|Ribavirin|ribavirin|mesh-list
14391732|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
14391733|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391734|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
14391735|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391736|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
14391737|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391738|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
14391739|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391740|NCT01358968|Gemcitabine|gemcitabine|mesh-list
14391741|NCT01358968|Pemetrexed|pemetrexed|mesh-list
14391742|NCT01358968|Desipramine|desipramine|mesh-list
14391743|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14391744|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
14391745|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391746|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923387|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391747|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
14391748|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391749|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391750|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391751|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
14391752|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391753|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14391754|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14923388|NCT02535650|Tipifarnib|tipifarnib|mesh-list
14391755|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14391756|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391757|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391758|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14391759|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391760|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391761|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
14391762|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391763|NCT01359007|Leucovorin|leucovorin|mesh-list
14391764|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
14391765|NCT01359007|Irinotecan|irinotecan|mesh-list
14391766|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391767|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14391768|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14391769|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391770|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391771|NCT01359007|Antidotes|antidotes|mesh-ancestor
14391772|NCT01359007|Protective Agents|protective agents|mesh-ancestor
14391773|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391774|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
14391775|NCT01359007|Vitamins|vitamins|mesh-ancestor
14391776|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
14391777|NCT01359150|Tofacitinib|tofacitinib|mesh-list
14391778|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14391779|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391780|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391781|NCT01359592|Prednisone|prednisone|mesh-list
14391782|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
14391783|NCT01359592|Rituximab|rituximab|mesh-list
14391784|NCT01359592|Doxorubicin|doxorubicin|mesh-list
14391785|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14391786|NCT01359592|Vincristine|vincristine|mesh-list
14391787|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14391788|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14391789|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
14391790|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391791|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14391792|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14391793|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
14391794|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391795|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391796|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14391797|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14391798|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14391799|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14391800|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14391801|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391802|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391803|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
14391804|NCT01359592|Hormones|hormones|mesh-ancestor
14391805|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391806|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14391807|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14391808|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
14391809|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
14391810|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
14391811|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14391812|NCT01359644|Ribavirin|ribavirin|mesh-list
14391813|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
14391814|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
14391815|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391816|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
14391817|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391818|NCT01359735|Bacitracin|bacitracin|mesh-list
14391819|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14391820|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391821|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14391822|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
14391823|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14391824|NCT01359956|Interferons|interferons|mesh-list
14391825|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
14391826|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
14391827|NCT01359956|Dacarbazine|dacarbazine|mesh-list
14391828|NCT01359956|Fotemustine|fotemustine|mesh-list
14391829|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391830|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
14391831|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391832|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
14391833|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391834|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14391835|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
14391836|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391837|NCT01360021|Budesonide|budesonide|mesh-list
14391838|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14391839|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391840|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14391841|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
14391842|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391843|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391844|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14391845|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
14734874|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14734875|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
14734876|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734877|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734878|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734879|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236901|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15236902|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14391846|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
14391847|NCT01360021|Hormones|hormones|mesh-ancestor
14391848|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14391849|NCT01360450|Clonidine|clonidine|mesh-list
14391850|NCT01360450|Analgesics|analgesics|mesh-ancestor
14391851|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
14391852|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391853|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391854|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14391855|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
14391856|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
14391857|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14391858|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14391859|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14391860|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
14391861|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391862|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391863|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14391864|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391865|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14391866|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391867|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391868|NCT01360762|Pentamidine|pentamidine|mesh-list
14391869|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
14391870|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391871|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14391872|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14391873|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14391874|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14391875|NCT01360866|Citalopram|citalopram|mesh-list
14391876|NCT01360866|Fluoxetine|fluoxetine|mesh-list
14391877|NCT01360866|Paroxetine|paroxetine|mesh-list
14391878|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14391879|NCT01360866|Sertraline|sertraline|mesh-list
14391880|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14391881|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391882|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391883|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391884|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391885|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
14391886|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391887|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14391888|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391889|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391890|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391891|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14391892|NCT01360866|Analgesics|analgesics|mesh-ancestor
14391893|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
14391894|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
14391895|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14469946|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
14734880|NCT00537888|Fluconazole|fluconazole|mesh-list
14391896|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391897|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391898|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
14391899|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
14391900|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14391901|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391902|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14391903|NCT01361009|Pramipexole|pramipexole|mesh-list
14391904|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
14391905|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391906|NCT01361009|Protective Agents|protective agents|mesh-ancestor
14391907|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391908|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14391909|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14391910|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
14391911|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
14391912|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734881|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
14734882|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734883|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14734884|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14734885|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734886|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734887|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14391913|NCT01361048|Metronidazole|metronidazole|mesh-list
14391914|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14391915|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14391916|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14391917|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14391918|NCT01361217|Midazolam|midazolam|mesh-list
14391919|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
14391920|NCT01361217|Caffeine|caffeine|mesh-list
14391921|NCT01361217|Fluoxetine|fluoxetine|mesh-list
14391922|NCT01361217|Omeprazole|omeprazole|mesh-list
14391923|NCT01361217|Lovastatin|lovastatin|mesh-list
14923389|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923390|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
14391924|NCT01361217|L 647318|l 647318|mesh-list
14391925|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
14391926|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14923391|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14391927|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14391928|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14391929|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391930|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14391931|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14391932|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391933|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14391934|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
14391935|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
14391936|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
14391937|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
14391938|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391939|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391940|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14391941|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14391942|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14391943|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391944|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14391945|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14391946|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14391947|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14391948|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
14391949|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14391950|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391951|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391952|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
14391953|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14391954|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391955|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14391956|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391957|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
14391958|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
14391959|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14391960|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14391961|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14391962|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14391963|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
14391964|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14391965|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14391966|NCT01361308|Paroxetine|paroxetine|mesh-list
14391967|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14391968|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14391969|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14391970|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14391971|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14391972|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
14391973|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391974|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14391975|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
14391976|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14391977|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14391978|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14391979|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14391980|NCT01361464|Tipifarnib|tipifarnib|mesh-list
14391981|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14391982|NCT01361594|Insulin|insulin|mesh-list
14391983|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14391984|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14391985|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391986|NCT01361607|Nabiximols|nabiximols|mesh-list
14391987|NCT01361607|Analgesics|analgesics|mesh-ancestor
14391988|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
14391989|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391990|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391991|NCT01361620|Aspirin|aspirin|mesh-list
14391992|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14391993|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14391994|NCT01361620|Analgesics|analgesics|mesh-ancestor
14391995|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
14391996|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14391997|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14391998|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14391999|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392000|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14392001|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14392002|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392003|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14392004|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14392005|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392006|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
14392007|NCT01361633|Cycloserine|cycloserine|mesh-list
14392008|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14392009|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392010|NCT01361633|Renal Agents|renal agents|mesh-ancestor
14392011|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14392012|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
14392013|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14392014|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
14392015|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392016|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14392017|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
14392018|NCT01361711|Ofatumumab|ofatumumab|mesh-list
14392019|NCT01361711|Antibodies|antibodies|mesh-list
14392020|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
14392021|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14392022|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
14392023|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392024|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466864|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466865|NCT02251912|Oxytocin|oxytocin|mesh-list
14466866|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
14466867|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14466868|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466869|NCT02251938|Sirolimus|sirolimus|mesh-list
14466870|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14466871|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466872|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14466873|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466874|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
14466875|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466876|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
14466877|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466878|NCT02251990|Grazoprevir|grazoprevir|mesh-list
14466879|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
14466880|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466881|NCT02252016|Grazoprevir|grazoprevir|mesh-list
14466882|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
14466883|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466884|NCT02252042|Docetaxel|docetaxel|mesh-list
14466885|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
14466886|NCT02252042|Methotrexate|methotrexate|mesh-list
14466887|NCT02252042|Cetuximab|cetuximab|mesh-list
14466888|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466889|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14392025|NCT01362127|Cisplatin|cisplatin|mesh-list
14392026|NCT01362127|Carboplatin|carboplatin|mesh-list
14392027|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
14392028|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392029|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
14392030|NCT01362140|Hematinics|hematinics|mesh-ancestor
14392031|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
14392032|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14392033|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14392034|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392035|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
14392036|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392037|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
14392038|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14392039|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392040|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392041|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392042|NCT01362205|Analgesics|analgesics|mesh-ancestor
14392043|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
14392044|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392045|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14392046|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14392047|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14392048|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
14734888|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
14734889|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236903|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15236904|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236905|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236906|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15236907|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15236908|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15236909|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15236910|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15236911|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14392049|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392050|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392051|NCT01362296|Docetaxel|docetaxel|mesh-list
14392052|NCT01362296|Trametinib|trametinib|mesh-list
14392053|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392054|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
14392055|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
14392056|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
14392057|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392058|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14392059|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392060|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14392061|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14392062|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14392063|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14392064|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392065|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392066|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392067|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14392068|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14392069|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14392070|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
14392071|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392072|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392073|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14392074|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14392075|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
14392076|NCT01362491|Ibuprofen|ibuprofen|mesh-list
14392077|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392078|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392079|NCT01362491|Analgesics|analgesics|mesh-ancestor
14392080|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
14392081|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392082|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392083|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392084|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392085|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14392086|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392087|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392088|NCT01362530|Ondansetron|ondansetron|mesh-list
14392089|NCT01362530|Aprepitant|aprepitant|mesh-list
14392090|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
14392091|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
14392092|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
14392093|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392094|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392095|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14392096|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
14392097|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392098|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14392099|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
14734890|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734891|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15236912|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236913|NCT04207931|Fluocinonide|fluocinonide|mesh-list
15236914|NCT04207931|Triamcinolone|triamcinolone|mesh-list
14392100|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392101|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392102|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14392103|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392104|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392105|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14392106|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14392107|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14392108|NCT01362608|Triamcinolone|triamcinolone|mesh-list
14392109|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15236915|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15236916|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15236917|NCT04207931|Betamethasone|betamethasone|mesh-list
15236918|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
15236919|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15236920|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
14392110|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14392111|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15236921|NCT04207931|Clobetasol|clobetasol|mesh-list
15236922|NCT04207931|Minoxidil|minoxidil|mesh-list
15236923|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14392112|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392113|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
14392114|NCT01362608|Hormones|hormones|mesh-ancestor
14392115|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392116|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392117|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392118|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
14392119|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392120|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392121|NCT01362686|Rivastigmine|rivastigmine|mesh-list
14392122|NCT01362686|Donepezil|donepezil|mesh-list
14392123|NCT01362686|Galantamine|galantamine|mesh-list
14392124|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14392125|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392126|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392127|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
14392128|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392129|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392130|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
14734892|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14734893|NCT00537901|Bevacizumab|bevacizumab|mesh-list
14734894|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734895|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734896|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734897|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734898|NCT00537901|Growth Substances|growth substances|mesh-ancestor
14734899|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734900|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734901|NCT00537953|Miltefosine|miltefosine|mesh-list
14392131|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14392132|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
14392133|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392134|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14392135|NCT01362686|Protective Agents|protective agents|mesh-ancestor
14392136|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
14392137|NCT01362790|Pentostatin|pentostatin|mesh-list
14392138|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14392139|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392140|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
14392141|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392142|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392143|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14392144|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
14392145|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392146|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392147|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14392148|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14392149|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392150|NCT01362959|Nicotine|nicotine|mesh-list
14392151|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14392152|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
14392153|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392154|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392155|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14392156|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14392157|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
14392158|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734902|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14734903|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
14734904|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734905|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734906|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14734907|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14734908|NCT00537966|Ritonavir|ritonavir|mesh-list
14734909|NCT00537966|Darunavir|darunavir|mesh-list
14734910|NCT00537966|Tenofovir|tenofovir|mesh-list
14734911|NCT00537966|Lamivudine|lamivudine|mesh-list
14392159|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734912|NCT00537966|Emtricitabine|emtricitabine|mesh-list
14392160|NCT01363011|Darunavir|darunavir|mesh-list
14392161|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14392162|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14392163|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14392164|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
14392165|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392166|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392167|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14392168|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14392169|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
14392170|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392171|NCT01363050|Ketorolac|ketorolac|mesh-list
14392172|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14392173|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392174|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392175|NCT01363050|Analgesics|analgesics|mesh-ancestor
14392176|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
14392177|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392178|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392179|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392180|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392181|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14392182|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392183|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392184|NCT01363076|Ketorolac|ketorolac|mesh-list
14392185|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14392186|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392187|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392188|NCT01363076|Analgesics|analgesics|mesh-ancestor
14392189|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
14392190|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392191|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392192|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392193|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392194|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14392195|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392196|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392197|NCT01363128|Cytarabine|cytarabine|mesh-list
14392198|NCT01363128|Dexamethasone|dexamethasone|mesh-list
14392199|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
14392200|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
14392201|NCT01363128|Doxorubicin|doxorubicin|mesh-list
14392202|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14392203|NCT01363128|Methotrexate|methotrexate|mesh-list
14392204|NCT01363128|Vincristine|vincristine|mesh-list
14392205|NCT01363128|Ofatumumab|ofatumumab|mesh-list
14392206|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14392207|NCT01363128|BB 1101|bb 1101|mesh-list
14392208|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392209|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
14392210|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392211|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392212|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14392213|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
14392214|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392215|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392216|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14392217|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392218|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
14392219|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
14392220|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392221|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14392222|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
14392223|NCT01363128|Hormones|hormones|mesh-ancestor
14392224|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392225|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14392226|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14392227|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14392228|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14392229|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392230|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14392231|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
14392232|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14392233|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14392234|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
14392235|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392236|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14392237|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14392238|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
14392239|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392240|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14392241|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14392242|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14392243|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
14392244|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
14392245|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14392246|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14392247|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392248|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14392249|NCT01363349|Risperidone|risperidone|mesh-list
14392250|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14392251|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
14392252|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392253|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392254|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392255|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14392256|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392257|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392258|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14392259|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14392260|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
14392261|NCT01363440|Aflibercept|aflibercept|mesh-list
14392262|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14392263|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14392264|NCT01363440|Growth Substances|growth substances|mesh-ancestor
14392265|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392266|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
14392267|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392268|NCT01363479|Dexamethasone|dexamethasone|mesh-list
14392269|NCT01363479|Palonosetron|palonosetron|mesh-list
14392270|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392271|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
14392272|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
14392273|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392274|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392275|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14392276|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
14392277|NCT01363479|Hormones|hormones|mesh-ancestor
14392278|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392279|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14392280|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392281|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14392282|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14392283|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
14392284|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392285|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392286|NCT01363661|Molsidomine|molsidomine|mesh-list
14392287|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
14392288|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14392289|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392290|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14392291|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14392292|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14392293|NCT01363700|Epinastine|epinastine|mesh-list
14392294|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392295|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392296|NCT01363700|Analgesics|analgesics|mesh-ancestor
14392297|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
14392298|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392299|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392300|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392301|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392302|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14392303|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14392304|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14392305|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
14392306|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
14392307|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392308|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392309|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14392310|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14392311|NCT01363843|Leucovorin|leucovorin|mesh-list
14392312|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
14392313|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392314|NCT01363843|Antidotes|antidotes|mesh-ancestor
14392315|NCT01363843|Protective Agents|protective agents|mesh-ancestor
14392316|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392317|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
14392318|NCT01363843|Vitamins|vitamins|mesh-ancestor
14392319|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
14392320|NCT01363986|Trastuzumab|trastuzumab|mesh-list
14392321|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14392322|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392323|NCT01363999|Atorvastatin|atorvastatin|mesh-list
14392324|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
14392325|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14392326|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14392327|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
14392328|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392329|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14392330|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14392331|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392332|NCT01364090|Interferons|interferons|mesh-list
14392333|NCT01364090|Ribavirin|ribavirin|mesh-list
14392334|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
14392335|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
14392336|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14392337|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392338|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
14392339|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392340|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
14392341|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392342|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
14392343|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392344|NCT01364259|Amifostine|amifostine|mesh-list
14392345|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14392346|NCT01364259|Protective Agents|protective agents|mesh-ancestor
14392347|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392348|NCT01364298|Pregabalin|pregabalin|mesh-list
14392349|NCT01364298|Gabapentin|gabapentin|mesh-list
14392350|NCT01364298|Analgesics|analgesics|mesh-ancestor
14392351|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
14392352|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392353|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392354|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
14392355|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14392356|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14392357|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392358|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14392359|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14392360|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392361|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392362|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14392363|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14392364|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14392365|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392366|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
14734913|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
14923392|NCT02527681|Cephalosporins|cephalosporins|mesh-list
14923393|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14923394|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923395|NCT02526017|Nivolumab|nivolumab|mesh-list
14923396|NCT02526017|Sargramostim|sargramostim|mesh-list
14734914|NCT00537966|Abacavir|abacavir|mesh-list
14734915|NCT00537966|Dolutegravir|dolutegravir|mesh-list
14734916|NCT00537966|Cobicistat|cobicistat|mesh-list
14734917|NCT00537966|Rilpivirine|rilpivirine|mesh-list
14734918|NCT00537966|Elvitegravir|elvitegravir|mesh-list
14734919|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14734920|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14734921|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
15236924|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15236925|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923397|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923398|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923399|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14923400|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236926|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
15236927|NCT04207931|Hormones|hormones|mesh-ancestor
14734922|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734923|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734924|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14734925|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14734926|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
14734927|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734928|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14734929|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14734930|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14734931|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14734932|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14734933|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14734934|NCT00538005|Bevacizumab|bevacizumab|mesh-list
14734935|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
14923401|NCT02526017|Immunologic Factors|immunologic factors|mesh-ancestor
14923402|NCT02526017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236928|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236929|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236930|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236931|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
15236932|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236933|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236934|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15236935|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
14923403|NCT02520362|Denosumab|denosumab|mesh-list
14923404|NCT02520362|Diphosphonates|diphosphonates|mesh-list
14923405|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14923406|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923407|NCT02516657|Liraglutide|liraglutide|mesh-list
14392367|NCT01364389|Prednisone|prednisone|mesh-list
14392368|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392369|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
14392370|NCT01364389|Hormones|hormones|mesh-ancestor
14392371|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392372|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392373|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14392374|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392375|NCT01364428|Insulin|insulin|mesh-list
14392376|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14392377|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
14392378|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392379|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392380|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
14392381|NCT01364467|Guaifenesin|guaifenesin|mesh-list
14392382|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14392383|NCT01364467|Expectorants|expectorants|mesh-ancestor
14392384|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
14392385|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14392386|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14392387|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
14392388|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392389|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392390|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392391|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
14392392|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14392393|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
14392394|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
14392395|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392396|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
14392397|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14392398|NCT01364558|Diazepam|diazepam|mesh-list
14392399|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14392400|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
14392401|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
14392402|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
14392403|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392404|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392405|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14392406|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14392407|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392408|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14392409|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14392410|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14392411|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392412|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14923408|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392413|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14923409|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392414|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
14392415|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
14392416|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
14392417|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
14392418|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392419|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392420|NCT01364584|Exenatide|exenatide|mesh-list
14392421|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392422|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392423|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14392424|NCT01364584|Incretins|incretins|mesh-ancestor
14392425|NCT01364584|Hormones|hormones|mesh-ancestor
14392426|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392427|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
14392428|NCT01364623|Testosterone|testosterone|mesh-list
14392429|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
14392430|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
14392431|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14392432|NCT01364623|Androgens|androgens|mesh-ancestor
14392433|NCT01364623|Hormones|hormones|mesh-ancestor
14392434|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392435|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392436|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14392437|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392438|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
14392439|NCT01364649|Vortioxetine|vortioxetine|mesh-list
14392440|NCT01364649|Citalopram|citalopram|mesh-list
14392441|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14392442|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14392443|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14392444|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392445|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392446|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
14392447|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392448|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14392449|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
14392450|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14392451|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14923410|NCT02516657|Incretins|incretins|mesh-ancestor
14923411|NCT02516657|Hormones|hormones|mesh-ancestor
14923412|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923413|NCT02500849|Busulfan|busulfan|mesh-list
14923414|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
14923415|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923416|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923417|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
14923418|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923419|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14923420|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923421|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14923422|NCT02482233|Nicotine|nicotine|mesh-list
14923423|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14923424|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
14923425|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923426|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923427|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14923428|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14923429|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
14392452|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392453|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392454|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14392455|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14392456|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14392457|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14392458|NCT01364727|Amrubicin|amrubicin|mesh-list
14392459|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392460|NCT01364922|Acetaminophen|acetaminophen|mesh-list
14392461|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14392462|NCT01364922|Hydrocodone|hydrocodone|mesh-list
14392463|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392464|NCT01364922|Analgesics|analgesics|mesh-ancestor
14392465|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
14392466|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923430|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931061|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392467|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392468|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
14392469|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14392470|NCT01364922|Narcotics|narcotics|mesh-ancestor
14734936|NCT00538005|Sorafenib|sorafenib|mesh-list
14734937|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14734938|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734939|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14734940|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14734941|NCT00538005|Growth Substances|growth substances|mesh-ancestor
14734942|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734943|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
14734944|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14392471|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392472|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
14392473|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
14392474|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392475|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392476|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923431|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392477|NCT01365052|Naproxen|naproxen|mesh-list
14392478|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392479|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392480|NCT01365052|Analgesics|analgesics|mesh-ancestor
14392481|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
14392482|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392483|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392484|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392485|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392486|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
14392487|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14392488|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392489|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392490|NCT01365091|Metformin|metformin|mesh-list
14392491|NCT01365091|Saxagliptin|saxagliptin|mesh-list
14392492|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392493|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392494|NCT01365091|Incretins|incretins|mesh-ancestor
14392495|NCT01365091|Hormones|hormones|mesh-ancestor
14392496|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392497|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14392498|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14392499|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392500|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392501|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14392502|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
14923432|NCT02454855|Melatonin|melatonin|mesh-list
14923433|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
14923434|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923435|NCT02454855|Protective Agents|protective agents|mesh-ancestor
14923436|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392503|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392504|NCT01365468|Everolimus|everolimus|mesh-list
14392505|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734945|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923437|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14923438|NCT02450331|Atezolizumab|atezolizumab|mesh-list
14923439|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392506|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392507|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
14392508|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392509|NCT01365481|Amlodipine|amlodipine|mesh-list
14392510|NCT01365481|Valsartan|valsartan|mesh-list
14392511|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14392512|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14392513|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14392514|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14392515|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392516|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14392517|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392518|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
14392519|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14392520|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14392521|NCT01365481|Diuretics|diuretics|mesh-ancestor
14392522|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
14392523|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14392524|NCT01365507|Insulin|insulin|mesh-list
14392525|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
14392526|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392527|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392528|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
14392529|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392530|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
15236936|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15236937|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
15236938|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15236939|NCT04199468|Ketamine|ketamine|mesh-list
15236940|NCT04199468|Dronabinol|dronabinol|mesh-list
15236941|NCT04199468|Analgesics|analgesics|mesh-ancestor
14392531|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14392532|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14392533|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392534|NCT01365585|Urological Agents|urological agents|mesh-ancestor
14392535|NCT01365611|Fluticasone|fluticasone|mesh-list
14392536|NCT01365611|Xhance|xhance|mesh-list
14392537|NCT01365611|Ketorolac|ketorolac|mesh-list
14392538|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14392539|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392540|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14392541|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
14392542|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392543|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392544|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14392545|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
14392546|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392547|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14392548|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392549|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392550|NCT01365611|Analgesics|analgesics|mesh-ancestor
14392551|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
14392552|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392553|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15236942|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
15236943|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15236944|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236945|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15236946|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15236947|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
14923440|NCT02427620|Cytarabine|cytarabine|mesh-list
14923441|NCT02427620|Dexamethasone|dexamethasone|mesh-list
14923442|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
15236948|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
14392554|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392555|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392556|NCT01365624|Ketorolac|ketorolac|mesh-list
14392557|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14392558|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392559|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392560|NCT01365624|Analgesics|analgesics|mesh-ancestor
14392561|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
14392562|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392563|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392564|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392565|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392566|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14392567|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392568|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392569|NCT01365650|Fluticasone|fluticasone|mesh-list
14392570|NCT01365650|Xhance|xhance|mesh-list
14392571|NCT01365650|Ketorolac|ketorolac|mesh-list
15236949|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15236950|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14392572|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14392573|NCT01365650|Phenylephrine|phenylephrine|mesh-list
14392574|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
14392575|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392576|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14392577|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
14392578|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392579|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392580|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14392581|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
14392582|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392583|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14392584|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392585|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392586|NCT01365650|Analgesics|analgesics|mesh-ancestor
14392587|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
14392588|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392589|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14392590|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392591|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392592|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14392593|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14392594|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
14392595|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392596|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
14392597|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
14734946|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236951|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15236952|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15236953|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236954|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
15236955|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15236956|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15236957|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15236958|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15236959|NCT04199468|Hormones|hormones|mesh-ancestor
15236960|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15236961|NCT04191187|Fludarabine|fludarabine|mesh-list
15236962|NCT04191187|Melphalan|melphalan|mesh-list
14392598|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14392599|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14392600|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
14392601|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14392602|NCT01365650|Protective Agents|protective agents|mesh-ancestor
14392603|NCT01365819|Varenicline|varenicline|mesh-list
14392604|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14392605|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14392606|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
14392607|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392608|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392609|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392610|NCT01366196|Pregabalin|pregabalin|mesh-list
14392611|NCT01366196|Analgesics|analgesics|mesh-ancestor
14392612|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
14392613|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392614|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392615|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
14392616|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14392617|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14392618|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392619|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14392620|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14392621|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392622|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392623|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14392624|NCT01366209|Pirfenidone|pirfenidone|mesh-list
14392625|NCT01366209|Analgesics|analgesics|mesh-ancestor
14392626|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
14392627|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392628|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392629|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392630|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392631|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392632|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392633|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392634|NCT01366534|Vaccines|vaccines|mesh-list
14392635|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
14392636|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392637|NCT01366638|Ribavirin|ribavirin|mesh-list
14392638|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14923443|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
14923444|NCT02427620|Rituximab|rituximab|mesh-list
14923445|NCT02427620|Doxorubicin|doxorubicin|mesh-list
14923446|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14923447|NCT02427620|Methotrexate|methotrexate|mesh-list
14923448|NCT02427620|Vincristine|vincristine|mesh-list
14923449|NCT02427620|Daunorubicin|daunorubicin|mesh-list
14923450|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14923451|NCT02427620|Antibodies|antibodies|mesh-list
14923452|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
14923453|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14392639|NCT01366638|Simeprevir|simeprevir|mesh-list
14392640|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
14466890|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923454|NCT02427620|BB 1101|bb 1101|mesh-list
14923455|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923456|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
14392641|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392642|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
14392643|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392644|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
14392645|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392646|NCT01366885|Vitamin D|vitamin d|mesh-list
14392647|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
14392648|NCT01366885|Vitamins|vitamins|mesh-ancestor
14392649|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
14392650|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392651|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14392652|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14392653|NCT01366976|Acetaminophen|acetaminophen|mesh-list
14392654|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392655|NCT01366976|Analgesics|analgesics|mesh-ancestor
14392656|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
14392657|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392658|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923457|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923458|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923459|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14392659|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
14392660|NCT01367119|Ketamine|ketamine|mesh-list
14392661|NCT01367119|Methohexital|methohexital|mesh-list
14392662|NCT01367119|Analgesics|analgesics|mesh-ancestor
14392663|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
14392664|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392665|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392666|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14923460|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
14923461|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923462|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923463|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14923464|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923465|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
14392667|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14392668|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
14392669|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
14392670|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392671|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14923466|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
14923467|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392672|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14392673|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392674|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392675|NCT01367158|Vaccines|vaccines|mesh-list
14392676|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
14392677|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392678|NCT01367249|Bromfenac|bromfenac|mesh-list
14392679|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14392680|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14392681|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14392682|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392683|NCT01367249|Analgesics|analgesics|mesh-ancestor
14392684|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
14392685|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392686|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392687|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392688|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392689|NCT01367275|Irinotecan|irinotecan|mesh-list
14392690|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14392691|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14392692|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392693|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392694|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392695|NCT01367457|Sirolimus|sirolimus|mesh-list
14392696|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14392697|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392698|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14392699|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392700|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
14392701|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392702|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
14392703|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466891|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14466892|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466893|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14466894|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14466895|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
14466896|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14466897|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466898|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14466899|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
14466900|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14466901|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466902|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14466903|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14466904|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
14466905|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466906|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14466907|NCT02252081|Metformin|metformin|mesh-list
14466908|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14466909|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466910|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14466911|NCT02252354|Relugolix|relugolix|mesh-list
14466912|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
14466913|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
14466914|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466915|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466916|NCT02252406|Ranolazine|ranolazine|mesh-list
14466917|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14466918|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14466919|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466920|NCT02252445|Propofol|propofol|mesh-list
14466921|NCT02252445|Sevoflurane|sevoflurane|mesh-list
14466922|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14466923|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466924|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466925|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14466926|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
14466927|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
14466928|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14466929|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14466930|NCT02252536|Gabapentin|gabapentin|mesh-list
14466931|NCT02252536|Analgesics|analgesics|mesh-ancestor
14466932|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
14466933|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14466934|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466935|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
14466936|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14466937|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14734947|NCT00538018|Telithromycin|telithromycin|mesh-list
14392704|NCT01367834|Hormones|hormones|mesh-list
14392705|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392706|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392707|NCT01367886|Fesoterodine|fesoterodine|mesh-list
14392708|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14392709|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14392710|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
14392711|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392712|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392713|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392714|NCT01367886|Urological Agents|urological agents|mesh-ancestor
14392715|NCT01368081|Metformin|metformin|mesh-list
14392716|NCT01368081|Empagliflozin|empagliflozin|mesh-list
14392717|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392718|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392719|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14392720|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392721|NCT01368263|Letrozole|letrozole|mesh-list
14392722|NCT01368263|Anastrozole|anastrozole|mesh-list
14392723|NCT01368263|Goserelin|goserelin|mesh-list
14392724|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392725|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14392726|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14392727|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392728|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392729|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14392730|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
14392731|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392732|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392733|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14392734|NCT01368276|Molgramostim|molgramostim|mesh-list
14392735|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14392736|NCT01368276|Sargramostim|sargramostim|mesh-list
14392737|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
14392738|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392739|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392740|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14392741|NCT01368432|Citalopram|citalopram|mesh-list
14392742|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14392743|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14392744|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14392745|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392746|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392747|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
14392748|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392749|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14392750|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
14392751|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14392752|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14392753|NCT01368497|Entecavir|entecavir|mesh-list
14392754|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
14392755|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392756|NCT01368536|Amlodipine|amlodipine|mesh-list
14392757|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
14392758|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14392759|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14392760|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14392761|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392762|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14392763|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392764|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
14392765|NCT01368536|Diuretics|diuretics|mesh-ancestor
14392766|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
14392767|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14392768|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
14392769|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14392770|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392771|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
14392772|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392773|NCT01368653|Nicotine|nicotine|mesh-list
14392774|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14392775|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
14392776|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392777|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392778|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14392779|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14392780|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
14392781|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392782|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392783|NCT01368809|Fentanyl|fentanyl|mesh-list
14392784|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14392785|NCT01368809|Narcotics|narcotics|mesh-ancestor
14392786|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392787|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392788|NCT01368809|Analgesics|analgesics|mesh-ancestor
14392789|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
14392790|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392791|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14392792|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14392793|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
14392794|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
14392795|NCT01369069|Insulin|insulin|mesh-list
14392796|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14392797|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392798|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392799|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14392800|NCT01369199|Entecavir|entecavir|mesh-list
14392801|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
14392802|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392803|NCT01369329|Ustekinumab|ustekinumab|mesh-list
14392804|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392805|NCT01369342|Ustekinumab|ustekinumab|mesh-list
14734948|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734949|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734950|NCT00538044|Simvastatin|simvastatin|mesh-list
14734951|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14734952|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14734953|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
14734954|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734955|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14734956|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14923468|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14392806|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392807|NCT01369355|Ustekinumab|ustekinumab|mesh-list
14392808|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392809|NCT01369433|Sirolimus|sirolimus|mesh-list
14392810|NCT01369433|Paclitaxel|paclitaxel|mesh-list
14392811|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14392812|NCT01369433|Capecitabine|capecitabine|mesh-list
14392813|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14392814|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392815|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923469|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
14923470|NCT02427620|Hormones|hormones|mesh-ancestor
14923471|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923472|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14923473|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
14923474|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392816|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
14392817|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
14392818|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392819|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14392820|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
14392821|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14392822|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392823|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14392824|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
14392825|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392826|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
14392827|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392828|NCT01369485|Caffeine|caffeine|mesh-list
14392829|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14392830|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392831|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14392832|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392833|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392834|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14392835|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14392836|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
14392837|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392838|NCT01369615|Oxycodone|oxycodone|mesh-list
14392839|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14392840|NCT01369615|Narcotics|narcotics|mesh-ancestor
14392841|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392842|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392843|NCT01369615|Analgesics|analgesics|mesh-ancestor
14392844|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
14392845|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392846|NCT01369680|Ketamine|ketamine|mesh-list
14392847|NCT01369680|Analgesics|analgesics|mesh-ancestor
14392848|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
14392849|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392850|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392851|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14392852|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14392853|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
14392854|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
14392855|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392856|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14392857|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14392858|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392859|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392860|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
14392861|NCT01369732|Hematinics|hematinics|mesh-ancestor
14392862|NCT01369745|Prednisone|prednisone|mesh-list
14392863|NCT01369745|Prednisolone|prednisolone|mesh-list
14392864|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14392865|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
14392866|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14392867|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
14392868|NCT01369745|Dipyridamole|dipyridamole|mesh-list
14392869|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14392870|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
14392871|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392872|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
14392873|NCT01369745|Hormones|hormones|mesh-ancestor
14392874|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392875|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392876|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14392877|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392878|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
14392879|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
14392880|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392881|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14392882|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14392883|NCT01369745|Protective Agents|protective agents|mesh-ancestor
14392884|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14392885|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392886|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392887|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14392888|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
14392889|NCT01369849|Rituximab|rituximab|mesh-list
14392890|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14392891|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14392892|NCT01369849|Antibodies|antibodies|mesh-list
14392893|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
14392894|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14392895|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
14392896|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392897|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392898|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392899|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14392900|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
14392901|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392902|NCT01369875|Aldesleukin|aldesleukin|mesh-list
14392903|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
14392904|NCT01369875|Fludarabine|fludarabine|mesh-list
14392905|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392906|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
14392907|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392908|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392909|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14392910|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
14392911|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392912|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392913|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14392914|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14392915|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14392916|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
14392917|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14392918|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
14392919|NCT01369888|Fludarabine|fludarabine|mesh-list
14392920|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392921|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
14392922|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392923|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14392924|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14392925|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
14392926|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392927|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392928|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14392929|NCT01370005|Empagliflozin|empagliflozin|mesh-list
14392930|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14392931|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392932|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14392933|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392934|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
14392935|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14392936|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14392937|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392938|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14392939|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14392940|NCT01370213|Interleukin-2|interleukin-2|mesh-list
14392941|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14392942|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392943|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14392944|NCT01370213|Analgesics|analgesics|mesh-ancestor
14392945|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
14392946|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392947|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392948|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
14392949|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14392950|NCT01370265|Adenosine|adenosine|mesh-list
14392951|NCT01370265|Regadenoson|regadenoson|mesh-list
14392952|NCT01370265|Analgesics|analgesics|mesh-ancestor
14392953|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
14392954|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392955|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392956|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14392957|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
14392958|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14392959|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
14392960|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
14392961|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392962|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392963|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14392964|NCT01370356|Varenicline|varenicline|mesh-list
14392965|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14392966|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14392967|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
14392968|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392969|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392970|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392971|NCT01370369|Testosterone|testosterone|mesh-list
14392972|NCT01370369|Androgens|androgens|mesh-ancestor
14392973|NCT01370369|Hormones|hormones|mesh-ancestor
14392974|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392975|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392976|NCT01370408|Dexamethasone|dexamethasone|mesh-list
14392977|NCT01370408|Ondansetron|ondansetron|mesh-list
14392978|NCT01370408|Palonosetron|palonosetron|mesh-list
14392979|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14392980|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
14392981|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
14392982|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14392983|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14392984|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14392985|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
14392986|NCT01370408|Hormones|hormones|mesh-ancestor
14392987|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14392988|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14392989|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14392990|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
14392991|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
14392992|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14392993|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
14392994|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14392995|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14392996|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14392997|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14392998|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14392999|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14393000|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14393001|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14393002|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
14393003|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14734957|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734958|NCT00538070|Glycine|glycine|mesh-list
14734959|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
14734960|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14734961|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734962|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734963|NCT00538096|Blinatumomab|blinatumomab|mesh-list
14734964|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236963|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236964|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236965|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15236966|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
15236967|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236968|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15236969|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
15236970|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15236971|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
15236972|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15236973|NCT04181476|Protective Agents|protective agents|mesh-ancestor
15236974|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393004|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14393005|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393006|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
14393007|NCT01370460|Coagulants|coagulants|mesh-ancestor
14393008|NCT01370499|Serotonin|serotonin|mesh-list
14393009|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14393010|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14393011|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
14393012|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393013|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393014|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393015|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14393016|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14393017|NCT01370525|Esomeprazole|esomeprazole|mesh-list
14393018|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14393019|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14393020|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14393021|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393022|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393023|NCT01370538|Esomeprazole|esomeprazole|mesh-list
14393024|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14393025|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14393026|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14393027|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393028|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393029|NCT01370564|Diuretics|diuretics|mesh-list
14393030|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
14393031|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393032|NCT01370616|Amoxicillin|amoxicillin|mesh-list
15236975|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
15236976|NCT04162015|Carboplatin|carboplatin|mesh-list
15236977|NCT04162015|Nivolumab|nivolumab|mesh-list
15236978|NCT04162015|Pemetrexed|pemetrexed|mesh-list
15236979|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393033|NCT01370616|Tazobactam|tazobactam|mesh-list
14393034|NCT01370616|Piperacillin|piperacillin|mesh-list
14393035|NCT01370616|Ertapenem|ertapenem|mesh-list
14393036|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14734965|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
14734966|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734967|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14734968|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14734969|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734970|NCT00538148|Telithromycin|telithromycin|mesh-list
14734971|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734972|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14734973|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
14734974|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14734975|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14734976|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15236980|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236981|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15236982|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15236983|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15236984|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15236985|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15236986|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
15236987|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
14393037|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393038|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393039|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14393040|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393041|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393042|NCT01370642|Ribavirin|ribavirin|mesh-list
14393043|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
14393044|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393045|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
14393046|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393047|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14393048|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14393049|NCT01370655|Diuretics|diuretics|mesh-ancestor
14393050|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
14393051|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393052|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14393053|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14923475|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14923476|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14923477|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14923478|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14923479|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
14923480|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923481|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14923482|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
14923483|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
14393054|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393055|NCT01370694|Prednisolone|prednisolone|mesh-list
14393056|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
14393057|NCT01370694|Vincristine|vincristine|mesh-list
14393058|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393059|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
14393060|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393061|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14393062|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14393063|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
14393064|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393065|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393066|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14393067|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14393068|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
14393069|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
14393070|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
14393071|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14393072|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
14393073|NCT01370694|Hormones|hormones|mesh-ancestor
14393074|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393075|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393076|NCT01371110|Midazolam|midazolam|mesh-list
14393077|NCT01371110|Ketamine|ketamine|mesh-list
14393078|NCT01371110|Analgesics|analgesics|mesh-ancestor
15236988|NCT04129723|Protective Agents|protective agents|mesh-ancestor
15236989|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236990|NCT04121455|Bevacizumab|bevacizumab|mesh-list
15236991|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
15236992|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15236993|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15236994|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15236995|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15236996|NCT04121455|Growth Substances|growth substances|mesh-ancestor
15236997|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15236998|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
15236999|NCT04111978|Letrozole|letrozole|mesh-list
15237000|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237001|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15237002|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15237003|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237004|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237005|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15237006|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
15237007|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237008|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237009|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
14393079|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
14393080|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393081|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393082|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14393083|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14393084|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
14393085|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
14393086|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14393087|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14393088|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14393089|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393090|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393091|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14393092|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14393093|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14393094|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14393095|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14393096|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
14393097|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
14393098|NCT01371565|Mifepristone|mifepristone|mesh-list
14393099|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14393100|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
14393101|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14393102|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393103|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14393104|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14393105|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14393106|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
14393107|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14393108|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14393109|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
14393110|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393111|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
14393112|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14393113|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14393114|NCT01371643|Octreotide|octreotide|mesh-list
14393115|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14393116|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393117|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393118|NCT01371656|Levofloxacin|levofloxacin|mesh-list
14393119|NCT01371656|Ofloxacin|ofloxacin|mesh-list
14393120|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14393121|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393122|NCT01371656|Renal Agents|renal agents|mesh-ancestor
14393123|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393124|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14393125|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14393126|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393127|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393128|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393129|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14393130|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14393131|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14393132|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14393133|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14393134|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14393135|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393136|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237010|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
14393137|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393138|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
14393139|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14393140|NCT01371747|Losartan|losartan|mesh-list
14393141|NCT01371747|Spironolactone|spironolactone|mesh-list
14393142|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14393143|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14393144|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14393145|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14393146|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923484|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14923485|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14923486|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
14923487|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923488|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923489|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
15237011|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393147|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14393148|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
14393149|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393150|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393151|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14393152|NCT01371747|Diuretics|diuretics|mesh-ancestor
14393153|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
14393154|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
14393155|NCT01371786|Ciclesonide|ciclesonide|mesh-list
14393156|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14393157|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
14393158|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14393159|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
14393160|NCT01371786|Hormones|hormones|mesh-ancestor
14393161|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393162|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393163|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
14393164|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14393165|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393166|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393167|NCT01371851|Doxazosin|doxazosin|mesh-list
14393168|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14393169|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14393170|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14393171|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14393172|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
14393173|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393174|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393175|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393176|NCT01371877|Vitamin D|vitamin d|mesh-list
14393177|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
14393178|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
15237012|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237013|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237014|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
15237015|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
15237016|NCT04066751|Ivacaftor|ivacaftor|mesh-list
14393179|NCT01371877|Vitamins|vitamins|mesh-list
14393180|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
15237017|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15237018|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15237019|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237020|NCT04065789|Dexamethasone|dexamethasone|mesh-list
15237021|NCT04065789|Lenalidomide|lenalidomide|mesh-list
15237022|NCT04065789|Daratumumab|daratumumab|mesh-list
15237023|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237024|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
15237025|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
15237026|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237027|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237028|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237029|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
15237030|NCT04065789|Hormones|hormones|mesh-ancestor
15237031|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237032|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393181|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393182|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14393183|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14393184|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
14393185|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14393186|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14393187|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
14393188|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393189|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393190|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393191|NCT01371994|Urological Agents|urological agents|mesh-ancestor
14393192|NCT01372150|Fluoxetine|fluoxetine|mesh-list
14393193|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14393194|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14393195|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14393196|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14393197|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393198|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393199|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
14393200|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393201|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14393202|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
14393203|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14393204|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14393205|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14393206|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393207|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14393208|NCT01372202|Paclitaxel|paclitaxel|mesh-list
14393209|NCT01372202|Fluorouracil|fluorouracil|mesh-list
14393210|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
14393211|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14393212|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393213|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
14393214|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
14393215|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
14393216|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393217|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
14393218|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14393219|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393220|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
14393221|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393222|NCT01372254|Nicotine|nicotine|mesh-list
14393223|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14393224|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
14393225|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393226|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393227|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14393228|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14393229|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
14393230|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393231|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393232|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14393233|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734977|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734978|NCT00538187|Bortezomib|bortezomib|mesh-list
14734979|NCT00538187|Obatoclax|obatoclax|mesh-list
14734980|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734981|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393234|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14393235|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393236|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393237|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
14393238|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14393239|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
14393240|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393241|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393242|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14393243|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
14393244|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
14393245|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14393246|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
14393247|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393248|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393249|NCT01372995|Vitamin D|vitamin d|mesh-list
14393250|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
14393251|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
14393252|NCT01372995|Vitamins|vitamins|mesh-list
14393253|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
14393254|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393255|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14393256|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14393257|NCT01373164|Gemcitabine|gemcitabine|mesh-list
14393258|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14393259|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
14393260|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393261|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393262|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
14393263|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393264|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393265|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393266|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
14393267|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466938|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14466939|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14466940|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14466941|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14466942|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14466943|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466944|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
14466945|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
14466946|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14734982|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393268|NCT01373229|Plerixafor|plerixafor|mesh-list
14393269|NCT01373229|Rituximab|rituximab|mesh-list
14393270|NCT01373229|Lenalidomide|lenalidomide|mesh-list
14393271|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14393272|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393273|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
14393274|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393275|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14393276|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14393277|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14393278|NCT01373229|Growth Substances|growth substances|mesh-ancestor
14393279|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14393280|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14393281|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14393282|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
14393283|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393284|NCT01373294|Lenalidomide|lenalidomide|mesh-list
14393285|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
14393286|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
14393287|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393288|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14393289|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14393290|NCT01373294|Growth Substances|growth substances|mesh-ancestor
14393291|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
14393292|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393293|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14393294|NCT01373450|Liraglutide|liraglutide|mesh-list
14393295|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14393296|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393297|NCT01373450|Incretins|incretins|mesh-ancestor
14393298|NCT01373450|Hormones|hormones|mesh-ancestor
14393299|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393300|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14393301|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14393302|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14393303|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14734983|NCT00538239|Sirolimus|sirolimus|mesh-list
15237033|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237034|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
14734984|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14734985|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237035|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15237036|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15237037|NCT04065789|Growth Substances|growth substances|mesh-ancestor
15237038|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
15237039|NCT04047953|Paclitaxel|paclitaxel|mesh-list
15237040|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15237041|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
15237042|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237043|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237044|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14393304|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
14393305|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14393306|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393307|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393308|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14393309|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14393310|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393311|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393312|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393313|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14393314|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
14393315|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14393316|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393317|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14393318|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14393319|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14393320|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14734986|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15237045|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
15237046|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237047|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237048|NCT04031599|Hormones|hormones|mesh-list
14393321|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
14734987|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734988|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
14734989|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393322|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14393323|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
14393324|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14393325|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393326|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14393327|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393328|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393329|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
14393330|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14393331|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393332|NCT01374217|Clarithromycin|clarithromycin|mesh-list
14393333|NCT01374217|Dexamethasone|dexamethasone|mesh-list
14393334|NCT01374217|Lenalidomide|lenalidomide|mesh-list
14393335|NCT01374217|Tadalafil|tadalafil|mesh-list
14393336|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14393337|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
14393338|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
14393339|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393340|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393341|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14393342|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
14393343|NCT01374217|Hormones|hormones|mesh-ancestor
14393344|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393345|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393346|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393347|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
14393348|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14393349|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14393350|NCT01374217|Growth Substances|growth substances|mesh-ancestor
14393351|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
14393352|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393353|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393354|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14393355|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393356|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393357|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14393358|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14393359|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
14393360|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14393361|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14393362|NCT01374217|Urological Agents|urological agents|mesh-ancestor
14393363|NCT01374269|Acetaminophen|acetaminophen|mesh-list
14393364|NCT01374269|Celecoxib|celecoxib|mesh-list
14393365|NCT01374269|Naproxen|naproxen|mesh-list
14393366|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14393367|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14923490|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923491|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237049|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393368|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14393369|NCT01374269|Analgesics|analgesics|mesh-ancestor
14393370|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
14393371|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393372|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393373|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
14393374|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14393375|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14393376|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14393377|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393378|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393379|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
14393380|NCT01374425|Leucovorin|leucovorin|mesh-list
14393381|NCT01374425|Bevacizumab|bevacizumab|mesh-list
14393382|NCT01374425|Fluorouracil|fluorouracil|mesh-list
14393383|NCT01374425|Capecitabine|capecitabine|mesh-list
14734990|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
14734991|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734992|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
14393384|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
14393385|NCT01374425|Irinotecan|irinotecan|mesh-list
14393386|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14393387|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393388|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14393389|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14393390|NCT01374425|Growth Substances|growth substances|mesh-ancestor
14393391|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393392|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
14393393|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
14393394|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393395|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14393396|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393397|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
14393398|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14393399|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14393400|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393401|NCT01374425|Antidotes|antidotes|mesh-ancestor
14393402|NCT01374425|Protective Agents|protective agents|mesh-ancestor
14393403|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
14393404|NCT01374425|Vitamins|vitamins|mesh-ancestor
14393405|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
14393406|NCT01374451|Everolimus|everolimus|mesh-list
14393407|NCT01374451|Pasireotide|pasireotide|mesh-list
14393408|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14734993|NCT00538265|Tacrolimus|tacrolimus|mesh-list
14734994|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
14734995|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14734996|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
14734997|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14734998|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14734999|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735000|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735001|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14735002|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735003|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14735004|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
14735005|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14735006|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237050|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237051|NCT04030559|Niraparib|niraparib|mesh-list
15237052|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15237053|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237054|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237055|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237056|NCT04025658|Oxytocin|oxytocin|mesh-list
15237057|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
15237058|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15237059|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237060|NCT04019821|Insulin|insulin|mesh-list
15237061|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15237062|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
15237063|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
14735007|NCT00538317|Tirofiban|tirofiban|mesh-list
14393409|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393410|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
14393411|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393412|NCT01374451|Hormones|hormones|mesh-ancestor
14393413|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393414|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14393415|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14393416|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393417|NCT01374568|Incretins|incretins|mesh-ancestor
14393418|NCT01374568|Hormones|hormones|mesh-ancestor
14393419|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393420|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14393421|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
14393422|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393423|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393424|NCT01374802|Ritonavir|ritonavir|mesh-list
14393425|NCT01374802|Darunavir|darunavir|mesh-list
14393426|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14393427|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14393428|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
14393429|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393430|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393431|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14393432|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14393433|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
14393434|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393435|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14393436|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14393437|NCT01374906|Pasireotide|pasireotide|mesh-list
14393438|NCT01374906|Hormones|hormones|mesh-ancestor
14393439|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393440|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393441|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14393442|NCT01374919|Hematinics|hematinics|mesh-ancestor
14393443|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14393444|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14393445|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
14393446|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393447|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
14393448|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393449|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14393450|NCT01375010|Vitamin D|vitamin d|mesh-list
14393451|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
14393452|NCT01375010|Vitamins|vitamins|mesh-list
14393453|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
14393454|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393455|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14393456|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14393457|NCT01375049|Aztreonam|aztreonam|mesh-list
14393458|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393459|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393460|NCT01375075|Atorvastatin|atorvastatin|mesh-list
14393461|NCT01375075|Evacetrapib|evacetrapib|mesh-list
14393462|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14393463|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14393464|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
14735008|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14393465|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393466|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14393467|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14393468|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393469|NCT01375127|Tofacitinib|tofacitinib|mesh-list
14393470|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14393471|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393472|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393473|NCT01375140|Prednisone|prednisone|mesh-list
14393474|NCT01375140|Lenalidomide|lenalidomide|mesh-list
14393475|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14393476|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
14393477|NCT01375140|Hormones|hormones|mesh-ancestor
14393478|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393479|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393480|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393481|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393482|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
14393483|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14393484|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14393485|NCT01375140|Growth Substances|growth substances|mesh-ancestor
14393486|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
14393487|NCT01375374|Lacosamide|lacosamide|mesh-list
14393488|NCT01375374|Levetiracetam|levetiracetam|mesh-list
14393489|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
14393490|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
14393491|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14393492|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14393493|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14393494|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923492|NCT02427581|Poly I-C|poly i-c|mesh-list
14923493|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14923494|NCT02427581|Poly ICLC|poly iclc|mesh-list
14923495|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
14923496|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
14923497|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393495|NCT01375491|Doxycycline|doxycycline|mesh-list
14393496|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393497|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393498|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
14393499|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14393500|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14393501|NCT01375608|Decitabine|decitabine|mesh-list
14393502|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14393503|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
14393504|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393505|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393506|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393507|NCT01375660|Vitamin D|vitamin d|mesh-list
14393508|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
14393509|NCT01375660|Vitamins|vitamins|mesh-ancestor
14393510|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
14393511|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393512|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14393513|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14393514|NCT01375751|Evolocumab|evolocumab|mesh-list
14393515|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14393516|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14393517|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
14393518|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393519|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14393520|NCT01375764|Ezetimibe|ezetimibe|mesh-list
14393521|NCT01375764|Evolocumab|evolocumab|mesh-list
14393522|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14393523|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14393524|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14393525|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
14393526|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393527|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14393528|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
14393529|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393530|NCT01375777|Ezetimibe|ezetimibe|mesh-list
14393531|NCT01375777|Evolocumab|evolocumab|mesh-list
14923498|NCT02427581|Laxatives|laxatives|mesh-ancestor
14923499|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923500|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
14393532|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14393533|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14393534|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14393535|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
14393536|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393537|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14393538|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
14393539|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393540|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
14393541|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14393542|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393543|NCT01376167|Chloroquine|chloroquine|mesh-list
14393544|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14393545|NCT01376167|Primaquine|primaquine|mesh-list
14393546|NCT01376167|Tafenoquine|tafenoquine|mesh-list
14393547|NCT01376167|Amebicides|amebicides|mesh-ancestor
14393548|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14393549|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14393550|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393551|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
14393552|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14393553|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14393554|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14735009|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14735010|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735011|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14735012|NCT00538330|Tamoxifen|tamoxifen|mesh-list
14735013|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14735014|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
14753113|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393555|NCT01376167|Analgesics|analgesics|mesh-ancestor
14393556|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
14393557|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393558|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393559|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14393560|NCT01376167|Filaricides|filaricides|mesh-ancestor
14393561|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
14393562|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
14393563|NCT01376245|Fluticasone|fluticasone|mesh-list
14393564|NCT01376245|Xhance|xhance|mesh-list
14393565|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14393566|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14393567|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
14393568|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393569|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393570|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14393571|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
14393572|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
14393573|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14393574|NCT01376297|Dexamethasone|dexamethasone|mesh-list
14393575|NCT01376297|Aprepitant|aprepitant|mesh-list
14393576|NCT01376297|Palonosetron|palonosetron|mesh-list
14393577|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14393578|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
14393579|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
14393580|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393581|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393582|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14393583|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
14393584|NCT01376297|Hormones|hormones|mesh-ancestor
14393585|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393586|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393587|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393588|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14393589|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393590|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393591|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14393592|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14393593|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
14923501|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393594|NCT01376310|Gemcitabine|gemcitabine|mesh-list
14393595|NCT01376310|Paclitaxel|paclitaxel|mesh-list
14393596|NCT01376310|Docetaxel|docetaxel|mesh-list
14393597|NCT01376310|Carboplatin|carboplatin|mesh-list
14393598|NCT01376310|Pemetrexed|pemetrexed|mesh-list
14393599|NCT01376310|Everolimus|everolimus|mesh-list
14393600|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14393601|NCT01376310|Trametinib|trametinib|mesh-list
14393602|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14393603|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393604|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14393605|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14393606|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14393607|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393608|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14393609|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
14393610|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
14393611|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393612|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393613|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393614|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
14393615|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237064|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
15237065|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15237066|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237067|NCT04006288|Aspirin|aspirin|mesh-list
14393616|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14393617|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14393618|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14393619|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14393620|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14393621|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
14393622|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393623|NCT01376362|Interferons|interferons|mesh-list
14393624|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
14393625|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393626|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
14393627|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393628|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14466947|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923502|NCT02423525|Afatinib|afatinib|mesh-list
14923503|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923504|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923505|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923506|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923507|NCT02369653|Apixaban|apixaban|mesh-list
14923508|NCT02369653|Anticoagulants|anticoagulants|mesh-list
14923509|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14923510|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
14923511|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14923512|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
14923513|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923514|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923515|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
14923516|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237068|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
15237069|NCT04006288|Clopidogrel|clopidogrel|mesh-list
15237070|NCT04006288|Ticagrelor|ticagrelor|mesh-list
15237071|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15237072|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15237073|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15237074|NCT04006288|Analgesics|analgesics|mesh-ancestor
15237075|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
15237076|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237077|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237078|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237079|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237080|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15237081|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15237082|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237083|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14393629|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14393630|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393631|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14393632|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393633|NCT01376700|Factor VIII|factor viii|mesh-list
14393634|NCT01376700|Coagulants|coagulants|mesh-ancestor
14393635|NCT01376804|Valganciclovir|valganciclovir|mesh-list
14393636|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
14393637|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393638|NCT01377194|Milnacipran|milnacipran|mesh-list
14393639|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
14393640|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14393641|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14393642|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14393643|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393644|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393645|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393646|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
14393647|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14393648|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14393649|NCT01377194|Analgesics|analgesics|mesh-ancestor
14393650|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
14393651|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393652|NCT01377389|Ipilimumab|ipilimumab|mesh-list
14393653|NCT01377389|Leuprolide|leuprolide|mesh-list
14393654|NCT01377389|Goserelin|goserelin|mesh-list
14393655|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14393656|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393657|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14393658|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393659|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14393660|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
14393661|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14393662|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393663|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393664|NCT01377467|Denosumab|denosumab|mesh-list
14923517|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393665|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14393666|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393667|NCT01377480|Posaconazole|posaconazole|mesh-list
14393668|NCT01377480|Benzonidazole|benzonidazole|mesh-list
14393669|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
14393670|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393671|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14393672|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14393673|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14393674|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14393675|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14393676|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393677|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393678|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14393679|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
14393680|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393681|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393682|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393683|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
14393684|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
14393685|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14393686|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14393687|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393688|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14393689|NCT01377623|Analgesics|analgesics|mesh-ancestor
14393690|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
14393691|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393692|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14393693|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14393694|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14393695|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
14393696|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393697|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393698|NCT01377636|Isoproterenol|isoproterenol|mesh-list
14393699|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14393700|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14393701|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
14393702|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393703|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393704|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393705|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14393706|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
14393707|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393708|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14393709|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
14393710|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14393711|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
14393712|NCT01377636|Protective Agents|protective agents|mesh-ancestor
14393713|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
14393714|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14393715|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393716|NCT01377922|Amifampridine|amifampridine|mesh-list
14923518|NCT02326974|Pertuzumab|pertuzumab|mesh-list
14923519|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14393717|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14393718|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393719|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393720|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14393721|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14393722|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393723|NCT01377987|Acetazolamide|acetazolamide|mesh-list
14393724|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
14393725|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14393726|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393727|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393728|NCT01377987|Diuretics|diuretics|mesh-ancestor
14393729|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
14393730|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393731|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14923520|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393732|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
14393733|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
14393734|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393735|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
14393736|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393737|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
14393738|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14393739|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
14393740|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14393741|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393742|NCT01378117|Incretins|incretins|mesh-ancestor
14393743|NCT01378117|Hormones|hormones|mesh-ancestor
14393744|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393745|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14393746|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
14393747|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393748|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393749|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
14393750|NCT01378273|Hematinics|hematinics|mesh-ancestor
14393751|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
14393752|NCT01378299|Testosterone|testosterone|mesh-list
14393753|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
14393754|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
14393755|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14393756|NCT01378299|Androgens|androgens|mesh-ancestor
14393757|NCT01378299|Hormones|hormones|mesh-ancestor
14393758|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393759|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393760|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14393761|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393762|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
14393763|NCT01378325|Phenylephrine|phenylephrine|mesh-list
14393764|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
14393765|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14393766|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
14393767|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
14393768|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393769|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393770|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
14393771|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14393772|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
14393773|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
14393774|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14393775|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14393776|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14393777|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
14393778|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393779|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393780|NCT01378325|Protective Agents|protective agents|mesh-ancestor
14393781|NCT01378377|Niacinamide|niacinamide|mesh-list
14393782|NCT01378377|Sirolimus|sirolimus|mesh-list
14393783|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393784|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393785|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14393786|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393787|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
14393788|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393789|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
14393790|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393791|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
14393792|NCT01378377|Vitamins|vitamins|mesh-ancestor
14393793|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
14393794|NCT01378416|Decitabine|decitabine|mesh-list
14393795|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14393796|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
14393797|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393798|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393799|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393800|NCT01378429|Ciclesonide|ciclesonide|mesh-list
14393801|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
14393802|NCT01378429|Hormones|hormones|mesh-ancestor
14393803|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393804|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393805|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14393806|NCT01378520|Ketoconazole|ketoconazole|mesh-list
14393807|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
14393808|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393809|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14393810|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14393811|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393812|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393813|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14393814|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
14393815|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393816|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393817|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14393818|NCT01378858|Varenicline|varenicline|mesh-list
14393819|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14393820|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14393821|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
14923521|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
14923522|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14923523|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14393822|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393823|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393824|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393825|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14393826|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393827|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14393828|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393829|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393830|NCT01378975|Vemurafenib|vemurafenib|mesh-list
14393831|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393832|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14393833|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393834|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393835|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
14393836|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14393837|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14393838|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393839|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14923524|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923525|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
14923526|NCT02314988|Coagulants|coagulants|mesh-ancestor
15237084|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15237085|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237086|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
15237087|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15237088|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15237089|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15237090|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
14923527|NCT02299999|Gemcitabine|gemcitabine|mesh-list
14923528|NCT02299999|Paclitaxel|paclitaxel|mesh-list
14923529|NCT02299999|Vincristine|vincristine|mesh-list
15237091|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393840|NCT01378988|Analgesics|analgesics|mesh-ancestor
14393841|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
14393842|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393843|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14393844|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14393845|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14393846|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
14393847|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14393848|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393849|NCT01379183|Erythromycin|erythromycin|mesh-list
14393850|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
14393851|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14393852|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
14393853|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393854|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393855|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14393856|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14393857|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393858|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393859|NCT01379508|Tenofovir|tenofovir|mesh-list
14393860|NCT01379508|Telbivudine|telbivudine|mesh-list
14393861|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
14393862|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393863|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14393864|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14393865|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923530|NCT02299999|Vinorelbine|vinorelbine|mesh-list
15237092|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15237093|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
15237094|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15237095|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
15237096|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
15237097|NCT03943667|Gemcitabine|gemcitabine|mesh-list
14923531|NCT02299999|Vinblastine|vinblastine|mesh-list
14923532|NCT02299999|Docetaxel|docetaxel|mesh-list
14923533|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
14923534|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
14923535|NCT02299999|Bevacizumab|bevacizumab|mesh-list
14393866|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393867|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14923536|NCT02299999|Cisplatin|cisplatin|mesh-list
14923537|NCT02299999|Carboplatin|carboplatin|mesh-list
14923538|NCT02299999|Doxorubicin|doxorubicin|mesh-list
14923539|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14923540|NCT02299999|Capecitabine|capecitabine|mesh-list
14923541|NCT02299999|Methotrexate|methotrexate|mesh-list
14923542|NCT02299999|Durvalumab|durvalumab|mesh-list
14923543|NCT02299999|Epirubicin|epirubicin|mesh-list
14923544|NCT02299999|Olaparib|olaparib|mesh-list
14923545|NCT02299999|Mitomycins|mitomycins|mesh-list
14393868|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14393869|NCT01379521|Everolimus|everolimus|mesh-list
14393870|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393871|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393872|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
14393873|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393874|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
14393875|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
14393876|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14393877|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14393878|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393879|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393880|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393881|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14393882|NCT01379664|Sevoflurane|sevoflurane|mesh-list
14393883|NCT01379664|Isoflurane|isoflurane|mesh-list
14393884|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14393885|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14393886|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
14393887|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
14393888|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14393889|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393890|NCT01379937|Vaccines|vaccines|mesh-list
14393891|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
14393892|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393893|NCT01380080|Efavirenz|efavirenz|mesh-list
14923546|NCT02299999|Mitomycin|mitomycin|mesh-list
14923547|NCT02299999|Bicalutamide|bicalutamide|mesh-list
14923548|NCT02299999|Taxane|taxane|mesh-list
14923549|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923550|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923551|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923552|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923553|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
14923554|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923555|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923556|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
14923557|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923558|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923559|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14923560|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
14923561|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14923562|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923563|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923564|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923565|NCT02299999|Growth Substances|growth substances|mesh-ancestor
14466948|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
14923566|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923567|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14393894|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14393895|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14393896|NCT01380080|Rifampin|rifampin|mesh-list
14393897|NCT01380080|Isoniazid|isoniazid|mesh-list
14393898|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
14393899|NCT01380080|Ethambutol|ethambutol|mesh-list
14393900|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
14393901|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14923568|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
14393902|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14393903|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393904|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393905|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
14393906|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393907|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14393908|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14393909|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14393910|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14393911|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14923569|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
14923570|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923571|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393912|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14393913|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14393914|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14393915|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14393916|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
14393917|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393918|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
14923572|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14923573|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14923574|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14393919|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14393920|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14923575|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14923576|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
14923577|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923578|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
14923579|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14923580|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14393921|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14393922|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14393923|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14393924|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
14393925|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14393926|NCT01380093|Naltrexone|naltrexone|mesh-list
14393927|NCT01380093|Morphine|morphine|mesh-list
14393928|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14393929|NCT01380093|Narcotics|narcotics|mesh-ancestor
14393930|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14393931|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393932|NCT01380093|Analgesics|analgesics|mesh-ancestor
14393933|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
14393934|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393935|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14393936|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14393937|NCT01380106|Lenalidomide|lenalidomide|mesh-list
14393938|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
14393939|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393940|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14393941|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14393942|NCT01380106|Growth Substances|growth substances|mesh-ancestor
14393943|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
14393944|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466949|NCT02252965|Metformin|metformin|mesh-list
14466950|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14466951|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466952|NCT02253160|Sargramostim|sargramostim|mesh-list
14466953|NCT02253160|Lenograstim|lenograstim|mesh-list
14466954|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
14466955|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466956|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14466957|NCT02253173|Estradiol|estradiol|mesh-list
14466958|NCT02253173|Estrogens|estrogens|mesh-ancestor
14466959|NCT02253173|Hormones|hormones|mesh-ancestor
14466960|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466961|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237098|NCT03943667|Paclitaxel|paclitaxel|mesh-list
15237099|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237100|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237101|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923581|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14923582|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
14923583|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
14466962|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
14466963|NCT02253654|Hematinics|hematinics|mesh-ancestor
14466964|NCT02253992|Nivolumab|nivolumab|mesh-list
14466965|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14466966|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466967|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14466968|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466969|NCT02254252|Nicorandil|nicorandil|mesh-list
14466970|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
14466971|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
14466972|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14466973|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14466974|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
14466975|NCT02254252|Vitamins|vitamins|mesh-ancestor
14466976|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
14466977|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466978|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14923584|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923585|NCT02293109|Leucovorin|leucovorin|mesh-list
14923586|NCT02293109|Cytarabine|cytarabine|mesh-list
14923587|NCT02293109|Dexamethasone|dexamethasone|mesh-list
14923588|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
14923589|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14923590|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14923591|NCT02293109|Prednisolone|prednisolone|mesh-list
15237102|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
15237103|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237104|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237105|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237106|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
15237107|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
15237108|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237109|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237110|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237111|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
15237112|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237113|NCT03936933|Goserelin|goserelin|mesh-list
15237114|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237115|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237116|NCT03936218|Goserelin|goserelin|mesh-list
15237117|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237118|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237119|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15237120|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14466979|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14923592|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
14923593|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
14393945|NCT01380184|Sirolimus|sirolimus|mesh-list
14393946|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14393947|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393948|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14393949|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393950|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
14393951|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393952|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
14393953|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393954|NCT01380197|Morphine|morphine|mesh-list
14393955|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14393956|NCT01380197|Narcotics|narcotics|mesh-ancestor
14393957|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14393958|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393959|NCT01380197|Analgesics|analgesics|mesh-ancestor
14393960|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
14393961|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14393962|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
14393963|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393964|NCT01380366|Hormones|hormones|mesh-list
14393965|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14393966|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393967|NCT01380535|Methoxsalen|methoxsalen|mesh-list
14393968|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14393969|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
14393970|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
14393971|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14393972|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393973|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
14393974|NCT01380730|Evolocumab|evolocumab|mesh-list
14393975|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14393976|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14393977|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14393978|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
14393979|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393980|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14393981|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
14393982|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393983|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
14393984|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
14393985|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14393986|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393987|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393988|NCT01380782|Nintedanib|nintedanib|mesh-list
14393989|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14393990|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14393991|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14393992|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393993|NCT01380990|Busulfan|busulfan|mesh-list
14393994|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
15237121|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237122|NCT03923699|Anesthetics|anesthetics|mesh-list
15237123|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237124|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393995|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14393996|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14393997|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
14393998|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14393999|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14394000|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394001|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14394002|NCT01381016|Hormones|hormones|mesh-list
14394003|NCT01381016|Estradiol|estradiol|mesh-list
14394004|NCT01381016|Progesterone|progesterone|mesh-list
14394005|NCT01381016|Estrogens|estrogens|mesh-list
14394006|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394007|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735015|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735016|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735017|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735018|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735019|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14735020|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14735021|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14735022|NCT00538382|Artesunate|artesunate|mesh-list
14394008|NCT01381016|Progestins|progestins|mesh-ancestor
14394009|NCT01381120|Acetaminophen|acetaminophen|mesh-list
14394010|NCT01381120|Oxycodone|oxycodone|mesh-list
14394011|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
14394012|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394013|NCT01381120|Analgesics|analgesics|mesh-ancestor
14394014|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
14394015|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394016|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735023|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
14735024|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14735025|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14735026|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735027|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735028|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
14735029|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
14735030|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14735031|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
14735032|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
14735033|NCT00538395|Doxorubicin|doxorubicin|mesh-list
14735034|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14735035|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735036|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
14394017|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
14394018|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14394019|NCT01381120|Narcotics|narcotics|mesh-ancestor
14394020|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14394021|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14394022|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14394023|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
14394024|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394025|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394026|NCT01381120|Urological Agents|urological agents|mesh-ancestor
14394027|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
14394028|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14394029|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
14394030|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394031|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394032|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14394033|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
14394034|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
14394035|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14394036|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
14394037|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394038|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394039|NCT01381471|Fluticasone|fluticasone|mesh-list
14394040|NCT01381471|Xhance|xhance|mesh-list
14394041|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14394042|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394043|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14394044|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
14394045|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394046|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394047|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14735037|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735038|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14735039|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14735040|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
15237125|NCT03911661|Warfarin|warfarin|mesh-list
15237126|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
15237127|NCT03908255|Vitamins|vitamins|mesh-list
15237128|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
15237129|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237130|NCT03900754|Oxytocin|oxytocin|mesh-list
15237131|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
15237132|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15237133|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237134|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15237135|NCT03897244|Amoxicillin|amoxicillin|mesh-list
15237136|NCT03897244|Metronidazole|metronidazole|mesh-list
15237137|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14735041|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237138|NCT03897244|Rabeprazole|rabeprazole|mesh-list
15237139|NCT03897244|Bismuth|bismuth|mesh-list
15237140|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14394048|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
14735042|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735043|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14735044|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14735045|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14735046|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14394049|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394050|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14394051|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14394052|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14394053|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14394054|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
14394055|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394056|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394057|NCT01381549|Imipenem|imipenem|mesh-list
14394058|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14394059|NCT01381549|Cilastatin|cilastatin|mesh-list
14394060|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14394061|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394062|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
14394063|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394064|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394065|NCT01381562|Meropenem|meropenem|mesh-list
14394066|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14394067|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394068|NCT01381692|Sirolimus|sirolimus|mesh-list
14394069|NCT01381692|Dexamethasone|dexamethasone|mesh-list
14394070|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
14394071|NCT01381692|Rituximab|rituximab|mesh-list
14394072|NCT01381692|Bortezomib|bortezomib|mesh-list
14394073|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14394074|NCT01381692|Antibodies|antibodies|mesh-list
14394075|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
14394076|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14394077|NCT01381692|BB 1101|bb 1101|mesh-list
14394078|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
14394079|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394080|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394081|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
14394082|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
14394083|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394084|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394085|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
14394086|NCT01381692|Hormones|hormones|mesh-ancestor
14394087|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394088|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14394089|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394090|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
14735047|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735048|NCT00538421|Propofol|propofol|mesh-list
15237141|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237142|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
14735049|NCT00538421|Sevoflurane|sevoflurane|mesh-list
14735050|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14735051|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735052|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735053|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14735054|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
14735055|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
14735056|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14735057|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14735058|NCT00538486|Metformin|metformin|mesh-list
14735059|NCT00538486|Amlodipine|amlodipine|mesh-list
14735060|NCT00538486|Telmisartan|telmisartan|mesh-list
14735061|NCT00538486|Candesartan|candesartan|mesh-list
14735062|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
14735063|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14735064|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735065|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14735066|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15237143|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15237144|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15237145|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15237146|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237147|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237148|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237149|NCT03897244|Antacids|antacids|mesh-ancestor
14394091|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394092|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394093|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394094|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14394095|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394096|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14394097|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
14394098|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394099|NCT01381718|Modafinil|modafinil|mesh-list
14394100|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14394101|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394102|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14394103|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14394104|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14394105|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394106|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14394107|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
14394108|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394109|NCT01381874|Prednisone|prednisone|mesh-list
14394110|NCT01381874|Prednisolone|prednisolone|mesh-list
14394111|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14394112|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
14394113|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14394114|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
14394115|NCT01381874|Exemestane|exemestane|mesh-list
14394116|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
14394117|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14394118|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
14394119|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394120|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
14394121|NCT01381874|Hormones|hormones|mesh-ancestor
14394122|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394123|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394124|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14394125|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394126|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
14735067|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14735068|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735069|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14735070|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
14735071|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14735072|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14735073|NCT00538499|Fentanyl|fentanyl|mesh-list
14735074|NCT00538499|Bupivacaine|bupivacaine|mesh-list
14735075|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
14735076|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
14735077|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735078|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735079|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
14735080|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735081|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14735082|NCT00538499|Narcotics|narcotics|mesh-ancestor
14735083|NCT00538499|Analgesics|analgesics|mesh-ancestor
14735084|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14735085|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14735086|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
14735087|NCT00538525|Docetaxel|docetaxel|mesh-list
14735088|NCT00538525|Doxorubicin|doxorubicin|mesh-list
14735089|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923594|NCT02293109|Rituximab|rituximab|mesh-list
14394127|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
14394128|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394129|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394130|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14394131|NCT01381874|Protective Agents|protective agents|mesh-ancestor
14394132|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14394133|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14923595|NCT02293109|Doxorubicin|doxorubicin|mesh-list
14923596|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14923597|NCT02293109|Methotrexate|methotrexate|mesh-list
14923598|NCT02293109|Vincristine|vincristine|mesh-list
14923599|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14394134|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394135|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394136|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14394137|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
14394138|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14394139|NCT01381900|Metformin|metformin|mesh-list
14394140|NCT01381900|Canagliflozin|canagliflozin|mesh-list
14394141|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14394142|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394143|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14394144|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394145|NCT01381926|Exenatide|exenatide|mesh-list
14394146|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14394147|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394148|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14394149|NCT01381926|Incretins|incretins|mesh-ancestor
14394150|NCT01381926|Hormones|hormones|mesh-ancestor
14394151|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394152|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14394153|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
14394154|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14735090|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923600|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
14923601|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
14394155|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14394156|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
14394157|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394158|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
14394159|NCT01382225|Protective Agents|protective agents|mesh-ancestor
14394160|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
14394161|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14394162|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394163|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394164|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14394165|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14394166|NCT01382303|Protective Agents|protective agents|mesh-ancestor
14394167|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394168|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
14394169|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14394170|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
14394171|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
14394172|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14394173|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14394174|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394175|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
14394176|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394177|NCT01382940|Acetaminophen|acetaminophen|mesh-list
14394178|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
14394179|NCT01382940|Rituximab|rituximab|mesh-list
14394180|NCT01382940|Methotrexate|methotrexate|mesh-list
14394181|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
14394182|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14394183|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14394184|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394185|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
14394186|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394187|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394188|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14394189|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
14394190|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14394191|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14394192|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
14394193|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394194|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394195|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735091|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
15237150|NCT03878316|Oxytocin|oxytocin|mesh-list
15237151|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
15237152|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15237153|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237154|NCT03869034|Leucovorin|leucovorin|mesh-list
15237155|NCT03869034|Fluorouracil|fluorouracil|mesh-list
15237156|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
15237157|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
15237158|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237159|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237160|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237161|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237162|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
15237163|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237164|NCT03869034|Antidotes|antidotes|mesh-ancestor
15237165|NCT03869034|Protective Agents|protective agents|mesh-ancestor
15237166|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
15237167|NCT03869034|Vitamins|vitamins|mesh-ancestor
15237168|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
15237169|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15237170|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15237171|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237172|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237173|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15237174|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15237175|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237176|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
15237177|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237178|NCT03854110|Gemcitabine|gemcitabine|mesh-list
15237179|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237180|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
15237181|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237182|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237183|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
15237184|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237185|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237186|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237187|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
15237188|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237189|NCT03851081|Vincristine|vincristine|mesh-list
15237190|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
15237191|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237192|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237193|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
15237194|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
15237195|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237196|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237197|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237198|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15237199|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
15237200|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237201|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237202|NCT03822468|Letrozole|letrozole|mesh-list
15237203|NCT03822468|Anastrozole|anastrozole|mesh-list
15237204|NCT03822468|Goserelin|goserelin|mesh-list
15237205|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394196|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14394197|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394198|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15237206|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15237207|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15237208|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394199|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394200|NCT01382940|Analgesics|analgesics|mesh-ancestor
14394201|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
14394202|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394203|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
14394204|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394205|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
14394206|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
14394207|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394208|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
14394209|NCT01382940|Hormones|hormones|mesh-ancestor
14394210|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394211|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14394212|NCT01382940|Protective Agents|protective agents|mesh-ancestor
14394213|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
14394214|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394215|NCT01383096|Artefenomel|artefenomel|mesh-list
14394216|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14394217|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
14394218|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14394219|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14394220|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394221|NCT01383161|Curcumin|curcumin|mesh-list
14394222|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14394223|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394224|NCT01383161|Analgesics|analgesics|mesh-ancestor
14394225|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
14394226|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394227|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394228|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394229|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394230|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394231|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394232|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394233|NCT01383200|Lidocaine|lidocaine|mesh-list
14394234|NCT01383200|Tetracaine|tetracaine|mesh-list
14394235|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
14394236|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
14394237|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735092|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237209|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237210|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15237211|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
15237212|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237213|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237214|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237215|NCT03819465|Gemcitabine|gemcitabine|mesh-list
15237216|NCT03819465|Paclitaxel|paclitaxel|mesh-list
15237217|NCT03819465|Carboplatin|carboplatin|mesh-list
15237218|NCT03819465|Pemetrexed|pemetrexed|mesh-list
15237219|NCT03819465|Durvalumab|durvalumab|mesh-list
15237220|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237221|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237222|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
15237223|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
15237224|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237225|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237226|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237227|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
15237228|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
15237229|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237230|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237231|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237232|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
15237233|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237234|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15237235|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15237236|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14394238|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394239|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
14394240|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394241|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14394242|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14394243|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14394244|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394245|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394246|NCT01383356|Metformin|metformin|mesh-list
14394247|NCT01383356|Linagliptin|linagliptin|mesh-list
14394248|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14394249|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394250|NCT01383356|Incretins|incretins|mesh-ancestor
14394251|NCT01383356|Hormones|hormones|mesh-ancestor
14394252|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394253|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14394254|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
14394255|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394256|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394257|NCT01383486|Naproxen|naproxen|mesh-list
14394258|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14394259|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394260|NCT01383486|Analgesics|analgesics|mesh-ancestor
14394261|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
14394262|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394263|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394264|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394265|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394266|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
14394267|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14394268|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394269|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394270|NCT01383499|Bromides|bromides|mesh-list
14394271|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
14394272|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14394273|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
14394274|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394275|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394276|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14394277|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14394278|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
14394279|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14394280|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14394281|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394282|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394283|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
14394284|NCT01383707|Leucovorin|leucovorin|mesh-list
14394285|NCT01383707|Bevacizumab|bevacizumab|mesh-list
14394286|NCT01383707|Fluorouracil|fluorouracil|mesh-list
14394287|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
14394288|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
14394289|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14394290|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394291|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14394292|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14394293|NCT01383707|Growth Substances|growth substances|mesh-ancestor
14394294|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394295|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14394296|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
14394297|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394298|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14394299|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394300|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
14394301|NCT01383707|Antidotes|antidotes|mesh-ancestor
14394302|NCT01383707|Protective Agents|protective agents|mesh-ancestor
14394303|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
14394304|NCT01383707|Vitamins|vitamins|mesh-ancestor
14394305|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
14394306|NCT01383759|Dexamethasone|dexamethasone|mesh-list
14394307|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
14394308|NCT01383759|Bortezomib|bortezomib|mesh-list
14394309|NCT01383759|BB 1101|bb 1101|mesh-list
14394310|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394311|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
14394312|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
14394313|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394314|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394315|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394316|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
14394317|NCT01383759|Hormones|hormones|mesh-ancestor
14394318|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394319|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14394320|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394321|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
14394322|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394323|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394324|NCT01383928|Dexamethasone|dexamethasone|mesh-list
14394325|NCT01383928|Lenalidomide|lenalidomide|mesh-list
14394326|NCT01383928|Ixazomib|ixazomib|mesh-list
14394327|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394328|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
14394329|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
14394330|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394331|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394332|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394333|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
14394334|NCT01383928|Hormones|hormones|mesh-ancestor
14394335|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394336|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14394337|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394338|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
14394339|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14394340|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14394341|NCT01383928|Growth Substances|growth substances|mesh-ancestor
14394342|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
15237237|NCT03797014|Tenofovir|tenofovir|mesh-list
15237238|NCT03797014|Emtricitabine|emtricitabine|mesh-list
15237239|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
15237240|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
15237241|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237242|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15237243|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15237244|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237245|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237246|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14394343|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
14394344|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394345|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394346|NCT01383954|Diclofenac|diclofenac|mesh-list
14394347|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14394348|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394349|NCT01383954|Analgesics|analgesics|mesh-ancestor
14394350|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
14394351|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237247|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15237248|NCT03787628|Cannabidiol|cannabidiol|mesh-list
15237249|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
15237250|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
15237251|NCT03766126|Fludarabine|fludarabine|mesh-list
14394352|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394353|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394354|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394355|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14394356|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394357|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394358|NCT01383993|Voriconazole|voriconazole|mesh-list
14394359|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
14394360|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394361|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14394362|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14394363|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394364|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394365|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14394366|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
14394367|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394368|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394369|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14394370|NCT01384292|Naloxegol|naloxegol|mesh-list
14394371|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14394372|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394373|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
14394374|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394375|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
14394376|NCT01384539|Calcitriol|calcitriol|mesh-list
14394377|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14394378|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394379|NCT01384539|Vitamins|vitamins|mesh-ancestor
14394380|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
14735093|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735094|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14735095|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14735096|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14735097|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735098|NCT00538538|Ranibizumab|ranibizumab|mesh-list
14735099|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14735100|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14735101|NCT00538538|Growth Substances|growth substances|mesh-ancestor
14735102|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735103|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
15237252|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237253|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
15237254|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394381|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14394382|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14394383|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394384|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394385|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14394386|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
14394387|NCT01384591|Losartan|losartan|mesh-list
14394388|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14394389|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14394390|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14394391|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14394392|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14394393|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394394|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
14394395|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394396|NCT01384591|Expectorants|expectorants|mesh-ancestor
14394397|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
14394398|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14394399|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
14394400|NCT01384591|Protective Agents|protective agents|mesh-ancestor
14394401|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394402|NCT01384591|Antidotes|antidotes|mesh-ancestor
14394403|NCT01384734|Ritonavir|ritonavir|mesh-list
14394404|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14394405|NCT01384734|Tenofovir|tenofovir|mesh-list
14394406|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
14394407|NCT01384734|Fostemsavir|fostemsavir|mesh-list
14394408|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14394409|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14394410|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
14394411|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394412|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394413|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15237255|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237256|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15237257|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
14394414|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14394415|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
14394416|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394417|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14394418|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14394419|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14394420|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14394421|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14394422|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14394423|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15237258|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237259|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237260|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15237261|NCT03758781|Nivolumab|nivolumab|mesh-list
15237262|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237263|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237264|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14753114|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15237265|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237266|NCT03742349|Spartalizumab|spartalizumab|mesh-list
15237267|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15237268|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237269|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237270|NCT03737136|Bortezomib|bortezomib|mesh-list
15237271|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237272|NCT03736265|Carvedilol|carvedilol|mesh-list
15237273|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15237274|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15237275|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
15237276|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237277|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394424|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14923602|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923603|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
14923604|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394425|NCT01384877|Lidocaine|lidocaine|mesh-list
14394426|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
14394427|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
14394428|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14394429|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394430|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
14394431|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394432|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14394433|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14394434|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14394435|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394436|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394437|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
14394438|NCT01385098|Vitamin D|vitamin d|mesh-list
14394439|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
14394440|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
14394441|NCT01385098|Vitamins|vitamins|mesh-list
14394442|NCT01385098|Calcium|calcium|mesh-list
14394443|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
14394444|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394445|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14394446|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14394447|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14394448|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14394449|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
14394450|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394451|NCT01385189|Antacids|antacids|mesh-ancestor
14394452|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394453|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394454|NCT01385566|Vaccines|vaccines|mesh-list
14394455|NCT01385566|Immunoglobulins|immunoglobulins|mesh-list
14394456|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
14394457|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394458|NCT01385748|Clonidine|clonidine|mesh-list
14394459|NCT01385748|Analgesics|analgesics|mesh-ancestor
14394460|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
14394461|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394462|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394463|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14394464|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
14394465|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
14394466|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14394467|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14394468|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14394469|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
14394470|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14923605|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923606|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14394471|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394472|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14394473|NCT01386554|Hormones|hormones|mesh-ancestor
14394474|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394475|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394476|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
14394477|NCT01386606|Enclomiphene|enclomiphene|mesh-list
14394478|NCT01386606|Clomiphene|clomiphene|mesh-list
14394479|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
14923607|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
14923608|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923609|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923610|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14923611|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923612|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
14923613|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
14923614|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923615|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394480|NCT01386606|Testosterone|testosterone|mesh-list
14394481|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
14394482|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
14394483|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14394484|NCT01386606|Androgens|androgens|mesh-ancestor
14394485|NCT01386606|Hormones|hormones|mesh-ancestor
14394486|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394487|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394488|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14394489|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923616|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
14923617|NCT02293109|Hormones|hormones|mesh-ancestor
14923618|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923619|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14923620|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923621|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14394490|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
14394491|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14394492|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
14394493|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14394494|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
14394495|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14394496|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14394497|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14394498|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
14394499|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14394500|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
14394501|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394502|NCT01386645|Expectorants|expectorants|mesh-ancestor
14394503|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
14394504|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14394505|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
14394506|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394507|NCT01386645|Protective Agents|protective agents|mesh-ancestor
14394508|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394509|NCT01386645|Antidotes|antidotes|mesh-ancestor
14394510|NCT01386970|Lamivudine|lamivudine|mesh-list
14394511|NCT01386970|Zidovudine|zidovudine|mesh-list
14394512|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14394513|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14394514|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14394515|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394516|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394517|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
14394518|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394519|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14394520|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14394521|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
14394522|NCT01386983|Finasteride|finasteride|mesh-list
14394523|NCT01386983|Dutasteride|dutasteride|mesh-list
14394524|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14394525|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14394526|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394527|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394528|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
14394529|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394530|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394531|NCT01386983|Urological Agents|urological agents|mesh-ancestor
14394532|NCT01387022|Tenofovir|tenofovir|mesh-list
14394533|NCT01387022|Lamivudine|lamivudine|mesh-list
14394534|NCT01387022|Efavirenz|efavirenz|mesh-list
14394535|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
14394536|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394537|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14394538|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14394539|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394540|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394541|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14394542|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14394543|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14394544|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14394545|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14394546|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14394547|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14394548|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14394549|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
14394550|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14394551|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14394552|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14394553|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394554|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394555|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
14394556|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394557|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394558|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14394559|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394560|NCT01387139|Ketamine|ketamine|mesh-list
14394561|NCT01387139|Propofol|propofol|mesh-list
14394562|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14394563|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14394564|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394565|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14394566|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
14394567|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
14394568|NCT01387139|Analgesics|analgesics|mesh-ancestor
14394569|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
14394570|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394571|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14394572|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14394573|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14394574|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394575|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394576|NCT01387178|Fluticasone|fluticasone|mesh-list
14394577|NCT01387178|Xhance|xhance|mesh-list
14394578|NCT01387178|Bromides|bromides|mesh-list
14394579|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
14394580|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14394581|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394582|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14394583|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
14394584|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394585|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394586|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15237278|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237279|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15237280|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
15237281|NCT03736265|Protective Agents|protective agents|mesh-ancestor
15237282|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15237283|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15237284|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15237285|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
14394587|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
14394588|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394589|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14394590|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
14394591|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14394592|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
15237286|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15237287|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15237288|NCT03705507|Dexamethasone|dexamethasone|mesh-list
15237289|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237290|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
15237291|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
15237292|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237293|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237294|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237295|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
15237296|NCT03705507|Hormones|hormones|mesh-ancestor
15237297|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394593|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394594|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394595|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14394596|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14394597|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14394598|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
14394599|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
14394600|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14394601|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14394602|NCT01387464|Bromfenac|bromfenac|mesh-list
14394603|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14394604|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394605|NCT01387464|Analgesics|analgesics|mesh-ancestor
14394606|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
14394607|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394608|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394609|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394610|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14466980|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466981|NCT02254291|Incretins|incretins|mesh-ancestor
14466982|NCT02254291|Hormones|hormones|mesh-ancestor
14923622|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15237298|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237299|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735104|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735105|NCT00538564|Tadalafil|tadalafil|mesh-list
14735106|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
14735107|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14735108|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14394611|NCT01387516|Nicotine|nicotine|mesh-list
14394612|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15237300|NCT03667716|Nivolumab|nivolumab|mesh-list
15237301|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237302|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237303|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15237304|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237305|NCT03665129|Avdoralimab|avdoralimab|mesh-list
15237306|NCT03665129|Durvalumab|durvalumab|mesh-list
15237307|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237308|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237309|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237310|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
15237311|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237312|NCT03648021|Acetaminophen|acetaminophen|mesh-list
15237313|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15237314|NCT03648021|Analgesics|analgesics|mesh-ancestor
15237315|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
15237316|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237317|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237318|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
15237319|NCT03617731|Dexamethasone|dexamethasone|mesh-list
15237320|NCT03617731|Lenalidomide|lenalidomide|mesh-list
15237321|NCT03617731|Bortezomib|bortezomib|mesh-list
15237322|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237323|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
15237324|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
15237325|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237326|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237327|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237328|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
15237329|NCT03617731|Hormones|hormones|mesh-ancestor
15237330|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237331|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735109|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735110|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735111|NCT00538564|Urological Agents|urological agents|mesh-ancestor
14735112|NCT00538603|Paclitaxel|paclitaxel|mesh-list
15237332|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237333|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
15237334|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15237335|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15237336|NCT03617731|Growth Substances|growth substances|mesh-ancestor
15237337|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
15237338|NCT03614949|Atezolizumab|atezolizumab|mesh-list
15237339|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237340|NCT03596164|Teduglutide|teduglutide|mesh-list
15237341|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237342|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15237343|NCT03596164|Protective Agents|protective agents|mesh-ancestor
15237344|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237345|NCT03590821|Aspirin|aspirin|mesh-list
14394613|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
14394614|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394615|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394616|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14394617|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14394618|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
14394619|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394620|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735113|NCT00538603|Carboplatin|carboplatin|mesh-list
14394621|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14394622|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14394623|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14394624|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735114|NCT00538603|Doxorubicin|doxorubicin|mesh-list
14735115|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15237346|NCT03590821|Celecoxib|celecoxib|mesh-list
15237347|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15237348|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15237349|NCT03590821|Analgesics|analgesics|mesh-ancestor
15237350|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
15237351|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237352|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237353|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237354|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237355|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15237356|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15237357|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237358|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14394625|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394626|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14394627|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14923623|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14923624|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923625|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14923626|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
14923627|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923628|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14923629|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
15237359|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14394628|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14394629|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
14394630|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394631|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394632|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14394633|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14394634|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
14394635|NCT01387607|Pregabalin|pregabalin|mesh-list
14394636|NCT01387607|Analgesics|analgesics|mesh-ancestor
14394637|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
14394638|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394639|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394640|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
14394641|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14394642|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394643|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394644|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14394645|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14394646|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14394647|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14394648|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14394649|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
14394650|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
14394651|NCT01387815|Adalimumab|adalimumab|mesh-list
14394652|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394653|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394654|NCT01387932|Doxorubicin|doxorubicin|mesh-list
14394655|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
14394656|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14394657|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237360|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237361|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
14394658|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14394659|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14394660|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394661|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394662|NCT01388335|Warfarin|warfarin|mesh-list
14394663|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
14394664|NCT01388361|Insulin|insulin|mesh-list
14394665|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14394666|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
14394667|NCT01388361|Liraglutide|liraglutide|mesh-list
14394668|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14394669|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394670|NCT01388361|Incretins|incretins|mesh-ancestor
14735116|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14735117|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735118|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735119|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735120|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735121|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735122|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14923630|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394671|NCT01388361|Hormones|hormones|mesh-ancestor
14394672|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394673|NCT01388478|Pramipexole|pramipexole|mesh-list
14394674|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
14394675|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394676|NCT01388478|Protective Agents|protective agents|mesh-ancestor
14394677|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394678|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14394679|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14394680|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
14394681|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
14394682|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394683|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14394684|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14394685|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14394686|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
14394687|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394688|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394689|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14394690|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14394691|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
14394692|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394693|NCT01388647|Carboplatin|carboplatin|mesh-list
14394694|NCT01388647|Trastuzumab|trastuzumab|mesh-list
14394695|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394696|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14394697|NCT01388790|Cetuximab|cetuximab|mesh-list
14394698|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394699|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14394700|NCT01388946|Ropivacaine|ropivacaine|mesh-list
14394701|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
14394702|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
14394703|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14394704|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394705|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
14394706|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394707|NCT01388985|Vaccines|vaccines|mesh-list
14394708|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
14394709|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394710|NCT01389076|Methotrexate|methotrexate|mesh-list
14394711|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
14394712|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14394713|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
14394714|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14394715|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394716|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14394717|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
14394718|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394719|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394720|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394721|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394722|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14394723|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394724|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
14394725|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394726|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14394727|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14394728|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14394729|NCT01389102|Estradiol|estradiol|mesh-list
14394730|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14394731|NCT01389102|Estrogens|estrogens|mesh-ancestor
14394732|NCT01389102|Hormones|hormones|mesh-ancestor
14394733|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394734|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394735|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14394736|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
14394737|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14394738|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14394739|NCT01389284|Naproxen|naproxen|mesh-list
14394740|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14394741|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394742|NCT01389284|Analgesics|analgesics|mesh-ancestor
14394743|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
14394744|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394745|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394746|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394747|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394748|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
14394749|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14394750|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394751|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394752|NCT01389323|Interferons|interferons|mesh-list
14394753|NCT01389323|Ribavirin|ribavirin|mesh-list
14394754|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
14394755|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
14394756|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14394757|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394758|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
14394759|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394760|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
14394761|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394762|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
14394763|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394764|NCT01389596|Pregabalin|pregabalin|mesh-list
14394765|NCT01389596|Analgesics|analgesics|mesh-ancestor
14394766|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
14394767|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394768|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394769|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
14394770|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14394771|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394772|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394773|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14394774|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14394775|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14394776|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14394777|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14394778|NCT01389752|Charcoal|charcoal|mesh-list
14394779|NCT01389752|Antidotes|antidotes|mesh-ancestor
14923631|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14923632|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14923633|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
14923634|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394780|NCT01389752|Protective Agents|protective agents|mesh-ancestor
14394781|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394782|NCT01389856|Bosentan|bosentan|mesh-list
14394783|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14394784|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14394785|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394786|NCT01389973|Ustekinumab|ustekinumab|mesh-list
14394787|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394788|NCT01390064|Vaccines|vaccines|mesh-list
14394789|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
14394790|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394791|NCT01390077|Nitisinone|nitisinone|mesh-list
14394792|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394793|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394794|NCT01390220|Midazolam|midazolam|mesh-list
14923635|NCT02293109|Antidotes|antidotes|mesh-ancestor
14394795|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14394796|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14394797|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14923636|NCT02293109|Protective Agents|protective agents|mesh-ancestor
15237362|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15237363|NCT03576612|Valacyclovir|valacyclovir|mesh-list
15237364|NCT03576612|Acyclovir|acyclovir|mesh-list
15237365|NCT03576612|Nivolumab|nivolumab|mesh-list
15237366|NCT03576612|Temozolomide|temozolomide|mesh-list
15237367|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237368|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237369|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15237370|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237371|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15237372|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
15237373|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
15237374|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237375|NCT03557307|Benralizumab|benralizumab|mesh-list
15237376|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15237377|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
15237378|NCT03543189|Nivolumab|nivolumab|mesh-list
14394798|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394799|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14394800|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14394801|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14394802|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14394803|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
14394804|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
14394805|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
14394806|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
14394807|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394808|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394809|NCT01390233|Dinoprostone|dinoprostone|mesh-list
14394810|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
14394811|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14394812|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394813|NCT01390246|Bupropion|bupropion|mesh-list
14394814|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14394815|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
14394816|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14394817|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14394818|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15237379|NCT03543189|Androgens|androgens|mesh-list
15237380|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237381|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394819|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394820|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394821|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
14394822|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394823|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394824|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14394825|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14394826|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394827|NCT01390389|Ubiquinone|ubiquinone|mesh-list
14394828|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
14394829|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
14394830|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394831|NCT01390389|Vitamins|vitamins|mesh-ancestor
14394832|NCT01390402|Aldesleukin|aldesleukin|mesh-list
14394833|NCT01390402|Methotrexate|methotrexate|mesh-list
14394834|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
14394835|NCT01390402|Fludarabine|fludarabine|mesh-list
14394836|NCT01390402|Busulfan|busulfan|mesh-list
14394837|NCT01390402|Interleukin-2|interleukin-2|mesh-list
14394838|NCT01390402|Tacrolimus|tacrolimus|mesh-list
15237382|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15237383|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237384|NCT03543189|Hormones|hormones|mesh-ancestor
15237385|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923637|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
14923638|NCT02293109|Vitamins|vitamins|mesh-ancestor
14923639|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
14923640|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923641|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923642|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923643|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
14923644|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14923645|NCT02270034|Crizotinib|crizotinib|mesh-list
14923646|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237386|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237387|NCT03505710|Trastuzumab|trastuzumab|mesh-list
15237388|NCT03505710|Camptothecin|camptothecin|mesh-list
15237389|NCT03505710|Immunoconjugates|immunoconjugates|mesh-list
14394839|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
14394840|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14394841|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14394842|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
14394843|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14394844|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394845|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14394846|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
14394847|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394848|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923647|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923648|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237390|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237391|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237392|NCT03505710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237393|NCT03505710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15237394|NCT03505710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15237395|NCT03505710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237396|NCT03505710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237397|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
15237398|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237399|NCT03482479|Naltrexone|naltrexone|mesh-list
15237400|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14394849|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394850|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394851|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14394852|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394853|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
14394854|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394855|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14394856|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
14394857|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394858|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14394859|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
14394860|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14394861|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14394862|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394863|NCT01390402|Analgesics|analgesics|mesh-ancestor
14394864|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
14394865|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394866|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14394867|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14394868|NCT01390428|Grazoprevir|grazoprevir|mesh-list
14735123|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14394869|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
14394870|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237401|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14735124|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14735125|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735126|NCT00538655|Modafinil|modafinil|mesh-list
14735127|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14394871|NCT01390441|Acetaminophen|acetaminophen|mesh-list
14394872|NCT01390441|Loratadine|loratadine|mesh-list
14394873|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
14394874|NCT01390441|Rituximab|rituximab|mesh-list
14394875|NCT01390441|Methotrexate|methotrexate|mesh-list
14394876|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14394877|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394878|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
14394879|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394880|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394881|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14394882|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
14394883|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14394884|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14394885|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
14394886|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394887|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394888|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394889|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14394890|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394891|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14394892|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14394893|NCT01390441|Analgesics|analgesics|mesh-ancestor
14394894|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
14394895|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14394896|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
14394897|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394898|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
14394899|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
14394900|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14394901|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
14394902|NCT01390441|Hormones|hormones|mesh-ancestor
14394903|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14394904|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14394905|NCT01390441|Protective Agents|protective agents|mesh-ancestor
14394906|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
14394907|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14394908|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14394909|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14394910|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
14394911|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
14394912|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394913|NCT01390584|Prednisone|prednisone|mesh-list
14394914|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
14394915|NCT01390584|Dacarbazine|dacarbazine|mesh-list
14394916|NCT01390584|Doxorubicin|doxorubicin|mesh-list
14394917|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14394918|NCT01390584|Etoposide|etoposide|mesh-list
14394919|NCT01390584|Vincristine|vincristine|mesh-list
14394920|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
14394921|NCT01390584|Bleomycin|bleomycin|mesh-list
14394922|NCT01390584|Vinblastine|vinblastine|mesh-list
14394923|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
14394924|NCT01390584|Procarbazine|procarbazine|mesh-list
14394925|NCT01390584|Imidazole|imidazole|mesh-list
14394926|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394927|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
14394928|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394929|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14394930|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14394931|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
14735128|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394932|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394933|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394934|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14735129|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14394935|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14394936|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14394937|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14394938|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394939|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14394940|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
14394941|NCT01390584|Hormones|hormones|mesh-ancestor
14394942|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237402|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237403|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
15237404|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237405|NCT03455829|Osimertinib|osimertinib|mesh-list
15237406|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237407|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15237408|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394943|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14394944|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14394945|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
14394946|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
14394947|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
14394948|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
14394949|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
14394950|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14394951|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
14394952|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394953|NCT01390818|Niacinamide|niacinamide|mesh-list
14394954|NCT01390818|Sirolimus|sirolimus|mesh-list
14394955|NCT01390818|Elafin|elafin|mesh-list
14394956|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
14394957|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14394958|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394959|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
14394960|NCT01390818|Vitamins|vitamins|mesh-ancestor
14394961|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
14394962|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394963|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14394964|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394965|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14394966|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14394967|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
14394968|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14394969|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
14394970|NCT01390844|Ribavirin|ribavirin|mesh-list
14394971|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14394972|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
14394973|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394974|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
14394975|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394976|NCT01390857|Valacyclovir|valacyclovir|mesh-list
14394977|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
14394978|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14394979|NCT01390870|Alfuzosin|alfuzosin|mesh-list
14394980|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394981|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14394982|NCT01390870|Urological Agents|urological agents|mesh-ancestor
14394983|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14394984|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14394985|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14394986|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
14394987|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14394988|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
14394989|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
14394990|NCT01390909|Lactitol|lactitol|mesh-list
14394991|NCT01390909|Cathartics|cathartics|mesh-ancestor
15237409|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237410|NCT03446157|Cetuximab|cetuximab|mesh-list
15237411|NCT03446157|Palbociclib|palbociclib|mesh-list
15237412|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237413|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237414|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15237415|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237416|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237417|NCT03428958|Leucovorin|leucovorin|mesh-list
15237418|NCT03428958|Bevacizumab|bevacizumab|mesh-list
14394992|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237419|NCT03428958|Cetuximab|cetuximab|mesh-list
15237420|NCT03428958|Panitumumab|panitumumab|mesh-list
14394993|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14394994|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14394995|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14394996|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14394997|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14394998|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14394999|NCT01390948|Bevacizumab|bevacizumab|mesh-list
14395000|NCT01390948|Temozolomide|temozolomide|mesh-list
14395001|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395002|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395003|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395004|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395005|NCT01390948|Growth Substances|growth substances|mesh-ancestor
14395006|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395007|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395008|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14395009|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
14395010|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395011|NCT01391013|Ritonavir|ritonavir|mesh-list
14395012|NCT01391013|Darunavir|darunavir|mesh-list
14395013|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14395014|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14395015|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14395016|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
14395017|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395018|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395019|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14395020|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14395021|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
14395022|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395023|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14395024|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14395025|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14395026|NCT01391130|Sunitinib|sunitinib|mesh-list
14395027|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395028|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395029|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395030|NCT01391130|Growth Substances|growth substances|mesh-ancestor
14395031|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395032|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395033|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395034|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395035|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395036|NCT01391273|Bimatoprost|bimatoprost|mesh-list
14395037|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14395038|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15237421|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
15237422|NCT03428958|Irinotecan|irinotecan|mesh-list
15237423|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
15237424|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237425|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237426|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395039|NCT01391286|Bimatoprost|bimatoprost|mesh-list
14395040|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14395041|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14395042|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
14395043|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14395044|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14395045|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14395046|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395047|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395048|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395049|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395050|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395051|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14395052|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395053|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
14395054|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14395055|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14395056|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14395057|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395058|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237427|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15237428|NCT03428958|Growth Substances|growth substances|mesh-ancestor
15237429|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395059|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395060|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395061|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395062|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14395063|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395064|NCT01391325|Allopurinol|allopurinol|mesh-list
14395065|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
14395066|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395067|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395068|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
14395069|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395070|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14395071|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
14395072|NCT01391325|Protective Agents|protective agents|mesh-ancestor
14395073|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395074|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14395075|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14395076|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
14395077|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14395078|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
14395079|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395080|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395081|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14395082|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
14395083|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14395084|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14735130|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14735131|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15237430|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
15237431|NCT03428958|Antidotes|antidotes|mesh-ancestor
15237432|NCT03428958|Protective Agents|protective agents|mesh-ancestor
15237433|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
15237434|NCT03428958|Vitamins|vitamins|mesh-ancestor
15237435|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
15237436|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15237437|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15237438|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237439|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237440|NCT03393611|Cytarabine|cytarabine|mesh-list
15237441|NCT03393611|Fludarabine|fludarabine|mesh-list
15237442|NCT03393611|Melphalan|melphalan|mesh-list
15237443|NCT03393611|Daunorubicin|daunorubicin|mesh-list
15237444|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
15237445|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237446|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14735132|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735133|NCT00538694|Daptomycin|daptomycin|mesh-list
14735134|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14735135|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735136|NCT00538720|Vitamin D|vitamin d|mesh-list
14735137|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
14735138|NCT00538720|Vitamins|vitamins|mesh-ancestor
14735139|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
14395085|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14395086|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
14395087|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395088|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395089|NCT01391663|Alogliptin|alogliptin|mesh-list
14395090|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14395091|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237447|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
15237448|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237449|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237450|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
15237451|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237452|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
14395092|NCT01391663|Incretins|incretins|mesh-ancestor
14395093|NCT01391663|Hormones|hormones|mesh-ancestor
14395094|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395095|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14395096|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
14395097|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395098|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395099|NCT01391793|Dexamethasone|dexamethasone|mesh-list
14395100|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395101|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
14395102|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
14395103|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395104|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395105|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395106|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
14395107|NCT01391793|Hormones|hormones|mesh-ancestor
14395108|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395109|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14395110|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395111|NCT01391858|Pregabalin|pregabalin|mesh-list
14395112|NCT01391858|Analgesics|analgesics|mesh-ancestor
14395113|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
14395114|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395115|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395116|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
14395117|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14395118|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395119|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395120|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14395121|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14735140|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735141|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14753115|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15237453|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237454|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15237455|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
15237456|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14395122|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14395123|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237457|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15237458|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15237459|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15237460|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395124|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14395125|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
14395126|NCT01392183|Sirolimus|sirolimus|mesh-list
14395127|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14395128|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395129|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14395130|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395131|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
14395132|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14395133|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
14395134|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395135|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14395136|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14395137|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395138|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
14395139|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
14395140|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
14395141|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395142|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
14395143|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
14395144|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395145|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14395146|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
14395147|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
14395148|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395149|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395150|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14395151|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14395152|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14395153|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395154|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395155|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14395156|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395157|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395158|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
14923649|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923650|NCT02195986|Estradiol|estradiol|mesh-list
14923651|NCT02195986|Estrogens|estrogens|mesh-ancestor
14923652|NCT02195986|Hormones|hormones|mesh-ancestor
14923653|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923654|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923655|NCT02183883|Afatinib|afatinib|mesh-list
14923656|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923657|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923658|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923659|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923660|NCT02158507|Lapatinib|lapatinib|mesh-list
14923661|NCT02158507|Veliparib|veliparib|mesh-list
14923662|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923663|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923664|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923665|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923666|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14923667|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
14923668|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14923669|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
14923670|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923671|NCT02094625|Expectorants|expectorants|mesh-ancestor
14923672|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
14923673|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14923674|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
14923675|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923676|NCT02094625|Protective Agents|protective agents|mesh-ancestor
14923677|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923678|NCT02094625|Antidotes|antidotes|mesh-ancestor
14923679|NCT02087423|Durvalumab|durvalumab|mesh-list
14923680|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923681|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923682|NCT01982630|Liraglutide|liraglutide|mesh-list
14923683|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14923684|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923685|NCT01982630|Incretins|incretins|mesh-ancestor
14923686|NCT01982630|Hormones|hormones|mesh-ancestor
14923687|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923688|NCT01982448|Paclitaxel|paclitaxel|mesh-list
14923689|NCT01982448|Cisplatin|cisplatin|mesh-list
14395159|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395160|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14395161|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
14395162|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395163|NCT01392378|Acetaminophen|acetaminophen|mesh-list
14395164|NCT01392378|Ibuprofen|ibuprofen|mesh-list
14395165|NCT01392378|Vaccines|vaccines|mesh-list
14395166|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14395167|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
14395168|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395169|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14395170|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14395171|NCT01392378|Analgesics|analgesics|mesh-ancestor
14395172|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
14395173|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395174|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395175|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395176|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14395177|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395178|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395179|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
14395180|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
14395181|NCT01392469|Bosentan|bosentan|mesh-list
14395182|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
14395183|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395184|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395185|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395186|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395187|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
14395188|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14395189|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14395190|NCT01392469|Urological Agents|urological agents|mesh-ancestor
14395191|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14395192|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14395193|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
14395194|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395195|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395196|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395197|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395198|NCT01392560|Empagliflozin|empagliflozin|mesh-list
14395199|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14395200|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395201|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14395202|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395203|NCT01392573|Insulin|insulin|mesh-list
14395204|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14395205|NCT01392573|Liraglutide|liraglutide|mesh-list
14395206|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
14395207|NCT01392573|Xultophy|xultophy|mesh-list
14395208|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14923690|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237461|NCT03382301|Cyclosporine|cyclosporine|mesh-list
15237462|NCT03382301|Cyclosporins|cyclosporins|mesh-list
15237463|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237464|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237465|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237466|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
15237467|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237468|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
15237469|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237470|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
15237471|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237472|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15237473|NCT03340506|Trametinib|trametinib|mesh-list
14395209|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237474|NCT03340506|Dabrafenib|dabrafenib|mesh-list
14395210|NCT01392573|Incretins|incretins|mesh-ancestor
14395211|NCT01392573|Hormones|hormones|mesh-ancestor
14395212|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395213|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
14395214|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14395215|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395216|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14395217|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395218|NCT01392703|Dasatinib|dasatinib|mesh-list
14395219|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395220|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395221|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395222|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395223|NCT01392859|Levocetirizine|levocetirizine|mesh-list
14395224|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14395225|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14395226|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
14395227|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
14395228|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395229|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395230|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395231|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
14395232|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14395233|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14395234|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14395235|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395236|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395237|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395238|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395239|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395240|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14395241|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395242|NCT01392989|Cyclosporine|cyclosporine|mesh-list
14395243|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
14395244|NCT01392989|Cyclosporins|cyclosporins|mesh-list
14395245|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
14395246|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14395247|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395248|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395249|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14395250|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
14395251|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395252|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
14395253|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395254|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
14395255|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395256|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14395257|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14395258|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395259|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14395260|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
14395261|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14395262|NCT01393106|Idelalisib|idelalisib|mesh-list
14395263|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395264|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395265|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395266|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14395267|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14395268|NCT01393158|Apremilast|apremilast|mesh-list
14395269|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14395270|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14395271|NCT01393158|Analgesics|analgesics|mesh-ancestor
14395272|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
14395273|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395274|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395275|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395276|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395277|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14395278|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14395279|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395280|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466983|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14466984|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14466985|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
14466986|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14466987|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14466988|NCT02254304|Interferons|interferons|mesh-list
14466989|NCT02254304|Interferon-beta|interferon-beta|mesh-list
14466990|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
14466991|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466992|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
14466993|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14466994|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
14466995|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14466996|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14466997|NCT02254551|Bortezomib|bortezomib|mesh-list
14466998|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14466999|NCT02254681|Gemcitabine|gemcitabine|mesh-list
14467000|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467001|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14467002|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
14467003|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467004|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
14467005|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467006|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467007|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14467008|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
15237475|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237476|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15237477|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237478|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237479|NCT03331198|Venetoclax|venetoclax|mesh-list
15237480|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237481|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15237482|NCT03296553|Valganciclovir|valganciclovir|mesh-list
15237483|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
15237484|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237485|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15237486|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237487|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237488|NCT03253796|Golimumab|golimumab|mesh-list
15237489|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15237490|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237491|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237492|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
15237493|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237494|NCT03205423|Gabapentin|gabapentin|mesh-list
15237495|NCT03205423|Analgesics|analgesics|mesh-ancestor
15237496|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
15237497|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237498|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237499|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
15237500|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15237501|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15237502|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237503|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15237504|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15237505|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15237506|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237507|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237508|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
15237509|NCT03187379|Bupivacaine|bupivacaine|mesh-list
15237510|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
15237511|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
15237512|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237513|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237514|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
15237515|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237516|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
15237517|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237518|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237519|NCT03150914|Sirolimus|sirolimus|mesh-list
14395281|NCT01393392|Methadone|methadone|mesh-list
14395282|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14395283|NCT01393392|Narcotics|narcotics|mesh-ancestor
14395284|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395285|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923691|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923692|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14395286|NCT01393392|Analgesics|analgesics|mesh-ancestor
14395287|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
14395288|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395289|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
14395290|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
14395291|NCT01393405|Methotrexate|methotrexate|mesh-list
14395292|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14395293|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
14395294|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14395295|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395296|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14395297|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
14395298|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395299|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395300|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
14395301|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395302|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14395303|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14395304|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
14395305|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395306|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14395307|NCT01393457|Levodopa|levodopa|mesh-list
14395308|NCT01393457|Carbidopa|carbidopa|mesh-list
14395309|NCT01393457|Ropinirole|ropinirole|mesh-list
14395310|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14395311|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14395312|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
14395313|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395314|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395315|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395316|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14395317|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395318|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
14395319|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
14395320|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14395321|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14395322|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395323|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395324|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
14395325|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395326|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395327|NCT01393626|Tofacitinib|tofacitinib|mesh-list
14395328|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395329|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395330|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395331|NCT01393704|Vasopressins|vasopressins|mesh-list
14395332|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
14395333|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
14395334|NCT01393704|Coagulants|coagulants|mesh-ancestor
14395335|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14395336|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14395337|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
14395338|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395339|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14395340|NCT01393717|Antibodies|antibodies|mesh-list
14395341|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
14395342|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14395343|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
14395344|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
14395345|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395346|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395347|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395348|NCT01393730|Prednisone|prednisone|mesh-list
14395349|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
14395350|NCT01393730|Dutasteride|dutasteride|mesh-list
14395351|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395352|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
14395353|NCT01393730|Hormones|hormones|mesh-ancestor
14395354|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395355|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923693|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923694|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14923695|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923696|NCT01951469|Pemetrexed|pemetrexed|mesh-list
14923697|NCT01951469|Gefitinib|gefitinib|mesh-list
14923698|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395356|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14395357|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395358|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14395359|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395360|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395361|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
14395362|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14395363|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14395364|NCT01393899|Tofacitinib|tofacitinib|mesh-list
14395365|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395366|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395367|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395368|NCT01393964|Dexamethasone|dexamethasone|mesh-list
14395369|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
14395370|NCT01393964|Lenalidomide|lenalidomide|mesh-list
14395371|NCT01393964|Elotuzumab|elotuzumab|mesh-list
14395372|NCT01393964|BB 1101|bb 1101|mesh-list
14395373|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395374|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
14395375|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
14395376|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395377|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395378|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395379|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
14395380|NCT01393964|Hormones|hormones|mesh-ancestor
14395381|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395382|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14395383|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395384|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
14395385|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395386|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395387|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
14395388|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395389|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395390|NCT01393964|Growth Substances|growth substances|mesh-ancestor
14395391|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395392|NCT01393990|Tamoxifen|tamoxifen|mesh-list
14395393|NCT01393990|Midazolam|midazolam|mesh-list
14395394|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14395395|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14395396|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395397|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395398|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14923699|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395399|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14395400|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14395401|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14395402|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
14395403|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
14395404|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
14395405|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
14395406|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395407|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395408|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14395409|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
14395410|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395411|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14395412|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395413|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14395414|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14395415|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14395416|NCT01394185|Dronabinol|dronabinol|mesh-list
14395417|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
14395418|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395419|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14395420|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14395421|NCT01394185|Analgesics|analgesics|mesh-ancestor
14395422|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
14395423|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395424|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15237520|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15237521|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237522|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15237523|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395425|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14395426|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395427|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395428|NCT01394185|Hormones|hormones|mesh-ancestor
14395429|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395430|NCT01394250|Lidocaine|lidocaine|mesh-list
14395431|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
14395432|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
14395433|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395434|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395435|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
14395436|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395437|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14395438|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14395439|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14395440|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395441|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395442|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
14395443|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14395444|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
14395445|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395446|NCT01394510|Expectorants|expectorants|mesh-ancestor
14395447|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
14395448|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14395449|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
14395450|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395451|NCT01394510|Protective Agents|protective agents|mesh-ancestor
14395452|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395453|NCT01394510|Antidotes|antidotes|mesh-ancestor
14395454|NCT01394523|Bupivacaine|bupivacaine|mesh-list
15237524|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
15237525|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237526|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
15237527|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237528|NCT03148795|Talazoparib|talazoparib|mesh-list
15237529|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15237530|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237531|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237532|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237533|NCT03098485|Azithromycin|azithromycin|mesh-list
15237534|NCT03098485|Levofloxacin|levofloxacin|mesh-list
15237535|NCT03098485|Ofloxacin|ofloxacin|mesh-list
15237536|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
15237537|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
15237538|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15237539|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395455|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
14395456|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
14395457|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395458|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395459|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
14395460|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395461|NCT01394614|Vaccines|vaccines|mesh-list
14395462|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
14395463|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395464|NCT01394627|Eplerenone|eplerenone|mesh-list
14395465|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14395466|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
14395467|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395468|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395469|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14395470|NCT01394627|Diuretics|diuretics|mesh-ancestor
14395471|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
14395472|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14395473|NCT01394718|Acetaminophen|acetaminophen|mesh-list
14395474|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14395475|NCT01394718|Analgesics|analgesics|mesh-ancestor
14395476|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
14395477|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395478|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395479|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
14395480|NCT01394939|Irinotecan|irinotecan|mesh-list
14395481|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14395482|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14395483|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395484|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395485|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395486|NCT01394952|Dulaglutide|dulaglutide|mesh-list
15237540|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14395487|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14395488|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395489|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
14395490|NCT01394991|Hematinics|hematinics|mesh-ancestor
14395491|NCT01395017|Dasatinib|dasatinib|mesh-list
14395492|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395493|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15237541|NCT03098485|Renal Agents|renal agents|mesh-ancestor
15237542|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15237543|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15237544|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237545|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395494|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395495|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395496|NCT01395030|Choline|choline|mesh-list
14395497|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
14395498|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14395499|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
14395500|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395501|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395502|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14395503|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
14395504|NCT01395043|Epinephrine|epinephrine|mesh-list
14395505|NCT01395043|Bupivacaine|bupivacaine|mesh-list
14395506|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
14395507|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
14395508|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395509|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395510|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
14395511|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395512|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14395513|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14395514|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14395515|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395516|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395517|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14395518|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14395519|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
14395520|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14395521|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
14395522|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
14395523|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
14395524|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14395525|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
14395526|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395527|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237546|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237547|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15237548|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15237549|NCT03086486|Linezolid|linezolid|mesh-list
15237550|NCT03086486|Bedaquiline|bedaquiline|mesh-list
15237551|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15237552|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237553|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15237554|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237555|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237556|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
15237557|NCT03077243|Cisplatin|cisplatin|mesh-list
15237558|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237559|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
15237560|NCT03049449|Fludarabine|fludarabine|mesh-list
15237561|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237562|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
15237563|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237564|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395528|NCT01395329|Metoprolol|metoprolol|mesh-list
14395529|NCT01395329|Nebivolol|nebivolol|mesh-list
14395530|NCT01395329|Nitroprusside|nitroprusside|mesh-list
14395531|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14395532|NCT01395329|BQ 788|bq 788|mesh-list
14395533|NCT01395329|Acetylcholine|acetylcholine|mesh-list
14395534|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14395535|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14395536|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
14395537|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
14395538|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395539|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395540|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14395541|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14395542|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14395543|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
14395544|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395545|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395546|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
14395547|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14395548|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14395549|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14395550|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14395551|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14395552|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395553|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14395554|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14395555|NCT01395524|Naloxegol|naloxegol|mesh-list
14395556|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14395557|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395558|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
14395559|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395560|NCT01395537|Paclitaxel|paclitaxel|mesh-list
14395561|NCT01395537|Carboplatin|carboplatin|mesh-list
14395562|NCT01395537|Lapatinib|lapatinib|mesh-list
14395563|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14395564|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395565|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14395566|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
14395567|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
14395568|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395569|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395570|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395571|NCT01395758|Gemcitabine|gemcitabine|mesh-list
14395572|NCT01395758|Docetaxel|docetaxel|mesh-list
14395573|NCT01395758|Pemetrexed|pemetrexed|mesh-list
14395574|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14395575|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237565|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15237566|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
15237567|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237568|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237569|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15237570|NCT03000569|Levodopa|levodopa|mesh-list
14395576|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
14753116|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
15237571|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
15237572|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15237573|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
15237574|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237575|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237576|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395577|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395578|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395579|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
14395580|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395581|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395582|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14395583|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
14395584|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395585|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
14395586|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
14395587|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
14395588|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14395589|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14395590|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395591|NCT01395784|Pioglitazone|pioglitazone|mesh-list
14395592|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14395593|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395594|NCT01395797|Pioglitazone|pioglitazone|mesh-list
14395595|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14395596|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395597|NCT01395823|Vitamin D|vitamin d|mesh-list
14395598|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
14395599|NCT01395823|Vitamins|vitamins|mesh-ancestor
14395600|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
14395601|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395602|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14395603|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14395604|NCT01395888|Fluticasone|fluticasone|mesh-list
14395605|NCT01395888|Xhance|xhance|mesh-list
14395606|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
14395607|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395608|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14395609|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
14395610|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395611|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395612|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14395613|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
14395614|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
14395615|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14395616|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
14395617|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14395618|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395619|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395620|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395621|NCT01395901|Ondansetron|ondansetron|mesh-list
14395622|NCT01395901|Palonosetron|palonosetron|mesh-list
14395623|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
14923700|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923701|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14923702|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14395624|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
14395625|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395626|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395627|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395628|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
14395629|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14395630|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14395631|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
14395632|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395633|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395634|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14395635|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14923703|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923704|NCT01940809|Nivolumab|nivolumab|mesh-list
14923705|NCT01940809|Ipilimumab|ipilimumab|mesh-list
14923706|NCT01940809|Trametinib|trametinib|mesh-list
14923707|NCT01940809|Dabrafenib|dabrafenib|mesh-list
14395636|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395637|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14923708|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395638|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14395639|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14395640|NCT01396005|Buprenorphine|buprenorphine|mesh-list
14395641|NCT01396005|Methadone|methadone|mesh-list
14395642|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14395643|NCT01396005|Naloxone|naloxone|mesh-list
14395644|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14395645|NCT01396005|Narcotics|narcotics|mesh-ancestor
14395646|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395647|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395648|NCT01396005|Analgesics|analgesics|mesh-ancestor
14395649|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
14395650|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395651|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14923709|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923710|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14923711|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923712|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14923713|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923714|NCT01891747|Ascorbic Acid|ascorbic acid|mesh-list
14923715|NCT01891747|Bevacizumab|bevacizumab|mesh-list
14923716|NCT01891747|Temozolomide|temozolomide|mesh-list
14923717|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395652|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
14395653|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
15237577|NCT02994784|Melphalan|melphalan|mesh-list
15237578|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15237579|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
15237580|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237581|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237582|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15237583|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237584|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
15237585|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237586|NCT02964507|Fulvestrant|fulvestrant|mesh-list
15237587|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237588|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237589|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15237590|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15237591|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
15237592|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395654|NCT01396057|Dexamethasone|dexamethasone|mesh-list
14395655|NCT01396057|Ranibizumab|ranibizumab|mesh-list
14395656|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395657|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
14395658|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
14395659|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395660|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395661|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395662|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
14395663|NCT01396057|Hormones|hormones|mesh-ancestor
14395664|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395665|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14395666|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395667|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395668|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395669|NCT01396057|Growth Substances|growth substances|mesh-ancestor
14395670|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395671|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14395672|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395673|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395674|NCT01396083|Dexamethasone|dexamethasone|mesh-list
14923718|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923719|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923720|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923721|NCT01891747|Growth Substances|growth substances|mesh-ancestor
14923722|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395675|NCT01396083|Ranibizumab|ranibizumab|mesh-list
14395676|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395677|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
14395678|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
14395679|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395680|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395681|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923723|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923724|NCT01891747|Vitamins|vitamins|mesh-ancestor
14395682|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
14395683|NCT01396083|Hormones|hormones|mesh-ancestor
14395684|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395685|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14395686|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923725|NCT01891747|Micronutrients|micronutrients|mesh-ancestor
14923726|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14923727|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
14923728|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923729|NCT01891747|Antioxidants|antioxidants|mesh-ancestor
14923730|NCT01891747|Protective Agents|protective agents|mesh-ancestor
14923731|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14923732|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14923733|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237593|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237594|NCT02964078|Aldesleukin|aldesleukin|mesh-list
15237595|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
15237596|NCT02964078|Interleukin-2|interleukin-2|mesh-list
15237597|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395687|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395688|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395689|NCT01396083|Growth Substances|growth substances|mesh-ancestor
14395690|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395691|NCT01396148|Sunitinib|sunitinib|mesh-list
14395692|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395693|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395694|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395695|NCT01396148|Growth Substances|growth substances|mesh-ancestor
15237598|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237599|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15237600|NCT02964078|Analgesics|analgesics|mesh-ancestor
15237601|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
15237602|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395696|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395697|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395698|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395699|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395700|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395701|NCT01396265|Rifampin|rifampin|mesh-list
14395702|NCT01396265|Afatinib|afatinib|mesh-list
14923734|NCT01879228|Incretins|incretins|mesh-ancestor
14923735|NCT01879228|Hormones|hormones|mesh-ancestor
14923736|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923737|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14923738|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
14395703|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14395704|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
14395705|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14395706|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395707|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
14395708|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14395709|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395710|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395711|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14395712|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14395713|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14395714|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14395715|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14395716|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14395717|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237603|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395718|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14395719|NCT01396395|Nicorandil|nicorandil|mesh-list
14395720|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14395721|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14395722|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
14395723|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
14395724|NCT01396395|Vitamins|vitamins|mesh-ancestor
14395725|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
14395726|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395727|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
14395728|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
14395729|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395730|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395731|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395732|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
14395733|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
14395734|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14395735|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
14395736|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395737|NCT01396447|Cariprazine|cariprazine|mesh-list
14395738|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14395739|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14395740|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395741|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395742|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14395743|NCT01396486|Inositol|inositol|mesh-list
14395744|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
14395745|NCT01396486|Vitamins|vitamins|mesh-ancestor
14395746|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
14923739|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923740|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923741|NCT01829958|Prednisone|prednisone|mesh-list
14395747|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395748|NCT01396512|Vaccines|vaccines|mesh-list
14395749|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
14395750|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395751|NCT01397084|Esomeprazole|esomeprazole|mesh-list
14395752|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14395753|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395754|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14395755|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395756|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395757|NCT01397409|Ranibizumab|ranibizumab|mesh-list
14395758|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395759|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395760|NCT01397409|Growth Substances|growth substances|mesh-ancestor
14395761|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395762|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395763|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395764|NCT01397422|Amantadine|amantadine|mesh-list
14395765|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14395766|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14395767|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
14395768|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923742|NCT01829958|Rituximab|rituximab|mesh-list
14923743|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237604|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15237605|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15237606|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
15237607|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237608|NCT02955394|Fulvestrant|fulvestrant|mesh-list
15237609|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237610|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237611|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15237612|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15237613|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
15237614|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395769|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
14395770|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395771|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395772|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237615|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237616|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15237617|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
14395773|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14395774|NCT01397422|Analgesics|analgesics|mesh-ancestor
14395775|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
14395776|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395777|NCT01397448|Rabeprazole|rabeprazole|mesh-list
14395778|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14395779|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395780|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14395781|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395782|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395783|NCT01397461|Retapamulin|retapamulin|mesh-list
14395784|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14395785|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395786|NCT01397591|Bortezomib|bortezomib|mesh-list
14395787|NCT01397591|Ofatumumab|ofatumumab|mesh-list
14395788|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395789|NCT01397825|Rituximab|rituximab|mesh-list
14395790|NCT01397825|Vincristine|vincristine|mesh-list
14395791|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395792|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395793|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
14395794|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395795|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237618|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15237619|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15237620|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237621|NCT02942017|Brexanolone|brexanolone|mesh-list
15237622|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
15237623|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237624|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237625|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237626|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
15237627|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
15237628|NCT02942004|Pregnanolone|pregnanolone|mesh-list
15237629|NCT02942004|Brexanolone|brexanolone|mesh-list
15237630|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
15237631|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237632|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237633|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237634|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
15237635|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
15237636|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
15237637|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237638|NCT02939573|Dapsone|dapsone|mesh-list
15237639|NCT02939573|Colchicine|colchicine|mesh-list
15237640|NCT02939573|Azathioprine|azathioprine|mesh-list
15237641|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
15237642|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237643|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
15237644|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
15237645|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237646|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237647|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237648|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
15237649|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237650|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237651|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
15237652|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237653|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237654|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
15237655|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15237656|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15237657|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15237658|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237659|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
15237660|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15237661|NCT02929589|Ibuprofen|ibuprofen|mesh-list
15237662|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
15237663|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15237664|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15237665|NCT02929589|Analgesics|analgesics|mesh-ancestor
15237666|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
15237667|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237668|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237669|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237670|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237671|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15237672|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237673|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237674|NCT02929589|Narcotics|narcotics|mesh-ancestor
15237675|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237676|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
15237677|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15237678|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237679|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15237680|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15237681|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237682|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237683|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395796|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14395797|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14395798|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14395799|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14395800|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395801|NCT01397890|Budesonide|budesonide|mesh-list
14395802|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
14395803|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
14395804|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14395805|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395806|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14395807|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
14395808|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395809|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395810|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14395811|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
14395812|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
14395813|NCT01397890|Hormones|hormones|mesh-ancestor
14395814|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14395815|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14395816|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14395817|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14395818|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
14395819|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395820|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395821|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
14395822|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14395823|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395824|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
14395825|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14395826|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14395827|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395828|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
14395829|NCT01398280|Coagulants|coagulants|mesh-ancestor
14395830|NCT01398410|Rabeprazole|rabeprazole|mesh-list
14395831|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14395832|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14395833|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14395834|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395835|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395836|NCT01398514|Citalopram|citalopram|mesh-list
14395837|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14395838|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14395839|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395840|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395841|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395842|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
14395843|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735142|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14735143|NCT00538811|Interferons|interferons|mesh-list
14735144|NCT00538811|Ribavirin|ribavirin|mesh-list
14395844|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14395845|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
14395846|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14735145|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
14735146|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
14395847|NCT01398943|Antioxidants|antioxidants|mesh-list
14395848|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395849|NCT01398943|Protective Agents|protective agents|mesh-ancestor
14395850|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395851|NCT01398956|Levetiracetam|levetiracetam|mesh-list
14395852|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
14395853|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
14395854|NCT01398982|Bupivacaine|bupivacaine|mesh-list
14395855|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
15237684|NCT02861300|Capecitabine|capecitabine|mesh-list
15237685|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237686|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
15237687|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237688|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237689|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
15237690|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
14923744|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923745|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
14395856|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
15237691|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237692|NCT02840227|Anesthetics|anesthetics|mesh-list
15237693|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237694|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237695|NCT02820857|Bevacizumab|bevacizumab|mesh-list
15237696|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237697|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237698|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395857|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14395858|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395859|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
14395860|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467009|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467010|NCT02254772|Ipilimumab|ipilimumab|mesh-list
14467011|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467012|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467013|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14467014|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467015|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
14467016|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467017|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467018|NCT02255110|Doxorubicin|doxorubicin|mesh-list
14467019|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14467020|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467021|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14467022|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14467023|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467024|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467025|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14467026|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14467027|NCT02255175|Estradiol|estradiol|mesh-list
14467028|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14467029|NCT02255175|Progesterone|progesterone|mesh-list
14467030|NCT02255175|Estrogens|estrogens|mesh-ancestor
14467031|NCT02255175|Hormones|hormones|mesh-ancestor
14467032|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467033|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467034|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14467035|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
14467036|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923746|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923747|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923748|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923749|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
14923750|NCT01829958|Hormones|hormones|mesh-ancestor
14923751|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923752|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14923753|NCT01805271|Everolimus|everolimus|mesh-list
15237699|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15237700|NCT02820857|Growth Substances|growth substances|mesh-ancestor
15237701|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237702|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
15237703|NCT02796391|Nicotine|nicotine|mesh-list
15237704|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14395861|NCT01399008|Colchicine|colchicine|mesh-list
14395862|NCT01399008|Allopurinol|allopurinol|mesh-list
14395863|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
14923754|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923755|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923756|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
14923757|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931062|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
14931063|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931064|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14931065|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14931066|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14931067|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14931068|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931069|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931070|NCT01437371|Ramipril|ramipril|mesh-list
14931071|NCT01437371|Enalapril|enalapril|mesh-list
14931072|NCT01437371|Lisinopril|lisinopril|mesh-list
14931073|NCT01437371|Captopril|captopril|mesh-list
14931074|NCT01437371|Trandolapril|trandolapril|mesh-list
14931075|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14931076|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14931077|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
15237705|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
15237706|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395864|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395865|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14395866|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14395867|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14395868|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237707|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237708|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15237709|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14395869|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735147|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
14735148|NCT00538811|Amantadine|amantadine|mesh-list
14735149|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735150|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
14735151|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735152|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
14735153|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735154|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
14735155|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735156|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14735157|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14735158|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
15237710|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395870|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
14395871|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395872|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14395873|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
14395874|NCT01399008|Protective Agents|protective agents|mesh-ancestor
14395875|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395876|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
14395877|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14395878|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395879|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14395880|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
14395881|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14395882|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395883|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395884|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237711|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237712|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237713|NCT02775435|Paclitaxel|paclitaxel|mesh-list
15237714|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15237715|NCT02775435|Carboplatin|carboplatin|mesh-list
15237716|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
15237717|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237718|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237719|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
15237720|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
14395885|NCT01399125|Rivastigmine|rivastigmine|mesh-list
14395886|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14735159|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931078|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395887|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395888|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395889|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
14395890|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395891|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395892|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14395893|NCT01399125|Protective Agents|protective agents|mesh-ancestor
14395894|NCT01399190|Bevacizumab|bevacizumab|mesh-list
14395895|NCT01399190|Capecitabine|capecitabine|mesh-list
14395896|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
14395897|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395898|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395899|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14395900|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14395901|NCT01399190|Growth Substances|growth substances|mesh-ancestor
14395902|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395903|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
14395904|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14395905|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
14395906|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395907|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
14395908|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14395909|NCT01399372|Cytarabine|cytarabine|mesh-list
14395910|NCT01399372|Rituximab|rituximab|mesh-list
14395911|NCT01399372|Methotrexate|methotrexate|mesh-list
14395912|NCT01399372|Vincristine|vincristine|mesh-list
14395913|NCT01399372|Procarbazine|procarbazine|mesh-list
14395914|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395915|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395916|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
14395917|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735160|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14735161|NCT00538811|Analgesics|analgesics|mesh-ancestor
14735162|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
14735163|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735164|NCT00538876|Decitabine|decitabine|mesh-list
14735165|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14735166|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
14923758|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
14923759|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14395918|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395919|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14395920|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
14395921|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14395922|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14395923|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
14395924|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395925|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
14395926|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395927|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14395928|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14395929|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14395930|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
15237721|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237722|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237723|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14395931|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735167|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923760|NCT01744093|Doxycycline|doxycycline|mesh-list
15237724|NCT02767531|Orlistat|orlistat|mesh-list
15237725|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237726|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237727|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14395932|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14395933|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735168|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735169|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735170|NCT00538889|Citalopram|citalopram|mesh-list
14395934|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14395935|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14395936|NCT01399593|Eculizumab|eculizumab|mesh-list
14395937|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14395938|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14395939|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
14395940|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395941|NCT01399697|Methotrexate|methotrexate|mesh-list
14395942|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15237728|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15237729|NCT02757898|Biotin|biotin|mesh-list
15237730|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
15237731|NCT02757898|Vitamins|vitamins|mesh-ancestor
15237732|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
15237733|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237734|NCT02737306|Leronlimab|leronlimab|mesh-list
15237735|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15237736|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15237737|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237738|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14395943|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
14395944|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14395945|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395946|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14395947|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
14395948|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395949|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14395950|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
14395951|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14395952|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14395953|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14395954|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
14395955|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14395956|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14395957|NCT01399723|Amoxicillin|amoxicillin|mesh-list
14395958|NCT01399723|Penicillins|penicillins|mesh-list
14395959|NCT01399723|Penicillin G|penicillin g|mesh-list
14395960|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14395961|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
14395962|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14395963|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395964|NCT01399827|Methylphenidate|methylphenidate|mesh-list
14395965|NCT01399827|Amphetamine|amphetamine|mesh-list
14395966|NCT01399827|Adderall|adderall|mesh-list
15237739|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15237740|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
15237741|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237742|NCT02728648|Oxycodone|oxycodone|mesh-list
15237743|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14395967|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
14395968|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14395969|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14395970|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14395971|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395972|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14395973|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14395974|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14395975|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395976|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
14395977|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395978|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14395979|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
14395980|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
14395981|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
15237744|NCT02728648|Narcotics|narcotics|mesh-ancestor
14395982|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14395983|NCT01399866|Cycloserine|cycloserine|mesh-list
14395984|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14395985|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14395986|NCT01399866|Renal Agents|renal agents|mesh-ancestor
14395987|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14395988|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
14395989|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14395990|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
14395991|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395992|NCT01399905|Carbidopa|carbidopa|mesh-list
14395993|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14395994|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14395995|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
14395996|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14395997|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14395998|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14395999|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14396000|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396001|NCT01400113|Asenapine|asenapine|mesh-list
14396002|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14396003|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14396004|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396005|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396006|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14396007|NCT01400139|Hydrocodone|hydrocodone|mesh-list
14396008|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14396009|NCT01400139|Narcotics|narcotics|mesh-ancestor
14396010|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396011|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396012|NCT01400139|Analgesics|analgesics|mesh-ancestor
14396013|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
14396014|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396015|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
14396016|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
14396017|NCT01400243|Nicotine|nicotine|mesh-list
14396018|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14396019|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
14396020|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396021|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396022|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14396023|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14396024|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
14396025|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396026|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396027|NCT01400412|Ritonavir|ritonavir|mesh-list
14396028|NCT01400412|Darunavir|darunavir|mesh-list
14396029|NCT01400412|Tenofovir|tenofovir|mesh-list
14396030|NCT01400412|Emtricitabine|emtricitabine|mesh-list
14396031|NCT01400412|Maraviroc|maraviroc|mesh-list
14396032|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14396033|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14396034|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
14396035|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396036|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396037|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14396038|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14396039|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
14396040|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396041|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14396042|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14396043|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14396044|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14396045|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14396046|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14396047|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14396048|NCT01400451|Ipilimumab|ipilimumab|mesh-list
14396049|NCT01400451|Vemurafenib|vemurafenib|mesh-list
14396050|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14396051|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396052|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14396053|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396054|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14396055|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396056|NCT01400503|Siltuximab|siltuximab|mesh-list
14396057|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396058|NCT01400516|Vitamin D|vitamin d|mesh-list
14396059|NCT01400516|Teriparatide|teriparatide|mesh-list
14396060|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14396061|NCT01400516|Calcium|calcium|mesh-list
14396062|NCT01400516|Vitamins|vitamins|mesh-ancestor
14396063|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
14396064|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396065|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14396066|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14396067|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14396068|NCT01400906|Fluticasone|fluticasone|mesh-list
14396069|NCT01400906|Xhance|xhance|mesh-list
14396070|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14396071|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14396072|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
14396073|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396074|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396075|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14396076|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
14396077|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14396078|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14396079|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14396080|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
14396081|NCT01400958|Modafinil|modafinil|mesh-list
14396082|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14396083|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396084|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14396085|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14396086|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14396087|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396088|NCT01401010|Doripenem|doripenem|mesh-list
14396089|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396090|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735171|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14735172|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14735173|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15237745|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237746|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237747|NCT02728648|Analgesics|analgesics|mesh-ancestor
15237748|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
15237749|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237750|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
15237751|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
15237752|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237753|NCT02679170|Crizotinib|crizotinib|mesh-list
15237754|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237755|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15237756|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237757|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237758|NCT02614547|Brexanolone|brexanolone|mesh-list
15237759|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
15237760|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237761|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237762|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237763|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
15237764|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
15237765|NCT02599454|Atezolizumab|atezolizumab|mesh-list
14396091|NCT01401023|Tigecycline|tigecycline|mesh-list
14396092|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396093|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396094|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14396095|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396096|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396097|NCT01401166|Trastuzumab|trastuzumab|mesh-list
14396098|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14396099|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396100|NCT01401322|Lenalidomide|lenalidomide|mesh-list
14396101|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
14396102|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396103|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14396104|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14396105|NCT01401322|Growth Substances|growth substances|mesh-ancestor
14396106|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
14396107|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396108|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
14396109|NCT01401465|Ciclesonide|ciclesonide|mesh-list
14396110|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14396111|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
14396112|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14396113|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
14396114|NCT01401465|Hormones|hormones|mesh-ancestor
14396115|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237766|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237767|NCT02595905|Cisplatin|cisplatin|mesh-list
15237768|NCT02595905|Veliparib|veliparib|mesh-list
15237769|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396116|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396117|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
14396118|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396119|NCT01401543|Tadalafil|tadalafil|mesh-list
14396120|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
14396121|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14396122|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14396123|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396124|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396125|NCT01401543|Urological Agents|urological agents|mesh-ancestor
14396126|NCT01401595|Dexetimide|dexetimide|mesh-list
14396127|NCT01401595|Citalopram|citalopram|mesh-list
14396128|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14396129|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14396130|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396131|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396132|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396133|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
14396134|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396135|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14396136|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
14396137|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14396138|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14396139|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14396140|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
14396141|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
15237770|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15237771|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237772|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237773|NCT02592551|Durvalumab|durvalumab|mesh-list
15237774|NCT02592551|Tremelimumab|tremelimumab|mesh-list
15237775|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237776|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237777|NCT02589691|Rocuronium|rocuronium|mesh-list
15237778|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15237779|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15237780|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15237781|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237782|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237783|NCT02583048|Dolutegravir|dolutegravir|mesh-list
15237784|NCT02583048|Bedaquiline|bedaquiline|mesh-list
15237785|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15237786|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15237787|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396142|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396143|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14396144|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14735174|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396145|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
14396146|NCT01401647|Lidocaine|lidocaine|mesh-list
14396147|NCT01401647|Amiodarone|amiodarone|mesh-list
14735175|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237788|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396148|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
14396149|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
14396150|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396151|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237789|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15237790|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15237791|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
15237792|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237793|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
15237794|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396152|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
14396153|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396154|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14396155|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14396156|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14396157|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396158|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396159|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
14396160|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14396161|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14396162|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14396163|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396164|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14396165|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14396166|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14396167|NCT01401959|Trastuzumab|trastuzumab|mesh-list
14396168|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14396169|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396170|NCT01402011|Lidocaine|lidocaine|mesh-list
14396171|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
14396172|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
14396173|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396174|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396175|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
14396176|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396177|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14396178|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14396179|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14396180|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396181|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396182|NCT01402050|Dinoprostone|dinoprostone|mesh-list
14396183|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
14396184|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14396185|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396186|NCT01402063|Temozolomide|temozolomide|mesh-list
14396187|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
15237795|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
15237796|NCT02546986|Azacitidine|azacitidine|mesh-list
15237797|NCT02546986|Cc-486|cc-486|mesh-list
15237798|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237799|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237800|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15237801|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
15237802|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237803|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237804|NCT02539160|Ticagrelor|ticagrelor|mesh-list
15237805|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15237806|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15237807|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15237808|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15237809|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
14923761|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14923762|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923763|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
14923764|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14923765|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14923766|NCT01740297|Ipilimumab|ipilimumab|mesh-list
14923767|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14923768|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237810|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14923769|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923770|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14923771|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923772|NCT01729754|Etanercept|etanercept|mesh-list
14923773|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14923774|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14923775|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14923776|NCT01729754|Analgesics|analgesics|mesh-ancestor
14923777|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
15237811|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237812|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237813|NCT02536300|Idelalisib|idelalisib|mesh-list
15237814|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237815|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237816|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237817|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
15237818|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237819|NCT02477618|Brexanolone|brexanolone|mesh-list
15237820|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
15237821|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237822|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237823|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237824|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
15237825|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
15237826|NCT02473497|Crizotinib|crizotinib|mesh-list
15237827|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237828|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15237829|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237830|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237831|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
15237832|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237833|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237834|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
15237835|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15237836|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15237837|NCT02444429|Prednisolone|prednisolone|mesh-list
15237838|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
15237839|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15237840|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
15237841|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237842|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
15237843|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
15237844|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237845|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237846|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396188|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14923778|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237847|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
15237848|NCT02444429|Hormones|hormones|mesh-ancestor
15237849|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237850|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15237851|NCT02444429|Protective Agents|protective agents|mesh-ancestor
15237852|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237853|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237854|NCT02424851|Thalidomide|thalidomide|mesh-list
15237855|NCT02424851|Dexamethasone|dexamethasone|mesh-list
15237856|NCT02424851|Bortezomib|bortezomib|mesh-list
15237857|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14396189|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
14923779|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923780|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923781|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923782|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923783|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923784|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
14923785|NCT01718743|Lenalidomide|lenalidomide|mesh-list
14923786|NCT01718743|Ixazomib|ixazomib|mesh-list
14923787|NCT01718743|Glycine|glycine|mesh-list
14923788|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
14923789|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923790|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923791|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923792|NCT01718743|Growth Substances|growth substances|mesh-ancestor
14923793|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923794|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923795|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735176|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
14735177|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735178|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14735179|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
14735180|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14396190|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396191|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396192|NCT01402284|Dexamethasone|dexamethasone|mesh-list
14396193|NCT01402284|Lenalidomide|lenalidomide|mesh-list
14396194|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14396195|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
14396196|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
14923796|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
14923797|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237858|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237859|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
15237860|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
15237861|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237862|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237863|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237864|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
15237865|NCT02424851|Hormones|hormones|mesh-ancestor
15237866|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237867|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237868|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237869|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15237870|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
15237871|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237872|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237873|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
15237874|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
15237875|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15237876|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237877|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15237878|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15237879|NCT02424851|Growth Substances|growth substances|mesh-ancestor
15237880|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
14735181|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
14396197|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923798|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
14923799|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15237881|NCT02423876|Hydromorphone|hydromorphone|mesh-list
14396198|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735182|NCT00538954|Antacids|antacids|mesh-ancestor
14735183|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735184|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14735185|NCT00538967|Doxycycline|doxycycline|mesh-list
14396199|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396200|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
14396201|NCT01402284|Hormones|hormones|mesh-ancestor
14396202|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396203|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14396204|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396205|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
14396206|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14396207|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14396208|NCT01402284|Growth Substances|growth substances|mesh-ancestor
14396209|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
14396210|NCT01402375|Acetaminophen|acetaminophen|mesh-list
14396211|NCT01402375|Oxycodone|oxycodone|mesh-list
14396212|NCT01402375|Hydrocodone|hydrocodone|mesh-list
14396213|NCT01402375|Codeine|codeine|mesh-list
14396214|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14396215|NCT01402375|Analgesics|analgesics|mesh-ancestor
14396216|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
14396217|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396218|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396219|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
14396220|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14396221|NCT01402375|Narcotics|narcotics|mesh-ancestor
14396222|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396223|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
14396224|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
14396225|NCT01402427|Verapamil|verapamil|mesh-list
14396226|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14396227|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14396228|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396229|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396230|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14396231|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396232|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
14396233|NCT01402492|Naltrexone|naltrexone|mesh-list
14396234|NCT01402492|Buprenorphine|buprenorphine|mesh-list
14396235|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14396236|NCT01402492|Naloxone|naloxone|mesh-list
14396237|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14396238|NCT01402492|Narcotics|narcotics|mesh-ancestor
14396239|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396240|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396241|NCT01402492|Analgesics|analgesics|mesh-ancestor
14396242|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
14396243|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396244|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14396245|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14396246|NCT01402544|Ranibizumab|ranibizumab|mesh-list
14396247|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14396248|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14396249|NCT01402544|Growth Substances|growth substances|mesh-ancestor
14735186|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14735187|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396250|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396251|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
14396252|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396253|NCT01402817|Sunitinib|sunitinib|mesh-list
14396254|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396255|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14396256|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14735188|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
14396257|NCT01402817|Growth Substances|growth substances|mesh-ancestor
14396258|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396259|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
14735189|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14735190|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14396260|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14396261|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396262|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396263|NCT01402869|Lidocaine|lidocaine|mesh-list
14396264|NCT01402869|Epinephrine|epinephrine|mesh-list
14396265|NCT01402869|Prilocaine|prilocaine|mesh-list
14396266|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
14396267|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
15237882|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15237883|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237884|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
15237885|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237886|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15237887|NCT02423876|Narcotics|narcotics|mesh-ancestor
15237888|NCT02423876|Analgesics|analgesics|mesh-ancestor
15237889|NCT02400814|Atezolizumab|atezolizumab|mesh-list
15237890|NCT02400814|Antibodies|antibodies|mesh-list
15237891|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14923800|NCT01668784|Nivolumab|nivolumab|mesh-list
15237892|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
15237893|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237894|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237895|NCT02319837|Leuprolide|leuprolide|mesh-list
15237896|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15237897|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
15237898|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14923801|NCT01668784|Everolimus|everolimus|mesh-list
14923802|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923803|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923804|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14923805|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923806|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923807|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
15237899|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237900|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14396268|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396269|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396270|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
14396271|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396272|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14396273|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14396274|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14396275|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396276|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396277|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14396278|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14396279|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
14923808|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237901|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237902|NCT02285504|Brexanolone|brexanolone|mesh-list
14735191|NCT00539071|Risperidone|risperidone|mesh-list
14735192|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14735193|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
14735194|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735195|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735196|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735197|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14735198|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14735199|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735200|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14735201|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14735202|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
14735203|NCT00539123|Buprenorphine|buprenorphine|mesh-list
14735204|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14735205|NCT00539123|Narcotics|narcotics|mesh-ancestor
14735206|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735207|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735208|NCT00539123|Analgesics|analgesics|mesh-ancestor
14396280|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396281|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14396282|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14396283|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
14396284|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14396285|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
14396286|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
14396287|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
14396288|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14396289|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
14396290|NCT01402947|Mesalamine|mesalamine|mesh-list
14396291|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396292|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396293|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14396294|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14396295|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396296|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396297|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396298|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14396299|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14396300|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14396301|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14396302|NCT01402947|Analgesics|analgesics|mesh-ancestor
14396303|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
14396304|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396305|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396306|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14396307|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14396308|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14396309|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
15237903|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
15237904|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396310|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396311|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
14396312|NCT01403051|Vitamin D|vitamin d|mesh-list
14735209|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
14735210|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735211|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14735212|NCT00539149|Amoxicillin|amoxicillin|mesh-list
14735213|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14735214|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735215|NCT00539331|Paclitaxel|paclitaxel|mesh-list
14735216|NCT00539331|Carboplatin|carboplatin|mesh-list
14735217|NCT00539331|Cediranib|cediranib|mesh-list
14735218|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14735219|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735220|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735221|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735222|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735223|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735224|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14396313|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
15237905|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237906|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237907|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
15237908|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
14396314|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
14396315|NCT01403051|Vitamins|vitamins|mesh-list
15237909|NCT02257528|Nivolumab|nivolumab|mesh-list
14396316|NCT01403051|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14396317|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
14396318|NCT01403051|Calcium|calcium|mesh-list
14396319|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
14396320|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396321|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14396322|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14396323|NCT01403051|Antacids|antacids|mesh-ancestor
14396324|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396325|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396326|NCT01403051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14396327|NCT01403051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14396328|NCT01403051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396329|NCT01403051|Antiviral Agents|antiviral agents|mesh-ancestor
14396330|NCT01403051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396331|NCT01403051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14396332|NCT01403051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14396333|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
14396334|NCT01403116|Testosterone|testosterone|mesh-list
14396335|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
14396336|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
14396337|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14396338|NCT01403116|Androgens|androgens|mesh-ancestor
14396339|NCT01403116|Hormones|hormones|mesh-ancestor
14923809|NCT01622998|Nicotine|nicotine|mesh-list
14923810|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14923811|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
14923812|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15237910|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237911|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396340|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396341|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396342|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14396343|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396344|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
14396345|NCT01403246|Lenalidomide|lenalidomide|mesh-list
14396346|NCT01403246|Chlorambucil|chlorambucil|mesh-list
14396347|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
14396348|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396349|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14396350|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14396351|NCT01403246|Growth Substances|growth substances|mesh-ancestor
14396352|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
14396353|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396354|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14396355|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
14396356|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396357|NCT01403376|Interferons|interferons|mesh-list
14396358|NCT01403376|Interferon-beta|interferon-beta|mesh-list
14396359|NCT01403376|Teriflunomide|teriflunomide|mesh-list
14396360|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
14396361|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396362|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
14396363|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396364|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14923813|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923814|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14923815|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14923816|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
14923817|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14923818|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923819|NCT01595620|Dronabinol|dronabinol|mesh-list
14923820|NCT01595620|Capsaicin|capsaicin|mesh-list
14923821|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
14923822|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923823|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14923824|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14923825|NCT01595620|Analgesics|analgesics|mesh-ancestor
14923826|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
14923827|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923828|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14923829|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14923830|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14923831|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237912|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15237913|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237914|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15237915|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15237916|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
15237917|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
15237918|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15237919|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
15237920|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15237921|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
15237922|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237923|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
15237924|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
15237925|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15237926|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15237927|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
15237928|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237929|NCT02073968|Paclitaxel|paclitaxel|mesh-list
15237930|NCT02073968|Carboplatin|carboplatin|mesh-list
15237931|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15237932|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15237933|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237934|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
15237935|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
15237936|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
15237937|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237938|NCT01971970|Adalimumab|adalimumab|mesh-list
15237939|NCT01971970|Infliximab|infliximab|mesh-list
14396365|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
14396366|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396367|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14396368|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14396369|NCT01403376|Analgesics|analgesics|mesh-ancestor
14396370|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
14396371|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396372|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237940|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923832|NCT01595620|Hormones|hormones|mesh-ancestor
14923833|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923834|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
14396373|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14396374|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396375|NCT01403610|Bevacizumab|bevacizumab|mesh-list
14396376|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
14396377|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14396378|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396379|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14396380|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923835|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
14923836|NCT01591629|Dronabinol|dronabinol|mesh-list
14923837|NCT01591629|Naloxone|naloxone|mesh-list
14923838|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14923839|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923840|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
14923841|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923842|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
14923843|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14923844|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14923845|NCT01591629|Analgesics|analgesics|mesh-ancestor
15237941|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237942|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
15237943|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15237944|NCT01969409|Rituximab|rituximab|mesh-list
15237945|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15237946|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237947|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
15237948|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237949|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237950|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
15237951|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15237952|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15237953|NCT01942122|Analgesics|analgesics|mesh-ancestor
15237954|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
15237955|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923846|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14396381|NCT01403610|Growth Substances|growth substances|mesh-ancestor
14396382|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396383|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
14396384|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14396385|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
14735225|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753117|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753118|NCT05266456|Vaccines|vaccines|mesh-list
14753119|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14753120|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
14753121|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396386|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396387|NCT01403805|Vaccines|vaccines|mesh-list
14396388|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15237956|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396389|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
14396390|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396391|NCT01404208|Cycloserine|cycloserine|mesh-list
14396392|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14396393|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396394|NCT01404208|Renal Agents|renal agents|mesh-ancestor
14396395|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14396396|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
14396397|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396398|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
14396399|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396400|NCT01404260|Gemcitabine|gemcitabine|mesh-list
14396401|NCT01404260|Carboplatin|carboplatin|mesh-list
14396402|NCT01404260|Gefitinib|gefitinib|mesh-list
14396403|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396404|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14396405|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
14396406|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396407|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
14396408|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396409|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396410|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396411|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
14396412|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396413|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14396414|NCT01404325|Everolimus|everolimus|mesh-list
14753122|NCT05262777|Lidocaine|lidocaine|mesh-list
14753123|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
15237957|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237958|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15237959|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15237960|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15237961|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237962|NCT01940094|Prednisone|prednisone|mesh-list
15237963|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
15237964|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15237965|NCT01940094|Hormones|hormones|mesh-ancestor
15237966|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237967|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237968|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15237969|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237970|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
15237971|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237972|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
15237973|NCT01869829|Clotrimazole|clotrimazole|mesh-list
15237974|NCT01869829|Miconazole|miconazole|mesh-list
15237975|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15237976|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15237977|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15237978|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15237979|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753124|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
14923847|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14923848|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14923849|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923850|NCT01591629|Hormones|hormones|mesh-ancestor
14923851|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923852|NCT01564537|Dexamethasone|dexamethasone|mesh-list
14923853|NCT01564537|Lenalidomide|lenalidomide|mesh-list
14923854|NCT01564537|Ixazomib|ixazomib|mesh-list
14923855|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923856|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
14923857|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
14923858|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923859|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923860|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923861|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
14923862|NCT01564537|Hormones|hormones|mesh-ancestor
14923863|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923864|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14923865|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923866|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
14923867|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923868|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923869|NCT01564537|Growth Substances|growth substances|mesh-ancestor
14923870|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923871|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
14923872|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923873|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923874|NCT01538966|Octreotide|octreotide|mesh-list
14923875|NCT01538966|Lanreotide|lanreotide|mesh-list
14923876|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923877|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14923878|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923879|NCT01525069|Gemcitabine|gemcitabine|mesh-list
14923880|NCT01525069|Dexamethasone|dexamethasone|mesh-list
14923881|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
14923882|NCT01525069|Floxuridine|floxuridine|mesh-list
14923883|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923884|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
14923885|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
14923886|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14923887|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923888|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14923889|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
14923890|NCT01525069|Hormones|hormones|mesh-ancestor
14396415|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923891|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14923892|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14923893|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923894|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14396416|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396417|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
14396418|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396419|NCT01404429|Methotrexate|methotrexate|mesh-list
14396420|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15237980|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237981|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15237982|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
15237983|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15237984|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237985|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15237986|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15237987|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
15237988|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15237989|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
15237990|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15237991|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14396421|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
14396422|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14396423|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396424|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14396425|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
15237992|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15237993|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
15237994|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15237995|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15237996|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15237997|NCT01754779|Indapamide|indapamide|mesh-list
15237998|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
14396426|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396427|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396428|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
14396429|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396430|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14396431|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396432|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
14396433|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14735226|NCT00539396|Insulin|insulin|mesh-list
14735227|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14735228|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735229|NCT00539409|Insulin|insulin|mesh-list
14735230|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
14396434|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14396435|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14396436|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14396437|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14396438|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
14396439|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396440|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396441|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14396442|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14396443|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
14396444|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735231|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14467037|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14467038|NCT02255175|Progestins|progestins|mesh-ancestor
14467039|NCT02255279|Vaccines|vaccines|mesh-list
14467040|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
14467041|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467042|NCT02255357|Oxytocin|oxytocin|mesh-list
15237999|NCT01754779|Citric Acid|citric acid|mesh-list
15238000|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
15238001|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
15238002|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15238003|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
15238004|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
14735232|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14923895|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
14396445|NCT01404832|Lansoprazole|lansoprazole|mesh-list
14396446|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
14396447|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14396448|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396449|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14396450|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396451|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396452|NCT01404923|Mebeverine|mebeverine|mesh-list
14396453|NCT01404923|Alverine|alverine|mesh-list
14396454|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
14396455|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
14396456|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396457|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396458|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
14396459|NCT01404936|Interferons|interferons|mesh-list
14396460|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
14396461|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
14396462|NCT01404936|Doxorubicin|doxorubicin|mesh-list
14396463|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14396464|NCT01404936|Bleomycin|bleomycin|mesh-list
14396465|NCT01404936|Dacarbazine|dacarbazine|mesh-list
14396466|NCT01404936|Vinblastine|vinblastine|mesh-list
14396467|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14396468|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238005|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238006|NCT01754779|Diuretics|diuretics|mesh-ancestor
15238007|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
15238008|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238009|NCT01754779|Expectorants|expectorants|mesh-ancestor
15238010|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
15238011|NCT01754779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15238012|NCT01754779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15238013|NCT01754779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15238014|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
15238015|NCT01752491|Temozolomide|temozolomide|mesh-list
15238016|NCT01752491|Vitamins|vitamins|mesh-ancestor
15238017|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
15238018|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238019|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15238020|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
15238021|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238022|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238023|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
15238024|NCT01752491|Protective Agents|protective agents|mesh-ancestor
15238025|NCT01665144|Siponimod|siponimod|mesh-list
15238026|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15238027|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238028|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396469|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14396470|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14396471|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396472|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735233|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238029|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
15238030|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238031|NCT01578954|Lenalidomide|lenalidomide|mesh-list
15238032|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
15238033|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396473|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
14396474|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396475|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
14396476|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396477|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14396478|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
14396479|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14396480|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
14396481|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
14396482|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14396483|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
14396484|NCT01404949|Tretinoin|tretinoin|mesh-list
14396485|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396486|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
14396487|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
14396488|NCT01405027|Interferons|interferons|mesh-list
14396489|NCT01405027|Ribavirin|ribavirin|mesh-list
14396490|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
14735234|NCT00539435|Insulin|insulin|mesh-list
14735235|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
14735236|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14735237|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735238|NCT00539448|Insulin|insulin|mesh-list
14735239|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14735240|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
14735241|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
14735242|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14735243|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735244|NCT00539565|Prednisolone|prednisolone|mesh-list
14735245|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14735246|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
14735247|NCT00539565|Hormones|hormones|mesh-ancestor
14735248|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735249|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735250|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735251|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735252|NCT00539630|Docetaxel|docetaxel|mesh-list
14735253|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238034|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15238035|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15238036|NCT01578954|Growth Substances|growth substances|mesh-ancestor
15238037|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
15238038|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238039|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15238040|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238041|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238042|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238043|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15238044|NCT01218555|Lenalidomide|lenalidomide|mesh-list
15238045|NCT01218555|Everolimus|everolimus|mesh-list
15238046|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
15238047|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238048|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15238049|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15238050|NCT01218555|Growth Substances|growth substances|mesh-ancestor
14396491|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
14396492|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14396493|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14735254|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
15238051|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
15238052|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735255|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735256|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753125|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396494|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396495|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
14396496|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396497|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
14396498|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396499|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
14396500|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396501|NCT01405053|Rufinamide|rufinamide|mesh-list
14396502|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
14396503|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15238053|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396504|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14396505|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396506|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396507|NCT01405456|Eplerenone|eplerenone|mesh-list
14396508|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14396509|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
14396510|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396511|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396512|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14396513|NCT01405456|Diuretics|diuretics|mesh-ancestor
14396514|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
14396515|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14396516|NCT01405508|Brivaracetam|brivaracetam|mesh-list
14396517|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
14396518|NCT01405560|Ribavirin|ribavirin|mesh-list
14396519|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
14396520|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396521|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
14396522|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396523|NCT01405742|Factor VIII|factor viii|mesh-list
14396524|NCT01405742|Coagulants|coagulants|mesh-ancestor
14396525|NCT01405768|Lidocaine|lidocaine|mesh-list
14396526|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
14396527|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
14396528|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396529|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396530|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
14396531|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396532|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14396533|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14396534|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14396535|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396536|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238054|NCT01161394|Pioglitazone|pioglitazone|mesh-list
15238055|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15238056|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238057|NCT01141712|Cytarabine|cytarabine|mesh-list
15238058|NCT01141712|Etoposide|etoposide|mesh-list
15238059|NCT01141712|Melphalan|melphalan|mesh-list
15238060|NCT01141712|Carmustine|carmustine|mesh-list
15238061|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15238062|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238063|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15238064|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15238065|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238066|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238067|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15238068|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
15238069|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
15238070|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238071|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238072|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
15238073|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238074|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15238075|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
15238076|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15238077|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
15238078|NCT01111305|Reslizumab|reslizumab|mesh-list
15238079|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15238080|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
15238081|NCT01111305|Filaricides|filaricides|mesh-ancestor
14396537|NCT01405820|Natalizumab|natalizumab|mesh-list
15238082|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
15238083|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
15238084|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15238085|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238086|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15238087|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238088|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238089|NCT00921856|Acetylcholine|acetylcholine|mesh-list
15238090|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
15238091|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15238092|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
15238093|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238094|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238095|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238096|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
15238097|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14396538|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
14396539|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396540|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15238098|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238099|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238100|NCT00659646|Levofloxacin|levofloxacin|mesh-list
15238101|NCT00659646|Ofloxacin|ofloxacin|mesh-list
15238102|NCT00659646|Gentamicins|gentamicins|mesh-list
15238103|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15238104|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238105|NCT00659646|Renal Agents|renal agents|mesh-ancestor
15238106|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15238107|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15238108|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15238109|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238110|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238111|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396541|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14396542|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396543|NCT01405911|Incretins|incretins|mesh-ancestor
14396544|NCT01405911|Hormones|hormones|mesh-ancestor
14396545|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396546|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14396547|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
14396548|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396549|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396550|NCT01405924|Dexamethasone|dexamethasone|mesh-list
14396551|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
14396552|NCT01405924|Aprepitant|aprepitant|mesh-list
14396553|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14396554|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
14396555|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
14396556|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396557|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396558|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396559|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
15238112|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15238113|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15238114|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15238115|NCT00567580|Leuprolide|leuprolide|mesh-list
15238116|NCT00567580|Goserelin|goserelin|mesh-list
14396560|NCT01405924|Hormones|hormones|mesh-ancestor
14396561|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396562|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14396563|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396564|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14396565|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396566|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396567|NCT01405937|Ribavirin|ribavirin|mesh-list
14396568|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
14396569|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396570|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
14396571|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396572|NCT01405950|Clonidine|clonidine|mesh-list
14396573|NCT01405950|Tizanidine|tizanidine|mesh-list
14396574|NCT01405950|Analgesics|analgesics|mesh-ancestor
14396575|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
14467043|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
14396576|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396577|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396578|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
14396579|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14396580|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14396581|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
14396582|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
14396583|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14396584|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14923896|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923897|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
14923898|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923899|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396585|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14396586|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
14396587|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396588|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396589|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14396590|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
14396591|NCT01406015|Spironolactone|spironolactone|mesh-list
14396592|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14396593|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
14396594|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396595|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396596|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14396597|NCT01406015|Diuretics|diuretics|mesh-ancestor
14396598|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
14396599|NCT01406223|Bupropion|bupropion|mesh-list
14396600|NCT01406223|Nicotine|nicotine|mesh-list
14396601|NCT01406223|Varenicline|varenicline|mesh-list
14396602|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14396603|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
14396604|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396605|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396606|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14396607|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14396608|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
14396609|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396610|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396611|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14396612|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
14396613|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14923900|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923901|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
14923902|NCT01515306|Paclitaxel|paclitaxel|mesh-list
14923903|NCT01515306|Ramucirumab|ramucirumab|mesh-list
14923904|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923905|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923906|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
14923907|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
14923908|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
14396614|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14396615|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14396616|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396617|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
14396618|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14396619|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15238117|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15238118|NCT00567580|Flutamide|flutamide|mesh-list
15238119|NCT00567580|Bicalutamide|bicalutamide|mesh-list
15238120|NCT00567580|Buserelin|buserelin|mesh-list
15238121|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15238122|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
15238123|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15238124|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238125|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15238126|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238127|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
15238128|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
15238129|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238130|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
15238131|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15238132|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
14923909|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396620|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396621|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
14396622|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14396623|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396624|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396625|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14396626|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396627|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14396628|NCT01406795|Heparin|heparin|mesh-list
14396629|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
14396630|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14923910|NCT01513187|Interferons|interferons|mesh-list
14923911|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
14923912|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
14396631|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14396632|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396633|NCT01406873|Mexiletine|mexiletine|mesh-list
14396634|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14396635|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14396636|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14396637|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396638|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923913|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923914|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
14923915|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923916|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
14396639|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14396640|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
14396641|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396642|NCT01407094|Sertraline|sertraline|mesh-list
14396643|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
14396644|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14396645|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14396646|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14396647|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396648|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396649|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396650|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
14396651|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396652|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
14396653|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
14396654|NCT01407523|Levetiracetam|levetiracetam|mesh-list
14396655|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
14396656|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
14735257|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735258|NCT00539669|Docetaxel|docetaxel|mesh-list
14735259|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735260|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735261|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735262|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735263|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735264|NCT00539773|Interferons|interferons|mesh-list
14735265|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735266|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
14735267|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735268|NCT00539786|Rabeprazole|rabeprazole|mesh-list
14735269|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14396657|NCT01407575|Buprenorphine|buprenorphine|mesh-list
14735270|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14923917|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923918|NCT01464268|Riboflavin|riboflavin|mesh-list
14923919|NCT01464268|Dextrans|dextrans|mesh-list
14735271|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14735272|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238133|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15238134|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14396658|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14396659|NCT01407575|Narcotics|narcotics|mesh-ancestor
14396660|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396661|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396662|NCT01407575|Analgesics|analgesics|mesh-ancestor
14396663|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
14396664|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396665|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14396666|NCT01408030|Bevacizumab|bevacizumab|mesh-list
14396667|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
14396668|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
14396669|NCT01408030|Estrogens|estrogens|mesh-list
14396670|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14396671|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396672|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14396673|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14396674|NCT01408030|Growth Substances|growth substances|mesh-ancestor
14396675|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396676|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
14396677|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14396678|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14396679|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396680|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
14396681|NCT01408030|Coagulants|coagulants|mesh-ancestor
14396682|NCT01408030|Hormones|hormones|mesh-ancestor
14396683|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396684|NCT01408043|Plerixafor|plerixafor|mesh-list
14396685|NCT01408043|Etoposide|etoposide|mesh-list
14396686|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
14396687|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14396688|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396689|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14396690|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14396691|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396692|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396693|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14396694|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14396695|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
14396696|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396697|NCT01408563|Fludarabine|fludarabine|mesh-list
14396698|NCT01408563|Melphalan|melphalan|mesh-list
14396699|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396700|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238135|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
15238136|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238137|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238138|NCT00477412|Cytarabine|cytarabine|mesh-list
15238139|NCT00477412|Dexamethasone|dexamethasone|mesh-list
15238140|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
15238141|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
15238142|NCT00477412|Rituximab|rituximab|mesh-list
15238143|NCT00477412|Doxorubicin|doxorubicin|mesh-list
15238144|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15238145|NCT00477412|Methotrexate|methotrexate|mesh-list
15238146|NCT00477412|Vincristine|vincristine|mesh-list
15238147|NCT00477412|Bortezomib|bortezomib|mesh-list
15238148|NCT00477412|Daunorubicin|daunorubicin|mesh-list
15238149|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15238150|NCT00477412|Antibodies|antibodies|mesh-list
15238151|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
15238152|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15238153|NCT00477412|BB 1101|bb 1101|mesh-list
15238154|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238155|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
15238156|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238157|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15238158|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15238159|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
15238160|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238161|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238162|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15238163|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923920|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
15238164|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
15238165|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
15238166|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238167|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238168|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
14396701|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396702|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
14735273|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735274|NCT00539799|Prednisolone|prednisolone|mesh-list
14735275|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14735276|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
14735277|NCT00539799|Hormones|hormones|mesh-ancestor
14735278|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735279|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735280|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735281|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735282|NCT00539877|Irinotecan|irinotecan|mesh-list
14735283|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14396703|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396704|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14396705|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
14396706|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14396707|NCT01408576|Epratuzumab|epratuzumab|mesh-list
14396708|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14396709|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396710|NCT01408628|Insulin|insulin|mesh-list
14396711|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14396712|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396713|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
14396714|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14396715|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14396716|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14396717|NCT01408888|Dulaglutide|dulaglutide|mesh-list
14396718|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14396719|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396720|NCT01408888|Incretins|incretins|mesh-ancestor
14396721|NCT01408888|Hormones|hormones|mesh-ancestor
14396722|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396723|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14396724|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14396725|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396726|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396727|NCT01408901|Molgramostim|molgramostim|mesh-list
14396728|NCT01408901|Sargramostim|sargramostim|mesh-list
14396729|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
14396730|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396731|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396732|NCT01408914|Rifampin|rifampin|mesh-list
14396733|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14396734|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
14396735|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396736|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396737|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
14396738|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14396739|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396740|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396741|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14735284|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15238169|NCT00477412|Hormones|hormones|mesh-ancestor
15238170|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238171|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15238172|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15238173|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15238174|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15238175|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238176|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15238177|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
15238178|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15238179|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15238180|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
15238181|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
15238182|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14396742|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14396743|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14396744|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14396745|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14396746|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14396747|NCT01409239|Insulin|insulin|mesh-list
14396748|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14396749|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14396750|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396751|NCT01409564|Cilostazol|cilostazol|mesh-list
14396752|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14396753|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
14396754|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396755|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396756|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14396757|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
14396758|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14396759|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14396760|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396761|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14396762|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
14396763|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15238183|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15238184|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
15238185|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238186|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15238187|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
14396764|NCT01409564|Protective Agents|protective agents|mesh-ancestor
14396765|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14396766|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14396767|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396768|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
14396769|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14396770|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396771|NCT01409837|Lisinopril|lisinopril|mesh-list
14396772|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14396773|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
14396774|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396775|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396776|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15238188|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
15238189|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238190|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
14396777|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14396778|NCT01409837|Protective Agents|protective agents|mesh-ancestor
14396779|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396780|NCT01409915|Molgramostim|molgramostim|mesh-list
15238191|NCT00369317|Cytarabine|cytarabine|mesh-list
14396781|NCT01409915|Sargramostim|sargramostim|mesh-list
14396782|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
15238192|NCT00369317|Etoposide|etoposide|mesh-list
15238193|NCT00369317|Daunorubicin|daunorubicin|mesh-list
15238194|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
15238195|NCT00369317|Asparaginase|asparaginase|mesh-list
15238196|NCT00369317|Thioguanine|thioguanine|mesh-list
15238197|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15238198|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238199|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15238200|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15238201|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238202|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238203|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15238204|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
15238205|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
15238206|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238207|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238208|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
15238209|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238210|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15238211|NCT00261807|Daptomycin|daptomycin|mesh-list
15238212|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15238213|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396783|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396784|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396785|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
14396786|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
14396787|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14396788|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14396789|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396790|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396791|NCT01409993|Urological Agents|urological agents|mesh-ancestor
14396792|NCT01410058|Efavirenz|efavirenz|mesh-list
14396793|NCT01410058|Nevirapine|nevirapine|mesh-list
14396794|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14396795|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14396796|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396797|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396798|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
14396799|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396800|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14396801|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14396802|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14396803|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14396804|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14396805|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14396806|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14396807|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14396808|NCT01410084|Vitamin D|vitamin d|mesh-list
14396809|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
14396810|NCT01410084|Vitamins|vitamins|mesh-list
14396811|NCT01410084|Vitamin E|vitamin e|mesh-list
14396812|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
14396813|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396814|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14396815|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14396816|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
14396817|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396818|NCT01410084|Protective Agents|protective agents|mesh-ancestor
15238214|NCT05216653|Capecitabine|capecitabine|mesh-list
15238215|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
14396819|NCT01410227|Factor VIII|factor viii|mesh-list
14396820|NCT01410227|Coagulants|coagulants|mesh-ancestor
14396821|NCT01410240|Hemostatics|hemostatics|mesh-list
14396822|NCT01410240|Coagulants|coagulants|mesh-ancestor
14396823|NCT01410344|Vidarabine|vidarabine|mesh-list
14396824|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
14396825|NCT01410344|Melphalan|melphalan|mesh-list
14396826|NCT01410344|Busulfan|busulfan|mesh-list
14396827|NCT01410344|Fludarabine|fludarabine|mesh-list
14396828|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
14396829|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396830|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
14396831|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396832|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14396833|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14396834|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
14396835|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396836|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396837|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14396838|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14396839|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
14396840|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
14396841|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396842|NCT01410409|Acetaminophen|acetaminophen|mesh-list
14396843|NCT01410409|Pantoprazole|pantoprazole|mesh-list
14396844|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14396845|NCT01410409|Analgesics|analgesics|mesh-ancestor
14396846|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
14396847|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396848|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396849|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
14396850|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14396851|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396852|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14396853|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396854|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396855|NCT01410448|Cyclosporine|cyclosporine|mesh-list
14396856|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
14396857|NCT01410448|Everolimus|everolimus|mesh-list
14396858|NCT01410448|Cyclosporins|cyclosporins|mesh-list
14396859|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396860|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396861|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396862|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
15238216|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15238217|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
15238218|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238219|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396863|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396864|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
14396865|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396866|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
14396867|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14396868|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14396869|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396870|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14396871|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14396872|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
14396873|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396874|NCT01410565|Apaziquone|apaziquone|mesh-list
14396875|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396876|NCT01410604|Metformin|metformin|mesh-list
14396877|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14396878|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396879|NCT01411085|Risperidone|risperidone|mesh-list
14396880|NCT01411085|Desipramine|desipramine|mesh-list
14396881|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14396882|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
14396883|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396884|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396885|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396886|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14396887|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14396888|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396889|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14396890|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14396891|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
15238220|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
15238221|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15238222|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238223|NCT05216419|Vitamins|vitamins|mesh-ancestor
15238224|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
15238225|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15238226|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
15238227|NCT05216237|Apatinib|apatinib|mesh-list
15238228|NCT05216237|Tegafur|tegafur|mesh-list
15238229|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238230|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15238231|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238232|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238233|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15238234|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
15238235|NCT05215925|Cetuximab|cetuximab|mesh-list
14396892|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14396893|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
14396894|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14396895|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14396896|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14396897|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396898|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
14396899|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14396900|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14396901|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
15238236|NCT05215925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238237|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238238|NCT05215873|Misoprostol|misoprostol|mesh-list
15238239|NCT05215873|Oxytocin|oxytocin|mesh-list
15238240|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
14396902|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396903|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14396904|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14396905|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
14396906|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
14396907|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238241|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15238242|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238243|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15238244|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
15238245|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15238246|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238247|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
15238248|NCT05215743|Antioxidants|antioxidants|mesh-list
14396908|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396909|NCT01411215|Etanercept|etanercept|mesh-list
14396910|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14396911|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14396912|NCT01411215|Analgesics|analgesics|mesh-ancestor
14396913|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
14396914|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396915|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396916|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14923921|NCT01464268|Vitamins|vitamins|mesh-ancestor
14923922|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
14923923|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923924|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14923925|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
14923926|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
14923927|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
14923928|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
14396917|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14396918|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396919|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396920|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
14396921|NCT01411501|Mosapride|mosapride|mesh-list
14396922|NCT01411501|Citric Acid|citric acid|mesh-list
14396923|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
14396924|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
14923929|NCT01433965|Lenalidomide|lenalidomide|mesh-list
15238249|NCT05215743|Deferoxamine|deferoxamine|mesh-list
15238250|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
15238251|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396925|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14396926|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
14396927|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
14396928|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396929|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396930|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14396931|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
14396932|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14396933|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467044|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14467045|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467046|NCT02255461|Palbociclib|palbociclib|mesh-list
14467047|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467048|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14467049|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467050|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467051|NCT02255500|Bupivacaine|bupivacaine|mesh-list
14467052|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
14467053|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
14467054|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467055|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467056|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
14467057|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467058|NCT02255513|Methylphenidate|methylphenidate|mesh-list
14467059|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14467060|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467061|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14467062|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14467063|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14467064|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467065|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
14467066|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467067|NCT02255565|Methylphenidate|methylphenidate|mesh-list
14467068|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14467069|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467070|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14467071|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14467072|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14467073|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467074|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
14467075|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467076|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14467077|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
14396934|NCT01411696|Dexamethasone|dexamethasone|mesh-list
14396935|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14396936|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
14396937|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
14396938|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238252|NCT05215743|Expectorants|expectorants|mesh-ancestor
15238253|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
15238254|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15238255|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238256|NCT05215743|Protective Agents|protective agents|mesh-ancestor
15238257|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238258|NCT05215743|Siderophores|siderophores|mesh-ancestor
15238259|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15238260|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
15238261|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
15238262|NCT05215730|Copper|copper|mesh-list
14396939|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396940|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14396941|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
14396942|NCT01411696|Hormones|hormones|mesh-ancestor
14396943|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14396944|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14396945|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396946|NCT01411774|Cycloserine|cycloserine|mesh-list
14396947|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14396948|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396949|NCT01411774|Renal Agents|renal agents|mesh-ancestor
14396950|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14396951|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
14396952|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396953|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
14396954|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396955|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
14396956|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14396957|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396958|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
14396959|NCT01411995|Lidocaine|lidocaine|mesh-list
14396960|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
14396961|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
14396962|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396963|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396964|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
14396965|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14396966|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14396967|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14396968|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14396969|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14396970|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396971|NCT01412060|Cariprazine|cariprazine|mesh-list
14396972|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14396973|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14735285|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238263|NCT05215730|Trace Elements|trace elements|mesh-ancestor
14923930|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
14396974|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14396975|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396976|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14396977|NCT01412164|Sirolimus|sirolimus|mesh-list
14396978|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14396979|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14396980|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14396981|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396982|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
14396983|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14396984|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
14396985|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396986|NCT01412229|Paclitaxel|paclitaxel|mesh-list
14396987|NCT01412229|Carboplatin|carboplatin|mesh-list
14396988|NCT01412229|Cetuximab|cetuximab|mesh-list
14396989|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14923931|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923932|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923933|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923934|NCT01433965|Growth Substances|growth substances|mesh-ancestor
14923935|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923936|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923937|NCT01360593|Gemcitabine|gemcitabine|mesh-list
14923938|NCT01360593|Capecitabine|capecitabine|mesh-list
14923939|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14923940|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
14923941|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923942|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923943|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
14923944|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923945|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923946|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14923947|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
14923948|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923949|NCT01354977|Resveratrol|resveratrol|mesh-list
14923950|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
14923951|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923952|NCT01354977|Protective Agents|protective agents|mesh-ancestor
14923953|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238264|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
15238265|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238266|NCT05215665|Lenvatinib|lenvatinib|mesh-list
15238267|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238268|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14396990|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14396991|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
14396992|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
14396993|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
14396994|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14396995|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14396996|NCT01412281|Vaccines|vaccines|mesh-list
14396997|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
14396998|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14396999|NCT01412372|Mesalamine|mesalamine|mesh-list
14397000|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14397001|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14397002|NCT01412372|Analgesics|analgesics|mesh-ancestor
14397003|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
14397004|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397005|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238269|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238270|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238271|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
15238272|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
15238273|NCT05215366|Coagulants|coagulants|mesh-ancestor
15238274|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15238275|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14735286|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735287|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735288|NCT00539890|Insulin|insulin|mesh-list
14923954|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238276|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
14397006|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397007|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397008|NCT01412424|Octreotide|octreotide|mesh-list
14397009|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397010|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14397011|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397012|NCT01412710|Vitamin D|vitamin d|mesh-list
14397013|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
14397014|NCT01412710|Vitamins|vitamins|mesh-ancestor
14397015|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
14397016|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397017|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14397018|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14397019|NCT01412879|Leucovorin|leucovorin|mesh-list
14397020|NCT01412879|Cytarabine|cytarabine|mesh-list
14397021|NCT01412879|Dexamethasone|dexamethasone|mesh-list
14397022|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
14397023|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14735289|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14735290|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735291|NCT00539968|Docetaxel|docetaxel|mesh-list
14735292|NCT00539968|Lonafarnib|lonafarnib|mesh-list
14735293|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735294|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735295|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735296|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735297|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735298|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14923955|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14923956|NCT01354431|Nivolumab|nivolumab|mesh-list
14923957|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923958|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14923959|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14923960|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923961|NCT01334606|Insulin|insulin|mesh-list
14923962|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14923963|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397024|NCT01412879|Rituximab|rituximab|mesh-list
14735299|NCT00540072|Daptomycin|daptomycin|mesh-list
14735300|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15238277|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238278|NCT05215106|Durvalumab|durvalumab|mesh-list
14397025|NCT01412879|Doxorubicin|doxorubicin|mesh-list
14397026|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14397027|NCT01412879|Methotrexate|methotrexate|mesh-list
14397028|NCT01412879|Vincristine|vincristine|mesh-list
14397029|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
14397030|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397031|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
14397032|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397033|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397034|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14397035|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
14397036|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397037|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397038|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14397039|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397040|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
14397041|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
14397042|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397043|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397044|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
14397045|NCT01412879|Hormones|hormones|mesh-ancestor
14397046|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397047|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14397048|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397049|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14397050|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14397051|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14397052|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397053|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14397054|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
14397055|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397056|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14397057|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
14397058|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
14397059|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14397060|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14397061|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
14397062|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397063|NCT01412879|Antidotes|antidotes|mesh-ancestor
14397064|NCT01412879|Protective Agents|protective agents|mesh-ancestor
14397065|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
14397066|NCT01412879|Vitamins|vitamins|mesh-ancestor
14397067|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
14397068|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14397069|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
14397070|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
14397071|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
14397072|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14397073|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
14397074|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397075|NCT01412957|Panitumumab|panitumumab|mesh-list
14397076|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397077|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735301|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397078|NCT01413178|Melphalan|melphalan|mesh-list
14397079|NCT01413178|Busulfan|busulfan|mesh-list
14735302|NCT00540085|Rocuronium|rocuronium|mesh-list
14397080|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14397081|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
14397082|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397083|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397084|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14397085|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397086|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
14397087|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397088|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14397089|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
14397090|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397091|NCT01413360|Vitamins|vitamins|mesh-list
14397092|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
14397093|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
14397094|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397095|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
14397096|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397097|NCT01413360|Protective Agents|protective agents|mesh-ancestor
14397098|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14397099|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397100|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397101|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397102|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14397103|NCT01413516|Varenicline|varenicline|mesh-list
14397104|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14397105|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14397106|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
15238279|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238280|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238281|NCT05214911|Loratadine|loratadine|mesh-list
15238282|NCT05214911|Prednisolone|prednisolone|mesh-list
15238283|NCT05214911|Desloratadine|desloratadine|mesh-list
15238284|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15238285|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
15238286|NCT05214911|Hormones|hormones|mesh-ancestor
15238287|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238288|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238289|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15238290|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238291|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15238292|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
15238293|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238294|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238295|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15238296|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15238297|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
15238298|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
15238299|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
15238300|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
15238301|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15238302|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15238303|NCT05214872|Calcium|calcium|mesh-list
15238304|NCT05214872|Mitogens|mitogens|mesh-list
15238305|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15238306|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238307|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238308|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238309|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
15238310|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15238311|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
15238312|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238313|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15238314|NCT05193591|Autoantibodies|autoantibodies|mesh-list
15238315|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
15238316|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238317|NCT05193487|Anesthetics|anesthetics|mesh-list
15238318|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15238319|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238320|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15238321|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15238322|NCT05189145|Hormones|hormones|mesh-list
15238323|NCT05189145|Estradiol|estradiol|mesh-list
15238324|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15238325|NCT05189145|Progesterone|progesterone|mesh-list
15238326|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
15238327|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238328|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238329|NCT05189145|Estrogens|estrogens|mesh-ancestor
15238330|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15238331|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
15238332|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15238333|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15238334|NCT05189145|Progestins|progestins|mesh-ancestor
15238335|NCT05186571|Vaccines|vaccines|mesh-list
15238336|NCT05186571|Immunologic Factors|immunologic factors|mesh-ancestor
15238337|NCT05186571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238338|NCT05183854|Vaccines|vaccines|mesh-list
14397107|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397108|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397109|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397110|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14397111|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14397112|NCT01413542|Enalaprilat|enalaprilat|mesh-list
14397113|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14397114|NCT01413542|Bradykinin|bradykinin|mesh-list
14397115|NCT01413542|Glucagon|glucagon|mesh-list
14397116|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14397117|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14397118|NCT01413542|Substance P|substance p|mesh-list
14397119|NCT01413542|Neurokinin A|neurokinin a|mesh-list
14397120|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14397121|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397122|NCT01413542|Incretins|incretins|mesh-ancestor
14397123|NCT01413542|Hormones|hormones|mesh-ancestor
14397124|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397125|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
14397126|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397127|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397128|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397129|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
14397130|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
14397131|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14397132|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397133|NCT01413750|Paclitaxel|paclitaxel|mesh-list
14397134|NCT01413750|Carboplatin|carboplatin|mesh-list
14397135|NCT01413750|Vorinostat|vorinostat|mesh-list
14397136|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14397137|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397138|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14397139|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14397140|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14397141|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397142|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14397143|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397144|NCT01413958|Loratadine|loratadine|mesh-list
14397145|NCT01413958|Phenylephrine|phenylephrine|mesh-list
14397146|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
14397147|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14397148|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
14397149|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
14397150|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397151|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397152|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
14397153|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14397154|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
14397155|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
14923964|NCT01233297|Azithromycin|azithromycin|mesh-list
15238339|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14397156|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14397157|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14397158|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14397159|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
14397160|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397161|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397162|NCT01413958|Protective Agents|protective agents|mesh-ancestor
14397163|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
14397164|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
14397165|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14397166|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14397167|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14397168|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
14397169|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
14397170|NCT01414010|Amoxicillin|amoxicillin|mesh-list
14397171|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14397172|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397173|NCT01414075|Iron|iron|mesh-list
14397174|NCT01414075|Trace Elements|trace elements|mesh-ancestor
14397175|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
14397176|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397177|NCT01414153|Bevacizumab|bevacizumab|mesh-list
14397178|NCT01414153|Ranibizumab|ranibizumab|mesh-list
14397179|NCT01414153|Aflibercept|aflibercept|mesh-list
14397180|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14397181|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397182|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238340|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
15238341|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238342|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15238343|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
15238344|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238345|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238346|NCT05160922|Crizotinib|crizotinib|mesh-list
15238347|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397183|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14397184|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14397185|NCT01414153|Growth Substances|growth substances|mesh-ancestor
14397186|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397187|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
14397188|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
14397189|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
14397190|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397191|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397192|NCT01414257|Methotrexate|methotrexate|mesh-list
14397193|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14397194|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
14397195|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397196|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397197|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14397198|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
14397199|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397200|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397201|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14397202|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397203|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14397204|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397205|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
14397206|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397207|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14397208|NCT01414855|Prednisone|prednisone|mesh-list
14397209|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
14397210|NCT01414855|Doxorubicin|doxorubicin|mesh-list
14397211|NCT01414855|Vincristine|vincristine|mesh-list
14397212|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
14397213|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397214|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
14397215|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397216|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397217|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14397218|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
14397219|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397220|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397221|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14397222|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14397223|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14397224|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14397225|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397226|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397227|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
14397228|NCT01414855|Hormones|hormones|mesh-ancestor
14397229|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397230|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14397231|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14397232|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
14397233|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
14397234|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
14397235|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397236|NCT01415349|Omeprazole|omeprazole|mesh-list
14397237|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14397238|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397239|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14397240|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397241|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397242|NCT01415401|Timolol|timolol|mesh-list
14397243|NCT01415401|Brinzolamide|brinzolamide|mesh-list
14397244|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14397245|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14397246|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
14397247|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397248|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397249|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397250|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14397251|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14397252|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397253|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14397254|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14397255|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14397256|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397257|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14397258|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14397259|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397260|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397261|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
14397262|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397263|NCT01415518|Budesonide|budesonide|mesh-list
14397264|NCT01415518|Theophylline|theophylline|mesh-list
14397265|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
14397266|NCT01415518|Ipratropium|ipratropium|mesh-list
14397267|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14397268|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14735303|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14735304|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14735305|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14735306|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397269|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14397270|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
14397271|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397272|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397273|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14397274|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
14397275|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
14397276|NCT01415518|Hormones|hormones|mesh-ancestor
14397277|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397278|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14397279|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14397280|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14397281|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
14397282|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397283|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397284|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14397285|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
14397286|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14397287|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397288|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
14397289|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14397290|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14397291|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
14397292|NCT01415531|Nebivolol|nebivolol|mesh-list
14397293|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14397294|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
14397295|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14397296|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14397297|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14397298|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
14397299|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397300|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397301|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397302|NCT01415583|Dexamethasone|dexamethasone|mesh-list
14397303|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397304|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
14397305|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
14397306|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397307|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397308|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238348|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15238349|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238350|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735307|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735308|NCT00540098|Paroxetine|paroxetine|mesh-list
14735309|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14735310|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14735311|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15238351|NCT05154994|Durvalumab|durvalumab|mesh-list
15238352|NCT05154994|Ipilimumab|ipilimumab|mesh-list
15238353|NCT05154994|Tremelimumab|tremelimumab|mesh-list
15238354|NCT05154994|Belinostat|belinostat|mesh-list
15238355|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
15238356|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14397309|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
15238357|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
15238358|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238359|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238360|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
15238361|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238362|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14397310|NCT01415583|Hormones|hormones|mesh-ancestor
14397311|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397312|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14397313|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397314|NCT01415921|Bromides|bromides|mesh-list
14397315|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14397316|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
14397317|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14397318|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397319|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397320|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
14397321|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397322|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397323|NCT01415960|Leuprolide|leuprolide|mesh-list
14397324|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14397325|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
14397326|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397327|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397328|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14397329|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397330|NCT01416155|Natalizumab|natalizumab|mesh-list
14397331|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
14397332|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397333|NCT01416181|Natalizumab|natalizumab|mesh-list
14397334|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
14397335|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397336|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14397337|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
14397338|NCT01416194|Diphosphonates|diphosphonates|mesh-list
14397339|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14397340|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
14397341|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397342|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397343|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14397344|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14397345|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15238363|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238364|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15238365|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238366|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15238367|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
15238368|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238369|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15238370|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
15238371|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238372|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238373|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15238374|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15238375|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15238376|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
15238377|NCT05130788|Nicotine|nicotine|mesh-list
15238378|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15238379|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
15238380|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238381|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238382|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15238383|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15238384|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
15238385|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735312|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735313|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735314|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
14735315|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238386|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238387|NCT05114915|Docetaxel|docetaxel|mesh-list
15238388|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238389|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
14397346|NCT01416389|Lenograstim|lenograstim|mesh-list
14397347|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14735316|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14735317|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
14735318|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14735319|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14735320|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14735321|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735322|NCT00540137|Ritonavir|ritonavir|mesh-list
15238390|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
14397348|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
14397349|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397350|NCT01416441|Aripiprazole|aripiprazole|mesh-list
14397351|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
14397352|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397353|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14397354|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14735323|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15238391|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238392|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238393|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
15238394|NCT05064280|Lenvatinib|lenvatinib|mesh-list
15238395|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238396|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238397|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15238398|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238399|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238400|NCT05048849|Somatomedin B|somatomedin b|mesh-list
15238401|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15238402|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15238403|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
15238404|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238405|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238406|NCT05047640|Vaccines|vaccines|mesh-list
15238407|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
15238408|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238409|NCT05038618|Somatomedin B|somatomedin b|mesh-list
15238410|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15238411|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15238412|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
14397355|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397356|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397357|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
14397358|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
14397359|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397360|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397361|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14397362|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14397363|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
14397364|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14397365|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14397366|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14397367|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14397368|NCT01416584|Methadone|methadone|mesh-list
14397369|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14397370|NCT01416584|Narcotics|narcotics|mesh-ancestor
14397371|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397372|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397373|NCT01416584|Analgesics|analgesics|mesh-ancestor
14397374|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
14397375|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397376|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
14397377|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
14397378|NCT01416636|Treprostinil|treprostinil|mesh-list
14397379|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14397380|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
14397381|NCT01417000|Pancrelipase|pancrelipase|mesh-list
14397382|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397383|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
14397384|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397385|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397386|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14397387|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
14397388|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397389|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397390|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14397391|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397392|NCT01417026|Oxytocin|oxytocin|mesh-list
14397393|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
14397394|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15238413|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238414|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238415|NCT04992013|Niraparib|niraparib|mesh-list
15238416|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15238417|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238418|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238419|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238420|NCT04967079|Trametinib|trametinib|mesh-list
15238421|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238422|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15238423|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238424|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238425|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
15238426|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15238427|NCT04964193|Cyproterone|cyproterone|mesh-list
14397395|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397396|NCT01417078|Diazepam|diazepam|mesh-list
14397397|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14397398|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
14397399|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
14397400|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
14397401|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397402|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397403|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397404|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14397405|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397406|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14397407|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14923965|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14923966|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14923967|NCT01226732|Capecitabine|capecitabine|mesh-list
14923968|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14923969|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
14923970|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923971|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238428|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
15238429|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15238430|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15238431|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15238432|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
15238433|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15238434|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238435|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15238436|NCT04964193|Estrogens|estrogens|mesh-ancestor
15238437|NCT04964193|Hormones|hormones|mesh-ancestor
15238438|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238439|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
15238440|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
15238441|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238442|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15238443|NCT04958876|Naltrexone|naltrexone|mesh-list
15238444|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15238445|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15238446|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238447|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
15238448|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238449|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15238450|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15238451|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238452|NCT04926285|Venetoclax|venetoclax|mesh-list
15238453|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
15238454|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238455|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15238456|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15238457|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238458|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238459|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
15238460|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15238461|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238462|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
15238463|NCT04896320|Tucatinib|tucatinib|mesh-list
15238464|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238465|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15238466|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238467|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238468|NCT04865796|Lactoferrin|lactoferrin|mesh-list
15238469|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238470|NCT04858269|Paclitaxel|paclitaxel|mesh-list
15238471|NCT04858269|Carboplatin|carboplatin|mesh-list
15238472|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
15238473|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15238474|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238475|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
15238476|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
15238477|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238478|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238479|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923972|NCT01216683|Rituximab|rituximab|mesh-list
14397408|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14397409|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14397410|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397411|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14397412|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
14397413|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
14397414|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
14397415|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
14397416|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397417|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397418|NCT01417156|Nintedanib|nintedanib|mesh-list
14397419|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397420|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14397421|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397422|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397423|NCT01417195|Menotropins|menotropins|mesh-list
14397424|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14397425|NCT01417195|Hormones|hormones|mesh-ancestor
14397426|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397427|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397428|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14397429|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
14397430|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397431|NCT01417481|Glycine|glycine|mesh-list
14397432|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
14397433|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397434|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397435|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397436|NCT01418001|Gemcitabine|gemcitabine|mesh-list
14397437|NCT01418001|Docetaxel|docetaxel|mesh-list
14735324|NCT00540137|Nevirapine|nevirapine|mesh-list
14397438|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14397439|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
14397440|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397441|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397442|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
14397443|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397444|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397445|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397446|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
14397447|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397448|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
14397449|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
14397450|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
14397451|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14397452|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14397453|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14397454|NCT01418209|Estradiol|estradiol|mesh-list
15238480|NCT04844528|Niacinamide|niacinamide|mesh-list
15238481|NCT04844528|Niacin|niacin|mesh-list
15238482|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
15238483|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
14735325|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14735326|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14735327|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
14735328|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735329|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735330|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14735331|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14735332|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
14735333|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735334|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14735335|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14735336|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14735337|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14735338|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14923973|NCT01216683|Lenalidomide|lenalidomide|mesh-list
15238484|NCT04844528|Vitamins|vitamins|mesh-ancestor
15238485|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
15238486|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397455|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15238487|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15238488|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
15238489|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238490|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15238491|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
15238492|NCT04818086|Buprenorphine|buprenorphine|mesh-list
15238493|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
15238494|NCT04818086|Lemborexant|lemborexant|mesh-list
15238495|NCT04818086|Naloxone|naloxone|mesh-list
15238496|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15238497|NCT04818086|Narcotics|narcotics|mesh-ancestor
15238498|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15238499|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238500|NCT04818086|Analgesics|analgesics|mesh-ancestor
15238501|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
15238502|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238503|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15238504|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
15238505|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238506|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238507|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15238508|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15238509|NCT04811118|Docetaxel|docetaxel|mesh-list
15238510|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238511|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
15238512|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
15238513|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238514|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238515|NCT04793685|Prazosin|prazosin|mesh-list
15238516|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15238517|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14397456|NCT01418209|Progesterone|progesterone|mesh-list
14397457|NCT01418209|Estrogens|estrogens|mesh-ancestor
14397458|NCT01418209|Hormones|hormones|mesh-ancestor
14397459|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397460|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397461|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14397462|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
14397463|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397464|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14397465|NCT01418209|Progestins|progestins|mesh-ancestor
14397466|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14397467|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14397468|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397469|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397470|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397471|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14397472|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
14397473|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397474|NCT01418339|Aripiprazole|aripiprazole|mesh-list
14397475|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
14397476|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397477|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14397478|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14397479|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397480|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397481|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
14397482|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
14397483|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397484|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397485|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14397486|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14397487|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
14397488|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14397489|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14923974|NCT01216683|Bortezomib|bortezomib|mesh-list
14923975|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14923976|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14923977|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397490|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14397491|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14397492|NCT01418352|Aripiprazole|aripiprazole|mesh-list
14397493|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
14397494|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397495|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14397496|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14923978|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
14923979|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923980|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14923981|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14923982|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14923983|NCT01216683|Growth Substances|growth substances|mesh-ancestor
14923984|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
14923985|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14397497|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397498|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397499|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
14397500|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
14397501|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397502|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397503|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14397504|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14397505|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
14397506|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14397507|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14397508|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14397509|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14397510|NCT01418365|Metronidazole|metronidazole|mesh-list
14397511|NCT01418365|Mesalamine|mesalamine|mesh-list
14397512|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397513|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14397514|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14397515|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14397516|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14397517|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14397518|NCT01418365|Analgesics|analgesics|mesh-ancestor
14397519|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
14397520|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397521|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397522|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397523|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467078|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469947|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469948|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469949|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469950|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
14469951|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469952|NCT02301390|Amiodarone|amiodarone|mesh-list
14469953|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14469954|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
14469955|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14469956|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469957|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469958|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14469959|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14469960|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14469961|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469962|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14469963|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14469964|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14469965|NCT02301403|Nicotine|nicotine|mesh-list
14923986|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
14923987|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14923988|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
15238518|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15238519|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15238520|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
15238521|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238522|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238523|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238524|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15238525|NCT04785287|Nivolumab|nivolumab|mesh-list
15238526|NCT04785287|Antibodies|antibodies|mesh-list
15238527|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
15238528|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15238529|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
15238530|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238531|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238532|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15238533|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238534|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
15238535|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15238536|NCT04703036|Glycine|glycine|mesh-list
15238537|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
15238538|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238539|NCT04703036|Expectorants|expectorants|mesh-ancestor
14397524|NCT01419184|Vancomycin|vancomycin|mesh-list
14397525|NCT01419184|Daptomycin|daptomycin|mesh-list
14397526|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14397527|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397528|NCT01419197|Trastuzumab|trastuzumab|mesh-list
14397529|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14397530|NCT01419197|Maytansine|maytansine|mesh-list
14397531|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397532|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397533|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14397534|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
14397535|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
14397536|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
14397537|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397538|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14397539|NCT01419236|Testosterone|testosterone|mesh-list
14397540|NCT01419236|Androgens|androgens|mesh-ancestor
14397541|NCT01419236|Hormones|hormones|mesh-ancestor
14397542|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397543|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397544|NCT01419275|Xenon|xenon|mesh-list
14397545|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14397546|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
14397547|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
14397548|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397549|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397550|NCT01419535|Mifepristone|mifepristone|mesh-list
14397551|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14397552|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
14397553|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397554|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397555|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14397556|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14397557|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14397558|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
14397559|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14397560|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14397561|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
14397562|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397563|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
14397564|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14397565|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14923989|NCT01162109|Astringents|astringents|mesh-ancestor
14923990|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923991|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
14923992|NCT01152541|Riboflavin|riboflavin|mesh-list
14923993|NCT01152541|Dextrans|dextrans|mesh-list
14923994|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14923995|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
14923996|NCT01152541|Vitamins|vitamins|mesh-ancestor
14923997|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
14923998|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14923999|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14924000|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
14924001|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
14924002|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
14924003|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
15238540|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
15238541|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15238542|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
15238543|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238544|NCT04703036|Protective Agents|protective agents|mesh-ancestor
15238545|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238546|NCT04703036|Antidotes|antidotes|mesh-ancestor
15238547|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
15238548|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238549|NCT04695652|Somatomedin B|somatomedin b|mesh-list
15238550|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15238551|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15238552|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
15238553|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238554|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238555|NCT04647084|Lidocaine|lidocaine|mesh-list
15238556|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
15238557|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
14924004|NCT01112072|Riboflavin|riboflavin|mesh-list
14397566|NCT01419639|Everolimus|everolimus|mesh-list
14397567|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397568|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397569|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
14397570|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397571|NCT01419665|Rituximab|rituximab|mesh-list
14397572|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397573|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397574|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
14397575|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397576|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397577|NCT01419717|Denosumab|denosumab|mesh-list
14397578|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14397579|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238558|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15238559|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238560|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
15238561|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238562|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15238563|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15238564|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15238565|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15238566|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397580|NCT01419795|Rituximab|rituximab|mesh-list
14397581|NCT01419795|Lenalidomide|lenalidomide|mesh-list
14397582|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397583|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397584|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
14397585|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397586|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397587|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14397588|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14397589|NCT01419795|Growth Substances|growth substances|mesh-ancestor
14397590|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14397591|NCT01419977|Dalteparin|dalteparin|mesh-list
14397592|NCT01419977|Tinzaparin|tinzaparin|mesh-list
14397593|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14397594|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
14397595|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14924005|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
14924006|NCT01112072|Vitamins|vitamins|mesh-ancestor
14924007|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
14924008|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924009|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14924010|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
14397596|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14397597|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397598|NCT01420081|Gedatolisib|gedatolisib|mesh-list
14397599|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14397600|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397601|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397602|NCT01420146|Trastuzumab|trastuzumab|mesh-list
14397603|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397604|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397605|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
14397606|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397607|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
14397608|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
14397609|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14397610|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14397611|NCT01420549|Simvastatin|simvastatin|mesh-list
14397612|NCT01420549|Ezetimibe|ezetimibe|mesh-list
14397613|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14397614|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14924011|NCT01107717|Metformin|metformin|mesh-list
14924012|NCT01107717|Pioglitazone|pioglitazone|mesh-list
14924013|NCT01107717|Exenatide|exenatide|mesh-list
14924014|NCT01107717|Glyburide|glyburide|mesh-list
14924015|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924016|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924017|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14924018|NCT01107717|Incretins|incretins|mesh-ancestor
14397615|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
14467079|NCT02256111|Androgens|androgens|mesh-list
14924019|NCT01107717|Hormones|hormones|mesh-ancestor
14931079|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14397616|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397617|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14397618|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14397619|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397620|NCT01420653|Acetaminophen|acetaminophen|mesh-list
14397621|NCT01420653|Ibuprofen|ibuprofen|mesh-list
14397622|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14397623|NCT01420653|Analgesics|analgesics|mesh-ancestor
14397624|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
14397625|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397626|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397627|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
14397628|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14397629|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397630|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397631|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14397632|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397633|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397634|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14397635|NCT01420679|Aminopterin|aminopterin|mesh-list
14397636|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14397637|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397638|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397639|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397640|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
14397641|NCT01421017|Imiquimod|imiquimod|mesh-list
14397642|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924020|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924021|NCT01104350|Gemcitabine|gemcitabine|mesh-list
14924022|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14924023|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
14924024|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397643|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
14397644|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397645|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397646|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14397647|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
14397648|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397649|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397650|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14397651|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14397652|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
14397653|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14397654|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14924025|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924026|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
14924027|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924028|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924029|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924030|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
14924031|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924032|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
14397655|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15238567|NCT04632927|Ustekinumab|ustekinumab|mesh-list
15238568|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
15238569|NCT04620798|Antibodies|antibodies|mesh-list
15238570|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
15238571|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238572|NCT04582383|Doxycycline|doxycycline|mesh-list
15238573|NCT04582383|Spironolactone|spironolactone|mesh-list
15238574|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15238575|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238576|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
15238577|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15238578|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15238579|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15238580|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
15238581|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238582|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238583|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15238584|NCT04582383|Diuretics|diuretics|mesh-ancestor
15238585|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
15238586|NCT04576078|Nefopam|nefopam|mesh-list
15238587|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15238588|NCT04576078|Analgesics|analgesics|mesh-ancestor
15238589|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
15238590|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238591|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238592|NCT04557449|Letrozole|letrozole|mesh-list
15238593|NCT04557449|Fulvestrant|fulvestrant|mesh-list
15238594|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238595|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15238596|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15238597|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238598|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238599|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15238600|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
15238601|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397656|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397657|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397658|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397659|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14397660|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14397661|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14924033|NCT01085097|Prednisone|prednisone|mesh-list
14397662|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
14397663|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397664|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397665|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14397666|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14397667|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
14397668|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14397669|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14397670|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
14397671|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
14397672|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14397673|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397674|NCT01421186|Dexamethasone|dexamethasone|mesh-list
14397675|NCT01421186|Lenalidomide|lenalidomide|mesh-list
14397676|NCT01421186|Pomalidomide|pomalidomide|mesh-list
14397677|NCT01421186|Felzartamab|felzartamab|mesh-list
14397678|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397679|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
14397680|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
14397681|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397682|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397683|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397684|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
14397685|NCT01421186|Hormones|hormones|mesh-ancestor
14397686|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397687|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14397688|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397689|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
14397690|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14397691|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14397692|NCT01421186|Growth Substances|growth substances|mesh-ancestor
14735339|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14735340|NCT00540202|Lumefantrine|lumefantrine|mesh-list
14735341|NCT00540202|Artemether|artemether|mesh-list
14735342|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14735343|NCT00540202|Quinine|quinine|mesh-list
14924034|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
15238602|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397693|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14397694|NCT01421225|Insulin|insulin|mesh-list
14397695|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14397696|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14397697|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397698|NCT01421303|Etanercept|etanercept|mesh-list
14397699|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14397700|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14397701|NCT01421303|Analgesics|analgesics|mesh-ancestor
14397702|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
14397703|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238603|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15238604|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15238605|NCT04530409|Dexamethasone|dexamethasone|mesh-list
15238606|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
15238607|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397704|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397705|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397706|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15238608|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
15238609|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
15238610|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238611|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238612|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238613|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
15238614|NCT04530409|Hormones|hormones|mesh-ancestor
15238615|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397707|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397708|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14397709|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
14397710|NCT01421342|Aripiprazole|aripiprazole|mesh-list
14397711|NCT01421342|Bupropion|bupropion|mesh-list
14397712|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
14397713|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14397714|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397715|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14397716|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14397717|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397718|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397719|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
14397720|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397721|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397722|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14397723|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14397724|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397725|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14397726|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14397727|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397728|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
14397729|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14397730|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14397731|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
14397732|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14397733|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14397734|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14397735|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14397736|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14397737|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14397738|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14397739|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
14397740|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397741|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397742|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14397743|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14397744|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
14397745|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397746|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
14397747|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14397748|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397749|NCT01421472|Paclitaxel|paclitaxel|mesh-list
14397750|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14397751|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397752|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14397753|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14397754|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14397755|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397756|NCT01421498|Lifitegrast|lifitegrast|mesh-list
14397757|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14397758|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14397759|NCT01421511|Linezolid|linezolid|mesh-list
14397760|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14397761|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397762|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14397763|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397764|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397765|NCT01421589|Hormones|hormones|mesh-list
14397766|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397767|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397768|NCT01421641|Lidocaine|lidocaine|mesh-list
14397769|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
14397770|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
14397771|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397772|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397773|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
14397774|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397775|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14397776|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14397777|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14397778|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397779|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397780|NCT01421667|Rituximab|rituximab|mesh-list
14397781|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14397782|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14397783|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397784|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
14397785|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397786|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14397787|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14397788|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14397789|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397790|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397791|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14397792|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397793|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397794|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
14397795|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397796|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
14397797|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397798|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397799|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
14397800|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14397801|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14397802|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397803|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397804|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
14397805|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397806|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397807|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14924035|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14924036|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14924037|NCT01085097|Prednisolone|prednisolone|mesh-list
14924038|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
14924039|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14397808|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14397809|NCT01422200|Vaccines|vaccines|mesh-list
14397810|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
14397811|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397812|NCT01422213|Vortioxetine|vortioxetine|mesh-list
14397813|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
14397814|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397815|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14397816|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14397817|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397818|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397819|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14397820|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14397821|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397822|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397823|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397824|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
14397825|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14397826|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14397827|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14397828|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14397829|NCT01422226|Alprostadil|alprostadil|mesh-list
14397830|NCT01422226|Misoprostol|misoprostol|mesh-list
14397831|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14397832|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
14397833|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14397834|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397835|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14397836|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14397837|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
14397838|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14397839|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
14397840|NCT01422226|Urological Agents|urological agents|mesh-ancestor
14397841|NCT01422304|Atropine|atropine|mesh-list
14397842|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
14397843|NCT01422304|Neostigmine|neostigmine|mesh-list
14924040|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
14924041|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14924042|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
14924043|NCT01085097|Hormones|hormones|mesh-ancestor
14924044|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924045|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924046|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14924047|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924048|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14924049|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14924050|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
14924051|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14924052|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924053|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924054|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924055|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
14924056|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
14924057|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238616|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15238617|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238618|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15238619|NCT04530409|Protective Agents|protective agents|mesh-ancestor
15238620|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
15238621|NCT04505774|Empagliflozin|empagliflozin|mesh-list
15238622|NCT04505774|Canagliflozin|canagliflozin|mesh-list
15238623|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
15238624|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15238625|NCT04505774|Heparin|heparin|mesh-list
14397844|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14924058|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238626|NCT04505774|Calcium heparin|calcium heparin|mesh-list
15238627|NCT04505774|Enoxaparin|enoxaparin|mesh-list
14397845|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14397846|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14397847|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
14397848|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238628|NCT04505774|Dalteparin|dalteparin|mesh-list
15238629|NCT04505774|Tinzaparin|tinzaparin|mesh-list
15238630|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15238631|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
14397849|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397850|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14397851|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14397852|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
14397853|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
14397854|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14397855|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14397856|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
14397857|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397858|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397859|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14397860|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397861|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14397862|NCT01422369|Ritonavir|ritonavir|mesh-list
14397863|NCT01422369|Darunavir|darunavir|mesh-list
14397864|NCT01422369|Pitavastatin|pitavastatin|mesh-list
14397865|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14397866|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14397867|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
14397868|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397869|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397870|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14397871|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14397872|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
14397873|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397874|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14397875|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14397876|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14397877|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14397878|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14397879|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
14397880|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14397881|NCT01422382|Diltiazem|diltiazem|mesh-list
14397882|NCT01422382|Pitavastatin|pitavastatin|mesh-list
14397883|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14397884|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14397885|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397886|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397887|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14397888|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397889|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
14397890|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14397891|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14397892|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14397893|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
14397894|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397895|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14397896|NCT01422408|Fluocinonide|fluocinonide|mesh-list
14397897|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397898|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
14397899|NCT01422408|Hormones|hormones|mesh-ancestor
14397900|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397901|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397902|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14735344|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
14735345|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14735346|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14735347|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735348|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14735349|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735350|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14735351|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735352|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14735353|NCT00540202|Analgesics|analgesics|mesh-ancestor
14735354|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
14735355|NCT00540241|Pemetrexed|pemetrexed|mesh-list
14735356|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238632|NCT04505774|Clopidogrel|clopidogrel|mesh-list
14924059|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14924060|NCT01085097|Protective Agents|protective agents|mesh-ancestor
14397903|NCT01422434|Calcitriol|calcitriol|mesh-list
14397904|NCT01422434|Betamethasone|betamethasone|mesh-list
14397905|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
14397906|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14397907|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
14397908|NCT01422434|Calcipotriene|calcipotriene|mesh-list
14397909|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14397910|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14397911|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
14397912|NCT01422434|Hormones|hormones|mesh-ancestor
14397913|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397914|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397915|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14397916|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
14397917|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
14397918|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14397919|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14397920|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397921|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397922|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14397923|NCT01422434|Vitamins|vitamins|mesh-ancestor
14397924|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
14397925|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14397926|NCT01422538|Mannitol|mannitol|mesh-list
14397927|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14397928|NCT01422538|Diuretics|diuretics|mesh-ancestor
14397929|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
14397930|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397931|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14397932|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
14397933|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14397934|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14397935|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397936|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397937|NCT01422876|Linagliptin|linagliptin|mesh-list
14397938|NCT01422876|Empagliflozin|empagliflozin|mesh-list
14397939|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14397940|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397941|NCT01422876|Incretins|incretins|mesh-ancestor
14924061|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
14397942|NCT01422876|Hormones|hormones|mesh-ancestor
14397943|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14397944|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14397945|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
14397946|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397947|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397948|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14397949|NCT01422915|Colestipol|colestipol|mesh-list
14397950|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15238633|NCT04505774|Ticagrelor|ticagrelor|mesh-list
15238634|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15238635|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15238636|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15238637|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15238638|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
15238639|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238640|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238641|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238642|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
15238643|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15238644|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15238645|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15238646|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15238647|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15238648|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15238649|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14397951|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
14397952|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397953|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14397954|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
14397955|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
14397956|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
14397957|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397958|NCT01423162|Protective Agents|protective agents|mesh-ancestor
14397959|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397960|NCT01423162|Vitamins|vitamins|mesh-ancestor
14397961|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
14397962|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14397963|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14397964|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14397965|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14397966|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14397967|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14397968|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14397969|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14397970|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14397971|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
14397972|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14397973|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397974|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14397975|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14397976|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
14397977|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14397978|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14397979|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
14397980|NCT01423604|Capecitabine|capecitabine|mesh-list
14397981|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14397982|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
14397983|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397984|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14397985|NCT01423812|Ritonavir|ritonavir|mesh-list
14397986|NCT01423812|Darunavir|darunavir|mesh-list
14397987|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14397988|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14397989|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
14397990|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14397991|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14397992|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14397993|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14397994|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
14397995|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14397996|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14397997|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14397998|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
14397999|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398000|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398001|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14398002|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14398003|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398004|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398005|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398006|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
14398007|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14398008|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
14398009|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398010|NCT01424033|Expectorants|expectorants|mesh-ancestor
14398011|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398012|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14398013|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
14398014|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398015|NCT01424033|Protective Agents|protective agents|mesh-ancestor
14398016|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398017|NCT01424033|Antidotes|antidotes|mesh-ancestor
14398018|NCT01424228|Prucalopride|prucalopride|mesh-list
14398019|NCT01424228|Laxatives|laxatives|mesh-ancestor
14398020|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398021|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14398022|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14398023|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
14398024|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398025|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398026|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398027|NCT01424566|Nabiximols|nabiximols|mesh-list
14398028|NCT01424566|Analgesics|analgesics|mesh-ancestor
14398029|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
14398030|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398031|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398032|NCT01424644|Vaccines|vaccines|mesh-list
14398033|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
14398034|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398035|NCT01424813|Albuterol|albuterol|mesh-list
14398036|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14398037|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
14398038|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398039|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398040|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14398041|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398042|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
14398043|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14398044|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15238650|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238651|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238652|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238653|NCT04504812|Analgesics|analgesics|mesh-ancestor
15238654|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
15238655|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238656|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
14398045|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15238657|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15238658|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
15238659|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
15238660|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15238661|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14398046|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14398047|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
14398048|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398049|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398050|NCT01424930|Prednisone|prednisone|mesh-list
14398051|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398052|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
14398053|NCT01424930|Hormones|hormones|mesh-ancestor
14398054|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398055|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238662|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238663|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
15238664|NCT04489108|Coagulants|coagulants|mesh-ancestor
15238665|NCT04471675|Docetaxel|docetaxel|mesh-list
14398056|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14398057|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398058|NCT01425203|Ribavirin|ribavirin|mesh-list
14398059|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14398060|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
14398061|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398062|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
14398063|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398064|NCT01425229|Bosentan|bosentan|mesh-list
14398065|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14398066|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14398067|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398068|NCT01425281|Everolimus|everolimus|mesh-list
14398069|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398070|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14398071|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
14398072|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398073|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
14398074|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398075|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
14398076|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398077|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398078|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14398079|NCT01425359|Ranolazine|ranolazine|mesh-list
14398080|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14398081|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398082|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398083|NCT01425463|Glycine|glycine|mesh-list
14398084|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
14398085|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398086|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398087|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467080|NCT02256111|Hormones|hormones|mesh-ancestor
14467081|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467082|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467083|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15238666|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238667|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
15238668|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
15238669|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238670|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238671|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
15238672|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238673|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
15238674|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15238675|NCT04453839|Protective Agents|protective agents|mesh-ancestor
15238676|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238677|NCT04439513|Hemostatics|hemostatics|mesh-list
15238678|NCT04439513|Coagulants|coagulants|mesh-ancestor
15238679|NCT04431375|Tenofovir|tenofovir|mesh-list
15238680|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
15238681|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238682|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15238683|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15238684|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238685|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238686|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15238687|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15238688|NCT04410913|Psilocybin|psilocybin|mesh-list
15238689|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
14398088|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
14398089|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14398090|NCT01425801|Albuterol|albuterol|mesh-list
14398091|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14398092|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
14398093|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398094|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398095|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14398096|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398097|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
14398098|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14398099|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14398100|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14398101|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14398102|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14398103|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398104|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398105|NCT01425853|Celecoxib|celecoxib|mesh-list
14398106|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14398107|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14398108|NCT01425853|Analgesics|analgesics|mesh-ancestor
14398109|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
14398110|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398111|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398112|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398113|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398114|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14398115|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14398116|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398117|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398118|NCT01426009|Bromides|bromides|mesh-list
14398119|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
14398120|NCT01426009|Ipratropium|ipratropium|mesh-list
14398121|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14398122|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
14398123|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398124|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924062|NCT01025089|Doxorubicin|doxorubicin|mesh-list
14924063|NCT01025089|Cetuximab|cetuximab|mesh-list
14924064|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924065|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
14924066|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924067|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398125|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14398126|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398127|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
14398128|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14398129|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
14398130|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398131|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398132|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
14398133|NCT01426269|Metronidazole|metronidazole|mesh-list
14398134|NCT01426269|Doxycycline|doxycycline|mesh-list
14398135|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398136|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398137|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14398138|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14398139|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
14398140|NCT01426347|Vitamin D|vitamin d|mesh-list
14398141|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
14398142|NCT01426347|Vitamins|vitamins|mesh-ancestor
14398143|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
14398144|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398145|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14398146|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14398147|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
14398148|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14398149|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398150|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14398151|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
14398152|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398153|NCT01426438|Aspirin|aspirin|mesh-list
14398154|NCT01426438|Niacin|niacin|mesh-list
14398155|NCT01426438|Fenofibrate|fenofibrate|mesh-list
14924068|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14398156|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14924069|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
14398157|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14398158|NCT01426438|Analgesics|analgesics|mesh-ancestor
14398159|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
14398160|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398161|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398162|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398163|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398164|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14398165|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14398166|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398167|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14398168|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14398169|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398170|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
14398171|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14398172|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
14398173|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14398174|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
14398175|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
14398176|NCT01426438|Vitamins|vitamins|mesh-ancestor
14398177|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
14398178|NCT01426763|Complement C1s|complement c1s|mesh-list
14398179|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14398180|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14398181|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
14398182|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398183|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14398184|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14398185|NCT01426854|Nepafenac|nepafenac|mesh-list
14398186|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14398187|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14398188|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14398189|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14398190|NCT01426854|Analgesics|analgesics|mesh-ancestor
14398191|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
14398192|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398193|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398194|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398195|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398196|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14398197|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14398198|NCT01426867|Brinzolamide|brinzolamide|mesh-list
14398199|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14398200|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14398201|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14398202|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14398203|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14398204|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
14398205|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398206|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398207|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398208|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14398209|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398210|NCT01426958|Ritonavir|ritonavir|mesh-list
14398211|NCT01426958|Afatinib|afatinib|mesh-list
14924070|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398212|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14467084|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924071|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924072|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14924073|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14924074|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14924075|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14924076|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924077|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14924078|NCT00962988|Bupropion|bupropion|mesh-list
15238690|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238691|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398213|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14398214|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
14398215|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398216|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398217|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14398218|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14398219|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
14398220|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398221|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14398222|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14398223|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398224|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14398225|NCT01427309|Vaccines|vaccines|mesh-list
14398226|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
14398227|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398228|NCT01427504|Etravirine|etravirine|mesh-list
14398229|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14398230|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14398231|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398232|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398233|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
14398234|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398235|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
14398236|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14398237|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
14398238|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398239|NCT01427517|Expectorants|expectorants|mesh-ancestor
14398240|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398241|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14398242|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
14398243|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398244|NCT01427517|Protective Agents|protective agents|mesh-ancestor
14398245|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398246|NCT01427517|Antidotes|antidotes|mesh-ancestor
14398247|NCT01427595|Metformin|metformin|mesh-list
14398248|NCT01427595|Progesterone|progesterone|mesh-list
14398249|NCT01427595|Estradiol|estradiol|mesh-list
14398250|NCT01427595|Estrogens|estrogens|mesh-list
14398251|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398252|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398253|NCT01427595|Progestins|progestins|mesh-ancestor
14735357|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735358|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735359|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14735360|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14735361|NCT00540280|Gemcitabine|gemcitabine|mesh-list
14735362|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735363|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14735364|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
14735365|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735366|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
14735367|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735368|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735369|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735370|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
14735371|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735372|NCT00540345|Interferons|interferons|mesh-list
14735373|NCT00540345|Ribavirin|ribavirin|mesh-list
14735374|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
14735375|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
14735376|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14735377|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735378|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
14735379|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735380|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
14735381|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735382|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
14735383|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735384|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
14398254|NCT01427595|Hormones|hormones|mesh-ancestor
14398255|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398256|NCT01427608|Olanzapine|olanzapine|mesh-list
14735385|NCT00540384|Hematinics|hematinics|mesh-ancestor
14735386|NCT00540410|Artesunate|artesunate|mesh-list
14924079|NCT00962988|Nicotine|nicotine|mesh-list
14398257|NCT01427608|Sertraline|sertraline|mesh-list
14398258|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
14398259|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
14398260|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398261|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398262|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398263|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14398264|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14398265|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398266|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398267|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14398268|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14398269|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398270|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398271|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398272|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
14398273|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
14398274|NCT01427738|Nystatin|nystatin|mesh-list
14398275|NCT01427738|Gentian Violet|gentian violet|mesh-list
14398276|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398277|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398278|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
14398279|NCT01427738|Ionophores|ionophores|mesh-ancestor
14398280|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398281|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398282|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14398283|NCT01427751|Dexamethasone|dexamethasone|mesh-list
14398284|NCT01427751|Ranibizumab|ranibizumab|mesh-list
14398285|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398286|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
14398287|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
14398288|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398289|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924080|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14924081|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
14924082|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924083|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238692|NCT04369664|Atorvastatin|atorvastatin|mesh-list
15238693|NCT04369664|Ezetimibe|ezetimibe|mesh-list
15238694|NCT04369664|Evolocumab|evolocumab|mesh-list
14398290|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398291|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
14398292|NCT01427751|Hormones|hormones|mesh-ancestor
14398293|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398294|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14398295|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398296|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14398297|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14398298|NCT01427751|Growth Substances|growth substances|mesh-ancestor
14398299|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
14398300|NCT01427803|Naproxen|naproxen|mesh-list
14398301|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14398302|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14398303|NCT01427803|Analgesics|analgesics|mesh-ancestor
14398304|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
14398305|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398306|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398307|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398308|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398309|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
14398310|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14398311|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398312|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398313|NCT01427881|Cyclosporine|cyclosporine|mesh-list
14398314|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
14398315|NCT01427881|Busulfan|busulfan|mesh-list
14398316|NCT01427881|Fludarabine|fludarabine|mesh-list
14398317|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
14398318|NCT01427881|Cyclosporins|cyclosporins|mesh-list
14398319|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14398320|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
14398321|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398322|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398323|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14398324|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
14398325|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398326|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398327|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14398328|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14398329|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
14398330|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398331|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
14398332|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398333|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
14398334|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14398335|NCT01427907|Calcium|calcium|mesh-list
14398336|NCT01427907|Sevelamer|sevelamer|mesh-list
14398337|NCT01427907|Calcium acetate|calcium acetate|mesh-list
14398338|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14398339|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398340|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
14398341|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
14398342|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398343|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
14398344|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
14398345|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14398346|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398347|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398348|NCT01427933|Ramucirumab|ramucirumab|mesh-list
14398349|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398350|NCT01427972|Eplerenone|eplerenone|mesh-list
14398351|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14398352|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
14398353|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398354|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398355|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14398356|NCT01427972|Diuretics|diuretics|mesh-ancestor
14398357|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
14398358|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14735387|NCT00540410|Lumefantrine|lumefantrine|mesh-list
15238695|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14735388|NCT00540410|Amodiaquine|amodiaquine|mesh-list
14398359|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
14398360|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14398361|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
14398362|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398363|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
14398364|NCT01428024|Protective Agents|protective agents|mesh-ancestor
14398365|NCT01428063|Interferons|interferons|mesh-list
14398366|NCT01428063|Ribavirin|ribavirin|mesh-list
14398367|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
14398368|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
14398369|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14398370|NCT01428063|Asunaprevir|asunaprevir|mesh-list
14398371|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398372|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
14398373|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398374|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
14398375|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398376|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
14398377|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398378|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
14398379|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398380|NCT01428076|Polidocanol|polidocanol|mesh-list
14398381|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14398382|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14398383|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
14398384|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398385|NCT01428193|Flutamide|flutamide|mesh-list
14398386|NCT01428193|Estradiol|estradiol|mesh-list
14398387|NCT01428193|Progesterone|progesterone|mesh-list
14398388|NCT01428193|Estrogens|estrogens|mesh-ancestor
14398389|NCT01428193|Hormones|hormones|mesh-ancestor
14398390|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398391|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398392|NCT01428193|Progestins|progestins|mesh-ancestor
14398393|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
14398394|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
14398395|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14398396|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398397|NCT01428245|Estradiol|estradiol|mesh-list
14398398|NCT01428245|Estrogens|estrogens|mesh-list
14398399|NCT01428245|Progesterone|progesterone|mesh-list
14398400|NCT01428245|Hormones|hormones|mesh-ancestor
14398401|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398402|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398403|NCT01428245|Progestins|progestins|mesh-ancestor
14398404|NCT01428258|Coal Tar|coal tar|mesh-list
14398405|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
14398406|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
14398407|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14398408|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14398409|NCT01428336|Cosyntropin|cosyntropin|mesh-list
14398410|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
14398411|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398412|NCT01428336|Hormones|hormones|mesh-ancestor
14398413|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398414|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398415|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398416|NCT01428583|Naltrexone|naltrexone|mesh-list
14398417|NCT01428583|Oxycodone|oxycodone|mesh-list
14398418|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14398419|NCT01428583|Narcotics|narcotics|mesh-ancestor
14398420|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398421|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924084|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14398422|NCT01428583|Analgesics|analgesics|mesh-ancestor
14398423|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
14398424|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398425|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14398426|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14398427|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
14398428|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
14398429|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
14398430|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14398431|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14398432|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14398433|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398434|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
14398435|NCT01428713|Coagulants|coagulants|mesh-ancestor
14398436|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14398437|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398438|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14398439|NCT01428882|Midazolam|midazolam|mesh-list
14398440|NCT01428882|Propofol|propofol|mesh-list
14398441|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14398442|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398443|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398444|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14735389|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14735390|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
14735391|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14735392|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14735393|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735394|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735395|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
14735396|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
14924085|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14924086|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
14398445|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
14398446|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
14398447|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14398448|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14398449|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14398450|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924087|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924088|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924089|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14398451|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
14398452|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
14398453|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398454|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398455|NCT01429051|Fentanyl|fentanyl|mesh-list
14398456|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14398457|NCT01429051|Narcotics|narcotics|mesh-ancestor
14398458|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398459|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398460|NCT01429051|Analgesics|analgesics|mesh-ancestor
14924090|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
14924091|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924092|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14924093|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14924094|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14924095|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
14924096|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14924097|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14924098|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924099|NCT00920621|Vitamin D|vitamin d|mesh-list
14924100|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
14398461|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
14398462|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398463|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14398464|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14398465|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
14398466|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
14398467|NCT01429077|Levodopa|levodopa|mesh-list
14398468|NCT01429077|Carbidopa|carbidopa|mesh-list
14398469|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14398470|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14398471|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
14398472|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398473|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398474|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398475|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14398476|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924101|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
14924102|NCT00920621|Vitamins|vitamins|mesh-list
14924103|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
14924104|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924105|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14924106|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14924107|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
14924108|NCT00916747|Pravastatin|pravastatin|mesh-list
14924109|NCT00916747|Lonafarnib|lonafarnib|mesh-list
14398477|NCT01429259|Meropenem|meropenem|mesh-list
14398478|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398479|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398480|NCT01429272|Aspirin|aspirin|mesh-list
14398481|NCT01429272|Minocycline|minocycline|mesh-list
14398482|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14398483|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15238696|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15238697|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
15238698|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238699|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14398484|NCT01429272|Analgesics|analgesics|mesh-ancestor
14398485|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
14398486|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238700|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15238701|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238702|NCT04315038|Anesthetics|anesthetics|mesh-list
15238703|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15238704|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238705|NCT04304144|Dexamethasone|dexamethasone|mesh-list
14924110|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14398487|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398488|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398489|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398490|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14398491|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14398492|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398493|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14398494|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14398495|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398496|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
14398497|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398498|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398499|NCT01429285|Hydromorphone|hydromorphone|mesh-list
14398500|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14398501|NCT01429285|Narcotics|narcotics|mesh-ancestor
14398502|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398503|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398504|NCT01429285|Analgesics|analgesics|mesh-ancestor
14398505|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
14398506|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398507|NCT01429298|Hydromorphone|hydromorphone|mesh-list
14398508|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14398509|NCT01429298|Narcotics|narcotics|mesh-ancestor
14398510|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398511|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398512|NCT01429298|Analgesics|analgesics|mesh-ancestor
14398513|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
14398514|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398515|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14398516|NCT01429350|Plasminogen|plasminogen|mesh-list
14398517|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14398518|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14398519|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398520|NCT01429584|Bupivacaine|bupivacaine|mesh-list
14398521|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
14398522|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
14398523|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398524|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398525|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
14398526|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398527|NCT01429792|Ribavirin|ribavirin|mesh-list
14398528|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14398529|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
14398530|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398531|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
14398532|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398533|NCT01429987|Plecanatide|plecanatide|mesh-list
14398534|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14398535|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
14398536|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398537|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398538|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14398539|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14398540|NCT01430104|Teriparatide|teriparatide|mesh-list
14398541|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14398542|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398543|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14398544|NCT01430182|Morphine|morphine|mesh-list
14398545|NCT01430182|Methadone|methadone|mesh-list
14398546|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14398547|NCT01430182|Narcotics|narcotics|mesh-ancestor
14398548|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398549|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398550|NCT01430182|Analgesics|analgesics|mesh-ancestor
14398551|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
14398552|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398553|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
14398554|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398555|NCT01430403|Fluticasone|fluticasone|mesh-list
14398556|NCT01430403|Xhance|xhance|mesh-list
14398557|NCT01430403|Omalizumab|omalizumab|mesh-list
14398558|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14398559|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398560|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14398561|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
14398562|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398563|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398564|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14398565|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398566|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14398567|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14398568|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
14398569|NCT01430442|Sumatriptan|sumatriptan|mesh-list
14398570|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14398571|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14398572|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14398573|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
14398574|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398575|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398576|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398577|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
14398578|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
14398579|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398580|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14398581|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398582|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398583|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14398584|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14924111|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398585|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398586|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398587|NCT01430559|Meloxicam|meloxicam|mesh-list
14398588|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14398589|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14398590|NCT01430559|Analgesics|analgesics|mesh-ancestor
14398591|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
14398592|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398593|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398594|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398595|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398596|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14398597|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14398598|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398599|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467085|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467086|NCT02256189|Incretins|incretins|mesh-ancestor
14467087|NCT02256189|Hormones|hormones|mesh-ancestor
14467088|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467089|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14467090|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
14467091|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467092|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467093|NCT02256267|Rifampin|rifampin|mesh-list
14467094|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14924112|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14924113|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14467095|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
14924114|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
14924115|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924116|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14924117|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14924118|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924119|NCT00856947|Vitamin D|vitamin d|mesh-list
14924120|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
14924121|NCT00856947|Vitamins|vitamins|mesh-ancestor
14924122|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
14924123|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398600|NCT01430585|Letrozole|letrozole|mesh-list
14398601|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398602|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14398603|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14398604|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398605|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398606|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14398607|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
14398608|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398609|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398610|NCT01430611|Vaccines|vaccines|mesh-list
14398611|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
14398612|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398613|NCT01430819|Vaccines|vaccines|mesh-list
14398614|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
14398615|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398616|NCT01431014|Dexamethasone|dexamethasone|mesh-list
14398617|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
14398618|NCT01431014|BB 1101|bb 1101|mesh-list
14398619|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398620|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
14398621|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
14398622|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398623|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398624|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398625|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
14398626|NCT01431014|Hormones|hormones|mesh-ancestor
14398627|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398628|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14398629|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398630|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
14398631|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398632|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398633|NCT01431105|Atorvastatin|atorvastatin|mesh-list
14398634|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14398635|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14398636|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
14398637|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398638|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14398639|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14398640|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398641|NCT01431170|Trimethoprim|trimethoprim|mesh-list
14398642|NCT01431170|Polymyxins|polymyxins|mesh-list
14398643|NCT01431170|Polymyxin B|polymyxin b|mesh-list
14398644|NCT01431170|Besifloxacin|besifloxacin|mesh-list
14398645|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
14398646|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14398647|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398648|NCT01431170|Renal Agents|renal agents|mesh-ancestor
14398649|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
14924124|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14924125|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15238706|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
15238707|NCT04304144|Bortezomib|bortezomib|mesh-list
15238708|NCT04304144|Daratumumab|daratumumab|mesh-list
14398650|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14398651|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14398652|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14924126|NCT00785525|Lenograstim|lenograstim|mesh-list
14924127|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14924128|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
14924129|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924130|NCT00768820|Risperidone|risperidone|mesh-list
14924131|NCT00768820|Methylphenidate|methylphenidate|mesh-list
14924132|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14924133|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
14924134|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924135|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924136|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924137|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14924138|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15238709|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238710|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
14924139|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14924140|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924141|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14924142|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
15238711|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238712|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15238713|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15238714|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
15238715|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238716|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238717|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15238718|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15238719|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
15238720|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
15238721|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238722|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238723|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
15238724|NCT04304144|Hormones|hormones|mesh-ancestor
15238725|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238726|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15238727|NCT04256629|Allopurinol|allopurinol|mesh-list
15238728|NCT04256629|Verinurad|verinurad|mesh-list
15238729|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
15238730|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238731|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238732|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
15238733|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15238734|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15238735|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
15238736|NCT04256629|Protective Agents|protective agents|mesh-ancestor
15238737|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238738|NCT04231084|Epoprostenol|epoprostenol|mesh-list
15238739|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
15238740|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
15238741|NCT04231084|Tezosentan|tezosentan|mesh-list
15238742|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15238743|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
15238744|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924143|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14924144|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14924145|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14924146|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14924147|NCT00682318|Ethanol|ethanol|mesh-list
14924148|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14924149|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924150|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14924151|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924152|NCT00680901|Capecitabine|capecitabine|mesh-list
14924153|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
14924154|NCT00680901|Lapatinib|lapatinib|mesh-list
14924155|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14924156|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
15238745|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238746|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15238747|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
15238748|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15238749|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
15238750|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238751|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238752|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15238753|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
15238754|NCT04231084|Protective Agents|protective agents|mesh-ancestor
14931080|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15238755|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14398653|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398654|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398655|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14398656|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14398657|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14398658|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398659|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14398660|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14398661|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398662|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14398663|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
14398664|NCT01431274|Olodaterol|olodaterol|mesh-list
14398665|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14398666|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
14398667|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398668|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398669|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14398670|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398671|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
14398672|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14398673|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
14398674|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398675|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398676|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
14398677|NCT01431287|Olodaterol|olodaterol|mesh-list
14398678|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14398679|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
14398680|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398681|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398682|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14398683|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398684|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
14398685|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14398686|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
14398687|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398688|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467096|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14467097|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467098|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
14467099|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14467100|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467101|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467102|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14467103|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14467104|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14467105|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14467106|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14467107|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14467108|NCT02256358|Midazolam|midazolam|mesh-list
14467109|NCT02256358|Ketamine|ketamine|mesh-list
14467110|NCT02256358|Analgesics|analgesics|mesh-ancestor
15238756|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15238757|NCT04186494|Liraglutide|liraglutide|mesh-list
15238758|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15238759|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238760|NCT04186494|Incretins|incretins|mesh-ancestor
15238761|NCT04186494|Hormones|hormones|mesh-ancestor
15238762|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238763|NCT04180995|Axitinib|axitinib|mesh-list
15238764|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238765|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15238766|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238767|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238768|NCT04165772|Capecitabine|capecitabine|mesh-list
15238769|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15238770|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
15238771|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398689|NCT01431339|Vancomycin|vancomycin|mesh-list
14398690|NCT01431339|Linezolid|linezolid|mesh-list
14398691|NCT01431339|Dalbavancin|dalbavancin|mesh-list
14924157|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398692|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398693|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398694|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14398695|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398696|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398697|NCT01431391|Leuprolide|leuprolide|mesh-list
14398698|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14398699|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
14398700|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14398701|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398702|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14398703|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398704|NCT01431521|Pioglitazone|pioglitazone|mesh-list
14398705|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398706|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398707|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
14398708|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
14398709|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398710|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398711|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398712|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
14398713|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14398714|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398715|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398716|NCT01431716|Epoprostenol|epoprostenol|mesh-list
14398717|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14398718|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14398719|NCT01431755|Lidocaine|lidocaine|mesh-list
14398720|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
14398721|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
14398722|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
14398723|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398724|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398725|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
14398726|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398727|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14398728|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14398729|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14398730|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398731|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398732|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14398733|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
14398734|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
14398735|NCT01431755|Protective Agents|protective agents|mesh-ancestor
14398736|NCT01431794|Gemcitabine|gemcitabine|mesh-list
14398737|NCT01431794|Paclitaxel|paclitaxel|mesh-list
14398738|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14398739|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238772|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238773|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15238774|NCT04163952|Panitumumab|panitumumab|mesh-list
15238775|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15238776|NCT04163952|Antibodies|antibodies|mesh-list
15238777|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
15238778|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15238779|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
15238780|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238781|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238782|NCT04112199|Terlipressin|terlipressin|mesh-list
15238783|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14398740|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
14398741|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
14398742|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
14398743|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398744|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14398745|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
14398746|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
14398747|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398748|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238784|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15238785|NCT04083963|Paclitaxel|paclitaxel|mesh-list
15238786|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
15238787|NCT04083963|Carboplatin|carboplatin|mesh-list
15238788|NCT04083963|Doxorubicin|doxorubicin|mesh-list
15238789|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15238790|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238791|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
15238792|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
15238793|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238794|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238795|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238796|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
15238797|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238798|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398749|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14398750|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
14398751|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238799|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15238800|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
15238801|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15238802|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15238803|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15238804|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15238805|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238806|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
15238807|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
15238808|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238809|NCT04014075|Trastuzumab|trastuzumab|mesh-list
15238810|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238811|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238812|NCT04003285|Pregnanolone|pregnanolone|mesh-list
15238813|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
15238814|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15238815|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398752|NCT01431950|Fluticasone|fluticasone|mesh-list
14398753|NCT01431950|Xhance|xhance|mesh-list
14398754|NCT01431950|Albuterol|albuterol|mesh-list
14398755|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398756|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14398757|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
14398758|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398759|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398760|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14398761|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
14398762|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
14398763|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14398764|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
14398765|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14398766|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14398767|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14398768|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14398769|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
14398770|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398771|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398772|NCT01431963|Lamotrigine|lamotrigine|mesh-list
14398773|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
14398774|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14398775|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398776|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735397|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14398777|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14398778|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735398|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
14735399|NCT00540501|Oseltamivir|oseltamivir|mesh-list
14735400|NCT00540501|Zanamivir|zanamivir|mesh-list
14735401|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
14735402|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735403|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735404|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735405|NCT00540527|Plasminogen|plasminogen|mesh-list
14735406|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14735407|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14735408|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14735409|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735410|NCT00540605|Tenofovir|tenofovir|mesh-list
14735411|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
14735412|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735413|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14735414|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14735415|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735416|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735417|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14735418|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14735419|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
14735420|NCT00540696|Hematinics|hematinics|mesh-ancestor
14735421|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
14735422|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398779|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14398780|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14398781|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398782|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398783|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14398784|NCT01431976|Lamotrigine|lamotrigine|mesh-list
14398785|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
14398786|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14398787|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398788|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398789|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14398790|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398791|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14398792|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14398793|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398794|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398795|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14398796|NCT01431989|Amoxicillin|amoxicillin|mesh-list
14398797|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398798|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398799|NCT01432015|Aprepitant|aprepitant|mesh-list
14398800|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
14398801|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
14398802|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
14398803|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398804|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398805|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398806|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14398807|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398808|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398809|NCT01432145|Methotrexate|methotrexate|mesh-list
14398810|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
14398811|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14398812|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
14398813|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14398814|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398815|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14398816|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
15238816|NCT03925532|Denosumab|denosumab|mesh-list
15238817|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15238818|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735423|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735424|NCT00540748|Oxytocin|oxytocin|mesh-list
15238819|NCT03790111|Gemcitabine|gemcitabine|mesh-list
15238820|NCT03790111|Cisplatin|cisplatin|mesh-list
15238821|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398817|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398818|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398819|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14398820|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398821|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14398822|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735425|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
14735426|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15238822|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15238823|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
15238824|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238825|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
15238826|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238827|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238828|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238829|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
15238830|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238831|NCT03771586|Ketamine|ketamine|mesh-list
15238832|NCT03771586|Analgesics|analgesics|mesh-ancestor
15238833|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
15238834|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238835|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238836|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14735427|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735428|NCT00540787|Quinidine|quinidine|mesh-list
14735429|NCT00540787|Amiodarone|amiodarone|mesh-list
14735430|NCT00540787|Sotalol|sotalol|mesh-list
14735431|NCT00540787|Flecainide|flecainide|mesh-list
14735432|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14735433|NCT00540787|Propafenone|propafenone|mesh-list
15238837|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14735434|NCT00540787|Dofetilide|dofetilide|mesh-list
14735435|NCT00540787|Cifenline|cifenline|mesh-list
15238838|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
15238839|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
15238840|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398823|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
14398824|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398825|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14398826|NCT01432171|Lacosamide|lacosamide|mesh-list
14398827|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
14398828|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14398829|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14398830|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398831|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398832|NCT01432236|Pregabalin|pregabalin|mesh-list
14398833|NCT01432236|Analgesics|analgesics|mesh-ancestor
14398834|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
14398835|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398836|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398837|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
14398838|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14398839|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398840|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398841|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14398842|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14398843|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14398844|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398845|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398846|NCT01432262|Vaccines|vaccines|mesh-list
14398847|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14398848|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
14398849|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398850|NCT01432275|Insulin|insulin|mesh-list
14398851|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398852|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398853|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
14398854|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14398855|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14398856|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14398857|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398858|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398859|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
14398860|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398861|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398862|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14398863|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735436|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
15238841|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15238842|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14735437|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14735438|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735439|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
14735440|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14735441|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14735442|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735443|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14931081|NCT01437371|Protective Agents|protective agents|mesh-ancestor
15238843|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238844|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238845|NCT03769181|Cemiplimab|cemiplimab|mesh-list
15238846|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238847|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238848|NCT03767582|Nivolumab|nivolumab|mesh-list
15238849|NCT03767582|Vaccines|vaccines|mesh-list
15238850|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
15238851|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238852|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238853|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238854|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15238855|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238856|NCT03706885|Efavirenz|efavirenz|mesh-list
15238857|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15238858|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15238859|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238860|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238861|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
15238862|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238863|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15238864|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15238865|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15238866|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15238867|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15238868|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15238869|NCT03560960|Pramlintide|pramlintide|mesh-list
15238870|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15238871|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238872|NCT03518606|Durvalumab|durvalumab|mesh-list
15238873|NCT03518606|Vinorelbine|vinorelbine|mesh-list
15238874|NCT03518606|Tremelimumab|tremelimumab|mesh-list
15238875|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14735444|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14735445|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14735446|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735447|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14735448|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14735449|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15238876|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238877|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15238878|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
15238879|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
15238880|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735450|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14735451|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14735452|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
14735453|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238881|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238882|NCT03504423|Leucovorin|leucovorin|mesh-list
15238883|NCT03504423|Folic Acid|folic acid|mesh-list
15238884|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
15238885|NCT03504423|Irinotecan|irinotecan|mesh-list
15238886|NCT03504423|Folfirinox|folfirinox|mesh-list
14735454|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
14735455|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
15238887|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
15238888|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238889|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15238890|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15238891|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398864|NCT01432405|Pioglitazone|pioglitazone|mesh-list
14735456|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735457|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14735458|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14735459|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
14735460|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14735461|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14735462|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735463|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14735464|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14735465|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
14735466|NCT00540800|Docetaxel|docetaxel|mesh-list
14735467|NCT00540800|Capecitabine|capecitabine|mesh-list
15238892|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238893|NCT03504423|Antidotes|antidotes|mesh-ancestor
14398865|NCT01432405|Exenatide|exenatide|mesh-list
14398866|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398867|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398868|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14398869|NCT01432405|Incretins|incretins|mesh-ancestor
14398870|NCT01432405|Hormones|hormones|mesh-ancestor
14398871|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398872|NCT01432444|Aripiprazole|aripiprazole|mesh-list
14398873|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
14398874|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398875|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14398876|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14398877|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398878|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398879|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
14398880|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
14398881|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398882|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398883|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14398884|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14398885|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
14398886|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14398887|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14398888|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14398889|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14398890|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14398891|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14398892|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14398893|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398894|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398895|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14398896|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398897|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
14398898|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14398899|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14398900|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
14398901|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398902|NCT01432561|Cysteamine|cysteamine|mesh-list
14398903|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14467111|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
14735468|NCT00540800|Epirubicin|epirubicin|mesh-list
14735469|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735470|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735471|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735472|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735473|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735474|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14735475|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
14735476|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14735477|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14735478|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14735479|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735480|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14735481|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14735482|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14735483|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14735484|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735485|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
14398904|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398905|NCT01432574|Vaccines|vaccines|mesh-list
14398906|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
14398907|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398908|NCT01432600|Dexamethasone|dexamethasone|mesh-list
14398909|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
14398910|NCT01432600|Pomalidomide|pomalidomide|mesh-list
14398911|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14398912|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
14398913|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398914|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14398915|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14398916|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
14398917|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398918|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398919|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14398920|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14398921|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
14398922|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
14398923|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398924|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14398925|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
14398926|NCT01432600|Hormones|hormones|mesh-ancestor
14398927|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398928|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14398929|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14398930|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15238894|NCT03504423|Protective Agents|protective agents|mesh-ancestor
15238895|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238896|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
15238897|NCT03504423|Vitamins|vitamins|mesh-ancestor
15238898|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
14398931|NCT01432600|Growth Substances|growth substances|mesh-ancestor
14398932|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
14398933|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14398934|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398935|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398936|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398937|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15238899|NCT03504423|Hematinics|hematinics|mesh-ancestor
15238900|NCT03424525|Trimethoprim|trimethoprim|mesh-list
15238901|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15238902|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238903|NCT03424525|Renal Agents|renal agents|mesh-ancestor
15238904|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
15238905|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15238906|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15238907|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15238908|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238909|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238910|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15238911|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15238912|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15238913|NCT03284853|Latanoprost|latanoprost|mesh-list
15238914|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15238915|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15238916|NCT03206463|Dronabinol|dronabinol|mesh-list
15238917|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
15238918|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238919|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15238920|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15238921|NCT03206463|Analgesics|analgesics|mesh-ancestor
15238922|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
14398938|NCT01432938|Dulaglutide|dulaglutide|mesh-list
14398939|NCT01432938|Warfarin|warfarin|mesh-list
14398940|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
14398941|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398942|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398943|NCT01433055|Minocycline|minocycline|mesh-list
14398944|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14398945|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398946|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
14398947|NCT01433081|Analgesics|analgesics|mesh-ancestor
14398948|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
14398949|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398950|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398951|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
14398952|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14398953|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14398954|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
14398955|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14398956|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14398957|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398958|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14924158|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924159|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924160|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924161|NCT00678730|Dronabinol|dronabinol|mesh-list
14924162|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
14924163|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924164|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924165|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14924166|NCT00678730|Analgesics|analgesics|mesh-ancestor
14924167|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
14924168|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924169|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14924170|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14924171|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924172|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924173|NCT00678730|Hormones|hormones|mesh-ancestor
14924174|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924175|NCT00667251|Paclitaxel|paclitaxel|mesh-list
14924176|NCT00667251|Docetaxel|docetaxel|mesh-list
14924177|NCT00667251|Trastuzumab|trastuzumab|mesh-list
15238923|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14398959|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
14398960|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14398961|NCT01433107|Terbinafine|terbinafine|mesh-list
14398962|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
14398963|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14398964|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398965|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398966|NCT01433172|Vaccines|vaccines|mesh-list
14398967|NCT01433172|Immunologic Factors|immunologic factors|mesh-ancestor
14398968|NCT01433172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398969|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14398970|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
14398971|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398972|NCT01433913|Metformin|metformin|mesh-list
14398973|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398974|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398975|NCT01433978|Maleic acid|maleic acid|mesh-list
14398976|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398977|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398978|NCT01433991|Lenvatinib|lenvatinib|mesh-list
14398979|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14398980|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14398981|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14398982|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398983|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
14398984|NCT01434121|Vitamins|vitamins|mesh-ancestor
14398985|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
14398986|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398987|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
14398988|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14398989|NCT01434121|Protective Agents|protective agents|mesh-ancestor
14398990|NCT01434186|Metformin|metformin|mesh-list
14398991|NCT01434186|Saxagliptin|saxagliptin|mesh-list
14398992|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14398993|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14398994|NCT01434186|Incretins|incretins|mesh-ancestor
14398995|NCT01434186|Hormones|hormones|mesh-ancestor
14398996|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14398997|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14398998|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
14398999|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399000|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399001|NCT01434342|Nicotine|nicotine|mesh-list
14399002|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14399003|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
14399004|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735486|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735487|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735488|NCT00540891|Alfuzosin|alfuzosin|mesh-list
14735489|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14735490|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14735491|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15238924|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15238925|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15238926|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15238927|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238928|NCT03206463|Hormones|hormones|mesh-ancestor
15238929|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238930|NCT03166761|Dexamethasone|dexamethasone|mesh-list
15238931|NCT03166761|Triamcinolone|triamcinolone|mesh-list
15238932|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15238933|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15238934|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14399005|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399006|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14735492|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14735493|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735494|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735495|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735496|NCT00540891|Urological Agents|urological agents|mesh-ancestor
14735497|NCT00540930|Ranibizumab|ranibizumab|mesh-list
14735498|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14735499|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14735500|NCT00540930|Growth Substances|growth substances|mesh-ancestor
15238935|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399007|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14399008|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
14399009|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399010|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399011|NCT01434472|Vidarabine|vidarabine|mesh-list
14399012|NCT01434472|Cyclosporine|cyclosporine|mesh-list
14399013|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
14399014|NCT01434472|Rituximab|rituximab|mesh-list
14399015|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14399016|NCT01434472|Fludarabine|fludarabine|mesh-list
14399017|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
14399018|NCT01434472|Antibodies|antibodies|mesh-list
14399019|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
14399020|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14399021|NCT01434472|Cyclosporins|cyclosporins|mesh-list
14399022|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
15238936|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
15238937|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
15238938|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15238939|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238940|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15238941|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
15238942|NCT03166761|Hormones|hormones|mesh-ancestor
15238943|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15238944|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14924178|NCT00667251|Lapatinib|lapatinib|mesh-list
14924179|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14924180|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924181|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14924182|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14924183|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14924184|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924185|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14924186|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924187|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924188|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
14924189|NCT00602459|Rituximab|rituximab|mesh-list
14924190|NCT00602459|Fludarabine|fludarabine|mesh-list
14924191|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
14924192|NCT00602459|Lenalidomide|lenalidomide|mesh-list
14924193|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14924194|NCT00602459|Antibodies|antibodies|mesh-list
14924195|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
15238945|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924196|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14924197|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399023|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399024|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924198|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
14924199|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735501|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735502|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
14735503|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735504|NCT00540943|Irinotecan|irinotecan|mesh-list
14735505|NCT00540943|Cetuximab|cetuximab|mesh-list
14924200|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399025|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14735506|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14735507|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14735508|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735509|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735510|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735511|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14735512|NCT00540956|Cytarabine|cytarabine|mesh-list
14735513|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14735514|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
14735515|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735516|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735517|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
14735518|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735519|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735520|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
14735521|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735522|NCT00541008|Sunitinib|sunitinib|mesh-list
14735523|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735524|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14735525|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14735526|NCT00541008|Growth Substances|growth substances|mesh-ancestor
14735527|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735528|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
14735529|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14735530|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735531|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735532|NCT00541021|Gemcitabine|gemcitabine|mesh-list
14399026|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14399027|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
14399028|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399029|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399030|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
14399031|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399032|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399033|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
14399034|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
14399035|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14399036|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14399037|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14399038|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
14399039|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14399040|NCT01435018|Tenofovir|tenofovir|mesh-list
14399041|NCT01435018|Emtricitabine|emtricitabine|mesh-list
14399042|NCT01435018|Efavirenz|efavirenz|mesh-list
14399043|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14399044|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14399045|NCT01435018|Paclitaxel|paclitaxel|mesh-list
14399046|NCT01435018|Etoposide|etoposide|mesh-list
14399047|NCT01435018|Vincristine|vincristine|mesh-list
14399048|NCT01435018|Bleomycin|bleomycin|mesh-list
14399049|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14399050|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399051|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14399052|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14399053|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14399054|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399055|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14399056|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14399057|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399058|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
14399059|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399060|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14399061|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14399062|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14399063|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14399064|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14399065|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14399066|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14399067|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14399068|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14399069|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14735533|NCT00541021|Sorafenib|sorafenib|mesh-list
14735534|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14399070|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14399071|NCT01435122|Axitinib|axitinib|mesh-list
14399072|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399073|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14399074|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399075|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399076|NCT01435174|Ranolazine|ranolazine|mesh-list
14399077|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
14399078|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14399079|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14399080|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399081|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399082|NCT01435382|Bococizumab|bococizumab|mesh-list
14399083|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14399084|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14399085|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
14399086|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399087|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14399088|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14399089|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14399090|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14399091|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14399092|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14399093|NCT01435460|Analgesics|analgesics|mesh-ancestor
14399094|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
14399095|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399096|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399097|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399098|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399099|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14399100|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14399101|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
14399102|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
14399103|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399104|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399105|NCT01435577|Tapentadol|tapentadol|mesh-list
14399106|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14399107|NCT01435577|Narcotics|narcotics|mesh-ancestor
14399108|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399109|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399110|NCT01435577|Analgesics|analgesics|mesh-ancestor
14399111|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
14399112|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399113|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14399114|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14399115|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399116|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399117|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399118|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399119|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
14399120|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14399121|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399122|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15238946|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238947|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
15238948|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238949|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238950|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
15238951|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
15238952|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15238953|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
14399123|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
14399124|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399125|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14399126|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399127|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14399128|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14399129|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399130|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238954|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238955|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15238956|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15238957|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
15238958|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238959|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238960|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14399131|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
14399132|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399133|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
14399134|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
14399135|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399136|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15238961|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238962|NCT03072147|Teriparatide|teriparatide|mesh-list
14399137|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14399138|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399139|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399140|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399141|NCT01435824|Amoxicillin|amoxicillin|mesh-list
14924201|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14399142|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14399143|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924202|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
14399144|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14399145|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14399146|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14399147|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735535|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
14735536|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735537|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735538|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
14735539|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735540|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735541|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399148|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399149|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399150|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14399151|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14399152|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14399153|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399154|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399155|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399156|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14399157|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14399158|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
14399159|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14399160|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14399161|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
14399162|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
14399163|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14399164|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399165|NCT01436071|Fluticasone|fluticasone|mesh-list
14399166|NCT01436071|Xhance|xhance|mesh-list
14399167|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399168|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14399169|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
14399170|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399171|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399172|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14399173|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399174|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
14399175|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14399176|NCT01436110|Fluticasone|fluticasone|mesh-list
14399177|NCT01436110|Xhance|xhance|mesh-list
14399178|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399179|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14399180|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
14399181|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399182|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399183|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14399184|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399185|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14399186|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14399187|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14399188|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14399189|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399190|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14399191|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14399192|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399193|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399194|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
14399195|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399196|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14399197|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
14399198|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399199|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14399200|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399201|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14399202|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14399203|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399204|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399205|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
14399206|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399207|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14399208|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
14399209|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399210|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14399211|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399212|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14399213|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14399214|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399215|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924203|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924204|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924205|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14924206|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14399216|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
14399217|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399218|NCT01436201|Dulaglutide|dulaglutide|mesh-list
14399219|NCT01436201|Digoxin|digoxin|mesh-list
14399220|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14399221|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14399222|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399223|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399224|NCT01436201|Protective Agents|protective agents|mesh-ancestor
14924207|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
14399225|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924208|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14924209|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14924210|NCT00602459|Growth Substances|growth substances|mesh-ancestor
14924211|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
14924212|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14924213|NCT00600015|Sorafenib|sorafenib|mesh-list
14924214|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924215|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924216|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924217|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924218|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14924219|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14924220|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924221|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14924222|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14924223|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14924224|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924225|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
14924226|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399226|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14399227|NCT01436266|Folic Acid|folic acid|mesh-list
14399228|NCT01436266|Misoprostol|misoprostol|mesh-list
14399229|NCT01436266|Vitamins|vitamins|mesh-ancestor
14399230|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
14399231|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399232|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14399233|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
14399234|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14399235|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14399236|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399237|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
14399238|NCT01436266|Hematinics|hematinics|mesh-ancestor
14399239|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
14399240|NCT01436279|Mifepristone|mifepristone|mesh-list
14399241|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14399242|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
14399243|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14399244|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399245|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14399246|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14399247|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14399248|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
14399249|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14399250|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14399251|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
14399252|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399253|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
14399254|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14399255|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14399256|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
14399257|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
14399258|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
14399259|NCT01436305|Abatacept|abatacept|mesh-list
14399260|NCT01436305|Tacrolimus|tacrolimus|mesh-list
14399261|NCT01436305|Basiliximab|basiliximab|mesh-list
14399262|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399263|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
14399264|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399265|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14399266|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399267|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399268|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14399269|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399270|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14399271|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
14399272|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14399273|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399274|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399275|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
14399276|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
14399277|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399278|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399279|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
14399280|NCT01436305|Hormones|hormones|mesh-ancestor
14399281|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399282|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14399283|NCT01436305|Protective Agents|protective agents|mesh-ancestor
14399284|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14399285|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14399286|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399287|NCT01436370|Vaccines|vaccines|mesh-list
14399288|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
14399289|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399290|NCT01436500|Ifetroban|ifetroban|mesh-list
14399291|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14399292|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
14399293|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14399294|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
14399295|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14399296|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
15238963|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15238964|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238965|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15238966|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
15238967|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15238968|NCT03016533|Lamivudine|lamivudine|mesh-list
15238969|NCT03016533|Dolutegravir|dolutegravir|mesh-list
15238970|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15238971|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15238972|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15238973|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238974|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
15238975|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15238976|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14399297|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399298|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399299|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
14467112|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467113|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467114|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14467115|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14467116|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
14467117|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
14467118|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467119|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14467120|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14467121|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467122|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467123|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14467124|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14467125|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14467126|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14467127|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14467128|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
14467129|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
14467130|NCT02256436|Paclitaxel|paclitaxel|mesh-list
14467131|NCT02256436|Docetaxel|docetaxel|mesh-list
14467132|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
14467133|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14467134|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467135|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14467136|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14467137|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
15238977|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15238978|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15238979|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15238980|NCT03011814|Lenalidomide|lenalidomide|mesh-list
15238981|NCT03011814|Durvalumab|durvalumab|mesh-list
15238982|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
15238983|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15238984|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
15238985|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
15238986|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467138|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467139|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467140|NCT02256540|Resveratrol|resveratrol|mesh-list
14467141|NCT02256540|Estradiol|estradiol|mesh-list
14467142|NCT02256540|Estrogens|estrogens|mesh-ancestor
14467143|NCT02256540|Hormones|hormones|mesh-ancestor
14467144|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735542|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
14735543|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735544|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14735545|NCT00541047|Leuprolide|leuprolide|mesh-list
15238987|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15238988|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15238989|NCT03011814|Growth Substances|growth substances|mesh-ancestor
14924227|NCT00447122|Gemcitabine|gemcitabine|mesh-list
15238990|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
14399300|NCT01436643|Fluoxetine|fluoxetine|mesh-list
14399301|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14399302|NCT01436643|Citalopram|citalopram|mesh-list
14399303|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14399304|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14399305|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14399306|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399307|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15238991|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238992|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15238993|NCT02962414|Everolimus|everolimus|mesh-list
15238994|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15238995|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399308|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399309|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
14399310|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399311|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14399312|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
15238996|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
15238997|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15238998|NCT02947165|Spartalizumab|spartalizumab|mesh-list
15238999|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14399313|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399314|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14399315|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14399316|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399317|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14399318|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14399319|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399320|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
14399321|NCT01436799|Alfentanil|alfentanil|mesh-list
14399322|NCT01436799|Propofol|propofol|mesh-list
14399323|NCT01436799|Desflurane|desflurane|mesh-list
14399324|NCT01436799|Rocuronium|rocuronium|mesh-list
14399325|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14399326|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399327|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399328|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14399329|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
14399330|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
14399331|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14399332|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14399333|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14399334|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735546|NCT00541047|Goserelin|goserelin|mesh-list
14735547|NCT00541047|Bicalutamide|bicalutamide|mesh-list
14735548|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14735549|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
14735550|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14735551|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735552|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735553|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735554|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
14924228|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
14924229|NCT00447122|Lapatinib|lapatinib|mesh-list
14924230|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14924231|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
14924232|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924233|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924234|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
14735555|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
14735556|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735557|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
14735558|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
14735559|NCT00541073|Pemetrexed|pemetrexed|mesh-list
14735560|NCT00541073|Vitamins|vitamins|mesh-ancestor
15239000|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239001|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399335|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14399336|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14399337|NCT01436799|Narcotics|narcotics|mesh-ancestor
14399338|NCT01436799|Analgesics|analgesics|mesh-ancestor
14399339|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
14399340|NCT01437267|Vaccines|vaccines|mesh-list
14399341|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14399342|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
14399343|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399344|NCT01437397|Bromides|bromides|mesh-list
14399345|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
14399346|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15239002|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15239003|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239004|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239005|NCT02905318|Palbociclib|palbociclib|mesh-list
15239006|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239007|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15239008|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399347|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
14399348|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399349|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399350|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14399351|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399352|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14399353|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14399354|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14399355|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399356|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399357|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399358|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
14399359|NCT01437449|Carboplatin|carboplatin|mesh-list
14399360|NCT01437449|Docetaxel|docetaxel|mesh-list
14399361|NCT01437449|Cetuximab|cetuximab|mesh-list
14399362|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399363|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14399364|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14399365|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14399366|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399367|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14735561|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
14924235|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924236|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924237|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924238|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
14924239|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239009|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239010|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
15239011|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239012|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239013|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
15239014|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15239015|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15239016|NCT02767804|Crizotinib|crizotinib|mesh-list
15239017|NCT02767804|Ensartinib|ensartinib|mesh-list
15239018|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239019|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15239020|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239021|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239022|NCT02721069|Diazepam|diazepam|mesh-list
15239023|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15239024|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
15239025|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
15239026|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
14735562|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735563|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399368|NCT01437540|Bromides|bromides|mesh-list
14399369|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
15239027|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239028|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239029|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399370|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14399371|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
14399372|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399373|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399374|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14399375|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399376|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14399377|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14399378|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14399379|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399380|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399381|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399382|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
14399383|NCT01437605|Poly I-C|poly i-c|mesh-list
14399384|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
14399385|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
14399386|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399387|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
14399388|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399389|NCT01437878|Iloprost|iloprost|mesh-list
14399390|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14399391|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
14399392|NCT01437995|Fluticasone|fluticasone|mesh-list
14399393|NCT01437995|Xhance|xhance|mesh-list
14399394|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14399395|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14399396|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399397|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14399398|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
14399399|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399400|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399401|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14399402|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399403|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
14399404|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14399405|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14399406|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14399407|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14399408|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399409|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399410|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399411|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
14399412|NCT01437995|Hormones|hormones|mesh-ancestor
14399413|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399414|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
14399415|NCT01438060|Aripiprazole|aripiprazole|mesh-list
14399416|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
14399417|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399418|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14399419|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14399420|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399421|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399422|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
14399423|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
14399424|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399425|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399426|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14399427|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14399428|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
14399429|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14399430|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14399431|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14399432|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14399433|NCT01438151|Infliximab|infliximab|mesh-list
14399434|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14399435|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399436|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399437|NCT01438177|Chloroquine|chloroquine|mesh-list
14399438|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
14399439|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14399440|NCT01438177|Bortezomib|bortezomib|mesh-list
14399441|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399442|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
14399443|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399444|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399445|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14399446|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
14399447|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399448|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399449|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15239030|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15239031|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239032|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15239033|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15239034|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15239035|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15239036|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239037|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15239038|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
15239039|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
15239040|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
14399450|NCT01438177|Amebicides|amebicides|mesh-ancestor
15239041|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
15239042|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239043|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239044|NCT02719613|Dexamethasone|dexamethasone|mesh-list
15239045|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
14735564|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735565|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735566|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14735567|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14735568|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
15239046|NCT02719613|Nivolumab|nivolumab|mesh-list
15239047|NCT02719613|Lenalidomide|lenalidomide|mesh-list
14399451|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14399452|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14399453|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399454|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
14399455|NCT01438411|Cholic Acids|cholic acids|mesh-list
14399456|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399457|NCT01438424|Lamivudine|lamivudine|mesh-list
14399458|NCT01438424|Entecavir|entecavir|mesh-list
15239048|NCT02719613|Bortezomib|bortezomib|mesh-list
15239049|NCT02719613|Pomalidomide|pomalidomide|mesh-list
15239050|NCT02719613|Elotuzumab|elotuzumab|mesh-list
15239051|NCT02719613|BB 1101|bb 1101|mesh-list
15239052|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239053|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
15239054|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
14399459|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14399460|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14399461|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399462|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399463|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
14399464|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399465|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14399466|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14399467|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14399468|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
14399469|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399470|NCT01438710|Tacrolimus|tacrolimus|mesh-list
14399471|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399472|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
14399473|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399474|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14399475|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399476|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399477|NCT01438814|Metformin|metformin|mesh-list
14399478|NCT01438814|Linagliptin|linagliptin|mesh-list
14399479|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14399480|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399481|NCT01438814|Incretins|incretins|mesh-ancestor
14735569|NCT00541073|Hematinics|hematinics|mesh-ancestor
15239055|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239056|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239057|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399482|NCT01438814|Hormones|hormones|mesh-ancestor
14399483|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399484|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14399485|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
14399486|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399487|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399488|NCT01438840|Maleic acid|maleic acid|mesh-list
14399489|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399490|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399491|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
14399492|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14399493|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399494|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399495|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14399496|NCT01438957|Analgesics|analgesics|mesh-ancestor
14399497|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
14399498|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399499|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14399500|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14399501|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14399502|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399503|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735570|NCT00541086|Tamoxifen|tamoxifen|mesh-list
14735571|NCT00541086|Letrozole|letrozole|mesh-list
14735572|NCT00541086|Anastrozole|anastrozole|mesh-list
14735573|NCT00541086|Exemestane|exemestane|mesh-list
14735574|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735575|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735576|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14735577|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14735578|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399504|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399505|NCT01439009|Tolvaptan|tolvaptan|mesh-list
14399506|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14399507|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399508|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
14399509|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399510|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
14399511|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14399512|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14399513|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399514|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14399515|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14399516|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
14399517|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14399518|NCT01439126|Clonidine|clonidine|mesh-list
14399519|NCT01439126|Analgesics|analgesics|mesh-ancestor
14399520|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
14399521|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399522|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399523|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14399524|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
15239058|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
15239059|NCT02719613|Hormones|hormones|mesh-ancestor
15239060|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239061|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239062|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239063|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
15239064|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239065|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399525|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
14399526|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14399527|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14399528|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14399529|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399530|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399531|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399532|NCT01439204|Abatacept|abatacept|mesh-list
14399533|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14735579|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14735580|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
14399534|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399535|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399536|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399537|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
14399538|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399539|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399540|NCT01439282|Capecitabine|capecitabine|mesh-list
14399541|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14399542|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
14399543|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399544|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399545|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14399546|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
14399547|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399548|NCT01439373|Interferons|interferons|mesh-list
14399549|NCT01439373|Ribavirin|ribavirin|mesh-list
14399550|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
14399551|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
14399552|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14399553|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399554|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
14399555|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399556|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
14399557|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399558|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
14399559|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399560|NCT01439555|Simvastatin|simvastatin|mesh-list
14399561|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14399562|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14399563|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
14399564|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399565|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14399566|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14399567|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399568|NCT01439568|Carboplatin|carboplatin|mesh-list
14399569|NCT01439568|Etoposide|etoposide|mesh-list
14399570|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399571|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14399572|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14399573|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14399574|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399575|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399576|NCT01439672|Insulin|insulin|mesh-list
14399577|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14399578|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399579|NCT01439711|Letrozole|letrozole|mesh-list
14399580|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399581|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14399582|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14399583|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399584|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399585|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14399586|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
14399587|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399588|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399589|NCT01439815|Fluticasone|fluticasone|mesh-list
14399590|NCT01439815|Xhance|xhance|mesh-list
14399591|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399592|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14399593|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
14399594|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399595|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399596|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14399597|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399598|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14399599|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14399600|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
14399601|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14399602|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399603|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14399604|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399605|NCT01439867|Cinacalcet|cinacalcet|mesh-list
15239066|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239067|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15239068|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
15239069|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15239070|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15239071|NCT02719613|Growth Substances|growth substances|mesh-ancestor
15239072|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
15239073|NCT02717507|Carvedilol|carvedilol|mesh-list
15239074|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15239075|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15239076|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
15239077|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239078|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239079|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239080|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15239081|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
15239082|NCT02717507|Protective Agents|protective agents|mesh-ancestor
15239083|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15239084|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15239085|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15239086|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
15239087|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14399606|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14399607|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399608|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14399609|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
14399610|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399611|NCT01439880|Evolocumab|evolocumab|mesh-list
14399612|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14399613|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14399614|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
14399615|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399616|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14399617|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
14399618|NCT01439945|Antacids|antacids|mesh-ancestor
15239088|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15239089|NCT02658981|Nivolumab|nivolumab|mesh-list
15239090|NCT02658981|Antibodies|antibodies|mesh-list
15239091|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15239092|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
15239093|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399619|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399620|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399621|NCT01440101|Natalizumab|natalizumab|mesh-list
14399622|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
14399623|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399624|NCT01440569|Darunavir|darunavir|mesh-list
14399625|NCT01440569|Cobicistat|cobicistat|mesh-list
14399626|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14399627|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14399628|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
15239094|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239095|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239096|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15239097|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239098|NCT02575794|Masoprocol|masoprocol|mesh-list
15239099|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
15239100|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239101|NCT02575794|Protective Agents|protective agents|mesh-ancestor
15239102|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239103|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15239104|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239105|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15239106|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15239107|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239108|NCT02575794|Analgesics|analgesics|mesh-ancestor
15239109|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
15239110|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239111|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239112|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239113|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
14399629|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239114|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239115|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15239116|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239117|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239118|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
15239119|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239120|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239121|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15239122|NCT02389465|Celecoxib|celecoxib|mesh-list
15239123|NCT02389465|Dexetimide|dexetimide|mesh-list
15239124|NCT02389465|Citalopram|citalopram|mesh-list
15239125|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15239126|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14399630|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399631|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14399632|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14399633|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
14399634|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399635|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14399636|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14399637|NCT01440764|Furosemide|furosemide|mesh-list
14399638|NCT01440764|Diuretics|diuretics|mesh-ancestor
14399639|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
14399640|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399641|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14399642|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399643|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399644|NCT01440803|Teriparatide|teriparatide|mesh-list
14399645|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14735581|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735582|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239127|NCT02389465|Analgesics|analgesics|mesh-ancestor
14399646|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399647|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14399648|NCT01440816|Interleukin-12|interleukin-12|mesh-list
14399649|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14399650|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
14399651|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399652|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14399653|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14399654|NCT01440816|Growth Substances|growth substances|mesh-ancestor
14399655|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
14399656|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399657|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14399658|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
14399659|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399660|NCT01441037|Danazol|danazol|mesh-list
14399661|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14399662|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
14399663|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399664|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399665|NCT01441063|Zidovudine|zidovudine|mesh-list
14399666|NCT01441063|Valganciclovir|valganciclovir|mesh-list
14399667|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
14399668|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399669|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14399670|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14399671|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399672|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
14399673|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735583|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735584|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14735585|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14735586|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14735587|NCT00541112|Leucovorin|leucovorin|mesh-list
14735588|NCT00541112|Fluorouracil|fluorouracil|mesh-list
14735589|NCT00541112|Capecitabine|capecitabine|mesh-list
14735590|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
14735591|NCT00541112|Cetuximab|cetuximab|mesh-list
14735592|NCT00541112|Calcium|calcium|mesh-list
14735593|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
14735594|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14735595|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735596|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
14735597|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735598|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14735599|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735600|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735601|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
14735602|NCT00541112|Antidotes|antidotes|mesh-ancestor
14735603|NCT00541112|Protective Agents|protective agents|mesh-ancestor
14735604|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
14735605|NCT00541112|Vitamins|vitamins|mesh-ancestor
14735606|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
14735607|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14735608|NCT00541125|Leucovorin|leucovorin|mesh-list
14735609|NCT00541125|Bevacizumab|bevacizumab|mesh-list
14735610|NCT00541125|Fluorouracil|fluorouracil|mesh-list
14735611|NCT00541125|Irinotecan|irinotecan|mesh-list
14735612|NCT00541125|Calcium|calcium|mesh-list
14735613|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
14735614|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14735615|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735616|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14735617|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14735618|NCT00541125|Growth Substances|growth substances|mesh-ancestor
14735619|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735620|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
14735621|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14735622|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
14735623|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735624|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14735625|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735626|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
14735627|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14735628|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14735629|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735630|NCT00541125|Antidotes|antidotes|mesh-ancestor
14735631|NCT00541125|Protective Agents|protective agents|mesh-ancestor
14735632|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
14735633|NCT00541125|Vitamins|vitamins|mesh-ancestor
14399674|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14399675|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14399676|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14399677|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399678|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
14399679|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
14399680|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
14735634|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
14399681|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14399682|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14399683|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399684|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399685|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399686|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
14399687|NCT01441180|Ribavirin|ribavirin|mesh-list
14399688|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
14399689|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399690|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
14399691|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399692|NCT01441245|Furosemide|furosemide|mesh-list
14399693|NCT01441245|Diuretics|diuretics|mesh-ancestor
14399694|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
14399695|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399696|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14399697|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399698|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399699|NCT01441401|Gabapentin|gabapentin|mesh-list
14399700|NCT01441401|Analgesics|analgesics|mesh-ancestor
15239128|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
15239129|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239130|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399701|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
14399702|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399703|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399704|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
14399705|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14399706|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14399707|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399708|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399709|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14399710|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14399711|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399712|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399713|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
14399714|NCT01441414|Axitinib|axitinib|mesh-list
14399715|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399716|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14399717|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399718|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399719|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14399720|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14399721|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14399722|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399723|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399724|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399725|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399726|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14399727|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
14399728|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239131|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239132|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239133|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15239134|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15239135|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239136|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239137|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15239138|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15239139|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15239140|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239141|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
15239142|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15239143|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
15239144|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239145|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14399729|NCT01441570|Metoprolol|metoprolol|mesh-list
14399730|NCT01441570|Nebivolol|nebivolol|mesh-list
14399731|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14399732|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14399733|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
14399734|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
14399735|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399736|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399737|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14399738|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14399739|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14399740|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
14399741|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399742|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399743|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
14399744|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14399745|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14399746|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14399747|NCT01441596|Vinorelbine|vinorelbine|mesh-list
14399748|NCT01441596|Afatinib|afatinib|mesh-list
14399749|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14399750|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399751|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
14399752|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
14399753|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14399754|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399755|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14399756|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399757|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14399758|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14399759|NCT01441635|Norethindrone|norethindrone|mesh-list
14399760|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
14399761|NCT01441635|Estradiol|estradiol|mesh-list
14399762|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14399763|NCT01441635|Progesterone|progesterone|mesh-list
14399764|NCT01441635|Estrogens|estrogens|mesh-ancestor
14399765|NCT01441635|Hormones|hormones|mesh-ancestor
14399766|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399767|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399768|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14399769|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
14399770|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14399771|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14399772|NCT01441635|Progestins|progestins|mesh-ancestor
14399773|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14399774|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14399775|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14399776|NCT01441765|Pidilizumab|pidilizumab|mesh-list
14399777|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14399778|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399779|NCT01441843|Lorazepam|lorazepam|mesh-list
14399780|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
14399781|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
14399782|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
14399783|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399784|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399785|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399786|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14399787|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399788|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14399789|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14399790|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399791|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
14399792|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
14399793|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399794|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399795|NCT01441882|Dasatinib|dasatinib|mesh-list
14399796|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399797|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14399798|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399799|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399800|NCT01441960|Rocuronium|rocuronium|mesh-list
14399801|NCT01441960|Succinylcholine|succinylcholine|mesh-list
14399802|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14735635|NCT00541138|Tamoxifen|tamoxifen|mesh-list
14399803|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14399804|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14399805|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399806|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239146|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15239147|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
15239148|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
15239149|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15239150|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15239151|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
15239152|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
15239153|NCT02335060|Dronabinol|dronabinol|mesh-list
15239154|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15239155|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
15239156|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239157|NCT02335060|Expectorants|expectorants|mesh-ancestor
15239158|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
15239159|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15239160|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
15239161|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239162|NCT02335060|Protective Agents|protective agents|mesh-ancestor
15239163|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239164|NCT02335060|Antidotes|antidotes|mesh-ancestor
15239165|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
15239166|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239167|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239168|NCT02335060|Analgesics|analgesics|mesh-ancestor
15239169|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
15239170|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239171|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15239172|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15239173|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399807|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14399808|NCT01441973|Elotuzumab|elotuzumab|mesh-list
15239174|NCT02335060|Hormones|hormones|mesh-ancestor
15239175|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239176|NCT02297438|Letrozole|letrozole|mesh-list
14399809|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399810|NCT01442038|Ranolazine|ranolazine|mesh-list
14399811|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14399812|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399813|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399814|NCT01442064|Ranibizumab|ranibizumab|mesh-list
14399815|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14399816|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14399817|NCT01442064|Growth Substances|growth substances|mesh-ancestor
14399818|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399819|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
14399820|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399821|NCT01442155|Capecitabine|capecitabine|mesh-list
14399822|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
14399823|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14399824|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
14399825|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399826|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467145|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467146|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
14467147|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467148|NCT02256540|Protective Agents|protective agents|mesh-ancestor
14467149|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467150|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14467151|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
14467152|NCT02256969|Prednisolone|prednisolone|mesh-list
14467153|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14467154|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
14467155|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14467156|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
14467157|NCT02256969|Mineral Oil|mineral oil|mesh-list
14467158|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14467159|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
14467160|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467161|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
14467162|NCT02256969|Hormones|hormones|mesh-ancestor
14467163|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467164|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467165|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14467166|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467167|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
14467168|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
14467169|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467170|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14467171|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14467172|NCT02256969|Protective Agents|protective agents|mesh-ancestor
14467173|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14467174|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467175|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14467176|NCT02256969|Renal Agents|renal agents|mesh-ancestor
14467177|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14467178|NCT02256969|Emollients|emollients|mesh-ancestor
14467179|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469966|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14469967|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
14469968|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735636|NCT00541138|Carboplatin|carboplatin|mesh-list
15239177|NCT02297438|Palbociclib|palbociclib|mesh-list
15239178|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239179|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15239180|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15239181|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239182|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239183|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15239184|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
15239185|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239186|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239187|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15239188|NCT02297412|Minocycline|minocycline|mesh-list
15239189|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239190|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239191|NCT02292758|Bevacizumab|bevacizumab|mesh-list
15239192|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15239193|NCT02292758|Cetuximab|cetuximab|mesh-list
14399827|NCT01442376|Ondansetron|ondansetron|mesh-list
14399828|NCT01442376|Palonosetron|palonosetron|mesh-list
14399829|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
14399830|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
14399831|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399832|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399833|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399834|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
14399835|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14399836|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14399837|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
14399838|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399839|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399840|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14399841|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14399842|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399843|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14399844|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14399845|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14399846|NCT01442493|Methadone|methadone|mesh-list
14399847|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14399848|NCT01442493|Narcotics|narcotics|mesh-ancestor
14399849|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14399850|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399851|NCT01442493|Analgesics|analgesics|mesh-ancestor
14924240|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924241|NCT00430040|Carvedilol|carvedilol|mesh-list
14924242|NCT00430040|Lisinopril|lisinopril|mesh-list
14924243|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14924244|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14924245|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
14924246|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924247|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924248|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924249|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14924250|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
14924251|NCT00430040|Protective Agents|protective agents|mesh-ancestor
15239194|NCT02292758|Irinotecan|irinotecan|mesh-list
14399852|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
14399853|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399854|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
14399855|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399856|NCT01442688|Amoxicillin|amoxicillin|mesh-list
14399857|NCT01442688|Mesalamine|mesalamine|mesh-list
14399858|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14399859|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399860|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14399861|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14399862|NCT01442688|Analgesics|analgesics|mesh-ancestor
14399863|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
14399864|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399865|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399866|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399867|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399868|NCT01442714|Lenalidomide|lenalidomide|mesh-list
14399869|NCT01442714|Azacitidine|azacitidine|mesh-list
14399870|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
14399871|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399872|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14399873|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14399874|NCT01442714|Growth Substances|growth substances|mesh-ancestor
15239195|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
15239196|NCT02292758|Antibodies|antibodies|mesh-list
14399875|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
14399876|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399877|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14399878|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
14399879|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399880|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399881|NCT01442779|Interferons|interferons|mesh-list
14399882|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
14399883|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399884|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
14399885|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399886|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
14399887|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399888|NCT01443026|Lycopene|lycopene|mesh-list
14399889|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399890|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
15239197|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
15239198|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15239199|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
15239200|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239201|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15239202|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15239203|NCT02292758|Growth Substances|growth substances|mesh-ancestor
15239204|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239205|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
15239206|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
14399891|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239207|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14924252|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14924253|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399892|NCT01443026|Protective Agents|protective agents|mesh-ancestor
14399893|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399894|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14399895|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14399896|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399897|NCT01443078|Gemcitabine|gemcitabine|mesh-list
14399898|NCT01443078|Carboplatin|carboplatin|mesh-list
14399899|NCT01443078|Docetaxel|docetaxel|mesh-list
14399900|NCT01443078|Pemetrexed|pemetrexed|mesh-list
14399901|NCT01443078|Vinorelbine|vinorelbine|mesh-list
14399902|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399903|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14399904|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
14399905|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399906|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
14399907|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399908|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399909|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399910|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
14399911|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399912|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14399913|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14399914|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14399915|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14399916|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14399917|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14399918|NCT01443130|Chloroquine|chloroquine|mesh-list
14399919|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
14399920|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
14399921|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14399922|NCT01443130|Amebicides|amebicides|mesh-ancestor
14399923|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14399924|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14399925|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14399926|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
14399927|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399928|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14399929|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399930|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399931|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14399932|NCT01443130|Renal Agents|renal agents|mesh-ancestor
14399933|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
14399934|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14399935|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
14399936|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399937|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14399938|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14399939|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
14399940|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14735637|NCT00541138|Topotecan|topotecan|mesh-list
14735638|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735639|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735640|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14735641|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14735642|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735643|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14735644|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
14735645|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735646|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735647|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735648|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14735649|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14735650|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14399941|NCT01443546|Leuprolide|leuprolide|mesh-list
14399942|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14399943|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
15239208|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15239209|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399944|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14399945|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399946|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14399947|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399948|NCT01443858|Meclizine|meclizine|mesh-list
14399949|NCT01443858|Nicotine|nicotine|mesh-list
14399950|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14399951|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
14399952|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399953|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399954|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14399955|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14399956|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
14399957|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14399958|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399959|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
14399960|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14399961|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14399962|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
14399963|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
14399964|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14399965|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
15239210|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399966|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14399967|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14399968|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399969|NCT01444430|Budesonide|budesonide|mesh-list
14399970|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14399971|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14399972|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14399973|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
14399974|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399975|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399976|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14399977|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
14399978|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
14399979|NCT01444430|Hormones|hormones|mesh-ancestor
14399980|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14399981|NCT01444651|Tadalafil|tadalafil|mesh-list
14399982|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
14399983|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14399984|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14399985|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14399986|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735651|NCT00541164|Ubiquinone|ubiquinone|mesh-list
14735652|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
14735653|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
14735654|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735655|NCT00541164|Vitamins|vitamins|mesh-ancestor
14735656|NCT00541177|Atropine|atropine|mesh-list
14735657|NCT00541177|Tropicamide|tropicamide|mesh-list
14735658|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14735659|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14735660|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14735661|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
15239211|NCT02250326|Paclitaxel|paclitaxel|mesh-list
15239212|NCT02250326|Azacitidine|azacitidine|mesh-list
15239213|NCT02250326|Cc-486|cc-486|mesh-list
15239214|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15239215|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735662|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14399987|NCT01444651|Urological Agents|urological agents|mesh-ancestor
14399988|NCT01444716|Ofatumumab|ofatumumab|mesh-list
14399989|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14399990|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399991|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
14399992|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399993|NCT01444742|Cytarabine|cytarabine|mesh-list
14399994|NCT01444742|Clofarabine|clofarabine|mesh-list
14399995|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15239216|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
15239217|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
15239218|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
15239219|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239220|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15239221|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
15239222|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239223|NCT02102113|Dronabinol|dronabinol|mesh-list
15239224|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
15239225|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14399996|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
14399997|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14399998|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14399999|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
14400000|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400001|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400002|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
14400003|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400004|NCT01444781|Vaccines|vaccines|mesh-list
14400005|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14400006|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
14400007|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400008|NCT01444898|Exenatide|exenatide|mesh-list
14400009|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400010|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400011|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14400012|NCT01444898|Incretins|incretins|mesh-ancestor
14400013|NCT01444898|Hormones|hormones|mesh-ancestor
14400014|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400015|NCT01444924|Bupivacaine|bupivacaine|mesh-list
14400016|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
14400017|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
14400018|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400019|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400020|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
15239226|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239227|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14400021|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400022|NCT01445028|Isotretinoin|isotretinoin|mesh-list
14400023|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400024|NCT01445080|Sorafenib|sorafenib|mesh-list
14400025|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400026|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14400027|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239228|NCT02102113|Analgesics|analgesics|mesh-ancestor
14400028|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400029|NCT01445535|Prednisone|prednisone|mesh-list
14400030|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
15239229|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
15239230|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400031|NCT01445535|Rituximab|rituximab|mesh-list
14400032|NCT01445535|Doxorubicin|doxorubicin|mesh-list
14400033|NCT01445535|Etoposide|etoposide|mesh-list
14400034|NCT01445535|Vincristine|vincristine|mesh-list
14400035|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400036|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
14400037|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400038|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14400039|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14400040|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
14400041|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400042|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400043|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14400044|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400045|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14400046|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14400047|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14400048|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400049|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400050|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
14400051|NCT01445535|Hormones|hormones|mesh-ancestor
14400052|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400053|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14400054|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14400055|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
14400056|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
14400057|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
14400058|NCT01445548|Sirolimus|sirolimus|mesh-list
14400059|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14400060|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400061|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14400062|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400063|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
15239231|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15239232|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15239233|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239234|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239235|NCT02102113|Hormones|hormones|mesh-ancestor
15239236|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239237|NCT01922076|Adavosertib|adavosertib|mesh-list
14400064|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400065|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
14400066|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400067|NCT01445626|Dexamethasone|dexamethasone|mesh-list
14400068|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400069|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
14400070|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
14400071|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400072|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400073|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400074|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
14400075|NCT01445626|Hormones|hormones|mesh-ancestor
14400076|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400077|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14400078|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400079|NCT01445678|Metronidazole|metronidazole|mesh-list
14400080|NCT01445678|Meropenem|meropenem|mesh-list
14400081|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400082|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14400083|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14400084|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14400085|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
14400086|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14400087|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
14400088|NCT01445821|Fludarabine|fludarabine|mesh-list
14400089|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
14400090|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400091|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
14400092|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400093|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14400094|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14400095|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
14400096|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400097|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400098|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14400099|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400100|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
14400101|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
14400102|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400103|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400104|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
14400105|NCT01445821|Hormones|hormones|mesh-ancestor
14400106|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400107|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14400108|NCT01445821|Protective Agents|protective agents|mesh-ancestor
14735663|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735664|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14735665|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
15239238|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735666|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
14735667|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
14735668|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14735669|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14735670|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
15239239|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239240|NCT01864018|Dexamethasone|dexamethasone|mesh-list
14735671|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735672|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239241|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
15239242|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
15239243|NCT01864018|Ixazomib|ixazomib|mesh-list
15239244|NCT01864018|Ichthammol|ichthammol|mesh-list
15239245|NCT01864018|BB 1101|bb 1101|mesh-list
15239246|NCT01864018|Glycine|glycine|mesh-list
15239247|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239248|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
14400109|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14400110|NCT01445847|Lidocaine|lidocaine|mesh-list
15239249|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400111|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
14400112|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
14400113|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400114|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735673|NCT00541216|Ephedrine|ephedrine|mesh-list
14735674|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14735675|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735676|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
14400115|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
14400116|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400117|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14400118|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14400119|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14400120|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14400121|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400122|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
14400123|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14400124|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400125|NCT01445886|Calcitriol|calcitriol|mesh-list
14400126|NCT01445886|Calcipotriene|calcipotriene|mesh-list
14400127|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400128|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14400129|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400130|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14400131|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14400132|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400133|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15239250|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239251|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15239252|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
15239253|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239254|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239255|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15239256|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400134|NCT01445886|Vitamins|vitamins|mesh-ancestor
14735677|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
15239257|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
15239258|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
15239259|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400135|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
14400136|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14400137|NCT01445951|Insulin|insulin|mesh-list
14400138|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14400139|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
14400140|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400141|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400142|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
14400143|NCT01446042|Testosterone|testosterone|mesh-list
14400144|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
14400145|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
14735678|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735679|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14735680|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
14735681|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735682|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735683|NCT00541281|Prednisone|prednisone|mesh-list
14735684|NCT00541281|Docetaxel|docetaxel|mesh-list
14735685|NCT00541281|Estramustine|estramustine|mesh-list
14924254|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14924255|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
14400146|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14400147|NCT01446042|Androgens|androgens|mesh-ancestor
14400148|NCT01446042|Hormones|hormones|mesh-ancestor
14400149|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400150|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400151|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14400152|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400153|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
14400154|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14400155|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14400156|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400157|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400158|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14400159|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
14400160|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400161|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400162|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14400163|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400164|NCT01446809|Doxorubicin|doxorubicin|mesh-list
14400165|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14400166|NCT01446809|Ifosfamide|ifosfamide|mesh-list
14400167|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
14400168|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14400169|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400170|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14400171|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14400172|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400173|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400174|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14400175|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
14924256|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14400176|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
14400177|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14400178|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400179|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
14400180|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
14400181|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14400182|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400183|NCT01447225|Gemcitabine|gemcitabine|mesh-list
14400184|NCT01447225|Carboplatin|carboplatin|mesh-list
14400185|NCT01447225|Pemetrexed|pemetrexed|mesh-list
15239260|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239261|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
14400186|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400187|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14400188|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
14400189|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400190|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
14400191|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400192|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239262|NCT01864018|Hormones|hormones|mesh-ancestor
15239263|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239264|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239265|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
15239266|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239267|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
15239268|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
15239269|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239270|NCT01856270|Amitriptyline|amitriptyline|mesh-list
15239271|NCT01856270|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15239272|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15239273|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
15239274|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239275|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239276|NCT01856270|Analgesics|analgesics|mesh-ancestor
15239277|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
15239278|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239279|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239280|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14400193|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400194|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
14735686|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400195|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400196|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14400197|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400198|NCT01447407|Vaccines|vaccines|mesh-list
14400199|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
14400200|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
14467180|NCT02256982|Gemcitabine|gemcitabine|mesh-list
14467181|NCT02256982|Cisplatin|cisplatin|mesh-list
14467182|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400201|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400202|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15239281|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15239282|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15239283|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239284|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
15239285|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400203|NCT01447420|Ribavirin|ribavirin|mesh-list
14400204|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14400205|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
14400206|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400207|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
14400208|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400209|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
14400210|NCT01447433|Calcium|calcium|mesh-list
14400211|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14400212|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400213|NCT01447433|Antacids|antacids|mesh-ancestor
14400214|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400215|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400216|NCT01447446|Ribavirin|ribavirin|mesh-list
14400217|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
14400218|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
15239286|NCT01856270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15239287|NCT01856270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15239288|NCT01856270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239289|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
15239290|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
15239291|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400219|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14400220|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14400221|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14400222|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
14400223|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400224|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
14400225|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400226|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
14400227|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400228|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400229|NCT01447511|Rifampin|rifampin|mesh-list
14400230|NCT01447511|Fluconazole|fluconazole|mesh-list
15239292|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15239293|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239294|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400231|NCT01447511|Warfarin|warfarin|mesh-list
14735687|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735688|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735689|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735690|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735691|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14735692|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
14400232|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
14400233|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14400234|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
14400235|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239295|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
15239296|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239297|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15239298|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239299|NCT01503515|Fluconazole|fluconazole|mesh-list
15239300|NCT01503515|Voriconazole|voriconazole|mesh-list
15239301|NCT01503515|Caspofungin|caspofungin|mesh-list
15239302|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
15239303|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239304|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14735693|NCT00541281|Hormones|hormones|mesh-ancestor
14735694|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735695|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735696|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239305|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15239306|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239307|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239308|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14400236|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400237|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
14400238|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400239|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400240|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400241|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14400242|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14400243|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14400244|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14400245|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14400246|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14400247|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
14400248|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14400249|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14400250|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15239309|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
15239310|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239311|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239312|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15239313|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14400251|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
14400252|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400253|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400254|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14400255|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14400256|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
14400257|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14400258|NCT01447706|Paclitaxel|paclitaxel|mesh-list
14400259|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14400260|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400261|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
14400262|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
14400263|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
14400264|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400265|NCT01447849|Lubiprostone|lubiprostone|mesh-list
14400266|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14400267|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14400268|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400269|NCT01447888|Morphine|morphine|mesh-list
14400270|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14400271|NCT01447888|Narcotics|narcotics|mesh-ancestor
14400272|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400273|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400274|NCT01447888|Analgesics|analgesics|mesh-ancestor
14400275|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
14400276|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735697|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14735698|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
14735699|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
14735700|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14735701|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
14735702|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15239314|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15239315|NCT01491893|Vaccines|vaccines|mesh-list
15239316|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
15239317|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239318|NCT01180374|Dronabinol|dronabinol|mesh-list
15239319|NCT01180374|Cannabidiol|cannabidiol|mesh-list
15239320|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
15239321|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
15239322|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239323|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239324|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239325|NCT01180374|Analgesics|analgesics|mesh-ancestor
15239326|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
15239327|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924257|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14924258|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14924259|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
14924260|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924261|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14924262|NCT00324805|Gemcitabine|gemcitabine|mesh-list
14924263|NCT00324805|Bevacizumab|bevacizumab|mesh-list
14924264|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14924265|NCT00324805|Cisplatin|cisplatin|mesh-list
14924266|NCT00324805|Docetaxel|docetaxel|mesh-list
14924267|NCT00324805|Pemetrexed|pemetrexed|mesh-list
14400277|NCT01447927|Metformin|metformin|mesh-list
14400278|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400279|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400280|NCT01448044|Interferons|interferons|mesh-list
14400281|NCT01448044|Ribavirin|ribavirin|mesh-list
14400282|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
14400283|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
14400284|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14400285|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400286|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
14400287|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400288|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
14400289|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400290|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
14400291|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400292|NCT01448057|Acetaminophen|acetaminophen|mesh-list
14400293|NCT01448057|Dimethindene|dimethindene|mesh-list
14400294|NCT01448057|Phenylephrine|phenylephrine|mesh-list
14400295|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
14400296|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14400297|NCT01448057|Analgesics|analgesics|mesh-ancestor
14400298|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
14400299|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400300|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400301|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
14400302|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400303|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14400304|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
14735703|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
14735704|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735705|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735706|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
14735707|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
14735708|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14735709|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
14735710|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400305|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
14400306|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
14400307|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14400308|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
14400309|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
14400310|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14400311|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14400312|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14400313|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14400314|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400315|NCT01448057|Protective Agents|protective agents|mesh-ancestor
14735711|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924268|NCT00324805|Vinorelbine|vinorelbine|mesh-list
14924269|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
14924270|NCT00324805|Antibodies|antibodies|mesh-list
14924271|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
14924272|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14924273|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
14924274|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924275|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14924276|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15239328|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15239329|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15239330|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400316|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
14400317|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400318|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14735712|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14735713|NCT00541359|Bortezomib|bortezomib|mesh-list
14924277|NCT00324805|Growth Substances|growth substances|mesh-ancestor
14735714|NCT00541359|Topotecan|topotecan|mesh-list
14735715|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735716|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14735717|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14735718|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735719|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735720|NCT00541372|Insulin|insulin|mesh-list
15239331|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239332|NCT01180374|Hormones|hormones|mesh-ancestor
14400319|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
14400320|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
14400321|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14400322|NCT01448213|Fluorometholone|fluorometholone|mesh-list
14400323|NCT01448213|Prednisolone|prednisolone|mesh-list
14400324|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15239333|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239334|NCT00357565|Cyclosporine|cyclosporine|mesh-list
15239335|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
15239336|NCT00357565|Fludarabine|fludarabine|mesh-list
15239337|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
15239338|NCT00357565|Melphalan|melphalan|mesh-list
15239339|NCT00357565|Busulfan|busulfan|mesh-list
15239340|NCT00357565|Cyclosporins|cyclosporins|mesh-list
14400325|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
14735721|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15239341|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400326|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14735722|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735723|NCT00541411|Dactinomycin|dactinomycin|mesh-list
14735724|NCT00541411|Vincristine|vincristine|mesh-list
14735725|NCT00541411|Ifosfamide|ifosfamide|mesh-list
14735726|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14735727|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735728|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735729|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735730|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735731|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735732|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14735733|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
14735734|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14735735|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735736|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14735737|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14735738|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735739|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14735740|NCT00541463|Nelfinavir|nelfinavir|mesh-list
14735741|NCT00541463|Indinavir|indinavir|mesh-list
15239342|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15239343|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
15239344|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239345|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239346|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
15239347|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239348|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239349|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
15239350|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239351|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14735742|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735743|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14735744|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14735745|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
14735746|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735747|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14735748|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14735749|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
14735750|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735751|NCT00541489|Naproxen|naproxen|mesh-list
14735752|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14735753|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14735754|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14735755|NCT00541489|Analgesics|analgesics|mesh-ancestor
14735756|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
14735757|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735758|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735759|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14735760|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239352|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239353|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15239354|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15239355|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15239356|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
15239357|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239358|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15239359|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
15239360|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15239361|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
15239362|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239363|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
15239364|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239365|NCT00245960|Etanercept|etanercept|mesh-list
15239366|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15239367|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239368|NCT00245960|Analgesics|analgesics|mesh-ancestor
15239369|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
15239370|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400327|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
14400328|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14400329|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
14400330|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400331|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
14400332|NCT01448213|Hormones|hormones|mesh-ancestor
14400333|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400334|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400335|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14400336|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400337|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
14400338|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
14400339|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400340|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239371|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239372|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239373|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239374|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239375|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239376|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
15239377|NCT00136903|Cyclosporine|cyclosporine|mesh-list
14400341|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14735761|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
15239378|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
15239379|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
14735762|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14735763|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735764|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735765|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14735766|NCT00541515|Insulin|insulin|mesh-list
14735767|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14735768|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735769|NCT00541554|Aripiprazole|aripiprazole|mesh-list
14400342|NCT01448213|Protective Agents|protective agents|mesh-ancestor
15239380|NCT00136903|Prednisone|prednisone|mesh-list
15239381|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
15239382|NCT00136903|Tacrolimus|tacrolimus|mesh-list
15239383|NCT00136903|Cyclosporins|cyclosporins|mesh-list
15239384|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239385|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
15239386|NCT00136903|Hormones|hormones|mesh-ancestor
15239387|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239388|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239389|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239390|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239391|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239392|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
15239393|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15239394|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239395|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400343|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14400344|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
14400345|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14400346|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14400347|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
14400348|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400349|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14400350|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14400351|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400352|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400353|NCT01448525|Bimatoprost|bimatoprost|mesh-list
14400354|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14400355|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14400356|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14400357|NCT01448616|Tenofovir|tenofovir|mesh-list
14400358|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
14400359|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400360|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14400361|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400362|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400363|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400364|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14400365|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14400366|NCT01448707|Ritonavir|ritonavir|mesh-list
14400367|NCT01448707|Darunavir|darunavir|mesh-list
14400368|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15239396|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
14400369|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14400370|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
14400371|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400372|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400373|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14400374|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14400375|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
14400376|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400377|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14400378|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14400379|NCT01448824|Ketoconazole|ketoconazole|mesh-list
14400380|NCT01448824|Evacetrapib|evacetrapib|mesh-list
14400381|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
14400382|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400383|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14400384|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14400385|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400386|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400387|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14400388|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
14400389|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400390|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400391|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14400392|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14400393|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14400394|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
14400395|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14400396|NCT01449006|Maraviroc|maraviroc|mesh-list
14400397|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14400398|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14400399|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400400|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14400401|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14400402|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
14400403|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400404|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14400405|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14400406|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
14400407|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
14400408|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400409|NCT01449279|Ipilimumab|ipilimumab|mesh-list
14400410|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400411|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400412|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14400413|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400414|NCT01449370|Serabelisib|serabelisib|mesh-list
14400415|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400416|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400417|NCT01449630|Celecoxib|celecoxib|mesh-list
14400418|NCT01449630|LY3031207|ly3031207|mesh-list
14400419|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14400420|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14400421|NCT01449630|Analgesics|analgesics|mesh-ancestor
14400422|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
14400423|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400424|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400425|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400426|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14400427|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14400428|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14400429|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400430|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400431|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
14400432|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
14400433|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467183|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14467184|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
15239397|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239398|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
15239399|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239400|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15239401|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15239402|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
15239403|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239404|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
15239405|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
15239406|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239407|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14467185|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467186|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
15239408|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14467187|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467188|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467189|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14467190|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
14400434|NCT01449682|Dexamethasone|dexamethasone|mesh-list
14400435|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
14400436|NCT01449682|BB 1101|bb 1101|mesh-list
14400437|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400438|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
15239409|NCT00136903|Protective Agents|protective agents|mesh-ancestor
15239410|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
14735770|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
14735771|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14735772|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14735773|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14735774|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735775|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735776|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
14735777|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
14735778|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735779|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735780|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14735781|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14735782|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
14735783|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14735784|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14735785|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14735786|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14735787|NCT00541567|Ibipinabant|ibipinabant|mesh-list
14735788|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14735789|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14735790|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735791|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735792|NCT00541567|Hormones|hormones|mesh-ancestor
14735793|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735794|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735795|NCT00541710|Genistein|genistein|mesh-list
14735796|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14735797|NCT00541710|Protective Agents|protective agents|mesh-ancestor
14735798|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735799|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400439|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
15239411|NCT05218915|Dulaglutide|dulaglutide|mesh-list
15239412|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15239413|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239414|NCT05218889|Gemcitabine|gemcitabine|mesh-list
15239415|NCT05218889|Paclitaxel|paclitaxel|mesh-list
15239416|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15239417|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15239418|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239419|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
15239420|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
15239421|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
15239422|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239423|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15239424|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
15239425|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
14735800|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14735801|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735802|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735803|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
14735804|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14735805|NCT00541710|Estrogens|estrogens|mesh-ancestor
15239426|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239427|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239428|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239429|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
15239430|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239431|NCT05218616|Sunitinib|sunitinib|mesh-list
15239432|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239433|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15239434|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15239435|NCT05218616|Growth Substances|growth substances|mesh-ancestor
15239436|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239437|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
14735806|NCT00541710|Hormones|hormones|mesh-ancestor
14735807|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735808|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15239438|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15239439|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239440|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239441|NCT05218577|Selenium|selenium|mesh-list
14735809|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14735810|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735811|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735812|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14735813|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14735814|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735815|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
14735816|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735817|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
14735818|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14735819|NCT00541814|Cyclosporine|cyclosporine|mesh-list
14735820|NCT00541814|Cyclosporins|cyclosporins|mesh-list
14735821|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735822|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735823|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735824|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
14735825|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735826|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
14735827|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735828|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
15239442|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
15239443|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239444|NCT05218577|Protective Agents|protective agents|mesh-ancestor
15239445|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239446|NCT05218577|Trace Elements|trace elements|mesh-ancestor
15239447|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
15239448|NCT05218486|Isotretinoin|isotretinoin|mesh-list
15239449|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
15239450|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
14735829|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239451|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15239452|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239453|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735830|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14735831|NCT00541840|Sorafenib|sorafenib|mesh-list
14735832|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735833|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14735834|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735835|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239454|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239455|NCT05218161|Analgesics|analgesics|mesh-ancestor
15239456|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
15239457|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239458|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15239459|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15239460|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15239461|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
15239462|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239463|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239464|NCT05217836|Hepcidins|hepcidins|mesh-list
15239465|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239466|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
15239467|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14735836|NCT00541853|Candesartan|candesartan|mesh-list
14735837|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
14735838|NCT00541853|Cilnidipine|cilnidipine|mesh-list
14735839|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15239468|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15239469|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15239470|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15239471|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239472|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
15239473|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239474|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735840|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14735841|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14735842|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735843|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14735844|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14735845|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14735846|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735847|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14735848|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14735849|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735850|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239475|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15239476|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735851|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14735852|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14735853|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735854|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
14735855|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735856|NCT00541918|Propofol|propofol|mesh-list
14735857|NCT00541918|Sevoflurane|sevoflurane|mesh-list
14735858|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14735859|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735860|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735861|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14735862|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
14735863|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
14735864|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14735865|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14735866|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
14735867|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14735868|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14735869|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
14735870|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735871|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735872|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735873|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
14735874|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
14735875|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14735876|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
14735877|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14735878|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
14735879|NCT00542074|Ethanol|ethanol|mesh-list
14735880|NCT00542074|Emollients|emollients|mesh-list
14735881|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
14735882|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14735883|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735884|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14735885|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735886|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14400440|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239477|NCT05217342|Diuretics|diuretics|mesh-list
15239478|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
14735887|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
14735888|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14735889|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
14735890|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14735891|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735892|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14735893|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14735894|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735895|NCT00542139|Betamethasone|betamethasone|mesh-list
15239479|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239480|NCT05217238|Remifentanil|remifentanil|mesh-list
15239481|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15239482|NCT05217238|Narcotics|narcotics|mesh-ancestor
14400441|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400442|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400443|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
14400444|NCT01449682|Hormones|hormones|mesh-ancestor
14400445|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400446|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14400447|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400448|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
15239483|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239484|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239485|NCT05217238|Analgesics|analgesics|mesh-ancestor
15239486|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
15239487|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239488|NCT05217160|Morphine|morphine|mesh-list
15239489|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15239490|NCT05217160|Narcotics|narcotics|mesh-ancestor
14735896|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14735897|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
14735898|NCT00542139|Hormones|hormones|mesh-ancestor
14735899|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735900|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735901|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15239491|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239492|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239493|NCT05217160|Analgesics|analgesics|mesh-ancestor
15239494|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
15239495|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239496|NCT05217069|Leucovorin|leucovorin|mesh-list
15239497|NCT05217069|Folic Acid|folic acid|mesh-list
15239498|NCT05217069|Irinotecan|irinotecan|mesh-list
15239499|NCT05217069|Cetuximab|cetuximab|mesh-list
14400449|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400450|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400451|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14400452|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400453|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400454|NCT01449747|Incretins|incretins|mesh-ancestor
14400455|NCT01449747|Hormones|hormones|mesh-ancestor
14400456|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400457|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14400458|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
14400459|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400460|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400461|NCT01449929|Ritonavir|ritonavir|mesh-list
14400462|NCT01449929|Darunavir|darunavir|mesh-list
14400463|NCT01449929|Dolutegravir|dolutegravir|mesh-list
14400464|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14400465|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14400466|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
15239500|NCT05217069|Avelumab|avelumab|mesh-list
15239501|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
15239502|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15239503|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14400467|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400468|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400469|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14400470|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15239504|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239505|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239506|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735902|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
14735903|NCT00542152|Cyclosporine|cyclosporine|mesh-list
14735904|NCT00542152|Infliximab|infliximab|mesh-list
14735905|NCT00542152|Cyclosporins|cyclosporins|mesh-list
14735906|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735907|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735908|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14735909|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
14735910|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735911|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
14735912|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14735913|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14735914|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14735915|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14735916|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14735917|NCT00542165|Alfuzosin|alfuzosin|mesh-list
14735918|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14735919|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14735920|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14735921|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
14735922|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735923|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735924|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735925|NCT00542165|Urological Agents|urological agents|mesh-ancestor
14735926|NCT00542243|Finasteride|finasteride|mesh-list
14735927|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14735928|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14735929|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735930|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239507|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239508|NCT05217069|Antidotes|antidotes|mesh-ancestor
14924278|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924279|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
14924280|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
14924281|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14924282|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
14924283|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924284|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
14924285|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924286|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239509|NCT05217069|Protective Agents|protective agents|mesh-ancestor
15239510|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239511|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
15239512|NCT05217069|Vitamins|vitamins|mesh-ancestor
15239513|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
15239514|NCT05217069|Hematinics|hematinics|mesh-ancestor
15239515|NCT05216822|Racecadotril|racecadotril|mesh-list
15239516|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
15239517|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239518|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14400471|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
14400472|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400473|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14400474|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14400475|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14400476|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14400477|NCT01449955|Sirolimus|sirolimus|mesh-list
14400478|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239519|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239520|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239521|NCT05215470|Nivolumab|nivolumab|mesh-list
15239522|NCT05215470|Ipilimumab|ipilimumab|mesh-list
15239523|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239524|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239525|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15239526|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735931|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
14735932|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14735933|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735934|NCT00542243|Urological Agents|urological agents|mesh-ancestor
14735935|NCT00542295|Mebeverine|mebeverine|mesh-list
14735936|NCT00542295|Alverine|alverine|mesh-list
14735937|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
14735938|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
14735939|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400479|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239527|NCT05195242|Dexamethasone|dexamethasone|mesh-list
15239528|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239529|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
15239530|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
15239531|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239532|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239533|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239534|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
15239535|NCT05195242|Hormones|hormones|mesh-ancestor
15239536|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239537|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239538|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239539|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
14400480|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14400481|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400482|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
14400483|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400484|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
14400485|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735940|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735941|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
14735942|NCT00542347|Esomeprazole|esomeprazole|mesh-list
14735943|NCT00542347|Omeprazole|omeprazole|mesh-list
14735944|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14735945|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14735946|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14735947|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735948|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735949|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
14735950|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14735951|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735952|NCT00542412|Riluzole|riluzole|mesh-list
14735953|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
14735954|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14735955|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14735956|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735957|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735958|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735959|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14735960|NCT00542412|Protective Agents|protective agents|mesh-ancestor
14400486|NCT01450007|Dexamethasone|dexamethasone|mesh-list
14400487|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
14400488|NCT01450007|Ropivacaine|ropivacaine|mesh-list
14400489|NCT01450007|BB 1101|bb 1101|mesh-list
14400490|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400491|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
14400492|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
14400493|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400494|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400495|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400496|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
14735961|NCT00542451|Paclitaxel|paclitaxel|mesh-list
14735962|NCT00542451|Trastuzumab|trastuzumab|mesh-list
14735963|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14735964|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14735965|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
14735966|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
14735967|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
14735968|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735969|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14735970|NCT00542555|Naproxen|naproxen|mesh-list
14400497|NCT01450007|Hormones|hormones|mesh-ancestor
14400498|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400499|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14400500|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400501|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14400502|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400503|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400504|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
14400505|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
14400506|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400507|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
14400508|NCT01450098|Evacetrapib|evacetrapib|mesh-list
14735971|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14735972|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15239540|NCT05193565|Sirolimus|sirolimus|mesh-list
14400509|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
14400510|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14400511|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14400512|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
14400513|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400514|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14400515|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
14735973|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14735974|NCT00542555|Analgesics|analgesics|mesh-ancestor
14735975|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
14400516|NCT01450098|Protective Agents|protective agents|mesh-ancestor
14400517|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400518|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
14400519|NCT01450137|Hormones|hormones|mesh-ancestor
14400520|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400521|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400522|NCT01450189|Tenofovir|tenofovir|mesh-list
14400523|NCT01450189|Emtricitabine|emtricitabine|mesh-list
14400524|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
14400525|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14400526|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
14400527|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400528|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14400529|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400530|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400531|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400532|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14400533|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14400534|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14400535|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14400536|NCT01450306|Cycloserine|cycloserine|mesh-list
14400537|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14735976|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400538|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400539|NCT01450306|Renal Agents|renal agents|mesh-ancestor
14400540|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14400541|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
14400542|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14400543|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
14400544|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400545|NCT01450319|Cetuximab|cetuximab|mesh-list
14400546|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400547|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400548|NCT01450683|Itraconazole|itraconazole|mesh-list
14400549|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
14400550|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400551|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14400552|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14400553|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400554|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400555|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14400556|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
14400557|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400558|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400559|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14400560|NCT01450696|Capecitabine|capecitabine|mesh-list
14400561|NCT01450696|Trastuzumab|trastuzumab|mesh-list
14400562|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400563|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14400564|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
14400565|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400566|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400567|NCT01450761|Carboplatin|carboplatin|mesh-list
14400568|NCT01450761|Etoposide|etoposide|mesh-list
14400569|NCT01450761|Ipilimumab|ipilimumab|mesh-list
14400570|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400571|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14400572|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14400573|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14400574|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400575|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400576|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400577|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15239541|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15239542|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239543|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15239544|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
15239545|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239546|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924287|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239547|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239548|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239549|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
15239550|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400578|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
14400579|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14400580|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400581|NCT01450800|Renal Agents|renal agents|mesh-ancestor
14400582|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239551|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
15239552|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239553|NCT05192460|Vaccines|vaccines|mesh-list
15239554|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
15239555|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239556|NCT05186779|Progestins|progestins|mesh-list
15239557|NCT05186779|Hormones|hormones|mesh-ancestor
15239558|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400583|NCT01450813|Bromides|bromides|mesh-list
14400584|NCT01450813|Rocuronium|rocuronium|mesh-list
14400585|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
14400586|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14400587|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14400588|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14400589|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400590|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239559|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735977|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735978|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14735979|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14735980|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
14735981|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15239560|NCT05177133|Capecitabine|capecitabine|mesh-list
15239561|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
15239562|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15239563|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
15239564|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239565|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239566|NCT05176964|Capecitabine|capecitabine|mesh-list
15239567|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
14400591|NCT01450826|Ondansetron|ondansetron|mesh-list
14400592|NCT01450826|Aprepitant|aprepitant|mesh-list
14735982|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14735983|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735984|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14735985|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
14735986|NCT00542568|Hematinics|hematinics|mesh-ancestor
14735987|NCT00542607|Levocetirizine|levocetirizine|mesh-list
14400593|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
14400594|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
14400595|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400596|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400597|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400598|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
14400599|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400600|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14400601|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
14400602|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400603|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400604|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14400605|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14400606|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400607|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14400608|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14400609|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14400610|NCT01451203|Methotrexate|methotrexate|mesh-list
14400611|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
14400612|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14400613|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
14400614|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14400615|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400616|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14400617|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
14400618|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400619|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239568|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753126|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400620|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400621|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400622|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14924288|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
14924289|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
14924290|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
14924291|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14924292|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400623|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400624|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
14400625|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14400626|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400627|NCT01451398|Insulin|insulin|mesh-list
14400628|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400629|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400630|NCT01451411|Conivaptan|conivaptan|mesh-list
14400631|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15239569|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
15239570|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239571|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400632|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400633|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
14400634|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400635|NCT01451541|Ciclesonide|ciclesonide|mesh-list
14400636|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
14400637|NCT01451541|Hormones|hormones|mesh-ancestor
14400638|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400639|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400640|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14400641|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14924293|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14924294|NCT00310180|Tamoxifen|tamoxifen|mesh-list
14924295|NCT00310180|Letrozole|letrozole|mesh-list
15239572|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
15239573|NCT05175781|Ketamine|ketamine|mesh-list
15239574|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15239575|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239576|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239577|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14924296|NCT00310180|Anastrozole|anastrozole|mesh-list
14924297|NCT00310180|Exemestane|exemestane|mesh-list
14735988|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14735989|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14735990|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
14735991|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
14735992|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14735993|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14735994|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14735995|NCT00542711|Curcumin|curcumin|mesh-list
14735996|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14735997|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14735998|NCT00542711|Analgesics|analgesics|mesh-ancestor
14735999|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
14736000|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736001|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736002|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736003|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736004|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736005|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736006|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736007|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
14736008|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14736009|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736010|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14736011|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
15239578|NCT05175781|Analgesics|analgesics|mesh-ancestor
15239579|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
15239580|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239581|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15239582|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14736012|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14736013|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736014|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736015|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736016|NCT00542802|Carbamazepine|carbamazepine|mesh-list
14736017|NCT00542802|Levetiracetam|levetiracetam|mesh-list
14736018|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
14736019|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
14400642|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14400643|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14400644|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14400645|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400646|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400647|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400648|NCT01451606|Analgesics|analgesics|mesh-ancestor
14400649|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
14400650|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239583|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15239584|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
15239585|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239586|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400651|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
14400652|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14400653|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
14400654|NCT01451632|Irinotecan|irinotecan|mesh-list
14400655|NCT01451632|Cetuximab|cetuximab|mesh-list
14400656|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14400657|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14400658|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400659|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400660|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400661|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400662|NCT01451645|Colchicine|colchicine|mesh-list
14400663|NCT01451645|Allopurinol|allopurinol|mesh-list
14400664|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
14400665|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239587|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14400666|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
14400667|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
14736020|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
14736021|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14736022|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14736023|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736024|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736025|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14736026|NCT00542802|Analgesics|analgesics|mesh-ancestor
14736027|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
14736028|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736029|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14736030|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14736031|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736032|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14736033|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14736034|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
14736035|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736036|NCT00542893|Dacarbazine|dacarbazine|mesh-list
14924298|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924299|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924300|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14400668|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
14400669|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400670|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400671|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
14400672|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400673|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14400674|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
14400675|NCT01451645|Protective Agents|protective agents|mesh-ancestor
14400676|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400677|NCT01451749|Donepezil|donepezil|mesh-list
14400678|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14400679|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924301|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14924302|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400680|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736037|NCT00542893|Oblimersen|oblimersen|mesh-list
14736038|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14736039|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
14736040|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736041|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736042|NCT00542984|Teriparatide|teriparatide|mesh-list
14736043|NCT00542984|Calcitonin|calcitonin|mesh-list
14736044|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
14736045|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14736046|NCT00542984|Katacalcin|katacalcin|mesh-list
14400681|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
14400682|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400683|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400684|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
14400685|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
14400686|NCT01451762|Promethazine|promethazine|mesh-list
14400687|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14400688|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14400689|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400690|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400691|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
14400692|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
14400693|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
14400694|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400695|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
14400696|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
14400697|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400698|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14400699|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
14400700|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
14400701|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400702|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400703|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14400704|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
14400705|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400706|NCT01451775|Empagliflozin|empagliflozin|mesh-list
14400707|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14400708|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239588|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14400709|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400710|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400711|NCT01451814|Nicotine|nicotine|mesh-list
14400712|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14400713|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
14400714|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400715|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400716|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14736047|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15239589|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
15239590|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
15239591|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15239592|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15239593|NCT05160428|Vaccines|vaccines|mesh-list
15239594|NCT05160428|Immunologic Factors|immunologic factors|mesh-ancestor
15239595|NCT05160428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239596|NCT05146232|Anesthetics|anesthetics|mesh-list
15239597|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239598|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239599|NCT05141305|Aspirin|aspirin|mesh-list
15239600|NCT05141305|Clopidogrel|clopidogrel|mesh-list
15239601|NCT05141305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15239602|NCT05141305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239603|NCT05141305|Analgesics|analgesics|mesh-ancestor
14736048|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736049|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14736050|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
14753127|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
14753128|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753129|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14924303|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15239604|NCT05141305|Sensory System Agents|sensory system agents|mesh-ancestor
15239605|NCT05141305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239606|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239607|NCT05141305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239608|NCT05141305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239609|NCT05141305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15239610|NCT05141305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15239611|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239612|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15239613|NCT05141305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15239614|NCT05141305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239615|NCT05141305|Antipyretics|antipyretics|mesh-ancestor
15239616|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15239617|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15239618|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15239619|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
15239620|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239621|NCT05114486|Pilocarpine|pilocarpine|mesh-list
15239622|NCT05114486|Miotics|miotics|mesh-ancestor
15239623|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
15239624|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239625|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239626|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15239627|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15239628|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
15239629|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239630|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239631|NCT05089708|Trifarotene|trifarotene|mesh-list
15239632|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
15239633|NCT05072184|Anesthetics|anesthetics|mesh-list
15239634|NCT05072184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239635|NCT05072184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239636|NCT05065294|Psilocybin|psilocybin|mesh-list
14400717|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14400718|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
14400719|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400720|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400721|NCT01451827|Tolvaptan|tolvaptan|mesh-list
14400722|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14400723|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400724|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
14400725|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400726|NCT01451996|Loratadine|loratadine|mesh-list
14400727|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
15239637|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
15239638|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
15239639|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239640|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239641|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15239642|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
15239643|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239644|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239645|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15239646|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15239647|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14400728|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400729|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14400730|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14400731|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14400732|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
14400733|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
14400734|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736051|NCT00543023|Teriparatide|teriparatide|mesh-list
14736052|NCT00543023|Calcitonin|calcitonin|mesh-list
14400735|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736053|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
14736054|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14736055|NCT00543023|Katacalcin|katacalcin|mesh-list
15239648|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
14736056|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14736057|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736058|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14736059|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
14736060|NCT00543049|Sunitinib|sunitinib|mesh-list
14736061|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736062|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736063|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736064|NCT00543049|Growth Substances|growth substances|mesh-ancestor
14736065|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400736|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400737|NCT01452126|Ropivacaine|ropivacaine|mesh-list
14400738|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
14736066|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736067|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736068|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736069|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736070|NCT00543075|Oblimersen|oblimersen|mesh-list
14736071|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239649|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15239650|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15239651|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239652|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
15239653|NCT05053867|Coagulants|coagulants|mesh-ancestor
15239654|NCT05052970|Dexamethasone|dexamethasone|mesh-list
15239655|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
14400739|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
14400740|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400741|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239656|NCT05052970|Bortezomib|bortezomib|mesh-list
15239657|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
15239658|NCT05052970|BB 1101|bb 1101|mesh-list
15239659|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239660|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
15239661|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
15239662|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239663|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400742|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
14400743|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400744|NCT01452347|Warfarin|warfarin|mesh-list
14400745|NCT01452347|Dabigatran|dabigatran|mesh-list
14400746|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
14736072|NCT00543114|Rituximab|rituximab|mesh-list
15239664|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239665|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
14400747|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
15239666|NCT05052970|Hormones|hormones|mesh-ancestor
15239667|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239668|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239669|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239670|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
15239671|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239672|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239673|NCT05052970|Analgesics|analgesics|mesh-ancestor
15239674|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
15239675|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15239676|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15239677|NCT05029973|Bevacizumab|bevacizumab|mesh-list
14400748|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14400749|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
14736073|NCT00543114|Fludarabine|fludarabine|mesh-list
14400750|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400751|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400752|NCT01452529|Hydrocodone|hydrocodone|mesh-list
14736074|NCT00543114|Lenalidomide|lenalidomide|mesh-list
14736075|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736076|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736077|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
14736078|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736079|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736080|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736081|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736082|NCT00543114|Growth Substances|growth substances|mesh-ancestor
14736083|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736084|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14736085|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14736086|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
14736087|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736088|NCT00543179|Lanreotide|lanreotide|mesh-list
14736089|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736090|NCT00543205|Oblimersen|oblimersen|mesh-list
14736091|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736092|NCT00543218|Teriparatide|teriparatide|mesh-list
14736093|NCT00543218|Calcitonin|calcitonin|mesh-list
14736094|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
14736095|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14736096|NCT00543218|Katacalcin|katacalcin|mesh-list
15239678|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239679|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239680|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15239681|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15239682|NCT05029973|Growth Substances|growth substances|mesh-ancestor
15239683|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239684|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
15239685|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
15239686|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400753|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14400754|NCT01452529|Narcotics|narcotics|mesh-ancestor
15239687|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239688|NCT05008783|Capecitabine|capecitabine|mesh-list
15239689|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
15239690|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15239691|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
15239692|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239693|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736097|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14736098|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736099|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15239694|NCT05005728|Carboplatin|carboplatin|mesh-list
15239695|NCT05005728|Olaparib|olaparib|mesh-list
15239696|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239697|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15239698|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239699|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239700|NCT04986579|Trastuzumab|trastuzumab|mesh-list
15239701|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239702|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239703|NCT04969250|Vaccines|vaccines|mesh-list
15239704|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
15239705|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400755|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400756|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400757|NCT01452529|Analgesics|analgesics|mesh-ancestor
14400758|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
14400759|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400760|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
14400761|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
14400762|NCT01452789|Morphine|morphine|mesh-list
14400763|NCT01452789|Buprenorphine|buprenorphine|mesh-list
14400764|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14736100|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14736101|NCT00543231|Oblimersen|oblimersen|mesh-list
14736102|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736103|NCT00543244|Interferons|interferons|mesh-list
14736104|NCT00543244|Ribavirin|ribavirin|mesh-list
14736105|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
14736106|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14736107|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736108|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
14736109|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736110|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
14736111|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736112|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
14400765|NCT01452789|Narcotics|narcotics|mesh-ancestor
14400766|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400767|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400768|NCT01452789|Analgesics|analgesics|mesh-ancestor
14400769|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
14400770|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400771|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14400772|NCT01453023|Fluticasone|fluticasone|mesh-list
14400773|NCT01453023|Xhance|xhance|mesh-list
14400774|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400775|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14400776|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
14400777|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736113|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736114|NCT00543335|Sorafenib|sorafenib|mesh-list
14736115|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400778|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400779|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14400780|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
14400781|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
14400782|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14400783|NCT01453049|Glimepiride|glimepiride|mesh-list
14400784|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
14400785|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14400786|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400787|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400788|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400789|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
14400790|NCT01453075|Valacyclovir|valacyclovir|mesh-list
14400791|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
14400792|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736116|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14400793|NCT01453153|Gemcitabine|gemcitabine|mesh-list
14400794|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14400795|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
14400796|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400797|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400798|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
14400799|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400800|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400801|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400802|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
14400803|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400804|NCT01453205|Rituximab|rituximab|mesh-list
14400805|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400806|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400807|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
14400808|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400809|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14400810|NCT01453348|Vaccines|vaccines|mesh-list
14400811|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
14400812|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400813|NCT01453374|Naltrexone|naltrexone|mesh-list
14400814|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14400815|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14400816|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400817|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
14400818|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400819|NCT01453595|Dactolisib|dactolisib|mesh-list
14400820|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400821|NCT01453725|Golimumab|golimumab|mesh-list
14736117|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736118|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736119|NCT00543361|Metformin|metformin|mesh-list
14736120|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14736121|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736122|NCT00543413|Enalapril|enalapril|mesh-list
14736123|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14736124|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
14736125|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736126|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736127|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14736128|NCT00543504|Bevacizumab|bevacizumab|mesh-list
14736129|NCT00543504|Trastuzumab|trastuzumab|mesh-list
14736130|NCT00543504|Cetuximab|cetuximab|mesh-list
14736131|NCT00543504|Sunitinib|sunitinib|mesh-list
14736132|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14400822|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14400823|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400824|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239706|NCT04930315|Apatinib|apatinib|mesh-list
15239707|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736133|NCT00543504|Sorafenib|sorafenib|mesh-list
14736134|NCT00543504|Lapatinib|lapatinib|mesh-list
14736135|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736136|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736137|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736138|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736139|NCT00543504|Growth Substances|growth substances|mesh-ancestor
14736140|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736141|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736142|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736143|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736144|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736145|NCT00543608|Vancomycin|vancomycin|mesh-list
14736146|NCT00543608|Iclaprim|iclaprim|mesh-list
14736147|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14736148|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736149|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14736150|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736151|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736152|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14736153|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14736154|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14736155|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
14736156|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14736157|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736158|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14736159|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15239708|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15239709|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239710|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239711|NCT04921007|Bupivacaine|bupivacaine|mesh-list
15239712|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
15239713|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
15239714|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14400825|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
14400826|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400827|NCT01453855|Travoprost|travoprost|mesh-list
14400828|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14400829|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14400830|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14400831|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14400832|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
14400833|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400834|NCT01454076|Clarithromycin|clarithromycin|mesh-list
14400835|NCT01454076|Rifampin|rifampin|mesh-list
14400836|NCT01454076|Ketoconazole|ketoconazole|mesh-list
14400837|NCT01454076|Ixazomib|ixazomib|mesh-list
14400838|NCT01454076|Glycine|glycine|mesh-list
14400839|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14400840|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400841|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14400842|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400843|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924304|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
14924305|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924306|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736160|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14736161|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736162|NCT00543634|Estrogens|estrogens|mesh-ancestor
14736163|NCT00543634|Hormones|hormones|mesh-ancestor
14736164|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736165|NCT00543647|Fenofibrate|fenofibrate|mesh-list
14736166|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14736167|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
14736168|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736169|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14736170|NCT00543686|Fluticasone|fluticasone|mesh-list
14736171|NCT00543686|Montelukast|montelukast|mesh-list
14736172|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736173|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14736174|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
14736175|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736176|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736177|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14736178|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
14736179|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
14736180|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14736181|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14736182|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
14736183|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736184|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14736185|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14736186|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736187|NCT00543829|Tamoxifen|tamoxifen|mesh-list
14736188|NCT00543829|Docetaxel|docetaxel|mesh-list
14736189|NCT00543829|Doxorubicin|doxorubicin|mesh-list
14736190|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14736191|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736192|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
14736193|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
14736194|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
14736195|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400844|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14400845|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14400846|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14400847|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
14400848|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
14400849|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400850|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14400851|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14736196|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14736197|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14736198|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736199|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736200|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14736201|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
14736202|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736203|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736204|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239715|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239716|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
15239717|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239718|NCT04920994|Bupivacaine|bupivacaine|mesh-list
15239719|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
15239720|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
15239721|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239722|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239723|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
15239724|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239725|NCT04909515|Isotretinoin|isotretinoin|mesh-list
15239726|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
15239727|NCT04908579|Ketamine|ketamine|mesh-list
15239728|NCT04908579|Bupivacaine|bupivacaine|mesh-list
15239729|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
15239730|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
15239731|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239732|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239733|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
14400852|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14400853|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14400854|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14400855|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14400856|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
14400857|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14400858|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14400859|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
14400860|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400861|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400862|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400863|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
14400864|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
14400865|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400866|NCT01454102|Gemcitabine|gemcitabine|mesh-list
14400867|NCT01454102|Paclitaxel|paclitaxel|mesh-list
14400868|NCT01454102|Bevacizumab|bevacizumab|mesh-list
14400869|NCT01454102|Carboplatin|carboplatin|mesh-list
14400870|NCT01454102|Nivolumab|nivolumab|mesh-list
14400871|NCT01454102|Pemetrexed|pemetrexed|mesh-list
14400872|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14400873|NCT01454102|Ipilimumab|ipilimumab|mesh-list
14400874|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14400875|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400876|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
14400877|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
14400878|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
14400879|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400880|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14400881|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14400882|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14400883|NCT01454102|Growth Substances|growth substances|mesh-ancestor
14736205|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14736206|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14736207|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14736208|NCT00543842|Bevacizumab|bevacizumab|mesh-list
14736209|NCT00543842|Capecitabine|capecitabine|mesh-list
14736210|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14736211|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736212|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736213|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736214|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736215|NCT00543842|Growth Substances|growth substances|mesh-ancestor
14736216|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400884|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736217|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
14400885|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14400886|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14400887|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
14400888|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
14400889|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400890|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400891|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736218|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736219|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
14736220|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736221|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736222|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736223|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
14736224|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14736225|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
14736226|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736227|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736228|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14736229|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
14736230|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14736231|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
14736232|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736233|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736234|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14736235|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
14736236|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
14736237|NCT00543933|Protective Agents|protective agents|mesh-ancestor
14736238|NCT00543959|Pioglitazone|pioglitazone|mesh-list
14736239|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14736240|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736241|NCT00544011|Bevacizumab|bevacizumab|mesh-list
14736242|NCT00544011|Fluorouracil|fluorouracil|mesh-list
14736243|NCT00544011|Capecitabine|capecitabine|mesh-list
14736244|NCT00544011|Irinotecan|irinotecan|mesh-list
14736245|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736246|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736247|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736248|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736249|NCT00544011|Growth Substances|growth substances|mesh-ancestor
14736250|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736251|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736252|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
14736253|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736254|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736255|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736256|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
14924307|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14924308|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14924309|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14924310|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14924311|NCT00309985|Docetaxel|docetaxel|mesh-list
14924312|NCT00309985|Androgens|androgens|mesh-list
14924313|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924314|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14924315|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14924316|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
15239734|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239735|NCT04908579|Analgesics|analgesics|mesh-ancestor
15239736|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15239737|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15239738|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
15239739|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15239740|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15239741|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239742|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239743|NCT04903210|Niacinamide|niacinamide|mesh-list
15239744|NCT04903210|Niacin|niacin|mesh-list
15239745|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
15239746|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
14736257|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14736258|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736259|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736260|NCT00544037|Interferons|interferons|mesh-list
14736261|NCT00544037|Interferon-beta|interferon-beta|mesh-list
14736262|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
14736263|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736264|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
14736265|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736266|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
14736267|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736268|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14736269|NCT00544050|Levetiracetam|levetiracetam|mesh-list
14736270|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
14736271|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
14736272|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
14736273|NCT00544063|Irinotecan|irinotecan|mesh-list
14736274|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736275|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14736276|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736277|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736278|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736279|NCT00544128|Ritonavir|ritonavir|mesh-list
14736280|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14736281|NCT00544128|Tenofovir|tenofovir|mesh-list
14736282|NCT00544128|Lamivudine|lamivudine|mesh-list
14736283|NCT00544128|Emtricitabine|emtricitabine|mesh-list
14736284|NCT00544128|Abacavir|abacavir|mesh-list
14736285|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14736286|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14736287|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
14736288|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736289|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736290|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14736291|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14736292|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
14736293|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736294|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14736295|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14736296|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14736297|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14736298|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
14736299|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736300|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
14736301|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736302|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736303|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
14736304|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14736305|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14736306|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736307|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14736308|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736309|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14736310|NCT00544193|Gemcitabine|gemcitabine|mesh-list
14736311|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736312|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
14736313|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736314|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736315|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
14736316|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736317|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736318|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736319|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
14736320|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736321|NCT00544219|Prednisone|prednisone|mesh-list
14736322|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
14736323|NCT00544219|Rituximab|rituximab|mesh-list
14736324|NCT00544219|Doxorubicin|doxorubicin|mesh-list
14736325|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14736326|NCT00544219|Vincristine|vincristine|mesh-list
14736327|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736328|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
14400892|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
14400893|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14400894|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14400895|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400896|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14400897|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
14400898|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14400899|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400900|NCT01454362|Nicotine|nicotine|mesh-list
14400901|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14400902|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
14400903|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400904|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400905|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14400906|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14400907|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
14400908|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400909|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400910|NCT01454414|Permethrin|permethrin|mesh-list
14400911|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400912|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400913|NCT01454596|Aldesleukin|aldesleukin|mesh-list
14400914|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
14400915|NCT01454596|Fludarabine|fludarabine|mesh-list
14400916|NCT01454596|Mitogens|mitogens|mesh-list
14400917|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400918|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
14400919|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400920|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736329|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736330|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736331|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14736332|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
14736333|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736334|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736335|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14736336|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736337|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14736338|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14736339|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736340|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239747|NCT04903210|Vitamins|vitamins|mesh-ancestor
15239748|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
15239749|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239750|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15239751|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
15239752|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239753|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15239754|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
15239755|NCT04896658|Dexamethasone|dexamethasone|mesh-list
15239756|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
15239757|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15239758|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
15239759|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239760|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239761|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15239762|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
15239763|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239764|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239765|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15239766|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239767|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
15239768|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
15239769|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400921|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14400922|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
14400923|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400924|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400925|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14400926|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14400927|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14400928|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14400929|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
14400930|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400931|NCT01454739|Factor VIII|factor viii|mesh-list
14400932|NCT01454739|Coagulants|coagulants|mesh-ancestor
14400933|NCT01454778|Paclitaxel|paclitaxel|mesh-list
14400934|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14400935|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400936|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
14400937|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
14400938|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14400939|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400940|NCT01454791|Diclofenac|diclofenac|mesh-list
14400941|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15239770|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14400942|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15239771|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
15239772|NCT04896658|Hormones|hormones|mesh-ancestor
15239773|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239774|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239775|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15239776|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239777|NCT04802837|Vancomycin|vancomycin|mesh-list
15239778|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15239779|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239780|NCT04779138|Vaccines|vaccines|mesh-list
14736341|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736342|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
14736343|NCT00544219|Hormones|hormones|mesh-ancestor
14736344|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736345|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14736346|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14736347|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
14736348|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
14736349|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
15239781|NCT04779138|Immunologic Factors|immunologic factors|mesh-ancestor
15239782|NCT04779138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239783|NCT04769401|Progesterone|progesterone|mesh-list
15239784|NCT04769401|Progestins|progestins|mesh-ancestor
15239785|NCT04769401|Hormones|hormones|mesh-ancestor
15239786|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239787|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239788|NCT04742023|Insulin|insulin|mesh-list
14736350|NCT00544232|Paclitaxel|paclitaxel|mesh-list
14736351|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14736352|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
14736353|NCT00544232|Methotrexate|methotrexate|mesh-list
14736354|NCT00544232|Epirubicin|epirubicin|mesh-list
14736355|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
14736356|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14736357|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736358|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
14736359|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
14736360|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
14736361|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736362|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736363|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
14736364|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736365|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736366|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14736367|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
14736368|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14736369|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14736370|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
14736371|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14400943|NCT01454791|Analgesics|analgesics|mesh-ancestor
14400944|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
14736372|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736373|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
14736374|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
14736375|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736376|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14736377|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14736378|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14736379|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14736380|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736381|NCT00544232|Hematinics|hematinics|mesh-ancestor
14736382|NCT00544284|Temozolomide|temozolomide|mesh-list
14736383|NCT00544284|Bortezomib|bortezomib|mesh-list
14736384|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14736385|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
14736386|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736387|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736388|NCT00544349|Leucovorin|leucovorin|mesh-list
14736389|NCT00544349|Fluorouracil|fluorouracil|mesh-list
14736390|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
14736391|NCT00544349|Cetuximab|cetuximab|mesh-list
14736392|NCT00544349|Calcium|calcium|mesh-list
14736393|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
14736394|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14736395|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736396|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
14736397|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736398|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736399|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736400|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736401|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
14736402|NCT00544349|Antidotes|antidotes|mesh-ancestor
14736403|NCT00544349|Protective Agents|protective agents|mesh-ancestor
14736404|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
14736405|NCT00544349|Vitamins|vitamins|mesh-ancestor
14736406|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
14736407|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736408|NCT00544362|Fluorouracil|fluorouracil|mesh-list
14736409|NCT00544362|Cetuximab|cetuximab|mesh-list
14924317|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924318|NCT00309985|Hormones|hormones|mesh-ancestor
14924319|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924320|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924321|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
14736410|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736411|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
14736412|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736413|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736414|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924322|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14736415|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
15239789|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15239790|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736416|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924323|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
14924324|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14924325|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924326|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15239791|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
15239792|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15239793|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15239794|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239795|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
15239796|NCT04733157|Coagulants|coagulants|mesh-ancestor
15239797|NCT04727424|Budesonide|budesonide|mesh-list
15239798|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
15239799|NCT04727424|Maleic acid|maleic acid|mesh-list
15239800|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239801|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15239802|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
15239803|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239804|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239805|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15239806|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
15239807|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
15239808|NCT04727424|Hormones|hormones|mesh-ancestor
15239809|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239810|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239811|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239812|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15239813|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15239814|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239815|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239816|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15239817|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15239818|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15239819|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239820|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
15239821|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15239822|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
15239823|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15239824|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15239825|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15239826|NCT04724252|Gabapentin|gabapentin|mesh-list
14736417|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736418|NCT00544388|Levocetirizine|levocetirizine|mesh-list
15239827|NCT04724252|Analgesics|analgesics|mesh-ancestor
15239828|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
15239829|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239830|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400945|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400946|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400947|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14400948|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239831|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
15239832|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15239833|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15239834|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239835|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15239836|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15239837|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15239838|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239839|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239840|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
15239841|NCT04720781|Esomeprazole|esomeprazole|mesh-list
15239842|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15239843|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239844|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15239845|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239846|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239847|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
14400949|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14400950|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400951|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400952|NCT01454934|Gemcitabine|gemcitabine|mesh-list
14400953|NCT01454934|Docetaxel|docetaxel|mesh-list
14400954|NCT01454934|Pemetrexed|pemetrexed|mesh-list
14400955|NCT01454934|Vinorelbine|vinorelbine|mesh-list
14400956|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14400957|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
14400958|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239848|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15239849|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15239850|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
15239851|NCT04719208|Listerine|listerine|mesh-list
14400959|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14400960|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
14400961|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14400962|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14400963|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14400964|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
14400965|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400966|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
14400967|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
14400968|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
14400969|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14400970|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14400971|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14400972|NCT01455012|Rotigotine|rotigotine|mesh-list
14400973|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
14400974|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
14400975|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14400976|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400977|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467191|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467192|NCT02257372|Albuterol|albuterol|mesh-list
14467193|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14467194|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
14467195|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467196|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467197|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14467198|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
14467199|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
14467200|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14467201|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14467202|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14736419|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14736420|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14736421|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
14736422|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
14736423|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736424|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736425|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736426|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
14400978|NCT01455194|Ciclesonide|ciclesonide|mesh-list
14400979|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
14400980|NCT01455194|Hormones|hormones|mesh-ancestor
14400981|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14400982|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400983|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14400984|NCT01455220|Natalizumab|natalizumab|mesh-list
14400985|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
14400986|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400987|NCT01455415|Pregabalin|pregabalin|mesh-list
14400988|NCT01455415|Analgesics|analgesics|mesh-ancestor
14400989|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
14400990|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14400991|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14400992|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
14467203|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14467204|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
14467205|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467206|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467207|NCT02257385|Albuterol|albuterol|mesh-list
14467208|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
14467209|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14467210|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
14467211|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467212|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467213|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14467214|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
14467215|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
14467216|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14467217|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
14467218|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467219|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467220|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
14400993|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14400994|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14400995|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14400996|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14400997|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14400998|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14400999|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401000|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736427|NCT00544505|Fluorouracil|fluorouracil|mesh-list
14736428|NCT00544505|Epirubicin|epirubicin|mesh-list
14736429|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736430|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
14736431|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736432|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736433|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14736434|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
14736435|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736436|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736437|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14736438|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
14736439|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736440|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14736441|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14736442|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736443|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736444|NCT00544518|Metformin|metformin|mesh-list
14736445|NCT00544518|Benfluorex|benfluorex|mesh-list
14736446|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14736447|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736448|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14736449|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
14736450|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736451|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14736452|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
14736453|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14736454|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
14736455|NCT00544570|Melphalan|melphalan|mesh-list
14736456|NCT00544570|Carmustine|carmustine|mesh-list
14736457|NCT00544570|Etoposide|etoposide|mesh-list
14736458|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736459|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
14736460|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736461|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736462|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14401001|NCT01455428|Pregabalin|pregabalin|mesh-list
14401002|NCT01455428|Analgesics|analgesics|mesh-ancestor
15239852|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15239853|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15239854|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401003|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
14401004|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401005|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401006|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
14401007|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14401008|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401009|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401010|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14401011|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14401012|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14401013|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401014|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401015|NCT01455519|Hydromorphone|hydromorphone|mesh-list
14401016|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14401017|NCT01455519|Narcotics|narcotics|mesh-ancestor
15239855|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
15239856|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
14736463|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
14736464|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736465|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239857|NCT04718116|Tramadol|tramadol|mesh-list
15239858|NCT04718116|Tapentadol|tapentadol|mesh-list
15239859|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14401018|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401019|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401020|NCT01455519|Analgesics|analgesics|mesh-ancestor
14401021|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
14401022|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401023|NCT01456039|Romidepsin|romidepsin|mesh-list
14401024|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14401025|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401026|NCT01456130|Alogliptin|alogliptin|mesh-list
14401027|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
14401028|NCT01456130|Secretagogues|secretagogues|mesh-list
14401029|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14401030|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401031|NCT01456130|Incretins|incretins|mesh-ancestor
15239860|NCT04718116|Narcotics|narcotics|mesh-ancestor
14401032|NCT01456130|Hormones|hormones|mesh-ancestor
14736466|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14736467|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14736468|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14736469|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736470|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239861|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15239862|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239863|NCT04718116|Analgesics|analgesics|mesh-ancestor
15239864|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
15239865|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736471|NCT00544596|Acetic Acid|acetic acid|mesh-list
14736472|NCT00544596|Etoposide|etoposide|mesh-list
14736473|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
14736474|NCT00544596|Retinol acetate|retinol acetate|mesh-list
14736475|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
14736476|NCT00544596|Gossypol|gossypol|mesh-list
14736477|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736478|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14736479|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14401033|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401034|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14401035|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
14401036|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401037|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401038|NCT01456143|Proflavine|proflavine|mesh-list
14401039|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14401040|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401041|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
14401042|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14401043|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14401044|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14401045|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401046|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14401047|NCT01456169|Diuretics|diuretics|mesh-ancestor
14401048|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
14401049|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401050|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14401051|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401052|NCT01456299|Remifentanil|remifentanil|mesh-list
14401053|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14401054|NCT01456299|Narcotics|narcotics|mesh-ancestor
14401055|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401056|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401057|NCT01456299|Analgesics|analgesics|mesh-ancestor
14401058|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
14401059|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401060|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14401061|NCT01456780|Tobramycin|tobramycin|mesh-list
14401062|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
14401063|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401064|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401065|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14401066|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14401067|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14401068|NCT01456936|Bupropion|bupropion|mesh-list
14401069|NCT01456936|Nicotine|nicotine|mesh-list
14401070|NCT01456936|Varenicline|varenicline|mesh-list
14401071|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14401072|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
14401073|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401074|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401075|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14401076|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14401077|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
14401078|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401079|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401080|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14401081|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
14401082|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401083|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14736480|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15239866|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15239867|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14401084|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14401085|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401086|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
14401087|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15239868|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15239869|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239870|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
15239871|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736481|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736482|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736483|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14736484|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736485|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15239872|NCT04707872|Antibodies|antibodies|mesh-list
15239873|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
14401088|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14401089|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401090|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
14401091|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239874|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401092|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14401093|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14401094|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401095|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736486|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
14736487|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736488|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14736489|NCT00544596|Protective Agents|protective agents|mesh-ancestor
14736490|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14736491|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
14736492|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14401096|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14401097|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14401098|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401099|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14401100|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14401101|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401102|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401103|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
14401104|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401105|NCT01457430|Icatibant|icatibant|mesh-list
14401106|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14401107|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14401108|NCT01457430|Analgesics|analgesics|mesh-ancestor
14401109|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
14401110|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401111|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401112|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401113|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401114|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14401115|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14401116|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401117|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14401118|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14401119|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
14401120|NCT01457521|Ibuprofen|ibuprofen|mesh-list
14401121|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14401122|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14401123|NCT01457521|Analgesics|analgesics|mesh-ancestor
14401124|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
14401125|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401126|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401127|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401128|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401129|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14736493|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14401130|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239875|NCT04706715|Cemiplimab|cemiplimab|mesh-list
15239876|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14401131|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401132|NCT01457573|Tamsulosin|tamsulosin|mesh-list
14401133|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
14401134|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14401135|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14401136|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14401137|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
14401138|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401139|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401140|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401141|NCT01457573|Urological Agents|urological agents|mesh-ancestor
14401142|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14401143|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14401144|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
14401145|NCT01457703|Letrozole|letrozole|mesh-list
14401146|NCT01457703|Cetrorelix|cetrorelix|mesh-list
14401147|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14401148|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401149|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14401150|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14401151|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401152|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401153|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14736494|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14401154|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
14401155|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401156|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401157|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14401158|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
14401159|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14401160|NCT01457703|Hormones|hormones|mesh-ancestor
14401161|NCT01457846|Paclitaxel|paclitaxel|mesh-list
14401162|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14401163|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736495|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14736496|NCT00544609|Sorafenib|sorafenib|mesh-list
14736497|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736498|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736499|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736500|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736501|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
14736502|NCT00544687|Nortriptyline|nortriptyline|mesh-list
14736503|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736504|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14736505|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14736506|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14736507|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
14736508|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736509|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14736510|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15239877|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239878|NCT04701190|Norepinephrine|norepinephrine|mesh-list
15239879|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239880|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15239881|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15239882|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
15239883|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239884|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239885|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
15239886|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
14401164|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14401165|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14401166|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14401167|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401168|NCT01457885|Busulfan|busulfan|mesh-list
14401169|NCT01457885|Clofarabine|clofarabine|mesh-list
14401170|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
14401171|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401172|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14401173|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
14401174|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401175|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14401176|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401177|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14401178|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14401179|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
14401180|NCT01457924|Ofatumumab|ofatumumab|mesh-list
14401181|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14401182|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401183|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
14401184|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401185|NCT01457950|Denosumab|denosumab|mesh-list
14401186|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14401187|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401188|NCT01458106|Factor VIII|factor viii|mesh-list
14401189|NCT01458106|Coagulants|coagulants|mesh-ancestor
14401190|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
14401191|NCT01458171|Antibodies|antibodies|mesh-list
14401192|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
14401193|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14401194|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14401195|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
14401196|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401197|NCT01458210|Dulaglutide|dulaglutide|mesh-list
14401198|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
14401199|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14401200|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14401201|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736511|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14736512|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736513|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
14736514|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736515|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736516|NCT00544700|Bevacizumab|bevacizumab|mesh-list
14736517|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736518|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736519|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736520|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14401202|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14736521|NCT00544700|Growth Substances|growth substances|mesh-ancestor
14736522|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736523|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736524|NCT00544791|Melatonin|melatonin|mesh-list
14924327|NCT00214916|Insulin|insulin|mesh-list
14401203|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401204|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14401205|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14401206|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401207|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401208|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401209|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14401210|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
14401211|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14401212|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14401213|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14401214|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14401215|NCT01458275|Ciclesonide|ciclesonide|mesh-list
14401216|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
14401217|NCT01458275|Hormones|hormones|mesh-ancestor
14401218|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401219|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401220|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14401221|NCT01458366|Carboplatin|carboplatin|mesh-list
14401222|NCT01458366|Etoposide|etoposide|mesh-list
14401223|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
14401224|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14401225|NCT01458366|Ofatumumab|ofatumumab|mesh-list
14736525|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
14736526|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736527|NCT00544791|Protective Agents|protective agents|mesh-ancestor
14736528|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736529|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753130|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14753131|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14753132|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401226|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401227|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14401228|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14401229|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14401230|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401231|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401232|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14401233|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
14401234|NCT01458418|Montelukast|montelukast|mesh-list
14401235|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14401236|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
14401237|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14401238|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
14401239|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401240|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401241|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14401242|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14401243|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401244|NCT01458522|Lacosamide|lacosamide|mesh-list
14401245|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
14401246|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
14401247|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14401248|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14401249|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401250|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401251|NCT01458535|Ritonavir|ritonavir|mesh-list
14401252|NCT01458535|Ribavirin|ribavirin|mesh-list
14401253|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14401254|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14401255|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
14401256|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401257|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401258|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14401259|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14401260|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
14401261|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401262|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14401263|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14401264|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
14401265|NCT01458561|Thrombin|thrombin|mesh-list
15239887|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239888|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15239889|NCT04700423|Ivermectin|ivermectin|mesh-list
15239890|NCT04700423|Albendazole|albendazole|mesh-list
15239891|NCT04700423|Moxidectin|moxidectin|mesh-list
15239892|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15239893|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15239894|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
15239895|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
15239896|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15239897|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15239898|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
15239899|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
15239900|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
15239901|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239902|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239903|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
15239904|NCT04666454|Adenosine|adenosine|mesh-list
15239905|NCT04666454|Dipyridamole|dipyridamole|mesh-list
15239906|NCT04666454|Apixaban|apixaban|mesh-list
15239907|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15239908|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
14736530|NCT00544804|Lapatinib|lapatinib|mesh-list
14736531|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736532|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736533|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736534|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736535|NCT00544986|Anastrozole|anastrozole|mesh-list
14736536|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14736537|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736538|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14736539|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14736540|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736541|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736542|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14736543|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
14736544|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736545|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736546|NCT00544999|Cytarabine|cytarabine|mesh-list
14736547|NCT00544999|Everolimus|everolimus|mesh-list
14736548|NCT00544999|Daunorubicin|daunorubicin|mesh-list
14736549|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736550|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
14401266|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14401267|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
14401268|NCT01458561|Coagulants|coagulants|mesh-ancestor
14401269|NCT01458574|Tofacitinib|tofacitinib|mesh-list
14401270|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736551|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736552|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736553|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
14736554|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736555|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736556|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
14736557|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736558|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14736559|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14736560|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736561|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736562|NCT00545012|Levetiracetam|levetiracetam|mesh-list
14401271|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401272|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401273|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14401274|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14401275|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14736563|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
14401276|NCT01458639|Xenon|xenon|mesh-list
14401277|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14401278|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
14401279|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
14736564|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
14736565|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
14736566|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14401280|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401281|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401282|NCT01458951|Tofacitinib|tofacitinib|mesh-list
14736567|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401283|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14401284|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401285|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401286|NCT01458990|Omeprazole|omeprazole|mesh-list
14401287|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14401288|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14401289|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14401290|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401291|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401292|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14401293|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14401294|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
14401295|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14401296|NCT01459588|Laxatives|laxatives|mesh-ancestor
14401297|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14401298|NCT01459614|Gemcitabine|gemcitabine|mesh-list
14401299|NCT01459614|Docetaxel|docetaxel|mesh-list
14736568|NCT00545129|Tanezumab|tanezumab|mesh-list
14736569|NCT00545129|Analgesics|analgesics|mesh-ancestor
14736570|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
14736571|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736572|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736573|NCT00545142|Valproic Acid|valproic acid|mesh-list
14736574|NCT00545142|Aripiprazole|aripiprazole|mesh-list
14736575|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
14736576|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736577|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14736578|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14736579|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14736580|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736581|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
14736582|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
15239909|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15239910|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
15239911|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239912|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239913|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
15239914|NCT04666454|Analgesics|analgesics|mesh-ancestor
15239915|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
15239916|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15239917|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239918|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15239919|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
14401300|NCT01459614|Capecitabine|capecitabine|mesh-list
14736583|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924328|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15239920|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14736584|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736585|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14736586|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14736587|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
14736588|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14736589|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14401301|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401302|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14401303|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
14401304|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401305|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
14401306|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401307|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401308|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14401309|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
14401310|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401311|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
14401312|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
14401313|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
14401314|NCT01459718|Deferasirox|deferasirox|mesh-list
14401315|NCT01459718|Deferoxamine|deferoxamine|mesh-list
14401316|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14401317|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
14401318|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
14401319|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401320|NCT01459718|Siderophores|siderophores|mesh-ancestor
14401321|NCT01459796|Rilonacept|rilonacept|mesh-list
14401322|NCT01459796|Allopurinol|allopurinol|mesh-list
14401323|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
14401324|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401325|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401326|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
14401327|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401328|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14401329|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
14401330|NCT01459796|Protective Agents|protective agents|mesh-ancestor
14401331|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736590|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14736591|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14736592|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
14736593|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736594|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
14736595|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
14736596|NCT00545194|Dinoprostone|dinoprostone|mesh-list
14736597|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
14736598|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14736599|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736600|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
14736601|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14736602|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736603|NCT00545246|Docetaxel|docetaxel|mesh-list
14736604|NCT00545246|Aflibercept|aflibercept|mesh-list
14736605|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736606|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
14736607|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
14736608|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
14736609|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736610|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15239921|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
15239922|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
15239923|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15239924|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15239925|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15239926|NCT04606316|Nivolumab|nivolumab|mesh-list
15239927|NCT04606316|Ipilimumab|ipilimumab|mesh-list
15239928|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15239929|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239930|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15239931|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239932|NCT04601883|Colchicine|colchicine|mesh-list
15239933|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
15239934|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239935|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
14401332|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401333|NCT01459913|Interferons|interferons|mesh-list
14401334|NCT01459913|Ribavirin|ribavirin|mesh-list
14401335|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
14401336|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
14401337|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14401338|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401339|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
14401340|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401341|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
14401342|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736611|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736612|NCT00545246|Growth Substances|growth substances|mesh-ancestor
14736613|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736614|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736615|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
14736616|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14736617|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14736618|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14736619|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14736620|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736621|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736622|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736623|NCT00545389|Mesalamine|mesalamine|mesh-list
14736624|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14736625|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14736626|NCT00545389|Analgesics|analgesics|mesh-ancestor
14736627|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
14736628|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736629|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736630|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736631|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736632|NCT00545467|Aripiprazole|aripiprazole|mesh-list
14736633|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
14736634|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736635|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14736636|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14736637|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14736638|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736639|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
14736640|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
14736641|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736642|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736643|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14736644|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14736645|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
14736646|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14736647|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14736648|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14736649|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14736650|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
14736651|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14736652|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736653|NCT00545493|Tacrolimus|tacrolimus|mesh-list
14736654|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
14736655|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14924329|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14736656|NCT00545493|Antibodies|antibodies|mesh-list
14401343|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
14736657|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736658|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
14736659|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736660|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14736661|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736662|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736663|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
14736664|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
14736665|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736666|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736667|NCT00545558|Tenofovir|tenofovir|mesh-list
14736668|NCT00545558|Emtricitabine|emtricitabine|mesh-list
14736669|NCT00545558|Efavirenz|efavirenz|mesh-list
14736670|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14736671|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
14736672|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736673|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14736674|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14736675|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736676|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736677|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14736678|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15239936|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
15239937|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
15239938|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239939|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239940|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
15239941|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15239942|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239943|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15239944|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239945|NCT04573777|Evolocumab|evolocumab|mesh-list
14736679|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14736680|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14736681|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14736682|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14736683|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14736684|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14736685|NCT00545675|Valproic Acid|valproic acid|mesh-list
14401344|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401345|NCT01460225|Lubiprostone|lubiprostone|mesh-list
14401346|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15239946|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15239947|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15239948|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
15239949|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239950|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15239951|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
15239952|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15239953|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
15239954|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14736686|NCT00545675|Aripiprazole|aripiprazole|mesh-list
14736687|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
14736688|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736689|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14736690|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14736691|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14736692|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736693|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
14736694|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
14736695|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736696|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736697|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14736698|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14736699|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
14736700|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14736701|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15239955|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401347|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401348|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401349|NCT01460290|Asenapine|asenapine|mesh-list
14401350|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14401351|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15239956|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14401352|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401353|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401354|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401355|NCT01460342|Tadalafil|tadalafil|mesh-list
14401356|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
14401357|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14401358|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14401359|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401360|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736702|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14736703|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14736704|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
14401361|NCT01460342|Urological Agents|urological agents|mesh-ancestor
14401362|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
14401363|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401364|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401365|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14401366|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14401367|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401368|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401369|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401370|NCT01460381|Quinidine|quinidine|mesh-list
14401371|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
14401372|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14401373|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14401374|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
14401375|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401376|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401377|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401378|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14401379|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
14401380|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14401381|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14401382|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401383|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401384|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14401385|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14401386|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
14401387|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14736705|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736706|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
14736707|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
14736708|NCT00545831|Taurolidine|taurolidine|mesh-list
14736709|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736710|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14401388|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14924330|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924331|NCT00066963|Fluorides|fluorides|mesh-list
14736711|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736712|NCT00545857|Pioglitazone|pioglitazone|mesh-list
14736713|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14736714|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736715|NCT00545870|Bevacizumab|bevacizumab|mesh-list
14736716|NCT00545870|Ranibizumab|ranibizumab|mesh-list
14736717|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14736718|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736719|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736720|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736721|NCT00545870|Growth Substances|growth substances|mesh-ancestor
14736722|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736723|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736724|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
14736725|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14736726|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736727|NCT00545935|Artesunate|artesunate|mesh-list
14736728|NCT00545935|Amodiaquine|amodiaquine|mesh-list
14736729|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
14736730|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14736731|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14736732|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736733|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736734|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
14736735|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
14736736|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14736737|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
14401389|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14736738|NCT00545961|Amoxicillin|amoxicillin|mesh-list
14736739|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
14736740|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
14736741|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14736742|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401390|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14401391|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14401392|NCT01460407|Clarithromycin|clarithromycin|mesh-list
14401393|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401394|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736743|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736744|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14736745|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736746|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736747|NCT00546039|Genistein|genistein|mesh-list
14736748|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14736749|NCT00546039|Protective Agents|protective agents|mesh-ancestor
14736750|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736751|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736752|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736753|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736754|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736755|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
14736756|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14736757|NCT00546039|Estrogens|estrogens|mesh-ancestor
14736758|NCT00546039|Hormones|hormones|mesh-ancestor
14736759|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736760|NCT00546065|Esomeprazole|esomeprazole|mesh-list
14736761|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14736762|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14401395|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14401396|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401397|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736763|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14736764|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924332|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
14736765|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736766|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
14736767|NCT00546130|Cisplatin|cisplatin|mesh-list
14736768|NCT00546130|Irinotecan|irinotecan|mesh-list
14736769|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736770|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14736771|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14736772|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736773|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736774|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14736775|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
14736776|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736777|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14736778|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
14736779|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736780|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
14736781|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14736782|NCT00546130|Protective Agents|protective agents|mesh-ancestor
14736783|NCT00546143|Omalizumab|omalizumab|mesh-list
14736784|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14736785|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14736786|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14736787|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
14736788|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
14736789|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736790|NCT00546169|Thrombin|thrombin|mesh-list
14736791|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
14736792|NCT00546169|Coagulants|coagulants|mesh-ancestor
14736793|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
14736794|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14736795|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
14736796|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736797|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736798|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14736799|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
14736800|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
14736801|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14736802|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
14736803|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924333|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
15239957|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239958|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736804|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736805|NCT00546286|Timolol|timolol|mesh-list
15239959|NCT04560166|Irinotecan|irinotecan|mesh-list
15239960|NCT04560166|Temozolomide|temozolomide|mesh-list
15239961|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15239962|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15239963|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15239964|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15239965|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15239966|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15239967|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
15239968|NCT04559646|Hemostatics|hemostatics|mesh-list
15239969|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15239970|NCT04559646|Coagulants|coagulants|mesh-ancestor
15239971|NCT04546126|Dexamethasone|dexamethasone|mesh-list
15239972|NCT04546126|Cosyntropin|cosyntropin|mesh-list
15239973|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736806|NCT00546286|Dorzolamide|dorzolamide|mesh-list
14736807|NCT00546286|Maleic acid|maleic acid|mesh-list
14736808|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14736809|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14736810|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
14401398|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14401399|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14401400|NCT01460628|Modafinil|modafinil|mesh-list
14401401|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14401402|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401403|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14401404|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14401405|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14401406|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401407|NCT01460719|Vaccines|vaccines|mesh-list
14736811|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736812|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736813|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239974|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
15239975|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
14401408|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
14401409|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401410|NCT01460875|Interferons|interferons|mesh-list
14401411|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
14736814|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14736815|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14736816|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736817|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14736818|NCT00546325|Rimonabant|rimonabant|mesh-list
14736819|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14401412|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
14401413|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401414|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
14401415|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401416|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
14401417|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401418|NCT01460940|Lenalidomide|lenalidomide|mesh-list
14401419|NCT01460940|Panobinostat|panobinostat|mesh-list
14401420|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14401421|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
14401422|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401423|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14401424|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736820|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14736821|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14736822|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736823|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736824|NCT00546325|Hormones|hormones|mesh-ancestor
14736825|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736826|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736827|NCT00546403|Modafinil|modafinil|mesh-list
14736828|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14736829|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736830|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14736831|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14401425|NCT01460940|Growth Substances|growth substances|mesh-ancestor
14736832|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14736833|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736834|NCT00546442|Metformin|metformin|mesh-list
14736835|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14736836|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736837|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14401426|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
14401427|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401428|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401429|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401430|NCT01461057|Capecitabine|capecitabine|mesh-list
14401431|NCT01461057|Trastuzumab|trastuzumab|mesh-list
14401432|NCT01461057|Pertuzumab|pertuzumab|mesh-list
14401433|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401434|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736838|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14401435|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
14401436|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401437|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14401438|NCT01461096|Vaccines|vaccines|mesh-list
14401439|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
14401440|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401441|NCT01461369|Diclofenac|diclofenac|mesh-list
14401442|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14401443|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14401444|NCT01461369|Analgesics|analgesics|mesh-ancestor
14401445|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
14401446|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401447|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401448|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401449|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401450|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14401451|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401452|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401453|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14401454|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401455|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14401456|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14401457|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14401458|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401459|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
14401460|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401461|NCT01461551|Propofol|propofol|mesh-list
14401462|NCT01461551|Sevoflurane|sevoflurane|mesh-list
14401463|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14401464|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401465|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401466|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14736839|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14736840|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14736841|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736842|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736843|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924334|NCT00066963|Protective Agents|protective agents|mesh-ancestor
15239976|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401467|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
14401468|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
14401469|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14401470|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14401471|NCT01461668|Retapamulin|retapamulin|mesh-list
14401472|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401473|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401474|NCT01461733|Amiodarone|amiodarone|mesh-list
14401475|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14401476|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
14401477|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14401478|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401479|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401480|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14401481|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14401482|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14401483|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401484|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14401485|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15239977|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239978|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15239979|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
15239980|NCT04546126|Hormones|hormones|mesh-ancestor
15239981|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15239982|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15239983|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401486|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14401487|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14401488|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
14401489|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14401490|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14401491|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14401492|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
14401493|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14401494|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401495|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14401496|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14401497|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14401498|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14736844|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15239984|NCT04538352|Insulin|insulin|mesh-list
15239985|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15239986|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
15239987|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15239988|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239989|NCT04531176|Liraglutide|liraglutide|mesh-list
15239990|NCT04531176|Topiramate|topiramate|mesh-list
15239991|NCT04531176|Orlistat|orlistat|mesh-list
15239992|NCT04531176|Phentermine|phentermine|mesh-list
15239993|NCT04531176|Naltrexone|naltrexone|mesh-list
15239994|NCT04531176|Bupropion|bupropion|mesh-list
14736845|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
14736846|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736847|NCT00546507|Celecoxib|celecoxib|mesh-list
14736848|NCT00546507|Diclofenac|diclofenac|mesh-list
14736849|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14736850|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14736851|NCT00546507|Analgesics|analgesics|mesh-ancestor
14736852|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
14736853|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736854|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736855|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15239995|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15239996|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14736856|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15239997|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15239998|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
15239999|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240000|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15240001|NCT04531176|Incretins|incretins|mesh-ancestor
15240002|NCT04531176|Hormones|hormones|mesh-ancestor
15240003|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240004|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15240005|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
15240006|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15240007|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15240008|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14401499|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401500|NCT01461928|Rituximab|rituximab|mesh-list
14401501|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14401502|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401503|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
14401504|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401505|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467221|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14467222|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14467223|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14736857|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14736858|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14736859|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736860|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736861|NCT00546520|Ciclesonide|ciclesonide|mesh-list
14736862|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
14736863|NCT00546520|Hormones|hormones|mesh-ancestor
14736864|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736865|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736866|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14736867|NCT00546533|Etanercept|etanercept|mesh-list
14736868|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14736869|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14736870|NCT00546533|Analgesics|analgesics|mesh-ancestor
14736871|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
14736872|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736873|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736874|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736875|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736876|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14736877|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736878|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
14736879|NCT00546546|Methotrexate|methotrexate|mesh-list
14736880|NCT00546546|Azathioprine|azathioprine|mesh-list
14736881|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14736882|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14736883|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
14467224|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14467225|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
14467226|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
14467227|NCT02257541|Infigratinib|infigratinib|mesh-list
14467228|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467229|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14736884|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14736885|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736886|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736887|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
14736888|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736889|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736890|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
14736891|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736892|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14736893|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
14736894|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736895|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14736896|NCT00546559|Simvastatin|simvastatin|mesh-list
14736897|NCT00546559|Pravastatin|pravastatin|mesh-list
14736898|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14736899|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14401506|NCT01462227|Naltrexone|naltrexone|mesh-list
14401507|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14401508|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14401509|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401510|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
14736900|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
14736901|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736902|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14736903|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14736904|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736905|NCT00546650|Sumatriptan|sumatriptan|mesh-list
14736906|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14736907|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14736908|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14736909|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
14736910|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736911|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736912|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240009|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401511|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401512|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
14401513|NCT01462253|Clofarabine|clofarabine|mesh-list
14401514|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14401515|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
14401516|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401517|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401518|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240010|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240011|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
14401519|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
14401520|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401521|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401522|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15240012|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240013|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15240014|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15240015|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401523|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14401524|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
14401525|NCT01462266|Metformin|metformin|mesh-list
14401526|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
14401527|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14401528|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14401529|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401530|NCT01462266|Incretins|incretins|mesh-ancestor
14401531|NCT01462266|Hormones|hormones|mesh-ancestor
14401532|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401533|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14736913|NCT00546676|Telithromycin|telithromycin|mesh-list
14736914|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14736915|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736916|NCT00546741|Metformin|metformin|mesh-list
14736917|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
14736918|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14401534|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
14401535|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401536|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401537|NCT01462279|Thiamine|thiamine|mesh-list
14401538|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
14401539|NCT01462279|Vitamins|vitamins|mesh-ancestor
14924335|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924336|NCT00055731|Aspirin|aspirin|mesh-list
14924337|NCT00055731|Docetaxel|docetaxel|mesh-list
14401540|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
14401541|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401542|NCT01462318|Vitamin K|vitamin k|mesh-list
14736919|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736920|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14736921|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736922|NCT00546832|Celecoxib|celecoxib|mesh-list
14736923|NCT00546832|Diclofenac|diclofenac|mesh-list
14736924|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14736925|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14736926|NCT00546832|Analgesics|analgesics|mesh-ancestor
14736927|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
14736928|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14736929|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736930|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14736931|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14736932|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14736933|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14736934|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736935|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736936|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14736937|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14924338|NCT00055731|Goserelin|goserelin|mesh-list
14924339|NCT00055731|Bicalutamide|bicalutamide|mesh-list
14401543|NCT01462318|Midazolam|midazolam|mesh-list
14401544|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
14401545|NCT01462318|Caffeine|caffeine|mesh-list
14401546|NCT01462318|Omeprazole|omeprazole|mesh-list
14924340|NCT00055731|Estramustine|estramustine|mesh-list
14401547|NCT01462318|Warfarin|warfarin|mesh-list
14401548|NCT01462318|Daclizumab|daclizumab|mesh-list
14401549|NCT01462318|Vitamins|vitamins|mesh-ancestor
14401550|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
14401551|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401552|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14401553|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14401554|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401555|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14401556|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14401557|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401558|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14401559|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
14401560|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
14401561|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
14401562|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
14401563|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401564|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401565|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
14401566|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14401567|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14401568|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14401569|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401570|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14401571|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14401572|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14401573|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14401574|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
14401575|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14401576|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14401577|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
14401578|NCT01462318|Coagulants|coagulants|mesh-ancestor
14401579|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
14401580|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
14401581|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14401582|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14401583|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14401584|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
14401585|NCT01462344|Fluticasone|fluticasone|mesh-list
14924341|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924342|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
14924343|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
14924344|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
14924345|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924346|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14401586|NCT01462344|Xhance|xhance|mesh-list
14924347|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14924348|NCT00055731|Analgesics|analgesics|mesh-ancestor
14924349|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
14924350|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924351|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401587|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14401588|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14401589|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
14401590|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401591|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401592|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14924352|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14924353|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14924354|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14924355|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14924356|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14401593|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
14401594|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
14401595|NCT01462344|Hormones|hormones|mesh-ancestor
14401596|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401597|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
14401598|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401599|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
14401600|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14401601|NCT01462435|Celecoxib|celecoxib|mesh-list
14401602|NCT01462435|Diclofenac|diclofenac|mesh-list
14401603|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14401604|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14924357|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14401605|NCT01462435|Analgesics|analgesics|mesh-ancestor
14401606|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
14401607|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401608|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401609|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401610|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401611|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14401612|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14401613|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401614|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401615|NCT01462565|Epoprostenol|epoprostenol|mesh-list
14401616|NCT01462565|Tezosentan|tezosentan|mesh-list
14401617|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14401618|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14401619|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
14401620|NCT01462695|Sunitinib|sunitinib|mesh-list
14401621|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401622|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14401623|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14401624|NCT01462695|Growth Substances|growth substances|mesh-ancestor
14401625|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401626|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
14401627|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15240016|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
15240017|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15240018|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15240019|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15240020|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
15240021|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
15240022|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
15240023|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
15240024|NCT04496362|Heparin|heparin|mesh-list
15240025|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
15240026|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15240027|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15240028|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240029|NCT04465266|Tolperisone|tolperisone|mesh-list
15240030|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15240031|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240032|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15240033|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401628|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401629|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401630|NCT01462773|Interferons|interferons|mesh-list
14401631|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
14401632|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
14736938|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14736939|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14736940|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736941|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14736942|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736943|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14736944|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
14401633|NCT01462773|Bortezomib|bortezomib|mesh-list
14401634|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401635|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
14401636|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401637|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
14401638|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401639|NCT01462812|Sumatriptan|sumatriptan|mesh-list
14401640|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14401641|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14401642|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14401643|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
14401644|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401645|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401646|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401647|NCT01462877|Fenofibrate|fenofibrate|mesh-list
14401648|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14401649|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
14401650|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401651|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14401652|NCT01462929|Bromides|bromides|mesh-list
14401653|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
14401654|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14401655|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
14401656|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401657|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401658|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14401659|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
14401660|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
14401661|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14401662|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
14401663|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401664|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401665|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
14401666|NCT01462942|Bromides|bromides|mesh-list
14401667|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
14401668|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14401669|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
14401670|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401671|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240034|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
15240035|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15240036|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15240037|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
15240038|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240039|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240040|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240041|NCT04437108|Urological Agents|urological agents|mesh-ancestor
15240042|NCT04434300|Daptomycin|daptomycin|mesh-list
15240043|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15240044|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240045|NCT04433767|Nicotine|nicotine|mesh-list
15240046|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15240047|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
14401672|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14401673|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
15240048|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240049|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240050|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15240051|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15240052|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
15240053|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240054|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240055|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
14401674|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14401675|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14401676|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14401677|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
14401678|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401679|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401680|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
14401681|NCT01463033|Levetiracetam|levetiracetam|mesh-list
14401682|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
14401683|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
14401684|NCT01463098|Zolpidem|zolpidem|mesh-list
14401685|NCT01463098|Lemborexant|lemborexant|mesh-list
14736945|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14736946|NCT00546936|Ranibizumab|ranibizumab|mesh-list
14736947|NCT00546936|Verteporfin|verteporfin|mesh-list
14736948|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736949|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14736950|NCT00546936|Growth Substances|growth substances|mesh-ancestor
14736951|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736952|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
14736953|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736954|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14736955|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
14736956|NCT00547001|Estradiol|estradiol|mesh-list
15240056|NCT04423588|Lansoprazole|lansoprazole|mesh-list
14401686|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14401687|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14401688|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401689|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401690|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14401691|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
14401692|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
14401693|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401694|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401695|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14401696|NCT01463111|Lamotrigine|lamotrigine|mesh-list
14401697|NCT01463111|Valproic Acid|valproic acid|mesh-list
14401698|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401699|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401700|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401701|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
14401702|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14401703|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401704|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240057|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14736957|NCT00547001|Estrogens|estrogens|mesh-ancestor
14736958|NCT00547001|Hormones|hormones|mesh-ancestor
14401705|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
14401706|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14401707|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401708|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14401709|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14401710|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14401711|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
15240058|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15240059|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14401712|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401713|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14401714|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
14401715|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14401716|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14401717|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14401718|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
14401719|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14401720|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401721|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15240060|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240061|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401722|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14401723|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14401724|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14401725|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401726|NCT01463306|Pregabalin|pregabalin|mesh-list
14401727|NCT01463306|Analgesics|analgesics|mesh-ancestor
14401728|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
14401729|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240062|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
15240063|NCT04407377|Tolperisone|tolperisone|mesh-list
15240064|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15240065|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
15240066|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15240067|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15240068|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240069|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15240070|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240071|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15240072|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240073|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
15240074|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
15240075|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15240076|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15240077|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240078|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240079|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240080|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240081|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
15240082|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
15240083|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14401730|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401731|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
14401732|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14401733|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401734|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401735|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14401736|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14401737|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14401738|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401739|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401740|NCT01463384|Minocycline|minocycline|mesh-list
14401741|NCT01463384|Tetracycline|tetracycline|mesh-list
14401742|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401743|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401744|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14401745|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401746|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401747|NCT01463982|Capecitabine|capecitabine|mesh-list
14401748|NCT01463982|Irinotecan|irinotecan|mesh-list
14401749|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14401750|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
14401751|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401752|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401753|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14401754|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14401755|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401756|NCT01464190|Sevelamer|sevelamer|mesh-list
14401757|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
14401758|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
14401759|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401760|NCT01464229|Iloperidone|iloperidone|mesh-list
14401761|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14401762|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14401763|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401764|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401765|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401766|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14401767|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14401768|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401769|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401770|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14401771|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401772|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401773|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
14401774|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401775|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
14401776|NCT01464359|Busulfan|busulfan|mesh-list
14736959|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736960|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736961|NCT00547053|Amiloride|amiloride|mesh-list
14924358|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924359|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
14401777|NCT01464359|Fludarabine|fludarabine|mesh-list
14401778|NCT01464359|Interleukin-2|interleukin-2|mesh-list
14401779|NCT01464359|Allopurinol|allopurinol|mesh-list
14401780|NCT01464359|Levetiracetam|levetiracetam|mesh-list
14401781|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14401782|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
14467230|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467231|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467232|NCT02257632|Ranibizumab|ranibizumab|mesh-list
14467233|NCT02257632|Aflibercept|aflibercept|mesh-list
14467234|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14736962|NCT00547053|Diuretics|diuretics|mesh-ancestor
14736963|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
14736964|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736965|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14401783|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401784|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401785|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14401786|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
14401787|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401788|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401789|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14401790|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
14401791|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14401792|NCT01464359|Analgesics|analgesics|mesh-ancestor
14401793|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
14401794|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401795|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
14401796|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
14401797|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401798|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
14401799|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14401800|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
14401801|NCT01464359|Protective Agents|protective agents|mesh-ancestor
14401802|NCT01464424|Bimatoprost|bimatoprost|mesh-list
14401803|NCT01464424|Travoprost|travoprost|mesh-list
14401804|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14401805|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14401806|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14401807|NCT01464697|Progesterone|progesterone|mesh-list
15240084|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15240085|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240086|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736966|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15240087|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240088|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240089|NCT04307797|Exenatide|exenatide|mesh-list
15240090|NCT04307797|Glucagon|glucagon|mesh-list
15240091|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15240092|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15240093|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240094|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15240095|NCT04307797|Incretins|incretins|mesh-ancestor
14401808|NCT01464697|Progestins|progestins|mesh-ancestor
15240096|NCT04307797|Hormones|hormones|mesh-ancestor
14401809|NCT01464697|Hormones|hormones|mesh-ancestor
14401810|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240097|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14736967|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14736968|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736969|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14736970|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14753133|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753134|NCT05260021|Tirzepatide|tirzepatide|mesh-list
14753135|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14753136|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753137|NCT05260021|Incretins|incretins|mesh-ancestor
14753138|NCT05260021|Hormones|hormones|mesh-ancestor
14753139|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753140|NCT05258747|Olaparib|olaparib|mesh-list
14753141|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14753142|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753143|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401811|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753144|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753145|NCT05254639|Donepezil|donepezil|mesh-list
14753146|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14753147|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753148|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753149|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
14753150|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753151|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753152|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
14753153|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
14753154|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14753155|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753156|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
14753157|NCT05252988|Loperamide|loperamide|mesh-list
14401812|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14401813|NCT01464788|Argatroban|argatroban|mesh-list
14401814|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14401815|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14401816|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240098|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15240099|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
15240100|NCT04297150|Apixaban|apixaban|mesh-list
15240101|NCT04297150|Edoxaban|edoxaban|mesh-list
14401817|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
14401818|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14401819|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
14401820|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401821|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
15240102|NCT04297150|Dabigatran|dabigatran|mesh-list
15240103|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14401822|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14401823|NCT01464827|Ritonavir|ritonavir|mesh-list
14401824|NCT01464827|Ribavirin|ribavirin|mesh-list
14401825|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14401826|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14401827|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
14401828|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401829|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401830|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14401831|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14401832|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
14401833|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401834|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14401835|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14401836|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
14401837|NCT01464840|Azithromycin|azithromycin|mesh-list
14401838|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401839|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401840|NCT01464879|Testosterone|testosterone|mesh-list
14401841|NCT01464879|Androgens|androgens|mesh-ancestor
14401842|NCT01464879|Hormones|hormones|mesh-ancestor
14401843|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401844|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401845|NCT01464931|Denosumab|denosumab|mesh-list
14736971|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
14736972|NCT00547092|Tadalafil|tadalafil|mesh-list
14736973|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
14736974|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14736975|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14736976|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736977|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736978|NCT00547092|Urological Agents|urological agents|mesh-ancestor
14924360|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14401846|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14401847|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401848|NCT01465022|Estrogens|estrogens|mesh-list
14401849|NCT01465022|Progestins|progestins|mesh-list
14401850|NCT01465022|Hormones|hormones|mesh-ancestor
14401851|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401852|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240104|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
15240105|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15240106|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
15240107|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240108|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240109|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
14401853|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
14401854|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14401855|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401856|NCT01465178|Vitamins|vitamins|mesh-ancestor
14401857|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
14401858|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14401859|NCT01465191|Morphine|morphine|mesh-list
14401860|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14401861|NCT01465191|Narcotics|narcotics|mesh-ancestor
14401862|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14736979|NCT00547131|Temozolomide|temozolomide|mesh-list
14736980|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14736981|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
14736982|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736983|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736984|NCT00547144|Gemcitabine|gemcitabine|mesh-list
14736985|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14736986|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
14924361|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
14924362|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
14736987|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14736988|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14736989|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
14924363|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924364|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14924365|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
14924366|NCT01397500|Testosterone|testosterone|mesh-list
14924367|NCT01397500|Androgens|androgens|mesh-ancestor
14924368|NCT01397500|Hormones|hormones|mesh-ancestor
14924369|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924370|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924371|NCT01397513|Aspirin|aspirin|mesh-list
14924372|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14924373|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15240110|NCT04249323|Prednisone|prednisone|mesh-list
15240111|NCT04249323|Cortisone|cortisone|mesh-list
14736990|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736991|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14736992|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14736993|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
14736994|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14736995|NCT00547170|Doxycycline|doxycycline|mesh-list
14736996|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15240112|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240113|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
15240114|NCT04249323|Hormones|hormones|mesh-ancestor
15240115|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240116|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240117|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240118|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240119|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14924374|NCT01397513|Analgesics|analgesics|mesh-ancestor
14736997|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14736998|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
14736999|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14737000|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14737001|NCT00547183|Tadalafil|tadalafil|mesh-list
14737002|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737003|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737004|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737005|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737006|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737007|NCT00547183|Urological Agents|urological agents|mesh-ancestor
14737008|NCT00547196|Cyclosporine|cyclosporine|mesh-list
14737009|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
14737010|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
14924375|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
14924376|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924377|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737011|NCT00547196|Melphalan|melphalan|mesh-list
14737012|NCT00547196|Busulfan|busulfan|mesh-list
14737013|NCT00547196|Fludarabine|fludarabine|mesh-list
14737014|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
14737015|NCT00547196|Cyclosporins|cyclosporins|mesh-list
14737016|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737017|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
14737018|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737019|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14924378|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14924379|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401863|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401864|NCT01465191|Analgesics|analgesics|mesh-ancestor
14401865|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
14401866|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401867|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
14401868|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14401869|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14401870|NCT01465334|Prednisolone|prednisolone|mesh-list
14401871|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
14401872|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
14401873|NCT01465334|Ofatumumab|ofatumumab|mesh-list
14401874|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14401875|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
14401876|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401877|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
14737020|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14924380|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14401878|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
14737021|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
14401879|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401880|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401881|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14401882|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
14401883|NCT01465334|Hormones|hormones|mesh-ancestor
14401884|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401885|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14401886|NCT01465334|Protective Agents|protective agents|mesh-ancestor
14401887|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14401888|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401889|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14401890|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14401891|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
14401892|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401893|NCT01465347|Protective Agents|protective agents|mesh-ancestor
14401894|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401895|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14401896|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240120|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15240121|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15240122|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737022|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737023|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240123|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240124|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15240125|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
15240126|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240127|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240128|NCT04218357|Probenecid|probenecid|mesh-list
15240129|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
15240130|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
15240131|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737024|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14737025|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737026|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
14737027|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737028|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
14737029|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737030|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14737031|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14737032|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14737033|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14737034|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
14737035|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14737036|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
14401897|NCT01465386|Bortezomib|bortezomib|mesh-list
14401898|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401899|NCT01465412|Adenosine|adenosine|mesh-list
14401900|NCT01465412|Analgesics|analgesics|mesh-ancestor
14401901|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
14401902|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401903|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401904|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14401905|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
14401906|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14401907|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
14401908|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
14401909|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401910|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401911|NCT01465464|Orantinib|orantinib|mesh-list
14401912|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14401913|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401914|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401915|NCT01465659|Temozolomide|temozolomide|mesh-list
14401916|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14737037|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14737038|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
14737039|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
14737040|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737041|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401917|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
14737042|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14737043|NCT00547209|Analgesics|analgesics|mesh-ancestor
14737044|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
14737045|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737046|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
14737047|NCT00547287|Tadalafil|tadalafil|mesh-list
14737048|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737049|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14401918|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401919|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401920|NCT01465763|Tofacitinib|tofacitinib|mesh-list
14401921|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14401922|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401923|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401924|NCT01465802|Doxycycline|doxycycline|mesh-list
14401925|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
14401926|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14401927|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401928|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
14401929|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14401930|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14401931|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14401932|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
14401933|NCT01465802|Hormones|hormones|mesh-ancestor
14401934|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14401935|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401936|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14401937|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
14401938|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14401939|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
14401940|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
14401941|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401942|NCT01465997|Lacosamide|lacosamide|mesh-list
14737050|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15240132|NCT04218357|Renal Agents|renal agents|mesh-ancestor
15240133|NCT04190056|Tamoxifen|tamoxifen|mesh-list
15240134|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
15240135|NCT04190056|Vorinostat|vorinostat|mesh-list
15240136|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14401943|NCT01465997|Carbamazepine|carbamazepine|mesh-list
14924381|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15240137|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240138|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15240139|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
15240140|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240141|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240142|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240143|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15240144|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15240145|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15240146|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15240147|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240148|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240149|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
15240150|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401944|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
14401945|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14401946|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14401947|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14401948|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401949|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
14401950|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14401951|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14401952|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401953|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14401954|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14401955|NCT01465997|Analgesics|analgesics|mesh-ancestor
14401956|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
14401957|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401958|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14401959|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14401960|NCT01466062|Palivizumab|palivizumab|mesh-list
14401961|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
14401962|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401963|NCT01466127|Oxytocin|oxytocin|mesh-list
14401964|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
14401965|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14401966|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401967|NCT01466153|Rituximab|rituximab|mesh-list
14401968|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14401969|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14401970|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401971|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
14401972|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401973|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14401974|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14401975|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
14401976|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401977|NCT01466179|Blinatumomab|blinatumomab|mesh-list
14401978|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14401979|NCT01466192|Ribavirin|ribavirin|mesh-list
14401980|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14401981|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
14401982|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401983|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
14401984|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14401985|NCT01466270|Donepezil|donepezil|mesh-list
14401986|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14401987|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14401988|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14401989|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
14401990|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14401991|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14401992|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
14401993|NCT01466348|Acetaminophen|acetaminophen|mesh-list
14401994|NCT01466348|Caffeine|caffeine|mesh-list
14401995|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14401996|NCT01466348|Analgesics|analgesics|mesh-ancestor
14401997|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
14401998|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14401999|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402000|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
14402001|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14402002|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14402003|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402004|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402005|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14402006|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14924382|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924383|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14924384|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14924385|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924386|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
14931082|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402007|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
14402008|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402009|NCT01466361|Nicotine|nicotine|mesh-list
14402010|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14402011|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
14402012|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402013|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402014|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14402015|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14402016|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
14402017|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737051|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737052|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737053|NCT00547287|Urological Agents|urological agents|mesh-ancestor
14737054|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
14737055|NCT00547352|Tadalafil|tadalafil|mesh-list
14402018|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402019|NCT01466387|Vaccines|vaccines|mesh-list
14402020|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
14402021|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402022|NCT01466491|Lidocaine|lidocaine|mesh-list
14402023|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
14402024|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
14402025|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402026|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402027|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
14402028|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402029|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14402030|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14402031|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14402032|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402033|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402034|NCT01466595|Rifaximin|rifaximin|mesh-list
14402035|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402036|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402037|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402038|NCT01466660|Gefitinib|gefitinib|mesh-list
14402039|NCT01466660|Afatinib|afatinib|mesh-list
14737056|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737057|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737058|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15240151|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
15240152|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
15240153|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15240154|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
15240155|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15240156|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240157|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15240158|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15240159|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15240160|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15240161|NCT04136366|Methotrexate|methotrexate|mesh-list
15240162|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15240163|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
14402040|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402041|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737059|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737060|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737061|NCT00547352|Urological Agents|urological agents|mesh-ancestor
14737062|NCT00547417|Tadalafil|tadalafil|mesh-list
14737063|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737064|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737065|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737066|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737067|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737068|NCT00547417|Urological Agents|urological agents|mesh-ancestor
14737069|NCT00547443|Paclitaxel|paclitaxel|mesh-list
14737070|NCT00547443|Carboplatin|carboplatin|mesh-list
14737071|NCT00547443|Sorafenib|sorafenib|mesh-list
14737072|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14737073|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240164|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15240165|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240166|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15240167|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
15240168|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737074|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
14737075|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737076|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737077|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737078|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737079|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737080|NCT00547495|Tadalafil|tadalafil|mesh-list
14402042|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402043|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402044|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
14402045|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14402046|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14402047|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14737081|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
15240169|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240170|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
15240171|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240172|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15240173|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240174|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
15240175|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240176|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15240177|NCT04112641|Niacinamide|niacinamide|mesh-list
15240178|NCT04112641|Niacin|niacin|mesh-list
15240179|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
15240180|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
15240181|NCT04112641|Vitamins|vitamins|mesh-ancestor
15240182|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
15240183|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240184|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15240185|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
15240186|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240187|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15240188|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
15240189|NCT04108962|Benralizumab|benralizumab|mesh-list
15240190|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15240191|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
15240192|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
15240193|NCT04090684|Celecoxib|celecoxib|mesh-list
15240194|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15240195|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15240196|NCT04090684|Analgesics|analgesics|mesh-ancestor
15240197|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
15240198|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240199|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240200|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240201|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240202|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14737082|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737083|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737084|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240203|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15240204|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402048|NCT01466673|Desogestrel|desogestrel|mesh-list
14402049|NCT01466673|Norgestimate|norgestimate|mesh-list
14402050|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14737085|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737086|NCT00547495|Urological Agents|urological agents|mesh-ancestor
14737087|NCT00547508|Tadalafil|tadalafil|mesh-list
14737088|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737089|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737090|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737091|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737092|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737093|NCT00547508|Urological Agents|urological agents|mesh-ancestor
14737094|NCT00547547|Selenium|selenium|mesh-list
14737095|NCT00547547|Capecitabine|capecitabine|mesh-list
14737096|NCT00547547|Irinotecan|irinotecan|mesh-list
14737097|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737098|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
14737099|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737100|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737101|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14737102|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737103|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737104|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
14737105|NCT00547547|Protective Agents|protective agents|mesh-ancestor
14737106|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737107|NCT00547547|Trace Elements|trace elements|mesh-ancestor
14737108|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
14737109|NCT00547573|Tadalafil|tadalafil|mesh-list
14737110|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737111|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737112|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737113|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737114|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737115|NCT00547573|Urological Agents|urological agents|mesh-ancestor
14737116|NCT00547599|Tadalafil|tadalafil|mesh-list
14737117|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737118|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737119|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737120|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737121|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737122|NCT00547599|Urological Agents|urological agents|mesh-ancestor
14402051|NCT01466673|Estradiol|estradiol|mesh-list
14402052|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14402053|NCT01466673|Estrogens|estrogens|mesh-ancestor
14402054|NCT01466673|Hormones|hormones|mesh-ancestor
14402055|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737123|NCT00547612|Substance P|substance p|mesh-list
14737124|NCT00547612|Neurokinin A|neurokinin a|mesh-list
14737125|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402056|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402057|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14402058|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
14402059|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14402060|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14402061|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14402062|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14402063|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14737126|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737127|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737128|NCT00547625|Tadalafil|tadalafil|mesh-list
14737129|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737130|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14737131|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737132|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737133|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737134|NCT00547625|Urological Agents|urological agents|mesh-ancestor
14737135|NCT00547664|Morphine|morphine|mesh-list
14737136|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14737137|NCT00547664|Narcotics|narcotics|mesh-ancestor
14737138|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737139|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737140|NCT00547664|Analgesics|analgesics|mesh-ancestor
14737141|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
14737142|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737143|NCT00547768|Fexofenadine|fexofenadine|mesh-list
14737144|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14737145|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14737146|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14737147|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
14737148|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
14402064|NCT01466673|Progestins|progestins|mesh-ancestor
14402065|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402066|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402067|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14402068|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14402069|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402070|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402071|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402072|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14402073|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14402074|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402075|NCT01466790|Ribavirin|ribavirin|mesh-list
14402076|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
14402077|NCT01466790|Simeprevir|simeprevir|mesh-list
14402078|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
14402079|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402080|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
14402081|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402082|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
14402083|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402084|NCT01467076|Alprostadil|alprostadil|mesh-list
14402085|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14402086|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
14402087|NCT01467076|Urological Agents|urological agents|mesh-ancestor
14402088|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
14402089|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14402090|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
14402091|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737149|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402092|NCT01467466|Expectorants|expectorants|mesh-ancestor
14402093|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
14402094|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14402095|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
14402096|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402097|NCT01467466|Protective Agents|protective agents|mesh-ancestor
14402098|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402099|NCT01467466|Antidotes|antidotes|mesh-ancestor
14402100|NCT01467479|Interferons|interferons|mesh-list
14402101|NCT01467479|Ribavirin|ribavirin|mesh-list
14402102|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
14402103|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
14402104|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14402105|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14402106|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402107|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
14402108|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402109|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
14402110|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402111|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
14402112|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402113|NCT01467492|Interferons|interferons|mesh-list
14402114|NCT01467492|Ribavirin|ribavirin|mesh-list
14402115|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
14402116|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
14402117|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14924387|NCT01397630|Oxytocin|oxytocin|mesh-list
14924388|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
14924389|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14924390|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924391|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
14402118|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402119|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
14402120|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402121|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
14402122|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402123|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
14402124|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402125|NCT01467505|Interferons|interferons|mesh-list
14402126|NCT01467505|Ribavirin|ribavirin|mesh-list
14402127|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
14402128|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
14402129|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14402130|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14402131|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737150|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737151|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737152|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
14737153|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14737154|NCT00547885|Narcotics|narcotics|mesh-ancestor
14737155|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737156|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737157|NCT00547885|Analgesics|analgesics|mesh-ancestor
14737158|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
14737159|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737160|NCT00547989|Bupivacaine|bupivacaine|mesh-list
14737161|NCT00547989|Ropivacaine|ropivacaine|mesh-list
14737162|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
14737163|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
14737164|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737165|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402132|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
14402133|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402134|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
14737166|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
14737167|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737168|NCT00548002|Levofloxacin|levofloxacin|mesh-list
14737169|NCT00548002|Ofloxacin|ofloxacin|mesh-list
14402135|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402136|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
14402137|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467235|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14467236|NCT02257632|Growth Substances|growth substances|mesh-ancestor
14467237|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467238|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
14467239|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467240|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14467241|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
14467242|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14467243|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14467244|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
14467245|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467246|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
14467247|NCT02257957|Protective Agents|protective agents|mesh-ancestor
14467248|NCT02257970|Ketoprofen|ketoprofen|mesh-list
14467249|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467250|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467251|NCT02257970|Analgesics|analgesics|mesh-ancestor
14467252|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
14467253|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467254|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467255|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467256|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467257|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14467258|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467259|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467260|NCT02258074|Niacinamide|niacinamide|mesh-list
14467261|NCT02258074|Niacin|niacin|mesh-list
14467262|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
14467263|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
14467264|NCT02258074|Vitamins|vitamins|mesh-ancestor
14467265|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
14467266|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467267|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14467268|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
14467269|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467270|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14467271|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
14467272|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14467273|NCT02258217|Hormones|hormones|mesh-ancestor
14467274|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467275|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737170|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
14737171|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14737172|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737173|NCT00548002|Renal Agents|renal agents|mesh-ancestor
14737174|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14737175|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14737176|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737177|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737178|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467276|NCT02258334|Vaccines|vaccines|mesh-list
14467277|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
14737179|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240205|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240206|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15240207|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240208|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15240209|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15240210|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240211|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15240212|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15240213|NCT04051619|Oxytocin|oxytocin|mesh-list
15240214|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
15240215|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14467278|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467279|NCT02258412|Ethanol|ethanol|mesh-list
14467280|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14467281|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
14467282|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402138|NCT01467583|PENTA|penta|mesh-list
14402139|NCT01467583|Fondaparinux|fondaparinux|mesh-list
14402140|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14402141|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
14402142|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14402143|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
14402144|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402145|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402146|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
14402147|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14402148|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14402149|NCT01467661|Anagrelide|anagrelide|mesh-list
14402150|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14402151|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14402152|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402153|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14402154|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14402155|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
14402156|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14402157|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
14737180|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14737181|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14737182|NCT00548067|Amlodipine|amlodipine|mesh-list
14737183|NCT00548067|Valsartan|valsartan|mesh-list
14737184|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14737185|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14737186|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14737187|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737188|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737189|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14737190|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737191|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737192|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14737193|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14737194|NCT00548067|Diuretics|diuretics|mesh-ancestor
14737195|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
14737196|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14737197|NCT00548080|Caspofungin|caspofungin|mesh-list
14931083|NCT01437462|Propofol|propofol|mesh-list
14402158|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14737198|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
14402159|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402160|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14402161|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14402162|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402163|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14402164|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14402165|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14402166|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14402167|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
14402168|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737199|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737200|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737201|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737202|NCT00548288|Pamidronate|pamidronate|mesh-list
14737203|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14737204|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737205|NCT00548301|Cyclosporine|cyclosporine|mesh-list
14737206|NCT00548301|Cyclosporins|cyclosporins|mesh-list
14737207|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737208|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737209|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737210|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
14737211|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737212|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
14402169|NCT01467999|Guanfacine|guanfacine|mesh-list
14402170|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14402171|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14402172|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14402173|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14753158|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
14402174|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
14402175|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402176|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402177|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402178|NCT01468012|Levodopa|levodopa|mesh-list
14402179|NCT01468012|Carbidopa|carbidopa|mesh-list
14402180|NCT01468012|Entacapone|entacapone|mesh-list
14402181|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14402182|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14402183|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14402184|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
14402185|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402186|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402187|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402188|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14402189|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402190|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14402191|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14402192|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
14402193|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
14402194|NCT01468181|Dulaglutide|dulaglutide|mesh-list
14402195|NCT01468181|Biguanides|biguanides|mesh-list
14402196|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14402197|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14402198|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14402199|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402200|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402201|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402202|NCT01468207|Adalimumab|adalimumab|mesh-list
14402203|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402204|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402205|NCT01468233|Adalimumab|adalimumab|mesh-list
14402206|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402207|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402208|NCT01468311|Daclizumab|daclizumab|mesh-list
14402209|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14402210|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
14402211|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402212|NCT01468337|Interferons|interferons|mesh-list
14402213|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
14402214|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402215|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
14402216|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402217|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
14402218|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14924392|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402219|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402220|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402221|NCT01468532|Prednisone|prednisone|mesh-list
14402222|NCT01468532|Docetaxel|docetaxel|mesh-list
14402223|NCT01468532|Pasireotide|pasireotide|mesh-list
14402224|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402225|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
14402226|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
14402227|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
14402228|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402229|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402230|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
14402231|NCT01468532|Hormones|hormones|mesh-ancestor
14402232|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402233|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402234|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14402235|NCT01468558|Ketoconazole|ketoconazole|mesh-list
14402236|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
15240216|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240217|NCT04045301|Omalizumab|omalizumab|mesh-list
15240218|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15240219|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15240220|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15240221|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
15240222|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
14402237|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402238|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14402239|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14402240|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402241|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402242|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14402243|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
14402244|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402245|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402246|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14402247|NCT01468584|Ribavirin|ribavirin|mesh-list
14402248|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14402249|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
14402250|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402251|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
14402252|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402253|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
14402254|NCT01468818|Fludarabine|fludarabine|mesh-list
14402255|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14402256|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
14402257|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402258|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402259|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14402260|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
14402261|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402262|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402263|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14737213|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737214|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
14402264|NCT01468844|Minocycline|minocycline|mesh-list
14402265|NCT01468844|Bevacizumab|bevacizumab|mesh-list
14402266|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14402267|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402268|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14402269|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14402270|NCT01468844|Growth Substances|growth substances|mesh-ancestor
14402271|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402272|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
14402273|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402274|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402275|NCT01468909|Paclitaxel|paclitaxel|mesh-list
14402276|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14402277|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14402278|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402279|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
14402280|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
14402281|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
14402282|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402283|NCT01468987|Insulin|insulin|mesh-list
14402284|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14402285|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
14402286|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
14737215|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737216|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14737217|NCT00548379|Vitamin D|vitamin d|mesh-list
14737218|NCT00548379|Vitamins|vitamins|mesh-ancestor
14737219|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
14737220|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737221|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14737222|NCT00548483|Dexamethasone|dexamethasone|mesh-list
15240223|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240224|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
15240225|NCT04033107|Metformin|metformin|mesh-list
15240226|NCT04033107|Vitamins|vitamins|mesh-ancestor
15240227|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
15240228|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240229|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15240230|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
14402287|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15240231|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737223|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14737224|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
14737225|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
14737226|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737227|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737228|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14737229|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
14737230|NCT00548483|Hormones|hormones|mesh-ancestor
14402288|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402289|NCT01469000|Pemetrexed|pemetrexed|mesh-list
14402290|NCT01469000|Gefitinib|gefitinib|mesh-list
14402291|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402292|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402293|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402294|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14402295|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14402296|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737231|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737232|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14737233|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737234|NCT00548509|Vitamin K|vitamin k|mesh-list
14737235|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
14737236|NCT00548509|Menatetrenone|menatetrenone|mesh-list
14737237|NCT00548509|Vitamins|vitamins|mesh-ancestor
14402297|NCT01469013|Methotrexate|methotrexate|mesh-list
14402298|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14402299|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
14402300|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14402301|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402302|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14402303|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
14402304|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240232|NCT04033107|Protective Agents|protective agents|mesh-ancestor
14737238|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
14737239|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402305|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737240|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14737241|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14737242|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737243|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
14737244|NCT00548509|Coagulants|coagulants|mesh-ancestor
14737245|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
14737246|NCT00548561|Razoxane|razoxane|mesh-list
14737247|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737248|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14737249|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14737250|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737251|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737252|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737253|NCT00548561|Protective Agents|protective agents|mesh-ancestor
14737254|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737255|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737256|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737257|NCT00548574|Mesalamine|mesalamine|mesh-list
14737258|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14737259|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14737260|NCT00548574|Analgesics|analgesics|mesh-ancestor
14737261|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
14737262|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737263|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737264|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14737265|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737266|NCT00548678|Aspirin|aspirin|mesh-list
14737267|NCT00548678|Diclofenac|diclofenac|mesh-list
14737268|NCT00548678|Ketorolac|ketorolac|mesh-list
14737269|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14737270|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14737271|NCT00548678|Analgesics|analgesics|mesh-ancestor
14402306|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
14402307|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402308|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14402309|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14402310|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
14402311|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402312|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14402313|NCT01469052|Axitinib|axitinib|mesh-list
14402314|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402315|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14402316|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402317|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402318|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
14402319|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14402320|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737272|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
14737273|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737274|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737275|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14737276|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402321|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402322|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
14402323|NCT01469065|Vitamins|vitamins|mesh-ancestor
14402324|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
14402325|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402326|NCT01469221|Apaziquone|apaziquone|mesh-list
14402327|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402328|NCT01469234|Loratadine|loratadine|mesh-list
14737277|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14737278|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14402329|NCT01469234|Fexofenadine|fexofenadine|mesh-list
14924393|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
14402330|NCT01469234|Terfenadine|terfenadine|mesh-list
14402331|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
14402332|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
14402333|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14402334|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14402335|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14402336|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
14402337|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
14402338|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402339|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402340|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402341|NCT01469364|Aztreonam|aztreonam|mesh-list
14402342|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402343|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402344|NCT01469377|Cariprazine|cariprazine|mesh-list
14402345|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14402346|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14402347|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240233|NCT04006457|Vaccines|vaccines|mesh-list
15240234|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
15240235|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240236|NCT03950245|Glucagon|glucagon|mesh-list
15240237|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15240238|NCT03950245|Incretins|incretins|mesh-ancestor
15240239|NCT03950245|Hormones|hormones|mesh-ancestor
15240240|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240241|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402348|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402349|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14737279|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737280|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14737281|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14737282|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737283|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
14737284|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
14737285|NCT00548704|Razoxane|razoxane|mesh-list
14737286|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737287|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14737288|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15240242|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402350|NCT01469546|Axitinib|axitinib|mesh-list
14402351|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240243|NCT03939104|Artesunate|artesunate|mesh-list
14737289|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14402352|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14402353|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402354|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402355|NCT01469585|Doxycycline|doxycycline|mesh-list
14402356|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402357|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402358|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
14402359|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14402360|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14402361|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
14402362|NCT01469637|Mesalamine|mesalamine|mesh-list
14402363|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402364|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15240244|NCT03939104|Lumefantrine|lumefantrine|mesh-list
15240245|NCT03939104|Artemether|artemether|mesh-list
15240246|NCT03939104|Piperaquine|piperaquine|mesh-list
15240247|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15240248|NCT03939104|Amodiaquine|amodiaquine|mesh-list
14402365|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14402366|NCT01469637|Analgesics|analgesics|mesh-ancestor
14402367|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
14402368|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402369|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402370|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402371|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402372|NCT01469767|Fluocinonide|fluocinonide|mesh-list
14402373|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402374|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
14402375|NCT01469767|Hormones|hormones|mesh-ancestor
14402376|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402377|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402378|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14402379|NCT01469819|Lubiprostone|lubiprostone|mesh-list
14402380|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14402381|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402382|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402383|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
14402384|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14402385|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14402386|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
14402387|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402388|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402389|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402390|NCT01470001|Urological Agents|urological agents|mesh-ancestor
14402391|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
14402392|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14402393|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
14402394|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402395|NCT01470027|Expectorants|expectorants|mesh-ancestor
15240249|NCT03939104|Mefloquine|mefloquine|mesh-list
15240250|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
15240251|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15240252|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15240253|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402396|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
14402397|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14402398|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
14402399|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402400|NCT01470027|Protective Agents|protective agents|mesh-ancestor
14402401|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402402|NCT01470027|Antidotes|antidotes|mesh-ancestor
14402403|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14402404|NCT01470118|Dextrans|dextrans|mesh-list
15240254|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240255|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
14402405|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14402406|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14402407|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
14402408|NCT01470118|Alcaftadine|alcaftadine|mesh-list
14402409|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
14402410|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
14737290|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737291|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737292|NCT00548704|Protective Agents|protective agents|mesh-ancestor
14737293|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737294|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737295|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737296|NCT00548821|Cisplatin|cisplatin|mesh-list
14737297|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240256|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
15240257|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15240258|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
14402411|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
14402412|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14402413|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14402414|NCT01470118|Analgesics|analgesics|mesh-ancestor
14402415|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
14402416|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402417|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402418|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402419|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402420|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14402421|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14402422|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14402423|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
14402424|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
15240259|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15240260|NCT03913091|Bupivacaine|bupivacaine|mesh-list
15240261|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
15240262|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
15240263|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240264|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240265|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
15240266|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240267|NCT03906136|Adalimumab|adalimumab|mesh-list
15240268|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240269|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240270|NCT03893955|Paclitaxel|paclitaxel|mesh-list
15240271|NCT03893955|Carboplatin|carboplatin|mesh-list
15240272|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15240273|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240274|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
15240275|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
14402425|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737298|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
15240276|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
15240277|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402426|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402427|NCT01470144|Epoprostenol|epoprostenol|mesh-list
14402428|NCT01470144|Tezosentan|tezosentan|mesh-list
14402429|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14402430|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15240278|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15240279|NCT03889249|Tenecteplase|tenecteplase|mesh-list
15240280|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15240281|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15240282|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240283|NCT03858322|Paclitaxel|paclitaxel|mesh-list
15240284|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
15240285|NCT03858322|Carboplatin|carboplatin|mesh-list
15240286|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15240287|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402431|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
14402432|NCT01470170|Alfentanil|alfentanil|mesh-list
14402433|NCT01470170|Propofol|propofol|mesh-list
14402434|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14402435|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402436|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402437|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14402438|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
14402439|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
14402440|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14402441|NCT01470170|Narcotics|narcotics|mesh-ancestor
14402442|NCT01470170|Analgesics|analgesics|mesh-ancestor
14402443|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
14402444|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402445|NCT01470196|Dexamethasone|dexamethasone|mesh-list
14402446|NCT01470196|Rituximab|rituximab|mesh-list
15240288|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
15240289|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
15240290|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
15240291|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240292|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240293|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
15240294|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240295|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240296|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240297|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
15240298|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14402447|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240299|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
15240300|NCT03822637|Albuterol|albuterol|mesh-list
14402448|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
15240301|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15240302|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14737299|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737300|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
14737301|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737302|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737303|NCT00548899|Sorafenib|sorafenib|mesh-list
14402449|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
14402450|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402451|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402452|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402453|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
14737304|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737305|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737306|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737307|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737308|NCT00548938|Temozolomide|temozolomide|mesh-list
14737309|NCT00548938|Carmustine|carmustine|mesh-list
14737310|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14737311|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
15240303|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
15240304|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240305|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240306|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14402454|NCT01470196|Hormones|hormones|mesh-ancestor
15240307|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
15240308|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
15240309|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15240310|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15240311|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15240312|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15240313|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
15240314|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402455|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402456|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14402457|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402458|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240315|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240316|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
14402459|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
14402460|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402461|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
15240317|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240318|NCT03822637|Expectorants|expectorants|mesh-ancestor
15240319|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15240320|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
15240321|NCT03822637|Protective Agents|protective agents|mesh-ancestor
15240322|NCT03822637|Antidotes|antidotes|mesh-ancestor
15240323|NCT03802591|Capecitabine|capecitabine|mesh-list
15240324|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
14402462|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402463|NCT01470417|Gemcitabine|gemcitabine|mesh-list
14402464|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14402465|NCT01470417|Paclitaxel|paclitaxel|mesh-list
14402466|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14402467|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
15240325|NCT03802591|Antibodies|antibodies|mesh-list
15240326|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14402468|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402469|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402470|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
14402471|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402472|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402473|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14402474|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
14402475|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402476|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14402477|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14402478|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14402479|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14402480|NCT01470469|Guanfacine|guanfacine|mesh-list
14402481|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14402482|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14402483|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15240327|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
14737312|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737313|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737314|NCT00548964|Ketamine|ketamine|mesh-list
14737315|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
14737316|NCT00548964|Analgesics|analgesics|mesh-ancestor
14737317|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
14737318|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737319|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737320|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14737321|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14737322|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
14737323|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
14737324|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402484|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14402485|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
14402486|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402487|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402488|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402489|NCT01470599|Tofacitinib|tofacitinib|mesh-list
14402490|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14402491|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402492|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402493|NCT01470612|Tofacitinib|tofacitinib|mesh-list
15240328|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402494|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14402495|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402496|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402497|NCT01470651|Modafinil|modafinil|mesh-list
14402498|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14402499|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240329|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15240330|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
15240331|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402500|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14402501|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14402502|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14402503|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402504|NCT01470859|Levodopa|levodopa|mesh-list
14402505|NCT01470859|Carbidopa|carbidopa|mesh-list
14402506|NCT01470859|Pramipexole|pramipexole|mesh-list
14402507|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14402508|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14402509|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14402510|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
14402511|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402512|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402513|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402514|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14402515|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402516|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
14402517|NCT01470859|Protective Agents|protective agents|mesh-ancestor
14402518|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
14402519|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14402520|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
14402521|NCT01470989|Triamcinolone|triamcinolone|mesh-list
14402522|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14402523|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14737325|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14737326|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14737327|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737328|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737329|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
14737330|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15240332|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240333|NCT03802565|Tolperisone|tolperisone|mesh-list
15240334|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15240335|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240336|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14737331|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737332|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
14737333|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14737334|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
14402524|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14402525|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402526|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
14402527|NCT01470989|Hormones|hormones|mesh-ancestor
14402528|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402529|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737335|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14737336|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737337|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737338|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14737339|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402530|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14402531|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
14402532|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402533|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402534|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
14402535|NCT01471015|Hematinics|hematinics|mesh-ancestor
15240337|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240338|NCT03763422|Temozolomide|temozolomide|mesh-list
15240339|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240340|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
15240341|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240342|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240343|NCT03752307|Prednisone|prednisone|mesh-list
15240344|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
15240345|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
14402536|NCT01471054|Dexamethasone|dexamethasone|mesh-list
14402537|NCT01471054|Bevacizumab|bevacizumab|mesh-list
14402538|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14402539|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402540|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14402541|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14402542|NCT01471054|Growth Substances|growth substances|mesh-ancestor
14402543|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402544|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
14402545|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240346|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402546|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
14402547|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
14402548|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402549|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402550|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
14402551|NCT01471054|Hormones|hormones|mesh-ancestor
14402552|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402553|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14402554|NCT01471093|Rebamipide|rebamipide|mesh-list
14402555|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14402556|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14402557|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14402558|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402559|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
14402560|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402561|NCT01471093|Protective Agents|protective agents|mesh-ancestor
14402562|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402563|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402564|NCT01471171|Bromides|bromides|mesh-list
14737340|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14753159|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14753160|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14753161|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14753162|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14753163|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
14753164|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753165|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14753166|NCT05248984|Ketorolac|ketorolac|mesh-list
14753167|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15240347|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
15240348|NCT03752307|Hormones|hormones|mesh-ancestor
15240349|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240350|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240351|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240352|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240353|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
15240354|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
15240355|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240356|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15240357|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15240358|NCT03752307|Protective Agents|protective agents|mesh-ancestor
14924394|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924395|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924396|NCT01397994|Nicorandil|nicorandil|mesh-list
14924397|NCT01397994|Atenolol|atenolol|mesh-list
14924398|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14924399|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14924400|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
14924401|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
14924402|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924403|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240359|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14402565|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
14402566|NCT01471197|Pemetrexed|pemetrexed|mesh-list
14402567|NCT01471197|Ipilimumab|ipilimumab|mesh-list
14402568|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402569|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402570|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402571|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14402572|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14402573|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14402574|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14402575|NCT01471353|Capecitabine|capecitabine|mesh-list
14402576|NCT01471353|Sorafenib|sorafenib|mesh-list
15240360|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15240361|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
14924404|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15240362|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240363|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402577|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14402578|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
14402579|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402580|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402581|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14402582|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402583|NCT01471379|Milnacipran|milnacipran|mesh-list
14402584|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
14402585|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14402586|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14402587|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402588|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402589|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737341|NCT00549107|Simendan|simendan|mesh-list
15240364|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
15240365|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
15240366|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
15240367|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15240368|NCT03740334|Dexamethasone|dexamethasone|mesh-list
15240369|NCT03740334|Everolimus|everolimus|mesh-list
15240370|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240371|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
15240372|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
15240373|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240374|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240375|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15240376|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
15240377|NCT03740334|Hormones|hormones|mesh-ancestor
15240378|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240379|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240380|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240381|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240382|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
15240383|NCT03734653|Testosterone|testosterone|mesh-list
14737342|NCT00549107|Milrinone|milrinone|mesh-list
14737343|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14737344|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737345|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14737346|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14737347|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402590|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402591|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14402592|NCT01471379|Analgesics|analgesics|mesh-ancestor
14402593|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
14402594|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402595|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
14402596|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402597|NCT01471574|Interferons|interferons|mesh-list
14402598|NCT01471574|Ribavirin|ribavirin|mesh-list
14402599|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
14402600|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
14402601|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14402602|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402603|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
14402604|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402605|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
14402606|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402607|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
14402608|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402609|NCT01471639|Ketorolac|ketorolac|mesh-list
14402610|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14402611|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14402612|NCT01471639|Analgesics|analgesics|mesh-ancestor
14402613|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
14402614|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402615|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402616|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402617|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14402618|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14402619|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402620|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737348|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737349|NCT00549107|Protective Agents|protective agents|mesh-ancestor
14737350|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737351|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14737352|NCT00549120|Propranolol|propranolol|mesh-list
14737353|NCT00549120|Albuterol|albuterol|mesh-list
15240384|NCT03734653|Androgens|androgens|mesh-ancestor
14737354|NCT00549120|Ipratropium|ipratropium|mesh-list
14737355|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14737356|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14737357|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
14402621|NCT01471691|Ranibizumab|ranibizumab|mesh-list
14737358|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737359|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737360|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737361|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15240385|NCT03734653|Hormones|hormones|mesh-ancestor
15240386|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240387|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240388|NCT03637556|Deferasirox|deferasirox|mesh-list
15240389|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15240390|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
14737362|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14737363|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
14737364|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14737365|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
14737366|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737367|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14737368|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
14737369|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
14737370|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14737371|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14737372|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14737373|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14737374|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14737375|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
14737376|NCT00549133|Irbesartan|irbesartan|mesh-list
14737377|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14737378|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14737379|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14737380|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737381|NCT00549146|Fluticasone|fluticasone|mesh-list
14737382|NCT00549146|Xhance|xhance|mesh-list
14737383|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14737384|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14737385|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14737386|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14737387|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
15240391|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
14737388|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737389|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240392|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240393|NCT03627897|Bupivacaine|bupivacaine|mesh-list
15240394|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
15240395|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
15240396|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240397|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240398|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
15240399|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240400|NCT03603184|Paclitaxel|paclitaxel|mesh-list
15240401|NCT03603184|Carboplatin|carboplatin|mesh-list
15240402|NCT03603184|Atezolizumab|atezolizumab|mesh-list
14924405|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14924406|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14924407|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
14924408|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924409|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924410|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
14924411|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
14924412|NCT01397994|Vitamins|vitamins|mesh-ancestor
14924413|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
14924414|NCT01398033|Paclitaxel|paclitaxel|mesh-list
14924415|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14924416|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924417|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
14737390|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14737391|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
14737392|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
14737393|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14737394|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14737395|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14737396|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14737397|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
14737398|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737399|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737400|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
14737401|NCT00549146|Hormones|hormones|mesh-ancestor
14737402|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737403|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
14737404|NCT00549289|Cyclosporine|cyclosporine|mesh-list
14737405|NCT00549289|Cyclosporins|cyclosporins|mesh-list
14737406|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737407|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737408|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737409|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
14737410|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737411|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
14737412|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402622|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14737413|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
14737414|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737415|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14737416|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
14737417|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14737418|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737419|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737420|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
14737421|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737422|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737423|NCT00549419|Dobutamine|dobutamine|mesh-list
14737424|NCT00549419|Norepinephrine|norepinephrine|mesh-list
14737425|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14737426|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14737427|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
14737428|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737429|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737430|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737431|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
14737432|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
14737433|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924418|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
14924419|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737434|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14402623|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14402624|NCT01471691|Growth Substances|growth substances|mesh-ancestor
14402625|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402626|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
14402627|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402628|NCT01471782|Blinatumomab|blinatumomab|mesh-list
14402629|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737435|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14737436|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14737437|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14737438|NCT00549419|Protective Agents|protective agents|mesh-ancestor
14737439|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
14737440|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14737441|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14737442|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14737443|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737444|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737445|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
14737446|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737447|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737448|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14737449|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737450|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
14737451|NCT00549536|Calcium|calcium|mesh-list
14737452|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14737453|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737454|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14737455|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
14737456|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14737457|NCT00549588|Protective Agents|protective agents|mesh-ancestor
14737458|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737459|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
14737460|NCT00549614|Acipimox|acipimox|mesh-list
14737461|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14737462|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
14737463|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737464|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14737465|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
14402630|NCT01472185|Ranolazine|ranolazine|mesh-list
14737466|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14402631|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14402632|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402633|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402634|NCT01472380|Efavirenz|efavirenz|mesh-list
14402635|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
14402636|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14737467|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14737468|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14737469|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14737470|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737471|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737472|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14737473|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14737474|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14737475|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14737476|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
14737477|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737478|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737479|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14737480|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14737481|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
14737482|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14737483|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14737484|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
14737485|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14737486|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
14737487|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14737488|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14737489|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14737490|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14737491|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14737492|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402637|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14402638|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402639|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402640|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
15240403|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15240404|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240405|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
15240406|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
15240407|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
15240408|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240409|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
15240410|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
14402641|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402642|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14402643|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14402644|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14402645|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14402646|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14402647|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14402648|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14402649|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14402650|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
14402651|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14402652|NCT01472432|Vildagliptin|vildagliptin|mesh-list
14737493|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14737494|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737495|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737496|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737497|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
14737498|NCT00549874|Glyburide|glyburide|mesh-list
14737499|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737500|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737501|NCT00549887|Insulin|insulin|mesh-list
14737502|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14737503|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737504|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737505|NCT00549926|Atorvastatin|atorvastatin|mesh-list
14737506|NCT00549926|Pravastatin|pravastatin|mesh-list
14737507|NCT00549926|Pitavastatin|pitavastatin|mesh-list
14737508|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14737509|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14737510|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
15240411|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240412|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402653|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14402654|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402655|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14402656|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
14402657|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402658|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402659|NCT01472445|Vitamin D|vitamin d|mesh-list
14931084|NCT01437462|Sevoflurane|sevoflurane|mesh-list
14931085|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14931086|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931087|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931088|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14931089|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
14931090|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
14931091|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14931092|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14931093|NCT01437566|Fulvestrant|fulvestrant|mesh-list
14931094|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931095|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240413|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240414|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
15240415|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
15240416|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
15240417|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
15240418|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240419|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240420|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240421|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
14737511|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737512|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14737513|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14737514|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737515|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
14737516|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14737517|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737518|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737519|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14737520|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737521|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14737522|NCT00550004|Gemcitabine|gemcitabine|mesh-list
14737523|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737524|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
14737525|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737526|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737527|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
14737528|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737529|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737530|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737531|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
14737532|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737533|NCT00550095|Valsartan|valsartan|mesh-list
14737534|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14737535|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15240422|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
15240423|NCT03502031|Losartan|losartan|mesh-list
15240424|NCT03502031|Valsartan|valsartan|mesh-list
15240425|NCT03502031|Enalapril|enalapril|mesh-list
15240426|NCT03502031|Enalaprilat|enalaprilat|mesh-list
15240427|NCT03502031|Lisinopril|lisinopril|mesh-list
14402660|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
14402661|NCT01472445|Vitamins|vitamins|mesh-ancestor
14402662|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
14402663|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402664|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15240428|NCT03502031|Perindopril|perindopril|mesh-list
15240429|NCT03502031|Spironolactone|spironolactone|mesh-list
15240430|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15240431|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14402665|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14402666|NCT01472549|Ethanol|ethanol|mesh-list
14402667|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
14402668|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14737536|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14737537|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924420|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924421|NCT01398046|Dasatinib|dasatinib|mesh-list
14924422|NCT01398046|Rabeprazole|rabeprazole|mesh-list
14924423|NCT01398046|Betaine|betaine|mesh-list
14402669|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402670|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402671|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402672|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
14402673|NCT01472835|Fentanyl|fentanyl|mesh-list
15240432|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15240433|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402674|NCT01472835|Midazolam|midazolam|mesh-list
14402675|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14402676|NCT01472835|Narcotics|narcotics|mesh-ancestor
14402677|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402678|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402679|NCT01472835|Analgesics|analgesics|mesh-ancestor
14402680|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
14402681|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402682|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14924424|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924425|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924426|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924427|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924428|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14924429|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14924430|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14924431|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
14924432|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15240434|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14737538|NCT00550108|Ethanol|ethanol|mesh-list
14737539|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14737540|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737541|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737542|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737543|NCT00550121|Ascorbic Acid|ascorbic acid|mesh-list
14737544|NCT00550121|Vitamins|vitamins|mesh-ancestor
14737545|NCT00550121|Micronutrients|micronutrients|mesh-ancestor
14737546|NCT00550121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737547|NCT00550121|Antioxidants|antioxidants|mesh-ancestor
14737548|NCT00550121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737549|NCT00550121|Protective Agents|protective agents|mesh-ancestor
14737550|NCT00550160|Artesunate|artesunate|mesh-list
14737551|NCT00550160|Amodiaquine|amodiaquine|mesh-list
14737552|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
14737553|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15240435|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15240436|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
14737554|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14737555|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737556|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737557|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
14737558|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
14737559|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14737560|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
14737561|NCT00550199|Gemcitabine|gemcitabine|mesh-list
14737562|NCT00550199|Panobinostat|panobinostat|mesh-list
14737563|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737564|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
14737565|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737566|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737567|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
14737568|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737569|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737570|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737571|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
14737572|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737573|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14737574|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
14737575|NCT00550303|Estrogens|estrogens|mesh-list
14737576|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14737577|NCT00550303|Hormones|hormones|mesh-ancestor
14737578|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737579|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737580|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15240437|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240438|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240439|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15240440|NCT03502031|Diuretics|diuretics|mesh-ancestor
14924433|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
14924434|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14737581|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14737582|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
15240441|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
15240442|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15240443|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
15240444|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240445|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15240446|NCT03502031|Protective Agents|protective agents|mesh-ancestor
15240447|NCT03452111|ST 1435|st 1435|mesh-list
15240448|NCT03452111|Testosterone|testosterone|mesh-list
15240449|NCT03452111|Androgens|androgens|mesh-ancestor
14402683|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14402684|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
14402685|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
14402686|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14402687|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14402688|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14402689|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402690|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
14402691|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
14402692|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402693|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402694|NCT01472874|Trientine|trientine|mesh-list
14402695|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
14402696|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
14402697|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402698|NCT01472965|Ethanol|ethanol|mesh-list
14402699|NCT01472965|Heparin|heparin|mesh-list
14737583|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15240450|NCT03452111|Hormones|hormones|mesh-ancestor
14402700|NCT01472965|Calcium heparin|calcium heparin|mesh-list
14402701|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
14402702|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15240451|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240452|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240453|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15240454|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
15240455|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15240456|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15240457|NCT03441555|Venetoclax|venetoclax|mesh-list
15240458|NCT03441555|Alvocidib|alvocidib|mesh-list
15240459|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240460|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
15240461|NCT03441555|Growth Substances|growth substances|mesh-ancestor
15240462|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240463|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15240464|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402703|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14402704|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737584|NCT00550329|Glipizide|glipizide|mesh-list
14737585|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737586|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737587|NCT00550342|Rituximab|rituximab|mesh-list
14737588|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14737589|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737590|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
14737591|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737592|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737593|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
14737594|NCT00550433|Estrogens|estrogens|mesh-list
14737595|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14737596|NCT00550433|Hormones|hormones|mesh-ancestor
14737597|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737598|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737599|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14737600|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14737601|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
14737602|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14737603|NCT00550485|Citalopram|citalopram|mesh-list
14737604|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14737605|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14737606|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737607|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737608|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737609|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
14737610|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737611|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14402705|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14402706|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402707|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402708|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402709|NCT01473368|Amoxicillin|amoxicillin|mesh-list
14402710|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
14402711|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
14402712|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14402713|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14737612|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
14737613|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15240465|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240466|NCT03439293|Dexamethasone|dexamethasone|mesh-list
15240467|NCT03439293|Daratumumab|daratumumab|mesh-list
15240468|NCT03439293|Ixazomib|ixazomib|mesh-list
15240469|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240470|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
15240471|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
15240472|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240473|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240474|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402714|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240475|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
15240476|NCT03439293|Hormones|hormones|mesh-ancestor
15240477|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240478|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240479|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240480|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
15240481|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240482|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402715|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14402716|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402717|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402718|NCT01473381|Dexetimide|dexetimide|mesh-list
14402719|NCT01473381|Citalopram|citalopram|mesh-list
14402720|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14402721|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14737614|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
14737615|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14737616|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737617|NCT00550563|Vitamins|vitamins|mesh-ancestor
14737618|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
14737619|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14737620|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14737621|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14737622|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737623|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
14737624|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14737625|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737626|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
14737627|NCT00550784|Paclitaxel|paclitaxel|mesh-list
14737628|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
14737629|NCT00550784|Melphalan|melphalan|mesh-list
14737630|NCT00550784|Topotecan|topotecan|mesh-list
14737631|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14737632|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737633|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
14737634|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737635|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737636|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737637|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737638|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
14737639|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737640|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737641|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14737642|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
14737643|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14737644|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14737645|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737646|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402722|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14737647|NCT00550810|Sunitinib|sunitinib|mesh-list
14737648|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737649|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14737650|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15240483|NCT03438526|Melatonin|melatonin|mesh-list
15240484|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
15240485|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240486|NCT03438526|Protective Agents|protective agents|mesh-ancestor
15240487|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240488|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240489|NCT03416179|Cytarabine|cytarabine|mesh-list
15240490|NCT03416179|Azacitidine|azacitidine|mesh-list
15240491|NCT03416179|Daunorubicin|daunorubicin|mesh-list
15240492|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15240493|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
15240494|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737651|NCT00550810|Growth Substances|growth substances|mesh-ancestor
14737652|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737653|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
14737654|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737655|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402723|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402724|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402725|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737656|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737657|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
14737658|NCT00550901|Razoxane|razoxane|mesh-list
14737659|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737660|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14737661|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14737662|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737663|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737664|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737665|NCT00550901|Protective Agents|protective agents|mesh-ancestor
14737666|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737667|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737668|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737669|NCT00550927|Bevacizumab|bevacizumab|mesh-list
14402726|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
14402727|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402728|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14402729|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
14737670|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14737671|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240495|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240496|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
15240497|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240498|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240499|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
15240500|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240501|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402730|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402731|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14402732|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14402733|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
14402734|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
14402735|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402736|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14402737|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14402738|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
14402739|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14402740|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15240502|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15240503|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15240504|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15240505|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
15240506|NCT03409198|Doxorubicin|doxorubicin|mesh-list
15240507|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15240508|NCT03409198|Nivolumab|nivolumab|mesh-list
14737672|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14737673|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14737674|NCT00550927|Growth Substances|growth substances|mesh-ancestor
14737675|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737676|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
14737677|NCT00550992|Leucovorin|leucovorin|mesh-list
14737678|NCT00550992|Cytarabine|cytarabine|mesh-list
14737679|NCT00550992|Cyclosporine|cyclosporine|mesh-list
14737680|NCT00550992|Prednisone|prednisone|mesh-list
14737681|NCT00550992|Prednisolone|prednisolone|mesh-list
14737682|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
14737683|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14737684|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14737685|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14737686|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
14737687|NCT00550992|Melphalan|melphalan|mesh-list
14737688|NCT00550992|Busulfan|busulfan|mesh-list
14737689|NCT00550992|Methotrexate|methotrexate|mesh-list
14737690|NCT00550992|Etoposide|etoposide|mesh-list
14737691|NCT00550992|Vincristine|vincristine|mesh-list
14737692|NCT00550992|Daunorubicin|daunorubicin|mesh-list
14737693|NCT00550992|Asparaginase|asparaginase|mesh-list
14737694|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
14737695|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
14737696|NCT00550992|Pegaspargase|pegaspargase|mesh-list
14737697|NCT00550992|Thioguanine|thioguanine|mesh-list
14737698|NCT00550992|Cyclosporins|cyclosporins|mesh-list
14737699|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14737700|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
14737701|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737702|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
14737703|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737704|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737705|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14737706|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
14402741|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14402742|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
14402743|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402744|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14402745|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14402746|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402747|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402748|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737707|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737708|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240509|NCT03409198|Ipilimumab|ipilimumab|mesh-list
15240510|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240511|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
15240512|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240513|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240514|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240515|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
14737709|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14737710|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14737711|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
14737712|NCT00550992|Hormones|hormones|mesh-ancestor
15240516|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240517|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402749|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
14402750|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402751|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15240518|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15240519|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14402752|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14402753|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
14402754|NCT01473407|Hematinics|hematinics|mesh-ancestor
14402755|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
14402756|NCT01473420|Hematinics|hematinics|mesh-ancestor
14402757|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14402758|NCT01473524|Cathartics|cathartics|mesh-ancestor
14402759|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402760|NCT01473563|Pemetrexed|pemetrexed|mesh-list
14402761|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402762|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402763|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737713|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737714|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14402764|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14402765|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14402766|NCT01473589|Vitamin D|vitamin d|mesh-list
14402767|NCT01473589|Teriparatide|teriparatide|mesh-list
14402768|NCT01473589|Calcium|calcium|mesh-list
14737715|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14737716|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
14737717|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14737718|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737719|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
15240520|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15240521|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15240522|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240523|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240524|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15240525|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
14402769|NCT01473589|Vitamins|vitamins|mesh-ancestor
14402770|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
14737720|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
14737721|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737722|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14737723|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14737724|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14737725|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14737726|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14402771|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402772|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14402773|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14467283|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467284|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467285|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
14467286|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14467287|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467288|NCT02258529|Rituximab|rituximab|mesh-list
14737727|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
14737728|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737729|NCT00550992|Antidotes|antidotes|mesh-ancestor
14737730|NCT00550992|Protective Agents|protective agents|mesh-ancestor
14737731|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
14467289|NCT02258529|Idelalisib|idelalisib|mesh-list
14467290|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467291|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467292|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
14467293|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467294|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467295|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467296|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467297|NCT02259010|Itraconazole|itraconazole|mesh-list
14467298|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
14467299|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467300|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14467301|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14467302|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467303|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467304|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14467305|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
14467306|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467307|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467308|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14467309|NCT02259088|Ranibizumab|ranibizumab|mesh-list
14467310|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14467311|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14467312|NCT02259088|Growth Substances|growth substances|mesh-ancestor
14467313|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467314|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
14467315|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467316|NCT02259231|Nivolumab|nivolumab|mesh-list
14467317|NCT02259231|Ipilimumab|ipilimumab|mesh-list
14467318|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467319|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467320|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14467321|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467322|NCT02259348|Aldesleukin|aldesleukin|mesh-list
14467323|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
15240526|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
14467324|NCT02259348|Melphalan|melphalan|mesh-list
14467325|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
14467326|NCT02259348|Thiotepa|thiotepa|mesh-list
14467327|NCT02259348|Rituximab|rituximab|mesh-list
14467328|NCT02259348|Fludarabine|fludarabine|mesh-list
14467329|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
14467330|NCT02259348|Interleukin-2|interleukin-2|mesh-list
14467331|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14467332|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
14467333|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467334|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467335|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14467336|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
14467337|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240527|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14737732|NCT00550992|Vitamins|vitamins|mesh-ancestor
14737733|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
15240528|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15240529|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240530|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240531|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737734|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14737735|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737736|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737737|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
14737738|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14737739|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737740|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14737741|NCT00550992|Analgesics|analgesics|mesh-ancestor
14737742|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
15240532|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240533|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
15240534|NCT03353922|Tolperisone|tolperisone|mesh-list
15240535|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15240536|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
15240537|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15240538|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15240539|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240540|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14402774|NCT01473602|Vitamin D|vitamin d|mesh-list
14737743|NCT00551005|Celecoxib|celecoxib|mesh-list
14737744|NCT00551005|Etoposide|etoposide|mesh-list
14737745|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14737746|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737747|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14737748|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737749|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737750|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737751|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14737752|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14737753|NCT00551005|Analgesics|analgesics|mesh-ancestor
14737754|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
14737755|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737756|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737757|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14737758|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737759|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14737760|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14737761|NCT00551018|Tenofovir|tenofovir|mesh-list
14737762|NCT00551018|Emtricitabine|emtricitabine|mesh-list
14737763|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
14737764|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737765|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14737766|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14737767|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240541|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240542|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15240543|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240544|NCT03346239|Citalopram|citalopram|mesh-list
14402775|NCT01473602|Teriparatide|teriparatide|mesh-list
14402776|NCT01473602|Calcium|calcium|mesh-list
15240545|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15240546|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15240547|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15240548|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240549|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240550|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
15240551|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402777|NCT01473602|Vitamins|vitamins|mesh-ancestor
14402778|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
14737768|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402779|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402780|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14402781|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14402782|NCT01473745|Daminozide|daminozide|mesh-list
14402783|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14402784|NCT01473745|Growth Substances|growth substances|mesh-ancestor
14402785|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402786|NCT01473836|Metronidazole|metronidazole|mesh-list
14402787|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
14402788|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737769|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14737770|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14737771|NCT00551044|Bicalutamide|bicalutamide|mesh-list
14737772|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
14737773|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
14737774|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737775|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737776|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753168|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14753169|NCT05248984|Analgesics|analgesics|mesh-ancestor
14753170|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
14753171|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753172|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753173|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14402789|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402790|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14402791|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14402792|NCT01473940|Gemcitabine|gemcitabine|mesh-list
14402793|NCT01473940|Ipilimumab|ipilimumab|mesh-list
14753174|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753175|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14753176|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753177|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753178|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
14753179|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14753180|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753181|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402794|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14402795|NCT01473940|Antibodies|antibodies|mesh-list
14753182|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14753183|NCT05246007|Analgesics|analgesics|mesh-ancestor
14753184|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
14753185|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753186|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14402796|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
14402797|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14402798|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
14402799|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402800|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14402801|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
14402802|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402803|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402804|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
14402805|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402806|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402807|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14402808|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14402809|NCT01473953|Liraglutide|liraglutide|mesh-list
14402810|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14402811|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402812|NCT01473953|Incretins|incretins|mesh-ancestor
14402813|NCT01473953|Hormones|hormones|mesh-ancestor
14402814|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402815|NCT01474018|Bromocriptine|bromocriptine|mesh-list
14402816|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14402817|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14402818|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
14402819|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402820|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737777|NCT00551096|Gemcitabine|gemcitabine|mesh-list
14737778|NCT00551096|Capecitabine|capecitabine|mesh-list
14737779|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737780|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
14737781|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737782|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737783|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
14737784|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737785|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737786|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737787|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
14737788|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737789|NCT00551109|SA 4503|sa 4503|mesh-list
14737790|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
14737791|NCT00551122|Gemcitabine|gemcitabine|mesh-list
14737792|NCT00551122|Paclitaxel|paclitaxel|mesh-list
14737793|NCT00551122|Ifosfamide|ifosfamide|mesh-list
14737794|NCT00551122|Lenograstim|lenograstim|mesh-list
14737795|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14402821|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
14402822|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
15240552|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15240553|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
15240554|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402823|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737796|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737797|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
15240555|NCT03259074|Adalimumab|adalimumab|mesh-list
15240556|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240557|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240558|NCT03236857|Venetoclax|venetoclax|mesh-list
15240559|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240560|NCT03188705|Aspirin|aspirin|mesh-list
14737798|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737799|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737800|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737801|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737802|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
14737803|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
14737804|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737805|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737806|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737807|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
14737808|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737809|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14737810|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14737811|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
14737812|NCT00551239|Rituximab|rituximab|mesh-list
14737813|NCT00551239|Fludarabine|fludarabine|mesh-list
14737814|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
14737815|NCT00551239|Pixantrone|pixantrone|mesh-list
15240561|NCT03188705|Clopidogrel|clopidogrel|mesh-list
15240562|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15240563|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15240564|NCT03188705|Analgesics|analgesics|mesh-ancestor
15240565|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
15240566|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240567|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240568|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240569|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240570|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15240571|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15240572|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402824|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402825|NCT01474109|Macitentan|macitentan|mesh-list
15240573|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15240574|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14402826|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14402827|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14402828|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402829|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14402830|NCT01474122|Macitentan|macitentan|mesh-list
14402831|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14402832|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14402833|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402834|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14402835|NCT01474200|Furosemide|furosemide|mesh-list
14402836|NCT01474200|Diuretics|diuretics|mesh-list
14402837|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14402838|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
14402839|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402840|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402841|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402842|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
15240575|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240576|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
14402843|NCT01474213|Remifentanil|remifentanil|mesh-list
14402844|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14402845|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402846|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402847|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14402848|NCT01474213|Analgesics|analgesics|mesh-ancestor
14402849|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
14402850|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402851|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14402852|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15240577|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15240578|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15240579|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15240580|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
15240581|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240582|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
15240583|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240584|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240585|NCT03173456|Acetaminophen|acetaminophen|mesh-list
15240586|NCT03173456|Ibuprofen|ibuprofen|mesh-list
15240587|NCT03173456|Oxycodone|oxycodone|mesh-list
15240588|NCT03173456|Hydrocodone|hydrocodone|mesh-list
15240589|NCT03173456|Codeine|codeine|mesh-list
15240590|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15240591|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15240592|NCT03173456|Analgesics|analgesics|mesh-ancestor
14402853|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14402854|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
14402855|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402856|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402857|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14402858|NCT01474213|Narcotics|narcotics|mesh-ancestor
14402859|NCT01474239|Bevacizumab|bevacizumab|mesh-list
14402860|NCT01474239|Fotemustine|fotemustine|mesh-list
14402861|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14402862|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402863|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14402864|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14402865|NCT01474239|Growth Substances|growth substances|mesh-ancestor
14402866|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402867|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
14402868|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
14402869|NCT01474486|Thiamine|thiamine|mesh-list
14402870|NCT01474486|Micronutrients|micronutrients|mesh-list
14402871|NCT01474486|Trace Elements|trace elements|mesh-list
14402872|NCT01474486|Vitamins|vitamins|mesh-ancestor
14402873|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402874|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
14402875|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14402876|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14402877|NCT01474512|Ixekizumab|ixekizumab|mesh-list
14737816|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14737817|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737818|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
15240593|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
14402878|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
14402879|NCT01474538|Insulin|insulin|mesh-list
14402880|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14402881|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
14402882|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
14402883|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14402884|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402885|NCT01474551|Vemurafenib|vemurafenib|mesh-list
14402886|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402887|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737819|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737820|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737821|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737822|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
14737823|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737824|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737825|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14737826|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14737827|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737828|NCT00551252|Gemcitabine|gemcitabine|mesh-list
14737829|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
14737830|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14737831|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
14737832|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737833|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737834|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
14737835|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737836|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737837|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737838|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
14737839|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737840|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737841|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
14737842|NCT00551265|Oregovomab|oregovomab|mesh-list
14737843|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14737844|NCT00551265|Antibodies|antibodies|mesh-list
14737845|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
14737846|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14737847|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737848|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
14737849|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737850|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737851|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14737852|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
14737853|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737854|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737855|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14737856|NCT00551317|Darapladib|darapladib|mesh-list
14737857|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14737858|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737859|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737860|NCT00551343|Exenatide|exenatide|mesh-list
14737861|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737862|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737863|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14737864|NCT00551343|Incretins|incretins|mesh-ancestor
14737865|NCT00551343|Hormones|hormones|mesh-ancestor
14737866|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737867|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
14402888|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737868|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737869|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737870|NCT00551382|Montelukast|montelukast|mesh-list
14737871|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15240594|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240595|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402889|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402890|NCT01474590|Doxycycline|doxycycline|mesh-list
14402891|NCT01474590|Isotretinoin|isotretinoin|mesh-list
14402892|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402893|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402894|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
14402895|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14402896|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14402897|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
14402898|NCT01474746|Sertraline|sertraline|mesh-list
14402899|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
14402900|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402901|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14402902|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14402903|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402904|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402905|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14737872|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
14737873|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14737874|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
14737875|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737876|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737877|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14737878|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14737879|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737880|NCT00551512|Cisplatin|cisplatin|mesh-list
14737881|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737882|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
14737883|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737884|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737885|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
14737886|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737887|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737888|NCT00551577|Carboplatin|carboplatin|mesh-list
14924435|NCT01398072|Azithromycin|azithromycin|mesh-list
15240596|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240597|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240598|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15240599|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924436|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
14924437|NCT01398072|Doxycycline|doxycycline|mesh-list
14924438|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14924439|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924440|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14924441|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14924442|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924443|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240600|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240601|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15240602|NCT03173456|Narcotics|narcotics|mesh-ancestor
15240603|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240604|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
15240605|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
15240606|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
15240607|NCT03161678|Clopidogrel|clopidogrel|mesh-list
15240608|NCT03161678|Ticagrelor|ticagrelor|mesh-list
15240609|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15240610|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15240611|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15240612|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15240613|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
15240614|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240615|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240616|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402906|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
14924444|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924445|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
14924446|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14924447|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14924448|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
15240617|NCT03136055|Paclitaxel|paclitaxel|mesh-list
15240618|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
15240619|NCT03136055|Irinotecan|irinotecan|mesh-list
15240620|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15240621|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240622|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14737889|NCT00551577|Docetaxel|docetaxel|mesh-list
14737890|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737891|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
14737892|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737893|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737894|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737895|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14402907|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402908|NCT01474772|Pregabalin|pregabalin|mesh-list
14402909|NCT01474772|Analgesics|analgesics|mesh-ancestor
14402910|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
15240623|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14402911|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402912|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402913|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
14737896|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737897|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737898|NCT00551590|Incretins|incretins|mesh-ancestor
14737899|NCT00551590|Hormones|hormones|mesh-ancestor
14737900|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737901|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14924449|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
14924450|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14924451|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
14924452|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240624|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14402914|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14402915|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14402916|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402917|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14402918|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14402919|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14402920|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737902|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
15240625|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240626|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240627|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15240628|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15240629|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240630|NCT03101566|Gemcitabine|gemcitabine|mesh-list
15240631|NCT03101566|Nivolumab|nivolumab|mesh-list
15240632|NCT03101566|Ipilimumab|ipilimumab|mesh-list
15240633|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240634|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15240635|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
15240636|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737903|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737904|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737905|NCT00551733|Paclitaxel|paclitaxel|mesh-list
14737906|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14737907|NCT00551733|Carboplatin|carboplatin|mesh-list
14737908|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14737909|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14737910|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737911|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
14737912|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
14737913|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
14737914|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737915|NCT00551824|Mitomycins|mitomycins|mesh-list
14737916|NCT00551824|Mitomycin|mitomycin|mesh-list
14737917|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14737918|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737919|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
14753187|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15240637|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
14737920|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737921|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14737922|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737923|NCT00551850|MP 412|mp 412|mesh-list
14737924|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737925|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14737926|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737927|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402921|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402922|NCT01474915|Promethazine|promethazine|mesh-list
14402923|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
14402924|NCT01474915|Dexamethasone|dexamethasone|mesh-list
14402925|NCT01474915|Ondansetron|ondansetron|mesh-list
14402926|NCT01474915|Aprepitant|aprepitant|mesh-list
15240638|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240639|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240640|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737928|NCT00551889|Celecoxib|celecoxib|mesh-list
14737929|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
14737930|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14737931|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
14737932|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737933|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737934|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240641|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
15240642|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402927|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240643|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240644|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15240645|NCT03020199|Betamethasone|betamethasone|mesh-list
15240646|NCT03020199|Calcipotriene|calcipotriene|mesh-list
15240647|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15240648|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240649|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
15240650|NCT03020199|Hormones|hormones|mesh-ancestor
15240651|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14737935|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
14737936|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737937|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737938|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14924453|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924454|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14924455|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
14924456|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14737939|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14737940|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14402928|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
14402929|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
14402930|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402931|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402932|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14402933|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
14737941|NCT00551889|Analgesics|analgesics|mesh-ancestor
14737942|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
14737943|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14737944|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14737945|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14924457|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14924458|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14924459|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14924460|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924461|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924462|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14402934|NCT01474915|Hormones|hormones|mesh-ancestor
14402935|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402936|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14402937|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402938|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
14402939|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
14402940|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14402941|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
14402942|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402943|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402944|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14402945|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14402946|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402947|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14402948|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14402949|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14402950|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14402951|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
14402952|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
14402953|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14402954|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14402955|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14402956|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
14402957|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
14737946|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15240652|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240653|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15240654|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
15240655|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
15240656|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
15240657|NCT03006068|Upadacitinib|upadacitinib|mesh-list
15240658|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15240659|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15240660|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240661|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737947|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737948|NCT00551954|Acarbose|acarbose|mesh-list
14737949|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14737950|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737951|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737952|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737953|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737954|NCT00552149|Cetuximab|cetuximab|mesh-list
14737955|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14737956|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737957|NCT00552201|Tacrolimus|tacrolimus|mesh-list
14737958|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924463|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14924464|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14924465|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
14924466|NCT01398189|Clozapine|clozapine|mesh-list
14924467|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14924468|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
14924469|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924470|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924471|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924472|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14924473|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14924474|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402958|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
14402959|NCT01474993|Sulforaphane|sulforaphane|mesh-list
14402960|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14402961|NCT01474993|Protective Agents|protective agents|mesh-ancestor
14402962|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402963|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14402964|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14402965|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14402966|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14402967|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
14402968|NCT01475253|Lidocaine|lidocaine|mesh-list
14402969|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
14402970|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
14402971|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402972|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402973|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
14737959|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
14737960|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737961|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14737962|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737963|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737964|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
14737965|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737966|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737967|NCT00552266|Methylphenidate|methylphenidate|mesh-list
14737968|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14737969|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737970|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14402974|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14402975|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14402976|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14402977|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14402978|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737971|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14737972|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14737973|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737974|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
14737975|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240662|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240663|NCT03003520|Prednisone|prednisone|mesh-list
15240664|NCT03003520|Prednisolone|prednisolone|mesh-list
15240665|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
15240666|NCT03003520|Rituximab|rituximab|mesh-list
15240667|NCT03003520|Doxorubicin|doxorubicin|mesh-list
15240668|NCT03003520|Vincristine|vincristine|mesh-list
15240669|NCT03003520|Lenalidomide|lenalidomide|mesh-list
15240670|NCT03003520|Durvalumab|durvalumab|mesh-list
15240671|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240672|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
15240673|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240674|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240675|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240676|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
15240677|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240678|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240679|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15240680|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240681|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15240682|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15240683|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15240684|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240685|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240686|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
15240687|NCT03003520|Hormones|hormones|mesh-ancestor
15240688|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240689|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240690|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15240691|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
15240692|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
15240693|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
15240694|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15240695|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15240696|NCT03003520|Growth Substances|growth substances|mesh-ancestor
15240697|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
14737976|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
14737977|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14737978|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737979|NCT00552461|Rituximab|rituximab|mesh-list
14402979|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402980|NCT01475331|Ethanol|ethanol|mesh-list
14402981|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14402982|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14402983|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14402984|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402985|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14402986|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14402987|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14402988|NCT01475461|Incretins|incretins|mesh-ancestor
14402989|NCT01475461|Hormones|hormones|mesh-ancestor
14402990|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14402991|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14402992|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
14402993|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14402994|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14402995|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
14402996|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14402997|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14402998|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14737980|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14737981|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14737982|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
14737983|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737984|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14737985|NCT00552500|Valproic Acid|valproic acid|mesh-list
14737986|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
14737987|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14737988|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14737989|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
14737990|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14402999|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14403000|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14403001|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403002|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403003|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403004|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14403005|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
14403006|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14403007|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403008|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14737991|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14737992|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
14737993|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14737994|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14737995|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14737996|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
14737997|NCT00552630|Penicillamine|penicillamine|mesh-list
14737998|NCT00552630|Antidotes|antidotes|mesh-ancestor
14737999|NCT00552630|Protective Agents|protective agents|mesh-ancestor
14738000|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738001|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
14738002|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
14738003|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738004|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738005|NCT00552656|Sirolimus|sirolimus|mesh-list
14738006|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14738007|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738008|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14738009|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738010|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
14738011|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738012|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
14738013|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738014|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14738015|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14738016|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14738017|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14738018|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738019|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738020|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738021|NCT00552682|Analgesics|analgesics|mesh-ancestor
14738022|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
14738023|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738024|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
14738025|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14738026|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
14738027|NCT00552734|Insulin|insulin|mesh-list
14738028|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14738029|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14738030|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738031|NCT00552747|Fenofibrate|fenofibrate|mesh-list
14738032|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14738033|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
14738034|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738035|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14738036|NCT00552799|Penicillins|penicillins|mesh-list
14738037|NCT00552799|Penicillin V|penicillin v|mesh-list
14738038|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14738039|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738040|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
14924475|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14738041|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14738042|NCT00552864|Ropivacaine|ropivacaine|mesh-list
14738043|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
14738044|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
14403009|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14403010|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14403011|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14403012|NCT01475643|Prednisolone|prednisolone|mesh-list
14403013|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14403014|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
14403015|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14403016|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
14403017|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14403018|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
14403019|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403020|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
14403021|NCT01475643|Hormones|hormones|mesh-ancestor
14403022|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403023|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403024|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14403025|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403026|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
14403027|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
14403028|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403029|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14738045|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
14738046|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738047|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738048|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
14738049|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753188|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14403030|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14403031|NCT01475643|Protective Agents|protective agents|mesh-ancestor
14753189|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
14753190|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753191|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753192|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14753193|NCT05245292|Antibodies|antibodies|mesh-list
14753194|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
14753195|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14753196|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
14753197|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
14753198|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753199|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753200|NCT05243940|Lidocaine|lidocaine|mesh-list
14753201|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
14924476|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
14753202|NCT05243940|Ketamine|ketamine|mesh-list
14924477|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
14924478|NCT01398202|Vitamin D|vitamin d|mesh-list
14924479|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
14924480|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14924481|NCT01398202|Calcifediol|calcifediol|mesh-list
14403032|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14924482|NCT01398202|Vitamins|vitamins|mesh-ancestor
14738050|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
14738051|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14738052|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738053|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
14738054|NCT00553072|Analgesics|analgesics|mesh-ancestor
14738055|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
14738056|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738057|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738058|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
14738059|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738060|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14738061|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
14738062|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14738063|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14738064|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738065|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14738066|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
14738067|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14738068|NCT00553124|Vitamin E|vitamin e|mesh-list
14738069|NCT00553124|Selenium|selenium|mesh-list
14738070|NCT00553124|Vitamins|vitamins|mesh-ancestor
14738071|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
14738072|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738073|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
14738074|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738075|NCT00553124|Protective Agents|protective agents|mesh-ancestor
14738076|NCT00553124|Trace Elements|trace elements|mesh-ancestor
14738077|NCT00553137|Fluconazole|fluconazole|mesh-list
14738078|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
14738079|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403033|NCT01475721|Fluticasone|fluticasone|mesh-list
14403034|NCT01475721|Xhance|xhance|mesh-list
14403035|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14403036|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14403037|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
14738080|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15240698|NCT02992015|Gemcitabine|gemcitabine|mesh-list
15240699|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15240700|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
15240701|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240702|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240703|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
15240704|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240705|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240706|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240707|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
15240708|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240709|NCT02991495|Vaccines|vaccines|mesh-list
15240710|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
15240711|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240712|NCT02928406|Atezolizumab|atezolizumab|mesh-list
14403038|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738081|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14738082|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738083|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738084|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14738085|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
14738086|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738087|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738088|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14738089|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14738090|NCT00553189|Topotecan|topotecan|mesh-list
14738091|NCT00553189|Veliparib|veliparib|mesh-list
14738092|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14738093|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14738094|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738095|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738096|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738097|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14738098|NCT00553293|Hormones|hormones|mesh-list
14738099|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14738100|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738101|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738102|NCT00553345|Vitamin E|vitamin e|mesh-list
14738103|NCT00553345|Selenium|selenium|mesh-list
14738104|NCT00553345|Vitamins|vitamins|mesh-ancestor
14738105|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
14738106|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738107|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
14738108|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738109|NCT00553345|Protective Agents|protective agents|mesh-ancestor
14738110|NCT00553345|Trace Elements|trace elements|mesh-ancestor
14738111|NCT00553423|Lactulose|lactulose|mesh-list
14738112|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14738113|NCT00553449|Rabeprazole|rabeprazole|mesh-list
14738114|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14738115|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14738116|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14738117|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738118|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403039|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403040|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14403041|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
14403042|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
14403043|NCT01475721|Hormones|hormones|mesh-ancestor
15240713|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240714|NCT02918370|Aripiprazole|aripiprazole|mesh-list
15240715|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
15240716|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14738119|NCT00553488|Insulin|insulin|mesh-list
15240717|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15240718|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15240719|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240720|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240721|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
15240722|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
15240723|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240724|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240725|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15240726|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15240727|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
15240728|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14738120|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14738121|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
14738122|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14738123|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738124|NCT00553553|Morphine|morphine|mesh-list
14738125|NCT00553553|Remifentanil|remifentanil|mesh-list
14738126|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14738127|NCT00553553|Narcotics|narcotics|mesh-ancestor
14738128|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738129|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738130|NCT00553553|Analgesics|analgesics|mesh-ancestor
14738131|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
14738132|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738133|NCT00553618|Aldesleukin|aldesleukin|mesh-list
14738134|NCT00553618|Dacarbazine|dacarbazine|mesh-list
14738135|NCT00553618|Interleukin-2|interleukin-2|mesh-list
14738136|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14738137|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
14738138|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738139|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738140|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14738141|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14738142|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
14738143|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738144|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14738145|NCT00553618|Analgesics|analgesics|mesh-ancestor
14467338|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738146|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
14738147|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738148|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738149|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
14738150|NCT00553683|Poly ICLC|poly iclc|mesh-list
14738151|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738152|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
14738153|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738154|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738155|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14738156|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
14738157|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738158|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738159|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15240729|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15240730|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15240731|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15240732|NCT02891824|Bevacizumab|bevacizumab|mesh-list
15240733|NCT02891824|Atezolizumab|atezolizumab|mesh-list
14738160|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
14738161|NCT00553709|Nicotine|nicotine|mesh-list
14403044|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240734|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240735|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240736|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15240737|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15240738|NCT02891824|Growth Substances|growth substances|mesh-ancestor
14403045|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
14403046|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403047|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
14403048|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14403049|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
14403050|NCT01475734|Incretins|incretins|mesh-ancestor
14403051|NCT01475734|Hormones|hormones|mesh-ancestor
14403052|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403053|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403054|NCT01475825|Mipomersen|mipomersen|mesh-list
14738162|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14738163|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
14738164|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738165|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738166|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14738167|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14738168|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
14738169|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738170|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738171|NCT00553722|Eplerenone|eplerenone|mesh-list
14738172|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14738173|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
14738174|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738175|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738176|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14738177|NCT00553722|Diuretics|diuretics|mesh-ancestor
14738178|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
14738179|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14738180|NCT00553748|Alovudine|alovudine|mesh-list
14738181|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
14403055|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14403056|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14403057|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
14403058|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403059|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14403060|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14403061|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
14738182|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738183|NCT00553800|Bevacizumab|bevacizumab|mesh-list
14738184|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14738185|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738186|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738187|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738188|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738189|NCT00553800|Growth Substances|growth substances|mesh-ancestor
14738190|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738191|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14738192|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14738193|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738194|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738195|NCT00553878|Dutasteride|dutasteride|mesh-list
15240739|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738196|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15240740|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
15240741|NCT02862457|Paclitaxel|paclitaxel|mesh-list
15240742|NCT02862457|Cisplatin|cisplatin|mesh-list
14738197|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14738198|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738199|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738200|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
14403062|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403063|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14403064|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14403065|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14403066|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14403067|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
14403068|NCT01476202|Nicotine|nicotine|mesh-list
14403069|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14403070|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
14403071|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403072|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403073|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14403074|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14403075|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
14738201|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738202|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738203|NCT00553930|Interferons|interferons|mesh-list
14738204|NCT00553930|Ribavirin|ribavirin|mesh-list
14738205|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
14738206|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
14738207|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14738208|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738209|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
14738210|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738211|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
14738212|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738213|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
14403076|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403077|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738214|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738215|NCT00553943|Cytarabine|cytarabine|mesh-list
14738216|NCT00553943|Rituximab|rituximab|mesh-list
14738217|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738218|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738219|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
14738220|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738221|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738222|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14403078|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
14403079|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14403080|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14403081|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
14403082|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403083|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14403084|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
14403085|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403086|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403087|NCT01476449|Ranibizumab|ranibizumab|mesh-list
14738223|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
14738224|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924483|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
14924484|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240743|NCT02862457|Carboplatin|carboplatin|mesh-list
15240744|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
15240745|NCT02862457|Pemetrexed|pemetrexed|mesh-list
15240746|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15240747|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240748|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
15240749|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
15240750|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
15240751|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240752|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240753|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403088|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738225|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
14738226|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738227|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738228|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14738229|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14738230|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14738231|NCT00553995|Analgesics|analgesics|mesh-ancestor
14738232|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
14738233|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738234|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738235|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738236|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738237|NCT00554086|Bicalutamide|bicalutamide|mesh-list
14738238|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
14738239|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
14738240|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738241|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738242|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738243|NCT00554125|Sirolimus|sirolimus|mesh-list
14738244|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14738245|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738246|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14738247|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738248|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
14738249|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924485|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14924486|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14924487|NCT01398267|Lisinopril|lisinopril|mesh-list
14924488|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14924489|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
14924490|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738250|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
14924491|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924492|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14924493|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14924494|NCT01398267|Protective Agents|protective agents|mesh-ancestor
14924495|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924496|NCT01398293|Ritonavir|ritonavir|mesh-list
14924497|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
14924498|NCT01398293|Lactams|lactams|mesh-list
14924499|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14738251|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738252|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14738253|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14738254|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14738255|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
14738256|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738257|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14738258|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14738259|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738260|NCT00554164|Prednisone|prednisone|mesh-list
14738261|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
14738262|NCT00554164|Doxorubicin|doxorubicin|mesh-list
14738263|NCT00554164|Vincristine|vincristine|mesh-list
14738264|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738265|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
14738266|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738267|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738268|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14738269|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
14738270|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738271|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738272|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14738273|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14738274|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14738275|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14738276|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738277|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738278|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
14738279|NCT00554164|Hormones|hormones|mesh-ancestor
14738280|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738281|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14738282|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14738283|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
14738284|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
14738285|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
14738286|NCT00554177|Mifepristone|mifepristone|mesh-list
14738287|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14738288|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
14738289|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14738290|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738291|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14738292|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14738293|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14738294|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
14738295|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14738296|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14738297|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
14738298|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738299|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
14738300|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14738301|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14738302|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
15240754|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15240755|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15240756|NCT02845323|Nivolumab|nivolumab|mesh-list
15240757|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738303|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738304|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14738305|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14738306|NCT00554203|Analgesics|analgesics|mesh-ancestor
14738307|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
14738308|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738309|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738310|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738311|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738312|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14738313|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
14738314|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
14738315|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
15240758|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240759|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15240760|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240761|NCT02790515|Sirolimus|sirolimus|mesh-list
15240762|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
15240763|NCT02790515|Melphalan|melphalan|mesh-list
15240764|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
15240765|NCT02790515|Thiotepa|thiotepa|mesh-list
15240766|NCT02790515|Rituximab|rituximab|mesh-list
15240767|NCT02790515|Fludarabine|fludarabine|mesh-list
15240768|NCT02790515|Blinatumomab|blinatumomab|mesh-list
14738316|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738317|NCT00554242|Protective Agents|protective agents|mesh-ancestor
15240769|NCT02790515|Tacrolimus|tacrolimus|mesh-list
15240770|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
15240771|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15240772|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240773|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
15240774|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240775|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240776|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240777|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
15240778|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240779|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240780|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15240781|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240782|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15240783|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240784|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15240785|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240786|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15240787|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
15240788|NCT02733042|Rituximab|rituximab|mesh-list
15240789|NCT02733042|Durvalumab|durvalumab|mesh-list
15240790|NCT02733042|Lenalidomide|lenalidomide|mesh-list
15240791|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15240792|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240793|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240794|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
15240795|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240796|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240797|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15240798|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15240799|NCT02733042|Growth Substances|growth substances|mesh-ancestor
15240800|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
15240801|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15240802|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
15240803|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240804|NCT02663518|Rituximab|rituximab|mesh-list
15240805|NCT02663518|Nivolumab|nivolumab|mesh-list
15240806|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
15240807|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15240808|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240809|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
15240810|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240811|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240812|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14738318|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738319|NCT00554242|Vitamins|vitamins|mesh-ancestor
14738320|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
14738321|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14738322|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738323|NCT00554346|Etoricoxib|etoricoxib|mesh-list
14738324|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14738325|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14738326|NCT00554346|Analgesics|analgesics|mesh-ancestor
14738327|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
14738328|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738329|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738330|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738331|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738332|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14738333|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14738334|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738335|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738336|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
14738337|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14738338|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14738339|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
14924500|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14924501|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14924502|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
14924503|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924504|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924505|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14924506|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14738340|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738341|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14738342|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14738343|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738344|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738345|NCT00554424|Lidocaine|lidocaine|mesh-list
14738346|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
14738347|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
14738348|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738349|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738350|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
14924507|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
14924508|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924509|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14924510|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14924511|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14924512|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14924513|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14924514|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924515|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14924516|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
14924517|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14924518|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924519|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14924520|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14924521|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14924522|NCT01398371|Digoxin|digoxin|mesh-list
14924523|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14738351|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738352|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14738353|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14738354|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14738355|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14738356|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738357|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
14738358|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14738359|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738360|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14738361|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738362|NCT00554476|Triamcinolone|triamcinolone|mesh-list
14738363|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14738364|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14738365|NCT00554476|Indomethacin|indomethacin|mesh-list
14738366|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14738367|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738368|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
14738369|NCT00554476|Hormones|hormones|mesh-ancestor
14924524|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14924525|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924526|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924527|NCT01398371|Protective Agents|protective agents|mesh-ancestor
14924528|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403089|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14403090|NCT01476449|Growth Substances|growth substances|mesh-ancestor
14403091|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403092|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
14403093|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403094|NCT01476475|Insulin|insulin|mesh-list
14403095|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14403096|NCT01476475|Metformin|metformin|mesh-list
14924529|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
14924530|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14924531|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
14924532|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924533|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240813|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240814|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
15240815|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
15240816|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
15240817|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924534|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14924535|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
14924536|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14924537|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
14924538|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924539|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924540|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14924541|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
14924542|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
14924543|NCT01398384|Protective Agents|protective agents|mesh-ancestor
14924544|NCT01398501|Sorafenib|sorafenib|mesh-list
14924545|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924546|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924547|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924548|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924549|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14924550|NCT01398592|Vildagliptin|vildagliptin|mesh-list
14924551|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15240818|NCT02575144|Clarithromycin|clarithromycin|mesh-list
15240819|NCT02575144|Dexamethasone|dexamethasone|mesh-list
15240820|NCT02575144|Lenalidomide|lenalidomide|mesh-list
14403097|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
15240821|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240822|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
15240823|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
14403098|NCT01476475|Lixisenatide|lixisenatide|mesh-list
14403099|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403100|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403101|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15240824|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240825|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240826|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15240827|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
15240828|NCT02575144|Hormones|hormones|mesh-ancestor
15240829|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240830|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240831|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240832|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
15240833|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15240834|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15240835|NCT02575144|Growth Substances|growth substances|mesh-ancestor
14403102|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14403103|NCT01477320|Pantoprazole|pantoprazole|mesh-list
14403104|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14403105|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403106|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14403107|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403108|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403109|NCT01477333|Treprostinil|treprostinil|mesh-list
14403110|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14403111|NCT01477463|Vitamin D|vitamin d|mesh-list
14738370|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738371|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738372|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738373|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
14738374|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738375|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403112|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
14403113|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
14403114|NCT01477463|Vitamins|vitamins|mesh-list
14403115|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
14403116|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403117|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14403118|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14403119|NCT01477762|Dexamethasone|dexamethasone|mesh-list
14403120|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403121|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
14403122|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
14403123|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403124|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403125|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403126|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
14403127|NCT01477762|Hormones|hormones|mesh-ancestor
14403128|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403129|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14403130|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403131|NCT01477853|Metformin|metformin|mesh-list
14738376|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14738377|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14738378|NCT00554476|Analgesics|analgesics|mesh-ancestor
14738379|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
14738380|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738381|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738382|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
14738383|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
14738384|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14738385|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14738386|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14738387|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14738388|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14738389|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738390|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738391|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
14738392|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403132|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14403133|NCT01477853|Glimepiride|glimepiride|mesh-list
14403134|NCT01477853|Atorvastatin|atorvastatin|mesh-list
14403135|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403136|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738393|NCT00554528|Meloxicam|meloxicam|mesh-list
14738394|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15240836|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
15240837|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15240838|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240839|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15240840|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240841|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240842|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15240843|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15240844|NCT02574286|Vitamin D|vitamin d|mesh-list
15240845|NCT02574286|Vitamins|vitamins|mesh-ancestor
15240846|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
15240847|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240848|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14403137|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14403138|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14738395|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14738396|NCT00554528|Analgesics|analgesics|mesh-ancestor
14738397|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
14738398|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738399|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738400|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738401|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738402|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14738403|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14738404|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738405|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738406|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14738407|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14738408|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14738409|NCT00554632|Norgestimate|norgestimate|mesh-list
14738410|NCT00554632|Norelgestromin|norelgestromin|mesh-list
14738411|NCT00554632|Ortho Evra|ortho evra|mesh-list
14738412|NCT00554632|Estradiol|estradiol|mesh-list
14738413|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14738414|NCT00554632|Estrogens|estrogens|mesh-ancestor
14738415|NCT00554632|Hormones|hormones|mesh-ancestor
14738416|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738417|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738418|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14738419|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
14738420|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14738421|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14738422|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14738423|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15240849|NCT02542956|Bupivacaine|bupivacaine|mesh-list
14738424|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14738425|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14738426|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
14738427|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14738428|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14738429|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14738430|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738431|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738432|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
14738433|NCT00554710|Budesonide|budesonide|mesh-list
14738434|NCT00554710|Azathioprine|azathioprine|mesh-list
14738435|NCT00554710|Infliximab|infliximab|mesh-list
14738436|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240850|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
15240851|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
15240852|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240853|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240854|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
15240855|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240856|NCT02471144|Etanercept|etanercept|mesh-list
15240857|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15240858|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15240859|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15240860|NCT02471144|Analgesics|analgesics|mesh-ancestor
15240861|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
15240862|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240863|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240864|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240865|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240866|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15240867|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240868|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
15240869|NCT02440464|Fludarabine|fludarabine|mesh-list
14738437|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
14738438|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
14738439|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240870|NCT02440464|Bortezomib|bortezomib|mesh-list
14403139|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
14403140|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403141|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14403142|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14403143|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403144|NCT01477853|Incretins|incretins|mesh-ancestor
14403145|NCT01477853|Hormones|hormones|mesh-ancestor
14403146|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403147|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14403148|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
14403149|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14403150|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403151|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
14403152|NCT01477892|Remifentanil|remifentanil|mesh-list
14403153|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14403154|NCT01477892|Narcotics|narcotics|mesh-ancestor
14403155|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403156|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403157|NCT01477892|Analgesics|analgesics|mesh-ancestor
14403158|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
14403159|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403160|NCT01478048|Dexamethasone|dexamethasone|mesh-list
14403161|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
14403162|NCT01478048|Bortezomib|bortezomib|mesh-list
14403163|NCT01478048|Elotuzumab|elotuzumab|mesh-list
14403164|NCT01478048|BB 1101|bb 1101|mesh-list
14403165|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403166|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
15240871|NCT02440464|Melphalan|melphalan|mesh-list
15240872|NCT02440464|Ixazomib|ixazomib|mesh-list
15240873|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240874|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240875|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738440|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240876|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
15240877|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240878|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14403167|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
14403168|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240879|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
15240880|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15240881|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
15240882|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240883|NCT02366728|Temozolomide|temozolomide|mesh-list
15240884|NCT02366728|Basiliximab|basiliximab|mesh-list
15240885|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
14738441|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14738442|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
14738443|NCT00554710|Hormones|hormones|mesh-ancestor
15240886|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240887|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14738444|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738445|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14738446|NCT00554710|Protective Agents|protective agents|mesh-ancestor
14738447|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738448|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14738449|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14738450|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
14738451|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
14738452|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738453|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
14738454|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738455|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14738456|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738457|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
14738458|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14738459|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738460|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14738461|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738462|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738463|NCT00554827|Vitamins|vitamins|mesh-list
14738464|NCT00554827|Folic Acid|folic acid|mesh-list
14738465|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
14738466|NCT00554827|Hydroxocobalamin|hydroxocobalamin|mesh-list
15240888|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
15240889|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403169|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403170|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403171|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
14403172|NCT01478048|Hormones|hormones|mesh-ancestor
14403173|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403174|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14403175|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240890|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738467|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
14738468|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14738469|NCT00554827|Aminopterin|aminopterin|mesh-list
14738470|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
14738471|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738472|NCT00554827|Hematinics|hematinics|mesh-ancestor
14738473|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14738474|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738475|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738476|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738477|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
14738478|NCT00554918|Prednisolone|prednisolone|mesh-list
14738479|NCT00554918|Docetaxel|docetaxel|mesh-list
14738480|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738481|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
14738482|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
15240891|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240892|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
15240893|NCT02344355|Temozolomide|temozolomide|mesh-list
15240894|NCT02344355|Vitamins|vitamins|mesh-ancestor
15240895|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
15240896|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738483|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14738484|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240897|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14738485|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738486|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
14738487|NCT00554918|Hormones|hormones|mesh-ancestor
14738488|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738489|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738490|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14738491|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14753203|NCT05243940|Remifentanil|remifentanil|mesh-list
14753204|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
14753205|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
14753206|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753207|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753208|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
14753209|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753210|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14753211|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14753212|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14753213|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753214|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753215|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14753216|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14753217|NCT05243940|Analgesics|analgesics|mesh-ancestor
14753218|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14753219|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14753220|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14753221|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
14753222|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753223|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14753224|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14753225|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
14753226|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14753227|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14753228|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14753229|NCT05243940|Narcotics|narcotics|mesh-ancestor
14753230|NCT05237141|Etonogestrel|etonogestrel|mesh-list
14753231|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14753232|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
14753233|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14753234|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753235|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14753236|NCT05236894|Nicotine|nicotine|mesh-list
14753237|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15240898|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
15240899|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240900|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240901|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
15240902|NCT02344355|Protective Agents|protective agents|mesh-ancestor
15240903|NCT02332850|Dexamethasone|dexamethasone|mesh-list
15240904|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240905|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
14738492|NCT00555022|Bromides|bromides|mesh-list
14738493|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
14738494|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14738495|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
14738496|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738497|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738498|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14738499|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
14738500|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
14738501|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14738502|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
14738503|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738504|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738505|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
14738506|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
14738507|NCT00555087|Testosterone|testosterone|mesh-list
14738508|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
15240906|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
15240907|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240908|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240909|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15240910|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
14738509|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
14738510|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14738511|NCT00555087|Androgens|androgens|mesh-ancestor
14738512|NCT00555087|Hormones|hormones|mesh-ancestor
14738513|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738514|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738515|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14738516|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738517|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
14738518|NCT00555100|Dexamethasone|dexamethasone|mesh-list
14738519|NCT00555100|Lenalidomide|lenalidomide|mesh-list
14738520|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738521|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
14738522|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
14738523|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403176|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
14403177|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738524|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738525|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14738526|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
14738527|NCT00555100|Hormones|hormones|mesh-ancestor
14738528|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738529|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14738530|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738531|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
14738532|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738533|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738534|NCT00555100|Growth Substances|growth substances|mesh-ancestor
15240911|NCT02332850|Hormones|hormones|mesh-ancestor
14403178|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403179|NCT01478256|Erythromycin|erythromycin|mesh-list
15240912|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240913|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15240914|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403180|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
14403181|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14403182|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
14403183|NCT01478256|Besifloxacin|besifloxacin|mesh-list
14403184|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14403185|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403186|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403187|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14403188|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403189|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403190|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14403191|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14403192|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403193|NCT01478321|Bevacizumab|bevacizumab|mesh-list
15240915|NCT02313870|Clobetasol|clobetasol|mesh-list
15240916|NCT02313870|Methotrexate|methotrexate|mesh-list
15240917|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14738535|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
14738536|NCT00555139|Alprazolam|alprazolam|mesh-list
14403194|NCT01478321|Temozolomide|temozolomide|mesh-list
14738537|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14738538|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738539|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738540|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14738541|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14738542|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14738543|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
14738544|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
14738545|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738546|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738547|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14738548|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14738549|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14738550|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
14738551|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738552|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14738553|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14738554|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738555|NCT00555256|Sirolimus|sirolimus|mesh-list
14738556|NCT00555256|Sunitinib|sunitinib|mesh-list
14738557|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738558|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738559|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738560|NCT00555256|Growth Substances|growth substances|mesh-ancestor
14738561|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738562|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
14738563|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14738564|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738565|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738566|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14738567|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738568|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14738569|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
14738570|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738571|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
14738572|NCT00555334|Lamivudine|lamivudine|mesh-list
14738573|NCT00555334|Entecavir|entecavir|mesh-list
14738574|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14738575|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14738576|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738577|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738578|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
14738579|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738580|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14738581|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14738582|NCT00555347|Modafinil|modafinil|mesh-list
14738583|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14738584|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738585|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14738586|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14738587|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14403195|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14403196|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403197|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14403198|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14403199|NCT01478321|Growth Substances|growth substances|mesh-ancestor
14403200|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403201|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
14403202|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14403203|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
14403204|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738588|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738589|NCT00555373|Sirolimus|sirolimus|mesh-list
14738590|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14738591|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738592|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14738593|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738594|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
14738595|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738596|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
14738597|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738598|NCT00555386|Selenium|selenium|mesh-list
14738599|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
14738600|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738601|NCT00555386|Protective Agents|protective agents|mesh-ancestor
14738602|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738603|NCT00555386|Trace Elements|trace elements|mesh-ancestor
14738604|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
14738605|NCT00555399|Temozolomide|temozolomide|mesh-list
14738606|NCT00555399|Vorinostat|vorinostat|mesh-list
14738607|NCT00555399|Isotretinoin|isotretinoin|mesh-list
14738608|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14738609|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
14738610|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738611|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738612|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14403205|NCT01478581|Dexamethasone|dexamethasone|mesh-list
14403206|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403207|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
14403208|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
14738613|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738614|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
14738615|NCT00555412|Loxapine|loxapine|mesh-list
14738616|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14738617|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14738618|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738619|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240918|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
15240919|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15240920|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240921|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15240922|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
15240923|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240924|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240925|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
15240926|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240927|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15240928|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240929|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
15240930|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15240931|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15240932|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15240933|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
15240934|NCT02313870|Hormones|hormones|mesh-ancestor
15240935|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240936|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15240937|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240938|NCT02243709|Mifepristone|mifepristone|mesh-list
15240939|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15240940|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
15240941|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15240942|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240943|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15240944|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14403209|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403210|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403211|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403212|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
14738620|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14738621|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14738622|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
14738623|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738624|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738625|NCT00555542|Rituximab|rituximab|mesh-list
14738626|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738627|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738628|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
14738629|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738630|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738631|NCT00555555|Factor VIII|factor viii|mesh-list
14738632|NCT00555555|Coagulants|coagulants|mesh-ancestor
14738633|NCT00555594|Bevacizumab|bevacizumab|mesh-list
14738634|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14403213|NCT01478581|Hormones|hormones|mesh-ancestor
14403214|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403215|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14738635|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738636|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738637|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738638|NCT00555594|Growth Substances|growth substances|mesh-ancestor
14738639|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738640|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14738641|NCT00555607|Prednisolone|prednisolone|mesh-list
14738642|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738643|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
14403216|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403217|NCT01478594|Bevacizumab|bevacizumab|mesh-list
14403218|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14403219|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403220|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14403221|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738644|NCT00555607|Hormones|hormones|mesh-ancestor
14738645|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738646|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738647|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14738648|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738649|NCT00555776|Gabapentin|gabapentin|mesh-list
14738650|NCT00555776|Analgesics|analgesics|mesh-ancestor
14738651|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
14738652|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738653|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738654|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
14738655|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14738656|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14738657|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738658|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14738659|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14738660|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14738661|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738662|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738663|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
15240945|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15240946|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
15240947|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15240948|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15240949|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
14738664|NCT00555854|Benzocaine|benzocaine|mesh-list
14403222|NCT01478594|Growth Substances|growth substances|mesh-ancestor
14403223|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403224|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14403225|NCT01478828|Lovastatin|lovastatin|mesh-list
14403226|NCT01478828|L 647318|l 647318|mesh-list
14403227|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
14403228|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14403229|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14738665|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
14738666|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
14738667|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738668|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738669|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
14403230|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
14403231|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403232|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14403233|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14403234|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403235|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
14403236|NCT01478971|Hematinics|hematinics|mesh-ancestor
14403237|NCT01479127|Silicon|silicon|mesh-list
14403238|NCT01479127|Levodopa|levodopa|mesh-list
14403239|NCT01479127|Carbidopa|carbidopa|mesh-list
14403240|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14403241|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14403242|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
14403243|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403244|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403245|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403246|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14403247|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403248|NCT01479127|Trace Elements|trace elements|mesh-ancestor
14403249|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
14403250|NCT01479270|Epinephrine|epinephrine|mesh-list
14403251|NCT01479270|Ropivacaine|ropivacaine|mesh-list
14403252|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
14403253|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
14738670|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738671|NCT00555867|Anastrozole|anastrozole|mesh-list
14738672|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14738673|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738674|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14738675|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14738676|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738677|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738678|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14403254|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403255|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403256|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
14403257|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403258|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14403259|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14403260|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
15240950|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15240951|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
14403261|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403262|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403263|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14403264|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14403265|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
14403266|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14403267|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
15240952|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15240953|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15240954|NCT02236806|Ramipril|ramipril|mesh-list
15240955|NCT02236806|Bisoprolol|bisoprolol|mesh-list
15240956|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14403268|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
14738679|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
14738680|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738681|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403269|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
14403270|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14403271|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
14403272|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
14403273|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403274|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14403275|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14403276|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14403277|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14403278|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14403279|NCT01479374|Analgesics|analgesics|mesh-ancestor
14403280|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
14403281|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403282|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403283|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403284|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14403285|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14403286|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14403287|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14403288|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
14403289|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
14403290|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403291|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403292|NCT01479439|Losartan|losartan|mesh-list
14738682|NCT00555984|Remifentanil|remifentanil|mesh-list
14738683|NCT00555984|Propofol|propofol|mesh-list
14738684|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
15240957|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
15240958|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240959|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240960|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15240961|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
15240962|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
15240963|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15240964|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240965|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15240966|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14403293|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14403294|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14403295|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14403296|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14403297|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403298|NCT01479465|Leucovorin|leucovorin|mesh-list
14403299|NCT01479465|Fluorouracil|fluorouracil|mesh-list
14403300|NCT01479465|Irinotecan|irinotecan|mesh-list
14403301|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
14403302|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403303|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14403304|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403305|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403306|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
14403307|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403308|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14403309|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14403310|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738685|NCT00555984|Sevoflurane|sevoflurane|mesh-list
14738686|NCT00555984|Anesthetics|anesthetics|mesh-list
14738687|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15240967|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15240968|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
15240969|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15240970|NCT02236572|Everolimus|everolimus|mesh-list
15240971|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240972|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15240973|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
15240974|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240975|NCT02220452|Anesthetics|anesthetics|mesh-list
15240976|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240977|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240978|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15240979|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240980|NCT02083354|Trametinib|trametinib|mesh-list
15240981|NCT02083354|Dabrafenib|dabrafenib|mesh-list
14738688|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738689|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738690|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
15240982|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15240983|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15240984|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15240985|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15240986|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
15240987|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15240988|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
15240989|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
15240990|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
14738691|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15240991|NCT02065635|Propofol|propofol|mesh-list
15240992|NCT02065635|Sevoflurane|sevoflurane|mesh-list
15240993|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15240994|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15240995|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15240996|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15240997|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
15240998|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
15240999|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15241000|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15241001|NCT02061514|Propofol|propofol|mesh-list
15241002|NCT02061514|Desflurane|desflurane|mesh-list
15241003|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15241004|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241005|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241006|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15241007|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
15241008|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
14738692|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14738693|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14738694|NCT00555984|Narcotics|narcotics|mesh-ancestor
14738695|NCT00555984|Analgesics|analgesics|mesh-ancestor
14738696|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
14738697|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738698|NCT00556023|Gemcitabine|gemcitabine|mesh-list
14738699|NCT00556023|Tremelimumab|tremelimumab|mesh-list
14738700|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14738701|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
14738702|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738703|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738704|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
14738705|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738706|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403311|NCT01479465|Antidotes|antidotes|mesh-ancestor
15241009|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15241010|NCT01937468|Interleukin-2|interleukin-2|mesh-list
15241011|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241012|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15241013|NCT01937468|Analgesics|analgesics|mesh-ancestor
15241014|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
14738707|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738708|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
14738709|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738710|NCT00556062|Vaccines|vaccines|mesh-list
14738711|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
14738712|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738713|NCT00556088|Paclitaxel|paclitaxel|mesh-list
14738714|NCT00556088|Bevacizumab|bevacizumab|mesh-list
14738715|NCT00556088|Carboplatin|carboplatin|mesh-list
14738716|NCT00556088|Panobinostat|panobinostat|mesh-list
14738717|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14738718|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738719|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14738720|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14738721|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14738722|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738723|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738724|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738725|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738726|NCT00556088|Growth Substances|growth substances|mesh-ancestor
14738727|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738728|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
14738729|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14738730|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403312|NCT01479465|Protective Agents|protective agents|mesh-ancestor
14403313|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
14738731|NCT00556127|Cytarabine|cytarabine|mesh-list
14738732|NCT00556127|Dexamethasone|dexamethasone|mesh-list
14738733|NCT00556127|Prednisone|prednisone|mesh-list
14738734|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
14738735|NCT00556127|Melphalan|melphalan|mesh-list
14738736|NCT00556127|Carmustine|carmustine|mesh-list
14738737|NCT00556127|Rituximab|rituximab|mesh-list
14738738|NCT00556127|Etoposide|etoposide|mesh-list
14738739|NCT00556127|Vincristine|vincristine|mesh-list
14738740|NCT00556127|Epirubicin|epirubicin|mesh-list
14738741|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
15241015|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403314|NCT01479465|Vitamins|vitamins|mesh-ancestor
14738742|NCT00556127|Sargramostim|sargramostim|mesh-list
14738743|NCT00556127|Lenograstim|lenograstim|mesh-list
15241016|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738744|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738745|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
14738746|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738747|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738748|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14738749|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
14738750|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738751|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738752|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14738753|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738754|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
14738755|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
14738756|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738757|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14738758|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
14738759|NCT00556127|Hormones|hormones|mesh-ancestor
14738760|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738761|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15241017|NCT01775813|Metformin|metformin|mesh-list
15241018|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15241019|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241020|NCT01694069|Tazobactam|tazobactam|mesh-list
15241021|NCT01694069|Piperacillin|piperacillin|mesh-list
14403315|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
14403316|NCT01479517|Tetracaine|tetracaine|mesh-list
14403317|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
14403318|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
14403319|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403320|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403321|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
14738762|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14403322|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403323|NCT01479530|Rasagiline|rasagiline|mesh-list
14403324|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14403325|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403326|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403327|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14403328|NCT01479530|Protective Agents|protective agents|mesh-ancestor
14403329|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403330|NCT01479621|Fluticasone|fluticasone|mesh-list
14738763|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14738764|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14738765|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14738766|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738767|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14738768|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
14738769|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
14738770|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738771|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
14403331|NCT01479621|Xhance|xhance|mesh-list
14403332|NCT01479621|Albuterol|albuterol|mesh-list
14403333|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
15241022|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15241023|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15241024|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241025|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15241026|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241027|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241028|NCT01446016|Paclitaxel|paclitaxel|mesh-list
15241029|NCT01446016|Docetaxel|docetaxel|mesh-list
15241030|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15241031|NCT01446016|Taxane|taxane|mesh-list
15241032|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15241033|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738772|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
14738773|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
14738774|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14403334|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403335|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14403336|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
14403337|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403338|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403339|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14403340|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
15241034|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
14403341|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
14403342|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14403343|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
14403344|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14403345|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14403346|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14403347|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14403348|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403349|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403350|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
14403351|NCT01479764|Neostigmine|neostigmine|mesh-list
14403352|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14403353|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403354|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403355|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
14403356|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403357|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403358|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14403359|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
14403360|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403361|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14403362|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14403363|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14403364|NCT01479868|Interferons|interferons|mesh-list
14403365|NCT01479868|Ribavirin|ribavirin|mesh-list
14403366|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
14403367|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
14403368|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14403369|NCT01479868|Simeprevir|simeprevir|mesh-list
14403370|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403371|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
14403372|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403373|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
14403374|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403375|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
14403376|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403377|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
14403378|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467339|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15241035|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
15241036|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
15241037|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241038|NCT01434602|Everolimus|everolimus|mesh-list
15241039|NCT01434602|Sorafenib|sorafenib|mesh-list
15241040|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241041|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241042|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
15241043|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241044|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15241045|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241046|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241047|NCT01399918|Bevacizumab|bevacizumab|mesh-list
15241048|NCT01399918|Everolimus|everolimus|mesh-list
15241049|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241050|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241051|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15241052|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15241053|NCT01399918|Growth Substances|growth substances|mesh-ancestor
15241054|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241055|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
15241056|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241057|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
15241058|NCT01078454|Dexamethasone|dexamethasone|mesh-list
15241059|NCT01078454|Bortezomib|bortezomib|mesh-list
14738775|NCT00556127|Analgesics|analgesics|mesh-ancestor
14738776|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
14738777|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15241060|NCT01078454|Melphalan|melphalan|mesh-list
14403379|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
14403380|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14403381|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14403382|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403383|NCT01480089|Ropivacaine|ropivacaine|mesh-list
14403384|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
14403385|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
14403386|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403387|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403388|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
15241061|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241062|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
15241063|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
15241064|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241065|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241066|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403389|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403390|NCT01480219|Voriconazole|voriconazole|mesh-list
14738778|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14753238|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
15241067|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
15241068|NCT01078454|Hormones|hormones|mesh-ancestor
14403391|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
14403392|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403393|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14403394|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14403395|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403396|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403397|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14403398|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
14403399|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14738779|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738780|NCT00556192|Rituximab|rituximab|mesh-list
14738781|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738782|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738783|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
14738784|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738785|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738786|NCT00556205|Bevacizumab|bevacizumab|mesh-list
14738787|NCT00556205|Sunitinib|sunitinib|mesh-list
14738788|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738789|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738790|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738791|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738792|NCT00556205|Growth Substances|growth substances|mesh-ancestor
14738793|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738794|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
14738795|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14738796|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738797|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403400|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403401|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14403402|NCT01480232|Nicotine|nicotine|mesh-list
14403403|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14403404|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
14403405|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403406|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403407|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14403408|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14738798|NCT00556257|Cyclosporine|cyclosporine|mesh-list
14738799|NCT00556257|Cyclosporins|cyclosporins|mesh-list
14738800|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738801|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738802|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738803|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
14738804|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738805|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
14738806|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738807|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14738808|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738809|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14738810|NCT00556270|Fentanyl|fentanyl|mesh-list
14403409|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
14403410|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738811|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14738812|NCT00556270|Narcotics|narcotics|mesh-ancestor
14738813|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738814|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738815|NCT00556270|Analgesics|analgesics|mesh-ancestor
14403411|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403412|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14403413|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
14403414|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738816|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
14738817|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403415|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14403416|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
14403417|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14403418|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14403419|NCT01480297|Analgesics|analgesics|mesh-ancestor
14403420|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
14403421|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403422|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403423|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403424|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14403425|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14403426|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403427|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738818|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14738819|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14738820|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
14738821|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
14738822|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14738823|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14738824|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738825|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14738826|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14403428|NCT01480596|Belimumab|belimumab|mesh-list
14403429|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403430|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
14403431|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403432|NCT01480674|Trastuzumab|trastuzumab|mesh-list
14403433|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14403434|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403435|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
14403436|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403437|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403438|NCT01481116|Glimepiride|glimepiride|mesh-list
14403439|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14403440|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403441|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403442|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403443|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
14403444|NCT01481545|Leucovorin|leucovorin|mesh-list
14403445|NCT01481545|Bevacizumab|bevacizumab|mesh-list
14403446|NCT01481545|Fluorouracil|fluorouracil|mesh-list
14403447|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
14403448|NCT01481545|Raltitrexed|raltitrexed|mesh-list
14738827|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14738828|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738829|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
15241069|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241070|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14403449|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
14403450|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14403451|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403452|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15241071|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241072|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15241073|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
15241074|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403453|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14403454|NCT01481545|Growth Substances|growth substances|mesh-ancestor
14403455|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403456|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
14403457|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
14403458|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403459|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14403460|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403461|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
14403462|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14403463|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403464|NCT01481545|Antidotes|antidotes|mesh-ancestor
14403465|NCT01481545|Protective Agents|protective agents|mesh-ancestor
14403466|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
14403467|NCT01481545|Vitamins|vitamins|mesh-ancestor
14403468|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
14403469|NCT01481740|Phenylephrine|phenylephrine|mesh-list
14403470|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
14403471|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14403472|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
14403473|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
14403474|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403475|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403476|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
14403477|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14403478|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
14403479|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
14403480|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14403481|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15241075|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15241076|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241077|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
15241078|NCT00472654|Vitamin D|vitamin d|mesh-list
15241079|NCT00472654|Vitamins|vitamins|mesh-ancestor
15241080|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
14403482|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14403483|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
14403484|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403485|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403486|NCT01481740|Protective Agents|protective agents|mesh-ancestor
14403487|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
14403488|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14738830|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241081|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738831|NCT00556348|Bevacizumab|bevacizumab|mesh-list
14738832|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738833|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738834|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14738835|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14738836|NCT00556348|Growth Substances|growth substances|mesh-ancestor
14738837|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738838|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
14738839|NCT00556361|Ketamine|ketamine|mesh-list
14738840|NCT00556361|Analgesics|analgesics|mesh-ancestor
14738841|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
14738842|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738843|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738844|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14738845|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14738846|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
14738847|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
14738848|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738849|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14738850|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15241082|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14738851|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241083|NCT00458536|Molgramostim|molgramostim|mesh-list
15241084|NCT00458536|Sargramostim|sargramostim|mesh-list
15241085|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
15241086|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241087|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241088|NCT00112840|Bevacizumab|bevacizumab|mesh-list
14738852|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403489|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403490|NCT01482091|Fentanyl|fentanyl|mesh-list
14403491|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14403492|NCT01482091|Narcotics|narcotics|mesh-ancestor
14403493|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403494|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403495|NCT01482091|Analgesics|analgesics|mesh-ancestor
14403496|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
14403497|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403498|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14403499|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14403500|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
14403501|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
14738853|NCT00556387|Ketamine|ketamine|mesh-list
14738854|NCT00556387|Analgesics|analgesics|mesh-ancestor
14738855|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
14738856|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738857|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738858|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14738859|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14738860|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
14738861|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
14738862|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14738863|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14738864|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14738865|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738866|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738867|NCT00556413|Leucovorin|leucovorin|mesh-list
14738868|NCT00556413|Fluorouracil|fluorouracil|mesh-list
14738869|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
14738870|NCT00556413|Irinotecan|irinotecan|mesh-list
14738871|NCT00556413|Cetuximab|cetuximab|mesh-list
14738872|NCT00556413|Calcium|calcium|mesh-list
14738873|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
14738874|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14738875|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738876|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
14738877|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403502|NCT01482169|Adenosine|adenosine|mesh-list
14403503|NCT01482169|Regadenoson|regadenoson|mesh-list
14403504|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14403505|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14403506|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
14403507|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
14403508|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738878|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14738879|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738880|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738881|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
14738882|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15241089|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241090|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241091|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15241092|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15241093|NCT00112840|Growth Substances|growth substances|mesh-ancestor
15241094|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241095|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
14403509|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403510|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403511|NCT01482169|Analgesics|analgesics|mesh-ancestor
14403512|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
14403513|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403514|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14403515|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
14403516|NCT01482715|Rucaparib|rucaparib|mesh-list
14403517|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14403518|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403519|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738883|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15241096|NCT05223244|Triamcinolone|triamcinolone|mesh-list
15241097|NCT05223244|Heparin|heparin|mesh-list
15241098|NCT05223244|Bupivacaine|bupivacaine|mesh-list
15241099|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15241100|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
15241101|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
14738884|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738885|NCT00556413|Antidotes|antidotes|mesh-ancestor
14738886|NCT00556413|Protective Agents|protective agents|mesh-ancestor
14738887|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
14738888|NCT00556413|Vitamins|vitamins|mesh-ancestor
15241102|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241103|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241104|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
15241105|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241106|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
15241107|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15241108|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15241109|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738889|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
14738890|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738891|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
14738892|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14738893|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
14738894|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738895|NCT00556465|Expectorants|expectorants|mesh-ancestor
14738896|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
14738897|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14738898|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
15241110|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14738899|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241111|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
15241112|NCT05223244|Hormones|hormones|mesh-ancestor
15241113|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241114|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15241115|NCT05223244|Protective Agents|protective agents|mesh-ancestor
15241116|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14403520|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403521|NCT01482767|Interferons|interferons|mesh-list
14403522|NCT01482767|Ribavirin|ribavirin|mesh-list
14403523|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
14403524|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
15241117|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
15241118|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
15241119|NCT05223088|Apatinib|apatinib|mesh-list
15241120|NCT05223088|Tegafur|tegafur|mesh-list
15241121|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241122|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15241123|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241124|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241125|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15241126|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
15241127|NCT05223075|Lidocaine|lidocaine|mesh-list
15241128|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15241129|NCT05223075|Carticaine|carticaine|mesh-list
15241130|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
15241131|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
15241132|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403525|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14403526|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403527|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
14403528|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403529|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
14403530|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403531|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
14403532|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403533|NCT01482910|Aflibercept|aflibercept|mesh-list
14403534|NCT01482910|Verteporfin|verteporfin|mesh-list
14403535|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14403536|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14403537|NCT01482910|Growth Substances|growth substances|mesh-ancestor
14403538|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403539|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
14403540|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403541|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14403542|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14403543|NCT01482962|Gemcitabine|gemcitabine|mesh-list
14403544|NCT01482962|Romidepsin|romidepsin|mesh-list
14403545|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14403546|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
14403547|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403548|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403549|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
14403550|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241133|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241134|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
15241135|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241136|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15241137|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15241138|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15241139|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15241140|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241141|NCT05223010|Sevoflurane|sevoflurane|mesh-list
15241142|NCT05223010|Melatonin|melatonin|mesh-list
15241143|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15241144|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15241145|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15241146|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
15241147|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
15241148|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241149|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241150|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
15241151|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241152|NCT05223010|Protective Agents|protective agents|mesh-ancestor
14403551|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403552|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241153|NCT05222932|Avelumab|avelumab|mesh-list
15241154|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14403553|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
14403554|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403555|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14403556|NCT01483144|Eflornithine|eflornithine|mesh-list
14403557|NCT01483144|Sulindac|sulindac|mesh-list
14403558|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403559|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14403560|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14738900|NCT00556465|Protective Agents|protective agents|mesh-ancestor
14738901|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738902|NCT00556465|Antidotes|antidotes|mesh-ancestor
14738903|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14738904|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
14738905|NCT00556608|Hylan|hylan|mesh-list
14738906|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14738907|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
14738908|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738909|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
14738910|NCT00556608|Protective Agents|protective agents|mesh-ancestor
14738911|NCT00556621|Gemcitabine|gemcitabine|mesh-list
14738912|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738913|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14738914|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
14738915|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738916|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
14738917|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403561|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14738918|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241155|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241156|NCT05222828|Mepivacaine|mepivacaine|mesh-list
15241157|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
14738919|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738920|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
14738921|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738922|NCT00556634|Efavirenz|efavirenz|mesh-list
14738923|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14738924|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14738925|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738926|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738927|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
14738928|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738929|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14738930|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14738931|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14738932|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14738933|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14738934|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14738935|NCT00556699|Rituximab|rituximab|mesh-list
14738936|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738937|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241158|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
15241159|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241160|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241161|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
15241162|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241163|NCT05222646|Metoclopramide|metoclopramide|mesh-list
15241164|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
15241165|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
15241166|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241167|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241168|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403562|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14738938|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
14738939|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738940|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753239|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753240|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753241|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14753242|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14753243|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
14753244|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241169|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15241170|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15241171|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
14753245|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753246|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
14753247|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
14753248|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
14753249|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
14753250|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14753251|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753252|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753253|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14753254|NCT05225610|Analgesics|analgesics|mesh-ancestor
14753255|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
14753256|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753257|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14753258|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14753259|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14753260|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
14753261|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753262|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753263|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
15241172|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241173|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241174|NCT05222633|Ranibizumab|ranibizumab|mesh-list
15241175|NCT05222633|Aflibercept|aflibercept|mesh-list
15241176|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15241177|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15241178|NCT05222633|Growth Substances|growth substances|mesh-ancestor
15241179|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241180|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
15241181|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241182|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15241183|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14403563|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14403564|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403565|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403566|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14403567|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14403568|NCT01483144|Analgesics|analgesics|mesh-ancestor
14403569|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
14403570|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403571|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403572|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403573|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14738941|NCT00556959|Clonidine|clonidine|mesh-list
14738942|NCT00556959|Analgesics|analgesics|mesh-ancestor
14738943|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
14738944|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738945|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738946|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14738947|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
14738948|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
14738949|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14738950|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14738951|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14738952|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14738953|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738954|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738955|NCT00557011|Amphetamine|amphetamine|mesh-list
14738956|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14738957|NCT00557011|Adderall|adderall|mesh-list
14738958|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14738959|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738960|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
14738961|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
14738962|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14738963|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
14738964|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738965|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738966|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
14738967|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14738968|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14738969|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14738970|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14738971|NCT00557102|Leucovorin|leucovorin|mesh-list
14738972|NCT00557102|Fluorouracil|fluorouracil|mesh-list
14738973|NCT00557102|Irinotecan|irinotecan|mesh-list
14738974|NCT00557102|Cetuximab|cetuximab|mesh-list
14403574|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14403575|NCT01483560|Metformin|metformin|mesh-list
14403576|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403577|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403578|NCT01483599|Adalimumab|adalimumab|mesh-list
14403579|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403580|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14403581|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
14403582|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14403583|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
14403584|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403585|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403586|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14738975|NCT00557102|Calcium|calcium|mesh-list
14403587|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
14738976|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
14403588|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
14753264|NCT05222529|Bromides|bromides|mesh-list
14403589|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14403590|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
14403591|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14738977|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14738978|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14738979|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
14738980|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14738981|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14738982|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14738983|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14738984|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
14738985|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14738986|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14738987|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14738988|NCT00557102|Antidotes|antidotes|mesh-ancestor
14738989|NCT00557102|Protective Agents|protective agents|mesh-ancestor
14738990|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
14738991|NCT00557102|Vitamins|vitamins|mesh-ancestor
14738992|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
14738993|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14738994|NCT00557180|Beclomethasone|beclomethasone|mesh-list
14738995|NCT00557180|Bromides|bromides|mesh-list
14738996|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
14403592|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403593|NCT01483651|Insulin|insulin|mesh-list
14738997|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14738998|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14403594|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14738999|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
14403595|NCT01483651|Glucagon|glucagon|mesh-list
14403596|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403597|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403598|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403599|NCT01483651|Hormones|hormones|mesh-ancestor
14403600|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241184|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403601|NCT01483690|Dexamethasone|dexamethasone|mesh-list
14403602|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
14403603|NCT01483690|Methotrexate|methotrexate|mesh-list
14403604|NCT01483690|Vincristine|vincristine|mesh-list
14403605|NCT01483690|Decitabine|decitabine|mesh-list
14403606|NCT01483690|Asparaginase|asparaginase|mesh-list
14403607|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
14403608|NCT01483690|Vorinostat|vorinostat|mesh-list
14403609|NCT01483690|Pegaspargase|pegaspargase|mesh-list
14403610|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14403611|NCT01483690|BB 1101|bb 1101|mesh-list
14403612|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739000|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739001|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739002|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739003|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
15241185|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739004|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
14739005|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15241186|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15241187|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15241188|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241189|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
15241190|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739006|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
14739007|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403613|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
14739008|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739009|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14739010|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14739011|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14739012|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739013|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
15241191|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
15241192|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241193|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241194|NCT05222334|Bupivacaine|bupivacaine|mesh-list
15241195|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
15241196|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
15241197|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241198|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241199|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
15241200|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241201|NCT05222243|Calcium|calcium|mesh-list
14403614|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
14403615|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403616|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403617|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403618|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
14403619|NCT01483690|Hormones|hormones|mesh-ancestor
14403620|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403621|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14403622|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403623|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
14403624|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403625|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403626|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14403627|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
14403628|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14739014|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739015|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
14739016|NCT00557180|Hormones|hormones|mesh-ancestor
14739017|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739018|NCT00557206|Docetaxel|docetaxel|mesh-list
14739019|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
14739020|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241202|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15241203|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241204|NCT05222204|Gemcitabine|gemcitabine|mesh-list
15241205|NCT05222204|Paclitaxel|paclitaxel|mesh-list
15241206|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15241207|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241208|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
15241209|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
15241210|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
15241211|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241212|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15241213|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
15241214|NCT05222204|Antiviral Agents|antiviral agents|mesh-ancestor
15241215|NCT05222204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241216|NCT05222204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241217|NCT05222204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241218|NCT05222204|Immunologic Factors|immunologic factors|mesh-ancestor
14739021|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14739022|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14739023|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14739024|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739025|NCT00557219|Fenoldopam|fenoldopam|mesh-list
15241219|NCT05222204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241220|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
15241221|NCT05222191|Spironolactone|spironolactone|mesh-list
14403629|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14403630|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
14403631|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
14403632|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14403633|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403634|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
14403635|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14403636|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14403637|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14403638|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14403639|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14403640|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14403641|NCT01483690|Analgesics|analgesics|mesh-ancestor
14403642|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
14739026|NCT00557219|Ketanserin|ketanserin|mesh-list
14403643|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14739027|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14739028|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
14739029|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
14739030|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
14739031|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403644|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14403645|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14403646|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15241222|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15241223|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
15241224|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241225|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241226|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14403647|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14403648|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403649|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403650|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14403651|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
14403652|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403653|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403654|NCT01484197|Maleic acid|maleic acid|mesh-list
14403655|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403656|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403657|NCT01484275|Siltuximab|siltuximab|mesh-list
14403658|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403659|NCT01484340|Nicotine|nicotine|mesh-list
14403660|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14403661|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
14403662|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403663|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403664|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14403665|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14403666|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
14403667|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403668|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403669|NCT01484431|Tadalafil|tadalafil|mesh-list
14403670|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
14403671|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14403672|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14403673|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403674|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403675|NCT01484431|Urological Agents|urological agents|mesh-ancestor
14403676|NCT01484496|Belimumab|belimumab|mesh-list
14739032|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739033|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739034|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14739035|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14739036|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
14739037|NCT00557232|Bevacizumab|bevacizumab|mesh-list
14739038|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739039|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739040|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14739041|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14739042|NCT00557232|Growth Substances|growth substances|mesh-ancestor
14739043|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241227|NCT05222191|Diuretics|diuretics|mesh-ancestor
15241228|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
15241229|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15241230|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15241231|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739044|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
14739045|NCT00557427|Fluoxetine|fluoxetine|mesh-list
14739046|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14739047|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15241232|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403677|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403678|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
14403679|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403680|NCT01484561|Tofacitinib|tofacitinib|mesh-list
14403681|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15241233|NCT05222165|Infigratinib|infigratinib|mesh-list
15241234|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241235|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
15241236|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14403682|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403683|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403684|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15241237|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15241238|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15241239|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241240|NCT05222113|Remdesivir|remdesivir|mesh-list
15241241|NCT05222113|Favipiravir|favipiravir|mesh-list
15241242|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
15241243|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241244|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
14739048|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739049|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739050|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241245|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241246|NCT05221892|Thiamine|thiamine|mesh-list
15241247|NCT05221892|Pyridoxine|pyridoxine|mesh-list
15241248|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
15241249|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
15241250|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
14403685|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14403686|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
14403687|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403688|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403689|NCT01484873|Exenatide|exenatide|mesh-list
14403690|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403691|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403692|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14403693|NCT01484873|Incretins|incretins|mesh-ancestor
14403694|NCT01484873|Hormones|hormones|mesh-ancestor
14403695|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403696|NCT01484951|Timolol|timolol|mesh-list
14403697|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14403698|NCT01484951|Brinzolamide|brinzolamide|mesh-list
14403699|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14403700|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14403701|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14403702|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
14403703|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403704|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403705|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403706|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14403707|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14403708|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14403709|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403710|NCT01484977|Lacosamide|lacosamide|mesh-list
14403711|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
14403712|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14403713|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14403714|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14403715|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403716|NCT01485055|Infliximab|infliximab|mesh-list
14403717|NCT01485055|Basiliximab|basiliximab|mesh-list
14403718|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
14403719|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403720|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14403721|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403722|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
14403723|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403724|NCT01485094|Pregabalin|pregabalin|mesh-list
14403725|NCT01485094|Analgesics|analgesics|mesh-ancestor
14403726|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
14403727|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403728|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403729|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
14403730|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14403731|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14403732|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403733|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14403734|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14403735|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14403736|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403737|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14403738|NCT01485172|Ropinirole|ropinirole|mesh-list
14403739|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14403740|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14403741|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
14403742|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
14403743|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403744|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403745|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403746|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
14403747|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14403748|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403749|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403750|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14403751|NCT01485380|Analgesics|analgesics|mesh-ancestor
14403752|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
14403753|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403754|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14403755|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14403756|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14403757|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
14403758|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403759|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403760|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
14403761|NCT01485393|Zolpidem|zolpidem|mesh-list
14403762|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14403763|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403764|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403765|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14403766|NCT01485393|Analgesics|analgesics|mesh-ancestor
14403767|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
14403768|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739051|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
14739052|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739053|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14403769|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14403770|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14403771|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14403772|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
14403773|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403774|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403775|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14403776|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14403777|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
14403778|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
14403779|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
14403780|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
14403781|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403782|NCT01485614|Metformin|metformin|mesh-list
14403783|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14403784|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403785|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739054|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
14739055|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739056|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14739057|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14739058|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739059|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14739060|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14739061|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739062|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
14739063|NCT00557544|Ketoprofen|ketoprofen|mesh-list
14739064|NCT00557544|Metoclopramide|metoclopramide|mesh-list
14739065|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
14739066|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
14739067|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241251|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241252|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
15241253|NCT05221892|Vitamins|vitamins|mesh-ancestor
15241254|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
15241255|NCT05221892|Hematinics|hematinics|mesh-ancestor
15241256|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
15241257|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241258|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241259|NCT05221879|Enoxaparin|enoxaparin|mesh-list
15241260|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
15241261|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15241262|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14739068|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739069|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739070|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14739071|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15241263|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403786|NCT01485614|Incretins|incretins|mesh-ancestor
15241264|NCT05221775|Lenvatinib|lenvatinib|mesh-list
14403787|NCT01485614|Hormones|hormones|mesh-ancestor
14403788|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739072|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
14739073|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739074|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739075|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14739076|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14739077|NCT00557544|Analgesics|analgesics|mesh-ancestor
14739078|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
15241265|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241266|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14739079|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739080|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739081|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14739082|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739083|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
14739084|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739085|NCT00557700|Bromides|bromides|mesh-list
14739086|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
14739087|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14739088|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
14739089|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739090|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739091|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739092|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
14739093|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
14739094|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14739095|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
14739096|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739097|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403789|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14403790|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
14403791|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241267|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241268|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241269|NCT05221749|Fluorides|fluorides|mesh-list
15241270|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
14403792|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403793|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14403794|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14403795|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14403796|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403797|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403798|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14403799|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14403800|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14403801|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14403802|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
14403803|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403804|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403805|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14403806|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14403807|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
14403808|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14403809|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14403810|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
14403811|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
14739098|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
14739099|NCT00557713|Bevacizumab|bevacizumab|mesh-list
14739100|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739101|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739102|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14739103|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14739104|NCT00557713|Growth Substances|growth substances|mesh-ancestor
14739105|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739106|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
14739107|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
14739108|NCT00557739|Nortriptyline|nortriptyline|mesh-list
14739109|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241271|NCT05221749|Protective Agents|protective agents|mesh-ancestor
15241272|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241273|NCT05221736|Ethanol|ethanol|mesh-list
15241274|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14739110|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
14403812|NCT01485796|Antibodies|antibodies|mesh-list
14403813|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
14403814|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14403815|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14403816|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
14403817|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403818|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14403819|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14403820|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14403821|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14403822|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403823|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403824|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403825|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14403826|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
14403827|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14403828|NCT01485991|Simeprevir|simeprevir|mesh-list
14403829|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
14403830|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403831|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
14403832|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403833|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403834|NCT01486043|Metformin|metformin|mesh-list
14403835|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403836|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403837|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
14403838|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14403839|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14403840|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14403841|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14403842|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739111|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14739112|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15241275|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241276|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241277|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739113|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
14739114|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739115|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15241278|NCT05221645|Rituximab|rituximab|mesh-list
15241279|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
15241280|NCT05221645|Carboplatin|carboplatin|mesh-list
15241281|NCT05221645|Etoposide|etoposide|mesh-list
15241282|NCT05221645|Ifosfamide|ifosfamide|mesh-list
15241283|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241284|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241285|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
15241286|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241287|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241288|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14739116|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14739117|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739118|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739119|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739120|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739121|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739122|NCT00557791|Ranibizumab|ranibizumab|mesh-list
14739123|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14739124|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14739125|NCT00557791|Growth Substances|growth substances|mesh-ancestor
14739126|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739127|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
15241289|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15241290|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15241291|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241292|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241293|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15241294|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
15241295|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
15241296|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
15241297|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15241298|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241299|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241300|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
14403843|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
14403844|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403845|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403846|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14403847|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403848|NCT01486615|Melatonin|melatonin|mesh-list
14403849|NCT01486615|Alprazolam|alprazolam|mesh-list
14403850|NCT01486615|Azaperone|azaperone|mesh-list
14403851|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
14924552|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924553|NCT01398592|Incretins|incretins|mesh-ancestor
14924554|NCT01398592|Hormones|hormones|mesh-ancestor
14924555|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924556|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14924557|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
15241301|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14403852|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403853|NCT01486615|Protective Agents|protective agents|mesh-ancestor
14403854|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241302|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241303|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241304|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15241305|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15241306|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241307|NCT05221554|Tacrine|tacrine|mesh-list
15241308|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15241309|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241310|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241311|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
15241312|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241313|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241314|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15241315|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
15241316|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403855|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403856|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14403857|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14403858|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14403859|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14403860|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
14403861|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
14403862|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403863|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14403864|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14403865|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
14403866|NCT01486758|Azithromycin|azithromycin|mesh-list
14403867|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14403868|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403869|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14403870|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14403871|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403872|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14403873|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14403874|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14403875|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403876|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
14403877|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739128|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739129|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
14739130|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14739131|NCT00557817|Hematinics|hematinics|mesh-ancestor
14739132|NCT00557843|Bupivacaine|bupivacaine|mesh-list
14739133|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
14739134|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
14403878|NCT01486927|Factor VIII|factor viii|mesh-list
14403879|NCT01486927|Coagulants|coagulants|mesh-ancestor
14403880|NCT01486966|Insulin|insulin|mesh-list
14403881|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14403882|NCT01486966|Metformin|metformin|mesh-list
14403883|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
14403884|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
14403885|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
14403886|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
14403887|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
14403888|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14403889|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403890|NCT01487161|Triamcinolone|triamcinolone|mesh-list
14403891|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14403892|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14403893|NCT01487161|FX006|fx006|mesh-list
14403894|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14403895|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403896|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
14739135|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403897|NCT01487161|Hormones|hormones|mesh-ancestor
14403898|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739136|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403899|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739137|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
14739138|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739139|NCT00557921|Aspirin|aspirin|mesh-list
14403900|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403901|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
14403902|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403903|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403904|NCT01487200|Triamcinolone|triamcinolone|mesh-list
14403905|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14403906|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14403907|NCT01487200|FX006|fx006|mesh-list
14403908|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14739140|NCT00557921|Omeprazole|omeprazole|mesh-list
14739141|NCT00557921|Clopidogrel|clopidogrel|mesh-list
14739142|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14739143|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14739144|NCT00557921|Analgesics|analgesics|mesh-ancestor
14739145|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
14739146|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739147|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739148|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739149|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739150|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14739151|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14403909|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403910|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
14403911|NCT01487200|Hormones|hormones|mesh-ancestor
14403912|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403913|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403914|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14403915|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
14403916|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403917|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753265|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
14403918|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15241317|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
15241318|NCT05221502|Bedaquiline|bedaquiline|mesh-list
15241319|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
15241320|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
15241321|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15241322|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241323|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15241324|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241325|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
15241326|NCT05221411|Tacrolimus|tacrolimus|mesh-list
15241327|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241328|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
15241329|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241330|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15241331|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241332|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241333|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15241334|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241335|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15241336|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
15241337|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15241338|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403919|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403920|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14403921|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403922|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403923|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
14403924|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14403925|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403926|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14403927|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
14403928|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14403929|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403930|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403931|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467340|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467341|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14467342|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
14467343|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
14467344|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467345|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467346|NCT02259348|Analgesics|analgesics|mesh-ancestor
14467347|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
14467348|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467349|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14467350|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14467351|NCT02259582|Carboplatin|carboplatin|mesh-list
14467352|NCT02259582|Pemetrexed|pemetrexed|mesh-list
14467353|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467354|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467355|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467356|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14467357|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14467358|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
14467359|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14467360|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
14467361|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467362|NCT02260154|Mebeverine|mebeverine|mesh-list
14467363|NCT02260154|Alverine|alverine|mesh-list
14467364|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
14467365|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
14467366|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
14467367|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467368|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467369|NCT02260258|Rocuronium|rocuronium|mesh-list
14403932|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
14739152|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739153|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14739154|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14739155|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739156|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
14739157|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14739158|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14739159|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14739160|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
14739161|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739162|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14739163|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739164|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14739165|NCT00557934|Dobutamine|dobutamine|mesh-list
14739166|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14739167|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
14403933|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403934|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14403935|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403936|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403937|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
14403938|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403939|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403940|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14403941|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
14403942|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14403943|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
14403944|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403945|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403946|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14403947|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
14403948|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14403949|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14403950|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14403951|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14403952|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403953|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403954|NCT01488071|Vortioxetine|vortioxetine|mesh-list
14739168|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
14739169|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739170|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739171|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14739172|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14739173|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14739174|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739175|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739176|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739177|NCT00557934|Protective Agents|protective agents|mesh-ancestor
14739178|NCT00557960|Amphetamine|amphetamine|mesh-list
14739179|NCT00557960|Adderall|adderall|mesh-list
14739180|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14739181|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14403955|NCT01488071|S 20098|s 20098|mesh-list
14403956|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
14739182|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14739183|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739184|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739185|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739186|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739187|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739188|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14739189|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
14739190|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
14739191|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739192|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
14739193|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14739194|NCT00558051|Vaccines|vaccines|mesh-list
14739195|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
14739196|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739197|NCT00558077|Metformin|metformin|mesh-list
14739198|NCT00558077|Clomiphene|clomiphene|mesh-list
14739199|NCT00558077|Enclomiphene|enclomiphene|mesh-list
14739200|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
14739201|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14739202|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739203|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14739204|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
14739205|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739206|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14739207|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
14739208|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14739209|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14739210|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14739211|NCT00558090|Morphine|morphine|mesh-list
14739212|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14739213|NCT00558090|Narcotics|narcotics|mesh-ancestor
14739214|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14739215|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739216|NCT00558090|Analgesics|analgesics|mesh-ancestor
14739217|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
14739218|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739219|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
14739220|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14739221|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
14739222|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14403957|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739223|NCT00558142|Expectorants|expectorants|mesh-ancestor
14739224|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
14739225|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14739226|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
14739227|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739228|NCT00558142|Protective Agents|protective agents|mesh-ancestor
14739229|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739230|NCT00558142|Antidotes|antidotes|mesh-ancestor
14739231|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
14739232|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14739233|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14739234|NCT00558181|Prednisolone|prednisolone|mesh-list
14739235|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
14739236|NCT00558181|Rituximab|rituximab|mesh-list
14739237|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14739238|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
14739239|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739240|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739241|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
14739242|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403958|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14403959|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14403960|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14403961|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403962|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14403963|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14403964|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14403965|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403966|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14403967|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
14403968|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14403969|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14403970|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14739243|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14403971|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14403972|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14403973|NCT01488188|Vaccines|vaccines|mesh-list
14403974|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
14403975|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739244|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739245|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
14403976|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14403977|NCT01488279|Dexamethasone|dexamethasone|mesh-list
14403978|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
14403979|NCT01488279|BB 1101|bb 1101|mesh-list
14403980|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14403981|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
14403982|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
14403983|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14403984|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14403985|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14403986|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
14403987|NCT01488279|Hormones|hormones|mesh-ancestor
14403988|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14403989|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14403990|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14403991|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
14403992|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14403993|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14403994|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14739246|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
14739247|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739248|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739249|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
14739250|NCT00558181|Hormones|hormones|mesh-ancestor
14739251|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739252|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14739253|NCT00558181|Protective Agents|protective agents|mesh-ancestor
14739254|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14739255|NCT00558298|Risperidone|risperidone|mesh-list
14739256|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14739257|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
14739258|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739259|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924558|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241339|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
15241340|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15241341|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241342|NCT05221190|Lidocaine|lidocaine|mesh-list
15241343|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
15241344|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
15241345|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241346|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241347|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
15241348|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241349|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15241350|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15241351|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15241352|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15241353|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241354|NCT05221164|Aspirin|aspirin|mesh-list
15241355|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15241356|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15241357|NCT05221164|Analgesics|analgesics|mesh-ancestor
15241358|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
15241359|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924559|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924560|NCT01398618|Rifampin|rifampin|mesh-list
14924561|NCT01398618|Isoniazid|isoniazid|mesh-list
14739260|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739261|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14739262|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14739263|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14739264|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739265|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14403995|NCT01488279|Incretins|incretins|mesh-ancestor
14739266|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
14739267|NCT00558337|Levodopa|levodopa|mesh-list
14739268|NCT00558337|Carbidopa|carbidopa|mesh-list
14739269|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14739270|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14739271|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14924562|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14924563|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
14924564|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14924565|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924566|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
14924567|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14924568|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924569|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924570|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14739272|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
14739273|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241360|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241361|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241362|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241363|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15241364|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15241365|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241366|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15241367|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15241368|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241369|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
15241370|NCT05220527|Triamcinolone|triamcinolone|mesh-list
15241371|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
15241372|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241373|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
15241374|NCT05220527|Hormones|hormones|mesh-ancestor
15241375|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241376|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241377|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
15241378|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15241379|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
14739274|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739275|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739276|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14739277|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739278|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14739279|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
14739280|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
14739281|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14739282|NCT00558376|Laxatives|laxatives|mesh-ancestor
14739283|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739284|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
14739285|NCT00558454|Hematinics|hematinics|mesh-ancestor
14739286|NCT00558480|Vitamins|vitamins|mesh-list
14739287|NCT00558480|Vitamin A|vitamin a|mesh-list
14739288|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
14739289|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
14739290|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739291|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
14739292|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739293|NCT00558480|Protective Agents|protective agents|mesh-ancestor
15241380|NCT05220527|Protective Agents|protective agents|mesh-ancestor
15241381|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
15241382|NCT05220280|Infliximab|infliximab|mesh-list
15241383|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241384|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15241385|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241386|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241387|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
15241388|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15241389|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241390|NCT05220228|Prucalopride|prucalopride|mesh-list
14739294|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14739295|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739296|NCT00558493|Clevudine|clevudine|mesh-list
14739297|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
14739298|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739299|NCT00558506|Abatacept|abatacept|mesh-list
14739300|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14739301|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739302|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739303|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739304|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
14739305|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739306|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739307|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
14739308|NCT00558623|Calcium|calcium|mesh-list
14739309|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14739310|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739311|NCT00558623|Antacids|antacids|mesh-ancestor
15241391|NCT05220228|Laxatives|laxatives|mesh-ancestor
15241392|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739312|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739313|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739314|NCT00558662|Monensin|monensin|mesh-list
14739315|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
14739316|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739317|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14739318|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14739319|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
14403996|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15241393|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14739320|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
14739321|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
14739322|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739323|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241394|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14403997|NCT01488318|Cetuximab|cetuximab|mesh-list
14403998|NCT01488318|Dasatinib|dasatinib|mesh-list
14403999|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404000|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404001|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14404002|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404003|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404004|NCT01488409|Acipimox|acipimox|mesh-list
14404005|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14404006|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
14404007|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404008|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14404009|NCT01488487|Everolimus|everolimus|mesh-list
14404010|NCT01488487|Pasireotide|pasireotide|mesh-list
14739324|NCT00558662|Ionophores|ionophores|mesh-ancestor
15241395|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
15241396|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241397|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241398|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241399|NCT05220020|Lenvatinib|lenvatinib|mesh-list
15241400|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241401|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15241402|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241403|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241404|NCT05219669|Nalmefene|nalmefene|mesh-list
15241405|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14404011|NCT01488487|Somatostatin|somatostatin|mesh-list
14739325|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14924571|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14924572|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14404012|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404013|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404014|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
14404015|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404016|NCT01488487|Hormones|hormones|mesh-ancestor
14404017|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404018|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14404019|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14404020|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14404021|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
14404022|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404023|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739326|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
14739327|NCT00558818|Clevudine|clevudine|mesh-list
14739328|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
14739329|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739330|NCT00558883|Acarbose|acarbose|mesh-list
14739331|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15241406|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739332|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739333|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404024|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404025|NCT01488578|Urological Agents|urological agents|mesh-ancestor
14404026|NCT01488877|Spironolactone|spironolactone|mesh-list
14404027|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14404028|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
14404029|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404030|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404031|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14739334|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14739335|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739336|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
14739337|NCT00558961|Chlorambucil|chlorambucil|mesh-list
15241407|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
14404032|NCT01488877|Diuretics|diuretics|mesh-ancestor
14404033|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
15241408|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404034|NCT01489020|Vaccines|vaccines|mesh-list
14404035|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
14404036|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404037|NCT01489189|Ranibizumab|ranibizumab|mesh-list
14404038|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14404039|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14404040|NCT01489189|Growth Substances|growth substances|mesh-ancestor
14739338|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739339|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14739340|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241409|NCT05219656|Cyclosporine|cyclosporine|mesh-list
15241410|NCT05219656|Cyclosporins|cyclosporins|mesh-list
15241411|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241412|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241413|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241414|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
15241415|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241416|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
15241417|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241418|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
15241419|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241420|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15241421|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15241422|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14404041|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739341|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739342|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14739343|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
14739344|NCT00559026|Dacarbazine|dacarbazine|mesh-list
14739345|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14739346|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
14739347|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739348|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739349|NCT00559052|Pancrelipase|pancrelipase|mesh-list
14739350|NCT00559052|Pancreatin|pancreatin|mesh-list
14739351|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14753266|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14753267|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14753268|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14753269|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
14753270|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404042|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14404043|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753271|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404044|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
14753272|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753273|NCT05220358|Fostemsavir|fostemsavir|mesh-list
14753274|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14753275|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14753276|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
14924573|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14924574|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14753277|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404045|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
14404046|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14404047|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
14404048|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404049|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404050|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241423|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241424|NCT05219409|Incretins|incretins|mesh-ancestor
15241425|NCT05219409|Hormones|hormones|mesh-ancestor
15241426|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241427|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15241428|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
15241429|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241430|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241431|NCT05219266|Midostaurin|midostaurin|mesh-list
15241432|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241433|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15241434|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241435|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404051|NCT01489670|Bimatoprost|bimatoprost|mesh-list
14404052|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14404053|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14404054|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14404055|NCT01489826|HU 211|hu 211|mesh-list
14404056|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14404057|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
14404058|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
14404059|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404060|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404061|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14404062|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14404063|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14404064|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404065|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404066|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14404067|NCT01489826|Protective Agents|protective agents|mesh-ancestor
14404068|NCT01489891|Lidocaine|lidocaine|mesh-list
14404069|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
14404070|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
14404071|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404072|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404073|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
14739352|NCT00559091|Ribavirin|ribavirin|mesh-list
14739353|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
14739354|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739355|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
14739356|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739357|NCT00559169|Verapamil|verapamil|mesh-list
14739358|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14739359|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14739360|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739361|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739362|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14739363|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739364|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
14739365|NCT00559182|Omeprazole|omeprazole|mesh-list
14739366|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14739367|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739368|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14739369|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404074|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404075|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14739370|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739371|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
14739372|NCT00559195|Hematinics|hematinics|mesh-ancestor
14739373|NCT00559286|Telmisartan|telmisartan|mesh-list
14739374|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14739375|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14739376|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14739377|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739378|NCT00559312|Fluticasone|fluticasone|mesh-list
14404076|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14404077|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14404078|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404079|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404080|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
14404081|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14404082|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14404083|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
14739379|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14739380|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14739381|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739382|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14739383|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
14739384|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739385|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739386|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739387|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14739388|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14739389|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14739390|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14739391|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14739392|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14739393|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739394|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739395|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739396|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
14739397|NCT00559312|Hormones|hormones|mesh-ancestor
14739398|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404084|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404085|NCT01489969|Melatonin|melatonin|mesh-list
15241436|NCT05198453|Vaccines|vaccines|mesh-list
14404086|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
15241437|NCT05198453|Immunologic Factors|immunologic factors|mesh-ancestor
15241438|NCT05198453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241439|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15241440|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15241441|NCT05197374|Estradiol|estradiol|mesh-list
15241442|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14739399|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
14739400|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14739401|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
14739402|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739403|NCT00559351|Fluorouracil|fluorouracil|mesh-list
14739404|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739405|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
14739406|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739407|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14739408|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739409|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
14739410|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739411|NCT00559429|Docetaxel|docetaxel|mesh-list
14739412|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14739413|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404087|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404088|NCT01489969|Protective Agents|protective agents|mesh-ancestor
14404089|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739414|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14739415|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14739416|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14739417|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739418|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14739419|NCT00559429|Analgesics|analgesics|mesh-ancestor
14739420|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
14739421|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739422|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739423|NCT00559455|Leucovorin|leucovorin|mesh-list
14739424|NCT00559455|Fluorouracil|fluorouracil|mesh-list
14739425|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
14739426|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
14739427|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739428|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14739429|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739430|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739431|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
14739432|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739433|NCT00559455|Antidotes|antidotes|mesh-ancestor
14739434|NCT00559455|Protective Agents|protective agents|mesh-ancestor
15241443|NCT05197374|Estrogens|estrogens|mesh-ancestor
15241444|NCT05197374|Hormones|hormones|mesh-ancestor
15241445|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241446|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241447|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15241448|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
15241449|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14404090|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404091|NCT01490060|Dexamethasone|dexamethasone|mesh-list
14404092|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
14739435|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
14739436|NCT00559455|Vitamins|vitamins|mesh-ancestor
14739437|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
14739438|NCT00559481|Ketoconazole|ketoconazole|mesh-list
14739439|NCT00559481|Dexamethasone|dexamethasone|mesh-list
14739440|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
14739441|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15241450|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14739442|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14404093|NCT01490060|Doxorubicin|doxorubicin|mesh-list
14739443|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14404094|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14404095|NCT01490060|Vincristine|vincristine|mesh-list
14739444|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739445|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
14739446|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
14739447|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739448|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739449|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739450|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
14739451|NCT00559481|Hormones|hormones|mesh-ancestor
14739452|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739453|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14739454|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739455|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
14739456|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241451|NCT05191290|Heparin|heparin|mesh-list
14404096|NCT01490060|Ifosfamide|ifosfamide|mesh-list
15241452|NCT05191290|Calcium heparin|calcium heparin|mesh-list
15241453|NCT05191290|Citric Acid|citric acid|mesh-list
15241454|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
15241455|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
15241456|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15241457|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
15241458|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
15241459|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241460|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15241461|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15241462|NCT05189028|Gemcitabine|gemcitabine|mesh-list
15241463|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241464|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15241465|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
15241466|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241467|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
15241468|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241469|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241470|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241471|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
15241472|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241473|NCT05187377|Hormones|hormones|mesh-list
15241474|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241475|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241476|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
15241477|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15241478|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241479|NCT05181124|Naproxen|naproxen|mesh-list
15241480|NCT05181124|Meloxicam|meloxicam|mesh-list
15241481|NCT05181124|Aceclofenac|aceclofenac|mesh-list
15241482|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15241483|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15241484|NCT05181124|Analgesics|analgesics|mesh-ancestor
15241485|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
14739457|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14739458|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14739459|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739460|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739461|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14739462|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
14924575|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14924576|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14924577|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14924578|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
14924579|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14924580|NCT01398657|Androgens|androgens|mesh-list
14404097|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
14404098|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
14404099|NCT01490060|Aprepitant|aprepitant|mesh-list
14404100|NCT01490060|BB 1101|bb 1101|mesh-list
14404101|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14404102|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
14404103|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
14404104|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404105|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739463|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14739464|NCT00559494|Minocycline|minocycline|mesh-list
14404106|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14404107|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
14404108|NCT01490060|Hormones|hormones|mesh-ancestor
14404109|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404110|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14404111|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404112|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
14404113|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404114|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404115|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14404116|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14404117|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14404118|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14404119|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
14404120|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
14739465|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14739466|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739467|NCT00559546|Montelukast|montelukast|mesh-list
14739468|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739469|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
14739470|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14739471|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
14739472|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739473|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739474|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14739475|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14739476|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739477|NCT00559676|Leucovorin|leucovorin|mesh-list
14739478|NCT00559676|Fluorouracil|fluorouracil|mesh-list
14739479|NCT00559676|Capecitabine|capecitabine|mesh-list
14739480|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
14739481|NCT00559676|Irinotecan|irinotecan|mesh-list
14739482|NCT00559676|Calcium|calcium|mesh-list
14739483|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
14739484|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14739485|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739486|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
14739487|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739488|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14739489|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404121|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
14404122|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14404123|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
14404124|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14404125|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924581|NCT01398657|Hormones|hormones|mesh-ancestor
14404126|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
14404127|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
14404128|NCT01490086|Aripiprazole|aripiprazole|mesh-list
14404129|NCT01490086|RP5063|rp5063|mesh-list
14404130|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
14404131|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739490|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739491|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
14739492|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14739493|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14739494|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739495|NCT00559676|Antidotes|antidotes|mesh-ancestor
14739496|NCT00559676|Protective Agents|protective agents|mesh-ancestor
14739497|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
14739498|NCT00559676|Vitamins|vitamins|mesh-ancestor
14739499|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
14739500|NCT00559689|Budesonide|budesonide|mesh-list
14739501|NCT00559689|Beclomethasone|beclomethasone|mesh-list
14739502|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739503|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14739504|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
14739505|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739506|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739507|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739508|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
14739509|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
14739510|NCT00559689|Hormones|hormones|mesh-ancestor
14739511|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739512|NCT00559702|Natalizumab|natalizumab|mesh-list
14739513|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
14739514|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739515|NCT00559715|Bevacizumab|bevacizumab|mesh-list
14739516|NCT00559715|Ranibizumab|ranibizumab|mesh-list
14739517|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739518|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739519|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14739520|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14739521|NCT00559715|Growth Substances|growth substances|mesh-ancestor
14739522|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739523|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
14739524|NCT00559741|Leucovorin|leucovorin|mesh-list
14739525|NCT00559741|Fluorouracil|fluorouracil|mesh-list
14739526|NCT00559741|Irinotecan|irinotecan|mesh-list
14739527|NCT00559741|Cetuximab|cetuximab|mesh-list
14739528|NCT00559741|Calcium|calcium|mesh-list
14739529|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
14739530|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14739531|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404132|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14404133|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14739532|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
14739533|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739534|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14739535|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739536|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739537|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
14404134|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404135|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404136|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
14404137|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
14404138|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404139|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404140|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15241486|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241487|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241488|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241489|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241490|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
15241491|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15241492|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241493|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404141|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14739538|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15241494|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14739539|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14739540|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739541|NCT00559741|Antidotes|antidotes|mesh-ancestor
14404142|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
14404143|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14404144|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14404145|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14404146|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14404147|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
14404148|NCT01490125|Albuterol|albuterol|mesh-list
14404149|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
14404150|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14404151|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
14404152|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404153|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404154|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14404155|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404156|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
14404157|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14404158|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
15241495|NCT05179499|Norepinephrine|norepinephrine|mesh-list
15241496|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15241497|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15241498|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
14404159|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404160|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404161|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
14404162|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14404163|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14404164|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14924582|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924583|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924584|NCT01398670|Insulin|insulin|mesh-list
14924585|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14924586|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
14924587|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924588|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924589|NCT01398722|Insulin|insulin|mesh-list
14924590|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14924591|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924592|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924593|NCT01398995|Insulin|insulin|mesh-list
14924594|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924595|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404165|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14404166|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14404167|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14404168|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14404169|NCT01490580|Atropine|atropine|mesh-list
14404170|NCT01490580|Sufentanil|sufentanil|mesh-list
14404171|NCT01490580|Propofol|propofol|mesh-list
14404172|NCT01490580|Atracurium|atracurium|mesh-list
14404173|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15241499|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241500|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241501|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241502|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
15241503|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
15241504|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241505|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15241506|NCT05168644|Niclosamide|niclosamide|mesh-list
15241507|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
14404174|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14924596|NCT01399086|Fulvestrant|fulvestrant|mesh-list
14739542|NCT00559741|Protective Agents|protective agents|mesh-ancestor
14739543|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
14739544|NCT00559741|Vitamins|vitamins|mesh-ancestor
14739545|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
14739546|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739547|NCT00559858|Pyridoxine|pyridoxine|mesh-list
14739548|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
14739549|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
14739550|NCT00559858|Vitamins|vitamins|mesh-ancestor
14739551|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
14739552|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739553|NCT00559975|Vaccines|vaccines|mesh-list
14739554|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
14739555|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739556|NCT00560079|Allopurinol|allopurinol|mesh-list
14739557|NCT00560079|Dipyridamole|dipyridamole|mesh-list
14739558|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
14739559|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739560|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739561|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
14739562|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739563|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14739564|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
14739565|NCT00560079|Protective Agents|protective agents|mesh-ancestor
14739566|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739567|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14739568|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14739569|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
14739570|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
14739571|NCT00560092|Analgesics|analgesics|mesh-ancestor
14739572|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
14739573|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404175|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404176|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14404177|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
14404178|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
14404179|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14404180|NCT01490580|Narcotics|narcotics|mesh-ancestor
14404181|NCT01490580|Analgesics|analgesics|mesh-ancestor
14404182|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
14404183|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404184|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14404185|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14404186|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14404187|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
14404188|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14404189|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404190|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
14404191|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
14404192|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14404193|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14404194|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
14404195|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404196|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404197|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14404198|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14739574|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404199|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14404200|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14739575|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
14739576|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14739577|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14739578|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
14404201|NCT01490697|Cycloserine|cycloserine|mesh-list
14404202|NCT01490697|Mifepristone|mifepristone|mesh-list
14404203|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14739579|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14739580|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739581|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739582|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14739583|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
14739584|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14404204|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
14404205|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14404206|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739585|NCT00560118|Fotemustine|fotemustine|mesh-list
14739586|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739587|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14404207|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14404208|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15241508|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15241509|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
15241510|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15241511|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241512|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
15241513|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
15241514|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15241515|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241516|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404209|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14404210|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
14404211|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14404212|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14404213|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
14404214|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404215|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
14739588|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
14739589|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739590|NCT00560170|Simvastatin|simvastatin|mesh-list
14739591|NCT00560170|Ezetimibe|ezetimibe|mesh-list
14739592|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14739593|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14739594|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14739595|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
14739596|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739597|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14739598|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14739599|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739600|NCT00560209|Landiolol|landiolol|mesh-list
14739601|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14739602|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14739603|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739604|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739605|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739606|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739607|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14739608|NCT00560222|Lactoferrin|lactoferrin|mesh-list
14739609|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739610|NCT00560274|Ribavirin|ribavirin|mesh-list
14739611|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14739612|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
14739613|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739614|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
14739615|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739616|NCT00560300|Vitamin D|vitamin d|mesh-list
14739617|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
14739618|NCT00560300|Calcitriol|calcitriol|mesh-list
14739619|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
15241517|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15241518|NCT05165836|Analgesics|analgesics|mesh-ancestor
15241519|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
15241520|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241521|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15241522|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15241523|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15241524|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
15241525|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241526|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241527|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
15241528|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241529|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241530|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
15241531|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241532|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241533|NCT05139225|Daratumumab|daratumumab|mesh-list
15241534|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241535|NCT05126264|Ibuprofen|ibuprofen|mesh-list
15241536|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15241537|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14739620|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14739621|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
14739622|NCT00560300|Calcium|calcium|mesh-list
14739623|NCT00560300|Sevelamer|sevelamer|mesh-list
14739624|NCT00560300|Vitamins|vitamins|mesh-ancestor
14739625|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
14739626|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739627|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14739628|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15241538|NCT05126264|Analgesics|analgesics|mesh-ancestor
15241539|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
15241540|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241541|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739629|NCT00560300|Antacids|antacids|mesh-ancestor
14739630|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404216|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14404217|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14404218|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14404219|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404220|NCT01490697|Renal Agents|renal agents|mesh-ancestor
14404221|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14404222|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
14739631|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739632|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14739633|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739634|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14739635|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
14739636|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
14739637|NCT00560326|Tacrolimus|tacrolimus|mesh-list
14739638|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739639|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
14739640|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739641|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14739642|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924597|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14924598|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753278|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14739643|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739644|NCT00560378|Tacrolimus|tacrolimus|mesh-list
14404223|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14404224|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
14404225|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404226|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
14404227|NCT01490723|Rituximab|rituximab|mesh-list
14404228|NCT01490723|Methotrexate|methotrexate|mesh-list
14404229|NCT01490723|Fludarabine|fludarabine|mesh-list
14739645|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739646|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
14404230|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
14404231|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14404232|NCT01490723|Tacrolimus|tacrolimus|mesh-list
14404233|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
14404234|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14404235|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14404236|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404237|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404238|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
14404239|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739647|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739648|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14739649|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739650|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739651|NCT00560430|Telmisartan|telmisartan|mesh-list
14739652|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14739653|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15241542|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241543|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241544|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15241545|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241546|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241547|NCT05095311|Cetirizine|cetirizine|mesh-list
15241548|NCT05095311|Nedocromil|nedocromil|mesh-list
15241549|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15241550|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15241551|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15241552|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
15241553|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
15241554|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241555|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739654|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15241556|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241557|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
15241558|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
15241559|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241560|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15241561|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
15241562|NCT05085873|Midazolam|midazolam|mesh-list
15241563|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
15241564|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15241565|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15241566|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241567|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241568|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15241569|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15241570|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15241571|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15241572|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
15241573|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
15241574|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
15241575|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
14739655|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739656|NCT00560443|Ketorolac|ketorolac|mesh-list
14739657|NCT00560443|Tramadol|tramadol|mesh-list
14739658|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14739659|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14739660|NCT00560443|Analgesics|analgesics|mesh-ancestor
14739661|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
14739662|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739663|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739664|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241576|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404240|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241577|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241578|NCT05081375|Enoxaparin|enoxaparin|mesh-list
15241579|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
15241580|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15241581|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15241582|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241583|NCT05062174|Mifepristone|mifepristone|mesh-list
15241584|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15241585|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
15241586|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15241587|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241588|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14924599|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14924600|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14924601|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
14924602|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924603|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739665|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739666|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14739667|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739668|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739669|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14739670|NCT00560443|Narcotics|narcotics|mesh-ancestor
14739671|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14739672|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14739673|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14739674|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
14739675|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
14739676|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739677|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739678|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14924604|NCT01399151|Vitamin D|vitamin d|mesh-list
14924605|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
14924606|NCT01399151|Vitamins|vitamins|mesh-list
14924607|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
14924608|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924609|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14924610|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15241589|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15241590|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15241591|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
15241592|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15241593|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14739679|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14924611|NCT01399216|Fucoidan|fucoidan|mesh-list
14924612|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14924613|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739680|NCT00560495|Growth Substances|growth substances|mesh-ancestor
14739681|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739682|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
14739683|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241594|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
15241595|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241596|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
15241597|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15241598|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15241599|NCT05053152|Relugolix|relugolix|mesh-list
15241600|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
15241601|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
15241602|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241603|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241604|NCT05052827|Caseins|caseins|mesh-list
15241605|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
14739684|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14739685|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
14739686|NCT00560547|Hematinics|hematinics|mesh-ancestor
14739687|NCT00560586|Budesonide|budesonide|mesh-list
14739688|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739689|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15241606|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
15241607|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404241|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14404242|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
14404243|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14739690|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
14739691|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241608|NCT05049278|Phenylephrine|phenylephrine|mesh-list
14404244|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14404245|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
15241609|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
15241610|NCT05049278|Norepinephrine|norepinephrine|mesh-list
15241611|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15241612|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
15241613|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
14404246|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404247|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
14404248|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404249|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14404250|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404251|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14404252|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404253|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14404254|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14404255|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14404256|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
14404257|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14404258|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14404259|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
14739692|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739693|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739694|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404260|NCT01490788|Amitriptyline|amitriptyline|mesh-list
14404261|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
14404262|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15241614|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241615|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739695|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
14739696|NCT00560586|Hormones|hormones|mesh-ancestor
14739697|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739698|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
14739699|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14739700|NCT00560599|Mupirocin|mupirocin|mesh-list
14739701|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14739702|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739703|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
14739704|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
14739705|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15241616|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
15241617|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15241618|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
14739706|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14739707|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404263|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
14404264|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739708|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739709|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14739710|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14739711|NCT00560690|Metformin|metformin|mesh-list
14739712|NCT00560690|Interferons|interferons|mesh-list
14404265|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14404266|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404267|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14404268|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404269|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14739713|NCT00560690|Ribavirin|ribavirin|mesh-list
14404270|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14739714|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15241619|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404271|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14404272|NCT01490788|Analgesics|analgesics|mesh-ancestor
14404273|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
14404274|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14404275|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14404276|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404277|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404278|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
14404279|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404280|NCT01490866|Leucovorin|leucovorin|mesh-list
14404281|NCT01490866|Bevacizumab|bevacizumab|mesh-list
14404282|NCT01490866|Fluorouracil|fluorouracil|mesh-list
14404283|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
14404284|NCT01490866|Axitinib|axitinib|mesh-list
14404285|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404286|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404287|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14404288|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14404289|NCT01490866|Growth Substances|growth substances|mesh-ancestor
14404290|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404291|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
14404292|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
14404293|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404294|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14404295|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404296|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
14404297|NCT01490866|Antidotes|antidotes|mesh-ancestor
14404298|NCT01490866|Protective Agents|protective agents|mesh-ancestor
14404299|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
14404300|NCT01490866|Vitamins|vitamins|mesh-ancestor
14404301|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
14924614|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
14924615|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404302|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924616|NCT01399242|Everolimus|everolimus|mesh-list
14739715|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739716|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739717|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
14739718|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739719|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
14739720|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739721|NCT00560820|Deferasirox|deferasirox|mesh-list
14739722|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14739723|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
14739724|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
14739725|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739726|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14753279|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14753280|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924617|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924618|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
14924619|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924620|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753281|NCT05218499|Doxorubicin|doxorubicin|mesh-list
14753282|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14753283|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753284|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14753285|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14753286|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753287|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753288|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14753289|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14753290|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
14753291|NCT05217589|Hormones|hormones|mesh-ancestor
14753292|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241620|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15241621|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15241622|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14924621|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
14924622|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14739727|NCT00560924|Estradiol|estradiol|mesh-list
14739728|NCT00560924|Estrogens|estrogens|mesh-ancestor
14739729|NCT00560924|Hormones|hormones|mesh-ancestor
14739730|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924623|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931096|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14931097|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14931098|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
14931210|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241623|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
15241624|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739731|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739732|NCT00560963|Everolimus|everolimus|mesh-list
15241625|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241626|NCT05049278|Protective Agents|protective agents|mesh-ancestor
15241627|NCT05039632|Nivolumab|nivolumab|mesh-list
15241628|NCT05039632|Ipilimumab|ipilimumab|mesh-list
15241629|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241630|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241631|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15241632|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241633|NCT05011357|Phenylephrine|phenylephrine|mesh-list
15241634|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
15241635|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14739733|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924624|NCT01399346|Insulin|insulin|mesh-list
14924625|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14924626|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
14924627|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
14924628|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14924629|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924630|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404303|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404304|NCT01490918|Metformin|metformin|mesh-list
14404305|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14404306|NCT01490918|Acarbose|acarbose|mesh-list
14404307|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14404308|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404309|NCT01490918|Incretins|incretins|mesh-ancestor
14404310|NCT01490918|Hormones|hormones|mesh-ancestor
14404311|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404312|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14404313|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
14404314|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404315|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404316|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14404317|NCT01490931|Ketorolac|ketorolac|mesh-list
14404318|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14404319|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14404320|NCT01490931|Analgesics|analgesics|mesh-ancestor
14404321|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
14924631|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14924632|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14404322|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404323|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739734|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241636|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
15241637|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
15241638|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241639|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241640|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
15241641|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15241642|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
15241643|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14739735|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
14739736|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739737|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14739738|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
14739739|NCT00560976|Hematinics|hematinics|mesh-ancestor
14739740|NCT00561028|Antibodies|antibodies|mesh-list
14739741|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
14739742|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739743|NCT00561054|Cetuximab|cetuximab|mesh-list
14739744|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739745|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739746|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
14739747|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14739748|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14739749|NCT00561067|Prednisolone|prednisolone|mesh-list
14739750|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
14739751|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
15241644|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15241645|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15241646|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14404324|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14404325|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739752|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14739753|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
14739754|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739755|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
14739756|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
14739757|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739758|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739759|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739760|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
14739761|NCT00561067|Hormones|hormones|mesh-ancestor
14739762|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739763|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14739764|NCT00561067|Protective Agents|protective agents|mesh-ancestor
14739765|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14739766|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739767|NCT00561067|Hematinics|hematinics|mesh-ancestor
14739768|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14739769|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
14739770|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14739771|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739772|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739773|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14739774|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14739775|NCT00561093|Protective Agents|protective agents|mesh-ancestor
14739776|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739777|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
14739778|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14739779|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
14739780|NCT00561106|Valacyclovir|valacyclovir|mesh-list
15241647|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
15241648|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739781|NCT00561106|Prednisone|prednisone|mesh-list
14404326|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14404327|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404328|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739782|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739783|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
14739784|NCT00561106|Hormones|hormones|mesh-ancestor
14739785|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739786|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739787|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14739788|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739789|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
14739790|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739791|NCT00561119|Gemcitabine|gemcitabine|mesh-list
14739792|NCT00561119|Paclitaxel|paclitaxel|mesh-list
14739793|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14739794|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739795|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14739796|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14739797|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14739798|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739799|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14739800|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
14739801|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
14739802|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739803|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739804|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739805|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
14739806|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739807|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
15241649|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241650|NCT05011357|Protective Agents|protective agents|mesh-ancestor
15241651|NCT05011188|Antibodies|antibodies|mesh-list
15241652|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
15241653|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
15241654|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
15241655|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241656|NCT05008809|Leucovorin|leucovorin|mesh-list
15241657|NCT05008809|Fluorouracil|fluorouracil|mesh-list
15241658|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
15241659|NCT05008809|Irinotecan|irinotecan|mesh-list
15241660|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
15241661|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
15241662|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739808|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
15241663|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15241664|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241665|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241666|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
15241667|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241668|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15241669|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14739809|NCT00561132|Antacids|antacids|mesh-ancestor
14739810|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739811|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14739812|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14739813|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739814|NCT00561184|Vaccines|vaccines|mesh-list
14739815|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
14739816|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739817|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
14739818|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14739819|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739820|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14739821|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
14739822|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15241670|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241671|NCT05008809|Antidotes|antidotes|mesh-ancestor
15241672|NCT05008809|Protective Agents|protective agents|mesh-ancestor
15241673|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
14404329|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
14404330|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14404331|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404332|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404333|NCT01491035|Vortioxetine|vortioxetine|mesh-list
14404334|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
14404335|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14404336|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14404337|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15241674|NCT05008809|Vitamins|vitamins|mesh-ancestor
15241675|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
15241676|NCT04963816|Dexamethasone|dexamethasone|mesh-list
15241677|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
15241678|NCT04963816|Bupivacaine|bupivacaine|mesh-list
15241679|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15241680|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15241681|NCT04963816|BB 1101|bb 1101|mesh-list
15241682|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241683|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
14739823|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739824|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14739825|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15241684|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
15241685|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404338|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404339|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404340|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14404341|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14739826|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14739827|NCT00561223|Iloprost|iloprost|mesh-list
14739828|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14739829|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
14404342|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404343|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404344|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404345|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
14404346|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14404347|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14404348|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14404349|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14404350|NCT01491113|Levetiracetam|levetiracetam|mesh-list
14404351|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
14739830|NCT00561288|Acetaminophen|acetaminophen|mesh-list
14739831|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14739832|NCT00561288|Analgesics|analgesics|mesh-ancestor
14739833|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
14739834|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739835|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739836|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
14739837|NCT00561327|Losartan|losartan|mesh-list
14739838|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14739839|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14739840|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14404352|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
14404353|NCT01491607|Vaccines|vaccines|mesh-list
14404354|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
14404355|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404356|NCT01491633|Dasatinib|dasatinib|mesh-list
14404357|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241686|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241687|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15241688|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
15241689|NCT04963816|Hormones|hormones|mesh-ancestor
15241690|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241691|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15241692|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241693|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
14404358|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14404359|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404360|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404361|NCT01491672|Everolimus|everolimus|mesh-list
14404362|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739841|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14739842|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739843|NCT00561379|Rituximab|rituximab|mesh-list
14739844|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739845|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739846|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
14739847|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404363|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404364|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
14404365|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404366|NCT01491737|Trastuzumab|trastuzumab|mesh-list
14404367|NCT01491737|Pertuzumab|pertuzumab|mesh-list
14404368|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14739848|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739849|NCT00561496|Tenofovir|tenofovir|mesh-list
14739850|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
14739851|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739852|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14739853|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14739854|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739855|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739856|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14404369|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404370|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404371|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14404372|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739857|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14404373|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739858|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
14739859|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739860|NCT00561522|Capecitabine|capecitabine|mesh-list
14739861|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14739862|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
14404374|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14404375|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
14404376|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404377|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404378|NCT01491841|Rituximab|rituximab|mesh-list
14404379|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14404380|NCT01491841|Pixantrone|pixantrone|mesh-list
14404381|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404382|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404383|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
14404384|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404385|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404386|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14404387|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
14404388|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404389|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14404390|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14404391|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404392|NCT01491919|Lisinopril|lisinopril|mesh-list
14404393|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14404394|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
14404395|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404396|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739863|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404397|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14404398|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14404399|NCT01491919|Protective Agents|protective agents|mesh-ancestor
14404400|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404401|NCT01491958|Methotrexate|methotrexate|mesh-list
14404402|NCT01491958|Atorvastatin|atorvastatin|mesh-list
14404403|NCT01491958|Tacrolimus|tacrolimus|mesh-list
14404404|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14404405|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
14404406|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14404407|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404408|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14404409|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
14404410|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404411|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404412|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
14404413|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739864|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739865|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14739866|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
14739867|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739868|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14739869|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14739870|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14739871|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739872|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
14739873|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14739874|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924633|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14404414|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14739875|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15241694|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241695|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241696|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
14924634|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14924635|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924636|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924637|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14924638|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15241697|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
14404415|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404416|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
14404417|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404418|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14739876|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
14739877|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14739878|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
14739879|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739880|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739881|NCT00561704|Losartan|losartan|mesh-list
14739882|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14739883|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14739884|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14739885|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14739886|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739887|NCT00561717|Cetirizine|cetirizine|mesh-list
14739888|NCT00561717|Loratadine|loratadine|mesh-list
14739889|NCT00561717|Azelastine|azelastine|mesh-list
14739890|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14739891|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14739892|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14739893|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
14739894|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
14739895|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739896|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739897|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739898|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
14739899|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14739900|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14739901|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
14739902|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739903|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739904|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
14739905|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14739906|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739907|NCT00561756|Vaccines|vaccines|mesh-list
14739908|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
14739909|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739910|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
14924639|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
14924640|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241698|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241699|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
15241700|NCT04933552|Siponimod|siponimod|mesh-list
15241701|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15241702|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404419|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14404420|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14404421|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14404422|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14404423|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14404424|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15241703|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15241704|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
15241705|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241706|NCT04933240|Tamoxifen|tamoxifen|mesh-list
15241707|NCT04933240|Estradiol|estradiol|mesh-list
15241708|NCT04933240|Estrogens|estrogens|mesh-ancestor
15241709|NCT04933240|Hormones|hormones|mesh-ancestor
15241710|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241711|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241712|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14924641|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241713|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
14739911|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14739912|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
14739913|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14739914|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739915|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14739916|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404425|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404426|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404427|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
14404428|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739917|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14739918|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14739919|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14739920|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739921|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739922|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739923|NCT00561899|Piperaquine|piperaquine|mesh-list
14739924|NCT00561899|Amodiaquine|amodiaquine|mesh-list
14739925|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
14739926|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14739927|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14739928|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739929|NCT00561964|Irbesartan|irbesartan|mesh-list
14739930|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14739931|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14739932|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14739933|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241714|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15241715|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404429|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14404430|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14404431|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404432|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404433|NCT01492400|Dexamethasone|dexamethasone|mesh-list
14404434|NCT01492400|Ranibizumab|ranibizumab|mesh-list
15241716|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15241717|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15241718|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15241719|NCT04924322|Enoxaparin|enoxaparin|mesh-list
15241720|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
15241721|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15241722|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15241723|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241724|NCT04917861|Vaccines|vaccines|mesh-list
15241725|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
14404435|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14404436|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
15241726|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404437|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
14404438|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404439|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241727|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15241728|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15241729|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
15241730|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241731|NCT04915768|Antacids|antacids|mesh-ancestor
15241732|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241733|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15241734|NCT04891289|Gemcitabine|gemcitabine|mesh-list
14404440|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14404441|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
14404442|NCT01492400|Hormones|hormones|mesh-ancestor
14404443|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404444|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14404445|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404446|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14404447|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14404448|NCT01492400|Growth Substances|growth substances|mesh-ancestor
14739934|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
14739935|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739936|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739937|NCT00562055|Reboxetine|reboxetine|mesh-list
14739938|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14739939|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14739940|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14739941|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14739942|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404449|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
14404450|NCT01492426|Ribavirin|ribavirin|mesh-list
14404451|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14404452|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
14739943|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
14739944|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14739945|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739946|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
14739947|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14739948|NCT00562068|Prednisolone|prednisolone|mesh-list
14739949|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
14739950|NCT00562068|Doxorubicin|doxorubicin|mesh-list
14739951|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14739952|NCT00562068|Vincristine|vincristine|mesh-list
14739953|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
14924642|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15241735|NCT04891289|Dexamethasone|dexamethasone|mesh-list
14404453|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404454|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
14404455|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241736|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
15241737|NCT04891289|Floxuridine|floxuridine|mesh-list
15241738|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241739|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
15241740|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
15241741|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241742|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241743|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15241744|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
14739954|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739955|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
14739956|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241745|NCT04891289|Hormones|hormones|mesh-ancestor
14404456|NCT01492582|Vaccines|vaccines|mesh-list
14404457|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
14404458|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404459|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
14404460|NCT01492673|Bevacizumab|bevacizumab|mesh-list
14404461|NCT01492673|Topotecan|topotecan|mesh-list
14404462|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404463|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
14404464|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404465|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404466|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14404467|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
14404468|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404469|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404470|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14404471|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404472|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14404473|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14404474|NCT01492673|Growth Substances|growth substances|mesh-ancestor
14404475|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14404476|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14404477|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14404478|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404479|NCT01492686|Edaravone|edaravone|mesh-list
14404480|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14739957|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14739958|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15241746|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404481|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
14404482|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404483|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15241747|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15241748|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241749|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15241750|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
15241751|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241752|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
15241753|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241754|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241755|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404484|NCT01492686|Protective Agents|protective agents|mesh-ancestor
14404485|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404486|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
14404487|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14404488|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404489|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404490|NCT01493180|Rebamipide|rebamipide|mesh-list
14404491|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14404492|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
14404493|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14404494|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14404495|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
14404496|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404497|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
14739959|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
14924643|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14924644|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
14924645|NCT01399463|Paclitaxel|paclitaxel|mesh-list
14739960|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739961|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739962|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14739963|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14739964|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14739965|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14739966|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739967|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14739968|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
14739969|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
14924646|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15241756|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
14739970|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
14739971|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14739972|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
14739973|NCT00562068|Hormones|hormones|mesh-ancestor
14739974|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14739975|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14739976|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14739977|NCT00562133|Insulin|insulin|mesh-list
14739978|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14739979|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
14739980|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14739981|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739982|NCT00562172|Metformin|metformin|mesh-list
14739983|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
14739984|NCT00562172|Glimepiride|glimepiride|mesh-list
15241757|NCT04891250|Ivermectin|ivermectin|mesh-list
15241758|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15241759|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15241760|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
15241761|NCT04889703|Salicylates|salicylates|mesh-list
15241762|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14739985|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924647|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924648|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
14924649|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
14924650|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
14924651|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924652|NCT01399515|Valproic Acid|valproic acid|mesh-list
14924653|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
14924654|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924655|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924656|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
14924657|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924658|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924659|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
15241763|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
15241764|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
14739986|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14739987|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14739988|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14739989|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
14404498|NCT01493180|Protective Agents|protective agents|mesh-ancestor
14404499|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14404500|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14404501|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
14404502|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404503|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404504|NCT01493427|Travoprost|travoprost|mesh-list
14404505|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14404506|NCT01493531|Allopurinol|allopurinol|mesh-list
14404507|NCT01493531|Lesinurad|lesinurad|mesh-list
14404508|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
14404509|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404510|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404511|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
14404512|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404513|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14404514|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
14404515|NCT01493531|Protective Agents|protective agents|mesh-ancestor
14404516|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404517|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
14404518|NCT01493531|Renal Agents|renal agents|mesh-ancestor
14404519|NCT01493557|Pantoprazole|pantoprazole|mesh-list
14404520|NCT01493557|Dabigatran|dabigatran|mesh-list
14404521|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
14404522|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14739990|NCT00562185|Carboplatin|carboplatin|mesh-list
14739991|NCT00562185|Doxorubicin|doxorubicin|mesh-list
14739992|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14404523|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
14404524|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404525|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404526|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
14404527|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14404528|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15241765|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
15241766|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15241767|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15241768|NCT04889703|Analgesics|analgesics|mesh-ancestor
15241769|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
14739993|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14739994|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14739995|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14739996|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14739997|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14739998|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14739999|NCT00562198|Carbidopa|carbidopa|mesh-list
14740000|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14740001|NCT00562198|Entacapone|entacapone|mesh-list
14740002|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15241770|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404529|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14404530|NCT01493687|Azelaic acid|azelaic acid|mesh-list
14404531|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404532|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14404533|NCT01493947|Metronidazole|metronidazole|mesh-list
14404534|NCT01493947|Ivermectin|ivermectin|mesh-list
14404535|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404536|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14404537|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14404538|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14924660|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15241771|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241772|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241773|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241774|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14404539|NCT01494038|Isoniazid|isoniazid|mesh-list
14404540|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
14404541|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14404542|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404543|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14404544|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14404545|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
14404546|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740003|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15241775|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241776|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241777|NCT04887792|Acetazolamide|acetazolamide|mesh-list
14740004|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
14740005|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740006|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740007|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740008|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14740009|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740010|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14740011|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
14740012|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
14740013|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14740014|NCT00562224|Abexinostat|abexinostat|mesh-list
14740015|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14740016|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740017|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740018|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
14740019|NCT00562250|Glimepiride|glimepiride|mesh-list
14740020|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14740021|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740022|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14740023|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740024|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14740025|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740026|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
14740027|NCT00562289|Aspirin|aspirin|mesh-list
14740028|NCT00562289|Dipyridamole|dipyridamole|mesh-list
14740029|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
14740030|NCT00562289|Apixaban|apixaban|mesh-list
14740031|NCT00562289|Dabigatran|dabigatran|mesh-list
15241778|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
15241779|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15241780|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241781|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241782|NCT04887792|Diuretics|diuretics|mesh-ancestor
15241783|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
14740032|NCT00562289|Antivitamins K|antivitamins k|mesh-list
14740033|NCT00562289|Clopidogrel|clopidogrel|mesh-list
14740034|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14740035|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14740036|NCT00562289|Analgesics|analgesics|mesh-ancestor
14740037|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
14740038|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740039|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740040|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241784|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241785|NCT04875715|Hydroquinone|hydroquinone|mesh-list
15241786|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
15241787|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241788|NCT04875715|Protective Agents|protective agents|mesh-ancestor
15241789|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241790|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15241791|NCT04873375|Cemiplimab|cemiplimab|mesh-list
15241792|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241793|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241794|NCT04857931|Colchicine|colchicine|mesh-list
15241795|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
14404547|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14404548|NCT01494350|Gentamicins|gentamicins|mesh-list
14404549|NCT01494350|Paromomycin|paromomycin|mesh-list
14404550|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14404551|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404552|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14404553|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404554|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404555|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14404556|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14404557|NCT01494467|Azelaic acid|azelaic acid|mesh-list
14404558|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404559|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
14404560|NCT01494506|Leucovorin|leucovorin|mesh-list
14404561|NCT01494506|Fluorouracil|fluorouracil|mesh-list
14404562|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
14404563|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404564|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14404565|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404566|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404567|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
14404568|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404569|NCT01494506|Antidotes|antidotes|mesh-ancestor
14404570|NCT01494506|Protective Agents|protective agents|mesh-ancestor
14404571|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
14404572|NCT01494506|Vitamins|vitamins|mesh-ancestor
14404573|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
14404574|NCT01494532|Ropinirole|ropinirole|mesh-list
14404575|NCT01494532|Levodopa|levodopa|mesh-list
14404576|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14404577|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
14404578|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740041|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241796|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241797|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
15241798|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
15241799|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
15241800|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241801|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404579|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404580|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404581|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15241802|NCT04814433|Lidocaine|lidocaine|mesh-list
15241803|NCT04814433|Epinephrine|epinephrine|mesh-list
15241804|NCT04814433|Racepinephrine|racepinephrine|mesh-list
15241805|NCT04814433|Bupivacaine|bupivacaine|mesh-list
14740042|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14740043|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14740044|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740045|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15241806|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
15241807|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
15241808|NCT04814433|Thrombin|thrombin|mesh-list
15241809|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
15241810|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
15241811|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
15241812|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241813|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241814|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
15241815|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241816|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15241817|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15241818|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15241819|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15241820|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241821|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15241822|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15241823|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
15241824|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241825|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15241826|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15241827|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
15241828|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14740046|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14740047|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740048|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
15241829|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
15241830|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
14740049|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15241831|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
15241832|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15241833|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15241834|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14404582|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14740050|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14740051|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14740052|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
14740053|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740054|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14740055|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
14740056|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14404583|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
14404584|NCT01494584|Ezogabine|ezogabine|mesh-list
14404585|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
14404586|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404587|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404588|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14740057|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
14740058|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
14740059|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14740060|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
14740061|NCT00562406|Ranibizumab|ranibizumab|mesh-list
14740062|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14740063|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14740064|NCT00562406|Growth Substances|growth substances|mesh-ancestor
14740065|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740066|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
14740067|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740068|NCT00562419|Irinotecan|irinotecan|mesh-list
14740069|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14740070|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14740071|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740072|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740073|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740074|NCT00562458|Anastrozole|anastrozole|mesh-list
14740075|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14740076|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740077|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14740078|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14740079|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740080|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740081|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14740082|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
14740083|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740084|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740085|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
14740086|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14740087|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14740088|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
14740089|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740090|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14740091|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14740092|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740093|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740094|NCT00562523|Sorafenib|sorafenib|mesh-list
15241835|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
15241836|NCT04814433|Coagulants|coagulants|mesh-ancestor
15241837|NCT04805125|Vaccines|vaccines|mesh-list
15241838|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
15241839|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241840|NCT04789499|Theophylline|theophylline|mesh-list
15241841|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15241842|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
15241843|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740095|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740096|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14740097|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740098|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740099|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
14740100|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740101|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
14740102|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740103|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740104|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14740105|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
14740106|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241844|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241845|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15241846|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404589|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14404590|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
14404591|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404592|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404593|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14404594|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404595|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
14404596|NCT01494610|Hormones|hormones|mesh-ancestor
14467370|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14740107|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241847|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15241848|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241849|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241850|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
15241851|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15241852|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15241853|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
15241854|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241855|NCT04776993|Methimazole|methimazole|mesh-list
15241856|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
15241857|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
15241858|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241859|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241860|NCT04765644|Celecoxib|celecoxib|mesh-list
14740108|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15241861|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15241862|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15241863|NCT04765644|Analgesics|analgesics|mesh-ancestor
15241864|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
15241865|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241866|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241867|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241868|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15241869|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15241870|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14404597|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740109|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14740110|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
14740111|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740112|NCT00562705|Hormones|hormones|mesh-list
14740113|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740114|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404598|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
14404599|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14404600|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
14404601|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14404602|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14404603|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753293|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753294|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753295|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753810|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753811|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241871|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241872|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241873|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14753812|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14924661|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14924662|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924663|NCT01399645|Insulin|insulin|mesh-list
14924664|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14924665|NCT01399645|Metformin|metformin|mesh-list
14924666|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
14924667|NCT01399645|Liraglutide|liraglutide|mesh-list
14924668|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924669|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924670|NCT01399645|Incretins|incretins|mesh-ancestor
14924671|NCT01399645|Hormones|hormones|mesh-ancestor
14924672|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924673|NCT01399840|Talazoparib|talazoparib|mesh-list
14924674|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14924675|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924676|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241874|NCT04747314|Aripiprazole|aripiprazole|mesh-list
15241875|NCT04747314|Mirtazapine|mirtazapine|mesh-list
15241876|NCT04747314|Citalopram|citalopram|mesh-list
15241877|NCT04747314|Bupropion|bupropion|mesh-list
15241878|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15241879|NCT04747314|Sertraline|sertraline|mesh-list
15241880|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
15241881|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15241882|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14740115|NCT00562770|Valacyclovir|valacyclovir|mesh-list
14740116|NCT00562770|Valganciclovir|valganciclovir|mesh-list
14740117|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
14740118|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740119|NCT00562809|Irbesartan|irbesartan|mesh-list
14740120|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14740121|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14740122|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14740123|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740124|NCT00562835|Thiamine|thiamine|mesh-list
14740125|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
14740126|NCT00562835|Vitamins|vitamins|mesh-ancestor
14740127|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
14740128|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740129|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740130|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
14740131|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
14740132|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740133|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14740134|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
14740135|NCT00562835|Hormones|hormones|mesh-ancestor
14740136|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740137|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14740138|NCT00562835|Protective Agents|protective agents|mesh-ancestor
14740139|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
14740140|NCT00562913|Sorafenib|sorafenib|mesh-list
15241883|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15241884|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241885|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241886|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
15241887|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241888|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15241889|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15241890|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15241891|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15241892|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
15241893|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15241894|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15241895|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241896|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15241897|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15241898|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15241899|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
15241900|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15241901|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15241902|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15241903|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15241904|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15241905|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15241906|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14740141|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241907|NCT04747314|Analgesics|analgesics|mesh-ancestor
15241908|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
15241909|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15241910|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
15241911|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
15241912|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15241913|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15241914|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15241915|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15241916|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
15241917|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15241918|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15241919|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
15241920|NCT04740645|Coagulants|coagulants|mesh-ancestor
15241921|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15241922|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
15241923|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241924|NCT04730193|Caffeine|caffeine|mesh-list
15241925|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14740142|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14740143|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241926|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241927|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15241928|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241929|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241930|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15241931|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15241932|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
15241933|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241934|NCT04717765|Vitamin E|vitamin e|mesh-list
15241935|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
15241936|NCT04717765|Tocopherols|tocopherols|mesh-list
15241937|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
14740144|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740145|NCT00562939|Vaccines|vaccines|mesh-list
14740146|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14740147|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
14740148|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740149|NCT00562952|Telmisartan|telmisartan|mesh-list
14740150|NCT00562952|Bisoprolol|bisoprolol|mesh-list
14740151|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14740152|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14740153|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14740154|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740155|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
14740156|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
14740157|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740158|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241938|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241939|NCT04717765|Protective Agents|protective agents|mesh-ancestor
15241940|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404604|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
14467371|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14467372|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15241941|NCT04717765|Vitamins|vitamins|mesh-ancestor
15241942|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
14740159|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14740160|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14740161|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14404605|NCT01494987|Glimepiride|glimepiride|mesh-list
14404606|NCT01494987|Ranolazine|ranolazine|mesh-list
14404607|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14404608|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14404609|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404610|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404611|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
14404612|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14404613|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404614|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740162|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740163|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740164|NCT00563017|Risperidone|risperidone|mesh-list
14740165|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14740166|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
14740167|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740168|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740169|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740170|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14740171|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14404615|NCT01495000|Denosumab|denosumab|mesh-list
14404616|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14404617|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404618|NCT01495481|Adenosine|adenosine|mesh-list
14404619|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
14404620|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14404621|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404622|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404623|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14404624|NCT01495481|Analgesics|analgesics|mesh-ancestor
14404625|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
14404626|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404627|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14404628|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14404629|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14404630|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
14404631|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404632|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404633|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14404634|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
14404635|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14404636|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
14404637|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
14404638|NCT01495572|Aldesleukin|aldesleukin|mesh-list
14404639|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
14404640|NCT01495572|Fludarabine|fludarabine|mesh-list
14404641|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404642|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
14404643|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404644|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404645|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14404646|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
14404647|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404648|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404649|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14404650|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14740172|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740173|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14740174|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14740175|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
14740176|NCT00563056|Fluticasone|fluticasone|mesh-list
14404651|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14404652|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
14404653|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404654|NCT01495585|Lonafarnib|lonafarnib|mesh-list
14404655|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404656|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404657|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14404658|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
14404659|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404660|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14404661|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14404662|NCT01495793|Rotigotine|rotigotine|mesh-list
14404663|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
14404664|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
14404665|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404666|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740177|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
14740178|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14404667|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404668|NCT01495819|Nicotine|nicotine|mesh-list
14404669|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14404670|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
14404671|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404672|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404673|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14404674|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14404675|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
14404676|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404677|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404678|NCT01495858|Naproxen|naproxen|mesh-list
14740179|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
14740180|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740181|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740182|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14740183|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
14740184|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14740185|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14740186|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14740187|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740188|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404679|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14404680|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14404681|NCT01495858|Analgesics|analgesics|mesh-ancestor
14404682|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
14404683|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404684|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241943|NCT04705818|Durvalumab|durvalumab|mesh-list
15241944|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241945|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241946|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
15241947|NCT04704219|Lenvatinib|lenvatinib|mesh-list
15241948|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15241949|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241950|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15241951|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241952|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241953|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14740189|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740190|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740191|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14740192|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14740193|NCT00563069|Midazolam|midazolam|mesh-list
14740194|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14740195|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14740196|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740197|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740198|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14740199|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14740200|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14740201|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14740202|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
14740203|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
15241954|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15241955|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241956|NCT04671355|Fluticasone|fluticasone|mesh-list
15241957|NCT04671355|Xhance|xhance|mesh-list
15241958|NCT04671355|Beclomethasone|beclomethasone|mesh-list
15241959|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
15241960|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
15241961|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15241962|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15241963|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
15241964|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404685|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14404686|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404687|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
14404688|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14404689|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404690|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740204|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
14740205|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
14740206|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740207|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740208|NCT00563095|Interferons|interferons|mesh-list
14740209|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740210|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
14740211|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740212|NCT00563108|Basiliximab|basiliximab|mesh-list
14740213|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740214|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
14740215|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740216|NCT00563147|Sirolimus|sirolimus|mesh-list
14740217|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740218|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740219|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14740220|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740221|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
14740222|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404691|NCT01495923|Gabapentin|gabapentin|mesh-list
14404692|NCT01495923|Analgesics|analgesics|mesh-ancestor
14404693|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
14404694|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404695|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404696|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
14404697|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14404698|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14404699|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740223|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
14740224|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15241965|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740225|NCT00563160|Gemcitabine|gemcitabine|mesh-list
14404700|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14740226|NCT00563160|Carboplatin|carboplatin|mesh-list
14740227|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740228|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14740229|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
14740230|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740231|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
14740232|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740233|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740234|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740235|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
14740236|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740237|NCT00563212|Interferons|interferons|mesh-list
14740238|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
14740239|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740240|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
14740241|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740242|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
14740243|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14404701|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14404702|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14404703|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404704|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404705|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
14404706|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
14404707|NCT01496131|Goserelin|goserelin|mesh-list
14404708|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
14404709|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404710|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404711|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404712|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14740244|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740245|NCT00563238|Metoprolol|metoprolol|mesh-list
15241966|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14404713|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
14404714|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404715|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404716|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14404717|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14404718|NCT01496183|Olanzapine|olanzapine|mesh-list
14404719|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
14404720|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
14404721|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404722|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404723|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14404724|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14404725|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14404726|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404727|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14404728|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14404729|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14404730|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404731|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404732|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404733|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
14404734|NCT01496365|Pregabalin|pregabalin|mesh-list
14404735|NCT01496365|Analgesics|analgesics|mesh-ancestor
14404736|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
14404737|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404738|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404739|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
14404740|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14740246|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15241967|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
15241968|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
15241969|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15241970|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15241971|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15241972|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15241973|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
15241974|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15241975|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241976|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15241977|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15241978|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15241979|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
15241980|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
15241981|NCT04671355|Hormones|hormones|mesh-ancestor
15241982|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15241983|NCT04651400|Antithrombins|antithrombins|mesh-list
15241984|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
15241985|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15241986|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
15241987|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15241988|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15241989|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
15241990|NCT04627246|Vaccines|vaccines|mesh-list
15241991|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
15241992|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404741|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404742|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404743|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14404744|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14404745|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14404746|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404747|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14404748|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14404749|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14404750|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14404751|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404752|NCT01496469|Febuxostat|febuxostat|mesh-list
14404753|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
14404754|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404755|NCT01496612|Buspirone|buspirone|mesh-list
14404756|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14404757|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14404758|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404759|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404760|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14404761|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14404762|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
14740247|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14740248|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
14740249|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
14740250|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740251|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404763|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740252|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14740253|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14740254|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14740255|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740256|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740257|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740258|NCT00563251|Azithromycin|azithromycin|mesh-list
14740259|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740260|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740261|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
14740262|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740263|NCT00563342|Ethanol|ethanol|mesh-list
14740264|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14740265|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740266|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740267|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740268|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
14740269|NCT00563355|Hematinics|hematinics|mesh-ancestor
14740270|NCT00563394|Ofloxacin|ofloxacin|mesh-list
14740271|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14740272|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740273|NCT00563394|Renal Agents|renal agents|mesh-ancestor
14740274|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740275|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14740276|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14740277|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740278|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740279|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740280|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14740281|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14740282|NCT00563433|Ofloxacin|ofloxacin|mesh-list
14404764|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404765|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14404766|NCT01496807|Ipilimumab|ipilimumab|mesh-list
14404767|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404768|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404769|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14404770|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404771|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
14404772|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404773|NCT01496846|Lidocaine|lidocaine|mesh-list
14404774|NCT01496846|Carticaine|carticaine|mesh-list
14404775|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
14404776|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
14404777|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14404778|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404779|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
14740283|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14740284|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404780|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404781|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14404782|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14404783|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14404784|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404785|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740285|NCT00563433|Renal Agents|renal agents|mesh-ancestor
14740286|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740287|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14740288|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14740289|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740290|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740291|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740292|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14740293|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14740294|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
14740295|NCT00563446|Hematinics|hematinics|mesh-ancestor
14740296|NCT00563472|Desogestrel|desogestrel|mesh-list
14740297|NCT00563472|Progesterone|progesterone|mesh-list
14740298|NCT00563472|Progestins|progestins|mesh-ancestor
14740299|NCT00563472|Hormones|hormones|mesh-ancestor
14740300|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740301|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740302|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14740303|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14740304|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14740305|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
14740306|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14740307|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14740308|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14740309|NCT00563485|Doxazosin|doxazosin|mesh-list
14740310|NCT00563485|Terazosin|terazosin|mesh-list
14740311|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14404786|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14404787|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15241993|NCT04626128|Aflibercept|aflibercept|mesh-list
14404788|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404789|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14404790|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14404791|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404792|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404793|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
14404794|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404795|NCT01497275|Rituximab|rituximab|mesh-list
14404796|NCT01497275|Bortezomib|bortezomib|mesh-list
14404797|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404798|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404799|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
14404800|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404801|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404802|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
14404803|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
14740312|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14740313|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15241994|NCT04626128|Axitinib|axitinib|mesh-list
15241995|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15241996|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15241997|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15241998|NCT04626128|Growth Substances|growth substances|mesh-ancestor
15241999|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404804|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242000|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
15242001|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14404805|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
14404806|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14740314|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14740315|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740316|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740317|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740318|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740319|NCT00563485|Urological Agents|urological agents|mesh-ancestor
14740320|NCT00563524|Fezakinumab|fezakinumab|mesh-list
14740321|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14740322|NCT00563589|Cyclosporine|cyclosporine|mesh-list
14404807|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14404808|NCT01497496|Prednisolone|prednisolone|mesh-list
14404809|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
14404810|NCT01497496|Lenalidomide|lenalidomide|mesh-list
14404811|NCT01497496|Ofatumumab|ofatumumab|mesh-list
14404812|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14404813|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
14404814|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
14404815|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404816|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14924677|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924678|NCT01399853|Vaccines|vaccines|mesh-list
14924679|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
14924680|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924681|NCT01400009|Vitamin D|vitamin d|mesh-list
14924682|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
14924683|NCT01400009|Vitamins|vitamins|mesh-ancestor
14924684|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
14924685|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404817|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14404818|NCT01497496|Growth Substances|growth substances|mesh-ancestor
14404819|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
14740323|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
14740324|NCT00563589|Methotrexate|methotrexate|mesh-list
14740325|NCT00563589|Cyclosporins|cyclosporins|mesh-list
14404820|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404821|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14404822|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
14404823|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
14404824|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740326|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14740327|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
14924686|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14404825|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14404826|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
14404827|NCT01497496|Hormones|hormones|mesh-ancestor
14740328|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14740329|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404828|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14404829|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14404830|NCT01497496|Protective Agents|protective agents|mesh-ancestor
14404831|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14404832|NCT01497808|Ipilimumab|ipilimumab|mesh-list
14404833|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14404834|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404835|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14404836|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404837|NCT01497860|Vinorelbine|vinorelbine|mesh-list
14404838|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14404839|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404840|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
14404841|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
14404842|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
14404843|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404844|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14404845|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14404846|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14404847|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
14404848|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404849|NCT01497938|Insulin|insulin|mesh-list
14404850|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14404851|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404852|NCT01498068|Interferons|interferons|mesh-list
14404853|NCT01498068|Ribavirin|ribavirin|mesh-list
14404854|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
14404855|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
15242002|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242003|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242004|NCT04625088|Atropine|atropine|mesh-list
14740330|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14740331|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
14740332|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740333|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740334|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14740335|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242005|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15242006|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15242007|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15242008|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
15242009|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242010|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740336|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15242011|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15242012|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
15242013|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
15242014|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
15242015|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15242016|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15242017|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
15242018|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242019|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242020|NCT04614545|Phentermine|phentermine|mesh-list
14740337|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740338|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
14740339|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740340|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14740341|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
14740342|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740343|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14740344|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14740345|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14740346|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
14740347|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740348|NCT00563615|Tegaserod|tegaserod|mesh-list
14404856|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14404857|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404858|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
14404859|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404860|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
14404861|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404862|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
14404863|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404864|NCT01498120|Rotigotine|rotigotine|mesh-list
14404865|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
14404866|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
14404867|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404868|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404869|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404870|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
14404871|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14404872|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404873|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14740349|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15242021|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14740350|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
14740351|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740352|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740353|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740354|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14740355|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
14740356|NCT00563654|Alfuzosin|alfuzosin|mesh-list
14740357|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14740358|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15242022|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242023|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
14740359|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15242024|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15242025|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
15242026|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
15242027|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242028|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
15242029|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242030|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242031|NCT04610671|Nivolumab|nivolumab|mesh-list
15242032|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242033|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242034|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242035|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242036|NCT04597671|Durvalumab|durvalumab|mesh-list
15242037|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242038|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242039|NCT04588727|Aspirin|aspirin|mesh-list
15242040|NCT04588727|Ticagrelor|ticagrelor|mesh-list
14404874|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404875|NCT01498289|Leucovorin|leucovorin|mesh-list
14404876|NCT01498289|Docetaxel|docetaxel|mesh-list
14404877|NCT01498289|Fluorouracil|fluorouracil|mesh-list
14404878|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
14404879|NCT01498289|Irinotecan|irinotecan|mesh-list
14404880|NCT01498289|Calcium|calcium|mesh-list
14404881|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
14404882|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404883|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
14404884|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
14404885|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
14404886|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404887|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14404888|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404889|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
14404890|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14404891|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404892|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
14404893|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14404894|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14404895|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740360|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740361|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740362|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740363|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740364|NCT00563654|Urological Agents|urological agents|mesh-ancestor
14740365|NCT00563758|Tegaserod|tegaserod|mesh-list
14740366|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14740367|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
14740368|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740369|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740370|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740371|NCT00563771|Rasburicase|rasburicase|mesh-list
14740372|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
14740373|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740374|NCT00563823|Vatalanib|vatalanib|mesh-list
14740375|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14404896|NCT01498289|Antidotes|antidotes|mesh-ancestor
14404897|NCT01498289|Protective Agents|protective agents|mesh-ancestor
14404898|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
14404899|NCT01498289|Vitamins|vitamins|mesh-ancestor
14740376|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740377|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740378|NCT00563836|Catumaxomab|catumaxomab|mesh-list
14740379|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14740380|NCT00563849|Leflunomide|leflunomide|mesh-list
14740381|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740382|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740383|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740384|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
14740385|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404900|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
14740386|NCT00563862|Fluorouracil|fluorouracil|mesh-list
14924687|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14404901|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
14404902|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
14404903|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740387|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404904|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404905|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14404906|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14404907|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924688|NCT01400022|Cortisone|cortisone|mesh-list
14924689|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14924690|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
14740388|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
14740389|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740390|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14740391|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740392|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
14740393|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740394|NCT00563875|Aspirin|aspirin|mesh-list
14740395|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14740396|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14740397|NCT00563875|Analgesics|analgesics|mesh-ancestor
14740398|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
14404908|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404909|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404910|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
14404911|NCT01498445|Decitabine|decitabine|mesh-list
14404912|NCT01498445|Dasatinib|dasatinib|mesh-list
14404913|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14404914|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
14404915|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404916|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404917|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404918|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14404919|NCT01498458|Capecitabine|capecitabine|mesh-list
14404920|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14404921|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
14404922|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404923|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404924|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14404925|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14404926|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14404927|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404928|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404929|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740399|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404930|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14404931|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404932|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
14404933|NCT01498588|Doxorubicin|doxorubicin|mesh-list
14404934|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404935|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
14404936|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404937|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14404938|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14404939|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
14404940|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404941|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404942|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14404943|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14740400|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740401|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740402|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740403|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14740404|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14740405|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740406|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14740407|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14740408|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740409|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
14740410|NCT00563914|Amodiaquine|amodiaquine|mesh-list
14740411|NCT00563914|Ferroquine|ferroquine|mesh-list
14740412|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
14740413|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14740414|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14740415|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740416|NCT00563927|Fluorouracil|fluorouracil|mesh-list
14740417|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740418|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
14740419|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740420|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14740421|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740422|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
14740423|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740424|NCT00563953|Doxorubicin|doxorubicin|mesh-list
14740425|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14740426|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404944|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14404945|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14404946|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404947|NCT01498679|Fluticasone|fluticasone|mesh-list
14404948|NCT01498679|Xhance|xhance|mesh-list
14404949|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14404950|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14404951|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
14404952|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14404953|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404954|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14404955|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
14404956|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
14740427|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14740428|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14740429|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404957|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14404958|NCT01498744|Clindamycin|clindamycin|mesh-list
14404959|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
14404960|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
14404961|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14404962|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14404963|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14404964|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404965|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404966|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
14404967|NCT01498822|Levetiracetam|levetiracetam|mesh-list
14404968|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
14404969|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
14404970|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14404971|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14404972|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14404973|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404974|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14404975|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14404976|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14404977|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14404978|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404979|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14404980|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
14404981|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404982|NCT01498952|Sorafenib|sorafenib|mesh-list
14404983|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404984|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14404985|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14404986|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740430|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924691|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924692|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14924693|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924694|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924695|NCT01400100|Octreotide|octreotide|mesh-list
14924696|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14740431|NCT00563992|Valproic Acid|valproic acid|mesh-list
14740432|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14740433|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740434|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740435|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
14740436|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14740437|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740438|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740439|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
14740440|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
14740441|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740442|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14740443|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
14740444|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14740445|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
14740446|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14740447|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740448|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14740449|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14740450|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14740451|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740452|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14740453|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14740454|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14740455|NCT00564057|Candesartan|candesartan|mesh-list
14740456|NCT00564057|Lercanidipine|lercanidipine|mesh-list
14740457|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14740458|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14740459|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14740460|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740461|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14740462|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14740463|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14740464|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740465|NCT00564148|Bevacizumab|bevacizumab|mesh-list
14740466|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14740467|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740468|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14740469|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14740470|NCT00564148|Growth Substances|growth substances|mesh-ancestor
14740471|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740472|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
14740473|NCT00564174|Aspirin|aspirin|mesh-list
14740474|NCT00564174|Heparin|heparin|mesh-list
14740475|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14740476|NCT00564174|Tinzaparin|tinzaparin|mesh-list
14740477|NCT00564174|Dalteparin|dalteparin|mesh-list
14740478|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14924697|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14924698|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14404987|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14404988|NCT01498978|Ipilimumab|ipilimumab|mesh-list
14404989|NCT01498978|Antibodies|antibodies|mesh-list
14404990|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
14404991|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14404992|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
14404993|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14404994|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14404995|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14404996|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404997|NCT01499134|Metoprolol|metoprolol|mesh-list
14404998|NCT01499134|Nebivolol|nebivolol|mesh-list
14924699|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924700|NCT01400165|Pindolol|pindolol|mesh-list
14924701|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14740479|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242041|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15242042|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242043|NCT04588727|Analgesics|analgesics|mesh-ancestor
14924702|NCT01400165|Trazodone|trazodone|mesh-list
14924703|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
14924704|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924705|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14924706|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15242044|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
15242045|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242046|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242047|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242048|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242049|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15242050|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14924707|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242051|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14404999|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14740480|NCT00564174|Analgesics|analgesics|mesh-ancestor
15242052|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15242053|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15242054|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242055|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
15242056|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15242057|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15242058|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14924708|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242059|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
14405000|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14405001|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
14405002|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
14405003|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405004|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405005|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14405006|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14405007|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14405008|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405009|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405010|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405011|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
14405012|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14405013|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14405014|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14405015|NCT01499147|Vidarabine|vidarabine|mesh-list
14405016|NCT01499147|Fludarabine|fludarabine|mesh-list
14405017|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
14405018|NCT01499147|Melphalan|melphalan|mesh-list
14405019|NCT01499147|Busulfan|busulfan|mesh-list
14405020|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
14405021|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405022|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14405023|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
14405024|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405025|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405026|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
14405027|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405028|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
14405029|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405030|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14405031|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
14405032|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14405033|NCT01499199|Dolutegravir|dolutegravir|mesh-list
14405034|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14405035|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14405036|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405037|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405038|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14405039|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14924709|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14924710|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14924711|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14924712|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14924713|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924714|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924715|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
14924716|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14924717|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14924718|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14924719|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
14924720|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14924721|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14405040|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
14405041|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405042|NCT01499277|Vancomycin|vancomycin|mesh-list
14405043|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14405044|NCT01499277|Aztreonam|aztreonam|mesh-list
15242060|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242061|NCT04564898|Trifluridine|trifluridine|mesh-list
15242062|NCT04564898|Bevacizumab|bevacizumab|mesh-list
15242063|NCT04564898|Capecitabine|capecitabine|mesh-list
15242064|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242065|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242066|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15242067|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14405045|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740481|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
14740482|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740483|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740484|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740485|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740486|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14740487|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14740488|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753296|NCT05212311|Chitosan|chitosan|mesh-list
14924722|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
14924723|NCT01400191|Metformin|metformin|mesh-list
14924724|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924725|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924726|NCT01400217|Beclomethasone|beclomethasone|mesh-list
14924727|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14924728|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
14924729|NCT01400217|Hormones|hormones|mesh-ancestor
14924730|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924731|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924732|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14924733|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
14924734|NCT01400256|Valsartan|valsartan|mesh-list
14924735|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14924736|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14924737|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14924738|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924739|NCT01400308|Mupirocin|mupirocin|mesh-list
14924740|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14924741|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924742|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14924743|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924744|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924745|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
14924746|NCT01400464|Prednisone|prednisone|mesh-list
14924747|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14924748|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
14924749|NCT01400464|Hormones|hormones|mesh-ancestor
14924750|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924751|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924752|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14924753|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924754|NCT01400568|Fluticasone|fluticasone|mesh-list
14924755|NCT01400568|Xhance|xhance|mesh-list
14924756|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242068|NCT04564898|Growth Substances|growth substances|mesh-ancestor
15242069|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242070|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
14924757|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14924758|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
14924759|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924760|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924761|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14924762|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
14924763|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
14924764|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14924765|NCT01400633|Decitabine|decitabine|mesh-list
14924766|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14924767|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
14924768|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924769|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924770|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242071|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14740489|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14740490|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14740491|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740492|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
14740493|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
14740494|NCT00564187|Irbesartan|irbesartan|mesh-list
14740495|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14740496|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15242072|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
15242073|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242074|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
15242075|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242076|NCT04562779|Naltrexone|naltrexone|mesh-list
15242077|NCT04562779|Ketamine|ketamine|mesh-list
15242078|NCT04562779|Analgesics|analgesics|mesh-ancestor
15242079|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
15242080|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405046|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405047|NCT01499290|Metronidazole|metronidazole|mesh-list
14405048|NCT01499290|Meropenem|meropenem|mesh-list
14740497|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14405049|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405050|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405051|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14405052|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14405053|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
14405054|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14405055|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405056|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14405057|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
14740498|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740499|NCT00564200|Dexamethasone|dexamethasone|mesh-list
14740500|NCT00564200|Fludarabine|fludarabine|mesh-list
14740501|NCT00564200|Bortezomib|bortezomib|mesh-list
14740502|NCT00564200|Melphalan|melphalan|mesh-list
14740503|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740504|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
14740505|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
14740506|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740507|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740508|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14740509|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
14740510|NCT00564200|Hormones|hormones|mesh-ancestor
14740511|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740512|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14740513|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740514|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740515|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740516|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
14405058|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405059|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405060|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924771|NCT01400646|Vitamins|vitamins|mesh-list
14924772|NCT01400646|Vitamin K|vitamin k|mesh-list
14405061|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405062|NCT01499368|Omeprazole|omeprazole|mesh-list
14405063|NCT01499368|Famotidine|famotidine|mesh-list
14924773|NCT01400646|Warfarin|warfarin|mesh-list
14924774|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
14924775|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
14924776|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740517|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14740518|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
14740519|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14740520|NCT00564213|Mitomycins|mitomycins|mesh-list
14740521|NCT00564213|Mitomycin|mitomycin|mesh-list
14740522|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14740523|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924777|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
14924778|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14924779|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
14924780|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15242081|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242082|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15242083|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15242084|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
15242085|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
15242086|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242087|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14740524|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
14740525|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740526|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14740527|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740528|NCT00564252|Finasteride|finasteride|mesh-list
14740529|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14405064|NCT01499368|Lafutidine|lafutidine|mesh-list
14405065|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14740530|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14740531|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740532|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740533|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
14405066|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14405067|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14405068|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405069|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405070|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14405071|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
14405072|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
14405073|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405074|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405075|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
14405076|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
14405077|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14405078|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14405079|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405080|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405081|NCT01499498|Urological Agents|urological agents|mesh-ancestor
14405082|NCT01499576|Acetic Acid|acetic acid|mesh-list
14405083|NCT01499576|Retinol acetate|retinol acetate|mesh-list
14405084|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405085|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405086|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14405087|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
14405088|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405089|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14405090|NCT01499576|Protective Agents|protective agents|mesh-ancestor
14405091|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405092|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14405093|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14405094|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405095|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14405096|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14405097|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740534|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740535|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740536|NCT00564252|Urological Agents|urological agents|mesh-ancestor
14753297|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14753298|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14753299|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
14753300|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753301|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14753302|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
14753303|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
14753304|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
14753305|NCT05212311|Coagulants|coagulants|mesh-ancestor
14753306|NCT05211947|BI 425809|bi 425809|mesh-list
14753307|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
14753308|NCT05210764|Ketamine|ketamine|mesh-list
14753309|NCT05210764|Anesthetics|anesthetics|mesh-list
14753310|NCT05210764|Propofol|propofol|mesh-list
14753311|NCT05210764|Sevoflurane|sevoflurane|mesh-list
14753312|NCT05210764|Esketamine|esketamine|mesh-list
14405098|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405099|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
14405100|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405101|NCT01499849|Dexamethasone|dexamethasone|mesh-list
14405102|NCT01499849|Granisetron|granisetron|mesh-list
14405103|NCT01499849|Rolapitant|rolapitant|mesh-list
14405104|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405105|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
14405106|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
14405107|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405108|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405109|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14405110|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
14405111|NCT01499849|Hormones|hormones|mesh-ancestor
14405112|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405113|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14405114|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405115|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14405116|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
14405117|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405118|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405119|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14405120|NCT01499940|Vitamin D|vitamin d|mesh-list
14405121|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
14405122|NCT01499940|Vitamins|vitamins|mesh-ancestor
14405123|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
14405124|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405125|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14405126|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14405127|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14405128|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14405129|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
14405130|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405131|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242088|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15242089|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242090|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242091|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15242092|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15242093|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15242094|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14740537|NCT00564330|Esomeprazole|esomeprazole|mesh-list
14740538|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14740539|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14405132|NCT01500213|Dexamethasone|dexamethasone|mesh-list
14405133|NCT01500213|Granisetron|granisetron|mesh-list
14405134|NCT01500213|Rolapitant|rolapitant|mesh-list
14405135|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405136|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
14924781|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
14405137|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
14405138|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405139|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405140|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14405141|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
14405142|NCT01500213|Hormones|hormones|mesh-ancestor
14405143|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242095|NCT04547790|Psyllium|psyllium|mesh-list
15242096|NCT04547790|Cathartics|cathartics|mesh-ancestor
15242097|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15242098|NCT04523363|Metformin|metformin|mesh-list
15242099|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15242100|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242101|NCT04517435|Prednisone|prednisone|mesh-list
15242102|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
15242103|NCT04517435|Rituximab|rituximab|mesh-list
15242104|NCT04517435|Doxorubicin|doxorubicin|mesh-list
15242105|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15242106|NCT04517435|Vincristine|vincristine|mesh-list
15242107|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405144|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14405145|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405146|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14405147|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
14405148|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242108|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
15242109|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242110|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242111|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242112|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
15242113|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242114|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242115|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15242116|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242117|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15242118|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15242119|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15242120|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405149|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405150|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14405151|NCT01500226|Dexamethasone|dexamethasone|mesh-list
14405152|NCT01500226|Granisetron|granisetron|mesh-list
14405153|NCT01500226|Rolapitant|rolapitant|mesh-list
14405154|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405155|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
14405156|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
14405157|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405158|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405159|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14405160|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
14405161|NCT01500226|Hormones|hormones|mesh-ancestor
15242121|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405162|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405163|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14405164|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405165|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15242122|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
15242123|NCT04517435|Hormones|hormones|mesh-ancestor
15242124|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242125|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15242126|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15242127|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
15242128|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
15242129|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
15242130|NCT04509050|Ivacaftor|ivacaftor|mesh-list
15242131|NCT04509050|Elexacaftor|elexacaftor|mesh-list
15242132|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15242133|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15242134|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242135|NCT04503993|Antibodies|antibodies|mesh-list
15242136|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
15242137|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
15242138|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242139|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
15242140|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15242141|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242142|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242143|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242144|NCT04484922|Analgesics|analgesics|mesh-ancestor
15242145|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
15242146|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405166|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
14405167|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405168|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405169|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14405170|NCT01500278|Adalimumab|adalimumab|mesh-list
14405171|NCT01500278|Methotrexate|methotrexate|mesh-list
14405172|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
14405173|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14405174|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
14740540|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14740541|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740542|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740543|NCT00564408|Carbachol|carbachol|mesh-list
14740544|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14740545|NCT00564408|Miotics|miotics|mesh-ancestor
14740546|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
14740547|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740548|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740549|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14405175|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15242147|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15242148|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15242149|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15242150|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
15242151|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242152|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242153|NCT04446390|Listerine|listerine|mesh-list
15242154|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
15242155|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
15242156|NCT04446390|Protective Agents|protective agents|mesh-ancestor
14405176|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740550|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
14740551|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740552|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740553|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14740554|NCT00564408|Analgesics|analgesics|mesh-ancestor
14740555|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
14740556|NCT00564408|Protective Agents|protective agents|mesh-ancestor
14740557|NCT00564460|Finasteride|finasteride|mesh-list
14740558|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14740559|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14740560|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740561|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740562|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
14740563|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740564|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740565|NCT00564460|Urological Agents|urological agents|mesh-ancestor
14740566|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
14740567|NCT00564512|Rituximab|rituximab|mesh-list
14740568|NCT00564512|Fludarabine|fludarabine|mesh-list
14740569|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
14740570|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740571|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
14740572|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740573|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740574|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14740575|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
14740576|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740577|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740578|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14740579|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14740580|NCT00564525|Amitriptyline|amitriptyline|mesh-list
14405177|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14405178|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
14405179|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405180|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405181|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
14405182|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405183|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14405184|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405185|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
14405186|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405187|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14405188|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405189|NCT01500317|Oxycodone|oxycodone|mesh-list
14405190|NCT01500317|Tapentadol|tapentadol|mesh-list
14405191|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14405192|NCT01500317|Narcotics|narcotics|mesh-ancestor
14405193|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405194|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405195|NCT01500317|Analgesics|analgesics|mesh-ancestor
14405196|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
14405197|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405198|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14405199|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14405200|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14405201|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405202|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405203|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405204|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14405205|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14405206|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405207|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14405208|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14405209|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
14405210|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405211|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405212|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405213|NCT01500382|Urological Agents|urological agents|mesh-ancestor
14405214|NCT01500434|Aspirin|aspirin|mesh-list
14405215|NCT01500434|Ticlopidine|ticlopidine|mesh-list
14405216|NCT01500434|Clopidogrel|clopidogrel|mesh-list
14405217|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14405218|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405219|NCT01500434|Analgesics|analgesics|mesh-ancestor
14405220|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
14405221|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405222|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405223|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405224|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405225|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14405226|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14405227|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405228|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14405229|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14405230|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405231|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
15242157|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242158|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15242159|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242160|NCT04436913|Fluorides|fluorides|mesh-list
15242161|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
15242162|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
15242163|NCT04436913|Protective Agents|protective agents|mesh-ancestor
15242164|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242165|NCT04429880|Oxytocin|oxytocin|mesh-list
14405232|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14405233|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14405234|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15242166|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
15242167|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15242168|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242169|NCT04412707|Dexamethasone|dexamethasone|mesh-list
15242170|NCT04412707|Melphalan|melphalan|mesh-list
15242171|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242172|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
15242173|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
15242174|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242175|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242176|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15242177|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
15242178|NCT04412707|Hormones|hormones|mesh-ancestor
15242179|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242180|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15242181|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242182|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242183|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
15242184|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242185|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14740581|NCT00564525|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14740582|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14740583|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
14740584|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14740585|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14740586|NCT00564525|Analgesics|analgesics|mesh-ancestor
14740587|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
14740588|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740589|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740590|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15242186|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405235|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
14405236|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405237|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14405238|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14467373|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467374|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467375|NCT02260388|Mexiletine|mexiletine|mesh-list
14740591|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14740592|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14467376|NCT02260388|Pregabalin|pregabalin|mesh-list
14467377|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14467378|NCT02260388|Nortriptyline|nortriptyline|mesh-list
14467379|NCT02260388|Analgesics|analgesics|mesh-ancestor
14467380|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
14467381|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467382|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405239|NCT01500694|Guanfacine|guanfacine|mesh-list
14405240|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15242187|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
15242188|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
15242189|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15242190|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15242191|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
14740593|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740594|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740595|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924782|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924783|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924784|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14924785|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14740596|NCT00564525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14740597|NCT00564525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14740598|NCT00564525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740599|NCT00564538|Tacrolimus|tacrolimus|mesh-list
14740600|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
14740601|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14740602|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242192|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242193|NCT04390945|Capecitabine|capecitabine|mesh-list
15242194|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15242195|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
15242196|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242197|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242198|NCT04381364|Ciclesonide|ciclesonide|mesh-list
15242199|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
15242200|NCT04381364|Hormones|hormones|mesh-ancestor
15242201|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242202|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242203|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15242204|NCT04375384|Cetuximab|cetuximab|mesh-list
15242205|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242206|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242207|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
15242208|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242209|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242210|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
15242211|NCT04363164|Testosterone|testosterone|mesh-list
15242212|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
15242213|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
15242214|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15242215|NCT04363164|Androgens|androgens|mesh-ancestor
15242216|NCT04363164|Hormones|hormones|mesh-ancestor
15242217|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242218|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242219|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14740603|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
14924786|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
15242220|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242221|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
15242222|NCT04337827|Rituximab|rituximab|mesh-list
15242223|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
15242224|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14740604|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740605|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14924787|NCT01400646|Coagulants|coagulants|mesh-ancestor
14924788|NCT01400672|Imiquimod|imiquimod|mesh-list
14924789|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14924790|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
14924791|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924792|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924793|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
14924794|NCT01400685|Rituximab|rituximab|mesh-list
14924795|NCT01400685|Lenalidomide|lenalidomide|mesh-list
14924796|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14924797|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14924798|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924799|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
14924800|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924801|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14924802|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15242225|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242226|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
15242227|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242228|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740606|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740607|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740608|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
14740609|NCT00564551|Calcium|calcium|mesh-list
14740610|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14740611|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740612|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14740613|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14740614|NCT00564564|Clomipramine|clomipramine|mesh-list
14740615|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
14740616|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14740617|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14740618|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14740619|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740620|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740621|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14740622|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14740623|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14740624|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14740625|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740626|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740627|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
14740628|NCT00564590|Melatonin|melatonin|mesh-list
14740629|NCT00564590|Omeprazole|omeprazole|mesh-list
14740630|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
14740631|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740632|NCT00564590|Protective Agents|protective agents|mesh-ancestor
14740633|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740634|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740635|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14740636|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14740637|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14740638|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740639|NCT00564603|Dexamethasone|dexamethasone|mesh-list
15242229|NCT04332068|Ivermectin|ivermectin|mesh-list
14740640|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
15242230|NCT04332068|Permethrin|permethrin|mesh-list
15242231|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15242232|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242233|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242234|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242235|NCT04327024|Allopurinol|allopurinol|mesh-list
15242236|NCT04327024|Verinurad|verinurad|mesh-list
15242237|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
15242238|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242239|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242240|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
15242241|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242242|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15242243|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
15242244|NCT04327024|Protective Agents|protective agents|mesh-ancestor
15242245|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242246|NCT04324840|Temozolomide|temozolomide|mesh-list
15242247|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242248|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
15242249|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405241|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14405242|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14405243|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14405244|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405245|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405246|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405247|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405248|NCT01500720|Topotecan|topotecan|mesh-list
14405249|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14405250|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14405251|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405252|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405253|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405254|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
14405255|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14405256|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
14405257|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405258|NCT01501110|Expectorants|expectorants|mesh-ancestor
14405259|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14405260|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14405261|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
14405262|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405263|NCT01501110|Protective Agents|protective agents|mesh-ancestor
14740641|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14740642|NCT00564603|BB 1101|bb 1101|mesh-list
14740643|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740644|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
14740645|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
14740646|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242250|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405264|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242251|NCT04322669|Pidotimod|pidotimod|mesh-list
15242252|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15242253|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
15242254|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242255|NCT04296396|Oxycodone|oxycodone|mesh-list
15242256|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15242257|NCT04296396|Narcotics|narcotics|mesh-ancestor
15242258|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405265|NCT01501110|Antidotes|antidotes|mesh-ancestor
14405266|NCT01501162|Ethanol|ethanol|mesh-list
14405267|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14405268|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405269|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405270|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405271|NCT01501929|Metoprolol|metoprolol|mesh-list
14405272|NCT01501929|Nebivolol|nebivolol|mesh-list
14405273|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14405274|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14405275|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
14405276|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
14405277|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405278|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405279|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14405280|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14405281|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14405282|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405283|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405284|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740647|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242259|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740648|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14740649|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
14740650|NCT00564603|Hormones|hormones|mesh-ancestor
14740651|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740652|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14405285|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
14405286|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14405287|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14405288|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15242260|NCT04296396|Analgesics|analgesics|mesh-ancestor
15242261|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
15242262|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242263|NCT04291521|Ketamine|ketamine|mesh-list
14405289|NCT01502072|Ribavirin|ribavirin|mesh-list
14405290|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
14405291|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405292|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
15242264|NCT04291521|Propofol|propofol|mesh-list
15242265|NCT04291521|Etomidate|etomidate|mesh-list
15242266|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15242267|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242268|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242269|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15242270|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
14405293|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405294|NCT01502228|Sunitinib|sunitinib|mesh-list
14405295|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405296|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14405297|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14405298|NCT01502228|Growth Substances|growth substances|mesh-ancestor
14405299|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405300|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
14405301|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14405302|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405303|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405304|NCT01502293|Interleukin-12|interleukin-12|mesh-list
14405305|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14405306|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
14405307|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405308|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14405309|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14405310|NCT01502293|Growth Substances|growth substances|mesh-ancestor
14405311|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
14405312|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405313|NCT01502306|Nicotine|nicotine|mesh-list
14405314|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14405315|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
14405316|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405317|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405318|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14405319|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14405320|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
14405321|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405322|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405323|NCT01502410|Sorafenib|sorafenib|mesh-list
15242271|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
15242272|NCT04291521|Analgesics|analgesics|mesh-ancestor
14405324|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405325|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14405326|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405327|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405328|NCT01502423|Adalimumab|adalimumab|mesh-list
14467383|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
14467384|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14467385|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14740653|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740654|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
14740655|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740656|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740657|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
14740658|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14740659|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
14740660|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405329|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405330|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405331|NCT01502644|Morphine|morphine|mesh-list
14405332|NCT01502644|Oxycodone|oxycodone|mesh-list
14405333|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14405334|NCT01502644|Narcotics|narcotics|mesh-ancestor
14405335|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405336|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405337|NCT01502644|Analgesics|analgesics|mesh-ancestor
14405338|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
14405339|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405340|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
14405341|NCT01502761|Analgesics|analgesics|mesh-ancestor
14405342|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
14405343|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405344|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242273|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
15242274|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242275|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15242276|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15242277|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15242278|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242279|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242280|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
15242281|NCT04240171|Glimepiride|glimepiride|mesh-list
15242282|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15242283|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242284|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15242285|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242286|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15242287|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242288|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
15242289|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
15242290|NCT04239092|Temozolomide|temozolomide|mesh-list
15242291|NCT04239092|Irinotecan|irinotecan|mesh-list
15242292|NCT04239092|Topotecan|topotecan|mesh-list
15242293|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242294|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
15242295|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242296|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242297|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242298|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
15242299|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740661|NCT00564642|Expectorants|expectorants|mesh-ancestor
14405345|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
14740662|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
14405346|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405347|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14405348|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
14405349|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14405350|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14405351|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405352|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14405353|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
14405354|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14405355|NCT01502787|Metoprolol|metoprolol|mesh-list
14405356|NCT01502787|Nebivolol|nebivolol|mesh-list
14405357|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
14405358|NCT01502787|Giapreza|giapreza|mesh-list
14405359|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
14405360|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14405361|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14405362|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
14405363|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
14405364|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405365|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740663|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14740664|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
14740665|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740666|NCT00564642|Protective Agents|protective agents|mesh-ancestor
14740667|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740668|NCT00564642|Antidotes|antidotes|mesh-ancestor
14740669|NCT00564655|Epinephrine|epinephrine|mesh-list
14740670|NCT00564655|Racepinephrine|racepinephrine|mesh-list
14740671|NCT00564655|Bupivacaine|bupivacaine|mesh-list
14740672|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
14740673|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
14740674|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
14740675|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740676|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740677|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
14740678|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740679|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14740680|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14740681|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740682|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740683|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740684|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14740685|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14740686|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
14740687|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14924803|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14924804|NCT01400685|Growth Substances|growth substances|mesh-ancestor
14924805|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
14924806|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14924807|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
14924808|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924809|NCT01400737|Ibuprofen|ibuprofen|mesh-list
14924810|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14924811|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14924812|NCT01400737|Analgesics|analgesics|mesh-ancestor
14924813|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
14924814|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740688|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
14740689|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
14405366|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14405367|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14405368|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14405369|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405370|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405371|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405372|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
14405373|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14405374|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14405375|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14405376|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14405377|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14405378|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
14405379|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405380|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14405381|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
15242300|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242301|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15242302|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15242303|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15242304|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242305|NCT04235101|Trastuzumab|trastuzumab|mesh-list
15242306|NCT04235101|Niraparib|niraparib|mesh-list
15242307|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242308|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242309|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15242310|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242311|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740690|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
14740691|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14740692|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
14405382|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14405383|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14405384|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405385|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405386|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14405387|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14405388|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405389|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
14405390|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405391|NCT01503229|Prednisone|prednisone|mesh-list
14405392|NCT01503229|Cortisone|cortisone|mesh-list
14740693|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
14405393|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
14405394|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405395|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
14405396|NCT01503229|Hormones|hormones|mesh-ancestor
14405397|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405398|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242312|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
15242313|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14405399|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14405400|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405401|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14405402|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405403|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740694|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14740695|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740696|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
14740697|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14740698|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14740699|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14740700|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14740701|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740702|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
14740703|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405404|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
14405405|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14405406|NCT01503749|Lenograstim|lenograstim|mesh-list
14405407|NCT01503749|Sargramostim|sargramostim|mesh-list
14405408|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14405409|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
14405410|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405411|NCT01504204|Adapalene|adapalene|mesh-list
14405412|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14405413|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14405414|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
14740704|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740705|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14405415|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14405416|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405417|NCT01504204|Analgesics|analgesics|mesh-ancestor
14405418|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
14405419|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405420|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405421|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405422|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405423|NCT01504412|Pregabalin|pregabalin|mesh-list
14405424|NCT01504412|Analgesics|analgesics|mesh-ancestor
14740706|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740707|NCT00564720|Gemcitabine|gemcitabine|mesh-list
14740708|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
14740709|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14740710|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15242314|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405425|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
14405426|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405427|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740711|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
15242315|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
15242316|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
15242317|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15242318|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242319|NCT04214691|Acetaminophen|acetaminophen|mesh-list
15242320|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242321|NCT04214691|Analgesics|analgesics|mesh-ancestor
15242322|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
15242323|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242324|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405428|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
14405429|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14405430|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14405431|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405432|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14405433|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14405434|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14405435|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740712|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740713|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740714|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
14405436|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14405437|NCT01504477|Bortezomib|bortezomib|mesh-list
14405438|NCT01504477|Panitumumab|panitumumab|mesh-list
14405439|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405440|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14924815|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924816|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405441|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
14405442|NCT01504711|Aprepitant|aprepitant|mesh-list
14740715|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740716|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740717|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740718|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
14740719|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740720|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14740721|NCT00564772|Ritonavir|ritonavir|mesh-list
14405443|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
14405444|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
14405445|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405446|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405447|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14405448|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14405449|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405450|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405451|NCT01504841|Etravirine|etravirine|mesh-list
14405452|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14405453|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14405454|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405455|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242325|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
15242326|NCT04205630|Trastuzumab|trastuzumab|mesh-list
15242327|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242328|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242329|NCT04204941|Doxorubicin|doxorubicin|mesh-list
15242330|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15242331|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15242332|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405456|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
14405457|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405458|NCT01504854|Resveratrol|resveratrol|mesh-list
15242333|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15242334|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15242335|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242336|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242337|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
15242338|NCT04198766|Antibodies|antibodies|mesh-list
15242339|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
15242340|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242341|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242342|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242343|NCT04198116|Guanfacine|guanfacine|mesh-list
15242344|NCT04198116|Varenicline|varenicline|mesh-list
14405459|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
14405460|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405461|NCT01504854|Protective Agents|protective agents|mesh-ancestor
14405462|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405463|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405464|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14405465|NCT01504867|Aspirin|aspirin|mesh-list
14405466|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14405467|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405468|NCT01504867|Analgesics|analgesics|mesh-ancestor
14405469|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
14405470|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405471|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405472|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405473|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242345|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15242346|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15242347|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
15242348|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242349|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242350|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242351|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15242352|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15242353|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15242354|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15242355|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740722|NCT00564772|Lopinavir|lopinavir|mesh-list
14740723|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
14740724|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14740725|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14924817|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14924818|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14924819|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924820|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924821|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
14924822|NCT01400750|Tobramycin|tobramycin|mesh-list
14924823|NCT01400750|Colistin|colistin|mesh-list
14924824|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405474|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14740726|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
14740727|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740728|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740729|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14740730|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14740731|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
14740732|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740733|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14740734|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14740735|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14740736|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14740737|NCT00564824|Caffeine|caffeine|mesh-list
14405475|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15242356|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
15242357|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
15242358|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15242359|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
15242360|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242361|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242362|NCT04183452|Progestins|progestins|mesh-ancestor
15242363|NCT04183452|Hormones|hormones|mesh-ancestor
14405476|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405477|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14405478|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14405479|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405480|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
14405481|NCT01504971|Rabeprazole|rabeprazole|mesh-list
14405482|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14405483|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14405484|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14405485|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405486|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405487|NCT01505114|Tenofovir|tenofovir|mesh-list
14405488|NCT01505114|Emtricitabine|emtricitabine|mesh-list
14405489|NCT01505114|Maraviroc|maraviroc|mesh-list
14405490|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
14405491|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405492|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14405493|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14924825|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242364|NCT04165135|Factor VIII|factor viii|mesh-list
14405494|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924826|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14405495|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405496|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14405497|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14405498|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14405499|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14405500|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14405501|NCT01505179|Ranolazine|ranolazine|mesh-list
14405502|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14405503|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14405504|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405505|NCT01505465|Melatonin|melatonin|mesh-list
14405506|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
14405507|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405508|NCT01505465|Protective Agents|protective agents|mesh-ancestor
14405509|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405510|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405511|NCT01505491|Adalimumab|adalimumab|mesh-list
14405512|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405513|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405514|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
14405515|NCT01505634|Imipenem|imipenem|mesh-list
14405516|NCT01505634|Relebactam|relebactam|mesh-list
14405517|NCT01505634|Cilastatin|cilastatin|mesh-list
14405518|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405519|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405520|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14405521|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14405522|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405523|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405524|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405525|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14405526|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14405527|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
14405528|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14405529|NCT01505647|Vaccines|vaccines|mesh-list
14405530|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
14405531|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405532|NCT01505673|Liraglutide|liraglutide|mesh-list
14405533|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14405534|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405535|NCT01505673|Incretins|incretins|mesh-ancestor
14405536|NCT01505673|Hormones|hormones|mesh-ancestor
14405537|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405538|NCT01505868|Carboplatin|carboplatin|mesh-list
14405539|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405540|NCT01505881|Warfarin|warfarin|mesh-list
14405541|NCT01505881|Dabigatran|dabigatran|mesh-list
14405542|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
14405543|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
14405544|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14740738|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15242365|NCT04165135|Coagulants|coagulants|mesh-ancestor
15242366|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
15242367|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
15242368|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15242369|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242370|NCT04155710|Interleukin-2|interleukin-2|mesh-list
15242371|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242372|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242373|NCT04155710|Analgesics|analgesics|mesh-ancestor
14740739|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242374|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
15242375|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242376|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405545|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
14405546|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405547|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405548|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
14405549|NCT01505933|Propofol|propofol|mesh-list
14405550|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14405551|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405552|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405553|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14405554|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
14405555|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
14405556|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405557|NCT01505933|Analgesics|analgesics|mesh-ancestor
14405558|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
14405559|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242377|NCT04126096|Lactams|lactams|mesh-list
15242378|NCT04126096|beta-Lactams|beta-lactams|mesh-list
15242379|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15242380|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242381|NCT04113187|Propranolol|propranolol|mesh-list
15242382|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15242383|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15242384|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
15242385|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242386|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242387|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405560|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14405561|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14405562|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15242388|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14405563|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405564|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405565|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405566|NCT01506193|Vaccines|vaccines|mesh-list
14405567|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
14405568|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405569|NCT01506271|Imipenem|imipenem|mesh-list
14405570|NCT01506271|Relebactam|relebactam|mesh-list
14405571|NCT01506271|Cilastatin|cilastatin|mesh-list
14405572|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405573|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405574|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
14405575|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405576|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405577|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14405578|NCT01506453|Gabapentin|gabapentin|mesh-list
14405579|NCT01506453|Analgesics|analgesics|mesh-ancestor
14405580|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
14740740|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14740741|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740742|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740743|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14740744|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14740745|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
14740746|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924827|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14924828|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924829|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924830|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924831|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14924832|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14924833|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
14924834|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
14924835|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924836|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924837|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
14924838|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924839|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924840|NCT01400828|Desloratadine|desloratadine|mesh-list
14924841|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14924842|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
14924843|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931211|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15242389|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15242390|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
14405581|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405582|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405583|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
15242391|NCT04098666|Metformin|metformin|mesh-list
15242392|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15242393|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242394|NCT04095208|Nivolumab|nivolumab|mesh-list
15242395|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242396|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242397|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242398|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242399|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
14405584|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15242400|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
15242401|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242402|NCT04088591|Protective Agents|protective agents|mesh-ancestor
15242403|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242404|NCT04088591|Vitamins|vitamins|mesh-ancestor
14740747|NCT00564941|Deferasirox|deferasirox|mesh-list
14740748|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14740749|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
14740750|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
14740751|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740752|NCT00564993|Dobutamine|dobutamine|mesh-list
14740753|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14740754|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
14740755|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
14740756|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740757|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740758|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14740759|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14740760|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14740761|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405585|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15242405|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
15242406|NCT04067609|Dexamethasone|dexamethasone|mesh-list
15242407|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242408|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
15242409|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
15242410|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242411|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242412|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15242413|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
15242414|NCT04067609|Hormones|hormones|mesh-ancestor
15242415|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405586|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405587|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14405588|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14405589|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14405590|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405591|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405592|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
14405593|NCT01506609|Paclitaxel|paclitaxel|mesh-list
14405594|NCT01506609|Carboplatin|carboplatin|mesh-list
14405595|NCT01506609|Temozolomide|temozolomide|mesh-list
14405596|NCT01506609|Veliparib|veliparib|mesh-list
14405597|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14405598|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405599|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
14405600|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
14405601|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
14405602|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405603|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14740762|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242416|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15242417|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405604|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
14405605|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14405606|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405607|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
14405608|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14405609|NCT01506726|Salicylates|salicylates|mesh-list
14405610|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14405611|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405612|NCT01506726|Analgesics|analgesics|mesh-ancestor
14405613|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
14405614|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405615|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405616|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405617|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405618|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14405619|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405620|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405621|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405622|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
14405623|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
14405624|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
14405625|NCT01506882|Levetiracetam|levetiracetam|mesh-list
14405626|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
14405627|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
14405628|NCT01506908|Nicotine|nicotine|mesh-list
14405629|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14405630|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
14405631|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405632|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405633|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14405634|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14405635|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
14405636|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405637|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405638|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
14405639|NCT01506947|Hematinics|hematinics|mesh-ancestor
14405640|NCT01507051|Vitamin K|vitamin k|mesh-list
14405641|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
14405642|NCT01507051|Warfarin|warfarin|mesh-list
14405643|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
14405644|NCT01507051|Vitamins|vitamins|mesh-ancestor
14405645|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
15242418|NCT04061980|Nivolumab|nivolumab|mesh-list
14405646|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405647|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
14740763|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740764|NCT00564993|Protective Agents|protective agents|mesh-ancestor
14740765|NCT00565006|Anacetrapib|anacetrapib|mesh-list
14740766|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14740767|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14740768|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
14740769|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740770|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14740771|NCT00565019|Triamcinolone|triamcinolone|mesh-list
14740772|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14740773|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14740774|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14740775|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740776|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
14740777|NCT00565019|Hormones|hormones|mesh-ancestor
14740778|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740779|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740780|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14740781|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
14740782|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740783|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405648|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14405649|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
14740784|NCT00565097|Lanreotide|lanreotide|mesh-list
14740785|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740786|NCT00565123|Levofloxacin|levofloxacin|mesh-list
14740787|NCT00565123|Ofloxacin|ofloxacin|mesh-list
14740788|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14740789|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14740790|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14740791|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924844|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405650|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14405651|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
14405652|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405653|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405654|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14405655|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14405656|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
14405657|NCT01507051|Coagulants|coagulants|mesh-ancestor
14405658|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
14405659|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405660|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
14924845|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924846|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14924847|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14924848|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
14740792|NCT00565123|Renal Agents|renal agents|mesh-ancestor
14740793|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740794|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14740795|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14740796|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740797|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405661|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740798|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924849|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
14924850|NCT01400867|Vancomycin|vancomycin|mesh-list
14924851|NCT01400867|Clindamycin|clindamycin|mesh-list
14405662|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405663|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14405664|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
14405665|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405666|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405667|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14740799|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14740800|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14740801|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
14740802|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14740803|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740804|NCT00565175|Famotidine|famotidine|mesh-list
14740805|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14740806|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14740807|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14740808|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
14740809|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
14740810|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740811|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740812|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740813|NCT00565188|Adenosine|adenosine|mesh-list
14740814|NCT00565188|Analgesics|analgesics|mesh-ancestor
14740815|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
14740816|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405668|NCT01507181|Midazolam|midazolam|mesh-list
14405669|NCT01507181|Ketamine|ketamine|mesh-list
14405670|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
14405671|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
14405672|NCT01507181|Analgesics|analgesics|mesh-ancestor
14405673|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
14405674|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405675|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405676|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14405677|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14405678|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
14405679|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
14405680|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405681|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14405682|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405683|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405684|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14405685|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14405686|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14405687|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14405688|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14405689|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
14405690|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
14405691|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14740817|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740818|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14740819|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
14740820|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14740821|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
14740822|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
14740823|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740824|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740825|NCT00565214|Vitamins|vitamins|mesh-list
15242419|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242420|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242421|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242422|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242423|NCT04042077|Vancomycin|vancomycin|mesh-list
15242424|NCT04042077|Tazobactam|tazobactam|mesh-list
15242425|NCT04042077|Linezolid|linezolid|mesh-list
15242426|NCT04042077|Piperacillin|piperacillin|mesh-list
15242427|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15242428|NCT04042077|Tigecycline|tigecycline|mesh-list
15242429|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15242430|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242431|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15242432|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242433|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242434|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15242435|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
15242436|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
15242437|NCT04022239|Melphalan|melphalan|mesh-list
15242438|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15242439|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
14740826|NCT00565214|Vitamin E|vitamin e|mesh-list
14740827|NCT00565214|Selenium|selenium|mesh-list
14740828|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
14740829|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740830|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
14740831|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740832|NCT00565214|Protective Agents|protective agents|mesh-ancestor
14740833|NCT00565214|Trace Elements|trace elements|mesh-ancestor
14740834|NCT00565227|Docetaxel|docetaxel|mesh-list
14740835|NCT00565227|Vorinostat|vorinostat|mesh-list
14740836|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740837|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14740838|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14740839|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14740840|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740841|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15242440|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14740842|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242441|NCT04022239|Rituximab|rituximab|mesh-list
15242442|NCT04022239|Fludarabine|fludarabine|mesh-list
14740843|NCT00565240|Letrozole|letrozole|mesh-list
14740844|NCT00565240|NuvaRing|nuvaring|mesh-list
14740845|NCT00565240|Desogestrel|desogestrel|mesh-list
14740846|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242443|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15242444|NCT04022239|Tacrolimus|tacrolimus|mesh-list
15242445|NCT04022239|Antibodies|antibodies|mesh-list
15242446|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
15242447|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15242448|NCT04022239|Lenograstim|lenograstim|mesh-list
15242449|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242450|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
15242451|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242452|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242453|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242454|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
14405692|NCT01507220|Morphine|morphine|mesh-list
14405693|NCT01507220|Bupivacaine|bupivacaine|mesh-list
14405694|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
14405695|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
14405696|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405697|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405698|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
14405699|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405700|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14405701|NCT01507220|Narcotics|narcotics|mesh-ancestor
14405702|NCT01507220|Analgesics|analgesics|mesh-ancestor
14405703|NCT01507246|Morphine|morphine|mesh-list
14405704|NCT01507246|Bupivacaine|bupivacaine|mesh-list
14405705|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
14405706|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
14405707|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405708|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740847|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14740848|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15242455|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242456|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242457|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14740849|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740850|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740851|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15242458|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15242459|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15242460|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242461|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15242462|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15242463|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
15242464|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405709|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
15242465|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242466|NCT04012996|Meloxicam|meloxicam|mesh-list
15242467|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15242468|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242469|NCT04012996|Analgesics|analgesics|mesh-ancestor
15242470|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
15242471|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242472|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242473|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740852|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
14740853|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14740854|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740855|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15242474|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242475|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15242476|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14405710|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242477|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242478|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405711|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14405712|NCT01507246|Narcotics|narcotics|mesh-ancestor
14405713|NCT01507246|Analgesics|analgesics|mesh-ancestor
14405714|NCT01507779|Vaccines|vaccines|mesh-list
14405715|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
14405716|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405717|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14405718|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
14405719|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405720|NCT01508117|Axitinib|axitinib|mesh-list
14405721|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405722|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14405723|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405724|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740856|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
15242479|NCT04010539|Azithromycin|azithromycin|mesh-list
15242480|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
15242481|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15242482|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242483|NCT04009668|Adalimumab|adalimumab|mesh-list
15242484|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242485|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242486|NCT04008238|Trabectedin|trabectedin|mesh-list
15242487|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242488|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
15242489|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242490|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242491|NCT03995017|Nivolumab|nivolumab|mesh-list
15242492|NCT03995017|Ramucirumab|ramucirumab|mesh-list
15242493|NCT03995017|Rucaparib|rucaparib|mesh-list
15242494|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242495|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242496|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242497|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242498|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15242499|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242500|NCT03980314|Nivolumab|nivolumab|mesh-list
15242501|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242502|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242503|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242504|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242505|NCT03972527|Analgesics|analgesics|mesh-list
15242506|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
15242507|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242508|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242509|NCT03926299|Clobetasol|clobetasol|mesh-list
15242510|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242511|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
15242512|NCT03926299|Hormones|hormones|mesh-ancestor
15242513|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242514|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242515|NCT03923374|Buprenorphine|buprenorphine|mesh-list
15242516|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15242517|NCT03923374|Narcotics|narcotics|mesh-ancestor
15242518|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242519|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242520|NCT03923374|Analgesics|analgesics|mesh-ancestor
15242521|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
15242522|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242523|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15242524|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
15242525|NCT03918798|Procaine|procaine|mesh-list
15242526|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15242527|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
15242528|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
15242529|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242530|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242531|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
15242532|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242533|NCT03915678|Atezolizumab|atezolizumab|mesh-list
15242534|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15242535|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405725|NCT01508325|Metoprolol|metoprolol|mesh-list
14405726|NCT01508325|Bisoprolol|bisoprolol|mesh-list
14405727|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14405728|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14405729|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
14405730|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
14405731|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405732|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405733|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14405734|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14405735|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14740857|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14740858|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14740859|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14740860|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14740861|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14740862|NCT00565240|Progestins|progestins|mesh-ancestor
14740863|NCT00565240|Hormones|hormones|mesh-ancestor
14740864|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
14740865|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14740866|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
14740867|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740868|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242536|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
15242537|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242538|NCT03913104|Mifepristone|mifepristone|mesh-list
15242539|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15242540|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
15242541|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15242542|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242543|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15242544|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15242545|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15242546|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
14740869|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14740870|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
14740871|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14740872|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
14740873|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740874|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740875|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14740876|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14740877|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
14405736|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405737|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405738|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405739|NCT01508455|Fentanyl|fentanyl|mesh-list
14405740|NCT01508455|Midazolam|midazolam|mesh-list
14405741|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
14405742|NCT01508455|Morphine|morphine|mesh-list
14405743|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14405744|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405745|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405746|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405747|NCT01508455|Analgesics|analgesics|mesh-ancestor
14405748|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
14405749|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405750|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14405751|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14740878|NCT00565253|Protective Agents|protective agents|mesh-ancestor
14740879|NCT00565292|Anacetrapib|anacetrapib|mesh-list
14924852|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
14405752|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14924853|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
14405753|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
14405754|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405755|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405756|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14405757|NCT01508455|Narcotics|narcotics|mesh-ancestor
14405758|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14405759|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14405760|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
14924854|NCT01400867|Cefazolin|cefazolin|mesh-list
14924855|NCT01400867|Linezolid|linezolid|mesh-list
14924856|NCT01400867|Cephalexin|cephalexin|mesh-list
14924857|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14405761|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
14405762|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14405763|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14405764|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14405765|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
14405766|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
14740880|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14740881|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14740882|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
14740883|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740884|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14740885|NCT00565318|Benphothiamine|benphothiamine|mesh-list
14740886|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14740887|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
14405767|NCT01508676|Diclofenac|diclofenac|mesh-list
14405768|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14405769|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14405770|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14405771|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405772|NCT01508676|Analgesics|analgesics|mesh-ancestor
14405773|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
14405774|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405775|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405776|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14924858|NCT01400867|Aztreonam|aztreonam|mesh-list
14924859|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14405777|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14405778|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405779|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405780|NCT01508702|Lesinurad|lesinurad|mesh-list
14405781|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
14405782|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405783|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
14740888|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740889|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
14740890|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
14740891|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740892|NCT00565331|Rituximab|rituximab|mesh-list
14740893|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14740894|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740895|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
14740896|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740897|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740898|NCT00565383|Fentanyl|fentanyl|mesh-list
14740899|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14740900|NCT00565383|Narcotics|narcotics|mesh-ancestor
14740901|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14740902|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740903|NCT00565383|Analgesics|analgesics|mesh-ancestor
14405784|NCT01508702|Renal Agents|renal agents|mesh-ancestor
14405785|NCT01508832|Lidocaine|lidocaine|mesh-list
14405786|NCT01508832|Bupivacaine|bupivacaine|mesh-list
14405787|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
14405788|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
14405789|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405790|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405791|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
14405792|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405793|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14405794|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14405795|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14405796|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14405797|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405798|NCT01508936|Reslizumab|reslizumab|mesh-list
14405799|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14924860|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924861|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14405800|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
14740904|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
14740905|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740906|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14740907|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14740908|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
14740909|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
14740910|NCT00565396|Losartan|losartan|mesh-list
14740911|NCT00565396|Fosinopril|fosinopril|mesh-list
14740912|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14740913|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14740914|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14740915|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14740916|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740917|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14740918|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
14740919|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740920|NCT00565422|Citalopram|citalopram|mesh-list
14740921|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14740922|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14740923|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14740924|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740925|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740926|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
14740927|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740928|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14740929|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
14740930|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14740931|NCT00565461|Vaccines|vaccines|mesh-list
14740932|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
14740933|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740934|NCT00565487|Capecitabine|capecitabine|mesh-list
14740935|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14740936|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14740937|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
14740938|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740939|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740940|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14740941|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14740942|NCT00565500|Ibuprofen|ibuprofen|mesh-list
14740943|NCT00565500|Celecoxib|celecoxib|mesh-list
14924862|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924863|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924864|NCT01400945|Pantoprazole|pantoprazole|mesh-list
14924865|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14924866|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14924867|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15242547|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15242548|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15242549|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
15242550|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242551|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
15242552|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15242553|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14924868|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924869|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924870|NCT01401036|Umirolimus|umirolimus|mesh-list
14924871|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14924872|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405801|NCT01509079|Vitamin D|vitamin d|mesh-list
14740944|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14740945|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14740946|NCT00565500|Analgesics|analgesics|mesh-ancestor
14740947|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
15242554|NCT03905265|Moxidectin|moxidectin|mesh-list
15242555|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
15242556|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15242557|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242558|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
14405802|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
14405803|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
14405804|NCT01509079|Vitamins|vitamins|mesh-list
14405805|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
14405806|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405807|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14405808|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14405809|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14405810|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
14405811|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467386|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467387|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14467388|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14467389|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14467390|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467391|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14467392|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14467393|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14467394|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467395|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
14467396|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
15242559|NCT03905135|Avelumab|avelumab|mesh-list
15242560|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242561|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242562|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15242563|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15242564|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
15242565|NCT03893903|Avelumab|avelumab|mesh-list
14467397|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14467398|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14467399|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
14467400|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14467401|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14467402|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14467403|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
14467404|NCT02260440|Azacitidine|azacitidine|mesh-list
14467405|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467406|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467407|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14467408|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
14467409|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467410|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467411|NCT02260492|Fluticasone|fluticasone|mesh-list
14467412|NCT02260492|Xhance|xhance|mesh-list
14467413|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14467414|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14467415|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467416|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14467417|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
14740948|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740949|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740950|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14740951|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14740952|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14740953|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242566|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242567|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405812|NCT01509404|Valganciclovir|valganciclovir|mesh-list
14405813|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
14405814|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405815|NCT01509547|Varenicline|varenicline|mesh-list
14405816|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14405817|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14405818|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
14405819|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405820|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405821|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405822|NCT01509586|Lobeline|lobeline|mesh-list
14405823|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14740954|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740955|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14740956|NCT00565539|Interferons|interferons|mesh-list
14740957|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740958|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
14740959|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740960|NCT00565591|Albuterol|albuterol|mesh-list
14740961|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14740962|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
14740963|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14740964|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740965|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14740966|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
14740967|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
14740968|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14740969|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14740970|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14405824|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
14740971|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14740972|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
14740973|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14740974|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740975|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
14740976|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14740977|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14740978|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14740979|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14740980|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14740981|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405825|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405826|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405827|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14740982|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14740983|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740984|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14740985|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
14740986|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14405828|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14405829|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
14405830|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405831|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405832|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
14405833|NCT01509625|Fulvestrant|fulvestrant|mesh-list
14405834|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14405835|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405836|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14405837|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14405838|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
14405839|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405840|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405841|NCT01509638|Bupivacaine|bupivacaine|mesh-list
14405842|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
14405843|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
14405844|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405845|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405846|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
14405847|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405848|NCT01509807|Morphine|morphine|mesh-list
14740987|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242568|NCT03875092|Paclitaxel|paclitaxel|mesh-list
15242569|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15242570|NCT03875092|Carboplatin|carboplatin|mesh-list
15242571|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
15242572|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15242573|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740988|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14740989|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14740990|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15242574|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
15242575|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
15242576|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
15242577|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242578|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242579|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
15242580|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15242581|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15242582|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242583|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
15242584|NCT03868956|Coagulants|coagulants|mesh-ancestor
14405849|NCT01509807|Bupivacaine|bupivacaine|mesh-list
14740991|NCT00565656|Bevacizumab|bevacizumab|mesh-list
14740992|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14740993|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14740994|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14740995|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14740996|NCT00565656|Growth Substances|growth substances|mesh-ancestor
14740997|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14740998|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
14740999|NCT00565682|Etoricoxib|etoricoxib|mesh-list
14741000|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741001|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14741002|NCT00565682|Analgesics|analgesics|mesh-ancestor
14741003|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
14741004|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741005|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741006|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741007|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741008|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14741009|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741010|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741011|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741012|NCT00565708|Aspirin|aspirin|mesh-list
14741013|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741014|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14741015|NCT00565708|Analgesics|analgesics|mesh-ancestor
14741016|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
14741017|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741018|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924873|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
14924874|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741019|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242585|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
15242586|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242587|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242588|NCT03841097|Tacrolimus|tacrolimus|mesh-list
14924875|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
14924876|NCT01401075|Doxifluridine|doxifluridine|mesh-list
14924877|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924878|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14924879|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14924880|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
14924881|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924882|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14924883|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
15242589|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242590|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
15242591|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242592|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15242593|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242594|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242595|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
15242596|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242597|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242598|NCT03814356|Methylphenidate|methylphenidate|mesh-list
15242599|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15242600|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242601|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15242602|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15242603|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14741020|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741021|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15242604|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242605|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
15242606|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242607|NCT03814200|Rifampin|rifampin|mesh-list
15242608|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15242609|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
15242610|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15242611|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242612|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
15242613|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15242614|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741022|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15242615|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242616|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14405850|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
14405851|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
14405852|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405853|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405854|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
14405855|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405856|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14405857|NCT01509807|Narcotics|narcotics|mesh-ancestor
14405858|NCT01509807|Analgesics|analgesics|mesh-ancestor
14405859|NCT01509846|Vaccines|vaccines|mesh-list
14405860|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
14405861|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405862|NCT01510145|Travoprost|travoprost|mesh-list
14405863|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14405864|NCT01510158|Allopurinol|allopurinol|mesh-list
14405865|NCT01510158|Lesinurad|lesinurad|mesh-list
14405866|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
14405867|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405868|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405869|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
14405870|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405871|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14405872|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
14405873|NCT01510158|Protective Agents|protective agents|mesh-ancestor
14741023|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741024|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14741025|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741026|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741027|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
14741028|NCT00565955|Montelukast|montelukast|mesh-list
14741029|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14741030|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741031|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14741032|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
14741033|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405874|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405875|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
14405876|NCT01510158|Renal Agents|renal agents|mesh-ancestor
14741034|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741035|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14741036|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14741037|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741038|NCT00565968|Sorafenib|sorafenib|mesh-list
14741039|NCT00565968|Melphalan|melphalan|mesh-list
14741040|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741041|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15242617|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15242618|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15242619|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15242620|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15242621|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15242622|NCT03811847|Methylphenidate|methylphenidate|mesh-list
15242623|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15242624|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242625|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15242626|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15242627|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15242628|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242629|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
15242630|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242631|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
15242632|NCT03809624|Antibodies|antibodies|mesh-list
15242633|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
15242634|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242635|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242636|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405877|NCT01510327|Aspirin|aspirin|mesh-list
14405878|NCT01510327|Everolimus|everolimus|mesh-list
14405879|NCT01510327|Ticlopidine|ticlopidine|mesh-list
14405880|NCT01510327|Clopidogrel|clopidogrel|mesh-list
14405881|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14405882|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405883|NCT01510327|Analgesics|analgesics|mesh-ancestor
14405884|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
14405885|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741042|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741043|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741044|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14741045|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
14741046|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14741047|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405886|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405887|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405888|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405889|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14405890|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14405891|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405892|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14405893|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741048|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
14741049|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741050|NCT00565981|Fludarabine|fludarabine|mesh-list
14741051|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
14741052|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
14741053|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741054|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14741055|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
14741056|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741057|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14741058|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
14741059|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741060|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741061|NCT00566046|Levetiracetam|levetiracetam|mesh-list
14741062|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
14741063|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
14741064|NCT00566124|Insulin|insulin|mesh-list
14741065|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14741066|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
14741067|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
14741068|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
14741069|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
14741070|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
14741071|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741072|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753313|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741073|NCT00566241|Mecasermin|mecasermin|mesh-list
14405894|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405895|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
14405896|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405897|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405898|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
14405899|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14405900|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14405901|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14405902|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
14405903|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405904|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14405905|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14405906|NCT01510379|Promethazine|promethazine|mesh-list
15242637|NCT03805022|Doxorubicin|doxorubicin|mesh-list
15242638|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15242639|NCT03805022|Ifosfamide|ifosfamide|mesh-list
15242640|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
15242641|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14741074|NCT00566241|Growth Substances|growth substances|mesh-ancestor
14741075|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741076|NCT00566267|Simvastatin|simvastatin|mesh-list
14741077|NCT00566267|Ezetimibe|ezetimibe|mesh-list
14741078|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14741079|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14741080|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
14741081|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741082|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14741083|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14741084|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741085|NCT00566332|Fludarabine|fludarabine|mesh-list
14741086|NCT00566332|Chlorambucil|chlorambucil|mesh-list
15242642|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242643|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15242644|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14405907|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
14405908|NCT01510379|Ondansetron|ondansetron|mesh-list
14405909|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
14741087|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741088|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741089|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14741090|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
14741091|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14741092|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14741093|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14741094|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14741095|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242645|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242646|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242647|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242648|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
15242649|NCT03802240|Pemetrexed|pemetrexed|mesh-list
15242650|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242651|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242652|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242653|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15242654|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15242655|NCT03798678|Dexamethasone|dexamethasone|mesh-list
15242656|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
15242657|NCT03798678|Ichthammol|ichthammol|mesh-list
15242658|NCT03798678|BB 1101|bb 1101|mesh-list
15242659|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242660|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
15242661|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
15242662|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242663|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242664|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15242665|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
14405910|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
15242666|NCT03798678|Hormones|hormones|mesh-ancestor
14405911|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14405912|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405913|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14741096|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14741097|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741098|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741099|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14741100|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14741101|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
14741102|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741103|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
14741104|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14741105|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741106|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
14741107|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741108|NCT00566553|Protective Agents|protective agents|mesh-ancestor
14741109|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741110|NCT00566592|Ethanol|ethanol|mesh-list
14924884|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924885|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14924886|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
15242667|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242668|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15242669|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405914|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
14405915|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
14405916|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14405917|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
14405918|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741111|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14924887|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924888|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
14924889|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14924890|NCT01401179|Clarithromycin|clarithromycin|mesh-list
14924891|NCT01401179|Cefazolin|cefazolin|mesh-list
14924892|NCT01401179|Erythromycin|erythromycin|mesh-list
14924893|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
14924894|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14924895|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
15242670|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
15242671|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242672|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242673|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
15242674|NCT03784066|Durvalumab|durvalumab|mesh-list
15242675|NCT03784066|Tremelimumab|tremelimumab|mesh-list
14924896|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15242676|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14741112|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741113|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405919|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405920|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14405921|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14405922|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14405923|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14405924|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14405925|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14405926|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
14405927|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
14405928|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14405929|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14405930|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14405931|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
14405932|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
14405933|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
14405934|NCT01510457|Milnacipran|milnacipran|mesh-list
14405935|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
14405936|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14405937|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14405938|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14741114|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741115|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
14741116|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14741117|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
14741118|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14405939|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405940|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14405941|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405942|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405943|NCT01510457|Analgesics|analgesics|mesh-ancestor
14741119|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741120|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14405944|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
14405945|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741121|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14741122|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14741123|NCT00566683|Meperidine|meperidine|mesh-list
14741124|NCT00566683|Diazepam|diazepam|mesh-list
14741125|NCT00566683|Alfentanil|alfentanil|mesh-list
14741126|NCT00566683|Propofol|propofol|mesh-list
14741127|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14741128|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741129|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741130|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15242677|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242678|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405946|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
14405947|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14405948|NCT01510769|Febuxostat|febuxostat|mesh-list
14405949|NCT01510769|Lesinurad|lesinurad|mesh-list
14405950|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
14741131|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
15242679|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
15242680|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242681|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
15242682|NCT03740009|Estrogens|estrogens|mesh-list
15242683|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15242684|NCT03740009|Hormones|hormones|mesh-ancestor
15242685|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242686|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741132|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
14741133|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15242687|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15242688|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14741134|NCT00566683|Narcotics|narcotics|mesh-ancestor
14741135|NCT00566683|Analgesics|analgesics|mesh-ancestor
14741136|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
14741137|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741138|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14741139|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
14741140|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
15242689|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
15242690|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15242691|NCT03738852|Insulin|insulin|mesh-list
14741141|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
14741142|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14924897|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924898|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14924899|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924900|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924901|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14924902|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14924903|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931099|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242692|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741143|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14741144|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15242693|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741145|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15242694|NCT03738397|Upadacitinib|upadacitinib|mesh-list
15242695|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15242696|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
15242697|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242698|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15242699|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15242700|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242701|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242702|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242703|NCT03727061|Carboplatin|carboplatin|mesh-list
15242704|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
14405951|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405952|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
14405953|NCT01510769|Renal Agents|renal agents|mesh-ancestor
14405954|NCT01510912|Diclofenac|diclofenac|mesh-list
14405955|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14405956|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14405957|NCT01510912|Analgesics|analgesics|mesh-ancestor
14405958|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
14405959|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741146|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14741147|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741148|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
14741149|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
14741150|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741151|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741152|NCT00566761|Triamcinolone|triamcinolone|mesh-list
14741153|NCT00566761|Bevacizumab|bevacizumab|mesh-list
14741154|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741155|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741156|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741157|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741158|NCT00566761|Growth Substances|growth substances|mesh-ancestor
14741159|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741160|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741161|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741162|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
14741163|NCT00566761|Hormones|hormones|mesh-ancestor
14741164|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14741165|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14741166|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741167|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14741168|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741169|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741170|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
14741171|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14741172|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
14741173|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741174|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14741175|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14741176|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14741177|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405960|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405961|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14405962|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14405963|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14405964|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405965|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405966|NCT01511068|Sargramostim|sargramostim|mesh-list
14405967|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
14405968|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405969|NCT01511107|Amoxicillin|amoxicillin|mesh-list
14405970|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
14405971|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
14405972|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14405973|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14741178|NCT00566891|Tirofiban|tirofiban|mesh-list
14741179|NCT00566891|Clopidogrel|clopidogrel|mesh-list
14741180|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14741181|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14741182|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15242705|NCT03727061|Fluorouracil|fluorouracil|mesh-list
15242706|NCT03727061|Nivolumab|nivolumab|mesh-list
15242707|NCT03727061|Cetuximab|cetuximab|mesh-list
15242708|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
15242709|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14741183|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14741184|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
14741185|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741186|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405974|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14405975|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15242710|NCT03727061|Trioxsalen|trioxsalen|mesh-list
15242711|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405976|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405977|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741187|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741188|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14741189|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14741190|NCT00566904|Aspirin|aspirin|mesh-list
14741191|NCT00566904|Lidocaine|lidocaine|mesh-list
14741192|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
14741193|NCT00566904|Anesthetics|anesthetics|mesh-list
14741194|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741195|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741196|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
14741197|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741198|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14741199|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14741200|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14741201|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14741202|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741203|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741204|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14741205|NCT00566904|Analgesics|analgesics|mesh-ancestor
14741206|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741207|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741208|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14741209|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14741210|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14741211|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741212|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741213|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
14741214|NCT00567034|Naltrexone|naltrexone|mesh-list
14741215|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14741216|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14741217|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741218|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
14741219|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741220|NCT00567047|Vildagliptin|vildagliptin|mesh-list
14741221|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741222|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741223|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14741224|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
14741225|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741226|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741227|NCT00567060|Piracetam|piracetam|mesh-list
14741228|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14405978|NCT01511315|Ustekinumab|ustekinumab|mesh-list
14405979|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
14924904|NCT01401192|Gemcitabine|gemcitabine|mesh-list
14924905|NCT01401192|Cisplatin|cisplatin|mesh-list
14405980|NCT01511445|Silicon|silicon|mesh-list
14405981|NCT01511445|Trace Elements|trace elements|mesh-ancestor
14405982|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
14405983|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405984|NCT01511536|Prednisone|prednisone|mesh-list
14741229|NCT00567060|Protective Agents|protective agents|mesh-ancestor
14741230|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741231|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
14741232|NCT00567099|Aripiprazole|aripiprazole|mesh-list
14741233|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
14741234|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741235|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14741236|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14741237|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741238|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741239|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
14741240|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
14741241|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741242|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741243|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14741244|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14924906|NCT01401192|Pemetrexed|pemetrexed|mesh-list
14924907|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405985|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
14405986|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741245|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
14741246|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14741247|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14741248|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14741249|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14741250|NCT00567177|Cyclosporine|cyclosporine|mesh-list
14741251|NCT00567177|Cyclosporins|cyclosporins|mesh-list
14741252|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741253|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741254|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405987|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
14405988|NCT01511536|Hormones|hormones|mesh-ancestor
14924908|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14924909|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
14924910|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924911|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
14924912|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924913|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924914|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14405989|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14405990|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14405991|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14405992|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14405993|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14405994|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14405995|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14405996|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
14405997|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14405998|NCT01511640|Pregabalin|pregabalin|mesh-list
14405999|NCT01511640|Analgesics|analgesics|mesh-ancestor
14741255|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
14741256|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741257|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
14741258|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741259|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
14741260|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741261|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14406000|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
14406001|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406002|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406003|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
14406004|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14406005|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406006|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406007|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14406008|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14406009|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14406010|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406011|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14406012|NCT01511809|Ritonavir|ritonavir|mesh-list
14406013|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14406014|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14406015|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14406016|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
14406017|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406018|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741262|NCT00567216|Nadolol|nadolol|mesh-list
14741263|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14406019|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14741264|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14741265|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
14741266|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741267|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741268|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741269|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14741270|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14741271|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
14741272|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
14741273|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741274|NCT00567372|Bevacizumab|bevacizumab|mesh-list
14741275|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741276|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741277|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741278|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741279|NCT00567372|Growth Substances|growth substances|mesh-ancestor
14741280|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741281|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741282|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14741283|NCT00567411|Apraclonidine|apraclonidine|mesh-list
14741284|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14741285|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14741286|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14741287|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14741288|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
14741289|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741290|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741291|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741292|NCT00567450|Ropivacaine|ropivacaine|mesh-list
14741293|NCT00567450|Mepivacaine|mepivacaine|mesh-list
14741294|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
14741295|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
14741296|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741297|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741298|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
14741299|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741300|NCT00567463|Fluticasone|fluticasone|mesh-list
14741301|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741302|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14741303|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
14406020|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14406021|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
14406022|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406023|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14406024|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14406025|NCT01511939|Diclofenac|diclofenac|mesh-list
14406026|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14406027|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14741304|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741305|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741306|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14741307|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741308|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
14741309|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14924915|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
14924916|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924917|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14741310|NCT00567528|Ibuprofen|ibuprofen|mesh-list
14741311|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741312|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14741313|NCT00567528|Analgesics|analgesics|mesh-ancestor
14741314|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
14741315|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741316|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741317|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741318|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741319|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741320|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741321|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741322|NCT00567554|Paclitaxel|paclitaxel|mesh-list
14741323|NCT00567554|Docetaxel|docetaxel|mesh-list
14741324|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14741325|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
14741326|NCT00567554|Bevacizumab|bevacizumab|mesh-list
14741327|NCT00567554|Trastuzumab|trastuzumab|mesh-list
14741328|NCT00567554|Everolimus|everolimus|mesh-list
14741329|NCT00567554|Epirubicin|epirubicin|mesh-list
14741330|NCT00567554|Lapatinib|lapatinib|mesh-list
14741331|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14741332|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741333|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
14741334|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
14741335|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
14741336|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741337|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14741338|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
14741339|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741340|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741341|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14741342|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
14741343|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14741344|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741345|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741346|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741347|NCT00567554|Growth Substances|growth substances|mesh-ancestor
14741348|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741349|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15242712|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242713|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
15242714|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242715|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15242716|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242717|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
15242718|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242719|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242720|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
15242721|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15242722|NCT03705845|Tocotrienols|tocotrienols|mesh-list
15242723|NCT03705845|Vitamin E|vitamin e|mesh-list
15242724|NCT03705845|Tocopherols|tocopherols|mesh-list
15242725|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
15242726|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242727|NCT03705845|Protective Agents|protective agents|mesh-ancestor
15242728|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242729|NCT03705845|Vitamins|vitamins|mesh-ancestor
15242730|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
15242731|NCT03689244|Selexipag|selexipag|mesh-list
15242732|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15242733|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
15242734|NCT03674320|Testosterone|testosterone|mesh-list
15242735|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
15242736|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
14406028|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14406029|NCT01511939|Analgesics|analgesics|mesh-ancestor
14406030|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
14406031|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406032|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406033|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406034|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14406035|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406036|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406037|NCT01511978|Amifampridine|amifampridine|mesh-list
14406038|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14406039|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406040|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406041|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15242737|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15242738|NCT03674320|Androgens|androgens|mesh-ancestor
15242739|NCT03674320|Hormones|hormones|mesh-ancestor
15242740|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242741|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242742|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15242743|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242744|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
15242745|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
15242746|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15242747|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242748|NCT03650894|Nivolumab|nivolumab|mesh-list
15242749|NCT03650894|Ipilimumab|ipilimumab|mesh-list
15242750|NCT03650894|Bicalutamide|bicalutamide|mesh-list
15242751|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242752|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741350|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14406042|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14741351|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14741352|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741353|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14741354|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
14741355|NCT00567606|Calcium|calcium|mesh-list
14741356|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14741357|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741358|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14741359|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14741360|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242753|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242754|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741361|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14741362|NCT00567658|Esomeprazole|esomeprazole|mesh-list
14741363|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14741364|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14741365|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14741366|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741367|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741368|NCT00567697|Ranibizumab|ranibizumab|mesh-list
14741369|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741370|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741371|NCT00567697|Growth Substances|growth substances|mesh-ancestor
14741372|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741373|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741374|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741375|NCT00567710|Risperidone|risperidone|mesh-list
14741376|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14741377|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
14741378|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741379|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741380|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741381|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14741382|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14741383|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741384|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741385|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14741386|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
14741387|NCT00567762|Tacrolimus|tacrolimus|mesh-list
14741388|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14741389|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
14741390|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741391|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14741392|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741393|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741394|NCT00567775|Insulin|insulin|mesh-list
14741395|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14741396|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741397|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741398|NCT00567788|Bimatoprost|bimatoprost|mesh-list
14741399|NCT00567788|Latanoprost|latanoprost|mesh-list
14741400|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14406043|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406044|NCT01512108|Liraglutide|liraglutide|mesh-list
14406045|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14406046|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406047|NCT01512108|Incretins|incretins|mesh-ancestor
14406048|NCT01512108|Hormones|hormones|mesh-ancestor
14406049|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406050|NCT01512160|Ibuprofen|ibuprofen|mesh-list
14406051|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741401|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14741402|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14741403|NCT00567814|Oxazepam|oxazepam|mesh-list
15242755|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
15242756|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
15242757|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242758|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242759|NCT03639610|Dexamethasone|dexamethasone|mesh-list
15242760|NCT03639610|Melphalan|melphalan|mesh-list
15242761|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242762|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
15242763|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
15242764|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242765|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242766|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15242767|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
15242768|NCT03639610|Hormones|hormones|mesh-ancestor
15242769|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242770|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15242771|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242772|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14741404|NCT00567814|Metyrapone|metyrapone|mesh-list
14741405|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
14741406|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741407|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741408|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14741409|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741410|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741411|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14741412|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14741413|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741414|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
14741415|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
14741416|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741417|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14741418|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14741419|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741420|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14741421|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14741422|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741423|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741424|NCT00567918|Tacrolimus|tacrolimus|mesh-list
14406052|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14406053|NCT01512160|Analgesics|analgesics|mesh-ancestor
14406054|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
14406055|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406056|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406057|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406058|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406059|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741425|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14741426|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
14741427|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406060|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406061|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741428|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14741429|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406062|NCT01512225|Domperidone|domperidone|mesh-list
14406063|NCT01512225|Maleic acid|maleic acid|mesh-list
14406064|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406065|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406066|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
14406067|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
14406068|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406069|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406070|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14406071|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14406072|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
14406073|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406074|NCT01512251|Vemurafenib|vemurafenib|mesh-list
14406075|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406076|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14406077|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406078|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406079|NCT01512446|Alendronate|alendronate|mesh-list
14406080|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14406081|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406082|NCT01512745|Apatinib|apatinib|mesh-list
14406083|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406084|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14406085|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406086|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406087|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14406088|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406089|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406090|NCT01512797|Incretins|incretins|mesh-ancestor
14406091|NCT01512797|Hormones|hormones|mesh-ancestor
14406092|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406093|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14406094|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
14406095|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406096|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406097|NCT01512979|Metformin|metformin|mesh-list
14406098|NCT01512979|Linagliptin|linagliptin|mesh-list
14406099|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406100|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406101|NCT01512979|Incretins|incretins|mesh-ancestor
14406102|NCT01512979|Hormones|hormones|mesh-ancestor
14406103|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406104|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14406105|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
14406106|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406107|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406108|NCT01513122|Ritonavir|ritonavir|mesh-list
14406109|NCT01513122|Lopinavir|lopinavir|mesh-list
14406110|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
14406111|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14406112|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15242773|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
15242774|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242775|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15242776|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242777|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
15242778|NCT03635892|Nivolumab|nivolumab|mesh-list
15242779|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242780|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242781|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242782|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242783|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
15242784|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242785|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242786|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
15242787|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14406113|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
14406114|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406115|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406116|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14406117|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14741430|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741431|NCT00567931|Tryptophan|tryptophan|mesh-list
14741432|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14741433|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
14741434|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741435|NCT00567957|Remifentanil|remifentanil|mesh-list
14406118|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
14406119|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406120|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14406121|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14406122|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14406123|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14406124|NCT01513317|Siltuximab|siltuximab|mesh-list
14406125|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406126|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
14406127|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
14406128|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14406129|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
14406130|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406131|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741436|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14741437|NCT00567957|Narcotics|narcotics|mesh-ancestor
14741438|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741439|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741440|NCT00567957|Analgesics|analgesics|mesh-ancestor
14741441|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
14406132|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14406133|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
14406134|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
14406135|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14406136|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
14406137|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406138|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406139|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14406140|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14741442|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741443|NCT00567983|Cyclosporine|cyclosporine|mesh-list
14741444|NCT00567983|Cyclosporins|cyclosporins|mesh-list
14741445|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741446|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741447|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14741448|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
14406141|NCT01513473|Insulin|insulin|mesh-list
14406142|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14406143|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
14406144|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
14406145|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406146|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406147|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14406148|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
14406149|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406150|NCT01513590|Insulin|insulin|mesh-list
14406151|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
14406152|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406153|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406154|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14406155|NCT01513759|Plasminogen|plasminogen|mesh-list
14406156|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14406157|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14741449|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406158|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406159|NCT01513902|Tofacitinib|tofacitinib|mesh-list
14406160|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14406161|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406162|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406163|NCT01514149|Metformin|metformin|mesh-list
14406164|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406165|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406166|NCT01514201|Temozolomide|temozolomide|mesh-list
14406167|NCT01514201|Veliparib|veliparib|mesh-list
14406168|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14406169|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
14406170|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406171|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406172|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14406173|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406174|NCT01514240|Mesalamine|mesalamine|mesh-list
14406175|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14406176|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14406177|NCT01514240|Analgesics|analgesics|mesh-ancestor
15242788|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242789|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242790|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15242791|NCT03589729|Cytarabine|cytarabine|mesh-list
15242792|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
15242793|NCT03589729|Idarubicin|idarubicin|mesh-list
15242794|NCT03589729|Cladribine|cladribine|mesh-list
15242795|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
15242796|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
15242797|NCT03589729|Razoxane|razoxane|mesh-list
15242798|NCT03589729|Calicheamicins|calicheamicins|mesh-list
15242799|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15242800|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
15242801|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242802|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242803|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
15242804|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406178|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
14406179|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741450|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
15242805|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242806|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
14741451|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741452|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
14741453|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406180|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406181|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406182|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406183|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14406184|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
14406185|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406186|NCT01514370|Interferons|interferons|mesh-list
14406187|NCT01514370|Interferon-beta|interferon-beta|mesh-list
14406188|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
14406189|NCT01514370|Curcumin|curcumin|mesh-list
15242807|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242808|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15242809|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15242810|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15242811|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242812|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242813|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15242814|NCT03589729|Protective Agents|protective agents|mesh-ancestor
15242815|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
15242816|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
15242817|NCT03588754|Propranolol|propranolol|mesh-list
15242818|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15242819|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15242820|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
15242821|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242822|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242823|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242824|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15242825|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15242826|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
15242827|NCT03569293|Upadacitinib|upadacitinib|mesh-list
15242828|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15242829|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15242830|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741454|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14741455|NCT00568048|Bevacizumab|bevacizumab|mesh-list
14741456|NCT00568048|Temozolomide|temozolomide|mesh-list
14741457|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741458|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242831|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242832|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242833|NCT03564678|Folic Acid|folic acid|mesh-list
15242834|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
15242835|NCT03564678|Vitamins|vitamins|mesh-ancestor
15242836|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
15242837|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242838|NCT03564678|Hematinics|hematinics|mesh-ancestor
15242839|NCT03520491|Nivolumab|nivolumab|mesh-list
14406190|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242840|NCT03520491|Ipilimumab|ipilimumab|mesh-list
14741459|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15242841|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242842|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242843|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242844|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242845|NCT03495388|Oxycodone|oxycodone|mesh-list
15242846|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14741460|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741461|NCT00568048|Growth Substances|growth substances|mesh-ancestor
14741462|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741463|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741464|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14741465|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
14741466|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741467|NCT00568074|Repaglinide|repaglinide|mesh-list
14741468|NCT00568074|Acarbose|acarbose|mesh-list
14741469|NCT00568074|Gliquidone|gliquidone|mesh-list
14741470|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741471|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741472|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14741473|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741474|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741475|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
14741476|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14741477|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
14741478|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741479|NCT00568113|Expectorants|expectorants|mesh-ancestor
14741480|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741481|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14741482|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
14741483|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741484|NCT00568113|Protective Agents|protective agents|mesh-ancestor
14741485|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242847|NCT03495388|Narcotics|narcotics|mesh-ancestor
15242848|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242849|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242850|NCT03495388|Analgesics|analgesics|mesh-ancestor
15242851|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
14741486|NCT00568113|Antidotes|antidotes|mesh-ancestor
14741487|NCT00568152|Aspirin|aspirin|mesh-list
14741488|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15242852|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242853|NCT03488420|Edoxaban|edoxaban|mesh-list
15242854|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14741489|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14741490|NCT00568152|Analgesics|analgesics|mesh-ancestor
14741491|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
14741492|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741493|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741494|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242855|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
14741495|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741496|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14741497|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14741498|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242856|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15242857|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
15242858|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242859|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242860|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
14741499|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15242861|NCT03476330|Quercetin|quercetin|mesh-list
15242862|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
14741500|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741501|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741502|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
14741503|NCT00568217|Acetaminophen|acetaminophen|mesh-list
15242863|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242864|NCT03476330|Protective Agents|protective agents|mesh-ancestor
15242865|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242866|NCT03473977|Benralizumab|benralizumab|mesh-list
15242867|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14406191|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
14406192|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406193|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14406194|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14406195|NCT01514370|Analgesics|analgesics|mesh-ancestor
14406196|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
14406197|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406198|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406199|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741504|NCT00568217|Ibuprofen|ibuprofen|mesh-list
14741505|NCT00568217|Diclofenac|diclofenac|mesh-list
15242868|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
15242869|NCT03461445|Tacrolimus|tacrolimus|mesh-list
15242870|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242871|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
14741506|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741507|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14741508|NCT00568217|Analgesics|analgesics|mesh-ancestor
14741509|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
14741510|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741511|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741512|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741513|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741514|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741515|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741516|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741517|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
14753314|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753315|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14753316|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14753317|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
14753318|NCT05210764|Analgesics|analgesics|mesh-ancestor
14753319|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
14753320|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753321|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14753322|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14753323|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14753324|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753325|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753326|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14753327|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14753328|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
14753329|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14753330|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
14753331|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14753332|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
14753333|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14753334|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
14753335|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753336|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753337|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
14753338|NCT05210374|Copper|copper|mesh-list
14753339|NCT05210374|Doxorubicin|doxorubicin|mesh-list
14753340|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14753341|NCT05210374|Disulfiram|disulfiram|mesh-list
14753342|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14753343|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753344|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14753345|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14753346|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242872|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753813|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14741518|NCT00568295|Acetaminophen|acetaminophen|mesh-list
14741519|NCT00568295|Rofecoxib|rofecoxib|mesh-list
14741520|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14741521|NCT00568295|Analgesics|analgesics|mesh-ancestor
14741522|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
14741523|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242873|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15242874|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242875|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242876|NCT03451006|Metformin|metformin|mesh-list
15242877|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15242878|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242879|NCT03437421|Vitamin D|vitamin d|mesh-list
15242880|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
15242881|NCT03437421|Vitamins|vitamins|mesh-ancestor
15242882|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
15242883|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242884|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15242885|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15242886|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15242887|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242888|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242889|NCT03396211|Nivolumab|nivolumab|mesh-list
15242890|NCT03396211|Apatinib|apatinib|mesh-list
15242891|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15242892|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242893|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15242894|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242895|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15242896|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242897|NCT03392441|Insulin|insulin|mesh-list
15242898|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15242899|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242900|NCT03389243|Acetaminophen|acetaminophen|mesh-list
15242901|NCT03389243|Dipyrone|dipyrone|mesh-list
15242902|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242903|NCT03389243|Analgesics|analgesics|mesh-ancestor
15242904|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
15242905|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242906|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753814|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242907|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
15242908|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15242909|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242910|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15242911|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
15242912|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15242913|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15242914|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242915|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
15242916|NCT03364491|Coagulants|coagulants|mesh-ancestor
15242917|NCT03338920|Sumatriptan|sumatriptan|mesh-list
15242918|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15242919|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15242920|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15242921|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
15242922|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242923|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242924|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242925|NCT03243838|Apatinib|apatinib|mesh-list
14406200|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406201|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741524|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242926|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242927|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15242928|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242929|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242930|NCT03237780|Atezolizumab|atezolizumab|mesh-list
15242931|NCT03237780|Halichondrin B|halichondrin b|mesh-list
15242932|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15242933|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242934|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
15242935|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242936|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
15242937|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
15242938|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
15242939|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242940|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
15242941|NCT03221309|Narcotics|narcotics|mesh-ancestor
15242942|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15242943|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242944|NCT03221309|Analgesics|analgesics|mesh-ancestor
15242945|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
15242946|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242947|NCT03205761|Olaparib|olaparib|mesh-list
15242948|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15242949|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242950|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242951|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242952|NCT03151811|Dexamethasone|dexamethasone|mesh-list
15242953|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
15242954|NCT03151811|Melphalan|melphalan|mesh-list
15242955|NCT03151811|Pomalidomide|pomalidomide|mesh-list
15242956|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242957|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
15242958|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
15242959|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242960|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242961|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15242962|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
15242963|NCT03151811|Hormones|hormones|mesh-ancestor
15242964|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15242965|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14741525|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
14741526|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14741527|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741528|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741529|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741530|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741531|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741532|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741533|NCT00568347|Fluticasone|fluticasone|mesh-list
14741534|NCT00568347|Xhance|xhance|mesh-list
15242966|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242967|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15242968|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
15242969|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242970|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15242971|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15242972|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
15242973|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15242974|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15242975|NCT03151811|Growth Substances|growth substances|mesh-ancestor
14741535|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14741536|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14741537|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15242976|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
15242977|NCT03126968|Epinephrine|epinephrine|mesh-list
15242978|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14741538|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14741539|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
14741540|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741541|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741542|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14741543|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741544|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
15242979|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15242980|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
14741545|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14741546|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14741547|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14741548|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14741549|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14741550|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242981|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741551|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242982|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15242983|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15242984|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14924918|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14741552|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
14741553|NCT00568347|Hormones|hormones|mesh-ancestor
14741554|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14741555|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
14741556|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
14741557|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14741558|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15242985|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15242986|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
14406202|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406203|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
14406204|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14406205|NCT01514422|Minocycline|minocycline|mesh-list
14406206|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14406207|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15242987|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15242988|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14406208|NCT01514448|Everolimus|everolimus|mesh-list
14406209|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406210|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14406211|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
14406212|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406213|NCT01514513|Permethrin|permethrin|mesh-list
14924919|NCT01401387|Pancreatin|pancreatin|mesh-list
14924920|NCT01401387|Pancrelipase|pancrelipase|mesh-list
14924921|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14924922|NCT01401491|Clozapine|clozapine|mesh-list
14924923|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
14924924|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14924925|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
14924926|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15242989|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
15242990|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
15242991|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
15242992|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15242993|NCT03086096|Irinotecan|irinotecan|mesh-list
15242994|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15242995|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15242996|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15242997|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406214|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406215|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406216|NCT01514734|Timolol|timolol|mesh-list
14406217|NCT01514734|Brinzolamide|brinzolamide|mesh-list
14406218|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14406219|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14406220|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406221|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406222|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406223|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406224|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14406225|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14406226|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406227|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14406228|NCT01514864|Dasatinib|dasatinib|mesh-list
14406229|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406230|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14406231|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406232|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406233|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
14406234|NCT01515046|Gemcitabine|gemcitabine|mesh-list
14406235|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14406236|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
14406237|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406238|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406239|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
14406240|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406241|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406242|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14406243|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
14406244|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406245|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
14406246|NCT01515046|Protective Agents|protective agents|mesh-ancestor
14406247|NCT01515046|Vitamins|vitamins|mesh-ancestor
14406248|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
14406249|NCT01515176|Ofatumumab|ofatumumab|mesh-list
14406250|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14406251|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406252|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
14406253|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406254|NCT01515189|Ipilimumab|ipilimumab|mesh-list
14741559|NCT00568412|Analgesics|analgesics|mesh-ancestor
15242998|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15242999|NCT03085680|Curcumin|curcumin|mesh-list
15243000|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15243001|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15243002|NCT03085680|Analgesics|analgesics|mesh-ancestor
15243003|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
15243004|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243005|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243006|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243007|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15243008|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406255|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14406256|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406257|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14406258|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406259|NCT01515345|Clopidogrel|clopidogrel|mesh-list
14406260|NCT01515345|Ticagrelor|ticagrelor|mesh-list
14406261|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14406262|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14406263|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14406264|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14406265|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14741560|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
14741561|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741562|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741563|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741564|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741565|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14741566|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14741567|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
14741568|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14741569|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741570|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741571|NCT00568477|Rituximab|rituximab|mesh-list
14741572|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741573|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406266|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
14406267|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406268|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406269|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406270|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14406271|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14406272|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
14406273|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406274|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14406275|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14406276|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
14406277|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
14406278|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406279|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406280|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14406281|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14406282|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14406283|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14406284|NCT01515540|Lidocaine|lidocaine|mesh-list
14406285|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
14406286|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
14406287|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406288|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406289|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
14406290|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406291|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14406292|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14406293|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14406294|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406295|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406296|NCT01515566|Fentanyl|fentanyl|mesh-list
14406297|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14406298|NCT01515566|Narcotics|narcotics|mesh-ancestor
14406299|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406300|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406301|NCT01515566|Analgesics|analgesics|mesh-ancestor
15243009|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243010|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243011|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
15243012|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15243013|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406302|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
14406303|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406304|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14406305|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14406306|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
14406307|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
14467418|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467419|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467420|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14467421|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
14467422|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
14467423|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14467424|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14467425|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14467426|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14467427|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
14467428|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467429|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467430|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
15243014|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15243015|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15243016|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
15243017|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243018|NCT03051282|Enalapril|enalapril|mesh-list
15243019|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14741574|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
14741575|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741576|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741577|NCT00568503|Bromides|bromides|mesh-list
14741578|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
14741579|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15243020|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
15243021|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243022|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243023|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15243024|NCT03039673|Interleukin-2|interleukin-2|mesh-list
15243025|NCT03039673|Riluzole|riluzole|mesh-list
15243026|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243027|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15243028|NCT03039673|Analgesics|analgesics|mesh-ancestor
15243029|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
14406308|NCT01515657|Aspirin|aspirin|mesh-list
14406309|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14406310|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14406311|NCT01515657|Analgesics|analgesics|mesh-ancestor
14406312|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
14741580|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
14741581|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406313|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406314|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406315|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406316|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406317|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14406318|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14406319|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406320|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14406321|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14406322|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406323|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
14406324|NCT01515865|Midodrine|midodrine|mesh-list
14406325|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
14741582|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931100|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406326|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
14406327|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406328|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406329|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14406330|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14406331|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14406332|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14406333|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406334|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406335|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406336|NCT01515891|Opicapone|opicapone|mesh-list
14406337|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14406338|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406339|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406340|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14924927|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924928|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924929|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14924930|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14924931|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14924932|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14924933|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
14924934|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
14924935|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14924936|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14924937|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14924938|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14924939|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14924940|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
14741583|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14741584|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741585|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
14741586|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14741587|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
14406341|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14406342|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
14406343|NCT01515995|Analgesics|analgesics|mesh-ancestor
14406344|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
14406345|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406346|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406347|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
14741588|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741589|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741590|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
14406348|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406349|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14406350|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
14406351|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14741591|NCT00568529|Capecitabine|capecitabine|mesh-list
14741592|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
14741593|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14741594|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
14741595|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931101|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
14406352|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406353|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406354|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14406355|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
14406356|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14406357|NCT01516008|Tapentadol|tapentadol|mesh-list
14406358|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14406359|NCT01516008|Narcotics|narcotics|mesh-ancestor
14406360|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406361|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406362|NCT01516008|Analgesics|analgesics|mesh-ancestor
14406363|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
14406364|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406365|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14406366|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14406367|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406368|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406369|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406370|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406371|NCT01516268|Sufentanil|sufentanil|mesh-list
14406372|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14406373|NCT01516268|Narcotics|narcotics|mesh-ancestor
14406374|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406375|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406376|NCT01516268|Analgesics|analgesics|mesh-ancestor
14406377|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
14406378|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406379|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14406380|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14406381|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
14406382|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
14406383|NCT01516424|Risperidone|risperidone|mesh-list
14406384|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14406385|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
14406386|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406387|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406388|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406389|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14406390|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14406391|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406392|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14406393|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14406394|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
14406395|NCT01516684|Lidocaine|lidocaine|mesh-list
14406396|NCT01516684|Fentanyl|fentanyl|mesh-list
14406397|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
14406398|NCT01516684|Prilocaine|prilocaine|mesh-list
14406399|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14406400|NCT01516684|Propofol|propofol|mesh-list
14406401|NCT01516684|Anesthetics|anesthetics|mesh-list
14406402|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741596|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741597|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
14741598|NCT00568542|Hematinics|hematinics|mesh-ancestor
14741599|NCT00568568|Hormones|hormones|mesh-list
14924941|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14467431|NCT02260492|Hormones|hormones|mesh-ancestor
14467432|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467433|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
14467434|NCT02260531|Trastuzumab|trastuzumab|mesh-list
14467435|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467436|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467437|NCT02260622|Aspirin|aspirin|mesh-list
14467438|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
14467439|NCT02260622|Clopidogrel|clopidogrel|mesh-list
14467440|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467441|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467442|NCT02260622|Analgesics|analgesics|mesh-ancestor
14467443|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
14467444|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467445|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467446|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467447|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406403|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406404|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
14406405|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406406|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14406407|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14406408|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14406409|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406410|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406411|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14406412|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14406413|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
14406414|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14406415|NCT01516684|Narcotics|narcotics|mesh-ancestor
14406416|NCT01516684|Analgesics|analgesics|mesh-ancestor
14406417|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14406418|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14406419|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14406420|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406421|NCT01516879|Atorvastatin|atorvastatin|mesh-list
14406422|NCT01516879|Ezetimibe|ezetimibe|mesh-list
14406423|NCT01516879|Evolocumab|evolocumab|mesh-list
14406424|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14406425|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14406426|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
14406427|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406428|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14406429|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14406430|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406431|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
14406432|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14406433|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14406434|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14406435|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406436|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406437|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
15243030|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406438|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406439|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406440|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14406441|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406442|NCT01516957|Brodalumab|brodalumab|mesh-list
14406443|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14406444|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
14406445|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
14406446|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406447|NCT01516970|Ritonavir|ritonavir|mesh-list
14406448|NCT01516970|Lopinavir|lopinavir|mesh-list
14406449|NCT01516970|Darunavir|darunavir|mesh-list
14406450|NCT01516970|Zidovudine|zidovudine|mesh-list
14406451|NCT01516970|Efavirenz|efavirenz|mesh-list
14406452|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14406453|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14741600|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14741601|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741602|NCT00568672|Olanzapine|olanzapine|mesh-list
15243031|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741603|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
14741604|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
14741605|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741606|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741607|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14741608|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14741609|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14406454|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
15243032|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
15243033|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15243034|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15243035|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243036|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243037|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15243038|NCT03039673|Protective Agents|protective agents|mesh-ancestor
15243039|NCT03033225|Verteporfin|verteporfin|mesh-list
15243040|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15243041|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
14741610|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741611|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741612|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14741613|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14741614|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14741615|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741616|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243042|NCT03011034|Daratumumab|daratumumab|mesh-list
15243043|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243044|NCT02999477|Paclitaxel|paclitaxel|mesh-list
15243045|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
14741617|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
14741618|NCT00568711|Doxycycline|doxycycline|mesh-list
14741619|NCT00568711|Rifampin|rifampin|mesh-list
14741620|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14741621|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406455|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406456|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406457|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14406458|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14406459|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
14406460|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406461|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14406462|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14406463|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
14406464|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14406465|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14406466|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14741622|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
14741623|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14741624|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14741625|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14741626|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
14741627|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
14741628|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14741629|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741630|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243046|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15243047|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243048|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243049|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243050|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
15243051|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243052|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243053|NCT02980666|Teduglutide|teduglutide|mesh-list
15243054|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15243055|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15243056|NCT02980666|Protective Agents|protective agents|mesh-ancestor
15243057|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406467|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14406468|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14406469|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14406470|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14406471|NCT01517074|Sirolimus|sirolimus|mesh-list
14924942|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14924943|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924944|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14924945|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14924946|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14406472|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14406473|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406474|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14406475|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406476|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
14406477|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14406478|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
14406479|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741631|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14741632|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14741633|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14741634|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14741635|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14924947|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14924948|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924949|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
14924950|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924951|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924952|NCT01401933|Rifampin|rifampin|mesh-list
14406480|NCT01517295|Hydrocodone|hydrocodone|mesh-list
14406481|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14406482|NCT01517295|Narcotics|narcotics|mesh-ancestor
14406483|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406484|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406485|NCT01517295|Analgesics|analgesics|mesh-ancestor
14406486|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
14406487|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406488|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
14406489|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
14406490|NCT01517373|Glimepiride|glimepiride|mesh-list
14406491|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14741636|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14741637|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
15243058|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
15243059|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243060|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406492|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406493|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406494|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14406495|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
14406496|NCT01517412|Metformin|metformin|mesh-list
14406497|NCT01517412|Lixisenatide|lixisenatide|mesh-list
14406498|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406499|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406500|NCT01517750|Immunoconjugates|immunoconjugates|mesh-list
14406501|NCT01517750|Immunologic Factors|immunologic factors|mesh-ancestor
14406502|NCT01517750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406503|NCT01517893|Simvastatin|simvastatin|mesh-list
14741638|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243061|NCT02962102|Calcitriol|calcitriol|mesh-list
15243062|NCT02962102|Calcifediol|calcifediol|mesh-list
14741639|NCT00568750|Dasatinib|dasatinib|mesh-list
14741640|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741641|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14741642|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741643|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741644|NCT00568763|Sargramostim|sargramostim|mesh-list
14924953|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15243063|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15243064|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243065|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15243066|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406504|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14406505|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15243067|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741645|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
14741646|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741647|NCT00568789|Zolpidem|zolpidem|mesh-list
15243068|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15243069|NCT02962102|Vitamins|vitamins|mesh-ancestor
15243070|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
15243071|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15243072|NCT02950259|Indomethacin|indomethacin|mesh-list
15243073|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
15243074|NCT02950259|Omeprazole|omeprazole|mesh-list
15243075|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243076|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
15243077|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243078|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15243079|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15243080|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
14406506|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
14406507|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406508|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14406509|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14406510|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406511|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
15243081|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406512|NCT01517984|Prednisone|prednisone|mesh-list
14406513|NCT01517984|Tacrolimus|tacrolimus|mesh-list
14406514|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
14406515|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14741648|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14406516|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14741649|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14406517|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
15243082|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243083|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15243084|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15243085|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15243086|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14741650|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14741651|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741652|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14741653|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
14741654|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
14741655|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741656|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741657|NCT00568815|Rituximab|rituximab|mesh-list
14741658|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741659|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741660|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
14741661|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741662|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741663|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14741664|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741665|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14741666|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741667|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406518|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406519|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
14406520|NCT01517984|Hormones|hormones|mesh-ancestor
14406521|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406522|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406523|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14406524|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406525|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
14406526|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406527|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406528|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14406529|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14406530|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
14406531|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14924954|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
14924955|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14924956|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14924957|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
14924958|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14924959|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14924960|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924961|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14406532|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406533|NCT01518153|Vidarabine|vidarabine|mesh-list
14406534|NCT01518153|Methotrexate|methotrexate|mesh-list
15243087|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243088|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15243089|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15243090|NCT02950259|Analgesics|analgesics|mesh-ancestor
15243091|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
15243092|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243093|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406535|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
14406536|NCT01518153|Fludarabine|fludarabine|mesh-list
14406537|NCT01518153|Melphalan|melphalan|mesh-list
14406538|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
14406539|NCT01518153|Tacrolimus|tacrolimus|mesh-list
14406540|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14406541|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
14406542|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14406543|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406544|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14406545|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
14406546|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406547|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406548|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
14406549|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406550|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14406551|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14406552|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
14406553|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406554|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14406555|NCT01518153|Antiviral Agents|antiviral agents|mesh-ancestor
14406556|NCT01518153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406557|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14406558|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14406559|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
14406560|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14406561|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14406562|NCT01518192|Doxycycline|doxycycline|mesh-list
14406563|NCT01518192|Cefuroxime|cefuroxime|mesh-list
14406564|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
14406565|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14406566|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406567|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
14406568|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14406569|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14741668|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
14741669|NCT00568880|Bortezomib|bortezomib|mesh-list
14741670|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741671|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
14741672|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14741673|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14741674|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741675|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741676|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741677|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741678|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14741679|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741680|NCT00568971|Docetaxel|docetaxel|mesh-list
14741681|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741682|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
14406570|NCT01518244|Timolol|timolol|mesh-list
14406571|NCT01518244|Brinzolamide|brinzolamide|mesh-list
14741683|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
14406572|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14406573|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14406574|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406575|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406576|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406577|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406578|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14406579|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14406580|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406581|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14406582|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
14406583|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14406584|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14406585|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14406586|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406587|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406588|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
14406589|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406590|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406591|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14406592|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406593|NCT01518309|Pimavanserin|pimavanserin|mesh-list
14406594|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14406595|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14406596|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14406597|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14406598|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406599|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406600|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14406601|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14406602|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14406603|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
14406604|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406605|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406606|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
14406607|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14406608|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14406609|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406610|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14406611|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14741684|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
14741685|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741686|NCT00568984|Metformin|metformin|mesh-list
14741687|NCT00568984|Repaglinide|repaglinide|mesh-list
14741688|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741689|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741690|NCT00569088|Mannitol|mannitol|mesh-list
14741691|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14741692|NCT00569088|Diuretics|diuretics|mesh-ancestor
14406612|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406613|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406614|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406615|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14406616|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
14406617|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14406618|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406619|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14406620|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14406621|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14406622|NCT01518946|Midodrine|midodrine|mesh-list
14406623|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
14406624|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
14406625|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406626|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406627|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14406628|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14406629|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14406630|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14406631|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406632|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467448|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14741693|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
14924962|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14924963|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14924964|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14924965|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14924966|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14924967|NCT01402024|Aprepitant|aprepitant|mesh-list
14924968|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
14924969|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
14924970|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14924971|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741694|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741695|NCT00569101|Tacrolimus|tacrolimus|mesh-list
14741696|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14741697|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
14741698|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741699|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14741700|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741701|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741702|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14741703|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14741704|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741705|NCT00569296|Aldesleukin|aldesleukin|mesh-list
14924972|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14741706|NCT00569296|Sargramostim|sargramostim|mesh-list
14741707|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
14741708|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741709|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741710|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14741711|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14741712|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
14741713|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741714|NCT00569335|Bevacizumab|bevacizumab|mesh-list
14741715|NCT00569335|Irinotecan|irinotecan|mesh-list
14741716|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467449|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14467450|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467451|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14467452|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14741717|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741718|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741719|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15243094|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
15243095|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
15243096|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15243097|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15243098|NCT02947750|Folic Acid|folic acid|mesh-list
15243099|NCT02947750|Hematinics|hematinics|mesh-ancestor
15243100|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
15243101|NCT02947750|Vitamins|vitamins|mesh-ancestor
15243102|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
15243103|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243104|NCT02921893|Dexamethasone|dexamethasone|mesh-list
14406633|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406634|NCT01518972|Prazosin|prazosin|mesh-list
14406635|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14406636|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14406637|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14406638|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14406639|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406640|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406641|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406642|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406643|NCT01519063|Naltrexone|naltrexone|mesh-list
14406644|NCT01519063|Memantine|memantine|mesh-list
14406645|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14406646|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14406647|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406648|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
14406649|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406650|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14406651|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14406652|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
14406653|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406654|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243105|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
15243106|NCT02921893|Lenalidomide|lenalidomide|mesh-list
15243107|NCT02921893|Ixazomib|ixazomib|mesh-list
14741720|NCT00569335|Growth Substances|growth substances|mesh-ancestor
14467453|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741721|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741722|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
15243108|NCT02921893|Ichthammol|ichthammol|mesh-list
15243109|NCT02921893|BB 1101|bb 1101|mesh-list
15243110|NCT02921893|Glycine|glycine|mesh-list
15243111|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467454|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
14467455|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14467456|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15243112|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
14467457|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14406655|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14406656|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14406657|NCT01519089|Tofacitinib|tofacitinib|mesh-list
14406658|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14741723|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14741724|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14741725|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243113|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
15243114|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406659|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406660|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406661|NCT01519167|Fentanyl|fentanyl|mesh-list
14406662|NCT01519167|Midazolam|midazolam|mesh-list
14406663|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
14406664|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14406665|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406666|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406667|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14406668|NCT01519167|Analgesics|analgesics|mesh-ancestor
14406669|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
14924973|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14924974|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924975|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924976|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
14924977|NCT01402076|Midazolam|midazolam|mesh-list
14924978|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14924979|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14924980|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406670|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243115|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243116|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15243117|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
15243118|NCT02921893|Hormones|hormones|mesh-ancestor
15243119|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14924981|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924982|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14924983|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14924984|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15243120|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15243121|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243122|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
15243123|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243124|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243125|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
15243126|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15243127|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15243128|NCT02921893|Growth Substances|growth substances|mesh-ancestor
15243129|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
15243130|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
14406671|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14741726|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741727|NCT00569400|Insulin|insulin|mesh-list
14741728|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14741729|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741730|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243131|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
15243132|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243133|NCT02880020|Nivolumab|nivolumab|mesh-list
15243134|NCT02880020|Ipilimumab|ipilimumab|mesh-list
15243135|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243136|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243137|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15243138|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243139|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
15243140|NCT02853331|Sunitinib|sunitinib|mesh-list
15243141|NCT02853331|Axitinib|axitinib|mesh-list
15243142|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243143|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406672|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15243144|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15243145|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15243146|NCT02853331|Growth Substances|growth substances|mesh-ancestor
14406673|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14406674|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406675|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406676|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243147|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243148|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
15243149|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14406677|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14406678|NCT01519167|Narcotics|narcotics|mesh-ancestor
14406679|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14406680|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14406681|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
14406682|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
14406683|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14406684|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14406685|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14406686|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
14406687|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
15243150|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741731|NCT00569452|Insulin|insulin|mesh-list
14741732|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14406688|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
14406689|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14406690|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14406691|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406692|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
14406693|NCT01519245|Coagulants|coagulants|mesh-ancestor
14406694|NCT01519271|Rivastigmine|rivastigmine|mesh-list
14406695|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14406696|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406697|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406698|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
14406699|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406700|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741733|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741734|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406701|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14741735|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
14741736|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14741737|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
14741738|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741739|NCT00569465|Expectorants|expectorants|mesh-ancestor
14741740|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741741|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14741742|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
14741743|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741744|NCT00569465|Protective Agents|protective agents|mesh-ancestor
14406702|NCT01519271|Protective Agents|protective agents|mesh-ancestor
14406703|NCT01519284|Levodopa|levodopa|mesh-list
14741745|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741746|NCT00569465|Antidotes|antidotes|mesh-ancestor
14741747|NCT00569621|Moxaverine|moxaverine|mesh-list
14741748|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
14741749|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
14741750|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741751|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741752|NCT00569699|Bevacizumab|bevacizumab|mesh-list
14741753|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741754|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741755|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741756|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741757|NCT00569699|Growth Substances|growth substances|mesh-ancestor
14741758|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741759|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741760|NCT00569712|Budesonide|budesonide|mesh-list
14406704|NCT01519284|Carbidopa|carbidopa|mesh-list
14406705|NCT01519284|Opicapone|opicapone|mesh-list
14406706|NCT01519284|Entacapone|entacapone|mesh-list
14406707|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14406708|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14406709|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
14406710|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406711|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406712|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406713|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14406714|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406715|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14406716|NCT01519323|Vemurafenib|vemurafenib|mesh-list
14406717|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467458|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
14467459|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467460|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14406718|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14406719|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406720|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406721|NCT01519518|Heparin|heparin|mesh-list
14406722|NCT01519518|Calcium heparin|calcium heparin|mesh-list
14406723|NCT01519518|Bivalirudin|bivalirudin|mesh-list
14406724|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
14406725|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14406726|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14406727|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406728|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
14741761|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
14741762|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741763|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14741764|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
14741765|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406729|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14406730|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
14406731|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406732|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14406733|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14406734|NCT01519635|Diuretics|diuretics|mesh-ancestor
14406735|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
14406736|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406737|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14406738|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406739|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406740|NCT01519674|Insulin|insulin|mesh-list
14406741|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14406742|NCT01519674|Metformin|metformin|mesh-list
14406743|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
14406744|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
14406745|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14406746|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14406747|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
14406748|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14406749|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
14406750|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14406751|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406752|NCT01519674|Incretins|incretins|mesh-ancestor
14406753|NCT01519674|Hormones|hormones|mesh-ancestor
14406754|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406755|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14406756|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
14406757|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406758|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406759|NCT01519700|Lenograstim|lenograstim|mesh-list
14406760|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14406761|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
14406762|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406763|NCT01519765|Misoprostol|misoprostol|mesh-list
14406764|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14406765|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
14406766|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14406767|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406768|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14406769|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14406770|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
14406771|NCT01519778|Tedizolid|tedizolid|mesh-list
14406772|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14406773|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406774|NCT01519791|Methotrexate|methotrexate|mesh-list
14406775|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
14406776|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14406777|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
14406778|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14406779|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406780|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14406781|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
14406782|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406783|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406784|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
14406785|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406786|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14406787|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14406788|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
14406789|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406790|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14406791|NCT01519817|Vaccines|vaccines|mesh-list
14406792|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
14406793|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406794|NCT01519882|Rotigotine|rotigotine|mesh-list
14406795|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
14406796|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
14406797|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406798|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406799|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406800|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14406801|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
14741766|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741767|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14741768|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741769|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
14741770|NCT00569712|Hormones|hormones|mesh-ancestor
14741771|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406802|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406803|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
14406804|NCT01519947|Hematinics|hematinics|mesh-ancestor
14406805|NCT01520207|Mannitol|mannitol|mesh-list
14406806|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14406807|NCT01520207|Diuretics|diuretics|mesh-ancestor
14406808|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
14406809|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406810|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
14406811|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
14406812|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
14406813|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14741772|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14406814|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14406815|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741773|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14741774|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14741775|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
14741776|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741777|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741778|NCT00569751|Paclitaxel|paclitaxel|mesh-list
14741779|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14406816|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406817|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14924985|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14924986|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
14924987|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
14406818|NCT01520402|Warfarin|warfarin|mesh-list
14406819|NCT01520402|Anticoagulants|anticoagulants|mesh-list
14406820|NCT01520454|Heparin|heparin|mesh-list
14406821|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14406822|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
14406823|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14406824|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14406825|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406826|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14406827|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14406828|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14406829|NCT01520519|Rituximab|rituximab|mesh-list
14406830|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14406831|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406832|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
14406833|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406834|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406835|NCT01520688|Fluticasone|fluticasone|mesh-list
14406836|NCT01520688|Xhance|xhance|mesh-list
14406837|NCT01520688|Budesonide|budesonide|mesh-list
14406838|NCT01520688|Beclomethasone|beclomethasone|mesh-list
14406839|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406840|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14406841|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
14406842|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406843|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406844|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14406845|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
14406846|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
14406847|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14924988|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
14924989|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
14924990|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14924991|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14924992|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14924993|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14924994|NCT01402089|Sunitinib|sunitinib|mesh-list
14924995|NCT01402089|Midazolam|midazolam|mesh-list
14924996|NCT01402089|Caffeine|caffeine|mesh-list
14924997|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14741780|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14924998|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14924999|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14406848|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
15243151|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243152|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15243153|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15243154|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15243155|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
15243156|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406849|NCT01520688|Hormones|hormones|mesh-ancestor
14925000|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925001|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14741781|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
14741782|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
14406850|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406851|NCT01520727|Opicapone|opicapone|mesh-list
14741783|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
14741784|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741785|NCT00569790|Bevacizumab|bevacizumab|mesh-list
14741786|NCT00569790|Irinotecan|irinotecan|mesh-list
14741787|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741788|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741789|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14925002|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14925003|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15243157|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243158|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243159|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
15243160|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243161|NCT02812524|Ipilimumab|ipilimumab|mesh-list
15243162|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243163|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243164|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15243165|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925004|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14925005|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
14925006|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
14925007|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
14925008|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
14925009|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925010|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925011|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925012|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14925013|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925014|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14925015|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14406852|NCT01520727|Entacapone|entacapone|mesh-list
15243166|NCT02777424|Thrombin|thrombin|mesh-list
14925016|NCT01402089|Growth Substances|growth substances|mesh-ancestor
14925017|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14925018|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15243167|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
15243168|NCT02777424|Coagulants|coagulants|mesh-ancestor
15243169|NCT02748369|Glucagon|glucagon|mesh-list
15243170|NCT02748369|Hormones|hormones|mesh-list
15243171|NCT02748369|Somatostatin|somatostatin|mesh-list
14406853|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14406854|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406855|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406856|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14406857|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14406858|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14406859|NCT01520922|Ofatumumab|ofatumumab|mesh-list
14406860|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14406861|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
14406862|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406863|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406864|NCT01520987|Opicapone|opicapone|mesh-list
14406865|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14406866|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406867|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406868|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14406869|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14406870|NCT01521117|Donepezil|donepezil|mesh-list
14406871|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14406872|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406873|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243172|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243173|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243174|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925019|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14925020|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14925021|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14925022|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
14925023|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
14925024|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925025|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925026|NCT01402193|Anastrozole|anastrozole|mesh-list
14925027|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925028|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925029|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15243175|NCT02734290|Paclitaxel|paclitaxel|mesh-list
15243176|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
15243177|NCT02734290|Capecitabine|capecitabine|mesh-list
15243178|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15243179|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243180|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243181|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243182|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
15243183|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406874|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
14406875|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406876|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406877|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
14406878|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
14406879|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14406880|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741790|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741791|NCT00569790|Growth Substances|growth substances|mesh-ancestor
14925030|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14925031|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925032|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925033|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14925034|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
14925035|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925036|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925037|NCT01402245|Vaccines|vaccines|mesh-list
14925038|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14925039|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
14925040|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925041|NCT01402271|Paclitaxel|paclitaxel|mesh-list
14925042|NCT01402271|Carboplatin|carboplatin|mesh-list
14925043|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14925044|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406881|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
14406882|NCT01521364|Clarithromycin|clarithromycin|mesh-list
14406883|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14406884|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14406885|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14406886|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406887|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406888|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14925045|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14925046|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
14925047|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
14925048|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243184|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741792|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741793|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741794|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14741795|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14741796|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741797|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741798|NCT00569816|Sevoflurane|sevoflurane|mesh-list
14741799|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14741800|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14741801|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
14741802|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
14741803|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15243185|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15243186|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
15243187|NCT02667587|Nivolumab|nivolumab|mesh-list
14406889|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14406890|NCT01521546|Eplerenone|eplerenone|mesh-list
14406891|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14406892|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
14406893|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406894|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243188|NCT02667587|Temozolomide|temozolomide|mesh-list
15243189|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243190|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243191|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14406895|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14406896|NCT01521546|Diuretics|diuretics|mesh-ancestor
14406897|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
15243192|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243193|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15243194|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
15243195|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
14406898|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15243196|NCT02630368|Avelumab|avelumab|mesh-list
15243197|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243198|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
14406899|NCT01521559|Aflibercept|aflibercept|mesh-list
14406900|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14406901|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14406902|NCT01521559|Growth Substances|growth substances|mesh-ancestor
14406903|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406904|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
14406905|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467461|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
14467462|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14467463|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
14467464|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
14467465|NCT02260635|Evacetrapib|evacetrapib|mesh-list
14467466|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14467467|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14467468|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
14467469|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467470|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14467471|NCT02260648|Atorvastatin|atorvastatin|mesh-list
14467472|NCT02260648|Ezetimibe|ezetimibe|mesh-list
14467473|NCT02260648|Evacetrapib|evacetrapib|mesh-list
14467474|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14467475|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14467476|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
14467477|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467478|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14467479|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14467480|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467481|NCT02260791|Adalimumab|adalimumab|mesh-list
14467482|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467483|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467484|NCT02260804|Rituximab|rituximab|mesh-list
14467485|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467486|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467487|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
14467488|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467489|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467490|NCT02260817|Choline|choline|mesh-list
14467491|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
14467492|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14467493|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
14467494|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467495|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14467496|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14467497|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
14467498|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14467499|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
14467500|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467501|NCT02260934|Acetaminophen|acetaminophen|mesh-list
14467502|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
14467503|NCT02260934|Promethazine|promethazine|mesh-list
15243199|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243200|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15243201|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15243202|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
15243203|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243204|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243205|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15243206|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243207|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15243208|NCT02616965|Romidepsin|romidepsin|mesh-list
14467504|NCT02260934|Prednisone|prednisone|mesh-list
14406906|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14406907|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
14406908|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925049|NCT01402297|Acetovanillone|acetovanillone|mesh-list
14925050|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14925051|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14925052|NCT01402297|Analgesics|analgesics|mesh-ancestor
14925053|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
14925054|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925055|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925056|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406909|NCT01521923|Methotrexate|methotrexate|mesh-list
14406910|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
14406911|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14406912|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
14406913|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14406914|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406915|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14406916|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
14406917|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406918|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406919|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
14406920|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406921|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14406922|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14406923|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
14406924|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15243209|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243210|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243211|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15243212|NCT02613416|Denosumab|denosumab|mesh-list
15243213|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15243214|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243215|NCT02601014|Nivolumab|nivolumab|mesh-list
15243216|NCT02601014|Ipilimumab|ipilimumab|mesh-list
15243217|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243218|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406925|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15243219|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15243220|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243221|NCT02598999|Lactoferrin|lactoferrin|mesh-list
15243222|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
15243223|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243224|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15243225|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243226|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243227|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15243228|NCT02581787|Antibodies|antibodies|mesh-list
14406926|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14406927|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
14406928|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14406929|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
14406930|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406931|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14406932|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14406933|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14406934|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406935|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406936|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406937|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406938|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406939|NCT01522417|Tirofiban|tirofiban|mesh-list
15243229|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
15243230|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14406940|NCT01522417|Eptifibatide|eptifibatide|mesh-list
14406941|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14406942|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14406943|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406944|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14406945|NCT01522443|Prednisone|prednisone|mesh-list
14406946|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
14406947|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14406948|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
14406949|NCT01522443|Hormones|hormones|mesh-ancestor
14406950|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14406951|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406952|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14406953|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406954|NCT01522443|Analgesics|analgesics|mesh-ancestor
14406955|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
14406956|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406957|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14406958|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14406959|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14406960|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925057|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14406961|NCT01522456|Tretinoin|tretinoin|mesh-list
14406962|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
14406963|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14406964|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
14406965|NCT01522651|Dronedarone|dronedarone|mesh-list
14406966|NCT01522651|Ranolazine|ranolazine|mesh-list
14406967|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14406968|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14406969|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406970|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14406971|NCT01522950|Atenolol|atenolol|mesh-list
14406972|NCT01522950|Nebivolol|nebivolol|mesh-list
14406973|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14406974|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14406975|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
14406976|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
14406977|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925058|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
14406978|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406979|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14406980|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14406981|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14406982|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
14406983|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406984|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406985|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
14406986|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14406987|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14406988|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14406989|NCT01522963|Nicotine|nicotine|mesh-list
14406990|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14406991|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
14406992|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14406993|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14406994|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14406995|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14406996|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
15243231|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
14741804|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741805|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
14741806|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
14741807|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14741808|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741809|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14741810|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14741811|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741812|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741813|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243232|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
15243233|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243234|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243235|NCT02581085|Tocotrienols|tocotrienols|mesh-list
15243236|NCT02581085|Vitamin E|vitamin e|mesh-list
15243237|NCT02581085|Tocopherols|tocopherols|mesh-list
15243238|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
15243239|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243240|NCT02581085|Protective Agents|protective agents|mesh-ancestor
14406997|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14406998|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14406999|NCT01523275|Mitomycins|mitomycins|mesh-list
14407000|NCT01523275|Mitomycin|mitomycin|mesh-list
14407001|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407002|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407003|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
14407004|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407005|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14407006|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407007|NCT01523301|Rotigotine|rotigotine|mesh-list
14407008|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
14407009|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
14407010|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407011|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407012|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407013|NCT01523366|Clopidogrel|clopidogrel|mesh-list
14407014|NCT01523366|Ticagrelor|ticagrelor|mesh-list
14407015|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14407016|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14407017|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14407018|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14407019|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
14407020|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407021|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407022|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407023|NCT01523392|Clopidogrel|clopidogrel|mesh-list
14407024|NCT01523392|Ticagrelor|ticagrelor|mesh-list
14407025|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14407026|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14407027|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14407028|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14407029|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
14407030|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407031|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407032|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407033|NCT01523457|Folfirinox|folfirinox|mesh-list
14407034|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407035|NCT01523496|Vitamin D|vitamin d|mesh-list
14407036|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
14407037|NCT01523496|Calcifediol|calcifediol|mesh-list
15243241|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243242|NCT02581085|Vitamins|vitamins|mesh-ancestor
15243243|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
15243244|NCT02579096|Allopurinol|allopurinol|mesh-list
15243245|NCT02579096|Febuxostat|febuxostat|mesh-list
15243246|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
15243247|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243248|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243249|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
14407038|NCT01523496|Vitamins|vitamins|mesh-list
15243250|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14407039|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
14407040|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407041|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14407042|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14407043|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14407044|NCT01523587|Afatinib|afatinib|mesh-list
14407045|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407046|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14407047|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407048|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407049|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
14407050|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14407051|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407052|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407053|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14741814|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14407054|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14407055|NCT01523834|Panobinostat|panobinostat|mesh-list
14407056|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407057|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14407058|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407059|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407060|NCT01523886|Rocuronium|rocuronium|mesh-list
14407061|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14741815|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14741816|NCT00569920|Dexamethasone|dexamethasone|mesh-list
14741817|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
14741818|NCT00569920|BB 1101|bb 1101|mesh-list
14741819|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741820|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
14741821|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
14741822|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741823|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243251|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15243252|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
15243253|NCT02579096|Protective Agents|protective agents|mesh-ancestor
15243254|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243255|NCT02577406|Cytarabine|cytarabine|mesh-list
15243256|NCT02577406|Azacitidine|azacitidine|mesh-list
15243257|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15243258|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
15243259|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243260|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243261|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
15243262|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243263|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243264|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
15243265|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243266|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243267|NCT02538666|Nivolumab|nivolumab|mesh-list
15243268|NCT02538666|Ipilimumab|ipilimumab|mesh-list
15243269|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14741824|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14407062|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14407063|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14407064|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407065|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407066|NCT01524133|Sertraline|sertraline|mesh-list
14407067|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
14407068|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14407069|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14407070|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14407071|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14407072|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407073|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407074|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
14407075|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407076|NCT01524198|Budesonide|budesonide|mesh-list
14407077|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14741825|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
14741826|NCT00569920|Hormones|hormones|mesh-ancestor
14741827|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14741828|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14741829|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741830|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
14407078|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14407079|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
14407080|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407081|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407082|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14407083|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407084|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
14407085|NCT01524198|Hormones|hormones|mesh-ancestor
14407086|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407087|NCT01524289|Anacetrapib|anacetrapib|mesh-list
14407088|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14407089|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14407090|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
14407091|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407092|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14407093|NCT01524302|Levofloxacin|levofloxacin|mesh-list
14407094|NCT01524302|Ofloxacin|ofloxacin|mesh-list
14407095|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14407096|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14407097|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407098|NCT01524302|Renal Agents|renal agents|mesh-ancestor
14925059|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925060|NCT01402297|Protective Agents|protective agents|mesh-ancestor
14925061|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925062|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14741831|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741832|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741833|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
14741834|NCT00569985|Carmustine|carmustine|mesh-list
14741835|NCT00569985|Etoposide|etoposide|mesh-list
14741836|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
14741837|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243270|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243271|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15243272|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243273|NCT02527200|Liraglutide|liraglutide|mesh-list
14925063|NCT01402336|Cetrorelix|cetrorelix|mesh-list
15243274|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741838|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
14925064|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15243275|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243276|NCT02527200|Incretins|incretins|mesh-ancestor
15243277|NCT02527200|Hormones|hormones|mesh-ancestor
15243278|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243279|NCT02516696|Clarithromycin|clarithromycin|mesh-list
15243280|NCT02516696|Dexamethasone|dexamethasone|mesh-list
15243281|NCT02516696|Lenalidomide|lenalidomide|mesh-list
15243282|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243283|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
14925065|NCT01402336|Hormones|hormones|mesh-ancestor
15243284|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
15243285|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243286|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407099|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14407100|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14407101|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14407102|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243287|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15243288|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
15243289|NCT02516696|Hormones|hormones|mesh-ancestor
15243290|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243291|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14407103|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407104|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243292|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741839|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741840|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741841|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14741842|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
14741843|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741844|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741845|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14741846|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14741847|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14741848|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14407105|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14407106|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14407107|NCT01524627|Varenicline|varenicline|mesh-list
14407108|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14741849|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741850|NCT00570050|Insulin|insulin|mesh-list
14741851|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14741852|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741853|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741854|NCT00570180|Bortezomib|bortezomib|mesh-list
14741855|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753347|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753348|NCT05210374|Trace Elements|trace elements|mesh-ancestor
14753349|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
14753350|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753351|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14753352|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14753353|NCT05208333|Albendazole|albendazole|mesh-list
14753354|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
14753355|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14753356|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753357|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
14925066|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925067|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925068|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
14925069|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14925070|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
14925071|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14925072|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15243293|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
15243294|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15243295|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15243296|NCT02516696|Growth Substances|growth substances|mesh-ancestor
15243297|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
15243298|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15243299|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243300|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15243301|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243302|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243303|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15243304|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15243305|NCT02511106|Osimertinib|osimertinib|mesh-list
15243306|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741856|NCT00570193|Ranibizumab|ranibizumab|mesh-list
14741857|NCT00570193|Verteporfin|verteporfin|mesh-list
15243307|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243308|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243309|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243310|NCT02491099|Afatinib|afatinib|mesh-list
15243311|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243312|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243313|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243314|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243315|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
15243316|NCT02476058|Promethazine|promethazine|mesh-list
15243317|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15243318|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14741858|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741859|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741860|NCT00570193|Growth Substances|growth substances|mesh-ancestor
14741861|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741862|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741863|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741864|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14741865|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
14741866|NCT00570219|Valproic Acid|valproic acid|mesh-list
14741867|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
14741868|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741869|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741870|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
15243319|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15243320|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243321|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
15243322|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
15243323|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
14741871|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741872|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741873|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
15243324|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243325|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
14741874|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14741875|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15243326|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
15243327|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14407109|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14407110|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
15243328|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15243329|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
15243330|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
15243331|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243332|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243333|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15243334|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
15243335|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
15243336|NCT02451553|Capecitabine|capecitabine|mesh-list
15243337|NCT02451553|Afatinib|afatinib|mesh-list
14925073|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925074|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925075|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14925076|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
14925077|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
14925078|NCT01402479|Ramipril|ramipril|mesh-list
14925079|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14925080|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
14925081|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925082|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925083|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14925084|NCT01402583|Ribavirin|ribavirin|mesh-list
15243338|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14407111|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407112|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407113|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407114|NCT01524679|Interferons|interferons|mesh-list
14407115|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
14407116|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
14407117|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14407118|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407119|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
14407120|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407121|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
14407122|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407123|NCT01524770|Dulaglutide|dulaglutide|mesh-list
14407124|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407125|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407126|NCT01524783|Everolimus|everolimus|mesh-list
14407127|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407128|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407129|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
14407130|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407131|NCT01524796|Pregabalin|pregabalin|mesh-list
14407132|NCT01524796|Analgesics|analgesics|mesh-ancestor
14407133|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
14407134|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407135|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407136|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
14925085|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
15243339|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
15243340|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741876|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14741877|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
14741878|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14741879|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
14741880|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741881|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741882|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14741883|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
14741884|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14741885|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
14741886|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741887|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243341|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243342|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243343|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243344|NCT02432209|Orlistat|orlistat|mesh-list
15243345|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243346|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243347|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15243348|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15243349|NCT02422381|Gemcitabine|gemcitabine|mesh-list
15243350|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
15243351|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15243352|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
15243353|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243354|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243355|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
15243356|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243357|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243358|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243359|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
15243360|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243361|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243362|NCT02418195|Ketamine|ketamine|mesh-list
15243363|NCT02418195|Analgesics|analgesics|mesh-ancestor
15243364|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
15243365|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243366|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243367|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15243368|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14741888|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14741889|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
14741890|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
14741891|NCT00570245|Protective Agents|protective agents|mesh-ancestor
14741892|NCT00570284|Panobinostat|panobinostat|mesh-list
14407137|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14407138|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14407139|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407140|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14407141|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14407142|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14407143|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14407144|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14407145|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
14407146|NCT01524887|Antibodies|antibodies|mesh-list
14407147|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
14407148|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14407149|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14407150|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
14407151|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407152|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
14407153|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14407154|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
14407155|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407156|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
14407157|NCT01524913|Protective Agents|protective agents|mesh-ancestor
14407158|NCT01524978|Cetuximab|cetuximab|mesh-list
14741893|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741894|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15243369|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
14407159|NCT01524978|Vemurafenib|vemurafenib|mesh-list
14407160|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14407161|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407162|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14407163|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407164|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407165|NCT01524991|Gemcitabine|gemcitabine|mesh-list
14407166|NCT01524991|Ipilimumab|ipilimumab|mesh-list
14407167|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407168|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14407169|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
14407170|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407171|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
14407172|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407173|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407174|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407175|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
14407176|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407177|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14407178|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14407179|NCT01525082|Bevacizumab|bevacizumab|mesh-list
14407180|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15243370|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
14407181|NCT01525082|Capecitabine|capecitabine|mesh-list
15243371|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15243372|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15243373|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15243374|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243375|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243376|NCT02392637|Gemcitabine|gemcitabine|mesh-list
15243377|NCT02392637|Paclitaxel|paclitaxel|mesh-list
15243378|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15243379|NCT02392637|Cisplatin|cisplatin|mesh-list
15243380|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15243381|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243382|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243383|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243384|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
14407182|NCT01525082|Temozolomide|temozolomide|mesh-list
14407183|NCT01525082|Antibodies|antibodies|mesh-list
14407184|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
14407185|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14407186|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407187|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14407188|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14407189|NCT01525082|Growth Substances|growth substances|mesh-ancestor
14407190|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407191|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
14407192|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
14407193|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14407194|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
14407195|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407196|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14407197|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
14407198|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14407199|NCT01525173|Bimatoprost|bimatoprost|mesh-list
14407200|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14407201|NCT01525173|Latanoprost|latanoprost|mesh-list
14407202|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14407203|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
14407204|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14407205|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14407206|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14407207|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14407208|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14407209|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14741895|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741896|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741897|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15243385|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243386|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15243387|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
15243388|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
15243389|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243390|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243391|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243392|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
15243393|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243394|NCT02376699|Gemcitabine|gemcitabine|mesh-list
15243395|NCT02376699|Paclitaxel|paclitaxel|mesh-list
15243396|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
15243397|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15243398|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243399|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243400|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243401|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
15243402|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407210|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407211|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407212|NCT01525225|Metformin|metformin|mesh-list
14407213|NCT01525225|Saxagliptin|saxagliptin|mesh-list
14407214|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407215|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407216|NCT01525225|Incretins|incretins|mesh-ancestor
14407217|NCT01525225|Hormones|hormones|mesh-ancestor
14407218|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407219|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14407220|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
14407221|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407222|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407223|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
14407224|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14407225|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407226|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407227|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407228|NCT01525407|Atorvastatin|atorvastatin|mesh-list
14407229|NCT01525407|Calcium|calcium|mesh-list
14407230|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14741898|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741899|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14741900|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407231|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407232|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14407233|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14407234|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
14407235|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407236|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14407237|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14407238|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407239|NCT01525550|Sunitinib|sunitinib|mesh-list
14407240|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741901|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741902|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
14741903|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14741904|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
14741905|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
14741906|NCT00570440|Estradiol|estradiol|mesh-list
14741907|NCT00570440|Estrogens|estrogens|mesh-ancestor
14741908|NCT00570440|Hormones|hormones|mesh-ancestor
14741909|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243403|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15243404|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
15243405|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
15243406|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243407|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243408|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243409|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
15243410|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243411|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243412|NCT02372630|Linagliptin|linagliptin|mesh-list
15243413|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15243414|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243415|NCT02372630|Incretins|incretins|mesh-ancestor
15243416|NCT02372630|Hormones|hormones|mesh-ancestor
15243417|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243418|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15243419|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
14407241|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14407242|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14407243|NCT01525550|Growth Substances|growth substances|mesh-ancestor
14407244|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407245|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
14407246|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14407247|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407248|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407249|NCT01525602|Paclitaxel|paclitaxel|mesh-list
14407250|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14407251|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407252|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
14407253|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
14407254|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
14407255|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407256|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
14407257|NCT01525615|Olodaterol|olodaterol|mesh-list
14407258|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14407259|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
14407260|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407261|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407262|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14407263|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407264|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
14407265|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14407266|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
14407267|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407268|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407269|NCT01525628|Tolbutamide|tolbutamide|mesh-list
14407270|NCT01525628|Interferons|interferons|mesh-list
14407271|NCT01525628|Tenofovir|tenofovir|mesh-list
14407272|NCT01525628|Ribavirin|ribavirin|mesh-list
14407273|NCT01525628|Midazolam|midazolam|mesh-list
14407274|NCT01525628|Caffeine|caffeine|mesh-list
14407275|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407276|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
14407277|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407278|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14407279|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14407280|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14407281|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407282|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14407283|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14407284|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14407285|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14407286|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
14407287|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
14407288|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
14407289|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
14407290|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243420|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14741910|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741911|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14741912|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14741913|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14741914|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14741915|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14741916|NCT00570479|Anecortave|anecortave|mesh-list
14741917|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741918|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741919|NCT00570479|Growth Substances|growth substances|mesh-ancestor
14741920|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925086|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243421|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243422|NCT02341014|Lenalidomide|lenalidomide|mesh-list
15243423|NCT02341014|Romidepsin|romidepsin|mesh-list
15243424|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
14407291|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407292|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14407293|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14407294|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407295|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14407296|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14407297|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
14407298|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15243425|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243426|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14407299|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14407300|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14407301|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15243427|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15243428|NCT02341014|Growth Substances|growth substances|mesh-ancestor
15243429|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
15243430|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243431|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407302|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
14407303|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407304|NCT01525641|Pramipexole|pramipexole|mesh-list
14407305|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
14925087|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
14925088|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243432|NCT02270814|Paclitaxel|paclitaxel|mesh-list
14407306|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407307|NCT01525641|Protective Agents|protective agents|mesh-ancestor
14407308|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407309|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14407310|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14407311|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
14407312|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
14407313|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407314|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
14407315|NCT01525875|Antacids|antacids|mesh-ancestor
14407316|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407317|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14407318|NCT01526057|Rituximab|rituximab|mesh-list
14407319|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14407320|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407321|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
14407322|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407323|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14407324|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14407325|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
14407326|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
14407327|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14407328|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14407329|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14407330|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15243433|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15243434|NCT02270814|Cisplatin|cisplatin|mesh-list
15243435|NCT02270814|Carboplatin|carboplatin|mesh-list
15243436|NCT02270814|Cetuximab|cetuximab|mesh-list
15243437|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15243438|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243439|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243440|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243441|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
15243442|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243443|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243444|NCT02253316|Dexamethasone|dexamethasone|mesh-list
14741921|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741922|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741923|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
14741924|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15243445|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
14407331|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407332|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407333|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407334|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
14407335|NCT01526213|Fexofenadine|fexofenadine|mesh-list
15243446|NCT02253316|Lenalidomide|lenalidomide|mesh-list
15243447|NCT02253316|Ixazomib|ixazomib|mesh-list
15243448|NCT02253316|BB 1101|bb 1101|mesh-list
15243449|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243450|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
15243451|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
15243452|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243453|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243454|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15243455|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
15243456|NCT02253316|Hormones|hormones|mesh-ancestor
15243457|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243458|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15243459|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243460|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
15243461|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243462|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243463|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
15243464|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15243465|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15243466|NCT02253316|Growth Substances|growth substances|mesh-ancestor
14407336|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14467505|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
14741925|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
15243467|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
15243468|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15243469|NCT02245230|Trimethaphan|trimethaphan|mesh-list
15243470|NCT02245230|Phenylephrine|phenylephrine|mesh-list
15243471|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
15243472|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
15243473|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15243474|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
14925089|NCT01402596|Midazolam|midazolam|mesh-list
14925090|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
15243475|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
15243476|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243477|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243478|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
15243479|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14925091|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925092|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14925093|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925094|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925095|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14925096|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14407337|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14407338|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14407339|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
15243480|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
15243481|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243482|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15243483|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15243484|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15243485|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
15243486|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243487|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243488|NCT02245230|Protective Agents|protective agents|mesh-ancestor
15243489|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15243490|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
15243491|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15243492|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
15243493|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15243494|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15243495|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
15243496|NCT02224573|Cannabidiol|cannabidiol|mesh-list
14925097|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14925098|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14925099|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
14925100|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
14925101|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
14925102|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
14925103|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407340|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
14407341|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407342|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925104|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925105|NCT01402622|Propofol|propofol|mesh-list
14925106|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
14407343|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407344|NCT01526356|Sirolimus|sirolimus|mesh-list
14407345|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14407346|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407347|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407348|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407349|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
14407350|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407351|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
14407352|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407353|NCT01526538|Cycloserine|cycloserine|mesh-list
14407354|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14407355|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407356|NCT01526538|Renal Agents|renal agents|mesh-ancestor
14925107|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925108|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243497|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
14925109|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15243498|NCT02164643|Flutemetamol|flutemetamol|mesh-list
14407357|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14407358|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
14407359|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14407360|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
14407361|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407362|NCT01526551|Vaccines|vaccines|mesh-list
14407363|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
14407364|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407365|NCT01526577|Ticagrelor|ticagrelor|mesh-list
14407366|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14407367|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14407368|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15243499|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14741926|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14741927|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741928|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14741929|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407369|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14407370|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
14407371|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407372|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407373|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407374|NCT01526733|Insulin|insulin|mesh-list
14407375|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14741930|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
14741931|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14741932|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
14407376|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
14407377|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
14407378|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407379|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407380|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
14407381|NCT01527045|Cyclosporine|cyclosporine|mesh-list
14407382|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
14407383|NCT01527045|Fludarabine|fludarabine|mesh-list
14407384|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
14407385|NCT01527045|Atorvastatin|atorvastatin|mesh-list
14407386|NCT01527045|Calcium|calcium|mesh-list
14407387|NCT01527045|Cyclosporins|cyclosporins|mesh-list
14407388|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14407389|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407390|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14407391|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407392|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14407393|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
14407394|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407395|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407396|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
14407397|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407398|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
14407399|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14741933|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925110|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15243500|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243501|NCT02155920|Everolimus|everolimus|mesh-list
15243502|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243503|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243504|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
15243505|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243506|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14407400|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
14407401|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14407402|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14407403|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14407404|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14407405|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14407406|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14407407|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407408|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14407409|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
14407410|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14407411|NCT01527110|Zanamivir|zanamivir|mesh-list
14407412|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
14407413|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407414|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407415|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407416|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14407417|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
14407418|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
14407419|NCT01527357|Coagulants|coagulants|mesh-ancestor
14407420|NCT01527383|Vaccines|vaccines|mesh-list
14407421|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
14407422|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407423|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
14407424|NCT01527487|Docetaxel|docetaxel|mesh-list
14407425|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407426|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
14407427|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407428|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14407429|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14407430|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
14407431|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407432|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407433|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14407434|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
14407435|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
14407436|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
14407437|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14407438|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
14407439|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14407440|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14407441|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14407442|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407443|NCT01527682|Dorzolamide|dorzolamide|mesh-list
14407444|NCT01527682|Latanoprost|latanoprost|mesh-list
14407445|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14407446|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14407447|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14407448|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14407449|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407450|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467506|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14467507|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14467508|NCT02260934|Prednisolone|prednisolone|mesh-list
14467509|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
14467510|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
14467511|NCT02260934|Rituximab|rituximab|mesh-list
14467512|NCT02260934|Belimumab|belimumab|mesh-list
14467513|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14467514|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
14467515|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14467516|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
14467517|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467518|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467519|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14467520|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
14467521|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407451|NCT01528254|Metformin|metformin|mesh-list
14407452|NCT01528254|Vildagliptin|vildagliptin|mesh-list
14407453|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407454|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407455|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14741934|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741935|NCT00570622|Pioglitazone|pioglitazone|mesh-list
14741936|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14741937|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741938|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
14741939|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14741940|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
14741941|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741942|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
14741943|NCT00570648|Protective Agents|protective agents|mesh-ancestor
14741944|NCT00570726|Ranibizumab|ranibizumab|mesh-list
14741945|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741946|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14407456|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
14407457|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407458|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407459|NCT01528345|Fulvestrant|fulvestrant|mesh-list
14741947|NCT00570726|Growth Substances|growth substances|mesh-ancestor
14741948|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407460|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14407461|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407462|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14407463|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14407464|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
14407465|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407466|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407467|NCT01528592|Levodopa|levodopa|mesh-list
14407468|NCT01528592|Carbidopa|carbidopa|mesh-list
14407469|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14741949|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741950|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243507|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15243508|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243509|NCT02123823|Everolimus|everolimus|mesh-list
15243510|NCT02123823|Exemestane|exemestane|mesh-list
15243511|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243512|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243513|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
14925111|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
14925112|NCT01402674|Phentermine|phentermine|mesh-list
14925113|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14925114|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925115|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
15243514|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741951|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14741952|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925116|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14925117|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
14925118|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
14407470|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14925119|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925120|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
14407471|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14407472|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
14407473|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407474|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407475|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407476|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14407477|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407478|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15243515|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15243516|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15243517|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243518|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243519|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15243520|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243521|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243522|NCT01966471|Maytansine|maytansine|mesh-list
15243523|NCT01966471|Docetaxel|docetaxel|mesh-list
15243524|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15243525|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
15243526|NCT01966471|Doxorubicin|doxorubicin|mesh-list
15243527|NCT01966471|Fluorouracil|fluorouracil|mesh-list
15243528|NCT01966471|Trastuzumab|trastuzumab|mesh-list
15243529|NCT01966471|Epirubicin|epirubicin|mesh-list
15243530|NCT01966471|Pertuzumab|pertuzumab|mesh-list
15243531|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15243532|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243533|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243534|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243535|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
15243536|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243537|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407479|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
14407480|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
14407481|NCT01528709|Atorvastatin|atorvastatin|mesh-list
14407482|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14407483|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14407484|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
14407485|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407486|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14407487|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14407488|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407489|NCT01528735|Ribavirin|ribavirin|mesh-list
14407490|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
14407491|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407492|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
14407493|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407494|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14407495|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14407496|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
14407497|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14407498|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14407499|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407500|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14407501|NCT01528891|Analgesics|analgesics|mesh-ancestor
14407502|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
14407503|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407504|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14407505|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14407506|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14407507|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14407508|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407509|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407510|NCT01528969|Sorbitol|sorbitol|mesh-list
14407511|NCT01528969|Cathartics|cathartics|mesh-ancestor
14407512|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14407513|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14407514|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243538|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
15243539|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243540|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15243541|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15243542|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
15243543|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15243544|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407515|NCT01529112|Lenvatinib|lenvatinib|mesh-list
14407516|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407517|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14407518|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407519|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407520|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
14741953|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
14741954|NCT00570830|Hormones|hormones|mesh-ancestor
14741955|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14741956|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741957|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
14741958|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14741959|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14741960|NCT00570856|Folic Acid|folic acid|mesh-list
14741961|NCT00570856|Hematinics|hematinics|mesh-ancestor
14741962|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
14741963|NCT00570856|Vitamins|vitamins|mesh-ancestor
14741964|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
14741965|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741966|NCT00570882|Sunitinib|sunitinib|mesh-list
14741967|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741968|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14741969|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14741970|NCT00570882|Growth Substances|growth substances|mesh-ancestor
14741971|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741972|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
14741973|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14741974|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407521|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14407522|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14407523|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14407524|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14407525|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407526|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
14407527|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407528|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407529|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14407530|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407531|NCT01529268|Cysteamine|cysteamine|mesh-list
14407532|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14407533|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407534|NCT01529346|Ibuprofen|ibuprofen|mesh-list
14407535|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14407536|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14407537|NCT01529346|Analgesics|analgesics|mesh-ancestor
14407538|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
14407539|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407540|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741975|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741976|NCT00570895|Ascorbic Acid|ascorbic acid|mesh-list
14741977|NCT00570895|Vitamins|vitamins|mesh-ancestor
14407541|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14407542|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14741978|NCT00570895|Micronutrients|micronutrients|mesh-ancestor
14741979|NCT00570895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741980|NCT00570895|Antioxidants|antioxidants|mesh-ancestor
14741981|NCT00570895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741982|NCT00570895|Protective Agents|protective agents|mesh-ancestor
14741983|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
15243545|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15243546|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15243547|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243548|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
15243549|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15243550|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15243551|NCT01927744|Docetaxel|docetaxel|mesh-list
15243552|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14741984|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
14741985|NCT00570934|Calcium|calcium|mesh-list
14741986|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14407543|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14407544|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407545|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407546|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
14407547|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14407548|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
14407549|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407550|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407551|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14407552|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407553|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14407554|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
14407555|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407556|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407557|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14407558|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
14407559|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
14407560|NCT01529502|Protective Agents|protective agents|mesh-ancestor
14407561|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14407562|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14407563|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14407564|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14407565|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
14407566|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14407567|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14407568|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14407569|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
14741987|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14741988|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14741989|NCT00570934|Vitamins|vitamins|mesh-ancestor
14741990|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
14741991|NCT00570999|Mitogens|mitogens|mesh-list
14741992|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
14741993|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14741994|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
14741995|NCT00571116|Disulfiram|disulfiram|mesh-list
14741996|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14741997|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14741998|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14741999|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742000|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742001|NCT00571129|Mitomycins|mitomycins|mesh-list
14742002|NCT00571129|Mitomycin|mitomycin|mesh-list
14742003|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14742004|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742005|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
14742006|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742007|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14742008|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742009|NCT00571142|Bevacizumab|bevacizumab|mesh-list
14742010|NCT00571142|Temazepam|temazepam|mesh-list
15243553|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243554|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243555|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243556|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
15243557|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243558|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243559|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243560|NCT01774721|Gefitinib|gefitinib|mesh-list
15243561|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243562|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243563|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243564|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243565|NCT01747447|Vitamin D|vitamin d|mesh-list
15243566|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
14407570|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243567|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
15243568|NCT01747447|Vitamins|vitamins|mesh-list
15243569|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
15243570|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742011|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742012|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742013|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14742014|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14742015|NCT00571142|Growth Substances|growth substances|mesh-ancestor
14742016|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742017|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
14407571|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407572|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407573|NCT01529645|Vaccines|vaccines|mesh-list
14407574|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
14407575|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407576|NCT01529749|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14407577|NCT01529749|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14407578|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
14407579|NCT01529749|Losartan|losartan|mesh-list
14407580|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14407581|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14407582|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14407583|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14407584|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407585|NCT01529749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14407586|NCT01529749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14407587|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407588|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
14407589|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407590|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14407591|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14407592|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14407593|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14407594|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
14407595|NCT01529827|Methotrexate|methotrexate|mesh-list
14407596|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
14407597|NCT01529827|Fludarabine|fludarabine|mesh-list
14407598|NCT01529827|Melphalan|melphalan|mesh-list
14407599|NCT01529827|Tacrolimus|tacrolimus|mesh-list
14407600|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14407601|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
14407602|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14407603|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407604|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14407605|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
14407606|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407607|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407608|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14407609|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407610|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14407611|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407612|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
14407613|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14407614|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14407615|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14407616|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407617|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14742018|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14742019|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742020|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14742021|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14742022|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742023|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
14742024|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
14742025|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407618|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
14407619|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14407620|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407621|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14407622|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
14407623|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14407624|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14407625|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742026|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742027|NCT00571155|Levetiracetam|levetiracetam|mesh-list
14742028|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
14742029|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
14742030|NCT00571246|Topiramate|topiramate|mesh-list
14742031|NCT00571246|Lamotrigine|lamotrigine|mesh-list
14742032|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
14742033|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742034|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742035|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14742036|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14742037|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742038|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14742039|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14742040|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14742041|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742042|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742043|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14742044|NCT00571285|Vitamin D|vitamin d|mesh-list
14742045|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
14742046|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
14742047|NCT00571285|Vitamins|vitamins|mesh-list
14742048|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
14742049|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742050|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14742051|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14742052|NCT00571298|Gemcitabine|gemcitabine|mesh-list
15243571|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14407626|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243572|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15243573|NCT01746836|Ponatinib|ponatinib|mesh-list
15243574|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243575|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243576|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243577|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243578|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15243579|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
15243580|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243581|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14407627|NCT01530178|Incretins|incretins|mesh-ancestor
14407628|NCT01530178|Hormones|hormones|mesh-ancestor
14407629|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407630|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14407631|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
14407632|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407633|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407634|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14407635|NCT01530243|Terazosin|terazosin|mesh-list
14925121|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407636|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14407637|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14407638|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
14742053|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
14742054|NCT00571298|Amifostine|amifostine|mesh-list
14742055|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742056|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14742057|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
14742058|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742059|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
14742060|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742061|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742062|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742063|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
14742064|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742065|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14742066|NCT00571298|Protective Agents|protective agents|mesh-ancestor
14742067|NCT00571298|Antidotes|antidotes|mesh-ancestor
14925122|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925123|NCT01402843|Valsartan|valsartan|mesh-list
14407639|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407640|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407641|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407642|NCT01530243|Urological Agents|urological agents|mesh-ancestor
14407643|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14407644|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14407645|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14407646|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14407647|NCT01530334|Gefitinib|gefitinib|mesh-list
14407648|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407649|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14407650|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407651|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407652|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
14407653|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14407654|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14407655|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407656|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
14407657|NCT01530399|Coagulants|coagulants|mesh-ancestor
14407658|NCT01530464|Ambrisentan|ambrisentan|mesh-list
14407659|NCT01530464|Aminophylline|aminophylline|mesh-list
14742068|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
14742069|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
14407660|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14407661|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14407662|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
14407663|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407664|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407665|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14407666|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407667|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14407668|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14407669|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407670|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407671|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14407672|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14407673|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
14407674|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407675|NCT01530464|Protective Agents|protective agents|mesh-ancestor
14407676|NCT01531153|Galantamine|galantamine|mesh-list
14407677|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14407678|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407679|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407680|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
14407681|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407682|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407683|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14407684|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
14407685|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407686|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
14407687|NCT01531205|Leuprolide|leuprolide|mesh-list
14407688|NCT01531205|Goserelin|goserelin|mesh-list
14407689|NCT01531205|Bicalutamide|bicalutamide|mesh-list
14407690|NCT01531205|Androgens|androgens|mesh-list
14407691|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14407692|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
14407693|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14407694|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407695|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14407696|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407697|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
14407698|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
14407699|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407700|NCT01531205|Hormones|hormones|mesh-ancestor
14407701|NCT01531439|Naloxone|naloxone|mesh-list
14407702|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14407703|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407704|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
14407705|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407706|NCT01531673|Ivacaftor|ivacaftor|mesh-list
14407707|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14407708|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14407709|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407710|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14407711|NCT01531959|Midodrine|midodrine|mesh-list
14742070|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14742071|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
14742072|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
14742073|NCT00571337|Infliximab|infliximab|mesh-list
14742074|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
15243582|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
15243583|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243584|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243585|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15243586|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15243587|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15243588|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
15243589|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
15243590|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15243591|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15243592|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15243593|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15243594|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
15243595|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15243596|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407712|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
14742075|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742076|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742077|NCT00571506|Pioglitazone|pioglitazone|mesh-list
14742078|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
14742079|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742080|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742081|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14742082|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14742083|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
15243597|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15243598|NCT01656434|Estrogens|estrogens|mesh-ancestor
15243599|NCT01656434|Hormones|hormones|mesh-ancestor
15243600|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243601|NCT01656434|Trace Elements|trace elements|mesh-ancestor
14742084|NCT00571636|Fentanyl|fentanyl|mesh-list
14742085|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14742086|NCT00571636|Narcotics|narcotics|mesh-ancestor
14742087|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742088|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742089|NCT00571636|Analgesics|analgesics|mesh-ancestor
14742090|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
14742091|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407713|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
14407714|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407715|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407716|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14407717|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14407718|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14407719|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14407720|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14407721|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407722|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742092|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14742093|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14742094|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
14742095|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
15243602|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
14407723|NCT01531998|Dexamethasone|dexamethasone|mesh-list
14407724|NCT01531998|Lenalidomide|lenalidomide|mesh-list
14407725|NCT01531998|Bortezomib|bortezomib|mesh-list
14407726|NCT01531998|Siltuximab|siltuximab|mesh-list
14407727|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14407728|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
14407729|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
14407730|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407731|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407732|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14407733|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
14407734|NCT01531998|Hormones|hormones|mesh-ancestor
14407735|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407736|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14407737|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407738|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
14407739|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14407740|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14407741|NCT01531998|Growth Substances|growth substances|mesh-ancestor
14407742|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
14407743|NCT01532089|Bevacizumab|bevacizumab|mesh-list
14407744|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14407745|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14407746|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
14407747|NCT01532089|Antibodies|antibodies|mesh-list
14407748|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
14407749|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14407750|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
14407751|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742096|NCT00571675|Prednisone|prednisone|mesh-list
14742097|NCT00571675|Docetaxel|docetaxel|mesh-list
14742098|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742099|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
14742100|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
14742101|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
14742102|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742103|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742104|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
14742105|NCT00571675|Hormones|hormones|mesh-ancestor
14742106|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742107|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742108|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14742109|NCT00571714|Ribavirin|ribavirin|mesh-list
14742110|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14742111|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
14742112|NCT00571714|Betaine|betaine|mesh-list
14742113|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
14742114|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742115|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
14742116|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407752|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14407753|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14407754|NCT01532089|Growth Substances|growth substances|mesh-ancestor
14407755|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407756|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14742117|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
14742118|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742119|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742120|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
14742121|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14742122|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14742123|NCT00571727|Mecasermin|mecasermin|mesh-list
14742124|NCT00571727|Growth Substances|growth substances|mesh-ancestor
14742125|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742126|NCT00571740|Leucovorin|leucovorin|mesh-list
14742127|NCT00571740|Bevacizumab|bevacizumab|mesh-list
14742128|NCT00571740|Cetuximab|cetuximab|mesh-list
14407757|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
14742129|NCT00571740|Fluorouracil|fluorouracil|mesh-list
14742130|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
14742131|NCT00571740|Calcium|calcium|mesh-list
14742132|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
14742133|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742134|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742135|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14742136|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15243603|NCT01601522|Ranitidine|ranitidine|mesh-list
15243604|NCT01601522|Desloratadine|desloratadine|mesh-list
15243605|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
15243606|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
15243607|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15243608|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
15243609|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407758|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14407759|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407760|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407761|NCT01532128|Opicapone|opicapone|mesh-list
14407762|NCT01532128|Rasagiline|rasagiline|mesh-list
14407763|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14407764|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407765|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407766|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15243610|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243611|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243612|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15243613|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
15243614|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15243615|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15243616|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15243617|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15243618|NCT01599494|Progesterone|progesterone|mesh-list
15243619|NCT01599494|Ganirelix|ganirelix|mesh-list
15243620|NCT01599494|Progestins|progestins|mesh-ancestor
15243621|NCT01599494|Hormones|hormones|mesh-ancestor
15243622|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243623|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243624|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15243625|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243626|NCT01518517|Asparaginase|asparaginase|mesh-list
14407767|NCT01532128|Protective Agents|protective agents|mesh-ancestor
14742137|NCT00571740|Growth Substances|growth substances|mesh-ancestor
14742138|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742139|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
14742140|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14742141|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
14742142|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742143|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14742144|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742145|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
14742146|NCT00571740|Antidotes|antidotes|mesh-ancestor
14742147|NCT00571740|Protective Agents|protective agents|mesh-ancestor
14742148|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
14742149|NCT00571740|Vitamins|vitamins|mesh-ancestor
14742150|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
14742151|NCT00571753|Isoniazid|isoniazid|mesh-list
14742152|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
14742153|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14742154|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742155|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15243627|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243628|NCT01496118|Panobinostat|panobinostat|mesh-list
14742156|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14742157|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
14742158|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742159|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14742160|NCT00571805|Varenicline|varenicline|mesh-list
14742161|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14742162|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14742163|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
14742164|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925124|NCT01402843|Pitavastatin|pitavastatin|mesh-list
14925125|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14407768|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407769|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14407770|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14407771|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14407772|NCT01532141|Opicapone|opicapone|mesh-list
14407773|NCT01532141|Rasagiline|rasagiline|mesh-list
14925126|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14925127|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14925128|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925129|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14925130|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14925131|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14925132|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
14925133|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925134|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14925135|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
14925136|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14925137|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14925138|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925139|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
14925140|NCT01402882|Coagulants|coagulants|mesh-ancestor
14931102|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14742165|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407774|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14742166|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742167|NCT00571870|Cetrorelix|cetrorelix|mesh-list
14407775|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407776|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407777|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14407778|NCT01532141|Protective Agents|protective agents|mesh-ancestor
14407779|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407780|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14407781|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14407782|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14407783|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
14407784|NCT01532349|Vitamins|vitamins|mesh-ancestor
14742168|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14742169|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
15243629|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243630|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15243631|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243632|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243633|NCT01415674|Afatinib|afatinib|mesh-list
15243634|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407785|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
14407786|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407787|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14407788|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14407789|NCT01532414|Enclomiphene|enclomiphene|mesh-list
14407790|NCT01532414|Clomiphene|clomiphene|mesh-list
14407791|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
14407792|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14407793|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
14407794|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407795|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407796|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14407797|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
14407798|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14407799|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14407800|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14407801|NCT01532648|Budesonide|budesonide|mesh-list
15243635|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243636|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243637|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243638|NCT01371630|Cytarabine|cytarabine|mesh-list
14742170|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14742171|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243639|NCT01371630|Prednisone|prednisone|mesh-list
15243640|NCT01371630|Cortisone|cortisone|mesh-list
15243641|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
15243642|NCT01371630|Rituximab|rituximab|mesh-list
14407802|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243643|NCT01371630|Methotrexate|methotrexate|mesh-list
15243644|NCT01371630|Vincristine|vincristine|mesh-list
14407803|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14742172|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
14742173|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742174|NCT00571935|Insulin|insulin|mesh-list
14742175|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14407804|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
14407805|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742176|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
14742177|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742178|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742179|NCT00572013|Rituximab|rituximab|mesh-list
14742180|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742181|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742182|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
14742183|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742184|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742185|NCT00572026|Methylphenidate|methylphenidate|mesh-list
14742186|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14742187|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742188|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14742189|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14742190|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14742191|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243645|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
15243646|NCT01371630|Blinatumomab|blinatumomab|mesh-list
14407806|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407807|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14407808|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407809|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
14407810|NCT01532648|Hormones|hormones|mesh-ancestor
14407811|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14407812|NCT01532687|Gemcitabine|gemcitabine|mesh-list
14407813|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14407814|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
14407815|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407816|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742192|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
14742193|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742194|NCT00572065|Cytarabine|cytarabine|mesh-list
14742195|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
14742196|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14925141|NCT01403025|Liraglutide|liraglutide|mesh-list
14407817|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
14407818|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407819|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407820|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407821|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
14407822|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407823|NCT01532700|Ofatumumab|ofatumumab|mesh-list
14407824|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407825|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
14407826|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
14407827|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407828|NCT01533077|Levodopa|levodopa|mesh-list
14407829|NCT01533077|Carbidopa|carbidopa|mesh-list
14742197|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
14742198|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742199|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742200|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
14407830|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14407831|NCT01533077|Opicapone|opicapone|mesh-list
14742201|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925142|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407832|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14407833|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14407834|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
14407835|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407836|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407837|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407838|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14407839|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407840|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14407841|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
14407842|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
14407843|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14407844|NCT01533116|Levodopa|levodopa|mesh-list
14407845|NCT01533116|Carbidopa|carbidopa|mesh-list
14407846|NCT01533116|Opicapone|opicapone|mesh-list
14407847|NCT01533116|Benserazide|benserazide|mesh-list
14407848|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14407849|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14407850|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
14407851|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407852|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407853|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407854|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14407855|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407856|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14407857|NCT01533181|Topotecan|topotecan|mesh-list
14407858|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14407859|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14407860|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407861|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407862|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407863|NCT01533207|Gemcitabine|gemcitabine|mesh-list
14407864|NCT01533207|Docetaxel|docetaxel|mesh-list
14407865|NCT01533207|Doxorubicin|doxorubicin|mesh-list
14407866|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14407867|NCT01533207|Lenograstim|lenograstim|mesh-list
14407868|NCT01533207|Sargramostim|sargramostim|mesh-list
14407869|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14407870|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
14407871|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407872|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407873|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
14407874|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407875|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742202|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742203|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
14742204|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407876|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407877|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
14407878|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407879|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
14407880|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
14407881|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
14407882|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407883|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14407884|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14407885|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14407886|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14407887|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14407888|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14407889|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
14742205|NCT00572078|Sorafenib|sorafenib|mesh-list
14742206|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742207|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14742208|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742209|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753358|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15243647|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
15243648|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15243649|NCT01371630|Muromonab-CD3|muromonab-cd3|mesh-list
15243650|NCT01371630|Antibodies|antibodies|mesh-list
15243651|NCT01371630|Immunoglobulins|immunoglobulins|mesh-list
15243652|NCT01371630|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15243653|NCT01371630|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15243654|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243655|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
15243656|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243657|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14407890|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243658|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14742210|NCT00572169|Thalidomide|thalidomide|mesh-list
14742211|NCT00572169|Dexamethasone|dexamethasone|mesh-list
14742212|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
14742213|NCT00572169|Cisplatin|cisplatin|mesh-list
14742214|NCT00572169|Doxorubicin|doxorubicin|mesh-list
14742215|NCT00572169|Etoposide|etoposide|mesh-list
15243659|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
15243660|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243661|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243662|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14742216|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14742217|NCT00572169|Bortezomib|bortezomib|mesh-list
14742218|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742219|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
14742220|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742221|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742222|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15243663|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243664|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
15243665|NCT01371630|Hormones|hormones|mesh-ancestor
14925143|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925144|NCT01403025|Incretins|incretins|mesh-ancestor
14925145|NCT01403025|Hormones|hormones|mesh-ancestor
14925146|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925147|NCT01403103|Vitamin D|vitamin d|mesh-list
14925148|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
14925149|NCT01403103|Vitamins|vitamins|mesh-ancestor
14925150|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
14925151|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407891|NCT01533428|Capsaicin|capsaicin|mesh-list
14925152|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14925153|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14925154|NCT01403168|Analgesics|analgesics|mesh-list
14925155|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
15243666|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243667|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925156|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407892|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
14407893|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
14407894|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
14407895|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407896|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407897|NCT01533493|Memantine|memantine|mesh-list
14407898|NCT01533493|Methylphenidate|methylphenidate|mesh-list
14742223|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
14742224|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742225|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742226|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14742227|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742228|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
14742229|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
14742230|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742231|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925157|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407899|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14407900|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742232|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
14742233|NCT00572169|Hormones|hormones|mesh-ancestor
14407901|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14407902|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14407903|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14407904|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407905|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
14407906|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407907|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14407908|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14407909|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14407910|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14407911|NCT01533597|Tamsulosin|tamsulosin|mesh-list
14407912|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
14407913|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14407914|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14407915|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14407916|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
14407917|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407918|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407919|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407920|NCT01533597|Urological Agents|urological agents|mesh-ancestor
14407921|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14407922|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14407923|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
14742234|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742235|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14742236|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14742237|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14742238|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14742239|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742240|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14742241|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
14742242|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14742243|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742244|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15243668|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15243669|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
15243670|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15243671|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15243672|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
15243673|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
15243674|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407924|NCT01533688|Bisacodyl|bisacodyl|mesh-list
14407925|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14407926|NCT01533688|Cathartics|cathartics|mesh-ancestor
14407927|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14407928|NCT01533688|Laxatives|laxatives|mesh-ancestor
14407929|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
14407930|NCT01533922|Olodaterol|olodaterol|mesh-list
14407931|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14407932|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
14407933|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407934|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407935|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14407936|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407937|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
14407938|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14407939|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
14407940|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407941|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407942|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
14407943|NCT01533935|Olodaterol|olodaterol|mesh-list
14407944|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14407945|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
14407946|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14407947|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407948|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243675|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15243676|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15243677|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
15243678|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243679|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14407949|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
14407950|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
14407951|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14407952|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
14407953|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14407954|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407955|NCT01533948|Axitinib|axitinib|mesh-list
14407956|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407957|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14407958|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407959|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407960|NCT01534013|Insulin|insulin|mesh-list
14407961|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14407962|NCT01534013|Pancrelipase|pancrelipase|mesh-list
14407963|NCT01534013|Pancreatin|pancreatin|mesh-list
14407964|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14407965|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407966|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14407967|NCT01534078|Doxorubicin|doxorubicin|mesh-list
14407968|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14407969|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14407970|NCT01534078|Dacarbazine|dacarbazine|mesh-list
14407971|NCT01534078|Vinblastine|vinblastine|mesh-list
14407972|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14407973|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407974|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14407975|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14407976|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14407977|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407978|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14407979|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14407980|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
14407981|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14407982|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14407983|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14407984|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14407985|NCT01534182|Interferons|interferons|mesh-list
14407986|NCT01534182|Interferon-beta|interferon-beta|mesh-list
14407987|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
14407988|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14407989|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
14407990|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14407991|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
15243680|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
15243681|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
15243682|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
15243683|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15243684|NCT01358669|Denosumab|denosumab|mesh-list
15243685|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15243686|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243687|NCT01350934|Vitamin D|vitamin d|mesh-list
15243688|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
15243689|NCT01350934|Alendronate|alendronate|mesh-list
15243690|NCT01350934|Calcitriol|calcitriol|mesh-list
15243691|NCT01350934|Calcium|calcium|mesh-list
15243692|NCT01350934|Vitamins|vitamins|mesh-ancestor
15243693|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
14407992|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14407993|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
14753359|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15243694|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243695|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14407994|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14407995|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14407996|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14407997|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14407998|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14407999|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408000|NCT01534195|Prednisolone|prednisolone|mesh-list
14408001|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14408002|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
14408003|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14408004|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
14408005|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14408006|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14925158|NCT01403181|Ribavirin|ribavirin|mesh-list
14925159|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15243696|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14408007|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14408008|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
15243697|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15243698|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15243699|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243700|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15243701|NCT01304511|Ganirelix|ganirelix|mesh-list
15243702|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243703|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243704|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243705|NCT01286207|Rizatriptan|rizatriptan|mesh-list
15243706|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15243707|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
15243708|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243709|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243710|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243711|NCT01263769|Axitinib|axitinib|mesh-list
15243712|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243713|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15243714|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742245|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14742246|NCT00572169|Growth Substances|growth substances|mesh-ancestor
14742247|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
14742248|NCT00572208|Gabapentin|gabapentin|mesh-list
14742249|NCT00572208|Analgesics|analgesics|mesh-ancestor
14742250|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
14742251|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742252|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742253|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
14742254|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15243715|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925160|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
14931103|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15243716|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
15243717|NCT01227187|Protein C|protein c|mesh-list
15243718|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15243719|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
15243720|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15243721|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15243722|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243723|NCT01222247|Betamethasone|betamethasone|mesh-list
15243724|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243725|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
15243726|NCT01222247|Hormones|hormones|mesh-ancestor
15243727|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243728|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243729|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14408009|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742255|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14742256|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742257|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742258|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14742259|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14742260|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742261|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742262|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
14742263|NCT00572299|Alendronate|alendronate|mesh-list
14742264|NCT00572299|Prednisone|prednisone|mesh-list
14742265|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742266|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
14742267|NCT00572299|Hormones|hormones|mesh-ancestor
14742268|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408010|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
14408011|NCT01534195|Hormones|hormones|mesh-ancestor
14408012|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408013|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408014|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14408015|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408016|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
14408017|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
14408018|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408019|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925161|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925162|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
14925163|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925164|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
14925165|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925166|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
14925167|NCT01403285|Molgramostim|molgramostim|mesh-list
14408020|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14408021|NCT01534195|Protective Agents|protective agents|mesh-ancestor
14408022|NCT01534208|Enclomiphene|enclomiphene|mesh-list
14408023|NCT01534208|Clomiphene|clomiphene|mesh-list
14408024|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
14408025|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14408026|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
14408027|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408028|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408029|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14408030|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
14408031|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14408032|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14408033|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14408034|NCT01534260|Bortezomib|bortezomib|mesh-list
14408035|NCT01534260|Sorafenib|sorafenib|mesh-list
14408036|NCT01534260|Vorinostat|vorinostat|mesh-list
14408037|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408038|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14408039|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408040|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925168|NCT01403285|Imiquimod|imiquimod|mesh-list
14925169|NCT01403285|Sargramostim|sargramostim|mesh-list
14408041|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14408042|NCT01534351|Tamsulosin|tamsulosin|mesh-list
15243730|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243731|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15243732|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
14408043|NCT01534351|Finasteride|finasteride|mesh-list
14408044|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14408045|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14408046|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14408047|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
14408048|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408049|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408050|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408051|NCT01534351|Urological Agents|urological agents|mesh-ancestor
14408052|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14408053|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14408054|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408055|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
14408056|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408057|NCT01534416|Bupivacaine|bupivacaine|mesh-list
14408058|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
14408059|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
14408060|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408061|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408062|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
14408063|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408064|NCT01534520|Lidocaine|lidocaine|mesh-list
14742269|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243733|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243734|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15243735|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
15243736|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243737|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243738|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15243739|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15243740|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15243741|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
15243742|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15243743|NCT01146418|Hormones|hormones|mesh-ancestor
15243744|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243745|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243746|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15243747|NCT01144416|Hormones|hormones|mesh-ancestor
15243748|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243749|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243750|NCT01077817|Alendronate|alendronate|mesh-list
15243751|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
15243752|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
15243753|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15243754|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
15243755|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15243756|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243757|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15243758|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15243759|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243760|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15243761|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15243762|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243763|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243764|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15243765|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15243766|NCT01065779|Alendronate|alendronate|mesh-list
15243767|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15243768|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243769|NCT01056159|Albuterol|albuterol|mesh-list
15243770|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15243771|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
15243772|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243773|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243774|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243775|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243776|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
14408065|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
14408066|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
14408067|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408068|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408069|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
14408070|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408071|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14408072|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14408073|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14408074|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14408075|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408076|NCT01534637|Gemcitabine|gemcitabine|mesh-list
14408077|NCT01534637|Fluorouracil|fluorouracil|mesh-list
14408078|NCT01534637|Capecitabine|capecitabine|mesh-list
14408079|NCT01534637|Aprepitant|aprepitant|mesh-list
14408080|NCT01534637|Antiemetics|antiemetics|mesh-list
14408081|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14408082|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
14408083|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408084|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408085|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
14408086|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408087|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408088|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408089|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
14408090|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408091|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
14408092|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408093|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408094|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14408095|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408096|NCT01534897|Dabrafenib|dabrafenib|mesh-list
14408097|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408098|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14408099|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408100|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467522|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467523|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14467524|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467525|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467526|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
14467527|NCT02260934|Hormones|hormones|mesh-ancestor
14467528|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467529|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14467530|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467531|NCT02260934|Analgesics|analgesics|mesh-ancestor
14467532|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
14467533|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467534|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
14467535|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
14467536|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
14467537|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14467538|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14467539|NCT02260934|Protective Agents|protective agents|mesh-ancestor
14467540|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14467541|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14467542|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925170|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925171|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
14925172|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925173|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14925174|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14467543|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
14467544|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
14467545|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14408101|NCT01534962|Ranolazine|ranolazine|mesh-list
14408102|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14408103|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14408104|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408105|NCT01535001|Acetaminophen|acetaminophen|mesh-list
14408106|NCT01535001|Pantoprazole|pantoprazole|mesh-list
14408107|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408108|NCT01535001|Analgesics|analgesics|mesh-ancestor
14408109|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
14408110|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408111|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408112|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
14408113|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14408114|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408115|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14408116|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408117|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408118|NCT01535040|Memantine|memantine|mesh-list
14408119|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14408120|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14408121|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
14408122|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408123|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408124|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408125|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14408126|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14408127|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
14408128|NCT01535053|Leucovorin|leucovorin|mesh-list
14408129|NCT01535053|Folic Acid|folic acid|mesh-list
14408130|NCT01535053|Dactinomycin|dactinomycin|mesh-list
14408131|NCT01535053|Methotrexate|methotrexate|mesh-list
14408132|NCT01535053|Calcium|calcium|mesh-list
14408133|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
14408134|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14408135|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408136|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14408137|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14408138|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
14408139|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14408140|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14408141|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
14408142|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408143|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408144|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
14408145|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408146|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14408147|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408148|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
14408149|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408150|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14408151|NCT01535053|Antidotes|antidotes|mesh-ancestor
14408152|NCT01535053|Protective Agents|protective agents|mesh-ancestor
14408153|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
14408154|NCT01535053|Vitamins|vitamins|mesh-ancestor
14408155|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
14408156|NCT01535053|Hematinics|hematinics|mesh-ancestor
14408157|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408158|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408159|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14408160|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14408161|NCT01535235|Lisinopril|lisinopril|mesh-list
14408162|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14408163|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
15243777|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15243778|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15243779|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15243780|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15243781|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
15243782|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243783|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243784|NCT00988260|Ganirelix|ganirelix|mesh-list
15243785|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
14408164|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408165|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408166|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14408167|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14408168|NCT01535235|Protective Agents|protective agents|mesh-ancestor
14408169|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408170|NCT01535261|Ranibizumab|ranibizumab|mesh-list
14408171|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14408172|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14408173|NCT01535261|Growth Substances|growth substances|mesh-ancestor
14408174|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408175|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14408176|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408177|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
14408178|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14408179|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408180|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408181|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408182|NCT01535287|Analgesics|analgesics|mesh-ancestor
14408183|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
14408184|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408185|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14408186|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14408187|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14408188|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
14408189|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408190|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408191|NCT01535443|Bromfenac|bromfenac|mesh-list
14408192|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14408193|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408194|NCT01535443|Analgesics|analgesics|mesh-ancestor
14408195|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
14408196|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408197|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408198|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408199|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408200|NCT01535573|Dexetimide|dexetimide|mesh-list
14408201|NCT01535573|Citalopram|citalopram|mesh-list
14408202|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14408203|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14742270|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14408204|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14408205|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408206|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408207|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
14408208|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408209|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14408210|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
14408211|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14408212|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14408213|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14408214|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
14408215|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
14408216|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408217|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14408218|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14408219|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
14408220|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
14408221|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14408222|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14467546|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
14742271|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742272|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14742273|NCT00572312|Atorvastatin|atorvastatin|mesh-list
14742274|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14742275|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14408223|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408224|NCT01535924|Gemcitabine|gemcitabine|mesh-list
14408225|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14408226|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14408227|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
14408228|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408229|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408230|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
14408231|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408232|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408233|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408234|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
14408235|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408236|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14408237|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
14408238|NCT01535937|Midazolam|midazolam|mesh-list
14408239|NCT01535937|Ketamine|ketamine|mesh-list
14408240|NCT01535937|Analgesics|analgesics|mesh-ancestor
14408241|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
14925175|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
14925176|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408242|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742276|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
14742277|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742278|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14742279|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14742280|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408243|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408244|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14408245|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14408246|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
14408247|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
14408248|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408249|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14408250|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14408251|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408252|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408253|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14408254|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14408255|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14408256|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14408257|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14408258|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
14408259|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
14408260|NCT01535976|Ketamine|ketamine|mesh-list
14408261|NCT01535976|Analgesics|analgesics|mesh-ancestor
14742281|NCT00572364|Olaparib|olaparib|mesh-list
14742282|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14742283|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742284|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243786|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243787|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243788|NCT00974571|Cetirizine|cetirizine|mesh-list
15243789|NCT00974571|Montelukast|montelukast|mesh-list
15243790|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243791|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243792|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15243793|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243794|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243795|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243796|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15243797|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243798|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243799|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15243800|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15243801|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14742285|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742286|NCT00572390|Estrogens|estrogens|mesh-list
14742287|NCT00572390|Hormones|hormones|mesh-ancestor
14742288|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408262|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
14408263|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408264|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408265|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14408266|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14408267|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
14408268|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
14408269|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408270|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14408271|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14408272|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408273|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408274|NCT01536067|Bortezomib|bortezomib|mesh-list
14408275|NCT01536067|Ofatumumab|ofatumumab|mesh-list
14408276|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408277|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
14408278|NCT01536262|Olodaterol|olodaterol|mesh-list
14408279|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14408280|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
14408281|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408282|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408283|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14408284|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408285|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
14408286|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14408287|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
14408288|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408289|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408290|NCT01536366|Repaglinide|repaglinide|mesh-list
14408291|NCT01536366|Opicapone|opicapone|mesh-list
14408292|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14408293|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408294|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14408295|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408296|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408297|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14408298|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14408299|NCT01536379|Belimumab|belimumab|mesh-list
14408300|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408301|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
14408302|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408303|NCT01536392|Ondansetron|ondansetron|mesh-list
14408304|NCT01536392|Granisetron|granisetron|mesh-list
14408305|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
14408306|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
14408307|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408308|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408309|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742289|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742290|NCT00572559|Vancomycin|vancomycin|mesh-list
14408310|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
14408311|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
14742291|NCT00572559|Linezolid|linezolid|mesh-list
14408312|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14408313|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
14408314|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408315|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408316|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14408317|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14408318|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408319|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14408320|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14408321|NCT01536535|Prednisone|prednisone|mesh-list
14408322|NCT01536535|Mesalamine|mesalamine|mesh-list
14408323|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408324|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
14408325|NCT01536535|Hormones|hormones|mesh-ancestor
14408326|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408327|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408328|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14408329|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408330|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14408331|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408332|NCT01536535|Analgesics|analgesics|mesh-ancestor
14408333|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
14408334|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408335|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408336|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
14408337|NCT01536561|Antibodies|antibodies|mesh-list
14408338|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14408339|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
14742292|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14742293|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742294|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14742295|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408340|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
14408341|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408342|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408343|NCT01536574|Ropinirole|ropinirole|mesh-list
14408344|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14408345|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14408346|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
14742296|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408347|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
15243802|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
15243803|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
15243804|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243805|NCT00972738|Loratadine|loratadine|mesh-list
14742297|NCT00572637|Delanzomib|delanzomib|mesh-list
14742298|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
14742299|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
14742300|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742301|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742302|NCT00572650|Vildagliptin|vildagliptin|mesh-list
14742303|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742304|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742305|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14742306|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
14742307|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742308|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742309|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
14742310|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14742311|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
15243806|NCT00972738|Montelukast|montelukast|mesh-list
14408348|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408349|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408350|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408351|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14408352|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14408353|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
14408354|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408355|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742312|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742313|NCT00572663|Expectorants|expectorants|mesh-ancestor
14742314|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742315|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14742316|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
14742317|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742318|NCT00572663|Protective Agents|protective agents|mesh-ancestor
15243807|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243808|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243809|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15243810|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243811|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742319|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742320|NCT00572663|Antidotes|antidotes|mesh-ancestor
14742321|NCT00572689|Exenatide|exenatide|mesh-list
14742322|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742323|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742324|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14742325|NCT00572689|Incretins|incretins|mesh-ancestor
15243812|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243813|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14742326|NCT00572689|Hormones|hormones|mesh-ancestor
14742327|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243814|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243815|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243816|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
15243817|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
14408356|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14408357|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408358|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14408359|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14408360|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14408361|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
14408362|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408363|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408364|NCT01536704|Nicotine|nicotine|mesh-list
14408365|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14408366|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
14408367|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408368|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408369|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14408370|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14408371|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
14408372|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408373|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408374|NCT01536886|Betamethasone|betamethasone|mesh-list
14408375|NCT01536886|Calcipotriene|calcipotriene|mesh-list
14408376|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408377|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
14408378|NCT01536886|Hormones|hormones|mesh-ancestor
14408379|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408380|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408381|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14408382|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408383|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
14408384|NCT01536938|Calcitriol|calcitriol|mesh-list
14408385|NCT01536938|Betamethasone|betamethasone|mesh-list
14408386|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
14408387|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14408388|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
14408389|NCT01536938|Calcipotriene|calcipotriene|mesh-list
14408390|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14408391|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408392|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
14408393|NCT01536938|Hormones|hormones|mesh-ancestor
14408394|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408395|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408396|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14408397|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742328|NCT00572741|Ascorbic Acid|ascorbic acid|mesh-list
14742329|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
14742330|NCT00572741|Vitamins|vitamins|mesh-ancestor
14742331|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
14742332|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742333|NCT00572741|Antioxidants|antioxidants|mesh-ancestor
14742334|NCT00572741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742335|NCT00572741|Protective Agents|protective agents|mesh-ancestor
14925177|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925178|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15243818|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15243819|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15243820|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15243821|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
15243822|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
15243823|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243824|NCT00968201|Montelukast|montelukast|mesh-list
15243825|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243826|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243827|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15243828|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243829|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243830|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243831|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15243832|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243833|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408398|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
14408399|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14408400|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14408401|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14408402|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408403|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14408404|NCT01536938|Vitamins|vitamins|mesh-ancestor
14408405|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
15243834|NCT00968149|Montelukast|montelukast|mesh-list
15243835|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243836|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243837|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15243838|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243839|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243840|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243841|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15243842|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243843|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243844|NCT00963469|Loratadine|loratadine|mesh-list
15243845|NCT00963469|Montelukast|montelukast|mesh-list
15243846|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14408406|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14408407|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
14408408|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408409|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408410|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14408411|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14408412|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408413|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408414|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408415|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
14408416|NCT01537029|Doxorubicin|doxorubicin|mesh-list
14408417|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15243847|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243848|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15243849|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243850|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243851|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243852|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15243853|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243854|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243855|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
15243856|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
15243857|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15243858|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15243859|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15243860|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
15243861|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
15243862|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243863|NCT00960141|Loratadine|loratadine|mesh-list
15243864|NCT00960141|Montelukast|montelukast|mesh-list
15243865|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243866|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408418|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
14408419|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408420|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15243867|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14408421|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14408422|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
14408423|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408424|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408425|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14408426|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14408427|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14408428|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14408429|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408430|NCT01537042|Rotigotine|rotigotine|mesh-list
14408431|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
14408432|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
14408433|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408434|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408435|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243868|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243869|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243870|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243871|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15243872|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243873|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925179|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14408436|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14408437|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14408438|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14408439|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14408440|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408441|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408442|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408443|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
14408444|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14408445|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
14408446|NCT01537081|Guaifenesin|guaifenesin|mesh-list
14408447|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14408448|NCT01537081|Expectorants|expectorants|mesh-ancestor
14408449|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408450|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14408451|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14408452|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14408453|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408454|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408455|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408456|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
14408457|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14408458|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
14408459|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
14408460|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408461|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
14408462|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14408463|NCT01537120|Vildagliptin|vildagliptin|mesh-list
14408464|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14408465|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408466|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14408467|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
14408468|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408469|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408470|NCT01537133|Fluticasone|fluticasone|mesh-list
14408471|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408472|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14408473|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
14408474|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408475|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408476|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243874|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
14408477|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408478|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
14408479|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14408480|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
14742336|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
14742337|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742338|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742339|NCT00572819|Misoprostol|misoprostol|mesh-list
14742340|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14742341|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
14742342|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14408481|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14408482|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
14408483|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408484|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
14408485|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
14408486|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14408487|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14408488|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408489|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408490|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408491|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408492|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
14408493|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
14408494|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
14408495|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408496|NCT01537549|Protective Agents|protective agents|mesh-ancestor
14408497|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408498|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
14408499|NCT01537549|Vitamins|vitamins|mesh-ancestor
14408500|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
14408501|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
14408502|NCT01537666|Vancomycin|vancomycin|mesh-list
14408503|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408504|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408505|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
14408506|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14925180|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
14925181|NCT01403363|Fentanyl|fentanyl|mesh-list
14925182|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14408507|NCT01537783|Mupirocin|mupirocin|mesh-list
14408508|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14408509|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408510|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
14408511|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
14408512|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408513|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14408514|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408515|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408516|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
14742343|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925183|NCT01403363|Narcotics|narcotics|mesh-ancestor
14408517|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14925184|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408518|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
14408519|NCT01537887|Evacetrapib|evacetrapib|mesh-list
14408520|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408521|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408522|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14408523|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14408524|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408525|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742344|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14742345|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742346|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
14742347|NCT00572884|Permethrin|permethrin|mesh-list
14742348|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742349|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742350|NCT00573001|Ritonavir|ritonavir|mesh-list
14408526|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408527|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14408528|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14408529|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
14408530|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14408531|NCT01537900|Grazoprevir|grazoprevir|mesh-list
14408532|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
14408533|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408534|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
14408535|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14408536|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
14408537|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408538|NCT01537926|Expectorants|expectorants|mesh-ancestor
14742351|NCT00573001|Lopinavir|lopinavir|mesh-list
14742352|NCT00573001|Tenofovir|tenofovir|mesh-list
14408539|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408540|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14408541|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
14408542|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408543|NCT01537926|Protective Agents|protective agents|mesh-ancestor
14408544|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408545|NCT01537926|Antidotes|antidotes|mesh-ancestor
14408546|NCT01538472|Cytarabine|cytarabine|mesh-list
14408547|NCT01538472|Rituximab|rituximab|mesh-list
14408548|NCT01538472|Melphalan|melphalan|mesh-list
14408549|NCT01538472|Carmustine|carmustine|mesh-list
14408550|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14408551|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14408552|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408553|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
14408554|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408555|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408556|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14408557|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
14408558|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408559|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
14408560|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408561|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408562|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14408563|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
14408564|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14408565|NCT01538719|Rilonacept|rilonacept|mesh-list
14408566|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925185|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408567|NCT01538745|Ketamine|ketamine|mesh-list
14408568|NCT01538745|Morphine|morphine|mesh-list
14742353|NCT00573001|Zidovudine|zidovudine|mesh-list
14742354|NCT00573001|Emtricitabine|emtricitabine|mesh-list
14408569|NCT01538745|Analgesics|analgesics|mesh-ancestor
14408570|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
14742355|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14408571|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408572|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408573|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14408574|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14408575|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
14408576|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
14408577|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408578|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14408579|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14925186|NCT01403363|Analgesics|analgesics|mesh-ancestor
14925187|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
15243875|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
14742356|NCT00573001|Nevirapine|nevirapine|mesh-list
14742357|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14742358|NCT00573001|Efavirenz|efavirenz|mesh-list
14742359|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14742360|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14742361|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
14742362|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243876|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15243877|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15243878|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15243879|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
14408580|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408581|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408582|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14408583|NCT01538745|Narcotics|narcotics|mesh-ancestor
15243880|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
15243881|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243882|NCT00943683|Montelukast|montelukast|mesh-list
15243883|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243884|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243885|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15243886|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
14408584|NCT01538862|Sargramostim|sargramostim|mesh-list
14408585|NCT01538862|Lenograstim|lenograstim|mesh-list
14408586|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
14408587|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408588|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14408589|NCT01539083|Thalidomide|thalidomide|mesh-list
14408590|NCT01539083|Dexamethasone|dexamethasone|mesh-list
14408591|NCT01539083|Prednisolone|prednisolone|mesh-list
14408592|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
14408593|NCT01539083|Bortezomib|bortezomib|mesh-list
14408594|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408595|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
14408596|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408597|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408598|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14408599|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
14408600|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408601|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408602|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14408603|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408604|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
14742363|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742364|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14742365|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14742366|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
14742367|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742368|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14742369|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14742370|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14742371|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14742372|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
14742373|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14742374|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14742375|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14742376|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14408605|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
14408606|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408607|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408608|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
14408609|NCT01539083|Hormones|hormones|mesh-ancestor
14408610|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408611|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14408612|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
14408613|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408614|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408615|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14408616|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14408617|NCT01539083|Growth Substances|growth substances|mesh-ancestor
14408618|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
14408619|NCT01539135|Methylene Blue|methylene blue|mesh-list
14408620|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408621|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408622|NCT01539291|Idelalisib|idelalisib|mesh-list
14408623|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408624|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408625|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408626|NCT01539317|Lidocaine|lidocaine|mesh-list
14408627|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
14408628|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
14408629|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408630|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408631|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
14408632|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15243887|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243888|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243889|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15243890|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14408633|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14408634|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15243891|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243892|NCT00943397|Montelukast|montelukast|mesh-list
15243893|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243894|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243895|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15243896|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
14408635|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14408636|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15243897|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243898|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243899|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15243900|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243901|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408637|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408638|NCT01539512|Rituximab|rituximab|mesh-list
14408639|NCT01539512|Idelalisib|idelalisib|mesh-list
14408640|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14408641|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408642|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
14408643|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408644|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408645|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408646|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408647|NCT01539538|Sufentanil|sufentanil|mesh-list
14408648|NCT01539538|Morphine|morphine|mesh-list
15243902|NCT00911547|Beclomethasone|beclomethasone|mesh-list
15243903|NCT00911547|Montelukast|montelukast|mesh-list
15243904|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15243905|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
15243906|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14408649|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14408650|NCT01539538|Narcotics|narcotics|mesh-ancestor
14408651|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408652|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408653|NCT01539538|Analgesics|analgesics|mesh-ancestor
14408654|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
14408655|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408656|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14408657|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14408658|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
14408659|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
14408660|NCT01539642|Sufentanil|sufentanil|mesh-list
14408661|NCT01539642|Dsuvia|dsuvia|mesh-list
14408662|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14408663|NCT01539642|Narcotics|narcotics|mesh-ancestor
14408664|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408665|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408666|NCT01539642|Analgesics|analgesics|mesh-ancestor
15243907|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243908|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15243909|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243910|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14408667|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
15243911|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243912|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742377|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14742378|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15243913|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243914|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
15243915|NCT00911547|Hormones|hormones|mesh-ancestor
15243916|NCT00899379|Rizatriptan|rizatriptan|mesh-list
15243917|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15243918|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
15243919|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243920|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243921|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408668|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742379|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14742380|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742381|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
14742382|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742383|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14742384|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742385|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742386|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15243922|NCT00898677|Sumatriptan|sumatriptan|mesh-list
15243923|NCT00898677|Rizatriptan|rizatriptan|mesh-list
15243924|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15243925|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15243926|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15243927|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
15243928|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243929|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243930|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243931|NCT00897949|Rizatriptan|rizatriptan|mesh-list
15243932|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15243933|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
15243934|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243935|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243936|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243937|NCT00897104|Sumatriptan|sumatriptan|mesh-list
15243938|NCT00897104|Rizatriptan|rizatriptan|mesh-list
15243939|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15243940|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15243941|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14408669|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14408670|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14408671|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
14408672|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
14408673|NCT01539837|Deferiprone|deferiprone|mesh-list
14408674|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14408675|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
14408676|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
14408677|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408678|NCT01540474|Vaccines|vaccines|mesh-list
14408679|NCT01540474|Immunologic Factors|immunologic factors|mesh-ancestor
14408680|NCT01540474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408681|NCT01540487|Metformin|metformin|mesh-list
14408682|NCT01540487|Linagliptin|linagliptin|mesh-list
14408683|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14408684|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408685|NCT01540487|Incretins|incretins|mesh-ancestor
14408686|NCT01540487|Hormones|hormones|mesh-ancestor
14408687|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408688|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14408689|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
14408690|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408691|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467547|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
15243942|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
14467548|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408692|NCT01540565|Veliparib|veliparib|mesh-list
14925188|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925189|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925190|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14408693|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14408694|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408695|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408696|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408697|NCT01540838|Acetaminophen|acetaminophen|mesh-list
14408698|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408699|NCT01540838|Analgesics|analgesics|mesh-ancestor
14408700|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
14408701|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408702|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408703|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
14408704|NCT01541215|Metformin|metformin|mesh-list
14408705|NCT01541215|Liraglutide|liraglutide|mesh-list
14408706|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14408707|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408708|NCT01541215|Incretins|incretins|mesh-ancestor
14408709|NCT01541215|Hormones|hormones|mesh-ancestor
14408710|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408711|NCT01541358|Listerine|listerine|mesh-list
14408712|NCT01541358|Fluorides|fluorides|mesh-list
14408713|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
14408714|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
14408715|NCT01541358|Protective Agents|protective agents|mesh-ancestor
14408716|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408717|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14408718|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408719|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14408720|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14408721|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14408722|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408723|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408724|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14408725|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14408726|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14408727|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
14408728|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408729|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408730|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14408731|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14408732|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
14408733|NCT01541735|Pantoprazole|pantoprazole|mesh-list
14408734|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14408735|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408736|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15243943|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15243944|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408737|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742387|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
14742388|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742389|NCT00573404|Sunitinib|sunitinib|mesh-list
14742390|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
14742391|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742392|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14408738|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408739|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14408740|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14408741|NCT01541930|Metronidazole|metronidazole|mesh-list
14408742|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408743|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408744|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14408745|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14408746|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
14408747|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14408748|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925191|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
15243945|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243946|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
15243947|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15243948|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
15243949|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15243950|NCT00803790|Vitamin D|vitamin d|mesh-list
14742393|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14742394|NCT00573404|Growth Substances|growth substances|mesh-ancestor
14742395|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742396|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
14742397|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14742398|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408749|NCT01542125|Lidocaine|lidocaine|mesh-list
14408750|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
14408751|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
14408752|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408753|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408754|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
14408755|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408756|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14408757|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14408758|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14408759|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14408760|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408761|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
14408762|NCT01542255|Dacarbazine|dacarbazine|mesh-list
14408763|NCT01542255|Vinblastine|vinblastine|mesh-list
14408764|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408765|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
14408766|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408767|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408768|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14408769|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
14408770|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408771|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408772|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14408773|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14408774|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
14408775|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
14408776|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
14408777|NCT01542372|Prazosin|prazosin|mesh-list
14408778|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14408779|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14408780|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14408781|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14408782|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
14408783|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408784|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408785|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408786|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14408787|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408788|NCT01542541|Rifaximin|rifaximin|mesh-list
14408789|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14408790|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408791|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408792|NCT01542645|Fentanyl|fentanyl|mesh-list
14408793|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
15243951|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
15243952|NCT00803790|Alendronate|alendronate|mesh-list
15243953|NCT00803790|Vitamins|vitamins|mesh-list
15243954|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
15243955|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408794|NCT01542645|Methadone|methadone|mesh-list
14742399|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742400|NCT00573417|Modafinil|modafinil|mesh-list
14742401|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15243956|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15243957|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15243958|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15243959|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
15243960|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243961|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15243962|NCT00773357|Carvedilol|carvedilol|mesh-list
15243963|NCT00773357|Guanfacine|guanfacine|mesh-list
15243964|NCT00773357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15243965|NCT00773357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15243966|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
15243967|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408795|NCT01542645|Narcotics|narcotics|mesh-ancestor
15243968|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742402|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742403|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14742404|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14742405|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15243969|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408796|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14408797|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408798|NCT01542645|Analgesics|analgesics|mesh-ancestor
14408799|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
14408800|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408801|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14408802|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14408803|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
14408804|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
14408805|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
14408806|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408807|NCT01542684|Azacitidine|azacitidine|mesh-list
14408808|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14408809|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
14408810|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408811|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408812|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408813|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
14408814|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
14408815|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408816|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
14408817|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
14408818|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408819|NCT01543074|Protective Agents|protective agents|mesh-ancestor
14408820|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408821|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14408822|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408823|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14408824|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408825|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
14408826|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408827|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
14408828|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408829|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408830|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14408831|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
14408832|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408833|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408834|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14408835|NCT01543178|Rifaximin|rifaximin|mesh-list
14408836|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15243970|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15243971|NCT00773357|Antioxidants|antioxidants|mesh-ancestor
15243972|NCT00773357|Protective Agents|protective agents|mesh-ancestor
14408837|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408838|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408839|NCT01543204|Etanercept|etanercept|mesh-list
14408840|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15243973|NCT00773357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15243974|NCT00773357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15243975|NCT00773357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15243976|NCT00773357|Vasodilator Agents|vasodilator agents|mesh-ancestor
15243977|NCT00773357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15243978|NCT00773357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15243979|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15243980|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15243981|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15243982|NCT00745108|Tibolone|tibolone|mesh-list
15243983|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15243984|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15243985|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15243986|NCT00745108|Hormones|hormones|mesh-ancestor
14408841|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408842|NCT01543204|Analgesics|analgesics|mesh-ancestor
14408843|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
14408844|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408845|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408846|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408847|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408848|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408849|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408850|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
14408851|NCT01543568|Aflibercept|aflibercept|mesh-list
14408852|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14408853|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14408854|NCT01543568|Growth Substances|growth substances|mesh-ancestor
14408855|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408856|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
14408857|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408858|NCT01543685|Celecoxib|celecoxib|mesh-list
14408859|NCT01543685|Indomethacin|indomethacin|mesh-list
14408860|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14408861|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14925192|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
14925193|NCT01403389|Eculizumab|eculizumab|mesh-list
14742406|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742407|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
14742408|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14742409|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
14925194|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14408862|NCT01543685|Analgesics|analgesics|mesh-ancestor
14408863|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
14408864|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408865|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408866|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408867|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408868|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14408869|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14408870|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408871|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408872|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
14408873|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
14408874|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14408875|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
14408876|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408877|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14408878|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408879|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408880|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
14408881|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408882|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408883|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14408884|NCT01543958|Sevelamer|sevelamer|mesh-list
14408885|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
14408886|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
14408887|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408888|NCT01544062|Acetaminophen|acetaminophen|mesh-list
14408889|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408890|NCT01544062|Analgesics|analgesics|mesh-ancestor
14408891|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
14408892|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408893|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408894|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
14408895|NCT01544114|Naproxen|naproxen|mesh-list
14408896|NCT01544114|Esomeprazole|esomeprazole|mesh-list
14408897|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14408898|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14408899|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14408900|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408901|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408902|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14408903|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408904|NCT01544114|Analgesics|analgesics|mesh-ancestor
14408905|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
14408906|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742410|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408907|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408908|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408909|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408910|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
14408911|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14408912|NCT01544153|Nicotine|nicotine|mesh-list
14408913|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14408914|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
14408915|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408916|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408917|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14408918|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14408919|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
14408920|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14408921|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408922|NCT01544179|Pemetrexed|pemetrexed|mesh-list
14408923|NCT01544179|Gefitinib|gefitinib|mesh-list
14408924|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408925|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408926|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408927|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14408928|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14408929|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14408930|NCT01544309|Atorvastatin|atorvastatin|mesh-list
14408931|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14408932|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14408933|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14408934|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
14408935|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408936|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14408937|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14408938|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15243987|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14408939|NCT01544348|Omalizumab|omalizumab|mesh-list
14408940|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14408941|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14408942|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
14408943|NCT01544491|Everolimus|everolimus|mesh-list
14408944|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408945|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14408946|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
14408947|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408948|NCT01544920|Interferons|interferons|mesh-list
14408949|NCT01544920|Ribavirin|ribavirin|mesh-list
14408950|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
14408951|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
14408952|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14408953|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408954|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
14408955|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408956|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
14408957|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408958|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
14408959|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408960|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14408961|NCT01544998|Tadalafil|tadalafil|mesh-list
14408962|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
14408963|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14408964|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14408965|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408966|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408967|NCT01544998|Urological Agents|urological agents|mesh-ancestor
15243988|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
15243989|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
15243990|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15243991|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15243992|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
15243993|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15243994|NCT00725491|Ganirelix|ganirelix|mesh-list
15243995|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
15243996|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15243997|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
15243998|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15243999|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244000|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15244001|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244002|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244003|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
14408968|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
14467549|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15244004|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244005|NCT00725374|Tibolone|tibolone|mesh-list
14408969|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408970|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
14408971|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
14408972|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742411|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742412|NCT00573547|Fluoxetine|fluoxetine|mesh-list
14742413|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14742414|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14742415|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14742416|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742417|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742418|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
14742419|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742420|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14408973|NCT01545141|Interferons|interferons|mesh-list
14408974|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
14408975|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
14408976|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14408977|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14408978|NCT01545141|Poly I-C|poly i-c|mesh-list
14408979|NCT01545141|Celecoxib|celecoxib|mesh-list
14408980|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14408981|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
14408982|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14408983|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
14408984|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14408985|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14408986|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14408987|NCT01545141|Analgesics|analgesics|mesh-ancestor
14408988|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
14408989|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14408990|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14408991|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14408992|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14408993|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14742421|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
14742422|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742423|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14742424|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14742425|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742426|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
14742427|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
14742428|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14742429|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14742430|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742431|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742432|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
14742433|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
14742434|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
14742435|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742436|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
14742437|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
15244006|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
15244007|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244008|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244009|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244010|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14408994|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14408995|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14408996|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
14408997|NCT01545336|Anastrozole|anastrozole|mesh-list
14408998|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14408999|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409000|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14409001|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15244011|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244012|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244013|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15244014|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
15244015|NCT00725374|Hormones|hormones|mesh-ancestor
15244016|NCT00724789|Ganirelix|ganirelix|mesh-list
14409002|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409003|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409004|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14409005|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
14409006|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244017|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244018|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244019|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244020|NCT00711607|Estradiol|estradiol|mesh-list
15244021|NCT00711607|Estrogens|estrogens|mesh-ancestor
15244022|NCT00711607|Hormones|hormones|mesh-ancestor
15244023|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244024|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244025|NCT00703014|Progesterone|progesterone|mesh-list
15244026|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244027|NCT00703014|Ganirelix|ganirelix|mesh-list
15244028|NCT00703014|Progestins|progestins|mesh-ancestor
15244029|NCT00703014|Hormones|hormones|mesh-ancestor
14409007|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409008|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14409009|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
14409010|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409011|NCT01545388|Metformin|metformin|mesh-list
14409012|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14409013|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14409014|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409015|NCT01545388|Incretins|incretins|mesh-ancestor
14409016|NCT01545388|Hormones|hormones|mesh-ancestor
14409017|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409018|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14409019|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
14409020|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409021|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409022|NCT01545700|Dexamethasone|dexamethasone|mesh-list
14409023|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
14409024|NCT01545700|BB 1101|bb 1101|mesh-list
14409025|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409026|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
14409027|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
14409028|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409029|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409030|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409031|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
14409032|NCT01545700|Hormones|hormones|mesh-ancestor
14409033|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409034|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925195|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925196|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
14925197|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925198|NCT01403415|Sirolimus|sirolimus|mesh-list
14925199|NCT01403415|Dexamethasone|dexamethasone|mesh-list
14925200|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
14925201|NCT01403415|Methotrexate|methotrexate|mesh-list
14925202|NCT01403415|Vincristine|vincristine|mesh-list
14925203|NCT01403415|Asparaginase|asparaginase|mesh-list
14925204|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
14925205|NCT01403415|Pegaspargase|pegaspargase|mesh-list
14925206|NCT01403415|BB 1101|bb 1101|mesh-list
14925207|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925208|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
14925209|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
15244030|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244031|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244032|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244033|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244034|NCT00702988|Hormones|hormones|mesh-ancestor
15244035|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244036|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244037|NCT00702845|Hormones|hormones|mesh-list
15244038|NCT00702845|Progesterone|progesterone|mesh-list
15244039|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244040|NCT00702845|Ganirelix|ganirelix|mesh-list
14925210|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925211|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925212|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925213|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
14925214|NCT01403415|Hormones|hormones|mesh-ancestor
14925215|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925216|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925217|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925218|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14925219|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
14925220|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409035|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409036|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
14409037|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409038|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409039|NCT01545765|Lidocaine|lidocaine|mesh-list
14409040|NCT01545765|Tetracaine|tetracaine|mesh-list
15244041|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244042|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244043|NCT00702845|Progestins|progestins|mesh-ancestor
15244044|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
14409041|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
14409042|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
14409043|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409044|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409045|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
14409046|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409047|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14409048|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14409049|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14409050|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409051|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409052|NCT01545817|Everolimus|everolimus|mesh-list
14409053|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409054|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409055|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
14409056|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409057|NCT01545843|Fluoxetine|fluoxetine|mesh-list
14409058|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14409059|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14409060|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409061|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409062|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409063|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
14409064|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244045|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15244046|NCT00702806|Ganirelix|ganirelix|mesh-list
15244047|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244048|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244049|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244050|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15244051|NCT00702624|Hormones|hormones|mesh-list
15244052|NCT00702624|Progesterone|progesterone|mesh-list
15244053|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244054|NCT00702624|Ganirelix|ganirelix|mesh-list
15244055|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244056|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742438|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742439|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14742440|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
14742441|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
14925221|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14925222|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
14925223|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409065|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14409066|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
14409067|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409068|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14409069|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14742442|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742443|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244057|NCT00702624|Progestins|progestins|mesh-ancestor
15244058|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244059|NCT00702546|Hormones|hormones|mesh-list
15244060|NCT00702546|Progesterone|progesterone|mesh-list
15244061|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244062|NCT00702546|Ganirelix|ganirelix|mesh-list
15244063|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244064|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244065|NCT00702546|Progestins|progestins|mesh-ancestor
15244066|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244067|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14409070|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409071|NCT01546038|Cytarabine|cytarabine|mesh-list
14409072|NCT01546038|Decitabine|decitabine|mesh-list
14409073|NCT01546038|Daunorubicin|daunorubicin|mesh-list
14409074|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14409075|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
14409076|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409077|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742444|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14742445|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14742446|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14742447|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742448|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14409078|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
14409079|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409080|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409081|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
14409082|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409083|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14409084|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14409085|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14409086|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409087|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
14409088|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14409089|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409090|NCT01546402|Dexamethasone|dexamethasone|mesh-list
14742449|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
14742450|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14409091|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
14409092|NCT01546402|BB 1101|bb 1101|mesh-list
15244068|NCT00702520|Hormones|hormones|mesh-list
14409093|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409094|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
14409095|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
14409096|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409097|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409098|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409099|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
14409100|NCT01546402|Hormones|hormones|mesh-ancestor
14409101|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409102|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409103|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409104|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
14409105|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409106|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409107|NCT01546454|Leuprolide|leuprolide|mesh-list
14409108|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14409109|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14409110|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
14409111|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14409112|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14409113|NCT01546454|Estradiol|estradiol|mesh-list
14409114|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14409115|NCT01546454|Progesterone|progesterone|mesh-list
14409116|NCT01546454|Estrogens|estrogens|mesh-ancestor
14409117|NCT01546454|Hormones|hormones|mesh-ancestor
14409118|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409119|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409120|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14409121|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
14409122|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409123|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14409124|NCT01546454|Progestins|progestins|mesh-ancestor
14409125|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14409126|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
14409127|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409128|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409129|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14409130|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14409131|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14409132|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14409133|NCT01546623|Leuprolide|leuprolide|mesh-list
14409134|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14409135|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
14409136|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409137|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409138|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409139|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409140|NCT01546649|Leuprolide|leuprolide|mesh-list
14409141|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14409142|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
14409143|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409144|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409145|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409146|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409147|NCT01546688|Zonisamide|zonisamide|mesh-list
14409148|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
14409149|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14409150|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409151|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409152|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14409153|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409154|NCT01546857|Gabapentin|gabapentin|mesh-list
14409155|NCT01546857|Analgesics|analgesics|mesh-ancestor
14409156|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
14409157|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409158|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409159|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
14409160|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14409161|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14409162|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409163|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409164|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14409165|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14409166|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409167|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409168|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
14409169|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
14409170|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409171|NCT01547000|Guanfacine|guanfacine|mesh-list
14409172|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14409173|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14409174|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14409175|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14409176|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
14409177|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409178|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409179|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409180|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
14409181|NCT01547286|Miotics|miotics|mesh-ancestor
14409182|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
14409183|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409184|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409185|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14409186|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14409187|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
14409188|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14409189|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14409190|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
14409191|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925224|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
14925225|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925226|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14925227|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925228|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
14409192|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467550|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
14467551|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
14467552|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14467553|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
14467554|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467555|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
14467556|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14467557|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14467558|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14467559|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14467560|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467561|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
14467562|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467563|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467564|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14467565|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467566|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
14467567|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14467568|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14467569|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14467570|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14467571|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742451|NCT00573638|Latanoprost|latanoprost|mesh-list
14742452|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14742453|NCT00573664|Gabapentin|gabapentin|mesh-list
14742454|NCT00573664|Analgesics|analgesics|mesh-ancestor
14467572|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
14467573|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467574|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467575|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14467576|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467577|NCT02261727|Prednisone|prednisone|mesh-list
14467578|NCT02261727|Cortisone|cortisone|mesh-list
14467579|NCT02261727|Theophylline|theophylline|mesh-list
14467580|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467581|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
14467582|NCT02261727|Hormones|hormones|mesh-ancestor
14467583|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467584|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467585|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14467586|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467587|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14467588|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
14467589|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467590|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14467591|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
14467592|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14467593|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467594|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467595|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
14742455|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
14409193|NCT01547299|Leuprolide|leuprolide|mesh-list
14409194|NCT01547299|Dutasteride|dutasteride|mesh-list
14742456|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742457|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742458|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
14742459|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14742460|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14409195|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14409196|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
14409197|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409198|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409199|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409200|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409201|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14409202|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14409203|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409204|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409205|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
14409206|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409207|NCT01547390|Aspirin|aspirin|mesh-list
14409208|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14409209|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14409210|NCT01547390|Analgesics|analgesics|mesh-ancestor
14409211|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
14409212|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409213|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409214|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409215|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409216|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14409217|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14409218|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409219|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14409220|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14409221|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742461|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742462|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742463|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14742464|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14742465|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742466|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742467|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
14742468|NCT00573690|Carboplatin|carboplatin|mesh-list
14742469|NCT00573690|Etoposide|etoposide|mesh-list
14925229|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742470|NCT00573690|Pemetrexed|pemetrexed|mesh-list
14742471|NCT00573690|Sorafenib|sorafenib|mesh-list
15244069|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244070|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244071|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244072|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
15244073|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15244074|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
15244075|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409222|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
14409223|NCT01547598|Timolol|timolol|mesh-list
14409224|NCT01547598|Bimatoprost|bimatoprost|mesh-list
14409225|NCT01547598|Travoprost|travoprost|mesh-list
14409226|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14409227|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14409228|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14409229|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14409230|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
14409231|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409232|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409233|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409234|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14409235|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14409236|NCT01547806|Plerixafor|plerixafor|mesh-list
14409237|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14409238|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14409239|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
14409240|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409241|NCT01548417|Mifepristone|mifepristone|mesh-list
14409242|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14409243|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
14925230|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14925231|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14925232|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
14925233|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
15244076|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15244077|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244078|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244079|NCT00702338|Hormones|hormones|mesh-list
15244080|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244081|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244082|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244083|NCT00702273|Progesterone|progesterone|mesh-list
15244084|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244085|NCT00702273|Ganirelix|ganirelix|mesh-list
15244086|NCT00702273|Progestins|progestins|mesh-ancestor
15244087|NCT00702273|Hormones|hormones|mesh-ancestor
15244088|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409244|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409245|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244089|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244090|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244091|NCT00702234|Progesterone|progesterone|mesh-list
15244092|NCT00702234|Progestins|progestins|mesh-ancestor
15244093|NCT00702234|Hormones|hormones|mesh-ancestor
15244094|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244095|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244096|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244097|NCT00702195|Hormones|hormones|mesh-ancestor
15244098|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244099|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244100|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15244101|NCT00697255|Hormones|hormones|mesh-list
15244102|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14409246|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14409247|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14409248|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14409249|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
14409250|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14409251|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14409252|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
14409253|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409254|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
14409255|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14409256|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14409257|NCT01548573|Thalidomide|thalidomide|mesh-list
14409258|NCT01548573|Dexamethasone|dexamethasone|mesh-list
14409259|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
14409260|NCT01548573|Melphalan|melphalan|mesh-list
14409261|NCT01548573|Doxorubicin|doxorubicin|mesh-list
14409262|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15244103|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742472|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742473|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14742474|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14742475|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14742476|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742477|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742478|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14925234|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
14925235|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14925236|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409263|NCT01548573|Etoposide|etoposide|mesh-list
14409264|NCT01548573|Bortezomib|bortezomib|mesh-list
14409265|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
14409266|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409267|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
14409268|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409269|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409270|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14409271|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
15244104|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244105|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15244106|NCT00696878|Progesterone|progesterone|mesh-list
14925237|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14925238|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
14925239|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
15244107|NCT00696878|Progestins|progestins|mesh-ancestor
15244108|NCT00696878|Hormones|hormones|mesh-ancestor
15244109|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244110|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244111|NCT00696800|Progesterone|progesterone|mesh-list
15244112|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244113|NCT00696800|Ganirelix|ganirelix|mesh-list
15244114|NCT00696800|Progestins|progestins|mesh-ancestor
15244115|NCT00696800|Hormones|hormones|mesh-ancestor
15244116|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244117|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244118|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244119|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15244120|NCT00647933|Lynestrenol|lynestrenol|mesh-list
15244121|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15244122|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15244123|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14409272|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925240|NCT01403415|Analgesics|analgesics|mesh-ancestor
14742479|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14742480|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14742481|NCT00573742|Candesartan|candesartan|mesh-list
14742482|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14742483|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14742484|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15244124|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
15244125|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15244126|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409273|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409274|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14409275|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409276|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
14409277|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
14409278|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409279|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409280|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
14409281|NCT01548573|Hormones|hormones|mesh-ancestor
14409282|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409283|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409284|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14409285|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14409286|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14409287|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409288|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14409289|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
14409290|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14409291|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409292|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14409293|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14409294|NCT01548573|Growth Substances|growth substances|mesh-ancestor
14409295|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
14409296|NCT01548638|Galantamine|galantamine|mesh-list
14409297|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14409298|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409299|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409300|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
14409301|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409302|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409303|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14409304|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
14409305|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409306|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
14409307|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
14409308|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14409309|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
14742485|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244127|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15244128|NCT00647933|Estrogens|estrogens|mesh-ancestor
15244129|NCT00647933|Hormones|hormones|mesh-ancestor
15244130|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244131|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15244132|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
15244133|NCT00641771|Alendronate|alendronate|mesh-list
15244134|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14409310|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409311|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409312|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14409313|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
14409314|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742486|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14742487|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
14742488|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742489|NCT00573885|Protective Agents|protective agents|mesh-ancestor
14742490|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742491|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14742492|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14409315|NCT01549002|Fentanyl|fentanyl|mesh-list
14409316|NCT01549002|Morphine|morphine|mesh-list
14409317|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14409318|NCT01549002|Narcotics|narcotics|mesh-ancestor
14409319|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409320|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409321|NCT01549002|Analgesics|analgesics|mesh-ancestor
14409322|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
14409323|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409324|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14409325|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14409326|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
14409327|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
14409328|NCT01549041|Asenapine|asenapine|mesh-list
14409329|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14409330|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14409331|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409332|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409333|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409334|NCT01549223|Misoprostol|misoprostol|mesh-list
14409335|NCT01549223|Oxytocin|oxytocin|mesh-list
14409336|NCT01549223|Methylergonovine|methylergonovine|mesh-list
14409337|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
14409338|NCT01549223|Carboprost|carboprost|mesh-list
14409339|NCT01549223|Maleic acid|maleic acid|mesh-list
14409340|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
14409341|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14742493|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409342|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409343|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14409344|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
14742494|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14742495|NCT00573924|Lansoprazole|lansoprazole|mesh-list
14742496|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
14742497|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14742498|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14742499|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742500|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742501|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409345|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14409346|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409347|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409348|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409349|NCT01549587|Listerine|listerine|mesh-list
14409350|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
14409351|NCT01549587|Fluorides|fluorides|mesh-list
14409352|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
14409353|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
14409354|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
14409355|NCT01549587|Protective Agents|protective agents|mesh-ancestor
14409356|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409357|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14409358|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409359|NCT01549613|Vancomycin|vancomycin|mesh-list
14409360|NCT01549613|Daptomycin|daptomycin|mesh-list
14409361|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14409362|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409363|NCT01549652|Morphine|morphine|mesh-list
14409364|NCT01549652|Ondansetron|ondansetron|mesh-list
14409365|NCT01549652|Naloxone|naloxone|mesh-list
14409366|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14409367|NCT01549652|Narcotics|narcotics|mesh-ancestor
14409368|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409369|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409370|NCT01549652|Analgesics|analgesics|mesh-ancestor
14409371|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
14409372|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409373|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
14409374|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
14409375|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409376|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
14409377|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409378|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14742502|NCT00573950|Cilostazol|cilostazol|mesh-list
14742503|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14742504|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
14742505|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742506|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742507|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14742508|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742509|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14742510|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14742511|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742512|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14409379|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
14409380|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409381|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409382|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14409383|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14409384|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409385|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15244135|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244136|NCT00641771|Vitamins|vitamins|mesh-ancestor
15244137|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
15244138|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244139|NCT00616967|Paclitaxel|paclitaxel|mesh-list
14742513|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
14742514|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14742515|NCT00573950|Protective Agents|protective agents|mesh-ancestor
14742516|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14742517|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14742518|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742519|NCT00573963|Ropivacaine|ropivacaine|mesh-list
14742520|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
14742521|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
14742522|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742523|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742524|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
14742525|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409386|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14409387|NCT01549873|Propofol|propofol|mesh-list
15244140|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15244141|NCT00616967|Carboplatin|carboplatin|mesh-list
15244142|NCT00616967|Vorinostat|vorinostat|mesh-list
15244143|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15244144|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244145|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
15244146|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
15244147|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
15244148|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244149|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15244150|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244151|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15244152|NCT00598208|Hormones|hormones|mesh-ancestor
14742526|NCT00574015|Acetaminophen|acetaminophen|mesh-list
14409388|NCT01549873|Desflurane|desflurane|mesh-list
14409389|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14409390|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409391|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409392|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14409393|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
14409394|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
14742527|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14742528|NCT00574015|Hydrocodone|hydrocodone|mesh-list
14742529|NCT00574015|Bupivacaine|bupivacaine|mesh-list
14742530|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
14742531|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
14742532|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742533|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742534|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
14742535|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742536|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14742537|NCT00574015|Analgesics|analgesics|mesh-ancestor
14742538|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
15244153|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244154|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244155|NCT00519857|Tibolone|tibolone|mesh-list
15244156|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
15244157|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244158|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244159|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244160|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15244161|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244162|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244163|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15244164|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
15244165|NCT00519857|Hormones|hormones|mesh-ancestor
15244166|NCT00480662|Alendronate|alendronate|mesh-list
15244167|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244168|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244169|NCT00461032|Montelukast|montelukast|mesh-list
15244170|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244171|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244172|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244173|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244174|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244175|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244176|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244177|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14742539|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14742540|NCT00574015|Narcotics|narcotics|mesh-ancestor
14409395|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15244178|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244179|NCT00446056|Ketotifen|ketotifen|mesh-list
15244180|NCT00446056|Montelukast|montelukast|mesh-list
15244181|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244182|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742541|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
14742542|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742543|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14742544|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742545|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753360|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14753361|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753362|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
15244183|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244184|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244185|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244186|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244187|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244188|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244189|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244190|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244191|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
14409396|NCT01549886|Rituximab|rituximab|mesh-list
14409397|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14409398|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409399|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
14409400|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244192|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
15244193|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15244194|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
15244195|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
15244196|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15244197|NCT00442338|Aminophylline|aminophylline|mesh-list
15244198|NCT00442338|Theophylline|theophylline|mesh-list
15244199|NCT00442338|Montelukast|montelukast|mesh-list
15244200|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244201|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244202|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244203|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
14409401|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409402|NCT01549951|Prednisone|prednisone|mesh-list
14409403|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409404|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
14409405|NCT01549951|Hormones|hormones|mesh-ancestor
14409406|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409407|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409408|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409409|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409410|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14409411|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14409412|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409413|NCT01549964|Incretins|incretins|mesh-ancestor
14409414|NCT01549964|Hormones|hormones|mesh-ancestor
14409415|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409416|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14409417|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
14409418|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409419|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409420|NCT01550224|Temozolomide|temozolomide|mesh-list
14409421|NCT01550224|Vorinostat|vorinostat|mesh-list
14409422|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14409423|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
14409424|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409425|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244204|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409426|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14409427|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409428|NCT01550341|Buprenorphine|buprenorphine|mesh-list
14409429|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14409430|NCT01550341|Naloxone|naloxone|mesh-list
14409431|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14409432|NCT01550341|Narcotics|narcotics|mesh-ancestor
14409433|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409434|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409435|NCT01550341|Analgesics|analgesics|mesh-ancestor
14409436|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
14409437|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409438|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14409439|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
14409440|NCT01550367|Aldesleukin|aldesleukin|mesh-list
14409441|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
14409442|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14409443|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14409444|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409445|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409446|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409447|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409448|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409449|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14409450|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14409451|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
14409452|NCT01550471|Ciclesonide|ciclesonide|mesh-list
14409453|NCT01550471|Beclomethasone|beclomethasone|mesh-list
14409454|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409455|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
14409456|NCT01550471|Hormones|hormones|mesh-ancestor
14409457|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409458|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409459|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14409460|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
14409461|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14409462|NCT01550705|Isoniazid|isoniazid|mesh-list
14409463|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
14409464|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14409465|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742546|NCT00574041|Interferons|interferons|mesh-list
14409466|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14409467|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14409468|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
14409469|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409470|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14409471|NCT01550744|Ustekinumab|ustekinumab|mesh-list
14409472|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409473|NCT01550965|Adalimumab|adalimumab|mesh-list
14409474|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409475|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409476|NCT01551056|Cetirizine|cetirizine|mesh-list
14409477|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14409478|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14409479|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14409480|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
15244205|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244206|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244207|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244208|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244209|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15244210|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
15244211|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244212|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15244213|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15244214|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409481|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
14409482|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409483|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409484|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409485|NCT01551212|Everolimus|everolimus|mesh-list
14409486|NCT01551212|Tacrolimus|tacrolimus|mesh-list
14409487|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409488|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
14409489|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409490|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14409491|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409492|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409493|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409494|NCT01551303|Oxytocin|oxytocin|mesh-list
14409495|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
14409496|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409497|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409498|NCT01551745|Bevacizumab|bevacizumab|mesh-list
14409499|NCT01551745|Vaccines|vaccines|mesh-list
14409500|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
15244215|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15244216|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15244217|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
14409501|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409502|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14409503|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409504|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14409505|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14409506|NCT01551745|Growth Substances|growth substances|mesh-ancestor
14409507|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
14409508|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
14409509|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14409510|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
14409511|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409512|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925241|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
14925242|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14925243|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14925244|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
14925245|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14925246|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
14925247|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925248|NCT01403506|Expectorants|expectorants|mesh-ancestor
15244218|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244219|NCT00442338|Protective Agents|protective agents|mesh-ancestor
15244220|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
15244221|NCT00431093|Tibolone|tibolone|mesh-list
15244222|NCT00431093|Estradiol|estradiol|mesh-list
15244223|NCT00431093|Estrogens|estrogens|mesh-ancestor
15244224|NCT00431093|Hormones|hormones|mesh-ancestor
15244225|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244226|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409513|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14409514|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
14409515|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14409516|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14409517|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14409518|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
14925249|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
14925250|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14925251|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
15244227|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
15244228|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
14742547|NCT00574041|Interferon-beta|interferon-beta|mesh-list
14409519|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409520|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409521|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14409522|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14742548|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
14742549|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742550|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
14742551|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742552|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
14742553|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742554|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14742555|NCT00574093|Ranibizumab|ranibizumab|mesh-list
14742556|NCT00574093|Verteporfin|verteporfin|mesh-list
14742557|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14409523|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14409524|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409525|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409526|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409527|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409528|NCT01552057|Analgesics|analgesics|mesh-ancestor
14409529|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
14409530|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409531|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
14409532|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409533|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
14409534|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14409535|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
14409536|NCT01552343|Coagulants|coagulants|mesh-ancestor
14409537|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14409538|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
14409539|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409540|NCT01552369|Valganciclovir|valganciclovir|mesh-list
14409541|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
14409542|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409543|NCT01552408|Ranibizumab|ranibizumab|mesh-list
14409544|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14409545|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14409546|NCT01552408|Growth Substances|growth substances|mesh-ancestor
14409547|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409548|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
14409549|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409550|NCT01552603|Pancrelipase|pancrelipase|mesh-list
14409551|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409552|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
14409553|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
14409554|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409555|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14409556|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14409557|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409558|NCT01552694|Incretins|incretins|mesh-ancestor
14409559|NCT01552694|Hormones|hormones|mesh-ancestor
14409560|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409561|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14409562|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14742558|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14742559|NCT00574093|Growth Substances|growth substances|mesh-ancestor
14742560|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742561|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
14742562|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742563|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14742564|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
14742565|NCT00574353|Misonidazole|misonidazole|mesh-list
14409563|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409564|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409565|NCT01552772|Aripiprazole|aripiprazole|mesh-list
14409566|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
14409567|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742566|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742567|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14742568|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14742569|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742570|NCT00574366|Everolimus|everolimus|mesh-list
14742571|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14742572|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742573|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742574|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
14409568|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15244229|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15244230|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244231|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244232|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15244233|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
15244234|NCT00398931|Alendronate|alendronate|mesh-list
15244235|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244236|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244237|NCT00398606|Alendronate|alendronate|mesh-list
15244238|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
14409569|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14742575|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244239|NCT00398606|Calcium|calcium|mesh-list
14409570|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409571|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409572|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
14409573|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
14409574|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409575|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409576|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14409577|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14409578|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
14409579|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14409580|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14409581|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14409582|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14409583|NCT01552902|Methylphenidate|methylphenidate|mesh-list
14409584|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14409585|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14409586|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409587|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14409588|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14409589|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409590|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409591|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
14409592|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409593|NCT01552915|Methylphenidate|methylphenidate|mesh-list
14409594|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14409595|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14409596|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409597|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14409598|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14409599|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409600|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409601|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
14409602|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409603|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
14409604|NCT01552928|Anagrelide|anagrelide|mesh-list
14409605|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14409606|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409607|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14409608|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14409609|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409610|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409611|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409612|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14409613|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14409614|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14931212|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15244240|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15244241|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244242|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244243|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14409615|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
14409616|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14742576|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14742577|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742578|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742579|NCT00574470|Infliximab|infliximab|mesh-list
15244244|NCT00398606|Antacids|antacids|mesh-ancestor
14742580|NCT00574470|Daclizumab|daclizumab|mesh-list
14742581|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
14742582|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15244245|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15244246|NCT00395408|Beclomethasone|beclomethasone|mesh-list
15244247|NCT00395408|Montelukast|montelukast|mesh-list
15244248|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244249|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409617|NCT01553058|Adalimumab|adalimumab|mesh-list
14742583|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742584|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742585|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
14742586|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742587|NCT00574483|Quinacrine|quinacrine|mesh-list
15244250|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244251|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244252|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244253|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244254|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244255|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244256|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14409618|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409619|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409620|NCT01553084|Nicotine|nicotine|mesh-list
14409621|NCT01553084|Varenicline|varenicline|mesh-list
14409622|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14409623|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
14409624|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409625|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409626|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14409627|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14409628|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
14409629|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409630|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409631|NCT01553136|Varenicline|varenicline|mesh-list
14409632|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14409633|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14409634|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
14409635|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409636|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409637|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409638|NCT01553188|Prednisone|prednisone|mesh-list
14409639|NCT01553188|Trebananib|trebananib|mesh-list
14409640|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409641|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
14409642|NCT01553188|Hormones|hormones|mesh-ancestor
14409643|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409644|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409645|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409646|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409647|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14409648|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14409649|NCT01553188|Growth Substances|growth substances|mesh-ancestor
14409650|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
14409651|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
14409652|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14409653|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409654|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409655|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
14409656|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409657|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409658|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14409659|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
14409660|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409661|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15244257|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15244258|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
15244259|NCT00395408|Hormones|hormones|mesh-ancestor
15244260|NCT00394069|Montelukast|montelukast|mesh-list
14742588|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
14742589|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14742590|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
14742591|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15244261|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244262|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244263|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244264|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244265|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244266|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244267|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244268|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14409662|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244269|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244270|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
15244271|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244272|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15244273|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244274|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244275|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14409663|NCT01553318|Ketotifen|ketotifen|mesh-list
14409664|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
14409665|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409666|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14409667|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
14409668|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
14409669|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409670|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409671|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409672|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14409673|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14409674|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15244276|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15244277|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244278|NCT00289874|Montelukast|montelukast|mesh-list
15244279|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244280|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244281|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244282|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244283|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244284|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244285|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244286|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244287|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742592|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742593|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
14742594|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14742595|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
14742596|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742597|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742598|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742599|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
14925252|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925253|NCT01403506|Protective Agents|protective agents|mesh-ancestor
14925254|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925255|NCT01403506|Antidotes|antidotes|mesh-ancestor
14409675|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
14742600|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409676|NCT01553591|Eluxadoline|eluxadoline|mesh-list
14409677|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409678|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
14409679|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14409680|NCT01553708|Mitogens|mitogens|mesh-list
14409681|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14409682|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409683|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14409684|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409685|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14409686|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14409687|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
14409688|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14409689|NCT01553747|Eluxadoline|eluxadoline|mesh-list
14409690|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409691|NCT01553851|Trametinib|trametinib|mesh-list
14409692|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409693|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14409694|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409695|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409696|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
14409697|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
14409698|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409699|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409700|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409701|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
14409702|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14409703|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409704|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409705|NCT01554241|Vitamin D|vitamin d|mesh-list
14409706|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
14409707|NCT01554241|Vitamins|vitamins|mesh-ancestor
14409708|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
14409709|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409710|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14409711|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14409712|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
14409713|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409714|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
14409715|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409716|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409717|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14409718|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
14409719|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409720|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409721|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14409722|NCT01554488|Fluticasone|fluticasone|mesh-list
14409723|NCT01554488|Xhance|xhance|mesh-list
15244288|NCT00250458|Rizatriptan|rizatriptan|mesh-list
15244289|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15244290|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
15244291|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244292|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244293|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244294|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15244295|NCT00245570|Montelukast|montelukast|mesh-list
15244296|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15244297|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
15244298|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244299|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244300|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244301|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244302|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15244303|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15244304|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15244305|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
15244306|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244307|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244308|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244309|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244310|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409724|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409725|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14409726|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
14409727|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409728|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409729|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14409730|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
14409731|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409732|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14409733|NCT01554514|Rituximab|rituximab|mesh-list
14409734|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925256|NCT01403545|Curcumin|curcumin|mesh-list
14925257|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14925258|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14925259|NCT01403545|Analgesics|analgesics|mesh-ancestor
14925260|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
14925261|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925262|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925263|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925264|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14925265|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925266|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925267|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925268|NCT01403649|Vaccines|vaccines|mesh-list
14925269|NCT01403649|Immunologic Factors|immunologic factors|mesh-ancestor
14925270|NCT01403649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925271|NCT01403662|Minocycline|minocycline|mesh-list
14925272|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14742601|NCT00574600|Vaccines|vaccines|mesh-list
14742602|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
14742603|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742604|NCT00574639|Alprazolam|alprazolam|mesh-list
14742605|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14742606|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742607|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742608|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14742609|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14742610|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14742611|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
14409735|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409736|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
14409737|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409738|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467596|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14467597|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14467598|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
14467599|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467600|NCT02261805|Doxorubicin|doxorubicin|mesh-list
14467601|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14467602|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467603|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14467604|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14467605|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467606|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467607|NCT02261948|Simendan|simendan|mesh-list
14467608|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14467609|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
14467610|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14467611|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14467612|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467613|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467614|NCT02261948|Protective Agents|protective agents|mesh-ancestor
14467615|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467616|NCT02261961|Vaccines|vaccines|mesh-list
14467617|NCT02261961|Immunologic Factors|immunologic factors|mesh-ancestor
14467618|NCT02261961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467619|NCT02262130|Omalizumab|omalizumab|mesh-list
14467620|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14467621|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14467622|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
14467623|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
14467624|NCT02262728|Simeprevir|simeprevir|mesh-list
14467625|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
14467626|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467627|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
14742612|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
14925273|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467628|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925274|NCT01403740|Cyclosporine|cyclosporine|mesh-list
14409739|NCT01554618|Exenatide|exenatide|mesh-list
14409740|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14409741|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409742|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14409743|NCT01554618|Incretins|incretins|mesh-ancestor
14409744|NCT01554618|Hormones|hormones|mesh-ancestor
14409745|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409746|NCT01554683|Levetiracetam|levetiracetam|mesh-list
14409747|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
14409748|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
14409749|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14409750|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
14409751|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409752|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14409753|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14409754|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
14409755|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409756|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409757|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14409758|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
14409759|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14409760|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14409761|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14409762|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14409763|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409764|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409765|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
14409766|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409767|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409768|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14409769|NCT01555164|Metformin|metformin|mesh-list
14409770|NCT01555164|Ranolazine|ranolazine|mesh-list
14409771|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14409772|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409773|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14409774|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409775|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409776|NCT01555463|Azelaic acid|azelaic acid|mesh-list
14409777|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409778|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409779|NCT01555541|Cytarabine|cytarabine|mesh-list
14409780|NCT01555541|Etoposide|etoposide|mesh-list
14409781|NCT01555541|Ofatumumab|ofatumumab|mesh-list
14409782|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14409783|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409784|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14409785|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14409786|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409787|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409788|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14742613|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742614|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742615|NCT00574652|Aldesleukin|aldesleukin|mesh-list
14742616|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742617|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14742618|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14742619|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
14742620|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742621|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14742622|NCT00574730|Rituximab|rituximab|mesh-list
14409789|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
14409790|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
14409791|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925275|NCT01403740|Rituximab|rituximab|mesh-list
14742623|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742624|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742625|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
14742626|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742627|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742628|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
14742629|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742630|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
14742631|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14742632|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742633|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14742634|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
15244311|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244312|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14409792|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409793|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
14409794|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409795|NCT01555671|Meperidine|meperidine|mesh-list
14409796|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14409797|NCT01555671|Narcotics|narcotics|mesh-ancestor
14409798|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409799|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409800|NCT01555671|Analgesics|analgesics|mesh-ancestor
14409801|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
14409802|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409803|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14409804|NCT01555697|Memantine|memantine|mesh-list
14409805|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14409806|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14409807|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
14409808|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409809|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409810|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409811|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14409812|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14409813|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
14409814|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14409815|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
14409816|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409817|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409818|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14409819|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15244313|NCT00229970|Montelukast|montelukast|mesh-list
15244314|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244315|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244316|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244317|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244318|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244319|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244320|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244321|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244322|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244323|NCT00140946|Montelukast|montelukast|mesh-list
15244324|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244325|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409820|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14409821|NCT01556165|Rasagiline|rasagiline|mesh-list
14409822|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14409823|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409824|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409825|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14409826|NCT01556165|Protective Agents|protective agents|mesh-ancestor
14409827|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409828|NCT01556347|Rituximab|rituximab|mesh-list
14409829|NCT01556347|Bortezomib|bortezomib|mesh-list
14409830|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
14409831|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14409832|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14409833|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14409834|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409835|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
14409836|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409837|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409838|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409839|NCT01556425|Naltrexone|naltrexone|mesh-list
14409840|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14409841|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14409842|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409843|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
14925276|NCT01403740|Azathioprine|azathioprine|mesh-list
14925277|NCT01403740|Cyclosporins|cyclosporins|mesh-list
14925278|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925279|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925280|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
14925281|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925282|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14925283|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925284|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925285|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925286|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
14925287|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925288|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
14925289|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14409844|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409845|NCT01556438|Dexamethasone|dexamethasone|mesh-list
14409846|NCT01556438|Bortezomib|bortezomib|mesh-list
14409847|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409848|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
14409849|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
14409850|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409851|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409852|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409853|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
14409854|NCT01556438|Hormones|hormones|mesh-ancestor
14409855|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409856|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14409857|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409858|NCT01556594|Glucagon|glucagon|mesh-list
14742635|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15244326|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742636|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742637|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742638|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742639|NCT00574756|Ranolazine|ranolazine|mesh-list
14742640|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14742641|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14925290|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
15244327|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244328|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244329|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244330|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244331|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244332|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244333|NCT00140881|Montelukast|montelukast|mesh-list
15244334|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244335|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244336|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244337|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244338|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244339|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244340|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244341|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244342|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244343|NCT00111722|Rizatriptan|rizatriptan|mesh-list
15244344|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244345|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409859|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14409860|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409861|NCT01556594|Hormones|hormones|mesh-ancestor
14409862|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409863|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409864|NCT01556594|Incretins|incretins|mesh-ancestor
14409865|NCT01556633|Oseltamivir|oseltamivir|mesh-list
14409866|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
14409867|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14409868|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409869|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409870|NCT01556724|Ropivacaine|ropivacaine|mesh-list
14409871|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
14409872|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
14409873|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409874|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409875|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
14409876|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409877|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
14409878|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14409879|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409880|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409881|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409882|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
14409883|NCT01556932|Promethazine|promethazine|mesh-list
14409884|NCT01556932|Lorazepam|lorazepam|mesh-list
14409885|NCT01556932|Haloperidol|haloperidol|mesh-list
14409886|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14409887|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14409888|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14409889|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409890|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
14409891|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
14409892|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
14409893|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409894|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
14409895|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
14409896|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409897|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14409898|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
14409899|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
14409900|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409901|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409902|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14409903|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
14409904|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409905|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14409906|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14409907|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14409908|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14409909|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
14409910|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14409911|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
14409912|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14409913|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
14409914|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
14409915|NCT01556997|Amlodipine|amlodipine|mesh-list
14409916|NCT01556997|Perindopril|perindopril|mesh-list
14409917|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14409918|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14409919|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14409920|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409921|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14409922|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409923|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
14409924|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14409925|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
14409926|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409927|NCT01557166|Liraglutide|liraglutide|mesh-list
14409928|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14409929|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409930|NCT01557166|Incretins|incretins|mesh-ancestor
14409931|NCT01557166|Hormones|hormones|mesh-ancestor
14409932|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409933|NCT01557244|Fesoterodine|fesoterodine|mesh-list
14409934|NCT01557244|Oxybutynin|oxybutynin|mesh-list
14409935|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14409936|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14409937|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
14409938|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14409939|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409940|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409941|NCT01557244|Urological Agents|urological agents|mesh-ancestor
14409942|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
14409943|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
14409944|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409945|NCT01557283|Etanercept|etanercept|mesh-list
14409946|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14409947|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14409948|NCT01557283|Analgesics|analgesics|mesh-ancestor
14409949|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
14409950|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409951|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409952|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409953|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409954|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409955|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409956|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
14409957|NCT01557322|Etanercept|etanercept|mesh-list
14409958|NCT01557322|Methotrexate|methotrexate|mesh-list
14409959|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14409960|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
14409961|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14409962|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409963|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14409964|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
14409965|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409966|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14409967|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
14409968|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409969|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14409970|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14409971|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
14409972|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14409973|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14409974|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14409975|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14409976|NCT01557322|Analgesics|analgesics|mesh-ancestor
14409977|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
14409978|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14409979|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742642|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742643|NCT00574769|Bevacizumab|bevacizumab|mesh-list
14742644|NCT00574769|Docetaxel|docetaxel|mesh-list
14742645|NCT00574769|Everolimus|everolimus|mesh-list
14742646|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742647|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742648|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14742649|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14742650|NCT00574769|Growth Substances|growth substances|mesh-ancestor
14742651|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742652|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
14742653|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
14409980|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14409981|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14409982|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14409983|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409984|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409985|NCT01557504|Metformin|metformin|mesh-list
14409986|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14409987|NCT01557504|Hormones|hormones|mesh-list
14409988|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14409989|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14409990|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14409991|NCT01557504|Incretins|incretins|mesh-ancestor
14409992|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14409993|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
14409994|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14409995|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14409996|NCT01557517|Clobetasol|clobetasol|mesh-list
14742654|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
14742655|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
14409997|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14409998|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
14409999|NCT01557517|Hormones|hormones|mesh-ancestor
14410000|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410001|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410002|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14410003|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14410004|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14410005|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14410006|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410007|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
14410008|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410009|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410010|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
14410011|NCT01557868|Hylan|hylan|mesh-list
14410012|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14410013|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
14410014|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410015|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
14410016|NCT01557868|Protective Agents|protective agents|mesh-ancestor
14410017|NCT01557920|Propofol|propofol|mesh-list
14410018|NCT01557920|Sevoflurane|sevoflurane|mesh-list
14410019|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14410020|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410021|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410022|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14410023|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
14410024|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
14410025|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14410026|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14410027|NCT01557946|Citalopram|citalopram|mesh-list
14410028|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14410029|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14742656|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742657|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742658|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
14742659|NCT00574925|Esomeprazole|esomeprazole|mesh-list
14925291|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14925292|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
14410030|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14742660|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14742661|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742662|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14742663|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742664|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742665|NCT00574964|Temozolomide|temozolomide|mesh-list
14742666|NCT00574964|Carmustine|carmustine|mesh-list
14742667|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14742668|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
14742669|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742670|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244346|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244347|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15244348|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
15244349|NCT00111709|Rizatriptan|rizatriptan|mesh-list
15244350|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244351|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244352|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742671|NCT00575068|Galiximab|galiximab|mesh-list
14742672|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742673|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742674|NCT00575224|Interferons|interferons|mesh-list
14742675|NCT00575224|Ribavirin|ribavirin|mesh-list
14742676|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742677|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
14742678|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742679|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
14742680|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742681|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14742682|NCT00575302|Hormones|hormones|mesh-ancestor
14742683|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742684|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742685|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14742686|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14742687|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
14742688|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742689|NCT00575354|Sevoflurane|sevoflurane|mesh-list
14742690|NCT00575354|Isoflurane|isoflurane|mesh-list
14410031|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410032|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410033|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
14410034|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410035|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14410036|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
14410037|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410038|NCT01557959|Docetaxel|docetaxel|mesh-list
14410039|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14410040|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410041|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
14410042|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
14410043|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
14410044|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742691|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15244353|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15244354|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
15244355|NCT00095004|Rizatriptan|rizatriptan|mesh-list
15244356|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244357|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244358|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244359|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15244360|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
15244361|NCT00092963|Rizatriptan|rizatriptan|mesh-list
15244362|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742692|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14742693|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
14742694|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
14742695|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742696|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742697|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
14742698|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742699|NCT00575406|Prednisolone|prednisolone|mesh-list
14742700|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
14742701|NCT00575406|Rituximab|rituximab|mesh-list
14742702|NCT00575406|Doxorubicin|doxorubicin|mesh-list
15244363|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244364|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410045|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14410046|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410047|NCT01558063|Ketamine|ketamine|mesh-list
14410048|NCT01558063|Analgesics|analgesics|mesh-ancestor
14410049|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
14410050|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410051|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410052|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14410053|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14410054|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
14410055|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
14410056|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742703|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14742704|NCT00575406|Vincristine|vincristine|mesh-list
14742705|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742706|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
14742707|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742708|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742709|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14742710|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
14742711|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742712|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742713|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14742714|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742715|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14742716|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14742717|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14742718|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410057|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14410058|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14742719|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15244365|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15244366|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
15244367|NCT00092885|Montelukast|montelukast|mesh-list
15244368|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244369|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244370|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244371|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244372|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244373|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244374|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244375|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244376|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244377|NCT00092131|Montelukast|montelukast|mesh-list
14742720|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
14742721|NCT00575406|Hormones|hormones|mesh-ancestor
14742722|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742723|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14742724|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14742725|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
14742726|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
14742727|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
14742728|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
14742729|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14742730|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
14742731|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742732|NCT00575419|Expectorants|expectorants|mesh-ancestor
14742733|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742734|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14742735|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
14742736|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742737|NCT00575419|Protective Agents|protective agents|mesh-ancestor
14742738|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742739|NCT00575419|Antidotes|antidotes|mesh-ancestor
15244378|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244379|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244380|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244381|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244382|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244383|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244384|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244385|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244386|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244387|NCT00092118|Montelukast|montelukast|mesh-list
15244388|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244389|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244390|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244391|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244392|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244393|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244394|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244395|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244396|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244397|NCT00092105|Montelukast|montelukast|mesh-list
15244398|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244399|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742740|NCT00575523|Atropine|atropine|mesh-list
14742741|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14742742|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14742743|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14410059|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410060|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410061|NCT01558089|Etanercept|etanercept|mesh-list
14410062|NCT01558089|Methotrexate|methotrexate|mesh-list
14410063|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14410064|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
14410065|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14410066|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410067|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14410068|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
14410069|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410070|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410071|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
14410072|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410073|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14410074|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410075|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
14410076|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14410077|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14410078|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14410079|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14410080|NCT01558089|Analgesics|analgesics|mesh-ancestor
14410081|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
14742744|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
14742745|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742746|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925293|NCT01403818|Mitiglinide|mitiglinide|mesh-list
14410082|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410083|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410084|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14410085|NCT01558128|Amiodarone|amiodarone|mesh-list
14410086|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14410087|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
14410088|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14410089|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14410090|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410091|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14742747|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244400|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244401|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
14410092|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14410093|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14410094|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410095|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14410096|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14410097|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14410098|NCT01558271|Liraglutide|liraglutide|mesh-list
14410099|NCT01558271|Dulaglutide|dulaglutide|mesh-list
14410100|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14410101|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410102|NCT01558271|Incretins|incretins|mesh-ancestor
14410103|NCT01558271|Hormones|hormones|mesh-ancestor
14410104|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410105|NCT01558661|Axitinib|axitinib|mesh-list
14410106|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410107|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14410108|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410109|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410110|NCT01558674|Torsemide|torsemide|mesh-list
14410111|NCT01558674|Furosemide|furosemide|mesh-list
14410112|NCT01558674|Diuretics|diuretics|mesh-ancestor
14410113|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
14410114|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410115|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14410116|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14410117|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410118|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14410119|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14410120|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14410121|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14410122|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14410123|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410124|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410125|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244402|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244403|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244404|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244405|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244406|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244407|NCT00092092|Budesonide|budesonide|mesh-list
15244408|NCT00092092|Montelukast|montelukast|mesh-list
14410126|NCT01558700|Analgesics|analgesics|mesh-ancestor
14410127|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
14410128|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410129|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
14410130|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410131|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
14410132|NCT01559012|Clonidine|clonidine|mesh-list
14410133|NCT01559012|Analgesics|analgesics|mesh-ancestor
14410134|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
14410135|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410136|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410137|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14410138|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
14410139|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
14410140|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14410141|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14410142|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14410143|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
14410144|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410145|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410146|NCT01559064|Lidocaine|lidocaine|mesh-list
14410147|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
14410148|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
14410149|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
14410150|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410151|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410152|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
14410153|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410154|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14410155|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14410156|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14410157|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14410158|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410159|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14410160|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
14410161|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
14410162|NCT01559064|Protective Agents|protective agents|mesh-ancestor
14410163|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14410164|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
14410165|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410166|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
14410167|NCT01559116|Olodaterol|olodaterol|mesh-list
15244409|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15244410|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15244411|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
15244412|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244413|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244414|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244415|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244416|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
15244417|NCT00092092|Hormones|hormones|mesh-ancestor
15244418|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244419|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244420|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244421|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244422|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15244423|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244424|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
14410168|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14410169|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
14410170|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244425|NCT00092066|Alendronate|alendronate|mesh-list
15244426|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15244427|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244428|NCT00092066|Vitamins|vitamins|mesh-ancestor
15244429|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
14410171|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410172|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14410173|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
14410174|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
14410175|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14410176|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
14410177|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410178|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410179|NCT01559129|Pomalidomide|pomalidomide|mesh-list
14410180|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
14410181|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410182|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14410183|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14410184|NCT01559129|Growth Substances|growth substances|mesh-ancestor
14410185|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
14410186|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410187|NCT01559259|Acetaminophen|acetaminophen|mesh-list
15244430|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244431|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
15244432|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244433|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244434|NCT00092040|Alendronate|alendronate|mesh-list
15244435|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
14410188|NCT01559259|Ibuprofen|ibuprofen|mesh-list
14410189|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15244436|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244437|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244438|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244439|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15244440|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15244441|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15244442|NCT00092027|Alendronate|alendronate|mesh-list
15244443|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244444|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244445|NCT00092014|Vitamin D|vitamin d|mesh-list
15244446|NCT00092014|Alendronate|alendronate|mesh-list
15244447|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
15244448|NCT00092014|Calcium|calcium|mesh-list
15244449|NCT00092014|Vitamins|vitamins|mesh-ancestor
15244450|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
15244451|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410190|NCT01559259|Analgesics|analgesics|mesh-ancestor
14410191|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
14410192|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410193|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410194|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
14410195|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14410196|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410197|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14410198|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14410199|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410200|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410201|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
14410202|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14410203|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14410204|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
14410205|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410206|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410207|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410208|NCT01559389|Urological Agents|urological agents|mesh-ancestor
14410209|NCT01559454|Buprenorphine|buprenorphine|mesh-list
14410210|NCT01559454|Methadone|methadone|mesh-list
14410211|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14410212|NCT01559454|Naloxone|naloxone|mesh-list
14410213|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14410214|NCT01559454|Narcotics|narcotics|mesh-ancestor
14410215|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410216|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410217|NCT01559454|Analgesics|analgesics|mesh-ancestor
14410218|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
14410219|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410220|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14410221|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
14410222|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
14410223|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
14410224|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14410225|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14410226|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14410227|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14410228|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14410229|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
14410230|NCT01559675|Prednisolone|prednisolone|mesh-list
14410231|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
14410232|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14410233|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
14410234|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410235|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
14410236|NCT01559675|Hormones|hormones|mesh-ancestor
14410237|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410238|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410239|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14410240|NCT01559675|Protective Agents|protective agents|mesh-ancestor
14410241|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14410242|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410243|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
14410244|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
14410245|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410246|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14410247|NCT01559844|Ribavirin|ribavirin|mesh-list
14410248|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
14410249|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
14410250|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410251|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
14410252|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410253|NCT01559857|Pioglitazone|pioglitazone|mesh-list
14410254|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14410255|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410256|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14410257|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
14410258|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14410259|NCT01559922|Protective Agents|protective agents|mesh-ancestor
14410260|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410261|NCT01559935|Clarithromycin|clarithromycin|mesh-list
14410262|NCT01559935|Dexamethasone|dexamethasone|mesh-list
14410263|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
14410264|NCT01559935|Lenalidomide|lenalidomide|mesh-list
14410265|NCT01559935|BB 1101|bb 1101|mesh-list
14410266|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410267|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
14410268|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
14410269|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410270|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410271|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14410272|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
14410273|NCT01559935|Hormones|hormones|mesh-ancestor
14410274|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410275|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14410276|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410277|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
14410278|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410279|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410280|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
14410281|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14410282|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14410283|NCT01559935|Growth Substances|growth substances|mesh-ancestor
14410284|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
14410285|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14410286|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410287|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14410288|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14410289|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14410290|NCT01560143|Tigecycline|tigecycline|mesh-list
14410291|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14410292|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410293|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14410294|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410295|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925294|NCT01403818|Calcium|calcium|mesh-list
15244452|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15244453|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244454|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15244455|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15244456|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244457|NCT00090142|Montelukast|montelukast|mesh-list
15244458|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244459|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244460|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244461|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244462|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244463|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410296|NCT01560403|Teduglutide|teduglutide|mesh-list
14410297|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931213|NCT01437982|Protective Agents|protective agents|mesh-ancestor
14410298|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15244464|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244465|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14742748|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742749|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
14742750|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
14742751|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14742752|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14742753|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
14410299|NCT01560403|Protective Agents|protective agents|mesh-ancestor
14410300|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410301|NCT01560416|Fulvestrant|fulvestrant|mesh-list
14410302|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14410303|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410304|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14410305|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14410306|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
14410307|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410308|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410309|NCT01560624|Treprostinil|treprostinil|mesh-list
14410310|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14410311|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14410312|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14410313|NCT01560923|Tryptophan|tryptophan|mesh-list
14410314|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14410315|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
14410316|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410317|NCT01560949|Gemcitabine|gemcitabine|mesh-list
14410318|NCT01560949|Fluorouracil|fluorouracil|mesh-list
14410319|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
14410320|NCT01560949|Irinotecan|irinotecan|mesh-list
14410321|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14410322|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
14410323|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410324|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410325|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
14410326|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410327|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410328|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742754|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742755|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742756|NCT00575549|Dobutamine|dobutamine|mesh-list
14742757|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14742758|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
14742759|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
14742760|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742761|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742762|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14742763|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14742764|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15244466|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244467|NCT00076973|Montelukast|montelukast|mesh-list
15244468|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244469|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
14410329|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
14410330|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410331|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14410332|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14467629|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467630|NCT02262754|Naproxen|naproxen|mesh-list
14467631|NCT02262754|PF-06372865|pf-06372865|mesh-list
14467632|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467633|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467634|NCT02262754|Analgesics|analgesics|mesh-ancestor
14467635|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
14467636|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244470|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15244471|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
15244472|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244473|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244474|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244475|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14410333|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
14410334|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14410335|NCT01561053|Antibodies|antibodies|mesh-list
14410336|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
14410337|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410338|NCT01561079|Buprenorphine|buprenorphine|mesh-list
14410339|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14410340|NCT01561079|Narcotics|narcotics|mesh-ancestor
14410341|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410342|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410343|NCT01561079|Analgesics|analgesics|mesh-ancestor
15244476|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244477|NCT00043108|Paclitaxel|paclitaxel|mesh-list
15244478|NCT00043108|Carboplatin|carboplatin|mesh-list
15244479|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15244480|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244481|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
15244482|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
15244483|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
15244484|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742765|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
14742766|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742767|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742768|NCT00575549|Protective Agents|protective agents|mesh-ancestor
14742769|NCT00575601|Simvastatin|simvastatin|mesh-list
14742770|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14410344|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
14410345|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410346|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14410347|NCT01561313|Adalimumab|adalimumab|mesh-list
14410348|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410349|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14410350|NCT01561469|Vancomycin|vancomycin|mesh-list
14410351|NCT01561469|Linezolid|linezolid|mesh-list
14410352|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14742771|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14410353|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410354|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14742772|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
14410355|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410356|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410357|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14742773|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742774|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14742775|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14742776|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742777|NCT00575614|Prucalopride|prucalopride|mesh-list
14742778|NCT00575614|Laxatives|laxatives|mesh-ancestor
14742779|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742780|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14742781|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14742782|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
14742783|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410358|NCT01561703|Amoxicillin|amoxicillin|mesh-list
14410359|NCT01561703|Azithromycin|azithromycin|mesh-list
14410360|NCT01561703|Clindamycin|clindamycin|mesh-list
14410361|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
14410362|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14410363|NCT01561703|Cephalexin|cephalexin|mesh-list
14410364|NCT01561703|Cefdinir|cefdinir|mesh-list
14410365|NCT01561703|Cefaclor|cefaclor|mesh-list
14410366|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410367|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14410368|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410369|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410370|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14410371|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
14410372|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14410373|NCT01561755|Antibodies|antibodies|mesh-list
14410374|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
14410375|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14410376|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
14410377|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742784|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410378|NCT01561833|Sorafenib|sorafenib|mesh-list
14410379|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410380|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14410381|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410382|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410383|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14742785|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742786|NCT00575627|Interferons|interferons|mesh-list
14742787|NCT00575627|Ribavirin|ribavirin|mesh-list
14742788|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
14742789|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
14410384|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14410385|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14410386|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244485|NCT05225597|Carbachol|carbachol|mesh-list
15244486|NCT05225597|Epinephrine|epinephrine|mesh-list
15244487|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15244488|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15244489|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
14410387|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742790|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15244490|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244491|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244492|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244493|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15244494|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14410388|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410389|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14410390|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14410391|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
14410392|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410393|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244495|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
14410394|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14410395|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14410396|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
14410397|NCT01561963|Rifampin|rifampin|mesh-list
14410398|NCT01561963|Apremilast|apremilast|mesh-list
14410399|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14410400|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
14410401|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14410402|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410403|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
14410404|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14410405|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410406|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410407|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14410408|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14410409|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14410410|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14410411|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14410412|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14410413|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14410414|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14410415|NCT01561963|Analgesics|analgesics|mesh-ancestor
14410416|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
14410417|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410418|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410419|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410420|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15244496|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244497|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244498|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244499|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
15244500|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
15244501|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15244502|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15244503|NCT05225597|Miotics|miotics|mesh-ancestor
15244504|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15244505|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
15244506|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15244507|NCT05225597|Analgesics|analgesics|mesh-ancestor
15244508|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
15244509|NCT05225597|Protective Agents|protective agents|mesh-ancestor
15244510|NCT05225558|Vancomycin|vancomycin|mesh-list
15244511|NCT05225558|Delpazolid|delpazolid|mesh-list
15244512|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
15244513|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15244514|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244515|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15244516|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410421|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14742791|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742792|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
14742793|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14742794|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
14931214|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14410422|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14410423|NCT01561976|Metformin|metformin|mesh-list
14410424|NCT01561976|Glimepiride|glimepiride|mesh-list
14410425|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14410426|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410427|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14410428|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410429|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
14410430|NCT01562028|Bevacizumab|bevacizumab|mesh-list
14410431|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14410432|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14410433|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410434|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14410435|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14410436|NCT01562028|Growth Substances|growth substances|mesh-ancestor
14410437|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410438|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14410439|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14410440|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410441|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410442|NCT01562041|Ranolazine|ranolazine|mesh-list
14410443|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14410444|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14410445|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410446|NCT01562132|Fluconazole|fluconazole|mesh-list
14410447|NCT01562132|Flucytosine|flucytosine|mesh-list
14410448|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
14410449|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410450|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14410451|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14410452|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410453|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410454|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14410455|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
14410456|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410457|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410458|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14410459|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14410460|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
14410461|NCT01562314|Cannabidiol|cannabidiol|mesh-list
14410462|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
14410463|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
14410464|NCT01562548|Guaifenesin|guaifenesin|mesh-list
14410465|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14410466|NCT01562548|Expectorants|expectorants|mesh-ancestor
14410467|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
14410468|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14410469|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14410470|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
14410471|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410472|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410473|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410474|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
14410475|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14410476|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
14742795|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742796|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
14742797|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742798|NCT00575640|Hydralazine|hydralazine|mesh-list
14742799|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15244517|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244518|NCT05225155|Enoxaparin|enoxaparin|mesh-list
15244519|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
15244520|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14742800|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
14742801|NCT00575718|Nicotine|nicotine|mesh-list
14742802|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14742803|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
14742804|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742805|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742806|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14742807|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14742808|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
14742809|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244521|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15244522|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244523|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
15244524|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15244525|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244526|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15244527|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244528|NCT05225064|Vaccines|vaccines|mesh-list
15244529|NCT05225064|Immunologic Factors|immunologic factors|mesh-ancestor
15244530|NCT05225064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244531|NCT05224999|Nivolumab|nivolumab|mesh-list
15244532|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15244533|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410477|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
14410478|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410479|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
14410480|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14410481|NCT01562678|Liraglutide|liraglutide|mesh-list
14410482|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14410483|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410484|NCT01562678|Incretins|incretins|mesh-ancestor
14410485|NCT01562678|Hormones|hormones|mesh-ancestor
14410486|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410487|NCT01562743|Rotigotine|rotigotine|mesh-list
14410488|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
15244534|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15244535|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410489|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
14410490|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410491|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410492|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410493|NCT01562886|Rilpivirine|rilpivirine|mesh-list
14410494|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14925295|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14742810|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410495|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14925296|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925297|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14410496|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410497|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410498|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
14410499|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410500|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14410501|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14925298|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244536|NCT05224687|Daptomycin|daptomycin|mesh-list
15244537|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15244538|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925299|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14925300|NCT01403844|Carotenoids|carotenoids|mesh-list
14925301|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
14925302|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925303|NCT01403844|Protective Agents|protective agents|mesh-ancestor
14925304|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410502|NCT01563029|Fluticasone|fluticasone|mesh-list
14410503|NCT01563029|Xhance|xhance|mesh-list
14410504|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410505|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14410506|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
14410507|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410508|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410509|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14410510|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
14410511|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
14410512|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14410513|NCT01563055|Ofatumumab|ofatumumab|mesh-list
14410514|NCT01563055|Chlorambucil|chlorambucil|mesh-list
14410515|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410516|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14410517|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
14410518|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410519|NCT01563081|Cetirizine|cetirizine|mesh-list
14410520|NCT01563081|Levocetirizine|levocetirizine|mesh-list
14410521|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14410522|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14410523|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
14410524|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
14410525|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410526|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410527|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410528|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14410529|NCT01563172|Listerine|listerine|mesh-list
15244539|NCT05224388|Heparin|heparin|mesh-list
15244540|NCT05224388|Enoxaparin|enoxaparin|mesh-list
15244541|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
15244542|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15244543|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15244544|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244545|NCT05224336|Niacin|niacin|mesh-list
14410530|NCT01563172|Fluorides|fluorides|mesh-list
14410531|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
14410532|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
14410533|NCT01563172|Protective Agents|protective agents|mesh-ancestor
14410534|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410535|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14410536|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410537|NCT01563185|Ibuprofen|ibuprofen|mesh-list
14410538|NCT01563185|Famotidine|famotidine|mesh-list
15244546|NCT05224336|Psilocybin|psilocybin|mesh-list
15244547|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15244548|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
15244549|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244550|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15244551|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
15244552|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
15244553|NCT05224336|Vitamins|vitamins|mesh-ancestor
15244554|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
15244555|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244556|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
15244557|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15244558|NCT05224167|Melatonin|melatonin|mesh-list
15244559|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
15244560|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
14410539|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14410540|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14410541|NCT01563185|Analgesics|analgesics|mesh-ancestor
15244561|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244562|NCT05224167|Protective Agents|protective agents|mesh-ancestor
14410542|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
14410543|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410544|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410545|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410546|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14410547|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14410548|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410549|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410550|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14410551|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14410552|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14410553|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
14410554|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
14410555|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410556|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14410557|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410558|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410559|NCT01563354|Everolimus|everolimus|mesh-list
14410560|NCT01563354|Pasireotide|pasireotide|mesh-list
14410561|NCT01563354|Somatostatin|somatostatin|mesh-list
14410562|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410563|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410564|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
14410565|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410566|NCT01563354|Hormones|hormones|mesh-ancestor
14410567|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410568|NCT01563406|Ethanol|ethanol|mesh-list
14925305|NCT01403896|Plerixafor|plerixafor|mesh-list
14925306|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14925307|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14410569|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
14410570|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14410571|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410572|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410573|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410574|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
14410575|NCT01563536|Ritonavir|ritonavir|mesh-list
14410576|NCT01563536|Ribavirin|ribavirin|mesh-list
14410577|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14410578|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14410579|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
14410580|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410581|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410582|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14410583|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14410584|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
14410585|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410586|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14410587|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14410588|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
15244563|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244564|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244565|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
15244566|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
15244567|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15244568|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
15244569|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
14410589|NCT01564277|Allopurinol|allopurinol|mesh-list
14410590|NCT01564277|Rasburicase|rasburicase|mesh-list
14410591|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
14410592|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410593|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410594|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
14410595|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14410596|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14410597|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
14410598|NCT01564277|Protective Agents|protective agents|mesh-ancestor
14410599|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410600|NCT01564758|Linezolid|linezolid|mesh-list
14410601|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14410602|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410603|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14410604|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925308|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
15244570|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925309|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244571|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
15244572|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244573|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15244574|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244575|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244576|NCT05224089|Dexamethasone|dexamethasone|mesh-list
15244577|NCT05224089|Epinephrine|epinephrine|mesh-list
14410605|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410606|NCT01564784|Cytarabine|cytarabine|mesh-list
14410607|NCT01564784|Fludarabine|fludarabine|mesh-list
14410608|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
14410609|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14410610|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410611|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14410612|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
14410613|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410614|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410615|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
14410616|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410617|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
14410618|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244578|NCT05224089|Bupivacaine|bupivacaine|mesh-list
14925310|NCT01403948|BI 836826|bi 836826|mesh-list
14925311|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925312|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925313|NCT01404000|Charcoal|charcoal|mesh-list
14925314|NCT01404000|Antidotes|antidotes|mesh-ancestor
14925315|NCT01404000|Protective Agents|protective agents|mesh-ancestor
14925316|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925317|NCT01404013|Montelukast|montelukast|mesh-list
14410619|NCT01564784|Analgesics|analgesics|mesh-ancestor
14410620|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
14410621|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410622|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14410623|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14410624|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410625|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14410626|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14410627|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14410628|NCT01564862|Vortioxetine|vortioxetine|mesh-list
14410629|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14410630|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14410631|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14410632|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410633|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410634|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410635|NCT01564862|Analgesics|analgesics|mesh-ancestor
14410636|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
14410637|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410638|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
14410639|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410640|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
14410641|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14925318|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15244579|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15244580|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
15244581|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
14410642|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14410643|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410644|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14410645|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
14410646|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14410647|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14410648|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14410649|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14410650|NCT01564914|Bevacizumab|bevacizumab|mesh-list
14410651|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14410652|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244582|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244583|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244584|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15244585|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
15244586|NCT05224089|Hormones|hormones|mesh-ancestor
15244587|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244588|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244589|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244590|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244591|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
15244592|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
15244593|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244594|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
15244595|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15244596|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15244597|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
15244598|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410653|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14410654|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14410655|NCT01564914|Growth Substances|growth substances|mesh-ancestor
14410656|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410657|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
14410658|NCT01565083|Trastuzumab|trastuzumab|mesh-list
14410659|NCT01565083|Pertuzumab|pertuzumab|mesh-list
14410660|NCT01565083|Vinorelbine|vinorelbine|mesh-list
14410661|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15244599|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15244600|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15244601|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244602|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244603|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
15244604|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
14742811|NCT00575796|Vinblastine|vinblastine|mesh-list
14742812|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14742813|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742814|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14410662|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410663|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14410664|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14410665|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14410666|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14467637|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467638|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467639|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467640|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
14467641|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14467642|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467643|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467644|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
14467645|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
14742815|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
14742816|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14742817|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742818|NCT00575835|Vitamin D|vitamin d|mesh-list
14742819|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
14742820|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
14742821|NCT00575835|Vitamins|vitamins|mesh-list
14742822|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
14410667|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410668|NCT01565148|Ranibizumab|ranibizumab|mesh-list
14410669|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14410670|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14410671|NCT01565148|Growth Substances|growth substances|mesh-ancestor
14410672|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410673|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
14410674|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410675|NCT01565499|Paclitaxel|paclitaxel|mesh-list
14410676|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14410677|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410678|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14742823|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742824|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14742825|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14742826|NCT00575848|Glycine|glycine|mesh-list
14742827|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
14742828|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742829|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742830|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742831|NCT00575861|Zileuton|zileuton|mesh-list
14742832|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14742833|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14742834|NCT00575861|Analgesics|analgesics|mesh-ancestor
14742835|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
14742836|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742837|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742838|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742839|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742840|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14410679|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14410680|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14410681|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410682|NCT01565538|Pemetrexed|pemetrexed|mesh-list
14410683|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14410684|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410685|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410686|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410687|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14410688|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14410689|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14410690|NCT01565616|Fludarabine|fludarabine|mesh-list
14410691|NCT01565616|Busulfan|busulfan|mesh-list
14410692|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
14410693|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14410694|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410695|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410696|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410697|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
14410698|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410699|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
14410700|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14742841|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931215|NCT01438021|Methotrexate|methotrexate|mesh-list
15244605|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15244606|NCT05224050|Nicotine|nicotine|mesh-list
15244607|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15244608|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
15244609|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244610|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244611|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15244612|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15244613|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
15244614|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244615|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410701|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14410702|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
14410703|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14410704|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14410705|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14410706|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410707|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410708|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410709|NCT01565694|Urological Agents|urological agents|mesh-ancestor
14410710|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
14410711|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14410712|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14410713|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
14410714|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244616|NCT05223907|Propofol|propofol|mesh-list
14742842|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742843|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14410715|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410716|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410717|NCT01565707|Urological Agents|urological agents|mesh-ancestor
14410718|NCT01565850|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14410719|NCT01565850|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14410720|NCT01565850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14410721|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742844|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
14742845|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244617|NCT05223907|Etomidate|etomidate|mesh-list
15244618|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15244619|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244620|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244621|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14410722|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410723|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
14410724|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410725|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14410726|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14410727|NCT01565889|Ritonavir|ritonavir|mesh-list
15244622|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
15244623|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
15244624|NCT05223829|Brexanolone|brexanolone|mesh-list
15244625|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
15244626|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244627|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244628|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410728|NCT01565889|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14410729|NCT01565889|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14410730|NCT01565889|Ribavirin|ribavirin|mesh-list
14410731|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14410732|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14410733|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
14410734|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410735|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410736|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14410737|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14410738|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
14410739|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14410740|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14410741|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14410742|NCT01565889|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14410743|NCT01565889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14410744|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
14410745|NCT01565902|Siponimod|siponimod|mesh-list
14410746|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14410747|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410748|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410749|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
14410750|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410751|NCT01565941|Insulin|insulin|mesh-list
14410752|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14410753|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14410754|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410755|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14410756|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14410757|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14410758|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410759|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410760|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410761|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14410762|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14410763|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14410764|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
14410765|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410766|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410767|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15244629|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
15244630|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
15244631|NCT05223647|Carboplatin|carboplatin|mesh-list
15244632|NCT05223647|Etoposide|etoposide|mesh-list
15244633|NCT05223647|Durvalumab|durvalumab|mesh-list
14410768|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14410769|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
14410770|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14410771|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15244634|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244635|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15244636|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15244637|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15244638|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244639|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244640|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15244641|NCT05223400|Clindamycin|clindamycin|mesh-list
15244642|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
15244643|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
15244644|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15244645|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244646|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15244647|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244648|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244649|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15244650|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15244651|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
15244652|NCT05202002|Hormones|hormones|mesh-ancestor
15244653|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244654|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244655|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244656|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244657|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
15244658|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742846|NCT00575874|Pioglitazone|pioglitazone|mesh-list
14742847|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742848|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753363|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753364|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753365|NCT05208047|Sunitinib|sunitinib|mesh-list
14753366|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753367|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14753368|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14753369|NCT05208047|Growth Substances|growth substances|mesh-ancestor
14753370|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753371|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753372|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14753373|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753374|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410772|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
14410773|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14410774|NCT01566409|Laxatives|laxatives|mesh-ancestor
14410775|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14410776|NCT01566435|Paclitaxel|paclitaxel|mesh-list
14410777|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14410778|NCT01566435|Fluorouracil|fluorouracil|mesh-list
14410779|NCT01566435|Cetuximab|cetuximab|mesh-list
14410780|NCT01566435|Antibodies|antibodies|mesh-list
14410781|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14410782|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14410783|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410784|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
14410785|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
14410786|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
14410787|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410788|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
14410789|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410790|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
14410791|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14410792|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410793|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14410794|NCT01566448|Ketamine|ketamine|mesh-list
14410795|NCT01566448|Analgesics|analgesics|mesh-ancestor
14410796|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
14410797|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410798|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410799|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14410800|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14410801|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
14410802|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
14410803|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410804|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14410805|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14410806|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410807|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753375|NCT05207137|Vaccines|vaccines|mesh-list
14410808|NCT01566526|Dexamethasone|dexamethasone|mesh-list
14410809|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410810|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
14410811|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
14410812|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410813|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742849|NCT00575913|Alfuzosin|alfuzosin|mesh-list
14742850|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14742851|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14742852|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14742853|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
14742854|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753376|NCT05207137|Immunologic Factors|immunologic factors|mesh-ancestor
14925319|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244659|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244660|NCT05194124|alpha-MSH|alpha-msh|mesh-list
15244661|NCT05194124|Hormones|hormones|mesh-ancestor
15244662|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244663|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244664|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
15244665|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244666|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244667|NCT05169905|Vaccines|vaccines|mesh-list
15244668|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
15244669|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244670|NCT05169866|Amiodarone|amiodarone|mesh-list
15244671|NCT05169866|Nifekalant|nifekalant|mesh-list
15244672|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15244673|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
15244674|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15244675|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15244676|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244677|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15244678|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14410814|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14410815|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
15244679|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15244680|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410816|NCT01566526|Hormones|hormones|mesh-ancestor
15244681|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14742855|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742856|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742857|NCT00575913|Urological Agents|urological agents|mesh-ancestor
14742858|NCT00575952|Paclitaxel|paclitaxel|mesh-list
14742859|NCT00575952|Doxorubicin|doxorubicin|mesh-list
14742860|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14742861|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14742862|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742863|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
14742864|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
14742865|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
15244682|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15244683|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15244684|NCT05153395|Insulin|insulin|mesh-list
14410817|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14410818|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14410819|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410820|NCT01566539|Vasopressins|vasopressins|mesh-list
14410821|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
14410822|NCT01566539|Lorazepam|lorazepam|mesh-list
14410823|NCT01566539|Oxytocin|oxytocin|mesh-list
14410824|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
14410825|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14410826|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410827|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
14410828|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
14410829|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
14410830|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410831|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14410832|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14410833|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410834|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14410835|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14410836|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410837|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
15244685|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15244686|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15244687|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244688|NCT05137600|Clarithromycin|clarithromycin|mesh-list
15244689|NCT05137600|Midazolam|midazolam|mesh-list
15244690|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15244691|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15244692|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742866|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410838|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
14410839|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410840|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410841|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
14410842|NCT01566539|Coagulants|coagulants|mesh-ancestor
15244693|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244694|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15244695|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14410843|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14410844|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14410845|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
14410846|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
14410847|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14410848|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14410849|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14410850|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
14410851|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410852|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410853|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410854|NCT01566721|Trastuzumab|trastuzumab|mesh-list
14410855|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15244696|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15244697|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15244698|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
15244699|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
15244700|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
15244701|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
15244702|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410856|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410857|NCT01566773|Bromides|bromides|mesh-list
14410858|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
14410859|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14410860|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
14410861|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410862|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410863|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14410864|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14410865|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
14410866|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14410867|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
14410868|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410869|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410870|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
14410871|NCT01566838|Bupivacaine|bupivacaine|mesh-list
15244703|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244704|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15244705|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244706|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15244707|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244708|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15244709|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15244710|NCT05137548|Tenofovir|tenofovir|mesh-list
14410872|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
14410873|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
14410874|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410875|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410876|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
14410877|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467646|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467647|NCT02263079|Interferons|interferons|mesh-list
15244711|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
15244712|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244713|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15244714|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15244715|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467648|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
15244716|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244717|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14742867|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14410878|NCT01567085|Eculizumab|eculizumab|mesh-list
14410879|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14410880|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410881|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
14410882|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410883|NCT01567163|Docetaxel|docetaxel|mesh-list
14410884|NCT01567163|Ramucirumab|ramucirumab|mesh-list
14410885|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14410886|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14410887|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14410888|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14410889|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410890|NCT01567527|Aripiprazole|aripiprazole|mesh-list
14410891|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
14410892|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14410893|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14410894|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14410895|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410896|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410897|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
14410898|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
14410899|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742868|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14742869|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14742870|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742871|NCT00575978|Hydralazine|hydralazine|mesh-list
15244718|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15244719|NCT05091294|Anesthetics|anesthetics|mesh-list
15244720|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
15244721|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244722|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244723|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
15244724|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742872|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14742873|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
14742874|NCT00576017|Fentanyl|fentanyl|mesh-list
14742875|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14742876|NCT00576017|Narcotics|narcotics|mesh-ancestor
14742877|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742878|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742879|NCT00576017|Analgesics|analgesics|mesh-ancestor
14742880|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
15244725|NCT05082285|Vaccines|vaccines|mesh-list
15244726|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
15244727|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244728|NCT05072704|Sufentanil|sufentanil|mesh-list
15244729|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
15244730|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15244731|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244732|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244733|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15244734|NCT05072704|Analgesics|analgesics|mesh-ancestor
15244735|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
15244736|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244737|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15244738|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15244739|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15244740|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
15244741|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244742|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742881|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742882|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15244743|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15244744|NCT05072704|Narcotics|narcotics|mesh-ancestor
15244745|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15244746|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15244747|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
15244748|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
15244749|NCT05041426|Valganciclovir|valganciclovir|mesh-list
15244750|NCT05041426|Letermovir|letermovir|mesh-list
15244751|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
15244752|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244753|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15244754|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244755|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244756|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244757|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
15244758|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15244759|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244760|NCT04987372|Lidocaine|lidocaine|mesh-list
15244761|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
14410900|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410901|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15244762|NCT04987372|Pregabalin|pregabalin|mesh-list
15244763|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
15244764|NCT04987372|Ketamine|ketamine|mesh-list
15244765|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
15244766|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
15244767|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14410902|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14410903|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
14410904|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14410905|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15244768|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244769|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
15244770|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244771|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15244772|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15244773|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14742883|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14742884|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
14742885|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
15244774|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15244775|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244776|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15244777|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15244778|NCT04987372|Analgesics|analgesics|mesh-ancestor
15244779|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15244780|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15244781|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15244782|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
15244783|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15244784|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15244785|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15244786|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
15244787|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14410906|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14410907|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14410908|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14410909|NCT01567826|Atorvastatin|atorvastatin|mesh-list
14410910|NCT01567826|Simvastatin|simvastatin|mesh-list
14410911|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14410912|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14410913|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
14410914|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410915|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14410916|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14410917|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410918|NCT01567852|Ketamine|ketamine|mesh-list
14410919|NCT01567852|Methohexital|methohexital|mesh-list
14410920|NCT01567852|Analgesics|analgesics|mesh-ancestor
14410921|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
14410922|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410923|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410924|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14410925|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14410926|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
14410927|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
14410928|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467649|NCT02263079|Lamivudine|lamivudine|mesh-list
14467650|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
14467651|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14467652|NCT02263079|Entecavir|entecavir|mesh-list
14467653|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467654|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
14467655|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467656|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
14467657|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467658|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14467659|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14410929|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14410930|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14410931|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410932|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410933|NCT01567865|Vaccines|vaccines|mesh-list
14410934|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
14410935|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410936|NCT01568008|Bimatoprost|bimatoprost|mesh-list
14410937|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14410938|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14410939|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14410940|NCT01568034|Levodopa|levodopa|mesh-list
14410941|NCT01568034|Carbidopa|carbidopa|mesh-list
14410942|NCT01568034|Opicapone|opicapone|mesh-list
14410943|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14410944|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14410945|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
14925320|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
14925321|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14925322|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
14925323|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925324|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742886|NCT00576069|Fluticasone|fluticasone|mesh-list
14742887|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
14742888|NCT00576069|Prednisone|prednisone|mesh-list
14742889|NCT00576069|Budesonide|budesonide|mesh-list
14410946|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410947|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410948|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410949|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14410950|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410951|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14410952|NCT01568047|Levodopa|levodopa|mesh-list
14410953|NCT01568047|Carbidopa|carbidopa|mesh-list
14410954|NCT01568047|Opicapone|opicapone|mesh-list
14410955|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14410956|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14742890|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
14742891|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14742892|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14742893|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14742894|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742895|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
14410957|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
14410958|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410959|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410960|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742896|NCT00576069|Hormones|hormones|mesh-ancestor
14742897|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742898|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742899|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14742900|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742901|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14742902|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
14742903|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742904|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14742905|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
14410961|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14742906|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14742907|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14410962|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410963|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14410964|NCT01568073|Levodopa|levodopa|mesh-list
14410965|NCT01568073|Carbidopa|carbidopa|mesh-list
14410966|NCT01568073|Opicapone|opicapone|mesh-list
14410967|NCT01568073|Entacapone|entacapone|mesh-list
14410968|NCT01568073|Benserazide|benserazide|mesh-list
14410969|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14410970|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14410971|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
14742908|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14742909|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14742910|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14742911|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
14742912|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742913|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742914|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
14410972|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14410973|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410974|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410975|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14410976|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925325|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15244788|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15244789|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
15244790|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15244791|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15244792|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15244793|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15244794|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15244795|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
14925326|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14925327|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925328|NCT01404104|Sirolimus|sirolimus|mesh-list
15244796|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14410977|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14410978|NCT01568112|Aspirin|aspirin|mesh-list
14410979|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14410980|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14410981|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14410982|NCT01568112|Analgesics|analgesics|mesh-ancestor
14410983|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
14742915|NCT00576173|Acetaminophen|acetaminophen|mesh-list
14742916|NCT00576173|Tramadol|tramadol|mesh-list
14742917|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14742918|NCT00576173|Analgesics|analgesics|mesh-ancestor
14742919|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
14742920|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244797|NCT04981067|Ropivacaine|ropivacaine|mesh-list
15244798|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
15244799|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
15244800|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244801|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244802|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
15244803|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410984|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14410985|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14410986|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14410987|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14410988|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14410989|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14925329|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14925330|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925331|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14925332|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925333|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
14925334|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925335|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
14925336|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925337|NCT01404117|Interferons|interferons|mesh-list
14925338|NCT01404117|Interferon-beta|interferon-beta|mesh-list
14925339|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
14925340|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
14925341|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925342|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
14925343|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925344|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
14925345|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925346|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14925347|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925348|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14925349|NCT01404130|Isotretinoin|isotretinoin|mesh-list
15244804|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
15244805|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14410990|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14410991|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14410992|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14410993|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14410994|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
14410995|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
14925350|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
15244806|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
14925351|NCT01404156|Leucovorin|leucovorin|mesh-list
14925352|NCT01404156|Paclitaxel|paclitaxel|mesh-list
14410996|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14410997|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
14410998|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
14410999|NCT01568255|Vitamin D|vitamin d|mesh-list
14411000|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14411001|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411002|NCT01568255|Vitamins|vitamins|mesh-ancestor
14411003|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
14411004|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14411005|NCT01568528|Oxytocin|oxytocin|mesh-list
14411006|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
14411007|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411008|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411009|NCT01568866|Dexamethasone|dexamethasone|mesh-list
14411010|NCT01568866|Bortezomib|bortezomib|mesh-list
14411011|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15244807|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244808|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244809|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15244810|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15244811|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15244812|NCT04964050|Diuretics|diuretics|mesh-ancestor
14925353|NCT01404156|Docetaxel|docetaxel|mesh-list
14925354|NCT01404156|Carboplatin|carboplatin|mesh-list
14925355|NCT01404156|Fluorouracil|fluorouracil|mesh-list
15244813|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
15244814|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925356|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
14411012|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
14411013|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
14925357|NCT01404156|Epirubicin|epirubicin|mesh-list
14411014|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411015|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411016|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411017|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
14411018|NCT01568866|Hormones|hormones|mesh-ancestor
14411019|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411020|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14411021|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411022|NCT01568892|Dolutegravir|dolutegravir|mesh-list
14411023|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14411024|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14411025|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411026|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411027|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14411028|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14411029|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
14411030|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411031|NCT01568905|Nicotine|nicotine|mesh-list
14411032|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14411033|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
14411034|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411035|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411036|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14411037|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14411038|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
14411039|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411040|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411041|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14411042|NCT01568944|Lansoprazole|lansoprazole|mesh-list
14411043|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411044|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14411045|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411046|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14411047|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411048|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411049|NCT01569087|Lenograstim|lenograstim|mesh-list
14411050|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14411051|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
14411052|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411053|NCT01569126|Fluoxetine|fluoxetine|mesh-list
14411054|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14411055|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15244815|NCT04905862|Antipyretics|antipyretics|mesh-list
14411056|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15244816|NCT04905862|Analgesics|analgesics|mesh-list
15244817|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244818|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
15244819|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244820|NCT04898309|Complement C1s|complement c1s|mesh-list
15244821|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
15244822|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
15244823|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
15244824|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244825|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15244826|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411057|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411058|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411059|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
14411060|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411061|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14411062|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
14411063|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411064|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15244827|NCT04895202|Siponimod|siponimod|mesh-list
15244828|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14411065|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14411066|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411067|NCT01569152|Methotrexate|methotrexate|mesh-list
14411068|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14411069|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
14411070|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411071|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411072|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14411073|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
14411074|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411075|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244829|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244830|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15244831|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
15244832|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742921|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742922|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
14411076|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14411077|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411078|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14411079|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411080|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
14411081|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411082|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14411083|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
14411084|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14411085|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
14411086|NCT01569191|Epinastine|epinastine|mesh-list
14411087|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14411088|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14411089|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
14742923|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15244833|NCT04840264|Docetaxel|docetaxel|mesh-list
15244834|NCT04840264|Fluorouracil|fluorouracil|mesh-list
15244835|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
15244836|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244837|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
15244838|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
15244839|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411090|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
14411091|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411092|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411093|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411094|NCT01569295|Rituximab|rituximab|mesh-list
14742924|NCT00576173|Narcotics|narcotics|mesh-ancestor
14742925|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14742926|NCT00576225|Paclitaxel|paclitaxel|mesh-list
14742927|NCT00576225|Carboplatin|carboplatin|mesh-list
14742928|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14742929|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14742930|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742931|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14742932|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14411095|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14411096|NCT01569295|Idelalisib|idelalisib|mesh-list
14411097|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411098|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411099|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
14411100|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411101|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742933|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411102|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14411103|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
14411104|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411105|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411106|NCT01569451|Rituximab|rituximab|mesh-list
14742934|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742935|NCT00576238|Betamethasone|betamethasone|mesh-list
14742936|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
14742937|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14742938|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
14742939|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14742940|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742941|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
14742942|NCT00576238|Hormones|hormones|mesh-ancestor
14742943|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742944|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742945|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14742946|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
14742947|NCT00576329|Ketorolac|ketorolac|mesh-list
14742948|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14742949|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14742950|NCT00576329|Analgesics|analgesics|mesh-ancestor
14742951|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
14742952|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14742953|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742954|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742955|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742956|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14742957|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742958|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742959|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
14742960|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742961|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742962|NCT00576394|Insulin|insulin|mesh-list
14742963|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14742964|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14742965|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742966|NCT00576433|Rituximab|rituximab|mesh-list
14742967|NCT00576433|Methotrexate|methotrexate|mesh-list
14742968|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14742969|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14742970|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
14742971|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742972|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14742973|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14411107|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
14411108|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
14411109|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411110|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411111|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
14411112|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411113|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411114|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14411115|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411116|NCT01569464|Rotigotine|rotigotine|mesh-list
14411117|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
14411118|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
14411119|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411120|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411121|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411122|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14411123|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14411124|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411125|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14411126|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14411127|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411128|NCT01569841|Insulin|insulin|mesh-list
14411129|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14411130|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
14411131|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14411132|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411133|NCT01570036|Trastuzumab|trastuzumab|mesh-list
14411134|NCT01570036|Molgramostim|molgramostim|mesh-list
14411135|NCT01570036|Sargramostim|sargramostim|mesh-list
14411136|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411137|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411138|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
14411139|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411140|NCT01570192|Vancomycin|vancomycin|mesh-list
14411141|NCT01570192|Gentamicins|gentamicins|mesh-list
14742974|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
14742975|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411142|NCT01570192|Meropenem|meropenem|mesh-list
14411143|NCT01570192|Linezolid|linezolid|mesh-list
14411144|NCT01570192|Tobramycin|tobramycin|mesh-list
14411145|NCT01570192|Amikacin|amikacin|mesh-list
14411146|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14411147|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411148|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14411149|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411150|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411151|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
14411152|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14742976|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14742977|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
14742978|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411153|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14411154|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
14411155|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411156|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411157|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14411158|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14411159|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14411160|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14411161|NCT01570244|Estrogens|estrogens|mesh-ancestor
14925358|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14925359|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925360|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
14925361|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
14925362|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
14925363|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925364|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
14925365|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14925366|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411162|NCT01570244|Hormones|hormones|mesh-ancestor
14411163|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411164|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
14411165|NCT01570309|Vitamin D|vitamin d|mesh-list
14411166|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14411167|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411168|NCT01570309|Vitamins|vitamins|mesh-ancestor
14411169|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
14742979|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
14742980|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14742981|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14742982|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14742983|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14742984|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14742985|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14742986|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
14742987|NCT00576459|Hormones|hormones|mesh-ancestor
14742988|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14742989|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742990|NCT00576511|Prucalopride|prucalopride|mesh-list
14742991|NCT00576511|Laxatives|laxatives|mesh-ancestor
14742992|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14742993|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14742994|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14411170|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14411171|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
14742995|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
14742996|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14742997|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14742998|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14742999|NCT00576550|Betamethasone|betamethasone|mesh-list
14743000|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
14743001|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14743002|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
14743003|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14743004|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743005|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
14743006|NCT00576550|Hormones|hormones|mesh-ancestor
14743007|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743008|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743009|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14411172|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
14743010|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
14743011|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
14743012|NCT00576602|Hematinics|hematinics|mesh-ancestor
14743013|NCT00576615|Propofol|propofol|mesh-list
14743014|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14743015|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743016|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743017|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14743018|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
14743019|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
14743020|NCT00576706|Misoprostol|misoprostol|mesh-list
14743021|NCT00576706|Rebamipide|rebamipide|mesh-list
14743022|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14743023|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
14743024|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14743025|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743026|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14743027|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411173|NCT01570348|Fludarabine|fludarabine|mesh-list
14411174|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
14411175|NCT01570348|Tacrolimus|tacrolimus|mesh-list
14743028|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
14743029|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
14743030|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244840|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244841|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
15244842|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15244843|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15244844|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
15244845|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244846|NCT04839042|Cloricromen|cloricromen|mesh-list
15244847|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14411176|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411177|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
14411178|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411179|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411180|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14411181|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
14411182|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411183|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411184|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14411185|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14411186|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
14411187|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14411188|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411189|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14411190|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14743031|NCT00576706|Protective Agents|protective agents|mesh-ancestor
14743032|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244848|NCT04822467|Ethanol|ethanol|mesh-list
15244849|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14743033|NCT00576784|Pioglitazone|pioglitazone|mesh-list
14743034|NCT00576784|Glimepiride|glimepiride|mesh-list
14411191|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
14411192|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14411193|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411194|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14411195|NCT01570387|Dexamethasone|dexamethasone|mesh-list
14411196|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
14411197|NCT01570387|Pomalidomide|pomalidomide|mesh-list
14411198|NCT01570387|BB 1101|bb 1101|mesh-list
14743035|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14743036|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743037|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15244850|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244851|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244852|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244853|NCT04808973|Lamivudine|lamivudine|mesh-list
15244854|NCT04808973|Dolutegravir|dolutegravir|mesh-list
15244855|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15244856|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15244857|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244858|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244859|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
15244860|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15244861|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15244862|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15244863|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15244864|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15244865|NCT04804007|Etoposide|etoposide|mesh-list
14743038|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743039|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
14753377|NCT05207137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753378|NCT05201001|Carboplatin|carboplatin|mesh-list
15244866|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15244867|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411199|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411200|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
14753379|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743040|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
14743041|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14743042|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743043|NCT00576914|Endostatins|endostatins|mesh-list
14743044|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743045|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743046|NCT00576914|Growth Substances|growth substances|mesh-ancestor
14753380|NCT05199662|Tenecteplase|tenecteplase|mesh-list
14925367|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
14925368|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925369|NCT01404156|Antidotes|antidotes|mesh-ancestor
14925370|NCT01404156|Protective Agents|protective agents|mesh-ancestor
14411201|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
14411202|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411203|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411204|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411205|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
14411206|NCT01570387|Hormones|hormones|mesh-ancestor
14411207|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411208|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14411209|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411210|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
14411211|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411212|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411213|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
14411214|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14411215|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14411216|NCT01570387|Growth Substances|growth substances|mesh-ancestor
14925371|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
14925372|NCT01404156|Vitamins|vitamins|mesh-ancestor
14925373|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
15244868|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15244869|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14411217|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
14411218|NCT01570491|Anesthetics|anesthetics|mesh-list
14411219|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411220|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411221|NCT01570751|Insulin|insulin|mesh-list
14411222|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15244870|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244871|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244872|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
15244873|NCT04787692|Narcotics|narcotics|mesh-ancestor
14411223|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
15244874|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244875|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244876|NCT04787692|Analgesics|analgesics|mesh-ancestor
14411224|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14411225|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411226|NCT01570868|Ponatinib|ponatinib|mesh-list
14411227|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411228|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14411229|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467660|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467661|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467662|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14467663|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14467664|NCT02263326|Lamivudine|lamivudine|mesh-list
14467665|NCT02263326|Dolutegravir|dolutegravir|mesh-list
14467666|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14467667|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14467668|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14467669|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411230|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411231|NCT01571232|Dexamethasone|dexamethasone|mesh-list
14411232|NCT01571232|Bevacizumab|bevacizumab|mesh-list
14411233|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411234|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411235|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14411236|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14411237|NCT01571232|Growth Substances|growth substances|mesh-ancestor
14411238|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411239|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
14411240|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411241|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
14411242|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
14411243|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411244|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411245|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
14743047|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743048|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
14743049|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411246|NCT01571232|Hormones|hormones|mesh-ancestor
14411247|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411248|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14411249|NCT01571284|Aflibercept|aflibercept|mesh-list
14411250|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743050|NCT00577018|Prucalopride|prucalopride|mesh-list
14743051|NCT00577018|Laxatives|laxatives|mesh-ancestor
14743052|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14743053|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14743054|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14743055|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
14743056|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743057|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743058|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743059|NCT00577057|Fluorouracil|fluorouracil|mesh-list
14411251|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14411252|NCT01571284|Growth Substances|growth substances|mesh-ancestor
14411253|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411254|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
14411255|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411256|NCT01571362|Naltrexone|naltrexone|mesh-list
14411257|NCT01571362|Oxycodone|oxycodone|mesh-list
14411258|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14411259|NCT01571362|Narcotics|narcotics|mesh-ancestor
14411260|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411261|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411262|NCT01571362|Analgesics|analgesics|mesh-ancestor
14411263|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
14411264|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411265|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14411266|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14411267|NCT01571453|Vortioxetine|vortioxetine|mesh-list
14411268|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14411269|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14411270|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14411271|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411272|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743060|NCT00577057|Capecitabine|capecitabine|mesh-list
14411273|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411274|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411275|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14411276|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
14411277|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411278|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14411279|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14411280|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411281|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14411282|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
14411283|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14743061|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411284|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14743062|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
14743063|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743064|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14743065|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743066|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
14411285|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14411286|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14411287|NCT01571557|Dexamethasone|dexamethasone|mesh-list
14411288|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411289|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
14411290|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
14743067|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743068|NCT00577109|Leucovorin|leucovorin|mesh-list
14743069|NCT00577109|Bevacizumab|bevacizumab|mesh-list
14743070|NCT00577109|Cetuximab|cetuximab|mesh-list
14743071|NCT00577109|Irinotecan|irinotecan|mesh-list
14743072|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743073|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743074|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14411291|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743075|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743076|NCT00577109|Growth Substances|growth substances|mesh-ancestor
14743077|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743078|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
15244877|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
15244878|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244879|NCT04755244|Azacitidine|azacitidine|mesh-list
15244880|NCT04755244|Venetoclax|venetoclax|mesh-list
14743079|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14743080|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14743081|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743082|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743083|NCT00577109|Antidotes|antidotes|mesh-ancestor
14743084|NCT00577109|Protective Agents|protective agents|mesh-ancestor
14743085|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
14743086|NCT00577109|Vitamins|vitamins|mesh-ancestor
14925374|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14925375|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14925376|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14925377|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925378|NCT01404169|Donepezil|donepezil|mesh-list
14925379|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15244881|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15244882|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
14925380|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925381|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925382|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
14925383|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925384|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925385|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
15244883|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244884|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244885|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15244886|NCT04741945|Metformin|metformin|mesh-list
15244887|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15244888|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244889|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15244890|NCT04733742|Tenecteplase|tenecteplase|mesh-list
15244891|NCT04733742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15244892|NCT04733742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15244893|NCT04733742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244894|NCT04720612|Omalizumab|omalizumab|mesh-list
15244895|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15244896|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15244897|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
15244898|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15244899|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14411292|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743087|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
14743088|NCT00577161|Vidarabine|vidarabine|mesh-list
14743089|NCT00577161|Rituximab|rituximab|mesh-list
14743090|NCT00577161|Fludarabine|fludarabine|mesh-list
14743091|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
15244900|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14743092|NCT00577161|Pixantrone|pixantrone|mesh-list
14743093|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743094|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743095|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
14743096|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743097|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743098|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14743099|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
14743100|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743101|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743102|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
14743103|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743104|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14743105|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14743106|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743107|NCT00577200|Midazolam|midazolam|mesh-list
14743108|NCT00577200|Sufentanil|sufentanil|mesh-list
14743109|NCT00577200|Propofol|propofol|mesh-list
14743110|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14743111|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743112|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743113|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14743114|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
14743115|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
14743116|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14743117|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743118|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743119|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743120|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
14743121|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
14743122|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743123|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743124|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14743125|NCT00577200|Narcotics|narcotics|mesh-ancestor
14743126|NCT00577200|Analgesics|analgesics|mesh-ancestor
14743127|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
14743128|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743129|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
14743130|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
14743131|NCT00577369|Desflurane|desflurane|mesh-list
14743132|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15244901|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244902|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15244903|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15244904|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244905|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15244906|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
15244907|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244908|NCT04661137|Dexamethasone|dexamethasone|mesh-list
15244909|NCT04661137|Daratumumab|daratumumab|mesh-list
14743133|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
14743134|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
14743135|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743136|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244910|NCT04661137|Pomalidomide|pomalidomide|mesh-list
15244911|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15244912|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
15244913|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
15244914|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244915|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244916|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15244917|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
15244918|NCT04661137|Hormones|hormones|mesh-ancestor
15244919|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244920|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244921|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244922|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
15244923|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15244924|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15244925|NCT04661137|Growth Substances|growth substances|mesh-ancestor
14743137|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
14743138|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14743139|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743140|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743141|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14743142|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411293|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411294|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
14411295|NCT01571557|Hormones|hormones|mesh-ancestor
14411296|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411297|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14411298|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743143|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14743144|NCT00577668|Thalidomide|thalidomide|mesh-list
14743145|NCT00577668|Dexamethasone|dexamethasone|mesh-list
14743146|NCT00577668|Melphalan|melphalan|mesh-list
14743147|NCT00577668|Bortezomib|bortezomib|mesh-list
14743148|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743149|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
14743150|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
14743151|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743152|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743153|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14743154|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
14743155|NCT00577668|Hormones|hormones|mesh-ancestor
14743156|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15244926|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
15244927|NCT04657666|Nabiximols|nabiximols|mesh-list
15244928|NCT04657666|Analgesics|analgesics|mesh-ancestor
15244929|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
15244930|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244931|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244932|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
15244933|NCT04643574|Fludarabine|fludarabine|mesh-list
15244934|NCT04643574|Interleukin-2|interleukin-2|mesh-list
15244935|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411299|NCT01572038|Paclitaxel|paclitaxel|mesh-list
14411300|NCT01572038|Docetaxel|docetaxel|mesh-list
14411301|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14411302|NCT01572038|Trastuzumab|trastuzumab|mesh-list
15244936|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
15244937|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244938|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15244939|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15244940|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
15244941|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244942|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15244943|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15244944|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15244945|NCT04643574|Analgesics|analgesics|mesh-ancestor
15244946|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
15244947|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244948|NCT04633889|Deferoxamine|deferoxamine|mesh-list
14411303|NCT01572038|Pertuzumab|pertuzumab|mesh-list
15244949|NCT04633889|Siderophores|siderophores|mesh-ancestor
14411304|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15244950|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14743157|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15244951|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
15244952|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
15244953|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244954|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
15244955|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
15244956|NCT04620252|Calcium|calcium|mesh-list
14743158|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743159|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14743160|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
14743161|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743162|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14743163|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411305|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411306|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14411307|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14411308|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411309|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411310|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411311|NCT01572727|Paclitaxel|paclitaxel|mesh-list
14411312|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14411313|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411314|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
14411315|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
14411316|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411317|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411318|NCT01572740|Liraglutide|liraglutide|mesh-list
14411319|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14411320|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743164|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
14743165|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
14743166|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14743167|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743168|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743169|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743170|NCT00577668|Growth Substances|growth substances|mesh-ancestor
14743171|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
15244957|NCT04620252|Fluorides|fluorides|mesh-list
15244958|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15244959|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244960|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15244961|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244962|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
15244963|NCT04620252|Protective Agents|protective agents|mesh-ancestor
15244964|NCT04620252|Antacids|antacids|mesh-ancestor
15244965|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14743172|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15244966|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15244967|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15244968|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244969|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244970|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15244971|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15244972|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244973|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
15244974|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743173|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
14743174|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743175|NCT00577694|Clofarabine|clofarabine|mesh-list
14743176|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
15244975|NCT04544007|Poly ICLC|poly iclc|mesh-list
15244976|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
15244977|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
15244978|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244979|NCT04510207|Vaccines|vaccines|mesh-list
15244980|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
15244981|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244982|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
15244983|NCT04509115|Narcotics|narcotics|mesh-ancestor
15244984|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15244985|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244986|NCT04509115|Analgesics|analgesics|mesh-ancestor
15244987|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
15244988|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743177|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14411321|NCT01572740|Incretins|incretins|mesh-ancestor
14411322|NCT01572740|Hormones|hormones|mesh-ancestor
14411323|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411324|NCT01572792|Bromides|bromides|mesh-list
14411325|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
14411326|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14411327|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
14743178|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
14743179|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15244989|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
15244990|NCT04499495|Mesalamine|mesalamine|mesh-list
15244991|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14411328|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411329|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411330|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14411331|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
14411332|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15244992|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15244993|NCT04499495|Analgesics|analgesics|mesh-ancestor
15244994|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
15244995|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15244996|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15244997|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15244998|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15244999|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
15245000|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15245001|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245002|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15245003|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15245004|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245005|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
15245006|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
15245007|NCT04479566|Calcium|calcium|mesh-list
15245008|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14743180|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245009|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245010|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
14411333|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14411334|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14411335|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
14411336|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411337|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411338|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
14411339|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
14411340|NCT01572844|Antidotes|antidotes|mesh-ancestor
14411341|NCT01572844|Protective Agents|protective agents|mesh-ancestor
15245011|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245012|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245013|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245014|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
15245015|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245016|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245017|NCT04479566|Antacids|antacids|mesh-ancestor
15245018|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245019|NCT04428307|Artemisinins|artemisinins|mesh-list
15245020|NCT04428307|Artemisinin|artemisinin|mesh-list
15245021|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
15245022|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15245023|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14743181|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743182|NCT00577798|Doxorubicin|doxorubicin|mesh-list
14411342|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411343|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
14411344|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411345|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
14411346|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14411347|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411348|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
14411349|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
14411350|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
14411351|NCT01573000|Antibodies|antibodies|mesh-list
14411352|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
14411353|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
14743183|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14743184|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14743185|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245024|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245025|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
15245026|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245027|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245028|NCT04356495|Ciclesonide|ciclesonide|mesh-list
15245029|NCT04356495|Interferons|interferons|mesh-list
15245030|NCT04356495|Interferon-beta|interferon-beta|mesh-list
15245031|NCT04356495|Telmisartan|telmisartan|mesh-list
15245032|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
15245033|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743186|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14411354|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743187|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15245034|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743188|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743189|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245035|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
15245036|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245037|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15245038|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15245039|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14411355|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411356|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
14411357|NCT01573052|Gabapentin|gabapentin|mesh-list
14411358|NCT01573052|Analgesics|analgesics|mesh-ancestor
14411359|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
15245040|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245041|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
15245042|NCT04356495|Hormones|hormones|mesh-ancestor
15245043|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245044|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14743190|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
14743191|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
14411360|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411361|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411362|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
14411363|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14411364|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14411365|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411366|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743192|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14743193|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743194|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743195|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14743196|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743197|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14743198|NCT00577850|Alendronate|alendronate|mesh-list
14743199|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
14743200|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14743201|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743202|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14743203|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743204|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743205|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14743206|NCT00577967|Gabapentin|gabapentin|mesh-list
14743207|NCT00577967|Analgesics|analgesics|mesh-ancestor
14743208|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
14743209|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743210|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245045|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
15245046|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15245047|NCT04355572|Vitamin D|vitamin d|mesh-list
15245048|NCT04355572|Vitamins|vitamins|mesh-ancestor
15245049|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
15245050|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245051|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15245052|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
15245053|NCT04303507|Chloroquine|chloroquine|mesh-list
14743211|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
14743212|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743213|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743214|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743215|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743216|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14743217|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14743218|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743219|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245054|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
15245055|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15245056|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15245057|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245058|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245059|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245060|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411367|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15245061|NCT04303507|Amebicides|amebicides|mesh-ancestor
14743220|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
14743221|NCT00577980|Testosterone|testosterone|mesh-list
14743222|NCT00577980|Androgens|androgens|mesh-ancestor
14743223|NCT00577980|Hormones|hormones|mesh-ancestor
14743224|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743225|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753381|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14753382|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14753383|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753384|NCT05199194|Tenecteplase|tenecteplase|mesh-list
14753385|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14753386|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14411368|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14411369|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411370|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411371|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
14753387|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411372|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14411373|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14411374|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
14411375|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
14411376|NCT01573169|Enoxaparin|enoxaparin|mesh-list
14411377|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
14411378|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14411379|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14411380|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411381|NCT01573273|Oxytocin|oxytocin|mesh-list
14411382|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
14411383|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411384|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411385|NCT01573442|Testosterone|testosterone|mesh-list
14411386|NCT01573442|Androgens|androgens|mesh-ancestor
14411387|NCT01573442|Hormones|hormones|mesh-ancestor
14411388|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411389|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411390|NCT01573533|Rituximab|rituximab|mesh-list
14411391|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753388|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
14753389|NCT05182073|Fludarabine|fludarabine|mesh-list
14753390|NCT05182073|Daratumumab|daratumumab|mesh-list
14411392|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411393|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
14411394|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411395|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411396|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14411397|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411398|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14411399|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411400|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411401|NCT01573767|Fluticasone|fluticasone|mesh-list
14411402|NCT01573767|Xhance|xhance|mesh-list
14411403|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411404|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14411405|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
14411406|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411407|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411408|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14411409|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
14411410|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14411411|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14411412|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
14411413|NCT01573910|Ofloxacin|ofloxacin|mesh-list
14411414|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14411415|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14411416|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14411417|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411418|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14411419|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14411420|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743226|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
14743227|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14743228|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14743229|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14743230|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743231|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743232|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
14743233|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743234|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743235|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15245062|NCT04238819|Irinotecan|irinotecan|mesh-list
15245063|NCT04238819|Temozolomide|temozolomide|mesh-list
15245064|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15245065|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15245066|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245067|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245068|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245069|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14411421|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411422|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411423|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14743236|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743237|NCT00578149|Paclitaxel|paclitaxel|mesh-list
14743238|NCT00578149|Bevacizumab|bevacizumab|mesh-list
14743239|NCT00578149|Carboplatin|carboplatin|mesh-list
14743240|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14743241|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743242|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
14743243|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
14743244|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
15245070|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
14411424|NCT01573910|Renal Agents|renal agents|mesh-ancestor
14411425|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14411426|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14411427|NCT01573949|Metformin|metformin|mesh-list
14411428|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14411429|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411430|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14411431|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
14411432|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411433|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14411434|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14411435|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411436|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411437|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411438|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
14743245|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743246|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743247|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743248|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743249|NCT00578149|Growth Substances|growth substances|mesh-ancestor
14743250|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743251|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
14743252|NCT00578201|Cetuximab|cetuximab|mesh-list
14743253|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411439|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411440|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14411441|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14411442|NCT01574248|Icatibant|icatibant|mesh-list
14411443|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14411444|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14411445|NCT01574248|Analgesics|analgesics|mesh-ancestor
14411446|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
14411447|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411448|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411449|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411450|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411451|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14411452|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14743254|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411453|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411454|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14411455|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411456|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
14467670|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467671|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
14467672|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467673|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14467674|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14467675|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14467676|NCT02263547|Teriflunomide|teriflunomide|mesh-list
14467677|NCT02263547|Colestipol|colestipol|mesh-list
14467678|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467679|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467680|NCT02263547|Analgesics|analgesics|mesh-ancestor
14467681|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
14467682|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467683|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467684|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467685|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467686|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14467687|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
14467688|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14467689|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
14467690|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467691|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14467692|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
14467693|NCT02264353|Donepezil|donepezil|mesh-list
14467694|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14467695|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467696|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467697|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
14467698|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467699|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467700|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
14467701|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
14467702|NCT02264574|Chlorambucil|chlorambucil|mesh-list
14467703|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467704|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467705|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14467706|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
14467707|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467708|NCT02264821|Morphine|morphine|mesh-list
14467709|NCT02264821|Ropivacaine|ropivacaine|mesh-list
14467710|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
14411457|NCT01574326|Sevelamer|sevelamer|mesh-list
14411458|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
14411459|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
14411460|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411461|NCT01574612|Acyclovir|acyclovir|mesh-list
14411462|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
14411463|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411464|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
14411465|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411466|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
14411467|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
14411468|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
14411469|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14411470|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
14411471|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411472|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411473|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14411474|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
14411475|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14411476|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14743255|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
14743256|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
14743257|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743258|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
14743259|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743260|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743261|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14743262|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
14743263|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743264|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743265|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14743266|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925386|NCT01404182|Vaccines|vaccines|mesh-list
15245071|NCT04200963|Nivolumab|nivolumab|mesh-list
15245072|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245073|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245074|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15245075|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245076|NCT04200911|Sirolimus|sirolimus|mesh-list
15245077|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15245078|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245079|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15245080|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245081|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
14925387|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
15245082|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245083|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
15245084|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245085|NCT04140162|Dexamethasone|dexamethasone|mesh-list
15245086|NCT04140162|Lenalidomide|lenalidomide|mesh-list
15245087|NCT04140162|Bortezomib|bortezomib|mesh-list
15245088|NCT04140162|Daratumumab|daratumumab|mesh-list
14925388|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925389|NCT01404312|Pyridoxine|pyridoxine|mesh-list
14925390|NCT01404312|Pyridoxal|pyridoxal|mesh-list
14925391|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
14925392|NCT01404312|Isoniazid|isoniazid|mesh-list
14925393|NCT01404312|Rifapentine|rifapentine|mesh-list
14925394|NCT01404312|Vitamins|vitamins|mesh-ancestor
14925395|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
14925396|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925397|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
14925398|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
14925399|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14925400|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925401|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14925402|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14925403|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
14925404|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925405|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14925406|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14925407|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
14411477|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14925408|NCT01404338|Halobetasol|halobetasol|mesh-list
15245089|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15245090|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
15245091|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
15245092|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245093|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411478|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14411479|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411480|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411481|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
14411482|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14411483|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
14411484|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14411485|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14411486|NCT01574703|Bupropion|bupropion|mesh-list
14411487|NCT01574703|Nicotine|nicotine|mesh-list
14411488|NCT01574703|Varenicline|varenicline|mesh-list
14411489|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14411490|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
14411491|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411492|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411493|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14411494|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14411495|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
14411496|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411497|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411498|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14411499|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
14411500|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411501|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14411502|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14411503|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411504|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
14411505|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14411506|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14411507|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411508|NCT01574716|Gemcitabine|gemcitabine|mesh-list
14411509|NCT01574716|Docetaxel|docetaxel|mesh-list
14411510|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14411511|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
14411512|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245094|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245095|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
15245096|NCT04140162|Hormones|hormones|mesh-ancestor
15245097|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245098|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15245099|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245100|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
15245101|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15245102|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15245103|NCT04140162|Growth Substances|growth substances|mesh-ancestor
15245104|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
15245105|NCT04104178|Clindamycin|clindamycin|mesh-list
15245106|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
15245107|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
15245108|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15245109|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245110|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15245111|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245112|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245113|NCT03999268|Insulin|insulin|mesh-list
15245114|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15245115|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245116|NCT03974828|Anesthetics|anesthetics|mesh-list
15245117|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245118|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245119|NCT03971643|Vilobelimab|vilobelimab|mesh-list
15245120|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15245121|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245122|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
15245123|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245124|NCT03929718|Spironolactone|spironolactone|mesh-list
15245125|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15245126|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
14411513|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411514|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
14411515|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411516|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411517|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411518|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
14411519|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411520|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14411521|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
15245127|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245128|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743267|NCT00578370|Cyclosporine|cyclosporine|mesh-list
14743268|NCT00578370|Betamethasone|betamethasone|mesh-list
14743269|NCT00578370|Calcipotriene|calcipotriene|mesh-list
14743270|NCT00578370|Cyclosporins|cyclosporins|mesh-list
14743271|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743272|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743273|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743274|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
15245129|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15245130|NCT03929718|Diuretics|diuretics|mesh-ancestor
15245131|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
15245132|NCT03918915|Atropine|atropine|mesh-list
15245133|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15245134|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15245135|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15245136|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
15245137|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743275|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743276|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
14743277|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743278|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
14743279|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245138|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245139|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15245140|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
15245141|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
15245142|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
14411522|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411523|NCT01574807|Lidocaine|lidocaine|mesh-list
14411524|NCT01574807|Mepivacaine|mepivacaine|mesh-list
14411525|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
14411526|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
14411527|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411528|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411529|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
14411530|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411531|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15245143|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15245144|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15245145|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
14411532|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14411533|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14411534|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411535|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411536|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
15245146|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245147|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245148|NCT03882918|Gaboxadol|gaboxadol|mesh-list
15245149|NCT03882918|Analgesics|analgesics|mesh-ancestor
14743280|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14743281|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743282|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
14743283|NCT00578370|Hormones|hormones|mesh-ancestor
14743284|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743285|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14743286|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
14743287|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
14743288|NCT00578435|Busulfan|busulfan|mesh-list
14743289|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743290|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
14411537|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14411538|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14411539|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14411540|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411541|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411542|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
14411543|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411544|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411545|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14411546|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743291|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743292|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743293|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14743294|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
14743295|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743296|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743297|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14743298|NCT00578526|Sunitinib|sunitinib|mesh-list
14743299|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743300|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743301|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743302|NCT00578526|Growth Substances|growth substances|mesh-ancestor
14743303|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743304|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
14743305|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14743306|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743307|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743308|NCT00578591|Rituximab|rituximab|mesh-list
14743309|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743310|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743311|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
14743312|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743313|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743314|NCT00578721|Aspirin|aspirin|mesh-list
14743315|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14743316|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14743317|NCT00578721|Analgesics|analgesics|mesh-ancestor
14743318|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
14743319|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743320|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743321|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743322|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743323|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14743324|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14753391|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15245150|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
15245151|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245152|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245153|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
15245154|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
15245155|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
15245156|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743325|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743326|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14743327|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14743328|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743329|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
14743330|NCT00578760|Aspirin|aspirin|mesh-list
14743331|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15245157|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411547|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14411548|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14411549|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
14925409|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14925410|NCT01404364|Triamcinolone|triamcinolone|mesh-list
14925411|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
14925412|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925413|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
14925414|NCT01404364|Hormones|hormones|mesh-ancestor
15245158|NCT03878459|Pioglitazone|pioglitazone|mesh-list
15245159|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15245160|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245161|NCT03850067|Carboplatin|carboplatin|mesh-list
14411550|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14411551|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14411552|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14411553|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411554|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411555|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411556|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14411557|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14411558|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14411559|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
14411560|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411561|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467711|NCT02264821|Anesthetics|anesthetics|mesh-list
14743332|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15245162|NCT03850067|Nivolumab|nivolumab|mesh-list
15245163|NCT03850067|Etoposide|etoposide|mesh-list
15245164|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
15245165|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245166|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245167|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15245168|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245169|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15245170|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14467712|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14743333|NCT00578760|Analgesics|analgesics|mesh-ancestor
14743334|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
14743335|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245171|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15245172|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245173|NCT03843008|Melatonin|melatonin|mesh-list
15245174|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
14743336|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743337|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743338|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245175|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411562|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14411563|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14411564|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
14411565|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14411566|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14411567|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
14411568|NCT01575834|Denosumab|denosumab|mesh-list
14411569|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14411570|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411571|NCT01575860|Lenalidomide|lenalidomide|mesh-list
14411572|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
14411573|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411574|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14411575|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14411576|NCT01575860|Growth Substances|growth substances|mesh-ancestor
14411577|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
14411578|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411579|NCT01575873|Denosumab|denosumab|mesh-list
14411580|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14411581|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411582|NCT01575899|Amoxicillin|amoxicillin|mesh-list
14411583|NCT01575899|Clarithromycin|clarithromycin|mesh-list
14411584|NCT01575899|Levofloxacin|levofloxacin|mesh-list
14411585|NCT01575899|Ofloxacin|ofloxacin|mesh-list
14411586|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
14411587|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14411588|NCT01575899|Rabeprazole|rabeprazole|mesh-list
14411589|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14411590|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411591|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14411592|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411593|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411594|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14411595|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14411596|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14411597|NCT01575899|Renal Agents|renal agents|mesh-ancestor
14411598|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14411599|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14411600|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411601|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14411602|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14411603|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411604|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14411605|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14411606|NCT01576042|Amiodarone|amiodarone|mesh-list
14411607|NCT01576042|Sotalol|sotalol|mesh-list
14411608|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14411609|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
14411610|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14411611|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411612|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411613|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14411614|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14411615|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14411616|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411617|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14411618|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15245176|NCT03843008|Protective Agents|protective agents|mesh-ancestor
15245177|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245178|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411619|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14411620|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14411621|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15245179|NCT03840616|Fluconazole|fluconazole|mesh-list
15245180|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
15245181|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245182|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15245183|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14411622|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
14411623|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411624|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245184|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245185|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245186|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15245187|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
14411625|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
14411626|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
14411627|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411628|NCT01576172|Prednisone|prednisone|mesh-list
14411629|NCT01576172|Cortisone|cortisone|mesh-list
14411630|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
14411631|NCT01576172|Veliparib|veliparib|mesh-list
14411632|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411633|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
14411634|NCT01576172|Hormones|hormones|mesh-ancestor
14411635|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411636|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411637|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14411638|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411639|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14411640|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411641|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411642|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
14411643|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14411644|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14743339|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14743340|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14743341|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743342|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14743343|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14743344|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743345|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
14743346|NCT00578825|Ritonavir|ritonavir|mesh-list
14743347|NCT00578825|Lopinavir|lopinavir|mesh-list
14743348|NCT00578825|Ribavirin|ribavirin|mesh-list
14743349|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14743350|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14743351|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
14743352|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743353|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743354|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14411645|NCT01576276|Ketorolac|ketorolac|mesh-list
14743355|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14743356|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
14743357|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743358|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14743359|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14743360|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
14743361|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
14743362|NCT00579046|Hematinics|hematinics|mesh-ancestor
14411646|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14411647|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14411648|NCT01576276|Analgesics|analgesics|mesh-ancestor
14743363|NCT00579085|Ketamine|ketamine|mesh-list
15245188|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411649|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
14411650|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411651|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245189|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245190|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15245191|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15245192|NCT03837977|Leucovorin|leucovorin|mesh-list
15245193|NCT03837977|Folic Acid|folic acid|mesh-list
15245194|NCT03837977|Docetaxel|docetaxel|mesh-list
15245195|NCT03837977|Fluorouracil|fluorouracil|mesh-list
15245196|NCT03837977|Irinotecan|irinotecan|mesh-list
15245197|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
15245198|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245199|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
15245200|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
15245201|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
15245202|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245203|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
15245204|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15245205|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245206|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
15245207|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245208|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15245209|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15245210|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245211|NCT03837977|Antidotes|antidotes|mesh-ancestor
15245212|NCT03837977|Protective Agents|protective agents|mesh-ancestor
15245213|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
15245214|NCT03837977|Vitamins|vitamins|mesh-ancestor
15245215|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
15245216|NCT03837977|Hematinics|hematinics|mesh-ancestor
15245217|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
15245218|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15245219|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15245220|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
15245221|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245222|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245223|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245224|NCT03787654|Urological Agents|urological agents|mesh-ancestor
15245225|NCT03772353|Letrozole|letrozole|mesh-list
15245226|NCT03772353|Fulvestrant|fulvestrant|mesh-list
15245227|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15245228|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245229|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15245230|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245231|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245232|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15245233|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
15245234|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245235|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245236|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15245237|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15245238|NCT03697720|Naproxen|naproxen|mesh-list
15245239|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15245240|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15245241|NCT03697720|Analgesics|analgesics|mesh-ancestor
15245242|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
15245243|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245244|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411652|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743364|NCT00579085|Analgesics|analgesics|mesh-ancestor
15245245|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15245246|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245247|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
15245248|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15245249|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245250|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411653|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411654|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14411655|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411656|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411657|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
14411658|NCT01576341|Hematinics|hematinics|mesh-ancestor
14411659|NCT01576406|Crizotinib|crizotinib|mesh-list
14411660|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411661|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14411662|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411663|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411664|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14411665|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
14411666|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411667|NCT01576523|Complement C1s|complement c1s|mesh-list
14411668|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14411669|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14743365|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
14743366|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743367|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743368|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14743369|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14743370|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
14411670|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
14411671|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411672|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14411673|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411674|NCT01576588|Rituximab|rituximab|mesh-list
14411675|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
14925415|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925416|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925417|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411676|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411677|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925418|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
14925419|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
14925420|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925421|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925422|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14925423|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14925424|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925425|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411678|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
14411679|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743371|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
14743372|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743373|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14743374|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15245251|NCT03649633|Vitamins|vitamins|mesh-list
14411680|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411681|NCT01576588|Hormones|hormones|mesh-ancestor
14411682|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411683|NCT01576705|Leucovorin|leucovorin|mesh-list
14411684|NCT01576705|Folic Acid|folic acid|mesh-list
14411685|NCT01576705|Hormones|hormones|mesh-list
14411686|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
14411687|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743375|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245252|NCT03649633|Ascorbic Acid|ascorbic acid|mesh-list
15245253|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
15245254|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
15245255|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245256|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411688|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411689|NCT01576705|Antidotes|antidotes|mesh-ancestor
14743376|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743377|NCT00579475|Mifepristone|mifepristone|mesh-list
14743378|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14743379|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
14743380|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14743381|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743382|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14411690|NCT01576705|Protective Agents|protective agents|mesh-ancestor
14411691|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
14743383|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14743384|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14743385|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
14743386|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15245257|NCT03649633|Antioxidants|antioxidants|mesh-ancestor
15245258|NCT03649633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245259|NCT03649633|Protective Agents|protective agents|mesh-ancestor
15245260|NCT03623373|Cytarabine|cytarabine|mesh-list
15245261|NCT03623373|Rituximab|rituximab|mesh-list
15245262|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15245263|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
15245264|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245265|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245266|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
15245267|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743387|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14925426|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15245268|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245269|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15245270|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
15245271|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245272|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
15245273|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245274|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245275|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15245276|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
15245277|NCT03603964|Guadecitabine|guadecitabine|mesh-list
14411692|NCT01576705|Vitamins|vitamins|mesh-ancestor
14411693|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
14411694|NCT01576705|Hematinics|hematinics|mesh-ancestor
14411695|NCT01576718|Fluticasone|fluticasone|mesh-list
14411696|NCT01576718|Xhance|xhance|mesh-list
14411697|NCT01576718|Albuterol|albuterol|mesh-list
14411698|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
14411699|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411700|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14411701|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
14411702|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411703|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411704|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14411705|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
14411706|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
14411707|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14411708|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
14411709|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411710|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14411711|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14411712|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
14411713|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411714|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411715|NCT01576809|Acetaminophen|acetaminophen|mesh-list
15245278|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743388|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
14743389|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743390|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
15245279|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15245280|NCT03583528|Edotreotide|edotreotide|mesh-list
15245281|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14411716|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
14411717|NCT01576809|Phenylephrine|phenylephrine|mesh-list
14411718|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
14411719|NCT01576809|Guaifenesin|guaifenesin|mesh-list
14411720|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14411721|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14411722|NCT01576809|Analgesics|analgesics|mesh-ancestor
14411723|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
14411724|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743391|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245282|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245283|NCT03582774|Edetic Acid|edetic acid|mesh-list
15245284|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
15245285|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
15245286|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
15245287|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245288|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
15245289|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15245290|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14743392|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14743393|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
14743394|NCT00579592|Rituximab|rituximab|mesh-list
14743395|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
14925427|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
15245291|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
15245292|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245293|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245294|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
15245295|NCT03512210|Velpatasvir|velpatasvir|mesh-list
15245296|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
15245297|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245298|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15245299|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15245300|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245301|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
15245302|NCT03502577|Fludarabine|fludarabine|mesh-list
14411725|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411726|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
14411727|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14411728|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
15245303|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245304|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
14411729|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
14743396|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743397|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743398|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
14743399|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743400|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743401|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14411730|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
14411731|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14411732|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
14411733|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
14411734|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14411735|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15245305|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245306|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245307|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15245308|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
15245309|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245310|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743402|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14743403|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
14743404|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14743405|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743406|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743407|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743408|NCT00579644|Minocycline|minocycline|mesh-list
14743409|NCT00579644|Methotrexate|methotrexate|mesh-list
14743410|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14743411|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
14411736|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14411737|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
14411738|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411739|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411740|NCT01576809|Protective Agents|protective agents|mesh-ancestor
14411741|NCT01576809|Expectorants|expectorants|mesh-ancestor
14411742|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
14411743|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14411744|NCT01576874|Oxytocin|oxytocin|mesh-list
14411745|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
14411746|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411747|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411748|NCT01576952|Bromfenac|bromfenac|mesh-list
14411749|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14411750|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14411751|NCT01576952|Analgesics|analgesics|mesh-ancestor
14743412|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245311|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15245312|NCT03493854|Paclitaxel|paclitaxel|mesh-list
15245313|NCT03493854|Docetaxel|docetaxel|mesh-list
15245314|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
15245315|NCT03493854|Doxorubicin|doxorubicin|mesh-list
15245316|NCT03493854|Trastuzumab|trastuzumab|mesh-list
14743413|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743414|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14411752|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
14411753|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411754|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411755|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411756|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411757|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14411758|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14411759|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14411760|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411761|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411762|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411763|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14411764|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14411765|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
14411766|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411767|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411768|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14925428|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925429|NCT01404377|Ropivacaine|ropivacaine|mesh-list
14743415|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
14925430|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
14925431|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
14925432|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925433|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743416|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743417|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743418|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
14743419|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743420|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14743421|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743422|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
14743423|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743424|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14743425|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14743426|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743427|NCT00579956|Meropenem|meropenem|mesh-list
14743428|NCT00579956|Ceftazidime|ceftazidime|mesh-list
14743429|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14743430|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743431|NCT00579969|Timolol|timolol|mesh-list
14743432|NCT00579969|Latanoprost|latanoprost|mesh-list
14743433|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15245317|NCT03493854|Pertuzumab|pertuzumab|mesh-list
15245318|NCT03493854|Hormones|hormones|mesh-list
15245319|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15245320|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245321|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
14743434|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14743435|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
14743436|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925434|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
14925435|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925436|NCT01404442|Midazolam|midazolam|mesh-list
14411769|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14411770|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
14411771|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14411772|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14411773|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14411774|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411775|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411776|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411777|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14411778|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14411779|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
14411780|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411781|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411782|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14411783|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14411784|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
14411785|NCT01577706|Alprazolam|alprazolam|mesh-list
14411786|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
14411787|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14925437|NCT01404442|Ketamine|ketamine|mesh-list
15245322|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
15245323|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411788|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411789|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411790|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14411791|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14411792|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14411793|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
14411794|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
14411795|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411796|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411797|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14411798|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14411799|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14411800|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411801|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
14411802|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
14411803|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14411804|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14411805|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14411806|NCT01577966|Analgesics|analgesics|mesh-ancestor
14411807|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
14411808|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411809|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411810|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411811|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411812|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411813|NCT01578278|Fluticasone|fluticasone|mesh-list
14411814|NCT01578278|Xhance|xhance|mesh-list
14411815|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
14411816|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411817|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14411818|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
14411819|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411820|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411821|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14411822|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
14411823|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
14411824|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14411825|NCT01578317|Vaccines|vaccines|mesh-list
14411826|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
14411827|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411828|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14411829|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14411830|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411831|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411832|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
14411833|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411834|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14411835|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14411836|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14411837|NCT01578486|Analgesics|analgesics|mesh-ancestor
14411838|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
14743437|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411839|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411840|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743438|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743439|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14925438|NCT01404442|Analgesics|analgesics|mesh-ancestor
15245324|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245325|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245326|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
15245327|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245328|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245329|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14411841|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411842|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411843|NCT01578499|Methotrexate|methotrexate|mesh-list
14411844|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14411845|NCT01578499|Bexarotene|bexarotene|mesh-list
14411846|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14411847|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
14411848|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14411849|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411850|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15245330|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
15245331|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15245332|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15245333|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15245334|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15245335|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925439|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
14925440|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245336|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245337|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245338|NCT03383770|Anesthetics|anesthetics|mesh-list
15245339|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245340|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245341|NCT03381274|Osimertinib|osimertinib|mesh-list
15245342|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245343|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15245344|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245345|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245346|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
15245347|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245348|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245349|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14411851|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
14411852|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411853|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411854|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14411855|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411856|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14411857|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411858|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
14411859|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411860|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14411861|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743440|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14743441|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14743442|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14743443|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
14743444|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14743445|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
14743446|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743447|NCT00579995|Expectorants|expectorants|mesh-ancestor
14743448|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
14743449|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14743450|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
14743451|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245350|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245351|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245352|NCT03073941|Cimetidine|cimetidine|mesh-list
15245353|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15245354|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245355|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15245356|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
15245357|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
15245358|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245359|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245360|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245361|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15245362|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15245363|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743452|NCT00579995|Protective Agents|protective agents|mesh-ancestor
14925441|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411862|NCT01578551|Metformin|metformin|mesh-list
14411863|NCT01578551|Biguanides|biguanides|mesh-list
14411864|NCT01578551|Paclitaxel|paclitaxel|mesh-list
14411865|NCT01578551|Bevacizumab|bevacizumab|mesh-list
14411866|NCT01578551|Carboplatin|carboplatin|mesh-list
14411867|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14411868|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411869|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
14411870|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
14411871|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411872|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411873|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14411874|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14411875|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14411876|NCT01578551|Growth Substances|growth substances|mesh-ancestor
14411877|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411878|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
14411879|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14411880|NCT01578707|Ofatumumab|ofatumumab|mesh-list
14411881|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411882|NCT01578772|Telmisartan|telmisartan|mesh-list
14411883|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14411884|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14411885|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14411886|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411887|NCT01578850|Etanercept|etanercept|mesh-list
14411888|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14411889|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14743453|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743454|NCT00579995|Antidotes|antidotes|mesh-ancestor
14411890|NCT01578850|Analgesics|analgesics|mesh-ancestor
14411891|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
14411892|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411893|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411894|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411895|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14411896|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411897|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14411898|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
14411899|NCT01578980|Pancrelipase|pancrelipase|mesh-list
14411900|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411901|NCT01579162|Cholic Acids|cholic acids|mesh-list
14411902|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411903|NCT01579305|Lidocaine|lidocaine|mesh-list
14743455|NCT00580060|Molgramostim|molgramostim|mesh-list
14743456|NCT00580060|Sargramostim|sargramostim|mesh-list
14743457|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
15245364|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
15245365|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15245366|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15245367|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245368|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
14411904|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
15245369|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
15245370|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245371|NCT02668822|Ibuprofen|ibuprofen|mesh-list
15245372|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15245373|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15245374|NCT02668822|Analgesics|analgesics|mesh-ancestor
15245375|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
15245376|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245377|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245378|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743458|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743459|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743460|NCT00580112|Dexamethasone|dexamethasone|mesh-list
14743461|NCT00580112|Trabectedin|trabectedin|mesh-list
14743462|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743463|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
14411905|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
14411906|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14411907|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411908|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
14411909|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411910|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14411911|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14411912|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14411913|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411914|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411915|NCT01579318|Interleukin-12|interleukin-12|mesh-list
14411916|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14411917|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
14411918|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411919|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14411920|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14411921|NCT01579318|Growth Substances|growth substances|mesh-ancestor
14411922|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
14411923|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411924|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
14743464|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
14743465|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245379|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245380|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14743466|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743467|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14743468|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
14743469|NCT00580112|Hormones|hormones|mesh-ancestor
14743470|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411925|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14411926|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14411927|NCT01579513|Prednisolone|prednisolone|mesh-list
14411928|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
14411929|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14411930|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
14411931|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
14411932|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743471|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14743472|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743473|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14743474|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
14743475|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753392|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14753393|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
14411933|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
14411934|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
14411935|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245381|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245382|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245383|NCT02668783|Ibuprofen|ibuprofen|mesh-list
15245384|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15245385|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15245386|NCT02668783|Etonogestrel|etonogestrel|mesh-list
15245387|NCT02668783|Estradiol|estradiol|mesh-list
15245388|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15245389|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15245390|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15245391|NCT02668783|Analgesics|analgesics|mesh-ancestor
15245392|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
15245393|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245394|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245395|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15245396|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245397|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15245398|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245399|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245400|NCT02668783|Estrogens|estrogens|mesh-ancestor
15245401|NCT02668783|Hormones|hormones|mesh-ancestor
15245402|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245403|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245404|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245405|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14743476|NCT00580190|Alprazolam|alprazolam|mesh-list
14743477|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14743478|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743479|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411936|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411937|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245406|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245407|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15245408|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15245409|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
15245410|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15245411|NCT02616146|Etonogestrel|etonogestrel|mesh-list
15245412|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15245413|NCT02616146|Estradiol|estradiol|mesh-list
15245414|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15245415|NCT02616146|Estrogens|estrogens|mesh-ancestor
15245416|NCT02616146|Hormones|hormones|mesh-ancestor
15245417|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245418|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245419|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245420|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245421|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245422|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245423|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15245424|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15245425|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245426|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15245427|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
15245428|NCT02538510|Vorinostat|vorinostat|mesh-list
15245429|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245430|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245431|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15245432|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245433|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245434|NCT02489942|Empagliflozin|empagliflozin|mesh-list
15245435|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15245436|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245437|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14743480|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743481|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743482|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245438|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245439|NCT02477644|Olaparib|olaparib|mesh-list
15245440|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15245441|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245442|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411938|NCT01579513|Hormones|hormones|mesh-ancestor
14411939|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411940|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14411941|NCT01579513|Protective Agents|protective agents|mesh-ancestor
14411942|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14411943|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411944|NCT01579578|Paclitaxel|paclitaxel|mesh-list
14411945|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14411946|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411947|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
14411948|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
14411949|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
14411950|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411951|NCT01579812|Metformin|metformin|mesh-list
14411952|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14411953|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411954|NCT01580020|Dexamethasone|dexamethasone|mesh-list
14411955|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14411956|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
14411957|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
15245443|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245444|NCT02420860|Lenalidomide|lenalidomide|mesh-list
14743483|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
15245445|NCT02420860|Elotuzumab|elotuzumab|mesh-list
14743484|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
14411958|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411959|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743485|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743486|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743487|NCT00580242|Lenalidomide|lenalidomide|mesh-list
14743488|NCT00580242|Bortezomib|bortezomib|mesh-list
14743489|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
14743490|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743491|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743492|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743493|NCT00580242|Growth Substances|growth substances|mesh-ancestor
14743494|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14743495|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743496|NCT00580320|Bortezomib|bortezomib|mesh-list
14743497|NCT00580320|Dacarbazine|dacarbazine|mesh-list
14743498|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411960|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411961|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
14411962|NCT01580020|Hormones|hormones|mesh-ancestor
14743499|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14743500|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
14743501|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743502|NCT00580359|Capecitabine|capecitabine|mesh-list
14743503|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14743504|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
14743505|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743506|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743507|NCT00580424|Norethindrone|norethindrone|mesh-list
14743508|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
14743509|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14743510|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14743511|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14743512|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
14743513|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14743514|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743515|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14743516|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14925442|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14411963|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14411964|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14743517|NCT00580437|Dobutamine|dobutamine|mesh-list
14411965|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411966|NCT01580293|Factor VIII|factor viii|mesh-list
14411967|NCT01580293|Coagulants|coagulants|mesh-ancestor
14411968|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
14411969|NCT01580410|Mitomycins|mitomycins|mesh-list
14411970|NCT01580410|Mitomycin|mitomycin|mesh-list
14411971|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14411972|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14411973|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
14411974|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411975|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14743518|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14743519|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
14743520|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
14743521|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743522|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743523|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15245446|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
15245447|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245448|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15245449|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15245450|NCT02420860|Growth Substances|growth substances|mesh-ancestor
15245451|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
15245452|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245453|NCT02420613|Sirolimus|sirolimus|mesh-list
15245454|NCT02420613|Vorinostat|vorinostat|mesh-list
15245455|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15245456|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245457|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15245458|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245459|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
15245460|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245461|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
15245462|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411976|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411977|NCT01580423|Aprepitant|aprepitant|mesh-list
14411978|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
14411979|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
14411980|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14411981|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411982|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14411983|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14411984|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14411985|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411986|NCT01580488|Calcitriol|calcitriol|mesh-list
14411987|NCT01580488|Calcipotriene|calcipotriene|mesh-list
14411988|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14411989|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
14411990|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14411991|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14411992|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14411993|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14411994|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14411995|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15245463|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15245464|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14411996|NCT01580488|Vitamins|vitamins|mesh-ancestor
14411997|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
14411998|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14411999|NCT01580592|Omalizumab|omalizumab|mesh-list
14412000|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14412001|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14412002|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14412003|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412004|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
14412005|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412006|NCT01580618|Tenecteplase|tenecteplase|mesh-list
14412007|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14412008|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14412009|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467713|NCT02264821|Narcotics|narcotics|mesh-ancestor
14467714|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467715|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467716|NCT02264821|Analgesics|analgesics|mesh-ancestor
14467717|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
14467718|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467719|NCT02264990|Paclitaxel|paclitaxel|mesh-list
14467720|NCT02264990|Carboplatin|carboplatin|mesh-list
14467721|NCT02264990|Pemetrexed|pemetrexed|mesh-list
14467722|NCT02264990|Veliparib|veliparib|mesh-list
14467723|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14467724|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467725|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
14467726|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
15245465|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245466|NCT02409342|Gemcitabine|gemcitabine|mesh-list
15245467|NCT02409342|Carboplatin|carboplatin|mesh-list
15245468|NCT02409342|Pemetrexed|pemetrexed|mesh-list
15245469|NCT02409342|Atezolizumab|atezolizumab|mesh-list
15245470|NCT02409342|Antibodies|antibodies|mesh-list
15245471|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15245472|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
15245473|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245474|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245475|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15245476|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
15245477|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245478|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
14467727|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
15245479|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412010|NCT01580670|Infliximab|infliximab|mesh-list
15245480|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245481|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245482|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15245483|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15245484|NCT02394535|Paclitaxel|paclitaxel|mesh-list
15245485|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14412011|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14412012|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245486|NCT02394535|Capecitabine|capecitabine|mesh-list
15245487|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15245488|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245489|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
14743524|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14412013|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412014|NCT01580969|Minocycline|minocycline|mesh-list
14743525|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14743526|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
14412015|NCT01580969|Bevacizumab|bevacizumab|mesh-list
14412016|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412017|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412018|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14412019|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14412020|NCT01580969|Growth Substances|growth substances|mesh-ancestor
14412021|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412022|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
14412023|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14412024|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412025|NCT01580995|Valacyclovir|valacyclovir|mesh-list
14412026|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
14412027|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412028|NCT01581281|Topiramate|topiramate|mesh-list
14412029|NCT01581281|Amitriptyline|amitriptyline|mesh-list
14412030|NCT01581281|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14412031|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
14412032|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412033|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412034|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14412035|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
14412036|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14412037|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14412038|NCT01581281|Analgesics|analgesics|mesh-ancestor
14412039|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
14412040|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412041|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14412042|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14412043|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412044|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412045|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
14412046|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412047|NCT01581281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14412048|NCT01581281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14412049|NCT01581281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412050|NCT01581307|Leucovorin|leucovorin|mesh-list
14412051|NCT01581307|Folic Acid|folic acid|mesh-list
14412052|NCT01581307|Fluorouracil|fluorouracil|mesh-list
14743527|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412053|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
14412054|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
14412055|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
14412056|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412057|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14412058|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412059|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412060|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
14412061|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412062|NCT01581307|Antidotes|antidotes|mesh-ancestor
14412063|NCT01581307|Protective Agents|protective agents|mesh-ancestor
14412064|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
14412065|NCT01581307|Vitamins|vitamins|mesh-ancestor
14412066|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
14412067|NCT01581307|Hematinics|hematinics|mesh-ancestor
14412068|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
14412069|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412070|NCT01581658|Empagliflozin|empagliflozin|mesh-list
14412071|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14412072|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412073|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412074|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412075|NCT01581710|Montelukast|montelukast|mesh-list
14412076|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14412077|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412078|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14412079|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
15245490|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
15245491|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
15245492|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245493|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14412080|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412081|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412082|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14412083|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14412084|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412085|NCT01581931|Metformin|metformin|mesh-list
14412086|NCT01581931|Linagliptin|linagliptin|mesh-list
14412087|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14743528|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743529|NCT00580437|Protective Agents|protective agents|mesh-ancestor
14743530|NCT00580450|Thymalfasin|thymalfasin|mesh-list
14743531|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14743532|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
14743533|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245494|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
15245495|NCT02385110|Dexamethasone|dexamethasone|mesh-list
15245496|NCT02385110|Methotrexate|methotrexate|mesh-list
15245497|NCT02385110|Etoposide|etoposide|mesh-list
15245498|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
15245499|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15245500|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
14412088|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412089|NCT01581931|Incretins|incretins|mesh-ancestor
14412090|NCT01581931|Hormones|hormones|mesh-ancestor
14469969|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469970|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14469971|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14469972|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
14469973|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412091|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412092|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14412093|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
14412094|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412095|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412096|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
14412097|NCT01581970|Cetuximab|cetuximab|mesh-list
14412098|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925443|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14925444|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
14925445|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
14925446|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925447|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14925448|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14925449|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925450|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925451|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925452|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14925453|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14925454|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14925455|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14925456|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
14925457|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
14925458|NCT01404468|Lidocaine|lidocaine|mesh-list
14925459|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
14925460|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
14925461|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925462|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925463|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
14925464|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925465|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14925466|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14925467|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14412099|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
14412100|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245501|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
14925468|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14925469|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925470|NCT01404507|Abciximab|abciximab|mesh-list
14925471|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
15245502|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245503|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245504|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245505|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
14743534|NCT00580489|Fentanyl|fentanyl|mesh-list
14743535|NCT00580489|Morphine|morphine|mesh-list
14743536|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14743537|NCT00580489|Narcotics|narcotics|mesh-ancestor
14743538|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925472|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14412101|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412102|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14412103|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
14412104|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412105|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412106|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14412107|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412108|NCT01582009|Everolimus|everolimus|mesh-list
14925473|NCT01404598|Naproxen|naproxen|mesh-list
14925474|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14925475|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14925476|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14925477|NCT01404598|Analgesics|analgesics|mesh-ancestor
14925478|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
14925479|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925480|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925481|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15245506|NCT02385110|Hormones|hormones|mesh-ancestor
14412109|NCT01582009|Panobinostat|panobinostat|mesh-list
14743539|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743540|NCT00580489|Analgesics|analgesics|mesh-ancestor
14743541|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
14743542|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743543|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925482|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412110|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14412111|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412112|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412113|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
15245507|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245508|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14412114|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412115|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412116|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412117|NCT01582061|Pasireotide|pasireotide|mesh-list
14412118|NCT01582061|Hormones|hormones|mesh-ancestor
14412119|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412120|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412121|NCT01582152|Bevacizumab|bevacizumab|mesh-list
14412122|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412123|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412124|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14412125|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14412126|NCT01582152|Growth Substances|growth substances|mesh-ancestor
14412127|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412128|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
14412129|NCT01582243|Vildagliptin|vildagliptin|mesh-list
14412130|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412131|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412132|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14412133|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
14412134|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412135|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412136|NCT01582282|Psyllium|psyllium|mesh-list
14412137|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
14412138|NCT01582282|Cathartics|cathartics|mesh-ancestor
14412139|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14412140|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
14412141|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14412142|NCT01582308|Vildagliptin|vildagliptin|mesh-list
14412143|NCT01582308|Saxagliptin|saxagliptin|mesh-list
14412144|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412145|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412146|NCT01582308|Incretins|incretins|mesh-ancestor
14412147|NCT01582308|Hormones|hormones|mesh-ancestor
14412148|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412149|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14412150|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
14412151|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412152|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412153|NCT01582451|Insulin|insulin|mesh-list
14412154|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14412155|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
15245509|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245510|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15245511|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
14412156|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412157|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412158|NCT01582477|Bupivacaine|bupivacaine|mesh-list
14412159|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
14412160|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
14412161|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412162|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245512|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245513|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15245514|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
15245515|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245516|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
15245517|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245518|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15245519|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412163|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
14412164|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412165|NCT01582490|Bupivacaine|bupivacaine|mesh-list
14412166|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
14412167|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
14412168|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412169|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412170|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
14412171|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412172|NCT01582854|Actovegin|actovegin|mesh-list
14412173|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14412174|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412175|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14412176|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14412177|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
14412178|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412179|NCT01582854|Protective Agents|protective agents|mesh-ancestor
14412180|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14412181|NCT01582880|Riboflavin|riboflavin|mesh-list
14412182|NCT01582880|Vitamins|vitamins|mesh-ancestor
14412183|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
14412184|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412185|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
14412186|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14412187|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
14412188|NCT01582945|Ketamine|ketamine|mesh-list
14743544|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14743545|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
14743546|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
14743547|NCT00580619|Methyldopa|methyldopa|mesh-list
14743548|NCT00580619|Trimethaphan|trimethaphan|mesh-list
14412189|NCT01582945|Analgesics|analgesics|mesh-ancestor
14412190|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
14412191|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412192|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412193|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14412194|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14412195|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
14412196|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
14412197|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412198|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14743549|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
14743550|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743551|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14743552|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
14743553|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
14743554|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743555|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743556|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14743557|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14743558|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14412199|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14412200|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412201|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412202|NCT01583166|Epinephrine|epinephrine|mesh-list
14412203|NCT01583166|Bupivacaine|bupivacaine|mesh-list
14412204|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
14412205|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
14412206|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412207|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412208|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
14412209|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412210|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14412211|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14925483|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
14925484|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14412212|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
14412213|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412214|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412215|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14412216|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14412217|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
14412218|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14412219|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412220|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
14412221|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
14412222|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14412223|NCT01583179|Buprenorphine|buprenorphine|mesh-list
14412224|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14743559|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
14743560|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743561|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14743562|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14743563|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14743564|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14743565|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
14412225|NCT01583179|Narcotics|narcotics|mesh-ancestor
14412226|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412227|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412228|NCT01583179|Analgesics|analgesics|mesh-ancestor
14412229|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
14412230|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412231|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14412232|NCT01583218|Enoxaparin|enoxaparin|mesh-list
14412233|NCT01583218|Betrixaban|betrixaban|mesh-list
14412234|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
14743566|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
14743567|NCT00580814|Methylphenidate|methylphenidate|mesh-list
14743568|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14743569|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743570|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14743571|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14743572|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743573|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925485|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245520|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
14412235|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14412236|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14412237|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412238|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14412239|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
14412240|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14412241|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
14412242|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412243|NCT01583374|Thalidomide|thalidomide|mesh-list
14412244|NCT01583374|Apremilast|apremilast|mesh-list
14412245|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15245521|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245522|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15245523|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15245524|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15245525|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15245526|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245527|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
15245528|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412246|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15245529|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245530|NCT02316834|Talazoparib|talazoparib|mesh-list
15245531|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15245532|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245533|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743574|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
14743575|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743576|NCT00580827|Disulfiram|disulfiram|mesh-list
14743577|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14743578|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14743579|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743580|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743581|NCT00580905|Adenosine|adenosine|mesh-list
14743582|NCT00580905|Nitroprusside|nitroprusside|mesh-list
14743583|NCT00580905|Analgesics|analgesics|mesh-ancestor
14743584|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
14743585|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412247|NCT01583374|Analgesics|analgesics|mesh-ancestor
14412248|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
14412249|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412250|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412251|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412252|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412253|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14412254|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14412255|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412256|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412257|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412258|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
14412259|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
14412260|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14412261|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412262|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14412263|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14412264|NCT01583374|Growth Substances|growth substances|mesh-ancestor
14743586|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743587|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14743588|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
14743589|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14743590|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
15245534|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245535|NCT02293655|Methylphenidate|methylphenidate|mesh-list
15245536|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14412265|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
14412266|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412267|NCT01583530|Belimumab|belimumab|mesh-list
14412268|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412269|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
14412270|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412271|NCT01583543|Olaparib|olaparib|mesh-list
15245537|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245538|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15245539|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15245540|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412272|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14412273|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412274|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412275|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412276|NCT01583686|Aldesleukin|aldesleukin|mesh-list
14412277|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
14412278|NCT01583686|Fludarabine|fludarabine|mesh-list
14412279|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412280|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
14743591|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
14925486|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925487|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14412281|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412282|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412283|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14412284|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
14412285|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412286|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412287|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14412288|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14412289|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14412290|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
14412291|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412292|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
14412293|NCT01583985|Narcotics|narcotics|mesh-ancestor
15245541|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245542|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
15245543|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245544|NCT02275546|NuvaRing|nuvaring|mesh-list
15245545|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15245546|NCT02275546|Desogestrel|desogestrel|mesh-list
15245547|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14412294|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245548|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245549|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245550|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245551|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245552|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15245553|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245554|NCT02275546|Estrogens|estrogens|mesh-ancestor
14743592|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743593|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743594|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14743595|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14743596|NCT00580931|Niacinamide|niacinamide|mesh-list
14743597|NCT00580931|Niacin|niacin|mesh-list
14743598|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
14743599|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
14743600|NCT00580931|Vitamins|vitamins|mesh-ancestor
14743601|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
14743602|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743603|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14743604|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
14743605|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743606|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14743607|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
14743608|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
14743609|NCT00581009|Sertraline|sertraline|mesh-list
14743610|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
14743611|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14412295|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412296|NCT01583985|Analgesics|analgesics|mesh-ancestor
14412297|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
14412298|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412299|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
14412300|NCT01584232|Dulaglutide|dulaglutide|mesh-list
14743612|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15245555|NCT02275546|Hormones|hormones|mesh-ancestor
14925488|NCT01404637|Tamsulosin|tamsulosin|mesh-list
15245556|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245557|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15245558|NCT02275546|Progestins|progestins|mesh-ancestor
15245559|NCT02131597|Guadecitabine|guadecitabine|mesh-list
15245560|NCT02131597|Azacitidine|azacitidine|mesh-list
15245561|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245562|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14412301|NCT01584232|Biguanides|biguanides|mesh-list
14743613|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14743614|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15245563|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
14412302|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14925489|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14925490|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14925491|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14925492|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
14925493|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412303|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412304|NCT01584388|Rituximab|rituximab|mesh-list
14412305|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412306|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412307|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
14412308|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412309|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412310|NCT01584440|Quinidine|quinidine|mesh-list
14412311|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
14412312|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
14743615|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743616|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743617|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
14743618|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743619|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412313|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412314|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14412315|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14412316|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412317|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412318|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412319|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14412320|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14412321|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
14412322|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14412323|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
14412324|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14412325|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14412326|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412327|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412328|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14412329|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14412330|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
14412331|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14412332|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14412333|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412334|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14412335|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14412336|NCT01584518|Furosemide|furosemide|mesh-list
14412337|NCT01584518|Diuretics|diuretics|mesh-ancestor
14412338|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
14412339|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412340|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14412341|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412342|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412343|NCT01584544|Capecitabine|capecitabine|mesh-list
14412344|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14743620|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
14743621|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743622|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743623|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14743624|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
14743625|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743626|NCT00581139|Midazolam|midazolam|mesh-list
14743627|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
14925494|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925495|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925496|NCT01404637|Urological Agents|urological agents|mesh-ancestor
14925497|NCT01404676|Glimepiride|glimepiride|mesh-list
14925498|NCT01404676|Vildagliptin|vildagliptin|mesh-list
14925499|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14925500|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14925501|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925502|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743628|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743629|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743630|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14743631|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14743632|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743633|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743634|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743635|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14743636|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
14743637|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
14743638|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
14743639|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743640|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412345|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
14412346|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412347|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412348|NCT01584648|Trametinib|trametinib|mesh-list
14412349|NCT01584648|Dabrafenib|dabrafenib|mesh-list
14412350|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412351|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14412352|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412353|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412354|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
14925503|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
14925504|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14925505|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
14925506|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925507|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925508|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
14925509|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15245564|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245565|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245566|NCT02077166|Rituximab|rituximab|mesh-list
15245567|NCT02077166|Lenalidomide|lenalidomide|mesh-list
15245568|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412355|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14412356|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14412357|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14412358|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412359|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412360|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
14412361|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412362|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412363|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14412364|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412365|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14412366|NCT01585025|Cathartics|cathartics|mesh-ancestor
14412367|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14412368|NCT01585038|Efavirenz|efavirenz|mesh-list
14412369|NCT01585038|Rilpivirine|rilpivirine|mesh-list
14412370|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14412371|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14412372|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412373|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412374|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
15245569|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245570|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
14743641|NCT00581165|Etanercept|etanercept|mesh-list
14743642|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14743643|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14743644|NCT00581165|Analgesics|analgesics|mesh-ancestor
14743645|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
14743646|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743647|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743648|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743649|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743650|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245571|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245572|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245573|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15245574|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15245575|NCT02077166|Growth Substances|growth substances|mesh-ancestor
14743651|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412375|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412376|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14743652|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
14743653|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14743654|NCT00581217|Laxatives|laxatives|mesh-ancestor
14743655|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14743656|NCT00581425|Interferons|interferons|mesh-list
14743657|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
14743658|NCT00581425|Imiquimod|imiquimod|mesh-list
14743659|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743660|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
14743661|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743662|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
14743663|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743664|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15245576|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
15245577|NCT02027935|Aldesleukin|aldesleukin|mesh-list
15245578|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
15245579|NCT02027935|Ipilimumab|ipilimumab|mesh-list
15245580|NCT02027935|Interleukin-2|interleukin-2|mesh-list
15245581|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245582|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
14743665|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
14412377|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14412378|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14412379|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14412380|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14412381|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14412382|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14412383|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14925510|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925511|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925512|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14925513|NCT01404689|Analgesics|analgesics|mesh-ancestor
14925514|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
14925515|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925516|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14925517|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15245583|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245584|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245585|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15245586|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
15245587|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245588|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245589|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15245590|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245591|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15245592|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14412384|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14412385|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14412386|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412387|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
15245593|NCT02027935|Analgesics|analgesics|mesh-ancestor
15245594|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
15245595|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245596|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15245597|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15245598|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
15245599|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245600|NCT01965132|Adalimumab|adalimumab|mesh-list
14925518|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14412388|NCT01585168|Memantine|memantine|mesh-list
15245601|NCT01965132|Etanercept|etanercept|mesh-list
15245602|NCT01965132|Golimumab|golimumab|mesh-list
15245603|NCT01965132|Abatacept|abatacept|mesh-list
15245604|NCT01965132|Infliximab|infliximab|mesh-list
15245605|NCT01965132|Upadacitinib|upadacitinib|mesh-list
15245606|NCT01965132|Ustekinumab|ustekinumab|mesh-list
15245607|NCT01965132|Ixekizumab|ixekizumab|mesh-list
15245608|NCT01965132|Tofacitinib|tofacitinib|mesh-list
15245609|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245610|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
15245611|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245612|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245613|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412389|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14412390|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14412391|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
14412392|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412393|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412394|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412395|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14412396|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14412397|NCT01585194|Nivolumab|nivolumab|mesh-list
14412398|NCT01585194|Ipilimumab|ipilimumab|mesh-list
14412399|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412400|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412401|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14412402|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412403|NCT01585207|Vigabatrin|vigabatrin|mesh-list
14412404|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
14412405|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412406|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412407|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
14412408|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412409|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412410|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
14412411|NCT01585246|Urological Agents|urological agents|mesh-ancestor
14412412|NCT01585272|Rivastigmine|rivastigmine|mesh-list
14412413|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14412414|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412415|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412416|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
14412417|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412418|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412419|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14412420|NCT01585272|Protective Agents|protective agents|mesh-ancestor
14412421|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14412422|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14412423|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412424|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412425|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
14412426|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412427|NCT01585324|Ribavirin|ribavirin|mesh-list
14412428|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14412429|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
15245614|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
15245615|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245616|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14412430|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412431|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
14412432|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412433|NCT01585428|Aldesleukin|aldesleukin|mesh-list
14412434|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
14412435|NCT01585428|Fludarabine|fludarabine|mesh-list
14412436|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412437|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
15245617|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15245618|NCT01965132|Analgesics|analgesics|mesh-ancestor
15245619|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
15245620|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245621|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245622|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15245623|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245624|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15245625|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245626|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15245627|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15245628|NCT01891344|Rucaparib|rucaparib|mesh-list
15245629|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15245630|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245631|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245632|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245633|NCT01847274|Niraparib|niraparib|mesh-list
14412438|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412439|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412440|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14412441|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
14412442|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412443|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412444|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14412445|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14412446|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14412447|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
14412448|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412449|NCT01585441|Finasteride|finasteride|mesh-list
14412450|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14412451|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14412452|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245634|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15245635|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245636|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245637|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245638|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15245639|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15245640|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245641|NCT01670656|Ibuprofen|ibuprofen|mesh-list
15245642|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
15245643|NCT01670656|Etonogestrel|etonogestrel|mesh-list
15245644|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15245645|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15245646|NCT01670656|Analgesics|analgesics|mesh-ancestor
15245647|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
15245648|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245649|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245650|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412453|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245651|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245652|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15245653|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245654|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245655|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245656|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245657|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245658|NCT01648751|Estrogens|estrogens|mesh-list
15245659|NCT01648751|Hormones|hormones|mesh-ancestor
15245660|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245661|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245662|NCT01498770|Olanzapine|olanzapine|mesh-list
15245663|NCT01498770|Risperidone|risperidone|mesh-list
15245664|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15245665|NCT01498770|Aripiprazole|aripiprazole|mesh-list
15245666|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15245667|NCT01498770|Ziprasidone|ziprasidone|mesh-list
15245668|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15245669|NCT01498770|Clozapine|clozapine|mesh-list
15245670|NCT01498770|Asenapine|asenapine|mesh-list
15245671|NCT01498770|Amisulpride|amisulpride|mesh-list
15245672|NCT01498770|Iloperidone|iloperidone|mesh-list
15245673|NCT01498770|Sertindole|sertindole|mesh-list
15245674|NCT01498770|Zotepine|zotepine|mesh-list
14412454|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
14412455|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412456|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743666|NCT00581607|Bosentan|bosentan|mesh-list
15245675|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15245676|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
15245677|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925519|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
15245678|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245679|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245680|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15245681|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245682|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245683|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245684|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15245685|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
15245686|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
15245687|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
14743667|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14743668|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14743669|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743670|NCT00581685|Celecoxib|celecoxib|mesh-list
14743671|NCT00581685|Pregabalin|pregabalin|mesh-list
14743672|NCT00581685|Analgesics|analgesics|mesh-ancestor
14743673|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
14743674|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925520|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245688|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245689|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245690|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15245691|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15245692|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15245693|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
15245694|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
15245695|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15245696|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15245697|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15245698|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15245699|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15245700|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15245701|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15245702|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
15245703|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
15245704|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
15245705|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15245706|NCT01335399|Dexamethasone|dexamethasone|mesh-list
15245707|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
15245708|NCT01335399|Lenalidomide|lenalidomide|mesh-list
15245709|NCT01335399|Elotuzumab|elotuzumab|mesh-list
15245710|NCT01335399|BB 1101|bb 1101|mesh-list
14412457|NCT01585441|Urological Agents|urological agents|mesh-ancestor
14925521|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245711|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15245712|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
14743675|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743676|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
14743677|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14743678|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743679|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743680|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14743681|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743682|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743683|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743684|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743685|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14743686|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14743687|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925522|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
14925523|NCT01404702|Aldesleukin|aldesleukin|mesh-list
14925524|NCT01404702|Interleukin-2|interleukin-2|mesh-list
15245713|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
14412458|NCT01585558|Tamoxifen|tamoxifen|mesh-list
14412459|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15245714|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412460|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
14412461|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412462|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412463|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14412464|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412465|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14412466|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14412467|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14412468|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
14412469|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743688|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412470|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412471|NCT01585831|Testosterone|testosterone|mesh-list
14743689|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14743690|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14743691|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743692|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14743693|NCT00581789|Sunitinib|sunitinib|mesh-list
14743694|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743695|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14743696|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743697|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743698|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743699|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743700|NCT00581789|Growth Substances|growth substances|mesh-ancestor
14743701|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743702|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753394|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753395|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753396|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14753397|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
14753398|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753399|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753400|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14412472|NCT01585831|Androgens|androgens|mesh-ancestor
14412473|NCT01585831|Hormones|hormones|mesh-ancestor
14412474|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753401|NCT05174832|Paclitaxel|paclitaxel|mesh-list
14753402|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
14753403|NCT05174832|Olaparib|olaparib|mesh-list
14753404|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15245715|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245716|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245717|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
15245718|NCT01335399|Hormones|hormones|mesh-ancestor
15245719|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245720|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15245721|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245722|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
15245723|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245724|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245725|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
15245726|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15245727|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15245728|NCT01335399|Growth Substances|growth substances|mesh-ancestor
15245729|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
15245730|NCT01277211|NuvaRing|nuvaring|mesh-list
15245731|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245732|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245733|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245734|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245735|NCT01267812|Rituximab|rituximab|mesh-list
15245736|NCT01267812|Bortezomib|bortezomib|mesh-list
15245737|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15245738|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245739|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
14743703|NCT00582582|Vitamin D|vitamin d|mesh-list
14743704|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14743705|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14743706|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14743707|NCT00582582|Docetaxel|docetaxel|mesh-list
14743708|NCT00582582|Vitamins|vitamins|mesh-ancestor
14743709|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
15245740|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245741|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245742|NCT01244828|Asenapine|asenapine|mesh-list
15245743|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15245744|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245745|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245746|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245747|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245748|NCT01047540|Pritelivir|pritelivir|mesh-list
15245749|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
15245750|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15245751|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245752|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245753|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
15245754|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
15245755|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15245756|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15245757|NCT01044056|NuvaRing|nuvaring|mesh-list
15245758|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
15245759|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245760|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245761|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245762|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245763|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15245764|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245765|NCT01044056|Estrogens|estrogens|mesh-ancestor
15245766|NCT01044056|Hormones|hormones|mesh-ancestor
15245767|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245768|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15245769|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15245770|NCT01005056|Desogestrel|desogestrel|mesh-list
15245771|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245772|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15245773|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245774|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245775|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245776|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245777|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245778|NCT01005056|Estrogens|estrogens|mesh-ancestor
15245779|NCT01005056|Hormones|hormones|mesh-ancestor
15245780|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245781|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15245782|NCT01005056|Progestins|progestins|mesh-ancestor
15245783|NCT00967746|Etonogestrel|etonogestrel|mesh-list
15245784|NCT00967746|Desogestrel|desogestrel|mesh-list
15245785|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245786|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245787|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245788|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245789|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245790|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245791|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15245792|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14743710|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743711|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743712|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14743713|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14743714|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14743715|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743716|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14412475|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412476|NCT01585987|Ipilimumab|ipilimumab|mesh-list
14412477|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14743717|NCT00582634|Docetaxel|docetaxel|mesh-list
14743718|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412478|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412479|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14743719|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
14743720|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14743721|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14743722|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743723|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
14743724|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14743725|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743726|NCT00582985|Antibodies|antibodies|mesh-list
15245793|NCT00967746|Progestins|progestins|mesh-ancestor
15245794|NCT00967746|Hormones|hormones|mesh-ancestor
15245795|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245796|NCT00944216|Emollients|emollients|mesh-list
15245797|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
15245798|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15245799|NCT00920634|Hormones|hormones|mesh-ancestor
15245800|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245801|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245802|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15245803|NCT00920361|Hormones|hormones|mesh-ancestor
15245804|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245805|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245806|NCT00886691|Bevacizumab|bevacizumab|mesh-list
14412480|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412481|NCT01586091|Fexofenadine|fexofenadine|mesh-list
14412482|NCT01586091|Levocetirizine|levocetirizine|mesh-list
14412483|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14412484|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14412485|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
14412486|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
14412487|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412488|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412489|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412490|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14412491|NCT01586156|Carvedilol|carvedilol|mesh-list
14412492|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14412493|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14412494|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
14412495|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412496|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412497|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412498|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14412499|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
14412500|NCT01586156|Protective Agents|protective agents|mesh-ancestor
14412501|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14412502|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412503|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14412504|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
14412505|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14412506|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14412507|NCT01586195|Vemurafenib|vemurafenib|mesh-list
14412508|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412509|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14412510|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743727|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
15245807|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15245808|NCT00886691|Everolimus|everolimus|mesh-list
15245809|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
15245810|NCT00886691|Antibodies|antibodies|mesh-list
15245811|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
15245812|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15245813|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
15245814|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245815|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15245816|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15245817|NCT00886691|Growth Substances|growth substances|mesh-ancestor
15245818|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245819|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
14412511|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412512|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
14412513|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14412514|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
14412515|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412516|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
14412517|NCT01586312|Protective Agents|protective agents|mesh-ancestor
14412518|NCT01586338|Hylan|hylan|mesh-list
14412519|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
14412520|NCT01586338|Protective Agents|protective agents|mesh-ancestor
14412521|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412522|NCT01586806|Dexamethasone|dexamethasone|mesh-list
14412523|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
14412524|NCT01586806|Bupivacaine|bupivacaine|mesh-list
14412525|NCT01586806|BB 1101|bb 1101|mesh-list
14412526|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412527|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
14412528|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
14412529|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412530|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412531|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14412532|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
15245820|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
15245821|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15245822|NCT00878462|Asenapine|asenapine|mesh-list
15245823|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14412533|NCT01586806|Hormones|hormones|mesh-ancestor
14412534|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412535|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14412536|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412537|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
15245824|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245825|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245826|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245827|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245828|NCT00778999|Desogestrel|desogestrel|mesh-list
15245829|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245830|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15245831|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245832|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245833|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245834|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245835|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245836|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15245837|NCT00778999|Progestins|progestins|mesh-ancestor
15245838|NCT00778999|Hormones|hormones|mesh-ancestor
15245839|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245840|NCT00725413|Etonogestrel|etonogestrel|mesh-list
15245841|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245842|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245843|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245844|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412538|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245845|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14412539|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412540|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
14412541|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
14412542|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412543|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
14412544|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
14412545|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14412546|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412547|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412548|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
14412549|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412550|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412551|NCT01586962|Acetaminophen|acetaminophen|mesh-list
14412552|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
14412553|NCT01586962|Ephedrine|ephedrine|mesh-list
14925525|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925526|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14925527|NCT01404702|Analgesics|analgesics|mesh-ancestor
14925528|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
14925529|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925530|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412554|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14412555|NCT01586962|Analgesics|analgesics|mesh-ancestor
14412556|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
14412557|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412558|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412559|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
14412560|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14412561|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
14412562|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14412563|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412564|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
14412565|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14412566|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14412567|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
14412568|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
14412569|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412570|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412571|NCT01586975|Aspirin|aspirin|mesh-list
14412572|NCT01586975|Clopidogrel|clopidogrel|mesh-list
14412573|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14412574|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14412575|NCT01586975|Analgesics|analgesics|mesh-ancestor
14412576|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
14412577|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412578|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412579|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412580|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412581|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14412582|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14412583|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412584|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14412585|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14412586|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412587|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
14412588|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14412589|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14412590|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14412591|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
14412592|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412593|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
14412594|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14412595|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
14412596|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925531|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15245846|NCT00651807|Etonogestrel|etonogestrel|mesh-list
15245847|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245848|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245849|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245850|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245851|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245852|NCT00620464|Etonogestrel|etonogestrel|mesh-list
15245853|NCT00620464|Desogestrel|desogestrel|mesh-list
15245854|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245855|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245856|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245857|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245858|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245859|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245860|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15245861|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15245862|NCT00620464|Progestins|progestins|mesh-ancestor
15245863|NCT00620464|Hormones|hormones|mesh-ancestor
15245864|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245865|NCT00620035|Etonogestrel|etonogestrel|mesh-list
15245866|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245867|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245868|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14412597|NCT01587001|Expectorants|expectorants|mesh-ancestor
14412598|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412599|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14412600|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
14412601|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412602|NCT01587001|Protective Agents|protective agents|mesh-ancestor
14412603|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412604|NCT01587001|Antidotes|antidotes|mesh-ancestor
14412605|NCT01587027|Aminophylline|aminophylline|mesh-list
14412606|NCT01587027|Methazolamide|methazolamide|mesh-list
14412607|NCT01587027|Theophylline|theophylline|mesh-list
14412608|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14412609|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
14412610|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412611|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412612|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14412613|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412614|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14412615|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412616|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412617|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
14412618|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14412619|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14412620|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
14412621|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412622|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14412623|NCT01587027|Protective Agents|protective agents|mesh-ancestor
14412624|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14412625|NCT01587027|Diuretics|diuretics|mesh-ancestor
14412626|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
14412627|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
14412628|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14412629|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
14412630|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412631|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412632|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14412633|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412634|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
14412635|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15245869|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245870|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245871|NCT00541684|Atenolol|atenolol|mesh-list
15245872|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
15245873|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245874|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245875|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245876|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
15245877|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245878|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15245879|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15245880|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
15245881|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14925532|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14925533|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
14925534|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925535|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15245882|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15245883|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14412636|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
14412637|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412638|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412639|NCT01587118|Asenapine|asenapine|mesh-list
14412640|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14412641|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14412642|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412643|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412644|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14467728|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245884|NCT00431431|Tibolone|tibolone|mesh-list
14467729|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467730|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14467731|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14467732|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14925536|NCT01404715|Metformin|metformin|mesh-list
15245885|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
15245886|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
15245887|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245888|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245889|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15245890|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15245891|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245892|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15245893|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
15245894|NCT00431431|Hormones|hormones|mesh-ancestor
15245895|NCT00413764|Tibolone|tibolone|mesh-list
15245896|NCT00413764|Norethindrone|norethindrone|mesh-list
15245897|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
15245898|NCT00413764|Estradiol|estradiol|mesh-list
15245899|NCT00413764|Estrogens|estrogens|mesh-ancestor
15245900|NCT00413764|Hormones|hormones|mesh-ancestor
15245901|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245902|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245903|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245904|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245905|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245906|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245907|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15245908|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15245909|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15245910|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
15245911|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
15245912|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14743728|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743729|NCT00583063|Sirolimus|sirolimus|mesh-list
14743730|NCT00583063|Sunitinib|sunitinib|mesh-list
15245913|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15245914|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245915|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15245916|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
14412645|NCT01587274|Acetaminophen|acetaminophen|mesh-list
14412646|NCT01587274|Naproxen|naproxen|mesh-list
14412647|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14412648|NCT01587274|Oxycodone|oxycodone|mesh-list
15245917|NCT00408863|Tibolone|tibolone|mesh-list
15245918|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
15245919|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
15245920|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245921|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245922|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15245923|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14412649|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
14412650|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14412651|NCT01587274|Analgesics|analgesics|mesh-ancestor
14412652|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
14412653|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412654|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412655|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
14412656|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14412657|NCT01587274|Narcotics|narcotics|mesh-ancestor
14743731|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412658|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412659|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14412660|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412661|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15245924|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245925|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15245926|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
15245927|NCT00408863|Hormones|hormones|mesh-ancestor
15245928|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
14412662|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
14412663|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14412664|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412665|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412666|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14412667|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
14412668|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14412669|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14412670|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14412671|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14412672|NCT01587651|Ticagrelor|ticagrelor|mesh-list
14412673|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14412674|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14412675|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14412676|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14412677|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14412678|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
14412679|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245929|NCT00403793|Etonogestrel|etonogestrel|mesh-list
15245930|NCT00403793|Testosterone|testosterone|mesh-list
15245931|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
15245932|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
15245933|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15245934|NCT00403793|Androgens|androgens|mesh-ancestor
15245935|NCT00403793|Hormones|hormones|mesh-ancestor
15245936|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15245937|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245938|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15245939|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15245940|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
15245941|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15245942|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
15245943|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15245944|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15245945|NCT00159796|Olanzapine|olanzapine|mesh-list
14412680|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925537|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
14925538|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14925539|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925540|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925541|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14925542|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925543|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245946|NCT00159796|Asenapine|asenapine|mesh-list
14412681|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412682|NCT01587885|Omeprazole|omeprazole|mesh-list
14412683|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14412684|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14412685|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14412686|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15245947|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
14925544|NCT01404741|Azacitidine|azacitidine|mesh-list
15245948|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
15245949|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245950|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245951|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245952|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14412687|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412688|NCT01587989|Methotrexate|methotrexate|mesh-list
14412689|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14412690|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
14412691|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14412692|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412693|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14412694|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
14925545|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15245953|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245954|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245955|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245956|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15245957|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15245958|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15245959|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245960|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245961|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
15245962|NCT00159744|Olanzapine|olanzapine|mesh-list
14925546|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
14925547|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925548|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925549|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925550|NCT01404767|Metoprolol|metoprolol|mesh-list
14925551|NCT01404767|Esmolol|esmolol|mesh-list
14925552|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14925553|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14925554|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
14412695|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412696|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412697|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
14412698|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925555|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
14925556|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925557|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925558|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14925559|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14925560|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14925561|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
14925562|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245963|NCT00159744|Asenapine|asenapine|mesh-list
14412699|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14412700|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412701|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
14412702|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412703|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14412704|NCT01588158|Acetaminophen|acetaminophen|mesh-list
14412705|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14412706|NCT01588158|Hydrocodone|hydrocodone|mesh-list
14412707|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14412708|NCT01588158|Analgesics|analgesics|mesh-ancestor
14412709|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
15245964|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
15245965|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
15245966|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245967|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245968|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245969|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15245970|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245971|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245972|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245973|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14412710|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412711|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412712|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
14412713|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14412714|NCT01588158|Narcotics|narcotics|mesh-ancestor
14412715|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412716|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
14412717|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
14412718|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14412719|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412720|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412721|NCT01588184|Bevacizumab|bevacizumab|mesh-list
14412722|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412723|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412724|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14412725|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14412726|NCT01588184|Growth Substances|growth substances|mesh-ancestor
14412727|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245974|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14412728|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
14412729|NCT01588405|Treprostinil|treprostinil|mesh-list
14412730|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14412731|NCT01588418|Exenatide|exenatide|mesh-list
14412732|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412733|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412734|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14412735|NCT01588418|Incretins|incretins|mesh-ancestor
14412736|NCT01588418|Hormones|hormones|mesh-ancestor
14412737|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412738|NCT01588457|Lamotrigine|lamotrigine|mesh-list
14412739|NCT01588457|Valproic Acid|valproic acid|mesh-list
14412740|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14412741|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
14412742|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
14412743|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245975|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15245976|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245977|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412744|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14412745|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245978|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
15245979|NCT00143182|Olanzapine|olanzapine|mesh-list
15245980|NCT00143182|Asenapine|asenapine|mesh-list
15245981|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
15245982|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
15245983|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15245984|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15245985|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15245986|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15245987|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15245988|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15245989|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15245990|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15245991|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15245992|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15245993|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15245994|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15245995|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
15245996|NCT03705442|Loperamide|loperamide|mesh-list
15245997|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
15245998|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14412746|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412747|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412748|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412749|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412750|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
14412751|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
14412752|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14412753|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412754|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14412755|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14412756|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
14412757|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412758|NCT01588470|Pioglitazone|pioglitazone|mesh-list
14412759|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412760|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412761|NCT01588496|Evolocumab|evolocumab|mesh-list
14412762|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14412763|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14412764|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
14412765|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412766|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14412767|NCT01588561|Nicotine|nicotine|mesh-list
14412768|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14412769|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
14412770|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412771|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412772|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14412773|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14412774|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
14412775|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412776|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412777|NCT01588951|Cytarabine|cytarabine|mesh-list
15245999|NCT03705429|Paclitaxel|paclitaxel|mesh-list
15246000|NCT03705429|Docetaxel|docetaxel|mesh-list
15246001|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15246002|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
14743732|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14743733|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14743734|NCT00583063|Growth Substances|growth substances|mesh-ancestor
15246003|NCT03705429|Trastuzumab|trastuzumab|mesh-list
15246004|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14925563|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412778|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14412779|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
14412780|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412781|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412782|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
14412783|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412784|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412785|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
14412786|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412787|NCT01588990|Leucovorin|leucovorin|mesh-list
14412788|NCT01588990|Bevacizumab|bevacizumab|mesh-list
14412789|NCT01588990|Capecitabine|capecitabine|mesh-list
14412790|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
14412791|NCT01588990|Irinotecan|irinotecan|mesh-list
14925564|NCT01404793|Rocuronium|rocuronium|mesh-list
14412792|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412793|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412794|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14412795|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14412796|NCT01588990|Growth Substances|growth substances|mesh-ancestor
14412797|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412798|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14412799|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14412800|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
14412801|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412802|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14412803|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14412804|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412805|NCT01588990|Antidotes|antidotes|mesh-ancestor
15246005|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412806|NCT01588990|Protective Agents|protective agents|mesh-ancestor
15246006|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14925565|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14925566|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14925567|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14925568|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246007|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14412807|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
14412808|NCT01588990|Vitamins|vitamins|mesh-ancestor
14412809|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
14412810|NCT01589094|Gemcitabine|gemcitabine|mesh-list
14412811|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412812|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14412813|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
14412814|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412815|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
14412816|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412817|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412818|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412819|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
14412820|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412821|NCT01589263|Tamsulosin|tamsulosin|mesh-list
14412822|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14412823|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14412824|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14412825|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
14412826|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412827|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412828|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412829|NCT01589263|Urological Agents|urological agents|mesh-ancestor
14412830|NCT01589445|Metformin|metformin|mesh-list
14412831|NCT01589445|Pioglitazone|pioglitazone|mesh-list
14412832|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412833|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412834|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
14412835|NCT01589497|Rifampin|rifampin|mesh-list
14412836|NCT01589497|Isoniazid|isoniazid|mesh-list
14412837|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
14412838|NCT01589497|Ethambutol|ethambutol|mesh-list
14412839|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14412840|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412841|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14412842|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14412843|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412844|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412845|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412846|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14412847|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
14412848|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
14412849|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14412850|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14412851|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14412852|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14412853|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14412854|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14412855|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14412856|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14412857|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14412858|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
14925569|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925570|NCT01404806|Dolutegravir|dolutegravir|mesh-list
15246008|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246009|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246010|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15246011|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
15246012|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246013|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246014|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14412859|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14412860|NCT01589510|Bimatoprost|bimatoprost|mesh-list
14925571|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14925572|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14412861|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14412862|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14412863|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14412864|NCT01589653|Insulin|insulin|mesh-list
14412865|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14412866|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
14412867|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
14412868|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14412869|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
14412870|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14412871|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
14412872|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412873|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412874|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14412875|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
14412876|NCT01589822|Coagulants|coagulants|mesh-ancestor
15246015|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
15246016|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15246017|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15246018|NCT03705351|Temozolomide|temozolomide|mesh-list
15246019|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15246020|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
15246021|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246022|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246023|NCT03705195|Gliclazide|gliclazide|mesh-list
15246024|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412877|NCT01589978|Aspirin|aspirin|mesh-list
14412878|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
15246025|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246026|NCT03705065|Bupivacaine|bupivacaine|mesh-list
15246027|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
15246028|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
14743735|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743736|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
14743737|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14743738|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743739|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743740|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14743741|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743742|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14412879|NCT01589978|Salicylates|salicylates|mesh-list
14412880|NCT01589978|Ticlopidine|ticlopidine|mesh-list
14412881|NCT01589978|Clopidogrel|clopidogrel|mesh-list
14412882|NCT01589978|Ticagrelor|ticagrelor|mesh-list
14412883|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14412884|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14412885|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14412886|NCT01589978|Analgesics|analgesics|mesh-ancestor
14412887|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
14412888|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412889|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412890|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14412891|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412892|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14412893|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14412894|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412895|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14412896|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14743743|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
14925573|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412897|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412898|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
14412899|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14412900|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14412901|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14412902|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
14743744|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14743745|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
14743746|NCT00583180|Capsaicin|capsaicin|mesh-list
14743747|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
14743748|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
14743749|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
14743750|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743751|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743752|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14743753|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14743754|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14743755|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743756|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743757|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743758|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743759|NCT00583193|Analgesics|analgesics|mesh-ancestor
14743760|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
14743761|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246029|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246030|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246031|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
15246032|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246033|NCT03704909|Epinephrine|epinephrine|mesh-list
15246034|NCT03704909|Racepinephrine|racepinephrine|mesh-list
15246035|NCT03704909|Ephedrine|ephedrine|mesh-list
15246036|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
15246037|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15246038|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15246039|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
15246040|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246041|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246042|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246043|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15246044|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15246045|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
15246046|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246047|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15246048|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
15246049|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
15246050|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
14412903|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412904|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412905|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
14412906|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
14412907|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
14412908|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14412909|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14412910|NCT01590017|Cisplatin|cisplatin|mesh-list
14412911|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412912|NCT01590082|Doxycycline|doxycycline|mesh-list
15246051|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14412913|NCT01590082|Temozolomide|temozolomide|mesh-list
14412914|NCT01590082|Ipilimumab|ipilimumab|mesh-list
14412915|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14412916|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
14412917|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412918|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14412919|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14412920|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14412921|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14412922|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412923|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
14412924|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14412925|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14412926|NCT01590433|Exenatide|exenatide|mesh-list
14412927|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412928|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412929|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14412930|NCT01590433|Incretins|incretins|mesh-ancestor
14412931|NCT01590433|Hormones|hormones|mesh-ancestor
14412932|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412933|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
14412934|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14412935|NCT01590758|Pexiganan|pexiganan|mesh-list
14412936|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14412937|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14412938|NCT01590771|Metformin|metformin|mesh-list
14412939|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15246052|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15246053|NCT03704831|Anesthetics|anesthetics|mesh-list
15246054|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
15246055|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246056|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246057|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
15246058|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246059|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
15246060|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15246061|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743762|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
14743763|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743764|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
14743765|NCT00583258|Alfuzosin|alfuzosin|mesh-list
14743766|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14412940|NCT01590771|Glimepiride|glimepiride|mesh-list
14412941|NCT01590771|Gliclazide|gliclazide|mesh-list
14412942|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14412943|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412944|NCT01590771|Incretins|incretins|mesh-ancestor
14412945|NCT01590771|Hormones|hormones|mesh-ancestor
14412946|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412947|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14412948|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
14412949|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412950|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412951|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14743767|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14743768|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14743769|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
14743770|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743771|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743772|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743773|NCT00583258|Urological Agents|urological agents|mesh-ancestor
14743774|NCT00583271|Triamcinolone|triamcinolone|mesh-list
14743775|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743776|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
14743777|NCT00583271|Hormones|hormones|mesh-ancestor
14743778|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467733|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
14467734|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14467735|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
14467736|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467737|NCT02265224|Expectorants|expectorants|mesh-ancestor
14467738|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
14467739|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14467740|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
14467741|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412952|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14412953|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
14412954|NCT01590797|Metformin|metformin|mesh-list
14412955|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14412956|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14743779|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412957|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412958|NCT01590797|Incretins|incretins|mesh-ancestor
14412959|NCT01590797|Hormones|hormones|mesh-ancestor
14412960|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14412961|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14412962|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
14412963|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14412964|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743780|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
15246062|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15246063|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246064|NCT03704766|Defensins|defensins|mesh-list
14743781|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14743782|NCT00583349|Paclitaxel|paclitaxel|mesh-list
14743783|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14743784|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743785|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
14743786|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
14743787|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
14743788|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743789|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14743790|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
14743791|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14743792|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
14743793|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743794|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14743795|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14743796|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14743797|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14743798|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743799|NCT00583518|Hormones|hormones|mesh-list
14743800|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
14412965|NCT01590875|Adenosine|adenosine|mesh-list
14412966|NCT01590875|Analgesics|analgesics|mesh-ancestor
14412967|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
14412968|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412969|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743801|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743802|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743803|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14412970|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14412971|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
14412972|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14412973|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
14412974|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
15246065|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
15246066|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246067|NCT03704753|Ropivacaine|ropivacaine|mesh-list
15246068|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
15246069|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
15246070|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246071|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246072|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
15246073|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412975|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246074|NCT03704714|Prednisone|prednisone|mesh-list
15246075|NCT03704714|Cortisone|cortisone|mesh-list
15246076|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
15246077|NCT03704714|Rituximab|rituximab|mesh-list
15246078|NCT03704714|Doxorubicin|doxorubicin|mesh-list
15246079|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15246080|NCT03704714|Nivolumab|nivolumab|mesh-list
15246081|NCT03704714|Vincristine|vincristine|mesh-list
15246082|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15246083|NCT03704714|Antibodies|antibodies|mesh-list
15246084|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
15246085|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15246086|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15246087|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
15246088|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246089|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14412976|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412977|NCT01590979|Ranolazine|ranolazine|mesh-list
14412978|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14412979|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14412980|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412981|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14412982|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14412983|NCT01591382|Ketamine|ketamine|mesh-list
14412984|NCT01591382|Hydromorphone|hydromorphone|mesh-list
14412985|NCT01591382|Analgesics|analgesics|mesh-ancestor
14412986|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
14412987|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14412988|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14412989|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14412990|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14412991|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
14412992|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
14412993|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14412994|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14412995|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14412996|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14412997|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14412998|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14412999|NCT01591382|Narcotics|narcotics|mesh-ancestor
14413000|NCT01591460|Ribavirin|ribavirin|mesh-list
14413001|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14413002|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
14413003|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
14413004|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413005|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
14413006|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413007|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
14413008|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413009|NCT01591616|Lidocaine|lidocaine|mesh-list
14413010|NCT01591616|Prilocaine|prilocaine|mesh-list
15246090|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15246091|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
15246092|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246093|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246094|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15246095|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15246096|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15246097|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15246098|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246099|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15246100|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
14413011|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
14413012|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
15246101|NCT03704714|Hormones|hormones|mesh-ancestor
15246102|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15246103|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15246104|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15246105|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15246106|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
14413013|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413014|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246107|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
15246108|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246109|NCT03704623|Acetaminophen|acetaminophen|mesh-list
15246110|NCT03704623|Parecoxib|parecoxib|mesh-list
15246111|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15246112|NCT03704623|Analgesics|analgesics|mesh-ancestor
15246113|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
15246114|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246115|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246116|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
15246117|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14413015|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
14413016|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413017|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14413018|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14413019|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14413020|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14413021|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413022|NCT01591733|Capecitabine|capecitabine|mesh-list
14413023|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
14413024|NCT01591733|Irinotecan|irinotecan|mesh-list
14413025|NCT01591733|Folfirinox|folfirinox|mesh-list
14413026|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413027|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
14413028|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413029|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413030|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14413031|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14413032|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413033|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
14413034|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14413035|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14413036|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15246118|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14413037|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14413038|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246119|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246120|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246121|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15246122|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15246123|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246124|NCT03704506|Amoxicillin|amoxicillin|mesh-list
14413039|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
14413040|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246125|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15246126|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246127|NCT03704480|Durvalumab|durvalumab|mesh-list
15246128|NCT03704480|Tremelimumab|tremelimumab|mesh-list
15246129|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15246130|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246131|NCT03704363|Infliximab|infliximab|mesh-list
15246132|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
15246133|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15246134|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246135|NCT03704246|Antibodies|antibodies|mesh-list
15246136|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15246137|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
15246138|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246139|NCT03704220|Warfarin|warfarin|mesh-list
15246140|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
15246141|NCT03704181|Colchicine|colchicine|mesh-list
15246142|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
15246143|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246144|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
15246145|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
15246146|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246147|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246148|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246149|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
15246150|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15246151|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15246152|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15246153|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15246154|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246155|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14743804|NCT00583778|Ipratropium|ipratropium|mesh-list
14743805|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14925574|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925575|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14925576|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14743806|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
15246156|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743807|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743808|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413041|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413042|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14413043|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413044|NCT01591785|Retapamulin|retapamulin|mesh-list
14413045|NCT01591785|Petrolatum|petrolatum|mesh-list
14413046|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413047|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413048|NCT01591785|Emollients|emollients|mesh-ancestor
14413049|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413050|NCT01591837|Vaccines|vaccines|mesh-list
14413051|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
14413052|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413053|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
14413054|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14743809|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14743810|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
14925577|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
14413055|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413056|NCT01592006|Ribavirin|ribavirin|mesh-list
14413057|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14743811|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15246157|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413058|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
15246158|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15246159|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246160|NCT03704077|Paclitaxel|paclitaxel|mesh-list
15246161|NCT03704077|Nivolumab|nivolumab|mesh-list
15246162|NCT03704077|Ramucirumab|ramucirumab|mesh-list
14413059|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413060|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
14413061|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413062|NCT01592045|Aldesleukin|aldesleukin|mesh-list
14413063|NCT01592045|Molgramostim|molgramostim|mesh-list
14413064|NCT01592045|Dinutuximab|dinutuximab|mesh-list
14413065|NCT01592045|Isotretinoin|isotretinoin|mesh-list
14413066|NCT01592045|Sargramostim|sargramostim|mesh-list
14413067|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
14413068|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413069|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413070|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14413071|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14413072|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
14413073|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413074|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413075|NCT01592240|Bococizumab|bococizumab|mesh-list
14413076|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14413077|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15246163|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15246164|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413078|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
14413079|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413080|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14413081|NCT01592292|Adalimumab|adalimumab|mesh-list
14413082|NCT01592292|Etanercept|etanercept|mesh-list
14413083|NCT01592292|Rituximab|rituximab|mesh-list
14413084|NCT01592292|Infliximab|infliximab|mesh-list
14413085|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14413086|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413087|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
14413088|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413089|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413090|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14413091|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413092|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14413093|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14413094|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413095|NCT01592292|Analgesics|analgesics|mesh-ancestor
14413096|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
14413097|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413098|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15246165|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
14413099|NCT01592409|Dronabinol|dronabinol|mesh-list
14413100|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
15246166|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
14413101|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413102|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14413103|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413104|NCT01592409|Analgesics|analgesics|mesh-ancestor
14413105|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
14413106|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413107|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14413108|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15246167|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246168|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246169|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14413109|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413110|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413111|NCT01592409|Hormones|hormones|mesh-ancestor
14413112|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413113|NCT01592695|Ethanol|ethanol|mesh-list
15246170|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15246171|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15246172|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246173|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413114|NCT01592695|Bupropion|bupropion|mesh-list
14413115|NCT01592695|Nicotine|nicotine|mesh-list
14413116|NCT01592695|Varenicline|varenicline|mesh-list
14413117|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14413118|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
14413119|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413120|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413121|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14413122|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14413123|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
14413124|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413125|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413126|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14413127|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413128|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413129|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14413130|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
14413131|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14413132|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14413133|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14413134|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14413135|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
14925578|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925579|NCT01404819|Anesthetics|anesthetics|mesh-list
14925580|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413136|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14413137|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14413138|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413139|NCT01592708|Erythromycin|erythromycin|mesh-list
14925581|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413140|NCT01592708|Ibuprofen|ibuprofen|mesh-list
14413141|NCT01592708|Ketorolac|ketorolac|mesh-list
14413142|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14413143|NCT01592708|Fentanyl|fentanyl|mesh-list
14413144|NCT01592708|Scopolamine|scopolamine|mesh-list
14413145|NCT01592708|Droperidol|droperidol|mesh-list
14413146|NCT01592708|Remifentanil|remifentanil|mesh-list
14413147|NCT01592708|Hydrocodone|hydrocodone|mesh-list
14413148|NCT01592708|Ondansetron|ondansetron|mesh-list
14413149|NCT01592708|Antiemetics|antiemetics|mesh-list
14413150|NCT01592708|Propofol|propofol|mesh-list
14413151|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
14413152|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413153|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413154|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14413155|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14413156|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
14413157|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14413158|NCT01592708|Narcotics|narcotics|mesh-ancestor
14413159|NCT01592708|Analgesics|analgesics|mesh-ancestor
14413160|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
14413161|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413162|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14413163|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14413164|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413165|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14413166|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413167|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14413168|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413169|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413170|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
14413171|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15246174|NCT03703596|Docetaxel|docetaxel|mesh-list
15246175|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246176|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
15246177|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
15246178|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246179|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413172|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
14413173|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413174|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14413175|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
14413176|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246180|NCT03703427|Capecitabine|capecitabine|mesh-list
15246181|NCT03703427|Vinorelbine|vinorelbine|mesh-list
15246182|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15246183|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
15246184|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246185|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925582|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14925583|NCT01404871|Citalopram|citalopram|mesh-list
15246186|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15246187|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
14413177|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14413178|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14413179|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14413180|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14413181|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
14413182|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
14413183|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15246188|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
15246189|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246190|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
15246191|NCT03703349|Analgesics|analgesics|mesh-ancestor
15246192|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
15246193|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246194|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246195|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
15246196|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413184|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413185|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14413186|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
15246197|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15246198|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
14925584|NCT01404871|Clomipramine|clomipramine|mesh-list
14925585|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14925586|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14925587|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14925588|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925589|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925590|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
15246199|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15246200|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15246201|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246202|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14413187|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14413188|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
14413189|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14413190|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
14413191|NCT01592708|Hormones|hormones|mesh-ancestor
14413192|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413193|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14413194|NCT01592708|Protective Agents|protective agents|mesh-ancestor
14413195|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14413196|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413197|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15246203|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
15246204|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15246205|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
15246206|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15246207|NCT03703271|Methotrexate|methotrexate|mesh-list
15246208|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15246209|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
15246210|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15246211|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246212|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15246213|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
15246214|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246215|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246216|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
15246217|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246218|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15246219|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413198|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14413199|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
14413200|NCT01592747|Memantine|memantine|mesh-list
14413201|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14413202|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14413203|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
14413204|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413205|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413206|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413207|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14413208|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14413209|NCT01592773|Memantine|memantine|mesh-list
14413210|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14413211|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14413212|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
14413213|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413214|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413215|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413216|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14467742|NCT02265224|Protective Agents|protective agents|mesh-ancestor
14413217|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14413218|NCT01592786|Memantine|memantine|mesh-list
14413219|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14413220|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14413221|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
14413222|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413223|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413224|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413225|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14413226|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14413227|NCT01592851|Fluorides|fluorides|mesh-list
14413228|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
14413229|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
14413230|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
14413231|NCT01592851|Protective Agents|protective agents|mesh-ancestor
14413232|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413233|NCT01592864|Fluorides|fluorides|mesh-list
14413234|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
14413235|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
14413236|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
14413237|NCT01592864|Protective Agents|protective agents|mesh-ancestor
14413238|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413239|NCT01593020|Paclitaxel|paclitaxel|mesh-list
14413240|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
14413241|NCT01593020|Doxorubicin|doxorubicin|mesh-list
14413242|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14413243|NCT01593020|Fluorouracil|fluorouracil|mesh-list
14413244|NCT01593020|Epirubicin|epirubicin|mesh-list
15246220|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
15246221|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246222|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15246223|NCT03703206|Anesthetics|anesthetics|mesh-list
15246224|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
15246225|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246226|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246227|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
15246228|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246229|NCT03703167|Rituximab|rituximab|mesh-list
15246230|NCT03703167|Lenalidomide|lenalidomide|mesh-list
15246231|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15246232|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413245|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14413246|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413247|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
15246233|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
14413248|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
14413249|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246234|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246235|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246236|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15246237|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15246238|NCT03703167|Growth Substances|growth substances|mesh-ancestor
15246239|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
15246240|NCT03703154|Tacrolimus|tacrolimus|mesh-list
15246241|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15246242|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
15246243|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246244|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15246245|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246246|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246247|NCT03703089|Gemcitabine|gemcitabine|mesh-list
15246248|NCT03703089|Paclitaxel|paclitaxel|mesh-list
15246249|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15246250|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246251|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
15246252|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14413250|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413251|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413252|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
14413253|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413254|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413255|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14413256|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
14413257|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14413258|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14413259|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14413260|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14413261|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413262|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
14413263|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413264|NCT01593215|Yohimbine|yohimbine|mesh-list
14413265|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
15246253|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246254|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246255|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413266|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
14413267|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413268|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925591|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925592|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15246256|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
14413269|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14413270|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14413271|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14413272|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
14413273|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413274|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413275|NCT01593215|Urological Agents|urological agents|mesh-ancestor
14413276|NCT01593592|Amoxicillin|amoxicillin|mesh-list
14925593|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
15246257|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
15246258|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246259|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246260|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15246261|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
15246262|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246263|NCT03703063|Leucovorin|leucovorin|mesh-list
15246264|NCT03703063|Gemcitabine|gemcitabine|mesh-list
15246265|NCT03703063|Paclitaxel|paclitaxel|mesh-list
15246266|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15246267|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246268|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
15246269|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
15246270|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246271|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246272|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15246273|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
15246274|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
15246275|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925594|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14925595|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246276|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246277|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413277|NCT01593592|Clarithromycin|clarithromycin|mesh-list
14413278|NCT01593592|Omeprazole|omeprazole|mesh-list
14413279|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413280|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413281|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14413282|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14413283|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15246278|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
14925596|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14925597|NCT01404871|Analgesics|analgesics|mesh-ancestor
14925598|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
14925599|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
14925600|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14413284|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413285|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413286|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14413287|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14413288|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14413289|NCT01593670|Decitabine|decitabine|mesh-list
14413290|NCT01593670|Interleukin-2|interleukin-2|mesh-list
14413291|NCT01593670|Vorinostat|vorinostat|mesh-list
14413292|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413293|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
14413294|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413295|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246279|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925601|NCT01405079|Vinorelbine|vinorelbine|mesh-list
14925602|NCT01405079|Gefitinib|gefitinib|mesh-list
14925603|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925604|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14925605|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
14925606|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
14925607|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
14925608|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925609|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14925610|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925611|NCT01405118|Metformin|metformin|mesh-list
14925612|NCT01405118|Tofacitinib|tofacitinib|mesh-list
14925613|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15246280|NCT03703063|Antidotes|antidotes|mesh-ancestor
15246281|NCT03703063|Protective Agents|protective agents|mesh-ancestor
15246282|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
15246283|NCT03703063|Vitamins|vitamins|mesh-ancestor
15246284|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
15246285|NCT03703050|Nivolumab|nivolumab|mesh-list
15246286|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15246287|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246288|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15246289|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246290|NCT03702985|Capecitabine|capecitabine|mesh-list
15246291|NCT03702985|Irinotecan|irinotecan|mesh-list
15246292|NCT03702985|Amifostine|amifostine|mesh-list
15246293|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15246294|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
15246295|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246296|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246297|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15246298|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15246299|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413296|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413297|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413298|NCT01593670|Analgesics|analgesics|mesh-ancestor
14413299|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
15246300|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15246301|NCT03702985|Protective Agents|protective agents|mesh-ancestor
15246302|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246303|NCT03702959|Betamethasone|betamethasone|mesh-list
14413300|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413301|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413302|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14413303|NCT01593722|Ivermectin|ivermectin|mesh-list
15246304|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15246305|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
15246306|NCT03702959|Hormones|hormones|mesh-ancestor
15246307|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15246308|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246309|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15246310|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
15246311|NCT03702946|Oxytocin|oxytocin|mesh-list
15246312|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
15246313|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15246314|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246315|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15246316|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15246317|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413304|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
14413305|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14413306|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413307|NCT01593722|Filaricides|filaricides|mesh-ancestor
14413308|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
14413309|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
14743812|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
14743813|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743814|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743815|NCT00583869|Pregabalin|pregabalin|mesh-list
14743816|NCT00583869|Analgesics|analgesics|mesh-ancestor
14413310|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14413311|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743817|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
14743818|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743819|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743820|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
15246318|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15246319|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246320|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246321|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
15246322|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15246323|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15246324|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743821|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14743822|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743823|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743824|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14743825|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743826|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743827|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743828|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15246325|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246326|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
15246327|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246328|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246329|NCT03702803|Alprazolam|alprazolam|mesh-list
15246330|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15246331|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246332|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246333|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15246334|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743829|NCT00583986|Albuterol|albuterol|mesh-list
14743830|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14743831|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
14743832|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743833|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743834|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14743835|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
14743836|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
14743837|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14743838|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14743839|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14743840|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14743841|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
14743842|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743843|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743844|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
14743845|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14743846|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14743847|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
14743848|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753405|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246335|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15246336|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
15246337|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
15246338|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246339|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246340|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
15246341|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15246342|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
15246343|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246344|NCT03702738|Expectorants|expectorants|mesh-ancestor
15246345|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
15246346|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15246347|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
15246348|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246349|NCT03702738|Protective Agents|protective agents|mesh-ancestor
15246350|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246351|NCT03702738|Antidotes|antidotes|mesh-ancestor
15246352|NCT03702647|Ropivacaine|ropivacaine|mesh-list
15246353|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
15246354|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
15246355|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246356|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246357|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
15246358|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246359|NCT03702621|Bupivacaine|bupivacaine|mesh-list
15246360|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
15246361|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
14413312|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467743|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467744|NCT02265224|Antidotes|antidotes|mesh-ancestor
14467745|NCT02265237|Ritonavir|ritonavir|mesh-list
14467746|NCT02265237|Ribavirin|ribavirin|mesh-list
14467747|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14467748|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14467749|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
15246362|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925614|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246363|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467750|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467751|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467752|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15246364|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
14925615|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14925616|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925617|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925618|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
14925619|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14925620|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14925621|NCT01405131|Prednisolone|prednisolone|mesh-list
14925622|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
14925623|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14925624|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
14925625|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15246365|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467753|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15246366|NCT03702582|Warfarin|warfarin|mesh-list
15246367|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
15246368|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
15246369|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15246370|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
15246371|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15246372|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
15246373|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246374|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246375|NCT03702530|Albendazole|albendazole|mesh-list
15246376|NCT03702530|Vaccines|vaccines|mesh-list
15246377|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
15246378|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15246379|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413313|NCT01593748|Gemcitabine|gemcitabine|mesh-list
14413314|NCT01593748|Docetaxel|docetaxel|mesh-list
14413315|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413316|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
14413317|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413318|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413319|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
14413320|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413321|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413322|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15246380|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
15246381|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15246382|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15246383|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
14925626|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
14925627|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
15246384|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
15246385|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246386|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246387|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246388|NCT03702530|Immunologic Factors|immunologic factors|mesh-ancestor
14925628|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925629|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925630|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925631|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
14925632|NCT01405131|Hormones|hormones|mesh-ancestor
14925633|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15246389|NCT03702530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246390|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
15246391|NCT03702491|Apatinib|apatinib|mesh-list
15246392|NCT03702491|Tegafur|tegafur|mesh-list
15246393|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246394|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15246395|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246396|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246397|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15246398|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
14925634|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14925635|NCT01405131|Protective Agents|protective agents|mesh-ancestor
14925636|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925637|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246399|NCT03702426|Norfloxacin|norfloxacin|mesh-list
15246400|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15246401|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246402|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15246403|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15246404|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246405|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246406|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246407|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15246408|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14413323|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
15246409|NCT03702400|Phenylephrine|phenylephrine|mesh-list
15246410|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
15246411|NCT03702400|Norepinephrine|norepinephrine|mesh-list
15246412|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15246413|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
15246414|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
14413324|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413325|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14413326|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14413327|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14413328|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14413329|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14413330|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413331|NCT01594125|Nintedanib|nintedanib|mesh-list
14413332|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413333|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14413334|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413335|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413336|NCT01594281|Ranibizumab|ranibizumab|mesh-list
14413337|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14413338|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14413339|NCT01594281|Growth Substances|growth substances|mesh-ancestor
14413340|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413341|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
14413342|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413343|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
14413344|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14413345|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
14413346|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413347|NCT01594333|Methotrexate|methotrexate|mesh-list
14413348|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14413349|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
14413350|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14413351|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413352|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413353|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
14413354|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413355|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413356|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413357|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743849|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246415|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246416|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246417|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
15246418|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15246419|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
15246420|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
15246421|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15246422|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15246423|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15246424|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
15246425|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246426|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743850|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246427|NCT03702400|Protective Agents|protective agents|mesh-ancestor
15246428|NCT03702387|Anesthetics|anesthetics|mesh-list
14743851|NCT00584090|Urological Agents|urological agents|mesh-ancestor
14743852|NCT00584155|Ofloxacin|ofloxacin|mesh-list
14743853|NCT00584155|Levofloxacin|levofloxacin|mesh-list
15246429|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246430|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246431|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
15246432|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246433|NCT03702205|Betaine|betaine|mesh-list
15246434|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15246435|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
15246436|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15246437|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
15246438|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246439|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15246440|NCT03702140|Teriparatide|teriparatide|mesh-list
14413358|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14413359|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413360|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
14413361|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413362|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14413363|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
14413364|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14413365|NCT01594424|Antibodies|antibodies|mesh-list
14413366|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
14413367|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14743854|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14413368|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
14413369|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413370|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
14743855|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743856|NCT00584155|Renal Agents|renal agents|mesh-ancestor
14743857|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15246441|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15246442|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246443|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14413371|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14413372|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
14413373|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14413374|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413375|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14413376|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14413377|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14743858|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14743859|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14743860|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413378|NCT01594749|Dexamethasone|dexamethasone|mesh-list
14413379|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
14413380|NCT01594749|Ondansetron|ondansetron|mesh-list
14413381|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
14413382|NCT01594749|Aprepitant|aprepitant|mesh-list
14413383|NCT01594749|BB 1101|bb 1101|mesh-list
14413384|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14413385|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
14413386|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
14413387|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413388|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413389|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14413390|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
14413391|NCT01594749|Hormones|hormones|mesh-ancestor
14413392|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413393|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14413394|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413395|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
14413396|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413397|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413398|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
14413399|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413400|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14413401|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
14413402|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413403|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14743861|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753406|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
15246444|NCT03702023|Acetaminophen|acetaminophen|mesh-list
15246445|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15246446|NCT03702023|Analgesics|analgesics|mesh-ancestor
14743862|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743863|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14743864|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14743865|NCT00584168|Dexamethasone|dexamethasone|mesh-list
14743866|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743867|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
14743868|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
14743869|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743870|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743871|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14743872|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
14743873|NCT00584168|Hormones|hormones|mesh-ancestor
14743874|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743875|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14743876|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743877|NCT00584298|Octreotide|octreotide|mesh-list
14743878|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14413404|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14413405|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413406|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14413407|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14413408|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14413409|NCT01594762|Pexiganan|pexiganan|mesh-list
14743879|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14743880|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753407|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753408|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
15246447|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
15246448|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246449|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413410|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413411|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413412|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
14413413|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14413414|NCT01594827|Vancomycin|vancomycin|mesh-list
14413415|NCT01594827|Doxycycline|doxycycline|mesh-list
14413416|NCT01594827|Rifampin|rifampin|mesh-list
14413417|NCT01594827|Trimethoprim|trimethoprim|mesh-list
14413418|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
14413419|NCT01594827|Mupirocin|mupirocin|mesh-list
15246450|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
15246451|NCT03701984|Lidocaine|lidocaine|mesh-list
15246452|NCT03701984|Tramadol|tramadol|mesh-list
15246453|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
15246454|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
15246455|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246456|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246457|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
15246458|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246459|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15246460|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15246461|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15246462|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743881|NCT00584376|Pregabalin|pregabalin|mesh-list
14413420|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14413421|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413422|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
14413423|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413424|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413425|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
14413426|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14413427|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14413428|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14413429|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
14413430|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
14413431|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14413432|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413433|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413434|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14413435|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14413436|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14413437|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14413438|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14413439|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14413440|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14413441|NCT01594827|Renal Agents|renal agents|mesh-ancestor
14413442|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14413443|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14413444|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14413445|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14413446|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14413447|NCT01594931|Artesunate|artesunate|mesh-list
14413448|NCT01594931|Pyronaridine|pyronaridine|mesh-list
14413449|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
14413450|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14413451|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14413452|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413453|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413454|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
14413455|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
14413456|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14413457|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
14413458|NCT01594970|Bimatoprost|bimatoprost|mesh-list
14413459|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14413460|NCT01595282|Ibuprofen|ibuprofen|mesh-list
14413461|NCT01595282|Ketorolac|ketorolac|mesh-list
14413462|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14413463|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413464|NCT01595282|Analgesics|analgesics|mesh-ancestor
14413465|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
14413466|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413467|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413468|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14413469|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413470|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14413471|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413472|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413473|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
14413474|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14413475|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14413476|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
14413477|NCT01595438|Ceftazidime|ceftazidime|mesh-list
14743882|NCT00584376|Analgesics|analgesics|mesh-ancestor
14413478|NCT01595438|Doripenem|doripenem|mesh-list
14413479|NCT01595438|Avibactam|avibactam|mesh-list
14467754|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
14413480|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14413481|NCT01595438|Trimethoprim|trimethoprim|mesh-list
14413482|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
14413483|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413484|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413485|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14413486|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14413487|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413488|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413489|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413490|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14413491|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14413492|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14413493|NCT01595438|Renal Agents|renal agents|mesh-ancestor
14413494|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
14413495|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14413496|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14413497|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14413498|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14413499|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14413500|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14413501|NCT01595516|Ascorbic Acid|ascorbic acid|mesh-list
14413502|NCT01595516|Metoprolol|metoprolol|mesh-list
14413503|NCT01595516|Nebivolol|nebivolol|mesh-list
14413504|NCT01595516|Bradykinin|bradykinin|mesh-list
14743883|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
14743884|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246463|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246464|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15246465|NCT03701984|Narcotics|narcotics|mesh-ancestor
15246466|NCT03701984|Analgesics|analgesics|mesh-ancestor
15246467|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
14413505|NCT01595516|Kininogens|kininogens|mesh-list
14413506|NCT01595516|Vitamins|vitamins|mesh-ancestor
14413507|NCT01595516|Micronutrients|micronutrients|mesh-ancestor
14413508|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413509|NCT01595516|Antioxidants|antioxidants|mesh-ancestor
14413510|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413511|NCT01595516|Protective Agents|protective agents|mesh-ancestor
14413512|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14413513|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14413514|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
14413515|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
14413516|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413517|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14413518|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14413519|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14413520|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
14413521|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413522|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
14413523|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14413524|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14413525|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15246468|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15246469|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15246470|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15246471|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246472|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
15246473|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246474|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246475|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14413526|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14413527|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
14925638|NCT01405144|Fluorouracil|fluorouracil|mesh-list
14413528|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413529|NCT01595529|Trimethoprim|trimethoprim|mesh-list
14413530|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
14413531|NCT01595529|Cephalexin|cephalexin|mesh-list
14413532|NCT01595529|Cefixime|cefixime|mesh-list
14413533|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14413534|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413535|NCT01595529|Renal Agents|renal agents|mesh-ancestor
14413536|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
14413537|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14413538|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14413539|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14413540|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413541|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413542|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14413543|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15246476|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246477|NCT03701880|Bisoprolol|bisoprolol|mesh-list
15246478|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15246479|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
15246480|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
15246481|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246482|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246483|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14413544|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14413545|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413546|NCT01595646|Insulin|insulin|mesh-list
14413547|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14413548|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
14413549|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14413550|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413551|NCT01595854|Dabigatran|dabigatran|mesh-list
14413552|NCT01595854|Ticagrelor|ticagrelor|mesh-list
14413553|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14413554|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14413555|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14413556|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14413557|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
14413558|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246484|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15246485|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15246486|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
15246487|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246488|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246489|NCT03701750|Heparin|heparin|mesh-list
15246490|NCT03701750|Enoxaparin|enoxaparin|mesh-list
15246491|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15246492|NCT03701750|Tinzaparin|tinzaparin|mesh-list
14925639|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
14925640|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246493|NCT03701750|Dalteparin|dalteparin|mesh-list
14413559|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413560|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413561|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
14413562|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14413563|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
14413564|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413565|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
14413566|NCT01596062|Cyclosporine|cyclosporine|mesh-list
15246494|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
15246495|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
15246496|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15246497|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14413567|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
14413568|NCT01596062|Everolimus|everolimus|mesh-list
14413569|NCT01596062|Cyclosporins|cyclosporins|mesh-list
14413570|NCT01596062|Basiliximab|basiliximab|mesh-list
15246498|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413571|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413572|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413573|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413574|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
14413575|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413576|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
14413577|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413578|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413579|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413580|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14413581|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413582|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14413583|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14413584|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
14413585|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413586|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
14413587|NCT01596088|Razoxane|razoxane|mesh-list
14413588|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413589|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14413590|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14413591|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14413592|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413593|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413594|NCT01596088|Protective Agents|protective agents|mesh-ancestor
14413595|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413596|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14413597|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14413598|NCT01596127|Rituximab|rituximab|mesh-list
14413599|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14413600|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413601|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
14413602|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246499|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
15246500|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15246501|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15246502|NCT03701698|Prednisolone|prednisolone|mesh-list
15246503|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
15246504|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14413603|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413604|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
14413605|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14413606|NCT01596335|Antibodies|antibodies|mesh-list
14413607|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
14413608|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413609|NCT01596504|Metformin|metformin|mesh-list
14413610|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
14413611|NCT01596504|Liraglutide|liraglutide|mesh-list
14413612|NCT01596504|Lixisenatide|lixisenatide|mesh-list
14925641|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14925642|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925643|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925644|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
14925645|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925646|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
14925647|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14413613|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14413614|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413615|NCT01596504|Incretins|incretins|mesh-ancestor
14413616|NCT01596504|Hormones|hormones|mesh-ancestor
14413617|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413618|NCT01596699|Fludarabine|fludarabine|mesh-list
14413619|NCT01596699|Busulfan|busulfan|mesh-list
14413620|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
14413621|NCT01596699|Clofarabine|clofarabine|mesh-list
14413622|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413623|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413624|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
14413625|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413626|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413627|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
14413628|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413629|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
14413630|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14413631|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14413632|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14413633|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
14413634|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14413635|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413636|NCT01596842|Vitamins|vitamins|mesh-ancestor
14413637|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
14413638|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14413639|NCT01597193|Fulvestrant|fulvestrant|mesh-list
14413640|NCT01597193|Anastrozole|anastrozole|mesh-list
14413641|NCT01597193|Exemestane|exemestane|mesh-list
14413642|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14413643|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246505|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
15246506|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15246507|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
15246508|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
15246509|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246510|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246511|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15246512|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
15246513|NCT03701698|Hormones|hormones|mesh-ancestor
15246514|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15246515|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15246516|NCT03701698|Protective Agents|protective agents|mesh-ancestor
14413644|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14413645|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14413646|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
14413647|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413648|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413649|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14413650|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14413651|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413652|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413653|NCT01597245|Etanercept|etanercept|mesh-list
14413654|NCT01597245|Ixekizumab|ixekizumab|mesh-list
14413655|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14413656|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413657|NCT01597245|Analgesics|analgesics|mesh-ancestor
14413658|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
14413659|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413660|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413661|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14413662|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413663|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14413664|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413665|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
14413666|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413667|NCT01597258|Crizotinib|crizotinib|mesh-list
14413668|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413669|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14413670|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413671|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413672|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14413673|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14413674|NCT01597479|Anesthetics|anesthetics|mesh-list
14413675|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
14413676|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
14413677|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413678|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413679|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
14413680|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413681|NCT01597492|Vaccines|vaccines|mesh-list
14413682|NCT01597492|Belimumab|belimumab|mesh-list
14413683|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
14413684|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413685|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413686|NCT01597505|Vancomycin|vancomycin|mesh-list
14413687|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413688|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413689|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
14413690|NCT01597557|Analgesics|analgesics|mesh-ancestor
14413691|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
14413692|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413693|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413694|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
14413695|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413696|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14413697|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
14413698|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14413699|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14413700|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413701|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14413702|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
14413703|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14413704|NCT01597622|Belimumab|belimumab|mesh-list
14413705|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413706|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
14413707|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413708|NCT01597908|Trametinib|trametinib|mesh-list
14413709|NCT01597908|Vemurafenib|vemurafenib|mesh-list
14413710|NCT01597908|Dabrafenib|dabrafenib|mesh-list
14413711|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413712|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14413713|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413714|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413715|NCT01597973|Meropenem|meropenem|mesh-list
14413716|NCT01597973|Colistin|colistin|mesh-list
14413717|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413718|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413719|NCT01598090|Ribavirin|ribavirin|mesh-list
14413720|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14413721|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
14413722|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413723|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
14413724|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413725|NCT01598207|Dronabinol|dronabinol|mesh-list
14413726|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
14413727|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413728|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14413729|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413730|NCT01598207|Analgesics|analgesics|mesh-ancestor
14413731|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
14413732|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413733|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14413734|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14413735|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413736|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413737|NCT01598207|Hormones|hormones|mesh-ancestor
14413738|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413739|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14413740|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14413741|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14413742|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14413743|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413744|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413745|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246517|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15246518|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246519|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
15246520|NCT03701672|Analgesics|analgesics|mesh-list
15246521|NCT03701672|Narcotics|narcotics|mesh-ancestor
15246522|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246523|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246524|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
15246525|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246526|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
15246527|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15246528|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15246529|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246530|NCT03701529|Anesthetics|anesthetics|mesh-list
15246531|NCT03701529|Propofol|propofol|mesh-list
15246532|NCT03701529|Sevoflurane|sevoflurane|mesh-list
15246533|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246534|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246535|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15246536|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15246537|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
15246538|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15246539|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15246540|NCT03701503|Hormones|hormones|mesh-list
15246541|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15246542|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246543|NCT03701490|Progesterone|progesterone|mesh-list
15246544|NCT03701490|Progestins|progestins|mesh-ancestor
14743885|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743886|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
14743887|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14743888|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15246545|NCT03701490|Hormones|hormones|mesh-ancestor
15246546|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15246547|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413746|NCT01598298|Analgesics|analgesics|mesh-ancestor
14413747|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
14413748|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413749|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
14413750|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14413751|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
14413752|NCT01598311|Vancomycin|vancomycin|mesh-list
14413753|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413754|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413755|NCT01598506|Hydromorphone|hydromorphone|mesh-list
14413756|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14413757|NCT01598506|Narcotics|narcotics|mesh-ancestor
14413758|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413759|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925648|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15246548|NCT03701451|Decitabine|decitabine|mesh-list
15246549|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15246550|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
15246551|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246552|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246553|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246554|NCT03701321|Dexamethasone|dexamethasone|mesh-list
15246555|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
15246556|NCT03701321|Bortezomib|bortezomib|mesh-list
15246557|NCT03701321|Venetoclax|venetoclax|mesh-list
15246558|NCT03701321|Daratumumab|daratumumab|mesh-list
14413760|NCT01598506|Analgesics|analgesics|mesh-ancestor
15246559|NCT03701321|Ichthammol|ichthammol|mesh-list
15246560|NCT03701321|BB 1101|bb 1101|mesh-list
15246561|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15246562|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
15246563|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
15246564|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246565|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246566|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15246567|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
15246568|NCT03701321|Hormones|hormones|mesh-ancestor
15246569|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743889|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743890|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14743891|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743892|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743893|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743894|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15246570|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15246571|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246572|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
15246573|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925649|NCT01405157|Prednisolone|prednisolone|mesh-list
14925650|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
14925651|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14925652|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
15246574|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413761|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
14413762|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413763|NCT01598545|Hydromorphone|hydromorphone|mesh-list
14413764|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14413765|NCT01598545|Narcotics|narcotics|mesh-ancestor
14413766|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246575|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
15246576|NCT03701256|Atracurium|atracurium|mesh-list
15246577|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15246578|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15246579|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15246580|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246581|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246582|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15246583|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15246584|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
15246585|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15246586|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246587|NCT03701126|Bupivacaine|bupivacaine|mesh-list
15246588|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
15246589|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
14413767|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413768|NCT01598545|Analgesics|analgesics|mesh-ancestor
14413769|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
14413770|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413771|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
14413772|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14413773|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
14413774|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14413775|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413776|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14413777|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14413778|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14413779|NCT01598701|Acetaminophen|acetaminophen|mesh-list
14413780|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413781|NCT01598701|Analgesics|analgesics|mesh-ancestor
14413782|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
14925653|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15246590|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15246591|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246592|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
15246593|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246594|NCT03701087|Vitamin D|vitamin d|mesh-list
15246595|NCT03701087|Vitamins|vitamins|mesh-ancestor
14413783|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413784|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246596|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
14413785|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
15246597|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246598|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15246599|NCT03701022|Apatinib|apatinib|mesh-list
15246600|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246601|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15246602|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413786|NCT01598740|Spironolactone|spironolactone|mesh-list
14413787|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14413788|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
14413789|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413790|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413791|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14413792|NCT01598740|Diuretics|diuretics|mesh-ancestor
14413793|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
14413794|NCT01598753|Tramadol|tramadol|mesh-list
14413795|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14925654|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
14925655|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
14413796|NCT01598753|Narcotics|narcotics|mesh-ancestor
14413797|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413798|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413799|NCT01598753|Analgesics|analgesics|mesh-ancestor
14413800|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
14413801|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413802|NCT01598896|Clonidine|clonidine|mesh-list
14413803|NCT01598896|Dronabinol|dronabinol|mesh-list
14413804|NCT01598896|Analgesics|analgesics|mesh-ancestor
14413805|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
14413806|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413807|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413808|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14413809|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
14413810|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
14413811|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14413812|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14413813|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14413814|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
14413815|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413816|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413817|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
14413818|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14413819|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14413820|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14413821|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14413822|NCT01598896|Hormones|hormones|mesh-ancestor
14413823|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413824|NCT01598987|Cyclosporine|cyclosporine|mesh-list
14413825|NCT01598987|Everolimus|everolimus|mesh-list
14413826|NCT01598987|Tacrolimus|tacrolimus|mesh-list
14413827|NCT01598987|Cyclosporins|cyclosporins|mesh-list
14413828|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413829|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
14413830|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413831|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14413832|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413833|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413834|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
14413835|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413836|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14413837|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14413838|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413839|NCT01599104|Olmesartan|olmesartan|mesh-list
14413840|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14413841|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14925656|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925657|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925658|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925659|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
14925660|NCT01405157|Hormones|hormones|mesh-ancestor
14925661|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743895|NCT00584389|Rimonabant|rimonabant|mesh-list
14743896|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14743897|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14743898|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14743899|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925662|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14925663|NCT01405157|Protective Agents|protective agents|mesh-ancestor
14925664|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925665|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925666|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
14925667|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14925668|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15246603|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246604|NCT03700905|Nivolumab|nivolumab|mesh-list
15246605|NCT03700905|Ipilimumab|ipilimumab|mesh-list
15246606|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15246607|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246608|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15246609|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925669|NCT01405170|Prednisolone|prednisolone|mesh-list
14925670|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
14925671|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14925672|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
14925673|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925674|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
14413842|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14413843|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14413844|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413845|NCT01599234|Nabiximols|nabiximols|mesh-list
14413846|NCT01599234|Analgesics|analgesics|mesh-ancestor
14413847|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
14413848|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413849|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413850|NCT01599325|Azacitidine|azacitidine|mesh-list
14413851|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14413852|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
14413853|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413854|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413855|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413856|NCT01599650|Ranibizumab|ranibizumab|mesh-list
14413857|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14413858|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14413859|NCT01599650|Growth Substances|growth substances|mesh-ancestor
14413860|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413861|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
14413862|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413863|NCT01599754|Axitinib|axitinib|mesh-list
14413864|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413865|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14413866|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413867|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413868|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
14413869|NCT01599806|Ceftazidime|ceftazidime|mesh-list
14413870|NCT01599806|Doripenem|doripenem|mesh-list
15246610|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15246611|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15246612|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413871|NCT01599806|Avibactam|avibactam|mesh-list
14413872|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14413873|NCT01599806|Trimethoprim|trimethoprim|mesh-list
14413874|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
14413875|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14413876|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14413877|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14413878|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14413879|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413880|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925675|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
15246613|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15246614|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246615|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246616|NCT03700801|Insulin|insulin|mesh-list
15246617|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15246618|NCT03700801|Metformin|metformin|mesh-list
15246619|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
15246620|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
15246621|NCT03700801|Saxagliptin|saxagliptin|mesh-list
15246622|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14413881|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413882|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14413883|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14413884|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14413885|NCT01599806|Renal Agents|renal agents|mesh-ancestor
14413886|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
14413887|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14413888|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14413889|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14413890|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14413891|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14413892|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14413893|NCT01600053|Lenalidomide|lenalidomide|mesh-list
14413894|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
14413895|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413896|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14413897|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14413898|NCT01600053|Growth Substances|growth substances|mesh-ancestor
14413899|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
14413900|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413901|NCT01600170|Atorvastatin|atorvastatin|mesh-list
14413902|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14413903|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14413904|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
14413905|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413906|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14743900|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743901|NCT00584389|Hormones|hormones|mesh-ancestor
14743902|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743903|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743904|NCT00584493|Tremelimumab|tremelimumab|mesh-list
14743905|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246623|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246624|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15246625|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246626|NCT03700801|Incretins|incretins|mesh-ancestor
14413907|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14413908|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246627|NCT03700801|Hormones|hormones|mesh-ancestor
15246628|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15246629|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15246630|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
14413909|NCT01600287|Propofol|propofol|mesh-list
14413910|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14413911|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14413912|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413913|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14413914|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
14413915|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
14467755|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467756|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14467757|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14467758|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
14467759|NCT02265341|Ponatinib|ponatinib|mesh-list
14467760|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467761|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15246631|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246632|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
15246633|NCT03700788|Calcium|calcium|mesh-list
15246634|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15246635|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246636|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14467762|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467763|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467764|NCT02265510|Gemcitabine|gemcitabine|mesh-list
14467765|NCT02265510|Dexamethasone|dexamethasone|mesh-list
14467766|NCT02265510|Paclitaxel|paclitaxel|mesh-list
14467767|NCT02265510|Lenalidomide|lenalidomide|mesh-list
14467768|NCT02265510|Bortezomib|bortezomib|mesh-list
14467769|NCT02265510|Azacitidine|azacitidine|mesh-list
15246637|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246638|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
15246639|NCT03700749|Iodine|iodine|mesh-list
15246640|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
14467770|NCT02265510|Pomalidomide|pomalidomide|mesh-list
14413916|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14413917|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14413918|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413919|NCT01600703|Incretins|incretins|mesh-ancestor
14413920|NCT01600703|Hormones|hormones|mesh-ancestor
14413921|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413922|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14413923|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
14413924|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467771|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14413925|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413926|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
14413927|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14413928|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14413929|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14413930|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14413931|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413932|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
14413933|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413934|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413935|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14413936|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413937|NCT01600885|Guanfacine|guanfacine|mesh-list
14413938|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14413939|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14413940|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14413941|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14413942|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
14413943|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743906|NCT00584532|Genistein|genistein|mesh-list
14743907|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14743908|NCT00584532|Protective Agents|protective agents|mesh-ancestor
14413944|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413945|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413946|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
14413947|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14413948|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413949|NCT01601132|Colchicine|colchicine|mesh-list
14743909|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246641|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15246642|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
14413950|NCT01601132|Theophylline|theophylline|mesh-list
14413951|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
14413952|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14743910|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925676|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15246643|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
15246644|NCT03700749|Povidone|povidone|mesh-list
15246645|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15246646|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246647|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
15246648|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
15246649|NCT03700749|Trace Elements|trace elements|mesh-ancestor
15246650|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
15246651|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413953|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
14413954|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
15246652|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
15246653|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
15246654|NCT03700645|Allopurinol|allopurinol|mesh-list
15246655|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
15246656|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246657|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246658|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
15246659|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246660|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15246661|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
15246662|NCT03700645|Protective Agents|protective agents|mesh-ancestor
15246663|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246664|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
15246665|NCT03700515|Hematinics|hematinics|mesh-ancestor
15246666|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
15246667|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
14743911|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15246668|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15246669|NCT03700489|Protective Agents|protective agents|mesh-ancestor
14413955|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
14413956|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246670|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743912|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14743913|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413957|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413958|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14413959|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
14413960|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14413961|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413962|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14413963|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
14413964|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14413965|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413966|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
14743914|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
14743915|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14743916|NCT00584532|Estrogens|estrogens|mesh-ancestor
14743917|NCT00584532|Hormones|hormones|mesh-ancestor
14743918|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743919|NCT00584571|Dexetimide|dexetimide|mesh-list
14743920|NCT00584571|Citalopram|citalopram|mesh-list
14743921|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14743922|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14743923|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14743924|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743925|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743926|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
14743927|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743928|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14743929|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14743930|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743931|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14413967|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14413968|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14413969|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
14413970|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14413971|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14413972|NCT01601236|Hormones|hormones|mesh-ancestor
14743932|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15246671|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
15246672|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15246673|NCT03700476|Gemcitabine|gemcitabine|mesh-list
15246674|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246675|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15246676|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
15246677|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246678|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
15246679|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246680|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246681|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15246682|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
15246683|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246684|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
15246685|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14413973|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14413974|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14413975|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
14413976|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14413977|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
14413978|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14413979|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14413980|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413981|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413982|NCT01601470|Urological Agents|urological agents|mesh-ancestor
14413983|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14413984|NCT01601535|Irinotecan|irinotecan|mesh-list
14925677|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925678|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14925679|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
14925680|NCT01405170|Hormones|hormones|mesh-ancestor
14925681|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925682|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14925683|NCT01405170|Protective Agents|protective agents|mesh-ancestor
14925684|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925685|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925686|NCT01405235|Paclitaxel|paclitaxel|mesh-list
14925687|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14925688|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14925689|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413985|NCT01601535|Temozolomide|temozolomide|mesh-list
14413986|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14413987|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14413988|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14413989|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14413990|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14413991|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14413992|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
14413993|NCT01601626|Pyridoxine|pyridoxine|mesh-list
14413994|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
14413995|NCT01601626|Ritonavir|ritonavir|mesh-list
14413996|NCT01601626|Lopinavir|lopinavir|mesh-list
14413997|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
14413998|NCT01601626|Rifampin|rifampin|mesh-list
14413999|NCT01601626|Isoniazid|isoniazid|mesh-list
14414000|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
14414001|NCT01601626|Ethambutol|ethambutol|mesh-list
14414002|NCT01601626|Rifabutin|rifabutin|mesh-list
14414003|NCT01601626|Vitamins|vitamins|mesh-ancestor
14414004|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
14414005|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414006|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14414007|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15246686|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
15246687|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15246688|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15246689|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15246690|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
15246691|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246692|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246693|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15246694|NCT03700359|Etoposide|etoposide|mesh-list
15246695|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15246696|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414008|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
14414009|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414010|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414011|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14414012|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14414013|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
14414014|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414015|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14414016|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14414017|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
14414018|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14414019|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14414020|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14414021|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
14414022|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14414023|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
14414024|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14414025|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14414026|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14414027|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14414028|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14414029|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14414030|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14414031|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14414032|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14414033|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
14414034|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14414035|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
14414036|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14414037|NCT01601821|Sirolimus|sirolimus|mesh-list
14414038|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14414039|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15246697|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15246698|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15246699|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246700|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246701|NCT03700333|Pemetrexed|pemetrexed|mesh-list
15246702|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15246703|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15246704|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15246705|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15246706|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14414040|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14414041|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414042|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
14414043|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414044|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
14414045|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414046|NCT01601847|Vitamin D|vitamin d|mesh-list
14414047|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
14414048|NCT01601847|Vitamins|vitamins|mesh-ancestor
14414049|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
14414050|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743933|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
14414051|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14414052|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14414053|NCT01601873|Heparin|heparin|mesh-list
14414054|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
14414055|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14414056|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14414057|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414058|NCT01602068|Dexamethasone|dexamethasone|mesh-list
14414059|NCT01602068|Citric Acid|citric acid|mesh-list
14414060|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
14414061|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14414062|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414063|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
14414064|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
14414065|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414066|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414067|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14414068|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
14414069|NCT01602068|Hormones|hormones|mesh-ancestor
14414070|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14743934|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
14414071|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414072|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414073|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
14414074|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14414075|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
14414076|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
14743935|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414077|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414078|NCT01602224|Dexamethasone|dexamethasone|mesh-list
14414079|NCT01602224|Bortezomib|bortezomib|mesh-list
14414080|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414081|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
14925690|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14743936|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14414082|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
14414083|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414084|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414085|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14414086|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
14414087|NCT01602224|Hormones|hormones|mesh-ancestor
14414088|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414089|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414090|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414091|NCT01602315|Cetuximab|cetuximab|mesh-list
14414092|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414093|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14743937|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14743938|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
14743939|NCT00584610|Copper|copper|mesh-list
14743940|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
14743941|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14414094|NCT01602510|Lamotrigine|lamotrigine|mesh-list
14414095|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
14414096|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14743942|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
14743943|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14743944|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743945|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14743946|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14743947|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14743948|NCT00584610|Trace Elements|trace elements|mesh-ancestor
14743949|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
14743950|NCT00584636|Budesonide|budesonide|mesh-list
14743951|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14743952|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14743953|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
14743954|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743955|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743956|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14743957|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
14743958|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
14743959|NCT00584636|Hormones|hormones|mesh-ancestor
14743960|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414097|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414098|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743961|NCT00584662|Phenylephrine|phenylephrine|mesh-list
14743962|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
14414099|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14414100|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414101|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14414102|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14414103|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14414104|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414105|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14414106|NCT01602562|Valacyclovir|valacyclovir|mesh-list
14414107|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
14414108|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414109|NCT01602679|Progesterone|progesterone|mesh-list
14414110|NCT01602679|Progestins|progestins|mesh-ancestor
14414111|NCT01602679|Hormones|hormones|mesh-ancestor
14414112|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414113|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414114|NCT01602692|Lidocaine|lidocaine|mesh-list
14414115|NCT01602692|Epinephrine|epinephrine|mesh-list
14414116|NCT01602692|Racepinephrine|racepinephrine|mesh-list
14414117|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14414118|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
14414119|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
14414120|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
14414121|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14414122|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414123|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
14414124|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414125|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14414126|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14414127|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14414128|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414129|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414130|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14414131|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14414132|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
14414133|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414134|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14414135|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14414136|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
14414137|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14414138|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
14414139|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
14414140|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
14414141|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14414142|NCT01603082|Clopidogrel|clopidogrel|mesh-list
14414143|NCT01603082|Ticagrelor|ticagrelor|mesh-list
14414144|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14414145|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14414146|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14414147|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14414148|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
14414149|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414150|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414151|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414152|NCT01603277|Antibodies|antibodies|mesh-list
14414153|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14414154|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
14414155|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414156|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
14414157|NCT01603420|Docetaxel|docetaxel|mesh-list
14414158|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
14414159|NCT01603420|Hormones|hormones|mesh-list
14414160|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14925691|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14414161|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14414162|NCT01603420|Androgens|androgens|mesh-list
14414163|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414164|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14414165|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14414166|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14414167|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414168|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414169|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414170|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
14414171|NCT01603420|Protective Agents|protective agents|mesh-ancestor
14414172|NCT01603420|Vitamins|vitamins|mesh-ancestor
14414173|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
14414174|NCT01603420|Estrogens|estrogens|mesh-ancestor
14414175|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414176|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
14414177|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14414178|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14414179|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414180|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414181|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414182|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414183|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414184|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
14925692|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14414185|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414186|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
14414187|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14414188|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14414189|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414190|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414191|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414192|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414193|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414194|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414195|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14414196|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414197|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
14414198|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14414199|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14414200|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414201|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414202|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414203|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414204|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414205|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414206|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14414207|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414208|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
14414209|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14414210|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14414211|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414212|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414213|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414214|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414215|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414216|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414217|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14414218|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414219|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
14414220|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14414221|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14414222|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414223|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414224|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414225|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414226|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414227|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414228|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14414229|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414230|NCT01603940|Losartan|losartan|mesh-list
14414231|NCT01603940|Benazepril|benazepril|mesh-list
14414232|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14414233|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14414234|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14414235|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14414236|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414237|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14414238|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
14414239|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414240|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
14414241|NCT01604109|Caseins|caseins|mesh-list
14414242|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14414243|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
14414244|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414245|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414246|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414247|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
14414248|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
14414249|NCT01604265|Nabiximols|nabiximols|mesh-list
14414250|NCT01604265|Analgesics|analgesics|mesh-ancestor
14414251|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
14414252|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414253|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414254|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
14414255|NCT01604278|Bromides|bromides|mesh-list
14414256|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
14414257|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925693|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925694|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
14925695|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14925696|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14925697|NCT01405248|Protective Agents|protective agents|mesh-ancestor
14925698|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925699|NCT01405326|Adalimumab|adalimumab|mesh-list
14925700|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925701|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14925702|NCT01405339|Budesonide|budesonide|mesh-list
14925703|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925704|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14925705|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
14925706|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925707|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925708|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14414258|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14414259|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14414260|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414261|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414262|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414263|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414264|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14414265|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
14414266|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414267|NCT01604785|Dopamine|dopamine|mesh-list
14414268|NCT01604785|Propofol|propofol|mesh-list
14414269|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
14414270|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14414271|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14414272|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925709|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
14414273|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14414274|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
14414275|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
14414276|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14414277|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
14414278|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
14414279|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414280|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
14414281|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414282|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414283|NCT01604785|Protective Agents|protective agents|mesh-ancestor
14414284|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
14414285|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
14414286|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414287|NCT01605032|Bortezomib|bortezomib|mesh-list
14414288|NCT01605032|Melphalan|melphalan|mesh-list
14414289|NCT01605032|Busulfan|busulfan|mesh-list
14414290|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414291|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14414292|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
14414293|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414294|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14414295|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414296|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
14414297|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414298|NCT01605071|Estradiol|estradiol|mesh-list
14414299|NCT01605071|Estrogens|estrogens|mesh-ancestor
14414300|NCT01605071|Hormones|hormones|mesh-ancestor
14414301|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414302|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414303|NCT01605136|Afamelanotide|afamelanotide|mesh-list
14414304|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
14414305|NCT01605227|Prednisone|prednisone|mesh-list
14414306|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414307|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
14414308|NCT01605227|Hormones|hormones|mesh-ancestor
14414309|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414310|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414311|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414312|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414313|NCT01605396|Exemestane|exemestane|mesh-list
14414314|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414315|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14414316|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14414317|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414318|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414319|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14414320|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
14414321|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414322|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414323|NCT01605539|Cannabidiol|cannabidiol|mesh-list
14414324|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
14414325|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
14414326|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14414327|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414328|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414329|NCT01605890|Tenofovir|tenofovir|mesh-list
14414330|NCT01605890|Emtricitabine|emtricitabine|mesh-list
14414331|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
14414332|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14414333|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
14414334|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925710|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
14414335|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14414336|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14414337|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414338|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414339|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14414340|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14414341|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14414342|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14414343|NCT01605903|Acetaminophen|acetaminophen|mesh-list
14414344|NCT01605903|Ibuprofen|ibuprofen|mesh-list
14414345|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14414346|NCT01605903|Analgesics|analgesics|mesh-ancestor
14414347|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
14414348|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414349|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414350|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
14414351|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14414352|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414353|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14414354|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14414355|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414356|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414357|NCT01605942|Dexamethasone|dexamethasone|mesh-list
14414358|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414359|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
14414360|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
14414361|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414362|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414363|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14414364|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
14414365|NCT01605942|Hormones|hormones|mesh-ancestor
14414366|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414367|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414368|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414369|NCT01606007|Metformin|metformin|mesh-list
14414370|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
14414371|NCT01606007|Saxagliptin|saxagliptin|mesh-list
14414372|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14414373|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414374|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14414375|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414376|NCT01606007|Incretins|incretins|mesh-ancestor
14414377|NCT01606007|Hormones|hormones|mesh-ancestor
14414378|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414379|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14414380|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14414381|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414382|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14414383|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
14414384|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414385|NCT01606124|Protective Agents|protective agents|mesh-ancestor
14414386|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414387|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14414388|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14414389|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414390|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14414391|NCT01606137|Nabiximols|nabiximols|mesh-list
14414392|NCT01606137|Analgesics|analgesics|mesh-ancestor
14414393|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
14414394|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414395|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414396|NCT01606176|Nabiximols|nabiximols|mesh-list
14414397|NCT01606176|Analgesics|analgesics|mesh-ancestor
14414398|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
14414399|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414400|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414401|NCT01606189|Nabiximols|nabiximols|mesh-list
14414402|NCT01606189|Analgesics|analgesics|mesh-ancestor
14414403|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
14414404|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414405|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414406|NCT01606202|Nabiximols|nabiximols|mesh-list
14414407|NCT01606202|Analgesics|analgesics|mesh-ancestor
14414408|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
14414409|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414410|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414411|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14414412|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14414413|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14414414|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14414415|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414416|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414417|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14414418|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14414419|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
14414420|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414421|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414422|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14414423|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14414424|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
14414425|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14414426|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14414427|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14414428|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14414429|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414430|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414431|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14414432|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14414433|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
14414434|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414435|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414436|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14414437|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14414438|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
14414439|NCT01606306|Fluticasone|fluticasone|mesh-list
14414440|NCT01606306|Xhance|xhance|mesh-list
14414441|NCT01606306|Montelukast|montelukast|mesh-list
14414442|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414443|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14414444|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
14414445|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414446|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414447|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14414448|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
14414449|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
14414450|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14414451|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14414452|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
14414453|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414454|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14414455|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14414456|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414457|NCT01606319|Acetaminophen|acetaminophen|mesh-list
14414458|NCT01606319|Ibuprofen|ibuprofen|mesh-list
14414459|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14414460|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14414461|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14414462|NCT01606319|Analgesics|analgesics|mesh-ancestor
14414463|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
14414464|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414465|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414466|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
14414467|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14414468|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14414469|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414470|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467772|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467773|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
14467774|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
14414471|NCT01606748|Gemcitabine|gemcitabine|mesh-list
14414472|NCT01606748|Necitumumab|necitumumab|mesh-list
14414473|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414474|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14414475|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
14414476|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414477|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
14414478|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414479|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414480|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414481|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
14414482|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414483|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414484|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14414485|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
14414486|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414487|NCT01606787|Mannitol|mannitol|mesh-list
14414488|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14414489|NCT01606787|Diuretics|diuretics|mesh-ancestor
14414490|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
14414491|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414492|NCT01606800|Ribavirin|ribavirin|mesh-list
14414493|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
14414494|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14414495|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
14414496|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414497|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
14414498|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414499|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414500|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
14414501|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14743963|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14743964|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14743965|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
14743966|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743967|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743968|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743969|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
14743970|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
14743971|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743972|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
14743973|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14743974|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
14743975|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14414502|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743976|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
14743977|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14743978|NCT00584662|Protective Agents|protective agents|mesh-ancestor
14743979|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14743980|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
14743981|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414503|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414504|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14414505|NCT01606852|Analgesics|analgesics|mesh-ancestor
14414506|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
14414507|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414508|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14414509|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14414510|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14414511|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
14414512|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414513|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414514|NCT01607073|Verapamil|verapamil|mesh-list
14414515|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14414516|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14414517|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414518|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414519|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14414520|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414521|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
14414522|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14414523|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14414524|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
14414525|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14414526|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
14414527|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14414528|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414529|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14414530|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414531|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414532|NCT01607346|Ezogabine|ezogabine|mesh-list
14414533|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
14414534|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414535|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414536|NCT01607411|Fluorides|fluorides|mesh-list
14414537|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
14414538|NCT01607411|Protective Agents|protective agents|mesh-ancestor
14414539|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414540|NCT01607450|Glucagon|glucagon|mesh-list
14414541|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14414542|NCT01607450|Incretins|incretins|mesh-ancestor
14414543|NCT01607450|Hormones|hormones|mesh-ancestor
14414544|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414545|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414546|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14414547|NCT01607476|Corticosterone|corticosterone|mesh-list
14414548|NCT01607476|Flutemetamol|flutemetamol|mesh-list
14414549|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414550|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14414551|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414552|NCT01607554|Irinotecan|irinotecan|mesh-list
14414553|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14414554|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14414555|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414556|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414557|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414558|NCT01607593|Sertraline|sertraline|mesh-list
14414559|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
14414560|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414561|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14414562|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14414563|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414564|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414565|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414566|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
14414567|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414568|NCT01607645|Cytarabine|cytarabine|mesh-list
14414569|NCT01607645|Decitabine|decitabine|mesh-list
14414570|NCT01607645|Azacitidine|azacitidine|mesh-list
14414571|NCT01607645|Idarubicin|idarubicin|mesh-list
14414572|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14414573|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
14414574|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414575|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414576|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
14414577|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414578|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414579|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
14414580|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414581|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414582|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14414583|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14925711|NCT01405339|Hormones|hormones|mesh-ancestor
14414584|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14414585|NCT01607853|Calcitriol|calcitriol|mesh-list
14414586|NCT01607853|Betamethasone|betamethasone|mesh-list
14414587|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414588|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
14414589|NCT01607853|Hormones|hormones|mesh-ancestor
14414590|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414591|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414592|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14414593|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
14414594|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14414595|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14414596|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414597|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414598|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14414599|NCT01607853|Vitamins|vitamins|mesh-ancestor
14414600|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
14414601|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14414602|NCT01607905|Acetaminophen|acetaminophen|mesh-list
14414603|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14414604|NCT01607905|Analgesics|analgesics|mesh-ancestor
14414605|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
14414606|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414607|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414608|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
14414609|NCT01608087|Bevacizumab|bevacizumab|mesh-list
14414610|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414611|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414612|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14414613|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14414614|NCT01608087|Growth Substances|growth substances|mesh-ancestor
14414615|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414616|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
14414617|NCT01608295|Paroxetine|paroxetine|mesh-list
14414618|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
14414619|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14414620|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14414621|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14414622|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414623|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14743982|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14743983|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743984|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743985|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14743986|NCT00584779|Gabapentin|gabapentin|mesh-list
14743987|NCT00584779|Analgesics|analgesics|mesh-ancestor
14925712|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925713|NCT01405352|Vitamin A|vitamin a|mesh-list
14414624|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414625|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
14414626|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414627|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14414628|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414629|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14414630|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14414631|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414632|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14414633|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14414634|NCT01608308|Acetaminophen|acetaminophen|mesh-list
14414635|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14414636|NCT01608308|Analgesics|analgesics|mesh-ancestor
14414637|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
14414638|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414639|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414640|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
14414641|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
14414642|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14414643|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14414644|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414645|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414646|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414647|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414648|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414649|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414650|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14414651|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414652|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
14414653|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14414654|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14414655|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414656|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414657|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414658|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414659|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414660|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414661|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14414662|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414663|NCT01608724|Saxagliptin|saxagliptin|mesh-list
14743988|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
14743989|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14743990|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925714|NCT01405352|Vitamins|vitamins|mesh-ancestor
14925715|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
14925716|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925717|NCT01405365|Metronidazole|metronidazole|mesh-list
14925718|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14743991|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
14743992|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14743993|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14743994|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14743995|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14743996|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14743997|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14743998|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14743999|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925719|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14414664|NCT01608724|Incretins|incretins|mesh-ancestor
14414665|NCT01608724|Hormones|hormones|mesh-ancestor
14467775|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
14467776|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467777|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414666|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414667|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414668|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14414669|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
14414670|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414671|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414672|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14414673|NCT01609010|Interferons|interferons|mesh-list
14414674|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
14414675|NCT01609010|Rituximab|rituximab|mesh-list
14414676|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414677|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414678|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
14414679|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414680|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14414681|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
14414682|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414683|NCT01609023|Rituximab|rituximab|mesh-list
14414684|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414685|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414686|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
14414687|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414688|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14414689|NCT01609218|Charcoal|charcoal|mesh-list
14925720|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14925721|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14925722|NCT01405430|Bevacizumab|bevacizumab|mesh-list
14925723|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925724|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925725|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14925726|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14925727|NCT01405430|Growth Substances|growth substances|mesh-ancestor
14925728|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925729|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
14925730|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
14925731|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14414690|NCT01609218|Antidotes|antidotes|mesh-ancestor
14414691|NCT01609218|Protective Agents|protective agents|mesh-ancestor
14414692|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414693|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14414694|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14414695|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14414696|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414697|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414698|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414699|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414700|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14414701|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14414702|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414703|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
14414704|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414705|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14414706|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14414707|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14414708|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414709|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14414710|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414711|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414712|NCT01609556|Maytansine|maytansine|mesh-list
14414713|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14414714|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414715|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14414716|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14414717|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14414718|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414719|NCT01609933|Interferons|interferons|mesh-list
14414720|NCT01609933|Ritonavir|ritonavir|mesh-list
14414721|NCT01609933|Ribavirin|ribavirin|mesh-list
14414722|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
14414723|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
14414724|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14414725|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414726|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
14414727|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414728|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14414729|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14414730|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
14414731|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414732|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414733|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14414734|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14414735|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14414736|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14414737|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
14414738|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
14414739|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414740|NCT01610011|Glycine|glycine|mesh-list
14414741|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
14414742|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414743|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414744|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414745|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
14414746|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14414747|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
14414748|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414749|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414750|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14414751|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
14414752|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
14414753|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14744000|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
14744001|NCT00585000|Tremelimumab|tremelimumab|mesh-list
14744002|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744003|NCT00585091|Phenylephrine|phenylephrine|mesh-list
14744004|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
14744005|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14414754|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414755|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414756|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414757|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14414758|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14414759|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414760|NCT01610154|Incretins|incretins|mesh-ancestor
14414761|NCT01610154|Hormones|hormones|mesh-ancestor
14414762|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414763|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14414764|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14414765|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414766|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414767|NCT01610167|Listerine|listerine|mesh-list
14744006|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
14414768|NCT01610167|Fluorides|fluorides|mesh-list
14744007|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
14414769|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
14414770|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
14414771|NCT01610167|Protective Agents|protective agents|mesh-ancestor
14414772|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414773|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14414774|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414775|NCT01610206|Gemcitabine|gemcitabine|mesh-list
14414776|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14414777|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
14414778|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414779|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744008|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744009|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744010|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
14744011|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14414780|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
14414781|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414782|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414783|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414784|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
14744012|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
14744013|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
14744014|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14744015|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14744016|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14744017|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
14744018|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744019|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744020|NCT00585091|Protective Agents|protective agents|mesh-ancestor
14925732|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14414785|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414786|NCT01610284|Fulvestrant|fulvestrant|mesh-list
14414787|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414788|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414789|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14925733|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14414790|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14414791|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
14414792|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414793|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414794|NCT01610297|Deferasirox|deferasirox|mesh-list
14414795|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14414796|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
14414797|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
14414798|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414799|NCT01610336|Gefitinib|gefitinib|mesh-list
14414800|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414801|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14414802|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414803|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414804|NCT01610492|Belimumab|belimumab|mesh-list
14414805|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414806|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
14414807|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414808|NCT01610557|Bevacizumab|bevacizumab|mesh-list
14414809|NCT01610557|Ranibizumab|ranibizumab|mesh-list
14414810|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414811|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925734|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14925735|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925736|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
14414812|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14414813|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14414814|NCT01610557|Growth Substances|growth substances|mesh-ancestor
14414815|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414816|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
14414817|NCT01610570|Plicamycin|plicamycin|mesh-list
14414818|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14414819|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414820|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14414821|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414822|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14414823|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414824|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414825|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14414826|NCT01610596|Halobetasol|halobetasol|mesh-list
14414827|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14414828|NCT01610687|Nabiximols|nabiximols|mesh-list
14414829|NCT01610687|Analgesics|analgesics|mesh-ancestor
14414830|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
14414831|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414832|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414833|NCT01610700|Nabiximols|nabiximols|mesh-list
14414834|NCT01610700|Analgesics|analgesics|mesh-ancestor
14414835|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
14744021|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14744022|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14744023|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14744024|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
14744025|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744026|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14744027|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14744028|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744029|NCT00585156|Celecoxib|celecoxib|mesh-list
14744030|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14744031|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14744032|NCT00585156|Analgesics|analgesics|mesh-ancestor
14744033|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
14744034|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744035|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744036|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744037|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14414836|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414837|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414838|NCT01610713|Nabiximols|nabiximols|mesh-list
14414839|NCT01610713|Analgesics|analgesics|mesh-ancestor
14925737|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925738|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925739|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14925740|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925741|NCT01405521|Vaccines|vaccines|mesh-list
14925742|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
14925743|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925744|NCT01405573|Sorafenib|sorafenib|mesh-list
14925745|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925746|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14925747|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925748|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925749|NCT01405586|Gemcitabine|gemcitabine|mesh-list
14414840|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
14414841|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925750|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744038|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14744039|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14414842|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414843|NCT01611090|Rituximab|rituximab|mesh-list
14414844|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14414845|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414846|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414847|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
14414848|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414849|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744040|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744041|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744042|NCT00585260|Mannitol|mannitol|mesh-list
14414850|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14414851|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
14414852|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414853|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14414854|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14414855|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14925751|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14925752|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
14925753|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414856|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414857|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414858|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414859|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414860|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14414861|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
14414862|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14414863|NCT01611259|Rituximab|rituximab|mesh-list
14414864|NCT01611259|Lenalidomide|lenalidomide|mesh-list
14414865|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14744043|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14744044|NCT00585260|Diuretics|diuretics|mesh-ancestor
14744045|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
14744046|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744047|NCT00585442|Vitamin D|vitamin d|mesh-list
14744048|NCT00585442|Calcitriol|calcitriol|mesh-list
14744049|NCT00585442|Vitamins|vitamins|mesh-ancestor
14744050|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
14744051|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414866|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414867|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
14414868|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414869|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14414870|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14414871|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14414872|NCT01611259|Growth Substances|growth substances|mesh-ancestor
14414873|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
14414874|NCT01611298|Vaccines|vaccines|mesh-list
14414875|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
14414876|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414877|NCT01611558|Ipilimumab|ipilimumab|mesh-list
14414878|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14414879|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414880|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14414881|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744052|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14744053|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14744054|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14414882|NCT01611571|Teriparatide|teriparatide|mesh-list
14744055|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14744056|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744057|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14744058|NCT00585455|Sertraline|sertraline|mesh-list
14744059|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
14744060|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14744061|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14744062|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14744063|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14744064|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744065|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744066|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
14925754|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
14414883|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
14925755|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925756|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414884|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
14414885|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
14414886|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14414887|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414888|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14744067|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744068|NCT00585507|Fulvestrant|fulvestrant|mesh-list
14744069|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14925757|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925758|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
14414889|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14414890|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414891|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414892|NCT01611662|Gemcitabine|gemcitabine|mesh-list
14414893|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414894|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14414895|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
14414896|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925759|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925760|NCT01405612|Midazolam|midazolam|mesh-list
14925761|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925762|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14925763|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744070|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744071|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14744072|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14744073|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744074|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744075|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744076|NCT00585520|Progesterone|progesterone|mesh-list
14925764|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925765|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14744077|NCT00585520|Progestins|progestins|mesh-ancestor
14744078|NCT00585520|Hormones|hormones|mesh-ancestor
14744079|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925766|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14925767|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14925768|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14925769|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
14925770|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
14925771|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
14414897|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
14925772|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
14925773|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925774|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925775|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
14925776|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925777|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925778|NCT01405846|Gefitinib|gefitinib|mesh-list
14925779|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414898|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414899|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744080|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744081|NCT00585559|Acetaminophen|acetaminophen|mesh-list
14744082|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
14744083|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14744084|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14744085|NCT00585559|Analgesics|analgesics|mesh-ancestor
14744086|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
14744087|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744088|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744089|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
14744090|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
14744091|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744092|NCT00585559|Expectorants|expectorants|mesh-ancestor
14744093|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
14744094|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14744095|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
14744096|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744097|NCT00585559|Protective Agents|protective agents|mesh-ancestor
14744098|NCT00585559|Antidotes|antidotes|mesh-ancestor
14744099|NCT00585741|Alovudine|alovudine|mesh-list
14744100|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
14744101|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414900|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414901|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
14414902|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414903|NCT01611857|Leucovorin|leucovorin|mesh-list
14414904|NCT01611857|Fluorouracil|fluorouracil|mesh-list
14414905|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
14414906|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
14414907|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
14414908|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414909|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14414910|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414911|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14414912|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
14414913|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414914|NCT01611857|Antidotes|antidotes|mesh-ancestor
14414915|NCT01611857|Protective Agents|protective agents|mesh-ancestor
14414916|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
14414917|NCT01611857|Vitamins|vitamins|mesh-ancestor
14414918|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
14744102|NCT00585754|Guanfacine|guanfacine|mesh-list
14414919|NCT01611935|Vasopressins|vasopressins|mesh-list
14414920|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
14744103|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14744104|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14414921|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
14414922|NCT01611935|Coagulants|coagulants|mesh-ancestor
14414923|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14414924|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14414925|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
14414926|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414927|NCT01611948|Aprepitant|aprepitant|mesh-list
14414928|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
14414929|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
14414930|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414931|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414932|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14414933|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14414934|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414935|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414936|NCT01611974|Maribavir|maribavir|mesh-list
14414937|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
14414938|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414939|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
14414940|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
14414941|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
14414942|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414943|NCT01612156|Lidocaine|lidocaine|mesh-list
14414944|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
14414945|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
14414946|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14414947|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414948|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
14414949|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414950|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14414951|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14414952|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14414953|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14414954|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414955|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
14414956|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14414957|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
14414958|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14414959|NCT01612221|Expectorants|expectorants|mesh-ancestor
14414960|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
14414961|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14414962|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
14414963|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414964|NCT01612221|Protective Agents|protective agents|mesh-ancestor
14414965|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414966|NCT01612221|Antidotes|antidotes|mesh-ancestor
14414967|NCT01612546|Camptothecin|camptothecin|mesh-list
14414968|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14414969|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414970|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14414971|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14414972|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14414973|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414974|NCT01612702|Dexamethasone|dexamethasone|mesh-list
14925780|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14414975|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14414976|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
14414977|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
14414978|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14414979|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414980|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14414981|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
14414982|NCT01612702|Hormones|hormones|mesh-ancestor
14414983|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14414984|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14414985|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14414986|NCT01612858|Metformin|metformin|mesh-list
14414987|NCT01612858|Pioglitazone|pioglitazone|mesh-list
14414988|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14414989|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14414990|NCT01612884|Clopidogrel|clopidogrel|mesh-list
14414991|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14414992|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14414993|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14414994|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14414995|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14414996|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
14414997|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14414998|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14414999|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415000|NCT01613027|Rituximab|rituximab|mesh-list
14415001|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14415002|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415003|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
14415004|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415005|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14415006|NCT01613118|Irbesartan|irbesartan|mesh-list
14415007|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14415008|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14415009|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14415010|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467778|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
14467779|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
14467780|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467781|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467782|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14467783|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
14925781|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467784|NCT02265510|Hormones|hormones|mesh-ancestor
14467785|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467786|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14467787|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14467788|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
14467789|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
14467790|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467791|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467792|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14467793|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
14467794|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14467795|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14467796|NCT02265510|Growth Substances|growth substances|mesh-ancestor
14925782|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925783|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
14467797|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
14467798|NCT02265744|Antibodies|antibodies|mesh-list
14925784|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14925785|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
14925786|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925787|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925788|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
14925789|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925790|NCT01405989|Ketoconazole|ketoconazole|mesh-list
14925791|NCT01405989|Darexaban|darexaban|mesh-list
14415011|NCT01613131|Estradiol|estradiol|mesh-list
14415012|NCT01613131|Estrogens|estrogens|mesh-ancestor
14415013|NCT01613131|Hormones|hormones|mesh-ancestor
14415014|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415015|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415016|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
14415017|NCT01613326|Albuterol|albuterol|mesh-list
14415018|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
14415019|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14415020|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
14415021|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415022|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415023|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415024|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415025|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
14415026|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14415027|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
14415028|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415029|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415030|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
14415031|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14415032|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14415033|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14415034|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14415035|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
14415036|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14415037|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14415038|NCT01613599|Rituximab|rituximab|mesh-list
14925792|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
14744105|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14744106|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14744107|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
14744108|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744109|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744110|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744111|NCT00585793|Lopinavir|lopinavir|mesh-list
14744112|NCT00585793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14925793|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415039|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14415040|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415041|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
14415042|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415043|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14415044|NCT01613716|Dexamethasone|dexamethasone|mesh-list
14415045|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415046|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
14415047|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
14415048|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415049|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415050|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415051|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
14415052|NCT01613716|Hormones|hormones|mesh-ancestor
14415053|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415054|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14415055|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415056|NCT01614093|Oxytocin|oxytocin|mesh-list
14415057|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
14415058|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14415059|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415060|NCT01614210|Tamoxifen|tamoxifen|mesh-list
14415061|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14744113|NCT00585793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14744114|NCT00585793|Protease Inhibitors|protease inhibitors|mesh-ancestor
14415062|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744115|NCT00585793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744116|NCT00585793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744117|NCT00585793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14744118|NCT00585793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14744119|NCT00585793|Antiviral Agents|antiviral agents|mesh-ancestor
14744120|NCT00585793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744121|NCT00585793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14744122|NCT00585793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14925794|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14925795|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14925796|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925797|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925798|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14925799|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
14925800|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925801|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415063|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415064|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415065|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14415066|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415067|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14415068|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14415069|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14415070|NCT01614457|Ivacaftor|ivacaftor|mesh-list
14415071|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14415072|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415073|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415074|NCT01614470|Ivacaftor|ivacaftor|mesh-list
14415075|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14415076|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415077|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415078|NCT01614509|Triamcinolone|triamcinolone|mesh-list
14415079|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14415080|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14415081|NCT01614509|Bevacizumab|bevacizumab|mesh-list
14415082|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14415083|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14415084|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415085|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14415086|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14415087|NCT01614509|Growth Substances|growth substances|mesh-ancestor
14415088|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415089|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
14415090|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415091|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
14415092|NCT01614509|Hormones|hormones|mesh-ancestor
14415093|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415094|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415095|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
14415096|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415097|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415098|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14415099|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14415100|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415101|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415102|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14415103|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415104|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415105|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
14415106|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415107|NCT01614769|Glimepiride|glimepiride|mesh-list
14415108|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14415109|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14415110|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415111|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415112|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
14415113|NCT01614795|Sirolimus|sirolimus|mesh-list
14415114|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14415115|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415116|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415117|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14415118|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415119|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
14415120|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415121|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
14415122|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415123|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
14415124|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14415125|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14415126|NCT01614886|Rivastigmine|rivastigmine|mesh-list
14415127|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14415128|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415129|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415130|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
14415131|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415132|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415133|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14415134|NCT01614886|Protective Agents|protective agents|mesh-ancestor
14415135|NCT01615198|Olmesartan|olmesartan|mesh-list
14415136|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14415137|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14925802|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14925803|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14925804|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
14925805|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14925806|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
14925807|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
14925808|NCT01406002|Rifampin|rifampin|mesh-list
14925809|NCT01406002|Darexaban|darexaban|mesh-list
14925810|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14925811|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
14925812|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14925813|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925814|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
14925815|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14925816|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925817|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925818|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14415138|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14415139|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14415140|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415141|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14415142|NCT01615731|Digoxin|digoxin|mesh-list
14415143|NCT01615731|Misoprostol|misoprostol|mesh-list
14415144|NCT01615731|Mifepristone|mifepristone|mesh-list
14415145|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14415146|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
14415147|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14415148|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415149|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14415150|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415151|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
14415152|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14415153|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14415154|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415155|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415156|NCT01615731|Protective Agents|protective agents|mesh-ancestor
14415157|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14415158|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14415159|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14415160|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14415161|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
14415162|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14415163|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14415164|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
14415165|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415166|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
14415167|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14415168|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14415169|NCT01615809|Amphotericin B|amphotericin b|mesh-list
14415170|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14415171|NCT01615809|Amebicides|amebicides|mesh-ancestor
14415172|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14415173|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14415174|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415175|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415176|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
14415177|NCT01615822|Artefenomel|artefenomel|mesh-list
14415178|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
14415179|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14415180|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14415181|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415182|NCT01615939|Bupivacaine|bupivacaine|mesh-list
14415183|NCT01615939|Ropivacaine|ropivacaine|mesh-list
14415184|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
14415185|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
14415186|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415187|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415188|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
14415189|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415190|NCT01616082|Phentermine|phentermine|mesh-list
14415191|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14925819|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14925820|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14925821|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14925822|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14925823|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14415192|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415193|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
14415194|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14925824|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14925825|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
14925826|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14925827|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
14925828|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
14925829|NCT01406080|Adapalene|adapalene|mesh-list
14925830|NCT01406080|Tretinoin|tretinoin|mesh-list
14925831|NCT01406080|Emollients|emollients|mesh-list
14415195|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
14415196|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
14415197|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415198|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
14415199|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415200|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415201|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
14415202|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415203|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415204|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14415205|NCT01616173|Dexamethasone|dexamethasone|mesh-list
14415206|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
14415207|NCT01616173|BB 1101|bb 1101|mesh-list
14415208|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415209|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
14415210|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
14415211|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415212|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415213|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415214|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
14415215|NCT01616173|Hormones|hormones|mesh-ancestor
14415216|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415217|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14415218|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415219|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
14415220|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415221|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415222|NCT01616459|Vaccines|vaccines|mesh-list
14415223|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14415224|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
14925832|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14415225|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415226|NCT01616654|Tazarotene|tazarotene|mesh-list
14415227|NCT01616654|Trifarotene|trifarotene|mesh-list
14415228|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415229|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
14415230|NCT01616693|Zinc|zinc|mesh-list
14415231|NCT01616693|Vaccines|vaccines|mesh-list
14415232|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
14415233|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415234|NCT01616693|Trace Elements|trace elements|mesh-ancestor
14415235|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
14415236|NCT01617083|Azithromycin|azithromycin|mesh-list
14415237|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415238|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415239|NCT01617148|Aflibercept|aflibercept|mesh-list
14415240|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14415241|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14415242|NCT01617148|Growth Substances|growth substances|mesh-ancestor
14415243|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415244|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
14415245|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415246|NCT01617434|Liraglutide|liraglutide|mesh-list
14415247|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415248|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415249|NCT01617434|Incretins|incretins|mesh-ancestor
14415250|NCT01617434|Hormones|hormones|mesh-ancestor
14415251|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415252|NCT01617447|Aripiprazole|aripiprazole|mesh-list
14415253|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
14415254|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415255|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14415256|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14415257|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415258|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415259|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
14415260|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
14415261|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415262|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415263|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14415264|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14415265|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
14415266|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14415267|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14415268|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14415269|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14415270|NCT01617460|Aripiprazole|aripiprazole|mesh-list
14415271|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
14415272|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415273|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14415274|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14415275|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925833|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14925834|NCT01406080|Analgesics|analgesics|mesh-ancestor
14415276|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415277|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
14415278|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
14415279|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415280|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415281|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14467799|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
14925835|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
14415282|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14415283|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
14415284|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14415285|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14415286|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14415287|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14415288|NCT01617577|Lenograstim|lenograstim|mesh-list
14415289|NCT01617577|Sargramostim|sargramostim|mesh-list
14415290|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14415291|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
14415292|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415293|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14415294|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
14415295|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415296|NCT01617668|Paclitaxel|paclitaxel|mesh-list
14415297|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14925836|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925837|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925838|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14925839|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14925840|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
14925841|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925842|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
14925843|NCT01406132|Peficitinib|peficitinib|mesh-list
14925844|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925845|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925846|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14925847|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
14925848|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925849|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
14415298|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415299|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
14415300|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
14415301|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
14925850|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14415302|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415303|NCT01617681|Valsartan|valsartan|mesh-list
14415304|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14415305|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14415306|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14415307|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415308|NCT01618162|Liraglutide|liraglutide|mesh-list
14415309|NCT01618162|Xultophy|xultophy|mesh-list
14925851|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14415310|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415311|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415312|NCT01618162|Incretins|incretins|mesh-ancestor
14415313|NCT01618162|Hormones|hormones|mesh-ancestor
14467800|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744123|NCT00585871|Metoprolol|metoprolol|mesh-list
14744124|NCT00585871|Clonidine|clonidine|mesh-list
14744125|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14744126|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14925852|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
14744127|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
14744128|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
14744129|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744130|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744131|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14744132|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14744133|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14744134|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
14415314|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415315|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
14415316|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
14415317|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14415318|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415319|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415320|NCT01618266|Dexamethasone|dexamethasone|mesh-list
14415321|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415322|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
14415323|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
14415324|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415325|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415326|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415327|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
14415328|NCT01618266|Hormones|hormones|mesh-ancestor
14415329|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415330|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14415331|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415332|NCT01618305|Lamivudine|lamivudine|mesh-list
14415333|NCT01618305|Zidovudine|zidovudine|mesh-list
14415334|NCT01618305|Efavirenz|efavirenz|mesh-list
14415335|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14415336|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
14415337|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14415338|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14415339|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415340|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415341|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
14415342|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415343|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14415344|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14415345|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
14415346|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14467801|NCT02265796|Ranolazine|ranolazine|mesh-list
14744135|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744136|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415347|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14744137|NCT00585871|Analgesics|analgesics|mesh-ancestor
14744138|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
14744139|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14415348|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14415349|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14415350|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14415351|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14415352|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14415353|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14744140|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14744141|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14744142|NCT00586092|Bevacizumab|bevacizumab|mesh-list
14744143|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14744144|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744145|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14744146|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14744147|NCT00586092|Growth Substances|growth substances|mesh-ancestor
14744148|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744149|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
14744150|NCT00586118|Propofol|propofol|mesh-list
14744151|NCT00586118|Sevoflurane|sevoflurane|mesh-list
14415354|NCT01618669|Regadenoson|regadenoson|mesh-list
14415355|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14415356|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14415357|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
14415358|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
14415359|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415360|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415361|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415362|NCT01618708|Hylan|hylan|mesh-list
14415363|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
14415364|NCT01618708|Protective Agents|protective agents|mesh-ancestor
14415365|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415366|NCT01619059|Metformin|metformin|mesh-list
14415367|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
14415368|NCT01619059|Saxagliptin|saxagliptin|mesh-list
14415369|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415370|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415371|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14415372|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415373|NCT01619059|Incretins|incretins|mesh-ancestor
14415374|NCT01619059|Hormones|hormones|mesh-ancestor
14415375|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415376|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14415377|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
14415378|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744152|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14415379|NCT01619410|Clindamycin|clindamycin|mesh-list
14415380|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
14415381|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
14415382|NCT01619410|Linezolid|linezolid|mesh-list
14415383|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415384|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415385|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14415386|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415387|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415388|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
14415389|NCT01619423|Edetic Acid|edetic acid|mesh-list
14415390|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
14415391|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14415392|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
14415393|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
14415394|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415395|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
14415396|NCT01619423|Vitamins|vitamins|mesh-ancestor
14415397|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
14415398|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415399|NCT01619774|Trametinib|trametinib|mesh-list
14415400|NCT01619774|Dabrafenib|dabrafenib|mesh-list
14415401|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415402|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14415403|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415404|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415405|NCT01619852|Lidocaine|lidocaine|mesh-list
14415406|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
14415407|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
14415408|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415409|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415410|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
14415411|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415412|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14415413|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14415414|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14415415|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415416|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415417|NCT01619865|Edotreotide|edotreotide|mesh-list
14415418|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14415419|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415420|NCT01619878|Lumefantrine|lumefantrine|mesh-list
14415421|NCT01619878|Artemether|artemether|mesh-list
14415422|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14415423|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
14415424|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14415425|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14415426|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415427|NCT01619982|Vancomycin|vancomycin|mesh-list
14415428|NCT01619982|Cefazolin|cefazolin|mesh-list
14415429|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415430|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415431|NCT01620047|Fentanyl|fentanyl|mesh-list
14415432|NCT01620047|Ropivacaine|ropivacaine|mesh-list
14415433|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
14415434|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
14415435|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415436|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415437|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
14415438|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415439|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14415440|NCT01620047|Narcotics|narcotics|mesh-ancestor
14415441|NCT01620047|Analgesics|analgesics|mesh-ancestor
14415442|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14415443|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14415444|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
14415445|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14415446|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14415447|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14415448|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415449|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415450|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415451|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14415452|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14415453|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14415454|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
14415455|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415456|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415457|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14415458|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14415459|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
14415460|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14415461|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14415462|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
14415463|NCT01620138|Cabergoline|cabergoline|mesh-list
14415464|NCT01620138|Pasireotide|pasireotide|mesh-list
14415465|NCT01620138|Hormones|hormones|mesh-ancestor
14415466|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415467|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415468|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14415469|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14415470|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
14415471|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
14415472|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415473|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415474|NCT01620177|Ethanol|ethanol|mesh-list
14415475|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14415476|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415477|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415478|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415479|NCT01620190|Paclitaxel|paclitaxel|mesh-list
14415480|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14415481|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14415482|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415483|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
14415484|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
14415485|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
14415486|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467802|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14467803|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14467804|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415487|NCT01620216|Sorafenib|sorafenib|mesh-list
14415488|NCT01620216|Sunitinib|sunitinib|mesh-list
14415489|NCT01620216|Dasatinib|dasatinib|mesh-list
14415490|NCT01620216|Ponatinib|ponatinib|mesh-list
14415491|NCT01620216|Idelalisib|idelalisib|mesh-list
14415492|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
14415493|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14415494|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14415495|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415496|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415497|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14415498|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14925853|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925854|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925855|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925856|NCT01406158|Urological Agents|urological agents|mesh-ancestor
14925857|NCT01406171|Isavuconazole|isavuconazole|mesh-list
14925858|NCT01406171|Midazolam|midazolam|mesh-list
14925859|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925860|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14415499|NCT01620216|Growth Substances|growth substances|mesh-ancestor
14925861|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415500|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415501|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
14415502|NCT01620489|Liraglutide|liraglutide|mesh-list
14415503|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415504|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415505|NCT01620489|Incretins|incretins|mesh-ancestor
14415506|NCT01620489|Hormones|hormones|mesh-ancestor
14415507|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415508|NCT01620593|Metformin|metformin|mesh-list
14415509|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415510|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415511|NCT01621009|Bupropion|bupropion|mesh-list
14415512|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14415513|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
14415514|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415515|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14415516|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14415517|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415518|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415519|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
14415520|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415521|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415522|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14415523|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14415524|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415525|NCT01621178|Insulin|insulin|mesh-list
14925862|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415526|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14415527|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
14415528|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
14415529|NCT01621178|Dulaglutide|dulaglutide|mesh-list
14415530|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415531|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415532|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14415533|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14415534|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14415535|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415536|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415537|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415538|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415539|NCT01621191|Analgesics|analgesics|mesh-ancestor
14415540|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
14415541|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415542|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
14415543|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415544|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
14415545|NCT01621230|Fentanyl|fentanyl|mesh-list
14415546|NCT01621230|Bupivacaine|bupivacaine|mesh-list
14415547|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
14415548|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
14415549|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415550|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415551|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
14415552|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415553|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14415554|NCT01621230|Narcotics|narcotics|mesh-ancestor
14415555|NCT01621230|Analgesics|analgesics|mesh-ancestor
14415556|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14415557|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14415558|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
14415559|NCT01621477|Cytarabine|cytarabine|mesh-list
14415560|NCT01621477|Plerixafor|plerixafor|mesh-list
14415561|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
14415562|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
14415563|NCT01621477|Busulfan|busulfan|mesh-list
14415564|NCT01621477|Clofarabine|clofarabine|mesh-list
14415565|NCT01621477|Tacrolimus|tacrolimus|mesh-list
14415566|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
14415567|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14415568|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415569|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
14415570|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415571|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14415572|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14415573|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
14415574|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415575|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415576|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14415577|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14415578|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
14415579|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
14415580|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415581|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14415582|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415583|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14415584|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14415585|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
14415586|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415587|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14415588|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14415589|NCT01621490|Nivolumab|nivolumab|mesh-list
14415590|NCT01621490|Ipilimumab|ipilimumab|mesh-list
14415591|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14415592|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415593|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14415594|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415595|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14415596|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14415597|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415598|NCT01621672|Lenalidomide|lenalidomide|mesh-list
14415599|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
14415600|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415601|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14415602|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14415603|NCT01621672|Growth Substances|growth substances|mesh-ancestor
14415604|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14415605|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415606|NCT01621776|Insulin|insulin|mesh-list
14415607|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14415608|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
14415609|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
14415610|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
14415611|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415612|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415613|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
14415614|NCT01621880|Bevacizumab|bevacizumab|mesh-list
14415615|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14415616|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415617|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14415618|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14415619|NCT01621880|Growth Substances|growth substances|mesh-ancestor
14415620|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415621|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
14415622|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415623|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
14415624|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
14415625|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415626|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415627|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
14415628|NCT01621880|Hormones|hormones|mesh-ancestor
14415629|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415630|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14415631|NCT01621880|Protective Agents|protective agents|mesh-ancestor
14415632|NCT01622231|Fluticasone|fluticasone|mesh-list
14415633|NCT01622231|Xhance|xhance|mesh-list
14415634|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415635|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14744153|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744154|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744155|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14415636|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
14415637|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415638|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415639|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415640|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415641|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415642|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14415643|NCT01622257|Metformin|metformin|mesh-list
14744156|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
14744157|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
14744158|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14744159|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14744160|NCT00586131|Citric Acid|citric acid|mesh-list
14744161|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
14415644|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415645|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415646|NCT01622296|Lidocaine|lidocaine|mesh-list
14415647|NCT01622296|Epinephrine|epinephrine|mesh-list
14415648|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
14415649|NCT01622296|Anesthetics|anesthetics|mesh-list
14744162|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
14415650|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415651|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415652|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
14744163|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14744164|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
14744165|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
14744166|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744167|NCT00586274|Fludarabine|fludarabine|mesh-list
14744168|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
14925863|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14925864|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14925865|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14925866|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14925867|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
14925868|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
14925869|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
14925870|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
14925871|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925872|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925873|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
14925874|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925875|NCT01406197|Progesterone|progesterone|mesh-list
14925876|NCT01406197|Progestins|progestins|mesh-ancestor
14925877|NCT01406197|Hormones|hormones|mesh-ancestor
14925878|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925879|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744169|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744170|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14925880|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
14925881|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
14415653|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415654|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14415655|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14415656|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14415657|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415658|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415659|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14415660|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14415661|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
14415662|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415663|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14415664|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14415665|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
14415666|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415667|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415668|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
14415669|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
14415670|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14415671|NCT01622543|Leucovorin|leucovorin|mesh-list
14415672|NCT01622543|Bevacizumab|bevacizumab|mesh-list
14415673|NCT01622543|Fluorouracil|fluorouracil|mesh-list
14415674|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
14415675|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14415676|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415677|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14415678|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14415679|NCT01622543|Growth Substances|growth substances|mesh-ancestor
14415680|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925882|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14925883|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415681|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
14415682|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
14467805|NCT02265913|Acyclovir|acyclovir|mesh-list
14925884|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14415683|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415684|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14415685|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415686|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
14415687|NCT01622543|Antidotes|antidotes|mesh-ancestor
14415688|NCT01622543|Protective Agents|protective agents|mesh-ancestor
14415689|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
14415690|NCT01622543|Vitamins|vitamins|mesh-ancestor
14415691|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
14415692|NCT01622569|Fluticasone|fluticasone|mesh-list
14415693|NCT01622569|Xhance|xhance|mesh-list
14415694|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415695|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14415696|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
14415697|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415698|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415699|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415700|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415701|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415702|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14415703|NCT01622660|Gemcitabine|gemcitabine|mesh-list
14415704|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14415705|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
14415706|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415707|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415708|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
14415709|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415710|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415711|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415712|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
14415713|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415714|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
14415715|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
14415716|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14415717|NCT01622673|Antacids|antacids|mesh-list
14415718|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
14415719|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
14415720|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
14415721|NCT01622673|TEMPO|tempo|mesh-list
14415722|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415723|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14415724|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14415725|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
14415726|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415727|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14415728|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14415729|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415730|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415731|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415732|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14415733|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
14415734|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
14415735|NCT01622673|Protective Agents|protective agents|mesh-ancestor
14415736|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14415737|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
14415738|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415739|NCT01623271|Gabapentin|gabapentin|mesh-list
14415740|NCT01623271|Analgesics|analgesics|mesh-ancestor
14415741|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
14415742|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415743|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415744|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
14415745|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14415746|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14415747|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415748|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415749|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14415750|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14415751|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415752|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415753|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
14415754|NCT01623310|Fluticasone|fluticasone|mesh-list
14415755|NCT01623310|Xhance|xhance|mesh-list
14415756|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415757|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14415758|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
14415759|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415760|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415761|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415762|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415763|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415764|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14415765|NCT01623323|Fluticasone|fluticasone|mesh-list
14415766|NCT01623323|Xhance|xhance|mesh-list
14415767|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415768|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14415769|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
14415770|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415771|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415772|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415773|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415774|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415775|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14415776|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
14415777|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
14415778|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14415779|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415780|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14415781|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14415782|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14415783|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14415784|NCT01623479|Bimatoprost|bimatoprost|mesh-list
14415785|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14415786|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14415787|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14415788|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415789|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415790|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
14415791|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415792|NCT01623752|Etanercept|etanercept|mesh-list
14415793|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14415794|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14415795|NCT01623752|Analgesics|analgesics|mesh-ancestor
14415796|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
14415797|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415798|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415799|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415800|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14415801|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415802|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415803|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
14415804|NCT01623869|Trebananib|trebananib|mesh-list
14415805|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14415806|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14415807|NCT01623869|Growth Substances|growth substances|mesh-ancestor
14415808|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415809|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
14415810|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415811|NCT01624090|Plicamycin|plicamycin|mesh-list
14415812|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14415813|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415814|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14415815|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415816|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14415817|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415818|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415819|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14415820|NCT01624142|Evolocumab|evolocumab|mesh-list
14415821|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14415822|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14415823|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
14415824|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415825|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14415826|NCT01624194|Oxytocin|oxytocin|mesh-list
14415827|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
14415828|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14415829|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415830|NCT01624233|Ixekizumab|ixekizumab|mesh-list
14415831|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415832|NCT01624259|Metformin|metformin|mesh-list
14415833|NCT01624259|Liraglutide|liraglutide|mesh-list
14415834|NCT01624259|Dulaglutide|dulaglutide|mesh-list
14415835|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14415836|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415837|NCT01624259|Incretins|incretins|mesh-ancestor
14415838|NCT01624259|Hormones|hormones|mesh-ancestor
14415839|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415840|NCT01624467|Necitumumab|necitumumab|mesh-list
14415841|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14415842|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415843|NCT01624662|Fluticasone|fluticasone|mesh-list
14415844|NCT01624662|Xhance|xhance|mesh-list
14415845|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14415846|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14415847|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
14415848|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415849|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415850|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415851|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415852|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415853|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14415854|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
14415855|NCT01624948|Everolimus|everolimus|mesh-list
14415856|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415857|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415858|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
14415859|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415860|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14415861|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14415862|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
14415863|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415864|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415865|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415866|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415867|NCT01624974|Montelukast|montelukast|mesh-list
14415868|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14415869|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
14415870|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14415871|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
14415872|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14415873|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415874|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14415875|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14415876|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415877|NCT01625000|Risperidone|risperidone|mesh-list
14415878|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14415879|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
14415880|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415881|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415882|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415883|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14415884|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14415885|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415886|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415887|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14415888|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
14415889|NCT01625013|Hylan|hylan|mesh-list
14415890|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
14415891|NCT01625013|Protective Agents|protective agents|mesh-ancestor
14415892|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415893|NCT01625091|Naltrexone|naltrexone|mesh-list
14415894|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14415895|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14415896|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415897|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
14415898|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415899|NCT01625169|Etravirine|etravirine|mesh-list
14415900|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14415901|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14415902|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415903|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415904|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
14415905|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415906|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14415907|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14415908|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415909|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415910|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
14415911|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415912|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
14925885|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14925886|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925887|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925888|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925889|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925890|NCT01406262|Incretins|incretins|mesh-ancestor
14415913|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
14415914|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415915|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
14415916|NCT01625377|Everolimus|everolimus|mesh-list
14415917|NCT01625377|Tacrolimus|tacrolimus|mesh-list
14415918|NCT01625377|Basiliximab|basiliximab|mesh-list
14415919|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415920|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
14415921|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415922|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14415923|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415924|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415925|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415926|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14415927|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14415928|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
14415929|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14415930|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415931|NCT01625455|Aprepitant|aprepitant|mesh-list
14415932|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
14415933|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
14415934|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415935|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415936|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415937|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14415938|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415939|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415940|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
14415941|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14415942|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415943|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415944|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14415945|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14415946|NCT01625845|Protective Agents|protective agents|mesh-ancestor
14415947|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415948|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
14415949|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14415950|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
14415951|NCT01625897|Risperidone|risperidone|mesh-list
14415952|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14415953|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
14415954|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415955|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415956|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415957|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14415958|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14467806|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
14415959|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415960|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415961|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14415962|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
14415963|NCT01625923|Olanzapine|olanzapine|mesh-list
14415964|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
14415965|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
14415966|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14415967|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415968|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14415969|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14415970|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14415971|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14415972|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14415973|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14415974|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14415975|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14415976|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415977|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14415978|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
14415979|NCT01626092|Cyclosporine|cyclosporine|mesh-list
14415980|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
14415981|NCT01626092|Melphalan|melphalan|mesh-list
14415982|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
14415983|NCT01626092|Clofarabine|clofarabine|mesh-list
14415984|NCT01626092|Cyclosporins|cyclosporins|mesh-list
14415985|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14415986|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14415987|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14415988|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
14415989|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14415990|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
14415991|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14415992|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
14415993|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14415994|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14415995|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14415996|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14415997|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14415998|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
14415999|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14416000|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14416001|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
14416002|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14416003|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14416004|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14416005|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
14416006|NCT01626118|Indomethacin|indomethacin|mesh-list
14416007|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14416008|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14416009|NCT01626118|Analgesics|analgesics|mesh-ancestor
14416010|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
14416011|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416012|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416013|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416014|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416015|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
14416016|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
14416017|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14416018|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14416019|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416020|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416021|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14416022|NCT01626352|Ofatumumab|ofatumumab|mesh-list
14416023|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14416024|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
14416025|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416026|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416027|NCT01626664|Gemcitabine|gemcitabine|mesh-list
14416028|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
14416029|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
14416030|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14416031|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
14416032|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416033|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416034|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
14416035|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416036|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416037|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416038|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
14416039|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416040|NCT01626872|Risperidone|risperidone|mesh-list
14416041|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14416042|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
14416043|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416044|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416045|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416046|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14416047|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14416048|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416049|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14416050|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14416051|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
14416052|NCT01627067|Metformin|metformin|mesh-list
14416053|NCT01627067|Everolimus|everolimus|mesh-list
14416054|NCT01627067|Exemestane|exemestane|mesh-list
14416055|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14416056|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416057|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416058|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416059|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
14416060|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14416061|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14416062|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416063|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416064|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14416065|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
14416066|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416067|NCT01627249|Bevacizumab|bevacizumab|mesh-list
14416068|NCT01627249|Ranibizumab|ranibizumab|mesh-list
14416069|NCT01627249|Aflibercept|aflibercept|mesh-list
14416070|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14416071|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416072|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14416073|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14416074|NCT01627249|Growth Substances|growth substances|mesh-ancestor
14416075|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416076|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
14416077|NCT01627327|Fluticasone|fluticasone|mesh-list
14416078|NCT01627327|Xhance|xhance|mesh-list
14416079|NCT01627327|Bromides|bromides|mesh-list
14925891|NCT01406262|Hormones|hormones|mesh-ancestor
14925892|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925893|NCT01406275|Amoxicillin|amoxicillin|mesh-list
14925894|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
14925895|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
14925896|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14416080|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
14416081|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416082|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14416083|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
14416084|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416085|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416086|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14416087|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
14416088|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
14416089|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14416090|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
14416091|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14416092|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
14416093|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416094|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416095|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
14467807|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467808|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
14467809|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
14469974|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469975|NCT02301416|Topiramate|topiramate|mesh-list
14469976|NCT02301416|Phentermine|phentermine|mesh-list
14469977|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
14469978|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14469979|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469980|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14469981|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
14469982|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14469983|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
14469984|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
14469985|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469986|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
14469987|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469988|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469989|NCT02301624|Eculizumab|eculizumab|mesh-list
14469990|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14469991|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469992|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
14469993|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469994|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
14469995|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14469996|NCT02301936|Ledipasvir|ledipasvir|mesh-list
14416096|NCT01627782|Ketamine|ketamine|mesh-list
14416097|NCT01627782|Analgesics|analgesics|mesh-ancestor
14416098|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
14416099|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416100|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416101|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14416102|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14416103|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
14416104|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
14416105|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416106|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14416107|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14416108|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416109|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416110|NCT01627860|Topiramate|topiramate|mesh-list
14416111|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
14416112|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14416113|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416114|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
14416115|NCT01628107|Hematinics|hematinics|mesh-ancestor
14416116|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
14416117|NCT01628120|Hematinics|hematinics|mesh-ancestor
14416118|NCT01628393|Ozanimod|ozanimod|mesh-list
14416119|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14416120|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416121|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416122|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
14416123|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416124|NCT01628549|Sarecycline|sarecycline|mesh-list
14416125|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14416126|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416127|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
14416128|NCT01628588|Bimatoprost|bimatoprost|mesh-list
14416129|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416130|NCT01628601|Timolol|timolol|mesh-list
14416131|NCT01628601|Bimatoprost|bimatoprost|mesh-list
14416132|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14416133|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14416134|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
14416135|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416136|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416137|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416138|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14416139|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416140|NCT01628692|Ribavirin|ribavirin|mesh-list
14416141|NCT01628692|Simeprevir|simeprevir|mesh-list
14416142|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
14467810|NCT02266433|Dexamethasone|dexamethasone|mesh-list
14416143|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416144|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
14416145|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416146|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
14416147|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416148|NCT01628874|Lidocaine|lidocaine|mesh-list
14416149|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14416150|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
14416151|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
14416152|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416153|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416154|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
14416155|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416156|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14416157|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14416158|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14416159|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416160|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416161|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14416162|NCT01628913|Everolimus|everolimus|mesh-list
14416163|NCT01628913|Dactolisib|dactolisib|mesh-list
14416164|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416165|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416166|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
14416167|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416168|NCT01628926|Ropinirole|ropinirole|mesh-list
14416169|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14416170|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14416171|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
14416172|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
14416173|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416174|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416175|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416176|NCT01628965|Rotigotine|rotigotine|mesh-list
14416177|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
14416178|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
14416179|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416180|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416181|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416182|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
14416183|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14416184|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
14416185|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416186|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
14416187|NCT01629134|Protective Agents|protective agents|mesh-ancestor
14416188|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
14416189|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
14416190|NCT01629290|Protective Agents|protective agents|mesh-ancestor
14416191|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416192|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
14416193|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14416194|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
14416195|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14416196|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
14416197|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416198|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416199|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
14416200|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
14416201|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14416202|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
14416203|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14416204|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416205|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14416206|NCT01629589|Vaccines|vaccines|mesh-list
14416207|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
14416208|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416209|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14416210|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
14416211|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416212|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14416213|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
14416214|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14416215|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14416216|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14416217|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416218|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416219|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416220|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
14416221|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416222|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14416223|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14416224|NCT01630109|Metoclopramide|metoclopramide|mesh-list
14416225|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
14416226|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
14416227|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416228|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416229|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14416230|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14416231|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14416232|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
14416233|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416234|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416235|NCT01630135|Fluticasone|fluticasone|mesh-list
14416236|NCT01630135|Xhance|xhance|mesh-list
14416237|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416238|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14416239|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
14416240|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416241|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416242|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14416243|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
14416244|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
14416245|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14416246|NCT01630811|Quinidine|quinidine|mesh-list
14416247|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
14416248|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
14416249|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
14416250|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14416251|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14416252|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416253|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416254|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416255|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14416256|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14416257|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
14416258|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14416259|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
14416260|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14416261|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14416262|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416263|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416264|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14416265|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14416266|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
14416267|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14416268|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14416269|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416270|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14416271|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14416272|NCT01631110|Vaccines|vaccines|mesh-list
14416273|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
14416274|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416275|NCT01631149|Rocuronium|rocuronium|mesh-list
14416276|NCT01631149|Atracurium|atracurium|mesh-list
14416277|NCT01631149|Mivacurium|mivacurium|mesh-list
14416278|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14416279|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14416280|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14416281|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416282|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416283|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14416284|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14416285|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
14925897|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14925898|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14925899|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925900|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467811|NCT02266433|Ketorolac|ketorolac|mesh-list
14925901|NCT01406301|PENTA|penta|mesh-list
14416286|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416287|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416288|NCT01631214|Alendronate|alendronate|mesh-list
14416289|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14416290|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14416291|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416292|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
14416293|NCT01631227|Eprosartan|eprosartan|mesh-list
14416294|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416295|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14416296|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14416297|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416298|NCT01631630|Pioglitazone|pioglitazone|mesh-list
14416299|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14416300|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416301|NCT01631656|Azelaic acid|azelaic acid|mesh-list
14416302|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416303|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
14416304|NCT01631682|Propranolol|propranolol|mesh-list
14416305|NCT01631682|Oxytocin|oxytocin|mesh-list
14416306|NCT01631682|Mifepristone|mifepristone|mesh-list
14416307|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
14416308|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14416309|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416310|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14416311|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14416312|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
14416313|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416314|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416315|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14416316|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416317|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
14416318|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14416319|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
14744171|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
14744172|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
14744173|NCT00586365|Naproxen|naproxen|mesh-list
14744174|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14744175|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14416320|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14416321|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14416322|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14416323|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
14416324|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14416325|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14416326|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
14416327|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416328|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
14744176|NCT00586365|Analgesics|analgesics|mesh-ancestor
14744177|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
14744178|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744179|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744180|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744181|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744182|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
14744183|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14744184|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744185|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744186|NCT00586430|Lorazepam|lorazepam|mesh-list
14744187|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
14744188|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
14744189|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
14744190|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416329|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14416330|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14416331|NCT01631825|Rotigotine|rotigotine|mesh-list
14416332|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
14416333|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
14416334|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416335|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744191|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744192|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744193|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14416336|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416337|NCT01631864|Amlodipine|amlodipine|mesh-list
14416338|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14416339|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416340|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14416341|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416342|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744194|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744195|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14744196|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14744197|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14744198|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
14416343|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14416344|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416345|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
14416346|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14416347|NCT01632150|Thalidomide|thalidomide|mesh-list
14416348|NCT01632150|Dexamethasone|dexamethasone|mesh-list
14416349|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
14416350|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
14416351|NCT01632150|Elotuzumab|elotuzumab|mesh-list
14416352|NCT01632150|BB 1101|bb 1101|mesh-list
14416353|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416354|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
14416355|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416356|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416357|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14416358|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
14416359|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416360|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416361|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14416362|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744199|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
14416363|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
14416364|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
14744200|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416365|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416366|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14416367|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
14416368|NCT01632150|Hormones|hormones|mesh-ancestor
14416369|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416370|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14416371|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
14416372|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416373|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
14416374|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14416375|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416376|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14416377|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14416378|NCT01632150|Growth Substances|growth substances|mesh-ancestor
14416379|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
14416380|NCT01632215|Gabapentin|gabapentin|mesh-list
14416381|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
14416382|NCT01632215|Analgesics|analgesics|mesh-ancestor
14416383|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
14416384|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416385|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416386|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14416387|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14416388|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416389|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14416390|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14416391|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14416392|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467812|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416393|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416394|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
14416395|NCT01632241|Belimumab|belimumab|mesh-list
14416396|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416397|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
14416398|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416399|NCT01632306|Leucovorin|leucovorin|mesh-list
14744201|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744202|NCT00586443|Bevacizumab|bevacizumab|mesh-list
14744203|NCT00586443|Panitumumab|panitumumab|mesh-list
14416400|NCT01632306|Gemcitabine|gemcitabine|mesh-list
14416401|NCT01632306|Paclitaxel|paclitaxel|mesh-list
14416402|NCT01632306|Fluorouracil|fluorouracil|mesh-list
14416403|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
14416404|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14416405|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416406|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
14416407|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
14416408|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
14416409|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416410|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14416411|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
14416412|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
14416413|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416414|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416415|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416416|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
14416417|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416418|NCT01632306|Antidotes|antidotes|mesh-ancestor
14416419|NCT01632306|Protective Agents|protective agents|mesh-ancestor
14416420|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
14416421|NCT01632306|Vitamins|vitamins|mesh-ancestor
14416422|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
14416423|NCT01632345|Efavirenz|efavirenz|mesh-list
14416424|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14416425|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14416426|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14416427|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416428|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416429|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
14416430|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416431|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14416432|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14416433|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14416434|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14416435|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14416436|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14416437|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14416438|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14416439|NCT01632423|Bimatoprost|bimatoprost|mesh-list
14416440|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416441|NCT01632566|Celecoxib|celecoxib|mesh-list
14416442|NCT01632566|Simvastatin|simvastatin|mesh-list
14416443|NCT01632566|LY3031207|ly3031207|mesh-list
14416444|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14416445|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14416446|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
14416447|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416448|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14416449|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14416450|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416451|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14416452|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14416453|NCT01632566|Analgesics|analgesics|mesh-ancestor
14416454|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
14416455|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416456|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416457|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416458|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416459|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14416460|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14416461|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
14416462|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
14416463|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416464|NCT01632579|Celecoxib|celecoxib|mesh-list
14416465|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14416466|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14416467|NCT01632579|Analgesics|analgesics|mesh-ancestor
14416468|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
14416469|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416470|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416471|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416472|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416473|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14416474|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14416475|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416476|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416477|NCT01632709|Bupivacaine|bupivacaine|mesh-list
14416478|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
14416479|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
14416480|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416481|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416482|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
14416483|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416484|NCT01632891|Ritonavir|ritonavir|mesh-list
14416485|NCT01632891|Lopinavir|lopinavir|mesh-list
14416486|NCT01632891|Tenofovir|tenofovir|mesh-list
14416487|NCT01632891|Emtricitabine|emtricitabine|mesh-list
14416488|NCT01632891|Nevirapine|nevirapine|mesh-list
14416489|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14416490|NCT01632891|Efavirenz|efavirenz|mesh-list
14416491|NCT01632891|Trimethoprim|trimethoprim|mesh-list
14416492|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
14416493|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14416494|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14416495|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
14416496|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416497|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416498|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14416499|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14416500|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
14416501|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416502|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14416503|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14467813|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
14416504|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14416505|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14416506|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14925902|NCT01406301|Fondaparinux|fondaparinux|mesh-list
14925903|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14925904|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
14925905|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14416507|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14416508|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14416509|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14416510|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14416511|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14416512|NCT01632891|Renal Agents|renal agents|mesh-ancestor
14416513|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
14416514|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14416515|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14416516|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14416517|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14416518|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14416519|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
14416520|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416521|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
14416522|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416523|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416524|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14416525|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14416526|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14416527|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14416528|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416529|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416530|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
14416531|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416532|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14416533|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14416534|NCT01633060|Fulvestrant|fulvestrant|mesh-list
14416535|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14416536|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416537|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14416538|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14416539|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
14416540|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416541|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416542|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
14416543|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14416544|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
14416545|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14416546|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416547|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416548|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
14416549|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416550|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14416551|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416552|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14925906|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
14416553|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416554|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416555|NCT01633853|Vitamin D|vitamin d|mesh-list
14416556|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
14416557|NCT01633853|Calcitriol|calcitriol|mesh-list
14416558|NCT01633853|Vitamins|vitamins|mesh-list
14416559|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
14416560|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416561|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14416562|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14416563|NCT01633853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14416564|NCT01633853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416565|NCT01633853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416566|NCT01633853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14416567|NCT01633944|Buprenorphine|buprenorphine|mesh-list
14416568|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14416569|NCT01633944|Narcotics|narcotics|mesh-ancestor
14416570|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416571|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416572|NCT01633944|Analgesics|analgesics|mesh-ancestor
14416573|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
14416574|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416575|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14416576|NCT01634100|Empagliflozin|empagliflozin|mesh-list
14416577|NCT01634100|Rifampin|rifampin|mesh-list
14416578|NCT01634100|Probenecid|probenecid|mesh-list
14416579|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14416580|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416581|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14416582|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416583|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14925907|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416584|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
14416585|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14416586|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416587|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
14416588|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14416589|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416590|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14416591|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14416592|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14416593|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14416594|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14416595|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14416596|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
14416597|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
14416598|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416599|NCT01634100|Renal Agents|renal agents|mesh-ancestor
14416600|NCT01634113|Bromides|bromides|mesh-list
14416601|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
14416602|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14416603|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
14416604|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416605|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416606|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14416607|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
14416608|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
14416609|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14416610|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
14416611|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416612|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416613|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
14416614|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
14416615|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14416616|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
14416617|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416618|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416619|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14416620|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
14416621|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
14416622|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14416623|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
14416624|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744204|NCT00586443|Everolimus|everolimus|mesh-list
14744205|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467814|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
14744206|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416625|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416626|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
14416627|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14416628|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
14416629|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416630|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416631|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14416632|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
14416633|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
14416634|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14416635|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
14416636|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416637|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416638|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
14416639|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14416640|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416641|NCT01634178|Apremilast|apremilast|mesh-list
14416642|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14744207|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14744208|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14744209|NCT00586443|Growth Substances|growth substances|mesh-ancestor
14744210|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744211|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
14744212|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744213|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
14753409|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416643|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14416644|NCT01634178|Analgesics|analgesics|mesh-ancestor
14416645|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
14416646|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416647|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416648|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14753410|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753411|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14753412|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753413|NCT05174507|Empagliflozin|empagliflozin|mesh-list
14753414|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14753415|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14416649|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416650|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14416651|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14416652|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416653|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467815|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467816|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467817|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14467818|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
14467819|NCT02266433|Hormones|hormones|mesh-ancestor
14467820|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467821|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14467822|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467823|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467824|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467825|NCT02266433|Analgesics|analgesics|mesh-ancestor
14467826|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
14467827|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467828|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14467829|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467830|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467831|NCT02266472|Metformin|metformin|mesh-list
14467832|NCT02266472|Empagliflozin|empagliflozin|mesh-list
14467833|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14467834|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467835|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14467836|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467837|NCT02266706|Tazobactam|tazobactam|mesh-list
14467838|NCT02266706|Ceftolozane|ceftolozane|mesh-list
14467839|NCT02266706|Cephalosporins|cephalosporins|mesh-list
14744214|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
14744215|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744216|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
14744217|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744218|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744219|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14744220|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
14744221|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744222|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931216|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14467840|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14467841|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
14467842|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14467843|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469997|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
14416654|NCT01634191|Apremilast|apremilast|mesh-list
14416655|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14416656|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14416657|NCT01634191|Analgesics|analgesics|mesh-ancestor
14416658|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
14416659|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416660|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416661|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416662|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416663|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14416664|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14416665|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416666|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416667|NCT01634243|Rotigotine|rotigotine|mesh-list
14416668|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
14416669|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
14416670|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416671|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416672|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416673|NCT01634555|Leucovorin|leucovorin|mesh-list
14416674|NCT01634555|Folic Acid|folic acid|mesh-list
14416675|NCT01634555|Fluorouracil|fluorouracil|mesh-list
14416676|NCT01634555|Irinotecan|irinotecan|mesh-list
14416677|NCT01634555|Ramucirumab|ramucirumab|mesh-list
14416678|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
14416679|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
14416680|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416681|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14416682|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416683|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416684|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
14416685|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416686|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14416687|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14416688|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416689|NCT01634555|Antidotes|antidotes|mesh-ancestor
14416690|NCT01634555|Protective Agents|protective agents|mesh-ancestor
14416691|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
14416692|NCT01634555|Vitamins|vitamins|mesh-ancestor
14416693|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
14416694|NCT01634555|Hematinics|hematinics|mesh-ancestor
14416695|NCT01634854|Misoprostol|misoprostol|mesh-list
14416696|NCT01634854|Oxytocin|oxytocin|mesh-list
14416697|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
14416698|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14416699|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416700|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14416701|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
14416702|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14416703|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14416704|NCT01635062|Calcitriol|calcitriol|mesh-list
14416705|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14416706|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14416707|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416708|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14416709|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416710|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416711|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14416712|NCT01635062|Vitamins|vitamins|mesh-ancestor
14416713|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
14416714|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14416715|NCT01635101|Acetaminophen|acetaminophen|mesh-list
14416716|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14416717|NCT01635101|Analgesics|analgesics|mesh-ancestor
14416718|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
14416719|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416720|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416721|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
14416722|NCT01635153|Micronutrients|micronutrients|mesh-list
14416723|NCT01635153|Trace Elements|trace elements|mesh-list
14416724|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416725|NCT01635218|Fluoxetine|fluoxetine|mesh-list
14416726|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14416727|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14416728|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416729|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416730|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416731|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
14416732|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416733|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14416734|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
14416735|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14744223|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14744224|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
14744225|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
14744226|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14744227|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14744228|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744229|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925908|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925909|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
14925910|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14925911|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14925912|NCT01406327|Ambrisentan|ambrisentan|mesh-list
14925913|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14925914|NCT01406392|Misoprostol|misoprostol|mesh-list
14925915|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14925916|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
14925917|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14925918|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416736|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14416737|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14925919|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14925920|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14416738|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416739|NCT01635439|Dinoprostone|dinoprostone|mesh-list
14416740|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
14416741|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14744230|NCT00586794|Urological Agents|urological agents|mesh-ancestor
14744231|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
14416742|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416743|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
14416744|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14416745|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14416746|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14416747|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416748|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416749|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
14416750|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416751|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416752|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14416753|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416754|NCT01635764|Adalimumab|adalimumab|mesh-list
14416755|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416756|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416757|NCT01636063|Misoprostol|misoprostol|mesh-list
14416758|NCT01636063|Mifepristone|mifepristone|mesh-list
14416759|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14416760|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
14416761|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14416762|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416763|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14416764|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14416765|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
14416766|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14416767|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14416768|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14416769|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14416770|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
14416771|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14416772|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14416773|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
14416774|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416775|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
14744232|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744233|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744234|NCT00586911|Betaine|betaine|mesh-list
14744235|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744236|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
14744237|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14744238|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
14744239|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744240|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14744241|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
14744242|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744243|NCT00586976|Ropivacaine|ropivacaine|mesh-list
14744244|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
14744245|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
14744246|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744247|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744248|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
14416776|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14416777|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14416778|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14416779|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14416780|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
14744249|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744250|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
14744251|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744252|NCT00587119|Budesonide|budesonide|mesh-list
14744253|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744254|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14744255|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
14744256|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744257|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744258|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14744259|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
14744260|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
14416781|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416782|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416783|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14416784|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
14416785|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14416786|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14416787|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14416788|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
14416789|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416790|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416791|NCT01636206|Lifitegrast|lifitegrast|mesh-list
14416792|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14416793|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14416794|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14416795|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
14416796|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416797|NCT01636934|Minocycline|minocycline|mesh-list
14416798|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14416799|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416800|NCT01636947|Dexamethasone|dexamethasone|mesh-list
14416801|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
14416802|NCT01636947|Ondansetron|ondansetron|mesh-list
14416803|NCT01636947|Aprepitant|aprepitant|mesh-list
14416804|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
14416805|NCT01636947|Metoclopramide|metoclopramide|mesh-list
14416806|NCT01636947|Granisetron|granisetron|mesh-list
14416807|NCT01636947|Tropisetron|tropisetron|mesh-list
14416808|NCT01636947|Dolasetron|dolasetron|mesh-list
14416809|NCT01636947|Alizapride|alizapride|mesh-list
14416810|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14744261|NCT00587119|Hormones|hormones|mesh-ancestor
14744262|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744263|NCT00587145|Docetaxel|docetaxel|mesh-list
14416811|NCT01636947|BB 1101|bb 1101|mesh-list
14416812|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416813|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
14925921|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
14416814|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
14416815|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416816|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416817|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14416818|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
14416819|NCT01636947|Hormones|hormones|mesh-ancestor
14416820|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416821|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14416822|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416823|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
14416824|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744264|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744265|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
14744266|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
14744267|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
14744268|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744269|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14744270|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14744271|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
14416825|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416826|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
14416827|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
14416828|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14416829|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
14416830|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416831|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14416832|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14744272|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416833|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416834|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14416835|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14416836|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14416837|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14416838|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14416839|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
14416840|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14416841|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14416842|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
14744273|NCT00587249|Antacids|antacids|mesh-ancestor
14744274|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744275|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744276|NCT00587327|Atosiban|atosiban|mesh-list
14744277|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744278|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744279|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416843|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416844|NCT01637077|Pregabalin|pregabalin|mesh-list
14744280|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
14416845|NCT01637077|Analgesics|analgesics|mesh-ancestor
14416846|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
14416847|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416848|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416849|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
14416850|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14416851|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14416852|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416853|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14416854|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14416855|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14416856|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416857|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14416858|NCT01637090|Everolimus|everolimus|mesh-list
14416859|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925922|NCT01406431|Valsartan|valsartan|mesh-list
14925923|NCT01406431|Pitavastatin|pitavastatin|mesh-list
14925924|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14925925|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14925926|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14416860|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416861|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
14416862|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416863|NCT01637272|Pasireotide|pasireotide|mesh-list
14416864|NCT01637272|Hormones|hormones|mesh-ancestor
14416865|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416866|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416867|NCT01637402|Prednisone|prednisone|mesh-list
14416868|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
14416869|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14416870|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
14416871|NCT01637402|Hormones|hormones|mesh-ancestor
14416872|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416873|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744281|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14744282|NCT00587379|Atorvastatin|atorvastatin|mesh-list
14744283|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14744284|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14744285|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
14744286|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744287|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14744288|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14744289|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744290|NCT00587444|Heparin|heparin|mesh-list
14744291|NCT00587444|Calcium heparin|calcium heparin|mesh-list
14744292|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
14416874|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14416875|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416876|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14416877|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744293|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14744294|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14744295|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744296|NCT00587470|Candesartan|candesartan|mesh-list
14744297|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
14744298|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14744299|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14744300|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14744301|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744302|NCT00587496|Aspirin|aspirin|mesh-list
14744303|NCT00587496|Valacyclovir|valacyclovir|mesh-list
14744304|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14744305|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14744306|NCT00587496|Analgesics|analgesics|mesh-ancestor
14416878|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416879|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
14416880|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14416881|NCT01637584|Prazosin|prazosin|mesh-list
14416882|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416883|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14416884|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14416885|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14416886|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
14416887|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416888|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416889|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416890|NCT01637623|Allopurinol|allopurinol|mesh-list
14416891|NCT01637623|Losartan|losartan|mesh-list
14416892|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14416893|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416894|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14416895|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14416896|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416897|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
14416898|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416899|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
14416900|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14416901|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14416902|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
14416903|NCT01637623|Protective Agents|protective agents|mesh-ancestor
14416904|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416905|NCT01637935|Pioglitazone|pioglitazone|mesh-list
14416906|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14416907|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416908|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
14744307|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
14744308|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744309|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744310|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744311|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744312|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14744313|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14744314|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744315|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14416909|NCT01638000|Mirabegron|mirabegron|mesh-list
14416910|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14416911|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14416912|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
14925927|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925928|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14925929|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14925930|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14416913|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925931|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
14925932|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925933|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14925934|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
14925935|NCT01406470|Antibodies|antibodies|mesh-list
14925936|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
14416914|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416915|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416916|NCT01638000|Urological Agents|urological agents|mesh-ancestor
14416917|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14416918|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14416919|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14416920|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
14416921|NCT01638013|Peficitinib|peficitinib|mesh-list
14416922|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416923|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416924|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416925|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
14416926|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416927|NCT01638052|Clonidine|clonidine|mesh-list
14416928|NCT01638052|Bupivacaine|bupivacaine|mesh-list
14416929|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
14416930|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
14416931|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925937|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14925938|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14925939|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
14416932|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416933|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
14416934|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14416935|NCT01638052|Analgesics|analgesics|mesh-ancestor
14416936|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14416937|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
14416938|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
14416939|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14416940|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14416941|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14416942|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
14416943|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416944|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416945|NCT01638429|Rifaximin|rifaximin|mesh-list
14416946|NCT01638429|Neomycin|neomycin|mesh-list
14416947|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14416948|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14416949|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744316|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14744317|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744318|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
14744319|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
14744320|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744321|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
14744322|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14744323|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925940|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
14925941|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416950|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14925942|NCT01406496|Insulin|insulin|mesh-list
14925943|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14925944|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14925945|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925946|NCT01406522|Tacrine|tacrine|mesh-list
14925947|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14925948|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925949|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925950|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
14925951|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925952|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744324|NCT00587665|Ketamine|ketamine|mesh-list
14925953|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14744325|NCT00587665|Analgesics|analgesics|mesh-ancestor
14744326|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
14744327|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744328|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744329|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14744330|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14416951|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416952|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416953|NCT01638546|Temozolomide|temozolomide|mesh-list
14416954|NCT01638546|Veliparib|veliparib|mesh-list
14416955|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14416956|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
14416957|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416958|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416959|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14416960|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416961|NCT01639001|Carboplatin|carboplatin|mesh-list
14416962|NCT01639001|Pemetrexed|pemetrexed|mesh-list
14416963|NCT01639001|Crizotinib|crizotinib|mesh-list
14416964|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14416965|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14416966|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416967|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14744331|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
14744332|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
14416968|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14416969|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14416970|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14416971|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
14416972|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416973|NCT01639157|Buspirone|buspirone|mesh-list
14416974|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14416975|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14416976|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14416977|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416978|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14416979|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14744333|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744334|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14744335|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14744336|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744337|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744338|NCT00587717|Simvastatin|simvastatin|mesh-list
14744339|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14744340|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14744341|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
14744342|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744343|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14744344|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14744345|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744346|NCT00587873|Leucovorin|leucovorin|mesh-list
14744347|NCT00587873|Methotrexate|methotrexate|mesh-list
14744348|NCT00587873|Thioguanine|thioguanine|mesh-list
14744349|NCT00587873|Calcium|calcium|mesh-list
14744350|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
14744351|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14744352|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744353|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14744354|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
14744355|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14744356|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14744357|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
14744358|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744359|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744360|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
14744361|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744362|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14744363|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744364|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
14744365|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744366|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14416980|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
14416981|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14416982|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14416983|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
14744367|NCT00587873|Antidotes|antidotes|mesh-ancestor
14744368|NCT00587873|Protective Agents|protective agents|mesh-ancestor
14744369|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
14744370|NCT00587873|Vitamins|vitamins|mesh-ancestor
14744371|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
14744372|NCT00588003|Anastrozole|anastrozole|mesh-list
14416984|NCT01639222|Vitamin D|vitamin d|mesh-list
14416985|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
14416986|NCT01639222|Calcium|calcium|mesh-list
14416987|NCT01639222|Vitamins|vitamins|mesh-ancestor
14416988|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
14416989|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416990|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14744373|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14744374|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744375|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14744376|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14744377|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744378|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744379|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14744380|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744381|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744382|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744383|NCT00588016|Itraconazole|itraconazole|mesh-list
14416991|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14416992|NCT01639339|Belimumab|belimumab|mesh-list
14416993|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14416994|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
14416995|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14416996|NCT01639352|Pasireotide|pasireotide|mesh-list
14416997|NCT01639352|Hormones|hormones|mesh-ancestor
14416998|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14416999|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417000|NCT01639560|Varenicline|varenicline|mesh-list
14417001|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14417002|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14417003|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
14417004|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417005|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417006|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417007|NCT01639599|Dexamethasone|dexamethasone|mesh-list
14417008|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
14417009|NCT01639599|Haloperidol|haloperidol|mesh-list
14417010|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
14417011|NCT01639599|BB 1101|bb 1101|mesh-list
14417012|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417013|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
14417014|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
14417015|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417016|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417017|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417018|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
14417019|NCT01639599|Hormones|hormones|mesh-ancestor
14744384|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
14744385|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417020|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14925954|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
14417021|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14417022|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417023|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
14417024|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417025|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417026|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14417027|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14417028|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744386|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14744387|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14744388|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744389|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744390|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14744391|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744392|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744393|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925955|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925956|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
14417029|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14417030|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14417031|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
14417032|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14925957|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14925958|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
14925959|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14417033|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14417034|NCT01639729|Sufentanil|sufentanil|mesh-list
14417035|NCT01639729|Dsuvia|dsuvia|mesh-list
14417036|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14417037|NCT01639729|Narcotics|narcotics|mesh-ancestor
14417038|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417039|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417040|NCT01639729|Analgesics|analgesics|mesh-ancestor
14417041|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
14417042|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417043|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14417044|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14417045|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
14417046|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
14417047|NCT01639833|Hemostatics|hemostatics|mesh-list
14417048|NCT01639833|Coagulants|coagulants|mesh-ancestor
14417049|NCT01639872|Risperidone|risperidone|mesh-list
14417050|NCT01639872|Clozapine|clozapine|mesh-list
14417051|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14417052|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
14417053|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417054|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417055|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417056|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14417057|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14925960|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14925961|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14925962|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925963|NCT01406535|Urological Agents|urological agents|mesh-ancestor
14925964|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14417058|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417059|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14417060|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14417061|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
14417062|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
14417063|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
14417064|NCT01640171|Ketorolac|ketorolac|mesh-list
14417065|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14417066|NCT01640171|Lidocaine|lidocaine|mesh-list
14417067|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
14417068|NCT01640171|Anesthetics|anesthetics|mesh-list
14417069|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
14417070|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417071|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417072|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
14417073|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744394|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14744395|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
14744396|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14744397|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14744398|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744399|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
14417074|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14417075|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14417076|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14417077|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14417078|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417079|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14417080|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417081|NCT01640171|Analgesics|analgesics|mesh-ancestor
14417082|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417083|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14417084|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417085|NCT01640184|Vitamin D|vitamin d|mesh-list
14417086|NCT01640184|Vitamins|vitamins|mesh-ancestor
14417087|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
14417088|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417089|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14417090|NCT01640197|Resveratrol|resveratrol|mesh-list
14417091|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
14417092|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417093|NCT01640197|Protective Agents|protective agents|mesh-ancestor
14417094|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417095|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417096|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14417097|NCT01640340|Dexamethasone|dexamethasone|mesh-list
14417098|NCT01640340|Ondansetron|ondansetron|mesh-list
14417099|NCT01640340|Aprepitant|aprepitant|mesh-list
14417100|NCT01640340|Palonosetron|palonosetron|mesh-list
14417101|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417102|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
14417103|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
14417104|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417105|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744400|NCT00588133|Coagulants|coagulants|mesh-ancestor
14417106|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417107|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
14417108|NCT01640340|Hormones|hormones|mesh-ancestor
14417109|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14417110|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14417111|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417112|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
14417113|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
14417114|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14417115|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
14417116|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417117|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417118|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14417119|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14417120|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417121|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14417122|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14417123|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14417124|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14467844|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14467845|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467846|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467847|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14467848|NCT02266706|Renal Agents|renal agents|mesh-ancestor
14467849|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
14467850|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467851|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
14467852|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14467853|NCT02266888|Rituximab|rituximab|mesh-list
14467854|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467855|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467856|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
14467857|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467858|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467859|NCT02267083|Doxorubicin|doxorubicin|mesh-list
14467860|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14467861|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467862|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14467863|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14467864|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467865|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744401|NCT00588172|Metformin|metformin|mesh-list
14744402|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14744403|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744404|NCT00588302|Moexipril|moexipril|mesh-list
14744405|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14744406|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
14744407|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467866|NCT02267187|Anesthetics|anesthetics|mesh-list
14467867|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467868|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467869|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
14467870|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14467871|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925965|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
14925966|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925967|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14467872|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467873|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467874|NCT02267538|Analgesics|analgesics|mesh-ancestor
14467875|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
14467876|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467877|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14467878|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14467879|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14467880|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
14467881|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744408|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925968|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14925969|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925970|NCT01406639|Ranibizumab|ranibizumab|mesh-list
14925971|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14925972|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14417125|NCT01640834|Glucagon|glucagon|mesh-list
14417126|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417127|NCT01640834|Hormones|hormones|mesh-ancestor
14417128|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14417129|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417130|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
14417131|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14417132|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14417133|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417134|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
14417135|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
14417136|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14417137|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
14417138|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417139|NCT01640964|Terlipressin|terlipressin|mesh-list
14417140|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14417141|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14417142|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
14417143|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14417144|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
14417145|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417146|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417147|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14417148|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
14417149|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14744409|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14744410|NCT00588523|Temozolomide|temozolomide|mesh-list
14744411|NCT00588523|Busulfan|busulfan|mesh-list
14744412|NCT00588523|Thiotepa|thiotepa|mesh-list
14744413|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14744414|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
14744415|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744416|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744417|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744418|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
14744419|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744420|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14753416|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417150|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14417151|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14417152|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14417153|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417154|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417155|NCT01641120|Interferons|interferons|mesh-list
14417156|NCT01641120|Interferon-beta|interferon-beta|mesh-list
14417157|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
14417158|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417159|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
14417160|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417161|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
14417162|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417163|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14417164|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14417165|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
14417166|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417167|NCT01641159|Buspirone|buspirone|mesh-list
14417168|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14417169|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14417170|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417171|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417172|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14753417|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14753418|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753419|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753420|NCT05169684|Docetaxel|docetaxel|mesh-list
14753421|NCT05169684|Nivolumab|nivolumab|mesh-list
14417173|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14417174|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
14417175|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417176|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417177|NCT01641237|Listerine|listerine|mesh-list
14753422|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753423|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
14925973|NCT01406639|Growth Substances|growth substances|mesh-ancestor
14417178|NCT01641237|Fluorides|fluorides|mesh-list
14417179|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
14417180|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
14417181|NCT01641237|Protective Agents|protective agents|mesh-ancestor
14417182|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417183|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14417184|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417185|NCT01641367|Tenofovir|tenofovir|mesh-list
14417186|NCT01641367|Emtricitabine|emtricitabine|mesh-list
14925974|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417187|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
14417188|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14417189|NCT01641367|Darunavir|darunavir|mesh-list
14417190|NCT01641367|Etravirine|etravirine|mesh-list
14417191|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14417192|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
14417193|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
14417194|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417195|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14417196|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14417197|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417198|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417199|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14417200|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14417201|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14417202|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14417203|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14417204|NCT01641445|Topiramate|topiramate|mesh-list
14417205|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
14417206|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14417207|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417208|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
14417209|NCT01641640|Ribavirin|ribavirin|mesh-list
14417210|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
14417211|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417212|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
14417213|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417214|NCT01641653|Midazolam|midazolam|mesh-list
14417215|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14417216|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14417217|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417218|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417219|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14417220|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14417221|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14417222|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14417223|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
14417224|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
14417225|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
14417226|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
14417227|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417228|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417229|NCT01641692|Albuterol|albuterol|mesh-list
14417230|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14417231|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
14417232|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417233|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417234|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14417235|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
14417236|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
14417237|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14417238|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14417239|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14417240|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14417241|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
14417242|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417243|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417244|NCT01641809|Tenofovir|tenofovir|mesh-list
14417245|NCT01641809|Lamivudine|lamivudine|mesh-list
14417246|NCT01641809|Emtricitabine|emtricitabine|mesh-list
14417247|NCT01641809|Efavirenz|efavirenz|mesh-list
14417248|NCT01641809|Abacavir|abacavir|mesh-list
14417249|NCT01641809|Rilpivirine|rilpivirine|mesh-list
14417250|NCT01641809|Cabotegravir|cabotegravir|mesh-list
14417251|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
14417252|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417253|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14417254|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14417255|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417256|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417257|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14417258|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14417259|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14744421|NCT00588835|Dexamethasone|dexamethasone|mesh-list
14744422|NCT00588835|Ondansetron|ondansetron|mesh-list
14744423|NCT00588835|Aprepitant|aprepitant|mesh-list
14744424|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744425|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
14417260|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14417261|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14417262|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14417263|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14417264|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14417265|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14417266|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14417267|NCT01641822|Tobramycin|tobramycin|mesh-list
14417268|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417269|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417270|NCT01641900|Eszopiclone|eszopiclone|mesh-list
14417271|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14417272|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744426|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
14744427|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744428|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744429|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417273|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417274|NCT01641926|Interferons|interferons|mesh-list
14417275|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
14417276|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
14417277|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14417278|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14417279|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417280|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
14417281|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417282|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
14417283|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417284|NCT01641939|Trastuzumab|trastuzumab|mesh-list
14417285|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14417286|NCT01641939|Maytansine|maytansine|mesh-list
14417287|NCT01641939|Taxane|taxane|mesh-list
14417288|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14417289|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417290|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14417291|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14417292|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14417293|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14417294|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417295|NCT01641952|Rituximab|rituximab|mesh-list
14417296|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14417297|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417298|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
14417299|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417300|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417301|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
14417302|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
14417303|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417304|NCT01642147|Anesthetics|anesthetics|mesh-list
14417305|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417306|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417307|NCT01642212|Budesonide|budesonide|mesh-list
14744430|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
14744431|NCT00588835|Hormones|hormones|mesh-ancestor
14417308|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417309|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14417310|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
14417311|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417312|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417313|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14417314|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
14417315|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
14417316|NCT01642212|Hormones|hormones|mesh-ancestor
14417317|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14417318|NCT01642238|Aspirin|aspirin|mesh-list
14417319|NCT01642238|Hirudins|hirudins|mesh-list
14417320|NCT01642238|Bivalirudin|bivalirudin|mesh-list
14417321|NCT01642238|Clopidogrel|clopidogrel|mesh-list
14417322|NCT01642238|Ticagrelor|ticagrelor|mesh-list
14417323|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14417324|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417325|NCT01642238|Analgesics|analgesics|mesh-ancestor
14417326|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
14417327|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417328|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417329|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417330|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417331|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14417332|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14417333|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417334|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14417335|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14417336|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417337|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
14417338|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14417339|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14417340|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14417341|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
14744432|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744433|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14744434|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744435|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
14744436|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
14744437|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14744438|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
14744439|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744440|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744441|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14744442|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14744443|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744444|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14417342|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417343|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
14744445|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14744446|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14744447|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
14744448|NCT00588913|Aldesleukin|aldesleukin|mesh-list
14744449|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744450|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14744451|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14744452|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
14744453|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744454|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14744455|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744456|NCT00588926|Remifentanil|remifentanil|mesh-list
14744457|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14744458|NCT00588926|Narcotics|narcotics|mesh-ancestor
14744459|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744460|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744461|NCT00588926|Analgesics|analgesics|mesh-ancestor
14417344|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14417345|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
14417346|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
14925975|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
14925976|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14925977|NCT01406678|Sufentanil|sufentanil|mesh-list
14925978|NCT01406678|Dsuvia|dsuvia|mesh-list
14925979|NCT01406678|Isoflurane|isoflurane|mesh-list
14925980|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
14925981|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14925982|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925983|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14925984|NCT01406678|Narcotics|narcotics|mesh-ancestor
14925985|NCT01406678|Analgesics|analgesics|mesh-ancestor
14925986|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
14925987|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14925988|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14925989|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14925990|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
14925991|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14417347|NCT01642251|Cisplatin|cisplatin|mesh-list
14417348|NCT01642251|Etoposide|etoposide|mesh-list
14417349|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
14744462|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
14925992|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
14925993|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
14925994|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14417350|NCT01642251|Veliparib|veliparib|mesh-list
14417351|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
14417352|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417353|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14417354|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14417355|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14417356|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417357|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417358|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14417359|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
14417360|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
14417361|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14417362|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14417363|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14417364|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
14417365|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14417366|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14417367|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
14417368|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417369|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417370|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417371|NCT01642277|Urological Agents|urological agents|mesh-ancestor
14417372|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
14925995|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14925996|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
14925997|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14925998|NCT01406704|Protective Agents|protective agents|mesh-ancestor
14417373|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
14417374|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14417375|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14417376|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417377|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417378|NCT01642407|Urological Agents|urological agents|mesh-ancestor
14417379|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
14469998|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417380|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14417381|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753424|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
14417382|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417383|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417384|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14417385|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14417386|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417387|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417388|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417389|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14417390|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
14417391|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14417392|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14417393|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14417394|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14417395|NCT01642589|Vaccines|vaccines|mesh-list
14417396|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
14417397|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417398|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
14417399|NCT01642602|Lansoprazole|lansoprazole|mesh-list
14417400|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14417401|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417402|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14417403|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417404|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417405|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
14417406|NCT01642615|Lansoprazole|lansoprazole|mesh-list
14417407|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14417408|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417409|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14417410|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417411|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417412|NCT01642914|Linaclotide|linaclotide|mesh-list
14417413|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14417414|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
14417415|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469999|NCT02301975|Fluticasone|fluticasone|mesh-list
14417416|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417417|NCT01643382|Insulin|insulin|mesh-list
14417418|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14417419|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14417420|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417421|NCT01643408|Asparaginase|asparaginase|mesh-list
14417422|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417423|NCT01643616|Midazolam|midazolam|mesh-list
14417424|NCT01643616|Ropivacaine|ropivacaine|mesh-list
14417425|NCT01643616|Prilocaine|prilocaine|mesh-list
14417426|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
14417427|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
14417428|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417429|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417430|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
14417431|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417432|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14417433|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14753425|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
14417434|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14417435|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14417436|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14417437|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14417438|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
14417439|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
14417440|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
14417441|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417442|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417443|NCT01643668|Busulfan|busulfan|mesh-list
14417444|NCT01643668|Clofarabine|clofarabine|mesh-list
14417445|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
14925999|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
14926000|NCT01406704|Vitamins|vitamins|mesh-ancestor
14926001|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
14470000|NCT02301975|Xhance|xhance|mesh-list
14470001|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14744463|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744464|NCT00589082|Daunorubicin|daunorubicin|mesh-list
14744465|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14744466|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926002|NCT01406782|Rituximab|rituximab|mesh-list
14417446|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417447|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417448|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
14417449|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417450|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14926003|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926004|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926005|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
14926006|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926007|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14926008|NCT01407016|Metronidazole|metronidazole|mesh-list
14926009|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926010|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14926011|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14926012|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14926013|NCT01407211|Vitamin A|vitamin a|mesh-list
14926014|NCT01407211|Vitamins|vitamins|mesh-ancestor
14417451|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417452|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14417453|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14417454|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
14417455|NCT01643772|Oxycodone|oxycodone|mesh-list
14417456|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14417457|NCT01643772|Narcotics|narcotics|mesh-ancestor
14417458|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417459|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417460|NCT01643772|Analgesics|analgesics|mesh-ancestor
14417461|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
14417462|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417463|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14417464|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14744467|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14744468|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14744469|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744470|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744471|NCT00589134|Ganirelix|ganirelix|mesh-list
14744472|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744473|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744474|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744475|NCT00589186|Celecoxib|celecoxib|mesh-list
14744476|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14744477|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14744478|NCT00589186|Analgesics|analgesics|mesh-ancestor
14744479|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
14744480|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744481|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744482|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744483|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744484|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14744485|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14744486|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744487|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744488|NCT00589238|Paclitaxel|paclitaxel|mesh-list
14926015|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
14744489|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
14926016|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926017|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
14744490|NCT00589238|Carboplatin|carboplatin|mesh-list
14744491|NCT00589238|Doxorubicin|doxorubicin|mesh-list
14744492|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14744493|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14744494|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744495|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
14744496|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
14744497|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
14744498|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744499|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744500|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
14744501|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744502|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417465|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14417466|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417467|NCT01643928|Rituximab|rituximab|mesh-list
14417468|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14417469|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417470|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
14417471|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417472|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417473|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14417474|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
14417475|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417476|NCT01644188|Ezetimibe|ezetimibe|mesh-list
14417477|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14417478|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14417479|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14417480|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
14417481|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417482|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14417483|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
14417484|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417485|NCT01644331|Tolvaptan|tolvaptan|mesh-list
14417486|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14417487|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417488|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
14417489|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417490|NCT01644396|Adalimumab|adalimumab|mesh-list
14417491|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417492|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417493|NCT01644474|Ezetimibe|ezetimibe|mesh-list
14744503|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14744504|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
14744505|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14744506|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14744507|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14744508|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14744509|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744510|NCT00589251|Penicillins|penicillins|mesh-list
14417494|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14417495|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14417496|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14417497|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
14417498|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417499|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14417500|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
14417501|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417502|NCT01644500|Glimepiride|glimepiride|mesh-list
14417503|NCT01644500|Dulaglutide|dulaglutide|mesh-list
14417504|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14417505|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14417506|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417507|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417508|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
14926018|NCT01407237|Giapreza|giapreza|mesh-list
14926019|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
14926020|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14926021|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14926022|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
14417509|NCT01644643|Metronidazole|metronidazole|mesh-list
14417510|NCT01644643|Ceftazidime|ceftazidime|mesh-list
14417511|NCT01644643|Avibactam|avibactam|mesh-list
14417512|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417513|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417514|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14417515|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14417516|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14417517|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417518|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417519|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
14417520|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14417521|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
14417522|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417523|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417524|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14417525|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14417526|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
14417527|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14417528|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
14417529|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417530|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417531|NCT01644890|Paclitaxel|paclitaxel|mesh-list
14417532|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14417533|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417534|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14417535|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14417536|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14417537|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744511|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14744512|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744513|NCT00589264|Copper|copper|mesh-list
14744514|NCT00589264|Trace Elements|trace elements|mesh-ancestor
14744515|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
14926023|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931217|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
14417538|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
14417539|NCT01645098|Ketamine|ketamine|mesh-list
14417540|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14417541|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417542|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417543|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417544|NCT01645098|Analgesics|analgesics|mesh-ancestor
14417545|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
14417546|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417547|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14417548|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14417549|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14417550|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14417551|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417552|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417553|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14417554|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14417555|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
14417556|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
14417557|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14417558|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14417559|NCT01645111|Clevidipine|clevidipine|mesh-list
14417560|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14417561|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14417562|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417563|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14417564|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417565|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
14417566|NCT01645176|Atorvastatin|atorvastatin|mesh-list
14417567|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14417568|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14417569|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
14417570|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417571|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14417572|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14744516|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744517|NCT00589316|Iodine|iodine|mesh-list
14744518|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
14744519|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
14417573|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417574|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
14417575|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14417576|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14417577|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417578|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417579|NCT01645280|Methotrexate|methotrexate|mesh-list
14744520|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
14744521|NCT00589316|Fludarabine|fludarabine|mesh-list
14744522|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
14744523|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14744524|NCT00589316|Tacrolimus|tacrolimus|mesh-list
14744525|NCT00589316|Antibodies|antibodies|mesh-list
14744526|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
14744527|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14744528|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744529|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
14417580|NCT01645280|Ustekinumab|ustekinumab|mesh-list
14417581|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14417582|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
14417583|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14417584|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417585|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14417586|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
14417587|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417588|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417589|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
14417590|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417591|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14417592|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417593|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
14417594|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417595|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14417596|NCT01645735|Vancomycin|vancomycin|mesh-list
14417597|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
14417598|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14417599|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417600|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417601|NCT01645930|Dexamethasone|dexamethasone|mesh-list
14417602|NCT01645930|Lenalidomide|lenalidomide|mesh-list
14417603|NCT01645930|Ixazomib|ixazomib|mesh-list
14417604|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417605|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
14417606|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
14417607|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417608|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417609|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417610|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
14417611|NCT01645930|Hormones|hormones|mesh-ancestor
14744530|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470002|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744531|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417612|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14417613|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14417614|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417615|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
14417616|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14417617|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14417618|NCT01645930|Growth Substances|growth substances|mesh-ancestor
14417619|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
14417620|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
14417621|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744532|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14744533|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
14744534|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744535|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744536|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14744537|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14744538|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
14744539|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14744540|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744541|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14744542|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14744543|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
14744544|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14744545|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744546|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14744547|NCT00589316|Trace Elements|trace elements|mesh-ancestor
14744548|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
14744549|NCT00589381|Fenretinide|fenretinide|mesh-list
14744550|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744551|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14744552|NCT00589381|Protective Agents|protective agents|mesh-ancestor
14744553|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744554|NCT00589394|Vaccines|vaccines|mesh-list
14744555|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14744556|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
14744557|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744558|NCT00589485|Cobalt|cobalt|mesh-list
14744559|NCT00589485|Trace Elements|trace elements|mesh-ancestor
14744560|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
14744561|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744562|NCT00589732|Valsartan|valsartan|mesh-list
14417622|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417623|NCT01646021|Sirolimus|sirolimus|mesh-list
14417624|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417625|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417626|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14417627|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417628|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
14417629|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417630|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
14417631|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417632|NCT01646073|Adalimumab|adalimumab|mesh-list
14417633|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417634|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417635|NCT01646125|Docetaxel|docetaxel|mesh-list
14417636|NCT01646125|Pemetrexed|pemetrexed|mesh-list
14417637|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417638|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14417639|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14417640|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14417641|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417642|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417643|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14417644|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14417645|NCT01646151|Bimatoprost|bimatoprost|mesh-list
14417646|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14417647|NCT01646177|Etanercept|etanercept|mesh-list
14417648|NCT01646177|Ixekizumab|ixekizumab|mesh-list
14417649|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14417650|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417651|NCT01646177|Analgesics|analgesics|mesh-ancestor
14417652|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
14417653|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417654|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417655|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417656|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417657|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417658|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417659|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
14417660|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
14417661|NCT01646255|Levodopa|levodopa|mesh-list
14417662|NCT01646255|Rotigotine|rotigotine|mesh-list
14417663|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14417664|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14417665|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
14417666|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417667|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417668|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417669|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
14417670|NCT01646268|Rotigotine|rotigotine|mesh-list
14417671|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
14417672|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
14417673|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417674|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417675|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417676|NCT01646320|Metformin|metformin|mesh-list
14417677|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
14417678|NCT01646320|Saxagliptin|saxagliptin|mesh-list
14417679|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14417680|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417681|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14417682|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417683|NCT01646320|Incretins|incretins|mesh-ancestor
14417684|NCT01646320|Hormones|hormones|mesh-ancestor
14417685|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14417686|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14417687|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
14417688|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417689|NCT01646385|Etanercept|etanercept|mesh-list
14417690|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
14417691|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14417692|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417693|NCT01646385|Analgesics|analgesics|mesh-ancestor
14417694|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
14744563|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14744564|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14744565|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14744566|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744567|NCT00589862|Clopidogrel|clopidogrel|mesh-list
14744568|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14744569|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14744570|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14744571|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14744572|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
14926024|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417695|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417696|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417697|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417698|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14417699|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417700|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
14744573|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744574|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744575|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744576|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
14926025|NCT01407289|Insulin|insulin|mesh-list
14417701|NCT01646398|Vaccines|vaccines|mesh-list
14417702|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14417703|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
14417704|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417705|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14417706|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14417707|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417708|NCT01646762|Paclitaxel|paclitaxel|mesh-list
14417709|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14417710|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14417711|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417712|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14417713|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14417714|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14417715|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417716|NCT01646814|Aspirin|aspirin|mesh-list
14417717|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14417718|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417719|NCT01646814|Analgesics|analgesics|mesh-ancestor
14417720|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
14417721|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417722|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417723|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417724|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417725|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14417726|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14417727|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417728|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14417729|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14417730|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417731|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
14417732|NCT01646827|Aripiprazole|aripiprazole|mesh-list
14926026|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
14926027|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
14926028|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14926029|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926030|NCT01407432|Folic Acid|folic acid|mesh-list
14417733|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
14417734|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14417735|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14417736|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14417737|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417738|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417739|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
14417740|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
14417741|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417742|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417743|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14417744|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14926031|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
14926032|NCT01407432|Hematinics|hematinics|mesh-ancestor
14417745|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
14417746|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14417747|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14417748|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14417749|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14467882|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467883|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
14467884|NCT02267746|Tazarotene|tazarotene|mesh-list
14467885|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
14467886|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
14467887|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
14467888|NCT02267746|Vitamins|vitamins|mesh-ancestor
14467889|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
14467890|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467891|NCT02267772|Acetaminophen|acetaminophen|mesh-list
14467892|NCT02267772|Morphine|morphine|mesh-list
14467893|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14467894|NCT02267772|Narcotics|narcotics|mesh-ancestor
14467895|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14467896|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467897|NCT02267772|Analgesics|analgesics|mesh-ancestor
14467898|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
14467899|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467900|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467901|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
14467902|NCT02268045|Rituximab|rituximab|mesh-list
14467903|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14467904|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467905|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
14467906|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467907|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467908|NCT02268058|Acetaminophen|acetaminophen|mesh-list
14467909|NCT02268058|Ibuprofen|ibuprofen|mesh-list
14467910|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467911|NCT02268058|Analgesics|analgesics|mesh-ancestor
14467912|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
14467913|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467914|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467915|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
14467916|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467917|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467918|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467919|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14467920|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467921|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417750|NCT01647282|Minocycline|minocycline|mesh-list
14417751|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417752|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417753|NCT01647516|Ozanimod|ozanimod|mesh-list
14417754|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14417755|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417756|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417757|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
14417758|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417759|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14417760|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14417761|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
14417762|NCT01647581|Hormones|hormones|mesh-ancestor
14417763|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14417764|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417765|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417766|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417767|NCT01647945|Tacrolimus|tacrolimus|mesh-list
14417768|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417769|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
14417770|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417771|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14417772|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417773|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417774|NCT01648101|Ezogabine|ezogabine|mesh-list
14417775|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
14417776|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14417777|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417778|NCT01648140|Interferons|interferons|mesh-list
14417779|NCT01648140|Ribavirin|ribavirin|mesh-list
14417780|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
14417781|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
14417782|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14417783|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417784|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
14417785|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417786|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
14417787|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417788|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
14417789|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417790|NCT01648283|Methadone|methadone|mesh-list
14417791|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14417792|NCT01648283|Narcotics|narcotics|mesh-ancestor
14417793|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417794|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417795|NCT01648283|Analgesics|analgesics|mesh-ancestor
14417796|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
14417797|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417798|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
14417799|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
14926033|NCT01407432|Vitamins|vitamins|mesh-ancestor
14417800|NCT01648348|Bevacizumab|bevacizumab|mesh-list
14417801|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14417802|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
14417803|NCT01648348|Antibodies|antibodies|mesh-list
14417804|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
14926034|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
14417805|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14417806|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
14417807|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417808|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14417809|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14417810|NCT01648348|Growth Substances|growth substances|mesh-ancestor
14417811|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417812|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
14417813|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
14417814|NCT01648582|Metformin|metformin|mesh-list
14417815|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
14417816|NCT01648582|Dulaglutide|dulaglutide|mesh-list
14417817|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14417818|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417819|NCT01648699|Hydromorphone|hydromorphone|mesh-list
14417820|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14417821|NCT01648699|Narcotics|narcotics|mesh-ancestor
14417822|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14417823|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417824|NCT01648699|Analgesics|analgesics|mesh-ancestor
14417825|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
14417826|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417827|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14417828|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14417829|NCT01649180|Axitinib|axitinib|mesh-list
14417830|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417831|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14417832|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417833|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417834|NCT01649271|Trastuzumab|trastuzumab|mesh-list
14417835|NCT01649271|Afatinib|afatinib|mesh-list
14417836|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14417837|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417838|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14417839|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417840|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417841|NCT01649297|Empagliflozin|empagliflozin|mesh-list
14417842|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14417843|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417844|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14417845|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417846|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14417847|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
14744577|NCT00589901|Capecitabine|capecitabine|mesh-list
14744578|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744579|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
14744580|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744581|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744582|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14744583|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
14744584|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744585|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744586|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14744587|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14744588|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
14744589|NCT00589927|Cilostazol|cilostazol|mesh-list
14744590|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14744591|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
14744592|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744593|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744594|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14744595|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
14744596|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14744597|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14744598|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744599|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14744600|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
14744601|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14744602|NCT00589927|Protective Agents|protective agents|mesh-ancestor
14744603|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14744604|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14744605|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744606|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
14744607|NCT00589953|Hematinics|hematinics|mesh-ancestor
14744608|NCT00589992|Ibutilide|ibutilide|mesh-list
14744609|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14744610|NCT00590070|Adenosine|adenosine|mesh-list
14744611|NCT00590070|Nitroprusside|nitroprusside|mesh-list
14744612|NCT00590070|Analgesics|analgesics|mesh-ancestor
14744613|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
14744614|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417848|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417849|NCT01649427|Tacrolimus|tacrolimus|mesh-list
14417850|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417851|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
14417852|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417853|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14417854|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417855|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417856|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
14417857|NCT01649609|Sirolimus|sirolimus|mesh-list
14417858|NCT01649609|Tacrolimus|tacrolimus|mesh-list
14744615|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744616|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14744617|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
14744618|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14744619|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
14744620|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
14744621|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417859|NCT01649609|Antimetabolites|antimetabolites|mesh-list
14417860|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744622|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744623|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14744624|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14417861|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
14417862|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417863|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14417864|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744625|NCT00590122|Levodopa|levodopa|mesh-list
14744626|NCT00590122|Carbidopa|carbidopa|mesh-list
14744627|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14417865|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417866|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14417867|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417868|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14744628|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14417869|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
14417870|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417871|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417872|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
14417873|NCT01649765|Belimumab|belimumab|mesh-list
14417874|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14417875|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
14417876|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417877|NCT01649791|Lenalidomide|lenalidomide|mesh-list
14417878|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
14417879|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417880|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14417881|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14417882|NCT01649791|Growth Substances|growth substances|mesh-ancestor
14417883|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
14417884|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417885|NCT01649856|Rituximab|rituximab|mesh-list
14417886|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14417887|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417888|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
14417889|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417890|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417891|NCT01649869|Valganciclovir|valganciclovir|mesh-list
14417892|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
14417893|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417894|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
14417895|NCT01649947|Paclitaxel|paclitaxel|mesh-list
14417896|NCT01649947|Bevacizumab|bevacizumab|mesh-list
14417897|NCT01649947|Carboplatin|carboplatin|mesh-list
14417898|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14417899|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417900|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
14417901|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
14417902|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
14417903|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417904|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14417905|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14417906|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14417907|NCT01649947|Growth Substances|growth substances|mesh-ancestor
14417908|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417909|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
14417910|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
14417911|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14417912|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14926035|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926036|NCT01407471|Clobetasol|clobetasol|mesh-list
14417913|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417914|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926037|NCT01407471|Spironolactone|spironolactone|mesh-list
14417915|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14926038|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14926039|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
14926040|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926041|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744629|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14744630|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
14744631|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744632|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744633|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744634|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14417916|NCT01650194|Prednisone|prednisone|mesh-list
14417917|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
14417918|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417919|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
14417920|NCT01650194|Hormones|hormones|mesh-ancestor
14417921|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14417922|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417923|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14926042|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14926043|NCT01407471|Diuretics|diuretics|mesh-ancestor
14744635|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744636|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14744637|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
14926044|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
14926045|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926046|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
14926047|NCT01407471|Hormones|hormones|mesh-ancestor
14926048|NCT01407484|Prednisone|prednisone|mesh-list
14926049|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926050|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
14926051|NCT01407484|Hormones|hormones|mesh-ancestor
14926052|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926053|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926054|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14926055|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926056|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14926057|NCT01407562|Paclitaxel|paclitaxel|mesh-list
14926058|NCT01407562|Carboplatin|carboplatin|mesh-list
14926059|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14926060|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926061|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14417924|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926062|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14926063|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14926064|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926065|NCT01407666|Anesthetics|anesthetics|mesh-list
14417925|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14417926|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417927|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744638|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
14744639|NCT00590174|Aspirin|aspirin|mesh-list
14744640|NCT00590174|Clopidogrel|clopidogrel|mesh-list
14417928|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
14417929|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14417930|NCT01650246|Lesinurad|lesinurad|mesh-list
14417931|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
14417932|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417933|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
14417934|NCT01650246|Renal Agents|renal agents|mesh-ancestor
14417935|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
14417936|NCT01650298|Thrombin|thrombin|mesh-list
14417937|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
14417938|NCT01650298|Coagulants|coagulants|mesh-ancestor
14417939|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
14417940|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14417941|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
14417942|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417943|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417944|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
14417945|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
14417946|NCT01650519|Ibuprofen|ibuprofen|mesh-list
14417947|NCT01650519|Ketorolac|ketorolac|mesh-list
14417948|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14417949|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417950|NCT01650519|Analgesics|analgesics|mesh-ancestor
14417951|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
14417952|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14417953|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417954|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14417955|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417956|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14417957|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417958|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417959|NCT01650545|Cyclosporine|cyclosporine|mesh-list
14417960|NCT01650545|Sirolimus|sirolimus|mesh-list
14417961|NCT01650545|Tacrolimus|tacrolimus|mesh-list
14744641|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14744642|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14417962|NCT01650545|Cyclosporins|cyclosporins|mesh-list
14417963|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744643|NCT00590174|Analgesics|analgesics|mesh-ancestor
14744644|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
14744645|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744646|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744647|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744648|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744649|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14744650|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14744651|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744652|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14744653|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14744654|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744655|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
14744656|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14744657|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14417964|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
14417965|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744658|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14744659|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
14744660|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14417966|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14744661|NCT00590213|Bicalutamide|bicalutamide|mesh-list
14417967|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417968|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417969|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
14417970|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417971|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
14417972|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744662|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
14744663|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744664|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744665|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744666|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744667|NCT00590278|Raltitrexed|raltitrexed|mesh-list
14744668|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14744669|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
14744670|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744671|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744672|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14744673|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744674|NCT00590343|Vatalanib|vatalanib|mesh-list
14744675|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14744676|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744677|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744678|NCT00590408|Ubiquinone|ubiquinone|mesh-list
14744679|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
14744680|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
14744681|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744682|NCT00590408|Vitamins|vitamins|mesh-ancestor
14744683|NCT00590447|Rituximab|rituximab|mesh-list
14744684|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14744685|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744686|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
14744687|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744688|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417973|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14417974|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14417975|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417976|NCT01650558|Chloroquine|chloroquine|mesh-list
14417977|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14417978|NCT01650558|Amebicides|amebicides|mesh-ancestor
14417979|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14417980|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14417981|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14417982|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
14744689|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
14744690|NCT00590603|Bortezomib|bortezomib|mesh-list
14417983|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14417984|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14417985|NCT01650558|Renal Agents|renal agents|mesh-ancestor
14417986|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14744691|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
14744692|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744693|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
14744694|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744695|NCT00590603|Protective Agents|protective agents|mesh-ancestor
14744696|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744697|NCT00590603|Vitamins|vitamins|mesh-ancestor
14744698|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
14744699|NCT00590629|Niacin|niacin|mesh-list
14744700|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
14744701|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14744702|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
14744703|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744704|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14744705|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14744706|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
14744707|NCT00590629|Vitamins|vitamins|mesh-ancestor
14744708|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
14417987|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
14417988|NCT01650805|Ponatinib|ponatinib|mesh-list
14417989|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14417990|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14417991|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14417992|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14417993|NCT01651000|Calcifediol|calcifediol|mesh-list
14417994|NCT01651000|Vitamins|vitamins|mesh-ancestor
14417995|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
14417996|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14417997|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14417998|NCT01651039|Dexamethasone|dexamethasone|mesh-list
14417999|NCT01651039|Lenalidomide|lenalidomide|mesh-list
14418000|NCT01651039|Panobinostat|panobinostat|mesh-list
14418001|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14418002|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
14418003|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
14418004|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418005|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418006|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14418007|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
14418008|NCT01651039|Hormones|hormones|mesh-ancestor
14418009|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418010|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14744709|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418011|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744710|NCT00590694|Ranibizumab|ranibizumab|mesh-list
14744711|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14744712|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14744713|NCT00590694|Growth Substances|growth substances|mesh-ancestor
14744714|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744715|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
14744716|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418012|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
14418013|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14418014|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14926066|NCT01407666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926067|NCT01407666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926068|NCT01407679|Alitretinoin|alitretinoin|mesh-list
14926069|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926070|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926071|NCT01407822|Gemcitabine|gemcitabine|mesh-list
14926072|NCT01407822|Cisplatin|cisplatin|mesh-list
14926073|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14926074|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418015|NCT01651039|Growth Substances|growth substances|mesh-ancestor
14418016|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14418017|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14418018|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418019|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418020|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
14418021|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14418022|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418023|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418024|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14418025|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14418026|NCT01651442|Zolpidem|zolpidem|mesh-list
14744717|NCT00590785|Tamoxifen|tamoxifen|mesh-list
14744718|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
14744719|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
14744720|NCT00590785|Doxorubicin|doxorubicin|mesh-list
14744721|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744722|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
14744723|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744724|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14418027|NCT01651442|Trazodone|trazodone|mesh-list
14744725|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14926075|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14926076|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
14418028|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14418029|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14418030|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418031|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418032|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14418033|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
14418034|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
14418035|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418036|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418037|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14418038|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14418039|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14418040|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14418041|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14418042|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418043|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
14418044|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14418045|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
14418046|NCT01651780|Heparin|heparin|mesh-list
14418047|NCT01651780|Calcium heparin|calcium heparin|mesh-list
14418048|NCT01651780|Bivalirudin|bivalirudin|mesh-list
14926077|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418049|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
14418050|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14418051|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14418052|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418053|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
14418054|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14418055|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
14418056|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418057|NCT01651793|Caffeine|caffeine|mesh-list
14418058|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14418059|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418060|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14418061|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418062|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418063|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14418064|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14418065|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
14418066|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418067|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
14418068|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14418069|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14418070|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418071|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
14418072|NCT01651806|Coagulants|coagulants|mesh-ancestor
14418073|NCT01651936|Methotrexate|methotrexate|mesh-list
14467922|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
14926078|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
14418074|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14418075|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
14418076|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14418077|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418078|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418079|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
14418080|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418081|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418082|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
14418083|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418084|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14418085|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418086|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
14418087|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14418088|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14418089|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
14418090|NCT01652040|Testosterone|testosterone|mesh-list
14418091|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
14418092|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
14418093|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14418094|NCT01652040|Androgens|androgens|mesh-ancestor
14418095|NCT01652040|Hormones|hormones|mesh-ancestor
14418096|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418097|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418098|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14418099|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418100|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
14418101|NCT01652469|Docetaxel|docetaxel|mesh-list
14418102|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14418103|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418104|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
14418105|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
14418106|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
14418107|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418108|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14418109|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744726|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
14744727|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744728|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744729|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14744730|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14744731|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14744732|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14744733|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744734|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14744735|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744736|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744737|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14418110|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
14418111|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14744738|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14744739|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14744740|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14744741|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14744742|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744743|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14926079|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926080|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926081|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418112|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14418113|NCT01652495|Prednisolone|prednisolone|mesh-list
14418114|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
14418115|NCT01652495|Triamcinolone|triamcinolone|mesh-list
14418116|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14418117|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14418118|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14418119|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
14418120|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14418121|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14418122|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
14418123|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
14418124|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418125|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418126|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14418127|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
14418128|NCT01652495|Hormones|hormones|mesh-ancestor
14418129|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418130|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14418131|NCT01652495|Protective Agents|protective agents|mesh-ancestor
14418132|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14418133|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418134|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418135|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
14418136|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418137|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418138|NCT01652573|Calcitonin|calcitonin|mesh-list
14418139|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
14418140|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14418141|NCT01652573|Katacalcin|katacalcin|mesh-list
14418142|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14418143|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418144|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14418145|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
14418146|NCT01652664|Timolol|timolol|mesh-list
14418147|NCT01652664|Travoprost|travoprost|mesh-list
14418148|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14418149|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14418150|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14418151|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14418152|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
14418153|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418154|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418155|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926082|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
14926083|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418156|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14418157|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14418158|NCT01652690|Denosumab|denosumab|mesh-list
14418159|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14418160|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418161|NCT01652703|Evolocumab|evolocumab|mesh-list
14418162|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14418163|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14418164|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
14418165|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418166|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14418167|NCT01652716|Exenatide|exenatide|mesh-list
14418168|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14926084|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14926085|NCT01407848|Furosemide|furosemide|mesh-list
14418169|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418170|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14418171|NCT01652716|Incretins|incretins|mesh-ancestor
14418172|NCT01652716|Hormones|hormones|mesh-ancestor
14418173|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744744|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14753426|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418174|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14418175|NCT01652729|Exenatide|exenatide|mesh-list
14418176|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14418177|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418178|NCT01652729|Incretins|incretins|mesh-ancestor
14418179|NCT01652729|Hormones|hormones|mesh-ancestor
14753427|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753428|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14753429|NCT05169567|Fulvestrant|fulvestrant|mesh-list
14753430|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14753431|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753432|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14753433|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14753434|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
14418180|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418181|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14418182|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14418183|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418184|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418185|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14418186|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
14418187|NCT01652872|Hematinics|hematinics|mesh-ancestor
14418188|NCT01652976|Leucovorin|leucovorin|mesh-list
14418189|NCT01652976|Fluorouracil|fluorouracil|mesh-list
14418190|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
14418191|NCT01652976|Dasatinib|dasatinib|mesh-list
14418192|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
14418193|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418194|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418195|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418196|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418197|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
14418198|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418199|NCT01652976|Antidotes|antidotes|mesh-ancestor
14418200|NCT01652976|Protective Agents|protective agents|mesh-ancestor
14418201|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
14418202|NCT01652976|Vitamins|vitamins|mesh-ancestor
14418203|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
14418204|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14418205|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418206|NCT01653158|Docetaxel|docetaxel|mesh-list
14418207|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418208|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
14418209|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
14418210|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
14418211|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744745|NCT00590837|Lomustine|lomustine|mesh-list
14744746|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14744747|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
14744748|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744749|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926086|NCT01407848|Diuretics|diuretics|mesh-ancestor
14418212|NCT01653262|Brivaracetam|brivaracetam|mesh-list
14418213|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
14418214|NCT01653327|Ketamine|ketamine|mesh-list
14418215|NCT01653327|Analgesics|analgesics|mesh-ancestor
14418216|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
14418217|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418218|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418219|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14744750|NCT00590915|Asparaginase|asparaginase|mesh-list
14744751|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744752|NCT00590928|Esomeprazole|esomeprazole|mesh-list
14744753|NCT00590928|Ranitidine|ranitidine|mesh-list
14744754|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14744755|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14418220|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14418221|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
14418222|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
14418223|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744756|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744757|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14744758|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744759|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744760|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14744761|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
14744762|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
14744763|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744764|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744765|NCT00591162|Tetracycline|tetracycline|mesh-list
14744766|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14744767|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744768|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14744769|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744770|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744771|NCT00591188|Interferons|interferons|mesh-list
14744772|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
14744773|NCT00591188|Capecitabine|capecitabine|mesh-list
14744774|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14744775|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
14744776|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744777|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744778|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
14744779|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744780|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
14744781|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744782|NCT00591201|Infliximab|infliximab|mesh-list
14744783|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
14744784|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744785|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14744786|NCT00591357|Loperamide|loperamide|mesh-list
14744787|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
14744788|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744789|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14744790|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744791|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14744792|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744793|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744794|NCT00591487|Lidocaine|lidocaine|mesh-list
14744795|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
14744796|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
14744797|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744798|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744799|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
14744800|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744801|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14744802|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14926087|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
14744803|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14744804|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14744805|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744806|NCT00591526|Cytarabine|cytarabine|mesh-list
14744807|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14744808|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
14744809|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744810|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744811|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
14744812|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14744813|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744814|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
14744815|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744816|NCT00591604|Vitamin D|vitamin d|mesh-list
14744817|NCT00591604|Vitamins|vitamins|mesh-ancestor
14744818|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
14744819|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744820|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14744821|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14744822|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14744823|NCT00591617|Narcotics|narcotics|mesh-ancestor
14744824|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418224|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14418225|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14418226|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418227|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418228|NCT01653418|Cytarabine|cytarabine|mesh-list
14418229|NCT01653418|Etoposide|etoposide|mesh-list
14418230|NCT01653418|Bortezomib|bortezomib|mesh-list
14418231|NCT01653418|Melphalan|melphalan|mesh-list
14418232|NCT01653418|Carmustine|carmustine|mesh-list
14418233|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14418234|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744825|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744826|NCT00591617|Analgesics|analgesics|mesh-ancestor
14418235|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14418236|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14418237|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418238|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418239|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418240|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
14418241|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
14744827|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
14418242|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418243|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418244|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
14418245|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418246|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14418247|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
14418248|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14418249|NCT01653509|Acyclovir|acyclovir|mesh-list
14418250|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
14418251|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418252|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14418253|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14418254|NCT01653743|Hormones|hormones|mesh-ancestor
14418255|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418256|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418257|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14467923|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14467924|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467925|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14467926|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467927|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
14467928|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
14467929|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14467930|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
14467931|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467932|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467933|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14467934|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
14467935|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14467936|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14467937|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14467938|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
14467939|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14467940|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467941|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14467942|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14467943|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14467944|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
14467945|NCT02268864|Simeprevir|simeprevir|mesh-list
14467946|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
14467947|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14467948|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
14467949|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418258|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
14418259|NCT01653847|Everolimus|everolimus|mesh-list
14418260|NCT01653847|Tacrolimus|tacrolimus|mesh-list
14418261|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418262|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
14418263|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418264|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14418265|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418266|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418267|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418268|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14418269|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14418270|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
14418271|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14418272|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418273|NCT01653912|Paclitaxel|paclitaxel|mesh-list
14418274|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14418275|NCT01653912|Carboplatin|carboplatin|mesh-list
14418276|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14418277|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418278|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
14418279|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
14418280|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
14418281|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418282|NCT01654107|Nicotine|nicotine|mesh-list
14418283|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14418284|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
14418285|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418286|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418287|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14418288|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14418289|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
14926088|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418290|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418291|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418292|NCT01654224|Vaccines|vaccines|mesh-list
14418293|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
14418294|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418295|NCT01654276|Febuxostat|febuxostat|mesh-list
14418296|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
14418297|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14418298|NCT01654302|Lidocaine|lidocaine|mesh-list
14418299|NCT01654302|Tetracaine|tetracaine|mesh-list
14418300|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
14418301|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
14418302|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418303|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418304|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
14418305|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418306|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14418307|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14418308|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14418309|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418310|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418311|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
14418312|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14418313|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418314|NCT01654445|Tenecteplase|tenecteplase|mesh-list
14418315|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14418316|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14418317|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418318|NCT01654536|Ciclesonide|ciclesonide|mesh-list
14418319|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
14418320|NCT01654536|Hormones|hormones|mesh-ancestor
14418321|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418322|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418323|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14418324|NCT01654601|Clozapine|clozapine|mesh-list
14418325|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14418326|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
14418327|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418328|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418329|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418330|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14418331|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14418332|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418333|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14418334|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
14418335|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
14418336|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
14418337|NCT01654861|Gemcitabine|gemcitabine|mesh-list
14418338|NCT01654861|Vitamins|vitamins|mesh-ancestor
14418339|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
14418340|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418341|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418342|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
14418343|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418344|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418345|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
14418346|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418347|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418348|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418349|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
14418350|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
14418351|NCT01654861|Protective Agents|protective agents|mesh-ancestor
14418352|NCT01655043|Regadenoson|regadenoson|mesh-list
14418353|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14418354|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14418355|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
14418356|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
14418357|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418358|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418359|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418360|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
14418361|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14418362|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14418363|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
14418364|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418365|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418366|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418367|NCT01655069|Urological Agents|urological agents|mesh-ancestor
14418368|NCT01655563|Tacrolimus|tacrolimus|mesh-list
14418369|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418370|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
14418371|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418372|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14418373|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744828|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14744829|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14744830|NCT00591643|Epinephrine|epinephrine|mesh-list
14744831|NCT00591643|Racepinephrine|racepinephrine|mesh-list
14744832|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
14744833|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14744834|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14744835|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
14744836|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418374|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418375|NCT01655693|Doxorubicin|doxorubicin|mesh-list
14418376|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14418377|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14418378|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418379|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14418380|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14418381|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418382|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418383|NCT01655719|Pioglitazone|pioglitazone|mesh-list
14418384|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14418385|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418386|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
14418387|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
14418388|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
14418389|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418390|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418391|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
14418392|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418393|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14418394|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418395|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418396|NCT01656031|Cytarabine|cytarabine|mesh-list
14418397|NCT01656031|Clofarabine|clofarabine|mesh-list
14418398|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418399|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
14418400|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418401|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418402|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
14418403|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418404|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418405|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
14418406|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418407|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14418408|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
14418409|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14418410|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
14418411|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14418412|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418413|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14418414|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14418415|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418416|NCT01656187|Memantine|memantine|mesh-list
14418417|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14418418|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14418419|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
14418420|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418421|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418422|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418423|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14418424|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14418425|NCT01656252|Cytarabine|cytarabine|mesh-list
14418426|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418427|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
14418428|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418429|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418430|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
14418431|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418432|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418433|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
14418434|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418435|NCT01656304|Bevacizumab|bevacizumab|mesh-list
14418436|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14418437|NCT01656304|Antibodies|antibodies|mesh-list
14418438|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
14418439|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14418440|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418441|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14418442|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14418443|NCT01656304|Growth Substances|growth substances|mesh-ancestor
14418444|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418445|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
14418446|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
14418447|NCT01656395|Montelukast|montelukast|mesh-list
14418448|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14418449|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
14418450|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14418451|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
14418452|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418453|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418454|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14418455|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14418456|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418457|NCT01656629|Vitamin D|vitamin d|mesh-list
14418458|NCT01656629|Alendronate|alendronate|mesh-list
14418459|NCT01656629|Teriparatide|teriparatide|mesh-list
14418460|NCT01656629|Calcium|calcium|mesh-list
14418461|NCT01656629|Vitamins|vitamins|mesh-ancestor
14418462|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
14418463|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418464|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14418465|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14418466|NCT01656733|Nicotine|nicotine|mesh-list
14418467|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14418468|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
14418469|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418470|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418471|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14418472|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14418473|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
14418474|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418475|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744837|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744838|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744839|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14744840|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14744841|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
14744842|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418476|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14418477|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14418478|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418479|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14418480|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14418481|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418482|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418483|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
14418484|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418485|NCT01657162|Alendronate|alendronate|mesh-list
14418486|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14926089|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14926090|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926091|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931104|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931105|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
14931106|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931107|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931108|NCT01437592|Insulin|insulin|mesh-list
14931109|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931110|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418487|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418488|NCT01657266|Nepafenac|nepafenac|mesh-list
14418489|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14418490|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14418491|NCT01657266|Analgesics|analgesics|mesh-ancestor
14418492|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
14418493|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418494|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418495|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14418496|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14418497|NCT01657292|Octenidine|octenidine|mesh-list
14418498|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418499|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14418500|NCT01657461|Plasminogen|plasminogen|mesh-list
14418501|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14418502|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14418503|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14418504|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418505|NCT01657760|Citalopram|citalopram|mesh-list
14418506|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14418507|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14418508|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418509|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418510|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418511|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
14418512|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418513|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14418514|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
14418515|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14418516|NCT01657799|Veliparib|veliparib|mesh-list
14418517|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14418518|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418519|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418520|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418521|NCT01657877|Calcium|calcium|mesh-list
14418522|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14418523|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418524|NCT01657903|Listerine|listerine|mesh-list
14418525|NCT01657903|Fluorides|fluorides|mesh-list
14418526|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
14418527|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
14418528|NCT01657903|Protective Agents|protective agents|mesh-ancestor
14418529|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418530|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14418531|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418532|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
14418533|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14418534|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418535|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14418536|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14418537|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418538|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418539|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418540|NCT01658150|Isradipine|isradipine|mesh-list
14418541|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14418542|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14418543|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418544|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418545|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14418546|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418547|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
14418548|NCT01658228|Donepezil|donepezil|mesh-list
14418549|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14418550|NCT01658228|Citalopram|citalopram|mesh-list
14418551|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14418552|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418553|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418554|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
14418555|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418556|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418557|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
14418558|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14418559|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14418560|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418561|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14418562|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
14418563|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14418564|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14418565|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
14418566|NCT01658436|Dactolisib|dactolisib|mesh-list
14418567|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418568|NCT01658579|Insulin|insulin|mesh-list
14418569|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14418570|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
14418571|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14418572|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418573|NCT01658657|Metoprolol|metoprolol|mesh-list
14418574|NCT01658657|Amlodipine|amlodipine|mesh-list
14418575|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14418576|NCT01658657|Lisinopril|lisinopril|mesh-list
14418577|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
14418578|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14418579|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14418580|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418581|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418582|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14418583|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418584|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
14418585|NCT01658657|Diuretics|diuretics|mesh-ancestor
14418586|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
14418587|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14418588|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14418589|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
14418590|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
14418591|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418592|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14418593|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14418594|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14418595|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
14418596|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418597|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14418598|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
14926092|NCT01407887|Artesunate|artesunate|mesh-list
14418599|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418600|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14418601|NCT01658657|Protective Agents|protective agents|mesh-ancestor
14418602|NCT01658839|Travoprost|travoprost|mesh-list
14418603|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14418604|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14418605|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14418606|NCT01658904|Melphalan|melphalan|mesh-list
14418607|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
14418608|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418609|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14418610|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
14418611|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418612|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418613|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14418614|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418615|NCT01658943|Fluorouracil|fluorouracil|mesh-list
14418616|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
14926093|NCT01407887|Amodiaquine|amodiaquine|mesh-list
14926094|NCT01407887|Methylene Blue|methylene blue|mesh-list
14926095|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
14926096|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14926097|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14926098|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926099|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926100|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
14926101|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
14926102|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14926103|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
14418617|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
14418618|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418619|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418620|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418621|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418622|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
14418623|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418624|NCT01658995|Doxycycline|doxycycline|mesh-list
14926104|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418625|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14418626|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926105|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418627|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
14418628|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14418629|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14418630|NCT01659021|Ofatumumab|ofatumumab|mesh-list
14418631|NCT01659021|Idelalisib|idelalisib|mesh-list
14418632|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418633|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418634|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418635|NCT01659320|Minocycline|minocycline|mesh-list
14418636|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14418637|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418638|NCT01659567|Interferons|interferons|mesh-list
14418639|NCT01659567|Ribavirin|ribavirin|mesh-list
14418640|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
14418641|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
14418642|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14418643|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418644|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
14418645|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418646|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
14418647|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418648|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
14418649|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418650|NCT01659853|Azelaic acid|azelaic acid|mesh-list
14418651|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14418652|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14418653|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14418654|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14418655|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14418656|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
14418657|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418658|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418659|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418660|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418661|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
14418662|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
14418663|NCT01659866|Gentamicins|gentamicins|mesh-list
14418664|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
14418665|NCT01659866|Imipenem|imipenem|mesh-list
14418666|NCT01659866|Amikacin|amikacin|mesh-list
14418667|NCT01659866|Cefuroxime|cefuroxime|mesh-list
14418668|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14418669|NCT01659866|Aztreonam|aztreonam|mesh-list
14418670|NCT01659866|Trimethoprim|trimethoprim|mesh-list
14418671|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
14926106|NCT01407978|Vaccines|vaccines|mesh-list
14418672|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14418673|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418674|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14418675|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14418676|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418677|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418678|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418679|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14418680|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14418681|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14418682|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14418683|NCT01659866|Renal Agents|renal agents|mesh-ancestor
14418684|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
14418685|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14418686|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14418687|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14418688|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14418689|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14418690|NCT01660022|Piperaquine|piperaquine|mesh-list
14418691|NCT01660022|Artefenomel|artefenomel|mesh-list
14418692|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
14418693|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14418694|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14418695|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418696|NCT01660191|Atorvastatin|atorvastatin|mesh-list
14418697|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14418698|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14418699|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14418700|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
14418701|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418702|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14418703|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14418704|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418705|NCT01660256|Rebamipide|rebamipide|mesh-list
14418706|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14418707|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14418708|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
14418709|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418710|NCT01660256|Protective Agents|protective agents|mesh-ancestor
14418711|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418712|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418713|NCT01660334|Voriconazole|voriconazole|mesh-list
14418714|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
14418715|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418716|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14418717|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14418718|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418719|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418720|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14418721|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
14418722|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418723|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418724|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14418725|NCT01660672|Levetiracetam|levetiracetam|mesh-list
14418726|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
14418727|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
14418728|NCT01660711|Leucovorin|leucovorin|mesh-list
14418729|NCT01660711|Fluorouracil|fluorouracil|mesh-list
14418730|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
14418731|NCT01660711|Irinotecan|irinotecan|mesh-list
14418732|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
14418733|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418734|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418735|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418736|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418737|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
14418738|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418739|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14418740|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14418741|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418742|NCT01660711|Antidotes|antidotes|mesh-ancestor
14418743|NCT01660711|Protective Agents|protective agents|mesh-ancestor
14418744|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
14418745|NCT01660711|Vitamins|vitamins|mesh-ancestor
14418746|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
14418747|NCT01660763|Sufentanil|sufentanil|mesh-list
14418748|NCT01660763|Dsuvia|dsuvia|mesh-list
14418749|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14418750|NCT01660763|Narcotics|narcotics|mesh-ancestor
14418751|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418752|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418753|NCT01660763|Analgesics|analgesics|mesh-ancestor
14418754|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
14418755|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418756|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14418757|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14418758|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
14418759|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
14418760|NCT01660802|Dexamethasone|dexamethasone|mesh-list
14418761|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14418762|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
14418763|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
14418764|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418765|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418766|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14418767|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
14418768|NCT01660802|Hormones|hormones|mesh-ancestor
14418769|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14418770|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14418771|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467950|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467951|NCT02268955|Ibuprofen|ibuprofen|mesh-list
14467952|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467953|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467954|NCT02268955|Analgesics|analgesics|mesh-ancestor
14467955|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
14467956|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467957|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467958|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467959|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467960|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14467961|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467962|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467963|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
14467964|NCT02269163|Antibodies|antibodies|mesh-list
14467965|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
14467966|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14467967|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14467968|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
14467969|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
14467970|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467971|NCT02269241|Drospirenone|drospirenone|mesh-list
14467972|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14467973|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
14467974|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14467975|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467976|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14467977|NCT02269241|Diuretics|diuretics|mesh-ancestor
14467978|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
14467979|NCT02269943|Azacitidine|azacitidine|mesh-list
14467980|NCT02269943|Cc-486|cc-486|mesh-list
14467981|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14467982|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
14926107|NCT01407978|Immunologic Factors|immunologic factors|mesh-ancestor
14926108|NCT01407978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926109|NCT01408004|Everolimus|everolimus|mesh-list
14926110|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926111|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926112|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
14926113|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926114|NCT01408056|Mupirocin|mupirocin|mesh-list
14926115|NCT01408056|Timolol|timolol|mesh-list
14467983|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926116|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14418772|NCT01660893|Phenylephrine|phenylephrine|mesh-list
14418773|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
14418774|NCT01660893|Tetracaine|tetracaine|mesh-list
14418775|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
14418776|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
14418777|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418778|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418779|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
14418780|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418781|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14418782|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14418783|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
14418784|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418785|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418786|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
14418787|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
14418788|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
14418789|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14418790|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
14418791|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14418792|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
14418793|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14418794|NCT01660893|Protective Agents|protective agents|mesh-ancestor
14418795|NCT01660906|Dasatinib|dasatinib|mesh-list
14418796|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418797|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14418798|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418799|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418800|NCT01661088|Folfirinox|folfirinox|mesh-list
14418801|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418802|NCT01661114|Gemcitabine|gemcitabine|mesh-list
14418803|NCT01661114|Fluorouracil|fluorouracil|mesh-list
14418804|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418805|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418806|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
14418807|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418808|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
14418809|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418810|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418811|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418812|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
14418813|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418814|NCT01661140|Methotrexate|methotrexate|mesh-list
14418815|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14418816|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
14418817|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14418818|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418819|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418820|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
14418821|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418822|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418823|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
14418824|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418825|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14418826|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418827|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
14418828|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14418829|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14418830|NCT01661270|Aflibercept|aflibercept|mesh-list
14418831|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14418832|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14418833|NCT01661270|Growth Substances|growth substances|mesh-ancestor
14418834|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418835|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
14418836|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418837|NCT01661283|Bevacizumab|bevacizumab|mesh-list
14418838|NCT01661283|Everolimus|everolimus|mesh-list
14418839|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14418840|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418841|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14418842|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14418843|NCT01661283|Growth Substances|growth substances|mesh-ancestor
14418844|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418845|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
14418846|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418847|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
14418848|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
14418849|NCT01661595|Tadalafil|tadalafil|mesh-list
14418850|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
14418851|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14418852|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14418853|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418854|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418855|NCT01661595|Urological Agents|urological agents|mesh-ancestor
14418856|NCT01661621|Doxazosin|doxazosin|mesh-list
14418857|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14418858|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14418859|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14418860|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14418861|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14418862|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14418863|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418864|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418865|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418866|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14418867|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14418868|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
14418869|NCT01661621|Urological Agents|urological agents|mesh-ancestor
14418870|NCT01661790|Bevacizumab|bevacizumab|mesh-list
14418871|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14418872|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418873|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14418874|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14418875|NCT01661790|Growth Substances|growth substances|mesh-ancestor
14418876|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418877|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
14418878|NCT01661881|Cytarabine|cytarabine|mesh-list
14418879|NCT01661881|Rituximab|rituximab|mesh-list
14418880|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14418881|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14418882|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418883|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
14418884|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418885|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14418886|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418887|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
14418888|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418889|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
14418890|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418891|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14418892|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14418893|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
14418894|NCT01661946|Bevacizumab|bevacizumab|mesh-list
14418895|NCT01661946|Ranibizumab|ranibizumab|mesh-list
14418896|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14418897|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418898|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14418899|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14418900|NCT01661946|Growth Substances|growth substances|mesh-ancestor
14418901|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418902|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
14418903|NCT01661972|Capecitabine|capecitabine|mesh-list
14418904|NCT01661972|Aflibercept|aflibercept|mesh-list
14418905|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14418906|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
14418907|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418908|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14418909|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14418910|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14418911|NCT01661972|Growth Substances|growth substances|mesh-ancestor
14418912|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418913|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
14418914|NCT01662115|Nicotine|nicotine|mesh-list
14418915|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14418916|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
14418917|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418918|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926117|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14418919|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14418920|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14418921|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
14418922|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418923|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418924|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14418925|NCT01662297|Trazodone|trazodone|mesh-list
14418926|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
14418927|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14418928|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14418929|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14744843|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14744844|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
14744845|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
14744846|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
14744847|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14744848|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
14744849|NCT00591708|Citric Acid|citric acid|mesh-list
14418930|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418931|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418932|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14418933|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14418934|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14418935|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418936|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418937|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744850|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
14418938|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
14418939|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14418940|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14418941|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14418942|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14418943|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418944|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418945|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14418946|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14418947|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14418948|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
14418949|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418950|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926118|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
14926119|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926120|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926121|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926122|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14744851|NCT00591708|Calcium|calcium|mesh-list
14744852|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
14744853|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14744854|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744855|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14744856|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
14744857|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14744858|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
14744859|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
14418951|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14418952|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14418953|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
14418954|NCT01662336|Ritonavir|ritonavir|mesh-list
14418955|NCT01662336|Lopinavir|lopinavir|mesh-list
14418956|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14418957|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14418958|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
14418959|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14418960|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418961|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14418962|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14418963|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
14418964|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418965|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14418966|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14418967|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
14418968|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14418969|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14418970|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14418971|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14418972|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926123|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14744860|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744861|NCT00591916|Thrombin|thrombin|mesh-list
14744862|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
14418973|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
14418974|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418975|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418976|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14418977|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14418978|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14418979|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14418980|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14418981|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14418982|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14418983|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14418984|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14418985|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14418986|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
14418987|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14418988|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14418989|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14418990|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14418991|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
14418992|NCT01662791|Rifaximin|rifaximin|mesh-list
14418993|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14418994|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14418995|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14418996|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14418997|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
14418998|NCT01662856|Coagulants|coagulants|mesh-ancestor
14418999|NCT01662895|Deferoxamine|deferoxamine|mesh-list
14419000|NCT01662895|Siderophores|siderophores|mesh-ancestor
14744863|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
14744864|NCT00591916|Coagulants|coagulants|mesh-ancestor
14744865|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14744866|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
14744867|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744868|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
14744869|NCT00591916|Protective Agents|protective agents|mesh-ancestor
14744870|NCT00591994|Piribedil|piribedil|mesh-list
14744871|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14744872|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14744873|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
14744874|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
14744875|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744876|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744877|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744878|NCT00592111|Prednisone|prednisone|mesh-list
14744879|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
14744880|NCT00592111|Etoposide|etoposide|mesh-list
14744881|NCT00592111|Vincristine|vincristine|mesh-list
14744882|NCT00592111|Doxorubicin|doxorubicin|mesh-list
14744883|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14419001|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14926124|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14419002|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
14926125|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926126|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14926127|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744884|NCT00592111|Bleomycin|bleomycin|mesh-list
14419003|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
14744885|NCT00592111|Vinblastine|vinblastine|mesh-list
14744886|NCT00592111|Procarbazine|procarbazine|mesh-list
14419004|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419005|NCT01662908|Heparin|heparin|mesh-list
14419006|NCT01662908|Enoxaparin|enoxaparin|mesh-list
14419007|NCT01662908|Calcium heparin|calcium heparin|mesh-list
14419008|NCT01662908|Warfarin|warfarin|mesh-list
14419009|NCT01662908|Edoxaban|edoxaban|mesh-list
14419010|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
14419011|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14419012|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14419013|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419014|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14419015|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
14419016|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14419017|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419018|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419019|NCT01662986|Bromides|bromides|mesh-list
14419020|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
14419021|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14419022|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
14419023|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419024|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419025|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14419026|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
14419027|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
14419028|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14419029|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
14419030|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419031|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419032|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
14419033|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
14419034|NCT01662999|Saxagliptin|saxagliptin|mesh-list
14419035|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14419036|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419037|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14419038|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419039|NCT01662999|Incretins|incretins|mesh-ancestor
14419040|NCT01662999|Hormones|hormones|mesh-ancestor
14419041|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419042|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14419043|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419044|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419045|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
14419046|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419047|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14419048|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14419049|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419050|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419051|NCT01663103|Rilonacept|rilonacept|mesh-list
14419052|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419053|NCT01663233|Amlodipine|amlodipine|mesh-list
14419054|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14419055|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14419056|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14419057|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14419058|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419059|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14419060|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419061|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
14419062|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14419063|NCT01663259|Cetuximab|cetuximab|mesh-list
14419064|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14419065|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419066|NCT01663272|Gemcitabine|gemcitabine|mesh-list
14419067|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419068|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
14926128|NCT01408095|Glimepiride|glimepiride|mesh-list
14926129|NCT01408095|Globalagliatin|globalagliatin|mesh-list
14926130|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14926131|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14926132|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926133|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419069|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419070|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926134|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
14926135|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
14926136|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926137|NCT01408160|Cytarabine|cytarabine|mesh-list
14926138|NCT01408160|Immunotoxins|immunotoxins|mesh-list
14926139|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419071|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
14419072|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419073|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419074|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744887|NCT00592111|Mitogens|mitogens|mesh-list
14744888|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744889|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
14744890|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744891|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14419075|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
14419076|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419077|NCT01663532|Aripiprazole|aripiprazole|mesh-list
14419078|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
14419079|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14419080|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14419081|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14419082|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14419083|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419084|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
14419085|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
14419086|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419087|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419088|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14419089|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14419090|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
14419091|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14419092|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14419093|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14419094|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14419095|NCT01663623|Azathioprine|azathioprine|mesh-list
14744892|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14744893|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
14744894|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744895|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744896|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14744897|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744898|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
14744899|NCT00592111|Hormones|hormones|mesh-ancestor
14744900|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744901|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14744902|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14744903|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14744904|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14744905|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14744906|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14744907|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14744908|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14744909|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14419096|NCT01663623|Belimumab|belimumab|mesh-list
14419097|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
14419098|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419099|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419100|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419101|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419102|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
14419103|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419104|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14419105|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
14419106|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419107|NCT01663727|Paclitaxel|paclitaxel|mesh-list
14419108|NCT01663727|Bevacizumab|bevacizumab|mesh-list
14419109|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14419110|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419111|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
14419112|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
14419113|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
14419114|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419115|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14419116|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14419117|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14419118|NCT01663727|Growth Substances|growth substances|mesh-ancestor
14419119|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744910|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
14744911|NCT00592137|Calcium|calcium|mesh-list
14744912|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14744913|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419120|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
14419121|NCT01663740|Valganciclovir|valganciclovir|mesh-list
14419122|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
14419123|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419124|NCT01663857|Gemcitabine|gemcitabine|mesh-list
14419125|NCT01663857|Carboplatin|carboplatin|mesh-list
14419126|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419127|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419128|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
14419129|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419130|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
14419131|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419132|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419133|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419134|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
14419135|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419136|NCT01663935|Levodopa|levodopa|mesh-list
14419137|NCT01663935|Carbidopa|carbidopa|mesh-list
14419138|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14419139|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14419140|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
14419141|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419142|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419143|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419144|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14419145|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419146|NCT01663987|Bromides|bromides|mesh-list
14419147|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
14419148|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14419149|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
14419150|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419151|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419152|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14419153|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
14419154|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
14419155|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14419156|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
14419157|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419158|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419159|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
14419160|NCT01664039|Bimatoprost|bimatoprost|mesh-list
14419161|NCT01664039|Travoprost|travoprost|mesh-list
14419162|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14419163|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14419164|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14419165|NCT01664247|Liraglutide|liraglutide|mesh-list
14419166|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14419167|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419168|NCT01664247|Incretins|incretins|mesh-ancestor
14744914|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14419169|NCT01664247|Hormones|hormones|mesh-ancestor
14744915|NCT00592150|Fenoldopam|fenoldopam|mesh-list
14419170|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419171|NCT01664494|Capecitabine|capecitabine|mesh-list
14419172|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419173|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
14419174|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419175|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419176|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14419177|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419178|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419179|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419180|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419181|NCT01664559|Ketorolac|ketorolac|mesh-list
14419182|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14419183|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14419184|NCT01664559|Analgesics|analgesics|mesh-ancestor
14419185|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
14419186|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419187|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419188|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419189|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14419190|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14419191|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419192|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419193|NCT01664624|Exenatide|exenatide|mesh-list
14419194|NCT01664624|Alogliptin|alogliptin|mesh-list
14419195|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14419196|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419197|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14419198|NCT01664624|Incretins|incretins|mesh-ancestor
14419199|NCT01664624|Hormones|hormones|mesh-ancestor
14419200|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419201|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14419202|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
14926140|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
14419203|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419204|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419205|NCT01664741|Nicotine|nicotine|mesh-list
14419206|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14419207|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
14419208|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419209|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419210|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14419211|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14419212|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
14419213|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419214|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419215|NCT01664793|Vaccines|vaccines|mesh-list
14419216|NCT01664793|Immunologic Factors|immunologic factors|mesh-ancestor
14419217|NCT01664793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419218|NCT01664858|Calcium|calcium|mesh-list
14419219|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14419220|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419221|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14419222|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419223|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419224|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419225|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419226|NCT01664923|Bicalutamide|bicalutamide|mesh-list
14419227|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
14419228|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
14419229|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419230|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419231|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419232|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14419233|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14419234|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
14419235|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14419236|NCT01664949|Laxatives|laxatives|mesh-ancestor
14744916|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14744917|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
14744918|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
14744919|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
14744920|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744921|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744922|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744923|NCT00592215|Misoprostol|misoprostol|mesh-list
14744924|NCT00592215|Mifepristone|mifepristone|mesh-list
14744925|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14744926|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
14926141|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926142|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926143|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
14926144|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926145|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926146|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
14926147|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926148|NCT01408173|Caffeine|caffeine|mesh-list
14419237|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419238|NCT01665508|Nebivolol|nebivolol|mesh-list
14419239|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14419240|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
14419241|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14419242|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14744927|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14926149|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
14419243|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14419244|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
14419245|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419246|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744928|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744929|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14744930|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744931|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
14744932|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14744933|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14419247|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419248|NCT01665599|Testosterone|testosterone|mesh-list
14419249|NCT01665599|Androgens|androgens|mesh-ancestor
14419250|NCT01665599|Hormones|hormones|mesh-ancestor
14419251|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744934|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14419252|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419253|NCT01665768|Rituximab|rituximab|mesh-list
14419254|NCT01665768|Everolimus|everolimus|mesh-list
14419255|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14419256|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419257|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
14419258|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419259|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14419260|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419261|NCT01665911|Listerine|listerine|mesh-list
14419262|NCT01665911|Fluorides|fluorides|mesh-list
14419263|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
14419264|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
14419265|NCT01665911|Protective Agents|protective agents|mesh-ancestor
14744935|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14419266|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419267|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14419268|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419269|NCT01665950|Simvastatin|simvastatin|mesh-list
14419270|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14419271|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14419272|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
14744936|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
14744937|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14419273|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419274|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14419275|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14419276|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467984|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14467985|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14467986|NCT02270242|Aspirin|aspirin|mesh-list
14467987|NCT02270242|Ticagrelor|ticagrelor|mesh-list
14467988|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14467989|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14467990|NCT02270242|Analgesics|analgesics|mesh-ancestor
14467991|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
14467992|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14467993|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14467994|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14467995|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14467996|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14467997|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14467998|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14467999|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14468000|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14468001|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468002|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
14468003|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14468004|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14468005|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14468006|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
14468007|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468008|NCT02270255|Lidocaine|lidocaine|mesh-list
14468009|NCT02270255|Ropivacaine|ropivacaine|mesh-list
14468010|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
14468011|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
14468012|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468013|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468014|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
14468015|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468016|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14419277|NCT01666119|Buprenorphine|buprenorphine|mesh-list
14419278|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14419279|NCT01666119|Narcotics|narcotics|mesh-ancestor
14419280|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14419281|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419282|NCT01666119|Analgesics|analgesics|mesh-ancestor
14419283|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
14419284|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419285|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14419286|NCT01666197|Diclofenac|diclofenac|mesh-list
14419287|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14419288|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14419289|NCT01666197|Analgesics|analgesics|mesh-ancestor
14419290|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
14419291|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419292|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419293|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419294|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14419295|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14419296|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419297|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419298|NCT01666210|Dexamethasone|dexamethasone|mesh-list
14419299|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419300|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
14419301|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
14419302|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419303|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419304|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744938|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14744939|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
14744940|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744941|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
14419305|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
14419306|NCT01666210|Hormones|hormones|mesh-ancestor
14419307|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419308|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419309|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419310|NCT01666314|Prednisone|prednisone|mesh-list
14419311|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419312|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
14744942|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14931111|NCT01437618|Bevacizumab|bevacizumab|mesh-list
14419313|NCT01666314|Hormones|hormones|mesh-ancestor
14419314|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419315|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419316|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419317|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419318|NCT01666444|Doxorubicin|doxorubicin|mesh-list
14419319|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14419320|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14419321|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419322|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14419323|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14419324|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470003|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14470004|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
14470005|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470006|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470007|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14470008|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
14419325|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419326|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14419327|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
14419328|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14419329|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
14419330|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419331|NCT01666652|Antacids|antacids|mesh-ancestor
14419332|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419333|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419334|NCT01666730|Leucovorin|leucovorin|mesh-list
14419335|NCT01666730|Metformin|metformin|mesh-list
14419336|NCT01666730|Fluorouracil|fluorouracil|mesh-list
14419337|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
14419338|NCT01666730|Calcium|calcium|mesh-list
14419339|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
14419340|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14419341|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419342|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14419343|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
14419344|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419345|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419346|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419347|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419348|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
14419349|NCT01666730|Antidotes|antidotes|mesh-ancestor
14419350|NCT01666730|Protective Agents|protective agents|mesh-ancestor
14419351|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
14419352|NCT01666730|Vitamins|vitamins|mesh-ancestor
14419353|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
14419354|NCT01666782|Vaccines|vaccines|mesh-list
14419355|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
14419356|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419357|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
14419358|NCT01666912|Etonogestrel|etonogestrel|mesh-list
14419359|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14419360|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419361|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14419362|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14419363|NCT01666951|Tacrolimus|tacrolimus|mesh-list
14744943|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14744944|NCT00592241|Insulin|insulin|mesh-list
14744945|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14419364|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419365|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
14419366|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419367|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14419368|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419369|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419370|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
14419371|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470009|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470010|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14470011|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14470012|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14470013|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14470014|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14470015|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470016|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470017|NCT02301988|Paclitaxel|paclitaxel|mesh-list
14470018|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14744946|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14744947|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744948|NCT00592280|Pancrelipase|pancrelipase|mesh-list
14744949|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744950|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
14744951|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14744952|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
14744953|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744954|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14744955|NCT00592332|Alprazolam|alprazolam|mesh-list
14419372|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14419373|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14419374|NCT01667029|Analgesics|analgesics|mesh-ancestor
14419375|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
14419376|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419377|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419378|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419379|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14419380|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419381|NCT01667107|Posaconazole|posaconazole|mesh-list
14419382|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
14419383|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419384|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14419385|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14419386|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14419387|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14744956|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14419388|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14744957|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926150|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926151|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14926152|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419389|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419390|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419391|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14926153|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14926154|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926155|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14419392|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
14419393|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419394|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419395|NCT01667419|Vemurafenib|vemurafenib|mesh-list
14419396|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419397|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419398|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419399|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419400|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14419401|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
14419402|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419403|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14419404|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419405|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419406|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419407|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419408|NCT01667679|Sumatriptan|sumatriptan|mesh-list
14419409|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14419410|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14419411|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14419412|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
14419413|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419414|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419415|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419416|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
14419417|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
14744958|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744959|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14744960|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14744961|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14744962|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
14744963|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
14744964|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14744965|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744966|NCT00592410|Insulin|insulin|mesh-list
14744967|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14744968|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14419418|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419419|NCT01667796|Vitamin D|vitamin d|mesh-list
14419420|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
14419421|NCT01667796|Vitamins|vitamins|mesh-ancestor
14419422|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
14419423|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419424|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14419425|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14419426|NCT01667900|Dulaglutide|dulaglutide|mesh-list
14419427|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14419428|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419429|NCT01667926|Ketamine|ketamine|mesh-list
14419430|NCT01667926|Analgesics|analgesics|mesh-ancestor
14419431|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
14419432|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419433|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419434|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14419435|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14419436|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
14744969|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744970|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
14744971|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14744972|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419437|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
14744973|NCT00592566|Dexamethasone|dexamethasone|mesh-list
14744974|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14744975|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14744976|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
14744977|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
14744978|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419438|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14744979|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744980|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14744981|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
14744982|NCT00592566|Hormones|hormones|mesh-ancestor
14419439|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14419440|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14419441|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419442|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419443|NCT01667978|Ritonavir|ritonavir|mesh-list
14419444|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14419445|NCT01667978|Norethindrone|norethindrone|mesh-list
14419446|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
14744983|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14744984|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14744985|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14744986|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
14744987|NCT00592566|Coagulants|coagulants|mesh-ancestor
14926156|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14926157|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
14744988|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14744989|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
14926158|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419447|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
14419448|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14419449|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14419450|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419451|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419452|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14419453|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14419454|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
14419455|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419456|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14419457|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14419458|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14419459|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14419460|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14419461|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
14419462|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14419463|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419464|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14419465|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14419466|NCT01668004|Golimumab|golimumab|mesh-list
14419467|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14419468|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419469|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419470|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
14419471|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419472|NCT01668017|Niacinamide|niacinamide|mesh-list
14419473|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
14926159|NCT01408186|Rabeprazole|rabeprazole|mesh-list
14419474|NCT01668017|Vitamins|vitamins|mesh-ancestor
14419475|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
14419476|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419477|NCT01668030|Bacitracin|bacitracin|mesh-list
14419478|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14419479|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419480|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14419481|NCT01668654|Ezogabine|ezogabine|mesh-list
14419482|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
14419483|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14419484|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419485|NCT01668667|Gabapentin|gabapentin|mesh-list
14419486|NCT01668667|Analgesics|analgesics|mesh-ancestor
14419487|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
14419488|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419489|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14744990|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
14744991|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419490|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
14419491|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14744992|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
14744993|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
14744994|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
14744995|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744996|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
14744997|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14419492|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14419493|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14419494|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14419495|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14419496|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14419497|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419498|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14744998|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
14744999|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745000|NCT00592618|Expectorants|expectorants|mesh-ancestor
14745001|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
14745002|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14745003|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
14745004|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745005|NCT00592618|Protective Agents|protective agents|mesh-ancestor
14745006|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745007|NCT00592618|Antidotes|antidotes|mesh-ancestor
14745008|NCT00592670|Fluoxetine|fluoxetine|mesh-list
14745009|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14745010|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14419499|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
14419500|NCT01668719|Dexamethasone|dexamethasone|mesh-list
14419501|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
14419502|NCT01668719|Lenalidomide|lenalidomide|mesh-list
14419503|NCT01668719|Bortezomib|bortezomib|mesh-list
14419504|NCT01668719|Elotuzumab|elotuzumab|mesh-list
14419505|NCT01668719|Ichthammol|ichthammol|mesh-list
14419506|NCT01668719|BB 1101|bb 1101|mesh-list
14419507|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419508|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
14419509|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
14419510|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745011|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745012|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926160|NCT01408186|Famotidine|famotidine|mesh-list
14926161|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14926162|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926163|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14926164|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419511|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419512|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419513|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
14419514|NCT01668719|Hormones|hormones|mesh-ancestor
14419515|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419516|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419517|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419518|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
14419519|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14419520|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14419521|NCT01668719|Growth Substances|growth substances|mesh-ancestor
14419522|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
14419523|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419524|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419525|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419526|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14419527|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
14419528|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
14419529|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419530|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745013|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419531|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419532|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
14419533|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
14745014|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
14745015|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745016|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14745017|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
14745018|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14419534|NCT01668836|Resveratrol|resveratrol|mesh-list
14419535|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
14419536|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419537|NCT01668836|Protective Agents|protective agents|mesh-ancestor
14419538|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419539|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419540|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14419541|NCT01669122|Nicotine|nicotine|mesh-list
14419542|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14419543|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
14419544|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419545|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419546|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14419547|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14419548|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
14419549|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419550|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419551|NCT01669343|Letrozole|letrozole|mesh-list
14419552|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419553|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14419554|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14419555|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419556|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419557|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14419558|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
14419559|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419560|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419561|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
14419562|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14419563|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
14419564|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419565|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419566|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14419567|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14419568|NCT01669434|Ramipril|ramipril|mesh-list
14419569|NCT01669434|Enalapril|enalapril|mesh-list
14419570|NCT01669434|Enalaprilat|enalaprilat|mesh-list
14419571|NCT01669434|Lisinopril|lisinopril|mesh-list
14419572|NCT01669434|Perindopril|perindopril|mesh-list
14419573|NCT01669434|Benazepril|benazepril|mesh-list
14419574|NCT01669434|Captopril|captopril|mesh-list
14419575|NCT01669434|Quinapril|quinapril|mesh-list
14419576|NCT01669434|Trandolapril|trandolapril|mesh-list
14419577|NCT01669434|Fosinopril|fosinopril|mesh-list
14419578|NCT01669434|Moexipril|moexipril|mesh-list
14419579|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14926165|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926166|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14926167|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
14926168|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
14419580|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419581|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419582|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419583|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14419584|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14419585|NCT01669434|Protective Agents|protective agents|mesh-ancestor
14419586|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419587|NCT01669538|Galantamine|galantamine|mesh-list
14419588|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14419589|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419590|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419591|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
14419592|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419593|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419594|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14419595|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
14419596|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419597|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
14419598|NCT01669642|Ketamine|ketamine|mesh-list
14419599|NCT01669642|Analgesics|analgesics|mesh-ancestor
14419600|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
14419601|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419602|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419603|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14926169|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419604|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14419605|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
14419606|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
14745019|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14745020|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14745021|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753435|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753436|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753437|NCT05168657|Pancrelipase|pancrelipase|mesh-list
14419607|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14419608|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14419609|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14419610|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419611|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753438|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419612|NCT01669720|Aflibercept|aflibercept|mesh-list
14419613|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14419614|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14419615|NCT01669720|Growth Substances|growth substances|mesh-ancestor
14419616|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753439|NCT05161208|Varenicline|varenicline|mesh-list
14419617|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
14419618|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419619|NCT01669785|Listerine|listerine|mesh-list
14419620|NCT01669785|Fluorides|fluorides|mesh-list
14745022|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
14745023|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
14745024|NCT00592917|Calcium|calcium|mesh-list
14745025|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745026|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745027|NCT00592917|Vitamins|vitamins|mesh-ancestor
14745028|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
14745029|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14745030|NCT00592917|Antacids|antacids|mesh-ancestor
14745031|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745032|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745033|NCT00592930|Olanzapine|olanzapine|mesh-list
14745034|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
14745035|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
14745036|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745037|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745038|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419621|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
14419622|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
14419623|NCT01669785|Protective Agents|protective agents|mesh-ancestor
14419624|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419625|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14419626|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419627|NCT01669798|Nintedanib|nintedanib|mesh-list
14419628|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419629|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419630|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419631|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419632|NCT01669811|Esomeprazole|esomeprazole|mesh-list
14745039|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14745040|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14745041|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745042|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745043|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14419633|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14419634|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419635|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14745044|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14745045|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753440|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14745046|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745047|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745048|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
14745049|NCT00592969|Metformin|metformin|mesh-list
14745050|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
14419636|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419637|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419638|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
14419639|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
14419640|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
14419641|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14745051|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
14745052|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745053|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745054|NCT00593008|Gemcitabine|gemcitabine|mesh-list
14745055|NCT00593008|Sirolimus|sirolimus|mesh-list
14745056|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419642|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14419643|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14419644|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419645|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419646|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419647|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419648|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14419649|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14419650|NCT01670019|Asenapine|asenapine|mesh-list
14419651|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14419652|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14419653|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14419654|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419655|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14419656|NCT01670097|Dexamethasone|dexamethasone|mesh-list
14419657|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419658|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
14419659|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
14745057|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
14745058|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745059|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745060|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
14419660|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419661|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419662|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14753441|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14419663|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
14419664|NCT01670097|Hormones|hormones|mesh-ancestor
14419665|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419666|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419667|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419668|NCT01670110|Pasireotide|pasireotide|mesh-list
14419669|NCT01670110|Hormones|hormones|mesh-ancestor
14419670|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419671|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419672|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
14419673|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
14419674|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419675|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419676|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419677|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
14419678|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
14419679|NCT01670526|Rivastigmine|rivastigmine|mesh-list
14419680|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14419681|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419682|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419683|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
14419684|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419685|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419686|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14419687|NCT01670526|Protective Agents|protective agents|mesh-ancestor
14419688|NCT01670721|Leucovorin|leucovorin|mesh-list
14419689|NCT01670721|Fluorouracil|fluorouracil|mesh-list
14926170|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926171|NCT01408199|Lenalidomide|lenalidomide|mesh-list
14926172|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
14926173|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926174|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14926175|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14926176|NCT01408199|Growth Substances|growth substances|mesh-ancestor
14926177|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
14926178|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926179|NCT01408290|Vaccines|vaccines|mesh-list
14926180|NCT01408290|Immunologic Factors|immunologic factors|mesh-ancestor
14926181|NCT01408290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926182|NCT01408342|Rituximab|rituximab|mesh-list
14926183|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
14926184|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926185|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419690|NCT01670721|Irinotecan|irinotecan|mesh-list
14419691|NCT01670721|Aflibercept|aflibercept|mesh-list
14419692|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
14419693|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419694|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14419695|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419696|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419697|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
14419698|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419699|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14419700|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14419701|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419702|NCT01670721|Antidotes|antidotes|mesh-ancestor
14419703|NCT01670721|Protective Agents|protective agents|mesh-ancestor
14419704|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
14419705|NCT01670721|Vitamins|vitamins|mesh-ancestor
14419706|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
14419707|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14419708|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14419709|NCT01670721|Growth Substances|growth substances|mesh-ancestor
14419710|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
14419711|NCT01671280|Azithromycin|azithromycin|mesh-list
14419712|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14419713|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419714|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
14419715|NCT01671319|Docetaxel|docetaxel|mesh-list
14419716|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419717|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
14419718|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419719|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14419720|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14419721|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
14419722|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419723|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419724|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14419725|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
14419726|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
14419727|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
14419728|NCT01671332|Suramin|suramin|mesh-list
14419729|NCT01671332|Docetaxel|docetaxel|mesh-list
14419730|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419731|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14419732|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14419733|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14419734|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419735|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
14419736|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
14419737|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14419738|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419739|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14419740|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14419741|NCT01671423|Prednisone|prednisone|mesh-list
14419742|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419743|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
14419744|NCT01671423|Hormones|hormones|mesh-ancestor
14419745|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419746|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419747|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419748|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419749|NCT01671488|Mitomycins|mitomycins|mesh-list
14419750|NCT01671488|Mitomycin|mitomycin|mesh-list
14419751|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14419752|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419753|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
14419754|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419755|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14419756|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419757|NCT01672710|Niacin|niacin|mesh-list
14419758|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14419759|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
14419760|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419761|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14419762|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
14419763|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
14419764|NCT01672710|Vitamins|vitamins|mesh-ancestor
14419765|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
14419766|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419767|NCT01672723|Naltrexone|naltrexone|mesh-list
14419768|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14419769|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14419770|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419771|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
14419772|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419773|NCT01672736|Dexamethasone|dexamethasone|mesh-list
14419774|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
14419775|NCT01672736|Bortezomib|bortezomib|mesh-list
14419776|NCT01672736|BB 1101|bb 1101|mesh-list
14419777|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419778|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
14419779|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
14419780|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419781|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419782|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419783|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
14419784|NCT01672736|Hormones|hormones|mesh-ancestor
14419785|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419786|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419787|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419788|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419789|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419790|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419791|NCT01672788|Metformin|metformin|mesh-list
14419792|NCT01672788|Empagliflozin|empagliflozin|mesh-list
14419793|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14419794|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419795|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14419796|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419797|NCT01672801|Nimodipine|nimodipine|mesh-list
14419798|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14419799|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14419800|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14419801|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419802|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14419803|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419804|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
14419805|NCT01672827|Flutemetamol|flutemetamol|mesh-list
14419806|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14419807|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468017|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468018|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468019|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468020|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468021|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
14468022|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14468023|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14468024|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14468025|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14468026|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468027|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468028|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
14468029|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468030|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468031|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14468032|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468033|NCT02270944|Vaccines|vaccines|mesh-list
14468034|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
14468035|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468036|NCT02270983|Linaclotide|linaclotide|mesh-list
14468037|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14468038|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
14468039|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468040|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14468041|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
14468042|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14468043|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468044|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468045|NCT02271425|Evacetrapib|evacetrapib|mesh-list
14468046|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14468047|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14468048|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
14468049|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468050|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14468051|NCT02271698|Dexamethasone|dexamethasone|mesh-list
14468052|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
14468053|NCT02271698|BB 1101|bb 1101|mesh-list
14468054|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468055|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
14468056|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
14468057|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468058|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468059|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14468060|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
14468061|NCT02271698|Hormones|hormones|mesh-ancestor
14468062|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468063|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419808|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
14419809|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14419810|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14419811|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419812|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14419813|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
14419814|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14419815|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419816|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419817|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419818|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
14419819|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419820|NCT01672983|Ritonavir|ritonavir|mesh-list
14419821|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14419822|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14419823|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419824|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419825|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419826|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14419827|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14419828|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
14419829|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419830|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14419831|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14419832|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
14419833|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419834|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419835|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419836|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419837|NCT01673191|Dexamethasone|dexamethasone|mesh-list
14419838|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
14419839|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14419840|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14419841|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
14419842|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
14419843|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419844|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419845|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14419846|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
14419847|NCT01673191|Hormones|hormones|mesh-ancestor
14419848|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419849|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419850|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419851|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14419852|NCT01673282|Lacosamide|lacosamide|mesh-list
14419853|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
14419854|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14419855|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14419856|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14419857|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419858|NCT01673386|Sunitinib|sunitinib|mesh-list
14419859|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419860|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14419861|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14419862|NCT01673386|Growth Substances|growth substances|mesh-ancestor
14419863|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419864|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
14419865|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419866|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419867|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419868|NCT01673490|Tamsulosin|tamsulosin|mesh-list
14419869|NCT01673490|Dutasteride|dutasteride|mesh-list
14419870|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14419871|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14419872|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14419873|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
14419874|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419875|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419876|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419877|NCT01673490|Urological Agents|urological agents|mesh-ancestor
14419878|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14419879|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14419880|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419881|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
14419882|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419883|NCT01673594|Naltrexone|naltrexone|mesh-list
14926186|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
14419884|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14419885|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14926187|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926188|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14926189|NCT01408394|Ecopipam|ecopipam|mesh-list
14926190|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14926191|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14926192|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926193|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419886|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419887|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
14419888|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14419889|NCT01673646|Pasireotide|pasireotide|mesh-list
14419890|NCT01673646|Hormones|hormones|mesh-ancestor
14419891|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14419892|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419893|NCT01673828|Pregnanolone|pregnanolone|mesh-list
14419894|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14419895|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
14419896|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14419897|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419898|NCT01673854|Ipilimumab|ipilimumab|mesh-list
14419899|NCT01673854|Vemurafenib|vemurafenib|mesh-list
14419900|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14419901|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419902|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14419903|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419904|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14419905|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419906|NCT01673984|Goserelin|goserelin|mesh-list
14419907|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14419908|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14419909|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419910|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
14419911|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14419912|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
14419913|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14419914|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419915|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14419916|NCT01674010|Inositol|inositol|mesh-list
14419917|NCT01674010|Lamotrigine|lamotrigine|mesh-list
14419918|NCT01674010|Valproic Acid|valproic acid|mesh-list
14419919|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
14419920|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14419921|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14419922|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419923|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745061|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419924|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419925|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14419926|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14419927|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14419928|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14419929|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14419930|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419931|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
14419932|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419933|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
14419934|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
14419935|NCT01674010|Vitamins|vitamins|mesh-ancestor
14419936|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
14419937|NCT01674062|Trastuzumab|trastuzumab|mesh-list
14419938|NCT01674062|Pertuzumab|pertuzumab|mesh-list
14419939|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14419940|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419941|NCT01674569|Ranibizumab|ranibizumab|mesh-list
14419942|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14419943|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14419944|NCT01674569|Growth Substances|growth substances|mesh-ancestor
14419945|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419946|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
14419947|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14419948|NCT01674621|Abaloparatide|abaloparatide|mesh-list
14419949|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14419950|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14419951|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745062|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419952|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14419953|NCT01674647|Vitamin K|vitamin k|mesh-list
14419954|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
14419955|NCT01674647|Vitamins|vitamins|mesh-ancestor
14745063|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926194|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14926195|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14926196|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
14745064|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
14926197|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926198|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926199|NCT01408446|Menthol|menthol|mesh-list
14926200|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
14926201|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926202|NCT01408498|Testosterone|testosterone|mesh-list
14926203|NCT01408498|Androgens|androgens|mesh-ancestor
14745065|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926204|NCT01408498|Hormones|hormones|mesh-ancestor
14926205|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926206|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926207|NCT01408524|Diltiazem|diltiazem|mesh-list
14926208|NCT01408524|Labetalol|labetalol|mesh-list
14926209|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14419956|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
14419957|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419958|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14419959|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
14419960|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14419961|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
14419962|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419963|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419964|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
14745066|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745067|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745068|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
14745069|NCT00593060|Sirolimus|sirolimus|mesh-list
14745070|NCT00593060|Cetuximab|cetuximab|mesh-list
14745071|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14745072|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745073|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745074|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745075|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745076|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
14745077|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14419965|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14419966|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14419967|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
14419968|NCT01674647|Coagulants|coagulants|mesh-ancestor
14419969|NCT01674712|Simvastatin|simvastatin|mesh-list
14419970|NCT01674712|Fenofibrate|fenofibrate|mesh-list
14419971|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14419972|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14419973|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
14419974|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419975|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14419976|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14419977|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14419978|NCT01674725|Ribavirin|ribavirin|mesh-list
14419979|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
14419980|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419981|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
14419982|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14419983|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
14419984|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
14419985|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
14419986|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745078|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
14745079|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419987|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14419988|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
14419989|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
14419990|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14419991|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14419992|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14419993|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14419994|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
14419995|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14745080|NCT00593099|Bupropion|bupropion|mesh-list
14745081|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14745082|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
14745083|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14419996|NCT01675128|Irinotecan|irinotecan|mesh-list
14419997|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14419998|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14419999|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420000|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420001|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420002|NCT01675141|Lenalidomide|lenalidomide|mesh-list
14420003|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
14420004|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420005|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14420006|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14420007|NCT01675141|Growth Substances|growth substances|mesh-ancestor
14420008|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
14420009|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420010|NCT01675154|Orlistat|orlistat|mesh-list
14420011|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420012|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420013|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14420014|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14420015|NCT01675167|Buprenorphine|buprenorphine|mesh-list
14420016|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14420017|NCT01675167|Narcotics|narcotics|mesh-ancestor
14420018|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420019|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420020|NCT01675167|Analgesics|analgesics|mesh-ancestor
14420021|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
14420022|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420023|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14420024|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
14420025|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
14420026|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
14420027|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14420028|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420029|NCT01675297|Vitamins|vitamins|mesh-ancestor
14420030|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
14420031|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14420032|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14420033|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420034|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420035|NCT01675531|Oxycodone|oxycodone|mesh-list
14420036|NCT01675531|Naloxone|naloxone|mesh-list
14420037|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14420038|NCT01675531|Narcotics|narcotics|mesh-ancestor
14420039|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420040|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420041|NCT01675531|Analgesics|analgesics|mesh-ancestor
14420042|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
14420043|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420044|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14420045|NCT01675622|Morphine|morphine|mesh-list
14420046|NCT01675622|Oxycodone|oxycodone|mesh-list
14420047|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14420048|NCT01675622|Narcotics|narcotics|mesh-ancestor
14420049|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420050|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745084|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14745085|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14420051|NCT01675622|Analgesics|analgesics|mesh-ancestor
14420052|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
14420053|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420054|NCT01675635|Morphine|morphine|mesh-list
14420055|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14420056|NCT01675635|Narcotics|narcotics|mesh-ancestor
14420057|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420058|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420059|NCT01675635|Analgesics|analgesics|mesh-ancestor
14420060|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
14420061|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420062|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
14420063|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14420064|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
14420065|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420066|NCT01675661|Expectorants|expectorants|mesh-ancestor
14420067|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
14420068|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14420069|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
14420070|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420071|NCT01675661|Protective Agents|protective agents|mesh-ancestor
14420072|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420073|NCT01675661|Antidotes|antidotes|mesh-ancestor
14420074|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
14420075|NCT01675765|Cisplatin|cisplatin|mesh-list
14420076|NCT01675765|Pemetrexed|pemetrexed|mesh-list
14420077|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
14420078|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420079|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420080|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420081|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14420082|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
14420083|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420084|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420085|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14745086|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745087|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745088|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
14745089|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745090|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745091|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14745092|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14745093|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745094|NCT00593125|Levetiracetam|levetiracetam|mesh-list
14745095|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
14745096|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
14926210|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14926211|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926212|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926213|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14926214|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926215|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
14926216|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14926217|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14926218|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
14420086|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420087|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14420088|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14420089|NCT01675778|Hydromorphone|hydromorphone|mesh-list
14420090|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14420091|NCT01675778|Narcotics|narcotics|mesh-ancestor
14420092|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420093|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420094|NCT01675778|Analgesics|analgesics|mesh-ancestor
14420095|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
14420096|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420097|NCT01676116|Liraglutide|liraglutide|mesh-list
14420098|NCT01676116|Exenatide|exenatide|mesh-list
14420099|NCT01676116|Xultophy|xultophy|mesh-list
14420100|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420101|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420102|NCT01676116|Incretins|incretins|mesh-ancestor
14420103|NCT01676116|Hormones|hormones|mesh-ancestor
14420104|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420105|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14420106|NCT01676220|Insulin|insulin|mesh-list
14420107|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14420108|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
14420109|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420110|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420111|NCT01676311|Huperzine A|huperzine a|mesh-list
14420112|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14420113|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420114|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420115|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14420116|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420117|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420118|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14420119|NCT01676311|Protective Agents|protective agents|mesh-ancestor
14420120|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
14420121|NCT01676415|Prednisone|prednisone|mesh-list
14420122|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
14420123|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420124|NCT01676415|Hormones|hormones|mesh-ancestor
14420125|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420126|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420127|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14420128|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420129|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
14420130|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14420131|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
14420132|NCT01677195|Antacids|antacids|mesh-ancestor
14420133|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420134|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14420135|NCT01677286|Doxycycline|doxycycline|mesh-list
14420136|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14420137|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420138|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
14420139|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14420140|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14420141|NCT01677299|Metformin|metformin|mesh-list
14420142|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420143|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420144|NCT01677377|Risperidone|risperidone|mesh-list
14420145|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14420146|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
14420147|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420148|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420149|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420150|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14420151|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14420152|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420153|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14420154|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14420155|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
14420156|NCT01677507|Timolol|timolol|mesh-list
14420157|NCT01677507|Latanoprost|latanoprost|mesh-list
14420158|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14420159|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14420160|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
14420161|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420162|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420163|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420164|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14420165|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14420166|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14420167|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14420168|NCT01677741|Dabrafenib|dabrafenib|mesh-list
14420169|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420170|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420171|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420172|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420173|NCT01677858|Dexamethasone|dexamethasone|mesh-list
14420174|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420175|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
14420176|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
14420177|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420178|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420179|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14420180|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
14420181|NCT01677858|Hormones|hormones|mesh-ancestor
14420182|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420183|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14420184|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420185|NCT01677988|Folfirinox|folfirinox|mesh-list
14420186|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420187|NCT01678131|Ribavirin|ribavirin|mesh-list
14420188|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14420189|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
14420190|NCT01678131|Liver Extracts|liver extracts|mesh-list
14420191|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
14420192|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420193|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
14420194|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420195|NCT01678131|Hematinics|hematinics|mesh-ancestor
14420196|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420197|NCT01678209|Methylphenidate|methylphenidate|mesh-list
14420198|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14420199|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14420200|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420201|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14420202|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14420203|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420204|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420205|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
14420206|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420207|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14420208|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14420209|NCT01678313|Celecoxib|celecoxib|mesh-list
14420210|NCT01678313|Doxazosin|doxazosin|mesh-list
14745097|NCT00593138|Methylphenidate|methylphenidate|mesh-list
14420211|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14745098|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14745099|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14745100|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745101|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14420212|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14420213|NCT01678313|Analgesics|analgesics|mesh-ancestor
14745102|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14745103|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745104|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745105|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
14745106|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745107|NCT00593151|Interferons|interferons|mesh-list
14745108|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
14745109|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
14420214|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
14745110|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14745111|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745112|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
14745113|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745114|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
14420215|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420216|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420217|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420218|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420219|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14420220|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14420221|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420222|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420223|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14420224|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14420225|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14420226|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14420227|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
14420228|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420229|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14420230|NCT01678443|Antibodies|antibodies|mesh-list
14420231|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
14420232|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14420233|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
14420234|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420235|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420236|NCT01678794|Candesartan|candesartan|mesh-list
14420237|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14420238|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14420239|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14420240|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420241|NCT01678820|Metformin|metformin|mesh-list
14420242|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14420243|NCT01678820|Glimepiride|glimepiride|mesh-list
14420244|NCT01678820|Simvastatin|simvastatin|mesh-list
14420245|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420246|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420247|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14420248|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14420249|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
14420250|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420251|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14420252|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14420253|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420254|NCT01678820|Incretins|incretins|mesh-ancestor
14420255|NCT01678820|Hormones|hormones|mesh-ancestor
14420256|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420257|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14420258|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
14420259|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14420260|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420261|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
14420262|NCT01678911|Gabapentin|gabapentin|mesh-list
14420263|NCT01678911|Analgesics|analgesics|mesh-ancestor
14420264|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
14926219|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926220|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
14926221|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
14926222|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926223|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14926224|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14420265|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420266|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420267|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
14420268|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14420269|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14420270|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420271|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745115|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745116|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
14745117|NCT00593164|Analgesics|analgesics|mesh-ancestor
14745118|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
14745119|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745120|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745121|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
14926225|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14753442|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
14745122|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745123|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14745124|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
14745125|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14420272|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14420273|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14420274|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420275|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420276|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
14420277|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14420278|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
14420279|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
14420280|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14420281|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14420282|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420283|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420284|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14420285|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14420286|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14420287|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
14420288|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
14420289|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14420290|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14420291|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420292|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420293|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14420294|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14468064|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468065|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14468066|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468067|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468068|NCT02271854|Diclofenac|diclofenac|mesh-list
14468069|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14468070|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468071|NCT02271854|Analgesics|analgesics|mesh-ancestor
14468072|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
14468073|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468074|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468075|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468076|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468077|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14468078|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468079|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468080|NCT02271906|Afatinib|afatinib|mesh-list
14468081|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468082|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14468083|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468084|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468085|NCT02271984|Praziquantel|praziquantel|mesh-list
14468086|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
14468087|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14468088|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468089|NCT02272413|Bevacizumab|bevacizumab|mesh-list
14745126|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420295|NCT01679405|Gemcitabine|gemcitabine|mesh-list
14420296|NCT01679405|Cisplatin|cisplatin|mesh-list
14420297|NCT01679405|Afatinib|afatinib|mesh-list
14420298|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420299|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14420300|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
14420301|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420302|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
14420303|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420304|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420305|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420306|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
14420307|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420308|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420309|NCT01679613|Ketoconazole|ketoconazole|mesh-list
14420310|NCT01679613|Nintedanib|nintedanib|mesh-list
14420311|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
14420312|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420313|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14420314|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14420315|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420316|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420317|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14420318|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
14420319|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420320|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420321|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14420322|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420323|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420324|NCT01680172|Ketamine|ketamine|mesh-list
14420325|NCT01680172|Analgesics|analgesics|mesh-ancestor
14420326|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
14420327|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420328|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420329|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14420330|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14420331|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
14420332|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
14420333|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420334|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14420335|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14420336|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420337|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420338|NCT01680341|Insulin|insulin|mesh-list
14420339|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14420340|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
14420341|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
14420342|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14420343|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420344|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420345|NCT01680458|Fluconazole|fluconazole|mesh-list
14420346|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
14745127|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745128|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745129|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
14745130|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14745131|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
14745132|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745133|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745134|NCT00593255|Insulin|insulin|mesh-list
14745135|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14745136|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
14745137|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
14745138|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
14745139|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
14745140|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745141|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745142|NCT00593294|Drospirenone|drospirenone|mesh-list
14420347|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420348|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14420349|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14420350|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420351|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420352|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14420353|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
14420354|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420355|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420356|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14420357|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14420358|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
14420359|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14420360|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
14420361|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420362|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
14420363|NCT01680497|Protective Agents|protective agents|mesh-ancestor
14420364|NCT01680549|Gabapentin|gabapentin|mesh-list
14420365|NCT01680549|Analgesics|analgesics|mesh-ancestor
14420366|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
14420367|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745143|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14420368|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420369|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
14420370|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14420371|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14420372|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420373|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14420374|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14420375|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14420376|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420377|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420378|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
14420379|NCT01680653|Glucagon|glucagon|mesh-list
14420380|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14926226|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14926227|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14926228|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926229|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926230|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
14926231|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926232|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926233|NCT01408680|Ubiquinone|ubiquinone|mesh-list
14745144|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745145|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14420381|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14420382|NCT01680653|Hormones|hormones|mesh-ancestor
14420383|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420384|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420385|NCT01680653|Incretins|incretins|mesh-ancestor
14420386|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
14420387|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
14420388|NCT01680861|Everolimus|everolimus|mesh-list
14420389|NCT01680861|Tacrolimus|tacrolimus|mesh-list
14420390|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420391|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
14420392|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420393|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14420394|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420395|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420396|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420397|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745146|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
14745147|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745148|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14745149|NCT00593294|Diuretics|diuretics|mesh-ancestor
14745150|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
14745151|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14745152|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14745153|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14745154|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
14745155|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14745156|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14745157|NCT00593294|Estrogens|estrogens|mesh-ancestor
14745158|NCT00593294|Hormones|hormones|mesh-ancestor
14745159|NCT00593463|Cycloserine|cycloserine|mesh-list
14745160|NCT00593463|Verapamil|verapamil|mesh-list
14745161|NCT00593463|Diltiazem|diltiazem|mesh-list
14745162|NCT00593463|Isradipine|isradipine|mesh-list
14745163|NCT00593463|Nifedipine|nifedipine|mesh-list
14745164|NCT00593463|Gabapentin|gabapentin|mesh-list
14745165|NCT00593463|Naloxone|naloxone|mesh-list
14745166|NCT00593463|Analgesics|analgesics|mesh-ancestor
14745167|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
14420398|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14745168|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745169|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420399|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
14420400|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14420401|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420402|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420403|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
14420404|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
14420405|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420406|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14420407|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
14420408|NCT01680861|Hormones|hormones|mesh-ancestor
14420409|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420410|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14420411|NCT01680861|Protective Agents|protective agents|mesh-ancestor
14420412|NCT01680887|Varenicline|varenicline|mesh-list
14420413|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14926234|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
14926235|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
14926236|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926237|NCT01408680|Vitamins|vitamins|mesh-ancestor
14926238|NCT01408797|Bortezomib|bortezomib|mesh-list
14926239|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926240|NCT01408810|Infliximab|infliximab|mesh-list
14926241|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
14745170|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
14745171|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14745172|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14745173|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745174|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745175|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14745176|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14745177|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745178|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745179|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
14926242|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926243|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420414|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14926244|NCT01408836|Prednisolone|prednisolone|mesh-list
14420415|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
14745180|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14745181|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14745182|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745183|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745184|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
14745185|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
14745186|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14745187|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14745188|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745189|NCT00593463|Renal Agents|renal agents|mesh-ancestor
14420416|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745190|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14926245|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14926246|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
14926247|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14926248|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
14926249|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14926250|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
14420417|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420418|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420419|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14420420|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
14420421|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14420422|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14420423|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14420424|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420425|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420426|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420427|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
14420428|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420429|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14420430|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14420431|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
14420432|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14420433|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420434|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14420435|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
14926251|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420436|NCT01681030|Coagulants|coagulants|mesh-ancestor
14420437|NCT01681095|Tryptophan|tryptophan|mesh-list
14420438|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14420439|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
14420440|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14420441|NCT01681186|Lansoprazole|lansoprazole|mesh-list
14420442|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
14420443|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14420444|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14420445|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14420446|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420447|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420448|NCT01681212|Ipilimumab|ipilimumab|mesh-list
14420449|NCT01681212|Dacarbazine|dacarbazine|mesh-list
14420450|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14420451|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420452|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14420453|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420454|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14420455|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
14420456|NCT01681433|Prednisone|prednisone|mesh-list
14420457|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
14420458|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420459|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
14420460|NCT01681433|Hormones|hormones|mesh-ancestor
14420461|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420462|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420463|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14420464|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420465|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14420466|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420467|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420468|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
14420469|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14420470|NCT01681472|Leucovorin|leucovorin|mesh-list
14420471|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
14420472|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
14420473|NCT01681472|Antidotes|antidotes|mesh-ancestor
14420474|NCT01681472|Protective Agents|protective agents|mesh-ancestor
14420475|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420476|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
14420477|NCT01681472|Vitamins|vitamins|mesh-ancestor
14420478|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
14420479|NCT01681576|Valsartan|valsartan|mesh-list
14420480|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14420481|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14926252|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
14420482|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14420483|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14420484|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420485|NCT01681849|Paroxetine|paroxetine|mesh-list
14420486|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14420487|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14420488|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420489|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420490|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420491|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
14420492|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420493|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14420494|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
14420495|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14420496|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14420497|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14420498|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420499|NCT01681992|Vaccines|vaccines|mesh-list
14420500|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
14420501|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420502|NCT01682031|Selenium|selenium|mesh-list
14420503|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
14420504|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420505|NCT01682031|Protective Agents|protective agents|mesh-ancestor
14420506|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420507|NCT01682031|Trace Elements|trace elements|mesh-ancestor
14420508|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
14420509|NCT01682044|Rituximab|rituximab|mesh-list
14420510|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14420511|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420512|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
14420513|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420514|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420515|NCT01682083|Trametinib|trametinib|mesh-list
14420516|NCT01682083|Dabrafenib|dabrafenib|mesh-list
14420517|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420518|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420519|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420520|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420521|NCT01682135|Ramucirumab|ramucirumab|mesh-list
14420522|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420523|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
14420524|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14420525|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14745191|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
14745192|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745193|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
14420526|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14420527|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420528|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420529|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
14420530|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420531|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420532|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14420533|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420534|NCT01682213|Dabrafenib|dabrafenib|mesh-list
14420535|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420536|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420537|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420538|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745194|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14745195|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14745196|NCT00593502|Oseltamivir|oseltamivir|mesh-list
14745197|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
14745198|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745199|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745200|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745201|NCT00593567|Levofloxacin|levofloxacin|mesh-list
14745202|NCT00593567|Ofloxacin|ofloxacin|mesh-list
14745203|NCT00593567|Gentamicins|gentamicins|mesh-list
14745204|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14745205|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745206|NCT00593567|Renal Agents|renal agents|mesh-ancestor
14745207|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745208|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14745209|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14745210|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420539|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14420540|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
14420541|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14420542|NCT01682512|Rituximab|rituximab|mesh-list
14420543|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14420544|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420545|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
14420546|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420547|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420548|NCT01682538|Nitisinone|nitisinone|mesh-list
14420549|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420550|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420551|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
14420552|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14420553|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14420554|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14420555|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420556|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420557|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
14420558|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420559|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420560|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14420561|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420562|NCT01682642|Goserelin|goserelin|mesh-list
14420563|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14420564|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420565|NCT01682681|Topiramate|topiramate|mesh-list
14420566|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
14420567|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420568|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420569|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
14420570|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
14420571|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420572|NCT01682759|Metformin|metformin|mesh-list
14420573|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
14420574|NCT01682759|Glimepiride|glimepiride|mesh-list
14420575|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420576|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420577|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14420578|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420579|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
14420580|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14420581|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14420582|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14745211|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745212|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745213|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14420583|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
14420584|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
14420585|NCT01682837|Citric Acid|citric acid|mesh-list
14420586|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
14745214|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14745215|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14745216|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
14745217|NCT00593580|Alendronate|alendronate|mesh-list
14745218|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745219|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745220|NCT00593580|Vitamins|vitamins|mesh-ancestor
14745221|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
14745222|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14745223|NCT00593619|Iron|iron|mesh-list
14745224|NCT00593619|Dextrans|dextrans|mesh-list
14926253|NCT01408836|Hormones|hormones|mesh-ancestor
14926254|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926255|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926256|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14926257|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926258|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
14926259|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
14926260|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926261|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926262|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14926263|NCT01408836|Protective Agents|protective agents|mesh-ancestor
14926264|NCT01408849|Omeprazole|omeprazole|mesh-list
14926265|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14420587|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
14745225|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14745226|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
14745227|NCT00593619|Trace Elements|trace elements|mesh-ancestor
14420588|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14745228|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
14926266|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745229|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420589|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
14420590|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
14420591|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420592|NCT01682837|Diuretics|diuretics|mesh-ancestor
14420593|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
14745230|NCT00593619|Hematinics|hematinics|mesh-ancestor
14745231|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
14745232|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
14745233|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
14745234|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
14745235|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14745236|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745237|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745238|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14745239|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14745240|NCT00593658|Protective Agents|protective agents|mesh-ancestor
14745241|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745242|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
14745243|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14420594|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420595|NCT01682837|Expectorants|expectorants|mesh-ancestor
14420596|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
14420597|NCT01682837|Cathartics|cathartics|mesh-ancestor
14420598|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14420599|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
14420600|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14420601|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14420602|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14420603|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
14420604|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420605|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420606|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420607|NCT01683058|Aripiprazole|aripiprazole|mesh-list
14420608|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
14420609|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14420610|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14420611|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14420612|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420613|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420614|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
14420615|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
14420616|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420617|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420618|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14420619|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14420620|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
14420621|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14420622|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14420623|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14420624|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14745244|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
14745245|NCT00593697|Docetaxel|docetaxel|mesh-list
14745246|NCT00593697|Trastuzumab|trastuzumab|mesh-list
14745247|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745248|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
14745249|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
14745250|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
14420625|NCT01683071|Bupivacaine|bupivacaine|mesh-list
14420626|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
14420627|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
14420628|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420629|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420630|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
14420631|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420632|NCT01683266|Insulin|insulin|mesh-list
14420633|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14420634|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
14420635|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420636|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420637|NCT01683331|Insulin|insulin|mesh-list
14420638|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420639|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420640|NCT01683422|Gemcitabine|gemcitabine|mesh-list
14420641|NCT01683422|Capecitabine|capecitabine|mesh-list
14420642|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14420643|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14420644|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
14420645|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420646|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420647|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
14420648|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420649|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420650|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420651|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
14420652|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420653|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420654|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
14420655|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14420656|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420657|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420658|NCT01683994|Prednisone|prednisone|mesh-list
14420659|NCT01683994|Docetaxel|docetaxel|mesh-list
14420660|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745251|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420661|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
14420662|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
14420663|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
14420664|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420665|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420666|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
14420667|NCT01683994|Hormones|hormones|mesh-ancestor
14420668|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420669|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420670|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14420671|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14420672|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
14420673|NCT01684020|Coagulants|coagulants|mesh-ancestor
14420674|NCT01684202|Tolvaptan|tolvaptan|mesh-list
14420675|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14420676|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420677|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
14420678|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420679|NCT01684215|Letrozole|letrozole|mesh-list
14420680|NCT01684215|Palbociclib|palbociclib|mesh-list
14420681|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420682|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14420683|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14420684|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420685|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420686|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14420687|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
14420688|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420689|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420690|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420691|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
14420692|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14420693|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
14420694|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420695|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420696|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14420697|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14420698|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
14420699|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14420700|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
14420701|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14420702|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
14420703|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420704|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745252|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14745253|NCT00593710|Losartan|losartan|mesh-list
14926267|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14926268|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420705|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
14420706|NCT01684722|Vitamin D|vitamin d|mesh-list
14420707|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
14420708|NCT01684722|Vitamins|vitamins|mesh-list
14420709|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
14420710|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420711|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14420712|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14420713|NCT01684748|Olmesartan|olmesartan|mesh-list
14420714|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14420715|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14420716|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14420717|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14420718|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926269|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926270|NCT01408927|Aspirin|aspirin|mesh-list
14926271|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14926272|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14745254|NCT00593710|Atenolol|atenolol|mesh-list
14745255|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14745256|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14420719|NCT01684878|Gemcitabine|gemcitabine|mesh-list
14420720|NCT01684878|Paclitaxel|paclitaxel|mesh-list
14420721|NCT01684878|Topotecan|topotecan|mesh-list
14420722|NCT01684878|Pertuzumab|pertuzumab|mesh-list
14420723|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14420724|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420725|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
14420726|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
14420727|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
14420728|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420729|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14420730|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
14420731|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
14420732|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420733|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420734|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420735|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
14420736|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420737|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14420738|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14420739|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14420740|NCT01684943|Insulin|insulin|mesh-list
14420741|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420742|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420743|NCT01685060|Ceritinib|ceritinib|mesh-list
14420744|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420745|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420746|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420747|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420748|NCT01685073|Zolpidem|zolpidem|mesh-list
14420749|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14420750|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14420751|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420752|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420753|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14420754|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
14420755|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
14420756|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420757|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468090|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14468091|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468092|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14468093|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14468094|NCT02272413|Growth Substances|growth substances|mesh-ancestor
14468095|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468096|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
14468097|NCT02272725|Ibuprofen|ibuprofen|mesh-list
14468098|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14468099|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468100|NCT02272725|Analgesics|analgesics|mesh-ancestor
14468101|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
14468102|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468103|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468104|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468105|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468106|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14468107|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468108|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468109|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
14468110|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468111|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14468112|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468113|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468114|NCT02272816|Carboplatin|carboplatin|mesh-list
14468115|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468116|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
14468117|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
14468118|NCT02272842|Vitamins|vitamins|mesh-ancestor
14468119|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
14420758|NCT01685138|Ceritinib|ceritinib|mesh-list
14420759|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420760|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14420761|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420762|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420763|NCT01685203|Ribavirin|ribavirin|mesh-list
14420764|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
14420765|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420766|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
14420767|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420768|NCT01685242|Cetirizine|cetirizine|mesh-list
14420769|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14420770|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14420771|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14420772|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
14420773|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
14420774|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420775|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420776|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420777|NCT01685372|Vaccines|vaccines|mesh-list
14420778|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
14420779|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420780|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
14420781|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
14420782|NCT01685411|Busulfan|busulfan|mesh-list
14420783|NCT01685411|Allopurinol|allopurinol|mesh-list
14420784|NCT01685411|Levetiracetam|levetiracetam|mesh-list
14420785|NCT01685411|Tacrolimus|tacrolimus|mesh-list
14420786|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14420787|NCT01685411|Lenograstim|lenograstim|mesh-list
14420788|NCT01685411|Sargramostim|sargramostim|mesh-list
14420789|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420790|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
14420791|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420792|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420793|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14420794|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
14420795|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420796|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420797|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14420798|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14420799|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14420800|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420801|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14420802|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14420803|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
14420804|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14420805|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420806|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
14420807|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
14420808|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
14420809|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
14420810|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14420811|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
14420812|NCT01685411|Protective Agents|protective agents|mesh-ancestor
14420813|NCT01685684|Oxycodone|oxycodone|mesh-list
14420814|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14420815|NCT01685684|Narcotics|narcotics|mesh-ancestor
14420816|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14420817|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420818|NCT01685684|Analgesics|analgesics|mesh-ancestor
14420819|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
14420820|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420821|NCT01685801|Ivacaftor|ivacaftor|mesh-list
14420822|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14420823|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420824|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420825|NCT01685983|Prednisolone|prednisolone|mesh-list
14420826|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
14420827|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420828|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
14420829|NCT01685983|Hormones|hormones|mesh-ancestor
14420830|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420831|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420832|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14420833|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420834|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14420835|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420836|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745257|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14745258|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14420837|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
14420838|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14420839|NCT01685996|Zonisamide|zonisamide|mesh-list
14420840|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
14420841|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14420842|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420843|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420844|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14420845|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420846|NCT01686152|Imiquimod|imiquimod|mesh-list
14745259|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745260|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
14745261|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
14745262|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420847|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14745263|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745264|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14420848|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
14420849|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420850|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420851|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
14420852|NCT01686165|Rituximab|rituximab|mesh-list
14420853|NCT01686165|Belinostat|belinostat|mesh-list
14420854|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14420855|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14420856|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420857|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
14420858|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420859|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420860|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14420861|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420862|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420863|NCT01686451|Simvastatin|simvastatin|mesh-list
14420864|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14420865|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14420866|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
14420867|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420868|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14420869|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14420870|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420871|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
14420872|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14420873|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14420874|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14420875|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14420876|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420877|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
14420878|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420879|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420880|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14420881|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420882|NCT01686633|Fluticasone|fluticasone|mesh-list
14420883|NCT01686633|Xhance|xhance|mesh-list
14420884|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420885|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14745265|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14745266|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14745267|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
14745268|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745269|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
14745270|NCT00593801|Hematinics|hematinics|mesh-ancestor
14745271|NCT00593853|Methylphenidate|methylphenidate|mesh-list
14745272|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14745273|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745274|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14745275|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14926273|NCT01408927|Analgesics|analgesics|mesh-ancestor
14420886|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
14745276|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926274|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
14926275|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926276|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926277|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926278|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14926279|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14926280|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14420887|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420888|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420889|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14420890|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
14420891|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
14420892|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14420893|NCT01686646|Acetaminophen|acetaminophen|mesh-list
14745277|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420894|NCT01686646|Caffeine|caffeine|mesh-list
14420895|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14420896|NCT01686646|Analgesics|analgesics|mesh-ancestor
14420897|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
14420898|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420899|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420900|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
14745278|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
14745279|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745280|NCT00593879|Mecamylamine|mecamylamine|mesh-list
14420901|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14420902|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14420903|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420904|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420905|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14420906|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14420907|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
14420908|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14420909|NCT01686828|Letrozole|letrozole|mesh-list
14420910|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
14420911|NCT01686828|Acyline|acyline|mesh-list
14420912|NCT01686828|Testosterone|testosterone|mesh-list
14420913|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
14420914|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
14420915|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14420916|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420917|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14420918|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14420919|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420920|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420921|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14420922|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
14420923|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420924|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420925|NCT01686828|Androgens|androgens|mesh-ancestor
14420926|NCT01686828|Hormones|hormones|mesh-ancestor
14420927|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14420928|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
14420929|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14420930|NCT01686932|Vildagliptin|vildagliptin|mesh-list
14420931|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14420932|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420933|NCT01686932|Incretins|incretins|mesh-ancestor
14420934|NCT01686932|Hormones|hormones|mesh-ancestor
14420935|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14420936|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14420937|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
14420938|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420939|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420940|NCT01687101|Menthol|menthol|mesh-list
14420941|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
14420942|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14420943|NCT01687166|Acifluorfen|acifluorfen|mesh-list
14420944|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420945|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420946|NCT01687179|Sirolimus|sirolimus|mesh-list
14420947|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
14420948|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14420949|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420950|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14420951|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14420952|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
14420953|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14420954|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
14420955|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420956|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
14420957|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14931112|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14420958|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14420959|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420960|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420961|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14420962|NCT01687218|Tenofovir|tenofovir|mesh-list
14420963|NCT01687218|Emtricitabine|emtricitabine|mesh-list
14420964|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14420965|NCT01687218|Glycerol|glycerol|mesh-list
14420966|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
14420967|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420968|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14420969|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14420970|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420971|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420972|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14926281|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926282|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14926283|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14926284|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14420973|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14420974|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14420975|NCT01687218|Protective Agents|protective agents|mesh-ancestor
14420976|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420977|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
14420978|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
14420979|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420980|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
14420981|NCT01687270|Ribavirin|ribavirin|mesh-list
14420982|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
14420983|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14420984|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
14420985|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14420986|NCT01687283|Fluticasone|fluticasone|mesh-list
14420987|NCT01687283|Xhance|xhance|mesh-list
14420988|NCT01687283|Budesonide|budesonide|mesh-list
14420989|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14420990|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14420991|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
14420992|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14420993|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14420994|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14420995|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
14420996|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14420997|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14420998|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
14420999|NCT01687283|Hormones|hormones|mesh-ancestor
14421000|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421001|NCT01687296|Fluticasone|fluticasone|mesh-list
14421002|NCT01687296|Xhance|xhance|mesh-list
14421003|NCT01687296|Prednisone|prednisone|mesh-list
14421004|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14421005|NCT01687296|Albuterol|albuterol|mesh-list
14421006|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421007|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
14926285|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
14421008|NCT01687296|Hormones|hormones|mesh-ancestor
14421009|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926286|NCT01408953|Bevacizumab|bevacizumab|mesh-list
14421010|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421011|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14421012|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421013|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421014|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
14745281|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14745282|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14745283|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
14745284|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421015|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421016|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421017|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421018|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421019|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14421020|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
14421021|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14421022|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14421023|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14421024|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14421025|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
14421026|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421027|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421028|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14421029|NCT01687400|Decitabine|decitabine|mesh-list
14421030|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14421031|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
14421032|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745285|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745286|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14745287|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14745288|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
14745289|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745290|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745291|NCT00593996|Vitamin D|vitamin d|mesh-list
14745292|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
14745293|NCT00593996|Vitamins|vitamins|mesh-ancestor
14745294|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
14745295|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745296|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14745297|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745298|NCT00594087|Eszopiclone|eszopiclone|mesh-list
14745299|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14745300|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745301|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745302|NCT00594126|Imetelstat|imetelstat|mesh-list
14926287|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926288|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926289|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14421033|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421034|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421035|NCT01687413|Cisplatin|cisplatin|mesh-list
14421036|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421037|NCT01687478|Olanzapine|olanzapine|mesh-list
14421038|NCT01687478|Fluoxetine|fluoxetine|mesh-list
14421039|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
14421040|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
14421041|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421042|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421043|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926290|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14926291|NCT01408953|Growth Substances|growth substances|mesh-ancestor
14926292|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421044|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14926293|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
14421045|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14421046|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421047|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14421048|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14421049|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14421050|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14421051|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421052|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421053|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
14421054|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14421055|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
14421056|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14421057|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14421058|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421059|NCT01687673|Sirolimus|sirolimus|mesh-list
14421060|NCT01687673|Sorafenib|sorafenib|mesh-list
14421061|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421062|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14421063|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421064|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421065|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14421066|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421067|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14421068|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
14421069|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421070|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
14421071|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421072|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14421073|NCT01687712|Hormones|hormones|mesh-ancestor
14421074|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421075|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421076|NCT01687998|Evacetrapib|evacetrapib|mesh-list
14421077|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14421078|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14421079|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
14421080|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421081|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14421082|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
14421083|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14745303|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
14745304|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745305|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745306|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14745307|NCT00594191|Simvastatin|simvastatin|mesh-list
14745308|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14745309|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14745310|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
14745311|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745312|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14745313|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14745314|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745315|NCT00594217|Progesterone|progesterone|mesh-list
14745316|NCT00594217|Progestins|progestins|mesh-ancestor
14421084|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14421085|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14421086|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421087|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
14745317|NCT00594217|Hormones|hormones|mesh-ancestor
14421088|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421089|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421090|NCT01688102|Vitamin D|vitamin d|mesh-list
14421091|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
14421092|NCT01688102|Vitamins|vitamins|mesh-ancestor
14421093|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
14421094|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421095|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14421096|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14421097|NCT01688336|Leucovorin|leucovorin|mesh-list
14421098|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
14421099|NCT01688336|Irinotecan|irinotecan|mesh-list
14421100|NCT01688336|Folfirinox|folfirinox|mesh-list
14421101|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421102|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14421103|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14421104|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421105|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421106|NCT01688336|Antidotes|antidotes|mesh-ancestor
14421107|NCT01688336|Protective Agents|protective agents|mesh-ancestor
14421108|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421109|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
14421110|NCT01688336|Vitamins|vitamins|mesh-ancestor
14421111|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
14421112|NCT01688466|Pomalidomide|pomalidomide|mesh-list
14421113|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
14421114|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421115|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14421116|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14421117|NCT01688466|Growth Substances|growth substances|mesh-ancestor
14421118|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
14421119|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421120|NCT01688596|Bupivacaine|bupivacaine|mesh-list
14421121|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
14421122|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
14745318|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745319|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745320|NCT00594269|Risperidone|risperidone|mesh-list
14745321|NCT00594269|Citalopram|citalopram|mesh-list
14745322|NCT00594269|Sertraline|sertraline|mesh-list
14745323|NCT00594269|Paroxetine|paroxetine|mesh-list
14421123|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421124|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421125|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
14745324|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14421126|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421127|NCT01688609|Paclitaxel|paclitaxel|mesh-list
14421128|NCT01688609|Trastuzumab|trastuzumab|mesh-list
14421129|NCT01688609|Lapatinib|lapatinib|mesh-list
14421130|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14421131|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421132|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
14421133|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
14421134|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
14421135|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421136|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14421137|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14421138|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421139|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
14421140|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14421141|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421142|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14421143|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14421144|NCT01688739|Erenumab|erenumab|mesh-list
14421145|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14421146|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421147|NCT01688739|Analgesics|analgesics|mesh-ancestor
14421148|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
14421149|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421150|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421151|NCT01688830|Dabigatran|dabigatran|mesh-list
14421152|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
14421153|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14421154|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
14421155|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421156|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421157|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
14421158|NCT01688921|Vaccines|vaccines|mesh-list
14745325|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
14745326|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745327|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421159|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
14421160|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421161|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14421162|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421163|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14421164|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926294|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
14421165|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421166|NCT01689207|Aztreonam|aztreonam|mesh-list
14421167|NCT01689207|Avibactam|avibactam|mesh-list
14421168|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745328|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745329|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14745330|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14745331|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745332|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745333|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14745334|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
14745335|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14745336|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14745337|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14421169|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421170|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14421171|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421172|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421173|NCT01689324|Vaccines|vaccines|mesh-list
14421174|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
14421175|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421176|NCT01689363|Histamine|histamine|mesh-list
14421177|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
14421178|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
14421179|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421180|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421181|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926295|NCT01408979|Analgesics|analgesics|mesh-ancestor
14421182|NCT01689441|Calcitriol|calcitriol|mesh-list
14421183|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14421184|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421185|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14421186|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14421187|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421188|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14421189|NCT01689441|Vitamins|vitamins|mesh-ancestor
14926296|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
14926297|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926298|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926299|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
14926300|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926301|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14926302|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
14926303|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14926304|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926305|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926306|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14926307|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
14421190|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
14421191|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14421192|NCT01689519|Vemurafenib|vemurafenib|mesh-list
14421193|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421194|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14421195|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421196|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421197|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14421198|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
14421199|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421200|NCT01689649|Topiramate|topiramate|mesh-list
14421201|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
14421202|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14421203|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421204|NCT01689779|Vitamin D|vitamin d|mesh-list
14421205|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
14421206|NCT01689779|Vitamins|vitamins|mesh-ancestor
14421207|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
14421208|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421209|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14421210|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14421211|NCT01690000|Melatonin|melatonin|mesh-list
14421212|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
14421213|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421214|NCT01690000|Protective Agents|protective agents|mesh-ancestor
14421215|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421216|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421217|NCT01690052|Pilocarpine|pilocarpine|mesh-list
14421218|NCT01690052|Cevimeline|cevimeline|mesh-list
14421219|NCT01690052|Miotics|miotics|mesh-ancestor
14421220|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
14421221|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421222|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421223|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14421224|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14421225|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
14421226|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421227|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421228|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14421229|NCT01690143|Melphalan|melphalan|mesh-list
14421230|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14421231|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
14421232|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745338|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14745339|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
14745340|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14421233|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421234|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14421235|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421236|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
14421237|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421238|NCT01690520|Cyclosporine|cyclosporine|mesh-list
14421239|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
14421240|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
14421241|NCT01690520|Thiotepa|thiotepa|mesh-list
14421242|NCT01690520|Fludarabine|fludarabine|mesh-list
14421243|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
14421244|NCT01690520|Cyclosporins|cyclosporins|mesh-list
14421245|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421246|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
14421247|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421248|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421249|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14421250|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
14421251|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421252|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421253|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14421254|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14421255|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
14421256|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421257|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
14421258|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421259|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421260|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14421261|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14421262|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14421263|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
14421264|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14421265|NCT01690546|Naltrexone|naltrexone|mesh-list
14421266|NCT01690546|Buprenorphine|buprenorphine|mesh-list
14421267|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14421268|NCT01690546|Naloxone|naloxone|mesh-list
14421269|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14421270|NCT01690546|Narcotics|narcotics|mesh-ancestor
14421271|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421272|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421273|NCT01690546|Analgesics|analgesics|mesh-ancestor
14421274|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
14421275|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421276|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14421277|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14421278|NCT01690663|Dexamethasone|dexamethasone|mesh-list
14421279|NCT01690663|Bupivacaine|bupivacaine|mesh-list
14421280|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421281|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
14421282|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
14421283|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421284|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421285|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14421286|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
14421287|NCT01690663|Hormones|hormones|mesh-ancestor
14421288|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421289|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14421290|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421291|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
14421292|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
14421293|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421294|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
14421295|NCT01690988|Ketamine|ketamine|mesh-list
14421296|NCT01690988|Analgesics|analgesics|mesh-ancestor
14421297|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
14421298|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421299|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421300|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14421301|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14421302|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
14421303|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
14421304|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421305|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14421306|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14421307|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421308|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421309|NCT01691092|Ketamine|ketamine|mesh-list
14421310|NCT01691092|Analgesics|analgesics|mesh-ancestor
14421311|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
14745341|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14745342|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745343|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
14745344|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14745345|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745346|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745347|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14745348|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745349|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14745350|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14745351|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
14745352|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745353|NCT00594373|Tenofovir|tenofovir|mesh-list
14421312|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421313|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421314|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14926308|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14926309|NCT01409005|Gemcitabine|gemcitabine|mesh-list
14421315|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14421316|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
14421317|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
14421318|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421319|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14421320|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14421321|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421322|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468120|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468121|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
14468122|NCT02272842|Hematinics|hematinics|mesh-ancestor
14468123|NCT02273050|Metformin|metformin|mesh-list
14468124|NCT02273050|Saxagliptin|saxagliptin|mesh-list
14468125|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468126|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468127|NCT02273050|Incretins|incretins|mesh-ancestor
14926310|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14926311|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
14926312|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926313|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926314|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
14926315|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926316|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926317|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926318|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
14926319|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926320|NCT01409018|Itraconazole|itraconazole|mesh-list
14926321|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14926322|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
14926323|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926324|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14926325|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14468128|NCT02273050|Hormones|hormones|mesh-ancestor
14468129|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468130|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14468131|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
14468132|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468133|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421323|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
14421324|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14421325|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421326|NCT01691313|Vanoxerine|vanoxerine|mesh-list
14421327|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14421328|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14421329|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14421330|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421331|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
14421332|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421333|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421334|NCT01691326|Vaccines|vaccines|mesh-list
14421335|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
14421336|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421337|NCT01691339|Vaccines|vaccines|mesh-list
14421338|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
14421339|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421340|NCT01691482|Albuterol|albuterol|mesh-list
14421341|NCT01691482|Ipratropium|ipratropium|mesh-list
14421342|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421343|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
14421344|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421345|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421346|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421347|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421348|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
14421349|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14421350|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14421351|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14421352|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14421353|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
14421354|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421355|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421356|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14421357|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
14421358|NCT01691508|Prednisone|prednisone|mesh-list
14421359|NCT01691508|Prednisolone|prednisolone|mesh-list
14421360|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421361|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
14421362|NCT01691508|Hormones|hormones|mesh-ancestor
14421363|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421364|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421365|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14421366|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421367|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
14421368|NCT01691534|Clofazimine|clofazimine|mesh-list
14421369|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
14421370|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14421371|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421372|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421373|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
14421374|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
14421375|NCT01691560|Listerine|listerine|mesh-list
14421376|NCT01691560|Calcium|calcium|mesh-list
14421377|NCT01691560|Fluorides|fluorides|mesh-list
14421378|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
14421379|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
14421380|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14421381|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421382|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14421383|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
14421384|NCT01691560|Protective Agents|protective agents|mesh-ancestor
14421385|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14421386|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421387|NCT01691690|Acetaminophen|acetaminophen|mesh-list
14421388|NCT01691690|Dexamethasone|dexamethasone|mesh-list
14421389|NCT01691690|Midazolam|midazolam|mesh-list
14421390|NCT01691690|Morphine|morphine|mesh-list
14421391|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
14421392|NCT01691690|Ondansetron|ondansetron|mesh-list
14421393|NCT01691690|Propofol|propofol|mesh-list
14421394|NCT01691690|Sevoflurane|sevoflurane|mesh-list
14421395|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421396|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
14421397|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
14421398|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421399|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421400|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14421401|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
14926326|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926327|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926328|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14421402|NCT01691690|Hormones|hormones|mesh-ancestor
14421403|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421404|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14421405|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421406|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14421407|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421408|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14421409|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
14421410|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
14421411|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14926329|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
14421412|NCT01691690|Narcotics|narcotics|mesh-ancestor
14421413|NCT01691690|Analgesics|analgesics|mesh-ancestor
14421414|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
14421415|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14421416|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14421417|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14421418|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14421419|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
14421420|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
14421421|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421422|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421423|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14421424|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
14421425|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14421426|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14421427|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
14421428|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421429|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14421430|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
14421431|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14421432|NCT01691768|Tenofovir|tenofovir|mesh-list
14421433|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
14421434|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421435|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14421436|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14421437|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421438|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421439|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14421440|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14421441|NCT01691781|Lisinopril|lisinopril|mesh-list
14421442|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14421443|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
14421444|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421445|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421446|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14421447|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14421448|NCT01691781|Protective Agents|protective agents|mesh-ancestor
14421449|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421450|NCT01691794|Ritonavir|ritonavir|mesh-list
14421451|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14421452|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14421453|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14421454|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
14421455|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421456|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421457|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14421458|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14421459|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
14421460|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421461|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14421462|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14421463|NCT01691833|Vitamin D|vitamin d|mesh-list
14421464|NCT01691833|Vitamins|vitamins|mesh-ancestor
14421465|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
14421466|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421467|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14421468|NCT01691885|Fluticasone|fluticasone|mesh-list
14421469|NCT01691885|Xhance|xhance|mesh-list
14421470|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421471|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421472|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
14421473|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421474|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421475|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421476|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421477|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
14745354|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
14421478|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14421479|NCT01691898|Rituximab|rituximab|mesh-list
14421480|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
14745355|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421481|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14421482|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421483|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
14421484|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421485|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421486|NCT01692197|Cytarabine|cytarabine|mesh-list
14421487|NCT01692197|Dexamethasone|dexamethasone|mesh-list
14421488|NCT01692197|Idarubicin|idarubicin|mesh-list
14421489|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421490|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
14421491|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
14421492|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421493|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421494|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14421495|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
14421496|NCT01692197|Hormones|hormones|mesh-ancestor
14468134|NCT02273115|Oxytocin|oxytocin|mesh-list
14421497|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421498|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14421499|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421500|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14421501|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
14421502|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421503|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
14421504|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421505|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421506|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
14421507|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14421508|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14421509|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14421510|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421511|NCT01692301|Amlodipine|amlodipine|mesh-list
14421512|NCT01692301|Valsartan|valsartan|mesh-list
14421513|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14421514|NCT01692301|Olmesartan|olmesartan|mesh-list
14421515|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14421516|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14421517|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14421518|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14421519|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14421520|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421521|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14421522|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421523|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
14421524|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14421525|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14421526|NCT01692301|Diuretics|diuretics|mesh-ancestor
14421527|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
14421528|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14421529|NCT01692340|Lycopene|lycopene|mesh-list
14421530|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421531|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
14421532|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421533|NCT01692340|Protective Agents|protective agents|mesh-ancestor
14421534|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421535|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14421536|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14421537|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421538|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
14421539|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14421540|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14421541|NCT01692626|Analgesics|analgesics|mesh-ancestor
14926330|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926331|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926332|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14926333|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14926334|NCT01409148|Antibodies|antibodies|mesh-list
14926335|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14926336|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
14926337|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926338|NCT01409161|Vitamins|vitamins|mesh-list
14926339|NCT01409161|Vitamin A|vitamin a|mesh-list
14926340|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
14926341|NCT01409161|Tretinoin|tretinoin|mesh-list
14926342|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
14421542|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
14926343|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
14421543|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421544|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421545|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421546|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421547|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421548|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421549|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
14421550|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14421551|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421552|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421553|NCT01692756|Triamcinolone|triamcinolone|mesh-list
14421554|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14421555|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14421556|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14421557|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14421558|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421559|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
14421560|NCT01692756|Hormones|hormones|mesh-ancestor
14421561|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421562|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421563|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421564|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
14421565|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421566|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421567|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
14421568|NCT01693029|Hematinics|hematinics|mesh-ancestor
14421569|NCT01693068|Dacarbazine|dacarbazine|mesh-list
14421570|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14421571|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
14421572|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421573|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421574|NCT01693185|Midazolam|midazolam|mesh-list
14421575|NCT01693185|Meperidine|meperidine|mesh-list
14421576|NCT01693185|Remifentanil|remifentanil|mesh-list
14421577|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14421578|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14421579|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421580|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421581|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14421582|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14421583|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14421584|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14421585|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
14421586|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
14421587|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
14421588|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
14421589|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421590|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421591|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14421592|NCT01693185|Narcotics|narcotics|mesh-ancestor
14421593|NCT01693185|Analgesics|analgesics|mesh-ancestor
14421594|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
14421595|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421596|NCT01693523|Minocycline|minocycline|mesh-list
14421597|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14421598|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421599|NCT01693562|Durvalumab|durvalumab|mesh-list
14421600|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14421601|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421602|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
14421603|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14421604|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
14421605|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421606|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14421607|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14745356|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14745357|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14745358|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745359|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745360|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14745361|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14421608|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14421609|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
14421610|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421611|NCT01694433|Vitamin D|vitamin d|mesh-list
14421612|NCT01694433|Calcitriol|calcitriol|mesh-list
14421613|NCT01694433|Calcipotriene|calcipotriene|mesh-list
14421614|NCT01694433|Vitamins|vitamins|mesh-ancestor
14421615|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
14421616|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421617|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14421618|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421619|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14421620|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14421621|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14421622|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421623|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14421624|NCT01694706|Omeprazole|omeprazole|mesh-list
14421625|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14421626|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14421627|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14421628|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421629|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421630|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
14421631|NCT01694771|Olodaterol|olodaterol|mesh-list
14421632|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421633|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
14421634|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421635|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421636|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421637|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421638|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
14421639|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14421640|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
14926344|NCT01409161|Calicheamicins|calicheamicins|mesh-list
14421641|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421642|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421643|NCT01694966|Methylene Blue|methylene blue|mesh-list
14421644|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421645|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745362|NCT00594542|Lidocaine|lidocaine|mesh-list
14745363|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14745364|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
14745365|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745366|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745367|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
14745368|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745369|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14745370|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14745371|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14421646|NCT01695135|Prednisone|prednisone|mesh-list
14421647|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
14421648|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421649|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
14421650|NCT01695135|Hormones|hormones|mesh-ancestor
14421651|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421652|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421653|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14421654|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421655|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14421656|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421657|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421658|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
14421659|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14421660|NCT01695239|Adalimumab|adalimumab|mesh-list
14421661|NCT01695239|Ixekizumab|ixekizumab|mesh-list
14421662|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421663|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421664|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421665|NCT01695291|Minocycline|minocycline|mesh-list
14421666|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14421667|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421668|NCT01695330|Bortezomib|bortezomib|mesh-list
14421669|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421670|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14421671|NCT01695668|Cyclosporine|cyclosporine|mesh-list
14421672|NCT01695668|Cyclosporins|cyclosporins|mesh-list
14421673|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421674|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421675|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421676|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
14421677|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421678|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
14421679|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421680|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421681|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745372|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745373|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421682|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14421683|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14421684|NCT01695772|Bevacizumab|bevacizumab|mesh-list
14421685|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14421686|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421687|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14421688|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14421689|NCT01695772|Growth Substances|growth substances|mesh-ancestor
14421690|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421691|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
14421692|NCT01695954|Ritonavir|ritonavir|mesh-list
14421693|NCT01695954|Darunavir|darunavir|mesh-list
14421694|NCT01695954|Efavirenz|efavirenz|mesh-list
14421695|NCT01695954|Pitavastatin|pitavastatin|mesh-list
14421696|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14421697|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14421698|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
14421699|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421700|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421701|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14421702|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14421703|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
14421704|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421705|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14468135|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
14421706|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14421707|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14421708|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14421709|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14421710|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14421711|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14421712|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14421713|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14421714|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14421715|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14421716|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14421717|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
14745374|NCT00594555|Cytarabine|cytarabine|mesh-list
14745375|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
14745376|NCT00594555|Cladribine|cladribine|mesh-list
14745377|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14745378|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
14745379|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745380|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421718|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14421719|NCT01696032|Gemcitabine|gemcitabine|mesh-list
14421720|NCT01696032|Paclitaxel|paclitaxel|mesh-list
14421721|NCT01696032|Carboplatin|carboplatin|mesh-list
14421722|NCT01696032|Doxorubicin|doxorubicin|mesh-list
14421723|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14421724|NCT01696032|Topotecan|topotecan|mesh-list
14421725|NCT01696032|Guadecitabine|guadecitabine|mesh-list
14421726|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14421727|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421728|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
14421729|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
14421730|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
14421731|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421732|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14421733|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
14421734|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
14421735|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421736|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421737|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421738|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
14421739|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745381|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
14421740|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14421741|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14421742|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14421743|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14421744|NCT01696045|Ipilimumab|ipilimumab|mesh-list
14421745|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14421746|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421747|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14421748|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421749|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
14421750|NCT01696058|Olodaterol|olodaterol|mesh-list
14421751|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421752|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
14421753|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421754|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421755|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421756|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421757|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
14421758|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14421759|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
14421760|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421761|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421762|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
14421763|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421764|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
14421765|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421766|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421767|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421768|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421769|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
14421770|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14421771|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
14421772|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745382|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926345|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
14421773|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421774|NCT01696084|Cytarabine|cytarabine|mesh-list
14421775|NCT01696084|Daunorubicin|daunorubicin|mesh-list
14421776|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14421777|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
14421778|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421779|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421780|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
14421781|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14421782|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421783|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
14421784|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421785|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14421786|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14421787|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14421788|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421789|NCT01696214|Fluticasone|fluticasone|mesh-list
14421790|NCT01696214|Xhance|xhance|mesh-list
14421791|NCT01696214|Theophylline|theophylline|mesh-list
14421792|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14421793|NCT01696214|Ipratropium|ipratropium|mesh-list
14421794|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14421795|NCT01696214|Montelukast|montelukast|mesh-list
14421796|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421797|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421798|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
14421799|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421800|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421801|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421802|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421803|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421804|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14421805|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14421806|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14421807|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14421808|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
14421809|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421810|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421811|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14421812|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
14421813|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421814|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14421815|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14421816|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14421817|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
14421818|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14421819|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421820|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
14421821|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14421822|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14421823|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
14421824|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
14421825|NCT01696214|Hormones|hormones|mesh-ancestor
14421826|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
14421827|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
14421828|NCT01696279|Calcium|calcium|mesh-list
14421829|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14421830|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421831|NCT01696279|Antacids|antacids|mesh-ancestor
14421832|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421833|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14421834|NCT01696695|Capecitabine|capecitabine|mesh-list
14421835|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14421836|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
14421837|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421838|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421839|NCT01696760|Aspirin|aspirin|mesh-list
14421840|NCT01696760|Enoxaparin|enoxaparin|mesh-list
14421841|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
14421842|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
14421843|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14421844|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14421845|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421846|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14421847|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14421848|NCT01696760|Analgesics|analgesics|mesh-ancestor
14421849|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
14421850|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421851|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421852|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421853|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421854|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14421855|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14421856|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14421857|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
14421858|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
14421859|NCT01696877|Molgramostim|molgramostim|mesh-list
14421860|NCT01696877|Sargramostim|sargramostim|mesh-list
14421861|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421862|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
14421863|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421864|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421865|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14926346|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926347|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
14926348|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926349|NCT01409161|Protective Agents|protective agents|mesh-ancestor
14926350|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14926351|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926352|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
14926353|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926354|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926355|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14926356|NCT01409174|Interferons|interferons|mesh-list
14926357|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
14421866|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
14421867|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926358|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
14926359|NCT01409174|Aldesleukin|aldesleukin|mesh-list
14421868|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421869|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14421870|NCT01696942|Mesalamine|mesalamine|mesh-list
14421871|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421872|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421873|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14421874|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14421875|NCT01696942|Analgesics|analgesics|mesh-ancestor
14421876|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
14421877|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421878|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421879|NCT01696955|Cetuximab|cetuximab|mesh-list
14421880|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926360|NCT01409174|Cisplatin|cisplatin|mesh-list
14926361|NCT01409174|Temozolomide|temozolomide|mesh-list
14926362|NCT01409174|Ipilimumab|ipilimumab|mesh-list
14926363|NCT01409174|Interleukin-2|interleukin-2|mesh-list
14926364|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926365|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
14926366|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926367|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14926368|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
14926369|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926370|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926371|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14926372|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
14926373|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926374|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14926375|NCT01409174|Analgesics|analgesics|mesh-ancestor
14926376|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
14421881|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421882|NCT01697345|Testosterone|testosterone|mesh-list
14421883|NCT01697345|Androgens|androgens|mesh-ancestor
14421884|NCT01697345|Hormones|hormones|mesh-ancestor
14421885|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421886|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421887|NCT01697579|Ondansetron|ondansetron|mesh-list
14421888|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
14421889|NCT01697579|Aprepitant|aprepitant|mesh-list
14421890|NCT01697579|Serotonin|serotonin|mesh-list
14421891|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
14421892|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
14421893|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421894|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421895|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14421896|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
14421897|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
14421898|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14421899|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
14421900|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421901|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421902|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14421903|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14421904|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421905|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14421906|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14421907|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14421908|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14468136|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14468137|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468138|NCT02273180|Insulin|insulin|mesh-list
14468139|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14468140|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
14468141|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
14468142|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468143|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468144|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
14468145|NCT02273726|Hematinics|hematinics|mesh-ancestor
14468146|NCT02273973|Letrozole|letrozole|mesh-list
14468147|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468148|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14468149|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14468150|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468151|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468152|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14421909|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
14421910|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14421911|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14421912|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14421913|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
14421914|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421915|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421916|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421917|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14421918|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
14421919|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14421920|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14421921|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14421922|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14421923|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421924|NCT01697956|Beclomethasone|beclomethasone|mesh-list
14421925|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421926|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
14421927|NCT01697956|Hormones|hormones|mesh-ancestor
14421928|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421929|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421930|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421931|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421932|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14421933|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14421934|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14421935|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14421936|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14421937|NCT01697969|Analgesics|analgesics|mesh-ancestor
14421938|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
14421939|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421940|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421941|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421942|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14421943|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14421944|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14421945|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14421946|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
14421947|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
14421948|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421949|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421950|NCT01698320|Albuterol|albuterol|mesh-list
14421951|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14421952|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
14421953|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14421954|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421955|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14421956|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
14421957|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
14421958|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14421959|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14421960|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14421961|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14421962|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
14421963|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14421964|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421965|NCT01698554|Bimatoprost|bimatoprost|mesh-list
14421966|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14421967|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14421968|NCT01698710|Paclitaxel|paclitaxel|mesh-list
14421969|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14421970|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14421971|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421972|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
14421973|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
14421974|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
14421975|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14421976|NCT01698775|Glipizide|glipizide|mesh-list
14421977|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14421978|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421979|NCT01698801|Dexamethasone|dexamethasone|mesh-list
14745383|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14421980|NCT01698801|Lenalidomide|lenalidomide|mesh-list
14421981|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14421982|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
14421983|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
14421984|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745384|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
14745385|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926377|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926378|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14926379|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14926380|NCT01409187|Interferons|interferons|mesh-list
14926381|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
14926382|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
14745386|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14745387|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745388|NCT00594633|Donepezil|donepezil|mesh-list
14745389|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14745390|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745391|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745392|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
14745393|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745394|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745395|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
14745396|NCT00594737|Memantine|memantine|mesh-list
14745397|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14745398|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14745399|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
14745400|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745401|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745402|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745403|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14745404|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14753443|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753444|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753445|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753446|NCT05142189|Docetaxel|docetaxel|mesh-list
14753447|NCT05142189|Cemiplimab|cemiplimab|mesh-list
14753448|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926383|NCT01409187|Aldesleukin|aldesleukin|mesh-list
14421985|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14421986|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14421987|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
14745405|NCT00594867|Aspirin|aspirin|mesh-list
14421988|NCT01698801|Hormones|hormones|mesh-ancestor
14468153|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
14421989|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14421990|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14421991|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14421992|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
14421993|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14421994|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14421995|NCT01698801|Growth Substances|growth substances|mesh-ancestor
14421996|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
14421997|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14421998|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14421999|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14422000|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14422001|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14745406|NCT00594867|Acetaminophen|acetaminophen|mesh-list
14745407|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14745408|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14745409|NCT00594867|Analgesics|analgesics|mesh-ancestor
14745410|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
14745411|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745412|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745413|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745414|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745415|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14422002|NCT01698814|Analgesics|analgesics|mesh-ancestor
14422003|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
14422004|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422005|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422006|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422007|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422008|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14422009|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14422010|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14422011|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
14422012|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
14422013|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422014|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422015|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
14422016|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14422017|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422018|NCT01699022|CycloProvera|cycloprovera|mesh-list
14422019|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14422020|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14422021|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14422022|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
14422023|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14422024|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422025|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14422026|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14422027|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
14422028|NCT01699178|Testosterone|testosterone|mesh-list
14422029|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
14422030|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
14422031|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14422032|NCT01699178|Androgens|androgens|mesh-ancestor
14422033|NCT01699178|Hormones|hormones|mesh-ancestor
14422034|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422035|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422036|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14422037|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422038|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
14422039|NCT01699607|Amphetamine|amphetamine|mesh-list
14422040|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
14422041|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14422042|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422043|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
14422044|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
14422045|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422046|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
14422047|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422048|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422049|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
14422050|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14422051|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14422052|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422053|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14422054|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
14422055|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14422056|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14422057|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14422058|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
14422059|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422060|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422061|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422062|NCT01699815|Acetaminophen|acetaminophen|mesh-list
14422063|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14422064|NCT01699815|Analgesics|analgesics|mesh-ancestor
14422065|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
14926384|NCT01409187|Ipilimumab|ipilimumab|mesh-list
14926385|NCT01409187|Interleukin-2|interleukin-2|mesh-list
14926386|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926387|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
14926388|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926389|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926390|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14926391|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926392|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
14926393|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926394|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14926395|NCT01409187|Analgesics|analgesics|mesh-ancestor
14926396|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
14926397|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926398|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14926399|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14926400|NCT01409278|Ropivacaine|ropivacaine|mesh-list
14926401|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
14926402|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
14926403|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926404|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926405|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
14745416|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14745417|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745418|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14745419|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14745420|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745421|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
14745422|NCT00595049|Bosentan|bosentan|mesh-list
14745423|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14745424|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14745425|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745426|NCT00595140|Octreotide|octreotide|mesh-list
14745427|NCT00595140|Dopamine|dopamine|mesh-list
14745428|NCT00595140|Cabergoline|cabergoline|mesh-list
14745429|NCT00595140|Somatostatin|somatostatin|mesh-list
14422066|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422067|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422068|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
14422069|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14422070|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
14926406|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926407|NCT01409369|Charcoal|charcoal|mesh-list
14926408|NCT01409369|Antidotes|antidotes|mesh-ancestor
14745430|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
14926409|NCT01409369|Protective Agents|protective agents|mesh-ancestor
14926410|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422071|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14422072|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14422073|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422074|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422075|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422076|NCT01700179|Ribavirin|ribavirin|mesh-list
14422077|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
14422078|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422079|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
14422080|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422081|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
14422082|NCT01700192|Loratadine|loratadine|mesh-list
14422083|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14422084|NCT01700192|Epinephrine|epinephrine|mesh-list
14422085|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14422086|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14422087|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14422088|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
14422089|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422090|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422091|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422092|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14422093|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14422094|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
14422095|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422096|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14422097|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422098|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
14422099|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
14422100|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14422101|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422102|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422103|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14422104|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
14422105|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14422106|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14422107|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
14422108|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
14422109|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14422110|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14422111|NCT01700192|Analgesics|analgesics|mesh-ancestor
14422112|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
14422113|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422114|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14422115|NCT01700387|Topiramate|topiramate|mesh-list
14422116|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
14422117|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14422118|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14422119|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14422120|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422121|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422122|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
14422123|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422124|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422125|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14422126|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422127|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
14422128|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14926411|NCT01409395|Metformin|metformin|mesh-list
14926412|NCT01409395|Nizatidine|nizatidine|mesh-list
14926413|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14926414|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926415|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14926416|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14422129|NCT01700517|Anesthetics|anesthetics|mesh-list
14422130|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926417|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14422131|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422132|NCT01700530|Simvastatin|simvastatin|mesh-list
14422133|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14422134|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14422135|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14422136|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
14422137|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422138|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14422139|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422140|NCT01700621|Vaccines|vaccines|mesh-list
14422141|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
14422142|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422143|NCT01700673|Azacitidine|azacitidine|mesh-list
14422144|NCT01700673|Sargramostim|sargramostim|mesh-list
14422145|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14422146|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
14422147|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422148|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926418|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
14926419|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
14926420|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422149|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422150|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
14422151|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422152|NCT01700829|Midazolam|midazolam|mesh-list
14422153|NCT01700829|Ketamine|ketamine|mesh-list
14422154|NCT01700829|Analgesics|analgesics|mesh-ancestor
14422155|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
14422156|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422157|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422158|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14422159|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14422160|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
14745431|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745432|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14745433|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745434|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14745435|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
14745436|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
14926421|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745437|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753449|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
14422161|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
14422162|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422163|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14422164|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14422165|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422166|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422167|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14422168|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14422169|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14422170|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14422171|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14422172|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
14422173|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
14422174|NCT01700907|Sevoflurane|sevoflurane|mesh-list
14422175|NCT01700907|Desflurane|desflurane|mesh-list
14422176|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14422177|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14422178|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
14422179|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
14422180|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422181|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422182|NCT01700959|Melatonin|melatonin|mesh-list
14422183|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
14422184|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422185|NCT01700959|Protective Agents|protective agents|mesh-ancestor
14422186|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422187|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422188|NCT01701037|Trametinib|trametinib|mesh-list
14422189|NCT01701037|Dabrafenib|dabrafenib|mesh-list
14422190|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422191|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14422192|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422193|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422194|NCT01701063|Ribavirin|ribavirin|mesh-list
14422195|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14422196|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
14422197|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422198|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
14422199|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422200|NCT01701102|Fentanyl|fentanyl|mesh-list
14422201|NCT01701102|Mepivacaine|mepivacaine|mesh-list
14422202|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14422203|NCT01701102|Narcotics|narcotics|mesh-ancestor
14422204|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422205|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422206|NCT01701102|Analgesics|analgesics|mesh-ancestor
14422207|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
14422208|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422209|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14422210|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14422211|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
14422212|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
14422213|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
14422214|NCT01701115|Bupivacaine|bupivacaine|mesh-list
14422215|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
14422216|NCT01701115|Mepivacaine|mepivacaine|mesh-list
14422217|NCT01701115|Anesthetics|anesthetics|mesh-list
14422218|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422219|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422220|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
14422221|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422222|NCT01701258|Amisulpride|amisulpride|mesh-list
14422223|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14422224|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14422225|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422226|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422227|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14422228|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14422229|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
14422230|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422231|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422232|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14422233|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
14422234|NCT01701362|Pregabalin|pregabalin|mesh-list
14422235|NCT01701362|Analgesics|analgesics|mesh-ancestor
14422236|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
14422237|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422238|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422239|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
14422240|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14422241|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422242|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422243|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14422244|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14422245|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14422246|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422247|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14422248|NCT01701375|Palbociclib|palbociclib|mesh-list
14745438|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745439|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
14745440|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745441|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745442|NCT00595140|Protective Agents|protective agents|mesh-ancestor
14745443|NCT00595140|Hormones|hormones|mesh-ancestor
14745444|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422249|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422250|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14422251|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422252|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422253|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
14422254|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14422255|NCT01701401|Ledipasvir|ledipasvir|mesh-list
14422256|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
14422257|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422258|NCT01701414|Bupivacaine|bupivacaine|mesh-list
14422259|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
14422260|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
14422261|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422262|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422263|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
14422264|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422265|NCT01701505|Phenylephrine|phenylephrine|mesh-list
14422266|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
14422267|NCT01701505|Tetracaine|tetracaine|mesh-list
14422268|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
14422269|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
14422270|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422271|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422272|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
14422273|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422274|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14926422|NCT01409408|Amlodipine|amlodipine|mesh-list
14422275|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14422276|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
14422277|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422278|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422279|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
14422280|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
14422281|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
14422282|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14422283|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422284|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14422285|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
14422286|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14422287|NCT01701505|Protective Agents|protective agents|mesh-ancestor
14422288|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14422289|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422290|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422291|NCT01701973|Incretins|incretins|mesh-ancestor
14422292|NCT01701973|Hormones|hormones|mesh-ancestor
14422293|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422294|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14422295|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422296|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422297|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422298|NCT01702025|Aminophylline|aminophylline|mesh-list
14422299|NCT01702025|Methazolamide|methazolamide|mesh-list
14422300|NCT01702025|Theophylline|theophylline|mesh-list
14422301|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14422302|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
14422303|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422304|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422305|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14422306|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422307|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14422308|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422309|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422310|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
14422311|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14422312|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14422313|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
14422314|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422315|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14422316|NCT01702025|Protective Agents|protective agents|mesh-ancestor
14422317|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14422318|NCT01702025|Diuretics|diuretics|mesh-ancestor
14422319|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
14422320|NCT01702233|Dexamethasone|dexamethasone|mesh-list
14422321|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
14422322|NCT01702233|BB 1101|bb 1101|mesh-list
14422323|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422324|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
14422325|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
14422326|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422327|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422328|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14422329|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
14422330|NCT01702233|Hormones|hormones|mesh-ancestor
14422331|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422332|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14422333|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422334|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422335|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422336|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422337|NCT01702246|Simvastatin|simvastatin|mesh-list
14422338|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14422339|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14422340|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
14422341|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422342|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14422343|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14422344|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422345|NCT01702298|Metformin|metformin|mesh-list
14422346|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14422347|NCT01702298|Simvastatin|simvastatin|mesh-list
14422348|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422349|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422350|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14422351|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14422352|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
14422353|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422354|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14422355|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14422356|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422357|NCT01702298|Incretins|incretins|mesh-ancestor
14745445|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14422358|NCT01702298|Hormones|hormones|mesh-ancestor
14422359|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422360|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14422361|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422362|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
14422363|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422364|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422365|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14422366|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
14745446|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14422367|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422368|NCT01702519|Nicotine|nicotine|mesh-list
14422369|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14422370|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
14422371|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422372|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422373|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14422374|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14422375|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
14422376|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422377|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422378|NCT01702532|Nicotine|nicotine|mesh-list
14422379|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14422380|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
14422381|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422382|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422383|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14422384|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14422385|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
14422386|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422387|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422388|NCT01702558|Capecitabine|capecitabine|mesh-list
14422389|NCT01702558|Trastuzumab|trastuzumab|mesh-list
14422390|NCT01702558|Maytansine|maytansine|mesh-list
14422391|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14422392|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14422393|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
14422394|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422395|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422396|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14422397|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14422398|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
14926423|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14422399|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
14422400|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
14422401|NCT01702844|Paclitaxel|paclitaxel|mesh-list
14745447|NCT00595322|Bevacizumab|bevacizumab|mesh-list
14745448|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14422402|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14745449|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745450|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14745451|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14745452|NCT00595322|Growth Substances|growth substances|mesh-ancestor
14745453|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745454|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
14745455|NCT00595374|Insulin|insulin|mesh-list
14745456|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14745457|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
14926424|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14422403|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422404|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
14422405|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
14422406|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
14422407|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422408|NCT01702961|Cytarabine|cytarabine|mesh-list
14422409|NCT01702961|Etoposide|etoposide|mesh-list
14422410|NCT01702961|Rituximab|rituximab|mesh-list
14422411|NCT01702961|Melphalan|melphalan|mesh-list
14422412|NCT01702961|Carmustine|carmustine|mesh-list
14422413|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14422414|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422415|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14422416|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14422417|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422418|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422419|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14745458|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
14745459|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
14422420|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
14422421|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
14422422|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422423|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14422424|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
14422425|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422426|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14422427|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422428|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14422429|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
14422430|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14422431|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
14422432|NCT01702987|Atorvastatin|atorvastatin|mesh-list
14422433|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14422434|NCT01702987|Simvastatin|simvastatin|mesh-list
14422435|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14422436|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14422437|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
14422438|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422439|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14422440|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14422441|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422442|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
14422443|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422444|NCT01702987|Vitamins|vitamins|mesh-ancestor
14422445|NCT01703039|Riluzole|riluzole|mesh-list
14422446|NCT01703039|Sertraline|sertraline|mesh-list
14422447|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
14422448|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14422449|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14422450|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14422451|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926425|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926426|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926427|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14422452|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422453|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422454|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
14422455|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422456|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
14422457|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14422458|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14422459|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14422460|NCT01703039|Protective Agents|protective agents|mesh-ancestor
14422461|NCT01703091|Docetaxel|docetaxel|mesh-list
14422462|NCT01703091|Ramucirumab|ramucirumab|mesh-list
14422463|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422464|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
14422465|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
14422466|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
14422467|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422468|NCT01703117|Riluzole|riluzole|mesh-list
14422469|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
14422470|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14422471|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14422472|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422473|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422474|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422475|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14422476|NCT01703117|Protective Agents|protective agents|mesh-ancestor
14422477|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14422478|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422479|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422480|NCT01703221|Incretins|incretins|mesh-ancestor
14422481|NCT01703221|Hormones|hormones|mesh-ancestor
14422482|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422483|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14422484|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422485|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422486|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422487|NCT01703260|Pioglitazone|pioglitazone|mesh-list
14926428|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926429|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
14926430|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14926431|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14422488|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422489|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422490|NCT01703286|Glimepiride|glimepiride|mesh-list
14422491|NCT01703286|Linagliptin|linagliptin|mesh-list
14422492|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14422493|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422494|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422495|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14422496|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
14422497|NCT01703286|Incretins|incretins|mesh-ancestor
14422498|NCT01703286|Hormones|hormones|mesh-ancestor
14422499|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422500|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14422501|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422502|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422503|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422504|NCT01703507|Ipilimumab|ipilimumab|mesh-list
14422505|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14422506|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422507|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14422508|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422509|NCT01703741|Testosterone|testosterone|mesh-list
14422510|NCT01703741|Androgens|androgens|mesh-ancestor
14422511|NCT01703741|Hormones|hormones|mesh-ancestor
14422512|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422513|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745460|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
14926432|NCT01409499|Sorafenib|sorafenib|mesh-list
14422514|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
14422515|NCT01703845|Olodaterol|olodaterol|mesh-list
14422516|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14422517|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
14422518|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422519|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422520|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14422521|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422522|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
14422523|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14422524|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
14422525|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422526|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422527|NCT01703858|Pantoprazole|pantoprazole|mesh-list
14422528|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14422529|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14422530|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14422531|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422532|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422533|NCT01704079|Calcifediol|calcifediol|mesh-list
14422534|NCT01704079|Vitamins|vitamins|mesh-ancestor
14422535|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
14422536|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422537|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14422538|NCT01704261|Metformin|metformin|mesh-list
14422539|NCT01704261|Glimepiride|glimepiride|mesh-list
14422540|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422541|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422542|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14422543|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14422544|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
14422545|NCT01704287|Paclitaxel|paclitaxel|mesh-list
14422546|NCT01704287|Carboplatin|carboplatin|mesh-list
14422547|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
14422548|NCT01704287|Temozolomide|temozolomide|mesh-list
14422549|NCT01704287|Dacarbazine|dacarbazine|mesh-list
14422550|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14745461|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
14422551|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422552|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
14422553|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
14422554|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
14422555|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422556|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14422557|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14422558|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
14422559|NCT01704521|Ribavirin|ribavirin|mesh-list
14422560|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
14745462|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745463|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745464|NCT00595543|Diclofenac|diclofenac|mesh-list
14745465|NCT00595543|Ketorolac|ketorolac|mesh-list
14745466|NCT00595543|Bromfenac|bromfenac|mesh-list
14745467|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14745468|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14422561|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422562|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
14422563|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422564|NCT01704599|Vitamins|vitamins|mesh-list
14422565|NCT01704599|Folic Acid|folic acid|mesh-list
14422566|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
14422567|NCT01704599|Pyridoxine|pyridoxine|mesh-list
14422568|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
14422569|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
14745469|NCT00595543|Analgesics|analgesics|mesh-ancestor
14422570|NCT01704599|Adalimumab|adalimumab|mesh-list
14422571|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
14422572|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926433|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926434|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14422573|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422574|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422575|NCT01704599|Hematinics|hematinics|mesh-ancestor
14422576|NCT01704651|Alvimopan|alvimopan|mesh-list
14422577|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14422578|NCT01704755|Ribavirin|ribavirin|mesh-list
14422579|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
14422580|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422581|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
14422582|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422583|NCT01704781|Lenalidomide|lenalidomide|mesh-list
14422584|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
14422585|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422586|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14422587|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14422588|NCT01704781|Growth Substances|growth substances|mesh-ancestor
14422589|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
14422590|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422591|NCT01705145|Ivacaftor|ivacaftor|mesh-list
14422592|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14422593|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422594|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422595|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14422596|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14422597|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422598|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14422599|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
14422600|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422601|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14422602|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14422603|NCT01705288|Morphine|morphine|mesh-list
14422604|NCT01705288|Narcotics|narcotics|mesh-list
14422605|NCT01705288|Anesthetics|anesthetics|mesh-list
14422606|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422607|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422608|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14422609|NCT01705288|Analgesics|analgesics|mesh-ancestor
14422610|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
14422611|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926435|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422612|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14422613|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422614|NCT01705496|Fialuridine|fialuridine|mesh-list
14422615|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
14422616|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422617|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14422618|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926436|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926437|NCT01409603|Naproxen|naproxen|mesh-list
14926438|NCT01409603|Darexaban|darexaban|mesh-list
14926439|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14926440|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14926441|NCT01409603|Analgesics|analgesics|mesh-ancestor
14926442|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
14926443|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926444|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926445|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422619|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422620|NCT01705509|Ranolazine|ranolazine|mesh-list
14422621|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14422622|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422623|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422624|NCT01705574|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14422625|NCT01705574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14422626|NCT01705574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14422627|NCT01705574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422628|NCT01705574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422629|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
14422630|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422631|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14422632|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14422633|NCT01705587|Teriparatide|teriparatide|mesh-list
14422634|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14422635|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745470|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
14745471|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745472|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745473|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745474|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745475|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14745476|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753450|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
14422636|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14422637|NCT01705691|Paclitaxel|paclitaxel|mesh-list
14422638|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
14422639|NCT01705691|Doxorubicin|doxorubicin|mesh-list
14422640|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14422641|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422642|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
14422643|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
14422644|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
14422645|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422646|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745477|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745478|NCT00595569|Insulin|insulin|mesh-list
14745479|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745480|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745481|NCT00595933|Muramidase|muramidase|mesh-list
14745482|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745483|NCT00595972|Endostar protein|endostar protein|mesh-list
14745484|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14422647|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
14422648|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422649|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422650|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14422651|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
14422652|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14422653|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14422654|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14422655|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14422656|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422657|NCT01705964|Epinephrine|epinephrine|mesh-list
14422658|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14422659|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14422660|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14422661|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422662|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422663|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422664|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14422665|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14422666|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
14422667|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422668|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14422669|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422670|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
14422671|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
14422672|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14422673|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
14422674|NCT01706146|Apixaban|apixaban|mesh-list
14422675|NCT01706146|Dabigatran|dabigatran|mesh-list
14422676|NCT01706146|Anticoagulants|anticoagulants|mesh-list
14422677|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14422678|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
14422679|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14422680|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422681|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422682|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422683|NCT01706198|Fluticasone|fluticasone|mesh-list
14422684|NCT01706198|Xhance|xhance|mesh-list
14422685|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422686|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14422687|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
14422688|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422689|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422690|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14422691|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422692|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422693|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14422694|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
14422695|NCT01706250|Salicylates|salicylates|mesh-list
14422696|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422697|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
14422698|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
14422699|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422700|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14422701|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14422702|NCT01706250|Analgesics|analgesics|mesh-ancestor
14422703|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
14422704|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422705|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422706|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422707|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422708|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14422709|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422710|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422711|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
14422712|NCT01706263|Salicylates|salicylates|mesh-list
14422713|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422714|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
14422715|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
14422716|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422717|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14422718|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14422719|NCT01706263|Analgesics|analgesics|mesh-ancestor
14422720|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
14422721|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422722|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422723|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422724|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422725|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14422726|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422727|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422728|NCT01706328|Fluticasone|fluticasone|mesh-list
14422729|NCT01706328|Xhance|xhance|mesh-list
14745485|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14745486|NCT00595972|Growth Substances|growth substances|mesh-ancestor
14745487|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745488|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
14745489|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745490|NCT00595985|Sorafenib|sorafenib|mesh-list
14745491|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745492|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14422730|NCT01706328|Albuterol|albuterol|mesh-list
14422731|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14422732|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422733|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14422734|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
14422735|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422736|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422737|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14422738|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422739|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422740|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14422741|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14422742|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14422743|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14422744|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
14422745|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422746|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422747|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
14422748|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14422749|NCT01706575|Interferons|interferons|mesh-list
14422750|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422751|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
14422752|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422753|NCT01706588|Diclofenac|diclofenac|mesh-list
14745493|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745494|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745495|NCT00596037|Hormones|hormones|mesh-list
14745496|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745497|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745498|NCT00596050|Lidocaine|lidocaine|mesh-list
14422754|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14422755|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14422756|NCT01706588|Analgesics|analgesics|mesh-ancestor
14745499|NCT00596050|Fentanyl|fentanyl|mesh-list
14745500|NCT00596050|Midazolam|midazolam|mesh-list
14745501|NCT00596050|Ketamine|ketamine|mesh-list
14745502|NCT00596050|Etomidate|etomidate|mesh-list
14745503|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
14745504|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
14745505|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745506|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745507|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
14422757|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
14422758|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422759|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745508|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745509|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14745510|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14745511|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14745512|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745513|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745514|NCT00596050|Analgesics|analgesics|mesh-ancestor
14422760|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422761|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422762|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14422763|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422764|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422765|NCT01706666|Dexamethasone|dexamethasone|mesh-list
14422766|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
14422767|NCT01706666|Lenalidomide|lenalidomide|mesh-list
14422768|NCT01706666|Bortezomib|bortezomib|mesh-list
14422769|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14422770|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
14422771|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422772|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422773|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14422774|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
14422775|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422776|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422777|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14422778|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422779|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
14422780|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
14422781|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422782|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14422783|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
14422784|NCT01706666|Hormones|hormones|mesh-ancestor
14422785|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745515|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14422786|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14422787|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14422788|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14745516|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14745517|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
14745518|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14745519|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14745520|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745521|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14745522|NCT00596050|Narcotics|narcotics|mesh-ancestor
14745523|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14745524|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14745525|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14745526|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14745527|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745528|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
14745529|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
14745530|NCT00596063|Insulin|insulin|mesh-list
14745531|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745532|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745533|NCT00596115|Pramipexole|pramipexole|mesh-list
14745534|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
14745535|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745536|NCT00596115|Protective Agents|protective agents|mesh-ancestor
14745537|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745538|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14745539|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14745540|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
14422789|NCT01706666|Growth Substances|growth substances|mesh-ancestor
14422790|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
14422791|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
14422792|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14422793|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422794|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
14745541|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
14745542|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422795|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422796|NCT01706952|Epinephrine|epinephrine|mesh-list
14422797|NCT01706952|Racepinephrine|racepinephrine|mesh-list
14422798|NCT01706952|Cocaine|cocaine|mesh-list
14422799|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14422800|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
14422801|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14422802|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14422803|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
14422804|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422805|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422806|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422807|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14422808|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14422809|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
14422810|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422811|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14745543|NCT00596128|Insulin|insulin|mesh-list
14745544|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422812|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422813|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
14422814|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
14422815|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14422816|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
14422817|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
14422818|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422819|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
14422820|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14422821|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14422822|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422823|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
14422824|NCT01707004|Vidarabine|vidarabine|mesh-list
14422825|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
14422826|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
14422827|NCT01707004|Busulfan|busulfan|mesh-list
14422828|NCT01707004|Fludarabine|fludarabine|mesh-list
14422829|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
14422830|NCT01707004|Azacitidine|azacitidine|mesh-list
14422831|NCT01707004|Decitabine|decitabine|mesh-list
14422832|NCT01707004|Tacrolimus|tacrolimus|mesh-list
14422833|NCT01707004|Lenograstim|lenograstim|mesh-list
14422834|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14422835|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
14422836|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422837|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14422838|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14422839|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
14422840|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422841|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422842|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14422843|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14422844|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
14422845|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
14422846|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14422847|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14422848|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14422849|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422850|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14422851|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14422852|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
14422853|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14422854|NCT01707043|Calcitriol|calcitriol|mesh-list
14422855|NCT01707043|Betamethasone|betamethasone|mesh-list
14422856|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
14422857|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14422858|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
14422859|NCT01707043|Calcipotriene|calcipotriene|mesh-list
14422860|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14422861|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14422862|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
14422863|NCT01707043|Hormones|hormones|mesh-ancestor
14422864|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422865|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422866|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14422867|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
14422868|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422869|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14422870|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14422871|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422872|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422873|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14422874|NCT01707043|Vitamins|vitamins|mesh-ancestor
14422875|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
14422876|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14422877|NCT01707147|Linagliptin|linagliptin|mesh-list
14422878|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422879|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422880|NCT01707147|Incretins|incretins|mesh-ancestor
14422881|NCT01707147|Hormones|hormones|mesh-ancestor
14422882|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422883|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14422884|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422885|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422886|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422887|NCT01707225|Octreotide|octreotide|mesh-list
14422888|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14422889|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14422890|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422891|NCT01707290|Ivacaftor|ivacaftor|mesh-list
14422892|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14422893|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14422894|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422895|NCT01707381|Timolol|timolol|mesh-list
14422896|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14422897|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14422898|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
14422899|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422900|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422901|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422902|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14422903|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14422904|NCT01707420|Gabapentin|gabapentin|mesh-list
14422905|NCT01707420|Analgesics|analgesics|mesh-ancestor
14422906|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
14422907|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422908|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422909|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
14422910|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14422911|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14422912|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745545|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745546|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14745547|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
14745548|NCT00596154|Busulfan|busulfan|mesh-list
14745549|NCT00596154|Thiotepa|thiotepa|mesh-list
14422913|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14422914|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14745550|NCT00596154|Rituximab|rituximab|mesh-list
14745551|NCT00596154|Methotrexate|methotrexate|mesh-list
14422915|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14422916|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422917|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422918|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
14422919|NCT01707667|Prucalopride|prucalopride|mesh-list
14422920|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14422921|NCT01707667|Laxatives|laxatives|mesh-ancestor
14926446|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14926447|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
14926448|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14926449|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926450|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926451|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14926452|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
14926453|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14926454|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
14926455|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
14926456|NCT01409616|Aspirin|aspirin|mesh-list
14926457|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
14926458|NCT01409616|Salicylates|salicylates|mesh-list
14422922|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14422923|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14422924|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14422925|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
14422926|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14422927|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422928|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422929|NCT01708122|Fentanyl|fentanyl|mesh-list
14422930|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14422931|NCT01708122|Narcotics|narcotics|mesh-ancestor
14422932|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14422933|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422934|NCT01708122|Analgesics|analgesics|mesh-ancestor
14422935|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
14422936|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422937|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14422938|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14422939|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
14422940|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
14926459|NCT01409616|Darexaban|darexaban|mesh-list
14926460|NCT01409616|Clopidogrel|clopidogrel|mesh-list
14926461|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14926462|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14926463|NCT01409616|Analgesics|analgesics|mesh-ancestor
14926464|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
14422941|NCT01708278|Folic Acid|folic acid|mesh-list
14422942|NCT01708278|Quercetin|quercetin|mesh-list
14422943|NCT01708278|Hematinics|hematinics|mesh-ancestor
14422944|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
14422945|NCT01708278|Vitamins|vitamins|mesh-ancestor
14422946|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
14422947|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422948|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
14422949|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422950|NCT01708278|Protective Agents|protective agents|mesh-ancestor
14422951|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
14422952|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14422953|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14422954|NCT01708525|Protective Agents|protective agents|mesh-ancestor
14422955|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422956|NCT01708590|Brodalumab|brodalumab|mesh-list
14422957|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14926465|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926466|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926467|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926468|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14926469|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14926470|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14926471|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422958|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422959|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
14422960|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422961|NCT01708603|Ustekinumab|ustekinumab|mesh-list
14422962|NCT01708603|Brodalumab|brodalumab|mesh-list
14422963|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14422964|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422965|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
14422966|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422967|NCT01708629|Ustekinumab|ustekinumab|mesh-list
14422968|NCT01708629|Brodalumab|brodalumab|mesh-list
14422969|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14422970|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422971|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
14422972|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422973|NCT01708902|Metformin|metformin|mesh-list
14422974|NCT01708902|Linagliptin|linagliptin|mesh-list
14422975|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14422976|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422977|NCT01708902|Incretins|incretins|mesh-ancestor
14422978|NCT01708902|Hormones|hormones|mesh-ancestor
14422979|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14422980|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14422981|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
14422982|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14422983|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14422984|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
14422985|NCT01708915|Capsaicin|capsaicin|mesh-list
14422986|NCT01708915|Nonivamide|nonivamide|mesh-list
14422987|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
14422988|NCT01708915|Vitamins|vitamins|mesh-ancestor
14422989|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
14422990|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14422991|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
14422992|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14422993|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
14422994|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
14422995|NCT01709032|Deferasirox|deferasirox|mesh-list
14422996|NCT01709032|Deferiprone|deferiprone|mesh-list
14422997|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14422998|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
14422999|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
14423000|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423001|NCT01709084|Tenofovir|tenofovir|mesh-list
14423002|NCT01709084|Emtricitabine|emtricitabine|mesh-list
14423003|NCT01709084|Efavirenz|efavirenz|mesh-list
14423004|NCT01709084|Rilpivirine|rilpivirine|mesh-list
14423005|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
14423006|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423007|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14423008|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14423009|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423010|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423011|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14423012|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14423013|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14423014|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423015|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14423016|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14423017|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14423018|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14423019|NCT01709110|Vitamin D|vitamin d|mesh-list
14423020|NCT01709110|Teriparatide|teriparatide|mesh-list
14423021|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
14423022|NCT01709110|Calcium|calcium|mesh-list
14423023|NCT01709110|Vitamins|vitamins|mesh-ancestor
14423024|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
14423025|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423026|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14423027|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14423028|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14926472|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14423029|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14423030|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423031|NCT01709149|Riluzole|riluzole|mesh-list
14423032|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
14423033|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14423034|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14926473|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14926474|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926475|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
14423035|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423036|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423037|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423038|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14423039|NCT01709149|Protective Agents|protective agents|mesh-ancestor
14423040|NCT01709162|Ipilimumab|ipilimumab|mesh-list
14423041|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14423042|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423043|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14423044|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423045|NCT01709227|Furosemide|furosemide|mesh-list
14423046|NCT01709227|Diuretics|diuretics|mesh-ancestor
14423047|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
14423048|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423049|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14423050|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14423051|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423052|NCT01709305|Metformin|metformin|mesh-list
14423053|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14423054|NCT01709305|Glimepiride|glimepiride|mesh-list
14423055|NCT01709305|Acarbose|acarbose|mesh-list
14423056|NCT01709305|Repaglinide|repaglinide|mesh-list
14423057|NCT01709305|Gliclazide|gliclazide|mesh-list
14423058|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14423059|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423060|NCT01709305|Incretins|incretins|mesh-ancestor
14423061|NCT01709305|Hormones|hormones|mesh-ancestor
14423062|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423063|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14423064|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
14745552|NCT00596154|Vincristine|vincristine|mesh-list
14745553|NCT00596154|Procarbazine|procarbazine|mesh-list
14745554|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745555|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
14745556|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745557|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745558|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14423065|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423066|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423067|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14423068|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423069|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
14423070|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14423071|NCT01709409|Poractant alfa|poractant alfa|mesh-list
14423072|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14423073|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
14423074|NCT01709422|Midazolam|midazolam|mesh-list
14423075|NCT01709422|Meperidine|meperidine|mesh-list
14423076|NCT01709422|Propofol|propofol|mesh-list
14423077|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14423078|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423079|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423080|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14423081|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
14423082|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
14423083|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14423084|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14423085|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14423086|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14423087|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
14423088|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
14423089|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423090|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423091|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14423092|NCT01709422|Narcotics|narcotics|mesh-ancestor
14423093|NCT01709422|Analgesics|analgesics|mesh-ancestor
14423094|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
14423095|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423096|NCT01709474|Vitamin D|vitamin d|mesh-list
14423097|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
14423098|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
14423099|NCT01709474|Vitamins|vitamins|mesh-list
14423100|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
14423101|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423102|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14423103|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14423104|NCT01709500|Atorvastatin|atorvastatin|mesh-list
14423105|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14423106|NCT01709500|Simvastatin|simvastatin|mesh-list
14423107|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14423108|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14423109|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
14423110|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423111|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14423112|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14423113|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423114|NCT01709513|Atorvastatin|atorvastatin|mesh-list
14423115|NCT01709513|Ezetimibe|ezetimibe|mesh-list
14423116|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14423117|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14423118|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
14423119|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423120|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14423121|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14423122|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423123|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
14423124|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
14423125|NCT01709578|Methotrexate|methotrexate|mesh-list
14423126|NCT01709578|Leflunomide|leflunomide|mesh-list
14423127|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14423128|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
14423129|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14423130|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423131|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14423132|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
14423133|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423134|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423135|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
14423136|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423137|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14423138|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423139|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
14423140|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423141|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14423142|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
14423143|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14423144|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14423145|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423146|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14423147|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14423148|NCT01709578|Analgesics|analgesics|mesh-ancestor
14423149|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
14423150|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423151|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423152|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14423153|NCT01709695|Guanfacine|guanfacine|mesh-list
14423154|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14423155|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14423156|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14423157|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14423158|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
14423159|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423160|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423161|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423162|NCT01709708|Bupivacaine|bupivacaine|mesh-list
14423163|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
14423164|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
14423165|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423166|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423167|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
14926476|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14926477|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14926478|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14926479|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
14926480|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926481|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926482|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
14926483|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
14926484|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926485|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14926486|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
14926487|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14926488|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
14926489|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
14931113|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931114|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14931115|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14931116|NCT01437618|Growth Substances|growth substances|mesh-ancestor
14423168|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423169|NCT01709721|Hydromorphone|hydromorphone|mesh-list
14423170|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14423171|NCT01709721|Narcotics|narcotics|mesh-ancestor
14423172|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423173|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423174|NCT01709721|Analgesics|analgesics|mesh-ancestor
14423175|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
14423176|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468154|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468155|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931117|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423177|NCT01709747|Hydromorphone|hydromorphone|mesh-list
14423178|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14423179|NCT01709747|Narcotics|narcotics|mesh-ancestor
14423180|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423181|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423182|NCT01709747|Analgesics|analgesics|mesh-ancestor
14423183|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
14423184|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423185|NCT01709838|Deferasirox|deferasirox|mesh-list
14423186|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14423187|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
14423188|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
14423189|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423190|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
14423191|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14423192|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14423193|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14423194|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
14423195|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423196|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423197|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423198|NCT01709903|Fluticasone|fluticasone|mesh-list
14423199|NCT01709903|Xhance|xhance|mesh-list
14423200|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
14423201|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14423202|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14423203|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423204|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14423205|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
14423206|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423207|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423208|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14423209|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
14423210|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14423211|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14423212|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14423213|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14423214|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14423215|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
14423216|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423217|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423218|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
14423219|NCT01709903|Hormones|hormones|mesh-ancestor
14423220|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423221|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
14423222|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14423223|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14423224|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14423225|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
14423226|NCT01709981|Colchicine|colchicine|mesh-list
14423227|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
14423228|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423229|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
14423230|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
14423231|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
14423232|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423233|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423234|NCT01710020|Tofacitinib|tofacitinib|mesh-list
14423235|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14423236|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423237|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423238|NCT01710033|Tofacitinib|tofacitinib|mesh-list
14423239|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14423240|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423241|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423242|NCT01710046|Tofacitinib|tofacitinib|mesh-list
14423243|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14423244|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423245|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423246|NCT01710137|Varenicline|varenicline|mesh-list
14423247|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14423248|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14423249|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
14423250|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423251|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423252|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423253|NCT01710254|Regadenoson|regadenoson|mesh-list
14423254|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14423255|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14423256|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
14423257|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
14423258|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423259|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423260|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423261|NCT01710332|Aflibercept|aflibercept|mesh-list
14423262|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14423263|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14423264|NCT01710332|Growth Substances|growth substances|mesh-ancestor
14468156|NCT02274038|Pemetrexed|pemetrexed|mesh-list
14423265|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423266|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14423267|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423268|NCT01710345|Sufentanil|sufentanil|mesh-list
14423269|NCT01710345|Dsuvia|dsuvia|mesh-list
14423270|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14423271|NCT01710345|Narcotics|narcotics|mesh-ancestor
14423272|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423273|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423274|NCT01710345|Analgesics|analgesics|mesh-ancestor
14423275|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
14423276|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926490|NCT01409694|Vitamin D|vitamin d|mesh-list
14926491|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
14423277|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14423278|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14423279|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
14423280|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
14423281|NCT01710358|Adalimumab|adalimumab|mesh-list
14423282|NCT01710358|Methotrexate|methotrexate|mesh-list
14423283|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14423284|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
14423285|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14423286|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423287|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14423288|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
14423289|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423290|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423291|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
14423292|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423293|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14423294|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423295|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
14423296|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423297|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14423298|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423299|NCT01710501|Interferons|interferons|mesh-list
14423300|NCT01710501|Ribavirin|ribavirin|mesh-list
14423301|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
14423302|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
14423303|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14423304|NCT01710501|Grazoprevir|grazoprevir|mesh-list
14423305|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423306|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
14423307|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423308|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
14926492|NCT01409694|Vitamins|vitamins|mesh-list
14926493|NCT01409694|Memantine|memantine|mesh-list
14423309|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423310|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
14423311|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423312|NCT01710527|Metformin|metformin|mesh-list
14423313|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14423314|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745559|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
14745560|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745561|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745562|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14745563|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14745564|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14423315|NCT01710657|Lacosamide|lacosamide|mesh-list
14423316|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
14423317|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14423318|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14423319|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14423320|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423321|NCT01710709|Aripiprazole|aripiprazole|mesh-list
14423322|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
14423323|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14423324|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14423325|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14423326|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423327|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423328|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
14423329|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
14423330|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423331|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423332|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14423333|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14423334|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
14423335|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14423336|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14423337|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14423338|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14423339|NCT01710787|Phenylephrine|phenylephrine|mesh-list
14423340|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
14423341|NCT01710787|Tetracaine|tetracaine|mesh-list
14423342|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
14423343|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
14423344|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423345|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745565|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
14423346|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
14423347|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423348|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14423349|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14423350|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
14423351|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423352|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423353|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
14423354|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
14423355|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
14423356|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14423357|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
14745566|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14745567|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14745568|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
14745569|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
14745570|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753451|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
14423358|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14423359|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
14423360|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14423361|NCT01710787|Protective Agents|protective agents|mesh-ancestor
14423362|NCT01710800|Esomeprazole|esomeprazole|mesh-list
14423363|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14423364|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14423365|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14423366|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423367|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423368|NCT01710839|Ranibizumab|ranibizumab|mesh-list
14423369|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14423370|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14423371|NCT01710839|Growth Substances|growth substances|mesh-ancestor
14423372|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423373|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
14423374|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423375|NCT01711177|Travoprost|travoprost|mesh-list
14423376|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14423377|NCT01711359|Folic Acid|folic acid|mesh-list
14423378|NCT01711359|Methotrexate|methotrexate|mesh-list
14423379|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14423380|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
14423381|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14423382|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423383|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14423384|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
14423385|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423386|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423387|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14423388|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423389|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14926494|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
14926495|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423390|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423391|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
14423392|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423393|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14423394|NCT01711359|Hematinics|hematinics|mesh-ancestor
14423395|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
14423396|NCT01711359|Vitamins|vitamins|mesh-ancestor
14423397|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
14423398|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
14423399|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14423400|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
14423401|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423402|NCT01711645|Antacids|antacids|mesh-ancestor
14423403|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423404|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14423405|NCT01711658|Lapatinib|lapatinib|mesh-list
14423406|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926496|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14926497|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14926498|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14926499|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14926500|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
14926501|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423407|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14423408|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423409|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423410|NCT01711853|Dabigatran|dabigatran|mesh-list
14423411|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
14423412|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14423413|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
14423414|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423415|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423416|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
14423417|NCT01711866|Rotigotine|rotigotine|mesh-list
14423418|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
14423419|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
14423420|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423421|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423422|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423423|NCT01711918|Domperidone|domperidone|mesh-list
14423424|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
14423425|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
14423426|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423427|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423428|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14423429|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14423430|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
14423431|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423432|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423433|NCT01712009|Loratadine|loratadine|mesh-list
14423434|NCT01712009|Naproxen|naproxen|mesh-list
14423435|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14423436|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14423437|NCT01712009|Analgesics|analgesics|mesh-ancestor
14423438|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
14423439|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423440|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423441|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423442|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423443|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
14423444|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14423445|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423446|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423447|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
14423448|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14423449|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14423450|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14423451|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14423452|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
14423453|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
14423454|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423455|NCT01712178|Adalimumab|adalimumab|mesh-list
14423456|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423457|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423458|NCT01712204|Febuxostat|febuxostat|mesh-list
14423459|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
14423460|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423461|NCT01712230|Leuprolide|leuprolide|mesh-list
14423462|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14423463|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
14423464|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14423465|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423466|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14423467|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423468|NCT01712360|Naftifine|naftifine|mesh-list
14423469|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
14423470|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423471|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
14423472|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423473|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
14423474|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14423475|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14423476|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14423477|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
14423478|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423479|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423480|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423481|NCT01712984|Fluconazole|fluconazole|mesh-list
14423482|NCT01712984|Vaccines|vaccines|mesh-list
14423483|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
14423484|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423485|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
14423486|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423487|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14423488|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423489|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423490|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423491|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14423492|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
14423493|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423494|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14423495|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14423496|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
14423497|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
14423498|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423499|NCT01713400|Sirolimus|sirolimus|mesh-list
14423500|NCT01713400|Ustekinumab|ustekinumab|mesh-list
14423501|NCT01713400|Tacrolimus|tacrolimus|mesh-list
14423502|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423503|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
14423504|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423505|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14423506|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423507|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423508|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14423509|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423510|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14423511|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423512|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
14423513|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
14423514|NCT01713530|Insulin|insulin|mesh-list
14423515|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14423516|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
14423517|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
14423518|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14423519|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14423520|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423521|NCT01713608|Artefenomel|artefenomel|mesh-list
14745571|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14745572|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14423522|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
14423523|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14423524|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14423525|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423526|NCT01713621|Artefenomel|artefenomel|mesh-list
14423527|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
14423528|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14423529|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14423530|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423531|NCT01713946|Everolimus|everolimus|mesh-list
14423532|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
14423533|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423534|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745573|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14745574|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
14745575|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
14745576|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
14745577|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423535|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
14423536|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423537|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14926502|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926503|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14926504|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14926505|NCT01409733|Doxorubicin|doxorubicin|mesh-list
14423538|NCT01714310|Fluoxetine|fluoxetine|mesh-list
14423539|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14423540|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14926506|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14926507|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926508|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14926509|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14926510|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423541|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14423542|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745578|NCT00596206|Leflunomide|leflunomide|mesh-list
14745579|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423543|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423544|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
14423545|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423546|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14423547|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
14423548|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14423549|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14423550|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423551|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423552|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14423553|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14745580|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745581|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745582|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
14745583|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745584|NCT00596219|Celecoxib|celecoxib|mesh-list
14745585|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14745586|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14745587|NCT00596219|Analgesics|analgesics|mesh-ancestor
14745588|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
14423554|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
14423555|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
14423556|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14423557|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14423558|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423559|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
14423560|NCT01714336|Coagulants|coagulants|mesh-ancestor
14423561|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
14423562|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
14423563|NCT01714544|Hormones|hormones|mesh-ancestor
14423564|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423565|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423566|NCT01714609|Sorafenib|sorafenib|mesh-list
14423567|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423568|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14745589|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745590|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423569|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423570|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423571|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14423572|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
14423573|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14423574|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
14423575|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14423576|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423577|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14926511|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926512|NCT01409772|Ethanol|ethanol|mesh-list
14926513|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14926514|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926515|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926516|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926517|NCT01410162|Tacrolimus|tacrolimus|mesh-list
14926518|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926519|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
14926520|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926521|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14926522|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926523|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926524|NCT01410201|Dexamethasone|dexamethasone|mesh-list
14926525|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
14926526|NCT01410201|BB 1101|bb 1101|mesh-list
14926527|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926528|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
14926529|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
14926530|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423578|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14423579|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423580|NCT01715207|Atenolol|atenolol|mesh-list
14423581|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14423582|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14423583|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
14423584|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
14423585|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423586|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423587|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14423588|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14423589|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14423590|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
14423591|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423592|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423593|NCT01715233|Leucovorin|leucovorin|mesh-list
14423594|NCT01715233|Carboplatin|carboplatin|mesh-list
14423595|NCT01715233|Docetaxel|docetaxel|mesh-list
14423596|NCT01715233|Fluorouracil|fluorouracil|mesh-list
14423597|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423598|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
14423599|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
14423600|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
14423601|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423602|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
14423603|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14423604|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423605|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
14423606|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423607|NCT01715233|Antidotes|antidotes|mesh-ancestor
14423608|NCT01715233|Protective Agents|protective agents|mesh-ancestor
14423609|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
14423610|NCT01715233|Vitamins|vitamins|mesh-ancestor
14423611|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
14423612|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
14423613|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14423614|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14423615|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14423616|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
14423617|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423618|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423619|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423620|NCT01715415|Ribavirin|ribavirin|mesh-list
14423621|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
14423622|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423623|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
14423624|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423625|NCT01715805|Cariprazine|cariprazine|mesh-list
14423626|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
14423627|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14423628|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14423629|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14423630|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423631|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423632|NCT01715896|Golimumab|golimumab|mesh-list
14423633|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
14423634|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14423635|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423636|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423637|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
14423638|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423639|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423640|NCT01716039|Adalimumab|adalimumab|mesh-list
14423641|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423642|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468157|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468158|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468159|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468160|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14468161|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14468162|NCT02274311|Clomiphene|clomiphene|mesh-list
14468163|NCT02274311|Enclomiphene|enclomiphene|mesh-list
14468164|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
14468165|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14468166|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
14468167|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468168|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468169|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14468170|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
14468171|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14468172|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14468173|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14468174|NCT02274766|Amantadine|amantadine|mesh-list
14468175|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14468176|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14468177|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
14468178|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468179|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
14468180|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468181|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468182|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468183|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468184|NCT02274766|Analgesics|analgesics|mesh-ancestor
14468185|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
14468186|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468187|NCT02274792|Etanercept|etanercept|mesh-list
14468188|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14926531|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926532|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745591|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745592|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745593|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14745594|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14745595|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745596|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745597|NCT00596297|Bevacizumab|bevacizumab|mesh-list
14468189|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14745598|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14745599|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745600|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14745601|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14745602|NCT00596297|Growth Substances|growth substances|mesh-ancestor
14745603|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745604|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
14745605|NCT00596336|Imiquimod|imiquimod|mesh-list
14745606|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14745607|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
14745608|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926533|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
14926534|NCT01410201|Hormones|hormones|mesh-ancestor
14926535|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926536|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14423643|NCT01716156|Ribavirin|ribavirin|mesh-list
14926537|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423644|NCT01716156|Grazoprevir|grazoprevir|mesh-list
14423645|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
14423646|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423647|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
14423648|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423649|NCT01716195|Paclitaxel|paclitaxel|mesh-list
14423650|NCT01716195|Carboplatin|carboplatin|mesh-list
14423651|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14423652|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423653|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
14423654|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
14423655|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
14423656|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423657|NCT01716208|Ofatumumab|ofatumumab|mesh-list
14423658|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423659|NCT01716221|Dexetimide|dexetimide|mesh-list
14423660|NCT01716221|Bupropion|bupropion|mesh-list
14423661|NCT01716221|Citalopram|citalopram|mesh-list
14423662|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14423663|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
14423664|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14423665|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14423666|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14745609|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745610|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
14745611|NCT00596375|Lidocaine|lidocaine|mesh-list
14745612|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
14745613|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
14926538|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
14423667|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468190|NCT02274792|Analgesics|analgesics|mesh-ancestor
14468191|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
14468192|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468193|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468194|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468195|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468196|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14468197|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14468198|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
14423668|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423669|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
14423670|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423671|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423672|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14423673|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423674|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423675|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14423676|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
14423677|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14423678|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14423679|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
14423680|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
14423681|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423682|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14423683|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14423684|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
14423685|NCT01716234|Posaconazole|posaconazole|mesh-list
14423686|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
14423687|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423688|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14423689|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14423690|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14423691|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14423692|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423693|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745614|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745615|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745616|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
14745617|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745618|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14745619|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14745620|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14745621|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745622|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745623|NCT00596414|Midazolam|midazolam|mesh-list
14745624|NCT00596414|Meperidine|meperidine|mesh-list
14745625|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14745626|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14745627|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745628|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745629|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14745630|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14745631|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745632|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14926539|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423694|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423695|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14423696|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
14423697|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423698|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423699|NCT01716585|Ribavirin|ribavirin|mesh-list
14423700|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
14423701|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423702|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
14423703|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423704|NCT01716715|Paclitaxel|paclitaxel|mesh-list
14423705|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14423706|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14423707|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423708|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
14423709|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
14423710|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
14423711|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423712|NCT01716754|Omalizumab|omalizumab|mesh-list
14423713|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14423714|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14423715|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
14423716|NCT01717040|Pioglitazone|pioglitazone|mesh-list
14423717|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14423718|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423719|NCT01717053|Prednisone|prednisone|mesh-list
14423720|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
14423721|NCT01717053|Androgens|androgens|mesh-list
14423722|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423723|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
14423724|NCT01717053|Hormones|hormones|mesh-ancestor
14423725|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423726|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423727|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14423728|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423729|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14423730|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423731|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423732|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
14423733|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423734|NCT01717209|Epoprostenol|epoprostenol|mesh-list
14423735|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
14423736|NCT01717209|Tezosentan|tezosentan|mesh-list
14423737|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14423738|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
14423739|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423740|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423741|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14423742|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14423743|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14423744|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
14423745|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423746|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423747|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14423748|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
14423749|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
14423750|NCT01717209|Protective Agents|protective agents|mesh-ancestor
14423751|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14423752|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14423753|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
14423754|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14423755|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14423756|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
14423757|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423758|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14423759|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14423760|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423761|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423762|NCT01717313|Metformin|metformin|mesh-list
14423763|NCT01717313|Glimepiride|glimepiride|mesh-list
14423764|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14423765|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423766|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14423767|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14423768|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
14423769|NCT01717326|Ribavirin|ribavirin|mesh-list
14423770|NCT01717326|Grazoprevir|grazoprevir|mesh-list
14423771|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
14423772|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423773|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
14423774|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423775|NCT01717456|Loperamide|loperamide|mesh-list
14423776|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
14423777|NCT01717456|Laxatives|laxatives|mesh-list
14423778|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14423779|NCT01717638|Vaccines|vaccines|mesh-list
14423780|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
14423781|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423782|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14423783|NCT01717742|Plasminogen|plasminogen|mesh-list
14423784|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14423785|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14423786|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423787|NCT01717768|Testosterone|testosterone|mesh-list
14423788|NCT01717768|Androgens|androgens|mesh-ancestor
14423789|NCT01717768|Hormones|hormones|mesh-ancestor
14745633|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
14745634|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
14745635|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
14745636|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
14745637|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423790|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423791|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423792|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
14745638|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745639|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14745640|NCT00596414|Narcotics|narcotics|mesh-ancestor
14423793|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
14745641|NCT00596414|Analgesics|analgesics|mesh-ancestor
14423794|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
14423795|NCT01717898|Prednisone|prednisone|mesh-list
14423796|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
14423797|NCT01717898|Dactolisib|dactolisib|mesh-list
14423798|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423799|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
14423800|NCT01717898|Hormones|hormones|mesh-ancestor
14423801|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423802|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423803|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14423804|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423805|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14423806|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423807|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423808|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
14423809|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423810|NCT01718353|Prednisone|prednisone|mesh-list
14423811|NCT01718353|Docetaxel|docetaxel|mesh-list
14423812|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423813|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
14423814|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
14423815|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
14423816|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423817|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14423818|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
14423819|NCT01718353|Hormones|hormones|mesh-ancestor
14423820|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423821|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423822|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14423823|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14423824|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14423825|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423826|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14423827|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14423828|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745642|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
14745643|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745644|NCT00596479|Lenograstim|lenograstim|mesh-list
14745645|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14745646|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
14745647|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745648|NCT00596531|Acamprosate|acamprosate|mesh-list
14745649|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14745650|NCT00596557|Everolimus|everolimus|mesh-list
14745651|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745652|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745653|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
14745654|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745655|NCT00596596|Prucalopride|prucalopride|mesh-list
14745656|NCT00596596|Laxatives|laxatives|mesh-ancestor
14423829|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423830|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
14423831|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423832|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14423833|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14423834|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423835|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14423836|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14423837|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14423838|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423839|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
14423840|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423841|NCT01718691|Rituximab|rituximab|mesh-list
14423842|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14423843|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423844|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
14423845|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423846|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14423847|NCT01719003|Metformin|metformin|mesh-list
14423848|NCT01719003|Empagliflozin|empagliflozin|mesh-list
14423849|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14423850|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423851|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14423852|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423853|NCT01719172|Hemostatics|hemostatics|mesh-list
14423854|NCT01719172|Coagulants|coagulants|mesh-ancestor
14423855|NCT01719367|Atenolol|atenolol|mesh-list
14423856|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14423857|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14423858|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
14423859|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
14931118|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
14423860|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423861|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423862|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14423863|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14423864|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14423865|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
14423866|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423867|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423868|NCT01719380|Cetuximab|cetuximab|mesh-list
14423869|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14423870|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423871|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14423872|NCT01719653|Laxatives|laxatives|mesh-ancestor
14423873|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14423874|NCT01719757|Oxycodone|oxycodone|mesh-list
14423875|NCT01719757|Naloxone|naloxone|mesh-list
14423876|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14423877|NCT01719757|Narcotics|narcotics|mesh-ancestor
14423878|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423879|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423880|NCT01719757|Analgesics|analgesics|mesh-ancestor
14423881|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
14423882|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423883|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14423884|NCT01719783|Vaccines|vaccines|mesh-list
14423885|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
14423886|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423887|NCT01719861|Desipramine|desipramine|mesh-list
14423888|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14423889|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
14423890|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14423891|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423892|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423893|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14423894|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14423895|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14423896|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
14423897|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423898|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423899|NCT01720043|Bortezomib|bortezomib|mesh-list
14423900|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423901|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
14423902|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
14423903|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423904|NCT01720225|Azacitidine|azacitidine|mesh-list
14423905|NCT01720225|Decitabine|decitabine|mesh-list
14423906|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14423907|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
14423908|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423909|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423910|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423911|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14423912|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14423913|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423914|NCT01720264|Incretins|incretins|mesh-ancestor
14423915|NCT01720264|Hormones|hormones|mesh-ancestor
14423916|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423917|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14423918|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
14423919|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423920|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423921|NCT01720277|Vaccines|vaccines|mesh-list
14423922|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
14423923|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423924|NCT01720316|Glycine|glycine|mesh-list
14423925|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
14423926|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423927|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423928|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423929|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
14423930|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
14423931|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14423932|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14423933|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423934|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423935|NCT01720524|Urological Agents|urological agents|mesh-ancestor
14423936|NCT01720602|Letrozole|letrozole|mesh-list
14423937|NCT01720602|Vorinostat|vorinostat|mesh-list
14423938|NCT01720602|Anastrozole|anastrozole|mesh-list
14423939|NCT01720602|Exemestane|exemestane|mesh-list
14423940|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14423941|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14423942|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14423943|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14423944|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423945|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423946|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14423947|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
14468199|NCT02274870|Bupivacaine|bupivacaine|mesh-list
14926540|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745657|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745658|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14745659|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14745660|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
14423948|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14423949|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423950|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14423951|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14423952|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14423953|NCT01720667|Levetiracetam|levetiracetam|mesh-list
14423954|NCT01720667|Phenobarbital|phenobarbital|mesh-list
14423955|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
14423956|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
14423957|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14423958|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423959|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423960|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14423961|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14423962|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14423963|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423964|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
14745661|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745662|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745663|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745664|NCT00596609|Morphine|morphine|mesh-list
14745665|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14745666|NCT00596609|Narcotics|narcotics|mesh-ancestor
14745667|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745668|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745669|NCT00596609|Analgesics|analgesics|mesh-ancestor
14745670|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
14745671|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926541|NCT01410214|Cisplatin|cisplatin|mesh-list
14926542|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14926543|NCT01410214|Vinorelbine|vinorelbine|mesh-list
14926544|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745672|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14745673|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926545|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14423965|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
14423966|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14926546|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926547|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423967|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14423968|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14423969|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
14423970|NCT01720797|Anesthetics|anesthetics|mesh-list
14423971|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
14423972|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14423973|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423974|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
14423975|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423976|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423977|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
14423978|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423979|NCT01721070|Ketoconazole|ketoconazole|mesh-list
14423980|NCT01721070|Sufentanil|sufentanil|mesh-list
14423981|NCT01721070|Dsuvia|dsuvia|mesh-list
14423982|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14423983|NCT01721070|Narcotics|narcotics|mesh-ancestor
14423984|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14423985|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14423986|NCT01721070|Analgesics|analgesics|mesh-ancestor
14423987|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
14423988|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14423989|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14423990|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14423991|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
14423992|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
14423993|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
14423994|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14423995|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14423996|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14423997|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14423998|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14423999|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14424000|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
14424001|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424002|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14424003|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14424004|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14424005|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14424006|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
14424007|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424008|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
14424009|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14424010|NCT01721226|Narcotics|narcotics|mesh-ancestor
14424011|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424012|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424013|NCT01721226|Analgesics|analgesics|mesh-ancestor
14424014|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
14424015|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745674|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424016|NCT01721317|Ezogabine|ezogabine|mesh-list
14424017|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
14424018|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14424019|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424020|NCT01721330|Naltrexone|naltrexone|mesh-list
14424021|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14424022|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14424023|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424024|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
14424025|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424026|NCT01721408|Imipenem|imipenem|mesh-list
14424027|NCT01721408|Tigecycline|tigecycline|mesh-list
14424028|NCT01721408|Cilastatin|cilastatin|mesh-list
14424029|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14424030|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424031|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14424032|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424033|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424034|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
14424035|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
14424036|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14424037|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424038|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424039|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14424040|NCT01721460|Analgesics|analgesics|mesh-ancestor
14424041|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
14424042|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424043|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14424044|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14424045|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14424046|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
14424047|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424048|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424049|NCT01721486|Acetaminophen|acetaminophen|mesh-list
14745675|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424050|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14424051|NCT01721486|Analgesics|analgesics|mesh-ancestor
14424052|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
14424053|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424054|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424055|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
14424056|NCT01721564|Bosentan|bosentan|mesh-list
14424057|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14424058|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14424059|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424060|NCT01721603|Trametinib|trametinib|mesh-list
14424061|NCT01721603|Dabrafenib|dabrafenib|mesh-list
14424062|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424063|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424064|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424065|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424066|NCT01721772|Nivolumab|nivolumab|mesh-list
14424067|NCT01721772|Dacarbazine|dacarbazine|mesh-list
14745676|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745677|NCT00596804|Veltuzumab|veltuzumab|mesh-list
14745678|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753452|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753453|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753454|NCT05133895|Prednisone|prednisone|mesh-list
14753455|NCT05133895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14753456|NCT05133895|Glucocorticoids|glucocorticoids|mesh-ancestor
14424068|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14424069|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424070|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14424071|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424072|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14424073|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
14424074|NCT01721876|Cytarabine|cytarabine|mesh-list
14424075|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14424076|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
14424077|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424078|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424079|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
14424080|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424081|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14424082|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
14424083|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424084|NCT01721967|Ranolazine|ranolazine|mesh-list
14424085|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14424086|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14424087|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424088|NCT01722045|Aflibercept|aflibercept|mesh-list
14424089|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424090|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14424091|NCT01722045|Growth Substances|growth substances|mesh-ancestor
14424092|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424093|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
14424094|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424095|NCT01722071|Oxytocin|oxytocin|mesh-list
14424096|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
14424097|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14424098|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424099|NCT01722097|Rocuronium|rocuronium|mesh-list
14424100|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14424101|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14424102|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14424103|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424104|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424105|NCT01722162|Bevacizumab|bevacizumab|mesh-list
14424106|NCT01722162|Capecitabine|capecitabine|mesh-list
14424107|NCT01722162|Levocetirizine|levocetirizine|mesh-list
14424108|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14424109|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424110|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424111|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14424112|NCT01722162|Growth Substances|growth substances|mesh-ancestor
14424113|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424114|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
14424115|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14424116|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
14424117|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424118|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14424119|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14424120|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
14424121|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
14424122|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424123|NCT01722266|Liraglutide|liraglutide|mesh-list
14424124|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14424125|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424126|NCT01722266|Incretins|incretins|mesh-ancestor
14424127|NCT01722266|Hormones|hormones|mesh-ancestor
14424128|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424129|NCT01722292|Carboplatin|carboplatin|mesh-list
14424130|NCT01722292|Etoposide|etoposide|mesh-list
14424131|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424132|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14926548|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14926549|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
14926550|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
14926551|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
14926552|NCT01410370|Endostar protein|endostar protein|mesh-list
14424133|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14424134|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14424135|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424136|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424137|NCT01722318|Plecanatide|plecanatide|mesh-list
14424138|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14424139|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
14424140|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424141|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14424142|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
14424143|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14424144|NCT01722435|Narcotics|narcotics|mesh-ancestor
14424145|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424146|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424147|NCT01722435|Analgesics|analgesics|mesh-ancestor
14424148|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
14424149|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926553|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424150|NCT01722487|Chlorambucil|chlorambucil|mesh-list
14424151|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14424152|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
14424153|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424154|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468200|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
14468201|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
14468202|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468203|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468204|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
14468205|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468206|NCT02274948|Metformin|metformin|mesh-list
14468207|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468208|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468209|NCT02275052|Albuterol|albuterol|mesh-list
14468210|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14468211|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
14468212|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468213|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468214|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14468215|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14468216|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
14468217|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14468218|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14468219|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14468220|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14468221|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
14468222|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468223|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468224|NCT02275156|Evolocumab|evolocumab|mesh-list
14468225|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14468226|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14468227|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
14468228|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424155|NCT01722604|Brinzolamide|brinzolamide|mesh-list
14424156|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14424157|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424158|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424159|NCT01722669|Quercetin|quercetin|mesh-list
14424160|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
14424161|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424162|NCT01722669|Protective Agents|protective agents|mesh-ancestor
14424163|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424164|NCT01723072|Omalizumab|omalizumab|mesh-list
14424165|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14424166|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14424167|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14424168|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
14424169|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
14424170|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424171|NCT01723228|Rasagiline|rasagiline|mesh-list
14424172|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14424173|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424174|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424175|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14424176|NCT01723228|Protective Agents|protective agents|mesh-ancestor
14424177|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424178|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
14424179|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
14424180|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424181|NCT01723384|Naltrexone|naltrexone|mesh-list
14424182|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14424183|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14424184|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424185|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
14424186|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424187|NCT01723514|Erenumab|erenumab|mesh-list
14424188|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14424189|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424190|NCT01723514|Analgesics|analgesics|mesh-ancestor
14424191|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
14424192|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424193|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424194|NCT01723696|Vitamins|vitamins|mesh-list
14424195|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
14424196|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
14424197|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424198|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
14424199|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424200|NCT01723696|Protective Agents|protective agents|mesh-ancestor
14424201|NCT01723722|Methadone|methadone|mesh-list
14424202|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14424203|NCT01723722|Narcotics|narcotics|mesh-ancestor
14424204|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424205|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424206|NCT01723722|Analgesics|analgesics|mesh-ancestor
14424207|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
14424208|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424209|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
14424210|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14424211|NCT01723904|Rotigotine|rotigotine|mesh-list
14424212|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
14424213|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
14424214|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424215|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424216|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424217|NCT01724021|Prednisone|prednisone|mesh-list
14424218|NCT01724021|Prednisolone|prednisolone|mesh-list
14424219|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14424220|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
14424221|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14424222|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
14424223|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
14424224|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14424225|NCT01724021|Rituximab|rituximab|mesh-list
14424226|NCT01724021|Vincristine|vincristine|mesh-list
14424227|NCT01724021|Doxorubicin|doxorubicin|mesh-list
14424228|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14424229|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14424230|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
14424231|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14424232|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
14424233|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424234|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14424235|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14424236|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
14424237|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424238|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424239|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14424240|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14424241|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14424242|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
14424243|NCT01724021|Hormones|hormones|mesh-ancestor
14424244|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424245|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14424246|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14424247|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
14424248|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
14424249|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
14424250|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
14424251|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
14753457|NCT05133895|Hormones|hormones|mesh-ancestor
14424252|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424253|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14424254|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14424255|NCT01724021|Protective Agents|protective agents|mesh-ancestor
14424256|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14424257|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14424258|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14424259|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424260|NCT01724177|Lenalidomide|lenalidomide|mesh-list
14424261|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
14424262|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424263|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424264|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14424265|NCT01724177|Growth Substances|growth substances|mesh-ancestor
14424266|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
14424267|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424268|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14424269|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424270|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424271|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424272|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424273|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424274|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14424275|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14424276|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
14424277|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424278|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424279|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14424280|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14424281|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
14424282|NCT01724489|Hormones|hormones|mesh-list
14424283|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424284|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424285|NCT01724528|Allopurinol|allopurinol|mesh-list
14424286|NCT01724528|Febuxostat|febuxostat|mesh-list
14424287|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
14424288|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424289|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424290|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
14424291|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14424292|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14424293|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
14424294|NCT01724528|Protective Agents|protective agents|mesh-ancestor
14424295|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424296|NCT01725126|Metformin|metformin|mesh-list
14424297|NCT01725126|Liraglutide|liraglutide|mesh-list
14424298|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14424299|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424300|NCT01725126|Incretins|incretins|mesh-ancestor
14424301|NCT01725126|Hormones|hormones|mesh-ancestor
14424302|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424303|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14424304|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
14424305|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424306|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424307|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424308|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424309|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424310|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14424311|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
14424312|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424313|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424314|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424315|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424316|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424317|NCT01725386|Capecitabine|capecitabine|mesh-list
14424318|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14424319|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
14424320|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424321|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424322|NCT01725451|Testosterone|testosterone|mesh-list
14424323|NCT01725451|Androgens|androgens|mesh-ancestor
14424324|NCT01725451|Hormones|hormones|mesh-ancestor
14424325|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424326|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424327|NCT01725529|Ribavirin|ribavirin|mesh-list
14424328|NCT01725529|Simeprevir|simeprevir|mesh-list
14424329|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
14424330|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424331|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
14424332|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424333|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
14424334|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424335|NCT01726023|Metronidazole|metronidazole|mesh-list
14424336|NCT01726023|Meropenem|meropenem|mesh-list
14424337|NCT01726023|Ceftazidime|ceftazidime|mesh-list
14424338|NCT01726023|Avibactam|avibactam|mesh-list
14926554|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14926555|NCT01410370|Growth Substances|growth substances|mesh-ancestor
14926556|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926557|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
14926558|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926559|NCT01410630|Telbivudine|telbivudine|mesh-list
14926560|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
14926561|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926562|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14424339|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14424340|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424341|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14424342|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14424343|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14424344|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14424345|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424346|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424347|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
14424348|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14424349|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14424350|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14424351|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424352|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424353|NCT01726049|Urological Agents|urological agents|mesh-ancestor
14424354|NCT01726270|Tamsulosin|tamsulosin|mesh-list
14424355|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14424356|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14424357|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14424358|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
14424359|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424360|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424361|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424362|NCT01726270|Urological Agents|urological agents|mesh-ancestor
14424363|NCT01726335|Risperidone|risperidone|mesh-list
14424364|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14424365|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
14424366|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424367|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424368|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424369|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424370|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424371|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424372|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424373|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14424374|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
14424375|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14424376|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
14424377|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424378|NCT01726621|Insulin|insulin|mesh-list
14424379|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14424380|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424381|NCT01726738|Trametinib|trametinib|mesh-list
14424382|NCT01726738|Dabrafenib|dabrafenib|mesh-list
14424383|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424384|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424385|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424386|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424387|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
14424388|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14424389|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
14424390|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424391|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424392|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14424393|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
14424394|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
14424395|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14424396|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
14424397|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424398|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424399|NCT01727089|Bevacizumab|bevacizumab|mesh-list
14424400|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14424401|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
14424402|NCT01727089|Antibodies|antibodies|mesh-list
14424403|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
14424404|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14424405|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
14424406|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424407|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424408|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14424409|NCT01727089|Growth Substances|growth substances|mesh-ancestor
14424410|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424411|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14424412|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
14424413|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
14424414|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14424415|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14424416|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14424417|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
14424418|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424419|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424420|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424421|NCT01727258|Fluorides|fluorides|mesh-list
14424422|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
14424423|NCT01727258|Protective Agents|protective agents|mesh-ancestor
14424424|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424425|NCT01727336|Axitinib|axitinib|mesh-list
14424426|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424427|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424428|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424429|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424430|NCT01727414|Methylphenidate|methylphenidate|mesh-list
14424431|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14424432|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424433|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14424434|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14424435|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14424436|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424437|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
14424438|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424439|NCT01727700|Aripiprazole|aripiprazole|mesh-list
14424440|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
14424441|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424442|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424443|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424444|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424445|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424446|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
14424447|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
14424448|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424449|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926563|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424450|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14424451|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14424452|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
14424453|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14424454|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14424455|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14424456|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14424457|NCT01727713|Aripiprazole|aripiprazole|mesh-list
14424458|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
14424459|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424460|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424461|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424462|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424463|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424464|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
14424465|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
14424466|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424467|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424468|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14424469|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14424470|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
14424471|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14424472|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14424473|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14424474|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14424475|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14424476|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
14424477|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
14424478|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424479|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424480|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424481|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424482|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424483|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
14424484|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424485|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424486|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
14424487|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
14424488|NCT01727791|Pregabalin|pregabalin|mesh-list
14424489|NCT01727791|Analgesics|analgesics|mesh-ancestor
14424490|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
14424491|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424492|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424493|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
14424494|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14424495|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14424496|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424497|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14424498|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14424499|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424500|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424501|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424502|NCT01728077|Brivaracetam|brivaracetam|mesh-list
14424503|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
14424504|NCT01728194|Citalopram|citalopram|mesh-list
14424505|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14424506|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14424507|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14424508|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424509|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424510|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
14424511|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424512|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14424513|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
14424514|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424515|NCT01728246|Acetaminophen|acetaminophen|mesh-list
14424516|NCT01728246|Tramadol|tramadol|mesh-list
14424517|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14424518|NCT01728246|Analgesics|analgesics|mesh-ancestor
14424519|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
14424520|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424521|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424522|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
14424523|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14424524|NCT01728246|Narcotics|narcotics|mesh-ancestor
14424525|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424526|NCT01728324|Ribavirin|ribavirin|mesh-list
14424527|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
14424528|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424529|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
14424530|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424531|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
14424532|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14424533|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14424534|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14424535|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14424536|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424537|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
14424538|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424539|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424540|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14424541|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424542|NCT01728376|Daptomycin|daptomycin|mesh-list
14424543|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14424544|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424545|NCT01728584|Bromides|bromides|mesh-list
14424546|NCT01728584|Rocuronium|rocuronium|mesh-list
14424547|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
14424548|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14424549|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14424550|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14424551|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424552|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424553|NCT01728623|Lenvatinib|lenvatinib|mesh-list
14424554|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424555|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424556|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424557|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424558|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
14424559|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14424560|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14424561|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424562|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
14424563|NCT01728636|Coagulants|coagulants|mesh-ancestor
14424564|NCT01728779|Nelfinavir|nelfinavir|mesh-list
14424565|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14424566|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14424567|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
14424568|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424569|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424570|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14424571|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14424572|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
14424573|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424574|NCT01728805|Vorinostat|vorinostat|mesh-list
14424575|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
14424576|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424577|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14424578|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424579|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424580|NCT01729156|Metformin|metformin|mesh-list
14424581|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14424582|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424583|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
14424584|NCT01729338|Lenalidomide|lenalidomide|mesh-list
14424585|NCT01729338|Bortezomib|bortezomib|mesh-list
14424586|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14424587|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
14424588|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424589|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14424590|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14424591|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
14424592|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424593|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424594|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14424595|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424596|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14424597|NCT01729338|Growth Substances|growth substances|mesh-ancestor
14424598|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
14424599|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
14424600|NCT01729494|Prednisone|prednisone|mesh-list
14424601|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
14424602|NCT01729494|Abatacept|abatacept|mesh-list
14424603|NCT01729494|Tacrolimus|tacrolimus|mesh-list
14424604|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
14424605|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14424606|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14424607|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
14424608|NCT01729494|Hormones|hormones|mesh-ancestor
14424609|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424610|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424611|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14424612|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424613|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14424614|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
14424615|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14424616|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424617|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424618|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14424619|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14424620|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
14424621|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14424622|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424623|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14424624|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14424625|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14424626|NCT01729559|Heparin|heparin|mesh-list
14424627|NCT01729559|Enoxaparin|enoxaparin|mesh-list
14424628|NCT01729559|Calcium heparin|calcium heparin|mesh-list
14424629|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
14926564|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926565|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
14926566|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14926567|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926568|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
14926569|NCT01410708|Dasatinib|dasatinib|mesh-list
14926570|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926571|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14926572|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926573|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926574|NCT01410747|Tacrolimus|tacrolimus|mesh-list
14926575|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926576|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
14424630|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
14424631|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14424632|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14424633|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424634|NCT01729598|Valproic Acid|valproic acid|mesh-list
14424635|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
14424636|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424637|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424638|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
14424639|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424640|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424641|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
14424642|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424643|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424644|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424645|NCT01729728|Tapentadol|tapentadol|mesh-list
14424646|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14424647|NCT01729728|Narcotics|narcotics|mesh-ancestor
14424648|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424649|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424650|NCT01729728|Analgesics|analgesics|mesh-ancestor
14424651|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
14424652|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424653|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14424654|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14424655|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14424656|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424657|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
14424658|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424659|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14424660|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14424661|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14424662|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14424663|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
14424664|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424665|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424666|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424667|NCT01729819|Urological Agents|urological agents|mesh-ancestor
14424668|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
14424669|NCT01729819|Coagulants|coagulants|mesh-ancestor
14424670|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14424671|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
14424672|NCT01729845|Cytarabine|cytarabine|mesh-list
14424673|NCT01729845|Etoposide|etoposide|mesh-list
14424674|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
14424675|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
14424676|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
14424677|NCT01729845|Decitabine|decitabine|mesh-list
14424678|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14424679|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424680|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14424681|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14424682|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424683|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424684|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14424685|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
14424686|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
14424687|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424688|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14424689|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
14424690|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424691|NCT01729845|Analgesics|analgesics|mesh-ancestor
14424692|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
14424693|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424694|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
14424695|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
14424696|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14424697|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14424698|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14424699|NCT01729871|Vitamin K|vitamin k|mesh-list
14424700|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
14424701|NCT01729871|Vitamins|vitamins|mesh-ancestor
14424702|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
14424703|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424704|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14424705|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
14424706|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14424707|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
14424708|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424709|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424710|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
14424711|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14424712|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14424713|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
14424714|NCT01729871|Coagulants|coagulants|mesh-ancestor
14424715|NCT01729923|Celecoxib|celecoxib|mesh-list
14424716|NCT01729923|Capecitabine|capecitabine|mesh-list
14424717|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
14424718|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14424719|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
14424720|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424721|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424722|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14424723|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14424724|NCT01729923|Analgesics|analgesics|mesh-ancestor
14424725|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
14424726|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424727|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424728|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14424729|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14424730|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14424731|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14424732|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424733|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14424734|NCT01730040|Atorvastatin|atorvastatin|mesh-list
14424735|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14424736|NCT01730040|Ezetimibe|ezetimibe|mesh-list
14424737|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14424738|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14424739|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
14424740|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424741|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14424742|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14424743|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424744|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14424745|NCT01730053|Ezetimibe|ezetimibe|mesh-list
14424746|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14424747|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14424748|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
14424749|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424750|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14424751|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14424752|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424753|NCT01730378|Vaccines|vaccines|mesh-list
14424754|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
14424755|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424756|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
14424757|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14424758|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424759|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14424760|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424761|NCT01730586|Paclitaxel|paclitaxel|mesh-list
14424762|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14424763|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14424764|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424765|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
14424766|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
14424767|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
14424768|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424769|NCT01730729|Cabergoline|cabergoline|mesh-list
14424770|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14424771|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14424772|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
14424773|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
14424774|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424775|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424776|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424777|NCT01730846|Doxazosin|doxazosin|mesh-list
14424778|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14424779|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14424780|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14424781|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14424782|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
14424783|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424784|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424785|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424786|NCT01730872|Prednisolone|prednisolone|mesh-list
14424787|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14424788|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
14424789|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14424790|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
14424791|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14424792|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14424793|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14926577|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926578|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14424794|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
14424795|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14424796|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
14424797|NCT01730872|Hormones|hormones|mesh-ancestor
14424798|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424799|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424800|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14424801|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424802|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
14424803|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
14424804|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424805|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14424806|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14424807|NCT01730872|Protective Agents|protective agents|mesh-ancestor
14424808|NCT01730950|Bevacizumab|bevacizumab|mesh-list
14424809|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14424810|NCT01730950|Antibodies|antibodies|mesh-list
14424811|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
14424812|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14424813|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424814|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424815|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14424816|NCT01730950|Growth Substances|growth substances|mesh-ancestor
14424817|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424818|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
14424819|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
14468229|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14468230|NCT02275338|Lanreotide|lanreotide|mesh-list
14468231|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468232|NCT02275611|Oxytocin|oxytocin|mesh-list
14468233|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
14468234|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14468235|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468236|NCT02275780|Ritonavir|ritonavir|mesh-list
14468237|NCT02275780|Darunavir|darunavir|mesh-list
14468238|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14468239|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14468240|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14468241|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
14468242|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468243|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468244|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14468245|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14468246|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
14468247|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468248|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14468249|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14468250|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14468251|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14468252|NCT02276027|Ceritinib|ceritinib|mesh-list
14468253|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468254|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14468255|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468256|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468257|NCT02276040|Bupivacaine|bupivacaine|mesh-list
14468258|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
14468259|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
14468260|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468261|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468262|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
14468263|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468264|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
14926579|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931119|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
14468265|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
14424820|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14424821|NCT01731002|Latanoprost|latanoprost|mesh-list
14424822|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14424823|NCT01731041|Ticagrelor|ticagrelor|mesh-list
14424824|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14424825|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14424826|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14424827|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14424828|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
14424829|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424830|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424831|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424832|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14424833|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424834|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424835|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424836|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424837|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424838|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14424839|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14424840|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14424841|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
14424842|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424843|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424844|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14424845|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14424846|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
14424847|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14424848|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14424849|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
14424850|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
14424851|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14424852|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424853|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424854|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14424855|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14424856|NCT01731886|Dexamethasone|dexamethasone|mesh-list
14424857|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
14424858|NCT01731886|Melphalan|melphalan|mesh-list
14424859|NCT01731886|Lenalidomide|lenalidomide|mesh-list
14424860|NCT01731886|Sargramostim|sargramostim|mesh-list
14424861|NCT01731886|Lenograstim|lenograstim|mesh-list
14424862|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14424863|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
14424864|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424865|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14424866|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14424867|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
14424868|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424869|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424870|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14424871|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14424872|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
14424873|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
14424874|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424875|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14424876|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
14424877|NCT01731886|Hormones|hormones|mesh-ancestor
14424878|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424879|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14424880|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14424881|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14424882|NCT01731886|Growth Substances|growth substances|mesh-ancestor
14424883|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
14424884|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14424885|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14424886|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
14424887|NCT01731938|Coagulants|coagulants|mesh-ancestor
14424888|NCT01731951|Imetelstat|imetelstat|mesh-list
14424889|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
14424890|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424891|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424892|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424893|NCT01732445|Danazol|danazol|mesh-list
14424894|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14424895|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14424896|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
14926580|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926581|NCT01410916|Eculizumab|eculizumab|mesh-list
14926582|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14926583|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926584|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
14926585|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926586|NCT01410942|Methylphenidate|methylphenidate|mesh-list
14424897|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424898|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424899|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424900|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424901|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424902|NCT01732458|Ondansetron|ondansetron|mesh-list
14424903|NCT01732458|Aprepitant|aprepitant|mesh-list
14926587|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14424904|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
14424905|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14424906|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424907|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
14424908|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
14424909|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424910|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14424911|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
14424912|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14424913|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14424914|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
14424915|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424916|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424917|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14424918|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14424919|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14424920|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14424921|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14424922|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
14424923|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14424924|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14424925|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14424926|NCT01732588|Artefenomel|artefenomel|mesh-list
14424927|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
14424928|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14424929|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14424930|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424931|NCT01732640|Paclitaxel|paclitaxel|mesh-list
14424932|NCT01732640|Cisplatin|cisplatin|mesh-list
14424933|NCT01732640|Carboplatin|carboplatin|mesh-list
14424934|NCT01732640|Afatinib|afatinib|mesh-list
14424935|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14424936|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424937|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
14424938|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
14424939|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
14424940|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424941|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14424942|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424943|NCT01732718|Atorvastatin|atorvastatin|mesh-list
14424944|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14424945|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14424946|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
14424947|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424948|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14424949|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14424950|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14424951|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14424952|NCT01732757|Dextrans|dextrans|mesh-list
14424953|NCT01732757|Alcaftadine|alcaftadine|mesh-list
14424954|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
14424955|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
14424956|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
14424957|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14424958|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14424959|NCT01732757|Analgesics|analgesics|mesh-ancestor
14424960|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
14424961|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14424962|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424963|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14424964|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14424965|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14424966|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14424967|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14424968|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
14424969|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
14424970|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14424971|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424972|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
14424973|NCT01732770|Denosumab|denosumab|mesh-list
14424974|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14424975|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424976|NCT01732783|Panitumumab|panitumumab|mesh-list
14424977|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14424978|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14424979|NCT01732796|Ribavirin|ribavirin|mesh-list
14424980|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
14424981|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14424982|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
14424983|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424984|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
14424985|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14424986|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424987|NCT05317364|Estradiol|estradiol|mesh-list
14424988|NCT05317364|Estrogens|estrogens|mesh-ancestor
14424989|NCT05317364|Hormones|hormones|mesh-ancestor
14424990|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14424991|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424992|NCT05317325|Vaccines|vaccines|mesh-list
14424993|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
14424994|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14424995|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
14424996|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14424997|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
14424998|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926588|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926589|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14926590|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14926591|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926592|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926593|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
14926594|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926595|NCT01410968|Poly ICLC|poly iclc|mesh-list
14424999|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
14425000|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
14425001|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
14425002|NCT05317039|Calcium|calcium|mesh-list
14425003|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14425004|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926596|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
14926597|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
14926598|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926599|NCT01411072|Gemcitabine|gemcitabine|mesh-list
14425005|NCT05317000|Nivolumab|nivolumab|mesh-list
14425006|NCT05317000|Azacitidine|azacitidine|mesh-list
14425007|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926600|NCT01411072|Fluorouracil|fluorouracil|mesh-list
14926601|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14926602|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
14926603|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926604|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926605|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
14926606|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926607|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926608|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425008|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425009|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14425010|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425011|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14425012|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
14425013|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425014|NCT05316935|Letrozole|letrozole|mesh-list
14425015|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14425016|NCT05316935|Cyproterone|cyproterone|mesh-list
14425017|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
14425018|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425019|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14425020|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14425021|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425022|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425023|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14425024|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
14425025|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425026|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425027|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14425028|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14926609|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
14425029|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14425030|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
14425031|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14425032|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14425033|NCT05316935|Estrogens|estrogens|mesh-ancestor
14425034|NCT05316935|Hormones|hormones|mesh-ancestor
14425035|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
14425036|NCT05316883|Clozapine|clozapine|mesh-list
14425037|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14425038|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
14425039|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425040|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425041|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425042|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14425043|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14425044|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425045|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14425046|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
14425047|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
14425048|NCT05316857|Itraconazole|itraconazole|mesh-list
14425049|NCT05316857|Rifampin|rifampin|mesh-list
14425050|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
14425051|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425052|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14425053|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14425054|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425055|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425056|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14425057|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14926610|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745679|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14926611|NCT01411098|Etoposide|etoposide|mesh-list
14926612|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
14926613|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926614|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14926615|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14926616|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14745680|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14745681|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14745682|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745683|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926617|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745684|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425058|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425059|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425060|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14425061|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14425062|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
14425063|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14425064|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
14425065|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14425066|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14425067|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14425068|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14425069|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14425070|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14425071|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14425072|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14425073|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
14425074|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425075|NCT05316675|Isotretinoin|isotretinoin|mesh-list
14425076|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
14468266|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14468267|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
14468268|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468269|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468270|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14468271|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
14468272|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
14468273|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14468274|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
14468275|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425077|NCT05316493|Megestrol|megestrol|mesh-list
14425078|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
14425079|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
14425080|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
14425081|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14425082|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425083|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14425084|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14425085|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14425086|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14425087|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14425088|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425089|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425090|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
14425091|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14425092|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
14425093|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14931120|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14425094|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425095|NCT05316467|Megestrol|megestrol|mesh-list
14425096|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
14425097|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14425098|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14425099|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14425100|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
14425101|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14425102|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425103|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14425104|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14425105|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425106|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425107|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
14425108|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14425109|NCT05316428|Ethanol|ethanol|mesh-list
14425110|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14745685|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745686|NCT00596986|Analgesics|analgesics|mesh-ancestor
14926618|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926619|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14926620|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14926621|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14926622|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
14926623|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926624|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14926625|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14926626|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926627|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
14926628|NCT01411124|Promethazine|promethazine|mesh-list
14926629|NCT01411124|Gabapentin|gabapentin|mesh-list
14926630|NCT01411124|Analgesics|analgesics|mesh-ancestor
14926631|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
14926632|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926633|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926634|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
14926635|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14926636|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14926637|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745687|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
14745688|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745689|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
14745690|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745691|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
14745692|NCT00597064|Prednisone|prednisone|mesh-list
14425111|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425112|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425113|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425114|NCT05316376|Paclitaxel|paclitaxel|mesh-list
14425115|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14425116|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425117|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425118|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425119|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425120|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425121|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425122|NCT05316298|Gentamicins|gentamicins|mesh-list
14425123|NCT05316298|Calcium|calcium|mesh-list
14425124|NCT05316298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14425125|NCT05316298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425126|NCT05316298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14425127|NCT05316298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425128|NCT05316298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14425129|NCT05316298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425130|NCT05316298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425131|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14425132|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425133|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425134|NCT05316168|Dexamethasone|dexamethasone|mesh-list
14425135|NCT05316168|Bupivacaine|bupivacaine|mesh-list
14425136|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425137|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
14425138|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
14425139|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425140|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425141|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425142|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
14425143|NCT05316168|Hormones|hormones|mesh-ancestor
14425144|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425145|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425146|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425147|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
14425148|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
14425149|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425150|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
14425151|NCT05316129|Hormones|hormones|mesh-list
14425152|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14425153|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425154|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425155|NCT05316116|Siltuximab|siltuximab|mesh-list
14425156|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425157|NCT05315999|Palonosetron|palonosetron|mesh-list
14425158|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
14425159|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
14425160|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745693|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745694|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
14745695|NCT00597064|Hormones|hormones|mesh-ancestor
14745696|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425161|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425162|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425163|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14425164|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14425165|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
14425166|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425167|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425168|NCT05315947|Brivaracetam|brivaracetam|mesh-list
14425169|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
14425170|NCT05315830|Vaccines|vaccines|mesh-list
14425171|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
14425172|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425173|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
14425174|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14425175|NCT05315713|Atezolizumab|atezolizumab|mesh-list
14425176|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425177|NCT05315648|Anesthetics|anesthetics|mesh-list
14425178|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425179|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425180|NCT05315557|Terlipressin|terlipressin|mesh-list
14425181|NCT05315557|Vasopressins|vasopressins|mesh-list
14425182|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
14425183|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
14425184|NCT05315557|Coagulants|coagulants|mesh-ancestor
14425185|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14425186|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14425187|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
14425188|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425189|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14425190|NCT05315479|Meloxicam|meloxicam|mesh-list
14425191|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14425192|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14425193|NCT05315479|Analgesics|analgesics|mesh-ancestor
14425194|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
14425195|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425196|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425197|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425198|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14425199|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14425200|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14425201|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425202|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425203|NCT05315388|Vitamins|vitamins|mesh-list
14425204|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
14425205|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425206|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14425207|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
14425208|NCT05315128|Methotrexate|methotrexate|mesh-list
14425209|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14425210|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
14425211|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14425212|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425213|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14425214|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
14425215|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425216|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425217|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
14425218|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425219|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14425220|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425221|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
14425222|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14425223|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14468276|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468277|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14468278|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14468279|NCT02276274|Alogliptin|alogliptin|mesh-list
14468280|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468281|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468282|NCT02276274|Incretins|incretins|mesh-ancestor
14468283|NCT02276274|Hormones|hormones|mesh-ancestor
14468284|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468285|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14468286|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
14468287|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468288|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468289|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14468290|NCT02276482|Metronidazole|metronidazole|mesh-list
14468291|NCT02276482|Vancomycin|vancomycin|mesh-list
14468292|NCT02276482|Clindamycin|clindamycin|mesh-list
14468293|NCT02276482|Cefazolin|cefazolin|mesh-list
14468294|NCT02276482|Linezolid|linezolid|mesh-list
14468295|NCT02276482|Cephalexin|cephalexin|mesh-list
14468296|NCT02276482|Aztreonam|aztreonam|mesh-list
14468297|NCT02276482|Tedizolid|tedizolid|mesh-list
14468298|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926638|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14468299|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14745697|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745698|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14745699|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745700|NCT00597181|Mitomycins|mitomycins|mesh-list
14745701|NCT00597181|Mitomycin|mitomycin|mesh-list
14745702|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745703|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468300|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14468301|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14425224|NCT05314998|Leucovorin|leucovorin|mesh-list
14425225|NCT05314998|Folic Acid|folic acid|mesh-list
14425226|NCT05314998|Gemcitabine|gemcitabine|mesh-list
14425227|NCT05314998|Fluorouracil|fluorouracil|mesh-list
14425228|NCT05314998|Capecitabine|capecitabine|mesh-list
14425229|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
14425230|NCT05314998|Irinotecan|irinotecan|mesh-list
14425231|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
14425232|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14745704|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
14425233|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
14425234|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425235|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425236|NCT05314998|Antiviral Agents|antiviral agents|mesh-ancestor
14425237|NCT05314998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425238|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425239|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425240|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
14425241|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425242|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14425243|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14425244|NCT05314998|Antidotes|antidotes|mesh-ancestor
14425245|NCT05314998|Protective Agents|protective agents|mesh-ancestor
14425246|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
14425247|NCT05314998|Vitamins|vitamins|mesh-ancestor
14425248|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
14425249|NCT05314998|Hematinics|hematinics|mesh-ancestor
14425250|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
14425251|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
14425252|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425253|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
14425254|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425255|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
14425256|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14425257|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14425258|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14425259|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14425260|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425261|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
14425262|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425263|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425264|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14425265|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425266|NCT05308420|Morphine|morphine|mesh-list
14425267|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425268|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425269|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14425270|NCT05308420|Narcotics|narcotics|mesh-ancestor
14425271|NCT05308420|Analgesics|analgesics|mesh-ancestor
14425272|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
14425273|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425274|NCT05303792|Cytarabine|cytarabine|mesh-list
14425275|NCT05303792|Dexamethasone|dexamethasone|mesh-list
14425276|NCT05303792|Prednisone|prednisone|mesh-list
14425277|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
14425278|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
14425279|NCT05303792|Rituximab|rituximab|mesh-list
14425280|NCT05303792|Doxorubicin|doxorubicin|mesh-list
14425281|NCT05303792|Methotrexate|methotrexate|mesh-list
14425282|NCT05303792|Vincristine|vincristine|mesh-list
14425283|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
14425284|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14425285|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425286|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
14425287|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425288|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14425289|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14425290|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
14425291|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425292|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425293|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14425294|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425295|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
14425296|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
14425297|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425298|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425299|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
14425300|NCT05303792|Hormones|hormones|mesh-ancestor
14425301|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425302|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425303|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425304|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14425305|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14425306|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14425307|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425308|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14425309|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
14425310|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14425311|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14425312|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
14425313|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14425314|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14425315|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14425316|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
14425317|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425318|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425319|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425320|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425321|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425322|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14425323|NCT05303792|Protective Agents|protective agents|mesh-ancestor
14425324|NCT05302297|Cemiplimab|cemiplimab|mesh-list
14425325|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425326|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425327|NCT05302011|Carboplatin|carboplatin|mesh-list
14425328|NCT05302011|Docetaxel|docetaxel|mesh-list
14425329|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
14425330|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425331|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425332|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425333|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425334|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425335|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425336|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
14425337|NCT05297396|Narcotics|narcotics|mesh-ancestor
14425338|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425339|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425340|NCT05297396|Analgesics|analgesics|mesh-ancestor
14425341|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
14425342|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425343|NCT05296837|Doxycycline|doxycycline|mesh-list
14425344|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14425345|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425346|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
14425347|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14425348|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14425349|NCT05282550|Trazodone|trazodone|mesh-list
14425350|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14425351|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14425352|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425353|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425354|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14926639|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14926640|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14425355|NCT05282550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14425356|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14425357|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14425358|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425359|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425360|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
14425361|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14425362|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
14425363|NCT05252442|Vaccines|vaccines|mesh-list
14425364|NCT05252442|Immunologic Factors|immunologic factors|mesh-ancestor
14425365|NCT05252442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425366|NCT05252390|Olaparib|olaparib|mesh-list
14425367|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14425368|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425369|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425370|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425371|NCT05251259|Montelukast|montelukast|mesh-list
14425372|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14425373|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
14425374|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14425375|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
14425376|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425377|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425378|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14425379|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14425380|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425381|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
14425382|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14425383|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425384|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
14425385|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425386|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425387|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
14425388|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425389|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425390|NCT05213169|Apomorphine|apomorphine|mesh-list
14425391|NCT05213169|Emetics|emetics|mesh-ancestor
14425392|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425393|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
14425394|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425395|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425396|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
14425397|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
14425398|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425399|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425400|NCT05212623|Vaccines|vaccines|mesh-list
14425401|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
14425402|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425403|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
14425404|NCT05201638|Calcium|calcium|mesh-list
14425405|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14425406|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425407|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14425408|NCT05192265|Artesunate|artesunate|mesh-list
14425409|NCT05192265|Lumefantrine|lumefantrine|mesh-list
14425410|NCT05192265|Artemether|artemether|mesh-list
14425411|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14425412|NCT05192265|Pyronaridine|pyronaridine|mesh-list
14425413|NCT05192265|Antimalarials|antimalarials|mesh-list
14425414|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14425415|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14425416|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425417|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425418|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
14425419|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
14425420|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14425421|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
14425422|NCT05191004|Fulvestrant|fulvestrant|mesh-list
14425423|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425424|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425425|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14425426|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14745705|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745706|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14745707|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745708|NCT00597233|Insulin|insulin|mesh-list
14745709|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14425427|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
14425428|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425429|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468302|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468303|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468304|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14468305|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14468306|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14468307|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
14468308|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468309|NCT02276872|Treprostinil|treprostinil|mesh-list
14468310|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14468311|NCT02277249|Digoxin|digoxin|mesh-list
14468312|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14468313|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14468314|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468315|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468316|NCT02277249|Protective Agents|protective agents|mesh-ancestor
14468317|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468318|NCT02277548|Pregabalin|pregabalin|mesh-list
14425430|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
14425431|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425432|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425433|NCT05174650|Atezolizumab|atezolizumab|mesh-list
14425434|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425435|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14425436|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
14425437|NCT05171686|Torsemide|torsemide|mesh-list
14425438|NCT05171686|Furosemide|furosemide|mesh-list
14425439|NCT05171686|Bumetanide|bumetanide|mesh-list
14425440|NCT05171686|Diuretics|diuretics|mesh-list
14425441|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14425442|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
14425443|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425444|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14425445|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14425446|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425447|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14425448|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14425449|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14425450|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425451|NCT05167643|Anastrozole|anastrozole|mesh-list
14425452|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425453|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425454|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14425455|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14926641|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931121|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14425456|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468319|NCT02277548|Analgesics|analgesics|mesh-ancestor
14926642|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926643|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
14926644|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14926645|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14926646|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
14926647|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
14926648|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
14926649|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
14926650|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926651|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14926652|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
14926653|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
14926654|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14926655|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
14926656|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926657|NCT01411176|Menthol|menthol|mesh-list
14926658|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
14926659|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926660|NCT01411189|Menthol|menthol|mesh-list
14926661|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
14926662|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926663|NCT01411202|Doxycycline|doxycycline|mesh-list
14926664|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14926665|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926666|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
14926667|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14926668|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14926669|NCT01411254|Betamethasone|betamethasone|mesh-list
14926670|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
14926671|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14425457|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425458|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14425459|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
14425460|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425461|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425462|NCT05166343|Epinephrine|epinephrine|mesh-list
14425463|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14425464|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14425465|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
14425466|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425467|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425468|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425469|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14425470|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14425471|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
14425472|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425473|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14425474|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
14425475|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
14425476|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
14425477|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14425478|NCT05161338|Estradiol|estradiol|mesh-list
14425479|NCT05161338|Progesterone|progesterone|mesh-list
14425480|NCT05161338|Estrogens|estrogens|mesh-ancestor
14425481|NCT05161338|Hormones|hormones|mesh-ancestor
14425482|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425483|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425484|NCT05161338|Progestins|progestins|mesh-ancestor
14425485|NCT05145400|Dexamethasone|dexamethasone|mesh-list
14425486|NCT05145400|Lenalidomide|lenalidomide|mesh-list
14425487|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425488|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
14425489|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
14425490|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425491|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425492|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425493|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
14425494|NCT05145400|Hormones|hormones|mesh-ancestor
14425495|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425496|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425497|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425498|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
14425499|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14425500|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14425501|NCT05145400|Growth Substances|growth substances|mesh-ancestor
14425502|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
14425503|NCT05137054|Dexamethasone|dexamethasone|mesh-list
14425504|NCT05137054|Lenalidomide|lenalidomide|mesh-list
14425505|NCT05137054|Bortezomib|bortezomib|mesh-list
14425506|NCT05137054|Daratumumab|daratumumab|mesh-list
14425507|NCT05137054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425508|NCT05137054|Antiemetics|antiemetics|mesh-ancestor
14425509|NCT05137054|Autonomic Agents|autonomic agents|mesh-ancestor
14425510|NCT05137054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425511|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425512|NCT05137054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425513|NCT05137054|Glucocorticoids|glucocorticoids|mesh-ancestor
14425514|NCT05137054|Hormones|hormones|mesh-ancestor
14425515|NCT05137054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425516|NCT05137054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425517|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425518|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
14425519|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14425520|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14425521|NCT05137054|Growth Substances|growth substances|mesh-ancestor
14425522|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
14425523|NCT05127928|Vitamins|vitamins|mesh-list
14425524|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
14425525|NCT05127928|Vitamin E|vitamin e|mesh-list
14425526|NCT05127928|Tocopherols|tocopherols|mesh-list
14425527|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
14425528|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425529|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
14425530|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425531|NCT05127928|Protective Agents|protective agents|mesh-ancestor
14425532|NCT05115409|Rituximab|rituximab|mesh-list
14425533|NCT05115409|Antibodies|antibodies|mesh-list
14425534|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
14425535|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425536|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425537|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425538|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14425539|NCT05113186|Lenvatinib|lenvatinib|mesh-list
14425540|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425541|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14425542|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425543|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425544|NCT05112536|Paclitaxel|paclitaxel|mesh-list
14425545|NCT05112536|Carboplatin|carboplatin|mesh-list
14425546|NCT05112536|Doxorubicin|doxorubicin|mesh-list
14425547|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
14425548|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425549|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425550|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425551|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425552|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425553|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425554|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14425555|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14425556|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14425557|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425558|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425559|NCT05111808|Methylene Blue|methylene blue|mesh-list
14425560|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425561|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425562|NCT05093140|Prednisone|prednisone|mesh-list
14425563|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
14425564|NCT05093140|Vincristine|vincristine|mesh-list
14425565|NCT05093140|Doxorubicin|doxorubicin|mesh-list
14425566|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14425567|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425568|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
14425569|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425570|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14425571|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14425572|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
14425573|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425574|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425575|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14425576|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425577|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
14425578|NCT05093140|Hormones|hormones|mesh-ancestor
14425579|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425580|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425581|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425582|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425583|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425584|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425585|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14425586|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14425587|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14425588|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425589|NCT05090371|Ofatumumab|ofatumumab|mesh-list
14425590|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425591|NCT05082025|Fulvestrant|fulvestrant|mesh-list
14425592|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14745710|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
14425593|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425594|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14425595|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14745711|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
14745712|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
14745713|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
14425596|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
14425597|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425598|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425599|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
14425600|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425601|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
14425602|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14425603|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14425604|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425605|NCT05061368|Urological Agents|urological agents|mesh-ancestor
14425606|NCT05058404|Prednisone|prednisone|mesh-list
14425607|NCT05058404|Rituximab|rituximab|mesh-list
14425608|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14425609|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
14425610|NCT05058404|Vincristine|vincristine|mesh-list
14425611|NCT05058404|Doxorubicin|doxorubicin|mesh-list
14425612|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425613|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425614|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
14425615|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425616|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14425617|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14425618|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
14425619|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425620|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425621|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14425622|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425623|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
14425624|NCT05058404|Hormones|hormones|mesh-ancestor
14425625|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425626|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425627|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425628|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425629|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425630|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425631|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14425632|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14425633|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14425634|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425635|NCT05044611|Amiloride|amiloride|mesh-list
14745714|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745715|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745716|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14745717|NCT00597259|Entecavir|entecavir|mesh-list
14745718|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
14745719|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745720|NCT00597389|Propranolol|propranolol|mesh-list
14745721|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14745722|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14745723|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
14745724|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745725|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745726|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745727|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14745728|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14745729|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
14745730|NCT00597415|Celecoxib|celecoxib|mesh-list
14745731|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14425636|NCT05044611|Diuretics|diuretics|mesh-ancestor
14425637|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
14425638|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425639|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14425640|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14425641|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926672|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
14926673|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14926674|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926675|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
14926676|NCT01411254|Hormones|hormones|mesh-ancestor
14745732|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14745733|NCT00597415|Analgesics|analgesics|mesh-ancestor
14745734|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
14745735|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745736|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745737|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745738|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745739|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14425642|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425643|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14425644|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14425645|NCT05039281|Atezolizumab|atezolizumab|mesh-list
14425646|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14425647|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425648|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
14425649|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425650|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
14425651|NCT05036681|Futibatinib|futibatinib|mesh-list
14425652|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425653|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468320|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
14468321|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468322|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468323|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
14468324|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14468325|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468326|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468327|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14468328|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14745740|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14745741|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745742|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745743|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14745744|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745745|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14745746|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745747|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745748|NCT00597623|Adalimumab|adalimumab|mesh-list
14745749|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745750|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745751|NCT00597662|Icodextrin|icodextrin|mesh-list
14745752|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
14745753|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14745754|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
14745755|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14745756|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745757|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
14745758|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
14745759|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425654|NCT05017012|Paclitaxel|paclitaxel|mesh-list
14425655|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14425656|NCT05017012|Carboplatin|carboplatin|mesh-list
14425657|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
14425658|NCT05017012|Pemetrexed|pemetrexed|mesh-list
14425659|NCT05017012|Axitinib|axitinib|mesh-list
14425660|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425661|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425662|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425663|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425664|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425665|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425666|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425667|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425668|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14425669|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14745760|NCT00598013|Pioglitazone|pioglitazone|mesh-list
14745761|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745762|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745763|NCT00598052|Citalopram|citalopram|mesh-list
14745764|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14425670|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14425671|NCT05006794|Gemcitabine|gemcitabine|mesh-list
14425672|NCT05006794|Docetaxel|docetaxel|mesh-list
14425673|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14425674|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
14425675|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425676|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425677|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
14425678|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425679|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425680|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425681|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
14425682|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425683|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425684|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425685|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
14745765|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14745766|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14745767|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745768|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745769|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
14745770|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745771|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14745772|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
14745773|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14745774|NCT00598091|Gemcitabine|gemcitabine|mesh-list
14745775|NCT00598091|Dasatinib|dasatinib|mesh-list
14745776|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14745777|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
14745778|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745779|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745780|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
14745781|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745782|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425686|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
14745783|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425687|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
14425688|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14425689|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14425690|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425691|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425692|NCT04985929|Urological Agents|urological agents|mesh-ancestor
14425693|NCT04955236|Fentanyl|fentanyl|mesh-list
14425694|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14425695|NCT04955236|Narcotics|narcotics|mesh-ancestor
14425696|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425697|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425698|NCT04955236|Analgesics|analgesics|mesh-ancestor
14425699|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
14425700|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425701|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14425702|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14425703|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
14425704|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
14745784|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
14745785|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745786|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14745787|NCT00598156|Bevacizumab|bevacizumab|mesh-list
14745788|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14745789|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14745790|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745791|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14745792|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14926677|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926678|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926679|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14926680|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
14926681|NCT01411280|Methylphenidate|methylphenidate|mesh-list
14926682|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14926683|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926684|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14926685|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14926686|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926687|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926688|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
14926689|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926690|NCT01411410|Paclitaxel|paclitaxel|mesh-list
14926691|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14926692|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926693|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
14926694|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
14926695|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
14926696|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926697|NCT01411423|Sorafenib|sorafenib|mesh-list
14926698|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926699|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14926700|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425705|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
14926701|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931122|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425706|NCT04934722|Androgens|androgens|mesh-list
14425707|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425708|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425709|NCT04934722|Hormones|hormones|mesh-ancestor
14425710|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425711|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425712|NCT04926818|Ofatumumab|ofatumumab|mesh-list
14425713|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14425714|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14425715|NCT04926818|Siponimod|siponimod|mesh-list
14425716|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425717|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
14425718|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425719|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14425720|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425721|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425722|NCT04908956|Osimertinib|osimertinib|mesh-list
14425723|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425724|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14425725|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425726|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425727|NCT04907227|Dexamethasone|dexamethasone|mesh-list
14926702|NCT01411436|Sorafenib|sorafenib|mesh-list
14926703|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926704|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14425728|NCT04907227|Prednisone|prednisone|mesh-list
14425729|NCT04907227|Docetaxel|docetaxel|mesh-list
14425730|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
14425731|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425732|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
14425733|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
14425734|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425735|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425736|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425737|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
14425738|NCT04907227|Hormones|hormones|mesh-ancestor
14425739|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425740|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425741|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425742|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425743|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425744|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425745|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425746|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425747|NCT04904549|Vaccines|vaccines|mesh-list
14425748|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
14425749|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425750|NCT04903652|Vinorelbine|vinorelbine|mesh-list
14425751|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425752|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425753|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
14926705|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926706|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425754|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425755|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425756|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425757|NCT04894188|Goserelin|goserelin|mesh-list
14425758|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425759|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425760|NCT04891770|Tenofovir|tenofovir|mesh-list
14425761|NCT04891770|Nivolumab|nivolumab|mesh-list
14425762|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425763|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425764|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14425765|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425766|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
14425767|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425768|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14425769|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14425770|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425771|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14425772|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14425773|NCT04887285|Anesthetics|anesthetics|mesh-list
14425774|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
14425775|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425776|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425777|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
14425778|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425779|NCT04882241|Leucovorin|leucovorin|mesh-list
14425780|NCT04882241|Docetaxel|docetaxel|mesh-list
14425781|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
14425782|NCT04882241|Fluorouracil|fluorouracil|mesh-list
14425783|NCT04882241|Capecitabine|capecitabine|mesh-list
14425784|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
14425785|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425786|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
14425787|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
14425788|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
14425789|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425790|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425791|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
14425792|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14425793|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425794|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
14425795|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425796|NCT04882241|Antidotes|antidotes|mesh-ancestor
14425797|NCT04882241|Protective Agents|protective agents|mesh-ancestor
14425798|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
14425799|NCT04882241|Vitamins|vitamins|mesh-ancestor
14425800|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
14425801|NCT04870112|Carboplatin|carboplatin|mesh-list
14425802|NCT04870112|Etoposide|etoposide|mesh-list
14425803|NCT04870112|Durvalumab|durvalumab|mesh-list
14425804|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425805|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14425806|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14425807|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14425808|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425809|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425810|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425811|NCT04867135|Amikacin|amikacin|mesh-list
14425812|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14425813|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926707|NCT01411514|Prednisone|prednisone|mesh-list
14926708|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926709|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
14425814|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
14425815|NCT04865887|Lenvatinib|lenvatinib|mesh-list
14425816|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425817|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425818|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14425819|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926710|NCT01411514|Hormones|hormones|mesh-ancestor
14926711|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926712|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926713|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931123|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
14425820|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425821|NCT04863716|Fentanyl|fentanyl|mesh-list
14425822|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14425823|NCT04863716|Narcotics|narcotics|mesh-ancestor
14425824|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425825|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425826|NCT04863716|Analgesics|analgesics|mesh-ancestor
14425827|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
14425828|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425829|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14425830|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14425831|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
14425832|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
14425833|NCT04860661|Esketamine|esketamine|mesh-list
14425834|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
14425835|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14425836|NCT04858776|Dexamethasone|dexamethasone|mesh-list
14425837|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425838|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
14425839|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
14425840|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425841|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425842|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425843|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
14425844|NCT04858776|Hormones|hormones|mesh-ancestor
14425845|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425846|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425847|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425848|NCT04854512|Metformin|metformin|mesh-list
14425849|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14425850|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425851|NCT04848662|Budesonide|budesonide|mesh-list
14425852|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425853|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14425854|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
14425855|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425856|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425857|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14425858|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
14425859|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
14425860|NCT04848662|Hormones|hormones|mesh-ancestor
14425861|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425862|NCT04838717|Doxycycline|doxycycline|mesh-list
14425863|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14425864|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14425865|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
14425866|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14425867|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14425868|NCT04834557|Digoxin|digoxin|mesh-list
14425869|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14745793|NCT00598156|Growth Substances|growth substances|mesh-ancestor
14745794|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745795|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
14745796|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14745797|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745798|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745799|NCT00598169|Dexamethasone|dexamethasone|mesh-list
14745800|NCT00598169|Rituximab|rituximab|mesh-list
14745801|NCT00598169|Carboplatin|carboplatin|mesh-list
14745802|NCT00598169|Etoposide|etoposide|mesh-list
14745803|NCT00598169|Bortezomib|bortezomib|mesh-list
14745804|NCT00598169|Ifosfamide|ifosfamide|mesh-list
14745805|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745806|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
14745807|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
14745808|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745809|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745810|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745811|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
14745812|NCT00598169|Hormones|hormones|mesh-ancestor
14745813|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745814|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14745815|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745816|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14745817|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
14745818|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14425870|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14425871|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14425872|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745819|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14745820|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14745821|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14745822|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745823|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745824|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14745825|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
14745826|NCT00598195|Ketamine|ketamine|mesh-list
14745827|NCT00598195|Analgesics|analgesics|mesh-ancestor
14745828|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
14425873|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425874|NCT04834557|Protective Agents|protective agents|mesh-ancestor
14425875|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745829|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745830|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926714|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926715|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14926716|NCT01411670|Protein C|protein c|mesh-list
14926717|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
14926718|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14926719|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14926720|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926721|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926722|NCT01411735|Enalapril|enalapril|mesh-list
14926723|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14425876|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14425877|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425878|NCT04826692|Metformin|metformin|mesh-list
14425879|NCT04826692|Biguanides|biguanides|mesh-list
14425880|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14425881|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425882|NCT04826237|Dexamethasone|dexamethasone|mesh-list
14425883|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
14425884|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14425885|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14425886|NCT04826237|Prednisolone|prednisolone|mesh-list
14425887|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
14425888|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14425889|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14425890|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
14425891|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425892|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
14425893|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
14425894|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425895|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425896|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425897|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
14425898|NCT04826237|Hormones|hormones|mesh-ancestor
14926724|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
14425899|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745831|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14745832|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14745833|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
14926725|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926726|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425900|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14425901|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425902|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14425903|NCT04826237|Protective Agents|protective agents|mesh-ancestor
14425904|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14425905|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14425906|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
14425907|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425908|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425909|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14425910|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
14425911|NCT04825990|Olaparib|olaparib|mesh-list
14425912|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425913|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425914|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14425915|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425916|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425917|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
14425918|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14425919|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468329|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14468330|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468331|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14468332|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14468333|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14468334|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14468335|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468336|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14468337|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
14468338|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468339|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14468340|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
14468341|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468342|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14468343|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745834|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
14745835|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14745836|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14468344|NCT02278003|Propofol|propofol|mesh-list
14468345|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14468346|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468347|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468348|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14468349|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
14468350|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
14745837|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14745838|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926727|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14926728|NCT01411930|Olanzapine|olanzapine|mesh-list
14926729|NCT01411930|Aripiprazole|aripiprazole|mesh-list
14926730|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
14926731|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
14926732|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926733|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425920|NCT04812626|Triamcinolone|triamcinolone|mesh-list
14425921|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14745839|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745840|NCT00598234|Celecoxib|celecoxib|mesh-list
14745841|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14745842|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14745843|NCT00598234|Analgesics|analgesics|mesh-ancestor
14745844|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
14745845|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745846|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745847|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745848|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14745849|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14425922|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14745850|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14745851|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745852|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745853|NCT00598247|Paclitaxel|paclitaxel|mesh-list
14745854|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14745855|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14745856|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745857|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
14745858|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
14745859|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
14745860|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745861|NCT00598338|Prucalopride|prucalopride|mesh-list
14745862|NCT00598338|Laxatives|laxatives|mesh-ancestor
14745863|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14745864|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14745865|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14745866|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
14745867|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425923|NCT04812626|Fluorouracil|fluorouracil|mesh-list
14425924|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14425925|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
14425926|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425927|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14425928|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425929|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14425930|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
14425931|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425932|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14425933|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
14425934|NCT04812626|Hormones|hormones|mesh-ancestor
14425935|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14425936|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425937|NCT04810494|Lidocaine|lidocaine|mesh-list
14425938|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
14425939|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
14425940|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14425941|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425942|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
14425943|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425944|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14425945|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14425946|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14425947|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14425948|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425949|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
14425950|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14425951|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14425952|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425953|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
14425954|NCT04803747|Coagulants|coagulants|mesh-ancestor
14425955|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
14425956|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14425957|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14425958|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425959|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
14425960|NCT04797156|Coagulants|coagulants|mesh-ancestor
14425961|NCT04790175|Tolvaptan|tolvaptan|mesh-list
14425962|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14425963|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425964|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
14425965|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425966|NCT04785300|Dasatinib|dasatinib|mesh-list
14425967|NCT04785300|Quercetin|quercetin|mesh-list
14425968|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425969|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14425970|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14425971|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425972|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
14425973|NCT04785300|Protective Agents|protective agents|mesh-ancestor
14425974|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425975|NCT04778904|Nivolumab|nivolumab|mesh-list
14425976|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14425977|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14425978|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14425979|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425980|NCT04771481|Metoclopramide|metoclopramide|mesh-list
14425981|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
14425982|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
14425983|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14425984|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14425985|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425986|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14425987|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14745868|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745869|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745870|NCT00598377|Cosyntropin|cosyntropin|mesh-list
14745871|NCT00598377|Hormones|hormones|mesh-ancestor
14745872|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745873|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745874|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
14745875|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
14745876|NCT00598403|Cefditoren|cefditoren|mesh-list
14745877|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14425988|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
14425989|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14425990|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425991|NCT04764162|Choline|choline|mesh-list
14425992|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
14425993|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14425994|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
14425995|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14425996|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14425997|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14745878|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745879|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14745880|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14745881|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745882|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745883|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745884|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14926734|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926735|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14926736|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14926737|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926738|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14926739|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14926740|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14425998|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
14425999|NCT04745910|Rasburicase|rasburicase|mesh-list
14426000|NCT04745910|Uric Acid|uric acid|mesh-list
14426001|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
14926741|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926742|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926743|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926744|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
14426002|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426003|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
14426004|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426005|NCT04745910|Protective Agents|protective agents|mesh-ancestor
14426006|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426007|NCT04728217|Factor VIII|factor viii|mesh-list
14426008|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
14426009|NCT04728217|Coagulants|coagulants|mesh-ancestor
14426010|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
14426011|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426012|NCT04725695|Lidocaine|lidocaine|mesh-list
14426013|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
14426014|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
14426015|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426016|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426017|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
14745885|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14426018|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426019|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14426020|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14426021|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14426022|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14426023|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426024|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
14426025|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14426026|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14426027|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426028|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
14426029|NCT04724772|Coagulants|coagulants|mesh-ancestor
14426030|NCT04721691|Cannabidiol|cannabidiol|mesh-list
14426031|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
14426032|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14426033|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14426034|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426035|NCT04669002|Olaparib|olaparib|mesh-list
14426036|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14426037|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426038|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426039|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426040|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
14426041|NCT04660799|Promethazine|promethazine|mesh-list
14745886|NCT00598429|Alprostadil|alprostadil|mesh-list
14426042|NCT04660799|Prednisone|prednisone|mesh-list
14426043|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
14426044|NCT04660799|Rituximab|rituximab|mesh-list
14426045|NCT04660799|Doxorubicin|doxorubicin|mesh-list
14426046|NCT04660799|Vincristine|vincristine|mesh-list
14426047|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14426048|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
14426049|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426050|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
14426051|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926745|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
14926746|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
14926747|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
14926748|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14926749|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14926750|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14926751|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14926752|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14926753|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14926754|NCT01411969|Phenylephrine|phenylephrine|mesh-list
14926755|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
14745887|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14745888|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
14745889|NCT00598429|Urological Agents|urological agents|mesh-ancestor
14745890|NCT00598533|Sirolimus|sirolimus|mesh-list
14745891|NCT00598533|Probucol|probucol|mesh-list
14426052|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426053|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14426054|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
14426055|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426056|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426057|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14426058|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14745892|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745893|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745894|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745895|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745896|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
14745897|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745898|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
14745899|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745900|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14745901|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14745902|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
14426059|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745903|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926756|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14926757|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14926758|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
14926759|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926760|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926761|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926762|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
14426060|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14426061|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14426062|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426063|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426064|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
14426065|NCT04660799|Hormones|hormones|mesh-ancestor
14426066|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14426067|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14426068|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14426069|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
14426070|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
14426071|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
14426072|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
14426073|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426074|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14426075|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14426076|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426077|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
14426078|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
14426079|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
14426080|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
14426081|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14426082|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
14426083|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426084|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14426085|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
14426086|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14426087|NCT04642287|Fluorouracil|fluorouracil|mesh-list
14426088|NCT04642287|Calcipotriene|calcipotriene|mesh-list
14426089|NCT04642287|Petrolatum|petrolatum|mesh-list
14745904|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14745905|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
14745906|NCT00598533|Protective Agents|protective agents|mesh-ancestor
14745907|NCT00598572|Deferoxamine|deferoxamine|mesh-list
14426090|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
14426091|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426092|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426093|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745908|NCT00598572|Siderophores|siderophores|mesh-ancestor
14745909|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14745910|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
14745911|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
14745912|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745913|NCT00598611|Loratadine|loratadine|mesh-list
14745914|NCT00598611|Desloratadine|desloratadine|mesh-list
14745915|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14745916|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
14745917|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14745918|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745919|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426094|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426095|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
14426096|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426097|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
14426098|NCT04642287|Emollients|emollients|mesh-ancestor
14426099|NCT04639960|Risperidone|risperidone|mesh-list
14426100|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14426101|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
14426102|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426103|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426104|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426105|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14426106|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14426107|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426108|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14426109|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14426110|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
14426111|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
14426112|NCT04637763|Fludarabine|fludarabine|mesh-list
14426113|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426114|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
14426115|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426116|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426117|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14426118|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
14426119|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426120|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426121|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14745920|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14745921|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14745922|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
14745923|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
14426122|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
14426123|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426124|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426125|NCT04622228|Carboplatin|carboplatin|mesh-list
14426126|NCT04622228|Etoposide|etoposide|mesh-list
14426127|NCT04622228|Atezolizumab|atezolizumab|mesh-list
14426128|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426129|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14426130|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14745924|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
14426131|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14426132|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426133|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426134|NCT04605094|Benralizumab|benralizumab|mesh-list
14426135|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14426136|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
14426137|NCT04594239|Lidocaine|lidocaine|mesh-list
14745925|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
14745926|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14745927|NCT00598624|Treosulfan|treosulfan|mesh-list
14745928|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14745929|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
14426138|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
14926763|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
14426139|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
14426140|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
14426141|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426142|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426143|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
14426144|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426145|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14426146|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14426147|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14426148|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14426149|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426150|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14426151|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
14426152|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
14426153|NCT04594239|Protective Agents|protective agents|mesh-ancestor
14426154|NCT04581343|Gemcitabine|gemcitabine|mesh-list
14426155|NCT04581343|Paclitaxel|paclitaxel|mesh-list
14426156|NCT04581343|Spartalizumab|spartalizumab|mesh-list
14426157|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14426158|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426159|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
14426160|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
14426161|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
14426162|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426163|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426164|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
14426165|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
14426166|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426167|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426168|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426169|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
14426170|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426171|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14426172|NCT04580771|Cisplatin|cisplatin|mesh-list
14426173|NCT04580771|Vaccines|vaccines|mesh-list
14426174|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
14426175|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426176|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426177|NCT04579120|Corticosterone|corticosterone|mesh-list
14426178|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426179|NCT04566016|Anesthetics|anesthetics|mesh-list
14426180|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426181|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468351|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
14468352|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14468353|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14468354|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468355|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
14468356|NCT02278263|Coagulants|coagulants|mesh-ancestor
14468357|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
14468358|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
14468359|NCT02278341|Hematinics|hematinics|mesh-ancestor
14468360|NCT02278471|Losartan|losartan|mesh-list
14468361|NCT02278471|Amlodipine|amlodipine|mesh-list
14468362|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14468363|NCT02278471|Atorvastatin|atorvastatin|mesh-list
14745930|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745931|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745932|NCT00598637|Everolimus|everolimus|mesh-list
14926764|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14745933|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745934|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745935|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
14745936|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745937|NCT00598676|Sirolimus|sirolimus|mesh-list
14745938|NCT00598676|Everolimus|everolimus|mesh-list
14745939|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745940|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745941|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
14745942|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926765|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
14926766|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14426182|NCT04552795|Lamivudine|lamivudine|mesh-list
14426183|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14426184|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426185|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426186|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926767|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
14926768|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14926769|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
14926770|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14426187|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
14426188|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426189|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14426190|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14426191|NCT04537234|Vaccines|vaccines|mesh-list
14426192|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
14426193|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426194|NCT04514653|Ranibizumab|ranibizumab|mesh-list
14426195|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14426196|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14426197|NCT04514653|Growth Substances|growth substances|mesh-ancestor
14426198|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426199|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
14426200|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426201|NCT04514393|Methotrexate|methotrexate|mesh-list
14426202|NCT04514393|Temozolomide|temozolomide|mesh-list
14426203|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14426204|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
14426205|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14426206|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745943|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745944|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745945|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745946|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
14745947|NCT00598715|Sirolimus|sirolimus|mesh-list
14926771|NCT01411969|Protective Agents|protective agents|mesh-ancestor
14926772|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
14926773|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14926774|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926775|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926776|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
14926777|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926778|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926779|NCT01412073|Misoprostol|misoprostol|mesh-list
14926780|NCT01412073|Oxytocin|oxytocin|mesh-list
14926781|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
14926782|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14926783|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926784|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14926785|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
14926786|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14926787|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926788|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
14926789|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14745948|NCT00598715|Paclitaxel|paclitaxel|mesh-list
14745949|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14745950|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745951|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
14745952|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
14745953|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
14745954|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745955|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745956|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745957|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14745958|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
14745959|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14745960|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
14745961|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745962|NCT00598793|Insulin|insulin|mesh-list
14745963|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14745964|NCT00598793|Metformin|metformin|mesh-list
14745965|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
14745966|NCT00598793|Pioglitazone|pioglitazone|mesh-list
14745967|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
14745968|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
14745969|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14745970|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745971|NCT00598858|Prednisone|prednisone|mesh-list
14745972|NCT00598858|Cortisone|cortisone|mesh-list
14745973|NCT00598858|Docetaxel|docetaxel|mesh-list
14745974|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14745975|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
14745976|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
14745977|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
14745978|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745979|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14745980|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
14745981|NCT00598858|Hormones|hormones|mesh-ancestor
14745982|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14745983|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745984|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14926790|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
14926791|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926792|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
14926793|NCT01412190|Protective Agents|protective agents|mesh-ancestor
14926794|NCT01412294|Capecitabine|capecitabine|mesh-list
14926795|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926796|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14926797|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
14753458|NCT05133895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753459|NCT05133895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753460|NCT05133895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14753461|NCT05133895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753462|NCT05131828|Metformin|metformin|mesh-list
14753463|NCT05131828|Clemastine|clemastine|mesh-list
14753464|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14753465|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14745985|NCT00598897|Clarithromycin|clarithromycin|mesh-list
14745986|NCT00598897|Rifabutin|rifabutin|mesh-list
14745987|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14745988|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14745989|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14745990|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14745991|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14745992|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14745993|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14745994|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14745995|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
14745996|NCT00598923|Topiramate|topiramate|mesh-list
14745997|NCT00598923|Phenytoin|phenytoin|mesh-list
14745998|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
14745999|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14746000|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746001|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14926798|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926799|NCT01412307|Lenalidomide|lenalidomide|mesh-list
14926800|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14926801|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
14926802|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926803|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14926804|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14926805|NCT01412307|Growth Substances|growth substances|mesh-ancestor
14926806|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
14926807|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926808|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14926809|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
14926810|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926811|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
14926812|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14926813|NCT01412385|Antibodies|antibodies|mesh-list
14926814|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
14926815|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14926816|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
14926817|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
14926818|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926819|NCT01412411|Micronutrients|micronutrients|mesh-list
14426207|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426208|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
14426209|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426210|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426211|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14426212|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426213|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14426214|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426215|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
14426216|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426217|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426218|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14426219|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
14426220|NCT04507711|Palonosetron|palonosetron|mesh-list
14426221|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
14426222|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
14426223|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426224|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426225|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14426226|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14426227|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14426228|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
14426229|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426230|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426231|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14746002|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14746003|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746004|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746005|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14746006|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14746007|NCT00598962|Azithromycin|azithromycin|mesh-list
14426232|NCT04504123|Doxycycline|doxycycline|mesh-list
14426233|NCT04504123|Tetracycline|tetracycline|mesh-list
14426234|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426235|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
14426236|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14426237|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14746008|NCT00598962|Rifampin|rifampin|mesh-list
14746009|NCT00598962|Rifabutin|rifabutin|mesh-list
14746010|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14926820|NCT01412411|Trace Elements|trace elements|mesh-list
14426238|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14426239|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426240|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426241|NCT04502706|Rituximab|rituximab|mesh-list
14426242|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426243|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426244|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
14426245|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426246|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426247|NCT04499274|Ondansetron|ondansetron|mesh-list
14926821|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926822|NCT01412437|Verapamil|verapamil|mesh-list
14926823|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14926824|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14926825|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14426248|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
14426249|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
14426250|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426251|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426252|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14426253|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
14426254|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
14746011|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746012|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14746013|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
14746014|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
14746015|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14746016|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746017|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746018|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14746019|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14746020|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14746021|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14746022|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14746023|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14746024|NCT00599079|Azithromycin|azithromycin|mesh-list
14746025|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746026|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746027|NCT00599222|Ranibizumab|ranibizumab|mesh-list
14926826|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426255|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14746028|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746029|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14746030|NCT00599222|Growth Substances|growth substances|mesh-ancestor
14746031|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746032|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746033|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746034|NCT00599235|Hydralazine|hydralazine|mesh-list
14746035|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
14746036|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
14746037|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14746038|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14746039|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746040|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746041|NCT00599235|Urological Agents|urological agents|mesh-ancestor
14426256|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
14426257|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426258|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426259|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14426260|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14426261|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426262|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14426263|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14426264|NCT04484025|Ebselen|ebselen|mesh-list
14426265|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14426266|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426267|NCT04484025|Analgesics|analgesics|mesh-ancestor
14426268|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
14426269|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426270|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426271|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426272|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426273|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14426274|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14426275|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
14426276|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426277|NCT04484025|Protective Agents|protective agents|mesh-ancestor
14746042|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14746043|NCT00599274|Interferons|interferons|mesh-list
14746044|NCT00599274|Interferon-beta|interferon-beta|mesh-list
14746045|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
14746046|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746047|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
14746048|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746049|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
14746050|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746051|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14746052|NCT00599287|Haloperidol|haloperidol|mesh-list
14426278|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14426279|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746053|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
14746054|NCT00599287|Methylphenidate|methylphenidate|mesh-list
14746055|NCT00599287|Rivastigmine|rivastigmine|mesh-list
14426280|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14426281|NCT04483973|Ebselen|ebselen|mesh-list
14746056|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14753466|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
14426282|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14426283|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426284|NCT04483973|Analgesics|analgesics|mesh-ancestor
14426285|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
14426286|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426287|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426288|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426289|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426290|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14426291|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14426292|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
14746057|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746058|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14746059|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14746060|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746061|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746062|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
14426293|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426294|NCT04483973|Protective Agents|protective agents|mesh-ancestor
14426295|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14426296|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426297|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14426298|NCT04471714|Baclofen|baclofen|mesh-list
14426299|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14426300|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426301|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14426302|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426303|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14426304|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
14426305|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
14426306|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426307|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426308|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14426309|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426310|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426311|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931124|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926827|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14926828|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926829|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
14926830|NCT01412515|Everolimus|everolimus|mesh-list
14926831|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926832|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926833|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
14926834|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926835|NCT01412567|Vaccines|vaccines|mesh-list
14926836|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
14926837|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926838|NCT01412632|Remifentanil|remifentanil|mesh-list
14926839|NCT01412632|Propofol|propofol|mesh-list
14926840|NCT01412632|Prilocaine|prilocaine|mesh-list
14926841|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14926842|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926843|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926844|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14926845|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
14926846|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
14926847|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14426312|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
14926848|NCT01412632|Narcotics|narcotics|mesh-ancestor
14426313|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426314|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14426315|NCT04428866|Glucagon|glucagon|mesh-list
14426316|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14426317|NCT04428866|Hormones|hormones|mesh-ancestor
14426318|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14426319|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426320|NCT04425239|Leucovorin|leucovorin|mesh-list
14426321|NCT04425239|Folic Acid|folic acid|mesh-list
14426322|NCT04425239|Fluorouracil|fluorouracil|mesh-list
14426323|NCT04425239|Irinotecan|irinotecan|mesh-list
14426324|NCT04425239|Panitumumab|panitumumab|mesh-list
14426325|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
14426326|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
14426327|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426328|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426329|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426330|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426331|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
14426332|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426333|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14426334|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14426335|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426336|NCT04425239|Antidotes|antidotes|mesh-ancestor
14426337|NCT04425239|Protective Agents|protective agents|mesh-ancestor
14426338|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
14926849|NCT01412632|Analgesics|analgesics|mesh-ancestor
14926850|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
14426339|NCT04425239|Vitamins|vitamins|mesh-ancestor
14426340|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
14426341|NCT04425239|Hematinics|hematinics|mesh-ancestor
14426342|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426343|NCT04421560|Rituximab|rituximab|mesh-list
14426344|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
14426345|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426346|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426347|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
14426348|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426349|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426350|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
14426351|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426352|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426353|NCT04413344|Bromocriptine|bromocriptine|mesh-list
14426354|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14426355|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14426356|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
14426357|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14426358|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426359|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
14426360|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
14426361|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426362|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426363|NCT04395508|Trastuzumab|trastuzumab|mesh-list
14426364|NCT04395508|Pertuzumab|pertuzumab|mesh-list
14426365|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426366|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426367|NCT04388839|Dactinomycin|dactinomycin|mesh-list
14426368|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
14426369|NCT04388839|Vincristine|vincristine|mesh-list
14426370|NCT04388839|Vinorelbine|vinorelbine|mesh-list
14426371|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426372|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
14426373|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426374|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426375|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14426376|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
14426377|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426378|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426379|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14426380|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14426381|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
14426382|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
14426383|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
14426384|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14426385|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426386|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14426387|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14426388|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426389|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426390|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
14426391|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
14746063|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746064|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
14746065|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
14746066|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926851|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926852|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
14926853|NCT01412645|Resveratrol|resveratrol|mesh-list
14746067|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14746068|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14746069|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14426392|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14426393|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14426394|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926854|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
14926855|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926856|NCT01412645|Protective Agents|protective agents|mesh-ancestor
14926857|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926858|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426395|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426396|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426397|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426398|NCT04381936|Aspirin|aspirin|mesh-list
14746070|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746071|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746072|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14746073|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14746074|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14746075|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746076|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
14926859|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14426399|NCT04381936|Empagliflozin|empagliflozin|mesh-list
14426400|NCT04381936|Ritonavir|ritonavir|mesh-list
14426401|NCT04381936|Lopinavir|lopinavir|mesh-list
14426402|NCT04381936|Azithromycin|azithromycin|mesh-list
14426403|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
14926860|NCT01412658|Glycerol|glycerol|mesh-list
14426404|NCT04381936|Colchicine|colchicine|mesh-list
14426405|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14426406|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14426407|NCT04381936|Antibodies|antibodies|mesh-list
14426408|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
14426409|NCT04381936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14426410|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
14426411|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426412|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14426413|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426414|NCT04381936|Analgesics|analgesics|mesh-ancestor
14426415|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
14426416|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426417|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426418|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426419|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14426420|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14426421|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426422|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14426423|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14426424|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426425|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
14426426|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14426427|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14426428|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
14426429|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14426430|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14426431|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
14426432|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426433|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14746077|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14746078|NCT00599287|Protective Agents|protective agents|mesh-ancestor
14746079|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
14746080|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14746081|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
14746082|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746083|NCT00599534|Montelukast|montelukast|mesh-list
14746084|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14746085|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
14926861|NCT01412658|Caseins|caseins|mesh-list
14753467|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926862|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14926863|NCT01412658|Protective Agents|protective agents|mesh-ancestor
14926864|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926865|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
14926866|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
14426434|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14926867|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426435|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14426436|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
14426437|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14426438|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14426439|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14426440|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14426441|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
14926868|NCT01412671|Sorafenib|sorafenib|mesh-list
14926869|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926870|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14926871|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926872|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426442|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
14426443|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
14426444|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14426445|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426446|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
14426447|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426448|NCT04379999|Aspirin|aspirin|mesh-list
14426449|NCT04379999|Atorvastatin|atorvastatin|mesh-list
14426450|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14426451|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426452|NCT04379999|Analgesics|analgesics|mesh-ancestor
14426453|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
14426454|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426455|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426456|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426457|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426458|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14426459|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14426460|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426461|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14746086|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14746087|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
14746088|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14746089|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746090|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14746091|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14746092|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746093|NCT00599560|Vasopressins|vasopressins|mesh-list
14746094|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
14926873|NCT01412840|Diclofenac|diclofenac|mesh-list
14426462|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14426463|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426464|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
14426465|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14426466|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14426467|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
14426468|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14426469|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14426470|NCT04369365|Azithromycin|azithromycin|mesh-list
14426471|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14426472|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426473|NCT04329221|Calcitriol|calcitriol|mesh-list
14426474|NCT04329221|Fluorouracil|fluorouracil|mesh-list
14426475|NCT04329221|Calcipotriene|calcipotriene|mesh-list
14426476|NCT04329221|Petrolatum|petrolatum|mesh-list
14426477|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
14426478|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426479|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426480|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426481|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426482|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
14426483|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426484|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
14426485|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14426486|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14426487|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14426488|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14426489|NCT04329221|Vitamins|vitamins|mesh-ancestor
14746095|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
14426490|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
14426491|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14426492|NCT04329221|Emollients|emollients|mesh-ancestor
14426493|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
14426494|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14426495|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
14426496|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926874|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14926875|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14926876|NCT01412840|Analgesics|analgesics|mesh-ancestor
14926877|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
14926878|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426497|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426498|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14426499|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
14426500|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14426501|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
14426502|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426503|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426504|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14426505|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
14426506|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
14426507|NCT04292483|Protective Agents|protective agents|mesh-ancestor
14426508|NCT04291508|Acetaminophen|acetaminophen|mesh-list
14926879|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926880|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926881|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426509|NCT04291508|Ascorbic Acid|ascorbic acid|mesh-list
14426510|NCT04291508|Vitamins|vitamins|mesh-ancestor
14426511|NCT04291508|Micronutrients|micronutrients|mesh-ancestor
14426512|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426513|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426514|NCT04291508|Analgesics|analgesics|mesh-ancestor
14426515|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
14426516|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426517|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
14426518|NCT04291508|Antioxidants|antioxidants|mesh-ancestor
14426519|NCT04291508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426520|NCT04291508|Protective Agents|protective agents|mesh-ancestor
14426521|NCT04278768|Azacitidine|azacitidine|mesh-list
14426522|NCT04278768|Venetoclax|venetoclax|mesh-list
14426523|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426524|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
14426525|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426526|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426527|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426528|NCT04268771|Rituximab|rituximab|mesh-list
14746096|NCT00599560|Coagulants|coagulants|mesh-ancestor
14746097|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14746098|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14746099|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
14746100|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746101|NCT00599573|Ondansetron|ondansetron|mesh-list
14746102|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
14746103|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
14746104|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746105|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746106|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14746107|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
14746108|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
14746109|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14746110|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
14746111|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746112|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746113|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14746114|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14926882|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14746115|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926883|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426529|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426530|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426531|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
14426532|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426533|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426534|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
14426535|NCT04267120|Lenvatinib|lenvatinib|mesh-list
14426536|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426537|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426538|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14426539|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426540|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426541|NCT04265651|Infigratinib|infigratinib|mesh-list
14426542|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468364|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14468365|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14468366|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
14468367|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468368|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14468369|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14468370|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468371|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14468372|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14746116|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746117|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14746118|NCT00599625|Pravastatin|pravastatin|mesh-list
14746119|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14746120|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14746121|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
14746122|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746123|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14746124|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14746125|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746126|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14746127|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
14746128|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
14746129|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14468373|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468374|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14468375|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468376|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
14468377|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14468378|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14468379|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14468380|NCT02278471|Diuretics|diuretics|mesh-ancestor
14468381|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
14468382|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14468383|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14468384|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468385|NCT02278614|Timolol|timolol|mesh-list
14468386|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14468387|NCT02278614|Latanoprost|latanoprost|mesh-list
14468388|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14468389|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14468390|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14468391|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14468392|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468393|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468394|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468395|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14468396|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14468397|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
14468398|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14746130|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
14746131|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746132|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
14746133|NCT00599716|Protective Agents|protective agents|mesh-ancestor
14746134|NCT00599807|Vitamin D|vitamin d|mesh-list
14746135|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
14746136|NCT00599807|Vitamins|vitamins|mesh-ancestor
14746137|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
14746138|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426543|NCT04246619|Pregabalin|pregabalin|mesh-list
14746139|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14746140|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14746141|NCT00599820|Bevacizumab|bevacizumab|mesh-list
14746142|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14746143|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746144|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746145|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14746146|NCT00599820|Growth Substances|growth substances|mesh-ancestor
14746147|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746148|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746149|NCT00599833|Cetuximab|cetuximab|mesh-list
14746150|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14746151|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746152|NCT00599885|Valsartan|valsartan|mesh-list
14746153|NCT00599885|Telmisartan|telmisartan|mesh-list
14426544|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14426545|NCT04246619|Analgesics|analgesics|mesh-ancestor
14426546|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
14426547|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426548|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426549|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
14426550|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14426551|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14426552|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426553|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14426554|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14426555|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14746154|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14426556|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426557|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14426558|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14426559|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14426560|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426561|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
14426562|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
14426563|NCT04246359|Interferons|interferons|mesh-list
14426564|NCT04246359|Rituximab|rituximab|mesh-list
14426565|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426566|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426567|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
14426568|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426569|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426570|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
14426571|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746155|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14746156|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14746157|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746158|NCT00599898|Nifedipine|nifedipine|mesh-list
14746159|NCT00599898|Atosiban|atosiban|mesh-list
14746160|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14746161|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746162|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746163|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14746164|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746165|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
14746166|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
14746167|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14746168|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
14746169|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14746170|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14746171|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14746172|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14746173|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746174|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746175|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746176|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746177|NCT00599911|Analgesics|analgesics|mesh-ancestor
14746178|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
14426572|NCT04241640|Nefopam|nefopam|mesh-list
14426573|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426574|NCT04241640|Analgesics|analgesics|mesh-ancestor
14426575|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
14426576|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426577|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746179|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746180|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
14746181|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746182|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
14746183|NCT00599937|Tretinoin|tretinoin|mesh-list
14746184|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746185|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
14746186|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14746187|NCT00599950|Mitomycins|mitomycins|mesh-list
14746188|NCT00599950|Mitomycin|mitomycin|mesh-list
14746189|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14746190|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746191|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
14746192|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746193|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14746194|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746195|NCT00600041|Pantoprazole|pantoprazole|mesh-list
14746196|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14746197|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14746198|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14746199|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746200|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746201|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
14746202|NCT00600054|Antibodies|antibodies|mesh-list
14746203|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14746204|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
14746205|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746206|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14746207|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746208|NCT00600093|Amantadine|amantadine|mesh-list
14746209|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14746210|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14746211|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
14746212|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746213|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
14426586|NCT04232683|Tamsulosin|tamsulosin|mesh-list
14746214|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746215|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746216|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746217|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14746218|NCT00600093|Analgesics|analgesics|mesh-ancestor
14746219|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
14746220|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746221|NCT00600145|Mirtazapine|mirtazapine|mesh-list
14746222|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
14426587|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14426588|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14426589|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14426590|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
14426591|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426592|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426593|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426594|NCT04232683|Urological Agents|urological agents|mesh-ancestor
14426595|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
14426596|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14426597|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
14426598|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426599|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426600|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14426601|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14426602|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14426603|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
14426604|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426605|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426606|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14426607|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
14426608|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
14426609|NCT04231773|Protective Agents|protective agents|mesh-ancestor
14426610|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
14426611|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14426612|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
14426613|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426614|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426615|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14426616|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
14426617|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14426618|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
14426619|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426620|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426621|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14426622|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
14426623|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
14426624|NCT04231760|Protective Agents|protective agents|mesh-ancestor
14426625|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
14426626|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14426627|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
14426628|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426629|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426630|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14426631|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
14426632|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14426633|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
14426634|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426635|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426636|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14426637|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
14426638|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
14426639|NCT04216927|Protective Agents|protective agents|mesh-ancestor
14426640|NCT04216316|Gemcitabine|gemcitabine|mesh-list
14426641|NCT04216316|Carboplatin|carboplatin|mesh-list
14426642|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
14426643|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426644|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426645|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
14426646|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426647|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
14426648|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426649|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426650|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426651|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
14746223|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746224|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14746225|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
14746226|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
14746227|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426652|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426653|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426654|NCT04196868|Metformin|metformin|mesh-list
14426655|NCT04196868|Methotrexate|methotrexate|mesh-list
14426656|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14426657|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426658|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14426659|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
14426660|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14426661|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426662|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
14426663|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426664|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426665|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
14426666|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426667|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14426668|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746228|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746229|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746230|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14746231|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14746232|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746233|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14746234|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14746235|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14746236|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
14746237|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14746238|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14746239|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
14746240|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14746241|NCT00600158|Lidocaine|lidocaine|mesh-list
14746242|NCT00600158|Hydromorphone|hydromorphone|mesh-list
14746243|NCT00600158|Bupivacaine|bupivacaine|mesh-list
14746244|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
14746245|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
14746246|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746247|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746248|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
14746249|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746250|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14746251|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14746252|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14746253|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746254|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746255|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14746256|NCT00600158|Narcotics|narcotics|mesh-ancestor
14746257|NCT00600158|Analgesics|analgesics|mesh-ancestor
14746258|NCT00600210|Bevacizumab|bevacizumab|mesh-list
14746259|NCT00600210|Carboplatin|carboplatin|mesh-list
14746260|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14746261|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746262|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746263|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14926884|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426669|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
14426670|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426671|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426672|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
14426673|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14426674|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
14426675|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426676|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426677|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14426678|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
14926885|NCT01412892|Everolimus|everolimus|mesh-list
14926886|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926887|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926888|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
14926889|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926890|NCT01413022|Leucovorin|leucovorin|mesh-list
14426679|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14426680|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
14426681|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426682|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426683|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14426684|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
14426685|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
14426686|NCT04181359|Protective Agents|protective agents|mesh-ancestor
14426687|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
14426688|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14426689|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426690|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426691|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426692|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14426693|NCT04166435|Temozolomide|temozolomide|mesh-list
14426694|NCT04166435|Olaparib|olaparib|mesh-list
14426695|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14426696|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
14426697|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426698|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426699|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14426700|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426701|NCT04154787|Rituximab|rituximab|mesh-list
14746264|NCT00600210|Growth Substances|growth substances|mesh-ancestor
14926891|NCT01413022|Fluorouracil|fluorouracil|mesh-list
14426702|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426703|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426704|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
14426705|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426706|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426707|NCT04154150|Ketamine|ketamine|mesh-list
14426708|NCT04154150|Analgesics|analgesics|mesh-ancestor
14426709|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
14426710|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426711|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426712|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14746265|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746266|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746267|NCT00600249|Docetaxel|docetaxel|mesh-list
14746268|NCT00600249|Cetuximab|cetuximab|mesh-list
14746269|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746270|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
14746271|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
14746272|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
14426713|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14426714|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
14426715|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
14426716|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426717|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14426718|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14426719|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426720|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426721|NCT04107051|Nalmefene|nalmefene|mesh-list
14426722|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14426723|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426724|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
14426725|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746273|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746274|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14746275|NCT00600262|Bevacizumab|bevacizumab|mesh-list
14746276|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14746277|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746278|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746279|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14746280|NCT00600262|Growth Substances|growth substances|mesh-ancestor
14746281|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746282|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746283|NCT00600301|Triamcinolone|triamcinolone|mesh-list
14746284|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14746285|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14746286|NCT00600301|Bevacizumab|bevacizumab|mesh-list
14746287|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14746288|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14926892|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
14926893|NCT01413022|Irinotecan|irinotecan|mesh-list
14926894|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
14926895|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926896|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14926897|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926898|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14926899|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
14926900|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926901|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14426726|NCT04090567|Olaparib|olaparib|mesh-list
14426727|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14746289|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746290|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746291|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14746292|NCT00600301|Growth Substances|growth substances|mesh-ancestor
14746293|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746294|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746295|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14746296|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
14426728|NCT04090567|Cediranib|cediranib|mesh-list
14426729|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426730|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426731|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426732|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14426733|NCT04062097|Vitamin K|vitamin k|mesh-list
14426734|NCT04062097|Dabigatran|dabigatran|mesh-list
14426735|NCT04062097|Vitamins|vitamins|mesh-ancestor
14426736|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
14746297|NCT00600301|Hormones|hormones|mesh-ancestor
14746298|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14746299|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746300|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
14746301|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746302|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746303|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
14746304|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
14746305|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14746306|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14926902|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14926903|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926904|NCT01413022|Antidotes|antidotes|mesh-ancestor
14426737|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426738|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
14426739|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14746307|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746308|NCT00600405|Ibuprofen|ibuprofen|mesh-list
14746309|NCT00600405|Oxycodone|oxycodone|mesh-list
14746310|NCT00600405|Tamsulosin|tamsulosin|mesh-list
14746311|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14746312|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14746313|NCT00600405|Analgesics|analgesics|mesh-ancestor
14746314|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
14746315|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746316|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746317|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426740|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
14426741|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426742|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426743|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
14426744|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14426745|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14426746|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
14746318|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14746319|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14746320|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746321|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746322|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14746323|NCT00600405|Narcotics|narcotics|mesh-ancestor
14746324|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14926905|NCT01413022|Protective Agents|protective agents|mesh-ancestor
14926906|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
14926907|NCT01413022|Vitamins|vitamins|mesh-ancestor
14926908|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
14926909|NCT01413048|Carvedilol|carvedilol|mesh-list
14926910|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14426747|NCT04062097|Coagulants|coagulants|mesh-ancestor
14426748|NCT04026009|Vaccines|vaccines|mesh-list
14426749|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
14426750|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426751|NCT04007874|Vitamin E|vitamin e|mesh-list
14426752|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
14426753|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14426754|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14426755|NCT04007874|Vitamins|vitamins|mesh-ancestor
14426756|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
14426757|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426758|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14426759|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
14426760|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14426761|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14426762|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14426763|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14426764|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
14746325|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14426765|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426766|NCT04007874|Protective Agents|protective agents|mesh-ancestor
14426767|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14426768|NCT04007874|Estrogens|estrogens|mesh-ancestor
14426769|NCT04007874|Hormones|hormones|mesh-ancestor
14426770|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14426771|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14426772|NCT04005079|Ofloxacin|ofloxacin|mesh-list
14426773|NCT04005079|Prednisolone|prednisolone|mesh-list
14426774|NCT04005079|Pilocarpine|pilocarpine|mesh-list
14426775|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426776|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
14426777|NCT04005079|Hormones|hormones|mesh-ancestor
14426778|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14426779|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426780|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14426781|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426782|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
14426783|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426784|NCT04005079|Miotics|miotics|mesh-ancestor
14426785|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14426786|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14426787|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
14426788|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426789|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426790|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14426791|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426792|NCT04005079|Renal Agents|renal agents|mesh-ancestor
14426793|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14426794|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14426795|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14426796|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426797|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14426798|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14426799|NCT04004611|Mirikizumab|mirikizumab|mesh-list
14426800|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14426801|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426802|NCT04004611|Analgesics|analgesics|mesh-ancestor
14426803|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
14746326|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14746327|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14746328|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
14746329|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746330|NCT00600405|Urological Agents|urological agents|mesh-ancestor
14746331|NCT00600483|Gentamicins|gentamicins|mesh-list
14746332|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14426804|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426805|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746333|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426806|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426807|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426808|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14426809|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926911|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14926912|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14926913|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926914|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926915|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926916|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14926917|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
14426810|NCT03999749|Nivolumab|nivolumab|mesh-list
14426811|NCT03999749|Ipilimumab|ipilimumab|mesh-list
14426812|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426813|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426814|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14426815|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426816|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
14426817|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14426818|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426819|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426820|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14426821|NCT03957304|Analgesics|analgesics|mesh-ancestor
14426822|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
14426823|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426824|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14426825|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14426826|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14426827|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
14426828|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426829|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746334|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14746335|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746336|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746337|NCT00600509|Levetiracetam|levetiracetam|mesh-list
14746338|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
14746339|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
14746340|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
14746341|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
14746342|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746343|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14746344|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746345|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746346|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
14746347|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14746348|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926918|NCT01413048|Protective Agents|protective agents|mesh-ancestor
14926919|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14426852|NCT03924791|Dexamethasone|dexamethasone|mesh-list
14426853|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
14426854|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14426855|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14426856|NCT03924791|Prednisolone|prednisolone|mesh-list
14426857|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
14426858|NCT03924791|Lidocaine|lidocaine|mesh-list
14426859|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14426860|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
14426861|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14426862|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
14426863|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
14426864|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426865|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426866|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14746349|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14746350|NCT00600535|Hormones|hormones|mesh-ancestor
14746351|NCT00600548|Miltefosine|miltefosine|mesh-list
14746352|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14746353|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
14746354|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746355|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746356|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14746357|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14746358|NCT00600587|Gemcitabine|gemcitabine|mesh-list
14746359|NCT00600587|Carboplatin|carboplatin|mesh-list
14746360|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14746361|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746362|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14746363|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
14746364|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746365|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
14746366|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746367|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746368|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746369|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
14746370|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746371|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14746372|NCT00600600|Tigecycline|tigecycline|mesh-list
14746373|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746374|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746375|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14746376|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426867|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
14426868|NCT03924791|Hormones|hormones|mesh-ancestor
14426869|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14426870|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14426871|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426872|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
14426873|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
14426874|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14426875|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
14426876|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14426877|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14426878|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14746377|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753468|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14753469|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
14753470|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
14426879|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14426880|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426881|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14426882|NCT03924791|Protective Agents|protective agents|mesh-ancestor
14426883|NCT03914443|Cisplatin|cisplatin|mesh-list
14426884|NCT03914443|Docetaxel|docetaxel|mesh-list
14426885|NCT03914443|Fluorouracil|fluorouracil|mesh-list
14426886|NCT03914443|Nivolumab|nivolumab|mesh-list
14426887|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426888|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
14426889|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
14426890|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753471|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426891|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426892|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
14426893|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426894|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746378|NCT00600626|Insulin|insulin|mesh-list
14426895|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
14426896|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426897|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426898|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14426899|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
14426900|NCT03899103|Rituximab|rituximab|mesh-list
14426901|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14426902|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426903|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
14426904|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426905|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426906|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14426907|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14426908|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
14426909|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14426910|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426911|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426912|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468399|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468400|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468401|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468402|NCT02279641|Allopurinol|allopurinol|mesh-list
14468403|NCT02279641|Verinurad|verinurad|mesh-list
14468404|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
14468405|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468406|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468407|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
14468408|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468409|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14468410|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
14468411|NCT02279641|Protective Agents|protective agents|mesh-ancestor
14468412|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468413|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468414|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
14468415|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468416|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14746379|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14426913|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
14426914|NCT03878472|Apatinib|apatinib|mesh-list
14426915|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426916|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14426917|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426918|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426919|NCT03861871|Fenfluramine|fenfluramine|mesh-list
14426920|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14746380|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
14746381|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
14746382|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14426921|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14426922|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14426923|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426924|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426925|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
14426926|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426927|NCT03856216|Rituximab|rituximab|mesh-list
14426928|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14426929|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14426930|NCT03856216|Methotrexate|methotrexate|mesh-list
14426931|NCT03856216|Fludarabine|fludarabine|mesh-list
14426932|NCT03856216|Melphalan|melphalan|mesh-list
14426933|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14426934|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
14426935|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14426936|NCT03856216|Antibodies|antibodies|mesh-list
14426937|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
14426938|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14926920|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14926921|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14926922|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
14926923|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14926924|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14926925|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
14926926|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14926927|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926928|NCT01413230|Vitamins|vitamins|mesh-ancestor
14926929|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
14926930|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14426939|NCT03856216|Lenograstim|lenograstim|mesh-list
14931125|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931126|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
14931127|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14931128|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14931129|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
14931130|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931131|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426940|NCT03856216|Tacrolimus|tacrolimus|mesh-list
14426941|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14426942|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
14426943|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746383|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
14746384|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
14746385|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
14746386|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
14746387|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14746388|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746389|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14746390|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14426944|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426945|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14746391|NCT00600639|Prednisolone|prednisolone|mesh-list
14746392|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14426946|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14426947|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
14746393|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
14746394|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14746395|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
14746396|NCT00600639|Albuterol|albuterol|mesh-list
14746397|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14746398|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
14426948|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14426949|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14926931|NCT01413477|Calcitriol|calcitriol|mesh-list
14926932|NCT01413477|Betamethasone|betamethasone|mesh-list
14926933|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
14926934|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14926935|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
14926936|NCT01413477|Calcipotriene|calcipotriene|mesh-list
14926937|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14426950|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
14426951|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426952|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926938|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926939|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
14926940|NCT01413477|Hormones|hormones|mesh-ancestor
14926941|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14926942|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926943|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14926944|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
14926945|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926946|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14926947|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14426953|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426954|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14426955|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426956|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426957|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14426958|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14746399|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746400|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
14746401|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14746402|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
14746403|NCT00600639|Hormones|hormones|mesh-ancestor
14746404|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14746405|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746406|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14426959|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14426960|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
14426961|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14426962|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14426963|NCT03816163|Gemcitabine|gemcitabine|mesh-list
14426964|NCT03816163|Paclitaxel|paclitaxel|mesh-list
14426965|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14746407|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746408|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
14746409|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
14926948|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746410|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746411|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14746412|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14746413|NCT00600639|Protective Agents|protective agents|mesh-ancestor
14746414|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14746415|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14746416|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
14746417|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
14746418|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14746419|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14746420|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14746421|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14746422|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
14746423|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14426966|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426967|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14426968|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14426969|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14426970|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746424|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746425|NCT00600691|Finasteride|finasteride|mesh-list
14746426|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14746427|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14746428|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746429|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746430|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
14746431|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14746432|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746433|NCT00600691|Urological Agents|urological agents|mesh-ancestor
14746434|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14426971|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426972|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
14426973|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
14746435|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746436|NCT00600769|Clarithromycin|clarithromycin|mesh-list
14746437|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746438|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14426974|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746439|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14746440|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746441|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926949|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926950|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14926951|NCT01413477|Vitamins|vitamins|mesh-ancestor
14746442|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14746443|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14746444|NCT00600847|Loratadine|loratadine|mesh-list
14746445|NCT00600847|Desloratadine|desloratadine|mesh-list
14746446|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14926952|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
14426975|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426976|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426977|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
14426978|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426979|NCT03813199|Methotrexate|methotrexate|mesh-list
14426980|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14426981|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
14426982|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14426983|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14426984|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14426985|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
14426986|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14426987|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14426988|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
14926953|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14926954|NCT01413490|Rimantadine|rimantadine|mesh-list
14926955|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
14926956|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14926957|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426989|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14426990|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14426991|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14426992|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
14426993|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14426994|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14426995|NCT03809234|Ondansetron|ondansetron|mesh-list
14426996|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
14426997|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
14426998|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14426999|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427000|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427001|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
14427002|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
14427003|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14746447|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
14926958|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427004|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
14427005|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427006|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427007|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14427008|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14427009|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14427010|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14427011|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14427012|NCT03804580|Osimertinib|osimertinib|mesh-list
14427013|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427014|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14427015|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427016|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427017|NCT03781765|Methylphenidate|methylphenidate|mesh-list
14427018|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14746448|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746449|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746450|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746451|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14746452|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14746453|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
14746454|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
14746455|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
14746456|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14746457|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14746458|NCT00600873|Pramipexole|pramipexole|mesh-list
14746459|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
14746460|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746461|NCT00600873|Protective Agents|protective agents|mesh-ancestor
14746462|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746463|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14746464|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14746465|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
14427019|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14427020|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427021|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14427022|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14427023|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14427024|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427025|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
14427026|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427027|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14746466|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
14427028|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
14427029|NCT03781752|Methylphenidate|methylphenidate|mesh-list
14427030|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14427031|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427032|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14427033|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14427034|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14427035|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427036|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
14427037|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427038|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
14427039|NCT03719326|Paclitaxel|paclitaxel|mesh-list
14427040|NCT03719326|Doxorubicin|doxorubicin|mesh-list
14427041|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14427042|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14427043|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427044|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427045|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427046|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427047|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427048|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427049|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14427050|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14427051|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427052|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427053|NCT03718065|Lofexidine|lofexidine|mesh-list
14427054|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14427055|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14427056|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427057|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
14427058|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427059|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14427060|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14427061|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14427062|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
14427063|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427064|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427065|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14427066|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427067|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427068|NCT03711188|Nivolumab|nivolumab|mesh-list
14427069|NCT03711188|Ipilimumab|ipilimumab|mesh-list
14427070|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427071|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427072|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14427073|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427074|NCT03696199|Anesthetics|anesthetics|mesh-list
14427075|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14427076|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427077|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
14427078|NCT03684785|Cemiplimab|cemiplimab|mesh-list
14427079|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427080|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427081|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
14427082|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14427083|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
14746467|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746468|NCT00600912|SMOFlipid|smoflipid|mesh-list
14926959|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926960|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
14926961|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14926962|NCT01413620|Vitamins|vitamins|mesh-list
14926963|NCT01413620|Vitamin E|vitamin e|mesh-list
14926964|NCT01413620|Tocopherols|tocopherols|mesh-list
14926965|NCT01413620|Tocotrienols|tocotrienols|mesh-list
14926966|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
14926967|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
14926968|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926969|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
14926970|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746469|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14746470|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14746471|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14746472|NCT00600964|Obatoclax|obatoclax|mesh-list
14746473|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746474|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746475|NCT00600977|Doxorubicin|doxorubicin|mesh-list
14746476|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14746477|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14746478|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746479|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14746480|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14746481|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746482|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746483|NCT00600990|Vestipitant|vestipitant|mesh-list
14746484|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14926971|NCT01413620|Protective Agents|protective agents|mesh-ancestor
14926972|NCT01413711|Vigabatrin|vigabatrin|mesh-list
14926973|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
14926974|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931132|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746485|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746486|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746487|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746488|NCT00601016|Imiquimod|imiquimod|mesh-list
14746489|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14746490|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
14746491|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746492|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746493|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
14746494|NCT00601042|Lobeline|lobeline|mesh-list
14746495|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14746496|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
14746497|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746498|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746499|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14746500|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14746501|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
14746502|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746503|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746504|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
14746505|NCT00601159|Gemcitabine|gemcitabine|mesh-list
14746506|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926975|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926976|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
14746507|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14926977|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14926978|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926979|NCT01413763|Imiquimod|imiquimod|mesh-list
14427084|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14926980|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14926981|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
14926982|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926983|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14926984|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
14926985|NCT01413854|Diclofenac|diclofenac|mesh-list
14926986|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14427085|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
14926987|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14926988|NCT01413854|Analgesics|analgesics|mesh-ancestor
14926989|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
14926990|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14926991|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14926992|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14926993|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14926994|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14926995|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14926996|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14926997|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
14926998|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14926999|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
14927000|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14927001|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427086|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746508|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
14927002|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14927003|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14427087|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427088|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14746509|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746510|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
14746511|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746512|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746513|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746514|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
14746515|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746516|NCT00601198|Leucovorin|leucovorin|mesh-list
14746517|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
14746518|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
14927004|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14427089|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14427090|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14427091|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
14927005|NCT01414231|Cytarabine|cytarabine|mesh-list
14927006|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14927007|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
14927008|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927009|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427092|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927010|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
14927011|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927012|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927013|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
14927014|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927015|NCT01414465|Orlistat|orlistat|mesh-list
14927016|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927017|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927018|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14927019|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14927020|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14927021|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
14927022|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927023|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
14927024|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
14927025|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14927026|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927027|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14427093|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427094|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14427095|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
14927028|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14427096|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
14427097|NCT03679312|Protective Agents|protective agents|mesh-ancestor
14427098|NCT03654833|Bevacizumab|bevacizumab|mesh-list
14427099|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
14427100|NCT03654833|Atezolizumab|atezolizumab|mesh-list
14427101|NCT03654833|Niraparib|niraparib|mesh-list
14427102|NCT03654833|Rucaparib|rucaparib|mesh-list
14427103|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427104|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427105|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14427106|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14427107|NCT03654833|Growth Substances|growth substances|mesh-ancestor
14427108|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746519|NCT00601198|Amifostine|amifostine|mesh-list
14927029|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427109|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
14427110|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14427111|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427112|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427113|NCT03646175|Choline|choline|mesh-list
14427114|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
14427115|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14427116|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
14427117|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427118|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427119|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14427120|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
14427121|NCT03634839|Nicotine|nicotine|mesh-list
14746520|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427122|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14427123|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
14427124|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427125|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427126|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14427127|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14427128|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
14427129|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427130|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427131|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14427132|NCT03555149|Bevacizumab|bevacizumab|mesh-list
14427133|NCT03555149|Atezolizumab|atezolizumab|mesh-list
14427134|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427135|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427136|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14427137|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14427138|NCT03555149|Growth Substances|growth substances|mesh-ancestor
14427139|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427140|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
14427141|NCT03552471|Rucaparib|rucaparib|mesh-list
14427142|NCT03552471|Maytansine|maytansine|mesh-list
14427143|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14427144|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427145|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427146|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427147|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427148|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427149|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427150|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427151|NCT03535506|Palbociclib|palbociclib|mesh-list
14427152|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427153|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14427154|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427155|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746521|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427156|NCT03527108|Nivolumab|nivolumab|mesh-list
14427157|NCT03527108|Ramucirumab|ramucirumab|mesh-list
14427158|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427159|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427160|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14427161|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427162|NCT03516305|Alprazolam|alprazolam|mesh-list
14427163|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14427164|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14427165|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427166|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14427167|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14427168|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14427169|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
14427170|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
14427171|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427172|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427173|NCT03499483|Tenofovir|tenofovir|mesh-list
14427174|NCT03499483|Emtricitabine|emtricitabine|mesh-list
14427175|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14427176|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
14427177|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427178|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14427179|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14427180|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427181|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427182|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14927030|NCT01414556|Incretins|incretins|mesh-ancestor
14927031|NCT01414556|Hormones|hormones|mesh-ancestor
14927032|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927033|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927034|NCT01414569|Dexamethasone|dexamethasone|mesh-list
14927035|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
14427183|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14427184|NCT03494530|Edoxaban|edoxaban|mesh-list
14427185|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14427186|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
14427187|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14427188|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
14427189|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468417|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927036|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14427190|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427191|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
14427192|NCT03478956|Etrolizumab|etrolizumab|mesh-list
14427193|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427194|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
14746522|NCT00601198|Antidotes|antidotes|mesh-ancestor
14746523|NCT00601198|Protective Agents|protective agents|mesh-ancestor
14746524|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
14746525|NCT00601198|Vitamins|vitamins|mesh-ancestor
14746526|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
14746527|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14746528|NCT00601211|Pilocarpine|pilocarpine|mesh-list
14746529|NCT00601211|Miotics|miotics|mesh-ancestor
14746530|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
14927037|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
14427195|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427196|NCT03453489|Tryptophan|tryptophan|mesh-list
14427197|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14427198|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
14427199|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14427200|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14427201|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14468418|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468419|NCT02279732|Paclitaxel|paclitaxel|mesh-list
14468420|NCT02279732|Carboplatin|carboplatin|mesh-list
14468421|NCT02279732|Ipilimumab|ipilimumab|mesh-list
14468422|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14468423|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468424|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
14468425|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
14468426|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
14468427|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468428|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14468429|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14468430|NCT02279862|Ipilimumab|ipilimumab|mesh-list
14468431|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14468432|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468433|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14468434|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468435|NCT02280044|Rifaximin|rifaximin|mesh-list
14468436|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746531|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927038|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
14931133|NCT01437670|Urological Agents|urological agents|mesh-ancestor
14427202|NCT03356860|Paclitaxel|paclitaxel|mesh-list
14427203|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
14427204|NCT03356860|Durvalumab|durvalumab|mesh-list
14427205|NCT03356860|Epirubicin|epirubicin|mesh-list
14427206|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427207|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427208|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427209|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427210|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427211|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427212|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427213|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
14427214|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427215|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927039|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427216|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14427217|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
14427218|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14427219|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427220|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14427221|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14427222|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427223|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427224|NCT03348930|Tolcapone|tolcapone|mesh-list
14427225|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14927040|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927041|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14927042|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
14927043|NCT01414569|Hormones|hormones|mesh-ancestor
14927044|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927045|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14927046|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927047|NCT01414608|Paclitaxel|paclitaxel|mesh-list
14927048|NCT01414608|Cisplatin|cisplatin|mesh-list
14927049|NCT01414608|Carboplatin|carboplatin|mesh-list
14927050|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14427226|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14427227|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14427228|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427229|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427230|NCT03336216|Leucovorin|leucovorin|mesh-list
14427231|NCT03336216|Gemcitabine|gemcitabine|mesh-list
14427232|NCT03336216|Paclitaxel|paclitaxel|mesh-list
14427233|NCT03336216|Fluorouracil|fluorouracil|mesh-list
14427234|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
14427235|NCT03336216|Nivolumab|nivolumab|mesh-list
14427236|NCT03336216|Irinotecan|irinotecan|mesh-list
14427237|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427238|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427239|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427240|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427241|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427242|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427243|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427244|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
14427245|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
14427246|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427247|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427248|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427249|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
14427250|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427251|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427252|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14427253|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14427254|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427255|NCT03336216|Antidotes|antidotes|mesh-ancestor
14746532|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746533|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14427256|NCT03336216|Protective Agents|protective agents|mesh-ancestor
14427257|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
14427258|NCT03336216|Vitamins|vitamins|mesh-ancestor
14427259|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
14427260|NCT03301896|Spartalizumab|spartalizumab|mesh-list
14427261|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14427262|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427263|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427264|NCT03290391|Naltrexone|naltrexone|mesh-list
14427265|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14427266|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14427267|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427268|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
14427269|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427270|NCT03282240|Vaccines|vaccines|mesh-list
14427271|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
14427272|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427273|NCT03263429|Irinotecan|irinotecan|mesh-list
14427274|NCT03263429|Panitumumab|panitumumab|mesh-list
14427275|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14427276|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427277|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427278|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427279|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427280|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427281|NCT03260868|Insulin|insulin|mesh-list
14427282|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14427283|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
14427284|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
14427285|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
14427286|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14427287|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427288|NCT03244020|Aspirin|aspirin|mesh-list
14427289|NCT03244020|Enoxaparin|enoxaparin|mesh-list
14427290|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14427291|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14427292|NCT03244020|Analgesics|analgesics|mesh-ancestor
14427293|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
14427294|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427295|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427296|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14427297|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427298|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14427299|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14427300|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427301|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14427302|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14746534|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14746535|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
14746536|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427303|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427304|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
14427305|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
14427306|NCT03232593|Atezolizumab|atezolizumab|mesh-list
14427307|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427308|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
14427309|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14427310|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14427311|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14427312|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427313|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
14427314|NCT03211286|Coagulants|coagulants|mesh-ancestor
14427315|NCT03164616|Gemcitabine|gemcitabine|mesh-list
14427316|NCT03164616|Cisplatin|cisplatin|mesh-list
14427317|NCT03164616|Carboplatin|carboplatin|mesh-list
14931134|NCT01437696|Vitamin D|vitamin d|mesh-list
14427318|NCT03164616|Pemetrexed|pemetrexed|mesh-list
14427319|NCT03164616|Durvalumab|durvalumab|mesh-list
14427320|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14427321|NCT03164616|Tremelimumab|tremelimumab|mesh-list
14427322|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427323|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427324|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
14427325|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427326|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
14427327|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427328|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427329|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427330|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
14427331|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427332|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14427333|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14427334|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427335|NCT03162510|Paclitaxel|paclitaxel|mesh-list
14427336|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14427337|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
14427338|NCT03162510|Tegafur|tegafur|mesh-list
14427339|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427340|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427341|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427342|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427343|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427344|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427345|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427346|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
14427347|NCT03162497|Azithromycin|azithromycin|mesh-list
14427348|NCT03162497|Doxycycline|doxycycline|mesh-list
14427349|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14427350|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427351|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
14427352|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14427353|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14427354|NCT03161756|Denosumab|denosumab|mesh-list
14427355|NCT03161756|Nivolumab|nivolumab|mesh-list
14427356|NCT03161756|Ipilimumab|ipilimumab|mesh-list
14427357|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427358|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427359|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14427360|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427361|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14427362|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427363|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
14427364|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
14427365|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
14427366|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427367|NCT03127007|Atezolizumab|atezolizumab|mesh-list
14427368|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427369|NCT03101748|Paclitaxel|paclitaxel|mesh-list
14427370|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
14427371|NCT03101748|Doxorubicin|doxorubicin|mesh-list
14427372|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14427373|NCT03101748|Trastuzumab|trastuzumab|mesh-list
14427374|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14427375|NCT03101748|Daunorubicin|daunorubicin|mesh-list
14427376|NCT03101748|Pertuzumab|pertuzumab|mesh-list
14427377|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14427378|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14427379|NCT03101748|Antibodies|antibodies|mesh-list
14427380|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
14427381|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14427382|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427383|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427384|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427385|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427386|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427387|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427388|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427389|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
14427390|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427391|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427392|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14427393|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
14427394|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14427395|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14427396|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14427397|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427398|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427399|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14427400|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14427401|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427402|NCT03058757|Mitomycins|mitomycins|mesh-list
14427403|NCT03058757|Mitomycin|mitomycin|mesh-list
14427404|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14427405|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427406|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
14427407|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427408|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14427409|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427410|NCT02996760|Mitogens|mitogens|mesh-list
14427411|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427412|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427413|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14427414|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427415|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14427416|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427417|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427418|NCT02987946|Nadroparin|nadroparin|mesh-list
14427419|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
14427420|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14427421|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14427422|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427423|NCT02969083|Gemcitabine|gemcitabine|mesh-list
14427424|NCT02969083|Cisplatin|cisplatin|mesh-list
14427425|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427426|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427427|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
14427428|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427429|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
14427430|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427431|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427432|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427433|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
14427434|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427435|NCT02965963|Dopamine|dopamine|mesh-list
14427436|NCT02965963|Metoclopramide|metoclopramide|mesh-list
14427437|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
14427438|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
14427439|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427440|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427441|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427442|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14427443|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14427444|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
14427445|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427446|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427447|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14427448|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
14427449|NCT02965963|Protective Agents|protective agents|mesh-ancestor
14427450|NCT02884206|Valsartan|valsartan|mesh-list
14427451|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14427452|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14427453|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14427454|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14427455|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427456|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
14427457|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14427458|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14427459|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427460|NCT02866383|Nivolumab|nivolumab|mesh-list
14427461|NCT02866383|Ipilimumab|ipilimumab|mesh-list
14427462|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427463|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427464|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14427465|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427466|NCT02865473|Pilocarpine|pilocarpine|mesh-list
14427467|NCT02865473|Miotics|miotics|mesh-ancestor
14427468|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
14427469|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427470|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427471|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14427472|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14746537|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746538|NCT00601276|Leuprolide|leuprolide|mesh-list
14746539|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
14746540|NCT00601276|Cyproterone|cyproterone|mesh-list
14746541|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14746542|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
14746543|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14746544|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427473|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
14427474|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427475|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427476|NCT02850419|Doxorubicin|doxorubicin|mesh-list
14427477|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14427478|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14746545|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14746546|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746547|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
14746548|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
14746549|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14746550|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14427479|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427480|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14427481|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427482|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427483|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427484|NCT02847624|Tolvaptan|tolvaptan|mesh-list
14427485|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14427486|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427487|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
14427488|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427489|NCT02841371|Edetic Acid|edetic acid|mesh-list
14427490|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
14427491|NCT02841371|Antidotes|antidotes|mesh-ancestor
14427492|NCT02841371|Protective Agents|protective agents|mesh-ancestor
14427493|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427494|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
14427495|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
14427496|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746551|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
14746552|NCT00601289|Temozolomide|temozolomide|mesh-list
14746553|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14746554|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
14746555|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427497|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14427498|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
14427499|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14427500|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14427501|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14427502|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427503|NCT02811133|Inositol|inositol|mesh-list
14427504|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
14427505|NCT02811133|Vitamins|vitamins|mesh-ancestor
14427506|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
14427507|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427508|NCT02788708|Paclitaxel|paclitaxel|mesh-list
14427509|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14427510|NCT02788708|Lenvatinib|lenvatinib|mesh-list
14427511|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427512|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427513|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427514|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427515|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427516|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427517|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14427518|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427519|NCT02783859|Amoxicillin|amoxicillin|mesh-list
14427520|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
14427521|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
14427522|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14427523|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14427524|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427525|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427526|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427527|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14427528|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
14427529|NCT02706405|Fludarabine|fludarabine|mesh-list
14427530|NCT02706405|Durvalumab|durvalumab|mesh-list
14427531|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
14427532|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14427533|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
14427534|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427535|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
14927051|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14927052|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927053|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
14927054|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
14927055|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
14927056|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427536|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427537|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427538|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14427539|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
14427540|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427541|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427542|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14427543|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427544|NCT02655523|Dexamethasone|dexamethasone|mesh-list
14427545|NCT02655523|Triamcinolone|triamcinolone|mesh-list
14427546|NCT02655523|Bupivacaine|bupivacaine|mesh-list
14746556|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746557|NCT00601302|Amlodipine|amlodipine|mesh-list
14746558|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14746559|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14746560|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746561|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746562|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14746563|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746564|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
14427547|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14427548|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
14427549|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
14746565|NCT00601315|Clarithromycin|clarithromycin|mesh-list
14427550|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427551|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427552|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427553|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
14427554|NCT02655523|Hormones|hormones|mesh-ancestor
14427555|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14427556|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14427557|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427558|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
14427559|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
14427560|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14427561|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
14427562|NCT02652169|Amikacin|amikacin|mesh-list
14427563|NCT02652169|Teicoplanin|teicoplanin|mesh-list
14427564|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14427565|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427566|NCT02636270|Mecasermin|mecasermin|mesh-list
14427567|NCT02636270|Growth Substances|growth substances|mesh-ancestor
14427568|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427569|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
14427570|NCT02620865|Leucovorin|leucovorin|mesh-list
14427571|NCT02620865|Folic Acid|folic acid|mesh-list
14427572|NCT02620865|Gemcitabine|gemcitabine|mesh-list
14427573|NCT02620865|Aldesleukin|aldesleukin|mesh-list
14427574|NCT02620865|Paclitaxel|paclitaxel|mesh-list
14427575|NCT02620865|Camptothecin|camptothecin|mesh-list
14746566|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746567|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427576|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14427577|NCT02620865|Fluorouracil|fluorouracil|mesh-list
14427578|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
14427579|NCT02620865|Irinotecan|irinotecan|mesh-list
14427580|NCT02620865|Interleukin-2|interleukin-2|mesh-list
14427581|NCT02620865|Antibodies|antibodies|mesh-list
14427582|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
14427583|NCT02620865|Sargramostim|sargramostim|mesh-list
14427584|NCT02620865|Calcium|calcium|mesh-list
14427585|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
14427586|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427587|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427588|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427589|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427590|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427591|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427592|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
14427593|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427594|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427595|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
14427596|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
14427597|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427598|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427599|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427600|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14427601|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14427602|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14427603|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427604|NCT02620865|Antidotes|antidotes|mesh-ancestor
14427605|NCT02620865|Protective Agents|protective agents|mesh-ancestor
14427606|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
14427607|NCT02620865|Vitamins|vitamins|mesh-ancestor
14427608|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
14427609|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14427610|NCT02620865|Analgesics|analgesics|mesh-ancestor
14427611|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
14427612|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427613|NCT02620865|Hematinics|hematinics|mesh-ancestor
14427614|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14427615|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14427616|NCT02611960|Gemcitabine|gemcitabine|mesh-list
14427617|NCT02611960|Capecitabine|capecitabine|mesh-list
14427618|NCT02611960|Docetaxel|docetaxel|mesh-list
14427619|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
14427620|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14746568|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14746569|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746570|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746571|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14746572|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14746573|NCT00601328|Calcitriol|calcitriol|mesh-list
14746574|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14746575|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746576|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14746577|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746578|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746579|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14427621|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
14427622|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746580|NCT00601328|Vitamins|vitamins|mesh-ancestor
14427623|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427624|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
14427625|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427626|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427627|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427628|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
14427629|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427630|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427631|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
14927057|NCT01414816|Interferons|interferons|mesh-list
14927058|NCT01414816|Interferon-beta|interferon-beta|mesh-list
14927059|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
14927060|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927061|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
14927062|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427632|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
14927063|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
14927064|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427633|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427634|NCT02611323|Rituximab|rituximab|mesh-list
14427635|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
14746581|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
14746582|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14746583|NCT00601432|Levofloxacin|levofloxacin|mesh-list
14746584|NCT00601432|Ofloxacin|ofloxacin|mesh-list
14746585|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14746586|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746587|NCT00601432|Renal Agents|renal agents|mesh-ancestor
14746588|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14927065|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14927066|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
14427636|NCT02611323|Venetoclax|venetoclax|mesh-list
14427637|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427638|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427639|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
14427640|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427641|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427642|NCT02585375|Latanoprost|latanoprost|mesh-list
14427643|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14427644|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14468437|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468438|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14468439|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
14468440|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14468441|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468442|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468443|NCT02280421|Cyclosporine|cyclosporine|mesh-list
14468444|NCT02280421|Cyclosporins|cyclosporins|mesh-list
14468445|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468446|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468447|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14468448|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
14746589|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14746590|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14746591|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746592|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746593|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746594|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14746595|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14427645|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
14427646|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427647|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
14427648|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427649|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427650|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14427651|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
14427652|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427653|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427654|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14427655|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
14427656|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427657|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
14427658|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427659|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427660|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14427661|NCT02516813|Peposertib|peposertib|mesh-list
14427662|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14427663|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427664|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427665|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
14746596|NCT00601510|Capecitabine|capecitabine|mesh-list
14927067|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14927068|NCT01414868|Montelukast|montelukast|mesh-list
14427666|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427667|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427668|NCT02478775|Cetrorelix|cetrorelix|mesh-list
14427669|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14427670|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
14427671|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14427672|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427673|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
14427674|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14427675|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
14427676|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14927069|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14927070|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14927071|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
14927072|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
14927073|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927074|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927075|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14927076|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14927077|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927078|NCT01414881|Mipomersen|mipomersen|mesh-list
14927079|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14927080|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14927081|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
14927082|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927083|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14427677|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427678|NCT02422641|Methotrexate|methotrexate|mesh-list
14427679|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14427680|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
14427681|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14427682|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746597|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
14746598|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746599|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14746600|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
14746601|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746602|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14746603|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746604|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
14746605|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
14746606|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746607|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927084|NCT01414972|Vitamin A|vitamin a|mesh-list
14927085|NCT01414972|Vitamins|vitamins|mesh-ancestor
14927086|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
14927087|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927088|NCT01414998|Nicotine|nicotine|mesh-list
14927089|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14927090|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
14927091|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927092|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427683|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427684|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
14427685|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427686|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427687|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14427688|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427689|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14746608|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746609|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
14746610|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14427690|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427691|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
14427692|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427693|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14427694|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
14427695|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427696|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427697|NCT02394132|Imiquimod|imiquimod|mesh-list
14427698|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14427699|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
14427700|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427701|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427702|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
14427703|NCT02392871|Trametinib|trametinib|mesh-list
14427704|NCT02392871|Dabrafenib|dabrafenib|mesh-list
14427705|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427706|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14427707|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427708|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427709|NCT02382575|Rituximab|rituximab|mesh-list
14427710|NCT02382575|Tacrolimus|tacrolimus|mesh-list
14746611|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746612|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746613|NCT00601562|Zidovudine|zidovudine|mesh-list
14746614|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
14927093|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14427711|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14746615|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746616|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14746617|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14746618|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746619|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
14746620|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746621|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14746622|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14746623|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
14746624|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
14427712|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427713|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427714|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
14427715|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427716|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427717|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427718|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427719|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427720|NCT02239874|Vitamin D|vitamin d|mesh-list
14427721|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
14427722|NCT02239874|Vitamins|vitamins|mesh-list
14427723|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
14427724|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427725|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14427726|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14427727|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14427728|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14427729|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427730|NCT02199236|Capecitabine|capecitabine|mesh-list
14427731|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427732|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
14427733|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427734|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427735|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
14427736|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14427737|NCT02153580|Fludarabine|fludarabine|mesh-list
14427738|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
14427739|NCT02153580|Etoposide|etoposide|mesh-list
14427740|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
14427741|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
14427742|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427743|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
14427744|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427745|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427746|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14427747|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
14427748|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427749|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427750|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14427751|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427752|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
14427753|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427754|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14427755|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427756|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427757|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
14427758|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
14427759|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427760|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427761|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427762|NCT02118584|Etrolizumab|etrolizumab|mesh-list
14427763|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427764|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
14746625|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14427765|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427766|NCT02115997|Prednisone|prednisone|mesh-list
14427767|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
14427768|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14427769|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14427770|NCT02115997|Prednisolone|prednisolone|mesh-list
14427771|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
14427772|NCT02115997|Rituximab|rituximab|mesh-list
14427773|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14427774|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
14427775|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427776|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427777|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
14427778|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427779|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427780|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14427781|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
14427782|NCT02115997|Hormones|hormones|mesh-ancestor
14427783|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14427784|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14427785|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
14427786|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
14427787|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427788|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427789|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14427790|NCT02115997|Protective Agents|protective agents|mesh-ancestor
14427791|NCT02003144|Eculizumab|eculizumab|mesh-list
14427792|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14427793|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427794|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
14427795|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427796|NCT01746238|Bevacizumab|bevacizumab|mesh-list
14427797|NCT01746238|Doxorubicin|doxorubicin|mesh-list
14427798|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427799|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427800|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14427801|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14427802|NCT01746238|Growth Substances|growth substances|mesh-ancestor
14427803|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427804|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
14427805|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14427806|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14427807|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427808|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427809|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427810|NCT01648205|Ranolazine|ranolazine|mesh-list
14427811|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14427812|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14427813|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427814|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
14427815|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14427816|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427817|NCT01641055|Caseins|caseins|mesh-list
14427818|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
14427819|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
14427820|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427821|NCT01622088|Pramipexole|pramipexole|mesh-list
14427822|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
14427823|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427824|NCT01622088|Protective Agents|protective agents|mesh-ancestor
14427825|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427826|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14427827|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14427828|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
14427829|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
14427830|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427831|NCT01420874|Leucovorin|leucovorin|mesh-list
14427832|NCT01420874|Fluorouracil|fluorouracil|mesh-list
14427833|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
14427834|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
14427835|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427836|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427837|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427838|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427839|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
14427840|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427841|NCT01420874|Antidotes|antidotes|mesh-ancestor
14427842|NCT01420874|Protective Agents|protective agents|mesh-ancestor
14427843|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
14427844|NCT01420874|Vitamins|vitamins|mesh-ancestor
14746626|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746627|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746628|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
14746629|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14746630|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746631|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427845|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
14427846|NCT01312922|Dexetimide|dexetimide|mesh-list
14427847|NCT01312922|Pipamperone|pipamperone|mesh-list
14427848|NCT01312922|Citalopram|citalopram|mesh-list
14427849|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14427850|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14427851|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14427852|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427853|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427854|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
14427855|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427856|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14427857|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
14427858|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14427859|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14427860|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14746632|NCT00601588|Sertraline|sertraline|mesh-list
14746633|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
14427861|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
14427862|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
14427863|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427864|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14427865|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14427866|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
14427867|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14427868|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14427869|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14427870|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14427871|NCT01093326|Ponesimod|ponesimod|mesh-list
14427872|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14427873|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427874|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427875|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
14427876|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427877|NCT01091831|Dexamethasone|dexamethasone|mesh-list
14427878|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
14427879|NCT01091831|Melphalan|melphalan|mesh-list
14427880|NCT01091831|Lenalidomide|lenalidomide|mesh-list
14427881|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427882|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
14427883|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427884|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427885|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14427886|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
14427887|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746634|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746635|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14746636|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14746637|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746638|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746639|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746640|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
14746641|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746642|NCT00601614|Temozolomide|temozolomide|mesh-list
14746643|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14746644|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
14746645|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746646|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746647|NCT00601666|Zolpidem|zolpidem|mesh-list
14746648|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14746649|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14746650|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746651|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746652|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14746653|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
14746654|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
14427888|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746655|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746656|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927094|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14927095|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
14927096|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927097|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927098|NCT01415011|Afatinib|afatinib|mesh-list
14927099|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927100|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14927101|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927102|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427889|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14427890|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14427891|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
14427892|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
14427893|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427894|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14427895|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
14427896|NCT01091831|Hormones|hormones|mesh-ancestor
14427897|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14427898|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14427899|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14427900|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14427901|NCT01091831|Growth Substances|growth substances|mesh-ancestor
14427902|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
14427903|NCT01063517|Paclitaxel|paclitaxel|mesh-list
14427904|NCT01063517|Olaparib|olaparib|mesh-list
14427905|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427906|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427907|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
14746657|NCT00601692|Docetaxel|docetaxel|mesh-list
14746658|NCT00601692|Irinotecan|irinotecan|mesh-list
14427908|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427909|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427910|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427911|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14746659|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746660|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
14746661|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
14746662|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
14746663|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746664|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14746665|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14746666|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746667|NCT00601874|Pilocarpine|pilocarpine|mesh-list
14746668|NCT00601874|Miotics|miotics|mesh-ancestor
14746669|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
14746670|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927103|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
14927104|NCT01415128|Desipramine|desipramine|mesh-list
14927105|NCT01415128|Omeprazole|omeprazole|mesh-list
14927106|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14927107|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14927108|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14746671|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746672|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14746673|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14746674|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
14746675|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746676|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746677|NCT00601887|Meloxicam|meloxicam|mesh-list
14746678|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14927109|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927110|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927111|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14927112|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927113|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14427912|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427913|NCT00915681|Silybin|silybin|mesh-list
14427914|NCT00915681|Protective Agents|protective agents|mesh-ancestor
14427915|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427916|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427917|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427918|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
14427919|NCT00813423|Sunitinib|sunitinib|mesh-list
14427920|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427921|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14427922|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14427923|NCT00813423|Growth Substances|growth substances|mesh-ancestor
14427924|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427925|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746679|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14746680|NCT00601887|Analgesics|analgesics|mesh-ancestor
14746681|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
14427926|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14427927|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427928|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427929|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
14427930|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14427931|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14427932|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14427933|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427934|NCT00773695|Paclitaxel|paclitaxel|mesh-list
14427935|NCT00773695|Docetaxel|docetaxel|mesh-list
14746682|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746683|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746684|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14746685|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14746686|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14746687|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14746688|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746689|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746690|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14746691|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746692|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14746693|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927114|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
14427936|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
14746694|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746695|NCT00601978|Levodopa|levodopa|mesh-list
14746696|NCT00601978|Carbidopa|carbidopa|mesh-list
14746697|NCT00601978|Entacapone|entacapone|mesh-list
14746698|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14746699|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14746700|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14746701|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
14746702|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746703|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746704|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427937|NCT00773695|Bevacizumab|bevacizumab|mesh-list
14427938|NCT00773695|Fluorouracil|fluorouracil|mesh-list
14427939|NCT00773695|Epirubicin|epirubicin|mesh-list
14427940|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14427941|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14427942|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14427943|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
14427944|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14427945|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
14427946|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427947|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14427948|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
14427949|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427950|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14427951|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14427952|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
14427953|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14427954|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14427955|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14427956|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14427957|NCT00773695|Growth Substances|growth substances|mesh-ancestor
14427958|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
14427959|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
14427960|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14427961|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14746705|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14746706|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746707|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14746708|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14746709|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
14746710|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
14746711|NCT00601991|Aflibercept|aflibercept|mesh-list
14746712|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
14427962|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14427963|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14746713|NCT00601991|Growth Substances|growth substances|mesh-ancestor
14746714|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927115|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14927116|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14927117|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14427964|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
14427965|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14427966|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14427967|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14427968|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14427969|NCT00700596|Salvinorin A|salvinorin a|mesh-list
14427970|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
14427971|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427972|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14427973|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14927118|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927119|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
14927120|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927121|NCT01415141|Ribavirin|ribavirin|mesh-list
14927122|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14927123|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
14927124|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927125|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
14927126|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746715|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746716|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14746717|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746718|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746719|NCT00602004|Losartan|losartan|mesh-list
14427974|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14427975|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14427976|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14427977|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427978|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14427979|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14427980|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427981|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
14427982|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427983|NCT01732822|Clopidogrel|clopidogrel|mesh-list
14427984|NCT01732822|Ticagrelor|ticagrelor|mesh-list
14427985|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14427986|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14427987|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14427988|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14427989|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
14427990|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14427991|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427992|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14427993|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
14427994|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14427995|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14427996|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14427997|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14427998|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
14746720|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14746721|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14746722|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14746723|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14746724|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746725|NCT00602017|Amlodipine|amlodipine|mesh-list
14746726|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14746727|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14746728|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746729|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746730|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14927127|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14927128|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
14927129|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
14927130|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
14927131|NCT01415336|Doxorubicin|doxorubicin|mesh-list
14927132|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14927133|NCT01415336|Capecitabine|capecitabine|mesh-list
14927134|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927135|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
14927136|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927137|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927138|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14927139|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
14927140|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927141|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927142|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14927143|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14927144|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14927145|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14927146|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927147|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14927148|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
14927149|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14427999|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428000|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428001|NCT01733316|Cysteamine|cysteamine|mesh-list
14428002|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14428003|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428004|NCT01733329|Folic Acid|folic acid|mesh-list
14428005|NCT01733329|Misoprostol|misoprostol|mesh-list
14428006|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14746731|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746732|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
14746733|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14746734|NCT00602030|Entinostat|entinostat|mesh-list
14746735|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746736|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14746737|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746738|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746739|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14746740|NCT00602056|Vaccines|vaccines|mesh-list
14746741|NCT00602056|Immunologic Factors|immunologic factors|mesh-ancestor
14746742|NCT00602056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746743|NCT00602082|Capecitabine|capecitabine|mesh-list
14746744|NCT00602082|Streptozocin|streptozocin|mesh-list
14746745|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746746|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14746747|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
14746748|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746749|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14746750|NCT00602095|Misoprostol|misoprostol|mesh-list
14927150|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14428007|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
14428008|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14428009|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428010|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14428011|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14428012|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
14428013|NCT01733329|Hematinics|hematinics|mesh-ancestor
14428014|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
14428015|NCT01733329|Vitamins|vitamins|mesh-ancestor
14428016|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
14428017|NCT01733472|Remifentanil|remifentanil|mesh-list
14428018|NCT01733472|Propofol|propofol|mesh-list
14428019|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
14746751|NCT00602095|Dinoprostone|dinoprostone|mesh-list
14927151|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14428020|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428021|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428022|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14428023|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14428024|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
14428025|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14428026|NCT01733472|Narcotics|narcotics|mesh-ancestor
14428027|NCT01733472|Analgesics|analgesics|mesh-ancestor
14428028|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
14428029|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428030|NCT01733680|Amiloride|amiloride|mesh-list
14428031|NCT01733680|Diuretics|diuretics|mesh-ancestor
14428032|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
14428033|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428034|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14428035|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14428036|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14428037|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428038|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14428039|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14428040|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14428041|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
14428042|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14428043|NCT01733745|Vitamins|vitamins|mesh-list
14428044|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14428045|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
14428046|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428047|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14428048|NCT01733758|Liraglutide|liraglutide|mesh-list
14428049|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
14428050|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14428051|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14428052|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428053|NCT01733758|Incretins|incretins|mesh-ancestor
14428054|NCT01733758|Hormones|hormones|mesh-ancestor
14428055|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428056|NCT01733953|Atorvastatin|atorvastatin|mesh-list
14428057|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14428058|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14428059|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
14428060|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428061|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14428062|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14428063|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428064|NCT01734161|Dexamethasone|dexamethasone|mesh-list
14428065|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428066|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
14428067|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
14428068|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428069|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428070|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14428071|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
14428072|NCT01734161|Hormones|hormones|mesh-ancestor
14428073|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428074|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14428075|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428076|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14428077|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
14428078|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428079|NCT01734395|Galantamine|galantamine|mesh-list
14428080|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14428081|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428082|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428083|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
14428084|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428085|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428086|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14428087|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
14927152|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14927153|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927154|NCT01415505|Valsartan|valsartan|mesh-list
14927155|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14927156|NCT01415505|Nebivolol|nebivolol|mesh-list
14428088|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428089|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
14927157|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14927158|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14927159|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14927160|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927161|NCT01415505|Diuretics|diuretics|mesh-ancestor
14927162|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
14927163|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468449|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428090|NCT01734512|Everolimus|everolimus|mesh-list
14428091|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428092|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428093|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
14428094|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428095|NCT01734525|Anidulafungin|anidulafungin|mesh-list
14428096|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
14428097|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428098|NCT01734551|Clonidine|clonidine|mesh-list
14428099|NCT01734551|Morphine|morphine|mesh-list
14428100|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14428101|NCT01734551|Narcotics|narcotics|mesh-ancestor
14428102|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428103|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428104|NCT01734551|Analgesics|analgesics|mesh-ancestor
14428105|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
14428106|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428107|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14428108|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
14428109|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
14428110|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14428111|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14428112|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14428113|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
14428114|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428115|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428116|NCT01734772|Dabigatran|dabigatran|mesh-list
14428117|NCT01734772|Ticagrelor|ticagrelor|mesh-list
14428118|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14428119|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14428120|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14428121|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14428122|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
14428123|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428124|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746752|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14428125|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428126|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
14746753|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
14746754|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14428127|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14428128|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
14428129|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428130|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
14428131|NCT01734785|Empagliflozin|empagliflozin|mesh-list
14428132|NCT01734785|Linagliptin|linagliptin|mesh-list
14428133|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14428134|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428135|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14927164|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14931135|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
14428136|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428137|NCT01734785|Incretins|incretins|mesh-ancestor
14428138|NCT01734785|Hormones|hormones|mesh-ancestor
14428139|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428140|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14428141|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
14428142|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428143|NCT01734850|Busulfan|busulfan|mesh-list
14428144|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
14428145|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428146|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428147|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
14428148|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428149|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14428150|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428151|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14428152|NCT01734889|Nitisinone|nitisinone|mesh-list
14428153|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428154|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428155|NCT01734902|Scopolamine|scopolamine|mesh-list
14428156|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14428157|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14428158|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
14746755|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746756|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14746757|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14746758|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
14746759|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
14428159|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
14428160|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428161|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468450|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
14468451|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468452|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
14468453|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468454|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14468455|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14468456|NCT02280473|Laxatives|laxatives|mesh-ancestor
14468457|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14468458|NCT02280811|Aldesleukin|aldesleukin|mesh-list
14468459|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
14468460|NCT02280811|Fludarabine|fludarabine|mesh-list
14468461|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14468462|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
14468463|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468464|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428162|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14428163|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
14428164|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14428165|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
14428166|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428167|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428168|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14428169|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
14428170|NCT01735279|Mineral Oil|mineral oil|mesh-list
14428171|NCT01735279|Emollients|emollients|mesh-ancestor
14428172|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
14428173|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
14428174|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746760|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
14746761|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746762|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14746763|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428175|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14428176|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428177|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428178|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
14428179|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428180|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428181|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14428182|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
14428183|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428184|NCT01735630|Inositol|inositol|mesh-list
14428185|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
14428186|NCT01735630|Vitamins|vitamins|mesh-ancestor
14428187|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
14428188|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428189|NCT01736085|Nicotine|nicotine|mesh-list
14428190|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14428191|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
14428192|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428193|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428194|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14428195|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14428196|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
14428197|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746764|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746765|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
14746766|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746767|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14746768|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746769|NCT00602173|Cilostazol|cilostazol|mesh-list
14746770|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14746771|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
14428198|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428199|NCT01736176|Levodopa|levodopa|mesh-list
14428200|NCT01736176|Carbidopa|carbidopa|mesh-list
14428201|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14428202|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14428203|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14428204|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
14428205|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428206|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428207|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428208|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14428209|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428210|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14428211|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
14428212|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
14428213|NCT01736189|Adalimumab|adalimumab|mesh-list
14428214|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428215|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428216|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
14428217|NCT01736215|Hematinics|hematinics|mesh-ancestor
14428218|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
14428219|NCT01736254|Evacetrapib|evacetrapib|mesh-list
14428220|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14428221|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
14428222|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428223|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14428224|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14428225|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14428226|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428227|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14428228|NCT01736358|Ketorolac|ketorolac|mesh-list
14428229|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14746772|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746773|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746774|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14746775|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
14746776|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14746777|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14746778|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746779|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14746780|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
14746781|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14746782|NCT00602173|Protective Agents|protective agents|mesh-ancestor
14746783|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14746784|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14428230|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14428231|NCT01736358|Analgesics|analgesics|mesh-ancestor
14428232|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
14428233|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428234|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428235|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14746785|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746786|NCT00602186|Prazosin|prazosin|mesh-list
14746787|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14746788|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14428236|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428237|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14428238|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428239|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428240|NCT01736475|Factor VIII|factor viii|mesh-list
14428241|NCT01736475|BAX 855|bax 855|mesh-list
14428242|NCT01736475|Coagulants|coagulants|mesh-ancestor
14428243|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14428244|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14428245|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
14428246|NCT01736579|Antibodies|antibodies|mesh-list
14428247|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
14428248|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14428249|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14746789|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14428250|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
14428251|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428252|NCT01736696|Tofacitinib|tofacitinib|mesh-list
14428253|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14428254|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428255|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428256|NCT01736852|Oxytocin|oxytocin|mesh-list
14428257|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
14428258|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14428259|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428260|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
14428261|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14428262|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428263|NCT01736865|Vitamins|vitamins|mesh-ancestor
14428264|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
14428265|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14428266|NCT01736917|Dexamethasone|dexamethasone|mesh-list
14428267|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
14428268|NCT01736917|Aprepitant|aprepitant|mesh-list
14428269|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428270|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
14428271|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
14428272|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428273|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428274|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14428275|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
14428276|NCT01736917|Hormones|hormones|mesh-ancestor
14428277|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428278|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14428279|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428280|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14428281|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428282|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428283|NCT01736943|Doxorubicin|doxorubicin|mesh-list
14428284|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14428285|NCT01736943|Bortezomib|bortezomib|mesh-list
14746790|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14746791|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
14746792|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746793|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746794|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746795|NCT00602251|Terbinafine|terbinafine|mesh-list
14746796|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
14746797|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746798|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746799|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746800|NCT00602303|Torsemide|torsemide|mesh-list
14746801|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14746802|NCT00602303|Diuretics|diuretics|mesh-ancestor
14746803|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
14746804|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746805|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14746806|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746807|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746808|NCT00602316|Chelating Agents|chelating agents|mesh-list
14746809|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
14746810|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746811|NCT00602342|Terbinafine|terbinafine|mesh-list
14746812|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
14746813|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746814|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746815|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746816|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
14746817|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
14746818|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746819|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746820|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746821|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
14746822|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14746823|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746824|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746825|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
14746826|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
14746827|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746828|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746829|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746830|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
14746831|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14746832|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746833|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746834|NCT00602407|Cilostazol|cilostazol|mesh-list
14746835|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14746836|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
14746837|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746838|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746839|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14746840|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
14746841|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14746842|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14746843|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931136|NCT01437696|Vitamins|vitamins|mesh-list
14746844|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14746845|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
14746846|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14746847|NCT00602407|Protective Agents|protective agents|mesh-ancestor
14746848|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14746849|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14746850|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753472|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753473|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14753815|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753816|NCT04964063|Listerine|listerine|mesh-list
14753817|NCT04964063|Fluorides|fluorides|mesh-list
14753818|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
14753819|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
14753820|NCT04964063|Protective Agents|protective agents|mesh-ancestor
14753821|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753822|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14753823|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753824|NCT04958538|Methotrexate|methotrexate|mesh-list
14753825|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14753826|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
14753827|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14753828|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753829|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753830|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
14753831|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753832|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753833|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14753834|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753835|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14753836|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428286|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14428287|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428288|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14428289|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14428290|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428291|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428292|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14428293|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
14428294|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14428295|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14428296|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14428297|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428298|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428299|NCT01737593|Acetaminophen|acetaminophen|mesh-list
14428300|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14428301|NCT01737593|Analgesics|analgesics|mesh-ancestor
14428302|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
14428303|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428304|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428305|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
14428306|NCT01737710|Vaccines|vaccines|mesh-list
14428307|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
14428308|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428309|NCT01737840|Pantoprazole|pantoprazole|mesh-list
14428310|NCT01737840|Ranitidine|ranitidine|mesh-list
14428311|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14428312|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14428313|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14428314|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14428315|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428316|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428317|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14428318|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
14428319|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
14428320|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428321|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428322|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
14428323|NCT01737879|Hematinics|hematinics|mesh-ancestor
14428324|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
14428325|NCT01737931|Promethazine|promethazine|mesh-list
14753837|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
14753838|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428326|NCT01737931|Dexamethasone|dexamethasone|mesh-list
14428327|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14428328|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
14428329|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428330|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
14428331|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
14428332|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428333|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428334|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14428335|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
14428336|NCT01737931|Hormones|hormones|mesh-ancestor
14428337|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428338|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14428339|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746851|NCT00602498|Clarithromycin|clarithromycin|mesh-list
14746852|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746853|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746854|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14746855|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746856|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746857|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14746858|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14746859|NCT00602511|Thalidomide|thalidomide|mesh-list
14746860|NCT00602511|Bortezomib|bortezomib|mesh-list
14746861|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746862|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746863|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
14746864|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746865|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
14746866|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746867|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746868|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746869|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14746870|NCT00602511|Growth Substances|growth substances|mesh-ancestor
14746871|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
14746872|NCT00602524|Pilocarpine|pilocarpine|mesh-list
14746873|NCT00602524|Miotics|miotics|mesh-ancestor
14746874|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
14746875|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746876|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428340|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14428341|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14428342|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428343|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
14428344|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
14428345|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
14428346|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
14428347|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428348|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428349|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14746877|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14746878|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14746879|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
14428350|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
14428351|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
14428352|NCT01737944|Methotrexate|methotrexate|mesh-list
14746880|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746881|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746882|NCT00602550|Zidovudine|zidovudine|mesh-list
14746883|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
14746884|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746885|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14746886|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14428353|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14428354|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
14428355|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14428356|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428357|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14428358|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
14428359|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428360|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428361|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
14428362|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428363|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14428364|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428365|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
14428366|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428367|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14428368|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14428369|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14428370|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14428371|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14428372|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428373|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
14428374|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428375|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428376|NCT01738503|Buprenorphine|buprenorphine|mesh-list
14428377|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14428378|NCT01738503|Narcotics|narcotics|mesh-ancestor
14428379|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428380|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428381|NCT01738503|Analgesics|analgesics|mesh-ancestor
14428382|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
14428383|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428384|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14428385|NCT01738594|Romidepsin|romidepsin|mesh-list
14428386|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14428387|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428388|NCT01738646|Bevacizumab|bevacizumab|mesh-list
14428389|NCT01738646|Vorinostat|vorinostat|mesh-list
14428390|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14428391|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428392|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14428393|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14428394|NCT01738646|Growth Substances|growth substances|mesh-ancestor
14428395|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428396|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
14428397|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14428398|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746887|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746888|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
14746889|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746890|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14746891|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14746892|NCT00602589|Levofloxacin|levofloxacin|mesh-list
14746893|NCT00602589|Ofloxacin|ofloxacin|mesh-list
14746894|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14746895|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746896|NCT00602589|Renal Agents|renal agents|mesh-ancestor
14746897|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14428399|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746898|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14746899|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14746900|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746901|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746902|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746903|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14746904|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14746905|NCT00602615|Torsemide|torsemide|mesh-list
14746906|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14746907|NCT00602615|Diuretics|diuretics|mesh-ancestor
14746908|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
14746909|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746910|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14746911|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746912|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746913|NCT00602680|Donepezil|donepezil|mesh-list
14746914|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14746915|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746916|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746917|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
14746918|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746919|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746920|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
14746921|NCT00602693|Sirolimus|sirolimus|mesh-list
14746922|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
14746923|NCT00602693|Fludarabine|fludarabine|mesh-list
14746924|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
14746925|NCT00602693|Allopurinol|allopurinol|mesh-list
14746926|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746927|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
14746928|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746929|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14746930|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14746931|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
14746932|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746933|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746934|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14746935|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14746936|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
14746937|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14746938|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14746939|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14746940|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
14746941|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746942|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
14746943|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14746944|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
14746945|NCT00602693|Protective Agents|protective agents|mesh-ancestor
14428400|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
14428401|NCT01738672|Entonox|entonox|mesh-list
14428402|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14428403|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
14428404|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
14428405|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428406|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428407|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14428408|NCT01738672|Analgesics|analgesics|mesh-ancestor
14428409|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
14428410|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428411|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14428412|NCT01738971|Progestins|progestins|mesh-list
14428413|NCT01738971|Hormones|hormones|mesh-ancestor
14428414|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428415|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428416|NCT01739335|Mifepristone|mifepristone|mesh-list
14428417|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14428418|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
14428419|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14428420|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428421|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14428422|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14428423|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14428424|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
14428425|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14428426|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14428427|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
14428428|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428429|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
14428430|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14428431|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14428432|NCT01739361|Acetaminophen|acetaminophen|mesh-list
14428433|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14428434|NCT01739361|Analgesics|analgesics|mesh-ancestor
14428435|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
14428436|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428437|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428438|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
14428439|NCT01739400|Macitentan|macitentan|mesh-list
14428440|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14428441|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14428442|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428443|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14428444|NCT01739595|Enclomiphene|enclomiphene|mesh-list
14428445|NCT01739595|Clomiphene|clomiphene|mesh-list
14428446|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
14428447|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14428448|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
14428449|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428450|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428451|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14428452|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
14428453|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14428454|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14428455|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14428456|NCT01739699|Acetaminophen|acetaminophen|mesh-list
14428457|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14428458|NCT01739699|Analgesics|analgesics|mesh-ancestor
14428459|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
14428460|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428461|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428462|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
14428463|NCT01739764|Vemurafenib|vemurafenib|mesh-list
14428464|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746946|NCT00602706|Melphalan|melphalan|mesh-list
14746947|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14746948|NCT00602706|Sargramostim|sargramostim|mesh-list
14931137|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
14428465|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14428466|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428467|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428468|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
14428469|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14428470|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
14428471|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428472|NCT01739790|Expectorants|expectorants|mesh-ancestor
14428473|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14428474|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14428475|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
14428476|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428477|NCT01739790|Protective Agents|protective agents|mesh-ancestor
14428478|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428479|NCT01739790|Antidotes|antidotes|mesh-ancestor
14428480|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
14428481|NCT01739933|Propofol|propofol|mesh-list
14428482|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14428483|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428484|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428485|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14428486|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
14428487|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
14428488|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14428489|NCT01739933|Analgesics|analgesics|mesh-ancestor
14428490|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
14428491|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428492|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14428493|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14428494|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14428495|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
14428496|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428497|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428498|NCT01740089|Ribavirin|ribavirin|mesh-list
14428499|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14428500|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
14428501|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428502|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
14428503|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428504|NCT01740206|Methylphenidate|methylphenidate|mesh-list
14428505|NCT01740206|Amphetamine|amphetamine|mesh-list
14428506|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14428507|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428508|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14428509|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14428510|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746949|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14746950|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
14746951|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746952|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746953|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14746954|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14746955|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
14746956|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746957|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14746958|NCT00602706|Analgesics|analgesics|mesh-ancestor
14746959|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
14428511|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746960|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428512|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
14428513|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428514|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
14428515|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
14428516|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428517|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
14428518|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14428519|NCT01740258|Bevacizumab|bevacizumab|mesh-list
14428520|NCT01740258|Temozolomide|temozolomide|mesh-list
14428521|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14428522|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428523|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14428524|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14428525|NCT01740258|Growth Substances|growth substances|mesh-ancestor
14428526|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428527|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
14428528|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14428529|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
14428530|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428531|NCT01740323|Curcumin|curcumin|mesh-list
14428532|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14428533|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14428534|NCT01740323|Analgesics|analgesics|mesh-ancestor
14428535|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
14428536|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428537|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428538|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428539|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428540|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428541|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428542|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428543|NCT01740362|Tofacitinib|tofacitinib|mesh-list
14428544|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14428545|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746961|NCT00602719|Zolpidem|zolpidem|mesh-list
14428546|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428547|NCT01740388|Besifloxacin|besifloxacin|mesh-list
14428548|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14428549|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428550|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14428551|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14428552|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428553|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428554|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428555|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
14428556|NCT01740401|Ipilimumab|ipilimumab|mesh-list
14428557|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428558|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
14428559|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428560|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428561|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14428562|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
14428563|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428564|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428565|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14428566|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14428567|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14428568|NCT01740414|Ibudilast|ibudilast|mesh-list
14428569|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14428570|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
14428571|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428572|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428573|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14428574|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
14428575|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14428576|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428577|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428578|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14428579|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
14428580|NCT01740713|Deferiprone|deferiprone|mesh-list
14428581|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14428582|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
14428583|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
14746962|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14746963|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14746964|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14746965|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746966|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14746967|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
14746968|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
14746969|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746970|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746971|NCT00602849|Sertraline|sertraline|mesh-list
14428584|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428585|NCT01740726|Fluoxetine|fluoxetine|mesh-list
14428586|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14428587|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14428588|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14428589|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428590|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428591|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
14428592|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428593|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14428594|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
14428595|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14428596|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14428597|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14428598|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468465|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14468466|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
14468467|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468468|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746972|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
14746973|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14746974|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14746975|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14746976|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14746977|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746978|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14746979|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
14746980|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746981|NCT00602862|Bevacizumab|bevacizumab|mesh-list
14468469|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14468470|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14746982|NCT00602862|Sorafenib|sorafenib|mesh-list
14746983|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14746984|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746985|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14746986|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14428599|NCT01740791|Velpatasvir|velpatasvir|mesh-list
14428600|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
14428601|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428602|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14428603|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14428604|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14428605|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14428606|NCT01741259|Meperidine|meperidine|mesh-list
14428607|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14428608|NCT01741259|Narcotics|narcotics|mesh-ancestor
14428609|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428610|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428611|NCT01741259|Analgesics|analgesics|mesh-ancestor
14428612|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
14428613|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428614|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14428615|NCT01741454|Tamsulosin|tamsulosin|mesh-list
14428616|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14428617|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14428618|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14428619|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14428620|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
14428621|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428622|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428623|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428624|NCT01741454|Urological Agents|urological agents|mesh-ancestor
14428625|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14428626|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14428627|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
14428628|NCT01741532|Deferiprone|deferiprone|mesh-list
14428629|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14428630|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
14428631|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
14428632|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428633|NCT01741545|Interferons|interferons|mesh-list
14746987|NCT00602862|Growth Substances|growth substances|mesh-ancestor
14428634|NCT01741545|Ribavirin|ribavirin|mesh-list
14428635|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14746988|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746989|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
14927165|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927166|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
14927167|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14927168|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14927169|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14927170|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
14927171|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927172|NCT01415557|Micronutrients|micronutrients|mesh-list
14927173|NCT01415557|Trace Elements|trace elements|mesh-list
14927174|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927175|NCT01415596|Albuterol|albuterol|mesh-list
14927176|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14927177|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
14428636|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
14428637|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428638|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
14428639|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428640|NCT01741792|Blinatumomab|blinatumomab|mesh-list
14428641|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428642|NCT01742117|Clopidogrel|clopidogrel|mesh-list
14428643|NCT01742117|Ticagrelor|ticagrelor|mesh-list
14428644|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14428645|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14428646|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14428647|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14428648|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
14428649|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428650|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428651|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428652|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14428653|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14428654|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428655|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14428656|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746990|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14746991|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14746992|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14746993|NCT00602901|Naproxen|naproxen|mesh-list
14746994|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14428657|NCT01742286|Ceritinib|ceritinib|mesh-list
14428658|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428659|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14428660|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428661|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428662|NCT01742832|Citalopram|citalopram|mesh-list
14428663|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14428664|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14428665|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14428666|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14428667|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428668|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428669|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
14746995|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14927178|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927179|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14746996|NCT00602901|Analgesics|analgesics|mesh-ancestor
14746997|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
14746998|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14746999|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747000|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747001|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747002|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
14747003|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14747004|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747005|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747006|NCT00603031|Glucagon|glucagon|mesh-list
14747007|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14747008|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747009|NCT00603031|Hormones|hormones|mesh-ancestor
14747010|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747011|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747012|NCT00603031|Incretins|incretins|mesh-ancestor
14747013|NCT00603083|Ketorolac|ketorolac|mesh-list
14747014|NCT00603083|Ropivacaine|ropivacaine|mesh-list
14747015|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
14747016|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
14747017|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747018|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747019|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
14428670|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428671|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14747020|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747021|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14747022|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14747023|NCT00603083|Analgesics|analgesics|mesh-ancestor
14747024|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747025|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747026|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14747027|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747028|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747029|NCT00603109|Rimonabant|rimonabant|mesh-list
14747030|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14747031|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14747032|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14747033|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747034|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747035|NCT00603109|Hormones|hormones|mesh-ancestor
14747036|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747037|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747038|NCT00603135|Levetiracetam|levetiracetam|mesh-list
14747039|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
14747040|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
14747041|NCT00603317|Amoxicillin|amoxicillin|mesh-list
14747042|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
14747043|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
14747044|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14747045|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747046|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747047|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747048|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747049|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14428672|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
14428673|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14428674|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14428675|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14428676|NCT01742897|Fentanyl|fentanyl|mesh-list
14428677|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14428678|NCT01742897|Narcotics|narcotics|mesh-ancestor
14428679|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428680|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428681|NCT01742897|Analgesics|analgesics|mesh-ancestor
14747050|NCT00603343|Propiverine|propiverine|mesh-list
14747051|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
14747052|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
14747053|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927180|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14428682|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
14428683|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428684|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14428685|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14428686|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
14428687|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
14428688|NCT01743001|Macitentan|macitentan|mesh-list
14428689|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14428690|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14428691|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428692|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14428693|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14428694|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14428695|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14428696|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14428697|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14747054|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747055|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14747056|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14747057|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
14747058|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747059|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747060|NCT00603343|Urological Agents|urological agents|mesh-ancestor
14747061|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14747062|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747063|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14747064|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747065|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747066|NCT00603434|Methylphenidate|methylphenidate|mesh-list
14747067|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14747068|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747069|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14747070|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14747071|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747072|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747073|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
14747074|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428698|NCT01743027|Analgesics|analgesics|mesh-ancestor
14428699|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
14747075|NCT00603759|Celecoxib|celecoxib|mesh-list
14747076|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14747077|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14747078|NCT00603759|Analgesics|analgesics|mesh-ancestor
14747079|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
14753474|NCT05127044|Bilirubin|bilirubin|mesh-list
14428700|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428701|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428702|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428703|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428704|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14428705|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14428706|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14428707|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
14428708|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
14428709|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428710|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428711|NCT01743131|Abatacept|abatacept|mesh-list
14428712|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14428713|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428714|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428715|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428716|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
14428717|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428718|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428719|NCT01743521|Ribavirin|ribavirin|mesh-list
14428720|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
14428721|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428722|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
14428723|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428724|NCT01743560|Everolimus|everolimus|mesh-list
14428725|NCT01743560|Exemestane|exemestane|mesh-list
14428726|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747080|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428727|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428728|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
14428729|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428730|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14428731|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14428732|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428733|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428734|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14428735|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
14428736|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428737|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
14428738|NCT01743677|Tofacitinib|tofacitinib|mesh-list
14428739|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14428740|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428741|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14428742|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14428743|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428744|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428745|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428746|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14428747|NCT01743729|Lifitegrast|lifitegrast|mesh-list
14428748|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14428749|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14428750|NCT01743859|Lenalidomide|lenalidomide|mesh-list
14428751|NCT01743859|Azacitidine|azacitidine|mesh-list
14428752|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
14428753|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428754|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14428755|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14428756|NCT01743859|Growth Substances|growth substances|mesh-ancestor
14428757|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
14428758|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428759|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14428760|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
14428761|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428762|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428763|NCT01743976|Donepezil|donepezil|mesh-list
14428764|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14428765|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428766|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428767|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
14428768|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428769|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747081|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428770|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
14428771|NCT01744197|Lidocaine|lidocaine|mesh-list
14428772|NCT01744197|Tetracaine|tetracaine|mesh-list
14428773|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
14428774|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
14428775|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428776|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428777|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
14428778|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428779|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14428780|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14428781|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14428782|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14428783|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428784|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
14428785|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14428786|NCT01744353|Paclitaxel|paclitaxel|mesh-list
14428787|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428788|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428789|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14428790|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
14428791|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
14428792|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
14428793|NCT01744496|Rotigotine|rotigotine|mesh-list
14428794|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
14428795|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
14428796|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428797|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428798|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428799|NCT01744574|Progesterone|progesterone|mesh-list
14428800|NCT01744574|Progestins|progestins|mesh-ancestor
14428801|NCT01744574|Hormones|hormones|mesh-ancestor
14428802|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428803|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428804|NCT01744704|Mitogens|mitogens|mesh-list
14428805|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
14428806|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428807|NCT01744730|Clindamycin|clindamycin|mesh-list
14428808|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
14428809|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
14428810|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14428811|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428812|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14428813|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428814|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428815|NCT01744782|Cysteamine|cysteamine|mesh-list
14747082|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747083|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747084|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14747085|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14747086|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747087|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747088|NCT00603772|Tretinoin|tretinoin|mesh-list
14747089|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747090|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
14747091|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
14747092|NCT00603785|Omalizumab|omalizumab|mesh-list
14747093|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14747094|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747095|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
14747096|NCT00603824|PENTA|penta|mesh-list
14747097|NCT00603824|Lepirudin|lepirudin|mesh-list
14747098|NCT00603824|Fondaparinux|fondaparinux|mesh-list
14747099|NCT00603824|Argatroban|argatroban|mesh-list
14747100|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14747101|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
14747102|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14747103|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
14747104|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747105|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747106|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
14747107|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14747108|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14747109|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14747110|NCT00604006|Spironolactone|spironolactone|mesh-list
14747111|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14428816|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14428817|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428818|NCT01744821|Vitamin D|vitamin d|mesh-list
14428819|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
14428820|NCT01744821|Vitamins|vitamins|mesh-ancestor
14428821|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
14428822|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428823|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14428824|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14747112|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
14753475|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
14428825|NCT01745055|Methotrexate|methotrexate|mesh-list
14428826|NCT01745055|Tofacitinib|tofacitinib|mesh-list
14428827|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14428828|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
14428829|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14428830|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747113|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747114|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747115|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14747116|NCT00604006|Diuretics|diuretics|mesh-ancestor
14747117|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
14747118|NCT00604032|Tretinoin|tretinoin|mesh-list
14747119|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747120|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
14747121|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
14747122|NCT00604058|Vaccines|vaccines|mesh-list
14747123|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
14747124|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747125|NCT00604084|Ivermectin|ivermectin|mesh-list
14747126|NCT00604084|Permethrin|permethrin|mesh-list
14747127|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14747128|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747129|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747130|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747131|NCT00604253|Insulin|insulin|mesh-list
14747132|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14747133|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
14428831|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14428832|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
14428833|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428834|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428835|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
14428836|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428837|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14428838|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428839|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
14428840|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14428841|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14428842|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14428843|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
14428844|NCT01745094|Mirabegron|mirabegron|mesh-list
14428845|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14428846|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14428847|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
14428848|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428849|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428850|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428851|NCT01745094|Urological Agents|urological agents|mesh-ancestor
14747134|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
14747135|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
14747136|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
14747137|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747138|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747139|NCT00604344|Insulin|insulin|mesh-list
14747140|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14428852|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14428853|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14428854|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14428855|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14428856|NCT01745133|Calcitriol|calcitriol|mesh-list
14428857|NCT01745133|Clobetasol|clobetasol|mesh-list
14428858|NCT01745133|Calcipotriene|calcipotriene|mesh-list
14428859|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428860|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
14428861|NCT01745133|Hormones|hormones|mesh-ancestor
14428862|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14428863|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428864|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
14428865|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14428866|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14428867|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14428868|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428869|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14428870|NCT01745133|Vitamins|vitamins|mesh-ancestor
14428871|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
14428872|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14428873|NCT01745367|Paclitaxel|paclitaxel|mesh-list
14428874|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14428875|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428876|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
14428877|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
14428878|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
14428879|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428880|NCT01745380|Phenylephrine|phenylephrine|mesh-list
14747141|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
14747142|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
14747143|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
14747144|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
14747145|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747146|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747147|NCT00604357|Sirolimus|sirolimus|mesh-list
14747148|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747149|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747150|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14747151|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747152|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
14747153|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747154|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
14927181|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
14428881|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
14428882|NCT01745380|Tetracaine|tetracaine|mesh-list
14428883|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
14428884|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
14428885|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14428886|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927182|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
14428887|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
14428888|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14428889|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14428890|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14428891|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
14428892|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14428893|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428894|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
14428895|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
14428896|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
14428897|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14428898|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
14428899|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14428900|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
14428901|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14428902|NCT01745380|Protective Agents|protective agents|mesh-ancestor
14428903|NCT01745822|Tenofovir|tenofovir|mesh-list
14428904|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
14428905|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428906|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14428907|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14428908|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428909|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428910|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14428911|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14428912|NCT01746043|Minocycline|minocycline|mesh-list
14428913|NCT01746043|Modafinil|modafinil|mesh-list
14428914|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14428915|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428916|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14428917|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428918|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14428919|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14428920|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14428921|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428922|NCT01746095|Vancomycin|vancomycin|mesh-list
14428923|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14428924|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747155|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747156|NCT00604396|Insulin|insulin|mesh-list
14747157|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14428925|NCT01746173|Gemcitabine|gemcitabine|mesh-list
14428926|NCT01746173|Plerixafor|plerixafor|mesh-list
14428927|NCT01746173|Prednisone|prednisone|mesh-list
14428928|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
14428929|NCT01746173|Melphalan|melphalan|mesh-list
14428930|NCT01746173|Busulfan|busulfan|mesh-list
14428931|NCT01746173|Doxorubicin|doxorubicin|mesh-list
14428932|NCT01746173|Etoposide|etoposide|mesh-list
14428933|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
14428934|NCT01746173|Vincristine|vincristine|mesh-list
14428935|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14428936|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
14428937|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428938|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747158|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
14747159|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
14747160|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
14747161|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
14747162|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747163|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428939|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14428940|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
14428941|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428942|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428943|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14428944|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14428945|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
14428946|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
14428947|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14428948|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14428949|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14428950|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14428951|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14428952|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14428953|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
14428954|NCT01746173|Hormones|hormones|mesh-ancestor
14428955|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747164|NCT00604409|Capecitabine|capecitabine|mesh-list
14747165|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14747166|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
14428956|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14428957|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14428958|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
14428959|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
14428960|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
14428961|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14428962|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14428963|NCT01746225|Paclitaxel|paclitaxel|mesh-list
14428964|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14428965|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14428966|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14428967|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14428968|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14428969|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428970|NCT01746264|Vitamin D|vitamin d|mesh-list
14428971|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
14428972|NCT01746264|Vitamins|vitamins|mesh-ancestor
14428973|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
14428974|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428975|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14428976|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14428977|NCT01746420|Becaplermin|becaplermin|mesh-list
14428978|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
14428979|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14428980|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14428981|NCT01746420|Growth Substances|growth substances|mesh-ancestor
14428982|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428983|NCT01746511|Glycerol|glycerol|mesh-list
14428984|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14428985|NCT01746511|Protective Agents|protective agents|mesh-ancestor
14428986|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14428987|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
14428988|NCT01746732|Evacetrapib|evacetrapib|mesh-list
14428989|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14428990|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14428991|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14428992|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
14428993|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14428994|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14428995|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14428996|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927183|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14927184|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14927185|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14927186|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14927187|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14927188|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927189|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927190|NCT01415687|Bisacodyl|bisacodyl|mesh-list
14927191|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
14927192|NCT01415687|Citric Acid|citric acid|mesh-list
14428997|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14927193|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
14927194|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
14428998|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14428999|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429000|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429001|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14429002|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
14429003|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14429004|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429005|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14429006|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14429007|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14429008|NCT01746901|Naltrexone|naltrexone|mesh-list
14429009|NCT01746901|Oxycodone|oxycodone|mesh-list
14429010|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14429011|NCT01746901|Narcotics|narcotics|mesh-ancestor
14429012|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429013|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429014|NCT01746901|Analgesics|analgesics|mesh-ancestor
14429015|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
14429016|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429017|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14429018|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14429019|NCT01746940|Cocaine|cocaine|mesh-list
14429020|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14429021|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
14429022|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
14429023|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429024|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429025|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
14429026|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429027|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14429028|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14429029|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14429030|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747167|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747168|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747169|NCT00604435|Docetaxel|docetaxel|mesh-list
14747170|NCT00604435|Epirubicin|epirubicin|mesh-list
14747171|NCT00604435|Endostatins|endostatins|mesh-list
14747172|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747173|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
14747174|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
14747175|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
14747176|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747177|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14429031|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747178|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14927195|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14927196|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
14927197|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
14927198|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927199|NCT01415687|Cathartics|cathartics|mesh-ancestor
14927200|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14927201|NCT01415687|Laxatives|laxatives|mesh-ancestor
14927202|NCT01415713|Leucovorin|leucovorin|mesh-list
14927203|NCT01415713|Gemcitabine|gemcitabine|mesh-list
14927204|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
14927205|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14927206|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
14927207|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927208|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927209|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
14429032|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
14429033|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429034|NCT01746979|Gemcitabine|gemcitabine|mesh-list
14429035|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429036|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
14429037|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429038|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429039|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
14429040|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429041|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429042|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429043|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
14429044|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429045|NCT01747330|Pancreatin|pancreatin|mesh-list
14429046|NCT01747330|Pancrelipase|pancrelipase|mesh-list
14429047|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429048|NCT01747499|Azacitidine|azacitidine|mesh-list
14927210|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927211|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927212|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927213|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
14927214|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927215|NCT01415713|Antidotes|antidotes|mesh-ancestor
14927216|NCT01415713|Protective Agents|protective agents|mesh-ancestor
14927217|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
14927218|NCT01415713|Vitamins|vitamins|mesh-ancestor
14927219|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
14927220|NCT01415765|Prednisone|prednisone|mesh-list
14927221|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
14927222|NCT01415765|Rituximab|rituximab|mesh-list
14927223|NCT01415765|Doxorubicin|doxorubicin|mesh-list
14927224|NCT01415765|Etoposide|etoposide|mesh-list
14927225|NCT01415765|Vincristine|vincristine|mesh-list
14927226|NCT01415765|Pevonedistat|pevonedistat|mesh-list
14927227|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927228|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
14927229|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429049|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429050|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
14927230|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927231|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14927232|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
14927233|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927234|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927235|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14429051|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429052|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429053|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429054|NCT01747551|Leucovorin|leucovorin|mesh-list
14429055|NCT01747551|Fluorouracil|fluorouracil|mesh-list
14429056|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
14429057|NCT01747551|Aflibercept|aflibercept|mesh-list
14429058|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
14429059|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429060|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429061|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429062|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429063|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
14429064|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429065|NCT01747551|Antidotes|antidotes|mesh-ancestor
14429066|NCT01747551|Protective Agents|protective agents|mesh-ancestor
14429067|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
14429068|NCT01747551|Vitamins|vitamins|mesh-ancestor
14429069|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
14927236|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14927237|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14927238|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14927239|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14429070|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14429071|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14429072|NCT01747551|Growth Substances|growth substances|mesh-ancestor
14927240|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927241|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14927242|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
14429073|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
14429074|NCT01747629|Albuterol|albuterol|mesh-list
14429075|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14429076|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
14429077|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429078|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429079|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14429080|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
14429081|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
14429082|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14429083|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14429084|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14429085|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14429086|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
14429087|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429088|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429089|NCT01747850|Ethanol|ethanol|mesh-list
14429090|NCT01747850|Nabiximols|nabiximols|mesh-list
14429091|NCT01747850|Dronabinol|dronabinol|mesh-list
14429092|NCT01747850|Cannabidiol|cannabidiol|mesh-list
14429093|NCT01747850|Peppermint oil|peppermint oil|mesh-list
14429094|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14429095|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429096|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429097|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429098|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
14429099|NCT01747850|Analgesics|analgesics|mesh-ancestor
14429100|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
14429101|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429102|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
14429103|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14429104|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429105|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14429106|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14429107|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429108|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429109|NCT01747850|Hormones|hormones|mesh-ancestor
14429110|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429111|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
14429112|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
14429113|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429114|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
14429115|NCT01747915|Pregabalin|pregabalin|mesh-list
14429116|NCT01747915|Analgesics|analgesics|mesh-ancestor
14429117|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
14429118|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429119|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429120|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
14429121|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14747179|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14747180|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747181|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14747182|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14747183|NCT00604435|Growth Substances|growth substances|mesh-ancestor
14747184|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747185|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
14747186|NCT00604578|Pioglitazone|pioglitazone|mesh-list
14747187|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747188|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429122|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429123|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429124|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14429125|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14429126|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14429127|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429128|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14429129|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
14429130|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14927243|NCT01415765|Hormones|hormones|mesh-ancestor
14747189|NCT00604591|Tolcapone|tolcapone|mesh-list
14747190|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14747191|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14747192|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14747193|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747194|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747195|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
14429131|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
14429132|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429133|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429134|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14429135|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
14429136|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14429137|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
14429138|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429139|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429140|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14429141|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14429142|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
14429143|NCT01748045|Protective Agents|protective agents|mesh-ancestor
14468471|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14468472|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
14468473|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468474|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14468475|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14468476|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
14468477|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
14468478|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747196|NCT00604630|Hematinics|hematinics|mesh-ancestor
14747197|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
14747198|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14429144|NCT01748240|Azacitidine|azacitidine|mesh-list
14429145|NCT01748240|Vorinostat|vorinostat|mesh-list
14429146|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429147|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
14429148|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429149|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429150|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429151|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14747199|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753476|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753477|NCT05127044|Protective Agents|protective agents|mesh-ancestor
14753478|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753479|NCT05122208|Famotidine|famotidine|mesh-list
14753480|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14753481|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429152|NCT01748292|Ranibizumab|ranibizumab|mesh-list
14429153|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14429154|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14429155|NCT01748292|Growth Substances|growth substances|mesh-ancestor
14429156|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429157|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
14429158|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429159|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
14429160|NCT01748643|Rocuronium|rocuronium|mesh-list
14753482|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14753483|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
14753484|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
14753485|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753486|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753487|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753488|NCT05121909|Listerine|listerine|mesh-list
14753489|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14429161|NCT01748643|Neostigmine|neostigmine|mesh-list
14429162|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14429163|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14927244|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927245|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14927246|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14927247|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
14927248|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
14927249|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
14429164|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14429165|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429166|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429167|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14429168|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429169|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429170|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
14429171|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429172|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14429173|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
14429174|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14429175|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14753490|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
14753491|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
14753492|NCT05121909|Protective Agents|protective agents|mesh-ancestor
14753493|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927250|NCT01415778|Bicalutamide|bicalutamide|mesh-list
14429176|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14429177|NCT01748799|Ethanol|ethanol|mesh-list
14429178|NCT01748799|Nabiximols|nabiximols|mesh-list
14429179|NCT01748799|Dronabinol|dronabinol|mesh-list
14429180|NCT01748799|Cannabidiol|cannabidiol|mesh-list
14429181|NCT01748799|Peppermint oil|peppermint oil|mesh-list
14429182|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14429183|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429184|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429185|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429186|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
14429187|NCT01748799|Analgesics|analgesics|mesh-ancestor
14429188|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
14429189|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429190|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
14429191|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14429192|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429193|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14429194|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14429195|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429196|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429197|NCT01748799|Hormones|hormones|mesh-ancestor
14429198|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429199|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
14429200|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
14429201|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429202|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
14429203|NCT01748825|Adavosertib|adavosertib|mesh-list
14429204|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429205|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429206|NCT01748942|Dexamethasone|dexamethasone|mesh-list
14747200|NCT00604682|Apremilast|apremilast|mesh-list
14747201|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14747202|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14747203|NCT00604682|Analgesics|analgesics|mesh-ancestor
14747204|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
14747205|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747206|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747207|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429207|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
14747208|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927251|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
14429208|NCT01748942|Ichthammol|ichthammol|mesh-list
14429209|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14429210|NCT01748942|BB 1101|bb 1101|mesh-list
14429211|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429212|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
14429213|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
14747209|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14747210|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14747211|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747212|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747213|NCT00604864|Infliximab|infliximab|mesh-list
14747214|NCT00604864|Antibodies|antibodies|mesh-list
14747215|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14747216|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
14429214|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429215|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429216|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429217|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
14429218|NCT01748942|Hormones|hormones|mesh-ancestor
14429219|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429220|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14429221|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429222|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
14429223|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429224|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747217|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747218|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
14747219|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747220|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747221|NCT00604942|Domperidone|domperidone|mesh-list
14747222|NCT00604942|Esomeprazole|esomeprazole|mesh-list
14747223|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14747224|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429225|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14429226|NCT01748955|Bupropion|bupropion|mesh-list
14429227|NCT01748955|Paroxetine|paroxetine|mesh-list
14429228|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14429229|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
14429230|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14429231|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14429232|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14429233|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429234|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429235|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
14429236|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429237|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429238|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14429239|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14747225|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14747226|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747227|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747228|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
14747229|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
14927252|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
14429240|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429241|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14747230|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429242|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
14429243|NCT01748994|Pioglitazone|pioglitazone|mesh-list
14429244|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14429245|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429246|NCT01749215|Topiramate|topiramate|mesh-list
14429247|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
14429248|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14429249|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429250|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
14429251|NCT01749293|Busulfan|busulfan|mesh-list
14429252|NCT01749293|Fludarabine|fludarabine|mesh-list
14429253|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429254|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
14429255|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429256|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14429257|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14747231|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747232|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14747233|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
14747234|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747235|NCT00604955|Paromomycin|paromomycin|mesh-list
14747236|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747237|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747238|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14747239|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14747240|NCT00605020|Insulin|insulin|mesh-list
14747241|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14747242|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
14429258|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
14429259|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429260|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747243|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
14747244|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14747245|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
14747246|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
14429261|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14429262|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
14429263|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14429264|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14429265|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14429266|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429267|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429268|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
14429269|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429270|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429271|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14429272|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429273|NCT01749501|Rocuronium|rocuronium|mesh-list
14429274|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14429275|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14429276|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14747247|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747248|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747249|NCT00605098|Ritonavir|ritonavir|mesh-list
14747250|NCT00605098|Lopinavir|lopinavir|mesh-list
14927253|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927254|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927255|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927256|NCT01415791|Bicalutamide|bicalutamide|mesh-list
14927257|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
14927258|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
14927259|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927260|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429277|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429278|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429279|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
14429280|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
14429281|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14429282|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429283|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14429284|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14429285|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927261|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927262|NCT01415895|Clonidine|clonidine|mesh-list
14927263|NCT01415895|Naltrexone|naltrexone|mesh-list
14927264|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14927265|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14927266|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927267|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
14429286|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429287|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429288|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14429289|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14429290|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14429291|NCT01749605|Renal Agents|renal agents|mesh-ancestor
14429292|NCT01749904|Timolol|timolol|mesh-list
14429293|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14429294|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14429295|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
14429296|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429297|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429298|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429299|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14429300|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14429301|NCT01749930|Timolol|timolol|mesh-list
14429302|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14429303|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14429304|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
14429305|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429306|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429307|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429308|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14429309|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14429310|NCT01749956|Leucovorin|leucovorin|mesh-list
14429311|NCT01749956|Fluorouracil|fluorouracil|mesh-list
14429312|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
14429313|NCT01749956|Aflibercept|aflibercept|mesh-list
14429314|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
14429315|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429316|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429317|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429318|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429319|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
14429320|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429321|NCT01749956|Antidotes|antidotes|mesh-ancestor
14429322|NCT01749956|Protective Agents|protective agents|mesh-ancestor
14429323|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
14429324|NCT01749956|Vitamins|vitamins|mesh-ancestor
14927268|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927269|NCT01415895|Analgesics|analgesics|mesh-ancestor
14927270|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14927271|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
14927272|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
14927273|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14927274|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14927275|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14927276|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
14927277|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927278|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927279|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
14927280|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927281|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
14927282|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927283|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927284|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14927285|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
14927286|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927287|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927288|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14927289|NCT01416116|Lidocaine|lidocaine|mesh-list
14927290|NCT01416116|Tramadol|tramadol|mesh-list
14927291|NCT01416116|Capsaicin|capsaicin|mesh-list
14927292|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
14927293|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
14927294|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14927295|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927296|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
14927297|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429325|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
14429326|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14429327|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14429328|NCT01749956|Growth Substances|growth substances|mesh-ancestor
14429329|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
14429330|NCT01749982|Choline|choline|mesh-list
14429331|NCT01749982|Betaine|betaine|mesh-list
14429332|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
14429333|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14429334|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
14429335|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429336|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429337|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14429338|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
14429339|NCT01750086|Denosumab|denosumab|mesh-list
14429340|NCT01750086|Alendronate|alendronate|mesh-list
14429341|NCT01750086|Teriparatide|teriparatide|mesh-list
14429342|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14429343|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429344|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14429345|NCT01750268|Topiramate|topiramate|mesh-list
14429346|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
14429347|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14429348|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429349|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
14429350|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14429351|NCT01750294|Diuretics|diuretics|mesh-ancestor
14429352|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
14429353|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429354|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14429355|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429356|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429357|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
14429358|NCT01750398|Leuprolide|leuprolide|mesh-list
14429359|NCT01750398|Goserelin|goserelin|mesh-list
14429360|NCT01750398|Testosterone|testosterone|mesh-list
14429361|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
14429362|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
14429363|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14429364|NCT01750398|Androgens|androgens|mesh-ancestor
14429365|NCT01750398|Hormones|hormones|mesh-ancestor
14429366|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429367|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429368|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14429369|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429370|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
14429371|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14429372|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
14429373|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14429374|NCT01750697|Rituximab|rituximab|mesh-list
14429375|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14429376|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429377|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
14429378|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429379|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14429380|NCT01750840|Cimetidine|cimetidine|mesh-list
14429381|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14429382|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747251|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14747252|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14747253|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
14747254|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429383|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14429384|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
14429385|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
14429386|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747255|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429387|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429388|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429389|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14429390|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14429391|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429392|NCT01750918|Fluorouracil|fluorouracil|mesh-list
14429393|NCT01750918|Panitumumab|panitumumab|mesh-list
14429394|NCT01750918|Trametinib|trametinib|mesh-list
14429395|NCT01750918|Dabrafenib|dabrafenib|mesh-list
14429396|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
14429397|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429398|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429399|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429400|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429401|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
14747256|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14747257|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14747258|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
14747259|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747260|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14747261|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14747262|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
14747263|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
14747264|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747265|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747266|NCT00605137|Insulin|insulin|mesh-list
14747267|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14747268|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
14747269|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
14747270|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
14747271|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
14747272|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747273|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747274|NCT00605371|Lamotrigine|lamotrigine|mesh-list
14747275|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
14747276|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14747277|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747278|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747279|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14747280|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747281|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14747282|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14747283|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747284|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14747285|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14747286|NCT00605397|Trastuzumab|trastuzumab|mesh-list
14747287|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14747288|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747289|NCT00605410|Bromides|bromides|mesh-list
14747290|NCT00605410|Ipratropium|ipratropium|mesh-list
14747291|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
14747292|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14747293|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
14747294|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747295|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747296|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747297|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
14747298|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14927298|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14747299|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
14747300|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429402|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747301|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747302|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
14747303|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
14747304|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
14429403|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14429404|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14429405|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429406|NCT01750931|Meloxicam|meloxicam|mesh-list
14429407|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14429408|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429409|NCT01750931|Analgesics|analgesics|mesh-ancestor
14429410|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
14429411|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429412|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429413|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429414|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14429415|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14429416|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14429417|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429418|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429419|NCT01751087|Vitamins|vitamins|mesh-list
14429420|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
14429421|NCT01751087|Misoprostol|misoprostol|mesh-list
14429422|NCT01751087|Mifepristone|mifepristone|mesh-list
14429423|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
14429424|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747305|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14747306|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14747307|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429425|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14429426|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
14429427|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14429428|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14429429|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429430|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
14429431|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
14429432|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14429433|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14429434|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14429435|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14429436|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
14429437|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14429438|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14429439|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
14429440|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429441|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
14429442|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14429443|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14429444|NCT01751113|Fluticasone|fluticasone|mesh-list
14429445|NCT01751113|Xhance|xhance|mesh-list
14429446|NCT01751113|Bromides|bromides|mesh-list
14429447|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
14429448|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14429449|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14429450|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429451|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14429452|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
14429453|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429454|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429455|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14429456|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
14429457|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
14429458|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14429459|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
14429460|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14429461|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
14429462|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429463|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429464|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14429465|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14429466|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14429467|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
14429468|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
14429469|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
14429470|NCT01751113|Hormones|hormones|mesh-ancestor
14429471|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429472|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
14429473|NCT01751178|Ethanol|ethanol|mesh-list
14429474|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
14429475|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14429476|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14429477|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429478|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429479|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429480|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
14429481|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14429482|NCT01751386|Baclofen|baclofen|mesh-list
14429483|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14927299|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14927300|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14927301|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927302|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927303|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14927304|NCT01416116|Narcotics|narcotics|mesh-ancestor
14747308|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429484|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429485|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14429486|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429487|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14429488|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
14429489|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
14429490|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429491|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429492|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
14429493|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429494|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14429495|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429496|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429497|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
14429498|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429499|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429500|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14429501|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
14429502|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14429503|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14429504|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
14429505|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429506|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14429507|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14429508|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429509|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429510|NCT01751646|Vitamin D|vitamin d|mesh-list
14429511|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
14429512|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
14429513|NCT01751646|Vitamins|vitamins|mesh-list
14429514|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
14429515|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429516|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14429517|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14429518|NCT01751724|Caffeine|caffeine|mesh-list
14429519|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
14429520|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429521|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14429522|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429523|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14429524|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429525|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14429526|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14429527|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
14429528|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429529|NCT01751802|Ecopipam|ecopipam|mesh-list
14429530|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14429531|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14747309|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747310|NCT00605683|Cabergoline|cabergoline|mesh-list
14747311|NCT00605683|Pramipexole|pramipexole|mesh-list
14747312|NCT00605683|Ropinirole|ropinirole|mesh-list
14747313|NCT00605683|Bromocriptine|bromocriptine|mesh-list
14747314|NCT00605683|Lisuride|lisuride|mesh-list
14747315|NCT00605683|Apomorphine|apomorphine|mesh-list
14747316|NCT00605683|Pergolide|pergolide|mesh-list
14747317|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14927305|NCT01416116|Analgesics|analgesics|mesh-ancestor
14747318|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14429532|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747319|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
14747320|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
14747321|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747322|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747323|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747324|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
14747325|NCT00605683|Protective Agents|protective agents|mesh-ancestor
14747326|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
14747327|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747328|NCT00605683|Emetics|emetics|mesh-ancestor
14747329|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
14747330|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747331|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747332|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14747333|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
14747334|NCT00605774|Epinephrine|epinephrine|mesh-list
14747335|NCT00605774|Racepinephrine|racepinephrine|mesh-list
14747336|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
14747337|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14747338|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14747339|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747340|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747341|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747342|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429533|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429534|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14429535|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14429536|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
14429537|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429538|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429539|NCT01751867|Decitabine|decitabine|mesh-list
14429540|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429541|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
14747343|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14747344|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14747345|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
14747346|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747347|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747348|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
14747349|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
14747350|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
14747351|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14429542|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429543|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429544|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429545|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
14429546|NCT01752413|Hematinics|hematinics|mesh-ancestor
14429547|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
14429548|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429549|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14429550|NCT01752426|Protective Agents|protective agents|mesh-ancestor
14429551|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927306|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
14927307|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
14927308|NCT01416207|Interferons|interferons|mesh-list
14927309|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
14429552|NCT01752712|Oxytocin|oxytocin|mesh-list
14429553|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
14747352|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
14747353|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
14747354|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747355|NCT00605787|Protective Agents|protective agents|mesh-ancestor
14747356|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747357|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14747358|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14747359|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14747360|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
14927310|NCT01416207|Interferon-beta|interferon-beta|mesh-list
14429554|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14927311|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927312|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
14927313|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927314|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14927315|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
14927316|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927317|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
14927318|NCT01416220|Paroxetine|paroxetine|mesh-list
14927319|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
14927320|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14927321|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927322|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927323|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
14927324|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14927325|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14927326|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429555|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429556|NCT01752842|Fenofibrate|fenofibrate|mesh-list
14747361|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747362|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747363|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747364|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
14747365|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14747366|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14747367|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14747368|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747369|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429557|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14429558|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
14429559|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429560|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14429561|NCT01752855|Adalimumab|adalimumab|mesh-list
14429562|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429563|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14429564|NCT01752933|Guadecitabine|guadecitabine|mesh-list
14429565|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429566|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
14429567|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14429568|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429569|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14747370|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747371|NCT00605930|Niacinamide|niacinamide|mesh-list
14747372|NCT00605930|Niacin|niacin|mesh-list
14747373|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
14747374|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
14747375|NCT00605930|Vitamins|vitamins|mesh-ancestor
14747376|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
14747377|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747378|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14747379|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
14747380|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747381|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14747382|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
14747383|NCT00605995|Simvastatin|simvastatin|mesh-list
14747384|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14747385|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14747386|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
14747387|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747388|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14747389|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14747390|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747391|NCT00606060|Factor VIII|factor viii|mesh-list
14747392|NCT00606060|Coagulants|coagulants|mesh-ancestor
14747393|NCT00606099|Adefovir|adefovir|mesh-list
14747394|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14429570|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14429571|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429572|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429573|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429574|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14429575|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14429576|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14429577|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
14429578|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14429579|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
14429580|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14429581|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429582|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14429583|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14747395|NCT00606099|Telbivudine|telbivudine|mesh-list
14747396|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
14747397|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429584|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429585|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
14429586|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14747398|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14747399|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14747400|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747401|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747402|NCT00606125|Sorafenib|sorafenib|mesh-list
14429587|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14429588|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14429589|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429590|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429591|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
14429592|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429593|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429594|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14429595|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429596|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
14429597|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14429598|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14429599|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14429600|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429601|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429602|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
14429603|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747403|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747404|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14747405|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747406|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747407|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
14747408|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14747409|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
14747410|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747411|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747412|NCT00606203|Milnacipran|milnacipran|mesh-list
14747413|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
14747414|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14747415|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14747416|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927327|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14927328|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14429604|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429605|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14429606|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429607|NCT01753362|Liraglutide|liraglutide|mesh-list
14429608|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14429609|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429610|NCT01753362|Incretins|incretins|mesh-ancestor
14429611|NCT01753362|Hormones|hormones|mesh-ancestor
14429612|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429613|NCT01753401|Prednisone|prednisone|mesh-list
14429614|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14429615|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429616|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
14429617|NCT01753401|Hormones|hormones|mesh-ancestor
14429618|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429619|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429620|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14429621|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429622|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
14429623|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14429624|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
14429625|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429626|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429627|NCT01753570|Interferon-beta|interferon-beta|mesh-list
14429628|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429629|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
14429630|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429631|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
14429632|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429633|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
14429634|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14429635|NCT01753856|Vitamin D|vitamin d|mesh-list
14927329|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927330|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927331|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
14927332|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14927333|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14927334|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14927335|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
14429636|NCT01753856|Denosumab|denosumab|mesh-list
14429637|NCT01753856|Teriparatide|teriparatide|mesh-list
14429638|NCT01753856|Tetracycline|tetracycline|mesh-list
14429639|NCT01753856|Demeclocycline|demeclocycline|mesh-list
14429640|NCT01753856|Calcium|calcium|mesh-list
14429641|NCT01753856|Vitamins|vitamins|mesh-ancestor
14429642|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
14429643|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429644|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14429645|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14429646|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14429647|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429648|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14429649|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429650|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429651|NCT01754259|Ranolazine|ranolazine|mesh-list
14429652|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14429653|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429654|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927336|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14927337|NCT01416337|Trametinib|trametinib|mesh-list
14429655|NCT01754376|Aldesleukin|aldesleukin|mesh-list
14927338|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927339|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14927340|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927341|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927342|NCT01416350|Azithromycin|azithromycin|mesh-list
14927343|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14927344|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429656|NCT01754376|Interleukin-2|interleukin-2|mesh-list
14429657|NCT01754376|Vemurafenib|vemurafenib|mesh-list
14927345|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14429658|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429659|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429660|NCT01754376|Analgesics|analgesics|mesh-ancestor
14429661|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
14429662|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429663|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429664|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14429665|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14429666|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
14429667|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429668|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14429669|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429670|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429671|NCT01754389|Sirolimus|sirolimus|mesh-list
14429672|NCT01754389|Methotrexate|methotrexate|mesh-list
14429673|NCT01754389|Bortezomib|bortezomib|mesh-list
14429674|NCT01754389|Tacrolimus|tacrolimus|mesh-list
14429675|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14429676|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
14429677|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14429678|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429679|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429680|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
14429681|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429682|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429683|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
14429684|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429685|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14429686|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429687|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
14429688|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927346|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14927347|NCT01416480|Theobromine|theobromine|mesh-list
14927348|NCT01416480|Dipropizine|dipropizine|mesh-list
14927349|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14927350|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
14927351|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927352|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927353|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14927354|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
14927355|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
14927356|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
14927357|NCT01416558|Paclitaxel|paclitaxel|mesh-list
14429689|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14429690|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14927358|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14927359|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927360|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
14927361|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
14927362|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
14747417|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747418|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747419|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747420|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14747421|NCT00606203|Analgesics|analgesics|mesh-ancestor
14747422|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
14747423|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747424|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
14747425|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14747426|NCT00606242|Fluticasone|fluticasone|mesh-list
14747427|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747428|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14747429|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
14747430|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747431|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927363|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429691|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747432|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747433|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
14747434|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14429692|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429693|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14429694|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
14429695|NCT01754402|Dexamethasone|dexamethasone|mesh-list
14429696|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14429697|NCT01754402|Pomalidomide|pomalidomide|mesh-list
14429698|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429699|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
14429700|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
14429701|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429702|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429703|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747435|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14747436|NCT00606268|Micafungin|micafungin|mesh-list
14747437|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
14747438|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747439|NCT00606333|Sirolimus|sirolimus|mesh-list
14747440|NCT00606333|Paclitaxel|paclitaxel|mesh-list
14747441|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14747442|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14747443|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747444|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14747445|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14747446|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14747447|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747448|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747449|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747450|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14747451|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
14747452|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747453|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
14747454|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747455|NCT00606411|Topiramate|topiramate|mesh-list
14747456|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
14747457|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14429704|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
14429705|NCT01754402|Hormones|hormones|mesh-ancestor
14429706|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429707|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14429708|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429709|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14429710|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
14429711|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429712|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
14429713|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14429714|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14429715|NCT01754402|Growth Substances|growth substances|mesh-ancestor
14429716|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
14429717|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14429718|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
14429719|NCT01754480|Coagulants|coagulants|mesh-ancestor
14429720|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14747458|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429721|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14429722|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14429723|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14429724|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747459|NCT00606437|Fludarabine|fludarabine|mesh-list
14747460|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747461|NCT00606450|Thalidomide|thalidomide|mesh-list
14747462|NCT00606450|Apremilast|apremilast|mesh-list
14747463|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14429725|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429726|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429727|NCT01754493|Analgesics|analgesics|mesh-ancestor
14429728|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
14429729|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429730|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
14429731|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14429732|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
14468479|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468480|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
14468481|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468482|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468483|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468484|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470019|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470020|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
14470021|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
14470022|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
14470023|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470024|NCT02302092|Cefepime|cefepime|mesh-list
14470025|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470026|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470027|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
14747464|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14747465|NCT00606450|Analgesics|analgesics|mesh-ancestor
14747466|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
14747467|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747468|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747469|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747470|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747471|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14747472|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14747473|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747474|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747475|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747476|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
14747477|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
14747478|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747479|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747480|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14747481|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14747482|NCT00606450|Growth Substances|growth substances|mesh-ancestor
14429733|NCT01754623|Gemcitabine|gemcitabine|mesh-list
14429734|NCT01754623|Fluorouracil|fluorouracil|mesh-list
14429735|NCT01754623|Capecitabine|capecitabine|mesh-list
14429736|NCT01754623|Docetaxel|docetaxel|mesh-list
14429737|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14747483|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14747484|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747485|NCT00606515|Paclitaxel|paclitaxel|mesh-list
14747486|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14747487|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14747488|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747489|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
14747490|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
14747491|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
14747492|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429738|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
14429739|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429740|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429741|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
14429742|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429743|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429744|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429745|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
14429746|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429747|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
14429748|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
14429749|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
14429750|NCT01754909|Enalapril|enalapril|mesh-list
14429751|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14429752|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
14429753|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429754|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429755|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14429756|NCT01755026|Cefazolin|cefazolin|mesh-list
14429757|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14429758|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429759|NCT01755091|Dronabinol|dronabinol|mesh-list
14429760|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
14429761|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429762|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14429763|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429764|NCT01755091|Analgesics|analgesics|mesh-ancestor
14429765|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
14429766|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429767|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14429768|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14429769|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429770|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429771|NCT01755091|Hormones|hormones|mesh-ancestor
14429772|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429773|NCT01755156|Metformin|metformin|mesh-list
14429774|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
14429775|NCT01755156|Glimepiride|glimepiride|mesh-list
14429776|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14429777|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429778|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14429779|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429780|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
14429781|NCT01755169|Ketamine|ketamine|mesh-list
14927364|NCT01416649|Exenatide|exenatide|mesh-list
14927365|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14927366|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927367|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14927368|NCT01416649|Incretins|incretins|mesh-ancestor
14927369|NCT01416649|Hormones|hormones|mesh-ancestor
14927370|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927371|NCT01416662|Gemcitabine|gemcitabine|mesh-list
14429782|NCT01755169|Analgesics|analgesics|mesh-ancestor
14429783|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
14927372|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14429784|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747493|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14747494|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
14747495|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14747496|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14747497|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14747498|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747499|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747500|NCT00606775|Carvedilol|carvedilol|mesh-list
14747501|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14747502|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14747503|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14429785|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429786|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14429787|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14429788|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
14429789|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
14927373|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
14429790|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429791|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14429792|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14429793|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429794|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429795|NCT01755234|Propofol|propofol|mesh-list
14429796|NCT01755234|Sevoflurane|sevoflurane|mesh-list
14429797|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14429798|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429799|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429800|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14429801|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
14429802|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
14429803|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14429804|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14429805|NCT01755416|Insulin|insulin|mesh-list
14429806|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14429807|NCT01755416|Liraglutide|liraglutide|mesh-list
14429808|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14927374|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927375|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927376|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
14927377|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927378|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927379|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927380|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
14927381|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927382|NCT01416701|Vitamin D|vitamin d|mesh-list
14927383|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
14927384|NCT01416701|Vitamins|vitamins|mesh-list
14927385|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
14927386|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927387|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927388|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14927389|NCT01416831|Interleukin-2|interleukin-2|mesh-list
14927390|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429809|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429810|NCT01755416|Incretins|incretins|mesh-ancestor
14429811|NCT01755416|Hormones|hormones|mesh-ancestor
14429812|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429813|NCT01755546|Buprenorphine|buprenorphine|mesh-list
14747504|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747505|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747506|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747507|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14747508|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
14747509|NCT00606775|Protective Agents|protective agents|mesh-ancestor
14747510|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14747511|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747512|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14747513|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
14747514|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14747515|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14927391|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429814|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14429815|NCT01755546|Narcotics|narcotics|mesh-ancestor
14429816|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429817|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429818|NCT01755546|Analgesics|analgesics|mesh-ancestor
14429819|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
14429820|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429821|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14429822|NCT01755637|Albendazole|albendazole|mesh-list
14429823|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
14429824|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14429825|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429826|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
14429827|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14429828|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14429829|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
14429830|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
14429831|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
14429832|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429833|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429834|NCT01755702|Acetaminophen|acetaminophen|mesh-list
14429835|NCT01755702|Ibuprofen|ibuprofen|mesh-list
14429836|NCT01755702|Caffeine|caffeine|mesh-list
14429837|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14927392|NCT01416831|Analgesics|analgesics|mesh-ancestor
14927393|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
14927394|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927395|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927396|NCT01416870|Bicalutamide|bicalutamide|mesh-list
14927397|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
14927398|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
14927399|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927400|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927401|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927402|NCT01416883|Bicalutamide|bicalutamide|mesh-list
14927403|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
14747516|NCT00606814|Docetaxel|docetaxel|mesh-list
14747517|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747518|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
14429838|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429839|NCT01755702|Analgesics|analgesics|mesh-ancestor
14429840|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
14429841|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429842|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429843|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429844|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14429845|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14927404|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
14429846|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429847|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429848|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
14429849|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14429850|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14429851|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14429852|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14927405|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927406|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927407|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927408|NCT01416909|Laxatives|laxatives|mesh-list
14927409|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14927410|NCT01416948|Methylphenidate|methylphenidate|mesh-list
14927411|NCT01416948|Galantamine|galantamine|mesh-list
14429853|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
14429854|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429855|NCT01755949|Colchicine|colchicine|mesh-list
14429856|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
14429857|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14429858|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
14429859|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
14429860|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
14429861|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429862|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429863|NCT01756079|Ribavirin|ribavirin|mesh-list
14429864|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14429865|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
14429866|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429867|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
14429868|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429869|NCT01756157|Complement C1s|complement c1s|mesh-list
14429870|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14927412|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14927413|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927414|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14429871|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14429872|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
14429873|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429874|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14429875|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429876|NCT01756209|Acetaminophen|acetaminophen|mesh-list
14429877|NCT01756209|Ibuprofen|ibuprofen|mesh-list
14429878|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14429879|NCT01756209|Analgesics|analgesics|mesh-ancestor
14747519|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
14747520|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
14747521|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747522|NCT00606866|Sorafenib|sorafenib|mesh-list
14747523|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747524|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14747525|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747526|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753494|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753495|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
14753496|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14753497|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753498|NCT05113368|Fulvestrant|fulvestrant|mesh-list
14753499|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14753500|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753501|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14753502|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14753503|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
14429880|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
14429881|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429882|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429883|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
14429884|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14927415|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14927416|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927417|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429885|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14429886|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753504|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753505|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753506|NCT05112263|Cyclosporine|cyclosporine|mesh-list
14753507|NCT05112263|Cyclosporins|cyclosporins|mesh-list
14753508|NCT05112263|Tofacitinib|tofacitinib|mesh-list
14753509|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753510|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753511|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14753512|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
14753513|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753514|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
14753515|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753516|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
14753517|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753518|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14753519|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14753520|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
14753521|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14753522|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14753523|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14753524|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753525|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753526|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14753527|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753528|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753529|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14753530|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753531|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14429887|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14429888|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429889|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429890|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14429891|NCT01756456|Mitogens|mitogens|mesh-list
14429892|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14429893|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429894|NCT01756833|Doxycycline|doxycycline|mesh-list
14429895|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14429896|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429897|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
14429898|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14429899|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14429900|NCT01756885|Varenicline|varenicline|mesh-list
14429901|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14429902|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14429903|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
14429904|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429905|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429906|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429907|NCT01757275|Esomeprazole|esomeprazole|mesh-list
14429908|NCT01757275|Cimetidine|cimetidine|mesh-list
14429909|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14429910|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14429911|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14429912|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429913|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429914|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14429915|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
14429916|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
14429917|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429918|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429919|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14429920|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14429921|NCT01757288|Paclitaxel|paclitaxel|mesh-list
14429922|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14429923|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14429924|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429925|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
14429926|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
14429927|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
14429928|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429929|NCT01757561|Propofol|propofol|mesh-list
14429930|NCT01757561|Sevoflurane|sevoflurane|mesh-list
14429931|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14429932|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429933|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927418|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
14927419|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927420|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14927421|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927422|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
14429934|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14429935|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
14429936|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
14429937|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14429938|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14429939|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14429940|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14747527|NCT00606957|Vitamin D|vitamin d|mesh-list
14747528|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
14747529|NCT00606957|Vitamins|vitamins|mesh-ancestor
14747530|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
14747531|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747532|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14747533|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14747534|NCT00606983|Tamsulosin|tamsulosin|mesh-list
14747535|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14747536|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14927423|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14429941|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429942|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14429943|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
14429944|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429945|NCT01758432|Apixaban|apixaban|mesh-list
14429946|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14429947|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
14429948|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14429949|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
14429950|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429951|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429952|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
14429953|NCT01758523|Dutasteride|dutasteride|mesh-list
14429954|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14429955|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14429956|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429957|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429958|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
14927424|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
14927425|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927426|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
14927427|NCT01416961|Etoposide|etoposide|mesh-list
14927428|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
14927429|NCT01416961|Cisplatin|cisplatin|mesh-list
14927430|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14747537|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14747538|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747539|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747540|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747541|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747542|NCT00606983|Urological Agents|urological agents|mesh-ancestor
14747543|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14747544|NCT00607035|Olmesartan|olmesartan|mesh-list
14747545|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14747546|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14747547|NCT00607035|Diuretics|diuretics|mesh-ancestor
14747548|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
14747549|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747550|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14747551|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747552|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747553|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14747554|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14747555|NCT00607074|Albendazole|albendazole|mesh-list
14747556|NCT00607074|Anthelmintics|anthelmintics|mesh-list
14747557|NCT00607074|Secnidazole|secnidazole|mesh-list
14747558|NCT00607074|Metronidazole|metronidazole|mesh-list
14747559|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14747560|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747561|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
14747562|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14747563|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14747564|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
14747565|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
14747566|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
14747567|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747568|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747569|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747570|NCT00607152|Allopurinol|allopurinol|mesh-list
14747571|NCT00607152|Rasburicase|rasburicase|mesh-list
14747572|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
14747573|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747574|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927431|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927432|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14927433|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14927434|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927435|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927436|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
14927437|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927438|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
14927439|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927440|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927441|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14927442|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
14927443|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747575|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
14927444|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927445|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14927446|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14927447|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
14927448|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14927449|NCT01417065|Sirolimus|sirolimus|mesh-list
14927450|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14927451|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429959|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14429960|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429961|NCT01758588|Interferons|interferons|mesh-list
14429962|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
14429963|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14429964|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429965|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
14429966|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14429967|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
14429968|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429969|NCT01758731|Cetuximab|cetuximab|mesh-list
14747576|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747577|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14747578|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
14747579|NCT00607152|Protective Agents|protective agents|mesh-ancestor
14747580|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429970|NCT01758731|Olaparib|olaparib|mesh-list
14429971|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14429972|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14429973|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14429974|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14429975|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14429976|NCT01759277|Anesthetics|anesthetics|mesh-list
14429977|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
14429978|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14429979|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429980|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
14429981|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429982|NCT01759407|Epinephrine|epinephrine|mesh-list
14747581|NCT00607178|Vaccines|vaccines|mesh-list
14747582|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
14747583|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747584|NCT00607217|Vaccines|vaccines|mesh-list
14747585|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
14747586|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927452|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14927453|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927454|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
14927455|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927456|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
14927457|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747587|NCT00607282|Udenafil|udenafil|mesh-list
14753532|NCT05108935|Buprenorphine|buprenorphine|mesh-list
14927458|NCT01417169|Micafungin|micafungin|mesh-list
14927459|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
14927460|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927461|NCT01417273|Vitamin A|vitamin a|mesh-list
14927462|NCT01417273|Vitamins|vitamins|mesh-ancestor
14927463|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
14927464|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927465|NCT01417351|Vitamin D|vitamin d|mesh-list
14927466|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
14927467|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
14927468|NCT01417351|Vitamins|vitamins|mesh-list
14429983|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14429984|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14429985|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
14429986|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14429987|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927469|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
14927470|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927471|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927472|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14429988|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14429989|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14429990|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14429991|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
14747588|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14747589|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14747590|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747591|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747592|NCT00607438|Paclitaxel|paclitaxel|mesh-list
14747593|NCT00607438|Sorafenib|sorafenib|mesh-list
14747594|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14747595|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14747596|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747597|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
14747598|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
14747599|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
14927473|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
14927474|NCT01417364|Testosterone|testosterone|mesh-list
14429992|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14429993|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14927475|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
14927476|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
14927477|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14429994|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
14429995|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
14429996|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
14429997|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14429998|NCT01759420|Ondansetron|ondansetron|mesh-list
14429999|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
14430000|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
14430001|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430002|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430003|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430004|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
14430005|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430006|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14430007|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
14430008|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430009|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430010|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14430011|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14430012|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14430013|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14430014|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14430015|NCT01759602|Complement C1s|complement c1s|mesh-list
14430016|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14430017|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14430018|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
14430019|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430020|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14430021|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430022|NCT01759862|Aminophylline|aminophylline|mesh-list
14430023|NCT01759862|Theophylline|theophylline|mesh-list
14430024|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14430025|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
14430026|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430027|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430028|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14430029|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430030|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14430031|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430032|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430033|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
14430034|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14430035|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14430036|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
14430037|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430038|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14430039|NCT01759862|Protective Agents|protective agents|mesh-ancestor
14430040|NCT01760304|Budesonide|budesonide|mesh-list
14430041|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
14430042|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430043|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14430044|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
14430045|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430046|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430047|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14430048|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430049|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
14430050|NCT01760304|Hormones|hormones|mesh-ancestor
14430051|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430052|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14927478|NCT01417364|Androgens|androgens|mesh-ancestor
14927479|NCT01417364|Hormones|hormones|mesh-ancestor
14927480|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927481|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927482|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14927483|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927484|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
14430053|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14430054|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14430055|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
14430056|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430057|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430058|NCT01760447|Metformin|metformin|mesh-list
14430059|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14430060|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430061|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430062|NCT01760447|Incretins|incretins|mesh-ancestor
14430063|NCT01760447|Hormones|hormones|mesh-ancestor
14430064|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927485|NCT01417390|Gemcitabine|gemcitabine|mesh-list
14927486|NCT01417390|Cisplatin|cisplatin|mesh-list
14927487|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927488|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14430065|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14927489|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
14927490|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927491|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
14927492|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927493|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927494|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927495|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
14927496|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927497|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
14927498|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
14927499|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14927500|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14927501|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927502|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927503|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927504|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927505|NCT01417429|Galantamine|galantamine|mesh-list
14927506|NCT01417429|Nicotine|nicotine|mesh-list
14927507|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14927508|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
14927509|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927510|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927511|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14927512|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14927513|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
14927514|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927515|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927516|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14927517|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927518|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14927519|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
14927520|NCT01417494|Leucovorin|leucovorin|mesh-list
14927521|NCT01417494|Bevacizumab|bevacizumab|mesh-list
14927522|NCT01417494|Fluorouracil|fluorouracil|mesh-list
14927523|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
14430066|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
14430067|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430068|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430069|NCT01760785|Valproic Acid|valproic acid|mesh-list
14430070|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
14430071|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430072|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927524|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14927525|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927526|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14927527|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14927528|NCT01417494|Growth Substances|growth substances|mesh-ancestor
14927529|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927530|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
14430073|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
14430074|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430075|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430076|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
14430077|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14430078|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14430079|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14430080|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14430081|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14430082|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430083|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430084|NCT01761747|Ponatinib|ponatinib|mesh-list
14430085|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430086|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14747600|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747601|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14747602|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747603|NCT00607503|Terbutaline|terbutaline|mesh-list
14747604|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14747605|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
14747606|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747607|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747608|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747609|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
14747610|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
14747611|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
14747612|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14747613|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14747614|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14747615|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14747616|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747617|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430087|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430088|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430089|NCT01762059|Pancrelipase|pancrelipase|mesh-list
14430090|NCT01762059|Pancreatin|pancreatin|mesh-list
14430091|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430092|NCT01762501|Amlodipine|amlodipine|mesh-list
14430093|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14430094|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14430095|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14430096|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14430097|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430098|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14430099|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747618|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747619|NCT00607542|Baclofen|baclofen|mesh-list
14747620|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14430100|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
14430101|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14430102|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14927531|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
14430103|NCT01762800|Fluticasone|fluticasone|mesh-list
14430104|NCT01762800|Xhance|xhance|mesh-list
14430105|NCT01762800|Bromides|bromides|mesh-list
14430106|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
14430107|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14430108|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14747621|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747622|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14747623|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747624|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14747625|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
14747626|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
14430109|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430110|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14430111|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
14430112|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430113|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430114|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14430115|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430116|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430117|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14430118|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
14430119|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14430120|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
14430121|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430122|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430123|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14430124|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14430125|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14430126|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747627|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747628|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747629|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14430127|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
14747630|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14747631|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14747632|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747633|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747634|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747635|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430128|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
14430129|NCT01762800|Hormones|hormones|mesh-ancestor
14430130|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430131|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
14468485|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468486|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
14468487|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
14468488|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14468489|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14468490|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468491|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
14468492|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468493|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468494|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468495|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468496|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14468497|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468498|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
14468499|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14747636|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747637|NCT00607581|Dexamethasone|dexamethasone|mesh-list
14747638|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
14747639|NCT00607581|Lenalidomide|lenalidomide|mesh-list
14747640|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747641|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
14747642|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747643|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747644|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14747645|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
14747646|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747647|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747648|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14747649|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747650|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
14747651|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
14747652|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747653|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747654|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
14747655|NCT00607581|Hormones|hormones|mesh-ancestor
14747656|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747657|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14747658|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14747659|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14747660|NCT00607581|Growth Substances|growth substances|mesh-ancestor
14747661|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
14747662|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14747663|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14747664|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
14747665|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747666|NCT00607685|Fluorouracil|fluorouracil|mesh-list
14747667|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
14747668|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
14747669|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747670|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14747671|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747672|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747673|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
14747674|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747675|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14747676|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
14747677|NCT00607685|Protective Agents|protective agents|mesh-ancestor
14747678|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
14747679|NCT00607711|Ifosfamide|ifosfamide|mesh-list
14747680|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14747681|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
14747682|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747683|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747684|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
14747685|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747686|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747687|NCT00607750|Mecamylamine|mecamylamine|mesh-list
14747688|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14747689|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14747690|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
14747691|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747692|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747693|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14747694|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14747695|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
14747696|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747697|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747698|NCT00607763|Micafungin|micafungin|mesh-list
14747699|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
14747700|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747701|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
14747702|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14747703|NCT00607932|Protective Agents|protective agents|mesh-ancestor
14747704|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747705|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747706|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
14747707|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747708|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747709|NCT00607958|Ritonavir|ritonavir|mesh-list
14747710|NCT00607958|Tipranavir|tipranavir|mesh-list
14747711|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14747712|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14747713|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
14747714|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747715|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747716|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14747717|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14747718|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
14747719|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747720|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14747721|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14747722|NCT00607971|Renzapride|renzapride|mesh-list
14747723|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14747724|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
14747725|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747726|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747727|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747728|NCT00607984|Melphalan|melphalan|mesh-list
14747729|NCT00607984|Thiotepa|thiotepa|mesh-list
14927532|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927533|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14747730|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14747731|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
14747732|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747733|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747734|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14747735|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747736|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
14927534|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927535|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
14927536|NCT01417494|Antidotes|antidotes|mesh-ancestor
14927537|NCT01417494|Protective Agents|protective agents|mesh-ancestor
14927538|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
14927539|NCT01417494|Vitamins|vitamins|mesh-ancestor
14927540|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
14927541|NCT01417572|Lidocaine|lidocaine|mesh-list
14927542|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
14927543|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
14747737|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747738|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
14927544|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14927545|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747739|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
14747740|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14747741|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747742|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747743|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
14430132|NCT01762904|Ethanol|ethanol|mesh-list
14430133|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
14430134|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14430135|NCT01762904|Triclosan|triclosan|mesh-list
14430136|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14430137|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430138|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14430139|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430140|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
14430141|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430142|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14430143|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14430144|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
14430145|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430146|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14430147|NCT01762943|Leuprolide|leuprolide|mesh-list
14430148|NCT01762943|Estradiol|estradiol|mesh-list
14430149|NCT01762943|Progesterone|progesterone|mesh-list
14430150|NCT01762943|Estrogens|estrogens|mesh-ancestor
14430151|NCT01762943|Hormones|hormones|mesh-ancestor
14430152|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430153|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430154|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14430155|NCT01762943|Progestins|progestins|mesh-ancestor
14430156|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14430157|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
14430158|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14430159|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430160|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14430161|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14430162|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430163|NCT01763164|Dacarbazine|dacarbazine|mesh-list
14430164|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14430165|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
14430166|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430167|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430168|NCT01763346|Metformin|metformin|mesh-list
14430169|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430170|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430171|NCT01763606|Aspirin|aspirin|mesh-list
14430172|NCT01763606|Enoxaparin|enoxaparin|mesh-list
14430173|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14430174|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14430175|NCT01763606|Analgesics|analgesics|mesh-ancestor
14430176|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
14430177|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430178|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430179|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430180|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14430181|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14747744|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14747745|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747746|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747747|NCT00608101|Dexamethasone|dexamethasone|mesh-list
14747748|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
14747749|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747750|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
14747751|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
14747752|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747753|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430182|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14430183|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470028|NCT02302339|Nivolumab|nivolumab|mesh-list
14430184|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14430185|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14430186|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430187|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
14747754|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747755|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
14747756|NCT00608101|Hormones|hormones|mesh-ancestor
14747757|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747758|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14747759|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747760|NCT00608179|Glimepiride|glimepiride|mesh-list
14747761|NCT00608179|Glyburide|glyburide|mesh-list
14747762|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14747763|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14747764|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747765|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747766|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
14747767|NCT00608218|Ciclesonide|ciclesonide|mesh-list
14747768|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
14747769|NCT00608218|Hormones|hormones|mesh-ancestor
14747770|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747771|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747772|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14747773|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
14747774|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14747775|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747776|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747777|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14430188|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
14430189|NCT01763645|Paclitaxel|paclitaxel|mesh-list
14430190|NCT01763645|Bevacizumab|bevacizumab|mesh-list
14430191|NCT01763645|Carboplatin|carboplatin|mesh-list
14430192|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14430193|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430194|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
14430195|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
14430196|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
14430197|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430198|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14430199|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14430200|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14430201|NCT01763645|Growth Substances|growth substances|mesh-ancestor
14430202|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430203|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
14430204|NCT01763827|Ezetimibe|ezetimibe|mesh-list
14430205|NCT01763827|Evolocumab|evolocumab|mesh-list
14430206|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14430207|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14747778|NCT00608231|Analgesics|analgesics|mesh-ancestor
14430208|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14430209|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
14430210|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430211|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14430212|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
14430213|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430214|NCT01763866|Atorvastatin|atorvastatin|mesh-list
14430215|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14430216|NCT01763866|Simvastatin|simvastatin|mesh-list
14430217|NCT01763866|Ezetimibe|ezetimibe|mesh-list
14430218|NCT01763866|Evolocumab|evolocumab|mesh-list
14430219|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14430220|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14430221|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14430222|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
14430223|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430224|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14430225|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14430226|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430227|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
14430228|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430229|NCT01763905|Ezetimibe|ezetimibe|mesh-list
14430230|NCT01763905|Evolocumab|evolocumab|mesh-list
14430231|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14430232|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14747779|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
14747780|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747781|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14747782|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14430233|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14430234|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
14430235|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747783|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14747784|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747785|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747786|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747787|NCT00608335|Micafungin|micafungin|mesh-list
14747788|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
14747789|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747790|NCT00608361|Dasatinib|dasatinib|mesh-list
14747791|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927546|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
14927547|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927548|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14927549|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14927550|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14927551|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927552|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927553|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14927554|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14927555|NCT01417754|Toremifene|toremifene|mesh-list
14927556|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14927557|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927558|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14927559|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14927560|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
14927561|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430236|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14430237|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
14430238|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430239|NCT01763918|Evolocumab|evolocumab|mesh-list
14747792|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14927562|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927563|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927564|NCT01417767|Decitabine|decitabine|mesh-list
14927565|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14927566|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
14927567|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927568|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927569|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927570|NCT01417806|Topotecan|topotecan|mesh-list
14927571|NCT01417806|Pasireotide|pasireotide|mesh-list
14927572|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14927573|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14927574|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927575|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927576|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927577|NCT01417806|Hormones|hormones|mesh-ancestor
14927578|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927579|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927580|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14927581|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14927582|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14927583|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14927584|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14927585|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
14927586|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927587|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927588|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927589|NCT01417897|Insulin|insulin|mesh-list
14927590|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14430240|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14747793|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747794|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747795|NCT00608374|Fludarabine|fludarabine|mesh-list
14430241|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14747796|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
14747797|NCT00608374|Chlorambucil|chlorambucil|mesh-list
14747798|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747799|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14747800|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
14747801|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747802|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747803|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
14747804|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747805|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14747806|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
14747807|NCT00608595|Celecoxib|celecoxib|mesh-list
14747808|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14747809|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14430242|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
14430243|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430244|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14430245|NCT01763931|Digoxin|digoxin|mesh-list
14430246|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14430247|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14430248|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430249|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430250|NCT01763931|Protective Agents|protective agents|mesh-ancestor
14430251|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430252|NCT01763996|Febuxostat|febuxostat|mesh-list
14430253|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
14430254|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14430255|NCT01764022|Paclitaxel|paclitaxel|mesh-list
14430256|NCT01764022|Trastuzumab|trastuzumab|mesh-list
14430257|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14430258|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430259|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14430260|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14430261|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14430262|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430263|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14430264|NCT01764464|Gabapentin|gabapentin|mesh-list
14430265|NCT01764464|Analgesics|analgesics|mesh-ancestor
14430266|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
14430267|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430268|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430269|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
14430270|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14430271|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14430272|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14430273|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14430274|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14430275|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14430276|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430277|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430278|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
14430279|NCT01764607|Sirolimus|sirolimus|mesh-list
14430280|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14430281|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430282|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14430283|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430284|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
14430285|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430286|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
14430287|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430288|NCT01764633|Evolocumab|evolocumab|mesh-list
14430289|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14430290|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14430291|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
14430292|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430293|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14747810|NCT00608595|Analgesics|analgesics|mesh-ancestor
14747811|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
14747812|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747813|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747814|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747815|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747816|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14747817|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14747818|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747819|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747820|NCT00608673|Betamethasone|betamethasone|mesh-list
14747821|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
14747822|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14747823|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
14747824|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
14747825|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14747826|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747827|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
14747828|NCT00608673|Hormones|hormones|mesh-ancestor
14430294|NCT01764685|Topiramate|topiramate|mesh-list
14430295|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
14430296|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430297|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430298|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
14430299|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747829|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747830|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747831|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747832|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
14747833|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14430300|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430301|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14430302|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14430303|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430304|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430305|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430306|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14747834|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14747835|NCT00608673|Analgesics|analgesics|mesh-ancestor
14747836|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
14747837|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747838|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14747839|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
14747840|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747841|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
14430307|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14430308|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
14430309|NCT01765179|Testosterone|testosterone|mesh-list
14430310|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
14430311|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
14430312|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14430313|NCT01765179|Androgens|androgens|mesh-ancestor
14430314|NCT01765179|Hormones|hormones|mesh-ancestor
14430315|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430316|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430317|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14430318|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430319|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
14430320|NCT01765192|Montelukast|montelukast|mesh-list
14430321|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14430322|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430323|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14430324|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
14747842|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14747843|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927591|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
14927592|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
14927593|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14927594|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927595|NCT01417923|Vitamin D|vitamin d|mesh-list
14927596|NCT01417923|Vitamins|vitamins|mesh-ancestor
14927597|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
14927598|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927599|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927600|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14927601|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
14927602|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430325|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430326|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430327|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14430328|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14430329|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430330|NCT01765270|Saxagliptin|saxagliptin|mesh-list
14927603|NCT01418118|Dobutamine|dobutamine|mesh-list
14927604|NCT01418118|Epinephrine|epinephrine|mesh-list
14927605|NCT01418118|Norepinephrine|norepinephrine|mesh-list
14927606|NCT01418118|Dopexamine|dopexamine|mesh-list
14927607|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14430331|NCT01765270|Incretins|incretins|mesh-ancestor
14430332|NCT01765270|Hormones|hormones|mesh-ancestor
14430333|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430334|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430335|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14430336|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
14430337|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430338|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430339|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430340|NCT01765543|Rifampin|rifampin|mesh-list
14430341|NCT01765543|Vemurafenib|vemurafenib|mesh-list
14430342|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14430343|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
14430344|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14430345|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430346|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
14430347|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14430348|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430349|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927608|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14927609|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
14927610|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927611|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927612|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747844|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747845|NCT00608699|Niacin|niacin|mesh-list
14747846|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14747847|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
14747848|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927613|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14927614|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14927615|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
14927616|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430350|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14430351|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14430352|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14430353|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14430354|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14747849|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14747850|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
14747851|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
14747852|NCT00608699|Vitamins|vitamins|mesh-ancestor
14927617|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14927618|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
14927619|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
14927620|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
14927621|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14927622|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14927623|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14747853|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
14927624|NCT01418118|Protective Agents|protective agents|mesh-ancestor
14927625|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
14430355|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14430356|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430357|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14430358|NCT01765569|Vemurafenib|vemurafenib|mesh-list
14430359|NCT01765569|Digoxin|digoxin|mesh-list
14430360|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14430361|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14430362|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430363|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430364|NCT01765569|Protective Agents|protective agents|mesh-ancestor
14430365|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430366|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430367|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14430368|NCT01765582|Leucovorin|leucovorin|mesh-list
14430369|NCT01765582|Folic Acid|folic acid|mesh-list
14430370|NCT01765582|Bevacizumab|bevacizumab|mesh-list
14430371|NCT01765582|Fluorouracil|fluorouracil|mesh-list
14430372|NCT01765582|Capecitabine|capecitabine|mesh-list
14430373|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
14430374|NCT01765582|Irinotecan|irinotecan|mesh-list
14430375|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
14430376|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14430377|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430378|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14430379|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14430380|NCT01765582|Growth Substances|growth substances|mesh-ancestor
14430381|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430382|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
14430383|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
14430384|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430385|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14430386|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430387|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
14430388|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14430389|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14430390|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430391|NCT01765582|Antidotes|antidotes|mesh-ancestor
14430392|NCT01765582|Protective Agents|protective agents|mesh-ancestor
14430393|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
14430394|NCT01765582|Vitamins|vitamins|mesh-ancestor
14430395|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
14430396|NCT01765582|Hematinics|hematinics|mesh-ancestor
14430397|NCT01765764|Bimatoprost|bimatoprost|mesh-list
14430398|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14430399|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14430400|NCT01765803|Thioridazine|thioridazine|mesh-list
14430401|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14430402|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14430403|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14430404|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430405|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14430406|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14430407|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
14430408|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430409|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430410|NCT01766024|Interferons|interferons|mesh-list
14430411|NCT01766024|Interferon-beta|interferon-beta|mesh-list
14430412|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
14430413|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430414|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
14430415|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747854|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747855|NCT00608712|Esomeprazole|esomeprazole|mesh-list
14747856|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14747857|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430416|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
14430417|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430418|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14430419|NCT01766050|Abatacept|abatacept|mesh-list
14430420|NCT01766050|Losartan|losartan|mesh-list
14430421|NCT01766050|Midazolam|midazolam|mesh-list
14430422|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
14430423|NCT01766050|Caffeine|caffeine|mesh-list
14430424|NCT01766050|Omeprazole|omeprazole|mesh-list
14430425|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14430426|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14430427|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14430428|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430429|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14430430|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14430431|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14430432|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14430433|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
14430434|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
14430435|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
14430436|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
14747858|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14747859|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747860|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747861|NCT00608725|Propranolol|propranolol|mesh-list
14747862|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14747863|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14747864|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747865|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747866|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747867|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747868|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14747869|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14747870|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
14747871|NCT00608790|Albuterol|albuterol|mesh-list
14747872|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14747873|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
14747874|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747875|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747876|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747877|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430437|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430438|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430439|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14430440|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14430441|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14430442|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14747878|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
14747879|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14747880|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14747881|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14747882|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14430443|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14430444|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430445|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14430446|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430447|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14430448|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14430449|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14430450|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14430451|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
14430452|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
14430453|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430454|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14430455|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14747883|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747884|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747885|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747886|NCT00608803|Doxorubicin|doxorubicin|mesh-list
14747887|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14747888|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747889|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14747890|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14747891|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747892|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747893|NCT00608816|Epinephrine|epinephrine|mesh-list
14747894|NCT00608816|Racepinephrine|racepinephrine|mesh-list
14747895|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
14747896|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14747897|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14747898|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
14747899|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747900|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747901|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747902|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14747903|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14747904|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
14747905|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14747906|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14747907|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430456|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14430457|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430458|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430459|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
14927626|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
14927627|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
14927628|NCT01418131|Tacrolimus|tacrolimus|mesh-list
14927629|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14927630|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927631|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
14927632|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927633|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927634|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927635|NCT01418144|Ropivacaine|ropivacaine|mesh-list
14927636|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
14747908|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
14747909|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
14747910|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14747911|NCT00608946|Copper|copper|mesh-list
14747912|NCT00608946|Trace Elements|trace elements|mesh-ancestor
14747913|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
14747914|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747915|NCT00608972|Bevacizumab|bevacizumab|mesh-list
14747916|NCT00608972|Carboplatin|carboplatin|mesh-list
14747917|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14747918|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747919|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14747920|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14747921|NCT00608972|Growth Substances|growth substances|mesh-ancestor
14927637|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
14927638|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747922|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747923|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753533|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14753534|NCT05108935|Naloxone|naloxone|mesh-list
14753535|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14753536|NCT05108935|Narcotics|narcotics|mesh-ancestor
14753537|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753538|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753539|NCT05108935|Analgesics|analgesics|mesh-ancestor
14753540|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
14753541|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753542|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14753543|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14753544|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14753545|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753546|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753547|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
14753548|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753549|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14753550|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14753551|NCT05105841|Venetoclax|venetoclax|mesh-list
14753552|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
14753553|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753554|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753555|NCT05104983|Sirolimus|sirolimus|mesh-list
14753556|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14753557|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753558|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14753559|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753560|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
14753561|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14753562|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
14753563|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753564|NCT05104554|Folic Acid|folic acid|mesh-list
14753565|NCT05104554|Micronutrients|micronutrients|mesh-list
14753566|NCT05104554|Trace Elements|trace elements|mesh-list
14753567|NCT05104554|Hematinics|hematinics|mesh-ancestor
14753568|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
14753569|NCT05104554|Vitamins|vitamins|mesh-ancestor
14753570|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753571|NCT05103605|Osimertinib|osimertinib|mesh-list
14753572|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927639|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927640|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
14927641|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927642|NCT01418157|Acetazolamide|acetazolamide|mesh-list
14927643|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
14927644|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14927645|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753573|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14753574|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747924|NCT00609011|Temozolomide|temozolomide|mesh-list
14747925|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14747926|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
14747927|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747928|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747929|NCT00609063|Atorvastatin|atorvastatin|mesh-list
14747930|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14747931|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14747932|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
14747933|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747934|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14747935|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14747936|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747937|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
14747938|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
14747939|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747940|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14747941|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
14430460|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14430461|NCT01766076|Atorvastatin|atorvastatin|mesh-list
14430462|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14430463|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14430464|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
14430465|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430466|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14430467|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14430468|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430469|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
14430470|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
14430471|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430472|NCT01766219|Protective Agents|protective agents|mesh-ancestor
14430473|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430474|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
14430475|NCT01766219|Vitamins|vitamins|mesh-ancestor
14430476|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
14430477|NCT01766310|Folic Acid|folic acid|mesh-list
14430478|NCT01766310|Hematinics|hematinics|mesh-ancestor
14430479|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
14430480|NCT01766310|Vitamins|vitamins|mesh-ancestor
14430481|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
14430482|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430483|NCT01766336|Inositol|inositol|mesh-list
14747942|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747943|NCT00609154|Glucagon|glucagon|mesh-list
14747944|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14747945|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14747946|NCT00609154|Hormones|hormones|mesh-ancestor
14747947|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14747948|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747949|NCT00609154|Incretins|incretins|mesh-ancestor
14747950|NCT00609180|Antioxidants|antioxidants|mesh-list
14430484|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
14430485|NCT01766336|Vitamins|vitamins|mesh-ancestor
14430486|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
14430487|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430488|NCT01766440|Calcitriol|calcitriol|mesh-list
14430489|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14430490|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430491|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14430492|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14430493|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430494|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14430495|NCT01766440|Vitamins|vitamins|mesh-ancestor
14430496|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
14430497|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14430498|NCT01766466|Ticagrelor|ticagrelor|mesh-list
14430499|NCT01766466|Cangrelor|cangrelor|mesh-list
14430500|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14430501|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14430502|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14430503|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14430504|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
14430505|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430506|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430507|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430508|NCT01766713|Ezetimibe|ezetimibe|mesh-list
14430509|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14430510|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14430511|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
14430512|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430513|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14430514|NCT01766778|Metformin|metformin|mesh-list
14430515|NCT01766778|Vildagliptin|vildagliptin|mesh-list
14430516|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430517|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430518|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14430519|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
14430520|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747951|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747952|NCT00609180|Protective Agents|protective agents|mesh-ancestor
14747953|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747954|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14747955|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
14747956|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14747957|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14747958|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14747959|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14747960|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747961|NCT00609284|Carboplatin|carboplatin|mesh-list
14747962|NCT00609284|Cetuximab|cetuximab|mesh-list
14747963|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747964|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14747965|NCT00609375|Cefepime|cefepime|mesh-list
14747966|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14747967|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14747968|NCT00609388|Tacrolimus|tacrolimus|mesh-list
14747969|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14747970|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
14747971|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747972|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14747973|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747974|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747975|NCT00609401|Sorafenib|sorafenib|mesh-list
14747976|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14747977|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14747978|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14747979|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747980|NCT00609531|Citalopram|citalopram|mesh-list
14747981|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14747982|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14747983|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747984|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430521|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430522|NCT01767103|Deferiprone|deferiprone|mesh-list
14430523|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14430524|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
14430525|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
14430526|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430527|NCT01767116|Ribavirin|ribavirin|mesh-list
14430528|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
14430529|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430530|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
14430531|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430532|NCT01767155|Doxorubicin|doxorubicin|mesh-list
14430533|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14430534|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14430535|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430536|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14430537|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14430538|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430539|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430540|NCT01767285|Etonogestrel|etonogestrel|mesh-list
14430541|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14430542|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
14430543|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14430544|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430545|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14430546|NCT01767506|Azithromycin|azithromycin|mesh-list
14430547|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14430548|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430549|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
14430550|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
14430551|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14430552|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14430553|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14430554|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14430555|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430556|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
14430557|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430558|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430559|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14430560|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430561|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14430562|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14430563|NCT01767519|Urological Agents|urological agents|mesh-ancestor
14430564|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
14430565|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14430566|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14430567|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
14430568|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430569|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14747985|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747986|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
14747987|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14747988|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14747989|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
14747990|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14747991|NCT00609544|Rilonacept|rilonacept|mesh-list
14747992|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14747993|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14747994|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14747995|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14747996|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14747997|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14747998|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14747999|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748000|NCT00609557|Analgesics|analgesics|mesh-ancestor
14748001|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
14748002|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748003|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
14748004|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14748005|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
14748006|NCT00609570|Calcium|calcium|mesh-list
14748007|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14748008|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748009|NCT00609596|Dutasteride|dutasteride|mesh-list
14748010|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14748011|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14748012|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748013|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748014|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
14748015|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748016|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748017|NCT00609752|Prednisolone|prednisolone|mesh-list
14748018|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748019|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
14748020|NCT00609752|Hormones|hormones|mesh-ancestor
14748021|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748022|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748023|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14748024|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748025|NCT00609817|Dexamethasone|dexamethasone|mesh-list
14748026|NCT00609817|Bortezomib|bortezomib|mesh-list
14748027|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748028|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
14748029|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
14748030|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430570|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14430571|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430572|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430573|NCT01767792|Bevacizumab|bevacizumab|mesh-list
14430574|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
14430575|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14430576|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430577|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14430578|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14430579|NCT01767792|Growth Substances|growth substances|mesh-ancestor
14430580|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430581|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
14430582|NCT01767909|Insulin|insulin|mesh-list
14430583|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14430584|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430585|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430586|NCT01767987|Ranolazine|ranolazine|mesh-list
14430587|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14430588|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14430589|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430590|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14748031|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430591|NCT01768286|Ledipasvir|ledipasvir|mesh-list
14430592|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
14430593|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430594|NCT01768520|Celecoxib|celecoxib|mesh-list
14430595|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14430596|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14430597|NCT01768520|Analgesics|analgesics|mesh-ancestor
14430598|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
14430599|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430600|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748032|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14748033|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
14748034|NCT00609817|Hormones|hormones|mesh-ancestor
14748035|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748036|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14748037|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748038|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
14748039|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748040|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
14748041|NCT00609856|Pioglitazone|pioglitazone|mesh-list
14748042|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748043|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748044|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
14748045|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748046|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748047|NCT00609934|Sorafenib|sorafenib|mesh-list
14748048|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748049|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14748050|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748051|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748052|NCT00609960|Midazolam|midazolam|mesh-list
14748053|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14430601|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748054|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14748055|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748056|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748057|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14748058|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14748059|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14748060|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14748061|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
14748062|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
14748063|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
14748064|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
14748065|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748066|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748067|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14748068|NCT00609999|Dasatinib|dasatinib|mesh-list
14748069|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748070|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14748071|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748072|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748073|NCT00610038|Glyburide|glyburide|mesh-list
14748074|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748075|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748076|NCT00610051|Alprostadil|alprostadil|mesh-list
14430602|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14430603|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14430604|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14430605|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430606|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430607|NCT01768559|Insulin|insulin|mesh-list
14430608|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14430609|NCT01768559|Metformin|metformin|mesh-list
14430610|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
14430611|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
14430612|NCT01768559|Lixisenatide|lixisenatide|mesh-list
14430613|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430614|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430615|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
14430616|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
14430617|NCT01768572|Methotrexate|methotrexate|mesh-list
14430618|NCT01768572|Leflunomide|leflunomide|mesh-list
14430619|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14430620|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
14430621|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14430622|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430623|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14430624|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
14748077|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14748078|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
14927646|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927647|NCT01418157|Diuretics|diuretics|mesh-ancestor
14927648|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
14927649|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927650|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
14927651|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
14927652|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
14927653|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14927654|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927655|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
14927656|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927657|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14430625|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430626|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430627|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430628|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430629|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14927658|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14927659|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
14927660|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430630|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430631|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
14430632|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14430633|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14430634|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
14430635|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14430636|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14430637|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430638|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14430639|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14430640|NCT01768572|Analgesics|analgesics|mesh-ancestor
14430641|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
14430642|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430643|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430644|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430645|NCT01768637|Aspirin|aspirin|mesh-list
14430646|NCT01768637|Clopidogrel|clopidogrel|mesh-list
14430647|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14430648|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14430649|NCT01768637|Analgesics|analgesics|mesh-ancestor
14430650|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
14430651|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430652|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430653|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14927661|NCT01418274|Ritonavir|ritonavir|mesh-list
14927662|NCT01418274|Citalopram|citalopram|mesh-list
14927663|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14927664|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14927665|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
14927666|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927667|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927668|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14927669|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14430654|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14430655|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14430656|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14748079|NCT00610051|Urological Agents|urological agents|mesh-ancestor
14748080|NCT00610077|Letrozole|letrozole|mesh-list
14927670|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
14927671|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927672|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14748081|NCT00610077|Clomiphene|clomiphene|mesh-list
14748082|NCT00610077|Enclomiphene|enclomiphene|mesh-list
14748083|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
14748084|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748085|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748086|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14927673|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14927674|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14927675|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14927676|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927677|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470029|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
14470030|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14470031|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470032|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470033|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14470034|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470035|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
14470036|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470037|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14470038|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470039|NCT02302807|Paclitaxel|paclitaxel|mesh-list
14470040|NCT02302807|Docetaxel|docetaxel|mesh-list
14748087|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14927678|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
14927679|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927680|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14927681|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
14927682|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14931138|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430657|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430658|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14430659|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14430660|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430661|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
14430662|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14748088|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748089|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14748090|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
14748091|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748092|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748093|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14430663|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14430664|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14430665|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
14430666|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430667|NCT01768858|Adalimumab|adalimumab|mesh-list
14430668|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430669|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468500|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468501|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468502|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468503|NCT02281552|Tofacitinib|tofacitinib|mesh-list
14468504|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14468505|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468506|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468507|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468508|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
14468509|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468510|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468511|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468512|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468513|NCT02281760|Trametinib|trametinib|mesh-list
14468514|NCT02281760|Dabrafenib|dabrafenib|mesh-list
14468515|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14468516|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468517|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14468518|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748094|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
14430670|NCT01769170|Cidofovir|cidofovir|mesh-list
14430671|NCT01769170|Brincidofovir|brincidofovir|mesh-list
14430672|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
14430673|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430674|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430675|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430676|NCT01769209|Cytarabine|cytarabine|mesh-list
14430677|NCT01769209|Dexamethasone|dexamethasone|mesh-list
14430678|NCT01769209|Doxorubicin|doxorubicin|mesh-list
14430679|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14430680|NCT01769209|Methotrexate|methotrexate|mesh-list
14430681|NCT01769209|Vincristine|vincristine|mesh-list
14430682|NCT01769209|Bortezomib|bortezomib|mesh-list
14430683|NCT01769209|Asparaginase|asparaginase|mesh-list
14430684|NCT01769209|Pegaspargase|pegaspargase|mesh-list
14430685|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430686|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
14430687|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
14430688|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430689|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430690|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430691|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
14430692|NCT01769209|Hormones|hormones|mesh-ancestor
14430693|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430694|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14430695|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430696|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14430697|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14430698|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14430699|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430700|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430701|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14430702|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
14430703|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14430704|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14927683|NCT01418417|Pantoprazole|pantoprazole|mesh-list
14927684|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14927685|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14927686|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14927687|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430705|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
14430706|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430707|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14430708|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430709|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
14430710|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14430711|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14430712|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
14430713|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430714|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14430715|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
14430716|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14430717|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14430718|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14430719|NCT01769222|Ipilimumab|ipilimumab|mesh-list
14430720|NCT01769222|Antibodies|antibodies|mesh-list
14430721|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
14430722|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14430723|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
14430724|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430725|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430726|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14430727|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430728|NCT01769339|Miconazole|miconazole|mesh-list
14430729|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
14430730|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430731|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
14430732|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430733|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14430734|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14430735|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470041|NCT02302807|Atezolizumab|atezolizumab|mesh-list
14470042|NCT02302807|Antibodies|antibodies|mesh-list
14470043|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14470044|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470045|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14470046|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14470047|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14470048|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470049|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
14470050|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430736|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430737|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14430738|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
14430739|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430740|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430741|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14430742|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14430743|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
14430744|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430745|NCT01769365|Amoxicillin|amoxicillin|mesh-list
14430746|NCT01769365|Metronidazole|metronidazole|mesh-list
14430747|NCT01769365|Clarithromycin|clarithromycin|mesh-list
14430748|NCT01769365|Pantoprazole|pantoprazole|mesh-list
14430749|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14430750|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430751|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14430752|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14430753|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14430754|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430755|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430756|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14430757|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14430758|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14430759|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430760|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14430761|NCT01769378|Glimepiride|glimepiride|mesh-list
14430762|NCT01769378|Dulaglutide|dulaglutide|mesh-list
14430763|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14430764|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430765|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748095|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14748096|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14748097|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14748098|NCT00610103|Apomorphine|apomorphine|mesh-list
14748099|NCT00610103|Emetics|emetics|mesh-ancestor
14748100|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748101|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
14748102|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748103|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14748104|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
14748105|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
14748106|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748107|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748108|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
14748109|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
14748110|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748111|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14748112|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14748113|NCT00610142|Analgesics|analgesics|mesh-ancestor
14748114|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
14748115|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748116|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748117|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748118|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14748119|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748120|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
14748121|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14748122|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430766|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430767|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
14430768|NCT01769391|Paclitaxel|paclitaxel|mesh-list
14430769|NCT01769391|Carboplatin|carboplatin|mesh-list
14430770|NCT01769391|Necitumumab|necitumumab|mesh-list
14430771|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14430772|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430773|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
14430774|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
14430775|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
14430776|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430777|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14430778|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
14430779|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14430780|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430781|NCT01769456|Tenofovir|tenofovir|mesh-list
14430782|NCT01769456|Emtricitabine|emtricitabine|mesh-list
14430783|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14430784|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
14430785|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430786|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14430787|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14430788|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430789|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430790|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14430791|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14430792|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14430793|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14470051|NCT02302846|Ixazomib|ixazomib|mesh-list
14470052|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470053|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
14470054|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470055|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470056|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
14748123|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748124|NCT00610246|Sorafenib|sorafenib|mesh-list
14748125|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748126|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14748127|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748128|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748129|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
14748130|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14430794|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14430795|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430796|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430797|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
14430798|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430799|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14748131|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14748132|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748133|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
14748134|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
14748135|NCT00610350|Simendan|simendan|mesh-list
14748136|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14748137|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
14748138|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14748139|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14927688|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927689|NCT01418430|Daclizumab|daclizumab|mesh-list
14927690|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748140|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748141|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748142|NCT00610350|Protective Agents|protective agents|mesh-ancestor
14748143|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748144|NCT00610454|Levetiracetam|levetiracetam|mesh-list
14748145|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
14748146|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
14748147|NCT00610493|Sirolimus|sirolimus|mesh-list
14748148|NCT00610493|Bevacizumab|bevacizumab|mesh-list
14748149|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748150|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748151|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14748152|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14748153|NCT00610493|Growth Substances|growth substances|mesh-ancestor
14748154|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748155|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
14748156|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14748157|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748158|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14748159|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
14748160|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748161|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
14748162|NCT00610506|Dexetimide|dexetimide|mesh-list
14430800|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14748163|NCT00610506|Citalopram|citalopram|mesh-list
14748164|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14748165|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14748166|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14748167|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748168|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748169|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
14748170|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748171|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14748172|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
14748173|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14927691|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
14927692|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927693|NCT01418443|Pantoprazole|pantoprazole|mesh-list
14927694|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14430801|NCT01769508|Fluorouracil|fluorouracil|mesh-list
14430802|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
14430803|NCT01769508|Lapatinib|lapatinib|mesh-list
14430804|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
14430805|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430806|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14430807|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430808|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430809|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
14430810|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430811|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14430812|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430813|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
14430814|NCT01769586|Promethazine|promethazine|mesh-list
14430815|NCT01769586|Midazolam|midazolam|mesh-list
14430816|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14430817|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14430818|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14430819|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430820|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14430821|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14430822|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14430823|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14430824|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
14430825|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
14430826|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
14430827|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
14430828|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430829|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430830|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14430831|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
14430832|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
14748174|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14748175|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14748176|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
14748177|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
14748178|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430833|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430834|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
14430835|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
14430836|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430837|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14430838|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
14430839|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
14430840|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14430841|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
14430842|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430843|NCT01770145|Levodopa|levodopa|mesh-list
14927695|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14927696|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14927697|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927698|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927699|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14927700|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927701|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14927702|NCT01418534|Isosorbide|isosorbide|mesh-list
14748179|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14748180|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14748181|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
14748182|NCT00610545|Atorvastatin|atorvastatin|mesh-list
14748183|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14748184|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14748185|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
14430844|NCT01770145|Carbidopa|carbidopa|mesh-list
14430845|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14430846|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
14430847|NCT01770145|Apomorphine|apomorphine|mesh-list
14430848|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14430849|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14430850|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
14430851|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430852|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430853|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430854|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14430855|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430856|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14430857|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
14748186|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748187|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14748188|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14748189|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748190|NCT00610571|Temozolomide|temozolomide|mesh-list
14748191|NCT00610571|Topotecan|topotecan|mesh-list
14748192|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14430858|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
14430859|NCT01770145|Emetics|emetics|mesh-ancestor
14430860|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
14430861|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430862|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14430863|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
14430864|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14430865|NCT01770353|Hematinics|hematinics|mesh-ancestor
14430866|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14430867|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14430868|NCT01770392|Rifampin|rifampin|mesh-list
14430869|NCT01770392|Nintedanib|nintedanib|mesh-list
14430870|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14430871|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
14430872|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14430873|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430874|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
14430875|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14430876|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430877|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430878|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14430879|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14430880|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14430881|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14430882|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14430883|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14430884|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430885|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14430886|NCT01770483|Interferons|interferons|mesh-list
14430887|NCT01770483|Ribavirin|ribavirin|mesh-list
14430888|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
14430889|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
14430890|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14430891|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
14430892|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14430893|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
14430894|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430895|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
14430896|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430897|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14430898|NCT01770652|Deferiprone|deferiprone|mesh-list
14430899|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14430900|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
14430901|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
14430902|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430903|NCT01770743|Vaccines|vaccines|mesh-list
14430904|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
14430905|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430906|NCT01770912|Triamcinolone|triamcinolone|mesh-list
14430907|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14430908|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14430909|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14430910|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748193|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
14748194|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748195|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748196|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14430911|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
14430912|NCT01770912|Hormones|hormones|mesh-ancestor
14927703|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14927704|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14927705|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14927706|NCT01418534|Diuretics|diuretics|mesh-ancestor
14927707|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
14927708|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927709|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
14927710|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14927711|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430913|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14430914|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430915|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14430916|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
14430917|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14430918|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430919|NCT01771250|Insulin|insulin|mesh-list
14927712|NCT01418547|Isosorbide|isosorbide|mesh-list
14927713|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14927714|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14927715|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14927716|NCT01418547|Diuretics|diuretics|mesh-ancestor
14927717|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
14927718|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927719|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
14748197|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14748198|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748199|NCT00610584|Cetirizine|cetirizine|mesh-list
14748200|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14748201|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14748202|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14748203|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
14927720|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14927721|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927722|NCT01418586|Alfuzosin|alfuzosin|mesh-list
14927723|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14927724|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14927725|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14927726|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
14927727|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927728|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927729|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927730|NCT01418586|Urological Agents|urological agents|mesh-ancestor
14430920|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14430921|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
14430922|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748204|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
14430923|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430924|NCT01771627|Nicotine|nicotine|mesh-list
14748205|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927731|NCT01418599|Alfuzosin|alfuzosin|mesh-list
14927732|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14927733|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14430925|NCT01771627|Varenicline|varenicline|mesh-list
14430926|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14430927|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
14430928|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430929|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430930|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14430931|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14430932|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
14430933|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430934|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430935|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14430936|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14430937|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430938|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
14430939|NCT01771952|Hylan|hylan|mesh-list
14430940|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14430941|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
14430942|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430943|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
14430944|NCT01771952|Protective Agents|protective agents|mesh-ancestor
14430945|NCT01772134|Fluticasone|fluticasone|mesh-list
14430946|NCT01772134|Xhance|xhance|mesh-list
14430947|NCT01772134|Bromides|bromides|mesh-list
14430948|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14430949|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430950|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14430951|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
14430952|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430953|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430954|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14430955|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430956|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430957|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14430958|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14430959|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14430960|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14430961|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
14430962|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430963|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430964|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
14430965|NCT01772147|Fluticasone|fluticasone|mesh-list
14430966|NCT01772147|Xhance|xhance|mesh-list
14748206|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748207|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748208|NCT00610610|Paroxetine|paroxetine|mesh-list
14748209|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14748210|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14748211|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14748212|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748213|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748214|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
14748215|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748216|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14748217|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
14748218|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14748219|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14748220|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14748221|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748222|NCT00610623|Azithromycin|azithromycin|mesh-list
14927734|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14927735|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
14430967|NCT01772147|Bromides|bromides|mesh-list
14430968|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14430969|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430970|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14430971|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
14748223|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14748224|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748225|NCT00610792|Doxorubicin|doxorubicin|mesh-list
14748226|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14748227|NCT00610792|Bortezomib|bortezomib|mesh-list
14748228|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14748229|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748230|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14430972|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430973|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14430974|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14430975|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430976|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430977|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14430978|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14430979|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14430980|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14430981|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
14430982|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748231|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14748232|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748233|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748234|NCT00610818|Mitogens|mitogens|mesh-list
14748235|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
14748236|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748237|NCT00610870|Atorvastatin|atorvastatin|mesh-list
14748238|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14748239|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14748240|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
14748241|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748242|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14748243|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14748244|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748245|NCT00610909|Paroxetine|paroxetine|mesh-list
14748246|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14748247|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14748248|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14748249|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748250|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14430983|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430984|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
14430985|NCT01772368|Fluticasone|fluticasone|mesh-list
14430986|NCT01772368|Xhance|xhance|mesh-list
14430987|NCT01772368|Albuterol|albuterol|mesh-list
14430988|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14430989|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14430990|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
14430991|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14430992|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14430993|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
14430994|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14430995|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748251|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
14748252|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748253|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14748254|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
14748255|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14748256|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14748257|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14748258|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753575|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753576|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14753577|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14753578|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14753579|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927736|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927737|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14430996|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14430997|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
14430998|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14430999|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14431000|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14431001|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14431002|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
14431003|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431004|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431005|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
14431006|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14431007|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
14431008|NCT01772368|Hormones|hormones|mesh-ancestor
14431009|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431010|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
14431011|NCT01772537|Propofol|propofol|mesh-list
14431012|NCT01772537|Isoflurane|isoflurane|mesh-list
14431013|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14431014|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431015|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431016|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14431017|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
14431018|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
14431019|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14431020|NCT01772758|Antioxidants|antioxidants|mesh-list
14431021|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431022|NCT01772758|Protective Agents|protective agents|mesh-ancestor
14431023|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431024|NCT01772823|Tenofovir|tenofovir|mesh-list
14431025|NCT01772823|Emtricitabine|emtricitabine|mesh-list
14431026|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14431027|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
14431028|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431029|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14431030|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14431031|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431032|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431033|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14431034|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14431035|NCT01773070|Ritonavir|ritonavir|mesh-list
14431036|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14431037|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14431038|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14431039|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431040|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431041|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14431042|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14431043|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
14431044|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431045|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14431046|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14431047|NCT01773109|Irinotecan|irinotecan|mesh-list
14431048|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
14431049|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
14431050|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14431051|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431052|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431053|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431054|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14431055|NCT01773122|Dapsone|dapsone|mesh-list
14431056|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431057|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
14431058|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14431059|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14431060|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14431061|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431062|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748259|NCT00610948|Leucovorin|leucovorin|mesh-list
14748260|NCT00610948|Fluorouracil|fluorouracil|mesh-list
14748261|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
14748262|NCT00610948|Everolimus|everolimus|mesh-list
14748263|NCT00610948|Panitumumab|panitumumab|mesh-list
14748264|NCT00610948|Calcium|calcium|mesh-list
14748265|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
14748266|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14748267|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748268|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
14748269|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748270|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14748271|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748272|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748273|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
14748274|NCT00610948|Antidotes|antidotes|mesh-ancestor
14748275|NCT00610948|Protective Agents|protective agents|mesh-ancestor
14748276|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
14748277|NCT00610948|Vitamins|vitamins|mesh-ancestor
14748278|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
14748279|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748280|NCT00611000|Folic Acid|folic acid|mesh-list
14748281|NCT00611000|Hematinics|hematinics|mesh-ancestor
14748282|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
14748283|NCT00611000|Vitamins|vitamins|mesh-ancestor
14748284|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
14748285|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431063|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
14431064|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14431065|NCT01773473|Insulin|insulin|mesh-list
14431066|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14431067|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
14431068|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431069|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431070|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
14748286|NCT00611039|Ritonavir|ritonavir|mesh-list
14748287|NCT00611039|Darunavir|darunavir|mesh-list
14748288|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14431071|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
14431072|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748289|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14748290|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
14431073|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
14431074|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431075|NCT01773954|Aflibercept|aflibercept|mesh-list
14431076|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14431077|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14431078|NCT01773954|Growth Substances|growth substances|mesh-ancestor
14431079|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431080|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
14431081|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927738|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927739|NCT01418599|Urological Agents|urological agents|mesh-ancestor
14927740|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14927741|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14927742|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14927743|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927744|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431082|NCT01773993|Pregabalin|pregabalin|mesh-list
14431083|NCT01773993|Analgesics|analgesics|mesh-ancestor
14431084|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
14431085|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431086|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431087|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
14431088|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14431089|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431090|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431091|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14431092|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14431093|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14431094|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431095|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14431096|NCT01774149|Diazepam|diazepam|mesh-list
14431097|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14431098|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
14431099|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
14431100|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
14431101|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431102|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431103|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14431104|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14431105|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431106|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14431107|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14431108|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14431109|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14431110|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14431111|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14431112|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
14431113|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
14431114|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
14431115|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
14431116|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431117|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431118|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
14431119|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14431120|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431121|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431122|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431123|NCT01774305|Analgesics|analgesics|mesh-ancestor
14431124|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
14431125|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431126|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14431127|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14431128|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14431129|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
14431130|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431131|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431132|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14431133|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14431134|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14431135|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431136|NCT01774604|Indomethacin|indomethacin|mesh-list
14431137|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14431138|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431139|NCT01774604|Analgesics|analgesics|mesh-ancestor
14431140|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
14431141|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431142|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431143|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431144|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431145|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
14431146|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
14431147|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14431148|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14431149|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431150|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431151|NCT01774786|Fluorouracil|fluorouracil|mesh-list
14431152|NCT01774786|Capecitabine|capecitabine|mesh-list
14431153|NCT01774786|Trastuzumab|trastuzumab|mesh-list
14431154|NCT01774786|Pertuzumab|pertuzumab|mesh-list
14431155|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431156|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
14431157|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431158|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431159|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431160|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
14431161|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431162|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431163|NCT01774851|Paclitaxel|paclitaxel|mesh-list
14431164|NCT01774851|Trastuzumab|trastuzumab|mesh-list
14431165|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14431166|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431167|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
14431168|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
14431169|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
14431170|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431171|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431172|NCT01774903|Fentanyl|fentanyl|mesh-list
14431173|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14431174|NCT01774903|Narcotics|narcotics|mesh-ancestor
14431175|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431176|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431177|NCT01774903|Analgesics|analgesics|mesh-ancestor
14431178|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
14431179|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431180|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14431181|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14431182|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
14431183|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
14431184|NCT01774929|Fentanyl|fentanyl|mesh-list
14431185|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14431186|NCT01774929|Narcotics|narcotics|mesh-ancestor
14431187|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431188|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431189|NCT01774929|Analgesics|analgesics|mesh-ancestor
14431190|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
14431191|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431192|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14431193|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14431194|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
14431195|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
14431196|NCT01774968|Insulin|insulin|mesh-list
14431197|NCT01774968|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14431198|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431199|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431200|NCT01775124|Ranibizumab|ranibizumab|mesh-list
14431201|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14431202|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14431203|NCT01775124|Growth Substances|growth substances|mesh-ancestor
14431204|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431205|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
14431206|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431207|NCT01775189|Naltrexone|naltrexone|mesh-list
14431208|NCT01775189|Oxycodone|oxycodone|mesh-list
14431209|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14431210|NCT01775189|Narcotics|narcotics|mesh-ancestor
14431211|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431212|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431213|NCT01775189|Analgesics|analgesics|mesh-ancestor
14431214|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
14431215|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431216|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14431217|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14431218|NCT01775501|Leucovorin|leucovorin|mesh-list
14431219|NCT01775501|Fluorouracil|fluorouracil|mesh-list
14431220|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
14431221|NCT01775501|Sorafenib|sorafenib|mesh-list
14431222|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
14431223|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431224|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431225|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431226|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431227|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
14431228|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431229|NCT01775501|Antidotes|antidotes|mesh-ancestor
14431230|NCT01775501|Protective Agents|protective agents|mesh-ancestor
14748291|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748292|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431231|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
14431232|NCT01775501|Vitamins|vitamins|mesh-ancestor
14431233|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
14927745|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927746|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927747|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14927748|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
14927749|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14927750|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14927751|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14927752|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14927753|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927754|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927755|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927756|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927757|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14927758|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
14927759|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14927760|NCT01418651|Milnacipran|milnacipran|mesh-list
14927761|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14927762|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14927763|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927764|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927765|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927766|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927767|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14927768|NCT01418651|Analgesics|analgesics|mesh-ancestor
14927769|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
14927770|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927771|NCT01418729|Pravastatin|pravastatin|mesh-list
14927772|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14927773|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14927774|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
14927775|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748293|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14748294|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14748295|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
14748296|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748297|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14748298|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14748299|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
14927776|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14927777|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14927778|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431234|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14431235|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431236|NCT01775787|Menthol|menthol|mesh-list
14431237|NCT01775787|Nicotine|nicotine|mesh-list
14431238|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14431239|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
14431240|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431241|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431242|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14431243|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14431244|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
14431245|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431246|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431247|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
14431248|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
14468519|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468520|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14468521|NCT02281760|Protective Agents|protective agents|mesh-ancestor
14468522|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748300|NCT05331664|Polymyxins|polymyxins|mesh-list
14431249|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14431250|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
14431251|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14431252|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431253|NCT01775865|Analgesics|analgesics|mesh-ancestor
14431254|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
14431255|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431256|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927779|NCT01418742|Doxycycline|doxycycline|mesh-list
14927780|NCT01418742|Panitumumab|panitumumab|mesh-list
14927781|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14927782|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927783|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
14927784|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14927785|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14927786|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431257|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431258|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431259|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14431260|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431261|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431262|NCT01776008|Anastrozole|anastrozole|mesh-list
14431263|NCT01776008|Goserelin|goserelin|mesh-list
14431264|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14431265|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431266|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14431267|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14431268|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431269|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431270|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14431271|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
14431272|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431273|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431274|NCT01776424|Aspirin|aspirin|mesh-list
14431275|NCT01776424|Pantoprazole|pantoprazole|mesh-list
14431276|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
14431277|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14431278|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431279|NCT01776424|Analgesics|analgesics|mesh-ancestor
14431280|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
14431281|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431282|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431283|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431284|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431285|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14431286|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14431287|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431288|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14431289|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14431290|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431291|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
14431292|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14431293|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
14927787|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431294|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14431295|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
14431296|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
14431297|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14431298|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14431299|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14431300|NCT01777139|Ezogabine|ezogabine|mesh-list
14431301|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
14431302|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431303|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431304|NCT01777152|Prednisone|prednisone|mesh-list
14431305|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
14431306|NCT01777152|Doxorubicin|doxorubicin|mesh-list
14431307|NCT01777152|Vincristine|vincristine|mesh-list
14431308|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14431309|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431310|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
14431311|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431312|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431313|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14431314|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
14431315|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431316|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431317|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14431318|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14431319|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14431320|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14431321|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431322|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431323|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
14431324|NCT01777152|Hormones|hormones|mesh-ancestor
14431325|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431326|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14431327|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14431328|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
14431329|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
14431330|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
14431331|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431332|NCT01777191|Ixekizumab|ixekizumab|mesh-list
14431333|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14431334|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
14431335|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14431336|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14431337|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
14431338|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431339|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431340|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431341|NCT01777217|Urological Agents|urological agents|mesh-ancestor
14431342|NCT01777269|Tamsulosin|tamsulosin|mesh-list
14431343|NCT01777269|Dutasteride|dutasteride|mesh-list
14431344|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14431345|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14431346|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14431347|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
14431348|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431349|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431350|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431351|NCT01777269|Urological Agents|urological agents|mesh-ancestor
14431352|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14431353|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14431354|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431355|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
14431356|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431357|NCT01777282|Biguanides|biguanides|mesh-list
14431358|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14431359|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14431360|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
14431361|NCT01777282|Incretins|incretins|mesh-ancestor
14431362|NCT01777282|Hormones|hormones|mesh-ancestor
14431363|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431364|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431365|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431366|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431367|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431368|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
14431369|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14431370|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
14431371|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431372|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431373|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14431374|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
14431375|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
14431376|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14431377|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
14431378|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431379|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431380|NCT01777412|Bevacizumab|bevacizumab|mesh-list
14431381|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431382|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431383|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14431384|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14431385|NCT01777412|Growth Substances|growth substances|mesh-ancestor
14431386|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431387|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
14431388|NCT01777542|Insulin|insulin|mesh-list
14431389|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14431390|NCT01777542|Mitogens|mitogens|mesh-list
14431391|NCT01777542|Mecasermin|mecasermin|mesh-list
14431392|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431393|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431394|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14927788|NCT01418794|Sirolimus|sirolimus|mesh-list
14927789|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14927790|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431395|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431396|NCT01777542|Growth Substances|growth substances|mesh-ancestor
14431397|NCT01777581|Milnacipran|milnacipran|mesh-list
14431398|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
14431399|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14431400|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14431401|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431402|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927791|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14927792|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927793|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
14927794|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431403|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431404|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431405|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431406|NCT01777581|Analgesics|analgesics|mesh-ancestor
14431407|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
14431408|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431409|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
14431410|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14431411|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
14431412|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14431413|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14431414|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14431415|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431416|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431417|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
14431418|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431419|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431420|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14431421|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431422|NCT01777763|Posaconazole|posaconazole|mesh-list
14431423|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
14431424|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431425|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14431426|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14431427|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14431428|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14927795|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
14431429|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14431430|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431431|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431432|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14431433|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
14431434|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431435|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431436|NCT01777945|Docetaxel|docetaxel|mesh-list
14431437|NCT01777945|Capecitabine|capecitabine|mesh-list
14927796|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927797|NCT01419041|Crizotinib|crizotinib|mesh-list
14431438|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431439|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14431440|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14431441|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14431442|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431443|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431444|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
14431445|NCT01777997|Tenofovir|tenofovir|mesh-list
14431446|NCT01777997|Emtricitabine|emtricitabine|mesh-list
14431447|NCT01777997|Rilpivirine|rilpivirine|mesh-list
14431448|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
14431449|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431450|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14431451|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14431452|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431453|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431454|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14431455|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14431456|NCT01778010|Cocaine|cocaine|mesh-list
14927798|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927799|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14927800|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927801|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927802|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
14927803|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14927804|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14431457|NCT01778010|Modafinil|modafinil|mesh-list
14431458|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14748301|NCT05331664|Trimethoprim|trimethoprim|mesh-list
14748302|NCT05331664|Prednisolone|prednisolone|mesh-list
14748303|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
14748304|NCT05331664|Triamcinolone|triamcinolone|mesh-list
14748305|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14748306|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14748307|NCT05331664|Atropine|atropine|mesh-list
14431459|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431460|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14927805|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927806|NCT01419119|Vitamins|vitamins|mesh-ancestor
14927807|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
14927808|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927809|NCT01419132|Furosemide|furosemide|mesh-list
14927810|NCT01419132|Diuretics|diuretics|mesh-list
14927811|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
14927812|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927813|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14431461|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14431462|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14431463|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431464|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
14431465|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
14431466|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431467|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
14431468|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431469|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14431470|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14431471|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14431472|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431473|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
14431474|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927814|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927815|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927816|NCT01419262|Vitamin D|vitamin d|mesh-list
14927817|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
14431475|NCT01778049|Empagliflozin|empagliflozin|mesh-list
14431476|NCT01778049|Linagliptin|linagliptin|mesh-list
14431477|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14431478|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431479|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431480|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431481|NCT01778049|Incretins|incretins|mesh-ancestor
14431482|NCT01778049|Hormones|hormones|mesh-ancestor
14431483|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431484|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14431485|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
14431486|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431487|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
14431488|NCT01778465|Salicylates|salicylates|mesh-list
14431489|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14431490|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431491|NCT01778465|Analgesics|analgesics|mesh-ancestor
14431492|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
14431493|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431494|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431495|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431496|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431497|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14431498|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431499|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431500|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431501|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
14431502|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
14431503|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
14431504|NCT01778634|Azithromycin|azithromycin|mesh-list
14431505|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14431506|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431507|NCT01778985|Estrogens|estrogens|mesh-list
14431508|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14431509|NCT01778985|Hormones|hormones|mesh-ancestor
14431510|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431511|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431512|NCT01779167|Thalidomide|thalidomide|mesh-list
14431513|NCT01779167|Rituximab|rituximab|mesh-list
14431514|NCT01779167|Lenalidomide|lenalidomide|mesh-list
14431515|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431516|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431517|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
14927818|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
14927819|NCT01419262|Vitamins|vitamins|mesh-list
14431518|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431519|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431520|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14431521|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14431522|NCT01779167|Growth Substances|growth substances|mesh-ancestor
14431523|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14431524|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431525|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
14431526|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14431527|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431528|NCT01779375|Metformin|metformin|mesh-list
14431529|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
14431530|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431531|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431532|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14431533|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14431534|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431535|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431536|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
14431537|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431538|NCT01779869|Regadenoson|regadenoson|mesh-list
14431539|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14431540|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14431541|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
14431542|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
14431543|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431544|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431545|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431546|NCT01780324|Lidocaine|lidocaine|mesh-list
14431547|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
14431548|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
14431549|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431550|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431551|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
14431552|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431553|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14431554|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14431555|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14431556|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431557|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431558|NCT01780337|Oxytocin|oxytocin|mesh-list
14431559|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
14431560|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14431561|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431562|NCT01780389|Milnacipran|milnacipran|mesh-list
14431563|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
14431564|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14431565|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14431566|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431567|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431568|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431569|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431570|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431571|NCT01780389|Analgesics|analgesics|mesh-ancestor
14431572|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
14431573|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431574|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
14431575|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14431576|NCT01780454|Rituximab|rituximab|mesh-list
14431577|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431578|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431579|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
14431580|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431581|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431582|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14431583|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14431584|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14431585|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
14431586|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431587|NCT01780545|Docetaxel|docetaxel|mesh-list
14431588|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431589|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
14431590|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
14431591|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
14431592|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431593|NCT01780662|Gemcitabine|gemcitabine|mesh-list
14431594|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14431595|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14431596|NCT01780662|Antibodies|antibodies|mesh-list
14431597|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
14431598|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14431599|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
14431600|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
14431601|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431602|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431603|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
14431604|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431605|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431606|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
14431607|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431608|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431609|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431610|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
14431611|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14431612|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14431613|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
14431614|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431615|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14431616|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14431617|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431618|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431619|NCT01780935|Ranibizumab|ranibizumab|mesh-list
14431620|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14431621|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14431622|NCT01780935|Growth Substances|growth substances|mesh-ancestor
14431623|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431624|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
14431625|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431626|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
14431627|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
14431628|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431629|NCT01780974|Protective Agents|protective agents|mesh-ancestor
14431630|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431631|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
14431632|NCT01780974|Vitamins|vitamins|mesh-ancestor
14431633|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
14431634|NCT01780987|Heparin|heparin|mesh-list
14431635|NCT01780987|Calcium heparin|calcium heparin|mesh-list
14431636|NCT01780987|Warfarin|warfarin|mesh-list
14431637|NCT01780987|Apixaban|apixaban|mesh-list
14431638|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
14431639|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14431640|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14431641|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431642|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14431643|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
14431644|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14431645|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
14431646|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431647|NCT01781169|Vitamin D|vitamin d|mesh-list
14431648|NCT01781169|Vitamins|vitamins|mesh-ancestor
14431649|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
14431650|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431651|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14431652|NCT01781234|Insulin|insulin|mesh-list
14431653|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431654|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431655|NCT01781403|Capecitabine|capecitabine|mesh-list
14431656|NCT01781403|Temozolomide|temozolomide|mesh-list
14431657|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431658|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
14431659|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431660|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431661|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14431662|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
14431663|NCT01781468|Modafinil|modafinil|mesh-list
14431664|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14431665|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431666|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14431667|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14431668|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14431669|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431670|NCT01781611|Aspirin|aspirin|mesh-list
14431671|NCT01781611|Dipyridamole|dipyridamole|mesh-list
14431672|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14431673|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431674|NCT01781611|Analgesics|analgesics|mesh-ancestor
14431675|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
14431676|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431677|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431678|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431679|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431680|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14431681|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14431682|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431683|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14431684|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14431685|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431686|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
14431687|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14431688|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
14431689|NCT01781806|Tenofovir|tenofovir|mesh-list
14431690|NCT01781806|Emtricitabine|emtricitabine|mesh-list
14431691|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
14431692|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431693|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14431694|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14431695|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431696|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431697|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14431698|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14431699|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
14431700|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431701|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14431702|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431703|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431704|NCT01782131|Voriconazole|voriconazole|mesh-list
14431705|NCT01782131|Posaconazole|posaconazole|mesh-list
14431706|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
14431707|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431708|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14431709|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14431710|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431711|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431712|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14431713|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
14431714|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431715|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431716|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14431717|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14431718|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14431719|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14431720|NCT01782222|Rotigotine|rotigotine|mesh-list
14431721|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
14431722|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
14431723|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431724|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431725|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431726|NCT01782495|Ritonavir|ritonavir|mesh-list
14431727|NCT01782495|Ribavirin|ribavirin|mesh-list
14431728|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14431729|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14431730|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
14431731|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431732|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431733|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14927820|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
14431734|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14431735|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
14431736|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431737|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14431738|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14431739|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
14468523|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14468524|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
14468525|NCT02281773|BI 409306|bi 409306|mesh-list
14468526|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14468527|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468528|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468529|NCT02282293|Piperaquine|piperaquine|mesh-list
14468530|NCT02282293|Trimethoprim|trimethoprim|mesh-list
14468531|NCT02282293|Artenimol|artenimol|mesh-list
14468532|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
14468533|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
14468534|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14468535|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14468536|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468537|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14468538|NCT02282293|Renal Agents|renal agents|mesh-ancestor
14468539|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14468540|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468541|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468542|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14468543|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14468544|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14468545|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
14431740|NCT01782690|Gemcitabine|gemcitabine|mesh-list
14431741|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14431742|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431743|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
14431744|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431745|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431746|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
14431747|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431748|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431749|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431750|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
14431751|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431752|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14431753|NCT01782742|Bexarotene|bexarotene|mesh-list
14431754|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431755|NCT01782859|Prednisone|prednisone|mesh-list
14431756|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
14431757|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14431758|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14431759|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14431760|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431761|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
14431762|NCT01782859|Hormones|hormones|mesh-ancestor
14431763|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431764|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431765|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14431766|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431767|NCT01782872|Ropivacaine|ropivacaine|mesh-list
14748308|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14748309|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14748310|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748311|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
14748312|NCT05331664|Hormones|hormones|mesh-ancestor
14748313|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748314|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748315|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14748316|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748317|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
14748318|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748319|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14748320|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748321|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14748322|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14748323|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748324|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431768|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
14431769|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
14431770|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14431771|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431772|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
14431773|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431774|NCT01782885|Acetaminophen|acetaminophen|mesh-list
14431775|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431776|NCT01782885|Analgesics|analgesics|mesh-ancestor
14431777|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
14431778|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431779|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431780|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
14431781|NCT01782898|Esmolol|esmolol|mesh-list
14431782|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14431783|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14748325|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14748326|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
14748327|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14748328|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14748329|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14431784|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14431785|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
14431786|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431787|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431788|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431789|NCT01782963|Dexamethasone|dexamethasone|mesh-list
14431790|NCT01782963|Lenalidomide|lenalidomide|mesh-list
14431791|NCT01782963|Bortezomib|bortezomib|mesh-list
14431792|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431793|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
14431794|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
14431795|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431796|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431797|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14431798|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
14748330|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14748331|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748332|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
14748333|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14748334|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14748335|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14748336|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14748337|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
14748338|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
14748339|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
14748340|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14748341|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14748342|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
14748343|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748344|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14748345|NCT05331664|Renal Agents|renal agents|mesh-ancestor
14748346|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
14748347|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14748348|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14431799|NCT01782963|Hormones|hormones|mesh-ancestor
14431800|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431801|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14431802|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431803|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
14431804|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14431805|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14431806|NCT01782963|Growth Substances|growth substances|mesh-ancestor
14431807|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
14431808|NCT01783054|Gemcitabine|gemcitabine|mesh-list
14431809|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431810|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
14431811|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431812|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431813|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
14431814|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431815|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431816|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431817|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
14431818|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431819|NCT01783236|Acetaminophen|acetaminophen|mesh-list
14431820|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14431821|NCT01783236|Analgesics|analgesics|mesh-ancestor
14431822|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
14431823|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431824|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431825|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
14748349|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14431826|NCT01783444|Capecitabine|capecitabine|mesh-list
14431827|NCT01783444|Everolimus|everolimus|mesh-list
14431828|NCT01783444|Exemestane|exemestane|mesh-list
14431829|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14431830|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
14431831|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431832|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431833|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431834|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
14431835|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431836|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14431837|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14431838|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431839|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14431840|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
14748350|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14431841|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431842|NCT01783470|Mirabegron|mirabegron|mesh-list
14431843|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
14431844|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
14431845|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14431846|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14431847|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748351|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14748352|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14431848|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431849|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431850|NCT01783470|Urological Agents|urological agents|mesh-ancestor
14431851|NCT01783548|Beclomethasone|beclomethasone|mesh-list
14431852|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431853|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
14431854|NCT01783548|Hormones|hormones|mesh-ancestor
14431855|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431856|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431857|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14431858|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
14431859|NCT01783561|Caffeine|caffeine|mesh-list
14431860|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
14431861|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431862|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14431863|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431864|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14431865|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431866|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14431867|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14431868|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
14431869|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431870|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
14431871|NCT01783574|Testosterone|testosterone|mesh-list
14431872|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
14431873|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
14431874|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14431875|NCT01783574|Androgens|androgens|mesh-ancestor
14431876|NCT01783574|Hormones|hormones|mesh-ancestor
14431877|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431878|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431879|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14431880|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431881|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
14431882|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
14431883|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
14431884|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431885|NCT01783821|Budesonide|budesonide|mesh-list
14431886|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
14431887|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431888|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14431889|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
14431890|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431891|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431892|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14431893|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
14431894|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
14431895|NCT01783821|Hormones|hormones|mesh-ancestor
14431896|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431897|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14431898|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14431899|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14431900|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
14431901|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431902|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431903|NCT01783847|Prednisolone|prednisolone|mesh-list
14431904|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14431905|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
14431906|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14431907|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
14431908|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
14431909|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14431910|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
14431911|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14431912|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
14431913|NCT01783847|Hormones|hormones|mesh-ancestor
14431914|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14431915|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431916|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14431917|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431918|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
14431919|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
14431920|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431921|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14431922|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14431923|NCT01783847|Protective Agents|protective agents|mesh-ancestor
14431924|NCT01783847|Hematinics|hematinics|mesh-ancestor
14431925|NCT01783860|Azithromycin|azithromycin|mesh-list
14431926|NCT01783860|Doxycycline|doxycycline|mesh-list
14431927|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14431928|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431929|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
14431930|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14431931|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14431932|NCT01783886|Aflibercept|aflibercept|mesh-list
14748353|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
14748354|NCT05331651|Tropisetron|tropisetron|mesh-list
14748355|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14748356|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14748357|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14748358|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
14748359|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431933|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14431934|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14431935|NCT01783886|Growth Substances|growth substances|mesh-ancestor
14431936|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431937|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
14431938|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431939|NCT01783912|Nicotine|nicotine|mesh-list
14431940|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14431941|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
14431942|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431943|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431944|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14431945|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14431946|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
14431947|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14431948|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431949|NCT01783938|Nivolumab|nivolumab|mesh-list
14431950|NCT01783938|Ipilimumab|ipilimumab|mesh-list
14431951|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14431952|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431953|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14431954|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431955|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
14431956|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431957|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
14431958|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431959|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431960|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14431961|NCT01784029|Vitamin D|vitamin d|mesh-list
14431962|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
14431963|NCT01784029|Vitamins|vitamins|mesh-ancestor
14431964|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
14431965|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431966|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14431967|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14431968|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
14431969|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14431970|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14431971|NCT01784419|Ivacaftor|ivacaftor|mesh-list
14431972|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14748360|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748361|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748362|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
14748363|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
14748364|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14431973|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431974|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431975|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
14431976|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
14431977|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14431978|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14431979|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431980|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14431981|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431982|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14431983|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14431984|NCT01784666|Isradipine|isradipine|mesh-list
14431985|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14431986|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14431987|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14431988|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14431989|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14431990|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748365|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14431991|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
14431992|NCT01784770|Azithromycin|azithromycin|mesh-list
14431993|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14431994|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14431995|NCT01784861|Everolimus|everolimus|mesh-list
14431996|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14431997|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14431998|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
14431999|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432000|NCT01784965|Liraglutide|liraglutide|mesh-list
14432001|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432002|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432003|NCT01784965|Incretins|incretins|mesh-ancestor
14432004|NCT01784965|Hormones|hormones|mesh-ancestor
14432005|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432006|NCT01785095|Hormones|hormones|mesh-list
14432007|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14432008|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432009|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432010|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
14432011|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14432012|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14432013|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
14432014|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432015|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14432016|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14432017|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432018|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432019|NCT01785186|Pyridoxine|pyridoxine|mesh-list
14432020|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
14432021|NCT01785186|Rifampin|rifampin|mesh-list
14432022|NCT01785186|Isoniazid|isoniazid|mesh-list
14432023|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
14432024|NCT01785186|Ethambutol|ethambutol|mesh-list
14432025|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432026|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432027|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14432028|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14432029|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432030|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432031|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432032|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432033|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14432034|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
14432035|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
14432036|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14432037|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14432038|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14432039|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14432040|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14432041|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14432042|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14432043|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14432044|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14432045|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
14432046|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14432047|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
14432048|NCT01785186|Vitamins|vitamins|mesh-ancestor
14432049|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
14432050|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
14432051|NCT01785459|Bupivacaine|bupivacaine|mesh-list
14432052|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
14432053|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
14432054|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14432055|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432056|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
14432057|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432058|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
14432059|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
14432060|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432061|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14432062|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14432063|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432064|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14432065|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
14432066|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432067|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432068|NCT01785472|Olmesartan|olmesartan|mesh-list
14432069|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14432070|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14432071|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14432072|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14432073|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14927821|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927822|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927823|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14927824|NCT01419340|Donepezil|donepezil|mesh-list
14927825|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14927826|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927827|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927828|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
14927829|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432074|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432075|NCT01785615|Atorvastatin|atorvastatin|mesh-list
14432076|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14432077|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14432078|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
14432079|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432080|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14432081|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14432082|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432083|NCT01785810|Maraviroc|maraviroc|mesh-list
14432084|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14432085|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14432086|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432087|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14432088|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14927830|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927831|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
14927832|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14927833|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14927834|NCT01419353|Estradiol|estradiol|mesh-list
14927835|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14927836|NCT01419353|Estrogens|estrogens|mesh-ancestor
14927837|NCT01419353|Hormones|hormones|mesh-ancestor
14927838|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14927839|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432089|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
14432090|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432091|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14432092|NCT01786109|Dronabinol|dronabinol|mesh-list
14432093|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
14432094|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432095|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432096|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14432097|NCT01786109|Analgesics|analgesics|mesh-ancestor
14432098|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
14432099|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432100|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14432101|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14432102|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432103|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748366|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14748367|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14748368|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
14748369|NCT05331573|Apomorphine|apomorphine|mesh-list
14748370|NCT05331573|Emetics|emetics|mesh-ancestor
14748371|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748372|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
14748373|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748374|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14748375|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
14748376|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
14748377|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748378|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748379|NCT05331521|Vincristine|vincristine|mesh-list
14432104|NCT01786109|Hormones|hormones|mesh-ancestor
14432105|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432106|NCT01786161|Vancomycin|vancomycin|mesh-list
14432107|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432108|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432109|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14432110|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14432111|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432112|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432113|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
14432114|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432115|NCT01786239|Risperidone|risperidone|mesh-list
14432116|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14432117|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
14748380|NCT05331521|Temozolomide|temozolomide|mesh-list
14748381|NCT05331521|Lomustine|lomustine|mesh-list
14748382|NCT05331521|Procarbazine|procarbazine|mesh-list
14748383|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14432118|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432119|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432120|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432121|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14432122|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14432123|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14432124|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432125|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14432126|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
14432127|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14432128|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432129|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748384|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748385|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
14748386|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
14432130|NCT01786343|Decitabine|decitabine|mesh-list
14432131|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14432132|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
14432133|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432134|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432135|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432136|NCT01786551|Eplerenone|eplerenone|mesh-list
14432137|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14432138|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
14432139|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432140|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432141|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14432142|NCT01786551|Diuretics|diuretics|mesh-ancestor
14432143|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
14432144|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14432145|NCT01786603|Rasagiline|rasagiline|mesh-list
14432146|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14432147|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432148|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432149|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14432150|NCT01786603|Protective Agents|protective agents|mesh-ancestor
14432151|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432152|NCT01786668|Tofacitinib|tofacitinib|mesh-list
14432153|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14432154|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432155|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432156|NCT01786707|Metformin|metformin|mesh-list
14432157|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432158|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432159|NCT01786902|Hormones|hormones|mesh-list
14432160|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432161|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432162|NCT01786967|Fesoterodine|fesoterodine|mesh-list
14432163|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14432164|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14432165|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14748387|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
14748388|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748389|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14748390|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
14432166|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432167|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432168|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432169|NCT01786967|Urological Agents|urological agents|mesh-ancestor
14432170|NCT01787006|Fluorouracil|fluorouracil|mesh-list
14432171|NCT01787006|Cetuximab|cetuximab|mesh-list
14432172|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432173|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
14432174|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432175|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14432176|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927840|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14432177|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
14432178|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432179|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14432180|NCT01787032|Ketoconazole|ketoconazole|mesh-list
14432181|NCT01787032|Voriconazole|voriconazole|mesh-list
14432182|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
14432183|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432184|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14432185|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14432186|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432187|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432188|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14432189|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
14432190|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432191|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432192|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14432193|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
14432194|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14432195|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14432196|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
14432197|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432198|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432199|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14432200|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
14432201|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14432202|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14927841|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
14927842|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432203|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14432204|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
14432205|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432206|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432207|NCT01787188|Meloxicam|meloxicam|mesh-list
14432208|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14432209|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14432210|NCT01787188|Analgesics|analgesics|mesh-ancestor
14432211|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
14432212|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432213|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432214|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432215|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432216|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14432217|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14432218|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432219|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432220|NCT01787240|Citalopram|citalopram|mesh-list
14432221|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14432222|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14432223|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432224|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432225|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432226|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
14432227|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432228|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14432229|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
14432230|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432231|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14432232|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
14432233|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432234|NCT01787331|Itraconazole|itraconazole|mesh-list
14432235|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
14748391|NCT05331469|Insulin|insulin|mesh-list
14927843|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14927844|NCT01419366|Donepezil|donepezil|mesh-list
14927845|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14927846|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927847|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927848|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
14748392|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748393|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748394|NCT05331183|Ivacaftor|ivacaftor|mesh-list
14748395|NCT05331183|Elexacaftor|elexacaftor|mesh-list
14748396|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14748397|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14748398|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927849|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14927850|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927851|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
14927852|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
14927853|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927854|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
14927855|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14927856|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14927857|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927858|NCT01419392|Urological Agents|urological agents|mesh-ancestor
14927859|NCT01419405|Pregabalin|pregabalin|mesh-list
14927860|NCT01419405|Remifentanil|remifentanil|mesh-list
14927861|NCT01419405|Analgesics|analgesics|mesh-ancestor
14927862|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
14927863|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927864|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927865|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
14927866|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14927867|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927868|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927869|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14927870|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14927871|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14432236|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432237|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14432238|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14432239|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432240|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432241|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14432242|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
14432243|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432244|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432245|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14432246|NCT01787916|Liraglutide|liraglutide|mesh-list
14432247|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432248|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432249|NCT01787916|Incretins|incretins|mesh-ancestor
14432250|NCT01787916|Hormones|hormones|mesh-ancestor
14432251|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468546|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14468547|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
14468548|NCT02282514|Rituximab|rituximab|mesh-list
14468549|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
14468550|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748399|NCT05331144|Losartan|losartan|mesh-list
14748400|NCT05331144|Amlodipine|amlodipine|mesh-list
14748401|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
14748402|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
14748403|NCT05331144|Giapreza|giapreza|mesh-list
14748404|NCT05331144|Calcium|calcium|mesh-list
14748405|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14748406|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
14748407|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14927872|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468551|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
14748408|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927873|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14927874|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14927875|NCT01419405|Narcotics|narcotics|mesh-ancestor
14927876|NCT01419457|Favipiravir|favipiravir|mesh-list
14927877|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
14927878|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927879|NCT01419548|Paclitaxel|paclitaxel|mesh-list
14927880|NCT01419548|Carboplatin|carboplatin|mesh-list
14927881|NCT01419548|Veliparib|veliparib|mesh-list
14927882|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14927883|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927884|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
14927885|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
14927886|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
14927887|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748409|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14748410|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14927888|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14927889|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927890|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14927891|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927892|NCT01419691|Auranofin|auranofin|mesh-list
14927893|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927894|NCT01419730|Vitamin D|vitamin d|mesh-list
14432252|NCT01788215|Doxycycline|doxycycline|mesh-list
14432253|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432254|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432255|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
14432256|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14432257|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14432258|NCT01788228|Vaccines|vaccines|mesh-list
14432259|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
14927895|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
14927896|NCT01419730|Vitamins|vitamins|mesh-ancestor
14748411|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748412|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
14748413|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14748414|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14748415|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14748416|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14748417|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
14748418|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748419|NCT05331131|Ketamine|ketamine|mesh-list
14748420|NCT05331131|Analgesics|analgesics|mesh-ancestor
14748421|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
14748422|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748423|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748424|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14748425|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14748426|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
14748427|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
14748428|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748429|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14748430|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14748431|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748432|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748433|NCT05331053|Atorvastatin|atorvastatin|mesh-list
14927897|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
14927898|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927899|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927900|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14432260|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432261|NCT01788358|Candesartan|candesartan|mesh-list
14432262|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
14432263|NCT01788358|Nifedipine|nifedipine|mesh-list
14432264|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14432265|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14432266|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14432267|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432268|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14432269|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432270|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14432271|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432272|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
14432273|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
14748434|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14748435|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14748436|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
14748437|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748438|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14748439|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14748440|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748441|NCT05330871|Vaccines|vaccines|mesh-list
14748442|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
14748443|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748444|NCT05330858|Rabeprazole|rabeprazole|mesh-list
14748445|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14748446|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14748447|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14748448|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927901|NCT01419821|Vitamin D|vitamin d|mesh-list
14432274|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14748449|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927902|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
14432275|NCT01788566|Gemcitabine|gemcitabine|mesh-list
14432276|NCT01788566|Necitumumab|necitumumab|mesh-list
14432277|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432278|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14432279|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
14432280|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748450|NCT05330429|Leucovorin|leucovorin|mesh-list
14432281|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
14748451|NCT05330429|Bevacizumab|bevacizumab|mesh-list
14748452|NCT05330429|Magrolimab|magrolimab|mesh-list
14748453|NCT05330429|Fluorouracil|fluorouracil|mesh-list
14748454|NCT05330429|Irinotecan|irinotecan|mesh-list
14432282|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432283|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432284|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432285|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
14432286|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432287|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14432288|NCT01788631|Regadenoson|regadenoson|mesh-list
14432289|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14432290|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14432291|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
14432292|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
14432293|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432294|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927903|NCT01419821|Vitamins|vitamins|mesh-list
14927904|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
14927905|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927906|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14927907|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14927908|NCT01419834|Antibodies|antibodies|mesh-list
14432295|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927909|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14927910|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
14927911|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927912|NCT01419847|Ciclopirox|ciclopirox|mesh-list
14927913|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
14927914|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927915|NCT01419873|Insulin|insulin|mesh-list
14927916|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14927917|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432296|NCT01789047|Topiramate|topiramate|mesh-list
14432297|NCT01789047|Amantadine|amantadine|mesh-list
14432298|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
14432299|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432300|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432301|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14432302|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14432303|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
14432304|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432305|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
14432306|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748455|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748456|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748457|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14748458|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14927918|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748459|NCT05330429|Growth Substances|growth substances|mesh-ancestor
14931139|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14748460|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748461|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
14748462|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
14748463|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748464|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14748465|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748466|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
14748467|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14748468|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14748469|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748470|NCT05330429|Antidotes|antidotes|mesh-ancestor
14748471|NCT05330429|Protective Agents|protective agents|mesh-ancestor
14748472|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
14748473|NCT05330429|Vitamins|vitamins|mesh-ancestor
14748474|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
14748475|NCT05330390|Levetiracetam|levetiracetam|mesh-list
14748476|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
14748477|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
14748478|NCT05330377|Cytarabine|cytarabine|mesh-list
14748479|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
14748480|NCT05330377|Cladribine|cladribine|mesh-list
14432307|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432308|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14432309|NCT01789047|Analgesics|analgesics|mesh-ancestor
14432310|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
14432311|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432312|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
14432313|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432314|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432315|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14432316|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14432317|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748481|NCT05330377|Lenograstim|lenograstim|mesh-list
14748482|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14748483|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
14748484|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748485|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748486|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
14748487|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748488|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748489|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
14748490|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748491|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14748492|NCT05330377|Analgesics|analgesics|mesh-ancestor
14432318|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432319|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432320|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14432321|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14432322|NCT01789255|Cyclosporine|cyclosporine|mesh-list
14432323|NCT01789255|Methotrexate|methotrexate|mesh-list
14432324|NCT01789255|Vorinostat|vorinostat|mesh-list
14432325|NCT01789255|Tacrolimus|tacrolimus|mesh-list
14432326|NCT01789255|Cyclosporins|cyclosporins|mesh-list
14432327|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14432328|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
14432329|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432330|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432331|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14432332|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
14432333|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432334|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432335|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14432336|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432337|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14748493|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
14748494|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432338|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432339|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
14432340|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432341|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14432342|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14432343|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
14748495|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14748496|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14432344|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432345|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14432346|NCT01789281|Everolimus|everolimus|mesh-list
14748497|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748503|NCT05330273|Efavirenz|efavirenz|mesh-list
14748504|NCT05330273|Lumefantrine|lumefantrine|mesh-list
14748505|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14748506|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14748507|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748508|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748509|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
14432347|NCT01789281|Octreotide|octreotide|mesh-list
14432348|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432349|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432350|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
14927919|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14927920|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14927921|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927922|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14927923|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
14927924|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927925|NCT01420094|Aspirin|aspirin|mesh-list
14927926|NCT01420094|Acetaminophen|acetaminophen|mesh-list
14748510|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748511|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14748512|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14748513|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14432351|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927927|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14927928|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14927929|NCT01420094|Analgesics|analgesics|mesh-ancestor
14927930|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
14927931|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14927932|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432352|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432353|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432354|NCT01789320|Triamcinolone|triamcinolone|mesh-list
14432355|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14432356|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14432357|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14432358|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432359|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
14432360|NCT01789320|Hormones|hormones|mesh-ancestor
14432361|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432362|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432363|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432364|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
14927933|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14927934|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14927935|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14927936|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14927937|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927938|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14927939|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14927940|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927941|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
14927942|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
14432365|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432366|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432367|NCT01789606|Ibuprofen|ibuprofen|mesh-list
14748514|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14748515|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14748516|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14748517|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
14748518|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14748519|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14753580|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927943|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14927944|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
14927945|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
14927946|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14927947|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927948|NCT01420250|Bicalutamide|bicalutamide|mesh-list
14927949|NCT01420250|Hormones|hormones|mesh-list
14753581|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14432368|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14927950|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14927951|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
14927952|NCT01420250|Androgens|androgens|mesh-list
14432369|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14432370|NCT01789606|Analgesics|analgesics|mesh-ancestor
14432371|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
14432372|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432373|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432374|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748520|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14927953|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748521|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
14748522|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748523|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14748524|NCT05330130|Hormones|hormones|mesh-ancestor
14748525|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748526|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748527|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
14748528|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14748529|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14748530|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14748531|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14748532|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748533|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
14748534|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748535|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432375|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432376|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14432377|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432378|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432379|NCT01789814|Clopidogrel|clopidogrel|mesh-list
14432380|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14432381|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14432382|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14432383|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14432384|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14748536|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14748537|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432385|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
14432386|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432387|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432388|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432389|NCT01789905|Tigecycline|tigecycline|mesh-list
14748538|NCT05330065|Bevacizumab|bevacizumab|mesh-list
14748539|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748540|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748541|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14748542|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14748543|NCT05330065|Growth Substances|growth substances|mesh-ancestor
14748544|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748545|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
14748546|NCT05330000|Voriconazole|voriconazole|mesh-list
14748547|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
14748548|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432390|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432391|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432392|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14432393|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432394|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432395|NCT01789970|Hydrocodone|hydrocodone|mesh-list
14432396|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14432397|NCT01789970|Narcotics|narcotics|mesh-ancestor
14927954|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927955|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
14927956|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14927957|NCT01420302|Insulin|insulin|mesh-list
14927958|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14432398|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14432399|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432400|NCT01789970|Analgesics|analgesics|mesh-ancestor
14432401|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
14432402|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432403|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
14432404|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
14432405|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14432406|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432407|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748549|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14748550|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14748551|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748552|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748553|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14748554|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
14432408|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432409|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432410|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
14432411|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14432412|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
14432413|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14432414|NCT01790438|Insulin|insulin|mesh-list
14432415|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14432416|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
14432417|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
14432418|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
14432419|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14432420|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432421|NCT01790490|Ketamine|ketamine|mesh-list
14432422|NCT01790490|Lorazepam|lorazepam|mesh-list
14748555|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748556|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748557|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14748558|NCT05329857|Metformin|metformin|mesh-list
14748559|NCT05329857|Vildagliptin|vildagliptin|mesh-list
14748560|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748561|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748562|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14748563|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
14927959|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432423|NCT01790490|Analgesics|analgesics|mesh-ancestor
14432424|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
14748564|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748565|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432425|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432426|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748566|NCT05329844|Vildagliptin|vildagliptin|mesh-list
14748567|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432427|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14432428|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14432429|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
14432430|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
14432431|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14432432|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14432433|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14432434|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432435|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432436|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
14432437|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
14432438|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
14432439|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432440|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14432441|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14432442|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14432443|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432444|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
14432445|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
14432446|NCT01790503|Temozolomide|temozolomide|mesh-list
14432447|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14432448|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
14432449|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432450|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432451|NCT01790516|Cetuximab|cetuximab|mesh-list
14927960|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927961|NCT01420328|Simvastatin|simvastatin|mesh-list
14927962|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14432452|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432453|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14432454|NCT01790568|Methotrexate|methotrexate|mesh-list
14927963|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14927964|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14927965|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
14927966|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14927967|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14927968|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14927969|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927970|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14927971|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14927972|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927973|NCT01420341|Renal Agents|renal agents|mesh-ancestor
14927974|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14927975|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
14927976|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14927977|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14432455|NCT01790568|Vorinostat|vorinostat|mesh-list
14432456|NCT01790568|Tacrolimus|tacrolimus|mesh-list
14927978|NCT01420367|Metronidazole|metronidazole|mesh-list
14927979|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14927980|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14927981|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14927982|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14927983|NCT01420406|Vitamin A|vitamin a|mesh-list
14927984|NCT01420406|Vitamins|vitamins|mesh-ancestor
14927985|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
14927986|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927987|NCT01420471|Triamcinolone|triamcinolone|mesh-list
14927988|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14927989|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14927990|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14927991|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14927992|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
14927993|NCT01420471|Hormones|hormones|mesh-ancestor
14432457|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14432458|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
14432459|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432460|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432461|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14432462|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
14748568|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748569|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14432463|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748570|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
14748571|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927994|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432464|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432465|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
14432466|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432467|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14432468|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748572|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748573|NCT05329766|Leucovorin|leucovorin|mesh-list
14748574|NCT05329766|Fluorouracil|fluorouracil|mesh-list
14748575|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
14748576|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
14748577|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748578|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14748579|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748580|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748581|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
14748582|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748583|NCT05329766|Antidotes|antidotes|mesh-ancestor
14748584|NCT05329766|Protective Agents|protective agents|mesh-ancestor
14748585|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
14748586|NCT05329766|Vitamins|vitamins|mesh-ancestor
14748587|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
14748588|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
14748589|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14748590|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14748591|NCT05329740|Prednisolone|prednisolone|mesh-list
14748592|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
14748593|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14748594|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
14748595|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748596|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
14927995|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14927996|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432469|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
14432470|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432471|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14432472|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14432473|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14432474|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
14432475|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
14432476|NCT01790594|Abatacept|abatacept|mesh-list
14432477|NCT01790594|Tacrolimus|tacrolimus|mesh-list
14432478|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
14432479|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14432480|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432481|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
14432482|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432483|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14432484|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432485|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432486|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14432487|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432488|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14432489|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
14432490|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432491|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432492|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432493|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
14432494|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
14432495|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432496|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432497|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
14432498|NCT01790594|Hormones|hormones|mesh-ancestor
14927997|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
14927998|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14927999|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928000|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
14928001|NCT01420523|Maraviroc|maraviroc|mesh-list
14928002|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14928003|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14928004|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
14928005|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928006|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14432499|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432500|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14432501|NCT01790594|Protective Agents|protective agents|mesh-ancestor
14748597|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
14748598|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928007|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14928008|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432502|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14432503|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432504|NCT01790659|Gentamicins|gentamicins|mesh-list
14432505|NCT01790659|Paromomycin|paromomycin|mesh-list
14432506|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432507|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432508|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14432509|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432510|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432511|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14432512|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14432513|NCT01790685|Dexamethasone|dexamethasone|mesh-list
14432514|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432515|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
14432516|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
14432517|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748599|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748600|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14748601|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
14748602|NCT05329740|Hormones|hormones|mesh-ancestor
14748603|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748604|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14748605|NCT05329740|Protective Agents|protective agents|mesh-ancestor
14748606|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14748607|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748608|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
14748609|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748610|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748611|NCT05329454|Ibuprofen|ibuprofen|mesh-list
14748612|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14748613|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14748614|NCT05329454|Analgesics|analgesics|mesh-ancestor
14748615|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
14748616|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748617|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748618|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748619|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748620|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14432518|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432519|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432520|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
14432521|NCT01790685|Hormones|hormones|mesh-ancestor
14432522|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432523|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432524|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432525|NCT01790828|Factor VIII|factor viii|mesh-list
14432526|NCT01790828|Coagulants|coagulants|mesh-ancestor
14432527|NCT01791153|Prednisone|prednisone|mesh-list
14432528|NCT01791153|Methotrexate|methotrexate|mesh-list
14432529|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432530|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
14432531|NCT01791153|Hormones|hormones|mesh-ancestor
14432532|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432533|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432534|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432535|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432536|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14432537|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
14432538|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432539|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14432540|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
14432541|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432542|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
14432543|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432544|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14432545|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432546|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
14432547|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432548|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14432549|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14432550|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
14432551|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14432552|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14432553|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14432554|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
14432555|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432556|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432557|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14432558|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14748621|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748622|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748623|NCT05329428|Vitamin D|vitamin d|mesh-list
14748624|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
14748625|NCT05329428|Vitamins|vitamins|mesh-list
14748626|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
14748627|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748628|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14432559|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14928009|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928010|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14928011|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14432560|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432561|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432562|NCT01791465|Exenatide|exenatide|mesh-list
14432563|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432564|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432565|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14748629|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14748630|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
14748631|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
14748632|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748633|NCT05327348|Protective Agents|protective agents|mesh-ancestor
14748634|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748635|NCT05327348|Vitamins|vitamins|mesh-ancestor
14748636|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
14748637|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14748638|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14748639|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748640|NCT05321251|Insulin|insulin|mesh-list
14748641|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748642|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748643|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
14748644|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14748645|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14748646|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748647|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
14748648|NCT05321199|Coagulants|coagulants|mesh-ancestor
14748649|NCT05320731|Lidocaine|lidocaine|mesh-list
14748650|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
14748651|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
14928012|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14928013|NCT01420575|Olanzapine|olanzapine|mesh-list
14928014|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
14928015|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
14928016|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928017|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748652|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748653|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748654|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
14748655|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748656|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14748657|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14748658|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14748659|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14748660|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748661|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
14748662|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14928018|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928019|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14928020|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14928021|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748663|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748664|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748665|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14748666|NCT05320705|Analgesics|analgesics|mesh-ancestor
14748667|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
14432566|NCT01791465|Incretins|incretins|mesh-ancestor
14432567|NCT01791465|Hormones|hormones|mesh-ancestor
14432568|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432569|NCT01791491|Abatacept|abatacept|mesh-list
14432570|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14748668|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748669|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14748670|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14748671|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14748672|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928022|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14928023|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14928024|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14432571|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748673|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748674|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748675|NCT05310968|Aspirin|aspirin|mesh-list
14748676|NCT05310968|Tirofiban|tirofiban|mesh-list
14748677|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14748678|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14748679|NCT05310968|Analgesics|analgesics|mesh-ancestor
14748680|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
14748681|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432572|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432573|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432574|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
14432575|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432576|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432577|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14432578|NCT01791803|Nicotine|nicotine|mesh-list
14432579|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14432580|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
14432581|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432582|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432583|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14432584|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14748682|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748683|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748684|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748685|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14748686|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14748687|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748688|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14748689|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14748690|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748691|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
14748692|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
14748693|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748694|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
14748695|NCT05308901|Lenvatinib|lenvatinib|mesh-list
14748696|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748697|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748698|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14748699|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748700|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748701|NCT05301322|Vaccines|vaccines|mesh-list
14748702|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
14748703|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753582|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753583|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753584|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
14753585|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753586|NCT05091567|Carboplatin|carboplatin|mesh-list
14753587|NCT05091567|Etoposide|etoposide|mesh-list
14432585|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
14432586|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432587|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432588|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
14432589|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432590|NCT01791972|Albuterol|albuterol|mesh-list
14432591|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14432592|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
14432593|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432594|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432595|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14432596|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
14432597|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
14432598|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432599|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14432600|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14432601|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14432602|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
14432603|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753588|NCT05091567|Atezolizumab|atezolizumab|mesh-list
14432604|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432605|NCT01792115|Vitamins|vitamins|mesh-list
14432606|NCT01792115|Vitamin E|vitamin e|mesh-list
14432607|NCT01792115|Tocopherols|tocopherols|mesh-list
14432608|NCT01792115|Tocotrienols|tocotrienols|mesh-list
14432609|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
14432610|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
14432611|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432612|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
14432613|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432614|NCT01792115|Protective Agents|protective agents|mesh-ancestor
14432615|NCT01792284|Insulin|insulin|mesh-list
14432616|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14432617|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
14432618|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432619|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432620|NCT01792518|Linagliptin|linagliptin|mesh-list
14432621|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432622|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432623|NCT01792518|Incretins|incretins|mesh-ancestor
14432624|NCT01792518|Hormones|hormones|mesh-ancestor
14432625|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432626|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14432627|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
14432628|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748704|NCT05291403|Erythromycin|erythromycin|mesh-list
14748705|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
14748706|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14748707|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
14748708|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14748709|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748710|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14748711|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14432629|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432630|NCT01792830|Metformin|metformin|mesh-list
14432631|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
14432632|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14432633|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432634|NCT01793051|Minocycline|minocycline|mesh-list
14432635|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432636|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432637|NCT01793285|Etanercept|etanercept|mesh-list
14432638|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14432639|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14432640|NCT01793285|Analgesics|analgesics|mesh-ancestor
14432641|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
14432642|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432643|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432644|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432645|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748712|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748713|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748714|NCT05281510|Vesatolimod|vesatolimod|mesh-list
14748715|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
14748716|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432646|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432647|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432648|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
14432649|NCT01793688|Ampicillin|ampicillin|mesh-list
14432650|NCT01793688|Sulbactam|sulbactam|mesh-list
14432651|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432652|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432653|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14432654|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432655|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432656|NCT01793883|Laninamivir|laninamivir|mesh-list
14432657|NCT01793883|Zanamivir|zanamivir|mesh-list
14432658|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
14432659|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432660|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432661|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432662|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14432663|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14432664|NCT01794039|Dexamethasone|dexamethasone|mesh-list
14748717|NCT05267470|Docetaxel|docetaxel|mesh-list
14748718|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
14748719|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432665|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
14432666|NCT01794039|Lenalidomide|lenalidomide|mesh-list
14432667|NCT01794039|Pomalidomide|pomalidomide|mesh-list
14432668|NCT01794039|Ichthammol|ichthammol|mesh-list
14432669|NCT01794039|BB 1101|bb 1101|mesh-list
14432670|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432671|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
14432672|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
14432673|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432674|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432675|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432676|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
14432677|NCT01794039|Hormones|hormones|mesh-ancestor
14432678|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432679|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432680|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432681|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
14432682|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14432683|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14432684|NCT01794039|Growth Substances|growth substances|mesh-ancestor
14432685|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14432686|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
14432687|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432688|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432689|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
14432690|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14432691|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432692|NCT01794455|Candesartan|candesartan|mesh-list
14432693|NCT01794455|Sertraline|sertraline|mesh-list
14432694|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
14432695|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432696|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14432697|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14432698|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432699|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432700|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432701|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
14432702|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432703|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14432704|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14432705|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14928025|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928026|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928027|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928028|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
14928029|NCT01420666|Acetaminophen|acetaminophen|mesh-list
14928030|NCT01420666|Ibuprofen|ibuprofen|mesh-list
14928031|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14432706|NCT01794689|Morphine|morphine|mesh-list
14432707|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14432708|NCT01794689|Narcotics|narcotics|mesh-ancestor
14432709|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14432710|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432711|NCT01794689|Analgesics|analgesics|mesh-ancestor
14432712|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
14432713|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432714|NCT01794702|Cytarabine|cytarabine|mesh-list
14432715|NCT01794702|Decitabine|decitabine|mesh-list
14748720|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14748721|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14748722|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14748723|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748724|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748725|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
14432716|NCT01794702|Clofarabine|clofarabine|mesh-list
14432717|NCT01794702|Idarubicin|idarubicin|mesh-list
14432718|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14432719|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
14432720|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432721|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432722|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
14432723|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432724|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432725|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
14432726|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432727|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432728|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14432729|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14432730|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14432731|NCT01794741|Fluticasone|fluticasone|mesh-list
14432732|NCT01794741|Xhance|xhance|mesh-list
14432733|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432734|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14432735|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
14432736|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432737|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432738|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14432739|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
14432740|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
14748726|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748727|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748728|NCT05244993|Paclitaxel|paclitaxel|mesh-list
14748729|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14748730|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748731|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14748732|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14748733|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14748734|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928032|NCT01420666|Analgesics|analgesics|mesh-ancestor
14928033|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
14432741|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14432742|NCT01794780|Fluticasone|fluticasone|mesh-list
14432743|NCT01794780|Budesonide|budesonide|mesh-list
14432744|NCT01794780|Theophylline|theophylline|mesh-list
14432745|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
14432746|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
14432747|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14432748|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432749|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14432750|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
14432751|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748735|NCT05244018|Vitamin D|vitamin d|mesh-list
14748736|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
14748737|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
14748738|NCT05244018|Vitamins|vitamins|mesh-list
14748739|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
14928034|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928035|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928036|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
14432752|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432753|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14432754|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
14432755|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
14432756|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14432757|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
14432758|NCT01794780|Hormones|hormones|mesh-ancestor
14432759|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432760|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14432761|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14432762|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14432763|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928037|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928038|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928039|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928040|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14928041|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928042|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928043|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
14928044|NCT01420692|Gliclazide|gliclazide|mesh-list
14432764|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432765|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432766|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
14432767|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14432768|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
14432769|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14432770|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432771|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
14432772|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14432773|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14432774|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
14432775|NCT01794845|Docetaxel|docetaxel|mesh-list
14432776|NCT01794845|Cetuximab|cetuximab|mesh-list
14432777|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432778|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14432779|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14432780|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14432781|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432782|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14432783|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
14748740|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748741|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14748742|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14432784|NCT01795495|Remifentanil|remifentanil|mesh-list
14432785|NCT01795495|Methadone|methadone|mesh-list
14748743|NCT05232929|Risdiplam|risdiplam|mesh-list
14748744|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14748745|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748746|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748747|NCT05223673|Trifluridine|trifluridine|mesh-list
14748748|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
14748749|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432786|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14748750|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
14432787|NCT01795495|Narcotics|narcotics|mesh-ancestor
14432788|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748751|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748752|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
14432789|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432790|NCT01795495|Analgesics|analgesics|mesh-ancestor
14432791|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
14432792|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432793|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
14432794|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14432795|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
14432796|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14432797|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432798|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432799|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14432800|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
14432801|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14432802|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
14432803|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
14432804|NCT01795547|Aripiprazole|aripiprazole|mesh-list
14432805|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14432806|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
14432807|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432808|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14432809|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14432810|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14432811|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748753|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14748754|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14748755|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14748756|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432812|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
14432813|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
14432814|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432815|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432816|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14432817|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14432818|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
14432819|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14432820|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14432821|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14432822|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14432823|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
14432824|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432825|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14432826|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432827|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432828|NCT01795898|Fentanyl|fentanyl|mesh-list
14432829|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14432830|NCT01795898|Narcotics|narcotics|mesh-ancestor
14432831|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14432832|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432833|NCT01795898|Analgesics|analgesics|mesh-ancestor
14432834|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
14432835|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432836|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14432837|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14432838|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
14432839|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
14432840|NCT01795937|Itraconazole|itraconazole|mesh-list
14748757|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748758|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
14748759|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748760|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748761|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14748762|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748763|NCT05214807|Chitosan|chitosan|mesh-list
14748764|NCT05214807|Hylan|hylan|mesh-list
14748765|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14748766|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14748767|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
14748768|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748769|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14748770|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
14748771|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
14748772|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
14748773|NCT05214807|Coagulants|coagulants|mesh-ancestor
14432841|NCT01795937|Atorvastatin|atorvastatin|mesh-list
14432842|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14748774|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
14748775|NCT05214807|Protective Agents|protective agents|mesh-ancestor
14748776|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748777|NCT05212571|Ketamine|ketamine|mesh-list
14748778|NCT05212571|Esketamine|esketamine|mesh-list
14748779|NCT05212571|Analgesics|analgesics|mesh-ancestor
14748780|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
14748781|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748782|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748783|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14748784|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14748785|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
14748786|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
14748787|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748788|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14748789|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14748790|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748791|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748792|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14748793|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14748794|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
14748795|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
14748796|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748797|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
14748798|NCT05188508|Temozolomide|temozolomide|mesh-list
14748799|NCT05188508|Olaparib|olaparib|mesh-list
14748800|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14748801|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748802|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14748803|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
14748804|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748805|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14748806|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748807|NCT05176951|Treprostinil|treprostinil|mesh-list
14748808|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14748809|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14748810|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14748811|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14748812|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
14748813|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748814|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14748815|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14748816|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748817|NCT05150938|Vitamin K|vitamin k|mesh-list
14748818|NCT05150938|Heparin|heparin|mesh-list
14748819|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14432843|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14432844|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14432845|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
14928045|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14928046|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928047|NCT01420822|Fluticasone|fluticasone|mesh-list
14928048|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928049|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14928050|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
14928051|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928052|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432846|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432847|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14432848|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14432849|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928053|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14928054|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
14928055|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
14928056|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14928057|NCT01420900|Tacrine|tacrine|mesh-list
14928058|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14928059|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928060|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928061|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
14432850|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
14432851|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432852|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14928062|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928063|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928064|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14928065|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
14928066|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928067|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
14928068|NCT01420913|Pregabalin|pregabalin|mesh-list
14928069|NCT01420913|Analgesics|analgesics|mesh-ancestor
14928070|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
14928071|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928072|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928073|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
14928074|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14928075|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928076|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928077|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14748820|NCT05150938|Tinzaparin|tinzaparin|mesh-list
14748821|NCT05150938|Dalteparin|dalteparin|mesh-list
14432853|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14432854|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14432855|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
14432856|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432857|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432858|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14432859|NCT01796301|Teriparatide|teriparatide|mesh-list
14432860|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14432861|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432862|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14468552|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468553|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468554|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14468555|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
14468556|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468557|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748822|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
14748823|NCT05150938|Vitamins|vitamins|mesh-ancestor
14748824|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
14748825|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748826|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
14748827|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14748828|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14748829|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748830|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14748831|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
14748832|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14748833|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
14748834|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748835|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14748836|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
14748837|NCT05150938|Coagulants|coagulants|mesh-ancestor
14748838|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
14748839|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
14748840|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748841|NCT05147272|Gemcitabine|gemcitabine|mesh-list
14748842|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14748843|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
14748844|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748845|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748846|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
14748847|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928078|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14928079|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14468558|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14468559|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14468560|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468561|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
14468562|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
14468563|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468564|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14468565|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
14468566|NCT02282514|Hormones|hormones|mesh-ancestor
14468567|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748848|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748849|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432863|NCT01796470|Idelalisib|idelalisib|mesh-list
14432864|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432865|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432866|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432867|NCT01796665|Clindamycin|clindamycin|mesh-list
14432868|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
14432869|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
14432870|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14432871|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432872|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432873|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14432874|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432875|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432876|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
14928080|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928081|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14432877|NCT01796964|Aflibercept|aflibercept|mesh-list
14432878|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14432879|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14432880|NCT01796964|Growth Substances|growth substances|mesh-ancestor
14432881|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432882|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
14432883|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432884|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
14432885|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14432886|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14432887|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14432888|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432889|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432890|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14432891|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432892|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432893|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14432894|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432895|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
14432896|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14748850|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
14748851|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748852|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
14748853|NCT05142254|Tadalafil|tadalafil|mesh-list
14748854|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
14432897|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14432898|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14432899|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432900|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432901|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
14432902|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14432903|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432904|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14432905|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432906|NCT01797120|Everolimus|everolimus|mesh-list
14432907|NCT01797120|Fulvestrant|fulvestrant|mesh-list
14432908|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432909|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432910|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
14432911|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432912|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432913|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14748855|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14748856|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14748857|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748858|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748859|NCT05142254|Urological Agents|urological agents|mesh-ancestor
14928082|NCT01421043|Triazolam|triazolam|mesh-list
14432914|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14432915|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
14432916|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432917|NCT01797302|Vitamin D|vitamin d|mesh-list
14432918|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
14432919|NCT01797302|Vitamins|vitamins|mesh-ancestor
14432920|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
14432921|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432922|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14432923|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14432924|NCT01797432|Triamcinolone|triamcinolone|mesh-list
14432925|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14432926|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14432927|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14432928|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432929|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
14432930|NCT01797432|Hormones|hormones|mesh-ancestor
14432931|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432932|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432933|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432934|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
14432935|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432936|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432937|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14432938|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14432939|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14432940|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
14432941|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432942|NCT01797484|Ranolazine|ranolazine|mesh-list
14432943|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14432944|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14432945|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432946|NCT01797575|Aspirin|aspirin|mesh-list
14432947|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
14432948|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14432949|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14432950|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14432951|NCT01797575|Analgesics|analgesics|mesh-ancestor
14432952|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
14432953|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432954|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432955|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432956|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14432957|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14432958|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14432959|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14432960|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14432961|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14432962|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14432963|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
14432964|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
14432965|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432966|NCT01797575|Expectorants|expectorants|mesh-ancestor
14432967|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14432968|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14432969|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
14432970|NCT01797575|Protective Agents|protective agents|mesh-ancestor
14432971|NCT01797575|Antidotes|antidotes|mesh-ancestor
14432972|NCT01797822|Dexamethasone|dexamethasone|mesh-list
14432973|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
14432974|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14432975|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
14432976|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
14432977|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14432978|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432979|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14432980|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
14748860|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748861|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
14748862|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14432981|NCT01797822|Hormones|hormones|mesh-ancestor
14432982|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14432983|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14432984|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14432985|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14432986|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14432987|NCT01797965|Daclizumab|daclizumab|mesh-list
14432988|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14432989|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
14432990|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432991|NCT01798056|Vaccines|vaccines|mesh-list
14432992|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
14432993|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14432994|NCT01798225|Doxycycline|doxycycline|mesh-list
14432995|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14432996|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14432997|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
14432998|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14432999|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14433000|NCT01798264|Exenatide|exenatide|mesh-list
14433001|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14433002|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433003|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14433004|NCT01798264|Incretins|incretins|mesh-ancestor
14433005|NCT01798264|Hormones|hormones|mesh-ancestor
14433006|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433007|NCT01798316|Acetaminophen|acetaminophen|mesh-list
14433008|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433009|NCT01798316|Analgesics|analgesics|mesh-ancestor
14433010|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
14433011|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748863|NCT05137717|Maribavir|maribavir|mesh-list
14433012|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433013|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
14433014|NCT01798394|Progesterone|progesterone|mesh-list
14433015|NCT01798394|Progestins|progestins|mesh-ancestor
14433016|NCT01798394|Hormones|hormones|mesh-ancestor
14433017|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433018|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433019|NCT01798485|Docetaxel|docetaxel|mesh-list
14433020|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433021|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
14433022|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
14433023|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
14433024|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433025|NCT01798550|Enoxaparin|enoxaparin|mesh-list
14433026|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
14433027|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14433028|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14433029|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433030|NCT01798706|Lixisenatide|lixisenatide|mesh-list
14433031|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14433032|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433033|NCT01798992|Metoprolol|metoprolol|mesh-list
14433034|NCT01798992|Carvedilol|carvedilol|mesh-list
14433035|NCT01798992|Doxazosin|doxazosin|mesh-list
14433036|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14433037|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14433038|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
14433039|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
14433040|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433041|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433042|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14433043|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14433044|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14433045|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
14433046|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433047|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433048|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
14433049|NCT01798992|Protective Agents|protective agents|mesh-ancestor
14433050|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14748864|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
14748865|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748866|NCT05132595|Ketorolac|ketorolac|mesh-list
14748867|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14748868|NCT05132595|Esketamine|esketamine|mesh-list
14748869|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14748870|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14748871|NCT05132595|Analgesics|analgesics|mesh-ancestor
14748872|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
14748873|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748874|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748875|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748876|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748877|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14433051|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433052|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14433053|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
14433054|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14433055|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14433056|NCT01799213|Meloxicam|meloxicam|mesh-list
14433057|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433058|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433059|NCT01799213|Analgesics|analgesics|mesh-ancestor
14433060|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
14433061|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433062|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433063|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433064|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433065|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14433066|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14433067|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433068|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433069|NCT01799226|Triclosan|triclosan|mesh-list
14433070|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14433071|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433072|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14433073|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14433074|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
14748878|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748879|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748880|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
14748881|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433075|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433076|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14433077|NCT01799590|Topiramate|topiramate|mesh-list
14433078|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
14748882|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
14748883|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14748884|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
14748885|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748886|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14748887|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748888|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748889|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
14748890|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14748891|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
14433079|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14433080|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748892|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14748893|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
14748894|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748895|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748896|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
14753589|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753590|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14753591|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14753592|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14753593|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753594|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753595|NCT05088980|Lidocaine|lidocaine|mesh-list
14753596|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
14753597|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
14753598|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753599|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753600|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
14753601|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753602|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14753603|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14753604|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14753605|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14753606|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753607|NCT05074355|Azacitidine|azacitidine|mesh-list
14753608|NCT05074355|Venetoclax|venetoclax|mesh-list
14753609|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753610|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
14753611|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753612|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928083|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14928084|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14928085|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14928086|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928087|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928088|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14753613|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433081|NCT01799941|Quinidine|quinidine|mesh-list
14433082|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
14433083|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
14433084|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
14433085|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14748897|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
14748898|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
14748899|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748900|NCT05082909|Probenecid|probenecid|mesh-list
14748901|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
14748902|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
14748903|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748904|NCT05082909|Renal Agents|renal agents|mesh-ancestor
14433086|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14433087|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433088|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433089|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433090|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14433091|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14433092|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928089|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
14928090|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
14928091|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928092|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433093|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14433094|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
14433095|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14433096|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14433097|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433098|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433099|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14433100|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14433101|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
14433102|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14433103|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14433104|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433105|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14433106|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433107|NCT01799993|Amikacin|amikacin|mesh-list
14433108|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14433109|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433110|NCT01800838|Silicon|silicon|mesh-list
14433111|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
14433112|NCT01800838|Trace Elements|trace elements|mesh-ancestor
14433113|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
14433114|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433115|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
14433116|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14433117|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14433118|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433119|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
14433120|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14433121|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14433122|NCT01800877|Phenylephrine|phenylephrine|mesh-list
14433123|NCT01800877|Dopamine|dopamine|mesh-list
14433124|NCT01800877|Vasopressins|vasopressins|mesh-list
14433125|NCT01800877|Epinephrine|epinephrine|mesh-list
14433126|NCT01800877|Norepinephrine|norepinephrine|mesh-list
14433127|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14433128|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14433129|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14433130|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
14433131|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433132|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433133|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433134|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14433135|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14433136|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
14433137|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433138|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14433139|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
14433140|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
14433141|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
14433142|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14433143|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
14433144|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14433145|NCT01800877|Protective Agents|protective agents|mesh-ancestor
14433146|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
14433147|NCT01800877|Coagulants|coagulants|mesh-ancestor
14433148|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14433149|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
14433150|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
14433151|NCT01800968|Liraglutide|liraglutide|mesh-list
14433152|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14433153|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433154|NCT01800968|Incretins|incretins|mesh-ancestor
14433155|NCT01800968|Hormones|hormones|mesh-ancestor
14433156|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433157|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14433158|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433159|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14433160|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433161|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433162|NCT01801124|Bupivacaine|bupivacaine|mesh-list
14748927|NCT05073315|Adalimumab|adalimumab|mesh-list
14748928|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433163|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
14433164|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
14433165|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433166|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433167|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
14433168|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433169|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
14433170|NCT01801280|Pantoprazole|pantoprazole|mesh-list
14433171|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14433172|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433173|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14433174|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
14433175|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14433176|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433177|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433178|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433179|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14433180|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14433181|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14433182|NCT01801436|Bortezomib|bortezomib|mesh-list
14433183|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433184|NCT01801449|Rilonacept|rilonacept|mesh-list
14433185|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433186|NCT01801475|Ondansetron|ondansetron|mesh-list
14433187|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
14433188|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
14748929|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748930|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
14748931|NCT05069935|Fludarabine|fludarabine|mesh-list
14748932|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14748933|NCT05069935|Antibodies|antibodies|mesh-list
14433189|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748934|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
14433190|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433191|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14433192|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
14433193|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14433194|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14433195|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
14748935|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14748936|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14748937|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
14748938|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748939|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14748940|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14748941|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
14748942|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748943|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14748944|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14928093|NCT01421069|Etanercept|etanercept|mesh-list
14928094|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928095|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14928096|NCT01421069|Analgesics|analgesics|mesh-ancestor
14928097|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
14928098|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433196|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433197|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433198|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14433199|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14433200|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748945|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14928099|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433201|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433202|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14433203|NCT01801735|Meloxicam|meloxicam|mesh-list
14433204|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433205|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433206|NCT01801735|Analgesics|analgesics|mesh-ancestor
14433207|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
14433208|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433209|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433210|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433211|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433212|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14433213|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14433214|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433215|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433216|NCT01801917|Siponimod|siponimod|mesh-list
14433217|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14433218|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433219|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14433220|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
14433221|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433222|NCT01802073|Vancomycin|vancomycin|mesh-list
14433223|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14433224|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433225|NCT01802216|Minocycline|minocycline|mesh-list
14433226|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14433227|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433228|NCT01802333|Cytarabine|cytarabine|mesh-list
14433229|NCT01802333|Daunorubicin|daunorubicin|mesh-list
14433230|NCT01802333|Vorinostat|vorinostat|mesh-list
14433231|NCT01802333|Idarubicin|idarubicin|mesh-list
14433232|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14433233|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
14433234|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433235|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433236|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
14433237|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433238|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14433239|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
14433240|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433241|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14433242|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14433243|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14433244|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433245|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14433246|NCT01802385|Sertraline|sertraline|mesh-list
14433247|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
14433248|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433249|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14433250|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14433251|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468568|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14433252|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748946|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14748947|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14748948|NCT05069740|Analgesics|analgesics|mesh-ancestor
14748949|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
14748950|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748951|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433253|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433254|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
14433255|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433256|NCT01802437|Fluoxetine|fluoxetine|mesh-list
14433257|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14433258|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14433259|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433260|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433261|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433262|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
14433263|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433264|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14433265|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
14433266|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433267|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14433268|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433269|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433270|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14433271|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14433272|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14433273|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433274|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433275|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
14433276|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433277|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433278|NCT01802580|Fluocinonide|fluocinonide|mesh-list
14433279|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433280|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
14433281|NCT01802580|Hormones|hormones|mesh-ancestor
14433282|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433283|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433284|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14433285|NCT01802775|Aspirin|aspirin|mesh-list
14433286|NCT01802775|Edoxaban|edoxaban|mesh-list
14433287|NCT01802775|Clopidogrel|clopidogrel|mesh-list
14433288|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433289|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433290|NCT01802775|Analgesics|analgesics|mesh-ancestor
14433291|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
14433292|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433293|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433294|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433295|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433296|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14433297|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14433298|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433299|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14433300|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14433301|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753614|NCT05073679|Naltrexone|naltrexone|mesh-list
14433302|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
14433303|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14433304|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14433305|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14433306|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
14433307|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433308|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14433309|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
14433310|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14433311|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
14433312|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
14433313|NCT01802879|Panobinostat|panobinostat|mesh-list
14433314|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433315|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14433316|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433317|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433318|NCT01803074|Ritonavir|ritonavir|mesh-list
14433319|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14433320|NCT01803074|Tenofovir|tenofovir|mesh-list
14433321|NCT01803074|Emtricitabine|emtricitabine|mesh-list
14433322|NCT01803074|BMS-955176|bms-955176|mesh-list
14928100|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928101|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928102|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928103|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14928104|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
14928105|NCT01421121|Vaccines|vaccines|mesh-list
14928106|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
14928107|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928108|NCT01421160|Citric Acid|citric acid|mesh-list
14928109|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
14928110|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
14928111|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14433323|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14928112|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
14928113|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
14928114|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928115|NCT01421173|Gemcitabine|gemcitabine|mesh-list
14433324|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14433325|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
14433326|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433327|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433328|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14433329|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14433330|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
14433331|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14748952|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14748953|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433332|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14433333|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433334|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14433335|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14433336|NCT01803269|Topotecan|topotecan|mesh-list
14433337|NCT01803269|Camptothecin|camptothecin|mesh-list
14433338|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14433339|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14433340|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433341|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433342|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433343|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14748954|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
14748955|NCT05059626|Simvastatin|simvastatin|mesh-list
14748956|NCT05059626|Estrogens|estrogens|mesh-list
14748957|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14433344|NCT01803282|Leucovorin|leucovorin|mesh-list
14433345|NCT01803282|Gemcitabine|gemcitabine|mesh-list
14433346|NCT01803282|Paclitaxel|paclitaxel|mesh-list
14433347|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14433348|NCT01803282|Bevacizumab|bevacizumab|mesh-list
14433349|NCT01803282|Carboplatin|carboplatin|mesh-list
14748958|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14748959|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
14748960|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748961|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14748962|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14748963|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748964|NCT05059626|Hormones|hormones|mesh-ancestor
14748965|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14748966|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753615|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14433350|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
14433351|NCT01803282|Irinotecan|irinotecan|mesh-list
14433352|NCT01803282|Pemetrexed|pemetrexed|mesh-list
14433353|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14433354|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433355|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
14433356|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
14433357|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
14433358|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433359|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14433360|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14433361|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14433362|NCT01803282|Growth Substances|growth substances|mesh-ancestor
14433363|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433364|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
14433365|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14433366|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
14433367|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
14433368|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433369|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433370|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14433371|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
14433372|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14433373|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14433374|NCT01803282|Antidotes|antidotes|mesh-ancestor
14433375|NCT01803282|Protective Agents|protective agents|mesh-ancestor
14433376|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
14433377|NCT01803282|Vitamins|vitamins|mesh-ancestor
14433378|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
14433379|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14433380|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14468569|NCT02282514|Protective Agents|protective agents|mesh-ancestor
14468570|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14468571|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14468572|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14468573|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14468574|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
14468575|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468576|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468577|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
14928116|NCT01421173|Dexamethasone|dexamethasone|mesh-list
14928117|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
14928118|NCT01421173|Rituximab|rituximab|mesh-list
14433381|NCT01804036|Zolpidem|zolpidem|mesh-list
14928119|NCT01421173|Melphalan|melphalan|mesh-list
14928120|NCT01421173|Busulfan|busulfan|mesh-list
14928121|NCT01421173|Vorinostat|vorinostat|mesh-list
14928122|NCT01421173|BB 1101|bb 1101|mesh-list
14928123|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928124|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
14433382|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14433383|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14433384|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433385|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433386|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14433387|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
14433388|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
14433389|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433390|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433391|NCT01804049|Metformin|metformin|mesh-list
14433392|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14433393|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433394|NCT01804075|Morphine|morphine|mesh-list
14433395|NCT01804075|Methadone|methadone|mesh-list
14433396|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14433397|NCT01804075|Narcotics|narcotics|mesh-ancestor
14433398|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433399|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433400|NCT01804075|Analgesics|analgesics|mesh-ancestor
14433401|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
14748967|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14748968|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14748969|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
14748970|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14748971|NCT05051449|Ketamine|ketamine|mesh-list
14748972|NCT05051449|Analgesics|analgesics|mesh-ancestor
14748973|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
14748974|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14748975|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748976|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14748977|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14748978|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
14748979|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
14748980|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14748981|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14748982|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14748983|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14748984|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748985|NCT05023967|Metformin|metformin|mesh-list
14748986|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14748987|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14748988|NCT05022758|Warfarin|warfarin|mesh-list
14748989|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
14748990|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
14928125|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
14928126|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433402|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433403|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
14433404|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
14433405|NCT01804101|Cytarabine|cytarabine|mesh-list
14433406|NCT01804101|Daunorubicin|daunorubicin|mesh-list
14748991|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14748992|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
14748993|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14748994|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
14748995|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14748996|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14748997|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
14748998|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14928127|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928128|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928129|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
14748999|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14749000|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
14749001|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749002|NCT05018585|Antacids|antacids|mesh-ancestor
14433407|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14433408|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
14433409|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433410|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928130|NCT01421173|Hormones|hormones|mesh-ancestor
14433411|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
14433412|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433413|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14433414|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
14433415|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433416|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14433417|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14433418|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14433419|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433420|NCT01804465|Ipilimumab|ipilimumab|mesh-list
14433421|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14433422|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433423|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14433424|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433425|NCT01804673|Fentanyl|fentanyl|mesh-list
14433426|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14433427|NCT01804673|Narcotics|narcotics|mesh-ancestor
14433428|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433429|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433430|NCT01804673|Analgesics|analgesics|mesh-ancestor
14433431|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
14433432|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433433|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14433434|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14433435|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
14433436|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
14433437|NCT01804946|Oseltamivir|oseltamivir|mesh-list
14433438|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
14433439|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433440|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433441|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749003|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749004|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14749005|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14749006|NCT05018585|Vitamins|vitamins|mesh-ancestor
14749007|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
14749008|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14749009|NCT05009069|Fluorouracil|fluorouracil|mesh-list
14749010|NCT05009069|Capecitabine|capecitabine|mesh-list
14749011|NCT05009069|Atezolizumab|atezolizumab|mesh-list
14749012|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
14749013|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749014|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749015|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749016|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749017|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
14749018|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749019|NCT05005273|Nivolumab|nivolumab|mesh-list
14749020|NCT05005273|Ipilimumab|ipilimumab|mesh-list
14749021|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749022|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749023|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749024|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433442|NCT01805037|Rituximab|rituximab|mesh-list
14433443|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14749025|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
14749026|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
14749027|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749028|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
14749029|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
14749030|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749031|NCT04998617|Curcumin|curcumin|mesh-list
14749032|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433444|NCT01805037|Antibodies|antibodies|mesh-list
14433445|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
14433446|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14749033|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14749034|NCT04998617|Analgesics|analgesics|mesh-ancestor
14749035|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
14749036|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749037|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749038|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749039|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749040|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749041|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749042|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749043|NCT04988308|Adalimumab|adalimumab|mesh-list
14749044|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749045|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749046|NCT04981041|Clopidogrel|clopidogrel|mesh-list
14433447|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
14433448|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
14433449|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433450|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14433451|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433452|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433453|NCT01805089|Melatonin|melatonin|mesh-list
14433454|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
14433455|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433456|NCT01805089|Protective Agents|protective agents|mesh-ancestor
14433457|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433458|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433459|NCT01805297|Aflibercept|aflibercept|mesh-list
14433460|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14433461|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14433462|NCT01805297|Growth Substances|growth substances|mesh-ancestor
14433463|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433464|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
14433465|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433466|NCT01805323|Dexamethasone|dexamethasone|mesh-list
14433467|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928131|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928132|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14433468|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
14433469|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
14433470|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433471|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433472|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14433473|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
14433474|NCT01805323|Hormones|hormones|mesh-ancestor
14433475|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433476|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14433477|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433478|NCT01805687|Zileuton|zileuton|mesh-list
14433479|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433480|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433481|NCT01805687|Analgesics|analgesics|mesh-ancestor
14433482|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
14433483|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433484|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433485|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749047|NCT04981041|Ticagrelor|ticagrelor|mesh-list
14749048|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14749049|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14433486|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749050|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14433487|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14749051|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14749052|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14749053|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
14749054|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749055|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749056|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749057|NCT04967508|Ustekinumab|ustekinumab|mesh-list
14749058|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749059|NCT04965714|Nivolumab|nivolumab|mesh-list
14749060|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749061|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749062|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749063|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749064|NCT04963036|Anesthetics|anesthetics|mesh-list
14749065|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14749066|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749067|NCT04939467|Pirfenidone|pirfenidone|mesh-list
14749068|NCT04939467|Nintedanib|nintedanib|mesh-list
14749069|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749070|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14749071|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749072|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749073|NCT04939467|Analgesics|analgesics|mesh-ancestor
14749074|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
14749075|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433488|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433489|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433490|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14433491|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
14433492|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433493|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
14433494|NCT01805882|Ledipasvir|ledipasvir|mesh-list
14433495|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
14433496|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433497|NCT01805895|Minocycline|minocycline|mesh-list
14433498|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14433499|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433500|NCT01806064|Axitinib|axitinib|mesh-list
14433501|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433502|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14433503|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433504|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433505|NCT01806259|Ketorolac|ketorolac|mesh-list
14433506|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14433507|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433508|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433509|NCT01806259|Analgesics|analgesics|mesh-ancestor
14433510|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
14433511|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433512|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433513|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433514|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433515|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14433516|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433517|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433518|NCT01806298|Hormones|hormones|mesh-list
14433519|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433520|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433521|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14433522|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
14749076|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749077|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14749078|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14749079|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749080|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749081|NCT04938232|Nivolumab|nivolumab|mesh-list
14749082|NCT04938232|Ipilimumab|ipilimumab|mesh-list
14433523|NCT01806545|Coagulants|coagulants|mesh-ancestor
14749083|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749084|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749085|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749086|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749087|NCT04928222|Doxorubicin|doxorubicin|mesh-list
14749088|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14749089|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749090|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14749091|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14749092|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749093|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749094|NCT04908605|Melatonin|melatonin|mesh-list
14749095|NCT04908605|Mirtazapine|mirtazapine|mesh-list
14749096|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
14749097|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749098|NCT04908605|Protective Agents|protective agents|mesh-ancestor
14433524|NCT01806571|Cytarabine|cytarabine|mesh-list
14433525|NCT01806571|Daunorubicin|daunorubicin|mesh-list
14433526|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14433527|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
14433528|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433529|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433530|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
14433531|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433532|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14433533|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
14433534|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433535|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14433536|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14433537|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14433538|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433539|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14433540|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
14433541|NCT01806584|Coagulants|coagulants|mesh-ancestor
14433542|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14433543|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
14433544|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433545|NCT01806623|Fluconazole|fluconazole|mesh-list
14433546|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
14433547|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433548|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14433549|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433550|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433551|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433552|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14433553|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
14433554|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749099|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749100|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928133|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928134|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14928135|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
14928136|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928137|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14928138|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
14928139|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928140|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
14928141|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928142|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749101|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
14749102|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14749103|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14749104|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
14749105|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
14749106|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749107|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14749108|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14749109|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14749110|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14749111|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14749112|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14749113|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14749114|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14928143|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14433555|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433556|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14433557|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14433558|NCT01806662|Ustekinumab|ustekinumab|mesh-list
14433559|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14433560|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14433561|NCT01806675|Glycine|glycine|mesh-list
14433562|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14433563|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433564|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
14433565|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433566|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433567|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14433568|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
14433569|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
14433570|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433571|NCT01806779|Bupropion|bupropion|mesh-list
14433572|NCT01806779|Nicotine|nicotine|mesh-list
14433573|NCT01806779|Varenicline|varenicline|mesh-list
14433574|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14433575|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
14433576|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433577|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433578|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14433579|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14433580|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
14433581|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433582|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433583|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14433584|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
14433585|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433586|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14433587|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14433588|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433589|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
14749115|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
14433590|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14433591|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433592|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433593|NCT01806857|Quinidine|quinidine|mesh-list
14749116|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14749117|NCT04901689|Leronlimab|leronlimab|mesh-list
14749118|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14749119|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14749120|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749121|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14749122|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14749123|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
14749124|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433594|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
14433595|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
14433596|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
14749125|NCT04901676|Leronlimab|leronlimab|mesh-list
14749126|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14749127|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14749128|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749129|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14749130|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14749131|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
14749132|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749133|NCT04895046|Niraparib|niraparib|mesh-list
14749134|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14749135|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749136|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749137|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749138|NCT04879225|Menthol|menthol|mesh-list
14749139|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
14749140|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749141|NCT04876781|Tofacitinib|tofacitinib|mesh-list
14749142|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14749143|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749144|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433597|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14433598|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14433599|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433600|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433601|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433602|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14433603|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14433604|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
14433605|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14433606|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
14433607|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14433608|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14433609|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433610|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433611|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14433612|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14433613|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
14433614|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14433615|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14433616|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433617|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14433618|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433619|NCT01807000|Prucalopride|prucalopride|mesh-list
14433620|NCT01807000|Laxatives|laxatives|mesh-ancestor
14433621|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14433622|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14433623|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14433624|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
14433625|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433626|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433627|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433628|NCT01807221|Eplerenone|eplerenone|mesh-list
14433629|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14433630|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
14433631|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433632|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433633|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14433634|NCT01807221|Diuretics|diuretics|mesh-ancestor
14433635|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
14433636|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14433637|NCT01807234|Ketorolac|ketorolac|mesh-list
14433638|NCT01807234|Sumatriptan|sumatriptan|mesh-list
14433639|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433640|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433641|NCT01807234|Analgesics|analgesics|mesh-ancestor
14433642|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
14433643|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433644|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433645|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433646|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433647|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14749149|NCT04871594|Nivolumab|nivolumab|mesh-list
14749150|NCT04871594|Ipilimumab|ipilimumab|mesh-list
14433648|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433649|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433650|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14433651|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14433652|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14433653|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
14433654|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433655|NCT01807455|Lidocaine|lidocaine|mesh-list
14433656|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
14433657|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
14749151|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749152|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749153|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749154|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749155|NCT04871412|Vitamin D|vitamin d|mesh-list
14749156|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
14749157|NCT04871412|Vitamins|vitamins|mesh-list
14749158|NCT04871412|Curcumin|curcumin|mesh-list
14749159|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
14749160|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749161|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14749162|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14749163|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14749164|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14749165|NCT04871412|Analgesics|analgesics|mesh-ancestor
14749166|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
14749167|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749168|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749169|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749170|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749171|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749172|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753616|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14753617|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753618|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
14753619|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753620|NCT05065736|Clofarabine|clofarabine|mesh-list
14753621|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753622|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
14753623|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753624|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753625|NCT05065190|Nintedanib|nintedanib|mesh-list
14753626|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753627|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14753628|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753629|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753630|NCT05063565|Durvalumab|durvalumab|mesh-list
14753631|NCT05063565|Tremelimumab|tremelimumab|mesh-list
14753632|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
14753633|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753634|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753635|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753636|NCT05057494|Venetoclax|venetoclax|mesh-list
14753637|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
14753638|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
14433658|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433659|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433660|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
14433661|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433662|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14433663|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14433664|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14433665|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433666|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433667|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14433668|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
14433669|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433670|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14433671|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
14433672|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14433673|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433674|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
14433675|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433676|NCT01807624|Phenylephrine|phenylephrine|mesh-list
14433677|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
14433678|NCT01807624|Tetracaine|tetracaine|mesh-list
14433679|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
14433680|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
14433681|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433682|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433683|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
14433684|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433685|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14433686|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14433687|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
14433688|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433689|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433690|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
14433691|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
14433692|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
14753639|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753640|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753641|NCT05053971|Entinostat|entinostat|mesh-list
14753642|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14433693|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14433694|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
14433695|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14433696|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
14433697|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14433698|NCT01807624|Protective Agents|protective agents|mesh-ancestor
14433699|NCT01807871|Nicotine|nicotine|mesh-list
14433700|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14433701|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
14433702|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433703|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433704|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14433705|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14433706|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
14433707|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433708|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433709|NCT01807923|Ivacaftor|ivacaftor|mesh-list
14749173|NCT04833140|Estradiol|estradiol|mesh-list
14749174|NCT04833140|Estrogens|estrogens|mesh-ancestor
14749175|NCT04833140|Hormones|hormones|mesh-ancestor
14433710|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14433711|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433712|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433713|NCT01807949|Ivacaftor|ivacaftor|mesh-list
14433714|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14433715|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433716|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433717|NCT01808092|Meropenem|meropenem|mesh-list
14433718|NCT01808092|Ceftazidime|ceftazidime|mesh-list
14433719|NCT01808092|Avibactam|avibactam|mesh-list
14433720|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14433721|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14433722|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433723|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14433724|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433725|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433726|NCT01808118|Adalimumab|adalimumab|mesh-list
14433727|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433728|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433729|NCT01808144|Febuxostat|febuxostat|mesh-list
14433730|NCT01808144|Lesinurad|lesinurad|mesh-list
14433731|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
14433732|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433733|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
14433734|NCT01808144|Renal Agents|renal agents|mesh-ancestor
14433735|NCT01808196|Losartan|losartan|mesh-list
14433736|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
14433737|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14433738|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14433739|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14433740|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14433741|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433742|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14433743|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
14433744|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
14433745|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433746|NCT01808313|Ambrisentan|ambrisentan|mesh-list
14433747|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14433748|NCT01808326|Chlorambucil|chlorambucil|mesh-list
14433749|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14433750|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
14433751|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433752|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433753|NCT01808339|Fluticasone|fluticasone|mesh-list
14433754|NCT01808339|Xhance|xhance|mesh-list
14433755|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433756|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14433757|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
14433758|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433759|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433760|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14433761|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
14433762|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
14433763|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14433764|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
14433765|NCT01808534|Ifosfamide|ifosfamide|mesh-list
14433766|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14749176|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749177|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749178|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
14749179|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749180|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749181|NCT04810078|Nivolumab|nivolumab|mesh-list
14749182|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749183|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749184|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749185|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749186|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
14749187|NCT04808934|Apixaban|apixaban|mesh-list
14749188|NCT04808934|Dabigatran|dabigatran|mesh-list
14749189|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14749190|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
14749191|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14749192|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
14749193|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749194|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749195|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
14749196|NCT04804553|Apremilast|apremilast|mesh-list
14749197|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14749198|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14749199|NCT04804553|Analgesics|analgesics|mesh-ancestor
14749200|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
14928144|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928145|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
14928146|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14928147|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14433767|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
14433768|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433769|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433770|NCT01808547|Bromfenac|bromfenac|mesh-list
14433771|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433772|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433773|NCT01808547|Analgesics|analgesics|mesh-ancestor
14433774|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
14433775|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433776|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433777|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433778|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433779|NCT01808573|Capecitabine|capecitabine|mesh-list
14433780|NCT01808573|Lapatinib|lapatinib|mesh-list
14433781|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14928148|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
14928149|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
14928150|NCT01421212|Antibodies|antibodies|mesh-list
14928151|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
14928152|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14928153|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14928154|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
14928155|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
14928156|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928157|NCT01421264|Gabapentin|gabapentin|mesh-list
14928158|NCT01421264|Analgesics|analgesics|mesh-ancestor
14928159|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
14928160|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928161|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928162|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
14928163|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14928164|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14433782|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
14433783|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749201|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928165|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928166|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14928167|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14928168|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14928169|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928170|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928171|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
14928172|NCT01421368|Tenofovir|tenofovir|mesh-list
14928173|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14928174|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
14928175|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
14928176|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
14928177|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
14928178|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928179|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14928180|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14433784|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433785|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14433786|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433787|NCT01808612|Fluoxetine|fluoxetine|mesh-list
14433788|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14433789|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14433790|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433791|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433792|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433793|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
14433794|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433795|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14433796|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
14433797|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433798|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14928181|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433799|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433800|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928182|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433801|NCT01808651|Fluoxetine|fluoxetine|mesh-list
14433802|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14433803|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14433804|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14433805|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433806|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433807|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
14433808|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928183|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14928184|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14928185|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14433809|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14433810|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
14433811|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433812|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14433813|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433814|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433815|NCT01808690|Metformin|metformin|mesh-list
14433816|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14433817|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433818|NCT01808755|Trimethoprim|trimethoprim|mesh-list
14433819|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
14433820|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14433821|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433822|NCT01808755|Renal Agents|renal agents|mesh-ancestor
14433823|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
14433824|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14433825|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14433826|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14433827|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433828|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433829|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14433830|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14433831|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14433832|NCT01809054|Aspirin|aspirin|mesh-list
14433833|NCT01809054|Fondaparinux|fondaparinux|mesh-list
14433834|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14433835|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433836|NCT01809054|Analgesics|analgesics|mesh-ancestor
14433837|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
14433838|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433839|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433840|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433841|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433842|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14433843|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14433844|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433845|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14433846|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14433847|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928186|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928187|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14928188|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14928189|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14928190|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14928191|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14928192|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14928193|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928194|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
14928195|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
14928196|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14928197|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928198|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14928199|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14928200|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14928201|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14928202|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928203|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433848|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
14433849|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14433850|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
14433851|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14433852|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
14433853|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
14433854|NCT01809106|Fentanyl|fentanyl|mesh-list
14433855|NCT01809106|Morphine|morphine|mesh-list
14433856|NCT01809106|Oxycodone|oxycodone|mesh-list
14433857|NCT01809106|Buprenorphine|buprenorphine|mesh-list
14433858|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14928204|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928205|NCT01421706|Clarithromycin|clarithromycin|mesh-list
14928206|NCT01421706|Sibutramine|sibutramine|mesh-list
14433859|NCT01809106|Narcotics|narcotics|mesh-ancestor
14433860|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433861|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433862|NCT01809106|Analgesics|analgesics|mesh-ancestor
14433863|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
14433864|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928207|NCT01421706|Clopidogrel|clopidogrel|mesh-list
14928208|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14928209|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14928210|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14749202|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749203|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749204|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749205|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14749206|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14749207|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749208|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749209|NCT04799249|Gemcitabine|gemcitabine|mesh-list
14749210|NCT04799249|Carboplatin|carboplatin|mesh-list
14749211|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749212|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749213|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
14749214|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749215|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
14749216|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433865|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14433866|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14433867|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
14433868|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
14928211|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14433869|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14433870|NCT01809132|Zinc|zinc|mesh-list
14433871|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
14749217|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749218|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749219|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
14749220|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749221|NCT04786548|Celecoxib|celecoxib|mesh-list
14749222|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14749223|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14433872|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14433873|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14433874|NCT01809132|Prednisolone|prednisolone|mesh-list
14433875|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
14433876|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14433877|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
14433878|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
14433879|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14433880|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
14433881|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433882|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
14433883|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
14433884|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433885|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433886|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14433887|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
14433888|NCT01809132|Hormones|hormones|mesh-ancestor
14433889|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433890|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14749224|NCT04786548|Analgesics|analgesics|mesh-ancestor
14433891|NCT01809132|Protective Agents|protective agents|mesh-ancestor
14433892|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14433893|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433894|NCT01809132|Trace Elements|trace elements|mesh-ancestor
14433895|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
14433896|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14433897|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14433898|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433899|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433900|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14433901|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14433902|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
14433903|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14433904|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
14433905|NCT01809132|Astringents|astringents|mesh-ancestor
14433906|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
14433907|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14433908|NCT01809210|Gemcitabine|gemcitabine|mesh-list
14433909|NCT01809210|Carboplatin|carboplatin|mesh-list
14433910|NCT01809210|Pemetrexed|pemetrexed|mesh-list
14433911|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433912|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14433913|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
14433914|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433915|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
14433916|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14433917|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433918|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14433919|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
14433920|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433921|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14433922|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14433923|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
14433924|NCT01809314|Hematinics|hematinics|mesh-ancestor
14433925|NCT01809327|Metformin|metformin|mesh-list
14433926|NCT01809327|Canagliflozin|canagliflozin|mesh-list
14433927|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14749225|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
14433928|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433929|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14433930|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433931|NCT01809639|Progesterone|progesterone|mesh-list
14749226|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749227|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749228|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14433932|NCT01809639|Progestins|progestins|mesh-ancestor
14433933|NCT01809639|Hormones|hormones|mesh-ancestor
14433934|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14433935|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433936|NCT01810016|Poly I-C|poly i-c|mesh-list
14433937|NCT01810016|Ipilimumab|ipilimumab|mesh-list
14433938|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14433939|NCT01810016|Vaccines|vaccines|mesh-list
14433940|NCT01810016|Poly ICLC|poly iclc|mesh-list
14433941|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
14433942|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433943|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14433944|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433945|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14433946|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433947|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
14433948|NCT01810016|Laxatives|laxatives|mesh-ancestor
14433949|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14433950|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
14433951|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468578|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14749229|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749230|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14749231|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14468579|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14468580|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468581|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
14468582|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
14468583|NCT02282813|Calcitriol|calcitriol|mesh-list
14468584|NCT02282813|Calcifediol|calcifediol|mesh-list
14468585|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14468586|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14468587|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468588|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14468589|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14749232|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14433952|NCT01810042|Ranibizumab|ranibizumab|mesh-list
14433953|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14433954|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14433955|NCT01810042|Growth Substances|growth substances|mesh-ancestor
14433956|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433957|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
14433958|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14433959|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14433960|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
14433961|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
14433962|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14433963|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14433964|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14433965|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14433966|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433967|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
14433968|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433969|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433970|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
14433971|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
14433972|NCT01810432|Evacetrapib|evacetrapib|mesh-list
14433973|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14433974|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14433975|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
14433976|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433977|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14433978|NCT01810666|Factor VIII|factor viii|mesh-list
14433979|NCT01810666|Coagulants|coagulants|mesh-ancestor
14433980|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
14433981|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14433982|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
14433983|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14433984|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433985|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14433986|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
14433987|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
14433988|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14433989|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
14433990|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433991|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433992|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
14433993|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
14433994|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14433995|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14433996|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14433997|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
14433998|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
14433999|NCT01810952|Insulin|insulin|mesh-list
14434000|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14434001|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
14434002|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
14434003|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
14434004|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
14434005|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
14434006|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434007|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434008|NCT01811147|Norepinephrine|norepinephrine|mesh-list
14434009|NCT01811147|Serotonin|serotonin|mesh-list
14434010|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14434011|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14434012|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14434013|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434014|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434015|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434016|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434017|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
14434018|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
14434019|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434020|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14434021|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14434022|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
14434023|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14434024|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434025|NCT01811186|Oxycodone|oxycodone|mesh-list
14434026|NCT01811186|Naloxone|naloxone|mesh-list
14434027|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434028|NCT01811186|Narcotics|narcotics|mesh-ancestor
14434029|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434030|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434031|NCT01811186|Analgesics|analgesics|mesh-ancestor
14434032|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
14434033|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434034|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14434035|NCT01811225|Progesterone|progesterone|mesh-list
14434036|NCT01811225|Progestins|progestins|mesh-ancestor
14434037|NCT01811225|Hormones|hormones|mesh-ancestor
14434038|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928212|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
14928213|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928214|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434039|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434040|NCT01811238|Oxycodone|oxycodone|mesh-list
14434041|NCT01811238|Naloxone|naloxone|mesh-list
14434042|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434043|NCT01811238|Narcotics|narcotics|mesh-ancestor
14928215|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928216|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14928217|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928218|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14928219|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928220|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14928221|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14749233|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749234|NCT04786275|Fentanyl|fentanyl|mesh-list
14749235|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14749236|NCT04786275|Narcotics|narcotics|mesh-ancestor
14749237|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14749238|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749239|NCT04786275|Analgesics|analgesics|mesh-ancestor
14749240|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
14749241|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749242|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14749243|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14749244|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
14749245|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
14749246|NCT04785820|Nivolumab|nivolumab|mesh-list
14749247|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749248|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749249|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749250|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928222|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
14749251|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
14749252|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14749253|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14749254|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749255|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
14749256|NCT04785651|Coagulants|coagulants|mesh-ancestor
14749257|NCT04745832|Prednisone|prednisone|mesh-list
14749258|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
14749259|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14434044|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434045|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434046|NCT01811238|Analgesics|analgesics|mesh-ancestor
14434047|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
14434048|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434049|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14434050|NCT01811355|Mexiletine|mexiletine|mesh-list
14434051|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14434052|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14434053|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14434054|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434055|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434056|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
14434057|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14434058|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
14434059|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434060|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
14434061|NCT01811654|Protective Agents|protective agents|mesh-ancestor
14434062|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
14434063|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
14434064|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
14434065|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14434066|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928223|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14749260|NCT04745832|Rituximab|rituximab|mesh-list
14749261|NCT04745832|Vincristine|vincristine|mesh-list
14434067|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434068|NCT01811732|Vancomycin|vancomycin|mesh-list
14434069|NCT01811732|Aztreonam|aztreonam|mesh-list
14434070|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14434071|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434072|NCT01811940|Topiramate|topiramate|mesh-list
14434073|NCT01811940|Adderall|adderall|mesh-list
14434074|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
14434075|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434076|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434077|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14434078|NCT01811953|Metformin|metformin|mesh-list
14434079|NCT01811953|Empagliflozin|empagliflozin|mesh-list
14434080|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434081|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434082|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14434083|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434084|NCT01812005|Rituximab|rituximab|mesh-list
14434085|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14434086|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434087|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
14434088|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434089|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434090|NCT01812044|Lidocaine|lidocaine|mesh-list
14434091|NCT01812044|Bupivacaine|bupivacaine|mesh-list
14434092|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
14434093|NCT01812044|Anesthetics|anesthetics|mesh-list
14434094|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434095|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434096|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
14434097|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434098|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14434099|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14434100|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14434101|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434102|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434103|NCT01812057|Dexamethasone|dexamethasone|mesh-list
14434104|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434105|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
14434106|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
14434107|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434108|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434109|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14434110|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
14434111|NCT01812057|Hormones|hormones|mesh-ancestor
14434112|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14434113|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14434114|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434115|NCT01812668|Fluorides|fluorides|mesh-list
14434116|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
14434117|NCT01812668|Protective Agents|protective agents|mesh-ancestor
14434118|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434119|NCT01812707|Atorvastatin|atorvastatin|mesh-list
14434120|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14434121|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14434122|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14434123|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
14434124|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434125|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14434126|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14749262|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749263|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
14749264|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434127|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434128|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
14434129|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434130|NCT01812759|Fentanyl|fentanyl|mesh-list
14434131|NCT01812759|Hydromorphone|hydromorphone|mesh-list
14434132|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434133|NCT01812759|Narcotics|narcotics|mesh-ancestor
14434134|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434135|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749265|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434136|NCT01812759|Analgesics|analgesics|mesh-ancestor
14434137|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
14434138|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434139|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14434140|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14434141|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
14434142|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
14434143|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14434144|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14434145|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434146|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
14434147|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14434148|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14434149|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434150|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
14434151|NCT01813058|Coagulants|coagulants|mesh-ancestor
14434152|NCT01813149|Clonidine|clonidine|mesh-list
14434153|NCT01813149|Phenylephrine|phenylephrine|mesh-list
14434154|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
14434155|NCT01813149|Anesthetics|anesthetics|mesh-list
14434156|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
14434157|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434158|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434159|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
14434160|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434161|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14434162|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
14434163|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
14434164|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
14434165|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14434166|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
14434167|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14434168|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14434169|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14434170|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14434171|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434172|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434173|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434174|NCT01813149|Protective Agents|protective agents|mesh-ancestor
14434175|NCT01813149|Analgesics|analgesics|mesh-ancestor
14749266|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14749267|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
14749268|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749269|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749270|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14749271|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749272|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749273|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
14749274|NCT04745832|Hormones|hormones|mesh-ancestor
14749275|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749276|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14749277|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14749278|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
14749279|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
14749280|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
14749281|NCT04738942|Vedolizumab|vedolizumab|mesh-list
14749282|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14749283|NCT04721548|Minoxidil|minoxidil|mesh-list
14749284|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14749285|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
14749286|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
14749287|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749288|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749289|NCT04675866|Paclitaxel|paclitaxel|mesh-list
14749290|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14749291|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14749292|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749293|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
14749294|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
14749295|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14749296|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749297|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
14749298|NCT04666740|Olaparib|olaparib|mesh-list
14749299|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749300|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749301|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14749302|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749303|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749304|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
14749305|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749306|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749307|NCT04657289|Ranibizumab|ranibizumab|mesh-list
14749308|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14749309|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14749310|NCT04657289|Growth Substances|growth substances|mesh-ancestor
14749311|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749312|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
14749313|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749314|NCT04657081|Decitabine|decitabine|mesh-list
14749315|NCT04657081|Venetoclax|venetoclax|mesh-list
14749316|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749317|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
14749318|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749319|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749320|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749321|NCT04639219|Trastuzumab|trastuzumab|mesh-list
14749322|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749323|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749324|NCT04623944|Cytarabine|cytarabine|mesh-list
14749325|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
14749326|NCT04623944|Fludarabine|fludarabine|mesh-list
14749327|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749328|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
14749329|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749330|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749331|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14749332|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
14749333|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749334|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749335|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14749336|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749337|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
14749338|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
14749339|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749340|NCT04620759|Psilocybin|psilocybin|mesh-list
14749341|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14749342|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
14749343|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749344|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14749345|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14749346|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
14749347|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749348|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434176|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14434177|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
14434178|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14434179|NCT01813214|Vemurafenib|vemurafenib|mesh-list
14434180|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749349|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14749350|NCT04612790|Benralizumab|benralizumab|mesh-list
14749351|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14749352|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14749353|NCT04607460|Coal Tar|coal tar|mesh-list
14749354|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
14749355|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749356|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14749357|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
14749358|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14749359|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14749360|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14749361|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14749362|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14749363|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434181|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14434182|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434183|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434184|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14434185|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14434186|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14434187|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
14434188|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434189|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14434190|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14434191|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434192|NCT01813422|Evolocumab|evolocumab|mesh-list
14434193|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14434194|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14434195|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
14434196|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434197|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14434198|NCT01813474|Olaparib|olaparib|mesh-list
14434199|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14434200|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434201|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434202|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434203|NCT01813734|Ponatinib|ponatinib|mesh-list
14434204|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434205|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14434206|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434207|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434208|NCT01813890|Tapentadol|tapentadol|mesh-list
14434209|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434210|NCT01813890|Narcotics|narcotics|mesh-ancestor
14434211|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434212|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434213|NCT01813890|Analgesics|analgesics|mesh-ancestor
14434214|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
14434215|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434216|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14434217|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14434218|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434219|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434220|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434221|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434222|NCT01814046|Aldesleukin|aldesleukin|mesh-list
14434223|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
14434224|NCT01814046|Fludarabine|fludarabine|mesh-list
14434225|NCT01814046|Interleukin-2|interleukin-2|mesh-list
14434226|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749364|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
14434227|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
14434228|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434229|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434230|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14434231|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
14434232|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434233|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434234|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14434235|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14434236|NCT01814046|Analgesics|analgesics|mesh-ancestor
14434237|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
14434238|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434239|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14434240|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14434241|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
14434242|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434243|NCT01814137|Insulin|insulin|mesh-list
14434244|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14928224|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
14928225|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14928226|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
14931140|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14931141|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14931142|NCT01437709|Ofatumumab|ofatumumab|mesh-list
14931143|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14434245|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
14434246|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
14434247|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14434248|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434249|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434250|NCT01814371|Mupirocin|mupirocin|mesh-list
14749365|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749366|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749367|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14749368|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749369|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14749370|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
14749371|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
14931144|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14931145|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
14434251|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14434252|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434253|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14434254|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434255|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434256|NCT01814397|Letrozole|letrozole|mesh-list
14434257|NCT01814397|Anastrozole|anastrozole|mesh-list
14434258|NCT01814397|Exemestane|exemestane|mesh-list
14434259|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434260|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14434261|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14434262|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434263|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434264|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14434265|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
14434266|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14434267|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434268|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14434269|NCT01814553|Afatinib|afatinib|mesh-list
14434270|NCT01814553|Loperamide|loperamide|mesh-list
14434271|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
14434272|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434273|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14434274|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434275|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434276|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14434277|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
14434278|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14434279|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14434280|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14434281|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434282|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434283|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
14434284|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434285|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434286|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14434287|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434288|NCT01814748|Metformin|metformin|mesh-list
14434289|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434290|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434291|NCT01814761|Bimatoprost|bimatoprost|mesh-list
14434292|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14434293|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
14434294|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
14434295|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434296|NCT01814813|Bevacizumab|bevacizumab|mesh-list
14434297|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14434298|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434299|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14434300|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14434301|NCT01814813|Growth Substances|growth substances|mesh-ancestor
14434302|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434303|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
14434304|NCT01814878|Acetaminophen|acetaminophen|mesh-list
14434305|NCT01814878|Tramadol|tramadol|mesh-list
14434306|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14434307|NCT01814878|Analgesics|analgesics|mesh-ancestor
14749372|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749373|NCT04567303|Ranibizumab|ranibizumab|mesh-list
14749374|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14749375|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14749376|NCT04567303|Growth Substances|growth substances|mesh-ancestor
14749377|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749378|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
14749379|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749380|NCT04562090|Mirabegron|mirabegron|mesh-list
14749381|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14749382|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14749383|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14749384|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434308|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
14434309|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434310|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434311|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
14434312|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434313|NCT01814878|Narcotics|narcotics|mesh-ancestor
14434314|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434315|NCT01815008|Aspirin|aspirin|mesh-list
14434316|NCT01815008|Clopidogrel|clopidogrel|mesh-list
14434317|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14434318|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14434319|NCT01815008|Analgesics|analgesics|mesh-ancestor
14434320|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
14928227|NCT01421797|Dexamethasone|dexamethasone|mesh-list
14434321|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434322|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434323|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434324|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434325|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14434326|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14434327|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434328|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14434329|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14434330|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434331|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
14434332|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14434333|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14434334|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14434335|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
14434336|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434337|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14434338|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14434339|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434340|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14434341|NCT01815333|Hematinics|hematinics|mesh-ancestor
14434342|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14434343|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14434344|NCT01815424|Tofacitinib|tofacitinib|mesh-list
14434345|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14434346|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434347|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434348|NCT01815736|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14434349|NCT01815736|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14434350|NCT01815736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14434351|NCT01815736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14434352|NCT01815736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434353|NCT01815736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434354|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
14434355|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434356|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14434357|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14434358|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
14434359|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434360|NCT01816048|Listerine|listerine|mesh-list
14434361|NCT01816048|Fluorides|fluorides|mesh-list
14434362|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
14434363|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
14434364|NCT01816048|Protective Agents|protective agents|mesh-ancestor
14434365|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434366|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14434367|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434368|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14434369|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14434370|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434371|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14434372|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14434373|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434374|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434375|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
14434376|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434377|NCT01816243|Fentanyl|fentanyl|mesh-list
14434378|NCT01816243|Morphine|morphine|mesh-list
14434379|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434380|NCT01816243|Narcotics|narcotics|mesh-ancestor
14434381|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434382|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434383|NCT01816243|Analgesics|analgesics|mesh-ancestor
14434384|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
14434385|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434386|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14434387|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14434388|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
14434389|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
14434390|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
14434391|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14434392|NCT01816295|Testosterone|testosterone|mesh-list
14434393|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
14434394|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
14434395|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14434396|NCT01816295|Androgens|androgens|mesh-ancestor
14434397|NCT01816295|Hormones|hormones|mesh-ancestor
14434398|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14434399|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434400|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14434401|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434402|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
14434403|NCT01816477|Ropivacaine|ropivacaine|mesh-list
14434404|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
14434405|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
14434406|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434407|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434408|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
14434409|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434410|NCT01816594|Paclitaxel|paclitaxel|mesh-list
14434411|NCT01816594|Trastuzumab|trastuzumab|mesh-list
14434412|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14434413|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434414|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
14434415|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
14434416|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
14434417|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434418|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14434419|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14434420|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468590|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468591|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14468592|NCT02282813|Vitamins|vitamins|mesh-ancestor
14468593|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
14468594|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14468595|NCT02282904|Sirolimus|sirolimus|mesh-list
14468596|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
14468597|NCT02282904|Busulfan|busulfan|mesh-list
14468598|NCT02282904|Fludarabine|fludarabine|mesh-list
14468599|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14468600|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
14468601|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468602|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468603|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14468604|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
14468605|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468606|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468607|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14749385|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749386|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749387|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749388|NCT04562090|Urological Agents|urological agents|mesh-ancestor
14749389|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
14749390|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
14749391|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
14749392|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14749393|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749394|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
14749395|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749396|NCT04554485|Blinatumomab|blinatumomab|mesh-list
14749397|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749398|NCT04554459|Ponatinib|ponatinib|mesh-list
14749399|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749400|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14749401|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749402|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749403|NCT04536298|Vitamin D|vitamin d|mesh-list
14749404|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
14749405|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
14749406|NCT04536298|Vitamins|vitamins|mesh-list
14749407|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
14749408|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749409|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14434421|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14434422|NCT01816984|Cetuximab|cetuximab|mesh-list
14434423|NCT01816984|Antibodies|antibodies|mesh-list
14434424|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
14434425|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14434426|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
14434427|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434428|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434429|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
14434430|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14434431|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14434432|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434433|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
14434434|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434435|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14434436|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14434437|NCT01817530|Norethindrone|norethindrone|mesh-list
14434438|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
14434439|NCT01817530|Estradiol|estradiol|mesh-list
14434440|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14434441|NCT01817530|Estrogens|estrogens|mesh-ancestor
14434442|NCT01817530|Hormones|hormones|mesh-ancestor
14434443|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14434444|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434445|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14434446|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
14434447|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14434448|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14434449|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14434450|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14434451|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14749410|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14434452|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14434453|NCT01817582|Cyclosporine|cyclosporine|mesh-list
14434454|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14749411|NCT04533750|Peposertib|peposertib|mesh-list
14749412|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14749413|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749414|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749415|NCT04524130|Lidocaine|lidocaine|mesh-list
14749416|NCT04524130|Ketamine|ketamine|mesh-list
14749417|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
14749418|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
14749419|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14749420|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749421|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
14749422|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749423|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14749424|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14749425|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14749426|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14749427|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749428|NCT04524130|Analgesics|analgesics|mesh-ancestor
14434455|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
14434456|NCT01817582|Cyclosporins|cyclosporins|mesh-list
14434457|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434458|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434459|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14434460|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
14434461|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434462|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
14434463|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749429|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14749430|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14749431|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
14749432|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14749433|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14749434|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749435|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14749436|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753643|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753644|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753645|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753646|NCT05053334|Omalizumab|omalizumab|mesh-list
14753647|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14753648|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14753649|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
14753650|NCT05048719|Dulaglutide|dulaglutide|mesh-list
14753651|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434464|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434465|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434466|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14434467|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14434468|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14434469|NCT01817764|Fluticasone|fluticasone|mesh-list
14434470|NCT01817764|Xhance|xhance|mesh-list
14434471|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14434472|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434473|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14434474|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
14434475|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753652|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434476|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434477|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14434478|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
14434479|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434480|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14434481|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14434482|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14434483|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14434484|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434485|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434486|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434487|NCT01817777|Metformin|metformin|mesh-list
14434488|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434489|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434490|NCT01817790|Fluticasone|fluticasone|mesh-list
14434491|NCT01817790|Xhance|xhance|mesh-list
14434492|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434493|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14434494|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
14434495|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434496|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434497|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14434498|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14434499|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434500|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14434501|NCT01817855|AZD7624|azd7624|mesh-list
14434502|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14434503|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434504|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434505|NCT01817907|Trazodone|trazodone|mesh-list
14434506|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14434507|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14434508|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434509|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434510|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14434511|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14434512|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14434513|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434514|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434515|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434516|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
14434517|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14434518|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
14434519|NCT01818063|Paclitaxel|paclitaxel|mesh-list
14434520|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
14749437|NCT04521231|Blinatumomab|blinatumomab|mesh-list
14749438|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749439|NCT04484532|Vaccines|vaccines|mesh-list
14749440|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
14749441|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434521|NCT01818063|Carboplatin|carboplatin|mesh-list
14434522|NCT01818063|Doxorubicin|doxorubicin|mesh-list
14434523|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14434524|NCT01818063|Veliparib|veliparib|mesh-list
14434525|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14434526|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434527|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
14434528|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
14434529|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
14434530|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434531|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14434532|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
14434533|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434534|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434535|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14434536|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
14434537|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14749442|NCT04482309|Trastuzumab|trastuzumab|mesh-list
14434538|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14749443|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14434539|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14749444|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434540|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14434541|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434542|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14434543|NCT01818141|Vancomycin|vancomycin|mesh-list
14434544|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
14434545|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14434546|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434547|NCT01818258|Ritonavir|ritonavir|mesh-list
14434548|NCT01818258|Lopinavir|lopinavir|mesh-list
14434549|NCT01818258|Lamivudine|lamivudine|mesh-list
14434550|NCT01818258|Zidovudine|zidovudine|mesh-list
14434551|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14434552|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14434553|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
14434554|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434555|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434556|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14434557|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14434558|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
14434559|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434560|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14434561|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14434562|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14434563|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14434564|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
14434565|NCT01818284|Plerixafor|plerixafor|mesh-list
14434566|NCT01818284|Lenograstim|lenograstim|mesh-list
14434567|NCT01818284|Sargramostim|sargramostim|mesh-list
14434568|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14434569|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
14434570|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434571|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14434572|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14434573|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
14434574|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749445|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
14749446|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749447|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749448|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14749449|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14749450|NCT04472637|Atorvastatin|atorvastatin|mesh-list
14749451|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14749452|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14434575|NCT01818336|Amoxicillin|amoxicillin|mesh-list
14434576|NCT01818336|Penicillins|penicillins|mesh-list
14434577|NCT01818336|Penicillin G|penicillin g|mesh-list
14434578|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14434579|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434580|NCT01818414|Vitamins|vitamins|mesh-list
14434581|NCT01818414|Folic Acid|folic acid|mesh-list
14434582|NCT01818414|Misoprostol|misoprostol|mesh-list
14434583|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
14749453|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
14749454|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749455|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14749456|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14434584|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434585|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14434586|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
14434587|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14434588|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14434589|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14434590|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
14434591|NCT01818414|Hematinics|hematinics|mesh-ancestor
14434592|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
14434593|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14434594|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14434595|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14434596|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
14434597|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434598|NCT01818700|Buprenorphine|buprenorphine|mesh-list
14434599|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434600|NCT01818700|Narcotics|narcotics|mesh-ancestor
14434601|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434602|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434603|NCT01818700|Analgesics|analgesics|mesh-ancestor
14749457|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749458|NCT04450329|Aflibercept|aflibercept|mesh-list
14434604|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
14434605|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434606|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14434607|NCT01818726|Deferasirox|deferasirox|mesh-list
14434608|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14434609|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
14434610|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
14434611|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434612|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14434613|NCT01818752|Prednisone|prednisone|mesh-list
14434614|NCT01818752|Bortezomib|bortezomib|mesh-list
14434615|NCT01818752|Melphalan|melphalan|mesh-list
14434616|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434617|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
14434618|NCT01818752|Hormones|hormones|mesh-ancestor
14434619|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14434620|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434621|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14434622|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434623|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14434624|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
14434625|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434626|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14434627|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14434628|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
14434629|NCT01819129|Insulin|insulin|mesh-list
14434630|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14434631|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
14434632|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
14434633|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
14434634|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14434635|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434636|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434637|NCT01819415|Bevacizumab|bevacizumab|mesh-list
14434638|NCT01819415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753653|NCT05048212|Nivolumab|nivolumab|mesh-list
14434639|NCT01819415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434640|NCT01819415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14434641|NCT01819415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14434642|NCT01819415|Growth Substances|growth substances|mesh-ancestor
14434643|NCT01819415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434644|NCT01819415|Growth Inhibitors|growth inhibitors|mesh-ancestor
14434645|NCT01819935|Vancomycin|vancomycin|mesh-list
14434646|NCT01819935|Linezolid|linezolid|mesh-list
14434647|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14434648|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434649|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14434650|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434651|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434652|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14434653|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
14434654|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14434655|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14434656|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434657|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434658|NCT01820572|Cyclosporine|cyclosporine|mesh-list
14434659|NCT01820572|Abatacept|abatacept|mesh-list
14434660|NCT01820572|Tacrolimus|tacrolimus|mesh-list
14434661|NCT01820572|Cyclosporins|cyclosporins|mesh-list
14434662|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14434663|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
14749459|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14749460|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14749461|NCT04450329|Growth Substances|growth substances|mesh-ancestor
14749462|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749463|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
14749464|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749465|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
14749466|NCT04445714|Saxagliptin|saxagliptin|mesh-list
14749467|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14928228|NCT01421797|Cosyntropin|cosyntropin|mesh-list
14928229|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928230|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
14928231|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
14928232|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434664|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434665|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14434666|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434667|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434668|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
14434669|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434670|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434671|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434672|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14434673|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434674|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14434675|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
14434676|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14434677|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14434678|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434679|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434680|NCT01820637|Paclitaxel|paclitaxel|mesh-list
14434681|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14434682|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434683|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
14434684|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
14434685|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
14434686|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434687|NCT01820754|Paclitaxel|paclitaxel|mesh-list
14434688|NCT01820754|Carboplatin|carboplatin|mesh-list
14434689|NCT01820754|Ipilimumab|ipilimumab|mesh-list
14753654|NCT05048212|Ipilimumab|ipilimumab|mesh-list
14434690|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14434691|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434692|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
14434693|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
14434694|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
14434695|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434696|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14434697|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14434698|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14434699|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14434700|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434701|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14434702|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14434703|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14434704|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434705|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434706|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14434707|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14434708|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14434709|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14434710|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434711|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434712|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434713|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14434714|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14434715|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
14434716|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14434717|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14434718|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
14434719|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14434720|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14434721|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434722|NCT01821560|Baclofen|baclofen|mesh-list
14434723|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14434724|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434725|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14434726|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434727|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14434728|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
14434729|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
14434730|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434731|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434732|NCT01821729|Leucovorin|leucovorin|mesh-list
14434733|NCT01821729|Fluorouracil|fluorouracil|mesh-list
14434734|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
14434735|NCT01821729|Folfirinox|folfirinox|mesh-list
14434736|NCT01821729|Losartan|losartan|mesh-list
14434737|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
14434738|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434739|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14434740|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434741|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14434742|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
14434743|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434744|NCT01821729|Antidotes|antidotes|mesh-ancestor
14434745|NCT01821729|Protective Agents|protective agents|mesh-ancestor
14434746|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
14434747|NCT01821729|Vitamins|vitamins|mesh-ancestor
14434748|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
14434749|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14434750|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14434751|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14434752|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14434753|NCT01822132|Naltrexone|naltrexone|mesh-list
14434754|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14434755|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14434756|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434757|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
14434758|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434759|NCT01822496|Paclitaxel|paclitaxel|mesh-list
14434760|NCT01822496|Etoposide|etoposide|mesh-list
14434761|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
14434762|NCT01822496|Cisplatin|cisplatin|mesh-list
14434763|NCT01822496|Carboplatin|carboplatin|mesh-list
14434764|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14434765|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14434766|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
14434767|NCT01822496|Crizotinib|crizotinib|mesh-list
14434768|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14434769|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434770|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
14434771|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
14749468|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749469|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14749470|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749471|NCT04445714|Incretins|incretins|mesh-ancestor
14749472|NCT04445714|Hormones|hormones|mesh-ancestor
14749473|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749474|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14749475|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
14749476|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749477|NCT04432623|Benserazide|benserazide|mesh-list
14749478|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14749479|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14749480|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434772|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
14434773|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434774|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14434775|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14434776|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434777|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14434778|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
14434779|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434780|NCT01822535|Midodrine|midodrine|mesh-list
14434781|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
14434782|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
14434783|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434784|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434785|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14434786|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14434787|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14434788|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14434789|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434790|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749481|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749482|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
14749483|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749484|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749485|NCT04431778|Ethosuximide|ethosuximide|mesh-list
14434791|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434792|NCT01822548|Metformin|metformin|mesh-list
14434793|NCT01822548|Vildagliptin|vildagliptin|mesh-list
14749486|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
14749487|NCT04423718|Aflibercept|aflibercept|mesh-list
14749488|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14749489|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14749490|NCT04423718|Growth Substances|growth substances|mesh-ancestor
14749491|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749492|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
14434794|NCT01822548|Glyburide|glyburide|mesh-list
14434795|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14434796|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434797|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14434798|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
14434799|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434800|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434801|NCT01822561|Eplerenone|eplerenone|mesh-list
14434802|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14434803|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
14434804|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14434805|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434806|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14434807|NCT01822561|Diuretics|diuretics|mesh-ancestor
14434808|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
14434809|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14434810|NCT01822587|Propranolol|propranolol|mesh-list
14434811|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14434812|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14434813|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434814|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434815|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434816|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434817|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14434818|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14434819|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
14434820|NCT01822665|Acetaminophen|acetaminophen|mesh-list
14434821|NCT01822665|Ibuprofen|ibuprofen|mesh-list
14928233|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928234|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928235|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
14928236|NCT01421797|Hormones|hormones|mesh-ancestor
14928237|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928238|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14928239|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928240|NCT01421810|Dexamethasone|dexamethasone|mesh-list
14928241|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434822|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14434823|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14434824|NCT01822665|Analgesics|analgesics|mesh-ancestor
14434825|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
14434826|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434827|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434828|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434829|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434830|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14434831|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928242|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
14468608|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14928243|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
14928244|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928245|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928246|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14434832|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434833|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
14749493|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434834|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14434835|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
14434836|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14434837|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14434838|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434839|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434840|NCT01822756|Gemcitabine|gemcitabine|mesh-list
14434841|NCT01822756|Paclitaxel|paclitaxel|mesh-list
14434842|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14434843|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434844|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
14434845|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
14434846|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
14434847|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434848|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14434849|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
14434850|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
14434851|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434852|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434853|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749494|NCT04423029|Nivolumab|nivolumab|mesh-list
14749495|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749496|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749497|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749498|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749499|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
14749500|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14749501|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434854|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
14434855|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434856|NCT01822821|Acetaminophen|acetaminophen|mesh-list
14434857|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14434858|NCT01822821|Analgesics|analgesics|mesh-ancestor
14434859|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
14434860|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434861|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434862|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
14434863|NCT01822886|Gemcitabine|gemcitabine|mesh-list
14434864|NCT01822886|Romidepsin|romidepsin|mesh-list
14434865|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749502|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749503|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14434866|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
14434867|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434868|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434869|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
14434870|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434871|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749504|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14928247|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
14928248|NCT01421810|Hormones|hormones|mesh-ancestor
14931218|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14434872|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14434873|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
14434874|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434875|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14434876|NCT01822899|Fluticasone|fluticasone|mesh-list
14434877|NCT01822899|Xhance|xhance|mesh-list
14434878|NCT01822899|Bromides|bromides|mesh-list
14434879|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14434880|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434881|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14434882|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
14434883|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434884|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434885|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14434886|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
14434887|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
14434888|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14434889|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14749505|NCT04417049|Protective Agents|protective agents|mesh-ancestor
14434890|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14434891|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14434892|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14434893|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434894|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434895|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
14434896|NCT01823146|Oxytocin|oxytocin|mesh-list
14434897|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
14434898|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14434899|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434900|NCT01823224|Acetaminophen|acetaminophen|mesh-list
14434901|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14434902|NCT01823224|Analgesics|analgesics|mesh-ancestor
14434903|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
14434904|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434905|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434906|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
14434907|NCT01823289|Itraconazole|itraconazole|mesh-list
14434908|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
14434909|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14434910|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14434911|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14434912|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434913|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434914|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14434915|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
14434916|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14434917|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434918|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14434919|NCT01823328|Ketamine|ketamine|mesh-list
14434920|NCT01823328|Etomidate|etomidate|mesh-list
14434921|NCT01823328|Analgesics|analgesics|mesh-ancestor
14434922|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
14434923|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434924|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749506|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749507|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14749508|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14749509|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
14749510|NCT04401748|Azacitidine|azacitidine|mesh-list
14749511|NCT04401748|Venetoclax|venetoclax|mesh-list
14749512|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749513|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
14749514|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749515|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749516|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749517|NCT04372927|Cisplatin|cisplatin|mesh-list
14749518|NCT04372927|Etoposide|etoposide|mesh-list
14434925|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14434926|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14434927|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
14434928|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
14434929|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434930|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14434931|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14434932|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14434933|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434934|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14434935|NCT01823497|Morphine|morphine|mesh-list
14434936|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14434937|NCT01823497|Narcotics|narcotics|mesh-ancestor
14434938|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14434939|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434940|NCT01823497|Analgesics|analgesics|mesh-ancestor
14434941|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
14434942|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434943|NCT01823510|Aspirin|aspirin|mesh-list
14434944|NCT01823510|Clopidogrel|clopidogrel|mesh-list
14434945|NCT01823510|Ticagrelor|ticagrelor|mesh-list
14434946|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14434947|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14434948|NCT01823510|Analgesics|analgesics|mesh-ancestor
14434949|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
14434950|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14434951|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434952|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14434953|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14434954|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14434955|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14434956|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434957|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14434958|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14434959|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434960|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
14434961|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14434962|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14434963|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14434964|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
14434965|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468609|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468610|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14468611|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
14468612|NCT02283294|Warfarin|warfarin|mesh-list
14468613|NCT02283294|Apixaban|apixaban|mesh-list
14749519|NCT04372927|Pemetrexed|pemetrexed|mesh-list
14434966|NCT01823679|Capecitabine|capecitabine|mesh-list
14434967|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14434968|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
14434969|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434970|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434971|NCT01823835|Palbociclib|palbociclib|mesh-list
14434972|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14434973|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14434974|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434975|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434976|NCT01824290|Tadalafil|tadalafil|mesh-list
14434977|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
14434978|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14434979|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14434980|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14434981|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434982|NCT01824290|Urological Agents|urological agents|mesh-ancestor
14434983|NCT01824342|Denosumab|denosumab|mesh-list
14434984|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14434985|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14434986|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14434987|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
14434988|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14434989|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14434990|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14434991|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14434992|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
14434993|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
14434994|NCT01824693|Melphalan|melphalan|mesh-list
14434995|NCT01824693|Busulfan|busulfan|mesh-list
14434996|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
14434997|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14434998|NCT01824693|Fludarabine|fludarabine|mesh-list
14434999|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
14435000|NCT01824693|Tacrolimus|tacrolimus|mesh-list
14435001|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435002|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
14749520|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
14749521|NCT04372927|Durvalumab|durvalumab|mesh-list
14749522|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
14749523|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
14435003|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435004|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14435005|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14435006|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
14435007|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435008|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435009|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14435010|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435011|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
14435012|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14435013|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435014|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14435015|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14435016|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
14435017|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435018|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435019|NCT01824823|Afatinib|afatinib|mesh-list
14435020|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435021|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435022|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435023|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435024|NCT01824901|Docetaxel|docetaxel|mesh-list
14435025|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435026|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14435027|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14435028|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14435029|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435030|NCT01825122|Nadolol|nadolol|mesh-list
14435031|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14435032|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14435033|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
14749524|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14749525|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
14435034|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435035|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435036|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435037|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14435038|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14435039|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
14435040|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
14435041|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435042|NCT01825408|Azithromycin|azithromycin|mesh-list
14435043|NCT01825408|Doxycycline|doxycycline|mesh-list
14435044|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14435045|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435046|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435047|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
14435048|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14435049|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14435050|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14435051|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435052|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435053|NCT01825512|Deferasirox|deferasirox|mesh-list
14435054|NCT01825512|Deferiprone|deferiprone|mesh-list
14435055|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14435056|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
14435057|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
14435058|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435059|NCT01825577|Methylphenidate|methylphenidate|mesh-list
14435060|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14435061|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435062|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14435063|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14435064|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435065|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435066|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
14435067|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749526|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749527|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14749528|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14435068|NCT01825655|Cetirizine|cetirizine|mesh-list
14435069|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14435070|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14435071|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14435072|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
14435073|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
14435074|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435075|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435076|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435077|NCT01825798|Metformin|metformin|mesh-list
14435078|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435079|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435080|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14435081|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
14435082|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14435083|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14435084|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435085|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435086|NCT01825876|Warfarin|warfarin|mesh-list
14435087|NCT01825876|Evacetrapib|evacetrapib|mesh-list
14749529|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14435088|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
14435089|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14435090|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14435091|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
14435092|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435093|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14435094|NCT01825889|Evacetrapib|evacetrapib|mesh-list
14435095|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14435096|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14435097|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
14435098|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435099|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14435100|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
14435101|NCT01825941|Promethazine|promethazine|mesh-list
14435102|NCT01825941|Metoclopramide|metoclopramide|mesh-list
14435103|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14435104|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14435105|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435106|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435107|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14435108|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
14435109|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
14435110|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435111|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
14435112|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
14435113|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14749530|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749531|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749532|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14749533|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14749534|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14435114|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14435115|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
14435116|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
14435117|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435118|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435119|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14435120|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
14435121|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
14435122|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14435123|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14435124|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
14435125|NCT01826370|Linagliptin|linagliptin|mesh-list
14435126|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435127|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435128|NCT01826370|Incretins|incretins|mesh-ancestor
14435129|NCT01826370|Hormones|hormones|mesh-ancestor
14435130|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435131|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14435132|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
14435133|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435134|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435135|NCT01826448|Vemurafenib|vemurafenib|mesh-list
14435136|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435137|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435138|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435139|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435140|NCT01826851|Bupivacaine|bupivacaine|mesh-list
14749535|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
14749536|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749537|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
14749538|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749539|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
14749540|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
14749541|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
14749542|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14749543|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14749544|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749545|NCT04353661|Azithromycin|azithromycin|mesh-list
14435141|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
14749546|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14749547|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435142|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
14435143|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435144|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435145|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
14435146|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749548|NCT04349267|Nivolumab|nivolumab|mesh-list
14749549|NCT04349267|Cetuximab|cetuximab|mesh-list
14749550|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749551|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749552|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749553|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749554|NCT04322006|Antibodies|antibodies|mesh-list
14749555|NCT04322006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14749556|NCT04322006|Immunologic Factors|immunologic factors|mesh-ancestor
14749557|NCT04322006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749558|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
14749559|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14749560|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14749561|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749562|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
14749563|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
14749564|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749565|NCT04303702|Oxytocin|oxytocin|mesh-list
14749566|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
14749567|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14749568|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749569|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
14749570|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14749571|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
14749572|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749573|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749574|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
14749575|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14435147|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
14749576|NCT04285567|Rituximab|rituximab|mesh-list
14749577|NCT04285567|Fludarabine|fludarabine|mesh-list
14749578|NCT04285567|Venetoclax|venetoclax|mesh-list
14749579|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
14749580|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749581|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
14749582|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749583|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749584|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14435148|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
14435149|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749585|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
14749586|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749587|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435150|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14435151|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14435152|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14435153|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435154|NCT01827163|Paclitaxel|paclitaxel|mesh-list
14435155|NCT01827163|Trastuzumab|trastuzumab|mesh-list
14435156|NCT01827163|Lapatinib|lapatinib|mesh-list
14435157|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14435158|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435159|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14435160|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14435161|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14435162|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435163|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14435164|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435165|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435166|NCT01827254|Sunitinib|sunitinib|mesh-list
14435167|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435168|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14435169|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14435170|NCT01827254|Growth Substances|growth substances|mesh-ancestor
14435171|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435172|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
14435173|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435174|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435175|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435176|NCT01827267|Sirolimus|sirolimus|mesh-list
14435177|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435178|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435179|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14435180|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435181|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
14435182|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435183|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
14435184|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749588|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14749589|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749590|NCT04250155|Atezolizumab|atezolizumab|mesh-list
14749591|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749592|NCT04247542|Vancomycin|vancomycin|mesh-list
14435185|NCT01827332|Oxytocin|oxytocin|mesh-list
14435186|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
14435187|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14435188|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435189|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
14435190|NCT01827358|Mupirocin|mupirocin|mesh-list
14435191|NCT01827358|Calcium|calcium|mesh-list
14435192|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14435193|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435194|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14435195|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14749593|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14749594|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749595|NCT04246437|Carbidopa|carbidopa|mesh-list
14749596|NCT04246437|Entacapone|entacapone|mesh-list
14749597|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14435196|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435197|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14435198|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435199|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435200|NCT01827462|Vaccines|vaccines|mesh-list
14435201|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
14435202|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435203|NCT01827475|Acetaminophen|acetaminophen|mesh-list
14435204|NCT01827475|Ibuprofen|ibuprofen|mesh-list
14435205|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14435206|NCT01827475|Analgesics|analgesics|mesh-ancestor
14435207|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
14435208|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435209|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435210|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
14435211|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14435212|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435213|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749598|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14749599|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
14435214|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14435215|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435216|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435217|NCT01827670|Fluorides|fluorides|mesh-list
14749600|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749601|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435218|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
14435219|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
14435220|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
14435221|NCT01827670|Protective Agents|protective agents|mesh-ancestor
14435222|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435223|NCT01827839|Vaccines|vaccines|mesh-list
14435224|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
14435225|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435226|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
14435227|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435228|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435229|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435230|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435231|NCT01827943|Sirolimus|sirolimus|mesh-list
14749602|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749603|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14749604|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749605|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14749606|NCT04240002|Cytarabine|cytarabine|mesh-list
14749607|NCT04240002|Fludarabine|fludarabine|mesh-list
14749608|NCT04240002|Sargramostim|sargramostim|mesh-list
14749609|NCT04240002|Lenograstim|lenograstim|mesh-list
14749610|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749611|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749612|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
14749613|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749614|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749615|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
14435232|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435233|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435234|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14435235|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435236|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
14435237|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435238|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
14435239|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435240|NCT01828034|Gemcitabine|gemcitabine|mesh-list
14435241|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435242|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435243|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
14435244|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435245|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
14435246|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435247|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435248|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435249|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
14435250|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435251|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
14435252|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14435253|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14435254|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
14749616|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749617|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
14749618|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749619|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14749620|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
14749621|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749622|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749623|NCT04222972|Gemcitabine|gemcitabine|mesh-list
14749624|NCT04222972|Paclitaxel|paclitaxel|mesh-list
14749625|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14749626|NCT04222972|Carboplatin|carboplatin|mesh-list
14749627|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
14749628|NCT04222972|Pemetrexed|pemetrexed|mesh-list
14749629|NCT04222972|Pralsetinib|pralsetinib|mesh-list
14749630|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14749631|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749632|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
14749633|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
14749634|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
14435255|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435256|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14435257|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14435258|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435259|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435260|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
14435261|NCT01828476|Navitoclax|navitoclax|mesh-list
14435262|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
14435263|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14435264|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14435265|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435266|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435267|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435268|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14435269|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435270|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
14435271|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14435272|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435273|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
14435274|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14435275|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14435276|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14435277|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435278|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435279|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435280|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
14749635|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749636|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749637|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
14749638|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
14749639|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749640|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749641|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749642|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
14749643|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749644|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749645|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14749646|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14749647|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
14749648|NCT04196413|Fludarabine|fludarabine|mesh-list
14749649|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749650|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
14749651|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749652|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749653|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14749654|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
14749655|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749656|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749657|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14749658|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
14749659|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14749660|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14928249|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928250|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14928251|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928252|NCT01421901|Ertapenem|ertapenem|mesh-list
14928253|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435281|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435282|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14435283|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14435284|NCT01828554|Capecitabine|capecitabine|mesh-list
14435285|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435286|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
14435287|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435288|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435289|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
14435290|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14435291|NCT01828593|Antibodies|antibodies|mesh-list
14435292|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
14435293|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435294|NCT01829217|Sunitinib|sunitinib|mesh-list
14435295|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435296|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14435297|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14435298|NCT01829217|Growth Substances|growth substances|mesh-ancestor
14435299|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435300|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
14435301|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435302|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435303|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435304|NCT01829243|Milnacipran|milnacipran|mesh-list
14435305|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
14435306|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14435307|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14435308|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435309|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435310|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435311|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435312|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14435313|NCT01829243|Analgesics|analgesics|mesh-ancestor
14435314|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
14435315|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435316|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
14435317|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14435318|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
14435319|NCT01829295|Prednisone|prednisone|mesh-list
14435320|NCT01829295|Methotrexate|methotrexate|mesh-list
14435321|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435322|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
14435323|NCT01829295|Hormones|hormones|mesh-ancestor
14435324|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435325|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435326|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14435327|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435328|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14435329|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
14435330|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14435331|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435332|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
14435333|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435334|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
14435335|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435336|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14435337|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435338|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
14435339|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14435340|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14435341|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14435342|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14435343|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
14435344|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435345|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435346|NCT01829399|Epinephrine|epinephrine|mesh-list
14435347|NCT01829399|Bupivacaine|bupivacaine|mesh-list
14435348|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
14435349|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
14435350|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435351|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435352|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
14435353|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435354|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14749661|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14435355|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14435356|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
14435357|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435358|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435359|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14435360|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14435361|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
14435362|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14435363|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
14435364|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
14435365|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
14435366|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14435367|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14435368|NCT01829425|Oxybutynin|oxybutynin|mesh-list
14435369|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14435370|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14435371|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
14435372|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435373|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928254|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928255|NCT01421914|Bupivacaine|bupivacaine|mesh-list
14928256|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
14928257|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
14928258|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928259|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928260|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
14928261|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435374|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435375|NCT01829425|Urological Agents|urological agents|mesh-ancestor
14435376|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
14435377|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
14435378|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435379|NCT01829503|Cytarabine|cytarabine|mesh-list
14435380|NCT01829503|Decitabine|decitabine|mesh-list
14435381|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435382|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
14435383|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435384|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435385|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
14435386|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435387|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435388|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
14435389|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435390|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435391|NCT01829516|Oxytocin|oxytocin|mesh-list
14435392|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
14435393|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14435394|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435395|NCT01829919|Paroxetine|paroxetine|mesh-list
14435396|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14435397|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14435398|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435399|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435400|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435401|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
14435402|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435403|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14435404|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14435405|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14435406|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14435407|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14435408|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435409|NCT01830127|Ribavirin|ribavirin|mesh-list
14435410|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
14435411|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435412|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
14435413|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435414|NCT01830140|Bimatoprost|bimatoprost|mesh-list
14435415|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14435416|NCT01830543|Aspirin|aspirin|mesh-list
14435417|NCT01830543|Vitamin K|vitamin k|mesh-list
14435418|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
14435419|NCT01830543|Clopidogrel|clopidogrel|mesh-list
14435420|NCT01830543|Ticagrelor|ticagrelor|mesh-list
14435421|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14435422|NCT01830543|Vitamins|vitamins|mesh-ancestor
14435423|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
14435424|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435425|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14435426|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14435427|NCT01830543|Analgesics|analgesics|mesh-ancestor
14435428|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
14435429|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435430|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435431|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14435432|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14435433|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14435434|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928262|NCT01421927|Lenalidomide|lenalidomide|mesh-list
14928263|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
14928264|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928265|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14928266|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14928267|NCT01421927|Growth Substances|growth substances|mesh-ancestor
14928268|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
14435435|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14435436|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14435437|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435438|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
14435439|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14928269|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928270|NCT01421940|Udenafil|udenafil|mesh-list
14435440|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14435441|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14435442|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
14435443|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435444|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14435445|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
14435446|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14435447|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
14435448|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
14435449|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14435450|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
14435451|NCT01830543|Coagulants|coagulants|mesh-ancestor
14468614|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
14468615|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14468616|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
14468617|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14468618|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
14468619|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468620|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468621|NCT02283658|Everolimus|everolimus|mesh-list
14468622|NCT02283658|Letrozole|letrozole|mesh-list
14468623|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468624|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14468625|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
14468626|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468627|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14468628|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14468629|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468630|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468631|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14468632|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
14468633|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468634|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14468635|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468636|NCT02283762|Riociguat|riociguat|mesh-list
14468637|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
14468638|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468639|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
14468640|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468641|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14468642|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468643|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14468644|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14468645|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468646|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468647|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468648|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
14468649|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468650|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468651|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468652|NCT02283814|Topiramate|topiramate|mesh-list
14468653|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14435452|NCT01830595|Lactoferrin|lactoferrin|mesh-list
14435453|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435454|NCT01830699|Triamcinolone|triamcinolone|mesh-list
14435455|NCT01830699|Rilonacept|rilonacept|mesh-list
14749662|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14749663|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749664|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
14749665|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749666|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749667|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14749668|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749669|NCT04177953|Carboplatin|carboplatin|mesh-list
14749670|NCT04177953|Nivolumab|nivolumab|mesh-list
14749671|NCT04177953|Pemetrexed|pemetrexed|mesh-list
14749672|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749673|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749674|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749675|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749676|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749677|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14749678|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14749679|NCT04153422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14749680|NCT04153422|Immunologic Factors|immunologic factors|mesh-ancestor
14749681|NCT04153422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749682|NCT04151082|Prednisone|prednisone|mesh-list
14749683|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
14435456|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435457|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
14435458|NCT01830699|Hormones|hormones|mesh-ancestor
14435459|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435460|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435461|NCT01830816|Ixazomib|ixazomib|mesh-list
14435462|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435463|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
14435464|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435465|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435466|NCT01830842|Nicotine|nicotine|mesh-list
14435467|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14435468|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
14435469|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435470|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435471|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14435472|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14435473|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
14435474|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435475|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435476|NCT01830881|Ibuprofen|ibuprofen|mesh-list
14435477|NCT01830881|Lidocaine|lidocaine|mesh-list
14435478|NCT01830881|Midazolam|midazolam|mesh-list
14435479|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
14435480|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
14435481|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435482|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435483|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
14435484|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435485|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14435486|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14435487|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14435488|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435489|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435490|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14435491|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14435492|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14435493|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14435494|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14435495|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14435496|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
14435497|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
14435498|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
14435499|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435500|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14435501|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14435502|NCT01830881|Analgesics|analgesics|mesh-ancestor
14435503|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435504|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14435505|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14435506|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435507|NCT01831089|Paclitaxel|paclitaxel|mesh-list
14435508|NCT01831089|Bevacizumab|bevacizumab|mesh-list
14435509|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14435510|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435511|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
14435512|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
14435513|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
14435514|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435515|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14928271|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14928272|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14928273|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928274|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928275|NCT01421979|Caffeine|caffeine|mesh-list
14928276|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14928277|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928278|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14435516|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14435517|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14435518|NCT01831089|Growth Substances|growth substances|mesh-ancestor
14435519|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435520|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14435521|NCT01831232|Cytarabine|cytarabine|mesh-list
14435522|NCT01831232|Idarubicin|idarubicin|mesh-list
14435523|NCT01831232|Pravastatin|pravastatin|mesh-list
14435524|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435525|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
14435526|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435527|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435528|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
14435529|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435530|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435531|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
14435532|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435533|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14435534|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14435535|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14435536|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435537|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14435538|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14435539|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14435540|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14435541|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14435542|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
14928279|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435543|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435544|NCT01831466|Tofacitinib|tofacitinib|mesh-list
14435545|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435546|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435547|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435548|NCT01831765|Insulin|insulin|mesh-list
14435549|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14435550|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
14435551|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
14435552|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14435553|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
14435554|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435555|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435556|NCT01831791|Dutasteride|dutasteride|mesh-list
14435557|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14435558|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14435559|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468654|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
14435560|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435561|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
14435562|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435563|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435564|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
14435565|NCT01831817|Listerine|listerine|mesh-list
14435566|NCT01831817|Calcium|calcium|mesh-list
14435567|NCT01831817|Fluorides|fluorides|mesh-list
14435568|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
14435569|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
14435570|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14435571|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435572|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14435573|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
14435574|NCT01831817|Protective Agents|protective agents|mesh-ancestor
14435575|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14435576|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435577|NCT01831934|Vaccines|vaccines|mesh-list
14435578|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
14435579|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435580|NCT01832038|Lacosamide|lacosamide|mesh-list
14435581|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
14435582|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14435583|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14435584|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435585|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435586|NCT01832402|Fentanyl|fentanyl|mesh-list
14435587|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14435588|NCT01832402|Narcotics|narcotics|mesh-ancestor
14435589|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435590|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435591|NCT01832402|Analgesics|analgesics|mesh-ancestor
14928280|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928281|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14928282|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14928283|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
14928284|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928285|NCT01421992|Methylphenidate|methylphenidate|mesh-list
14928286|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14928287|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928288|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14928289|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14928290|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928291|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928292|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
14928293|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928294|NCT01422018|Bevacizumab|bevacizumab|mesh-list
14928295|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14928296|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928297|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14928298|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14928299|NCT01422018|Growth Substances|growth substances|mesh-ancestor
14928300|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435592|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
14435593|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435594|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14435595|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14435596|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
14435597|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
14435598|NCT01832532|Liraglutide|liraglutide|mesh-list
14435599|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435600|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435601|NCT01832532|Incretins|incretins|mesh-ancestor
14435602|NCT01832532|Hormones|hormones|mesh-ancestor
14435603|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435604|NCT01832727|Dexamethasone|dexamethasone|mesh-list
14435605|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435606|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
14435607|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
14468655|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435608|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435609|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435610|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14435611|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
14435612|NCT01832727|Hormones|hormones|mesh-ancestor
14435613|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435614|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14435615|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435616|NCT01832766|Dronabinol|dronabinol|mesh-list
14435617|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
14435618|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435619|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14435620|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14435621|NCT01832766|Analgesics|analgesics|mesh-ancestor
14928301|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
14928302|NCT01422096|Leuprolide|leuprolide|mesh-list
14928303|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14928304|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
14928305|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14928306|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928307|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14928308|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928309|NCT01422109|Aspirin|aspirin|mesh-list
14928310|NCT01422109|Clopidogrel|clopidogrel|mesh-list
14928311|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928312|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14928313|NCT01422109|Analgesics|analgesics|mesh-ancestor
14928314|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
14435622|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
14435623|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435624|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14435625|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14435626|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435627|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435628|NCT01832766|Hormones|hormones|mesh-ancestor
14435629|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435630|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
14928315|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928316|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928317|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928318|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928319|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14928320|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14928321|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435631|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
14435632|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435633|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435634|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14435635|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
14435636|NCT01833026|Albuterol|albuterol|mesh-list
14435637|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14435638|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
14435639|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435640|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435641|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14435642|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
14435643|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
14435644|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14435645|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14435646|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14435647|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14435648|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
14435649|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435650|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435651|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
14435652|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14435653|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14435654|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14435655|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435656|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435657|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
14435658|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435659|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435660|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14435661|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435662|NCT01833143|Acyclovir|acyclovir|mesh-list
14435663|NCT01833143|Bortezomib|bortezomib|mesh-list
14435664|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435665|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
14435666|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435667|NCT01833455|Flecainide|flecainide|mesh-list
14435668|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14435669|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14435670|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14435671|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435672|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435673|NCT01833533|Ribavirin|ribavirin|mesh-list
14435674|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
14435675|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435676|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
14435677|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435678|NCT01833546|Gemcitabine|gemcitabine|mesh-list
14435679|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435680|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
14435681|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928322|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14435682|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928323|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14435683|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
14928324|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928325|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
14928326|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14928327|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14928328|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14928329|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
14928330|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928331|NCT01422122|Vitamin D|vitamin d|mesh-list
14928332|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
14928333|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
14928334|NCT01422122|Vitamins|vitamins|mesh-list
14928335|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
14435684|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435685|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435686|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435687|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
14435688|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435689|NCT01833741|Bimatoprost|bimatoprost|mesh-list
14435690|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14435691|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
14435692|NCT01833832|Antidotes|antidotes|mesh-ancestor
14435693|NCT01833832|Protective Agents|protective agents|mesh-ancestor
14435694|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435695|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
14435696|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435697|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
14435698|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435699|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435700|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
14435701|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
14435702|NCT01833845|Ribavirin|ribavirin|mesh-list
14435703|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
14435704|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
14435705|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435706|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
14435707|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435708|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
14435709|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14435710|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14435711|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435712|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14435713|NCT01833897|Cycloserine|cycloserine|mesh-list
14435714|NCT01833897|Ketamine|ketamine|mesh-list
14435715|NCT01833897|Olanzapine|olanzapine|mesh-list
14435716|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14435717|NCT01833897|Fluoxetine|fluoxetine|mesh-list
14435718|NCT01833897|Analgesics|analgesics|mesh-ancestor
14435719|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
14928336|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435720|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435721|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435722|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14435723|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14435724|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
14435725|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
14435726|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435727|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14435728|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14435729|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435730|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435731|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
14435732|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
14435733|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14435734|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14435735|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14435736|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14435737|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14435738|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14435739|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435740|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
14435741|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
14435742|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14435743|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14435744|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14435745|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435746|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14435747|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435748|NCT01833897|Renal Agents|renal agents|mesh-ancestor
14435749|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14435750|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
14435751|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435752|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
14435753|NCT01833988|Pancrelipase|pancrelipase|mesh-list
14435754|NCT01833988|Pancreatin|pancreatin|mesh-list
14435755|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14435756|NCT01834261|Oxytocin|oxytocin|mesh-list
14435757|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
14435758|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14435759|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435760|NCT01834274|Metformin|metformin|mesh-list
14435761|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14435762|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435763|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435764|NCT01834274|Incretins|incretins|mesh-ancestor
14435765|NCT01834274|Hormones|hormones|mesh-ancestor
14435766|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749684|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14749685|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14749686|NCT04151082|Prednisolone|prednisolone|mesh-list
14749687|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
14749688|NCT04151082|Cortisone|cortisone|mesh-list
14435767|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14435768|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
14435769|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435770|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435771|NCT01834404|Topiramate|topiramate|mesh-list
14435772|NCT01834404|Phentermine|phentermine|mesh-list
14435773|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
14435774|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435775|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435776|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14435777|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
14749689|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14749690|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
14749691|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749692|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
14749693|NCT04151082|Hormones|hormones|mesh-ancestor
14749694|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749695|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749696|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14749697|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749698|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
14749699|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
14749700|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749701|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14749702|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14749703|NCT04151082|Protective Agents|protective agents|mesh-ancestor
14749704|NCT04149574|Nivolumab|nivolumab|mesh-list
14749705|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
14749706|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749707|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435778|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14749708|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749709|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749710|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14749711|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
14749712|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749713|NCT04145076|Citalopram|citalopram|mesh-list
14749714|NCT04145076|Tianeptine|tianeptine|mesh-list
14749715|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14749716|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14749717|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928337|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14928338|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14928339|NCT01422291|Acetaminophen|acetaminophen|mesh-list
14435779|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
14435780|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
14435781|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435782|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
14435783|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435784|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435785|NCT01834586|Anesthetics|anesthetics|mesh-list
14435786|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928340|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14928341|NCT01422291|Morphine|morphine|mesh-list
14928342|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14928343|NCT01422291|Narcotics|narcotics|mesh-ancestor
14928344|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928345|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928346|NCT01422291|Analgesics|analgesics|mesh-ancestor
14928347|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
14928348|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928349|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14928350|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
14928351|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928352|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435787|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435788|NCT01834729|Alfuzosin|alfuzosin|mesh-list
14928353|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928354|NCT01422317|Tocopherols|tocopherols|mesh-list
14928355|NCT01422317|Vitamin E|vitamin e|mesh-list
14435789|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14435790|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14435791|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14435792|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14435793|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435794|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435795|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435796|NCT01834729|Urological Agents|urological agents|mesh-ancestor
14435797|NCT01835158|Sunitinib|sunitinib|mesh-list
14435798|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435799|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14435800|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14435801|NCT01835158|Growth Substances|growth substances|mesh-ancestor
14435802|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435803|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
14435804|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435805|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435806|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435807|NCT01835262|Ketamine|ketamine|mesh-list
14435808|NCT01835262|Morphine|morphine|mesh-list
14435809|NCT01835262|Analgesics|analgesics|mesh-ancestor
14435810|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
14435811|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435812|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435813|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14435814|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14435815|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
14435816|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
14435817|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435818|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14435819|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14435820|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435821|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435822|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14435823|NCT01835262|Narcotics|narcotics|mesh-ancestor
14435824|NCT01835431|Insulin|insulin|mesh-list
14435825|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14435826|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
14435827|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
14435828|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14435829|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
14435830|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435831|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435832|NCT01835470|Abatacept|abatacept|mesh-list
14435833|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14928356|NCT01422317|Tocotrienols|tocotrienols|mesh-list
14928357|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
14928358|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
14928359|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928360|NCT01422317|Protective Agents|protective agents|mesh-ancestor
14928361|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928362|NCT01422317|Vitamins|vitamins|mesh-ancestor
14928363|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
14928364|NCT01422330|Etravirine|etravirine|mesh-list
14928365|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14928366|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14928367|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928368|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928369|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
14928370|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928371|NCT01422460|Mitogens|mitogens|mesh-list
14928372|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
14928373|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928374|NCT01422499|Vorinostat|vorinostat|mesh-list
14928375|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928376|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14928377|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928378|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928379|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14928380|NCT01422590|Mitiglinide|mitiglinide|mesh-list
14435834|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435835|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435836|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435837|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
14435838|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435839|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14435840|NCT01835496|Deferiprone|deferiprone|mesh-list
14435841|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14435842|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
14435843|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
14435844|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435845|NCT01835587|Cc-486|cc-486|mesh-list
14435846|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435847|NCT01835912|Citric Acid|citric acid|mesh-list
14435848|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
14435849|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
14435850|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14435851|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
14435852|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
14749718|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749719|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749720|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
14749721|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749722|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14749723|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
14749724|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14749725|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14749726|NCT04133948|Nivolumab|nivolumab|mesh-list
14749727|NCT04133948|Ipilimumab|ipilimumab|mesh-list
14749728|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749729|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749730|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14749731|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749732|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
14749733|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749734|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
14749735|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928381|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14749736|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749737|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
14749738|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
14749739|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14749740|NCT04094961|Dexamethasone|dexamethasone|mesh-list
14749741|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
14749742|NCT04094961|Pomalidomide|pomalidomide|mesh-list
14749743|NCT04094961|Ixazomib|ixazomib|mesh-list
14749744|NCT04094961|BB 1101|bb 1101|mesh-list
14749745|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749746|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
14749747|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
14749748|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749749|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749750|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14435853|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435854|NCT01836029|Carboplatin|carboplatin|mesh-list
14435855|NCT01836029|Fluorouracil|fluorouracil|mesh-list
14435856|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435857|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
14435858|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435859|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14435860|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14435861|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
14435862|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435863|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14435864|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14435865|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435866|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435867|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435868|NCT01836185|Evacetrapib|evacetrapib|mesh-list
14435869|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14435870|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14435871|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
14435872|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435873|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14435874|NCT01836198|Clarithromycin|clarithromycin|mesh-list
14435875|NCT01836198|Ketoconazole|ketoconazole|mesh-list
14435876|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
14435877|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14435878|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435879|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14435880|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435881|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435882|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14435883|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14435884|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
14435885|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14435886|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14435887|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
14435888|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14435889|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435890|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14435891|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
14435892|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14435893|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14435894|NCT01836276|Varenicline|varenicline|mesh-list
14435895|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14435896|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14435897|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
14435898|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749751|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
14749752|NCT04094961|Hormones|hormones|mesh-ancestor
14435899|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435900|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435901|NCT01836471|Fluticasone|fluticasone|mesh-list
14435902|NCT01836471|Xhance|xhance|mesh-list
14435903|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
14435904|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14435905|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14435906|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
14435907|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435908|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435909|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14435910|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
14435911|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
14435912|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14435913|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14435914|NCT01836471|Growth Substances|growth substances|mesh-ancestor
14435915|NCT01836523|Liraglutide|liraglutide|mesh-list
14435916|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435917|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435918|NCT01836523|Incretins|incretins|mesh-ancestor
14435919|NCT01836523|Hormones|hormones|mesh-ancestor
14435920|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468656|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468657|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468658|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468659|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468660|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468661|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468662|NCT02283827|Phenytoin|phenytoin|mesh-list
14468663|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
14468664|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468665|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468666|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468667|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468668|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14468669|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14468670|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468671|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
14468672|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468673|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468674|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468675|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468676|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
14468677|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749753|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749754|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14749755|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749756|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
14749757|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749758|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749759|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
14749760|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14749761|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14749762|NCT04094961|Growth Substances|growth substances|mesh-ancestor
14749763|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753655|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14468678|NCT02284009|Incretins|incretins|mesh-ancestor
14468679|NCT02284009|Hormones|hormones|mesh-ancestor
14468680|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468681|NCT02284126|Vancomycin|vancomycin|mesh-list
14468682|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14468683|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468684|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
14468685|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14468686|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468687|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468688|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468689|NCT02284243|Analgesics|analgesics|mesh-ancestor
14468690|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
14468691|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468692|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14468693|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14468694|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14753656|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753657|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14928382|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928383|NCT01422590|Incretins|incretins|mesh-ancestor
14749764|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
14749765|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14749766|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
14749767|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749768|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
14749769|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
14749770|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749771|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
14749772|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749773|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
14749774|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749775|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749776|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
14749777|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749778|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
14749779|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
14749780|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749781|NCT04026412|Nivolumab|nivolumab|mesh-list
14749782|NCT04026412|Ipilimumab|ipilimumab|mesh-list
14749783|NCT04026412|Durvalumab|durvalumab|mesh-list
14749784|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749785|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749786|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14435921|NCT01836549|Imetelstat|imetelstat|mesh-list
14435922|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
14435923|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435924|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435925|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14435926|NCT01837069|Metoprolol|metoprolol|mesh-list
14435927|NCT01837069|Lisinopril|lisinopril|mesh-list
14435928|NCT01837069|Atorvastatin|atorvastatin|mesh-list
14435929|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14435930|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14435931|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14435932|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
14435933|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435934|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14435935|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14435936|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435937|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14435938|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14435939|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
14435940|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
14435941|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435942|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435943|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14435944|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14435945|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14435946|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
14435947|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435948|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
14435949|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14435950|NCT01837069|Protective Agents|protective agents|mesh-ancestor
14435951|NCT01837680|Insulin|insulin|mesh-list
14435952|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14435953|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14435954|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928384|NCT01422590|Hormones|hormones|mesh-ancestor
14749787|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435955|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14435956|NCT01837719|Cobicistat|cobicistat|mesh-list
14435957|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14435958|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14435959|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14435960|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14435961|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435962|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14435963|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14435964|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
14435965|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14435966|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14435967|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14435968|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
14435969|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
14435970|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14435971|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435972|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435973|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
14435974|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
14435975|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14435976|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14435977|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14435978|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
14435979|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435980|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14435981|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14435982|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928385|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928386|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14928387|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14928388|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928389|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928390|NCT01422603|Clofarabine|clofarabine|mesh-list
14928391|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14928392|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
14928393|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928394|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928395|NCT01422616|Metoprolol|metoprolol|mesh-list
14928396|NCT01422616|Clonidine|clonidine|mesh-list
14928397|NCT01422616|Hydralazine|hydralazine|mesh-list
14928398|NCT01422616|Labetalol|labetalol|mesh-list
14928399|NCT01422616|Nicardipine|nicardipine|mesh-list
14928400|NCT01422616|Phentolamine|phentolamine|mesh-list
14928401|NCT01422616|Urapidil|urapidil|mesh-list
14928402|NCT01422616|Enalaprilat|enalaprilat|mesh-list
14928403|NCT01422616|Enalapril|enalapril|mesh-list
14928404|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14928405|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
14928406|NCT01422616|Esmolol|esmolol|mesh-list
14928407|NCT01422616|Glycerol|glycerol|mesh-list
14928408|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14928409|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14928410|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
14928411|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
14928412|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928413|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928414|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14928415|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14928416|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14928417|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928418|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928419|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435983|NCT01838044|Celecoxib|celecoxib|mesh-list
14928420|NCT01422616|Analgesics|analgesics|mesh-ancestor
14928421|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
14435984|NCT01838044|Pregabalin|pregabalin|mesh-list
14435985|NCT01838044|Analgesics|analgesics|mesh-ancestor
14435986|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
14435987|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14435988|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14435989|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
14435990|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14435991|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14435992|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14435993|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14435994|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14435995|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14435996|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14435997|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14435998|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14435999|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14436000|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436001|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14436002|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14436003|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14436004|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436005|NCT01838200|Isoniazid|isoniazid|mesh-list
14436006|NCT01838200|Ipilimumab|ipilimumab|mesh-list
14436007|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
14436008|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14436009|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436010|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14436011|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436012|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
14436013|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14436014|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436015|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14436016|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14749788|NCT04016805|Venetoclax|venetoclax|mesh-list
14749789|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
14749790|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749791|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
14749792|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14749793|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749794|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749795|NCT03992443|Reteplase|reteplase|mesh-list
14749796|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14749797|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14749798|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749799|NCT03965728|Methotrexate|methotrexate|mesh-list
14749800|NCT03965728|Midazolam|midazolam|mesh-list
14749801|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14749802|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
14436017|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
14436018|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14436019|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14436020|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
14436021|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436022|NCT01838317|Pioglitazone|pioglitazone|mesh-list
14436023|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436024|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436025|NCT01838447|Vitamin D|vitamin d|mesh-list
14436026|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
14436027|NCT01838447|Vitamins|vitamins|mesh-ancestor
14436028|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
14436029|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436030|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14436031|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14436032|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
14436033|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
14436034|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749803|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14436035|NCT01838616|Oxycodone|oxycodone|mesh-list
14436036|NCT01838616|Tapentadol|tapentadol|mesh-list
14436037|NCT01838616|Naloxone|naloxone|mesh-list
14436038|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14436039|NCT01838616|Narcotics|narcotics|mesh-ancestor
14436040|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436041|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436042|NCT01838616|Analgesics|analgesics|mesh-ancestor
14436043|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
14436044|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436045|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14436046|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14436047|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14436048|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14436049|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436050|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436051|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436052|NCT01838642|Ponatinib|ponatinib|mesh-list
14436053|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436054|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14436055|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436056|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436057|NCT01838655|Nitisinone|nitisinone|mesh-list
14436058|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436059|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436060|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
14436061|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
14436062|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436063|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436064|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436065|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
14436066|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
14436067|NCT01838876|Cariprazine|cariprazine|mesh-list
14436068|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
14436069|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14436070|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14436071|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14436072|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436073|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436074|NCT01838941|Betaine|betaine|mesh-list
14436075|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436076|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
14436077|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14436078|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
14749804|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749805|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14436079|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749806|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
14749807|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749808|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749809|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749810|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436080|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14436081|NCT01839110|Ranolazine|ranolazine|mesh-list
14436082|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14436083|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14436084|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436085|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14436086|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
14436087|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436088|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
14436089|NCT01839279|Tizanidine|tizanidine|mesh-list
14436090|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14436091|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436092|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14436093|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14436094|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436095|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436096|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436097|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436098|NCT01839279|Analgesics|analgesics|mesh-ancestor
14928422|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14928423|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14928424|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14928425|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14928426|NCT01422616|Protective Agents|protective agents|mesh-ancestor
14928427|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
14928428|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
14928429|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14928430|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14436099|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
14436100|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436101|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
14436102|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14436103|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14436104|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
14436105|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
14436106|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14436107|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14436108|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14436109|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436110|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436111|NCT01839487|Gemcitabine|gemcitabine|mesh-list
14436112|NCT01839487|Dexamethasone|dexamethasone|mesh-list
14436113|NCT01839487|Paclitaxel|paclitaxel|mesh-list
14436114|NCT01839487|Enoxaparin|enoxaparin|mesh-list
14436115|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14436116|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436117|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
14436118|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
14436119|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
14436120|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436121|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436122|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
14436123|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
14436124|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436125|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436126|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436127|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
14436128|NCT01839487|Hormones|hormones|mesh-ancestor
14436129|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436130|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14436131|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14436132|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
14436133|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
14436134|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436135|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436136|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436137|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
14436138|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
14436139|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14436140|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14436141|NCT01839799|Gemcitabine|gemcitabine|mesh-list
14436142|NCT01839799|Paclitaxel|paclitaxel|mesh-list
14436143|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14436144|NCT01839799|Folfirinox|folfirinox|mesh-list
14436145|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14436146|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436147|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
14436148|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
14436149|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
14436150|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436151|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14436152|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
14436153|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
14436154|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436155|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436156|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436157|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
14436158|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436159|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
14436160|NCT01840228|Progesterone|progesterone|mesh-list
14436161|NCT01840228|Progestins|progestins|mesh-ancestor
14436162|NCT01840228|Hormones|hormones|mesh-ancestor
14436163|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436164|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749811|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14749812|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749813|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
14749814|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749815|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14749816|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14749817|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14749818|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436165|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
14436166|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14436167|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
14436168|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436169|NCT01840345|Expectorants|expectorants|mesh-ancestor
14436170|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
14436171|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14436172|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
14436173|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436174|NCT01840345|Protective Agents|protective agents|mesh-ancestor
14436175|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436176|NCT01840345|Antidotes|antidotes|mesh-ancestor
14436177|NCT01840410|Ranibizumab|ranibizumab|mesh-list
14749819|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14749820|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14436178|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14436179|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14436180|NCT01840410|Growth Substances|growth substances|mesh-ancestor
14436181|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436182|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
14749821|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14749822|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14436183|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436184|NCT01840579|Paclitaxel|paclitaxel|mesh-list
14436185|NCT01840579|Etoposide|etoposide|mesh-list
14436186|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14436187|NCT01840579|Carboplatin|carboplatin|mesh-list
14436188|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
14436189|NCT01840579|Pemetrexed|pemetrexed|mesh-list
14436190|NCT01840579|Ipilimumab|ipilimumab|mesh-list
14436191|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14436192|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436193|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
14436194|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
14436195|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
14436196|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14749823|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
14749824|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
14749825|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
14749826|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
14749827|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14749828|NCT03960554|Denosumab|denosumab|mesh-list
14749829|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14749830|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749831|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
14749832|NCT03959085|Leucovorin|leucovorin|mesh-list
14749833|NCT03959085|Folic Acid|folic acid|mesh-list
14749834|NCT03959085|Cytarabine|cytarabine|mesh-list
14436197|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14436198|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14436199|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14436200|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436201|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14436202|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14436203|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14436204|NCT01840605|Ketotifen|ketotifen|mesh-list
14436205|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
14436206|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
14436207|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
14436208|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14436209|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
14436210|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
14436211|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436212|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436213|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436214|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14436215|NCT01840943|Topotecan|topotecan|mesh-list
14436216|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14436217|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14436218|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436219|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436220|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436221|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14436222|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
14436223|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14436224|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436225|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
14436226|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436227|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
14436228|NCT01841593|Amlodipine|amlodipine|mesh-list
14436229|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14436230|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14436231|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14436232|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436233|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14436234|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436235|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
14436236|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14436237|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14436238|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
14436239|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749835|NCT03959085|Dexamethasone|dexamethasone|mesh-list
14749836|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
14749837|NCT03959085|Prednisolone|prednisolone|mesh-list
14749838|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14436240|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14436241|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14436242|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436243|NCT01841606|Ondansetron|ondansetron|mesh-list
14436244|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
14928431|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14928432|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14928433|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14928434|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928435|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14928436|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14928437|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
14931219|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436245|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
14436246|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436247|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436248|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436249|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
14436250|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
14436251|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14436252|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
14436253|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436254|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436255|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14436256|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14436257|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436258|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14436259|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14436260|NCT01841697|Metformin|metformin|mesh-list
14436261|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14436262|NCT01841697|Glimepiride|glimepiride|mesh-list
14436263|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436264|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436265|NCT01841697|Incretins|incretins|mesh-ancestor
14436266|NCT01841697|Hormones|hormones|mesh-ancestor
14436267|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436268|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14436269|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
14436270|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436271|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436272|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14436273|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436274|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
14436275|NCT01841762|Macitentan|macitentan|mesh-list
14436276|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14436277|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14436278|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436279|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14436280|NCT01842308|Melphalan|melphalan|mesh-list
14436281|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
14436282|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14436283|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14436284|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
14436285|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436286|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749839|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
14749840|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14749841|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
14749842|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
14749843|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14749844|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14749845|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14749846|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
14436287|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14436288|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436289|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
14436290|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436291|NCT01842334|Nicotine|nicotine|mesh-list
14436292|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14436293|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
14436294|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436295|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436296|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14436297|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14436298|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
14436299|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436300|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436301|NCT01842581|Rifaximin|rifaximin|mesh-list
14436302|NCT01842581|Lactulose|lactulose|mesh-list
14436303|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14436304|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749847|NCT03959085|Doxorubicin|doxorubicin|mesh-list
14436305|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436306|NCT01842594|Sirolimus|sirolimus|mesh-list
14436307|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
14436308|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14436309|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436310|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14436311|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436312|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
14436313|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749848|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14749849|NCT03959085|Methotrexate|methotrexate|mesh-list
14749850|NCT03959085|Vincristine|vincristine|mesh-list
14749851|NCT03959085|Daunorubicin|daunorubicin|mesh-list
14749852|NCT03959085|Asparaginase|asparaginase|mesh-list
14749853|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
14749854|NCT03959085|Pegaspargase|pegaspargase|mesh-list
14928438|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14928439|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
14436314|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
14436315|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436316|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
14436317|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14436318|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14436319|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436320|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436321|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14436322|NCT01842620|Metformin|metformin|mesh-list
14436323|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436324|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436325|NCT01842633|Acetaminophen|acetaminophen|mesh-list
14436326|NCT01842633|Ibuprofen|ibuprofen|mesh-list
14436327|NCT01842633|Caffeine|caffeine|mesh-list
14436328|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14436329|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14436330|NCT01842633|Analgesics|analgesics|mesh-ancestor
14436331|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
14436332|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436333|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436334|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436335|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14436336|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14436337|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436338|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436339|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
14436340|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14436341|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14436342|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14436343|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14436344|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
14436345|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436346|NCT01843023|Naltrexone|naltrexone|mesh-list
14436347|NCT01843023|Buprenorphine|buprenorphine|mesh-list
14436348|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14436349|NCT01843023|Narcotics|narcotics|mesh-ancestor
14436350|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436351|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436352|NCT01843023|Analgesics|analgesics|mesh-ancestor
14436353|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
14436354|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749855|NCT03959085|Thioguanine|thioguanine|mesh-list
14436355|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14436356|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14749856|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14749857|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14928440|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928441|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
14928442|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928443|NCT01422733|Dexamethasone|dexamethasone|mesh-list
14928444|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
14928445|NCT01422733|Cosyntropin|cosyntropin|mesh-list
14928446|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749858|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
14749859|NCT03959085|BB 1101|bb 1101|mesh-list
14749860|NCT03959085|Calcium|calcium|mesh-list
14749861|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
14749862|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
14749863|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14749864|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
14749865|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749866|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749867|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14749868|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
14749869|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928447|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
14928448|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
14928449|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436357|NCT01843205|Methamphetamine|methamphetamine|mesh-list
14436358|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14436359|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436360|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
14436361|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
14436362|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436363|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
14436364|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436365|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436366|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436367|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14436368|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14436369|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14436370|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14436371|NCT01843348|Cyclosporine|cyclosporine|mesh-list
14436372|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
14436373|NCT01843348|Everolimus|everolimus|mesh-list
14436374|NCT01843348|Tacrolimus|tacrolimus|mesh-list
14436375|NCT01843348|Cyclosporins|cyclosporins|mesh-list
14436376|NCT01843348|Basiliximab|basiliximab|mesh-list
14436377|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436378|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
14436379|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436380|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14436381|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436382|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436383|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
14436384|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14749870|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749871|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14749872|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14749873|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
14749874|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
14749875|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14749876|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14749877|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
14749878|NCT03959085|Hormones|hormones|mesh-ancestor
14749879|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14749880|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14749881|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
14749882|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14749883|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14749884|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14749885|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14436385|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
14436386|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749886|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14749887|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14749888|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14749889|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
14749890|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14749891|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14749892|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
14749893|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
14749894|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14749895|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14749896|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
14749897|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436387|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436388|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14436389|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14436390|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
14436391|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14436392|NCT01843621|Vaccines|vaccines|mesh-list
14928450|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928451|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928452|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
14928453|NCT01422733|Hormones|hormones|mesh-ancestor
14928454|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928455|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14928456|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928457|NCT01422746|Metformin|metformin|mesh-list
14928458|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14928459|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436393|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
14436394|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436395|NCT01843660|Acetaminophen|acetaminophen|mesh-list
14436396|NCT01843660|Tramadol|tramadol|mesh-list
14436397|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14436398|NCT01843660|Analgesics|analgesics|mesh-ancestor
14436399|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
14436400|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436401|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436402|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
14436403|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14436404|NCT01843660|Narcotics|narcotics|mesh-ancestor
14436405|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436406|NCT01843751|Buprenorphine|buprenorphine|mesh-list
14436407|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14436408|NCT01843751|Naloxone|naloxone|mesh-list
14436409|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14436410|NCT01843751|Narcotics|narcotics|mesh-ancestor
14436411|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14749898|NCT03959085|Antidotes|antidotes|mesh-ancestor
14749899|NCT03959085|Protective Agents|protective agents|mesh-ancestor
14749900|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
14749901|NCT03959085|Vitamins|vitamins|mesh-ancestor
14749902|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
14749903|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14749904|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
14749905|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
14749906|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
14749907|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14749908|NCT03959085|Hematinics|hematinics|mesh-ancestor
14749909|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749910|NCT03950739|Treprostinil|treprostinil|mesh-list
14749911|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14749912|NCT03946800|Durvalumab|durvalumab|mesh-list
14928460|NCT01422759|Spironolactone|spironolactone|mesh-list
14436412|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436413|NCT01843751|Analgesics|analgesics|mesh-ancestor
14749913|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749914|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928461|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14436414|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
14436415|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436416|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14436417|NCT01843920|Trimethoprim|trimethoprim|mesh-list
14436418|NCT01843920|Polymyxins|polymyxins|mesh-list
14436419|NCT01843920|Polymyxin B|polymyxin b|mesh-list
14436420|NCT01843920|Prednisolone|prednisolone|mesh-list
14436421|NCT01843920|Timolol|timolol|mesh-list
14436422|NCT01843920|Dorzolamide|dorzolamide|mesh-list
14436423|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436424|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
14436425|NCT01843920|Hormones|hormones|mesh-ancestor
14436426|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436427|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436428|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14436429|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436430|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14436431|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14436432|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436433|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436434|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436435|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14928462|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
14928463|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928464|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928465|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14928466|NCT01422759|Diuretics|diuretics|mesh-ancestor
14928467|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
14928468|NCT01422785|Clindamycin|clindamycin|mesh-list
14749915|NCT03939767|Aflibercept|aflibercept|mesh-list
14749916|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14749917|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14436436|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14436437|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14749918|NCT03939767|Growth Substances|growth substances|mesh-ancestor
14749919|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749920|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
14749921|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749922|NCT03932201|Factor VIII|factor viii|mesh-list
14749923|NCT03932201|Coagulants|coagulants|mesh-ancestor
14749924|NCT03929601|Rituximab|rituximab|mesh-list
14749925|NCT03929601|Abatacept|abatacept|mesh-list
14749926|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14749927|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14749928|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
14749929|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14749930|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749931|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14928469|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
14436438|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436439|NCT01843920|Renal Agents|renal agents|mesh-ancestor
14749932|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436440|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
14436441|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14436442|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14436443|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14436444|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436445|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14436446|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14436447|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14436448|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14436449|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14468695|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14468696|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468697|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468698|NCT02284386|Bupivacaine|bupivacaine|mesh-list
14468699|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
14468700|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
14468701|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468702|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468703|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
14468704|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468705|NCT02284464|Prednisone|prednisone|mesh-list
14468706|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468707|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
14468708|NCT02284464|Hormones|hormones|mesh-ancestor
14468709|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468710|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468711|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14468712|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468713|NCT02284516|Lifitegrast|lifitegrast|mesh-list
14468714|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14928470|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
14928471|NCT01422785|Tretinoin|tretinoin|mesh-list
14928472|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14928473|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14928474|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928475|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14928476|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928477|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928478|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14928479|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928480|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
14928481|NCT01422954|Chloroquine|chloroquine|mesh-list
14928482|NCT01422954|Mefloquine|mefloquine|mesh-list
14468715|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14468716|NCT02284555|Mupirocin|mupirocin|mesh-list
14468717|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14468718|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468719|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14468720|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468721|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468722|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14928483|NCT01422954|Proguanil|proguanil|mesh-list
14928484|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14928485|NCT01422954|Vaccines|vaccines|mesh-list
14928486|NCT01422954|Amebicides|amebicides|mesh-ancestor
14928487|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14468723|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
14928488|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14928489|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928490|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
14928491|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928492|NCT01422954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436450|NCT01844076|Quinacrine|quinacrine|mesh-list
14436451|NCT01844076|Capecitabine|capecitabine|mesh-list
14436452|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14436453|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
14436454|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436455|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436456|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
14436457|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14436458|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
14436459|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14436460|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436461|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
14436462|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14436463|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
14436464|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436465|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14436466|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
14436467|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14436468|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14436469|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14436470|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14436471|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436472|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436473|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
14436474|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436475|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14436476|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14436477|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14436478|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14436479|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14436480|NCT01844388|Laxatives|laxatives|mesh-ancestor
14436481|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436482|NCT01844531|Metformin|metformin|mesh-list
14436483|NCT01844531|Empagliflozin|empagliflozin|mesh-list
14436484|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436485|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436486|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14436487|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436488|NCT01844583|Rifampin|rifampin|mesh-list
14436489|NCT01844583|Esomeprazole|esomeprazole|mesh-list
14436490|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14436491|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436492|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14436493|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436494|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436495|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14436496|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
14436497|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14436498|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436499|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
14436500|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14436501|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14436502|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14436503|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14436504|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14436505|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14436506|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14436507|NCT01844687|Cannabidiol|cannabidiol|mesh-list
14436508|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
14436509|NCT01844700|Risperidone|risperidone|mesh-list
14436510|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14436511|NCT01844700|Aripiprazole|aripiprazole|mesh-list
14436512|NCT01844700|Ziprasidone|ziprasidone|mesh-list
14436513|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14436514|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
14436515|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436516|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436517|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436518|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14436519|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14436520|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436521|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14436522|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14436523|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
14436524|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
14436525|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
14436526|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14436527|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14436528|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14436529|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14436530|NCT01844778|Tobramycin|tobramycin|mesh-list
14436531|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14436532|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436533|NCT01844830|Phenylephrine|phenylephrine|mesh-list
14436534|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
14436535|NCT01844830|Tetracaine|tetracaine|mesh-list
14436536|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
14436537|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
14436538|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436539|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436540|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
14436541|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436542|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14436543|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14436544|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436545|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436546|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928493|NCT01422954|Immunologic Factors|immunologic factors|mesh-ancestor
14928494|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
14928495|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436547|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
14436548|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
14436549|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
14436550|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14436551|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
14436552|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14436553|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
14436554|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14436555|NCT01844830|Protective Agents|protective agents|mesh-ancestor
14436556|NCT01844895|Abatacept|abatacept|mesh-list
14436557|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14436558|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436559|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436560|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436561|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
14436562|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436563|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14749933|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14928496|NCT01423019|Synephrine|synephrine|mesh-list
14928497|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14928498|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14928499|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928500|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928501|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928502|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928503|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
14928504|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
14928505|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928506|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14436564|NCT01845025|Fluticasone|fluticasone|mesh-list
14436565|NCT01845025|Xhance|xhance|mesh-list
14436566|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
14436567|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436568|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14436569|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
14436570|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436571|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436572|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14436573|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
14436574|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
14436575|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14436576|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14436577|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14436578|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14436579|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436580|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436581|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436582|NCT01845077|Metformin|metformin|mesh-list
14436583|NCT01845077|Linagliptin|linagliptin|mesh-list
14436584|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436585|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436586|NCT01845077|Incretins|incretins|mesh-ancestor
14436587|NCT01845077|Hormones|hormones|mesh-ancestor
14436588|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436589|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14436590|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
14436591|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436592|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436593|NCT01845636|Atropine|atropine|mesh-list
14436594|NCT01845636|Donepezil|donepezil|mesh-list
14436595|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14436596|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14436597|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14436598|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436599|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436600|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14436601|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436602|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436603|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
14436604|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14436605|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14928507|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
14928508|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
14928509|NCT01423032|Fludarabine|fludarabine|mesh-list
14928510|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14928511|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928512|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928513|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928514|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
14928515|NCT01423123|Paclitaxel|paclitaxel|mesh-list
14928516|NCT01423123|Trastuzumab|trastuzumab|mesh-list
14928517|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14928518|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928519|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
14928520|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
14928521|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
14928522|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928523|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14928524|NCT01423175|Clofarabine|clofarabine|mesh-list
14928525|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14928526|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
14928527|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928528|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928529|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14928530|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14928531|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14436606|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14436607|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
14436608|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436609|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14436610|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
14436611|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
14436612|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
14436613|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14436614|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14436615|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
14436616|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436617|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14436618|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436619|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436620|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
14436621|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436622|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436623|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14436624|NCT01845831|Metformin|metformin|mesh-list
14436625|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
14436626|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14436627|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436628|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436629|NCT01845831|Incretins|incretins|mesh-ancestor
14436630|NCT01845831|Hormones|hormones|mesh-ancestor
14436631|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436632|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14436633|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
14436634|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436635|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436636|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
14436637|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14436638|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
14436639|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436640|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
14436641|NCT01846039|Protective Agents|protective agents|mesh-ancestor
14436642|NCT01846104|Vaccines|vaccines|mesh-list
14436643|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
14436644|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436645|NCT01846221|Clonidine|clonidine|mesh-list
14436646|NCT01846221|Fentanyl|fentanyl|mesh-list
14436647|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14436648|NCT01846221|Narcotics|narcotics|mesh-ancestor
14436649|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436650|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436651|NCT01846221|Analgesics|analgesics|mesh-ancestor
14436652|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
14436653|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436654|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14436655|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14436656|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
14436657|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
14436658|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14436659|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
14436660|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
14436661|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14436662|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14436663|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14436664|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436665|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436666|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436667|NCT01846299|Ranibizumab|ranibizumab|mesh-list
14436668|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14436669|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14436670|NCT01846299|Growth Substances|growth substances|mesh-ancestor
14436671|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436672|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
14436673|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436674|NCT01846416|Atezolizumab|atezolizumab|mesh-list
14436675|NCT01846416|Antibodies|antibodies|mesh-list
14436676|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
14436677|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436678|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436679|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14436680|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14436681|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
14436682|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436683|NCT01846455|Promethazine|promethazine|mesh-list
14436684|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
14436685|NCT01846455|Buprenorphine|buprenorphine|mesh-list
14436686|NCT01846455|Naloxone|naloxone|mesh-list
14436687|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14436688|NCT01846455|Narcotics|narcotics|mesh-ancestor
14436689|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436690|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436691|NCT01846455|Analgesics|analgesics|mesh-ancestor
14436692|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
14436693|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436694|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14436695|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
14436696|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
14436697|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14436698|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
14436699|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
14436700|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436701|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436702|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14436703|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14436704|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14436705|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
14436706|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
14436707|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
14436708|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
14436709|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436710|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
14436711|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14436712|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14436713|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436714|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
14436715|NCT01846507|Coagulants|coagulants|mesh-ancestor
14436716|NCT01846611|Dexamethasone|dexamethasone|mesh-list
14436717|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14436718|NCT01846611|Doxorubicin|doxorubicin|mesh-list
14436719|NCT01846611|Trabectedin|trabectedin|mesh-list
14436720|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436721|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
14436722|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
14436723|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436724|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436725|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436726|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
14436727|NCT01846611|Hormones|hormones|mesh-ancestor
14436728|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436729|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14436730|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436731|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14436732|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14436733|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14436734|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436735|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436736|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14436737|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
14436738|NCT01846624|Decitabine|decitabine|mesh-list
14436739|NCT01846624|Azacitidine|azacitidine|mesh-list
14436740|NCT01846624|Midostaurin|midostaurin|mesh-list
14928532|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928533|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928534|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14436741|NCT01846624|Staurosporine|staurosporine|mesh-list
14436742|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14436743|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
14436744|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436745|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436746|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436747|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14436748|NCT01846728|Estrogens|estrogens|mesh-list
14436749|NCT01846728|Hormones|hormones|mesh-ancestor
14436750|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436751|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436752|NCT01847001|Paclitaxel|paclitaxel|mesh-list
14436753|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14436754|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
14436755|NCT01847001|Doxorubicin|doxorubicin|mesh-list
14436756|NCT01847001|Trastuzumab|trastuzumab|mesh-list
14436757|NCT01847001|Pertuzumab|pertuzumab|mesh-list
14436758|NCT01847001|Propranolol|propranolol|mesh-list
14436759|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14436760|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436761|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
14436762|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
14436763|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
14436764|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436765|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436766|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
14436767|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436768|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14436769|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14436770|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
14436771|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14436772|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14436773|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14436774|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14436775|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436776|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14436777|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14436778|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14436779|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436780|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436781|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14436782|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14436783|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
14436784|NCT01847014|Macitentan|macitentan|mesh-list
14436785|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14436786|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14928535|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14928536|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14470057|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14470058|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14470059|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
14470060|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470061|NCT02303184|Aflibercept|aflibercept|mesh-list
14470062|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14470063|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14470064|NCT02303184|Growth Substances|growth substances|mesh-ancestor
14436787|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436788|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14436789|NCT01847131|Phenylephrine|phenylephrine|mesh-list
14436790|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
14436791|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14436792|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14436793|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436794|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436795|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436796|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436797|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
14436798|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
14436799|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436800|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
14436801|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14436802|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
14436803|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14436804|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
14436805|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14436806|NCT01847131|Protective Agents|protective agents|mesh-ancestor
14436807|NCT01847313|Liraglutide|liraglutide|mesh-list
14436808|NCT01847313|Glucagon|glucagon|mesh-list
14436809|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14436810|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436811|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436812|NCT01847313|Incretins|incretins|mesh-ancestor
14436813|NCT01847313|Hormones|hormones|mesh-ancestor
14436814|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436815|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436816|NCT01847443|Nicotine|nicotine|mesh-list
14436817|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14436818|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
14436819|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436820|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436821|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14436822|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14436823|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
14436824|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436825|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436826|NCT01847469|Zonisamide|zonisamide|mesh-list
14436827|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
14436828|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14436829|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14436830|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436831|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14436832|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436833|NCT01847638|Nepafenac|nepafenac|mesh-list
14436834|NCT01847638|Bromfenac|bromfenac|mesh-list
14436835|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14436836|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14436837|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14436838|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14436839|NCT01847638|Analgesics|analgesics|mesh-ancestor
14436840|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
14436841|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436842|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436843|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436844|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14436845|NCT01848041|Phenylephrine|phenylephrine|mesh-list
14436846|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
14436847|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14436848|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14436849|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14436850|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14436851|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
14436852|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14436853|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436854|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436855|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
14436856|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
14436857|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436858|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
14436859|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14436860|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
14436861|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14436862|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
14436863|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14436864|NCT01848041|Protective Agents|protective agents|mesh-ancestor
14436865|NCT01848054|Buprenorphine|buprenorphine|mesh-list
14436866|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14436867|NCT01848054|Naloxone|naloxone|mesh-list
14436868|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14436869|NCT01848054|Narcotics|narcotics|mesh-ancestor
14436870|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436871|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436872|NCT01848054|Analgesics|analgesics|mesh-ancestor
14436873|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
14436874|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436875|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14436876|NCT01848067|Prednisone|prednisone|mesh-list
14436877|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
14928537|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14928538|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928539|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928540|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928541|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14928542|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14928543|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
14928544|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14928545|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14436878|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436879|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
14436880|NCT01848067|Hormones|hormones|mesh-ancestor
14436881|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14436882|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436883|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14436884|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436885|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14436886|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436887|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436888|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
14436889|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14436890|NCT01848145|Ofatumumab|ofatumumab|mesh-list
14436891|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436892|NCT01848210|Troxerutin|troxerutin|mesh-list
14436893|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
14436894|NCT01848457|Methotrexate|methotrexate|mesh-list
14436895|NCT01848457|Pantoprazole|pantoprazole|mesh-list
14436896|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14436897|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
14436898|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14436899|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436900|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14436901|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
14928546|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
14928547|NCT01423292|Bupivacaine|bupivacaine|mesh-list
14928548|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
14928549|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
14436902|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436903|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436904|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14436905|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436906|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14436907|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14928550|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14436908|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
14436909|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14436910|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14436911|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14436912|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14436913|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14436914|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
14436915|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14436916|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436917|NCT01848899|Bivalirudin|bivalirudin|mesh-list
14436918|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
14436919|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14436920|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14436921|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436922|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436923|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
14436924|NCT01848990|Insulin|insulin|mesh-list
14436925|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14436926|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
14436927|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
14436928|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
14436929|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436930|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436931|NCT01849055|Celecoxib|celecoxib|mesh-list
14436932|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14436933|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14436934|NCT01849055|Analgesics|analgesics|mesh-ancestor
14436935|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
14436936|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14436937|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436938|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14436939|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14436940|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14436941|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14436942|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436943|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436944|NCT01849068|Ezetimibe|ezetimibe|mesh-list
14436945|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14436946|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14436947|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
14436948|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436949|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14436950|NCT01849276|Metformin|metformin|mesh-list
14436951|NCT01849276|Cytarabine|cytarabine|mesh-list
14436952|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436953|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436954|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14436955|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
14436956|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436957|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436958|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
14436959|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436960|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14436961|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
14436962|NCT01849289|Insulin|insulin|mesh-list
14436963|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14436964|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
14436965|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14436966|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436967|NCT01849419|Oxytocin|oxytocin|mesh-list
14436968|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
14928551|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436969|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14436970|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436971|NCT01849497|Evolocumab|evolocumab|mesh-list
14436972|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14436973|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14436974|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14436975|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
14436976|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436977|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14436978|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
14436979|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436980|NCT01849562|Ribavirin|ribavirin|mesh-list
14436981|NCT01849562|Odalasvir|odalasvir|mesh-list
14436982|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
14436983|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436984|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
14436985|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14436986|NCT01849588|Sorafenib|sorafenib|mesh-list
14436987|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436988|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14436989|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14436990|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14436991|NCT01849692|Ranibizumab|ranibizumab|mesh-list
14436992|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14436993|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14436994|NCT01849692|Growth Substances|growth substances|mesh-ancestor
14436995|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14436996|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
14436997|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14436998|NCT01849770|Mexiletine|mexiletine|mesh-list
14436999|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14437000|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14437001|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14437002|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437003|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437004|NCT01850030|Progesterone|progesterone|mesh-list
14437005|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
14437006|NCT01850030|Progestins|progestins|mesh-ancestor
14437007|NCT01850030|Hormones|hormones|mesh-ancestor
14437008|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437009|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437010|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
14437011|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14437012|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14437013|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437014|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
14437015|NCT01850394|Coagulants|coagulants|mesh-ancestor
14437016|NCT01850446|Oseltamivir|oseltamivir|mesh-list
14750031|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
14750032|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750033|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750034|NCT03899636|Folfirinox|folfirinox|mesh-list
14750035|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750036|NCT03889756|Midazolam|midazolam|mesh-list
14750037|NCT03889756|Ketamine|ketamine|mesh-list
14750038|NCT03889756|Analgesics|analgesics|mesh-ancestor
14750039|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
14750040|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750041|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750042|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14750043|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14750044|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
14750045|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
14750046|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14750047|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14750048|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14750049|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750050|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750051|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14750052|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14750053|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14437017|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
14437018|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437019|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437020|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468724|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468725|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468726|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468727|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468728|NCT02284854|Carbamazepine|carbamazepine|mesh-list
14468729|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468730|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
14468731|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
14468732|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14468733|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468734|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468735|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14468736|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468737|NCT02284854|Analgesics|analgesics|mesh-ancestor
14468738|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
14468739|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468740|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468741|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468742|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468743|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14468744|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14468745|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468746|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468747|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
14468748|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468749|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14750054|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14750055|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14750056|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
14437021|NCT01850602|Sevelamer|sevelamer|mesh-list
14437022|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
14750057|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
14750058|NCT03869892|Trifluridine|trifluridine|mesh-list
14750059|NCT03869892|Bevacizumab|bevacizumab|mesh-list
14437023|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
14437024|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437025|NCT01850615|Insulin|insulin|mesh-list
14437026|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14437027|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
14437028|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14437029|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437030|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
14437031|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437032|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
14437033|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14437034|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
14437035|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14750060|NCT03869892|Capecitabine|capecitabine|mesh-list
14750061|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14437036|NCT01851330|Ledipasvir|ledipasvir|mesh-list
14437037|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
14750062|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750063|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14750064|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14750065|NCT03869892|Growth Substances|growth substances|mesh-ancestor
14437038|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750066|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437039|NCT01851590|Terbinafine|terbinafine|mesh-list
14437040|NCT01851590|Amorolfine|amorolfine|mesh-list
14437041|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
14437042|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928552|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
14928553|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928554|NCT01423305|Budesonide|budesonide|mesh-list
14437043|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437044|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437045|NCT01851720|Fentanyl|fentanyl|mesh-list
14437046|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14437047|NCT01851720|Narcotics|narcotics|mesh-ancestor
14437048|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437049|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437050|NCT01851720|Analgesics|analgesics|mesh-ancestor
14437051|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
14437052|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437053|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14437054|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14437055|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
14437056|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
14437057|NCT01851863|Flupenthixol|flupenthixol|mesh-list
14437058|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14437059|NCT01851863|Omeprazole|omeprazole|mesh-list
14437060|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14437061|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437062|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14437063|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437064|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437065|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14437066|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14437067|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437068|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437069|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14437070|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14437071|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
14437072|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437073|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14928555|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
14437074|NCT01852019|Cangrelor|cangrelor|mesh-list
14437075|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14437076|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14437077|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14437078|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14437079|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
14437080|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437081|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437082|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437083|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
14437084|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14437085|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14437086|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14437087|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437088|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437089|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
14437090|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437091|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437092|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14928556|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14928557|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928558|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14928559|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
14928560|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928561|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928562|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14928563|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
14928564|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
14928565|NCT01423305|Hormones|hormones|mesh-ancestor
14928566|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928567|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14928568|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14928569|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14928570|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928571|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928572|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928573|NCT01423370|Tadalafil|tadalafil|mesh-list
14437093|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437094|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
14750067|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
14750068|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750069|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
14750070|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750071|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
14750072|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750073|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
14750074|NCT03851627|Testosterone|testosterone|mesh-list
14750075|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
14750076|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
14750077|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14750078|NCT03851627|Androgens|androgens|mesh-ancestor
14750079|NCT03851627|Hormones|hormones|mesh-ancestor
14750080|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750081|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750082|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750083|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750084|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
14750085|NCT03834948|Paclitaxel|paclitaxel|mesh-list
14750086|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
14750087|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750088|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750089|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750090|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750091|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750092|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928574|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
14750093|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750094|NCT03801525|Venetoclax|venetoclax|mesh-list
14750095|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750096|NCT03785678|Tenecteplase|tenecteplase|mesh-list
14750097|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14750098|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14750099|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750100|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14750101|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14750102|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14750103|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
14750104|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750105|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750106|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
14750107|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437095|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14437096|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14437097|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14437098|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437099|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437100|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
14437101|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750108|NCT03773445|Golimumab|golimumab|mesh-list
14750109|NCT03773445|Antibodies|antibodies|mesh-list
14750110|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14750111|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
14750112|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750113|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14750114|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928575|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14437102|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437103|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14437104|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437105|NCT01852071|Busulfan|busulfan|mesh-list
14437106|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
14437107|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750115|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14928576|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14928577|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750116|NCT03769311|Cetuximab|cetuximab|mesh-list
14928578|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437108|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437109|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
14437110|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437111|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928579|NCT01423370|Urological Agents|urological agents|mesh-ancestor
14928580|NCT01423435|Beraprost|beraprost|mesh-list
14928581|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14928582|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
14931146|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931147|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931148|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
14931149|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437112|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437113|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14437114|NCT01852162|Dabigatran|dabigatran|mesh-list
14437115|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
14437116|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14931150|NCT01437748|Bromides|bromides|mesh-list
14931151|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
14931152|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14931153|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
14931154|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931155|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931156|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14931157|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14931158|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
14437117|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
14437118|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437119|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437120|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
14437121|NCT01852175|Ticagrelor|ticagrelor|mesh-list
14437122|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14437123|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14437124|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14437125|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14437126|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14750117|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750118|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750119|NCT03739931|Durvalumab|durvalumab|mesh-list
14750120|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750121|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437127|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
14437128|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437129|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750122|NCT03710772|Cytarabine|cytarabine|mesh-list
14750123|NCT03710772|Dexamethasone|dexamethasone|mesh-list
14750124|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
14750125|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
14750126|NCT03710772|Rituximab|rituximab|mesh-list
14750127|NCT03710772|Doxorubicin|doxorubicin|mesh-list
14750128|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14750129|NCT03710772|Methotrexate|methotrexate|mesh-list
14750130|NCT03710772|Vincristine|vincristine|mesh-list
14750131|NCT03710772|Venetoclax|venetoclax|mesh-list
14750132|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14750133|NCT03710772|Antibodies|antibodies|mesh-list
14437130|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437131|NCT01852214|Ticagrelor|ticagrelor|mesh-list
14750134|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
14437132|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14928583|NCT01423487|Metformin|metformin|mesh-list
14928584|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14928585|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928586|NCT01423500|Fludarabine|fludarabine|mesh-list
14928587|NCT01423500|Etoposide|etoposide|mesh-list
14928588|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
14437133|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14437134|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14750135|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14750136|NCT03710772|BB 1101|bb 1101|mesh-list
14750137|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750138|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
14750139|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750140|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750141|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928589|NCT01423500|Thiotepa|thiotepa|mesh-list
14928590|NCT01423500|Treosulfan|treosulfan|mesh-list
14928591|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928592|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750142|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
14750143|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750144|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928593|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750145|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14750146|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437135|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14437136|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14437137|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
14437138|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437139|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437140|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437141|NCT01852292|Paclitaxel|paclitaxel|mesh-list
14437142|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750147|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
14750148|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
14750149|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750150|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14750151|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
14750152|NCT03710772|Hormones|hormones|mesh-ancestor
14750153|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750154|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750155|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
14750156|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750157|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14750158|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14750159|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14750160|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14750161|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
14750162|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14750163|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750164|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
14750165|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
14437143|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437144|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
14437145|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
14437146|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
14437147|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437148|NCT01852344|Methylphenidate|methylphenidate|mesh-list
14437149|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14437150|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437151|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14437152|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14437153|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437154|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437155|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
14437156|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437157|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14437158|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14437159|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14437160|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437161|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750166|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14750167|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14750168|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
14750169|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750170|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750171|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750172|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750173|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750174|NCT03690089|Atropine|atropine|mesh-list
14437162|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437163|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437164|NCT01852383|Analgesics|analgesics|mesh-ancestor
14437165|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
14437166|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437167|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
14437168|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14437169|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
14437170|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14437171|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
14437172|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437173|NCT01852669|Furosemide|furosemide|mesh-list
14437174|NCT01852669|Diuretics|diuretics|mesh-ancestor
14437175|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
14437176|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437177|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14437178|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14750175|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14750176|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14750177|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14750178|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
14750179|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750180|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750181|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14750182|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437179|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437180|NCT01852942|Losartan|losartan|mesh-list
14437181|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14437182|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14437183|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14437184|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14437185|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437186|NCT01852955|Acetaminophen|acetaminophen|mesh-list
14437187|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14437188|NCT01852955|Analgesics|analgesics|mesh-ancestor
14437189|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
14437190|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437191|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437192|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
14437193|NCT01853072|Prednisolone|prednisolone|mesh-list
14437194|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14437195|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
14437196|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14437197|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
14437198|NCT01853072|Nepafenac|nepafenac|mesh-list
14437199|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14437200|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
14750183|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
14750184|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
14750185|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14750186|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14750187|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
14750188|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750189|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750190|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
14750191|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14750192|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14750193|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750194|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
14750195|NCT03690037|Coagulants|coagulants|mesh-ancestor
14750196|NCT03687957|Temozolomide|temozolomide|mesh-list
14750197|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14750198|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
14750199|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750200|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750201|NCT03686332|Atezolizumab|atezolizumab|mesh-list
14437201|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437202|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
14928594|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
14928595|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928596|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14928597|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14928598|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14437203|NCT01853072|Hormones|hormones|mesh-ancestor
14437204|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437205|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437206|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14437207|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437208|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
14437209|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
14928599|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928600|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928601|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
14928602|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14437210|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437211|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437212|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14437213|NCT01853072|Protective Agents|protective agents|mesh-ancestor
14437214|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928603|NCT01423539|Rituximab|rituximab|mesh-list
14437215|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14437216|NCT01853072|Analgesics|analgesics|mesh-ancestor
14928604|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14437217|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
14437218|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437219|NCT01853085|Bimatoprost|bimatoprost|mesh-list
14437220|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14437221|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14437222|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14437223|NCT01853228|Cytarabine|cytarabine|mesh-list
14437224|NCT01853228|Decitabine|decitabine|mesh-list
14437225|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14437226|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
14437227|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437228|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437229|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
14437230|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437231|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437232|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
14437233|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437234|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437235|NCT01853254|Ribavirin|ribavirin|mesh-list
14437236|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14437237|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
14437238|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437239|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
14437240|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437241|NCT01853280|Methylphenidate|methylphenidate|mesh-list
14437242|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14928605|NCT01423539|Navitoclax|navitoclax|mesh-list
14437243|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437244|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14437245|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14437246|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437247|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437248|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
14437249|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437250|NCT01853475|Artefenomel|artefenomel|mesh-list
14437251|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
14437252|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14750202|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14750203|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750204|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
14750205|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750206|NCT03682068|Gemcitabine|gemcitabine|mesh-list
14437253|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14437254|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437255|NCT01853553|Spironolactone|spironolactone|mesh-list
14437256|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14437257|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
14437258|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437259|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437260|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14437261|NCT01853553|Diuretics|diuretics|mesh-ancestor
14437262|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
14437263|NCT01853618|Tremelimumab|tremelimumab|mesh-list
14437264|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437265|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14437266|NCT01853696|Prednisolone|prednisolone|mesh-list
14437267|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14437268|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
14437269|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14437270|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
14437271|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14437272|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
14437273|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437274|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
14437275|NCT01853696|Hormones|hormones|mesh-ancestor
14437276|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437277|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437278|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14437279|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437280|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
14437281|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
14437282|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437283|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437284|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14437285|NCT01853696|Protective Agents|protective agents|mesh-ancestor
14750207|NCT03682068|Carboplatin|carboplatin|mesh-list
14750208|NCT03682068|Durvalumab|durvalumab|mesh-list
14750209|NCT03682068|Tremelimumab|tremelimumab|mesh-list
14750210|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750211|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750212|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
14750213|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750214|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
14750215|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750216|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750217|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750218|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
14437286|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14437287|NCT01854047|Albuterol|albuterol|mesh-list
14750219|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750220|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750221|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
14750222|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
14750223|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750224|NCT03594552|Baclofen|baclofen|mesh-list
14750225|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14750226|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750227|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14750228|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750229|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14750230|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
14750231|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
14750232|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750233|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753658|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753659|NCT05043090|Durvalumab|durvalumab|mesh-list
14753660|NCT05043090|Sunitinib|sunitinib|mesh-list
14753661|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753662|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753663|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14753664|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14753665|NCT05043090|Growth Substances|growth substances|mesh-ancestor
14753666|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753667|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753668|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14753669|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753670|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753671|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14437288|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14437289|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
14753672|NCT05037045|Incretins|incretins|mesh-ancestor
14753673|NCT05037045|Hormones|hormones|mesh-ancestor
14437290|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750234|NCT03564691|Paclitaxel|paclitaxel|mesh-list
14750235|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14750236|NCT03564691|Cisplatin|cisplatin|mesh-list
14437291|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437292|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14437293|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437294|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
14437295|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14437296|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14437297|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14437298|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14437299|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
14437300|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437301|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437302|NCT01854177|Aprepitant|aprepitant|mesh-list
14437303|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
14437304|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
14437305|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
14437306|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437307|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437308|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437309|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14437310|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437311|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437312|NCT01854359|Idebenone|idebenone|mesh-list
14437313|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
14437314|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437315|NCT01854359|Protective Agents|protective agents|mesh-ancestor
14437316|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437317|NCT01854528|Interferons|interferons|mesh-list
14437318|NCT01854528|Ribavirin|ribavirin|mesh-list
14437319|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437320|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
14437321|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437322|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
14437323|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437324|NCT01854593|Bevacizumab|bevacizumab|mesh-list
14437325|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14437326|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437327|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14437328|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14437329|NCT01854593|Growth Substances|growth substances|mesh-ancestor
14437330|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437331|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
14437332|NCT01854645|Bromides|bromides|mesh-list
14437333|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
14437334|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14437335|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
14437336|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437337|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750237|NCT03564691|Carboplatin|carboplatin|mesh-list
14750238|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
14750239|NCT03564691|Pemetrexed|pemetrexed|mesh-list
14437338|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14437339|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437340|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
14437341|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14437342|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
14437343|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437344|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437345|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
14437346|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
14437347|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
14437348|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14437349|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
14437350|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437351|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437352|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14437353|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437354|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14437355|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14750240|NCT03564691|Lenvatinib|lenvatinib|mesh-list
14750241|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750242|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750243|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750244|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750245|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750246|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928606|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14928607|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928608|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
14928609|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928610|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750247|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750248|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750249|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14750250|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14437356|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14750251|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14437357|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
14437358|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437359|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437360|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14437361|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14928611|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928612|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
14928613|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928614|NCT01423591|Infliximab|infliximab|mesh-list
14928615|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
14928616|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928617|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437362|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14437363|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
14437364|NCT01854697|Interferons|interferons|mesh-list
14437365|NCT01854697|Ribavirin|ribavirin|mesh-list
14750252|NCT03539952|Penicillamine|penicillamine|mesh-list
14750253|NCT03539952|Trientine|trientine|mesh-list
14750254|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
14750255|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
14750256|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750257|NCT03539952|Antidotes|antidotes|mesh-ancestor
14750258|NCT03539952|Protective Agents|protective agents|mesh-ancestor
14750259|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750260|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750261|NCT03532295|Bevacizumab|bevacizumab|mesh-list
14750262|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750263|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750264|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14750265|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14750266|NCT03532295|Growth Substances|growth substances|mesh-ancestor
14750267|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750268|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
14750274|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
14750275|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
14928618|NCT01423695|Paclitaxel|paclitaxel|mesh-list
14437366|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
14437367|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
14437368|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14437369|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437370|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
14437371|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437372|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
14437373|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437374|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
14437375|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437376|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
14437377|NCT01854710|Loxapine|loxapine|mesh-list
14437378|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14437379|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437380|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14437381|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14437382|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437383|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437384|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437385|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437386|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14437387|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14437388|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437389|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14437390|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14437391|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
14437392|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437393|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14437394|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14437395|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14437396|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
14437397|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437398|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
14437399|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14437400|NCT01854827|Antibodies|antibodies|mesh-list
14437401|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
14437402|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14437403|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
14437404|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437405|NCT01854918|Evolocumab|evolocumab|mesh-list
14437406|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14437407|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14437408|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
14437409|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437410|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14437411|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
14437412|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
14437413|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928619|NCT01423695|Trastuzumab|trastuzumab|mesh-list
14437414|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437415|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437416|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
14437417|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
14437418|NCT01855074|Risperidone|risperidone|mesh-list
14437419|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14437420|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
14437421|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437422|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437423|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437424|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14437425|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14437426|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437427|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14437428|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14437429|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
14437430|NCT01855243|Insulin|insulin|mesh-list
14437431|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14437432|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14437433|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437434|NCT01855360|Doxycycline|doxycycline|mesh-list
14437435|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14437436|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14437437|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437438|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
14437439|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14437440|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14437441|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
14437442|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14437443|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437444|NCT01855750|Prednisone|prednisone|mesh-list
14437445|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
14437446|NCT01855750|Rituximab|rituximab|mesh-list
14437447|NCT01855750|Doxorubicin|doxorubicin|mesh-list
14437448|NCT01855750|Vincristine|vincristine|mesh-list
14437449|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437450|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
14437451|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437452|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437453|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14437454|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
14437455|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437456|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437457|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14437458|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14437459|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14437460|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14437461|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14437462|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437463|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437464|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
14437465|NCT01855750|Hormones|hormones|mesh-ancestor
14437466|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437467|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14437468|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14437469|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750276|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928620|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14928621|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928622|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
14928623|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14928624|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
14437470|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14437471|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14437472|NCT01855789|Methotrexate|methotrexate|mesh-list
14437473|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14437474|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
14437475|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14750277|NCT03513562|Venetoclax|venetoclax|mesh-list
14750278|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750279|NCT03457142|Dexamethasone|dexamethasone|mesh-list
14750280|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
14750281|NCT03457142|Abatacept|abatacept|mesh-list
14750282|NCT03457142|Ixazomib|ixazomib|mesh-list
14750283|NCT03457142|Ichthammol|ichthammol|mesh-list
14750284|NCT03457142|BB 1101|bb 1101|mesh-list
14750285|NCT03457142|Glycine|glycine|mesh-list
14750286|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750287|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
14750288|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
14437476|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437477|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14437478|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
14437479|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437480|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437481|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
14437482|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437483|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14437484|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750289|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750290|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750291|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14750292|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
14750293|NCT03457142|Hormones|hormones|mesh-ancestor
14928625|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437485|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
14750294|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750295|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750296|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750297|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750298|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
14750299|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750300|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750301|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750302|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
14750303|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750304|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14928626|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14437486|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437487|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14437488|NCT01855828|Paclitaxel|paclitaxel|mesh-list
14437489|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
14437490|NCT01855828|Fluorouracil|fluorouracil|mesh-list
14437491|NCT01855828|Trastuzumab|trastuzumab|mesh-list
14437492|NCT01855828|Epirubicin|epirubicin|mesh-list
14437493|NCT01855828|Pertuzumab|pertuzumab|mesh-list
14437494|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14437495|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437496|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
14437497|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14437498|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
14928627|NCT01423708|Everolimus|everolimus|mesh-list
14928628|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928629|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750305|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
14750306|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437499|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437500|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437501|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
14437502|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750307|NCT03456076|Gemcitabine|gemcitabine|mesh-list
14750308|NCT03456076|Carboplatin|carboplatin|mesh-list
14750309|NCT03456076|Pemetrexed|pemetrexed|mesh-list
14750310|NCT03456076|Vinorelbine|vinorelbine|mesh-list
14750311|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750312|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750313|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
14753839|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14437503|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437504|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14437505|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
14750314|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750315|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
14750316|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750317|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437506|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14437507|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
14437508|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14437509|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750318|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750319|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
14437510|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14437511|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14437512|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14437513|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437514|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14437515|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14437516|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14437517|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437518|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750320|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750321|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14750322|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14750323|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14437519|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437520|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437521|NCT01855919|Analgesics|analgesics|mesh-ancestor
14437522|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
14437523|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437524|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14437525|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14437526|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
14437527|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14437528|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
14437529|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
14437530|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437531|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437532|NCT01856114|Fentanyl|fentanyl|mesh-list
14437533|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14437534|NCT01856114|Narcotics|narcotics|mesh-ancestor
14437535|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437536|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437537|NCT01856114|Analgesics|analgesics|mesh-ancestor
14437538|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
14437539|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437540|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14437541|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14437542|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
14437543|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
14437544|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
14437545|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
14437546|NCT01856257|Abatacept|abatacept|mesh-list
14437547|NCT01856257|Tacrolimus|tacrolimus|mesh-list
14437548|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
14437549|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14437550|NCT01856257|Basiliximab|basiliximab|mesh-list
14437551|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437552|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
14437553|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437554|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14437555|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750324|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750325|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750326|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750327|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
14750328|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750329|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750330|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
14928630|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
14928631|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928632|NCT01423747|Fludarabine|fludarabine|mesh-list
14928633|NCT01423747|Etoposide|etoposide|mesh-list
14928634|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
14437556|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437557|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14437558|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437559|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14437560|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
14437561|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14437562|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437563|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437564|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
14437565|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
14750331|NCT03441893|Mesalamine|mesalamine|mesh-list
14750332|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14750333|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14750334|NCT03441893|Analgesics|analgesics|mesh-ancestor
14750335|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
14750336|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750337|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750338|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750339|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750340|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14750341|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750342|NCT03432949|Dexamethasone|dexamethasone|mesh-list
14750343|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
14437566|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437567|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437568|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
14437569|NCT01856257|Hormones|hormones|mesh-ancestor
14437570|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437571|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14437572|NCT01856257|Protective Agents|protective agents|mesh-ancestor
14437573|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14437574|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437575|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14437576|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
14437577|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437578|NCT01856530|Oxytocin|oxytocin|mesh-list
14437579|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
14437580|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14437581|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437582|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
14437583|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437584|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
14437585|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14468750|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14750344|NCT03432949|BB 1101|bb 1101|mesh-list
14750345|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750346|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
14928635|NCT01423747|Thiotepa|thiotepa|mesh-list
14437586|NCT01856712|Naltrexone|naltrexone|mesh-list
14437587|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14437588|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14437589|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437590|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
14437591|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437592|NCT01856790|Liraglutide|liraglutide|mesh-list
14750347|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
14437593|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14437594|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437595|NCT01856790|Incretins|incretins|mesh-ancestor
14437596|NCT01856790|Hormones|hormones|mesh-ancestor
14437597|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437598|NCT01856907|Metformin|metformin|mesh-list
14437599|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14437600|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14437601|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750348|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750349|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750350|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14750351|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
14750352|NCT03432949|Hormones|hormones|mesh-ancestor
14750353|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750354|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750355|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750356|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
14750357|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750358|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750359|NCT03421288|Leucovorin|leucovorin|mesh-list
14750360|NCT03421288|Docetaxel|docetaxel|mesh-list
14750361|NCT03421288|Fluorouracil|fluorouracil|mesh-list
14750362|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
14750363|NCT03421288|Atezolizumab|atezolizumab|mesh-list
14750364|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750365|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
14437602|NCT01856907|Incretins|incretins|mesh-ancestor
14437603|NCT01856907|Hormones|hormones|mesh-ancestor
14437604|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437605|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14437606|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14437607|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437608|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437609|NCT01857206|Vaccines|vaccines|mesh-list
14437610|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
14437611|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437612|NCT01857232|Dexamethasone|dexamethasone|mesh-list
14750366|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750367|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750368|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750369|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
14750370|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750371|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437613|NCT01857232|Ondansetron|ondansetron|mesh-list
14437614|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
14437615|NCT01857232|Aprepitant|aprepitant|mesh-list
14437616|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437617|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
14437618|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
14437619|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437620|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437621|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437622|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
14437623|NCT01857232|Hormones|hormones|mesh-ancestor
14750372|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
14437624|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437625|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14437626|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437627|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
14437628|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
14437629|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14437630|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
14437631|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437632|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437633|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14437634|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14437635|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437636|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14437637|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14437638|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14437639|NCT01857297|Vaccines|vaccines|mesh-list
14437640|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
14437641|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437642|NCT01857310|Folic Acid|folic acid|mesh-list
14750373|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750374|NCT03421288|Antidotes|antidotes|mesh-ancestor
14750375|NCT03421288|Protective Agents|protective agents|mesh-ancestor
14750376|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
14750377|NCT03421288|Vitamins|vitamins|mesh-ancestor
14750378|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
14750379|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
14750380|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14750381|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14750382|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14750383|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14750384|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750385|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
14750386|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750387|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750388|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14750389|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750390|NCT03379051|Lenalidomide|lenalidomide|mesh-list
14750391|NCT03379051|Venetoclax|venetoclax|mesh-list
14750392|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
14750393|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750394|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14750395|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14750396|NCT03379051|Growth Substances|growth substances|mesh-ancestor
14750397|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
14750398|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750399|NCT03377491|Gemcitabine|gemcitabine|mesh-list
14750400|NCT03377491|Paclitaxel|paclitaxel|mesh-list
14750401|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750402|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750403|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750404|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750405|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750406|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437643|NCT01857310|Hematinics|hematinics|mesh-ancestor
14750407|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750408|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
14750409|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
14750410|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750411|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750412|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750413|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
14750414|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750415|NCT03245892|Paclitaxel|paclitaxel|mesh-list
14750416|NCT03245892|Carboplatin|carboplatin|mesh-list
14750417|NCT03245892|Nivolumab|nivolumab|mesh-list
14750418|NCT03245892|Ipilimumab|ipilimumab|mesh-list
14750419|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750420|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750421|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750422|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750423|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750424|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750425|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14437644|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
14437645|NCT01857310|Vitamins|vitamins|mesh-ancestor
14437646|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
14437647|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437648|NCT01857323|Albuterol|albuterol|mesh-list
14437649|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14750426|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750427|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14750428|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750429|NCT03190915|Trametinib|trametinib|mesh-list
14750430|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750431|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14750432|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750433|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750434|NCT03150810|Temozolomide|temozolomide|mesh-list
14750435|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14750436|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
14750437|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750438|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750439|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
14750440|NCT03112603|Sirolimus|sirolimus|mesh-list
14437650|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
14437651|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437652|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437653|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14437654|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437655|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
14437656|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14437657|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14750441|NCT03112603|Rituximab|rituximab|mesh-list
14750442|NCT03112603|Methotrexate|methotrexate|mesh-list
14437658|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14437659|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14750443|NCT03112603|Everolimus|everolimus|mesh-list
14750444|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
14750445|NCT03112603|Pentostatin|pentostatin|mesh-list
14750446|NCT03112603|Infliximab|infliximab|mesh-list
14750447|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750448|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750449|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
14750450|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750451|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750452|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14750453|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
14750454|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14750455|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14437660|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
14437661|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437662|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437663|NCT01857362|Nitisinone|nitisinone|mesh-list
14437664|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437665|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437666|NCT01857531|Nicotine|nicotine|mesh-list
14437667|NCT01857531|Ganaxolone|ganaxolone|mesh-list
14437668|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14437669|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
14437670|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437671|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750456|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
14750457|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750458|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14750459|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750460|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14750461|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750462|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14750463|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14750464|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14750465|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
14750466|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14750467|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750468|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
14750469|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14750470|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14750471|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14750474|NCT03069937|Docetaxel|docetaxel|mesh-list
14750475|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750476|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750477|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750478|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750479|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750480|NCT03031730|Dexamethasone|dexamethasone|mesh-list
14750481|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
14750482|NCT03031730|Lenalidomide|lenalidomide|mesh-list
14750483|NCT03031730|Ichthammol|ichthammol|mesh-list
14750484|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14750485|NCT03031730|BB 1101|bb 1101|mesh-list
14750486|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437672|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14437673|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14437674|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
14437675|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437676|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437677|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
14437678|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
14437679|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
14437680|NCT01857583|PENTA|penta|mesh-list
14437681|NCT01857583|Edoxaban|edoxaban|mesh-list
14750487|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
14750488|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
14750489|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750490|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750491|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437682|NCT01857583|Fondaparinux|fondaparinux|mesh-list
14437683|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14437684|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
14437685|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14437686|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
14437687|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437688|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437689|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
14437690|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14437691|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14437692|NCT01857622|Edoxaban|edoxaban|mesh-list
14437693|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14437694|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
14437695|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14437696|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
14437697|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437698|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437699|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
14437700|NCT01858363|Paclitaxel|paclitaxel|mesh-list
14437701|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14437702|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437703|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750492|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
14437704|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
14928636|NCT01423747|Treosulfan|treosulfan|mesh-list
14437705|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
14437706|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437707|NCT01858428|Paclitaxel|paclitaxel|mesh-list
14437708|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750493|NCT03031730|Hormones|hormones|mesh-ancestor
14750494|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750495|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750496|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750497|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
14750498|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750499|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750500|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
14750501|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14750502|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14750503|NCT03031730|Growth Substances|growth substances|mesh-ancestor
14750504|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
14750505|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
14750506|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
14750507|NCT03007329|Exenatide|exenatide|mesh-list
14750508|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14437709|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437710|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14437711|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
14437712|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14437713|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437714|NCT01858532|Atrasentan|atrasentan|mesh-list
14437715|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437716|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14437717|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14437718|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437719|NCT01858766|Ribavirin|ribavirin|mesh-list
14437720|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
14437721|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437722|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
14928637|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437723|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753840|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
14928638|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928639|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14928640|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
14928641|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928642|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14928643|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14928644|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14928645|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928646|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928647|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
14928648|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14928649|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
14928650|NCT01423838|Oxybutynin|oxybutynin|mesh-list
14928651|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14928652|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14928653|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
14928654|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928655|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928656|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928657|NCT01423838|Urological Agents|urological agents|mesh-ancestor
14928658|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
14928659|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
14928660|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928661|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14928662|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14928663|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
14928664|NCT01423864|Prednisolone|prednisolone|mesh-list
14928665|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
14928666|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14928667|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14928668|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
14928669|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928670|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
14928671|NCT01423864|Hormones|hormones|mesh-ancestor
14928672|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928673|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928674|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14928675|NCT01423864|Protective Agents|protective agents|mesh-ancestor
14928676|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14928677|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437724|NCT01859013|Topiramate|topiramate|mesh-list
14437725|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
14928678|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
14928679|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
14750509|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750510|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14750511|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750512|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14750513|NCT03007329|Incretins|incretins|mesh-ancestor
14750514|NCT03007329|Hormones|hormones|mesh-ancestor
14750515|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750516|NCT02987257|Cyclosporine|cyclosporine|mesh-list
14750517|NCT02987257|Etanercept|etanercept|mesh-list
14750518|NCT02987257|Cyclosporins|cyclosporins|mesh-list
14750519|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750520|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750521|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750522|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
14750523|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750524|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
14750525|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750526|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14750527|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750528|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14750529|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14750530|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14750531|NCT02987257|Analgesics|analgesics|mesh-ancestor
14750532|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
14437726|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14437727|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437728|NCT01859078|Digoxin|digoxin|mesh-list
14437729|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14437730|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14437731|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437732|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437733|NCT01859078|Protective Agents|protective agents|mesh-ancestor
14437734|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437735|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
14437736|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14437737|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14437738|NCT01859390|Antioxidants|antioxidants|mesh-list
14437739|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437740|NCT01859390|Protective Agents|protective agents|mesh-ancestor
14437741|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437742|NCT01859637|Lenograstim|lenograstim|mesh-list
14437743|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14437744|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
14437745|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437746|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
14437747|NCT01859702|Dexamethasone|dexamethasone|mesh-list
14437748|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14437749|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750533|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437750|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
14750534|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750535|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14750536|NCT02977052|Nivolumab|nivolumab|mesh-list
14750537|NCT02977052|Ipilimumab|ipilimumab|mesh-list
14750538|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750539|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750540|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750541|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750542|NCT02973542|Ethosuximide|ethosuximide|mesh-list
14750543|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
14750544|NCT02973386|Cisplatin|cisplatin|mesh-list
14750545|NCT02973386|Capecitabine|capecitabine|mesh-list
14750546|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750547|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750548|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
14750549|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750550|NCT02949934|Tolcapone|tolcapone|mesh-list
14750551|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14750552|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14750553|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14750554|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750555|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750556|NCT02935634|Nivolumab|nivolumab|mesh-list
14750557|NCT02935634|Ipilimumab|ipilimumab|mesh-list
14750558|NCT02935634|Rucaparib|rucaparib|mesh-list
14437751|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
14437752|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437753|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437754|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437755|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
14437756|NCT01859702|Hormones|hormones|mesh-ancestor
14437757|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437758|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14437759|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437760|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14437761|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14437762|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437763|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14437764|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14437765|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437766|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437767|NCT01859715|Oxycodone|oxycodone|mesh-list
14437768|NCT01859715|Hydrocodone|hydrocodone|mesh-list
14750559|NCT02935634|Linrodostat|linrodostat|mesh-list
14750560|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750561|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437769|NCT01859715|Ondansetron|ondansetron|mesh-list
14750562|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750563|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750564|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14750565|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750566|NCT02908672|Atezolizumab|atezolizumab|mesh-list
14437770|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14437771|NCT01859715|Narcotics|narcotics|mesh-ancestor
14437772|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437773|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437774|NCT01859715|Analgesics|analgesics|mesh-ancestor
14437775|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
14750567|NCT02908672|Vemurafenib|vemurafenib|mesh-list
14750568|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14750569|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750570|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
14750571|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750572|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14750573|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750574|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750575|NCT02879617|Durvalumab|durvalumab|mesh-list
14437776|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437777|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
14437778|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
14750576|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750577|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750578|NCT02862275|Atezolizumab|atezolizumab|mesh-list
14750579|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14750580|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750581|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
14750582|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750583|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14750584|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14750585|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
14750586|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750587|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750588|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14750589|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750590|NCT02743494|Nivolumab|nivolumab|mesh-list
14750591|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750592|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750593|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750594|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750595|NCT02713386|Paclitaxel|paclitaxel|mesh-list
14750596|NCT02713386|Carboplatin|carboplatin|mesh-list
14750597|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14750598|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750599|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750600|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750601|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750602|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
14750603|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750604|NCT02702180|Molgramostim|molgramostim|mesh-list
14750605|NCT02702180|Sargramostim|sargramostim|mesh-list
14750606|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750607|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
14750608|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750609|NCT02668653|Cytarabine|cytarabine|mesh-list
14750610|NCT02668653|Daunorubicin|daunorubicin|mesh-list
14750611|NCT02668653|Idarubicin|idarubicin|mesh-list
14750612|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750613|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
14437779|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437780|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
14437781|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
14437782|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14437783|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
14437784|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437785|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437786|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14437787|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14437788|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14437789|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14437790|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
14753841|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14437791|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437792|NCT01859741|Carboplatin|carboplatin|mesh-list
14437793|NCT01859741|Etoposide|etoposide|mesh-list
14437794|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437795|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14437796|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14437797|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14437798|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437799|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437800|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14437801|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14437802|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437803|NCT01859793|Incretins|incretins|mesh-ancestor
14437804|NCT01859793|Hormones|hormones|mesh-ancestor
14437805|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14437806|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14437807|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
14437808|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437809|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437810|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
14437811|NCT01860170|Bortezomib|bortezomib|mesh-list
14437812|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437813|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
14437814|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437815|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437816|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14437817|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
14437818|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437819|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437820|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14437821|NCT01860287|Buprenorphine|buprenorphine|mesh-list
14437822|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14437823|NCT01860287|Narcotics|narcotics|mesh-ancestor
14437824|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437825|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437826|NCT01860287|Analgesics|analgesics|mesh-ancestor
14437827|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
14437828|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437829|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14437830|NCT01860521|Sufentanil|sufentanil|mesh-list
14437831|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
14437832|NCT01860521|Gemeprost|gemeprost|mesh-list
14437833|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
14437834|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
14437835|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437836|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437837|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
14437838|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437839|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14437840|NCT01860521|Narcotics|narcotics|mesh-ancestor
14437841|NCT01860521|Analgesics|analgesics|mesh-ancestor
14437842|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14437843|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14437844|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
14437845|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14437846|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
14750614|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750615|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750616|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
14750617|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750618|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750619|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
14750620|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750621|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14750622|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14750623|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14750624|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750625|NCT02652052|Dasatinib|dasatinib|mesh-list
14750626|NCT02652052|Quercetin|quercetin|mesh-list
14750627|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750628|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14750629|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750630|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750631|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
14750632|NCT02652052|Protective Agents|protective agents|mesh-ancestor
14750633|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750634|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
14750635|NCT02612311|Chlorambucil|chlorambucil|mesh-list
14750636|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750637|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437847|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14437848|NCT01860586|Bevacizumab|bevacizumab|mesh-list
14437849|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14437850|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437851|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14437852|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14437853|NCT01860586|Growth Substances|growth substances|mesh-ancestor
14437854|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437855|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
14437856|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
14437857|NCT01860703|Deferiprone|deferiprone|mesh-list
14437858|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14437859|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437860|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14437861|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14437862|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437863|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437864|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928680|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437865|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14437866|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
14437867|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
14437868|NCT01860807|Ibudilast|ibudilast|mesh-list
14437869|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14437870|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
14437871|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437872|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437873|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14437874|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437875|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14437876|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437877|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437878|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14437879|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
14437880|NCT01861002|Vidarabine|vidarabine|mesh-list
14437881|NCT01861002|Cytarabine|cytarabine|mesh-list
14928681|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928682|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
14928683|NCT01423955|Hematinics|hematinics|mesh-ancestor
14928684|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
14928685|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14928686|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928687|NCT01424111|Citalopram|citalopram|mesh-list
14928688|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14928689|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14928690|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14437882|NCT01861002|Methotrexate|methotrexate|mesh-list
14437883|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
14437884|NCT01861002|Azacitidine|azacitidine|mesh-list
14437885|NCT01861002|Fludarabine|fludarabine|mesh-list
14437886|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14437887|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
14437888|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14437889|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437890|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14437891|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
14437892|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437893|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437894|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
14750638|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14750639|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
14750640|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750641|NCT02595931|Irinotecan|irinotecan|mesh-list
14750642|NCT02595931|Camptothecin|camptothecin|mesh-list
14750643|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14750644|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14750645|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750646|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750647|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750648|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750649|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
14750650|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750651|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437895|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437896|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14437897|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437898|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
14437899|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14437900|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14437901|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
14437902|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437903|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14437904|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437905|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
14437906|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14437907|NCT01861665|Bupivacaine|bupivacaine|mesh-list
14437908|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
14437909|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
14437910|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437911|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437912|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
14437913|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437914|NCT01862250|Clonidine|clonidine|mesh-list
14437915|NCT01862250|Analgesics|analgesics|mesh-ancestor
14437916|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
14437917|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437918|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437919|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14437920|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
14437921|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
14437922|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14437923|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14437924|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14437925|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14437926|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437927|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437928|NCT01862328|Gemcitabine|gemcitabine|mesh-list
14437929|NCT01862328|Paclitaxel|paclitaxel|mesh-list
14437930|NCT01862328|Docetaxel|docetaxel|mesh-list
14437931|NCT01862328|Carboplatin|carboplatin|mesh-list
14437932|NCT01862328|Pevonedistat|pevonedistat|mesh-list
14437933|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14437934|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14437935|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
14437936|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
14437937|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
14437938|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437939|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14437940|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
14437941|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
14437942|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14437943|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437944|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14437945|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
14437946|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437947|NCT01862536|Tadalafil|tadalafil|mesh-list
14437948|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
14437949|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14437950|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14437951|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14437952|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437953|NCT01862536|Urological Agents|urological agents|mesh-ancestor
14437954|NCT01862614|Epinephrine|epinephrine|mesh-list
14437955|NCT01862614|Racepinephrine|racepinephrine|mesh-list
14437956|NCT01862614|Carticaine|carticaine|mesh-list
14437957|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
14437958|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14437959|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14437960|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14437961|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437962|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437963|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437964|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14437965|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14437966|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
14437967|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14437968|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14437969|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
14437970|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
14437971|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
14437972|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14437973|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
14437974|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
14437975|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14437976|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
14437977|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
14437978|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
14437979|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14437980|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14437981|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437982|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
14437983|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
14437984|NCT01862874|Vaccines|vaccines|mesh-list
14437985|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
14437986|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437987|NCT01862991|Digoxin|digoxin|mesh-list
14437988|NCT01862991|Misoprostol|misoprostol|mesh-list
14437989|NCT01862991|Mifepristone|mifepristone|mesh-list
14437990|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14437991|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
14437992|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14437993|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437994|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14753674|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753675|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753676|NCT05032807|Cannabidiol|cannabidiol|mesh-list
14753677|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
14753678|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
14753679|NCT05030506|Lenvatinib|lenvatinib|mesh-list
14753680|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753681|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753682|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14753683|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753684|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753685|NCT05024032|Tirzepatide|tirzepatide|mesh-list
14753686|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14753687|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14437995|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14437996|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
14437997|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14437998|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14753688|NCT05024032|Incretins|incretins|mesh-ancestor
14437999|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438000|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438001|NCT01862991|Protective Agents|protective agents|mesh-ancestor
14438002|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14438003|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14438004|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14438005|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14438006|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
14438007|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14438008|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14438009|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
14438010|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438011|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
14753689|NCT05024032|Hormones|hormones|mesh-ancestor
14438012|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14438013|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14438014|NCT01863134|Eptifibatide|eptifibatide|mesh-list
14438015|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14468751|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468752|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14468753|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
14750682|NCT02543255|Prednisone|prednisone|mesh-list
14750683|NCT02543255|Leuprolide|leuprolide|mesh-list
14750684|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
14750685|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750686|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
14750687|NCT02543255|Hormones|hormones|mesh-ancestor
14750688|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750689|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750690|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14468754|NCT02284893|Saxagliptin|saxagliptin|mesh-list
14468755|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468756|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468757|NCT02284893|Incretins|incretins|mesh-ancestor
14468758|NCT02284893|Hormones|hormones|mesh-ancestor
14468759|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468760|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14468761|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
14468762|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468763|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468764|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14468765|NCT02285010|Pregabalin|pregabalin|mesh-list
14468766|NCT02285010|Analgesics|analgesics|mesh-ancestor
14468767|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
14468768|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468769|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468770|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
14468771|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14468772|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468773|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468774|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14468775|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14468776|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14468777|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468778|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14468779|NCT02285153|Aspirin|aspirin|mesh-list
14468780|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
14468781|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14468782|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468783|NCT02285153|Analgesics|analgesics|mesh-ancestor
14750691|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750692|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14438016|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14438017|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
14438018|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14438019|NCT01863667|Glimepiride|glimepiride|mesh-list
14438020|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14438021|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438022|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438023|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438024|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
14438025|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14438026|NCT01863680|Hormones|hormones|mesh-list
14438027|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14438028|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438029|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928691|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750693|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
14750694|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14750695|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14750696|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750697|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750698|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
14750699|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14750700|NCT02500407|Atezolizumab|atezolizumab|mesh-list
14750701|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750702|NCT02488759|Nivolumab|nivolumab|mesh-list
14750703|NCT02488759|Ipilimumab|ipilimumab|mesh-list
14928692|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928693|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
14928694|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928695|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14928696|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
14928697|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14928698|NCT01424124|Montelukast|montelukast|mesh-list
14928699|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14928700|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
14928701|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14928702|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14928703|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438030|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14438031|NCT01863771|Golimumab|golimumab|mesh-list
14438032|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14438033|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438034|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438035|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
14438036|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438037|NCT01863849|Vaccines|vaccines|mesh-list
14438038|NCT01863849|Immunologic Factors|immunologic factors|mesh-ancestor
14438039|NCT01863849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438040|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14438041|NCT01863953|Bimatoprost|bimatoprost|mesh-list
14438042|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14750704|NCT02488759|Daratumumab|daratumumab|mesh-list
14750705|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750706|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750707|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14438043|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14438044|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14438045|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14438046|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14438047|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14438048|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
14438049|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438050|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438051|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438052|NCT01864005|Clopidogrel|clopidogrel|mesh-list
14438053|NCT01864005|Ticagrelor|ticagrelor|mesh-list
14438054|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14438055|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14438056|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14438057|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14438058|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
14438059|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750708|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750709|NCT02448381|Hypericin|hypericin|mesh-list
14750710|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
14928704|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928705|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14928706|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14928707|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438060|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928708|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14928709|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14928710|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
14438061|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438062|NCT01864148|Interferons|interferons|mesh-list
14438063|NCT01864148|Interferon-beta|interferon-beta|mesh-list
14438064|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
14438065|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438066|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
14438067|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438068|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
14438069|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438070|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14438071|NCT01864174|Metformin|metformin|mesh-list
14750711|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14750712|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750713|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
14928711|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928712|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750714|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750715|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750716|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750717|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750718|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
14750719|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750720|NCT02437279|Nivolumab|nivolumab|mesh-list
14750721|NCT02437279|Ipilimumab|ipilimumab|mesh-list
14750722|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750723|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750724|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750725|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750726|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
14750727|NCT02278887|Fludarabine|fludarabine|mesh-list
14750728|NCT02278887|Ipilimumab|ipilimumab|mesh-list
14750729|NCT02278887|Interleukin-2|interleukin-2|mesh-list
14928713|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14928714|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
14438072|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14750730|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750731|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
14750732|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750733|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750734|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14438073|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438074|NCT01865084|Tadalafil|tadalafil|mesh-list
14438075|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
14438076|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14438077|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14438078|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438079|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438080|NCT01865084|Urological Agents|urological agents|mesh-ancestor
14438081|NCT01865552|Etanercept|etanercept|mesh-list
14438082|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14438083|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438084|NCT01865552|Analgesics|analgesics|mesh-ancestor
14438085|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
14438086|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750735|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
14750736|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750737|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750738|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14928715|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
14438087|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438088|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438089|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438090|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438091|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438092|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
14438093|NCT01865708|Ethanol|ethanol|mesh-list
14438094|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14438095|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438096|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438097|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438098|NCT01865747|Everolimus|everolimus|mesh-list
14438099|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438100|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438101|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
14438102|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438103|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14438104|NCT01865812|Cathartics|cathartics|mesh-ancestor
14438105|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438106|NCT01866098|Naltrexone|naltrexone|mesh-list
14438107|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14438108|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14438109|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438110|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
14438111|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438112|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
14438113|NCT01866319|Ipilimumab|ipilimumab|mesh-list
14438114|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14438115|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438116|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14438117|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438118|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14438119|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438120|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14438121|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438122|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438123|NCT01866592|Adalimumab|adalimumab|mesh-list
14438124|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438125|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438126|NCT01866826|Rifaximin|rifaximin|mesh-list
14438127|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14438128|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438129|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438130|NCT01866917|Ropivacaine|ropivacaine|mesh-list
14438131|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
14438132|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
14438133|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438134|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438135|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
14438136|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438137|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
14438138|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14438139|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14438140|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438141|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
14438142|NCT01866943|Coagulants|coagulants|mesh-ancestor
14438143|NCT01867021|Vaccines|vaccines|mesh-list
14928716|NCT01424137|Hormones|hormones|mesh-ancestor
14438144|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
14438145|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438146|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14438147|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
14438148|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438149|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438150|NCT01867086|Carboplatin|carboplatin|mesh-list
14438151|NCT01867086|Vaccines|vaccines|mesh-list
14438152|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
14438153|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438154|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438155|NCT01867294|Doxycycline|doxycycline|mesh-list
14438156|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
14438157|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14438158|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14438159|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14438160|NCT01867294|Spironolactone|spironolactone|mesh-list
14438161|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
14438162|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438163|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14438164|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438165|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
14438166|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14438167|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14438168|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14438169|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
14438170|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438171|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438172|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14438173|NCT01867294|Diuretics|diuretics|mesh-ancestor
14438174|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
14438175|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14438176|NCT01867294|Protective Agents|protective agents|mesh-ancestor
14438177|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
14438178|NCT01867307|Empagliflozin|empagliflozin|mesh-list
14438179|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14438180|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438181|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438182|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438183|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
14750739|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750740|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750741|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14750742|NCT02278887|Analgesics|analgesics|mesh-ancestor
14750743|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
14750744|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750745|NCT02224144|Vitamin D|vitamin d|mesh-list
14750746|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
14750747|NCT02224144|Calcitriol|calcitriol|mesh-list
14750748|NCT02224144|Vitamins|vitamins|mesh-ancestor
14750749|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
14750750|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750751|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14750752|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14750753|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14750754|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14750755|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438184|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750756|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14750757|NCT02151981|Osimertinib|osimertinib|mesh-list
14750758|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750759|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14750760|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750761|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750762|NCT02030990|Fluorometholone|fluorometholone|mesh-list
14750763|NCT02030990|Mitomycins|mitomycins|mesh-list
14750764|NCT02030990|Mitomycin|mitomycin|mesh-list
14750765|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14750766|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750767|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
14750768|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750769|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14750770|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750771|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750772|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
14750773|NCT02030990|Hormones|hormones|mesh-ancestor
14750774|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750775|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750776|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14750777|NCT01972217|Prednisone|prednisone|mesh-list
14750778|NCT01972217|Prednisolone|prednisolone|mesh-list
14750779|NCT01972217|Olaparib|olaparib|mesh-list
14750780|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750781|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
14750782|NCT01972217|Hormones|hormones|mesh-ancestor
14750783|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750784|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750785|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750786|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750787|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14750788|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750789|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750790|NCT01898793|Vidarabine|vidarabine|mesh-list
14750791|NCT01898793|Aldesleukin|aldesleukin|mesh-list
14750792|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
14438185|NCT01867710|Dexamethasone|dexamethasone|mesh-list
14438186|NCT01867710|Prednisone|prednisone|mesh-list
14438187|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
14438188|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438189|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
14438190|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
14438191|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438192|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438193|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438194|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
14438195|NCT01867710|Hormones|hormones|mesh-ancestor
14438196|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438197|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14438198|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438199|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14438200|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438201|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438202|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
14438203|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14438204|NCT01868022|Paclitaxel|paclitaxel|mesh-list
14438205|NCT01868022|Docetaxel|docetaxel|mesh-list
14438206|NCT01868022|Carboplatin|carboplatin|mesh-list
14438207|NCT01868022|Pemetrexed|pemetrexed|mesh-list
14438208|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14438209|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438210|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14438211|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14438212|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14438213|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438214|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438215|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14438216|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14750793|NCT01898793|Fludarabine|fludarabine|mesh-list
14438217|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
14438218|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438219|NCT01868243|Warfarin|warfarin|mesh-list
14438220|NCT01868243|Dabigatran|dabigatran|mesh-list
14438221|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
14438222|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
14438223|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14438224|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
14438225|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438226|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438227|NCT01868334|Vaccines|vaccines|mesh-list
14438228|NCT01868334|Immunologic Factors|immunologic factors|mesh-ancestor
14438229|NCT01868334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438230|NCT01868425|Acetaminophen|acetaminophen|mesh-list
14438231|NCT01868425|Ketamine|ketamine|mesh-list
14438232|NCT01868425|Gabapentin|gabapentin|mesh-list
14438233|NCT01868425|Bupivacaine|bupivacaine|mesh-list
14438234|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
14438235|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
14438236|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438237|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438238|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
14438239|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438240|NCT01868425|Analgesics|analgesics|mesh-ancestor
14438241|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14438242|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14438243|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
14438244|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14438245|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14438246|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438247|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438248|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438249|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
14438250|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
14438251|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14438252|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14750794|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
14750795|NCT01898793|Interleukin-2|interleukin-2|mesh-list
14750796|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750797|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
14750798|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750799|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750800|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14750801|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
14750802|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750803|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438253|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14438254|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
14438255|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
14438256|NCT01868477|Deferasirox|deferasirox|mesh-list
14438257|NCT01868477|Hematinics|hematinics|mesh-ancestor
14438258|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14438259|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
14438260|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
14438261|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438262|NCT01868503|Lapatinib|lapatinib|mesh-list
14438263|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438264|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14438265|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438266|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438267|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
14438268|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438269|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438270|NCT01868633|Dexamethasone|dexamethasone|mesh-list
14438271|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438272|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
14438273|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
14438274|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438275|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438276|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438277|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
14438278|NCT01868633|Hormones|hormones|mesh-ancestor
14438279|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438280|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14438281|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438282|NCT01868776|Lidocaine|lidocaine|mesh-list
14438283|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
14438284|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
14438285|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438286|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438287|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
14438288|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438289|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14438290|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14438291|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14438292|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438293|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438294|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
14438295|NCT01868893|Chlorambucil|chlorambucil|mesh-list
14438296|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14438297|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438298|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14438299|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
14438300|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438301|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
14438302|NCT01869192|Docetaxel|docetaxel|mesh-list
14438303|NCT01869192|Capecitabine|capecitabine|mesh-list
14438304|NCT01869192|Epirubicin|epirubicin|mesh-list
14438305|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438306|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
14438307|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438308|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438309|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14438310|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
14438311|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438312|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438313|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14438314|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
14438315|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
14438316|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
14438317|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14438318|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
14438319|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14438320|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14438321|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14438322|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438323|NCT01869634|Ritonavir|ritonavir|mesh-list
14438324|NCT01869634|Darunavir|darunavir|mesh-list
14438325|NCT01869634|Emtricitabine|emtricitabine|mesh-list
14438326|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14438327|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14438328|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
14438329|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438330|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438331|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14438332|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14438333|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
14438334|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438335|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14438336|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14438337|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14438338|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14438339|NCT01869686|Denosumab|denosumab|mesh-list
14438340|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14438341|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438342|NCT01869699|Acetaminophen|acetaminophen|mesh-list
14438343|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14931159|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14438344|NCT01869699|Analgesics|analgesics|mesh-ancestor
14438345|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
14438346|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750804|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14750805|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750806|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
14750807|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
14750808|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750809|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14750810|NCT01898793|Analgesics|analgesics|mesh-ancestor
14750811|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
14750812|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750813|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14438347|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438348|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
14438349|NCT01869725|Octreotide|octreotide|mesh-list
14438350|NCT01869725|Edotreotide|edotreotide|mesh-list
14438351|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
14438352|NCT01869725|Somatostatin|somatostatin|mesh-list
14438353|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438354|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14438355|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438356|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438357|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438358|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14438359|NCT01869725|Hormones|hormones|mesh-ancestor
14750814|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14928717|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928718|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
14438360|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438361|NCT01870297|Liraglutide|liraglutide|mesh-list
14438362|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438363|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438364|NCT01870297|Incretins|incretins|mesh-ancestor
14438365|NCT01870297|Hormones|hormones|mesh-ancestor
14438366|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438367|NCT01870583|Iodine|iodine|mesh-list
14438368|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
14438369|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14438370|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
14438371|NCT01870583|Povidone|povidone|mesh-list
14438372|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14438373|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438374|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
14438375|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
14438376|NCT01870583|Trace Elements|trace elements|mesh-ancestor
14438377|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
14438378|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438379|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
14438380|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
14438381|NCT01870596|Cytarabine|cytarabine|mesh-list
14438382|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14438383|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
14438384|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438385|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438386|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
14438387|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438388|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438389|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
14438390|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438391|NCT01870739|Amlodipine|amlodipine|mesh-list
14438392|NCT01870739|Valsartan|valsartan|mesh-list
14438393|NCT01870739|Olmesartan|olmesartan|mesh-list
14438394|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14438395|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14438396|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14438397|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14438398|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438399|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438400|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14750815|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
14928719|NCT01424176|Pramipexole|pramipexole|mesh-list
14928720|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
14928721|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928722|NCT01424176|Protective Agents|protective agents|mesh-ancestor
14928723|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928724|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14928725|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14928726|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
14928727|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
14928728|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928729|NCT01424241|Octreotide|octreotide|mesh-list
14928730|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14928731|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14928732|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928733|NCT01424319|Atrasentan|atrasentan|mesh-list
14928734|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928735|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14928736|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14928737|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750816|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14750817|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14750818|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14750819|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14750820|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750821|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
14750822|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750823|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750824|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14438401|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438402|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
14438403|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14438404|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14438405|NCT01870843|Citalopram|citalopram|mesh-list
14438406|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14438407|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14438408|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438409|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438410|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438411|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
14438412|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438413|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14438414|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
14438415|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14438416|NCT01870921|Ticagrelor|ticagrelor|mesh-list
14750825|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750826|NCT01773707|Abatacept|abatacept|mesh-list
14750827|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14750828|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750829|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750830|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750831|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
14750832|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750833|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438417|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14438418|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14438419|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14438420|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14438421|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
14438422|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438423|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438424|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438425|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14438426|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14438427|NCT01870973|Analgesics|analgesics|mesh-list
14438428|NCT01870973|Anesthetics|anesthetics|mesh-list
14438429|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438430|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438431|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438432|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
14438433|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
14438434|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438435|NCT01870999|Aripiprazole|aripiprazole|mesh-list
14438436|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
14438437|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14438438|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14438439|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14438440|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438441|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438442|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
14750834|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
14438443|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
14438444|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438445|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438446|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14438447|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14438448|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
14438449|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14438450|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14438451|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14438452|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14468784|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
14468785|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468786|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468787|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468788|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468789|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14468790|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14468791|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468792|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14468793|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14468794|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468795|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
14750835|NCT01724866|Docetaxel|docetaxel|mesh-list
14750836|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750837|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
14750838|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750839|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14750840|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14750841|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
14750842|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750843|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750844|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14750845|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750846|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750847|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14468796|NCT02285283|Itraconazole|itraconazole|mesh-list
14468797|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
14750848|NCT01711021|Amphetamine|amphetamine|mesh-list
14438453|NCT01871077|Ketorolac|ketorolac|mesh-list
14438454|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14438455|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438456|NCT01871077|Analgesics|analgesics|mesh-ancestor
14438457|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
14438458|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438459|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438460|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438461|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438462|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14438463|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438464|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438465|NCT01871285|Morphine|morphine|mesh-list
14438466|NCT01871285|Oxycodone|oxycodone|mesh-list
14438467|NCT01871285|Buprenorphine|buprenorphine|mesh-list
14438468|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14438469|NCT01871285|Narcotics|narcotics|mesh-ancestor
14438470|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438471|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438472|NCT01871285|Analgesics|analgesics|mesh-ancestor
14438473|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
14438474|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438475|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14438476|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
14438477|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
14438478|NCT01871441|Tacrolimus|tacrolimus|mesh-list
14438479|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438480|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
14438481|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438482|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438483|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14438484|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
14438485|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438486|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438487|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14438488|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14438489|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438490|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14438491|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14438492|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
14438493|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14438494|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438495|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14438496|NCT01871532|Hormones|hormones|mesh-ancestor
14438497|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438498|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750849|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
14750850|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14750851|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750852|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
14750853|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
14750854|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750855|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
14750856|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14750857|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438499|NCT01871558|Metformin|metformin|mesh-list
14438500|NCT01871558|Vildagliptin|vildagliptin|mesh-list
14438501|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438502|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438503|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14438504|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
14438505|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438506|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438507|NCT01871870|Pancrelipase|pancrelipase|mesh-list
14438508|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438509|NCT01872611|Prednisolone|prednisolone|mesh-list
14438510|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14438511|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
14438512|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14438513|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
14438514|NCT01872611|Nepafenac|nepafenac|mesh-list
14438515|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14928738|NCT01424332|Aspirin|aspirin|mesh-list
14928739|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
14928740|NCT01424332|Salicylates|salicylates|mesh-list
14928741|NCT01424332|Darexaban|darexaban|mesh-list
14928742|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928743|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14928744|NCT01424332|Analgesics|analgesics|mesh-ancestor
14928745|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
14928746|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928747|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928748|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928749|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928750|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14928751|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14928752|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928753|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14931160|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
14438516|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
14438517|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750858|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14438518|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
14438519|NCT01872611|Hormones|hormones|mesh-ancestor
14468798|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438520|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438521|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438522|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14438523|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438524|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
14438525|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
14438526|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438527|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438528|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14438529|NCT01872611|Protective Agents|protective agents|mesh-ancestor
14438530|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14438531|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438532|NCT01872611|Analgesics|analgesics|mesh-ancestor
14438533|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
14438534|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438535|NCT01872689|Pirfenidone|pirfenidone|mesh-list
14438536|NCT01872689|Analgesics|analgesics|mesh-ancestor
14438537|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
14438538|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438539|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438540|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14438541|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438542|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438543|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438544|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438545|NCT01872715|Doxycycline|doxycycline|mesh-list
14438546|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14438547|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438548|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
14438549|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14438550|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14438551|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
14438552|NCT01872910|Celecoxib|celecoxib|mesh-list
14438553|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14438554|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438555|NCT01872910|Analgesics|analgesics|mesh-ancestor
14438556|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
14438557|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438558|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438559|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438560|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438561|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14438562|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14438563|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438564|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438565|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14438566|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
14438567|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438568|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
14438569|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438570|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
14438571|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14438572|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438573|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14438574|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438575|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438576|NCT01873729|Naltrexone|naltrexone|mesh-list
14438577|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14438578|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14438579|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438580|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
14438581|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438582|NCT01873859|Metformin|metformin|mesh-list
14438583|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438584|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438585|NCT01873950|Quinidine|quinidine|mesh-list
14438586|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
14438587|NCT01873950|Verapamil|verapamil|mesh-list
14438588|NCT01873950|Dofetilide|dofetilide|mesh-list
14438589|NCT01873950|Ranolazine|ranolazine|mesh-list
14438590|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14438591|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14438592|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438593|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438594|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14438595|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438596|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
14438597|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14438598|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14438599|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14438600|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
14438601|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438602|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
14438603|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14438604|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14438605|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438606|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438607|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14438608|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14438609|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
14438610|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14438611|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14438612|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14438613|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14438614|NCT01873989|Testosterone|testosterone|mesh-list
14438615|NCT01873989|Androgens|androgens|mesh-ancestor
14438616|NCT01873989|Hormones|hormones|mesh-ancestor
14438617|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438618|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438619|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14438620|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14438621|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14438622|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
14438623|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438624|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438625|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14438626|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
14438627|NCT01874119|Aprepitant|aprepitant|mesh-list
14438628|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
14438629|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
14438630|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438631|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438632|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438633|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14438634|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928754|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14928755|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928756|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
14928757|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928758|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
14928759|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
14928760|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
14928761|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14928762|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
14928763|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14928764|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
14928765|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
14928766|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14928767|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
14928768|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928769|NCT01424384|Citalopram|citalopram|mesh-list
14928770|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14928771|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14928772|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928773|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928774|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928775|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
14928776|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928777|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14928778|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
14438635|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438636|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
14438637|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
14438638|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14750859|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14750860|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14750861|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438639|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
14438640|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438641|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438642|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438643|NCT01874392|Insulin|insulin|mesh-list
14438644|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14438645|NCT01874392|Pancrelipase|pancrelipase|mesh-list
14438646|NCT01874392|Pancreatin|pancreatin|mesh-list
14438647|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438648|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438649|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438650|NCT01874535|Esomeprazole|esomeprazole|mesh-list
14438651|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14438652|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438653|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14438654|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438655|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438656|NCT01874665|Ponatinib|ponatinib|mesh-list
14438657|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438658|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14438659|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438660|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438661|NCT01874951|Naltrexone|naltrexone|mesh-list
14438662|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14438663|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14438664|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438665|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
14438666|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438667|NCT01875159|Caffeine|caffeine|mesh-list
14438668|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
14438669|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438670|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14750862|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14750863|NCT01670877|Trastuzumab|trastuzumab|mesh-list
14438671|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438672|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14438673|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438674|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14438675|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14438676|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
14438677|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438678|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
14438679|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14438680|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14438681|NCT01875237|Prednisolone|prednisolone|mesh-list
14438682|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
14438683|NCT01875237|Methotrexate|methotrexate|mesh-list
14438684|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
14438685|NCT01875237|Fludarabine|fludarabine|mesh-list
14438686|NCT01875237|Melphalan|melphalan|mesh-list
14438687|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
14438688|NCT01875237|Tacrolimus|tacrolimus|mesh-list
14438689|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14438690|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
14438691|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14438692|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
14438693|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14438694|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438695|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14438696|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
14438697|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438698|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438699|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
14438700|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438701|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14438702|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438703|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
14928779|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14928780|NCT01424449|Aripiprazole|aripiprazole|mesh-list
14928781|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
14928782|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14928783|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14928784|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14928785|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438704|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438705|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14438706|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14438707|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438708|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
14438709|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
14438710|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438711|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438712|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
14438713|NCT01875237|Hormones|hormones|mesh-ancestor
14438714|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14438715|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14438716|NCT01875237|Protective Agents|protective agents|mesh-ancestor
14438717|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14438718|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14438719|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
14438720|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14438721|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14438722|NCT01875250|Metronidazole|metronidazole|mesh-list
14438723|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438724|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14750864|NCT01670877|Fulvestrant|fulvestrant|mesh-list
14438725|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14438726|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14438727|NCT01875367|Trastuzumab|trastuzumab|mesh-list
14928786|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928787|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
14928788|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
14928789|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928790|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928791|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14928792|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14928793|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
14928794|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14928795|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14928796|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14928797|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14928798|NCT01424618|Leuprolide|leuprolide|mesh-list
14928799|NCT01424618|Ganirelix|ganirelix|mesh-list
14928800|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14928801|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
14928802|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14438728|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14438729|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438730|NCT01875445|Inositol|inositol|mesh-list
14438731|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
14438732|NCT01875445|Vitamins|vitamins|mesh-ancestor
14438733|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
14438734|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438735|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14438736|NCT01875510|SMOFlipid|smoflipid|mesh-list
14438737|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14438738|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14928803|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928804|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14438739|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14438740|NCT01875848|Buprenorphine|buprenorphine|mesh-list
14438741|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14438742|NCT01875848|Naloxone|naloxone|mesh-list
14438743|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14438744|NCT01875848|Narcotics|narcotics|mesh-ancestor
14438745|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438746|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438747|NCT01875848|Analgesics|analgesics|mesh-ancestor
14438748|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
14438749|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438750|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14438751|NCT01875991|Etanercept|etanercept|mesh-list
14438752|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14438753|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438754|NCT01875991|Analgesics|analgesics|mesh-ancestor
14438755|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
14438756|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438757|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438758|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438759|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438760|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438761|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438762|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
14438763|NCT01876082|Methotrexate|methotrexate|mesh-list
14438764|NCT01876082|Vinblastine|vinblastine|mesh-list
14438765|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14438766|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
14438767|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14438768|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438769|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14438770|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
14438771|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438772|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438773|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
14438774|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438775|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14438776|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14438777|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
14438778|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438779|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14438780|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14438781|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
14438782|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
14438783|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
14438784|NCT01876212|Dasatinib|dasatinib|mesh-list
14438785|NCT01876212|Vaccines|vaccines|mesh-list
14438786|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
14438787|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438788|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438789|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14438790|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438791|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438792|NCT01876251|Docetaxel|docetaxel|mesh-list
14438793|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438794|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14438795|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14438796|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14438797|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438798|NCT01876368|Olmesartan|olmesartan|mesh-list
14438799|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14438800|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14438801|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14438802|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14438803|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14438804|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438805|NCT01876381|Tolvaptan|tolvaptan|mesh-list
14438806|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14438807|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438808|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
14438809|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438810|NCT01876446|Irinotecan|irinotecan|mesh-list
14438811|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14438812|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14438813|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438814|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438815|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438816|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
14438817|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14438818|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438819|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
14438820|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
14438821|NCT01876732|Vitamins|vitamins|mesh-ancestor
14438822|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
14438823|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438824|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
14438825|NCT01876732|Hematinics|hematinics|mesh-ancestor
14438826|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
14438827|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14438828|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
14438829|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438830|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14438831|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14438832|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14438833|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438834|NCT01876823|Memantine|memantine|mesh-list
14438835|NCT01876823|Citalopram|citalopram|mesh-list
14438836|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14438837|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14438838|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
14438839|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438840|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438841|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438842|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14438843|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14438844|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14438845|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14438846|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438847|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
14438848|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14438849|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
14438850|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14438851|NCT01876992|Metformin|metformin|mesh-list
14438852|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14438853|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438854|NCT01877083|Lenvatinib|lenvatinib|mesh-list
14438855|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438856|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14438857|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438858|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438859|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
14438860|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14438861|NCT01877538|Donepezil|donepezil|mesh-list
14438862|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14438863|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750865|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750866|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750867|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750868|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14750869|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14750870|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
14750871|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750872|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750873|NCT01602380|Fulvestrant|fulvestrant|mesh-list
14750874|NCT01602380|Anastrozole|anastrozole|mesh-list
14750875|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14750876|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750877|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14750878|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14750879|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
14750880|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750881|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750882|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14750883|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14750884|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438864|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438865|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
14438866|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438867|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438868|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
14438869|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14438870|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
14438871|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438872|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14438873|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438874|NCT01877642|Lorazepam|lorazepam|mesh-list
14438875|NCT01877642|Loxapine|loxapine|mesh-list
14438876|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
14438877|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
14438878|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
14438879|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438880|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438881|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438882|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14438883|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438884|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14438885|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14438886|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14750885|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750886|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
14750887|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750888|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
14750889|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750890|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438887|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
14438888|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
14438889|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438890|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438891|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14438892|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14438893|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
14438894|NCT01877668|Adalimumab|adalimumab|mesh-list
14438895|NCT01877668|Tofacitinib|tofacitinib|mesh-list
14438896|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438897|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438898|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14438899|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438900|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438901|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
14438902|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14438903|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
14438904|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14438905|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
14438906|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438907|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438908|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
14438909|NCT01878006|Morphine|morphine|mesh-list
14438910|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14750891|NCT01518556|Idarubicin|idarubicin|mesh-list
14438911|NCT01878006|Narcotics|narcotics|mesh-ancestor
14750892|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14750893|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750894|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14750895|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14750896|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750897|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750898|NCT01412333|Interferons|interferons|mesh-list
14750899|NCT01412333|Interferon-beta|interferon-beta|mesh-list
14750900|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
14928805|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928806|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
14438912|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928807|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928808|NCT01424709|Gemcitabine|gemcitabine|mesh-list
14928809|NCT01424709|Cisplatin|cisplatin|mesh-list
14928810|NCT01424709|Docetaxel|docetaxel|mesh-list
14928811|NCT01424709|Irinotecan|irinotecan|mesh-list
14928812|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928813|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14928814|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
14928815|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438913|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750901|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
14928816|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
14928817|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750902|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750903|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
14750904|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750905|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
14750906|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750907|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14750908|NCT01247324|Interferons|interferons|mesh-list
14750909|NCT01247324|Interferon-beta|interferon-beta|mesh-list
14438914|NCT01878006|Analgesics|analgesics|mesh-ancestor
14438915|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
14438916|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468799|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14468800|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14468801|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468802|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468803|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14468804|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
14468805|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468806|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468807|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14468808|NCT02285634|Lidocaine|lidocaine|mesh-list
14468809|NCT02285634|Phenylephrine|phenylephrine|mesh-list
14468810|NCT02285634|Epinephrine|epinephrine|mesh-list
14468811|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
14468812|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
14468813|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
14468814|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468815|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750910|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
14750911|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
14750912|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750913|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
14750914|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750915|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
14750916|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750917|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14928818|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928819|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14928820|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
14750918|NCT01208662|Dexamethasone|dexamethasone|mesh-list
14750919|NCT01208662|Lenalidomide|lenalidomide|mesh-list
14750920|NCT01208662|Bortezomib|bortezomib|mesh-list
14750921|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750922|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
14928821|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468816|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
14468817|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468818|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14468819|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468820|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468821|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468822|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468823|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14750923|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
14750924|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928822|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750925|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928823|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
14928824|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
14438917|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14438918|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
14438919|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14438920|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14438921|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14438922|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438923|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438924|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438925|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
14438926|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438927|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14438928|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14438929|NCT01878526|Domperidone|domperidone|mesh-list
14438930|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
14438931|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
14438932|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438933|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438934|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14438935|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14438936|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
14928825|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14928826|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14928827|NCT01424761|Ubiquinone|ubiquinone|mesh-list
14438937|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14438938|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438939|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
14438940|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
14438941|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438942|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14438943|NCT01878656|Sevoflurane|sevoflurane|mesh-list
14438944|NCT01878656|Desflurane|desflurane|mesh-list
14438945|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14438946|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14438947|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
14438948|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
14438949|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14438950|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438951|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
14438952|NCT01878799|Ledipasvir|ledipasvir|mesh-list
14438953|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
14438954|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438955|NCT01878890|Efavirenz|efavirenz|mesh-list
14438956|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14928828|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
14928829|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
14438957|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14438958|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14438959|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438960|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
14438961|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14438962|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14438963|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14438964|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14750926|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14750927|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
14750928|NCT01208662|Hormones|hormones|mesh-ancestor
14438965|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14438966|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14750929|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750930|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14438967|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14438968|NCT01879319|Evolocumab|evolocumab|mesh-list
14438969|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14438970|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14438971|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14438972|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
14438973|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438974|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14438975|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
14438976|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438977|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14438978|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
14438979|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14438980|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14438981|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438982|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438983|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14438984|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
14438985|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14438986|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14438987|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14438988|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14438989|NCT01879371|Ibuprofen|ibuprofen|mesh-list
14438990|NCT01879371|Caffeine|caffeine|mesh-list
14438991|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14438992|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14438993|NCT01879371|Analgesics|analgesics|mesh-ancestor
14438994|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
14438995|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14438996|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14438997|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14438998|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14438999|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14439000|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439001|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439002|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14439003|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14439004|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14439005|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14439006|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
14439007|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439008|NCT01879579|Insulin|insulin|mesh-list
14439009|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14439010|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439011|NCT01879618|Dalteparin|dalteparin|mesh-list
14439012|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
14439013|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14439014|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14439015|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439016|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14439017|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
14439018|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439019|NCT05329116|Lidocaine|lidocaine|mesh-list
14439020|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
14439021|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
14439022|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
14439023|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439024|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439025|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
14468824|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14750931|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750932|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
14750933|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14750934|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14750935|NCT01208662|Growth Substances|growth substances|mesh-ancestor
14439026|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439027|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14439028|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14439029|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14439030|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14439031|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439032|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14439033|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439034|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14439035|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14439036|NCT05329116|Protective Agents|protective agents|mesh-ancestor
14439037|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
14439038|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14750936|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
14750937|NCT01198522|Gemcitabine|gemcitabine|mesh-list
14750938|NCT01198522|Antibodies|antibodies|mesh-list
14750939|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14439039|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
14439040|NCT05329090|Rituximab|rituximab|mesh-list
14439041|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439042|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439043|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
14439044|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439045|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439046|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
14750940|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
14750941|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750942|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14750943|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
14750944|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750945|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750946|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
14750947|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750948|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14750949|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14750950|NCT01134250|Paclitaxel|paclitaxel|mesh-list
14750951|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14750952|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14750953|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
14750954|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
14750955|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439047|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14439048|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14439049|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14439050|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
14439051|NCT05328674|Mitogens|mitogens|mesh-list
14439052|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439053|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439054|NCT05328635|Candesartan|candesartan|mesh-list
14439055|NCT05328635|Gabapentin|gabapentin|mesh-list
14439056|NCT05328635|Analgesics|analgesics|mesh-ancestor
14439057|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
14439058|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14750956|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750957|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
14750958|NCT00588185|Testosterone|testosterone|mesh-list
14750959|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
14750960|NCT00588185|Androgens|androgens|mesh-ancestor
14750961|NCT00588185|Hormones|hormones|mesh-ancestor
14750962|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14750963|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750964|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
14750965|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750966|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
14750967|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14750968|NCT05333289|Vaccines|vaccines|mesh-list
14750969|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
14750970|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750971|NCT05333250|Modafinil|modafinil|mesh-list
14750972|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14750973|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750974|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14750975|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14750976|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14750977|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750978|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14750979|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
14750980|NCT05333159|Empagliflozin|empagliflozin|mesh-list
14750981|NCT05333159|Canagliflozin|canagliflozin|mesh-list
14439059|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750982|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14753842|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750983|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14750984|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14750985|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750986|NCT05332821|Bevacizumab|bevacizumab|mesh-list
14439060|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
14439061|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14439062|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14750987|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14750988|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14750989|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439063|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439064|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14439065|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14439066|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14439067|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439068|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439069|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
14439070|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14439071|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14439072|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14750990|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14750991|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14750992|NCT05332821|Growth Substances|growth substances|mesh-ancestor
14439083|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
14439084|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
14439085|NCT05328427|Protective Agents|protective agents|mesh-ancestor
14439086|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439087|NCT05328414|Prednisolone|prednisolone|mesh-list
14439088|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14750993|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750994|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
14750995|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928830|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928831|NCT01424761|Vitamins|vitamins|mesh-ancestor
14750996|NCT05332795|Metformin|metformin|mesh-list
14750997|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14928832|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
14439089|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
14439090|NCT05328414|Hormones|hormones|mesh-ancestor
14928833|NCT01424826|Rifampin|rifampin|mesh-list
14928834|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14928835|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14928836|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
14928837|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928838|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14928839|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14928840|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928841|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928842|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14750998|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14750999|NCT05332730|Golimumab|golimumab|mesh-list
14439091|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439092|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439093|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14439094|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439095|NCT05328388|Lycopene|lycopene|mesh-list
14439096|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751000|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14751001|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14439097|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
14439098|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439099|NCT05328388|Protective Agents|protective agents|mesh-ancestor
14439100|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439101|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14439102|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14439103|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439104|NCT05328336|Paclitaxel|paclitaxel|mesh-list
14439105|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14439106|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439107|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439108|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439109|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439110|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439111|NCT05328310|Nebivolol|nebivolol|mesh-list
14439112|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14439113|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
14439114|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14751002|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751003|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751004|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
14751005|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751006|NCT05332717|Ascorbic Acid|ascorbic acid|mesh-list
14751007|NCT05332717|Melatonin|melatonin|mesh-list
14751008|NCT05332717|Vitamins|vitamins|mesh-ancestor
14751009|NCT05332717|Micronutrients|micronutrients|mesh-ancestor
14751010|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751011|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
14751012|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751013|NCT05332717|Protective Agents|protective agents|mesh-ancestor
14751014|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751015|NCT05332587|Rituximab|rituximab|mesh-list
14751016|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751017|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751018|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
14751019|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751020|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439115|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14439116|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14439117|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
14439118|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439119|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439120|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751021|NCT05332561|Trastuzumab|trastuzumab|mesh-list
14751022|NCT05332561|Pertuzumab|pertuzumab|mesh-list
14751023|NCT05332561|Atezolizumab|atezolizumab|mesh-list
14439129|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14439130|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
14439131|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14439132|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
14439133|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14439134|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439135|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14439136|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14439137|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439138|NCT05328154|Diphosphonates|diphosphonates|mesh-list
14439139|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14439140|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439141|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
14439142|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
14439143|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439144|NCT05328141|Protective Agents|protective agents|mesh-ancestor
14439145|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439146|NCT05328141|Vitamins|vitamins|mesh-ancestor
14439147|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
14468825|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14468826|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468827|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14468828|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14468829|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
14468830|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14468831|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
14468832|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
14468833|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
14468834|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14468835|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14468836|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
14468837|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14468838|NCT02285634|Protective Agents|protective agents|mesh-ancestor
14468839|NCT02285855|Metformin|metformin|mesh-list
14468840|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468841|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751024|NCT05332561|Olaparib|olaparib|mesh-list
14751025|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14468842|NCT02285920|Spironolactone|spironolactone|mesh-list
14751026|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751027|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14751028|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439148|NCT05328102|Lenalidomide|lenalidomide|mesh-list
14439149|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
14751029|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751030|NCT05332496|Bevacizumab|bevacizumab|mesh-list
14751031|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14439150|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439151|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14439152|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14439153|NCT05328102|Growth Substances|growth substances|mesh-ancestor
14439154|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14439155|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439156|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14439157|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14439158|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439159|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439160|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14439161|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14439162|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439163|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
14439164|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439165|NCT05327894|Blinatumomab|blinatumomab|mesh-list
14439166|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14439167|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439168|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
14439169|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439170|NCT05327777|Oxycodone|oxycodone|mesh-list
14439171|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14439172|NCT05327777|Narcotics|narcotics|mesh-ancestor
14439173|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439174|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439175|NCT05327777|Analgesics|analgesics|mesh-ancestor
14439176|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
14439177|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439178|NCT05327751|Celecoxib|celecoxib|mesh-list
14439179|NCT05327751|Capecitabine|capecitabine|mesh-list
14439180|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14439181|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
14439182|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439183|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439184|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14439185|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14439186|NCT05327751|Analgesics|analgesics|mesh-ancestor
14439187|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
14439188|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439189|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751032|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751033|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751034|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14751035|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14751036|NCT05332496|Growth Substances|growth substances|mesh-ancestor
14751037|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751038|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
14751039|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751040|NCT05332483|Megestrol|megestrol|mesh-list
14751041|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
14751042|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14751043|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14751044|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14751045|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
14751046|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14751047|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751048|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14751049|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14751050|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751051|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751052|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
14751053|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14751054|NCT05332470|Lamivudine|lamivudine|mesh-list
14751055|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14751056|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14751057|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751058|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751059|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
14751060|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751061|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14751062|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14751063|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
14751064|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14751065|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
14439190|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439191|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439192|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14439193|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14439194|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439195|NCT05327738|Atezolizumab|atezolizumab|mesh-list
14439196|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14439197|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439198|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
14439199|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439200|NCT05327699|Ketamine|ketamine|mesh-list
14439201|NCT05327699|Analgesics|analgesics|mesh-ancestor
14439202|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
14439203|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439204|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439205|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14439206|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14439207|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
14439208|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
14751066|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751067|NCT05332314|Ibuprofen|ibuprofen|mesh-list
14439209|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439210|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14439211|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14439212|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439213|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439214|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
14439215|NCT05327686|Nivolumab|nivolumab|mesh-list
14439216|NCT05327686|Ipilimumab|ipilimumab|mesh-list
14439217|NCT05327686|Avelumab|avelumab|mesh-list
14439218|NCT05327686|Lenvatinib|lenvatinib|mesh-list
14439219|NCT05327686|Axitinib|axitinib|mesh-list
14439220|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14439221|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751068|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14751069|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751070|NCT05332314|Analgesics|analgesics|mesh-ancestor
14751071|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
14751072|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439222|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439223|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14439224|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439225|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14439226|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751073|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751074|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751075|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14751076|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14751077|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751078|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751079|NCT05332106|Dienogest|dienogest|mesh-list
14751080|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14751081|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14751082|NCT05332106|Estradiol|estradiol|mesh-list
14439227|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
14439228|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439229|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
14439230|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
14439231|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439232|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
14439233|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439234|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439235|NCT05327582|Paclitaxel|paclitaxel|mesh-list
14439236|NCT05327582|Durvalumab|durvalumab|mesh-list
14439237|NCT05327582|Lenvatinib|lenvatinib|mesh-list
14439238|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14439239|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439240|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439241|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439242|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439243|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439244|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439245|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14439246|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439247|NCT05327556|Epinephrine|epinephrine|mesh-list
14751083|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14439248|NCT05327556|Racepinephrine|racepinephrine|mesh-list
14439249|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
14751084|NCT05332106|Nandrolone|nandrolone|mesh-list
14751085|NCT05332106|Estrogens|estrogens|mesh-ancestor
14439250|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14928843|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
14928844|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14928845|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
14928846|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14928847|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14928848|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14928849|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14751086|NCT05332106|Hormones|hormones|mesh-ancestor
14751087|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751088|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751089|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14751090|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
14439251|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14439252|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
14439253|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928850|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14928851|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14928852|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14928853|NCT01424839|Cisplatin|cisplatin|mesh-list
14928854|NCT01424839|Carboplatin|carboplatin|mesh-list
14439254|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439255|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928855|NCT01424839|Etoposide|etoposide|mesh-list
14928856|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
14439256|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14439257|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14439258|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
14439259|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439260|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14439261|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
14439262|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
14439263|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
14439264|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14439265|NCT05327530|Avelumab|avelumab|mesh-list
14439266|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439267|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439268|NCT05327439|Nicotine|nicotine|mesh-list
14439269|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14439270|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
14439271|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439272|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439273|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14439274|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14439275|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14751091|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14751092|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14751093|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14751094|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14928857|NCT01424839|Ifosfamide|ifosfamide|mesh-list
14439276|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439277|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439278|NCT05327426|Vaccines|vaccines|mesh-list
14439279|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
14439280|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928858|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
14928859|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439281|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
14928860|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14928861|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14928862|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14928863|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928864|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928865|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14928866|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
14928867|NCT01424891|Simvastatin|simvastatin|mesh-list
14928868|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14928869|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14928870|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
14928871|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439282|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14439283|NCT05327361|Protective Agents|protective agents|mesh-ancestor
14439284|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928872|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14928873|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14928874|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928875|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
14439285|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
14439286|NCT05327309|Bleomycin|bleomycin|mesh-list
14439287|NCT05327309|Propranolol|propranolol|mesh-list
14439288|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14439289|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14439290|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
14439291|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439292|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439293|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439294|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14439295|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14439296|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
14439297|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14439298|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439299|NCT05327296|Propofol|propofol|mesh-list
14439300|NCT05327296|Isoflurane|isoflurane|mesh-list
14439301|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14439302|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439303|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439304|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14439305|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
14439306|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
14439307|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14439308|NCT05327231|Docetaxel|docetaxel|mesh-list
14439309|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439310|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439311|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439312|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439313|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439314|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
14470065|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439315|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14439316|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439317|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14439318|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439319|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
14439320|NCT05327088|Nalbuphine|nalbuphine|mesh-list
14439321|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14439322|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439323|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439324|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14439325|NCT05327088|Analgesics|analgesics|mesh-ancestor
14439326|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
14439327|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439328|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14439329|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14439330|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14439331|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
14439332|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439333|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439334|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14439335|NCT05327088|Narcotics|narcotics|mesh-ancestor
14439336|NCT05327010|Talazoparib|talazoparib|mesh-list
14439337|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14439338|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439339|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439340|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439341|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
14439342|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14439343|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14439344|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439345|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
14439346|NCT05326997|Coagulants|coagulants|mesh-ancestor
14439347|NCT05326984|Metformin|metformin|mesh-list
14439348|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14751095|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14751096|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
14751097|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14439349|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751098|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751099|NCT05332106|Androgens|androgens|mesh-ancestor
14439350|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14439351|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928876|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14928877|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928878|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14751100|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
14439352|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439353|NCT05326867|Lidocaine|lidocaine|mesh-list
14439354|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
14439355|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
14439356|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439357|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439358|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
14751101|NCT05332067|Omalizumab|omalizumab|mesh-list
14751102|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14751103|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14439359|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439360|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14439361|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14439362|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14439363|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14439364|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439365|NCT05326841|Vitamin D|vitamin d|mesh-list
14439366|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
14439367|NCT05326841|Vitamins|vitamins|mesh-ancestor
14439368|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
14439369|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439370|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14439371|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14439372|NCT05326776|Oxytocin|oxytocin|mesh-list
14439373|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
14439374|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14439375|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439376|NCT05324995|Celecoxib|celecoxib|mesh-list
14439377|NCT05324995|Epinephrine|epinephrine|mesh-list
14439378|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14439379|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14439380|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
14439381|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439382|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439383|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439384|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14439385|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14439386|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
14928879|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14928880|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751104|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14751105|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
14751106|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
14751107|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751108|NCT05332028|Fentanyl|fentanyl|mesh-list
14751109|NCT05332028|Bupivacaine|bupivacaine|mesh-list
14751110|NCT05332028|Propofol|propofol|mesh-list
14751111|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
14751112|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
14751113|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14928881|NCT01425073|Renal Agents|renal agents|mesh-ancestor
14928882|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14928883|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
14439387|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439388|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14439389|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
14439390|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
14439391|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
14439392|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14470066|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
14751114|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928884|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14439393|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14439394|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14439395|NCT05324995|Analgesics|analgesics|mesh-ancestor
14439396|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
14439397|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439398|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439399|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14439400|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14439401|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439402|NCT05318521|Ibuprofen|ibuprofen|mesh-list
14439403|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14439404|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14439405|NCT05318521|Analgesics|analgesics|mesh-ancestor
14439406|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
14439407|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439408|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439409|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439410|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439411|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14439412|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439413|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439414|NCT05317546|Cannabidiol|cannabidiol|mesh-list
14439415|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
14468843|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14468844|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
14468845|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468846|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468847|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14468848|NCT02285920|Diuretics|diuretics|mesh-ancestor
14468849|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
14468850|NCT02285998|Vaccines|vaccines|mesh-list
14468851|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
14468852|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751115|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
14468853|NCT02286726|Cytarabine|cytarabine|mesh-list
14468854|NCT02286726|Daunorubicin|daunorubicin|mesh-list
14468855|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14468856|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
14468857|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468858|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468859|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
14468860|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468861|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14468862|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
14468863|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468864|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14468865|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14468866|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14468867|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468868|NCT02286843|Trastuzumab|trastuzumab|mesh-list
14468869|NCT02286843|Pertuzumab|pertuzumab|mesh-list
14468870|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14468871|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468872|NCT02286895|Vaccines|vaccines|mesh-list
14468873|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
14468874|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468875|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
14751116|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751117|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14751118|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14751119|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
14751120|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14751121|NCT05332028|Narcotics|narcotics|mesh-ancestor
14751122|NCT05332028|Analgesics|analgesics|mesh-ancestor
14751123|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14751124|NCT05331807|Vitamin D|vitamin d|mesh-list
14751125|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
14751126|NCT05331807|Vitamins|vitamins|mesh-list
14751127|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
14751128|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751129|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14751130|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14751131|NCT05331781|Morphine|morphine|mesh-list
14751132|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14751133|NCT05331781|Narcotics|narcotics|mesh-ancestor
14751134|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751135|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751136|NCT05331781|Analgesics|analgesics|mesh-ancestor
14751137|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
14751138|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751139|NCT05331768|Terlipressin|terlipressin|mesh-list
14751140|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14439416|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
14439417|NCT05311475|Azelastine|azelastine|mesh-list
14439418|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928885|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14928886|NCT01425099|Dolutegravir|dolutegravir|mesh-list
14439419|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14439420|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14439421|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14439422|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
14439423|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439424|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439425|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14439426|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
14439427|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14439428|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439429|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439430|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14439431|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14439432|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
14439433|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
14439434|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439435|NCT05304364|Naltrexone|naltrexone|mesh-list
14439436|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14439437|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14751141|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14751142|NCT05331690|Dexamethasone|dexamethasone|mesh-list
14751143|NCT05331690|Nepafenac|nepafenac|mesh-list
14928887|NCT01425099|Prednisone|prednisone|mesh-list
14928888|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928889|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
14439438|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751144|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928890|NCT01425099|Hormones|hormones|mesh-ancestor
14751145|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
14751146|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
14753843|NCT04951388|Somatomedin B|somatomedin b|mesh-list
14439439|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
14439440|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439441|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
14439442|NCT05302336|Docetaxel|docetaxel|mesh-list
14439443|NCT05302336|Doxorubicin|doxorubicin|mesh-list
14439444|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14439445|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439446|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
14439447|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439448|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439449|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14439450|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
14439451|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439452|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439453|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14439454|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439455|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
14928891|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14928892|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928893|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14439456|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439457|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14439458|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14439459|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14439460|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439461|NCT05301712|Naloxone|naloxone|mesh-list
14439462|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14439463|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439464|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
14439465|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439466|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14439467|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14439468|NCT05300841|Estradiol|estradiol|mesh-list
14439469|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14439470|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
14439471|NCT05300841|Estrogens|estrogens|mesh-ancestor
14439472|NCT05300841|Hormones|hormones|mesh-ancestor
14439473|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439474|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439475|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14439476|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
14439477|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14439478|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14439479|NCT05300841|Progestins|progestins|mesh-ancestor
14439480|NCT05290194|Capecitabine|capecitabine|mesh-list
14439481|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14439482|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14439483|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
14751147|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751148|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751149|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751150|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
14751151|NCT05331690|Hormones|hormones|mesh-ancestor
14751152|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751153|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751154|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751155|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14751156|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751157|NCT05331690|Analgesics|analgesics|mesh-ancestor
14751158|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
14468876|NCT02286921|Testosterone|testosterone|mesh-list
14751159|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14751160|NCT05324215|Fentanyl|fentanyl|mesh-list
14439484|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439485|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439486|NCT05287893|Pyronaridine|pyronaridine|mesh-list
14439487|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
14439488|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14439489|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14751161|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14751162|NCT05324215|Narcotics|narcotics|mesh-ancestor
14751163|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751164|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751165|NCT05324215|Analgesics|analgesics|mesh-ancestor
14751166|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
14751167|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751168|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14751169|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14751170|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
14751171|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
14751172|NCT05320991|Ketamine|ketamine|mesh-list
14751173|NCT05320991|Analgesics|analgesics|mesh-ancestor
14751174|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
14751175|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751176|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751177|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14751178|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14751179|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
14751180|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
14751181|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751182|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14751183|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14439490|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14439491|NCT05285358|Gemcitabine|gemcitabine|mesh-list
14439492|NCT05285358|Paclitaxel|paclitaxel|mesh-list
14439493|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14439494|NCT05285358|Cisplatin|cisplatin|mesh-list
14439495|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14439496|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439497|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439498|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439499|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439500|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751184|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439501|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14439502|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
14439503|NCT05285358|Antiviral Agents|antiviral agents|mesh-ancestor
14439504|NCT05285358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14439505|NCT05285358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439506|NCT05285358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439507|NCT05285358|Immunologic Factors|immunologic factors|mesh-ancestor
14439508|NCT05285358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439509|NCT05284591|Daratumumab|daratumumab|mesh-list
14439510|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439511|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14439512|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14439513|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439514|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439515|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14751185|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439516|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14439517|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439518|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
14439519|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439520|NCT05270057|Prednisone|prednisone|mesh-list
14439521|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
14439522|NCT05270057|Rituximab|rituximab|mesh-list
14439523|NCT05270057|Doxorubicin|doxorubicin|mesh-list
14439524|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14439525|NCT05270057|Etoposide|etoposide|mesh-list
14439526|NCT05270057|Vincristine|vincristine|mesh-list
14439527|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14439528|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439529|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
14439530|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439531|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439532|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14439533|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
14439534|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439535|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439536|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14439537|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439538|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14439539|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14439540|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14439541|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439542|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439543|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
14439544|NCT05270057|Hormones|hormones|mesh-ancestor
14439545|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439546|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14439547|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14439548|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439549|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439550|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439551|NCT05262751|Nintedanib|nintedanib|mesh-list
14439552|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439553|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14439554|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439555|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439556|NCT05261490|Doxorubicin|doxorubicin|mesh-list
14439557|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14439558|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14439559|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439560|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14439561|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14439562|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439563|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439564|NCT05251909|Benralizumab|benralizumab|mesh-list
14439565|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14439566|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
14439567|NCT05251129|Atorvastatin|atorvastatin|mesh-list
14439568|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14928894|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14928895|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14928896|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14928897|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928898|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928899|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14928900|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14928901|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
14928902|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14439569|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14439570|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
14439571|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928903|NCT01425125|Tolvaptan|tolvaptan|mesh-list
14928904|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14928905|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928906|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
14928907|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931161|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931162|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931163|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
14931220|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14931221|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
14931222|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439572|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14439573|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14439574|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439575|NCT05244226|Fentanyl|fentanyl|mesh-list
14439576|NCT05244226|Methadone|methadone|mesh-list
14439577|NCT05244226|Hydromorphone|hydromorphone|mesh-list
14439578|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14439579|NCT05244226|Narcotics|narcotics|mesh-ancestor
14439580|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439581|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439582|NCT05244226|Analgesics|analgesics|mesh-ancestor
14439583|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
14439584|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439585|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14439586|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14439587|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
14439588|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
14439589|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
14439590|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
14439591|NCT05242471|Golimumab|golimumab|mesh-list
14439592|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14439593|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439594|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439595|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
14751186|NCT05315024|Imiquimod|imiquimod|mesh-list
14751187|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14751188|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
14751189|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751190|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751191|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
14751192|NCT05313997|Diclofenac|diclofenac|mesh-list
14751193|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14751194|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751195|NCT05313997|Analgesics|analgesics|mesh-ancestor
14931223|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931224|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
14931225|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931226|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14931227|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931228|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
14931229|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14931230|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14931231|NCT01438073|Hormones|hormones|mesh-list
14931232|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931233|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931234|NCT01438086|Mecasermin|mecasermin|mesh-list
14931235|NCT01438086|Growth Substances|growth substances|mesh-ancestor
14439596|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439597|NCT05236543|Itraconazole|itraconazole|mesh-list
14439598|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
14439599|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751196|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
14753844|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14439600|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14439601|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14439602|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439603|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439604|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14439605|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
14439606|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439607|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439608|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14439609|NCT05229653|Ketamine|ketamine|mesh-list
14439610|NCT05229653|Analgesics|analgesics|mesh-ancestor
14439611|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
14439612|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439613|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439614|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14439615|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14439616|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
14439617|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
14439618|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439619|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14439620|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14439621|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439622|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439623|NCT05228574|Amiloride|amiloride|mesh-list
14439624|NCT05228574|Diuretics|diuretics|mesh-ancestor
14439625|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
14439626|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439627|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14439628|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14439629|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14439630|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439631|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14439632|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14439633|NCT05192850|Metformin|metformin|mesh-list
14439634|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14439635|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468877|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
14928908|NCT01425164|Carvedilol|carvedilol|mesh-list
14928909|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14928910|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14468878|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
14468879|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14468880|NCT02286921|Androgens|androgens|mesh-ancestor
14468881|NCT02286921|Hormones|hormones|mesh-ancestor
14751197|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751198|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751199|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751200|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14751201|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14751202|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751203|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751204|NCT05296603|Lenvatinib|lenvatinib|mesh-list
14751205|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439636|NCT05192200|Interferons|interferons|mesh-list
14439637|NCT05192200|Interferon-beta|interferon-beta|mesh-list
14439638|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439639|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
14439640|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14439641|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
14439642|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439643|NCT05180942|Atorvastatin|atorvastatin|mesh-list
14439644|NCT05180942|Calcium|calcium|mesh-list
14439645|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14439646|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439647|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14439648|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14439649|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
14439650|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439651|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14439652|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14439653|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439654|NCT05180357|Benralizumab|benralizumab|mesh-list
14439655|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14439656|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14439657|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14439658|NCT05177146|Ketamine|ketamine|mesh-list
14439659|NCT05177146|Analgesics|analgesics|mesh-ancestor
14439660|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
14439661|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439662|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439663|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14439664|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14439665|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
14439666|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
14439667|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439668|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14751206|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14751207|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751208|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439669|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14751209|NCT05287360|Apatinib|apatinib|mesh-list
14751210|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751211|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14751212|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751213|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751214|NCT05281471|Gemcitabine|gemcitabine|mesh-list
14751215|NCT05281471|Paclitaxel|paclitaxel|mesh-list
14751216|NCT05281471|Docetaxel|docetaxel|mesh-list
14751217|NCT05281471|Bevacizumab|bevacizumab|mesh-list
14751218|NCT05281471|Carboplatin|carboplatin|mesh-list
14751219|NCT05281471|Doxorubicin|doxorubicin|mesh-list
14751220|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14439670|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439671|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439672|NCT05169437|Niraparib|niraparib|mesh-list
14439673|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14439674|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439675|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439676|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439677|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14439678|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
14751221|NCT05281471|Taxane|taxane|mesh-list
14751222|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14751223|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751224|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14751225|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439679|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439680|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
14439681|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439682|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751226|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439701|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
14751227|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751228|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439702|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439703|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439704|NCT05123599|Tenofovir|tenofovir|mesh-list
14439705|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
14751229|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14751230|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14751231|NCT05281471|Growth Substances|growth substances|mesh-ancestor
14751232|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751233|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
14751234|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14751235|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
14751236|NCT05281471|Antiviral Agents|antiviral agents|mesh-ancestor
14751237|NCT05281471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751238|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751239|NCT05281471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439706|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751240|NCT05281471|Immunologic Factors|immunologic factors|mesh-ancestor
14751241|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14751242|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14751243|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14751244|NCT05280743|Oxycodone|oxycodone|mesh-list
14751245|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14751246|NCT05280743|Narcotics|narcotics|mesh-ancestor
14751247|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751248|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751249|NCT05280743|Analgesics|analgesics|mesh-ancestor
14751250|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
14751251|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439707|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14439708|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14439709|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439710|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439711|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14439712|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14439713|NCT05105282|Anesthetics|anesthetics|mesh-list
14439714|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
14439715|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751252|NCT05273541|Vaccines|vaccines|mesh-list
14751253|NCT05273541|Immunologic Factors|immunologic factors|mesh-ancestor
14751254|NCT05273541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439716|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439717|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
14439718|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439719|NCT05100160|Gabapentin|gabapentin|mesh-list
14439720|NCT05100160|Analgesics|analgesics|mesh-ancestor
14439721|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
14439722|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439723|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439724|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
14439725|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14439726|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14751255|NCT05267600|Prednisone|prednisone|mesh-list
14751256|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439727|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439728|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14439729|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14439730|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14439731|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439732|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439733|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
14439734|NCT05098210|Poly I-C|poly i-c|mesh-list
14439735|NCT05098210|Nivolumab|nivolumab|mesh-list
14439736|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14439737|NCT05098210|Poly ICLC|poly iclc|mesh-list
14439738|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439739|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439740|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14439741|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439742|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
14439743|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
14439744|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439745|NCT05098210|Laxatives|laxatives|mesh-ancestor
14439746|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14439747|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
14439748|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14439749|NCT05089734|Docetaxel|docetaxel|mesh-list
14439750|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439751|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439752|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439753|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439754|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439755|NCT05071716|Rifaximin|rifaximin|mesh-list
14439756|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14439757|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14439758|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14439759|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
14439760|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439761|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439762|NCT05063786|Capecitabine|capecitabine|mesh-list
14439763|NCT05063786|Trastuzumab|trastuzumab|mesh-list
14439764|NCT05063786|Vinorelbine|vinorelbine|mesh-list
14439765|NCT05063786|Fulvestrant|fulvestrant|mesh-list
14439766|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14751257|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
14439767|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
14751258|NCT05267600|Hormones|hormones|mesh-ancestor
14439768|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439769|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439770|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439771|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14439772|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439773|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439774|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439775|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14439776|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14439777|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14439778|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
14439779|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439780|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439790|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
14753845|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14439791|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14439792|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14439793|NCT05058287|Prednisolone|prednisolone|mesh-list
14439794|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
14439795|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14439796|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
14439797|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439798|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
14439799|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
14439800|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439801|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439802|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14439803|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
14439804|NCT05058287|Hormones|hormones|mesh-ancestor
14439805|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439806|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14439807|NCT05058287|Protective Agents|protective agents|mesh-ancestor
14439808|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14439809|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439810|NCT05046184|Midazolam|midazolam|mesh-list
14439811|NCT05046184|Ketamine|ketamine|mesh-list
14439812|NCT05046184|Analgesics|analgesics|mesh-ancestor
14439813|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
14439814|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439815|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439816|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14439817|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14439818|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
14439819|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
14439820|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439821|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14439822|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14439823|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439824|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439825|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14439826|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14439827|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14439828|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14439829|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14439830|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
14439831|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
14439832|NCT05041257|Maytansine|maytansine|mesh-list
14439833|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14439834|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439835|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
14439836|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
14439837|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
14439838|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751259|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439844|NCT05006573|Benralizumab|benralizumab|mesh-list
14439845|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14439846|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
14439847|NCT04999241|Mesalamine|mesalamine|mesh-list
14439848|NCT04999241|Infliximab|infliximab|mesh-list
14439849|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
14439850|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14439851|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14439852|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14439853|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14439854|NCT04999241|Analgesics|analgesics|mesh-ancestor
14439855|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
14439856|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439857|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439858|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14439859|NCT04999020|Ravulizumab|ravulizumab|mesh-list
14439860|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14439861|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439862|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
14439863|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468882|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468883|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468884|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14468885|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468886|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
14468887|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14468888|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14468889|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14468890|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468891|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468892|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
14468893|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468894|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468895|NCT02287350|Diclofenac|diclofenac|mesh-list
14468896|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14468897|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468898|NCT02287350|Analgesics|analgesics|mesh-ancestor
14468899|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
14468900|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468901|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468902|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468903|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468904|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14468905|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439864|NCT04986072|Nitroprusside|nitroprusside|mesh-list
14439865|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14439866|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
14439867|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14439868|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439869|NCT04981678|Buprenorphine|buprenorphine|mesh-list
14439870|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14439871|NCT04981678|Narcotics|narcotics|mesh-ancestor
14439872|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439873|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439874|NCT04981678|Analgesics|analgesics|mesh-ancestor
14439875|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
14439876|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439877|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14439878|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
14439879|NCT04976634|Lenvatinib|lenvatinib|mesh-list
14439880|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439881|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439882|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14439883|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439884|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439885|NCT04969627|Metformin|metformin|mesh-list
14439886|NCT04969627|Exenatide|exenatide|mesh-list
14439887|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14439888|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439889|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14439890|NCT04969627|Incretins|incretins|mesh-ancestor
14439891|NCT04969627|Hormones|hormones|mesh-ancestor
14439892|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14439893|NCT04956575|Vaccines|vaccines|mesh-list
14439894|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
14439895|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439896|NCT04953325|Vaccines|vaccines|mesh-list
14439897|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14751260|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751261|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751262|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751263|NCT05263453|Vemurafenib|vemurafenib|mesh-list
14751264|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751265|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14751266|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751267|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753690|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753691|NCT05018520|Prednisone|prednisone|mesh-list
14753692|NCT05018520|Rituximab|rituximab|mesh-list
14753693|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
14753694|NCT05018520|Vincristine|vincristine|mesh-list
14753695|NCT05018520|Doxorubicin|doxorubicin|mesh-list
14753696|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753697|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753698|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
14753699|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753700|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753701|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14753702|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14753703|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
14753704|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753705|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14753706|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14753707|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
14753708|NCT05018520|Hormones|hormones|mesh-ancestor
14439898|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
14439899|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439900|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14439901|NCT04944888|Eliglustat|eliglustat|mesh-list
14439902|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439903|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439904|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439905|NCT04941196|Ticagrelor|ticagrelor|mesh-list
14439906|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14439907|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14439908|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14439909|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14439910|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
14439911|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14439912|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439913|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439914|NCT04938856|Lamotrigine|lamotrigine|mesh-list
14439915|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
14439916|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14439917|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14439918|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439919|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14439920|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439921|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14439922|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14439923|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753846|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
14439924|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14439925|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14439929|NCT04935177|Antibodies|antibodies|mesh-list
14439930|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
14439931|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14439932|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
14439933|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14439934|NCT04935177|Eculizumab|eculizumab|mesh-list
14439935|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
14439936|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439937|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14439938|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439939|NCT04927780|Leucovorin|leucovorin|mesh-list
14439940|NCT04927780|Fluorouracil|fluorouracil|mesh-list
14439941|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
14439942|NCT04927780|Irinotecan|irinotecan|mesh-list
14751268|NCT05242874|Dexamethasone|dexamethasone|mesh-list
14751269|NCT05242874|Olanzapine|olanzapine|mesh-list
14751270|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
14751271|NCT05242874|Aprepitant|aprepitant|mesh-list
14751272|NCT05242874|Antiemetics|antiemetics|mesh-list
14751273|NCT05242874|Tropisetron|tropisetron|mesh-list
14751274|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751275|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
14751276|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928911|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
14928912|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14928913|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928914|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928915|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14439943|NCT04927780|Calcium|calcium|mesh-list
14751277|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439944|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
14439945|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14928916|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
14928917|NCT01425164|Protective Agents|protective agents|mesh-ancestor
14439946|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439947|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
14439948|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439949|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14439950|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439951|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14439952|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
14439953|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14439954|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14928918|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14928919|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928920|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14928921|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
14928922|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14928923|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14928924|NCT01425216|Sorafenib|sorafenib|mesh-list
14928925|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439955|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439956|NCT04927780|Antidotes|antidotes|mesh-ancestor
14439957|NCT04927780|Protective Agents|protective agents|mesh-ancestor
14439958|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
14439959|NCT04927780|Vitamins|vitamins|mesh-ancestor
14439960|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
14439961|NCT04923776|Carboplatin|carboplatin|mesh-list
14439962|NCT04923776|Etoposide|etoposide|mesh-list
14439963|NCT04923776|Atezolizumab|atezolizumab|mesh-list
14439964|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439965|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14439966|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14439967|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14439968|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439969|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439970|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
14439971|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14439972|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439973|NCT04885712|Metformin|metformin|mesh-list
14439974|NCT04885712|Pioglitazone|pioglitazone|mesh-list
14439975|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
14439976|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14439977|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439978|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14439979|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439980|NCT04884360|Olaparib|olaparib|mesh-list
14439981|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14439982|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14439983|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14439984|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14439985|NCT04871061|Fentanyl|fentanyl|mesh-list
14439986|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14439987|NCT04871061|Narcotics|narcotics|mesh-ancestor
14439988|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14439989|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14439990|NCT04871061|Analgesics|analgesics|mesh-ancestor
14439991|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
14439992|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14439993|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14439994|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14439995|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
14439996|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
14439997|NCT04867707|Zanamivir|zanamivir|mesh-list
14439998|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
14439999|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440000|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440001|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440002|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
14440003|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
14440004|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
14440005|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440006|NCT04837209|Niraparib|niraparib|mesh-list
14440007|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14440008|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751278|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751279|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
14751280|NCT05242874|Hormones|hormones|mesh-ancestor
14751281|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751282|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751283|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751284|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751285|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14751286|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14751287|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751288|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14751289|NCT05242874|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14751290|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14440009|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440010|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440011|NCT04837066|Imidacloprid|imidacloprid|mesh-list
14440012|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
14440013|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440014|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440015|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440016|NCT04827537|Metronidazole|metronidazole|mesh-list
14440017|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440018|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14440019|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14440020|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14440021|NCT04823052|Sulindac|sulindac|mesh-list
14440022|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14440023|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440024|NCT04823052|Analgesics|analgesics|mesh-ancestor
14440025|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
14440026|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440027|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440028|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440029|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440030|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440031|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14440032|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440033|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440034|NCT04814927|Copper|copper|mesh-list
14440035|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14440036|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
14440037|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
14440038|NCT04814927|Etonogestrel|etonogestrel|mesh-list
14440039|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14440040|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
14440041|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14440042|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440043|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14440044|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14440045|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14440046|NCT04814927|Trace Elements|trace elements|mesh-ancestor
14440047|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
14440048|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14440049|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14440050|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440051|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440052|NCT04810949|Vitamin D|vitamin d|mesh-list
14440053|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
14440054|NCT04810949|Vitamins|vitamins|mesh-ancestor
14440055|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
14440056|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440057|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14440058|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14440059|NCT04807894|Testosterone|testosterone|mesh-list
14440060|NCT04807894|Androgens|androgens|mesh-ancestor
14440061|NCT04807894|Hormones|hormones|mesh-ancestor
14440062|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440063|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440064|NCT04795583|Prednisone|prednisone|mesh-list
14440065|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440066|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
14440067|NCT04795583|Hormones|hormones|mesh-ancestor
14440068|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440069|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440070|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440071|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440072|NCT04775173|Sirolimus|sirolimus|mesh-list
14440073|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14440074|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440075|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14440076|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751291|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14751292|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751293|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
14440077|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
14440078|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751294|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14440079|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
14440080|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440081|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14440082|NCT04774068|Romidepsin|romidepsin|mesh-list
14440083|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440084|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14440085|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440086|NCT04767191|Lumefantrine|lumefantrine|mesh-list
14440087|NCT04767191|Artemether|artemether|mesh-list
14440088|NCT04767191|Piperaquine|piperaquine|mesh-list
14440089|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14440090|NCT04767191|Artenimol|artenimol|mesh-list
14440091|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
14440092|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14440093|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14440094|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440095|NCT04744831|Camptothecin|camptothecin|mesh-list
14440096|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
14440097|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14440098|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440099|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14440100|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14440101|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440102|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440103|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
14440104|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468906|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468907|NCT02287376|Diclofenac|diclofenac|mesh-list
14468908|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14468909|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14468910|NCT02287376|Analgesics|analgesics|mesh-ancestor
14468911|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
14468912|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468913|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468914|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468915|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468916|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14468917|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468918|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468919|NCT02287402|Voglibose|voglibose|mesh-list
14468920|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468921|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468922|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14468923|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14468924|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468925|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468926|NCT02287415|Warfarin|warfarin|mesh-list
14468927|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
14468928|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
14468929|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468930|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468931|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468932|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468933|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
14468934|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14468935|NCT02287467|Antibodies|antibodies|mesh-list
14468936|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
14468937|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14468938|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
14468939|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468940|NCT02287610|Prednisone|prednisone|mesh-list
14468941|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14468942|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
14468943|NCT02287610|Hormones|hormones|mesh-ancestor
14468944|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468945|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468946|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14468947|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14468948|NCT02287623|Bupivacaine|bupivacaine|mesh-list
14440105|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
14440106|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440107|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440108|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14440109|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
14440110|NCT04728087|Coagulants|coagulants|mesh-ancestor
14440111|NCT04711252|Palbociclib|palbociclib|mesh-list
14440112|NCT04711252|Anastrozole|anastrozole|mesh-list
14440113|NCT04711252|Hormones|hormones|mesh-list
14440114|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14751295|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14751296|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14751297|NCT05232344|Estradiol|estradiol|mesh-list
14751298|NCT05232344|Progesterone|progesterone|mesh-list
14751299|NCT05232344|Estrogens|estrogens|mesh-ancestor
14440115|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440116|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440117|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440118|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440119|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440120|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440121|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440122|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14440123|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14440124|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14440125|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
14440126|NCT04704154|Nivolumab|nivolumab|mesh-list
14440127|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440128|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440129|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14440130|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440138|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
14440139|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
14440140|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
14440141|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440142|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751300|NCT05232344|Hormones|hormones|mesh-ancestor
14753847|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440143|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
14440144|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440145|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
14440146|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14440147|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
14440148|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14440149|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
14440150|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440151|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440152|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
14440153|NCT04663347|Gemcitabine|gemcitabine|mesh-list
14440154|NCT04663347|Cytarabine|cytarabine|mesh-list
14440155|NCT04663347|Dexamethasone|dexamethasone|mesh-list
14440156|NCT04663347|Prednisone|prednisone|mesh-list
14440157|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
14440158|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14440159|NCT04663347|Rituximab|rituximab|mesh-list
14440160|NCT04663347|Carboplatin|carboplatin|mesh-list
14440161|NCT04663347|Doxorubicin|doxorubicin|mesh-list
14440162|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14440163|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
14751301|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751302|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751303|NCT05232344|Progestins|progestins|mesh-ancestor
14751304|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
14751305|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14751306|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440164|NCT04663347|Vincristine|vincristine|mesh-list
14440165|NCT04663347|Lenalidomide|lenalidomide|mesh-list
14440166|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440167|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
14751307|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751308|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14928926|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14928927|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928928|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928929|NCT01425242|Amlodipine|amlodipine|mesh-list
14928930|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14928931|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14440168|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440169|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440170|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14440171|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
14440172|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440173|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751309|NCT05195034|Analgesics|analgesics|mesh-ancestor
14751310|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
14751311|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751312|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14751313|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14440174|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14440175|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440176|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
14440177|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
14440178|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440179|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14440180|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
14440181|NCT04663347|Hormones|hormones|mesh-ancestor
14440182|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440183|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440184|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440185|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14440186|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
14440187|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
14440188|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751314|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14751315|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
14751316|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440189|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440190|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14440191|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14440192|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14440193|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14440194|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
14440195|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
14440196|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
14440197|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14440198|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14440199|NCT04663347|Growth Substances|growth substances|mesh-ancestor
14440200|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
14440201|NCT04654507|Dexamethasone|dexamethasone|mesh-list
14440202|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440203|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
14440204|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
14440205|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440206|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440207|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751317|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928932|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14928933|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928934|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14928935|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440208|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
14440209|NCT04654507|Hormones|hormones|mesh-ancestor
14440210|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440211|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440212|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440213|NCT04630834|Acetaminophen|acetaminophen|mesh-list
14440214|NCT04630834|Ibuprofen|ibuprofen|mesh-list
14440215|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440216|NCT04630834|Analgesics|analgesics|mesh-ancestor
14440217|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
14440218|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440219|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440220|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
14440221|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928936|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
14440222|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440223|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440224|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14440225|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440226|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440227|NCT04630769|Interleukin-2|interleukin-2|mesh-list
14440228|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440229|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440230|NCT04630769|Analgesics|analgesics|mesh-ancestor
14440231|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
14440232|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440233|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440234|NCT04624854|Aspirin|aspirin|mesh-list
14440235|NCT04624854|Clopidogrel|clopidogrel|mesh-list
14440236|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14440237|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440238|NCT04624854|Analgesics|analgesics|mesh-ancestor
14440239|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
14440240|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440241|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440242|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440243|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440244|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14440245|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14440246|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440247|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14440248|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14440249|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440250|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
14440251|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14440252|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14440253|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14440254|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
14440255|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440256|NCT04624230|Tofacitinib|tofacitinib|mesh-list
14440257|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440258|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440259|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440260|NCT04619706|Palmidrol|palmidrol|mesh-list
14928937|NCT01425320|Dapsone|dapsone|mesh-list
14440261|NCT04619706|Analgesics|analgesics|mesh-ancestor
14440262|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
14440263|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440264|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440265|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14440266|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440267|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440268|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440269|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
14440270|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440271|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14440272|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14440273|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440274|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928938|NCT01425320|Adapalene|adapalene|mesh-list
14928939|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928940|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14928941|NCT01425320|Analgesics|analgesics|mesh-ancestor
14928942|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
14928943|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440275|NCT04619706|Hormones|hormones|mesh-ancestor
14440276|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440277|NCT04619680|Nintedanib|nintedanib|mesh-list
14440278|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440279|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440280|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440281|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440282|NCT04615949|Cannabidiol|cannabidiol|mesh-list
14440283|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
14440284|NCT04607421|Leucovorin|leucovorin|mesh-list
14440285|NCT04607421|Bevacizumab|bevacizumab|mesh-list
14928944|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928945|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14928946|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928947|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
14928948|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928949|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
14928950|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14928951|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14928952|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14928953|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928954|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928955|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
14928956|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14928957|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14928958|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14928959|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14440286|NCT04607421|Cetuximab|cetuximab|mesh-list
14440287|NCT04607421|Fluorouracil|fluorouracil|mesh-list
14440288|NCT04607421|Capecitabine|capecitabine|mesh-list
14440289|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
14440290|NCT04607421|Irinotecan|irinotecan|mesh-list
14440291|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440292|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440293|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14440294|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14440295|NCT04607421|Growth Substances|growth substances|mesh-ancestor
14440296|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440297|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
14440298|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
14440299|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440300|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14440301|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440302|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
14440303|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14440304|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14440305|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440306|NCT04607421|Antidotes|antidotes|mesh-ancestor
14440307|NCT04607421|Protective Agents|protective agents|mesh-ancestor
14440308|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
14440309|NCT04607421|Vitamins|vitamins|mesh-ancestor
14440310|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
14440311|NCT04550377|Cannabidiol|cannabidiol|mesh-list
14440312|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
14440313|NCT04529772|Prednisone|prednisone|mesh-list
14440314|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
14440315|NCT04529772|Rituximab|rituximab|mesh-list
14440316|NCT04529772|Doxorubicin|doxorubicin|mesh-list
14440317|NCT04529772|Vincristine|vincristine|mesh-list
14440318|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
14440319|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440320|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
14440321|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440322|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440323|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14440324|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
14440325|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440326|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440327|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14440328|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440329|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14440330|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14440331|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14440332|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440333|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440334|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
14440335|NCT04529772|Hormones|hormones|mesh-ancestor
14440336|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440337|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440338|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14440339|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14440340|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14440341|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14440342|NCT04479306|Osimertinib|osimertinib|mesh-list
14440343|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440344|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440345|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440346|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440347|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14440348|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440349|NCT04461639|Factor VIII|factor viii|mesh-list
14440350|NCT04461639|Coagulants|coagulants|mesh-ancestor
14440351|NCT04458922|Atezolizumab|atezolizumab|mesh-list
14440352|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14440353|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440354|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
14440355|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440356|NCT04457219|Hemostatics|hemostatics|mesh-list
14440357|NCT04457219|Coagulants|coagulants|mesh-ancestor
14440358|NCT04443010|Temozolomide|temozolomide|mesh-list
14440359|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14440360|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
14440361|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440362|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440363|NCT04439357|Trametinib|trametinib|mesh-list
14440364|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14440365|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440366|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440367|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928960|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
14440368|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928961|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440369|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14440370|NCT04439357|Protective Agents|protective agents|mesh-ancestor
14440371|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440372|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14440373|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
14468949|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
14468950|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
14468951|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14468952|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468953|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
14468954|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468955|NCT02287779|Volixibat|volixibat|mesh-list
14468956|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14468957|NCT02287818|Febuxostat|febuxostat|mesh-list
14468958|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
14468959|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14468960|NCT02287909|Clopidogrel|clopidogrel|mesh-list
14468961|NCT02287909|Ticagrelor|ticagrelor|mesh-list
14468962|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14468963|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14468964|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14468965|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14468966|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
14468967|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468968|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468969|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468970|NCT02288156|Capsaicin|capsaicin|mesh-list
14468971|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
14468972|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
14468973|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
14468974|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14468975|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468976|NCT02288273|Exenatide|exenatide|mesh-list
14468977|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14468978|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468979|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14468980|NCT02288273|Incretins|incretins|mesh-ancestor
14468981|NCT02288273|Hormones|hormones|mesh-ancestor
14468982|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14468983|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14468984|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
14468985|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14468986|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14468987|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468988|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468989|NCT02288325|Milnacipran|milnacipran|mesh-list
14468990|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
14468991|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14440374|NCT04294160|Trametinib|trametinib|mesh-list
14440375|NCT04294160|Dabrafenib|dabrafenib|mesh-list
14440376|NCT04294160|Spartalizumab|spartalizumab|mesh-list
14440377|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440378|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440379|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440380|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440381|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14440382|NCT04281108|Fluticasone|fluticasone|mesh-list
14440383|NCT04281108|Xhance|xhance|mesh-list
14440384|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440385|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14440386|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
14440387|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440388|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440389|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14440390|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
14440391|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
14440392|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14440393|NCT04272333|Nivolumab|nivolumab|mesh-list
14440394|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440395|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440396|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14440397|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440398|NCT04254627|Etanercept|etanercept|mesh-list
14440399|NCT04254627|Mifepristone|mifepristone|mesh-list
14440400|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14440401|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440402|NCT04254627|Analgesics|analgesics|mesh-ancestor
14440403|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
14440404|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440405|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440406|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440407|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440408|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14440409|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440410|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
14440411|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14440412|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
14440413|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14440414|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14440415|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14751318|NCT05177614|Micronutrients|micronutrients|mesh-list
14440416|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14440417|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
14751319|NCT05177614|Trace Elements|trace elements|mesh-list
14440418|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14440419|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14440420|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
14440421|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440422|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
14440423|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14440424|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14440425|NCT04226495|Sufentanil|sufentanil|mesh-list
14440426|NCT04226495|Dsuvia|dsuvia|mesh-list
14440427|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14440428|NCT04226495|Narcotics|narcotics|mesh-ancestor
14440429|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440430|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440431|NCT04226495|Analgesics|analgesics|mesh-ancestor
14440432|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
14440433|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440434|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14440435|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14440436|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
14440437|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
14440438|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
14440439|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
14440440|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440441|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14440442|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440443|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
14440444|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751320|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751321|NCT05159934|Nicotine|nicotine|mesh-list
14751322|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14751323|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
14751324|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751325|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751326|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14440476|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
14440477|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440478|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440479|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440480|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440481|NCT04159519|Budesonide|budesonide|mesh-list
14440482|NCT04159519|Albuterol|albuterol|mesh-list
14440483|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
14440484|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14440485|NCT04159519|Benralizumab|benralizumab|mesh-list
14440486|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440487|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14440488|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
14440489|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440490|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440491|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14440492|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
14440493|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
14440494|NCT04159519|Hormones|hormones|mesh-ancestor
14440495|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440496|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14440497|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14440498|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14440499|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
14440500|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440501|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440502|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
14440503|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14440504|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
14440505|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440506|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440507|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
14440508|NCT04130516|Antibodies|antibodies|mesh-list
14440509|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
14440510|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440511|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440512|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440513|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14440514|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
14440515|NCT04103034|Coagulants|coagulants|mesh-ancestor
14928962|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14928963|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14928964|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928965|NCT01425411|Valsartan|valsartan|mesh-list
14928966|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14928967|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14928968|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14928969|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440516|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14440517|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
14440518|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440519|NCT04095364|Paclitaxel|paclitaxel|mesh-list
14440520|NCT04095364|Carboplatin|carboplatin|mesh-list
14440521|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14440522|NCT04095364|Letrozole|letrozole|mesh-list
14440523|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14440524|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440525|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
14440526|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
14440527|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
14440528|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440529|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14440530|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14440531|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440532|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14440533|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
14440534|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440535|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440536|NCT04091386|Factor VIII|factor viii|mesh-list
14751327|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14751328|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
14751329|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751330|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751331|NCT05151471|Edaravone|edaravone|mesh-list
14751332|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14751333|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
14751334|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751335|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14751336|NCT05151471|Protective Agents|protective agents|mesh-ancestor
14928970|NCT01425424|Vitamin D|vitamin d|mesh-list
14440537|NCT04091386|Coagulants|coagulants|mesh-ancestor
14440538|NCT04082364|Trastuzumab|trastuzumab|mesh-list
14440539|NCT04082364|Margetuximab|margetuximab|mesh-list
14440540|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440541|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440542|NCT04060108|Methamphetamine|methamphetamine|mesh-list
14440543|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14440544|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440545|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
14440546|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
14440547|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440548|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
14440549|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440550|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440551|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
14440552|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14440553|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14440554|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14440555|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14440556|NCT04058470|Prednisone|prednisone|mesh-list
14440557|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
14440558|NCT04058470|Rituximab|rituximab|mesh-list
14440559|NCT04058470|Doxorubicin|doxorubicin|mesh-list
14440560|NCT04058470|Vincristine|vincristine|mesh-list
14440561|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440562|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
14440563|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440564|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440565|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14440566|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
14440567|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440568|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440569|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14440570|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440571|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14440572|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14440573|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14440574|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440575|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440576|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
14440577|NCT04058470|Hormones|hormones|mesh-ancestor
14440578|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440579|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440580|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14440581|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14440582|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14440583|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14440584|NCT04046887|Gemcitabine|gemcitabine|mesh-list
14440585|NCT04046887|Paclitaxel|paclitaxel|mesh-list
14440586|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14440587|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440588|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
14440589|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
14440590|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
14440591|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440592|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14440593|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
14440594|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
14440595|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440596|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440597|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440598|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
14928971|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
14928972|NCT01425424|Vitamins|vitamins|mesh-list
14928973|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
14928974|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928975|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14928976|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14928977|NCT01425476|Vitamin D|vitamin d|mesh-list
14440599|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440600|NCT04041973|Lumefantrine|lumefantrine|mesh-list
14440601|NCT04041973|Artemether|artemether|mesh-list
14440602|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14440603|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
14440604|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14440605|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14440606|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14928978|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
14928979|NCT01425476|Celecoxib|celecoxib|mesh-list
14440613|NCT03956056|Poly I-C|poly i-c|mesh-list
14440614|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14440615|NCT03956056|Poly ICLC|poly iclc|mesh-list
14440616|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
14440617|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
14440618|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440619|NCT03956056|Laxatives|laxatives|mesh-ancestor
14440620|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14440621|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
14440622|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440623|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14440624|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
14440625|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440626|NCT03921060|Denosumab|denosumab|mesh-list
14440627|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14440628|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440629|NCT03904550|Rocuronium|rocuronium|mesh-list
14440630|NCT03904550|Cisatracurium|cisatracurium|mesh-list
14440631|NCT03904550|Neostigmine|neostigmine|mesh-list
14440632|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14440633|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14440634|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14440635|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440636|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440637|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14440638|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440639|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440640|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
14440641|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440642|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14440643|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
14751337|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751338|NCT05103332|Amlodipine|amlodipine|mesh-list
14751339|NCT05103332|Olmesartan|olmesartan|mesh-list
14751340|NCT05103332|Indapamide|indapamide|mesh-list
14440644|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
14751341|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14751342|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14751343|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14440645|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14440646|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440647|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14440648|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14440649|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440650|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440651|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440652|NCT03867500|Niacin|niacin|mesh-list
14440653|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14440654|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
14440655|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440656|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14440657|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
14440658|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
14440659|NCT03867500|Vitamins|vitamins|mesh-ancestor
14440660|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
14928980|NCT01425476|Vitamins|vitamins|mesh-ancestor
14440661|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440662|NCT03866174|Niacin|niacin|mesh-list
14440663|NCT03866174|Psilocybin|psilocybin|mesh-list
14440664|NCT03866174|Vitamins|vitamins|mesh-ancestor
14440665|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
14440666|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440667|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
14440668|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14440669|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
14440670|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440671|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14440672|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
14440673|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
14440674|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14440675|NCT03861052|Dulaglutide|dulaglutide|mesh-list
14440676|NCT03861052|Tirzepatide|tirzepatide|mesh-list
14440677|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14440678|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440679|NCT03861052|Incretins|incretins|mesh-ancestor
14440680|NCT03861052|Hormones|hormones|mesh-ancestor
14440681|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440682|NCT03858231|Acetaminophen|acetaminophen|mesh-list
14440683|NCT03858231|Ibuprofen|ibuprofen|mesh-list
14440684|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440685|NCT03858231|Analgesics|analgesics|mesh-ancestor
14440686|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
14440687|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440688|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440689|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
14440690|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14440691|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440692|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440693|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14440694|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440695|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928981|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
14440696|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14931164|NCT01437800|Metformin|metformin|mesh-list
14440697|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14440698|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
14440699|NCT03829683|Vitamins|vitamins|mesh-ancestor
14440700|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
14440701|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440702|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
14440703|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440704|NCT03829683|Protective Agents|protective agents|mesh-ancestor
14440705|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14440706|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14440707|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14440708|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14440709|NCT03802799|Cannabidiol|cannabidiol|mesh-list
14440710|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
14440711|NCT03799731|Trifluridine|trifluridine|mesh-list
14440712|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
14440713|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440714|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
14440715|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440716|NCT03778957|Bevacizumab|bevacizumab|mesh-list
14440717|NCT03778957|Durvalumab|durvalumab|mesh-list
14440718|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440719|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440720|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14440721|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14751344|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751345|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14751346|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440722|NCT03778957|Growth Substances|growth substances|mesh-ancestor
14440723|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440724|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
14440725|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
14751347|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
14440726|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
14440727|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14468992|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14468993|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14468994|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14468995|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14468996|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14468997|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
14468998|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14468999|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14469000|NCT02288325|Analgesics|analgesics|mesh-ancestor
14469001|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
14469002|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469003|NCT02288364|Lidocaine|lidocaine|mesh-list
14469004|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
14469005|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
14469006|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469007|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469008|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
14469009|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469010|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14469011|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14469012|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14440728|NCT03714308|Aflibercept|aflibercept|mesh-list
14440729|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14440730|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14440731|NCT03714308|Growth Substances|growth substances|mesh-ancestor
14440732|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440733|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
14440734|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440735|NCT03669718|Cemiplimab|cemiplimab|mesh-list
14440736|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440737|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440738|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
14440739|NCT03643796|Ketamine|ketamine|mesh-list
14440740|NCT03643796|Remifentanil|remifentanil|mesh-list
14440741|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14440742|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440743|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440744|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440745|NCT03643796|Analgesics|analgesics|mesh-ancestor
14440746|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
14440747|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440748|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14440749|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14440750|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14440751|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
14440752|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440753|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440754|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14440755|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14440756|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
14440757|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
14440758|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14440759|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14751348|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14751349|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14440760|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14751350|NCT05103332|Diuretics|diuretics|mesh-ancestor
14751351|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
14751352|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14751353|NCT05091866|Progesterone|progesterone|mesh-list
14751354|NCT05091866|Progestins|progestins|mesh-list
14751355|NCT05091866|Hormones|hormones|mesh-ancestor
14751356|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751357|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751358|NCT05076006|PF-06700841|pf-06700841|mesh-list
14751359|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14751360|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751361|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751362|NCT05056883|Ivermectin|ivermectin|mesh-list
14751363|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14751364|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751365|NCT05032820|Lenalidomide|lenalidomide|mesh-list
14751366|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
14751367|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751368|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14751369|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14751370|NCT05032820|Growth Substances|growth substances|mesh-ancestor
14440761|NCT03643796|Narcotics|narcotics|mesh-ancestor
14440762|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
14440763|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14440764|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440765|NCT03605342|Buprenorphine|buprenorphine|mesh-list
14440766|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14440767|NCT03605342|Narcotics|narcotics|mesh-ancestor
14440768|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440769|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440770|NCT03605342|Analgesics|analgesics|mesh-ancestor
14440771|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
14440772|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440773|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14440774|NCT03575052|Pimavanserin|pimavanserin|mesh-list
14440775|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14440776|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14440777|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14440778|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14440779|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440780|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440781|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14440782|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14440783|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14440784|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
14440785|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440786|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440787|NCT03550391|Memantine|memantine|mesh-list
14440788|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14440789|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14440790|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
14440791|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440792|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440793|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440794|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14440795|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14440796|NCT03541252|Cisplatin|cisplatin|mesh-list
14440797|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440798|NCT03521154|Osimertinib|osimertinib|mesh-list
14440799|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440800|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440801|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440802|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440803|NCT03513952|Atezolizumab|atezolizumab|mesh-list
14751371|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14751372|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440804|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14440805|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751373|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
14751374|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440806|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
14440807|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440808|NCT03475277|Ketamine|ketamine|mesh-list
14440809|NCT03475277|Analgesics|analgesics|mesh-ancestor
14440810|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
14440811|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440812|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440813|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14440814|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14440815|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
14440816|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
14440817|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440818|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14440819|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14440820|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440821|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440822|NCT03471364|Ketoconazole|ketoconazole|mesh-list
14751375|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
14751376|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
14751377|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14751378|NCT04986605|Methoxsalen|methoxsalen|mesh-list
14751379|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14751380|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
14751381|NCT04982029|Cannabidiol|cannabidiol|mesh-list
14751382|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
14751383|NCT04978428|Cannabidiol|cannabidiol|mesh-list
14751384|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
14751385|NCT04974528|Insulin|insulin|mesh-list
14751386|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14751387|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
14751388|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
14751389|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
14751390|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
14751391|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14751392|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753709|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14753710|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14753711|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14753712|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
14753713|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753714|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753715|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14753716|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14928982|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440823|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
14440824|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440825|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14440826|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14440827|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440828|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440829|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14440830|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
14440831|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440832|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440833|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14753717|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14753718|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440834|NCT03440450|Gemcitabine|gemcitabine|mesh-list
14440835|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14440836|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
14440837|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440838|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440839|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
14440840|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440841|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440842|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440843|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
14440844|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440845|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14440846|NCT03420014|Doxorubicin|doxorubicin|mesh-list
14440847|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14440848|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14440849|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440850|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14440851|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14440852|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440853|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440854|NCT03370510|Oxytocin|oxytocin|mesh-list
14440855|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
14440856|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14440857|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440858|NCT03360890|Docetaxel|docetaxel|mesh-list
14440859|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
14440860|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440861|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14440862|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14928983|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14928984|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14928985|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14440863|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14928986|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14928987|NCT01425476|Analgesics|analgesics|mesh-ancestor
14928988|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
14440864|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440865|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440866|NCT03299049|Rilpivirine|rilpivirine|mesh-list
14440867|NCT03299049|Cabotegravir|cabotegravir|mesh-list
14440868|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14440869|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14440870|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440871|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440872|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
14440873|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440874|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14440875|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14440876|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14440877|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14440878|NCT03252600|Dexamethasone|dexamethasone|mesh-list
14440879|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
14440880|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
14440881|NCT03252600|Lenalidomide|lenalidomide|mesh-list
14440882|NCT03252600|Elotuzumab|elotuzumab|mesh-list
14440883|NCT03252600|Ichthammol|ichthammol|mesh-list
14440884|NCT03252600|BB 1101|bb 1101|mesh-list
14440885|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440886|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
14440887|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440888|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440889|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14440890|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
14440891|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440892|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440893|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14440894|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440895|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
14440896|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
14440897|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440898|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14440899|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
14440900|NCT03252600|Hormones|hormones|mesh-ancestor
14440901|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14440902|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14440903|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14440904|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14440905|NCT03252600|Growth Substances|growth substances|mesh-ancestor
14440906|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
14440907|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
14440908|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440909|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
14440910|NCT03222570|Serotonin|serotonin|mesh-list
14440911|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14440912|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14440913|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
14440914|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14440915|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440916|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440917|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14440918|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14440919|NCT03212989|Vorinostat|vorinostat|mesh-list
14440920|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440921|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14440922|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440923|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440924|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
14440925|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440926|NCT03186638|Ibuprofen|ibuprofen|mesh-list
14440927|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14928989|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14928990|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751393|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14751394|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14751395|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
14440928|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14440929|NCT03186638|Analgesics|analgesics|mesh-ancestor
14440930|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
14440931|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14440932|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440933|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14440934|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14440935|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14440936|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440937|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440938|NCT03173248|Azacitidine|azacitidine|mesh-list
14440939|NCT03173248|Ivosidenib|ivosidenib|mesh-list
14440940|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14440941|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
14440942|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440943|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440944|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440945|NCT03169361|Ixazomib|ixazomib|mesh-list
14440946|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440947|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
14440948|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440949|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751396|NCT04923620|Cetuximab|cetuximab|mesh-list
14751397|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751398|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751399|NCT04916002|Cemiplimab|cemiplimab|mesh-list
14751400|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751401|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751402|NCT04914234|Metoprolol|metoprolol|mesh-list
14751403|NCT04914234|Atenolol|atenolol|mesh-list
14751404|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14751405|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14751406|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
14440961|NCT03093155|Bevacizumab|bevacizumab|mesh-list
14440962|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14440963|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440964|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14440965|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14440966|NCT03093155|Growth Substances|growth substances|mesh-ancestor
14440967|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440968|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
14440969|NCT03062059|Gemcitabine|gemcitabine|mesh-list
14440970|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14440971|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
14440972|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440973|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440974|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
14440975|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14440976|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440977|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14440978|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
14440979|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440980|NCT03054038|Afatinib|afatinib|mesh-list
14440981|NCT03054038|Necitumumab|necitumumab|mesh-list
14440982|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440983|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440984|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440985|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440986|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14469013|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469014|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469015|NCT02288377|Lanreotide|lanreotide|mesh-list
14469016|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469017|NCT02288819|Diuretics|diuretics|mesh-list
14469018|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14469019|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
14469020|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469021|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469022|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469023|NCT02289079|Bupivacaine|bupivacaine|mesh-list
14469024|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
14469025|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
14469026|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469027|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469028|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
14469029|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469030|NCT02289222|Dexamethasone|dexamethasone|mesh-list
14440987|NCT03041701|Dasatinib|dasatinib|mesh-list
14440988|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14440989|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14440990|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14440991|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14440992|NCT03021083|Fentanyl|fentanyl|mesh-list
14440993|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14440994|NCT03021083|Narcotics|narcotics|mesh-ancestor
14440995|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14440996|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14440997|NCT03021083|Analgesics|analgesics|mesh-ancestor
14440998|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
14440999|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441000|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14441001|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14441002|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
14441003|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
14441004|NCT03012529|Riboflavin|riboflavin|mesh-list
14441005|NCT03012529|Rifampin|rifampin|mesh-list
14441006|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14441007|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
14441008|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14441009|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441010|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
14441011|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14441012|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441013|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441014|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14441015|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14441016|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14441017|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14441018|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14441019|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14441020|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
14441021|NCT03012529|Vitamins|vitamins|mesh-ancestor
14441022|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
14441023|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441024|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14441025|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
14441026|NCT03000257|Venetoclax|venetoclax|mesh-list
14441027|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441028|NCT03000179|Avelumab|avelumab|mesh-list
14441029|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441030|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441031|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
14441032|NCT02990533|Testosterone|testosterone|mesh-list
14441033|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
14441034|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
14441035|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14441036|NCT02990533|Androgens|androgens|mesh-ancestor
14441037|NCT02990533|Hormones|hormones|mesh-ancestor
14441038|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441039|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441040|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441041|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441042|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
14441043|NCT02979327|Adderall|adderall|mesh-list
14441044|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14441045|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441046|NCT02977780|Temozolomide|temozolomide|mesh-list
14441047|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14441048|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
14441049|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441050|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441051|NCT02945813|Metformin|metformin|mesh-list
14441052|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14441053|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441054|NCT02909322|Hydromorphone|hydromorphone|mesh-list
14441055|NCT02909322|Bupivacaine|bupivacaine|mesh-list
14441056|NCT02909322|Ropivacaine|ropivacaine|mesh-list
14441057|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
14441058|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
14441059|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14441060|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441061|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
14441062|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441063|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14441064|NCT02909322|Narcotics|narcotics|mesh-ancestor
14441065|NCT02909322|Analgesics|analgesics|mesh-ancestor
14441066|NCT02891447|Cisplatin|cisplatin|mesh-list
14441067|NCT02891447|Mitomycins|mitomycins|mesh-list
14441068|NCT02891447|Mitomycin|mitomycin|mesh-list
14441069|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441070|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14441071|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
14441072|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441073|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14441074|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441075|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
14441076|NCT02876835|Hematinics|hematinics|mesh-ancestor
14441077|NCT02861573|Dexamethasone|dexamethasone|mesh-list
14441078|NCT02861573|Prednisone|prednisone|mesh-list
14441079|NCT02861573|Carboplatin|carboplatin|mesh-list
14441080|NCT02861573|Docetaxel|docetaxel|mesh-list
14441081|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
14441082|NCT02861573|Etoposide|etoposide|mesh-list
14441083|NCT02861573|Olaparib|olaparib|mesh-list
14441084|NCT02861573|Lenvatinib|lenvatinib|mesh-list
14441085|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
14441086|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751407|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
14751408|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441087|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
14441088|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
14441089|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751409|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751410|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14751411|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14751412|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14751413|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14751414|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751415|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751416|NCT04907370|Gemcitabine|gemcitabine|mesh-list
14441090|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751417|NCT04907370|Cisplatin|cisplatin|mesh-list
14751418|NCT04907370|Antibodies|antibodies|mesh-list
14441091|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441092|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
14441093|NCT02861573|Hormones|hormones|mesh-ancestor
14441094|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441095|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441096|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441097|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441098|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441099|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441100|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441101|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441102|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14751419|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
14751420|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
14751421|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751422|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751423|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14751424|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
14751425|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751426|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
14751427|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751428|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751429|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751430|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
14751431|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
14751432|NCT04904588|Melphalan|melphalan|mesh-list
14751433|NCT04904588|Busulfan|busulfan|mesh-list
14751434|NCT04904588|Fludarabine|fludarabine|mesh-list
14751435|NCT04904588|Tacrolimus|tacrolimus|mesh-list
14751436|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441103|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14751437|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
14751438|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751439|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14751440|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14751441|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
14751442|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751443|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441104|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14441105|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441106|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14441107|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14441108|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14441109|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
14441110|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14751444|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14751445|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14751446|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751447|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14751448|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14751449|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
14751450|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14751451|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441111|NCT02860039|Vaccines|vaccines|mesh-list
14441112|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
14441113|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441114|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
14441115|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441116|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441117|NCT02815033|Choline|choline|mesh-list
14441118|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
14441119|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14441120|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
14441121|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441122|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441123|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14441124|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
14441125|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14441126|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14441127|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441128|NCT02813642|Mitogens|mitogens|mesh-list
14441129|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441130|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441131|NCT02786875|Vitamin D|vitamin d|mesh-list
14441132|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
14441133|NCT02786875|Vitamins|vitamins|mesh-list
14441134|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
14441135|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441136|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14441137|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14441138|NCT02781792|Temozolomide|temozolomide|mesh-list
14441139|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14441140|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
14441141|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441142|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441143|NCT02766582|Paclitaxel|paclitaxel|mesh-list
14441144|NCT02766582|Carboplatin|carboplatin|mesh-list
14441145|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
14441146|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441147|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441148|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441149|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441150|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441151|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441152|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441153|NCT02734602|Ketamine|ketamine|mesh-list
14441154|NCT02734602|Analgesics|analgesics|mesh-ancestor
14441155|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
14441156|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441157|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441158|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14441159|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14441160|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
14441161|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
14441162|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14441163|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14441164|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14441165|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441166|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441167|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
14441168|NCT02727803|Melphalan|melphalan|mesh-list
14441169|NCT02727803|Busulfan|busulfan|mesh-list
14441170|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
14441171|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14441172|NCT02727803|Rituximab|rituximab|mesh-list
14441173|NCT02727803|Fludarabine|fludarabine|mesh-list
14441174|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
14441175|NCT02727803|Clofarabine|clofarabine|mesh-list
14441176|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14441177|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14441178|NCT02727803|Antibodies|antibodies|mesh-list
14441179|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
14441180|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14441181|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441182|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
14441183|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441184|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14441185|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14441186|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
14441187|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441188|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441189|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14441190|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14441191|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
14441192|NCT02647099|Aspirin|aspirin|mesh-list
14441193|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14441194|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14441195|NCT02647099|Analgesics|analgesics|mesh-ancestor
14441196|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
14441197|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441198|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441199|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441200|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14441201|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14441202|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14441203|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441204|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14441205|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14441206|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441207|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
14441208|NCT02632708|Cytarabine|cytarabine|mesh-list
14441209|NCT02632708|Etoposide|etoposide|mesh-list
14441210|NCT02632708|Daunorubicin|daunorubicin|mesh-list
14441211|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
14441212|NCT02632708|Idarubicin|idarubicin|mesh-list
14441213|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441214|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441215|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14441216|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14441217|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441218|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441219|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14441220|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
14441221|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
14441222|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441223|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441224|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
14441225|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441226|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14441227|NCT02632708|Analgesics|analgesics|mesh-ancestor
14441228|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
14441229|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441230|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
14441231|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441232|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441233|NCT02555787|Tacrolimus|tacrolimus|mesh-list
14441234|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441235|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
14441236|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14928991|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928992|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14928993|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14928994|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14928995|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14928996|NCT01425541|Progesterone|progesterone|mesh-list
14928997|NCT01425541|Estradiol|estradiol|mesh-list
14928998|NCT01425541|Estrogens|estrogens|mesh-list
14441237|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14441238|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441239|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751452|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14751453|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14751454|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751455|NCT04892706|Analgesics|analgesics|mesh-ancestor
14751456|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
14751457|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751458|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751459|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751460|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14928999|NCT01425541|Progestins|progestins|mesh-ancestor
14441240|NCT02506192|Prednisone|prednisone|mesh-list
14441241|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929000|NCT01425541|Hormones|hormones|mesh-ancestor
14929001|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929002|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929003|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
14929004|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14929005|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14929006|NCT01425580|Metformin|metformin|mesh-list
14929007|NCT01425580|Liraglutide|liraglutide|mesh-list
14929008|NCT01425580|Glimepiride|glimepiride|mesh-list
14929009|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14929010|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441242|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
14441243|NCT02506192|Hormones|hormones|mesh-ancestor
14441244|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441245|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441246|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441247|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441248|NCT02464969|Apixaban|apixaban|mesh-list
14441249|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14441250|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
14441251|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14441252|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
14441253|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441254|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441255|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
14441256|NCT02362503|Fostemsavir|fostemsavir|mesh-list
14441257|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14441258|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14441259|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
14441260|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441261|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14441262|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14441263|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441264|NCT02288247|Prednisolone|prednisolone|mesh-list
14441265|NCT02288247|Docetaxel|docetaxel|mesh-list
14441266|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441267|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441268|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441269|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441270|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441271|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441272|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
14441273|NCT02288247|Hormones|hormones|mesh-ancestor
14441274|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441275|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441276|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441277|NCT02281838|Enalapril|enalapril|mesh-list
14441278|NCT02281838|Hydralazine|hydralazine|mesh-list
14441279|NCT02281838|Labetalol|labetalol|mesh-list
14441280|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14441281|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
14929011|NCT01425580|Incretins|incretins|mesh-ancestor
14929012|NCT01425580|Hormones|hormones|mesh-ancestor
14441282|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441283|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441284|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14441285|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
14441286|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14441287|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14441288|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
14441289|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441290|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441291|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
14441292|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
14441293|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441294|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14441295|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14441296|NCT02270632|Methotrexate|methotrexate|mesh-list
14441297|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14441298|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
14441299|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14441300|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441301|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14441302|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
14441303|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441304|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441305|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
14441306|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441307|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14441308|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441309|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
14441310|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14441311|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14441312|NCT02261883|Treprostinil|treprostinil|mesh-list
14441313|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14441314|NCT02157974|Exenatide|exenatide|mesh-list
14441315|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14441316|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441317|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14441318|NCT02157974|Incretins|incretins|mesh-ancestor
14441319|NCT02157974|Hormones|hormones|mesh-ancestor
14441320|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441321|NCT02076646|Interleukin-2|interleukin-2|mesh-list
14441322|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441323|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14441324|NCT02076646|Analgesics|analgesics|mesh-ancestor
14441325|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
14441326|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441327|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441328|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
14441329|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441330|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14441331|NCT02007122|Cephalosporins|cephalosporins|mesh-list
14441332|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14441333|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441334|NCT01919086|Dexamethasone|dexamethasone|mesh-list
14441335|NCT01919086|Lenalidomide|lenalidomide|mesh-list
14441336|NCT01919086|Bortezomib|bortezomib|mesh-list
14441337|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441338|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
14441339|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
14441340|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441341|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441342|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441343|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
14441344|NCT01919086|Hormones|hormones|mesh-ancestor
14441345|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441346|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441347|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441348|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
14441349|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14441350|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14441351|NCT01919086|Growth Substances|growth substances|mesh-ancestor
14441352|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
14441353|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14441354|NCT01794143|Liraglutide|liraglutide|mesh-list
14441355|NCT01794143|Glimepiride|glimepiride|mesh-list
14441356|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14441357|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14441358|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441359|NCT01794143|Incretins|incretins|mesh-ancestor
14441360|NCT01794143|Hormones|hormones|mesh-ancestor
14441361|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441362|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
14441363|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441364|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441365|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14441366|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441367|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
14441368|NCT01766128|Zonisamide|zonisamide|mesh-list
14441369|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
14441370|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14441371|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14441372|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441373|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14441374|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441375|NCT01728259|Dexamethasone|dexamethasone|mesh-list
14441376|NCT01728259|Bortezomib|bortezomib|mesh-list
14441377|NCT01728259|Pomalidomide|pomalidomide|mesh-list
14441378|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441379|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
14441380|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
14441381|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441382|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441383|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441384|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
14441385|NCT01728259|Hormones|hormones|mesh-ancestor
14441386|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441387|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441388|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441389|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
14441390|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14441391|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14441392|NCT01728259|Growth Substances|growth substances|mesh-ancestor
14441393|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
14441394|NCT01727193|Azathioprine|azathioprine|mesh-list
14441395|NCT01727193|Leflunomide|leflunomide|mesh-list
14441396|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
14441397|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441398|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14441399|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441400|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441401|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
14441402|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441403|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14441404|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441405|NCT01643460|Ethanol|ethanol|mesh-list
14441406|NCT01643460|Paclitaxel|paclitaxel|mesh-list
14441407|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14441408|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441409|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441410|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441411|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441412|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441413|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441414|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14441415|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441416|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14441417|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441418|NCT01547741|Paclitaxel|paclitaxel|mesh-list
14441419|NCT01547741|Docetaxel|docetaxel|mesh-list
14441420|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
14441421|NCT01547741|Doxorubicin|doxorubicin|mesh-list
14441422|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441423|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441424|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441425|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441426|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441427|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441428|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441429|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
14441430|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441431|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14441432|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14441433|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
14441434|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14441435|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14441436|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14929013|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929014|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14929015|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441437|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14441438|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441439|NCT01500551|Tofacitinib|tofacitinib|mesh-list
14441440|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14441441|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929016|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
14441442|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469031|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
14469032|NCT02289222|Pomalidomide|pomalidomide|mesh-list
14469033|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469034|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
14469035|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
14469036|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469037|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469038|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469039|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
14469040|NCT02289222|Hormones|hormones|mesh-ancestor
14469041|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469042|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14469043|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469044|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14469045|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
14469046|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14469047|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14469048|NCT02289222|Growth Substances|growth substances|mesh-ancestor
14469049|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14470067|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470068|NCT02303262|Gemcitabine|gemcitabine|mesh-list
14470069|NCT02303262|Mocetinostat|mocetinostat|mesh-list
14470070|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14470071|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
14470072|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470073|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470074|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
14470075|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470076|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470077|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470078|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
14470079|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470080|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14470081|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14470082|NCT02303977|Gemcitabine|gemcitabine|mesh-list
14470083|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14470084|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14470085|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
14470086|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470087|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441443|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14441444|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14441445|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14441446|NCT00954876|Capecitabine|capecitabine|mesh-list
14441447|NCT00954876|Cetuximab|cetuximab|mesh-list
14441448|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14441449|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
14441450|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441451|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441452|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441465|NCT00181701|Paclitaxel|paclitaxel|mesh-list
14441466|NCT00181701|Carboplatin|carboplatin|mesh-list
14441467|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441468|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441469|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441470|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441471|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441472|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441473|NCT00084656|Ipilimumab|ipilimumab|mesh-list
14441474|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441475|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441476|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14441477|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441478|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
14441479|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441480|NCT01880086|Clomiphene|clomiphene|mesh-list
14441481|NCT01880086|Enclomiphene|enclomiphene|mesh-list
14441482|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
14441483|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14441484|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
14441485|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441486|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441487|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14441488|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
14441489|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14441490|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14441491|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14441492|NCT01880099|Galantamine|galantamine|mesh-list
14441493|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14441494|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441495|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441496|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
14441497|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441498|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441499|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14441500|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
14441501|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441502|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
14441503|NCT01880424|Linaclotide|linaclotide|mesh-list
14441504|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14441505|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
14441506|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441507|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441508|NCT01880437|Cytarabine|cytarabine|mesh-list
14441509|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14441510|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
14441511|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441512|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441513|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
14441514|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441515|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441516|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
14441517|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441518|NCT01880515|Tetracycline|tetracycline|mesh-list
14441519|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14441520|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441521|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14441522|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441523|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441524|NCT01880528|Lisinopril|lisinopril|mesh-list
14441525|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14441526|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
14441527|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441528|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441529|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14441530|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14441531|NCT01880528|Protective Agents|protective agents|mesh-ancestor
14441532|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441533|NCT01880593|Ketamine|ketamine|mesh-list
14441534|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
14441535|NCT01880593|Analgesics|analgesics|mesh-ancestor
14441536|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
14441537|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441538|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441539|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14441540|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14441541|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
14441542|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
14441543|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14441544|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14441545|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14441546|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441547|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441548|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
14441549|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14441550|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441551|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
14441552|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14441553|NCT01880723|Albuterol|albuterol|mesh-list
14441554|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14441555|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
14441556|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441557|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441558|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14751461|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
14751462|NCT04843761|Remdesivir|remdesivir|mesh-list
14751463|NCT04843761|Phentolamine|phentolamine|mesh-list
14751464|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
14751465|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
14751466|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751467|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
14751468|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751469|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14751470|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14751471|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
14751472|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751473|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751474|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14751475|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751476|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
14751477|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14441559|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
14441560|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
14441561|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14751478|NCT04843761|Protective Agents|protective agents|mesh-ancestor
14751479|NCT04822597|Lidocaine|lidocaine|mesh-list
14751480|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
14441562|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14441563|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14441564|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14441565|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
14441566|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441567|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441568|NCT01880736|Insulin|insulin|mesh-list
14441569|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14441570|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
14441571|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14441572|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441573|NCT01880840|Azelastine|azelastine|mesh-list
14441574|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14441575|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
14441576|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441577|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441578|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14441579|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14441580|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14441581|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441582|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441583|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14441584|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14441585|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14441586|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
14441587|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
14441588|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441589|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
14441590|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
14441591|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
14441592|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14441593|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441594|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
14441595|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441596|NCT01881113|Cetirizine|cetirizine|mesh-list
14441597|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14441598|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14441599|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14441600|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
14441601|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
14441602|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441603|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441604|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441605|NCT01881126|Timolol|timolol|mesh-list
14441606|NCT01881126|Bimatoprost|bimatoprost|mesh-list
14441607|NCT01881126|Travoprost|travoprost|mesh-list
14441608|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14441609|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14441610|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
14441611|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441612|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441613|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441614|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14441615|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14441616|NCT01881230|Gemcitabine|gemcitabine|mesh-list
14441617|NCT01881230|Paclitaxel|paclitaxel|mesh-list
14751481|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
14751482|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751483|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441618|NCT01881230|Carboplatin|carboplatin|mesh-list
14441619|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441620|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441621|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441622|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441623|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441624|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441625|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14441626|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
14441627|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
14441628|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441629|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441630|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441631|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
14441632|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441633|NCT01881412|Fluticasone|fluticasone|mesh-list
14441634|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441635|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14441636|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
14441637|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441638|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441639|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14441640|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
14751484|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
14751485|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751486|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14751487|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14751488|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14751489|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14751490|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441641|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14441642|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14441643|NCT01881789|Dexamethasone|dexamethasone|mesh-list
14751491|NCT04816643|Vaccines|vaccines|mesh-list
14751492|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
14441644|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
14441645|NCT01881789|Lenalidomide|lenalidomide|mesh-list
14441646|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441647|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
14441648|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441649|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14441650|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14441651|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
14441652|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441653|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441654|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14441655|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441656|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
14441657|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
14441658|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441659|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441660|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
14441661|NCT01881789|Hormones|hormones|mesh-ancestor
14441662|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441663|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441664|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14441665|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14441666|NCT01881789|Growth Substances|growth substances|mesh-ancestor
14441667|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
14441668|NCT01881828|Metformin|metformin|mesh-list
14441669|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14441670|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441671|NCT01882088|Psyllium|psyllium|mesh-list
14441672|NCT01882088|Cathartics|cathartics|mesh-ancestor
14441673|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441674|NCT01882439|Tofacitinib|tofacitinib|mesh-list
14441675|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14441676|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441677|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441678|NCT01882829|Quinidine|quinidine|mesh-list
14441679|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
14441680|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
14441681|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
14441682|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14441683|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14441684|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441685|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441686|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441687|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14441688|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14441689|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
14441690|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14441691|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
14441692|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14441693|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14441694|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441695|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441696|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14441697|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14441698|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
14441699|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14441700|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14441701|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14441702|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14441703|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14441704|NCT01882868|Leucovorin|leucovorin|mesh-list
14751493|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751494|NCT04740008|Nicotine|nicotine|mesh-list
14751495|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14441705|NCT01882868|Irinotecan|irinotecan|mesh-list
14441706|NCT01882868|Aflibercept|aflibercept|mesh-list
14441707|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
14441708|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14441709|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14441710|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441711|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441712|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441713|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14441714|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14441715|NCT01882868|Growth Substances|growth substances|mesh-ancestor
14441716|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441717|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
14441718|NCT01882868|Antidotes|antidotes|mesh-ancestor
14441719|NCT01882868|Protective Agents|protective agents|mesh-ancestor
14441720|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
14441721|NCT01882868|Vitamins|vitamins|mesh-ancestor
14441722|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
14441723|NCT01882907|Pioglitazone|pioglitazone|mesh-list
14441724|NCT01882907|Vildagliptin|vildagliptin|mesh-list
14441725|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14441726|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441727|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14441728|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14441729|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441730|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441731|NCT01882985|Lycopene|lycopene|mesh-list
14441732|NCT01882985|Docetaxel|docetaxel|mesh-list
14441733|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441734|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441735|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441736|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441737|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441738|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441739|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
14441740|NCT01882985|Protective Agents|protective agents|mesh-ancestor
14751496|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
14751497|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751498|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751499|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14441741|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441742|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14751500|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14751501|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
14751502|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441743|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14441744|NCT01883362|Midostaurin|midostaurin|mesh-list
14441745|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441746|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14441747|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441748|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441749|NCT01884337|Apixaban|apixaban|mesh-list
14441750|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14441751|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
14441752|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14441753|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
14751503|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751504|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14751505|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14751506|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14751507|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751508|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
14751509|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751510|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441754|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441755|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441756|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
14441757|NCT01884350|Apixaban|apixaban|mesh-list
14441758|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14441759|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
14441760|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14441761|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
14441762|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441763|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441764|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
14441765|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
14441766|NCT01884571|Prednisone|prednisone|mesh-list
14441767|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
14441768|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14441769|NCT01884571|Tacrolimus|tacrolimus|mesh-list
14441770|NCT01884571|Basiliximab|basiliximab|mesh-list
14441771|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441772|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
14441773|NCT01884571|Hormones|hormones|mesh-ancestor
14751511|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
14751512|NCT04676412|Lenvatinib|lenvatinib|mesh-list
14751513|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751514|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441774|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441775|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441776|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441777|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441778|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441779|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
14441780|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14751515|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14441781|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441782|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441783|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14441784|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14441785|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
14441786|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14441787|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441788|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
14441789|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
14441790|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441791|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441792|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14441793|NCT01884571|Protective Agents|protective agents|mesh-ancestor
14441794|NCT01884597|Ranibizumab|ranibizumab|mesh-list
14441795|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14441796|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14441797|NCT01884597|Growth Substances|growth substances|mesh-ancestor
14441798|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441799|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
14441800|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441801|NCT01884675|Ambrisentan|ambrisentan|mesh-list
14441802|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14441803|NCT01884844|Vitamin D|vitamin d|mesh-list
14441804|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
14441805|NCT01884844|Vitamins|vitamins|mesh-ancestor
14441806|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
14441807|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441808|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14441809|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14441810|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14441811|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14441812|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14441813|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14441814|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14441815|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
14441816|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441817|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441818|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441819|NCT01885104|Bisacodyl|bisacodyl|mesh-list
14441820|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14441821|NCT01885104|Laxatives|laxatives|mesh-list
14441822|NCT01885104|Cathartics|cathartics|mesh-ancestor
14441823|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441824|NCT01885182|Oxycodone|oxycodone|mesh-list
14441825|NCT01885182|Naloxone|naloxone|mesh-list
14441826|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14441827|NCT01885182|Narcotics|narcotics|mesh-ancestor
14441828|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14441829|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441830|NCT01885182|Analgesics|analgesics|mesh-ancestor
14441831|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
14441832|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441833|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14441834|NCT01885208|Exenatide|exenatide|mesh-list
14441835|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14441836|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751516|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751517|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751518|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
14751519|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441837|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14441838|NCT01885208|Incretins|incretins|mesh-ancestor
14441839|NCT01885208|Hormones|hormones|mesh-ancestor
14751520|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441840|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441841|NCT01885559|Telmisartan|telmisartan|mesh-list
14441842|NCT01885559|Lisinopril|lisinopril|mesh-list
14441843|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14441844|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14441845|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14441846|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14441847|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441848|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
14441849|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441850|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14441851|NCT01885559|Protective Agents|protective agents|mesh-ancestor
14441852|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441853|NCT01885910|Doxycycline|doxycycline|mesh-list
14441854|NCT01885910|Dapsone|dapsone|mesh-list
14441855|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14441856|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441857|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
14441858|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14441859|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14441860|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14441861|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441862|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441863|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
14441864|NCT01885936|Albuterol|albuterol|mesh-list
14441865|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14441866|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
14441867|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441868|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441869|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14441870|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
14441871|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
14441872|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14441873|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14441874|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14441875|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14441876|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
14441877|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441878|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441879|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14441880|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14441881|NCT01886105|Analgesics|analgesics|mesh-ancestor
14441882|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
14441883|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441884|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751521|NCT04644289|Durvalumab|durvalumab|mesh-list
14751522|NCT04644289|Olaparib|olaparib|mesh-list
14441885|NCT01886287|Octreotide|octreotide|mesh-list
14441886|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441887|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441888|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469050|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14469051|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14469052|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14469053|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14469054|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14469055|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
14469056|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469057|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469058|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469059|NCT02289417|Apremilast|apremilast|mesh-list
14469060|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14469061|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14469062|NCT02289417|Analgesics|analgesics|mesh-ancestor
14469063|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
14469064|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469065|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469066|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469067|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469068|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14469069|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14469070|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469071|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469072|NCT02289456|Paclitaxel|paclitaxel|mesh-list
14469073|NCT02289456|Carboplatin|carboplatin|mesh-list
14469074|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14469075|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469076|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14469077|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
14469078|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14469079|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469080|NCT02289690|Carboplatin|carboplatin|mesh-list
14469081|NCT02289690|Etoposide|etoposide|mesh-list
14469082|NCT02289690|Veliparib|veliparib|mesh-list
14469083|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469084|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14469085|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14469086|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14469087|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469088|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469089|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14469090|NCT02289833|Trastuzumab|trastuzumab|mesh-list
14469091|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14469092|NCT02289833|Maytansine|maytansine|mesh-list
14469093|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14469094|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469095|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441889|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14441890|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14441891|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14441892|NCT01886690|Laxatives|laxatives|mesh-ancestor
14441893|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441894|NCT01886937|Phentermine|phentermine|mesh-list
14441895|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14441896|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441897|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
14441898|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14441899|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
14441900|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
14441901|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441902|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
14441903|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441904|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441905|NCT01887132|Donepezil|donepezil|mesh-list
14441906|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14441907|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441908|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441909|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
14441910|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441911|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441912|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
14441913|NCT01887171|Tacrolimus|tacrolimus|mesh-list
14441914|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441915|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
14441916|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441917|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14441918|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441919|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441920|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14441921|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441922|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441923|NCT01887353|Ranolazine|ranolazine|mesh-list
14441924|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14441925|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14441926|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441927|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
14441928|NCT01887418|Testosterone|testosterone|mesh-list
14441929|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
14441930|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
14441931|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14441932|NCT01887418|Androgens|androgens|mesh-ancestor
14441933|NCT01887418|Hormones|hormones|mesh-ancestor
14441934|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441935|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441936|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751523|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14441937|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441938|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
14441939|NCT01887587|Dexamethasone|dexamethasone|mesh-list
14441940|NCT01887587|Doxorubicin|doxorubicin|mesh-list
14441941|NCT01887587|Vincristine|vincristine|mesh-list
14441942|NCT01887587|Ixazomib|ixazomib|mesh-list
14441943|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14441944|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
14441945|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
14441946|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441947|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441948|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14441949|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
14441950|NCT01887587|Hormones|hormones|mesh-ancestor
14441951|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14441952|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14441953|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441954|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14441955|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14441956|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14441957|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441958|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441959|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14441960|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14441961|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14441962|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14441963|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
14441964|NCT01887717|Sorafenib|sorafenib|mesh-list
14441965|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441966|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14441967|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441968|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441969|NCT01887990|Ketamine|ketamine|mesh-list
14441970|NCT01887990|Analgesics|analgesics|mesh-ancestor
14441971|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
14441972|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14441973|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441974|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14441975|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14441976|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
14441977|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
14441978|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14441979|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14441980|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14441981|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14441982|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441983|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
14441984|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14441985|NCT01888003|Hematinics|hematinics|mesh-ancestor
14441986|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14441987|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14441988|NCT01888432|Everolimus|everolimus|mesh-list
14441989|NCT01888432|Tacrolimus|tacrolimus|mesh-list
14441990|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14441991|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
14441992|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14441993|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14441994|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14441995|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14441996|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14441997|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
14441998|NCT01888497|Promethazine|promethazine|mesh-list
14441999|NCT01888497|Triazolam|triazolam|mesh-list
14442000|NCT01888497|Gabapentin|gabapentin|mesh-list
14442001|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442002|NCT01888497|Analgesics|analgesics|mesh-ancestor
14442003|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
14442004|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442005|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442006|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
14442007|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14442008|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14442009|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442010|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442011|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14442012|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14442013|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442014|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
14751524|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751525|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14751526|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751527|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751528|NCT04642365|Atezolizumab|atezolizumab|mesh-list
14751529|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751530|NCT04629443|Azacitidine|azacitidine|mesh-list
14753719|NCT05013632|Remdesivir|remdesivir|mesh-list
14751531|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14751532|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
14751533|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751534|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751535|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751536|NCT04626596|Etonogestrel|etonogestrel|mesh-list
14751537|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14751538|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
14751539|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14751540|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442015|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14442016|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14751541|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14751542|NCT04612725|Benralizumab|benralizumab|mesh-list
14751543|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14751544|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
14751545|NCT04607954|Durvalumab|durvalumab|mesh-list
14751546|NCT04607954|Topotecan|topotecan|mesh-list
14751547|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
14751548|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14751549|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
14751550|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751551|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751552|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
14751553|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751554|NCT04607954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14929017|NCT01425619|Lidocaine|lidocaine|mesh-list
14929018|NCT01425619|Prilocaine|prilocaine|mesh-list
14929019|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
14929020|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
14929021|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929022|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442017|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
14442018|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
14442019|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
14442020|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
14442021|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442022|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14442023|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
14442024|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
14442025|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14442026|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
14442027|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
14442028|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14442029|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
14442030|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
14442031|NCT01888952|Prednisone|prednisone|mesh-list
14442032|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442033|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
14442034|NCT01888952|Hormones|hormones|mesh-ancestor
14442035|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751555|NCT04607954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14751556|NCT04607954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929023|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
14442036|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442037|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14442038|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442039|NCT01889069|Prednisone|prednisone|mesh-list
14442040|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
14442041|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14442042|NCT01889069|Rituximab|rituximab|mesh-list
14442043|NCT01889069|Doxorubicin|doxorubicin|mesh-list
14442044|NCT01889069|Vincristine|vincristine|mesh-list
14442045|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751557|NCT04607954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751558|NCT04587791|Cannabidiol|cannabidiol|mesh-list
14442046|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
14442047|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442048|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442049|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14442050|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
14442051|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442052|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442053|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14442054|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14442055|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14442056|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14442057|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14442058|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442059|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442060|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
14442061|NCT01889069|Hormones|hormones|mesh-ancestor
14442062|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442063|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14442064|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14442065|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14442066|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14442067|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14442068|NCT01889602|Topiramate|topiramate|mesh-list
14442069|NCT01889602|Lorazepam|lorazepam|mesh-list
14442070|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
14442071|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14442072|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442073|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
14442074|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
14442075|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442076|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442077|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14442078|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442079|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14442080|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14442081|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442082|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
14442083|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
14442084|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442085|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442086|NCT01889667|Insulin|insulin|mesh-list
14442087|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14442088|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14442089|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442090|NCT01889797|Rituximab|rituximab|mesh-list
14442091|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
14442092|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14442093|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442094|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
14442095|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442096|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442097|NCT01889862|Dextrans|dextrans|mesh-list
14442098|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
14442099|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
14442100|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
14442101|NCT01890109|Erenumab|erenumab|mesh-list
14442102|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14442103|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442104|NCT01890109|Analgesics|analgesics|mesh-ancestor
14442105|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
14442106|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442107|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442108|NCT01890122|Metformin|metformin|mesh-list
14442109|NCT01890122|Alogliptin|alogliptin|mesh-list
14442110|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14442111|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442112|NCT01890122|Incretins|incretins|mesh-ancestor
14442113|NCT01890122|Hormones|hormones|mesh-ancestor
14442114|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442115|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14442116|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
14442117|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442118|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442119|NCT01890265|Pirfenidone|pirfenidone|mesh-list
14442120|NCT01890265|Nintedanib|nintedanib|mesh-list
14442121|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
14442122|NCT01890265|Antibodies|antibodies|mesh-list
14442123|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
14442124|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14442125|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
14442126|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442127|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442128|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14442129|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442130|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442131|NCT01890265|Analgesics|analgesics|mesh-ancestor
14442132|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
14442133|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442134|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442135|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442136|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442137|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442138|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14442139|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14442140|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442141|NCT01890473|Abatacept|abatacept|mesh-list
14442142|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14442143|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929024|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929025|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14929026|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14929027|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14929028|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929029|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929030|NCT01425658|Clonidine|clonidine|mesh-list
14442144|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442145|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442146|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
14442147|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442148|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442149|NCT01890642|Lidocaine|lidocaine|mesh-list
14442150|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
14442151|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
14442152|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442153|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442154|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
14442155|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442156|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14442157|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14442158|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14442159|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442160|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442161|NCT01890707|Anesthetics|anesthetics|mesh-list
14442162|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442163|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442164|NCT01890746|Cytarabine|cytarabine|mesh-list
14442165|NCT01890746|Daunorubicin|daunorubicin|mesh-list
14442166|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14442167|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
14442168|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442169|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442170|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
14442171|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14442172|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442173|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
14442174|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442175|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14442176|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14442177|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14442178|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442179|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14442180|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14442181|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442182|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14442183|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14442184|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442185|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442186|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
14442187|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442188|NCT01890967|Atorvastatin|atorvastatin|mesh-list
14442189|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14442190|NCT01890967|Simvastatin|simvastatin|mesh-list
14442191|NCT01890967|Ezetimibe|ezetimibe|mesh-list
14442192|NCT01890967|Pravastatin|pravastatin|mesh-list
14442193|NCT01890967|Pitavastatin|pitavastatin|mesh-list
14442194|NCT01890967|Lovastatin|lovastatin|mesh-list
14442195|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14442196|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14442197|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
14442198|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442199|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14442200|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14442201|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442202|NCT01891331|Fluconazole|fluconazole|mesh-list
14442203|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
14442204|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14442205|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14442206|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14442207|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442208|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442209|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14442210|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
14442211|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442212|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442213|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14442214|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14442215|NCT01891357|Paclitaxel|paclitaxel|mesh-list
14442216|NCT01891357|Trastuzumab|trastuzumab|mesh-list
14442217|NCT01891357|Lapatinib|lapatinib|mesh-list
14442218|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14442219|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442220|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
14442221|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
14442222|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
14469096|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
14929031|NCT01425658|Fentanyl|fentanyl|mesh-list
14929032|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14929033|NCT01425658|Narcotics|narcotics|mesh-ancestor
14929034|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442223|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442224|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14442225|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14442226|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442227|NCT01891669|PF-06263507|pf-06263507|mesh-list
14442228|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14442229|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442230|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14442231|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14442232|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442233|NCT01891864|Etanercept|etanercept|mesh-list
14442234|NCT01891864|GP2015|gp2015|mesh-list
14442235|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442236|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442237|NCT01891864|Analgesics|analgesics|mesh-ancestor
14442238|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
14442239|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442240|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442241|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442242|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442243|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442244|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751559|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
14751560|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14751561|NCT04553367|Meropenem|meropenem|mesh-list
14751562|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14751563|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751564|NCT04542278|Prednisone|prednisone|mesh-list
14751565|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929035|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751566|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
14751567|NCT04542278|Hormones|hormones|mesh-ancestor
14929036|NCT01425658|Analgesics|analgesics|mesh-ancestor
14751568|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751569|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751570|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751571|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751572|NCT04530838|Vaccines|vaccines|mesh-list
14751573|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14751574|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
14751575|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751576|NCT04500665|Colchicine|colchicine|mesh-list
14751577|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
14751578|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442245|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
14442246|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
14442247|NCT01891890|Lamotrigine|lamotrigine|mesh-list
14442248|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
14442249|NCT01891890|Levetiracetam|levetiracetam|mesh-list
14442250|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
14442251|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
14442252|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14442253|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442254|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442255|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14442256|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442257|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14442258|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14442259|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442260|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442261|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14442262|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14442263|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14442264|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14442265|NCT01891968|Bortezomib|bortezomib|mesh-list
14442266|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442267|NCT01892020|Insulin|insulin|mesh-list
14442268|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14442269|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
14442270|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
14442271|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14442272|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442273|NCT01892163|Dexamethasone|dexamethasone|mesh-list
14442274|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442275|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
14442276|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
14442277|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442278|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442279|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442280|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
14442281|NCT01892163|Hormones|hormones|mesh-ancestor
14442282|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442283|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14442284|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442285|NCT01892189|Ketamine|ketamine|mesh-list
14442286|NCT01892189|Analgesics|analgesics|mesh-ancestor
14442287|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
14442288|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442289|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442290|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14442291|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14442292|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
14442293|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
14442294|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442295|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14751579|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
14751580|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
14751581|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14751582|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751583|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751584|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
14751585|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751586|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14442296|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14751587|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442297|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442298|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442299|NCT01892345|Eculizumab|eculizumab|mesh-list
14442300|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14442301|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442302|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
14442303|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442304|NCT01892709|Hydromorphone|hydromorphone|mesh-list
14442305|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14442306|NCT01892709|Narcotics|narcotics|mesh-ancestor
14442307|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442308|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442309|NCT01892709|Analgesics|analgesics|mesh-ancestor
14442310|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
14442311|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442312|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14442313|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14442314|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
14442315|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
14442316|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14442317|NCT01893281|Testosterone|testosterone|mesh-list
14442318|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
14442319|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
14442320|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14442321|NCT01893281|Androgens|androgens|mesh-ancestor
14442322|NCT01893281|Hormones|hormones|mesh-ancestor
14442323|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751588|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442324|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442325|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14442326|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442327|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
14442328|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
14442329|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14442330|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14442331|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14442332|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14751589|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
14751590|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751591|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751592|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14751593|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
14751594|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14753720|NCT05013632|Antibodies|antibodies|mesh-list
14929037|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
14442333|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442334|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442335|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
14442336|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442337|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442338|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14442339|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442340|NCT01893567|Clobetasol|clobetasol|mesh-list
14442341|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442342|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
14442343|NCT01893567|Hormones|hormones|mesh-ancestor
14929038|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929039|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14929040|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14929041|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
14929042|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
14929043|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14929044|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
14929045|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
14929046|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14929047|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14929048|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14929049|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
14931165|NCT01437800|Glimepiride|glimepiride|mesh-list
14442344|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929050|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929051|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929052|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
14929053|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14929054|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14929055|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751595|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751596|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14751597|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753721|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14753722|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
14442345|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442346|NCT01893632|Gabapentin|gabapentin|mesh-list
14442347|NCT01893632|Analgesics|analgesics|mesh-ancestor
14753723|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753724|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
14442348|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
14442349|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442350|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442351|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
14442352|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14442353|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14442354|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442355|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442356|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14442357|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14929056|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
14442358|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442359|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929057|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
14442360|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
14442361|NCT01893801|Gemcitabine|gemcitabine|mesh-list
14442362|NCT01893801|Paclitaxel|paclitaxel|mesh-list
14442363|NCT01893801|Cisplatin|cisplatin|mesh-list
14442364|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14442365|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442366|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
14442367|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
14442368|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
14442369|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442370|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14442371|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
14442372|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
14751598|NCT04434092|Eculizumab|eculizumab|mesh-list
14751599|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14751600|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751601|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
14751602|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442373|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14442374|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442375|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442376|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
14442377|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442378|NCT01893827|Naltrexone|naltrexone|mesh-list
14442379|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14442380|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14442381|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442382|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
14442383|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442384|NCT01893879|Ketoprofen|ketoprofen|mesh-list
14442385|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442386|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442387|NCT01893879|Analgesics|analgesics|mesh-ancestor
14442388|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
14442389|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442390|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442391|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442392|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442393|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14442394|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442395|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442396|NCT01894022|Ambrisentan|ambrisentan|mesh-list
14442397|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14442398|NCT01894152|Everolimus|everolimus|mesh-list
14442399|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442400|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442401|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
14442402|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442403|NCT01894243|Olaparib|olaparib|mesh-list
14442404|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14442405|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442406|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442407|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442408|NCT01894256|Olaparib|olaparib|mesh-list
14442409|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14442410|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442411|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751603|NCT04432584|Eculizumab|eculizumab|mesh-list
14751604|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14751605|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751606|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
14751607|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751608|NCT04429022|Acetaminophen|acetaminophen|mesh-list
14751609|NCT04429022|Celecoxib|celecoxib|mesh-list
14751610|NCT04429022|Ketorolac|ketorolac|mesh-list
14751611|NCT04429022|Oxycodone|oxycodone|mesh-list
14751612|NCT04429022|Gabapentin|gabapentin|mesh-list
14442412|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751613|NCT04429022|Hydromorphone|hydromorphone|mesh-list
14442413|NCT01894477|Fludarabine|fludarabine|mesh-list
14442414|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
14442415|NCT01894477|Treosulfan|treosulfan|mesh-list
14442416|NCT01894477|Busulfan|busulfan|mesh-list
14442417|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442418|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14442419|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
14442420|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442421|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442422|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
14442423|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442424|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14442425|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
14442426|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14442427|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
14442428|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442429|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
14442430|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14442431|NCT01894555|Aspirin|aspirin|mesh-list
14442432|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442433|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442434|NCT01894555|Analgesics|analgesics|mesh-ancestor
14442435|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
14442436|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442437|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442438|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442439|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442440|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14442441|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14442442|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442443|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14442444|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14442445|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442446|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
14442447|NCT01894568|Insulin|insulin|mesh-list
14442448|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14442449|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
14751614|NCT04429022|Ropivacaine|ropivacaine|mesh-list
14442450|NCT01894568|Pioglitazone|pioglitazone|mesh-list
14442451|NCT01894568|Biguanides|biguanides|mesh-list
14442452|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14442453|NCT01894568|Meglitinide|meglitinide|mesh-list
14442454|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442455|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14442456|NCT01894581|Hormones|hormones|mesh-ancestor
14442457|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442458|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442459|NCT01894776|Maraviroc|maraviroc|mesh-list
14442460|NCT01894776|Rifabutin|rifabutin|mesh-list
14442461|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14442462|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14442463|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442464|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14442465|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14442466|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
14442467|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14442468|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14751615|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
14751616|NCT04429022|Anesthetics|anesthetics|mesh-list
14751617|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751618|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442469|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14442470|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14442471|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
14442472|NCT01894919|Vaccines|vaccines|mesh-list
14442473|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
14442474|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442475|NCT01894984|Risperidone|risperidone|mesh-list
14442476|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
14442477|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14442478|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
14442479|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442480|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469097|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
14442481|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442482|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14442483|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442484|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442485|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14442486|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
14442487|NCT01895036|Naltrexone|naltrexone|mesh-list
14442488|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14442489|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14751619|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
14751620|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751621|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751622|NCT04429022|Analgesics|analgesics|mesh-ancestor
14751623|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
14751624|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14751625|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929058|NCT01425736|Cisplatin|cisplatin|mesh-list
14442490|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442491|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
14442492|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442493|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
14442494|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14442495|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14442496|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442497|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
14442498|NCT01895101|Coagulants|coagulants|mesh-ancestor
14442499|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
14442500|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14442501|NCT01895127|Antibodies|antibodies|mesh-list
14442502|NCT01895127|Eculizumab|eculizumab|mesh-list
14442503|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
14442504|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442505|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14442506|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442507|NCT01895270|Isradipine|isradipine|mesh-list
14442508|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14442509|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14442510|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442511|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442512|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14751626|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442513|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442514|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
14442515|NCT01895309|Etanercept|etanercept|mesh-list
14442516|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442517|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442518|NCT01895309|Analgesics|analgesics|mesh-ancestor
14442519|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
14442520|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442521|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929059|NCT01425736|Docetaxel|docetaxel|mesh-list
14929060|NCT01425736|Fluorouracil|fluorouracil|mesh-list
14929061|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
14929062|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442522|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442523|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442524|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442525|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442526|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
14442527|NCT01895322|Tolvaptan|tolvaptan|mesh-list
14442528|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14442529|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442530|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
14442531|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442532|NCT01895335|Teriflunomide|teriflunomide|mesh-list
14442533|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442534|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442535|NCT01895335|Analgesics|analgesics|mesh-ancestor
14442536|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
14442537|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442538|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442539|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442540|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442541|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442542|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
14442543|NCT01895777|Dabigatran|dabigatran|mesh-list
14442544|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
14442545|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14442546|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
14442547|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442548|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442549|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
14929063|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
14442550|NCT01896050|Tamoxifen|tamoxifen|mesh-list
14442551|NCT01896050|Letrozole|letrozole|mesh-list
14929064|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
14442552|NCT01896050|Anastrozole|anastrozole|mesh-list
14442553|NCT01896050|Exemestane|exemestane|mesh-list
14442554|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929065|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
14929066|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929067|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
14929068|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14929069|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929070|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
14929071|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929072|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929073|NCT01425775|Vitamin D|vitamin d|mesh-list
14929074|NCT01425775|Vitamins|vitamins|mesh-ancestor
14929075|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
14929076|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929077|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14929078|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14929079|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14929080|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14929081|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929082|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929083|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929084|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929085|NCT01425827|Analgesics|analgesics|mesh-ancestor
14929086|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
14929087|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929088|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
14929089|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14929090|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
14929091|NCT01425840|Lidocaine|lidocaine|mesh-list
14929092|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
14929093|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
14929094|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929095|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929096|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
14929097|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929098|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14442555|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14442556|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14442557|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442558|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442559|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14442560|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
14442561|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442562|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442563|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14442564|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14442565|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14442566|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14442567|NCT01896128|Modafinil|modafinil|mesh-list
14442568|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14442569|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442570|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14442571|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14442572|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14442573|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929099|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14929100|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14929101|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442574|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
14442575|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
14442576|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14442577|NCT01896232|Cinacalcet|cinacalcet|mesh-list
14442578|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14442579|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442580|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14442581|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
14442582|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442583|NCT01896297|Dabigatran|dabigatran|mesh-list
14442584|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
14442585|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14442586|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
14442587|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442588|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442589|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
14442590|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
14442591|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14442592|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442593|NCT01896544|Vitamins|vitamins|mesh-ancestor
14929102|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929103|NCT01425996|Camptothecin|camptothecin|mesh-list
14929104|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14929105|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929106|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14929107|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14929108|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929109|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929110|NCT01426022|Ethanol|ethanol|mesh-list
14929111|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14929112|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929113|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929114|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929115|NCT01426074|Bevacizumab|bevacizumab|mesh-list
14929116|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929117|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751627|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14751628|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14751629|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751630|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751631|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14751632|NCT04429022|Narcotics|narcotics|mesh-ancestor
14751633|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
14751634|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14751635|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14751636|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14751637|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14751638|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14751639|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751640|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
14751641|NCT04413279|Dexamethasone|dexamethasone|mesh-list
14751642|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751643|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
14751644|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
14751645|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751646|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751647|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751648|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
14751649|NCT04413279|Hormones|hormones|mesh-ancestor
14751650|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751651|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751652|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751653|NCT04413253|Dexamethasone|dexamethasone|mesh-list
14751654|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14751655|NCT04413253|Lifitegrast|lifitegrast|mesh-list
14751656|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14751657|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751658|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
14751659|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
14751660|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751661|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751662|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751663|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
14751664|NCT04413253|Hormones|hormones|mesh-ancestor
14751665|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751666|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751667|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751668|NCT04333407|Aspirin|aspirin|mesh-list
14751669|NCT04333407|Omeprazole|omeprazole|mesh-list
14442594|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
14442595|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14442596|NCT01896557|Omeprazole|omeprazole|mesh-list
14442597|NCT01896557|Ranitidine|ranitidine|mesh-list
14442598|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14442599|NCT01896557|Clopidogrel|clopidogrel|mesh-list
14442600|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
14442601|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14442602|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14442603|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14442604|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
14442605|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442606|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442607|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442608|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14442609|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442610|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14442611|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442612|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14442613|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
14442614|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
14442615|NCT01896700|Methylphenidate|methylphenidate|mesh-list
14442616|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14442617|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442618|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14442619|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14442620|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14751670|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
14751671|NCT04333407|Clopidogrel|clopidogrel|mesh-list
14442621|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442622|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
14442623|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442624|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14442625|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14442626|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14442627|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
14442628|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14442629|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442630|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14442631|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14442632|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14442633|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14442634|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14442635|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14442636|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14442637|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14442638|NCT01896856|Trifluridine|trifluridine|mesh-list
14442639|NCT01896856|Irinotecan|irinotecan|mesh-list
14442640|NCT01896856|Guadecitabine|guadecitabine|mesh-list
14442641|NCT01896856|Azacitidine|azacitidine|mesh-list
14442642|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14442643|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14442644|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442645|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442646|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442647|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
14442648|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
14442649|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14442650|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14442651|NCT01896869|Ipilimumab|ipilimumab|mesh-list
14442652|NCT01896869|Folfirinox|folfirinox|mesh-list
14442653|NCT01896869|Vaccines|vaccines|mesh-list
14442654|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
14442655|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442656|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14442657|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442658|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14442659|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442660|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
14442661|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14442662|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14442663|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14442664|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14442665|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442666|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442667|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
14442668|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442669|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442670|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14442671|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442672|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
14442673|NCT01896921|Maraviroc|maraviroc|mesh-list
14442674|NCT01896921|Dolutegravir|dolutegravir|mesh-list
14442675|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14442676|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14442677|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
14442678|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14442679|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14442680|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14442681|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442682|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442683|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14442684|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14442685|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14442686|NCT01896934|Sertraline|sertraline|mesh-list
14442687|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
14442688|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442689|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14442690|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14442691|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442692|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442693|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442694|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
14442695|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442696|NCT01897233|Ivacaftor|ivacaftor|mesh-list
14442697|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14929118|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14929119|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14929120|NCT01426074|Growth Substances|growth substances|mesh-ancestor
14442698|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442699|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442700|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14442701|NCT01897285|Laxatives|laxatives|mesh-ancestor
14442702|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442703|NCT01897402|Vaccines|vaccines|mesh-list
14442704|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
14442705|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442706|NCT01897493|Digoxin|digoxin|mesh-list
14442707|NCT01897493|Evacetrapib|evacetrapib|mesh-list
14442708|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14442709|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14442710|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442711|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751672|NCT04333407|Atorvastatin|atorvastatin|mesh-list
14751673|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14751674|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751675|NCT04333407|Analgesics|analgesics|mesh-ancestor
14751676|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
14751677|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751678|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751679|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751680|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14751681|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14751682|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14929121|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442712|NCT01897493|Protective Agents|protective agents|mesh-ancestor
14442713|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442714|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14442715|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14442716|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
14442717|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14442718|NCT01897532|Linagliptin|linagliptin|mesh-list
14442719|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14442720|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442721|NCT01897532|Incretins|incretins|mesh-ancestor
14442722|NCT01897532|Hormones|hormones|mesh-ancestor
14442723|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442724|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14442725|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
14442726|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442727|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442728|NCT01897714|Dexamethasone|dexamethasone|mesh-list
14442729|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442730|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
14442731|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
14442732|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442733|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442734|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442735|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
14442736|NCT01897714|Hormones|hormones|mesh-ancestor
14442737|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442738|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14442739|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442740|NCT01897727|Spironolactone|spironolactone|mesh-list
14442741|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14442742|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
14442743|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442744|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442745|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14442746|NCT01897727|Diuretics|diuretics|mesh-ancestor
14442747|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
14442748|NCT01897792|Vitamins|vitamins|mesh-list
14442749|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
14442750|NCT01897792|Vitamin E|vitamin e|mesh-list
14442751|NCT01897792|Tocopherols|tocopherols|mesh-list
14442752|NCT01897792|Tocotrienols|tocotrienols|mesh-list
14442753|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
14442754|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
14442755|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442756|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
14442757|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751683|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751684|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14751685|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14442758|NCT01897792|Protective Agents|protective agents|mesh-ancestor
14442759|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
14442760|NCT01898091|Glycerol|glycerol|mesh-list
14442761|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
14442762|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442763|NCT01898091|Protective Agents|protective agents|mesh-ancestor
14442764|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442765|NCT01898091|Vitamins|vitamins|mesh-ancestor
14442766|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
14442767|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14442768|NCT01898130|Bevacizumab|bevacizumab|mesh-list
14442769|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14442770|NCT01898130|Antibodies|antibodies|mesh-list
14442771|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
14442772|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14442773|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442774|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14442775|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14442776|NCT01898130|Growth Substances|growth substances|mesh-ancestor
14442777|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442778|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
14442779|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
14442780|NCT01898195|Varenicline|varenicline|mesh-list
14442781|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14442782|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14442783|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
14442784|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442785|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442786|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442787|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
14442788|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14442789|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14751686|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751687|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
14751688|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14751689|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14751690|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
14751691|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14751692|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14751693|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14751694|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14751695|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14751696|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
14442790|NCT01898442|Ticagrelor|ticagrelor|mesh-list
14442791|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14442792|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14442793|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14442794|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14442795|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
14442796|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442797|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442798|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442799|NCT01898689|Ropivacaine|ropivacaine|mesh-list
14442800|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
14442801|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
14442802|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442803|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442804|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
14442805|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442806|NCT01898806|Triamcinolone|triamcinolone|mesh-list
14442807|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14442808|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14442809|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14442810|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442811|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
14442812|NCT01898806|Hormones|hormones|mesh-ancestor
14442813|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442814|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442815|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442816|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
14442817|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442818|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442819|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14442820|NCT01898923|Laxatives|laxatives|mesh-ancestor
14442821|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442822|NCT01899053|Serabelisib|serabelisib|mesh-list
14442823|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442824|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442825|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
14442826|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14929122|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
14929123|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14929124|NCT01426087|Somatostatin|somatostatin|mesh-list
14929125|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929126|NCT01426087|Hormones|hormones|mesh-ancestor
14929127|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442827|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
14442828|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751697|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751698|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14751699|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
14442829|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442830|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14442831|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
14442832|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
14442833|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14751700|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14751701|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
14751702|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
14751703|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14442834|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
14442835|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442836|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442837|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
14442838|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14442839|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14442840|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14442841|NCT01900431|Leucovorin|leucovorin|mesh-list
14442842|NCT01900431|Folic Acid|folic acid|mesh-list
14442843|NCT01900431|Prednisone|prednisone|mesh-list
14442844|NCT01900431|Methotrexate|methotrexate|mesh-list
14442845|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
14442846|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442847|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
14751704|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751705|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14931166|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14442848|NCT01900431|Hormones|hormones|mesh-ancestor
14751706|NCT04290546|Ipilimumab|ipilimumab|mesh-list
14442849|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14442850|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442851|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14442852|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442853|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14442854|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
14442855|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14442856|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14442857|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
14442858|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442859|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
14442860|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442861|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14442862|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442863|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
14442864|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442865|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14442866|NCT01900431|Antidotes|antidotes|mesh-ancestor
14442867|NCT01900431|Protective Agents|protective agents|mesh-ancestor
14442868|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
14442869|NCT01900431|Vitamins|vitamins|mesh-ancestor
14442870|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
14442871|NCT01900431|Hematinics|hematinics|mesh-ancestor
14442872|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14442873|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442874|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14442875|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442876|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469098|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
14469099|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469100|NCT02289898|Gemcitabine|gemcitabine|mesh-list
14469101|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14469102|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14469103|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
14469104|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469105|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469106|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
14469107|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469108|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469109|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469110|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
14469111|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469112|NCT02289950|Farletuzumab|farletuzumab|mesh-list
14469113|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442877|NCT01901146|Paclitaxel|paclitaxel|mesh-list
14442878|NCT01901146|Trastuzumab|trastuzumab|mesh-list
14442879|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14442880|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14442881|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14442882|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14751707|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14751708|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751709|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751710|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751711|NCT04286529|Calcitriol|calcitriol|mesh-list
14751712|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14751713|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751714|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14751715|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14751716|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442883|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14442884|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442885|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14442886|NCT01901185|Etanercept|etanercept|mesh-list
14442887|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442888|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442889|NCT01901185|Analgesics|analgesics|mesh-ancestor
14442890|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
14442891|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442892|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442893|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442894|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442895|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14442896|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14442897|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
14442898|NCT01901250|Fluorides|fluorides|mesh-list
14442899|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
14442900|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
14442901|NCT01901250|Protective Agents|protective agents|mesh-ancestor
14442902|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442903|NCT01901393|Ibuprofen|ibuprofen|mesh-list
14442904|NCT01901393|Ketorolac|ketorolac|mesh-list
14751717|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14751718|NCT04286529|Vitamins|vitamins|mesh-ancestor
14751719|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
14442905|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14442906|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14442907|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442908|NCT01901393|Analgesics|analgesics|mesh-ancestor
14442909|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
14442910|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442911|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442912|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14442913|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14442914|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14442915|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442916|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442917|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
14442918|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
14442919|NCT01901575|Remifentanil|remifentanil|mesh-list
14442920|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14442921|NCT01901575|Narcotics|narcotics|mesh-ancestor
14442922|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442923|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442924|NCT01901575|Analgesics|analgesics|mesh-ancestor
14442925|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
14442926|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442927|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
14442928|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14442929|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442930|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442931|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14442932|NCT01901588|Analgesics|analgesics|mesh-ancestor
14442933|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
14442934|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442935|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14442936|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14442937|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14442938|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
14442939|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442940|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442941|NCT01901614|Anesthetics|anesthetics|mesh-list
14442942|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14442943|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442944|NCT01901809|Dopamine|dopamine|mesh-list
14442945|NCT01901809|Furosemide|furosemide|mesh-list
14442946|NCT01901809|Diuretics|diuretics|mesh-ancestor
14442947|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
14442948|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442949|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14442950|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442951|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442952|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14442953|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
14442954|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
14442955|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442956|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
14442957|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442958|NCT01901809|Protective Agents|protective agents|mesh-ancestor
14442959|NCT01901848|Bupropion|bupropion|mesh-list
14442960|NCT01901848|Nicotine|nicotine|mesh-list
14442961|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14442962|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
14442963|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14442964|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442965|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14442966|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14442967|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
14442968|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442969|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442970|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14442971|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
14442972|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442973|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14442974|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14442975|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442976|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
14442977|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14442978|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14442979|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14442980|NCT01902004|Memantine|memantine|mesh-list
14442981|NCT01902004|Citalopram|citalopram|mesh-list
14442982|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14442983|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14442984|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14442985|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14442986|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14442987|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
14442988|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14442989|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14442990|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
14442991|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14442992|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14442993|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14442994|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
14442995|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14442996|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14442997|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14442998|NCT01902134|Tramadol|tramadol|mesh-list
14442999|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14443000|NCT01902134|Narcotics|narcotics|mesh-ancestor
14443001|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443002|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443003|NCT01902134|Analgesics|analgesics|mesh-ancestor
14443004|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
14443005|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443006|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14443007|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14443008|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443009|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14443010|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14443011|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
14443012|NCT01902459|Coagulants|coagulants|mesh-ancestor
14443013|NCT01902758|Ambrisentan|ambrisentan|mesh-list
14443014|NCT01902758|Theophylline|theophylline|mesh-list
14443015|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14443016|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
14443017|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443018|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443019|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14443020|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14443021|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14443022|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443023|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443024|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
14443025|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14443026|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14443027|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
14443028|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443029|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14443030|NCT01903005|Buprenorphine|buprenorphine|mesh-list
14443031|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14443032|NCT01903005|Naloxone|naloxone|mesh-list
14443033|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14443034|NCT01903005|Narcotics|narcotics|mesh-ancestor
14443035|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443036|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443037|NCT01903005|Analgesics|analgesics|mesh-ancestor
14443038|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
14469114|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14443039|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443040|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14443041|NCT01903031|Ritonavir|ritonavir|mesh-list
14443042|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14443043|NCT01903031|Tenofovir|tenofovir|mesh-list
14443044|NCT01903031|Efavirenz|efavirenz|mesh-list
14443045|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14443046|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14443047|NCT01903031|Etonogestrel|etonogestrel|mesh-list
14443048|NCT01903031|NuvaRing|nuvaring|mesh-list
14443049|NCT01903031|Estradiol|estradiol|mesh-list
14443050|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14443051|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14443052|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
14443053|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443054|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443055|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14443056|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14443057|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
14443058|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443059|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14443060|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14443061|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14443062|NCT01903031|Estrogens|estrogens|mesh-ancestor
14443063|NCT01903031|Hormones|hormones|mesh-ancestor
14443064|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443065|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443066|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14443067|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
14443068|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14443069|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14443070|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14443071|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14443072|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14443073|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14443074|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14443075|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14443076|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14443077|NCT01903252|Mesalamine|mesalamine|mesh-list
14443078|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14443079|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14443080|NCT01903252|Analgesics|analgesics|mesh-ancestor
14443081|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
14443082|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443083|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443084|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443085|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14443086|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
14443087|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14443088|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
14443089|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443090|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14443091|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443092|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14443093|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443094|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14443095|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443096|NCT01903356|Linagliptin|linagliptin|mesh-list
14443097|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14443098|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443099|NCT01903356|Incretins|incretins|mesh-ancestor
14443100|NCT01903356|Hormones|hormones|mesh-ancestor
14443101|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443102|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14443103|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
14443104|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443105|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443106|NCT01903434|Evacetrapib|evacetrapib|mesh-list
14443107|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14443108|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14443109|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
14443110|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443111|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14443112|NCT01903720|Dexamethasone|dexamethasone|mesh-list
14443113|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443114|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
14443115|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
14443116|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751720|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14751721|NCT04269200|Paclitaxel|paclitaxel|mesh-list
14751722|NCT04269200|Carboplatin|carboplatin|mesh-list
14751723|NCT04269200|Durvalumab|durvalumab|mesh-list
14443117|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443118|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14443119|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
14443120|NCT01903720|Hormones|hormones|mesh-ancestor
14443121|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443122|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14443123|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443124|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
14443125|NCT01903798|Prednisolone|prednisolone|mesh-list
14443126|NCT01903798|Rilonacept|rilonacept|mesh-list
14443127|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14443128|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443129|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14443130|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
14443131|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14751724|NCT04269200|Olaparib|olaparib|mesh-list
14751725|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14443132|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443133|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443134|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443135|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443136|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
14443137|NCT01903798|Hormones|hormones|mesh-ancestor
14443138|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443139|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443140|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14443141|NCT01903811|Dexamethasone|dexamethasone|mesh-list
14443142|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
14443143|NCT01903811|Ichthammol|ichthammol|mesh-list
14443144|NCT01903811|BB 1101|bb 1101|mesh-list
14443145|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443146|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
14443147|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
14443148|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443149|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443150|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14443151|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
14443152|NCT01903811|Hormones|hormones|mesh-ancestor
14443153|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443154|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14443155|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443156|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
14443157|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443158|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443159|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443160|NCT01903837|Naltrexone|naltrexone|mesh-list
14443161|NCT01903837|Olanzapine|olanzapine|mesh-list
14443162|NCT01903837|ALKS-33|alks-33|mesh-list
14443163|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
14443164|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
14443165|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443166|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443167|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14443168|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14443169|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14443170|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443171|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443172|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14443173|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14443174|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443175|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443176|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443177|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
14929128|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929129|NCT01426100|Telmisartan|telmisartan|mesh-list
14929130|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14929131|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14929132|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14929133|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443178|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14443179|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
14443180|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14443181|NCT01903993|Docetaxel|docetaxel|mesh-list
14443182|NCT01903993|Atezolizumab|atezolizumab|mesh-list
14443183|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443184|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14443185|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14443186|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14443187|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443188|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14443189|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14443190|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14443191|NCT01904071|Morphine|morphine|mesh-list
14443192|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14751726|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14751727|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751728|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14751729|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14751730|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14929134|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
14929135|NCT01426165|Analgesics|analgesics|mesh-ancestor
14929136|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
14929137|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929138|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929139|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
14929140|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443193|NCT01904071|Narcotics|narcotics|mesh-ancestor
14443194|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443195|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443196|NCT01904071|Analgesics|analgesics|mesh-ancestor
14443197|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
14751731|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751732|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751733|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
14751734|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751735|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14751736|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751737|NCT04235062|Furosemide|furosemide|mesh-list
14751738|NCT04235062|Calcium|calcium|mesh-list
14929141|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14443198|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443199|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14443200|NCT01904149|Tramadol|tramadol|mesh-list
14443201|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14443202|NCT01904149|Narcotics|narcotics|mesh-ancestor
14443203|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443204|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443205|NCT01904149|Analgesics|analgesics|mesh-ancestor
14751739|NCT04235062|Diuretics|diuretics|mesh-list
14929142|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
14929143|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14929144|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929145|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929146|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14929147|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
14929148|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14929149|NCT01426243|Vaccines|vaccines|mesh-list
14929150|NCT01426243|Immunologic Factors|immunologic factors|mesh-ancestor
14929151|NCT01426243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929152|NCT01426256|Vitamin D|vitamin d|mesh-list
14929153|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
14929154|NCT01426256|Vitamins|vitamins|mesh-ancestor
14929155|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
14929156|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929157|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14929158|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14929159|NCT01426334|Cyclosporine|cyclosporine|mesh-list
14929160|NCT01426334|Dasatinib|dasatinib|mesh-list
14929161|NCT01426334|Cyclosporins|cyclosporins|mesh-list
14929162|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929163|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929164|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929165|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
14929166|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929167|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
14929168|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929169|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443206|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
14443207|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443208|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14443209|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14443210|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443211|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929170|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929171|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14929172|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929173|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14929174|NCT01426399|Metformin|metformin|mesh-list
14443212|NCT01904526|Guanfacine|guanfacine|mesh-list
14929175|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14443213|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14929176|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929177|NCT01426464|Latanoprost|latanoprost|mesh-list
14751740|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14751741|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14751742|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751743|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
14751744|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14751745|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751746|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
14751747|NCT04088864|Fludarabine|fludarabine|mesh-list
14751748|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751749|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
14751750|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751751|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14443214|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14443215|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14443216|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14443217|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443218|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443219|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443220|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443221|NCT01904721|Bimatoprost|bimatoprost|mesh-list
14443222|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14443223|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14443224|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
14443225|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14443226|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443227|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443228|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14443229|NCT01904760|Analgesics|analgesics|mesh-ancestor
14443230|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
14443231|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443232|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14443233|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14443234|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14443235|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
14929178|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14929179|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14929180|NCT01426490|Vitamins|vitamins|mesh-list
14929181|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
14929182|NCT01426490|Folic Acid|folic acid|mesh-list
14929183|NCT01426490|Pyridoxine|pyridoxine|mesh-list
14443236|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469115|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
14929184|NCT01426490|Pyridoxal|pyridoxal|mesh-list
14929185|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
14929186|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
14443237|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443238|NCT01904864|Iron|iron|mesh-list
14443239|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
14443240|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443241|NCT01904864|Trace Elements|trace elements|mesh-ancestor
14443242|NCT01904903|Trastuzumab|trastuzumab|mesh-list
14443243|NCT01904903|Pertuzumab|pertuzumab|mesh-list
14443244|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14443245|NCT01904903|Maytansine|maytansine|mesh-list
14443246|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14443247|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443248|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14443249|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
14443250|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
14443251|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
14443252|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443253|NCT01905423|Albendazole|albendazole|mesh-list
14443254|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
14443255|NCT01905423|Piperazine|piperazine|mesh-list
14443256|NCT01905423|Mebendazole|mebendazole|mesh-list
14443257|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
14443258|NCT01905423|Citric Acid|citric acid|mesh-list
14443259|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
14443260|NCT01905423|DMP 777|dmp 777|mesh-list
14443261|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
14443262|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14443263|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
14443264|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
14443265|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443266|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
14443267|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14443268|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443269|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
14443270|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14443271|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14443272|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
14443273|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
14443274|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
14443275|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443276|NCT01905423|Filaricides|filaricides|mesh-ancestor
14443277|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
14443278|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14443279|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929187|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
14929188|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929189|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
14929190|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929191|NCT01426490|Protective Agents|protective agents|mesh-ancestor
14929192|NCT01426490|Hematinics|hematinics|mesh-ancestor
14929193|NCT01426542|Topiramate|topiramate|mesh-list
14929194|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
14929195|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14929196|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443280|NCT01905592|Niraparib|niraparib|mesh-list
14929197|NCT01426633|Gemcitabine|gemcitabine|mesh-list
14929198|NCT01426633|Trabectedin|trabectedin|mesh-list
14443281|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14443282|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443283|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929199|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14929200|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
14929201|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929202|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929203|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
14929204|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929205|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443284|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443285|NCT01905657|Docetaxel|docetaxel|mesh-list
14443286|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
14443287|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443288|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
14443289|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
14751752|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14751753|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
14751754|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443290|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14751755|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751756|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14751757|NCT04035486|Carboplatin|carboplatin|mesh-list
14751758|NCT04035486|Pemetrexed|pemetrexed|mesh-list
14751759|NCT04035486|Osimertinib|osimertinib|mesh-list
14751760|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751761|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751762|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751763|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14751764|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14929206|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929207|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
14929208|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443291|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929209|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14443292|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14443293|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
14443294|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14443295|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14751765|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14443296|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14443297|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14443298|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443299|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443300|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
14443301|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443302|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443303|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14443304|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443305|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
14443306|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14443307|NCT01905943|Chlorambucil|chlorambucil|mesh-list
14443308|NCT01905943|Fludarabine|fludarabine|mesh-list
14443309|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
14443310|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14443311|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
14443312|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443313|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14443314|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14443315|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
14443316|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443317|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443318|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14443319|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14443320|NCT01906008|Minocycline|minocycline|mesh-list
14443321|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14443322|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443323|NCT01906346|Cocaine|cocaine|mesh-list
14443324|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
14443325|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
14443326|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443327|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443328|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
14443329|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443330|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14443331|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14751766|NCT04029116|Fluconazole|fluconazole|mesh-list
14751767|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
14751768|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
14751769|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443332|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14443333|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443334|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443335|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
14443336|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443337|NCT01906372|Hormones|hormones|mesh-list
14443338|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14443339|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14443340|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
14443341|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443342|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929210|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
14929211|NCT01426646|Cisplatin|cisplatin|mesh-list
14929212|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929213|NCT01426737|Vildagliptin|vildagliptin|mesh-list
14443343|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443344|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443345|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14443346|NCT01906658|Hormones|hormones|mesh-ancestor
14443347|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443348|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443349|NCT01906866|Melatonin|melatonin|mesh-list
14443350|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
14443351|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443352|NCT01906866|Protective Agents|protective agents|mesh-ancestor
14443353|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443354|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443355|NCT01907100|Cisplatin|cisplatin|mesh-list
14443356|NCT01907100|Pemetrexed|pemetrexed|mesh-list
14443357|NCT01907100|Nintedanib|nintedanib|mesh-list
14443358|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443359|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443360|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443361|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14443362|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14443363|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14443364|NCT01907113|Empagliflozin|empagliflozin|mesh-list
14443365|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14443366|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443367|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14929214|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14929215|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929216|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14929217|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
14929218|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929219|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929220|NCT01426802|Vildagliptin|vildagliptin|mesh-list
14929221|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14443368|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443369|NCT01907217|Methohexital|methohexital|mesh-list
14443370|NCT01907217|Succinylcholine|succinylcholine|mesh-list
14443371|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14443372|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14443373|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14443374|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443375|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443376|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14443377|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
14443378|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
14443379|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443380|NCT01907321|Capsaicin|capsaicin|mesh-list
14443381|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
14929222|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443382|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443383|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
14443384|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443385|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443386|NCT01907334|Fluticasone|fluticasone|mesh-list
14443387|NCT01907334|Xhance|xhance|mesh-list
14443388|NCT01907334|Albuterol|albuterol|mesh-list
14443389|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14443390|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14443391|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
14443392|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443393|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14443394|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
14443395|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443396|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443397|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14443398|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
14443399|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443400|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14443401|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14443402|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14443403|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14443404|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443405|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443406|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443407|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
14443408|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14443409|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
14929223|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14929224|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
14929225|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929226|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929227|NCT01426815|Golimumab|golimumab|mesh-list
14929228|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14929229|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929230|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929231|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
14929232|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929233|NCT01426880|Paclitaxel|paclitaxel|mesh-list
14443410|NCT01907334|Hormones|hormones|mesh-ancestor
14443411|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443412|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
14443413|NCT01907334|Miotics|miotics|mesh-ancestor
14443414|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14443415|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14929234|NCT01426880|Carboplatin|carboplatin|mesh-list
14929235|NCT01426880|Lapatinib|lapatinib|mesh-list
14929236|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14929237|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929238|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
14929239|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
14929240|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
14929241|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929242|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14929243|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929244|NCT01426906|Rifampin|rifampin|mesh-list
14929245|NCT01426906|Ketoconazole|ketoconazole|mesh-list
14443416|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14443417|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14443418|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
14443419|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
14443420|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
14443421|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
14443422|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443423|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443424|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
14443425|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443426|NCT01907607|Palbociclib|palbociclib|mesh-list
14443427|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443428|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14443429|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443430|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443431|NCT01907815|Trametinib|trametinib|mesh-list
14443432|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443433|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14443434|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443435|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443436|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14443437|NCT01907854|Liraglutide|liraglutide|mesh-list
14929246|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14929247|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
14929248|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14443438|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14443439|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443440|NCT01907854|Incretins|incretins|mesh-ancestor
14443441|NCT01907854|Hormones|hormones|mesh-ancestor
14929249|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443442|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443443|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14443444|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
14443445|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443446|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443447|NCT01908062|Naltrexone|naltrexone|mesh-list
14443448|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14443449|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14443450|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443451|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
14443452|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443453|NCT01908101|Halichondrin B|halichondrin b|mesh-list
14751770|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14751771|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14443454|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
14443455|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
14443456|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
14443457|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443458|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443459|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
14443460|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443461|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
14443462|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
14443463|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443464|NCT01908140|Fluticasone|fluticasone|mesh-list
14443465|NCT01908140|Bromides|bromides|mesh-list
14443466|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
14443467|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14443468|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443469|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14443470|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
14443471|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443472|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443473|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14443474|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
14443475|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443476|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14443477|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14443478|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14443479|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14751772|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751773|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751774|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14751775|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
14751776|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751777|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751778|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14751779|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14751780|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14751781|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751782|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751783|NCT04019964|Nivolumab|nivolumab|mesh-list
14443480|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443481|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443482|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443483|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
14443484|NCT01908205|Oxytocin|oxytocin|mesh-list
14443485|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
14443486|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14443487|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443488|NCT01908582|Rifampin|rifampin|mesh-list
14443489|NCT01908582|Evacetrapib|evacetrapib|mesh-list
14443490|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14443491|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
14443492|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14929250|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
14929251|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14929252|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929253|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929254|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14929255|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14929256|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14929257|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14929258|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14929259|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14929260|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
14929261|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14443493|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443494|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
14443495|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14443496|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443497|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443498|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14443499|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14443500|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14443501|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14443502|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14443503|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14443504|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14443505|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14443506|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
14443507|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14929262|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14929263|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14929264|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
14929265|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929266|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929267|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14929268|NCT01426971|Ibuprofen|ibuprofen|mesh-list
14929269|NCT01426971|Caffeine|caffeine|mesh-list
14929270|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14929271|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14929272|NCT01426971|Analgesics|analgesics|mesh-ancestor
14929273|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
14929274|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929275|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929276|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443508|NCT01908699|Beraprost|beraprost|mesh-list
14443509|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14443510|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
14443511|NCT01908751|Vitamin D|vitamin d|mesh-list
14443512|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
14443513|NCT01908751|Vitamins|vitamins|mesh-list
14443514|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
14443515|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443516|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14443517|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14469116|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469117|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
14469118|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469119|NCT02290106|Pitavastatin|pitavastatin|mesh-list
14469120|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14469121|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14751784|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751785|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751786|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14751787|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751788|NCT04019015|Thrombin|thrombin|mesh-list
14469122|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14469123|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
14751789|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
14751790|NCT04019015|Coagulants|coagulants|mesh-ancestor
14751791|NCT03980769|Vidarabine|vidarabine|mesh-list
14751792|NCT03980769|Fludarabine|fludarabine|mesh-list
14751793|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
14751794|NCT03980769|Thiotepa|thiotepa|mesh-list
14751795|NCT03980769|Treosulfan|treosulfan|mesh-list
14751796|NCT03980769|Busulfan|busulfan|mesh-list
14751797|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14751798|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
14751799|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443518|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
14443519|NCT01908803|Dexamethasone|dexamethasone|mesh-list
14443520|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443521|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
14443522|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
14443523|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443524|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443525|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14443526|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
14443527|NCT01908803|Hormones|hormones|mesh-ancestor
14443528|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443529|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14443530|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443531|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14443532|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443533|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14443534|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14443535|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443536|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443537|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14443538|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14443539|NCT01908816|Ranibizumab|ranibizumab|mesh-list
14443540|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14443541|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14443542|NCT01908816|Growth Substances|growth substances|mesh-ancestor
14443543|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443544|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
14443545|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443546|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
14443547|NCT01908829|Mirabegron|mirabegron|mesh-list
14443548|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14443549|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14443550|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
14443551|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443552|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751800|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14751801|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
14751802|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443553|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443554|NCT01908829|Urological Agents|urological agents|mesh-ancestor
14443555|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14443556|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14443557|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14443558|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443559|NCT01908842|Buprenorphine|buprenorphine|mesh-list
14443560|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14443561|NCT01908842|Narcotics|narcotics|mesh-ancestor
14443562|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443563|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443564|NCT01908842|Analgesics|analgesics|mesh-ancestor
14443565|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
14929277|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929278|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14929279|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929280|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443566|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443567|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14443568|NCT01908972|Prednisolone|prednisolone|mesh-list
14443569|NCT01908972|Propranolol|propranolol|mesh-list
14443570|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443571|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
14443572|NCT01908972|Hormones|hormones|mesh-ancestor
14443573|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751803|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14443574|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443575|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14443576|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443577|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14443578|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14443579|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443580|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443581|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443582|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14443583|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14443584|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
14443585|NCT01909141|Metformin|metformin|mesh-list
14443586|NCT01909141|Pioglitazone|pioglitazone|mesh-list
14443587|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
14443588|NCT01909141|Letrozole|letrozole|mesh-list
14443589|NCT01909141|Clomiphene|clomiphene|mesh-list
14443590|NCT01909141|Enclomiphene|enclomiphene|mesh-list
14443591|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
14443592|NCT01909141|Hormones|hormones|mesh-list
14443593|NCT01909141|Estradiol|estradiol|mesh-list
14443594|NCT01909141|Testosterone|testosterone|mesh-list
14443595|NCT01909141|Progesterone|progesterone|mesh-list
14443596|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14443597|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14443598|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443599|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443600|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443601|NCT01909141|Estrogens|estrogens|mesh-ancestor
14443602|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14443603|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751804|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
14751805|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443604|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14751806|NCT03980769|Antiviral Agents|antiviral agents|mesh-ancestor
14443605|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14443606|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443607|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14443608|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
14443609|NCT01909141|Androgens|androgens|mesh-ancestor
14443610|NCT01909141|Progestins|progestins|mesh-ancestor
14443611|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14443612|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443613|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14443614|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
14443615|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14443616|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14443617|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14443618|NCT01909466|Aripiprazole|aripiprazole|mesh-list
14443619|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
14443620|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443621|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14443622|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14443623|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443624|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443625|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
14443626|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
14443627|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443628|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443629|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14443630|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14443631|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
14443632|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14443633|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14443634|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14443635|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14443636|NCT01909791|Bevacizumab|bevacizumab|mesh-list
14443637|NCT01909791|Aflibercept|aflibercept|mesh-list
14443638|NCT01909791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14443639|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443640|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14443641|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14443642|NCT01909791|Growth Substances|growth substances|mesh-ancestor
14443643|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443644|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
14443645|NCT01909804|Ribavirin|ribavirin|mesh-list
14443646|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
14443647|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443648|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
14443649|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751807|NCT03980769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14751808|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14751809|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
14751810|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14751811|NCT03936192|Meloxicam|meloxicam|mesh-list
14751812|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14751813|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751814|NCT03936192|Analgesics|analgesics|mesh-ancestor
14751815|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
14751816|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751817|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751818|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751819|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14751820|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14443650|NCT01910064|Adapalene|adapalene|mesh-list
14443651|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14751821|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14751822|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751823|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751824|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
14751825|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751826|NCT03915223|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14751827|NCT03915223|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14751828|NCT03915223|Methylprednisolone|methylprednisolone|mesh-list
14751829|NCT03915223|Prednisolone|prednisolone|mesh-list
14751830|NCT03915223|Prednisolone acetate|prednisolone acetate|mesh-list
14751831|NCT03915223|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14751832|NCT03915223|Prednisolone phosphate|prednisolone phosphate|mesh-list
14751833|NCT03915223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751834|NCT03915223|Glucocorticoids|glucocorticoids|mesh-ancestor
14751835|NCT03915223|Hormones|hormones|mesh-ancestor
14751836|NCT03915223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443652|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443653|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14443654|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14443655|NCT01910064|Analgesics|analgesics|mesh-ancestor
14443656|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
14443657|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443658|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443659|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443660|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14443661|NCT01910181|Vemurafenib|vemurafenib|mesh-list
14443662|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443663|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14443664|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443665|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443666|NCT01910311|Rifampin|rifampin|mesh-list
14751837|NCT03915223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443667|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14443668|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
14443669|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14443670|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443671|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
14443672|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14443673|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443674|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443675|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14443676|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14443677|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14443678|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14443679|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14443680|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14443681|NCT01910519|Vaccines|vaccines|mesh-list
14443682|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
14443683|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443684|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
14751838|NCT03915223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14751839|NCT03915223|Protective Agents|protective agents|mesh-ancestor
14751840|NCT03915223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14751841|NCT03915223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751842|NCT03915223|Antiemetics|antiemetics|mesh-ancestor
14751843|NCT03915223|Autonomic Agents|autonomic agents|mesh-ancestor
14751844|NCT03915223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751845|NCT03915223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14751846|NCT03901729|Furosemide|furosemide|mesh-list
14751847|NCT03901729|Diuretics|diuretics|mesh-ancestor
14751848|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
14751849|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751850|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14751851|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14751852|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751853|NCT03897335|Aminophylline|aminophylline|mesh-list
14751854|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14751855|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
14751856|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751857|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751858|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14751859|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
14751860|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14751861|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14751862|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751863|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751864|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14751865|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14751866|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
14751867|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751868|NCT03897335|Protective Agents|protective agents|mesh-ancestor
14751869|NCT03896230|Ketamine|ketamine|mesh-list
14751870|NCT03896230|Analgesics|analgesics|mesh-ancestor
14443685|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
14751871|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
14751872|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929281|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14470088|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
14470089|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470090|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470091|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470092|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
14470093|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470094|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
14470095|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470096|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470097|NCT02304159|Ribavirin|ribavirin|mesh-list
14470098|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
14470099|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
14470100|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470101|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
14470102|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470103|NCT02304432|Cycloserine|cycloserine|mesh-list
14470104|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14470105|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470106|NCT02304432|Renal Agents|renal agents|mesh-ancestor
14470107|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14470108|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
14470109|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470110|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
14470111|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470112|NCT02304484|Evolocumab|evolocumab|mesh-list
14470113|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14470114|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14470115|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
14470116|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470117|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14470118|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
14470119|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
14470120|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14470121|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14470122|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470123|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470124|NCT02304705|Urological Agents|urological agents|mesh-ancestor
14470125|NCT02304757|Alendronate|alendronate|mesh-list
14470126|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
14470127|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14470128|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470129|NCT02304926|Simvastatin|simvastatin|mesh-list
14470130|NCT02304926|Ezetimibe|ezetimibe|mesh-list
14470131|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14470132|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14470133|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14470134|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
14470135|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751873|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751874|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14751875|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14751876|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
14751877|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
14751878|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14751879|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14443686|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443687|NCT01911065|Vaccines|vaccines|mesh-list
14443688|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
14443689|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443690|NCT01911169|Vitamin D|vitamin d|mesh-list
14443691|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
14443692|NCT01911169|Vitamins|vitamins|mesh-list
14443693|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
14443694|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443695|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14443696|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14443697|NCT01911260|Chelating Agents|chelating agents|mesh-list
14443698|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
14443699|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443700|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
14751880|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14751881|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751882|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443701|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14443702|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
14443703|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
14443704|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443705|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443706|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14443707|NCT01911351|Analgesics|analgesics|mesh-ancestor
14443708|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
14443709|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443710|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14443711|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14443712|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14443713|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443714|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443715|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443716|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14443717|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14751883|NCT03879577|Tamoxifen|tamoxifen|mesh-list
14751884|NCT03879577|Docetaxel|docetaxel|mesh-list
14751885|NCT03879577|Trastuzumab|trastuzumab|mesh-list
14751886|NCT03879577|Letrozole|letrozole|mesh-list
14751887|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751888|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
14751889|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
14443718|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14443719|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443720|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443721|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443722|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14443723|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14443724|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
14443725|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14443726|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14443727|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
14751890|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
14751891|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751892|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751893|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14751894|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14751895|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751896|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14929282|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14929283|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14443728|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14443729|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14443730|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14443731|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443732|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929284|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14929285|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
14929286|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929287|NCT01426984|Methylphenidate|methylphenidate|mesh-list
14929288|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14443733|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443734|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14443735|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14443736|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14443737|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443738|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443739|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443740|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14443741|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14443742|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
14443743|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14443744|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14443745|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
14443746|NCT01911546|Everolimus|everolimus|mesh-list
14443747|NCT01911546|Tacrolimus|tacrolimus|mesh-list
14443748|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14443749|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
14443750|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443751|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14443752|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443753|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443754|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443755|NCT01911780|Amlodipine|amlodipine|mesh-list
14443756|NCT01911780|Telmisartan|telmisartan|mesh-list
14443757|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14443758|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14443759|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14443760|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443761|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443762|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14443763|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443764|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
14443765|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14929289|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929290|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14929291|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14929292|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929293|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929294|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
14929295|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931167|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443766|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14443767|NCT01911780|Diuretics|diuretics|mesh-ancestor
14443768|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
14443769|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14443770|NCT01911845|Ribavirin|ribavirin|mesh-list
14443771|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
14443772|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443773|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
14443774|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443775|NCT01912222|Ixazomib|ixazomib|mesh-list
14443776|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443777|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
14443778|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443779|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443780|NCT01912274|Azacitidine|azacitidine|mesh-list
14443781|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14443782|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
14443783|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443784|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443785|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443786|NCT01912352|Methylphenidate|methylphenidate|mesh-list
14443787|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14443788|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443789|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14443790|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14443791|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443792|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443793|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
14443794|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443795|NCT01912456|Complement C1s|complement c1s|mesh-list
14443796|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14443797|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14443798|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
14931168|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14931169|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14443799|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443800|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14443801|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14443802|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14443803|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14443804|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14443805|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443806|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443807|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443808|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443809|NCT01912612|Analgesics|analgesics|mesh-ancestor
14443810|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
14443811|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443812|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
14443813|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443814|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
14443815|NCT01912716|Indomethacin|indomethacin|mesh-list
14443816|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14443817|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14443818|NCT01912716|Analgesics|analgesics|mesh-ancestor
14443819|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
14443820|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751897|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
14443821|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443822|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14443823|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14443824|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
14443825|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
14443826|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14443827|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14443828|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443829|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443830|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14443831|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14443832|NCT01912807|Ondansetron|ondansetron|mesh-list
14443833|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
14443834|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
14443835|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443836|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443837|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14443838|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
14443839|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
14443840|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14443841|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
14443842|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443843|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443844|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14443845|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14443846|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443847|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443848|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14443849|NCT01912872|Omalizumab|omalizumab|mesh-list
14443850|NCT01912872|Budesonide|budesonide|mesh-list
14443851|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
14443852|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751898|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14751899|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751900|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14443853|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14443854|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
14751901|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14443855|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443856|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443857|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14443858|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
14443859|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
14443860|NCT01912872|Hormones|hormones|mesh-ancestor
14443861|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443862|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14443863|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14443864|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14443865|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443866|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443867|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443868|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14443869|NCT01912963|Trastuzumab|trastuzumab|mesh-list
14443870|NCT01912963|Pertuzumab|pertuzumab|mesh-list
14443871|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14443872|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443873|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
14443874|NCT01913340|Hematinics|hematinics|mesh-ancestor
14443875|NCT01913405|Factor VIII|factor viii|mesh-list
14443876|NCT01913405|BAX 855|bax 855|mesh-list
14443877|NCT01913405|Coagulants|coagulants|mesh-ancestor
14443878|NCT01913470|Losartan|losartan|mesh-list
14443879|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14443880|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14751902|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14751903|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14751904|NCT03864926|Tacrolimus|tacrolimus|mesh-list
14751905|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14751906|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
14751907|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443881|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14443882|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14443883|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751908|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14751909|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751910|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443884|NCT01913483|Heparin|heparin|mesh-list
14443885|NCT01913483|Calcium heparin|calcium heparin|mesh-list
14443886|NCT01913483|Bivalirudin|bivalirudin|mesh-list
14443887|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
14443888|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14443889|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14443890|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443891|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
14443892|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14443893|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
14443894|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14443895|NCT01913535|Aticaprant|aticaprant|mesh-list
14443896|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14443897|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443898|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
14443899|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443900|NCT01913639|Leucovorin|leucovorin|mesh-list
14443901|NCT01913639|Fluorouracil|fluorouracil|mesh-list
14443902|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
14443903|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
14443904|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443905|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14443906|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14443907|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14443908|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
14443909|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443910|NCT01913639|Antidotes|antidotes|mesh-ancestor
14443911|NCT01913639|Protective Agents|protective agents|mesh-ancestor
14443912|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
14443913|NCT01913639|Vitamins|vitamins|mesh-ancestor
14443914|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
14443915|NCT01914159|Ranibizumab|ranibizumab|mesh-list
14443916|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14443917|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14443918|NCT01914159|Growth Substances|growth substances|mesh-ancestor
14443919|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443920|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
14443921|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929296|NCT01427114|Prednisolone|prednisolone|mesh-list
14929297|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
14929298|NCT01427114|Rituximab|rituximab|mesh-list
14443922|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14443923|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14443924|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14443925|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443926|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443927|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443928|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14443929|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14443930|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14443931|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443932|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443933|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443934|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14443935|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14443936|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
14751911|NCT03830866|Carboplatin|carboplatin|mesh-list
14751912|NCT03830866|Durvalumab|durvalumab|mesh-list
14751913|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751914|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751915|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14751916|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14751917|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751918|NCT03736863|Apatinib|apatinib|mesh-list
14443937|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14443938|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14443939|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
14443940|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14443941|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14443942|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14443943|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443944|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443945|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443946|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443947|NCT01914666|Analgesics|analgesics|mesh-ancestor
14751919|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751920|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14751921|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751922|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751923|NCT03711305|Carboplatin|carboplatin|mesh-list
14751924|NCT03711305|Etoposide|etoposide|mesh-list
14751925|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751926|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14751927|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14751928|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14751929|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929299|NCT01427114|Vincristine|vincristine|mesh-list
14929300|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14443948|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
14443949|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443950|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
14443951|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14443952|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
14443953|NCT01914757|Benralizumab|benralizumab|mesh-list
14443954|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14443955|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
14443956|NCT01914926|Metoprolol|metoprolol|mesh-list
14443957|NCT01914926|Diltiazem|diltiazem|mesh-list
14443958|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14443959|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14443960|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
14443961|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
14443962|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443963|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443964|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14443965|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14443966|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14443967|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
14443968|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443969|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443970|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14443971|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14443972|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14443973|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
14443974|NCT01915108|Remifentanil|remifentanil|mesh-list
14443975|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14443976|NCT01915108|Narcotics|narcotics|mesh-ancestor
14443977|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14443978|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443979|NCT01915108|Analgesics|analgesics|mesh-ancestor
14443980|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
14443981|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14443982|NCT01915303|Cabergoline|cabergoline|mesh-list
14751930|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443983|NCT01915303|Pasireotide|pasireotide|mesh-list
14443984|NCT01915303|Hormones|hormones|mesh-ancestor
14443985|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14443986|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14443987|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14443988|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14443989|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
14443990|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
14443991|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14443992|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14443993|NCT01915732|Clindamycin|clindamycin|mesh-list
14443994|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
14929301|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
14443995|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
14443996|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14443997|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14443998|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14443999|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444000|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444001|NCT01915823|Fluticasone|fluticasone|mesh-list
14444002|NCT01915823|Xhance|xhance|mesh-list
14444003|NCT01915823|Azelastine|azelastine|mesh-list
14444004|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444005|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14444006|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
14444007|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444008|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444009|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14444010|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
14444011|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444012|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14444013|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14444014|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444015|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444016|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14444017|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14444018|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
14444019|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
14444020|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444021|NCT01915849|Licogliflozin|licogliflozin|mesh-list
14444022|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14444023|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444024|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444025|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444026|NCT01915914|Fluticasone|fluticasone|mesh-list
14444027|NCT01915914|Xhance|xhance|mesh-list
14444028|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444029|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14751947|NCT03672695|Venetoclax|venetoclax|mesh-list
14929302|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929303|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929304|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14929305|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
14751948|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444030|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
14444031|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931170|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
14444032|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444033|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14444034|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
14444035|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444036|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14444037|NCT01915940|Timolol|timolol|mesh-list
14444038|NCT01915940|Bimatoprost|bimatoprost|mesh-list
14444039|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14444040|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14444041|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14444042|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14929306|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444043|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
14444044|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444045|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444046|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444047|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14444048|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14444049|NCT01916109|Gemcitabine|gemcitabine|mesh-list
14444050|NCT01916109|Carboplatin|carboplatin|mesh-list
14444051|NCT01916109|Panitumumab|panitumumab|mesh-list
14751949|NCT03638128|Denosumab|denosumab|mesh-list
14751950|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14751951|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751952|NCT03608657|Apremilast|apremilast|mesh-list
14751953|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14444052|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444053|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14444054|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
14444055|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444056|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
14444057|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444058|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444059|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444060|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
14444061|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444062|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14444063|NCT01916226|Cetirizine|cetirizine|mesh-list
14444064|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14444065|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14444066|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14444067|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
14444068|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
14444069|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444070|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444071|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444072|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
14444073|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14444074|NCT01916629|Protective Agents|protective agents|mesh-ancestor
14444075|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444076|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444077|NCT01916681|Misoprostol|misoprostol|mesh-list
14751954|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14751955|NCT03608657|Analgesics|analgesics|mesh-ancestor
14751956|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
14444078|NCT01916681|Oxytocin|oxytocin|mesh-list
14444079|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
14444080|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14444081|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444082|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14444083|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
14444084|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14444085|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444086|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14444087|NCT01916824|Mirtazapine|mirtazapine|mesh-list
14444088|NCT01916824|Citalopram|citalopram|mesh-list
14444089|NCT01916824|Bupropion|bupropion|mesh-list
14444090|NCT01916824|Fluoxetine|fluoxetine|mesh-list
14444091|NCT01916824|Paroxetine|paroxetine|mesh-list
14444092|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14444093|NCT01916824|Sertraline|sertraline|mesh-list
14444094|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
14444095|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14444096|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14444097|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14444098|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444099|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444100|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444101|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
14444102|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444103|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14444104|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444105|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444106|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14444107|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
14444108|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14444109|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14444110|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751957|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14751958|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444111|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14444112|NCT01916824|Analgesics|analgesics|mesh-ancestor
14751959|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14751960|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14751961|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14444113|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
14444114|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14444115|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
14444116|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
14444117|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14444118|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14444119|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444120|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14444121|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14444122|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14444123|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14444124|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14444125|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14444126|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14444127|NCT01916941|Prazosin|prazosin|mesh-list
14444128|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14444129|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14444130|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14444131|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14444132|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
14444133|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444134|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444135|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469124|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469125|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469126|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14469127|NCT02290444|Hormones|hormones|mesh-list
14469128|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14469129|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14469130|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
14469131|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469132|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469133|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469134|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469135|NCT02290613|Ambrisentan|ambrisentan|mesh-list
14469136|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14469137|NCT02290873|Midazolam|midazolam|mesh-list
14469138|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14469139|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14931171|NCT01437813|Metformin|metformin|mesh-list
14444136|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
14444137|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14444138|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14444139|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14444140|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444141|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444142|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444143|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444144|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444145|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14444146|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444147|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14444148|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14444149|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444150|NCT01917214|Sunitinib|sunitinib|mesh-list
14444151|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444152|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14444153|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14444154|NCT01917214|Growth Substances|growth substances|mesh-ancestor
14444155|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444156|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
14444157|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14444158|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444159|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444160|NCT01917656|Metformin|metformin|mesh-list
14444161|NCT01917656|Liraglutide|liraglutide|mesh-list
14444162|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444163|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444164|NCT01917656|Incretins|incretins|mesh-ancestor
14444165|NCT01917656|Hormones|hormones|mesh-ancestor
14444166|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444167|NCT01917773|Octreotide|octreotide|mesh-list
14444168|NCT01917773|Bisacodyl|bisacodyl|mesh-list
14444169|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444170|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14444171|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444172|NCT01917773|Cathartics|cathartics|mesh-ancestor
14444173|NCT01917773|Laxatives|laxatives|mesh-ancestor
14444174|NCT01918306|Cisplatin|cisplatin|mesh-list
14444175|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444176|NCT01918332|Valsartan|valsartan|mesh-list
14444177|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14444178|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14444179|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14444180|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
14444181|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444182|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14444183|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14444184|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444185|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14444186|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14444187|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14444188|NCT01918371|Bevacizumab|bevacizumab|mesh-list
14444189|NCT01918371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14444190|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444191|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14444192|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14444193|NCT01918371|Growth Substances|growth substances|mesh-ancestor
14444194|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444195|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
14444196|NCT01918761|Pemetrexed|pemetrexed|mesh-list
14444197|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444198|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444199|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444200|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14444201|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14444202|NCT01919164|Mitogens|mitogens|mesh-list
14751962|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14751963|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444203|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
14751964|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931172|NCT01437813|Glimepiride|glimepiride|mesh-list
14444204|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444205|NCT01919190|Bupivacaine|bupivacaine|mesh-list
14444206|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
14444207|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
14444208|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444209|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444210|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
14444211|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444212|NCT01919216|Citalopram|citalopram|mesh-list
14444213|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14444214|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14444215|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444216|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444217|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444218|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
14444219|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444220|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14444221|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
14444222|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444223|NCT01919229|Letrozole|letrozole|mesh-list
14444224|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444225|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14444226|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14444227|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444228|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444229|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14444230|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
14751973|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
14751974|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14751975|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
14751976|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929307|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929308|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14929309|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929310|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14929311|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
14929312|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
14929313|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
14929314|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929315|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
14929316|NCT01427114|Hormones|hormones|mesh-ancestor
14929317|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929318|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14929319|NCT01427127|Ramosetron|ramosetron|mesh-list
14929320|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
14929321|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
14929322|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929323|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929324|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14929325|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14444231|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444232|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444233|NCT01919411|Amoxicillin|amoxicillin|mesh-list
14444234|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
14444235|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
14929326|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
14929327|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929328|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929329|NCT01427192|Acetazolamide|acetazolamide|mesh-list
14929330|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
14929331|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14929332|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444236|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14444237|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444238|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444239|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14444240|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444241|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444242|NCT01919450|Regadenoson|regadenoson|mesh-list
14444243|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14444244|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14444245|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
14444246|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
14444247|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444248|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444249|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444250|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
14444251|NCT01919489|Liraglutide|liraglutide|mesh-list
14444252|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444253|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444254|NCT01919489|Incretins|incretins|mesh-ancestor
14444255|NCT01919489|Hormones|hormones|mesh-ancestor
14444256|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444257|NCT01919606|Bupivacaine|bupivacaine|mesh-list
14444258|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
14444259|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
14444260|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444261|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444262|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
14444263|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444264|NCT01919697|Plecanatide|plecanatide|mesh-list
14444265|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14444266|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
14444267|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444268|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444269|NCT01919723|Ticagrelor|ticagrelor|mesh-list
14444270|NCT01919723|Eptifibatide|eptifibatide|mesh-list
14444271|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14444272|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14444273|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14444274|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14444275|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
14444276|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444277|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444278|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444279|NCT01919801|Icatibant|icatibant|mesh-list
14444280|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14444281|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14444282|NCT01919801|Analgesics|analgesics|mesh-ancestor
14444283|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
14444284|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444285|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444286|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444287|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14444288|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14444289|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14444290|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444291|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14751977|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14751978|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14751979|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
14751980|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14751981|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
14751982|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444292|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444293|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
14444294|NCT01919996|Azithromycin|azithromycin|mesh-list
14444295|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444296|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444297|NCT01920061|Docetaxel|docetaxel|mesh-list
14444298|NCT01920061|Gedatolisib|gedatolisib|mesh-list
14444299|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444300|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
14444301|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
14444302|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
14444303|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444304|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14444305|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444306|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
14444307|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14444308|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
14444309|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444310|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
14444311|NCT01920152|Protective Agents|protective agents|mesh-ancestor
14444312|NCT01920282|Nebivolol|nebivolol|mesh-list
14444313|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14444314|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
14444315|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14444316|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14444317|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14751983|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14751984|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14444318|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
14444319|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444320|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751985|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
14751986|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
14751987|NCT03576885|Protective Agents|protective agents|mesh-ancestor
14753725|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753726|NCT05013632|Antiviral Agents|antiviral agents|mesh-ancestor
14753727|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753728|NCT05011266|Buprenorphine|buprenorphine|mesh-list
14929333|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444321|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444322|NCT01920477|Ofatumumab|ofatumumab|mesh-list
14444323|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444324|NCT01920555|Midazolam|midazolam|mesh-list
14444325|NCT01920555|Ketamine|ketamine|mesh-list
14444326|NCT01920555|Analgesics|analgesics|mesh-ancestor
14444327|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
14444328|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444329|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444330|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14444331|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14444332|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
14444333|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
14444334|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444335|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14929334|NCT01427192|Diuretics|diuretics|mesh-ancestor
14929335|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
14444336|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14444337|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444338|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444339|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14444340|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14444341|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14444342|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14444343|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444344|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
14444345|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
14444346|NCT01920568|Vitamin D|vitamin d|mesh-list
14444347|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
14444348|NCT01920568|Denosumab|denosumab|mesh-list
14444349|NCT01920568|Calcium|calcium|mesh-list
14444350|NCT01920568|Vitamins|vitamins|mesh-ancestor
14444351|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
14444352|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444353|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14444354|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14444355|NCT01920711|Valsartan|valsartan|mesh-list
14444356|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14444357|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14444358|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14444359|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14444360|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444361|NCT01920802|Olanzapine|olanzapine|mesh-list
14444362|NCT01920802|Iloperidone|iloperidone|mesh-list
14444363|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
14444364|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
14444365|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444366|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444367|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444368|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14444369|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14444370|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444371|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444372|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14444373|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14444374|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444375|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444376|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444377|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
14444378|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
14444379|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14444380|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444381|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444382|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14444383|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
14444384|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444385|NCT01921205|Lacosamide|lacosamide|mesh-list
14444386|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
14444387|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14444388|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14444389|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444390|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444391|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14444392|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14444393|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14444394|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444395|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444396|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444397|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444398|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444399|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14751988|NCT03573648|Palbociclib|palbociclib|mesh-list
14751989|NCT03573648|Avelumab|avelumab|mesh-list
14751990|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14751991|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14751992|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751993|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14751994|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14751995|NCT03570814|Azithromycin|azithromycin|mesh-list
14751996|NCT03570814|Ivermectin|ivermectin|mesh-list
14751997|NCT03570814|Albendazole|albendazole|mesh-list
14444400|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444401|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
14444402|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14444403|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
14444404|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444405|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14444406|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444407|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14444408|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444409|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14444410|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444411|NCT01921387|Cytarabine|cytarabine|mesh-list
14444412|NCT01921387|Etoposide|etoposide|mesh-list
14444413|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
14444414|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
14444415|NCT01921387|Melphalan|melphalan|mesh-list
14444416|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
14444417|NCT01921387|Carmustine|carmustine|mesh-list
14444418|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14444419|NCT01921387|Antibodies|antibodies|mesh-list
14444420|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14444421|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
14444422|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444423|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14444424|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444425|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14444426|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14444427|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444428|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444429|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14444430|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
14444431|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
14444432|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444433|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444434|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14444435|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
14444436|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14444437|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
14444438|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444439|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14444440|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14444441|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14444442|NCT01921751|Gemcitabine|gemcitabine|mesh-list
14444443|NCT01921751|Paclitaxel|paclitaxel|mesh-list
14444444|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14444445|NCT01921751|Capecitabine|capecitabine|mesh-list
14444446|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14444447|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444448|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
14444449|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
14444450|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
14444451|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444452|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14444453|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
14444454|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
14444455|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444456|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444457|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444458|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
14444459|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444460|NCT01921829|Diuretics|diuretics|mesh-list
14444461|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
14444462|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444463|NCT01921894|Vitamin D|vitamin d|mesh-list
14444464|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
14444465|NCT01921894|Vitamins|vitamins|mesh-ancestor
14444466|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
14444467|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444468|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14444469|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14444470|NCT01922011|Vancomycin|vancomycin|mesh-list
14444471|NCT01922011|Daptomycin|daptomycin|mesh-list
14444472|NCT01922011|Nafcillin|nafcillin|mesh-list
14444473|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444474|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444475|NCT01922037|Omalizumab|omalizumab|mesh-list
14444476|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14444477|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14444478|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
14444479|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14444480|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14444481|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444482|NCT01922102|Ranibizumab|ranibizumab|mesh-list
14444483|NCT01922102|Verteporfin|verteporfin|mesh-list
14444484|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14444485|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14444486|NCT01922102|Growth Substances|growth substances|mesh-ancestor
14444487|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444488|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14444489|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444490|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14444491|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444492|NCT01922115|Trospium chloride|trospium chloride|mesh-list
14444493|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
14444494|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
14444495|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444496|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444497|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14444498|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14444499|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444500|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444501|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444502|NCT01922115|Urological Agents|urological agents|mesh-ancestor
14444503|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
14444504|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
14444505|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444506|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444507|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444508|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
14444509|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
14444510|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
14444511|NCT01922271|Albuterol|albuterol|mesh-list
14444512|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
14444513|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14444514|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
14444515|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444516|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444517|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14444518|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
14444519|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
14444520|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14444521|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444522|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444523|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444524|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
14444525|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14444526|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14444527|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14444528|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14444529|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14444530|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14444531|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14444532|NCT01922336|Infliximab|infliximab|mesh-list
14929336|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929337|NCT01427205|Cetuximab|cetuximab|mesh-list
14929338|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929339|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929340|NCT01427244|Trastuzumab|trastuzumab|mesh-list
14929341|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929342|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929343|NCT01427270|Oxycodone|oxycodone|mesh-list
14929344|NCT01427270|Naloxone|naloxone|mesh-list
14929345|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14929346|NCT01427270|Narcotics|narcotics|mesh-ancestor
14929347|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929348|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929349|NCT01427270|Analgesics|analgesics|mesh-ancestor
14929350|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
14929351|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929352|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14929353|NCT01427283|Oxycodone|oxycodone|mesh-list
14929354|NCT01427283|Naloxone|naloxone|mesh-list
14929355|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14929356|NCT01427283|Narcotics|narcotics|mesh-ancestor
14929357|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929358|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929359|NCT01427283|Analgesics|analgesics|mesh-ancestor
14929360|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
14929361|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444533|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444534|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444535|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14444536|NCT01922739|Hydrocodone|hydrocodone|mesh-list
14444537|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14444538|NCT01922739|Narcotics|narcotics|mesh-ancestor
14444539|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444540|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444541|NCT01922739|Analgesics|analgesics|mesh-ancestor
14444542|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
14444543|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444544|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
14444545|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
14444546|NCT01922934|Topiramate|topiramate|mesh-list
14444547|NCT01922934|Phentermine|phentermine|mesh-list
14444548|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
14444549|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444550|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444551|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14444552|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
14444553|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14444554|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
14444555|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
14444556|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444557|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
14444558|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444559|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444560|NCT01923129|Prazosin|prazosin|mesh-list
14444561|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14444562|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14444563|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14444564|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14444565|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
14444566|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444567|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444568|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444569|NCT01923311|Elvitegravir|elvitegravir|mesh-list
14444570|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14444571|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14444572|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
14444573|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444574|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14444575|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444576|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444577|NCT01923363|Tazobactam|tazobactam|mesh-list
14444578|NCT01923363|Piperacillin|piperacillin|mesh-list
14444579|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14444580|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444581|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444582|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14444583|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444584|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444585|NCT01923467|Nicotine|nicotine|mesh-list
14444586|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14444587|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
14444588|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444589|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444590|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14444591|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14444592|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444593|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444594|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444595|NCT01923896|Cycloserine|cycloserine|mesh-list
14444596|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14444597|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444598|NCT01923896|Renal Agents|renal agents|mesh-ancestor
14444599|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14444600|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
14444601|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444602|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
14444603|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444604|NCT01924169|Lenalidomide|lenalidomide|mesh-list
14444605|NCT01924169|Vaccines|vaccines|mesh-list
14444606|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
14444607|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444608|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14444609|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14444610|NCT01924169|Growth Substances|growth substances|mesh-ancestor
14444611|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
14444612|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444613|NCT01924182|Morphine|morphine|mesh-list
14444614|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14444615|NCT01924182|Narcotics|narcotics|mesh-ancestor
14444616|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444617|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444618|NCT01924182|Analgesics|analgesics|mesh-ancestor
14444619|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
14444620|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444621|NCT01924299|Fluconazole|fluconazole|mesh-list
14444622|NCT01924299|Ketoconazole|ketoconazole|mesh-list
14444623|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
14444624|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444625|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14444626|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14444627|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14751998|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14751999|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752000|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14752001|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
14752002|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
14752003|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14752004|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14752005|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
14752006|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752007|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752008|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929362|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14444628|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444629|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14444630|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
14444631|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444632|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444633|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14444634|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14444635|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14469140|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469141|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469142|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14469143|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14469144|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14469145|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14469146|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
14469147|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
14469148|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
14469149|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
14469150|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469151|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469152|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
14444636|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14444637|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14444638|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444639|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14444640|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14444641|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444642|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444643|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
14444644|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444645|NCT01924767|Empagliflozin|empagliflozin|mesh-list
14444646|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14444647|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444648|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444649|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444650|NCT01924871|Remifentanil|remifentanil|mesh-list
14444651|NCT01924871|Desflurane|desflurane|mesh-list
14444652|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14444653|NCT01924871|Narcotics|narcotics|mesh-ancestor
14444654|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444655|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444656|NCT01924871|Analgesics|analgesics|mesh-ancestor
14444657|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
14444658|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444659|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14444660|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
14444661|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
14444662|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
14444663|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14444664|NCT01924949|Ledipasvir|ledipasvir|mesh-list
14444665|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
14444666|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444667|NCT01925144|Omeprazole|omeprazole|mesh-list
14444668|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14444669|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444670|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14444671|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444672|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444673|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14444674|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14444675|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444676|NCT01925183|Interferons|interferons|mesh-list
14444677|NCT01925183|Ribavirin|ribavirin|mesh-list
14444678|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
14444679|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
14444680|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14444681|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444682|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
14444683|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444684|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
14444685|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444686|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
14444687|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444688|NCT01925274|Irinotecan|irinotecan|mesh-list
14444689|NCT01925274|Cetuximab|cetuximab|mesh-list
14444690|NCT01925274|Gedatolisib|gedatolisib|mesh-list
14444691|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14444692|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14444693|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444694|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444695|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444696|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14444697|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14444698|NCT01925469|Benzocaine|benzocaine|mesh-list
14444699|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
14444700|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
14444701|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444702|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929363|NCT01427322|Lapatinib|lapatinib|mesh-list
14929364|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929365|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14929366|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929367|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929368|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
14929369|NCT01427335|Calcium|calcium|mesh-list
14929370|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14752009|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752010|NCT03561376|Petrolatum|petrolatum|mesh-list
14752011|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
14752012|NCT03561376|Emollients|emollients|mesh-ancestor
14752013|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14752014|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
14752015|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14444703|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
14444704|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444705|NCT01925612|Prednisone|prednisone|mesh-list
14444706|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
14444707|NCT01925612|Rituximab|rituximab|mesh-list
14752016|NCT03561376|Protective Agents|protective agents|mesh-ancestor
14752017|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752018|NCT03486314|Rifampin|rifampin|mesh-list
14444708|NCT01925612|Doxorubicin|doxorubicin|mesh-list
14444709|NCT01925612|Vincristine|vincristine|mesh-list
14444710|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14444711|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14444712|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444713|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
14444714|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444715|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752019|NCT03486314|Paclitaxel|paclitaxel|mesh-list
14752020|NCT03486314|Docetaxel|docetaxel|mesh-list
14752021|NCT03486314|Carboplatin|carboplatin|mesh-list
14752022|NCT03486314|Pevonedistat|pevonedistat|mesh-list
14929371|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444716|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14444717|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
14444718|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444719|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444720|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14444721|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14444722|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14444723|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14444724|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14444725|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444726|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444727|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
14444728|NCT01925612|Hormones|hormones|mesh-ancestor
14444729|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444730|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14444731|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14444732|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14444733|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
14444734|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
14444735|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
14444736|NCT01925703|Hematinics|hematinics|mesh-ancestor
14444737|NCT01925768|Apremilast|apremilast|mesh-list
14444738|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14444739|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14444740|NCT01925768|Analgesics|analgesics|mesh-ancestor
14444741|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
14444742|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444743|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444744|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444745|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14444746|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14444747|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14444748|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444749|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444750|NCT01925781|Nicotine|nicotine|mesh-list
14444751|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14444752|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
14444753|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444754|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444755|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14444756|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14444757|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444758|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444759|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444760|NCT01925950|Beclomethasone|beclomethasone|mesh-list
14444761|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444762|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
14444763|NCT01925950|Hormones|hormones|mesh-ancestor
14444764|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444765|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444766|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14444767|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
14444768|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
14444769|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444770|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444771|NCT01926444|Trimebutine|trimebutine|mesh-list
14444772|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444773|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
14444774|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
14444775|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444776|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444777|NCT01926496|Imiquimod|imiquimod|mesh-list
14444778|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14444779|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
14444780|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444781|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444782|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
14444783|NCT01926626|Moclobemide|moclobemide|mesh-list
14444784|NCT01926626|Nicotine|nicotine|mesh-list
14444785|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14444786|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
14444787|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444788|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444789|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14444790|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14444791|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444792|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14444793|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444794|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
14444795|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444796|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14444797|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444798|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14444799|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
14444800|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444801|NCT01926886|Trastuzumab|trastuzumab|mesh-list
14444802|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14444803|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444804|NCT01926977|Ranibizumab|ranibizumab|mesh-list
14444805|NCT01926977|Aflibercept|aflibercept|mesh-list
14444806|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14444807|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14444808|NCT01926977|Growth Substances|growth substances|mesh-ancestor
14444809|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444810|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
14444811|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444812|NCT01927055|Mannitol|mannitol|mesh-list
14444813|NCT01927055|Droxidopa|droxidopa|mesh-list
14444814|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14444815|NCT01927055|Diuretics|diuretics|mesh-ancestor
14444816|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
14444817|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444818|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14444819|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14444820|NCT01927120|Sirolimus|sirolimus|mesh-list
14444821|NCT01927120|Aldesleukin|aldesleukin|mesh-list
14444822|NCT01927120|Tacrolimus|tacrolimus|mesh-list
14444823|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444824|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
14444825|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444826|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14444827|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444828|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444829|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444830|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444831|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14444832|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444833|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
14444834|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14444835|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14444836|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
14444837|NCT01927341|Panitumumab|panitumumab|mesh-list
14444838|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14444839|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444840|NCT01927718|Thalidomide|thalidomide|mesh-list
14444841|NCT01927718|Lenalidomide|lenalidomide|mesh-list
14444842|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
14444843|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444844|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14444845|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14444846|NCT01927718|Growth Substances|growth substances|mesh-ancestor
14444847|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752023|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14752024|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752025|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
14752026|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752027|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752028|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752029|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14752030|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
14752031|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752032|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752033|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
14444848|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444849|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444850|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
14444851|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444852|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444853|NCT01927757|Etanercept|etanercept|mesh-list
14444854|NCT01927757|Methotrexate|methotrexate|mesh-list
14444855|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14752034|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14752035|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752036|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14752037|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14752038|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14752039|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14752040|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14752041|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14929372|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14929373|NCT01427387|Linaclotide|linaclotide|mesh-list
14444856|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
14444857|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14444858|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444859|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14444860|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
14444861|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444862|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444863|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
14444864|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444865|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14444866|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444867|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
14444868|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14444869|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14444870|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14444871|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14444872|NCT01927757|Analgesics|analgesics|mesh-ancestor
14444873|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
14444874|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444875|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444876|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14444877|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14444878|NCT01927887|Hematinics|hematinics|mesh-ancestor
14444879|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14444880|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14444881|NCT01928186|Alovudine|alovudine|mesh-list
14444882|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
14444883|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444884|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14444885|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444886|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444887|NCT01928199|Incretins|incretins|mesh-ancestor
14444888|NCT01928199|Hormones|hormones|mesh-ancestor
14444889|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444890|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14444891|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
14444892|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444893|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444894|NCT01928225|Vaccines|vaccines|mesh-list
14444895|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
14444896|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444897|NCT01928290|Leucovorin|leucovorin|mesh-list
14444898|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14444899|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
14444900|NCT01928290|Fluorouracil|fluorouracil|mesh-list
14444901|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
14929374|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14929375|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
14929376|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929377|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14929378|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
14929379|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14444902|NCT01928290|Trastuzumab|trastuzumab|mesh-list
14929380|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14929381|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14929382|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929383|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929384|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
14929385|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929386|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929387|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14929388|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929389|NCT01427478|Afatinib|afatinib|mesh-list
14929390|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444903|NCT01928290|Irinotecan|irinotecan|mesh-list
14444904|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
14444905|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
14444906|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444907|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14444908|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444909|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14444910|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
14444911|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444912|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14444913|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14444914|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14444915|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444916|NCT01928290|Antidotes|antidotes|mesh-ancestor
14444917|NCT01928290|Protective Agents|protective agents|mesh-ancestor
14444918|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
14444919|NCT01928290|Vitamins|vitamins|mesh-ancestor
14444920|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
14444921|NCT01928329|Exenatide|exenatide|mesh-list
14444922|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14444923|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444924|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14444925|NCT01928329|Incretins|incretins|mesh-ancestor
14444926|NCT01928329|Hormones|hormones|mesh-ancestor
14444927|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14444928|NCT01928381|Pregabalin|pregabalin|mesh-list
14444929|NCT01928381|Analgesics|analgesics|mesh-ancestor
14444930|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
14444931|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444932|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444933|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
14444934|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14444935|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14444936|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444937|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14444938|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14444939|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14444940|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444941|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444942|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
14444943|NCT01928433|Finafloxacin|finafloxacin|mesh-list
14444944|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
14444945|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444946|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444947|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14444948|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14444949|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444950|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444951|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444952|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14444953|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14444954|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14444955|NCT01928433|Renal Agents|renal agents|mesh-ancestor
14444956|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14444957|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
14444958|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
14444959|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14444960|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444961|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444962|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
14444963|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14444964|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14444965|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444966|NCT01928680|Capecitabine|capecitabine|mesh-list
14444967|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444968|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14444969|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
14444970|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444971|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
14444972|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
14752042|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14752043|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14752044|NCT03425812|Analgesics|analgesics|mesh-ancestor
14752045|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
14752046|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752047|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444973|NCT01928693|Besifloxacin|besifloxacin|mesh-list
14444974|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14444975|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14444976|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14444977|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14444978|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14444979|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14444980|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14444981|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14444982|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14444983|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14444984|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14444985|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
14444986|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14444987|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444988|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14444989|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14752048|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14444990|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14444991|NCT01928719|Nicotine|nicotine|mesh-list
14444992|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14444993|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
14444994|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14444995|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14444996|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14444997|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14444998|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
14444999|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445000|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445001|NCT01928758|Nicotine|nicotine|mesh-list
14445002|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14445003|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
14445004|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445005|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445006|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14445007|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14445008|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
14445009|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445010|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445011|NCT01928771|Benralizumab|benralizumab|mesh-list
14445012|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14445013|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
14445014|NCT01928849|Valproic Acid|valproic acid|mesh-list
14445015|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
14445016|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445017|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445018|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
14445019|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445020|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445021|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
14445022|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14445023|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929391|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14929392|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752049|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752050|NCT03413995|Rucaparib|rucaparib|mesh-list
14752051|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14752052|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752053|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752054|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752055|NCT03377387|Capecitabine|capecitabine|mesh-list
14752056|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14752057|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
14752058|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752059|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752060|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14929393|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929394|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14929395|NCT01427491|Laxatives|laxatives|mesh-ancestor
14929396|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14929397|NCT01427582|Trabectedin|trabectedin|mesh-list
14929398|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14929399|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
14929400|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929401|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929402|NCT01427686|Dobutamine|dobutamine|mesh-list
14929403|NCT01427686|Dopamine|dopamine|mesh-list
14929404|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14929405|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
14929406|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
14445024|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14445025|NCT01928927|Telmisartan|telmisartan|mesh-list
14445026|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14445027|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14445028|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14445029|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445030|NCT01928940|Trametinib|trametinib|mesh-list
14445031|NCT01928940|Dabrafenib|dabrafenib|mesh-list
14445032|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445033|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14445034|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445035|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445036|NCT01929031|Ibuprofen|ibuprofen|mesh-list
14445037|NCT01929031|Caffeine|caffeine|mesh-list
14445038|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14445039|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14445040|NCT01929031|Analgesics|analgesics|mesh-ancestor
14445041|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
14445042|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445043|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445044|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14445045|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445046|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14445047|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445048|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445049|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14445050|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14445051|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14445052|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14931173|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14445053|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
14445054|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445055|NCT01929044|Anisodamine|anisodamine|mesh-list
14445056|NCT01929044|Scopolamine|scopolamine|mesh-list
14445057|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14445058|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14445059|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
14445060|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
14445061|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445062|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445063|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14445064|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
14445065|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14445066|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
14445067|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445068|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445069|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14445070|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
14445071|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14752061|NCT03335488|Glycerol|glycerol|mesh-list
14752062|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14752063|NCT03335488|Protective Agents|protective agents|mesh-ancestor
14752064|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752065|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752066|NCT03219268|Margetuximab|margetuximab|mesh-list
14752067|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752073|NCT03194893|Crizotinib|crizotinib|mesh-list
14752074|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752075|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14752076|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752077|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752078|NCT03186456|Aspirin|aspirin|mesh-list
14752079|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14752080|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14752081|NCT03186456|Analgesics|analgesics|mesh-ancestor
14752082|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
14445072|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14445073|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
14445074|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14445075|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14445076|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14445077|NCT01929044|Analgesics|analgesics|mesh-ancestor
14445078|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
14445079|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14445080|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445081|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14445082|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
14445083|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14445084|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
14445085|NCT01929044|Protective Agents|protective agents|mesh-ancestor
14445086|NCT01929083|Ibutilide|ibutilide|mesh-list
14445087|NCT01929083|Progesterone|progesterone|mesh-list
14752083|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752084|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445088|NCT01929083|Progestins|progestins|mesh-ancestor
14445089|NCT01929083|Hormones|hormones|mesh-ancestor
14445090|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445091|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445092|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14445093|NCT01929135|Atorvastatin|atorvastatin|mesh-list
14445094|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14445095|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14445096|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
14445097|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445098|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14445099|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14445100|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445101|NCT01929291|Vaccines|vaccines|mesh-list
14445102|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
14445103|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445104|NCT01929317|Ropinirole|ropinirole|mesh-list
14445105|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14445106|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14445107|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
14445108|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
14445109|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445110|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445111|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445112|NCT01929343|Lidocaine|lidocaine|mesh-list
14445113|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
14445114|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
14445115|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445116|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445117|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
14445118|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445119|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14445120|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14445121|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14445122|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445123|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445124|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
14445125|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445126|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445127|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14445128|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14445129|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445130|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445131|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445132|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14445133|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14445134|NCT01929642|Sirolimus|sirolimus|mesh-list
14445135|NCT01929642|Everolimus|everolimus|mesh-list
14445136|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445137|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14445138|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
14445139|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445140|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445141|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445142|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14445143|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
14445144|NCT01929759|Tenofovir|tenofovir|mesh-list
14445145|NCT01929759|Emtricitabine|emtricitabine|mesh-list
14445146|NCT01929759|Cobicistat|cobicistat|mesh-list
14445147|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14445148|NCT01929759|Elvitegravir|elvitegravir|mesh-list
14445149|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
14445150|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445151|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14445152|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14445153|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445154|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445155|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14445156|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14445157|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14445158|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14445159|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14445160|NCT01929863|Metformin|metformin|mesh-list
14445161|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14445162|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445163|NCT01929876|Itraconazole|itraconazole|mesh-list
14445164|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
14445165|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445166|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14445167|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14445168|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445169|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445170|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14445171|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
14445172|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445173|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445174|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14445175|NCT01929889|Iloperidone|iloperidone|mesh-list
14445176|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14445177|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14445178|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445179|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445180|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14445181|NCT01929980|Bortezomib|bortezomib|mesh-list
14445182|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445183|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
14445184|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
14445185|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14445186|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14445187|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
14445188|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445189|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14445190|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14445191|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445192|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929407|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929408|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929409|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14929410|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14929411|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14929412|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
14929413|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929414|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929415|NCT01427686|Protective Agents|protective agents|mesh-ancestor
14929416|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
14929417|NCT01427699|Antibodies|antibodies|mesh-list
14929418|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
14445193|NCT01930045|Antacids|antacids|mesh-ancestor
14445194|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469153|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14469154|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
14469155|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469156|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469157|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14469158|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469159|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14469160|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14469161|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14469162|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14469163|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470136|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14752085|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752086|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752087|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14752088|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14752089|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752090|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14752091|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14752092|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752093|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
14752094|NCT03184935|Decitabine|decitabine|mesh-list
14752095|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14752096|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
14752097|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445195|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14445196|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14445197|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445198|NCT01930188|Incretins|incretins|mesh-ancestor
14445199|NCT01930188|Hormones|hormones|mesh-ancestor
14445200|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445201|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14445202|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
14445203|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445204|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445205|NCT01930487|Antioxidants|antioxidants|mesh-list
14445206|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445207|NCT01930487|Protective Agents|protective agents|mesh-ancestor
14445208|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445209|NCT01930747|Remifentanil|remifentanil|mesh-list
14445210|NCT01930747|Sevoflurane|sevoflurane|mesh-list
14445211|NCT01930747|Rocuronium|rocuronium|mesh-list
14445212|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14445213|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14445214|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
14445215|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
14445216|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445217|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929419|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929420|NCT01427842|Vancomycin|vancomycin|mesh-list
14929421|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14929422|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929423|NCT01427868|Maleic acid|maleic acid|mesh-list
14929424|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929425|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929426|NCT01427946|Everolimus|everolimus|mesh-list
14929427|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929428|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929429|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
14445218|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14445219|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14445220|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14445221|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445222|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14445223|NCT01930747|Narcotics|narcotics|mesh-ancestor
14445224|NCT01930747|Analgesics|analgesics|mesh-ancestor
14445225|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
14445226|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
14445227|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14445228|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445229|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14445230|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
14445231|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445232|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445233|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445234|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445235|NCT01931059|Risperidone|risperidone|mesh-list
14445236|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14445237|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
14445238|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445239|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445240|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445241|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14445242|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14445243|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445244|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14445245|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14445246|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
14445247|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14445248|NCT01931150|Dapsone|dapsone|mesh-list
14445249|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445250|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
14445251|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14445252|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14445253|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14445254|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445255|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445256|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
14445257|NCT01931163|Everolimus|everolimus|mesh-list
14445258|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445259|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14445260|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
14445261|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445262|NCT01931202|Citalopram|citalopram|mesh-list
14445263|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14445264|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14445265|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445266|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445267|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445268|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
14445269|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445270|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14445271|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
14445272|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14445273|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14445274|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14445275|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14445276|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445277|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445278|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445279|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445280|NCT01931475|Analgesics|analgesics|mesh-ancestor
14445281|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
14445282|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445283|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
14445284|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14445285|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
14445286|NCT01931527|Rasburicase|rasburicase|mesh-list
14445287|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
14445288|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445289|NCT01931566|Pioglitazone|pioglitazone|mesh-list
14445290|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14445291|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445292|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14445293|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14445294|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445295|NCT01931839|Ivacaftor|ivacaftor|mesh-list
14445296|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14445297|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445298|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445299|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14929430|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445300|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14445301|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445302|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445303|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14445304|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445305|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445306|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
14445307|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445308|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14445309|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14445310|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445311|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445312|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14445313|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445314|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445315|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
14445316|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445317|NCT01932060|Oxytocin|oxytocin|mesh-list
14445318|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
14445319|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14445320|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445321|NCT01932112|Adenosine|adenosine|mesh-list
14445322|NCT01932112|Analgesics|analgesics|mesh-ancestor
14445323|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
14445324|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445325|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445326|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14445327|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
14445328|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14445329|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
14445330|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
14445331|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445332|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445333|NCT01932697|Docetaxel|docetaxel|mesh-list
14445334|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445335|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
14445336|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
14445337|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
14445338|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445339|NCT01932762|Ribavirin|ribavirin|mesh-list
14445340|NCT01932762|Grazoprevir|grazoprevir|mesh-list
14445341|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
14445342|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929431|NCT01427985|Atropine|atropine|mesh-list
14929432|NCT01427985|Fentanyl|fentanyl|mesh-list
14929433|NCT01427985|Mivacurium|mivacurium|mesh-list
14929434|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14929435|NCT01427985|Narcotics|narcotics|mesh-ancestor
14929436|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929437|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929438|NCT01427985|Analgesics|analgesics|mesh-ancestor
14929439|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
14445343|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
14445344|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445345|NCT01932788|Vitamin D|vitamin d|mesh-list
14445346|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
14445347|NCT01932788|Vitamins|vitamins|mesh-list
14445348|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
14445349|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445350|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14445351|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14445352|NCT01932996|Nicotine|nicotine|mesh-list
14929440|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929441|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14929442|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14929443|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
14929444|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
14929445|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14445353|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14445354|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
14445355|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445356|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445357|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14445358|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14445359|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
14445360|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445361|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445362|NCT01933048|Vaccines|vaccines|mesh-list
14445363|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
14445364|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445365|NCT01933217|Methylphenidate|methylphenidate|mesh-list
14445366|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14445367|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445368|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14445369|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14445370|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445371|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445372|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
14445373|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445374|NCT01933334|Pirfenidone|pirfenidone|mesh-list
14445375|NCT01933334|Analgesics|analgesics|mesh-ancestor
14445376|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
14445377|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445378|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445379|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14445380|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14445381|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752098|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752099|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752100|NCT03096418|Paclitaxel|paclitaxel|mesh-list
14752101|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14752102|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752103|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
14445382|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445383|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445384|NCT01933425|Rocuronium|rocuronium|mesh-list
14445385|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14445386|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14445387|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14445388|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445389|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445390|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
14445391|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14445392|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
14445393|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445394|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752104|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752105|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752106|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752107|NCT03085004|Gemcitabine|gemcitabine|mesh-list
14752108|NCT03085004|Ethanol|ethanol|mesh-list
14752109|NCT03085004|Paclitaxel|paclitaxel|mesh-list
14752110|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14752111|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752112|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14752113|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752114|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752115|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752116|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14752117|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
14752118|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
14752119|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752120|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752121|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752122|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
14752123|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752124|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14752125|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752126|NCT02993198|Carvedilol|carvedilol|mesh-list
14445395|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14445396|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14445397|NCT01933594|Romidepsin|romidepsin|mesh-list
14445398|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14445399|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445400|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14445401|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14445402|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445403|NCT01933672|Incretins|incretins|mesh-ancestor
14445404|NCT01933672|Hormones|hormones|mesh-ancestor
14445405|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445406|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14445407|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
14445408|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445409|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445410|NCT01933776|Vaccines|vaccines|mesh-list
14445411|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
14445412|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445413|NCT01933880|Methylphenidate|methylphenidate|mesh-list
14445414|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14445415|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445416|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14445417|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14445418|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445419|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445420|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
14445421|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445422|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
14445423|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445424|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445425|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14445426|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14445427|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445428|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445429|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14752127|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14752128|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14752129|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
14445430|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14445431|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14445432|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445433|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445434|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
14445435|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14445436|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14445437|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14445438|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14752130|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752131|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752132|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752133|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14752134|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
14752135|NCT02993198|Protective Agents|protective agents|mesh-ancestor
14752136|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14752137|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14752138|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14752139|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
14752140|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14752141|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14752142|NCT02875223|Itraconazole|itraconazole|mesh-list
14445439|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14445440|NCT01933984|Fluticasone|fluticasone|mesh-list
14445441|NCT01933984|Fenoterol|fenoterol|mesh-list
14445442|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14445443|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
14445444|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14445445|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
14445446|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445447|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445448|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14445449|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
14445450|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
14445451|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14445452|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14445453|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14445454|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14445455|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
14445456|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752143|NCT02875223|Rifampin|rifampin|mesh-list
14445457|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445458|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
14445459|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
14445460|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14445461|NCT01934192|Metoclopramide|metoclopramide|mesh-list
14445462|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
14445463|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
14445464|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445465|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445466|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14445467|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14445468|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14445469|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
14445470|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445471|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445472|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
14445473|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14445474|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
14445475|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445476|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
14445477|NCT01934218|Protective Agents|protective agents|mesh-ancestor
14445478|NCT01934231|Amoxicillin|amoxicillin|mesh-list
14445479|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
14445480|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
14445481|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14445482|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445483|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445484|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14445485|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445486|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445487|NCT01934556|Ranibizumab|ranibizumab|mesh-list
14445488|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14445489|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14445490|NCT01934556|Growth Substances|growth substances|mesh-ancestor
14445491|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445492|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
14445493|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445494|NCT01934582|Treprostinil|treprostinil|mesh-list
14445495|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14445496|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14445497|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445498|NCT01934894|Lapatinib|lapatinib|mesh-list
14445499|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445500|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14445501|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445502|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445503|NCT01934972|Cycloserine|cycloserine|mesh-list
14445504|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14445505|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445506|NCT01934972|Renal Agents|renal agents|mesh-ancestor
14445507|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14445508|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
14445509|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445510|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
14445511|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445512|NCT01935622|Doxycycline|doxycycline|mesh-list
14445513|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445514|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445515|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
14445516|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14445517|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14445518|NCT01935700|Colchicine|colchicine|mesh-list
14445519|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
14445520|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445521|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14445522|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14445523|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14445524|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445525|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445526|NCT01935791|Glucagon|glucagon|mesh-list
14445527|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14445528|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14445529|NCT01935791|Hormones|hormones|mesh-ancestor
14445530|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445531|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445532|NCT01935791|Incretins|incretins|mesh-ancestor
14445533|NCT01936181|Infliximab|infliximab|mesh-list
14445534|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14445535|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14445536|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445537|NCT01936363|Niacinamide|niacinamide|mesh-list
14929446|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14929447|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
14929448|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14929449|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
14929450|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
14929451|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
14929452|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14929453|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14929454|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
14929455|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445538|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
14445539|NCT01936363|Vitamins|vitamins|mesh-ancestor
14445540|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
14445541|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445542|NCT01936519|Cyclosporine|cyclosporine|mesh-list
14445543|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
14445544|NCT01936519|Everolimus|everolimus|mesh-list
14445545|NCT01936519|Tacrolimus|tacrolimus|mesh-list
14445546|NCT01936519|Cyclosporins|cyclosporins|mesh-list
14445547|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14445548|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14445549|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
14445550|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445551|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445552|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445553|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
14445554|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929456|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929457|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14929458|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14929459|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14929460|NCT01428037|Misoprostol|misoprostol|mesh-list
14929461|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14929462|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
14929463|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14929464|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929465|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14929466|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14929467|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
14929468|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14929469|NCT01428089|Progesterone|progesterone|mesh-list
14929470|NCT01428089|Progestins|progestins|mesh-ancestor
14929471|NCT01428089|Hormones|hormones|mesh-ancestor
14931174|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445555|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
14445556|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445557|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445558|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14445559|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14445560|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
14445561|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445562|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14445563|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445564|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752144|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
14752145|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
14752146|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752147|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14752148|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14752149|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752150|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445565|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445566|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14445567|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14445568|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445569|NCT01936857|Buprenorphine|buprenorphine|mesh-list
14445570|NCT01936857|Methadone|methadone|mesh-list
14445571|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14445572|NCT01936857|Naloxone|naloxone|mesh-list
14445573|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14445574|NCT01936857|Narcotics|narcotics|mesh-ancestor
14445575|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445576|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445577|NCT01936857|Analgesics|analgesics|mesh-ancestor
14445578|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
14445579|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445580|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14445581|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
14445582|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
14445583|NCT01936870|Fesoterodine|fesoterodine|mesh-list
14445584|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14445585|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14445586|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
14445587|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445588|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445589|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445590|NCT01936870|Urological Agents|urological agents|mesh-ancestor
14445591|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14445592|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
14445593|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14445594|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14445595|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
14445596|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445597|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445598|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14445599|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445600|NCT01937026|Probenecid|probenecid|mesh-list
14445601|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
14445602|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
14445603|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445604|NCT01937026|Renal Agents|renal agents|mesh-ancestor
14445605|NCT01937117|Trastuzumab|trastuzumab|mesh-list
14445606|NCT01937117|Pertuzumab|pertuzumab|mesh-list
14445607|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14445608|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445609|NCT01937260|Brodalumab|brodalumab|mesh-list
14445610|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
14445611|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14445612|NCT01937299|Travoprost|travoprost|mesh-list
14445613|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14445614|NCT01937299|Brinzolamide|brinzolamide|mesh-list
14445615|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14445616|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14445617|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14445618|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14445619|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14445620|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
14445621|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445622|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445623|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445624|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14445625|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445626|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14445627|NCT01937312|Travoprost|travoprost|mesh-list
14445628|NCT01937312|Brinzolamide|brinzolamide|mesh-list
14445629|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14445630|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14445631|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14445632|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14445633|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
14445634|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445635|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445636|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445637|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14445638|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445639|NCT01937364|Baclofen|baclofen|mesh-list
14445640|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14445641|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445642|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14445643|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445644|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14445645|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
14445646|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
14445647|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445648|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445649|NCT01937390|Bromides|bromides|mesh-list
14445650|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
14445651|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14445652|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
14445653|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445654|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445655|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14445656|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
14445657|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
14445658|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14445659|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
14445660|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445661|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445662|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
14445663|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
14445664|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14445665|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14445666|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445667|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
14445668|NCT01937559|Coagulants|coagulants|mesh-ancestor
14445669|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14445670|NCT01937598|Liraglutide|liraglutide|mesh-list
14445671|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14445672|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445673|NCT01937598|Incretins|incretins|mesh-ancestor
14445674|NCT01937598|Hormones|hormones|mesh-ancestor
14445675|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445676|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14445677|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
14445678|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445679|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469164|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469165|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14469166|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
14469167|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469168|NCT02291133|Bleomycin|bleomycin|mesh-list
14469169|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14469170|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469171|NCT02291289|Bevacizumab|bevacizumab|mesh-list
14469172|NCT02291289|Trastuzumab|trastuzumab|mesh-list
14469173|NCT02291289|Cetuximab|cetuximab|mesh-list
14469174|NCT02291289|Pertuzumab|pertuzumab|mesh-list
14469175|NCT02291289|Capecitabine|capecitabine|mesh-list
14469176|NCT02291289|Fluorouracil|fluorouracil|mesh-list
14469177|NCT02291289|Atezolizumab|atezolizumab|mesh-list
14469178|NCT02291289|Vemurafenib|vemurafenib|mesh-list
14469179|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14469180|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469181|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14469182|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14752151|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14469183|NCT02291289|Growth Substances|growth substances|mesh-ancestor
14469184|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445680|NCT01937715|Bevacizumab|bevacizumab|mesh-list
14445681|NCT01937715|Gedatolisib|gedatolisib|mesh-list
14445682|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14445683|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445684|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14445685|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14445686|NCT01937715|Growth Substances|growth substances|mesh-ancestor
14445687|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445688|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
14445689|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14445690|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445691|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445692|NCT01937871|Tadalafil|tadalafil|mesh-list
14445693|NCT01937871|Tamsulosin|tamsulosin|mesh-list
14445694|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
14445695|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14445696|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14445697|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445698|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445699|NCT01937871|Urological Agents|urological agents|mesh-ancestor
14445700|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14445701|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14445702|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14445703|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
14445704|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445705|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445706|NCT01937975|Grazoprevir|grazoprevir|mesh-list
14445707|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
14445708|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445709|NCT01938001|Rituximab|rituximab|mesh-list
14445710|NCT01938001|Lenalidomide|lenalidomide|mesh-list
14445711|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14445712|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445713|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
14445714|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445715|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445716|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14445717|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14445718|NCT01938001|Growth Substances|growth substances|mesh-ancestor
14445719|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
14445720|NCT01938040|Ibuprofen|ibuprofen|mesh-list
14445721|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14445722|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14445723|NCT01938040|Analgesics|analgesics|mesh-ancestor
14445724|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
14445725|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445726|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445727|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14445728|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445729|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14445730|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445731|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445732|NCT01938079|Ketamine|ketamine|mesh-list
14445733|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14445734|NCT01938079|Analgesics|analgesics|mesh-ancestor
14445735|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
14445736|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445737|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445738|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14445739|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14445740|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
14445741|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
14929472|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929473|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929474|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
14929475|NCT01428154|Hematinics|hematinics|mesh-ancestor
14929476|NCT01428180|Ibuprofen|ibuprofen|mesh-list
14929477|NCT01428180|Indomethacin|indomethacin|mesh-list
14929478|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14929479|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14929480|NCT01428180|Analgesics|analgesics|mesh-ancestor
14929481|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
14929482|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929483|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929484|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14445742|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445743|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14445744|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14445745|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445746|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445747|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
14445748|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14445749|NCT01938430|Ledipasvir|ledipasvir|mesh-list
14445750|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
14445751|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445752|NCT01938573|Gemcitabine|gemcitabine|mesh-list
14445753|NCT01938573|Sirolimus|sirolimus|mesh-list
14445754|NCT01938573|Cisplatin|cisplatin|mesh-list
14445755|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445756|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14929485|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445757|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
14445758|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445759|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
14445760|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445761|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445762|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14445763|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
14445764|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445765|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445766|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14445767|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
14445768|NCT01938625|Cyclosporine|cyclosporine|mesh-list
14445769|NCT01938625|Ribavirin|ribavirin|mesh-list
14445770|NCT01938625|Simeprevir|simeprevir|mesh-list
14445771|NCT01938625|Tacrolimus|tacrolimus|mesh-list
14445772|NCT01938625|Cyclosporins|cyclosporins|mesh-list
14445773|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14445774|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
14445775|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445776|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14445777|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445778|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445779|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
14445780|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445781|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
14445782|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445783|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
14445784|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
14445785|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
14445786|NCT01938664|Candesartan|candesartan|mesh-list
14445787|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14445788|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14445789|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14445790|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445791|NCT01938846|Paclitaxel|paclitaxel|mesh-list
14445792|NCT01938846|Exemestane|exemestane|mesh-list
14445793|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14445794|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445795|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14445796|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14445797|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14445798|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445799|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14445800|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14445801|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445802|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14445803|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
14752152|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
14445804|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445805|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445806|NCT01938989|Methamphetamine|methamphetamine|mesh-list
14445807|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
14445808|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14445809|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14445810|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14445811|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445812|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
14445813|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
14445814|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445815|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
14445816|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445817|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445818|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
14445819|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14445820|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14445821|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445822|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14445823|NCT01938989|Hormones|hormones|mesh-ancestor
14445824|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445825|NCT01939002|Interferons|interferons|mesh-list
14445826|NCT01939002|Interferon-beta|interferon-beta|mesh-list
14445827|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
14445828|NCT01939002|Naproxen|naproxen|mesh-list
14445829|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14445830|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14445831|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445832|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
14445833|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445834|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14445835|NCT01939002|Analgesics|analgesics|mesh-ancestor
14445836|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
14445837|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445838|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445839|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14445840|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
14445841|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14445842|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445843|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445844|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
14445845|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14445846|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14445847|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14445848|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
14445849|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445850|NCT01939197|Ritonavir|ritonavir|mesh-list
14445851|NCT01939197|Ribavirin|ribavirin|mesh-list
14445852|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14445853|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14445854|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
14753729|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14445855|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445856|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445857|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14445858|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14445859|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
14445860|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445861|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14445862|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14445863|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
14445864|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
14445865|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14445866|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
14445867|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445868|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445869|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14445870|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
14445871|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14445872|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
14445873|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445874|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14445875|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14445876|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
14445877|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
14445878|NCT01939301|Protective Agents|protective agents|mesh-ancestor
14445879|NCT01939314|Bupivacaine|bupivacaine|mesh-list
14445880|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14445881|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
14445882|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445883|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445884|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
14445885|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445886|NCT01939366|Pregabalin|pregabalin|mesh-list
14445887|NCT01939366|Analgesics|analgesics|mesh-ancestor
14445888|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
14445889|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14445890|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445891|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
14445892|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14445893|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14445894|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445895|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14445896|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14445897|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14469185|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
14445898|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14445899|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14445900|NCT01939496|Canagliflozin|canagliflozin|mesh-list
14445901|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14445902|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445903|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14445904|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445905|NCT01939899|Ixazomib|ixazomib|mesh-list
14445906|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445907|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14445908|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445909|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445910|NCT01939977|Calcifediol|calcifediol|mesh-list
14445911|NCT01939977|Vitamins|vitamins|mesh-ancestor
14445912|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
14445913|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445914|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14445915|NCT01940276|Prednisone|prednisone|mesh-list
14445916|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
14445917|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14445918|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
14445919|NCT01940276|Hormones|hormones|mesh-ancestor
14445920|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14445921|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445922|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14445923|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445924|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14445925|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445926|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445927|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
14445928|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14445929|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
14445930|NCT01940484|Hematinics|hematinics|mesh-ancestor
14445931|NCT01940497|Paclitaxel|paclitaxel|mesh-list
14445932|NCT01940497|Docetaxel|docetaxel|mesh-list
14445933|NCT01940497|Doxorubicin|doxorubicin|mesh-list
14445934|NCT01940497|Trastuzumab|trastuzumab|mesh-list
14753730|NCT05011266|Naloxone|naloxone|mesh-list
14445935|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14445936|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445937|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
14445938|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
14445939|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
14445940|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445941|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14445942|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14445943|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14445944|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445945|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14445946|NCT01940510|Rifampin|rifampin|mesh-list
14445947|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14445948|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
14445949|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14445950|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14445951|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
14445952|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14445953|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445954|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445955|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14445956|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14445957|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14445958|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14445959|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14445960|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14445961|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
14445962|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14445963|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14445964|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445965|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
14445966|NCT01940523|Coagulants|coagulants|mesh-ancestor
14445967|NCT01940887|Bevacizumab|bevacizumab|mesh-list
14445968|NCT01940887|Aflibercept|aflibercept|mesh-list
14445969|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14445970|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445971|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14445972|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14752153|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752154|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752155|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14445973|NCT01940887|Growth Substances|growth substances|mesh-ancestor
14445974|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445975|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
14445976|NCT01940900|Ranibizumab|ranibizumab|mesh-list
14445977|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14445978|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14445979|NCT01940900|Growth Substances|growth substances|mesh-ancestor
14445980|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445981|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
14445982|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445983|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
14445984|NCT01941095|Chloroquine|chloroquine|mesh-list
14445985|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
14445986|NCT01941095|Methotrexate|methotrexate|mesh-list
14445987|NCT01941095|Azathioprine|azathioprine|mesh-list
14445988|NCT01941095|Leflunomide|leflunomide|mesh-list
14445989|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14445990|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
14445991|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14445992|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14445993|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14445994|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
14445995|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14445996|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14445997|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
14445998|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14445999|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14446000|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14446001|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
14446002|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446003|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14446004|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
14446005|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14446006|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14446007|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446008|NCT01941095|Amebicides|amebicides|mesh-ancestor
14446009|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14446010|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14446011|NCT01941095|Analgesics|analgesics|mesh-ancestor
14446012|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
14446013|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446014|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446015|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446016|NCT01941537|Fezakinumab|fezakinumab|mesh-list
14446017|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
14446018|NCT01941628|Rocuronium|rocuronium|mesh-list
14446019|NCT01941628|Succinylcholine|succinylcholine|mesh-list
14446020|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14446021|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14446022|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14446023|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446024|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446025|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14446026|NCT01941927|Trametinib|trametinib|mesh-list
14446027|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446028|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14446029|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446030|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446031|NCT01942148|Aripiprazole|aripiprazole|mesh-list
14446032|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
14446033|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14446034|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14446035|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14446036|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446037|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446038|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
14446039|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
14446040|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446041|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446042|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14446043|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14446044|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
14446045|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14446046|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14446047|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14446048|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14446049|NCT01942161|Aripiprazole|aripiprazole|mesh-list
14446050|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
14446051|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14446052|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14446053|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14446054|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446055|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446056|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
14446057|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
14446058|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446059|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446060|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14446061|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14446062|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
14446063|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14446064|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14446065|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14446066|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14446067|NCT01942590|Clenbuterol|clenbuterol|mesh-list
14446068|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14446069|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14446070|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
14446071|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446072|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446073|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446074|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14446075|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
14446076|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446077|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14446078|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
14446079|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
14446080|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14446081|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14446082|NCT01942668|Estradiol|estradiol|mesh-list
14446083|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14446084|NCT01942668|Progesterone|progesterone|mesh-list
14752156|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14446085|NCT01942668|Estrogens|estrogens|mesh-ancestor
14446086|NCT01942668|Hormones|hormones|mesh-ancestor
14446087|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446088|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446089|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14446090|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
14446091|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14446092|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14446093|NCT01942668|Progestins|progestins|mesh-ancestor
14446094|NCT01942694|Vitamin D|vitamin d|mesh-list
14446095|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
14446096|NCT01942694|Vitamins|vitamins|mesh-ancestor
14446097|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
14446098|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446099|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14446100|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14446101|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
14446102|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
14446103|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446104|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446105|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446106|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
14446107|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
14446108|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
14446109|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
14446110|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446111|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446112|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446113|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
14446114|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
14446115|NCT01942993|Vemurafenib|vemurafenib|mesh-list
14446116|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446117|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14446118|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446119|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446120|NCT01943435|Acetaminophen|acetaminophen|mesh-list
14446121|NCT01943435|Ibuprofen|ibuprofen|mesh-list
14446122|NCT01943435|Celecoxib|celecoxib|mesh-list
14446123|NCT01943435|Diclofenac|diclofenac|mesh-list
14446124|NCT01943435|Gabapentin|gabapentin|mesh-list
14446125|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14446126|NCT01943435|Tramadol|tramadol|mesh-list
14446127|NCT01943435|Analgesics|analgesics|mesh-list
14446128|NCT01943435|Mirtazapine|mirtazapine|mesh-list
14446129|NCT01943435|Trazodone|trazodone|mesh-list
14446130|NCT01943435|Sertraline|sertraline|mesh-list
14446131|NCT01943435|Nortriptyline|nortriptyline|mesh-list
14446132|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
14446133|NCT01943435|Misoprostol|misoprostol|mesh-list
14446134|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14446135|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
14446136|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446137|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446138|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
14446139|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14446140|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446141|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446142|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14446143|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446144|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446145|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14446146|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14446147|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
14446148|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14446149|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14446150|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446151|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
14446152|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
14446153|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14446154|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14446155|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446156|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14446157|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14446158|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14446159|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446160|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
14446161|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14446162|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14446163|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446164|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
14446165|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14446166|NCT01943435|Narcotics|narcotics|mesh-ancestor
14446167|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14446168|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
14446169|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14446170|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
14446171|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
14446172|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14446173|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14446174|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14446175|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
14446176|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14446177|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14446178|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14446179|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14446180|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14446181|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14446182|NCT01943461|Avelumab|avelumab|mesh-list
14446183|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14446184|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14446185|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446186|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
14446187|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446188|NCT01943552|Bromides|bromides|mesh-list
14446189|NCT01943552|Ipratropium|ipratropium|mesh-list
14446190|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
14446191|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14446192|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
14446193|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446194|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446195|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14446196|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
14446197|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14446198|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
14446199|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446200|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446201|NCT01943565|Hydromorphone|hydromorphone|mesh-list
14446202|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446203|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446204|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14446205|NCT01943565|Narcotics|narcotics|mesh-ancestor
14446206|NCT01943565|Analgesics|analgesics|mesh-ancestor
14446207|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
14446208|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446209|NCT01943864|Trametinib|trametinib|mesh-list
14446210|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446211|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14446212|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446213|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929486|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14929487|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929488|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929489|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
14929490|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
14929491|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14929492|NCT01428284|Canagliflozin|canagliflozin|mesh-list
14929493|NCT01428284|Probenecid|probenecid|mesh-list
14929494|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14929495|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446214|NCT01944046|Oxytocin|oxytocin|mesh-list
14446215|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
14446216|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14446217|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446218|NCT01944098|Lidocaine|lidocaine|mesh-list
14446219|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
14446220|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
14446221|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446222|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446223|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
14446224|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446225|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14446226|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14446227|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14446228|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446229|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446230|NCT01944293|Midazolam|midazolam|mesh-list
14446231|NCT01944293|Ketamine|ketamine|mesh-list
14446232|NCT01944293|Analgesics|analgesics|mesh-ancestor
14446233|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
14446234|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446235|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446236|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14446237|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14446238|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
14446239|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
14446240|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446241|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14446242|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14446243|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446244|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446245|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14446246|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14446247|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14929496|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14929497|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929498|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
14929499|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
14929500|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446248|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14446249|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14446250|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
14446251|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
14446252|NCT01944319|Meropenem|meropenem|mesh-list
14446253|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446254|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446255|NCT01944371|Disulfiram|disulfiram|mesh-list
14446256|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14446257|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14446258|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446259|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446260|NCT01944423|Cycloserine|cycloserine|mesh-list
14446261|NCT01944423|Nicotine|nicotine|mesh-list
14446262|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14446263|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
14446264|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446265|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446266|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14446267|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14446268|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
14446269|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446270|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446271|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14446272|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446273|NCT01944423|Renal Agents|renal agents|mesh-ancestor
14446274|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14446275|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
14446276|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446277|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
14446278|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14446279|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
14446280|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446281|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
14446282|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446283|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446284|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14929501|NCT01428284|Renal Agents|renal agents|mesh-ancestor
14929502|NCT01428375|Acetaminophen|acetaminophen|mesh-list
14929503|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14929504|NCT01428375|Analgesics|analgesics|mesh-ancestor
14929505|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
14929506|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929507|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929508|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
14446285|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14446286|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929509|NCT01428388|Bevacizumab|bevacizumab|mesh-list
14929510|NCT01428388|Ranibizumab|ranibizumab|mesh-list
14446287|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446288|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446289|NCT01944839|Ranibizumab|ranibizumab|mesh-list
14446290|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14446291|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14446292|NCT01944839|Growth Substances|growth substances|mesh-ancestor
14446293|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446294|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
14446295|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446296|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
14446297|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
14446298|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446299|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446300|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446301|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
14446302|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
14469186|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14469187|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
14469188|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469189|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469190|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
14469191|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469192|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469193|NCT02291419|Aspirin|aspirin|mesh-list
14469194|NCT02291419|Ticagrelor|ticagrelor|mesh-list
14469195|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14469196|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14469197|NCT02291419|Analgesics|analgesics|mesh-ancestor
14469198|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
14469199|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469200|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469201|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469202|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469203|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14469204|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14469205|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469206|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14469207|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14469208|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469209|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
14446303|NCT01945086|Ustekinumab|ustekinumab|mesh-list
14446304|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14446305|NCT01945138|Insulin|insulin|mesh-list
14446306|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14446307|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446308|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446309|NCT01945216|Alogliptin|alogliptin|mesh-list
14446310|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446311|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446312|NCT01945216|Incretins|incretins|mesh-ancestor
14446313|NCT01945216|Hormones|hormones|mesh-ancestor
14446314|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446315|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14446316|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
14446317|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446318|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446319|NCT01945242|Alogliptin|alogliptin|mesh-list
14446320|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446321|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446322|NCT01945242|Incretins|incretins|mesh-ancestor
14446323|NCT01945242|Hormones|hormones|mesh-ancestor
14446324|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446325|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14446326|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
14446327|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446328|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446329|NCT01945281|Amphotericin B|amphotericin b|mesh-list
14446330|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14446331|NCT01945281|Caspofungin|caspofungin|mesh-list
14446332|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14446333|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
14446334|NCT01945281|Amebicides|amebicides|mesh-ancestor
14446335|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14446336|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14446337|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446338|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446339|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
14446340|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446341|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446342|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14446343|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446344|NCT01945294|Interferons|interferons|mesh-list
14446345|NCT01945294|Ribavirin|ribavirin|mesh-list
14446346|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
14446347|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
14446348|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14446349|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446350|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
14446351|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446352|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
14446353|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446354|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
14446355|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446356|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
14446357|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14446358|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14446359|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14446360|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446361|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446362|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
14446363|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446364|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446365|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14446366|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446367|NCT01945593|Factor VIII|factor viii|mesh-list
14446368|NCT01945593|BAX 855|bax 855|mesh-list
14446369|NCT01945593|Coagulants|coagulants|mesh-ancestor
14446370|NCT01945866|Dexamethasone|dexamethasone|mesh-list
14446371|NCT01945866|Ranibizumab|ranibizumab|mesh-list
14446372|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446373|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
14446374|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
14446375|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446376|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446377|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446378|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
14446379|NCT01945866|Hormones|hormones|mesh-ancestor
14446380|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446381|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446382|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446383|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14446384|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14446385|NCT01945866|Growth Substances|growth substances|mesh-ancestor
14446386|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
14446387|NCT01946152|Dexamethasone|dexamethasone|mesh-list
14446388|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
14446389|NCT01946152|Pomalidomide|pomalidomide|mesh-list
14446390|NCT01946152|Ichthammol|ichthammol|mesh-list
14446391|NCT01946152|Lenograstim|lenograstim|mesh-list
14446392|NCT01946152|BB 1101|bb 1101|mesh-list
14446393|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446394|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
14446395|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
14446396|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446397|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446398|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446399|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
14446400|NCT01946152|Hormones|hormones|mesh-ancestor
14446401|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446402|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446403|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446404|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14446405|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
14446406|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
14446407|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929511|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929512|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929513|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14929514|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14929515|NCT01428388|Growth Substances|growth substances|mesh-ancestor
14929516|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929517|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
14929518|NCT01428414|Paclitaxel|paclitaxel|mesh-list
14929519|NCT01428414|Carboplatin|carboplatin|mesh-list
14929520|NCT01428414|Trastuzumab|trastuzumab|mesh-list
14929521|NCT01428414|Epirubicin|epirubicin|mesh-list
14929522|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14929523|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929524|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
14929525|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
14929526|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
14929527|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929528|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929529|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14929530|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14929531|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14929532|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929533|NCT01428427|Gemcitabine|gemcitabine|mesh-list
14929534|NCT01428427|Trametinib|trametinib|mesh-list
14929535|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14929536|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
14929537|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929538|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469210|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14446408|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446409|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14446410|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14446411|NCT01946152|Growth Substances|growth substances|mesh-ancestor
14446412|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
14446413|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14929539|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
14929540|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929541|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929542|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929543|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
14446414|NCT01946165|Prednisone|prednisone|mesh-list
14446415|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
14446416|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446417|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
14446418|NCT01946165|Hormones|hormones|mesh-ancestor
14446419|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446420|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446421|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446422|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446423|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14446424|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446425|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446426|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
14446427|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14446428|NCT01946412|Ivacaftor|ivacaftor|mesh-list
14446429|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14446430|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446431|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446432|NCT01946425|Vaccines|vaccines|mesh-list
14446433|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
14446434|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446435|NCT01946438|Vaccines|vaccines|mesh-list
14929544|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929545|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14929546|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14929547|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
14929548|NCT01428492|Dexamethasone|dexamethasone|mesh-list
14929549|NCT01428492|Bortezomib|bortezomib|mesh-list
14929550|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929551|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
14446436|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
14446437|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446438|NCT01946529|Sirolimus|sirolimus|mesh-list
14446439|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
14446440|NCT01946529|Temozolomide|temozolomide|mesh-list
14446441|NCT01946529|Ifosfamide|ifosfamide|mesh-list
14446442|NCT01946529|Bevacizumab|bevacizumab|mesh-list
14446443|NCT01946529|Doxorubicin|doxorubicin|mesh-list
14446444|NCT01946529|Etoposide|etoposide|mesh-list
14446445|NCT01946529|Vincristine|vincristine|mesh-list
14446446|NCT01946529|Sorafenib|sorafenib|mesh-list
14446447|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14446448|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
14446449|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446450|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446451|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14446452|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
14446453|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446454|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446455|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14446456|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14446457|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14446458|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14446459|NCT01946529|Growth Substances|growth substances|mesh-ancestor
14446460|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
14446461|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14446462|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14446463|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14446464|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446465|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14446466|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
14446467|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
14446468|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
14446469|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14446470|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446471|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446472|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
14446473|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
14446474|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
14446475|NCT01946880|Chloroquine|chloroquine|mesh-list
14446476|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14446477|NCT01946880|Prednisone|prednisone|mesh-list
14446478|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446479|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
14446480|NCT01946880|Hormones|hormones|mesh-ancestor
14446481|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446482|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446483|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446484|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929552|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
14446485|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14446486|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14446487|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
14929553|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929554|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929555|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14929556|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
14929557|NCT01428492|Hormones|hormones|mesh-ancestor
14929558|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929559|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446488|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446489|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929560|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929561|NCT01428518|Lamotrigine|lamotrigine|mesh-list
14446490|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753731|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14446491|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446492|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
14446493|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14446494|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14446495|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446496|NCT01946880|Amebicides|amebicides|mesh-ancestor
14446497|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14446498|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14446499|NCT01946880|Analgesics|analgesics|mesh-ancestor
14446500|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
14446501|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446502|NCT01946880|Filaricides|filaricides|mesh-ancestor
14446503|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
14446504|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
14446505|NCT01947153|Metformin|metformin|mesh-list
14446506|NCT01947153|Linagliptin|linagliptin|mesh-list
14446507|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14752157|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
14752158|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752159|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
14752160|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14752161|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14752162|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14752163|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14752164|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14446508|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446509|NCT01947153|Incretins|incretins|mesh-ancestor
14446510|NCT01947153|Hormones|hormones|mesh-ancestor
14446511|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446512|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14446513|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
14446514|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446515|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446516|NCT01947855|Empagliflozin|empagliflozin|mesh-list
14446517|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14446518|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446519|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446520|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446521|NCT01947907|Hormones|hormones|mesh-list
14446522|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446523|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446524|NCT01947946|Benralizumab|benralizumab|mesh-list
14446525|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14446526|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14446527|NCT01948141|Nintedanib|nintedanib|mesh-list
14446528|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446529|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14446530|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446531|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446532|NCT01948310|Ranolazine|ranolazine|mesh-list
14446533|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14446534|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446535|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446536|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14446537|NCT01948388|Hormones|hormones|mesh-ancestor
14446538|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446539|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446540|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
14446541|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
14446542|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14446543|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14446544|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929562|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
14929563|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14929564|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929565|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929566|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14929567|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929568|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14929569|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14929570|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929571|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14929572|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14929573|NCT01428531|PENTA|penta|mesh-list
14446545|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446546|NCT01948518|Urological Agents|urological agents|mesh-ancestor
14446547|NCT01948791|Rivastigmine|rivastigmine|mesh-list
14446548|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14446549|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446550|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446551|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
14446552|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446553|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446554|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14446555|NCT01948791|Protective Agents|protective agents|mesh-ancestor
14446556|NCT01948830|Ranibizumab|ranibizumab|mesh-list
14446557|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14446558|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14446559|NCT01948830|Growth Substances|growth substances|mesh-ancestor
14446560|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446561|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14446562|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446563|NCT01948908|Midazolam|midazolam|mesh-list
14446564|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14446565|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14446566|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446567|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446568|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14446569|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14446570|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14446571|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14446572|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
14446573|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
14446574|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
14446575|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
14446576|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446577|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446578|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
14446579|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14446580|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446581|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446582|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446583|NCT01949051|Levocabastine|levocabastine|mesh-list
14446584|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14446585|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14929574|NCT01428531|Fondaparinux|fondaparinux|mesh-list
14446586|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
14446587|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
14446588|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446589|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446590|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446591|NCT01949116|Folic Acid|folic acid|mesh-list
14446592|NCT01949116|Methotrexate|methotrexate|mesh-list
14446593|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14446594|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
14446595|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14446596|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446597|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14446598|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
14446599|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446600|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446601|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
14446602|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446603|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14446604|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14446605|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
14929575|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14929576|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
14929577|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14929578|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
14929579|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929580|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929581|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
14929582|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14929583|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14929584|NCT01428544|PENTA|penta|mesh-list
14929585|NCT01428544|Fondaparinux|fondaparinux|mesh-list
14929586|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14929587|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
14929588|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14446606|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446607|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14446608|NCT01949116|Hematinics|hematinics|mesh-ancestor
14446609|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
14446610|NCT01949116|Vitamins|vitamins|mesh-ancestor
14446611|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
14446612|NCT01949337|Prednisone|prednisone|mesh-list
14446613|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446614|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
14446615|NCT01949337|Hormones|hormones|mesh-ancestor
14446616|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446617|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446618|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446619|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446620|NCT01949662|Lorazepam|lorazepam|mesh-list
14446621|NCT01949662|Haloperidol|haloperidol|mesh-list
14446622|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
14446623|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
14446624|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
14446625|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446626|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446627|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446628|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14446629|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14446630|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446631|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14929589|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
14929590|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446632|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14446633|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
14446634|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446635|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446636|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14446637|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
14446638|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14446639|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14752165|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14752166|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14446640|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
14446641|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
14446642|NCT01949844|Regadenoson|regadenoson|mesh-list
14446643|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14446644|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14446645|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
14446646|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
14446647|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446648|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446649|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446650|NCT01949870|Gemcitabine|gemcitabine|mesh-list
14446651|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446652|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14446653|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
14446654|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446655|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
14446656|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446657|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446658|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14446659|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
14446660|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446661|NCT01950039|Betaine|betaine|mesh-list
14446662|NCT01950039|Glycine|glycine|mesh-list
14446663|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
14446664|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446665|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446666|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446667|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446668|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
14446669|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14446670|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
14446671|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14446672|NCT01950169|Vitamin D|vitamin d|mesh-list
14446673|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
14446674|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
14446675|NCT01950169|Diphosphonates|diphosphonates|mesh-list
14446676|NCT01950169|Calcium|calcium|mesh-list
14446677|NCT01950169|Vitamins|vitamins|mesh-ancestor
14929591|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929592|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
14929593|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14929594|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14929595|NCT01428622|Olodaterol|olodaterol|mesh-list
14446678|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
14446679|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446680|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14752167|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752168|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14752169|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
14752170|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14752171|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14752172|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14752173|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752174|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752175|NCT02795858|Octreotide|octreotide|mesh-list
14752176|NCT02795858|Ramucirumab|ramucirumab|mesh-list
14752177|NCT02795858|Lanreotide|lanreotide|mesh-list
14752178|NCT02795858|Somatostatin|somatostatin|mesh-list
14752179|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14752180|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14752181|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752182|NCT02795858|Hormones|hormones|mesh-ancestor
14446681|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14753732|NCT05011266|Narcotics|narcotics|mesh-ancestor
14446682|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14446683|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446684|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446685|NCT01950260|Hormones|hormones|mesh-list
14929596|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14929597|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
14929598|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929599|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929600|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14929601|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
14931175|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14931176|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931177|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
14931178|NCT01437826|Selenium|selenium|mesh-list
14931179|NCT01437826|Antioxidants|antioxidants|mesh-list
14931180|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931181|NCT01437826|Protective Agents|protective agents|mesh-ancestor
14446686|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446687|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446688|NCT01950273|Rituximab|rituximab|mesh-list
14446689|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14446690|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446691|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
14446692|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446693|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446694|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14446695|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446696|NCT01950364|Rifampin|rifampin|mesh-list
14446697|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14446698|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14446699|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14446700|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446701|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
14931182|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931183|NCT01437826|Trace Elements|trace elements|mesh-ancestor
14446702|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446703|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14446704|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
14446705|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446706|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446707|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
14446708|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14446709|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446710|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446711|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14446712|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14446713|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14446714|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14446715|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14446716|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14446717|NCT01950741|Aflibercept|aflibercept|mesh-list
14446718|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14446719|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14446720|NCT01950741|Growth Substances|growth substances|mesh-ancestor
14446721|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446722|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
14446723|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446724|NCT01950819|Cyclosporine|cyclosporine|mesh-list
14446725|NCT01950819|Prednisone|prednisone|mesh-list
14446726|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
14446727|NCT01950819|Tacrolimus|tacrolimus|mesh-list
14446728|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
14446729|NCT01950819|Cyclosporins|cyclosporins|mesh-list
14446730|NCT01950819|Basiliximab|basiliximab|mesh-list
14446731|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446732|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
14446733|NCT01950819|Hormones|hormones|mesh-ancestor
14446734|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446735|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446736|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446737|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446738|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
14446739|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
14446740|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446741|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446742|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14446743|NCT01950819|Protective Agents|protective agents|mesh-ancestor
14929602|NCT01428817|Carbetocin|carbetocin|mesh-list
14929603|NCT01428817|Oxytocin|oxytocin|mesh-list
14929604|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
14929605|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14929606|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929607|NCT01428908|Vaccines|vaccines|mesh-list
14929608|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
14929609|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929610|NCT01428986|Maraviroc|maraviroc|mesh-list
14929611|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14929612|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14929613|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929614|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14929615|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14929616|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
14929617|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929618|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14929619|NCT01429025|Rituximab|rituximab|mesh-list
14929620|NCT01429025|Lenalidomide|lenalidomide|mesh-list
14929621|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14929622|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929623|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929624|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
14929625|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929626|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929627|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14929628|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14929629|NCT01429025|Growth Substances|growth substances|mesh-ancestor
14929630|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
14929631|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14929632|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
14929633|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929634|NCT01429090|Methantheline|methantheline|mesh-list
14929635|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14929636|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14929637|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
14446744|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929638|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446745|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
14929639|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929640|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929641|NCT01429129|Nicotine|nicotine|mesh-list
14929642|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14929643|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
14929644|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929645|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929646|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14929647|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14929648|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
14929649|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929650|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929651|NCT01429181|Methadone|methadone|mesh-list
14929652|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14929653|NCT01429181|Narcotics|narcotics|mesh-ancestor
14929654|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929655|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929656|NCT01429181|Analgesics|analgesics|mesh-ancestor
14929657|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
14929658|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446746|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14446747|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446748|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446749|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446750|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
14446751|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
14446752|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446753|NCT01951066|Dexamethasone|dexamethasone|mesh-list
14446754|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446755|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
14446756|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
14752183|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752184|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752185|NCT02794883|Durvalumab|durvalumab|mesh-list
14752186|NCT02794883|Ipilimumab|ipilimumab|mesh-list
14752187|NCT02794883|Tremelimumab|tremelimumab|mesh-list
14752188|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
14752189|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14752190|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
14752191|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752192|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752193|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
14752194|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752195|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14752196|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752197|NCT02771249|Pyridoxine|pyridoxine|mesh-list
14752198|NCT02771249|Darunavir|darunavir|mesh-list
14752199|NCT02771249|Cobicistat|cobicistat|mesh-list
14752200|NCT02771249|Isoniazid|isoniazid|mesh-list
14752201|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14752202|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14752203|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
14929659|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
14929660|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
14929661|NCT01429337|Midostaurin|midostaurin|mesh-list
14929662|NCT01429337|Staurosporine|staurosporine|mesh-list
14929663|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929664|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14929665|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446757|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446758|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446759|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446760|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
14446761|NCT01951066|Hormones|hormones|mesh-ancestor
14446762|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446763|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446764|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446765|NCT01951105|Naproxen|naproxen|mesh-list
14446766|NCT01951105|Levodopa|levodopa|mesh-list
14446767|NCT01951105|Carbidopa|carbidopa|mesh-list
14446768|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14446769|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14446770|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14446771|NCT01951105|Analgesics|analgesics|mesh-ancestor
14446772|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
14446773|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446774|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446775|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929666|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446776|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446777|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
14446778|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14446779|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446780|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446781|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14446782|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14446783|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
14446784|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446785|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14446786|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14446787|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
14446788|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
14446789|NCT01951118|Donepezil|donepezil|mesh-list
14446790|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14446791|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446792|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446793|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
14446794|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446795|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752204|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752205|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752206|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14752207|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14752208|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
14752209|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752210|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
14752211|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752212|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14752213|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14752214|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
14752215|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14752216|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14752217|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14752218|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
14752219|NCT02771249|Vitamins|vitamins|mesh-ancestor
14752220|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
14929667|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
14446796|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
14446797|NCT01951157|Gemcitabine|gemcitabine|mesh-list
14446798|NCT01951157|Docetaxel|docetaxel|mesh-list
14446799|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14446800|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
14446801|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446802|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446803|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
14446804|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446805|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446806|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14446807|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
14446808|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446809|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
14446810|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
14446811|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
14446812|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14446813|NCT01951339|Glimepiride|glimepiride|mesh-list
14446814|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446815|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446816|NCT01951339|Incretins|incretins|mesh-ancestor
14446817|NCT01951339|Hormones|hormones|mesh-ancestor
14446818|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446819|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14446820|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
14446821|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446822|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446823|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14446824|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14446825|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
14446826|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14446827|NCT01951391|Triclocarban|triclocarban|mesh-list
14446828|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14446829|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446830|NCT01951417|Adapalene|adapalene|mesh-list
14446831|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14446832|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
14446833|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14446834|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14446835|NCT01951417|Analgesics|analgesics|mesh-ancestor
14446836|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
14446837|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446838|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446839|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446840|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14446841|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
14446842|NCT01951586|Denosumab|denosumab|mesh-list
14446843|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14446844|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469211|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14469212|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14469213|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
14469214|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469215|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
14469216|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469217|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469218|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14469219|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
14469220|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14469221|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14469222|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752221|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752222|NCT02659059|Paclitaxel|paclitaxel|mesh-list
14469223|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
14469224|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469225|NCT02291679|Linaclotide|linaclotide|mesh-list
14469226|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14446845|NCT01951651|Exenatide|exenatide|mesh-list
14929668|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14929669|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14929670|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14929671|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929672|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929673|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
14929674|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929675|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929676|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14929677|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929678|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
14929679|NCT01429415|Analgesics|analgesics|mesh-ancestor
14929680|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
14929681|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929682|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929683|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
14929684|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929685|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14929686|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
14929687|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14929688|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929689|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446846|NCT01951651|Glipizide|glipizide|mesh-list
14446847|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446848|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446849|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14446850|NCT01951651|Incretins|incretins|mesh-ancestor
14446851|NCT01951651|Hormones|hormones|mesh-ancestor
14446852|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446853|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14446854|NCT01951768|Gentamicins|gentamicins|mesh-list
14446855|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446856|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14446857|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446858|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446859|NCT01951820|Lidocaine|lidocaine|mesh-list
14446860|NCT01951820|Tetracaine|tetracaine|mesh-list
14446861|NCT01951820|Carticaine|carticaine|mesh-list
14446862|NCT01951820|Benzocaine|benzocaine|mesh-list
14929690|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14929691|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
14929692|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14446863|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
14446864|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
14446865|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469227|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
14929693|NCT01429545|Nifedipine|nifedipine|mesh-list
14929694|NCT01429545|Vasotocin|vasotocin|mesh-list
14929695|NCT01429545|Atosiban|atosiban|mesh-list
14929696|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14929697|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929698|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929699|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14929700|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929701|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
14929702|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
14929703|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14929704|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
14929705|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929706|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
14929707|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14929708|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14929709|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929710|NCT01429610|Cytarabine|cytarabine|mesh-list
14929711|NCT01429610|Rituximab|rituximab|mesh-list
14929712|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929713|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752223|NCT02659059|Cisplatin|cisplatin|mesh-list
14752224|NCT02659059|Carboplatin|carboplatin|mesh-list
14752225|NCT02659059|Nivolumab|nivolumab|mesh-list
14752226|NCT02659059|Pemetrexed|pemetrexed|mesh-list
14752227|NCT02659059|Ipilimumab|ipilimumab|mesh-list
14752228|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14752229|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752230|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14752231|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752232|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752233|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929714|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
14929715|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929716|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929717|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14929718|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
14929719|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929720|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
14929721|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752234|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14929722|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929723|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
14929724|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14929725|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929726|NCT01429701|Gentamicins|gentamicins|mesh-list
14929727|NCT01429701|Polymyxins|polymyxins|mesh-list
14929728|NCT01429701|Polymyxin B|polymyxin b|mesh-list
14929729|NCT01429701|Prednisolone|prednisolone|mesh-list
14752235|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14752236|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752237|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14752238|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14752239|NCT02419287|Crizotinib|crizotinib|mesh-list
14752240|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752241|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14752242|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752243|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929730|NCT01429701|Betamethasone|betamethasone|mesh-list
14929731|NCT01429701|Benzocaine|benzocaine|mesh-list
14929732|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14446866|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446867|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
14446868|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446869|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14446870|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14446871|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14446872|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446873|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446874|NCT01951950|Nicardipine|nicardipine|mesh-list
14446875|NCT01951950|Esmolol|esmolol|mesh-list
14446876|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14446877|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14446878|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14446879|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
14446880|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446881|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446882|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446883|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14446884|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14446885|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14446886|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14752244|NCT02342444|Enoxaparin|enoxaparin|mesh-list
14752245|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
14752246|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
14446887|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
14446888|NCT01951963|Ketamine|ketamine|mesh-list
14446889|NCT01951963|Morphine|morphine|mesh-list
14446890|NCT01951963|Analgesics|analgesics|mesh-ancestor
14446891|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
14446892|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446893|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446894|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14446895|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14446896|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
14446897|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
14446898|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14446899|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14446900|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14446901|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752247|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14752248|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14752249|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752250|NCT02339922|Rituximab|rituximab|mesh-list
14752251|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14752252|NCT02339922|Ixazomib|ixazomib|mesh-list
14752253|NCT02339922|Antibodies|antibodies|mesh-list
14752254|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
14752255|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14752256|NCT02339922|Glycine|glycine|mesh-list
14752257|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
14446902|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446903|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14446904|NCT01951963|Narcotics|narcotics|mesh-ancestor
14446905|NCT01952054|Denosumab|denosumab|mesh-list
14446906|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14446907|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446908|NCT01952080|Teduglutide|teduglutide|mesh-list
14446909|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446910|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14446911|NCT01952080|Protective Agents|protective agents|mesh-ancestor
14446912|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446913|NCT01952145|Insulin|insulin|mesh-list
14446914|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14446915|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
14446916|NCT01952145|Liraglutide|liraglutide|mesh-list
14446917|NCT01952145|Xultophy|xultophy|mesh-list
14446918|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14446919|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446920|NCT01952145|Incretins|incretins|mesh-ancestor
14446921|NCT01952145|Hormones|hormones|mesh-ancestor
14446922|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14446923|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
14446924|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446925|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446926|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14446927|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14446928|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446929|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446930|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446931|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14446932|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14929733|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
14929734|NCT01429701|Hormones|hormones|mesh-ancestor
14931184|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
14446942|NCT01952834|Vancomycin|vancomycin|mesh-list
14446943|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14446944|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14446945|NCT01953003|Capecitabine|capecitabine|mesh-list
14446946|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14446947|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
14446948|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446949|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446950|NCT01953081|Metoclopramide|metoclopramide|mesh-list
14446951|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
14446952|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
14446953|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14446954|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446955|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14446956|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14446957|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14446958|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
14446959|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446960|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446961|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
14446962|NCT01953211|Norinyl|norinyl|mesh-list
14446963|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
14446964|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14446965|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14446966|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446967|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14446968|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14446969|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14446970|NCT01953328|Atorvastatin|atorvastatin|mesh-list
14446971|NCT01953328|Evolocumab|evolocumab|mesh-list
14446972|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14446973|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14446974|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14446975|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
14752258|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752259|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752260|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752261|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752262|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
14752263|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752264|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
14752265|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752266|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
14752267|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752268|NCT02258451|Everolimus|everolimus|mesh-list
14752269|NCT02258451|Exemestane|exemestane|mesh-list
14752270|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14446976|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752271|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929735|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929736|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929737|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14446977|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14446978|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14446979|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14446980|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
14446981|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446982|NCT01953432|Doxazosin|doxazosin|mesh-list
14446983|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14446984|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14446985|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14446986|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14446987|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
14446988|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14446989|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14446990|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446991|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
14446992|NCT01953692|Lenalidomide|lenalidomide|mesh-list
14446993|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14446994|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14446995|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
14446996|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14446997|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14446998|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14446999|NCT01953692|Growth Substances|growth substances|mesh-ancestor
14447000|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
14447001|NCT01953783|Ixazomib|ixazomib|mesh-list
14447002|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447003|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14447004|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447005|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447006|NCT01953913|Afatinib|afatinib|mesh-list
14447007|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447008|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14447009|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447010|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447011|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
14447012|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752272|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752273|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
14752274|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752275|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14752276|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14752277|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752278|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752279|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14752280|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
14752281|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929738|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929739|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929740|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14929741|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
14447013|NCT01954082|Inositol|inositol|mesh-list
14447014|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
14447015|NCT01954082|Vitamins|vitamins|mesh-ancestor
14447016|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
14447017|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447018|NCT01954121|Carbamazepine|carbamazepine|mesh-list
14447019|NCT01954121|Levetiracetam|levetiracetam|mesh-list
14447020|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
14447021|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
14447022|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
14447023|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14752282|NCT02074631|Vitamin D|vitamin d|mesh-list
14752283|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
14752284|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
14752285|NCT02074631|Pamidronate|pamidronate|mesh-list
14447024|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752286|NCT02074631|Calcium|calcium|mesh-list
14752287|NCT02074631|Vitamins|vitamins|mesh-ancestor
14447025|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447026|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14447027|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14447028|NCT01954121|Analgesics|analgesics|mesh-ancestor
14929742|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14929743|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929744|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14447029|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
14447030|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447031|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14447032|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14447033|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447034|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14447035|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14447036|NCT01954251|Vaccines|vaccines|mesh-list
14447037|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
14447038|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447039|NCT01954927|Gabapentin|gabapentin|mesh-list
14447040|NCT01954927|Analgesics|analgesics|mesh-ancestor
14447041|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
14929745|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929746|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929747|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
14929748|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
14929749|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929750|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
14447042|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447043|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447044|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
14447045|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14447046|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14447047|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447048|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14447049|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14447050|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14447051|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447052|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447053|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
14447054|NCT01955382|Artesunate|artesunate|mesh-list
14447055|NCT01955382|Amodiaquine|amodiaquine|mesh-list
14447056|NCT01955382|Charcoal|charcoal|mesh-list
14447057|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
14447058|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14447059|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14447060|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447061|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447062|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
14447063|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
14447064|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14447065|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
14447066|NCT01955382|Antidotes|antidotes|mesh-ancestor
14447067|NCT01955382|Protective Agents|protective agents|mesh-ancestor
14447068|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447069|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
14447070|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447071|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
14447072|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447073|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447074|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14447075|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
14447076|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447077|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447078|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14447079|NCT01955629|Capecitabine|capecitabine|mesh-list
14447080|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
14447081|NCT01955629|Aflibercept|aflibercept|mesh-list
14447082|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14447083|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
14447084|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447085|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447086|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14447087|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14447088|NCT01955629|Growth Substances|growth substances|mesh-ancestor
14447089|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447090|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
14447091|NCT01955707|Natalizumab|natalizumab|mesh-list
14447092|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
14447093|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447094|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14447095|NCT01956123|Hormones|hormones|mesh-ancestor
14447096|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447097|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447098|NCT01957150|Fluticasone|fluticasone|mesh-list
14447099|NCT01957150|Xhance|xhance|mesh-list
14929751|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
14447100|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447101|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14447102|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
14447103|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447104|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447105|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14447106|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
14447107|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447108|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14447109|NCT01957202|Levocabastine|levocabastine|mesh-list
14447110|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14447111|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14447112|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
14447113|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
14447114|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447115|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447116|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447117|NCT01957215|Indomethacin|indomethacin|mesh-list
14447118|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14447119|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14447120|NCT01957215|Analgesics|analgesics|mesh-ancestor
14447121|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
14447122|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447123|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447124|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447125|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447126|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
14447127|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
14447128|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14447129|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14447130|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447131|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447132|NCT01957410|Ketamine|ketamine|mesh-list
14447133|NCT01957410|Analgesics|analgesics|mesh-ancestor
14447134|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
14447135|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447136|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447137|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14929752|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14929753|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14929754|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
14929755|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929756|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929757|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929758|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
14929759|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
14447138|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14447139|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
14447140|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
14929760|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929761|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
14929762|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14929763|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
14929764|NCT01429818|Metformin|metformin|mesh-list
14929765|NCT01429818|Glimepiride|glimepiride|mesh-list
14929766|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14929767|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929768|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14929769|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929770|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
14929771|NCT01429831|Aripiprazole|aripiprazole|mesh-list
14929772|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
14929773|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14929774|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14929775|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14929776|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929777|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929778|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
14447141|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447142|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14447143|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14447144|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447145|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447146|NCT01957644|Azacitidine|azacitidine|mesh-list
14447147|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14447148|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
14447149|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447150|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447151|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929779|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
14929780|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929781|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929782|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14929783|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14929784|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
14929785|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14447152|NCT01957709|Interferons|interferons|mesh-list
14447153|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
14447154|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447155|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
14447156|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447157|NCT01957930|Insulin|insulin|mesh-list
14447158|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14447159|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14447160|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447161|NCT01958073|Estradiol|estradiol|mesh-list
14447162|NCT01958073|Estrogens|estrogens|mesh-list
14447163|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14447164|NCT01958073|Hormones|hormones|mesh-ancestor
14447165|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447166|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447167|NCT01958112|Trametinib|trametinib|mesh-list
14447168|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447169|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14447170|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447171|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447172|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14447173|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14929786|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14929787|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14929788|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14929789|NCT01429844|Cyclosporine|cyclosporine|mesh-list
14929790|NCT01429844|Tacrolimus|tacrolimus|mesh-list
14929791|NCT01429844|Cyclosporins|cyclosporins|mesh-list
14929792|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929793|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
14929794|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447174|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14447175|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469228|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469229|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469230|NCT02291913|Tamoxifen|tamoxifen|mesh-list
14469231|NCT02291913|Everolimus|everolimus|mesh-list
14469232|NCT02291913|Letrozole|letrozole|mesh-list
14469233|NCT02291913|Fulvestrant|fulvestrant|mesh-list
14469234|NCT02291913|Anastrozole|anastrozole|mesh-list
14469235|NCT02291913|Exemestane|exemestane|mesh-list
14469236|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469237|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469238|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
14469239|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469240|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14469241|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14469242|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752288|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
14752289|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752290|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14752291|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14752292|NCT02020707|Paclitaxel|paclitaxel|mesh-list
14752293|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14752294|NCT02020707|Bevacizumab|bevacizumab|mesh-list
14752295|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14929795|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14929796|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447176|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
14447177|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14447178|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
14447179|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447180|NCT01958476|Morphine|morphine|mesh-list
14447181|NCT01958476|Methadone|methadone|mesh-list
14447182|NCT01958476|Phenobarbital|phenobarbital|mesh-list
14447183|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14447184|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14447185|NCT01958476|Narcotics|narcotics|mesh-ancestor
14929797|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929798|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
14929799|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929800|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
14929801|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929802|NCT01429870|Triamcinolone|triamcinolone|mesh-list
14929803|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929804|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
14929805|NCT01429870|Hormones|hormones|mesh-ancestor
14447186|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447187|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447188|NCT01958476|Analgesics|analgesics|mesh-ancestor
14447189|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
14447190|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447191|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
14447192|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
14447193|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
14447194|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14447195|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14447196|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14447197|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447198|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447199|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
14447200|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
14447201|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14447202|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14447203|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14447204|NCT01958489|Pravastatin|pravastatin|mesh-list
14447205|NCT01958489|Evacetrapib|evacetrapib|mesh-list
14447206|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14447207|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14447208|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
14447209|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447210|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14929806|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929807|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929808|NCT01429935|Ibuprofen|ibuprofen|mesh-list
14447211|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14447212|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447213|NCT01958619|Artefenomel|artefenomel|mesh-list
14447214|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
14447215|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14447216|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14447217|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752296|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
14752297|NCT02020707|Antibodies|antibodies|mesh-list
14447218|NCT01958671|Metformin|metformin|mesh-list
14752298|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
14929809|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14447219|NCT01958671|Glimepiride|glimepiride|mesh-list
14447220|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
14447221|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14447222|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447223|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14447224|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447225|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
14447226|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14447227|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447228|NCT01958827|Adalimumab|adalimumab|mesh-list
14447229|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447230|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447231|NCT01958918|Ranibizumab|ranibizumab|mesh-list
14447232|NCT01958918|Aflibercept|aflibercept|mesh-list
14447233|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14447234|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14447235|NCT01958918|Growth Substances|growth substances|mesh-ancestor
14447236|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447237|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
14447238|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447239|NCT01959035|Aripiprazole|aripiprazole|mesh-list
14447240|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
14447241|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14447242|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14447243|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14447244|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447245|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447246|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
14447247|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
14447248|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752299|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14752300|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
14752301|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14752302|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752303|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
14752304|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752305|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752306|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752307|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14752308|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14752309|NCT02020707|Growth Substances|growth substances|mesh-ancestor
14752310|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752311|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752312|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
14752313|NCT01928394|Nivolumab|nivolumab|mesh-list
14752314|NCT01928394|Ipilimumab|ipilimumab|mesh-list
14752315|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752316|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752317|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14753733|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447249|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447250|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14447251|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14447252|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
14447253|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14447254|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14447255|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14447256|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14929810|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14929811|NCT01429935|Analgesics|analgesics|mesh-ancestor
14929812|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
14929813|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929814|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447257|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14447258|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14447259|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14447260|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14447261|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14447262|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14447263|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14447264|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
14447265|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447266|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447267|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447268|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14447269|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14447270|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14447271|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14447272|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14447273|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14447274|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14447275|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14447276|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447277|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447278|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447279|NCT01959334|Glucagon|glucagon|mesh-list
14447280|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14447281|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14929815|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929816|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929817|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14929818|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929819|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929820|NCT01430013|Endostar protein|endostar protein|mesh-list
14929821|NCT01430013|Endostatins|endostatins|mesh-list
14929822|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14929823|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14929824|NCT01430013|Growth Substances|growth substances|mesh-ancestor
14929825|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929826|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
14929827|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929828|NCT01430052|Gemcitabine|gemcitabine|mesh-list
14929829|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14929830|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
14929831|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929832|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929833|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
14929834|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929835|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929836|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929837|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
14929838|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929839|NCT01430065|Tacrolimus|tacrolimus|mesh-list
14929840|NCT01430065|Peficitinib|peficitinib|mesh-list
14929841|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929842|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
14929843|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447282|NCT01959334|Hormones|hormones|mesh-ancestor
14447283|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447284|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929844|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14929845|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929846|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929847|NCT01430078|Niacinamide|niacinamide|mesh-list
14929848|NCT01430078|Peficitinib|peficitinib|mesh-list
14929849|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929850|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929851|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929852|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
14929853|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929854|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
14929855|NCT01430078|Vitamins|vitamins|mesh-ancestor
14929856|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
14447285|NCT01959334|Incretins|incretins|mesh-ancestor
14447286|NCT01959490|Paclitaxel|paclitaxel|mesh-list
14447287|NCT01959490|Docetaxel|docetaxel|mesh-list
14447288|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
14447289|NCT01959490|Bevacizumab|bevacizumab|mesh-list
14447290|NCT01959490|Carboplatin|carboplatin|mesh-list
14447291|NCT01959490|Doxorubicin|doxorubicin|mesh-list
14447292|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14447293|NCT01959490|Trastuzumab|trastuzumab|mesh-list
14447294|NCT01959490|Pertuzumab|pertuzumab|mesh-list
14447295|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14447296|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447297|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14447298|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
14447299|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14447300|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447301|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447302|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
14447303|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929857|NCT01430195|Afamelanotide|afamelanotide|mesh-list
14929858|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
14929859|NCT01430234|Pancreatin|pancreatin|mesh-list
14929860|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14447304|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447305|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14447306|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
14447307|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14929861|NCT01430260|Ciclesonide|ciclesonide|mesh-list
14929862|NCT01430260|Cetirizine|cetirizine|mesh-list
14929863|NCT01430260|Levocetirizine|levocetirizine|mesh-list
14929864|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
14447308|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752318|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447309|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14447310|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14447311|NCT01959490|Growth Substances|growth substances|mesh-ancestor
14447312|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752319|NCT01657500|Gentamicins|gentamicins|mesh-list
14752320|NCT01657500|Dextrans|dextrans|mesh-list
14752321|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14752322|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752323|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447313|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14752324|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14929865|NCT01430260|Hormones|hormones|mesh-ancestor
14929866|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929867|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929868|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14929869|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14929870|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14929871|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
14929872|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
14929873|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929874|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929875|NCT01430312|Azelaic acid|azelaic acid|mesh-list
14929876|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929877|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14929878|NCT01430351|Metformin|metformin|mesh-list
14929879|NCT01430351|Mefloquine|mefloquine|mesh-list
14929880|NCT01430351|Temozolomide|temozolomide|mesh-list
14929881|NCT01430351|Memantine|memantine|mesh-list
14447314|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14447315|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14447316|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447317|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14447318|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
14447319|NCT01959503|Coagulants|coagulants|mesh-ancestor
14447320|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
14447321|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
14447322|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14447323|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
14447324|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447325|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447326|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14447327|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
14929882|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14929883|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929884|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14929885|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
14929886|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929887|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929888|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14929889|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14929890|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
14929891|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929892|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14929893|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14929894|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
14929895|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14929896|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14929897|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931185|NCT01437839|Apixaban|apixaban|mesh-list
14931186|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14447328|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
14447329|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14447330|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
14447331|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447332|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447333|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14447334|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14447335|NCT01959529|Insulin|insulin|mesh-list
14931187|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
14931188|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14931189|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
14931190|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447336|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14447337|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
14447338|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14447339|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447340|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
14447341|NCT01959672|Leucovorin|leucovorin|mesh-list
14447342|NCT01959672|Folic Acid|folic acid|mesh-list
14447343|NCT01959672|Gemcitabine|gemcitabine|mesh-list
14447344|NCT01959672|Nelfinavir|nelfinavir|mesh-list
14447345|NCT01959672|Fluorouracil|fluorouracil|mesh-list
14447346|NCT01959672|Oregovomab|oregovomab|mesh-list
14447347|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14447348|NCT01959672|Antibodies|antibodies|mesh-list
14447349|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
14447350|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14752325|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752326|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752327|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
14752328|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
14752329|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
14752330|NCT01497509|Epinephrine|epinephrine|mesh-list
14752331|NCT01497509|Racepinephrine|racepinephrine|mesh-list
14752332|NCT01497509|Fentanyl|fentanyl|mesh-list
14752333|NCT01497509|Bupivacaine|bupivacaine|mesh-list
14752334|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
14752335|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
14752336|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
14447351|NCT01959672|Calcium|calcium|mesh-list
14447352|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
14447353|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
14447354|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447355|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14447356|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
14447357|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447358|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447359|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
14447360|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447361|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447362|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447363|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14447364|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14447365|NCT01959672|Antidotes|antidotes|mesh-ancestor
14447366|NCT01959672|Protective Agents|protective agents|mesh-ancestor
14447367|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
14447368|NCT01959672|Vitamins|vitamins|mesh-ancestor
14447369|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
14447370|NCT01959672|Hematinics|hematinics|mesh-ancestor
14447371|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14447372|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14447373|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
14447374|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14447375|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14447376|NCT01959685|Enclomiphene|enclomiphene|mesh-list
14447377|NCT01959685|Clomiphene|clomiphene|mesh-list
14447378|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
14447379|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14447380|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
14447381|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447382|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447383|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14447384|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
14447385|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14447386|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14447387|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14929898|NCT01430520|Citalopram|citalopram|mesh-list
14929899|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14929900|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14929901|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14929902|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447388|NCT01959698|Rituximab|rituximab|mesh-list
14447389|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14447390|NCT01959698|Carboplatin|carboplatin|mesh-list
14447391|NCT01959698|Etoposide|etoposide|mesh-list
14447392|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
14447393|NCT01959698|Ifosfamide|ifosfamide|mesh-list
14447394|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
14447395|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
14447396|NCT01959698|Antibodies|antibodies|mesh-list
14447397|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
14447398|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14447399|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
14447400|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447401|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447402|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447403|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14447404|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14447405|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14929903|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14929904|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
14929905|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929906|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14929907|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
14929908|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14929909|NCT01430533|Azelaic acid|azelaic acid|mesh-list
14929910|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929911|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
14929912|NCT01430572|Everolimus|everolimus|mesh-list
14929913|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447406|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929914|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14929915|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
14447407|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447408|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14447409|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
14447410|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
14447411|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447412|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
14447413|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
14447414|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
14447415|NCT01959841|Valacyclovir|valacyclovir|mesh-list
14447416|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
14447417|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447418|NCT01959919|Factor VIII|factor viii|mesh-list
14447419|NCT01959919|Coagulants|coagulants|mesh-ancestor
14447420|NCT01959945|Vaccines|vaccines|mesh-list
14447421|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
14447422|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
14447423|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447424|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
14447425|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
14447426|NCT01960075|Levetiracetam|levetiracetam|mesh-list
14447427|NCT01960075|Valproic Acid|valproic acid|mesh-list
14447428|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
14447429|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
14447430|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447431|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447432|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
14447433|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447434|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447435|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
14447436|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14447437|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447438|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14447439|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14447440|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14447441|NCT01960114|Acetaminophen|acetaminophen|mesh-list
14447442|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14929916|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929917|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
14929918|NCT01430650|Urological Agents|urological agents|mesh-ancestor
14929919|NCT01430689|Vaccines|vaccines|mesh-list
14929920|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
14929921|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929922|NCT01430793|Vitamin D|vitamin d|mesh-list
14929923|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
14929924|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
14447443|NCT01960114|Analgesics|analgesics|mesh-ancestor
14447444|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
14447445|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929925|NCT01430793|Vitamins|vitamins|mesh-list
14929926|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
14929927|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929928|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14929929|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14929930|NCT01430806|Dronedarone|dronedarone|mesh-list
14929931|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14929932|NCT01430910|Ceftazidime|ceftazidime|mesh-list
14929933|NCT01430910|Avibactam|avibactam|mesh-list
14929934|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14929935|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929936|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14929937|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929938|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929939|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14929940|NCT01430923|Latanoprost|latanoprost|mesh-list
14929941|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14929942|NCT01431053|Aspirin|aspirin|mesh-list
14929943|NCT01431053|Exemestane|exemestane|mesh-list
14929944|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14929945|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14929946|NCT01431053|Analgesics|analgesics|mesh-ancestor
14929947|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
14929948|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929949|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929950|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929951|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929952|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14929953|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14929954|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929955|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14929956|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14929957|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929958|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
14929959|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14929960|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14929961|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14929962|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14929963|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
14929964|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14929965|NCT01431092|Melatonin|melatonin|mesh-list
14929966|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
14929967|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929968|NCT01431092|Protective Agents|protective agents|mesh-ancestor
14929969|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929970|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14929971|NCT01431118|Camphor|camphor|mesh-list
14929972|NCT01431118|Salicylates|salicylates|mesh-list
14929973|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
14929974|NCT01431118|Menthol|menthol|mesh-list
14929975|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14929976|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14929977|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
14929978|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
14929979|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14929980|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14929981|NCT01431118|Analgesics|analgesics|mesh-ancestor
14929982|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
14929983|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14929984|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929985|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14929986|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14929987|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14929988|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14929989|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14929990|NCT01431183|Vaccines|vaccines|mesh-list
14929991|NCT01431183|Immunologic Factors|immunologic factors|mesh-ancestor
14929992|NCT01431183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929993|NCT01431196|Vaccines|vaccines|mesh-list
14929994|NCT01431196|Immunologic Factors|immunologic factors|mesh-ancestor
14929995|NCT01431196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14929996|NCT01431326|Vancomycin|vancomycin|mesh-list
14929997|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
14929998|NCT01431326|Tazobactam|tazobactam|mesh-list
14929999|NCT01431326|Piperacillin|piperacillin|mesh-list
14930000|NCT01431326|Tobramycin|tobramycin|mesh-list
14930001|NCT01431326|Amikacin|amikacin|mesh-list
14930002|NCT01431326|Fosfomycin|fosfomycin|mesh-list
14930003|NCT01431326|Cefepime|cefepime|mesh-list
14930004|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14930005|NCT01431326|Nafcillin|nafcillin|mesh-list
14930006|NCT01431326|Cidofovir|cidofovir|mesh-list
14930007|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
14930008|NCT01431326|Bosentan|bosentan|mesh-list
14930009|NCT01431326|Labetalol|labetalol|mesh-list
14930010|NCT01431326|Nifedipine|nifedipine|mesh-list
14930011|NCT01431326|Spironolactone|spironolactone|mesh-list
14930012|NCT01431326|Pentobarbital|pentobarbital|mesh-list
14930013|NCT01431326|Oxycodone|oxycodone|mesh-list
14930014|NCT01431326|Alfentanil|alfentanil|mesh-list
14930015|NCT01431326|Haloperidol|haloperidol|mesh-list
14930016|NCT01431326|Zolpidem|zolpidem|mesh-list
14930017|NCT01431326|Ziprasidone|ziprasidone|mesh-list
14930018|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14930019|NCT01431326|Clozapine|clozapine|mesh-list
14930020|NCT01431326|Molindone|molindone|mesh-list
14930021|NCT01431326|Warfarin|warfarin|mesh-list
14930022|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
14930023|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
14930024|NCT01431326|Rocuronium|rocuronium|mesh-list
14930025|NCT01431326|Sevelamer|sevelamer|mesh-list
14930026|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930027|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
14930028|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
14930029|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930030|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930031|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14930032|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
14930033|NCT01431326|Hormones|hormones|mesh-ancestor
14930034|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930035|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14930036|NCT01431326|Protective Agents|protective agents|mesh-ancestor
14930037|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930038|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14447446|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447447|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
14447448|NCT01960140|Simvastatin|simvastatin|mesh-list
14447449|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14447450|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14447451|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
14447452|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447453|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14447454|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14447455|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447456|NCT01960296|Clopidogrel|clopidogrel|mesh-list
14447457|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14447458|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14447459|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14447460|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14447461|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
14447462|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447463|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447464|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447465|NCT01960387|Cytarabine|cytarabine|mesh-list
14447466|NCT01960387|Clofarabine|clofarabine|mesh-list
14447467|NCT01960387|Antimetabolites|antimetabolites|mesh-list
14447468|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14447469|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447470|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447471|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
14447472|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447473|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447474|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
14447475|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447476|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
14447477|NCT01960413|Montelukast|montelukast|mesh-list
14447478|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14447479|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
14447480|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14447481|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
14447482|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752337|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752338|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752339|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
14752340|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752341|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14752342|NCT01497509|Narcotics|narcotics|mesh-ancestor
14752343|NCT01497509|Analgesics|analgesics|mesh-ancestor
14752344|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14752345|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14752346|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
14930039|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14930040|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930041|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
14930042|NCT01431326|Coagulants|coagulants|mesh-ancestor
14752347|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14752348|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14752349|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930043|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14930044|NCT01431326|Narcotics|narcotics|mesh-ancestor
14930045|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930046|NCT01431326|Analgesics|analgesics|mesh-ancestor
14930047|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
14930048|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
14930049|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14930050|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930051|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14930052|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14930053|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14930054|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14930055|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14930056|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930057|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14930058|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14930059|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14930060|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
14930061|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14930062|NCT01431326|Diuretics|diuretics|mesh-ancestor
14930063|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
14930064|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14752350|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752351|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752352|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14752353|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14752354|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
14447483|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447484|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14447485|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14447486|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447487|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447488|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
14447489|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447490|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14752355|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14752356|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
14752357|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
14752358|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
14752359|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14752363|NCT01013649|Gemcitabine|gemcitabine|mesh-list
14752364|NCT01013649|Fluorouracil|fluorouracil|mesh-list
14447491|NCT01960842|Levodopa|levodopa|mesh-list
14447492|NCT01960842|Carbidopa|carbidopa|mesh-list
14447493|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14447494|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14447495|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14447496|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
14447497|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447498|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447499|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447500|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14447501|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447502|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14447503|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
14930065|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14930066|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14930067|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
14930068|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
14930069|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14447504|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
14447505|NCT01960855|Upadacitinib|upadacitinib|mesh-list
14447506|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14930070|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14930071|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14930072|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14930073|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14930074|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14930075|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
14930076|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930077|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14930078|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14930079|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14930080|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14930081|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
14447507|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14447508|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447509|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930082|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
14930083|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14930084|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
14447510|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447511|NCT01961271|Buprenorphine|buprenorphine|mesh-list
14447512|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14447513|NCT01961271|Narcotics|narcotics|mesh-ancestor
14447514|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447515|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447516|NCT01961271|Analgesics|analgesics|mesh-ancestor
14447517|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
14447518|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447519|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14447520|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
14447521|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14447522|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14447523|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
14447524|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
14447525|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447526|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447527|NCT01961323|Nebivolol|nebivolol|mesh-list
14447528|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14447529|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
14447530|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14447531|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14447532|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14447533|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
14447534|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447535|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447536|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447537|NCT01961349|Propofol|propofol|mesh-list
14447538|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14447539|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14447540|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447541|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447542|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14447543|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
14447544|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
14447545|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14447546|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14752365|NCT01013649|Capecitabine|capecitabine|mesh-list
14752366|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14752367|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14752368|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
14752369|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752370|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752371|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
14752372|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752373|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752374|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752375|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
14752376|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752377|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14752378|NCT00669734|Metronidazole|metronidazole|mesh-list
14752379|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
14752380|NCT00669734|Vaccines|vaccines|mesh-list
14752381|NCT00669734|Sargramostim|sargramostim|mesh-list
14752382|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
14752383|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447547|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14447548|NCT01962103|Paclitaxel|paclitaxel|mesh-list
14447549|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14447550|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14447551|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447552|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
14447553|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
14447554|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
14447555|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447556|NCT01962298|Rocuronium|rocuronium|mesh-list
14447557|NCT01962298|Neostigmine|neostigmine|mesh-list
14447558|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14447559|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14447560|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14447561|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447562|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447563|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14447564|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447565|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447566|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
14447567|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447568|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14447569|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
14447570|NCT01962428|Ticagrelor|ticagrelor|mesh-list
14447571|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14447572|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14447573|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14447574|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14447575|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
14447576|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447577|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447578|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447579|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
14752384|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752385|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752386|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752387|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14752388|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14752389|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
14752390|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752391|NCT00669734|Protective Agents|protective agents|mesh-ancestor
14752392|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
14752393|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752394|NCT00669734|Growth Substances|growth substances|mesh-ancestor
14930085|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14930086|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14930087|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
14930088|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
14447580|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
14447581|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447582|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
14447583|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14447584|NCT01962493|Listerine|listerine|mesh-list
14447585|NCT01962493|Fluorides|fluorides|mesh-list
14447586|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
14447587|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
14447588|NCT01962493|Protective Agents|protective agents|mesh-ancestor
14447589|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447590|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14447591|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447592|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
14447593|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447594|NCT01962688|Diuretics|diuretics|mesh-list
14447595|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
14447596|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447597|NCT01962870|Vasopressins|vasopressins|mesh-list
14752395|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14752396|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752397|NCT00630565|Dexamethasone|dexamethasone|mesh-list
14752398|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
14752399|NCT00630565|Busulfan|busulfan|mesh-list
14752400|NCT00630565|Etoposide|etoposide|mesh-list
14752401|NCT00630565|Sargramostim|sargramostim|mesh-list
14752402|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752403|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
14752404|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447598|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
14447599|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
14447600|NCT01962870|Coagulants|coagulants|mesh-ancestor
14752405|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447601|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14447602|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14447603|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
14447604|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447605|NCT01962896|Sirolimus|sirolimus|mesh-list
14447606|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14447607|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447608|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14447609|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447610|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447611|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14447612|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447613|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14447614|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
14447615|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447616|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
14447617|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447618|NCT01962922|Tacrolimus|tacrolimus|mesh-list
14447619|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447620|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
14447621|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447622|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14447623|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447624|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447625|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
14447626|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14447627|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
14447628|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447629|NCT01962961|Expectorants|expectorants|mesh-ancestor
14447630|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
14447631|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14447632|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
14447633|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447634|NCT01962961|Protective Agents|protective agents|mesh-ancestor
14447635|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447636|NCT01962961|Antidotes|antidotes|mesh-ancestor
14447637|NCT01962987|Diclofenac|diclofenac|mesh-list
14447638|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14447639|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14447640|NCT01962987|Analgesics|analgesics|mesh-ancestor
14447641|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
14447642|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447643|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447644|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447645|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447646|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14447647|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447648|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447649|NCT01963078|Oxytocin|oxytocin|mesh-list
14447650|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
14447651|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14447652|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447653|NCT01963091|Oxytocin|oxytocin|mesh-list
14447654|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
14447655|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14447656|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447657|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
14447658|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14447659|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14447660|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
14447661|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447662|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
14447663|NCT01963481|Exemestane|exemestane|mesh-list
14447664|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447665|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
14447666|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447667|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447668|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14447669|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
14447670|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447671|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447672|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14447673|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14447674|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14447675|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447676|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14447677|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
14447678|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447679|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
14447680|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14447681|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
14447682|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447683|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447684|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447685|NCT01963793|Aprepitant|aprepitant|mesh-list
14447686|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
14447687|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
14447688|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
14447689|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447690|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447691|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14447692|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14447693|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447694|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447695|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14447696|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14447697|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447698|NCT01963845|Incretins|incretins|mesh-ancestor
14447699|NCT01963845|Hormones|hormones|mesh-ancestor
14447700|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447701|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14447702|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
14447703|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447704|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469243|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469244|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14469245|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469246|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469247|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14469248|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14469249|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14469250|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14469251|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14469252|NCT02292082|Cefazolin|cefazolin|mesh-list
14469253|NCT02292082|Dexamethasone|dexamethasone|mesh-list
14469254|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
14469255|NCT02292082|Midazolam|midazolam|mesh-list
14469256|NCT02292082|Morphine|morphine|mesh-list
14469257|NCT02292082|Bupivacaine|bupivacaine|mesh-list
14469258|NCT02292082|Propofol|propofol|mesh-list
14469259|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469260|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
14469261|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
14469262|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469263|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469264|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469265|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
14469266|NCT02292082|Hormones|hormones|mesh-ancestor
14469267|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931236|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447705|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14447706|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
14447707|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447708|NCT01964326|Atorvastatin|atorvastatin|mesh-list
14447709|NCT01964326|Calcium|calcium|mesh-list
14447710|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14447711|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447712|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14447713|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14447714|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
14447715|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447716|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14447717|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14447718|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447719|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
14447720|NCT01964352|Olodaterol|olodaterol|mesh-list
14930089|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14930090|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14930091|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14930092|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930093|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14930094|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14930095|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
14930096|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14930097|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
14447721|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14447722|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
14447723|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447724|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447725|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14447726|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
14447727|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
14447728|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14447729|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
14447730|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447731|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447732|NCT01964378|Morphine|morphine|mesh-list
14447733|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14447734|NCT01964378|Narcotics|narcotics|mesh-ancestor
14447735|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447736|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447737|NCT01964378|Analgesics|analgesics|mesh-ancestor
14447738|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
14447739|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930098|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14930099|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14930100|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
14930101|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
14930102|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
14930103|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14930104|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
14930105|NCT01431352|Letrozole|letrozole|mesh-list
14930106|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930107|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14930108|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14930109|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930110|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930111|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14930112|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
14447740|NCT01964430|Gemcitabine|gemcitabine|mesh-list
14930113|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930114|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930115|NCT01431404|Etanercept|etanercept|mesh-list
14930116|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14930117|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14930118|NCT01431404|Analgesics|analgesics|mesh-ancestor
14930119|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
14930120|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447741|NCT01964430|Paclitaxel|paclitaxel|mesh-list
14447742|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14447743|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447744|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
14447745|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
14447746|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
14447747|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930121|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930122|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930123|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930124|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14930125|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930126|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
14447748|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14447749|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
14447750|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
14447751|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447752|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447753|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447754|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
14447755|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447756|NCT01964547|Nabiximols|nabiximols|mesh-list
14447757|NCT01964547|Analgesics|analgesics|mesh-ancestor
14447758|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
14447759|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447760|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447761|NCT01964716|Vaccines|vaccines|mesh-list
14447762|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14447763|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
14447764|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447765|NCT01964755|Leucovorin|leucovorin|mesh-list
14447766|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14447767|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
14447768|NCT01964755|Zidovudine|zidovudine|mesh-list
14447769|NCT01964755|Rituximab|rituximab|mesh-list
14447770|NCT01964755|Doxorubicin|doxorubicin|mesh-list
14447771|NCT01964755|Methotrexate|methotrexate|mesh-list
14447772|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
14930127|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
14447773|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
14447774|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14930128|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14930129|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447775|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447776|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
14447777|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447778|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447779|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14447780|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14447781|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14447782|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447783|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447784|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14447785|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
14447786|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14447787|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14447788|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
14447789|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447790|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14447791|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14447792|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14447793|NCT01964755|Antidotes|antidotes|mesh-ancestor
14447794|NCT01964755|Protective Agents|protective agents|mesh-ancestor
14447795|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
14447796|NCT01964755|Vitamins|vitamins|mesh-ancestor
14447797|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
14447798|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14447799|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
14447800|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447801|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14447802|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14447803|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
14447804|NCT01964898|Nicotine|nicotine|mesh-list
14447805|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14447806|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
14447807|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447808|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447809|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14447810|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14447811|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
14447812|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447813|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447814|NCT01964924|Trametinib|trametinib|mesh-list
14447815|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447816|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14447817|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447818|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447819|NCT01964963|Alogliptin|alogliptin|mesh-list
14447820|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14447821|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447822|NCT01964963|Incretins|incretins|mesh-ancestor
14930130|NCT01431430|Vitamins|vitamins|mesh-ancestor
14930131|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
14930132|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14930133|NCT01431443|Theobromine|theobromine|mesh-list
14930134|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14930135|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
14930136|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930137|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930138|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14930139|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
14930140|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
14930141|NCT01431456|Nadroparin|nadroparin|mesh-list
14930142|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
14447823|NCT01964963|Hormones|hormones|mesh-ancestor
14447824|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930143|NCT01431456|Dabigatran|dabigatran|mesh-list
14930144|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14930145|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
14930146|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14930147|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
14930148|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930149|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930150|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
14930151|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14930152|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14930153|NCT01431495|Clopidogrel|clopidogrel|mesh-list
14930154|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14930155|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14930156|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14447825|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14447826|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
14447827|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447828|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447829|NCT01965002|Aspirin|aspirin|mesh-list
14447830|NCT01965002|Enoxaparin|enoxaparin|mesh-list
14447831|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14447832|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14447833|NCT01965002|Analgesics|analgesics|mesh-ancestor
14447834|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
14447835|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447836|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447837|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447838|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447839|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14447840|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14447841|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447842|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14447843|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14447844|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447845|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
14447846|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
14447847|NCT01965327|Interferons|interferons|mesh-list
14447848|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
14752406|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14752407|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
14752408|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752409|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752410|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14752411|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752412|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
14752413|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
14752414|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752415|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14752416|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
14752417|NCT00630565|Hormones|hormones|mesh-ancestor
14930157|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14447849|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447850|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
14930158|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
14930159|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930160|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930161|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930162|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14930163|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
14930164|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930165|NCT01431612|Phenylephrine|phenylephrine|mesh-list
14930166|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
14930167|NCT01431612|Esmolol|esmolol|mesh-list
14930168|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14930169|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
14930170|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
14930171|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930172|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930173|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
14930174|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14447851|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447852|NCT01965366|Dexamethasone|dexamethasone|mesh-list
14447853|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447854|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
14447855|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
14447856|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447857|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447858|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14447859|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
14447860|NCT01965366|Hormones|hormones|mesh-ancestor
14447861|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447862|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14447863|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447864|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
14447865|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14447866|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447867|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14447868|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14447869|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447870|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447871|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447872|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
14447873|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14447874|NCT01965535|Ledipasvir|ledipasvir|mesh-list
14447875|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
14447876|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447877|NCT01965756|Metformin|metformin|mesh-list
14447878|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14447879|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447880|NCT01965834|Fenofibrate|fenofibrate|mesh-list
14447881|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
14447882|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14447883|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
14447884|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447885|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14447886|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14447887|NCT01966003|Paclitaxel|paclitaxel|mesh-list
14447888|NCT01966003|Bevacizumab|bevacizumab|mesh-list
14447889|NCT01966003|Carboplatin|carboplatin|mesh-list
14447890|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14447891|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447892|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
14447893|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
14447894|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
14447895|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447896|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14447897|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14447898|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14447899|NCT01966003|Growth Substances|growth substances|mesh-ancestor
14447900|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447901|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
14447902|NCT01966107|Bromides|bromides|mesh-list
14447903|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
14447904|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14447905|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14447906|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447907|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
14447908|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14447909|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
14447910|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447911|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447912|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14447913|NCT01966718|Hormones|hormones|mesh-ancestor
14447914|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447915|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447916|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14447917|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447918|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447919|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14930175|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
14447920|NCT01966978|Insulin|insulin|mesh-list
14447921|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14447922|NCT01966978|Metformin|metformin|mesh-list
14447923|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
14447924|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
14447925|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14447926|NCT01966978|Liraglutide|liraglutide|mesh-list
14447927|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
14447928|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14447929|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447930|NCT01966978|Incretins|incretins|mesh-ancestor
14447931|NCT01966978|Hormones|hormones|mesh-ancestor
14447932|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447933|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14447934|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14447935|NCT01967173|Fluticasone|fluticasone|mesh-list
14447936|NCT01967173|Xhance|xhance|mesh-list
14447937|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14447938|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14447939|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
14447940|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447941|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447942|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14447943|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
14447944|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
14447945|NCT01967173|Hormones|hormones|mesh-ancestor
14447946|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14447947|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
14447948|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447949|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447950|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14447951|NCT01967225|Linezolid|linezolid|mesh-list
14447952|NCT01967225|Tedizolid|tedizolid|mesh-list
14447953|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
14447954|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14447955|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14447956|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14447957|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447958|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447959|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
14447960|NCT01967433|Promethazine|promethazine|mesh-list
14447961|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14447962|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14447963|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14447964|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447965|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
14447966|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
14447967|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
14447968|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14447969|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
14930176|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
14930177|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14930178|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14930179|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14930180|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930181|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930182|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930183|NCT01431612|Protective Agents|protective agents|mesh-ancestor
14447970|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
14447971|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14447972|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14447973|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
14447974|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
14447975|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14447976|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447977|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14447978|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
14447979|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
14447980|NCT01967550|Diclofenac|diclofenac|mesh-list
14447981|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14447982|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14447983|NCT01967550|Analgesics|analgesics|mesh-ancestor
14447984|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
14447985|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931237|NCT01438112|Gemcitabine|gemcitabine|mesh-list
14447986|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14447987|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14447988|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14447989|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14447990|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447991|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447992|NCT01967576|Axitinib|axitinib|mesh-list
14447993|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14447994|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14447995|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14447996|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14447997|NCT01967628|Vitamin D|vitamin d|mesh-list
14447998|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
14447999|NCT01967628|Vitamins|vitamins|mesh-ancestor
14448000|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
14448001|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448002|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14448003|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14448004|NCT01967641|Buprenorphine|buprenorphine|mesh-list
14448005|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14448006|NCT01967641|Naloxone|naloxone|mesh-list
14448007|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14448008|NCT01967641|Narcotics|narcotics|mesh-ancestor
14448009|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448010|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448011|NCT01967641|Analgesics|analgesics|mesh-ancestor
14448012|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
14448013|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448014|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14448015|NCT01967862|Listerine|listerine|mesh-list
14448016|NCT01967862|Fluorides|fluorides|mesh-list
14448017|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
14448018|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
14448019|NCT01967862|Protective Agents|protective agents|mesh-ancestor
14448020|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448021|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14448022|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448023|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14448024|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14448025|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14448026|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14448027|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
14448028|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448029|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448030|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14448031|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14448032|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
14448033|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448034|NCT01968031|Istradefylline|istradefylline|mesh-list
14448035|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14448036|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14448037|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14448038|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
14448039|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448040|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448041|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448042|NCT01968057|Cyclosporine|cyclosporine|mesh-list
14448043|NCT01968057|Cyclosporins|cyclosporins|mesh-list
14448044|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448045|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448046|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14448047|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
14448048|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448049|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
14448050|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448051|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448052|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448053|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14448054|NCT01968070|Celecoxib|celecoxib|mesh-list
14448055|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14448056|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14931238|NCT01438112|Interferons|interferons|mesh-list
14448057|NCT01968070|Analgesics|analgesics|mesh-ancestor
14448058|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
14448059|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448060|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448061|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448062|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448063|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14448064|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14448065|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448066|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448067|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
14448068|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
14448069|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14448070|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14448071|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448072|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14448073|NCT01968213|Rucaparib|rucaparib|mesh-list
14448074|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14448075|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448076|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448077|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448078|NCT01968317|Metformin|metformin|mesh-list
14448079|NCT01968317|Megestrol|megestrol|mesh-list
14448080|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
14448081|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448082|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448083|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14448084|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14448085|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14448086|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
14448087|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14448088|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14448089|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14448090|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14930184|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14930185|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14930186|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14930187|NCT01431690|Warfarin|warfarin|mesh-list
14930188|NCT01431690|Anticoagulants|anticoagulants|mesh-list
14930189|NCT01431729|Propolis|propolis|mesh-list
14930190|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930191|NCT01431742|Buprenorphine|buprenorphine|mesh-list
14930192|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14930193|NCT01431742|Narcotics|narcotics|mesh-ancestor
14930194|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930195|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930196|NCT01431742|Analgesics|analgesics|mesh-ancestor
14930197|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
14930198|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930199|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14448091|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448092|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
14448093|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14448094|NCT01968356|Ethanol|ethanol|mesh-list
14448095|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
14448096|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14448097|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14448098|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448099|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448100|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448101|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
14448102|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448103|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
14448104|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14448105|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
14448106|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448107|NCT01968434|Carbocysteine|carbocysteine|mesh-list
14448108|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14448109|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448110|NCT01968434|Expectorants|expectorants|mesh-ancestor
14448111|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
14448112|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14448113|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14448114|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14448115|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
14448116|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448117|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
14448118|NCT01968694|Promethazine|promethazine|mesh-list
14448119|NCT01968694|Lidocaine|lidocaine|mesh-list
14448120|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
14448121|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
14448122|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448123|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448124|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
14931239|NCT01438112|Mitomycins|mitomycins|mesh-list
14448125|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448126|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14448127|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14448128|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14448129|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448130|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448131|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14448132|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14448133|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
14448134|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
14448135|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448136|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14448137|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
14448138|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
14448139|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448140|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14448141|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
14448142|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448143|NCT01968707|Ethanol|ethanol|mesh-list
14448144|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
14448145|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14448146|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14448147|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448148|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448149|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448150|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
14448151|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448152|NCT01968954|Bococizumab|bococizumab|mesh-list
14448153|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14448154|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14448155|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
14448156|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448157|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14448158|NCT01968967|Bococizumab|bococizumab|mesh-list
14448159|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14448160|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14448161|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
14448162|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448163|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14448164|NCT01968980|Bococizumab|bococizumab|mesh-list
14448165|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14448166|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14448167|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
14448168|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448169|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14930200|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14930201|NCT01431781|Somatostatin|somatostatin|mesh-list
14930202|NCT01431781|Hormones|hormones|mesh-ancestor
14930203|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930204|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930205|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
14930206|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14930207|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930208|NCT01431924|Fluticasone|fluticasone|mesh-list
14930209|NCT01431924|Xhance|xhance|mesh-list
14930210|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14930211|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930212|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14930213|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
14930214|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930215|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930216|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14930217|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
14930218|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14930219|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14930220|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14930221|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14930222|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14930223|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930224|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930225|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930226|NCT01432028|Drospirenone|drospirenone|mesh-list
14448170|NCT01969058|Isotretinoin|isotretinoin|mesh-list
14448171|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448172|NCT01969084|Linagliptin|linagliptin|mesh-list
14448173|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448174|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448175|NCT01969084|Incretins|incretins|mesh-ancestor
14448176|NCT01969084|Hormones|hormones|mesh-ancestor
14448177|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448178|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14448179|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
14448180|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448181|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448182|NCT01969201|Hormones|hormones|mesh-list
14448183|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448184|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469268|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14469269|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448185|NCT01969435|Cytarabine|cytarabine|mesh-list
14448186|NCT01969435|Etoposide|etoposide|mesh-list
14448187|NCT01969435|Melphalan|melphalan|mesh-list
14448188|NCT01969435|Carmustine|carmustine|mesh-list
14448189|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
14448190|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14448191|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448192|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14448193|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14448194|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448195|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448196|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14448197|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
14448198|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
14448199|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448200|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930227|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14930228|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14930229|NCT01432028|Estradiol|estradiol|mesh-list
14448201|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
14448202|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448203|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14448204|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
14448205|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14448206|NCT01969708|Bevacizumab|bevacizumab|mesh-list
14448207|NCT01969708|Aflibercept|aflibercept|mesh-list
14448208|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14448209|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448210|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14448211|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14448212|NCT01969708|Growth Substances|growth substances|mesh-ancestor
14448213|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448214|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
14448215|NCT01969721|Fluticasone|fluticasone|mesh-list
14448216|NCT01969721|Xhance|xhance|mesh-list
14448217|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
14930230|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14448218|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14448219|NCT01969721|Olodaterol|olodaterol|mesh-list
14448220|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448221|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14448222|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
14448223|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448224|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448225|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14448226|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
14448227|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448228|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14448229|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
14448230|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14448231|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
14448232|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448233|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448234|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14448235|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14448236|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14448237|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14448238|NCT01969747|Empagliflozin|empagliflozin|mesh-list
14448239|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14448240|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448241|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448242|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448243|NCT01969799|Amikacin|amikacin|mesh-list
14448244|NCT01969799|Fosfomycin|fosfomycin|mesh-list
14448245|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14448246|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448247|NCT01969851|Lacosamide|lacosamide|mesh-list
14448248|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
14448249|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14448250|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14448251|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448252|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448253|NCT01969916|Regadenoson|regadenoson|mesh-list
14448254|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14448255|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14448256|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
14448257|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
14448258|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448259|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448260|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448261|NCT01970176|Tadalafil|tadalafil|mesh-list
14448262|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
14448263|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14448264|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14448265|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448266|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448267|NCT01970176|Urological Agents|urological agents|mesh-ancestor
14448268|NCT01970241|Insulin|insulin|mesh-list
14448269|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14448270|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448271|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448272|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14448273|NCT01970371|Meropenem|meropenem|mesh-list
14448274|NCT01970371|Colistin|colistin|mesh-list
14448275|NCT01970371|Tigecycline|tigecycline|mesh-list
14448276|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448277|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14448278|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448279|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448280|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
14448281|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14448282|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
14448283|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448284|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
14448285|NCT01970397|Protective Agents|protective agents|mesh-ancestor
14448286|NCT01970475|Adalimumab|adalimumab|mesh-list
14448287|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448288|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448289|NCT01970488|Adalimumab|adalimumab|mesh-list
14448290|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448291|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448292|NCT01970527|Ipilimumab|ipilimumab|mesh-list
14448293|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14448294|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448295|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14448296|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448297|NCT01970540|Doxorubicin|doxorubicin|mesh-list
14448298|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14448299|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930231|NCT01432028|Progesterone|progesterone|mesh-list
14930232|NCT01432028|Estrogens|estrogens|mesh-ancestor
14448300|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14448301|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14448302|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448303|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448304|NCT01970878|Bromides|bromides|mesh-list
14448305|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
14448306|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14448307|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
14448308|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448309|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448310|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14448311|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
14448312|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
14448313|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14448314|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
14448315|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448316|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448317|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
14448318|NCT01970995|Menthol|menthol|mesh-list
14448319|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
14448320|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448321|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14448322|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
14448323|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14448324|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14448325|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14448326|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448327|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448328|NCT01971346|Etanercept|etanercept|mesh-list
14448329|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14448330|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14448331|NCT01971346|Analgesics|analgesics|mesh-ancestor
14448332|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
14448333|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448334|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448335|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448336|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448337|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448338|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14448339|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
14448340|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14448341|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
14448342|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14448343|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
14448344|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448345|NCT01971580|Ambrisentan|ambrisentan|mesh-list
14448346|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14448347|NCT01971593|Eplerenone|eplerenone|mesh-list
14448348|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14448349|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469270|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
14752418|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448350|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448351|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448352|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14448353|NCT01971593|Diuretics|diuretics|mesh-ancestor
14448354|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
14448355|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14448356|NCT01971645|Dexamethasone|dexamethasone|mesh-list
14448357|NCT01971645|Ropivacaine|ropivacaine|mesh-list
14448358|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448359|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
14448360|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
14448361|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448362|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448363|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448364|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
14448365|NCT01971645|Hormones|hormones|mesh-ancestor
14448366|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448367|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14448368|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448369|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
14448370|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
14448371|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448372|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
14448373|NCT01972074|Memantine|memantine|mesh-list
14448374|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14448375|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14448376|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
14448377|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448378|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448379|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448380|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14448381|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14448382|NCT01972152|Glucagon|glucagon|mesh-list
14448383|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448384|NCT01972152|Hormones|hormones|mesh-ancestor
14448385|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448386|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448387|NCT01972464|Progesterone|progesterone|mesh-list
14448388|NCT01972464|Progestins|progestins|mesh-ancestor
14448389|NCT01972464|Hormones|hormones|mesh-ancestor
14448390|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448391|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448392|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
14448393|NCT01972659|Analgesics|analgesics|mesh-ancestor
14448394|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
14448395|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448396|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448397|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
14448398|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448399|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14448400|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
14448401|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14448402|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448403|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448404|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14448405|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
14448406|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14448407|NCT01972724|Metformin|metformin|mesh-list
14448408|NCT01972724|Pioglitazone|pioglitazone|mesh-list
14448409|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448410|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448411|NCT01972789|Ranibizumab|ranibizumab|mesh-list
14448412|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14448413|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14448414|NCT01972789|Growth Substances|growth substances|mesh-ancestor
14448415|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448416|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
14448417|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448418|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
14448419|NCT01972841|Mirabegron|mirabegron|mesh-list
14448420|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14448421|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14448422|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
14448423|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448424|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448425|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448426|NCT01972841|Urological Agents|urological agents|mesh-ancestor
14448427|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14448428|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14448429|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14448430|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
14448431|NCT01973036|Oxytocin|oxytocin|mesh-list
14448432|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
14448433|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14448434|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448435|NCT01973205|Aspirin|aspirin|mesh-list
14448436|NCT01973205|Acetaminophen|acetaminophen|mesh-list
14448437|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14448438|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14448439|NCT01973205|Analgesics|analgesics|mesh-ancestor
14448440|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
14448441|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448442|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448443|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448444|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448445|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14448446|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14448447|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448448|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14448449|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14448450|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448451|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
14448452|NCT01973218|Vaccines|vaccines|mesh-list
14448453|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
14448454|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448455|NCT01973231|Liraglutide|liraglutide|mesh-list
14448456|NCT01973231|Lixisenatide|lixisenatide|mesh-list
14448457|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448458|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448459|NCT01973231|Incretins|incretins|mesh-ancestor
14448460|NCT01973231|Hormones|hormones|mesh-ancestor
14448461|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448462|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14448463|NCT01973283|Citalopram|citalopram|mesh-list
14448464|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
14448465|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14448466|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14448467|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448468|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448469|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448470|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
14448471|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448472|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14448473|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14448474|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448475|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14448476|NCT01973283|Analgesics|analgesics|mesh-ancestor
14448477|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
14448478|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
14448479|NCT01973335|Spironolactone|spironolactone|mesh-list
14448480|NCT01973335|Acetazolamide|acetazolamide|mesh-list
14448481|NCT01973335|Bumetanide|bumetanide|mesh-list
14448482|NCT01973335|Diuretics|diuretics|mesh-list
14448483|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14448484|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14448485|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
14448486|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448487|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448488|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14448489|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
14448490|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
14448491|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14448492|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448493|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448494|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448495|NCT01973348|Methamphetamine|methamphetamine|mesh-list
14448496|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14448497|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448498|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
14448499|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
14448500|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448501|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
14448502|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448503|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448504|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
14448505|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14448506|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14448507|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448508|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14448509|NCT01973387|Rituximab|rituximab|mesh-list
14448510|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14448511|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448512|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
14448513|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448514|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448515|NCT01973413|Insulin|insulin|mesh-list
14448516|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448517|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448518|NCT01973439|Abacavir|abacavir|mesh-list
14448519|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
14448520|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14448521|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14448522|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448523|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448524|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
14448525|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448526|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14448527|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14448528|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
14448529|NCT01973569|Denosumab|denosumab|mesh-list
14448530|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14448531|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448532|NCT01974141|Dapsone|dapsone|mesh-list
14448533|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448534|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
14448535|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14448536|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14448537|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14448538|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448539|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448540|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
14448541|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14448542|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
14448543|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14448544|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448545|NCT01974245|Vitamins|vitamins|mesh-ancestor
14752419|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14448546|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
14448547|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14448548|NCT01974323|Dapsone|dapsone|mesh-list
14448549|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448550|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
14448551|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14448552|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14448553|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14448554|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448555|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448556|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
14448557|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14448558|NCT01974687|Itraconazole|itraconazole|mesh-list
14448559|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
14448560|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
14448561|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448562|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14448563|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14448564|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930233|NCT01432028|Hormones|hormones|mesh-ancestor
14930234|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930235|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930236|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14930237|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
14448565|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448566|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14448567|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
14448568|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448569|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448570|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14448571|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
14448572|NCT01974700|Levetiracetam|levetiracetam|mesh-list
14448573|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
14448574|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
14448575|NCT01974752|Dacarbazine|dacarbazine|mesh-list
14448576|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14448577|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
14448578|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448579|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448580|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14448581|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
14448582|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448583|NCT01975220|Metformin|metformin|mesh-list
14448584|NCT01975220|Empagliflozin|empagliflozin|mesh-list
14448585|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14448586|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448587|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14448588|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448589|NCT01975246|Amlodipine|amlodipine|mesh-list
14448590|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14448591|NCT01975246|Telmisartan|telmisartan|mesh-list
14448592|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14448593|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14448594|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14469271|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
14448595|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448596|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448597|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14448598|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448599|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
14448600|NCT01975246|Diuretics|diuretics|mesh-ancestor
14448601|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
14448602|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14448603|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14448604|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14448605|NCT01975285|Dexamethasone|dexamethasone|mesh-list
14448606|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448607|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
14448608|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
14448609|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448610|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448611|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448612|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
14448613|NCT01975285|Hormones|hormones|mesh-ancestor
14448614|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448615|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14448616|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448617|NCT01975376|Bococizumab|bococizumab|mesh-list
14448618|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14448619|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14448620|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
14448621|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448622|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14448623|NCT01975389|Bococizumab|bococizumab|mesh-list
14448624|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14448625|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14448626|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
14448627|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448628|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14448629|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14448630|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
14448631|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448632|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
14448633|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
14448634|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448635|NCT01975701|Infigratinib|infigratinib|mesh-list
14448636|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448637|NCT01975831|Durvalumab|durvalumab|mesh-list
14448638|NCT01975831|Tremelimumab|tremelimumab|mesh-list
14448639|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14448640|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448641|NCT01975935|Amlexanox|amlexanox|mesh-list
14448642|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14469272|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469273|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
14469274|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14469275|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14469276|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
14469277|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14469278|NCT02292082|Narcotics|narcotics|mesh-ancestor
14469279|NCT02292082|Analgesics|analgesics|mesh-ancestor
14469280|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14469281|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14469282|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14469283|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14469284|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
14469285|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
14448643|NCT01976312|Ranibizumab|ranibizumab|mesh-list
14930238|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14930239|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14930240|NCT01432028|Progestins|progestins|mesh-ancestor
14930241|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14930242|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
14930243|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14448644|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14448645|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14448646|NCT01976312|Growth Substances|growth substances|mesh-ancestor
14448647|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448648|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
14448649|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448650|NCT01976338|Ranibizumab|ranibizumab|mesh-list
14448651|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14448652|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14448653|NCT01976338|Growth Substances|growth substances|mesh-ancestor
14448654|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448655|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
14448656|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448657|NCT01976364|Methotrexate|methotrexate|mesh-list
14448658|NCT01976364|Tofacitinib|tofacitinib|mesh-list
14448659|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14448660|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
14448661|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14448662|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448663|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14448664|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
14448665|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448666|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448667|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448668|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448669|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14448670|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14448671|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
14448672|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448673|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14448674|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14448675|NCT01976390|Sirolimus|sirolimus|mesh-list
14448676|NCT01976390|Everolimus|everolimus|mesh-list
14448677|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448678|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14448679|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
14448680|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448681|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14448682|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448683|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14448684|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
14448685|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
14448686|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448687|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
14448688|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448689|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448690|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14448691|NCT01976507|Dabigatran|dabigatran|mesh-list
14448692|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
14448693|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14448694|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
14448695|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448696|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448697|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
14448698|NCT01976572|Candesartan|candesartan|mesh-list
14448699|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14448700|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14448701|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14448702|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448703|NCT01976624|Timolol|timolol|mesh-list
14448704|NCT01976624|Bimatoprost|bimatoprost|mesh-list
14448705|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14448706|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14448707|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
14448708|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448709|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448710|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448711|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14448712|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14448713|NCT01976650|Dexamethasone|dexamethasone|mesh-list
14448714|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448715|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
14448716|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
14448717|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448718|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448719|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448720|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
14448721|NCT01976650|Hormones|hormones|mesh-ancestor
14448722|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448723|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14448724|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448725|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14448726|NCT01976728|Hormones|hormones|mesh-ancestor
14448727|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448728|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448729|NCT01976806|Aspirin|aspirin|mesh-list
14448730|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14448731|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14448732|NCT01976806|Analgesics|analgesics|mesh-ancestor
14448733|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
14448734|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448735|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448736|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448737|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448738|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14448739|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14448740|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752420|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14448741|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14448742|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14448743|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448744|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
14448745|NCT01976845|Midazolam|midazolam|mesh-list
14448746|NCT01976845|Propofol|propofol|mesh-list
14448747|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14448748|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448749|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448750|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14448751|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
14448752|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
14448753|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14448754|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14448755|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14448756|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14448757|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
14448758|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
14448759|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448760|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448761|NCT01976871|Rotigotine|rotigotine|mesh-list
14448762|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
14448763|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
14448764|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448765|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448766|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448767|NCT01976988|Heparin|heparin|mesh-list
14448768|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
14448769|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14448770|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14448771|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448772|NCT01977352|Bupivacaine|bupivacaine|mesh-list
14448773|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
14448774|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
14448775|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448776|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448777|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
14448778|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448779|NCT01977456|Eptifibatide|eptifibatide|mesh-list
14448780|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14448781|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14448782|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14448783|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448784|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14448785|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14448786|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448787|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448788|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
14448789|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448790|NCT01977677|Plerixafor|plerixafor|mesh-list
14448791|NCT01977677|Temozolomide|temozolomide|mesh-list
14448792|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14448793|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
14448794|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448795|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448796|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14448797|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14448798|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
14448799|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448800|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
14448801|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14448802|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14448803|NCT01977781|Prednisolone|prednisolone|mesh-list
14448804|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
14448805|NCT01977781|Tacrolimus|tacrolimus|mesh-list
14448806|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14448807|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
14448808|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14448809|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
14448810|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448811|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14448812|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448813|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448814|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448815|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
14448816|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
14448817|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448818|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448819|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
14448820|NCT01977781|Hormones|hormones|mesh-ancestor
14448821|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448822|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14448823|NCT01977781|Protective Agents|protective agents|mesh-ancestor
14448824|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14448825|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448826|NCT01977794|Amlodipine|amlodipine|mesh-list
14448827|NCT01977794|Bisoprolol|bisoprolol|mesh-list
14448828|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14448829|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14448830|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14448831|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448832|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14448833|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448834|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
14448835|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
14448836|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
14448837|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448838|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14448839|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14448840|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14448841|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14448842|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448843|NCT01977898|Morphine|morphine|mesh-list
14448844|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14448845|NCT01977898|Narcotics|narcotics|mesh-ancestor
14448846|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448847|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448848|NCT01977898|Analgesics|analgesics|mesh-ancestor
14448849|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
14448850|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448851|NCT01977937|Gabapentin|gabapentin|mesh-list
14448852|NCT01977937|Analgesics|analgesics|mesh-ancestor
14448853|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
14448854|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448855|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448856|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
14448857|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14448858|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14448859|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14448860|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14448861|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14448862|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14448863|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448864|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448865|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
14448866|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14448867|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
14448868|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448869|NCT01978184|Gemcitabine|gemcitabine|mesh-list
14448870|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
14448871|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14448872|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14448873|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
14448874|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448875|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448876|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
14448877|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448878|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448879|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14448880|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
14448881|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448882|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
14448883|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14448884|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14448885|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448886|NCT01978236|Trametinib|trametinib|mesh-list
14448887|NCT01978236|Dabrafenib|dabrafenib|mesh-list
14448888|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448889|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14448890|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448891|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448892|NCT01978600|Timolol|timolol|mesh-list
14448893|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14448894|NCT01978600|Brinzolamide|brinzolamide|mesh-list
14448895|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14448896|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14448897|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
14448898|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448899|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448900|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448901|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14448902|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14448903|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448904|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14448905|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14448906|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14448907|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14448908|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
14448909|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14448910|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14448911|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
14448912|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14448913|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14448914|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14448915|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448916|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448917|NCT01979016|Emollients|emollients|mesh-list
14448918|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
14448919|NCT01979185|Simvastatin|simvastatin|mesh-list
14448920|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14448921|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14448922|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
14448923|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448924|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14448925|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14448926|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448927|NCT01979276|Dexamethasone|dexamethasone|mesh-list
14448928|NCT01979276|Pomalidomide|pomalidomide|mesh-list
14448929|NCT01979276|Romidepsin|romidepsin|mesh-list
14448930|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448931|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
14448932|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
14752421|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14448933|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448934|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448935|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448936|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
14448937|NCT01979276|Hormones|hormones|mesh-ancestor
14448938|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448939|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14448940|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448941|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
14448942|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14448943|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14448944|NCT01979276|Growth Substances|growth substances|mesh-ancestor
14448945|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
14448946|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14448947|NCT01979445|Clopidogrel|clopidogrel|mesh-list
14448948|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14448949|NCT01979445|Cangrelor|cangrelor|mesh-list
14448950|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14448951|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14448952|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14448953|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14448954|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
14448955|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448956|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448957|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448958|NCT01979523|Trametinib|trametinib|mesh-list
14448959|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448960|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14448961|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448962|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448963|NCT01979952|Nintedanib|nintedanib|mesh-list
14448964|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448965|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14448966|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14448967|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448968|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
14448969|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
14448970|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448971|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
14448972|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14448973|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448974|NCT01980524|Acipimox|acipimox|mesh-list
14448975|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14448976|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
14448977|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448978|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14448979|NCT01980589|Dexamethasone|dexamethasone|mesh-list
14448980|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
14448981|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14448982|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
14448983|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14448984|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14448985|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14448986|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
14448987|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14448988|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14448989|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14448990|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14448991|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
14448992|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
14448993|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14448994|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14448995|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
14448996|NCT01980589|Hormones|hormones|mesh-ancestor
14448997|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14448998|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14930244|NCT01432028|Diuretics|diuretics|mesh-ancestor
14448999|NCT01980654|Rituximab|rituximab|mesh-list
14449000|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14449001|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449002|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
14449003|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449004|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449005|NCT01980706|Baclofen|baclofen|mesh-list
14449006|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14449007|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449008|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14449009|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449010|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14449011|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
14449012|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
14449013|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449014|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449015|NCT01980888|Rituximab|rituximab|mesh-list
14449016|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14449017|NCT01980888|Idelalisib|idelalisib|mesh-list
14449018|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14449019|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449020|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
14449021|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449022|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449023|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14449024|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
14449025|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449026|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449027|NCT01981473|Infliximab|infliximab|mesh-list
14449028|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449029|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449030|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449031|NCT01981616|Vedolizumab|vedolizumab|mesh-list
14449032|NCT01981616|Vaccines|vaccines|mesh-list
14449033|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
14449034|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449035|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449036|NCT01981759|Cycloserine|cycloserine|mesh-list
14449037|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14449038|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449039|NCT01981759|Renal Agents|renal agents|mesh-ancestor
14449040|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14449041|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
14449042|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14449043|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
14449044|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449045|NCT01981772|Lidocaine|lidocaine|mesh-list
14449046|NCT01981772|Epinephrine|epinephrine|mesh-list
14449047|NCT01981772|Racepinephrine|racepinephrine|mesh-list
14752422|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14752423|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752424|NCT05338086|Vitamin D|vitamin d|mesh-list
14752425|NCT05338086|Denosumab|denosumab|mesh-list
14752426|NCT05338086|Calcium|calcium|mesh-list
14752427|NCT05338086|Vitamins|vitamins|mesh-ancestor
14752428|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
14752429|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449048|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
14449049|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
14449050|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
14752430|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14449051|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449052|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449053|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
14449054|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449055|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14449056|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14449057|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14449058|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14449059|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449060|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14449061|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14449062|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
14449063|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449064|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14449065|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14449066|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
14449067|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14449068|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
14449069|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
14449070|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
14449071|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14449072|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
14449073|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14449074|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14449075|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449076|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
14449077|NCT01981863|Coagulants|coagulants|mesh-ancestor
14449078|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
14449079|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14449080|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14449081|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
14449082|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449083|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449084|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449085|NCT01981954|Urological Agents|urological agents|mesh-ancestor
14449086|NCT01981967|Vaccines|vaccines|mesh-list
14449087|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
14449088|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449089|NCT01982123|Edetic Acid|edetic acid|mesh-list
14449090|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
14449091|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
14449092|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
14449093|NCT01982123|Antidotes|antidotes|mesh-ancestor
14449094|NCT01982123|Protective Agents|protective agents|mesh-ancestor
14449095|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449096|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
14449097|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
14449098|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449099|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14449100|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
14449101|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14449102|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14449103|NCT01982240|Bisacodyl|bisacodyl|mesh-list
14449104|NCT01982240|Plecanatide|plecanatide|mesh-list
14449105|NCT01982240|Cathartics|cathartics|mesh-ancestor
14449106|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449107|NCT01982240|Laxatives|laxatives|mesh-ancestor
14449108|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14449109|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
14449110|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449111|NCT01982331|Vaccines|vaccines|mesh-list
14449112|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
14449113|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449114|NCT01982435|Ranibizumab|ranibizumab|mesh-list
14449115|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14449116|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14449117|NCT01982435|Growth Substances|growth substances|mesh-ancestor
14449118|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449119|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
14449120|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449121|NCT01982539|Diclofenac|diclofenac|mesh-list
14449122|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14449123|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14449124|NCT01982539|Analgesics|analgesics|mesh-ancestor
14449125|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
14449126|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449127|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449128|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14449129|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449130|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14449131|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449132|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449133|NCT01982643|Naltrexone|naltrexone|mesh-list
14449134|NCT01982643|Bupropion|bupropion|mesh-list
14449135|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14449136|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14449137|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449138|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
14449139|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449140|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14449141|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
14449142|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14449143|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14449144|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14449145|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14752431|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14752432|NCT05338021|Vancomycin|vancomycin|mesh-list
14752433|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752434|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752435|NCT05338008|Vancomycin|vancomycin|mesh-list
14752436|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752437|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752438|NCT05337969|Metformin|metformin|mesh-list
14752439|NCT05337969|Vildagliptin|vildagliptin|mesh-list
14752440|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14752441|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449146|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449147|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
14449148|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449149|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14449150|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14449151|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449152|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
14449153|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
14449154|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14449155|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
14449156|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449157|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449158|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14449159|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
14449160|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449161|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449162|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14449163|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14449164|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14449165|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
14449166|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14449167|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449168|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449169|NCT01982695|Losartan|losartan|mesh-list
14449170|NCT01982695|Lisinopril|lisinopril|mesh-list
14449171|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14449172|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14449173|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14449174|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14449175|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449176|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14449177|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
14449178|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449179|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14449180|NCT01982695|Protective Agents|protective agents|mesh-ancestor
14449181|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449182|NCT01982812|Levetiracetam|levetiracetam|mesh-list
14449183|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
14449184|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
14449185|NCT01982942|Ibudilast|ibudilast|mesh-list
14449186|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14449187|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
14449188|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449189|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449190|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14449191|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
14449192|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14449193|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449194|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449195|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14449196|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
14469286|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469287|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469288|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14469289|NCT02292082|Protective Agents|protective agents|mesh-ancestor
14469290|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14469291|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469292|NCT02292719|Ritonavir|ritonavir|mesh-list
14469293|NCT02292719|Ribavirin|ribavirin|mesh-list
14469294|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
14469295|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14469296|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14469297|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14469298|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469299|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449197|NCT01982955|Carboplatin|carboplatin|mesh-list
14449198|NCT01982955|Pemetrexed|pemetrexed|mesh-list
14449199|NCT01982955|Gefitinib|gefitinib|mesh-list
14449200|NCT01982955|Tepotinib|tepotinib|mesh-list
14449201|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449202|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449203|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449204|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14449205|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14449206|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14449207|NCT01983020|Lidocaine|lidocaine|mesh-list
14449208|NCT01983020|Ketamine|ketamine|mesh-list
14449209|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
14449210|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
14449211|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449212|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449213|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
14449214|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449215|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14449216|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14449217|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14449218|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14449219|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449220|NCT01983020|Analgesics|analgesics|mesh-ancestor
14449221|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14449222|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14449223|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
14449224|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14449225|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14449226|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449227|NCT01983111|Acetaminophen|acetaminophen|mesh-list
14449228|NCT01983111|Buprenorphine|buprenorphine|mesh-list
14449229|NCT01983111|Tramadol|tramadol|mesh-list
14449230|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14449231|NCT01983111|Analgesics|analgesics|mesh-ancestor
14449232|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
14449233|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449234|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449235|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
14449236|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14449237|NCT01983111|Narcotics|narcotics|mesh-ancestor
14449238|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449239|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14449240|NCT01983566|Omeprazole|omeprazole|mesh-list
14449241|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14449242|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449243|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14449244|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449245|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449246|NCT01983683|Vancomycin|vancomycin|mesh-list
14449247|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
14449248|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14449249|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449250|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14449251|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449252|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449253|NCT01983878|Ramucirumab|ramucirumab|mesh-list
14449254|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449255|NCT01983969|Pyridoxine|pyridoxine|mesh-list
14449256|NCT01983969|Gemcitabine|gemcitabine|mesh-list
14449257|NCT01983969|Dexamethasone|dexamethasone|mesh-list
14449258|NCT01983969|Rituximab|rituximab|mesh-list
14449259|NCT01983969|Azacitidine|azacitidine|mesh-list
14449260|NCT01983969|Melphalan|melphalan|mesh-list
14449261|NCT01983969|Busulfan|busulfan|mesh-list
14449262|NCT01983969|Vorinostat|vorinostat|mesh-list
14449263|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14449264|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
14449265|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
14449266|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449267|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449268|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449269|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
14449270|NCT01983969|Hormones|hormones|mesh-ancestor
14449271|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449272|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14449273|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449274|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14449275|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
14449276|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449277|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14449278|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
14449279|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449280|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
14449281|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449282|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449283|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14449284|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14449285|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
14449286|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14449287|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14449288|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
14449289|NCT01983969|Vitamins|vitamins|mesh-ancestor
14449290|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
14449291|NCT01984164|Candesartan|candesartan|mesh-list
14449292|NCT01984164|Lisinopril|lisinopril|mesh-list
14449293|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14449294|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14449295|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14449296|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449297|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14449298|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
14449299|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449300|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14449301|NCT01984164|Protective Agents|protective agents|mesh-ancestor
14449302|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449303|NCT01984229|Posaconazole|posaconazole|mesh-list
14449304|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
14449305|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449306|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14449307|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14449308|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14449309|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14449310|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14449311|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449312|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449313|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14449314|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
14449315|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449316|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449317|NCT01984242|Bevacizumab|bevacizumab|mesh-list
14449318|NCT01984242|Sunitinib|sunitinib|mesh-list
14449319|NCT01984242|Atezolizumab|atezolizumab|mesh-list
14449320|NCT01984242|Antibodies|antibodies|mesh-list
14449321|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14449322|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14449323|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449324|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14449325|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14449326|NCT01984242|Growth Substances|growth substances|mesh-ancestor
14449327|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449328|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14449329|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
14449330|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14449331|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449332|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449333|NCT01984294|Ribavirin|ribavirin|mesh-list
14449334|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
14449335|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449336|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
14449337|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449338|NCT01984398|Citric Acid|citric acid|mesh-list
14449339|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
14449340|NCT01984398|Enclomiphene|enclomiphene|mesh-list
14449341|NCT01984398|Clomiphene|clomiphene|mesh-list
14449342|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
14449343|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
14449344|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14449345|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
14449346|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
14449347|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449348|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14449349|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
14449350|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449351|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449352|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14449353|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
14449354|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14449355|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14449356|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14449357|NCT01984424|Atorvastatin|atorvastatin|mesh-list
14449358|NCT01984424|Ezetimibe|ezetimibe|mesh-list
14449359|NCT01984424|Evolocumab|evolocumab|mesh-list
14449360|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14449361|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14449362|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14449363|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
14449364|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449365|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14449366|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14449367|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449368|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
14449369|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449370|NCT01984684|Vancomycin|vancomycin|mesh-list
14449371|NCT01984684|Aztreonam|aztreonam|mesh-list
14449372|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14449373|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449374|NCT01984892|Poly ICLC|poly iclc|mesh-list
14449375|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
14449376|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
14449377|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449378|NCT01985126|Acetaminophen|acetaminophen|mesh-list
14449379|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
14449380|NCT01985126|Promethazine|promethazine|mesh-list
14449381|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
14449382|NCT01985126|Daratumumab|daratumumab|mesh-list
14449383|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14449384|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14449385|NCT01985126|Analgesics|analgesics|mesh-ancestor
14449386|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
14449387|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449388|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449389|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
14449390|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14449391|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
14449392|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
14449393|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449394|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
14449395|NCT01985126|Hormones|hormones|mesh-ancestor
14449396|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449397|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14449398|NCT01985126|Protective Agents|protective agents|mesh-ancestor
14449399|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449400|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
14449401|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14449402|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14449403|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449404|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
14449405|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
14449406|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14449407|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
14449408|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
14449409|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449410|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449411|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14449412|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
14449413|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449414|NCT01985321|Ethanol|ethanol|mesh-list
14449415|NCT01985321|Glycolic acid|glycolic acid|mesh-list
14449416|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14449417|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449418|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449419|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449420|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
14449421|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449422|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
14449423|NCT01985334|Bromides|bromides|mesh-list
14449424|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
14449425|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449426|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14449427|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14449428|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14449429|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
14449430|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449431|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449432|NCT01985425|Colchicine|colchicine|mesh-list
14449433|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
14449434|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449435|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
14449436|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
14449437|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
14449438|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449439|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449440|NCT01985581|Guanfacine|guanfacine|mesh-list
14449441|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14449442|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14449443|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14449444|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14449445|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14449446|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449447|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449448|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449449|NCT01985685|Thiamine|thiamine|mesh-list
14449450|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
14449451|NCT01985685|Vitamins|vitamins|mesh-ancestor
14449452|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
14449453|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449454|NCT01985763|Genistein|genistein|mesh-list
14449455|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14449456|NCT01985763|Protective Agents|protective agents|mesh-ancestor
14449457|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449458|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449459|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14449460|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449461|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449462|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
14449463|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14449464|NCT01985763|Estrogens|estrogens|mesh-ancestor
14449465|NCT01985763|Hormones|hormones|mesh-ancestor
14449466|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449467|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
14449468|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14449469|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
14449470|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449471|NCT01986010|Antacids|antacids|mesh-ancestor
14449472|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449473|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449474|NCT01986062|Amphetamine|amphetamine|mesh-list
14449475|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14449476|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449477|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
14449478|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
14449479|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449480|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
14449481|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449482|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449483|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14449484|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14449485|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14449486|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14449487|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14449488|NCT01986231|Glucagon|glucagon|mesh-list
14449489|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449490|NCT01986231|Hormones|hormones|mesh-ancestor
14449491|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449492|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449493|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
14449494|NCT01986361|Analgesics|analgesics|mesh-ancestor
14449495|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
14449496|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449497|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449498|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14449499|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14449500|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14449501|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449502|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14449503|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449504|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449505|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
14449506|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14449507|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449508|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14449509|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449510|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
14449511|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14449512|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449513|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14449514|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449515|NCT01986907|Ranibizumab|ranibizumab|mesh-list
14449516|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14449517|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14449518|NCT01986907|Growth Substances|growth substances|mesh-ancestor
14449519|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449520|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
14449521|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449522|NCT01986946|Hydromorphone|hydromorphone|mesh-list
14449523|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14449524|NCT01986946|Narcotics|narcotics|mesh-ancestor
14449525|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449526|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449527|NCT01986946|Analgesics|analgesics|mesh-ancestor
14449528|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
14449529|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449530|NCT01987102|Leucovorin|leucovorin|mesh-list
14449531|NCT01987102|Calcium|calcium|mesh-list
14449532|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
14449533|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14449534|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449535|NCT01987102|Antidotes|antidotes|mesh-ancestor
14449536|NCT01987102|Protective Agents|protective agents|mesh-ancestor
14449537|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
14449538|NCT01987102|Vitamins|vitamins|mesh-ancestor
14449539|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
14449540|NCT01987219|Bromides|bromides|mesh-list
14449541|NCT01987219|Albuterol|albuterol|mesh-list
14449542|NCT01987219|Ipratropium|ipratropium|mesh-list
14449543|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
14449544|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14449545|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
14449546|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449547|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449548|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14449549|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
14449550|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
14449551|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14469300|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14449552|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14449553|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14449554|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14449555|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
14449556|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449557|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449558|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14449559|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
14449560|NCT01987232|Carboplatin|carboplatin|mesh-list
14449561|NCT01987232|Etoposide|etoposide|mesh-list
14449562|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449563|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14449564|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14449565|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14449566|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449567|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449568|NCT01987427|Phentermine|phentermine|mesh-list
14449569|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14449570|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449571|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
14449572|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14449573|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
14449574|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
14449575|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449576|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
14449577|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449578|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449579|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
14449580|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14449581|NCT01987453|Ledipasvir|ledipasvir|mesh-list
14449582|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
14449583|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449584|NCT01987479|Methotrexate|methotrexate|mesh-list
14449585|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14449586|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
14449587|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14449588|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449589|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14449590|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
14449591|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449592|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449593|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449594|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449595|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14449596|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14449597|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
14449598|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449599|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14449600|NCT01987505|Rituximab|rituximab|mesh-list
14449601|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14449602|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449603|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
14449604|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449605|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449606|NCT01987596|Lenograstim|lenograstim|mesh-list
14449607|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14449608|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
14449609|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449610|NCT01987752|Timolol|timolol|mesh-list
14449611|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14449612|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14449613|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
14449614|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14449615|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14449616|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14449617|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
14449618|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449619|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449620|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449621|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14449622|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14449623|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14449624|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14449625|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14449626|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14449627|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14449628|NCT01987895|Vancomycin|vancomycin|mesh-list
14449629|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
14449630|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14449631|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449632|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14449633|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449634|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449635|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
14449636|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
14449637|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449638|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449639|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449640|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
14449641|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
14449642|NCT01988090|Vitamin D|vitamin d|mesh-list
14449643|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
14449644|NCT01988090|Vitamins|vitamins|mesh-list
14449645|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
14449646|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449647|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14449648|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14449649|NCT01988103|Thalidomide|thalidomide|mesh-list
14449650|NCT01988103|Apremilast|apremilast|mesh-list
14449651|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14449652|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14449653|NCT01988103|Analgesics|analgesics|mesh-ancestor
14449654|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
14449655|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449656|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449657|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14449658|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449659|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14449660|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14449661|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449662|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449663|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14449664|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
14449665|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
14449666|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14449667|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449668|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14449669|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14449670|NCT01988103|Growth Substances|growth substances|mesh-ancestor
14449671|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
14449672|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449673|NCT01988246|Aflibercept|aflibercept|mesh-list
14449674|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14449675|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14449676|NCT01988246|Growth Substances|growth substances|mesh-ancestor
14449677|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449678|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
14449679|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449680|NCT01988402|Allopurinol|allopurinol|mesh-list
14449681|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
14449682|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449683|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449684|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
14449685|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449686|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14449687|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
14449688|NCT01988402|Protective Agents|protective agents|mesh-ancestor
14449689|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449690|NCT01988662|Ranibizumab|ranibizumab|mesh-list
14449691|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14449692|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14449693|NCT01988662|Growth Substances|growth substances|mesh-ancestor
14449694|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449695|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
14449696|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449697|NCT01988779|Levofloxacin|levofloxacin|mesh-list
14449698|NCT01988779|Ofloxacin|ofloxacin|mesh-list
14449699|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14449700|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449701|NCT01988779|Renal Agents|renal agents|mesh-ancestor
14449702|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14449703|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14449704|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14449705|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449706|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449707|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449708|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14449709|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14449710|NCT01988922|Ketamine|ketamine|mesh-list
14449711|NCT01988922|Analgesics|analgesics|mesh-ancestor
14449712|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
14449713|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449714|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449715|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14449716|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14449717|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
14449718|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
14449719|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449720|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14449721|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14449722|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449723|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449724|NCT01989156|Menthol|menthol|mesh-list
14449725|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
14449726|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449727|NCT01989169|Midazolam|midazolam|mesh-list
14449728|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14449729|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14449730|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930245|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
14449731|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449732|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14449733|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14449734|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14449735|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14449736|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
14449737|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
14449738|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
14449739|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
14449740|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449741|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449742|NCT01989195|Manganese|manganese|mesh-list
14449743|NCT01989195|Trace Elements|trace elements|mesh-ancestor
14449744|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
14449745|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449746|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
14449747|NCT01989208|Cathartics|cathartics|mesh-ancestor
14449748|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449749|NCT01989221|Granisetron|granisetron|mesh-list
14449750|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
14449751|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
14449752|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449753|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449754|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449755|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14449756|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
14449757|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449758|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449759|NCT01989455|Deferiprone|deferiprone|mesh-list
14449760|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14449761|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
14449762|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
14449763|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449764|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14449765|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
14449766|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449767|NCT01989546|Talazoparib|talazoparib|mesh-list
14449768|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14449769|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449770|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449771|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449772|NCT01989572|Sargramostim|sargramostim|mesh-list
14449773|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
14449774|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449775|NCT01989689|Etanercept|etanercept|mesh-list
14449776|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14449777|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14449778|NCT01989689|Analgesics|analgesics|mesh-ancestor
14449779|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
14449780|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449781|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449782|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14449783|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449784|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449785|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14449786|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
14449787|NCT01989754|Canagliflozin|canagliflozin|mesh-list
14449788|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14449789|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449790|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14449791|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469301|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14469302|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
14469303|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469304|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14469305|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14469306|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
14469307|NCT02292771|Vasotocin|vasotocin|mesh-list
14469308|NCT02292771|Atosiban|atosiban|mesh-list
14469309|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469310|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469311|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469312|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
14469313|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14469314|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
14469315|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14469316|NCT02292784|Atosiban|atosiban|mesh-list
14469317|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469318|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469319|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469320|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
14469321|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14469322|NCT02293096|Metoprolol|metoprolol|mesh-list
14469323|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
14752442|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14469324|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14449792|NCT01989793|Losartan|losartan|mesh-list
14449793|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14752443|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
14752444|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752445|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753734|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753735|NCT05011266|Analgesics|analgesics|mesh-ancestor
14753736|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
14753737|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753738|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14753739|NCT05008887|Fluorouracil|fluorouracil|mesh-list
14753740|NCT05008887|Methotrexate|methotrexate|mesh-list
14753741|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
14753742|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753743|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753744|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753745|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14753746|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
14753747|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753748|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14753749|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
14753750|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14753751|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
14753752|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753753|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14449794|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14449795|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14449796|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14449797|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449798|NCT01989910|Efavirenz|efavirenz|mesh-list
14449799|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
14449800|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14449801|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14449802|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449803|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449804|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
14449805|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449806|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14449807|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14449808|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14449809|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14449810|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14449811|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14449812|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14449813|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14449814|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14449815|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14449816|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14449817|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449818|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14449819|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449820|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449821|NCT01990300|Pioglitazone|pioglitazone|mesh-list
14449822|NCT01990300|Alogliptin|alogliptin|mesh-list
14449823|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14449824|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449825|NCT01990300|Incretins|incretins|mesh-ancestor
14449826|NCT01990300|Hormones|hormones|mesh-ancestor
14449827|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449828|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14449829|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
14449830|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449831|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449832|NCT01990339|Lansoprazole|lansoprazole|mesh-list
14449833|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
14449834|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14449835|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14449836|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14449837|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449838|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449839|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14449840|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14449841|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449842|NCT01990560|Mifepristone|mifepristone|mesh-list
14449843|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14449844|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
14449845|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14449846|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449847|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14449848|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14449849|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14449850|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
14449851|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14449852|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14449853|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
14449854|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449855|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
14449856|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14449857|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14449858|NCT01990573|Methadone|methadone|mesh-list
14449859|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14449860|NCT01990573|Narcotics|narcotics|mesh-ancestor
14449861|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449862|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449863|NCT01990573|Analgesics|analgesics|mesh-ancestor
14449864|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
14449865|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449866|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
14449867|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
14449868|NCT01990677|Eplerenone|eplerenone|mesh-list
14449869|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14449870|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
14449871|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449872|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449873|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14449874|NCT01990677|Diuretics|diuretics|mesh-ancestor
14449875|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
14449876|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14449877|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
14449878|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14449879|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
14449880|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14449881|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449882|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14449883|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14449884|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14449885|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
14449886|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14449887|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14449888|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449889|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
14449890|NCT01990768|Coagulants|coagulants|mesh-ancestor
14449891|NCT01990859|Ipilimumab|ipilimumab|mesh-list
14449892|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14449893|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449894|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14449895|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449896|NCT01990898|Cyclosporine|cyclosporine|mesh-list
14449897|NCT01990898|Cyclosporins|cyclosporins|mesh-list
14449898|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469325|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14449899|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449900|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14449901|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
14449902|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449903|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
14449904|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14449905|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449906|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14449907|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14449908|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14449909|NCT01991197|Gliclazide|gliclazide|mesh-list
14449910|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14449911|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449912|NCT01991197|Incretins|incretins|mesh-ancestor
14449913|NCT01991197|Hormones|hormones|mesh-ancestor
14449914|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14449915|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14449916|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
14449917|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449918|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449919|NCT01991548|Insulin|insulin|mesh-list
14449920|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14449921|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449922|NCT01991743|Bupivacaine|bupivacaine|mesh-list
14449923|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
14449924|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
14449925|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449926|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449927|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
14449928|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14449929|NCT01991795|Ticagrelor|ticagrelor|mesh-list
14449930|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14449931|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14449932|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14449933|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14449934|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
14449935|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449936|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449937|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449938|NCT01991860|Amisulpride|amisulpride|mesh-list
14930246|NCT01432080|Azithromycin|azithromycin|mesh-list
14930247|NCT01432080|Prednisone|prednisone|mesh-list
14930248|NCT01432080|Budesonide|budesonide|mesh-list
14930249|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
14930250|NCT01432080|Montelukast|montelukast|mesh-list
14930251|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14930252|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930253|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
14449939|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14449940|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14449941|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14449942|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449943|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14449944|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14449945|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
14449946|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449947|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449948|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14449949|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
14449950|NCT01991977|Temozolomide|temozolomide|mesh-list
14449951|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14449952|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
14449953|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449954|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449955|NCT01992016|Ranolazine|ranolazine|mesh-list
14449956|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14449957|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14449958|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449959|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
14449960|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14449961|NCT01992172|Protective Agents|protective agents|mesh-ancestor
14449962|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449963|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449964|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
14449965|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14449966|NCT01992185|Protective Agents|protective agents|mesh-ancestor
14449967|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449968|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
14449969|NCT01992523|Ticagrelor|ticagrelor|mesh-list
14449970|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14449971|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14449972|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14449973|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14449974|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
14449975|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449976|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449977|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449978|NCT01992874|Niacinamide|niacinamide|mesh-list
14449979|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
14449980|NCT01992874|Vitamins|vitamins|mesh-ancestor
14449981|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
14930254|NCT01432080|Hormones|hormones|mesh-ancestor
14930255|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930256|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930257|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14930258|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14449982|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449983|NCT01993017|Bupropion|bupropion|mesh-list
14930259|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14449984|NCT01993017|Sertraline|sertraline|mesh-list
14449985|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
14449986|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14449987|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14449988|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14449989|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14449990|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14449991|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14449992|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
14449993|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14449994|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14449995|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14449996|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14449997|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14449998|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14449999|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
14450000|NCT01993108|Naltrexone|naltrexone|mesh-list
14450001|NCT01993108|Methylphenidate|methylphenidate|mesh-list
14450002|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14450003|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14450004|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450005|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
14450006|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450007|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14450008|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14450009|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14450010|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450011|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450012|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
14450013|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450014|NCT01993186|Glycerol|glycerol|mesh-list
14450015|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14450016|NCT01993186|Protective Agents|protective agents|mesh-ancestor
14450017|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450018|NCT01993329|Mitomycin|mitomycin|mesh-list
14450019|NCT01993329|Cisplatin|cisplatin|mesh-list
14450020|NCT01993329|Ifosfamide|ifosfamide|mesh-list
14450021|NCT01993329|Mesna|mesna|mesh-list
14450022|NCT01993329|Protective Agents|protective agents|mesh-ancestor
14450023|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450024|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
14450025|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450026|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14450027|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450028|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14450029|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450030|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14450031|NCT01993667|Acetazolamide|acetazolamide|mesh-list
14450032|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
14450033|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14450034|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469326|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
14450035|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450036|NCT01993667|Diuretics|diuretics|mesh-ancestor
14450037|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
14450038|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450039|NCT01993823|Clotrimazole|clotrimazole|mesh-list
14450040|NCT01993823|Miconazole|miconazole|mesh-list
14450041|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14450042|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450043|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
14450044|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14450045|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14450046|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450047|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450048|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14450049|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
14450050|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450051|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450052|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14450053|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14450054|NCT01993836|Anesthetics|anesthetics|mesh-list
14450055|NCT01993836|Propofol|propofol|mesh-list
14450056|NCT01993836|Isoflurane|isoflurane|mesh-list
14450057|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450058|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450059|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14450060|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14450061|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
14450062|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14450063|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
14450064|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14450065|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
14450066|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450067|NCT01993849|Expectorants|expectorants|mesh-ancestor
14450068|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
14450069|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14450070|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
14450071|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450072|NCT01993849|Protective Agents|protective agents|mesh-ancestor
14450073|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450074|NCT01993849|Antidotes|antidotes|mesh-ancestor
14450075|NCT01993875|Lubiprostone|lubiprostone|mesh-list
14450076|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14450077|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450078|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450079|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14450080|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
14450081|NCT01993888|Coagulants|coagulants|mesh-ancestor
14450082|NCT01993927|Voglibose|voglibose|mesh-list
14450083|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14469327|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
14450084|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450085|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14450086|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450087|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450088|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14450089|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
14450090|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14450091|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450092|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450093|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
14450094|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450095|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450096|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14450097|NCT01994226|Naproxen|naproxen|mesh-list
14450098|NCT01994226|Colchicine|colchicine|mesh-list
14450099|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14450100|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450101|NCT01994226|Analgesics|analgesics|mesh-ancestor
14450102|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
14450103|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450104|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450105|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450106|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450107|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
14450108|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14450109|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450110|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450111|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
14450112|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
14450113|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
14450114|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450115|NCT01994291|Ranibizumab|ranibizumab|mesh-list
14450116|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14450117|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14450118|NCT01994291|Growth Substances|growth substances|mesh-ancestor
14450119|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450120|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
14450121|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450122|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
14450123|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
14450124|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450125|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
14450126|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14450127|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14450128|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
14450129|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450130|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450131|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450132|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
14450133|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
14450134|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450135|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
14450136|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14450137|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
14450138|NCT01994590|Prednisone|prednisone|mesh-list
14450139|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
14450140|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450141|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
14450142|NCT01994590|Hormones|hormones|mesh-ancestor
14450143|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450144|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450145|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14450146|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450147|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14450148|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450149|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450150|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
14450151|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14450152|NCT01994720|Aspirin|aspirin|mesh-list
14450153|NCT01994720|Ticagrelor|ticagrelor|mesh-list
14450154|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14450155|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14450156|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14450157|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14450158|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
14450159|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450160|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450161|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450162|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14450163|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450164|NCT01994720|Analgesics|analgesics|mesh-ancestor
14450165|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
14450166|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450167|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450168|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450169|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14450170|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14450171|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14450172|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450173|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
14450174|NCT01994746|Glucagon|glucagon|mesh-list
14450175|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14450176|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450177|NCT01994746|Hormones|hormones|mesh-ancestor
14450178|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752446|NCT05337657|Letrozole|letrozole|mesh-list
14450179|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450180|NCT01994746|Incretins|incretins|mesh-ancestor
14450181|NCT01994837|Venetoclax|venetoclax|mesh-list
14450182|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450183|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14450184|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450185|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450186|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14450187|NCT01994993|Metronidazole|metronidazole|mesh-list
14450188|NCT01994993|Clindamycin|clindamycin|mesh-list
14450189|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
14450190|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
14450191|NCT01994993|Gentamicins|gentamicins|mesh-list
14450192|NCT01994993|Tazobactam|tazobactam|mesh-list
14450193|NCT01994993|Piperacillin|piperacillin|mesh-list
14450194|NCT01994993|Ampicillin|ampicillin|mesh-list
14450195|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14450196|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450197|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14450198|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14450199|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14450200|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450201|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450202|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14450203|NCT01995045|Triamcinolone|triamcinolone|mesh-list
14450204|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14450205|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14450206|NCT01995045|Bupivacaine|bupivacaine|mesh-list
14450207|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14450208|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
14450209|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
14450210|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450211|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450212|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
14450213|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450214|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450215|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
14450216|NCT01995045|Hormones|hormones|mesh-ancestor
14450217|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450218|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450219|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
14450220|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450221|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450222|NCT01995071|Ribavirin|ribavirin|mesh-list
14450223|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
14450224|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450225|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
14450226|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450227|NCT01995136|Travoprost|travoprost|mesh-list
14450228|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14450229|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14450230|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14450231|NCT01995201|Methotrexate|methotrexate|mesh-list
14450232|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14450233|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
14450234|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14450235|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450236|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450237|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
14450238|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450239|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450240|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
14450241|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450242|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14450243|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450244|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
14450245|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450246|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14450247|NCT01995266|Asunaprevir|asunaprevir|mesh-list
14450248|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
14450249|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450250|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450251|NCT01995513|Prednisone|prednisone|mesh-list
14450252|NCT01995513|Prednisolone|prednisolone|mesh-list
14450253|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
14450254|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450255|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
14450256|NCT01995513|Hormones|hormones|mesh-ancestor
14450257|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450258|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450259|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14450260|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450261|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14450262|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450263|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450264|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
14450265|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14450266|NCT01995526|Insulin|insulin|mesh-list
14450267|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450268|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450269|NCT01995825|Lamotrigine|lamotrigine|mesh-list
14450270|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
14450271|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14450272|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450273|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450274|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14450275|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450276|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14450277|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14450278|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450279|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14450280|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14469328|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469329|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469330|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14469331|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14469332|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14469333|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
14469334|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469335|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469336|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
14469337|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469338|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14469339|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14469340|NCT02293395|Aspirin|aspirin|mesh-list
14469341|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
14450281|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14450282|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450283|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14450284|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450285|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450286|NCT01996657|Warfarin|warfarin|mesh-list
14450287|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
14450288|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14450289|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
14450290|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14450291|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14450292|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450293|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
14450294|NCT01996826|Bevacizumab|bevacizumab|mesh-list
14450295|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14450296|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450297|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450298|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14450299|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14450300|NCT01996826|Growth Substances|growth substances|mesh-ancestor
14450301|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450302|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14450303|NCT01996826|Laxatives|laxatives|mesh-ancestor
14450304|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450305|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14450306|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14450307|NCT01996943|Ethanol|ethanol|mesh-list
14450308|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14450309|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450310|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450311|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450312|NCT01997229|Eculizumab|eculizumab|mesh-list
14450313|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14450314|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450315|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
14450316|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450317|NCT01997333|Capecitabine|capecitabine|mesh-list
14450318|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450319|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
14450320|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450321|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450322|NCT01997411|Glucagon|glucagon|mesh-list
14450323|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14450324|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450325|NCT01997411|Hormones|hormones|mesh-ancestor
14450326|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450327|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450328|NCT01997411|Incretins|incretins|mesh-ancestor
14450329|NCT01997515|Ketamine|ketamine|mesh-list
14450330|NCT01997515|Analgesics|analgesics|mesh-ancestor
14930260|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
14450331|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
14450332|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450333|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450334|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14450335|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14450336|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
14450337|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
14450338|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450339|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14450340|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14450341|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450342|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450343|NCT01997905|Protein S|protein s|mesh-list
14450344|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
14450345|NCT01998399|Ticagrelor|ticagrelor|mesh-list
14450346|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14450347|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14450348|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14450349|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14450350|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
14450351|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450352|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450353|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450354|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
14450355|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14450356|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14450357|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450358|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
14450359|NCT01998438|Coagulants|coagulants|mesh-ancestor
14450360|NCT01998880|Rituximab|rituximab|mesh-list
14450361|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
14450362|NCT01998880|Chlorambucil|chlorambucil|mesh-list
14450363|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450364|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450365|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
14450366|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450367|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450368|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14450369|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
14450370|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450371|NCT01998893|Rituximab|rituximab|mesh-list
14450372|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450373|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450374|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
14450375|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450376|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450377|NCT01998906|Paclitaxel|paclitaxel|mesh-list
14450378|NCT01998906|Doxorubicin|doxorubicin|mesh-list
14450379|NCT01998906|Trastuzumab|trastuzumab|mesh-list
14450380|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14450381|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450382|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
14450383|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
14450384|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
14450385|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450386|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14450387|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14450388|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14450389|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450390|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450391|NCT01998919|Gemcitabine|gemcitabine|mesh-list
14450392|NCT01998919|Carboplatin|carboplatin|mesh-list
14450393|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14450394|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450395|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450396|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
14450397|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450398|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
14450399|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450400|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450401|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450402|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
14450403|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450404|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14450405|NCT01998958|Esketamine|esketamine|mesh-list
14450406|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
14450407|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14450408|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
14450409|NCT01999114|Naltrexone|naltrexone|mesh-list
14450410|NCT01999114|Buprenorphine|buprenorphine|mesh-list
14450411|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14450412|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14450413|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450414|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14450415|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14450416|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450417|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450418|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450419|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14450420|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
14450421|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14450422|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450423|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14450424|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14450425|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14450426|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14450427|NCT01999114|Narcotics|narcotics|mesh-ancestor
14450428|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450429|NCT01999114|Analgesics|analgesics|mesh-ancestor
14450430|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
14450431|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450432|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14450433|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14450434|NCT01999218|Metformin|metformin|mesh-list
14450435|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14450436|NCT01999218|Glimepiride|glimepiride|mesh-list
14450437|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
14450438|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450439|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450440|NCT01999218|Incretins|incretins|mesh-ancestor
14450441|NCT01999218|Hormones|hormones|mesh-ancestor
14450442|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450443|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14450444|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
14450445|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450446|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450447|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14450448|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450449|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
14450450|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14450451|NCT01999322|Insulin|insulin|mesh-list
14450452|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14450453|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
14450454|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
14450455|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14450456|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450457|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450458|NCT01999335|Dexamethasone|dexamethasone|mesh-list
14450459|NCT01999335|Pomalidomide|pomalidomide|mesh-list
14450460|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450461|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
14450462|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
14450463|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450464|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450465|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450466|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
14450467|NCT01999335|Hormones|hormones|mesh-ancestor
14450468|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450469|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14450470|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450471|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
14450472|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14450473|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14450474|NCT01999335|Growth Substances|growth substances|mesh-ancestor
14450475|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
14450476|NCT01999348|Timolol|timolol|mesh-list
14450477|NCT01999348|Bimatoprost|bimatoprost|mesh-list
14450478|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14450479|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14450480|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
14450481|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450482|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450483|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450484|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14450485|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14450486|NCT01999400|Mesalamine|mesalamine|mesh-list
14450487|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14450488|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450489|NCT01999400|Analgesics|analgesics|mesh-ancestor
14450490|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
14450491|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450492|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450493|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450494|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450495|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
14450496|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
14450497|NCT01999530|Prazosin|prazosin|mesh-list
14450498|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14450499|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14450500|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14450501|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14450502|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
14450503|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450504|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450505|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450506|NCT01999868|Abatacept|abatacept|mesh-list
14450507|NCT01999868|Ustekinumab|ustekinumab|mesh-list
14450508|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
14450509|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
14450510|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753754|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469342|NCT02293395|Clopidogrel|clopidogrel|mesh-list
14450511|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14450512|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450513|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450514|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450515|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450516|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
14450517|NCT01999894|Memantine|memantine|mesh-list
14450518|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14450519|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14450520|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
14450521|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450522|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450523|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450524|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14450525|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14450526|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14450527|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
14450528|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14450529|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14450530|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14450531|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450532|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450533|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450534|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
14450535|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450536|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14450537|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14450538|NCT01999946|Naltrexone|naltrexone|mesh-list
14450539|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14450540|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14450541|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450542|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
14450543|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450544|NCT01999972|Axitinib|axitinib|mesh-list
14450545|NCT01999972|Crizotinib|crizotinib|mesh-list
14450546|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450547|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14450548|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469343|NCT02293395|Ticagrelor|ticagrelor|mesh-list
14450549|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450550|NCT01999985|Dasatinib|dasatinib|mesh-list
14450551|NCT01999985|Afatinib|afatinib|mesh-list
14450552|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450553|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14450554|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450555|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450556|NCT02000531|Gemcitabine|gemcitabine|mesh-list
14450557|NCT02000531|Cisplatin|cisplatin|mesh-list
14450558|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14450559|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450560|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450561|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
14450562|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450563|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
14450564|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450565|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450566|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450567|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
14450568|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450569|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14450570|NCT02000921|Nicotine|nicotine|mesh-list
14450571|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14450572|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
14450573|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450574|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450575|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14450576|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14450577|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
14450578|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450579|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450580|NCT02000973|Lidocaine|lidocaine|mesh-list
14450581|NCT02000973|Bupivacaine|bupivacaine|mesh-list
14450582|NCT02000973|Ropivacaine|ropivacaine|mesh-list
14450583|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
14450584|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
14450585|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450586|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450587|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
14450588|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450589|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14450590|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14450591|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14450592|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450593|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450594|NCT02001181|Tofacitinib|tofacitinib|mesh-list
14450595|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14450596|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450597|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450598|NCT02001987|Methotrexate|methotrexate|mesh-list
14450599|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14450600|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
14450601|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14450602|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450603|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450604|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
14450605|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450606|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450607|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14450608|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450609|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14450610|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450611|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
14450612|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450613|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14450614|NCT02002221|Metformin|metformin|mesh-list
14450615|NCT02002221|Vildagliptin|vildagliptin|mesh-list
14450616|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450617|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450618|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14450619|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
14450620|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450621|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450622|NCT02002650|Indomethacin|indomethacin|mesh-list
14450623|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14450624|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450625|NCT02002650|Analgesics|analgesics|mesh-ancestor
14450626|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
14450627|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450628|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450629|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450630|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450631|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
14450632|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
14450633|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14450634|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14450635|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450636|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450637|NCT02002767|Velpatasvir|velpatasvir|mesh-list
14450638|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
14450639|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450640|NCT02002832|Risperidone|risperidone|mesh-list
14450641|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14450642|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14450643|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
14450644|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450645|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450646|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450647|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14450648|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14450649|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450650|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14450651|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14450652|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
14450653|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14450654|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14450655|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14450656|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
14450657|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14450658|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14450659|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
14450660|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14450661|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14450662|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14450663|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14450664|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450665|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450666|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
14450667|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450668|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450669|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14450670|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450671|NCT02002975|Pioglitazone|pioglitazone|mesh-list
14450672|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450673|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450674|NCT02003014|Pioglitazone|pioglitazone|mesh-list
14450675|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450676|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450677|NCT02003365|Triamcinolone|triamcinolone|mesh-list
14450678|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14450679|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14450680|NCT02003365|FX006|fx006|mesh-list
14450681|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14450682|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450683|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
14450684|NCT02003365|Hormones|hormones|mesh-ancestor
14450685|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450686|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450687|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450688|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
14450689|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450690|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450691|NCT02003391|Timolol|timolol|mesh-list
14450692|NCT02003391|Travoprost|travoprost|mesh-list
14450693|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14450694|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14450695|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14450696|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14450697|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
14450698|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450699|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450700|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450701|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14450702|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14450703|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14450704|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14450705|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14450706|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14450707|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14450708|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
14450709|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450710|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450711|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469344|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14469345|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14469346|NCT02293395|Analgesics|analgesics|mesh-ancestor
14469347|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
14469348|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469349|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469350|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450712|NCT02003573|Decitabine|decitabine|mesh-list
14450713|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450714|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
14450715|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450716|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450717|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450718|NCT02003625|Meloxicam|meloxicam|mesh-list
14450719|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14450720|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450721|NCT02003625|Analgesics|analgesics|mesh-ancestor
14450722|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
14450723|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450724|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450725|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450726|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450727|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14450728|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14450729|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450730|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450731|NCT02003638|Niacin|niacin|mesh-list
14450732|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14450733|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
14450734|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450735|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14450736|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
14450737|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
14450738|NCT02003638|Vitamins|vitamins|mesh-ancestor
14450739|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
14450740|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450741|NCT02003898|Insulin|insulin|mesh-list
14450742|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450743|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450744|NCT02003911|Azithromycin|azithromycin|mesh-list
14450745|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14450746|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450747|NCT02004093|Gemcitabine|gemcitabine|mesh-list
14450748|NCT02004093|Paclitaxel|paclitaxel|mesh-list
14450749|NCT02004093|Carboplatin|carboplatin|mesh-list
14450750|NCT02004093|Pertuzumab|pertuzumab|mesh-list
14450751|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14450752|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450753|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
14450754|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
14450755|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
14450756|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450757|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450758|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
14450759|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
14450760|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450761|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450762|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450763|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
14450764|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450765|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450766|NCT02004132|Testosterone|testosterone|mesh-list
14450767|NCT02004132|Androgens|androgens|mesh-ancestor
14450768|NCT02004132|Hormones|hormones|mesh-ancestor
14450769|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450770|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450771|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
14450772|NCT02004262|Pancrelipase|pancrelipase|mesh-list
14450773|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450774|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
14450775|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450776|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450777|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14450778|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
14450779|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450780|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450781|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14450782|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450783|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
14450784|NCT02004366|Linagliptin|linagliptin|mesh-list
14450785|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450786|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450787|NCT02004366|Incretins|incretins|mesh-ancestor
14450788|NCT02004366|Hormones|hormones|mesh-ancestor
14450789|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450790|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14930261|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930262|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14930263|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
14930264|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14450791|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
14930265|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930266|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14930267|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14930268|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14930269|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930270|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930271|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450792|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450793|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450794|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
14450795|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14450796|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450797|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450798|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450799|NCT02004613|Analgesics|analgesics|mesh-ancestor
14450800|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
14450801|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450802|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14450803|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14450804|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14450805|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
14450806|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450807|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450808|NCT02004886|Metformin|metformin|mesh-list
14450809|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450810|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450811|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
14450812|NCT02004990|Povidone|povidone|mesh-list
14450813|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
14450814|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
14450815|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14450816|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450817|NCT02005029|Erythromycin|erythromycin|mesh-list
14450818|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
14450819|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14450820|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
14450821|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14450822|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450823|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450824|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14450825|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450826|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450827|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
14450828|NCT02005354|Anesthetics|anesthetics|mesh-list
14450829|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
14450830|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450831|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450832|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
14450833|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450834|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14450835|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
14450836|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450837|NCT02005354|Analgesics|analgesics|mesh-ancestor
14450838|NCT02005484|Trastuzumab|trastuzumab|mesh-list
14450839|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450840|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450841|NCT02005549|Bevacizumab|bevacizumab|mesh-list
14450842|NCT02005549|Docetaxel|docetaxel|mesh-list
14450843|NCT02005549|Capecitabine|capecitabine|mesh-list
14450844|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450845|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450846|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14450847|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14450848|NCT02005549|Growth Substances|growth substances|mesh-ancestor
14450849|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450850|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
14450851|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
14450852|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
14450853|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14450854|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450855|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450856|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
14450857|NCT02005562|Cyclosporine|cyclosporine|mesh-list
14450858|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
14450859|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
14450860|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14450861|NCT02005562|Cyclosporins|cyclosporins|mesh-list
14450862|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450863|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450864|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450865|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
14450866|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450867|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
14450868|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450869|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
14450870|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450871|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14469351|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450872|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14450873|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450874|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14450875|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
14450876|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14450877|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450878|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
14450879|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
14450880|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450881|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450882|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
14450883|NCT02005562|Hormones|hormones|mesh-ancestor
14450884|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450885|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14450886|NCT02005562|Protective Agents|protective agents|mesh-ancestor
14450887|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14450888|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14450889|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14450890|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14450891|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450892|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450893|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450894|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450895|NCT02005601|Analgesics|analgesics|mesh-ancestor
14450896|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
14450897|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450898|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
14450899|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14450900|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
14450901|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
14450902|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450903|NCT02005666|Clindamycin|clindamycin|mesh-list
14450904|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
14450905|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
14450906|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14450907|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14450908|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450909|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14450910|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450911|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450912|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
14450913|NCT02005887|Letrozole|letrozole|mesh-list
14450914|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14450915|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450916|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14450917|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14450918|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450919|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450920|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14450921|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
14450922|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14450923|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450924|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
14450925|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14450926|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
14450927|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14450928|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14450929|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14450930|NCT02006056|Ondansetron|ondansetron|mesh-list
14450931|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
14450932|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
14450933|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450934|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450935|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450936|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
14450937|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14450938|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14450939|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
14450940|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450941|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450942|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14450943|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14450944|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14450945|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14450946|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14450947|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14450948|NCT02006108|Hematinics|hematinics|mesh-ancestor
14450949|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14450950|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14450951|NCT02006121|Apomorphine|apomorphine|mesh-list
14450952|NCT02006121|Emetics|emetics|mesh-ancestor
14450953|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450954|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
14450955|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450956|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14450957|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
14450958|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
14450959|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14450960|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450961|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
14450962|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14450963|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14450964|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450965|NCT02006342|Insulin|insulin|mesh-list
14450966|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14930272|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14450967|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
14450968|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14450969|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450970|NCT02006576|Ibuprofen|ibuprofen|mesh-list
14450971|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14450972|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14450973|NCT02006576|Analgesics|analgesics|mesh-ancestor
14450974|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
14450975|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14450976|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450977|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14450978|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14450979|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14450980|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450981|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450982|NCT02006628|Cannabidiol|cannabidiol|mesh-list
14450983|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
14450984|NCT02006667|Gemcitabine|gemcitabine|mesh-list
14450985|NCT02006667|Trastuzumab|trastuzumab|mesh-list
14450986|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14450987|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14450988|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
14450989|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14450990|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
14450991|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14450992|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14450993|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14450994|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
14450995|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14450996|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14450997|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
14450998|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14450999|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14451000|NCT02006706|Prednisolone|prednisolone|mesh-list
14451001|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
14451002|NCT02006706|Rituximab|rituximab|mesh-list
14451003|NCT02006706|Methotrexate|methotrexate|mesh-list
14451004|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14451005|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
14451006|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451007|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451008|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
14451009|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451010|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451011|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14451012|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
14451013|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14451014|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14451015|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
14451016|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451017|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
14451018|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451019|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14451020|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451021|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14451022|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451023|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
14451024|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
14451025|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451026|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451027|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
14451028|NCT02006706|Hormones|hormones|mesh-ancestor
14451029|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451030|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14451031|NCT02006706|Protective Agents|protective agents|mesh-ancestor
14451032|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14451033|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
14451034|NCT02006732|Olodaterol|olodaterol|mesh-list
14451035|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14451036|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
14451037|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451038|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451039|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14451040|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
14451041|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
14451042|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14451043|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
14451044|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451045|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451046|NCT02006836|Insulin|insulin|mesh-list
14451047|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14451048|NCT02006836|Metformin|metformin|mesh-list
14451049|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
14451050|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14451051|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752447|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752448|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14752449|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14752450|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752451|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752452|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14752453|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
14930273|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
14451052|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
14451053|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451054|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451055|NCT02007096|Bupivacaine|bupivacaine|mesh-list
14451056|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
14451057|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
14451058|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451059|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451060|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
14451061|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451062|NCT02007278|Metformin|metformin|mesh-list
14451063|NCT02007278|Glimepiride|glimepiride|mesh-list
14451064|NCT02007278|Vildagliptin|vildagliptin|mesh-list
14451065|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14451066|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451067|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14451068|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451069|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
14451070|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14451071|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
14451072|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451073|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451074|NCT02007434|Loratadine|loratadine|mesh-list
14451075|NCT02007434|Ibuprofen|ibuprofen|mesh-list
14451076|NCT02007434|Lidocaine|lidocaine|mesh-list
14451077|NCT02007434|Epinephrine|epinephrine|mesh-list
14451078|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
14451079|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
14451080|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
14451081|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451082|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451083|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
14451084|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451085|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14451086|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14451087|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14451088|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451089|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451090|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14451091|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14451092|NCT02007434|Analgesics|analgesics|mesh-ancestor
14451093|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451094|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451095|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14451096|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451097|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14451098|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14451099|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14451100|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451101|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14451102|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14451103|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
14451104|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14451105|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
14451106|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
14451107|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
14451108|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14451109|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
14451110|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
14451111|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14451112|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14451113|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14451114|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
14451115|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
14451116|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14451117|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451118|NCT02007512|Exemestane|exemestane|mesh-list
14451119|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451120|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14451121|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14451122|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451123|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451124|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14451125|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
14451126|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451127|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451128|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14451129|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14451130|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14451131|NCT02007577|Analgesics|analgesics|mesh-ancestor
14451132|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
14451133|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451134|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451135|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451136|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451137|NCT02007863|Fludarabine|fludarabine|mesh-list
14451138|NCT02007863|Melphalan|melphalan|mesh-list
14451139|NCT02007863|Busulfan|busulfan|mesh-list
14451140|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451141|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451142|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451143|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
14451144|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451145|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14451146|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
14451147|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14451148|NCT02008227|Docetaxel|docetaxel|mesh-list
14451149|NCT02008227|Atezolizumab|atezolizumab|mesh-list
14451150|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451151|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14451152|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14451153|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14451154|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451155|NCT02008565|Loperamide|loperamide|mesh-list
14451156|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
14451157|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451158|NCT02008617|Bupivacaine|bupivacaine|mesh-list
14451159|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
14451160|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
14451161|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451162|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451163|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
14451164|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451165|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14451166|NCT02008682|Liraglutide|liraglutide|mesh-list
14451167|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14451168|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451169|NCT02008682|Incretins|incretins|mesh-ancestor
14451170|NCT02008682|Hormones|hormones|mesh-ancestor
14451171|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451172|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14451173|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
14451174|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451175|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451176|NCT02008773|Valacyclovir|valacyclovir|mesh-list
14451177|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
14451178|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451179|NCT02008877|Sirolimus|sirolimus|mesh-list
14451180|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14451181|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451182|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14451183|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451184|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
14451185|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451186|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
14451187|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451188|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14451189|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
14451190|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451191|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14451192|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
14451193|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451194|NCT02008942|Aspirin|aspirin|mesh-list
14451195|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14451196|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14451197|NCT02008942|Analgesics|analgesics|mesh-ancestor
14451198|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
14451199|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451200|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451201|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451202|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451203|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14451204|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14451205|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451206|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14451207|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14451208|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451209|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
14451210|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14451211|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14451212|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451213|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14451214|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14451215|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451216|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451217|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
14451218|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451219|NCT02009332|Gemcitabine|gemcitabine|mesh-list
14451220|NCT02009332|Sirolimus|sirolimus|mesh-list
14451221|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14451222|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
14451223|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451224|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451225|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
14451226|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451227|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451228|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451229|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
14451230|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451231|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14451232|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14451233|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
14451234|NCT02009397|Ipilimumab|ipilimumab|mesh-list
14451235|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451236|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451237|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14469352|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14451238|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451239|NCT02009722|Morphine|morphine|mesh-list
14451240|NCT02009722|Hydromorphone|hydromorphone|mesh-list
14451241|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14451242|NCT02009722|Narcotics|narcotics|mesh-ancestor
14451243|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451244|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451245|NCT02009722|Analgesics|analgesics|mesh-ancestor
14451246|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
14451247|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451248|NCT02009878|Tolvaptan|tolvaptan|mesh-list
14451249|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14451250|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451251|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
14451252|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451253|NCT02010021|Letrozole|letrozole|mesh-list
14451254|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451255|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14451256|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14451257|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451258|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451259|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14451260|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
14451261|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451262|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451263|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
14451264|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14451265|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
14451266|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451267|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
14451268|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14451269|NCT02010255|Ledipasvir|ledipasvir|mesh-list
14451270|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
14451271|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469353|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14469354|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469355|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14469356|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14451272|NCT02010567|Capecitabine|capecitabine|mesh-list
14451273|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14451274|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
14451275|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451276|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451277|NCT02010632|Clopidogrel|clopidogrel|mesh-list
14451278|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14451279|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14451280|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14451281|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14451282|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
14451283|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451284|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451285|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451286|NCT02010645|Decitabine|decitabine|mesh-list
14451287|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14451288|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
14451289|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451290|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451291|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451292|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
14451293|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14451294|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14451295|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14469357|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451296|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451297|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451298|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
14451299|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451300|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451301|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14451302|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451303|NCT02011113|Dexamethasone|dexamethasone|mesh-list
14451304|NCT02011113|Pomalidomide|pomalidomide|mesh-list
14451305|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451306|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
14451307|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
14451308|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451309|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451310|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451311|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
14451312|NCT02011113|Hormones|hormones|mesh-ancestor
14451313|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451314|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14451315|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451316|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
14451317|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14451318|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14451319|NCT02011113|Growth Substances|growth substances|mesh-ancestor
14451320|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
14451321|NCT02011386|Golimumab|golimumab|mesh-list
14451322|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14451323|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451324|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451325|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
14451326|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451327|NCT02011464|Bupivacaine|bupivacaine|mesh-list
14451328|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
14451329|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
14451330|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451331|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451332|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
14451333|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451334|NCT02011516|Baclofen|baclofen|mesh-list
14451335|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14451336|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451337|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14451338|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451339|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14451340|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
14451341|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
14451342|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451343|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931240|NCT01438112|Mitomycin|mitomycin|mesh-list
14451344|NCT02011945|Nivolumab|nivolumab|mesh-list
14451345|NCT02011945|Dasatinib|dasatinib|mesh-list
14451346|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451347|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451348|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14451349|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451350|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14451351|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451352|NCT02012192|Paclitaxel|paclitaxel|mesh-list
14451353|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14451354|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451355|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
14451356|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
14451357|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
14451358|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451359|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
14451360|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
14451361|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451362|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451363|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451364|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
14451365|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
14451366|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14451367|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14451368|NCT02012348|Triclocarban|triclocarban|mesh-list
14451369|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451370|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14451371|NCT02012491|Misoprostol|misoprostol|mesh-list
14451372|NCT02012491|Mifepristone|mifepristone|mesh-list
14451373|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14451374|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
14451375|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14451376|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451377|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14451378|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451379|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
14451380|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14451381|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14451382|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14451383|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14451384|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
14451385|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14451386|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14451387|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
14451388|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451389|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
14451390|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14451391|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14451392|NCT02012959|Tolvaptan|tolvaptan|mesh-list
14451393|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14451394|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451395|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
14451396|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451397|NCT02013037|Eculizumab|eculizumab|mesh-list
14451398|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14451399|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451400|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
14451401|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451402|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14451403|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451404|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14451405|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451406|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451407|NCT02013245|Vaccines|vaccines|mesh-list
14451408|NCT02013245|Immunoglobulins|immunoglobulins|mesh-list
14451409|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
14451410|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451411|NCT02013375|Sirolimus|sirolimus|mesh-list
14451412|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
14451413|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
14451414|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451415|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
14451416|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451417|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451418|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14451419|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
14451420|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451421|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451422|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14451423|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14451424|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451425|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14451426|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
14451427|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451428|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
14451429|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
14451430|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451431|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451432|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451433|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
14451434|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
14451435|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14451436|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14451437|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
14451438|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451439|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
14451440|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
14451441|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451442|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451443|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451444|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
14451445|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
14451446|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
14451447|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
14451448|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451449|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451450|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451451|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
14451452|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
14451453|NCT02013674|Remestemcel-l|remestemcel-l|mesh-list
14451454|NCT02013674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451455|NCT02013674|Antiviral Agents|antiviral agents|mesh-ancestor
14451456|NCT02013674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451457|NCT02013765|Trastuzumab|trastuzumab|mesh-list
14451458|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451459|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451460|NCT02013791|Cyclosporine|cyclosporine|mesh-list
14451461|NCT02013791|Cyclosporins|cyclosporins|mesh-list
14930274|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14930275|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14930276|NCT01432106|Valsartan|valsartan|mesh-list
14930277|NCT01432106|Ramipril|ramipril|mesh-list
14930278|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14930279|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14451462|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451463|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451464|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451465|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
14451466|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451467|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
14451468|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451469|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
14451470|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451471|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14451472|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
14451473|NCT02013817|Rituximab|rituximab|mesh-list
14451474|NCT02013817|Fludarabine|fludarabine|mesh-list
14451475|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451476|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
14451477|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451478|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451479|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14930280|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14451480|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
14451481|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451482|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451483|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14451484|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451485|NCT02013830|Bevacizumab|bevacizumab|mesh-list
14451486|NCT02013830|Capecitabine|capecitabine|mesh-list
14451487|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451488|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451489|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14451490|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14451491|NCT02013830|Growth Substances|growth substances|mesh-ancestor
14451492|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451493|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14451494|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14451495|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
14469358|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
14451496|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451497|NCT02014363|Amitriptyline|amitriptyline|mesh-list
14451498|NCT02014363|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14451499|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14451500|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
14451501|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14451502|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14451503|NCT02014363|Analgesics|analgesics|mesh-ancestor
14451504|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
14451505|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451506|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451507|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14451508|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14451509|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451510|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451511|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
14451512|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451513|NCT02014363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14451514|NCT02014363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14451515|NCT02014363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451516|NCT02014402|Thrombin|thrombin|mesh-list
14451517|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
14451518|NCT02014402|Coagulants|coagulants|mesh-ancestor
14451519|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14451520|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451521|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451522|NCT02014467|Vitamin D|vitamin d|mesh-list
14451523|NCT02014467|Denosumab|denosumab|mesh-list
14451524|NCT02014467|Calcium|calcium|mesh-list
14451525|NCT02014467|Vitamins|vitamins|mesh-ancestor
14451526|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
14451527|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451528|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14451529|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14451530|NCT02014584|Dutasteride|dutasteride|mesh-list
14451531|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14451532|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14451533|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451534|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451535|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
14451536|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451537|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451538|NCT02014740|Metformin|metformin|mesh-list
14451539|NCT02014740|Liraglutide|liraglutide|mesh-list
14451540|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14451541|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930281|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930282|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14930283|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
14930284|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930285|NCT01432119|Cetuximab|cetuximab|mesh-list
14930286|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14930287|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14930288|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930289|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14451542|NCT02014740|Incretins|incretins|mesh-ancestor
14451543|NCT02014740|Hormones|hormones|mesh-ancestor
14451544|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451545|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
14451546|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14451547|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
14451548|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451549|NCT02015195|Ethanol|ethanol|mesh-list
14451550|NCT02015195|Acetic Acid|acetic acid|mesh-list
14451551|NCT02015195|Retinol acetate|retinol acetate|mesh-list
14451552|NCT02015195|Lidocaine|lidocaine|mesh-list
14451553|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
14451554|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
14451555|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451556|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451557|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
14451558|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451559|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14451560|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14451561|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14451562|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451563|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451564|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14451565|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451566|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14451567|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14451568|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
14451569|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14451570|NCT02015195|Protective Agents|protective agents|mesh-ancestor
14451571|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451572|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
14451573|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14451574|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
14451575|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14451576|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14451577|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451578|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14752454|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752455|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752459|NCT05337449|Fluorides|fluorides|mesh-list
14752460|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
14752461|NCT05337449|Protective Agents|protective agents|mesh-ancestor
14752462|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752463|NCT05337332|Triamcinolone|triamcinolone|mesh-list
14752464|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14752465|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14752466|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14752467|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451579|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451580|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14451581|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451582|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14451583|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
14451584|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14451585|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14451586|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14451587|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451588|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451589|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451590|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
14451591|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451592|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14451593|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14451594|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
14451595|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14451596|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451597|NCT02015676|Paclitaxel|paclitaxel|mesh-list
14451598|NCT02015676|Trastuzumab|trastuzumab|mesh-list
14451599|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14451600|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451601|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14451602|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14451603|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14451604|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451605|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451606|NCT02015793|Adalimumab|adalimumab|mesh-list
14451607|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451608|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451609|NCT02015819|Leucovorin|leucovorin|mesh-list
14451610|NCT02015819|Flucytosine|flucytosine|mesh-list
14930290|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930291|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930292|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14930293|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
14930294|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930295|NCT01432223|Paclitaxel|paclitaxel|mesh-list
14930296|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14930297|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930298|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
14930299|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
14930300|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
14930301|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930302|NCT01432249|Etanercept|etanercept|mesh-list
14930303|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14930304|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14930305|NCT01432249|Analgesics|analgesics|mesh-ancestor
14930306|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
14930307|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930308|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451611|NCT02015819|Calcium|calcium|mesh-list
14451612|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
14451613|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14451614|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451615|NCT02015819|Antidotes|antidotes|mesh-ancestor
14451616|NCT02015819|Protective Agents|protective agents|mesh-ancestor
14451617|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
14451618|NCT02015819|Vitamins|vitamins|mesh-ancestor
14451619|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
14451620|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
14451621|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451622|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
14451623|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451624|NCT02016105|Adalimumab|adalimumab|mesh-list
14451625|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451626|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451627|NCT02016170|Ticagrelor|ticagrelor|mesh-list
14451628|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14451629|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14451630|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14451631|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14451632|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14451633|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
14451634|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451635|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451636|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451637|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14451638|NCT02016183|Candesartan|candesartan|mesh-list
14451639|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
14451640|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14451641|NCT02016183|Diuretics|diuretics|mesh-ancestor
14451642|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
14451643|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451644|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14451645|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451646|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451647|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14451648|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14451649|NCT02016482|Adalimumab|adalimumab|mesh-list
14451650|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451651|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451652|NCT02016625|Cyclosporine|cyclosporine|mesh-list
14451653|NCT02016625|Tacrolimus|tacrolimus|mesh-list
14451654|NCT02016625|Cyclosporins|cyclosporins|mesh-list
14451655|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451656|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
14451657|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451658|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14930309|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451659|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451660|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451661|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
14451662|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451663|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
14451664|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451665|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14451666|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
14451667|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451668|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
14451669|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14451670|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14451671|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14451672|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
14451673|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451674|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451675|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451676|NCT02016898|Mitomycins|mitomycins|mesh-list
14451677|NCT02016898|Mitomycin|mitomycin|mesh-list
14451678|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14451679|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451680|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
14451681|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451682|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14451683|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451684|NCT02017015|Gemcitabine|gemcitabine|mesh-list
14451685|NCT02017015|Paclitaxel|paclitaxel|mesh-list
14451686|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14451687|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451688|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14451689|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
14451690|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14451691|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451692|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14451693|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
14451694|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
14451695|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451696|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451697|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451698|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
14451699|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451700|NCT02017171|Allopurinol|allopurinol|mesh-list
14451701|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
14451702|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451703|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451704|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
14451705|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451706|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14451707|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
14451708|NCT02017171|Protective Agents|protective agents|mesh-ancestor
14451709|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451710|NCT02017327|Bimatoprost|bimatoprost|mesh-list
14451711|NCT02017327|Latanoprost|latanoprost|mesh-list
14451712|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14451713|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14451714|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14451715|NCT02017535|Fluoxetine|fluoxetine|mesh-list
14451716|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14451717|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14451718|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451719|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451720|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451721|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
14451722|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451723|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14451724|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
14451725|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14451726|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14451727|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14451728|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451729|NCT02017860|Everolimus|everolimus|mesh-list
14451730|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451731|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451732|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
14451733|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451734|NCT02017899|Vaccines|vaccines|mesh-list
14451735|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
14451736|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451737|NCT02018042|Abatacept|abatacept|mesh-list
14451738|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14451739|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451740|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451741|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451742|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
14451743|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451744|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451745|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14451746|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14451747|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469359|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14469360|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14469361|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14469362|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
14469363|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469364|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14469365|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
14469366|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14469367|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
14469368|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
14469369|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14469370|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14469371|NCT02293863|Oseltamivir|oseltamivir|mesh-list
14469372|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
14469373|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469374|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752468|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
14451748|NCT02018458|Paclitaxel|paclitaxel|mesh-list
14451749|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14451750|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
14451751|NCT02018458|Carboplatin|carboplatin|mesh-list
14451752|NCT02018458|Doxorubicin|doxorubicin|mesh-list
14451753|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14451754|NCT02018458|Vaccines|vaccines|mesh-list
14451755|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
14451756|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451757|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14451758|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451759|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
14451760|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
14451761|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
14451762|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451763|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451764|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451765|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14451766|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
14451767|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14451768|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14451769|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14451770|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14451771|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451772|NCT02018627|Glucagon|glucagon|mesh-list
14451773|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14451774|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451775|NCT02018627|Hormones|hormones|mesh-ancestor
14451776|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451777|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451778|NCT02018627|Incretins|incretins|mesh-ancestor
14451779|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
14451780|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
14451781|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
14451782|NCT02018653|Calcium|calcium|mesh-list
14451783|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14451784|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451785|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14451786|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451787|NCT02018822|Urethane|urethane|mesh-list
14451788|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451789|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14451790|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
14451791|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
14451792|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451793|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451794|NCT02019069|Cytarabine|cytarabine|mesh-list
14451795|NCT02019069|Daunorubicin|daunorubicin|mesh-list
14451796|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14451797|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
14451798|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451799|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451800|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
14451801|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451802|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451803|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
14451804|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451805|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14451806|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14451807|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14451808|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451809|NCT02019277|Paclitaxel|paclitaxel|mesh-list
14451810|NCT02019277|Docetaxel|docetaxel|mesh-list
14451811|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14451812|NCT02019277|Trastuzumab|trastuzumab|mesh-list
14451813|NCT02019277|Pertuzumab|pertuzumab|mesh-list
14451814|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14451815|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451816|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
14451817|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
14451818|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
14451819|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451820|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451821|NCT02019420|Linezolid|linezolid|mesh-list
14451822|NCT02019420|Tedizolid|tedizolid|mesh-list
14451823|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
14451824|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14451825|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451826|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14451827|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451828|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451829|NCT02019472|Adalimumab|adalimumab|mesh-list
14451830|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14451831|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451832|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451833|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
14451834|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451835|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
14451836|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14451837|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
14451838|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451839|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14451840|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
14451841|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14451842|NCT02019667|Protective Agents|protective agents|mesh-ancestor
14451843|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451844|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
14451845|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
14451846|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451847|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451848|NCT02019758|Fluticasone|fluticasone|mesh-list
14451849|NCT02019758|Budesonide|budesonide|mesh-list
14451850|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451851|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14451852|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
14451853|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451854|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451855|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14451856|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14451857|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
14451858|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14451859|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
14451860|NCT02019758|Hormones|hormones|mesh-ancestor
14451861|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451862|NCT02019940|Riluzole|riluzole|mesh-list
14451863|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
14451864|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14451865|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14451866|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451867|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451868|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451869|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14451870|NCT02019940|Protective Agents|protective agents|mesh-ancestor
14451871|NCT02019979|Metformin|metformin|mesh-list
14451872|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14451873|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451874|NCT02020031|Vancomycin|vancomycin|mesh-list
14451875|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14451876|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451877|NCT02020278|Tolvaptan|tolvaptan|mesh-list
14451878|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14451879|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451880|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
14451881|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451882|NCT02020408|Raclopride|raclopride|mesh-list
14451883|NCT02020408|Amphetamine|amphetamine|mesh-list
14451884|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
14451885|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14451886|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451887|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
14451888|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
14451889|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451890|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
14451891|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752469|NCT05337332|Hormones|hormones|mesh-ancestor
14451892|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451893|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
14451894|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14451895|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14451896|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451897|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14451898|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14451899|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14451900|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451901|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14451902|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14451903|NCT02020512|Bimatoprost|bimatoprost|mesh-list
14451904|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14451905|NCT02020577|Cetuximab|cetuximab|mesh-list
14451906|NCT02020577|Afatinib|afatinib|mesh-list
14451907|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14451908|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451909|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14451910|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451911|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451912|NCT02020616|Metformin|metformin|mesh-list
14451913|NCT02020616|Exenatide|exenatide|mesh-list
14451914|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14451915|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451916|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14451917|NCT02020616|Incretins|incretins|mesh-ancestor
14451918|NCT02020616|Hormones|hormones|mesh-ancestor
14451919|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451920|NCT02020941|Dexamethasone|dexamethasone|mesh-list
14451921|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14451922|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
14451923|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
14451924|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14451925|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451926|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14451927|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
14451928|NCT02020941|Hormones|hormones|mesh-ancestor
14451929|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451930|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14451931|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451932|NCT02021292|Macitentan|macitentan|mesh-list
14451933|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14451934|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14451935|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451936|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14451937|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
14451938|NCT02021318|Hematinics|hematinics|mesh-ancestor
14451939|NCT02021331|Ethanol|ethanol|mesh-list
14451940|NCT02021331|Povidone-Iodine|povidone-iodine|mesh-list
14451941|NCT02021331|Cimetidine|cimetidine|mesh-list
14451942|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14930310|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930311|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14930312|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930313|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
14931191|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451943|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14930314|NCT01432470|Oxytocin|oxytocin|mesh-list
14930315|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
14930316|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14930317|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451944|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14451945|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
14451946|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
14451947|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14451948|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451949|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451950|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14451951|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14451952|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451953|NCT02021331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14451954|NCT02021331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451955|NCT02021331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14451956|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14451957|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
14451958|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14451959|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14451960|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14451961|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451962|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
14451963|NCT02021643|Ribavirin|ribavirin|mesh-list
14451964|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
14451965|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451966|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
14451967|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451968|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
14451969|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14451970|NCT02021656|Ledipasvir|ledipasvir|mesh-list
14451971|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
14451972|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451973|NCT02021929|Sorafenib|sorafenib|mesh-list
14451974|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14451975|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14451976|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451977|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451978|NCT02021942|Pasireotide|pasireotide|mesh-list
14930318|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
14930319|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930320|NCT01432496|Ropivacaine|ropivacaine|mesh-list
14930321|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
14930322|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
14930323|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930324|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451979|NCT02021942|Hormones|hormones|mesh-ancestor
14930325|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
14930326|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930327|NCT01432522|Epinephrine|epinephrine|mesh-list
14930328|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14930329|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14930330|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930331|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930332|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930333|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930334|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14451980|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451981|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451982|NCT02022007|Metformin|metformin|mesh-list
14451983|NCT02022007|Saxagliptin|saxagliptin|mesh-list
14451984|NCT02022007|Biguanides|biguanides|mesh-list
14451985|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14451986|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14451987|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14451988|NCT02022007|Incretins|incretins|mesh-ancestor
14451989|NCT02022007|Hormones|hormones|mesh-ancestor
14451990|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14451991|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14451992|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14451993|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14451994|NCT02022657|Tenofovir|tenofovir|mesh-list
14451995|NCT02022657|Emtricitabine|emtricitabine|mesh-list
14451996|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14451997|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
14451998|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14451999|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14452000|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14452001|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452002|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452003|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14452004|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14452005|NCT02022748|Ticagrelor|ticagrelor|mesh-list
14452006|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14452007|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14452008|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14452009|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14452010|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
14452011|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452012|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452013|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452014|NCT02023099|Ritonavir|ritonavir|mesh-list
14452015|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14452016|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14452017|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452018|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452019|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452020|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14452021|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14452022|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
14452023|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452024|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14452025|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14452026|NCT02023112|Ritonavir|ritonavir|mesh-list
14930335|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14930336|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
14930337|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930338|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14930339|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
14930340|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
14930341|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
14930342|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14930343|NCT01432587|Diflunisal|diflunisal|mesh-list
14930344|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14930345|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14930346|NCT01432587|Analgesics|analgesics|mesh-ancestor
14930347|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
14452027|NCT02023112|Ribavirin|ribavirin|mesh-list
14452028|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14452029|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14452030|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452031|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452032|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452033|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14452034|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14930348|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452035|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
14930349|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452036|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452037|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14452038|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14452039|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
14452040|NCT02023125|Esomeprazole|esomeprazole|mesh-list
14452041|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14452042|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452043|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14452044|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452045|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452046|NCT02023151|Omalizumab|omalizumab|mesh-list
14452047|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14452048|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14452049|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
14452050|NCT02023411|Teriparatide|teriparatide|mesh-list
14452051|NCT02023411|Hormones|hormones|mesh-list
14452052|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
14452053|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452054|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452055|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14452056|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14452057|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14452058|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452059|NCT02023866|Cysteamine|cysteamine|mesh-list
14452060|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14452061|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452062|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14452063|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
14452064|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452065|NCT02024087|Sorafenib|sorafenib|mesh-list
14452066|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452067|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14452068|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452069|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452070|NCT02024204|Fluticasone|fluticasone|mesh-list
14452071|NCT02024204|Xhance|xhance|mesh-list
14452072|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14452073|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14452074|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452075|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14452076|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
14452077|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452078|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452079|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14452080|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
14452081|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
14452082|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14452083|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14452084|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14452085|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14930350|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930351|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14452086|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
14452087|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452088|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452089|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
14452090|NCT02024204|Hormones|hormones|mesh-ancestor
14452091|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452092|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
14452093|NCT02024386|Riociguat|riociguat|mesh-list
14452094|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
14452095|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452096|NCT02024477|Saxagliptin|saxagliptin|mesh-list
14452097|NCT02024477|Incretins|incretins|mesh-ancestor
14452098|NCT02024477|Hormones|hormones|mesh-ancestor
14452099|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452100|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452101|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14452102|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452103|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452104|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452105|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452106|NCT02024646|Brodalumab|brodalumab|mesh-list
14452107|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14452108|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
14452109|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
14452110|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452111|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
14452112|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14452113|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
14452114|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452115|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
14452116|NCT02024711|Protective Agents|protective agents|mesh-ancestor
14452117|NCT02024724|Dexamethasone|dexamethasone|mesh-list
14452118|NCT02024724|Triamcinolone|triamcinolone|mesh-list
14452119|NCT02024724|Bupivacaine|bupivacaine|mesh-list
14452120|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452121|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
14452122|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
14452123|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452124|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452125|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452126|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
14452127|NCT02024724|Hormones|hormones|mesh-ancestor
14452128|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452129|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14452130|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452131|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
14452132|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
14452133|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452134|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
14452135|NCT02024867|Trimethoprim|trimethoprim|mesh-list
14452136|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14452137|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
14452138|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14452139|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452140|NCT02024867|Renal Agents|renal agents|mesh-ancestor
14452141|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
14452142|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14452143|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14452144|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14452145|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452146|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452147|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14452148|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14452149|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14452150|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14452151|NCT02024971|Metformin|metformin|mesh-list
14452152|NCT02024971|Pioglitazone|pioglitazone|mesh-list
14452153|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452154|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452155|NCT02025075|Rocuronium|rocuronium|mesh-list
14452156|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14452157|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14452158|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14452159|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452160|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452161|NCT02025179|Teriparatide|teriparatide|mesh-list
14452162|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14452163|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452164|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14452165|NCT02025426|Phenylephrine|phenylephrine|mesh-list
14452166|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
14452167|NCT02025426|Ephedrine|ephedrine|mesh-list
14452168|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14452169|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
14452170|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
14452171|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452172|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452173|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
14452174|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14452175|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
14452176|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
14452177|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14452178|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14452179|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14452180|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
14452181|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452182|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452183|NCT02025426|Protective Agents|protective agents|mesh-ancestor
14452184|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14452185|NCT02025439|Amantadine|amantadine|mesh-list
14452186|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14452187|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14452188|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
14452189|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452190|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
14452191|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452192|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452193|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452194|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452195|NCT02025439|Analgesics|analgesics|mesh-ancestor
14452196|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
14452197|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452198|NCT02025621|Simendan|simendan|mesh-list
14452199|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14452200|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
14452201|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14452202|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14452203|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452204|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452205|NCT02025621|Protective Agents|protective agents|mesh-ancestor
14452206|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452207|NCT02025634|Acetaminophen|acetaminophen|mesh-list
14452208|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452209|NCT02025634|Analgesics|analgesics|mesh-ancestor
14452210|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
14452211|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452212|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452213|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
14469375|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469376|NCT02293902|Folic Acid|folic acid|mesh-list
14452214|NCT02025725|Metoclopramide|metoclopramide|mesh-list
14452215|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
14452216|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
14452217|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452218|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452219|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452220|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14452221|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14452222|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
14452223|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452224|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452225|NCT02025751|Metoclopramide|metoclopramide|mesh-list
14452226|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
14452227|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
14452228|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452229|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452230|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452231|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14452232|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14452233|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
14452234|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452235|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452236|NCT02025907|Canagliflozin|canagliflozin|mesh-list
14452237|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14452238|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452239|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452240|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452241|NCT02026011|Naltrexone|naltrexone|mesh-list
14452242|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14452243|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14452244|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452245|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
14452246|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452247|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
14452248|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14452249|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452250|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452251|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452252|NCT02026141|Analgesics|analgesics|mesh-ancestor
14452253|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
14452254|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452255|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14452256|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14452257|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14452258|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
14452259|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452260|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452261|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
14452262|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14452263|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14452264|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452265|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
14452266|NCT02026297|Coagulants|coagulants|mesh-ancestor
14452267|NCT02027311|Midazolam|midazolam|mesh-list
14452268|NCT02027311|Meperidine|meperidine|mesh-list
14452269|NCT02027311|Etomidate|etomidate|mesh-list
14452270|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14452271|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14452272|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452273|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452274|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14452275|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14452276|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14452277|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14452278|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
14452279|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
14452280|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
14452281|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
14452282|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452283|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452284|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14452285|NCT02027311|Narcotics|narcotics|mesh-ancestor
14452286|NCT02027311|Analgesics|analgesics|mesh-ancestor
14452287|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
14452288|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452289|NCT02027376|Docetaxel|docetaxel|mesh-list
14452290|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452291|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
14452292|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
14452293|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
14452294|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452295|NCT02027428|Paclitaxel|paclitaxel|mesh-list
14452296|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14452297|NCT02027428|Carboplatin|carboplatin|mesh-list
14452298|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14452299|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452300|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14452301|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
14452302|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14452303|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452304|NCT02028221|Metformin|metformin|mesh-list
14452305|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452306|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452307|NCT02028676|Lamivudine|lamivudine|mesh-list
14452308|NCT02028676|Zidovudine|zidovudine|mesh-list
14452309|NCT02028676|Efavirenz|efavirenz|mesh-list
14452310|NCT02028676|Nevirapine|nevirapine|mesh-list
14452311|NCT02028676|Abacavir|abacavir|mesh-list
14452312|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
14452313|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14452314|NCT02028676|Trimethoprim|trimethoprim|mesh-list
14452315|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
14452316|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14452317|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14469377|NCT02293902|Methotrexate|methotrexate|mesh-list
14452318|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14452319|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452320|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452321|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
14452322|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452323|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14452324|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14452325|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
14452326|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14452327|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14452328|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14452329|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14452330|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14452331|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14452332|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14452333|NCT02028676|Renal Agents|renal agents|mesh-ancestor
14452334|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
14452335|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14452336|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14452337|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14452338|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14452339|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14452340|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14452341|NCT02028715|Acetaminophen|acetaminophen|mesh-list
14452342|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452343|NCT02028715|Analgesics|analgesics|mesh-ancestor
14452344|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
14452345|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452346|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452347|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
14452348|NCT02028754|Levofloxacin|levofloxacin|mesh-list
14452349|NCT02028754|Ofloxacin|ofloxacin|mesh-list
14452350|NCT02028754|Prednisolone|prednisolone|mesh-list
14452351|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
14452352|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14452353|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452354|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
14452355|NCT02028754|Hormones|hormones|mesh-ancestor
14452356|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452357|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452358|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14452359|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452360|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452361|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14452362|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452363|NCT02028754|Renal Agents|renal agents|mesh-ancestor
14452364|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14452365|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14452366|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14452367|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452368|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452369|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14452370|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14452371|NCT02028754|Laxatives|laxatives|mesh-ancestor
14452372|NCT02028767|Metformin|metformin|mesh-list
14452373|NCT02028767|Empagliflozin|empagliflozin|mesh-list
14452374|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452375|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452376|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14931192|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
14452377|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452378|NCT02028780|Dabigatran|dabigatran|mesh-list
14452379|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
14452380|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14452381|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452382|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452383|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452384|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
14452385|NCT02028871|Insulin|insulin|mesh-list
14452386|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452387|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452388|NCT02029235|Acetaminophen|acetaminophen|mesh-list
14452389|NCT02029235|Ibuprofen|ibuprofen|mesh-list
14452390|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14452391|NCT02029235|Hydrocodone|hydrocodone|mesh-list
14452392|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452393|NCT02029235|Analgesics|analgesics|mesh-ancestor
14452394|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
14452395|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452396|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452397|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
14452398|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14452399|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452400|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14452401|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14452402|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452403|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452404|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14452405|NCT02029235|Narcotics|narcotics|mesh-ancestor
14452406|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452407|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
14452408|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
14452409|NCT02029274|Siponimod|siponimod|mesh-list
14452410|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14452411|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452412|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452413|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
14452414|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452415|NCT02029417|Cytarabine|cytarabine|mesh-list
14452416|NCT02029417|Decitabine|decitabine|mesh-list
14452417|NCT02029417|Azacitidine|azacitidine|mesh-list
14452418|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
14452419|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14452420|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
14452421|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452422|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452423|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
14452424|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452425|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452426|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
14452427|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452428|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452429|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14452430|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14452431|NCT02029495|Brodalumab|brodalumab|mesh-list
14452432|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14452433|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
14452434|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
14452435|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452436|NCT02029638|Acetaminophen|acetaminophen|mesh-list
14452437|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
14452438|NCT02029638|Promethazine|promethazine|mesh-list
14452439|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
14452440|NCT02029638|Prednisone|prednisone|mesh-list
14452441|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
14452442|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
14452443|NCT02029638|Fludarabine|fludarabine|mesh-list
14452444|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
14452445|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14452446|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452447|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
14452448|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452449|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14452450|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14452451|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
14452452|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452453|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452454|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14452455|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452456|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
14452457|NCT02029638|Hormones|hormones|mesh-ancestor
14452458|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452459|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14452460|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452461|NCT02029638|Analgesics|analgesics|mesh-ancestor
14452462|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
14452463|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452464|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
14452465|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14452466|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14452467|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
14452468|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14452469|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452470|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452471|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
14452472|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
14452473|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452474|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14452475|NCT02029638|Protective Agents|protective agents|mesh-ancestor
14452476|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14452477|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14452478|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452479|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
14452480|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
14452481|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14452482|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
14452483|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
14452484|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452485|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14452486|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
14452487|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
14452488|NCT02029703|Hylan|hylan|mesh-list
14452489|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
14452490|NCT02029703|Protective Agents|protective agents|mesh-ancestor
14452491|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452492|NCT02029755|Anesthetics|anesthetics|mesh-list
14452493|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
14452494|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452495|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452496|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
14452497|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452498|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
14452499|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14452500|NCT02029872|Mupirocin|mupirocin|mesh-list
14452501|NCT02029872|Calcium|calcium|mesh-list
14452502|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14452503|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452504|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14452505|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452506|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
14452507|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
14452508|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14452509|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14452510|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452511|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452512|NCT02030041|Vitamin D|vitamin d|mesh-list
14452513|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
14452514|NCT02030041|Simvastatin|simvastatin|mesh-list
14452515|NCT02030041|Vitamins|vitamins|mesh-ancestor
14452516|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
14452517|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452518|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14452519|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14452520|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14452521|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14452522|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
14452523|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452524|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14452525|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14452526|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452527|NCT02030405|Ixazomib|ixazomib|mesh-list
14452528|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14452529|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452530|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452531|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452532|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452533|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
14452534|NCT02030535|Olodaterol|olodaterol|mesh-list
14452535|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14452536|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
14452537|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452538|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452539|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14452540|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
14452541|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
14452542|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14452543|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
14452544|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452545|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452546|NCT02030574|Gemcitabine|gemcitabine|mesh-list
14452547|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452548|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14452549|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
14452550|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452551|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
14452552|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452553|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452554|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452555|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
14452556|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452557|NCT02030600|Insulin|insulin|mesh-list
14452558|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14452559|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
14452560|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452561|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452562|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
14452563|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
14452564|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14452565|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14452566|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452567|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
14452568|NCT02030821|Coagulants|coagulants|mesh-ancestor
14452569|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14452570|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
14452571|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452572|NCT02031458|Atezolizumab|atezolizumab|mesh-list
14452573|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452574|NCT02031536|Everolimus|everolimus|mesh-list
14452575|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452576|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452577|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
14452578|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452579|NCT02031640|Beclomethasone|beclomethasone|mesh-list
14452580|NCT02031640|Albuterol|albuterol|mesh-list
14452581|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
14452582|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
14452583|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452584|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452585|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14452586|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
14452587|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
14452588|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14452589|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14452590|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14452591|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14452592|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
14452593|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452594|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452595|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452596|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
14452597|NCT02031640|Hormones|hormones|mesh-ancestor
14452598|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452599|NCT02032173|Ranibizumab|ranibizumab|mesh-list
14452600|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14452601|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14452602|NCT02032173|Growth Substances|growth substances|mesh-ancestor
14452603|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452604|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
14452605|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452606|NCT02032212|Nicotine|nicotine|mesh-list
14452607|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14452608|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
14452609|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452610|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452611|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14452612|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14452613|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
14452614|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452615|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452616|NCT02032407|Dapsone|dapsone|mesh-list
14452617|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452618|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
14452619|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14452620|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14452621|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14452622|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452623|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452624|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
14452625|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14452626|NCT02032433|Naltrexone|naltrexone|mesh-list
14452627|NCT02032433|Buprenorphine|buprenorphine|mesh-list
14452628|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14452629|NCT02032433|Naloxone|naloxone|mesh-list
14452630|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14452631|NCT02032433|Narcotics|narcotics|mesh-ancestor
14452632|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452633|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452634|NCT02032433|Analgesics|analgesics|mesh-ancestor
14452635|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
14452636|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452637|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14452638|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14452639|NCT02032758|Propranolol|propranolol|mesh-list
14452640|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14452641|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14452642|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14452643|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452644|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452645|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452646|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14452647|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14452648|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
14452649|NCT02032810|Ipilimumab|ipilimumab|mesh-list
14452650|NCT02032810|Panobinostat|panobinostat|mesh-list
14452651|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14452652|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452653|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14452654|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452655|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14452656|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452657|NCT02032875|Ribavirin|ribavirin|mesh-list
14452658|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
14452659|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
14452660|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452661|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
14452662|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452663|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
14452664|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
14452665|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452666|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
14452667|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
14452668|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469378|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14469379|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
14469380|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14469381|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469382|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14469383|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
14469384|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469385|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469386|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469387|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469388|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14469389|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469390|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
14469391|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469392|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14469393|NCT02293902|Hematinics|hematinics|mesh-ancestor
14469394|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
14469395|NCT02293902|Vitamins|vitamins|mesh-ancestor
14469396|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
14469397|NCT02293993|Guadecitabine|guadecitabine|mesh-list
14469398|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469399|NCT02294019|Ibuprofen|ibuprofen|mesh-list
14469400|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14469401|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14469402|NCT02294019|Analgesics|analgesics|mesh-ancestor
14469403|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
14469404|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469405|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469406|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469407|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469408|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14469409|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469410|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469411|NCT02294058|Interferons|interferons|mesh-list
14452669|NCT02033369|Pramipexole|pramipexole|mesh-list
14452670|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
14452671|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452672|NCT02033369|Protective Agents|protective agents|mesh-ancestor
14452673|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452674|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14452675|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14452676|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
14452677|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
14452678|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452679|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14452680|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14452681|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452682|NCT02033889|Insulin|insulin|mesh-list
14452683|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14452684|NCT02033889|Metformin|metformin|mesh-list
14452685|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
14452686|NCT02033889|Glimepiride|glimepiride|mesh-list
14452687|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
14452688|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
14452689|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452690|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452691|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14452692|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452693|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
14452694|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14452695|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452696|NCT02033993|Paclitaxel|paclitaxel|mesh-list
14452697|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14452698|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14452699|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452700|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14452701|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14452702|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14452703|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452704|NCT02034006|Ranibizumab|ranibizumab|mesh-list
14452705|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14452706|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14452707|NCT02034006|Growth Substances|growth substances|mesh-ancestor
14452708|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452709|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
14452710|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452711|NCT02034019|Dexamethasone|dexamethasone|mesh-list
14452712|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452713|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
14452714|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
14452715|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930352|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14930353|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930354|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930355|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
14930356|NCT01432665|Testosterone|testosterone|mesh-list
14930357|NCT01432665|Androgens|androgens|mesh-ancestor
14930358|NCT01432665|Hormones|hormones|mesh-ancestor
14930359|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452716|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452717|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452718|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
14452719|NCT02034019|Hormones|hormones|mesh-ancestor
14452720|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452721|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14452722|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930360|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930361|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
14930362|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14930363|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14930364|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930365|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452723|NCT02034162|Mebendazole|mebendazole|mesh-list
14452724|NCT02034162|Piperazine|piperazine|mesh-list
14930366|NCT01432665|Urological Agents|urological agents|mesh-ancestor
14930367|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
14930368|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14930369|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930370|NCT01432704|Vitamins|vitamins|mesh-ancestor
14930371|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
14930372|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14452725|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
14452726|NCT02034162|DMP 777|dmp 777|mesh-list
14452727|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
14452728|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
14452729|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14452730|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452731|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
14452732|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
14452733|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
14452734|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452735|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452736|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452737|NCT02034435|Amlodipine|amlodipine|mesh-list
14452738|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14452739|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14452740|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14452741|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452742|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14452743|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452744|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
14452745|NCT02034513|Insulin|insulin|mesh-list
14452746|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14452747|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
14452748|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
14452749|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452750|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452751|NCT02034552|Prednisone|prednisone|mesh-list
14452752|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
14452753|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14452754|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452755|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
14452756|NCT02034552|Hormones|hormones|mesh-ancestor
14452757|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452758|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452759|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14452760|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452761|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14452762|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452763|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452764|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
14452765|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14452766|NCT02034565|Apixaban|apixaban|mesh-list
14452767|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14452768|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
14452769|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14452770|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452771|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452772|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452773|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
14452774|NCT02034578|Apixaban|apixaban|mesh-list
14452775|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14452776|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
14452777|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14452778|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452779|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452780|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452781|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
14452782|NCT02034591|Apixaban|apixaban|mesh-list
14452783|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14452784|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
14452785|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14452786|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452787|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452788|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452789|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
14452790|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14452791|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
14452792|NCT02034799|Coagulants|coagulants|mesh-ancestor
14452793|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14452794|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
14452795|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452796|NCT02034916|Talazoparib|talazoparib|mesh-list
14452797|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14452798|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452799|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452800|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452801|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
14452802|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14452803|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452804|NCT02035345|Carboplatin|carboplatin|mesh-list
14452805|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452806|NCT02035553|Pimavanserin|pimavanserin|mesh-list
14452807|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14452808|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14452809|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14452810|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14452811|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452812|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452813|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14452814|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14452815|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14452816|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
14452817|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452818|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452819|NCT02035696|Vaccines|vaccines|mesh-list
14452820|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
14452821|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452822|NCT02036424|Dexamethasone|dexamethasone|mesh-list
14452823|NCT02036424|Bevacizumab|bevacizumab|mesh-list
14452824|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14452825|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452826|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14452827|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14452828|NCT02036424|Growth Substances|growth substances|mesh-ancestor
14452829|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452830|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
14452831|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452832|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
14452833|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
14452834|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452835|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452836|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
14452837|NCT02036424|Hormones|hormones|mesh-ancestor
14452838|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452839|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14452840|NCT02036502|Dexamethasone|dexamethasone|mesh-list
14452841|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
14452842|NCT02036502|Lenalidomide|lenalidomide|mesh-list
14452843|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452844|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
14452845|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
14452846|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452847|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452848|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452849|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
14452850|NCT02036502|Hormones|hormones|mesh-ancestor
14452851|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452852|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14452853|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452854|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14452855|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
14452856|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14452857|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14452858|NCT02036502|Growth Substances|growth substances|mesh-ancestor
14452859|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
14452860|NCT02036515|Metformin|metformin|mesh-list
14452861|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14452862|NCT02036515|Glimepiride|glimepiride|mesh-list
14452863|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
14452864|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14452865|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452866|NCT02036515|Incretins|incretins|mesh-ancestor
14452867|NCT02036515|Hormones|hormones|mesh-ancestor
14452868|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14452869|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14452870|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452871|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452872|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452873|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14452874|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452875|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
14452876|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14452877|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14452878|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
14452879|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452880|NCT02036775|Ambroxol|ambroxol|mesh-list
14452881|NCT02036775|Expectorants|expectorants|mesh-ancestor
14452882|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14452883|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14452884|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452885|NCT02037061|Bupivacaine|bupivacaine|mesh-list
14452886|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
14452887|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
14452888|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452889|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452890|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
14452891|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452892|NCT02037165|Celecoxib|celecoxib|mesh-list
14452893|NCT02037165|Pregabalin|pregabalin|mesh-list
14452894|NCT02037165|Analgesics|analgesics|mesh-ancestor
14452895|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
14452896|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452897|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452898|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
14452899|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14452900|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14452901|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452902|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14452903|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14452904|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14452905|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452906|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14452907|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14452908|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452909|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452910|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14452911|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14452912|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14452913|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452914|NCT02037230|Gemcitabine|gemcitabine|mesh-list
14452915|NCT02037230|Adavosertib|adavosertib|mesh-list
14452916|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14452917|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
14452918|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452919|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452920|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
14452921|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452922|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452923|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14452924|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
14452925|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452926|NCT02037256|Bortezomib|bortezomib|mesh-list
14452927|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452928|NCT02037295|Vancomycin|vancomycin|mesh-list
14452929|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14452930|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14452931|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14452932|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14452933|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14452934|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452935|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452936|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14452937|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14452938|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452939|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
14452940|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14452941|NCT02037477|Esomeprazole|esomeprazole|mesh-list
14452942|NCT02037477|Rabeprazole|rabeprazole|mesh-list
14452943|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14452944|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14452945|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14452946|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452947|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452948|NCT02037555|Antithrombins|antithrombins|mesh-list
14452949|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
14452950|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14452951|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
14452952|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452953|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452954|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
14452955|NCT02037893|Antipyrine|antipyrine|mesh-list
14452956|NCT02037893|Benzocaine|benzocaine|mesh-list
14452957|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14452958|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
14452959|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
14452960|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14452961|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452962|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
14452963|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14452964|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14452965|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14452966|NCT02037893|Analgesics|analgesics|mesh-ancestor
14452967|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14452968|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14452969|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14452970|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
14452971|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452972|NCT02038010|Trastuzumab|trastuzumab|mesh-list
14452973|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14452974|NCT02038010|Maytansine|maytansine|mesh-list
14452975|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
14452976|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
14452977|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14452978|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14452979|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14452980|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14452981|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14452982|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14452983|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14452984|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
14452985|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452986|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14452987|NCT02038023|Iron|iron|mesh-list
14452988|NCT02038023|Dextrans|dextrans|mesh-list
14452989|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
14452990|NCT02038023|Trace Elements|trace elements|mesh-ancestor
14452991|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
14452992|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14452993|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
14452994|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
14452995|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
14452996|NCT02038023|Hematinics|hematinics|mesh-ancestor
14452997|NCT02038179|Allopurinol|allopurinol|mesh-list
14452998|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
14452999|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453000|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453001|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
14453002|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453003|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14453004|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
14453005|NCT02038179|Protective Agents|protective agents|mesh-ancestor
14453006|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453007|NCT02038647|Paclitaxel|paclitaxel|mesh-list
14453008|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14453009|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453010|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
14453011|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
14453012|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
14453013|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453014|NCT02038790|Buprenorphine|buprenorphine|mesh-list
14453015|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14453016|NCT02038790|Naloxone|naloxone|mesh-list
14453017|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14453018|NCT02038790|Narcotics|narcotics|mesh-ancestor
14453019|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453020|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453021|NCT02038790|Analgesics|analgesics|mesh-ancestor
14453022|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
14453023|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453024|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14453025|NCT02038881|Vaccines|vaccines|mesh-list
14453026|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
14453027|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453028|NCT02038894|Propofol|propofol|mesh-list
14453029|NCT02038894|Sevoflurane|sevoflurane|mesh-list
14453030|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14453031|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453032|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453033|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14453034|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
14453035|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
14453036|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14453037|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14453038|NCT02038907|Vaccines|vaccines|mesh-list
14453039|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
14453040|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453041|NCT02038920|Vedolizumab|vedolizumab|mesh-list
14453042|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453043|NCT02038933|Nivolumab|nivolumab|mesh-list
14453044|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14453045|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930373|NCT01432717|Luspatercept|luspatercept|mesh-list
14930374|NCT01432717|Hematinics|hematinics|mesh-ancestor
14930375|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
14930376|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14930377|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14930378|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14930379|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14930380|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930381|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
14930382|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930383|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930384|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14453046|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14453047|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453048|NCT02039115|Prednisone|prednisone|mesh-list
14453049|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453050|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
14453051|NCT02039115|Hormones|hormones|mesh-ancestor
14453052|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453053|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453054|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14453055|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453056|NCT02039427|Dexamethasone|dexamethasone|mesh-list
14453057|NCT02039427|Ketorolac|ketorolac|mesh-list
14453058|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453059|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
14453060|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
14930385|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930386|NCT01432821|Apomorphine|apomorphine|mesh-list
14453061|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453062|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453063|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453064|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
14453065|NCT02039427|Hormones|hormones|mesh-ancestor
14453066|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453067|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14453068|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453069|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14453070|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14453071|NCT02039427|Analgesics|analgesics|mesh-ancestor
14453072|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
14453073|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453074|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14453075|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453076|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453077|NCT02039505|Vedolizumab|vedolizumab|mesh-list
14453078|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453079|NCT02039674|Paclitaxel|paclitaxel|mesh-list
14453080|NCT02039674|Bevacizumab|bevacizumab|mesh-list
14453081|NCT02039674|Carboplatin|carboplatin|mesh-list
14453082|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
14453083|NCT02039674|Pemetrexed|pemetrexed|mesh-list
14453084|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14453085|NCT02039674|Ipilimumab|ipilimumab|mesh-list
14453086|NCT02039674|Gefitinib|gefitinib|mesh-list
14453087|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14453088|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453089|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14453090|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14453091|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14453092|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453093|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14453094|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14453095|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14453096|NCT02039674|Growth Substances|growth substances|mesh-ancestor
14453097|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453098|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
14453099|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453100|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14453101|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14453102|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14453103|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14453104|NCT02039778|Temozolomide|temozolomide|mesh-list
14453105|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14453106|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
14453107|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453108|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453109|NCT02039908|Methylphenidate|methylphenidate|mesh-list
14453110|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14453111|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453112|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14453113|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14453114|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14453115|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453116|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
14453117|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453118|NCT02039947|Trametinib|trametinib|mesh-list
14453119|NCT02039947|Dabrafenib|dabrafenib|mesh-list
14453120|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453121|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14453122|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453123|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453124|NCT02040116|Rituximab|rituximab|mesh-list
14453125|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14453126|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453127|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
14453128|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453129|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453130|NCT02040298|Clemastine|clemastine|mesh-list
14453131|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
14453132|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453133|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14453134|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
14453135|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
14453136|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453137|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930387|NCT01432821|Emetics|emetics|mesh-ancestor
14930388|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930389|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
14930390|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453138|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453139|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14453140|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14453141|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
14453142|NCT02040428|Coagulants|coagulants|mesh-ancestor
14469412|NCT02294058|Interferon-beta|interferon-beta|mesh-list
14469413|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
14469414|NCT02294058|Ozanimod|ozanimod|mesh-list
14930391|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453143|NCT02040532|Gabapentin|gabapentin|mesh-list
14453144|NCT02040532|Analgesics|analgesics|mesh-ancestor
14453145|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
14453146|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453147|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453148|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
14453149|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14453150|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14453151|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453152|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14453153|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14453154|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14453155|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453156|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453157|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
14453158|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14453159|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14453160|NCT02040766|Beclomethasone|beclomethasone|mesh-list
14453161|NCT02040766|Albuterol|albuterol|mesh-list
14453162|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
14453163|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
14453164|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453165|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453166|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14453167|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
14453168|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
14453169|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14453170|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14453171|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14453172|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14453173|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453174|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453175|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453176|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453177|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
14453178|NCT02040766|Hormones|hormones|mesh-ancestor
14453179|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453180|NCT02040779|Beclomethasone|beclomethasone|mesh-list
14453181|NCT02040779|Albuterol|albuterol|mesh-list
14453182|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
14453183|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
14453184|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453185|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453186|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14453187|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
14453188|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
14453189|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14453190|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14453191|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14453192|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14453193|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453194|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453195|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453196|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453197|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
14453198|NCT02040779|Hormones|hormones|mesh-ancestor
14453199|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453200|NCT02040870|Ceritinib|ceritinib|mesh-list
14453201|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453202|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14453203|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453204|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453205|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14453206|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
14453207|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453208|NCT02041299|Deferiprone|deferiprone|mesh-list
14453209|NCT02041299|Deferoxamine|deferoxamine|mesh-list
14453210|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14453211|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
14453212|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
14453213|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453214|NCT02041299|Siderophores|siderophores|mesh-ancestor
14453215|NCT02041325|Lenalidomide|lenalidomide|mesh-list
14453216|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
14453217|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453218|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14453219|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14453220|NCT02041325|Growth Substances|growth substances|mesh-ancestor
14453221|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
14453222|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453223|NCT02041429|Paclitaxel|paclitaxel|mesh-list
14453224|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14453225|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453226|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14453227|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14453228|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14453229|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453230|NCT02042183|Lubiprostone|lubiprostone|mesh-list
14453231|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14453232|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14453233|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453234|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
14453235|NCT02042443|Leucovorin|leucovorin|mesh-list
14453236|NCT02042443|Folic Acid|folic acid|mesh-list
14453237|NCT02042443|Fluorouracil|fluorouracil|mesh-list
14453238|NCT02042443|Capecitabine|capecitabine|mesh-list
14453239|NCT02042443|Trametinib|trametinib|mesh-list
14453240|NCT02042443|Calcium|calcium|mesh-list
14453241|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
14453242|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14453243|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453244|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14453245|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
14453246|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453247|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453248|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453249|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453250|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
14453251|NCT02042443|Antidotes|antidotes|mesh-ancestor
14453252|NCT02042443|Protective Agents|protective agents|mesh-ancestor
14453253|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
14453254|NCT02042443|Vitamins|vitamins|mesh-ancestor
14453255|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
14453256|NCT02042443|Hematinics|hematinics|mesh-ancestor
14453257|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14453258|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453259|NCT02042534|Warfarin|warfarin|mesh-list
14453260|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
14453261|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
14453262|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14453263|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
14453264|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14453265|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
14453266|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453267|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453268|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
14453269|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14453270|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453271|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
14453272|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
14453273|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14453274|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453275|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
14453276|NCT02043132|Coagulants|coagulants|mesh-ancestor
14453277|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
14453278|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14453279|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14453280|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14453281|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14453282|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453283|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
14453284|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453285|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453286|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14453287|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453288|NCT02043301|Bococizumab|bococizumab|mesh-list
14453289|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14453290|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14453291|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
14453292|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453293|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14453294|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
14453295|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
14453296|NCT02043366|Sufentanil|sufentanil|mesh-list
14453297|NCT02043366|Remifentanil|remifentanil|mesh-list
14453298|NCT02043366|Butorphanol|butorphanol|mesh-list
14453299|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14453300|NCT02043366|Narcotics|narcotics|mesh-ancestor
14453301|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453302|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453303|NCT02043366|Analgesics|analgesics|mesh-ancestor
14453304|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
14453305|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453306|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14453307|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14453308|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
14453309|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
14453310|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14453311|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14453312|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453313|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453314|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14453315|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453316|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453317|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
14453318|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
14453319|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14453320|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14453321|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
14453322|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453323|NCT02043652|Chloroquine|chloroquine|mesh-list
14453324|NCT02043652|Primaquine|primaquine|mesh-list
14453325|NCT02043652|Amebicides|amebicides|mesh-ancestor
14453326|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14453327|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14453328|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453329|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
14453330|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453331|NCT02043704|Acetaminophen|acetaminophen|mesh-list
14453332|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14453333|NCT02043704|Analgesics|analgesics|mesh-ancestor
14453334|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
14453335|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453336|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453337|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
14453338|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14453339|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453340|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453341|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453342|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14453343|NCT02044094|Buprenorphine|buprenorphine|mesh-list
14453344|NCT02044094|Hydromorphone|hydromorphone|mesh-list
14453345|NCT02044094|Naloxone|naloxone|mesh-list
14453346|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14453347|NCT02044094|Narcotics|narcotics|mesh-ancestor
14453348|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453349|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453350|NCT02044094|Analgesics|analgesics|mesh-ancestor
14453351|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
14453352|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453353|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14453354|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
14453355|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14453356|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453357|NCT02044367|Dabigatran|dabigatran|mesh-list
14453358|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
14453359|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14930392|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
14930393|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
14930394|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930395|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930396|NCT01432873|Selenium|selenium|mesh-list
14453360|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
14453361|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453362|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453363|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
14453364|NCT02044380|Afatinib|afatinib|mesh-list
14453365|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453366|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14453367|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453368|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453369|NCT02044393|Itraconazole|itraconazole|mesh-list
14453370|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
14453371|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930397|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
14453372|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14453373|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14453374|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453375|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453376|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14453377|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
14453378|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453379|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453380|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14930398|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930399|NCT01432873|Protective Agents|protective agents|mesh-ancestor
14930400|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930401|NCT01432873|Trace Elements|trace elements|mesh-ancestor
14930402|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
14453381|NCT02044510|Mirabegron|mirabegron|mesh-list
14453382|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14453383|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14453384|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14453385|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453386|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453387|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930403|NCT01432977|Acetaminophen|acetaminophen|mesh-list
14453388|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453389|NCT02044510|Urological Agents|urological agents|mesh-ancestor
14453390|NCT02044796|Cytarabine|cytarabine|mesh-list
14453391|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14453392|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
14453393|NCT02044796|Cladribine|cladribine|mesh-list
14453394|NCT02044796|Lenograstim|lenograstim|mesh-list
14453395|NCT02044796|Sargramostim|sargramostim|mesh-list
14453396|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453397|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
14453398|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453399|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453400|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
14453401|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453402|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453403|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
14453404|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453405|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14453406|NCT02044796|Analgesics|analgesics|mesh-ancestor
14453407|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
14453408|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453409|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14453410|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14453411|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453412|NCT02045264|Icatibant|icatibant|mesh-list
14453413|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14930404|NCT01432977|Droperidol|droperidol|mesh-list
14930405|NCT01432977|Ondansetron|ondansetron|mesh-list
14930406|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14453414|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14453415|NCT02045264|Analgesics|analgesics|mesh-ancestor
14453416|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
14453417|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453418|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453419|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453420|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453421|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14453422|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14453423|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453424|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14453425|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453426|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
14453427|NCT02045836|Vaccines|vaccines|mesh-list
14453428|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14453429|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
14453430|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930407|NCT01432977|Analgesics|analgesics|mesh-ancestor
14930408|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
14930409|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453431|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
14453432|NCT02045862|Mirabegron|mirabegron|mesh-list
14453433|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14453434|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14453435|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
14453436|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453437|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453438|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453439|NCT02045862|Urological Agents|urological agents|mesh-ancestor
14453440|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14453441|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14453442|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14453443|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453444|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
14453445|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
14453446|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14453447|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
14453448|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453449|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453450|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14453451|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
14453452|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14453453|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14453454|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14453455|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453456|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453457|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453458|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453459|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453460|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14453461|NCT02045979|Adalimumab|adalimumab|mesh-list
14453462|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453463|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453464|NCT02046070|Dexamethasone|dexamethasone|mesh-list
14453465|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
14453466|NCT02046070|Ixazomib|ixazomib|mesh-list
14453467|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453468|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
14453469|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453470|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453471|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14453472|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
14453473|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453474|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453475|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14453476|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453477|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
14453478|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
14453479|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453480|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453481|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
14453482|NCT02046070|Hormones|hormones|mesh-ancestor
14453483|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453484|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14453485|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14453486|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453487|NCT02046122|Cytarabine|cytarabine|mesh-list
14453488|NCT02046122|Idarubicin|idarubicin|mesh-list
14453489|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453490|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
14453491|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453492|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453493|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
14453494|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453495|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453496|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
14453497|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453498|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14453499|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14453500|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14453501|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453502|NCT02046200|Ethanol|ethanol|mesh-list
14453503|NCT02046200|Ivermectin|ivermectin|mesh-list
14453504|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14453505|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453506|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453507|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453508|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14453509|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14453510|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14453511|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14453512|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453513|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453514|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14453515|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14453516|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14453517|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14453518|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453519|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453520|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453521|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14453522|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14453523|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
14453524|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14453525|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14453526|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
14453527|NCT02046382|Acetaminophen|acetaminophen|mesh-list
14453528|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14453529|NCT02046382|Analgesics|analgesics|mesh-ancestor
14453530|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
14453531|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453532|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453533|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
14453534|NCT02046603|Methotrexate|methotrexate|mesh-list
14453535|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14453536|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
14453537|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14453538|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453539|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453540|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
14453541|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453542|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453543|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453544|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453545|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14453546|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453547|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
14453548|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453549|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14453550|NCT02046616|Methotrexate|methotrexate|mesh-list
14453551|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14453552|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
14453553|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14453554|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453555|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453556|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
14453557|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453558|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453559|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453560|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453561|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14453562|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453563|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
14453564|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453565|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14453566|NCT02046772|Morphine|morphine|mesh-list
14453567|NCT02046772|Bupivacaine|bupivacaine|mesh-list
14453568|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
14453569|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
14453570|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453571|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453572|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
14453573|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453574|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14453575|NCT02046772|Narcotics|narcotics|mesh-ancestor
14453576|NCT02046772|Analgesics|analgesics|mesh-ancestor
14453577|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
14453578|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14453579|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14453580|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
14453581|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453582|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453583|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453584|NCT02047032|Urological Agents|urological agents|mesh-ancestor
14453585|NCT02047045|Prucalopride|prucalopride|mesh-list
14453586|NCT02047045|Serotonin|serotonin|mesh-list
14453587|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14453588|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
14453589|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453590|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453591|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453592|NCT02047045|Laxatives|laxatives|mesh-ancestor
14453593|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453594|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14453595|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14453596|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
14453597|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453598|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14453599|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14453600|NCT02047227|Hormones|hormones|mesh-ancestor
14453601|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453602|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453603|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14453604|NCT02047253|Acyclovir|acyclovir|mesh-list
14453605|NCT02047253|Dexamethasone|dexamethasone|mesh-list
14453606|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453607|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
14453608|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
14453609|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453610|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453611|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453612|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
14453613|NCT02047253|Hormones|hormones|mesh-ancestor
14453614|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453615|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14453616|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453617|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
14453618|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453619|NCT02047500|Gemcitabine|gemcitabine|mesh-list
14453620|NCT02047500|Paclitaxel|paclitaxel|mesh-list
14453621|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14453622|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453623|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
14453624|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
14453625|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
14453626|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453627|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453628|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
14453629|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
14453630|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453631|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453632|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453633|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
14453634|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469415|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469416|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
14930410|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930411|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
14930412|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
14930413|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
14930414|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14930415|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
14469417|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469418|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
14469419|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469420|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14469421|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14469422|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469423|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469424|NCT02294253|Buprenorphine|buprenorphine|mesh-list
14469425|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14469426|NCT02294253|Naloxone|naloxone|mesh-list
14469427|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14469428|NCT02294253|Narcotics|narcotics|mesh-ancestor
14469429|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469430|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469431|NCT02294253|Analgesics|analgesics|mesh-ancestor
14469432|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
14469433|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469434|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14469435|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
14469436|NCT02294396|Mirabegron|mirabegron|mesh-list
14469437|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14469438|NCT02294396|Propiverine|propiverine|mesh-list
14469439|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14469440|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14469441|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
14469442|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469443|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469444|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469445|NCT02294396|Urological Agents|urological agents|mesh-ancestor
14930416|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453635|NCT02047734|Interferons|interferons|mesh-list
14453636|NCT02047734|Interferon-beta|interferon-beta|mesh-list
14453637|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
14453638|NCT02047734|Ozanimod|ozanimod|mesh-list
14453639|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453640|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
14453641|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453642|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
14453643|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453644|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14453645|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14453646|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453647|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453648|NCT02047903|Afatinib|afatinib|mesh-list
14930417|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14930418|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
14930419|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930420|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930421|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14453649|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453650|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14453651|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453652|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453653|NCT02047981|Azithromycin|azithromycin|mesh-list
14453654|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14453655|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453656|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14453657|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14453658|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453659|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453660|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
14453661|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453662|NCT02048241|Guanfacine|guanfacine|mesh-list
14453663|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14453664|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14453665|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14453666|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14930422|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14453667|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453668|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453669|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453670|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453671|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14453672|NCT02048891|Progesterone|progesterone|mesh-list
14453673|NCT02048891|Progestins|progestins|mesh-ancestor
14453674|NCT02048891|Hormones|hormones|mesh-ancestor
14453675|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453676|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453677|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
14453678|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14453679|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
14453680|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14453681|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14453682|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14453683|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453684|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
14453685|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453686|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
14453687|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453688|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453689|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14453690|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
14453691|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453692|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453693|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14453694|NCT02049307|Losartan|losartan|mesh-list
14453695|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14453696|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14453697|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14453698|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14453699|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453700|NCT02049385|Diazoxide|diazoxide|mesh-list
14453701|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14453702|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
14930423|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453703|NCT02049476|Dexamethasone|dexamethasone|mesh-list
14453704|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453705|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
14453706|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
14453707|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453708|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453709|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453710|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
14453711|NCT02049476|Hormones|hormones|mesh-ancestor
14453712|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453713|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14453714|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453715|NCT02049814|Metformin|metformin|mesh-list
14453716|NCT02049814|Acarbose|acarbose|mesh-list
14453717|NCT02049814|Voglibose|voglibose|mesh-list
14453718|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14453719|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453720|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14453721|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453722|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453723|NCT02049866|Denosumab|denosumab|mesh-list
14453724|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14453725|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453726|NCT02049944|Cefazolin|cefazolin|mesh-list
14453727|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14453728|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453729|NCT02049957|Fulvestrant|fulvestrant|mesh-list
14453730|NCT02049957|Exemestane|exemestane|mesh-list
14453731|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14453732|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453733|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14453734|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14453735|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
14453736|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453737|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453738|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14453739|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14453740|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453741|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453742|NCT02050321|Vemurafenib|vemurafenib|mesh-list
14453743|NCT02050321|Acitretin|acitretin|mesh-list
14453744|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453745|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14453746|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453747|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453748|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
14453749|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453750|NCT02050334|Caffeic acid|caffeic acid|mesh-list
14453751|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
14453752|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453753|NCT02050334|Protective Agents|protective agents|mesh-ancestor
14453754|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453755|NCT02051296|Minocycline|minocycline|mesh-list
14453756|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14453757|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453758|NCT02051335|Scopolamine|scopolamine|mesh-list
14453759|NCT02051335|Donepezil|donepezil|mesh-list
14453760|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14453761|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14453762|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453763|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453764|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
14453765|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453766|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453767|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
14453768|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14453769|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
14453770|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
14453771|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453772|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453773|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
14453774|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14453775|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14453776|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
14453777|NCT02051452|Methylphenidate|methylphenidate|mesh-list
14453778|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14453779|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453780|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14453781|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14453782|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14453783|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453784|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
14453785|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453786|NCT02051595|Vancomycin|vancomycin|mesh-list
14453787|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14453788|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453789|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
14453790|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14453791|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14453792|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453793|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
14453794|NCT02051686|Coagulants|coagulants|mesh-ancestor
14453795|NCT02052011|Ranolazine|ranolazine|mesh-list
14453796|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14453797|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14453798|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453799|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14453800|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14453801|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453802|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
14453803|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453804|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
14453805|NCT02052310|Hematinics|hematinics|mesh-ancestor
14453806|NCT02052414|Gabapentin|gabapentin|mesh-list
14453807|NCT02052414|Analgesics|analgesics|mesh-ancestor
14453808|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
14453809|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453810|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453811|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
14453812|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14453813|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14453814|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453815|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14453816|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14453817|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14453818|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453819|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453820|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
14453821|NCT02052440|Baclofen|baclofen|mesh-list
14453822|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14453823|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453824|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14453825|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453826|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14453827|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
14453828|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
14453829|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453830|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453831|NCT02052557|Bupivacaine|bupivacaine|mesh-list
14453832|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
14453833|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
14453834|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453835|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453836|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
14453837|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453838|NCT02052635|Clopidogrel|clopidogrel|mesh-list
14453839|NCT02052635|Ticagrelor|ticagrelor|mesh-list
14453840|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14453841|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14453842|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14453843|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14453844|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
14453845|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453846|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453847|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453848|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14453849|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453850|NCT02052960|Cisplatin|cisplatin|mesh-list
14453851|NCT02052960|Fluorouracil|fluorouracil|mesh-list
14453852|NCT02052960|Cetuximab|cetuximab|mesh-list
14453853|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453854|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
14453855|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453856|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453857|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453858|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
14453859|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453860|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14453861|NCT02053493|Isosorbide|isosorbide|mesh-list
14453862|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14453863|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14453864|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14453865|NCT02053493|Diuretics|diuretics|mesh-ancestor
14453866|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
14453867|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453868|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
14453869|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14453870|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453871|NCT02053610|Rituximab|rituximab|mesh-list
14453872|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
14453873|NCT02053610|Chlorambucil|chlorambucil|mesh-list
14453874|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14453875|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453876|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
14453877|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453878|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14453879|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14453880|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
14453881|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453882|NCT02053753|Denosumab|denosumab|mesh-list
14453883|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14453884|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453885|NCT02054156|Azithromycin|azithromycin|mesh-list
14453886|NCT02054156|Tobramycin|tobramycin|mesh-list
14453887|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14453888|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453889|NCT02054325|Polidocanol|polidocanol|mesh-list
14453890|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14453891|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14453892|NCT02054338|Gemcitabine|gemcitabine|mesh-list
14453893|NCT02054338|Paclitaxel|paclitaxel|mesh-list
14453894|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14453895|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453896|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
14453897|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
14453898|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
14453899|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453900|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14453901|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
14453902|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
14453903|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14453904|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14453905|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453906|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
14453907|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453908|NCT02054481|Ustekinumab|ustekinumab|mesh-list
14453909|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14453910|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453911|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
14453912|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453913|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
14453914|NCT02054520|Nivolumab|nivolumab|mesh-list
14453915|NCT02054520|Ipilimumab|ipilimumab|mesh-list
14453916|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14453917|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14453918|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14453919|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453920|NCT02054702|Aripiprazole|aripiprazole|mesh-list
14453921|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
14453922|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
14453923|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14453924|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14453925|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14453926|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14453927|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453928|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
14453929|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
14453930|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469446|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14453931|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453932|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14453933|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14453934|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
14453935|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14453936|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14453937|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14453938|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14453939|NCT02054754|HU 211|hu 211|mesh-list
14453940|NCT02054754|Dronabinol|dronabinol|mesh-list
14453941|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14453942|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
14453943|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
14453944|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453945|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453946|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14453947|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14453948|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14453949|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453950|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453951|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14453952|NCT02054754|Protective Agents|protective agents|mesh-ancestor
14453953|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
14453954|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14453955|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14453956|NCT02054754|Analgesics|analgesics|mesh-ancestor
14453957|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
14930424|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14453958|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14453959|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14453960|NCT02054754|Hormones|hormones|mesh-ancestor
14453961|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453962|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
14453963|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
14453964|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453965|NCT02055352|Fluticasone|fluticasone|mesh-list
14453966|NCT02055352|Budesonide|budesonide|mesh-list
14453967|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14453968|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14453969|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14453970|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
14453971|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14453972|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453973|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14453974|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
14453975|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
14453976|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14453977|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
14453978|NCT02055352|Hormones|hormones|mesh-ancestor
14453979|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14453980|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14453981|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14453982|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14453983|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
14453984|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14453985|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453986|NCT02055638|SRX246|srx246|mesh-list
14453987|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14453988|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14453989|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
14453990|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14453991|NCT02055820|Prednisone|prednisone|mesh-list
14453992|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
14453993|NCT02055820|Rituximab|rituximab|mesh-list
14453994|NCT02055820|Doxorubicin|doxorubicin|mesh-list
14453995|NCT02055820|Vincristine|vincristine|mesh-list
14453996|NCT02055820|Venetoclax|venetoclax|mesh-list
14453997|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
14453998|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14453999|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
14454000|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454001|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454002|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14454003|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
14454004|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454005|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454006|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14454007|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14454008|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14454009|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14454010|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14454011|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454012|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454013|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
14454014|NCT02055820|Hormones|hormones|mesh-ancestor
14454015|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454016|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14454017|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14454018|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
14454019|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
14454020|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
14454021|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
14454022|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14454023|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14454024|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
14454025|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
14454026|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454027|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454028|NCT02055976|Ezetimibe|ezetimibe|mesh-list
14454029|NCT02055976|Bococizumab|bococizumab|mesh-list
14454030|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14454031|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14454032|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
14454033|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454034|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14454035|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14454036|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
14454037|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14454038|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14454039|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14454040|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454041|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454042|NCT02056288|Fentanyl|fentanyl|mesh-list
14454043|NCT02056288|Ropivacaine|ropivacaine|mesh-list
14454044|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
14454045|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
14454046|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454047|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454048|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
14454049|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454050|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14454051|NCT02056288|Narcotics|narcotics|mesh-ancestor
14454052|NCT02056288|Analgesics|analgesics|mesh-ancestor
14454053|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14454054|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14454055|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
14454056|NCT02056301|Morphine|morphine|mesh-list
14454057|NCT02056301|Hydromorphone|hydromorphone|mesh-list
14454058|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14454059|NCT02056301|Narcotics|narcotics|mesh-ancestor
14454060|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454061|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454062|NCT02056301|Analgesics|analgesics|mesh-ancestor
14454063|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
14454064|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454065|NCT02056340|Atorvastatin|atorvastatin|mesh-list
14454066|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14454067|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14454068|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
14454069|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454070|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14454071|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14454072|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454073|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
14454074|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14454075|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454076|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14454077|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14454078|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454079|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454080|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454081|NCT02056626|Carvedilol|carvedilol|mesh-list
14454082|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14454083|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14454084|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454085|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454086|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454087|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454088|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14454089|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
14454090|NCT02056626|Protective Agents|protective agents|mesh-ancestor
14454091|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14454092|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454093|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14454094|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
14454095|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14454096|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14454097|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14454098|NCT02057198|Metronidazole|metronidazole|mesh-list
14454099|NCT02057198|Vancomycin|vancomycin|mesh-list
14454100|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
14454101|NCT02057198|Amebicides|amebicides|mesh-list
14454102|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454103|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14454104|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14454105|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
14454106|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
14454107|NCT02057250|Methotrexate|methotrexate|mesh-list
14454108|NCT02057250|Leflunomide|leflunomide|mesh-list
14454109|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14454110|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
14454111|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14454112|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454113|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14454114|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
14454115|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454116|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454117|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454118|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454119|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14454120|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14454121|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
14454122|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454123|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14454124|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
14454125|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14454126|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14454127|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454128|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14454129|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14454130|NCT02057250|Analgesics|analgesics|mesh-ancestor
14454131|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
14454132|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454133|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454134|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14454135|NCT02057393|Methylene Blue|methylene blue|mesh-list
14454136|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454137|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454138|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
14454139|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
14454140|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14454141|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14454142|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454143|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454144|NCT02057458|Urological Agents|urological agents|mesh-ancestor
14454145|NCT02057523|Hormones|hormones|mesh-list
14454146|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14454147|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14454148|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
14454149|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454150|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454151|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454152|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454153|NCT02057549|Haloperidol|haloperidol|mesh-list
14454154|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
14454155|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
14454156|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
14454157|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454158|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454159|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14454160|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14454161|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14454162|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454163|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14454164|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14454165|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
14454166|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454167|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454168|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14469447|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14469448|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14469449|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
14469450|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
14469451|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
14469452|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469453|NCT02294474|Insulin|insulin|mesh-list
14469454|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14469455|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
14469456|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
14469457|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14469458|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469459|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
14469460|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14454169|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14454170|NCT02057575|Latanoprost|latanoprost|mesh-list
14454171|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14454172|NCT02057640|Dexamethasone|dexamethasone|mesh-list
14454173|NCT02057640|Ixazomib|ixazomib|mesh-list
14454174|NCT02057640|Panobinostat|panobinostat|mesh-list
14454175|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454176|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
14454177|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
14454178|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454179|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454180|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14454181|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
14454182|NCT02057640|Hormones|hormones|mesh-ancestor
14454183|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454184|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14454185|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454186|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454187|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454188|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454189|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14454190|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
14454191|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14454192|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454193|NCT02057939|Leuprolide|leuprolide|mesh-list
14454194|NCT02057939|Androgens|androgens|mesh-list
14454195|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14454196|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
14454197|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14454198|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454199|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14454200|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454201|NCT02057939|Hormones|hormones|mesh-ancestor
14454202|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454203|NCT02058095|Tadalafil|tadalafil|mesh-list
14454204|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
14454205|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14454206|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14454207|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454208|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454209|NCT02058095|Urological Agents|urological agents|mesh-ancestor
14454210|NCT02058108|Telbivudine|telbivudine|mesh-list
14454211|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
14454212|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454213|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14454214|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454215|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454216|NCT02058147|Insulin|insulin|mesh-list
14454217|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14454218|NCT02058147|Metformin|metformin|mesh-list
14454219|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
14454220|NCT02058147|Lixisenatide|lixisenatide|mesh-list
14454221|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454222|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454223|NCT02058160|Insulin|insulin|mesh-list
14454224|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14454225|NCT02058160|Metformin|metformin|mesh-list
14454226|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
14454227|NCT02058160|Lixisenatide|lixisenatide|mesh-list
14454228|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454229|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454230|NCT02058251|Oxytocin|oxytocin|mesh-list
14454231|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
14454232|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14454233|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454234|NCT02058290|Morphine|morphine|mesh-list
14454235|NCT02058290|Bupivacaine|bupivacaine|mesh-list
14454236|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
14454237|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
14454238|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454239|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454240|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
14454241|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454242|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14454243|NCT02058290|Narcotics|narcotics|mesh-ancestor
14454244|NCT02058290|Analgesics|analgesics|mesh-ancestor
14454245|NCT02058368|Tamsulosin|tamsulosin|mesh-list
14454246|NCT02058368|Dutasteride|dutasteride|mesh-list
14454247|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14454248|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14454249|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14454250|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454251|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454252|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454253|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454254|NCT02058368|Urological Agents|urological agents|mesh-ancestor
14469461|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
14454255|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14454256|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14454257|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454258|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
14454259|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454260|NCT02058511|Anesthetics|anesthetics|mesh-list
14454261|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454262|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454263|NCT02058628|Clindamycin|clindamycin|mesh-list
14454264|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
14454265|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
14454266|NCT02058628|Azelaic acid|azelaic acid|mesh-list
14454267|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14454268|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454269|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14454270|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454271|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454272|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454273|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454274|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
14454275|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14454276|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14454277|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454278|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454279|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
14454280|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454281|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454282|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14454283|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454284|NCT02058940|Exenatide|exenatide|mesh-list
14454285|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454286|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454287|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14454288|NCT02058940|Incretins|incretins|mesh-ancestor
14454289|NCT02058940|Hormones|hormones|mesh-ancestor
14454290|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454291|NCT02058966|Entacapone|entacapone|mesh-list
14454292|NCT02058966|Methamphetamine|methamphetamine|mesh-list
14454293|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14454294|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14454295|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14454296|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454297|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454298|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14454299|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454300|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
14454301|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
14454302|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454303|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
14454304|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454305|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454306|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14454307|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14454308|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454309|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14454310|NCT02059070|Bupivacaine|bupivacaine|mesh-list
14454311|NCT02059070|Ropivacaine|ropivacaine|mesh-list
14454312|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
14454313|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
14454314|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454315|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454316|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
14454317|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454318|NCT02059135|Antithrombins|antithrombins|mesh-list
14454319|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
14454320|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14454321|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454322|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454323|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454324|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
14454325|NCT02059161|Insulin|insulin|mesh-list
14454326|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14454327|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
14454328|NCT02059161|MK-1293|mk-1293|mesh-list
14454329|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454330|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454331|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14454332|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
14454333|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454334|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14454335|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
14454336|NCT02059174|MK-1293|mk-1293|mesh-list
14454337|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454338|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454339|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14454340|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
14454341|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454342|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14454343|NCT02059187|Insulin|insulin|mesh-list
14454344|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14454345|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
14454346|NCT02059187|MK-1293|mk-1293|mesh-list
14454347|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454348|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454349|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14454350|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
14454351|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454352|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14454353|NCT02059213|Palbociclib|palbociclib|mesh-list
14454354|NCT02059213|Leuprolide|leuprolide|mesh-list
14454355|NCT02059213|Goserelin|goserelin|mesh-list
14454356|NCT02059213|Bicalutamide|bicalutamide|mesh-list
14454357|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454358|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14454359|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454360|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454361|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14454362|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
14454363|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14454364|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454365|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14454366|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
14454367|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
14454368|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454369|NCT02059239|Cytarabine|cytarabine|mesh-list
14454370|NCT02059239|Rituximab|rituximab|mesh-list
14454371|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
14454372|NCT02059239|Etoposide|etoposide|mesh-list
14454373|NCT02059239|Melphalan|melphalan|mesh-list
14454374|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14454375|NCT02059239|Carmustine|carmustine|mesh-list
14454376|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14454377|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454378|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
14454379|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454380|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454381|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14454382|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14454383|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14454384|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454385|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454386|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14454387|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
14454388|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
14454389|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454390|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14454391|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14454392|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
14454393|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14454394|NCT02059278|Latanoprost|latanoprost|mesh-list
14454395|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14454396|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14454397|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
14454398|NCT02059434|LAS190792|las190792|mesh-list
14454399|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14454400|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
14454401|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454402|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454403|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14454404|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
14454405|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
14454406|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14454407|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
14454408|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454409|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454410|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14454411|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14454412|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14454413|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14454414|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454415|NCT02059642|Metadoxine|metadoxine|mesh-list
14454416|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14454417|NCT02059902|Lidocaine|lidocaine|mesh-list
14454418|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
14454419|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
14454420|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454421|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454422|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
14454423|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454424|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14454425|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14454426|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14454427|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454428|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454429|NCT02060370|Sunitinib|sunitinib|mesh-list
14454430|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454431|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14454432|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14454433|NCT02060370|Growth Substances|growth substances|mesh-ancestor
14454434|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454435|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
14454436|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14454437|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454438|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454439|NCT02060383|Metformin|metformin|mesh-list
14454440|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14454441|NCT02060383|Liraglutide|liraglutide|mesh-list
14454442|NCT02060383|Pasireotide|pasireotide|mesh-list
14454443|NCT02060383|Somatostatin|somatostatin|mesh-list
14454444|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454445|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454446|NCT02060383|Incretins|incretins|mesh-ancestor
14454447|NCT02060383|Hormones|hormones|mesh-ancestor
14454448|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454449|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14454450|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454451|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454452|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454453|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
14454454|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454455|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454456|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14454457|NCT02061280|Fluticasone|fluticasone|mesh-list
14454458|NCT02061280|Xhance|xhance|mesh-list
14454459|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14454460|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14454461|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454462|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14454463|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
14454464|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454465|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454466|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14454467|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
14454468|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454469|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14454470|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14454471|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14454472|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14454473|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454474|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454475|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454476|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
14454477|NCT02061280|Hormones|hormones|mesh-ancestor
14454478|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454479|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
14454480|NCT02061384|Calcitriol|calcitriol|mesh-list
14454481|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14454482|NCT02061384|Tretinoin|tretinoin|mesh-list
14454483|NCT02061384|Isotretinoin|isotretinoin|mesh-list
14454484|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454485|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
14454486|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454487|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14454488|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454489|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14454490|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454491|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454492|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14454493|NCT02061384|Vitamins|vitamins|mesh-ancestor
14454494|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
14454495|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14454496|NCT02061397|Sirolimus|sirolimus|mesh-list
14454497|NCT02061397|Everolimus|everolimus|mesh-list
14454498|NCT02061397|Simvastatin|simvastatin|mesh-list
14454499|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454500|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14454501|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
14454502|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454503|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14454504|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454505|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14454506|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
14454507|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14454508|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14454509|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
14454510|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454511|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14454512|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14454513|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454514|NCT02061683|Bimatoprost|bimatoprost|mesh-list
14454515|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14454516|NCT02061774|Acetaminophen|acetaminophen|mesh-list
14454517|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14454518|NCT02061774|Analgesics|analgesics|mesh-ancestor
14454519|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
14454520|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454521|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454522|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
14454523|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
14454524|NCT02061969|Linagliptin|linagliptin|mesh-list
14454525|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454526|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454527|NCT02061969|Incretins|incretins|mesh-ancestor
14454528|NCT02061969|Hormones|hormones|mesh-ancestor
14454529|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454530|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14454531|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454532|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454533|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454534|NCT02062177|Midazolam|midazolam|mesh-list
14454535|NCT02062177|Propofol|propofol|mesh-list
14454536|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14454537|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454538|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454539|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14454540|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
14454541|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
14454542|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14454543|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14454544|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14454545|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14454546|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
14454547|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
14454548|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454549|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454550|NCT02062359|Aldesleukin|aldesleukin|mesh-list
14454551|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
14454552|NCT02062359|Fludarabine|fludarabine|mesh-list
14454553|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14454554|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
14454555|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454556|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454557|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14454558|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
14454559|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454560|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454561|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14454562|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14454563|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14454564|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
14454565|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454566|NCT02062632|Doxepin|doxepin|mesh-list
14454567|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14454568|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14454569|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454570|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454571|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14454572|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
14454573|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14454574|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
14454575|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
14454576|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454577|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454578|NCT02062645|Amlodipine|amlodipine|mesh-list
14454579|NCT02062645|Valsartan|valsartan|mesh-list
14454580|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14454581|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14454582|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14454583|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454584|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454585|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14454586|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454587|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
14454588|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14454589|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14454590|NCT02062658|Ketamine|ketamine|mesh-list
14454591|NCT02062658|Analgesics|analgesics|mesh-ancestor
14454592|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
14454593|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454594|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454595|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14454596|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14454597|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
14454598|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
14454599|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454600|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14454601|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14454602|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454603|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454604|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
14454605|NCT02062710|Promethazine|promethazine|mesh-list
14454606|NCT02062710|Phenylephrine|phenylephrine|mesh-list
14454607|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
14454608|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
14454609|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14454610|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
14454611|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
14454612|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454613|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454614|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
14454615|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14454616|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
14454617|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
14454618|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14454619|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14454620|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14454621|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454622|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454623|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454624|NCT02062710|Protective Agents|protective agents|mesh-ancestor
14454625|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14454626|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14454627|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454628|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
14454629|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
14454630|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
14454631|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
14454632|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14454633|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14454634|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
14454635|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
14454636|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14454637|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
14454638|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454639|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
14454640|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14454641|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14454642|NCT02062801|Ephedrine|ephedrine|mesh-list
14454643|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14454644|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454645|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
14454646|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
14454647|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454648|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14454649|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454650|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454651|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454652|NCT02062879|Ketamine|ketamine|mesh-list
14454653|NCT02062879|Hydromorphone|hydromorphone|mesh-list
14454654|NCT02062879|Analgesics|analgesics|mesh-ancestor
14454655|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
14454656|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454657|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454658|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14454659|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14454660|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
14454661|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
14454662|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454663|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14454664|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14454665|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454666|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454667|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14454668|NCT02062879|Narcotics|narcotics|mesh-ancestor
14454669|NCT02062905|Dexamethasone|dexamethasone|mesh-list
14454670|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454671|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
14454672|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
14454673|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454674|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454675|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14454676|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
14454677|NCT02062905|Hormones|hormones|mesh-ancestor
14752470|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454678|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454679|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14454680|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454681|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
14454682|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14454683|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14454684|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454685|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
14454686|NCT02063035|Coagulants|coagulants|mesh-ancestor
14454687|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
14454688|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14454689|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14454690|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
14454691|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
14454692|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454693|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454694|NCT02063698|Auranofin|auranofin|mesh-list
14454695|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469462|NCT02294604|Povidone|povidone|mesh-list
14469463|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14469464|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469465|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
14469466|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469467|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
14469468|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
14469469|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14469470|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469471|NCT02294734|Nemiralisib|nemiralisib|mesh-list
14469472|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469473|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469474|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469475|NCT02294773|Letrozole|letrozole|mesh-list
14469476|NCT02294773|Clomiphene|clomiphene|mesh-list
14469477|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469478|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14469479|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14469480|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469481|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469482|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14469483|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469484|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469485|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469486|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14469487|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
14469488|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14469489|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14469490|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14469491|NCT02294786|Capecitabine|capecitabine|mesh-list
14469492|NCT02294786|Lapatinib|lapatinib|mesh-list
14469493|NCT02294786|Octreotide|octreotide|mesh-list
14469494|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14469495|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
14469496|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469497|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469498|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469499|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469500|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469501|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14469502|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
14469503|NCT02295280|Promethazine|promethazine|mesh-list
14469504|NCT02295280|Codeine|codeine|mesh-list
14469505|NCT02295280|Metoclopramide|metoclopramide|mesh-list
14469506|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14469507|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14469508|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930425|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14454696|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
14454697|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
14454698|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14454699|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454700|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454701|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14454702|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454703|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14454704|NCT02064166|Insulin|insulin|mesh-list
14454705|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454706|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454707|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
14454708|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14454709|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
14454710|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14454711|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454712|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454713|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454714|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
14454715|NCT02064582|Leuprolide|leuprolide|mesh-list
14454716|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14454717|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
14454718|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14454719|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454720|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14454721|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454722|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
14454723|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14454724|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
14454725|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454726|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454727|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
14454728|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454729|NCT02064894|Ibuprofen|ibuprofen|mesh-list
14454730|NCT02064894|Morphine|morphine|mesh-list
14454731|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14454732|NCT02064894|Narcotics|narcotics|mesh-ancestor
14454733|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454734|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454735|NCT02064894|Analgesics|analgesics|mesh-ancestor
14454736|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
14454737|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454738|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14454739|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14454740|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454741|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454742|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14454743|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454744|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454745|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
14454746|NCT02064907|Lansoprazole|lansoprazole|mesh-list
14454747|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14454748|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14454749|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14454750|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454751|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454752|NCT02064920|Donepezil|donepezil|mesh-list
14454753|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14454754|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454755|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454756|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
14454757|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454758|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454759|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
14454760|NCT02064985|Ticagrelor|ticagrelor|mesh-list
14454761|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14454762|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14454763|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14454764|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14454765|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
14454766|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454767|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454768|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454769|NCT02065245|Penicillins|penicillins|mesh-list
14454770|NCT02065245|Streptomycin|streptomycin|mesh-list
14454771|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14454772|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454773|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14454774|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454775|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454776|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
14454777|NCT02065336|Entecavir|entecavir|mesh-list
14454778|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
14454779|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454780|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
14454781|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454782|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14454783|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
14454784|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
14454785|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454786|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454787|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454788|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14454789|NCT02065479|Ticagrelor|ticagrelor|mesh-list
14454790|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14454791|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14454792|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14454793|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14454794|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14454795|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
14454796|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454797|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454798|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454799|NCT02065557|Adalimumab|adalimumab|mesh-list
14454800|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454801|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454802|NCT02065570|Adalimumab|adalimumab|mesh-list
14454803|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454804|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454805|NCT02065622|Adalimumab|adalimumab|mesh-list
14454806|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454807|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454808|NCT02065687|Metformin|metformin|mesh-list
14454809|NCT02065687|Paclitaxel|paclitaxel|mesh-list
14454810|NCT02065687|Carboplatin|carboplatin|mesh-list
14454811|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14454812|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14454813|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454814|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
14454815|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
14454816|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
14454817|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454818|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454819|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454820|NCT02065713|Golimumab|golimumab|mesh-list
14454821|NCT02065713|Methotrexate|methotrexate|mesh-list
14931193|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14454822|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14454823|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
14454824|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14454825|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454826|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14454827|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
14454828|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454829|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454830|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454831|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454832|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14454833|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14454834|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
14454835|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454836|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14454837|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14454838|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454839|NCT02065791|Canagliflozin|canagliflozin|mesh-list
14454840|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14454841|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454842|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454843|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454844|NCT02066129|Fluticasone|fluticasone|mesh-list
14454845|NCT02066129|Xhance|xhance|mesh-list
14454846|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454847|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14454848|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
14454849|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454850|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454851|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14454852|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
14454853|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454854|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14454855|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
14454856|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
14454857|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14454858|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
14454859|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454860|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454861|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14454862|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
14454863|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
14454864|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14454865|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
14454866|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454867|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454868|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14454869|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454870|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14454871|NCT02066311|Nelfinavir|nelfinavir|mesh-list
14454872|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14454873|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14454874|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454875|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454876|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454877|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14454878|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14454879|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
14454880|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454881|NCT02066389|Upadacitinib|upadacitinib|mesh-list
14454882|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14454883|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14454884|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454885|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454886|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14454887|NCT02066402|Linezolid|linezolid|mesh-list
14454888|NCT02066402|Tedizolid|tedizolid|mesh-list
14454889|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
14454890|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14454891|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454892|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14454893|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454894|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454902|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
14454903|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14454904|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454905|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454906|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14454907|NCT02066727|Analgesics|analgesics|mesh-ancestor
14454908|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
14454909|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454910|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14454911|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14454912|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14454913|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454914|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930426|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14930427|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14930428|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14930429|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
14930430|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14930431|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
14930432|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930433|NCT01433289|Protective Agents|protective agents|mesh-ancestor
14930434|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930435|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14752471|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752472|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752473|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
14752474|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752475|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752476|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
14752477|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14930436|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14930437|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930438|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14752478|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
14752479|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
14752480|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752481|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752482|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752483|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14752484|NCT05337254|Analgesics|analgesics|mesh-ancestor
14752485|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
14930439|NCT01433328|Lidocaine|lidocaine|mesh-list
14454915|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454916|NCT02066792|Cycloserine|cycloserine|mesh-list
14454917|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14454918|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454919|NCT02066792|Renal Agents|renal agents|mesh-ancestor
14454920|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14454921|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
14454922|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14454923|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
14454924|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454925|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
14454926|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14454927|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
14454928|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14454929|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454930|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14454931|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14454932|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14454933|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14454934|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14454935|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
14454936|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454937|NCT02067676|Antacids|antacids|mesh-ancestor
14454938|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454939|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14454940|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
14454941|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
14454942|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
14454943|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14454944|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454945|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
14454946|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454947|NCT02068027|Clonidine|clonidine|mesh-list
14454948|NCT02068027|Analgesics|analgesics|mesh-ancestor
14454949|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
14454950|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14454951|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454952|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14454953|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
14454954|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
14454955|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14454956|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14454957|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14454958|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
14454959|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14454960|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454961|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14454962|NCT02068157|Trioxsalen|trioxsalen|mesh-list
14454963|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14454964|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
14454965|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14454966|NCT02068222|Ritonavir|ritonavir|mesh-list
14454967|NCT02068222|Ribavirin|ribavirin|mesh-list
14454968|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14454969|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14454970|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454971|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454972|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454973|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14454974|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14454975|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
14454976|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14454977|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14454978|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14454979|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
14454980|NCT02068443|Metformin|metformin|mesh-list
14454981|NCT02068443|Alogliptin|alogliptin|mesh-list
14454982|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14454983|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14454984|NCT02068443|Incretins|incretins|mesh-ancestor
14454985|NCT02068443|Hormones|hormones|mesh-ancestor
14454986|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14454987|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14454988|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
14454989|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14454990|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454991|NCT02068495|Amlodipine|amlodipine|mesh-list
14454992|NCT02068495|Candesartan|candesartan|mesh-list
14454993|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
14454994|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14454995|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14454996|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14454997|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14454998|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14454999|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455000|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
14455001|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14455002|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14455003|NCT02068508|Pioglitazone|pioglitazone|mesh-list
14455004|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14455005|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455006|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
14455007|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
14455008|NCT02068820|Protective Agents|protective agents|mesh-ancestor
14455009|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455010|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
14455011|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14455012|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455013|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14455014|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14455015|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455016|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455017|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455018|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14455019|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14455020|NCT02069041|Leucovorin|leucovorin|mesh-list
14455021|NCT02069041|Fluorouracil|fluorouracil|mesh-list
14455022|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
14455023|NCT02069041|Ramucirumab|ramucirumab|mesh-list
14455024|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
14455025|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455026|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14455027|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455028|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455029|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
14455030|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455031|NCT02069041|Antidotes|antidotes|mesh-ancestor
14455032|NCT02069041|Protective Agents|protective agents|mesh-ancestor
14455033|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
14455034|NCT02069041|Vitamins|vitamins|mesh-ancestor
14455035|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
14455036|NCT02069093|Dexamethasone|dexamethasone|mesh-list
14455037|NCT02069093|Everolimus|everolimus|mesh-list
14455038|NCT02069093|Exemestane|exemestane|mesh-list
14455039|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455040|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
14455041|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
14455042|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455043|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455044|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455045|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
14455046|NCT02069093|Hormones|hormones|mesh-ancestor
14455047|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455048|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14455049|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455050|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455051|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
14455052|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14455053|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14455054|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455055|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455056|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14455057|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
14455058|NCT02069184|Acetaminophen|acetaminophen|mesh-list
14455059|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455060|NCT02069184|Analgesics|analgesics|mesh-ancestor
14455061|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
14455062|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455063|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455064|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
14455065|NCT02069379|Metformin|metformin|mesh-list
14455066|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14455067|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455068|NCT02069392|Nicotine|nicotine|mesh-list
14455069|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14455070|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
14455071|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455072|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455073|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14455074|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14455075|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
14752486|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752487|NCT05337137|Bevacizumab|bevacizumab|mesh-list
14752488|NCT05337137|Nivolumab|nivolumab|mesh-list
14752489|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752490|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752491|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14752492|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14752493|NCT05337137|Growth Substances|growth substances|mesh-ancestor
14455076|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455077|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455078|NCT02069704|Leucovorin|leucovorin|mesh-list
14455079|NCT02069704|Folic Acid|folic acid|mesh-list
14455080|NCT02069704|Bevacizumab|bevacizumab|mesh-list
14455081|NCT02069704|Fluorouracil|fluorouracil|mesh-list
14455082|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
14455083|NCT02069704|Irinotecan|irinotecan|mesh-list
14455084|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
14455085|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14455086|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455087|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14455088|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14455089|NCT02069704|Growth Substances|growth substances|mesh-ancestor
14455090|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455091|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14455092|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
14455093|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455094|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14455095|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455096|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
14455097|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14455098|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14455099|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455100|NCT02069704|Antidotes|antidotes|mesh-ancestor
14455101|NCT02069704|Protective Agents|protective agents|mesh-ancestor
14455102|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
14455103|NCT02069704|Vitamins|vitamins|mesh-ancestor
14930440|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
14455104|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
14455105|NCT02069704|Hematinics|hematinics|mesh-ancestor
14455106|NCT02069847|Budesonide|budesonide|mesh-list
14455107|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455108|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14455109|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
14455110|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455111|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455112|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14455113|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
14455114|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
14455115|NCT02069847|Hormones|hormones|mesh-ancestor
14455116|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455117|NCT02070237|Enoxaparin|enoxaparin|mesh-list
14455118|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
14455119|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14455120|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14455121|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455122|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
14455123|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14455124|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14455125|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14455126|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455127|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455128|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
14455129|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455130|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455131|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14455132|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455133|NCT02070692|Tamoxifen|tamoxifen|mesh-list
14455134|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14455135|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
14455136|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455137|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455138|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14455139|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455140|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14455141|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14455142|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14455143|NCT02070744|Ivacaftor|ivacaftor|mesh-list
14455144|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14455145|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455146|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455147|NCT02070757|Meropenem|meropenem|mesh-list
14455148|NCT02070757|Tazobactam|tazobactam|mesh-list
14455149|NCT02070757|Ceftolozane|ceftolozane|mesh-list
14455150|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14455151|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14455152|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455153|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14455154|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455155|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455156|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14455157|NCT02070757|Renal Agents|renal agents|mesh-ancestor
14455158|NCT02070991|Macitentan|macitentan|mesh-list
14455159|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14455160|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14455161|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455162|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14455163|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14455164|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14455165|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14455166|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
14455167|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455168|NCT02071095|Poly I-C|poly i-c|mesh-list
14930441|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
14455169|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14455170|NCT02071095|Poly ICLC|poly iclc|mesh-list
14455171|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
14455172|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
14455173|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455174|NCT02071095|Laxatives|laxatives|mesh-ancestor
14455175|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455176|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
14455177|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455178|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14455179|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
14455180|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14455181|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
14455182|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455183|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455184|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14469509|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469510|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
14469511|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
14469512|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
14469513|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469514|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
14469515|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
14469516|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469517|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14469518|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
14469519|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
14469520|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469521|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455185|NCT02071810|Opicapone|opicapone|mesh-list
14455186|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14455187|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455188|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455189|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14455190|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14455191|NCT02071823|Opicapone|opicapone|mesh-list
14455192|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14455193|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455194|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455195|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14455196|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14455197|NCT02072096|Metformin|metformin|mesh-list
14455198|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
14455199|NCT02072096|Pioglitazone|pioglitazone|mesh-list
14455200|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14455201|NCT02072096|Liraglutide|liraglutide|mesh-list
14455202|NCT02072096|Exenatide|exenatide|mesh-list
14455203|NCT02072096|Glimepiride|glimepiride|mesh-list
14455204|NCT02072096|Linagliptin|linagliptin|mesh-list
14455205|NCT02072096|Acarbose|acarbose|mesh-list
14455206|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14455207|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455208|NCT02072096|Incretins|incretins|mesh-ancestor
14455209|NCT02072096|Hormones|hormones|mesh-ancestor
14455210|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455211|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14455212|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
14455213|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455214|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455215|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14455216|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14455217|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455218|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
14455219|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14455220|NCT02072200|Prednisone|prednisone|mesh-list
14455221|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455222|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
14455223|NCT02072200|Hormones|hormones|mesh-ancestor
14455224|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455225|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455226|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14455227|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455228|NCT02072226|Aspirin|aspirin|mesh-list
14455229|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14455230|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14455231|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455232|NCT02072226|Analgesics|analgesics|mesh-ancestor
14455233|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
14455234|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455235|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455236|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455237|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455238|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14455239|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14455240|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455241|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14455242|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14455243|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455244|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
14455245|NCT02072434|Enoxaparin|enoxaparin|mesh-list
14455246|NCT02072434|Warfarin|warfarin|mesh-list
14455247|NCT02072434|Edoxaban|edoxaban|mesh-list
14455248|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
14455249|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14455250|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14455251|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455252|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14455253|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
14455254|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14455255|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
14455256|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455257|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
14455258|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14455259|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
14455260|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14455261|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
14455262|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455263|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455264|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
14455265|NCT02072824|Pregabalin|pregabalin|mesh-list
14455266|NCT02072824|Analgesics|analgesics|mesh-ancestor
14455267|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
14455268|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455269|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455270|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
14455271|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14455272|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455273|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455274|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14455275|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14455276|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14455277|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14455278|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14455279|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
14455280|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14455281|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14455282|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14455283|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455284|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455285|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
14455286|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455287|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455288|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14455289|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455290|NCT02073448|Adapalene|adapalene|mesh-list
14455291|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14455292|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
14455293|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14455294|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455295|NCT02073448|Analgesics|analgesics|mesh-ancestor
14455296|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
14455297|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455298|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455299|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455300|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455301|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14455302|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14455303|NCT02073487|Paclitaxel|paclitaxel|mesh-list
14455304|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14455305|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14455306|NCT02073487|Trastuzumab|trastuzumab|mesh-list
14455307|NCT02073487|Lapatinib|lapatinib|mesh-list
14455308|NCT02073487|Pertuzumab|pertuzumab|mesh-list
14455309|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14455310|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455311|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
14455312|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
14455313|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
14455314|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455315|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14455316|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14455317|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455318|NCT02073565|Everolimus|everolimus|mesh-list
14455319|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455320|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455321|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
14455322|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455323|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
14455324|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14455325|NCT02073656|Ledipasvir|ledipasvir|mesh-list
14455326|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
14455327|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455328|NCT02073682|Heparin|heparin|mesh-list
14455329|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14455330|NCT02073682|Tinzaparin|tinzaparin|mesh-list
14455331|NCT02073682|Dalteparin|dalteparin|mesh-list
14455332|NCT02073682|Edoxaban|edoxaban|mesh-list
14455333|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
14455334|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14455335|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14455336|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455337|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14455338|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
14455339|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14455340|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
14455341|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455342|NCT02073747|Albuterol|albuterol|mesh-list
14455343|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14455344|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
14455345|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455346|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455347|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14455348|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
14455349|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
14455350|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14455351|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14455352|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14455353|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14455354|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
14455355|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455356|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455357|NCT02073929|Liraglutide|liraglutide|mesh-list
14455358|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14455359|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455360|NCT02073929|Incretins|incretins|mesh-ancestor
14455361|NCT02073929|Hormones|hormones|mesh-ancestor
14455362|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455363|NCT02074358|Apixaban|apixaban|mesh-list
14455364|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14455365|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
14455366|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14455367|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
14455368|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455369|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455370|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
14455371|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
14455372|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
14455373|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455374|NCT02074709|Bupivacaine|bupivacaine|mesh-list
14455375|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
14455376|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
14455377|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14455378|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455379|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
14455380|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455381|NCT02074735|Choline|choline|mesh-list
14455382|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14455383|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
14455384|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14455385|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
14455386|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455387|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455388|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14455389|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
14455390|NCT02074982|Ustekinumab|ustekinumab|mesh-list
14455391|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14455392|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
14455393|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455394|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
14455395|NCT02075047|Ziprasidone|ziprasidone|mesh-list
14455396|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14455397|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
14455398|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455399|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455400|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455401|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14455402|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14455403|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14455404|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14455405|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14455406|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
14455407|NCT02075073|Trastuzumab|trastuzumab|mesh-list
14455408|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14455409|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455410|NCT02075125|Ticagrelor|ticagrelor|mesh-list
14455411|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14455412|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14455413|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14469522|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14455414|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14455415|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14455416|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
14455417|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455418|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455419|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455420|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
14455421|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14455422|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
14455423|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455424|NCT02075255|Benralizumab|benralizumab|mesh-list
14455425|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14455426|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
14752494|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752495|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752496|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14752497|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752498|NCT05337085|Midazolam|midazolam|mesh-list
14752499|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
14752500|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14752501|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752502|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455427|NCT02075515|Vaccines|vaccines|mesh-list
14455428|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
14455429|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455430|NCT02075606|Lanreotide|lanreotide|mesh-list
14455431|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455432|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
14455433|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455434|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
14455435|NCT02075632|Hormones|hormones|mesh-ancestor
14455436|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455437|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455438|NCT02076100|Ruzasvir|ruzasvir|mesh-list
14455439|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
14455440|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455441|NCT02076152|Bevacizumab|bevacizumab|mesh-list
14455442|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14455443|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455444|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14455445|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14455446|NCT02076152|Growth Substances|growth substances|mesh-ancestor
14455447|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455448|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
14455449|NCT02076243|Paclitaxel|paclitaxel|mesh-list
14455450|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14455451|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455452|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14455453|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14930442|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930443|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752503|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14752504|NCT05337085|Analgesics|analgesics|mesh-ancestor
14752505|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
14752506|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752507|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14455454|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14455455|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455456|NCT02076321|Acetaminophen|acetaminophen|mesh-list
14455457|NCT02076321|Ibuprofen|ibuprofen|mesh-list
14455458|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455459|NCT02076321|Analgesics|analgesics|mesh-ancestor
14455460|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
14455461|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455462|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455463|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
14455464|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14455465|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455466|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455467|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14455468|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455469|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455470|NCT02076919|Acrizanib|acrizanib|mesh-list
14455471|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14455472|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14752508|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14752509|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14752510|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
14752511|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752512|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752513|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14752514|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14752515|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14752516|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14752517|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14455473|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14455474|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455475|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455476|NCT02076997|Methotrexate|methotrexate|mesh-list
14455477|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14455478|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
14455479|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14455480|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455481|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14455482|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
14455483|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455484|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455485|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
14455486|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455487|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14455488|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455489|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
14455490|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455491|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14455492|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14455493|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
14455494|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455495|NCT02078102|Meloxicam|meloxicam|mesh-list
14455496|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455497|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14455498|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455499|NCT02078102|Analgesics|analgesics|mesh-ancestor
14455500|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
14455501|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455502|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455503|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752518|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
14455504|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14455505|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14752519|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
14752520|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
14752521|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
14752522|NCT05336968|Triamcinolone|triamcinolone|mesh-list
14455506|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455507|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455508|NCT02078180|Bupropion|bupropion|mesh-list
14455509|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14455510|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
14455511|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14455512|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14455513|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14455514|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455515|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455516|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
14455517|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752523|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14455518|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455519|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14455520|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14455521|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455522|NCT02078193|Abatacept|abatacept|mesh-list
14455523|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14455524|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455525|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455526|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455527|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
14455528|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455529|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455530|NCT02078219|Allopurinol|allopurinol|mesh-list
14455531|NCT02078219|Verinurad|verinurad|mesh-list
14455532|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
14455533|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455534|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455535|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
14455536|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455537|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14455538|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
14455539|NCT02078219|Protective Agents|protective agents|mesh-ancestor
14455540|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455541|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14455542|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14455543|NCT02078284|Protective Agents|protective agents|mesh-ancestor
14455544|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455545|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14455546|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
14455547|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455548|NCT02078492|Ketorolac|ketorolac|mesh-list
14455549|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14455550|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14455551|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455552|NCT02078492|Analgesics|analgesics|mesh-ancestor
14455553|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
14455554|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455555|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455556|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455557|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455558|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14455559|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455560|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455561|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
14455562|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14455563|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455564|NCT02078726|Glucagon|glucagon|mesh-list
14455565|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455566|NCT02078726|Hormones|hormones|mesh-ancestor
14930444|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
14455567|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931194|NCT01437982|Prednisolone|prednisolone|mesh-list
14455568|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455569|NCT02078817|Ketamine|ketamine|mesh-list
14455570|NCT02078817|Analgesics|analgesics|mesh-ancestor
14455571|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
14455572|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455573|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455574|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14455575|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14455576|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
14455577|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
14455578|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14455579|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14455580|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14455581|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455582|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455583|NCT02078882|Abatacept|abatacept|mesh-list
14455584|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14455585|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455586|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455587|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455588|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
14455589|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455590|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455591|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
14455592|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14455593|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455594|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14455595|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455596|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455597|NCT02079077|Aspirin|aspirin|mesh-list
14455598|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
14455599|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
14455600|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14455601|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14455602|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455603|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455604|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455605|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455606|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14455607|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455608|NCT02079077|Analgesics|analgesics|mesh-ancestor
14455609|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
14455610|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455611|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455612|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455613|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14455614|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14455615|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14455616|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14455617|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
14455618|NCT02079519|Bevacizumab|bevacizumab|mesh-list
14455619|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14455620|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455621|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14455622|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14455623|NCT02079519|Growth Substances|growth substances|mesh-ancestor
14455624|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455625|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
14455626|NCT02079532|Rituximab|rituximab|mesh-list
14455627|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14455628|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455629|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
14455630|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455631|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455632|NCT02079636|Gemcitabine|gemcitabine|mesh-list
14455633|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
14455634|NCT02079636|Pemetrexed|pemetrexed|mesh-list
14455635|NCT02079636|Ramucirumab|ramucirumab|mesh-list
14455636|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14455637|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
14455638|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455639|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455640|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
14455641|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455642|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455643|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455644|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
14455645|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455646|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14455647|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14455648|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14455649|NCT02079649|Dexamethasone|dexamethasone|mesh-list
14455650|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14455651|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14455652|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455653|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
14455654|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
14455655|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455656|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455657|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455658|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
14455659|NCT02079649|Hormones|hormones|mesh-ancestor
14455660|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455661|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14455662|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455663|NCT02079805|Telmisartan|telmisartan|mesh-list
14455664|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14455665|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14455666|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14455667|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14455668|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455669|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
14455670|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14455671|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14455672|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455673|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14469523|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
14469524|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
14469525|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14469526|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14469527|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
14469528|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14469529|NCT02295280|Narcotics|narcotics|mesh-ancestor
14469530|NCT02295280|Analgesics|analgesics|mesh-ancestor
14469531|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
14469532|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469533|NCT02295553|Ketamine|ketamine|mesh-list
14469534|NCT02295553|Propofol|propofol|mesh-list
14469535|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14469536|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469537|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469538|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14469539|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
14469540|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
14752524|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14469541|NCT02295553|Analgesics|analgesics|mesh-ancestor
14469542|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
14455674|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
14455675|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
14455676|NCT02080195|Fludarabine|fludarabine|mesh-list
14455677|NCT02080195|Tacrolimus|tacrolimus|mesh-list
14455678|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
14455679|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14455680|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455681|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
14455682|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455683|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455684|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14455685|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
14455686|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455687|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455688|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14455689|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14455690|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455691|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14455692|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14455693|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
14455694|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14455695|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455696|NCT02080221|Leucovorin|leucovorin|mesh-list
14455697|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
14455698|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455699|NCT02080221|Antidotes|antidotes|mesh-ancestor
14455700|NCT02080221|Protective Agents|protective agents|mesh-ancestor
14455701|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455702|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
14455703|NCT02080221|Vitamins|vitamins|mesh-ancestor
14455704|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
14455705|NCT02080273|Listerine|listerine|mesh-list
14455706|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
14455707|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
14455708|NCT02080273|Protective Agents|protective agents|mesh-ancestor
14455709|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455710|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14455711|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455712|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
14455713|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14455714|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14455715|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455716|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
14455717|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14455718|NCT02080455|Atorvastatin|atorvastatin|mesh-list
14455719|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14455720|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14455721|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
14455722|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455723|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14455724|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14455725|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455726|NCT02080468|Norgestimate|norgestimate|mesh-list
14455727|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14455728|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
14455729|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14455730|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455731|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14455732|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14455733|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14455734|NCT02080637|Ambrisentan|ambrisentan|mesh-list
14455735|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14455736|NCT02080780|Clarithromycin|clarithromycin|mesh-list
14455737|NCT02080780|Diltiazem|diltiazem|mesh-list
14455738|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14455739|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455740|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14455741|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455742|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455743|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14455744|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14455745|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14455746|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14455747|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455748|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14455749|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455750|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
14455751|NCT02080819|Levodopa|levodopa|mesh-list
14455752|NCT02080819|Carbidopa|carbidopa|mesh-list
14455753|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14455754|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14455755|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
14455756|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455757|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455758|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455759|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14752525|NCT05336968|Ketorolac|ketorolac|mesh-list
14752526|NCT05336968|Ropivacaine|ropivacaine|mesh-list
14752527|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14455760|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455761|NCT02080832|Dexetimide|dexetimide|mesh-list
14455762|NCT02080832|Citalopram|citalopram|mesh-list
14455763|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14455764|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14455765|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455766|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455767|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455768|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
14455769|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455770|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14455771|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
14455772|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14455773|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14455774|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14455775|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
14455776|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
14455777|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455778|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14455779|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14455780|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
14455781|NCT02081001|Glucagon|glucagon|mesh-list
14455782|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455783|NCT02081001|Hormones|hormones|mesh-ancestor
14455784|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455785|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752528|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
14752529|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
14752530|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752531|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752532|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
14752533|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752534|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752535|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
14752536|NCT05336968|Hormones|hormones|mesh-ancestor
14753755|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14455786|NCT02081014|Glucagon|glucagon|mesh-list
14455787|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14455788|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455789|NCT02081014|Hormones|hormones|mesh-ancestor
14455790|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455791|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455792|NCT02081014|Incretins|incretins|mesh-ancestor
14455793|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
14455794|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14455795|NCT02081079|Ledipasvir|ledipasvir|mesh-list
14455796|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
14455797|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455798|NCT02081443|Ticagrelor|ticagrelor|mesh-list
14455799|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14455800|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14455801|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14455802|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14455803|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
14455804|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455805|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455806|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455807|NCT02081599|Insulin|insulin|mesh-list
14455808|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14455809|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455810|NCT02081638|Aspirin|aspirin|mesh-list
14455811|NCT02081638|Atorvastatin|atorvastatin|mesh-list
14455812|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14455813|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14455814|NCT02081638|Analgesics|analgesics|mesh-ancestor
14455815|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
14455816|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455817|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455818|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14455819|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455820|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14455821|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14455822|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455823|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14455824|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14455825|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455826|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
14455827|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14455828|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14455829|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
14455830|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14455831|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14455832|NCT02081690|Macitentan|macitentan|mesh-list
14455833|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14455834|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14455835|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455836|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14455837|NCT02081950|Enoxaparin|enoxaparin|mesh-list
14455838|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
14455839|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
14455840|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14455841|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14455842|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455843|NCT02081963|Amikacin|amikacin|mesh-list
14455844|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14455845|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455846|NCT02082210|Ramucirumab|ramucirumab|mesh-list
14455847|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455848|NCT02082392|Citalopram|citalopram|mesh-list
14455849|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14455850|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14455851|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455852|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455853|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455854|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
14455855|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455856|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14455857|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
14455858|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14455859|NCT02082522|Gemcitabine|gemcitabine|mesh-list
14455860|NCT02082522|Cisplatin|cisplatin|mesh-list
14455861|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14455862|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14455863|NCT02082522|Trioxsalen|trioxsalen|mesh-list
14455864|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455865|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14455866|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
14455867|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455868|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
14455869|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455870|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455871|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455872|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
14455873|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455874|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
14455875|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14455876|NCT02082678|Ondansetron|ondansetron|mesh-list
14455877|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
14455878|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
14455879|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455880|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455881|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455882|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
14455883|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
14455884|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14455885|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
14455886|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455887|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455888|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14455889|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14455890|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14455891|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14455892|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14455893|NCT02082769|Allopurinol|allopurinol|mesh-list
14455894|NCT02082769|Febuxostat|febuxostat|mesh-list
14455895|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
14455896|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455897|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455898|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
14455899|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14455900|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14455901|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
14455902|NCT02082769|Protective Agents|protective agents|mesh-ancestor
14455903|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455904|NCT02082912|Cycloserine|cycloserine|mesh-list
14455905|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14455906|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455907|NCT02082912|Renal Agents|renal agents|mesh-ancestor
14455908|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14455909|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
14455910|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14455911|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
14455912|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455913|NCT02083107|Misoprostol|misoprostol|mesh-list
14455914|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14455915|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
14455916|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14455917|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455918|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14455919|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14455920|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
14455921|NCT02083185|Leuprolide|leuprolide|mesh-list
14455922|NCT02083185|Relugolix|relugolix|mesh-list
14455923|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14455924|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
14455925|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14455926|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455927|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14455928|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455929|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
14455930|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
14455931|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14455932|NCT02083380|Piperaquine|piperaquine|mesh-list
14455933|NCT02083380|Artefenomel|artefenomel|mesh-list
14455934|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
14455935|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14455936|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14455937|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455938|NCT02083406|Artefenomel|artefenomel|mesh-list
14455939|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
14455940|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14455941|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14455942|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455943|NCT02083653|Fluorouracil|fluorouracil|mesh-list
14455944|NCT02083653|Capecitabine|capecitabine|mesh-list
14455945|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14455946|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
14455947|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455948|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14455949|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455950|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455951|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
14752537|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752538|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752539|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
14455952|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455953|NCT02083679|Gemcitabine|gemcitabine|mesh-list
14455954|NCT02083679|Paclitaxel|paclitaxel|mesh-list
14455955|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14455956|NCT02083679|Cisplatin|cisplatin|mesh-list
14455957|NCT02083679|Carboplatin|carboplatin|mesh-list
14455958|NCT02083679|Pemetrexed|pemetrexed|mesh-list
14455959|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14455960|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14455961|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14455962|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
14455963|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
14455964|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
14455965|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455966|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14455967|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
14455968|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
14455969|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14455970|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14455971|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14455972|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
14455973|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455974|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14455975|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14455976|NCT02083783|Amphetamine|amphetamine|mesh-list
14455977|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14455978|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455979|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
14455980|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
14455981|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14455982|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
14455983|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455984|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14455985|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
14455986|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14455987|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14455988|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14455989|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14455990|NCT02083809|Oxytocin|oxytocin|mesh-list
14455991|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
14455992|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14455993|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14455994|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
14455995|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14455996|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14455997|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
14455998|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14455999|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456000|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456001|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
14456002|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
14456003|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456004|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
14456005|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14456006|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
14456007|NCT02083926|Ketamine|ketamine|mesh-list
14930445|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930446|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14930447|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14930448|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14930449|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14930450|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456008|NCT02083926|Analgesics|analgesics|mesh-ancestor
14456009|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
14456010|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456011|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456012|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14456013|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14456014|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
14456015|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
14456016|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456017|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14456018|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14456019|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456020|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456021|NCT02083965|Factor VIII|factor viii|mesh-list
14456022|NCT02083965|Coagulants|coagulants|mesh-ancestor
14456023|NCT02084056|Metformin|metformin|mesh-list
14456024|NCT02084056|Linagliptin|linagliptin|mesh-list
14456025|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456026|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456027|NCT02084056|Incretins|incretins|mesh-ancestor
14456028|NCT02084056|Hormones|hormones|mesh-ancestor
14456029|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456030|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14456031|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
14456032|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456033|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456034|NCT02084069|Atorvastatin|atorvastatin|mesh-list
14456035|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14456036|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14456037|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
14456038|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456039|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14456040|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14456041|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456042|NCT02084082|Metformin|metformin|mesh-list
14456043|NCT02084082|Linagliptin|linagliptin|mesh-list
14456044|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456045|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456046|NCT02084082|Incretins|incretins|mesh-ancestor
14456047|NCT02084082|Hormones|hormones|mesh-ancestor
14456048|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456049|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14456050|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
14456051|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456052|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456053|NCT02084134|Dexamethasone|dexamethasone|mesh-list
14456054|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
14456055|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
14456056|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14456057|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14456058|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14456059|NCT02084134|BB 1101|bb 1101|mesh-list
14456060|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456061|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
14456062|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
14456063|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456064|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456065|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456066|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
14456067|NCT02084134|Hormones|hormones|mesh-ancestor
14456068|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456069|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14456070|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456071|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
14456072|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456073|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752540|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752541|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456074|NCT02084238|Interleukin-2|interleukin-2|mesh-list
14456075|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456076|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456077|NCT02084238|Analgesics|analgesics|mesh-ancestor
14456078|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
14456079|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456080|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456081|NCT02084511|Celecoxib|celecoxib|mesh-list
14456082|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14456083|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456084|NCT02084511|Analgesics|analgesics|mesh-ancestor
14456085|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
14456086|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456087|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456088|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456089|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456090|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14456091|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14456092|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456093|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456094|NCT02084706|Triamcinolone|triamcinolone|mesh-list
14456095|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14456096|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14456097|NCT02084706|Lidocaine|lidocaine|mesh-list
14456098|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14456099|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
14456100|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
14456101|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456102|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456103|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
14456104|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456105|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14456106|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14456107|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14456108|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14456109|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456110|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456111|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
14456112|NCT02084706|Hormones|hormones|mesh-ancestor
14456113|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456114|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456115|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
14456116|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456117|NCT02084797|Tolvaptan|tolvaptan|mesh-list
14456118|NCT02084797|Vasopressins|vasopressins|mesh-list
14456119|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
14456120|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14456121|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752542|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14752543|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14752544|NCT05336968|Analgesics|analgesics|mesh-ancestor
14456122|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
14456123|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456124|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
14456125|NCT02084797|Coagulants|coagulants|mesh-ancestor
14456126|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14456127|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14456128|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
14456129|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14456130|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456131|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
14456132|NCT02085161|Olodaterol|olodaterol|mesh-list
14456133|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14456134|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
14456135|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456136|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456137|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14456138|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
14456139|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
14456140|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14456141|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
14456142|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456143|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456144|NCT02085252|Bicalutamide|bicalutamide|mesh-list
14456145|NCT02085252|Leuprolide|leuprolide|mesh-list
14456146|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
14456147|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
14456148|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456149|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456150|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456151|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14456152|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
14456153|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14752545|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752546|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14752547|NCT05336825|Lidocaine|lidocaine|mesh-list
14752548|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
14752549|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
14752550|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930451|NCT01433445|Panobinostat|panobinostat|mesh-list
14456154|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14456155|NCT02085447|Haloperidol|haloperidol|mesh-list
14752551|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456156|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14456157|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
14456158|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
14456159|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14456160|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456161|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456162|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14456163|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14456164|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14456165|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
14456166|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456167|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456168|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14456169|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14456170|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
14456171|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
14456172|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
14456173|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456174|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456175|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14456176|NCT02085460|Rebamipide|rebamipide|mesh-list
14456177|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14456178|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456179|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
14456180|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456181|NCT02085460|Protective Agents|protective agents|mesh-ancestor
14456182|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456183|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456184|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
14456185|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14456186|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14456187|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456188|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
14456189|NCT02086500|Coagulants|coagulants|mesh-ancestor
14456190|NCT02086591|Doxycycline|doxycycline|mesh-list
14456191|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14456192|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456193|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
14930452|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930453|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14456194|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14456195|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14456196|NCT02086786|Risperidone|risperidone|mesh-list
14456197|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14456198|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
14456199|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456200|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456201|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456202|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14456203|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14456204|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456205|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14456206|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14456207|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
14456208|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14456209|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14456210|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14456211|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14456212|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14456213|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
14456214|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456215|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456216|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469543|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469544|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14469545|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14469546|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14930454|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930455|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930456|NCT01433614|Paclitaxel|paclitaxel|mesh-list
14930457|NCT01433614|Capecitabine|capecitabine|mesh-list
14930458|NCT01433614|Epirubicin|epirubicin|mesh-list
14930459|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14930460|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930461|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
14930462|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
14930463|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
14931241|NCT01438112|Valrubicin|valrubicin|mesh-list
14456217|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
14456218|NCT02087176|Adavosertib|adavosertib|mesh-list
14456219|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456220|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456221|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
14456222|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456223|NCT02087241|Carboplatin|carboplatin|mesh-list
14456224|NCT02087241|Pemetrexed|pemetrexed|mesh-list
14456225|NCT02087241|Adavosertib|adavosertib|mesh-list
14456226|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456227|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456228|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456229|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14456230|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14456231|NCT02087306|Brincidofovir|brincidofovir|mesh-list
14752552|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
14752553|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752554|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14752555|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14752556|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14752557|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14752558|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752559|NCT05336812|Venetoclax|venetoclax|mesh-list
14752560|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
14752561|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
14752562|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752563|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752564|NCT05336721|Capecitabine|capecitabine|mesh-list
14752565|NCT05336721|Chiauranib|chiauranib|mesh-list
14752566|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14931195|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14456232|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
14456233|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456234|NCT02087748|Diclofenac|diclofenac|mesh-list
14456235|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14456236|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456237|NCT02087748|Analgesics|analgesics|mesh-ancestor
14456238|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
14456239|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456240|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456241|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456242|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456243|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14456244|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752567|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
14456245|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752568|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752569|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752570|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14752571|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752572|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14753756|NCT05001828|Azacitidine|azacitidine|mesh-list
14753757|NCT05001828|Venetoclax|venetoclax|mesh-list
14753758|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753759|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
14930464|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930465|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753760|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753761|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456246|NCT02087943|Thalidomide|thalidomide|mesh-list
14456247|NCT02087943|Apremilast|apremilast|mesh-list
14456248|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14456249|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456250|NCT02087943|Analgesics|analgesics|mesh-ancestor
14456251|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
14753762|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930466|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
14930467|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14930468|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14930469|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14930470|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930471|NCT01433627|Hirudins|hirudins|mesh-list
14930472|NCT01433627|Bivalirudin|bivalirudin|mesh-list
14456252|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752573|NCT05336266|Ketorolac|ketorolac|mesh-list
14456253|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456254|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456255|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456256|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14456257|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14456258|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456259|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456260|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456261|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
14456262|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
14456263|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14456264|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456265|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14456266|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14456267|NCT02087943|Growth Substances|growth substances|mesh-ancestor
14456268|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
14456269|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456270|NCT02088034|Metformin|metformin|mesh-list
14456271|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456272|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456273|NCT02088177|Naltrexone|naltrexone|mesh-list
14456274|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14456275|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14456276|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456277|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
14456278|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456279|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
14456280|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14456281|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
14456282|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456283|NCT02088216|Expectorants|expectorants|mesh-ancestor
14456284|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
14456285|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14456286|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
14456287|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456288|NCT02088216|Protective Agents|protective agents|mesh-ancestor
14456289|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456290|NCT02088216|Antidotes|antidotes|mesh-ancestor
14456291|NCT02088541|Cytarabine|cytarabine|mesh-list
14456292|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
14456293|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14456294|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
14456295|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456296|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456297|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
14456298|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456299|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456300|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
14456301|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456302|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
14456303|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456304|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14456305|NCT02089113|Dexamethasone|dexamethasone|mesh-list
14456306|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456307|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
14456308|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
14456309|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456310|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456311|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14930473|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
14456312|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
14456313|NCT02089113|Hormones|hormones|mesh-ancestor
14469547|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931196|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
14456314|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456315|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14456316|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456317|NCT02089347|Vaccines|vaccines|mesh-list
14456318|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
14456319|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456320|NCT02089737|Panitumumab|panitumumab|mesh-list
14456321|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14456322|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456323|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
14456324|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14456325|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14456326|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456327|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14456328|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456329|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14456330|NCT02090075|Warfarin|warfarin|mesh-list
14456331|NCT02090075|Apixaban|apixaban|mesh-list
14456332|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
14456333|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14456334|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
14456335|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14456336|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
14456337|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456338|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456339|NCT02090374|Vitamin D|vitamin d|mesh-list
14456340|NCT02090374|Poly ICLC|poly iclc|mesh-list
14456341|NCT02090374|Vitamins|vitamins|mesh-ancestor
14456342|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
14456343|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456344|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14456345|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
14456346|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
14456347|NCT02090413|Aspirin|aspirin|mesh-list
14456348|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14456349|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14456350|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456351|NCT02090413|Analgesics|analgesics|mesh-ancestor
14456352|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
14456353|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456354|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456355|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456356|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456357|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14456358|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14456359|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456360|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14456361|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14456362|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456363|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
14456364|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456365|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456366|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
14456367|NCT02091206|Cannabidiol|cannabidiol|mesh-list
14456368|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
14456369|NCT02091362|Metformin|metformin|mesh-list
14456370|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456371|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456372|NCT02091375|Cannabidiol|cannabidiol|mesh-list
14456373|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
14456374|NCT02091414|Cyclosporine|cyclosporine|mesh-list
14456375|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
14456376|NCT02091414|Cyclosporins|cyclosporins|mesh-list
14456377|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456378|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456379|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456380|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
14456381|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456382|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
14456383|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456384|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456385|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456386|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14456387|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14456388|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456389|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14456390|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
14456391|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14456392|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
14456393|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14456394|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14456395|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14456396|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14456397|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14456398|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456399|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
14456400|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456401|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456402|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14456403|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456404|NCT02091882|Aripiprazole|aripiprazole|mesh-list
14456405|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
14456406|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14456407|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14456408|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14456409|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456410|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456411|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
14456412|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
14456413|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456414|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456415|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14456416|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14456417|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
14456418|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14456419|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14456420|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14456421|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14456422|NCT02091921|Ticagrelor|ticagrelor|mesh-list
14456423|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14456424|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14456425|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14456426|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14456427|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
14456428|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456429|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456430|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456431|NCT02091986|Budesonide|budesonide|mesh-list
14456432|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14456433|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456434|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14456435|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
14456436|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456437|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456438|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14456439|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
14456440|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
14456441|NCT02091986|Hormones|hormones|mesh-ancestor
14456442|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456443|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14456444|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14456445|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14456446|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456447|NCT02092116|Romidepsin|romidepsin|mesh-list
14456448|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14456449|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752574|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14753763|NCT04997993|Leflunomide|leflunomide|mesh-list
14456450|NCT02092168|Opicapone|opicapone|mesh-list
14456451|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14456452|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456453|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456454|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14456455|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14456456|NCT02092181|Mirabegron|mirabegron|mesh-list
14456457|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14456458|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14456459|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14456460|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
14456461|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456462|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456463|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456464|NCT02092181|Urological Agents|urological agents|mesh-ancestor
14456465|NCT02092220|Pancrelipase|pancrelipase|mesh-list
14456466|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456467|NCT02092285|Golimumab|golimumab|mesh-list
14456468|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14456469|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456470|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456471|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
14456472|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456473|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
14456474|NCT02092298|Cisplatin|cisplatin|mesh-list
14456475|NCT02092298|Mitomycins|mitomycins|mesh-list
14456476|NCT02092298|Mitomycin|mitomycin|mesh-list
14456477|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456478|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14456479|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
14456480|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456481|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14456482|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456483|NCT02092298|Antidotes|antidotes|mesh-ancestor
14456484|NCT02092298|Protective Agents|protective agents|mesh-ancestor
14456485|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456486|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
14456487|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
14456488|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14456489|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456490|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
14456491|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
14456492|NCT02092350|Grazoprevir|grazoprevir|mesh-list
14456493|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
14456494|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456495|NCT02092467|Adalimumab|adalimumab|mesh-list
14456496|NCT02092467|Etanercept|etanercept|mesh-list
14456497|NCT02092467|Tofacitinib|tofacitinib|mesh-list
14456498|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456499|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456500|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14456501|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456502|NCT02092467|Analgesics|analgesics|mesh-ancestor
14456503|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
14456504|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456505|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456506|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456507|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456508|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
14456509|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14456510|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456511|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456512|NCT02092961|Adalimumab|adalimumab|mesh-list
14456513|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456514|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456515|NCT02093026|Folic Acid|folic acid|mesh-list
14456516|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
14456517|NCT02093026|Rituximab|rituximab|mesh-list
14456518|NCT02093026|Methotrexate|methotrexate|mesh-list
14456519|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14456520|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456521|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
14456522|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456523|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456524|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14456525|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
14456526|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14456527|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14456528|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
14456529|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456530|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456531|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456532|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14456533|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456534|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14456535|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456536|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
14456537|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
14456538|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456539|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456540|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
14456541|NCT02093026|Hormones|hormones|mesh-ancestor
14456542|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456543|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14456544|NCT02093026|Protective Agents|protective agents|mesh-ancestor
14456545|NCT02093026|Hematinics|hematinics|mesh-ancestor
14456546|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
14456547|NCT02093026|Vitamins|vitamins|mesh-ancestor
14456548|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
14456549|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
14456550|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14456551|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
14456552|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456553|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456554|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14456555|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14456556|NCT02093351|Tamoxifen|tamoxifen|mesh-list
14456557|NCT02093351|Letrozole|letrozole|mesh-list
14456558|NCT02093351|Olaparib|olaparib|mesh-list
14456559|NCT02093351|Anastrozole|anastrozole|mesh-list
14456560|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456561|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14456562|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14456563|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456564|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456565|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14456566|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
14456567|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456568|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456569|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14456570|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14456571|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14456572|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14456573|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14456574|NCT02093390|Fluconazole|fluconazole|mesh-list
14456575|NCT02093390|Atorvastatin|atorvastatin|mesh-list
14456576|NCT02093390|Relugolix|relugolix|mesh-list
14456577|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14456578|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14456579|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
14456580|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456581|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14456582|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14456583|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456584|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
14456585|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456586|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14456587|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14456588|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14456589|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
14456590|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456591|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456592|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14456593|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14456594|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
14456595|NCT02093663|Mesalamine|mesalamine|mesh-list
14456596|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14456597|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456598|NCT02093663|Analgesics|analgesics|mesh-ancestor
14456599|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
14456600|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456601|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456602|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456603|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456604|NCT02093897|Factor VIII|factor viii|mesh-list
14456605|NCT02093897|Coagulants|coagulants|mesh-ancestor
14456606|NCT02093962|Pemetrexed|pemetrexed|mesh-list
14456607|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456608|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456609|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456610|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14456611|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14469548|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469549|NCT02295774|Methylene Blue|methylene blue|mesh-list
14469550|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469551|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469552|NCT02296099|Bupivacaine|bupivacaine|mesh-list
14469553|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
14469554|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
14469555|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469556|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469557|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
14469558|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469559|NCT02296112|Trametinib|trametinib|mesh-list
14456612|NCT02094443|Ribavirin|ribavirin|mesh-list
14456613|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
14456614|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456615|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
14456616|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456617|NCT02094534|Insulin|insulin|mesh-list
14456618|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456619|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456620|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14456621|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
14456622|NCT02094885|Coagulants|coagulants|mesh-ancestor
14456623|NCT02094898|Ketamine|ketamine|mesh-list
14456624|NCT02094898|Analgesics|analgesics|mesh-ancestor
14456625|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
14456626|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456627|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456628|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14456629|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14456630|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
14456631|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
14456632|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456633|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14456634|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14456635|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456636|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456637|NCT02094937|Fluticasone|fluticasone|mesh-list
14456638|NCT02094937|Xhance|xhance|mesh-list
14456639|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456640|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14456641|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
14456642|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456643|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456644|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14456645|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14456646|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456647|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14456648|NCT02095106|Calpastatin|calpastatin|mesh-list
14456649|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14456650|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
14456651|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456652|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456653|NCT02095158|Phenylephrine|phenylephrine|mesh-list
14456654|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
14456655|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14456656|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14456657|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14456658|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456659|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456660|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456661|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
14456662|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
14456663|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456664|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
14456665|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14456666|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
14456667|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14456668|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
14456669|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14456670|NCT02095158|Protective Agents|protective agents|mesh-ancestor
14456671|NCT02095197|Triamcinolone|triamcinolone|mesh-list
14456672|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456673|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
14456674|NCT02095197|Hormones|hormones|mesh-ancestor
14456675|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456676|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456677|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
14456678|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14456679|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14456680|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456681|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
14456682|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456683|NCT02095873|Resveratrol|resveratrol|mesh-list
14456684|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
14456685|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456686|NCT02095873|Protective Agents|protective agents|mesh-ancestor
14456687|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456688|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456689|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14456690|NCT02095951|Ethanol|ethanol|mesh-list
14456691|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14456692|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456693|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456694|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456695|NCT02096003|Morphine|morphine|mesh-list
14456696|NCT02096003|Hydromorphone|hydromorphone|mesh-list
14456697|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14456698|NCT02096003|Narcotics|narcotics|mesh-ancestor
14456699|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456700|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456701|NCT02096003|Analgesics|analgesics|mesh-ancestor
14456702|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
14456703|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456704|NCT02096029|Nicotine|nicotine|mesh-list
14456705|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14456706|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
14456707|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456708|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456709|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14930474|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14930475|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
14930476|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456710|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14456711|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
14456712|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456713|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456714|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
14456715|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14456716|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14456717|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14456718|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14456719|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14456720|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456721|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14456722|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456723|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456724|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14456725|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456726|NCT02096107|Everolimus|everolimus|mesh-list
14930477|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930478|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
14930479|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14930480|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14930481|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
14930482|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14930483|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930484|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930485|NCT01433705|Regadenoson|regadenoson|mesh-list
14930486|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930487|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14930488|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14930489|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
14456727|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456728|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456729|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
14456730|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456731|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14456732|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
14456733|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456734|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
14456735|NCT02096458|Lansoprazole|lansoprazole|mesh-list
14456736|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14456737|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456738|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14456739|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456740|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456741|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
14456742|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14456743|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
14456744|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
14456745|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456746|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456747|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14456748|NCT02096575|Analgesics|analgesics|mesh-ancestor
14456749|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
14456750|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456751|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
14456752|NCT02096588|Doxorubicin|doxorubicin|mesh-list
14456753|NCT02096588|Simvastatin|simvastatin|mesh-list
14456754|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456755|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
14456756|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456757|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456758|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14456759|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
14456760|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456761|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456762|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14456763|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14456764|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14456765|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14456766|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456767|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14456768|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14456769|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
14456770|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14456771|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14456772|NCT02096679|Osimertinib|osimertinib|mesh-list
14456773|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456774|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14456775|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456776|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456777|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
14456778|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14456779|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456780|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456781|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456782|NCT02096718|Afatinib|afatinib|mesh-list
14456783|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456784|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14456785|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456786|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456787|NCT02096744|Clonidine|clonidine|mesh-list
14456788|NCT02096744|Analgesics|analgesics|mesh-ancestor
14456789|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
14456790|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456791|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456792|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14456793|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
14456794|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
14456795|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14456796|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14456797|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14456798|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
14456799|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456800|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456801|NCT02096835|Dexamethasone|dexamethasone|mesh-list
14456802|NCT02096835|Tropisetron|tropisetron|mesh-list
14456803|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456804|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
14456805|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
14456806|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456807|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456808|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456809|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
14456810|NCT02096835|Hormones|hormones|mesh-ancestor
14456811|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456812|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14456813|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456814|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14456815|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14456816|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
14456817|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456818|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456819|NCT02096861|Infliximab|infliximab|mesh-list
14456820|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456821|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456822|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456823|NCT02096900|Midazolam|midazolam|mesh-list
14456824|NCT02096900|Zolpidem|zolpidem|mesh-list
14456825|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14456826|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14456827|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456828|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456829|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14456830|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14456831|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14456832|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14456833|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
14456834|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
14456835|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
14456836|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
14456837|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456838|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456839|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14456840|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14456841|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
14456842|NCT02096952|Methylphenidate|methylphenidate|mesh-list
14456843|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14456844|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456845|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14456846|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14456847|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14456848|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456849|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
14456850|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456851|NCT02097056|Donepezil|donepezil|mesh-list
14456852|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14456853|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456854|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456855|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
14456856|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456857|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456858|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
14456859|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
14456860|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14456861|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14456862|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
14456863|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456864|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14456865|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14456866|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456867|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456868|NCT02097238|Halichondrin B|halichondrin b|mesh-list
14456869|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
14456870|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
14456871|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
14456872|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456873|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456874|NCT02097303|Prednisone|prednisone|mesh-list
14456875|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
14456876|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14456877|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14456878|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
14456879|NCT02097303|Hormones|hormones|mesh-ancestor
14456880|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456881|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456882|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14456883|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456884|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14456885|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456886|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456887|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
14456888|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14456889|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14456890|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
14456891|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456892|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
14456893|NCT02097537|Miotics|miotics|mesh-ancestor
14456894|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
14456895|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456896|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456897|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14456898|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14456899|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
14456900|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14456901|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14456902|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
14456903|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456904|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456905|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
14456906|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14456907|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14456908|NCT02097719|Timolol|timolol|mesh-list
14456909|NCT02097719|Bimatoprost|bimatoprost|mesh-list
14456910|NCT02097719|Travoprost|travoprost|mesh-list
14456911|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14456912|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14456913|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
14456914|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456915|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456916|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456917|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14456918|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14456919|NCT02097732|Ipilimumab|ipilimumab|mesh-list
14456920|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14456921|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456922|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14456923|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456924|NCT02097745|Rituximab|rituximab|mesh-list
14456925|NCT02097745|Methotrexate|methotrexate|mesh-list
14456926|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14456927|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456928|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
14456929|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456930|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14456931|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14456932|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
14456933|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14456934|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14456935|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
14456936|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456937|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456938|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14456939|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14456940|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456941|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14456942|NCT02097823|Olanzapine|olanzapine|mesh-list
14456943|NCT02097823|Aprepitant|aprepitant|mesh-list
14456944|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
14456945|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
14456946|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14456947|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456948|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14456949|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14456950|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14456951|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14456952|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14456953|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14456954|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14456955|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14456956|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14456957|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14456958|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
14456959|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14456960|NCT02097849|Interferons|interferons|mesh-list
14456961|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14456962|NCT02097849|Vaccines|vaccines|mesh-list
14456963|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14456964|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
14456965|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456966|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14456967|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
14456968|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456969|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
14456970|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456971|NCT02098109|Plerixafor|plerixafor|mesh-list
14456972|NCT02098109|Lenograstim|lenograstim|mesh-list
14930490|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
14930491|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930492|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930493|NCT01433757|Ampicillin|ampicillin|mesh-list
14456973|NCT02098109|Sargramostim|sargramostim|mesh-list
14930494|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14456974|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14456975|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
14456976|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456977|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14456978|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14456979|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
14456980|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14456981|NCT02098395|Liraglutide|liraglutide|mesh-list
14456982|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456983|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456984|NCT02098395|Incretins|incretins|mesh-ancestor
14456985|NCT02098395|Hormones|hormones|mesh-ancestor
14456986|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14456987|NCT02098733|Pioglitazone|pioglitazone|mesh-list
14456988|NCT02098733|Glimepiride|glimepiride|mesh-list
14456989|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456990|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456991|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14456992|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14456993|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
14456994|NCT02098746|Pioglitazone|pioglitazone|mesh-list
14456995|NCT02098746|Glimepiride|glimepiride|mesh-list
14456996|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14456997|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14456998|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14456999|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457000|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
14457001|NCT02098993|Heparin|heparin|mesh-list
14457002|NCT02098993|Calcium heparin|calcium heparin|mesh-list
14457003|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
14457004|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14457005|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14457006|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457007|NCT02099006|Ketoprofen|ketoprofen|mesh-list
14457008|NCT02099006|Ketamine|ketamine|mesh-list
14457009|NCT02099006|Gabapentin|gabapentin|mesh-list
14457010|NCT02099006|Amitriptyline|amitriptyline|mesh-list
14457011|NCT02099006|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14457012|NCT02099006|Baclofen|baclofen|mesh-list
14457013|NCT02099006|Loperamide|loperamide|mesh-list
14457014|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
14457015|NCT02099006|Analgesics|analgesics|mesh-ancestor
14457016|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
14457017|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457018|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457019|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14457020|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14457021|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
14752575|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14752576|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14457022|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
14457023|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457024|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14457025|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14457026|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457027|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457028|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
14457029|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14457030|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14457031|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14457032|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
14457033|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14457034|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14457035|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14457036|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
14457037|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
14457038|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14457039|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14457040|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457041|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14457042|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14457043|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457044|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14457045|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
14457046|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14457047|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14457048|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14457049|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457050|NCT02099006|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14457051|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457052|NCT02099084|Teduglutide|teduglutide|mesh-list
14457053|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457054|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14457055|NCT02099084|Protective Agents|protective agents|mesh-ancestor
14457056|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457057|NCT02099110|Metformin|metformin|mesh-list
14457058|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
14457059|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14457060|NCT02099110|Glimepiride|glimepiride|mesh-list
14457061|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
14457062|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457063|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457064|NCT02099110|Incretins|incretins|mesh-ancestor
14457065|NCT02099110|Hormones|hormones|mesh-ancestor
14457066|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457067|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14457068|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457069|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457070|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457071|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14457072|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457073|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
14457074|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14457075|NCT02099461|Denosumab|denosumab|mesh-list
14457076|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14457077|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457078|NCT02099682|Lansoprazole|lansoprazole|mesh-list
14457079|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
14457080|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14457081|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457082|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14457083|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457084|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457085|NCT02099708|Lansoprazole|lansoprazole|mesh-list
14457086|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
14457087|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14457088|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457089|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14457090|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457091|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457092|NCT02099838|Metformin|metformin|mesh-list
14457093|NCT02099838|Pioglitazone|pioglitazone|mesh-list
14457094|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457095|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457096|NCT02100007|Topotecan|topotecan|mesh-list
14457097|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14457098|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14457099|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457100|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457101|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457102|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
14457103|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14457104|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457105|NCT02100228|Vitamin K|vitamin k|mesh-list
14457106|NCT02100228|Heparin|heparin|mesh-list
14457107|NCT02100228|Apixaban|apixaban|mesh-list
14457108|NCT02100228|Vitamins|vitamins|mesh-ancestor
14457109|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
14457110|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457111|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
14457112|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14457113|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14457114|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457115|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14457116|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
14457117|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14457118|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457119|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457120|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14457121|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
14457122|NCT02100228|Coagulants|coagulants|mesh-ancestor
14457123|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14457124|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14457125|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14752577|NCT05336266|Analgesics|analgesics|mesh-ancestor
14457126|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457127|NCT02100475|Insulin|insulin|mesh-list
14457128|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14457129|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
14457130|NCT02100475|Liraglutide|liraglutide|mesh-list
14457131|NCT02100475|Xultophy|xultophy|mesh-list
14457132|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457133|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457134|NCT02100475|Incretins|incretins|mesh-ancestor
14457135|NCT02100475|Hormones|hormones|mesh-ancestor
14457136|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457137|NCT02100514|Bococizumab|bococizumab|mesh-list
14457138|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14457139|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14457140|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
14457141|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457142|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14457143|NCT02100579|Bupivacaine|bupivacaine|mesh-list
14457144|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
14457145|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
14457146|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457147|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457148|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
14457149|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457150|NCT02100644|Lamotrigine|lamotrigine|mesh-list
14457151|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
14457152|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14457153|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14457154|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457155|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14457156|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457157|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14457158|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14457159|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457160|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14457161|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14457162|NCT02100657|Dexamethasone|dexamethasone|mesh-list
14457163|NCT02100657|Bortezomib|bortezomib|mesh-list
14457164|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457165|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
14457166|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
14457167|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457168|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457169|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457170|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
14457171|NCT02100657|Hormones|hormones|mesh-ancestor
14457172|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457173|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14457174|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457175|NCT02100670|Diclofenac|diclofenac|mesh-list
14457176|NCT02100670|Menthol|menthol|mesh-list
14457177|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14457178|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14457179|NCT02100670|Analgesics|analgesics|mesh-ancestor
14457180|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
14457181|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457182|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457183|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457184|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14457185|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14457186|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457187|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457188|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
14457189|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14457190|NCT02100696|Etrolizumab|etrolizumab|mesh-list
14457191|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457192|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
14457193|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457194|NCT02100748|Morphine|morphine|mesh-list
14457195|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14457196|NCT02100748|Narcotics|narcotics|mesh-ancestor
14457197|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457198|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457199|NCT02100748|Analgesics|analgesics|mesh-ancestor
14457200|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
14457201|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469560|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469561|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469562|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469563|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469564|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
14469565|NCT02296138|Olodaterol|olodaterol|mesh-list
14469566|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14469567|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
14469568|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469569|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469570|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14469571|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469572|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
14469573|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14469574|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14469575|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469576|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469577|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
14457202|NCT02100826|Cephalexin|cephalexin|mesh-list
14457203|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14457204|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457205|NCT02100930|Molgramostim|molgramostim|mesh-list
14457206|NCT02100930|Isotretinoin|isotretinoin|mesh-list
14457207|NCT02100930|Antibodies|antibodies|mesh-list
14457208|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14457209|NCT02100930|Sargramostim|sargramostim|mesh-list
14457210|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
14457211|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457212|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
14457213|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457214|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
14457215|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
14457216|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14457217|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14457218|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
14457219|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457220|NCT02101008|Disulfiram|disulfiram|mesh-list
14457221|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14457222|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14457223|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457224|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457225|NCT02101021|Gemcitabine|gemcitabine|mesh-list
14457226|NCT02101021|Paclitaxel|paclitaxel|mesh-list
14457227|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
14457228|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14457229|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457230|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
14457231|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
14457232|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
14457233|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457234|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14457235|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
14457236|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
14457237|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457238|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457239|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457240|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
14457241|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457242|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14457243|NCT02101034|Cetuximab|cetuximab|mesh-list
14457244|NCT02101034|Palbociclib|palbociclib|mesh-list
14457245|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14457246|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457247|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14457248|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457249|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457250|NCT02101112|Apixaban|apixaban|mesh-list
14457251|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14457252|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
14457253|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14457254|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457255|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457256|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457257|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
14457258|NCT02101190|Opicapone|opicapone|mesh-list
14457259|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14457260|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457261|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457262|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14457263|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14457264|NCT02101281|Mitogens|mitogens|mesh-list
14457265|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14457266|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457267|NCT02101359|Tetracaine|tetracaine|mesh-list
14457268|NCT02101359|Tropicamide|tropicamide|mesh-list
14457269|NCT02101359|Mydriatics|mydriatics|mesh-list
14457270|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
14457271|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
14457272|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457273|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457274|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
14457275|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457276|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
14457277|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14457278|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14457279|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
14457280|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457281|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457282|NCT02101918|Aflibercept|aflibercept|mesh-list
14457283|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
14457284|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14457285|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14457286|NCT02101918|Growth Substances|growth substances|mesh-ancestor
14457287|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457288|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
14457289|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457290|NCT02101983|Cytarabine|cytarabine|mesh-list
14457291|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14457292|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
14457293|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457294|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457295|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
14457296|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457297|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457298|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
14457299|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457300|NCT02102100|Menthol|menthol|mesh-list
14457301|NCT02102100|Nicotine|nicotine|mesh-list
14457302|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14457303|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
14457304|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457305|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457306|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14457307|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14457308|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
14457309|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457310|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457311|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
14457312|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
14457313|NCT02102932|Metformin|metformin|mesh-list
14457314|NCT02102932|Empagliflozin|empagliflozin|mesh-list
14457315|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457316|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457317|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14457318|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457319|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14457320|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457321|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
14457322|NCT02103114|Antithrombins|antithrombins|mesh-list
14457323|NCT02103114|Thrombin|thrombin|mesh-list
14457324|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
14457325|NCT02103114|Coagulants|coagulants|mesh-ancestor
14457326|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14457327|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457328|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457329|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457330|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
14457331|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14457332|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
14457333|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457334|NCT02103478|Decitabine|decitabine|mesh-list
14457335|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14457336|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
14457337|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457338|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457339|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457340|NCT02103855|Abatacept|abatacept|mesh-list
14457341|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14457342|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457343|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457344|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457345|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
14457346|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457347|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14457348|NCT02104414|Epinephrine|epinephrine|mesh-list
14457349|NCT02104414|Bupivacaine|bupivacaine|mesh-list
14457350|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
14457351|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
14457352|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457353|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457354|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
14457355|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457356|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14457357|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14457358|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457359|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457360|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457361|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14457362|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14457363|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
14457364|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14457365|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
14457366|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
14457367|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
14457368|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14457369|NCT02104505|Tocopherols|tocopherols|mesh-list
14457370|NCT02104505|Vitamin E|vitamin e|mesh-list
14457371|NCT02104505|Tocotrienols|tocotrienols|mesh-list
14457372|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
14457373|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
14457374|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
14457375|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457376|NCT02104505|Protective Agents|protective agents|mesh-ancestor
14469578|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
14457377|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457378|NCT02104505|Vitamins|vitamins|mesh-ancestor
14457379|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
14457380|NCT02104739|Exenatide|exenatide|mesh-list
14457381|NCT02104739|Saxagliptin|saxagliptin|mesh-list
14457382|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457383|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457384|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14457385|NCT02104739|Incretins|incretins|mesh-ancestor
14457386|NCT02104739|Hormones|hormones|mesh-ancestor
14457387|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457388|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14457389|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457390|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457391|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457392|NCT02104752|Curcumin|curcumin|mesh-list
14457393|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14457394|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14457395|NCT02104752|Analgesics|analgesics|mesh-ancestor
14457396|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
14457397|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457398|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457399|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457400|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14457401|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457402|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457403|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457404|NCT02104804|Insulin|insulin|mesh-list
14457405|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14457406|NCT02104804|Metformin|metformin|mesh-list
14457407|NCT02104804|Saxagliptin|saxagliptin|mesh-list
14457408|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
14457409|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457410|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457411|NCT02104804|Incretins|incretins|mesh-ancestor
14457412|NCT02104804|Hormones|hormones|mesh-ancestor
14457413|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457414|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14457415|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457416|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457417|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457418|NCT02104830|Lenograstim|lenograstim|mesh-list
14457419|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14457420|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
14753764|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457421|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457422|NCT02105272|Carteolol|carteolol|mesh-list
14457423|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14457424|NCT02105272|Latanoprost|latanoprost|mesh-list
14457425|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14457426|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14457427|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14457428|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457429|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457430|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457431|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457432|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14457433|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14457434|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
14457435|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
14457436|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457437|NCT02105285|Carteolol|carteolol|mesh-list
14457438|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14752578|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
14752579|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752580|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752581|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752582|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752583|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14752584|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752585|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752586|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14752587|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14752588|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
14752589|NCT05335993|Niraparib|niraparib|mesh-list
14752590|NCT05335993|Oregovomab|oregovomab|mesh-list
14752591|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14752592|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457439|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14457440|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14457441|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14457442|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457443|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457444|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457445|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457446|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14457447|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14457448|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
14457449|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
14457450|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457451|NCT02105324|Pancrelipase|pancrelipase|mesh-list
14457452|NCT02105324|Pancreatin|pancreatin|mesh-list
14457453|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457454|NCT02105415|Ketamine|ketamine|mesh-list
14457455|NCT02105415|Propofol|propofol|mesh-list
14457456|NCT02105415|Etomidate|etomidate|mesh-list
14457457|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14457458|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457459|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457460|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14457461|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
14457462|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
14457463|NCT02105415|Analgesics|analgesics|mesh-ancestor
14457464|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
14457465|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457466|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14457467|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14457468|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14457469|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457470|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457471|NCT02105454|Ribavirin|ribavirin|mesh-list
14457472|NCT02105454|Grazoprevir|grazoprevir|mesh-list
14457473|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
14457474|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457475|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
14457476|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457477|NCT02105467|Grazoprevir|grazoprevir|mesh-list
14457478|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
14457479|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457480|NCT02105558|Anesthetics|anesthetics|mesh-list
14457481|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457482|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457483|NCT02105662|Grazoprevir|grazoprevir|mesh-list
14752593|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752594|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752595|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14457484|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
14457485|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457486|NCT02105688|Grazoprevir|grazoprevir|mesh-list
14457487|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
14457488|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457489|NCT02105701|Ribavirin|ribavirin|mesh-list
14457490|NCT02105701|Grazoprevir|grazoprevir|mesh-list
14457491|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
14457492|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457493|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
14457494|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457495|NCT02105974|Fluticasone|fluticasone|mesh-list
14457496|NCT02105974|Xhance|xhance|mesh-list
14457497|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457498|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14457499|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
14457500|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457501|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457502|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14457503|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
14457504|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
14457505|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14457506|NCT02106156|Interferons|interferons|mesh-list
14457507|NCT02106156|Ribavirin|ribavirin|mesh-list
14457508|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
14457509|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
14457510|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14457511|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457512|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
14457513|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457514|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
14457515|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457516|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
14457517|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457518|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
14457519|NCT02106325|Promethazine|promethazine|mesh-list
14457520|NCT02106325|Ketamine|ketamine|mesh-list
14457521|NCT02106325|Analgesics|analgesics|mesh-ancestor
14457522|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
14457523|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457524|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457525|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14457526|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14457527|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
14457528|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
14457529|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457530|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14457531|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14457532|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457533|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457534|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14457535|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14457536|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
14457537|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
14457538|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
14457539|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457540|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14457541|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
14457542|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
14457543|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14457544|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
14457545|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
14457546|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
14457547|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14457548|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14457549|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14457550|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14457551|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457552|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
14457553|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457554|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457555|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14457556|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457557|NCT02106390|Vaccines|vaccines|mesh-list
14457558|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
14457559|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457560|NCT02106403|Disinfectants|disinfectants|mesh-list
14457561|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457562|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
14457563|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14457564|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14457565|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457566|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14457567|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457568|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14457569|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
14457570|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14457571|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14457572|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457573|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14457574|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457575|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14457576|NCT02106494|Dexamethasone|dexamethasone|mesh-list
14457577|NCT02106494|Ondansetron|ondansetron|mesh-list
14457578|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
14457579|NCT02106494|Aprepitant|aprepitant|mesh-list
14457580|NCT02106494|Granisetron|granisetron|mesh-list
14457581|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457582|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
14457583|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
14457584|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457585|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457586|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457587|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
14457588|NCT02106494|Hormones|hormones|mesh-ancestor
14457589|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457590|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14457591|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457592|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
14457593|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
14457594|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14457595|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
14457596|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457597|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457598|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14457599|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14457600|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457601|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14457602|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14457603|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14457604|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
14457605|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14457606|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457607|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14457608|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14457609|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457610|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457611|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457612|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14457613|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14457614|NCT02106884|Gemcitabine|gemcitabine|mesh-list
14457615|NCT02106884|Paclitaxel|paclitaxel|mesh-list
14457616|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14457617|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457618|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
14457619|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14457620|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
14457621|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457622|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14457623|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
14457624|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
14457625|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457626|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457627|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457628|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
14457629|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457630|NCT02106923|Metformin|metformin|mesh-list
14457631|NCT02106923|Empagliflozin|empagliflozin|mesh-list
14457632|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457633|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457634|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14930495|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930496|NCT01433770|Alefacept|alefacept|mesh-list
14930497|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
14930498|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
14930499|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930500|NCT01433887|Ribavirin|ribavirin|mesh-list
14930501|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14930502|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
14457635|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457636|NCT02106962|Bacitracin|bacitracin|mesh-list
14457637|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
14457638|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14457639|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14457640|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457641|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
14457642|NCT02106962|Coagulants|coagulants|mesh-ancestor
14457643|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14457644|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457645|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14457646|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
14457647|NCT02106975|Vitamins|vitamins|mesh-ancestor
14457648|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
14457649|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930503|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930504|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
14930505|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930506|NCT01433900|Latanoprost|latanoprost|mesh-list
14457650|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
14457651|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457652|NCT02106975|Protective Agents|protective agents|mesh-ancestor
14457653|NCT02107014|Naltrexone|naltrexone|mesh-list
14457654|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14457655|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14457656|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457657|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
14457658|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457659|NCT02107131|Ranibizumab|ranibizumab|mesh-list
14457660|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14457661|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14457662|NCT02107131|Growth Substances|growth substances|mesh-ancestor
14457663|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457664|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
14457665|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457666|NCT02107274|Azithromycin|azithromycin|mesh-list
14457667|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14457668|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457669|NCT02107339|Methadone|methadone|mesh-list
14457670|NCT02107339|Hydromorphone|hydromorphone|mesh-list
14457671|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14457672|NCT02107339|Narcotics|narcotics|mesh-ancestor
14457673|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457674|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457675|NCT02107339|Analgesics|analgesics|mesh-ancestor
14457676|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
14457677|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457678|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
14457679|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469579|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469580|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14469581|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469582|NCT02296190|Etripamil|etripamil|mesh-list
14469583|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14469584|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469585|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469586|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14469587|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930507|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14930508|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14930509|NCT01433952|Thiamine|thiamine|mesh-list
14930510|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
14930511|NCT01433952|Vitamins|vitamins|mesh-ancestor
14930512|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
14930513|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930514|NCT01434017|Dexamethasone|dexamethasone|mesh-list
14930515|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
14930516|NCT01434017|Droperidol|droperidol|mesh-list
14930517|NCT01434017|Ondansetron|ondansetron|mesh-list
14930518|NCT01434017|BB 1101|bb 1101|mesh-list
14930519|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14930520|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
14930521|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
14930522|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930523|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930524|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457680|NCT02107703|Fulvestrant|fulvestrant|mesh-list
14457681|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14457682|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457683|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14457684|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14457685|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
14457686|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457687|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457688|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14457689|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
14457690|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457691|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
14457692|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14457693|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457694|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457695|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14457696|NCT02108171|Analgesics|analgesics|mesh-ancestor
14457697|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
14457698|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457699|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14457700|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14457701|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14457702|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457703|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457704|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457705|NCT02108288|Carteolol|carteolol|mesh-list
14457706|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14457707|NCT02108288|Latanoprost|latanoprost|mesh-list
14457708|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14457709|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14457710|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14457711|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457712|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457713|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457714|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457715|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14457716|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14457717|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
14457718|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
14457719|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457720|NCT02109029|Insulin|insulin|mesh-list
14457721|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14457722|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457723|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457724|NCT02109133|Rocuronium|rocuronium|mesh-list
14457725|NCT02109133|Atracurium|atracurium|mesh-list
14457726|NCT02109133|Neostigmine|neostigmine|mesh-list
14457727|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14457728|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14457729|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14457730|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457731|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930525|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
14930526|NCT01434017|Hormones|hormones|mesh-ancestor
14930527|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930528|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14930529|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930530|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
14930531|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930532|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457732|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14457733|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457734|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457735|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
14457736|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457737|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14457738|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
14457739|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14457740|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14457741|NCT02109445|Gemcitabine|gemcitabine|mesh-list
14457742|NCT02109445|Paclitaxel|paclitaxel|mesh-list
14457743|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14457744|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14457745|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457746|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
14457747|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
14457748|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
14457749|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457750|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14457751|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
14457752|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
14457753|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457754|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457755|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457756|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
14457757|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457758|NCT02109484|Vaccines|vaccines|mesh-list
14457759|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
14457760|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457761|NCT02109562|Risperidone|risperidone|mesh-list
14457762|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14457763|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
14457764|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457765|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457766|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457767|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14457768|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14457769|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457770|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14457771|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14457772|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
14457773|NCT02109640|Oxycodone|oxycodone|mesh-list
14457774|NCT02109640|Naloxone|naloxone|mesh-list
14457775|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14457776|NCT02109640|Narcotics|narcotics|mesh-ancestor
14457777|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457778|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457779|NCT02109640|Analgesics|analgesics|mesh-ancestor
14457780|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
14457781|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457782|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14457783|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
14457784|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14457785|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14457786|NCT02110225|Mitogens|mitogens|mesh-list
14457787|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14457788|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457789|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
14457790|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14457791|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
14457792|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457793|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
14457794|NCT02110238|Protective Agents|protective agents|mesh-ancestor
14457795|NCT02110264|Naltrexone|naltrexone|mesh-list
14457796|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14457797|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14457798|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457799|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
14457800|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457801|NCT02110706|Rituximab|rituximab|mesh-list
14457802|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14457803|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457804|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
14457805|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457806|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14457807|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
14457808|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457809|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457810|NCT02111096|Metformin|metformin|mesh-list
14457811|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14457812|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457813|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457814|NCT02111096|Incretins|incretins|mesh-ancestor
14457815|NCT02111096|Hormones|hormones|mesh-ancestor
14457816|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457817|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14457818|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457819|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457820|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457821|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
14457822|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14457823|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457824|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
14457825|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457826|NCT02111369|Propranolol|propranolol|mesh-list
14457827|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
14457828|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14457829|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14457830|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457831|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
14457832|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457833|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457834|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14457835|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14457836|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457837|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14457838|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14457839|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
14457840|NCT02111447|Propofol|propofol|mesh-list
14457841|NCT02111447|Sevoflurane|sevoflurane|mesh-list
14457842|NCT02111447|Isoflurane|isoflurane|mesh-list
14457843|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14930533|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
14457844|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457845|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457846|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14457847|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
14457848|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
14457849|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14457850|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14457851|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
14457852|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14457853|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
14457854|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14457855|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457856|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457857|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457858|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
14457859|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14457860|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14457861|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14457862|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
14457863|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457864|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14457865|NCT02111746|Bupivacaine|bupivacaine|mesh-list
14457866|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
14457867|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
14457868|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457869|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457870|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
14457871|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457872|NCT02111785|Dexamethasone|dexamethasone|mesh-list
14457873|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457874|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
14457875|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
14457876|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457877|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457878|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14457879|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
14457880|NCT02111785|Hormones|hormones|mesh-ancestor
14457881|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14457882|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14457883|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457884|NCT02111798|Bupropion|bupropion|mesh-list
14457885|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14457886|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
14457887|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14457888|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14457889|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14457890|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14457891|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457892|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
14457893|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457894|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457895|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14457896|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14457897|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457898|NCT02111863|Aldesleukin|aldesleukin|mesh-list
14457899|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
14457900|NCT02111863|Fludarabine|fludarabine|mesh-list
14457901|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457902|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
14457903|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457904|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14457905|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14457906|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
14457907|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457908|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457909|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14457910|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14457911|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14457912|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
14457913|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457914|NCT02112045|Melphalan|melphalan|mesh-list
14457915|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14457916|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
14457917|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457918|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457919|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14457920|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14457921|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
14457922|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457923|NCT02112370|Epinephrine|epinephrine|mesh-list
14457924|NCT02112370|Racepinephrine|racepinephrine|mesh-list
14457925|NCT02112370|Ropivacaine|ropivacaine|mesh-list
14457926|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
14457927|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
14457928|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
14457929|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14457930|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457931|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
14457932|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457933|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14457934|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14457935|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
14457936|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14457937|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457938|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14457939|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14457940|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
14457941|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14457942|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
14457943|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
14457944|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
14457945|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14457946|NCT02112448|Acetaminophen|acetaminophen|mesh-list
14930534|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
14930535|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14930536|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
14930537|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930538|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14457947|NCT02112448|Ketorolac|ketorolac|mesh-list
14457948|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14457949|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14457950|NCT02112448|Analgesics|analgesics|mesh-ancestor
14457951|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
14457952|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14457953|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457954|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
14457955|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14457956|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14457957|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14457958|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14457959|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457960|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457961|NCT02113007|Rituximab|rituximab|mesh-list
14457962|NCT02113007|Temozolomide|temozolomide|mesh-list
14457963|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14457964|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14457965|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
14457966|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457967|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930539|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14457968|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14457969|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
14457970|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457971|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
14457972|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14457973|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457974|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14457975|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457976|NCT02113579|Fluorides|fluorides|mesh-list
14457977|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
14457978|NCT02113579|Protective Agents|protective agents|mesh-ancestor
14457979|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457980|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
14457981|NCT02114151|Simeprevir|simeprevir|mesh-list
14457982|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
14457983|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457984|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457985|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457986|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457987|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
14457988|NCT02114177|Simeprevir|simeprevir|mesh-list
14457989|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
14457990|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14457991|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
14457992|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14457993|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14457994|NCT02114385|Vaccines|vaccines|mesh-list
14457995|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
14457996|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14457997|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
14457998|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14457999|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458000|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14458001|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14458002|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469588|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14458003|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458004|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458005|NCT02114892|Resveratrol|resveratrol|mesh-list
14458006|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
14458007|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458008|NCT02114892|Protective Agents|protective agents|mesh-ancestor
14458009|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458010|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458011|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14458012|NCT02114931|Adalimumab|adalimumab|mesh-list
14458013|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458014|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458015|NCT02115048|Letrozole|letrozole|mesh-list
14458016|NCT02115048|Afatinib|afatinib|mesh-list
14458017|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458018|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14458019|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14458020|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458021|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458022|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14458023|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
14458024|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458025|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458026|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14458027|NCT02115113|Everolimus|everolimus|mesh-list
14458028|NCT02115113|Tacrolimus|tacrolimus|mesh-list
14458029|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458030|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
14458031|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458032|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14458033|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458034|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458035|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458036|NCT02115139|Ipilimumab|ipilimumab|mesh-list
14458037|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14458038|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458039|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14458040|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458041|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
14458042|NCT02115256|Terbutaline|terbutaline|mesh-list
14458043|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
14458044|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14458045|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
14458046|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458047|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458048|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14458049|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14458050|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
14458051|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
14458052|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14458053|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14458054|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14458055|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14458056|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14458057|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14458058|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469589|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14469590|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
14469591|NCT02296346|Prednisolone|prednisolone|mesh-list
14469592|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
14469593|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14469594|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
14469595|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469596|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
14469597|NCT02296346|Hormones|hormones|mesh-ancestor
14469598|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469599|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469600|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14469601|NCT02296346|Protective Agents|protective agents|mesh-ancestor
14469602|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14469603|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469604|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
14469605|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
14469606|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469607|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469608|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14469609|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
14469610|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470137|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14470138|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470139|NCT02305017|Acetaminophen|acetaminophen|mesh-list
14470140|NCT02305017|Opicapone|opicapone|mesh-list
14470141|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14470142|NCT02305017|Analgesics|analgesics|mesh-ancestor
14470143|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
14470144|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470145|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470146|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
14470147|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14470148|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470149|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470150|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14470151|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14470152|NCT02305238|Aflibercept|aflibercept|mesh-list
14470153|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14470154|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14470155|NCT02305238|Growth Substances|growth substances|mesh-ancestor
14470156|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470157|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
14470158|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470159|NCT02305277|Opicapone|opicapone|mesh-list
14470160|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14470161|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470162|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470163|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14470164|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14470166|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14470167|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470168|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470169|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14470170|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14470171|NCT02305329|Opicapone|opicapone|mesh-list
14470172|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14470173|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470174|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470175|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14470176|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14470177|NCT02305563|Cytarabine|cytarabine|mesh-list
14470178|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458059|NCT02115282|Exemestane|exemestane|mesh-list
14458060|NCT02115282|Goserelin|goserelin|mesh-list
14458061|NCT02115282|Entinostat|entinostat|mesh-list
14458062|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14458063|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458064|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14458065|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14458066|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458067|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458068|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14458069|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
14458070|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458071|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458072|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14458073|NCT02115308|Regadenoson|regadenoson|mesh-list
14458074|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14458075|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14458076|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
14458077|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
14458078|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14458079|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458080|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458081|NCT02115321|Grazoprevir|grazoprevir|mesh-list
14458082|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
14458083|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458084|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
14458085|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14458086|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458087|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14458088|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458089|NCT02115373|Tepotinib|tepotinib|mesh-list
14458090|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458091|NCT02115581|Ubiquinone|ubiquinone|mesh-list
14458092|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
14458093|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
14458094|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458095|NCT02115581|Vitamins|vitamins|mesh-ancestor
14458096|NCT02115750|Etanercept|etanercept|mesh-list
14458097|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14458098|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458099|NCT02115750|Analgesics|analgesics|mesh-ancestor
14458100|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
14458101|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458102|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469611|NCT02296775|Rituximab|rituximab|mesh-list
14458103|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458104|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458105|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458106|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458107|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
14458108|NCT02116205|Vaccines|vaccines|mesh-list
14458109|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
14458110|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458111|NCT02116309|Indomethacin|indomethacin|mesh-list
14458112|NCT02116309|Epinephrine|epinephrine|mesh-list
14458113|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14458114|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14458115|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
14458116|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14458117|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458118|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458119|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14458120|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14458121|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
14458122|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458123|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14458124|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
14458125|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
14458126|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
14458127|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14458128|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14458129|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458130|NCT02116309|Analgesics|analgesics|mesh-ancestor
14458131|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
14458132|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458133|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458134|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
14458135|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
14458136|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14458137|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14458138|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458139|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
14458140|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14458141|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14458142|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14458143|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469612|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14458144|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458145|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
14458146|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14458147|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458148|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14458149|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458150|NCT02116530|Dexamethasone|dexamethasone|mesh-list
14458151|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
14458152|NCT02116530|Doxorubicin|doxorubicin|mesh-list
14458153|NCT02116530|Ondansetron|ondansetron|mesh-list
14458154|NCT02116530|Olanzapine|olanzapine|mesh-list
14458155|NCT02116530|Aprepitant|aprepitant|mesh-list
14458156|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
14458157|NCT02116530|Palonosetron|palonosetron|mesh-list
14458158|NCT02116530|Granisetron|granisetron|mesh-list
14458159|NCT02116530|Antiemetics|antiemetics|mesh-list
14458160|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458161|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
14458162|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458163|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458164|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14458165|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
14458166|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458167|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458168|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14458169|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458170|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
14458171|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458172|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458173|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
14458174|NCT02116530|Hormones|hormones|mesh-ancestor
14458175|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458176|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14458177|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14458178|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14458179|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14458180|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458181|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
14458182|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
14458183|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14458184|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
14458185|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14458186|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14458187|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14458188|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14458189|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14458190|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14458191|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14458192|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14458193|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14458194|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14458195|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14458196|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
14458197|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
14458198|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
14458199|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
14458200|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458201|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14458202|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458203|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
14458204|NCT02116660|Ritonavir|ritonavir|mesh-list
14458205|NCT02116660|Lopinavir|lopinavir|mesh-list
14458206|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14458207|NCT02116660|Darunavir|darunavir|mesh-list
14458208|NCT02116660|Tenofovir|tenofovir|mesh-list
14458209|NCT02116660|Lamivudine|lamivudine|mesh-list
14458210|NCT02116660|Emtricitabine|emtricitabine|mesh-list
14458211|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
14458212|NCT02116660|Nevirapine|nevirapine|mesh-list
14458213|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14458214|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14458215|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
14458216|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458217|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458218|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14458219|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14458220|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
14458221|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458222|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14458223|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14458224|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14458225|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14458226|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14458227|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14458228|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14458229|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14458230|NCT02116777|Temozolomide|temozolomide|mesh-list
14458231|NCT02116777|Talazoparib|talazoparib|mesh-list
14458232|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14458233|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
14458234|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458235|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458236|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14458237|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458238|NCT02116803|Fulvestrant|fulvestrant|mesh-list
14458239|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14458240|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458241|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14458242|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14458243|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
14458244|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458245|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458246|NCT02116972|FX006|fx006|mesh-list
14458247|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458248|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
14458249|NCT02116972|Hormones|hormones|mesh-ancestor
14458250|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458251|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458252|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458253|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
14458254|NCT02117024|Gemcitabine|gemcitabine|mesh-list
14458255|NCT02117024|Paclitaxel|paclitaxel|mesh-list
14458256|NCT02117024|Vinorelbine|vinorelbine|mesh-list
14458257|NCT02117024|Docetaxel|docetaxel|mesh-list
14458258|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
14458259|NCT02117024|Pemetrexed|pemetrexed|mesh-list
14458260|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14458261|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14458262|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458263|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
14458264|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
14458265|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
14458266|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458267|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458268|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
14458269|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458270|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458271|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14458272|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
14930540|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14458273|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14458274|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458275|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
14458276|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
14458277|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458278|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458279|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14458280|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14458281|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14458282|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14458283|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14458284|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
14458285|NCT02117349|Coagulants|coagulants|mesh-ancestor
14458286|NCT02117479|Capecitabine|capecitabine|mesh-list
14458287|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458288|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
14458289|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458290|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458291|NCT02117570|Vaccines|vaccines|mesh-list
14458292|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
14458293|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458294|NCT02117648|Clarithromycin|clarithromycin|mesh-list
14458295|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458296|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458297|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14458298|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458299|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458300|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14458301|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14930541|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14458302|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14458303|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
14458304|NCT02117687|Glycerol|glycerol|mesh-list
14458305|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14458306|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
14458307|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458308|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
14458309|NCT02117687|Protective Agents|protective agents|mesh-ancestor
14458310|NCT02117687|Laxatives|laxatives|mesh-ancestor
14458311|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458312|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14458313|NCT02117934|Vaccines|vaccines|mesh-list
14458314|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
14458315|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458316|NCT02118012|Ribavirin|ribavirin|mesh-list
14458317|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
14458318|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458319|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
14458320|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458321|NCT02118337|Nivolumab|nivolumab|mesh-list
14458322|NCT02118337|Durvalumab|durvalumab|mesh-list
14458323|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14458324|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458325|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14458326|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458327|NCT02118597|Interferons|interferons|mesh-list
14458328|NCT02118597|Ribavirin|ribavirin|mesh-list
14458329|NCT02118597|Simeprevir|simeprevir|mesh-list
14458330|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458331|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
14458332|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458333|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
14458334|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458335|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
14458336|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458337|NCT02118714|Atrasentan|atrasentan|mesh-list
14458338|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458339|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14458340|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14458341|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458342|NCT02118831|Bevacizumab|bevacizumab|mesh-list
14458343|NCT02118831|Ranibizumab|ranibizumab|mesh-list
14458344|NCT02118831|Aflibercept|aflibercept|mesh-list
14458345|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14458346|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458347|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14458348|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14458349|NCT02118831|Growth Substances|growth substances|mesh-ancestor
14458350|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458351|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
14458352|NCT02118896|Tacrolimus|tacrolimus|mesh-list
14458353|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458354|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
14458355|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458356|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14930542|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14930543|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14458357|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458358|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458359|NCT02118961|Vaccines|vaccines|mesh-list
14458360|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
14458361|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458362|NCT02119026|Bevacizumab|bevacizumab|mesh-list
14458363|NCT02119026|Capecitabine|capecitabine|mesh-list
14458364|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
14458365|NCT02119026|Irinotecan|irinotecan|mesh-list
14458366|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14458367|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458368|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14458369|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14458370|NCT02119026|Growth Substances|growth substances|mesh-ancestor
14458371|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458372|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
14458373|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458374|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
14458375|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458376|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14458377|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14458378|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458379|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14458380|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
14458381|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458382|NCT02119156|Belimumab|belimumab|mesh-list
14458383|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458384|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
14458385|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458386|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14458387|NCT02119650|Pemetrexed|pemetrexed|mesh-list
14458388|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458389|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458390|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458391|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14458392|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14458393|NCT02119663|Capecitabine|capecitabine|mesh-list
14470165|NCT02305316|Opicapone|opicapone|mesh-list
14752607|NCT05335941|Pemetrexed|pemetrexed|mesh-list
14752608|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752609|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752610|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752611|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14752612|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14752613|NCT05335928|Abatacept|abatacept|mesh-list
14752614|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14752615|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752616|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752617|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752618|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
14752619|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752620|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752621|NCT05335915|Nicotine|nicotine|mesh-list
14752622|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14752623|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
14752624|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752625|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458394|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458395|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
14458396|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458397|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458398|NCT02119819|Metformin|metformin|mesh-list
14458399|NCT02119819|Exenatide|exenatide|mesh-list
14458400|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14458401|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458402|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14458403|NCT02119819|Incretins|incretins|mesh-ancestor
14458404|NCT02119819|Hormones|hormones|mesh-ancestor
14458405|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458406|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
14458407|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
14458408|NCT02120157|Busulfan|busulfan|mesh-list
14458409|NCT02120157|Tacrolimus|tacrolimus|mesh-list
14458410|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458411|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
14458412|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458413|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458414|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14458415|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
14458416|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458417|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458418|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14458419|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14458420|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458421|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14458422|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14458423|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
14458424|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458425|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458426|NCT02120261|Triamcinolone|triamcinolone|mesh-list
14458427|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14458428|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14458429|NCT02120261|Lidocaine|lidocaine|mesh-list
14458430|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14458431|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
14458432|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
14458433|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14458434|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458435|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
14458436|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458437|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14458438|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14458439|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14458440|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14458441|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458442|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458443|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
14458444|NCT02120261|Hormones|hormones|mesh-ancestor
14458445|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458446|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458447|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
14458448|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458449|NCT02120287|Bevacizumab|bevacizumab|mesh-list
14458450|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752626|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14752627|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14752628|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
14752629|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752630|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752631|NCT05335837|Anesthetics|anesthetics|mesh-list
14930544|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14930545|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14930546|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
14930547|NCT01434069|Leucovorin|leucovorin|mesh-list
14930548|NCT01434069|Fluorouracil|fluorouracil|mesh-list
14930549|NCT01434069|Pasireotide|pasireotide|mesh-list
14930550|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
14930551|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930552|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14930553|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458451|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458452|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14930554|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930555|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
14930556|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930557|NCT01434069|Antidotes|antidotes|mesh-ancestor
14930558|NCT01434069|Protective Agents|protective agents|mesh-ancestor
14930559|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
14930560|NCT01434069|Vitamins|vitamins|mesh-ancestor
14930561|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
14930562|NCT01434069|Hormones|hormones|mesh-ancestor
14930563|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14930564|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
14930565|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458453|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14458454|NCT02120287|Growth Substances|growth substances|mesh-ancestor
14458455|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458456|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
14458457|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
14458458|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
14458459|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458460|NCT02120352|Rilpivirine|rilpivirine|mesh-list
14458461|NCT02120352|Cabotegravir|cabotegravir|mesh-list
14458462|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14458463|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14458464|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458465|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458466|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
14458467|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458468|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14458469|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14458470|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14458471|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14458472|NCT02120417|Capecitabine|capecitabine|mesh-list
14458473|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458474|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
14458475|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458476|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458477|NCT02120664|Corticosterone|corticosterone|mesh-list
14458478|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458479|NCT02120794|Insulin|insulin|mesh-list
14458480|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14458481|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458482|NCT02120833|Decanoic acid|decanoic acid|mesh-list
14458483|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
14458484|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458485|NCT02120898|Imiquimod|imiquimod|mesh-list
14458486|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14458487|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
14458488|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458489|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458490|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
14458491|NCT02120924|Azelaic acid|azelaic acid|mesh-list
14458492|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458493|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14458494|NCT02120950|Aflibercept|aflibercept|mesh-list
14458495|NCT02120950|Verteporfin|verteporfin|mesh-list
14458496|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14458497|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14458498|NCT02120950|Growth Substances|growth substances|mesh-ancestor
14458499|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458500|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
14458501|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458502|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14458503|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
14458504|NCT02121002|Diclofenac|diclofenac|mesh-list
14458505|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14458506|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458507|NCT02121002|Analgesics|analgesics|mesh-ancestor
14458508|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
14458509|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458510|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458511|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458512|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458513|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14458514|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458515|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458516|NCT02121041|Losartan|losartan|mesh-list
14458517|NCT02121041|Amlodipine|amlodipine|mesh-list
14458518|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
14458519|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14458520|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14458521|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14458522|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458523|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14458524|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458525|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
14458526|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14458527|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14458528|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14458529|NCT02121041|Diuretics|diuretics|mesh-ancestor
14458530|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
14458531|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14458532|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
14458533|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14458534|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
14458535|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14458536|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458537|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14458538|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14458539|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14458540|NCT02121262|Dexamethasone|dexamethasone|mesh-list
14458541|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458542|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
14458543|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
14458544|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458545|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458546|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458547|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
14458548|NCT02121262|Hormones|hormones|mesh-ancestor
14458549|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458550|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14458551|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458552|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14458553|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14458554|NCT02121392|Bupivacaine|bupivacaine|mesh-list
14458555|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
14458556|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
14458557|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14458558|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458559|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
14458560|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458561|NCT02121418|Cytarabine|cytarabine|mesh-list
14458562|NCT02121418|Decitabine|decitabine|mesh-list
14458563|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14458564|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
14458565|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458566|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458567|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
14458568|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458569|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458570|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
14458571|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458572|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930566|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
14930567|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930568|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930569|NCT01434134|Metoprolol|metoprolol|mesh-list
14458573|NCT02121483|Empagliflozin|empagliflozin|mesh-list
14458574|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14458575|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458576|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14458577|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458578|NCT02121509|Metformin|metformin|mesh-list
14458579|NCT02121509|Linagliptin|linagliptin|mesh-list
14458580|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14458581|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458582|NCT02121509|Incretins|incretins|mesh-ancestor
14458583|NCT02121509|Hormones|hormones|mesh-ancestor
14458584|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458585|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14458586|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
14458587|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458588|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930570|NCT01434134|Candesartan|candesartan|mesh-list
14458589|NCT02121756|Dipyridamole|dipyridamole|mesh-list
14458590|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14458591|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458592|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458593|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14458594|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
14458595|NCT02121795|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14458596|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14458597|NCT02121795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14458598|NCT02121795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14458599|NCT02121795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458600|NCT02121795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458601|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
14458602|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458603|NCT02121795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14469613|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469614|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
14469615|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469616|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469617|NCT02296840|Acetaminophen|acetaminophen|mesh-list
14469618|NCT02296840|Ibuprofen|ibuprofen|mesh-list
14469619|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14752632|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752633|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752634|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
14752635|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14752636|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752637|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752638|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458604|NCT02121847|Cyclosporine|cyclosporine|mesh-list
14458605|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14458606|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14458607|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
14458608|NCT02121847|Cyclosporins|cyclosporins|mesh-list
14458609|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458610|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458611|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458612|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
14458613|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458614|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
14458615|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458616|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14458617|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458618|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14458619|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14458620|NCT02121847|Laxatives|laxatives|mesh-ancestor
14458621|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458622|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14458623|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14458624|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458625|NCT02122380|Incretins|incretins|mesh-ancestor
14458626|NCT02122380|Hormones|hormones|mesh-ancestor
14458627|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458628|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14458629|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
14458630|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458631|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458632|NCT02122471|Plecanatide|plecanatide|mesh-list
14458633|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14458634|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
14458635|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458636|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458637|NCT02122770|Itraconazole|itraconazole|mesh-list
14458638|NCT02122770|Fluconazole|fluconazole|mesh-list
14458639|NCT02122770|Paclitaxel|paclitaxel|mesh-list
14458640|NCT02122770|Docetaxel|docetaxel|mesh-list
14458641|NCT02122770|Carboplatin|carboplatin|mesh-list
14458642|NCT02122770|Pevonedistat|pevonedistat|mesh-list
14458643|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14458644|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458645|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
14458646|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
14458647|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
14458648|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458649|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
14458650|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458651|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14458652|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14458653|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458654|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14458655|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469620|NCT02296840|Hydrocodone|hydrocodone|mesh-list
14752639|NCT05335655|Analgesics|analgesics|mesh-ancestor
14458656|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458657|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458658|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14458659|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14458660|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14458661|NCT02123017|Lactulose|lactulose|mesh-list
14458662|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458663|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
14458664|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14458665|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458666|NCT02123446|Cephalexin|cephalexin|mesh-list
14458667|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458668|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458669|NCT02123459|Cephalexin|cephalexin|mesh-list
14458670|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458671|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458672|NCT02123472|Cephalexin|cephalexin|mesh-list
14458673|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458674|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458675|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
14458676|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14458677|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
14458678|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458679|NCT02123511|Expectorants|expectorants|mesh-ancestor
14458680|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
14458681|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14458682|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
14458683|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458684|NCT02123511|Protective Agents|protective agents|mesh-ancestor
14458685|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458686|NCT02123511|Antidotes|antidotes|mesh-ancestor
14458687|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
14458688|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14458689|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458690|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458691|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14458692|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14458693|NCT02123576|Protective Agents|protective agents|mesh-ancestor
14458694|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458695|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
14458696|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14458697|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
14458698|NCT02123849|Aspirin|aspirin|mesh-list
14458699|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14458700|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458701|NCT02123849|Analgesics|analgesics|mesh-ancestor
14458702|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
14458703|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458704|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458705|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458706|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458707|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14752640|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
14458708|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14458709|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458710|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14458711|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14458712|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458713|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
14458714|NCT02123966|Sirolimus|sirolimus|mesh-list
14458715|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458716|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458717|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14458718|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458719|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
14458720|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458721|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
14458722|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458723|NCT02124044|Asunaprevir|asunaprevir|mesh-list
14458724|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
14458725|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458726|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458727|NCT02124083|Vorinostat|vorinostat|mesh-list
14458728|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458729|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14458730|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458731|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458732|NCT02124161|Vaccines|vaccines|mesh-list
14458733|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14458734|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
14458735|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458736|NCT02124512|Rifaximin|rifaximin|mesh-list
14458737|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458738|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458739|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458740|NCT02124564|Lacosamide|lacosamide|mesh-list
14458741|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
14458742|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14458743|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14458744|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14458745|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458746|NCT02124707|Paclitaxel|paclitaxel|mesh-list
14458747|NCT02124707|Carboplatin|carboplatin|mesh-list
14458748|NCT02124707|Cetuximab|cetuximab|mesh-list
14458749|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14458750|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458751|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
14458752|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14458753|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14458754|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458755|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14458756|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
14458757|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14458758|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458759|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458760|NCT02124759|Sevelamer|sevelamer|mesh-list
14458761|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
14458762|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
14458763|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458764|NCT02124772|Trametinib|trametinib|mesh-list
14458765|NCT02124772|Dabrafenib|dabrafenib|mesh-list
14458766|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458767|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14458768|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458769|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458770|NCT02124798|Belimumab|belimumab|mesh-list
14458771|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458772|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
14458773|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458774|NCT02124811|Minocycline|minocycline|mesh-list
14458775|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458776|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458777|NCT02125279|Calcitriol|calcitriol|mesh-list
14458778|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14458779|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458780|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14458781|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14458782|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458783|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14458784|NCT02125279|Vitamins|vitamins|mesh-ancestor
14458785|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
14458786|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14458787|NCT02125292|Mesalamine|mesalamine|mesh-list
14458788|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14458789|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458790|NCT02125292|Analgesics|analgesics|mesh-ancestor
14458791|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
14458792|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458793|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458794|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458795|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458796|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14458797|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14458798|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458799|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
14458800|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458801|NCT02125721|Penicillamine|penicillamine|mesh-list
14458802|NCT02125721|Antidotes|antidotes|mesh-ancestor
14458803|NCT02125721|Protective Agents|protective agents|mesh-ancestor
14458804|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458805|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
14458806|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
14458807|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458808|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458809|NCT02125734|Bromides|bromides|mesh-list
14458810|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
14458811|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14458812|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
14458813|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458814|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458815|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14458816|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14458817|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
14458818|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14458819|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
14458820|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14458821|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458822|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
14458823|NCT02125877|Deferasirox|deferasirox|mesh-list
14458824|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14458825|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
14458826|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
14458827|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458828|NCT02126839|Albuterol|albuterol|mesh-list
14458829|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14458830|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
14458831|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458832|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458833|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14458834|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
14458835|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
14458836|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14458837|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14458838|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14458839|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14458840|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
14458841|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14458842|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458843|NCT02126969|Carboplatin|carboplatin|mesh-list
14458844|NCT02126969|Docetaxel|docetaxel|mesh-list
14458845|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458846|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
14458847|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
14458848|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
14458849|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458850|NCT02127125|Sevelamer|sevelamer|mesh-list
14458851|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
14458852|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
14458853|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458854|NCT02127372|Cisplatin|cisplatin|mesh-list
14458855|NCT02127372|Docetaxel|docetaxel|mesh-list
14458856|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
14458857|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458858|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14458859|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14458860|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14458861|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458862|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14458863|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458864|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
14458865|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14458866|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
14458867|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458868|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
14458869|NCT02127723|Protective Agents|protective agents|mesh-ancestor
14458870|NCT02127970|Dalbavancin|dalbavancin|mesh-list
14458871|NCT02127970|Teicoplanin|teicoplanin|mesh-list
14458872|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458873|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458874|NCT02128217|Ribavirin|ribavirin|mesh-list
14458875|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
14458876|NCT02128217|Ledipasvir|ledipasvir|mesh-list
14458877|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14458878|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
14458879|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458880|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
14458881|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458882|NCT02128230|Thalidomide|thalidomide|mesh-list
14458883|NCT02128230|Dexamethasone|dexamethasone|mesh-list
14458884|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
14458885|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
14458886|NCT02128230|Melphalan|melphalan|mesh-list
14458887|NCT02128230|Cisplatin|cisplatin|mesh-list
14458888|NCT02128230|Doxorubicin|doxorubicin|mesh-list
14458889|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14458890|NCT02128230|Etoposide|etoposide|mesh-list
14458891|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
14458892|NCT02128230|Lenalidomide|lenalidomide|mesh-list
14458893|NCT02128230|Lenograstim|lenograstim|mesh-list
14458894|NCT02128230|BB 1101|bb 1101|mesh-list
14458895|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14458896|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
14458897|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458898|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458899|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14458900|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
14458901|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458902|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458903|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14458904|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458905|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
14458906|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
14458907|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458908|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458909|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
14458910|NCT02128230|Hormones|hormones|mesh-ancestor
14458911|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14458912|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14458913|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
14458914|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458915|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14458916|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14458917|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14458918|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14458919|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14458920|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14458921|NCT02128230|Growth Substances|growth substances|mesh-ancestor
14458922|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
14458923|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
14458924|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14458925|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752641|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752642|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14458926|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14458927|NCT02128490|Naproxen|naproxen|mesh-list
14458928|NCT02128490|Colchicine|colchicine|mesh-list
14458929|NCT02128490|Febuxostat|febuxostat|mesh-list
14458930|NCT02128490|Lansoprazole|lansoprazole|mesh-list
14458931|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
14458932|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14458933|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458934|NCT02128490|Analgesics|analgesics|mesh-ancestor
14458935|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
14458936|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470179|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
14458937|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458938|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14458939|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14458940|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
14458941|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14458942|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14458943|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458944|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14458945|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
14458946|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14458947|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14458948|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14458949|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458950|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14458951|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
14458952|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
14458953|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458954|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
14458955|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14458956|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458957|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14458958|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14458959|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
14458960|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458961|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
14458962|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14458963|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458964|NCT02129075|Poly I-C|poly i-c|mesh-list
14458965|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14458966|NCT02129075|Poly ICLC|poly iclc|mesh-list
14458967|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
14458968|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
14458969|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
14458970|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458971|NCT02129075|Laxatives|laxatives|mesh-ancestor
14458972|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14458973|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
14458974|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14458975|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14458976|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14458977|NCT02129075|Protective Agents|protective agents|mesh-ancestor
14458978|NCT02129192|Amlodipine|amlodipine|mesh-list
14458979|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14458980|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14458981|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14458982|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14458983|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14458984|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458985|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
14458986|NCT02129426|Midazolam|midazolam|mesh-list
14458987|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
14458988|NCT02129426|Ketamine|ketamine|mesh-list
14458989|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14458990|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14458991|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14458992|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14458993|NCT02129426|Analgesics|analgesics|mesh-ancestor
14458994|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
14458995|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14458996|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14458997|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14458998|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14458999|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459000|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459001|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459002|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14459003|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14459004|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
14459005|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
14459006|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14459007|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14459008|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14459009|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14459010|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14459011|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14459012|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
14459013|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
14459014|NCT02129478|Olanzapine|olanzapine|mesh-list
14459015|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
14459016|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
14459017|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459018|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459019|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459020|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14459021|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14459022|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459023|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14459024|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14459025|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14459026|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459027|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459028|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459029|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
14459030|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
14459031|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459032|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459033|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
14459034|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14459035|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14459036|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14459037|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
14459038|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459039|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459040|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459041|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
14459042|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459043|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
14459044|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14459045|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14752643|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14459046|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459047|NCT02129725|Urological Agents|urological agents|mesh-ancestor
14469621|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14469622|NCT02296840|Analgesics|analgesics|mesh-ancestor
14469623|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
14469624|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469625|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469626|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
14469627|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14469628|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14469629|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14930571|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14930572|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14930573|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
14930574|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
14930575|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930576|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469630|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14469631|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469632|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469633|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14469634|NCT02296840|Narcotics|narcotics|mesh-ancestor
14469635|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469636|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
14469637|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469638|NCT02296892|Midazolam|midazolam|mesh-list
14459048|NCT02130024|Ranibizumab|ranibizumab|mesh-list
14459049|NCT02130024|Aflibercept|aflibercept|mesh-list
14459050|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14459051|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14459052|NCT02130024|Growth Substances|growth substances|mesh-ancestor
14459053|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459054|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
14459055|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459056|NCT02130063|Iron|iron|mesh-list
14459057|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14459058|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14459059|NCT02130063|Trace Elements|trace elements|mesh-ancestor
14459060|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
14459061|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459062|NCT02130063|Hematinics|hematinics|mesh-ancestor
14459063|NCT02130284|Insulin|insulin|mesh-list
14459064|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14459065|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14459066|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459067|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
14459068|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459069|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14459070|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459071|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459072|NCT02130635|Nemiralisib|nemiralisib|mesh-list
14459073|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14459074|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459075|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459076|NCT02131064|Carboplatin|carboplatin|mesh-list
14459077|NCT02131064|Docetaxel|docetaxel|mesh-list
14459078|NCT02131064|Trastuzumab|trastuzumab|mesh-list
14459079|NCT02131064|Pertuzumab|pertuzumab|mesh-list
14459080|NCT02131064|Maytansine|maytansine|mesh-list
14459081|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14459082|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459083|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
14459084|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
14459085|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
14459086|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459087|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459088|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14930577|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14930578|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14930579|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14930580|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930581|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930582|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930583|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14930584|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14931197|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14931198|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
14931199|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14931200|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
14459089|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
14459090|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14459091|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14459092|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14459093|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
14459094|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459095|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14459096|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14459097|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459098|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459099|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14459100|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14459101|NCT02131259|Afatinib|afatinib|mesh-list
14459102|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459103|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14459104|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459105|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459106|NCT02131272|Insulin|insulin|mesh-list
14459107|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14459108|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
14459109|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
14459110|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
14459111|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
14459112|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14459113|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459114|NCT02131324|Clobetasol|clobetasol|mesh-list
14459115|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459116|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
14459117|NCT02131324|Hormones|hormones|mesh-ancestor
14459118|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459119|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459120|NCT02132117|Phenylephrine|phenylephrine|mesh-list
14459121|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
14459122|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14459123|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14459124|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459125|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459126|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459127|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459128|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
14459129|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
14459130|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459131|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
14459132|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14459133|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459134|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14459135|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
14459136|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14459137|NCT02132117|Protective Agents|protective agents|mesh-ancestor
14459138|NCT02132169|Cetirizine|cetirizine|mesh-list
14459139|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14459140|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14459141|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14459142|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
14459143|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
14459144|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459145|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459146|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459147|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14459148|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14459149|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
14459150|NCT02132195|Hormones|hormones|mesh-ancestor
14459151|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459152|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459153|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459154|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459155|NCT02132247|Diclofenac|diclofenac|mesh-list
14459156|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14459157|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14459158|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14459159|NCT02132247|Analgesics|analgesics|mesh-ancestor
14459160|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
14459161|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459162|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459163|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459164|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459165|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14459166|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459167|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459168|NCT02132312|Phenylephrine|phenylephrine|mesh-list
14459169|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
14459170|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14459171|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
14459172|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
14459173|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459174|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459175|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
14459176|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14459177|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
14459178|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459179|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14459180|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14459181|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14459182|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459183|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459184|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459185|NCT02132312|Protective Agents|protective agents|mesh-ancestor
14459186|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
14459187|NCT02132468|Combretastatin|combretastatin|mesh-list
14459188|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14459189|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459190|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
14459191|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
14459192|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
14459193|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459194|NCT02132533|Nifedipine|nifedipine|mesh-list
14459195|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14459196|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459197|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459198|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14459199|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459200|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
14459201|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
14459202|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14459203|NCT02132637|Insulin|insulin|mesh-list
14459204|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14459205|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
14459206|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14459207|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459208|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
14459209|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459210|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459211|NCT02132767|Digoxin|digoxin|mesh-list
14459212|NCT02132767|Amiodarone|amiodarone|mesh-list
14459213|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
14459214|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14459215|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459216|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14459217|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14459218|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459219|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459220|NCT02132767|Protective Agents|protective agents|mesh-ancestor
14459221|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
14459222|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14459223|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459224|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14459225|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14459226|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14459227|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14459228|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14459229|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14459230|NCT02132832|Buspirone|buspirone|mesh-list
14459231|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14459232|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14459233|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459234|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459235|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14930585|NCT01434147|Bevacizumab|bevacizumab|mesh-list
14930586|NCT01434147|Capecitabine|capecitabine|mesh-list
14930587|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
14930588|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14930589|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930590|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14930591|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14930592|NCT01434147|Growth Substances|growth substances|mesh-ancestor
14930593|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459236|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14459237|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
14459238|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459239|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459240|NCT02132936|Calcipotriene|calcipotriene|mesh-list
14459241|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459242|NCT02132949|Paclitaxel|paclitaxel|mesh-list
14459243|NCT02132949|Docetaxel|docetaxel|mesh-list
14459244|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
14459245|NCT02132949|Doxorubicin|doxorubicin|mesh-list
14459246|NCT02132949|Fluorouracil|fluorouracil|mesh-list
14459247|NCT02132949|Trastuzumab|trastuzumab|mesh-list
14459248|NCT02132949|Epirubicin|epirubicin|mesh-list
14752644|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14930594|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752645|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14752646|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752647|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752648|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
14752649|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14752650|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752651|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14752652|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752653|NCT05335460|Capecitabine|capecitabine|mesh-list
14752654|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
14752655|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14752656|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
14752657|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752658|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459249|NCT02132949|Pertuzumab|pertuzumab|mesh-list
14459250|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14459251|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459252|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
14459253|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
14459254|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
14459255|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459256|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459257|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
14459258|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459259|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459260|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14459261|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
14459262|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14459263|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14459264|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14459265|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14459266|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459267|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
14459268|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14459269|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459270|NCT02133001|Esketamine|esketamine|mesh-list
14459271|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
14459272|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14459273|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
14459274|NCT02133131|Grazoprevir|grazoprevir|mesh-list
14459275|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
14459276|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459277|NCT02133352|Ranolazine|ranolazine|mesh-list
14459278|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14459279|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459280|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459281|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
14459282|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
14459283|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459284|NCT02133664|Protective Agents|protective agents|mesh-ancestor
14459285|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459286|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
14459287|NCT02133664|Vitamins|vitamins|mesh-ancestor
14459288|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
14459289|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
14459290|NCT02133742|Axitinib|axitinib|mesh-list
14459291|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459292|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459293|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14930595|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14930596|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
14930597|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930598|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
14930599|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14930600|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
14930601|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14930602|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930603|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14930604|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14930605|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14930606|NCT01434173|Amoxicillin|amoxicillin|mesh-list
14459294|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459295|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459296|NCT02133781|Vaccines|vaccines|mesh-list
14459297|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
14459298|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459299|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14459300|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459301|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14459302|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459303|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459304|NCT02134184|Vaccines|vaccines|mesh-list
14459305|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
14459306|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459307|NCT02134210|Etanercept|etanercept|mesh-list
14459308|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14459309|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14459310|NCT02134210|Analgesics|analgesics|mesh-ancestor
14459311|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
14459312|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459313|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459314|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459315|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459316|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459317|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459318|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
14459319|NCT02134314|Complement C1s|complement c1s|mesh-list
14459320|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14459321|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14459322|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
14459323|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459324|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14459325|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459326|NCT02134353|Mannitol|mannitol|mesh-list
14459327|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14459328|NCT02134353|Diuretics|diuretics|mesh-ancestor
14459329|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
14459330|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459331|NCT02134951|Ketamine|ketamine|mesh-list
14459332|NCT02134951|Analgesics|analgesics|mesh-ancestor
14459333|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
14459334|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459335|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459336|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14459337|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14459338|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
14459339|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
14930607|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
14459340|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459341|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14930608|NCT01434173|Clarithromycin|clarithromycin|mesh-list
14930609|NCT01434173|Doxycycline|doxycycline|mesh-list
14459342|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14459343|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459344|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459345|NCT02134977|Leuprolide|leuprolide|mesh-list
14459346|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14459347|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
14459348|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14752659|NCT05335356|Ustekinumab|ustekinumab|mesh-list
14459349|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459350|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14459351|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459352|NCT02135016|Lidocaine|lidocaine|mesh-list
14459353|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
14459354|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
14459355|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459356|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459357|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
14459358|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459359|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14459360|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14459361|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14459362|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459363|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459364|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
14459365|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14459366|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14459367|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459368|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459369|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459370|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459371|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
14459372|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
14459373|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459374|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
14459375|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14459376|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459377|NCT02135107|Rabeprazole|rabeprazole|mesh-list
14459378|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14459379|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459380|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14459381|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459382|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459383|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
14459384|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14459385|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14459386|NCT02135432|Ivacaftor|ivacaftor|mesh-list
14459387|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14459388|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459389|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459390|NCT02135445|Relugolix|relugolix|mesh-list
14459391|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
14459392|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
14459393|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459394|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459395|NCT02136420|Promethazine|promethazine|mesh-list
14459396|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
14459397|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
14459398|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459399|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14459400|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
14459401|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
14459402|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459403|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459404|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459405|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14459406|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14459407|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14459408|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459409|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
14459410|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
14459411|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
14459412|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459413|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
14459414|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
14752660|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
14752661|NCT05335317|Hormones|hormones|mesh-list
14752662|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752663|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752664|NCT05335278|Nintedanib|nintedanib|mesh-list
14752665|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752666|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14459415|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459416|NCT02136498|Varenicline|varenicline|mesh-list
14459417|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14459418|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14459419|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
14459420|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459421|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459422|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459423|NCT02136576|Listerine|listerine|mesh-list
14459424|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
14459425|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
14459426|NCT02136576|Protective Agents|protective agents|mesh-ancestor
14459427|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459428|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14459429|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459430|NCT02136914|Amantadine|amantadine|mesh-list
14459431|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14459432|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14459433|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
14459434|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459435|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
14459436|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459437|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459438|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459439|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14459440|NCT02136914|Analgesics|analgesics|mesh-ancestor
14459441|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
14459442|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459443|NCT02137226|Adalimumab|adalimumab|mesh-list
14459444|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459445|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459446|NCT02137369|Dexetimide|dexetimide|mesh-list
14459447|NCT02137369|Citalopram|citalopram|mesh-list
14459448|NCT02137369|Sertraline|sertraline|mesh-list
14459449|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
14459450|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14459451|NCT02137369|Serotonin|serotonin|mesh-list
14459452|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14459453|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459454|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459455|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459456|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
14459457|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459458|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14459459|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14459460|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14459461|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14459462|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
14459463|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
14459464|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459465|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14459466|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14459467|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
14459468|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14459469|NCT02137382|Pancrelipase|pancrelipase|mesh-list
14459470|NCT02137382|Pancreatin|pancreatin|mesh-list
14459471|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459472|NCT02137538|Letrozole|letrozole|mesh-list
14459473|NCT02137538|Anastrozole|anastrozole|mesh-list
14459474|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459475|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14459476|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14459477|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459478|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459479|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14459480|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
14459481|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459482|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459483|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14459484|NCT02137772|Letermovir|letermovir|mesh-list
14459485|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14459486|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459487|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459488|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459489|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
14459490|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459491|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14459492|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14459493|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459494|NCT02137837|Everolimus|everolimus|mesh-list
14459495|NCT02137837|Fulvestrant|fulvestrant|mesh-list
14459496|NCT02137837|Anastrozole|anastrozole|mesh-list
14459497|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459498|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459499|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
14459500|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459501|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14459502|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14459503|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14459504|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
14459505|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459506|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14459507|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14459508|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459509|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459510|NCT02138006|Insulin|insulin|mesh-list
14459511|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14459512|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14459513|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469639|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14469640|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14469641|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469642|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469643|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14469644|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14469645|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14469646|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14469647|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
14469648|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
14469649|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
14469650|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
14469651|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469652|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469653|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
14469654|NCT02296931|Analgesics|analgesics|mesh-ancestor
14469655|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
14469656|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469657|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469658|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
14469659|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469660|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14469661|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
14469662|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14469663|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14930610|NCT01434173|Levofloxacin|levofloxacin|mesh-list
14930611|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
14930612|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
14930613|NCT01434173|Cefuroxime|cefuroxime|mesh-list
14930614|NCT01434173|Telithromycin|telithromycin|mesh-list
14930615|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14930616|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14930617|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459514|NCT02138136|Lubiprostone|lubiprostone|mesh-list
14459515|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14459516|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459517|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459518|NCT02138747|Mirabegron|mirabegron|mesh-list
14459519|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14459520|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14459521|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14459522|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14459523|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459524|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459525|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459526|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459527|NCT02138747|Urological Agents|urological agents|mesh-ancestor
14459528|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14459529|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14459530|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
14459531|NCT02138825|Riociguat|riociguat|mesh-list
14459532|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
14459533|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459534|NCT02138838|Cinacalcet|cinacalcet|mesh-list
14459535|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14459536|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459537|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14459538|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
14459539|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459540|NCT02138916|Benralizumab|benralizumab|mesh-list
14459541|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14459542|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459543|NCT02139007|Alendronate|alendronate|mesh-list
14459544|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14459545|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459546|NCT02139046|Naproxen|naproxen|mesh-list
14459547|NCT02139046|Colchicine|colchicine|mesh-list
14459548|NCT02139046|Febuxostat|febuxostat|mesh-list
14459549|NCT02139046|Lansoprazole|lansoprazole|mesh-list
14459550|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
14459551|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14459552|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14459553|NCT02139046|Analgesics|analgesics|mesh-ancestor
14459554|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
14459555|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459556|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459557|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459558|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459559|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
14459560|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14459561|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459562|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459563|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14459564|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14459565|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14459566|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930618|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14930619|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14930620|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459567|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14459568|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459569|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14459570|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
14459571|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459572|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
14459573|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459574|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459575|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14459576|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
14459577|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459578|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459579|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14459580|NCT02139358|Gemcitabine|gemcitabine|mesh-list
14459581|NCT02139358|Trastuzumab|trastuzumab|mesh-list
14459582|NCT02139358|Pertuzumab|pertuzumab|mesh-list
14459583|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14459584|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
14459585|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459586|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459587|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
14459588|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459589|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459590|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459591|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
14459592|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459593|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459594|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
14459595|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14459596|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
14459597|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
14459598|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459599|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459600|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14459601|NCT02139540|Analgesics|analgesics|mesh-ancestor
14459602|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
14459603|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459604|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14459605|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459606|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459607|NCT02139644|Fluticasone|fluticasone|mesh-list
14459608|NCT02139644|Xhance|xhance|mesh-list
14459609|NCT02139644|Beclomethasone|beclomethasone|mesh-list
14459610|NCT02139644|Albuterol|albuterol|mesh-list
14459611|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14459612|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
14459613|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459614|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14459615|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
14459616|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459617|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459618|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14459619|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459620|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459621|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14459622|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14459623|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14459624|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459625|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459626|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459627|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
14459628|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14459629|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
14459630|NCT02139644|Hormones|hormones|mesh-ancestor
14459631|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459632|NCT02139943|Canagliflozin|canagliflozin|mesh-list
14459633|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14459634|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459635|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14459636|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459637|NCT02139982|Ropivacaine|ropivacaine|mesh-list
14459638|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
14459639|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
14459640|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459641|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459642|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
14459643|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459644|NCT02140060|Travoprost|travoprost|mesh-list
14459645|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14459646|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14459647|NCT02140060|Brinzolamide|brinzolamide|mesh-list
14459648|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14459649|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14459650|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459651|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459652|NCT02140164|Minocycline|minocycline|mesh-list
14459653|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14459654|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459655|NCT02140372|Colchicine|colchicine|mesh-list
14459656|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
14459657|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459658|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
14459659|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
14459660|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
14459661|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459662|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459663|NCT02140411|Ranibizumab|ranibizumab|mesh-list
14459664|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14459665|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14459666|NCT02140411|Growth Substances|growth substances|mesh-ancestor
14459667|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459668|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
14459669|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459670|NCT02140593|Rocuronium|rocuronium|mesh-list
14459671|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14459672|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14459673|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14459674|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459675|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459676|NCT02140645|Linagliptin|linagliptin|mesh-list
14459677|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14459678|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459679|NCT02140645|Incretins|incretins|mesh-ancestor
14459680|NCT02140645|Hormones|hormones|mesh-ancestor
14459681|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459682|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14459683|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
14459684|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459685|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459686|NCT02140970|Ibuprofen|ibuprofen|mesh-list
14459687|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14459688|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14459689|NCT02140970|Analgesics|analgesics|mesh-ancestor
14459690|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
14459691|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459692|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459693|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459694|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459695|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14459696|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459697|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459698|NCT02141217|Amoxicillin|amoxicillin|mesh-list
14459699|NCT02141217|Clindamycin|clindamycin|mesh-list
14459700|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
14459701|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
14459702|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
14459703|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
14459704|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14459705|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14459706|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459707|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14459708|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459709|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459710|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14459711|NCT02141295|Leucovorin|leucovorin|mesh-list
14459712|NCT02141295|Folic Acid|folic acid|mesh-list
14459713|NCT02141295|Bevacizumab|bevacizumab|mesh-list
14459714|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
14459715|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
14459716|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459717|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459718|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14459719|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14459720|NCT02141295|Growth Substances|growth substances|mesh-ancestor
14459721|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459722|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
14459723|NCT02141295|Antidotes|antidotes|mesh-ancestor
14459724|NCT02141295|Protective Agents|protective agents|mesh-ancestor
14459725|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
14459726|NCT02141295|Vitamins|vitamins|mesh-ancestor
14459727|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
14459728|NCT02141295|Hematinics|hematinics|mesh-ancestor
14459729|NCT02141451|Rituximab|rituximab|mesh-list
14459730|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459731|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459732|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
14459733|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459734|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459735|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14459736|NCT02141490|Hematinics|hematinics|mesh-ancestor
14459737|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14459738|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14459739|NCT02141555|Misoprostol|misoprostol|mesh-list
14459740|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14459741|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
14459742|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14459743|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459744|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14459745|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459746|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
14459747|NCT02141581|Vaccines|vaccines|mesh-list
14459748|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
14459749|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459750|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
14459751|NCT02141620|Cocaine|cocaine|mesh-list
14459752|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14459753|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
14459754|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459755|NCT02141620|Expectorants|expectorants|mesh-ancestor
14459756|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459757|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14459758|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
14459759|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459760|NCT02141620|Protective Agents|protective agents|mesh-ancestor
14459761|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459762|NCT02141620|Antidotes|antidotes|mesh-ancestor
14459763|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
14459764|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
14459765|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459766|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
14459767|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459768|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14459769|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14459770|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14459771|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14459772|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
14459773|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459774|NCT02141633|Fluticasone|fluticasone|mesh-list
14459775|NCT02141633|Xhance|xhance|mesh-list
14931201|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459776|NCT02141633|Albuterol|albuterol|mesh-list
14459777|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459778|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14459779|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
14459780|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459781|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752667|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752668|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930621|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459782|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14459783|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459784|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459785|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14459786|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
14459787|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14459788|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14459789|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14459790|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14459791|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459792|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459793|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459794|NCT02141659|Relugolix|relugolix|mesh-list
14459795|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
14459796|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
14459797|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14459798|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459799|NCT02141672|Cyclosporine|cyclosporine|mesh-list
14459800|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
14459801|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459802|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459803|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459804|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459805|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459806|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
14459807|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930622|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930623|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14930624|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
14930625|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14459808|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459809|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14459810|NCT02141854|Fluticasone|fluticasone|mesh-list
14459811|NCT02141854|Xhance|xhance|mesh-list
14459812|NCT02141854|Albuterol|albuterol|mesh-list
14459813|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14459814|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
14459815|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459816|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14459817|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
14459818|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459819|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459820|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14459821|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
14752669|NCT05335252|Dronabinol|dronabinol|mesh-list
14752670|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
14752671|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752672|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14752673|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14752674|NCT05335252|Analgesics|analgesics|mesh-ancestor
14752675|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
14752676|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752677|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14752678|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14752679|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930626|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930627|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14930628|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14930629|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14930630|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14930631|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14459822|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459823|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14459824|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14459825|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14459826|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
14459827|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459828|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459829|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
14459830|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14930632|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14930633|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
14930634|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14930635|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14930636|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14930637|NCT01434173|Renal Agents|renal agents|mesh-ancestor
14930638|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14930639|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14930640|NCT01434212|Interferons|interferons|mesh-list
14459831|NCT02141997|Adalimumab|adalimumab|mesh-list
14459832|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459833|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459834|NCT02142049|Lenalidomide|lenalidomide|mesh-list
14459835|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
14459836|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459837|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14459838|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14459839|NCT02142049|Growth Substances|growth substances|mesh-ancestor
14459840|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
14459841|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459842|NCT02142153|Olorofim|olorofim|mesh-list
14459843|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
14459844|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459845|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
14930641|NCT01434212|Ribavirin|ribavirin|mesh-list
14459846|NCT02142712|Promethazine|promethazine|mesh-list
14459847|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
14459848|NCT02142712|Pantoprazole|pantoprazole|mesh-list
14459849|NCT02142712|Famotidine|famotidine|mesh-list
14459850|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14459851|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459852|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14459853|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459854|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459855|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14459856|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14459857|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459858|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459859|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
14459860|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
14459861|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
14459862|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459863|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
14459864|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
14459865|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14459866|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
14459867|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
14459868|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14459869|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14459870|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
14459871|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459872|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
14459873|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
14459874|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14459875|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14459876|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14459877|NCT02142738|Gemcitabine|gemcitabine|mesh-list
14459878|NCT02142738|Paclitaxel|paclitaxel|mesh-list
14459879|NCT02142738|Carboplatin|carboplatin|mesh-list
14459880|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
14459881|NCT02142738|Pemetrexed|pemetrexed|mesh-list
14459882|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14459883|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459884|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
14459885|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
14459886|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
14459887|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459888|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14459889|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
14459890|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
14459891|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459892|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459893|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459894|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
14459895|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459896|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459897|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14459898|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14459899|NCT02143141|Morphine|morphine|mesh-list
14459900|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14459901|NCT02143141|Narcotics|narcotics|mesh-ancestor
14459902|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459903|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459904|NCT02143141|Analgesics|analgesics|mesh-ancestor
14459905|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
14459906|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459907|NCT02143648|Nalbuphine|nalbuphine|mesh-list
14459908|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14459909|NCT02143648|Narcotics|narcotics|mesh-ancestor
14459910|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459911|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459912|NCT02143648|Analgesics|analgesics|mesh-ancestor
14459913|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
14459914|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459915|NCT02143843|Bimatoprost|bimatoprost|mesh-list
14459916|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14459917|NCT02143973|Nalbuphine|nalbuphine|mesh-list
14459918|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14459919|NCT02143973|Narcotics|narcotics|mesh-ancestor
14459920|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14459921|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459922|NCT02143973|Analgesics|analgesics|mesh-ancestor
14459923|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
14459924|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459925|NCT02144012|Docetaxel|docetaxel|mesh-list
14459926|NCT02144012|Trastuzumab|trastuzumab|mesh-list
14459927|NCT02144012|Maytansine|maytansine|mesh-list
14459928|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14459929|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459930|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14459931|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14459932|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14459933|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459934|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14459935|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14459936|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14459937|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14459938|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14459939|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459940|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
14459941|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459942|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
14459943|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
14459944|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
14459945|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14459946|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
14459947|NCT02144259|Etonogestrel|etonogestrel|mesh-list
14459948|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14459949|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14459950|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14459951|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
14459952|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14459953|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459954|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14459955|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14459956|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14459957|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14459958|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459959|NCT02144675|Cytarabine|cytarabine|mesh-list
14459960|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
14459961|NCT02144675|Salicylates|salicylates|mesh-list
14459962|NCT02144675|Idarubicin|idarubicin|mesh-list
14459963|NCT02144675|Choline|choline|mesh-list
14459964|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14459965|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
14459966|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14459967|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14459968|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
14459969|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14459970|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459971|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
14459972|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14459973|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14459974|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14459975|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14459976|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14459977|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
14459978|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14459979|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14459980|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14459981|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
14459982|NCT02144675|Analgesics|analgesics|mesh-ancestor
14459983|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
14459984|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14459985|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14459986|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14459987|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459988|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459989|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14459990|NCT02144714|Adalimumab|adalimumab|mesh-list
14459991|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14459992|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14459993|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
14459994|NCT02145026|Hematinics|hematinics|mesh-ancestor
14459995|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
14459996|NCT02145039|Fludarabine|fludarabine|mesh-list
14459997|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14459998|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
14459999|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460000|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460001|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14460002|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
14460003|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460004|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460005|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14460006|NCT02145078|Gemcitabine|gemcitabine|mesh-list
14460007|NCT02145078|Docetaxel|docetaxel|mesh-list
14460008|NCT02145078|Pemetrexed|pemetrexed|mesh-list
14460009|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14460010|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
14460011|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460012|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460013|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
14460014|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460015|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460016|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460017|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
14460018|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460019|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14460020|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14460021|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14460022|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14460023|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14469664|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469665|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14469666|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
14469667|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14469668|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14469669|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14469670|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14469671|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469672|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469673|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14469674|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469675|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469676|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
14469677|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469678|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
14469679|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14469680|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
14469681|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14469682|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14469683|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469684|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
14469685|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469686|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469687|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14469688|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
14469689|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
14469690|NCT02297503|Protective Agents|protective agents|mesh-ancestor
14469691|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
14469692|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14469693|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
14469694|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14460024|NCT02145182|Eculizumab|eculizumab|mesh-list
14460025|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14460026|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460027|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
14460028|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460029|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14460030|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460031|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460032|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
14460033|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14460034|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14460035|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14460036|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460037|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460038|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
14460039|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460040|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460041|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14460042|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460043|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14460044|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
14460045|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
14460046|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
14460047|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14460048|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460049|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460050|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14460051|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14460052|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14460053|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14460054|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14460055|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14460056|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460057|NCT02146430|Pregabalin|pregabalin|mesh-list
14460058|NCT02146430|Analgesics|analgesics|mesh-ancestor
14460059|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
14460060|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460061|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460062|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
14460063|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14460064|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460065|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460066|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14460067|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14460068|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14460069|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460070|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14460071|NCT02147067|Ranolazine|ranolazine|mesh-list
14460072|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14460073|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460074|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460075|NCT02147132|Nicotine|nicotine|mesh-list
14752680|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460076|NCT02147132|Varenicline|varenicline|mesh-list
14460077|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14460078|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
14460079|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460080|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460081|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14460082|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14460083|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
14460084|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460085|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460086|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
14460087|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14460088|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
14460089|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460090|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460091|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14460092|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
14460093|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14460094|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
14460095|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460096|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460097|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14460098|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
14460099|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14460100|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14460101|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14460102|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460103|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460104|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
14460105|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460106|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460107|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14460108|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460109|NCT02147587|Tofacitinib|tofacitinib|mesh-list
14460110|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14460111|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460112|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460113|NCT02147691|Azelaic acid|azelaic acid|mesh-list
14460114|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14460115|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14460116|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14460117|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14460118|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460119|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460120|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460121|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460122|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460123|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460124|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14460125|NCT02147899|Secnidazole|secnidazole|mesh-list
14460126|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14460127|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14460128|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460129|NCT02148250|Insulin|insulin|mesh-list
14460130|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14460131|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14460132|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460133|NCT02148445|Nicotine|nicotine|mesh-list
14460134|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14460135|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
14460136|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460137|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460138|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14460139|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14460140|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
14460141|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460142|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460143|NCT02148588|Lidocaine|lidocaine|mesh-list
14460144|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
14460145|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
14460146|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460147|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460148|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
14460149|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460150|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14460151|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14460152|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14460153|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460154|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460155|NCT02148718|Adalimumab|adalimumab|mesh-list
14460156|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460157|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460158|NCT02148874|Vaccines|vaccines|mesh-list
14460159|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
14460160|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460161|NCT02149108|Nintedanib|nintedanib|mesh-list
14460162|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460163|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14460164|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469695|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460165|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460166|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
14460167|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14460168|NCT02149173|Fluorides|fluorides|mesh-list
14460169|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14460170|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460171|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
14460172|NCT02149173|Protective Agents|protective agents|mesh-ancestor
14460173|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460174|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
14460175|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
14460176|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460177|NCT02149199|Budesonide|budesonide|mesh-list
14460178|NCT02149199|Terbutaline|terbutaline|mesh-list
14460179|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
14460180|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460181|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14460182|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
14460183|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460184|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460185|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14460186|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
14460187|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
14460188|NCT02149199|Hormones|hormones|mesh-ancestor
14460189|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460190|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14460191|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14460192|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460193|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460194|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460195|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460196|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
14460197|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
14460198|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460199|NCT02149264|Testosterone|testosterone|mesh-list
14460200|NCT02149264|Androgens|androgens|mesh-ancestor
14460201|NCT02149264|Hormones|hormones|mesh-ancestor
14460202|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460203|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460204|NCT02149303|Dabigatran|dabigatran|mesh-list
14460205|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
14460206|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14460207|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
14460208|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460209|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460210|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
14460211|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14460212|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14460213|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14460214|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
14460215|NCT02149524|Trastuzumab|trastuzumab|mesh-list
14460216|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14460217|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460218|NCT02149836|Ezogabine|ezogabine|mesh-list
14460219|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
14460220|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460221|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460222|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
14460223|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
14460224|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14460225|NCT02149875|Protective Agents|protective agents|mesh-ancestor
14460226|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460227|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
14460228|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14460229|NCT02150213|Dexamethasone|dexamethasone|mesh-list
14460230|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460231|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
14460232|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
14460233|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460234|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460235|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460236|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
14460237|NCT02150213|Hormones|hormones|mesh-ancestor
14460238|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460239|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14460240|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460241|NCT02150499|Albuterol|albuterol|mesh-list
14460242|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14460243|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
14460244|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460245|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460246|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14460247|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14460248|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
14460249|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460250|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14460251|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14460252|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460253|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460254|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460255|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460256|NCT02150759|Fentanyl|fentanyl|mesh-list
14460257|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
14460258|NCT02150759|Ketamine|ketamine|mesh-list
14460259|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14460260|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460261|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460262|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460263|NCT02150759|Analgesics|analgesics|mesh-ancestor
14460264|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
14460265|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460266|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14460267|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14460268|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460269|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460270|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460271|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460272|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14460273|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14460274|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
14460275|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
14460276|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14460277|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14460278|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14460279|NCT02150759|Narcotics|narcotics|mesh-ancestor
14460280|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14460281|NCT02150954|Oxytocin|oxytocin|mesh-list
14460282|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
14460283|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460284|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460285|NCT02151058|Listerine|listerine|mesh-list
14460286|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
14460287|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
14460288|NCT02151058|Protective Agents|protective agents|mesh-ancestor
14460289|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460290|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14460291|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460292|NCT02151149|Paclitaxel|paclitaxel|mesh-list
14460293|NCT02151149|Carboplatin|carboplatin|mesh-list
14460294|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14460295|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460296|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
14460297|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
14460298|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
14460299|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460300|NCT02151253|Modafinil|modafinil|mesh-list
14460301|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14460302|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460303|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14460304|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14460305|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14460306|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460307|NCT02151448|Interferons|interferons|mesh-list
14460308|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
14460309|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
14460310|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14460311|NCT02151448|Celecoxib|celecoxib|mesh-list
14460312|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460313|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
14460314|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460315|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
14460316|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460317|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14460318|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460319|NCT02151448|Analgesics|analgesics|mesh-ancestor
14460320|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
14460321|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460322|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460323|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460324|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14460325|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14460326|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460327|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460328|NCT02151461|Metformin|metformin|mesh-list
14460329|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14460330|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460331|NCT02151487|Dexamethasone|dexamethasone|mesh-list
14460332|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
14460333|NCT02151487|Clonidine|clonidine|mesh-list
14460334|NCT02151487|Ropivacaine|ropivacaine|mesh-list
14460335|NCT02151487|BB 1101|bb 1101|mesh-list
14460336|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460337|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
14460338|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
14460339|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460340|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460341|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460342|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
14460343|NCT02151487|Hormones|hormones|mesh-ancestor
14460344|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460345|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14460346|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460347|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
14460348|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460349|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460350|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
14460351|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
14460352|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460353|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
14460354|NCT02151487|Analgesics|analgesics|mesh-ancestor
14460355|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14460356|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
14460357|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14460358|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14460359|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460360|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460361|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460362|NCT02151591|Varenicline|varenicline|mesh-list
14460363|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14460364|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14460365|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
14460366|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460367|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752681|NCT05335252|Hormones|hormones|mesh-ancestor
14930642|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
14460368|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460369|NCT02151643|Iron|iron|mesh-list
14460370|NCT02151643|Trace Elements|trace elements|mesh-ancestor
14460371|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
14460372|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460373|NCT02151682|Morphine|morphine|mesh-list
14460374|NCT02151682|Tapentadol|tapentadol|mesh-list
14460375|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14460376|NCT02151682|Narcotics|narcotics|mesh-ancestor
14460377|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460378|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460379|NCT02151682|Analgesics|analgesics|mesh-ancestor
14460380|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
14460381|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460382|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14460383|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14460384|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460385|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460386|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460387|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460388|NCT02151773|Vaccines|vaccines|mesh-list
14460389|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
14460390|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460391|NCT02151786|Lansoprazole|lansoprazole|mesh-list
14460392|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
14460393|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14460394|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460395|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14460396|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460397|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460398|NCT02151851|Methotrexate|methotrexate|mesh-list
14460399|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
14460400|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14460401|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
14460402|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460403|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460404|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14460405|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
14460406|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460407|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460408|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
14460409|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460410|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14460411|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460412|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
14460413|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460414|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14460415|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
14460416|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14460417|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
14460418|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460419|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460420|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14460421|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
14460422|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14460423|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
14460424|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460425|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460426|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14460427|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
14460428|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
14460429|NCT02151877|Protective Agents|protective agents|mesh-ancestor
14460430|NCT02151994|Zamicastat|zamicastat|mesh-list
14460431|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460432|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460433|NCT02152007|Sirolimus|sirolimus|mesh-list
14460434|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14460435|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460436|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14460437|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460438|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
14460439|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460440|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
14460441|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460442|NCT02152137|Paclitaxel|paclitaxel|mesh-list
14460443|NCT02152137|Efatutazone|efatutazone|mesh-list
14460444|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14460445|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460446|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14460447|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14460448|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14460449|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460450|NCT02152163|Ibuprofen|ibuprofen|mesh-list
14460451|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14460452|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460453|NCT02152163|Analgesics|analgesics|mesh-ancestor
14460454|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
14460455|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460456|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460457|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460458|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460459|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14460460|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460461|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460462|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
14460463|NCT02152345|Abatacept|abatacept|mesh-list
14460464|NCT02152345|Tacrolimus|tacrolimus|mesh-list
14460465|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14460466|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
14460467|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460468|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
14460469|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460470|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14460471|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460472|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460473|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460474|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460475|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
14460476|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
14460477|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460478|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460479|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
14460480|NCT02152345|Hormones|hormones|mesh-ancestor
14460481|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460482|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14460483|NCT02152345|Protective Agents|protective agents|mesh-ancestor
14460484|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14460485|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460486|NCT02152371|Metformin|metformin|mesh-list
14460487|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
14460488|NCT02152371|Dulaglutide|dulaglutide|mesh-list
14460489|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14460490|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460491|NCT02152384|Insulin|insulin|mesh-list
14460492|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14460493|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
14460494|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
14460495|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14460496|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460497|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14460498|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460499|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14460500|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460501|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460502|NCT02152696|Methotrexate|methotrexate|mesh-list
14460503|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14460504|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
14460505|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460506|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460507|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14460508|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
14460509|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460510|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460511|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
14460512|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460513|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14460514|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460515|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
14460516|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460517|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14930643|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
14460518|NCT02153489|Bromides|bromides|mesh-list
14460519|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
14460520|NCT02153671|Vaccines|vaccines|mesh-list
14460521|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
14460522|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460523|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
14460524|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
14460525|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14460526|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
14460527|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460528|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460529|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460530|NCT02153788|Temazepam|temazepam|mesh-list
14460531|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14460532|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460533|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460534|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14460535|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14460536|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14460537|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
14460538|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
14460539|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460540|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460541|NCT02153905|Aldesleukin|aldesleukin|mesh-list
14460542|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
14460543|NCT02153905|Fludarabine|fludarabine|mesh-list
14460544|NCT02153905|Interleukin-2|interleukin-2|mesh-list
14460545|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460546|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
14460547|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460548|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460549|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14460550|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
14460551|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460552|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460553|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14460554|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460555|NCT02153905|Analgesics|analgesics|mesh-ancestor
14460556|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
14460557|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460558|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14460559|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14460560|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
14460561|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460562|NCT02153918|Metronidazole|metronidazole|mesh-list
14460563|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460564|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14460565|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14460566|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14460567|NCT02153983|Colchicine|colchicine|mesh-list
14460568|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
14460569|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460570|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
14460571|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
14460572|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
14460573|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460574|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460575|NCT02154048|Dexamethasone|dexamethasone|mesh-list
14460576|NCT02154048|Ropivacaine|ropivacaine|mesh-list
14460577|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460578|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
14460579|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
14460580|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460581|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460582|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460583|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
14460584|NCT02154048|Hormones|hormones|mesh-ancestor
14460585|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460586|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14460587|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460588|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
14460589|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
14460590|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460591|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
14460592|NCT02154061|Metronidazole|metronidazole|mesh-list
14460593|NCT02154061|Vancomycin|vancomycin|mesh-list
14460594|NCT02154061|Neomycin|neomycin|mesh-list
14460595|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460596|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14460597|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14460598|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14460599|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14460600|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460601|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460602|NCT02154139|Leuprolide|leuprolide|mesh-list
14460603|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14460604|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
14460605|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460606|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460607|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14460608|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460609|NCT02154243|Midodrine|midodrine|mesh-list
14460610|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
14460611|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
14460612|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460613|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460614|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14460615|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14460616|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14460617|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460618|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460619|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460620|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460621|NCT02154347|Mitiglinide|mitiglinide|mesh-list
14460622|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14460623|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460624|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
14460625|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460626|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
14460627|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460628|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460629|NCT02154477|Insulin|insulin|mesh-list
14460630|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14460631|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460632|NCT02154763|Ropivacaine|ropivacaine|mesh-list
14460633|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
14460634|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
14460635|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460636|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460637|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
14460638|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460639|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
14460640|NCT02155010|Bupivacaine|bupivacaine|mesh-list
14460641|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
14460642|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
14460643|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460644|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460645|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
14460646|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460647|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14460648|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460649|NCT02155010|Analgesics|analgesics|mesh-ancestor
14460650|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14460651|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14460652|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460653|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460654|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460655|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460656|NCT02155101|Ritonavir|ritonavir|mesh-list
14460657|NCT02155101|Lopinavir|lopinavir|mesh-list
14460658|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14460659|NCT02155101|Darunavir|darunavir|mesh-list
14460660|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14460661|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14460662|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
14460663|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460664|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460665|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14460666|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14460667|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
14460668|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460669|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14460670|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14460671|NCT02155257|Gabapentin|gabapentin|mesh-list
14460672|NCT02155257|Modafinil|modafinil|mesh-list
14460673|NCT02155257|Analgesics|analgesics|mesh-ancestor
14460674|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
14460675|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460676|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930644|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930645|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
14930646|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930647|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
14460677|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
14460678|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14460679|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14460680|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460681|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14460682|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14460683|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14460684|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460685|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460686|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
14460687|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14460688|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14460689|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14460690|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14460691|NCT02155309|Scopolamine|scopolamine|mesh-list
14460692|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14460693|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14460694|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
14460695|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
14460696|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460697|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460698|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460699|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
14460700|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14460701|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
14460702|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460703|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460704|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14460705|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
14460706|NCT02155322|Interferons|interferons|mesh-list
14460707|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
14460708|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
14460709|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14460710|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460711|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
14460712|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460713|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
14460714|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460715|NCT02155335|Golimumab|golimumab|mesh-list
14931202|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
14930648|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930649|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
14930650|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460716|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14460717|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14460718|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460719|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14460720|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
14460721|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460722|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14460723|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460724|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14460725|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460726|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460727|NCT02155647|Avelumab|avelumab|mesh-list
14460728|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14460729|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460730|NCT02155660|Benralizumab|benralizumab|mesh-list
14460731|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14460732|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
14460733|NCT02155738|Acetaminophen|acetaminophen|mesh-list
14460734|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460735|NCT02155738|Analgesics|analgesics|mesh-ancestor
14460736|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
14460737|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460738|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460739|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
14460740|NCT02155829|Riluzole|riluzole|mesh-list
14460741|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
14460742|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14460743|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14460744|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460745|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460746|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460747|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14460748|NCT02155829|Protective Agents|protective agents|mesh-ancestor
14460749|NCT02155881|Ciclesonide|ciclesonide|mesh-list
14460750|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
14460751|NCT02155881|Hormones|hormones|mesh-ancestor
14460752|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460753|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460754|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14460755|NCT02155985|Aspirin|aspirin|mesh-list
14460756|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14460757|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460758|NCT02155985|Analgesics|analgesics|mesh-ancestor
14460759|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
14460760|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460761|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460762|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460763|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460764|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14460765|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14460766|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460767|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14460768|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14460769|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460770|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
14460771|NCT02156154|Acetaminophen|acetaminophen|mesh-list
14460772|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460773|NCT02156154|Analgesics|analgesics|mesh-ancestor
14460774|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
14460775|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460776|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460777|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
14460778|NCT02156492|Atorvastatin|atorvastatin|mesh-list
14460779|NCT02156492|Simvastatin|simvastatin|mesh-list
14460780|NCT02156492|Evacetrapib|evacetrapib|mesh-list
14460781|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14460782|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14460783|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
14460784|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460785|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14460786|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14460787|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460788|NCT02156804|Nivolumab|nivolumab|mesh-list
14460789|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14460790|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460791|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14460792|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460793|NCT02157103|Bevacizumab|bevacizumab|mesh-list
14460794|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14460795|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460796|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14460797|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14460798|NCT02157103|Growth Substances|growth substances|mesh-ancestor
14460799|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460800|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
14460801|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
14460802|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14460803|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460804|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14460805|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460806|NCT02157376|Esomeprazole|esomeprazole|mesh-list
14460807|NCT02157376|Cimetidine|cimetidine|mesh-list
14460808|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14460809|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460810|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14460811|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460812|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460813|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14460814|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
14460815|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
14460816|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460817|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460818|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14460819|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14460820|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14460821|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14460822|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
14460823|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
14460824|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14460825|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14460826|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
14460827|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460828|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460829|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14460830|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
14460831|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14460832|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14460833|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14460834|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
14460835|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14460836|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460837|NCT02157948|Denosumab|denosumab|mesh-list
14460838|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14460839|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460840|NCT02158039|Ethanol|ethanol|mesh-list
14460841|NCT02158039|Lidocaine|lidocaine|mesh-list
14460842|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
14460843|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
14460844|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14460845|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460846|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
14460847|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460848|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14460849|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14460850|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14460851|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14460852|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460853|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14460854|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460855|NCT02158273|Fenofibrate|fenofibrate|mesh-list
14460856|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14460857|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
14460858|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460859|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14460860|NCT02158364|Vaccines|vaccines|mesh-list
14460861|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
14460862|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460863|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
14460864|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
14460865|NCT02158442|Ticarcillin|ticarcillin|mesh-list
14460866|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14460867|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460868|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460869|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14460870|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460871|NCT02158520|Paclitaxel|paclitaxel|mesh-list
14460872|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14460873|NCT02158520|Bevacizumab|bevacizumab|mesh-list
14460874|NCT02158520|Ipilimumab|ipilimumab|mesh-list
14460875|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14460876|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
14460877|NCT02158520|Antibodies|antibodies|mesh-list
14460878|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
14460879|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14460880|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
14460881|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14460882|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460883|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
14460884|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
14460885|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
14460886|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460887|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14460888|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14460889|NCT02158520|Growth Substances|growth substances|mesh-ancestor
14460890|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460891|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
14460892|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
14460893|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14460894|NCT02158533|Naltrexone|naltrexone|mesh-list
14460895|NCT02158533|Buprenorphine|buprenorphine|mesh-list
14460896|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14460897|NCT02158533|Narcotics|narcotics|mesh-ancestor
14460898|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930651|NCT01434225|Bumetanide|bumetanide|mesh-list
14460899|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460900|NCT02158533|Analgesics|analgesics|mesh-ancestor
14460901|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
14460902|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460903|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14460904|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14460905|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
14460906|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14460907|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460908|NCT02158806|Aspirin|aspirin|mesh-list
14460909|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14460910|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460911|NCT02158806|Analgesics|analgesics|mesh-ancestor
14460912|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
14460913|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460914|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460915|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460916|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14460917|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14460918|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14460919|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460920|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14460921|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14460922|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460923|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
14460924|NCT02158936|Azacitidine|azacitidine|mesh-list
14460925|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14460926|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
14460927|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460928|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460929|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460930|NCT02158975|Ixazomib|ixazomib|mesh-list
14460931|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460932|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
14460933|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460934|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460935|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14460936|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
14460937|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460938|NCT02159352|Ritonavir|ritonavir|mesh-list
14460939|NCT02159352|Lopinavir|lopinavir|mesh-list
14460940|NCT02159352|Darunavir|darunavir|mesh-list
14460941|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14460942|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14460943|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
14460944|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14460945|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460946|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14460947|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14460948|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
14460949|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460950|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14460951|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14460952|NCT02159365|Dexamethasone|dexamethasone|mesh-list
14460953|NCT02159365|Lenalidomide|lenalidomide|mesh-list
14460954|NCT02159365|Elotuzumab|elotuzumab|mesh-list
14460955|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14460956|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
14460957|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
14460958|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14460959|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460960|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14460961|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
14460962|NCT02159365|Hormones|hormones|mesh-ancestor
14460963|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460964|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14460965|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460966|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
14460967|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14460968|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14460969|NCT02159365|Growth Substances|growth substances|mesh-ancestor
14460970|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
14460971|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
14460972|NCT02159469|Testosterone|testosterone|mesh-list
14460973|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
14460974|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
14460975|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14460976|NCT02159469|Androgens|androgens|mesh-ancestor
14460977|NCT02159469|Hormones|hormones|mesh-ancestor
14460978|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14460979|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460980|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14460981|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460982|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
14460983|NCT02159482|Interferons|interferons|mesh-list
14460984|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
14460985|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
14460986|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14460987|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
14460988|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14460989|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
14460990|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14460991|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14460992|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14460993|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14460994|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14460995|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14460996|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14460997|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14460998|NCT02159547|Analgesics|analgesics|mesh-ancestor
14460999|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
14461000|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461001|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461002|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461003|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469696|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469697|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
14469698|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469699|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469700|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14469701|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
14469702|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
14469703|NCT02297516|Protective Agents|protective agents|mesh-ancestor
14461004|NCT02159807|Fentanyl|fentanyl|mesh-list
14461005|NCT02159807|Bupivacaine|bupivacaine|mesh-list
14461006|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
14461007|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
14461008|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461009|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461010|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
14461011|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461012|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14461013|NCT02159807|Narcotics|narcotics|mesh-ancestor
14461014|NCT02159807|Analgesics|analgesics|mesh-ancestor
14461015|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14461016|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14461017|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
14461018|NCT02159859|Ertapenem|ertapenem|mesh-list
14461019|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14461020|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461021|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
14461022|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14461023|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461024|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14461025|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461026|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461027|NCT02159950|Vaccines|vaccines|mesh-list
14461028|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
14461029|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461030|NCT02159976|Amoxicillin|amoxicillin|mesh-list
14461031|NCT02159976|Metronidazole|metronidazole|mesh-list
14461032|NCT02159976|Clarithromycin|clarithromycin|mesh-list
14461033|NCT02159976|Tetracycline|tetracycline|mesh-list
14461034|NCT02159976|Pantoprazole|pantoprazole|mesh-list
14461035|NCT02159976|Bismuth|bismuth|mesh-list
14461036|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14461037|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461038|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14461039|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14461040|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14461041|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461042|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461043|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14461044|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14461045|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14461046|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461047|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14461048|NCT02159976|Antacids|antacids|mesh-ancestor
14461049|NCT02160041|Infigratinib|infigratinib|mesh-list
14461050|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461051|NCT02160145|Tolvaptan|tolvaptan|mesh-list
14461052|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14461053|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461054|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
14461055|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461056|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
14461057|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14461058|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14461059|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14461060|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461061|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461062|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
14461063|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461064|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461065|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14461066|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461067|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14461068|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14461069|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14461070|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461071|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461072|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14461073|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461074|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461075|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
14461076|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461077|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14461078|NCT02160730|Roscovitine|roscovitine|mesh-list
14461079|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461080|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
14461081|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461082|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14461083|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461084|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461085|NCT02160808|Secretin|secretin|mesh-list
14461086|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461087|NCT02160808|Hormones|hormones|mesh-ancestor
14461088|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14461089|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461090|NCT02160990|Exenatide|exenatide|mesh-list
14461091|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14461092|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461093|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14461094|NCT02160990|Incretins|incretins|mesh-ancestor
14461095|NCT02160990|Hormones|hormones|mesh-ancestor
14461096|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14461097|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14461098|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14461099|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14461100|NCT02161146|Analgesics|analgesics|mesh-ancestor
14461101|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
14461102|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461103|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461104|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461105|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461106|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14461107|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14461108|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14461109|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
14461110|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
14461111|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461112|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461113|NCT02161185|Midazolam|midazolam|mesh-list
14461114|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14461115|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14461116|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461117|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461118|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14461119|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14461120|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461121|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14930652|NCT01434225|Diuretics|diuretics|mesh-ancestor
14461122|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
14461123|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
14461124|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
14461125|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
14461126|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461127|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461128|NCT02161406|Abatacept|abatacept|mesh-list
14461129|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14461130|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461131|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461132|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14461133|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
14461134|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461135|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461136|NCT02161458|Dexetimide|dexetimide|mesh-list
14461137|NCT02161458|Citalopram|citalopram|mesh-list
14461138|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14461139|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14461140|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461141|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461142|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461143|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
14461144|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461145|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14461146|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
14461147|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461148|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461149|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461150|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
14461151|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
14461152|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461153|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14461154|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14461155|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
14461156|NCT02161484|Bupivacaine|bupivacaine|mesh-list
14461157|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
14461158|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
14461159|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461160|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461161|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
14461162|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461163|NCT02161562|Omalizumab|omalizumab|mesh-list
14461164|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14461165|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14461166|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14461167|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
14461168|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
14461169|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461170|NCT02161575|Ranibizumab|ranibizumab|mesh-list
14461171|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14461172|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14461173|NCT02161575|Growth Substances|growth substances|mesh-ancestor
14461174|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461175|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
14461176|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461177|NCT02161705|Ropivacaine|ropivacaine|mesh-list
14461178|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
14461179|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
14461180|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461181|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461182|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
14461183|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461184|NCT02161718|Olanzapine|olanzapine|mesh-list
14461185|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
14461186|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
14461187|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461188|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461189|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461190|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14461191|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14461192|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461193|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461194|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14461195|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14461196|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461197|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461198|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461199|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
14461200|NCT02161731|Warfarin|warfarin|mesh-list
14461201|NCT02161731|Evacetrapib|evacetrapib|mesh-list
14461202|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
14461203|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14461204|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14461205|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
14461206|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461207|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14461208|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
14461209|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14461210|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930653|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
14461211|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461212|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14461213|NCT02162433|Analgesics|analgesics|mesh-ancestor
14461214|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
14461215|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461216|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14461217|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14461218|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14461219|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
14461220|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461221|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461222|NCT02162667|Trastuzumab|trastuzumab|mesh-list
14461223|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14461224|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461225|NCT02162680|Lidocaine|lidocaine|mesh-list
14461226|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
14461227|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
14461228|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461229|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461230|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
14461231|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461232|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14461233|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14461234|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14461235|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461236|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461237|NCT02162719|Paclitaxel|paclitaxel|mesh-list
14461238|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14461239|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461240|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
14461241|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
14461242|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
14461243|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461244|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
14461245|NCT02162758|Lansoprazole|lansoprazole|mesh-list
14461246|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14461247|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461248|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14461249|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461250|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461251|NCT02162771|Prednisone|prednisone|mesh-list
14461252|NCT02162771|Prednisolone|prednisolone|mesh-list
14461253|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
14461254|NCT02162771|Rituximab|rituximab|mesh-list
14461255|NCT02162771|Vincristine|vincristine|mesh-list
14461256|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14461257|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
14461258|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461259|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461260|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14461261|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
14461262|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461263|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461264|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14461265|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14461266|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461267|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
14461268|NCT02162771|Hormones|hormones|mesh-ancestor
14461269|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14461270|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14461271|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14461272|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14461273|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14461274|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14461275|NCT02162862|Bupropion|bupropion|mesh-list
14461276|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14461277|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
14461278|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461279|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14461280|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14461281|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461282|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461283|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
14461284|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461285|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461286|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14461287|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14461288|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461289|NCT02163421|Vedolizumab|vedolizumab|mesh-list
14461290|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461291|NCT02163434|Gabapentin|gabapentin|mesh-list
14461292|NCT02163434|Metoclopramide|metoclopramide|mesh-list
14461293|NCT02163434|Analgesics|analgesics|mesh-ancestor
14461294|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
14461295|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461296|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461297|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
14461298|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14461299|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14461300|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461301|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461302|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14461303|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14461304|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461305|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461306|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
14461307|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
14461308|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
14461309|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461310|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14461311|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14461312|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
14461313|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
14461314|NCT02163447|Piperaquine|piperaquine|mesh-list
14461315|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
14461316|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14461317|NCT02163447|Artenimol|artenimol|mesh-list
14461318|NCT02163447|Artemisinins|artemisinins|mesh-list
14461319|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
14461320|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14461321|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14461322|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461323|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14461324|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461325|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461326|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14461327|NCT02163447|Renal Agents|renal agents|mesh-ancestor
14461328|NCT02163759|Adalimumab|adalimumab|mesh-list
14461329|NCT02163759|Etrolizumab|etrolizumab|mesh-list
14461330|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461331|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461332|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461333|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
14461334|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461335|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14461336|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14461337|NCT02163837|Rifaximin|rifaximin|mesh-list
14461338|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14461339|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461340|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461341|NCT02164240|Sunitinib|sunitinib|mesh-list
14461342|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461343|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14461344|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14461345|NCT02164240|Growth Substances|growth substances|mesh-ancestor
14461346|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461347|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
14461348|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14461349|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461350|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461351|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
14461352|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
14461353|NCT02164383|Nicotine|nicotine|mesh-list
14461354|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14461355|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
14461356|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461357|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461358|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14461359|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14461360|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
14461361|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461362|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461363|NCT02164422|Guanfacine|guanfacine|mesh-list
14461364|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14461365|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14461366|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14461367|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14461368|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
14461369|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461370|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461371|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461372|NCT02164513|Fluticasone|fluticasone|mesh-list
14461373|NCT02164513|Xhance|xhance|mesh-list
14461374|NCT02164513|Bromides|bromides|mesh-list
14461375|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461376|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14461377|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
14461378|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461379|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461380|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14461381|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
14461382|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
14461383|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14461384|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
14461385|NCT02164864|Aspirin|aspirin|mesh-list
14461386|NCT02164864|Warfarin|warfarin|mesh-list
14461387|NCT02164864|Dabigatran|dabigatran|mesh-list
14461388|NCT02164864|Clopidogrel|clopidogrel|mesh-list
14461389|NCT02164864|Ticagrelor|ticagrelor|mesh-list
14461390|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14461391|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14461392|NCT02164864|Analgesics|analgesics|mesh-ancestor
14461393|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
14461394|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461395|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461396|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461397|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461398|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14461399|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14469704|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14461400|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461401|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14461402|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14461403|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461404|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
14461405|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14461406|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14461407|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14461408|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
14461409|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461410|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
14461411|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
14461412|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14461413|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
14461414|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14461415|NCT02164916|Cetuximab|cetuximab|mesh-list
14461416|NCT02164916|Irinotecan|irinotecan|mesh-list
14461417|NCT02164916|Camptothecin|camptothecin|mesh-list
14461418|NCT02164916|Vemurafenib|vemurafenib|mesh-list
14461419|NCT02164916|Antibodies|antibodies|mesh-list
14461420|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
14461421|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14461422|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
14461423|NCT02164916|Mitogens|mitogens|mesh-list
14461424|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
14461425|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461426|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461427|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14461428|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14461429|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461430|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461431|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
14461432|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14461433|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14461434|NCT02164929|Acetaminophen|acetaminophen|mesh-list
14461435|NCT02164929|Dexamethasone|dexamethasone|mesh-list
14461436|NCT02164929|Lidocaine|lidocaine|mesh-list
14461437|NCT02164929|Epinephrine|epinephrine|mesh-list
14461438|NCT02164929|Midazolam|midazolam|mesh-list
14461439|NCT02164929|Hydromorphone|hydromorphone|mesh-list
14461440|NCT02164929|Ropivacaine|ropivacaine|mesh-list
14461441|NCT02164929|Propofol|propofol|mesh-list
14461442|NCT02164929|Sevoflurane|sevoflurane|mesh-list
14461443|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461444|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
14461445|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
14461446|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461447|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461448|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461449|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
14461450|NCT02164929|Hormones|hormones|mesh-ancestor
14461451|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14461452|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14461453|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461454|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
14461455|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
14461456|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461457|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
14461458|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14461459|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14461460|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14461461|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461462|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461463|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14461464|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14461465|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
14461466|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14461467|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14461468|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14461469|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461470|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
14461471|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
14461472|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461473|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14461474|NCT02164929|Analgesics|analgesics|mesh-ancestor
14461475|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
14461476|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14461477|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14461478|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14461479|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14461480|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
14461481|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14461482|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14461483|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14461484|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
14461485|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
14461486|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
14461487|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14461488|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14461489|NCT02164929|Narcotics|narcotics|mesh-ancestor
14461490|NCT02164981|Nitroprusside|nitroprusside|mesh-list
14461491|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14461492|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
14461493|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14461494|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461495|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
14461496|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14461497|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14461498|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14461499|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461500|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461501|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
14461502|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461503|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461504|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14461505|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461506|NCT02165202|Rilpivirine|rilpivirine|mesh-list
14461507|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14461508|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14461509|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461510|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461511|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
14461512|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461513|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14461514|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14461515|NCT02165397|Rituximab|rituximab|mesh-list
14461516|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14461517|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461518|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
14461519|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461520|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461521|NCT02166047|Vesatolimod|vesatolimod|mesh-list
14461522|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
14461523|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461524|NCT02166333|Vitamin D|vitamin d|mesh-list
14461525|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
14461526|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
14461527|NCT02166333|Vitamins|vitamins|mesh-list
14461528|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
14461529|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461530|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14461531|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14461532|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
14461533|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14461534|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461535|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461536|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14461537|NCT02166476|Levofloxacin|levofloxacin|mesh-list
14461538|NCT02166476|Ofloxacin|ofloxacin|mesh-list
14461539|NCT02166476|Meropenem|meropenem|mesh-list
14461540|NCT02166476|Tazobactam|tazobactam|mesh-list
14461541|NCT02166476|Piperacillin|piperacillin|mesh-list
14461542|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14461543|NCT02166476|Vaborbactam|vaborbactam|mesh-list
14461544|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
14461545|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461546|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14461547|NCT02166476|Renal Agents|renal agents|mesh-ancestor
14461548|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14461549|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14461550|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461551|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461552|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461553|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14461554|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14461555|NCT02166697|Candesartan|candesartan|mesh-list
14461556|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
14461557|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14461558|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14461559|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14461560|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461561|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
14461562|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14461563|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14461564|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
14461565|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461566|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461567|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461568|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14461569|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14461570|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14461571|NCT02167139|Adalimumab|adalimumab|mesh-list
14461572|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461573|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469705|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14469706|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469707|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
14469708|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14469709|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
14469710|NCT02298023|Coagulants|coagulants|mesh-ancestor
14469711|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14469712|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14469713|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14469714|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
14469715|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469716|NCT02298179|Antacids|antacids|mesh-ancestor
14469717|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469718|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469719|NCT02298192|Liraglutide|liraglutide|mesh-list
14469720|NCT02298192|Xultophy|xultophy|mesh-list
14469721|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14469722|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469723|NCT02298192|Incretins|incretins|mesh-ancestor
14469724|NCT02298192|Hormones|hormones|mesh-ancestor
14469725|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469726|NCT02298868|Baclofen|baclofen|mesh-list
14469727|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14469728|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469729|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14469730|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469731|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14469732|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
14469733|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
14469734|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469735|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461574|NCT02167204|Alovudine|alovudine|mesh-list
14461575|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
14461576|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461577|NCT02167217|Prednisolone|prednisolone|mesh-list
14461578|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14461579|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
14461580|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14461581|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
14461582|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14461583|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
14461584|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461585|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
14461586|NCT02167217|Hormones|hormones|mesh-ancestor
14461587|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14461588|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461589|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14461590|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461591|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
14461592|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
14461593|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461594|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461595|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14461596|NCT02167217|Protective Agents|protective agents|mesh-ancestor
14461597|NCT02167256|Saracatinib|saracatinib|mesh-list
14461598|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461599|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461600|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461601|NCT02167451|Maraviroc|maraviroc|mesh-list
14461602|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14461603|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14461604|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461605|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14461606|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14461607|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
14461608|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461609|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14461610|NCT02167893|Leuprolide|leuprolide|mesh-list
14461611|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14461612|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
14461613|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14461614|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461615|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14461616|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461617|NCT02168062|Leuprolide|leuprolide|mesh-list
14461618|NCT02168062|Goserelin|goserelin|mesh-list
14461619|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14461620|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14461621|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
14461622|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14461623|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461624|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14461625|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461626|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
14461627|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14461628|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
14461629|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14461630|NCT02168101|Ixazomib|ixazomib|mesh-list
14461631|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461632|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
14461633|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461634|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461635|NCT02168309|Labetalol|labetalol|mesh-list
14461636|NCT02168309|Nifedipine|nifedipine|mesh-list
14461637|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14461638|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461639|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461640|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14461641|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461642|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
14461643|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
14461644|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14461645|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14461646|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14461647|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
14461648|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461649|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14461650|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
14461651|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
14461652|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461653|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14461654|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14461655|NCT02168361|Interferons|interferons|mesh-list
14461656|NCT02168361|Ribavirin|ribavirin|mesh-list
14461657|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
14461658|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
14461659|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
14461660|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14461661|NCT02168361|Simeprevir|simeprevir|mesh-list
14461662|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461663|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
14461664|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461665|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
14461666|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461667|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
14461668|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461669|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
14461670|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461671|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
14461672|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14461673|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
14461674|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461675|NCT02168387|Expectorants|expectorants|mesh-ancestor
14461676|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
14461677|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14461678|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
14461679|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461680|NCT02168387|Protective Agents|protective agents|mesh-ancestor
14461681|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461682|NCT02168387|Antidotes|antidotes|mesh-ancestor
14461683|NCT02168439|Midazolam|midazolam|mesh-list
14461684|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
14461685|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14461686|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461687|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461688|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14461689|NCT02168439|Analgesics|analgesics|mesh-ancestor
14461690|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
14461691|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461692|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14461693|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14461694|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14461695|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
14461696|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461697|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461698|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14461699|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14461700|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14461701|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461702|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14461703|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
14461704|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
14461705|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
14461706|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
14461707|NCT02168478|Neomycin|neomycin|mesh-list
14461708|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14461709|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461710|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14461711|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461712|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461713|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
14461714|NCT02168491|Lixisenatide|lixisenatide|mesh-list
14461715|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14461716|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461717|NCT02168660|Vitamin D|vitamin d|mesh-list
14461718|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
14461719|NCT02168660|Vitamins|vitamins|mesh-ancestor
14461720|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
14461721|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461722|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14461723|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14461724|NCT02168803|Evacetrapib|evacetrapib|mesh-list
14461725|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14461726|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14461727|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
14461728|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461729|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14461730|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
14461731|NCT02168816|Metronidazole|metronidazole|mesh-list
14461732|NCT02168816|Vancomycin|vancomycin|mesh-list
14461733|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
14461734|NCT02168816|Clindamycin|clindamycin|mesh-list
14461735|NCT02168816|Meropenem|meropenem|mesh-list
14461736|NCT02168816|Tazobactam|tazobactam|mesh-list
14461737|NCT02168816|Linezolid|linezolid|mesh-list
14461738|NCT02168816|Piperacillin|piperacillin|mesh-list
14461739|NCT02168816|Daptomycin|daptomycin|mesh-list
14461740|NCT02168816|Cefepime|cefepime|mesh-list
14461741|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14461742|NCT02168816|Aztreonam|aztreonam|mesh-list
14461743|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14461744|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14461745|NCT02168816|Trimethoprim|trimethoprim|mesh-list
14461746|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
14461747|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461748|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14461749|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14461750|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461751|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461752|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461753|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14461754|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14461755|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14461756|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14461757|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14461758|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14461759|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14461760|NCT02168816|Renal Agents|renal agents|mesh-ancestor
14461761|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
14461762|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14461763|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461764|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14461765|NCT02168842|Isradipine|isradipine|mesh-list
14461766|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14461767|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14461768|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461769|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461770|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14461771|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461772|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
14461773|NCT02168855|Nicotine|nicotine|mesh-list
14461774|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14461775|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
14461776|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461777|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461778|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14461779|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14461780|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
14461781|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461782|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461783|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14461784|NCT02168946|Meropenem|meropenem|mesh-list
14461785|NCT02168946|Vaborbactam|vaborbactam|mesh-list
14461786|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14461787|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
14461788|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14461789|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
14461790|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461791|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461792|NCT02169115|Omalizumab|omalizumab|mesh-list
14461793|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14461794|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14461795|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14461796|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
14461797|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
14461798|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461799|NCT02169219|Prednisone|prednisone|mesh-list
14461800|NCT02169219|Rituximab|rituximab|mesh-list
14461801|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
14461802|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14461803|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461804|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
14461805|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461806|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461807|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461808|NCT02169219|Hormones|hormones|mesh-ancestor
14461809|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14461810|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14461811|NCT02169271|Aspirin|aspirin|mesh-list
14461812|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14461813|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14461814|NCT02169271|Analgesics|analgesics|mesh-ancestor
14461815|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
14461816|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461817|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461818|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14461819|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14461820|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14461821|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14461822|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461823|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14461824|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14461825|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461826|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
14461827|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14461828|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461829|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14461830|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461831|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461832|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
14461833|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14461834|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461835|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461836|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14461837|NCT02169336|Analgesics|analgesics|mesh-ancestor
14461838|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
14461839|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461840|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14461841|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14461842|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14461843|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
14461844|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461845|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461846|NCT02169414|Levodopa|levodopa|mesh-list
14461847|NCT02169414|Carbidopa|carbidopa|mesh-list
14461848|NCT02169414|Opicapone|opicapone|mesh-list
14461849|NCT02169414|Benserazide|benserazide|mesh-list
14461850|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461851|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461852|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
14461853|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461854|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461855|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461856|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14461857|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461858|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461859|NCT02169427|Opicapone|opicapone|mesh-list
14461860|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461861|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461862|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461863|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461864|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461865|NCT02169440|Opicapone|opicapone|mesh-list
14461866|NCT02169440|Warfarin|warfarin|mesh-list
14461867|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
14461868|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461869|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461870|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461871|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461872|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461873|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14461874|NCT02169453|Opicapone|opicapone|mesh-list
14461875|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14461876|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
14461877|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461878|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461879|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461880|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
14461881|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
14461882|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461883|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461884|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461885|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461886|NCT02169466|Opicapone|opicapone|mesh-list
14461887|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
14461888|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461889|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461890|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461891|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461892|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461893|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
14461894|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461895|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461896|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14461897|NCT02169479|Opicapone|opicapone|mesh-list
14461898|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14461899|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
14461900|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461901|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461902|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461903|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
14461904|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
14461905|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461906|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461907|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461908|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461909|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14461910|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14461911|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461912|NCT02169791|Ixazomib|ixazomib|mesh-list
14461913|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14461914|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
14461915|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461916|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461917|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
14461918|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14461919|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
14461920|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14461921|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461922|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14461923|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14461924|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14461925|NCT02169895|Opicapone|opicapone|mesh-list
14461926|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
14461927|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461928|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461929|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461930|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461931|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461932|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
14461933|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461934|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461935|NCT02170025|Riociguat|riociguat|mesh-list
14461936|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
14461937|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461938|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14461939|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
14461940|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14461941|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14461942|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461943|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461944|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14461945|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
14461946|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14461947|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14461948|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461949|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461950|NCT02170207|Lansoprazole|lansoprazole|mesh-list
14461951|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
14461952|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14461953|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14461954|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14461955|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461956|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461957|NCT02170220|Vortioxetine|vortioxetine|mesh-list
14461958|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
14461959|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14461960|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14461961|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14461962|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14461963|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461964|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14461965|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14461966|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14461967|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461968|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461969|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
14461970|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14461971|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14461972|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14461973|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14461974|NCT02170376|Levodopa|levodopa|mesh-list
14461975|NCT02170376|Carbidopa|carbidopa|mesh-list
14461976|NCT02170376|Opicapone|opicapone|mesh-list
14461977|NCT02170376|Entacapone|entacapone|mesh-list
14461978|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14461979|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14461980|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
14461981|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14461982|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14461983|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461984|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14461985|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14461986|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14461987|NCT02170519|Iloprost|iloprost|mesh-list
14461988|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14461989|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
14461990|NCT02170532|Albuterol|albuterol|mesh-list
14461991|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14461992|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
14461993|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14461994|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14461995|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14461996|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
14461997|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
14461998|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14461999|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14462000|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14462001|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14462002|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
14462003|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462004|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462005|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14462006|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
14462007|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14462008|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14462009|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462010|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462011|NCT02170662|Bimatoprost|bimatoprost|mesh-list
14462012|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14462013|NCT02171130|Glucagon|glucagon|mesh-list
14462014|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14462015|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14462016|NCT02171130|Hormones|hormones|mesh-ancestor
14462017|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462018|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462019|NCT02171130|Incretins|incretins|mesh-ancestor
14462020|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14462021|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
14462022|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14462023|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14462024|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462025|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462026|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14462027|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
14462028|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14930654|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930655|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14930656|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14930657|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930658|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
14930659|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14930660|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14930661|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14462029|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14462030|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462031|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462032|NCT02171429|Adalimumab|adalimumab|mesh-list
14462033|NCT02171429|Etrolizumab|etrolizumab|mesh-list
14462034|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462035|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462036|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14462037|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
14462038|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462039|NCT02171611|Dabigatran|dabigatran|mesh-list
14462040|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
14462041|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14462042|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
14462043|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462044|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462045|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
14462046|NCT02172040|Celecoxib|celecoxib|mesh-list
14462047|NCT02172040|Amlodipine|amlodipine|mesh-list
14462048|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14462049|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14462050|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462051|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462052|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462053|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462054|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
14462055|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14462056|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14462057|NCT02172040|Analgesics|analgesics|mesh-ancestor
14462058|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
14462059|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462060|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462061|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462062|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14462063|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14462064|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462065|NCT02172742|Digoxin|digoxin|mesh-list
14462066|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14462067|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14462068|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14462069|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462070|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462071|NCT02172742|Protective Agents|protective agents|mesh-ancestor
14462072|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462073|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
14462074|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14462075|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14462076|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462077|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14462078|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
14462079|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14462080|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14462081|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462082|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462083|NCT02173054|Adapalene|adapalene|mesh-list
14462084|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14462085|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14462086|NCT02173054|Analgesics|analgesics|mesh-ancestor
14462087|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
14462088|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462089|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462090|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462091|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462092|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
14462093|NCT02173392|Brodalumab|brodalumab|mesh-list
14462094|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
14462095|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14462096|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462097|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
14462098|NCT02173769|Olodaterol|olodaterol|mesh-list
14462099|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14462100|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
14462101|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462102|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462103|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14462104|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
14462105|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
14462106|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14462107|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
14462108|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462109|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462110|NCT02174276|Tenofovir|tenofovir|mesh-list
14462111|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
14462112|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462113|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14462114|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14462115|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462116|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462117|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14462118|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14462119|NCT02174419|Nalbuphine|nalbuphine|mesh-list
14462120|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14462121|NCT02174419|Narcotics|narcotics|mesh-ancestor
14462122|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462123|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462124|NCT02174419|Analgesics|analgesics|mesh-ancestor
14462125|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
14462126|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462127|NCT02174432|Nalbuphine|nalbuphine|mesh-list
14462128|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14462129|NCT02174432|Narcotics|narcotics|mesh-ancestor
14462130|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462131|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462132|NCT02174432|Analgesics|analgesics|mesh-ancestor
14462133|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
14462134|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462135|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14462136|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14462137|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14462138|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462139|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462140|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14462141|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14462142|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14462143|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14462144|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
14462145|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462146|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462147|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14462148|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14462149|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
14462150|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14462151|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14462152|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
14462153|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14462154|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14462155|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14462156|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462157|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462158|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14462159|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14462160|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14462161|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14462162|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14462163|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462164|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462165|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14462166|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14462167|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
14462168|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14462169|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14462170|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
14462171|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
14462172|NCT02174731|Hematinics|hematinics|mesh-ancestor
14462173|NCT02174848|Deferiprone|deferiprone|mesh-list
14462174|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14462175|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
14462176|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
14462177|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462178|NCT02174861|Erenumab|erenumab|mesh-list
14462179|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14462180|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462181|NCT02174861|Analgesics|analgesics|mesh-ancestor
14462182|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
14462183|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462184|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930662|NCT01434303|Trastuzumab|trastuzumab|mesh-list
14462185|NCT02174913|Fentanyl|fentanyl|mesh-list
14462186|NCT02174913|Propofol|propofol|mesh-list
14462187|NCT02174913|Atracurium|atracurium|mesh-list
14462188|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14462189|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462190|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462191|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14462192|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
14462193|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
14462194|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14462195|NCT02174913|Narcotics|narcotics|mesh-ancestor
14462196|NCT02174913|Analgesics|analgesics|mesh-ancestor
14462197|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
14462198|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462199|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14462200|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14462201|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14462202|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14462203|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14462204|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14462205|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
14462206|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462207|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462208|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
14462209|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
14462210|NCT02175212|Androgens|androgens|mesh-list
14462211|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14462212|NCT02175212|Hormones|hormones|mesh-ancestor
14462213|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462214|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462215|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
14462216|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462217|NCT02175212|Protective Agents|protective agents|mesh-ancestor
14462218|NCT02175212|Vitamins|vitamins|mesh-ancestor
14462219|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
14462220|NCT02175212|Estrogens|estrogens|mesh-ancestor
14462221|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14462222|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462223|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
14462224|NCT02175225|Deferoxamine|deferoxamine|mesh-list
14462225|NCT02175225|Siderophores|siderophores|mesh-ancestor
14462226|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14462227|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
14462228|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
14462229|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469736|NCT02298933|Eculizumab|eculizumab|mesh-list
14469737|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14469738|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469739|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
14469740|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469741|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
14469742|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14469743|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
14469744|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469745|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14469746|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14469747|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
14469748|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469749|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469750|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14469751|NCT02299050|Bromocriptine|bromocriptine|mesh-list
14469752|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14469753|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14469754|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469755|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469756|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469757|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
14469758|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
14469759|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469760|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469761|NCT02299089|Octreotide|octreotide|mesh-list
14469762|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14469763|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14930663|NCT01434303|Lapatinib|lapatinib|mesh-list
14462230|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
14462231|NCT02175277|Hematinics|hematinics|mesh-ancestor
14462232|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14462233|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
14462234|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462235|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462236|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462237|NCT02175758|Ribavirin|ribavirin|mesh-list
14462238|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
14462239|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
14462240|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462241|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
14462242|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462243|NCT02175771|Fluticasone|fluticasone|mesh-list
14462244|NCT02175771|Xhance|xhance|mesh-list
14462245|NCT02175771|Albuterol|albuterol|mesh-list
14462246|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14462247|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14462248|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
14462249|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462250|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14462251|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
14462252|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462253|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462254|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14462255|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
14462256|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
14462257|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14462258|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14462259|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14462260|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
14462261|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462262|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462263|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
14462264|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14462265|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
14462266|NCT02175771|Hormones|hormones|mesh-ancestor
14462267|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462268|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
14462269|NCT02175966|Ribavirin|ribavirin|mesh-list
14462270|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
14462271|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
14930664|NCT01434303|Entinostat|entinostat|mesh-list
14462272|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462273|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
14462274|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752682|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752683|NCT05335148|Colchicine|colchicine|mesh-list
14752684|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
14752685|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752686|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
14752687|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752688|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752689|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752690|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752691|NCT05335122|Bimatoprost|bimatoprost|mesh-list
14752692|NCT05335122|Travoprost|travoprost|mesh-list
14752693|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14753765|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462275|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
14462276|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14462277|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462278|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14462279|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14462280|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462281|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462282|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462283|NCT02176018|Quinidine|quinidine|mesh-list
14462284|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
14462285|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
14462286|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
14462287|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14462288|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14462289|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462290|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462291|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462292|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14462293|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14462294|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
14462295|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14462296|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
14462297|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14462298|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14462299|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462300|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462301|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14462302|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14462303|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
14462304|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14462305|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14462306|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462307|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14462308|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14462309|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
14462310|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14462311|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14462312|NCT02176031|Prednisolone|prednisolone|mesh-list
14462313|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
14462314|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14462315|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
14462316|NCT02176031|Natalizumab|natalizumab|mesh-list
14462317|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462318|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
14462319|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
14462320|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462321|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462322|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14462323|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
14462324|NCT02176031|Hormones|hormones|mesh-ancestor
14462325|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462326|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14462327|NCT02176031|Protective Agents|protective agents|mesh-ancestor
14462328|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14462329|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462330|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
14462331|NCT02176291|Buprenorphine|buprenorphine|mesh-list
14462332|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14462333|NCT02176291|Narcotics|narcotics|mesh-ancestor
14462334|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462335|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462336|NCT02176291|Analgesics|analgesics|mesh-ancestor
14462337|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
14462338|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462339|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14462340|NCT02176356|Bimatoprost|bimatoprost|mesh-list
14462341|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14462342|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
14462343|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14462344|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14462345|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
14462346|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14462347|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14462348|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462349|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462350|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
14462351|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462352|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462353|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14462354|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462355|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14462356|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14462357|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
14462358|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
14462359|NCT02176356|Protective Agents|protective agents|mesh-ancestor
14462360|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
14462361|NCT02176382|Denosumab|denosumab|mesh-list
14462362|NCT02176382|Teriparatide|teriparatide|mesh-list
14462363|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14462364|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462365|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462366|NCT02176421|Lidocaine|lidocaine|mesh-list
14462367|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
14462368|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
14462369|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462370|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462371|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
14462372|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462373|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14462374|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14462375|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14462376|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462377|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462378|NCT02176486|Ixazomib|ixazomib|mesh-list
14462379|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462380|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
14462381|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462382|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462383|NCT02176642|Oxybutynin|oxybutynin|mesh-list
14462384|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
14462385|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
14462386|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462387|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462388|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14462389|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14462390|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
14462391|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462392|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462393|NCT02176642|Urological Agents|urological agents|mesh-ancestor
14462394|NCT02176655|Aspirin|aspirin|mesh-list
14462395|NCT02176655|Sumatriptan|sumatriptan|mesh-list
14462396|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14462397|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14462398|NCT02176655|Analgesics|analgesics|mesh-ancestor
14462399|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
14462400|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462401|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462402|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462403|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462404|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14462405|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14462406|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462407|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14462408|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14462409|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462410|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
14462411|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14462412|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14462413|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14462414|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
14462415|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462416|NCT02177032|Vaccines|vaccines|mesh-list
14462417|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
14462418|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14462419|NCT02177032|Antibodies|antibodies|mesh-list
14462420|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
14462421|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462422|NCT02177786|Selonsertib|selonsertib|mesh-list
14462423|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14462424|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462425|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462426|NCT02177838|Cetuximab|cetuximab|mesh-list
14462427|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14462428|NCT02177838|Antibodies|antibodies|mesh-list
14462429|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
14462430|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14462431|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
14462432|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462433|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462434|NCT02177942|Micronutrients|micronutrients|mesh-list
14462435|NCT02177942|Trace Elements|trace elements|mesh-list
14462436|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462437|NCT02178059|Terbutaline|terbutaline|mesh-list
14462438|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14462439|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
14462440|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462441|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462442|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14462443|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
14462444|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
14462445|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
14462446|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14462447|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14462448|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14462449|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14462450|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14462451|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462452|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462453|NCT02178241|Gemcitabine|gemcitabine|mesh-list
14462454|NCT02178241|Halichondrin B|halichondrin b|mesh-list
14462455|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14462456|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
14462457|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462458|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462459|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
14462460|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462461|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462462|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14462463|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
14462464|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462465|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
14462466|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
14462467|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
14462468|NCT02178540|Tobramycin|tobramycin|mesh-list
14462469|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14462470|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462471|NCT02178553|Bupivacaine|bupivacaine|mesh-list
14462472|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
14462473|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
14462474|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462475|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462476|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
14462477|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462478|NCT02178696|Citalopram|citalopram|mesh-list
14462479|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
14462480|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14462481|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14462482|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462483|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462484|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462485|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
14462486|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462487|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14462488|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14462489|NCT02178800|Cabotegravir|cabotegravir|mesh-list
14462490|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14462491|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14462492|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462493|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462494|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14462495|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14462496|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
14462497|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462498|NCT02178995|Methylphenidate|methylphenidate|mesh-list
14462499|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14462500|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462501|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14462502|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14462503|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462504|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462505|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
14462506|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462507|NCT02179177|Apixaban|apixaban|mesh-list
14462508|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14462509|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
14462510|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14462511|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
14462512|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462513|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462514|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
14462515|NCT02179671|Docetaxel|docetaxel|mesh-list
14462516|NCT02179671|Gefitinib|gefitinib|mesh-list
14462517|NCT02179671|Tremelimumab|tremelimumab|mesh-list
14462518|NCT02179671|Osimertinib|osimertinib|mesh-list
14462519|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462520|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
14462521|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
14462522|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
14462523|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462524|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14462525|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462526|NCT02179788|Metformin|metformin|mesh-list
14462527|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14462528|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462529|NCT02179892|Acetaminophen|acetaminophen|mesh-list
14462530|NCT02179892|Dexamethasone|dexamethasone|mesh-list
14462531|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
14462532|NCT02179892|Bupivacaine|bupivacaine|mesh-list
14462533|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462534|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
14462535|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
14462536|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462537|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462538|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14462539|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
14462540|NCT02179892|Hormones|hormones|mesh-ancestor
14462541|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462542|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14462543|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462544|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
14462545|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
14462546|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462547|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
14462548|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14462549|NCT02179892|Analgesics|analgesics|mesh-ancestor
14462550|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
14462551|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
14462552|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14462553|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462554|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
14462555|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14462556|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462557|NCT02180100|Fluconazole|fluconazole|mesh-list
14462558|NCT02180100|Terconazole|terconazole|mesh-list
14462559|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
14462560|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462561|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14462562|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14462563|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462564|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462565|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14462566|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
14462567|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462568|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462569|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14462570|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14462571|NCT02180165|Voriconazole|voriconazole|mesh-list
14462572|NCT02180165|Posaconazole|posaconazole|mesh-list
14462573|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
14462574|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462575|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14462576|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14462577|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462578|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462579|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14462580|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
14462581|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462582|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462583|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14462584|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14462585|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14462586|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14462587|NCT02180438|Tenofovir|tenofovir|mesh-list
14462588|NCT02180438|Emtricitabine|emtricitabine|mesh-list
14462589|NCT02180438|Cobicistat|cobicistat|mesh-list
14462590|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14462591|NCT02180438|Elvitegravir|elvitegravir|mesh-list
14462592|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
14462593|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462594|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14462595|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14462596|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462597|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462598|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14462599|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14462600|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14462601|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14462602|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14462603|NCT02180659|Buprenorphine|buprenorphine|mesh-list
14462604|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14462605|NCT02180659|Narcotics|narcotics|mesh-ancestor
14462606|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462607|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462608|NCT02180659|Analgesics|analgesics|mesh-ancestor
14462609|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
14462610|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462611|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14462612|NCT02180672|Fluticasone|fluticasone|mesh-list
14462613|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462614|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14462615|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
14462616|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462617|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462618|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14462619|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
14462620|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14462621|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14462622|NCT02180828|Fluconazole|fluconazole|mesh-list
14462623|NCT02180828|Clotrimazole|clotrimazole|mesh-list
14462624|NCT02180828|Miconazole|miconazole|mesh-list
14462625|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
14462626|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462627|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14462628|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14462629|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462630|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462631|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14462632|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
14462633|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462634|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462635|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14462636|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14462637|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14462638|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14462639|NCT02181075|Doxorubicin|doxorubicin|mesh-list
14462640|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14462641|NCT02181075|Liver Extracts|liver extracts|mesh-list
14462642|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14462643|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462644|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14462645|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14462646|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462647|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462648|NCT02181075|Hematinics|hematinics|mesh-ancestor
14462649|NCT02181127|Glucagon|glucagon|mesh-list
14462650|NCT02181127|Pancrelipase|pancrelipase|mesh-list
14462651|NCT02181127|Pancreatin|pancreatin|mesh-list
14462652|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14462653|NCT02181127|Hormones|hormones|mesh-ancestor
14462654|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462655|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462656|NCT02181231|Buprenorphine|buprenorphine|mesh-list
14462657|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14462658|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14462659|NCT02181231|Narcotics|narcotics|mesh-ancestor
14462660|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462661|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462662|NCT02181231|Analgesics|analgesics|mesh-ancestor
14462663|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
14462664|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462665|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14462666|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14462667|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14462668|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462669|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462670|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462671|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14462672|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
14462673|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14462674|NCT02181296|Ropivacaine|ropivacaine|mesh-list
14462675|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
14462676|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
14462677|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462678|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462679|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
14462680|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462681|NCT02181387|Acetaminophen|acetaminophen|mesh-list
14462682|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14462683|NCT02181387|Analgesics|analgesics|mesh-ancestor
14462684|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
14462685|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462686|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462687|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
14462688|NCT02181413|Ixazomib|ixazomib|mesh-list
14462689|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462690|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462691|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
14462692|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462693|NCT02181426|Ketorolac|ketorolac|mesh-list
14462694|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14462695|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14462696|NCT02181426|Analgesics|analgesics|mesh-ancestor
14462697|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
14462698|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462699|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462700|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462701|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462702|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14462703|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462704|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462705|NCT02181504|Ranibizumab|ranibizumab|mesh-list
14462706|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14462707|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14462708|NCT02181504|Growth Substances|growth substances|mesh-ancestor
14462709|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462710|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14462711|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462712|NCT02181517|Ranibizumab|ranibizumab|mesh-list
14462713|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14462714|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14462715|NCT02181517|Growth Substances|growth substances|mesh-ancestor
14930665|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14930666|NCT01434303|Antibodies|antibodies|mesh-list
14930667|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
14462716|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462717|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
14462718|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462719|NCT02181556|Aflibercept|aflibercept|mesh-list
14462720|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14462721|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14462722|NCT02181556|Growth Substances|growth substances|mesh-ancestor
14462723|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462724|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
14462725|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462726|NCT02181634|Gemcitabine|gemcitabine|mesh-list
14462727|NCT02181634|Paclitaxel|paclitaxel|mesh-list
14462728|NCT02181634|Antimetabolites|antimetabolites|mesh-list
14462729|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14462730|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462731|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
14462732|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14462733|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14462734|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462735|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14462736|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
14462737|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462738|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462739|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14462740|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
14462741|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462742|NCT02181673|Golimumab|golimumab|mesh-list
14462743|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14462744|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462745|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14462746|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
14462747|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462748|NCT02181738|Doxorubicin|doxorubicin|mesh-list
14462749|NCT02181738|Nivolumab|nivolumab|mesh-list
14462750|NCT02181738|Dacarbazine|dacarbazine|mesh-list
14462751|NCT02181738|Vinblastine|vinblastine|mesh-list
14462752|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14462753|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462754|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14462755|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14462756|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462757|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462758|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14462759|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14462760|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14462761|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
14462762|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14462763|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
14462764|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
14462765|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
14462766|NCT02181816|Amlodipine|amlodipine|mesh-list
14462767|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14462768|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14462769|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14462770|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462771|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462772|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462773|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462774|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
14462775|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14462776|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14462777|NCT02181842|Pioglitazone|pioglitazone|mesh-list
14462778|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14462779|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462780|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14462781|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462782|NCT02182492|Clarithromycin|clarithromycin|mesh-list
14462783|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
14462784|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14462785|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462786|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14462787|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462788|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462789|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14462790|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14462791|NCT02182492|Hormones|hormones|mesh-ancestor
14462792|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462793|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462794|NCT02182830|Empagliflozin|empagliflozin|mesh-list
14462795|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14462796|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462797|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14462798|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462799|NCT02182895|Saxagliptin|saxagliptin|mesh-list
14462800|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14462801|NCT02182895|Incretins|incretins|mesh-ancestor
14462802|NCT02182895|Hormones|hormones|mesh-ancestor
14462803|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14462804|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462805|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
14462806|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462807|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462808|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14462809|NCT02182999|Ropivacaine|ropivacaine|mesh-list
14462810|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
14462811|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
14462812|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462813|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462814|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
14462815|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462816|NCT02183519|Capsaicin|capsaicin|mesh-list
14462817|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
14462818|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
14462819|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
14462820|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462821|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462822|NCT02183675|Amlodipine|amlodipine|mesh-list
14462823|NCT02183675|Telmisartan|telmisartan|mesh-list
14462824|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14462825|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14462826|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14462827|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14462828|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462829|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462830|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462831|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462832|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
14462833|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14462834|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14462835|NCT02183675|Diuretics|diuretics|mesh-ancestor
14462836|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
14462837|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14462838|NCT02183792|Furosemide|furosemide|mesh-list
14462839|NCT02183792|Tolvaptan|tolvaptan|mesh-list
14462840|NCT02183792|Diuretics|diuretics|mesh-ancestor
14462841|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
14462842|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462843|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14462844|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462845|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462846|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14469764|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469765|NCT02299141|Nintedanib|nintedanib|mesh-list
14469766|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469767|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469768|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469769|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469770|NCT02299297|Tofacitinib|tofacitinib|mesh-list
14469771|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469772|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469773|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469774|NCT02299336|Aflibercept|aflibercept|mesh-list
14469775|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14469776|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14469777|NCT02299336|Growth Substances|growth substances|mesh-ancestor
14469778|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469779|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
14469780|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14469781|NCT02299349|Epinephrine|epinephrine|mesh-list
14469782|NCT02299349|Racepinephrine|racepinephrine|mesh-list
14469783|NCT02299349|Morphine|morphine|mesh-list
14469784|NCT02299349|Bupivacaine|bupivacaine|mesh-list
14469785|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
14469786|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
14469787|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
14469788|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469789|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469790|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
14469791|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469792|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14469793|NCT02299349|Narcotics|narcotics|mesh-ancestor
14930668|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14930669|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14930670|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
14930671|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930672|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462847|NCT02184572|Vaccines|vaccines|mesh-list
14462848|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
14462849|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462850|NCT02184611|Bromides|bromides|mesh-list
14462851|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
14462852|NCT02185014|Adalimumab|adalimumab|mesh-list
14462853|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462854|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462855|NCT02185131|Mirtazapine|mirtazapine|mesh-list
14462856|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
14462857|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14462858|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14462859|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
14462860|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
14462861|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462862|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462863|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462864|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14462865|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14462866|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462867|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14462868|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14462869|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14462870|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
14462871|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14462872|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14462873|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
14462874|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14462875|NCT02185339|Rocuronium|rocuronium|mesh-list
14462876|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14462877|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14462878|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14462879|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462880|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462881|NCT02185534|Clopidogrel|clopidogrel|mesh-list
14462882|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14462883|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14462884|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14462885|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14462886|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
14462887|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14462888|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462889|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462890|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14462891|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14462892|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14462893|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14462894|NCT02186015|Vitamin D|vitamin d|mesh-list
14462895|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
14462896|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
14462897|NCT02186015|Vitamins|vitamins|mesh-list
14462898|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
14462899|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462900|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14462901|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462902|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14462903|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462904|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14462905|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462906|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462907|NCT02186652|Pantoprazole|pantoprazole|mesh-list
14462908|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14462909|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14462910|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14462911|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462912|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462913|NCT02186665|Calcitriol|calcitriol|mesh-list
14462914|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462915|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462916|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14462917|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462918|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462919|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14462920|NCT02186665|Vitamins|vitamins|mesh-ancestor
14462921|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
14462922|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14462923|NCT02186821|Ceritinib|ceritinib|mesh-list
14462924|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462925|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14462926|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462927|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462928|NCT02186847|Metformin|metformin|mesh-list
14462929|NCT02186847|Paclitaxel|paclitaxel|mesh-list
14462930|NCT02186847|Carboplatin|carboplatin|mesh-list
14469794|NCT02299349|Analgesics|analgesics|mesh-ancestor
14462931|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14462932|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462933|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
14462934|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14462935|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14462936|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462937|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14462938|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462939|NCT02186873|Golimumab|golimumab|mesh-list
14462940|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14462941|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14462942|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14462943|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
14462944|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462945|NCT02187016|Listerine|listerine|mesh-list
14462946|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14462947|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14462948|NCT02187055|Adalimumab|adalimumab|mesh-list
14462949|NCT02187055|Methotrexate|methotrexate|mesh-list
14462950|NCT02187055|Tofacitinib|tofacitinib|mesh-list
14462951|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14462952|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
14462953|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14462954|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462955|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14462956|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
14462957|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462958|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462959|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
14462960|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14462961|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14462962|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14462963|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
14462964|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14462965|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14462966|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752694|NCT05335018|Lenalidomide|lenalidomide|mesh-list
14752695|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
14752696|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752697|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14752698|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14752699|NCT05335018|Growth Substances|growth substances|mesh-ancestor
14752700|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752701|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752702|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
14930673|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14930674|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930675|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930676|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14930677|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14930678|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
14930679|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930680|NCT01434381|Antacids|antacids|mesh-ancestor
14930681|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930682|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14930683|NCT01434394|Cetuximab|cetuximab|mesh-list
14930684|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14930685|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14462967|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14462968|NCT02187159|Pregabalin|pregabalin|mesh-list
14462969|NCT02187159|Analgesics|analgesics|mesh-ancestor
14462970|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
14462971|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462972|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462973|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
14462974|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14462975|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462976|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462977|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462978|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14930686|NCT01434459|Gemcitabine|gemcitabine|mesh-list
14462979|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14462980|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462981|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14462982|NCT02187172|Ustekinumab|ustekinumab|mesh-list
14462983|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
14462984|NCT02187471|Pregabalin|pregabalin|mesh-list
14462985|NCT02187471|Analgesics|analgesics|mesh-ancestor
14462986|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
14462987|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14462988|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14462989|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
14462990|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14462991|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14462992|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14462993|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14462994|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14462995|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14462996|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14462997|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14462998|NCT02187744|Carboplatin|carboplatin|mesh-list
14462999|NCT02187744|Docetaxel|docetaxel|mesh-list
14463000|NCT02187744|Trastuzumab|trastuzumab|mesh-list
14463001|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463002|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14463003|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14463004|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14463005|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463006|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14463007|NCT02187809|Clobazam|clobazam|mesh-list
14463008|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
14463009|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14463010|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14463011|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463012|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463013|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14463014|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14463015|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
14463016|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
14463017|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463018|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463019|NCT02187861|Rituximab|rituximab|mesh-list
14463020|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14463021|NCT02187861|Venetoclax|venetoclax|mesh-list
14463022|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14463023|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463024|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
14463025|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463026|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463027|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14463028|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
14931203|NCT01437982|Hormones|hormones|mesh-ancestor
14463029|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463030|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14463031|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14463032|NCT02188459|Bupropion|bupropion|mesh-list
14463033|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14463034|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
14463035|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14463036|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14463037|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14463038|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14463039|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463040|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
14463041|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463042|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463043|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14463044|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14463045|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463046|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
14463047|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14463048|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14463049|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463050|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
14463051|NCT02188576|Coagulants|coagulants|mesh-ancestor
14463052|NCT02188719|Acetaminophen|acetaminophen|mesh-list
14463053|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
14463054|NCT02188719|Promethazine|promethazine|mesh-list
14463055|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
14463056|NCT02188719|Valganciclovir|valganciclovir|mesh-list
14463057|NCT02188719|Ganciclovir|ganciclovir|mesh-list
14463058|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
14463059|NCT02188719|Prednisone|prednisone|mesh-list
14463060|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14463061|NCT02188719|Everolimus|everolimus|mesh-list
14463062|NCT02188719|Liver Extracts|liver extracts|mesh-list
14463063|NCT02188719|Tacrolimus|tacrolimus|mesh-list
14463064|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
14463065|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14463066|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463067|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
14463068|NCT02188719|Hormones|hormones|mesh-ancestor
14463069|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463070|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463071|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14463072|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463073|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463074|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
14463075|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14463076|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463077|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463078|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463079|NCT02188719|Analgesics|analgesics|mesh-ancestor
14463080|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
14463081|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463082|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
14463083|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14463084|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14463085|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
14463086|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14463087|NCT02188719|Hematinics|hematinics|mesh-ancestor
14463088|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14463089|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14463090|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463091|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
14463092|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
14463093|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
14463094|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
14463095|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463096|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14463097|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
14463098|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
14463099|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463100|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14463101|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
14463102|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14463103|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
14463104|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14463105|NCT02188719|Protective Agents|protective agents|mesh-ancestor
14463106|NCT02188784|Iron|iron|mesh-list
14463107|NCT02188784|Trace Elements|trace elements|mesh-ancestor
14463108|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
14463109|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463110|NCT02189122|Aspirin|aspirin|mesh-list
14463111|NCT02189122|Bradykinin|bradykinin|mesh-list
14463112|NCT02189122|Kininogens|kininogens|mesh-list
14463113|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463114|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463115|NCT02189122|Analgesics|analgesics|mesh-ancestor
14463116|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
14463117|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463118|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463119|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463120|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463121|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14463122|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14463123|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463124|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14463125|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14463126|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463127|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
14463128|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
14463129|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14463130|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
14463131|NCT02189213|Sertraline|sertraline|mesh-list
14463132|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
14463133|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14463134|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14463135|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14463136|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14463137|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463138|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463139|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
14463140|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463141|NCT02189317|Bupivacaine|bupivacaine|mesh-list
14463142|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
14463143|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
14463144|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463145|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463146|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
14463147|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463148|NCT02189629|Trifarotene|trifarotene|mesh-list
14463149|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14463150|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14463151|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14463152|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463153|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14463154|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463155|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463156|NCT02189837|Atorvastatin|atorvastatin|mesh-list
14463157|NCT02189837|Evolocumab|evolocumab|mesh-list
14463158|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14463159|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14463160|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14463161|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
14463162|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463163|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14463164|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14463165|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463166|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
14463167|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463168|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14463169|NCT02189889|Hematinics|hematinics|mesh-ancestor
14463170|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14463171|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14463172|NCT02189941|Deferiprone|deferiprone|mesh-list
14463173|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14463174|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
14463175|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
14463176|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463177|NCT02190903|Anesthetics|anesthetics|mesh-list
14463178|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463179|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463180|NCT02191033|Nicotine|nicotine|mesh-list
14752703|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14752704|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
14752705|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752706|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
14752707|NCT05334745|Protective Agents|protective agents|mesh-ancestor
14752708|NCT05334654|Enoxaparin|enoxaparin|mesh-list
14752709|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
14752710|NCT05334654|Bivalirudin|bivalirudin|mesh-list
14463181|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14463182|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
14463183|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463184|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463185|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14463186|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14463187|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463188|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463189|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463190|NCT02191137|Riociguat|riociguat|mesh-list
14463191|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
14463192|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463193|NCT02191397|Dexetimide|dexetimide|mesh-list
14463194|NCT02191397|Citalopram|citalopram|mesh-list
14463195|NCT02191397|Bupropion|bupropion|mesh-list
14463196|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14463197|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14463198|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14463199|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463200|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463201|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
14463202|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463203|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14463204|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
14463205|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14463206|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14463207|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14463208|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
14463209|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
14463210|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463211|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14463212|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14463213|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463214|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14463215|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
14463216|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14463217|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14463218|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463219|NCT02191579|Topiramate|topiramate|mesh-list
14463220|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
14752711|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
14752712|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14463221|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14463222|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14463223|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14463224|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14463225|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463226|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463227|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463228|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463229|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14463230|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463231|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
14463232|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14463233|NCT02191865|Nintedanib|nintedanib|mesh-list
14463234|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463235|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14463236|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463237|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463238|NCT02192190|Celecoxib|celecoxib|mesh-list
14463239|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463240|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463241|NCT02192190|Analgesics|analgesics|mesh-ancestor
14463242|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
14463243|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463244|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463245|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463246|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463247|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14463248|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14463249|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463250|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463251|NCT02192541|Aflibercept|aflibercept|mesh-list
14463252|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14463253|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14463254|NCT02192541|Growth Substances|growth substances|mesh-ancestor
14463255|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463256|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
14463257|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463258|NCT02192684|Pioglitazone|pioglitazone|mesh-list
14463259|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14463260|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463261|NCT02192814|Lacosamide|lacosamide|mesh-list
14463262|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
14463263|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14463264|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14463265|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14463266|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469795|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14469796|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14469797|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
14469798|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469799|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469800|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14469801|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14469802|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
14469803|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14469804|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469805|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
14469806|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
14469807|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14469808|NCT02299375|Albuterol|albuterol|mesh-list
14469809|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14469810|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
14469811|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469812|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469813|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14469814|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
14469815|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
14469816|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14469817|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14469818|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14469819|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14469820|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
14469821|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14469822|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14469823|NCT02299388|Liraglutide|liraglutide|mesh-list
14469824|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14469825|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463267|NCT02192970|Bevacizumab|bevacizumab|mesh-list
14463268|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14463269|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463270|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14463271|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14463272|NCT02192970|Growth Substances|growth substances|mesh-ancestor
14463273|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463274|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
14463275|NCT02193165|Triclosan|triclosan|mesh-list
14463276|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
14463277|NCT02193165|Fluorides|fluorides|mesh-list
14463278|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
14463279|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
14463280|NCT02193165|Protective Agents|protective agents|mesh-ancestor
14463281|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463282|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14463283|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463284|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14463285|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14463286|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
14463287|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463288|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14463289|NCT02193347|Temozolomide|temozolomide|mesh-list
14463290|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14463291|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
14463292|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463293|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463294|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
14463295|NCT02193776|Rifampin|rifampin|mesh-list
14463296|NCT02193776|Isoniazid|isoniazid|mesh-list
14463297|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
14463298|NCT02193776|Ethambutol|ethambutol|mesh-list
14463299|NCT02193776|Bedaquiline|bedaquiline|mesh-list
14463300|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14463301|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463302|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14463303|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14463304|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463305|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463306|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463307|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14463308|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
14463309|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
14463310|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14463311|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14463312|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14463313|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14463314|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14752713|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14463315|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14463316|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14463317|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14463318|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14463319|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
14463320|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14463321|NCT02193815|Calcitriol|calcitriol|mesh-list
14463322|NCT02193815|Calcipotriene|calcipotriene|mesh-list
14463323|NCT02193815|Tofacitinib|tofacitinib|mesh-list
14463324|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14463325|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463326|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463327|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14463328|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14463329|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463330|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14463331|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14463332|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14463333|NCT02193815|Vitamins|vitamins|mesh-ancestor
14463334|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
14463335|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14463336|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
14463337|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463338|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
14463339|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463340|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463341|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14463342|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
14463343|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463344|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463345|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14463346|NCT02194062|Fluticasone|fluticasone|mesh-list
14463347|NCT02194062|Xhance|xhance|mesh-list
14463348|NCT02194062|Budesonide|budesonide|mesh-list
14463349|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463350|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14463351|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
14463352|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463353|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463354|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14463355|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
14463356|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
14463357|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14463358|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
14463359|NCT02194062|Hormones|hormones|mesh-ancestor
14463360|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463361|NCT02194088|Diclofenac|diclofenac|mesh-list
14463362|NCT02194088|Atropine|atropine|mesh-list
14463363|NCT02194088|Analgesics|analgesics|mesh-list
14463364|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463365|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463366|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
14463367|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463368|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463369|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463370|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463371|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14463372|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463373|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463374|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14463375|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14463376|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14463377|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
14463378|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14463379|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
14463380|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
14463381|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
14463382|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14463383|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14463384|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463385|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463386|NCT02194465|Spironolactone|spironolactone|mesh-list
14463387|NCT02194465|Tadalafil|tadalafil|mesh-list
14463388|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14463389|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
14463390|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
14463391|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14463392|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14463393|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463394|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463395|NCT02194465|Urological Agents|urological agents|mesh-ancestor
14463396|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
14463397|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463398|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463399|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14463400|NCT02194465|Diuretics|diuretics|mesh-ancestor
14463401|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
14463402|NCT02194465|Hormones|hormones|mesh-ancestor
14463403|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
14463404|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
14463405|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463406|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463407|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463408|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
14463409|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
14463410|NCT02194998|Ritonavir|ritonavir|mesh-list
14463411|NCT02194998|Ribavirin|ribavirin|mesh-list
14463412|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14463413|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14463414|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
14463415|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463416|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463417|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14463418|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14463419|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
14463420|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463421|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14463422|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14463423|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
14463424|NCT02195232|Quercetin|quercetin|mesh-list
14463425|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
14463426|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463427|NCT02195232|Protective Agents|protective agents|mesh-ancestor
14463428|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463429|NCT02195518|Tenofovir|tenofovir|mesh-list
14463430|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
14463431|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463432|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14463433|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14463434|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463435|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463436|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14463437|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14463438|NCT02195583|Zinc|zinc|mesh-list
14463439|NCT02195583|Listerine|listerine|mesh-list
14463440|NCT02195583|Fluorides|fluorides|mesh-list
14463441|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
14463442|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
14463443|NCT02195583|Protective Agents|protective agents|mesh-ancestor
14463444|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463445|NCT02195583|Trace Elements|trace elements|mesh-ancestor
14463446|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
14463447|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14463448|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463449|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
14463450|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14463451|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14463452|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14463453|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14463454|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463455|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463456|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463457|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463458|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14463459|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463460|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
14463461|NCT02195895|Vitamin D|vitamin d|mesh-list
14463462|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
14463463|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
14463464|NCT02195895|Alendronate|alendronate|mesh-list
14463465|NCT02195895|Vitamins|vitamins|mesh-list
14463466|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
14463467|NCT02195895|Antacids|antacids|mesh-list
14463468|NCT02195895|Calcium|calcium|mesh-list
14463469|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
14463470|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463471|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14463472|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14463473|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463474|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463475|NCT02195921|Antiemetics|antiemetics|mesh-list
14463476|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
14463477|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463478|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463479|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463480|NCT02196168|Cisplatin|cisplatin|mesh-list
14463481|NCT02196168|Adavosertib|adavosertib|mesh-list
14463482|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463483|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463484|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463485|NCT02196259|Ketamine|ketamine|mesh-list
14463486|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
14463487|NCT02196259|Anesthetics|anesthetics|mesh-list
14463488|NCT02196259|Analgesics|analgesics|mesh-ancestor
14463489|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
14463490|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463491|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463492|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14463493|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
14463494|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463495|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14463496|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14463497|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463498|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463499|NCT02196324|Serlopitant|serlopitant|mesh-list
14752714|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752715|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
14752716|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14752717|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
14752718|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752719|NCT05334485|Bromides|bromides|mesh-list
14752720|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14752721|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
14752722|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14752723|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753766|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463500|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14752724|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752725|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
14752726|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752727|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752728|NCT05334472|Ofatumumab|ofatumumab|mesh-list
14752729|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752730|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
14752731|NCT05334329|Fludarabine|fludarabine|mesh-list
14752732|NCT05334329|Atezolizumab|atezolizumab|mesh-list
14752733|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
14752734|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14752735|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930687|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14930688|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
14930689|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930690|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930691|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
14930692|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930693|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930694|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930695|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
14930696|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930697|NCT01434849|Timolol|timolol|mesh-list
14930698|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14930699|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14930700|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
14463501|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463502|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930701|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930702|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930703|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930704|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14930705|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14930706|NCT01434862|Pramlintide|pramlintide|mesh-list
14930707|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14930708|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14463503|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463504|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
14463505|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
14463506|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463507|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463508|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463509|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
14463510|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
14463511|NCT02196558|Quetmolimab|quetmolimab|mesh-list
14463512|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463513|NCT02196701|Adalimumab|adalimumab|mesh-list
14463514|NCT02196701|Methotrexate|methotrexate|mesh-list
14463515|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14752736|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
14753767|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
14930709|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930710|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
14930711|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14930712|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14930713|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930714|NCT01434888|Timolol|timolol|mesh-list
14930715|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14930716|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14930717|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14930718|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14930719|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930720|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930721|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463516|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
14463517|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14463518|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463519|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14463520|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
14463521|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463522|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463523|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14463524|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463525|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14463526|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463527|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
14463528|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463529|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14463530|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463531|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
14463532|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
14463533|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14463534|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
14463535|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930722|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930723|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14930724|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14930725|NCT01434901|Bethanechol|bethanechol|mesh-list
14930726|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14930727|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
14463536|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463537|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14463538|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
14463539|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14463540|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14463541|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14463542|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
14463543|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463544|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463545|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14463546|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14463547|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14463548|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463549|NCT02196831|Tesamorelin|tesamorelin|mesh-list
14463550|NCT02196831|Growth Substances|growth substances|mesh-ancestor
14463551|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463552|NCT02196857|Azacitidine|azacitidine|mesh-list
14463553|NCT02196857|Sorafenib|sorafenib|mesh-list
14463554|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14463555|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
14463556|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463557|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463558|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463559|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14463560|NCT02197065|Atorvastatin|atorvastatin|mesh-list
14463561|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14463562|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14463563|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
14463564|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463565|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14463566|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14463567|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463568|NCT02197247|Rifampin|rifampin|mesh-list
14463569|NCT02197247|Osimertinib|osimertinib|mesh-list
14463570|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14463571|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
14463572|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14463573|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463574|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
14463575|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14463576|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463577|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463578|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14463579|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14463580|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14463581|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14463582|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14463583|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14463584|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463585|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14469826|NCT02299388|Incretins|incretins|mesh-ancestor
14463586|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14463587|NCT02197273|Epinephrine|epinephrine|mesh-list
14463588|NCT02197273|Fentanyl|fentanyl|mesh-list
14463589|NCT02197273|Morphine|morphine|mesh-list
14463590|NCT02197273|Bupivacaine|bupivacaine|mesh-list
14463591|NCT02197273|Ropivacaine|ropivacaine|mesh-list
14463592|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
14463593|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
14463594|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463595|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463596|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
14463597|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463598|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14463599|NCT02197273|Narcotics|narcotics|mesh-ancestor
14463600|NCT02197273|Analgesics|analgesics|mesh-ancestor
14463601|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14463602|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14463603|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
14463604|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14463605|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14463606|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
14463607|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463608|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463609|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14463610|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14463611|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
14463612|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14463613|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
14463614|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
14463615|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
14463616|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14463617|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463618|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
14463619|NCT02197273|Hormones|hormones|mesh-ancestor
14463620|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463621|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14463622|NCT02197273|Protective Agents|protective agents|mesh-ancestor
14463623|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14463624|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463625|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
14463626|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14463627|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463628|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
14463629|NCT02197416|Dabigatran|dabigatran|mesh-list
14463630|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
14463631|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14463632|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
14463633|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463634|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463635|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
14463636|NCT02197455|Tofacitinib|tofacitinib|mesh-list
14463637|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14463638|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463639|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463640|NCT02197520|Insulin|insulin|mesh-list
14463641|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14463642|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
14463643|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
14463644|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14463645|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463646|NCT02197767|Rituximab|rituximab|mesh-list
14463647|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14463648|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463649|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
14463650|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463651|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463652|NCT02197897|Tamoxifen|tamoxifen|mesh-list
14463653|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14463654|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
14469827|NCT02299388|Hormones|hormones|mesh-ancestor
14752737|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752738|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463655|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463656|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463657|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14463658|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463659|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14463660|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14463661|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14463662|NCT02198235|Dexamethasone|dexamethasone|mesh-list
14463663|NCT02198235|Buprenorphine|buprenorphine|mesh-list
14463664|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463665|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
14463666|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
14463667|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463668|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463669|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463670|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
14463671|NCT02198235|Hormones|hormones|mesh-ancestor
14463672|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463673|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14463674|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463675|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14463676|NCT02198235|Narcotics|narcotics|mesh-ancestor
14463677|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463678|NCT02198235|Analgesics|analgesics|mesh-ancestor
14463679|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
14463680|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14463681|NCT02198651|Adalimumab|adalimumab|mesh-list
14463682|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463683|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463684|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
14463685|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
14463686|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14463687|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14463688|NCT02199041|Prednisolone|prednisolone|mesh-list
14463689|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
14463690|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
14463691|NCT02199041|Melphalan|melphalan|mesh-list
14463692|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
14463693|NCT02199041|Thiotepa|thiotepa|mesh-list
14463694|NCT02199041|Fludarabine|fludarabine|mesh-list
14463695|NCT02199041|Tacrolimus|tacrolimus|mesh-list
14463696|NCT02199041|Lenograstim|lenograstim|mesh-list
14463697|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14463698|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
14463699|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463700|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
14463701|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463702|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463703|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14463704|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
14463705|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463706|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463707|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14463708|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14463709|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463710|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14463711|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14463712|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
14463713|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14463714|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463715|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463716|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
14463717|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
14463718|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463719|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463720|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
14463721|NCT02199041|Hormones|hormones|mesh-ancestor
14463722|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463723|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14463724|NCT02199041|Protective Agents|protective agents|mesh-ancestor
14463725|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14463726|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14463727|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
14463728|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14463729|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14463730|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463731|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
14463732|NCT02199080|Coagulants|coagulants|mesh-ancestor
14463733|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14463734|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463735|NCT02199314|Desflurane|desflurane|mesh-list
14463736|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14463737|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
14463738|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
14463739|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463740|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463741|NCT02199496|Ustekinumab|ustekinumab|mesh-list
14463742|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14463743|NCT02199509|Levetiracetam|levetiracetam|mesh-list
14463744|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
14463745|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
14463746|NCT02199574|Bupivacaine|bupivacaine|mesh-list
14463747|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
14463748|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
14463749|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463750|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463751|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
14463752|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463753|NCT02199652|Prazosin|prazosin|mesh-list
14463754|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14463755|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14463756|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14463757|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14463758|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
14463759|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463760|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463761|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463762|NCT02199743|Haloperidol|haloperidol|mesh-list
14463763|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
14463764|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14463765|NCT02199743|Perphenazine|perphenazine|mesh-list
14463766|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
14463767|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
14463768|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463769|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463770|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463771|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14463772|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14463773|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463774|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14463775|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14463776|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
14463777|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463778|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463779|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14463780|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14463781|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14463782|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14463783|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
14463784|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14463785|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14463786|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
14463787|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14463788|NCT02199964|Cyclosporine|cyclosporine|mesh-list
14463789|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
14463790|NCT02199964|Cyclosporins|cyclosporins|mesh-list
14463791|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463792|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463793|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463794|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
14463795|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463796|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
14463797|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463798|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
14463799|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463800|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14463801|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14463802|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14463803|NCT02200445|Aldesleukin|aldesleukin|mesh-list
14463804|NCT02200445|Interleukin-2|interleukin-2|mesh-list
14463805|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463806|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463807|NCT02200445|Analgesics|analgesics|mesh-ancestor
14463808|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
14463809|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463810|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463811|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14463812|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14463813|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
14463814|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463815|NCT02201108|Teriflunomide|teriflunomide|mesh-list
14463816|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463817|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463818|NCT02201108|Analgesics|analgesics|mesh-ancestor
14463819|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
14463820|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463821|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463822|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463823|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463824|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463825|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
14463826|NCT02201212|Everolimus|everolimus|mesh-list
14463827|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463828|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463829|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
14463830|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463831|NCT02201251|Topiramate|topiramate|mesh-list
14463832|NCT02201251|Levetiracetam|levetiracetam|mesh-list
14463833|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
14463834|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14463835|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463836|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
14463837|NCT02201329|Azacitidine|azacitidine|mesh-list
14463838|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14463839|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
14463840|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463841|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14463842|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14469828|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14469829|NCT02300077|Fentanyl|fentanyl|mesh-list
14469830|NCT02300077|Morphine|morphine|mesh-list
14469831|NCT02300077|Methadone|methadone|mesh-list
14469832|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14469833|NCT02300077|Narcotics|narcotics|mesh-ancestor
14469834|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14469835|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14469836|NCT02300077|Analgesics|analgesics|mesh-ancestor
14469837|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
14469838|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14469839|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14469840|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14469841|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
14469842|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
14930728|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14930729|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930730|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14930731|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14930732|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
14930733|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930734|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930735|NCT01434914|Octenidine|octenidine|mesh-list
14930736|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14469843|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
14930737|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14463843|NCT02201394|Aspirin|aspirin|mesh-list
14463844|NCT02201394|Ticagrelor|ticagrelor|mesh-list
14463845|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463846|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463847|NCT02201394|Analgesics|analgesics|mesh-ancestor
14463848|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
14463849|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463850|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463851|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463852|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463853|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14463854|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14463855|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463856|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14463857|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14463858|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463859|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
14463860|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14463861|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14463862|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14463863|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
14463864|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463865|NCT02201524|Abrocitinib|abrocitinib|mesh-list
14463866|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14463867|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463868|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463869|NCT02201771|Aspirin|aspirin|mesh-list
14463870|NCT02201771|Ticagrelor|ticagrelor|mesh-list
14463871|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463872|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463873|NCT02201771|Analgesics|analgesics|mesh-ancestor
14463874|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
14463875|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463876|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463877|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463878|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463879|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14463880|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14463881|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463882|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14463883|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14752739|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14752740|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
14463884|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463885|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
14463886|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14463887|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14463888|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14463889|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
14752741|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752742|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14752743|NCT05334316|Dexamethasone|dexamethasone|mesh-list
14752744|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752745|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
14752746|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
14752747|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752748|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752749|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14752750|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
14752751|NCT05334316|Hormones|hormones|mesh-ancestor
14752752|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752753|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14752754|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752755|NCT05334277|Bevacizumab|bevacizumab|mesh-list
14752756|NCT05334277|Carboplatin|carboplatin|mesh-list
14752757|NCT05334277|Pemetrexed|pemetrexed|mesh-list
14752758|NCT05334277|Aflutinib|aflutinib|mesh-list
14752759|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752760|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752761|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14752762|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14752763|NCT05334277|Growth Substances|growth substances|mesh-ancestor
14752764|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752765|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
14752766|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752767|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752768|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14752769|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14752770|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14752771|NCT05334251|Anesthetics|anesthetics|mesh-list
14752772|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752773|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752774|NCT05334108|Ecopipam|ecopipam|mesh-list
14752775|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14752776|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14752777|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752778|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463890|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463891|NCT02201784|Ropivacaine|ropivacaine|mesh-list
14463892|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
14463893|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
14463894|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
14463895|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14463896|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463897|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
14463898|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463899|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
14463900|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14463901|NCT02201901|Velpatasvir|velpatasvir|mesh-list
14463902|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
14463903|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463904|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
14463905|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14930738|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14930739|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
14930740|NCT01435083|Coagulants|coagulants|mesh-ancestor
14930741|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14930742|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
14930743|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930744|NCT01435161|Telmisartan|telmisartan|mesh-list
14930745|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
14930746|NCT01435161|Nifedipine|nifedipine|mesh-list
14930747|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14930748|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14930749|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930750|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14930751|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14930752|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14930753|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930754|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
14930755|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
14930756|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14930757|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14930758|NCT01435200|Hematinics|hematinics|mesh-ancestor
14930759|NCT01435213|Insulin|insulin|mesh-list
14930760|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14930761|NCT01435213|Ketamine|ketamine|mesh-list
14930762|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14930763|NCT01435213|Atipamezole|atipamezole|mesh-list
14930764|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14930765|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930766|NCT01435213|Analgesics|analgesics|mesh-ancestor
14463906|NCT02201940|Velpatasvir|velpatasvir|mesh-list
14463907|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
14930767|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
14930768|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463908|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930769|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14463909|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
14930770|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14930771|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
14930772|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
14930773|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14930774|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14930775|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14930776|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14930777|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930778|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14930779|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14930780|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14930781|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
14930782|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14930783|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14463910|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
14463911|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463912|NCT02202135|Vancomycin|vancomycin|mesh-list
14463913|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14463914|NCT02202135|Aztreonam|aztreonam|mesh-list
14463915|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14463916|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463917|NCT02202161|Metformin|metformin|mesh-list
14463918|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14930784|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14463919|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14752779|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14463920|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463921|NCT02202161|Incretins|incretins|mesh-ancestor
14463922|NCT02202161|Hormones|hormones|mesh-ancestor
14463923|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14463924|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14463925|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
14463926|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463927|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463928|NCT02202499|Varenicline|varenicline|mesh-list
14463929|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14463930|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14463931|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463932|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752780|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14752781|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
14752782|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752783|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752784|NCT05334043|Curcumin|curcumin|mesh-list
14752785|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14752786|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14752787|NCT05334043|Analgesics|analgesics|mesh-ancestor
14752788|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
14752789|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752790|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752791|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752792|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752793|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752794|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752795|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752796|NCT05334004|Ritonavir|ritonavir|mesh-list
14752797|NCT05334004|Lopinavir|lopinavir|mesh-list
14752798|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14752799|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14752800|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
14463933|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463934|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463935|NCT02202551|Amantadine|amantadine|mesh-list
14463936|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14752801|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14463937|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14463938|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
14463939|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463940|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
14463941|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463942|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463943|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463944|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463945|NCT02202551|Analgesics|analgesics|mesh-ancestor
14463946|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
14463947|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463948|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
14463949|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14463950|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14930785|NCT01435252|Cetuximab|cetuximab|mesh-list
14930786|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14930787|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930788|NCT01435291|Tacrolimus|tacrolimus|mesh-list
14930789|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930790|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
14463951|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14463952|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14463953|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
14463954|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14463955|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463956|NCT02202837|Etanercept|etanercept|mesh-list
14463957|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463958|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463959|NCT02202837|Analgesics|analgesics|mesh-ancestor
14463960|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
14463961|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463962|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463963|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463964|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463965|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463966|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463967|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
14463968|NCT02202850|Etanercept|etanercept|mesh-list
14463969|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14463970|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463971|NCT02202850|Analgesics|analgesics|mesh-ancestor
14463972|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
14463973|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463974|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463975|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14463976|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14463977|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14463978|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14463979|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
14463980|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
14463981|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
14463982|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14463983|NCT02203019|Fentanyl|fentanyl|mesh-list
14463984|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
14463985|NCT02203019|Propofol|propofol|mesh-list
14463986|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14463987|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752802|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752803|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14752804|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14752805|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
14752806|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752807|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14752808|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14752809|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
14752810|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14752811|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752812|NCT05333744|Prednisone|prednisone|mesh-list
14752813|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14752814|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
14752815|NCT05333744|Hormones|hormones|mesh-ancestor
14463988|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14463989|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14463990|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
14463991|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
14463992|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14463993|NCT02203019|Analgesics|analgesics|mesh-ancestor
14463994|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
14463995|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14463996|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14752816|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752817|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752818|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14752819|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752820|NCT05333731|Oxytocin|oxytocin|mesh-list
14752821|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
14752822|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14752823|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752824|NCT05333640|Sirolimus|sirolimus|mesh-list
14752825|NCT05333640|Paclitaxel|paclitaxel|mesh-list
14463997|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14752826|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14752827|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752828|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
14752829|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
14752830|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
14752831|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752832|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14752833|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14752834|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14463998|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14463999|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14464000|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752835|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
14464001|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464002|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14464003|NCT02203019|Narcotics|narcotics|mesh-ancestor
14464004|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14464005|NCT02203032|Ustekinumab|ustekinumab|mesh-list
14464006|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14464007|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
14464008|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
14464009|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464010|NCT02203149|Grazoprevir|grazoprevir|mesh-list
14464011|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
14464012|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464013|NCT02203331|Anastrozole|anastrozole|mesh-list
14464014|NCT02203331|Leuprolide|leuprolide|mesh-list
14464015|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
14464016|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14464017|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464018|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14464019|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14464020|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464021|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464022|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14464023|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
14464024|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14464025|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464026|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14464027|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
14464028|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14464029|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14464030|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
14464031|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14464032|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14464033|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14464034|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14464035|NCT02203565|Eusol|eusol|mesh-list
14464036|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14464037|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
14464038|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464039|NCT02203578|Romidepsin|romidepsin|mesh-list
14464040|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14464041|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464042|NCT02203591|Ethanol|ethanol|mesh-list
14464043|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
14464044|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14464045|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14464046|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14464047|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464048|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464049|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
14464050|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
14464051|NCT02203630|Phenylephrine|phenylephrine|mesh-list
14464052|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
14464053|NCT02203630|Norepinephrine|norepinephrine|mesh-list
14464054|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14464055|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
14464056|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
14464057|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464058|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464059|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
14464060|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14464061|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
14464062|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14464063|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14464064|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14464065|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14752836|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752837|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
14752838|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753768|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753769|NCT04991493|Tramadol|tramadol|mesh-list
14753770|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14753771|NCT04991493|Narcotics|narcotics|mesh-ancestor
14753772|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753773|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753774|NCT04991493|Analgesics|analgesics|mesh-ancestor
14753775|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
14753776|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753777|NCT04989283|Paclitaxel|paclitaxel|mesh-list
14753778|NCT04989283|Etoposide|etoposide|mesh-list
14753779|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
14753780|NCT04989283|Cisplatin|cisplatin|mesh-list
14753781|NCT04989283|Carboplatin|carboplatin|mesh-list
14753782|NCT04989283|Pemetrexed|pemetrexed|mesh-list
14753783|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14753784|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
14753785|NCT04989283|Atezolizumab|atezolizumab|mesh-list
14753786|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14753787|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14464066|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
14464067|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464068|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464069|NCT02203630|Protective Agents|protective agents|mesh-ancestor
14464070|NCT02203786|Haloperidol|haloperidol|mesh-list
14752839|NCT05333419|Latanoprost|latanoprost|mesh-list
14752840|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14464071|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
14464072|NCT02203786|Fluphenazine|fluphenazine|mesh-list
14464073|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
14464074|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14464075|NCT02203786|Amphetamine|amphetamine|mesh-list
14464076|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
14464077|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
14464078|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
14752841|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14752842|NCT05327647|Bicalutamide|bicalutamide|mesh-list
14752843|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
14752844|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
14464079|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464080|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464081|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464082|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14464083|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14464084|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464085|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464086|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14464087|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
14464088|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464089|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464090|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14752845|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
14752846|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14752847|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752848|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752849|NCT05327595|Midazolam|midazolam|mesh-list
14752850|NCT05327595|Atorvastatin|atorvastatin|mesh-list
14752851|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14752852|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14752853|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
14752854|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752855|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14752856|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14752857|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752858|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14752859|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14752860|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752861|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752862|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14752863|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14752864|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14752865|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14752866|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
14752867|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
14752868|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
14752869|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
14752870|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752876|NCT05326425|Lazertinib|lazertinib|mesh-list
14752877|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14752878|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14752879|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752880|NCT05326360|Ramosetron|ramosetron|mesh-list
14752881|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
14752882|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
14752883|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752884|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752885|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14464091|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14464092|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
14464093|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14464094|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14464095|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14464096|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464097|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14464098|NCT02203838|Risperidone|risperidone|mesh-list
14464099|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14464100|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
14464101|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464102|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464103|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464104|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14464105|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14464106|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464107|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14464108|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14464109|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
14464110|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14464111|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14464112|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14464113|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464114|NCT02204410|Methylphenidate|methylphenidate|mesh-list
14464115|NCT02204410|Amphetamine|amphetamine|mesh-list
14464116|NCT02204410|Adderall|adderall|mesh-list
14464117|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
14464118|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14464119|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464120|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14464121|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14464122|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14464123|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464124|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
14464125|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464126|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
14464127|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
14464128|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464129|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
14464130|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14464131|NCT02204982|Rituximab|rituximab|mesh-list
14464132|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464133|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464134|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
14464135|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464136|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464137|NCT02205333|Rituximab|rituximab|mesh-list
14752886|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14752887|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
14752888|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14752889|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464138|NCT02205333|Durvalumab|durvalumab|mesh-list
14464139|NCT02205333|Tremelimumab|tremelimumab|mesh-list
14464140|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464141|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14464142|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
14464143|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464144|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14464145|NCT02205801|Bupivacaine|bupivacaine|mesh-list
14464146|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
14464147|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
14464148|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464149|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464150|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
14464151|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464152|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
14752890|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
14464153|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14464154|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14752891|NCT05325853|Propoxycaine|propoxycaine|mesh-list
14464155|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464156|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14752892|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
14752893|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
14464157|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14464158|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
14752894|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752895|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752896|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
14752897|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752898|NCT05325164|Morphine|morphine|mesh-list
14752899|NCT05325164|Methadone|methadone|mesh-list
14752900|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14752901|NCT05325164|Narcotics|narcotics|mesh-ancestor
14752902|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752903|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752904|NCT05325164|Analgesics|analgesics|mesh-ancestor
14752905|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
14752906|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752907|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
14752908|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
14752909|NCT05324059|Pregabalin|pregabalin|mesh-list
14752910|NCT05324059|Tramadol|tramadol|mesh-list
14752911|NCT05324059|Analgesics|analgesics|mesh-ancestor
14752912|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
14752913|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14752914|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752915|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
14752916|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14752917|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14752918|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752919|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14752920|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14752921|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14752922|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752923|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14752924|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14752925|NCT05324059|Narcotics|narcotics|mesh-ancestor
14752926|NCT05323708|Denosumab|denosumab|mesh-list
14752927|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14752928|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752929|NCT05322902|Propofol|propofol|mesh-list
14752930|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14752931|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14752932|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464159|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464160|NCT02205983|Acetaminophen|acetaminophen|mesh-list
14464161|NCT02205983|Hydromorphone|hydromorphone|mesh-list
14464162|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14464163|NCT02205983|Analgesics|analgesics|mesh-ancestor
14464164|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
14464165|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14464166|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464167|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
14464168|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14464169|NCT02205983|Narcotics|narcotics|mesh-ancestor
14464170|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14464171|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
14464172|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14464173|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
14464174|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930791|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464175|NCT02206152|Expectorants|expectorants|mesh-ancestor
14930792|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14930793|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930794|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930795|NCT01435343|Cytarabine|cytarabine|mesh-list
14930796|NCT01435343|Plerixafor|plerixafor|mesh-list
14930797|NCT01435343|Fludarabine|fludarabine|mesh-list
14930798|NCT01435343|Idarubicin|idarubicin|mesh-list
14930799|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14930800|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14930801|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
14930802|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14930803|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14930804|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
14930805|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14930806|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
14930807|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14930808|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14930809|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14930810|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14930811|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14930812|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14752933|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14752934|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
14752935|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
14752936|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
14752937|NCT05322733|Fludarabine|fludarabine|mesh-list
14752938|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
14752939|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14752940|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
14752941|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14752942|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14752943|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14752944|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
14752945|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14752946|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14752947|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14752948|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14464176|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
14464177|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14464178|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
14464179|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464180|NCT02206152|Protective Agents|protective agents|mesh-ancestor
14464181|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464182|NCT02206152|Antidotes|antidotes|mesh-ancestor
14464183|NCT02206620|Donepezil|donepezil|mesh-list
14464184|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14464185|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14464186|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14464187|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
14464188|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14464189|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14464190|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
14464191|NCT02206685|Methadone|methadone|mesh-list
14752949|NCT05321875|Candesartan|candesartan|mesh-list
14464192|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13955447|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
13955448|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
13955449|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955450|NCT03189732|Metformin|metformin|mesh-list
13955451|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13955452|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955453|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
13955454|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14470180|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470181|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470182|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
14470183|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470184|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470185|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
14470186|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955455|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
13955456|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955457|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955458|NCT03189069|Warfarin|warfarin|mesh-list
13955459|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
13955460|NCT03189069|Dabigatran|dabigatran|mesh-list
13955461|NCT03189069|Apixaban|apixaban|mesh-list
13955462|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
13955463|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13955464|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
13955465|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13955466|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
13955467|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955468|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955469|NCT03189329|Lidocaine|lidocaine|mesh-list
13955470|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
13955471|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
13955472|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
13955473|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955474|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955475|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
13955476|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955477|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13955478|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13955479|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13955480|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955481|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955482|NCT03188978|Atorvastatin|atorvastatin|mesh-list
13955483|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14470187|NCT02305758|Bevacizumab|bevacizumab|mesh-list
14470188|NCT02305758|Fluorouracil|fluorouracil|mesh-list
14470189|NCT02305758|Veliparib|veliparib|mesh-list
14470190|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470191|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470192|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14470193|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14470194|NCT02305758|Growth Substances|growth substances|mesh-ancestor
14470195|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470196|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
14470197|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
14470198|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955484|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14753848|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470199|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14470200|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470201|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
14470202|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14470203|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470204|NCT02305797|Lorazepam|lorazepam|mesh-list
14470205|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
14470206|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
14470207|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
14470208|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470209|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470210|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14470211|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13955485|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
13955486|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955487|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13955488|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13955489|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955490|NCT03188835|Glycerol|glycerol|mesh-list
13955491|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13955492|NCT03188835|Protective Agents|protective agents|mesh-ancestor
13955493|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955494|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
13955495|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
13955496|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13955497|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
13955498|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955499|NCT03188445|Protective Agents|protective agents|mesh-ancestor
14026338|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026339|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14026340|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14026341|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
14026342|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
14026343|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026344|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14026345|NCT02743975|Bevacizumab|bevacizumab|mesh-list
14026346|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955500|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955501|NCT03188445|Vitamins|vitamins|mesh-ancestor
13955502|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
13955503|NCT03188445|Trace Elements|trace elements|mesh-ancestor
13955504|NCT03188445|Hematinics|hematinics|mesh-ancestor
13955505|NCT03188471|Aspirin|aspirin|mesh-list
13955506|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955507|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955508|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955509|NCT03188471|Analgesics|analgesics|mesh-ancestor
13955510|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
13955511|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955512|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955513|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955514|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13955515|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13955516|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955517|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13955518|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13866397|NCT03700229|Rituximab|rituximab|mesh-list
13866398|NCT03700229|Bortezomib|bortezomib|mesh-list
13866399|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866400|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866401|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
13866402|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866403|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866404|NCT03700177|Dexamethasone|dexamethasone|mesh-list
13866405|NCT03700177|Ropivacaine|ropivacaine|mesh-list
13866406|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866407|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
13866408|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
13866409|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866410|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866411|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13866412|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
13866413|NCT03700177|Hormones|hormones|mesh-ancestor
13866414|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13866415|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13866416|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866417|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
13866418|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
13866419|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866420|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
13866421|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13866422|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
13866423|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866424|NCT03700099|Docetaxel|docetaxel|mesh-list
13866425|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866426|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
13866427|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
13866428|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
13955519|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866429|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866430|NCT03699956|Carboplatin|carboplatin|mesh-list
13866431|NCT03699956|Etoposide|etoposide|mesh-list
13866432|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866433|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13866434|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13866435|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13866436|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470212|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470213|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14470214|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14470215|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14470216|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
14470217|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
14470218|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470219|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470220|NCT02305849|Methotrexate|methotrexate|mesh-list
14470221|NCT02305849|Peficitinib|peficitinib|mesh-list
13866437|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866438|NCT03699904|Valacyclovir|valacyclovir|mesh-list
13866439|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
13866440|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866441|NCT03699839|Vaccines|vaccines|mesh-list
13866442|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
13866443|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866444|NCT03699774|Firuglipel|firuglipel|mesh-list
13866445|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13866446|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13866447|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13866448|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
13866449|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866450|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13866451|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13866452|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866453|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13866454|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866455|NCT03699696|Propofol|propofol|mesh-list
13866456|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13866457|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866458|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866459|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13866460|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
13866461|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
13866462|NCT03699618|Bevacizumab|bevacizumab|mesh-list
13866463|NCT03699618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866464|NCT03699618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753856|NCT04940065|Ofatumumab|ofatumumab|mesh-list
14753857|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753858|NCT04939844|Lenalidomide|lenalidomide|mesh-list
14753859|NCT04939844|Bortezomib|bortezomib|mesh-list
14753860|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
14753861|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753862|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14753863|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14753864|NCT04939844|Growth Substances|growth substances|mesh-ancestor
14753865|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753866|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753867|NCT04931602|Vitamin D|vitamin d|mesh-list
14753868|NCT04931602|Vitamins|vitamins|mesh-ancestor
14753869|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
14753870|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753871|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14753872|NCT04928846|Docetaxel|docetaxel|mesh-list
13866465|NCT03699618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13866466|NCT03699618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13866467|NCT03699618|Growth Substances|growth substances|mesh-ancestor
13866468|NCT03699618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866469|NCT03699618|Growth Inhibitors|growth inhibitors|mesh-ancestor
13955520|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
13955521|NCT03188510|Mirikizumab|mirikizumab|mesh-list
14470222|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14753873|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866470|NCT03699449|Paclitaxel|paclitaxel|mesh-list
13866471|NCT03699449|Durvalumab|durvalumab|mesh-list
13866472|NCT03699449|Olaparib|olaparib|mesh-list
13866473|NCT03699449|Tremelimumab|tremelimumab|mesh-list
13866474|NCT03699449|Cediranib|cediranib|mesh-list
13866475|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13866476|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13866477|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866478|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
13866479|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
13866480|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
13866481|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866482|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866483|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
13866484|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866485|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13866486|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866487|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13866488|NCT03699423|Atropine|atropine|mesh-list
13866489|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13866490|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13866491|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13866492|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13866493|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13866494|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
13866495|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866496|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866497|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13866498|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
13866499|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
13866500|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
13866501|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13866502|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13866503|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
13866504|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866505|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866506|NCT03699384|Azacitidine|azacitidine|mesh-list
13866507|NCT03699384|Avelumab|avelumab|mesh-list
13866508|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13866509|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
13866510|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866511|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866512|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866513|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866514|NCT03699332|Labetuzumab|labetuzumab|mesh-list
13866515|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866516|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866517|NCT03699293|Aspirin|aspirin|mesh-list
13866518|NCT03699293|Celecoxib|celecoxib|mesh-list
13866519|NCT03699293|Naproxen|naproxen|mesh-list
13866520|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13866521|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13866522|NCT03699293|Analgesics|analgesics|mesh-ancestor
13866523|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
13866524|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866525|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866526|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866527|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866528|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13866529|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13866530|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866531|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13866532|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13866533|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866534|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
13866535|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13866536|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
13866537|NCT03699254|Valganciclovir|valganciclovir|mesh-list
13866538|NCT03699254|Ganciclovir|ganciclovir|mesh-list
13866539|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13866540|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
13866541|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866542|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13866543|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866544|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866545|NCT03699215|Simendan|simendan|mesh-list
13866546|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13866547|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
13866548|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13866549|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13866550|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866551|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866552|NCT03699215|Protective Agents|protective agents|mesh-ancestor
13866553|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866554|NCT03699202|Ziresovir|ziresovir|mesh-list
13866555|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
13866556|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866557|NCT03699033|Paclitaxel|paclitaxel|mesh-list
13866558|NCT03699033|Carboplatin|carboplatin|mesh-list
13866559|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13866560|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866561|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
13866562|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
13866563|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
13866564|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866565|NCT03698916|Celecoxib|celecoxib|mesh-list
13866566|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13866567|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13866568|NCT03698916|Analgesics|analgesics|mesh-ancestor
13866569|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
13866570|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866571|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866572|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866573|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866574|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13866575|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13866576|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866577|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866578|NCT03698851|Methamphetamine|methamphetamine|mesh-list
13866579|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13866580|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866581|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
13866582|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
13866583|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866584|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
13866585|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866586|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866587|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
13866588|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13866589|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13866590|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13866591|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13866592|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
13866593|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13866594|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13866595|NCT03698734|Analgesics|analgesics|mesh-ancestor
13866596|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
13866597|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866598|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866599|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866600|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866601|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13866602|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
13866603|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866604|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13866605|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
13866606|NCT03698695|Mefloquine|mefloquine|mesh-list
13866607|NCT03698695|Donepezil|donepezil|mesh-list
13866608|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13866609|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866610|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866611|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
13866612|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866613|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866614|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
13866615|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
13866616|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13866617|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13866618|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866619|NCT03698682|Levofloxacin|levofloxacin|mesh-list
13866620|NCT03698682|Ofloxacin|ofloxacin|mesh-list
13866621|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13866622|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866623|NCT03698682|Renal Agents|renal agents|mesh-ancestor
13866624|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13866625|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13866626|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13866627|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866628|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866629|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866630|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13866631|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14026347|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026348|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14026349|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14026350|NCT02743975|Growth Substances|growth substances|mesh-ancestor
14026351|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026352|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
14026353|NCT02743663|Albuterol|albuterol|mesh-list
14026354|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
14026355|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
14026356|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026357|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026358|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14026359|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
14026360|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
14026361|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14026362|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14026363|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14026364|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14026365|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
14026366|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753874|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14026367|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026368|NCT02743572|Iron|iron|mesh-list
14026369|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14026370|NCT02743572|Trace Elements|trace elements|mesh-ancestor
14026371|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
14753875|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753876|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14026372|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026373|NCT02743572|Hematinics|hematinics|mesh-ancestor
14026374|NCT02743598|Liraglutide|liraglutide|mesh-list
14026375|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026376|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026377|NCT02743598|Incretins|incretins|mesh-ancestor
14026378|NCT02743598|Hormones|hormones|mesh-ancestor
14026379|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026380|NCT02743260|Metformin|metformin|mesh-list
14753877|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753878|NCT04921943|Azithromycin|azithromycin|mesh-list
14753879|NCT04921943|Rifampin|rifampin|mesh-list
14753880|NCT04921943|Ethambutol|ethambutol|mesh-list
14753881|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13866632|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
13866633|NCT03698669|Narcotics|narcotics|mesh-ancestor
13866634|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866635|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866636|NCT03698669|Analgesics|analgesics|mesh-ancestor
13866637|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
13866638|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866639|NCT03698630|Dexamethasone|dexamethasone|mesh-list
13866640|NCT03698630|Prednisolone|prednisolone|mesh-list
13866641|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13866642|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
13866643|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13866644|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
13866645|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13866646|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
13866647|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866648|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
13866649|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
13866650|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866651|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866652|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14753882|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866653|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
13866654|NCT03698630|Hormones|hormones|mesh-ancestor
13866655|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13866656|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13866657|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866658|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13866659|NCT03698630|Protective Agents|protective agents|mesh-ancestor
13866660|NCT03698617|Propofol|propofol|mesh-list
13866661|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13866662|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866663|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866664|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13866665|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
13866666|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
13866667|NCT03698513|Aspirin|aspirin|mesh-list
13866668|NCT03698513|Clopidogrel|clopidogrel|mesh-list
13866669|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13866670|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13866671|NCT03698513|Analgesics|analgesics|mesh-ancestor
13866672|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
13866673|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866674|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866675|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866676|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866677|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13866678|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13866679|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866680|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13866681|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13866682|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866683|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
13866684|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13866685|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13866686|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13866687|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
13866688|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866689|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
13866690|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
13866691|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
13866692|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
13866693|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866694|NCT03698474|Analgesics|analgesics|mesh-ancestor
13866695|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
13866696|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866697|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866698|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
13866699|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866700|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13866701|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
13866702|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13866703|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13866704|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13866705|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
13866706|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13866707|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
13866708|NCT03698474|Protective Agents|protective agents|mesh-ancestor
13866709|NCT03698474|Vitamins|vitamins|mesh-ancestor
13866710|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
13866711|NCT03698474|Cathartics|cathartics|mesh-ancestor
13866712|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13866713|NCT03698461|Leucovorin|leucovorin|mesh-list
13866714|NCT03698461|Bevacizumab|bevacizumab|mesh-list
13866715|NCT03698461|Fluorouracil|fluorouracil|mesh-list
13866716|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
13866717|NCT03698461|Atezolizumab|atezolizumab|mesh-list
13866718|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
13866719|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866720|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866721|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13866722|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13866723|NCT03698461|Growth Substances|growth substances|mesh-ancestor
13866724|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866725|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
13866726|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
13866727|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866728|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13866729|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13866730|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
13866731|NCT03698461|Antidotes|antidotes|mesh-ancestor
13866732|NCT03698461|Protective Agents|protective agents|mesh-ancestor
13866733|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
13866734|NCT03698461|Vitamins|vitamins|mesh-ancestor
13866735|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
13866736|NCT03698435|Valganciclovir|valganciclovir|mesh-list
13866737|NCT03698435|Ganciclovir|ganciclovir|mesh-list
13866738|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13866739|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
13866740|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866741|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13866742|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866743|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866744|NCT03698383|Trastuzumab|trastuzumab|mesh-list
13866745|NCT03698383|Gedatolisib|gedatolisib|mesh-list
13866746|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866747|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866748|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13866749|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866750|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866751|NCT03698292|Metoclopramide|metoclopramide|mesh-list
13866752|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
13866753|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
13866754|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866755|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866756|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13866757|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13866758|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13866759|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
13866760|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866761|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866762|NCT03698227|Doxorubicin|doxorubicin|mesh-list
13866763|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
13866764|NCT03698227|Razoxane|razoxane|mesh-list
13866765|NCT03698227|Olaratumab|olaratumab|mesh-list
13866766|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13866767|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866768|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13866769|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13866770|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866771|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866772|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13866773|NCT03698227|Protective Agents|protective agents|mesh-ancestor
13866774|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866775|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
13866776|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
13866777|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14470223|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
14470224|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14470225|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470226|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13866778|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13866779|NCT03697889|Naproxen|naproxen|mesh-list
13866780|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13866781|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13866782|NCT03697889|Analgesics|analgesics|mesh-ancestor
13866783|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
13866784|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866785|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866786|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866787|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866788|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
13866789|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14470227|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
13866790|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963002|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
13866791|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866792|NCT03697850|Atezolizumab|atezolizumab|mesh-list
13866793|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955522|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955523|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955524|NCT03188510|Analgesics|analgesics|mesh-ancestor
13955525|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
13955526|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955527|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955528|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955529|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955530|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13955531|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955532|NCT03188198|Prednisone|prednisone|mesh-list
13955533|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
13955534|NCT03188198|Rituximab|rituximab|mesh-list
13955535|NCT03188198|Doxorubicin|doxorubicin|mesh-list
13955536|NCT03188198|Etoposide|etoposide|mesh-list
13955537|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
13955538|NCT03188198|Vincristine|vincristine|mesh-list
13955539|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955540|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
13955541|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955542|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955543|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13955544|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
13955545|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955546|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955547|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13955548|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955549|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13955550|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13955551|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13955552|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955553|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955554|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
13955555|NCT03188198|Hormones|hormones|mesh-ancestor
13955556|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955557|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13955558|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13955559|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
13955560|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
13955561|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
13955562|NCT03188289|Chitosan|chitosan|mesh-list
13955563|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
13955564|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13955565|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
13955566|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955567|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
13955568|NCT03188289|Protective Agents|protective agents|mesh-ancestor
13955569|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13955570|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13955571|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
13955572|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955573|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13955574|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
13955575|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
13955576|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
13955577|NCT03188289|Coagulants|coagulants|mesh-ancestor
13955578|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
13955579|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13955580|NCT03188276|Ledipasvir|ledipasvir|mesh-list
13955581|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
13955582|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955583|NCT03188159|Vinorelbine|vinorelbine|mesh-list
13955584|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13955585|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955586|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
13955587|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
13955588|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
13955589|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955590|NCT03188172|Dexamethasone|dexamethasone|mesh-list
13955591|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
14026381|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13955592|NCT03188172|Melphalan|melphalan|mesh-list
13955593|NCT03188172|Lenalidomide|lenalidomide|mesh-list
13955594|NCT03188172|Bortezomib|bortezomib|mesh-list
13955595|NCT03188172|Daratumumab|daratumumab|mesh-list
13866794|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
13866795|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
13866796|NCT03697824|Fludarabine|fludarabine|mesh-list
13866797|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13866798|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
13866799|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866800|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866801|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13866802|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
13866803|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866804|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866805|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13866806|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866807|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13866808|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13866809|NCT03697746|Acetaminophen|acetaminophen|mesh-list
13866810|NCT03697746|Ibuprofen|ibuprofen|mesh-list
13866811|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13866812|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13866813|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13866814|NCT03697746|Analgesics|analgesics|mesh-ancestor
13866815|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
13866816|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866817|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866818|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13866819|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13866820|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13866821|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866822|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866823|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
13866824|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
13866825|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13866826|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13866827|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866828|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
13866829|NCT03697681|Coagulants|coagulants|mesh-ancestor
13866830|NCT03697668|Piperaquine|piperaquine|mesh-list
13866831|NCT03697668|Artenimol|artenimol|mesh-list
13866832|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
13866833|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866834|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13866835|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866836|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866837|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
13866838|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13866839|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13866840|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866841|NCT03697655|Daratumumab|daratumumab|mesh-list
13866842|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866843|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
13866844|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
13866845|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866846|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866847|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866848|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
13866849|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
13866850|NCT03697564|Gemcitabine|gemcitabine|mesh-list
13866851|NCT03697564|Nivolumab|nivolumab|mesh-list
13866852|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13866853|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
13866854|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866855|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866856|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
13866857|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866858|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866859|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13866860|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
13866861|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866862|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866863|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13866864|NCT03697408|Everolimus|everolimus|mesh-list
13866865|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866866|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13866867|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
13866868|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866869|NCT03697265|Pregnanolone|pregnanolone|mesh-list
13866870|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
13866871|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866872|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866873|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
13866874|NCT03697239|Gemcitabine|gemcitabine|mesh-list
13866875|NCT03697239|Paclitaxel|paclitaxel|mesh-list
13866876|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13866877|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13866878|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866879|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
13866880|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
13866881|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
13866882|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866883|NCT03697239|Vitamins|vitamins|mesh-ancestor
13866884|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
13866885|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866886|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13866887|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
13866888|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
13866889|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866890|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866891|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13866892|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
13866893|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
13866894|NCT03697239|Protective Agents|protective agents|mesh-ancestor
13866895|NCT03697161|Gaboxadol|gaboxadol|mesh-list
13866896|NCT03697161|Analgesics|analgesics|mesh-ancestor
13866897|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
13866898|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13866899|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866900|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
13866901|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
13866902|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
13866903|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866904|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866905|NCT03697057|Anesthetics|anesthetics|mesh-list
13866906|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866907|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866908|NCT03697044|Irinotecan|irinotecan|mesh-list
13866909|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13866910|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13866911|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866912|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866913|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866914|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
13866915|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
13866916|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13866917|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866918|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866919|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
13866920|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13866921|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866922|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866923|NCT03696940|Atorvastatin|atorvastatin|mesh-list
13866924|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13866925|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13866926|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
13866927|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866928|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13866929|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13866930|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866931|NCT03696901|Dalbavancin|dalbavancin|mesh-list
13866932|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13866933|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866934|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
13866935|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
13866936|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13866937|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866938|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866939|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
13866940|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13866941|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866942|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866943|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
13866944|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13866945|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13866946|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866947|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13866948|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13866949|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13866950|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866951|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866952|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13866953|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
13866954|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13866955|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866956|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13866957|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13866958|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13866959|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
13866960|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13866961|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13866962|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13866963|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866964|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
13866965|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866966|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866967|NCT03696290|Aztreonam|aztreonam|mesh-list
13866968|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13866969|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13866970|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
13866971|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13866972|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13866973|NCT03696186|Phenobarbital|phenobarbital|mesh-list
13866974|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
13866975|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13866976|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866977|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866978|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13866979|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13866980|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13866981|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13866982|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
13866983|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
13866984|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13866985|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14753883|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13866986|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13866987|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13866988|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
13866989|NCT03696121|Coagulants|coagulants|mesh-ancestor
13866990|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13866991|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
13866992|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866993|NCT03696095|Ropivacaine|ropivacaine|mesh-list
14470228|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470229|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470230|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470231|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470232|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14470233|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470234|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
14470235|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753884|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
14753885|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
13866994|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
13866995|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
13866996|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13866997|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13866998|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
13866999|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955596|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955597|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
13955598|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955599|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955600|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13955601|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
13955602|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955603|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955604|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13955605|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955606|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
13955607|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
13955608|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955609|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955610|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
13955611|NCT03188172|Hormones|hormones|mesh-ancestor
13955612|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955613|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13955614|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13955615|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13955616|NCT03188172|Growth Substances|growth substances|mesh-ancestor
13955617|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
13955618|NCT03187912|Riboflavin|riboflavin|mesh-list
13955619|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
13955620|NCT03187912|Vitamins|vitamins|mesh-ancestor
13955621|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
13955622|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955623|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13955624|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
13955625|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13955626|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13955627|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963003|NCT02723994|Vitamins|vitamins|mesh-ancestor
13963004|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
13963005|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13963006|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
13963007|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
13963008|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
13963009|NCT02677922|Azacitidine|azacitidine|mesh-list
13963010|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13963011|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
13963012|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963013|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963014|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963015|NCT02669173|Bevacizumab|bevacizumab|mesh-list
13963016|NCT02669173|Capecitabine|capecitabine|mesh-list
13963017|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963018|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963019|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13963020|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13963021|NCT02669173|Growth Substances|growth substances|mesh-ancestor
13963022|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963023|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
13963024|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13963025|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
13963026|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963027|NCT02642315|Gabapentin|gabapentin|mesh-list
13963028|NCT02642315|Analgesics|analgesics|mesh-ancestor
13963029|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
13963030|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963031|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963032|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
13963033|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13963034|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13963035|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963036|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13963037|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13963038|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13963039|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963040|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963041|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
13963042|NCT02631447|Nivolumab|nivolumab|mesh-list
13867000|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
13867001|NCT03695952|Nivolumab|nivolumab|mesh-list
13867002|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13867003|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867004|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867005|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867006|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
13867007|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13867008|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
13867009|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
13867010|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867011|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867012|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867013|NCT03695887|Analgesics|analgesics|mesh-ancestor
13867014|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
13867015|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867016|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13867017|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13867018|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867019|NCT03695835|Sargramostim|sargramostim|mesh-list
13867020|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
13867021|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867022|NCT03695822|Mirabegron|mirabegron|mesh-list
13867023|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13867024|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13867025|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13867026|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
13867027|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867028|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867029|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867030|NCT03695822|Urological Agents|urological agents|mesh-ancestor
13867031|NCT03695744|Dexamethasone|dexamethasone|mesh-list
13867032|NCT03695744|Bortezomib|bortezomib|mesh-list
13867033|NCT03695744|Daratumumab|daratumumab|mesh-list
13867034|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867035|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
13867036|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
13867037|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867038|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867039|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867040|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
13867041|NCT03695744|Hormones|hormones|mesh-ancestor
13867042|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867043|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13867044|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867045|NCT03695705|Rifaximin|rifaximin|mesh-list
13867046|NCT03695705|Norfloxacin|norfloxacin|mesh-list
13867047|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13867048|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867049|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867050|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13867051|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14026382|NCT02743260|Adefovir|adefovir|mesh-list
14026383|NCT02743260|Digoxin|digoxin|mesh-list
14026384|NCT02743260|Pitavastatin|pitavastatin|mesh-list
14026385|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026386|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026387|NCT02743260|Incretins|incretins|mesh-ancestor
14026388|NCT02743260|Hormones|hormones|mesh-ancestor
14026389|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026390|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14026391|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
14026392|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026393|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026394|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14026395|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14026396|NCT02743260|Protective Agents|protective agents|mesh-ancestor
14026397|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
14026398|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026399|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14026400|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14026401|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14026402|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13867052|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867053|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867054|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867055|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13867056|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13867057|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
13867058|NCT03695640|Analgesics|analgesics|mesh-ancestor
13867059|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
13867060|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867061|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867062|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
13867063|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867064|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13867065|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
13867066|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13867067|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13867068|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867069|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867070|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
13867071|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13867072|NCT03695445|Norepinephrine|norepinephrine|mesh-list
13867073|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13867074|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13867075|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
13867076|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867077|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867078|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867079|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
13867080|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
13867081|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867082|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13867083|NCT03695107|Nifedipine|nifedipine|mesh-list
13867084|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13867085|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13867086|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867087|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867088|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867089|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
13867090|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
13867091|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13867092|NCT03695029|Tenofovir|tenofovir|mesh-list
13867093|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
13867094|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867095|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13867096|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14931244|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931245|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931246|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
14931247|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931248|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931249|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931250|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
14931251|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931252|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14931253|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
14931254|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13867097|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867098|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867099|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13867100|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13867101|NCT03694977|Spartalizumab|spartalizumab|mesh-list
13867102|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13867103|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867104|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867105|NCT03694886|Caffeine|caffeine|mesh-list
13867106|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13955628|NCT03187899|Ropivacaine|ropivacaine|mesh-list
13867107|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867108|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13867109|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867110|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867111|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13867112|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13867113|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
13867114|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867115|NCT03694873|Celecoxib|celecoxib|mesh-list
13867116|NCT03694873|Tramadol|tramadol|mesh-list
13867117|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13867118|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867119|NCT03694873|Analgesics|analgesics|mesh-ancestor
13867120|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
13867121|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867122|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867123|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867124|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867125|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13867126|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13867127|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867128|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867129|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13867130|NCT03694873|Narcotics|narcotics|mesh-ancestor
13867131|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867132|NCT03694808|Vaccines|vaccines|mesh-list
13867133|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
13867134|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867135|NCT03694587|Ibuprofen|ibuprofen|mesh-list
13867136|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13867137|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867138|NCT03694587|Analgesics|analgesics|mesh-ancestor
13867139|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
13867140|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867141|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867142|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867143|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867144|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13867145|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867146|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867147|NCT03694535|Mitomycins|mitomycins|mesh-list
13867148|NCT03694535|Mitomycin|mitomycin|mesh-list
13867149|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13867150|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867151|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
13867152|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867153|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13867154|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867155|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
13867156|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867157|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955629|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
13955630|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
13955631|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955632|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955633|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
13955634|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955635|NCT03187795|Mirabegron|mirabegron|mesh-list
13955636|NCT03187795|Oxybutynin|oxybutynin|mesh-list
13955637|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13955638|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13955639|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13867158|NCT03694249|Ifetroban|ifetroban|mesh-list
13867159|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13867160|NCT03694236|Durvalumab|durvalumab|mesh-list
13867161|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867162|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867163|NCT03694119|Phenelzine|phenelzine|mesh-list
13867164|NCT03694119|Ozanimod|ozanimod|mesh-list
13867165|NCT03694119|Tyramine|tyramine|mesh-list
13867166|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13867167|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867168|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867169|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
13867170|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867171|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
13867172|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13867173|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13867174|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867175|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
13867176|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
13867177|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867178|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13867179|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13867180|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13867181|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
13867182|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867183|NCT03694080|Calcium|calcium|mesh-list
13867184|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867185|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867186|NCT03693976|Xylometazoline|xylometazoline|mesh-list
13867187|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
13867188|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13867189|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
13867190|NCT03693885|Oxytocin|oxytocin|mesh-list
13867191|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
13867192|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13867193|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867194|NCT03693872|Dopamine|dopamine|mesh-list
13867195|NCT03693872|Apomorphine|apomorphine|mesh-list
13867196|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
13867197|NCT03693872|Emetics|emetics|mesh-ancestor
13867198|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867199|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
13867200|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867201|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867202|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
13867203|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867204|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867205|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13867206|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
13867207|NCT03693872|Protective Agents|protective agents|mesh-ancestor
13867208|NCT03693833|Cannabidiol|cannabidiol|mesh-list
13867209|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
13867210|NCT03693638|Fentanyl|fentanyl|mesh-list
13867211|NCT03693638|Bupivacaine|bupivacaine|mesh-list
13867212|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867213|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
13867214|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867215|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867216|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
13867217|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867218|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13867219|NCT03693638|Narcotics|narcotics|mesh-ancestor
13867220|NCT03693638|Analgesics|analgesics|mesh-ancestor
13867221|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13867222|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13867223|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
13867224|NCT03693612|Paclitaxel|paclitaxel|mesh-list
13867225|NCT03693612|Docetaxel|docetaxel|mesh-list
13867226|NCT03693612|Cetuximab|cetuximab|mesh-list
13867227|NCT03693612|Tremelimumab|tremelimumab|mesh-list
13867228|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13867229|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867230|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
13867231|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
13867232|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753886|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13867233|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867234|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867235|NCT03693599|Carbetocin|carbetocin|mesh-list
13867236|NCT03693599|Syntometrine|syntometrine|mesh-list
13867237|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
13867238|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13867239|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867240|NCT03693573|Bevacizumab|bevacizumab|mesh-list
13867241|NCT03693573|Atezolizumab|atezolizumab|mesh-list
13867242|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867243|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867244|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13867245|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13867246|NCT03693573|Growth Substances|growth substances|mesh-ancestor
13867247|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867248|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
13867249|NCT03693560|Metformin|metformin|mesh-list
13867250|NCT03693560|Glimepiride|glimepiride|mesh-list
13867251|NCT03693560|Vildagliptin|vildagliptin|mesh-list
13867252|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13867253|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867254|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13867255|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867256|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
13867257|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13867258|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
13867259|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867260|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867261|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13867262|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13867263|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13867264|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
13867265|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867266|NCT03693404|Ketorolac|ketorolac|mesh-list
13867267|NCT03693404|Morphine|morphine|mesh-list
13867268|NCT03693404|Bupivacaine|bupivacaine|mesh-list
13867269|NCT03693404|Anesthetics|anesthetics|mesh-list
13867270|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
13867271|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867272|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867273|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867274|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
13867275|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867276|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13867277|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867278|NCT03693404|Analgesics|analgesics|mesh-ancestor
13867279|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867280|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867281|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13867282|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867283|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867284|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13867285|NCT03693404|Narcotics|narcotics|mesh-ancestor
13867286|NCT03693391|Fluorides|fluorides|mesh-list
13867287|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
13867288|NCT03693391|Protective Agents|protective agents|mesh-ancestor
13867289|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867290|NCT03693326|Spartalizumab|spartalizumab|mesh-list
13867291|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13867292|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867293|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867294|NCT03693248|Paclitaxel|paclitaxel|mesh-list
13867295|NCT03693248|Carboplatin|carboplatin|mesh-list
13867296|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13867297|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867298|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
13867299|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
13867300|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
13867301|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867302|NCT03693222|Morphine|morphine|mesh-list
13867303|NCT03693222|Tramadol|tramadol|mesh-list
13867304|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13867305|NCT03693222|Narcotics|narcotics|mesh-ancestor
13867306|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867307|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867308|NCT03693222|Analgesics|analgesics|mesh-ancestor
13867309|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
13867310|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867311|NCT03693183|Ketorolac|ketorolac|mesh-list
13867312|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13867313|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13867314|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867315|NCT03693183|Analgesics|analgesics|mesh-ancestor
13867316|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
13867317|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867318|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867319|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867320|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867321|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13867322|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867323|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867324|NCT03693170|Cetuximab|cetuximab|mesh-list
13867325|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867326|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867327|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
13867328|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13867329|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13867330|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
13867331|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13867332|NCT03693066|Disinfectants|disinfectants|mesh-list
13867333|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13867334|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867335|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
13867336|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13867337|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
13867338|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867339|NCT03692819|Amoxicillin|amoxicillin|mesh-list
13867340|NCT03692819|Metronidazole|metronidazole|mesh-list
13867341|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13867342|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867343|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13867344|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13867345|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
13867346|NCT03692754|Dexamethasone|dexamethasone|mesh-list
13867347|NCT03692754|Atorvastatin|atorvastatin|mesh-list
13867348|NCT03692754|Calcium|calcium|mesh-list
13867349|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867350|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
13867351|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
13867352|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867353|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867354|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867355|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
13867356|NCT03692754|Hormones|hormones|mesh-ancestor
13867357|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867358|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13867359|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867360|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867361|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13867362|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13867363|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13867364|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
13867365|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867366|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13867367|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13867368|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955640|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
13955641|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955642|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955643|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955644|NCT03187795|Urological Agents|urological agents|mesh-ancestor
13955645|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
13955646|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
13955647|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867369|NCT03692546|Bupivacaine|bupivacaine|mesh-list
13867370|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867371|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
13867372|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867373|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867374|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
13867375|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867376|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13867377|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13867378|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867379|NCT03692416|Prednisone|prednisone|mesh-list
13867380|NCT03692416|Ibuprofen|ibuprofen|mesh-list
13867381|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13867382|NCT03692416|Methotrexate|methotrexate|mesh-list
13867383|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867384|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
13867385|NCT03692416|Hormones|hormones|mesh-ancestor
13867386|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867387|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867388|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13867389|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867390|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13867391|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
13867392|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13867393|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13867394|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
13867395|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867396|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
13867397|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867398|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13867399|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867400|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
13867401|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867402|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13867403|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13867404|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867405|NCT03692416|Analgesics|analgesics|mesh-ancestor
13867406|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
13867407|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867408|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13867409|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13867410|NCT03692416|Protective Agents|protective agents|mesh-ancestor
13867411|NCT03692299|Metronidazole|metronidazole|mesh-list
13867412|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867413|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13867414|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13867415|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13867416|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
13867417|NCT03692286|Calcium|calcium|mesh-list
13867418|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867419|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867420|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13867421|NCT03692143|Alendronate|alendronate|mesh-list
13867422|NCT03692143|Teriparatide|teriparatide|mesh-list
13867423|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13867424|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867425|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867426|NCT03692065|Apixaban|apixaban|mesh-list
13867427|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13867428|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
13867429|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13867430|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
13867431|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867432|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867433|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
13867434|NCT03692026|Melatonin|melatonin|mesh-list
13867435|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
13867436|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
13867437|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867438|NCT03692026|Protective Agents|protective agents|mesh-ancestor
13867439|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867440|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867441|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13867442|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
13867443|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
13867444|NCT03692013|Losartan|losartan|mesh-list
13867445|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13867446|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13867447|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13867448|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13867449|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867450|NCT03691935|Ropivacaine|ropivacaine|mesh-list
13867451|NCT03691935|Anesthetics|anesthetics|mesh-list
13867452|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867453|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867454|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867455|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
13867456|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867457|NCT03691922|Epinephrine|epinephrine|mesh-list
13867458|NCT03691922|Racepinephrine|racepinephrine|mesh-list
13867459|NCT03691922|Bupivacaine|bupivacaine|mesh-list
13867460|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
13867461|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867462|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
13867463|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867464|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867465|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
13867466|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867467|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13867468|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13867469|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
13867470|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867471|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867472|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14470236|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14470237|NCT02306694|Factor VIII|factor viii|mesh-list
14470238|NCT02306694|Coagulants|coagulants|mesh-ancestor
14470239|NCT02306759|Ketamine|ketamine|mesh-list
14470240|NCT02306759|Analgesics|analgesics|mesh-ancestor
14470241|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
14470242|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470243|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470244|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14470245|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14470246|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
14470247|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
14470248|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470249|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14470250|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14470251|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470252|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470253|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
14470254|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470255|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470256|NCT02307318|Hemostatics|hemostatics|mesh-list
14470257|NCT02307318|Coagulants|coagulants|mesh-ancestor
14470258|NCT02307513|Apremilast|apremilast|mesh-list
14470259|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14470260|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867473|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13867474|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
13867475|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13867476|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
13867477|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
13867478|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
13867479|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13867480|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
13867481|NCT03691896|Vitamin D|vitamin d|mesh-list
13867482|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867483|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867484|NCT03691896|Vitamins|vitamins|mesh-ancestor
13867485|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
13867486|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13867487|NCT03691818|Ibuprofen|ibuprofen|mesh-list
13867488|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13867489|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867490|NCT03691818|Analgesics|analgesics|mesh-ancestor
13867491|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
13867492|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867493|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470261|NCT02307513|Analgesics|analgesics|mesh-ancestor
13867494|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867495|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867496|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13867497|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867498|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867499|NCT03691688|Aspirin|aspirin|mesh-list
13867500|NCT03691688|Clopidogrel|clopidogrel|mesh-list
13867501|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13867502|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867503|NCT03691688|Analgesics|analgesics|mesh-ancestor
13867504|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
13867505|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867506|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867507|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867508|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867509|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13867510|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13867511|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867512|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13867513|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13867514|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867515|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
13867516|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13867517|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13867518|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13867519|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
13867520|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867521|NCT03691662|Timolol|timolol|mesh-list
13867522|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13867523|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13867524|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13867525|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13867526|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
13867527|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867528|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867529|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867530|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13867531|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13867532|NCT03691649|Timolol|timolol|mesh-list
13867533|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13867534|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13867535|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13867536|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13867537|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
13867538|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867539|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867540|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867541|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13867542|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13867543|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13867544|NCT03691636|Lifitegrast|lifitegrast|mesh-list
13867545|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13867546|NCT03691493|Tamoxifen|tamoxifen|mesh-list
13867547|NCT03691493|Letrozole|letrozole|mesh-list
13867548|NCT03691493|Fulvestrant|fulvestrant|mesh-list
13867549|NCT03691493|Palbociclib|palbociclib|mesh-list
13867550|NCT03691493|Anastrozole|anastrozole|mesh-list
13867551|NCT03691493|Exemestane|exemestane|mesh-list
13867552|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867553|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13867554|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13867555|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867556|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867557|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13867558|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
13867559|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867560|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867561|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13867562|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13867563|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13867564|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13867565|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13867566|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13867567|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
13867568|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13867569|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
13867570|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867571|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
13867572|NCT03691467|Protective Agents|protective agents|mesh-ancestor
13867573|NCT03691454|Docetaxel|docetaxel|mesh-list
13867574|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
13867575|NCT03691454|Trastuzumab|trastuzumab|mesh-list
13867576|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867577|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
13867578|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
13867579|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
13867580|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867581|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867582|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
13867583|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13867584|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867585|NCT03691376|Aldesleukin|aldesleukin|mesh-list
13867586|NCT03691376|Melphalan|melphalan|mesh-list
13867587|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
13867588|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13867589|NCT03691376|Interleukin-2|interleukin-2|mesh-list
13867590|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13867591|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
13867592|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867593|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867594|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13867595|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867596|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
13867597|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867598|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867599|NCT03691376|Analgesics|analgesics|mesh-ancestor
13867600|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
13867601|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867602|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13867603|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13867604|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
13867605|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867606|NCT03691350|Nicotine|nicotine|mesh-list
13867607|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13867608|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
13867609|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867610|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867611|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13867612|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13867613|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
13867614|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867615|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867616|NCT03691337|Bupivacaine|bupivacaine|mesh-list
13867617|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13867618|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867619|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
13867620|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867621|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867622|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
13867623|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867624|NCT03691090|Paclitaxel|paclitaxel|mesh-list
13867625|NCT03691090|Cisplatin|cisplatin|mesh-list
13867626|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13867627|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867628|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
13867629|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
13867630|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
13867631|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867632|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
13867633|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
13867634|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470262|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
14470263|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470264|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867638|NCT03691038|Pregabalin|pregabalin|mesh-list
13867639|NCT03691038|Analgesics|analgesics|mesh-ancestor
13867640|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
13867641|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867642|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867643|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
13867644|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13867645|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13867646|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867647|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867648|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13867649|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13867650|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867651|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13955648|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13955649|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13955650|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
13955651|NCT03187691|Amphotericin B|amphotericin b|mesh-list
13955652|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13955653|NCT03187691|Amebicides|amebicides|mesh-ancestor
13955654|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13955655|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13955656|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955657|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470265|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14470266|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470267|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14470268|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14470269|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470270|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470271|NCT02307526|Bromides|bromides|mesh-list
14470272|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14470273|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
13955658|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
13955659|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
13955660|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13955661|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13955662|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13955663|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955664|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955665|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
13955666|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955667|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955668|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13955669|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955670|NCT03187548|Calcium|calcium|mesh-list
13955671|NCT03187548|Caseins|caseins|mesh-list
13955672|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13955673|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955674|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
13955675|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
13955676|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026403|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14026404|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
14026405|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14169145|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169146|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169147|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169148|NCT04844814|Prednisone|prednisone|mesh-list
14169149|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14169150|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169151|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
14169152|NCT04844814|Hormones|hormones|mesh-ancestor
14169153|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169154|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169155|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14169156|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169157|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169158|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
14169159|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14169160|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
14169161|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169162|NCT04844385|Paclitaxel|paclitaxel|mesh-list
14169163|NCT04844385|Capecitabine|capecitabine|mesh-list
14169164|NCT04844385|Nedaplatin|nedaplatin|mesh-list
14169165|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169166|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169167|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169168|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
14470274|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13867652|NCT03690947|Ranibizumab|ranibizumab|mesh-list
13867653|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13867654|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13867655|NCT03690947|Growth Substances|growth substances|mesh-ancestor
13867656|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867657|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
13867658|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867659|NCT03690921|Cisplatin|cisplatin|mesh-list
13867660|NCT03690921|Fluorouracil|fluorouracil|mesh-list
13867661|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867662|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
13867663|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867664|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13867665|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867666|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
13867667|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867668|NCT03690778|Metformin|metformin|mesh-list
13867669|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13867670|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13867671|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867672|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13867673|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13867674|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
13867675|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867676|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13867677|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13867678|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867679|NCT03690739|Gemcitabine|gemcitabine|mesh-list
13867680|NCT03690739|Paclitaxel|paclitaxel|mesh-list
13867681|NCT03690739|Bevacizumab|bevacizumab|mesh-list
13867682|NCT03690739|Carboplatin|carboplatin|mesh-list
13867683|NCT03690739|Trabectedin|trabectedin|mesh-list
13867684|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13867685|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867686|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
13867687|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
13867688|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
13867689|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867690|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867691|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13867692|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13867693|NCT03690739|Growth Substances|growth substances|mesh-ancestor
13867694|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867695|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
13867696|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13867697|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
13867698|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
13867699|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867700|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867701|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867702|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
13867703|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13867704|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
13867705|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
13867706|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13867707|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867708|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867709|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867710|NCT03690622|Analgesics|analgesics|mesh-ancestor
13867711|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
13867712|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867713|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13867714|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13867715|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13867716|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
13867717|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867718|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867719|NCT03690583|Zinc|zinc|mesh-list
13867720|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
13867721|NCT03690583|Trace Elements|trace elements|mesh-ancestor
13867722|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
13867723|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867724|NCT03690583|Astringents|astringents|mesh-ancestor
13867725|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
13867726|NCT03690414|Atropine|atropine|mesh-list
13867727|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13867728|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13867729|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13867730|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13867731|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13867732|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
13867733|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867734|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867735|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13867736|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
13867737|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
13867738|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
13867739|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13867740|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13867741|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
13867742|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867743|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867744|NCT03690323|Gemcitabine|gemcitabine|mesh-list
13867745|NCT03690323|Paclitaxel|paclitaxel|mesh-list
13867746|NCT03690323|Folfirinox|folfirinox|mesh-list
13867747|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13867748|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867749|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
13867750|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
13867751|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
13867752|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867753|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13867754|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
13867755|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
13867756|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867757|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867758|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867759|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
13867760|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867761|NCT03690167|Mitogens|mitogens|mesh-list
13867762|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
13867763|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867764|NCT03690115|Ponatinib|ponatinib|mesh-list
13867765|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867766|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13867767|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867768|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867769|NCT03689998|Melatonin|melatonin|mesh-list
13867770|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
13867771|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867772|NCT03689998|Protective Agents|protective agents|mesh-ancestor
13867773|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867774|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867775|NCT03689972|Natalizumab|natalizumab|mesh-list
13867776|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
13867777|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867778|NCT03689894|Rituximab|rituximab|mesh-list
13867779|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867780|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867781|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
13867782|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867783|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867784|NCT03689699|Nivolumab|nivolumab|mesh-list
13867785|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867786|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867787|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13867788|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867789|NCT03689465|Cyclosporine|cyclosporine|mesh-list
13867790|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
13867791|NCT03689465|Methotrexate|methotrexate|mesh-list
13867792|NCT03689465|Cyclosporins|cyclosporins|mesh-list
13867793|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13867794|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
13867795|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13867796|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867797|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13867798|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
13867799|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867800|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867801|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
13867802|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867803|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13867804|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867805|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
13867806|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867807|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13867808|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
13867809|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867810|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13867811|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13867812|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13867813|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
13867814|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13955677|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13955678|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13955679|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13955680|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955681|NCT03187457|Metronidazole|metronidazole|mesh-list
13955682|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955683|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13955684|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13955685|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13955686|NCT03187093|Vortioxetine|vortioxetine|mesh-list
13955687|NCT03187093|Citalopram|citalopram|mesh-list
13955688|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13955689|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13955690|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955691|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955692|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955693|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
13955694|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955695|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13955696|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
13955697|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13955698|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13955699|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14931255|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14931256|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14931257|NCT01438190|Metformin|metformin|mesh-list
14931258|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931259|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931260|NCT01438320|Quercetin|quercetin|mesh-list
14931261|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
14931262|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931263|NCT01438320|Protective Agents|protective agents|mesh-ancestor
14931264|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931265|NCT01438359|Furosemide|furosemide|mesh-list
14931266|NCT01438359|Diuretics|diuretics|mesh-ancestor
14931267|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
14931268|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931269|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14931270|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14931271|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867815|NCT03689114|Topiramate|topiramate|mesh-list
13867816|NCT03689114|Lamotrigine|lamotrigine|mesh-list
13867817|NCT03689114|Zonisamide|zonisamide|mesh-list
13867818|NCT03689114|Carbamazepine|carbamazepine|mesh-list
13867819|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
13867820|NCT03689114|Gabapentin|gabapentin|mesh-list
13867821|NCT03689114|Levetiracetam|levetiracetam|mesh-list
13867822|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
13867823|NCT03689114|Valproic Acid|valproic acid|mesh-list
13867824|NCT03689114|Analgesics|analgesics|mesh-ancestor
13867825|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
13867826|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867827|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867828|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13867829|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13867830|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867831|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13867832|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13867833|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13867834|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470275|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470276|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470277|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
14470278|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470279|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470280|NCT02307682|Aflibercept|aflibercept|mesh-list
14470281|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14470282|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14470283|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14470284|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14470285|NCT02307682|Growth Substances|growth substances|mesh-ancestor
14470286|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470287|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
14470288|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470289|NCT02307916|Mitogens|mitogens|mesh-list
14470290|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
14470291|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470292|NCT02308007|Metronidazole|metronidazole|mesh-list
14470293|NCT02308007|Terconazole|terconazole|mesh-list
14470294|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753887|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753888|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753889|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14767454|NCT00630019|Renal Agents|renal agents|mesh-ancestor
13867835|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867836|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
13867837|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13867838|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
13867839|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13867840|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13867841|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13867842|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13867843|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13867844|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867845|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
13867846|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13867847|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13867848|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13867849|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13867850|NCT03689075|Tacrolimus|tacrolimus|mesh-list
13867851|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867852|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
13867853|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867854|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13867855|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867856|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867857|NCT03689010|Azelaic acid|azelaic acid|mesh-list
13867858|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867859|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
13867860|NCT03688971|Ketoconazole|ketoconazole|mesh-list
14931272|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14931273|NCT01438372|Hematinics|hematinics|mesh-ancestor
14931274|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
14931275|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14931276|NCT01438515|Doxycycline|doxycycline|mesh-list
13867861|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
13867862|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867863|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13867864|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13867865|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867866|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867867|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13867868|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
13867869|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867870|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867871|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13867872|NCT03688958|Iodine|iodine|mesh-list
13867873|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
13867874|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13867875|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867876|NCT03688958|Trace Elements|trace elements|mesh-ancestor
13867877|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
13867878|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931277|NCT01438515|Rifampin|rifampin|mesh-list
14931278|NCT01438515|Mupirocin|mupirocin|mesh-list
14931279|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13867879|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
13867880|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867881|NCT03688659|Vancomycin|vancomycin|mesh-list
13867882|NCT03688659|Gentamicins|gentamicins|mesh-list
13867883|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13867884|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867885|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13867886|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867887|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867888|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
13867889|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867890|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13867891|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867892|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867893|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
13867894|NCT03688464|Promethazine|promethazine|mesh-list
13867895|NCT03688464|Melatonin|melatonin|mesh-list
13867896|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
13867897|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867898|NCT03688464|Protective Agents|protective agents|mesh-ancestor
13867899|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867900|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867901|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14026406|NCT02743455|Vaccines|vaccines|mesh-list
14931280|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867902|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13867903|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867904|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
13867905|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
13867906|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867907|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
13867908|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
13867909|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867910|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13867911|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
13867912|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
13867913|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13867914|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13867915|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
13867916|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
13867917|NCT03688451|Rituximab|rituximab|mesh-list
13867918|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867919|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867920|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
13867921|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867922|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867923|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13867924|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13867925|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867926|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
13867927|NCT03688269|Dexamethasone|dexamethasone|mesh-list
13867928|NCT03688269|Ropivacaine|ropivacaine|mesh-list
13867929|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867930|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
13867931|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
13867932|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867933|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867934|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867935|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
13867936|NCT03688269|Hormones|hormones|mesh-ancestor
13867937|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867938|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13867939|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867940|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
13867941|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
13867942|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13867943|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
13867944|NCT03688230|Cetuximab|cetuximab|mesh-list
13867945|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13867946|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867947|NCT03688191|Sirolimus|sirolimus|mesh-list
13867948|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13867949|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867950|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13867951|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867952|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
13867953|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13867954|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
13867955|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867956|NCT03688178|Temozolomide|temozolomide|mesh-list
14753890|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13867957|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13867958|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
13867959|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867960|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867961|NCT03687931|Dexamethasone|dexamethasone|mesh-list
13867962|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867963|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
13867964|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
13867965|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13867966|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867967|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13867968|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
13867969|NCT03687931|Hormones|hormones|mesh-ancestor
13867970|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867971|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13867972|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867973|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
14026407|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
13867974|NCT03687905|Chloroquine|chloroquine|mesh-list
13867975|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
14753891|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13867976|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13867977|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13867978|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13867979|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13867980|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13867981|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13867982|NCT03687905|Amebicides|amebicides|mesh-ancestor
13867983|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13867984|NCT03687606|Menotropins|menotropins|mesh-list
13867985|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13867986|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867987|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13867988|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
13867989|NCT03687515|Prednisone|prednisone|mesh-list
13867990|NCT03687515|Budesonide|budesonide|mesh-list
13867991|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13867992|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
13867993|NCT03687515|Hormones|hormones|mesh-ancestor
13867994|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13867995|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13867996|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13867997|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13867998|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13867999|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
13868000|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868001|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13868002|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
13868003|NCT03687463|Decitabine|decitabine|mesh-list
13868004|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13868005|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
13868006|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868007|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868008|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955700|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955701|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13955702|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13955703|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13955704|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13955705|NCT03187223|Melphalan|melphalan|mesh-list
13955706|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13955707|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13955708|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
13955709|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955710|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955711|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13955712|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955713|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
13955714|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955715|NCT03187392|Lidocaine|lidocaine|mesh-list
13955716|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
13955717|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
13955718|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955719|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955720|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
13955721|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955722|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13955723|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13955724|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13955725|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955726|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955727|NCT03187106|Metronidazole|metronidazole|mesh-list
13955728|NCT03187106|Cephalexin|cephalexin|mesh-list
13955729|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955730|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13955731|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13955732|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13955733|NCT03187496|Midazolam|midazolam|mesh-list
13955734|NCT03187496|Caffeine|caffeine|mesh-list
13955735|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13955736|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13955737|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13955738|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955739|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955740|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13868009|NCT03687268|Naloxone|naloxone|mesh-list
13868010|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13868011|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868012|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
13868013|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868014|NCT03687255|Tazobactam|tazobactam|mesh-list
13868015|NCT03687255|Piperacillin|piperacillin|mesh-list
13868016|NCT03687255|Cefepime|cefepime|mesh-list
13868017|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13868018|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
13868019|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868020|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868021|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13868022|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868023|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868024|NCT03687229|Insulin|insulin|mesh-list
13868025|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868026|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868027|NCT03687073|Silybin|silybin|mesh-list
13868028|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
13868029|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13868030|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868031|NCT03687073|Protective Agents|protective agents|mesh-ancestor
13868032|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868033|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13868034|NCT03687034|Temozolomide|temozolomide|mesh-list
13868035|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13868036|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
13868037|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868038|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868039|NCT03687021|Progesterone|progesterone|mesh-list
13868040|NCT03687021|Progestins|progestins|mesh-ancestor
13868041|NCT03687021|Hormones|hormones|mesh-ancestor
13868042|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868043|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868045|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
13868046|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868047|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13868048|NCT03686878|Lifitegrast|lifitegrast|mesh-list
13868049|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13868050|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13868051|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
13868052|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13868053|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13868054|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868055|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
13868056|NCT03686787|Coagulants|coagulants|mesh-ancestor
13868057|NCT03686774|Memantine|memantine|mesh-list
13868058|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13868059|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14026408|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026409|NCT02743182|Interferons|interferons|mesh-list
14026410|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
14026411|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
14026412|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14026413|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026414|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
14026415|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026416|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
14026417|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026418|NCT02743429|Dinutuximab|dinutuximab|mesh-list
14026419|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026420|NCT02743234|Vancomycin|vancomycin|mesh-list
14026421|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
14026422|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14026423|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026424|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
14026425|NCT02743247|Tacrolimus|tacrolimus|mesh-list
14026426|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026427|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
14026428|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026429|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14026430|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868060|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
13868061|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026431|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026432|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13868062|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868063|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868064|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13868065|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13868066|NCT03686722|Metformin|metformin|mesh-list
13868067|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868068|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753892|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14753893|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14753894|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13868069|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13868070|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13868071|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
13868072|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13868073|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
13868074|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868075|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868076|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868077|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
13868078|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868079|NCT03686657|Metformin|metformin|mesh-list
13868080|NCT03686657|Celecoxib|celecoxib|mesh-list
13868081|NCT03686657|Valsartan|valsartan|mesh-list
13868082|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868083|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868084|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13868085|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13868086|NCT03686657|Analgesics|analgesics|mesh-ancestor
13868087|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
13868088|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868089|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868090|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13868091|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13868092|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13868093|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868094|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868095|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13868096|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13868097|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13868098|NCT03686618|Secretin|secretin|mesh-list
13868099|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868100|NCT03686618|Hormones|hormones|mesh-ancestor
13868101|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868102|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868103|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
13868104|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
13868105|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13868106|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868107|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868108|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
13868109|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13868110|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868111|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868112|NCT03686254|Bevacizumab|bevacizumab|mesh-list
13868113|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13868114|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868115|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13868116|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13868117|NCT03686254|Growth Substances|growth substances|mesh-ancestor
13868118|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868119|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
13868120|NCT03686163|Mitogens|mitogens|mesh-list
13868121|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
13868122|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868123|NCT03686124|Atezolizumab|atezolizumab|mesh-list
13868124|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868125|NCT03686085|Dinoprostone|dinoprostone|mesh-list
13868126|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
13868127|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13868128|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868129|NCT03685890|Nivolumab|nivolumab|mesh-list
13868130|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753895|NCT04921358|Docetaxel|docetaxel|mesh-list
13868131|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868132|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13868133|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868134|NCT03685630|Brivaracetam|brivaracetam|mesh-list
13868135|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
13955741|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13955742|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13955743|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13955744|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
13955745|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
13955746|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
13955747|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
13955748|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955749|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955750|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13955751|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13955752|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
13955753|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13955754|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13955755|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955756|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13955757|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13955758|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13955759|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13955760|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
13955761|NCT03187015|Entinostat|entinostat|mesh-list
13955762|NCT03187015|Midazolam|midazolam|mesh-list
13955763|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13955764|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13955765|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955766|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955767|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13955768|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13955769|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13955770|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13955771|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
13955772|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
13955773|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
13955774|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
13955775|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955776|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955777|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955778|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13955779|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955780|NCT03187080|Bupivacaine|bupivacaine|mesh-list
13955781|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
13955782|NCT03187080|Anesthetics|anesthetics|mesh-list
13955783|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955784|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955785|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
13955786|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955787|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
13955788|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13955789|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955790|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
13955791|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13955792|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
13955793|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13955794|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13955795|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
13955796|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955797|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
13955798|NCT03186755|Protective Agents|protective agents|mesh-ancestor
13955799|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955800|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955801|NCT03186755|Analgesics|analgesics|mesh-ancestor
13955802|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
13955803|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955804|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955805|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955806|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13955807|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13955808|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13955809|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
13955810|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
13868136|NCT03685500|Emtricitabine|emtricitabine|mesh-list
13868137|NCT03685500|Darunavir|darunavir|mesh-list
13868138|NCT03685500|Cobicistat|cobicistat|mesh-list
13868139|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
13868140|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868141|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13868142|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13868143|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868144|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470295|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470296|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14470297|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14470298|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
14470299|NCT02308033|Metronidazole|metronidazole|mesh-list
14470300|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470301|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470302|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14470303|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14470304|NCT02308046|Terconazole|terconazole|mesh-list
14470305|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
13868145|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13868146|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13868147|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13868148|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13868149|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
13868150|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13868151|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13868152|NCT03685409|Metformin|metformin|mesh-list
13868153|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868154|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868155|NCT03685331|Olaparib|olaparib|mesh-list
13868156|NCT03685331|Fulvestrant|fulvestrant|mesh-list
13868157|NCT03685331|Palbociclib|palbociclib|mesh-list
13868158|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13868159|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868160|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868161|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868162|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13868163|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13868164|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13868165|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
13868166|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868167|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868168|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13868169|NCT03685149|Flecainide|flecainide|mesh-list
13868170|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13868171|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13868172|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13868173|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13868174|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868175|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13868176|NCT03685084|Piperacillin|piperacillin|mesh-list
13868177|NCT03685084|Cefepime|cefepime|mesh-list
13868178|NCT03685084|Lactams|lactams|mesh-list
13868179|NCT03685084|beta-Lactams|beta-lactams|mesh-list
13868180|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
13868181|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13868182|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868183|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
13868184|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13868185|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868186|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868187|NCT03685032|Dexamethasone|dexamethasone|mesh-list
13868188|NCT03685032|Ondansetron|ondansetron|mesh-list
13868189|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868190|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
13868191|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
13868192|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868193|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868194|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868195|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
13868196|NCT03685032|Hormones|hormones|mesh-ancestor
13868197|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868198|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14470306|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470307|NCT02308124|Midodrine|midodrine|mesh-list
13868199|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868200|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
13868201|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
13868202|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13868203|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
13868204|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868205|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868206|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13868207|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13868208|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868209|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13868210|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13868211|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
13868212|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13868213|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13868214|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868215|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
13868216|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
13868217|NCT03684876|Diuretics|diuretics|mesh-list
13868218|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
13868219|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868220|NCT03684863|Capecitabine|capecitabine|mesh-list
13868221|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13868222|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
13868223|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868224|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868225|NCT03684837|Vitamin D|vitamin d|mesh-list
13868226|NCT03684837|Vitamins|vitamins|mesh-ancestor
13868227|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
13868228|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868229|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13868230|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13868231|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
13868232|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13868233|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
13868234|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13868235|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868236|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13868237|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13868238|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868239|NCT03684772|Digoxin|digoxin|mesh-list
13868240|NCT03684772|Furosemide|furosemide|mesh-list
13868241|NCT03684772|Diuretics|diuretics|mesh-ancestor
13868242|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
13868243|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868244|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13868245|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13868246|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868247|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13868248|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13868249|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868250|NCT03684772|Protective Agents|protective agents|mesh-ancestor
13868251|NCT03684707|Metformin|metformin|mesh-list
13868252|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868253|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868254|NCT03684564|Warfarin|warfarin|mesh-list
13868255|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
13868256|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
13868257|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13868258|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
13868259|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13868260|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
13868261|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868262|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868263|NCT03684538|Zinc|zinc|mesh-list
13868264|NCT03684538|Trace Elements|trace elements|mesh-ancestor
13868265|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
13868266|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868267|NCT03684447|Propofol|propofol|mesh-list
13868268|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13868269|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868270|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868271|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13868272|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
13868273|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
13868274|NCT03684395|Warfarin|warfarin|mesh-list
13868275|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
13868276|NCT03684395|Dabigatran|dabigatran|mesh-list
13868277|NCT03684395|Apixaban|apixaban|mesh-list
13868278|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
13868279|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13868280|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
13868281|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13868282|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
13868283|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868284|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868285|NCT03684330|Vitamin D|vitamin d|mesh-list
13868286|NCT03684330|Vitamins|vitamins|mesh-ancestor
13868287|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
13868288|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868289|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13868290|NCT03683914|Dinoprostone|dinoprostone|mesh-list
13868291|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
13868292|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13868293|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868294|NCT03683810|Lactoferrin|lactoferrin|mesh-list
13868295|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
13868296|NCT03683810|Hematinics|hematinics|mesh-ancestor
13868297|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955811|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955812|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955813|NCT03186742|Eplerenone|eplerenone|mesh-list
13955814|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13955815|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
13955816|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955817|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955818|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13955819|NCT03186742|Diuretics|diuretics|mesh-ancestor
13955820|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
13955821|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13955822|NCT03186664|Nabiximols|nabiximols|mesh-list
13955823|NCT03186664|Analgesics|analgesics|mesh-ancestor
13955824|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
13955825|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955826|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955827|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
13955828|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13955829|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
13963043|NCT02631447|Ipilimumab|ipilimumab|mesh-list
14753896|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753897|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14753898|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14753899|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14753900|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767160|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767161|NCT00629031|Paromomycin|paromomycin|mesh-list
14767162|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14767163|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767164|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13868298|NCT03683667|Azithromycin|azithromycin|mesh-list
13868299|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868300|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868301|NCT03683563|Citric Acid|citric acid|mesh-list
13868302|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
13868303|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
13868304|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13868305|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
13868306|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
13868307|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868308|NCT03683433|Azacitidine|azacitidine|mesh-list
13868309|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13868310|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
13868311|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868312|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868313|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868314|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13868315|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868316|NCT03683277|Dexamethasone|dexamethasone|mesh-list
13868317|NCT03683277|Pomalidomide|pomalidomide|mesh-list
13868318|NCT03683277|Ixazomib|ixazomib|mesh-list
13868319|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868320|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
13868321|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
13868322|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868323|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868324|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868325|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
13868326|NCT03683277|Hormones|hormones|mesh-ancestor
13868327|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868328|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13868329|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868330|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
13868331|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13868332|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13868333|NCT03683277|Growth Substances|growth substances|mesh-ancestor
13868334|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
13868335|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
13868336|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868337|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868338|NCT03683108|Resveratrol|resveratrol|mesh-list
13868339|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
13868340|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868341|NCT03683108|Protective Agents|protective agents|mesh-ancestor
13868342|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868343|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868344|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13868345|NCT03683043|Leuprolide|leuprolide|mesh-list
13868346|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13868347|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
13868348|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13868349|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868350|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13868351|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868352|NCT03682978|Baclofen|baclofen|mesh-list
13868353|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13868354|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868355|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13868356|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868357|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13868358|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
13868359|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
13868360|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868361|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868362|NCT03682952|Alprostadil|alprostadil|mesh-list
13868363|NCT03682952|Beraprost|beraprost|mesh-list
13868364|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13868365|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
13868366|NCT03682952|Urological Agents|urological agents|mesh-ancestor
13868367|NCT03682939|Vaccines|vaccines|mesh-list
13868368|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
13868369|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868370|NCT03682718|Misoprostol|misoprostol|mesh-list
13868371|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13868372|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
13868373|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14169169|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
13868374|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868375|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13868376|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868377|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
13868378|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13868379|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
13868380|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868381|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868382|NCT03682653|Azithromycin|azithromycin|mesh-list
13868383|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868384|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868385|NCT03682640|Insulin|insulin|mesh-list
13868386|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13868387|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
13868388|NCT03682640|Azithromycin|azithromycin|mesh-list
13868389|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868390|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868391|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868392|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868393|NCT03682497|Spironolactone|spironolactone|mesh-list
13868394|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13868395|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
13868396|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868397|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868398|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13868399|NCT03682497|Diuretics|diuretics|mesh-ancestor
13868400|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
13868401|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
13868402|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13868403|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868404|NCT03682276|Nivolumab|nivolumab|mesh-list
13868405|NCT03682276|Ipilimumab|ipilimumab|mesh-list
13868406|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13868407|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868408|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13868409|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868410|NCT03682211|Fentanyl|fentanyl|mesh-list
13868411|NCT03682211|Morphine|morphine|mesh-list
13868412|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13868413|NCT03682211|Narcotics|narcotics|mesh-ancestor
13868414|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868415|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868416|NCT03682211|Analgesics|analgesics|mesh-ancestor
13868417|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
13868418|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868419|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13868420|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13868421|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
13868422|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
13868423|NCT03682198|Phenylephrine|phenylephrine|mesh-list
13868424|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
13868425|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13868426|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
13868427|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
13868428|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868429|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868430|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
13868431|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13868432|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
13868433|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
14026433|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026434|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14026435|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
14026436|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14026437|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026438|NCT02743390|Infliximab|infliximab|mesh-list
14026439|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
14026440|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14026441|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026442|NCT02743104|Lidocaine|lidocaine|mesh-list
14026443|NCT02743104|Atropine|atropine|mesh-list
14026444|NCT02743104|Midazolam|midazolam|mesh-list
14026445|NCT02743104|Ketamine|ketamine|mesh-list
14026446|NCT02743104|Propofol|propofol|mesh-list
14026447|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
14026448|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
14026449|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026450|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184182|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
13868434|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13868435|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13868436|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13868437|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
13868438|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868439|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868440|NCT03682198|Protective Agents|protective agents|mesh-ancestor
13868441|NCT03682172|Glucagon|glucagon|mesh-list
13868442|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13868443|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868444|NCT03682172|Hormones|hormones|mesh-ancestor
13868445|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868446|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868447|NCT03682172|Incretins|incretins|mesh-ancestor
13955830|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13955831|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955832|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13955833|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
13955834|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13955835|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13955836|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13955837|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955838|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955839|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
13955840|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955841|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955842|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13955843|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955844|NCT03186482|Rifampin|rifampin|mesh-list
13955845|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
13955846|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13955847|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
13955848|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13955849|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955850|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
13955851|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13955852|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955853|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955854|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13955855|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13955856|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13955857|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13955858|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13955859|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13955860|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
13955861|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13955862|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13955863|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13955864|NCT03186313|Ribavirin|ribavirin|mesh-list
13955865|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
13955866|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
13955867|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955868|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
13955869|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963044|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963045|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963046|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13963047|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963048|NCT02586831|Exenatide|exenatide|mesh-list
13963049|NCT02586831|Aldesleukin|aldesleukin|mesh-list
13963050|NCT02586831|Adalimumab|adalimumab|mesh-list
13963051|NCT02586831|Interleukin-2|interleukin-2|mesh-list
13963052|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
13963053|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13963054|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963055|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963056|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963057|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963058|NCT02586831|Analgesics|analgesics|mesh-ancestor
13963059|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
13963060|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963061|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963062|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13963063|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13868448|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
13868449|NCT03682029|Vitamins|vitamins|mesh-ancestor
13868450|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
13868451|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868452|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
13868453|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868454|NCT03682029|Protective Agents|protective agents|mesh-ancestor
13868455|NCT03681691|Estradiol|estradiol|mesh-list
13868456|NCT03681691|Estrogens|estrogens|mesh-ancestor
13868457|NCT03681691|Hormones|hormones|mesh-ancestor
13868458|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868459|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868460|NCT03681652|Azathioprine|azathioprine|mesh-list
13868461|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13868462|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
13868463|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868464|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13868465|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868466|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13868467|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
13868468|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868469|NCT03681639|Cobalt|cobalt|mesh-list
13868470|NCT03681639|Chromium|chromium|mesh-list
13868471|NCT03681639|Trace Elements|trace elements|mesh-ancestor
13868472|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
13868473|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868474|NCT03681613|Pyrantel|pyrantel|mesh-list
13868475|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
13868476|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
13868477|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
13868478|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13868479|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868480|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
13868481|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13868482|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13868483|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868484|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868485|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
13868486|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
13868487|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868488|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868489|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868490|NCT03681548|Doxorubicin|doxorubicin|mesh-list
13868491|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13868492|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13868493|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868494|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13868495|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13868496|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868497|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868498|NCT03681509|Pramipexole|pramipexole|mesh-list
13868499|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
13868500|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868501|NCT03681509|Protective Agents|protective agents|mesh-ancestor
13868502|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868503|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13868504|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13868505|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
13868506|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
13868507|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868508|NCT03681470|Dapsone|dapsone|mesh-list
13868509|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868510|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
13868511|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13868512|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13868513|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13868514|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868515|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868516|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
13868517|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868518|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
13868519|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868520|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868521|NCT03681275|Tofacitinib|tofacitinib|mesh-list
13868522|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13868523|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955870|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
13868524|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868525|NCT03681197|Metformin|metformin|mesh-list
13868526|NCT03681197|Clomiphene|clomiphene|mesh-list
13868527|NCT03681197|Enclomiphene|enclomiphene|mesh-list
13868528|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
13868529|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868530|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868531|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13868532|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
13868533|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868534|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13868535|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
13868536|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13868537|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13868538|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14470308|NCT02308124|Bromides|bromides|mesh-list
14470309|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14470310|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
14470311|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
14470312|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
14470313|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470314|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470315|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14470316|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14470317|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14470318|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13868550|NCT03680976|CXA-10|cxa-10|mesh-list
13868551|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868552|NCT03680885|Lidocaine|lidocaine|mesh-list
13868553|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
13868554|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
13868555|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868556|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868557|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
13868558|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868559|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13868560|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13868561|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13868562|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13868563|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868564|NCT03680716|Ropivacaine|ropivacaine|mesh-list
13868565|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
13868566|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
13868567|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868568|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868569|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
13868570|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868571|NCT03680638|Allopurinol|allopurinol|mesh-list
13868572|NCT03680638|Tempol|tempol|mesh-list
13868573|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
13868574|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868575|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868576|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
13868577|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13868578|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13868579|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
13868580|NCT03680638|Protective Agents|protective agents|mesh-ancestor
13868581|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868582|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13868583|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13868584|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13868585|NCT03680612|Cefepime|cefepime|mesh-list
13868586|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
13868587|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868588|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868589|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13868590|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868591|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868592|NCT03680573|Allopurinol|allopurinol|mesh-list
13868593|NCT03680573|Nitroprusside|nitroprusside|mesh-list
13868594|NCT03680573|Nitroarginine|nitroarginine|mesh-list
13868595|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
13868596|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
13868597|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868598|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868599|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
13868600|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13868601|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13868602|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
13868603|NCT03680573|Protective Agents|protective agents|mesh-ancestor
13868604|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868605|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13868606|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
13868607|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13868608|NCT03680560|Trastuzumab|trastuzumab|mesh-list
13868609|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13868610|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868611|NCT03680508|Antibodies|antibodies|mesh-list
13868612|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
13868613|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
13868614|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868615|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
13868616|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13868617|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13868618|NCT03680495|Prednisolone|prednisolone|mesh-list
13868619|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
13868620|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13868621|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
13868622|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868623|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
13868624|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
13868625|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868626|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868627|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868628|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
13868629|NCT03680495|Hormones|hormones|mesh-ancestor
13868630|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868631|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13868632|NCT03680495|Protective Agents|protective agents|mesh-ancestor
13868633|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13868634|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868635|NCT03680404|Allopurinol|allopurinol|mesh-list
13868636|NCT03680404|Phenylephrine|phenylephrine|mesh-list
13868637|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
13868638|NCT03680404|Tempol|tempol|mesh-list
13868639|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13868640|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
13868641|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
13868642|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868643|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868644|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
13868645|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13868646|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
13868647|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
13868648|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13868649|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13868650|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13868651|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
13868652|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868653|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868654|NCT03680404|Protective Agents|protective agents|mesh-ancestor
13868655|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
13868656|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868657|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
13868658|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13868659|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13868660|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
13868661|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13868662|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13868663|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13868664|NCT03680378|Cefepime|cefepime|mesh-list
13868665|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868666|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868667|NCT03680352|Cefepime|cefepime|mesh-list
13868668|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
13868669|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868670|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868671|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13868672|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868673|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868674|NCT03680339|Misoprostol|misoprostol|mesh-list
13868675|NCT03680339|Oxytocin|oxytocin|mesh-list
13868676|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
13868677|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13868678|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868679|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13868680|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
13868681|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13868682|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955871|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13955872|NCT03186053|Protective Agents|protective agents|mesh-ancestor
13955873|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955874|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
13955875|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13955876|NCT03186326|Bevacizumab|bevacizumab|mesh-list
13955877|NCT03186326|Cetuximab|cetuximab|mesh-list
13955878|NCT03186326|Avelumab|avelumab|mesh-list
13955879|NCT03186326|Panitumumab|panitumumab|mesh-list
13955880|NCT03186326|Aflibercept|aflibercept|mesh-list
13955881|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955882|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955883|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13955884|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13955885|NCT03186326|Growth Substances|growth substances|mesh-ancestor
13955886|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955887|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
13955888|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
13955889|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
13955890|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955891|NCT03186443|Pregabalin|pregabalin|mesh-list
13955892|NCT03186443|Gabapentin|gabapentin|mesh-list
13955893|NCT03186443|Analgesics|analgesics|mesh-ancestor
13955894|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
13955895|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955896|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955897|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
13955898|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13955899|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955900|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955901|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13955902|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13955903|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13955904|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955905|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13955906|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13955907|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13955908|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955909|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
13955910|NCT03186027|Ascorbic Acid|ascorbic acid|mesh-list
13955911|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
13955912|NCT03186027|Ubiquinone|ubiquinone|mesh-list
13955913|NCT03186027|Vitamins|vitamins|mesh-ancestor
13955914|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
13955915|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955916|NCT03186027|Antioxidants|antioxidants|mesh-ancestor
13955917|NCT03186027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955918|NCT03186027|Protective Agents|protective agents|mesh-ancestor
13955919|NCT03186131|Vitamin D|vitamin d|mesh-list
13955920|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
13955921|NCT03186131|Vitamins|vitamins|mesh-ancestor
13955922|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
13955923|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955924|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13955925|NCT03186040|Lacosamide|lacosamide|mesh-list
13955926|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
13955927|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13955928|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13955929|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955930|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955931|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13955932|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13955933|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13955934|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955935|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955936|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
13955937|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955938|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955939|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13955940|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955941|NCT03185871|Celecoxib|celecoxib|mesh-list
13868683|NCT03680183|Entecavir|entecavir|mesh-list
13868684|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
13868685|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868686|NCT03679949|Oxycodone|oxycodone|mesh-list
13868687|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13868688|NCT03679949|Narcotics|narcotics|mesh-ancestor
13868689|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868690|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868691|NCT03679949|Analgesics|analgesics|mesh-ancestor
13868692|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
13868693|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868694|NCT03679897|Ropivacaine|ropivacaine|mesh-list
13868695|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
13868696|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13868697|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
13868698|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
13868699|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868700|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868701|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
14753901|NCT04919096|Aflibercept|aflibercept|mesh-list
14753902|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14753903|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13868702|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868703|NCT03679676|Omalizumab|omalizumab|mesh-list
13868704|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13868705|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13868706|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
13868707|NCT03679546|Infliximab|infliximab|mesh-list
13868708|NCT03679546|Vedolizumab|vedolizumab|mesh-list
13868709|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
13868710|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868711|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13868712|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
13868713|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13868714|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13868715|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868716|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
13868717|NCT03679481|Coagulants|coagulants|mesh-ancestor
13868718|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
13868719|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13868720|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868721|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
13868722|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13868723|NCT03679442|Antidotes|antidotes|mesh-list
13868724|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868725|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
13868726|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868727|NCT03679442|Expectorants|expectorants|mesh-ancestor
13868728|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
13868729|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13868730|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
13868731|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868732|NCT03679442|Protective Agents|protective agents|mesh-ancestor
13868733|NCT03679390|Ketamine|ketamine|mesh-list
13868734|NCT03679390|Analgesics|analgesics|mesh-ancestor
13868735|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
13868736|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868737|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868738|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13868739|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13868740|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
13868741|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
13868742|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868743|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13868744|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13868745|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868746|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868747|NCT03679325|Vitamin D|vitamin d|mesh-list
13868748|NCT03679325|Vitamins|vitamins|mesh-ancestor
13868749|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
13868750|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868751|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13868752|NCT03679182|Olanzapine|olanzapine|mesh-list
13868753|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
13868754|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
13868755|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868756|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184183|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13868757|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868758|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13868759|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13868760|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868761|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13868762|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13868763|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13868764|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13868765|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868766|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868767|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
13868768|NCT03679065|Acetaminophen|acetaminophen|mesh-list
13868769|NCT03679065|Dexamethasone|dexamethasone|mesh-list
13868770|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
13868771|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13868772|NCT03679065|BB 1101|bb 1101|mesh-list
13868773|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868774|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
13868775|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
13868776|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868777|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868778|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868779|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
13868780|NCT03679065|Hormones|hormones|mesh-ancestor
13868781|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868782|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13868783|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868784|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
13868785|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868786|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868787|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13868788|NCT03679065|Analgesics|analgesics|mesh-ancestor
13868789|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
13868790|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
13868791|NCT03679052|Clonidine|clonidine|mesh-list
13868792|NCT03679052|Mirtazapine|mirtazapine|mesh-list
13868793|NCT03679052|Analgesics|analgesics|mesh-ancestor
13868794|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
13868795|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868796|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868797|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13868798|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
13868799|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
13868800|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13868801|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13868802|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13868803|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
13868804|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868805|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868806|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
13868807|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13868808|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13868809|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
13868810|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
13868811|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13868812|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13868813|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868814|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13868815|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13868816|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13868817|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13868818|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13868819|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
13868820|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13868821|NCT03679013|Acetaminophen|acetaminophen|mesh-list
13868822|NCT03679013|Gabapentin|gabapentin|mesh-list
13868823|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13868824|NCT03679013|Analgesics|analgesics|mesh-ancestor
13868825|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
13868826|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868827|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868828|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
14931281|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
13868829|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
13868830|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13868831|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13868832|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868833|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13868834|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13868835|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13868836|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868837|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868838|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
13868839|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
13868840|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13868841|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868842|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13868843|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
13868844|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13868845|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868846|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868847|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868848|NCT03678792|Morphine|morphine|mesh-list
13868849|NCT03678792|Buprenorphine|buprenorphine|mesh-list
13868850|NCT03678792|Tramadol|tramadol|mesh-list
13868851|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13868852|NCT03678792|Naloxone|naloxone|mesh-list
13868853|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13868854|NCT03678792|Narcotics|narcotics|mesh-ancestor
13868855|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868856|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868857|NCT03678792|Analgesics|analgesics|mesh-ancestor
13868858|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
13868859|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868860|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13868861|NCT03678675|Ketorolac|ketorolac|mesh-list
13868862|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13868863|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13868864|NCT03678675|Analgesics|analgesics|mesh-ancestor
13868865|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
13868866|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13868867|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868868|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868869|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13868870|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13868871|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868872|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868873|NCT03678649|Capecitabine|capecitabine|mesh-list
13868874|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13868875|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
13868876|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868877|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955942|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955943|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955944|NCT03185871|Analgesics|analgesics|mesh-ancestor
13955945|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
13955946|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955947|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955948|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955949|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955950|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13955951|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13955952|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955953|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955954|NCT03185988|Trastuzumab|trastuzumab|mesh-list
13955955|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955956|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955957|NCT03185845|Warfarin|warfarin|mesh-list
13955958|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
14026451|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
14026452|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026453|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14026454|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14026455|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14026456|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026457|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026458|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13868880|NCT03678610|Ionomycin|ionomycin|mesh-list
13868881|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
13868882|NCT03678610|Ionophores|ionophores|mesh-ancestor
13868883|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13868884|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868885|NCT03678532|Midazolam|midazolam|mesh-list
13868886|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13868887|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13868888|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868889|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868890|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13868891|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13868892|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13868893|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13868894|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
13868895|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
13868896|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
13868897|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
13868898|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868899|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868900|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13868901|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13868902|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13868903|NCT03678428|Leucovorin|leucovorin|mesh-list
13868904|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
13868905|NCT03678428|Irinotecan|irinotecan|mesh-list
13868906|NCT03678428|Floxuridine|floxuridine|mesh-list
13868907|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13868908|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13868909|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13868910|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868911|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868912|NCT03678428|Antidotes|antidotes|mesh-ancestor
13868913|NCT03678428|Protective Agents|protective agents|mesh-ancestor
13868914|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868915|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
13868916|NCT03678428|Vitamins|vitamins|mesh-ancestor
13868917|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
13868918|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13868919|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
14753904|NCT04919096|Growth Substances|growth substances|mesh-ancestor
14753905|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868920|NCT03678233|Testosterone|testosterone|mesh-list
13868921|NCT03678233|Androgens|androgens|mesh-ancestor
13868922|NCT03678233|Hormones|hormones|mesh-ancestor
14026459|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14753906|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
14753907|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753908|NCT04915755|Niraparib|niraparib|mesh-list
14753909|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13868923|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868924|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868925|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13868926|NCT03678142|Vancomycin|vancomycin|mesh-list
13868927|NCT03678142|Imipenem|imipenem|mesh-list
13868928|NCT03678142|Floxacillin|floxacillin|mesh-list
13868929|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868930|NCT03678116|Caffeine|caffeine|mesh-list
13868931|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13868932|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868933|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13868934|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868935|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868936|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13868937|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13868938|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
13868939|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13868940|NCT03678090|Plasminogen|plasminogen|mesh-list
13868941|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13868942|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13868943|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13868944|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868945|NCT03678038|Triamcinolone|triamcinolone|mesh-list
13868946|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13868947|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13868948|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13868949|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13868950|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
13868951|NCT03678038|Hormones|hormones|mesh-ancestor
13868952|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868953|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868954|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13868955|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
13868956|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868957|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868958|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13868959|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13868960|NCT03678012|Hematinics|hematinics|mesh-ancestor
13868961|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13868962|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13868963|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13868964|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13868965|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
13868966|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13868967|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
13868968|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868969|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
13868970|NCT03677895|Protective Agents|protective agents|mesh-ancestor
13868971|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
13868972|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13868973|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868974|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868975|NCT03677466|Tenecteplase|tenecteplase|mesh-list
13868976|NCT03677466|Streptokinase|streptokinase|mesh-list
13868977|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13868978|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13868979|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13868980|NCT03677336|Progesterone|progesterone|mesh-list
13868981|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
13868982|NCT03677336|Progestins|progestins|mesh-ancestor
13868983|NCT03677336|Hormones|hormones|mesh-ancestor
13868984|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13868985|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868986|NCT03677323|Sufentanil|sufentanil|mesh-list
13868987|NCT03677323|Droperidol|droperidol|mesh-list
14753910|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753911|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753912|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753913|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14753914|NCT04915729|Tenecteplase|tenecteplase|mesh-list
14753915|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14753916|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13868988|NCT03677323|Propofol|propofol|mesh-list
13868989|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13955959|NCT03185611|Rifaximin|rifaximin|mesh-list
14753917|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753918|NCT04909697|Sivelestat|sivelestat|mesh-list
14753919|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14753920|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
14753921|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13868990|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13868991|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13868992|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13868993|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
13868994|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
13868995|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13868996|NCT03677323|Narcotics|narcotics|mesh-ancestor
13868997|NCT03677323|Analgesics|analgesics|mesh-ancestor
13868998|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
13868999|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869000|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13869001|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
13869002|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
13869003|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869004|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13869005|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13869006|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13869007|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13869008|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13869009|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
13869010|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869011|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869012|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13869013|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13869014|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13869015|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
13869016|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869017|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13869018|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13869019|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869020|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
13869021|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14470319|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
14470320|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470321|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470322|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14470323|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470324|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
14470325|NCT02308163|Etanercept|etanercept|mesh-list
14470326|NCT02308163|Peficitinib|peficitinib|mesh-list
14470327|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14470328|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14470329|NCT02308163|Analgesics|analgesics|mesh-ancestor
14470330|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
14470331|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470332|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470333|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869022|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
13869023|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869024|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
14470334|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470335|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14470336|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470337|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
13869025|NCT03677258|Protective Agents|protective agents|mesh-ancestor
13869026|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13869027|NCT03676985|Antibodies|antibodies|mesh-list
13869028|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
13869029|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13869030|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
13869031|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869032|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869033|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13869034|NCT03676959|Antibodies|antibodies|mesh-list
13869035|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
14470338|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767165|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13869036|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13869037|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
13869038|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479070|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869039|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869040|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13869041|NCT03676946|Antibodies|antibodies|mesh-list
13869042|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
13869043|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13869044|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
13869045|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869046|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869047|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
13869048|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
13869049|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869050|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
13955960|NCT03185611|Azathioprine|azathioprine|mesh-list
13955961|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13955962|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955963|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955964|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
13955965|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955966|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13955967|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955968|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955969|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
13955970|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955971|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955972|NCT03185624|Rifaximin|rifaximin|mesh-list
13955973|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13955974|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955975|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955976|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
13955977|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
13955978|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955979|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955980|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955981|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13955982|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
13955983|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955984|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955985|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13955986|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
13955987|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955988|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
13955989|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13955990|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13955991|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955992|NCT03185364|Urological Agents|urological agents|mesh-ancestor
13955993|NCT03185403|Sufentanil|sufentanil|mesh-list
13955994|NCT03185403|Ropivacaine|ropivacaine|mesh-list
13955995|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
13955996|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
13955997|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955998|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955999|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
13956000|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956001|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13956002|NCT03185403|Narcotics|narcotics|mesh-ancestor
13956003|NCT03185403|Analgesics|analgesics|mesh-ancestor
13956004|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13956005|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13956006|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
13956007|NCT03185793|Benzbromarone|benzbromarone|mesh-list
13956008|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
13956009|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
13956010|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956011|NCT03185793|Renal Agents|renal agents|mesh-ancestor
13956012|NCT03185351|Midazolam|midazolam|mesh-list
13956013|NCT03185351|Bupivacaine|bupivacaine|mesh-list
13956014|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
13956015|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
13956016|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956017|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956018|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
13956019|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956020|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13956021|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13956022|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13956023|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13956024|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13869051|NCT03676764|Azithromycin|azithromycin|mesh-list
13869052|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869053|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869054|NCT03676621|Misoprostol|misoprostol|mesh-list
13869055|NCT03676621|Oxytocin|oxytocin|mesh-list
13869056|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
13869057|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13869058|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869059|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13869060|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
13869061|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13869062|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869063|NCT03676556|Lidocaine|lidocaine|mesh-list
13869064|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
14753922|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753923|NCT04907279|Aripiprazole|aripiprazole|mesh-list
14753924|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
14753925|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14753926|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14753927|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13869065|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
13869066|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869067|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869068|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
13869069|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869070|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13869071|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13869072|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13869073|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13869074|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869075|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
13869076|NCT03676504|Fludarabine|fludarabine|mesh-list
13869077|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13869078|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
13869079|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869080|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869081|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13869082|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
13869083|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869084|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869085|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13869086|NCT03676413|Fluticasone|fluticasone|mesh-list
13869087|NCT03676413|Xhance|xhance|mesh-list
13869088|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13869089|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13869090|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869091|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13869092|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
13869093|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869094|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869095|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13869096|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
13869097|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
13869098|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13869099|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13869100|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13869101|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13869102|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
13869103|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869104|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869105|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
13869106|NCT03676413|Hormones|hormones|mesh-ancestor
13869107|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869108|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
13869109|NCT03676374|Prucalopride|prucalopride|mesh-list
13869110|NCT03676374|Laxatives|laxatives|mesh-ancestor
13869111|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869112|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
13869113|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13869114|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
13869115|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869116|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963064|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
14753928|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869117|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869118|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13869119|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
13869120|NCT03676361|Coagulants|coagulants|mesh-ancestor
13869121|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13869122|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
13869123|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869124|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13869125|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13869126|NCT03676296|Puerarin|puerarin|mesh-list
13869127|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
13869128|NCT03676192|Bevacizumab|bevacizumab|mesh-list
13869129|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13869130|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869131|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13869132|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13869133|NCT03676192|Growth Substances|growth substances|mesh-ancestor
13869134|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869135|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
13869136|NCT03676140|Azithromycin|azithromycin|mesh-list
13869137|NCT03676140|Ivermectin|ivermectin|mesh-list
13869138|NCT03676140|Albendazole|albendazole|mesh-list
13869139|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
13869140|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869141|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869142|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13869143|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
13869144|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
13869145|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13869146|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13869147|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
13869148|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
13869149|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
13869150|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869151|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869152|NCT03676140|Filaricides|filaricides|mesh-ancestor
13869153|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
13869154|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
13869155|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869156|NCT03676114|Ketamine|ketamine|mesh-list
13869157|NCT03676114|Analgesics|analgesics|mesh-ancestor
13869158|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
13869159|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869160|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869161|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13869162|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13869163|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
13869164|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
13869165|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869166|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13869167|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13869168|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869169|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869170|NCT03676088|Mitogens|mitogens|mesh-list
13869171|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
13869172|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869173|NCT03676049|Cannabidiol|cannabidiol|mesh-list
13869174|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
13869175|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
13869176|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869177|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
13869178|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13869179|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
13869180|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13869181|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13869182|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869183|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
13869184|NCT03676023|Coagulants|coagulants|mesh-ancestor
13869185|NCT03675893|Letrozole|letrozole|mesh-list
13869186|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869187|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13869188|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13869189|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869190|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869191|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13869192|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
13869193|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869194|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869195|NCT03675854|Cefazolin|cefazolin|mesh-list
13869196|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869197|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869198|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
13869199|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
13869200|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13869201|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869202|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
13869203|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869204|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13869205|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13869206|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869207|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869208|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869209|NCT03675815|Ritonavir|ritonavir|mesh-list
13869210|NCT03675815|Darunavir|darunavir|mesh-list
13869211|NCT03675815|Tenofovir|tenofovir|mesh-list
13869212|NCT03675815|Lamivudine|lamivudine|mesh-list
13869213|NCT03675815|Emtricitabine|emtricitabine|mesh-list
13869214|NCT03675815|Dolutegravir|dolutegravir|mesh-list
13869215|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
13869216|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13869217|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13869218|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
13869219|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869220|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869221|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13869222|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13869223|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
13869224|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869225|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13869226|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13869227|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13869228|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13869229|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13869230|NCT03675802|Misoprostol|misoprostol|mesh-list
13869231|NCT03675802|Dinoprostone|dinoprostone|mesh-list
13869232|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13869233|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
13869234|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13869235|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869236|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13869237|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869238|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
13869239|NCT03675646|Morphine|morphine|mesh-list
13869240|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13869241|NCT03675646|Narcotics|narcotics|mesh-ancestor
13869242|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869243|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869244|NCT03675646|Analgesics|analgesics|mesh-ancestor
13869245|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
13869246|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869247|NCT03675594|Cobalt|cobalt|mesh-list
13869248|NCT03675594|Chromium|chromium|mesh-list
13869249|NCT03675594|Trace Elements|trace elements|mesh-ancestor
13869250|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
13869251|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869252|NCT03675555|Dexamethasone|dexamethasone|mesh-list
13869253|NCT03675555|Mirtazapine|mirtazapine|mesh-list
13869254|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13869255|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869256|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
13869257|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
13869258|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869259|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869260|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869261|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
13869262|NCT03675555|Hormones|hormones|mesh-ancestor
13869263|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869264|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13869265|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479071|NCT02463331|Filaricides|filaricides|mesh-ancestor
13869266|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
13869267|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13869268|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13869269|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
13869270|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
13869271|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869272|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869273|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13869274|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13869275|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869276|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13869277|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13869278|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13869279|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
13869280|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13869281|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13869282|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
13869283|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13869284|NCT03675191|Orlistat|orlistat|mesh-list
13869285|NCT03675191|Phentermine|phentermine|mesh-list
13869286|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869287|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869288|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13869289|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13869290|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13869291|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026460|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
14026461|NCT02743104|Analgesics|analgesics|mesh-ancestor
14026462|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14026463|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14026464|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14026465|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026466|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14026467|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14026468|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14026469|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14026470|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
14026471|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
14026472|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14026473|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
14026474|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14026475|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
14026476|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
14026477|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
14026478|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14026479|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14026480|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
14026481|NCT02743065|Doxorubicin|doxorubicin|mesh-list
14026482|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14026483|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026484|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14026485|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14026486|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026487|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026488|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14026489|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
14026490|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026491|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
14026492|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14026493|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026494|NCT02742675|Leuprolide|leuprolide|mesh-list
14026495|NCT02742675|Goserelin|goserelin|mesh-list
14026496|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14026497|NCT02742675|Flutamide|flutamide|mesh-list
14026498|NCT02742675|Bicalutamide|bicalutamide|mesh-list
14026499|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14026500|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
14026501|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14026502|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026503|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14026504|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026505|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
14026506|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
14026507|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026508|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
14026509|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14026510|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
14026511|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14026512|NCT02742805|Vitamin D|vitamin d|mesh-list
14026513|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
14026514|NCT02742805|Vitamins|vitamins|mesh-list
13869292|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
13869293|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
13869294|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
13869295|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869296|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
13869297|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869298|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
13869299|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869300|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956025|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13956026|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
13956027|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
13956028|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
13956029|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956030|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956031|NCT03185104|Fluorides|fluorides|mesh-list
13956032|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
13956033|NCT03185104|Protective Agents|protective agents|mesh-ancestor
13956034|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956035|NCT03185156|Propofol|propofol|mesh-list
13956036|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13956037|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956038|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956039|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13956040|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
13956041|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
13956042|NCT03184844|Thalidomide|thalidomide|mesh-list
13956043|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13956044|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
13956045|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956046|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
13956047|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13956048|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956049|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13956050|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13956051|NCT03184844|Growth Substances|growth substances|mesh-ancestor
13956052|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
13956053|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956054|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
13956055|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
13956056|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13956057|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956058|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956059|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
13956060|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13956061|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956062|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956063|NCT03185143|Acetaminophen|acetaminophen|mesh-list
13956064|NCT03185143|Sumatriptan|sumatriptan|mesh-list
13956065|NCT03185143|Naltrexone|naltrexone|mesh-list
13956066|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956067|NCT03185143|Analgesics|analgesics|mesh-ancestor
13956068|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
13956069|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956070|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956071|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
13956072|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13956073|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13956074|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13956075|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13956076|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13956077|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
13956078|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956079|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956080|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13956081|NCT03184870|Leucovorin|leucovorin|mesh-list
13956082|NCT03184870|Gemcitabine|gemcitabine|mesh-list
13956083|NCT03184870|Paclitaxel|paclitaxel|mesh-list
13956084|NCT03184870|Fluorouracil|fluorouracil|mesh-list
13956085|NCT03184870|Nivolumab|nivolumab|mesh-list
13956086|NCT03184870|Irinotecan|irinotecan|mesh-list
13956087|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13956088|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956089|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
13956090|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
13956091|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
13956092|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956093|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13869301|NCT03674866|Insulin|insulin|mesh-list
13869302|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13869303|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869304|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
13869305|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13869306|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869307|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13869308|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
13869309|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869310|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13869311|NCT03674671|Ketamine|ketamine|mesh-list
13869312|NCT03674671|Analgesics|analgesics|mesh-ancestor
13869313|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
13869314|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869315|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869316|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13869317|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13869318|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
13869319|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
13869320|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869321|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13869322|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13869323|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869324|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931282|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
14931283|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14931284|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
14931285|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14931286|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14931287|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13869325|NCT03674658|Propafenone|propafenone|mesh-list
13869326|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13869327|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13869328|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13869329|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13869330|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869331|NCT03674606|Aspirin|aspirin|mesh-list
13869332|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13869333|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13869334|NCT03674606|Analgesics|analgesics|mesh-ancestor
13869335|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
13869336|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869337|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869338|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869339|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869340|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13869341|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13869342|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869343|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13869344|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13869345|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869346|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
13869347|NCT03674541|Bromides|bromides|mesh-list
13869348|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
13869349|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
13869350|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13869351|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869352|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869353|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
13869354|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869355|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869356|NCT03674424|Avelumab|avelumab|mesh-list
13869357|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13869358|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869359|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
13869360|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
13869361|NCT03674411|Melphalan|melphalan|mesh-list
13869362|NCT03674411|Busulfan|busulfan|mesh-list
13869363|NCT03674411|Fludarabine|fludarabine|mesh-list
13869364|NCT03674411|Tacrolimus|tacrolimus|mesh-list
13869365|NCT03674411|Sargramostim|sargramostim|mesh-list
13869366|NCT03674411|Lenograstim|lenograstim|mesh-list
13869367|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026515|NCT02742805|Omalizumab|omalizumab|mesh-list
14026516|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
14931288|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
14931289|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
13869368|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
13869369|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869370|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869371|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13869372|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
13869373|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869374|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869375|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13869376|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13869377|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869378|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13869379|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13869380|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
13869381|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869382|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869383|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13869384|NCT03674385|Vitamin E|vitamin e|mesh-list
13869385|NCT03674385|Metformin|metformin|mesh-list
13869386|NCT03674385|Clomiphene|clomiphene|mesh-list
13869387|NCT03674385|Enclomiphene|enclomiphene|mesh-list
13869388|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
13869389|NCT03674385|Vitamins|vitamins|mesh-ancestor
13869390|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
13869391|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869392|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13869393|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869394|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
13869395|NCT03674385|Protective Agents|protective agents|mesh-ancestor
13869396|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13869397|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
13869398|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869399|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13869400|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
13869401|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13869402|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13869403|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13869404|NCT03674333|Folic Acid|folic acid|mesh-list
13869405|NCT03674333|Hematinics|hematinics|mesh-ancestor
13869406|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
13869407|NCT03674333|Vitamins|vitamins|mesh-ancestor
13869408|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
13869409|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869410|NCT03674294|Dexamethasone|dexamethasone|mesh-list
13869411|NCT03674294|Aprepitant|aprepitant|mesh-list
13869412|NCT03674294|Palonosetron|palonosetron|mesh-list
13869413|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869414|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
13869415|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
13869416|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869417|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869418|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869419|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
13869420|NCT03674294|Hormones|hormones|mesh-ancestor
13869421|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869422|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13869423|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869424|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13869425|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869426|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869427|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13869428|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13869429|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
13869430|NCT03674242|Gemcitabine|gemcitabine|mesh-list
13869431|NCT03674242|Carboplatin|carboplatin|mesh-list
13869432|NCT03674242|Asparaginase|asparaginase|mesh-list
13869433|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869434|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13869435|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
13869436|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869437|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
13869438|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869439|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869440|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13869441|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
13869442|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869443|NCT03674151|Povidone|povidone|mesh-list
13869444|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
13869445|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
13869446|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
13869447|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13869448|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13869449|NCT03674099|Prednisolone|prednisolone|mesh-list
13869450|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
13869451|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
13869452|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13869453|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
13869454|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869455|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
13869456|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
13869457|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869458|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869459|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869460|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
13869461|NCT03674099|Hormones|hormones|mesh-ancestor
13869462|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869463|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13869464|NCT03674099|Protective Agents|protective agents|mesh-ancestor
13869465|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13869466|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869467|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13869468|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869469|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869470|NCT03674073|Vaccines|vaccines|mesh-list
13869471|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
13869472|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869473|NCT03674060|Sorafenib|sorafenib|mesh-list
13869474|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869475|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13869476|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869477|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869478|NCT03674008|Propofol|propofol|mesh-list
13869479|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13869480|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869481|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869482|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13869483|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
13869484|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
13869485|NCT03673995|Inositol|inositol|mesh-list
13869486|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
13869487|NCT03673995|Vitamins|vitamins|mesh-ancestor
13869488|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
13869489|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869490|NCT03673735|Durvalumab|durvalumab|mesh-list
13869491|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869492|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13869493|NCT03673605|Warfarin|warfarin|mesh-list
13869494|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
13869495|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
13869496|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13869497|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
13869498|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13869499|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
13869500|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869501|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869502|NCT03673501|Sunitinib|sunitinib|mesh-list
13869503|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869504|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13869505|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13869506|NCT03673501|Growth Substances|growth substances|mesh-ancestor
13869507|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869508|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
13869509|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13869510|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869511|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956094|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
13956095|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
13956096|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956097|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956098|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13956099|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
13956100|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956101|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13956102|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13869512|NCT03673384|Fluticasone|fluticasone|mesh-list
13869513|NCT03673384|Xhance|xhance|mesh-list
13869514|NCT03673384|Histamine|histamine|mesh-list
13869515|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869516|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13869517|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
13869518|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869519|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869520|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13869521|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
13869522|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
13869523|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13869524|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
13869525|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
13869526|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869527|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869528|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13869529|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869530|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869531|NCT03673280|Morphine|morphine|mesh-list
13869532|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13869533|NCT03673280|Narcotics|narcotics|mesh-ancestor
13869534|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869535|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869536|NCT03673280|Analgesics|analgesics|mesh-ancestor
13869537|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
13869538|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869539|NCT03673163|Lidocaine|lidocaine|mesh-list
13869540|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
13869541|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
13869542|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869543|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869544|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
13869545|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869546|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13869547|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13869548|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13869549|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13869550|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869551|NCT03673137|Gemcitabine|gemcitabine|mesh-list
13869552|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13869553|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
13869554|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869555|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869556|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
13869557|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869558|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869559|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13869560|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
13869561|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869562|NCT03673072|Gemcitabine|gemcitabine|mesh-list
13869563|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869564|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13869565|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
13869566|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869567|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
13869568|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869569|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869570|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13869571|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
13869572|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869573|NCT03672812|Liraglutide|liraglutide|mesh-list
13869574|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13869575|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869576|NCT03672812|Incretins|incretins|mesh-ancestor
13869577|NCT03672812|Hormones|hormones|mesh-ancestor
13869578|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869579|NCT03672539|Cytarabine|cytarabine|mesh-list
13869580|NCT03672539|Daunorubicin|daunorubicin|mesh-list
13869581|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
13869582|NCT03672539|Calicheamicins|calicheamicins|mesh-list
13869583|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14026517|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869584|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
13869585|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869586|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869587|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
13869588|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869589|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13869590|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
13869591|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869592|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13869593|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13869594|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13869595|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869596|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13869597|NCT03672500|Epinephrine|epinephrine|mesh-list
13869598|NCT03672500|Bupivacaine|bupivacaine|mesh-list
13869599|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
13869600|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
13869601|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869602|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869603|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
13869604|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869605|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13869606|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13869607|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
13869608|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869609|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869610|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13869611|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13869612|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
13869613|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13869614|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
13869615|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
13869616|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
13869617|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13869618|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
13869619|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
13869620|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
13869621|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869622|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869623|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
13869624|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869625|NCT03672357|Liver Extracts|liver extracts|mesh-list
13869626|NCT03672357|Hematinics|hematinics|mesh-ancestor
13869627|NCT03672149|Cefazolin|cefazolin|mesh-list
13869628|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869629|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869630|NCT03672071|Ephedrine|ephedrine|mesh-list
13869631|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
13869632|NCT03672071|Norepinephrine|norepinephrine|mesh-list
13869633|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13869634|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869635|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
13869636|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
13869637|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869638|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13869639|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
13869640|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869641|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869642|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13869643|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13869644|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
13869645|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
13869646|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13869647|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13869648|NCT03672045|Carbetocin|carbetocin|mesh-list
13869649|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
13869650|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13869651|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869652|NCT03671941|Ticagrelor|ticagrelor|mesh-list
13869653|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13869654|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13869655|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13869656|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13869657|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
13869658|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869659|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869660|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869661|NCT03671915|Insulin|insulin|mesh-list
13869662|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13869663|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869664|NCT03671811|Megestrol|megestrol|mesh-list
13869665|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
13869666|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13869667|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13869668|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13869669|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
13869670|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13869671|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869672|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13869673|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13869674|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13869675|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869676|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
13869677|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13869678|NCT03671759|Caffeine|caffeine|mesh-list
13869679|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13869680|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869681|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13869682|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869683|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869684|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13869685|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13869686|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
13869687|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869688|NCT03671746|Ketorolac|ketorolac|mesh-list
13869689|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13869690|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13869691|NCT03671746|Analgesics|analgesics|mesh-ancestor
13869692|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
13869693|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869694|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869695|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869696|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869697|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13869698|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869699|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869700|NCT03671733|Liraglutide|liraglutide|mesh-list
13869701|NCT03671733|Exenatide|exenatide|mesh-list
13869702|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13869703|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869704|NCT03671733|Incretins|incretins|mesh-ancestor
13869705|NCT03671733|Hormones|hormones|mesh-ancestor
13869706|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869707|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13869708|NCT03671707|Nicotine|nicotine|mesh-list
13869709|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13869710|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
13869711|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026518|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14026519|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14026520|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14026521|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14026522|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
14026523|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
14026524|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14470339|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470340|NCT02308228|Metformin|metformin|mesh-list
14470341|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14470342|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470343|NCT02308501|Alcaftadine|alcaftadine|mesh-list
14470344|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14470345|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
14470346|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
14470347|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470348|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470349|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470350|NCT02308540|Vaccines|vaccines|mesh-list
14470351|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14470352|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
14470353|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470354|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
13869712|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869713|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13869714|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13869715|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
13869716|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869717|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956103|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13956104|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13956105|NCT03184870|Antidotes|antidotes|mesh-ancestor
13956106|NCT03184870|Protective Agents|protective agents|mesh-ancestor
13956107|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
13956108|NCT03184870|Vitamins|vitamins|mesh-ancestor
13956109|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
13956110|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
13956111|NCT03185130|Promethazine|promethazine|mesh-list
13956112|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
13956113|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13956114|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13956115|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956116|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956117|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
13956118|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
13956119|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
13956120|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956121|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
14470355|NCT02308748|Lidocaine|lidocaine|mesh-list
14470356|NCT02308748|Mexiletine|mexiletine|mesh-list
13956122|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
13956123|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956124|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13956125|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
13956126|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
13956127|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956128|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956129|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13956130|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
13956131|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
13956132|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13956133|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13956134|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13956135|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13956136|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
14470357|NCT02308748|Dofetilide|dofetilide|mesh-list
14470358|NCT02308748|Diltiazem|diltiazem|mesh-list
14470359|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
14470360|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
14026525|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
14026526|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14026527|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
13956137|NCT03184805|Aspirin|aspirin|mesh-list
13956138|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956139|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14026528|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026529|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026530|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
14026531|NCT02742285|Lumefantrine|lumefantrine|mesh-list
14026532|NCT02742285|Artemether|artemether|mesh-list
14026533|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14026534|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
14026535|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14026536|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13956140|NCT03184805|Analgesics|analgesics|mesh-ancestor
13956141|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
13956142|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956143|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956144|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956145|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956146|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13956147|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13956148|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956149|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13956150|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13956151|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956152|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
13963065|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963066|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026537|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470361|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869718|NCT03671655|Paclitaxel|paclitaxel|mesh-list
13869719|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13869720|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869721|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
13869722|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
13869723|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
13869724|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869725|NCT03671538|Pemetrexed|pemetrexed|mesh-list
13869726|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869727|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869728|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869729|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13869730|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13869731|NCT03671369|Vaccines|vaccines|mesh-list
13869732|NCT03671369|Immunologic Factors|immunologic factors|mesh-ancestor
13869733|NCT03671369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869734|NCT03671265|Apatinib|apatinib|mesh-list
13869735|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869736|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13869737|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869738|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869739|NCT03671174|Aspirin|aspirin|mesh-list
13869740|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
13869741|NCT03671174|Prednisone|prednisone|mesh-list
13869742|NCT03671174|Heparin|heparin|mesh-list
13869743|NCT03671174|Enoxaparin|enoxaparin|mesh-list
13869744|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13869745|NCT03671174|Tinzaparin|tinzaparin|mesh-list
13869746|NCT03671174|Dalteparin|dalteparin|mesh-list
13869747|NCT03671174|Nadroparin|nadroparin|mesh-list
13869748|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869749|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
13869750|NCT03671174|Hormones|hormones|mesh-ancestor
13869751|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869752|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869753|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13869754|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869755|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13869756|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13869757|NCT03671174|Analgesics|analgesics|mesh-ancestor
13869758|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
13869759|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869760|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869761|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13869762|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13869763|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869764|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13869765|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13869766|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869767|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
13869768|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
13869769|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
13869770|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13869771|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13869772|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869773|NCT03671161|Insulin|insulin|mesh-list
13869774|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13869775|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869776|NCT03671109|Piperaquine|piperaquine|mesh-list
13869777|NCT03671109|Artenimol|artenimol|mesh-list
13869778|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
13869779|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13869780|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13869781|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869782|NCT03671070|Epinephrine|epinephrine|mesh-list
13869783|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13869784|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13869785|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
13869786|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869787|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869788|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869789|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13869790|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13869791|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
13869792|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869793|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13869794|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
13869795|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
13869796|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
13869797|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13869798|NCT03671057|Midazolam|midazolam|mesh-list
13869799|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13869800|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13869801|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869802|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869803|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13869804|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13869805|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13869806|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13869807|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
13869808|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
13869809|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
13869810|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
13869811|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869812|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869813|NCT03671044|Docetaxel|docetaxel|mesh-list
13869814|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869815|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
13869816|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
13869817|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
13869818|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869819|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13869820|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13869821|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
13869822|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869823|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13869824|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13869825|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
13869826|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
13869827|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869828|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869829|NCT03670901|Rituximab|rituximab|mesh-list
13869830|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13869831|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869832|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
13869833|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869834|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869835|NCT03670888|Rituximab|rituximab|mesh-list
13869836|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13869837|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869838|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
13869839|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869840|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869841|NCT03670875|Curcumin|curcumin|mesh-list
13869842|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13869843|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13869844|NCT03670875|Analgesics|analgesics|mesh-ancestor
13869845|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
13869846|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869847|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869848|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869849|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13869850|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869851|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869852|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869853|NCT03670836|Misoprostol|misoprostol|mesh-list
13869854|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13869855|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
13869856|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13869857|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869858|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13869859|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869860|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
13869861|NCT03670758|Protein S|protein s|mesh-list
13869862|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
13869863|NCT03670706|Analgesics|analgesics|mesh-list
13869864|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
13869865|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869866|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869867|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
13869868|NCT03670212|Yohimbine|yohimbine|mesh-list
13869869|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869870|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
13869871|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
13869872|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869873|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869874|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13869875|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13869876|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13869877|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
13869878|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869879|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869880|NCT03670212|Urological Agents|urological agents|mesh-ancestor
13869881|NCT03670095|Memantine|memantine|mesh-list
13869882|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13869883|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13869884|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
13869885|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13869886|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869887|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869888|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13869889|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14470362|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470363|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
14470364|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470365|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14470366|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13869896|NCT03670043|Metformin|metformin|mesh-list
13869897|NCT03670043|Psyllium|psyllium|mesh-list
13869898|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13869899|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869900|NCT03670043|Cathartics|cathartics|mesh-ancestor
13869901|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956153|NCT03184649|Acetaminophen|acetaminophen|mesh-list
13956154|NCT03184649|Ibuprofen|ibuprofen|mesh-list
13956155|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956156|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956157|NCT03184649|Analgesics|analgesics|mesh-ancestor
13956158|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
13956159|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956160|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956161|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956162|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956163|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13956164|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956165|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956166|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
13956167|NCT03184480|Fluticasone|fluticasone|mesh-list
13956168|NCT03184480|Xhance|xhance|mesh-list
13956169|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956170|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13956171|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
13956172|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956173|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956174|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13956175|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
13956176|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
13956177|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13956178|NCT03184493|Metformin|metformin|mesh-list
13956179|NCT03184493|Celecoxib|celecoxib|mesh-list
13956180|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956181|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956182|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956183|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956184|NCT03184493|Analgesics|analgesics|mesh-ancestor
13956185|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
13956186|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956187|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956188|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956189|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13956190|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13956191|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956192|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956193|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13956194|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13956195|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13956196|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956197|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869902|NCT03669783|Dactinomycin|dactinomycin|mesh-list
13869903|NCT03669783|Carboplatin|carboplatin|mesh-list
13869904|NCT03669783|Doxorubicin|doxorubicin|mesh-list
13869905|NCT03669783|Etoposide|etoposide|mesh-list
13869906|NCT03669783|Vincristine|vincristine|mesh-list
13869907|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869908|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13869909|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13869910|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13869911|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869912|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869913|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13869914|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13869915|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869916|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13869917|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13869918|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
13869919|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
13869920|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
13869921|NCT03669757|Betamethasone|betamethasone|mesh-list
13869922|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
13869923|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13869924|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
13869925|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13869926|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869927|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
13869928|NCT03669757|Hormones|hormones|mesh-ancestor
13869929|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869930|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869931|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13869932|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
13869933|NCT03669601|Gemcitabine|gemcitabine|mesh-list
13869934|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13869935|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
13869936|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869937|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869938|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
13869939|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13869940|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869941|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13869942|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
13869943|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869944|NCT03669562|Alprostadil|alprostadil|mesh-list
13869945|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14931290|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14931291|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931292|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931293|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13869946|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
13869947|NCT03669562|Urological Agents|urological agents|mesh-ancestor
13869948|NCT03669484|Fentanyl|fentanyl|mesh-list
13869949|NCT03669484|Bromides|bromides|mesh-list
13869950|NCT03669484|Propofol|propofol|mesh-list
13869951|NCT03669484|Rocuronium|rocuronium|mesh-list
13869952|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13869953|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869954|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869955|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13869956|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
13869957|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
13869958|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13869959|NCT03669484|Narcotics|narcotics|mesh-ancestor
13869960|NCT03669484|Analgesics|analgesics|mesh-ancestor
13869961|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
13869962|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869963|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13869964|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
13869965|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13869966|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13869967|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13869968|NCT03669445|Dexamethasone|dexamethasone|mesh-list
13869969|NCT03669445|Lenalidomide|lenalidomide|mesh-list
13869970|NCT03669445|Daratumumab|daratumumab|mesh-list
13869971|NCT03669445|Ixazomib|ixazomib|mesh-list
13869972|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13869973|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
13869974|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
13869975|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13869976|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869977|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13869978|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
13869979|NCT03669445|Hormones|hormones|mesh-ancestor
13869980|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13869981|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13869982|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13869983|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
13869984|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13869985|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14931294|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14931295|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14931296|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13869986|NCT03669445|Growth Substances|growth substances|mesh-ancestor
13869987|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
13869988|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
13869989|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13869990|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13869991|NCT03669328|Anesthetics|anesthetics|mesh-list
13869992|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869993|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869994|NCT03669263|Fentanyl|fentanyl|mesh-list
13869995|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13869996|NCT03669263|Narcotics|narcotics|mesh-ancestor
13869997|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13869998|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13869999|NCT03669263|Analgesics|analgesics|mesh-ancestor
13870000|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
13870001|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870002|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13870003|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13870004|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
13870005|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
13870006|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
13870007|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13870008|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13870009|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870010|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
13870011|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
13870012|NCT03669029|Golimumab|golimumab|mesh-list
13870013|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13870014|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13870015|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870016|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870017|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
13870018|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870019|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
13870020|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
13870021|NCT03669003|Coagulants|coagulants|mesh-ancestor
13870022|NCT03668964|Vitamin D|vitamin d|mesh-list
13870023|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
13870024|NCT03668964|Vitamins|vitamins|mesh-list
13870025|NCT03668964|Vitamin E|vitamin e|mesh-list
13870026|NCT03668964|Tocopherols|tocopherols|mesh-list
13870027|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
13870028|NCT03668964|Vitamin A|vitamin a|mesh-list
13870029|NCT03668964|Riboflavin|riboflavin|mesh-list
13870030|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
13870031|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
13870032|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870033|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13870034|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13870035|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
13870036|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870037|NCT03668964|Protective Agents|protective agents|mesh-ancestor
13870038|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13870039|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
13870040|NCT03668860|Dexamethasone|dexamethasone|mesh-list
13870041|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
13870042|NCT03668860|Betamethasone|betamethasone|mesh-list
13870043|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
13870044|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13870045|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
13870046|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
13870047|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13870048|NCT03668860|BB 1101|bb 1101|mesh-list
13870049|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870050|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
13870051|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
13870052|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870053|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870054|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870055|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
13870056|NCT03668860|Hormones|hormones|mesh-ancestor
13870057|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870058|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931297|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14931298|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14931299|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14931300|NCT01438554|Trametinib|trametinib|mesh-list
14931301|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931302|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14931303|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931304|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931305|NCT01438567|Oxycodone|oxycodone|mesh-list
13870059|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870060|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
13870061|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870062|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870063|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13870064|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
13870065|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13870066|NCT03668808|Insulin|insulin|mesh-list
13870067|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13870068|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
13870069|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
13870070|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13870071|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870072|NCT03668730|Paclitaxel|paclitaxel|mesh-list
13870073|NCT03668730|Fluorouracil|fluorouracil|mesh-list
13870074|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13870075|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870076|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
13870077|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
13870078|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
13870079|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870080|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
13870081|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13870082|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870083|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
13870084|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870085|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
13870086|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13870087|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
13870088|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870089|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
13870090|NCT03668665|Protective Agents|protective agents|mesh-ancestor
13870091|NCT03668470|Dulaglutide|dulaglutide|mesh-list
13870092|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13870093|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870094|NCT03668431|Trametinib|trametinib|mesh-list
13870095|NCT03668431|Dabrafenib|dabrafenib|mesh-list
13870096|NCT03668431|Spartalizumab|spartalizumab|mesh-list
13870097|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870098|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13870099|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870100|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870101|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13870102|NCT03668418|Gemcitabine|gemcitabine|mesh-list
13870103|NCT03668418|Camptothecin|camptothecin|mesh-list
13870104|NCT03668418|Docetaxel|docetaxel|mesh-list
13870105|NCT03668418|Fluorouracil|fluorouracil|mesh-list
13870106|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
13870107|NCT03668418|Irinotecan|irinotecan|mesh-list
13870108|NCT03668418|Epirubicin|epirubicin|mesh-list
13870109|NCT03668418|Taxane|taxane|mesh-list
13870110|NCT03668418|Antimetabolites|antimetabolites|mesh-list
13870111|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13870112|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870113|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
13870114|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14931306|NCT01438567|Naloxone|naloxone|mesh-list
13870115|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
13870116|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870117|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13870118|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
13870119|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870120|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870121|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870122|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
13870123|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870124|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13870125|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13870126|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13870127|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13956198|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13956199|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13956200|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956201|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
13956202|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956203|NCT03184766|Ibuprofen|ibuprofen|mesh-list
13956204|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
13956205|NCT03184766|Ephedrine|ephedrine|mesh-list
13956206|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956207|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956208|NCT03184766|Analgesics|analgesics|mesh-ancestor
13956209|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
13956210|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956211|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956212|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956213|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956214|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13956215|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956216|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956217|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13956218|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
13956219|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13956220|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
13956221|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
13956222|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13956223|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13956224|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
13956225|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
13956226|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956227|NCT03184324|Esomeprazole|esomeprazole|mesh-list
13956228|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13956229|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956230|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13956231|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956232|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956233|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
13956234|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
13956235|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
13956236|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956237|NCT03184090|Palbociclib|palbociclib|mesh-list
13956238|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956239|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13956240|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956241|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956242|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
13956243|NCT03184194|Nivolumab|nivolumab|mesh-list
13956244|NCT03184194|Daratumumab|daratumumab|mesh-list
13956245|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13956246|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13956247|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
13956248|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956249|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956250|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13956251|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
14026538|NCT02742480|Dabigatran|dabigatran|mesh-list
14026539|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
14026540|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
14026541|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14026542|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
14026543|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931307|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14931308|NCT01438567|Narcotics|narcotics|mesh-ancestor
14479072|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
13956252|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870128|NCT03668340|Adavosertib|adavosertib|mesh-list
13870129|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870130|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870131|NCT03668262|Atracurium|atracurium|mesh-list
13870132|NCT03668262|Cisatracurium|cisatracurium|mesh-list
13870133|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13870134|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13870135|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13870136|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870137|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870138|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
13870139|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13870140|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
13870141|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870142|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870143|NCT03668054|Bevacizumab|bevacizumab|mesh-list
13870144|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13870145|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870146|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13870147|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13870148|NCT03668054|Growth Substances|growth substances|mesh-ancestor
13870149|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870150|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
13870151|NCT03668041|Gabapentin|gabapentin|mesh-list
13870152|NCT03668041|Trazodone|trazodone|mesh-list
13870153|NCT03668041|Eszopiclone|eszopiclone|mesh-list
13870154|NCT03668041|Analgesics|analgesics|mesh-ancestor
13870155|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
13870156|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870157|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870158|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
13870159|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13870160|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13870161|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870162|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13870163|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13870164|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13870165|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870166|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870167|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
13870168|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13870169|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13870170|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870171|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
13870172|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13870173|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
13870174|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13870175|NCT03668015|Sorbitol|sorbitol|mesh-list
13870176|NCT03668015|Cathartics|cathartics|mesh-ancestor
13870177|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870178|NCT03667963|Lactulose|lactulose|mesh-list
13870179|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870180|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13870181|NCT03667937|Laxatives|laxatives|mesh-ancestor
13870182|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870183|NCT03667820|Osimertinib|osimertinib|mesh-list
13870184|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870185|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13870186|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870187|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870188|NCT03667703|Famotidine|famotidine|mesh-list
13870189|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13870190|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870191|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13870192|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
13870193|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
13870194|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870195|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870196|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870197|NCT03667677|Amlodipine|amlodipine|mesh-list
13870198|NCT03667677|Tandospirone|tandospirone|mesh-list
13870199|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13870200|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13870201|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870202|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870203|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13870204|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870205|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
13870206|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13870207|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13870208|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870209|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13870210|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13870211|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
13870212|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870213|NCT03667651|Decanoic acid|decanoic acid|mesh-list
13870214|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
13870215|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870216|NCT03667352|Fentanyl|fentanyl|mesh-list
13870217|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13870218|NCT03667352|Narcotics|narcotics|mesh-ancestor
13870219|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870220|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870221|NCT03667352|Analgesics|analgesics|mesh-ancestor
13870222|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
13870223|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870224|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13870225|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13870226|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
13870227|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
13870228|NCT03667326|Aspirin|aspirin|mesh-list
13870229|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13870230|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13870231|NCT03667326|Analgesics|analgesics|mesh-ancestor
13870232|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
13870233|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870234|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870235|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870236|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753929|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753930|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
14753931|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
14753932|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753933|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870237|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13870238|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13870239|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870240|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13870241|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13870242|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870243|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
13870244|NCT03667313|Sirolimus|sirolimus|mesh-list
13870245|NCT03667313|Paclitaxel|paclitaxel|mesh-list
13870246|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13870247|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870248|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
13870249|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
13870250|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
13870251|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870252|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13870253|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870254|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13870255|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
13870256|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870257|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
13870258|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870259|NCT03667300|Linagliptin|linagliptin|mesh-list
13870260|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13870261|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870262|NCT03667300|Incretins|incretins|mesh-ancestor
13870263|NCT03667300|Hormones|hormones|mesh-ancestor
13870264|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870265|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13870266|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
13870267|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870268|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470367|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14470368|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479073|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
13870269|NCT03667235|Glutaral|glutaral|mesh-list
13870270|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
13870271|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870272|NCT03667222|Minocycline|minocycline|mesh-list
13870273|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13870274|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870275|NCT03667131|Enalapril|enalapril|mesh-list
13870276|NCT03667131|Enalaprilat|enalaprilat|mesh-list
13870277|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
13870278|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13870279|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870280|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
13870281|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13870282|NCT03667079|Vaccines|vaccines|mesh-list
13870283|NCT03667079|Immunologic Factors|immunologic factors|mesh-ancestor
13870284|NCT03667079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870285|NCT03667066|Clopidogrel|clopidogrel|mesh-list
13870286|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13870287|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13870288|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13870289|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13870290|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
13870291|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870292|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870293|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870294|NCT03667001|Lidocaine|lidocaine|mesh-list
13870295|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
13870296|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
13870297|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870298|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870299|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
13870300|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870301|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13870302|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13870303|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13870304|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870305|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870306|NCT03666949|Anesthetics|anesthetics|mesh-list
13870307|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870308|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870309|NCT03666884|Cyclosporine|cyclosporine|mesh-list
13870310|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13870311|NCT03666884|Cyclosporins|cyclosporins|mesh-list
13870312|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13870313|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870314|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870315|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870316|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
13870317|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870318|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
13870319|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870320|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
13870321|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13870322|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13956253|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956254|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13956255|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13956256|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13956257|NCT03183752|Metformin|metformin|mesh-list
13956258|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956259|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956260|NCT03183843|Warfarin|warfarin|mesh-list
13956261|NCT03183843|Dabigatran|dabigatran|mesh-list
13956262|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
13956263|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
13956264|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13956265|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
13956266|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956267|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956268|NCT03183674|Oxytocin|oxytocin|mesh-list
13956269|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
13956270|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13956271|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956272|NCT03183596|Dexamethasone|dexamethasone|mesh-list
13956273|NCT03183596|Bupivacaine|bupivacaine|mesh-list
13956274|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870323|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13870324|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
13870325|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13870326|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870327|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870328|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13870329|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13870330|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13870331|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
13870332|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870333|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870334|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13870335|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13870336|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
13870337|NCT03666650|Edoxaban|edoxaban|mesh-list
13870338|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13870339|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
13870340|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13870341|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
13870342|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870343|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870344|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
13870345|NCT03666546|Methamphetamine|methamphetamine|mesh-list
13870346|NCT03666546|Lactulose|lactulose|mesh-list
13870347|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870348|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13870349|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870350|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
13870351|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
13870352|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870353|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
13870354|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870355|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870356|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
13870357|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13870358|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13870359|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870360|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13870361|NCT03666494|Fentanyl|fentanyl|mesh-list
13870362|NCT03666494|Ketamine|ketamine|mesh-list
13870363|NCT03666494|Propofol|propofol|mesh-list
13870364|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13870365|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870366|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870367|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13870368|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
13870369|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
13870370|NCT03666494|Analgesics|analgesics|mesh-ancestor
13870371|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
13870372|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870373|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13870374|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13870375|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13870376|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870377|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870378|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13870379|NCT03666494|Narcotics|narcotics|mesh-ancestor
13870380|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13870381|NCT03666390|Midazolam|midazolam|mesh-list
13870382|NCT03666390|Ketamine|ketamine|mesh-list
13870383|NCT03666390|Analgesics|analgesics|mesh-ancestor
13870384|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
13870385|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870386|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870387|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13870388|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13870389|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
13870390|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
13870391|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870392|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13870393|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13870394|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870395|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870396|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13870397|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13870398|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13870399|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13870400|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13870401|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
13870402|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
13870403|NCT03666351|Losartan|losartan|mesh-list
13870404|NCT03666351|Amlodipine|amlodipine|mesh-list
13870405|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
13870406|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13870407|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13870408|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870409|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870410|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14753934|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13870411|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870412|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
13870413|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13870414|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13870415|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13870416|NCT03666351|Diuretics|diuretics|mesh-ancestor
13870417|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
13870418|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13870419|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
13870420|NCT03666325|Cetuximab|cetuximab|mesh-list
13870421|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13870422|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870423|NCT03666299|Lidocaine|lidocaine|mesh-list
13870424|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
13870425|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
13870426|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870427|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870428|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
13870429|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870430|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13870431|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13870432|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13870433|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870434|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870435|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
13870436|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13870437|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870438|NCT03666208|Sirolimus|sirolimus|mesh-list
13870439|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13870440|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870441|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13870442|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870443|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
13870444|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870445|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
13870446|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870447|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
13870448|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
13870449|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13870450|NCT03666195|Protective Agents|protective agents|mesh-ancestor
13870451|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870452|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
13870453|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14470369|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753935|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14753936|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
14753937|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14753938|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13870454|NCT03666065|Insulin|insulin|mesh-list
13870455|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13870456|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
13870457|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13870458|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470370|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470371|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470372|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14470373|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14470374|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470375|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470376|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14470377|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14470378|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14470379|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
14470380|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13870470|NCT03665779|Pyridoxine|pyridoxine|mesh-list
13870471|NCT03665779|Isosorbide|isosorbide|mesh-list
13870472|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13870473|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13870474|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13870475|NCT03665779|Diuretics|diuretics|mesh-ancestor
13870476|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
13870477|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870478|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
13870479|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13870480|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870481|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
13870482|NCT03665779|Vitamins|vitamins|mesh-ancestor
13870483|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
13870484|NCT03665766|Cycloserine|cycloserine|mesh-list
13870485|NCT03665766|Tacrolimus|tacrolimus|mesh-list
13870486|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870487|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
13870488|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870489|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13870490|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870491|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870492|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13870493|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870494|NCT03665766|Renal Agents|renal agents|mesh-ancestor
13870495|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13870496|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
13870497|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13870498|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
13870499|NCT03665753|Ketorolac|ketorolac|mesh-list
13870500|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13870501|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13870502|NCT03665753|Analgesics|analgesics|mesh-ancestor
13870503|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
13870504|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870505|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870506|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870507|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13870508|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13870509|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870510|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870511|NCT03665740|Resveratrol|resveratrol|mesh-list
13870512|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
13870513|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870514|NCT03665740|Protective Agents|protective agents|mesh-ancestor
13870515|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870516|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870517|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13870518|NCT03665610|Ozanimod|ozanimod|mesh-list
13870519|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13870520|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870521|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870522|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
13870523|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870524|NCT03665545|Poly I-C|poly i-c|mesh-list
13870525|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
13870526|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13870527|NCT03665545|Poly ICLC|poly iclc|mesh-list
13870528|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13870529|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870530|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
13870531|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
13870532|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870533|NCT03665545|Laxatives|laxatives|mesh-ancestor
13870534|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870535|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
13870536|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870537|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13870538|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13870539|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870540|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13870541|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13870542|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
13870543|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870544|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13870545|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13870546|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
13870547|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
13870548|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870549|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870550|NCT03665441|Leucovorin|leucovorin|mesh-list
13870551|NCT03665441|Gemcitabine|gemcitabine|mesh-list
13870552|NCT03665441|Paclitaxel|paclitaxel|mesh-list
13870553|NCT03665441|Irinotecan|irinotecan|mesh-list
13870554|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13870555|NCT03665441|Asparaginase|asparaginase|mesh-list
13870556|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13870557|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870558|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
13870559|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
13870560|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
13870561|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870562|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13870563|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
13870564|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
13870565|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870566|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870567|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870568|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
13870569|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870570|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13870571|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13870572|NCT03665441|Antidotes|antidotes|mesh-ancestor
13870573|NCT03665441|Protective Agents|protective agents|mesh-ancestor
13870574|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
13870575|NCT03665441|Vitamins|vitamins|mesh-ancestor
13870576|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
13870577|NCT03665428|Bismuth|bismuth|mesh-list
13870578|NCT03665428|Antacids|antacids|mesh-ancestor
13870579|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870580|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870581|NCT03665402|Isoniazid|isoniazid|mesh-list
13870582|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
13870583|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13870584|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870585|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13870586|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13870587|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
13870588|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870589|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13870590|NCT03665350|Insulin|insulin|mesh-list
13870591|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13870592|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956275|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
13956276|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
13956277|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956278|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956279|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956280|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
13956281|NCT03183596|Hormones|hormones|mesh-ancestor
13956282|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956283|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13956284|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956285|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
13956286|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
13956287|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956288|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
13956289|NCT03183557|Vitamin D|vitamin d|mesh-list
13870593|NCT03665181|Bismuth|bismuth|mesh-list
13870594|NCT03665181|Antacids|antacids|mesh-ancestor
13870595|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870596|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870597|NCT03664986|Bupivacaine|bupivacaine|mesh-list
13870598|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
14026544|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026545|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
14026546|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
14026547|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
14026548|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14026549|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
14026550|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026551|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
14026552|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931309|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931310|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931311|NCT01438567|Analgesics|analgesics|mesh-ancestor
14931312|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
14931313|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931314|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14931315|NCT01438580|Aspirin|aspirin|mesh-list
14931316|NCT01438580|Warfarin|warfarin|mesh-list
14026553|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026554|NCT02742233|Saxagliptin|saxagliptin|mesh-list
14026555|NCT02742233|Incretins|incretins|mesh-ancestor
14026556|NCT02742233|Hormones|hormones|mesh-ancestor
14026557|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026558|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026559|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14026560|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
14026561|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026562|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026563|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026564|NCT02742467|Amlodipine|amlodipine|mesh-list
14026565|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14026566|NCT02742467|Perindopril|perindopril|mesh-list
14026567|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14026568|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14026569|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026570|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026571|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14026572|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026573|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
14026574|NCT02742467|Diuretics|diuretics|mesh-ancestor
14026575|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
14026576|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14026577|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14026578|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
14026579|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026580|NCT02742181|Alvimopan|alvimopan|mesh-list
14470381|NCT02309359|Methotrexate|methotrexate|mesh-list
14931317|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14931318|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13870599|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
13870600|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870601|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870602|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
13870603|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870604|NCT03664908|Antibodies|antibodies|mesh-list
13870605|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
13870606|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870607|NCT03664895|Goserelin|goserelin|mesh-list
13870608|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13870609|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470382|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14470383|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
14470384|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14470385|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470386|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14470387|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
14470388|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470389|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931319|NCT01438580|Analgesics|analgesics|mesh-ancestor
13870619|NCT03664869|Mitomycins|mitomycins|mesh-list
13870620|NCT03664869|Mitomycin|mitomycin|mesh-list
13870621|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14753939|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14753940|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14753941|NCT04898894|Vidarabine|vidarabine|mesh-list
14753942|NCT04898894|Cytarabine|cytarabine|mesh-list
14753943|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
13870622|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870623|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
13870624|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870625|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13870626|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870627|NCT03664622|Ketamine|ketamine|mesh-list
13870628|NCT03664622|Morphine|morphine|mesh-list
13870629|NCT03664622|Analgesics|analgesics|mesh-ancestor
13870630|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
13870631|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870632|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870633|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13870634|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13870635|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
13870636|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
13870637|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870638|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13870639|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13870640|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870641|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870642|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13870643|NCT03664622|Narcotics|narcotics|mesh-ancestor
13870644|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13870645|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13870646|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870647|NCT03664440|Nevirapine|nevirapine|mesh-list
13870648|NCT03664440|Rilpivirine|rilpivirine|mesh-list
13870649|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13870650|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13870651|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870652|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870653|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
13870654|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870655|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13870656|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13870657|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13870658|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13870659|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
13870660|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13870661|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870662|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870663|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13870664|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13870665|NCT03664414|Protective Agents|protective agents|mesh-ancestor
13870666|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870667|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
13870668|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13870669|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
13870670|NCT03664388|Clopidogrel|clopidogrel|mesh-list
13870671|NCT03664388|Ticagrelor|ticagrelor|mesh-list
13870672|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13870673|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13870674|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13870675|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13870676|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
13870677|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870678|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753944|NCT04898894|Methotrexate|methotrexate|mesh-list
14753945|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
14753946|NCT04898894|Fludarabine|fludarabine|mesh-list
14753947|NCT04898894|Venetoclax|venetoclax|mesh-list
14753948|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14753949|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
14753950|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14753951|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870679|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753952|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14753953|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
14931320|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
14931321|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931322|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931323|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14931324|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14931325|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14931326|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14931327|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931328|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14931329|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14931330|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870680|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
13870681|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13870682|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13870683|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13870684|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870685|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870686|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
13870687|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870688|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870689|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13870690|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870691|NCT03664115|Itraconazole|itraconazole|mesh-list
13870692|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
13870693|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870694|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13870695|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13870696|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870697|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870698|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13870699|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
13870700|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870701|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870702|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13870703|NCT03664063|Azithromycin|azithromycin|mesh-list
14931331|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
14931332|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
14931333|NCT01438632|Insulin|insulin|mesh-list
14931334|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931335|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931336|NCT01438723|Metformin|metformin|mesh-list
14931337|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931338|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931339|NCT01438736|Etonogestrel|etonogestrel|mesh-list
14931340|NCT01438736|Desogestrel|desogestrel|mesh-list
14931341|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14753954|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753955|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753956|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
14753957|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14753958|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14753959|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14753960|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
14753961|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14753962|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14753963|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
14931342|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
13870704|NCT03664063|Ivermectin|ivermectin|mesh-list
13870705|NCT03664063|Albendazole|albendazole|mesh-list
13870706|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
13870707|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13870708|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870709|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13870710|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
13870711|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
13870712|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13870713|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13870714|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
13870715|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
14026581|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870716|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
13870717|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767166|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
13870718|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870719|NCT03664063|Filaricides|filaricides|mesh-ancestor
13870720|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
13870721|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
13870722|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870723|NCT03664050|Letrozole|letrozole|mesh-list
13870724|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870725|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13870726|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13870727|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870728|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870729|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13870730|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
13870731|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870732|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870733|NCT03664037|Dexamethasone|dexamethasone|mesh-list
13870734|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13870735|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870736|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
13870737|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
13870738|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870739|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870740|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870741|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
13870742|NCT03664037|Hormones|hormones|mesh-ancestor
13870743|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870744|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13870745|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870746|NCT03663751|Decitabine|decitabine|mesh-list
13870747|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13870748|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
13870749|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870750|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870751|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870752|NCT03663673|Decanoic acid|decanoic acid|mesh-list
13870753|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
13870754|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870755|NCT03663543|Estrogens|estrogens|mesh-list
13870756|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
13870757|NCT03663543|Hormones|hormones|mesh-ancestor
13870758|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870759|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870760|NCT03663478|Ropivacaine|ropivacaine|mesh-list
13870761|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
13870762|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
13870763|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870764|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870765|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
13870766|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870767|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
13870768|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13870769|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870770|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870771|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13956290|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
14753964|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14753965|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14753966|NCT04895436|Venetoclax|venetoclax|mesh-list
14753967|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
14753968|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753969|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13956291|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
13956292|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13956293|NCT03183557|Vitamins|vitamins|mesh-ancestor
14026582|NCT02742142|Fluorides|fluorides|mesh-list
13956294|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
14026583|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
14767167|NCT00629135|Metronidazole|metronidazole|mesh-list
13870772|NCT03663114|Lenvatinib|lenvatinib|mesh-list
13870773|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870774|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13870775|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870776|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870777|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
13870778|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13870779|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
13870780|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870781|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13870782|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13870783|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13870784|NCT03662958|Leuprolide|leuprolide|mesh-list
13870785|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13870786|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
13870787|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13870788|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870789|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13870790|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870791|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
13870792|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13870793|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
13870794|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870795|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870796|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870797|NCT03662763|Guanfacine|guanfacine|mesh-list
13870798|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13870799|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13870800|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13870801|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13870802|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
13870803|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870804|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870805|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870806|NCT03662724|Venetoclax|venetoclax|mesh-list
13870807|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870808|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
13870809|NCT03662711|Olodaterol|olodaterol|mesh-list
13870810|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
13870811|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870812|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870813|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13870814|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
13870815|NCT03662620|Amlodipine|amlodipine|mesh-list
13870816|NCT03662620|Telmisartan|telmisartan|mesh-list
13870817|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
13870818|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13870819|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13870820|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870821|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870822|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13870823|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870824|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
13870825|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13870826|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13870827|NCT03662620|Diuretics|diuretics|mesh-ancestor
13870828|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
13870829|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13870830|NCT03662568|Ritonavir|ritonavir|mesh-list
13870831|NCT03662568|Tenofovir|tenofovir|mesh-list
13870832|NCT03662568|Entecavir|entecavir|mesh-list
13870833|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13870834|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13870835|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
13870836|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870837|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870838|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13870839|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13870840|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
13870841|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870842|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13870843|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13870844|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13870845|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13870846|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
13870847|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13870848|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
13870849|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
13870850|NCT03662516|Estradiol|estradiol|mesh-list
13870851|NCT03662516|Abrocitinib|abrocitinib|mesh-list
13870852|NCT03662516|Estrogens|estrogens|mesh-ancestor
13870853|NCT03662516|Hormones|hormones|mesh-ancestor
13870854|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870855|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870856|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13870857|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13870858|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13870859|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13870860|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13870861|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13870862|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870863|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870864|NCT03662425|Oxytocin|oxytocin|mesh-list
13870865|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
13870866|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13870867|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870868|NCT03662412|Sirolimus|sirolimus|mesh-list
13870869|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13870870|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13870871|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13870872|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870873|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
13870874|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870875|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
13870876|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870877|NCT03662269|Indomethacin|indomethacin|mesh-list
13870878|NCT03662269|Omeprazole|omeprazole|mesh-list
13870879|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13870880|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870881|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13870882|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870883|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870884|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13870885|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13870886|NCT03662269|Analgesics|analgesics|mesh-ancestor
13870887|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
13870888|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870889|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870890|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870891|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13870892|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
13870893|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
13870894|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13870895|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13870896|NCT03662113|Domperidone|domperidone|mesh-list
13870897|NCT03662113|Simethicone|simethicone|mesh-list
13870898|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
13870899|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
13870900|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870901|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870902|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870903|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13870904|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
13870905|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870906|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870907|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
13870908|NCT03662113|Emollients|emollients|mesh-ancestor
13870909|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
13870910|NCT03662100|Mirikizumab|mirikizumab|mesh-list
13870911|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13870912|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13870913|NCT03662100|Analgesics|analgesics|mesh-ancestor
13870914|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
13870915|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870916|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870917|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870918|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13870919|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13870920|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13870921|NCT03662035|Apatinib|apatinib|mesh-list
13870922|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870923|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13870924|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13870925|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870926|NCT03661892|Dronabinol|dronabinol|mesh-list
13870927|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
13870928|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870929|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13870930|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13870931|NCT03661892|Analgesics|analgesics|mesh-ancestor
13870932|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
13870933|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870934|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13870935|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13870936|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870937|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870938|NCT03661892|Hormones|hormones|mesh-ancestor
13870939|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870940|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
13870941|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13870942|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13870943|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870944|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870945|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
13870946|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13870947|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870948|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
13870949|NCT03661775|Analgesics|analgesics|mesh-ancestor
13870950|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
13870951|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870952|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870953|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
13870954|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13870955|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13870956|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
13870957|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13870958|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13870959|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870960|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13870961|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
13870962|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13870963|NCT03661684|Prednisone|prednisone|mesh-list
13870964|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870965|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
13870966|NCT03661684|Hormones|hormones|mesh-ancestor
13870967|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870968|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870969|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13870970|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870971|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
14931343|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14931344|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870972|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13870973|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13870974|NCT03661567|Prednisolone|prednisolone|mesh-list
13870975|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
13870976|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13870977|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
13870978|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13870979|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
13870980|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
13870981|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13870982|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13870983|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931345|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14931346|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13870984|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
13870985|NCT03661567|Hormones|hormones|mesh-ancestor
13870986|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13870987|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13870988|NCT03661567|Protective Agents|protective agents|mesh-ancestor
13870989|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13870990|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870991|NCT03661515|Cytarabine|cytarabine|mesh-list
13870992|NCT03661515|Fludarabine|fludarabine|mesh-list
13870993|NCT03661515|Idarubicin|idarubicin|mesh-list
13870994|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13870995|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13870996|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
13870997|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13870998|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13870999|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
13871000|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871001|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
13871002|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871003|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13871004|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13871005|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13871006|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871007|NCT03661489|Propofol|propofol|mesh-list
13871008|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13871009|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871010|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871011|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13871012|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
13871013|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
13956295|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956296|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13956297|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
13956298|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956299|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
13956300|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956301|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956302|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13956303|NCT03183297|Fexofenadine|fexofenadine|mesh-list
13956304|NCT03183297|Naproxen|naproxen|mesh-list
14470390|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470391|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956305|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956306|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956307|NCT03183297|Analgesics|analgesics|mesh-ancestor
13956308|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
13956309|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956310|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956311|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956312|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956313|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
13956314|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13956315|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956316|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956317|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13956318|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13956319|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13956320|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
13956321|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
13956322|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956323|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
13956324|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
13956325|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
13956326|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956327|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956328|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956329|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13956330|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13956331|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956332|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13956333|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13956334|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
13956335|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956336|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956337|NCT03183492|Vaccines|vaccines|mesh-list
13956338|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
13956339|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963067|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13963068|NCT02586831|Incretins|incretins|mesh-ancestor
13963069|NCT02586831|Hormones|hormones|mesh-ancestor
14026584|NCT02742142|Protective Agents|protective agents|mesh-ancestor
13871014|NCT03661463|Aspirin|aspirin|mesh-list
13871015|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13871016|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871017|NCT03661463|Analgesics|analgesics|mesh-ancestor
13871018|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
13871019|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871020|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871021|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13871022|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871023|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13871024|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13871025|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871026|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13871027|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13871028|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871029|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
13871030|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
13871031|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13871032|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
13871033|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871034|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871035|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13871036|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
13871037|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13871038|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
13871039|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871040|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871041|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13871042|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
13871043|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
13871044|NCT03661385|Protective Agents|protective agents|mesh-ancestor
13871045|NCT03661307|Decitabine|decitabine|mesh-list
13871046|NCT03661307|Venetoclax|venetoclax|mesh-list
13871047|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13871048|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
14753981|NCT04892043|Nivolumab|nivolumab|mesh-list
14753982|NCT04892043|Ipilimumab|ipilimumab|mesh-list
13871049|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871050|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871051|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871052|NCT03661125|Saracatinib|saracatinib|mesh-list
13871053|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14753983|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14753984|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871054|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871055|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871056|NCT03660917|Riluzole|riluzole|mesh-list
13871057|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
13871058|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13871059|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13871060|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871061|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871062|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871063|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13871064|NCT03660917|Protective Agents|protective agents|mesh-ancestor
13871065|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13871066|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
13871067|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13871068|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
13871069|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13871070|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871071|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13871072|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13871073|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871074|NCT03660761|Apatinib|apatinib|mesh-list
13871075|NCT03660761|Temozolomide|temozolomide|mesh-list
13871076|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871077|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13871078|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871079|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871080|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13871081|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
14753985|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13871082|NCT03660488|Penicillins|penicillins|mesh-list
13871083|NCT03660488|Cefixime|cefixime|mesh-list
13871084|NCT03660488|Penicillin G|penicillin g|mesh-list
13871085|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
13871086|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
13871087|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871088|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871089|NCT03660475|Naltrexone|naltrexone|mesh-list
13871090|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13871091|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13871092|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871093|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
13871094|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871095|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
13871096|NCT03660436|BMS-986165|bms-986165|mesh-list
14026585|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026586|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
14026587|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14026588|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026589|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
14026590|NCT02742051|Fluorouracil|fluorouracil|mesh-list
14026591|NCT02742051|Everolimus|everolimus|mesh-list
14026592|NCT02742051|Letrozole|letrozole|mesh-list
14026593|NCT02742051|Epirubicin|epirubicin|mesh-list
14026594|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026595|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
14026596|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026597|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14026598|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14026599|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
14026600|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026601|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026602|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14026603|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
14026604|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14026605|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14026606|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14026607|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026608|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14026609|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
14026610|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026611|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14026612|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14026613|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14026614|NCT02742038|Fluorides|fluorides|mesh-list
14026615|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
14026616|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
14026617|NCT02742038|Protective Agents|protective agents|mesh-ancestor
14026618|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026619|NCT02741947|Levodopa|levodopa|mesh-list
14026620|NCT02741947|Benserazide|benserazide|mesh-list
14026621|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
14026622|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14026623|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14026624|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
14026625|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026626|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026627|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026628|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026629|NCT02741960|Metformin|metformin|mesh-list
14026630|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026631|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026632|NCT02741817|Aspirin|aspirin|mesh-list
14026633|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14026634|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14026635|NCT02741817|Analgesics|analgesics|mesh-ancestor
14026636|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
14026637|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026638|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026639|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14026640|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871097|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14026641|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14026642|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14026643|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871098|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871099|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13871100|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
13871101|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871102|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871103|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871104|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871105|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
13871106|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13871107|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
13871108|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
13871109|NCT03660306|Anesthetics|anesthetics|mesh-list
13871110|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871111|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871112|NCT03660306|Narcotics|narcotics|mesh-ancestor
13871113|NCT03660306|Analgesics|analgesics|mesh-ancestor
13871114|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
13871115|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871116|NCT03660293|Captopril|captopril|mesh-list
13871117|NCT03660293|Atorvastatin|atorvastatin|mesh-list
13871118|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13871119|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13871120|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
13871121|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871122|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13871123|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13871124|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871125|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13871126|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
13871127|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13871128|NCT03660267|Caffeine|caffeine|mesh-list
13871129|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13871130|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871131|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13871132|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871133|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871134|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13871135|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13871136|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
13871137|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871138|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13871139|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
13871140|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
13871141|NCT03660046|Etonogestrel|etonogestrel|mesh-list
13871142|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13871143|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
13871144|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13871145|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871146|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13871147|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13871148|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13871149|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13871150|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13871151|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13871152|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871153|NCT03660020|Anesthetics|anesthetics|mesh-list
13871154|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
13871155|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871156|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871157|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
13871158|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871159|NCT03659851|Simendan|simendan|mesh-list
13871160|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13871161|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
13871162|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13871163|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13871164|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871165|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871166|NCT03659851|Protective Agents|protective agents|mesh-ancestor
13871167|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956340|NCT03183115|Lugol's solution|lugol's solution|mesh-list
13956341|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
13956342|NCT03183115|Coagulants|coagulants|mesh-ancestor
13956343|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
13956344|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
13956345|NCT03182894|Azacitidine|azacitidine|mesh-list
13871168|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
13871169|NCT03659734|Narcotics|narcotics|mesh-ancestor
13871170|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871171|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871172|NCT03659734|Analgesics|analgesics|mesh-ancestor
13871173|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
13871174|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871175|NCT03659435|Rivastigmine|rivastigmine|mesh-list
13871176|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13871177|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871178|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871179|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
13871180|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14753986|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14753987|NCT04887298|Annamycin|annamycin|mesh-list
14753988|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13871181|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871182|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13871183|NCT03659435|Protective Agents|protective agents|mesh-ancestor
13871184|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13871185|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871186|NCT03659305|Bevacizumab|bevacizumab|mesh-list
13871187|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13871188|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871189|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13871190|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13871191|NCT03659305|Growth Substances|growth substances|mesh-ancestor
13871192|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871193|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
13871194|NCT03659292|Anesthetics|anesthetics|mesh-list
13871195|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753989|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871196|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871197|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
13871198|NCT03659162|Clotrimazole|clotrimazole|mesh-list
13871199|NCT03659162|Miconazole|miconazole|mesh-list
13871200|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871201|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13871202|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13871203|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13871204|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871205|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871206|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13871207|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
13871208|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13871209|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871210|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13871211|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13871212|NCT03659084|Deferasirox|deferasirox|mesh-list
13871213|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13871214|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
13871215|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
13871216|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871217|NCT03659058|Colchicine|colchicine|mesh-list
13871218|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13871219|NCT03659058|Antioxidants|antioxidants|mesh-list
13871220|NCT03659058|Silymarin|silymarin|mesh-list
13871221|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
13871222|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871223|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
13871224|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
13871225|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
13871226|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871227|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871228|NCT03659058|Protective Agents|protective agents|mesh-ancestor
13871229|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871230|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13871231|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871232|NCT03658993|Rifaximin|rifaximin|mesh-list
13871233|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871234|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871235|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871236|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14753990|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
13871237|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13871238|NCT03658850|Diuretics|diuretics|mesh-ancestor
13871239|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
13871240|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871241|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13871242|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13871243|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871244|NCT03658785|Aldesleukin|aldesleukin|mesh-list
13871245|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
13871246|NCT03658785|Fludarabine|fludarabine|mesh-list
13871247|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871248|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
13871249|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871250|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871251|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13871252|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
13871253|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871254|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871255|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13871256|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13871257|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13871258|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
13871259|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871260|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13871261|NCT03658746|Amoxicillin|amoxicillin|mesh-list
13871262|NCT03658746|Metronidazole|metronidazole|mesh-list
13871263|NCT03658746|Clarithromycin|clarithromycin|mesh-list
13871264|NCT03658746|Levofloxacin|levofloxacin|mesh-list
13871265|NCT03658746|Ofloxacin|ofloxacin|mesh-list
13871266|NCT03658746|Tetracycline|tetracycline|mesh-list
13871267|NCT03658746|Tinidazole|tinidazole|mesh-list
13871268|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13871269|NCT03658746|Furazolidone|furazolidone|mesh-list
13871270|NCT03658746|Bismuth|bismuth|mesh-list
13871271|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13871272|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871273|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
13871274|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13871275|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13871276|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13871277|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871278|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871279|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13871280|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13871281|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13871282|NCT03658746|Renal Agents|renal agents|mesh-ancestor
13871283|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13871284|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13871285|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871286|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13871287|NCT03658746|Antacids|antacids|mesh-ancestor
13871288|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871289|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13871290|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13871291|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13871292|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
13871293|NCT03658733|Amoxicillin|amoxicillin|mesh-list
13871294|NCT03658733|Tetracycline|tetracycline|mesh-list
13871295|NCT03658733|Furazolidone|furazolidone|mesh-list
13871296|NCT03658733|Esomeprazole|esomeprazole|mesh-list
13871297|NCT03658733|Rabeprazole|rabeprazole|mesh-list
13871298|NCT03658733|Bismuth|bismuth|mesh-list
13871299|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871300|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871301|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13871302|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871303|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13871304|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871305|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871306|NCT03658733|Antacids|antacids|mesh-ancestor
13871307|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13871308|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13871309|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13871310|NCT03658733|Renal Agents|renal agents|mesh-ancestor
13871311|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13871312|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13871313|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13871314|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13871315|NCT03658720|Ibuprofen|ibuprofen|mesh-list
13871316|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13871317|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871318|NCT03658720|Analgesics|analgesics|mesh-ancestor
13871319|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
13871320|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871321|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871322|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13871323|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871324|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13871325|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871326|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871327|NCT03658590|Dexamethasone|dexamethasone|mesh-list
13871328|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13871329|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
13871330|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
13871331|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871332|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871333|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871334|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
13871335|NCT03658590|Hormones|hormones|mesh-ancestor
13871336|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13871337|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13871338|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871339|NCT03658473|Naproxen|naproxen|mesh-list
13871340|NCT03658473|Rabeprazole|rabeprazole|mesh-list
13871341|NCT03658473|Rebamipide|rebamipide|mesh-list
13871342|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13871343|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871344|NCT03658473|Analgesics|analgesics|mesh-ancestor
13871345|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
13871346|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871347|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871348|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13871349|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871350|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
13871351|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13871352|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871353|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871354|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13871355|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871356|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13871357|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
13871358|NCT03658473|Protective Agents|protective agents|mesh-ancestor
13871359|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
13871360|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13871361|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871362|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
13871363|NCT03658421|Morphine|morphine|mesh-list
13871364|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13871365|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871366|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871367|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871368|NCT03658421|Analgesics|analgesics|mesh-ancestor
13871369|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
13871370|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871371|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13871372|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13871373|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13871374|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
13871375|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871376|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871377|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13871378|NCT03658421|Narcotics|narcotics|mesh-ancestor
13871379|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
13871380|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13871381|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13871382|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871383|NCT03658330|Naltrexone|naltrexone|mesh-list
13871384|NCT03658330|Ketamine|ketamine|mesh-list
13871385|NCT03658330|Analgesics|analgesics|mesh-ancestor
13871386|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
13871387|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871388|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871389|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13871390|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13871391|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
13871392|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
13871393|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871394|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13871395|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13871396|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871397|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871398|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13871399|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13871400|NCT03658317|Uric Acid|uric acid|mesh-list
13871401|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
13871402|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871403|NCT03658317|Protective Agents|protective agents|mesh-ancestor
13871404|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871405|NCT03658291|Levofloxacin|levofloxacin|mesh-list
13871406|NCT03658291|Ofloxacin|ofloxacin|mesh-list
13871407|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13871408|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871409|NCT03658291|Renal Agents|renal agents|mesh-ancestor
13871410|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871411|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13871412|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13871413|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871414|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871415|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871416|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13871417|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13871418|NCT03658213|Goserelin|goserelin|mesh-list
13871419|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931347|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14931348|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14931349|NCT01438736|Progestins|progestins|mesh-ancestor
14931350|NCT01438736|Hormones|hormones|mesh-ancestor
14931351|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931352|NCT01438749|Diazepam|diazepam|mesh-list
14931353|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14931354|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
13871420|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956346|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13956347|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956348|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13956349|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
13956350|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956351|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956352|NCT03182803|Antibodies|antibodies|mesh-list
13956353|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
13956354|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956355|NCT03183024|Benralizumab|benralizumab|mesh-list
13956356|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13956357|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
13956358|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13956359|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956360|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956361|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956362|NCT03182855|Ticagrelor|ticagrelor|mesh-list
13956363|NCT03182855|Cangrelor|cangrelor|mesh-list
13956364|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13956365|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13956366|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13956367|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13956368|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
13956369|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956370|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956371|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956372|NCT03182634|Olaparib|olaparib|mesh-list
13956373|NCT03182634|Fulvestrant|fulvestrant|mesh-list
13956374|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13956375|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956376|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956377|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956378|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13956379|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13871421|NCT03658109|Lidocaine|lidocaine|mesh-list
13871422|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
13871423|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
13871424|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871425|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871426|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
13871427|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871428|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13871429|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13871430|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13871431|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13871432|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871433|NCT03658057|Rocuronium|rocuronium|mesh-list
13871434|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13871435|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13871436|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13871437|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871438|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871439|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
13871440|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13871441|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871442|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13871443|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871444|NCT03657979|Ropivacaine|ropivacaine|mesh-list
13871445|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
13871446|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
13871447|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871448|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871449|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
13871450|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871451|NCT03657966|Gemcitabine|gemcitabine|mesh-list
13871452|NCT03657966|Paclitaxel|paclitaxel|mesh-list
13871453|NCT03657966|Carboplatin|carboplatin|mesh-list
13871454|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13871455|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871456|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
13871457|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
13871458|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
13871459|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871460|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13871461|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
13871462|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
13871463|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871464|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871465|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871466|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
13871467|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871468|NCT03657862|Fluorides|fluorides|mesh-list
13871469|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
13871470|NCT03657862|Protective Agents|protective agents|mesh-ancestor
13871471|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871472|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13871473|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871474|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13871475|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13871476|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13871477|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
13871478|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871479|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13871480|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13871481|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871482|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
13871483|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13871484|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871485|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
13871486|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13871487|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
13871488|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13871489|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871490|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13871491|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13871492|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13871493|NCT03657550|Niacin|niacin|mesh-list
13871494|NCT03657550|Amlodipine|amlodipine|mesh-list
13871495|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13871496|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13871497|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13871498|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871499|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13871500|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871501|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
13871502|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13871503|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
13871504|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13871505|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
13871506|NCT03657550|Vitamins|vitamins|mesh-ancestor
13871507|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
13871508|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
13871509|NCT03657472|Atorvastatin|atorvastatin|mesh-list
13871510|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13871511|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13871512|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
13871513|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871514|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13871515|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13871516|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871517|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13871518|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
13871519|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871520|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871521|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13871522|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13871523|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871524|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871525|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871526|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13871527|NCT03657433|Hematinics|hematinics|mesh-ancestor
13871528|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13871529|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13871530|NCT03657420|Dexamethasone|dexamethasone|mesh-list
13871531|NCT03657420|Pomalidomide|pomalidomide|mesh-list
13871532|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13871533|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
13871534|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
13871535|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871536|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871537|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871538|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
13871539|NCT03657420|Hormones|hormones|mesh-ancestor
13871540|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13871541|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13871542|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871543|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
13871544|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13871545|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13871546|NCT03657420|Growth Substances|growth substances|mesh-ancestor
13871547|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
13871548|NCT03657381|Antibodies|antibodies|mesh-list
13871549|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13871550|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
13871551|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871552|NCT03657355|Zolpidem|zolpidem|mesh-list
13871553|NCT03657355|Suvorexant|suvorexant|mesh-list
13871554|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13871555|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13871556|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871557|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871558|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13871559|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
13871560|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
13871561|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871562|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871563|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13871564|NCT03657212|Zolpidem|zolpidem|mesh-list
13871565|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13871566|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13871567|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479074|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
13871568|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871569|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13871570|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
13871571|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
13871572|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871573|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871574|NCT03657160|Vedolizumab|vedolizumab|mesh-list
13871575|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13871576|NCT03656965|Acyclovir|acyclovir|mesh-list
13871577|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
13871578|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871579|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
13871580|NCT03656952|PF-06700841|pf-06700841|mesh-list
13871581|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871582|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871583|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13871584|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13871585|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871586|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871587|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871588|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13871589|NCT03656783|Tenofovir|tenofovir|mesh-list
13871590|NCT03656783|Emtricitabine|emtricitabine|mesh-list
13871591|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
13871592|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
13871593|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871594|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13871595|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13871596|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871597|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871598|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13871599|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13871600|NCT03656679|Iodine|iodine|mesh-list
13871601|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13871602|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871603|NCT03656679|Trace Elements|trace elements|mesh-ancestor
13871604|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
13871605|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871606|NCT03656666|Thalidomide|thalidomide|mesh-list
13871607|NCT03656666|Apremilast|apremilast|mesh-list
13871608|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13871609|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871610|NCT03656666|Analgesics|analgesics|mesh-ancestor
13871611|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
14026644|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14026645|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14026646|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026647|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
14169170|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169171|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14169172|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
14169173|NCT04844489|Vaccines|vaccines|mesh-list
14169174|NCT04844489|Immunologic Factors|immunologic factors|mesh-ancestor
14169175|NCT04844489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169176|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
14169177|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14169178|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169179|NCT04844164|Vitamins|vitamins|mesh-ancestor
14169180|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
14169181|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14169182|NCT04844333|Anesthetics|anesthetics|mesh-list
14169183|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169184|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182905|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182906|NCT04732104|Lidocaine|lidocaine|mesh-list
14182907|NCT04732104|Xylometazoline|xylometazoline|mesh-list
14182908|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
14182909|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
14931355|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
14931356|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
14931357|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767168|NCT00629135|Tazobactam|tazobactam|mesh-list
13871612|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871613|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767169|NCT00629135|Piperacillin|piperacillin|mesh-list
14767170|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14767171|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14767172|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871614|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13871615|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871616|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13871617|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13871618|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871619|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871620|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871621|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
13871622|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
13871623|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871624|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871625|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14026648|NCT02741856|Paclitaxel|paclitaxel|mesh-list
14026649|NCT02741856|Carboplatin|carboplatin|mesh-list
14026650|NCT02741856|Capecitabine|capecitabine|mesh-list
14026651|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14026652|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026653|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
14026654|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
14026655|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
14026656|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026657|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14026658|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
14026659|NCT02741232|Lidocaine|lidocaine|mesh-list
14026660|NCT02741232|Epinephrine|epinephrine|mesh-list
14026661|NCT02741232|Racepinephrine|racepinephrine|mesh-list
14026662|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
14026663|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
14026664|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
14026665|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026666|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026667|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
14026668|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026669|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14026670|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14026671|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14026672|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13871626|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13871627|NCT03656666|Growth Substances|growth substances|mesh-ancestor
13871628|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
13871629|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871630|NCT03656627|Nivolumab|nivolumab|mesh-list
13871631|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13871632|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871633|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13871634|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871635|NCT03656614|Neostigmine|neostigmine|mesh-list
13871636|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13871637|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026673|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026674|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14026675|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14026676|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
14026677|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026678|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14026679|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14026680|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
14026681|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14026682|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
14026683|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
14026684|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
14026685|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14026686|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
14026687|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14026688|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026689|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14026690|NCT02741414|Amoxicillin|amoxicillin|mesh-list
14026691|NCT02741414|Metronidazole|metronidazole|mesh-list
14026692|NCT02741414|Clarithromycin|clarithromycin|mesh-list
14026693|NCT02741414|Levofloxacin|levofloxacin|mesh-list
14026694|NCT02741414|Ofloxacin|ofloxacin|mesh-list
14026695|NCT02741414|Tetracycline|tetracycline|mesh-list
14026696|NCT02741414|Furazolidone|furazolidone|mesh-list
14026697|NCT02741414|Esomeprazole|esomeprazole|mesh-list
14753991|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14026698|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026699|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13871638|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871639|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
13871640|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871641|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871642|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13871643|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
13871644|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871645|NCT03656588|Iodine|iodine|mesh-list
13871646|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
13871647|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13871648|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
13871649|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13871650|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13871651|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871652|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
13871653|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
13871654|NCT03656588|Trace Elements|trace elements|mesh-ancestor
13871655|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
13871656|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871657|NCT03656549|Pemetrexed|pemetrexed|mesh-list
13871658|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871659|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871660|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871661|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13871662|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13956380|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13956381|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
13956382|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956383|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956384|NCT03182595|Acetaminophen|acetaminophen|mesh-list
13956385|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956386|NCT03182595|Analgesics|analgesics|mesh-ancestor
13956387|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
13956388|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956389|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956390|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
13956391|NCT03182413|Modafinil|modafinil|mesh-list
13956392|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13956393|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956394|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
13956395|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13956396|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13956397|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956398|NCT03182504|Meropenem|meropenem|mesh-list
13956399|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13956400|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956401|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
13956402|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
13956403|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956404|NCT03182218|Heparin|heparin|mesh-list
13956405|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13956406|NCT03182218|Tinzaparin|tinzaparin|mesh-list
13956407|NCT03182218|Dalteparin|dalteparin|mesh-list
13956408|NCT03182218|Anticoagulants|anticoagulants|mesh-list
13956409|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13956410|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13956411|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956412|NCT03182296|Exenatide|exenatide|mesh-list
13956413|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956414|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956415|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13956416|NCT03182296|Incretins|incretins|mesh-ancestor
13956417|NCT03182296|Hormones|hormones|mesh-ancestor
13956418|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956419|NCT03182257|ONO-7579|ono-7579|mesh-list
13956420|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13956421|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956422|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956423|NCT03182374|Hylan|hylan|mesh-list
13956424|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
13956425|NCT03182374|Protective Agents|protective agents|mesh-ancestor
13956426|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956427|NCT03182322|Insulin|insulin|mesh-list
13956428|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956429|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956430|NCT03182231|Exenatide|exenatide|mesh-list
13956431|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13871663|NCT03656484|Metronidazole|metronidazole|mesh-list
13871664|NCT03656484|Tetracycline|tetracycline|mesh-list
13871665|NCT03656484|Melatonin|melatonin|mesh-list
13871666|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
13871667|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871668|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871669|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13871670|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13871671|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
13871672|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871673|NCT03656484|Protective Agents|protective agents|mesh-ancestor
13871674|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871675|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871676|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13871677|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
13871678|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
13871679|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13871680|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871681|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
13871682|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13871683|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13871684|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871685|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
13871686|NCT03656445|Coagulants|coagulants|mesh-ancestor
13871687|NCT03656432|Fluorides|fluorides|mesh-list
13871688|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
13871689|NCT03656432|Protective Agents|protective agents|mesh-ancestor
13871690|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871691|NCT03656393|Carboplatin|carboplatin|mesh-list
13871692|NCT03656393|Vinorelbine|vinorelbine|mesh-list
13871693|NCT03656393|Gefitinib|gefitinib|mesh-list
13871694|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871695|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13871696|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
13871697|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
13871698|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
13871699|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871700|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13871701|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871702|NCT03656289|Etonogestrel|etonogestrel|mesh-list
13871703|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13871704|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
13871705|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13871706|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871707|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13871708|NCT03656094|Docetaxel|docetaxel|mesh-list
13871709|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
13871710|NCT03656094|Pemetrexed|pemetrexed|mesh-list
13871711|NCT03656094|Vinorelbine|vinorelbine|mesh-list
13871712|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871713|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
13871714|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
13871715|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
13871716|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871717|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13871718|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871719|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13871720|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13871721|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13871722|NCT03656042|Lenograstim|lenograstim|mesh-list
13871723|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13871724|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
13871725|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871726|NCT03655964|Olmesartan|olmesartan|mesh-list
13871727|NCT03655964|Nebivolol|nebivolol|mesh-list
13871728|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
13871729|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13871730|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13871731|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871732|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
13871733|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13871734|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13871735|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13871736|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
13871737|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871738|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871739|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
13871740|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13871741|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871742|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871743|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871744|NCT03655847|Analgesics|analgesics|mesh-ancestor
13871745|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
13871746|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871747|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13871748|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13871749|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13871750|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
13871751|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871752|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871753|NCT03655834|Pemetrexed|pemetrexed|mesh-list
13871754|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871755|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871756|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871757|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13871758|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13871759|NCT03655821|Pemetrexed|pemetrexed|mesh-list
13871760|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871761|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871762|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871763|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13871764|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13871765|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
13871766|NCT03655717|Ethanol|ethanol|mesh-list
13871767|NCT03655717|Dronabinol|dronabinol|mesh-list
13871768|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13871769|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871770|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13871771|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871772|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
13871773|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13871774|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871775|NCT03655717|Analgesics|analgesics|mesh-ancestor
13871776|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
13871777|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871778|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13871779|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13871780|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871781|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871782|NCT03655717|Hormones|hormones|mesh-ancestor
13871783|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13871784|NCT03655665|Ofloxacin|ofloxacin|mesh-list
13871785|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13871786|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871787|NCT03655665|Renal Agents|renal agents|mesh-ancestor
13871788|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13871789|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13871790|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13871791|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871792|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871793|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871794|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13871795|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13871796|NCT03655613|Nivolumab|nivolumab|mesh-list
13871797|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13871798|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871799|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13871800|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871801|NCT03655535|PAZ320|paz320|mesh-list
13871802|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13871803|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871804|NCT03655457|Poractant alfa|poractant alfa|mesh-list
13871805|NCT03655457|Beractant|beractant|mesh-list
13871806|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
13871807|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
13871808|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
13871809|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13871810|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
13871811|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871812|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871813|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13871814|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
13871815|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13871816|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
13871817|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871818|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871819|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13871820|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
13871821|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
13871822|NCT03655392|Protective Agents|protective agents|mesh-ancestor
13871823|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
13871824|NCT03655002|Nivolumab|nivolumab|mesh-list
13871825|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871826|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
13871827|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871828|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871829|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13871830|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
13871831|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871832|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871833|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13871834|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13871835|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13871836|NCT03654989|Treprostinil|treprostinil|mesh-list
13871837|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13871838|NCT03654937|Vaccines|vaccines|mesh-list
13871839|NCT03654937|Immunologic Factors|immunologic factors|mesh-ancestor
13871840|NCT03654937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871841|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13871842|NCT03654794|Tacrolimus|tacrolimus|mesh-list
13871843|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871844|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
13871845|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871846|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13871847|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871848|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956432|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956433|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13956434|NCT03182231|Incretins|incretins|mesh-ancestor
13956435|NCT03182231|Hormones|hormones|mesh-ancestor
13956436|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956437|NCT03181919|Letrozole|letrozole|mesh-list
13956438|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956439|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13956440|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13956441|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956442|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956443|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13956444|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
13956445|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956446|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956447|NCT03182088|Norepinephrine|norepinephrine|mesh-list
13956448|NCT03182088|Bupivacaine|bupivacaine|mesh-list
13956449|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
13956450|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
13956451|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956452|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956453|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
13956454|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956455|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13956456|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13956457|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
13956458|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956459|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956460|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
13956461|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
14753992|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14753993|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14753994|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14753995|NCT04876937|Analgesics|analgesics|mesh-ancestor
14753996|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
14753997|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14753998|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14753999|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14754000|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14754001|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
14754002|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754003|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754004|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14754005|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
14754006|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754007|NCT04874025|Palbociclib|palbociclib|mesh-list
13871849|NCT03654768|Dasatinib|dasatinib|mesh-list
13871850|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
13871851|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871852|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13871853|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871854|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871855|NCT03654716|Cytarabine|cytarabine|mesh-list
13871856|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13871857|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
13871858|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871859|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871860|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
13871861|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13871862|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871863|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
13871864|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871865|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
13871866|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871867|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
13871868|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871869|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871870|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13871871|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
13871872|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871873|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871874|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13871875|NCT03654612|Apatinib|apatinib|mesh-list
13871876|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871877|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13871878|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871879|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871880|NCT03654365|Caffeine|caffeine|mesh-list
13871881|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13871882|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871883|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13871884|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871885|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871886|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13871887|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13871888|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
13871889|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871890|NCT03654274|Norethindrone|norethindrone|mesh-list
13871891|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
13871892|NCT03654274|Estradiol|estradiol|mesh-list
13871893|NCT03654274|Relugolix|relugolix|mesh-list
13871894|NCT03654274|Estrogens|estrogens|mesh-ancestor
13871895|NCT03654274|Hormones|hormones|mesh-ancestor
13871896|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13871897|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871898|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13871899|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
13871900|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13871901|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13871902|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13871903|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13871904|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13871905|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
13871906|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
13871907|NCT03654170|BI 425809|bi 425809|mesh-list
13871908|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
13871909|NCT03654144|Dienogest|dienogest|mesh-list
13871910|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
13871911|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
13871912|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13871913|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13871914|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871915|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13871916|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13871917|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13871918|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13871919|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
13871920|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13871921|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13871922|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871923|NCT03654105|Aspirin|aspirin|mesh-list
13871924|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13871925|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13871926|NCT03654105|Analgesics|analgesics|mesh-ancestor
13871927|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
13871928|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871929|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871930|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13871931|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871932|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13871933|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13871934|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871935|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13871936|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13871937|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871938|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
13871939|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
13871940|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13871941|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13871942|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13871943|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13871944|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871945|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
13871946|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871947|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871948|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13871949|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871950|NCT03654053|Simvastatin|simvastatin|mesh-list
13871951|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13871952|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13871953|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
13871954|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871955|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13871956|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13871957|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13871958|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
13871959|NCT03654040|Everolimus|everolimus|mesh-list
13871960|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13871961|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
13871962|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871963|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13871964|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13871965|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
13871966|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871967|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871968|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13871969|NCT03654027|Docetaxel|docetaxel|mesh-list
13871970|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13871971|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
13871972|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
13871973|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
13871974|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871975|NCT03653845|Epinephrine|epinephrine|mesh-list
13871976|NCT03653845|Racepinephrine|racepinephrine|mesh-list
13871977|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
13871978|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13871979|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13871980|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
13871981|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13871982|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871983|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13871984|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13871985|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13871986|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
13871987|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13871988|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13871989|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
13871990|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
13871991|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
13871992|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13871993|NCT03653663|Simvastatin|simvastatin|mesh-list
13871994|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13871995|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13871996|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
13871997|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13871998|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13871999|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13872000|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872001|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13872002|NCT03653546|Gefitinib|gefitinib|mesh-list
13872003|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872004|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13872005|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872006|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872007|NCT03653520|Diazepam|diazepam|mesh-list
13872008|NCT03653520|Tramadol|tramadol|mesh-list
13872009|NCT03653520|Ondansetron|ondansetron|mesh-list
13872010|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
13872011|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
13872012|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872013|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872014|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872015|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
13872016|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
13872017|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13872018|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
14026700|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14026701|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14026702|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14026703|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14026704|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026705|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026706|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14026707|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14026708|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14026709|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14026710|NCT02741414|Renal Agents|renal agents|mesh-ancestor
14026711|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14026712|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14026713|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026714|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14026715|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14026716|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14026717|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14026718|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14026719|NCT02741219|Sufentanil|sufentanil|mesh-list
14026720|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
14026721|NCT02741219|Dsuvia|dsuvia|mesh-list
14026722|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14026723|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026724|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026725|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14026726|NCT02741219|Analgesics|analgesics|mesh-ancestor
14026727|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
14026728|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026729|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14026730|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14026731|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14026732|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
14026733|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026734|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026735|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14026736|NCT02741219|Narcotics|narcotics|mesh-ancestor
14026737|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14026738|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13872019|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872020|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872021|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13872022|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13872023|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872024|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872025|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13872026|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13872027|NCT03653520|Narcotics|narcotics|mesh-ancestor
13872028|NCT03653520|Analgesics|analgesics|mesh-ancestor
13872029|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
13872030|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13872031|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
13872032|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13872033|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13872034|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13872035|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13872036|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
13872037|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
13872038|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
13872039|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
13872040|NCT03653338|Rituximab|rituximab|mesh-list
13872041|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
13872042|NCT03653338|Fludarabine|fludarabine|mesh-list
13872043|NCT03653338|Thiotepa|thiotepa|mesh-list
13872044|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
13872045|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872046|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872047|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
13872048|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872049|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872050|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872051|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13872052|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13872053|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
13872054|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13872055|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
13872056|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872057|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13872058|NCT03653260|Lidocaine|lidocaine|mesh-list
13872059|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
13872060|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
13872061|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872062|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872063|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
13872064|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872065|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13872066|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13872067|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13872068|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872069|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956462|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13956463|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
13956464|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13956465|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
13956466|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13956467|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956468|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13956469|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13956470|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13956471|NCT03182192|Exenatide|exenatide|mesh-list
13956472|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956473|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956474|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13956475|NCT03182192|Incretins|incretins|mesh-ancestor
13956476|NCT03182192|Hormones|hormones|mesh-ancestor
13956477|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956478|NCT03181880|Bromides|bromides|mesh-list
13956479|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
13956480|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13956481|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
13956482|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956483|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754008|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956484|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13956485|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
14026739|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
13872070|NCT03653052|Durvalumab|durvalumab|mesh-list
13872071|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872072|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872073|NCT03653000|Anesthetics|anesthetics|mesh-list
13872074|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
13872075|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872076|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872077|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
13872078|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872079|NCT03652974|Valproic Acid|valproic acid|mesh-list
13872080|NCT03652974|Clozapine|clozapine|mesh-list
13872081|NCT03652974|Amisulpride|amisulpride|mesh-list
13872082|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
13872083|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872084|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872085|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
13872086|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872087|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872088|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
13872089|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13872090|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872091|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872092|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13872093|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
13872094|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13872095|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
13872096|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13872097|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
13872098|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13872099|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
13872100|NCT03652961|Abatacept|abatacept|mesh-list
13872101|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13872102|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872103|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872104|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13872105|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
13872106|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872107|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872108|NCT03652896|Liver Extracts|liver extracts|mesh-list
13872109|NCT03652896|Hematinics|hematinics|mesh-ancestor
13872110|NCT03652870|Dexetimide|dexetimide|mesh-list
13872111|NCT03652870|Citalopram|citalopram|mesh-list
13872112|NCT03652870|Nortriptyline|nortriptyline|mesh-list
13872113|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13872114|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13872115|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872116|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872117|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872118|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
13872119|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872120|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13872121|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
13872122|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872123|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13872124|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13872125|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
13872126|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
13872127|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872128|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13872129|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13872130|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
13872131|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13872132|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13872133|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
13872134|NCT03652857|Apatinib|apatinib|mesh-list
13872135|NCT03652857|Vinorelbine|vinorelbine|mesh-list
13872136|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872137|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13872138|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872139|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872140|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13872141|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
13872142|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
13872143|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
13872144|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
13872145|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13872146|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13872147|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872148|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
13872149|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13872150|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
13872151|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872152|NCT03652753|Expectorants|expectorants|mesh-ancestor
13872153|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
13872154|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13872155|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
13872156|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872157|NCT03652753|Protective Agents|protective agents|mesh-ancestor
13872158|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872159|NCT03652753|Antidotes|antidotes|mesh-ancestor
13872160|NCT03652714|Anesthetics|anesthetics|mesh-list
13872161|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
13872162|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872163|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872164|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
13872165|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872166|NCT03652571|Nortriptyline|nortriptyline|mesh-list
13872167|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13872168|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
13872169|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872170|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13872171|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13872172|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872173|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872174|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
13872175|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872176|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872177|NCT03652493|Carboplatin|carboplatin|mesh-list
13872178|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872179|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
13872180|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13872181|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13872182|NCT03652480|Prednisolone|prednisolone|mesh-list
13872183|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
13872184|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13872185|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
13872186|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872187|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
13872188|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
13872189|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872190|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872191|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872192|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
13872193|NCT03652480|Hormones|hormones|mesh-ancestor
13872194|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13872195|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13872196|NCT03652480|Protective Agents|protective agents|mesh-ancestor
13872197|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13872198|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872199|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
13872200|NCT03652467|Deferoxamine|deferoxamine|mesh-list
13872201|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13872202|NCT03652467|Estrogens|estrogens|mesh-ancestor
13872203|NCT03652467|Hormones|hormones|mesh-ancestor
13872204|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13872205|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872206|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13872207|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872208|NCT03652467|Siderophores|siderophores|mesh-ancestor
13872209|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13872210|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
13872211|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
13872212|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872213|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13872214|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872215|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872216|NCT03652428|Gemcitabine|gemcitabine|mesh-list
13872217|NCT03652428|Paclitaxel|paclitaxel|mesh-list
13872218|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13872219|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872220|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
13872221|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
13872222|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
13872223|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872224|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13872225|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
13872226|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
13872227|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872228|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872229|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13872230|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
13872231|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872232|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
13872233|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13872234|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13872235|NCT03652376|Benralizumab|benralizumab|mesh-list
13872236|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13872237|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
13872238|NCT03652233|Nivolumab|nivolumab|mesh-list
13872239|NCT03652233|Afatinib|afatinib|mesh-list
13872240|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872241|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872242|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13872243|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872244|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13872245|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872246|NCT03652142|Nivolumab|nivolumab|mesh-list
13872247|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872248|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872249|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13872250|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872251|NCT03652116|Meperidine|meperidine|mesh-list
13872252|NCT03652116|Bupivacaine|bupivacaine|mesh-list
13872253|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
13872254|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
13872255|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872256|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872257|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
13872258|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872259|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13872260|NCT03652116|Narcotics|narcotics|mesh-ancestor
13872261|NCT03652116|Analgesics|analgesics|mesh-ancestor
13872262|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13872263|NCT03652103|Bupivacaine|bupivacaine|mesh-list
13872264|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
13872265|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
13872266|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872267|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872268|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
13872269|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872270|NCT03651947|Denosumab|denosumab|mesh-list
13872271|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13872272|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872273|NCT03651934|Iron|iron|mesh-list
13872274|NCT03651934|Selenium|selenium|mesh-list
13872275|NCT03651934|Trace Elements|trace elements|mesh-ancestor
13872276|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
13872277|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872278|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
13872279|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872280|NCT03651934|Protective Agents|protective agents|mesh-ancestor
13872281|NCT03651882|Oxytocin|oxytocin|mesh-list
13872282|NCT03651882|Carbetocin|carbetocin|mesh-list
13872283|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
13872284|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13872285|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872286|NCT03651726|Palmidrol|palmidrol|mesh-list
13872287|NCT03651726|Dronabinol|dronabinol|mesh-list
13872288|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
13872289|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872290|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872291|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872292|NCT03651726|Analgesics|analgesics|mesh-ancestor
13872293|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
13872294|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872295|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13872296|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13872297|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872298|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872299|NCT03651726|Hormones|hormones|mesh-ancestor
13872300|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13872301|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872302|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872303|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872304|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
13872305|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872306|NCT03651674|Olanzapine|olanzapine|mesh-list
13872307|NCT03651674|Clozapine|clozapine|mesh-list
13872308|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
13872309|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
13872310|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872311|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872312|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872313|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13872314|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13872315|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872316|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872317|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13872318|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13872319|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872320|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872321|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872322|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
13872323|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13872324|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
13872325|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
13872326|NCT03651661|Insulin|insulin|mesh-list
13872327|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13872328|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13872329|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872330|NCT03651557|Salicylates|salicylates|mesh-list
13872331|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872332|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872333|NCT03651557|Analgesics|analgesics|mesh-ancestor
13872334|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
13872335|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872336|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872337|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872338|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754009|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754010|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754011|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754012|NCT04861181|Niraparib|niraparib|mesh-list
14754013|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14754014|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754015|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754016|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754017|NCT04856631|Cetuximab|cetuximab|mesh-list
14754018|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754019|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872339|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13872340|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872341|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872342|NCT03651531|Metformin|metformin|mesh-list
13872343|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13872344|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872345|NCT03651427|Estradiol|estradiol|mesh-list
13872346|NCT03651427|Estrogens|estrogens|mesh-ancestor
13872347|NCT03651427|Hormones|hormones|mesh-ancestor
13872348|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13872349|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956486|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13956487|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13956488|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13956489|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
13956490|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956491|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956492|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
13956493|NCT03182114|Bupivacaine|bupivacaine|mesh-list
13956494|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
13956495|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
14754020|NCT04854499|Carboplatin|carboplatin|mesh-list
13872350|NCT03651219|Irinotecan|irinotecan|mesh-list
13872351|NCT03651219|Apatinib|apatinib|mesh-list
13872352|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13872353|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13872354|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872355|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872356|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872357|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13872358|NCT03650998|Ropivacaine|ropivacaine|mesh-list
13872359|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
13872360|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
13872361|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872362|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872363|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
13872364|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872365|NCT03650881|Adapalene|adapalene|mesh-list
13872366|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
13872367|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
13872368|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872369|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872370|NCT03650881|Analgesics|analgesics|mesh-ancestor
13872371|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
13872372|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872373|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872374|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872375|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872376|NCT03650777|Warfarin|warfarin|mesh-list
13872377|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
13872378|NCT03650738|Paclitaxel|paclitaxel|mesh-list
13872379|NCT03650738|Carboplatin|carboplatin|mesh-list
13872380|NCT03650738|Apatinib|apatinib|mesh-list
13872381|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13872382|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872383|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
13872384|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
13872385|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
13872386|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872387|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13872388|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872389|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13872390|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13872391|NCT03650582|Glucagon|glucagon|mesh-list
13872392|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872393|NCT03650582|Hormones|hormones|mesh-ancestor
13872394|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13872395|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872396|NCT03650543|Amoxicillin|amoxicillin|mesh-list
13872397|NCT03650543|Clarithromycin|clarithromycin|mesh-list
13872398|NCT03650543|Omeprazole|omeprazole|mesh-list
13872399|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13872400|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872401|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13872402|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872403|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13872404|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872405|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872406|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13872407|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13872408|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13872409|NCT03650361|Adapalene|adapalene|mesh-list
13872410|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872411|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872412|NCT03650361|Analgesics|analgesics|mesh-ancestor
13872413|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
13872414|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872415|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872416|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872417|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872418|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
13872419|NCT03650348|Atezolizumab|atezolizumab|mesh-list
13872420|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872421|NCT03650270|Phenytoin|phenytoin|mesh-list
13872422|NCT03650270|Midazolam|midazolam|mesh-list
13872423|NCT03650270|Phenobarbital|phenobarbital|mesh-list
13872424|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13872425|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13872426|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872427|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872428|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13872429|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13872430|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872431|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13872432|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
13872433|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
13872434|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
13872435|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
13872436|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872437|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872438|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
13872439|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13872440|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13872441|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872442|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13872443|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13872444|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13872445|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13872446|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13872447|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13872448|NCT03650257|Temozolomide|temozolomide|mesh-list
13872449|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13872450|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
13872451|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872452|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872453|NCT03650023|Chitosan|chitosan|mesh-list
13872454|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13872455|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13872456|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
13872457|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872458|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13872459|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
13872460|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
13872461|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
13872462|NCT03650023|Coagulants|coagulants|mesh-ancestor
13872463|NCT03649945|Docetaxel|docetaxel|mesh-list
13872464|NCT03649945|Endostar protein|endostar protein|mesh-list
13872465|NCT03649945|Nedaplatin|nedaplatin|mesh-list
13872466|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872467|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
13872468|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
13872469|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
13872470|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872471|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14470392|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14470393|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470394|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
14470395|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470396|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14470397|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
14470398|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14470399|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
14470400|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14470401|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
14470402|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872472|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13872473|NCT03649945|Growth Substances|growth substances|mesh-ancestor
14470403|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872474|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872475|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
13872476|NCT03649763|Lidocaine|lidocaine|mesh-list
13872477|NCT03649763|Bupivacaine|bupivacaine|mesh-list
13872478|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
13872479|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
13872480|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872481|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872482|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
13872483|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872484|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13872485|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13872486|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13872487|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13956496|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872488|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872489|NCT03649724|Leuprolide|leuprolide|mesh-list
13872490|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13872491|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
13872492|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13872493|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872494|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13872495|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872496|NCT03649711|Aspirin|aspirin|mesh-list
13872497|NCT03649711|Clopidogrel|clopidogrel|mesh-list
13872498|NCT03649711|Ticagrelor|ticagrelor|mesh-list
13872499|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872500|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872501|NCT03649711|Analgesics|analgesics|mesh-ancestor
13872502|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
13872503|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872504|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872505|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872506|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872507|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13872508|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13872509|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872510|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13872511|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13872512|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872513|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
14931358|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931359|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931360|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14931361|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931362|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14931363|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13872514|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13872515|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13872516|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13872517|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
13872518|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872519|NCT03649659|Fluorides|fluorides|mesh-list
13872520|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
13872521|NCT03649659|Protective Agents|protective agents|mesh-ancestor
13872522|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956497|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956498|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
13956499|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956500|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
13956501|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
13956502|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956503|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13956504|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
13956505|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956506|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956507|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13956508|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13956509|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13956510|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
13956511|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
13956512|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
13956513|NCT03181685|Cetrorelix|cetrorelix|mesh-list
13956514|NCT03181685|Progesterone|progesterone|mesh-list
13956515|NCT03181685|Progestins|progestins|mesh-ancestor
13956516|NCT03181685|Hormones|hormones|mesh-ancestor
13956517|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956518|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956519|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14931364|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13872523|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
13872524|NCT03649334|Ketorolac|ketorolac|mesh-list
13872525|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13872526|NCT03649334|Fentanyl|fentanyl|mesh-list
13872527|NCT03649334|Ketamine|ketamine|mesh-list
13872528|NCT03649334|Analgesics|analgesics|mesh-ancestor
13872529|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
13872530|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872531|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872532|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13872533|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13872534|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
13872535|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
13872536|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872537|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13872538|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13872539|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872540|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872541|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13872542|NCT03649334|Narcotics|narcotics|mesh-ancestor
13872543|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13872544|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872545|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872546|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872547|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872548|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13872549|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872550|NCT03649269|Bezafibrate|bezafibrate|mesh-list
13872551|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13872552|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
13872553|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872554|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13872555|NCT03649243|Propolis|propolis|mesh-list
13872556|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872557|NCT03649230|Palonosetron|palonosetron|mesh-list
13872558|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
13872559|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
13872560|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872561|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872562|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872563|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13872564|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13872565|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
13872566|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872567|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872568|NCT03649165|Acetaminophen|acetaminophen|mesh-list
13872569|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872570|NCT03649165|Analgesics|analgesics|mesh-ancestor
13872571|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
13872572|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872573|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872574|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
13872575|NCT03649152|Proxigermanium|proxigermanium|mesh-list
13872576|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872577|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
13872578|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
13872579|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872580|NCT03649061|Etanercept|etanercept|mesh-list
13872581|NCT03649061|Leflunomide|leflunomide|mesh-list
13872582|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872583|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872584|NCT03649061|Analgesics|analgesics|mesh-ancestor
13872585|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
13872586|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872587|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872588|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872589|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872590|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872591|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13872592|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
13872593|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872594|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872595|NCT03649048|Cisplatin|cisplatin|mesh-list
13872596|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872597|NCT03649009|Thiamine|thiamine|mesh-list
13872598|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
13872599|NCT03649009|Metoclopramide|metoclopramide|mesh-list
13872600|NCT03649009|Vitamins|vitamins|mesh-ancestor
13872601|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
13872602|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872603|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872604|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
13872605|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
13872606|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
13872607|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872608|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872609|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13872610|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13872611|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
13872612|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872613|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872614|NCT03648996|Allopurinol|allopurinol|mesh-list
13872615|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
13872616|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872617|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872618|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
13872619|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872620|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13872621|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
13872622|NCT03648996|Protective Agents|protective agents|mesh-ancestor
13872623|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872624|NCT03648970|Pravastatin|pravastatin|mesh-list
13872625|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13872626|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13872627|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
13872628|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872629|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13872630|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13872631|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872632|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
13872633|NCT03648697|Fludarabine|fludarabine|mesh-list
13872634|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13872635|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
13872636|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872637|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872638|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13872639|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
13872640|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872641|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872642|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13872643|NCT03648684|Caffeine|caffeine|mesh-list
13872644|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13872645|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872646|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13872647|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872648|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872649|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13872650|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13872651|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
13872652|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872653|NCT03648671|Rasagiline|rasagiline|mesh-list
13872654|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13872655|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872656|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872657|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13872658|NCT03648671|Protective Agents|protective agents|mesh-ancestor
13872659|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872660|NCT03648658|Acetaminophen|acetaminophen|mesh-list
13872661|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872662|NCT03648658|Analgesics|analgesics|mesh-ancestor
13872663|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
13872664|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872665|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872666|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
13872667|NCT03648554|Dulaglutide|dulaglutide|mesh-list
13872668|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13872669|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872670|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
13872671|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13872672|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872673|NCT03648528|Vitamins|vitamins|mesh-ancestor
13872674|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
13872675|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13872676|NCT03648437|Acetaminophen|acetaminophen|mesh-list
13872677|NCT03648437|Ibuprofen|ibuprofen|mesh-list
13872678|NCT03648437|Indomethacin|indomethacin|mesh-list
13872679|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13872680|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13872681|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872682|NCT03648437|Analgesics|analgesics|mesh-ancestor
13872683|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
13872684|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872685|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872686|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872687|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872688|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13872689|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872690|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872691|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
13872692|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
13872693|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
13872694|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13872695|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13872696|NCT03648333|Niacin|niacin|mesh-list
13872697|NCT03648333|Amlodipine|amlodipine|mesh-list
13872698|NCT03648333|Valsartan|valsartan|mesh-list
13872699|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
13872700|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13872701|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13872702|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872703|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872704|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13872705|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872706|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
13872707|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13872708|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13872709|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13872710|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
13872711|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13872712|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
13872713|NCT03648333|Vitamins|vitamins|mesh-ancestor
13872714|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
13872715|NCT03648229|Timolol|timolol|mesh-list
13872716|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13872717|NCT03648229|Latanoprost|latanoprost|mesh-list
13872718|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13872719|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13872720|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13872721|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
13872722|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872723|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872724|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872725|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13872726|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13872727|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
13872728|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872729|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
13872730|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
13872731|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
13872732|NCT03648034|Ropivacaine|ropivacaine|mesh-list
13872733|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
13872734|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
13872735|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872736|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872737|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
13872738|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872739|NCT03648008|Morphine|morphine|mesh-list
13872740|NCT03648008|Hydromorphone|hydromorphone|mesh-list
13872741|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13872742|NCT03648008|Narcotics|narcotics|mesh-ancestor
13872743|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872744|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872745|NCT03648008|Analgesics|analgesics|mesh-ancestor
13872746|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
13872747|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872748|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13872749|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13872750|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872751|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872752|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13872753|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872754|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872755|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
13872756|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872757|NCT03647969|Nivolumab|nivolumab|mesh-list
13872758|NCT03647969|Ipilimumab|ipilimumab|mesh-list
13872759|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872760|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872761|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13872762|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872763|NCT03647956|Bevacizumab|bevacizumab|mesh-list
13872764|NCT03647956|Carboplatin|carboplatin|mesh-list
13872765|NCT03647956|Pemetrexed|pemetrexed|mesh-list
13872766|NCT03647956|Atezolizumab|atezolizumab|mesh-list
13872767|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872768|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872769|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13872770|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13872771|NCT03647956|Growth Substances|growth substances|mesh-ancestor
13872772|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872773|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
13872774|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872775|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872776|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13872777|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13872778|NCT03647839|Nivolumab|nivolumab|mesh-list
13872779|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872780|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872781|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13872782|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956520|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
13956521|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13956522|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
13956523|NCT03181464|Lidocaine|lidocaine|mesh-list
13956524|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
13956525|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
13956526|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956527|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956528|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
13956529|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956530|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13956531|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13956532|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13956533|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13956534|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963070|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963071|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
13963072|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963073|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
14754021|NCT04854499|Docetaxel|docetaxel|mesh-list
14754022|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
14754023|NCT04854499|Magrolimab|magrolimab|mesh-list
14754024|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754025|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14754026|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14754027|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14754028|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754029|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872783|NCT03647774|Naltrexone|naltrexone|mesh-list
13872784|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13872785|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13872786|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872787|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
13872788|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872789|NCT03647670|Midazolam|midazolam|mesh-list
13872790|NCT03647670|Abrocitinib|abrocitinib|mesh-list
13872791|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13872792|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13872793|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872794|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872795|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13872796|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13872797|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872798|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13872799|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
13872800|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
13872801|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
13872802|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
13872803|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872804|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872805|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13872806|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872807|NCT03647579|Midazolam|midazolam|mesh-list
13872808|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
13872809|NCT03647579|Ketamine|ketamine|mesh-list
13872810|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13872811|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872812|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872813|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872814|NCT03647579|Analgesics|analgesics|mesh-ancestor
13872815|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
13872816|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872817|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13872818|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13872819|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13872820|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
13872821|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872822|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872823|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13872824|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13872825|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
13872826|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
13872827|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13872828|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13872829|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13872830|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13872831|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13872832|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13872833|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
13872834|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
13872835|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13872836|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872837|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
13872838|NCT03647423|Cetuximab|cetuximab|mesh-list
13872839|NCT03647423|Avelumab|avelumab|mesh-list
13872840|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13872841|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
13872842|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872843|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13872844|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13872845|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
13872846|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872847|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872848|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13872849|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13872850|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13872851|NCT03647280|Epirubicin|epirubicin|mesh-list
13872852|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872853|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872854|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13872855|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13872856|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13872857|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872858|NCT03647150|Amoxicillin|amoxicillin|mesh-list
13872859|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13872860|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872861|NCT03647124|Lenalidomide|lenalidomide|mesh-list
13872862|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
13872863|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872864|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13872865|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13872866|NCT03647124|Growth Substances|growth substances|mesh-ancestor
13872867|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
13872868|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872869|NCT03647072|Famotidine|famotidine|mesh-list
13872870|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13872871|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872872|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13872873|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
13872874|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
13872875|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872876|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872877|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872878|NCT03646916|Dexamethasone|dexamethasone|mesh-list
13872879|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
13872880|NCT03646916|BB 1101|bb 1101|mesh-list
13872881|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13872882|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
13872883|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
13872884|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872885|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872886|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13872887|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
13872888|NCT03646916|Hormones|hormones|mesh-ancestor
13872889|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13872890|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13872891|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872892|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
13872893|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872894|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872895|NCT03646825|Antioxidants|antioxidants|mesh-list
14026740|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
14026741|NCT02740933|Demeclocycline|demeclocycline|mesh-list
14026742|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14026743|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026744|NCT02740894|Gefitinib|gefitinib|mesh-list
14026745|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026746|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14026747|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026748|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026749|NCT02740829|Glucagon|glucagon|mesh-list
14026750|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14026751|NCT02740829|Hormones|hormones|mesh-ancestor
14026752|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026753|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026754|NCT02741063|Oxytocin|oxytocin|mesh-list
14026755|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
14026756|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13872896|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872897|NCT03646825|Protective Agents|protective agents|mesh-ancestor
13872898|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872899|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13872900|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13872901|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872902|NCT03646721|Incretins|incretins|mesh-ancestor
13872903|NCT03646721|Hormones|hormones|mesh-ancestor
13872904|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13872905|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13872906|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
13872907|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872908|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872909|NCT03646526|Amitriptyline|amitriptyline|mesh-list
13872910|NCT03646526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
13872911|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13872912|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
14026757|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872913|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14026758|NCT02741115|Udenafil|udenafil|mesh-list
13872914|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13872915|NCT03646526|Analgesics|analgesics|mesh-ancestor
13872916|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
13872917|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872918|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872919|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13872920|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13872921|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13872922|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872923|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
13872924|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872925|NCT03646526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13872926|NCT03646526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13872927|NCT03646526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872928|NCT03646500|Remifentanil|remifentanil|mesh-list
13872929|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13872930|NCT03646500|Narcotics|narcotics|mesh-ancestor
13872931|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872932|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872933|NCT03646500|Analgesics|analgesics|mesh-ancestor
13872934|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
13872935|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872936|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
13872937|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13872938|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13872939|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872940|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
13872941|NCT03646474|Coagulants|coagulants|mesh-ancestor
13872942|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
13872943|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
13872944|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026759|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14026760|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14026761|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026762|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026763|NCT02740868|Xenon|xenon|mesh-list
14026764|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14026765|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
14026766|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
14026767|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026768|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026769|NCT02741154|Letrozole|letrozole|mesh-list
14026770|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14026771|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026772|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14026773|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14026774|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026775|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026776|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14026777|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
14026778|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026779|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026780|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
14026781|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14026782|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
14026783|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14026784|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14026785|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14026786|NCT02740803|Listerine|listerine|mesh-list
14026787|NCT02740803|Fluorides|fluorides|mesh-list
14026788|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
14026789|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
14026790|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
14026791|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
14026792|NCT02740803|Protective Agents|protective agents|mesh-ancestor
14026793|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026794|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14026795|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026796|NCT02741024|Artesunate|artesunate|mesh-list
14026797|NCT02741024|Lumefantrine|lumefantrine|mesh-list
14026798|NCT02741024|Artemether|artemether|mesh-list
14026799|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
13872945|NCT03646370|Tenofovir|tenofovir|mesh-list
13872946|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
14026800|NCT02741024|Amodiaquine|amodiaquine|mesh-list
14026801|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
13872947|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13872948|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13872949|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13872950|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872951|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872952|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13872953|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13872954|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13872955|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13872956|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
13872957|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872958|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872959|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872960|NCT03646318|Ketanserin|ketanserin|mesh-list
13872961|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13872962|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13872963|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13872964|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
13872965|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13872966|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872967|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872968|NCT03646292|Pioglitazone|pioglitazone|mesh-list
13872969|NCT03646292|Empagliflozin|empagliflozin|mesh-list
13872970|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13872971|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872972|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13872973|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13872974|NCT03646266|Bromides|bromides|mesh-list
13872975|NCT03646266|Rocuronium|rocuronium|mesh-list
13872976|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
13872977|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13872978|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13872979|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13872980|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872981|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872982|NCT03646188|Doxorubicin|doxorubicin|mesh-list
13872983|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13872984|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13872985|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872986|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13872987|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13872988|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13872989|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956535|NCT03181243|Anesthetics|anesthetics|mesh-list
13956536|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956537|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956538|NCT03181360|Tenecteplase|tenecteplase|mesh-list
13956539|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13956540|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13956541|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956542|NCT03181815|Cytarabine|cytarabine|mesh-list
13956543|NCT03181815|Cladribine|cladribine|mesh-list
13956544|NCT03181815|Aclarubicin|aclarubicin|mesh-list
13956545|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
13956546|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13956547|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
13956548|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956549|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956550|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
13956551|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956552|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13956553|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
13956554|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956555|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13956556|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13956557|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13956558|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956559|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13956560|NCT03181386|Warfarin|warfarin|mesh-list
13956561|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
13956562|NCT03181386|Dabigatran|dabigatran|mesh-list
13956563|NCT03181386|Apixaban|apixaban|mesh-list
13956564|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
13956565|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14470404|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
13872990|NCT03646006|Bupivacaine|bupivacaine|mesh-list
13872991|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
13872992|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
13872993|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13872994|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13872995|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
13872996|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13872997|NCT03645980|Sorafenib|sorafenib|mesh-list
13872998|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13872999|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13873000|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873001|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873002|NCT03645876|Capecitabine|capecitabine|mesh-list
13873003|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
13873004|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13873005|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
13873006|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873007|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873008|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13873009|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13873010|NCT03645668|Meropenem|meropenem|mesh-list
13873011|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13873012|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873013|NCT03645642|Midodrine|midodrine|mesh-list
13873014|NCT03645642|Diuretics|diuretics|mesh-list
13873015|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
13873016|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873017|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
13873018|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
13873019|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873020|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13873021|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13873022|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13873023|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13873024|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
13873025|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873026|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873027|NCT03645304|Ropivacaine|ropivacaine|mesh-list
13873028|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
13873029|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
13873030|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873031|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873032|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
13873033|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873034|NCT03645200|Apatinib|apatinib|mesh-list
13873035|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873036|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13873037|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873038|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873039|NCT03645187|Celecoxib|celecoxib|mesh-list
13873040|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13873041|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873042|NCT03645187|Analgesics|analgesics|mesh-ancestor
13873043|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
13873044|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873045|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873046|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873047|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873048|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13873049|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13873050|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873051|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873052|NCT03645109|Vitamin D|vitamin d|mesh-list
13873053|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
13873054|NCT03645109|Vitamins|vitamins|mesh-ancestor
13873055|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
13873056|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873057|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13873058|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13873059|NCT03645057|Tacrolimus|tacrolimus|mesh-list
13873060|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873061|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
13873062|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873063|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14754030|NCT04848597|Paclitaxel|paclitaxel|mesh-list
14754031|NCT04848597|Antibodies|antibodies|mesh-list
13873064|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873065|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873066|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13873067|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873068|NCT03644823|Atezolizumab|atezolizumab|mesh-list
13873069|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873070|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
13873071|NCT03644706|Diuretics|diuretics|mesh-ancestor
13873072|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
13873073|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873074|NCT03644706|Expectorants|expectorants|mesh-ancestor
13873075|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
13873076|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
13873077|NCT03644667|Prednisone|prednisone|mesh-list
13873078|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
13873079|NCT03644667|Tacrolimus|tacrolimus|mesh-list
13873080|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
13873081|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873082|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
13873083|NCT03644667|Hormones|hormones|mesh-ancestor
13873084|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873085|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873086|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13873087|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873088|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873089|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
13873090|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873091|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873092|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13873093|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13873094|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
13873095|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13873096|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873097|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
13873098|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
13873099|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873100|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13873101|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13873102|NCT03644667|Protective Agents|protective agents|mesh-ancestor
13873103|NCT03644641|Propofol|propofol|mesh-list
13873104|NCT03644641|Desflurane|desflurane|mesh-list
13873105|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13873106|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873107|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873108|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13873109|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
13873110|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
13873111|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13873112|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
13873113|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
13873114|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
13873115|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873116|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13873117|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
13873118|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873119|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
13873120|NCT03644576|Ephedrine|ephedrine|mesh-list
13873121|NCT03644576|Ozanimod|ozanimod|mesh-list
13873122|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13873123|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
13873124|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873125|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873126|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13873127|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
13873128|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
13873129|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13873130|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13873131|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
13873132|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
13873133|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873134|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873135|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13873136|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873137|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
13873138|NCT03644511|Sorafenib|sorafenib|mesh-list
13873139|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873140|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13873141|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873142|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873143|NCT03644446|Bisoprolol|bisoprolol|mesh-list
13873144|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13873145|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
13873146|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
13873147|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873148|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873149|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13873150|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13873151|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13873152|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
13873153|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873154|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956566|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
13956567|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13956568|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
13956569|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956570|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956571|NCT03181178|Micronutrients|micronutrients|mesh-list
13956572|NCT03181178|Trace Elements|trace elements|mesh-list
13956573|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956574|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13956575|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
13956576|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
13956577|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956578|NCT03181100|Paclitaxel|paclitaxel|mesh-list
13956579|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13956580|NCT03181100|Bevacizumab|bevacizumab|mesh-list
13956581|NCT03181100|Atezolizumab|atezolizumab|mesh-list
13956582|NCT03181100|Vemurafenib|vemurafenib|mesh-list
13956583|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13956584|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
13956585|NCT03181100|Antibodies|antibodies|mesh-list
13956586|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
13956587|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13956588|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
13956589|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13956590|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956591|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
13956592|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
13956593|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
13956594|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956595|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13956596|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13956597|NCT03181100|Growth Substances|growth substances|mesh-ancestor
13956598|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956599|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
13956600|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
14754032|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14754033|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13956601|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13956602|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956603|NCT03180957|Adalimumab|adalimumab|mesh-list
13873155|NCT03644264|Sevelamer|sevelamer|mesh-list
13873156|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
13873157|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
13873158|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873159|NCT03644147|Acetaminophen|acetaminophen|mesh-list
13873160|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873161|NCT03644147|Analgesics|analgesics|mesh-ancestor
13873162|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
13873163|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873164|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873165|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
13873166|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
13873167|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13873168|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873169|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873170|NCT03643900|Indomethacin|indomethacin|mesh-list
13873171|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13873172|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873173|NCT03643900|Analgesics|analgesics|mesh-ancestor
13873174|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
13873175|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873176|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873177|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873178|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873179|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
14754034|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754035|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
13873180|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
13873181|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873182|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13873183|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873184|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873185|NCT03643874|Albuterol|albuterol|mesh-list
13873186|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13873187|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
13873188|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873189|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873190|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13873191|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
13873192|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
13873193|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873194|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13873195|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13873196|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13873197|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
13873198|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873199|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873200|NCT03643757|Bupivacaine|bupivacaine|mesh-list
13873201|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
13873202|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
13873203|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873204|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873205|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
13873206|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873207|NCT03643666|Dexamethasone|dexamethasone|mesh-list
13873208|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
13873209|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873210|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
13873211|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
13873212|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873213|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873214|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754036|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
14754037|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
14754038|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873215|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
13873216|NCT03643666|Hormones|hormones|mesh-ancestor
13873217|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873218|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13873219|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873220|NCT03643666|Analgesics|analgesics|mesh-ancestor
13873221|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
13873222|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
13873223|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873224|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13873225|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
13873226|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13873227|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13873228|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873229|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13873230|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
13873231|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873232|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
13873233|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13873234|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
13873235|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873236|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
13873237|NCT03643588|Protective Agents|protective agents|mesh-ancestor
13873238|NCT03643549|Temozolomide|temozolomide|mesh-list
13873239|NCT03643549|Bortezomib|bortezomib|mesh-list
13873240|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13873241|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
13873242|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873243|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873244|NCT03643510|Fulvestrant|fulvestrant|mesh-list
13873245|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13873246|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873247|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13873248|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13873249|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
13873250|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873251|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873252|NCT03643497|Meropenem|meropenem|mesh-list
13873253|NCT03643497|Linezolid|linezolid|mesh-list
13873254|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
13873255|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13873256|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13873257|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873258|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873259|NCT03643367|Propofol|propofol|mesh-list
13873260|NCT03643367|Sevoflurane|sevoflurane|mesh-list
13873261|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13873262|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873263|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873264|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13873265|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
13873266|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
13873267|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13873268|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13873269|NCT03643276|Cytarabine|cytarabine|mesh-list
13873270|NCT03643276|Dexamethasone|dexamethasone|mesh-list
13873271|NCT03643276|Prednisone|prednisone|mesh-list
13873272|NCT03643276|Prednisolone|prednisolone|mesh-list
13873273|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
13873274|NCT03643276|Ifosfamide|ifosfamide|mesh-list
13873275|NCT03643276|Doxorubicin|doxorubicin|mesh-list
13873276|NCT03643276|Methotrexate|methotrexate|mesh-list
13873277|NCT03643276|Fludarabine|fludarabine|mesh-list
13873278|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
13873279|NCT03643276|Etoposide|etoposide|mesh-list
13873280|NCT03643276|Vincristine|vincristine|mesh-list
13873281|NCT03643276|Bortezomib|bortezomib|mesh-list
13873282|NCT03643276|Daunorubicin|daunorubicin|mesh-list
13873283|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
13873284|NCT03643276|Pegaspargase|pegaspargase|mesh-list
13873285|NCT03643276|Blinatumomab|blinatumomab|mesh-list
13873286|NCT03643276|Vindesine|vindesine|mesh-list
13873287|NCT03643276|Asparaginase|asparaginase|mesh-list
13873288|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873289|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
13873290|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873291|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873292|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13873293|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
13873294|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873295|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873296|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13873297|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873298|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
13873299|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
13873300|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873301|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13873302|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
13873303|NCT03643276|Hormones|hormones|mesh-ancestor
13873304|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873305|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13873306|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13873307|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13873308|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13873309|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873310|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13873311|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
13873312|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873313|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13873314|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
13873315|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
13873316|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13873317|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13873318|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13873319|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
13873320|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873321|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
13873322|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
13873323|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
13873324|NCT03643107|Prednisolone|prednisolone|mesh-list
13873325|NCT03643107|Irofulven|irofulven|mesh-list
13873326|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873327|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
13873328|NCT03643107|Hormones|hormones|mesh-ancestor
13873329|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873330|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873331|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13873332|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873333|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13873334|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
13873335|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873336|NCT03642990|Niacinamide|niacinamide|mesh-list
13873337|NCT03642990|Niacin|niacin|mesh-list
13873338|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
13873339|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
13873340|NCT03642990|Vitamins|vitamins|mesh-ancestor
13873341|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
13873342|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873343|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13873344|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
13873345|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873346|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13873347|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
13873348|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13873349|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
13873350|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873351|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13873352|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13873353|NCT03642665|Estradiol|estradiol|mesh-list
13873354|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13873355|NCT03642665|Progesterone|progesterone|mesh-list
13873356|NCT03642665|Estrogens|estrogens|mesh-ancestor
13873357|NCT03642665|Hormones|hormones|mesh-ancestor
13873358|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873359|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873360|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13873361|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
13873362|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873363|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13873364|NCT03642665|Progestins|progestins|mesh-ancestor
13873365|NCT03642626|Vidarabine|vidarabine|mesh-list
13873366|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
13873367|NCT03642626|Fludarabine|fludarabine|mesh-list
13873368|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
13873369|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873370|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
13873371|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873372|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873373|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13873374|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
13873375|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873376|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873377|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13873378|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13873379|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
13873380|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
14026802|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14026803|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14026804|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026805|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026806|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
14026807|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
14026808|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14026809|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
14026810|NCT02740595|Nicotine|nicotine|mesh-list
14026811|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14754039|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754040|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
14754041|NCT04847557|Tirzepatide|tirzepatide|mesh-list
14754042|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14754043|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754044|NCT04847557|Incretins|incretins|mesh-ancestor
14754045|NCT04847557|Hormones|hormones|mesh-ancestor
14754046|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754047|NCT04846881|BI 425809|bi 425809|mesh-list
14754048|NCT04846881|Nootropic Agents|nootropic agents|mesh-ancestor
14754049|NCT04844606|Mirikizumab|mirikizumab|mesh-list
14754050|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14754051|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14754052|NCT04844606|Analgesics|analgesics|mesh-ancestor
14026812|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
14026813|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026814|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026815|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14026816|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14026817|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
14026818|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026819|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026820|NCT02740647|Amoxicillin|amoxicillin|mesh-list
14026821|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
14026822|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
14026823|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14026824|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14026825|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026826|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14026827|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026828|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026829|NCT02740712|Vitamin K|vitamin k|mesh-list
14026830|NCT02740712|Rucaparib|rucaparib|mesh-list
14026831|NCT02740712|Digoxin|digoxin|mesh-list
14026832|NCT02740712|Midazolam|midazolam|mesh-list
14026833|NCT02740712|Caffeine|caffeine|mesh-list
14026834|NCT02740712|Omeprazole|omeprazole|mesh-list
14026835|NCT02740712|Warfarin|warfarin|mesh-list
14026836|NCT02740712|Vitamins|vitamins|mesh-ancestor
14026837|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
14026838|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026839|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14026840|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14026841|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026842|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14026843|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14026844|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14026845|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14026846|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
14026847|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
14026848|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
14026849|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
14026850|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026851|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026852|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
14026853|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13873381|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873382|NCT03642600|Folic Acid|folic acid|mesh-list
13873383|NCT03642600|Inositol|inositol|mesh-list
13873384|NCT03642600|Liraglutide|liraglutide|mesh-list
13873385|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13873386|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873387|NCT03642600|Incretins|incretins|mesh-ancestor
13873388|NCT03642600|Hormones|hormones|mesh-ancestor
13873389|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873390|NCT03642600|Hematinics|hematinics|mesh-ancestor
13873391|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
13873392|NCT03642600|Vitamins|vitamins|mesh-ancestor
13873393|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
13956604|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956605|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956606|NCT03180970|Lugol's solution|lugol's solution|mesh-list
13956607|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13956608|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
13956609|NCT03180970|Coagulants|coagulants|mesh-ancestor
13956610|NCT03180879|Ibuprofen|ibuprofen|mesh-list
13956611|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956612|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956613|NCT03180879|Analgesics|analgesics|mesh-ancestor
13956614|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
13956615|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956616|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956617|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956618|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956619|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13956620|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956621|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956622|NCT03180944|Lugol's solution|lugol's solution|mesh-list
13956623|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13956624|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
13956625|NCT03180944|Coagulants|coagulants|mesh-ancestor
13956626|NCT03180775|Glycine|glycine|mesh-list
13956627|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
13956628|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956629|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956630|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956631|NCT03180723|Cyclosporine|cyclosporine|mesh-list
13956632|NCT03180723|Rituximab|rituximab|mesh-list
13956633|NCT03180723|Cyclosporins|cyclosporins|mesh-list
13956634|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13956635|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956636|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
13956637|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956638|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956639|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956640|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956641|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13956642|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
13956643|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956644|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
13956645|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13956646|NCT03180736|Dexamethasone|dexamethasone|mesh-list
13956647|NCT03180736|Daratumumab|daratumumab|mesh-list
13956648|NCT03180736|Pomalidomide|pomalidomide|mesh-list
13956649|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956650|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
13956651|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
13956652|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956653|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956654|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956655|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
13956656|NCT03180736|Hormones|hormones|mesh-ancestor
13956657|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956658|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13956659|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956660|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
13956661|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13956662|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13956663|NCT03180736|Growth Substances|growth substances|mesh-ancestor
13956664|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
13956665|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
13956666|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956667|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956668|NCT03180476|Apatinib|apatinib|mesh-list
14169185|NCT04844216|Lidocaine|lidocaine|mesh-list
13873394|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13873395|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13873396|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
13873397|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
13873398|NCT03642509|Apixaban|apixaban|mesh-list
13873399|NCT03642509|Edoxaban|edoxaban|mesh-list
13873400|NCT03642509|Dabigatran|dabigatran|mesh-list
13873401|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13873402|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
13873403|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13873404|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
13873405|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873406|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873407|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
13873408|NCT03642366|Tadalafil|tadalafil|mesh-list
13873409|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
13873410|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13873411|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13873412|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873413|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873414|NCT03642366|Urological Agents|urological agents|mesh-ancestor
13873415|NCT03642353|Listerine|listerine|mesh-list
13873416|NCT03642353|Triclosan|triclosan|mesh-list
13873417|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
13873418|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
13873419|NCT03642353|Protective Agents|protective agents|mesh-ancestor
13873420|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873421|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13873422|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873423|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13873424|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13873425|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
13873426|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873427|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13873428|NCT03642184|Empagliflozin|empagliflozin|mesh-list
13873429|NCT03642184|Linagliptin|linagliptin|mesh-list
13873430|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13873431|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873432|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13873433|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873434|NCT03642184|Incretins|incretins|mesh-ancestor
13873435|NCT03642184|Hormones|hormones|mesh-ancestor
13873436|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873437|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13873438|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
13873439|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873440|NCT03642145|Deflazacort|deflazacort|mesh-list
13873441|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873442|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873443|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
13873444|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873445|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
13873446|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13873447|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13873448|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13873449|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13873450|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873451|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
13873452|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873453|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873454|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13873455|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873456|NCT03641846|Tadalafil|tadalafil|mesh-list
13873457|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
13873458|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13873459|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13873460|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873461|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873462|NCT03641846|Urological Agents|urological agents|mesh-ancestor
13873463|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
13873464|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13873465|NCT03641651|Frovatriptan|frovatriptan|mesh-list
13873466|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14026854|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13873467|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
13873468|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873469|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873470|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873476|NCT03641456|Dexamethasone|dexamethasone|mesh-list
13873477|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
13873478|NCT03641456|Lenalidomide|lenalidomide|mesh-list
13873479|NCT03641456|Bortezomib|bortezomib|mesh-list
14754053|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
14754054|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754055|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754056|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754057|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873480|NCT03641456|BB 1101|bb 1101|mesh-list
13873481|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873482|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
13873483|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
13873484|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873485|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873486|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13873487|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
13873488|NCT03641456|Hormones|hormones|mesh-ancestor
13873489|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873490|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13873491|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873492|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
13873493|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873494|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873495|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
13873496|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13873497|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13873498|NCT03641456|Growth Substances|growth substances|mesh-ancestor
13873499|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
13873500|NCT03641404|Ergothioneine|ergothioneine|mesh-list
13873501|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
13873502|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873503|NCT03641404|Protective Agents|protective agents|mesh-ancestor
13873504|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873505|NCT03641209|Acetaminophen|acetaminophen|mesh-list
13873506|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13873507|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873508|NCT03641209|Analgesics|analgesics|mesh-ancestor
14754058|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14754059|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13873509|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
13873510|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873511|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873512|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
13873513|NCT03641053|Iodine|iodine|mesh-list
13873514|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
13873515|NCT03641053|Povidone|povidone|mesh-list
13873516|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13873517|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873518|NCT03641053|Trace Elements|trace elements|mesh-ancestor
13873519|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
13873520|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873521|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
13873522|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
13956669|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956670|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13956671|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956672|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956673|NCT03180632|Lorazepam|lorazepam|mesh-list
13956674|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
13956675|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
13956676|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
13956677|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956678|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931365|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14931366|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14931367|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14931368|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
14931369|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
14931370|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
13873523|NCT03640728|Tenofovir|tenofovir|mesh-list
13873524|NCT03640728|Entecavir|entecavir|mesh-list
13873525|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
13873526|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873527|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13873528|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13873529|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873530|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873531|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13873532|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13873533|NCT03640650|Triamcinolone|triamcinolone|mesh-list
13873534|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13873535|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13873536|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13873537|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13873538|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13873539|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
13873540|NCT03640650|Hormones|hormones|mesh-ancestor
13873541|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13873542|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873543|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873544|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
13873545|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873546|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873547|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13873548|NCT03640468|Lidocaine|lidocaine|mesh-list
13873549|NCT03640468|Midazolam|midazolam|mesh-list
13873550|NCT03640468|Ketamine|ketamine|mesh-list
13873551|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
13873552|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
13873553|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873554|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873555|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
13873556|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873557|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13873558|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13873559|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13873560|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13873561|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873562|NCT03640468|Analgesics|analgesics|mesh-ancestor
13873563|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13873564|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13873565|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
13873566|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13873567|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13873568|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873569|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13873570|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13873571|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13873572|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13873573|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13873574|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
13873575|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
13873576|NCT03640403|Artesunate|artesunate|mesh-list
13873577|NCT03640403|Piperaquine|piperaquine|mesh-list
13873578|NCT03640403|Amodiaquine|amodiaquine|mesh-list
13873579|NCT03640403|Artenimol|artenimol|mesh-list
13873580|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
13873581|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13873582|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13873583|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873584|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873585|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
13873586|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
13873587|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13873588|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
13873589|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
13873590|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
13873591|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13873592|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873593|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873594|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873595|NCT03640390|Analgesics|analgesics|mesh-ancestor
13873596|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
13873597|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873598|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13873599|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13873600|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13873601|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
13873602|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873603|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873604|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
13873605|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13873606|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
13873607|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13873608|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13873609|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13873610|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
13873611|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873612|NCT03640377|Praziquantel|praziquantel|mesh-list
13873613|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
13873614|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13873615|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873616|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13873617|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13873618|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
13873619|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13873620|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
13873621|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873622|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
13873623|NCT03640351|Protective Agents|protective agents|mesh-ancestor
13873624|NCT03640273|Loratadine|loratadine|mesh-list
13873625|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
13873626|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
13873627|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13873628|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13873629|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13873630|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
13873631|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
13873632|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873633|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873634|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873635|NCT03640247|Acetaminophen|acetaminophen|mesh-list
13873636|NCT03640247|Ibuprofen|ibuprofen|mesh-list
13873637|NCT03640247|Oxycodone|oxycodone|mesh-list
13873638|NCT03640247|Tramadol|tramadol|mesh-list
13873639|NCT03640247|Hydrocodone|hydrocodone|mesh-list
13873640|NCT03640247|Narcotics|narcotics|mesh-list
13873641|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873642|NCT03640247|Analgesics|analgesics|mesh-ancestor
13873643|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
13873644|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873645|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873646|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
13873647|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13873648|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873649|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873650|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13873651|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873652|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873653|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13873654|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873655|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
13873656|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
13873657|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
13873658|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
13873659|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13873660|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
13873661|NCT03640221|Diuretics|diuretics|mesh-ancestor
13873662|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
13873663|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873664|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13873665|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13873666|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873667|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13873668|NCT03640156|Oxytocin|oxytocin|mesh-list
13873669|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
13873670|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873671|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873672|NCT03640026|Tacrolimus|tacrolimus|mesh-list
13873673|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873674|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
13873675|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873676|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13873677|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873678|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873679|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
13873680|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873681|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13873682|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873683|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873684|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
13873685|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13873686|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873687|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873688|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873689|NCT03639896|Analgesics|analgesics|mesh-ancestor
13873690|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
13873691|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873692|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13873693|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13873694|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13873695|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
13873696|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873697|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873698|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13873699|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
13873700|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873701|NCT03639727|Mannitol|mannitol|mesh-list
13873702|NCT03639727|Citric Acid|citric acid|mesh-list
13873703|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
13873704|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13873705|NCT03639727|Diuretics|diuretics|mesh-ancestor
13873706|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
13873707|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873708|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
13873709|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13873710|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
13873711|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
13873712|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873713|NCT03639714|Nivolumab|nivolumab|mesh-list
13873714|NCT03639714|Ipilimumab|ipilimumab|mesh-list
13873715|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13873716|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873717|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13873718|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873719|NCT03639571|Ibuprofen|ibuprofen|mesh-list
13873720|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13873721|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873722|NCT03639571|Analgesics|analgesics|mesh-ancestor
13873723|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
13873724|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873725|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873726|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873727|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873728|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13873729|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873730|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873731|NCT03639558|Promethazine|promethazine|mesh-list
13873732|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
13873733|NCT03639558|Haloperidol|haloperidol|mesh-list
13873734|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
13873735|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
13873736|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
13873737|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
13873738|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873739|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873740|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13873741|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13873742|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13873743|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873744|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13873745|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13873746|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
13873747|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873748|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873749|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13873750|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
13873751|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
13873752|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13873753|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
13873754|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
13873755|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13873756|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13873757|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13873758|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
13873759|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
13873760|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
13873761|NCT03639545|Metformin|metformin|mesh-list
13873762|NCT03639545|Empagliflozin|empagliflozin|mesh-list
13873763|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13873764|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873765|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13873766|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873767|NCT03639532|Tacrine|tacrine|mesh-list
13873768|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13873769|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873770|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873771|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
13873772|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873773|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873774|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13873775|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
13873776|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873777|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
13873778|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
13873779|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
13873780|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873781|NCT03639519|Protective Agents|protective agents|mesh-ancestor
13873782|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873783|NCT03639519|Vitamins|vitamins|mesh-ancestor
13873784|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
13873785|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
13873786|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13873787|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13873788|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13873789|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
13873790|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873791|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13873792|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13873793|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873794|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13873795|NCT03639480|Amlodipine|amlodipine|mesh-list
13873796|NCT03639480|Valsartan|valsartan|mesh-list
13873797|NCT03639480|Atorvastatin|atorvastatin|mesh-list
13873798|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13873799|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13873800|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
13873801|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873802|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13873803|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13873804|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873805|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13873806|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13873807|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13873808|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13873809|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873810|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
13873811|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13873812|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13873813|NCT03639467|Gemcitabine|gemcitabine|mesh-list
13873814|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873815|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13873816|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
13873817|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873818|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
13873819|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873820|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873821|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13873822|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
13873823|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873824|NCT03639428|Midazolam|midazolam|mesh-list
13873825|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13873826|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13873827|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873828|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873829|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13873830|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13873831|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13873832|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13873833|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
13873834|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
13873835|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
13873836|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
13873837|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873838|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873839|NCT03639415|Oxycodone|oxycodone|mesh-list
13873840|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13873841|NCT03639415|Narcotics|narcotics|mesh-ancestor
13873842|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873843|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873844|NCT03639415|Analgesics|analgesics|mesh-ancestor
13873845|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
13873846|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873847|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
13873848|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13873849|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13873850|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873851|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
13873852|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
13956679|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956680|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13956681|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470405|NCT02309515|Lenalidomide|lenalidomide|mesh-list
14470406|NCT02309515|Vaccines|vaccines|mesh-list
14470407|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
14470408|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956682|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13956683|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13956684|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13956685|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
13956686|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
13956687|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956688|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956689|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
13956690|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956691|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
13956692|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
13956693|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
13956694|NCT03180593|Valsartan|valsartan|mesh-list
13956695|NCT03180593|Nebivolol|nebivolol|mesh-list
13956696|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13956697|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13956698|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13956699|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470409|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14470410|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13956700|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
13956701|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13956702|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13956703|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13956704|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
13956705|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956706|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956707|NCT03180229|Granisetron|granisetron|mesh-list
13956708|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
13956709|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
13956710|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956711|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956712|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956713|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13956714|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
14470411|NCT02309515|Growth Substances|growth substances|mesh-ancestor
13956715|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956716|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026855|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14026856|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026857|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14026858|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14026859|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14026860|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14026861|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
14026862|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14026863|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14026864|NCT02740712|Protective Agents|protective agents|mesh-ancestor
14026865|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14026866|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14026867|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
14026868|NCT02740712|Coagulants|coagulants|mesh-ancestor
14026869|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14026870|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026871|NCT02740426|Pirarubicin|pirarubicin|mesh-list
14026872|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026873|NCT02740270|Spartalizumab|spartalizumab|mesh-list
14026874|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14026875|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026876|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026877|NCT02740101|Oxytocin|oxytocin|mesh-list
14026878|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
14026879|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14026880|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026881|NCT02740192|Bupivacaine|bupivacaine|mesh-list
14026882|NCT02740192|Ropivacaine|ropivacaine|mesh-list
14026883|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
14026884|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
14026885|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026886|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026887|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
14026888|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026889|NCT02740179|Eplerenone|eplerenone|mesh-list
14026890|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14026891|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
14026892|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14026893|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026894|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14026895|NCT02740179|Diuretics|diuretics|mesh-ancestor
14026896|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
14470412|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
14470413|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470414|NCT02310568|PF-06372865|pf-06372865|mesh-list
14470415|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
14470416|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
14470417|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470418|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470419|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470420|NCT02310581|Buprenorphine|buprenorphine|mesh-list
14470421|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14470422|NCT02310581|Narcotics|narcotics|mesh-ancestor
14470423|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470424|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470425|NCT02310581|Analgesics|analgesics|mesh-ancestor
14026897|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14026898|NCT02740166|Propranolol|propranolol|mesh-list
14026899|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14026900|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14026901|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
14026902|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14026903|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026904|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873853|NCT03639168|Cisplatin|cisplatin|mesh-list
13873854|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873855|NCT03639155|Glycine|glycine|mesh-list
13873856|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
13873857|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873858|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873859|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873860|NCT03638960|Bupivacaine|bupivacaine|mesh-list
13873861|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
13873862|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
13873863|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873864|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873865|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
13873866|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873867|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
13873868|NCT03638947|Povidone|povidone|mesh-list
13873869|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
13873870|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
13873871|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13873872|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873873|NCT03638869|Methadone|methadone|mesh-list
13873874|NCT03638869|D-methadone|d-methadone|mesh-list
13873875|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13873876|NCT03638869|Narcotics|narcotics|mesh-ancestor
13873877|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873878|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873879|NCT03638869|Analgesics|analgesics|mesh-ancestor
13873880|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
13873881|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873882|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
13873883|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
13873884|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873885|NCT03638856|Misoprostol|misoprostol|mesh-list
13873886|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13873887|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
13873888|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13873889|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873890|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13873891|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13873892|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
13873893|NCT03638726|Atropine|atropine|mesh-list
13873894|NCT03638726|Phenylephrine|phenylephrine|mesh-list
13873895|NCT03638726|Epinephrine|epinephrine|mesh-list
13873896|NCT03638726|Racepinephrine|racepinephrine|mesh-list
13873897|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
13873898|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
13873899|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
13873900|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13873901|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13873902|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
13873903|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873904|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873905|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873906|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13873907|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13873908|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
13873909|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873910|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13873911|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
13873912|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
13873913|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
13873914|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13873915|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13873916|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
13873917|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13873918|NCT03638726|Protective Agents|protective agents|mesh-ancestor
13873919|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13873920|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13873921|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
13873922|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13873923|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13873924|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
13873925|NCT03638648|Capecitabine|capecitabine|mesh-list
13873926|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13873927|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
13873928|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873929|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873930|NCT03638440|Naloxegol|naloxegol|mesh-list
13873931|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13873932|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873933|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
13873934|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873935|NCT03638401|Morphine|morphine|mesh-list
13873936|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13873937|NCT03638401|Narcotics|narcotics|mesh-ancestor
13873938|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873939|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873940|NCT03638401|Analgesics|analgesics|mesh-ancestor
13873941|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
13873942|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873943|NCT03638375|Interferons|interferons|mesh-list
13873944|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
13873945|NCT03638375|Nivolumab|nivolumab|mesh-list
13873946|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13873947|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13873948|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13873949|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873950|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
13873951|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873952|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
13873953|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873954|NCT03638310|Gentamicins|gentamicins|mesh-list
13873955|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13873956|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873957|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13873958|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873959|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873960|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
13873961|NCT03638297|Antibodies|antibodies|mesh-list
13873962|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
13873963|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873964|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873965|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873966|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13873967|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13873968|NCT03638297|Analgesics|analgesics|mesh-ancestor
13873969|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
13873970|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13873971|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13873972|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13873973|NCT03638076|Ritonavir|ritonavir|mesh-list
13873974|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13873975|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13873976|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
13873977|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13873978|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13873979|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13873980|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13873981|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
13873982|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13873983|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13873984|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13873985|NCT03638063|Adenosine|adenosine|mesh-list
14026905|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14026906|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14026907|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
14026908|NCT02739958|Propofol|propofol|mesh-list
14026909|NCT02739958|Isoflurane|isoflurane|mesh-list
14026910|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14026911|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13873986|NCT03638063|Capsaicin|capsaicin|mesh-list
13873987|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
13873988|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
13873989|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
13873990|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14026912|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026913|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14026914|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
14026915|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
13873991|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13873992|NCT03638063|Analgesics|analgesics|mesh-ancestor
13873993|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13873994|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
13873995|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13873996|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
13873997|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
13873998|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13873999|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874000|NCT03638037|Vitamin D|vitamin d|mesh-list
13874001|NCT03638037|Vitamins|vitamins|mesh-ancestor
13874002|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
13874003|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874004|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13874015|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
13874016|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874017|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874018|NCT03637790|Rifampin|rifampin|mesh-list
13874019|NCT03637790|Abrocitinib|abrocitinib|mesh-list
13874020|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13874021|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
13874022|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874023|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874024|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
13874025|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13874026|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874027|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874028|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13874029|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13874030|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13874031|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13874032|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14931371|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
14931372|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874033|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13874034|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13874035|NCT03637582|Lidocaine|lidocaine|mesh-list
13874036|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
13874037|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
13874038|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874039|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874040|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
13874041|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874042|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13874043|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13874044|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13874045|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13874046|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874047|NCT03637543|Nivolumab|nivolumab|mesh-list
13874048|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874049|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874050|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13874051|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956717|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13956718|NCT03180346|Laxatives|laxatives|mesh-ancestor
13956719|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956720|NCT03180359|Vaccines|vaccines|mesh-list
13956721|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
13956722|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956723|NCT03180125|Lidocaine|lidocaine|mesh-list
14470426|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
13956724|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
13956725|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
14938583|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13874052|NCT03637400|Doxycycline|doxycycline|mesh-list
13874053|NCT03637400|Trimethoprim|trimethoprim|mesh-list
13874054|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
13874055|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874056|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874057|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
13874058|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13874059|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13874060|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13874061|NCT03637400|Renal Agents|renal agents|mesh-ancestor
13874062|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13874063|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874064|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874065|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13874066|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13874067|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13874068|NCT03637361|Methadone|methadone|mesh-list
13874069|NCT03637361|D-methadone|d-methadone|mesh-list
13874070|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13874071|NCT03637361|Narcotics|narcotics|mesh-ancestor
13874072|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874073|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874074|NCT03637361|Analgesics|analgesics|mesh-ancestor
13874075|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
13874076|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874077|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
13874078|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
13874079|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13874080|NCT03637335|Carboplatin|carboplatin|mesh-list
13874081|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874082|NCT03637283|Bevacizumab|bevacizumab|mesh-list
13874083|NCT03637283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874084|NCT03637283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874085|NCT03637283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13874086|NCT03637283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13874087|NCT03637283|Growth Substances|growth substances|mesh-ancestor
13874088|NCT03637283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874089|NCT03637283|Growth Inhibitors|growth inhibitors|mesh-ancestor
13874090|NCT03637075|Insulin|insulin|mesh-list
13874091|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13874092|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874093|NCT03637049|Midazolam|midazolam|mesh-list
13874094|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13874095|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874096|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874097|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874098|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13874099|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874100|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874101|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13874102|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
13874103|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
13874104|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
13874105|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
13874106|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874107|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874108|NCT03636971|Mannitol|mannitol|mesh-list
13874109|NCT03636971|Sorbitol|sorbitol|mesh-list
13874110|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
13874111|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13874112|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
13874113|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874114|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
13874115|NCT03636971|Protective Agents|protective agents|mesh-ancestor
13874116|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13874117|NCT03636971|Diuretics|diuretics|mesh-ancestor
13874118|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
13874119|NCT03636971|Cathartics|cathartics|mesh-ancestor
13874120|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874121|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
13874122|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
13874123|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13874124|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
14470427|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874125|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874126|NCT03636932|Expectorants|expectorants|mesh-ancestor
13874127|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
13874128|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13874129|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
13874130|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874131|NCT03636932|Protective Agents|protective agents|mesh-ancestor
13874132|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874133|NCT03636932|Antidotes|antidotes|mesh-ancestor
13874134|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13874135|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874136|NCT03636685|Paclitaxel|paclitaxel|mesh-list
13874137|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13874138|NCT03636685|Carboplatin|carboplatin|mesh-list
13874139|NCT03636685|Pemetrexed|pemetrexed|mesh-list
13874140|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13874141|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874142|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
13874143|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
13874144|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
13874145|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874146|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874147|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13874148|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13874149|NCT03636659|Amphotericin B|amphotericin b|mesh-list
13874150|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13874151|NCT03636659|Amebicides|amebicides|mesh-ancestor
13874152|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13874153|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13874154|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874155|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874156|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
13874157|NCT03636555|Oxytocin|oxytocin|mesh-list
13874158|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
13874159|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13874160|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874161|NCT03636542|Bupivacaine|bupivacaine|mesh-list
13874162|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
13874163|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
13874164|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874165|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874166|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
13874167|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874168|NCT03636477|Nivolumab|nivolumab|mesh-list
13874169|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874170|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874171|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13874172|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874173|NCT03636373|Triamcinolone|triamcinolone|mesh-list
13874174|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13874175|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13874176|NCT03636373|Etanercept|etanercept|mesh-list
13874177|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13874178|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13874179|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
13874180|NCT03636373|Hormones|hormones|mesh-ancestor
13874181|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874182|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874183|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13874184|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
13874185|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874186|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874187|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13874188|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13874189|NCT03636373|Analgesics|analgesics|mesh-ancestor
13874190|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
13874191|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874192|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13874193|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874194|NCT03636308|Gemcitabine|gemcitabine|mesh-list
13874195|NCT03636308|Paclitaxel|paclitaxel|mesh-list
13874196|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13874197|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13874198|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874199|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
13874200|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
13874201|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
13874202|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026916|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13874203|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13874204|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
13874205|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
13874206|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874207|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874208|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13874209|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
13874210|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874211|NCT03636178|Daminozide|daminozide|mesh-list
13874212|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
13874213|NCT03636178|Growth Substances|growth substances|mesh-ancestor
13874214|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874215|NCT03636048|Bupivacaine|bupivacaine|mesh-list
13874216|NCT03636048|Anesthetics|anesthetics|mesh-list
13874217|NCT03636048|Propofol|propofol|mesh-list
13874218|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
13874219|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874220|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874221|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
13874222|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874223|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874224|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13874225|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
13874226|NCT03635931|Mitogens|mitogens|mesh-list
13874227|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
13874228|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874229|NCT03635905|Gabapentin|gabapentin|mesh-list
13874230|NCT03635905|Analgesics|analgesics|mesh-ancestor
13874231|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
13874232|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874233|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874234|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
13874235|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13874236|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874237|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874238|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874239|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13874240|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13874241|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874242|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874243|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
13874244|NCT03635827|Xenon|xenon|mesh-list
13874245|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13874246|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
13874247|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
13874248|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874249|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956726|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
13956727|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956728|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956729|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
13956730|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956731|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13956732|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13956733|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13956734|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13956735|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956736|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13956737|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
13956738|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
13956739|NCT03180125|Protective Agents|protective agents|mesh-ancestor
13956740|NCT03180242|Trastuzumab|trastuzumab|mesh-list
13956741|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13956742|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956743|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13956744|NCT03180281|Glimepiride|glimepiride|mesh-list
13956745|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956746|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956747|NCT03180281|Incretins|incretins|mesh-ancestor
13956748|NCT03180281|Hormones|hormones|mesh-ancestor
13956749|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956750|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13956751|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
13956752|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956753|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956754|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13874250|NCT03635684|Acetaminophen|acetaminophen|mesh-list
13874251|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13874252|NCT03635684|Analgesics|analgesics|mesh-ancestor
13874253|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
13874254|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874255|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874256|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
13874257|NCT03635567|Paclitaxel|paclitaxel|mesh-list
13874258|NCT03635567|Bevacizumab|bevacizumab|mesh-list
13874259|NCT03635567|Carboplatin|carboplatin|mesh-list
13874260|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
13874261|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13874262|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874263|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
13874264|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
13874265|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
13874266|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874267|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874268|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13874269|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13874270|NCT03635567|Growth Substances|growth substances|mesh-ancestor
13874271|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874272|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
13874273|NCT03635437|Alprazolam|alprazolam|mesh-list
13874274|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
13874275|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874276|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874277|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874278|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13874279|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874280|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874281|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
13874282|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
13874283|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874284|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874285|NCT03635411|Niacinamide|niacinamide|mesh-list
13874286|NCT03635411|Niacin|niacin|mesh-list
13874287|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
13874288|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
13874289|NCT03635411|Vitamins|vitamins|mesh-ancestor
13874290|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
13874291|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874292|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13874293|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
13874294|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874295|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13874296|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
13874297|NCT03635398|Midazolam|midazolam|mesh-list
13874298|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13874299|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874300|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874301|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874302|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13874303|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874304|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874305|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13874306|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
13874307|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
13874308|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
13874309|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
13874310|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874311|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874312|NCT03635372|Sucralfate|sucralfate|mesh-list
13874313|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
13874314|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13874315|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874316|NCT03635372|Antacids|antacids|mesh-ancestor
13874317|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874318|NCT03635333|Nicotine|nicotine|mesh-list
14026917|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
14026918|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14026919|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
14026920|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874319|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13874320|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
13874321|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470428|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13874322|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874323|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13874324|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13874325|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
13874326|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874327|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874328|NCT03635125|Metoprolol|metoprolol|mesh-list
13874329|NCT03635125|Nebivolol|nebivolol|mesh-list
13874330|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13874331|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13874332|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
13874333|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
13874334|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874335|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874336|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13874337|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13874338|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13874339|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
13874340|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874341|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874342|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
13874343|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13874344|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13874345|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13874346|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
13874347|NCT03634917|Acamprosate|acamprosate|mesh-list
13874348|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
13874349|NCT03634917|Calcium|calcium|mesh-list
13874350|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13874351|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874352|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13874353|NCT03634917|Antacids|antacids|mesh-ancestor
13874354|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874355|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874356|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13874357|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
13874358|NCT03634852|Dexamethasone|dexamethasone|mesh-list
13874359|NCT03634852|Triamcinolone|triamcinolone|mesh-list
13874360|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13874361|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13874362|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13874363|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13874364|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13874365|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13874366|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
13874367|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
13874368|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874369|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874370|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874371|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
13874372|NCT03634852|Hormones|hormones|mesh-ancestor
13874373|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874374|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13874375|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874376|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874377|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874378|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13874379|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13874380|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874381|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874382|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13874383|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
13874384|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13874385|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13874386|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13874387|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13874388|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13874389|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
13874390|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13874391|NCT03634735|Thiamine|thiamine|mesh-list
13874392|NCT03634735|Vitamins|vitamins|mesh-ancestor
13874393|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
13874394|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874395|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
13874396|NCT03634605|Tetracycline|tetracycline|mesh-list
13874397|NCT03634605|Lidocaine|lidocaine|mesh-list
13874398|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
13874399|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
13874400|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874401|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874402|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
13874403|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874404|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13874405|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13874406|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13874407|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13874408|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874409|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874410|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874411|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13874412|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874413|NCT03634514|Hormones|hormones|mesh-list
13874414|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874415|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874416|NCT03634345|Fluconazole|fluconazole|mesh-list
13874417|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
13874418|NCT03634345|Abrocitinib|abrocitinib|mesh-list
13874419|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
13874420|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874421|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13874422|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13874423|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874424|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874425|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13874426|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
13874427|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874428|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874429|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13874430|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13874431|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13874432|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874433|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874434|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874435|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13874436|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13874437|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13874438|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874439|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
13874440|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13874441|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
13874442|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13874443|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13874444|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
13874445|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874446|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874447|NCT03634202|Capecitabine|capecitabine|mesh-list
13874448|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13874449|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
13874450|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874451|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874452|NCT03634189|Cannabidiol|cannabidiol|mesh-list
13874453|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
13874454|NCT03634137|Afamelanotide|afamelanotide|mesh-list
13874455|NCT03634137|alpha-MSH|alpha-msh|mesh-list
13874456|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
13874457|NCT03634137|Hormones|hormones|mesh-ancestor
13874458|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874459|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874460|NCT03634111|Morphine|morphine|mesh-list
13874461|NCT03634111|Ropivacaine|ropivacaine|mesh-list
13874462|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13874463|NCT03634111|Narcotics|narcotics|mesh-ancestor
13874464|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874465|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874466|NCT03634111|Analgesics|analgesics|mesh-ancestor
13874467|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
14026921|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
14026922|NCT02739880|Protective Agents|protective agents|mesh-ancestor
13874468|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874469|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
13874470|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
13874471|NCT03634059|Apatinib|apatinib|mesh-list
13874472|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874473|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13874474|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874475|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874476|NCT03634020|Sirolimus|sirolimus|mesh-list
13874477|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470429|NCT02310672|Macitentan|macitentan|mesh-list
13874478|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874479|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13874480|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874481|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
13874482|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13874483|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
13874484|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874485|NCT03633994|Heparin|heparin|mesh-list
13874486|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
13874487|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13874488|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13874489|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956755|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13956756|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
13956757|NCT03180255|Dexamethasone|dexamethasone|mesh-list
13956758|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
13956759|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13956760|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956761|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
13956762|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
13956763|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956764|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956765|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956766|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
13956767|NCT03180255|Hormones|hormones|mesh-ancestor
13956768|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956769|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13956770|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956771|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
13956772|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
13956773|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
13956774|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13956775|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13956776|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956777|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956778|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956779|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956780|NCT03180099|Bupivacaine|bupivacaine|mesh-list
13956781|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
13956782|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
13956783|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956784|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956785|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
13956786|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956787|NCT03179995|Octreotide|octreotide|mesh-list
13956788|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956789|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13956790|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956791|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
13956792|NCT03179839|Sertraline|sertraline|mesh-list
13956793|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
13956794|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13956795|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13956796|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13956797|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13956798|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956799|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956800|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
13956801|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956802|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13956803|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13956804|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956805|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14470430|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14938584|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13874490|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13874491|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13874492|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
13874493|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874494|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874495|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874496|NCT03633747|Propranolol|propranolol|mesh-list
13874497|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13874498|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13874499|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
13874500|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874501|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874502|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874503|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13874504|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13874505|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
13874506|NCT03633734|Folfirinox|folfirinox|mesh-list
13874507|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874508|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
13874509|NCT03633630|Antacids|antacids|mesh-ancestor
13874510|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874511|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874512|NCT03633604|HBOC 201|hboc 201|mesh-list
13874513|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
13874514|NCT03633591|Tolcapone|tolcapone|mesh-list
13874515|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13874516|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13874517|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13874518|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874519|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874520|NCT03633565|Prednisolone|prednisolone|mesh-list
13874521|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13874522|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
13874523|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13874524|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
13874525|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
13874526|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13874527|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
13874528|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
13874529|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13874530|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
13874531|NCT03633565|Hormones|hormones|mesh-ancestor
13874532|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874533|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874534|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13874535|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874536|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
13874537|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
13874538|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874539|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874540|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13874541|NCT03633565|Protective Agents|protective agents|mesh-ancestor
13874542|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
13874543|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13874544|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874545|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874546|NCT03633565|Urological Agents|urological agents|mesh-ancestor
13874547|NCT03633552|Temozolomide|temozolomide|mesh-list
13874548|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13874549|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
13874550|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874551|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874552|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
13874553|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874554|NCT03633266|Bevacizumab|bevacizumab|mesh-list
13874555|NCT03633266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874556|NCT03633266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874557|NCT03633266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13874558|NCT03633266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13874559|NCT03633266|Growth Substances|growth substances|mesh-ancestor
13874560|NCT03633266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874561|NCT03633266|Growth Inhibitors|growth inhibitors|mesh-ancestor
13874562|NCT03633175|Progesterone|progesterone|mesh-list
13874563|NCT03633175|Progestins|progestins|mesh-ancestor
13874564|NCT03633175|Hormones|hormones|mesh-ancestor
13874565|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874566|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874567|NCT03632915|Lacosamide|lacosamide|mesh-list
13874568|NCT03632915|Phenytoin|phenytoin|mesh-list
13874569|NCT03632915|Ketamine|ketamine|mesh-list
13874570|NCT03632915|Levetiracetam|levetiracetam|mesh-list
13874571|NCT03632915|Valproic Acid|valproic acid|mesh-list
13874572|NCT03632915|Phenobarbital|phenobarbital|mesh-list
13874573|NCT03632915|Analgesics|analgesics|mesh-ancestor
13874574|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
13874575|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874576|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874577|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13874578|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13874579|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
13874580|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
13874581|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874582|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13874583|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13874584|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874585|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874586|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
13874587|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
13874588|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874589|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
13874590|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
13874591|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874592|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874593|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13874594|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13874595|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13874596|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13874597|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13874598|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874599|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
13874600|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13874601|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13874602|NCT03632876|Vitamin A|vitamin a|mesh-list
13874603|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
13874604|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
13874605|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874606|NCT03632876|Protective Agents|protective agents|mesh-ancestor
13874607|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874608|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13874609|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874610|NCT03632876|Vitamins|vitamins|mesh-ancestor
13874611|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
13874612|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
13874613|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13874614|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13874615|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874616|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
13874617|NCT03632824|Coagulants|coagulants|mesh-ancestor
13874618|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
13874619|NCT03632772|Mirabegron|mirabegron|mesh-list
13874620|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13874621|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13874622|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
13874623|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874624|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874625|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874626|NCT03632772|Urological Agents|urological agents|mesh-ancestor
13874627|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13874628|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13874629|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13874630|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
13874631|NCT03632733|Tetracycline|tetracycline|mesh-list
13874632|NCT03632733|Clotrimazole|clotrimazole|mesh-list
13874633|NCT03632733|Miconazole|miconazole|mesh-list
13874634|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874635|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874636|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13874637|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874638|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874639|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14026923|NCT02739906|Insulin|insulin|mesh-list
13874640|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
13874641|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13874642|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13874643|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13874644|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
13874645|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874646|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874647|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13874648|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13874649|NCT03632681|Insulin|insulin|mesh-list
13874650|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13874651|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13874652|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874653|NCT03632642|Floxacillin|floxacillin|mesh-list
13874654|NCT03632642|Penicillin G|penicillin g|mesh-list
13874655|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
13874656|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
13874657|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874658|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874659|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
13874660|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
13874661|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
13874662|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874663|NCT03632590|Analgesics|analgesics|mesh-ancestor
13874664|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
13874665|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874666|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874667|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
13874668|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874669|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13874670|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
13874671|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13874672|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13874673|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13874674|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
13874675|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13874676|NCT03632590|Cathartics|cathartics|mesh-ancestor
13874677|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874678|NCT03632590|Antacids|antacids|mesh-ancestor
13874679|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
13874680|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
13874681|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13874682|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13874683|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
13874684|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874685|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874686|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
13874687|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874688|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874689|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874690|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13874691|NCT03632460|Analgesics|analgesics|mesh-ancestor
13874692|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
13874693|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874694|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13874695|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13874696|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13874697|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
13874698|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874699|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874700|NCT03632408|Zopiclone|zopiclone|mesh-list
13874701|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874702|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874703|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874704|NCT03632369|Xenon|xenon|mesh-list
13874705|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13874706|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
13874707|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
13874708|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874709|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874710|NCT03632330|Midazolam|midazolam|mesh-list
13874711|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
13874712|NCT03632330|Propofol|propofol|mesh-list
13874713|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14026924|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13874714|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874715|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874716|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13874717|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
13874718|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
13874719|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13874720|NCT03632330|Analgesics|analgesics|mesh-ancestor
13874721|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
13874722|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874723|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13874724|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13874725|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13874726|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
13874727|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874728|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874729|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13874730|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13874731|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874732|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874733|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
13874734|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
13874735|NCT03632317|Everolimus|everolimus|mesh-list
13874736|NCT03632317|Panobinostat|panobinostat|mesh-list
13874737|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874738|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13874739|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
13874740|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874741|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13874742|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874743|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874744|NCT03632304|Anesthetics|anesthetics|mesh-list
13874745|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874746|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874747|NCT03632213|Losartan|losartan|mesh-list
14026925|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
14026926|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14026927|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026928|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14026929|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
14026930|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026931|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14026932|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14026933|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026934|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
14026935|NCT02739815|Coagulants|coagulants|mesh-ancestor
14026936|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
14026937|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14026938|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
14026939|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026940|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14026941|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026942|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
14026943|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026944|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
14026945|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14026946|NCT02739711|Protective Agents|protective agents|mesh-ancestor
14026947|NCT02739672|Amlodipine|amlodipine|mesh-list
14026948|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14026949|NCT02739672|Telmisartan|telmisartan|mesh-list
14026950|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14026951|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14026952|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14026953|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14026954|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026955|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14026956|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026957|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
14026958|NCT02739672|Diuretics|diuretics|mesh-ancestor
14026959|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
14026960|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14026961|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14026962|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14026963|NCT02739685|Everolimus|everolimus|mesh-list
13874748|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13874749|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13874750|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13874751|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13874752|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874753|NCT03632187|Abatacept|abatacept|mesh-list
13874754|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13874755|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874756|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931373|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931374|NCT01438866|Fluorides|fluorides|mesh-list
14931375|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
14931376|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
14931377|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
14931378|NCT01438866|Protective Agents|protective agents|mesh-ancestor
14931379|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931380|NCT01438944|Nicotine|nicotine|mesh-list
14931381|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13874757|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13874758|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
13874759|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874760|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13874761|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
13874762|NCT03632161|Bupivacaine|bupivacaine|mesh-list
13874763|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
13874764|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
13874765|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874766|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874767|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
13874768|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874769|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874770|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13874771|NCT03632161|Analgesics|analgesics|mesh-ancestor
13874772|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13874773|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13874774|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13874775|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
13874776|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874777|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956806|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13956807|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13956808|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956809|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13956810|NCT03179904|Paclitaxel|paclitaxel|mesh-list
13956811|NCT03179904|Trastuzumab|trastuzumab|mesh-list
13956812|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13956813|NCT03179904|Letrozole|letrozole|mesh-list
13956814|NCT03179904|Fulvestrant|fulvestrant|mesh-list
13956815|NCT03179904|Anastrozole|anastrozole|mesh-list
13956816|NCT03179904|Exemestane|exemestane|mesh-list
13956817|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
13956818|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13956819|NCT03179904|Antibodies|antibodies|mesh-list
13956820|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
13956821|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13956822|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13956823|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956824|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
13956825|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
13956826|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
13956827|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956828|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
13956829|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956830|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13956831|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13956832|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956833|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13956834|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
13956835|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956836|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13956837|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13956838|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
13956839|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956840|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
14931382|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
14931383|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874778|NCT03632044|Ropivacaine|ropivacaine|mesh-list
13874779|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
13874780|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
13874781|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874782|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874783|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
13874784|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874785|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13874786|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13874787|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13874788|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874789|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
13874790|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874791|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874792|NCT03631953|Trametinib|trametinib|mesh-list
13874793|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874794|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13874795|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874796|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874797|NCT03631901|Diazepam|diazepam|mesh-list
13874798|NCT03631901|Melatonin|melatonin|mesh-list
13874799|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
13874800|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874801|NCT03631901|Protective Agents|protective agents|mesh-ancestor
13874802|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874803|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874804|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13874805|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
13874806|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
13874807|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
13874808|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874809|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874810|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874811|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13874812|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13874813|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13874814|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13874815|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13874816|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13874817|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
13874818|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
13874819|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
13874820|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
13874821|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874822|NCT03631875|Ketamine|ketamine|mesh-list
13874823|NCT03631875|Propofol|propofol|mesh-list
13874824|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13874825|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874826|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874827|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13874828|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
13874829|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
13874830|NCT03631875|Analgesics|analgesics|mesh-ancestor
13874831|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
13874832|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874833|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13874834|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13874835|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13874836|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874837|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874838|NCT03631862|Apatinib|apatinib|mesh-list
13874839|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874840|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13874841|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874842|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874843|NCT03631836|Bevacizumab|bevacizumab|mesh-list
13874844|NCT03631836|Antibodies|antibodies|mesh-list
13874845|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13874846|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874847|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874848|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13874849|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13874850|NCT03631836|Growth Substances|growth substances|mesh-ancestor
13874851|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874852|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
13874853|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
13874854|NCT03631823|Temozolomide|temozolomide|mesh-list
13874855|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13874856|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
13874857|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874858|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874859|NCT03631641|Nivolumab|nivolumab|mesh-list
13874860|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874861|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874862|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13874863|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874864|NCT03631615|Antibodies|antibodies|mesh-list
13874865|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
13874866|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874867|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
13874868|NCT03631602|Clotrimazole|clotrimazole|mesh-list
13874869|NCT03631602|Miconazole|miconazole|mesh-list
13874870|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874871|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13874872|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13874873|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13874874|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874875|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874876|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13874877|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
13874878|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874879|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874880|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13874881|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13874882|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13874883|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
13874884|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874885|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
13874886|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874887|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874888|NCT03631316|Valganciclovir|valganciclovir|mesh-list
13874889|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
13874890|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874891|NCT03631277|Calcium|calcium|mesh-list
13874892|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13874893|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874894|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13874895|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874896|NCT03631147|Rifaximin|rifaximin|mesh-list
13874897|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874898|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874899|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874900|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
13874901|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874902|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13874903|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874904|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
13874905|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13874906|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874907|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
13874908|NCT03630991|Edetic Acid|edetic acid|mesh-list
13874909|NCT03630991|Calcium|calcium|mesh-list
13874910|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
13874911|NCT03630991|Succimer|succimer|mesh-list
13874912|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874913|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13874914|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13874915|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
13874916|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13874917|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
13874918|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
13874919|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874920|NCT03630991|Antidotes|antidotes|mesh-ancestor
13874921|NCT03630991|Protective Agents|protective agents|mesh-ancestor
13874922|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13874923|NCT03630952|Aflibercept|aflibercept|mesh-list
13874924|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13874925|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13874926|NCT03630952|Growth Substances|growth substances|mesh-ancestor
13874927|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874928|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
13874929|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874930|NCT03630796|Sevoflurane|sevoflurane|mesh-list
13874931|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13874932|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13874933|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
13874934|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
13874935|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13874936|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874937|NCT03630614|Nicotine|nicotine|mesh-list
13874938|NCT03630614|Varenicline|varenicline|mesh-list
13874939|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13874940|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
13874941|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874942|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874943|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13874944|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13874945|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
13874946|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13874947|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956841|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13956842|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963074|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963075|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13963076|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963077|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963078|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
13963079|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963080|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963081|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963082|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
13963083|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13963084|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
13963085|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963086|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963087|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13963088|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
13963089|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
13963090|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13963091|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
13963092|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963093|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963094|NCT02419417|Nivolumab|nivolumab|mesh-list
13963095|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963096|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963097|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13963098|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963099|NCT02383251|Paclitaxel|paclitaxel|mesh-list
13963100|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13963101|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963102|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
13963103|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
13963104|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
13963105|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963106|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
13963107|NCT02248701|Finasteride|finasteride|mesh-list
14754077|NCT04840602|Rituximab|rituximab|mesh-list
14754078|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14754079|NCT04840602|Venetoclax|venetoclax|mesh-list
14754080|NCT04840602|Antibodies|antibodies|mesh-list
14754081|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
14754082|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14754083|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
14754084|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754085|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754086|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754087|NCT04821869|Albuterol|albuterol|mesh-list
14754088|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14754089|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
14754090|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874948|NCT03630367|Dexamethasone|dexamethasone|mesh-list
13874949|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13874950|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
13874951|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
13874952|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13874953|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874954|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13874955|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
13874956|NCT03630367|Hormones|hormones|mesh-ancestor
13874957|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874958|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13874959|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874960|NCT03630341|Clomiphene|clomiphene|mesh-list
13874961|NCT03630341|Enclomiphene|enclomiphene|mesh-list
13874962|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
13874963|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13874964|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
13874965|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13874966|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874967|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13874968|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
13874969|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13874970|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13874971|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13874972|NCT03630315|Bevacizumab|bevacizumab|mesh-list
13874973|NCT03630315|Ranibizumab|ranibizumab|mesh-list
13874974|NCT03630315|Aflibercept|aflibercept|mesh-list
13874975|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874976|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874977|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13874978|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13874979|NCT03630315|Growth Substances|growth substances|mesh-ancestor
13874980|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874981|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
13874982|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
13874983|NCT03630081|Meropenem|meropenem|mesh-list
13874984|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13874985|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13874986|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13874987|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13874988|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13874989|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13874990|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874991|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13874992|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13874993|NCT03630042|Rituximab|rituximab|mesh-list
13874994|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
13874995|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13874996|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13874997|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
13874998|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13874999|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13875000|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13875001|NCT03630029|Hematinics|hematinics|mesh-ancestor
13875002|NCT03629847|Everolimus|everolimus|mesh-list
13875003|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875004|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875005|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
13875006|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875007|NCT03629717|Vitamin D|vitamin d|mesh-list
13875008|NCT03629717|Denosumab|denosumab|mesh-list
13875009|NCT03629717|Calcium|calcium|mesh-list
13875010|NCT03629717|Vitamins|vitamins|mesh-ancestor
13875011|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
13875012|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875013|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13875014|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13875015|NCT03629639|Metformin|metformin|mesh-list
13875016|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13875017|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875018|NCT03629613|Antioxidants|antioxidants|mesh-list
13875019|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875020|NCT03629613|Protective Agents|protective agents|mesh-ancestor
13875021|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875022|NCT03629600|Indomethacin|indomethacin|mesh-list
13875023|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13875024|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875025|NCT03629600|Analgesics|analgesics|mesh-ancestor
13875026|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
13875027|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875028|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875029|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875030|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13875031|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
13875032|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
13875033|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13875034|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13875035|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875036|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875037|NCT03629522|Ondansetron|ondansetron|mesh-list
13875038|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
13875039|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
13875040|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875041|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875042|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875043|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
13875044|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
13875045|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13875046|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
13875047|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875048|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875049|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13875050|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13875051|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875052|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875053|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14470431|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14470432|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470433|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14470434|NCT02310750|PF-06700841|pf-06700841|mesh-list
14470435|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14470436|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470437|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470438|NCT02310789|Ivacaftor|ivacaftor|mesh-list
14470439|NCT02310789|Pilocarpine|pilocarpine|mesh-list
14470440|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
14470441|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14470442|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14470443|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470444|NCT02310789|Miotics|miotics|mesh-ancestor
14470445|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
14470446|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470447|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875071|NCT03629418|Phenylephrine|phenylephrine|mesh-list
13875072|NCT03629418|Norepinephrine|norepinephrine|mesh-list
13875073|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13875074|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
13875075|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
13875076|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875077|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026964|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875078|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
13875079|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13875080|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
13875081|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
13875082|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13875083|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13875084|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13875085|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875086|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875087|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875088|NCT03629418|Protective Agents|protective agents|mesh-ancestor
13875089|NCT03629379|Ustekinumab|ustekinumab|mesh-list
13875090|NCT03629379|Vedolizumab|vedolizumab|mesh-list
13875091|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
13875092|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875093|NCT03629288|Azithromycin|azithromycin|mesh-list
13875094|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13875095|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875096|NCT03629262|Sufentanil|sufentanil|mesh-list
13875097|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
13875098|NCT03629262|Dsuvia|dsuvia|mesh-list
13875099|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13875100|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875101|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875102|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875103|NCT03629262|Analgesics|analgesics|mesh-ancestor
13875104|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
13875105|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875106|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13875107|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13875108|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13875109|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875110|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875111|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875112|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13875113|NCT03629262|Narcotics|narcotics|mesh-ancestor
13875114|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13875115|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13875116|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
13875117|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
13875118|NCT03629223|Tepotinib|tepotinib|mesh-list
13875119|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875120|NCT03629210|Dexamethasone|dexamethasone|mesh-list
13875121|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875122|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
13875123|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
13875124|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875125|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875126|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875127|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
13875128|NCT03629210|Hormones|hormones|mesh-ancestor
13875129|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875130|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13875131|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875132|NCT03629093|Anesthetics|anesthetics|mesh-list
13875133|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
13875134|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875135|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754091|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754092|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13875138|NCT03628625|Letrozole|letrozole|mesh-list
13875139|NCT03628625|Misoprostol|misoprostol|mesh-list
13875140|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875141|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13875142|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13875143|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875144|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875145|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13875146|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
13875147|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875148|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875149|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13875150|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
13875151|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13875152|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13875153|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875154|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
13875155|NCT03628521|Gemcitabine|gemcitabine|mesh-list
13875156|NCT03628521|Carboplatin|carboplatin|mesh-list
13875157|NCT03628521|Pemetrexed|pemetrexed|mesh-list
13875158|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13875159|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875160|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13875161|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
13956843|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
13875162|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875163|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
13875164|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875165|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875166|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875167|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
13875168|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875169|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13875170|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13875171|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13875172|NCT03628443|Mitogens|mitogens|mesh-list
13875173|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
13875174|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875175|NCT03628430|Lidocaine|lidocaine|mesh-list
13875176|NCT03628430|Epinephrine|epinephrine|mesh-list
13875177|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
13875178|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
13875179|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875180|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875181|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
13875182|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875183|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13875184|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13875185|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13875186|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875187|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875188|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13875189|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13875190|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875191|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875192|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13875193|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13875194|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
13875195|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13875196|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
13875197|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
13875198|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
13875199|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13875200|NCT03628391|Haloperidol|haloperidol|mesh-list
13875201|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
13875202|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
13875203|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
13875204|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875205|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875206|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875207|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13875208|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13875209|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875210|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875211|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13875212|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
13875213|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875214|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875215|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13956844|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13956845|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
13956846|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13956847|NCT03179449|Hematinics|hematinics|mesh-ancestor
13956848|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13956849|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13956850|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
13956851|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
13956852|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956853|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956854|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
13956855|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13956856|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
13956857|NCT03179605|Clobetasol|clobetasol|mesh-list
13956858|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956859|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
13956860|NCT03179605|Hormones|hormones|mesh-ancestor
13956861|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956862|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956863|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
13956864|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13875216|NCT03628339|Tepotinib|tepotinib|mesh-list
13875217|NCT03628339|Midazolam|midazolam|mesh-list
13875218|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13875219|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13875220|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875221|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875222|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13875223|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13875224|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875225|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13875226|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
13875227|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
13875228|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
13875229|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
13875230|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875231|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875232|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875233|NCT03628300|Piperacillin|piperacillin|mesh-list
13875234|NCT03628300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13875235|NCT03628300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875236|NCT03628131|Carboplatin|carboplatin|mesh-list
13875237|NCT03628131|Etoposide|etoposide|mesh-list
13875238|NCT03628131|Ifosfamide|ifosfamide|mesh-list
13875239|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875240|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13875241|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13875242|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13875243|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875244|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875245|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13875246|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
13875247|NCT03628079|Mebendazole|mebendazole|mesh-list
13875248|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
13875249|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
13875250|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13875251|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875252|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
13875253|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
13875254|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
13875255|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875256|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875257|NCT03628053|Blinatumomab|blinatumomab|mesh-list
13875258|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
13875259|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875260|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13875261|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13875262|NCT03628040|Ropivacaine|ropivacaine|mesh-list
13875263|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
13875264|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
13875265|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875266|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875267|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
13875268|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470448|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14470449|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13875269|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13875270|NCT03627741|Triamcinolone|triamcinolone|mesh-list
13875271|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13875272|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13875273|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13875274|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875275|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
13875276|NCT03627741|Hormones|hormones|mesh-ancestor
13875277|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14470450|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
13875278|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875279|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875280|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
13875281|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875282|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875283|NCT03627715|Proxigermanium|proxigermanium|mesh-list
13875284|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875285|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
13875286|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
13875287|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875288|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
13875289|NCT03627546|Velpatasvir|velpatasvir|mesh-list
13875290|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
13875291|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875292|NCT03627468|Bromides|bromides|mesh-list
13875293|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
13875294|NCT03627390|Molybdenum|molybdenum|mesh-list
13875295|NCT03627390|Trace Elements|trace elements|mesh-ancestor
13875296|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
13875297|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875298|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
13875299|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13875300|NCT03627260|Protective Agents|protective agents|mesh-ancestor
13875301|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875302|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
13875303|NCT03627039|Metformin|metformin|mesh-list
13875304|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
13875305|NCT03627039|Empagliflozin|empagliflozin|mesh-list
13875306|NCT03627039|Canagliflozin|canagliflozin|mesh-list
13875307|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13875308|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875309|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13875310|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875311|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13875312|NCT03626831|Evolocumab|evolocumab|mesh-list
13875313|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13875314|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13875315|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
13875316|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875317|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13956865|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
13956866|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
13956867|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13956868|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956869|NCT03179293|Propofol|propofol|mesh-list
13956870|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13956871|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956872|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956873|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13956874|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
13956875|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
13956876|NCT03179280|Insulin|insulin|mesh-list
13956877|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
13956878|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956879|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956880|NCT03178994|Ketoconazole|ketoconazole|mesh-list
13956881|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
13956882|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956883|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13956884|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13956885|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956886|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956887|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13956888|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
13956889|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13956890|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956891|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13956892|NCT03179254|Metformin|metformin|mesh-list
13956893|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956894|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956895|NCT03178708|Amantadine|amantadine|mesh-list
13956896|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13956897|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13956898|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
13956899|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956900|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
13956901|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956902|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875318|NCT03626753|Acetaminophen|acetaminophen|mesh-list
13875319|NCT03626753|Piroxicam|piroxicam|mesh-list
13875320|NCT03626753|Nefopam|nefopam|mesh-list
13875321|NCT03626753|Proroxan|proroxan|mesh-list
13875322|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875323|NCT03626753|Analgesics|analgesics|mesh-ancestor
13875324|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
13875325|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875326|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875327|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
13875328|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13875329|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875330|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13875331|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13875332|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875333|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875334|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13875335|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13875336|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875337|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875338|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875339|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
13875340|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13875341|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13875342|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
13875343|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
13875344|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875345|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875346|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13875347|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13875348|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875349|NCT03626519|Menthol|menthol|mesh-list
13875350|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
13875351|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
13875352|NCT03626506|Amlodipine|amlodipine|mesh-list
13875353|NCT03626506|Indapamide|indapamide|mesh-list
13875354|NCT03626506|Spironolactone|spironolactone|mesh-list
13875355|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13875356|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13875357|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875358|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875359|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13875360|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875361|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
13875362|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13875363|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
13875364|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875365|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13875366|NCT03626506|Diuretics|diuretics|mesh-ancestor
13875367|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
13875368|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13875369|NCT03626454|Norepinephrine|norepinephrine|mesh-list
13875370|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13875371|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13875372|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13875373|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875374|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875375|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875376|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875377|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
13875378|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
13875379|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875380|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13875381|NCT03626298|Niacinamide|niacinamide|mesh-list
13875382|NCT03626298|Niacin|niacin|mesh-list
13875383|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
13875384|NCT03626298|Adapalene|adapalene|mesh-list
13875385|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
13875386|NCT03626298|Vitamins|vitamins|mesh-ancestor
13875387|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
13875388|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875389|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13875390|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
14026965|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875391|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875392|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13875393|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
13875394|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13875395|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875396|NCT03626298|Analgesics|analgesics|mesh-ancestor
13875397|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
13875398|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875399|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875400|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13875401|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
13875402|NCT03626259|Losartan|losartan|mesh-list
13875403|NCT03626259|Amlodipine|amlodipine|mesh-list
13875404|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13875405|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13875406|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875407|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875408|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13875409|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875410|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
13875411|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13875412|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13875413|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13875414|NCT03626064|Nicotine|nicotine|mesh-list
13875415|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13875416|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
13875417|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875418|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875419|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13875420|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13875421|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
13875422|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875423|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875424|NCT03625960|Cantharidin|cantharidin|mesh-list
13875425|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875426|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875427|NCT03625830|Paclitaxel|paclitaxel|mesh-list
13875428|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13875429|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875430|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
13875431|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
13875432|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
13875433|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875434|NCT03625739|Amoxicillin|amoxicillin|mesh-list
13875435|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
13875436|NCT03625739|Levofloxacin|levofloxacin|mesh-list
13875437|NCT03625739|Isoniazid|isoniazid|mesh-list
13875438|NCT03625739|Cycloserine|cycloserine|mesh-list
13875439|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
13875440|NCT03625739|Imipenem|imipenem|mesh-list
13875441|NCT03625739|Amikacin|amikacin|mesh-list
13875442|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
13875443|NCT03625739|Ethambutol|ethambutol|mesh-list
13875444|NCT03625739|Bedaquiline|bedaquiline|mesh-list
13875445|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13875446|NCT03625739|Clofazimine|clofazimine|mesh-list
13875447|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
13875448|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
13875449|NCT03625739|Streptomycin|streptomycin|mesh-list
13875450|NCT03625739|Kanamycin|kanamycin|mesh-list
13875451|NCT03625739|Ethionamide|ethionamide|mesh-list
13875452|NCT03625739|Capreomycin|capreomycin|mesh-list
13875453|NCT03625739|Thioacetazone|thioacetazone|mesh-list
13875454|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
13875455|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13875456|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875457|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13875458|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13875459|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875460|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875461|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875462|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13875463|NCT03625739|Renal Agents|renal agents|mesh-ancestor
13875464|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13875465|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13875466|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13875467|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
13875468|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13875469|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13875470|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
13875471|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13875472|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13875473|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875474|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13875475|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13875476|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13875477|NCT03625726|Thrombin|thrombin|mesh-list
13875478|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
13875479|NCT03625726|Coagulants|coagulants|mesh-ancestor
13875480|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
13875481|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13875482|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875483|NCT03625531|Letrozole|letrozole|mesh-list
13875484|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875485|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13875486|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13875487|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875488|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875489|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13875490|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
13875491|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875492|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875493|NCT03625518|Oxytocin|oxytocin|mesh-list
13875494|NCT03625518|Dinoprostone|dinoprostone|mesh-list
13875495|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
13875496|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13875497|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875498|NCT03625505|Venetoclax|venetoclax|mesh-list
13875499|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875500|NCT03625310|Listerine|listerine|mesh-list
13875501|NCT03625310|Fluorides|fluorides|mesh-list
13875502|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
13875503|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
13875504|NCT03625310|Protective Agents|protective agents|mesh-ancestor
13875505|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875506|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13875507|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875508|NCT03625219|Prednisone|prednisone|mesh-list
13875509|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875510|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
13875511|NCT03625219|Hormones|hormones|mesh-ancestor
13875512|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875513|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875514|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13875515|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875516|NCT03625167|Petrolatum|petrolatum|mesh-list
13875517|NCT03625167|Emollients|emollients|mesh-ancestor
13875518|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
13956903|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956904|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956905|NCT03178708|Analgesics|analgesics|mesh-ancestor
13956906|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
13956907|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956908|NCT03178955|Etanercept|etanercept|mesh-list
13956909|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956910|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956911|NCT03178955|Analgesics|analgesics|mesh-ancestor
13956912|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
13956913|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956914|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956915|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956916|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13956917|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13956918|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875519|NCT03625089|Atorvastatin|atorvastatin|mesh-list
13875520|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13875521|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13875522|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
13875523|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875524|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13875525|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13875526|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875527|NCT03625076|Lidocaine|lidocaine|mesh-list
13875528|NCT03625076|Propofol|propofol|mesh-list
13875529|NCT03625076|Etomidate|etomidate|mesh-list
13875530|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
13875531|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
13875532|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14026966|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
14026967|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026968|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14026969|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
14026970|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026971|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
14026972|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026973|NCT02739633|Gemcitabine|gemcitabine|mesh-list
14470451|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470452|NCT02311361|Durvalumab|durvalumab|mesh-list
14470453|NCT02311361|Tremelimumab|tremelimumab|mesh-list
14470454|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470455|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470456|NCT02311478|Copper|copper|mesh-list
14470457|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
14470458|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14470459|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470460|NCT02311478|Trace Elements|trace elements|mesh-ancestor
14470461|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
14470462|NCT02311881|Acetaminophen|acetaminophen|mesh-list
14470463|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14470464|NCT02311881|Analgesics|analgesics|mesh-ancestor
14470465|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
14470466|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470467|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470468|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
14470469|NCT02311907|Paclitaxel|paclitaxel|mesh-list
14470470|NCT02311907|Carboplatin|carboplatin|mesh-list
14470471|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14470472|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14470473|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470474|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14470475|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14470476|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14470477|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026974|NCT02739633|Paclitaxel|paclitaxel|mesh-list
14026975|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14026976|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14026977|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
14026978|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
14026979|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
14026980|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026981|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14026982|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
14026983|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
14026984|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026985|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14026986|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14026987|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
14026988|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026989|NCT02739477|Favipiravir|favipiravir|mesh-list
14026990|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
14026991|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14026992|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14026993|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14026994|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14470478|NCT02311933|Tamoxifen|tamoxifen|mesh-list
14470479|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14470480|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
14470481|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14470482|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470483|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14026995|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875533|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875534|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
13875535|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875536|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13875537|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13875538|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13875539|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875540|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875541|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13875542|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14754093|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
14754094|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14754095|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14754096|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14754097|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
14754098|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470484|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470485|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14470486|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14470487|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14470488|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14470489|NCT02312063|Glimepiride|glimepiride|mesh-list
14470490|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14470491|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470492|NCT02312063|Incretins|incretins|mesh-ancestor
14470493|NCT02312063|Hormones|hormones|mesh-ancestor
14470494|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754099|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754100|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
14754101|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14754102|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
14754103|NCT04809766|Fludarabine|fludarabine|mesh-list
14754104|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754105|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
14754106|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754107|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754108|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14754109|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
14754110|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754111|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754112|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14754113|NCT04809220|Dulaglutide|dulaglutide|mesh-list
13875543|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
13875544|NCT03625050|Celecoxib|celecoxib|mesh-list
13875545|NCT03625050|Esomeprazole|esomeprazole|mesh-list
13875546|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13875547|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875548|NCT03625050|Analgesics|analgesics|mesh-ancestor
13875549|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
13875550|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875551|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875552|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875553|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13875554|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14470495|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14470496|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
14470497|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479282|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875555|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13875556|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875557|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875558|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13875559|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875560|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13875561|NCT03625011|Gabapentin|gabapentin|mesh-list
13875562|NCT03625011|Analgesics|analgesics|mesh-ancestor
13875563|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
13875564|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875565|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875566|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
13875567|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13875568|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13875569|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875570|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875571|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13875572|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13875573|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875574|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875575|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
13875576|NCT03624985|Lidocaine|lidocaine|mesh-list
13875577|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
13875578|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
13875579|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875580|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875581|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
13875582|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875583|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13875584|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13875585|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13875586|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875587|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875588|NCT03624959|Itraconazole|itraconazole|mesh-list
13875589|NCT03624959|Rifampin|rifampin|mesh-list
13875590|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
14470498|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470499|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14470500|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470501|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
14470502|NCT02312219|Folic Acid|folic acid|mesh-list
14470503|NCT02312219|Methotrexate|methotrexate|mesh-list
13875591|NCT03624959|Ozanimod|ozanimod|mesh-list
13875592|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
13875593|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875594|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13875595|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13875596|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875597|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875598|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13875599|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
13875600|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875601|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875602|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13875603|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13875604|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
13875605|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13875606|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
13875607|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13875608|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13875609|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13875610|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13875611|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14470504|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13875612|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13875613|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13875614|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14470505|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
14470506|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14470507|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875615|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
13875616|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13875617|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13875618|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13875619|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875620|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
13875621|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
13875622|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13875623|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875624|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875625|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875626|NCT03624595|Analgesics|analgesics|mesh-ancestor
13875627|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
13875628|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956919|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
14470508|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13875629|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13875630|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13875631|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13875632|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875633|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875634|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875635|NCT03624322|Olanzapine|olanzapine|mesh-list
13875636|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
13875637|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
13875638|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875639|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875640|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875641|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13875642|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13875643|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875644|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875645|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13875646|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13875647|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875648|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875649|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875650|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
13875651|NCT03624309|Docetaxel|docetaxel|mesh-list
13875652|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875653|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
13875654|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
13875655|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
13875656|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875657|NCT03624283|Betahistine|betahistine|mesh-list
13875658|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
13875659|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
13875660|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
13875661|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875662|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470509|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
14470510|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470511|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470512|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470513|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470514|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14470515|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470516|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
14470517|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470518|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14470519|NCT02312219|Hematinics|hematinics|mesh-ancestor
14470520|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
14470521|NCT02312219|Vitamins|vitamins|mesh-ancestor
14470522|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
14470523|NCT02312622|Irinotecan|irinotecan|mesh-list
14470524|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
14470525|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14470526|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14470527|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470528|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470529|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470530|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13875663|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875664|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
13875665|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
13875666|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
13875667|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875668|NCT03624270|Protective Agents|protective agents|mesh-ancestor
13875669|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875670|NCT03624270|Vitamins|vitamins|mesh-ancestor
13875671|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
13875672|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875673|NCT03624244|Letrozole|letrozole|mesh-list
13875674|NCT03624244|Exemestane|exemestane|mesh-list
13875675|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13875676|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875677|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13875678|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470531|NCT02312739|Ketorolac|ketorolac|mesh-list
13875679|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470532|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14754114|NCT04809220|Biguanides|biguanides|mesh-list
13875680|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14470533|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
14470534|NCT02312739|Analgesics|analgesics|mesh-list
14470535|NCT02312739|Lorazepam|lorazepam|mesh-list
14470536|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14470537|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14470538|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
14470539|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470540|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470541|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14470542|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470543|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14470544|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470545|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470546|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14470547|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
14470548|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
14470549|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470550|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
14470551|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
14470552|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
14470553|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14470554|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14470555|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14470556|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14470557|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14470558|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
14470559|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
14470560|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470561|NCT02312882|Tofacitinib|tofacitinib|mesh-list
14470562|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13875681|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
13875682|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875683|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875684|NCT03624231|Durvalumab|durvalumab|mesh-list
13875685|NCT03624231|Tremelimumab|tremelimumab|mesh-list
13875686|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13875687|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875688|NCT03624205|Paclitaxel|paclitaxel|mesh-list
13875689|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13875690|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875691|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
13875692|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
13875693|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
13875694|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875695|NCT03624166|Ketamine|ketamine|mesh-list
13875696|NCT03624166|Anesthetics|anesthetics|mesh-list
13875697|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
13875698|NCT03624166|Analgesics|analgesics|mesh-ancestor
14470563|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470564|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875699|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
13875700|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875701|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875702|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13875703|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13875704|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875705|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13875706|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14470565|NCT02312934|Nicotine|nicotine|mesh-list
14754115|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
13875707|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875708|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875709|NCT03624062|Insulin|insulin|mesh-list
13875710|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13875711|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875712|NCT03624010|Simendan|simendan|mesh-list
13875713|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14470566|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13875714|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
13875715|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13875716|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13875717|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875718|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875719|NCT03624010|Protective Agents|protective agents|mesh-ancestor
13875720|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875730|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
13875731|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
13875732|NCT03623789|Hemostatics|hemostatics|mesh-list
13875733|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13875734|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13875735|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875736|NCT03623789|Coagulants|coagulants|mesh-ancestor
13875737|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
13875738|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875739|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13875740|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875741|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13875742|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13875743|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875744|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875745|NCT03623776|Carboplatin|carboplatin|mesh-list
13875746|NCT03623776|Pemetrexed|pemetrexed|mesh-list
13875747|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875748|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875749|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875750|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13875751|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13875752|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
13875753|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875754|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
13875755|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875756|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13875757|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13875758|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
13875759|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875760|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931384|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931385|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13875761|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14470567|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
13875762|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13875763|NCT03623711|Citalopram|citalopram|mesh-list
13875764|NCT03623711|Bupropion|bupropion|mesh-list
13875765|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13875766|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13875767|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875768|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875769|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875770|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
13875771|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875772|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13875773|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
13875774|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13875775|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875776|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13875777|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
13875778|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13875779|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13875780|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875781|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13875782|NCT03623711|Analgesics|analgesics|mesh-ancestor
13875783|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
13875784|NCT03623633|Denosumab|denosumab|mesh-list
13875785|NCT03623633|Alendronate|alendronate|mesh-list
13875786|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13875787|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13875788|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875789|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13875790|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
13875791|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875792|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13875793|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13875794|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
13875795|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13956920|NCT03178864|Heparin|heparin|mesh-list
13956921|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
13956922|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
13956923|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13956924|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13956925|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956926|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13956927|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
13956928|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13956929|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
13956930|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956931|NCT03178656|Sorafenib|sorafenib|mesh-list
13956932|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956933|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13956934|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956935|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956936|NCT03178721|Calcium|calcium|mesh-list
13956937|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13956938|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956939|NCT03178643|Piperaquine|piperaquine|mesh-list
13956940|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
13956941|NCT03178643|Amodiaquine|amodiaquine|mesh-list
13956942|NCT03178643|Artenimol|artenimol|mesh-list
13956943|NCT03178643|Proguanil|proguanil|mesh-list
13956944|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
13956945|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13956946|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13956947|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956948|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13956949|NCT03178643|Renal Agents|renal agents|mesh-ancestor
13956950|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
13956951|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956952|NCT03178747|Methylene Blue|methylene blue|mesh-list
13956953|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956954|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956955|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
13956956|NCT03178591|Vildagliptin|vildagliptin|mesh-list
13956957|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13956958|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956959|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13956960|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956961|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13956962|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
13956963|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875796|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
13875797|NCT03623529|Giapreza|giapreza|mesh-list
13875798|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
13875799|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13875800|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13875801|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
13875802|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875803|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875804|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13875805|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13875806|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875807|NCT03623256|Fentanyl|fentanyl|mesh-list
13875808|NCT03623256|Bupivacaine|bupivacaine|mesh-list
13875809|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
13875810|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
13875811|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875812|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875813|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
13875814|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875815|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13875816|NCT03623256|Narcotics|narcotics|mesh-ancestor
13875817|NCT03623256|Analgesics|analgesics|mesh-ancestor
13875818|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13875819|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13875820|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
13875821|NCT03623230|Bupivacaine|bupivacaine|mesh-list
13875822|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13875823|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
13875824|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
13875825|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875826|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875827|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
13875828|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875829|NCT03623087|Gemcitabine|gemcitabine|mesh-list
13875830|NCT03623087|Dexamethasone|dexamethasone|mesh-list
13875831|NCT03623087|Etoposide|etoposide|mesh-list
13875832|NCT03623087|Asparaginase|asparaginase|mesh-list
13875833|NCT03623087|Ifosfamide|ifosfamide|mesh-list
13875834|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875835|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875836|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
13875837|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
13875838|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875839|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875840|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13875841|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
13875842|NCT03623087|Hormones|hormones|mesh-ancestor
13875843|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875844|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13875845|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13875846|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
13875847|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875848|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
13875849|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875850|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875851|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13875852|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
13875853|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13875854|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13875855|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13875856|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13875857|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
13875858|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
13875859|NCT03623048|Propolis|propolis|mesh-list
13875860|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13875861|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875862|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
13875863|NCT03622918|Rifampin|rifampin|mesh-list
13875864|NCT03622918|Colistin|colistin|mesh-list
13875865|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13875866|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
13875867|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13875868|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875869|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
13875870|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13875871|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875872|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875873|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13875874|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13875875|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13875876|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13875877|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13875878|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13875879|NCT03622827|Endostar protein|endostar protein|mesh-list
13875880|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13875881|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13875882|NCT03622827|Growth Substances|growth substances|mesh-ancestor
13875883|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875884|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
13875885|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875886|NCT03622541|Sorafenib|sorafenib|mesh-list
13875887|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875888|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13875889|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875890|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875891|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
13875892|NCT03622502|Remifentanil|remifentanil|mesh-list
13875893|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13875894|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875895|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875896|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875897|NCT03622502|Analgesics|analgesics|mesh-ancestor
13875898|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
13875899|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875900|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13875901|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13875902|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13875903|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875904|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875905|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875906|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13875907|NCT03622502|Narcotics|narcotics|mesh-ancestor
13875908|NCT03622489|Acetaminophen|acetaminophen|mesh-list
13875909|NCT03622489|Dipyrone|dipyrone|mesh-list
13875910|NCT03622489|Ibuprofen|ibuprofen|mesh-list
13875911|NCT03622489|Morphine|morphine|mesh-list
13875912|NCT03622489|Tramadol|tramadol|mesh-list
13875913|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13875914|NCT03622489|Narcotics|narcotics|mesh-ancestor
14026996|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14026997|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14026998|NCT02739516|Letrozole|letrozole|mesh-list
14026999|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14027000|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027001|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14027002|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14027003|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027004|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027005|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14027006|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
14027007|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027008|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027009|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14027010|NCT02739399|Phenylephrine|phenylephrine|mesh-list
14027011|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
14027012|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14027013|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
14027014|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
14027015|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027016|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027017|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
14027018|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14027019|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
14027020|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
14027021|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14027022|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14027023|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14027024|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
14027025|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470568|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754116|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
13956964|NCT03178292|Levofloxacin|levofloxacin|mesh-list
14470569|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470570|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14470571|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14470572|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
14470573|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470574|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470575|NCT02313675|Acetaminophen|acetaminophen|mesh-list
14470576|NCT02313675|Ketorolac|ketorolac|mesh-list
14470577|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14470578|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14470579|NCT02313675|Analgesics|analgesics|mesh-ancestor
14470580|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
14470581|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875915|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875916|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875917|NCT03622489|Analgesics|analgesics|mesh-ancestor
13875918|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
13875919|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875920|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875921|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
13875922|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13875923|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13875924|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13875925|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13875926|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875927|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875928|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
13875929|NCT03622450|Levofloxacin|levofloxacin|mesh-list
13875930|NCT03622450|Gentamicins|gentamicins|mesh-list
13875931|NCT03622450|Meropenem|meropenem|mesh-list
13875932|NCT03622450|Amikacin|amikacin|mesh-list
13875933|NCT03622450|Colistin|colistin|mesh-list
13875934|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13875935|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13875936|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13875937|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13875938|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875939|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875940|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13875941|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13875942|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14470582|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470583|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
14470584|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14470585|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14470586|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470587|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14470588|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470589|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470590|NCT02313909|Aspirin|aspirin|mesh-list
14470591|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
14470592|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14470593|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14470594|NCT02313909|Analgesics|analgesics|mesh-ancestor
14470595|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
14470596|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470597|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470598|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14470599|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470600|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13875943|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13875944|NCT03622450|Renal Agents|renal agents|mesh-ancestor
13875945|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13875946|NCT03622060|Nicardipine|nicardipine|mesh-list
13875947|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
13875948|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
14470601|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14470602|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470603|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14470604|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14470605|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470606|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
14470607|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13875949|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14470608|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
13956965|NCT03178292|Ofloxacin|ofloxacin|mesh-list
13875950|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13875951|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13875952|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875953|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13875954|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875955|NCT03622047|Sufentanil|sufentanil|mesh-list
13875956|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
13875957|NCT03622047|Ropivacaine|ropivacaine|mesh-list
14470609|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14470610|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
13875958|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13875959|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13875960|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875961|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13875962|NCT03622047|Analgesics|analgesics|mesh-ancestor
13875963|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
13875964|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13875965|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13875966|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13875967|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13875968|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
13875969|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13875970|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875971|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
13875972|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
13875973|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13875974|NCT03622047|Narcotics|narcotics|mesh-ancestor
13875975|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13875976|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13875977|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
13875978|NCT03621995|Catalase|catalase|mesh-list
13875979|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
13875980|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875981|NCT03621995|Protective Agents|protective agents|mesh-ancestor
13875982|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956966|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14470611|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
13956967|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13956968|NCT03178292|Renal Agents|renal agents|mesh-ancestor
13956969|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13956970|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13956971|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13956972|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13956973|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956974|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13956975|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13956976|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13956977|NCT03178422|Nicotine|nicotine|mesh-list
13956978|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13956979|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
13956980|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13956981|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956982|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13956983|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13956984|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
13956985|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13956986|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13956987|NCT03178396|Melatonin|melatonin|mesh-list
13956988|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
14470612|NCT02314104|Ropivacaine|ropivacaine|mesh-list
14470613|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
14470614|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
14470615|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470616|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470617|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
13956989|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13875983|NCT03621904|Tamoxifen|tamoxifen|mesh-list
13875984|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
13875985|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
13875986|NCT03621904|Progesterone|progesterone|mesh-list
13875987|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13875988|NCT03621904|Progestins|progestins|mesh-ancestor
13875989|NCT03621904|Hormones|hormones|mesh-ancestor
13875990|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13875991|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13875992|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13875993|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
13875994|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13875995|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13875996|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13875997|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13875998|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13875999|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876000|NCT03621800|Menthol|menthol|mesh-list
13876001|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
13876002|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
13876003|NCT03621683|Antioxidants|antioxidants|mesh-list
14470618|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470619|NCT02314117|Fluorouracil|fluorouracil|mesh-list
14470620|NCT02314117|Capecitabine|capecitabine|mesh-list
14470621|NCT02314117|Ramucirumab|ramucirumab|mesh-list
14470622|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470623|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
14470624|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470625|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13876004|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876005|NCT03621683|Protective Agents|protective agents|mesh-ancestor
13876006|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876007|NCT03621618|Dobutamine|dobutamine|mesh-list
13876008|NCT03621618|Norepinephrine|norepinephrine|mesh-list
13876009|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13876010|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13876011|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
13876012|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876013|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876014|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876015|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
13876016|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
13876017|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876018|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13876019|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13876020|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13876021|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13876022|NCT03621618|Protective Agents|protective agents|mesh-ancestor
13876023|NCT03621553|Vitamin D|vitamin d|mesh-list
13876024|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
13876025|NCT03621553|Vitamins|vitamins|mesh-list
13876026|NCT03621553|Calcium|calcium|mesh-list
13876027|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
13876028|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876029|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13876030|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13876031|NCT03621527|Remifentanil|remifentanil|mesh-list
13876032|NCT03621527|Anesthetics|anesthetics|mesh-list
13876033|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876034|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876035|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13876036|NCT03621527|Narcotics|narcotics|mesh-ancestor
13876037|NCT03621527|Analgesics|analgesics|mesh-ancestor
13876038|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
13876039|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876040|NCT03621514|Lidocaine|lidocaine|mesh-list
13876041|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876042|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
13876043|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876044|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876045|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
13876046|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470626|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876047|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13876048|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14470627|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
13876049|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13876050|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13876051|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876052|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
13876053|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
13876054|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13876055|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876056|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876057|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
13876058|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13876059|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876060|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876061|NCT03621072|Fluconazole|fluconazole|mesh-list
13876062|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
13876063|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876064|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13876065|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13876066|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876067|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876068|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13876069|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
13876070|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876071|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876072|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13876073|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13876074|NCT03621046|Zolpidem|zolpidem|mesh-list
13876075|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13876076|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13876077|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876078|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876079|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13876080|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
13876081|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
13876082|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876083|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876084|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13876085|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13876086|NCT03620929|Estradiol|estradiol|mesh-list
13876087|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13876088|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
13876089|NCT03620929|Estrogens|estrogens|mesh-ancestor
13876090|NCT03620929|Hormones|hormones|mesh-ancestor
13876091|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876092|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876093|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13876094|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
13876095|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876096|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13876097|NCT03620929|Progestins|progestins|mesh-ancestor
13876098|NCT03620916|Morphine|morphine|mesh-list
13876099|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13876100|NCT03620916|Narcotics|narcotics|mesh-ancestor
13876101|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876102|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876103|NCT03620916|Analgesics|analgesics|mesh-ancestor
13876104|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
13876105|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876106|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
13876107|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
13876108|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13876109|NCT03620838|Progesterone|progesterone|mesh-list
13876110|NCT03620838|Progestins|progestins|mesh-ancestor
14470628|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479075|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479076|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14479077|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14479078|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
13876111|NCT03620838|Hormones|hormones|mesh-ancestor
13876112|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876113|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876114|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876115|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14479283|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14479284|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479285|NCT02467504|Analgesics|analgesics|mesh-ancestor
14479286|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
14479287|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479288|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479289|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479290|NCT02467621|Pantoprazole|pantoprazole|mesh-list
14479291|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14479292|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876116|NCT03620825|Indomethacin|indomethacin|mesh-list
13876117|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13876118|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876119|NCT03620825|Analgesics|analgesics|mesh-ancestor
13876120|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
13876121|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876122|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876123|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876124|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876125|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
13876126|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
13876127|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876128|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13876129|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876130|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876131|NCT03620760|Aspirin|aspirin|mesh-list
13876132|NCT03620760|Ticagrelor|ticagrelor|mesh-list
13876133|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13876134|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876135|NCT03620760|Analgesics|analgesics|mesh-ancestor
13876136|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
13876137|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876138|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876139|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876140|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876141|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13876142|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13876143|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876144|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13876145|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13876146|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876147|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
13876148|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13876149|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13876150|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13876151|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
13876152|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876153|NCT03620591|Lidocaine|lidocaine|mesh-list
13876154|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876155|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
13876156|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876157|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876158|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
13876159|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876160|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13876161|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13876162|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13876163|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13876164|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876165|NCT03620526|Iloprost|iloprost|mesh-list
13876166|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13876167|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
13876168|NCT03620513|Lidocaine|lidocaine|mesh-list
13876169|NCT03620513|Phenylephrine|phenylephrine|mesh-list
13876170|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
13876171|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
13876172|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
13876173|NCT03620513|Ephedrine|ephedrine|mesh-list
13876174|NCT03620513|Anesthetics|anesthetics|mesh-list
13876175|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876176|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876177|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876178|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
13876179|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876180|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13876181|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13876182|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13876183|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13876184|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876185|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13876186|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13876187|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
13876188|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876189|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
13876190|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
13876191|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13876192|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
13876193|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13876194|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
13876195|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13876196|NCT03620513|Protective Agents|protective agents|mesh-ancestor
13876197|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13876198|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13876199|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13876200|NCT03620461|Gemcitabine|gemcitabine|mesh-list
13876201|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13876202|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13876203|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
13876204|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876205|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876206|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
13876207|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876208|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876209|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876210|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
13876211|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876212|NCT03620435|Atezolizumab|atezolizumab|mesh-list
13876213|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876214|NCT03620422|Mannitol|mannitol|mesh-list
13876215|NCT03620422|Albuterol|albuterol|mesh-list
13876216|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13876217|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
13876218|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876219|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876220|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13876221|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
13876222|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
13876223|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876224|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13876225|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13876226|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13876227|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
13876228|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876229|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876230|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13876231|NCT03620422|Diuretics|diuretics|mesh-ancestor
13876232|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
13876233|NCT03620318|Crenolanib|crenolanib|mesh-list
13876234|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876235|NCT03620292|Bevacizumab|bevacizumab|mesh-list
13876236|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876237|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876238|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13876239|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13876240|NCT03620292|Growth Substances|growth substances|mesh-ancestor
13876241|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876242|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
13876243|NCT03620253|Modafinil|modafinil|mesh-list
13876244|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13876245|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876246|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
13876247|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13876248|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13876249|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876250|NCT03620149|Denosumab|denosumab|mesh-list
13876251|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13876252|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956990|NCT03178396|Protective Agents|protective agents|mesh-ancestor
13956991|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13956992|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13956993|NCT03178409|Liver Extracts|liver extracts|mesh-list
13956994|NCT03178409|Hematinics|hematinics|mesh-ancestor
13956995|NCT03178539|Diclofenac|diclofenac|mesh-list
13956996|NCT03178539|Ketorolac|ketorolac|mesh-list
13956997|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13956998|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13956999|NCT03178539|Analgesics|analgesics|mesh-ancestor
13957000|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
13957001|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957002|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957003|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957004|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13957005|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13957006|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957007|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957008|NCT03178500|Clomiphene|clomiphene|mesh-list
13957009|NCT03178500|Enclomiphene|enclomiphene|mesh-list
13957010|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
13957011|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13957012|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
13957013|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957014|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957015|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13957016|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
13957017|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13957018|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13957019|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13957020|NCT03178526|Lovastatin|lovastatin|mesh-list
13957021|NCT03178526|L 647318|l 647318|mesh-list
13957022|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
13957023|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13957024|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13957025|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
13957026|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957027|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13957028|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13957029|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957030|NCT03178123|Interferons|interferons|mesh-list
13957031|NCT03178123|Antibodies|antibodies|mesh-list
13957032|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13957033|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
13957034|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957035|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957036|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
13957037|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957038|NCT03177993|Ivermectin|ivermectin|mesh-list
13957039|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13957040|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957041|NCT03178084|Lamivudine|lamivudine|mesh-list
13957042|NCT03178084|Zidovudine|zidovudine|mesh-list
13957043|NCT03178084|Efavirenz|efavirenz|mesh-list
13957044|NCT03178084|Maraviroc|maraviroc|mesh-list
13957045|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13876253|NCT03620032|Vinorelbine|vinorelbine|mesh-list
13876254|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
13876255|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13876256|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876257|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
13876258|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
13876259|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
13876260|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876261|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876262|NCT03620019|Denosumab|denosumab|mesh-list
13876263|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
13876264|NCT03620019|Nivolumab|nivolumab|mesh-list
13876265|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876266|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876267|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13876268|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876269|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13876270|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876271|NCT03619876|Adalimumab|adalimumab|mesh-list
13876272|NCT03619876|Abatacept|abatacept|mesh-list
13876273|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876274|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876275|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13876276|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876277|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876278|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876279|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
13876280|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876281|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13876282|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13876283|NCT03619850|Hematinics|hematinics|mesh-ancestor
13876284|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13876285|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13876286|NCT03619824|Gemcitabine|gemcitabine|mesh-list
13876287|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876288|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13876289|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
13876290|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876291|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
13876292|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876293|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876294|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876295|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
13876296|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876297|NCT03619785|Acetaminophen|acetaminophen|mesh-list
13876298|NCT03619785|Ibuprofen|ibuprofen|mesh-list
14027026|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027027|NCT02739399|Protective Agents|protective agents|mesh-ancestor
14027028|NCT02739295|Sargramostim|sargramostim|mesh-list
14027029|NCT02739295|Immunologic Factors|immunologic factors|mesh-ancestor
14027030|NCT02739295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027031|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14027032|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027033|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14027034|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027035|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027036|NCT02739412|Aldesleukin|aldesleukin|mesh-list
14027037|NCT02739412|Interleukin-2|interleukin-2|mesh-list
14027038|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027039|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027040|NCT02739412|Analgesics|analgesics|mesh-ancestor
14027041|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
14027042|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027043|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027044|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14027045|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14027046|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
14027047|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027048|NCT02739204|Celecoxib|celecoxib|mesh-list
14027049|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14027050|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027051|NCT02739204|Analgesics|analgesics|mesh-ancestor
14027052|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
14027053|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027054|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876299|NCT03619785|Ketorolac|ketorolac|mesh-list
13876300|NCT03619785|Fentanyl|fentanyl|mesh-list
13876301|NCT03619785|Ketamine|ketamine|mesh-list
13876302|NCT03619785|Morphine|morphine|mesh-list
13876303|NCT03619785|Gabapentin|gabapentin|mesh-list
13876304|NCT03619785|Hydromorphone|hydromorphone|mesh-list
13876305|NCT03619785|Hydrocodone|hydrocodone|mesh-list
13876306|NCT03619785|Bupivacaine|bupivacaine|mesh-list
13876307|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876308|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
13876309|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876310|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876311|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
13876312|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876313|NCT03619785|Analgesics|analgesics|mesh-ancestor
13876314|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13876315|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13876316|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
13876317|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13876318|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13876319|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876320|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876321|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13876322|NCT03619785|Narcotics|narcotics|mesh-ancestor
13876323|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13876324|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876325|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
13876326|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13876327|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876328|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876329|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13876330|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876331|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
13876332|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13876333|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13876334|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13876335|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
13876336|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
13876337|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
13876338|NCT03619538|Nefopam|nefopam|mesh-list
13876339|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876340|NCT03619538|Analgesics|analgesics|mesh-ancestor
13876341|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
13876342|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876343|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876344|NCT03619408|Antacids|antacids|mesh-list
13876345|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876346|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876347|NCT03619330|Liraglutide|liraglutide|mesh-list
13876348|NCT03619330|Testosterone|testosterone|mesh-list
13876349|NCT03619330|Androgens|androgens|mesh-ancestor
13876350|NCT03619330|Hormones|hormones|mesh-ancestor
13876351|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876352|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876353|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13876354|NCT03619330|Incretins|incretins|mesh-ancestor
13876355|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13876356|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13876357|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
13876358|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876359|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876360|NCT03619057|Anesthetics|anesthetics|mesh-list
13876361|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876362|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876363|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
13876364|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13876365|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
13876366|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876367|NCT03618953|Atezolizumab|atezolizumab|mesh-list
13876368|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876369|NCT03618797|Fenofibrate|fenofibrate|mesh-list
13876370|NCT03618797|Pitavastatin|pitavastatin|mesh-list
13876371|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13876372|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
13876373|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876374|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13876375|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13963108|NCT02248701|Testosterone|testosterone|mesh-list
13876376|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13876377|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876378|NCT03618758|Paclitaxel|paclitaxel|mesh-list
13876379|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13876380|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876381|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
13876382|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
13876383|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
13876384|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876385|NCT03618654|Metformin|metformin|mesh-list
13876386|NCT03618654|Durvalumab|durvalumab|mesh-list
13876387|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
13876388|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13876389|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
13876390|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13876391|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470629|NCT02314143|Trametinib|trametinib|mesh-list
14470630|NCT02314143|Dabrafenib|dabrafenib|mesh-list
14470631|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470632|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14470633|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470634|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470635|NCT02314403|Rituximab|rituximab|mesh-list
14470636|NCT02314403|Abatacept|abatacept|mesh-list
13876392|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876393|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876394|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
13876395|NCT03618589|Pregabalin|pregabalin|mesh-list
14931386|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14754117|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13876396|NCT03618589|Analgesics|analgesics|mesh-ancestor
13876397|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
13876398|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876399|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876400|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
13876401|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13876402|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14470637|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470638|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470639|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
14470640|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470641|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470642|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14470643|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470644|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754118|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754119|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876403|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876404|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13876405|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13876406|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13876407|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876408|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13876409|NCT03618472|Metformin|metformin|mesh-list
13876410|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13876411|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957046|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13957047|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957048|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957049|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
13957050|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957051|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13957052|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13957053|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
13957054|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14754120|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767173|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14767174|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14767175|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767176|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767177|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931387|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
13957055|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14470645|NCT02314546|Lidocaine|lidocaine|mesh-list
13876412|NCT03618355|Sirolimus|sirolimus|mesh-list
13876413|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13876414|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876415|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13876416|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876417|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
13876418|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876419|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
13876420|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876421|NCT03618316|Cimetidine|cimetidine|mesh-list
13876422|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13876423|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876424|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13876425|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
13876426|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
13876427|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876428|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876429|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876430|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13876431|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13876432|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876433|NCT03618264|Dexamethasone|dexamethasone|mesh-list
13876434|NCT03618264|Ropivacaine|ropivacaine|mesh-list
13876435|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876436|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
13876437|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
13876438|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876439|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876440|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876441|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
13876442|NCT03618264|Hormones|hormones|mesh-ancestor
13876443|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876444|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13876445|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876446|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876447|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
13876448|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876449|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
13876450|NCT03618173|Dexamethasone|dexamethasone|mesh-list
13876451|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
13876452|NCT03618173|BB 1101|bb 1101|mesh-list
13876453|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876454|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
13876455|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
13876456|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876457|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876458|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876459|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
13876460|NCT03618173|Hormones|hormones|mesh-ancestor
13876461|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876462|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13876463|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876464|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
13876465|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876466|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876467|NCT03618108|Azithromycin|azithromycin|mesh-list
13876468|NCT03618108|Doxycycline|doxycycline|mesh-list
13876469|NCT03618108|Rifabutin|rifabutin|mesh-list
13876470|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13876471|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876472|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
13876473|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13876474|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13876475|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13876476|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
13876477|NCT03618082|Desflurane|desflurane|mesh-list
13876478|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13876479|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
13876480|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
13876481|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876482|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876483|NCT03617900|Acetaminophen|acetaminophen|mesh-list
13876484|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876485|NCT03617900|Analgesics|analgesics|mesh-ancestor
13876486|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
13876487|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169186|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
13876488|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876489|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
13876490|NCT03617705|Ethanol|ethanol|mesh-list
13876491|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13876492|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876493|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876494|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876495|NCT03617679|Rucaparib|rucaparib|mesh-list
13876496|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13876497|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876498|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876499|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876500|NCT03617666|Avelumab|avelumab|mesh-list
13876501|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876502|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876503|NCT03617575|Lactoferrin|lactoferrin|mesh-list
13876504|NCT03617575|Fesoterodine|fesoterodine|mesh-list
13876505|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876506|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13876507|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13876508|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
13876509|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876510|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876511|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876512|NCT03617575|Urological Agents|urological agents|mesh-ancestor
13876513|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
13876514|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13876515|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876516|NCT03617510|Analgesics|analgesics|mesh-ancestor
13876517|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
13876518|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876519|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876520|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876521|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876522|NCT03617484|Bortezomib|bortezomib|mesh-list
13876523|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876524|NCT03617471|Acetaminophen|acetaminophen|mesh-list
13876525|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876526|NCT03617471|Analgesics|analgesics|mesh-ancestor
13876527|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
13876528|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876529|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876530|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
13876531|NCT03617458|Metformin|metformin|mesh-list
13876532|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13876533|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876534|NCT03617432|Prednisone|prednisone|mesh-list
13876535|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
13876536|NCT03617432|Doxorubicin|doxorubicin|mesh-list
13876537|NCT03617432|Etoposide|etoposide|mesh-list
13876538|NCT03617432|Vincristine|vincristine|mesh-list
13876539|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876540|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
13876541|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876542|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876543|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13876544|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
13876545|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876546|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876547|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13876548|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13876549|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13876550|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13876551|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876552|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876553|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
13876554|NCT03617432|Hormones|hormones|mesh-ancestor
13876555|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876556|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13876557|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13876558|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
13876559|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
13876560|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
13876565|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
13876566|NCT03617289|Analgesics|analgesics|mesh-ancestor
13876567|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
13876568|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876569|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876570|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
13876571|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876572|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13876573|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
13876574|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13876575|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13876576|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876577|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13876578|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
13876579|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876580|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
13876581|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876582|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876583|NCT03617055|Cystatins|cystatins|mesh-list
13876584|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13876585|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
13876586|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876587|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876588|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
13876589|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876590|NCT03617016|Domperidone|domperidone|mesh-list
13876591|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
14470646|NCT02314546|Midazolam|midazolam|mesh-list
14470647|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14470648|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14470649|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470650|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470651|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14470652|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13876592|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
13876593|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876594|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876595|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876596|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13876597|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
13876598|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876599|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876600|NCT03616808|Hemostatics|hemostatics|mesh-list
13876601|NCT03616808|Coagulants|coagulants|mesh-ancestor
13876602|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
13876603|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13876604|NCT03616691|Bevacizumab|bevacizumab|mesh-list
13876605|NCT03616691|Atezolizumab|atezolizumab|mesh-list
13876606|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13876607|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876608|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876609|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13876610|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13876611|NCT03616691|Growth Substances|growth substances|mesh-ancestor
13876612|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876613|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
13876614|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
13876615|NCT03616639|Morphine|morphine|mesh-list
13876616|NCT03616639|Oxycodone|oxycodone|mesh-list
13876617|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13876618|NCT03616639|Narcotics|narcotics|mesh-ancestor
13876619|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876620|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876621|NCT03616639|Analgesics|analgesics|mesh-ancestor
13876622|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
13876623|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876624|NCT03616561|Apremilast|apremilast|mesh-list
13876625|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13876626|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876627|NCT03616561|Analgesics|analgesics|mesh-ancestor
13876628|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
13876629|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876630|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876631|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876632|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876633|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13876634|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13876635|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876636|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876637|NCT03616509|Hormones|hormones|mesh-list
13876638|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876639|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957056|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13957057|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13957058|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13957059|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13957060|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13957061|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
13957062|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13963109|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
13963110|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
13963111|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13963112|NCT02248701|Androgens|androgens|mesh-ancestor
13963113|NCT02248701|Hormones|hormones|mesh-ancestor
13963114|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963115|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963116|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13963117|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963118|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
13963119|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13963120|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13963121|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963122|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963123|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
13963124|NCT02248701|Urological Agents|urological agents|mesh-ancestor
13963125|NCT02245672|Fluticasone|fluticasone|mesh-list
13963126|NCT02245672|Xhance|xhance|mesh-list
13963127|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13963128|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963129|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13963130|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
13963131|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963132|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963133|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13963134|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
13963135|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
13963136|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13963137|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13963138|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13963139|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13963140|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
13963141|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963142|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963143|NCT02129751|Bupropion|bupropion|mesh-list
13963144|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13963145|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
13963146|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13963147|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13963148|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13963149|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13963150|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963151|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
13963152|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963153|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963154|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13876640|NCT03616405|Amoxicillin|amoxicillin|mesh-list
13876641|NCT03616405|Tetracycline|tetracycline|mesh-list
13876642|NCT03616405|Furazolidone|furazolidone|mesh-list
13876643|NCT03616405|Rabeprazole|rabeprazole|mesh-list
13876644|NCT03616405|Bismuth|bismuth|mesh-list
13876645|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13876646|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876647|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13876648|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876649|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14470653|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14470654|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14470655|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
14470656|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
14470657|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
13876650|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876651|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876652|NCT03616405|Antacids|antacids|mesh-ancestor
13876653|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13876654|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13876655|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13876656|NCT03616405|Renal Agents|renal agents|mesh-ancestor
13876657|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13876658|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13876659|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13876660|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13876661|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13876662|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13876663|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876664|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13876665|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876666|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876667|NCT03616288|Thiamine|thiamine|mesh-list
13876668|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
13876669|NCT03616288|Vitamins|vitamins|mesh-ancestor
13876670|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
13876671|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876672|NCT03616262|Lidocaine|lidocaine|mesh-list
13876673|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876674|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
13876675|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876676|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876677|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
13876678|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876679|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13876680|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13876681|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13876682|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13876683|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876684|NCT03616236|Buprenorphine|buprenorphine|mesh-list
13876685|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13876686|NCT03616236|Naloxone|naloxone|mesh-list
13876687|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13876688|NCT03616236|Narcotics|narcotics|mesh-ancestor
13876689|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876690|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470658|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
13876691|NCT03616236|Analgesics|analgesics|mesh-ancestor
13876692|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
13876693|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876694|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13876695|NCT03616132|Sirolimus|sirolimus|mesh-list
14470659|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470660|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470661|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
14470662|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
14470663|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470664|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14470665|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14470666|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14470667|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14470668|NCT02314728|Misoprostol|misoprostol|mesh-list
14470669|NCT02314728|Oxytocin|oxytocin|mesh-list
13876696|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13876697|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876698|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13876699|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876700|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
13876701|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876702|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
13876703|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876704|NCT03615950|Vitamin D|vitamin d|mesh-list
13876705|NCT03615950|Vitamins|vitamins|mesh-ancestor
13876706|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
13876707|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876708|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13876709|NCT03615833|Vitamin D|vitamin d|mesh-list
13876710|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
13876711|NCT03615833|Vitamins|vitamins|mesh-ancestor
13876712|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
13876713|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876714|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13876715|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13876716|NCT03615768|Clindamycin|clindamycin|mesh-list
13876717|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
13876718|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
13876719|NCT03615768|Adapalene|adapalene|mesh-list
13876720|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13876721|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876722|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13876723|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876724|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876725|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13876726|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876727|NCT03615768|Analgesics|analgesics|mesh-ancestor
13876728|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
13876729|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876730|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876731|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876732|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876733|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
13876734|NCT03615677|Esomeprazole|esomeprazole|mesh-list
13876735|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13876736|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876737|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13876738|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876739|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876740|NCT03615547|Clomiphene|clomiphene|mesh-list
13876741|NCT03615547|Enclomiphene|enclomiphene|mesh-list
13876742|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
13876743|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13876744|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
13876745|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876746|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876747|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13876748|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
13876749|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876750|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13876751|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14470670|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
14470671|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876752|NCT03615430|Anesthetics|anesthetics|mesh-list
13876753|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
13876754|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876755|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876756|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
13876757|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876758|NCT03615417|Anesthetics|anesthetics|mesh-list
13876759|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876760|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027055|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027056|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027057|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14027058|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14027059|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027060|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027061|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
14027062|NCT02739061|Sertraline|sertraline|mesh-list
14027063|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
14027064|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14027065|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14027066|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14027067|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14027068|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027069|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14027070|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
14027071|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027072|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14027073|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14027074|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027075|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14027076|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14027077|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14027078|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027079|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14027080|NCT02738970|Trastuzumab|trastuzumab|mesh-list
14027081|NCT02738970|Pertuzumab|pertuzumab|mesh-list
14027082|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027083|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027084|NCT02738918|Abatacept|abatacept|mesh-list
14027085|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14027086|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027087|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027088|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14027089|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
14027090|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027091|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027092|NCT02738931|Lamivudine|lamivudine|mesh-list
14027093|NCT02738931|Dolutegravir|dolutegravir|mesh-list
14027094|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14027095|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14027096|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027097|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027098|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
14027099|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027100|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14027101|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14027102|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14027103|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14027104|NCT02738905|Rifaximin|rifaximin|mesh-list
14027105|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027106|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027107|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027108|NCT02738814|Propofol|propofol|mesh-list
14027109|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14169187|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876761|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
13876762|NCT03615326|Capecitabine|capecitabine|mesh-list
13876763|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
13876764|NCT03615326|Trastuzumab|trastuzumab|mesh-list
13876765|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876766|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13876767|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13876768|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
13876769|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876770|NCT03615313|Antibodies|antibodies|mesh-list
13876771|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
13876772|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876773|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13876774|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13876775|NCT03614832|Clopidogrel|clopidogrel|mesh-list
13876776|NCT03614832|Ticagrelor|ticagrelor|mesh-list
13876777|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13876778|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13876779|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13876780|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13876781|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
13876782|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876783|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876784|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876785|NCT03614741|Tinzaparin|tinzaparin|mesh-list
13876786|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13876787|NCT03614741|Dalteparin|dalteparin|mesh-list
13876788|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
13876789|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13876790|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13876791|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876792|NCT03614715|Interferons|interferons|mesh-list
13876793|NCT03614715|Interferon-beta|interferon-beta|mesh-list
13876794|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
13876795|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876796|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
13876797|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876798|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
13876799|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876800|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13957063|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
13957064|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957065|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
13957066|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13957067|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13957068|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957069|NCT03177824|Urological Agents|urological agents|mesh-ancestor
13957070|NCT03177837|Acetazolamide|acetazolamide|mesh-list
13957071|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
13957072|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13957073|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957074|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957075|NCT03177837|Diuretics|diuretics|mesh-ancestor
13957076|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
13957077|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957078|NCT03177811|Acetazolamide|acetazolamide|mesh-list
13957079|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
13957080|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13957081|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957082|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957083|NCT03177811|Diuretics|diuretics|mesh-ancestor
13957084|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
13957085|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957086|NCT03177980|Clonidine|clonidine|mesh-list
13957087|NCT03177980|Fentanyl|fentanyl|mesh-list
13957088|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13957089|NCT03177980|Narcotics|narcotics|mesh-ancestor
13957090|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957091|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957092|NCT03177980|Analgesics|analgesics|mesh-ancestor
13957093|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
13957094|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957095|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13957096|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13957097|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
13957098|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
13957099|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13957100|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
13957101|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
13957102|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13957103|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13957104|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13957105|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
13957106|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957107|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957108|NCT03177850|Acetazolamide|acetazolamide|mesh-list
13957109|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
13876801|NCT03614533|Vaccines|vaccines|mesh-list
13876802|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
13876803|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876804|NCT03614494|Piroxicam|piroxicam|mesh-list
13876805|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
13876806|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13876807|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
13876808|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13876809|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876810|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13876811|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13876812|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13876813|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13876814|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876815|NCT03614494|Analgesics|analgesics|mesh-ancestor
13876816|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
13876817|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876818|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876819|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13876820|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13876821|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876822|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876823|NCT03614455|Itraconazole|itraconazole|mesh-list
13876824|NCT03614455|Posaconazole|posaconazole|mesh-list
13876825|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
13876826|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
13876827|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876828|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13876829|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13876830|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876831|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876832|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13876833|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
13876834|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876835|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876836|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13876837|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13876838|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13876839|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
13876840|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13876841|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876842|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
13876843|NCT03614403|Vitamin D|vitamin d|mesh-list
13876844|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
13876845|NCT03614403|Vitamins|vitamins|mesh-ancestor
13876846|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
13876847|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876848|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13876849|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13876850|NCT03614273|Epinephrine|epinephrine|mesh-list
13876851|NCT03614273|Racepinephrine|racepinephrine|mesh-list
13876852|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
13876853|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13876854|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13876855|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
13876856|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876857|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876858|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876859|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13876860|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13876861|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
13876862|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876863|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13876864|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
13876865|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
13876866|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
13876867|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13876868|NCT03614221|Tacrolimus|tacrolimus|mesh-list
13876869|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13876870|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
13876871|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876872|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13876873|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876874|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876875|NCT03614065|Endostar protein|endostar protein|mesh-list
13876876|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
13876877|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13876878|NCT03614065|Growth Substances|growth substances|mesh-ancestor
13876879|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876880|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
13876881|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876882|NCT03614052|Tamsulosin|tamsulosin|mesh-list
13876883|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13876884|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13876885|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13876886|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
13876887|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876888|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876889|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876890|NCT03614052|Urological Agents|urological agents|mesh-ancestor
13876891|NCT03613974|Lidocaine|lidocaine|mesh-list
13876892|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
13876893|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
13876894|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876895|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876896|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
13876897|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876898|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13876899|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13876900|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13876901|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13876902|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876903|NCT03613961|Anesthetics|anesthetics|mesh-list
13876904|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876905|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876906|NCT03613857|Clopidogrel|clopidogrel|mesh-list
13876907|NCT03613857|Ticagrelor|ticagrelor|mesh-list
13876908|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13876909|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13876910|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13876911|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13876912|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
13876913|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876914|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876915|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876916|NCT03613792|Fentanyl|fentanyl|mesh-list
13876917|NCT03613792|Midazolam|midazolam|mesh-list
13876918|NCT03613792|Ketamine|ketamine|mesh-list
13876919|NCT03613792|Remifentanil|remifentanil|mesh-list
13876920|NCT03613792|Analgesics|analgesics|mesh-ancestor
13876921|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
13876922|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876923|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876924|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13876925|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13876926|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
13876927|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
13876928|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876929|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13876930|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13876931|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876932|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876933|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13876934|NCT03613792|Narcotics|narcotics|mesh-ancestor
13876935|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13876936|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13876937|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13876938|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13876939|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13876940|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
13876941|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
13876942|NCT03613753|Irinotecan|irinotecan|mesh-list
13876943|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13876944|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13876945|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876946|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876947|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876948|NCT03613597|Etoposide|etoposide|mesh-list
13876949|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
13876950|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876951|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13876952|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13876953|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13876954|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13876955|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876956|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
13876957|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13876958|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13876959|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876960|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13876961|NCT03613558|Analgesics|analgesics|mesh-ancestor
13876962|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
13876963|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13876964|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13876965|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13876966|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13876967|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
13876968|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13876969|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876970|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13876971|NCT03613545|Rifaximin|rifaximin|mesh-list
13876972|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
13876973|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13876974|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13876975|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13876976|NCT03613428|Prednisone|prednisone|mesh-list
13876977|NCT03613428|Vincristine|vincristine|mesh-list
13876978|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13876979|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
13876980|NCT03613428|Hormones|hormones|mesh-ancestor
13876981|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13876982|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876983|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13876984|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13876985|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13876986|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
13876987|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
13876988|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
13876989|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876990|NCT03613389|Vitamin E|vitamin e|mesh-list
13876991|NCT03613389|Vitamins|vitamins|mesh-ancestor
13876992|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
13876993|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13876994|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
13876995|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13876996|NCT03613389|Protective Agents|protective agents|mesh-ancestor
13876997|NCT03613259|Alovudine|alovudine|mesh-list
13876998|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
13876999|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877000|NCT03613207|Lidocaine|lidocaine|mesh-list
13877001|NCT03613207|Prilocaine|prilocaine|mesh-list
13877002|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877003|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
13877004|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877005|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877006|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
14470672|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470673|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13877007|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877008|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877009|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13877010|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13877011|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877012|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877013|NCT03613168|Trastuzumab|trastuzumab|mesh-list
13877014|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877015|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957110|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14470674|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
14470675|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14470676|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14470677|NCT02315625|Everolimus|everolimus|mesh-list
14470678|NCT02315625|Sunitinib|sunitinib|mesh-list
14470679|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470680|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13957111|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957112|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957113|NCT03177850|Diuretics|diuretics|mesh-ancestor
13957114|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
13957115|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957116|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
14470681|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
13957117|NCT03177720|Imipenem|imipenem|mesh-list
13957118|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13957119|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957120|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13957121|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13957122|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957123|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957124|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957125|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13957126|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13957127|NCT03177538|Menotropins|menotropins|mesh-list
13957128|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13957129|NCT03177538|Hormones|hormones|mesh-ancestor
13957130|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957131|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957132|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13957133|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
13957134|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13957135|NCT03177434|Lactulose|lactulose|mesh-list
13957136|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957137|NCT03177174|Docetaxel|docetaxel|mesh-list
13957138|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957139|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
13957140|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
13957141|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
13957142|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957143|NCT03177252|Lidocaine|lidocaine|mesh-list
13957144|NCT03177252|Bupivacaine|bupivacaine|mesh-list
13957145|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
13957146|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
13957147|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957148|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957149|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
13957150|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957151|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13957152|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13957153|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13957154|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13957155|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957156|NCT03177317|Dexamethasone|dexamethasone|mesh-list
14169188|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
14470682|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877016|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
13877017|NCT03612947|Bupivacaine|bupivacaine|mesh-list
13877018|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877019|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
13877020|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877021|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877022|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
13877023|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877024|NCT03612947|Analgesics|analgesics|mesh-ancestor
13877025|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877026|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
13877027|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13877028|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877029|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877030|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13877031|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
13877032|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13877033|NCT03612817|Timolol|timolol|mesh-list
13877034|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13877035|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13877036|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877037|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877038|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877039|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877040|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877041|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13877042|NCT03612739|Azacitidine|azacitidine|mesh-list
13877043|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13877044|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
14470683|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14470684|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14470685|NCT02315625|Growth Substances|growth substances|mesh-ancestor
14470686|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
13877045|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877046|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877047|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877048|NCT03612557|Penicillins|penicillins|mesh-list
13877049|NCT03612557|Penicillin G|penicillin g|mesh-list
13877050|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
13877051|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
13877052|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877053|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877054|NCT03612492|Lidocaine|lidocaine|mesh-list
13877055|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
13877056|NCT03612492|Anesthetics|anesthetics|mesh-list
13877057|NCT03612492|Esmolol|esmolol|mesh-list
13877058|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877059|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877060|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
13877061|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877062|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877063|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13877064|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13877065|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877066|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877067|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13877068|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13877069|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877070|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877071|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13877072|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
13877073|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13877074|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877075|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877076|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13877077|NCT03612440|Analgesics|analgesics|mesh-ancestor
13877078|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
13877079|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877080|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13877081|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14470687|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13877082|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14470688|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877083|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877084|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877085|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877086|NCT03612401|Mirabegron|mirabegron|mesh-list
13877087|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13877088|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13877089|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13877090|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877091|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877092|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877093|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877094|NCT03612401|Urological Agents|urological agents|mesh-ancestor
13877095|NCT03612349|Menthol|menthol|mesh-list
13877096|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
13877097|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
13877098|NCT03612323|Piroxicam|piroxicam|mesh-list
13877099|NCT03612323|Carticaine|carticaine|mesh-list
13877100|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877101|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
13877102|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877103|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877104|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
13877105|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877106|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13877107|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13877108|NCT03612323|Analgesics|analgesics|mesh-ancestor
13877109|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877110|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13877111|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13877112|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877113|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877114|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13877115|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877116|NCT03612219|Apatinib|apatinib|mesh-list
13877117|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877118|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13877119|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877120|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877121|NCT03612180|Metoprolol|metoprolol|mesh-list
13877122|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877123|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13877124|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
13877125|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
13877126|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877127|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877128|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13877129|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13877130|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13877131|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877132|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877133|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877134|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
13877135|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
13877136|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877137|NCT03612037|Protective Agents|protective agents|mesh-ancestor
13877138|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877139|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
13877140|NCT03612037|Vitamins|vitamins|mesh-ancestor
13877141|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
13877142|NCT03611985|Taxane|taxane|mesh-list
13877143|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877144|NCT03611920|Tetracycline|tetracycline|mesh-list
13877145|NCT03611920|Dexamethasone|dexamethasone|mesh-list
13877146|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877147|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
13877148|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
13877149|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877150|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877151|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877152|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
13877153|NCT03611920|Hormones|hormones|mesh-ancestor
13877154|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877155|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13877156|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877157|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877158|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877159|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13877160|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877161|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877162|NCT03611595|Tretinoin|tretinoin|mesh-list
14027110|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027111|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027112|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14027113|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
14027114|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
14027115|NCT02739386|Ipilimumab|ipilimumab|mesh-list
14027116|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027117|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027118|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14027119|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027120|NCT02738619|Vitamin D|vitamin d|mesh-list
14027121|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
14027122|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
14027123|NCT02738619|Vitamins|vitamins|mesh-list
14027124|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
14027125|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027126|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14027127|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14027128|NCT02738658|Everolimus|everolimus|mesh-list
14027129|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027130|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14027131|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
14027132|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027133|NCT02738502|Ritonavir|ritonavir|mesh-list
14027134|NCT02738502|Darunavir|darunavir|mesh-list
14027135|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14027136|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14027137|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14027138|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027139|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027140|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14027141|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14027142|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
14027143|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027144|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14027145|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14027146|NCT02738346|Carboplatin|carboplatin|mesh-list
14027147|NCT02738346|Etoposide|etoposide|mesh-list
14027148|NCT02738346|Topotecan|topotecan|mesh-list
14027149|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027150|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14027151|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027152|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027153|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027154|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027155|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14027156|NCT02738632|Amlodipine|amlodipine|mesh-list
14027157|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14027158|NCT02738632|Telmisartan|telmisartan|mesh-list
14027159|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14027160|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14027161|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14027162|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14027163|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027164|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14027165|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027166|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
14027167|NCT02738632|Diuretics|diuretics|mesh-ancestor
14027168|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
14479079|NCT02463357|Metformin|metformin|mesh-list
13877163|NCT03611595|Isotretinoin|isotretinoin|mesh-list
13877164|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877165|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
13877166|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
13877167|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13877168|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13877169|NCT03611504|Hemostatics|hemostatics|mesh-list
13877170|NCT03611504|Coagulants|coagulants|mesh-ancestor
13877171|NCT03611491|Lidocaine|lidocaine|mesh-list
13877172|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877173|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
13877174|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877175|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877176|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
13877177|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877178|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877179|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13877180|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13877181|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14470689|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470690|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14470691|NCT02315872|Hormones|hormones|mesh-ancestor
14470692|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877182|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877183|NCT03611426|Thrombin|thrombin|mesh-list
13877184|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
13877185|NCT03611426|Coagulants|coagulants|mesh-ancestor
13957157|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957158|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
13957159|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
13957160|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957161|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957162|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957163|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
13957164|NCT03177317|Hormones|hormones|mesh-ancestor
13957165|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957166|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13957167|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957168|NCT03177239|Nivolumab|nivolumab|mesh-list
13957169|NCT03177239|Ipilimumab|ipilimumab|mesh-list
13957170|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13957171|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957172|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13957173|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957174|NCT03176849|Vitamin D|vitamin d|mesh-list
13957175|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
13957176|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
13957177|NCT03176849|Vitamins|vitamins|mesh-list
13957178|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
13957179|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957180|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13957181|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13957182|NCT03177109|Fluorides|fluorides|mesh-list
14470693|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470694|NCT02316171|Mitomycins|mitomycins|mesh-list
14470695|NCT02316171|Mitomycin|mitomycin|mesh-list
14470696|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14470697|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470698|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
14470699|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470700|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14470701|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470702|NCT02316353|Complement C1s|complement c1s|mesh-list
14470703|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
13957183|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
13957184|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
13957185|NCT03177109|Protective Agents|protective agents|mesh-ancestor
13957186|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957187|NCT03176966|Vitamin E|vitamin e|mesh-list
13957188|NCT03176966|Ropinirole|ropinirole|mesh-list
13957189|NCT03176966|Vitamins|vitamins|mesh-ancestor
13957190|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
13957191|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957192|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
13957193|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957194|NCT03176966|Protective Agents|protective agents|mesh-ancestor
13877186|NCT03611348|Latanoprost|latanoprost|mesh-list
13877187|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14470704|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14470705|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
14470706|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470707|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14470708|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470709|NCT02316613|Rituximab|rituximab|mesh-list
14470710|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470711|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470712|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
14470713|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470714|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470715|NCT02316847|Diazepam|diazepam|mesh-list
14470716|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14470717|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
14470718|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
13877188|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13877189|NCT03611244|Benzocaine|benzocaine|mesh-list
13877190|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877191|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
13877192|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877193|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877194|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
13877195|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470719|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
13877196|NCT03611179|Bevacizumab|bevacizumab|mesh-list
13877197|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877198|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877199|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13877200|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13877201|NCT03611179|Growth Substances|growth substances|mesh-ancestor
13877202|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877203|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
13877204|NCT03611049|Vitamin D|vitamin d|mesh-list
13877205|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
13877206|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
13877207|NCT03611049|Vitamins|vitamins|mesh-list
13877208|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
13877209|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877210|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13877211|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13877212|NCT03610945|Fluconazole|fluconazole|mesh-list
13877213|NCT03610945|Quinidine|quinidine|mesh-list
13877214|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
13877215|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877216|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13877217|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13877218|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877219|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877220|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13877221|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
13877222|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877223|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877224|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13877225|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13877226|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13877227|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13877228|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877229|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877230|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877231|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
13877232|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13877233|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13877234|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13877235|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13877236|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
13877237|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13877238|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13877239|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877240|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13877241|NCT03610932|Ascorbic Acid|ascorbic acid|mesh-list
13877242|NCT03610932|Vitamins|vitamins|mesh-ancestor
14470720|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470721|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877243|NCT03610932|Micronutrients|micronutrients|mesh-ancestor
13877244|NCT03610932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877245|NCT03610932|Antioxidants|antioxidants|mesh-ancestor
13877246|NCT03610932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877247|NCT03610932|Protective Agents|protective agents|mesh-ancestor
13877248|NCT03610893|Dexamethasone|dexamethasone|mesh-list
13877249|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
13877250|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877251|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
13877252|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
13877253|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877254|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877255|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877256|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
13877257|NCT03610893|Hormones|hormones|mesh-ancestor
13877258|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877259|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13877260|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877261|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13877262|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877263|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13877264|NCT03610893|Analgesics|analgesics|mesh-ancestor
13877265|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
13877266|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13877267|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13877268|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13877269|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877270|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877271|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877272|NCT03610880|Yimitasvir|yimitasvir|mesh-list
13877273|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
13877274|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877275|NCT03610711|Nivolumab|nivolumab|mesh-list
13877276|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877277|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877278|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13877279|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877280|NCT03610685|Prednisolone|prednisolone|mesh-list
13877281|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877282|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
13877283|NCT03610685|Hormones|hormones|mesh-ancestor
13877284|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877285|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877286|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13877287|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877288|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
13877289|NCT03610412|Antacids|antacids|mesh-ancestor
13877290|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877291|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877292|NCT03610347|Paclitaxel|paclitaxel|mesh-list
13877293|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13877294|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877295|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
13877296|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
13877297|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
13877298|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877299|NCT03610321|Gefarnate|gefarnate|mesh-list
13877300|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13877301|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877302|NCT03610282|Propofol|propofol|mesh-list
14754121|NCT04807972|Folfirinox|folfirinox|mesh-list
14754122|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754123|NCT04803201|Prednisone|prednisone|mesh-list
14754124|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
14754125|NCT04803201|Doxorubicin|doxorubicin|mesh-list
14754126|NCT04803201|Etoposide|etoposide|mesh-list
13877303|NCT03610282|Methylphenidate|methylphenidate|mesh-list
13877304|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13877305|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877306|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877307|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13877308|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
13877309|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
13877310|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13877311|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13877312|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13877313|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877314|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877315|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
13877316|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877317|NCT03610230|Iron|iron|mesh-list
13877318|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14470722|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14470723|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13877319|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13877320|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
13877321|NCT03610230|Trace Elements|trace elements|mesh-ancestor
13877322|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
13877323|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877324|NCT03610230|Hematinics|hematinics|mesh-ancestor
13877325|NCT03610178|Insulin|insulin|mesh-list
13877326|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13877327|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14470724|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470725|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14470726|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14470727|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14470728|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14470729|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14470730|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14470731|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
14470732|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
13877328|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877329|NCT03610139|Vitamin D|vitamin d|mesh-list
13877330|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
13877331|NCT03610139|Vitamins|vitamins|mesh-ancestor
13877332|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
13877333|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877334|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13877335|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14470733|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
14470734|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
14470735|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470736|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470737|NCT02317016|Osimertinib|osimertinib|mesh-list
14470738|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13877336|NCT03610100|Gemcitabine|gemcitabine|mesh-list
13877337|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13877338|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
13877339|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877340|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877341|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
14470739|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14470740|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14470741|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
14470742|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470743|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14470744|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14754127|NCT04803201|Vincristine|vincristine|mesh-list
13877342|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877343|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957195|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14470745|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754128|NCT04803201|Azacitidine|azacitidine|mesh-list
14754129|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470746|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470747|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14470748|NCT02317510|Anesthetics|anesthetics|mesh-list
14470749|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470750|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470751|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
14470752|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13877344|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13877345|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
13877346|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877347|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
13877348|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
13877349|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
13877350|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877351|NCT03609996|Ranibizumab|ranibizumab|mesh-list
13877352|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13877353|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13877354|NCT03609996|Growth Substances|growth substances|mesh-ancestor
13877355|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470753|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13877356|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
13877357|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754130|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
13877358|NCT03609970|Vitamin D|vitamin d|mesh-list
13877359|NCT03609970|Vitamins|vitamins|mesh-ancestor
13877360|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
13877361|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877362|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13877363|NCT03609892|Amoxicillin|amoxicillin|mesh-list
13877364|NCT03609892|Tetracycline|tetracycline|mesh-list
14754131|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754132|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754133|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14754134|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
14754135|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877365|NCT03609892|Furazolidone|furazolidone|mesh-list
13877366|NCT03609892|Esomeprazole|esomeprazole|mesh-list
13877367|NCT03609892|Bismuth|bismuth|mesh-list
13877368|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877369|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877370|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13877371|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877372|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13877373|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877374|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877375|NCT03609892|Antacids|antacids|mesh-ancestor
13877376|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13877377|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13877378|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13877379|NCT03609892|Renal Agents|renal agents|mesh-ancestor
14470754|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470755|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
14470756|NCT02317549|Coagulants|coagulants|mesh-ancestor
14470757|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
14470758|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14470759|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470760|NCT02317744|Naltrexone|naltrexone|mesh-list
13877380|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13877381|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14470761|NCT02317744|Bupropion|bupropion|mesh-list
14470762|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14470763|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14470764|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470765|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
14470766|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470767|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14470768|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
14470769|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14470770|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14470771|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14470772|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14470773|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877382|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13877383|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13877384|NCT03609827|Melphalan|melphalan|mesh-list
13877385|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14470774|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
14470775|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470776|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13877386|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
13877387|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877388|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877389|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13877390|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13877391|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
13877392|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877393|NCT03609814|Fludarabine|fludarabine|mesh-list
13877394|NCT03609814|Clofarabine|clofarabine|mesh-list
13877395|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877396|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13877397|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
13877398|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877399|NCT03609775|Ethanol|ethanol|mesh-list
13877400|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13877401|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877402|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877403|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957196|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13957197|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
13957198|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
13957199|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470777|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14470778|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470779|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14470780|NCT02317809|Hormones|hormones|mesh-ancestor
14470781|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14470782|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470783|NCT02318095|Gemcitabine|gemcitabine|mesh-list
14470784|NCT02318095|Paclitaxel|paclitaxel|mesh-list
14470785|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14470786|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470787|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14470788|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14470789|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14470790|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470791|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14754136|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957204|NCT03177083|Interferons|interferons|mesh-list
13957205|NCT03177083|Interferon-beta|interferon-beta|mesh-list
13957206|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
13957207|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
13957208|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957209|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
13957210|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957211|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
13957212|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957213|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13957214|NCT03176758|Anesthetics|anesthetics|mesh-list
13957215|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
13957216|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957217|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957218|NCT03176693|Doxazosin|doxazosin|mesh-list
13957219|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
13957220|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13957221|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13957222|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13957223|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14754137|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14754138|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14754139|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13957224|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
13957225|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470792|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
14470793|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
13957226|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957227|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754140|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13877404|NCT03609593|Rituximab|rituximab|mesh-list
13877405|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13877406|NCT03609593|Venetoclax|venetoclax|mesh-list
13877407|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877408|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877409|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
13877410|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877411|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13877412|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13877413|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
13877414|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877415|NCT03609580|Tamsulosin|tamsulosin|mesh-list
13877416|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13877417|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13877418|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14754141|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877419|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877420|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877421|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877422|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877423|NCT03609580|Urological Agents|urological agents|mesh-ancestor
13877424|NCT03609489|Capecitabine|capecitabine|mesh-list
13877425|NCT03609489|Apatinib|apatinib|mesh-list
13877426|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13877427|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
13877428|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877429|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877430|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13877431|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877432|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
13877433|NCT03609424|Spartalizumab|spartalizumab|mesh-list
13877434|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877435|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13877436|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877437|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877438|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13877439|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
13877440|NCT03609359|Lenvatinib|lenvatinib|mesh-list
13877441|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877442|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877443|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13877444|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877445|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877446|NCT03609307|Bevacizumab|bevacizumab|mesh-list
13877447|NCT03609307|Propranolol|propranolol|mesh-list
13877448|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877449|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877450|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13877451|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13877452|NCT03609307|Growth Substances|growth substances|mesh-ancestor
13877453|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877454|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
13877455|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13877456|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13877457|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877458|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877459|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877460|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13877461|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13877462|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
13877463|NCT03609294|Linagliptin|linagliptin|mesh-list
13877464|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13877465|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877466|NCT03609294|Incretins|incretins|mesh-ancestor
13877467|NCT03609294|Hormones|hormones|mesh-ancestor
13877468|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877469|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13877470|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
13877471|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877472|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877473|NCT03609190|Ketamine|ketamine|mesh-list
13877474|NCT03609190|Analgesics|analgesics|mesh-ancestor
13877475|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
14479080|NCT02463357|Nifedipine|nifedipine|mesh-list
13877476|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877477|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877478|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13877479|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13877480|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
13877481|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
13877482|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877483|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13877484|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13877485|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877486|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877487|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13877488|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13877489|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
13877490|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877491|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877492|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13877493|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13877494|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877495|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877496|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877497|NCT03609086|Melatonin|melatonin|mesh-list
13877498|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
13877499|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877500|NCT03609086|Protective Agents|protective agents|mesh-ancestor
13877501|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877502|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877503|NCT03609060|Dexamethasone|dexamethasone|mesh-list
13877504|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877505|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
13877506|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
13877507|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877508|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877509|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877510|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
13877511|NCT03609060|Hormones|hormones|mesh-ancestor
13877512|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877513|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13877514|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877515|NCT03609008|Cromakalim|cromakalim|mesh-list
13877516|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13877517|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13877518|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
13877519|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877520|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877521|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13877522|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
13877523|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
13877524|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
13877525|NCT03608761|Rebamipide|rebamipide|mesh-list
13877526|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13877527|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877528|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
13877529|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877530|NCT03608761|Protective Agents|protective agents|mesh-ancestor
13877531|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877532|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877533|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
13877534|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13877535|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
13877536|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877537|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13877538|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13877539|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
13877540|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877541|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877542|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13877543|NCT03608514|Terlipressin|terlipressin|mesh-list
13877544|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13877545|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13877546|NCT03608501|Thalidomide|thalidomide|mesh-list
13877547|NCT03608501|Dexamethasone|dexamethasone|mesh-list
14470794|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877548|NCT03608501|Ixazomib|ixazomib|mesh-list
14470795|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877549|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877550|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
13877551|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
13877552|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877553|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877554|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877555|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
13877556|NCT03608501|Hormones|hormones|mesh-ancestor
13877557|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754142|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754143|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
14754144|NCT04803201|Hormones|hormones|mesh-ancestor
14754145|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754146|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754147|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14754148|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
14754149|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
14754150|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
14754151|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14754152|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
14754153|NCT04792502|Lenalidomide|lenalidomide|mesh-list
14754154|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
13877558|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13877559|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877560|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877561|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13877562|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
13877563|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
13877564|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877565|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877566|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13877567|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13877568|NCT03608501|Growth Substances|growth substances|mesh-ancestor
13877569|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
13877570|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
13877571|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877572|NCT03608358|Metformin|metformin|mesh-list
13877573|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
13877574|NCT03608358|Saxagliptin|saxagliptin|mesh-list
13877575|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13877576|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877577|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13877578|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877579|NCT03608358|Incretins|incretins|mesh-ancestor
13877580|NCT03608358|Hormones|hormones|mesh-ancestor
13877581|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877582|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13877583|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
13877584|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877585|NCT03608306|Methamphetamine|methamphetamine|mesh-list
13877586|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13877587|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877588|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
13877589|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
13877590|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877591|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
13877592|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877593|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877594|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877595|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13877596|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13877597|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877598|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13877599|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13877600|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
13877601|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
13877602|NCT03608241|Estradiol|estradiol|mesh-list
13877603|NCT03608241|Estrogens|estrogens|mesh-ancestor
13877604|NCT03608241|Hormones|hormones|mesh-ancestor
13877605|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877606|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027169|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14169189|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877607|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13877608|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13877609|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13877610|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13877611|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
13877612|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13877613|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13877614|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877615|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877616|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877617|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877618|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
13877619|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
13877620|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877621|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
13877622|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13877623|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
13877624|NCT03608046|Irinotecan|irinotecan|mesh-list
13877625|NCT03608046|Cetuximab|cetuximab|mesh-list
13877626|NCT03608046|Avelumab|avelumab|mesh-list
13877627|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13877628|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13877629|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877630|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877631|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877632|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877633|NCT03608007|Ensartinib|ensartinib|mesh-list
13877634|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877635|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13877636|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877637|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877638|NCT03607955|Paclitaxel|paclitaxel|mesh-list
13877639|NCT03607955|Carboplatin|carboplatin|mesh-list
13877640|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13877641|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877642|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
13877643|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
13877644|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
13877645|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957228|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
13957229|NCT03177070|Methylene Blue|methylene blue|mesh-list
13957230|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957231|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957232|NCT03176628|Niacinamide|niacinamide|mesh-list
13957233|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
13957234|NCT03176628|Vitamins|vitamins|mesh-ancestor
13957235|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
13957236|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957237|NCT03176524|Glucagon|glucagon|mesh-list
13957238|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13957239|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957240|NCT03176524|Hormones|hormones|mesh-ancestor
13957241|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957242|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957243|NCT03176524|Incretins|incretins|mesh-ancestor
13957244|NCT03176264|Bevacizumab|bevacizumab|mesh-list
14754155|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754156|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14754157|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14754158|NCT04792502|Growth Substances|growth substances|mesh-ancestor
14754159|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
14754160|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754161|NCT04791059|Sufentanil|sufentanil|mesh-list
14931388|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957245|NCT03176264|Spartalizumab|spartalizumab|mesh-list
13957246|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13957247|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957248|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13957249|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13957250|NCT03176264|Growth Substances|growth substances|mesh-ancestor
13957251|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957252|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
13957253|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13957254|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754162|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
13877646|NCT03607916|Morphine|morphine|mesh-list
13877647|NCT03607916|Prilocaine|prilocaine|mesh-list
13877648|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13877649|NCT03607916|Narcotics|narcotics|mesh-ancestor
13877650|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877651|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877652|NCT03607916|Analgesics|analgesics|mesh-ancestor
13877653|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
13877654|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877655|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877656|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
13877657|NCT03607903|Adalimumab|adalimumab|mesh-list
13877658|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877659|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13877660|NCT03607851|Lacosamide|lacosamide|mesh-list
13877661|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
13877662|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13877663|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13877664|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877665|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877666|NCT03607734|Amoxicillin|amoxicillin|mesh-list
13877667|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877668|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877669|NCT03607656|Docetaxel|docetaxel|mesh-list
13877670|NCT03607656|Capecitabine|capecitabine|mesh-list
14027170|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14027171|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14169190|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169191|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
14169192|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169193|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14470796|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470797|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
14470798|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470799|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
14470800|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14470801|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14470802|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470803|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14470804|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14470805|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14470806|NCT02318303|Analgesics|analgesics|mesh-ancestor
14470807|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
14470808|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470809|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470810|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470811|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14470812|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14470813|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
14754163|NCT04791059|Ketamine|ketamine|mesh-list
13877671|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
13877672|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877673|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
13877674|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
13877675|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
13877676|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877677|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13877678|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
14169194|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14169195|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14169196|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169197|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169198|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14169199|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
14169200|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
14169201|NCT04844216|Protective Agents|protective agents|mesh-ancestor
14169202|NCT04844099|Piperaquine|piperaquine|mesh-list
14754164|NCT04791059|Esketamine|esketamine|mesh-list
13877679|NCT03607643|Leucovorin|leucovorin|mesh-list
13877680|NCT03607643|Gemcitabine|gemcitabine|mesh-list
13877681|NCT03607643|Bevacizumab|bevacizumab|mesh-list
14754165|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13877682|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
13877683|NCT03607643|Irinotecan|irinotecan|mesh-list
13877684|NCT03607643|Temozolomide|temozolomide|mesh-list
14754166|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754167|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877685|NCT03607643|Bortezomib|bortezomib|mesh-list
13877686|NCT03607643|Cannabidiol|cannabidiol|mesh-list
13877687|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877688|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877689|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13877690|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13877691|NCT03607643|Growth Substances|growth substances|mesh-ancestor
13877692|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877693|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
13877694|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13877695|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
13877696|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877697|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
13877698|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877699|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877700|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13877701|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
13877702|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13877703|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13877704|NCT03607643|Antidotes|antidotes|mesh-ancestor
13877705|NCT03607643|Protective Agents|protective agents|mesh-ancestor
13877706|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
13877707|NCT03607643|Vitamins|vitamins|mesh-ancestor
13877708|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
13877709|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13877710|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
13877711|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
13877712|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
13877713|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13877714|NCT03607578|Protective Agents|protective agents|mesh-ancestor
13877715|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877716|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
13877717|NCT03607383|Red yeast rice|red yeast rice|mesh-list
13877718|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13877719|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13877720|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13877721|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
13877722|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877723|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877724|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13877725|NCT03607331|Citalopram|citalopram|mesh-list
13877726|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13877727|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13877728|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877729|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877730|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877731|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
13877732|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877733|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13877734|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
13877735|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13877736|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
13877737|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877738|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
13877739|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877740|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877741|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
13877742|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877743|NCT03607175|Triamcinolone|triamcinolone|mesh-list
13877744|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13877745|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877746|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
13877747|NCT03607175|Hormones|hormones|mesh-ancestor
13877748|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877749|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877750|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13877751|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
13877752|NCT03607149|Pemetrexed|pemetrexed|mesh-list
13877753|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877754|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877755|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877756|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13877757|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13877758|NCT03607110|Fentanyl|fentanyl|mesh-list
13877759|NCT03607110|Ketamine|ketamine|mesh-list
13877760|NCT03607110|Analgesics|analgesics|mesh-ancestor
13877761|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
13877762|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877763|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877764|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13877765|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13877766|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
13877767|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
13877768|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877769|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13877770|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13877771|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877772|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877773|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13877774|NCT03607110|Narcotics|narcotics|mesh-ancestor
13877775|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13877776|NCT03607071|Prednisolone|prednisolone|mesh-list
13877777|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877778|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
13877779|NCT03607071|Hormones|hormones|mesh-ancestor
13877780|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877781|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877782|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13877783|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877784|NCT03606928|Leucovorin|leucovorin|mesh-list
13877785|NCT03606928|Docetaxel|docetaxel|mesh-list
13877786|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
13877787|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877788|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
13877789|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
13877790|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
13877791|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877792|NCT03606928|Antidotes|antidotes|mesh-ancestor
13877793|NCT03606928|Protective Agents|protective agents|mesh-ancestor
13877794|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877795|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
13877796|NCT03606928|Vitamins|vitamins|mesh-ancestor
13877797|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
13877798|NCT03606902|Fentanyl|fentanyl|mesh-list
13877799|NCT03606902|Bupivacaine|bupivacaine|mesh-list
13877800|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877801|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
13877802|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877803|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877804|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
13877805|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877806|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13877807|NCT03606902|Narcotics|narcotics|mesh-ancestor
13877808|NCT03606902|Analgesics|analgesics|mesh-ancestor
13877809|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13877810|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13877811|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
13877812|NCT03606889|Bupivacaine|bupivacaine|mesh-list
13877813|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
13877814|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
13877815|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877816|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877817|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
13877818|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877819|NCT03606824|Pitavastatin|pitavastatin|mesh-list
13877820|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13877821|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13877822|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13877823|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
13877824|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877825|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877826|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13877827|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
13877828|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13877829|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13877830|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877831|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
13877832|NCT03606785|Coagulants|coagulants|mesh-ancestor
13877833|NCT03606694|Metformin|metformin|mesh-list
13877834|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13877835|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877836|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
13877837|NCT03606681|Calcium|calcium|mesh-list
13877838|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13877839|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877840|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13877841|NCT03606590|Sorafenib|sorafenib|mesh-list
13877842|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877843|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13877844|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877845|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877846|NCT03606577|Dexamethasone|dexamethasone|mesh-list
13877847|NCT03606577|Lenalidomide|lenalidomide|mesh-list
13877848|NCT03606577|Daratumumab|daratumumab|mesh-list
13877849|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877850|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
13877851|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
13877852|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877853|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877854|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877855|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
13877856|NCT03606577|Hormones|hormones|mesh-ancestor
13877857|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13877858|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13877859|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877860|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
13877861|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13877862|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13877863|NCT03606577|Growth Substances|growth substances|mesh-ancestor
13877864|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
13877865|NCT03606473|Amphetamine|amphetamine|mesh-list
13877866|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
13877867|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13877868|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877869|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
13877870|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
13877871|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877872|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
13877873|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877874|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877875|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
13877876|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13877877|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13877878|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13877879|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13877880|NCT03606369|Ondansetron|ondansetron|mesh-list
13877881|NCT03606369|Palonosetron|palonosetron|mesh-list
13877882|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
13877883|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
13877884|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877885|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877886|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13877887|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
13877888|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
13877889|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13877890|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
13877891|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13877892|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877893|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13877894|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13877895|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877896|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13877897|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13877898|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13957255|NCT03176563|Fosfomycin|fosfomycin|mesh-list
13957256|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13957257|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957258|NCT03176316|Naloxone|naloxone|mesh-list
13957259|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13957260|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957261|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
13957262|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957263|NCT03176472|Ricolinostat|ricolinostat|mesh-list
13957264|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957265|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13957266|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957267|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877899|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
13877900|NCT03606174|Nivolumab|nivolumab|mesh-list
13877901|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877902|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877903|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13877904|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877905|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
13877906|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13877907|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13877908|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877909|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
13877910|NCT03606109|Coagulants|coagulants|mesh-ancestor
13877911|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
13877912|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13877913|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877914|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877915|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13877916|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13877917|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877918|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877919|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877920|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13877921|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
13877922|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13877923|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877924|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13877925|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13877926|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13877927|NCT03606018|Insulin|insulin|mesh-list
13877928|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13877929|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
13877930|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13877931|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877932|NCT03605940|Methoxsalen|methoxsalen|mesh-list
13877933|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13877934|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
13877935|NCT03605901|Methadone|methadone|mesh-list
13877936|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13877937|NCT03605901|Narcotics|narcotics|mesh-ancestor
13877938|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13877939|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877940|NCT03605901|Analgesics|analgesics|mesh-ancestor
13877941|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
13877942|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13877943|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
13877944|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
13877945|NCT03605758|Ivermectin|ivermectin|mesh-list
13877946|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13877947|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877948|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
13877949|NCT03605654|Tacrolimus|tacrolimus|mesh-list
13877950|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13877951|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
13877952|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877953|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13877954|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877955|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877956|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13877957|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877958|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13877959|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
13877960|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13877961|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13877962|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
13877963|NCT03605589|Blinatumomab|blinatumomab|mesh-list
13877964|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13877965|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13877966|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
13877967|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877968|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
13877969|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13877970|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
13877971|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
13877972|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877973|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
13877974|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13877975|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
13877976|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13877977|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
13877978|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13877979|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13877980|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
13877981|NCT03605199|Denosumab|denosumab|mesh-list
13877982|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13877983|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877984|NCT03605173|Vitamin D|vitamin d|mesh-list
13877985|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
13877986|NCT03605173|Vitamins|vitamins|mesh-list
13877987|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
13877988|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13877989|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13877990|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13877991|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
13877992|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
13877993|NCT03605056|Dexamethasone|dexamethasone|mesh-list
13877994|NCT03605056|Lenalidomide|lenalidomide|mesh-list
13877995|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13877996|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
13877997|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
13877998|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754168|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13877999|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878000|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878001|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
13878002|NCT03605056|Hormones|hormones|mesh-ancestor
13878003|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878004|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13878005|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878006|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
13878007|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13878008|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13878009|NCT03605056|Growth Substances|growth substances|mesh-ancestor
13878010|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
13878011|NCT03604874|Oxytocin|oxytocin|mesh-list
13878012|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
13878013|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13878014|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878015|NCT03604796|Acetaminophen|acetaminophen|mesh-list
14754169|NCT04791059|Analgesics|analgesics|mesh-ancestor
14754170|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
14754171|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754172|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14754173|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13878016|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13878017|NCT03604796|Analgesics|analgesics|mesh-ancestor
13878018|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
13878019|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878020|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878021|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
13878022|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13878023|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13878024|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878025|NCT03604744|Psilocybin|psilocybin|mesh-list
13878026|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
13878027|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878028|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13878029|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13878030|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13878031|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
14754174|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878032|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878033|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878034|NCT03604653|Cisplatin|cisplatin|mesh-list
13878035|NCT03604653|Doxorubicin|doxorubicin|mesh-list
13878036|NCT03604653|Mitomycins|mitomycins|mesh-list
14931389|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470814|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
14470815|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14470816|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470817|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14470818|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470819|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14470820|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470821|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470822|NCT02318602|Cannabidiol|cannabidiol|mesh-list
14470823|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
14470824|NCT02318667|Golimumab|golimumab|mesh-list
14470825|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14470826|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14470827|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470828|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
14470829|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470830|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14470831|NCT02318693|Glyburide|glyburide|mesh-list
14470832|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14470833|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470834|NCT02318693|Incretins|incretins|mesh-ancestor
14470835|NCT02318693|Hormones|hormones|mesh-ancestor
14470836|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14470837|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14470838|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
14754175|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14754176|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754177|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754178|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14754179|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14754180|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
14754181|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
14754182|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14754183|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14754184|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14754185|NCT04791059|Narcotics|narcotics|mesh-ancestor
14931390|NCT01439100|Oxycodone|oxycodone|mesh-list
14931391|NCT01439100|Naloxone|naloxone|mesh-list
14931392|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14931393|NCT01439100|Narcotics|narcotics|mesh-ancestor
14931394|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931395|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931396|NCT01439100|Analgesics|analgesics|mesh-ancestor
14931397|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
14931398|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931399|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14931400|NCT01439152|Maytansine|maytansine|mesh-list
14931401|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
14931402|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14470839|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470840|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470841|NCT02319031|Ribavirin|ribavirin|mesh-list
14470842|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
13878037|NCT03604653|Mitomycin|mitomycin|mesh-list
13878038|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878039|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13878040|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14754186|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14931403|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878041|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14470843|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
14470844|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878042|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878043|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878044|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
13878045|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13878046|NCT03604627|Calcium|calcium|mesh-list
13878047|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13878048|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878049|NCT03604575|Insulin|insulin|mesh-list
13878050|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13878051|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
13878052|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13878053|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878054|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
13878055|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957268|NCT03176446|Anesthetics|anesthetics|mesh-list
13957269|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
13957270|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957271|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957272|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
13957273|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957274|NCT03176537|Testosterone|testosterone|mesh-list
13957275|NCT03176537|Androgens|androgens|mesh-ancestor
13957276|NCT03176537|Hormones|hormones|mesh-ancestor
13957277|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957278|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957279|NCT03176212|Milk fat globule|milk fat globule|mesh-list
13957280|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957281|NCT03176121|Oxycodone|oxycodone|mesh-list
13957282|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13957283|NCT03176121|Narcotics|narcotics|mesh-ancestor
13957284|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957285|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957286|NCT03176121|Analgesics|analgesics|mesh-ancestor
13957287|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
13957288|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957289|NCT03176199|Oxycodone|oxycodone|mesh-list
13957290|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13957291|NCT03176199|Narcotics|narcotics|mesh-ancestor
13957292|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957293|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957294|NCT03176199|Analgesics|analgesics|mesh-ancestor
13957295|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
13957296|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957297|NCT03176186|Xenon|xenon|mesh-list
13957298|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13957299|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
13957300|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
13957301|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957302|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957303|NCT03175978|Methotrexate|methotrexate|mesh-list
13957304|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957305|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13957306|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
13957307|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13957308|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13957309|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
13957310|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957311|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957312|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
13957313|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957314|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13957315|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13957316|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
13957317|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13957318|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13957319|NCT03175939|Fluorouracil|fluorouracil|mesh-list
13957320|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957321|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
13957322|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957323|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13957324|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13957325|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
13957326|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957327|NCT03175926|Budesonide|budesonide|mesh-list
13878056|NCT03604471|Atorvastatin|atorvastatin|mesh-list
13878057|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13878058|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13878059|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
13878060|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878061|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13878062|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13878063|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878064|NCT03604419|Metformin|metformin|mesh-list
13878065|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13878066|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878067|NCT03604354|Pregabalin|pregabalin|mesh-list
13878068|NCT03604354|Tapentadol|tapentadol|mesh-list
13878069|NCT03604354|Analgesics|analgesics|mesh-ancestor
13878070|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
13878071|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878072|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878073|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
13878074|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13878075|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878076|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878077|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13878078|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13878079|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13878080|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878081|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13878082|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13878083|NCT03604354|Narcotics|narcotics|mesh-ancestor
13878084|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13878085|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13878086|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878087|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878088|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
13878089|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13878090|NCT03604315|Fluorides|fluorides|mesh-list
13878091|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13878092|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878093|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
13878094|NCT03604315|Protective Agents|protective agents|mesh-ancestor
13878095|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878096|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
13878097|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
13878098|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878099|NCT03604224|Canagliflozin|canagliflozin|mesh-list
13878100|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13878101|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878102|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13878103|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878104|NCT03604016|Tenofovir|tenofovir|mesh-list
13878105|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
13878106|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878107|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13878108|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13878109|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878110|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878111|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13878112|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13878113|NCT03604003|Losartan|losartan|mesh-list
13878114|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13878115|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13878116|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13878117|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13878118|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878119|NCT03603938|Losartan|losartan|mesh-list
13878120|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13878121|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13878122|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13878123|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13878124|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878125|NCT03603899|Xenon|xenon|mesh-list
13878126|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13878127|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
13878128|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
13878129|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878130|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878131|NCT03603834|Leucovorin|leucovorin|mesh-list
13878132|NCT03603834|Fluorouracil|fluorouracil|mesh-list
13878133|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
13878134|NCT03603834|Irinotecan|irinotecan|mesh-list
13878135|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
13878136|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878137|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13878138|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878139|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878140|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
13878141|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878142|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13878143|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13878144|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878145|NCT03603834|Antidotes|antidotes|mesh-ancestor
13878146|NCT03603834|Protective Agents|protective agents|mesh-ancestor
13878147|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
13878148|NCT03603834|Vitamins|vitamins|mesh-ancestor
13878149|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
13878150|NCT03603756|Paclitaxel|paclitaxel|mesh-list
13878151|NCT03603756|Irinotecan|irinotecan|mesh-list
13878152|NCT03603756|Apatinib|apatinib|mesh-list
13878153|NCT03603756|Nedaplatin|nedaplatin|mesh-list
13878154|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13878155|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027172|NCT02738177|Isosorbide|isosorbide|mesh-list
14027173|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14027174|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14027175|NCT02738177|Misoprostol|misoprostol|mesh-list
14027176|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14027177|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
14027178|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14027179|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027180|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14027181|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027182|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
14027183|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14027184|NCT02738177|Diuretics|diuretics|mesh-ancestor
14027185|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
14027186|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
14027187|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14027188|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027189|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
14027190|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14027191|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14027192|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027193|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
14027194|NCT02738073|Coagulants|coagulants|mesh-ancestor
14027195|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14027196|NCT02737943|Analgesics|analgesics|mesh-list
14027197|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027198|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
14027199|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027200|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027201|NCT02737709|Paclitaxel|paclitaxel|mesh-list
14027202|NCT02737709|Carboplatin|carboplatin|mesh-list
14027203|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14027204|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027205|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
14027206|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
14027207|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
14027208|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027209|NCT02737813|Bupivacaine|bupivacaine|mesh-list
14027210|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
14027211|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
14027212|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027213|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027214|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
14027215|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027216|NCT02737787|Nivolumab|nivolumab|mesh-list
14027217|NCT02737787|Vaccines|vaccines|mesh-list
13878156|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
14027218|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
14027219|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878157|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
13878158|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
13957328|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027220|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13878159|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878160|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13878161|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13878162|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878163|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13878164|NCT03603626|Pregabalin|pregabalin|mesh-list
13878165|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878166|NCT03603626|Analgesics|analgesics|mesh-ancestor
13878167|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
13878168|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878169|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
13878170|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13878171|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878172|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878173|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13878174|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13878175|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13878176|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878177|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13878178|NCT03603548|Tacrolimus|tacrolimus|mesh-list
13878179|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878180|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
13878181|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878182|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13878183|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878184|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878185|NCT03603496|Nicotine|nicotine|mesh-list
13878186|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13878187|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
13878188|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878189|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878190|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13878191|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13878192|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
13878193|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878194|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878195|NCT03603418|Dexamethasone|dexamethasone|mesh-list
13878196|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
13878197|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13878198|NCT03603418|BB 1101|bb 1101|mesh-list
13878199|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878200|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
13878201|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
13878202|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878203|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878204|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878205|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
13878206|NCT03603418|Hormones|hormones|mesh-ancestor
13878207|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878208|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13878209|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878210|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
13878211|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878212|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878213|NCT03603366|Aspirin|aspirin|mesh-list
13878214|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13878215|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13878216|NCT03603366|Analgesics|analgesics|mesh-ancestor
13878217|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
13878218|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878219|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878220|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878221|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13878222|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13878223|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13878224|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878225|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13878226|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13878227|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878228|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
13878229|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
13878230|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027221|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878231|NCT03603249|Trimetazidine|trimetazidine|mesh-list
13878232|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
13878233|NCT03603119|Dexamethasone|dexamethasone|mesh-list
13878234|NCT03603119|Midazolam|midazolam|mesh-list
13878235|NCT03603119|Ondansetron|ondansetron|mesh-list
14470845|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
14470846|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470847|NCT02319044|Durvalumab|durvalumab|mesh-list
14470848|NCT02319044|Tremelimumab|tremelimumab|mesh-list
14470849|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14470850|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13878236|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878237|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
13878238|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
13878239|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878240|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878241|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878242|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
13878243|NCT03603119|Hormones|hormones|mesh-ancestor
13878244|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878245|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13878246|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878247|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13878248|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13878249|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878250|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13878251|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13878252|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13878253|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13878254|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
13878255|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
13878256|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
13878257|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
13878258|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878259|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878260|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
13878261|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
13878262|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13878263|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
13878264|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13878265|NCT03603080|Metformin|metformin|mesh-list
14470851|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470852|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
14470853|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878266|NCT03603080|Topiramate|topiramate|mesh-list
13878267|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
13878268|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13878269|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878270|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
13878271|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13878272|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13878273|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878274|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13878275|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13878276|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878277|NCT03602898|Cyclosporine|cyclosporine|mesh-list
13878278|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
13878279|NCT03602898|Busulfan|busulfan|mesh-list
13878280|NCT03602898|Methotrexate|methotrexate|mesh-list
13878281|NCT03602898|Fludarabine|fludarabine|mesh-list
13878282|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
13878283|NCT03602898|Tacrolimus|tacrolimus|mesh-list
13878284|NCT03602898|Cyclosporins|cyclosporins|mesh-list
13878285|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13878286|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878287|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
13878288|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878289|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13878290|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13878291|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
13878292|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878293|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878294|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13878295|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13878296|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
13878297|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13878298|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13878299|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
13878300|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470854|NCT02319148|Itraconazole|itraconazole|mesh-list
13878301|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878302|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13878303|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13878304|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13878305|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
13878306|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878307|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13878308|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878309|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
13878310|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13878311|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
13878312|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878313|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878314|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13878315|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
13878316|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13878317|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
13878318|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878319|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878320|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13878321|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
13878322|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
13878323|NCT03602781|Protective Agents|protective agents|mesh-ancestor
13878324|NCT03602690|Ritonavir|ritonavir|mesh-list
13878325|NCT03602690|Darunavir|darunavir|mesh-list
13878326|NCT03602690|Dolutegravir|dolutegravir|mesh-list
13878327|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13878328|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13878329|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
13878330|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878331|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878332|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13878333|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13878334|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
13878335|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878336|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13878337|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13878338|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13878339|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13957329|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13957330|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
13957331|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957332|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957333|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13957334|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
13957335|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
13957336|NCT03175926|Hormones|hormones|mesh-ancestor
13957337|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957338|NCT03175679|Interleukin-2|interleukin-2|mesh-list
13957339|NCT03175679|Tegafur|tegafur|mesh-list
13957340|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957341|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957342|NCT03175679|Analgesics|analgesics|mesh-ancestor
13957343|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
13957344|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957345|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957346|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13957347|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
13957348|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957349|NCT03175666|Leucovorin|leucovorin|mesh-list
13957350|NCT03175666|Paclitaxel|paclitaxel|mesh-list
13957351|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
13957352|NCT03175666|Bevacizumab|bevacizumab|mesh-list
13957353|NCT03175666|Fluorouracil|fluorouracil|mesh-list
13957354|NCT03175666|Capecitabine|capecitabine|mesh-list
13957355|NCT03175666|Avelumab|avelumab|mesh-list
13957356|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13957357|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957358|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
13957359|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
13957360|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
13957361|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957362|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13957363|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
13957364|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957365|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13878340|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13878341|NCT03602638|Acarbose|acarbose|mesh-list
13878342|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13878343|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878344|NCT03602638|Incretins|incretins|mesh-ancestor
13878345|NCT03602638|Hormones|hormones|mesh-ancestor
13878346|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878347|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13878348|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
13878349|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878350|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878351|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13878352|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
13878353|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13878354|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878355|NCT03602560|Seladelpar|seladelpar|mesh-list
13878356|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13878357|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
13878358|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878359|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13878360|NCT03602547|Vorolanib|vorolanib|mesh-list
13878361|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13878362|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878363|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878364|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
13878365|NCT03602508|Mirabegron|mirabegron|mesh-list
13878366|NCT03602508|Fesoterodine|fesoterodine|mesh-list
13878367|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
13878368|NCT03602508|Oxybutynin|oxybutynin|mesh-list
13878369|NCT03602508|Darifenacin|darifenacin|mesh-list
13878370|NCT03602508|Propiverine|propiverine|mesh-list
13878371|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13878372|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13878373|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
13878374|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878375|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878376|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878377|NCT03602508|Urological Agents|urological agents|mesh-ancestor
13878378|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13878379|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13878380|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878381|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878382|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
13878383|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
13878384|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878385|NCT03602469|Bupivacaine|bupivacaine|mesh-list
13878386|NCT03602469|Propofol|propofol|mesh-list
13878387|NCT03602469|Sevoflurane|sevoflurane|mesh-list
13878388|NCT03602469|Rocuronium|rocuronium|mesh-list
13878389|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
13878390|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
13878391|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878392|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878393|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
13878394|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878395|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13878396|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13878397|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
13878398|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13878399|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13878400|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13878401|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13878402|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13878403|NCT03602430|Vitamin D|vitamin d|mesh-list
13878404|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
13878405|NCT03602430|Vitamins|vitamins|mesh-ancestor
13878406|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
13878407|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878408|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13878409|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13878410|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
13878411|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878412|NCT03602287|Lidocaine|lidocaine|mesh-list
13878413|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
13878414|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
13878415|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878416|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878417|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
13878418|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878419|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13878420|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13878421|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13878422|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878423|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878424|NCT03602261|Calcifediol|calcifediol|mesh-list
13878425|NCT03602261|Vitamins|vitamins|mesh-ancestor
13878426|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
13878427|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878428|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13878429|NCT03602248|Methamphetamine|methamphetamine|mesh-list
13878430|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13878431|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878432|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
13878433|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
13878434|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878435|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
13878436|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878437|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878438|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878439|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13878440|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13878441|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878442|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13878443|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13878444|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878445|NCT03602131|Gemcitabine|gemcitabine|mesh-list
13878446|NCT03602131|Busulfan|busulfan|mesh-list
13878447|NCT03602131|Cladribine|cladribine|mesh-list
13878448|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13878449|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
13878450|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878451|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878452|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
13878453|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878454|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878455|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878456|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
14470855|NCT02319148|Verapamil|verapamil|mesh-list
14470856|NCT02319148|Diltiazem|diltiazem|mesh-list
13878457|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878458|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
13878459|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13878460|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13878461|NCT03602118|Phenobarbital|phenobarbital|mesh-list
13878462|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
13878463|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13878464|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878465|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878466|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13878467|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13878468|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878469|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878470|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
13878471|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
13878472|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13878473|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13878474|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13878475|NCT03602027|Gefitinib|gefitinib|mesh-list
13878476|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878477|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13878478|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878479|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878480|NCT03602014|Droxidopa|droxidopa|mesh-list
13878481|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13878482|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13878483|NCT03601975|Gemcitabine|gemcitabine|mesh-list
13878484|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878485|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13878486|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
13878487|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878488|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
13878489|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878490|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878491|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878492|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
13878493|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878494|NCT03601897|Paclitaxel|paclitaxel|mesh-list
13878495|NCT03601897|Rebastinib|rebastinib|mesh-list
13878496|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13878497|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878498|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
13878499|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
13878500|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
13878501|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878502|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13878503|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878504|NCT03601871|Thalidomide|thalidomide|mesh-list
13878505|NCT03601871|Dexamethasone|dexamethasone|mesh-list
13878506|NCT03601871|Palonosetron|palonosetron|mesh-list
13878507|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
13878508|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878509|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
13878510|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
13878511|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878512|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878513|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878514|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
13878515|NCT03601871|Hormones|hormones|mesh-ancestor
13878516|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878517|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13878518|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878519|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878520|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
13878521|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
13878522|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13878523|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878524|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13878525|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13878526|NCT03601871|Growth Substances|growth substances|mesh-ancestor
13878527|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
14470857|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
14470858|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878528|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13878529|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
13878530|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878531|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878532|NCT03601806|Thalidomide|thalidomide|mesh-list
13878533|NCT03601806|Pomalidomide|pomalidomide|mesh-list
13878534|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878535|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
13878536|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878537|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
13878538|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13878539|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878540|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13878541|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13878542|NCT03601806|Growth Substances|growth substances|mesh-ancestor
13878543|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
13878544|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878545|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
13878546|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13878547|NCT03601624|Dexamethasone|dexamethasone|mesh-list
13878548|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
13878549|NCT03601624|Pomalidomide|pomalidomide|mesh-list
13878550|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878551|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
13878552|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878553|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13878554|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13878555|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
13878556|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878557|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878558|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13878559|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878560|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
13878561|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
13878562|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878563|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878564|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
13878565|NCT03601624|Hormones|hormones|mesh-ancestor
13878566|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878567|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13878568|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13878569|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13878570|NCT03601624|Growth Substances|growth substances|mesh-ancestor
13878571|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
13878572|NCT03601611|Prednisolone|prednisolone|mesh-list
13878573|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878574|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
13878575|NCT03601611|Hormones|hormones|mesh-ancestor
13878576|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878577|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878578|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13878579|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878580|NCT03601533|Phenol|phenol|mesh-list
13878581|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13878582|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878583|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
13878584|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13878585|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13878586|NCT03601338|Bemiparin|bemiparin|mesh-list
13878587|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
13878588|NCT03601260|Allopurinol|allopurinol|mesh-list
13878589|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
13878590|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878591|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878592|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
13878593|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13878594|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13878595|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
13878596|NCT03601260|Protective Agents|protective agents|mesh-ancestor
13878597|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878598|NCT03601091|Midazolam|midazolam|mesh-list
13878599|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
13878600|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13878601|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878602|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878603|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14169203|NCT04844099|Artenimol|artenimol|mesh-list
13878604|NCT03601091|Analgesics|analgesics|mesh-ancestor
13878605|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
13878606|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878607|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13878608|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13878609|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878610|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878611|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878612|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878613|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13878614|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13878615|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13878616|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13878617|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13878618|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
13878619|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
13878620|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
13878621|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
13957366|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13957367|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
13957368|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14470859|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14470860|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14470861|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957369|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13957370|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13957371|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13957372|NCT03175666|Growth Substances|growth substances|mesh-ancestor
13957373|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
13957374|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
13957375|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13957376|NCT03175666|Antidotes|antidotes|mesh-ancestor
13957377|NCT03175666|Protective Agents|protective agents|mesh-ancestor
13957378|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
13957379|NCT03175666|Vitamins|vitamins|mesh-ancestor
13957380|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
13957381|NCT03175705|Interleukin-2|interleukin-2|mesh-list
13957382|NCT03175705|Tegafur|tegafur|mesh-list
13957383|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957384|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957385|NCT03175705|Analgesics|analgesics|mesh-ancestor
13957386|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
13957387|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957388|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957389|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13957390|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
13957391|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957392|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13957393|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13957394|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13957395|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
13957396|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957397|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13957398|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13957399|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957400|NCT03175653|Oxycodone|oxycodone|mesh-list
13957401|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13957402|NCT03175653|Narcotics|narcotics|mesh-ancestor
13957403|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957404|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957405|NCT03175653|Analgesics|analgesics|mesh-ancestor
13957406|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
13957407|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957408|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
13957409|NCT03175341|Vitamins|vitamins|mesh-ancestor
13957410|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
13957411|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957412|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
13957413|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957414|NCT03175341|Protective Agents|protective agents|mesh-ancestor
13957415|NCT03175549|Apremilast|apremilast|mesh-list
13957416|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13957417|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957418|NCT03175549|Analgesics|analgesics|mesh-ancestor
13957419|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
13957420|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878622|NCT03600974|Domperidone|domperidone|mesh-list
13878623|NCT03600974|Citalopram|citalopram|mesh-list
13878624|NCT03600974|Esomeprazole|esomeprazole|mesh-list
13878625|NCT03600974|Omeprazole|omeprazole|mesh-list
13878626|NCT03600974|Rabeprazole|rabeprazole|mesh-list
13878627|NCT03600974|Pantoprazole|pantoprazole|mesh-list
13878628|NCT03600974|Lansoprazole|lansoprazole|mesh-list
13878629|NCT03600974|Mosapride|mosapride|mesh-list
13878630|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
13878631|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13878632|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878633|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13878634|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878635|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878636|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13878637|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13878638|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878639|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
13878640|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878641|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13878642|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
13878643|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13878644|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
13878645|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878646|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
13878647|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13878648|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
13878649|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13878650|NCT03600961|Sirolimus|sirolimus|mesh-list
13878651|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13878652|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878653|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13878654|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878655|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
13878656|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878657|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
13878658|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878659|NCT03600948|Sirolimus|sirolimus|mesh-list
13878660|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13878661|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878662|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13878663|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878664|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
13878665|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878666|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
13878667|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878668|NCT03600870|Midodrine|midodrine|mesh-list
13878669|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
13878670|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
13878671|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878672|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878673|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13878674|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13878675|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13878676|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878677|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878678|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878679|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878680|NCT03600857|Misoprostol|misoprostol|mesh-list
13878681|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13878682|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
14754187|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
14754188|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14754189|NCT04790903|Prednisone|prednisone|mesh-list
13878683|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14754190|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
13878684|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878685|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14754191|NCT04790903|Rituximab|rituximab|mesh-list
13878686|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878687|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
13878688|NCT03600831|Docetaxel|docetaxel|mesh-list
13878689|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878690|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
13878691|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
13878692|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
13878693|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878694|NCT03600818|Prednisone|prednisone|mesh-list
13878695|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878696|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
13878697|NCT03600818|Hormones|hormones|mesh-ancestor
13878698|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878699|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878700|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13878701|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878702|NCT03600766|Mirabegron|mirabegron|mesh-list
13878703|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13878704|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13878705|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878706|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878707|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878708|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878709|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878710|NCT03600766|Urological Agents|urological agents|mesh-ancestor
13878711|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
13878712|NCT03600727|Propofol|propofol|mesh-list
13878713|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13878714|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878715|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878716|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13878717|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
13878718|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
13878719|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13878720|NCT03600727|Analgesics|analgesics|mesh-ancestor
13878721|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
13878722|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878723|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13878724|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13878725|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878726|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878727|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878728|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878729|NCT03600623|Gemcitabine|gemcitabine|mesh-list
13878730|NCT03600623|Paclitaxel|paclitaxel|mesh-list
13878731|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13878732|NCT03600623|Fluorouracil|fluorouracil|mesh-list
13878733|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
13878734|NCT03600623|Irinotecan|irinotecan|mesh-list
13878735|NCT03600623|Folfirinox|folfirinox|mesh-list
13878736|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13878737|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878738|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
13878739|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
13878740|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
13878741|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878742|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13878743|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
13878744|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
13878745|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878746|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878747|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13878748|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
13878749|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878750|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13878751|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13878752|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
13878753|NCT03600506|Sympatholytics|sympatholytics|mesh-list
13878754|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13878755|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878756|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878757|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13878758|NCT03600506|Analgesics|analgesics|mesh-ancestor
13878759|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
13878760|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878761|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13878762|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13878763|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878764|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878765|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878766|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878767|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
13878768|NCT03600493|Lidocaine|lidocaine|mesh-list
13878769|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
13878770|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
13878771|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
13878772|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878773|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878774|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
13878775|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878776|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13878777|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13878778|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13878779|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878780|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878781|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13878782|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13878783|NCT03600493|Analgesics|analgesics|mesh-ancestor
13878784|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13878785|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13878786|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13878787|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
13878788|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878789|NCT03600467|Seviteronel|seviteronel|mesh-list
13878790|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878791|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13878792|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878793|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878794|NCT03600454|Anesthetics|anesthetics|mesh-list
13878795|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878796|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878797|NCT03600441|Abexinostat|abexinostat|mesh-list
13878798|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13878799|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878800|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878801|NCT03600363|Metformin|metformin|mesh-list
13878802|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13878803|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878804|NCT03600311|Vitamin D|vitamin d|mesh-list
13878805|NCT03600311|Calcium|calcium|mesh-list
13878806|NCT03600311|Vitamins|vitamins|mesh-ancestor
13878807|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
13878808|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169204|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
14754192|NCT04790903|Doxorubicin|doxorubicin|mesh-list
14754193|NCT04790903|Venetoclax|venetoclax|mesh-list
14754194|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754195|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
14754196|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754197|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754198|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14754199|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
14754200|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754201|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754202|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14754203|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754204|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14754205|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14754206|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13878809|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13878810|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13878811|NCT03600155|Nivolumab|nivolumab|mesh-list
13878812|NCT03600155|Ipilimumab|ipilimumab|mesh-list
13878813|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13878814|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878815|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13878816|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878817|NCT03600129|Ropivacaine|ropivacaine|mesh-list
13878818|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
13878819|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
13878820|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878821|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878822|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
13878823|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878824|NCT03600064|Misoprostol|misoprostol|mesh-list
13878825|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13878826|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
13878827|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13878828|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878829|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13878830|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878831|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
14754207|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754208|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878832|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
13878833|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13878834|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13878835|NCT03599778|Apatinib|apatinib|mesh-list
13878836|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878837|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13878838|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878839|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878840|NCT03599726|Donepezil|donepezil|mesh-list
13878841|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14754209|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
14754210|NCT04790903|Hormones|hormones|mesh-ancestor
14754211|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754212|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754213|NCT04790370|Heparin|heparin|mesh-list
14754214|NCT04790370|Calcium heparin|calcium heparin|mesh-list
14754215|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
14754216|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13878842|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878843|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878844|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
13878845|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878846|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878847|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
13878848|NCT03599609|Simvastatin|simvastatin|mesh-list
13878849|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13878850|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13878851|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
13878852|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878853|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13878854|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13878855|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878856|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
13878857|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
13878858|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
13878859|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
13878860|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13878861|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13878862|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878863|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13878864|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878865|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878866|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13878867|NCT03599596|Renal Agents|renal agents|mesh-ancestor
13878868|NCT03599518|Gefitinib|gefitinib|mesh-list
13878869|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878870|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754217|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14754218|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878871|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878872|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878873|NCT03599466|Lisinopril|lisinopril|mesh-list
13878874|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13878875|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
13878876|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878877|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878878|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13878879|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13878880|NCT03599466|Protective Agents|protective agents|mesh-ancestor
13878881|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878882|NCT03599453|Interferons|interferons|mesh-list
13878883|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
13878884|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
13878885|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
13878886|NCT03599453|Poly I-C|poly i-c|mesh-list
13878887|NCT03599453|Celecoxib|celecoxib|mesh-list
13878888|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
13878889|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
13878890|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
13878891|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
13878892|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13878893|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878894|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
13878895|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878896|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
13878897|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878898|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13878899|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13878900|NCT03599453|Analgesics|analgesics|mesh-ancestor
13878901|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
13878902|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027222|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14027223|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027224|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14027225|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
14027226|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14027227|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
14027228|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027229|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14027230|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14027231|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14027232|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14027233|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027234|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14027235|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
14027236|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14027237|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
14027238|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13878903|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13878904|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13878905|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13878906|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13878907|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878908|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878909|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
13878910|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13878911|NCT03599427|Lidocaine|lidocaine|mesh-list
13878912|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
13878913|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
13878914|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169205|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13878915|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878916|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
13878917|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13878918|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13878919|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13878920|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13878921|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878922|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957421|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957422|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957423|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13957424|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13957425|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13957426|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957427|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957428|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
13957429|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13957430|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
13957431|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957432|NCT03175081|Ropivacaine|ropivacaine|mesh-list
13957433|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
13957434|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
13957435|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957436|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957437|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
13957438|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957439|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
13957440|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13957441|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13957442|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
13957443|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957444|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13957445|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13957446|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957447|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754219|NCT04770896|Sorafenib|sorafenib|mesh-list
14754220|NCT04770896|Atezolizumab|atezolizumab|mesh-list
14754221|NCT04770896|Lenvatinib|lenvatinib|mesh-list
14754222|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754223|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754224|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754225|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754226|NCT04769050|Docetaxel|docetaxel|mesh-list
14754227|NCT04769050|Capecitabine|capecitabine|mesh-list
14754228|NCT04769050|Trastuzumab|trastuzumab|mesh-list
14754229|NCT04769050|Pertuzumab|pertuzumab|mesh-list
14754230|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754231|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
14754232|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
13957448|NCT03175016|Irinotecan|irinotecan|mesh-list
13957449|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13957450|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13957451|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957452|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957453|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957454|NCT03174938|Flutemetamol|flutemetamol|mesh-list
13957455|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13957456|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957457|NCT03174860|Diclofenac|diclofenac|mesh-list
13957458|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13957459|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957460|NCT03174860|Analgesics|analgesics|mesh-ancestor
13957461|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
13957462|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957463|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957464|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957465|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13957466|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13957467|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957468|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957469|NCT03174847|Eplerenone|eplerenone|mesh-list
13957470|NCT03174847|Amiloride|amiloride|mesh-list
14754233|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
14754234|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878923|NCT03599323|Clotrimazole|clotrimazole|mesh-list
13878924|NCT03599323|Miconazole|miconazole|mesh-list
13878925|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13878926|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878927|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
13878928|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13878929|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13878930|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878931|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878932|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13878933|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
13878934|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13878935|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878936|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13878937|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13878938|NCT03599284|Clopidogrel|clopidogrel|mesh-list
13878939|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13878940|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13878941|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13878942|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13878943|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
13878944|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878945|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878946|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878947|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
13878948|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
13878949|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13878950|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878951|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13878952|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878953|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878954|NCT03598959|Tofacitinib|tofacitinib|mesh-list
13878955|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13878956|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878957|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878958|NCT03598868|Vortioxetine|vortioxetine|mesh-list
13878959|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
13878960|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13878961|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13878962|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13878963|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13878964|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13878965|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13878966|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13878967|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13878968|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878969|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13878970|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
13878971|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13878972|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13878973|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13878974|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13878975|NCT03598842|Metronidazole|metronidazole|mesh-list
13878976|NCT03598842|Ivermectin|ivermectin|mesh-list
13878977|NCT03598842|Albendazole|albendazole|mesh-list
13878978|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
13878979|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13878980|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13878981|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13878982|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
13878983|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
13878984|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13878985|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
13878986|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
13878987|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
13878988|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13878989|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878990|NCT03598816|Durvalumab|durvalumab|mesh-list
13878991|NCT03598816|Tremelimumab|tremelimumab|mesh-list
13878992|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13878993|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13878994|NCT03598738|Esomeprazole|esomeprazole|mesh-list
13878995|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13878996|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13878997|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13878998|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13878999|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879000|NCT03598725|Prednisone|prednisone|mesh-list
13879001|NCT03598725|Rituximab|rituximab|mesh-list
13879002|NCT03598725|Factor VIII|factor viii|mesh-list
13879003|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13879004|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879005|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
13879006|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879007|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13879008|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879009|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
13879010|NCT03598725|Hormones|hormones|mesh-ancestor
13879011|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879012|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13879013|NCT03598725|Coagulants|coagulants|mesh-ancestor
13879014|NCT03598673|Nebivolol|nebivolol|mesh-list
13879015|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13879016|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
13879017|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13879018|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13879019|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879020|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879021|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879022|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879023|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879024|NCT03598634|Riboflavin|riboflavin|mesh-list
13879025|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
13879026|NCT03598634|Vitamins|vitamins|mesh-ancestor
13879027|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
13879028|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879029|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13879030|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
13879031|NCT03598595|Gemcitabine|gemcitabine|mesh-list
13879032|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
13879033|NCT03598595|Docetaxel|docetaxel|mesh-list
13879034|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13879035|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
13879036|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879037|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879038|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
13879039|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879040|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879041|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13879042|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
13879043|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879044|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
13879045|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
13879046|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
13879047|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
13879048|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13879049|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13879050|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479081|NCT02463357|Methazolamide|methazolamide|mesh-list
13879051|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
13879052|NCT03598582|Hematinics|hematinics|mesh-ancestor
13879053|NCT03598556|Vitamin D|vitamin d|mesh-list
13879054|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
13879055|NCT03598556|Vitamins|vitamins|mesh-ancestor
13879056|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
13879057|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879058|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13879059|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13879060|NCT03598452|Ganciclovir|ganciclovir|mesh-list
13879061|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13879062|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
13879063|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479082|NCT02463357|Quercetin|quercetin|mesh-list
13879064|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13879065|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879066|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879067|NCT03598426|Dexamethasone|dexamethasone|mesh-list
13879068|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879069|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
13879070|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
13879071|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879072|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879073|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13879074|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
13879075|NCT03598426|Hormones|hormones|mesh-ancestor
13879076|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879077|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13879078|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879079|NCT03598374|Folic Acid|folic acid|mesh-list
13879080|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
13879081|NCT03598374|Inositol|inositol|mesh-list
13879082|NCT03598374|Hematinics|hematinics|mesh-ancestor
13879083|NCT03598374|Vitamins|vitamins|mesh-ancestor
13879084|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
13879085|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879086|NCT03598348|Capecitabine|capecitabine|mesh-list
13879087|NCT03598348|Apatinib|apatinib|mesh-list
13879088|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13879089|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
13879090|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879091|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879092|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13879093|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879094|NCT03598192|Sufentanil|sufentanil|mesh-list
13879095|NCT03598192|Dsuvia|dsuvia|mesh-list
13879096|NCT03598192|Ropivacaine|ropivacaine|mesh-list
13879097|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
13879098|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
13879099|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879100|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879101|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
13879102|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879103|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879104|NCT03598192|Narcotics|narcotics|mesh-ancestor
13879105|NCT03598192|Analgesics|analgesics|mesh-ancestor
13879106|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13879107|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879108|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
13879109|NCT03598075|Pramlintide|pramlintide|mesh-list
13879110|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13879111|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879112|NCT03597997|Propofol|propofol|mesh-list
13879113|NCT03597997|Sevoflurane|sevoflurane|mesh-list
13879114|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879115|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879116|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879117|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879118|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
13879119|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
13879120|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13879121|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13879122|NCT03597945|Lidocaine|lidocaine|mesh-list
13879123|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
13879124|NCT03597945|Epinephrine|epinephrine|mesh-list
13879125|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
13879126|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
13879127|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879128|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879129|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
13879130|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879131|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13879132|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13879133|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13879134|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13879135|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027239|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879136|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13879137|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879138|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879139|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879140|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13879141|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13879142|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
13879143|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13879144|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
13879145|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
13879146|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
13879147|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13879148|NCT03597945|Analgesics|analgesics|mesh-ancestor
13879149|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
13879150|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13879151|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13879152|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
13879153|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879154|NCT03597919|Vaccines|vaccines|mesh-list
13879155|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
13879156|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879157|NCT03597893|Oxytocin|oxytocin|mesh-list
13879158|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
13879159|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879160|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879161|NCT03597867|Diclofenac|diclofenac|mesh-list
13879162|NCT03597867|Indomethacin|indomethacin|mesh-list
13879163|NCT03597867|Nepafenac|nepafenac|mesh-list
13879164|NCT03597867|Bromfenac|bromfenac|mesh-list
13879165|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13879166|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13879167|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13879168|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879169|NCT03597867|Analgesics|analgesics|mesh-ancestor
13879170|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
13879171|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879172|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879173|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879174|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13879175|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13879176|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879177|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879178|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
13879179|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
13879180|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879181|NCT03597815|Aflibercept|aflibercept|mesh-list
13879182|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13879183|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13879184|NCT03597815|Growth Substances|growth substances|mesh-ancestor
13879185|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879186|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
13879187|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879188|NCT03597776|Lidocaine|lidocaine|mesh-list
13879189|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
13879190|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
13879191|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879192|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879193|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
13879194|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879195|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13879196|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13879197|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13879198|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13879199|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957471|NCT03174847|Spironolactone|spironolactone|mesh-list
13957472|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
13957473|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
13957474|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
13957475|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957476|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957477|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13957478|NCT03174847|Diuretics|diuretics|mesh-ancestor
13957479|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
13957480|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13957481|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
13957482|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13957483|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13957484|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957485|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
13879200|NCT03597594|Fludarabine|fludarabine|mesh-list
13879201|NCT03597594|Busulfan|busulfan|mesh-list
13879202|NCT03597594|Thiotepa|thiotepa|mesh-list
13879203|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
13879204|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13879205|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879206|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879207|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13879208|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
13879209|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879210|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
13879211|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13879212|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13879213|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
13879214|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13879215|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879216|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
13879217|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
13879218|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879219|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879220|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
13879221|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879222|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879223|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879224|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879225|NCT03597477|Analgesics|analgesics|mesh-ancestor
13879226|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
13879227|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879228|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13879229|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13879230|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879231|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879232|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879233|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879234|NCT03597308|Acetaminophen|acetaminophen|mesh-list
13879235|NCT03597308|Ibuprofen|ibuprofen|mesh-list
13879236|NCT03597308|Oxycodone|oxycodone|mesh-list
13879237|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879238|NCT03597308|Analgesics|analgesics|mesh-ancestor
13879239|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
13879240|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879241|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879242|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
13879243|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13879244|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879245|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13879246|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13879247|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879248|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879249|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879250|NCT03597308|Narcotics|narcotics|mesh-ancestor
13879251|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879252|NCT03597282|Nivolumab|nivolumab|mesh-list
13879253|NCT03597282|Ipilimumab|ipilimumab|mesh-list
13879254|NCT03597282|Poly ICLC|poly iclc|mesh-list
13879255|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13879256|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879257|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13879258|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879259|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
13879260|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
13879261|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879262|NCT03597087|Anesthetics|anesthetics|mesh-list
13879263|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879264|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879265|NCT03597035|Spironolactone|spironolactone|mesh-list
13879266|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13879267|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
13879268|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879269|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879270|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13879271|NCT03597035|Diuretics|diuretics|mesh-ancestor
13879272|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
13879273|NCT03596970|Everolimus|everolimus|mesh-list
13879274|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879275|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13879276|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
13879277|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879278|NCT03596957|Tolvaptan|tolvaptan|mesh-list
13879279|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13879280|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879281|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
13879282|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879283|NCT03596918|Vincristine|vincristine|mesh-list
13879284|NCT03596918|Bleomycin|bleomycin|mesh-list
13879285|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13879286|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879287|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
13879288|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
13879289|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
13879290|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879291|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13879292|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
13879293|NCT03596892|Busulfan|busulfan|mesh-list
13879294|NCT03596892|Decitabine|decitabine|mesh-list
13879295|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13879296|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
13879297|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879298|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13879299|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13879300|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
13879301|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879302|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879303|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13879304|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13879305|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
13879306|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879307|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
13879308|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879309|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879310|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879311|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879312|NCT03596775|Analgesics|analgesics|mesh-ancestor
13879313|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
13879314|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879315|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13879316|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13879317|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879318|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14931404|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
14931405|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
14931406|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
14931407|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931408|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
14931409|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931410|NCT01439178|Bevacizumab|bevacizumab|mesh-list
14931411|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14931412|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931413|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14931414|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14931415|NCT01439178|Growth Substances|growth substances|mesh-ancestor
13879319|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879320|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879321|NCT03596749|Sevelamer|sevelamer|mesh-list
13879322|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
13879323|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
13879324|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879325|NCT03596502|Warfarin|warfarin|mesh-list
13879326|NCT03596502|Anticoagulants|anticoagulants|mesh-list
13879327|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
13879328|NCT03596424|Ketamine|ketamine|mesh-list
13879329|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879330|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879331|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879332|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879333|NCT03596424|Analgesics|analgesics|mesh-ancestor
13879334|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
13879335|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879336|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13879337|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13879338|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879339|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879340|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879341|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879342|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13879343|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879344|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
13879345|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
13879346|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13879347|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13879348|NCT03596294|Rifampin|rifampin|mesh-list
13879349|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13879350|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
13879351|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13879352|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879353|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
13879354|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13879355|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879356|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879357|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13879358|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13879359|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13879360|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13879361|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13879362|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13879363|NCT03596281|Bevacizumab|bevacizumab|mesh-list
13879364|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
13879365|NCT03596281|Doxorubicin|doxorubicin|mesh-list
13879366|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13879367|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13879368|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879369|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13879370|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13879371|NCT03596281|Growth Substances|growth substances|mesh-ancestor
13879372|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879373|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
13879374|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13879375|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13879376|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13879377|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879378|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879379|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
13879380|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13879381|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
13879382|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879383|NCT03596125|Expectorants|expectorants|mesh-ancestor
13879384|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
13879385|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13879386|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
13879387|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879388|NCT03596125|Protective Agents|protective agents|mesh-ancestor
13879389|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879390|NCT03596125|Antidotes|antidotes|mesh-ancestor
14479083|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14754235|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13879391|NCT03596099|Acetic Acid|acetic acid|mesh-list
13879392|NCT03596099|Retinol acetate|retinol acetate|mesh-list
13879393|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13879394|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879395|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13879396|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
13879397|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879398|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13879399|NCT03596099|Protective Agents|protective agents|mesh-ancestor
13879400|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879401|NCT03596060|Fentanyl|fentanyl|mesh-list
13879402|NCT03596060|Morphine|morphine|mesh-list
13879403|NCT03596060|Propofol|propofol|mesh-list
13879404|NCT03596060|Rocuronium|rocuronium|mesh-list
13879405|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879406|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879407|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879408|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879409|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
13879410|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
13879411|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879412|NCT03596060|Narcotics|narcotics|mesh-ancestor
13879413|NCT03596060|Analgesics|analgesics|mesh-ancestor
13879414|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
13879415|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879416|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13879417|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13879418|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13879419|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14754236|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
14754237|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754238|NCT04763135|Mirtazapine|mirtazapine|mesh-list
14754239|NCT04763135|Citalopram|citalopram|mesh-list
14754240|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14754241|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14754242|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14754243|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754244|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754245|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
14754246|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754247|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14754248|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
14754249|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14754250|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14754251|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
14754252|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
14754253|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14754254|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14754255|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754256|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14754257|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13879420|NCT03595982|Nifedipine|nifedipine|mesh-list
13879421|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13879422|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13879423|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879424|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13879425|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879426|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
13879427|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
13879428|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14754258|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13957486|NCT03174847|Hormones|hormones|mesh-ancestor
13957487|NCT03174821|Insulin|insulin|mesh-list
13879429|NCT03595930|Fluticasone|fluticasone|mesh-list
13879430|NCT03595930|Xhance|xhance|mesh-list
13879431|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879432|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13879433|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
13879434|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879435|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879436|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13879437|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
13879438|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
13879439|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13879440|NCT03595852|Cefazolin|cefazolin|mesh-list
13879441|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13879442|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879443|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
13879444|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13879445|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879446|NCT03595514|Dexamethasone|dexamethasone|mesh-list
13879447|NCT03595514|Lidocaine|lidocaine|mesh-list
13879448|NCT03595514|Epinephrine|epinephrine|mesh-list
13879449|NCT03595514|Bupivacaine|bupivacaine|mesh-list
13879450|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879451|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
13879452|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
13879453|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879454|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879455|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13879456|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
13879457|NCT03595514|Hormones|hormones|mesh-ancestor
13879458|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879459|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13879460|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879461|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
13879462|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
13879463|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879464|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
13879465|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13879466|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13879467|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13879468|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13879469|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879470|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13879471|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879472|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879473|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879474|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13879475|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13879476|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13879477|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
13879478|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
13879479|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
13879480|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13879481|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
13879482|NCT03595397|Fentanyl|fentanyl|mesh-list
13879483|NCT03595397|Bupivacaine|bupivacaine|mesh-list
13879484|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
13879485|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
13879486|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879487|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879488|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
13879489|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879490|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879491|NCT03595397|Narcotics|narcotics|mesh-ancestor
13879492|NCT03595397|Analgesics|analgesics|mesh-ancestor
13879493|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13879494|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879495|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
13879496|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13879497|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
13879498|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13879499|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13879500|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879501|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13879502|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
13879503|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879504|NCT03595371|Dapansutrile|dapansutrile|mesh-list
13879505|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879506|NCT03595319|Sevoflurane|sevoflurane|mesh-list
13879507|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13879508|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13879509|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
13879510|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
13879511|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879512|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879513|NCT03595254|Nicotine|nicotine|mesh-list
13879514|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13879515|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
13879516|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879517|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879518|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13879519|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13879520|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
13879521|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879522|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879523|NCT03595189|Cilastatin|cilastatin|mesh-list
13879524|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
13879525|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879526|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879527|NCT03595163|Folic Acid|folic acid|mesh-list
13879528|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
13879529|NCT03595163|Propofol|propofol|mesh-list
13879530|NCT03595163|Sevoflurane|sevoflurane|mesh-list
13879531|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879532|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879533|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879534|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879535|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
13879536|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
13879537|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13879538|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13879539|NCT03595163|Hematinics|hematinics|mesh-ancestor
13879540|NCT03595163|Vitamins|vitamins|mesh-ancestor
13879541|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
13879542|NCT03595085|Streptokinase|streptokinase|mesh-list
13879543|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13879544|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13879545|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879546|NCT03595046|Dexamethasone|dexamethasone|mesh-list
13879547|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
13879548|NCT03595046|Ropivacaine|ropivacaine|mesh-list
13879549|NCT03595046|BB 1101|bb 1101|mesh-list
13879550|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879551|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
13879552|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
13879553|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879554|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879555|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13879556|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
13879557|NCT03595046|Hormones|hormones|mesh-ancestor
13879558|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879559|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13879560|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879561|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
13879562|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879563|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879564|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
13879565|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
13879566|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879567|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
13879568|NCT03594968|Progesterone|progesterone|mesh-list
13879569|NCT03594968|Progestins|progestins|mesh-ancestor
13879570|NCT03594968|Hormones|hormones|mesh-ancestor
13879571|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879572|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879573|NCT03594825|Valsartan|valsartan|mesh-list
13879574|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13879575|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13879576|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13879577|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879578|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
13879579|NCT03594604|Norethindrone|norethindrone|mesh-list
13879580|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
13879581|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
13879582|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13879583|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879584|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879585|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13879586|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13879587|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13879588|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13879589|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13879590|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879591|NCT03594565|Fluticasone|fluticasone|mesh-list
13879592|NCT03594565|Xhance|xhance|mesh-list
13879593|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879594|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13879595|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
13879596|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879597|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879598|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13879599|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
13879600|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
13879601|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13879602|NCT03594513|Dipyrone|dipyrone|mesh-list
13879603|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
13879604|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13879605|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879606|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
13879607|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13879608|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879609|NCT03594513|Analgesics|analgesics|mesh-ancestor
13879610|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
13879611|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879612|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879613|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879614|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13879615|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
13879616|NCT03594461|Aflibercept|aflibercept|mesh-list
13879617|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13879618|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13879619|NCT03594461|Growth Substances|growth substances|mesh-ancestor
13879620|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879621|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
13879622|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879623|NCT03594435|Ibudilast|ibudilast|mesh-list
13879624|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13879625|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
13879626|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879627|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879628|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13879629|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
13879630|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13879631|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879632|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754259|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879633|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13879634|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
13879635|NCT03594396|Durvalumab|durvalumab|mesh-list
13879636|NCT03594396|Olaparib|olaparib|mesh-list
13879637|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13879638|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879639|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13879640|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879641|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957488|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13957489|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13957490|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957491|NCT03174795|Meropenem|meropenem|mesh-list
13957492|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13957493|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963155|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963156|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963538|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
13963539|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963540|NCT03143738|Anesthetics|anesthetics|mesh-list
13963541|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963542|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963543|NCT03143452|Lidocaine|lidocaine|mesh-list
13963544|NCT03143452|Tetracaine|tetracaine|mesh-list
13963545|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13963546|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
13963547|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
14027240|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14027241|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027242|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027243|NCT02737774|Carboplatin|carboplatin|mesh-list
14027244|NCT02737774|Pemetrexed|pemetrexed|mesh-list
14027245|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027246|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027247|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027248|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14027249|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14027250|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
14027251|NCT02737696|Narcotics|narcotics|mesh-ancestor
14027252|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027253|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027254|NCT02737696|Analgesics|analgesics|mesh-ancestor
14027255|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
14027256|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027257|NCT02738229|Valacyclovir|valacyclovir|mesh-list
14027258|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
14027259|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027260|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
14027261|NCT02737605|Esketamine|esketamine|mesh-list
14027262|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027263|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027264|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027265|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027266|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027267|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027268|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027269|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
14027270|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14027271|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
14027272|NCT02737371|Clotrimazole|clotrimazole|mesh-list
14027273|NCT02737371|Miconazole|miconazole|mesh-list
14027274|NCT02737371|Olorofim|olorofim|mesh-list
14027275|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027276|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14027277|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14027278|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14027279|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027280|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027281|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14027282|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
14027283|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027284|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027285|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14027286|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14027287|NCT02737423|Vitamin D|vitamin d|mesh-list
13879642|NCT03594240|Folic Acid|folic acid|mesh-list
13879643|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
13879644|NCT03594240|Vitamins|vitamins|mesh-ancestor
13879645|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
13879646|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879647|NCT03594240|Hematinics|hematinics|mesh-ancestor
13879648|NCT03594214|Vitamin D|vitamin d|mesh-list
13879649|NCT03594214|Vitamins|vitamins|mesh-ancestor
13879650|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
13879651|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879652|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13879653|NCT03594188|Anesthetics|anesthetics|mesh-list
13879654|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879655|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879656|NCT03594149|Levofloxacin|levofloxacin|mesh-list
13879657|NCT03594149|Ofloxacin|ofloxacin|mesh-list
13879658|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13879659|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879660|NCT03594149|Renal Agents|renal agents|mesh-ancestor
13879661|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13879662|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13879663|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13879664|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879665|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879666|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879667|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13879668|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13879669|NCT03593954|Ritonavir|ritonavir|mesh-list
13879670|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13879671|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13879672|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
13879673|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879674|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879675|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13879676|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13879677|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
13879678|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879679|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13879680|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13879681|NCT03593707|Metformin|metformin|mesh-list
13879682|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13879683|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879684|NCT03593668|Metformin|metformin|mesh-list
13879685|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13879686|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879687|NCT03593473|Oxytocin|oxytocin|mesh-list
13879688|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
13879689|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879690|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879691|NCT03593447|Ribavirin|ribavirin|mesh-list
13879692|NCT03593447|Yimitasvir|yimitasvir|mesh-list
13879693|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
13879694|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879695|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
13879696|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879697|NCT03593408|Fentanyl|fentanyl|mesh-list
13879698|NCT03593408|Midazolam|midazolam|mesh-list
13879699|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
13879700|NCT03593408|Morphine|morphine|mesh-list
13879701|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879702|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879703|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879704|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879705|NCT03593408|Analgesics|analgesics|mesh-ancestor
13879706|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
13879707|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879708|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13879709|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13879710|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879711|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879712|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879713|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879714|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879715|NCT03593408|Narcotics|narcotics|mesh-ancestor
13879716|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13879717|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879718|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
13879719|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
13879720|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13879721|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13879722|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13879723|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
13879724|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
13879725|NCT03593317|Spironolactone|spironolactone|mesh-list
13879726|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13879727|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
13879728|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879729|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879730|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13879731|NCT03593317|Diuretics|diuretics|mesh-ancestor
13879732|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
13879733|NCT03593304|Vitamins|vitamins|mesh-list
13879734|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
13879735|NCT03593304|Pyridoxine|pyridoxine|mesh-list
13879736|NCT03593304|Pyridoxal|pyridoxal|mesh-list
13879737|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
13879738|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
13879739|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
13879740|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879741|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13879742|NCT03593291|Dalteparin|dalteparin|mesh-list
13879743|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
13879744|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13879745|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13879746|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879747|NCT03593135|Metformin|metformin|mesh-list
13879748|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13879749|NCT03593135|Acetic Acid|acetic acid|mesh-list
13879750|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13879751|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879752|NCT03593135|Incretins|incretins|mesh-ancestor
13879753|NCT03593135|Hormones|hormones|mesh-ancestor
13879754|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879755|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13879756|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
13879757|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879758|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879759|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13879760|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879761|NCT03593044|Atropine|atropine|mesh-list
13879762|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13879763|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13879764|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13879765|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
13879766|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879767|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879768|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13879769|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
13879770|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
13879771|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
13879772|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13879773|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13879774|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
13879775|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879776|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879777|NCT03592992|Morphine|morphine|mesh-list
13879778|NCT03592992|Hydromorphone|hydromorphone|mesh-list
13879779|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879780|NCT03592992|Narcotics|narcotics|mesh-ancestor
13879781|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879782|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879783|NCT03592992|Analgesics|analgesics|mesh-ancestor
13879784|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
13879785|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879786|NCT03592901|Anesthetics|anesthetics|mesh-list
13879787|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879788|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879789|NCT03592836|Furosemide|furosemide|mesh-list
13879790|NCT03592836|Diuretics|diuretics|mesh-list
13879791|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
13879792|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
14027288|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
13879793|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879794|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14027289|NCT02737423|Vitamins|vitamins|mesh-ancestor
13879795|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879796|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
13879797|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
13879798|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13879799|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13879800|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879801|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879802|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879803|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13879804|NCT03592680|Ascorbic Acid|ascorbic acid|mesh-list
13879805|NCT03592680|Vitamins|vitamins|mesh-ancestor
13879806|NCT03592680|Micronutrients|micronutrients|mesh-ancestor
13879807|NCT03592680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879808|NCT03592680|Antioxidants|antioxidants|mesh-ancestor
13879809|NCT03592680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879810|NCT03592680|Protective Agents|protective agents|mesh-ancestor
13879811|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
13879812|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13879813|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879814|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13879815|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879816|NCT03592576|Venetoclax|venetoclax|mesh-list
13879817|NCT03592576|Navitoclax|navitoclax|mesh-list
13879818|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879819|NCT03592537|Fentanyl|fentanyl|mesh-list
13879820|NCT03592537|Midazolam|midazolam|mesh-list
13879821|NCT03592537|Bupivacaine|bupivacaine|mesh-list
13879822|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
13879823|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
13879824|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879825|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879826|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
13879827|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879828|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879829|NCT03592537|Narcotics|narcotics|mesh-ancestor
13879830|NCT03592537|Analgesics|analgesics|mesh-ancestor
13879831|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13879832|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13879833|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
13879834|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13879835|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13879836|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13879837|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13879838|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
13879839|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
13879840|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879841|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957494|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13957495|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13957496|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957497|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13957498|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957499|NCT03174561|Choline|choline|mesh-list
13957500|NCT03174561|Silymarin|silymarin|mesh-list
13957501|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
13957502|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13957503|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
13957504|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957505|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957506|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13957507|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
13957508|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
13957509|NCT03174561|Protective Agents|protective agents|mesh-ancestor
13957510|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957511|NCT03174782|Bupivacaine|bupivacaine|mesh-list
13957512|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
13957513|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
13957514|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957515|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957516|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
13957517|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957518|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
14470862|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767178|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13957519|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13879842|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
13879843|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
13879844|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13879845|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879846|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13879847|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13879848|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
13879849|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13879850|NCT03592485|Acetaminophen|acetaminophen|mesh-list
13879851|NCT03592485|Oxycodone|oxycodone|mesh-list
13879852|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13879853|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879854|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13879855|NCT03592485|Analgesics|analgesics|mesh-ancestor
13879856|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
13879857|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879858|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
13879859|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13879860|NCT03592485|Narcotics|narcotics|mesh-ancestor
14754260|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14754261|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14754262|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14754263|NCT04762875|Plerixafor|plerixafor|mesh-list
14754264|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14754265|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14754266|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
14754267|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879861|NCT03592472|Abexinostat|abexinostat|mesh-list
13879862|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13879863|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879864|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879865|NCT03592342|Clobetasol|clobetasol|mesh-list
13879866|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879867|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
13879868|NCT03592342|Hormones|hormones|mesh-ancestor
13879869|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879870|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879871|NCT03592277|Vitamins|vitamins|mesh-list
13879872|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
13879873|NCT03592277|Thiamine|thiamine|mesh-list
13879874|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
13879875|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879876|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
14754268|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14754269|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14754270|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754271|NCT04756726|Dexamethasone|dexamethasone|mesh-list
14754272|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754273|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
14754274|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
13879877|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879878|NCT03592277|Protective Agents|protective agents|mesh-ancestor
14754275|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879879|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
13879880|NCT03592199|Sunitinib|sunitinib|mesh-list
13879881|NCT03592199|Axitinib|axitinib|mesh-list
13879882|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879883|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13879884|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13879885|NCT03592199|Growth Substances|growth substances|mesh-ancestor
13879886|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879887|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
13879888|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13879889|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879890|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879891|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13879892|NCT03592082|Bismuth|bismuth|mesh-list
13879893|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
13879894|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879895|NCT03592082|Antacids|antacids|mesh-ancestor
13879896|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879897|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13879898|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
13879899|NCT03592069|Amoxicillin|amoxicillin|mesh-list
13879900|NCT03592069|Metronidazole|metronidazole|mesh-list
13879901|NCT03592069|Clarithromycin|clarithromycin|mesh-list
13879902|NCT03592069|Esomeprazole|esomeprazole|mesh-list
13879903|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13879904|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13879905|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13879906|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13879907|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13879908|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13879909|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13879910|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879911|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879912|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13879913|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13879914|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13879915|NCT03591991|Empagliflozin|empagliflozin|mesh-list
13879916|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13879917|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879918|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13879919|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879920|NCT03591913|Misoprostol|misoprostol|mesh-list
13879921|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13879922|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
13879923|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879924|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879925|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13879926|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13879927|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
13879928|NCT03591900|Insulin|insulin|mesh-list
13879929|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13879930|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879931|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13879932|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13879933|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13879934|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13879935|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13879936|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
13879937|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13879938|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879939|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879940|NCT03591861|Carmustine|carmustine|mesh-list
13879941|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13879942|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
13879943|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879944|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879945|NCT03591757|Tolcapone|tolcapone|mesh-list
13879946|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13879947|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13879948|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13879949|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027290|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
13879950|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879951|NCT03591744|Dexamethasone|dexamethasone|mesh-list
14169206|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13879952|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
13879953|NCT03591744|Doxorubicin|doxorubicin|mesh-list
13879954|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13879955|NCT03591744|Lenalidomide|lenalidomide|mesh-list
13879956|NCT03591744|Bortezomib|bortezomib|mesh-list
13879957|NCT03591744|Daratumumab|daratumumab|mesh-list
13879958|NCT03591744|Ichthammol|ichthammol|mesh-list
13879959|NCT03591744|BB 1101|bb 1101|mesh-list
13879960|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13879961|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
13879962|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
13879963|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13879964|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879965|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13879966|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
13879967|NCT03591744|Hormones|hormones|mesh-ancestor
13879968|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13879969|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13879970|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879971|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13879972|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13879973|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14754276|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754277|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754278|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
13879974|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13879975|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879976|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
13879977|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13879978|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13879979|NCT03591744|Growth Substances|growth substances|mesh-ancestor
13879980|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
13879981|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
13879982|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
13879983|NCT03591679|Oxytocin|oxytocin|mesh-list
13879984|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
13879985|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13879986|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13879987|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13879988|NCT03591575|Deferiprone|deferiprone|mesh-list
13879989|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13879990|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
13879991|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
13879992|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13879993|NCT03591549|Fulvestrant|fulvestrant|mesh-list
13879994|NCT03591549|Goserelin|goserelin|mesh-list
13879995|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13879996|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13879997|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13879998|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13879999|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
13880000|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880001|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880002|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
13880003|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13880004|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754279|NCT04756726|Hormones|hormones|mesh-ancestor
14754280|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754281|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754282|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754283|NCT04745975|Gemcitabine|gemcitabine|mesh-list
14754284|NCT04745975|Paclitaxel|paclitaxel|mesh-list
14754285|NCT04745975|Vinorelbine|vinorelbine|mesh-list
14754286|NCT04745975|Capecitabine|capecitabine|mesh-list
14754287|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14754288|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754289|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
13880005|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880006|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13880007|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13880008|NCT03591536|Protective Agents|protective agents|mesh-ancestor
13880009|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880010|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
13880011|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14754290|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
14754291|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
13880012|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
13880013|NCT03591471|Prednisone|prednisone|mesh-list
13880014|NCT03591471|Benazepril|benazepril|mesh-list
13880015|NCT03591471|Heparin|heparin|mesh-list
13880016|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13880017|NCT03591471|Tinzaparin|tinzaparin|mesh-list
13880018|NCT03591471|Dalteparin|dalteparin|mesh-list
13880019|NCT03591471|Calcium heparin|calcium heparin|mesh-list
13880020|NCT03591471|Dipyridamole|dipyridamole|mesh-list
13880021|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880022|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880023|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
13880024|NCT03591471|Hormones|hormones|mesh-ancestor
13880025|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880026|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13880027|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880028|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
13880029|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13880030|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13880031|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880032|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13880033|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
13880034|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880035|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13880036|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13880037|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13880038|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
13880039|NCT03591341|Melatonin|melatonin|mesh-list
13880040|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
13880041|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931416|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931417|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
14931418|NCT01439191|Vinorelbine|vinorelbine|mesh-list
14931419|NCT01439191|Antibodies|antibodies|mesh-list
14931420|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
14931421|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931422|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14931423|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931424|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
14931425|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
13880042|NCT03591341|Protective Agents|protective agents|mesh-ancestor
13880043|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880044|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880045|NCT03591289|Bromides|bromides|mesh-list
13880046|NCT03591289|Rocuronium|rocuronium|mesh-list
13880047|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
13880048|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13880049|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13880050|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13880051|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880052|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880053|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
13880054|NCT03591172|Propolis|propolis|mesh-list
13880055|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880056|NCT03591003|Antibodies|antibodies|mesh-list
14931426|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
13880057|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
13880058|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
13880059|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880060|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
13880061|NCT03590912|Cetirizine|cetirizine|mesh-list
13880062|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13880063|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
13880064|NCT03590912|Prednisolone|prednisolone|mesh-list
13880065|NCT03590912|Phenylephrine|phenylephrine|mesh-list
13880066|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
13880067|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
13880068|NCT03590912|Levocetirizine|levocetirizine|mesh-list
13880069|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
13880070|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
13880071|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880072|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880073|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
13880074|NCT03590912|Hormones|hormones|mesh-ancestor
13880075|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880076|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880077|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13880078|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880079|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
13880080|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880081|NCT03590912|Protective Agents|protective agents|mesh-ancestor
13880082|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
13880083|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13880084|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13880085|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
13880086|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880087|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880088|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13880089|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13880090|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
13880091|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
13880092|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13880093|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
13880094|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13880095|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
13880096|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13957520|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957521|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
13957522|NCT03174483|Fluticasone|fluticasone|mesh-list
13957523|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957524|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13957525|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
13957526|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957527|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957528|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13957529|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
13957530|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
13957531|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13957532|NCT03174457|Micafungin|micafungin|mesh-list
13957533|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
13957534|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957535|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
13957536|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13957537|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957538|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957539|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957540|NCT03174678|Analgesics|analgesics|mesh-ancestor
13957541|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
13957542|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957543|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13957544|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13957545|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13957546|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
13957547|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957548|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957549|NCT03174171|Everolimus|everolimus|mesh-list
13957550|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957551|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13957552|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
13957553|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957554|NCT03174080|Fluorides|fluorides|mesh-list
13957555|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
13957556|NCT03174080|Protective Agents|protective agents|mesh-ancestor
13880097|NCT03590873|Vasopressins|vasopressins|mesh-list
13880098|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
13880099|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880100|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
13880101|NCT03590873|Coagulants|coagulants|mesh-ancestor
13880102|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13880103|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13880104|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
13880105|NCT03590808|Vaccines|vaccines|mesh-list
13880106|NCT03590808|Immunologic Factors|immunologic factors|mesh-ancestor
13880107|NCT03590808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880108|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13880109|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13880110|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880111|NCT03590626|Dulaglutide|dulaglutide|mesh-list
13880112|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13880113|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880114|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
13880115|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880116|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
13880117|NCT03590587|Hormones|hormones|mesh-ancestor
13880118|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880119|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880120|NCT03590496|Calcium|calcium|mesh-list
13880121|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13880122|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880123|NCT03590444|Ranibizumab|ranibizumab|mesh-list
13880124|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13880125|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13880126|NCT03590444|Growth Substances|growth substances|mesh-ancestor
13880127|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880128|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
13880129|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880130|NCT03590431|Iodine|iodine|mesh-list
13880131|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
13880132|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13880133|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880134|NCT03590431|Trace Elements|trace elements|mesh-ancestor
13880135|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
13880136|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880137|NCT03590275|Folfirinox|folfirinox|mesh-list
13880138|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880139|NCT03590262|Metformin|metformin|mesh-list
14027291|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027292|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14027293|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14754292|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027294|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
14027295|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
14027296|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
14027297|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027298|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027299|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
14027300|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027301|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14027302|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14027303|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14027304|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
14027305|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027306|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14754293|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880140|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13880141|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880142|NCT03590210|Nivolumab|nivolumab|mesh-list
13880143|NCT03590210|Trabectedin|trabectedin|mesh-list
13880144|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880145|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880146|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13880147|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880148|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13880149|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
13880150|NCT03590197|Melatonin|melatonin|mesh-list
13880151|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
13880152|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880153|NCT03590197|Protective Agents|protective agents|mesh-ancestor
13880154|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880155|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880156|NCT03590171|Bortezomib|bortezomib|mesh-list
13880157|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880158|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
13880159|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13880160|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880161|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
13880162|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13880163|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13880164|NCT03590080|Prednisolone|prednisolone|mesh-list
13880165|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
13880166|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13880167|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
13880168|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880169|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
13880170|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
13880171|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880172|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880173|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13880174|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
13880175|NCT03590080|Hormones|hormones|mesh-ancestor
13880176|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880177|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13880178|NCT03590080|Protective Agents|protective agents|mesh-ancestor
13880179|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13880180|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880181|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
13880182|NCT03590054|Abexinostat|abexinostat|mesh-list
13880183|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880184|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880185|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13880186|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880187|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880188|NCT03589898|Gabapentin|gabapentin|mesh-list
13880189|NCT03589898|Analgesics|analgesics|mesh-ancestor
13880190|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
13880191|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880192|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880193|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
13880194|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13880195|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13880196|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880197|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13880198|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13880199|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13880200|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880201|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880202|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
13880203|NCT03589833|Methotrexate|methotrexate|mesh-list
13880204|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13880205|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
13880206|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13880207|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880208|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880209|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
13880210|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880211|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880212|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
13880213|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880214|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13880215|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13880216|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
13880217|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880218|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13880219|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
13880220|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
13880221|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880222|NCT03589690|Protective Agents|protective agents|mesh-ancestor
13880223|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880224|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
13880225|NCT03589690|Vitamins|vitamins|mesh-ancestor
13880226|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
13880227|NCT03589547|Durvalumab|durvalumab|mesh-list
13963157|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13880228|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880229|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880230|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
13880231|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13880232|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
13880233|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880234|NCT03589495|Expectorants|expectorants|mesh-ancestor
13880235|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
13880236|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13880237|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
13880238|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880239|NCT03589495|Protective Agents|protective agents|mesh-ancestor
13880240|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880241|NCT03589495|Antidotes|antidotes|mesh-ancestor
13880242|NCT03589430|Protein C|protein c|mesh-list
13880243|NCT03589430|Antithrombins|antithrombins|mesh-list
13880244|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
13880245|NCT03589430|Protein S|protein s|mesh-list
13880246|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13880247|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
13880248|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880249|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880250|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
13880251|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13880252|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13957557|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957558|NCT03174236|Metronidazole|metronidazole|mesh-list
13957559|NCT03174236|Gentamicins|gentamicins|mesh-list
13957560|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
13957561|NCT03174236|Penicillins|penicillins|mesh-list
13957562|NCT03174236|Penicillin G|penicillin g|mesh-list
13957563|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
13957564|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
13957565|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957566|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13957567|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13957568|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13957569|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13957570|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957571|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957572|NCT03174288|Spironolactone|spironolactone|mesh-list
13957573|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13957574|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
13957575|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957576|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957577|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13957578|NCT03174288|Diuretics|diuretics|mesh-ancestor
13957579|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
13957589|NCT03174353|Lanreotide|lanreotide|mesh-list
13957590|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957591|NCT03174067|Clonidine|clonidine|mesh-list
13957592|NCT03174067|Buprenorphine|buprenorphine|mesh-list
13957593|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13957594|NCT03174067|Narcotics|narcotics|mesh-ancestor
13957595|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957596|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957597|NCT03174067|Analgesics|analgesics|mesh-ancestor
13957598|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
13957599|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957600|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14027307|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14027308|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957601|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13957602|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
14027309|NCT02737254|Oxytocin|oxytocin|mesh-list
13957603|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
13957604|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13957605|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13880253|NCT03589222|Dexamethasone|dexamethasone|mesh-list
13880254|NCT03589222|Bortezomib|bortezomib|mesh-list
13880255|NCT03589222|Daratumumab|daratumumab|mesh-list
13880256|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880257|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
13880258|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
13880259|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880260|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880261|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13880262|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
13880263|NCT03589222|Hormones|hormones|mesh-ancestor
13880264|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880265|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13880266|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880267|NCT03589066|Rotigotine|rotigotine|mesh-list
13880268|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
13880269|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
13880270|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880271|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880272|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880273|NCT03589040|Darunavir|darunavir|mesh-list
13880274|NCT03589040|Rilpivirine|rilpivirine|mesh-list
13880275|NCT03589040|Etonogestrel|etonogestrel|mesh-list
13880276|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13880277|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13880278|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
13880279|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880280|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880281|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13880282|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13880283|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
13880284|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880285|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13880286|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13880287|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13880288|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
13880289|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13880290|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880291|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13880292|NCT03589027|Ritonavir|ritonavir|mesh-list
13880293|NCT03589027|Darunavir|darunavir|mesh-list
13880294|NCT03589027|Rilpivirine|rilpivirine|mesh-list
13880295|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
13880296|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13880297|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13880298|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
13880299|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880300|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880301|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13880302|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13880303|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
13880304|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880305|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13880306|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13880307|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13880308|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
13880309|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13880310|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880311|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13880312|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13880313|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13880314|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13880315|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13880316|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
13880317|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13880318|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880319|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880320|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880321|NCT03588988|Analgesics|analgesics|mesh-ancestor
13880322|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
13880323|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880324|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13880325|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13880326|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13880327|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
13880328|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880329|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880330|NCT03588936|Nivolumab|nivolumab|mesh-list
13880331|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880332|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880333|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13880334|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880335|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13880336|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13880337|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880338|NCT03588767|Vitamin D|vitamin d|mesh-list
13880339|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
13880340|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
13880341|NCT03588767|Vitamins|vitamins|mesh-list
13880342|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
13880343|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
13880344|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880345|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13880346|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13880347|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
13880348|NCT03588767|Hormones|hormones|mesh-ancestor
13880349|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880350|NCT03588715|Interferons|interferons|mesh-list
13880351|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
14470863|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14470864|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
14470865|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14470866|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470867|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14470868|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14470869|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14470870|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14470871|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14754294|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
14754295|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
13880352|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
13880353|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
13880354|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
13880355|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880356|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
13880357|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880358|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
13880359|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880360|NCT03588689|Ropivacaine|ropivacaine|mesh-list
13880361|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
13880362|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
13880363|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880364|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880365|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
14754296|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754297|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754298|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754299|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
14754300|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754301|NCT04745728|Prednisone|prednisone|mesh-list
14754302|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
14754303|NCT04745728|Rituximab|rituximab|mesh-list
13880366|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754304|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13880367|NCT03588676|Melatonin|melatonin|mesh-list
13880368|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
13880369|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880370|NCT03588676|Protective Agents|protective agents|mesh-ancestor
13880371|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880372|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880373|NCT03588611|Hirudins|hirudins|mesh-list
13880374|NCT03588611|Bivalirudin|bivalirudin|mesh-list
13880375|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
13880376|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13880377|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
13880378|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880379|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880380|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
13880381|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13880382|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13880383|NCT03588533|Capecitabine|capecitabine|mesh-list
13880384|NCT03588533|Trastuzumab|trastuzumab|mesh-list
13880385|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880386|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880387|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
13880388|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880389|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880390|NCT03588494|Endostar protein|endostar protein|mesh-list
13880391|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13880392|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13880393|NCT03588494|Growth Substances|growth substances|mesh-ancestor
13880394|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880395|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
13880396|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880397|NCT03588429|Sevoflurane|sevoflurane|mesh-list
13880398|NCT03588429|Isoflurane|isoflurane|mesh-list
13880399|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13880400|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13880401|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
13880402|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
13880403|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880404|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880405|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
13880406|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13880407|NCT03588351|Chitosan|chitosan|mesh-list
13880408|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13880409|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931427|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931428|NCT01439230|Donepezil|donepezil|mesh-list
13880410|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
13880411|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
13880412|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13880413|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13880414|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
13880415|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880416|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13880417|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
13880418|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
13880419|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
13880420|NCT03588351|Coagulants|coagulants|mesh-ancestor
13880421|NCT03588338|Acetaminophen|acetaminophen|mesh-list
13880422|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880423|NCT03588338|Analgesics|analgesics|mesh-ancestor
13880424|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
13880425|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880426|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880427|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
13880428|NCT03588273|Amoxicillin|amoxicillin|mesh-list
13880429|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13880430|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880431|NCT03588091|Docetaxel|docetaxel|mesh-list
13880432|NCT03588091|Trastuzumab|trastuzumab|mesh-list
13880433|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880434|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
13880435|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
13880436|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
13880437|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880438|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027310|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
14931429|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14027311|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13880439|NCT03588078|Azacitidine|azacitidine|mesh-list
13880440|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880441|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
13880442|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880443|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880444|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880445|NCT03588039|Paclitaxel|paclitaxel|mesh-list
13880446|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
13880447|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13880448|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880449|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
13880450|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
13880451|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
13880452|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880453|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880454|NCT03587961|Ivacaftor|ivacaftor|mesh-list
13880455|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13880456|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13880457|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880458|NCT03587779|Sevoflurane|sevoflurane|mesh-list
13880459|NCT03587779|Desflurane|desflurane|mesh-list
13880460|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13880461|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13880462|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
13880463|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
13880464|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880465|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880466|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13880467|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880468|NCT03587662|Gemcitabine|gemcitabine|mesh-list
13880469|NCT03587662|Doxorubicin|doxorubicin|mesh-list
13880470|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13880471|NCT03587662|Daunorubicin|daunorubicin|mesh-list
13880472|NCT03587662|Ixazomib|ixazomib|mesh-list
13880473|NCT03587662|Glycine|glycine|mesh-list
13880474|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880475|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
13880476|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880477|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880478|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
13880479|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880480|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880481|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13880482|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
13880483|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880484|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13880485|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13880486|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13880487|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
13880488|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
13880489|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880490|NCT03587610|Vaccines|vaccines|mesh-list
13880491|NCT03587610|Immunologic Factors|immunologic factors|mesh-ancestor
13880492|NCT03587610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957606|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13957607|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
13957608|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957609|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957610|NCT03174041|Itraconazole|itraconazole|mesh-list
13957611|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
13957612|NCT03174041|Midazolam|midazolam|mesh-list
13957613|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13957614|NCT03174041|Simvastatin|simvastatin|mesh-list
13957615|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13957616|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13957617|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957618|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957619|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13957620|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13957621|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13957622|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13957623|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
13957624|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
13957625|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
13957626|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
13957627|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957628|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880493|NCT03587558|Flecainide|flecainide|mesh-list
13880494|NCT03587558|Carvedilol|carvedilol|mesh-list
13880495|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13880496|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13880497|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
13880498|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880499|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880500|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880501|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13880502|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
13880503|NCT03587558|Protective Agents|protective agents|mesh-ancestor
13880504|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13880505|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13880506|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13880507|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
13880508|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13880509|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13880510|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13880511|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13880512|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13880513|NCT03587441|Neostigmine|neostigmine|mesh-list
13880514|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13880515|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880516|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880517|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
13880518|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880519|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880520|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13880521|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
13880522|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880523|NCT03587324|Clopidogrel|clopidogrel|mesh-list
13880524|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13880525|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13880526|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13880527|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13880528|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
13880529|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880530|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880531|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880532|NCT03587285|Goserelin|goserelin|mesh-list
13880533|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
13880534|NCT03587285|Bicalutamide|bicalutamide|mesh-list
13880535|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13880536|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880537|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13880538|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880539|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880540|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
13880541|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880542|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880543|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13880544|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
13880545|NCT03587220|Lidocaine|lidocaine|mesh-list
13880546|NCT03587220|Capsaicin|capsaicin|mesh-list
13880547|NCT03587220|Histamine|histamine|mesh-list
13880548|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
13880549|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
13880550|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880551|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880552|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
13880553|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880554|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13880555|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13880556|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13880557|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13880558|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880559|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
13880560|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
13880561|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
13880562|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
13880563|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880564|NCT03587194|Apremilast|apremilast|mesh-list
13957629|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13880565|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13880566|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880567|NCT03587194|Analgesics|analgesics|mesh-ancestor
13880568|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
13880569|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880570|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880571|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880572|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880573|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13880574|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13880575|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880576|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880577|NCT03587129|Apatinib|apatinib|mesh-list
13880578|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880579|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13880580|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880581|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880582|NCT03587077|Isosorbide|isosorbide|mesh-list
13880583|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13880584|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13880585|NCT03587077|Misoprostol|misoprostol|mesh-list
13880586|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13880587|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
13880588|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13880589|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880590|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13880591|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13880592|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
13880593|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13880594|NCT03587077|Diuretics|diuretics|mesh-ancestor
14027312|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027313|NCT02737202|Saracatinib|saracatinib|mesh-list
14027314|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027315|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027316|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027317|NCT02737228|Gemcitabine|gemcitabine|mesh-list
14027318|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14027319|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14027320|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
14027321|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027322|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027323|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
14027324|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027325|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027326|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14027327|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
14027328|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027329|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14027330|NCT02737124|Acetaminophen|acetaminophen|mesh-list
14027331|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027332|NCT02737124|Analgesics|analgesics|mesh-ancestor
14027333|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
14027334|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027335|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027336|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
14027337|NCT02737150|Anesthetics|anesthetics|mesh-list
14027338|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027339|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027340|NCT02737059|Codeine|codeine|mesh-list
14027341|NCT02737059|Naloxegol|naloxegol|mesh-list
14754305|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
14754306|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754307|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880595|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
14027342|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14027343|NCT02737059|Narcotics|narcotics|mesh-ancestor
14027344|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027345|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027346|NCT02737059|Analgesics|analgesics|mesh-ancestor
14027347|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
14027348|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027349|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
14027350|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
14027351|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14027352|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
13880596|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
13880597|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13880598|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880599|NCT03587038|Temozolomide|temozolomide|mesh-list
13880600|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13880601|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
13880602|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880603|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880604|NCT03587025|Amitriptyline|amitriptyline|mesh-list
13880605|NCT03587025|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
13880606|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13880607|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
13880608|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13880609|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880610|NCT03587025|Analgesics|analgesics|mesh-ancestor
13880611|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
13880612|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880613|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880614|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13880615|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13880616|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13880617|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880618|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
13880619|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880620|NCT03587025|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13880621|NCT03587025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13880622|NCT03587025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880623|NCT03586947|Vitamin D|vitamin d|mesh-list
13880624|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
13880625|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
13880626|NCT03586947|Vitamins|vitamins|mesh-list
13880627|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
13880628|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880629|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13880630|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13880631|NCT03586934|Acetaminophen|acetaminophen|mesh-list
13880632|NCT03586934|Celecoxib|celecoxib|mesh-list
13880633|NCT03586934|Ketorolac|ketorolac|mesh-list
13880634|NCT03586934|Meloxicam|meloxicam|mesh-list
13880635|NCT03586934|Morphine|morphine|mesh-list
13880636|NCT03586934|Oxycodone|oxycodone|mesh-list
13880637|NCT03586934|Tramadol|tramadol|mesh-list
14027353|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14470872|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
14754308|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14470873|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13880638|NCT03586934|Hydrocodone|hydrocodone|mesh-list
13880639|NCT03586934|Ropivacaine|ropivacaine|mesh-list
13880640|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13880641|NCT03586934|Narcotics|narcotics|mesh-ancestor
13880642|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880643|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880644|NCT03586934|Analgesics|analgesics|mesh-ancestor
13880645|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
13880646|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880647|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
13880648|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
13880649|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880650|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
13880651|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13880652|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880653|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880654|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13880655|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13880656|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880657|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880658|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
13880659|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
13880660|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13880661|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13880662|NCT03586869|Leucovorin|leucovorin|mesh-list
13880663|NCT03586869|Paclitaxel|paclitaxel|mesh-list
13880664|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
13880665|NCT03586869|Bevacizumab|bevacizumab|mesh-list
13880666|NCT03586869|Fluorouracil|fluorouracil|mesh-list
13880667|NCT03586869|Capecitabine|capecitabine|mesh-list
13880668|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
13880669|NCT03586869|Avelumab|avelumab|mesh-list
13880670|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13880671|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880672|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
13880673|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
13880674|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
13880675|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880676|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13880677|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
13880678|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880679|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880680|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13880681|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
13880682|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13880683|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880684|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13880685|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13880686|NCT03586869|Growth Substances|growth substances|mesh-ancestor
13880687|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
13880688|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
13880689|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880690|NCT03586869|Antidotes|antidotes|mesh-ancestor
13880691|NCT03586869|Protective Agents|protective agents|mesh-ancestor
13880692|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
13880693|NCT03586869|Vitamins|vitamins|mesh-ancestor
13880694|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
13880695|NCT03586817|Palonosetron|palonosetron|mesh-list
13880696|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
13880697|NCT03586817|Aprepitant|aprepitant|mesh-list
13880698|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
13880699|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
13880700|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880701|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880702|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13880703|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13880704|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13880705|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
13880706|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880707|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880708|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14027354|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
14754309|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
13880709|NCT03586791|Anesthetics|anesthetics|mesh-list
13880710|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880711|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880712|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13880713|NCT03586674|Fenofibrate|fenofibrate|mesh-list
13880714|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13880715|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
13880716|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880717|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13880718|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13880719|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13880720|NCT03586661|Niraparib|niraparib|mesh-list
13880721|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13880722|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880723|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880724|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880725|NCT03586466|Buprenorphine|buprenorphine|mesh-list
13880726|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13880727|NCT03586466|Naloxone|naloxone|mesh-list
13880728|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13880729|NCT03586466|Narcotics|narcotics|mesh-ancestor
13880730|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880731|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880732|NCT03586466|Analgesics|analgesics|mesh-ancestor
13880733|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
13880734|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880735|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13880736|NCT03586453|Osimertinib|osimertinib|mesh-list
13880737|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880738|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13880739|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880740|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880741|NCT03586414|Ubiquinone|ubiquinone|mesh-list
13880742|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
13880743|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880744|NCT03586323|Lidocaine|lidocaine|mesh-list
13880745|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
13880746|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
13880747|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880748|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880749|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
13880750|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880751|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13880752|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13880753|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13880754|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13880755|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880756|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
13880757|NCT03586219|Narcotics|narcotics|mesh-ancestor
13880758|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880759|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880760|NCT03586219|Analgesics|analgesics|mesh-ancestor
13880761|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
13880762|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880763|NCT03586154|Ketamine|ketamine|mesh-list
13880764|NCT03586154|Bupivacaine|bupivacaine|mesh-list
13880765|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
13880766|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
13880767|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880768|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880769|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
13880770|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880771|NCT03586154|Analgesics|analgesics|mesh-ancestor
13880772|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13880773|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13880774|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
13880775|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13880776|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13880777|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880778|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880779|NCT03586089|Diazepam|diazepam|mesh-list
13880780|NCT03586089|Phenobarbital|phenobarbital|mesh-list
13880781|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13880782|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
13880783|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
13880784|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
13880785|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880786|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880787|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957630|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13880788|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13880789|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880790|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13880791|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13880792|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13880793|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13880794|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13880795|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13880796|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
13880797|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
13880798|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
13880799|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
13880800|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880801|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880802|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13880803|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13880804|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13880805|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13880806|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13880807|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
13880808|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470874|NCT02319304|Leucovorin|leucovorin|mesh-list
14470875|NCT02319304|Fluorouracil|fluorouracil|mesh-list
14470876|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
14470877|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
14470878|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880809|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880810|NCT03585998|Cisplatin|cisplatin|mesh-list
13880811|NCT03585998|Etoposide|etoposide|mesh-list
13880812|NCT03585998|Durvalumab|durvalumab|mesh-list
13880813|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880814|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13880815|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13880816|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13880817|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880818|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880819|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13957631|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
13957632|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13957633|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13957634|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957635|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
13957636|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957637|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13957638|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13957639|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13957640|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
13957641|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957642|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13957643|NCT03173898|Anesthetics|anesthetics|mesh-list
13957644|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957645|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957646|NCT03173781|Droxidopa|droxidopa|mesh-list
13957647|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13957648|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13957649|NCT03173963|Empagliflozin|empagliflozin|mesh-list
13963158|NCT02070705|Hematinics|hematinics|mesh-ancestor
14027355|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
14931430|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880820|NCT03585894|Ketorolac|ketorolac|mesh-list
13880821|NCT03585894|Sumatriptan|sumatriptan|mesh-list
13880822|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13880823|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880824|NCT03585894|Analgesics|analgesics|mesh-ancestor
13880825|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
13880826|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880827|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880828|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880829|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880830|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13880831|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880832|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880833|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13880834|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13880835|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13880836|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
13880837|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880838|NCT03585829|Prednisolone|prednisolone|mesh-list
13880839|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
13880840|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880841|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
13880842|NCT03585829|Hormones|hormones|mesh-ancestor
13880843|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880844|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880845|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13880846|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880847|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13880848|NCT03585751|Simvastatin|simvastatin|mesh-list
13880849|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880850|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13880851|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13880852|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
13880853|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880854|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13880855|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13880856|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880857|NCT03585738|Folic Acid|folic acid|mesh-list
13880858|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
13880859|NCT03585738|Inositol|inositol|mesh-list
13880860|NCT03585738|Hematinics|hematinics|mesh-ancestor
13880861|NCT03585738|Vitamins|vitamins|mesh-ancestor
13880862|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
13880863|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880864|NCT03585725|Ribavirin|ribavirin|mesh-list
13880865|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
13880866|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880867|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
13880868|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880869|NCT03585686|Cytarabine|cytarabine|mesh-list
13880870|NCT03585686|Vemurafenib|vemurafenib|mesh-list
13880871|NCT03585686|Cladribine|cladribine|mesh-list
13880872|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880873|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
13880874|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880875|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027356|NCT02736604|Anesthetics|anesthetics|mesh-list
14027357|NCT02736604|Sevoflurane|sevoflurane|mesh-list
14027358|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027359|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027360|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14027361|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14027362|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
14027363|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027364|NCT02736604|Analgesics|analgesics|mesh-ancestor
14027365|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
14027366|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027367|NCT02736448|Capecitabine|capecitabine|mesh-list
14027368|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14027369|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
14027370|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027371|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027372|NCT02736591|Hormones|hormones|mesh-list
14027373|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14182910|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
13880876|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
13880877|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880878|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13880879|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
13880880|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880881|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13880882|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880883|NCT03585673|Docetaxel|docetaxel|mesh-list
13880884|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
13880885|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880886|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
13880887|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
13880888|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
13880889|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880890|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13880891|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13880892|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13880893|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13880894|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880895|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
13880896|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880897|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880898|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13880899|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880900|NCT03585556|Prednisolone|prednisolone|mesh-list
13880901|NCT03585556|Bevacizumab|bevacizumab|mesh-list
13880902|NCT03585556|Ranibizumab|ranibizumab|mesh-list
13880903|NCT03585556|Aflibercept|aflibercept|mesh-list
13880904|NCT03585556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880905|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880906|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13880907|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13880908|NCT03585556|Growth Substances|growth substances|mesh-ancestor
13880909|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880910|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
13880911|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880912|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
13880913|NCT03585556|Hormones|hormones|mesh-ancestor
13880914|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13880915|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13880916|NCT03585530|Raltitrexed|raltitrexed|mesh-list
13880917|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880918|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
13880919|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880920|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13880921|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13880922|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880923|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
13880924|NCT03585465|Capecitabine|capecitabine|mesh-list
13880925|NCT03585465|Nivolumab|nivolumab|mesh-list
13880926|NCT03585465|Vinblastine|vinblastine|mesh-list
13880927|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13880928|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
13880929|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880930|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880931|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13880932|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
13880933|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880934|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931431|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931432|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
14931433|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931434|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931435|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
14931436|NCT01439243|Donepezil|donepezil|mesh-list
14931437|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14931438|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931439|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931440|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
14931441|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931442|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931443|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
14931444|NCT01439399|Lidocaine|lidocaine|mesh-list
13880935|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14931445|NCT01439399|Ketamine|ketamine|mesh-list
14931446|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
14931447|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
14931448|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931449|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931450|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
14931451|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880936|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13880937|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
13880938|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13880939|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13880940|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13880941|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
13880942|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
13880943|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
13880944|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
13880945|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13880946|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880947|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880948|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880949|NCT03585452|Analgesics|analgesics|mesh-ancestor
13880950|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
13880951|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880952|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13880953|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13880954|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13880955|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
13880956|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13880957|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880958|NCT03585426|Vancomycin|vancomycin|mesh-list
13880959|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13880960|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13880961|NCT03585413|Micronutrients|micronutrients|mesh-list
13880962|NCT03585413|Trace Elements|trace elements|mesh-list
13880963|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880964|NCT03585374|Acetaminophen|acetaminophen|mesh-list
13880965|NCT03585374|Ketoprofen|ketoprofen|mesh-list
13880966|NCT03585374|Morphine|morphine|mesh-list
13880967|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
13880968|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13880969|NCT03585374|Narcotics|narcotics|mesh-ancestor
13880970|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13880971|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880972|NCT03585374|Analgesics|analgesics|mesh-ancestor
13880973|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
13880974|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880975|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13880976|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
13880977|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13880978|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13880979|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13880980|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13880981|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13880982|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880983|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13880984|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
13880985|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
13880986|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
13880987|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13880988|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13880989|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13880990|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
13880991|NCT03585179|Hydroquinone|hydroquinone|mesh-list
13880992|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13880993|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13880994|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13880995|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
13880996|NCT03585179|Coagulants|coagulants|mesh-ancestor
13880997|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
13880998|NCT03585179|Protective Agents|protective agents|mesh-ancestor
13880999|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881000|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13881001|NCT03585140|Doxycycline|doxycycline|mesh-list
13881002|NCT03585140|Adapalene|adapalene|mesh-list
13881003|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13881004|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881005|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
13881006|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13881007|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13881008|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881009|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881010|NCT03585140|Analgesics|analgesics|mesh-ancestor
13881011|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
13881012|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881013|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881014|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881015|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881016|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
13881017|NCT03585101|Grazoprevir|grazoprevir|mesh-list
13881018|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
13881019|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881020|NCT03585062|Paclitaxel|paclitaxel|mesh-list
13881021|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881022|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881023|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881024|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881025|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881026|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881027|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13881028|NCT03585036|Tramadol|tramadol|mesh-list
13881029|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13881030|NCT03585036|Narcotics|narcotics|mesh-ancestor
13881031|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881032|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881033|NCT03585036|Analgesics|analgesics|mesh-ancestor
13881034|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
13881035|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881036|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881037|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881038|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881039|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881040|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
13881041|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
13881042|NCT03584984|Coagulants|coagulants|mesh-ancestor
13881043|NCT03584919|Doxycycline|doxycycline|mesh-list
13881044|NCT03584919|Cefuroxime|cefuroxime|mesh-list
13881045|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
13881046|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13881047|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881048|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
13881049|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13881050|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13881051|NCT03584854|Methylergonovine|methylergonovine|mesh-list
13881052|NCT03584854|Carboprost|carboprost|mesh-list
13881053|NCT03584854|Dinoprost|dinoprost|mesh-list
13881054|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
13881055|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
13881056|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13881057|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881058|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13881059|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
13881060|NCT03584841|Pilocarpine|pilocarpine|mesh-list
13881061|NCT03584841|Miotics|miotics|mesh-ancestor
13881062|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
13881063|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881064|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881065|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13881066|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13881067|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
13881068|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881069|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881070|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
13881071|NCT03584698|Misoprostol|misoprostol|mesh-list
13881072|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13881073|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
13881074|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13881075|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881076|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13881077|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754310|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881078|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
13881079|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881080|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881081|NCT03584698|Analgesics|analgesics|mesh-ancestor
13881082|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
13881083|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881084|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881085|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881086|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13881087|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
13881088|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881089|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13881090|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
13881091|NCT03584529|Vitamin D|vitamin d|mesh-list
13881092|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
13881093|NCT03584529|Vitamins|vitamins|mesh-ancestor
13881094|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
13881095|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881096|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13881097|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13881098|NCT03584373|Acetaminophen|acetaminophen|mesh-list
13881099|NCT03584373|Ketorolac|ketorolac|mesh-list
13881100|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13881101|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
13881102|NCT03584373|Oxycodone|oxycodone|mesh-list
13881103|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881104|NCT03584373|Analgesics|analgesics|mesh-ancestor
13881105|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
13881106|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881107|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881108|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
13881109|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13881110|NCT03584373|Narcotics|narcotics|mesh-ancestor
13881111|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881112|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881113|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881114|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881115|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13881116|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881117|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881118|NCT03584360|Calcitriol|calcitriol|mesh-list
13881119|NCT03584360|Betamethasone|betamethasone|mesh-list
13881120|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
13881121|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13881122|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
13881123|NCT03584360|Calcipotriene|calcipotriene|mesh-list
13881124|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13881125|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881126|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
13881127|NCT03584360|Hormones|hormones|mesh-ancestor
13881128|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13881129|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881130|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13881131|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
13881132|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
13881133|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13881134|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13881135|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881136|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881137|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13881138|NCT03584360|Vitamins|vitamins|mesh-ancestor
13881139|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
13881140|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13957650|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14470879|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881141|NCT03584178|Budesonide|budesonide|mesh-list
13881142|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881143|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13881144|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
13881145|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881146|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881147|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13881148|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
13881149|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
13881150|NCT03584178|Hormones|hormones|mesh-ancestor
13881151|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13881152|NCT03584152|Acetaminophen|acetaminophen|mesh-list
13881153|NCT03584152|Ibuprofen|ibuprofen|mesh-list
13881154|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881155|NCT03584152|Analgesics|analgesics|mesh-ancestor
13881156|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
13881157|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881158|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881159|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
13881160|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881161|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881162|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881163|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13881164|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881165|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881166|NCT03584087|Terlipressin|terlipressin|mesh-list
13881167|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13881168|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13881169|NCT03584074|Celecoxib|celecoxib|mesh-list
13881170|NCT03584074|Pregabalin|pregabalin|mesh-list
13881171|NCT03584074|Analgesics|analgesics|mesh-ancestor
13881172|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
13881173|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881174|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931452|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14931453|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14931454|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14931455|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14931456|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931457|NCT01439399|Analgesics|analgesics|mesh-ancestor
13881175|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
13881176|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13881177|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881178|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881179|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13881180|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13881181|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13881182|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881183|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13881184|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881185|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881186|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881187|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881188|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13881189|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13881190|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881191|NCT03583957|Caffeine|caffeine|mesh-list
13881192|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13881193|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881194|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13881195|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881196|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881197|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13881198|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14931458|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14931459|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14931460|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
14931461|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14931462|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14931463|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931464|NCT01439438|Topiramate|topiramate|mesh-list
14931465|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
14931466|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931467|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881199|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
13881200|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881201|NCT03583892|Gabapentin|gabapentin|mesh-list
13881202|NCT03583892|Analgesics|analgesics|mesh-ancestor
13881203|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
13881204|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881205|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881206|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
13881207|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13881208|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13881209|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881210|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13881211|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13881212|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13881213|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881214|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881215|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
13881216|NCT03583866|Candesartan|candesartan|mesh-list
13881217|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13881218|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13881219|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13881220|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881221|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13881222|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13881223|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881224|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
13881225|NCT03583710|Cisplatin|cisplatin|mesh-list
13881226|NCT03583710|Etoposide|etoposide|mesh-list
13881227|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
13881228|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
13881229|NCT03583710|Mitotane|mitotane|mesh-list
13881230|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881231|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881232|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13881233|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13881234|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881235|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881236|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
13881237|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
13881238|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881239|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881240|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881241|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14470880|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470881|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470882|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
13881245|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
13881246|NCT03583567|Ranitidine|ranitidine|mesh-list
13881247|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
13881248|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13881249|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13881250|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13881251|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
13881252|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
13881253|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881254|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881255|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881256|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
13881257|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
13881258|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13881259|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13881260|NCT03583489|Ondansetron|ondansetron|mesh-list
13881261|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
13881262|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
13881263|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938585|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13881264|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881265|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13881266|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
13881267|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
14931468|NCT01439542|Hormones|hormones|mesh-list
13881268|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13881269|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
13881270|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881271|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881272|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13881273|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13881274|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881275|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13881276|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13881277|NCT03583476|Amoxicillin|amoxicillin|mesh-list
13881278|NCT03583476|Metronidazole|metronidazole|mesh-list
13881279|NCT03583476|Clarithromycin|clarithromycin|mesh-list
13881280|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13881281|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13881282|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881283|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13881284|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13881285|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13881286|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881287|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881288|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13881289|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13881290|NCT03583424|Cytarabine|cytarabine|mesh-list
13881291|NCT03583424|Etoposide|etoposide|mesh-list
13881292|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
13881293|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
13881294|NCT03583424|Melphalan|melphalan|mesh-list
13881295|NCT03583424|Venetoclax|venetoclax|mesh-list
13881296|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
13881297|NCT03583424|Carmustine|carmustine|mesh-list
13881298|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13881299|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881300|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881301|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13881302|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13881303|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881304|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881305|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881306|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
13881307|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
13881308|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881309|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881310|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
13881311|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881312|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13881313|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
13881314|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13881315|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
13881316|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
13881317|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881318|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881319|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881320|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
13881321|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13881322|NCT03583242|Growth Substances|growth substances|mesh-ancestor
13881323|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881324|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
13881325|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881326|NCT03583229|Aspirin|aspirin|mesh-list
13881327|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881328|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881329|NCT03583229|Analgesics|analgesics|mesh-ancestor
13881330|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
13881331|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881332|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881333|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938586|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
13881334|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881335|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13881336|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13881337|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881338|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13881339|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13881340|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881341|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
13881342|NCT03583164|Olorofim|olorofim|mesh-list
13881343|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
13881344|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881345|NCT03583138|Buprenorphine|buprenorphine|mesh-list
13881346|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13881347|NCT03583138|Narcotics|narcotics|mesh-ancestor
13881348|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881349|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881350|NCT03583138|Analgesics|analgesics|mesh-ancestor
13881351|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
13881352|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881353|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13881354|NCT03583086|Nivolumab|nivolumab|mesh-list
13881355|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13881356|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881357|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13881358|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881359|NCT03583021|Neostigmine|neostigmine|mesh-list
13881360|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13881361|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881362|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881363|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
13881364|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881365|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881366|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13881367|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
13881368|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881369|NCT03582930|Calfactant|calfactant|mesh-list
13881370|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
13881371|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
13881372|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
13881373|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13881374|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13881375|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881376|NCT03582917|Vitamins|vitamins|mesh-ancestor
13881377|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
13881378|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
13881379|NCT03582878|Sirolimus|sirolimus|mesh-list
13881380|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13881381|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881382|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13881383|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
13881384|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13881385|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881386|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881387|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881388|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
13881389|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881390|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
13881391|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881392|NCT03582865|Tamoxifen|tamoxifen|mesh-list
13881393|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13881394|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
13881395|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13881396|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881397|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13881398|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881399|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13881400|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13881401|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13881402|NCT03582605|Amoxicillin|amoxicillin|mesh-list
13881403|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13881404|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957651|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957652|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13957653|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957654|NCT03173612|Cytarabine|cytarabine|mesh-list
13957655|NCT03173612|Etoposide|etoposide|mesh-list
13957656|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
13957657|NCT03173612|Idarubicin|idarubicin|mesh-list
13881405|NCT03582332|Indomethacin|indomethacin|mesh-list
13881406|NCT03582332|Etoricoxib|etoricoxib|mesh-list
13881407|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881408|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881409|NCT03582332|Analgesics|analgesics|mesh-ancestor
13881410|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
13881411|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881412|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881413|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881414|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881415|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
13881416|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
13881417|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13881418|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13881419|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881420|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881421|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13881422|NCT03582319|Formaldehyde|formaldehyde|mesh-list
13881423|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
13881424|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881425|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
13881426|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13881427|NCT03582306|Protective Agents|protective agents|mesh-ancestor
13881428|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881429|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
13881430|NCT03582280|Calcium|calcium|mesh-list
13881431|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13881432|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881433|NCT03582280|Antacids|antacids|mesh-ancestor
13881434|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881435|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027374|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027375|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027376|NCT02736513|Osimertinib|osimertinib|mesh-list
14027377|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027378|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14027379|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027380|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027381|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14027382|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14027383|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931469|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14931470|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931471|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931472|NCT01439750|Rituximab|rituximab|mesh-list
13881436|NCT03582124|Panitumumab|panitumumab|mesh-list
14027384|NCT02736435|Leuprolide|leuprolide|mesh-list
14027385|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14027386|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
14027387|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14027388|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027389|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027390|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027391|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14027392|NCT02736682|Metronidazole|metronidazole|mesh-list
14027393|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14027394|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027395|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
14027396|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14027397|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14027398|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14027399|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
14027400|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14027401|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
14027402|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027403|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
14470883|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470884|NCT02319304|Antidotes|antidotes|mesh-ancestor
14470885|NCT02319304|Protective Agents|protective agents|mesh-ancestor
14470886|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
14470887|NCT02319304|Vitamins|vitamins|mesh-ancestor
14470888|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
14470889|NCT02319369|Azacitidine|azacitidine|mesh-list
14470890|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14931473|NCT01439750|Bortezomib|bortezomib|mesh-list
13881437|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13881438|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881439|NCT03582098|Rituximab|rituximab|mesh-list
13881440|NCT03582098|Idelalisib|idelalisib|mesh-list
13881441|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13881442|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881443|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
13881444|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881445|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881446|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881447|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881448|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13881449|NCT03582007|Murepavadin|murepavadin|mesh-list
13881450|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881451|NCT03581968|Pancrelipase|pancrelipase|mesh-list
13881452|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13881453|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
13881454|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13881455|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881456|NCT03581903|Vaccines|vaccines|mesh-list
13881457|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
13881458|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881459|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13881460|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13881461|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13881462|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881463|NCT03581773|Folic Acid|folic acid|mesh-list
13881464|NCT03581773|Hematinics|hematinics|mesh-ancestor
13881465|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
13881466|NCT03581773|Vitamins|vitamins|mesh-ancestor
13881467|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
13881468|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881469|NCT03581630|Naltrexone|naltrexone|mesh-list
13881470|NCT03581630|Bupropion|bupropion|mesh-list
13881471|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13881472|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13881473|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881474|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
13881475|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881476|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13881477|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
13881478|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13881479|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13881480|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13881481|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881482|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881483|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
13881484|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881485|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13881486|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13881487|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881488|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13881489|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13881490|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754311|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754312|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14754313|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754314|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754315|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
14754316|NCT04745728|Hormones|hormones|mesh-ancestor
14754317|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754318|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754319|NCT04742075|Durvalumab|durvalumab|mesh-list
14754320|NCT04742075|Olaparib|olaparib|mesh-list
14754321|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14754322|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754323|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754324|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
14754325|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754326|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14754327|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754328|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754329|NCT04710368|Evolocumab|evolocumab|mesh-list
13957658|NCT03173612|Dasatinib|dasatinib|mesh-list
14754330|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14754331|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14754332|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
14754333|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754334|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14754335|NCT04704934|Paclitaxel|paclitaxel|mesh-list
14754336|NCT04704934|Trastuzumab|trastuzumab|mesh-list
14754337|NCT04704934|Ramucirumab|ramucirumab|mesh-list
14754338|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14754339|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754340|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
14754341|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
14754342|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
14754343|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754344|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754345|NCT04702893|Nintedanib|nintedanib|mesh-list
14754346|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754347|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14931474|NCT01439750|Cladribine|cladribine|mesh-list
14931475|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14931476|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931477|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
14931478|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931479|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14931480|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931481|NCT01439802|Copper|copper|mesh-list
14931482|NCT01439802|Trace Elements|trace elements|mesh-ancestor
14931483|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
14754348|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754349|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881524|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
13881525|NCT03581370|Cephalosporins|cephalosporins|mesh-list
13881526|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
13881527|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13881528|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881529|NCT03581370|Renal Agents|renal agents|mesh-ancestor
13881530|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13881531|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13881532|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881533|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881534|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
13881535|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
13881536|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
13881537|NCT03581149|Laxatives|laxatives|mesh-list
13881538|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881539|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
13881540|NCT03581149|Protective Agents|protective agents|mesh-ancestor
13881541|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881542|NCT03581149|Vitamins|vitamins|mesh-ancestor
13881543|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
13881544|NCT03581149|Cathartics|cathartics|mesh-ancestor
13881545|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13881546|NCT03580980|Acetaminophen|acetaminophen|mesh-list
13881547|NCT03580980|Ketamine|ketamine|mesh-list
13881548|NCT03580980|Morphine|morphine|mesh-list
13881549|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
13881550|NCT03580980|Analgesics|analgesics|mesh-ancestor
13881551|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
13881552|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881553|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881554|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13881555|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13881556|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
13881557|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
13881558|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881559|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13881560|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13881561|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881562|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881563|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14931484|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931485|NCT01439984|Clomipramine|clomipramine|mesh-list
14931486|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14931487|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
14931488|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13881564|NCT03580980|Narcotics|narcotics|mesh-ancestor
14754350|NCT04692467|Amlodipine|amlodipine|mesh-list
13881565|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881566|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
13881567|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
13881568|NCT03580967|Vortioxetine|vortioxetine|mesh-list
13881569|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
13881570|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13881571|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13881572|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13881573|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881574|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881575|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13881576|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13881577|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881578|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881579|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881580|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
13881581|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13881582|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13881583|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13881584|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13881585|NCT03580902|Buprenorphine|buprenorphine|mesh-list
13881586|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13881587|NCT03580902|Naloxone|naloxone|mesh-list
13881588|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13881589|NCT03580902|Narcotics|narcotics|mesh-ancestor
13881590|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881591|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881592|NCT03580902|Analgesics|analgesics|mesh-ancestor
13881593|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
13881594|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881595|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13881596|NCT03580889|Atropine|atropine|mesh-list
13881597|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
13881598|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13881599|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13881600|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13881601|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
13881602|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881603|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881604|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13881605|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
13881606|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
13881607|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
13881608|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13881609|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13881610|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
13881611|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881612|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881613|NCT03580876|Azathioprine|azathioprine|mesh-list
13881614|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
13881615|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881616|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881617|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881618|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881619|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
13881620|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881621|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881622|NCT03580733|Caspofungin|caspofungin|mesh-list
13881623|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
13881624|NCT03580733|Clotrimazole|clotrimazole|mesh-list
13881625|NCT03580733|Miconazole|miconazole|mesh-list
13881626|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881627|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881628|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881629|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13881630|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13881631|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13881632|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13881633|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
13881634|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13881635|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881636|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13881637|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13881638|NCT03580694|Cemiplimab|cemiplimab|mesh-list
13881639|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13881640|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881641|NCT03580681|Vitamin E|vitamin e|mesh-list
13881642|NCT03580681|Vitamins|vitamins|mesh-ancestor
13881643|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
13881644|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881645|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
13881646|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881647|NCT03580681|Protective Agents|protective agents|mesh-ancestor
13957659|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
13957660|NCT03173612|Sargramostim|sargramostim|mesh-list
13957661|NCT03173612|Lenograstim|lenograstim|mesh-list
13957662|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13957663|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957664|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13957665|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13957666|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957667|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957668|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13957669|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
13957670|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
13957671|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957672|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13957673|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
13957674|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957675|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13957676|NCT03173612|Analgesics|analgesics|mesh-ancestor
13957677|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
13957678|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957679|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13957680|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13957681|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
13957682|NCT03173417|Fludarabine|fludarabine|mesh-list
13957683|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13957684|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
13957685|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957686|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470891|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
14767179|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13881648|NCT03580590|Diltiazem|diltiazem|mesh-list
13881649|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
13881650|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13881651|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13881652|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881653|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
13881654|NCT03580590|Coagulants|coagulants|mesh-ancestor
13881655|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13881656|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13881657|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881658|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13881659|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881660|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
13881661|NCT03580499|Vitamins|vitamins|mesh-list
13881662|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
13881663|NCT03580499|Pyridoxal|pyridoxal|mesh-list
13881664|NCT03580499|Pyridoxine|pyridoxine|mesh-list
13881665|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
13881666|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
13881667|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881668|NCT03580408|Nivolumab|nivolumab|mesh-list
13881669|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13881670|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881671|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13881672|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881673|NCT03580395|Paclitaxel|paclitaxel|mesh-list
13881674|NCT03580395|Apatinib|apatinib|mesh-list
13881675|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881676|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881677|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881678|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881679|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881680|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881681|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13881682|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881683|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
13881684|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13881685|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881686|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13881687|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
13881688|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13881689|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881690|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881691|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881692|NCT03580239|Everolimus|everolimus|mesh-list
13881693|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881694|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881695|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
13881696|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881697|NCT03580187|Morphine|morphine|mesh-list
13881698|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13881699|NCT03580187|Narcotics|narcotics|mesh-ancestor
13881700|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881701|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881702|NCT03580187|Analgesics|analgesics|mesh-ancestor
13881703|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
13881704|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881705|NCT03580148|Cortisone|cortisone|mesh-list
13881706|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13881707|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881708|NCT03580135|Propolis|propolis|mesh-list
13881709|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881710|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
13881711|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13881712|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13881713|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881714|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
13881715|NCT03580018|Coagulants|coagulants|mesh-ancestor
13881716|NCT03580005|Methylphenidate|methylphenidate|mesh-list
13881717|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13881718|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881719|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13881720|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13881721|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881722|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881723|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
13881724|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881725|NCT03579979|Methylene Blue|methylene blue|mesh-list
13881726|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881727|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881728|NCT03579927|Cytarabine|cytarabine|mesh-list
13881729|NCT03579927|Rituximab|rituximab|mesh-list
13881730|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13881731|NCT03579927|Etoposide|etoposide|mesh-list
13881732|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
13881733|NCT03579927|Melphalan|melphalan|mesh-list
13881734|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
13881735|NCT03579927|Carmustine|carmustine|mesh-list
13881736|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
13881737|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13881738|NCT03579927|Antibodies|antibodies|mesh-list
13881739|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
13881740|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13881741|NCT03579927|Lenograstim|lenograstim|mesh-list
13881742|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
13881743|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881744|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881745|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881746|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881747|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13881748|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13881749|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881750|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881751|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881752|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
13881753|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
13881754|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881755|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881756|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13881757|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13881758|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
13881759|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13881760|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
13881761|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
13881762|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881763|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881764|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881765|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
13881766|NCT03579888|Fludarabine|fludarabine|mesh-list
13881767|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881768|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
13881769|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881770|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881771|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13881772|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
13881773|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881774|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881775|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13881776|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
13881777|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
13881778|NCT03579875|Busulfan|busulfan|mesh-list
13881779|NCT03579875|Rituximab|rituximab|mesh-list
13881780|NCT03579875|Fludarabine|fludarabine|mesh-list
13881781|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931489|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14931490|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13881782|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
13881783|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881784|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881785|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13881786|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
13881787|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881788|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881789|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13881790|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13881791|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881792|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
14931491|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881793|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
13881794|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881795|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13881796|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
13881797|NCT03579875|Hormones|hormones|mesh-ancestor
14931492|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881798|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13881799|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14931493|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931494|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
14931495|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931496|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14931497|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
14931498|NCT01439997|Coagulants|coagulants|mesh-ancestor
13881800|NCT03579875|Protective Agents|protective agents|mesh-ancestor
13881801|NCT03579836|Gemcitabine|gemcitabine|mesh-list
13881802|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881803|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
13881804|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881805|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881806|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
13881807|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881808|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881809|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881810|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
13881811|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881812|NCT03579823|Adalimumab|adalimumab|mesh-list
13881813|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881814|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881815|NCT03579784|Paclitaxel|paclitaxel|mesh-list
13881816|NCT03579784|Durvalumab|durvalumab|mesh-list
13881817|NCT03579784|Olaparib|olaparib|mesh-list
13881818|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881819|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881820|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881821|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881822|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881823|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881824|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13881825|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13881826|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881827|NCT03579771|Gemcitabine|gemcitabine|mesh-list
13881828|NCT03579771|Paclitaxel|paclitaxel|mesh-list
13881829|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13881830|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881831|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881832|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881833|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881834|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881835|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881836|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881837|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
13881838|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
13881839|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881840|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881841|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881842|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
13881843|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881844|NCT03579758|Gemcitabine|gemcitabine|mesh-list
13881845|NCT03579758|Capecitabine|capecitabine|mesh-list
13881846|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027404|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027405|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169207|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169208|NCT04843982|Esketamine|esketamine|mesh-list
14169209|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
14169210|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169211|NCT04843943|Bevacizumab|bevacizumab|mesh-list
14169212|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14169213|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931499|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13881847|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881848|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
13881849|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881850|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
13881851|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881852|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881853|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881854|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
13881855|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881856|NCT03579732|Aspirin|aspirin|mesh-list
13881857|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881858|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881859|NCT03579732|Analgesics|analgesics|mesh-ancestor
13881860|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
13881861|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881862|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881863|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881864|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881865|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13881866|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13881867|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881868|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13881869|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13881870|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881871|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
13881872|NCT03579589|Neostigmine|neostigmine|mesh-list
13881873|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13881874|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881875|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881876|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
13881877|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881878|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881879|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13881880|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
13881881|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881882|NCT03579576|Ribavirin|ribavirin|mesh-list
13881883|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
13881884|NCT03579576|Velpatasvir|velpatasvir|mesh-list
13881885|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
13881886|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881887|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
13881888|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881889|NCT03579472|Halichondrin B|halichondrin b|mesh-list
13881890|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881891|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881892|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881893|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
13881894|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881895|NCT03579082|Decitabine|decitabine|mesh-list
13881896|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881897|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
13881898|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881899|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881900|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881901|NCT03579043|Cocaine|cocaine|mesh-list
13881902|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
13881903|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
13881904|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881905|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881906|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
13881907|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881908|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13881909|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13881910|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13881911|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881912|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881913|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
13881914|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881915|NCT03579004|Paclitaxel|paclitaxel|mesh-list
13881916|NCT03579004|Fluorouracil|fluorouracil|mesh-list
13881917|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13881918|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881919|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
13881920|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
13881921|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
13957687|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13881922|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881923|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
13881924|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881925|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881926|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
13881927|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881928|NCT03578900|Citric Acid|citric acid|mesh-list
13881929|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
13881930|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
13881931|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13881932|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
13881933|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
13881934|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881935|NCT03578874|Capecitabine|capecitabine|mesh-list
13881936|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
13881937|NCT03578874|Sorafenib|sorafenib|mesh-list
13881938|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13881939|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
13881940|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881941|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881942|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13881943|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881944|NCT03578822|Aspirin|aspirin|mesh-list
13881945|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13881946|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13881947|NCT03578822|Analgesics|analgesics|mesh-ancestor
13881948|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
13881949|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881950|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881951|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13881952|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881953|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13881954|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13881955|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881956|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13881957|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13881958|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13881959|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
13957688|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
13957689|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957690|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957691|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13957692|NCT03173235|Vitamin D|vitamin d|mesh-list
13957693|NCT03173235|Vitamins|vitamins|mesh-ancestor
13957694|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
13957695|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957696|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13957697|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13957698|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13957699|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13957700|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13957701|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13957702|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
13957703|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957704|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957705|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957706|NCT03173339|Remifentanil|remifentanil|mesh-list
13957707|NCT03173339|Sevoflurane|sevoflurane|mesh-list
13957708|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13957709|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13957710|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
13957711|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
13957712|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957713|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957714|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13957715|NCT03173339|Narcotics|narcotics|mesh-ancestor
13957716|NCT03173339|Analgesics|analgesics|mesh-ancestor
13957717|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
13957718|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957719|NCT03173326|Anesthetics|anesthetics|mesh-list
13957720|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957721|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957722|NCT03173508|Acetazolamide|acetazolamide|mesh-list
13957723|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
14754351|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13881960|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13881961|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
13881962|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
13881963|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13881964|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881965|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
13881966|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881967|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13881968|NCT03578679|Ivermectin|ivermectin|mesh-list
13881969|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13881970|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881971|NCT03578640|Grazoprevir|grazoprevir|mesh-list
13881972|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
13881973|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13881974|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13881975|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13881976|NCT03578432|Everolimus|everolimus|mesh-list
13881977|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13881978|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13881979|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
13881980|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881981|NCT03578354|Atenolol|atenolol|mesh-list
13881982|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
13881983|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13881984|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13881985|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
13881986|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
13881987|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13881988|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13881989|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13881990|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13881991|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13881992|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
13881993|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13881994|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13881995|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13881996|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13881997|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
13881998|NCT03578276|Prednisolone|prednisolone|mesh-list
13881999|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13882000|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
13882001|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14931500|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
14931501|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931502|NCT01440062|Vitamin D|vitamin d|mesh-list
14931503|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
14931504|NCT01440062|Vitamins|vitamins|mesh-list
14931505|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
14931506|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931507|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14931508|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14931509|NCT01440088|Doxorubicin|doxorubicin|mesh-list
14931510|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14931511|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13882002|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
13882003|NCT03578276|Bromfenac|bromfenac|mesh-list
14931512|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931513|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14931514|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14931515|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931516|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931517|NCT01440114|Fentanyl|fentanyl|mesh-list
13882004|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13882005|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
13882006|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882007|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
13882008|NCT03578276|Hormones|hormones|mesh-ancestor
13882009|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882010|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882011|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882012|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882013|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
13882014|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
13882015|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882016|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931518|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13882017|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13882018|NCT03578276|Protective Agents|protective agents|mesh-ancestor
13882019|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13882020|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13882021|NCT03578276|Analgesics|analgesics|mesh-ancestor
13882022|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
13882023|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882024|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13882025|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882026|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13882027|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13882028|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13882029|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13882030|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882031|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882032|NCT03578263|Oxytocin|oxytocin|mesh-list
13882033|NCT03578263|Carbetocin|carbetocin|mesh-list
13882034|NCT03578263|Ergonovine|ergonovine|mesh-list
13882035|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
13882036|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13882037|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882038|NCT03578042|Losartan|losartan|mesh-list
13882039|NCT03578042|Amlodipine|amlodipine|mesh-list
13882040|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13882041|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13882042|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13882043|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882044|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882045|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13882046|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882047|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
13882048|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13882049|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13882050|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13882051|NCT03578042|Diuretics|diuretics|mesh-ancestor
14754352|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14754353|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14754354|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754355|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14754356|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754357|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
14754358|NCT04690322|Factor VIII|factor viii|mesh-list
14754359|NCT04690322|BAX 855|bax 855|mesh-list
13882052|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
14754360|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14754361|NCT04690322|Coagulants|coagulants|mesh-ancestor
14754362|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
14754363|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931519|NCT01440114|Narcotics|narcotics|mesh-ancestor
14931520|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931521|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931522|NCT01440114|Analgesics|analgesics|mesh-ancestor
14931523|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
14931524|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931525|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14931526|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14931527|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
14931528|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
14931529|NCT01440127|Metformin|metformin|mesh-list
14931530|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931531|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931532|NCT01440140|Insulin|insulin|mesh-list
14931533|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13882053|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14931534|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931535|NCT01440270|Cetuximab|cetuximab|mesh-list
14931536|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882054|NCT03577977|Interferons|interferons|mesh-list
13882055|NCT03577977|Interferon-beta|interferon-beta|mesh-list
13882056|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
13882057|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754364|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14754365|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
13882058|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
13882059|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882060|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
13882061|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882062|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14931537|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931538|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14931539|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14931540|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931541|NCT01440335|Fenoterol|fenoterol|mesh-list
14931542|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14931543|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
14931544|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882063|NCT03577912|Anesthetics|anesthetics|mesh-list
13882064|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882065|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882066|NCT03577899|Aflibercept|aflibercept|mesh-list
13882067|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13882068|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13882069|NCT03577899|Growth Substances|growth substances|mesh-ancestor
13882070|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882071|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
13882072|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882073|NCT03577860|Bupivacaine|bupivacaine|mesh-list
13882074|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882075|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
13882076|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882077|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882078|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
13882079|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882080|NCT03577834|Acetic Acid|acetic acid|mesh-list
13882081|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13882082|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882083|NCT03577782|Vedolizumab|vedolizumab|mesh-list
14931545|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931546|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14931547|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
14931548|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
14931549|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
14931550|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14931551|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14931552|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14931553|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13882084|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882085|NCT03577743|Bevacizumab|bevacizumab|mesh-list
13882086|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882087|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882088|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13882089|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13882090|NCT03577743|Growth Substances|growth substances|mesh-ancestor
13882091|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882092|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
13882093|NCT03577652|Ticagrelor|ticagrelor|mesh-list
13882094|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13882095|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13882096|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13882097|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13882098|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
14754366|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14754367|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754368|NCT04675931|Artesunate|artesunate|mesh-list
14754369|NCT04675931|Lumefantrine|lumefantrine|mesh-list
14754370|NCT04675931|Artemether|artemether|mesh-list
14754371|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14754372|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
14754373|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14931554|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
13882099|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882100|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754374|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13882101|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882102|NCT03577626|Hemay005|hemay005|mesh-list
13882103|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
13882104|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13882105|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13882106|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882107|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882108|NCT03577574|Anesthetics|anesthetics|mesh-list
13882109|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882110|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882111|NCT03577496|Peppermint oil|peppermint oil|mesh-list
13882112|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
13882113|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
13882114|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882115|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882116|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882117|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
13882118|NCT03577457|Oxytocin|oxytocin|mesh-list
13882119|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
13882120|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13882121|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882122|NCT03577392|Capecitabine|capecitabine|mesh-list
13882123|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
13882124|NCT03577392|Endostatins|endostatins|mesh-list
13882125|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13882126|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
13882127|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882128|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882129|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13882130|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13882131|NCT03577392|Growth Substances|growth substances|mesh-ancestor
13882132|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882133|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
13882134|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
13882135|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13882136|NCT03577184|Metformin|metformin|mesh-list
13882137|NCT03577184|Vildagliptin|vildagliptin|mesh-list
13882138|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13882139|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882140|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13882141|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
13882142|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882143|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957724|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13957725|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957726|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957727|NCT03173508|Diuretics|diuretics|mesh-ancestor
13957728|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
13957729|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957730|NCT03173430|Blinatumomab|blinatumomab|mesh-list
13957731|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963159|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13963160|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13963161|NCT01979536|Cytarabine|cytarabine|mesh-list
13963162|NCT01979536|Dexamethasone|dexamethasone|mesh-list
13963163|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
13963164|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
13963165|NCT01979536|Ifosfamide|ifosfamide|mesh-list
13963166|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
13963167|NCT01979536|Doxorubicin|doxorubicin|mesh-list
13963168|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13963169|NCT01979536|Methotrexate|methotrexate|mesh-list
14931555|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931556|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931557|NCT01440361|Belimumab|belimumab|mesh-list
14931558|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931559|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
14931560|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931561|NCT01440400|Anesthetics|anesthetics|mesh-list
14931562|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963170|NCT01979536|Etoposide|etoposide|mesh-list
13963171|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
13963172|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13963173|NCT01979536|Crizotinib|crizotinib|mesh-list
13963174|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
13963175|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13963176|NCT01979536|Antibodies|antibodies|mesh-list
13882144|NCT03577158|Insulin|insulin|mesh-list
13882145|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13882146|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882147|NCT03577132|Atezolizumab|atezolizumab|mesh-list
13882148|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882149|NCT03576963|Nivolumab|nivolumab|mesh-list
13882150|NCT03576963|Guadecitabine|guadecitabine|mesh-list
13882151|NCT03576963|Azacitidine|azacitidine|mesh-list
13882152|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882153|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882154|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13882155|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882156|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13882157|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
13882158|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882159|NCT03576911|Ubiquinone|ubiquinone|mesh-list
13882160|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
13882161|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
13882162|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882163|NCT03576911|Vitamins|vitamins|mesh-ancestor
13882164|NCT03576820|Lidocaine|lidocaine|mesh-list
13882165|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13882166|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882167|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
13882168|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882169|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882170|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
13882171|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882172|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13882173|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13882174|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13882175|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882176|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882177|NCT03576794|Prednisolone|prednisolone|mesh-list
13882178|NCT03576794|Leflunomide|leflunomide|mesh-list
13882179|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882180|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
13882181|NCT03576794|Hormones|hormones|mesh-ancestor
13882182|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882183|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882184|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882185|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882186|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882187|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882188|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882189|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
13882190|NCT03576755|Spironolactone|spironolactone|mesh-list
13882191|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13882192|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
13882193|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882194|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882195|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13882196|NCT03576755|Diuretics|diuretics|mesh-ancestor
13882197|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
13882198|NCT03576677|Simendan|simendan|mesh-list
13882199|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13882200|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
13882201|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13882202|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13882203|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882204|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882205|NCT03576677|Protective Agents|protective agents|mesh-ancestor
13882206|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882207|NCT03576664|Carvedilol|carvedilol|mesh-list
13882208|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13882209|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13882210|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
13882211|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882212|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882213|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882214|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13882215|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
13882216|NCT03576664|Protective Agents|protective agents|mesh-ancestor
13882217|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13882218|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882219|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13882220|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
13882221|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13882222|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13882223|NCT03576651|Bevacizumab|bevacizumab|mesh-list
13882224|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882225|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882226|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13882227|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13882228|NCT03576651|Growth Substances|growth substances|mesh-ancestor
13882229|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882230|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
13882231|NCT03576638|Levodopa|levodopa|mesh-list
13882232|NCT03576638|Carbidopa|carbidopa|mesh-list
13882233|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13882234|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13882235|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13882236|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
13882237|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882238|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882239|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882240|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13882241|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882242|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13882243|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
13882244|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
13882245|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
13882246|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14027406|NCT02736240|Vaccines|vaccines|mesh-list
14027407|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14027408|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
14027409|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027410|NCT02736227|Everolimus|everolimus|mesh-list
14027411|NCT02736227|Tacrolimus|tacrolimus|mesh-list
14027412|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14027413|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
14027414|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027415|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14027416|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027417|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027418|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027419|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14027420|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14027421|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14027422|NCT02736032|Estradiol|estradiol|mesh-list
14027423|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14027424|NCT02736032|Progesterone|progesterone|mesh-list
14027425|NCT02736032|Estrogens|estrogens|mesh-ancestor
14027426|NCT02736032|Hormones|hormones|mesh-ancestor
14027427|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027428|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027429|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14027430|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
14027431|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14027432|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14027433|NCT02736032|Progestins|progestins|mesh-ancestor
14027434|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
14027435|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027436|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027437|NCT02736071|Celecoxib|celecoxib|mesh-list
14470892|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470893|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470894|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470895|NCT02319486|Carboplatin|carboplatin|mesh-list
14470896|NCT02319486|Etoposide|etoposide|mesh-list
14470897|NCT02319486|Vincristine|vincristine|mesh-list
13882247|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882248|NCT03576547|Dexamethasone|dexamethasone|mesh-list
13882249|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
13882250|NCT03576547|Rituximab|rituximab|mesh-list
13882251|NCT03576547|Venetoclax|venetoclax|mesh-list
13882252|NCT03576547|Ponatinib|ponatinib|mesh-list
13882253|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13882254|NCT03576547|Antibodies|antibodies|mesh-list
13882255|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
13882256|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13882257|NCT03576547|BB 1101|bb 1101|mesh-list
13882258|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
13882259|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882260|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882261|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
13882262|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
13882263|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882264|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882265|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
13882266|NCT03576547|Hormones|hormones|mesh-ancestor
13882267|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882268|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882269|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882270|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882271|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
13882272|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882273|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882274|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13882275|NCT03576508|Lidocaine|lidocaine|mesh-list
13882276|NCT03576508|Epinephrine|epinephrine|mesh-list
14931563|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931564|NCT01440439|Insulin|insulin|mesh-list
14931565|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14931566|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
14931567|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
14931568|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931569|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931570|NCT01440582|Dexamethasone|dexamethasone|mesh-list
14931571|NCT01440582|Lenalidomide|lenalidomide|mesh-list
14931572|NCT01440582|Bortezomib|bortezomib|mesh-list
14931573|NCT01440582|Panobinostat|panobinostat|mesh-list
14931574|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14931575|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
14931576|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
14931577|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931578|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931579|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882277|NCT03576508|Capsaicin|capsaicin|mesh-list
14754375|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754376|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754377|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
14754378|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
14754379|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14754380|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
14754381|NCT04673422|Montelukast|montelukast|mesh-list
14754382|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13882278|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882279|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
13882280|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882281|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882282|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
13882283|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882284|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13882285|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13882286|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13882287|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882288|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882289|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13882290|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13882291|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
13882292|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882293|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13882294|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14931580|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
13882295|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
14754383|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14931581|NCT01440582|Hormones|hormones|mesh-ancestor
14931582|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882296|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13882297|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
13882298|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
13882299|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
13882300|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13882301|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
13882302|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
13882303|NCT03576469|Complement C1s|complement c1s|mesh-list
13882304|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
13882305|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
13882306|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
13882307|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882308|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
13882309|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882310|NCT03576456|Alprazolam|alprazolam|mesh-list
13882311|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13882312|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882313|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882314|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13882315|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13882316|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13882317|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
13882318|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
13882319|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882320|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882321|NCT03576378|Prednisone|prednisone|mesh-list
13882322|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
13882323|NCT03576378|Etoposide|etoposide|mesh-list
13882324|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
13882325|NCT03576378|Procarbazine|procarbazine|mesh-list
13882326|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882327|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
13882328|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882329|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882330|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13882331|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
13882332|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882333|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882334|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13882335|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882336|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
13882337|NCT03576378|Hormones|hormones|mesh-ancestor
14754384|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14754385|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
14754386|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754387|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754388|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14754389|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14754390|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767180|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14767181|NCT00629148|Capecitabine|capecitabine|mesh-list
14767182|NCT00629148|Vinorelbine|vinorelbine|mesh-list
14767183|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14767184|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
14767185|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767186|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767187|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14767188|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
14767189|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
14767190|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
14767191|NCT00629187|Temozolomide|temozolomide|mesh-list
14767192|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14931583|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931584|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931585|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
14931586|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14931587|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14931588|NCT01440582|Growth Substances|growth substances|mesh-ancestor
14931589|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
14931590|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14931591|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931592|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882338|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882339|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882340|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13882341|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13882342|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13882343|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882344|NCT03576378|Analgesics|analgesics|mesh-ancestor
13882345|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
13882346|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882347|NCT03576287|Apremilast|apremilast|mesh-list
13882348|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13882349|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13882350|NCT03576287|Analgesics|analgesics|mesh-ancestor
13882351|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
13882352|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882353|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882354|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882355|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882356|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13882357|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13882358|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882359|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882360|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
13882361|NCT03576105|Methylene Blue|methylene blue|mesh-list
13882362|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882363|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882364|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
13882365|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
13882366|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882367|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
13882368|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
13882369|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
13882370|NCT03576053|Lidocaine|lidocaine|mesh-list
13882371|NCT03576053|Serotonin|serotonin|mesh-list
13882372|NCT03576053|Histamine|histamine|mesh-list
13882373|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882374|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
13882375|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882376|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882377|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
13882378|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882379|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13882380|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13882381|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13882382|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882383|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882384|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13882385|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
13882386|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882387|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
13882388|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
13882389|NCT03576040|Edotreotide|edotreotide|mesh-list
13882390|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13882391|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882392|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
13882393|NCT03576001|Testosterone|testosterone|mesh-list
13882394|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
13882395|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
13882396|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13882397|NCT03576001|Androgens|androgens|mesh-ancestor
13882398|NCT03576001|Hormones|hormones|mesh-ancestor
13882399|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882400|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882401|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882402|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882403|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
13882404|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
13882405|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13882406|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13882407|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882408|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
13882409|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
13882410|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882411|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
13882412|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882413|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882414|NCT03575637|Olanzapine|olanzapine|mesh-list
13882415|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
13882416|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
13882417|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931593|NCT01440608|Albendazole|albendazole|mesh-list
14931594|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
14931595|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14931596|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931597|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
14931598|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13882418|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882419|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882420|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13882421|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13882422|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882423|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13882424|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13882425|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13882426|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882427|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882428|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882429|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
13882430|NCT03575598|Nivolumab|nivolumab|mesh-list
13882431|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882432|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882433|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13882434|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882435|NCT03575572|Colchicine|colchicine|mesh-list
13882436|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
13882437|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882438|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
13882439|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
13882440|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
13882441|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882442|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882443|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
13882444|NCT03575520|Doxorubicin|doxorubicin|mesh-list
13882445|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882446|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
13882447|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882448|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882449|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13882450|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
13882451|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882452|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882453|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13882454|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13882455|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13882456|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13882457|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957732|NCT03172858|Oxytocin|oxytocin|mesh-list
13957733|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
13957734|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13957735|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957736|NCT03172936|Spartalizumab|spartalizumab|mesh-list
13957737|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13957738|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957739|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957740|NCT03172871|Aripiprazole|aripiprazole|mesh-list
13957741|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
13957742|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13957743|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13957744|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13957745|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957746|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957747|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
13957748|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
13957749|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957750|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957751|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13957752|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13957753|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
13957754|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14931599|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13882458|NCT03575325|Cytarabine|cytarabine|mesh-list
13882459|NCT03575325|Daunorubicin|daunorubicin|mesh-list
13882460|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13882461|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
13882462|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882463|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882464|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
13882465|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882466|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882467|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
13882468|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882469|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13882470|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13882471|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13882472|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882473|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
13882474|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13882475|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882476|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
13882477|NCT03575247|Hormones|hormones|mesh-ancestor
13882478|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882479|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882480|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
13882481|NCT03575234|Nivolumab|nivolumab|mesh-list
13882482|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882483|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
13882484|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882485|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882486|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13882487|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
13882488|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882489|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882490|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13882491|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882492|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13882493|NCT03575195|Rifaximin|rifaximin|mesh-list
13882494|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13882495|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882496|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882497|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13882498|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13882499|NCT03575078|Olaparib|olaparib|mesh-list
13882500|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13882501|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882502|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882503|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882504|NCT03575013|Docetaxel|docetaxel|mesh-list
13882505|NCT03575013|Avelumab|avelumab|mesh-list
13882506|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882507|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
13882508|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
13882509|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
13882510|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882511|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882512|NCT03575000|Bromocriptine|bromocriptine|mesh-list
13882513|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13882514|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13882515|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
13882516|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14470898|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470899|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14470900|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14470901|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14470902|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470903|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470904|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
14470905|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
14470906|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
14470907|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
14470908|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14470909|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
14470910|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470911|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14470912|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
14931600|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
14931601|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
14931602|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
14931603|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470913|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14931604|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882517|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882518|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
13882519|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
13882520|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882521|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882522|NCT03574909|Aspirin|aspirin|mesh-list
13882523|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13882524|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13882525|NCT03574909|Analgesics|analgesics|mesh-ancestor
13882526|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
13882527|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882528|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882529|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882530|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882531|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13882532|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13882533|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882534|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13882535|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13882536|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882537|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
13882538|NCT03574857|Metolazone|metolazone|mesh-list
13882539|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
13882540|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13882541|NCT03574857|Diuretics|diuretics|mesh-ancestor
13882542|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
13882543|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882544|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13882545|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882546|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882547|NCT03574701|Vitamin A|vitamin a|mesh-list
13882548|NCT03574701|Vitamins|vitamins|mesh-ancestor
13882549|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
13882550|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882551|NCT03574649|Paclitaxel|paclitaxel|mesh-list
13882552|NCT03574649|Docetaxel|docetaxel|mesh-list
13882553|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
13882554|NCT03574649|Carboplatin|carboplatin|mesh-list
13882555|NCT03574649|Fluorouracil|fluorouracil|mesh-list
13882556|NCT03574649|Avelumab|avelumab|mesh-list
13882557|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13882558|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931605|NCT01440621|Pyridoxine|pyridoxine|mesh-list
14931606|NCT01440621|Modafinil|modafinil|mesh-list
14931607|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14931608|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931609|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14931610|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14931611|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14931612|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931613|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
14931614|NCT01440621|Vitamins|vitamins|mesh-ancestor
14931615|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
14931616|NCT01440673|Aprepitant|aprepitant|mesh-list
14931617|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
13882559|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
13882560|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
13882561|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
14931618|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
13882562|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882563|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882564|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
13882565|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882566|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882567|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13882568|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
13882569|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13882570|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
13882571|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13882572|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882573|NCT03574402|Gemcitabine|gemcitabine|mesh-list
13882574|NCT03574402|Carboplatin|carboplatin|mesh-list
13882575|NCT03574402|Pemetrexed|pemetrexed|mesh-list
13882576|NCT03574402|Afatinib|afatinib|mesh-list
13882577|NCT03574402|Crizotinib|crizotinib|mesh-list
13882578|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
13882579|NCT03574402|Ensartinib|ensartinib|mesh-list
13882580|NCT03574402|Maleic acid|maleic acid|mesh-list
13882581|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882582|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13882583|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
13882584|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882585|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
13882586|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882587|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882588|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882589|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
13882590|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882591|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13882592|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13882593|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13882594|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882595|NCT03574376|Bupivacaine|bupivacaine|mesh-list
13882596|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882597|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
13882598|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882599|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882600|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
13882601|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882602|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
13882603|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13882604|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13882605|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882606|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13882607|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13882608|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
13882609|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882610|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882611|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
13882612|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13882613|NCT03574246|Benzydamine|benzydamine|mesh-list
13882614|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13882615|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882616|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
13882617|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
14931619|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931620|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931621|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931622|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14931623|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882618|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882619|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
13882620|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882621|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882622|NCT03574090|Amoxicillin|amoxicillin|mesh-list
13882623|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
13882624|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
13882625|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13882626|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14931624|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931625|NCT01440725|Mitogens|mitogens|mesh-list
13882627|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882628|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13882629|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931626|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
14931627|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931628|NCT01440751|Mitomycins|mitomycins|mesh-list
14931629|NCT01440751|Mitomycin|mitomycin|mesh-list
14931630|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14931631|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931632|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
14931633|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931634|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14931635|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931636|NCT01440790|Vitamins|vitamins|mesh-list
14931637|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
14931638|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
14931639|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931640|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
14931641|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931642|NCT01440790|Protective Agents|protective agents|mesh-ancestor
14931643|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
14931644|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14931645|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14931646|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931647|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931648|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931649|NCT01440842|Insulin|insulin|mesh-list
14931650|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13882630|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882631|NCT03574064|Glucagon|glucagon|mesh-list
13882632|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
13882633|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13882634|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882635|NCT03574064|Hormones|hormones|mesh-ancestor
13882636|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882637|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882638|NCT03574064|Incretins|incretins|mesh-ancestor
13882639|NCT03573999|Mannitol|mannitol|mesh-list
13882640|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13882641|NCT03573999|Diuretics|diuretics|mesh-ancestor
13882642|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
13882643|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882644|NCT03573986|Bevacizumab|bevacizumab|mesh-list
13882645|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882646|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882647|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13882648|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13882649|NCT03573986|Growth Substances|growth substances|mesh-ancestor
13882650|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882651|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
14931651|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931652|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882663|NCT03573934|Glucagon|glucagon|mesh-list
13882664|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13882665|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882666|NCT03573934|Hormones|hormones|mesh-ancestor
13882667|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882668|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882669|NCT03573934|Incretins|incretins|mesh-ancestor
13957755|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13957756|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13957757|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13957758|NCT03172988|Dexamethasone|dexamethasone|mesh-list
13957759|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
13957760|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
13957761|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
13957762|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13957763|NCT03172988|BB 1101|bb 1101|mesh-list
13957764|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957765|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
13957766|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
13957767|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957768|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957769|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957770|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
13957771|NCT03172988|Hormones|hormones|mesh-ancestor
13957772|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957773|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13957774|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957775|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
13957776|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957777|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957778|NCT03172988|Analgesics|analgesics|mesh-ancestor
13957779|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
13957780|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13957781|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957782|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13957783|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14470914|NCT02319668|Listerine|listerine|mesh-list
14470915|NCT02319668|Fluorides|fluorides|mesh-list
14470916|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
14470917|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
14470918|NCT02319668|Protective Agents|protective agents|mesh-ancestor
14470919|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470920|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13963177|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
14027438|NCT02736071|Tramadol|tramadol|mesh-list
14027439|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14470921|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470922|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
14470923|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
14027440|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027441|NCT02736071|Analgesics|analgesics|mesh-ancestor
14027442|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
14027443|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754391|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14754392|NCT04669041|Ezetimibe|ezetimibe|mesh-list
14754393|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14754394|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14754395|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
14754396|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754397|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14027444|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027445|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027446|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027447|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14027448|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14027449|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470924|NCT02319759|Ustekinumab|ustekinumab|mesh-list
14470925|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470926|NCT02320058|Nivolumab|nivolumab|mesh-list
14470927|NCT02320058|Ipilimumab|ipilimumab|mesh-list
14470928|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470929|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754398|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14754399|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882670|NCT03573687|Caseins|caseins|mesh-list
13882671|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
13882672|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
13882673|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882674|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
13882675|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13882676|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14931653|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
13882677|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882678|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13882679|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13882680|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
13882681|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882682|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882683|NCT03573596|Dasatinib|dasatinib|mesh-list
13882684|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882685|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13882686|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882687|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882688|NCT03573349|Ketamine|ketamine|mesh-list
13882689|NCT03573349|Analgesics|analgesics|mesh-ancestor
13882690|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
13882691|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882692|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882693|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13882694|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13882695|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
13882696|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
13882697|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882698|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13882699|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13882700|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882701|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882702|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
13882703|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13882704|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
14754412|NCT04661930|Fenofibrate|fenofibrate|mesh-list
14754413|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14754414|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
14754415|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754416|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14754417|NCT04657068|Gemcitabine|gemcitabine|mesh-list
14754418|NCT04657068|Irinotecan|irinotecan|mesh-list
14754419|NCT04657068|Camptothecin|camptothecin|mesh-list
14754420|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14754421|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
14754422|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754423|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754424|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
14754425|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754426|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931654|NCT01440933|Analgesics|analgesics|mesh-ancestor
13882705|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882706|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882707|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13882708|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
13882709|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13882710|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
13882711|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882712|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882713|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13882714|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
13882715|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
13882716|NCT03573284|Protective Agents|protective agents|mesh-ancestor
13882717|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
13882718|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13882719|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13882720|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882721|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
13882722|NCT03573245|Coagulants|coagulants|mesh-ancestor
13882723|NCT03573102|Aspirin|aspirin|mesh-list
13882724|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
13882725|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13882726|NCT03573102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13882727|NCT03573102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13882728|NCT03573102|Analgesics|analgesics|mesh-ancestor
13882729|NCT03573102|Sensory System Agents|sensory system agents|mesh-ancestor
13882730|NCT03573102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882731|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882732|NCT03573102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882733|NCT03573102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882734|NCT03573102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13882735|NCT03573102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13882736|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882737|NCT03573102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13882738|NCT03573102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13882739|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882740|NCT03573102|Antipyretics|antipyretics|mesh-ancestor
13882741|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
13882742|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13882743|NCT03573063|Androgens|androgens|mesh-list
13882744|NCT03573063|Hormones|hormones|mesh-ancestor
13882745|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882746|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882747|NCT03573050|Rivastigmine|rivastigmine|mesh-list
13882748|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13882749|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882750|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882751|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
13882752|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882753|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882754|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13882755|NCT03573050|Protective Agents|protective agents|mesh-ancestor
14931655|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
14931656|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931657|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931658|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
14931659|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931660|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14931661|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
13882756|NCT03573037|Anticoagulants|anticoagulants|mesh-list
13882757|NCT03572959|Triamcinolone|triamcinolone|mesh-list
13882758|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13882759|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13882760|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13882761|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882762|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
13882763|NCT03572959|Hormones|hormones|mesh-ancestor
13882764|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882765|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882766|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882767|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
13882768|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931662|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13882769|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882770|NCT03572933|Pregnanolone|pregnanolone|mesh-list
13882771|NCT03572933|Ganaxolone|ganaxolone|mesh-list
13882772|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
13882773|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882774|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882775|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882776|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
13882777|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
13882778|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
13882779|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882780|NCT03572829|Dexamethasone|dexamethasone|mesh-list
13882781|NCT03572829|Ondansetron|ondansetron|mesh-list
13882782|NCT03572829|Aprepitant|aprepitant|mesh-list
13882783|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882784|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
13882785|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
13882786|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882787|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882788|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882789|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
13882790|NCT03572829|Hormones|hormones|mesh-ancestor
13882791|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882792|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882793|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882794|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882795|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
13882796|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
13882797|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13882798|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
13882799|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882800|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13882801|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13882802|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882803|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13882804|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13882805|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13882806|NCT03572790|Prucalopride|prucalopride|mesh-list
13882807|NCT03572790|Laxatives|laxatives|mesh-ancestor
13882808|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882809|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
13882810|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13882811|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
13882812|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882813|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882814|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882815|NCT03572686|Dexamethasone|dexamethasone|mesh-list
13882816|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
13882817|NCT03572686|Ropivacaine|ropivacaine|mesh-list
13882818|NCT03572686|BB 1101|bb 1101|mesh-list
13882819|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882820|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
13882821|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
13882822|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882823|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882824|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882825|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
13882826|NCT03572686|Hormones|hormones|mesh-ancestor
13882827|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13882828|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882829|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882830|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
13882831|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882832|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882833|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882834|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
13882835|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931663|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14931664|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931665|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14931666|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
14931667|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14931668|NCT01440985|Nicotine|nicotine|mesh-list
14931669|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13882836|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
13882837|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
13882838|NCT03572647|Hematinics|hematinics|mesh-ancestor
13882839|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13882840|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13882841|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882842|NCT03572582|Nivolumab|nivolumab|mesh-list
13882843|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882844|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931670|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
14931671|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931672|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931673|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14931674|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14931675|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
14931676|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931677|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931678|NCT01440998|Paclitaxel|paclitaxel|mesh-list
14931679|NCT01440998|Carboplatin|carboplatin|mesh-list
14931680|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13882845|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13882846|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882847|NCT03572517|Morphine|morphine|mesh-list
13882848|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13882849|NCT03572517|Narcotics|narcotics|mesh-ancestor
13882850|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882851|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882852|NCT03572517|Analgesics|analgesics|mesh-ancestor
13882853|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
13882854|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882855|NCT03572400|Gemcitabine|gemcitabine|mesh-list
13882856|NCT03572400|Durvalumab|durvalumab|mesh-list
13882857|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13882858|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
13882859|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882860|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882861|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
13882862|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882863|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882864|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882865|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
13882866|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882867|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13882868|NCT03572387|Azacitidine|azacitidine|mesh-list
13882869|NCT03572387|Tretinoin|tretinoin|mesh-list
13882870|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13882871|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
13882872|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882873|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931681|NCT01440998|Dasatinib|dasatinib|mesh-list
14931682|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14931683|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931684|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
14931685|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
14931686|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
14931687|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931688|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14931689|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931690|NCT01441128|Crizotinib|crizotinib|mesh-list
14931691|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931692|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14931693|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931694|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882874|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470930|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14931695|NCT01441193|Vaccines|vaccines|mesh-list
14931696|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
14931697|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931698|NCT01441206|Rifampin|rifampin|mesh-list
14931699|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14931700|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
14931701|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14931702|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931703|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
14931704|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14931705|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931706|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882875|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
13882876|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
13882877|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13882878|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
13882879|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13882880|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13882881|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14931707|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14931708|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14931709|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14931710|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14931711|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13882882|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882883|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882884|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
13882885|NCT03572231|Mirabegron|mirabegron|mesh-list
13882886|NCT03572231|Fesoterodine|fesoterodine|mesh-list
13882887|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
13882888|NCT03572231|Oxybutynin|oxybutynin|mesh-list
13882889|NCT03572231|Darifenacin|darifenacin|mesh-list
13882890|NCT03572231|Propiverine|propiverine|mesh-list
13882891|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13882892|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13882893|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
13882894|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882895|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882896|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882897|NCT03572231|Urological Agents|urological agents|mesh-ancestor
13882898|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13882899|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13882900|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13882901|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
13882902|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
13882903|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
13882904|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882905|NCT03572088|Terlipressin|terlipressin|mesh-list
13882906|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13882907|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13882908|NCT03572010|Fesoterodine|fesoterodine|mesh-list
13882909|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13882910|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13882911|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
13882912|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13882913|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882914|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882915|NCT03572010|Urological Agents|urological agents|mesh-ancestor
14470931|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470932|NCT02320149|Sarecycline|sarecycline|mesh-list
14470933|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470934|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470935|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
14470936|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14470937|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
14470938|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14470939|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
14470940|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470941|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14470942|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14470943|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14470944|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
14470945|NCT02320695|Bacitracin|bacitracin|mesh-list
14470946|NCT02320695|Neomycin|neomycin|mesh-list
14470947|NCT02320695|Polymyxin B|polymyxin b|mesh-list
14470948|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14470949|NCT02320695|Ethanol|ethanol|mesh-list
14470950|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470951|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
14470952|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13882916|NCT03571945|Anesthetics|anesthetics|mesh-list
13882917|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882918|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882919|NCT03571932|Vaccines|vaccines|mesh-list
13882920|NCT03571932|Immunologic Factors|immunologic factors|mesh-ancestor
13882921|NCT03571932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882922|NCT03571919|Lidocaine|lidocaine|mesh-list
13882923|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882924|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
13882925|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882926|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882927|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
13882928|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882929|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13882930|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13882931|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13882932|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882933|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470953|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14470954|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470955|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14470956|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14470957|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470958|NCT02320721|Insulin|insulin|mesh-list
14470959|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13957798|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
13957799|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
13957800|NCT03173053|Clarithromycin|clarithromycin|mesh-list
13957801|NCT03173053|Doxycycline|doxycycline|mesh-list
13957802|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
13957803|NCT03173053|Rifampin|rifampin|mesh-list
13957804|NCT03173053|Clindamycin|clindamycin|mesh-list
13957805|NCT03173053|Trimethoprim|trimethoprim|mesh-list
13957806|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
13957807|NCT03173053|Mupirocin|mupirocin|mesh-list
13957808|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
14931712|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14931713|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14931714|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14931715|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931716|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931717|NCT01441232|Incretins|incretins|mesh-ancestor
14931718|NCT01441232|Hormones|hormones|mesh-ancestor
14931719|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957809|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13957810|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13957811|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957812|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
13957813|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13957814|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13957815|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931720|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14931721|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
14931722|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957816|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957817|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13957818|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13957819|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
13957820|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13957821|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13957822|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14931723|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931724|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14931725|NCT01441284|Pramipexole|pramipexole|mesh-list
14931726|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
14931727|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931728|NCT01441284|Protective Agents|protective agents|mesh-ancestor
14931729|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931730|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13957823|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13957824|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957825|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13957826|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13957827|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
13957828|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
13957829|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13963178|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14470960|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
13882934|NCT03571815|Listerine|listerine|mesh-list
13882935|NCT03571815|Fluorides|fluorides|mesh-list
13882936|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
13882937|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
13882938|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
13882939|NCT03571815|Protective Agents|protective agents|mesh-ancestor
13882940|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882941|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13882942|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882943|NCT03571737|Ibuprofen|ibuprofen|mesh-list
13882944|NCT03571737|Lidocaine|lidocaine|mesh-list
13882945|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882946|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
13882947|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882948|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882949|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
13882950|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13882951|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13882952|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13882953|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13882954|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13882955|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882956|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13882957|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13882958|NCT03571737|Analgesics|analgesics|mesh-ancestor
13882959|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13882960|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13882961|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13882962|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882963|NCT03571711|Meropenem|meropenem|mesh-list
13882964|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13882965|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882966|NCT03571594|Octreotide|octreotide|mesh-list
13882967|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13882968|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13882969|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882970|NCT03571490|Ropivacaine|ropivacaine|mesh-list
13882971|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
13882972|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
13882973|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13882974|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882975|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
13882976|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931731|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14931732|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
14931733|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
14931734|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931735|NCT01441297|Nintedanib|nintedanib|mesh-list
14931736|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931737|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14931738|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931739|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931740|NCT01441388|Bevacizumab|bevacizumab|mesh-list
14931741|NCT01441388|Sunitinib|sunitinib|mesh-list
13882977|NCT03571438|Sirolimus|sirolimus|mesh-list
13882978|NCT03571438|Sunitinib|sunitinib|mesh-list
13882979|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13882980|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13882981|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13882982|NCT03571438|Growth Substances|growth substances|mesh-ancestor
13882983|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13882984|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
13882985|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14931742|NCT01441388|Sorafenib|sorafenib|mesh-list
14931743|NCT01441388|Axitinib|axitinib|mesh-list
13882986|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13882987|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13882988|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13882989|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13882990|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13882991|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
13882992|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13882993|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
13882994|NCT03571321|Cytarabine|cytarabine|mesh-list
13882995|NCT03571321|Dexamethasone|dexamethasone|mesh-list
13882996|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
13882997|NCT03571321|Rituximab|rituximab|mesh-list
14931744|NCT01441388|Crizotinib|crizotinib|mesh-list
13882998|NCT03571321|Doxorubicin|doxorubicin|mesh-list
13882999|NCT03571321|Methotrexate|methotrexate|mesh-list
13883000|NCT03571321|Vincristine|vincristine|mesh-list
13883001|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
13883002|NCT03571321|Pegaspargase|pegaspargase|mesh-list
13883003|NCT03571321|Thioguanine|thioguanine|mesh-list
13883004|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13883005|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
13883006|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883007|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883008|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13883009|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
13883010|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883011|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883012|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13883013|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883014|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
13883015|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
13883016|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883017|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13883018|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
13883019|NCT03571321|Hormones|hormones|mesh-ancestor
13883020|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883021|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883022|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13883023|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13883024|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13883025|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13883026|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883027|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13883028|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
13883029|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883030|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13883031|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
13883032|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
13883033|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13883034|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13883035|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
13883036|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883037|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13883038|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
13883039|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
13883040|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
13883041|NCT03571308|Prednisolone|prednisolone|mesh-list
13883042|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
13883043|NCT03571308|Doxorubicin|doxorubicin|mesh-list
13883044|NCT03571308|Vincristine|vincristine|mesh-list
13883045|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
13883046|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13883047|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
13883048|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883049|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883050|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13883051|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
13883052|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883053|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883054|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13883055|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13883056|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13883057|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13883058|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883059|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13883060|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
13883061|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
13883062|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
14470961|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13883063|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883064|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
13883065|NCT03571308|Hormones|hormones|mesh-ancestor
13883066|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883067|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883068|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14470962|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883069|NCT03571230|Amoxicillin|amoxicillin|mesh-list
13883070|NCT03571230|Metronidazole|metronidazole|mesh-list
13883071|NCT03571230|Clarithromycin|clarithromycin|mesh-list
13883072|NCT03571230|Levofloxacin|levofloxacin|mesh-list
13883073|NCT03571230|Tetracycline|tetracycline|mesh-list
13883074|NCT03571230|Tinidazole|tinidazole|mesh-list
13883075|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13883076|NCT03571230|Furazolidone|furazolidone|mesh-list
13883077|NCT03571230|Bismuth|bismuth|mesh-list
13883078|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13883079|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883080|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
13883081|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13883082|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13883083|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13883084|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883085|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883086|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13883087|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13883088|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13883089|NCT03571230|Renal Agents|renal agents|mesh-ancestor
13883090|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13883091|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13883092|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883093|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13883094|NCT03571230|Antacids|antacids|mesh-ancestor
13883095|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13883096|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13883097|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13883098|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13883099|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
13883100|NCT03571126|Olanzapine|olanzapine|mesh-list
13883101|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
13883102|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
13883103|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883104|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883105|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13883106|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13883107|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13883108|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883109|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13883110|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13883111|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13883112|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13883113|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883114|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883115|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
13883116|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
13883117|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13883118|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13883119|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883120|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
13883121|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
13883122|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13883123|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13883124|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13883125|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
13883126|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883127|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13883128|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13883129|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883130|NCT03570983|Cytarabine|cytarabine|mesh-list
13883131|NCT03570983|Etoposide|etoposide|mesh-list
13883132|NCT03570983|Melphalan|melphalan|mesh-list
13883133|NCT03570983|Carmustine|carmustine|mesh-list
13883134|NCT03570983|Allopurinol|allopurinol|mesh-list
13883135|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13883136|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883137|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13883138|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13883139|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883140|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883141|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13883142|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
13883143|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
13883144|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883145|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13883146|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
13883147|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883148|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13883149|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
14931745|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14931746|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931747|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14931748|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14931749|NCT01441388|Growth Substances|growth substances|mesh-ancestor
14931750|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931751|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
14931752|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14931753|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931754|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931755|NCT01441427|Lenograstim|lenograstim|mesh-list
14931756|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13883150|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13883151|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
13883152|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883153|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13883154|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
13883155|NCT03570983|Protective Agents|protective agents|mesh-ancestor
13883156|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
13883157|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
13883158|NCT03570827|Androgens|androgens|mesh-list
13883159|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
13883160|NCT03570827|Hormones|hormones|mesh-ancestor
13883161|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883162|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883163|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
13883164|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883165|NCT03570827|Protective Agents|protective agents|mesh-ancestor
13883166|NCT03570827|Vitamins|vitamins|mesh-ancestor
13883167|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
13883168|NCT03570827|Estrogens|estrogens|mesh-ancestor
13883169|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883170|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883171|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
13883172|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
13883173|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13883174|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13883175|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883176|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
13883177|NCT03570710|Coagulants|coagulants|mesh-ancestor
13883178|NCT03570645|Dexamethasone|dexamethasone|mesh-list
13883179|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
13883180|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883181|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
13883182|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
13883183|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883184|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883185|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13883186|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
13883187|NCT03570645|Hormones|hormones|mesh-ancestor
13883188|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883189|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883190|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883191|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13883192|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883193|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883194|NCT03570645|Analgesics|analgesics|mesh-ancestor
13883195|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
13883196|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13883197|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13883198|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13883199|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
13883200|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883201|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883202|NCT03570541|Acetaminophen|acetaminophen|mesh-list
13883203|NCT03570541|Morphine|morphine|mesh-list
13883204|NCT03570541|Ropivacaine|ropivacaine|mesh-list
14931757|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
14931758|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938587|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14938588|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14938589|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14938590|NCT01482338|Progestins|progestins|mesh-ancestor
14938591|NCT01482338|Hormones|hormones|mesh-ancestor
14938592|NCT01482377|Cetuximab|cetuximab|mesh-list
14938593|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14938594|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14938595|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938596|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938597|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938598|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883205|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13883206|NCT03570541|Narcotics|narcotics|mesh-ancestor
13883207|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883208|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883209|NCT03570541|Analgesics|analgesics|mesh-ancestor
13883210|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
13883211|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883212|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
13883213|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
13883214|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883215|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
14938599|NCT01482416|Estrogens|estrogens|mesh-list
14938600|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14938601|NCT01482416|Hormones|hormones|mesh-ancestor
14938602|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938603|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883216|NCT03570359|Interferons|interferons|mesh-list
13883217|NCT03570359|Interferon-beta|interferon-beta|mesh-list
13883218|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
13883219|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938604|NCT01482442|Sorafenib|sorafenib|mesh-list
13883220|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
13883221|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883222|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
13883223|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883224|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13883225|NCT03570346|Hemay005|hemay005|mesh-list
13883226|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
13883227|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13883228|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14470963|NCT02321098|Amorolfine|amorolfine|mesh-list
14470964|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
14470965|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14470966|NCT02321319|Hydromorphone|hydromorphone|mesh-list
14470967|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14470968|NCT02321319|Narcotics|narcotics|mesh-ancestor
13883229|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883230|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883231|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
13883232|NCT03570320|Narcotics|narcotics|mesh-ancestor
13883233|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027450|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883234|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027451|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14027452|NCT02736071|Narcotics|narcotics|mesh-ancestor
14027453|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027454|NCT02736123|Nivolumab|nivolumab|mesh-list
14027455|NCT02736123|Ipilimumab|ipilimumab|mesh-list
14027456|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027457|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027458|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14027459|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027460|NCT02736019|Celecoxib|celecoxib|mesh-list
14470969|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883235|NCT03570320|Analgesics|analgesics|mesh-ancestor
13883236|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
14470970|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883237|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883238|NCT03570294|Atosiban|atosiban|mesh-list
14470971|NCT02321319|Analgesics|analgesics|mesh-ancestor
13883239|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
13883240|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883241|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883242|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
13883243|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883244|NCT03570281|Enoxaparin|enoxaparin|mesh-list
13883245|NCT03570281|Edoxaban|edoxaban|mesh-list
13883246|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
13883247|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13883248|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13883249|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931759|NCT01441505|Midazolam|midazolam|mesh-list
14931760|NCT01441505|Ketamine|ketamine|mesh-list
14931761|NCT01441505|Analgesics|analgesics|mesh-ancestor
14931762|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
14931763|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931764|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931765|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14931766|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14931767|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
14931768|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
14931769|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931770|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14931771|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14931772|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931773|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931774|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14931775|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14931776|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14931777|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14931778|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13883250|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13883251|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
13883252|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13883253|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
13883254|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883255|NCT03570164|Sevoflurane|sevoflurane|mesh-list
13883256|NCT03570164|Desflurane|desflurane|mesh-list
13883257|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13883258|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13883259|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
13883260|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
13883261|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883262|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883263|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
13883264|NCT03570112|Velpatasvir|velpatasvir|mesh-list
13883265|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
13883266|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883267|NCT03570099|Naloxone|naloxone|mesh-list
14931779|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
14931780|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
14931781|NCT01441531|Gabapentin|gabapentin|mesh-list
14931782|NCT01441531|Analgesics|analgesics|mesh-ancestor
13883268|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13883269|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883270|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
13883271|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957830|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13957831|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13957832|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13957833|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13957834|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13957835|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14470972|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
14470973|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470974|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
14470975|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14470976|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14470977|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14470978|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14470979|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470980|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
14470981|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931783|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
14931784|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931785|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931786|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
14931787|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14931788|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14931789|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931790|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14931791|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14931792|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13883272|NCT03569995|Cytarabine|cytarabine|mesh-list
13883273|NCT03569995|Rituximab|rituximab|mesh-list
13883274|NCT03569995|Methotrexate|methotrexate|mesh-list
13883275|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13883276|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883277|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
13883278|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883279|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883280|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13883281|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
13883282|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883283|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13883284|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
13883285|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883286|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
13883287|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883288|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13883289|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13883290|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13883291|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
13883292|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883293|NCT03569839|Propofol|propofol|mesh-list
14931793|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931794|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931795|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
14931796|NCT01441557|Amifampridine|amifampridine|mesh-list
13883294|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13883295|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883296|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883297|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13883298|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
13883299|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
13883300|NCT03569696|Nivolumab|nivolumab|mesh-list
13883301|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13883302|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931797|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14931798|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931799|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931800|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14931801|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14931802|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931803|NCT01441700|Anesthetics|anesthetics|mesh-list
14931804|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883303|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13883304|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883305|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
13883306|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13883307|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
13883308|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883309|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
13883310|NCT03569683|Protective Agents|protective agents|mesh-ancestor
13883311|NCT03569579|Memantine|memantine|mesh-list
13883312|NCT03569579|Donepezil|donepezil|mesh-list
13883313|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13883314|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883315|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883316|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
13883317|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883318|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883319|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
13883320|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13883321|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13883322|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
14931805|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931806|NCT01441804|Ribavirin|ribavirin|mesh-list
14931807|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13883323|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13883324|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13883325|NCT03569540|Glyburide|glyburide|mesh-list
13883326|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13883327|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883328|NCT03569241|Androgens|androgens|mesh-list
13883329|NCT03569241|Hormones|hormones|mesh-ancestor
13883330|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883331|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883332|NCT03569085|Sevoflurane|sevoflurane|mesh-list
13883333|NCT03569085|Isoflurane|isoflurane|mesh-list
13883334|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13883335|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13883336|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
13883337|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
13883338|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883339|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883340|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
13883341|NCT03569046|Bupivacaine|bupivacaine|mesh-list
13883342|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
13883343|NCT03569046|Anesthetics|anesthetics|mesh-list
13883344|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
13883345|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883346|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883347|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
13883348|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883349|NCT03568968|Niacinamide|niacinamide|mesh-list
13883350|NCT03568968|Niacin|niacin|mesh-list
13883351|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
13883352|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
13883353|NCT03568968|Vitamins|vitamins|mesh-ancestor
13883354|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
13883355|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883356|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13883357|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
13883358|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883359|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13883360|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
14931808|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
14931809|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
14931810|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931811|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
13883361|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
13883362|NCT03568916|Apixaban|apixaban|mesh-list
13883363|NCT03568916|Dabigatran|dabigatran|mesh-list
13883364|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13883365|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
13883366|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13883367|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
14754427|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14931812|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883368|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754428|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
14754429|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754430|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14754431|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14754432|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14754433|NCT04657003|Tirzepatide|tirzepatide|mesh-list
14754434|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14754435|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754436|NCT04657003|Incretins|incretins|mesh-ancestor
14754437|NCT04657003|Hormones|hormones|mesh-ancestor
13883369|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883370|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
13883371|NCT03568890|Aspirin|aspirin|mesh-list
13883372|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
14767193|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
14931813|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
14931814|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931815|NCT01441869|Metformin|metformin|mesh-list
14931816|NCT01441869|Saxagliptin|saxagliptin|mesh-list
14931817|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931818|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883373|NCT03568890|Apixaban|apixaban|mesh-list
14754438|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754439|NCT04655976|Docetaxel|docetaxel|mesh-list
13883374|NCT03568890|Edoxaban|edoxaban|mesh-list
13883375|NCT03568890|Dabigatran|dabigatran|mesh-list
13883376|NCT03568890|Clopidogrel|clopidogrel|mesh-list
13883377|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13883378|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883379|NCT03568890|Analgesics|analgesics|mesh-ancestor
13883380|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
13883381|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883382|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883383|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883384|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883385|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13883386|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14931819|NCT01441869|Incretins|incretins|mesh-ancestor
14931820|NCT01441869|Hormones|hormones|mesh-ancestor
14931821|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14931822|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14931823|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
14931824|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931825|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931826|NCT01441908|Pravastatin|pravastatin|mesh-list
14931827|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14931828|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14931829|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
14931830|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883387|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883388|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13883389|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13883390|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883391|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
13883392|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13883393|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13883394|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13883395|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
13883396|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883397|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13883398|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
13883399|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13883400|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
13883401|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
13883402|NCT03568838|Enoxaparin|enoxaparin|mesh-list
13883403|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
13883404|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13883405|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13883406|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883407|NCT03568721|Acetaminophen|acetaminophen|mesh-list
13883408|NCT03568721|Ibuprofen|ibuprofen|mesh-list
13883409|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883410|NCT03568721|Analgesics|analgesics|mesh-ancestor
13883411|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
13883412|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883413|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754440|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754441|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
14754442|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
14754443|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
14754444|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754445|NCT04647435|Tramadol|tramadol|mesh-list
14754446|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14754447|NCT04647435|Narcotics|narcotics|mesh-ancestor
14754448|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754449|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754450|NCT04647435|Analgesics|analgesics|mesh-ancestor
14754451|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
14931831|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13883414|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
13883415|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13883416|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883417|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883418|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13883419|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883420|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883421|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13883422|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13883423|NCT03568708|Estradiol|estradiol|mesh-list
13883424|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13883425|NCT03568708|Estrogens|estrogens|mesh-list
13883426|NCT03568708|Hormones|hormones|mesh-ancestor
13883427|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883428|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883429|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13883430|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
13883431|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883432|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13883433|NCT03568643|Amoxicillin|amoxicillin|mesh-list
13883434|NCT03568643|Azithromycin|azithromycin|mesh-list
13883435|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13883436|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883437|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
13883438|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13883439|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
13883440|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883441|NCT03568578|Entecavir|entecavir|mesh-list
13883442|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
13883443|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883444|NCT03568513|Curcumin|curcumin|mesh-list
13883445|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13883446|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883447|NCT03568513|Analgesics|analgesics|mesh-ancestor
13883448|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
13883449|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883450|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883451|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883452|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883453|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883454|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883455|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883456|NCT03568474|Fluorides|fluorides|mesh-list
13883457|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
13883458|NCT03568474|Protective Agents|protective agents|mesh-ancestor
13883459|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957836|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13957837|NCT03173053|Renal Agents|renal agents|mesh-ancestor
13957838|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13957839|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13957840|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13957841|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13957842|NCT03173066|Hematinics|hematinics|mesh-ancestor
13883460|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13883461|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
13883462|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883463|NCT03567941|Acetaminophen|acetaminophen|mesh-list
13883464|NCT03567941|Hydrocodone|hydrocodone|mesh-list
13883465|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883466|NCT03567941|Analgesics|analgesics|mesh-ancestor
13883467|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
13883468|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883469|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931832|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14931833|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931834|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
14931835|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931836|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
13883470|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
13883471|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13883472|NCT03567941|Narcotics|narcotics|mesh-ancestor
13883473|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883474|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
13883475|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
14931837|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14754452|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754453|NCT04645966|Acetaminophen|acetaminophen|mesh-list
14754454|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14754455|NCT04645966|Analgesics|analgesics|mesh-ancestor
14754456|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
14754457|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754458|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754459|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
13883476|NCT03567928|Propofol|propofol|mesh-list
13883477|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13883478|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883479|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883480|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13883481|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
13883482|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
14754460|NCT04644029|Tenofovir|tenofovir|mesh-list
14754461|NCT04644029|Emtricitabine|emtricitabine|mesh-list
14754462|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14754463|NCT04644029|Islatravir|islatravir|mesh-list
14754464|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
14754465|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754466|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14754467|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14754468|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754469|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754470|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14754471|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14754472|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
14754473|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14754474|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931838|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13883483|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
13883484|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
13883485|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13883486|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13883487|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13883488|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883489|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13883490|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13883491|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13883492|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13883493|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
13883494|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883495|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883496|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13883497|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13883498|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883499|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883500|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
13883501|NCT03567629|Leucovorin|leucovorin|mesh-list
13883502|NCT03567629|Bevacizumab|bevacizumab|mesh-list
13883503|NCT03567629|Cetuximab|cetuximab|mesh-list
13883504|NCT03567629|Fluorouracil|fluorouracil|mesh-list
13883505|NCT03567629|Capecitabine|capecitabine|mesh-list
13883506|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
13883507|NCT03567629|Irinotecan|irinotecan|mesh-list
13883508|NCT03567629|Calcium|calcium|mesh-list
13883509|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
13883510|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13883511|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883512|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13883513|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13883514|NCT03567629|Growth Substances|growth substances|mesh-ancestor
13883515|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883516|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
13883517|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13883518|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13883519|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
13883520|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883521|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13883522|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13883523|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
13883524|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13883525|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13883526|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883527|NCT03567629|Antidotes|antidotes|mesh-ancestor
13883528|NCT03567629|Protective Agents|protective agents|mesh-ancestor
13883529|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
13883530|NCT03567629|Vitamins|vitamins|mesh-ancestor
13883531|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
13883532|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13883533|NCT03567473|Dexamethasone|dexamethasone|mesh-list
13883534|NCT03567473|Epinephrine|epinephrine|mesh-list
13883535|NCT03567473|Racepinephrine|racepinephrine|mesh-list
13883536|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
13883537|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883538|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
13883539|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
13883540|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883541|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883542|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13883543|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
13883544|NCT03567473|Hormones|hormones|mesh-ancestor
13883545|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883546|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883547|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883548|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13883549|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13883550|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
13883551|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883552|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883553|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13883554|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13883555|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13883556|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
13883557|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
13883558|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
13883559|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13883560|NCT03567447|Droxidopa|droxidopa|mesh-list
13883561|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13963179|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
13883562|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13883563|NCT03567434|Ethanol|ethanol|mesh-list
13883564|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13883565|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883566|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883567|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931839|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931840|NCT01441934|Urological Agents|urological agents|mesh-ancestor
14931841|NCT01441947|Fulvestrant|fulvestrant|mesh-list
14931842|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931843|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931844|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14931845|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13883568|NCT03567408|Bivalirudin|bivalirudin|mesh-list
13883569|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
13883570|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14931846|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
14931847|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883571|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
13883572|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883573|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883574|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
13883575|NCT03567395|Melatonin|melatonin|mesh-list
13883576|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
13883577|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883578|NCT03567395|Protective Agents|protective agents|mesh-ancestor
13883579|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883580|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883581|NCT03567369|Dexamethasone|dexamethasone|mesh-list
13883582|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
13883583|NCT03567369|BB 1101|bb 1101|mesh-list
13883584|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883585|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
13883586|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
13883587|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883588|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883589|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13883590|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
13883591|NCT03567369|Hormones|hormones|mesh-ancestor
13883592|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883593|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883594|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883595|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
13883596|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883597|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883598|NCT03567343|Melatonin|melatonin|mesh-list
13883599|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
13883600|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883601|NCT03567343|Protective Agents|protective agents|mesh-ancestor
13883602|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754475|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754476|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14754477|NCT04642651|Analgesics|analgesics|mesh-ancestor
14754478|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
14754479|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754480|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14754481|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14754482|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14754483|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14754484|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754485|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883603|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883604|NCT03567304|Rilpivirine|rilpivirine|mesh-list
14027461|NCT02736019|Tramadol|tramadol|mesh-list
14027462|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14027463|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027464|NCT02736019|Analgesics|analgesics|mesh-ancestor
14027465|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
14027466|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027467|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027468|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027469|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027470|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14027471|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14027472|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027473|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027474|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14027475|NCT02736019|Narcotics|narcotics|mesh-ancestor
14027476|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027477|NCT02735837|Doxycycline|doxycycline|mesh-list
14027478|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027479|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027480|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
14027481|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14027482|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14027483|NCT02735928|Doxorubicin|doxorubicin|mesh-list
14027484|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027485|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14027486|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14754486|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14931848|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931849|NCT01441986|Amantadine|amantadine|mesh-list
14931850|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
14931851|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
14931852|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
14931853|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14931854|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14931855|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14931856|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931857|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931858|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13883605|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13883606|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13883607|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883608|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883609|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
13883610|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883611|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13883612|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13883613|NCT03567135|Temozolomide|temozolomide|mesh-list
13883614|NCT03567135|Apatinib|apatinib|mesh-list
13883615|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13883616|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
14754487|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14754488|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14754489|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754490|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
14754491|NCT04637594|Nivolumab|nivolumab|mesh-list
14754492|NCT04637594|Durvalumab|durvalumab|mesh-list
14754493|NCT04637594|Avelumab|avelumab|mesh-list
14754494|NCT04637594|Atezolizumab|atezolizumab|mesh-list
14754495|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754496|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754497|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13883617|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883618|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883619|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13883620|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883621|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
13883622|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883623|NCT03566914|Tadalafil|tadalafil|mesh-list
13883624|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
13883625|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13883626|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13883627|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883628|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883629|NCT03566914|Urological Agents|urological agents|mesh-ancestor
14754498|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754499|NCT04637529|Ibuprofen|ibuprofen|mesh-list
14754500|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14754501|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14754502|NCT04637529|Analgesics|analgesics|mesh-ancestor
14754503|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
14754504|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754505|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754506|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754507|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754508|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14754509|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767455|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13883643|NCT03566576|Docetaxel|docetaxel|mesh-list
13883644|NCT03566576|Pemetrexed|pemetrexed|mesh-list
13883645|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883646|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
13883647|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
13883648|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
13883649|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883650|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883651|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13883652|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13957843|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13957844|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13957845|NCT03173092|Dexamethasone|dexamethasone|mesh-list
13957846|NCT03173092|Lenalidomide|lenalidomide|mesh-list
13957847|NCT03173092|Ixazomib|ixazomib|mesh-list
13957848|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957849|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
13957850|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
13957851|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957852|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957853|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957854|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
13957855|NCT03173092|Hormones|hormones|mesh-ancestor
13957856|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957857|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13957858|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957859|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
13957860|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13957861|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13957862|NCT03173092|Growth Substances|growth substances|mesh-ancestor
13957863|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
13883653|NCT03566394|Gabapentin|gabapentin|mesh-list
13883654|NCT03566394|Analgesics|analgesics|mesh-ancestor
13883655|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
13883656|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883657|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883658|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
13883659|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13883660|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13883661|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883662|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13883663|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13883664|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13883665|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883666|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883667|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
13883668|NCT03566329|Lidocaine|lidocaine|mesh-list
13883669|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
13883670|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
13883671|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
13883672|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883673|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883674|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
13883675|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883676|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13883677|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13883678|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13883679|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13883680|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883681|NCT03566329|Analgesics|analgesics|mesh-ancestor
13883682|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
13883683|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13883684|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13883685|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
13883686|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883687|NCT03566316|Amlodipine|amlodipine|mesh-list
13883688|NCT03566316|Telmisartan|telmisartan|mesh-list
13883689|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
13883690|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13883691|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13883692|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13883693|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13883694|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883695|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13883696|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883697|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
13883698|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13883699|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13883700|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
13883701|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13883702|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13883703|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883704|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13883705|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13883706|NCT03566303|Vitamin K|vitamin k|mesh-list
13883707|NCT03566303|Warfarin|warfarin|mesh-list
13883708|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
13883709|NCT03566303|Vitamins|vitamins|mesh-ancestor
13883710|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
13883711|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883712|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
13883713|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13883714|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
13883715|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13883716|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
13883717|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883718|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883719|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13883720|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13883721|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
13883722|NCT03566303|Coagulants|coagulants|mesh-ancestor
13883723|NCT03566225|Metformin|metformin|mesh-list
13883724|NCT03566225|Pioglitazone|pioglitazone|mesh-list
13883725|NCT03566225|Clomiphene|clomiphene|mesh-list
13883726|NCT03566225|Enclomiphene|enclomiphene|mesh-list
13883727|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
13883728|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13883729|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883730|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13883731|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
13883732|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883733|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13883734|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
13883735|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883736|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13883737|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13883738|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
13883739|NCT03566134|DA-8010|da-8010|mesh-list
13883740|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13883741|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13883742|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
13883743|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883744|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883745|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883746|NCT03566134|Urological Agents|urological agents|mesh-ancestor
13883747|NCT03566069|Oxytocin|oxytocin|mesh-list
13883748|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
13883749|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883750|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883751|NCT03566030|Tenofovir|tenofovir|mesh-list
13883752|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
13883753|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883754|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13883755|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13883756|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883757|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883758|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13883759|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13883760|NCT03565536|Sorafenib|sorafenib|mesh-list
13883761|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883762|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13883763|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883764|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883765|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
13883766|NCT03565458|Empagliflozin|empagliflozin|mesh-list
13883767|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13883768|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883769|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13883770|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883771|NCT03565406|Nivolumab|nivolumab|mesh-list
13883772|NCT03565406|Ipilimumab|ipilimumab|mesh-list
13883773|NCT03565406|Mocetinostat|mocetinostat|mesh-list
13883774|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13883775|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883776|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13883777|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883778|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13883779|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883780|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13883781|NCT03565354|Hematinics|hematinics|mesh-ancestor
13883782|NCT03565302|Terbutaline|terbutaline|mesh-list
13883783|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
13883784|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13883785|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
13883786|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883787|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883788|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13883789|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
13883790|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13883791|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13883792|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13883793|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
13883794|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883795|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883796|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
13883797|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
13883798|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883799|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
13883800|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13883801|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13883802|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883803|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
13883804|NCT03565276|Coagulants|coagulants|mesh-ancestor
13883805|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13883806|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
13883807|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883808|NCT03565133|Quinine|quinine|mesh-list
13883809|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
13883810|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13883811|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13883812|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883813|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13883814|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883815|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13883816|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883817|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883818|NCT03565133|Analgesics|analgesics|mesh-ancestor
13883819|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
13883820|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
13883821|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13883822|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
13883823|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883824|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883825|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883826|NCT03564912|Capecitabine|capecitabine|mesh-list
13883827|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
13883828|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13883829|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
13883830|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931859|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14931860|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
14931861|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931862|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
14931863|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14931864|NCT01441986|Analgesics|analgesics|mesh-ancestor
14931865|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
14931866|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931867|NCT01442025|Infliximab|infliximab|mesh-list
14931868|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
14931869|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931870|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14931871|NCT01442168|Atovaquone|atovaquone|mesh-list
14931872|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931873|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
14931874|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14931875|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14931876|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931877|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931878|NCT01442246|Leuprolide|leuprolide|mesh-list
14931879|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14931880|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
14931881|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14931882|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931883|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883831|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883832|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
14931884|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931885|NCT01442272|Calcifediol|calcifediol|mesh-list
14931886|NCT01442272|Vitamins|vitamins|mesh-ancestor
14931887|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
14931888|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931889|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14931890|NCT01442311|Interferons|interferons|mesh-list
14931891|NCT01442311|Ribavirin|ribavirin|mesh-list
14931892|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
14931893|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
14931894|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14931895|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14931896|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
14931897|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931898|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
14931899|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931900|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
14931901|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931902|NCT01442428|Dexamethasone|dexamethasone|mesh-list
14931903|NCT01442428|Naproxen|naproxen|mesh-list
14931904|NCT01442428|Atorvastatin|atorvastatin|mesh-list
14931905|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14931906|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
13883833|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
13883834|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13883835|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883836|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13883837|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13883838|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
13883839|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13883840|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
13883841|NCT03564756|Vitamins|vitamins|mesh-ancestor
13883842|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
13883843|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883844|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
13883845|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883846|NCT03564756|Protective Agents|protective agents|mesh-ancestor
13957864|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
13957865|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957866|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957867|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
13957868|NCT03173131|Narcotics|narcotics|mesh-ancestor
13957869|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957870|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957871|NCT03173131|Analgesics|analgesics|mesh-ancestor
13957872|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
13957873|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957874|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
13957875|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13957876|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957877|NCT03172676|Amoxicillin|amoxicillin|mesh-list
13957878|NCT03172676|Clarithromycin|clarithromycin|mesh-list
13957879|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13957880|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13957881|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957882|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13957883|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957884|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957885|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14931907|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
14931908|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883847|NCT03564704|Cytarabine|cytarabine|mesh-list
13883848|NCT03564704|Dexamethasone|dexamethasone|mesh-list
13883849|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
13883850|NCT03564704|Methotrexate|methotrexate|mesh-list
13883851|NCT03564704|Etoposide|etoposide|mesh-list
13883852|NCT03564704|Vincristine|vincristine|mesh-list
13883853|NCT03564704|Doxorubicin|doxorubicin|mesh-list
13883854|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
13883855|NCT03564704|Idarubicin|idarubicin|mesh-list
13883856|NCT03564704|Pegaspargase|pegaspargase|mesh-list
13883857|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13883858|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
13883859|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883860|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13883861|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13883862|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
13883863|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883864|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883865|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13883866|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754510|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754511|NCT04635605|Methylene Blue|methylene blue|mesh-list
14754512|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754513|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754514|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
13883867|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
13883868|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
13883869|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883870|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931909|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931910|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14931911|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
14931912|NCT01442428|Hormones|hormones|mesh-ancestor
14931913|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883871|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
13883872|NCT03564704|Hormones|hormones|mesh-ancestor
13883873|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883874|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883875|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13883876|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
13883877|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883878|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13883879|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
13883880|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
13883881|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883882|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13883883|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13883884|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13883885|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13883886|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13883887|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
13883888|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883889|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
13883890|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
13883891|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
13883892|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13883893|NCT03564652|Azithromycin|azithromycin|mesh-list
13883894|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13883895|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883896|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13883897|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13883898|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13883899|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13883900|NCT03564548|Morphine|morphine|mesh-list
13883901|NCT03564548|Oxycodone|oxycodone|mesh-list
13883902|NCT03564548|Hydromorphone|hydromorphone|mesh-list
14027487|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14754515|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14754516|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754517|NCT04629534|Vitamins|vitamins|mesh-ancestor
14754518|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
14754519|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13883903|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13883904|NCT03564548|Narcotics|narcotics|mesh-ancestor
13883905|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027488|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883906|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883907|NCT03564548|Analgesics|analgesics|mesh-ancestor
13883908|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
13883909|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883910|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13883911|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13883912|NCT03564509|Hormones|hormones|mesh-ancestor
13883913|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883914|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883915|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13883916|NCT03564470|Dasatinib|dasatinib|mesh-list
13883917|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883918|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13883919|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883920|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883921|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
13883922|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883923|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883924|NCT03564301|Metronidazole|metronidazole|mesh-list
13883925|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883926|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13883927|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13883928|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13883929|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
13883930|NCT03564158|Meropenem|meropenem|mesh-list
13883931|NCT03564158|Vaborbactam|vaborbactam|mesh-list
13883932|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13883933|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883934|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13883935|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13883936|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883937|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883938|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883939|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14931914|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14931915|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883940|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
13883941|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13883942|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13883943|NCT03564106|Prednisolone|prednisolone|mesh-list
13883944|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
13883945|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13883946|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
13883947|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13883948|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
13883949|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
13883950|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883951|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883952|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13883953|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
13883954|NCT03564106|Hormones|hormones|mesh-ancestor
13883955|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13883956|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14470982|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14470983|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14470984|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14470985|NCT02321748|Montelukast|montelukast|mesh-list
14470986|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14470987|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14470988|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14470989|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
14470990|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14470991|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754520|NCT04629248|Acetaminophen|acetaminophen|mesh-list
13883957|NCT03564106|Protective Agents|protective agents|mesh-ancestor
13883958|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13883959|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883960|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
14754521|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
14754522|NCT04629248|Promethazine|promethazine|mesh-list
14754523|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
14754524|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
14754525|NCT04629248|Tacrolimus|tacrolimus|mesh-list
14754526|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754527|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
13883961|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13883962|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883963|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883964|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13883965|NCT03564093|Analgesics|analgesics|mesh-ancestor
13883966|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
13883967|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883968|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13883969|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13883970|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13883971|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
14931916|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14931917|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14931918|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
14931919|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931920|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14931921|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14931922|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931923|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14931924|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14931925|NCT01442428|Analgesics|analgesics|mesh-ancestor
14931926|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
14931927|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14931928|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
14931929|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14931930|NCT01442519|Mitomycins|mitomycins|mesh-list
14931931|NCT01442519|Mitomycin|mitomycin|mesh-list
14931932|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
14931933|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14931934|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13883972|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13883973|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883974|NCT03563963|Lidocaine|lidocaine|mesh-list
13883975|NCT03563963|Ropivacaine|ropivacaine|mesh-list
13883976|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13883977|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
13883978|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
13883979|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13883980|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13883981|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
13883982|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13883983|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13883984|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13883985|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13883986|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13883987|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883988|NCT03563950|Rifampin|rifampin|mesh-list
13883989|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13883990|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
13883991|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13883992|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13883993|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
13883994|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13883995|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13883996|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13883997|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13883998|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13883999|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14027489|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027490|NCT02735876|Rituximab|rituximab|mesh-list
14027491|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
14027492|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027493|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027494|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
14027495|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027496|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027497|NCT02735902|Aspirin|aspirin|mesh-list
14027498|NCT02735902|Vitamin K|vitamin k|mesh-list
14027499|NCT02735902|Anticoagulants|anticoagulants|mesh-list
14027500|NCT02735902|Vitamins|vitamins|mesh-ancestor
14027501|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
14027502|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027503|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14931935|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
13884000|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13884001|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13884002|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13884003|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
13884004|NCT03563937|Apixaban|apixaban|mesh-list
13884005|NCT03563937|Edoxaban|edoxaban|mesh-list
13884006|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
13884007|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13884008|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
13884009|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13884010|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
13884011|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884012|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884013|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
13884014|NCT03563833|Anesthetics|anesthetics|mesh-list
13884015|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884016|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884017|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
13884018|NCT03563794|Vildagliptin|vildagliptin|mesh-list
13884019|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13884020|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884021|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13884022|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
13884023|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884024|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884025|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
13884026|NCT03563729|Nivolumab|nivolumab|mesh-list
13884027|NCT03563729|Ipilimumab|ipilimumab|mesh-list
13884028|NCT03563729|Trametinib|trametinib|mesh-list
13884029|NCT03563729|Dabrafenib|dabrafenib|mesh-list
13884030|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884031|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884032|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13884033|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884034|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13884035|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884036|NCT03563664|Danazol|danazol|mesh-list
13884037|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13884038|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
13884039|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884040|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884041|NCT03563625|Bupivacaine|bupivacaine|mesh-list
13884042|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
13884043|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
13884044|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884045|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884046|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
13884047|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884048|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13884049|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884050|NCT03563534|Fluorides|fluorides|mesh-list
13884051|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
13884052|NCT03563534|Protective Agents|protective agents|mesh-ancestor
13884053|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884054|NCT03563365|Adapalene|adapalene|mesh-list
13884055|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
13884056|NCT03563365|Resveratrol|resveratrol|mesh-list
13884057|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
13884058|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884059|NCT03563365|Protective Agents|protective agents|mesh-ancestor
13884060|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884061|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884062|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13884063|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
13884064|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13884065|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13884066|NCT03563365|Analgesics|analgesics|mesh-ancestor
13884067|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
13884068|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884069|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884070|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884071|NCT03563248|Nivolumab|nivolumab|mesh-list
13884072|NCT03563248|Folfirinox|folfirinox|mesh-list
13884073|NCT03563248|Losartan|losartan|mesh-list
13884074|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884075|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884076|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13884077|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884078|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13884079|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13884080|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13884081|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13884082|NCT03563235|Calcitriol|calcitriol|mesh-list
13884083|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13884084|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884085|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13884086|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13884087|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884088|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13884089|NCT03563235|Vitamins|vitamins|mesh-ancestor
13884090|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
13884091|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13884092|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13884093|NCT03563222|SMOFlipid|smoflipid|mesh-list
13884094|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13884095|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13884096|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13884097|NCT03563170|Leucovorin|leucovorin|mesh-list
13884098|NCT03563170|Paclitaxel|paclitaxel|mesh-list
13884099|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
13884100|NCT03563170|Fluorouracil|fluorouracil|mesh-list
13884101|NCT03563170|Capecitabine|capecitabine|mesh-list
13884102|NCT03563170|Cetuximab|cetuximab|mesh-list
13884103|NCT03563170|Sorafenib|sorafenib|mesh-list
13884104|NCT03563170|Avelumab|avelumab|mesh-list
13884105|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13884106|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884107|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
13884108|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
13884109|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
13884110|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884111|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884112|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
13884113|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884114|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884115|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13884116|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
13884117|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13884118|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
13884119|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13884120|NCT03563170|Antidotes|antidotes|mesh-ancestor
13884121|NCT03563170|Protective Agents|protective agents|mesh-ancestor
13884122|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
13884123|NCT03563170|Vitamins|vitamins|mesh-ancestor
13884124|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
13884125|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754528|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754529|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14754530|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754531|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754532|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14754533|NCT04629248|Analgesics|analgesics|mesh-ancestor
14754534|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
14754535|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754536|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
14754537|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754538|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
14754539|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
14754540|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884126|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13884127|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884128|NCT03563144|Leucovorin|leucovorin|mesh-list
13884129|NCT03563144|Gemcitabine|gemcitabine|mesh-list
14754541|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
13884130|NCT03563144|Paclitaxel|paclitaxel|mesh-list
13884131|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
13884132|NCT03563144|Bevacizumab|bevacizumab|mesh-list
13884133|NCT03563144|Fluorouracil|fluorouracil|mesh-list
13884134|NCT03563144|Capecitabine|capecitabine|mesh-list
13884135|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
13884136|NCT03563144|Avelumab|avelumab|mesh-list
13884137|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13884138|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884139|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
13884140|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
13884141|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
13884142|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884143|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884144|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
13884145|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884146|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884147|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13884148|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
14754542|NCT04629248|Hormones|hormones|mesh-ancestor
14754543|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754544|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14754545|NCT04629248|Protective Agents|protective agents|mesh-ancestor
14754546|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754547|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754548|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14754549|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14754550|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754551|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
14754552|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
14754553|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14754554|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
14754555|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
13884149|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13884150|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884151|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13884152|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13884153|NCT03563144|Growth Substances|growth substances|mesh-ancestor
13884154|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
13884155|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13884156|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
13884157|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
13884158|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884159|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884160|NCT03563144|Antidotes|antidotes|mesh-ancestor
13884161|NCT03563144|Protective Agents|protective agents|mesh-ancestor
13884162|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
13884163|NCT03563144|Vitamins|vitamins|mesh-ancestor
13884164|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
13957886|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13957887|NCT03172793|Telavancin|telavancin|mesh-list
13957888|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13957889|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957890|NCT03172741|Dronabinol|dronabinol|mesh-list
13957891|NCT03172741|Cannabidiol|cannabidiol|mesh-list
13957892|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
13957893|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
13957894|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957895|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13957896|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957897|NCT03172741|Analgesics|analgesics|mesh-ancestor
13957898|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
13957899|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957900|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13963180|NCT01979536|BB 1101|bb 1101|mesh-list
13884165|NCT03563040|Methoxsalen|methoxsalen|mesh-list
13884166|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13884167|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
13884168|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13884169|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884170|NCT03563001|Budesonide|budesonide|mesh-list
13884171|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
13884172|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884173|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13884174|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
13884175|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884176|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884177|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13884178|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
13884179|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
13884180|NCT03563001|Hormones|hormones|mesh-ancestor
13884181|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884182|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13884183|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13884184|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13884185|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
13884186|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884187|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884188|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
13884189|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
13884190|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884191|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13884192|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14931936|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931937|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14931938|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931939|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14931940|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
14931941|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931942|NCT01442532|Midazolam|midazolam|mesh-list
14931943|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14931944|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14931945|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931946|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931947|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14931948|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13884193|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
13884194|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884195|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884196|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13884197|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
13884198|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
13884199|NCT03562923|Hormones|hormones|mesh-ancestor
13884200|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884201|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
13884202|NCT03562780|Acetaminophen|acetaminophen|mesh-list
13884203|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13884204|NCT03562780|Analgesics|analgesics|mesh-ancestor
13884205|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
13884206|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884207|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884208|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
13884209|NCT03562754|Heparin|heparin|mesh-list
13884210|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
13884211|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884212|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14931949|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13884213|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13884214|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
13884215|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
13884216|NCT03562611|Nalbuphine|nalbuphine|mesh-list
13884217|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13884218|NCT03562611|Narcotics|narcotics|mesh-ancestor
13884219|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884220|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884221|NCT03562611|Analgesics|analgesics|mesh-ancestor
13884222|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
13884223|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884224|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13884225|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13884226|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884227|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884228|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13884229|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884230|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884231|NCT03562585|Antibodies|antibodies|mesh-list
13884232|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13884233|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
13884234|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884235|NCT03562533|Paclitaxel|paclitaxel|mesh-list
13884236|NCT03562533|Carboplatin|carboplatin|mesh-list
13884237|NCT03562533|Doxorubicin|doxorubicin|mesh-list
13884238|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13884239|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13884240|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884241|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
13884242|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
13884243|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
13884244|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884245|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13884246|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13884247|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13884248|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884249|NCT03562507|Nivolumab|nivolumab|mesh-list
13884250|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884251|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884252|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13884253|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884254|NCT03562468|Niacinamide|niacinamide|mesh-list
13884255|NCT03562468|Niacin|niacin|mesh-list
13884256|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
13884257|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
13884258|NCT03562468|Vitamins|vitamins|mesh-ancestor
13884259|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
13884260|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884261|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13884262|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
13884263|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884264|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13884265|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
13884266|NCT03562416|Nintedanib|nintedanib|mesh-list
13884267|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884268|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13884269|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884270|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884271|NCT03562390|Irinotecan|irinotecan|mesh-list
13884272|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13884273|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13884274|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884275|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884276|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884277|NCT03562169|Thalidomide|thalidomide|mesh-list
13884278|NCT03562169|Dexamethasone|dexamethasone|mesh-list
14470992|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14470993|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14470994|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14470995|NCT02321800|Imipenem|imipenem|mesh-list
14470996|NCT02321800|Cilastatin|cilastatin|mesh-list
14470997|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14470998|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884279|NCT03562169|Ixazomib|ixazomib|mesh-list
14470999|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
13884280|NCT03562169|Glycine|glycine|mesh-list
13884281|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884282|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
13884283|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
13884284|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884285|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884286|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884287|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
13884288|NCT03562169|Hormones|hormones|mesh-ancestor
13884289|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884290|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13884291|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884292|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884293|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
13884294|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
14471000|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471001|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471002|NCT02321930|Tofacitinib|tofacitinib|mesh-list
14471003|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14471004|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471005|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471006|NCT02322047|Prazosin|prazosin|mesh-list
14471007|NCT02322047|Naltrexone|naltrexone|mesh-list
14471008|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14471009|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14471010|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471011|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
14471012|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754556|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884295|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13884296|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884297|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13884298|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13884299|NCT03562169|Growth Substances|growth substances|mesh-ancestor
13884300|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
13884301|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
13884302|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884303|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884304|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
13884305|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884306|NCT03562143|Iron|iron|mesh-list
13884307|NCT03562143|Trace Elements|trace elements|mesh-ancestor
13884308|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
13884309|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884310|NCT03562130|Teduglutide|teduglutide|mesh-list
13884311|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884312|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13884313|NCT03562130|Protective Agents|protective agents|mesh-ancestor
13884314|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884315|NCT03561935|Propafenone|propafenone|mesh-list
13884316|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13884317|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13884318|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13884319|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13884320|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884326|NCT03561740|Capecitabine|capecitabine|mesh-list
14027504|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027505|NCT02735902|Analgesics|analgesics|mesh-ancestor
14027506|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
14027507|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027508|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027509|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027510|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14027511|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14027512|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027513|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14027514|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14027515|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027516|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
14471013|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14754557|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14754558|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
14931950|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14931951|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
14931952|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
13884327|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13884328|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
13884329|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884330|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884331|NCT03561675|Acetazolamide|acetazolamide|mesh-list
13884332|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
13884333|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13884334|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884335|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884336|NCT03561675|Diuretics|diuretics|mesh-ancestor
13884337|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
13884338|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884339|NCT03561649|Adalimumab|adalimumab|mesh-list
13884340|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884341|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884342|NCT03561558|Ibuprofen|ibuprofen|mesh-list
13884343|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13884344|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13884345|NCT03561558|Analgesics|analgesics|mesh-ancestor
13884346|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
13884347|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884348|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884349|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884350|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884351|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13884352|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884353|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957901|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13957902|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957903|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957904|NCT03172741|Hormones|hormones|mesh-ancestor
13957905|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957906|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
13957907|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13957908|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13957909|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
13957910|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13957911|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957912|NCT03172624|Nivolumab|nivolumab|mesh-list
13957913|NCT03172624|Ipilimumab|ipilimumab|mesh-list
13957914|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13957915|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957916|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13957917|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957918|NCT03172377|Adalimumab|adalimumab|mesh-list
13957919|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957920|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13957921|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
13957922|NCT03172416|Nivolumab|nivolumab|mesh-list
13957923|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957924|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754559|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14754560|NCT04627142|Irinotecan|irinotecan|mesh-list
14754561|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14754562|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14754563|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754564|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754565|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754566|NCT04622904|Lidocaine|lidocaine|mesh-list
14754567|NCT04622904|Ketamine|ketamine|mesh-list
13957925|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14754568|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
14754569|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
14931953|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
13884354|NCT03561415|Posaconazole|posaconazole|mesh-list
13884355|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
13884356|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884357|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13884358|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13884359|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13884360|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13884361|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13884362|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884363|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884364|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13884365|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
13884366|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884367|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884368|NCT03561402|Teriflunomide|teriflunomide|mesh-list
13884369|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13884370|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13884371|NCT03561402|Analgesics|analgesics|mesh-ancestor
13884372|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
13884373|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884374|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884375|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884376|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884377|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884378|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
13884379|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
14754570|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754571|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884380|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884381|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13884382|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884383|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884384|NCT03561233|Omeprazole|omeprazole|mesh-list
13884385|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13884386|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884387|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13884388|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884389|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884390|NCT03561181|Vaccines|vaccines|mesh-list
13884391|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
13884392|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754572|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
14754573|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754574|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14754575|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14754576|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14754577|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14754578|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754579|NCT04622904|Analgesics|analgesics|mesh-ancestor
14754580|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14754581|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13884393|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13884394|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13884395|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754582|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
14754583|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14754584|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14754585|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754586|NCT04610736|Temozolomide|temozolomide|mesh-list
14754587|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14754588|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
13884396|NCT03560973|Gemcitabine|gemcitabine|mesh-list
13884397|NCT03560973|Ramucirumab|ramucirumab|mesh-list
13884398|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14471014|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14471015|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14471016|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14471017|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
13884399|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
14471018|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471019|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471020|NCT02322190|Methoxsalen|methoxsalen|mesh-list
13884400|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884401|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884402|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
13884403|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884404|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884405|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884406|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
13884407|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884408|NCT03560934|Dronabinol|dronabinol|mesh-list
13884409|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
13884410|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884411|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13884412|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13884413|NCT03560934|Analgesics|analgesics|mesh-ancestor
13884414|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
13884415|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884416|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13884417|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13884418|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884419|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884420|NCT03560934|Hormones|hormones|mesh-ancestor
13884421|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884422|NCT03560908|Dasatinib|dasatinib|mesh-list
13884423|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884424|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13884425|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884426|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884427|NCT03560882|Atorvastatin|atorvastatin|mesh-list
13884428|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13884429|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13884430|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
13884431|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884432|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13884433|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13884434|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884435|NCT03560856|Fulvestrant|fulvestrant|mesh-list
13884436|NCT03560856|Palbociclib|palbociclib|mesh-list
13884437|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13884438|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884439|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13884440|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13884441|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
13884442|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884443|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884444|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13884445|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884446|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884447|NCT03560804|Olmesartan|olmesartan|mesh-list
13884448|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
13884449|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13884450|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13884451|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13884452|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884453|NCT03560804|Diuretics|diuretics|mesh-ancestor
13884454|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
13884455|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884456|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13884457|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13884458|NCT03560752|Vaccines|vaccines|mesh-list
13884459|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
13884460|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027517|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13884461|NCT03560583|Metoclopramide|metoclopramide|mesh-list
13884462|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
13884463|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
13884464|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884465|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884466|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884467|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13884468|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13884469|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
13884470|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884471|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884472|NCT03560440|Vancomycin|vancomycin|mesh-list
13884473|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13884474|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884475|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13884476|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13884477|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13884478|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13884479|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884480|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884481|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884482|NCT03560427|Analgesics|analgesics|mesh-ancestor
13884483|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
13884484|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884485|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
13884486|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13884487|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
13884488|NCT03560375|Empagliflozin|empagliflozin|mesh-list
13884489|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13884490|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884491|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13884492|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884493|NCT03560362|Epinephrine|epinephrine|mesh-list
13884494|NCT03560362|Bupivacaine|bupivacaine|mesh-list
13884495|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
13884496|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
13884497|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884498|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884499|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
13884500|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884501|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13884502|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13884503|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
13884504|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884505|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884506|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13884507|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13884508|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
13884509|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13884510|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
13884511|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
13884512|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
13884513|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13884514|NCT03560349|Lidocaine|lidocaine|mesh-list
13884515|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
13884516|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
13884517|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884518|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884519|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
14027518|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
13884520|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884521|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13884522|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13884523|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13884524|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13884525|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884526|NCT03560336|Liraglutide|liraglutide|mesh-list
13884527|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13884528|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884529|NCT03560336|Incretins|incretins|mesh-ancestor
13884530|NCT03560336|Hormones|hormones|mesh-ancestor
13884531|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884532|NCT03560310|Ticagrelor|ticagrelor|mesh-list
13884533|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13884534|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13884535|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13884536|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13884537|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
13884538|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884539|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884540|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884541|NCT03560232|Clindamycin|clindamycin|mesh-list
13884542|NCT03560232|Gentamicins|gentamicins|mesh-list
13884543|NCT03560232|Cefazolin|cefazolin|mesh-list
13884544|NCT03560232|Tazobactam|tazobactam|mesh-list
13884545|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
13884546|NCT03560232|Piperacillin|piperacillin|mesh-list
13884547|NCT03560232|Ampicillin|ampicillin|mesh-list
13884548|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13884549|NCT03560232|Sulbactam|sulbactam|mesh-list
13884550|NCT03560232|Sultamicillin|sultamicillin|mesh-list
13884551|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13884552|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884553|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13884554|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884555|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884556|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13884557|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
13884558|NCT03560024|Growth Substances|growth substances|mesh-ancestor
13884559|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884560|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
13884561|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884562|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884563|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
13884564|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13884565|NCT03560011|Antibodies|antibodies|mesh-list
13884566|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
13884567|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884568|NCT03559985|Acetaminophen|acetaminophen|mesh-list
13884569|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13884570|NCT03559985|Analgesics|analgesics|mesh-ancestor
13884571|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
13884572|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884573|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884574|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
13884575|NCT03559920|Propofol|propofol|mesh-list
13884576|NCT03559920|Sevoflurane|sevoflurane|mesh-list
13884577|NCT03559920|Anesthetics|anesthetics|mesh-list
13884578|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13884579|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884580|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884581|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13884582|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
13884583|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13884584|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13884585|NCT03559868|Digoxin|digoxin|mesh-list
13884586|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13884587|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13884588|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884589|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884590|NCT03559868|Protective Agents|protective agents|mesh-ancestor
13884591|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884592|NCT03559803|Cisplatin|cisplatin|mesh-list
13884593|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884594|NCT03559790|Tenofovir|tenofovir|mesh-list
13884595|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
13884596|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884597|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13884598|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13884599|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884600|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884601|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13884602|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13884603|NCT03559751|Nicotine|nicotine|mesh-list
13884604|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13884605|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
13884606|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884607|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884608|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13884609|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13884610|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
13884611|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884612|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957926|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957927|NCT03172299|Aflibercept|aflibercept|mesh-list
13957928|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13957929|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13957930|NCT03172299|Growth Substances|growth substances|mesh-ancestor
13957931|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957932|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
13957933|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957934|NCT03172533|Dienogest|dienogest|mesh-list
13957935|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13957936|NCT03172533|Estradiol|estradiol|mesh-list
13957937|NCT03172533|Estrogens|estrogens|mesh-ancestor
13957938|NCT03172533|Hormones|hormones|mesh-ancestor
13957939|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957940|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957941|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13957942|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
13957943|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13957944|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13957945|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13957946|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13957947|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13957948|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
13957949|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13957950|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957951|NCT03172234|Amantadine|amantadine|mesh-list
13957952|NCT03172234|Gabapentin|gabapentin|mesh-list
13957953|NCT03172234|Analgesics|analgesics|mesh-ancestor
13957954|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
13957955|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027519|NCT02735902|Coagulants|coagulants|mesh-ancestor
14754589|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754590|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754591|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
14754592|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14754593|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754594|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754595|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14754596|NCT04608331|Analgesics|analgesics|mesh-ancestor
14754597|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
14754598|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754599|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14754600|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14754601|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14754602|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
14754603|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754604|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754605|NCT04605861|Liraglutide|liraglutide|mesh-list
14754606|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13884613|NCT03559725|Menthol|menthol|mesh-list
13884614|NCT03559725|Nicotine|nicotine|mesh-list
13884615|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13884616|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
13884617|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884618|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884619|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13884620|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13884621|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
13884622|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884623|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884624|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
13884625|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
13884626|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
13884627|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884628|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
13884629|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884630|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884631|NCT03559673|Lacosamide|lacosamide|mesh-list
13884632|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
13884633|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13884634|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13884635|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471021|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14754607|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884636|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884637|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
13884638|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884639|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
13884640|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884641|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884642|NCT03559504|Sevoflurane|sevoflurane|mesh-list
13884643|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13884644|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13884645|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
14027520|NCT02735798|Trastuzumab|trastuzumab|mesh-list
13884646|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
13884647|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471022|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
13884648|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884649|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
13884650|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13884651|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884652|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884653|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13884654|NCT03559413|Imiquimod|imiquimod|mesh-list
13884655|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
13884656|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884657|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13884658|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884659|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
13884660|NCT03559387|Sargramostim|sargramostim|mesh-list
13884661|NCT03559387|Lenograstim|lenograstim|mesh-list
13884662|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
13884663|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884664|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13884665|NCT03559348|Leucovorin|leucovorin|mesh-list
13884666|NCT03559348|Gemcitabine|gemcitabine|mesh-list
13884667|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13884668|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
13884669|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884670|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884671|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
13884672|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884673|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884674|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884675|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
13884676|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884677|NCT03559348|Antidotes|antidotes|mesh-ancestor
13884678|NCT03559348|Protective Agents|protective agents|mesh-ancestor
13884679|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
13884680|NCT03559348|Vitamins|vitamins|mesh-ancestor
13884681|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
13884682|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13884683|NCT03559114|Dalteparin|dalteparin|mesh-list
13884684|NCT03559114|Tinzaparin|tinzaparin|mesh-list
13884685|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13884686|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
13884687|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13884688|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13884689|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931954|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
14931955|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884690|NCT03559049|Carboplatin|carboplatin|mesh-list
13884691|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
13884692|NCT03559049|Pemetrexed|pemetrexed|mesh-list
13884693|NCT03559049|Rucaparib|rucaparib|mesh-list
13884694|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884695|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884696|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884697|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884698|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13884699|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14027521|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884700|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13884701|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
13884702|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884703|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
13884704|NCT03558919|Mirabegron|mirabegron|mesh-list
13884705|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13884706|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13884707|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
13884708|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884709|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884710|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884711|NCT03558919|Urological Agents|urological agents|mesh-ancestor
13884712|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13884713|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13884714|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13884715|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
13884716|NCT03558880|Anesthetics|anesthetics|mesh-list
13884717|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754608|NCT04605861|Incretins|incretins|mesh-ancestor
14754609|NCT04605861|Hormones|hormones|mesh-ancestor
14754610|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754611|NCT04600336|Oxybutynin|oxybutynin|mesh-list
14754612|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
14754613|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
14754614|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754615|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754616|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14754617|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14754618|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
14754619|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754620|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754621|NCT04600336|Urological Agents|urological agents|mesh-ancestor
14754622|NCT04597333|Dinoprostone|dinoprostone|mesh-list
14754623|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
14754624|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14754625|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884718|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884719|NCT03558867|Metformin|metformin|mesh-list
13884720|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13884721|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884722|NCT03558750|Rituximab|rituximab|mesh-list
13884723|NCT03558750|Nivolumab|nivolumab|mesh-list
13884724|NCT03558750|Lenalidomide|lenalidomide|mesh-list
13884725|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884726|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884727|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
13884728|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884729|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13884730|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13884731|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884732|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13884733|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13884734|NCT03558750|Growth Substances|growth substances|mesh-ancestor
13884735|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
13884736|NCT03558724|Bevacizumab|bevacizumab|mesh-list
13884737|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884738|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884739|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13884740|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13884741|NCT03558724|Growth Substances|growth substances|mesh-ancestor
13884742|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884743|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
13884744|NCT03558477|Esomeprazole|esomeprazole|mesh-list
13884745|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13884746|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884747|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13884748|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884749|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884750|NCT03558412|Decitabine|decitabine|mesh-list
13884751|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13884752|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
13884753|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884754|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884755|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754626|NCT04596579|Antibodies|antibodies|mesh-list
13884756|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13884757|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
13884758|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884759|NCT03558295|Anticoagulants|anticoagulants|mesh-list
14931956|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931957|NCT01442558|Bupivacaine|bupivacaine|mesh-list
14931958|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
14931959|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
14931960|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14931961|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884760|NCT03558243|Hemostatics|hemostatics|mesh-list
13884761|NCT03558243|Coagulants|coagulants|mesh-ancestor
13884762|NCT03558139|Avelumab|avelumab|mesh-list
13884763|NCT03558139|Magrolimab|magrolimab|mesh-list
13884764|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884765|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884766|NCT03557996|Listerine|listerine|mesh-list
13884767|NCT03557996|Fluorides|fluorides|mesh-list
13884768|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
13884769|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
13884770|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
13884771|NCT03557996|Protective Agents|protective agents|mesh-ancestor
13884772|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884773|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13884774|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884775|NCT03557983|Fenofibrate|fenofibrate|mesh-list
13884776|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13884777|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
13884778|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884779|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13957956|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957957|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
13957958|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13957959|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13957960|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957961|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13957962|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13957963|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13957964|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13957965|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957966|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
13957967|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13957968|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13957969|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
13957970|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13957971|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
13957972|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13957973|NCT03171974|Dexamethasone|dexamethasone|mesh-list
13957974|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13957975|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
13957976|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
13957977|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957978|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957979|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13957980|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
13957981|NCT03171974|Hormones|hormones|mesh-ancestor
13957982|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13957983|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13884780|NCT03557853|Golimumab|golimumab|mesh-list
13884781|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13884782|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884783|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884784|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
13884785|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884786|NCT03557840|Temocillin|temocillin|mesh-list
13884787|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14931962|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
14931963|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14931964|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
14931965|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13884788|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884789|NCT03557580|Isosorbide|isosorbide|mesh-list
13884790|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13884791|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13884792|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13884793|NCT03557580|Diuretics|diuretics|mesh-ancestor
13884794|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
13884795|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884796|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
13884797|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13884798|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884799|NCT03557437|Amoxicillin|amoxicillin|mesh-list
14931966|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
14931967|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931968|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
14931969|NCT01442571|Protective Agents|protective agents|mesh-ancestor
13884800|NCT03557437|Metronidazole|metronidazole|mesh-list
13884801|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
13884802|NCT03557437|Esomeprazole|esomeprazole|mesh-list
13884803|NCT03557437|Bismuth|bismuth|mesh-list
13884804|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884805|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13884806|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884807|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13884808|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13884809|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14027522|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027523|NCT02735590|Isoniazid|isoniazid|mesh-list
14027524|NCT02735590|Rifapentine|rifapentine|mesh-list
14027525|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
14027526|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14931970|NCT01442610|Rasagiline|rasagiline|mesh-list
14931971|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14027527|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471023|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14471024|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14471025|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14471026|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14471027|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14471028|NCT02322216|Analgesics|analgesics|mesh-ancestor
14471029|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
14471030|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027528|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14027529|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14027530|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
14027531|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027532|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14471031|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471032|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027533|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14027534|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
14027535|NCT02735694|Cycloserine|cycloserine|mesh-list
14027536|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13884810|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884811|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13884812|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884813|NCT03557437|Antacids|antacids|mesh-ancestor
13884814|NCT03557437|Diuretics|diuretics|mesh-ancestor
13884815|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
13884816|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884817|NCT03557437|Expectorants|expectorants|mesh-ancestor
13884818|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
13884819|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
13884820|NCT03557424|Cathartics|cathartics|mesh-ancestor
13884821|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884822|NCT03557255|Simendan|simendan|mesh-list
13884823|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13884824|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
13884825|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13884826|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13884827|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884828|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884829|NCT03557255|Protective Agents|protective agents|mesh-ancestor
13884830|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884831|NCT03557229|Vitamins|vitamins|mesh-list
13884832|NCT03557229|Ascorbic Acid|ascorbic acid|mesh-list
13884833|NCT03557229|Vitamin E|vitamin e|mesh-list
13884834|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
13884835|NCT03557229|Melatonin|melatonin|mesh-list
13884836|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13884837|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
13884838|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884839|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
13884840|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884841|NCT03557229|Protective Agents|protective agents|mesh-ancestor
13884842|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884843|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
13884844|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884845|NCT03557229|Expectorants|expectorants|mesh-ancestor
13884846|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
13884847|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13884848|NCT03557229|Antidotes|antidotes|mesh-ancestor
13884849|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
13884850|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884851|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884852|NCT03556917|Caffeine|caffeine|mesh-list
13884853|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13884854|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884855|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13884856|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884857|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884858|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13884859|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13884860|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
13884861|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884862|NCT03556852|Misoprostol|misoprostol|mesh-list
13884863|NCT03556852|Carbetocin|carbetocin|mesh-list
13884864|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13884865|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
13884866|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13884867|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884868|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13884869|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884870|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
13884871|NCT03556839|Paclitaxel|paclitaxel|mesh-list
13884872|NCT03556839|Bevacizumab|bevacizumab|mesh-list
13884873|NCT03556839|Carboplatin|carboplatin|mesh-list
13884874|NCT03556839|Atezolizumab|atezolizumab|mesh-list
13884875|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13884876|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884877|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
13884878|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
13884879|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
13884880|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884881|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13884882|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13884883|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13884884|NCT03556839|Growth Substances|growth substances|mesh-ancestor
13884885|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884886|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
13884887|NCT03556592|Metoprolol|metoprolol|mesh-list
13884888|NCT03556592|Midazolam|midazolam|mesh-list
13884889|NCT03556592|Caffeine|caffeine|mesh-list
13884890|NCT03556592|Omeprazole|omeprazole|mesh-list
13884891|NCT03556592|Warfarin|warfarin|mesh-list
13884892|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13884893|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13884894|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13884895|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884896|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13884897|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13884898|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13884899|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13884900|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
13884901|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
13884902|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
14754627|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
14754628|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754629|NCT04595565|Carboplatin|carboplatin|mesh-list
14754630|NCT04595565|Capecitabine|capecitabine|mesh-list
14754631|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754632|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14754633|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
14754634|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754635|NCT04593927|Siponimod|siponimod|mesh-list
14754636|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14754637|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754638|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754639|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
14754640|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754641|NCT04587830|Temozolomide|temozolomide|mesh-list
14754642|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14754643|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
14754644|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754645|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754646|NCT04585815|Axitinib|axitinib|mesh-list
14754647|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754648|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754649|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884903|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
14754650|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884904|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884905|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884906|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
13884907|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13884908|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884909|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13884910|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884911|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13884912|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13884913|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13884914|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13884915|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
13884916|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13884917|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13884918|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
13884919|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
13884920|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884921|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13884922|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13884923|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13884924|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
13884925|NCT03556384|Temozolomide|temozolomide|mesh-list
13884926|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13884927|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
13884928|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884929|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884930|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
13884931|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13884932|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
13884933|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884934|NCT03556371|Expectorants|expectorants|mesh-ancestor
13884935|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
13884936|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13884937|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
13884938|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884939|NCT03556371|Protective Agents|protective agents|mesh-ancestor
13884940|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884941|NCT03556371|Antidotes|antidotes|mesh-ancestor
13957984|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13957985|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
13957986|NCT03171987|Lidocaine|lidocaine|mesh-list
13957987|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
13957988|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
13957989|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13957990|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957991|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
13957992|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13957993|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13957994|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13957995|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13957996|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13957997|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13957998|NCT03171987|Analgesics|analgesics|mesh-ancestor
14471033|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754651|NCT04576455|Fulvestrant|fulvestrant|mesh-list
14754652|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14754653|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754654|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754655|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14754656|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14754657|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
14754658|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754659|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931972|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13884942|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
13884943|NCT03556098|Hormones|hormones|mesh-list
13884944|NCT03556098|Incretins|incretins|mesh-list
13884945|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884946|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884947|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884948|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
13884949|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13884950|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884951|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13884952|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931973|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931974|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14931975|NCT01442610|Protective Agents|protective agents|mesh-ancestor
13884953|NCT03555994|Liraglutide|liraglutide|mesh-list
13884954|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13884955|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884956|NCT03555994|Incretins|incretins|mesh-ancestor
13884957|NCT03555994|Hormones|hormones|mesh-ancestor
13884958|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471034|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14471035|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14471036|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14931976|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931977|NCT01442662|Gemcitabine|gemcitabine|mesh-list
14931978|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14931979|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
14931980|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14931981|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471037|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
14471038|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
14471039|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471040|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479084|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479085|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14479086|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479087|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479088|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14479089|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
14479090|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
13884973|NCT03555929|Dexamethasone|dexamethasone|mesh-list
13884974|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13884975|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
13884976|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
13884977|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884978|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754660|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14754661|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754662|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754663|NCT04576156|Imetelstat|imetelstat|mesh-list
14754664|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
14754665|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754666|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754667|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754668|NCT04576104|Metformin|metformin|mesh-list
14754669|NCT04576104|Megestrol|megestrol|mesh-list
14754670|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
14754671|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14931982|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
14754672|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754673|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13884979|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13884980|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
13884981|NCT03555929|Hormones|hormones|mesh-ancestor
13884982|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13884983|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13884984|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13884985|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13884986|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13884987|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13884988|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13884989|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13884990|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13884991|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13884992|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
13884993|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13884994|NCT03555617|Itraconazole|itraconazole|mesh-list
13884995|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
14931983|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931984|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14931985|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13884996|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13884997|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13884998|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13884999|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885000|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885001|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13885002|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
13885003|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885004|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885005|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13885006|NCT03555526|Amoxicillin|amoxicillin|mesh-list
13885007|NCT03555526|Metronidazole|metronidazole|mesh-list
13885008|NCT03555526|Clarithromycin|clarithromycin|mesh-list
13885009|NCT03555526|Levofloxacin|levofloxacin|mesh-list
13885010|NCT03555526|Ofloxacin|ofloxacin|mesh-list
13885011|NCT03555526|Tetracycline|tetracycline|mesh-list
13885012|NCT03555526|Esomeprazole|esomeprazole|mesh-list
13885013|NCT03555526|Bismuth|bismuth|mesh-list
13885014|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13885015|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885016|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13885017|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13885018|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13885019|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13885020|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13885021|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885022|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885023|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13885024|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13885025|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13885026|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13885027|NCT03555526|Renal Agents|renal agents|mesh-ancestor
13885028|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13885029|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13885030|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885031|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13885032|NCT03555526|Antacids|antacids|mesh-ancestor
13885033|NCT03555487|Choline|choline|mesh-list
13885034|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
13885035|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13885036|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
13885037|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754674|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13885038|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13885039|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13885040|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
13885041|NCT03555383|Hemostatics|hemostatics|mesh-list
13885042|NCT03555383|Coagulants|coagulants|mesh-ancestor
13885043|NCT03555188|Ondansetron|ondansetron|mesh-list
13885044|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
13885045|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
13885046|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885047|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885048|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13885049|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
13885050|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
13885051|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13885052|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
13885053|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885054|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885055|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13885056|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13885057|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885058|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885059|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13885060|NCT03555136|Vortioxetine|vortioxetine|mesh-list
13885061|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
13885062|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885063|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13885064|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14754675|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14754676|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
14754677|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14754678|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14754679|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14754680|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754681|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754682|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
14754683|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13885065|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885066|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885067|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13885068|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13885069|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885070|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754684|NCT04575038|Brequinar|brequinar|mesh-list
14754685|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754686|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754687|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754688|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754689|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
14754690|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754691|NCT04563520|Coagulants|coagulants|mesh-list
14754692|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14754693|NCT04558918|Eculizumab|eculizumab|mesh-list
13885071|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885072|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
13885073|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13885074|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13885075|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13885076|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13885077|NCT03555071|Vaccines|vaccines|mesh-list
13885078|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
13885079|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885080|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
13885081|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13885082|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885083|NCT03554980|Listerine|listerine|mesh-list
13885084|NCT03554980|Fluorides|fluorides|mesh-list
13885085|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
13885086|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
13885087|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
13885088|NCT03554980|Protective Agents|protective agents|mesh-ancestor
13885089|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885090|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13885091|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885092|NCT03554915|Midazolam|midazolam|mesh-list
13885093|NCT03554915|Ketamine|ketamine|mesh-list
14754694|NCT04558918|Ravulizumab|ravulizumab|mesh-list
13885094|NCT03554915|Analgesics|analgesics|mesh-ancestor
13885095|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
13885096|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885097|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885098|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13885099|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13885100|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
13885101|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
14471041|NCT02322242|Dexamethasone|dexamethasone|mesh-list
14471042|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
14471043|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14471044|NCT02322242|BB 1101|bb 1101|mesh-list
14931986|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
13885102|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885103|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13885104|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13885105|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885106|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885107|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13885108|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13885109|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13885110|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13885111|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885112|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
13885113|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
13885114|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
13885115|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13885116|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885117|NCT03554590|Insulin|insulin|mesh-list
13885118|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13885119|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027537|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027538|NCT02735694|Renal Agents|renal agents|mesh-ancestor
14027539|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14027540|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
14027541|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027542|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
14027543|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027544|NCT02735395|Amoxicillin|amoxicillin|mesh-list
14027545|NCT02735395|Metronidazole|metronidazole|mesh-list
14027546|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027547|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027548|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14027549|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14027550|NCT02735473|Choline|choline|mesh-list
14027551|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
14027552|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14027553|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
14027554|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027555|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027556|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14027557|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
14027558|NCT02735343|Ketamine|ketamine|mesh-list
14027559|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
14027560|NCT02735343|Analgesics|analgesics|mesh-ancestor
14027561|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
14027562|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027563|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027564|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14027565|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14931987|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14931988|NCT01442701|Triclosan|triclosan|mesh-list
14931989|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14931990|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14931991|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14931992|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14027566|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
14471045|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885120|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
13885121|NCT03554447|Dexetimide|dexetimide|mesh-list
13885122|NCT03554447|Citalopram|citalopram|mesh-list
13885123|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13885124|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13885125|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885126|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885127|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885128|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
13885129|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885130|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13885131|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
13885132|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885133|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13885134|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13885135|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
13885136|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
13885137|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885138|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13885139|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13885140|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
13885141|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13885142|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885143|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13885144|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13885145|NCT03554447|Protective Agents|protective agents|mesh-ancestor
13885146|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
13885147|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13885148|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
13885149|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13885150|NCT03554408|Antibodies|antibodies|mesh-list
13885151|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
13885152|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13885153|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
13885154|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885155|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885156|NCT03554395|Antibodies|antibodies|mesh-list
13885157|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13885158|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
13885159|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13957999|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13958000|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958001|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958002|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958003|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13958004|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958005|NCT03172052|Streptokinase|streptokinase|mesh-list
13958006|NCT03172052|Mesna|mesna|mesh-list
13958007|NCT03172052|Protective Agents|protective agents|mesh-ancestor
13958008|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958009|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13958010|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13958011|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958012|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
13958013|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13958014|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958015|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958016|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958017|NCT03172065|Analgesics|analgesics|mesh-ancestor
13958018|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
13958019|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958020|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13958021|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13958022|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13958023|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
13958024|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958025|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885160|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
13885161|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13885162|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13885163|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885164|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13885165|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13885166|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885167|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885168|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885169|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13885170|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
13885171|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13885172|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885173|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13885174|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13885175|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13885176|NCT03554291|Famotidine|famotidine|mesh-list
13885177|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13885178|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13885179|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13885180|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
13885181|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
13885182|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885183|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885184|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885185|NCT03554200|Empagliflozin|empagliflozin|mesh-list
13885186|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13885187|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885188|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13885189|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885190|NCT03554109|Leucovorin|leucovorin|mesh-list
13885191|NCT03554109|Paclitaxel|paclitaxel|mesh-list
13885192|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13885193|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
13885194|NCT03554109|Doxorubicin|doxorubicin|mesh-list
13885195|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13885196|NCT03554109|Fluorouracil|fluorouracil|mesh-list
13885197|NCT03554109|Avelumab|avelumab|mesh-list
13885198|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13885199|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885200|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
13885201|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
13885202|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
13885203|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885204|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13885205|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
13885206|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885207|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885208|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13885209|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
13885210|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13885211|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13885212|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13885213|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13885214|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885215|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
13885216|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13885217|NCT03554109|Antidotes|antidotes|mesh-ancestor
13885218|NCT03554109|Protective Agents|protective agents|mesh-ancestor
13885219|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
13885220|NCT03554109|Vitamins|vitamins|mesh-ancestor
13885221|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
13885222|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13885223|NCT03554031|Hormones|hormones|mesh-list
13885224|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885225|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471046|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
14471047|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
14471048|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471049|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471050|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471051|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
14471052|NCT02322242|Hormones|hormones|mesh-ancestor
14471053|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885226|NCT03553875|Memantine|memantine|mesh-list
13885227|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13885228|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13885229|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
13885230|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885231|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885232|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885233|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13885234|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13885235|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
13885236|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13885237|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471054|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14471055|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471056|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
14471057|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471058|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471059|NCT02322281|Gemcitabine|gemcitabine|mesh-list
13885244|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
13885245|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13885246|NCT03553628|Propolis|propolis|mesh-list
13885247|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13885248|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885249|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
13885250|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
13885251|NCT03553615|Ivermectin|ivermectin|mesh-list
13885252|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13885253|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885254|NCT03553537|Prednisone|prednisone|mesh-list
13885255|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
13885256|NCT03553537|Doxorubicin|doxorubicin|mesh-list
13885257|NCT03553537|Vincristine|vincristine|mesh-list
13885258|NCT03553537|Decitabine|decitabine|mesh-list
13885259|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13885260|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
13885261|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885262|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885263|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13885264|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
13885265|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885266|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885267|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13885268|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13885269|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13885270|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13885271|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885272|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885273|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
13885274|NCT03553537|Hormones|hormones|mesh-ancestor
13885275|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885276|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13885277|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13885278|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
13885279|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
13885280|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
13885281|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13885282|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
13885283|NCT03553446|Sevoflurane|sevoflurane|mesh-list
13885284|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13885285|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13885286|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
13885287|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
13885288|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885289|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885290|NCT03553433|Apremilast|apremilast|mesh-list
13885291|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13885292|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13885293|NCT03553433|Analgesics|analgesics|mesh-ancestor
13885294|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
13885295|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885296|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885297|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885298|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885299|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13958026|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
14471060|NCT02322281|Paclitaxel|paclitaxel|mesh-list
13885300|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13885301|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885302|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885303|NCT03553329|Trametinib|trametinib|mesh-list
13885304|NCT03553329|Dabrafenib|dabrafenib|mesh-list
13885305|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885306|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13885307|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885308|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885309|NCT03553303|Valsartan|valsartan|mesh-list
13885310|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13885311|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13885312|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13885313|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885314|NCT03553238|Cytarabine|cytarabine|mesh-list
13885315|NCT03553238|Dexamethasone|dexamethasone|mesh-list
13885316|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
13885317|NCT03553238|Methotrexate|methotrexate|mesh-list
13885318|NCT03553238|Etoposide|etoposide|mesh-list
13885319|NCT03553238|Vincristine|vincristine|mesh-list
13885320|NCT03553238|Doxorubicin|doxorubicin|mesh-list
13885321|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
13885322|NCT03553238|Idarubicin|idarubicin|mesh-list
13885323|NCT03553238|Pegaspargase|pegaspargase|mesh-list
13885324|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13885325|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
13885326|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885327|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885328|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13885329|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
13885330|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885331|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885332|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13885333|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885334|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
13885335|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
13885336|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885337|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13885338|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
13885339|NCT03553238|Hormones|hormones|mesh-ancestor
13885340|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885341|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13885342|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13885343|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
13885344|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13885345|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13885346|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
13885347|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
13885348|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885349|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13885350|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13885351|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13885352|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13885353|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13885354|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
13885355|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885356|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
13885357|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
13885358|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
13885359|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14471061|NCT02322281|Docetaxel|docetaxel|mesh-list
14471062|NCT02322281|Pemetrexed|pemetrexed|mesh-list
13885360|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
13885361|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13885362|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13885363|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885364|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
13885365|NCT03553186|Coagulants|coagulants|mesh-ancestor
13885366|NCT03553173|Bupropion|bupropion|mesh-list
13885367|NCT03553173|Varenicline|varenicline|mesh-list
13885368|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13885369|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
13885370|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885371|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13885372|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13885373|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885374|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885375|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
13885376|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885377|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885378|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13885379|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13885380|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885381|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13885382|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13885383|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
13885384|NCT03553108|Olaparib|olaparib|mesh-list
13885385|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13885386|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885387|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885388|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885389|NCT03553082|Propofol|propofol|mesh-list
13885390|NCT03553082|Sevoflurane|sevoflurane|mesh-list
13885391|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13885392|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885393|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885394|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13885395|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
13885396|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
13885397|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13885398|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13885399|NCT03553004|Niraparib|niraparib|mesh-list
13885400|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13885401|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885402|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754695|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14754696|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754697|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
14754698|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754699|NCT04553536|Sufentanil|sufentanil|mesh-list
13885403|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958027|NCT03171818|Hematinics|hematinics|mesh-ancestor
13958028|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
13958029|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
13958030|NCT03171831|Busulfan|busulfan|mesh-list
14471063|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14471064|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471065|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14471066|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
13958031|NCT03171831|Methotrexate|methotrexate|mesh-list
13958032|NCT03171831|Fludarabine|fludarabine|mesh-list
13958033|NCT03171831|Tacrolimus|tacrolimus|mesh-list
14471067|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14471068|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471069|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14471070|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
14471071|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
13885404|NCT03552770|Bevacizumab|bevacizumab|mesh-list
13885405|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13885406|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885407|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13885408|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13885409|NCT03552770|Growth Substances|growth substances|mesh-ancestor
13885410|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885411|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
13885412|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
13885413|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13885414|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13885415|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885416|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
13885417|NCT03552705|Coagulants|coagulants|mesh-ancestor
13885418|NCT03552666|Vitamin D|vitamin d|mesh-list
13885419|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
13885420|NCT03552666|Vitamins|vitamins|mesh-ancestor
13885421|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
13885422|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885423|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13885424|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13885425|NCT03552653|Vitamin D|vitamin d|mesh-list
13885426|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
13885427|NCT03552653|Vitamins|vitamins|mesh-list
13885428|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
13885429|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885430|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13885431|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13885432|NCT03552601|Methamphetamine|methamphetamine|mesh-list
13885433|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13885434|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885435|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
13885436|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
13885437|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885438|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
13885439|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885440|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885441|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
13885442|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13885443|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13885444|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885445|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13885446|NCT03552575|Valsartan|valsartan|mesh-list
13885447|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14931993|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
13885448|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13885449|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13885450|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885451|NCT03552406|Cetuximab|cetuximab|mesh-list
13885452|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13885453|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885454|NCT03552354|Argatroban|argatroban|mesh-list
13885455|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
13885456|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13885457|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
13885458|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885459|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885460|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
13885461|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13885462|NCT03552315|Chromium|chromium|mesh-list
13885463|NCT03552315|Trace Elements|trace elements|mesh-ancestor
13885464|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
13885465|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885466|NCT03552211|Biotin|biotin|mesh-list
13885467|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
13885468|NCT03552211|Vitamins|vitamins|mesh-ancestor
13885469|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
13885470|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885471|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
13885472|NCT03552146|Propofol|propofol|mesh-list
13885473|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13885474|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885475|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885476|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13885477|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
13885478|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
13885479|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13885480|NCT03552146|Analgesics|analgesics|mesh-ancestor
13885481|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
13885482|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885483|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13885484|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13885485|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13885486|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
13885487|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885488|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885489|NCT03552016|Riboflavin|riboflavin|mesh-list
13885490|NCT03552016|Vitamins|vitamins|mesh-ancestor
13885491|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
13885492|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885493|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
13885494|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13885495|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
13885496|NCT03551964|Ticagrelor|ticagrelor|mesh-list
13885497|NCT03551964|Cangrelor|cangrelor|mesh-list
13885498|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13885499|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13885500|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14754700|NCT04553536|Remifentanil|remifentanil|mesh-list
14754701|NCT04553536|Dsuvia|dsuvia|mesh-list
14754702|NCT04553536|Bromides|bromides|mesh-list
14754703|NCT04553536|Propofol|propofol|mesh-list
14754704|NCT04553536|Esketamine|esketamine|mesh-list
14754705|NCT04553536|Rocuronium|rocuronium|mesh-list
14754706|NCT04553536|Cisatracurium|cisatracurium|mesh-list
14931994|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885501|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13885502|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
13885503|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885504|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885505|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885506|NCT03551873|Plecanatide|plecanatide|mesh-list
13885507|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
13885508|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
13885509|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885510|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13885511|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13885512|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13885513|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885514|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
13885515|NCT03551808|Ketorolac|ketorolac|mesh-list
13885516|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13885517|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14754707|NCT04553536|Atracurium|atracurium|mesh-list
14754708|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13885518|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14931995|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14931996|NCT01442727|Selenium|selenium|mesh-list
14931997|NCT01442727|Selenious Acid|selenious acid|mesh-list
14931998|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
14931999|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
13885519|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13885520|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13885521|NCT03551808|Analgesics|analgesics|mesh-ancestor
13885522|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
13885523|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885524|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885525|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885526|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885527|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13885528|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885529|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885530|NCT03551652|Rocuronium|rocuronium|mesh-list
13885531|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13885532|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13885533|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13885534|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471072|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471073|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471074|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14471075|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
14471076|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471077|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14471078|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14471079|NCT02322320|Lenalidomide|lenalidomide|mesh-list
13885535|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885536|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
13885537|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13885538|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13885539|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885540|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
13885541|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
13885542|NCT03551548|Spironolactone|spironolactone|mesh-list
13885543|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13885544|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
13885545|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885546|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885547|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13885548|NCT03551548|Diuretics|diuretics|mesh-ancestor
13885549|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
13885550|NCT03551210|Levofloxacin|levofloxacin|mesh-list
13885551|NCT03551210|Ofloxacin|ofloxacin|mesh-list
13885552|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13885553|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885554|NCT03551210|Renal Agents|renal agents|mesh-ancestor
13885555|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13885556|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13885557|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13885558|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885559|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885560|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885561|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13885562|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13885563|NCT03551197|Budesonide|budesonide|mesh-list
13885564|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
13885565|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885566|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13885567|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
13885568|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885569|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885570|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13885571|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
13885572|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
13885573|NCT03551197|Hormones|hormones|mesh-ancestor
13885574|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885575|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13885576|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13885577|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14932000|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885578|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
13885579|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885580|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885581|NCT03551171|Niraparib|niraparib|mesh-list
13885582|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13885583|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885584|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885585|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958034|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
13958035|NCT03171831|Basiliximab|basiliximab|mesh-list
13958036|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958037|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
13958038|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958039|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958040|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958041|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
13958042|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958043|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958044|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958045|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13958046|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
13958047|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13958048|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958049|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
13958050|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
13958051|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958052|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13958053|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13958054|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13958055|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13958056|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13958057|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
13958058|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13958059|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958060|NCT03171727|Heparin|heparin|mesh-list
13958061|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13958062|NCT03171727|Tinzaparin|tinzaparin|mesh-list
13958063|NCT03171727|Dalteparin|dalteparin|mesh-list
13958064|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
13958065|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13958066|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13958067|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963181|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963182|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
13963183|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963184|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963185|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13963186|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
13963187|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963188|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963189|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13963190|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963191|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
13963192|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
13963193|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963194|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963195|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
13963196|NCT01979536|Hormones|hormones|mesh-ancestor
13963197|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963198|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13963199|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
13885586|NCT03551067|Midazolam|midazolam|mesh-list
13885587|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
13885588|NCT03551067|Ketamine|ketamine|mesh-list
13885589|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13885590|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885591|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885592|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14471080|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
14471081|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471082|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14471083|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471084|NCT02322320|Growth Substances|growth substances|mesh-ancestor
14471085|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
13885593|NCT03551067|Analgesics|analgesics|mesh-ancestor
13885594|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
13885595|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885596|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13885597|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13885598|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13885599|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
13885600|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885601|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885602|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13885603|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13885604|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
13885605|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
13885606|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13885607|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13885608|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13885609|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13885610|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13885611|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885612|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
13885613|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
13885614|NCT03550859|Telmisartan|telmisartan|mesh-list
13885615|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13885616|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13885617|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13885618|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
13885619|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885620|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13885621|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13885622|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885623|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13885624|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13885625|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13885626|NCT03550794|Thiamine|thiamine|mesh-list
13885627|NCT03550794|Vitamins|vitamins|mesh-ancestor
13885628|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
13885629|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885630|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
13885631|NCT03550781|Prednisone|prednisone|mesh-list
13885632|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
13885633|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13885634|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
13885635|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885636|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885637|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13885638|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
13885639|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885640|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885641|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13885642|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885643|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
13885644|NCT03550781|Hormones|hormones|mesh-ancestor
13885645|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471086|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471087|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14471088|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14754709|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754710|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754711|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13885646|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13885647|NCT03550677|Anesthetics|anesthetics|mesh-list
13958068|NCT03171740|Midazolam|midazolam|mesh-list
14754712|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
14754713|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
14754714|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13885648|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885649|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885650|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
13885651|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13885652|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13885653|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885654|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
13885655|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
13885656|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
13885657|NCT03550534|Calcium|calcium|mesh-list
13885658|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13885659|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885660|NCT03550534|Antacids|antacids|mesh-ancestor
13885661|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885662|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13885663|NCT03550508|Antibodies|antibodies|mesh-list
13885664|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13885665|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
13885666|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885667|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
13885668|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13885669|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13885670|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13885671|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885672|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885673|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
13885674|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885675|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885676|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13885677|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885678|NCT03549923|Esmolol|esmolol|mesh-list
13885679|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13885680|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14471089|NCT02322775|Benralizumab|benralizumab|mesh-list
14471090|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13885681|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13885682|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
13885683|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885684|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885685|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885686|NCT03549897|Albuterol|albuterol|mesh-list
13885687|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14471091|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14471092|NCT02322788|Terbutaline|terbutaline|mesh-list
14471093|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14471094|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
14471095|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885688|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
13885689|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885690|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885691|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13885692|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
13885693|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
13885694|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13885695|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13885696|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13885697|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13885698|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
13885699|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885700|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754715|NCT04553536|Narcotics|narcotics|mesh-ancestor
14754716|NCT04553536|Analgesics|analgesics|mesh-ancestor
13885701|NCT03549832|Ritonavir|ritonavir|mesh-list
13885702|NCT03549832|Ribavirin|ribavirin|mesh-list
13885703|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
13885704|NCT03549832|Simeprevir|simeprevir|mesh-list
13885705|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13885706|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13885707|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
13885708|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885709|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885710|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13885711|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13885712|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
13885713|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885714|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13885715|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13885716|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
13885717|NCT03549819|Cannabidiol|cannabidiol|mesh-list
13885718|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
13885719|NCT03549741|Cabergoline|cabergoline|mesh-list
13885720|NCT03549741|Clomiphene|clomiphene|mesh-list
13885721|NCT03549741|Enclomiphene|enclomiphene|mesh-list
13885722|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
13885723|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885724|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13885725|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
13885726|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885727|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885728|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13885729|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
13885730|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13958069|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
13885731|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13885732|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13885733|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13885734|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13885735|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
13885736|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
13885737|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885738|NCT03549728|Sargramostim|sargramostim|mesh-list
13885739|NCT03549728|Lenograstim|lenograstim|mesh-list
13885740|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
13885741|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885742|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13885743|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
13885744|NCT03549702|Povidone|povidone|mesh-list
13885745|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
13885746|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
13885747|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13885748|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885749|NCT03549689|Tenofovir|tenofovir|mesh-list
13885750|NCT03549689|Lamivudine|lamivudine|mesh-list
13885751|NCT03549689|Dolutegravir|dolutegravir|mesh-list
13885752|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
13885753|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885754|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13885755|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13885756|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885757|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885758|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13885759|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13885760|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13885761|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13885762|NCT03549663|Prednisone|prednisone|mesh-list
13885763|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
13885764|NCT03549663|Tacrolimus|tacrolimus|mesh-list
13885765|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885766|NCT03549663|Hormones|hormones|mesh-ancestor
13885767|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885768|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885769|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13885770|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885771|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13885772|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
13885773|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13885774|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885775|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885776|NCT03549611|Acetaminophen|acetaminophen|mesh-list
13885777|NCT03549611|Celecoxib|celecoxib|mesh-list
13885778|NCT03549611|Oxycodone|oxycodone|mesh-list
14027567|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
14754717|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
14754718|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754719|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
14754720|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14754721|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14754722|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14754723|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
14754724|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14754725|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14754726|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14754727|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
14754728|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754729|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885779|NCT03549611|Gabapentin|gabapentin|mesh-list
13885780|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14754730|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13885781|NCT03549611|Analgesics|analgesics|mesh-ancestor
13885782|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
13885783|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471096|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471097|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14471098|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
13885784|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885785|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
13885786|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13885787|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885788|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885789|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13885790|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13885791|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027568|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027569|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14027570|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14027571|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14027572|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027573|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
14027574|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
14027575|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027576|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14027577|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14027578|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14027579|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14027580|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
14027581|NCT02735356|Itraconazole|itraconazole|mesh-list
14027582|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
14027583|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027584|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14027585|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14027586|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027587|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027588|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14027589|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
14027590|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027591|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027592|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14027593|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
14027594|NCT02735603|Naltrexone|naltrexone|mesh-list
14027595|NCT02735603|Bupropion|bupropion|mesh-list
14027596|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027597|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027598|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027599|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027600|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027601|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027602|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027603|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027604|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14027605|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14027606|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
14027607|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027608|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14027609|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
14027610|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14027611|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14027612|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14027613|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14027614|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
14027615|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14027616|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14027617|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14027618|NCT02735330|Ethanol|ethanol|mesh-list
14027619|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14027620|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027621|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027622|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471099|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
14471100|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
14471101|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14471102|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14471103|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14932001|NCT01442727|Protective Agents|protective agents|mesh-ancestor
13885792|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885793|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13885794|NCT03549611|Narcotics|narcotics|mesh-ancestor
13885795|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885796|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
13885797|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13885798|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13885799|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885800|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13885801|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13885802|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885803|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
13958070|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13958071|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13958072|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958073|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958074|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958075|NCT03171740|Analgesics|analgesics|mesh-ancestor
13958076|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
13958077|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958078|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13958079|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13958080|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13958081|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
13958082|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958083|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958084|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13958085|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13958086|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13958087|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13958088|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14027623|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
14027624|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
14027625|NCT02735317|Gentamicins|gentamicins|mesh-list
14027626|NCT02735317|Dexamethasone|dexamethasone|mesh-list
14027627|NCT02735317|Procaine|procaine|mesh-list
14471104|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14471105|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
14471106|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471107|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471108|NCT02322814|Paclitaxel|paclitaxel|mesh-list
14471109|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14471110|NCT02322814|Atezolizumab|atezolizumab|mesh-list
14471111|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14932002|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471112|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471113|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
14471114|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
14471115|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
14932003|NCT01442727|Trace Elements|trace elements|mesh-ancestor
13885804|NCT03549312|Tenofovir|tenofovir|mesh-list
13885805|NCT03549312|Emtricitabine|emtricitabine|mesh-list
13885806|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
13885807|NCT03549312|Cobicistat|cobicistat|mesh-list
13885808|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13885809|NCT03549312|Velpatasvir|velpatasvir|mesh-list
13885810|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
13885811|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13885812|NCT03549312|Elvitegravir|elvitegravir|mesh-list
13885813|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
13885814|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885815|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13885816|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13885817|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885818|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885819|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13885820|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13885821|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13885822|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13885823|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13885824|NCT03549221|Ketorolac|ketorolac|mesh-list
13885825|NCT03549221|Epinephrine|epinephrine|mesh-list
13885826|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
13885827|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13885828|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13885829|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
13885830|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885831|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885832|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885833|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13885834|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13885835|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
13885836|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885837|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13885838|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
13885839|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
13885840|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
13885841|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13885842|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13885843|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13885844|NCT03549221|Analgesics|analgesics|mesh-ancestor
13885845|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
13885846|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13885847|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13885848|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13885849|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885850|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
13885851|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
13885852|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885853|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13885854|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
13885855|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479091|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13885856|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13885857|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13885858|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13885859|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885860|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885861|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885862|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885863|NCT03549026|Analgesics|analgesics|mesh-ancestor
13885864|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
13885865|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754731|NCT04551547|Vaccines|vaccines|mesh-list
14754732|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
14754733|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767194|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767195|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767196|NCT00629200|Interferons|interferons|mesh-list
13885866|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
13885867|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885868|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
13885869|NCT03548948|Iron|iron|mesh-list
13885870|NCT03548948|Trace Elements|trace elements|mesh-ancestor
13885871|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
13885872|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885873|NCT03548818|Interferons|interferons|mesh-list
13885874|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
13885875|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885876|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
13885877|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885878|NCT03548714|Ethanol|ethanol|mesh-list
13885879|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13885880|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885881|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885882|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885883|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
13885884|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13885885|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
13885886|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885887|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
13885888|NCT03548662|Protective Agents|protective agents|mesh-ancestor
13885889|NCT03548571|Temozolomide|temozolomide|mesh-list
13885890|NCT03548571|Vaccines|vaccines|mesh-list
13885891|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13885892|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
13885893|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885894|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767197|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
13885895|NCT03548571|Immunologic Factors|immunologic factors|mesh-ancestor
13885896|NCT03548571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885897|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
13885898|NCT03548493|Fentanyl|fentanyl|mesh-list
13885899|NCT03548493|Propofol|propofol|mesh-list
13885900|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13885901|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13885902|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885903|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13885904|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
13885905|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
13885906|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13885907|NCT03548493|Narcotics|narcotics|mesh-ancestor
13885908|NCT03548493|Analgesics|analgesics|mesh-ancestor
13885909|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
13885910|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885911|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13885912|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13885913|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
13885914|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13885915|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885916|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885917|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13885918|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
13885919|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13885920|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13885921|NCT03548454|Desipramine|desipramine|mesh-list
13885922|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13885923|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13885924|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885925|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885926|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13885927|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885928|NCT03548454|Analgesics|analgesics|mesh-ancestor
13885929|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
13885930|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13885931|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
13885932|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885933|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
13885934|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13885935|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885936|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13885937|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
14754734|NCT04549792|Ustekinumab|ustekinumab|mesh-list
14754735|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14754736|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
13885938|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
13885939|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
13885940|NCT03548311|Vitamins|vitamins|mesh-ancestor
13885941|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
13885942|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885943|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
13885944|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13885945|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
13885946|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885947|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
13885948|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13885949|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471116|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471117|NCT02322866|Sarecycline|sarecycline|mesh-list
14471118|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13885950|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885951|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13885952|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13885953|NCT03548129|Fosfomycin|fosfomycin|mesh-list
13885954|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
13885955|NCT03547895|Vitamin K|vitamin k|mesh-list
13885956|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
13885957|NCT03547895|Ribavirin|ribavirin|mesh-list
13885958|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
14027628|NCT02735317|Vitamins|vitamins|mesh-ancestor
14754737|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14471119|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754738|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754739|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754740|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13885959|NCT03547895|Furosemide|furosemide|mesh-list
13885960|NCT03547895|Spironolactone|spironolactone|mesh-list
13885961|NCT03547895|Silymarin|silymarin|mesh-list
13885962|NCT03547895|Vitamins|vitamins|mesh-ancestor
13885963|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
13885964|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13885965|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
13885966|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885967|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
13885968|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885969|NCT03547895|Diuretics|diuretics|mesh-ancestor
13885970|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
13885971|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13885972|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13885973|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13885974|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
13885975|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13885976|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13885977|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13885978|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13885979|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
13885980|NCT03547895|Coagulants|coagulants|mesh-ancestor
13885981|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
13885982|NCT03547895|Protective Agents|protective agents|mesh-ancestor
13885983|NCT03547830|Plerixafor|plerixafor|mesh-list
13885984|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13885985|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13885986|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
13885987|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13885988|NCT03547804|Apatinib|apatinib|mesh-list
13885989|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13885990|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13885991|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13885992|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13885993|NCT03547791|Betamethasone|betamethasone|mesh-list
13885994|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
13885995|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13885996|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
13885997|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13885998|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
13885999|NCT03547791|Hormones|hormones|mesh-ancestor
13886000|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886001|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886002|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13886003|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13886004|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
13886005|NCT03547778|Misoprostol|misoprostol|mesh-list
13886006|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13886007|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
13886008|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13886009|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886010|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13886011|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13886012|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
13886013|NCT03547700|Ixazomib|ixazomib|mesh-list
13886014|NCT03547700|Romidepsin|romidepsin|mesh-list
13886015|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886016|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
13886017|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886018|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886019|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13886020|NCT03547622|Galantamine|galantamine|mesh-list
13886021|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13886022|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886023|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886024|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
13886025|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886026|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886027|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13886028|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
13886029|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886030|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
13958089|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
13958090|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
13958091|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
13958092|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
13958093|NCT03171584|Itraconazole|itraconazole|mesh-list
13958094|NCT03171584|Fluconazole|fluconazole|mesh-list
13958095|NCT03171584|Terbinafine|terbinafine|mesh-list
13958096|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
13958097|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958098|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13958099|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13958100|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958101|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958102|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13958103|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
13958104|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958105|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958106|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13958107|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13958108|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13958109|NCT03171610|Fentanyl|fentanyl|mesh-list
13958110|NCT03171610|Sufentanil|sufentanil|mesh-list
13958111|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13958112|NCT03171610|Narcotics|narcotics|mesh-ancestor
13958113|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958114|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958115|NCT03171610|Analgesics|analgesics|mesh-ancestor
13958116|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
13958117|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958118|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13958119|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13958120|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
13958121|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
13958122|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
13958123|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13958124|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
13958125|NCT03171389|Ponatinib|ponatinib|mesh-list
13958126|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958127|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13958128|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958129|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958130|NCT03171090|Anesthetics|anesthetics|mesh-list
13958131|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
13958132|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958133|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958134|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
13958135|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958136|NCT03170895|Sorafenib|sorafenib|mesh-list
13958137|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
13958138|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958139|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13958140|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958141|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958142|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13958143|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13958144|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
13958145|NCT03171220|Fludarabine|fludarabine|mesh-list
13886031|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14932004|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
14932005|NCT01442766|Donepezil|donepezil|mesh-list
14932006|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14932007|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932008|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932009|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
14932010|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886032|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
13886033|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13886034|NCT03547505|Protective Agents|protective agents|mesh-ancestor
13886035|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886036|NCT03547375|Apatinib|apatinib|mesh-list
13886037|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886038|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886039|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886040|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886041|NCT03547362|Caseins|caseins|mesh-list
13886042|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
13886043|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
14932011|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932012|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
14932013|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
13886044|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886045|NCT03547232|Indomethacin|indomethacin|mesh-list
13886046|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13886047|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13886048|NCT03547232|Analgesics|analgesics|mesh-ancestor
13886049|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
13886050|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886051|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886052|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13886053|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13886054|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
13886055|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
13886056|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14932014|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14932015|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
13886057|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13886058|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886059|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886060|NCT03547219|Citalopram|citalopram|mesh-list
13886061|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13886062|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13886063|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886064|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886065|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886066|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
13886067|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886068|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13886069|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
14471120|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
14932016|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14932017|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
13886070|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13886071|NCT03547024|Midazolam|midazolam|mesh-list
13886072|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
13886073|NCT03547024|Omeprazole|omeprazole|mesh-list
13886074|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
13886075|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13886076|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
13886077|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
13886078|NCT03547024|Estradiol|estradiol|mesh-list
13886079|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13886080|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13886081|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886082|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886083|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13886084|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13886085|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13886086|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13886087|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
13886088|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
13886089|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
13886090|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
13886091|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886092|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886093|NCT03547024|Estrogens|estrogens|mesh-ancestor
13886094|NCT03547024|Hormones|hormones|mesh-ancestor
13886095|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886096|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13886097|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
13886098|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13886099|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13886100|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13886101|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13886102|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13886103|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886104|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13886105|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13886106|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13886107|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
14027629|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
14027630|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027631|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027632|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
14027633|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
14027634|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027635|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027636|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
14027637|NCT02735317|Hormones|hormones|mesh-ancestor
14027638|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027639|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027640|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027641|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
14027642|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027643|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027644|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14027645|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027646|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027647|NCT02735317|Hematinics|hematinics|mesh-ancestor
14027648|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
14027649|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
14027650|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027651|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
14027652|NCT02735031|Exenatide|exenatide|mesh-list
14027653|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14027654|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886108|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
13886109|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13886110|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13886111|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13886112|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
13886113|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13886114|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13886115|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
13886116|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
13886117|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13886118|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886119|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886120|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
13886121|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886122|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886123|NCT03546855|Apatinib|apatinib|mesh-list
13886124|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886125|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886126|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886127|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886128|NCT03546803|Protective Agents|protective agents|mesh-list
13886129|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886130|NCT03546634|Vaccines|vaccines|mesh-list
13886131|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
13886132|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886133|NCT03546608|Tepotinib|tepotinib|mesh-list
13886134|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886135|NCT03546530|Interferons|interferons|mesh-list
13886136|NCT03546530|Resveratrol|resveratrol|mesh-list
13886137|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886138|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
13886139|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886140|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
13886141|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886142|NCT03546530|Protective Agents|protective agents|mesh-ancestor
13886143|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886144|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886145|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13886146|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
13886147|NCT03546426|Interleukin-2|interleukin-2|mesh-list
13886148|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886149|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886150|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13886151|NCT03546426|Analgesics|analgesics|mesh-ancestor
13886152|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
13886153|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886154|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886155|NCT03546400|Methylphenidate|methylphenidate|mesh-list
13886156|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13886157|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886158|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13886159|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13886160|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886161|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886162|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
13886163|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886164|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
13886165|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886166|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886167|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
13886168|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13886169|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14754741|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14754742|NCT04546009|Letrozole|letrozole|mesh-list
14754743|NCT04546009|Palbociclib|palbociclib|mesh-list
14754744|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754745|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13886170|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886171|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886172|NCT03546283|Protective Agents|protective agents|mesh-ancestor
13886173|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471121|NCT02322892|Thiamine|thiamine|mesh-list
14471122|NCT02322892|Vitamins|vitamins|mesh-ancestor
14471123|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
14471124|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886174|NCT03546088|Anesthetics|anesthetics|mesh-list
13886175|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886176|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886177|NCT03546075|Resveratrol|resveratrol|mesh-list
13886178|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
13886179|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886180|NCT03546075|Protective Agents|protective agents|mesh-ancestor
13886181|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886182|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886183|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13886184|NCT03545997|Montelukast|montelukast|mesh-list
13886185|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13886186|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
13886187|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13886188|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
13886189|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886190|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886191|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13886192|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13886193|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958146|NCT03171220|Interleukin-2|interleukin-2|mesh-list
13958147|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958148|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
14471125|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
14471126|NCT02323048|Methamphetamine|methamphetamine|mesh-list
14471127|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14471128|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471129|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
14471130|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
14471131|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471132|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
14479092|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
14932018|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886194|NCT03545711|Irinotecan|irinotecan|mesh-list
13886195|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13886196|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13886197|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886198|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886199|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886200|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
13886201|NCT03545516|Bupivacaine|bupivacaine|mesh-list
13886202|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
13886203|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
13886204|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886205|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886206|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
13886207|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886208|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13886209|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13886210|NCT03545516|Analgesics|analgesics|mesh-ancestor
13886211|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13886212|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13886213|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13886214|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
13886215|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932019|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932020|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
14932021|NCT01442818|Hydromorphone|hydromorphone|mesh-list
14932022|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13886216|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886217|NCT03545373|Amoxicillin|amoxicillin|mesh-list
13886218|NCT03545373|Azithromycin|azithromycin|mesh-list
14932023|NCT01442818|Narcotics|narcotics|mesh-ancestor
13886219|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13886220|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886221|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
13886222|NCT03545347|Nandrolone|nandrolone|mesh-list
13886223|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
13886224|NCT03545347|Androgens|androgens|mesh-ancestor
13886225|NCT03545347|Hormones|hormones|mesh-ancestor
13886226|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886227|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886228|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
13886229|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13886230|NCT03545308|Rocuronium|rocuronium|mesh-list
13886231|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13886232|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13886233|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13886234|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886235|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886236|NCT03545243|Pantoprazole|pantoprazole|mesh-list
13886237|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13886238|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13886239|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13886240|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886241|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886242|NCT03545035|Rituximab|rituximab|mesh-list
13886243|NCT03545035|Idelalisib|idelalisib|mesh-list
13886244|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886245|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886246|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
13886247|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886248|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13886249|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886250|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886251|NCT03544996|Insulin|insulin|mesh-list
13886252|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13886253|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886254|NCT03544827|Atropine|atropine|mesh-list
13886255|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13886256|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13886257|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13886258|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
14754746|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14754747|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754748|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754749|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14754750|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
14767198|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
13886259|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886260|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886261|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14754751|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754752|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754753|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754754|NCT04543617|Atezolizumab|atezolizumab|mesh-list
13886262|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
13886263|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
13886264|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
13886265|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13886266|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13886267|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
13886268|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886269|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886270|NCT03544814|Cisplatin|cisplatin|mesh-list
13886271|NCT03544814|Pemetrexed|pemetrexed|mesh-list
13886272|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886273|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886274|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886275|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13886276|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13886277|NCT03544775|Anesthetics|anesthetics|mesh-list
13886278|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886279|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886280|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
13886281|NCT03544723|Nivolumab|nivolumab|mesh-list
13886282|NCT03544723|Durvalumab|durvalumab|mesh-list
13886283|NCT03544723|Atezolizumab|atezolizumab|mesh-list
13886284|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886285|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886286|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13886287|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886288|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
13886289|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886290|NCT03544671|Vitamin D|vitamin d|mesh-list
13886291|NCT03544671|Vitamins|vitamins|mesh-ancestor
13886292|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
13886293|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886294|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13886295|NCT03544606|Pyridoxine|pyridoxine|mesh-list
13886296|NCT03544606|Isosorbide|isosorbide|mesh-list
13886297|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13886298|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13886299|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13886300|NCT03544606|Diuretics|diuretics|mesh-ancestor
13886301|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
13886302|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886303|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
13886304|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13886305|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886306|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
13886307|NCT03544606|Vitamins|vitamins|mesh-ancestor
13886308|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
13886309|NCT03544567|Paclitaxel|paclitaxel|mesh-list
13886310|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13886311|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886312|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
13886313|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
13886314|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
13886315|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958149|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886316|NCT03544229|Maleic acid|maleic acid|mesh-list
13886317|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886318|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886319|NCT03544125|Durvalumab|durvalumab|mesh-list
13886320|NCT03544125|Olaparib|olaparib|mesh-list
13886321|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13886322|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
13886323|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13886324|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
13886325|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886326|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886327|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
13886328|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886329|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886330|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886331|NCT03544073|Leuprolide|leuprolide|mesh-list
13886332|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13886333|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
13886334|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13886335|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886336|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13886337|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886338|NCT03544047|Paclitaxel|paclitaxel|mesh-list
13886339|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13886340|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886341|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
13886342|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
13886343|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
13886344|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886345|NCT03543969|Vemurafenib|vemurafenib|mesh-list
13886346|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886347|NCT03543969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886348|NCT03543969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886349|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886350|NCT03543826|Rocuronium|rocuronium|mesh-list
13886351|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13886352|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13886353|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13886354|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958150|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932024|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886355|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886356|NCT03543774|Simvastatin|simvastatin|mesh-list
13886357|NCT03543774|Ezetimibe|ezetimibe|mesh-list
13886358|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
13886359|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13886360|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13886361|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
13886362|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886363|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13886364|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13886365|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886366|NCT03543683|Aspirin|aspirin|mesh-list
13886367|NCT03543683|Osimertinib|osimertinib|mesh-list
13886368|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13886369|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13886370|NCT03543683|Analgesics|analgesics|mesh-ancestor
13886371|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
13886372|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886373|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886374|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13886375|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13886376|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13886377|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13886378|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886379|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13886380|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13886381|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886382|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
13886383|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886384|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886385|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
13886386|NCT03543657|Hematinics|hematinics|mesh-ancestor
13886387|NCT03543436|Meropenem|meropenem|mesh-list
13886388|NCT03543436|Imipenem|imipenem|mesh-list
13886389|NCT03543436|Temocillin|temocillin|mesh-list
13886390|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13886391|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886392|NCT03543306|Trametinib|trametinib|mesh-list
13886393|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886394|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886395|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886396|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886397|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
13886398|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13886399|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13886400|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13886401|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886402|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886403|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
13886404|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886405|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886406|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13886407|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886408|NCT03543202|Anesthetics|anesthetics|mesh-list
13886409|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886410|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886411|NCT03543072|Diphosphonates|diphosphonates|mesh-list
13886412|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13886413|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886414|NCT03542955|Etoricoxib|etoricoxib|mesh-list
13886415|NCT03542955|Analgesics|analgesics|mesh-list
14932025|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932026|NCT01442818|Analgesics|analgesics|mesh-ancestor
13886416|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
13886417|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886418|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886419|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13886420|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13886421|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13886422|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13886423|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13886424|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13886425|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886426|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886427|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
14027655|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14027656|NCT02735031|Incretins|incretins|mesh-ancestor
14027657|NCT02735031|Hormones|hormones|mesh-ancestor
14027658|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027659|NCT02735057|Paclitaxel|paclitaxel|mesh-list
14027660|NCT02735057|Carboplatin|carboplatin|mesh-list
14027661|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14027662|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027663|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
14027664|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14027665|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14027666|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027667|NCT02734875|Anticoagulants|anticoagulants|mesh-list
14027668|NCT02735018|Epinephrine|epinephrine|mesh-list
14027669|NCT02735018|Racepinephrine|racepinephrine|mesh-list
14027670|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
14027671|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14027672|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14027673|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
14027674|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14027675|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027676|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027677|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14027678|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14027679|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
14027680|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027681|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14471133|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471134|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932027|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
14932028|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932029|NCT01442870|Metformin|metformin|mesh-list
14932030|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14932031|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932032|NCT01442909|Docetaxel|docetaxel|mesh-list
14932033|NCT01442909|Pemetrexed|pemetrexed|mesh-list
14932034|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886428|NCT03542851|Convulsants|convulsants|mesh-ancestor
13963200|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027682|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
14932035|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
13886429|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13886430|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886431|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
13886432|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
13886433|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886434|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886435|NCT03542825|Iron|iron|mesh-list
13886436|NCT03542825|Lactoferrin|lactoferrin|mesh-list
13886437|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
13886438|NCT03542825|Trace Elements|trace elements|mesh-ancestor
13886439|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
13886440|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886441|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886442|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
14932036|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
14932037|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
14932038|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932039|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932040|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13886443|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
13886444|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886445|NCT03542760|Methylene Blue|methylene blue|mesh-list
13886446|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886447|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886448|NCT03542617|Dexamethasone|dexamethasone|mesh-list
13886449|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13886450|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
13886451|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
13886452|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886453|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886454|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13886455|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
13886456|NCT03542617|Hormones|hormones|mesh-ancestor
13886457|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886458|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13886459|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886460|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
13886461|NCT03542552|Nifedipine|nifedipine|mesh-list
13886462|NCT03542552|Analgesics|analgesics|mesh-ancestor
13886463|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
13886464|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886465|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886466|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
13886467|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471135|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14471136|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14471137|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14471138|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471139|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14471140|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
13886468|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13886469|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
13886470|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13886471|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886472|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886473|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13886474|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
13886475|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13886476|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
13958151|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958152|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
13958153|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958154|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958155|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958156|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958157|NCT03171220|Analgesics|analgesics|mesh-ancestor
13958158|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
13958159|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958160|NCT03170713|Ibuprofen|ibuprofen|mesh-list
13958161|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13958162|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13958163|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958164|NCT03170713|Analgesics|analgesics|mesh-ancestor
13958165|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
13958166|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958167|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958168|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958169|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958170|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13958171|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958172|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958173|NCT03170596|Tazarotene|tazarotene|mesh-list
13958174|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
13958175|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
13958176|NCT03170687|Calpastatin|calpastatin|mesh-list
13958177|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13958178|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
13958179|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958180|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958181|NCT03170726|Ibuprofen|ibuprofen|mesh-list
13958182|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13958183|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13958184|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958185|NCT03170726|Analgesics|analgesics|mesh-ancestor
13958186|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
13958187|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958188|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958189|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958190|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958191|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13958192|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958193|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958194|NCT03170739|Dopamine|dopamine|mesh-list
13958195|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
13958196|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13958197|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958198|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958199|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958200|NCT03170739|Analgesics|analgesics|mesh-ancestor
13958201|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
13958202|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958203|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13958204|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13958205|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13958206|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
14471141|NCT02323217|Idazoxan|idazoxan|mesh-list
13886477|NCT03542461|Nivolumab|nivolumab|mesh-list
13886478|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886479|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886480|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13886481|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886482|NCT03542422|Apatinib|apatinib|mesh-list
13886483|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886484|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886485|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886486|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886487|NCT03542357|Calcitonin|calcitonin|mesh-list
13886488|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
13886489|NCT03542357|Sumatriptan|sumatriptan|mesh-list
13886490|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
13886491|NCT03542357|Katacalcin|katacalcin|mesh-list
13886492|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13886493|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13886494|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13886495|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
13886496|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886497|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886498|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886499|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13886500|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13886501|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
13886502|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
13886503|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886504|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
13886505|NCT03542279|Hormones|hormones|mesh-ancestor
13886506|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886507|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886508|NCT03542240|Curcumin|curcumin|mesh-list
13886509|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13886510|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13886511|NCT03542240|Analgesics|analgesics|mesh-ancestor
13886512|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
13886513|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886514|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886515|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13886516|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13886517|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886518|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886519|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886520|NCT03542214|Calcium|calcium|mesh-list
13886521|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13886522|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886523|NCT03542149|Tocopherols|tocopherols|mesh-list
13886524|NCT03542149|Vitamin E|vitamin e|mesh-list
13886525|NCT03542149|Tocotrienols|tocotrienols|mesh-list
13886526|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
13886527|NCT03542149|Piperaquine|piperaquine|mesh-list
13886528|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
13886529|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13886530|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13886531|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886532|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
13886533|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886534|NCT03542149|Protective Agents|protective agents|mesh-ancestor
13886535|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886536|NCT03542149|Vitamins|vitamins|mesh-ancestor
13886537|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
13886538|NCT03542058|Carvedilol|carvedilol|mesh-list
13886539|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13886540|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13886541|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
13886542|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886543|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886544|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886545|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13886546|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
13886547|NCT03542058|Protective Agents|protective agents|mesh-ancestor
13886548|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13886549|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886550|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13886551|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
13886552|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13886553|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14754755|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14754756|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754757|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
14754758|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886554|NCT03542006|Brinzolamide|brinzolamide|mesh-list
13886555|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13886556|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886557|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886558|NCT03541993|Resveratrol|resveratrol|mesh-list
13886559|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
13886560|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886561|NCT03541993|Protective Agents|protective agents|mesh-ancestor
13886562|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886563|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886564|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13886565|NCT03541928|Valacyclovir|valacyclovir|mesh-list
13886566|NCT03541928|Leuprolide|leuprolide|mesh-list
13886567|NCT03541928|Bicalutamide|bicalutamide|mesh-list
13886568|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13886569|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
13886570|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13886571|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886572|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13886573|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886574|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
13886575|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
13886576|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886577|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
13886578|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886579|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
13886580|NCT03541915|Analgesics|analgesics|mesh-ancestor
13886581|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
13886582|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886583|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886584|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
13886585|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886586|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13886587|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
13886588|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13886589|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886590|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886591|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13886592|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
13886593|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13886594|NCT03541902|Sunitinib|sunitinib|mesh-list
13886595|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886596|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13886597|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13886598|NCT03541902|Growth Substances|growth substances|mesh-ancestor
13886599|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886600|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
13886601|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886602|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886603|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886604|NCT03541837|Ropivacaine|ropivacaine|mesh-list
13886605|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
13886606|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
13886607|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886608|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886609|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
13886610|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886611|NCT03541798|Anesthetics|anesthetics|mesh-list
13886612|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886613|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886614|NCT03541759|Hydromorphone|hydromorphone|mesh-list
13886615|NCT03541759|Pirinitramide|pirinitramide|mesh-list
13886616|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13886617|NCT03541759|Narcotics|narcotics|mesh-ancestor
13886618|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886619|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886620|NCT03541759|Analgesics|analgesics|mesh-ancestor
13886621|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
13886622|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886623|NCT03541681|Anesthetics|anesthetics|mesh-list
13886624|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
13886625|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886626|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886627|NCT03541681|Hormones|hormones|mesh-ancestor
13886628|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886629|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13886630|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13886631|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13886632|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886633|NCT03541603|Simendan|simendan|mesh-list
13886634|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13886635|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
13886636|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13886637|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13886638|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886639|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886640|NCT03541603|Protective Agents|protective agents|mesh-ancestor
13886641|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886642|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
13886643|NCT03541564|BMS-986165|bms-986165|mesh-list
13886644|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13886645|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886646|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13886647|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13886648|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886649|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886650|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886651|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
13886652|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886653|NCT03541265|Bupivacaine|bupivacaine|mesh-list
13886654|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
13886655|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
13886656|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886657|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886658|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
13886659|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886660|NCT03541031|Micronutrients|micronutrients|mesh-list
13886661|NCT03541031|Trace Elements|trace elements|mesh-list
13886662|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886663|NCT03540979|Letrozole|letrozole|mesh-list
13886664|NCT03540979|Progesterone|progesterone|mesh-list
13886665|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886666|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13886667|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13886668|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886669|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886670|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13886671|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
13886672|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886673|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886674|NCT03540979|Progestins|progestins|mesh-ancestor
13886675|NCT03540979|Hormones|hormones|mesh-ancestor
13886676|NCT03540953|Mitomycins|mitomycins|mesh-list
13886677|NCT03540953|Mitomycin|mitomycin|mesh-list
13886678|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13886679|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886680|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
13886681|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886682|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13886683|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886684|NCT03540914|Acetazolamide|acetazolamide|mesh-list
13886685|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
13886686|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13886687|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886688|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886689|NCT03540914|Diuretics|diuretics|mesh-ancestor
13886690|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
13886691|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886692|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13886693|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886694|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886695|NCT03540836|Cortisone|cortisone|mesh-list
13886696|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958207|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958208|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958209|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13958210|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
13958211|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
13958212|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
13958213|NCT03170739|Protective Agents|protective agents|mesh-ancestor
13958214|NCT03170310|Apatinib|apatinib|mesh-list
13958215|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958216|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13958217|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958218|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958219|NCT03170323|Cyclosporine|cyclosporine|mesh-list
13958220|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
13958221|NCT03170323|Cyclosporins|cyclosporins|mesh-list
13958222|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958223|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958224|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958225|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
13958226|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958227|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
13958228|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958229|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
13958230|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958231|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13958232|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13958233|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958234|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13958235|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
13958236|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13958237|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13958238|NCT03170336|Amiloride|amiloride|mesh-list
13958239|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13958240|NCT03170336|Diuretics|diuretics|mesh-ancestor
13958241|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
13958242|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958243|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13958244|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13958245|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958246|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
13958247|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13958248|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
13958249|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13958250|NCT03170284|Bevacizumab|bevacizumab|mesh-list
13958251|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958252|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958253|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958254|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958255|NCT03170284|Growth Substances|growth substances|mesh-ancestor
13958256|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958257|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958258|NCT03170050|Lidocaine|lidocaine|mesh-list
13958259|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
13958260|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
13958261|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958262|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958263|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
13958264|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958265|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14027683|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
13886697|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
13886698|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
13886699|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13886700|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13886701|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886702|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886703|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886704|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13886705|NCT03540628|Ascorbic Acid|ascorbic acid|mesh-list
13886706|NCT03540628|Thiamine|thiamine|mesh-list
13886707|NCT03540628|Vitamins|vitamins|mesh-ancestor
13886708|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
13886709|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886710|NCT03540628|Antioxidants|antioxidants|mesh-ancestor
13886711|NCT03540628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886712|NCT03540628|Protective Agents|protective agents|mesh-ancestor
13886713|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
13886714|NCT03540485|Melatonin|melatonin|mesh-list
13886715|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
13886716|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886717|NCT03540485|Protective Agents|protective agents|mesh-ancestor
13886718|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886719|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886720|NCT03540472|Tacrolimus|tacrolimus|mesh-list
13886721|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13886722|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
13886723|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886724|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13886725|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886726|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886727|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
13886728|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13886729|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13886730|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886731|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
13886732|NCT03540368|Coagulants|coagulants|mesh-ancestor
13886733|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13886734|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13886735|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13886736|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
13886737|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886738|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14754759|NCT04540211|Paclitaxel|paclitaxel|mesh-list
14754760|NCT04540211|Atezolizumab|atezolizumab|mesh-list
13886739|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14754761|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14754762|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14754763|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754764|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
14754765|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
14754766|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
13886740|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886741|NCT03540225|Progesterone|progesterone|mesh-list
13886742|NCT03540225|Progestins|progestins|mesh-ancestor
13886743|NCT03540225|Hormones|hormones|mesh-ancestor
13886744|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886745|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886746|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
13886747|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
13886748|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886749|NCT03540199|Antibodies|antibodies|mesh-list
13886750|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13886751|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
13886752|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886753|NCT03540095|Bupivacaine|bupivacaine|mesh-list
13886754|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
13886755|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
13886756|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886757|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886758|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
13886759|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886760|NCT03540017|Cisplatin|cisplatin|mesh-list
13886761|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886762|NCT03539887|Ketamine|ketamine|mesh-list
13886763|NCT03539887|Analgesics|analgesics|mesh-ancestor
13886764|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
13886765|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886766|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886767|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13886768|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13886769|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
13886770|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
13886771|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886772|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13886773|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13886774|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886775|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886776|NCT03539731|Piperazine|piperazine|mesh-list
13886777|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
13886778|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
13886779|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13886780|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886781|NCT03539718|Taurolidine|taurolidine|mesh-list
13886782|NCT03539718|Heparin|heparin|mesh-list
13886783|NCT03539718|Calcium heparin|calcium heparin|mesh-list
13886784|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
13886785|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13886786|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13886787|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886788|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886789|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13886790|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886791|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
13886792|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13886793|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13886794|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886795|NCT03539562|Promethazine|promethazine|mesh-list
13886796|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
13886797|NCT03539562|Morphine|morphine|mesh-list
13886798|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13886799|NCT03539562|Narcotics|narcotics|mesh-ancestor
13886800|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886801|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886802|NCT03539562|Analgesics|analgesics|mesh-ancestor
13886803|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
13886804|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886805|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
13886806|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
13886807|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13886808|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
13886809|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
13886810|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886811|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886812|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13886813|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13886814|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13886815|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
13886816|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
13886817|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
13886818|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
13886819|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13886820|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
13886821|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13886822|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13886823|NCT03539445|Protective Agents|protective agents|mesh-ancestor
13886824|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886825|NCT03539367|Acetazolamide|acetazolamide|mesh-list
13886826|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
13886827|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13886828|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886829|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886830|NCT03539367|Diuretics|diuretics|mesh-ancestor
13886831|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
13886832|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886833|NCT03539328|Gemcitabine|gemcitabine|mesh-list
13886834|NCT03539328|Paclitaxel|paclitaxel|mesh-list
13886835|NCT03539328|Doxorubicin|doxorubicin|mesh-list
13886836|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13886837|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
13886838|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13886839|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886840|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
13886841|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
13886842|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
13886843|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886844|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13886845|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
13886846|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
13886847|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13886848|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886849|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13886850|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
13886851|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886852|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13886853|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13886854|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13886855|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886856|NCT03539224|Lamivudine|lamivudine|mesh-list
13886857|NCT03539224|Dolutegravir|dolutegravir|mesh-list
13886858|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13886859|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14754767|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754768|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
14754769|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754770|NCT04533997|Furosemide|furosemide|mesh-list
14754771|NCT04533997|Diuretics|diuretics|mesh-ancestor
14754772|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
14754773|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886860|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886861|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886862|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
13886863|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754774|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14754775|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14754776|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754777|NCT04533451|Carboplatin|carboplatin|mesh-list
14754778|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
14754779|NCT04533451|Pemetrexed|pemetrexed|mesh-list
14754780|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754781|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754782|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886864|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13886865|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13886866|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13886867|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13886868|NCT03539198|Nivolumab|nivolumab|mesh-list
13886869|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13886870|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886871|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13886872|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886873|NCT03539172|Apatinib|apatinib|mesh-list
13886874|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886875|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13886876|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886877|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886878|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13886879|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13958266|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13958267|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13958268|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13958269|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958270|NCT03170115|Aspirin|aspirin|mesh-list
13958271|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13958272|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13958273|NCT03170115|Analgesics|analgesics|mesh-ancestor
13958274|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
13958275|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958276|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958277|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958278|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958279|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13958280|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13958281|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958282|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13958283|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13958284|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958285|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
13958286|NCT03169959|Metformin|metformin|mesh-list
13958287|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
13958288|NCT03169959|Saxagliptin|saxagliptin|mesh-list
13958289|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13958290|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963201|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14027684|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
13886880|NCT03539055|Dabigatran|dabigatran|mesh-list
13886881|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
13886882|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13886883|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
13886884|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886885|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886886|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
13886887|NCT03539003|Remifentanil|remifentanil|mesh-list
13886888|NCT03539003|Propofol|propofol|mesh-list
13886889|NCT03539003|Sevoflurane|sevoflurane|mesh-list
13886890|NCT03539003|Desflurane|desflurane|mesh-list
13886891|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13886892|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886893|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886894|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13886895|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
13886896|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
13886897|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13886898|NCT03539003|Narcotics|narcotics|mesh-ancestor
13886899|NCT03539003|Analgesics|analgesics|mesh-ancestor
13886900|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
13886901|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886902|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13886903|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13886904|NCT03538704|Metformin|metformin|mesh-list
14932041|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14932042|NCT01442935|Leucovorin|leucovorin|mesh-list
14932043|NCT01442935|Folic Acid|folic acid|mesh-list
14932044|NCT01442935|Bevacizumab|bevacizumab|mesh-list
14932045|NCT01442935|Cetuximab|cetuximab|mesh-list
14932046|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
14932047|NCT01442935|Irinotecan|irinotecan|mesh-list
14932048|NCT01442935|Fluorouracil|fluorouracil|mesh-list
13886905|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13886906|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886907|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13886908|NCT03538691|Dexetimide|dexetimide|mesh-list
13886909|NCT03538691|Citalopram|citalopram|mesh-list
13886910|NCT03538691|Fluoxetine|fluoxetine|mesh-list
13886911|NCT03538691|Paroxetine|paroxetine|mesh-list
13886912|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13886913|NCT03538691|Sertraline|sertraline|mesh-list
13886914|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
13886915|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13886916|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13886917|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13886918|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886919|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886920|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
13886921|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886922|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13886923|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
13886924|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13886925|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13886926|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13886927|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
13886928|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
14754783|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886929|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886930|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13886931|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13886932|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
13886933|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13886934|NCT03538691|Analgesics|analgesics|mesh-ancestor
13886935|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
13886936|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
14754784|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14754785|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14754786|NCT04525547|Nintedanib|nintedanib|mesh-list
14754787|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754788|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754789|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754790|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886937|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13886938|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14932049|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
14932050|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932051|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886939|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886940|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
13886941|NCT03538496|Bupivacaine|bupivacaine|mesh-list
13886942|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
13886943|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
13886944|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886945|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754791|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14754792|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
14754793|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14754794|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14754795|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14754796|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754797|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754798|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
14754799|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14754800|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14754801|NCT04519476|Prednisolone|prednisolone|mesh-list
14754802|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
14754803|NCT04519476|Lenalidomide|lenalidomide|mesh-list
14754804|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14754805|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
13886946|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
13886947|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886948|NCT03538483|Bupivacaine|bupivacaine|mesh-list
13886949|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
13886950|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
13886951|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13886952|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886953|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
13886954|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886955|NCT03538457|Acetaminophen|acetaminophen|mesh-list
13886956|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13886957|NCT03538457|Analgesics|analgesics|mesh-ancestor
13886958|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
13886959|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13886960|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886961|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
13886962|NCT03538327|Silybin|silybin|mesh-list
13886963|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13886964|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886965|NCT03538327|Protective Agents|protective agents|mesh-ancestor
13886966|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886967|NCT03538171|Exemestane|exemestane|mesh-list
13886968|NCT03538171|Entinostat|entinostat|mesh-list
13886969|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13886970|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13886971|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13886972|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886973|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886974|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13886975|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
13886976|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13886977|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886978|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13886979|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
13886980|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
13886981|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
13886982|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13886983|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13886984|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13886985|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886986|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886987|NCT03537950|Cannabidiol|cannabidiol|mesh-list
13886988|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
13886989|NCT03537924|Acetazolamide|acetazolamide|mesh-list
13886990|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
13886991|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13886992|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13886993|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13886994|NCT03537924|Diuretics|diuretics|mesh-ancestor
13886995|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
13886996|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13886997|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13886998|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
13886999|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13887000|NCT03537807|Riluzole|riluzole|mesh-list
13887001|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
13887002|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13887003|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13887004|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887005|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887006|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887007|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13887008|NCT03537807|Protective Agents|protective agents|mesh-ancestor
13887009|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
13887010|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
13887011|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13887012|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
13887013|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13887014|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887015|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13887016|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13887017|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13887018|NCT03537612|Clonidine|clonidine|mesh-list
13887019|NCT03537612|Morphine|morphine|mesh-list
13887020|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13887021|NCT03537612|Narcotics|narcotics|mesh-ancestor
13887022|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887023|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887024|NCT03537612|Analgesics|analgesics|mesh-ancestor
13887025|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
13887026|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887027|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13887028|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
13887029|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
13887030|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13887031|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13887032|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13887033|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
13887034|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887035|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887036|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
13887037|NCT03537573|Narcotics|narcotics|mesh-ancestor
13887038|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887039|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887040|NCT03537573|Analgesics|analgesics|mesh-ancestor
13887041|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
13887042|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887043|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
13887044|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
13887045|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
13887046|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13887047|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887048|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887049|NCT03537534|Lidocaine|lidocaine|mesh-list
13887050|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
13887051|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
13887052|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887053|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887054|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
13887055|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887056|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13887057|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13887058|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13887059|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13887060|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887061|NCT03537495|Linezolid|linezolid|mesh-list
13887062|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13887063|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887064|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13887065|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887066|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887067|NCT03537443|Vitamin D|vitamin d|mesh-list
13887068|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
13887069|NCT03537443|Vitamins|vitamins|mesh-ancestor
13887070|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
13887071|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887072|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13887073|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13887074|NCT03537391|Fluorides|fluorides|mesh-list
13887075|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
13887076|NCT03537391|Protective Agents|protective agents|mesh-ancestor
13887077|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887078|NCT03537326|Budesonide|budesonide|mesh-list
13887079|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887080|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13887081|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
13887082|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887083|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887084|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13887085|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
13887086|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
13887087|NCT03537326|Hormones|hormones|mesh-ancestor
13887088|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958291|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13958292|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958293|NCT03169959|Incretins|incretins|mesh-ancestor
13958294|NCT03169959|Hormones|hormones|mesh-ancestor
13958295|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958296|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13958297|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
13958298|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958299|NCT03169751|Caffeine|caffeine|mesh-list
13958300|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13958301|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958302|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13958303|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958304|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958305|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13958306|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13958307|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
13958308|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958309|NCT03169764|Leucovorin|leucovorin|mesh-list
13958310|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
13958311|NCT03169764|Bevacizumab|bevacizumab|mesh-list
13958312|NCT03169764|Fluorouracil|fluorouracil|mesh-list
13958313|NCT03169764|Capecitabine|capecitabine|mesh-list
13958314|NCT03169764|Nivolumab|nivolumab|mesh-list
13958315|NCT03169764|Cetuximab|cetuximab|mesh-list
13958316|NCT03169764|Fulvestrant|fulvestrant|mesh-list
13958317|NCT03169764|Avelumab|avelumab|mesh-list
13958318|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958319|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958320|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958321|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
13958322|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958323|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958324|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958325|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
13958326|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958327|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958328|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958329|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958330|NCT03169764|Growth Substances|growth substances|mesh-ancestor
13958331|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958332|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
13958333|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958334|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13958335|NCT03169764|Antidotes|antidotes|mesh-ancestor
13958336|NCT03169764|Protective Agents|protective agents|mesh-ancestor
13958337|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
13958338|NCT03169764|Vitamins|vitamins|mesh-ancestor
13958339|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
13887089|NCT03537287|Progesterone|progesterone|mesh-list
13887090|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
13887091|NCT03537287|Progestins|progestins|mesh-ancestor
13887092|NCT03537287|Hormones|hormones|mesh-ancestor
13887093|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887094|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887095|NCT03537196|Ribavirin|ribavirin|mesh-list
13887096|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
13887097|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
13887098|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932052|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14932053|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14932054|NCT01442935|Growth Substances|growth substances|mesh-ancestor
14932055|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932056|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
14932057|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14932058|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14932059|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932060|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932061|NCT01442935|Antidotes|antidotes|mesh-ancestor
14932062|NCT01442935|Protective Agents|protective agents|mesh-ancestor
14932063|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
14932064|NCT01442935|Vitamins|vitamins|mesh-ancestor
14932065|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
14932066|NCT01442935|Hematinics|hematinics|mesh-ancestor
14932067|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
14932068|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14932069|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932070|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
14932071|NCT01442974|Gemcitabine|gemcitabine|mesh-list
14932072|NCT01442974|Paclitaxel|paclitaxel|mesh-list
14932073|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14932074|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932075|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
14932076|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
13887099|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
13887100|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887101|NCT03537157|Rifaximin|rifaximin|mesh-list
13887102|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13887103|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887104|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13887105|NCT03537144|Acetaminophen|acetaminophen|mesh-list
13887106|NCT03537144|Indomethacin|indomethacin|mesh-list
13887107|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13887108|NCT03537144|Analgesics|analgesics|mesh-ancestor
13887109|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
13887110|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887111|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887112|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
13887113|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13887114|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887115|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887116|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
13887117|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
13887118|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13887119|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13887120|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887121|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887122|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
13887123|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13887124|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887125|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13887126|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887127|NCT03537027|Vitamin D|vitamin d|mesh-list
13887128|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
13887129|NCT03537027|Vitamins|vitamins|mesh-ancestor
13887130|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
13887131|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887132|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13887133|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13887134|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
14932077|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
14932078|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932079|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14932080|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
13887135|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
13887136|NCT03536910|Coagulants|coagulants|mesh-ancestor
13887137|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13887138|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13887139|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
13887140|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887141|NCT03536845|Vitamin D|vitamin d|mesh-list
13887142|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
13887143|NCT03536845|Vitamins|vitamins|mesh-ancestor
13887144|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
13887145|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887146|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13887147|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13887148|NCT03536806|Canrenone|canrenone|mesh-list
13887149|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13887150|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
13887151|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887152|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887153|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13887154|NCT03536806|Diuretics|diuretics|mesh-ancestor
13887155|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
13887156|NCT03536780|Gemcitabine|gemcitabine|mesh-list
13887157|NCT03536780|Avelumab|avelumab|mesh-list
13887158|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13887159|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
13887160|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887161|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887162|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
13887163|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887164|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887165|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887166|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
13887167|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887168|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887169|NCT03536741|Anesthetics|anesthetics|mesh-list
13887170|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
13887171|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887172|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887173|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
13887174|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13887175|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13887176|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887177|NCT03536611|Warfarin|warfarin|mesh-list
13887178|NCT03536611|Dabigatran|dabigatran|mesh-list
13887179|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
13887180|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
13887181|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13887182|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
13887183|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887184|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887185|NCT03536598|Amlodipine|amlodipine|mesh-list
13887186|NCT03536598|Valsartan|valsartan|mesh-list
13887187|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13887188|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13887189|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13887190|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13887191|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887192|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13887193|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887194|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
13887195|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13887196|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13887197|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
13887198|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13887199|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13887200|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887201|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13887202|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13887203|NCT03536494|Mirabegron|mirabegron|mesh-list
13887204|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13887205|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13887206|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13887207|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
13887208|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887209|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887210|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887211|NCT03536494|Urological Agents|urological agents|mesh-ancestor
13887212|NCT03536481|Ensartinib|ensartinib|mesh-list
13887213|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887214|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13887215|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887216|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887217|NCT03536390|Methylphenidate|methylphenidate|mesh-list
13887218|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13887219|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887220|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13887221|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13887222|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13887223|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887224|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
13887225|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887226|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13887227|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
13887228|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887229|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13887230|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
13887231|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13887232|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
13887233|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13887234|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887235|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13887236|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13887237|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887238|NCT03536208|Warfarin|warfarin|mesh-list
13887239|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
13887240|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
13887241|NCT03536065|Narcotics|narcotics|mesh-ancestor
13887242|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887243|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887244|NCT03536065|Analgesics|analgesics|mesh-ancestor
13887245|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
13887246|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887247|NCT03536039|Prednisone|prednisone|mesh-list
13887248|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
13887249|NCT03536039|Rituximab|rituximab|mesh-list
13887250|NCT03536039|Doxorubicin|doxorubicin|mesh-list
13887251|NCT03536039|Vincristine|vincristine|mesh-list
13887252|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887253|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
13887254|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887255|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887256|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13887257|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
13887258|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887259|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887260|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14027685|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14027686|NCT02734771|Prednisone|prednisone|mesh-list
13887261|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887262|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13887263|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13887264|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13887265|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887266|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027687|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
14027688|NCT02734771|Rituximab|rituximab|mesh-list
14027689|NCT02734771|Doxorubicin|doxorubicin|mesh-list
14027690|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14027691|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887267|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
13887268|NCT03536039|Hormones|hormones|mesh-ancestor
13887269|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887270|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13887271|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13887272|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
13887273|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
13887274|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
13887275|NCT03535961|Etoposide|etoposide|mesh-list
13887276|NCT03535961|Apatinib|apatinib|mesh-list
13887277|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13887278|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887279|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13887280|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13887281|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887282|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887283|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13887284|NCT03535883|Anticoagulants|anticoagulants|mesh-list
13887285|NCT03535883|Coagulants|coagulants|mesh-list
13887286|NCT03535870|Fluticasone|fluticasone|mesh-list
13887287|NCT03535870|Xhance|xhance|mesh-list
13887288|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13887289|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13887290|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887291|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13887292|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
13887293|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887294|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887295|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13887296|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
13887297|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
13887298|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13887299|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13887300|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13887301|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13887302|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
13887303|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887304|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887305|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
13887306|NCT03535870|Hormones|hormones|mesh-ancestor
13887307|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887308|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
13887309|NCT03535792|Fentanyl|fentanyl|mesh-list
13887310|NCT03535792|Nalbuphine|nalbuphine|mesh-list
13887311|NCT03535792|Bupivacaine|bupivacaine|mesh-list
13887312|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
13887313|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
13887314|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887315|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887316|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
13887317|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887318|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13887319|NCT03535792|Narcotics|narcotics|mesh-ancestor
13887320|NCT03535792|Analgesics|analgesics|mesh-ancestor
14027692|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
13887321|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13887322|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13887323|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
13887324|NCT03535753|Decitabine|decitabine|mesh-list
13887325|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13887326|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
13887327|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887328|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887329|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887330|NCT03535701|Paclitaxel|paclitaxel|mesh-list
13887331|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13887332|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13887333|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887334|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
13887335|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
13887336|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
13887337|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887338|NCT03535662|Itraconazole|itraconazole|mesh-list
13887339|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
13887340|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887341|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13887342|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13887343|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887344|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887345|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13887346|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
13887347|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887348|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887349|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13887350|NCT03535558|Azithromycin|azithromycin|mesh-list
13887351|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
13887352|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13887353|NCT03535558|Trimethoprim|trimethoprim|mesh-list
13887354|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
13887355|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13887356|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887357|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13887358|NCT03535558|Renal Agents|renal agents|mesh-ancestor
13887359|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
13887360|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13887361|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13887362|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13887363|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887364|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887365|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13887366|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13887367|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13887368|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13958340|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13958341|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13958342|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13958343|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
13958344|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963202|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13963203|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13963204|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13963205|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
13963206|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13963207|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13963208|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
13963209|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
13963210|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13963211|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13963212|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13963213|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
13963214|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963215|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13963216|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
13963217|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
13963218|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
13963219|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
13963220|NCT01959633|Interferons|interferons|mesh-list
13887369|NCT03535519|Methotrexate|methotrexate|mesh-list
13887370|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13887371|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
13887372|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13887373|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887374|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13887375|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
13887376|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887377|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887378|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
13887379|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887380|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13887381|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887382|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
13887383|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887384|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13887385|NCT03535480|Sargramostim|sargramostim|mesh-list
13887386|NCT03535480|Lenograstim|lenograstim|mesh-list
13887387|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
13887388|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887389|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13887390|NCT03535415|Hormones|hormones|mesh-list
13887391|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887392|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887393|NCT03535376|Valsartan|valsartan|mesh-list
13887394|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13887395|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13887396|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13887397|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887398|NCT03535298|Interferons|interferons|mesh-list
13887399|NCT03535298|Interferon-beta|interferon-beta|mesh-list
13887400|NCT03535298|Teriflunomide|teriflunomide|mesh-list
13887401|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
13887402|NCT03535298|Ofatumumab|ofatumumab|mesh-list
13887403|NCT03535298|Cladribine|cladribine|mesh-list
13887404|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
13887405|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13887406|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
13887407|NCT03535298|Natalizumab|natalizumab|mesh-list
13887408|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
13887409|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
13887410|NCT03535298|Ozanimod|ozanimod|mesh-list
13887411|NCT03535298|Ponesimod|ponesimod|mesh-list
13887412|NCT03535298|Siponimod|siponimod|mesh-list
13887413|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887414|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887415|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
13887416|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887417|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887418|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
13887419|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887420|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887421|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13887422|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887423|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
13887424|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13887425|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13887426|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13887427|NCT03535298|Analgesics|analgesics|mesh-ancestor
13887428|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
13887429|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887430|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887431|NCT03535259|Sorafenib|sorafenib|mesh-list
13887432|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887433|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13887434|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887435|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471142|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14932081|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
13887436|NCT03535233|Triamcinolone|triamcinolone|mesh-list
13887437|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13887438|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14471143|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13887439|NCT03535233|Clobetasol|clobetasol|mesh-list
13887440|NCT03535233|Minoxidil|minoxidil|mesh-list
14932082|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887441|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13887442|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887443|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
13887444|NCT03535233|Hormones|hormones|mesh-ancestor
13887445|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887446|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887447|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887448|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
13887449|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887450|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887451|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13887452|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
13887453|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
13887454|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
13887455|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
13887456|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887457|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887458|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13887459|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13887460|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13887461|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
13887462|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887463|NCT03535168|Midazolam|midazolam|mesh-list
13887464|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13887465|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13887466|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887467|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887468|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13887469|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13887470|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13887471|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13887472|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
13887473|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
13887474|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
13887475|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
13887476|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887477|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887478|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13887479|NCT03535103|Hormones|hormones|mesh-ancestor
13887480|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887481|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887482|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
13887483|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13887484|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13887485|NCT03535090|Prednisolone|prednisolone|mesh-list
13887486|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
13887487|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13887488|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
13887489|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887490|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
13887491|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
13887492|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887493|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887494|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13887495|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
13887496|NCT03535090|Hormones|hormones|mesh-ancestor
13887497|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887498|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13887499|NCT03535090|Protective Agents|protective agents|mesh-ancestor
13887500|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13887501|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887502|NCT03535051|Tacrolimus|tacrolimus|mesh-list
13887503|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887504|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
13887505|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887506|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13887507|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471144|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14471145|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
14471146|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471147|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471148|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471149|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
13887508|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887509|NCT03534973|Caffeine|caffeine|mesh-list
13887510|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13887511|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887512|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13887513|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887514|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887515|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13887516|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13887517|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
13887518|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887519|NCT03534947|Imiquimod|imiquimod|mesh-list
13887520|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13887521|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
13887522|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887523|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887524|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
13887525|NCT03534895|Midazolam|midazolam|mesh-list
13887526|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
13887527|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887528|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887529|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13887530|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13887531|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13887532|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13887533|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13887534|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13887535|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
13887536|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
13887537|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
13887538|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887539|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887540|NCT03534869|Analgesics|analgesics|mesh-list
13887541|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
13887542|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887543|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887544|NCT03534713|Paclitaxel|paclitaxel|mesh-list
13887545|NCT03534713|Carboplatin|carboplatin|mesh-list
13887546|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13887547|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887548|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
13887549|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
13887550|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
13887551|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887552|NCT03534674|Vitamin D|vitamin d|mesh-list
13887553|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
13887554|NCT03534674|Vitamins|vitamins|mesh-ancestor
13887555|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
13887556|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887557|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13887558|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14471150|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14471151|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14471152|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471153|NCT02323334|Itraconazole|itraconazole|mesh-list
14471154|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
13887559|NCT03534661|Teduglutide|teduglutide|mesh-list
13887560|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
13887561|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027693|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027694|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027695|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14027696|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
14027697|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887562|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887563|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13887564|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13887565|NCT03534661|Protective Agents|protective agents|mesh-ancestor
13887566|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887567|NCT03534531|Methylprednisolone|methylprednisolone|mesh-list
13887568|NCT03534531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887569|NCT03534531|Antiemetics|antiemetics|mesh-ancestor
13887570|NCT03534531|Autonomic Agents|autonomic agents|mesh-ancestor
13887571|NCT03534531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887572|NCT03534531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887573|NCT03534531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13887574|NCT03534531|Glucocorticoids|glucocorticoids|mesh-ancestor
13887575|NCT03534531|Hormones|hormones|mesh-ancestor
13887576|NCT03534531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887577|NCT03534531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13887578|NCT03534531|Protective Agents|protective agents|mesh-ancestor
13887579|NCT03534505|Ketorolac|ketorolac|mesh-list
13887580|NCT03534505|Bupivacaine|bupivacaine|mesh-list
13887581|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
13887582|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
13887583|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887584|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887585|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
13887586|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887587|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13887588|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13887589|NCT03534505|Analgesics|analgesics|mesh-ancestor
13887590|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887591|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887592|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13887593|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887594|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887595|NCT03534492|Durvalumab|durvalumab|mesh-list
13887596|NCT03534492|Olaparib|olaparib|mesh-list
13887597|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887598|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887599|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13887600|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887601|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887602|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
13887603|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
13887604|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887605|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
13887606|NCT03534388|Eusol|eusol|mesh-list
13887607|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
13887608|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887609|NCT03534310|Liraglutide|liraglutide|mesh-list
13887610|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13887611|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887612|NCT03534310|Incretins|incretins|mesh-ancestor
13887613|NCT03534310|Hormones|hormones|mesh-ancestor
13887614|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887615|NCT03534297|Dapansutrile|dapansutrile|mesh-list
13887616|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887617|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
13887618|NCT03534102|Narcotics|narcotics|mesh-ancestor
13887619|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887620|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887621|NCT03534102|Analgesics|analgesics|mesh-ancestor
13887622|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
13887623|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887624|NCT03534037|Febuxostat|febuxostat|mesh-list
13887625|NCT03534037|Benzbromarone|benzbromarone|mesh-list
13887626|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
13887627|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887628|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
13887629|NCT03534037|Renal Agents|renal agents|mesh-ancestor
13887630|NCT03534024|Curcumin|curcumin|mesh-list
13887631|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13887632|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13887633|NCT03534024|Analgesics|analgesics|mesh-ancestor
13887634|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
13887635|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887636|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887637|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887638|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887639|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887640|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887641|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887642|NCT03533803|Indomethacin|indomethacin|mesh-list
13887643|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13887644|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13887645|NCT03533803|Analgesics|analgesics|mesh-ancestor
13887646|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
13887647|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887648|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887649|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887650|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887651|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
13887652|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
13887653|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13887654|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13887655|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887656|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958345|NCT03169738|Leucovorin|leucovorin|mesh-list
13958346|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
13958347|NCT03169738|Bevacizumab|bevacizumab|mesh-list
13958348|NCT03169738|Fluorouracil|fluorouracil|mesh-list
13958349|NCT03169738|Capecitabine|capecitabine|mesh-list
13958350|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
13958351|NCT03169738|Nivolumab|nivolumab|mesh-list
13958352|NCT03169738|Fulvestrant|fulvestrant|mesh-list
13958353|NCT03169738|Avelumab|avelumab|mesh-list
13958354|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958355|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958356|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958357|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
13958358|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958359|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958360|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958361|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
13958362|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958363|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958364|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958365|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958366|NCT03169738|Growth Substances|growth substances|mesh-ancestor
13958367|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958368|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
13958369|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958370|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13958371|NCT03169738|Antidotes|antidotes|mesh-ancestor
13887657|NCT03533699|Propranolol|propranolol|mesh-list
13887658|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13887659|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13887660|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
13887661|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887662|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887663|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887664|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13887665|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13887666|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
13887667|NCT03533556|Caffeine|caffeine|mesh-list
13887668|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13887669|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887670|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13887671|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887672|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887673|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13887674|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13887675|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
14932083|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932084|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932085|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
13887676|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887677|NCT03533452|Ropivacaine|ropivacaine|mesh-list
13887678|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
13887679|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
13887680|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887681|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887682|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
13887683|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887684|NCT03533387|Ibudilast|ibudilast|mesh-list
13887685|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13887686|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
13887687|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887688|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887689|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13887690|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
13887691|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13887692|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887693|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887694|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13887695|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
13887696|NCT03533361|Lenvatinib|lenvatinib|mesh-list
13887697|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887698|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13887699|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887700|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887701|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
13887702|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
13887703|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13887704|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887705|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
13887706|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
13887707|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13887708|NCT03533231|Metronidazole|metronidazole|mesh-list
13887709|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
13887710|NCT03533231|Propolis|propolis|mesh-list
13887711|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887712|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13887713|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13887714|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13887715|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13887716|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887717|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887718|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887719|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13958372|NCT03169738|Protective Agents|protective agents|mesh-ancestor
13887720|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13887721|NCT03533179|Glucagon|glucagon|mesh-list
13887722|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13887723|NCT03533179|Esmolol|esmolol|mesh-list
13887724|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13887725|NCT03533179|Hormones|hormones|mesh-ancestor
13887726|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13887727|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887728|NCT03533179|Incretins|incretins|mesh-ancestor
13887729|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13887730|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13887731|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13887732|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
13887733|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887734|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887735|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
13887736|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13887737|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13887738|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
13887739|NCT03533127|Bevacizumab|bevacizumab|mesh-list
13887740|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887741|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887742|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13887743|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13887744|NCT03533127|Growth Substances|growth substances|mesh-ancestor
13887745|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887746|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
13887747|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
13887748|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13887749|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13887750|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
13887751|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13887752|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13887753|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887754|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
13887755|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887756|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887757|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13887758|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887759|NCT03532919|Cystatins|cystatins|mesh-list
13887760|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13887761|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
13887762|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887763|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887764|NCT03532906|Bupivacaine|bupivacaine|mesh-list
13887765|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
13887766|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
13887767|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887768|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887769|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
13887770|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887771|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
13887772|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
13887773|NCT03532867|Protective Agents|protective agents|mesh-ancestor
13887774|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887775|NCT03532854|Valsartan|valsartan|mesh-list
13887776|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13887777|NCT03532854|Ezetimibe|ezetimibe|mesh-list
13887778|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13887779|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13887780|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
13887781|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887782|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13887783|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13887784|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887785|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13887786|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13887787|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13887788|NCT03532841|Tramadol|tramadol|mesh-list
13887789|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13887790|NCT03532841|Narcotics|narcotics|mesh-ancestor
13887791|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887792|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887793|NCT03532841|Analgesics|analgesics|mesh-ancestor
13887794|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
13887795|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887796|NCT03532802|Metoprolol|metoprolol|mesh-list
13887797|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13887798|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13887799|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
13887800|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
13887801|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887802|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887803|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13887804|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13887805|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13887806|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
13887807|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887808|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887809|NCT03532763|Tocotrienols|tocotrienols|mesh-list
13887810|NCT03532763|Vitamin E|vitamin e|mesh-list
13887811|NCT03532763|Tocopherols|tocopherols|mesh-list
13887812|NCT03532763|Tocovid|tocovid|mesh-list
13887813|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
13887814|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887815|NCT03532763|Protective Agents|protective agents|mesh-ancestor
13887816|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887817|NCT03532763|Vitamins|vitamins|mesh-ancestor
13887818|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
13887819|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
13887820|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887821|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887822|NCT03532711|Leucovorin|leucovorin|mesh-list
13887823|NCT03532711|Fluorouracil|fluorouracil|mesh-list
13887824|NCT03532711|Capecitabine|capecitabine|mesh-list
13887825|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
13887826|NCT03532711|Irinotecan|irinotecan|mesh-list
13887827|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
13887828|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887829|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
13887830|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887831|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13887832|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887833|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887834|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
13887835|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13887836|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13887837|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887838|NCT03532711|Antidotes|antidotes|mesh-ancestor
13887839|NCT03532711|Protective Agents|protective agents|mesh-ancestor
13887840|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
13887841|NCT03532711|Vitamins|vitamins|mesh-ancestor
13887842|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
13887843|NCT03532698|Aspirin|aspirin|mesh-list
13887844|NCT03532698|Osimertinib|osimertinib|mesh-list
13887845|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13887846|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13887847|NCT03532698|Analgesics|analgesics|mesh-ancestor
13887848|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
13887849|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887850|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887851|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13887852|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887853|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13887854|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13887855|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887856|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13887857|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13887858|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887859|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
13887860|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887861|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14932086|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887862|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
13887863|NCT05263609|Axitinib|axitinib|mesh-list
13887864|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887865|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887866|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13887867|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887868|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887869|NCT05263583|Bromides|bromides|mesh-list
13887870|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
14754806|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
14754807|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754808|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14754809|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13887875|NCT05263505|Methotrexate|methotrexate|mesh-list
13887876|NCT05263505|Azathioprine|azathioprine|mesh-list
13887877|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13887878|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
13887879|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13887880|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887881|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13887882|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
13887883|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887884|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887885|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
13887886|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887887|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13887888|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13887889|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
13887890|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13887891|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13887892|NCT05263284|Venetoclax|venetoclax|mesh-list
14932087|NCT01442987|Irbesartan|irbesartan|mesh-list
14932088|NCT01442987|Atorvastatin|atorvastatin|mesh-list
14932089|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13887893|NCT05263284|Adenosine|adenosine|mesh-list
13887894|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887895|NCT05263284|Analgesics|analgesics|mesh-ancestor
13887896|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
13887897|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887898|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887899|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13887900|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
13887901|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14932090|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14932091|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
14932092|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932093|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13887902|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
13887903|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
13887904|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13887905|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887906|NCT05262985|Durvalumab|durvalumab|mesh-list
13887907|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887908|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958373|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
13958374|NCT03169738|Vitamins|vitamins|mesh-ancestor
13958375|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
13958376|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14471155|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471156|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14471157|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14471158|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963221|NCT01959633|Vemurafenib|vemurafenib|mesh-list
14471159|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471160|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14471161|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
14471162|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471163|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471164|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14471165|NCT02324153|Riboflavin|riboflavin|mesh-list
14471166|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
14754810|NCT04519476|Growth Substances|growth substances|mesh-ancestor
14754811|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
14754812|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887909|NCT05262855|FAPI-46|fapi-46|mesh-list
13887910|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13887911|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887912|NCT05262738|Misoprostol|misoprostol|mesh-list
13887913|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13887914|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
13887915|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13887916|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887917|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13887918|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13887919|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
13887920|NCT05262608|Olaparib|olaparib|mesh-list
13887921|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13887922|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887923|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887924|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887925|NCT05262556|Nivolumab|nivolumab|mesh-list
13887926|NCT05262556|Ipilimumab|ipilimumab|mesh-list
13887927|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887928|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887929|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13887930|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887931|NCT05262465|Azacitidine|azacitidine|mesh-list
13887932|NCT05262465|Venetoclax|venetoclax|mesh-list
13887933|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13887934|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
14471167|NCT02324153|Vitamins|vitamins|mesh-ancestor
14471168|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
13887935|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887936|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887937|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887938|NCT05262452|Folfirinox|folfirinox|mesh-list
13887939|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887940|NCT05262413|Lenvatinib|lenvatinib|mesh-list
13887941|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887942|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13887943|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887944|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887945|NCT05262335|Paclitaxel|paclitaxel|mesh-list
13887946|NCT05262335|Docetaxel|docetaxel|mesh-list
13887947|NCT05262335|Capecitabine|capecitabine|mesh-list
13887948|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
14471169|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471170|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13887949|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13887950|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887951|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
13887952|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
13887953|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
13887954|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887955|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13887956|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
13887957|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
13887958|NCT05262322|Apixaban|apixaban|mesh-list
13887959|NCT05262322|Edoxaban|edoxaban|mesh-list
13887960|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13887961|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
13887962|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14471171|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
13887963|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
13887964|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13887965|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13887966|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
13887967|NCT05262270|Naltrexone|naltrexone|mesh-list
13887968|NCT05262270|Buprenorphine|buprenorphine|mesh-list
13887969|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13887970|NCT05262270|Narcotics|narcotics|mesh-ancestor
13887971|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887972|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887973|NCT05262270|Analgesics|analgesics|mesh-ancestor
13887974|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
13887975|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887976|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13887977|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13887978|NCT05262244|Bevacizumab|bevacizumab|mesh-list
13887979|NCT05262244|Vedolizumab|vedolizumab|mesh-list
13887980|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13887981|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13887982|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13887983|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13887984|NCT05262244|Growth Substances|growth substances|mesh-ancestor
13887985|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887986|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
13887987|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13887988|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
13887989|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13887990|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13887991|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13887992|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13887993|NCT05262166|Analgesics|analgesics|mesh-ancestor
13887994|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
13887995|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13887996|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13887997|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13887998|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13887999|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
13888000|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888001|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888002|NCT05261997|Metformin|metformin|mesh-list
13888003|NCT05261997|Acarbose|acarbose|mesh-list
13888004|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13888005|NCT05261997|Pancreatin|pancreatin|mesh-list
13888006|NCT05261997|Pancrelipase|pancrelipase|mesh-list
13888007|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888008|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13888009|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888010|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888011|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888012|NCT05261971|Etodolac|etodolac|mesh-list
13888013|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13888014|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888015|NCT05261971|Analgesics|analgesics|mesh-ancestor
13888016|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
13888017|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888018|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888019|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13888020|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13888021|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13888022|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13888023|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888024|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888025|NCT05261672|Midazolam|midazolam|mesh-list
13888026|NCT05261672|Bupivacaine|bupivacaine|mesh-list
13888027|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
13888028|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
13888029|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888030|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888031|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
13888032|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888033|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13888034|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13888035|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13888036|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13888037|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13888038|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14027698|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027699|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14027700|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027701|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14027702|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027703|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027704|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027705|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027706|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
14027707|NCT02734771|Hormones|hormones|mesh-ancestor
14027708|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027709|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027710|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
14027711|NCT02734732|Trimethoprim|trimethoprim|mesh-list
14027712|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
14027713|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027714|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027715|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027716|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027717|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027718|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027719|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027720|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14027721|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14027722|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14027723|NCT02734732|Renal Agents|renal agents|mesh-ancestor
14027724|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
14027725|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14027726|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14027727|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14027728|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14027729|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14027730|NCT02734524|Carboplatin|carboplatin|mesh-list
14027731|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027732|NCT02734511|Propofol|propofol|mesh-list
14027733|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14027734|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027735|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027736|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14027737|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
14027738|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
14169214|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14169215|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14169216|NCT04843943|Growth Substances|growth substances|mesh-ancestor
14169217|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169218|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
14169219|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
14169220|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14169221|NCT04843917|Antibodies|antibodies|mesh-list
14169222|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
14169223|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
14169224|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169225|NCT04843904|Rituximab|rituximab|mesh-list
14169226|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
14169227|NCT04843904|Venetoclax|venetoclax|mesh-list
14169228|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14169229|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169230|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
13888039|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
13888040|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
13888041|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
13888042|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888043|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888044|NCT05261594|Caffeine|caffeine|mesh-list
13888045|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13888046|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888047|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13888048|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888049|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888050|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13888051|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13888052|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
13888053|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888054|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13888055|NCT05261581|Analgesics|analgesics|mesh-list
13888056|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
13888057|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888058|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888059|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
13888060|NCT05261516|Analgesics|analgesics|mesh-ancestor
13888061|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
13888062|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888063|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888064|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
13888065|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888066|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13888067|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
13888068|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14471172|NCT02324270|Diclofenac|diclofenac|mesh-list
14471173|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14471174|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14471175|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14471176|NCT02324270|Analgesics|analgesics|mesh-ancestor
14471177|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
14471178|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471179|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471180|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14471181|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14471182|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14471183|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471184|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471185|NCT02324543|Gemcitabine|gemcitabine|mesh-list
14471186|NCT02324543|Docetaxel|docetaxel|mesh-list
13888069|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888070|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888071|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13888072|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
13888073|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13888074|NCT05261321|Dronabinol|dronabinol|mesh-list
13888075|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
13888076|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888077|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13888078|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888079|NCT05261321|Analgesics|analgesics|mesh-ancestor
13888080|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
13888081|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888082|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13888083|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14471187|NCT02324543|Capecitabine|capecitabine|mesh-list
14471188|NCT02324543|Irinotecan|irinotecan|mesh-list
13888084|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888085|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888086|NCT05261321|Hormones|hormones|mesh-ancestor
13888087|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888088|NCT05261269|Niraparib|niraparib|mesh-list
13888089|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13888090|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888091|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888092|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958377|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13958378|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13958379|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
13958380|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958381|NCT03169725|Vaccines|vaccines|mesh-list
13958382|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
13958383|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958384|NCT03170479|Vitamin D|vitamin d|mesh-list
13958385|NCT03170479|Vitamins|vitamins|mesh-ancestor
13958386|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
13958387|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958388|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14471189|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471190|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14471191|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
14471192|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471193|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
13958389|NCT03169933|Androgens|androgens|mesh-list
13958390|NCT03169933|Hormones|hormones|mesh-ancestor
13958391|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958392|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958393|NCT03170180|Sunitinib|sunitinib|mesh-list
13958394|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
13958395|NCT03170180|Gefitinib|gefitinib|mesh-list
13958396|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958397|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958398|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958399|NCT03170180|Growth Substances|growth substances|mesh-ancestor
13958400|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958401|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958402|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13958403|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958404|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958405|NCT03169790|Leucovorin|leucovorin|mesh-list
13958406|NCT03169790|Paclitaxel|paclitaxel|mesh-list
13958407|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
13958408|NCT03169790|Bevacizumab|bevacizumab|mesh-list
13958409|NCT03169790|Rituximab|rituximab|mesh-list
13958410|NCT03169790|Fluorouracil|fluorouracil|mesh-list
13958411|NCT03169790|Capecitabine|capecitabine|mesh-list
13958412|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
13958413|NCT03169790|Avelumab|avelumab|mesh-list
13958414|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13958415|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958416|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
13958417|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
13958418|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
13958419|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888093|NCT05241496|Lidocaine|lidocaine|mesh-list
14471194|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888094|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
13888095|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
13888096|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888097|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888098|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
13888099|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888100|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13888101|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13888102|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13888103|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888104|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754813|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754814|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
14754815|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
14754816|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754817|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754818|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
14754819|NCT04519476|Hormones|hormones|mesh-ancestor
14754820|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471195|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471196|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754821|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14471197|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
14471198|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471199|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14754822|NCT04519476|Protective Agents|protective agents|mesh-ancestor
14754823|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13888116|NCT05232071|Empagliflozin|empagliflozin|mesh-list
13888117|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13888118|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888119|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13888120|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888121|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
13888122|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13888123|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888124|NCT05224401|Amoxicillin|amoxicillin|mesh-list
13888125|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
13888126|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13888127|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
13888128|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
13888129|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
13888130|NCT05224401|Trimethoprim|trimethoprim|mesh-list
13888131|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
13888132|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13888133|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888134|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13888135|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13888136|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888137|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888138|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888139|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13888140|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14471200|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14471201|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14471202|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14471203|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14471204|NCT02324673|Cannabidiol|cannabidiol|mesh-list
13888141|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13888142|NCT05224401|Renal Agents|renal agents|mesh-ancestor
13888143|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
14471205|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
14932094|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14754824|NCT04500158|Lidocaine|lidocaine|mesh-list
13888144|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13888145|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13888146|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13888147|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13888148|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13888149|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13888150|NCT05223101|Telmisartan|telmisartan|mesh-list
13888151|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13888152|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13888153|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13888154|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888155|NCT05219942|Insulin|insulin|mesh-list
13888156|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
13888157|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13888158|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888159|NCT05216211|Bupivacaine|bupivacaine|mesh-list
13888160|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
13888161|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
13888162|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888163|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888164|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
13888165|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888166|NCT05201300|Propofol|propofol|mesh-list
13888167|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13888168|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888169|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888170|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13888171|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
13888172|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
13888173|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
13888174|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13888175|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888176|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888177|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888178|NCT05197439|Analgesics|analgesics|mesh-ancestor
13888179|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
13888180|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888181|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13888182|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13888183|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13888184|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
13888185|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888186|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888187|NCT05195775|Tadalafil|tadalafil|mesh-list
13888188|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
13888189|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13888190|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13888191|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888192|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888193|NCT05195775|Urological Agents|urological agents|mesh-ancestor
13888194|NCT05190315|Temozolomide|temozolomide|mesh-list
13888195|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
13888196|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13888197|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
13888198|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888199|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888200|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
13888201|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
13888202|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888203|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888204|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888205|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13888206|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13888207|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888208|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13888209|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13888210|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
13888211|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888212|NCT05186129|Clopidogrel|clopidogrel|mesh-list
13888213|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13888214|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13888215|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13888216|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13888217|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
13888218|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888219|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888220|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888221|NCT05175001|Betamethasone|betamethasone|mesh-list
13888222|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
13888223|NCT05175001|Ropivacaine|ropivacaine|mesh-list
13888224|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
13888225|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
13888226|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888227|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888228|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
13888229|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888230|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13888231|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
13888232|NCT05175001|Hormones|hormones|mesh-ancestor
13888233|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888234|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13888235|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
13888236|NCT05172167|Antibodies|antibodies|mesh-list
13888237|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
13888238|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888239|NCT05171231|Hemostatics|hemostatics|mesh-list
13888240|NCT05171231|Coagulants|coagulants|mesh-ancestor
14754825|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
14754826|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
14754827|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754828|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754829|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
14027739|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
14027740|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
14027741|NCT02734420|Coagulants|coagulants|mesh-ancestor
14027742|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
14027743|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027744|NCT02734407|Aflibercept|aflibercept|mesh-list
14027745|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14027746|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14027747|NCT02734407|Growth Substances|growth substances|mesh-ancestor
14027748|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027749|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
14027750|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027751|NCT02734173|Ritonavir|ritonavir|mesh-list
14027752|NCT02734173|Ribavirin|ribavirin|mesh-list
14027753|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14027754|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14027755|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
14027756|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027757|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027758|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14027759|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14027760|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
14027761|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027762|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14027763|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14027764|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
14027765|NCT02734069|Carboplatin|carboplatin|mesh-list
14027766|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027767|NCT02734186|Praziquantel|praziquantel|mesh-list
14027768|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
14027769|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14027770|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027771|NCT02734160|Durvalumab|durvalumab|mesh-list
14027772|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027773|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027774|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
14027775|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14027776|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14754830|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754831|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14754832|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13888246|NCT05164978|Antibodies|antibodies|mesh-list
13888247|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
13888248|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888249|NCT05162976|Nivolumab|nivolumab|mesh-list
13888250|NCT05162976|Azacitidine|azacitidine|mesh-list
13888251|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13888252|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888253|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13888254|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888255|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13888256|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
13888257|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888258|NCT05161806|Aflibercept|aflibercept|mesh-list
13888259|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13888260|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13888261|NCT05161806|Growth Substances|growth substances|mesh-ancestor
13888262|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888263|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
13888264|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888265|NCT05151484|Alendronate|alendronate|mesh-list
13888266|NCT05151484|Teriparatide|teriparatide|mesh-list
13888267|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13888268|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888269|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13888270|NCT05140148|Amantadine|amantadine|mesh-list
13888271|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13888272|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13888273|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
13888274|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888275|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
13888276|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888277|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888278|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888279|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888280|NCT05140148|Analgesics|analgesics|mesh-ancestor
13888281|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
13888282|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958420|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958421|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
13958422|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958423|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958424|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958425|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
13958426|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958427|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958428|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958429|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958430|NCT03169790|Growth Substances|growth substances|mesh-ancestor
13958431|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958432|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
13958433|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958434|NCT03169790|Antidotes|antidotes|mesh-ancestor
13958435|NCT03169790|Protective Agents|protective agents|mesh-ancestor
13958436|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
13958437|NCT03169790|Vitamins|vitamins|mesh-ancestor
13958438|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
13958439|NCT03169660|Aflibercept|aflibercept|mesh-list
13958440|NCT03169660|Mitogens|mitogens|mesh-list
13958441|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
13958442|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
13888283|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
13888284|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14027777|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027778|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
14027779|NCT02733952|Coagulants|coagulants|mesh-ancestor
14027780|NCT02733809|Sorafenib|sorafenib|mesh-list
14027781|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027782|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14027783|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027784|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027785|NCT02733640|Pantoprazole|pantoprazole|mesh-list
14027786|NCT02733640|Ranitidine|ranitidine|mesh-list
14027787|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
13888285|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888286|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888287|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888288|NCT05099055|Analgesics|analgesics|mesh-ancestor
14027788|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14027789|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027790|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14027791|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027792|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027793|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14027794|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
14027795|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
14027796|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14027797|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027798|NCT02733835|Remifentanil|remifentanil|mesh-list
14027799|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14027800|NCT02733835|Narcotics|narcotics|mesh-ancestor
14027801|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027802|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888289|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
13888290|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027803|NCT02733835|Analgesics|analgesics|mesh-ancestor
14027804|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
14027805|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027806|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14027807|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14027808|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027809|NCT02733822|Naloxone|naloxone|mesh-list
14027810|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14027811|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027812|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
14027813|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027814|NCT02733679|Metformin|metformin|mesh-list
14027815|NCT02733679|Pioglitazone|pioglitazone|mesh-list
14027816|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14027817|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027818|NCT02733874|Betamethasone|betamethasone|mesh-list
14027819|NCT02733874|Clobetasol|clobetasol|mesh-list
14027820|NCT02733874|Calcipotriene|calcipotriene|mesh-list
14027821|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027822|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
14027823|NCT02733874|Hormones|hormones|mesh-ancestor
14027824|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027825|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027826|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13888291|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13888292|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13888293|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13888294|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
13888295|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888296|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888297|NCT05092841|Naltrexone|naltrexone|mesh-list
13888298|NCT05092841|Baclofen|baclofen|mesh-list
13888299|NCT05092841|Sorbitol|sorbitol|mesh-list
13888300|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13888301|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13888302|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888303|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
13888304|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888305|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13888306|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13888307|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13888308|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
13888309|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
13888310|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888311|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888312|NCT05092841|Cathartics|cathartics|mesh-ancestor
13888313|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888314|NCT05090358|Canagliflozin|canagliflozin|mesh-list
13888315|NCT05090358|Fulvestrant|fulvestrant|mesh-list
13888316|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13888317|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888318|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13888319|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13888320|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
13888321|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888322|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888323|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13888324|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888325|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13888326|NCT05084638|Ofatumumab|ofatumumab|mesh-list
13888327|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888328|NCT05079217|Vaccines|vaccines|mesh-list
13888329|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
13888330|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888331|NCT05057130|Cisplatin|cisplatin|mesh-list
13888332|NCT05057130|Doxorubicin|doxorubicin|mesh-list
13888333|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13888334|NCT05057130|Methotrexate|methotrexate|mesh-list
13888335|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888336|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13888337|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13888338|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13888339|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888340|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888341|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13888342|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
13888343|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13888344|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888345|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13888346|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
13888347|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
13888348|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13888349|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13888350|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
13888351|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13888352|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13888353|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
13888354|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13888355|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13888356|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13888357|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888358|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888359|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
13888360|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888361|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888362|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13888363|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888364|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13888365|NCT05055713|Somatostatin|somatostatin|mesh-list
13888366|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13888367|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
13888368|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888369|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888370|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888371|NCT05055713|Hormones|hormones|mesh-ancestor
13888372|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888373|NCT05053087|Ropivacaine|ropivacaine|mesh-list
13888374|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
13888375|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
13888376|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888377|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888378|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
13888379|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754833|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14754834|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14754835|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754836|NCT04494412|Zanamivir|zanamivir|mesh-list
14754837|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
13888385|NCT05042791|Capecitabine|capecitabine|mesh-list
13888386|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13888387|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
13888388|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888389|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888390|NCT05041062|Nivolumab|nivolumab|mesh-list
13888391|NCT05041062|Ipilimumab|ipilimumab|mesh-list
13888392|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13888393|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888394|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13888395|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888396|NCT05030519|Trastuzumab|trastuzumab|mesh-list
13888397|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13888398|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888399|NCT05002946|Naltrexone|naltrexone|mesh-list
13888400|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13888401|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13888402|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888403|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
13888404|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888405|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
13888406|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888407|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
13888408|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13888409|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
13888410|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888411|NCT04985604|Niacinamide|niacinamide|mesh-list
13888412|NCT04985604|Vitamin B Complex|vitamin b complex|mesh-ancestor
13888413|NCT04985604|Vitamins|vitamins|mesh-ancestor
13888414|NCT04985604|Micronutrients|micronutrients|mesh-ancestor
13888415|NCT04985604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888416|NCT04983589|Pilocarpine|pilocarpine|mesh-list
13888417|NCT04983589|Miotics|miotics|mesh-ancestor
13888418|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
13888419|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888420|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888421|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13888422|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13888423|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
13888424|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888425|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888426|NCT04961619|Trametinib|trametinib|mesh-list
13888427|NCT04961619|Dabrafenib|dabrafenib|mesh-list
13888428|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888429|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13888430|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888431|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888432|NCT04947007|Bupivacaine|bupivacaine|mesh-list
13888433|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
13888434|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
13888435|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888436|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888437|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
13888438|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888439|NCT04943445|Paclitaxel|paclitaxel|mesh-list
13888440|NCT04943445|Carboplatin|carboplatin|mesh-list
13888441|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
13888442|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
13888443|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13888444|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888445|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
13888446|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
13888447|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
13888448|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888449|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13888450|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888451|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
13888452|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
13888453|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
13888454|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
13888455|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888456|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888457|NCT04929808|Emollients|emollients|mesh-list
13888458|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
13888459|NCT04910100|Timolol|timolol|mesh-list
13888460|NCT04910100|Nebivolol|nebivolol|mesh-list
13888461|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13888462|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13888463|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13888464|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13888465|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
13888466|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888467|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888468|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888469|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13888470|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13888471|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
13888472|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13888473|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13888474|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14471206|NCT02324699|Prednisone|prednisone|mesh-list
14471207|NCT02324699|Vedolizumab|vedolizumab|mesh-list
14471208|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14471209|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
14471210|NCT02324699|Hormones|hormones|mesh-ancestor
14471211|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471212|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471213|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14471214|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888484|NCT04907214|Empagliflozin|empagliflozin|mesh-list
13888485|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13888486|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888487|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13888488|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888489|NCT04907071|Coal Tar|coal tar|mesh-list
13888490|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
13888491|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
13888492|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
13888493|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13888494|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13888495|NCT04873583|Prednisolone|prednisolone|mesh-list
13888496|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
13888497|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13888498|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
13888499|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13888500|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
13888501|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
13888502|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888503|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888504|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471215|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888505|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
13888506|NCT04873583|Hormones|hormones|mesh-ancestor
13888507|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888508|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13888509|NCT04873583|Protective Agents|protective agents|mesh-ancestor
13888510|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13888511|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958443|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958444|NCT03169660|Growth Substances|growth substances|mesh-ancestor
13958445|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958446|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958447|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958448|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958449|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958450|NCT03169777|Leucovorin|leucovorin|mesh-list
13958451|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
13958452|NCT03169777|Bevacizumab|bevacizumab|mesh-list
13958453|NCT03169777|Fluorouracil|fluorouracil|mesh-list
13958454|NCT03169777|Capecitabine|capecitabine|mesh-list
13958455|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
13958456|NCT03169777|Nivolumab|nivolumab|mesh-list
13958457|NCT03169777|Cetuximab|cetuximab|mesh-list
13958458|NCT03169777|Fulvestrant|fulvestrant|mesh-list
13958459|NCT03169777|Avelumab|avelumab|mesh-list
13958460|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958461|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958462|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958463|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
13958464|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958465|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958466|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958467|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
13958468|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958469|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958470|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958471|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958472|NCT03169777|Growth Substances|growth substances|mesh-ancestor
13958473|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958474|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
13958475|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958476|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13958477|NCT03169777|Antidotes|antidotes|mesh-ancestor
13958478|NCT03169777|Protective Agents|protective agents|mesh-ancestor
13958479|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
13958480|NCT03169777|Vitamins|vitamins|mesh-ancestor
13958481|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
13958482|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13958483|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13958484|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13958485|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
13958486|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958487|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
13958488|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
13958489|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13958490|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13958491|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958492|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958493|NCT03169582|Urological Agents|urological agents|mesh-ancestor
13958494|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
13958495|NCT03169348|Ledipasvir|ledipasvir|mesh-list
13958496|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13958497|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
13958498|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958499|NCT03169504|Fluticasone|fluticasone|mesh-list
13958500|NCT03169504|Xhance|xhance|mesh-list
13958501|NCT03169504|Bromides|bromides|mesh-list
13958502|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
13958503|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958504|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13958505|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
13958506|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958507|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958508|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13958509|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
13958510|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
13958511|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13958512|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
13888512|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
13888513|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13888514|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13888515|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888516|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
13888517|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
13888518|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888519|NCT04815590|Buprenorphine|buprenorphine|mesh-list
13888520|NCT04815590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13888521|NCT04815590|Narcotics|narcotics|mesh-ancestor
13888522|NCT04815590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888523|NCT04815590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888524|NCT04815590|Analgesics|analgesics|mesh-ancestor
13888525|NCT04815590|Sensory System Agents|sensory system agents|mesh-ancestor
13888526|NCT04815590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888527|NCT04815590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13888528|NCT04806386|Psyllium|psyllium|mesh-list
13888529|NCT04806386|Cathartics|cathartics|mesh-ancestor
13888530|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888531|NCT04779554|Mitomycins|mitomycins|mesh-list
13888532|NCT04779554|Mitomycin|mitomycin|mesh-list
13888533|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13888534|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888535|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
13888536|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888537|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13888538|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888539|NCT04772248|Adalimumab|adalimumab|mesh-list
13888540|NCT04772248|Etanercept|etanercept|mesh-list
13888541|NCT04772248|Golimumab|golimumab|mesh-list
13888542|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
13888543|NCT04772248|Infliximab|infliximab|mesh-list
13888544|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
13888545|NCT04772248|Tofacitinib|tofacitinib|mesh-list
13888546|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13888547|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13888548|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
13888549|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888550|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13888551|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888552|NCT04772248|Analgesics|analgesics|mesh-ancestor
13888553|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
13888554|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888555|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888556|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13888557|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
13888558|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13888559|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888560|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888561|NCT04768010|Misoprostol|misoprostol|mesh-list
13888562|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13888563|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
13888564|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13888565|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888566|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13888567|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888568|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
13888569|NCT04756037|Relugolix|relugolix|mesh-list
13888570|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
13888571|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
13888572|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888573|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888574|NCT04747236|Gemcitabine|gemcitabine|mesh-list
13888575|NCT04747236|Azacitidine|azacitidine|mesh-list
13888576|NCT04747236|Romidepsin|romidepsin|mesh-list
13888577|NCT04747236|Belinostat|belinostat|mesh-list
13888578|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13888579|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
13888580|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888581|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888582|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
13888583|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888584|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888585|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13888586|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
13888587|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888588|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13888589|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13888590|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
13888591|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13888592|NCT04740580|Glycine|glycine|mesh-list
13888593|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
13888594|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888595|NCT04740580|Expectorants|expectorants|mesh-ancestor
13888596|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
13888597|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13888598|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
13888599|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888600|NCT04740580|Protective Agents|protective agents|mesh-ancestor
13888601|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888602|NCT04740580|Antidotes|antidotes|mesh-ancestor
13888603|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
13888604|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888605|NCT04676555|Ofatumumab|ofatumumab|mesh-list
13888606|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
13888607|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888608|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
13888609|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888610|NCT04674683|Nivolumab|nivolumab|mesh-list
13888611|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13888612|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888613|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13888614|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888615|NCT04659161|Xanomeline|xanomeline|mesh-list
13888616|NCT04659161|Trospium chloride|trospium chloride|mesh-list
13888617|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
13888618|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
13888619|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888620|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888621|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13888622|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13888623|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
13888624|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888625|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888626|NCT04659161|Urological Agents|urological agents|mesh-ancestor
13888627|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13888628|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13888629|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13888630|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13888631|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
13888632|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888633|NCT04634799|Plasminogen|plasminogen|mesh-list
13888634|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
13888635|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
13888636|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13888637|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13888638|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888639|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13888640|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
13888641|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888642|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
13888643|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13888644|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13888645|NCT04624776|Prednisolone|prednisolone|mesh-list
13888646|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
13888647|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13888648|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
13888649|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13888650|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
13888651|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
13888652|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888653|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888654|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13888655|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
13888656|NCT04624776|Hormones|hormones|mesh-ancestor
13888657|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888658|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13888659|NCT04624776|Protective Agents|protective agents|mesh-ancestor
13888660|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13888661|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888662|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13888663|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
13888664|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888665|NCT04617002|TIC10 compound|tic10 compound|mesh-list
13888666|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888667|NCT04581473|Paclitaxel|paclitaxel|mesh-list
13888668|NCT04581473|Irinotecan|irinotecan|mesh-list
13888669|NCT04581473|Apatinib|apatinib|mesh-list
13888670|NCT04581473|Antibodies|antibodies|mesh-list
13888671|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13888672|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888673|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
13888674|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
13888675|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
13888676|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888677|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
13888678|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888679|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13888680|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13888681|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888682|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13888683|NCT04571645|Heparin|heparin|mesh-list
13888684|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
13888685|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13888686|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13888687|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888688|NCT04569747|Tamoxifen|tamoxifen|mesh-list
13888689|NCT04569747|Trastuzumab|trastuzumab|mesh-list
13888690|NCT04569747|Pertuzumab|pertuzumab|mesh-list
13888691|NCT04569747|Letrozole|letrozole|mesh-list
13888692|NCT04569747|Anastrozole|anastrozole|mesh-list
13888693|NCT04569747|Leuprolide|leuprolide|mesh-list
13888694|NCT04569747|Exemestane|exemestane|mesh-list
13888695|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027827|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
14027828|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
14027829|NCT02733705|Fentanyl|fentanyl|mesh-list
14027830|NCT02733705|Propofol|propofol|mesh-list
14027831|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14027832|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027833|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027834|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14027835|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
14027836|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
14027837|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14027838|NCT02733705|Narcotics|narcotics|mesh-ancestor
14027839|NCT02733705|Analgesics|analgesics|mesh-ancestor
14027840|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
14027841|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027842|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14027843|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
14027844|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14027845|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14027846|NCT02733510|Prednisolone|prednisolone|mesh-list
14027847|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
14027848|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14027849|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
14027850|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027851|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
14027852|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
14027853|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027854|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027855|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027856|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
14027857|NCT02733510|Hormones|hormones|mesh-ancestor
14027858|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027859|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14027860|NCT02733510|Protective Agents|protective agents|mesh-ancestor
14471216|NCT02324842|Liraglutide|liraglutide|mesh-list
13888696|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888697|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13888698|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13888699|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888700|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888701|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13888702|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
13888703|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888704|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888705|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13888706|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13888707|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13888708|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13888709|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13888710|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
13888711|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14754838|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754839|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888714|NCT04554693|Metronidazole|metronidazole|mesh-list
13888715|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888716|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14754840|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754841|NCT04493203|Nivolumab|nivolumab|mesh-list
14754842|NCT04493203|Axitinib|axitinib|mesh-list
14754843|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754844|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754845|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13888717|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13888718|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13958513|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13958514|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
13958515|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958516|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958517|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
13958518|NCT03169426|Carvedilol|carvedilol|mesh-list
13958519|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13958520|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13958521|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
13958522|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958523|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958524|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958525|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13958526|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
13958527|NCT03169426|Protective Agents|protective agents|mesh-ancestor
13958528|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14754846|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754847|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754848|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754849|NCT04485559|Everolimus|everolimus|mesh-list
13888719|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13888720|NCT04549116|Progesterone|progesterone|mesh-list
13888721|NCT04549116|Progestins|progestins|mesh-ancestor
13888722|NCT04549116|Hormones|hormones|mesh-ancestor
13888723|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13888724|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888725|NCT04546841|Vaccines|vaccines|mesh-list
13888726|NCT04546841|Immunologic Factors|immunologic factors|mesh-ancestor
13888727|NCT04546841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888728|NCT04544202|Trametinib|trametinib|mesh-list
13888729|NCT04544202|Dabrafenib|dabrafenib|mesh-list
13888730|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888731|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13888732|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888733|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888734|NCT04542408|Heparin|heparin|mesh-list
13888735|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13888736|NCT04542408|Tinzaparin|tinzaparin|mesh-list
13888737|NCT04542408|Dalteparin|dalteparin|mesh-list
13888738|NCT04542408|Edoxaban|edoxaban|mesh-list
13888739|NCT04542408|Anticoagulants|anticoagulants|mesh-list
13888740|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13888741|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13888742|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888743|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13888744|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
13888745|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13888746|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
13888747|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888748|NCT04530383|Metformin|metformin|mesh-list
13888749|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13888750|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888751|NCT04528563|Ketorolac|ketorolac|mesh-list
13888752|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13888753|NCT04528563|Morphine|morphine|mesh-list
13888754|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13888755|NCT04528563|Narcotics|narcotics|mesh-ancestor
13888756|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888757|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888758|NCT04528563|Analgesics|analgesics|mesh-ancestor
13888759|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
13888760|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888761|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13888762|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888763|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13888764|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13888765|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13888766|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888767|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888768|NCT04521335|Copper|copper|mesh-list
13888769|NCT04521335|Disulfiram|disulfiram|mesh-list
14471217|NCT02324842|Canagliflozin|canagliflozin|mesh-list
14471218|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14471219|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471220|NCT02324842|Incretins|incretins|mesh-ancestor
13888770|NCT04521335|Trace Elements|trace elements|mesh-ancestor
13888771|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
13888772|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888773|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13888774|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
13888775|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888776|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888777|NCT04516278|Bevacizumab|bevacizumab|mesh-list
13888778|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13888779|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888780|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13888781|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13888782|NCT04516278|Growth Substances|growth substances|mesh-ancestor
13888783|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888784|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
14754850|NCT04485559|Trametinib|trametinib|mesh-list
14754851|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754852|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14471221|NCT02324842|Hormones|hormones|mesh-ancestor
14471222|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14754853|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
14754854|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754855|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754856|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888793|NCT04507178|Nadroparin|nadroparin|mesh-list
13888794|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
13888795|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13888796|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13888797|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888798|NCT04500899|Phenylephrine|phenylephrine|mesh-list
13888799|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13888800|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
13888801|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
13888802|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888803|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888804|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
13888805|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13888806|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
13888807|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
13888808|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13888809|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13888810|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13888811|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
13888812|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888813|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888814|NCT04500899|Protective Agents|protective agents|mesh-ancestor
13888815|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
13888816|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13888817|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888818|NCT04465760|Antibodies|antibodies|mesh-list
13888819|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
13888820|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
13888821|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888822|NCT04459286|Ritonavir|ritonavir|mesh-list
13888823|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13888824|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
13888825|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13888826|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13888827|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
13888828|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888829|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888830|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13888831|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13888832|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
13888833|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888834|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13888835|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13888836|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13888837|NCT04453852|Vaccines|vaccines|mesh-list
13888838|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
13888839|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888840|NCT04448834|Vincristine|vincristine|mesh-list
13888841|NCT04448834|Blinatumomab|blinatumomab|mesh-list
13888842|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13888843|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888844|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
13888845|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
13888846|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
13888847|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888848|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
13888849|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13888850|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13888851|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888852|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888853|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
13888854|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888855|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888856|NCT04424641|Antibodies|antibodies|mesh-list
13888857|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13888858|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
13888859|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888860|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
13888861|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
13888862|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13888863|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471223|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13888864|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932095|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888865|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888866|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13888867|NCT04379518|Interferons|interferons|mesh-list
13888868|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
13888869|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
13888870|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
13888871|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888872|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
13888873|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13888874|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
13888875|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888876|NCT04378114|Acetaminophen|acetaminophen|mesh-list
13888877|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13888878|NCT04378114|Analgesics|analgesics|mesh-ancestor
13888879|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
13888880|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888881|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888882|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
13888883|NCT04349124|Antihypertensive Agents|antihypertensive agents|mesh-list
13888884|NCT04349124|Nifedipine|nifedipine|mesh-list
13888885|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13888886|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888887|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888888|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13888889|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888890|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
13888891|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
13888892|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13888893|NCT04333160|Hylan|hylan|mesh-list
13888894|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
13888895|NCT04333160|Protective Agents|protective agents|mesh-ancestor
13888896|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888897|NCT04326283|Trametinib|trametinib|mesh-list
13888898|NCT04326283|Riluzole|riluzole|mesh-list
13888899|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888900|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13888901|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888902|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888903|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
13888904|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13888905|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13888906|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888907|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888908|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13888909|NCT04326283|Protective Agents|protective agents|mesh-ancestor
13888910|NCT04315233|Belinostat|belinostat|mesh-list
13888911|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888912|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13888913|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888914|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888915|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13888916|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
13888917|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888918|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13888919|NCT04285671|Trastuzumab|trastuzumab|mesh-list
13888920|NCT04285671|Necitumumab|necitumumab|mesh-list
13888921|NCT04285671|Cetuximab|cetuximab|mesh-list
13888922|NCT04285671|Osimertinib|osimertinib|mesh-list
13888923|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
13888924|NCT04285671|Antibodies|antibodies|mesh-list
13888925|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
13888926|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13888927|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
13888928|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888929|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13888930|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888931|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13888932|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13888933|NCT04279561|Edetic Acid|edetic acid|mesh-list
13888934|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13888935|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
13888936|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
13888937|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888938|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
13888939|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13888940|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13888941|NCT04269408|Nicardipine|nicardipine|mesh-list
13888942|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13888943|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13888944|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888945|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888946|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13888947|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888948|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
13888949|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13888950|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13888951|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13888952|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888953|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888954|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13888955|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888956|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888957|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
13888958|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888959|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
13888960|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13888961|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888962|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888963|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
13888964|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888965|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888966|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
13888967|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13888968|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888969|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888970|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
13888971|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13888972|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958529|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13958530|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13958531|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
13958532|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13958533|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13958534|NCT03169569|Hemostatics|hemostatics|mesh-list
13958535|NCT03169569|Coagulants|coagulants|mesh-ancestor
13958536|NCT03169413|Adenosine|adenosine|mesh-list
13958537|NCT03169413|Analgesics|analgesics|mesh-ancestor
13958538|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
13958539|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958540|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958541|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13958542|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
13958543|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13958544|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
13958545|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
13958546|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958547|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958548|NCT03169335|Paclitaxel|paclitaxel|mesh-list
13958549|NCT03169335|Bevacizumab|bevacizumab|mesh-list
13888973|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
13888974|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
13888975|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13888976|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888977|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888978|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
13888979|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888980|NCT04229368|Vitamin D|vitamin d|mesh-list
13888981|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
13888982|NCT04229368|Vitamins|vitamins|mesh-ancestor
13888983|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
13888984|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888985|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13888986|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13888987|NCT04225273|Lidocaine|lidocaine|mesh-list
13888988|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
13888989|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
13888990|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13888991|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13888992|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
13888993|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13888994|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13888995|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13888996|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13888997|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13888998|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13888999|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
13889000|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
13889001|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13889002|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889003|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889004|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
13889005|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889006|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13889007|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13889008|NCT04209296|Ketamine|ketamine|mesh-list
13889009|NCT04209296|Analgesics|analgesics|mesh-ancestor
13889010|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
13889011|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889012|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889013|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13889014|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13889015|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
13889016|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
13889017|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889018|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13889019|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13889020|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889021|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889022|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13889023|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13889024|NCT04196530|Atezolizumab|atezolizumab|mesh-list
13889025|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889026|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13889027|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13889028|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889029|NCT04174612|Cytarabine|cytarabine|mesh-list
13889030|NCT04174612|Daunorubicin|daunorubicin|mesh-list
13889031|NCT04174612|Midostaurin|midostaurin|mesh-list
13889032|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13889033|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
13889034|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889035|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889036|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
13889037|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889038|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13889039|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
13889040|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889041|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13889042|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13889043|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13889044|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889045|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13889046|NCT04163432|Carboplatin|carboplatin|mesh-list
13889047|NCT04163432|Pemetrexed|pemetrexed|mesh-list
13889048|NCT04163432|Durvalumab|durvalumab|mesh-list
13889049|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889050|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889051|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889052|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13889053|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13889054|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889055|NCT04163185|Meloxicam|meloxicam|mesh-list
13889056|NCT04163185|Rizatriptan|rizatriptan|mesh-list
13889057|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889058|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889059|NCT04163185|Analgesics|analgesics|mesh-ancestor
13889060|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
13889061|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889062|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889063|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889064|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889065|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13889066|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13889067|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889068|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889069|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13889070|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
13889071|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889072|NCT04161456|Apremilast|apremilast|mesh-list
13889073|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889074|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889075|NCT04161456|Analgesics|analgesics|mesh-ancestor
13889076|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
13889077|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889078|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889079|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889080|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889081|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13889082|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13889083|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889084|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932096|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932097|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14932098|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14027861|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027862|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027863|NCT02733471|Lidocaine|lidocaine|mesh-list
14027864|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
14027865|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
14027866|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027867|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027868|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
14027869|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027870|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14027871|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14027872|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14027873|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14027874|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027875|NCT02733458|Gemcitabine|gemcitabine|mesh-list
14027876|NCT02733458|Dexamethasone|dexamethasone|mesh-list
14027877|NCT02733458|Etoposide|etoposide|mesh-list
14932099|NCT01443065|Leucovorin|leucovorin|mesh-list
14932100|NCT01443065|Folic Acid|folic acid|mesh-list
14932101|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
14932102|NCT01443065|Panitumumab|panitumumab|mesh-list
14932103|NCT01443065|Fluorouracil|fluorouracil|mesh-list
14932104|NCT01443065|Rilotumumab|rilotumumab|mesh-list
14932105|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
13889093|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
13889094|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
13889095|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13889096|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13889097|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889098|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889099|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889100|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889101|NCT04144582|Docetaxel|docetaxel|mesh-list
13889102|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889103|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
13889104|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
13889105|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
13889106|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889107|NCT04134442|Bupivacaine|bupivacaine|mesh-list
13889108|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
13889109|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
13889110|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889111|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889112|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
13889113|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889114|NCT04129086|Ketamine|ketamine|mesh-list
13889115|NCT04129086|Analgesics|analgesics|mesh-ancestor
13889116|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
13889117|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889118|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889119|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13889120|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13889121|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
13889122|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
13889123|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889124|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13889125|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13889126|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889127|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889128|NCT04127786|Vaccines|vaccines|mesh-list
13889129|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
13889130|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889131|NCT04114136|Metformin|metformin|mesh-list
13889132|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
13889133|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
13889134|NCT04114136|Nivolumab|nivolumab|mesh-list
13889135|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13889136|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889137|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889138|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889139|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13889140|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889141|NCT04104685|Minocycline|minocycline|mesh-list
13889142|NCT04104685|Adapalene|adapalene|mesh-list
13889143|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13889144|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889145|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889146|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889147|NCT04104685|Analgesics|analgesics|mesh-ancestor
13889148|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
13889149|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889150|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889151|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889152|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889153|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
13889154|NCT04093765|Antimalarials|antimalarials|mesh-list
13889155|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13889156|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13889157|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889158|NCT04077424|Vaccines|vaccines|mesh-list
13889159|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
13889160|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
13889161|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889162|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
13889163|NCT04064684|Budesonide|budesonide|mesh-list
13889164|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889165|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13889166|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
13889167|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889168|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889169|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13889170|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
13889171|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
13889172|NCT04064684|Hormones|hormones|mesh-ancestor
13889173|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889174|NCT04051957|Isosorbide|isosorbide|mesh-list
13889175|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13889176|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13889177|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13889178|NCT04051957|Diuretics|diuretics|mesh-ancestor
13889179|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
13889180|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889181|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
13889182|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13889183|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889184|NCT04049864|Lenalidomide|lenalidomide|mesh-list
13889185|NCT04049864|Vaccines|vaccines|mesh-list
13889186|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
13889187|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889188|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889189|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889190|NCT04049864|Growth Substances|growth substances|mesh-ancestor
13889191|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889192|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889193|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13889194|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13889195|NCT04030143|Aripiprazole|aripiprazole|mesh-list
13889196|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
13889197|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13889198|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13889199|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13889200|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889201|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889202|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
13889203|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
13889204|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889205|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889206|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13889207|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13889208|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
13889209|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13889210|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13889211|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13889212|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13889213|NCT04030026|Nalbuphine|nalbuphine|mesh-list
13889214|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13889215|NCT04030026|Narcotics|narcotics|mesh-ancestor
13889216|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889217|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889218|NCT04030026|Analgesics|analgesics|mesh-ancestor
13889219|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
13889220|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889221|NCT04029610|Lidocaine|lidocaine|mesh-list
13889222|NCT04029610|Epinephrine|epinephrine|mesh-list
13889223|NCT04029610|Racepinephrine|racepinephrine|mesh-list
13889224|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
13889225|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
13889226|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
13889227|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889228|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889229|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
13889230|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889231|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13889232|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13889233|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13889234|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889235|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889236|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13889237|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13889238|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
13889239|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889240|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13889241|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13889242|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
13889243|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13889244|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
13889245|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
13889246|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
13889247|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13889248|NCT04021862|Antibodies|antibodies|mesh-list
13889249|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13889250|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
13889251|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958550|NCT03169335|Carboplatin|carboplatin|mesh-list
13958551|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13958552|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958553|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
13958554|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
13958555|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
13958556|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958557|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958558|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958559|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958560|NCT03169335|Growth Substances|growth substances|mesh-ancestor
13958561|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958562|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958563|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
13958564|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13958565|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958566|NCT03168997|Memantine|memantine|mesh-list
13958567|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13958568|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13958569|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
13958570|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958571|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958572|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958573|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13958574|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13958575|NCT03169114|Amikacin|amikacin|mesh-list
13958576|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13958577|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958578|NCT03169127|Ibuprofen|ibuprofen|mesh-list
13958579|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13958580|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889252|NCT03974100|Denosumab|denosumab|mesh-list
13889253|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13889254|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889255|NCT03970720|Metoclopramide|metoclopramide|mesh-list
13889256|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
13889257|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
13889258|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889259|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889260|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13889261|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13889262|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13889263|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
13889264|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889265|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889277|NCT03959592|Carotenoids|carotenoids|mesh-list
13889278|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
13889279|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889280|NCT03959592|Protective Agents|protective agents|mesh-ancestor
13889281|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889282|NCT03957590|Paclitaxel|paclitaxel|mesh-list
13889283|NCT03957590|Cisplatin|cisplatin|mesh-list
13889284|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13889285|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889286|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
13889287|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
13889288|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
13889289|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889290|NCT03955783|Venetoclax|venetoclax|mesh-list
13889291|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889292|NCT03949673|Celecoxib|celecoxib|mesh-list
13889293|NCT03949673|Diclofenac|diclofenac|mesh-list
13889294|NCT03949673|Naproxen|naproxen|mesh-list
13889295|NCT03949673|Fasinumab|fasinumab|mesh-list
13889296|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889297|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889298|NCT03949673|Analgesics|analgesics|mesh-ancestor
13889299|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
13889300|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889301|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889302|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889303|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889304|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13889305|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13889306|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889307|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889308|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
13889309|NCT03948646|Bromides|bromides|mesh-list
13889310|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
13889311|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
13889312|NCT03943147|BMS-986165|bms-986165|mesh-list
13889313|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13889314|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889315|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13889316|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
13889317|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13889318|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889319|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889320|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889321|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
13889322|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13889323|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
13889324|NCT03941262|Avelumab|avelumab|mesh-list
13889325|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14767199|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
13889326|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889327|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13889328|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
13889329|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889330|NCT03935958|Curcumin|curcumin|mesh-list
13889331|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889332|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889333|NCT03935958|Analgesics|analgesics|mesh-ancestor
13889334|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
13889335|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889336|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889337|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889338|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889339|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889340|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889341|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889342|NCT03928184|Lorecivivint|lorecivivint|mesh-list
13889343|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889344|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13889345|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
13889346|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889347|NCT03926026|Fluticasone|fluticasone|mesh-list
13889348|NCT03926026|Xhance|xhance|mesh-list
13889349|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889350|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13889351|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
13889352|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889353|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889354|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13889355|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
13889356|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
13889357|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13889358|NCT03925480|Azithromycin|azithromycin|mesh-list
13889359|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14754857|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754858|NCT04480190|Gemcitabine|gemcitabine|mesh-list
14754859|NCT04480190|Fluorouracil|fluorouracil|mesh-list
14754860|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754861|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13889360|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889361|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13889362|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13889363|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13889364|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13889365|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13889366|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889367|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889368|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13889369|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889370|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889371|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
13889372|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889373|NCT03912233|Ivacaftor|ivacaftor|mesh-list
13889374|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13889375|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889376|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889377|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13889378|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13889379|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13889380|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889381|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754862|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
13889382|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13889383|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889384|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889385|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
13889386|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754863|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754864|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
14754865|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754866|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754867|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14754868|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
14754869|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754870|NCT04480125|Azacitidine|azacitidine|mesh-list
14754871|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14754872|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
13889397|NCT03896009|Meloxicam|meloxicam|mesh-list
13889398|NCT03896009|Rizatriptan|rizatriptan|mesh-list
13889399|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889400|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889401|NCT03896009|Analgesics|analgesics|mesh-ancestor
13889402|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
13889403|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889404|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889405|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889406|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889407|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13889408|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13889409|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889410|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889411|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13889412|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
13889413|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14027878|NCT02733458|Pegaspargase|pegaspargase|mesh-list
14027879|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027880|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
14027881|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
14027882|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027883|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027884|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14027885|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
14027886|NCT02733458|Hormones|hormones|mesh-ancestor
14027887|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027888|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027889|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027890|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479093|NCT02463357|Protective Agents|protective agents|mesh-ancestor
14754873|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754874|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754875|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754876|NCT04472143|Granisetron|granisetron|mesh-list
14754877|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
14479094|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14479095|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479096|NCT02463357|Diuretics|diuretics|mesh-ancestor
14479097|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
14479098|NCT02463409|Theophylline|theophylline|mesh-list
14479099|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14479100|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
14479101|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479102|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889414|NCT03888378|Minocycline|minocycline|mesh-list
13889415|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13889416|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889417|NCT03881852|Reboxetine|reboxetine|mesh-list
13889418|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
13889419|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13889420|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13889421|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13889422|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889423|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889424|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
13889425|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889426|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889427|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13889428|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13889429|NCT03879408|Acetaminophen|acetaminophen|mesh-list
13889430|NCT03879408|Naproxen|naproxen|mesh-list
13889431|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
13889432|NCT03879408|Hydrocodone|hydrocodone|mesh-list
13889433|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889434|NCT03879408|Analgesics|analgesics|mesh-ancestor
13889435|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
13889436|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889437|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889438|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
13889439|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889440|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889441|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889442|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
13889443|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13889444|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889445|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889446|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13889447|NCT03879408|Narcotics|narcotics|mesh-ancestor
13889448|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889449|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
13889450|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
13889451|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13889452|NCT03877289|Oxybutynin|oxybutynin|mesh-list
13889453|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889454|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
13889455|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
13889456|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889457|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889458|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13889459|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13889460|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
13889461|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889462|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889463|NCT03877289|Urological Agents|urological agents|mesh-ancestor
13889464|NCT03866200|Resveratrol|resveratrol|mesh-list
13889465|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
13889466|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889467|NCT03866200|Protective Agents|protective agents|mesh-ancestor
13889468|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889469|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889470|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13889471|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
13889472|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13889473|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889474|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889475|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13889476|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889477|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13889478|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13889479|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13889480|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13889481|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13889482|NCT03856047|Liraglutide|liraglutide|mesh-list
13889483|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13889484|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889485|NCT03856047|Incretins|incretins|mesh-ancestor
13889486|NCT03856047|Hormones|hormones|mesh-ancestor
13958581|NCT03169127|Analgesics|analgesics|mesh-ancestor
14471224|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471225|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14471226|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
14471227|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471228|NCT02325401|Metformin|metformin|mesh-list
14471229|NCT02325401|Cisplatin|cisplatin|mesh-list
14471230|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471231|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14471232|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471233|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
14471234|NCT02325414|Diphosphonates|diphosphonates|mesh-list
14471235|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14471236|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471237|NCT02325518|Timolol|timolol|mesh-list
13889487|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889488|NCT03844074|Bevacizumab|bevacizumab|mesh-list
13889489|NCT03844074|Ranibizumab|ranibizumab|mesh-list
13889490|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889491|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889492|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889493|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889494|NCT03844074|Growth Substances|growth substances|mesh-ancestor
13889495|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889496|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889497|NCT03840837|Rivastigmine|rivastigmine|mesh-list
13889498|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13889499|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889500|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889501|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
13889502|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889503|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889504|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13889505|NCT03840837|Protective Agents|protective agents|mesh-ancestor
13889506|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13889507|NCT03836287|Bromides|bromides|mesh-list
13889508|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
13958582|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
13958583|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958584|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958585|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958586|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958587|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13958588|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958589|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958590|NCT03168958|Methadone|methadone|mesh-list
13958591|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13958592|NCT03168958|Narcotics|narcotics|mesh-ancestor
13958593|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958594|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958595|NCT03168958|Analgesics|analgesics|mesh-ancestor
13958596|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
13958597|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958598|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
13958599|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
13958600|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
13958601|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13958602|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958603|NCT03168828|Trospium chloride|trospium chloride|mesh-list
13958604|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
13958605|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
13958606|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958607|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958608|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13958609|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13958610|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
13958611|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958612|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958613|NCT03168828|Urological Agents|urological agents|mesh-ancestor
14754878|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
14754879|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754880|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754881|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754882|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14754883|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
13889509|NCT03834753|Bevacizumab|bevacizumab|mesh-list
13889510|NCT03834753|Ranibizumab|ranibizumab|mesh-list
13889511|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889512|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889513|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889514|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889515|NCT03834753|Growth Substances|growth substances|mesh-ancestor
13889516|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889517|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889518|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
13889519|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889520|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889521|NCT03832179|Dexamethasone|dexamethasone|mesh-list
13889522|NCT03832179|Bevacizumab|bevacizumab|mesh-list
13889523|NCT03832179|Ranibizumab|ranibizumab|mesh-list
13889524|NCT03832179|Aflibercept|aflibercept|mesh-list
13889525|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889526|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889527|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889528|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889529|NCT03832179|Growth Substances|growth substances|mesh-ancestor
13889530|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889531|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889532|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889533|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
13889534|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
13889535|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889536|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13889537|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
13889538|NCT03832179|Hormones|hormones|mesh-ancestor
13889539|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889540|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13889541|NCT03827018|Prednisone|prednisone|mesh-list
13889542|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
13889543|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889544|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
13889545|NCT03827018|Hormones|hormones|mesh-ancestor
13889546|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889547|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889548|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13889549|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889550|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889551|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
13889552|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
13889553|NCT03824587|Calcium|calcium|mesh-list
14471238|NCT02325518|Dorzolamide|dorzolamide|mesh-list
14471239|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14471240|NCT02325518|Maleic acid|maleic acid|mesh-list
14471241|NCT02325518|Brinzolamide|brinzolamide|mesh-list
14471242|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14471243|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14471244|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14471245|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
13889554|NCT03824587|Sevelamer|sevelamer|mesh-list
13889555|NCT03824587|Calcium acetate|calcium acetate|mesh-list
13889556|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13889557|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889558|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13889559|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
13889560|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
13889561|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889562|NCT03824587|Antacids|antacids|mesh-ancestor
13889563|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13889564|NCT03823300|Aflibercept|aflibercept|mesh-list
13889565|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889566|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889567|NCT03823300|Growth Substances|growth substances|mesh-ancestor
13889568|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471246|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889569|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889570|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889571|NCT03823287|Aflibercept|aflibercept|mesh-list
13889572|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889573|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889574|NCT03823287|Growth Substances|growth substances|mesh-ancestor
13889575|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889576|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889577|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889578|NCT03818828|Iodine|iodine|mesh-list
13889579|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
13889580|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13889581|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889582|NCT03818828|Trace Elements|trace elements|mesh-ancestor
13889583|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
13889584|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889585|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
14754884|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754885|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754886|NCT04464980|Naltrexone|naltrexone|mesh-list
14754887|NCT04464980|Buprenorphine|buprenorphine|mesh-list
13889586|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13889587|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13889588|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
13889589|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13889590|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889591|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889592|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
13889593|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889594|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889595|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13889596|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889600|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
13889601|NCT03799627|Glycine|glycine|mesh-list
13889602|NCT03799627|Hematinics|hematinics|mesh-ancestor
13889603|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
13889604|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889605|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889606|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889607|NCT03798743|Docetaxel|docetaxel|mesh-list
13889608|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889609|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
13889610|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
14027891|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027892|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13889611|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
13889612|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889613|NCT03793478|Cytarabine|cytarabine|mesh-list
13889614|NCT03793478|Fludarabine|fludarabine|mesh-list
13889615|NCT03793478|Etoposide|etoposide|mesh-list
13889616|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889617|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13889618|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
13889619|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889620|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13889621|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
13889622|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889623|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13889624|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13889625|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13889626|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889627|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
13889628|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889629|NCT03788967|Ertapenem|ertapenem|mesh-list
13889630|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13889631|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889632|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13889633|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13889634|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13889635|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889636|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889637|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13889638|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889639|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889640|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
13889641|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889642|NCT03783923|Deflazacort|deflazacort|mesh-list
13889643|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027893|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
14471247|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471248|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471249|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14471250|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14754888|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13889644|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13889645|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
13889646|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889647|NCT03782103|Ethanol|ethanol|mesh-list
13889648|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
13889649|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13889650|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13889651|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889652|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889653|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889654|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
13889655|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
13889656|NCT03780244|Mannitol|mannitol|mesh-list
13889657|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13889658|NCT03780244|Diuretics|diuretics|mesh-ancestor
13889659|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
13889660|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889661|NCT03778554|Metoprolol|metoprolol|mesh-list
13889662|NCT03778554|Carvedilol|carvedilol|mesh-list
13889663|NCT03778554|Nebivolol|nebivolol|mesh-list
13889664|NCT03778554|Bisoprolol|bisoprolol|mesh-list
13889665|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13889666|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13889667|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
13889668|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
13889669|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889670|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889671|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13889672|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13889673|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13889674|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
13889675|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889676|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889677|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
13889678|NCT03778554|Protective Agents|protective agents|mesh-ancestor
13889679|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13889680|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889681|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13889682|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
13889683|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13889684|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13889685|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13889686|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13889687|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13889688|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
13889689|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13889690|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
13889691|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889692|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
13889693|NCT03777917|Protective Agents|protective agents|mesh-ancestor
14471251|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471252|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14471253|NCT02325713|Praziquantel|praziquantel|mesh-list
14471254|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
14471255|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14471256|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471257|NCT02325739|Spartalizumab|spartalizumab|mesh-list
14471258|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14471259|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471260|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471261|NCT02326025|Doxorubicin|doxorubicin|mesh-list
14471262|NCT02326025|Olaratumab|olaratumab|mesh-list
14471263|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14471264|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471265|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14932106|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932107|NCT01443065|Antidotes|antidotes|mesh-ancestor
14932108|NCT01443065|Protective Agents|protective agents|mesh-ancestor
14471266|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14471267|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471268|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471269|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
14471270|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14471271|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
14471272|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471273|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14471274|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
14471275|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14471276|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
13889720|NCT03775421|Macitentan|macitentan|mesh-list
13889721|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13889722|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13889723|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889724|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
13889725|NCT03772964|Metformin|metformin|mesh-list
13889726|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13889727|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889728|NCT03768089|Ivacaftor|ivacaftor|mesh-list
13889729|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13889730|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889731|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889732|NCT03766295|Gemcitabine|gemcitabine|mesh-list
13889733|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13889734|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
13889735|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889736|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889737|NCT03766295|Antiviral Agents|antiviral agents|mesh-ancestor
13889738|NCT03766295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889739|NCT03766295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932109|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889740|NCT03766295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13889741|NCT03766295|Immunologic Factors|immunologic factors|mesh-ancestor
14754889|NCT04464980|Narcotics|narcotics|mesh-ancestor
14754890|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754891|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754892|NCT04464980|Analgesics|analgesics|mesh-ancestor
14932110|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
14932111|NCT01443065|Vitamins|vitamins|mesh-ancestor
14932112|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
14932113|NCT01443065|Hematinics|hematinics|mesh-ancestor
14932114|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932115|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
14932116|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889742|NCT03766295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889743|NCT03761225|Prednisone|prednisone|mesh-list
13889744|NCT03761225|Docetaxel|docetaxel|mesh-list
13889745|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889746|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
13889747|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
13889748|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
13889749|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889750|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889751|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
14027894|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
14471277|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471278|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14027895|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027896|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14027897|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
14027898|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14027899|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027900|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027901|NCT02733445|Dasatinib|dasatinib|mesh-list
14027902|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027903|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14027904|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027905|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027906|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
14027907|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027908|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027909|NCT02733107|Etoposide|etoposide|mesh-list
14027910|NCT02733107|Apatinib|apatinib|mesh-list
14027911|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14027912|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027913|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027914|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027915|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027916|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027917|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14027918|NCT02733237|Oxytocin|oxytocin|mesh-list
14027919|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
14027920|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14027921|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027922|NCT02733250|Paclitaxel|paclitaxel|mesh-list
14027923|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
14027924|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14027925|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027926|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
14027927|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
14027928|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
14027929|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027930|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14027931|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13889752|NCT03761225|Hormones|hormones|mesh-ancestor
14471279|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
14471280|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14471281|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14471282|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471283|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
14471284|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
14471285|NCT02326805|Metronidazole|metronidazole|mesh-list
14471286|NCT02326805|Vaccines|vaccines|mesh-list
14471287|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
14471288|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471289|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471290|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14471291|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14471292|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13889753|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889754|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889755|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13889756|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13889757|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13889758|NCT03740737|Hormones|hormones|mesh-ancestor
13889759|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889760|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889761|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13889762|NCT03738618|Hormones|hormones|mesh-ancestor
13889763|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889764|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889765|NCT03737123|Gemcitabine|gemcitabine|mesh-list
13889766|NCT03737123|Carboplatin|carboplatin|mesh-list
13889767|NCT03737123|Docetaxel|docetaxel|mesh-list
13889768|NCT03737123|Atezolizumab|atezolizumab|mesh-list
13889769|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889770|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13889771|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
13889772|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889773|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
13889774|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889775|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889776|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13889777|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
13889778|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889779|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
13889780|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
13889781|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
13889782|NCT03729362|Miglustat|miglustat|mesh-list
13889783|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889784|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889785|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13889786|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13889787|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
13889788|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889789|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13889790|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13889791|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889792|NCT03727022|Lorecivivint|lorecivivint|mesh-list
13889793|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889794|NCT03724825|Testosterone|testosterone|mesh-list
13889795|NCT03724825|Androgens|androgens|mesh-ancestor
13889796|NCT03724825|Hormones|hormones|mesh-ancestor
13889797|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889798|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889799|NCT03721965|Prednisone|prednisone|mesh-list
13889800|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
13889801|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889802|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
13889803|NCT03721965|Hormones|hormones|mesh-ancestor
13889804|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889805|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889806|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754893|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
14754894|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14754895|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14754896|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14754897|NCT04460248|Rituximab|rituximab|mesh-list
14754898|NCT04460248|Lenalidomide|lenalidomide|mesh-list
14754899|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
14754900|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754901|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889807|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889808|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
13889809|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
13889810|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889811|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13889812|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13889813|NCT03721965|Protective Agents|protective agents|mesh-ancestor
13889814|NCT03720613|Naloxegol|naloxegol|mesh-list
13889815|NCT03720613|Lubiprostone|lubiprostone|mesh-list
13889816|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13889817|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889818|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889819|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13889820|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889821|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
13889822|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889823|NCT03712371|Chitosan|chitosan|mesh-list
13889824|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13889825|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13889826|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
13889827|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889828|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13889829|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
13889830|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
13889831|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
13889832|NCT03712371|Coagulants|coagulants|mesh-ancestor
13889833|NCT03710564|Aflibercept|aflibercept|mesh-list
13889834|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889835|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889836|NCT03710564|Growth Substances|growth substances|mesh-ancestor
13889837|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889838|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889839|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889840|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13889841|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13889842|NCT03706521|Lorecivivint|lorecivivint|mesh-list
13889843|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889844|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
13889845|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13889846|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13889847|NCT03704584|Prednisolone|prednisolone|mesh-list
13889848|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
13889849|NCT03704584|Lidocaine|lidocaine|mesh-list
13889850|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13889851|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
13889852|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
13889853|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
13889854|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13889855|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889856|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
13889857|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889858|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13889859|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13889860|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13889861|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889862|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889863|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889864|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
13889865|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
14027932|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
14027933|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
13889866|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13889867|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
13889868|NCT03704584|Hormones|hormones|mesh-ancestor
13889869|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13889870|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13889871|NCT03704584|Protective Agents|protective agents|mesh-ancestor
13889872|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13889873|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889874|NCT03703102|KHK4083|khk4083|mesh-list
13889875|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
13889876|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
13889877|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13889878|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
13889879|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889880|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889881|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13889882|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
13889883|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889884|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889885|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13889886|NCT03691974|Fasinumab|fasinumab|mesh-list
13889887|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889888|NCT03691974|Analgesics|analgesics|mesh-ancestor
13889889|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
13889890|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889891|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754902|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
14754903|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958623|NCT03168698|Oxytocin|oxytocin|mesh-list
13958624|NCT03168698|Carbetocin|carbetocin|mesh-list
13958625|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
13958626|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13958627|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958628|NCT03168594|Cisplatin|cisplatin|mesh-list
13958629|NCT03168594|Irinotecan|irinotecan|mesh-list
13958630|NCT03168594|Etoposide|etoposide|mesh-list
13958631|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958632|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13958633|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13958634|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958635|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958636|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13958637|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13958638|NCT03168568|Valsartan|valsartan|mesh-list
13958639|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13958640|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13958641|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13958642|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958643|NCT03168464|Nivolumab|nivolumab|mesh-list
13958644|NCT03168464|Ipilimumab|ipilimumab|mesh-list
13958645|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471293|NCT02326844|Talazoparib|talazoparib|mesh-list
13958646|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889892|NCT03684278|Infliximab|infliximab|mesh-list
13889893|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
13889894|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13889895|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889896|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14754904|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754905|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14754906|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14754907|NCT04460248|Growth Substances|growth substances|mesh-ancestor
13889897|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
13889898|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889899|NCT03676751|Azithromycin|azithromycin|mesh-list
13889900|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13889901|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13889902|NCT03665038|Brexanolone|brexanolone|mesh-list
13889903|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
13889904|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889905|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889906|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889907|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
13889908|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
13889909|NCT03662659|Nivolumab|nivolumab|mesh-list
13889910|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889911|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889912|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13889913|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889914|NCT03662542|Golimumab|golimumab|mesh-list
13889915|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13889916|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13889917|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13889918|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13889919|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
13889920|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889921|NCT03660943|Capsaicin|capsaicin|mesh-list
13889922|NCT03660943|Antipruritics|antipruritics|mesh-ancestor
13889923|NCT03660943|Dermatologic Agents|dermatologic agents|mesh-ancestor
13889924|NCT03660943|Sensory System Agents|sensory system agents|mesh-ancestor
13889925|NCT03660943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889926|NCT03660943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889927|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13889928|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13889929|NCT03659929|Amphetamine|amphetamine|mesh-list
13889930|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13889931|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889932|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
13889933|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
13889934|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13889935|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
13889936|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13889937|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889938|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
13889939|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13889940|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13889941|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889942|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13889943|NCT03657797|Latanoprost|latanoprost|mesh-list
13889944|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13889945|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13889946|NCT03653026|Upadacitinib|upadacitinib|mesh-list
13889947|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
13889948|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13889949|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889950|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889951|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13889952|NCT03647592|Bevacizumab|bevacizumab|mesh-list
13889953|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13889954|NCT03647592|Gefitinib|gefitinib|mesh-list
13889955|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13889956|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889957|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13889958|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13889959|NCT03647592|Growth Substances|growth substances|mesh-ancestor
13889960|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889961|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
13889962|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13889963|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889964|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889965|NCT03647111|Crizotinib|crizotinib|mesh-list
13889966|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889967|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13889968|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889969|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889970|NCT03646994|Crizotinib|crizotinib|mesh-list
13889971|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471294|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14471295|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471296|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471297|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471298|NCT02327013|Vortioxetine|vortioxetine|mesh-list
14471299|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
14471300|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14471301|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14471302|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13889972|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13889973|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13889974|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889975|NCT03646968|Docetaxel|docetaxel|mesh-list
13889976|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889977|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
13889978|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
13889979|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
13889980|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889981|NCT03635996|Etripamil|etripamil|mesh-list
13889982|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13889983|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13889984|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889985|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13889986|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13889987|NCT03626545|Docetaxel|docetaxel|mesh-list
13889988|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13889989|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
13889990|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
13889991|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
13889992|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13889993|NCT03624127|Apremilast|apremilast|mesh-list
13889994|NCT03624127|BMS-986165|bms-986165|mesh-list
13889995|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13889996|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13889997|NCT03624127|Analgesics|analgesics|mesh-ancestor
13889998|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
13889999|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890000|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932117|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14932118|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932119|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
14932120|NCT01443104|Sirolimus|sirolimus|mesh-list
14932121|NCT01443104|Everolimus|everolimus|mesh-list
14932122|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932123|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932124|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
14932125|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932126|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14932127|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932128|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14932129|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
14932130|NCT01443117|Vaccines|vaccines|mesh-list
13890001|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890002|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890003|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13890004|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13890005|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890006|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932131|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
14932132|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890007|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890008|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13890009|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13890010|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13890011|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890012|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890013|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890014|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13890015|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890016|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890017|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890018|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890019|NCT03611881|Nicotine|nicotine|mesh-list
13890020|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13890021|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
13890022|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890023|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890024|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13890025|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13890026|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890027|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890028|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890029|NCT03611751|Apremilast|apremilast|mesh-list
13890030|NCT03611751|BMS-986165|bms-986165|mesh-list
13890031|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14027934|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027935|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14027936|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14027937|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027938|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14027939|NCT02733393|Lidocaine|lidocaine|mesh-list
14027940|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
14027941|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
14027942|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14027943|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027944|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
14027945|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14027946|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14027947|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14027948|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14027949|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14027950|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027951|NCT02733380|Thalidomide|thalidomide|mesh-list
14027952|NCT02733380|Dexamethasone|dexamethasone|mesh-list
14027953|NCT02733380|Doxorubicin|doxorubicin|mesh-list
14027954|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14027955|NCT02733380|Vinorelbine|vinorelbine|mesh-list
14027956|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
14027957|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14027958|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
14027959|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
14027960|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890032|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14027961|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890033|NCT03611751|Analgesics|analgesics|mesh-ancestor
13890034|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
13890035|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890036|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890037|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890038|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890039|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13890040|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13890041|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890042|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890043|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890044|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13890045|NCT03611010|Atorvastatin|atorvastatin|mesh-list
14471303|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471304|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471305|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14471306|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14471307|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471308|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471309|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471310|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
14471311|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14471312|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14471313|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14471314|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14471315|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
14471316|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14471317|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13890046|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13890047|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13890048|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
13890049|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890050|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13890051|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13890052|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890053|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13890054|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13890055|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890056|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890057|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890058|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13890059|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890060|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890061|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890062|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890063|NCT03603288|Idebenone|idebenone|mesh-list
13890064|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
13890065|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890066|NCT03603288|Protective Agents|protective agents|mesh-ancestor
13890067|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890068|NCT03594747|Paclitaxel|paclitaxel|mesh-list
13890069|NCT03594747|Carboplatin|carboplatin|mesh-list
13890070|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13890071|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890072|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
14027962|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890073|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
13890074|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
13890075|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890076|NCT03594058|Solabegron|solabegron|mesh-list
13890077|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13890078|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13890079|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13890080|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
13890081|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890082|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890083|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890084|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
13890085|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13890086|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
13890087|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890088|NCT03589768|Antacids|antacids|mesh-ancestor
13890089|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890090|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890091|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
13890092|NCT03588884|Calcifediol|calcifediol|mesh-list
13890093|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13890094|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890095|NCT03588884|Vitamins|vitamins|mesh-ancestor
13890096|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
13890097|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13890098|NCT03583359|Lidocaine|lidocaine|mesh-list
13890099|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
13890100|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
13890101|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890102|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890103|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
13890104|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890105|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13890106|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13890107|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13890108|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890109|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890110|NCT03580369|Omalizumab|omalizumab|mesh-list
13890111|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13890112|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13890113|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
13890114|NCT03580356|Omalizumab|omalizumab|mesh-list
13890115|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13890116|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13890117|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
13890118|NCT03571568|Rituximab|rituximab|mesh-list
13890119|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13890120|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890121|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
13890122|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890123|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890124|NCT03553498|Acetaminophen|acetaminophen|mesh-list
13890125|NCT03553498|Hydromorphone|hydromorphone|mesh-list
13890126|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13890127|NCT03553498|Analgesics|analgesics|mesh-ancestor
13890128|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
13890129|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890130|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890131|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
13890132|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13890133|NCT03553498|Narcotics|narcotics|mesh-ancestor
13890134|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890135|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
13890136|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
13890137|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890138|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890139|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890140|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13890141|NCT03542669|Doxorubicin|doxorubicin|mesh-list
13890142|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13890143|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890144|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13890145|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13890146|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958647|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13890147|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890148|NCT03541655|Celecoxib|celecoxib|mesh-list
13890149|NCT03541655|Bupivacaine|bupivacaine|mesh-list
13890150|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
13890151|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
13890152|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890153|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890154|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
13890155|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890156|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13890157|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13890158|NCT03541655|Analgesics|analgesics|mesh-ancestor
13890159|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890160|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890161|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13890162|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13890163|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890164|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890165|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13890166|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13890167|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890168|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13890169|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890170|NCT03521687|Apremilast|apremilast|mesh-list
13890171|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13890172|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13890173|NCT03521687|Analgesics|analgesics|mesh-ancestor
13890174|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
13890175|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890176|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890177|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890178|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890179|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13890180|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13890181|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890182|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890183|NCT03515044|Rifaximin|rifaximin|mesh-list
13890184|NCT03515044|Lactulose|lactulose|mesh-list
13890185|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13890186|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13890187|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890188|NCT03512964|Dolutegravir|dolutegravir|mesh-list
13890189|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
13890190|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13890191|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13890192|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890193|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890194|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13890195|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13890196|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
13890197|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13890198|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13890199|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13890200|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
13890201|NCT03510884|Niacin|niacin|mesh-list
13890202|NCT03510884|Niacinamide|niacinamide|mesh-list
13890203|NCT03510884|Atorvastatin|atorvastatin|mesh-list
13890204|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13890205|NCT03510884|Simvastatin|simvastatin|mesh-list
13890206|NCT03510884|Ezetimibe|ezetimibe|mesh-list
13890207|NCT03510884|Pravastatin|pravastatin|mesh-list
13890208|NCT03510884|Lovastatin|lovastatin|mesh-list
13890209|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
13890210|NCT03510884|Fenofibrate|fenofibrate|mesh-list
13890211|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13890212|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13890213|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
13890214|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890215|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13890216|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13890217|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890218|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
13890219|NCT03510884|Vitamins|vitamins|mesh-ancestor
13890220|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
13890221|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890222|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
13958648|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958649|NCT03168191|Menthol|menthol|mesh-list
13958650|NCT03168191|Nicotine|nicotine|mesh-list
13958651|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13958652|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
13958653|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958654|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958655|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13958656|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13958657|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
13958658|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958659|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958660|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
13958661|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
13958662|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13958663|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13958664|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958665|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
13963222|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963223|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
13963224|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963225|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13963226|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963227|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963228|NCT01936688|Etanercept|etanercept|mesh-list
13963229|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13963230|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963231|NCT01936688|Analgesics|analgesics|mesh-ancestor
13963232|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
13963233|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963234|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963235|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963236|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963237|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963238|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963239|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
14471318|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471319|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
14471320|NCT02327117|Coagulants|coagulants|mesh-ancestor
14027963|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
14027964|NCT02733380|Hormones|hormones|mesh-ancestor
14027965|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14027966|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14027967|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14027968|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14027969|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14027970|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14027971|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14027972|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027973|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14027974|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
14027975|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
14027976|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
14471321|NCT02327169|Paclitaxel|paclitaxel|mesh-list
14471322|NCT02327169|Irinotecan|irinotecan|mesh-list
14471323|NCT02327169|Cetuximab|cetuximab|mesh-list
14471324|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14471325|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471326|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
14027977|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14027978|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
14027979|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
14471327|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
13890223|NCT03499899|Carboplatin|carboplatin|mesh-list
13890224|NCT03499899|Spartalizumab|spartalizumab|mesh-list
13890225|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890226|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13890227|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890228|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13890229|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13890230|NCT03493932|Nivolumab|nivolumab|mesh-list
13890231|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13890232|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890233|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13890234|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890235|NCT03475706|Solabegron|solabegron|mesh-list
13890236|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13890237|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13890238|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13890239|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
13890240|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890241|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890242|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890243|NCT03472885|Eculizumab|eculizumab|mesh-list
13890244|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
13890245|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890246|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
13890247|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890248|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
13890249|NCT03471767|Bupropion|bupropion|mesh-list
13890250|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13890251|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
13890252|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13890253|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13890254|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13890255|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890256|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932133|NCT01443169|Pregabalin|pregabalin|mesh-list
14932134|NCT01443169|Analgesics|analgesics|mesh-ancestor
14932135|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
13890257|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
13890258|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890259|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890260|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13890261|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13890262|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890263|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
13890264|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
13890265|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13890266|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13890267|NCT03467113|Cannabidiol|cannabidiol|mesh-list
13890268|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
13890269|NCT03460756|Ganaxolone|ganaxolone|mesh-list
13890270|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
13890271|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890272|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890273|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890274|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
13890275|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
13890276|NCT03455504|Venetoclax|venetoclax|mesh-list
13890277|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890278|NCT03448081|Calcipotriene|calcipotriene|mesh-list
13890279|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890280|NCT03446807|Droxidopa|droxidopa|mesh-list
13890281|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13890282|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13890283|NCT03442751|Riboflavin|riboflavin|mesh-list
13890284|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13890285|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13890286|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
13890287|NCT03442751|Vitamins|vitamins|mesh-ancestor
13890288|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
13890289|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890290|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13890291|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890292|NCT03430843|Paclitaxel|paclitaxel|mesh-list
13890293|NCT03430843|Docetaxel|docetaxel|mesh-list
13890294|NCT03430843|Irinotecan|irinotecan|mesh-list
13890295|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13890296|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890297|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
13890298|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
13890299|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
13890300|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890301|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13890302|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13890303|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890304|NCT03427125|Sevelamer|sevelamer|mesh-list
13890305|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
13890306|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
13890307|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890308|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
13890309|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13890310|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13890311|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13890312|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
13890313|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890314|NCT03416530|TIC10 compound|tic10 compound|mesh-list
13890315|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890316|NCT03412890|Norethindrone|norethindrone|mesh-list
13890317|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
13890318|NCT03412890|Estradiol|estradiol|mesh-list
13890319|NCT03412890|Relugolix|relugolix|mesh-list
13890320|NCT03412890|Estrogens|estrogens|mesh-ancestor
13890321|NCT03412890|Hormones|hormones|mesh-ancestor
13890322|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890323|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890324|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13890325|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
13890326|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13890327|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13890328|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13890329|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13890330|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13890331|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
13890332|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
13890333|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13890334|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13890335|NCT03375203|Zolpidem|zolpidem|mesh-list
13890336|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13890337|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13890338|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890339|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890340|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13890341|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
13890342|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
13890343|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890344|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890345|NCT03373435|Glucagon|glucagon|mesh-list
13890346|NCT03373435|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13890347|NCT03373435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890348|NCT03373435|Hormones|hormones|mesh-ancestor
13890349|NCT03373435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890350|NCT03373435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890351|NCT03373435|Incretins|incretins|mesh-ancestor
13890352|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
13890353|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13890354|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890355|NCT03352427|Everolimus|everolimus|mesh-list
13890356|NCT03352427|Dasatinib|dasatinib|mesh-list
13890357|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890358|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890359|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
13890360|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890361|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13890362|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890363|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890364|NCT03350035|Ganaxolone|ganaxolone|mesh-list
13890365|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
13890366|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890367|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890368|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890369|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
13890370|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
14027980|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14027981|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14027982|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14027983|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14027984|NCT02733380|Growth Substances|growth substances|mesh-ancestor
14027985|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
14027986|NCT02733380|Analgesics|analgesics|mesh-ancestor
14027987|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
14027988|NCT02733341|Ticagrelor|ticagrelor|mesh-list
14027989|NCT02733341|Cangrelor|cangrelor|mesh-list
14027990|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14027991|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14027992|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14027993|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14027994|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
14027995|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14027996|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14027997|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14027998|NCT02732795|Morphine|morphine|mesh-list
14027999|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14028000|NCT02732795|Narcotics|narcotics|mesh-ancestor
14028001|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028002|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028003|NCT02732795|Analgesics|analgesics|mesh-ancestor
14028004|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
14028005|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169231|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169232|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169233|NCT04843839|Nepafenac|nepafenac|mesh-list
14169234|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14169235|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14169236|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
14169237|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14169238|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13890371|NCT03345082|Ranibizumab|ranibizumab|mesh-list
13890372|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13890373|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471328|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
13890374|NCT03345082|Growth Substances|growth substances|mesh-ancestor
13890375|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890376|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
13890377|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890378|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
13890379|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
13890380|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890381|NCT03340974|Protective Agents|protective agents|mesh-ancestor
13890382|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890383|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
13890384|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13890385|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471329|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471330|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14471331|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14471332|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471333|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13890391|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
13890392|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890393|NCT03321526|Norepinephrine|norepinephrine|mesh-list
13890394|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13890395|NCT03321526|Serotonin|serotonin|mesh-list
13890396|NCT03321526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
13890397|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
13890398|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13890399|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13890400|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13890401|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890402|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890403|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13890404|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13890405|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
13890406|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890407|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890408|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
13890409|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
13890410|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890411|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13890412|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13890413|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
13890414|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13890415|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890416|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
13890417|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13890418|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
13890419|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13890420|NCT03320434|Prednisolone|prednisolone|mesh-list
13890421|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13890422|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
13890423|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890424|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
13890425|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
13890426|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890427|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890428|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890429|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
13890430|NCT03320434|Hormones|hormones|mesh-ancestor
13890431|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890432|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13890433|NCT03320434|Protective Agents|protective agents|mesh-ancestor
13890434|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13890435|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890436|NCT03318393|Heparin|heparin|mesh-list
13890437|NCT03318393|Calcium heparin|calcium heparin|mesh-list
13890438|NCT03318393|Bivalirudin|bivalirudin|mesh-list
13890439|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
14471334|NCT02327741|Clopidogrel|clopidogrel|mesh-list
14471335|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14471336|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14471337|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14471338|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14471339|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
14471340|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890440|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13890441|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13890442|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890443|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
13890444|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13890445|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
13890446|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890447|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13890448|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13890449|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890450|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13890451|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471341|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471342|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471343|NCT02328040|Insulin|insulin|mesh-list
14471344|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14471345|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14471346|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
14471347|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14471348|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890460|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
13890461|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13890462|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13890463|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
13890464|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
13890465|NCT03301051|Vaccines|vaccines|mesh-list
13890466|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
13890467|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890468|NCT03295396|TIC10 compound|tic10 compound|mesh-list
13890469|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958666|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
13958667|NCT03168555|Cathartics|cathartics|mesh-ancestor
13958668|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13958669|NCT03168412|Vaccines|vaccines|mesh-list
13958670|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
13958671|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958672|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
13958673|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958674|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958675|NCT03168074|Lenvatinib|lenvatinib|mesh-list
13958676|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958677|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13958678|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958679|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958680|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
13958681|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13958682|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13958683|NCT03168035|NC-4016|nc-4016|mesh-list
13958684|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958685|NCT03168100|Dexamethasone|dexamethasone|mesh-list
13958686|NCT03168100|Lenalidomide|lenalidomide|mesh-list
13958687|NCT03168100|Bortezomib|bortezomib|mesh-list
13958688|NCT03168100|Elotuzumab|elotuzumab|mesh-list
13958689|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958690|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
13958691|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
13958692|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958693|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958694|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13958695|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
13958696|NCT03168100|Hormones|hormones|mesh-ancestor
13958697|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958698|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13958699|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958700|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
13958701|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958702|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958703|NCT03168100|Growth Substances|growth substances|mesh-ancestor
13890470|NCT03288454|Apixaban|apixaban|mesh-list
13890471|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13890472|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
13890473|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13890474|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
13890475|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890476|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890477|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
13890478|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
13890479|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13890480|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
13890481|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890482|NCT03284385|Adavosertib|adavosertib|mesh-list
13890483|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890484|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890485|NCT03263273|Minocycline|minocycline|mesh-list
13890486|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13890487|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13890488|NCT03254485|Praliciguat|praliciguat|mesh-list
13890489|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
13890490|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
13890491|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890492|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890493|NCT03250117|Ropinirole|ropinirole|mesh-list
13890494|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13890495|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13890496|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
13890497|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
13890498|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890499|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890500|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890501|NCT03241173|Nivolumab|nivolumab|mesh-list
13890502|NCT03241173|Ipilimumab|ipilimumab|mesh-list
13890503|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13890504|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890505|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13890506|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890507|NCT03234907|Vedolizumab|vedolizumab|mesh-list
13890508|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754908|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
14754909|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754910|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754911|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754912|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
14754913|NCT04456439|Promethazine|promethazine|mesh-list
13890515|NCT03228394|Ganaxolone|ganaxolone|mesh-list
13890516|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
13890517|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890518|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890519|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890520|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
13890521|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
13890522|NCT03217591|Praliciguat|praliciguat|mesh-list
13890523|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
13890524|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
13890525|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890526|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890527|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
13890528|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890529|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
13890530|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890531|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890532|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
13890533|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13890534|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
13890535|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13890536|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890537|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13890538|NCT03204396|Dulaglutide|dulaglutide|mesh-list
13890539|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13890540|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890541|NCT03198728|Testosterone|testosterone|mesh-list
13890542|NCT03198728|Androgens|androgens|mesh-ancestor
13890543|NCT03198728|Hormones|hormones|mesh-ancestor
13890544|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890545|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890546|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
13890547|NCT03197064|Aprepitant|aprepitant|mesh-list
13890548|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
13890549|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
13890550|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890551|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890552|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890553|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13890554|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890555|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890556|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
13890557|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13890558|NCT03191864|Fluticasone|fluticasone|mesh-list
13890559|NCT03191864|Xhance|xhance|mesh-list
13890560|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890561|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13890562|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
13890563|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890564|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890565|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13890566|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
13890567|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890568|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13890569|NCT03187834|Amoxicillin|amoxicillin|mesh-list
13890570|NCT03187834|Azithromycin|azithromycin|mesh-list
13890571|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13890572|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13890573|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13890574|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13890575|NCT03187834|Renal Agents|renal agents|mesh-ancestor
13890576|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
13890577|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13890578|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13890579|NCT03180684|Imiquimod|imiquimod|mesh-list
13890580|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13890581|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
13890582|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890583|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890584|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
13890585|NCT03175432|Bevacizumab|bevacizumab|mesh-list
13890586|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13890587|NCT03175432|Atezolizumab|atezolizumab|mesh-list
13890588|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
13890589|NCT03175432|Antibodies|antibodies|mesh-list
13890590|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
13890591|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13890592|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
13890593|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890594|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13890595|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13890596|NCT03175432|Growth Substances|growth substances|mesh-ancestor
13890597|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890598|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
13890599|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
13890600|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
13890601|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13890602|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
13890603|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13890604|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
13890605|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890606|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890607|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
13890608|NCT03163667|Everolimus|everolimus|mesh-list
13890609|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890610|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890611|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
13890612|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890613|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13890614|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13890615|NCT03161093|Naproxen|naproxen|mesh-list
13890616|NCT03161093|Fasinumab|fasinumab|mesh-list
13890617|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13890618|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13890619|NCT03161093|Analgesics|analgesics|mesh-ancestor
13890620|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
13890621|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890622|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890623|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890624|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890625|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
13890626|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13890627|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890628|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890629|NCT03150797|Melatonin|melatonin|mesh-list
13890630|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
13890631|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890632|NCT03150797|Protective Agents|protective agents|mesh-ancestor
13890633|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890634|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890635|NCT03148860|Methotrexate|methotrexate|mesh-list
13890636|NCT03148860|Ustekinumab|ustekinumab|mesh-list
13890637|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13890638|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
13890639|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13890640|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890641|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13890642|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
13890643|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890644|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890645|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890646|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890647|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13890648|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890649|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
13890650|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890651|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13890652|NCT03143153|Fluorouracil|fluorouracil|mesh-list
13890653|NCT03143153|Nivolumab|nivolumab|mesh-list
13890654|NCT03143153|Ipilimumab|ipilimumab|mesh-list
13890655|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890656|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
13890657|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890658|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13890659|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890660|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
13890661|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890662|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13890663|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14471349|NCT02328040|Incretins|incretins|mesh-ancestor
14471350|NCT02328040|Hormones|hormones|mesh-ancestor
14471351|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471352|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14471353|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
14471354|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471355|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471356|NCT02328404|Vitamin D|vitamin d|mesh-list
14471357|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
14471358|NCT02328404|Vitamins|vitamins|mesh-ancestor
14471359|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
14471360|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471361|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14471362|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13890678|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
13890679|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13890680|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13890681|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13890682|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890683|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890684|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890685|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890686|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890687|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890688|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890689|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13890690|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13890691|NCT03123783|Nivolumab|nivolumab|mesh-list
13890692|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13890693|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890694|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13890695|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890696|NCT03118570|Vitamin D|vitamin d|mesh-list
13890697|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
13890698|NCT03118570|Calcium|calcium|mesh-list
13890699|NCT03118570|Vitamins|vitamins|mesh-ancestor
13890700|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
13890701|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890702|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13890703|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13890704|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
13890705|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13890706|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
13890707|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13890708|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13890709|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890710|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890711|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890712|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13890713|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890714|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13890715|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
13890716|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890717|NCT03104842|Dexamethasone|dexamethasone|mesh-list
13890718|NCT03104842|Lenalidomide|lenalidomide|mesh-list
13890719|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890720|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
13890721|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
13890722|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890723|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890724|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890725|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
13890726|NCT03104842|Hormones|hormones|mesh-ancestor
13890727|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890728|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754914|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
14754915|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
14754916|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14754917|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14754918|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14754919|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754920|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754921|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
14754922|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
14754923|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
14754924|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890729|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890730|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
13890731|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13890732|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13890733|NCT03104842|Growth Substances|growth substances|mesh-ancestor
13890734|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
13890735|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13890736|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
13890737|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890738|NCT03094416|Esomeprazole|esomeprazole|mesh-list
13890739|NCT03094416|Omeprazole|omeprazole|mesh-list
13890740|NCT03094416|Rabeprazole|rabeprazole|mesh-list
13890741|NCT03094416|Pantoprazole|pantoprazole|mesh-list
13890742|NCT03094416|Lansoprazole|lansoprazole|mesh-list
13890743|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
13890744|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13890745|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13890746|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13890747|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890748|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890749|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
13890750|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14754925|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
13890751|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958704|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
13890752|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13890753|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13890754|NCT03082014|Losartan|losartan|mesh-list
13890755|NCT03082014|Atenolol|atenolol|mesh-list
13890756|NCT03082014|Amlodipine|amlodipine|mesh-list
13890757|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13890758|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13890759|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890760|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890761|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13890762|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890763|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
14754926|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
14754927|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754928|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14754929|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
14754930|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
14754931|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754932|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754933|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14754934|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
14754935|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
13890764|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13890765|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13890766|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13890767|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
13890768|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
13890769|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890770|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13890771|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13890772|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13890773|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
13890774|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754936|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
13890790|NCT03075462|Apatinib|apatinib|mesh-list
13890791|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890792|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13890793|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890794|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890795|NCT03070951|OBE2109|obe2109|mesh-list
13890796|NCT03070951|Hormone Antagonists|hormone antagonists|mesh-ancestor
13890797|NCT03070951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890798|NCT03070951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890799|NCT03070899|OBE2109|obe2109|mesh-list
13890800|NCT03070899|Hormone Antagonists|hormone antagonists|mesh-ancestor
13890801|NCT03070899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890802|NCT03070899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890803|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14169239|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14169240|NCT04843839|Analgesics|analgesics|mesh-ancestor
14169241|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
14169242|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169243|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169244|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169245|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169246|NCT04843839|Laxatives|laxatives|mesh-ancestor
14169247|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169248|NCT04843553|Niacinamide|niacinamide|mesh-list
14169249|NCT04843553|Niacin|niacin|mesh-list
14169250|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
14169251|NCT04843553|Vitamins|vitamins|mesh-ancestor
14169252|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
14169253|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169254|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
14169255|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13890804|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
13890805|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13890806|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
13890807|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13890808|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13890809|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890810|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890811|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890812|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13890813|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13890814|NCT03060980|Empagliflozin|empagliflozin|mesh-list
13890815|NCT03060980|Glimepiride|glimepiride|mesh-list
13890816|NCT03060980|Exenatide|exenatide|mesh-list
14028006|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14028007|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14028008|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14028009|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028010|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028011|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
14028012|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028013|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14028014|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14028015|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
14028016|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14028017|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14028018|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028019|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028020|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028021|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028022|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
14028023|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
14028024|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028025|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
14028026|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14028027|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
14028028|NCT02732522|Misoprostol|misoprostol|mesh-list
14028029|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14028030|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
14028031|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14028032|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028033|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14028034|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028035|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
14028036|NCT02732678|Propranolol|propranolol|mesh-list
14028037|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14028038|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14028039|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028040|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028041|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028042|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028043|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14028044|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14028045|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
14028046|NCT02732405|Grazoprevir|grazoprevir|mesh-list
14028047|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
14028048|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028049|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14028050|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
14028051|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
14028052|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14028053|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028054|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14028055|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14028056|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14028057|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028058|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028059|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14028060|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14028061|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14028062|NCT02732197|Thiopental|thiopental|mesh-list
14028063|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
14028064|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14028065|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958705|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
13890817|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13890818|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890819|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13890820|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890821|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13890822|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890823|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
13890824|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13890825|NCT03060980|Incretins|incretins|mesh-ancestor
13890826|NCT03060980|Hormones|hormones|mesh-ancestor
13890827|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958706|NCT03167918|Metformin|metformin|mesh-list
13958707|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
13958708|NCT03167918|Calcium|calcium|mesh-list
13958709|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13958710|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958711|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13958712|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13958713|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
13958714|NCT03167918|Coagulants|coagulants|mesh-ancestor
13958715|NCT03167905|Fentanyl|fentanyl|mesh-list
13958716|NCT03167905|Meperidine|meperidine|mesh-list
13958717|NCT03167905|Remifentanil|remifentanil|mesh-list
13958718|NCT03167905|Ropivacaine|ropivacaine|mesh-list
13958719|NCT03167905|Entonox|entonox|mesh-list
13958720|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
13958721|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
13958722|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958723|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958724|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
13958725|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958726|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13958727|NCT03167905|Narcotics|narcotics|mesh-ancestor
13958728|NCT03167905|Analgesics|analgesics|mesh-ancestor
13958729|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13958730|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13958731|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
13958732|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13958733|NCT03167957|Amphotericin B|amphotericin b|mesh-list
13958734|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13958735|NCT03167957|Amebicides|amebicides|mesh-ancestor
13958736|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13958737|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13958738|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958739|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13958740|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
13958741|NCT03167853|Antibodies|antibodies|mesh-list
13958742|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13958743|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
13958744|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958745|NCT03167619|Durvalumab|durvalumab|mesh-list
13958746|NCT03167619|Olaparib|olaparib|mesh-list
13958747|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958748|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958749|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13958750|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958751|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958752|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
13958753|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13958754|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
13958755|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958756|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
13958757|NCT03167333|Protective Agents|protective agents|mesh-ancestor
13958758|NCT03167372|Imidacloprid|imidacloprid|mesh-list
13958759|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
13958760|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890828|NCT03060772|Pioglitazone|pioglitazone|mesh-list
13890829|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13890830|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890831|NCT03057600|Paclitaxel|paclitaxel|mesh-list
13890832|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13890833|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890834|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
13890835|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
13890836|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
13890837|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890838|NCT03050060|Nelfinavir|nelfinavir|mesh-list
13890839|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
13890840|NCT03050060|Nivolumab|nivolumab|mesh-list
13890841|NCT03050060|Atezolizumab|atezolizumab|mesh-list
13890842|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13890843|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13890844|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890845|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13890846|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890847|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
13890848|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890849|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13890850|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13890851|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
13890852|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890853|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13890854|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13890855|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
13890856|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13890857|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
13890858|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13890859|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
13890860|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890861|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890862|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14754937|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754938|NCT04455750|Leuprolide|leuprolide|mesh-list
14754939|NCT04455750|Goserelin|goserelin|mesh-list
14754940|NCT04455750|Rucaparib|rucaparib|mesh-list
14754941|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14754942|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
14754943|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14754944|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890863|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
13890864|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13890865|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
13890866|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890867|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890868|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13890869|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
13890870|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
13890871|NCT03044314|Protective Agents|protective agents|mesh-ancestor
13890872|NCT03041311|Carboplatin|carboplatin|mesh-list
13890873|NCT03041311|Etoposide|etoposide|mesh-list
14754945|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14754946|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754947|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14754948|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754949|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754950|NCT04451772|Upadacitinib|upadacitinib|mesh-list
14754951|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14754952|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14754953|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14754954|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754955|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754956|NCT04432935|Lactoferrin|lactoferrin|mesh-list
14754957|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14754958|NCT04425538|Infliximab|infliximab|mesh-list
14754959|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14754960|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14754961|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14754962|NCT04412096|Timolol|timolol|mesh-list
14754963|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14754964|NCT04412096|Latanoprost|latanoprost|mesh-list
13890874|NCT03041311|Atezolizumab|atezolizumab|mesh-list
14754965|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14754966|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13890875|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890876|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13890877|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13890878|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14932136|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932137|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932138|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
14932139|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14932140|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932141|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932142|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14932143|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13890879|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890880|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890881|NCT03040973|Gefitinib|gefitinib|mesh-list
13890882|NCT03040973|Nazartinib|nazartinib|mesh-list
13890883|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890884|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13890885|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890886|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890887|NCT03022578|Lomustine|lomustine|mesh-list
13890888|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13890889|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
13890890|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890891|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890892|NCT03015259|Budesonide|budesonide|mesh-list
13890893|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
13890894|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
13890895|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890896|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13890897|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
13890898|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890899|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890900|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13890901|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
13890902|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
13890903|NCT03015259|Hormones|hormones|mesh-ancestor
13890904|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13890905|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13890906|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13890907|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13890908|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
13890909|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890910|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890911|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
13890912|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13890913|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13890914|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14169256|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
14754967|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14754968|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
14754969|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754970|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754971|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754972|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14754973|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14754974|NCT04396574|Lasmiditan|lasmiditan|mesh-list
14754975|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14754976|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
14754977|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767200|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14754978|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754979|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754980|NCT04396236|Lasmiditan|lasmiditan|mesh-list
14754981|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14754982|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
14754983|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14754984|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14754985|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754986|NCT04392011|Midazolam|midazolam|mesh-list
14754987|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
14754988|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14754989|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14754990|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14754991|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14754992|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14754993|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14754994|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14754995|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14754996|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
14754997|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
14754998|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
14754999|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
14755000|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755001|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755002|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
14755003|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
14755004|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14755005|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14755006|NCT04390763|Gemcitabine|gemcitabine|mesh-list
14755007|NCT04390763|Paclitaxel|paclitaxel|mesh-list
14755008|NCT04390763|Spartalizumab|spartalizumab|mesh-list
14755009|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14755010|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755011|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
14755012|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
14755013|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755014|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755015|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755016|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
14755017|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
14755018|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13890915|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890916|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890917|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890918|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890919|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890920|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890921|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890922|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
13890923|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13890924|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13890925|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13890926|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890927|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890928|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890929|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890930|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890931|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890932|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932144|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14932145|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932146|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14938605|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938606|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938607|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938608|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938609|NCT01482468|Palonosetron|palonosetron|mesh-list
14938610|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
14938611|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
14938612|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890933|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13890934|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13890935|NCT03011450|Fenofibrate|fenofibrate|mesh-list
13890936|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13890937|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
13890938|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890939|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13890940|NCT03009019|Celecoxib|celecoxib|mesh-list
13890941|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13890942|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13890943|NCT03009019|Analgesics|analgesics|mesh-ancestor
13890944|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
13890945|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890946|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890947|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890948|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890949|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13890950|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13890951|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890952|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890953|NCT03006276|Celecoxib|celecoxib|mesh-list
13890954|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13890955|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14938613|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938614|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938615|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13890956|NCT03006276|Analgesics|analgesics|mesh-ancestor
13890957|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
13890958|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890959|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890960|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13890961|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13890962|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13890963|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13890964|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13890965|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890966|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
13890967|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13890968|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13890969|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13890970|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13890971|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890972|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890973|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13890974|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890975|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13890976|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890977|NCT03001817|Fenofibrate|fenofibrate|mesh-list
13890978|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13890979|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
13890980|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890981|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13890982|NCT02999984|Busulfan|busulfan|mesh-list
13890983|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
13890984|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13890985|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13890986|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
13890987|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890988|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13890989|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13890990|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13890991|NCT02997657|Nicotine|nicotine|mesh-list
13890992|NCT02997657|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13890993|NCT02997657|Autonomic Agents|autonomic agents|mesh-ancestor
13890994|NCT02997657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13890995|NCT02997657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13890996|NCT02997657|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13890997|NCT02997657|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13890998|NCT02997657|Cholinergic Agents|cholinergic agents|mesh-ancestor
13890999|NCT02997657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891000|NCT02997657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891001|NCT02997501|Osimertinib|osimertinib|mesh-list
13891002|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891003|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13891004|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891005|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471363|NCT02328755|Methotrexate|methotrexate|mesh-list
14471364|NCT02328755|Tacrolimus|tacrolimus|mesh-list
14471365|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13891009|NCT02990806|Infliximab|infliximab|mesh-list
13891010|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
13891011|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13891012|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891013|NCT02989597|Dexamethasone|dexamethasone|mesh-list
13891014|NCT02989597|Sufentanil|sufentanil|mesh-list
13891015|NCT02989597|Ketamine|ketamine|mesh-list
13891016|NCT02989597|Remifentanil|remifentanil|mesh-list
13891017|NCT02989597|Methadone|methadone|mesh-list
13891018|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891019|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
13891020|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
13891021|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891022|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891023|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13891024|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
13891025|NCT02989597|Hormones|hormones|mesh-ancestor
13891026|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891027|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028066|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471366|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
13891028|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891029|NCT02989597|Analgesics|analgesics|mesh-ancestor
13891030|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
13891031|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13891032|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13891033|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
13891034|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
13891035|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891036|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13891037|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13891038|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891039|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891040|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13891041|NCT02989597|Narcotics|narcotics|mesh-ancestor
13891042|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13891043|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
13891044|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
13891045|NCT02986659|Metformin|metformin|mesh-list
13891046|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13891047|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891048|NCT02985619|Triamcinolone|triamcinolone|mesh-list
13891049|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13891050|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13891051|NCT02985619|Bevacizumab|bevacizumab|mesh-list
13891052|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13891053|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891054|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891055|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13891056|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13891057|NCT02985619|Growth Substances|growth substances|mesh-ancestor
13891058|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891059|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
13891060|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891061|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
13891062|NCT02985619|Hormones|hormones|mesh-ancestor
13891063|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891064|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891065|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
13891066|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891067|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891068|NCT02978456|Sirolimus|sirolimus|mesh-list
13891069|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13891070|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891071|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13891072|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891073|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
13891074|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891075|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
13891076|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891077|NCT02975271|Serlopitant|serlopitant|mesh-list
13891078|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13891079|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891080|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891081|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891082|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
13891083|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
13891084|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
13891085|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891086|NCT02971891|Furosemide|furosemide|mesh-list
13891087|NCT02971891|Diuretics|diuretics|mesh-ancestor
13891088|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
13891089|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891090|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13891091|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891092|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891093|NCT02968940|Avelumab|avelumab|mesh-list
13891094|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891095|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891096|NCT02964273|Tolvaptan|tolvaptan|mesh-list
13891097|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14028067|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14028068|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
14028069|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
14028070|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
13891098|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891099|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
13891100|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891101|NCT02946125|Phenylephrine|phenylephrine|mesh-list
13891102|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
13891103|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13891104|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13891105|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
13891106|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
13891107|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891108|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891109|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
13891110|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13891111|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
13891112|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
13891113|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13891114|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13891115|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13891116|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
13891117|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891118|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891119|NCT02946125|Protective Agents|protective agents|mesh-ancestor
13891120|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13891121|NCT02941926|Letrozole|letrozole|mesh-list
13891122|NCT02941926|Leuprolide|leuprolide|mesh-list
13891123|NCT02941926|Goserelin|goserelin|mesh-list
13891124|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891125|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13891126|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13891127|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891128|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891129|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13891130|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
13891131|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891132|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891133|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13891134|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
13891135|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13891136|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13891137|NCT02933671|Ropivacaine|ropivacaine|mesh-list
13891138|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
13891139|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
13891140|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891141|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891142|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
13891143|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891144|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13891145|NCT02924389|Dolutegravir|dolutegravir|mesh-list
13891146|NCT02924389|Triumeq|triumeq|mesh-list
13891147|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13891148|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13891149|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891150|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891151|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
14932147|NCT01443195|Iron|iron|mesh-list
13891152|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891153|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13891154|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13891155|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13891156|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13891157|NCT02923531|Nivolumab|nivolumab|mesh-list
13891158|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891159|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891160|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13891161|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891162|NCT02920008|Guadecitabine|guadecitabine|mesh-list
13891163|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891164|NCT02918006|Vaccines|vaccines|mesh-list
13891165|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
13891166|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891167|NCT02917629|Pioglitazone|pioglitazone|mesh-list
13891168|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13891169|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891170|NCT02913612|Timolol|timolol|mesh-list
13891171|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13891172|NCT02913612|Maleic acid|maleic acid|mesh-list
13891173|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13891174|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13891175|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
13891176|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891177|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891178|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891179|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13891180|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13891181|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891182|NCT02907359|Guadecitabine|guadecitabine|mesh-list
13891183|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891184|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
13891185|NCT02905188|Fludarabine|fludarabine|mesh-list
13891186|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891187|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
13891188|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891189|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891190|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13891191|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
13891192|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891193|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891194|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14028071|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
14028072|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028073|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891195|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
13891196|NCT02892149|Hematinics|hematinics|mesh-ancestor
13891197|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
13891198|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13891199|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891200|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13891201|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13891202|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891203|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891204|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
13891205|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891206|NCT02880956|Tilavonemab|tilavonemab|mesh-list
13891207|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
13891208|NCT02872116|Leucovorin|leucovorin|mesh-list
13891209|NCT02872116|Fluorouracil|fluorouracil|mesh-list
13891210|NCT02872116|Capecitabine|capecitabine|mesh-list
13891211|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
13891212|NCT02872116|Nivolumab|nivolumab|mesh-list
13891213|NCT02872116|Ipilimumab|ipilimumab|mesh-list
13891214|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
13891215|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028074|NCT02732067|Anesthetics|anesthetics|mesh-list
13891216|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13891217|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891218|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891219|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
13891220|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891221|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891222|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13891223|NCT02872116|Antidotes|antidotes|mesh-ancestor
13891224|NCT02872116|Protective Agents|protective agents|mesh-ancestor
13891225|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
13891226|NCT02872116|Vitamins|vitamins|mesh-ancestor
13891227|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
13891228|NCT02866227|TOL-463|tol-463|mesh-list
13891229|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891230|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
13891231|NCT02865850|Hematinics|hematinics|mesh-ancestor
13891232|NCT02863991|TIC10 compound|tic10 compound|mesh-list
13891233|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891234|NCT02858895|Interleukin-4|interleukin-4|mesh-list
13891235|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13891236|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
13891237|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891238|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891239|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891240|NCT02858037|Dapivirine|dapivirine|mesh-list
13891241|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13891242|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13891243|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
13891244|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958761|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958762|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958763|NCT03167385|Apatinib|apatinib|mesh-list
13958764|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958765|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13958766|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958767|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958768|NCT03167268|Lycopene|lycopene|mesh-list
13958769|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958770|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
13958771|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958772|NCT03167268|Protective Agents|protective agents|mesh-ancestor
13958773|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958774|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13958775|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13958776|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958777|NCT03167216|Cetirizine|cetirizine|mesh-list
13958778|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
13958779|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13958780|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13958781|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13958782|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
13958783|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
13958784|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958785|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958786|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958787|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
13958788|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
13958789|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13958790|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13958791|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
13958792|NCT03166956|Ascorbic Acid|ascorbic acid|mesh-list
13958793|NCT03166956|Vitamins|vitamins|mesh-ancestor
13958794|NCT03166956|Micronutrients|micronutrients|mesh-ancestor
13958795|NCT03166956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958796|NCT03166956|Antioxidants|antioxidants|mesh-ancestor
13958797|NCT03166956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958798|NCT03166956|Protective Agents|protective agents|mesh-ancestor
13958799|NCT03167164|Leucovorin|leucovorin|mesh-list
13958800|NCT03167164|Paclitaxel|paclitaxel|mesh-list
13958801|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
13958802|NCT03167164|Bevacizumab|bevacizumab|mesh-list
13958803|NCT03167164|Fluorouracil|fluorouracil|mesh-list
13958804|NCT03167164|Capecitabine|capecitabine|mesh-list
13958805|NCT03167164|Avelumab|avelumab|mesh-list
13958806|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13958807|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958808|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
13958809|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
13958810|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
13958811|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958812|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958813|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
13958814|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958815|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958816|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958817|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
13891245|NCT02846545|Golimumab|golimumab|mesh-list
13891246|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13891247|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891248|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891249|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
13891250|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891251|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13891252|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
13891253|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13891254|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
13891255|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13891256|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13891257|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891258|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13891259|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891260|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13891261|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891262|NCT02822508|Laxatives|laxatives|mesh-list
13891263|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13891264|NCT02820714|Laxatives|laxatives|mesh-list
13891265|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13891266|NCT02819440|Tadalafil|tadalafil|mesh-list
13891267|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
13891268|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13891269|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13891270|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891271|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891272|NCT02819440|Urological Agents|urological agents|mesh-ancestor
13891273|NCT02818894|Lidocaine|lidocaine|mesh-list
13891274|NCT02818894|Bupivacaine|bupivacaine|mesh-list
13891275|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
13891276|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
13891277|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891278|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891279|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
13891280|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891281|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13891282|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13891283|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13891284|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891285|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891286|NCT02814019|Idebenone|idebenone|mesh-list
14755019|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891287|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
13891288|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891289|NCT02814019|Protective Agents|protective agents|mesh-ancestor
14755020|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755021|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
14755022|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755023|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14755024|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
14755025|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14755026|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
14755027|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755028|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755029|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14755030|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
14755031|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14755032|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
14755033|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891290|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891291|NCT02813447|Sertraline|sertraline|mesh-list
13891292|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
13891293|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13891294|NCT02813447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13891295|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13891296|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891297|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891298|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891299|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
13891300|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891301|NCT02811939|Dronabinol|dronabinol|mesh-list
13891302|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
13891303|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891304|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13891305|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13891306|NCT02811939|Analgesics|analgesics|mesh-ancestor
13891307|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
13891308|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891309|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13891310|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13891311|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891312|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891313|NCT02811939|Hormones|hormones|mesh-ancestor
13891314|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891315|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
13891316|NCT02811861|Everolimus|everolimus|mesh-list
13891317|NCT02811861|Sunitinib|sunitinib|mesh-list
13891318|NCT02811861|Lenvatinib|lenvatinib|mesh-list
13891319|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891320|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891321|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891322|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
13891323|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891324|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13891325|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13891326|NCT02811861|Growth Substances|growth substances|mesh-ancestor
13891327|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
13891328|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13891329|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891330|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891331|NCT02811679|Blinatumomab|blinatumomab|mesh-list
13891332|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891333|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
13891334|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
13891335|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13891336|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13891337|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
13891338|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891339|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
13891340|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
13891341|NCT02805257|Mitomycins|mitomycins|mesh-list
13891342|NCT02805257|Mitomycin|mitomycin|mesh-list
13891343|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13891344|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891345|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
13891346|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891347|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13891348|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891349|NCT02804282|Furosemide|furosemide|mesh-list
13891350|NCT02804282|Diuretics|diuretics|mesh-ancestor
13891351|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
13891352|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891353|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13891354|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13958818|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13891355|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891356|NCT02804035|Furosemide|furosemide|mesh-list
13891357|NCT02804035|Diuretics|diuretics|mesh-ancestor
13891358|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
14755034|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755035|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14755036|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
14755037|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
14755038|NCT04388683|Protective Agents|protective agents|mesh-ancestor
13891359|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891360|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13891361|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891362|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891363|NCT02802813|Piperaquine|piperaquine|mesh-list
13891364|NCT02802813|Primaquine|primaquine|mesh-list
13891365|NCT02802813|Artenimol|artenimol|mesh-list
13891366|NCT02802813|Artemisinins|artemisinins|mesh-list
13891367|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
13891368|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13891369|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13891370|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891371|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
13891372|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13891373|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891374|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13891375|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891376|NCT02784288|Paclitaxel|paclitaxel|mesh-list
13891377|NCT02784288|Carboplatin|carboplatin|mesh-list
13891378|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13891379|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891380|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
13891381|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
13891382|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
13891383|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891384|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
13891385|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13891386|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891387|NCT02778399|OBE2109|obe2109|mesh-list
13891388|NCT02778399|Hormone Antagonists|hormone antagonists|mesh-ancestor
13891389|NCT02778399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891390|NCT02778399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891391|NCT02771626|Nivolumab|nivolumab|mesh-list
13891392|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755039|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
13891393|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755040|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13891394|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13891395|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891396|NCT02770716|Terlipressin|terlipressin|mesh-list
13891397|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13891398|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13891399|NCT02770391|Leuprolide|leuprolide|mesh-list
13891400|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13891401|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
13891402|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13891403|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891404|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13891405|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891406|NCT02762929|Bupivacaine|bupivacaine|mesh-list
13891407|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
13891408|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
13891409|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891410|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891411|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
13891412|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891413|NCT02755597|Dexamethasone|dexamethasone|mesh-list
13891414|NCT02755597|Bortezomib|bortezomib|mesh-list
13891415|NCT02755597|Venetoclax|venetoclax|mesh-list
13891416|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891417|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
13891418|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
13891419|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891420|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891421|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13891422|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
13891423|NCT02755597|Hormones|hormones|mesh-ancestor
13891424|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891425|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13891426|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891427|NCT02744833|Enoxaparin|enoxaparin|mesh-list
13891428|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
13891429|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
13891430|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13891431|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13891432|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891433|NCT02741791|Bupropion|bupropion|mesh-list
13891434|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13891435|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
13891436|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13891437|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13891438|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13891439|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891440|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891441|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
13891442|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891443|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891444|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13891445|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13891446|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891447|NCT02736968|Auranofin|auranofin|mesh-list
13891448|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891449|NCT02736149|Ubenimex|ubenimex|mesh-list
13891450|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13891451|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
13891452|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891453|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13891454|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891455|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13891456|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891457|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
13891458|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891459|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891460|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13891461|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13891462|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
13891463|NCT02735122|Acetaminophen|acetaminophen|mesh-list
13891464|NCT02735122|Ibuprofen|ibuprofen|mesh-list
13891465|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13891466|NCT02735122|Analgesics|analgesics|mesh-ancestor
13891467|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
14767201|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
13891468|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891469|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891470|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
13891471|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13891472|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891473|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891474|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13891475|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891476|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891477|NCT02733432|Fluconazole|fluconazole|mesh-list
13891478|NCT02733432|Rezafungin|rezafungin|mesh-list
13891479|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
13891480|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891481|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13891482|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13891483|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891484|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891485|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13891486|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
13891487|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891488|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891489|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13891490|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13891491|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
13891492|NCT02723162|Varenicline|varenicline|mesh-list
13891493|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13891494|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13891495|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13891496|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
13891497|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891498|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891499|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891500|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
13891501|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891502|NCT02723162|Expectorants|expectorants|mesh-ancestor
13891503|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
13891504|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13891505|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
13891506|NCT02723162|Protective Agents|protective agents|mesh-ancestor
13891507|NCT02723162|Antidotes|antidotes|mesh-ancestor
13891528|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13891529|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13891530|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13891531|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471367|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14471368|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471369|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14471370|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
14471371|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891532|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891533|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13891534|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891535|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891536|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
13891537|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891538|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
13891539|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891540|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891541|NCT02700529|Ubenimex|ubenimex|mesh-list
13891542|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13891543|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
13891544|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891545|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13891546|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891547|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13891548|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891549|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
13891550|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891551|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891552|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13891553|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13891554|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
13891555|NCT02689258|Bupivacaine|bupivacaine|mesh-list
13891556|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
13891557|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
13891558|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891559|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891560|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
13891561|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891562|NCT02683239|Fasinumab|fasinumab|mesh-list
13891563|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13891564|NCT02683239|Analgesics|analgesics|mesh-ancestor
13891565|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
13891566|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891567|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891568|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
13891569|NCT02680574|Hematinics|hematinics|mesh-ancestor
13891570|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
13891571|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13891572|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13891573|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13891574|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891575|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891576|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
13891577|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891578|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891579|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13891580|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891581|NCT02677545|Aspirin|aspirin|mesh-list
13891582|NCT02677545|Clopidogrel|clopidogrel|mesh-list
14932148|NCT01443195|Trace Elements|trace elements|mesh-ancestor
14932149|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
14932150|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932151|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14932152|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14932153|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14932154|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932155|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932156|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932157|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932158|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
14932159|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13891583|NCT02677545|Ticagrelor|ticagrelor|mesh-list
14932160|NCT01443221|Metformin|metformin|mesh-list
13891584|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14932161|NCT01443221|Mitiglinide|mitiglinide|mesh-list
14932162|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14932163|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932164|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
13891585|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13891586|NCT02677545|Analgesics|analgesics|mesh-ancestor
13891587|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
13891588|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891589|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891590|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891591|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891592|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13891593|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13891594|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891595|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13891596|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13891597|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891598|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
13891599|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13891600|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13891601|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13891602|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
13891603|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891604|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
13891605|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13891606|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13891607|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13891608|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891609|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891610|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
13891611|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891612|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891613|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13891614|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891615|NCT02677038|Olaparib|olaparib|mesh-list
13891616|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13891617|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891618|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891619|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891620|NCT02675829|Trastuzumab|trastuzumab|mesh-list
13891621|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
13891622|NCT02675829|Maytansine|maytansine|mesh-list
13891623|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891624|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891625|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13891626|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
13891627|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
13891628|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
13891629|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932165|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14932166|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13891630|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13891631|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13891632|NCT02664558|Ubenimex|ubenimex|mesh-list
13891633|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13891634|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
13891635|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891636|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13891637|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891638|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13891639|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891640|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
13891641|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891642|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891643|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13891644|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13891645|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
13891646|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
13891647|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891648|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891649|NCT02661282|Temozolomide|temozolomide|mesh-list
13891650|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13891651|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
13891652|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891653|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891654|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13891655|NCT02659397|Atorvastatin|atorvastatin|mesh-list
13891656|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13891657|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13891658|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
13891659|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891660|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13891661|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13891662|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891663|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13891664|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891665|NCT02654990|Dexamethasone|dexamethasone|mesh-list
13891666|NCT02654990|Bortezomib|bortezomib|mesh-list
13891667|NCT02654990|Panobinostat|panobinostat|mesh-list
13891668|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891669|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
13891670|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
13891671|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891672|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891673|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13891674|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
13891675|NCT02654990|Hormones|hormones|mesh-ancestor
13891676|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891677|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13891678|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891679|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13891680|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891681|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891682|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
13891683|NCT02650804|Gemcitabine|gemcitabine|mesh-list
13891684|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13891685|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
13891686|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891687|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891688|NCT02650804|Antiviral Agents|antiviral agents|mesh-ancestor
13891689|NCT02650804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891690|NCT02650804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891691|NCT02650804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891692|NCT02650804|Immunologic Factors|immunologic factors|mesh-ancestor
13891693|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471372|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891694|NCT02650804|Vitamins|vitamins|mesh-ancestor
13891695|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
13891696|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
13891697|NCT02648347|Hematinics|hematinics|mesh-ancestor
13958819|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958820|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958821|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958822|NCT03167164|Growth Substances|growth substances|mesh-ancestor
13958823|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958824|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
13958825|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958826|NCT03167164|Antidotes|antidotes|mesh-ancestor
13958827|NCT03167164|Protective Agents|protective agents|mesh-ancestor
13958828|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
13958829|NCT03167164|Vitamins|vitamins|mesh-ancestor
13958830|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
13958831|NCT03166891|Chiauranib|chiauranib|mesh-list
13958832|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958833|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13958834|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958835|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958836|NCT03167112|Leucovorin|leucovorin|mesh-list
13958837|NCT03167112|Fluorouracil|fluorouracil|mesh-list
13958838|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
13958839|NCT03167112|Irinotecan|irinotecan|mesh-list
13958840|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
13958841|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958842|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958843|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958844|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958845|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
13958846|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958847|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13958848|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13958849|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958850|NCT03167112|Antidotes|antidotes|mesh-ancestor
13958851|NCT03167112|Protective Agents|protective agents|mesh-ancestor
13958852|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
13958853|NCT03167112|Vitamins|vitamins|mesh-ancestor
13958854|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
13958855|NCT03167034|Acetazolamide|acetazolamide|mesh-list
13958856|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
13958857|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13958858|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958859|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958860|NCT03167034|Diuretics|diuretics|mesh-ancestor
13958861|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
13958862|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958863|NCT03167177|Leucovorin|leucovorin|mesh-list
13958864|NCT03167177|Paclitaxel|paclitaxel|mesh-list
13958865|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
13958866|NCT03167177|Bevacizumab|bevacizumab|mesh-list
13958867|NCT03167177|Fluorouracil|fluorouracil|mesh-list
13958868|NCT03167177|Capecitabine|capecitabine|mesh-list
13958869|NCT03167177|Nivolumab|nivolumab|mesh-list
13958870|NCT03167177|Avelumab|avelumab|mesh-list
13958871|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13958872|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958873|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
13958874|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
13958875|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
13958876|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958877|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958878|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
13958879|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958880|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958881|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958882|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
13958883|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958884|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958885|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958886|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958887|NCT03167177|Growth Substances|growth substances|mesh-ancestor
13958888|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
13958889|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
13958890|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13958891|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13958892|NCT03167177|Antidotes|antidotes|mesh-ancestor
13958893|NCT03167177|Protective Agents|protective agents|mesh-ancestor
13958894|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
14932167|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
14932168|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932169|NCT01443325|Lidocaine|lidocaine|mesh-list
14932170|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
13891698|NCT02646982|Candesartan|candesartan|mesh-list
13891699|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13891700|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13891701|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13891702|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891703|NCT02641028|Aticaprant|aticaprant|mesh-list
13891704|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13891705|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891706|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
13891707|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891708|NCT02638805|Metformin|metformin|mesh-list
13891709|NCT02638805|Liraglutide|liraglutide|mesh-list
13891710|NCT02638805|Exenatide|exenatide|mesh-list
13891711|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13891712|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891713|NCT02638805|Incretins|incretins|mesh-ancestor
13891714|NCT02638805|Hormones|hormones|mesh-ancestor
13891715|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891716|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13891717|NCT02636582|Molgramostim|molgramostim|mesh-list
13891718|NCT02636582|Vaccines|vaccines|mesh-list
13891719|NCT02636582|Sargramostim|sargramostim|mesh-list
13891720|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
13891721|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891722|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891723|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13891724|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13891725|NCT02627274|Trastuzumab|trastuzumab|mesh-list
13891726|NCT02627274|Cetuximab|cetuximab|mesh-list
13891727|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891728|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891729|NCT02626338|Vidarabine|vidarabine|mesh-list
14932171|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
14932172|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932173|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932174|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
14932175|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932176|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14932177|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14932178|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14932179|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932180|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932181|NCT01443338|Acitretin|acitretin|mesh-list
14932182|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
14932183|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
14932184|NCT01443377|Panitumumab|panitumumab|mesh-list
14471373|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14471374|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891730|NCT02626338|Cytarabine|cytarabine|mesh-list
13891731|NCT02626338|Fludarabine|fludarabine|mesh-list
13891732|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
13891733|NCT02626338|Etoposide|etoposide|mesh-list
13891734|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
13891735|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
13891736|NCT02626338|Idarubicin|idarubicin|mesh-list
13891737|NCT02626338|Crenolanib|crenolanib|mesh-list
13891738|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891739|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14028075|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028076|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028077|NCT02732262|Oxycodone|oxycodone|mesh-list
14028078|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14028079|NCT02732262|Narcotics|narcotics|mesh-ancestor
14028080|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028081|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028082|NCT02732262|Analgesics|analgesics|mesh-ancestor
14028083|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
14028084|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028085|NCT02732132|Fentanyl|fentanyl|mesh-list
14028086|NCT02732132|Midazolam|midazolam|mesh-list
14028087|NCT02732132|Ketamine|ketamine|mesh-list
14028088|NCT02732132|Propofol|propofol|mesh-list
14028089|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14028090|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028091|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028092|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14028093|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
14028094|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
14028095|NCT02732132|Analgesics|analgesics|mesh-ancestor
14028096|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
14028097|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932185|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932186|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028098|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14028099|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14028100|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14028101|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028102|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028103|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14028104|NCT02732132|Narcotics|narcotics|mesh-ancestor
14028105|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14028106|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14471375|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14471376|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932187|NCT01443416|Vaccines|vaccines|mesh-list
14932188|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14932189|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
14932190|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932191|NCT01443429|Beraprost|beraprost|mesh-list
13891740|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
13891741|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891742|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13891743|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
13891744|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891745|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
13891746|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891747|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13891748|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13891749|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13891750|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891751|NCT02626338|Analgesics|analgesics|mesh-ancestor
13891752|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
13891753|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891754|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13891755|NCT02626130|Tremelimumab|tremelimumab|mesh-list
13891756|NCT02626130|Ipilimumab|ipilimumab|mesh-list
13891757|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891758|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891759|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13891760|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891761|NCT02620553|Insulin|insulin|mesh-list
13891762|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13891763|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13891764|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891770|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
13891771|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13891772|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891773|NCT02609828|Tanezumab|tanezumab|mesh-list
13891774|NCT02609828|Analgesics|analgesics|mesh-ancestor
13891775|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
13891776|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891777|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891778|NCT02609048|Seladelpar|seladelpar|mesh-list
13891779|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13891780|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
13891781|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891782|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13891783|NCT02608697|Atorvastatin|atorvastatin|mesh-list
13891784|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13891785|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13891786|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
13891787|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891788|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13891789|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13891790|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891791|NCT02607930|Lamivudine|lamivudine|mesh-list
13891792|NCT02607930|Triumeq|triumeq|mesh-list
13891793|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13891794|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13891795|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891796|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891797|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
13891798|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891799|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13891800|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13891801|NCT02606305|Bevacizumab|bevacizumab|mesh-list
13891802|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
13891803|NCT02606305|Carboplatin|carboplatin|mesh-list
13891804|NCT02606305|Doxorubicin|doxorubicin|mesh-list
13891805|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13891806|NCT02606305|Maytansine|maytansine|mesh-list
13891807|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891808|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891809|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13891810|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13891811|NCT02606305|Growth Substances|growth substances|mesh-ancestor
13891812|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891813|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
13891814|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14471377|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
14471378|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14471379|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14471380|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14471381|NCT02329223|Omalizumab|omalizumab|mesh-list
14471382|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14471383|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13891815|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13891816|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13891817|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891818|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891819|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13891820|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
13891821|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
13891822|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
13891823|NCT02602353|Loxoprofen|loxoprofen|mesh-list
13891824|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13891825|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13891826|NCT02602353|Analgesics|analgesics|mesh-ancestor
13891827|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
13891828|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891829|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891830|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891831|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891832|NCT02598960|Nivolumab|nivolumab|mesh-list
13891833|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891834|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891835|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13891836|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891837|NCT02598557|Exemestane|exemestane|mesh-list
13891838|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891839|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13891840|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13891841|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891842|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891843|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13891844|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
13891845|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891846|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891847|NCT02597634|Ibuprofen|ibuprofen|mesh-list
13891848|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13891849|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13891850|NCT02597634|Analgesics|analgesics|mesh-ancestor
13891851|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
13891852|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891853|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891854|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891855|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891856|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13891857|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471384|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
13891858|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891859|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
13891860|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13891861|NCT02591199|Lidocaine|lidocaine|mesh-list
13891862|NCT02591199|Heparin|heparin|mesh-list
13891863|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
13891864|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
13891865|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891866|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891867|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
13891868|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891869|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13891870|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13891871|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13891872|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891873|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891874|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
13891875|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13891876|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13891877|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
13891878|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13891879|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
13891880|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13891881|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13891882|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028107|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14028108|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14028109|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
14028110|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
13891883|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13891884|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891885|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13891886|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891887|NCT02588677|Riluzole|riluzole|mesh-list
13891888|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
13891889|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13891890|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13891891|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891892|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891893|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891894|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13891895|NCT02588677|Protective Agents|protective agents|mesh-ancestor
13891896|NCT02580708|Trametinib|trametinib|mesh-list
13891897|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891898|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13891899|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891900|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891901|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
13891902|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13891903|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13891904|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13891905|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14028111|NCT02732288|Melatonin|melatonin|mesh-list
14028112|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
14028113|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028114|NCT02732288|Protective Agents|protective agents|mesh-ancestor
14028115|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028116|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13891906|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891907|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
13891908|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028117|NCT02732249|Metronidazole|metronidazole|mesh-list
14028118|NCT02732249|Clarithromycin|clarithromycin|mesh-list
14028119|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
13891909|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891910|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13891911|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891912|NCT02580305|Memantine|memantine|mesh-list
13891913|NCT02580305|Donepezil|donepezil|mesh-list
13891914|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
13891915|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14028120|NCT02732249|Esomeprazole|esomeprazole|mesh-list
14028121|NCT02732249|Bismuth|bismuth|mesh-list
13891916|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891917|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891918|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
13891919|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891920|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891921|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
13891922|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13891923|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13891924|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
13891925|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13891926|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13891927|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13891928|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
13891929|NCT02580058|Doxorubicin|doxorubicin|mesh-list
13891930|NCT02580058|Avelumab|avelumab|mesh-list
13891931|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13891932|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891933|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13891934|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13891935|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891936|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891937|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891938|NCT02578771|Methylene Blue|methylene blue|mesh-list
13891939|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891940|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891941|NCT02578680|Folic Acid|folic acid|mesh-list
13891942|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
13891943|NCT02578680|Hydroxocobalamin|hydroxocobalamin|mesh-list
13891944|NCT02578680|Dexamethasone|dexamethasone|mesh-list
13891945|NCT02578680|Carboplatin|carboplatin|mesh-list
13891946|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
13891947|NCT02578680|Pemetrexed|pemetrexed|mesh-list
13891948|NCT02578680|Vitamins|vitamins|mesh-ancestor
13891949|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
13891950|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891951|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891952|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13891953|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
13891954|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
13891955|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891956|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13891957|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
14932192|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14932193|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
14932194|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14932195|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14932196|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13891958|NCT02578680|Hormones|hormones|mesh-ancestor
13891959|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13891960|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13891961|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891962|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891963|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891964|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13891965|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13891966|NCT02578680|Hematinics|hematinics|mesh-ancestor
13891967|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
13891968|NCT02570490|Linezolid|linezolid|mesh-list
13891969|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
13891970|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13891971|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891972|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13891973|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13891974|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891975|NCT02568566|Vaccines|vaccines|mesh-list
13891976|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
13891977|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891978|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
13891979|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13891980|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14932197|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13891981|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13891982|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13891983|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13891984|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
13891985|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13891986|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891987|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13891988|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13891989|NCT02564744|Rituximab|rituximab|mesh-list
13891990|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13891991|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13891992|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
13891993|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13891994|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13891995|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
13891996|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13891997|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13891998|NCT02553343|Vaccines|vaccines|mesh-list
13891999|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
13892000|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892001|NCT02551237|Capecitabine|capecitabine|mesh-list
13892002|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892003|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
13892004|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892005|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892006|NCT02547818|Ibuprofen|ibuprofen|mesh-list
13892007|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13892008|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892009|NCT02547818|Analgesics|analgesics|mesh-ancestor
13892010|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
13892011|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892012|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892013|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892014|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892015|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13892016|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892017|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892018|NCT02539537|Leucovorin|leucovorin|mesh-list
13892019|NCT02539537|Folic Acid|folic acid|mesh-list
13892020|NCT02539537|Gemcitabine|gemcitabine|mesh-list
13892021|NCT02539537|Fluorouracil|fluorouracil|mesh-list
13892022|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
13892023|NCT02539537|Irinotecan|irinotecan|mesh-list
13892024|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
13892025|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892026|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
13892027|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892028|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892029|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
13892030|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892031|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892032|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892033|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
13892034|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892035|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13892036|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13892037|NCT02539537|Antidotes|antidotes|mesh-ancestor
13892038|NCT02539537|Protective Agents|protective agents|mesh-ancestor
13892039|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
13892040|NCT02539537|Vitamins|vitamins|mesh-ancestor
13892041|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
13892042|NCT02539537|Hematinics|hematinics|mesh-ancestor
13892043|NCT02527707|Ritonavir|ritonavir|mesh-list
13892044|NCT02527707|Lonafarnib|lonafarnib|mesh-list
13892045|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13892046|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13892047|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
13892048|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892049|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892050|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13892051|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13892052|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
13892053|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892054|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13892055|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13892056|NCT02521285|Aspirin|aspirin|mesh-list
13892057|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13892058|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892059|NCT02521285|Analgesics|analgesics|mesh-ancestor
13892060|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
13892061|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892062|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892063|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892064|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892065|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13892066|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13892067|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892068|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13892069|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13892070|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892071|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
13892072|NCT02519439|Ganaxolone|ganaxolone|mesh-list
13892073|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
13892074|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892075|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892076|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892077|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
13892078|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
13892079|NCT02515175|Vaccines|vaccines|mesh-list
13892080|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
14755041|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14755042|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892081|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892082|NCT02514447|Topotecan|topotecan|mesh-list
13892083|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13892084|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13892085|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892086|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892087|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892088|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
13892089|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13892090|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13892091|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892092|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
13892093|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892094|NCT02513485|Levodopa|levodopa|mesh-list
13892095|NCT02513485|Carbidopa|carbidopa|mesh-list
13892096|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13892097|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13892098|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
13892099|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892100|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892101|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892102|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13892103|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892104|NCT02513303|Sirolimus|sirolimus|mesh-list
13892105|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13892106|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892107|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14755043|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
14755044|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14755045|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
14755046|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13892108|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892109|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
13892110|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892111|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
13892112|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892113|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
13892114|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13892115|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755047|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
13892116|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13892117|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892118|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13892119|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
13892120|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
13892121|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892122|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892123|NCT02510599|Solithromycin|solithromycin|mesh-list
13892124|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13892125|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892126|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
13892127|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13958895|NCT03167177|Vitamins|vitamins|mesh-ancestor
13958896|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
13958897|NCT03166644|Sufentanil|sufentanil|mesh-list
13958898|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13892128|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
13892129|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13892130|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892131|NCT02504580|Bupivacaine|bupivacaine|mesh-list
13892132|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
13892133|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
13892134|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892135|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892136|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
13892137|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892138|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13892139|NCT02502669|Finasteride|finasteride|mesh-list
13892140|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13892141|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13892142|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892143|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892144|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
13892145|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892146|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892147|NCT02502669|Urological Agents|urological agents|mesh-ancestor
13892148|NCT02490488|Gemcitabine|gemcitabine|mesh-list
13892149|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892150|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
13892151|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892152|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892153|NCT02490488|Antiviral Agents|antiviral agents|mesh-ancestor
13892154|NCT02490488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892155|NCT02490488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892156|NCT02490488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892157|NCT02490488|Immunologic Factors|immunologic factors|mesh-ancestor
13892158|NCT02490488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892159|NCT02488408|Cytarabine|cytarabine|mesh-list
13892160|NCT02488408|Decitabine|decitabine|mesh-list
13892161|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892162|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
13892163|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892164|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892165|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
13892166|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892167|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892168|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
13892169|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892170|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892171|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13892172|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13892173|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13892174|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13892175|NCT02471222|Amantadine|amantadine|mesh-list
13892176|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13892177|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13892178|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
13892179|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892180|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
13892181|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892182|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892183|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892184|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892185|NCT02471222|Analgesics|analgesics|mesh-ancestor
13892186|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
13892187|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892188|NCT02470039|Insulin|insulin|mesh-list
13892189|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13892190|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
13892191|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892192|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892193|NCT02469155|Risperidone|risperidone|mesh-list
13892194|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13892195|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
13892196|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892197|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892198|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892199|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13892200|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13892201|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892202|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13892203|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13892204|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
13892205|NCT02466867|Naftifine|naftifine|mesh-list
13892206|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
13892207|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892208|NCT02465606|Triamcinolone|triamcinolone|mesh-list
13892209|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13892210|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13892211|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
13892212|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13892213|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892214|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
13892215|NCT02465606|Hormones|hormones|mesh-ancestor
13892216|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892217|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892218|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892219|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
13892220|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892221|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892222|NCT02462811|Acetaminophen|acetaminophen|mesh-list
13892223|NCT02462811|Promethazine|promethazine|mesh-list
13892224|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
14932198|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932199|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892225|NCT02462811|Hydrocodone|hydrocodone|mesh-list
13892226|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892227|NCT02462811|Analgesics|analgesics|mesh-ancestor
13892228|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
13892229|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892230|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892231|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
13892232|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13892233|NCT02462811|Narcotics|narcotics|mesh-ancestor
13892234|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892235|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
13892236|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
13892237|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
13892238|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892239|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13892240|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
13892241|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
13892242|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892243|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892244|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13892245|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13892246|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13892247|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
13892248|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
13892249|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
13892250|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
13892251|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13892252|NCT02454933|Durvalumab|durvalumab|mesh-list
13892253|NCT02454933|Osimertinib|osimertinib|mesh-list
13892254|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13892255|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892256|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13892257|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892258|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892259|NCT02447276|Fasinumab|fasinumab|mesh-list
13892260|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892261|NCT02447276|Analgesics|analgesics|mesh-ancestor
13892262|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
13892263|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892264|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892265|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
13892266|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892267|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892268|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
13892269|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892270|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892271|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
13892272|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13892273|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
13892274|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14182911|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892275|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13892276|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892277|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13892278|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892279|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13892280|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892281|NCT02435212|Deferasirox|deferasirox|mesh-list
13892282|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13892283|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
13892284|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
13892285|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892286|NCT02434744|Metformin|metformin|mesh-list
13892287|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892288|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892289|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
13892290|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13892291|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
13892292|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13892293|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13892294|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892295|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13892296|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892297|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13892298|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892299|NCT02413827|Ipilimumab|ipilimumab|mesh-list
13892300|NCT02413827|Poly ICLC|poly iclc|mesh-list
13892301|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13892302|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13892303|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892304|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13892305|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892306|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
13892307|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
13892308|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892309|NCT02406209|Prednisolone|prednisolone|mesh-list
14471385|NCT02329600|Triamcinolone|triamcinolone|mesh-list
14471386|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14471387|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14471388|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14471389|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14471390|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
14471391|NCT02329600|Hormones|hormones|mesh-ancestor
13892310|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13892311|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
13892312|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13892313|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
13892314|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13892315|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
13892316|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892317|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
13892318|NCT02406209|Hormones|hormones|mesh-ancestor
13892319|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892320|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892321|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13892322|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892323|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
13892324|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
14471392|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892325|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892326|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13892327|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13892328|NCT02406209|Protective Agents|protective agents|mesh-ancestor
13892329|NCT02405585|Leucovorin|leucovorin|mesh-list
13892330|NCT02405585|Gemcitabine|gemcitabine|mesh-list
13892331|NCT02405585|Fluorouracil|fluorouracil|mesh-list
13892332|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
13892333|NCT02405585|Irinotecan|irinotecan|mesh-list
13892334|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755048|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13892335|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
13892336|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892337|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892338|NCT02405585|Antiviral Agents|antiviral agents|mesh-ancestor
13892339|NCT02405585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892340|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892341|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892342|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
13892343|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892344|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13892345|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13892346|NCT02405585|Antidotes|antidotes|mesh-ancestor
13892347|NCT02405585|Protective Agents|protective agents|mesh-ancestor
13892348|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
13892349|NCT02405585|Vitamins|vitamins|mesh-ancestor
14028122|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028123|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471393|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755049|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755050|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14755051|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14755052|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14755053|NCT04383574|Vaccines|vaccines|mesh-list
14755054|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
14755055|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471394|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892350|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
13892351|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14471395|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
14471396|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471397|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471398|NCT02329964|Neostigmine|neostigmine|mesh-list
14471399|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14471400|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14471401|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471402|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471403|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
14471404|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471405|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471406|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14471407|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
14471408|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892352|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14755056|NCT04382326|Vaccines|vaccines|mesh-list
14755057|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14755058|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
14755059|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892353|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892354|NCT02405260|Incretins|incretins|mesh-ancestor
13892355|NCT02405260|Hormones|hormones|mesh-ancestor
13892356|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892357|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13892358|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
13892359|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892360|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892361|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
13892362|NCT02402270|Laxatives|laxatives|mesh-ancestor
13892363|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13892364|NCT02401815|Sunitinib|sunitinib|mesh-list
13892365|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892366|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13892367|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13892368|NCT02401815|Growth Substances|growth substances|mesh-ancestor
13892369|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892370|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
13892371|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13892372|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892373|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892374|NCT02401750|Naltrexone|naltrexone|mesh-list
13892375|NCT02401750|Oxycodone|oxycodone|mesh-list
13892376|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13892377|NCT02401750|Narcotics|narcotics|mesh-ancestor
13892378|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892379|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892380|NCT02401750|Analgesics|analgesics|mesh-ancestor
13892381|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
13892382|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892383|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13892384|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13892385|NCT02398500|Ranibizumab|ranibizumab|mesh-list
13892386|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13892387|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13892388|NCT02398500|Growth Substances|growth substances|mesh-ancestor
13892389|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892390|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
13892391|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892392|NCT02393937|Metronidazole|metronidazole|mesh-list
13892393|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892394|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13892395|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13892396|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13892397|NCT02392026|Metronidazole|metronidazole|mesh-list
13892398|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892399|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13892400|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13892401|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13892402|NCT02391571|Naltrexone|naltrexone|mesh-list
13892403|NCT02391571|Oxycodone|oxycodone|mesh-list
13892404|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13892405|NCT02391571|Narcotics|narcotics|mesh-ancestor
13892406|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892407|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892408|NCT02391571|Analgesics|analgesics|mesh-ancestor
13892409|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
13892410|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892411|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13892412|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13892413|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
13892414|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
13892415|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13892416|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13892417|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892418|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892419|NCT02390960|Urological Agents|urological agents|mesh-ancestor
14755060|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
14755061|NCT04377932|Fludarabine|fludarabine|mesh-list
13892420|NCT02389985|Paclitaxel|paclitaxel|mesh-list
13892421|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13892422|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892423|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
13892424|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
13892425|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
13892426|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892427|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
13892428|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13892429|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
13892430|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892431|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892432|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13892433|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
13892434|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
13892435|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13892436|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
13892437|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892438|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892439|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13892440|NCT02372578|Pregabalin|pregabalin|mesh-list
13892441|NCT02372578|Analgesics|analgesics|mesh-ancestor
13892442|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
13892443|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892444|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892445|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
13892446|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13892447|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13892448|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892449|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13892450|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13892451|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13892452|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892453|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13892454|NCT02365649|Upadacitinib|upadacitinib|mesh-list
13892455|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
13892456|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13892457|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892458|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892459|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892460|NCT02358538|Ganaxolone|ganaxolone|mesh-list
13892461|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
13892462|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892463|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892464|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892465|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
13892466|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
13892467|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13892468|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892469|NCT02342249|Oseltamivir|oseltamivir|mesh-list
13892470|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
13892471|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892472|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892473|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892474|NCT02339129|Ibuprofen|ibuprofen|mesh-list
13892475|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13892476|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892477|NCT02339129|Analgesics|analgesics|mesh-ancestor
13892478|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
13892479|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892480|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892481|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892482|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892483|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13892484|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892485|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892486|NCT02339064|Apomorphine|apomorphine|mesh-list
13892487|NCT02339064|Emetics|emetics|mesh-ancestor
13892488|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892489|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
13892490|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892491|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13892492|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
13892493|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
13892494|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028124|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13958899|NCT03166644|Narcotics|narcotics|mesh-ancestor
13892495|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958900|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958901|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958902|NCT03166644|Analgesics|analgesics|mesh-ancestor
13958903|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
13958904|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958905|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13958906|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13958907|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
13958908|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
13958909|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
13958910|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13958911|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
13958912|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958913|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
13958914|NCT03166865|Protective Agents|protective agents|mesh-ancestor
14471409|NCT02330094|Gabapentin|gabapentin|mesh-list
14471410|NCT02330094|Analgesics|analgesics|mesh-ancestor
14471411|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
13963253|NCT01861496|Cisplatin|cisplatin|mesh-list
13963254|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963255|NCT01826838|Dasatinib|dasatinib|mesh-list
13963256|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963257|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13963258|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963259|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963260|NCT01767675|Carboplatin|carboplatin|mesh-list
13963261|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963262|NCT01748149|Vemurafenib|vemurafenib|mesh-list
13963263|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963264|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13963265|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963266|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963267|NCT01502917|Antibodies|antibodies|mesh-list
13963268|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13963269|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
13963270|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963271|NCT00970866|Folic Acid|folic acid|mesh-list
13963272|NCT00970866|Micronutrients|micronutrients|mesh-list
13963273|NCT00970866|Trace Elements|trace elements|mesh-list
13963274|NCT00970866|Hematinics|hematinics|mesh-ancestor
13963275|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
13963276|NCT00970866|Vitamins|vitamins|mesh-ancestor
13963277|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963278|NCT00799396|Aspirin|aspirin|mesh-list
13963279|NCT00799396|Clopidogrel|clopidogrel|mesh-list
13963280|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13963281|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963282|NCT00799396|Analgesics|analgesics|mesh-ancestor
13963283|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
13963284|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963285|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963286|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963287|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963288|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13963289|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13963290|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963291|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13963292|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13963293|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963294|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
13963295|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13963296|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13963297|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13963298|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
13963299|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963300|NCT00069238|Prednisone|prednisone|mesh-list
13963301|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
13963302|NCT00069238|Doxorubicin|doxorubicin|mesh-list
13963303|NCT00069238|Etoposide|etoposide|mesh-list
13963304|NCT00069238|Vincristine|vincristine|mesh-list
13963305|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
13963306|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963307|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
13963308|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963309|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028125|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14471412|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892496|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13892497|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
13892498|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892499|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13892500|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892501|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
13892502|NCT02335918|Nivolumab|nivolumab|mesh-list
13892503|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13892504|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892505|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13892506|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892507|NCT02333643|Digoxin|digoxin|mesh-list
13892508|NCT02333643|Furosemide|furosemide|mesh-list
13892509|NCT02333643|Diuretics|diuretics|mesh-ancestor
13892510|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
13892511|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892512|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13892513|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13892514|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892515|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13892516|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13892517|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892518|NCT02333643|Protective Agents|protective agents|mesh-ancestor
13892519|NCT02332655|Cannabidiol|cannabidiol|mesh-list
13892520|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
13892521|NCT02329834|Furosemide|furosemide|mesh-list
13892522|NCT02329834|Diuretics|diuretics|mesh-ancestor
13892523|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
13892524|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892525|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13892526|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13892527|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892528|NCT02326454|Talaporfin|talaporfin|mesh-list
13892529|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892530|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13892531|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892532|NCT02324985|Ibuprofen|ibuprofen|mesh-list
13892533|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13892534|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892535|NCT02324985|Analgesics|analgesics|mesh-ancestor
13892536|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
13892537|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892538|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892539|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892540|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892541|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13892542|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892543|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892544|NCT02324725|Naltrexone|naltrexone|mesh-list
13892545|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13892546|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13892547|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892548|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
13892549|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892550|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
13892551|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892552|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892553|NCT02320708|Acetaminophen|acetaminophen|mesh-list
13892554|NCT02320708|Ibuprofen|ibuprofen|mesh-list
13892555|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892556|NCT02320708|Analgesics|analgesics|mesh-ancestor
13892557|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
13892558|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892559|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892560|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
13892561|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13892562|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892563|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892564|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13892565|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892566|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892567|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13892568|NCT02309671|Hormones|hormones|mesh-ancestor
13958915|NCT03166787|Ascorbic Acid|ascorbic acid|mesh-list
14028126|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13892569|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892570|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892571|NCT02306291|Cytarabine|cytarabine|mesh-list
13892572|NCT02306291|Etoposide|etoposide|mesh-list
13892573|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
13892574|NCT02306291|Idarubicin|idarubicin|mesh-list
13892575|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13892576|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892577|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13892578|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13892579|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892580|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892581|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892582|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
13892583|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
13892584|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892585|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892586|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
14471413|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471414|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
14471415|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14471416|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14471417|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471418|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14471419|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14471420|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14755062|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
13892587|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892588|NCT02306291|Analgesics|analgesics|mesh-ancestor
13892589|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
13892590|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892591|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13892592|NCT02302079|Ranibizumab|ranibizumab|mesh-list
13892593|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13892594|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13892595|NCT02302079|Growth Substances|growth substances|mesh-ancestor
13892596|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892597|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
13892598|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892599|NCT02301234|Celecoxib|celecoxib|mesh-list
13892600|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13892601|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13892602|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892603|NCT02301234|Analgesics|analgesics|mesh-ancestor
13892604|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
13892605|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892606|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892607|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892608|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892609|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13892610|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13892611|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892612|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892613|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
13892614|NCT02300142|Vaccines|vaccines|mesh-list
13892615|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
13892616|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892617|NCT02296645|Ethanol|ethanol|mesh-list
13892618|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
13892619|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13892620|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13892621|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892622|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892623|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892624|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
13892625|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892626|NCT02295865|Toreforant|toreforant|mesh-list
13892627|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
13892628|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
13892629|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892630|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892631|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892632|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13892633|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
13958916|NCT03166787|Tadalafil|tadalafil|mesh-list
13892634|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892635|NCT02282215|Lenograstim|lenograstim|mesh-list
13892636|NCT02282215|Sargramostim|sargramostim|mesh-list
13892637|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13892638|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
13892639|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892640|NCT02279823|Minoxidil|minoxidil|mesh-list
13892641|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13892642|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13892643|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
13892644|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
13892645|NCT02279602|Combretastatin|combretastatin|mesh-list
13892646|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13892647|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892648|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
13892649|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
13892650|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
13892651|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892652|NCT02278133|Cetuximab|cetuximab|mesh-list
13892653|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13892654|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892655|NCT02277106|Brexanolone|brexanolone|mesh-list
13892656|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
13892657|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892658|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892659|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892660|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
13892661|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
13892662|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13892663|NCT02271503|Carbidopa|carbidopa|mesh-list
13892664|NCT02271503|Levodopa|levodopa|mesh-list
13892665|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13892666|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
13892667|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892668|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13892669|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13892670|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
13892671|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
13892672|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892673|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892674|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13892675|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892676|NCT02271334|Albuterol|albuterol|mesh-list
13892677|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13892678|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
13892679|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892680|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892681|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13892682|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
13892683|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
13892684|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13892685|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13892686|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13892687|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13892688|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
13892689|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892690|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892691|NCT02260193|Glycine|glycine|mesh-list
13892692|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
13892693|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892694|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892695|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892696|NCT02257983|Ubiquinone|ubiquinone|mesh-list
13892697|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
13892698|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892699|NCT02257619|Docetaxel|docetaxel|mesh-list
13892700|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892701|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
13892702|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
13892703|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
13892704|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892705|NCT02255409|Vaccines|vaccines|mesh-list
13892706|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
13892707|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892708|NCT02252835|Colchicine|colchicine|mesh-list
13892709|NCT02252835|Febuxostat|febuxostat|mesh-list
13892710|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
13892711|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892712|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
13892713|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
13892714|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
13892715|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755063|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755064|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
14755065|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755066|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755067|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14755068|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
14755069|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755070|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755071|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14755072|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755073|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
14932200|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932201|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892716|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892717|NCT02244606|Fluconazole|fluconazole|mesh-list
13892718|NCT02244606|Micafungin|micafungin|mesh-list
13892719|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
13892720|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
13892721|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892722|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13892723|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13892724|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892725|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892726|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13892727|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
13892728|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892729|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892730|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13892731|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13892732|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
13892733|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13892734|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13892735|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13892736|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13892737|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892738|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
13892739|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892740|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892741|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13892742|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892743|NCT02236195|Mocetinostat|mocetinostat|mesh-list
13892744|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13892745|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892746|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892747|NCT02236156|Metronidazole|metronidazole|mesh-list
13892748|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892749|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13892750|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13892751|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13892752|NCT02230891|Carvedilol|carvedilol|mesh-list
14932202|NCT01443520|Analgesics|analgesics|mesh-ancestor
14932203|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
13892753|NCT02230891|Spironolactone|spironolactone|mesh-list
13892754|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13892755|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
13892756|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892757|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892758|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13892759|NCT02230891|Diuretics|diuretics|mesh-ancestor
13892760|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
13892761|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13892762|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13892763|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
13958917|NCT03166787|Charcoal|charcoal|mesh-list
14755074|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
14932204|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932205|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
14932206|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13892764|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892765|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892766|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13892767|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
13892768|NCT02230891|Protective Agents|protective agents|mesh-ancestor
13892769|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13892770|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13892771|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13892772|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
13892773|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13892774|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13892775|NCT02224235|Aspirin|aspirin|mesh-list
13892776|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13892777|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13892778|NCT02224235|Analgesics|analgesics|mesh-ancestor
13892779|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
13892780|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892781|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892782|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13892783|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892784|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13892785|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13892786|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892787|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13892788|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13892789|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892790|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
13892791|NCT02221232|Ethanol|ethanol|mesh-list
13892792|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
13892793|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13892794|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13892795|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892796|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13892797|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892798|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
13892799|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892800|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
13892801|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13892802|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13892803|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13892804|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
13892805|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13892806|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892807|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13892808|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13892809|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
13892810|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13892811|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
13892812|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892813|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892814|NCT02210806|Albuterol|albuterol|mesh-list
13892815|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13892816|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
13892817|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892818|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892819|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13892820|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
13892821|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
13892822|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13958918|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
14755075|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755076|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755077|NCT04371952|Doxycycline|doxycycline|mesh-list
14755078|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755079|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755080|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
14755081|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14755082|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14755083|NCT04365257|Prazosin|prazosin|mesh-list
14755084|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
14755085|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14755086|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14755087|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13892823|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13892824|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13892825|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13892826|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
13892827|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892828|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892829|NCT02207257|Edoxaban|edoxaban|mesh-list
13892830|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13892831|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
13892832|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14755088|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
14755089|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755090|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755091|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932207|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
13892833|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
13892834|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892835|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892836|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
13892837|NCT02206100|Enoxaparin|enoxaparin|mesh-list
13892838|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
13892839|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13892840|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13892841|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892842|NCT02206087|Heparin|heparin|mesh-list
13892843|NCT02206087|Calcium heparin|calcium heparin|mesh-list
13892844|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
13892845|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13892846|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13892847|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892848|NCT02205528|Metformin|metformin|mesh-list
13892849|NCT02205528|Liraglutide|liraglutide|mesh-list
13892850|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892851|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892852|NCT02205528|Incretins|incretins|mesh-ancestor
13892853|NCT02205528|Hormones|hormones|mesh-ancestor
13892854|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13958919|NCT03166787|Vitamins|vitamins|mesh-ancestor
13958920|NCT03166787|Micronutrients|micronutrients|mesh-ancestor
13958921|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958922|NCT03166787|Antioxidants|antioxidants|mesh-ancestor
13958923|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958924|NCT03166787|Protective Agents|protective agents|mesh-ancestor
13958925|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
13958926|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13958927|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13958928|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958929|NCT03166787|Urological Agents|urological agents|mesh-ancestor
13958930|NCT03166787|Antidotes|antidotes|mesh-ancestor
13958931|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
13958932|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
13958933|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958934|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
13958935|NCT03166254|Vaccines|vaccines|mesh-list
13958936|NCT03166254|Poly ICLC|poly iclc|mesh-list
13958937|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
13958938|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958939|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13958940|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958941|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
13958942|NCT03166306|Bevacizumab|bevacizumab|mesh-list
13958943|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14028127|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14028128|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028129|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14028130|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028131|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14028132|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14028133|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14471421|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958944|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958945|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13958946|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13958947|NCT03166306|Growth Substances|growth substances|mesh-ancestor
13958948|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958949|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
13892855|NCT02204345|Paclitaxel|paclitaxel|mesh-list
13892856|NCT02204345|Carboplatin|carboplatin|mesh-list
13892857|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13892858|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892859|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
13892860|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
13892861|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
13892862|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892863|NCT02200380|Plerixafor|plerixafor|mesh-list
13892864|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13892865|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13892866|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
13892867|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892868|NCT02187302|Bevacizumab|bevacizumab|mesh-list
13892869|NCT02187302|Sunitinib|sunitinib|mesh-list
13892870|NCT02187302|Everolimus|everolimus|mesh-list
13892871|NCT02187302|Sorafenib|sorafenib|mesh-list
13892872|NCT02187302|Axitinib|axitinib|mesh-list
13892873|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13892874|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892875|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13892876|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13892877|NCT02187302|Growth Substances|growth substances|mesh-ancestor
13892878|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892879|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
13892880|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892881|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
13892882|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13892883|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892884|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892885|NCT02184195|Olaparib|olaparib|mesh-list
13892886|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13892887|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892888|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892889|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892890|NCT02179749|Mifepristone|mifepristone|mesh-list
13892891|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13892892|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
13892893|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13892894|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892895|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13892896|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13892897|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13892898|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
13892899|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13892900|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13892901|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
13892902|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892903|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
13892904|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13892905|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13892906|NCT02179151|CKD732|ckd732|mesh-list
13892907|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13892908|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13892909|NCT02179151|Growth Substances|growth substances|mesh-ancestor
13892910|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892911|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
13892912|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892913|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13892914|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13892915|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
13892916|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892917|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13892918|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892919|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892920|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892921|NCT02172872|Decitabine|decitabine|mesh-list
13892922|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892923|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
13892924|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892925|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892926|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892927|NCT02160678|Tazarotene|tazarotene|mesh-list
13892928|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892929|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
13892930|NCT02160665|Tazarotene|tazarotene|mesh-list
13892931|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892932|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
13892933|NCT02153502|Quinidine|quinidine|mesh-list
13892934|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
13892935|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
13892936|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
13892937|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
13892938|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13892939|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13892940|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755092|NCT04357951|Cycloserine|cycloserine|mesh-list
14755093|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14755094|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755095|NCT04357951|Renal Agents|renal agents|mesh-ancestor
14755096|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13892941|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892942|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892943|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13892944|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13892945|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
13892946|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13892947|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
13892948|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13892949|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13892950|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13892951|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892952|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13892953|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13892954|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
13892955|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13892956|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13892957|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13892958|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13892959|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13892960|NCT02137343|Capecitabine|capecitabine|mesh-list
13892961|NCT02137343|Rilotumumab|rilotumumab|mesh-list
13892962|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892963|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892964|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
13892965|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892966|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13892967|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13892968|NCT02130687|Aprepitant|aprepitant|mesh-list
13892969|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13892970|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892971|NCT02130687|Incretins|incretins|mesh-ancestor
13892972|NCT02130687|Hormones|hormones|mesh-ancestor
13892973|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13892974|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13892975|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
13892976|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892977|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892978|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
13892979|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
13892980|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13892981|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13892982|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13892983|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13892984|NCT02125266|Methotrexate|methotrexate|mesh-list
13892985|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13892986|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
13892987|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13892988|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13892989|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13892990|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
13892991|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13892992|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13892993|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
13892994|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13892995|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13892996|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13892997|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
13892998|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13892999|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13893000|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
13893001|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893002|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
13893003|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13893004|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
13893005|NCT02116998|Vaccines|vaccines|mesh-list
13893006|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13893007|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
13893008|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893009|NCT02116998|Antacids|antacids|mesh-ancestor
13893010|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893011|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13893012|NCT02114060|Vaccines|vaccines|mesh-list
13893013|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
13893014|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893015|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
13893016|NCT02110368|Testosterone|testosterone|mesh-list
13893017|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
13893018|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
13893019|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13893020|NCT02110368|Androgens|androgens|mesh-ancestor
13893021|NCT02110368|Hormones|hormones|mesh-ancestor
13893022|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893023|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893024|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13893025|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893026|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
13893027|NCT02106546|Paclitaxel|paclitaxel|mesh-list
13893028|NCT02106546|Carboplatin|carboplatin|mesh-list
13893029|NCT02106546|Veliparib|veliparib|mesh-list
13893030|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13893031|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893032|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
13893033|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893034|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893035|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893036|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13893037|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893038|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13893039|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13893040|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
13893041|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13893042|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893043|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13893044|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13893045|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893046|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893047|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893048|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13893049|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13893050|NCT02104050|Dapansutrile|dapansutrile|mesh-list
13893051|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893052|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
13893053|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893054|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893055|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893056|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893057|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
13893058|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893059|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893060|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893061|NCT02092935|Vancomycin|vancomycin|mesh-list
13893062|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13893063|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893064|NCT02092922|Filanesib|filanesib|mesh-list
13893065|NCT02092922|Lenograstim|lenograstim|mesh-list
13893066|NCT02092922|Sargramostim|sargramostim|mesh-list
13893067|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13893068|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
13893069|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755097|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
13893070|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893071|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893072|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893073|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893074|NCT02092454|Benzocaine|benzocaine|mesh-list
13893075|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
13893076|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
13893077|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893078|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893079|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
13893080|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893081|NCT02092077|Hormones|hormones|mesh-list
13893082|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893083|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893084|NCT02083289|Latanoprost|latanoprost|mesh-list
13893085|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13893086|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13893087|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
13893088|NCT02081300|Testosterone|testosterone|mesh-list
13893089|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
13893090|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
13893091|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13893092|NCT02081300|Androgens|androgens|mesh-ancestor
13893093|NCT02081300|Hormones|hormones|mesh-ancestor
13893094|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893095|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893096|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13893097|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893098|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
13893099|NCT02081118|Exenatide|exenatide|mesh-list
13893100|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13893101|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893102|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13893103|NCT02081118|Incretins|incretins|mesh-ancestor
13893104|NCT02081118|Hormones|hormones|mesh-ancestor
13893105|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893106|NCT02077881|Gemcitabine|gemcitabine|mesh-list
13893107|NCT02077881|Paclitaxel|paclitaxel|mesh-list
13893108|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13893109|NCT02077881|Tryptophan|tryptophan|mesh-list
13893110|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13893111|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893112|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
13893113|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893114|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893115|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893116|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893117|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
13893118|NCT02077881|Antiviral Agents|antiviral agents|mesh-ancestor
13893119|NCT02077881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893120|NCT02077881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893121|NCT02077881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893122|NCT02077881|Immunologic Factors|immunologic factors|mesh-ancestor
13893123|NCT02077881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893124|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13893125|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
13893126|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13893127|NCT02074007|Benzocaine|benzocaine|mesh-list
13893128|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893129|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
13893130|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
13893131|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893132|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
13893133|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893134|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
13893135|NCT02073123|Nivolumab|nivolumab|mesh-list
13893136|NCT02073123|Ipilimumab|ipilimumab|mesh-list
13893137|NCT02073123|Tryptophan|tryptophan|mesh-list
13893138|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13893139|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893140|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13893141|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893142|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13893143|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
13893144|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13893145|NCT02072954|Asenapine|asenapine|mesh-list
13893146|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13893147|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13893148|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893149|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893150|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13893151|NCT02072863|Prednisone|prednisone|mesh-list
13893152|NCT02072863|Melphalan|melphalan|mesh-list
13893153|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893154|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
13893155|NCT02072863|Hormones|hormones|mesh-ancestor
13893156|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893157|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893158|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13893159|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893160|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13893161|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
13893162|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893163|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13893164|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893165|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
13893166|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13893167|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13893168|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
13893169|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893170|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13893171|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893172|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13893173|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893174|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
13893175|NCT02064426|Hematinics|hematinics|mesh-ancestor
13893176|NCT02063997|Colchicine|colchicine|mesh-list
13893177|NCT02063997|Allopurinol|allopurinol|mesh-list
13893178|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
13893179|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893180|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
13893181|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893182|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893183|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893184|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893185|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
13893186|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893187|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13893188|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
13893189|NCT02063997|Protective Agents|protective agents|mesh-ancestor
13893190|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893191|NCT02063295|CKD732|ckd732|mesh-list
13893192|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893193|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893194|NCT02063295|Growth Substances|growth substances|mesh-ancestor
13893195|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893196|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893197|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755098|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755099|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
14755100|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755101|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
14755102|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13893203|NCT02058420|Tocotrienols|tocotrienols|mesh-list
13893204|NCT02058420|Vitamin E|vitamin e|mesh-list
13893205|NCT02058420|Tocopherols|tocopherols|mesh-list
13893206|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
13893207|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893208|NCT02058420|Protective Agents|protective agents|mesh-ancestor
13893209|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893210|NCT02058420|Vitamins|vitamins|mesh-ancestor
13893211|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
13893212|NCT02057380|Dexamethasone|dexamethasone|mesh-list
13893213|NCT02057380|Paclitaxel|paclitaxel|mesh-list
13893214|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13893215|NCT02057380|Bortezomib|bortezomib|mesh-list
13893216|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13893217|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893218|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
14932208|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14932209|NCT01443572|Sevoflurane|sevoflurane|mesh-list
14932210|NCT01443572|Desflurane|desflurane|mesh-list
13893219|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893220|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893221|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893222|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893223|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
13893224|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
13893225|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893226|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893227|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13893228|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
13893229|NCT02057380|Hormones|hormones|mesh-ancestor
13893230|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893231|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13893232|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893233|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893234|NCT02057315|Ketoprofen|ketoprofen|mesh-list
13893235|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13893236|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13893237|NCT02057315|Analgesics|analgesics|mesh-ancestor
13893238|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
13893239|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893240|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893241|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893242|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893243|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13893244|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893245|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893246|NCT02057172|Liraglutide|liraglutide|mesh-list
13893247|NCT02057172|Exenatide|exenatide|mesh-list
13893248|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13893249|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893250|NCT02057172|Incretins|incretins|mesh-ancestor
13893251|NCT02057172|Hormones|hormones|mesh-ancestor
13893252|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893253|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13893254|NCT02052778|Futibatinib|futibatinib|mesh-list
13893255|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893256|NCT02052739|Brexanolone|brexanolone|mesh-list
13893257|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
13893258|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893259|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893260|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893261|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
13893262|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
13893263|NCT02052648|Bevacizumab|bevacizumab|mesh-list
13893264|NCT02052648|Temozolomide|temozolomide|mesh-list
13893265|NCT02052648|Tryptophan|tryptophan|mesh-list
13893266|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13893267|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893268|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893269|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893270|NCT02052648|Growth Substances|growth substances|mesh-ancestor
13893271|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893272|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893273|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13893274|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
13893275|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893276|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13893277|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
13893278|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13893279|NCT02050828|Ranibizumab|ranibizumab|mesh-list
13893280|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893281|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893282|NCT02050828|Growth Substances|growth substances|mesh-ancestor
13893283|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893284|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893285|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893286|NCT02047214|Bevacizumab|bevacizumab|mesh-list
13893287|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13893288|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893289|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893290|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893291|NCT02047214|Growth Substances|growth substances|mesh-ancestor
13893292|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893293|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893294|NCT02046395|Amlodipine|amlodipine|mesh-list
13893295|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13893296|NCT02046395|Hydralazine|hydralazine|mesh-list
13893297|NCT02046395|Terazosin|terazosin|mesh-list
13893298|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13893299|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13893300|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13893301|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893302|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13893303|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893304|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
13893305|NCT02046395|Diuretics|diuretics|mesh-ancestor
13893306|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
13893307|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13893308|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13893309|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13893310|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13893311|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
13893312|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893313|NCT02046395|Urological Agents|urological agents|mesh-ancestor
13893314|NCT02044341|Benzocaine|benzocaine|mesh-list
13893315|NCT02044341|Glycerol|glycerol|mesh-list
13893316|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13893317|NCT02044341|Protective Agents|protective agents|mesh-ancestor
13893318|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893319|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
13893320|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
13893321|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893322|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
13893323|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958950|NCT03166228|Glycine|glycine|mesh-list
13958951|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
13958952|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13958953|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958954|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958955|NCT03166605|Simethicone|simethicone|mesh-list
13958956|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
13958957|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958958|NCT03166605|Emollients|emollients|mesh-ancestor
13958959|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
13958960|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
13958961|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958962|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
13958963|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
13958964|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13958965|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
13958966|NCT03166397|Fludarabine|fludarabine|mesh-list
13958967|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13958968|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
13958969|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958970|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13958971|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13958972|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
13958973|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958974|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13958975|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13958976|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
13958977|NCT03166527|Antibodies|antibodies|mesh-list
13958978|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
13958979|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13958980|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13958981|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
13958982|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958983|NCT03166111|Lidocaine|lidocaine|mesh-list
13958984|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
13958985|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
13958986|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13958987|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13958988|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
13958989|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13958990|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13958991|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13958992|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13958993|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13958994|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13958995|NCT03165890|Acetazolamide|acetazolamide|mesh-list
13958996|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
13893324|NCT02042378|Rucaparib|rucaparib|mesh-list
13893325|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13893326|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893327|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893328|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893329|NCT02032277|Paclitaxel|paclitaxel|mesh-list
13893330|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
13893331|NCT02032277|Carboplatin|carboplatin|mesh-list
13893332|NCT02032277|Doxorubicin|doxorubicin|mesh-list
13893333|NCT02032277|Veliparib|veliparib|mesh-list
13893334|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13893335|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893336|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
13893337|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893338|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893339|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893340|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893341|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
13893342|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893343|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893344|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13893345|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
14932211|NCT01443572|Anesthetics|anesthetics|mesh-list
13893346|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13893347|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13893348|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13893349|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13893350|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893351|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13893352|NCT02030860|Gemcitabine|gemcitabine|mesh-list
13893353|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13893354|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893355|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
13893356|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893357|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893358|NCT02030860|Antiviral Agents|antiviral agents|mesh-ancestor
13893359|NCT02030860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893360|NCT02030860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893361|NCT02030860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893362|NCT02030860|Immunologic Factors|immunologic factors|mesh-ancestor
13893363|NCT02030860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028134|NCT02732249|Antacids|antacids|mesh-ancestor
14028135|NCT02732249|Diuretics|diuretics|mesh-ancestor
14028136|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
14028137|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028138|NCT02732249|Expectorants|expectorants|mesh-ancestor
14028139|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
14028140|NCT02732314|Desonide|desonide|mesh-list
14028141|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028142|NCT02732093|Lidocaine|lidocaine|mesh-list
14028143|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
14028144|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
14028145|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028146|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028147|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
14028148|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028149|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14028150|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14028151|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14028152|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14028153|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028154|NCT02732236|Rituximab|rituximab|mesh-list
14028155|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14028156|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028157|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
14028158|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028159|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028160|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
14028161|NCT02731950|Bupivacaine|bupivacaine|mesh-list
14028162|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
14028163|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
14028164|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028165|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893364|NCT02028338|Dapivirine|dapivirine|mesh-list
14028166|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
14932212|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13893365|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13893366|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13893367|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
13893368|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893369|NCT02026349|Favipiravir|favipiravir|mesh-list
13893370|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
13893371|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893372|NCT02019589|Progesterone|progesterone|mesh-list
13893373|NCT02019589|Progestins|progestins|mesh-ancestor
13893374|NCT02019589|Hormones|hormones|mesh-ancestor
14755103|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755104|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14755105|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755106|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14755107|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
13893375|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893376|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893377|NCT02018926|Azacitidine|azacitidine|mesh-list
13893378|NCT02018926|Mocetinostat|mocetinostat|mesh-list
13893379|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893380|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
13893381|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893382|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893383|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893384|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13893385|NCT02017717|Bevacizumab|bevacizumab|mesh-list
13893386|NCT02017717|Nivolumab|nivolumab|mesh-list
13893387|NCT02017717|Ipilimumab|ipilimumab|mesh-list
13893388|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13893389|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893390|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893391|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893392|NCT02017717|Growth Substances|growth substances|mesh-ancestor
13893393|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893394|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893395|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13893396|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893397|NCT02014649|Laninamivir|laninamivir|mesh-list
14755108|NCT04340882|Docetaxel|docetaxel|mesh-list
14755109|NCT04340882|Ramucirumab|ramucirumab|mesh-list
14755110|NCT04340882|Antibodies|antibodies|mesh-list
14755111|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
14755112|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14755113|NCT04340882|Lexatumumab|lexatumumab|mesh-list
14755114|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
14755115|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755116|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755117|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
14755118|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
14755119|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755120|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755121|NCT04338984|Fentanyl|fentanyl|mesh-list
14755122|NCT04338984|Anesthetics|anesthetics|mesh-list
13893398|NCT02014649|Zanamivir|zanamivir|mesh-list
13893399|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
13893400|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893401|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755123|NCT04338984|Ropivacaine|ropivacaine|mesh-list
13893402|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893403|NCT02014142|Latanoprost|latanoprost|mesh-list
13893404|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13893405|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13893406|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
13893407|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
13893408|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
13893409|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893410|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893411|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
13893412|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893413|NCT02009579|Nintedanib|nintedanib|mesh-list
13893414|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893415|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893416|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893417|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893418|NCT02008344|Favipiravir|favipiravir|mesh-list
13893419|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
13893420|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893421|NCT01999764|Retinol acetate|retinol acetate|mesh-list
13893422|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13893423|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
13893424|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893425|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13893426|NCT01999764|Protective Agents|protective agents|mesh-ancestor
13893427|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893428|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
13893429|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13893430|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893431|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13893432|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
13893433|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13893434|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893435|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893436|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893437|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
13893438|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893439|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893440|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893441|NCT01998035|Azacitidine|azacitidine|mesh-list
13893442|NCT01998035|Romidepsin|romidepsin|mesh-list
13893443|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893444|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
13893445|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893446|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893447|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893448|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13893449|NCT01994382|Rituximab|rituximab|mesh-list
13893450|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13893451|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893452|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
13893453|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893454|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893455|NCT01993641|Azacitidine|azacitidine|mesh-list
13893456|NCT01993641|Decitabine|decitabine|mesh-list
13893457|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893458|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
13893459|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893460|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893461|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893462|NCT01989429|Vitamin D|vitamin d|mesh-list
13893463|NCT01989429|Vitamins|vitamins|mesh-ancestor
13893464|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
13893465|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893466|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13893467|NCT01989325|Dexamethasone|dexamethasone|mesh-list
13893468|NCT01989325|Filanesib|filanesib|mesh-list
13893469|NCT01989325|Lenograstim|lenograstim|mesh-list
13893470|NCT01989325|Sargramostim|sargramostim|mesh-list
13893471|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
13893472|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893473|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
13893474|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
13893475|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893476|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893477|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13893478|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
13893479|NCT01989325|Hormones|hormones|mesh-ancestor
13893480|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893481|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13893482|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893483|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13893484|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
13893485|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
13893486|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893487|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893488|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893489|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893490|NCT01983306|Dolcanatide|dolcanatide|mesh-list
13893491|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
13893492|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
13893493|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893494|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13893495|NCT01978366|Halofuginone|halofuginone|mesh-list
13893496|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893497|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
13893498|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13893499|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13893500|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893501|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13893502|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893503|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893504|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893505|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893506|NCT01978366|Growth Substances|growth substances|mesh-ancestor
13893507|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893508|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893509|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
13893510|NCT01975818|Hematinics|hematinics|mesh-ancestor
13893511|NCT01975610|Spebrutinib|spebrutinib|mesh-list
13893512|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893513|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893514|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893515|NCT01973049|Ribavirin|ribavirin|mesh-list
13893516|NCT01973049|Asunaprevir|asunaprevir|mesh-list
13893517|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
13893518|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893519|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
13893520|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893521|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
13893522|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893523|NCT01972854|Riboflavin|riboflavin|mesh-list
13893524|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13893525|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
13893526|NCT01972854|Vitamins|vitamins|mesh-ancestor
13893527|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
13893528|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893529|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13893530|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
13893531|NCT01970501|Metoprolol|metoprolol|mesh-list
13893532|NCT01970501|Bucindolol|bucindolol|mesh-list
13893533|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13893534|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13893535|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
13893536|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
13893537|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893538|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893539|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13893540|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13893541|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13893542|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
13893543|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893544|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893545|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
13893546|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
13893547|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13893548|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13893549|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
13893550|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893551|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893552|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893553|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
13893554|NCT01968733|Solithromycin|solithromycin|mesh-list
13893555|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13893556|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893557|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13893558|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13893559|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893560|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893561|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893562|NCT01967810|Bevacizumab|bevacizumab|mesh-list
13893563|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13893564|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893565|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893566|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893567|NCT01967810|Growth Substances|growth substances|mesh-ancestor
13893568|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893569|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893570|NCT01964989|Vaccines|vaccines|mesh-list
13893571|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
13893572|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893573|NCT01963208|Ganaxolone|ganaxolone|mesh-list
13893574|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
13893575|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893576|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893577|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893578|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
13893579|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
13893580|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13893581|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13893582|NCT01959282|Niacinamide|niacinamide|mesh-list
13893583|NCT01959282|Peficitinib|peficitinib|mesh-list
13893584|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893585|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893586|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893587|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
13893588|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893589|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
13893590|NCT01959282|Vitamins|vitamins|mesh-ancestor
13893591|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
13893592|NCT01956812|Gemcitabine|gemcitabine|mesh-list
13893593|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893594|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
13893595|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893596|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893597|NCT01956812|Antiviral Agents|antiviral agents|mesh-ancestor
13893598|NCT01956812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893599|NCT01956812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893600|NCT01956812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893601|NCT01956812|Immunologic Factors|immunologic factors|mesh-ancestor
13893602|NCT01956812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893603|NCT01952990|Phenylephrine|phenylephrine|mesh-list
13893604|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
13893605|NCT01952990|Tetracaine|tetracaine|mesh-list
13893606|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
13893607|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
13893608|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893609|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893610|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
13893611|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893612|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13893613|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13893614|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
13893615|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893616|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893617|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
13893618|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
13893619|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
13893620|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13893621|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
13893622|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13893623|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
13893624|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13893625|NCT01952990|Protective Agents|protective agents|mesh-ancestor
13893626|NCT01951274|Serlopitant|serlopitant|mesh-list
13893627|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13893628|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893629|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893630|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893631|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13893632|NCT01941836|Ezetimibe|ezetimibe|mesh-list
13893633|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13893634|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13893635|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
13893636|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893637|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13893638|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893639|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13893640|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893641|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
13893642|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13893643|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13893644|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13893645|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13893646|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893647|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
13893648|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893649|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893650|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13893651|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893652|NCT01930357|Vaccines|vaccines|mesh-list
13893653|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
13893654|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893655|NCT01927198|Verinurad|verinurad|mesh-list
13893656|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
13893657|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893658|NCT01922843|Calcitriol|calcitriol|mesh-list
13893659|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13893660|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893661|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13893662|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13893663|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893664|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13893665|NCT01922843|Vitamins|vitamins|mesh-ancestor
13893666|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
13893667|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13893668|NCT01918397|Levofloxacin|levofloxacin|mesh-list
13893669|NCT01918397|Ofloxacin|ofloxacin|mesh-list
13893670|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13893671|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893672|NCT01918397|Renal Agents|renal agents|mesh-ancestor
13893673|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755124|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
13893674|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13893675|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13893676|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893677|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893678|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893679|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13893680|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13958997|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13958998|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13958999|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959000|NCT03165890|Diuretics|diuretics|mesh-ancestor
13959001|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
13959002|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959003|NCT03165942|Ethanol|ethanol|mesh-list
13959004|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13959005|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959006|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959007|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959008|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
13959009|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13959010|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959011|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
13959012|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
13959013|NCT03165929|Analgesics|analgesics|mesh-ancestor
13959014|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
13959015|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959016|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959017|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13959018|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959019|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959020|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959021|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13959022|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959023|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959024|NCT03165825|Dexamethasone|dexamethasone|mesh-list
13959025|NCT03165825|Betamethasone|betamethasone|mesh-list
13959026|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959027|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
13959028|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
13959029|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959030|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959031|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959032|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
13959033|NCT03165825|Hormones|hormones|mesh-ancestor
13959034|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959035|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13959036|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959037|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13959038|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
13959039|NCT03165344|Prednisone|prednisone|mesh-list
13959040|NCT03165344|Triamcinolone|triamcinolone|mesh-list
13959041|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13959042|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13959043|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
13959044|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
13959045|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13959046|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13959047|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
13959048|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13959049|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959050|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
13959051|NCT03165344|Hormones|hormones|mesh-ancestor
13959052|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959053|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959054|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13959055|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959056|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13959057|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
13959058|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959059|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959060|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13959061|NCT03165344|Antacids|antacids|mesh-ancestor
13959062|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959063|NCT03165383|Morphine|morphine|mesh-list
13893681|NCT01917383|Timolol|timolol|mesh-list
13893682|NCT01917383|Latanoprost|latanoprost|mesh-list
13893683|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13893684|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13893685|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
13893686|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893687|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893688|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893689|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13893690|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13893691|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13893692|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13893693|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
13893694|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13893695|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893696|NCT01909427|Methotrexate|methotrexate|mesh-list
13893697|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13893698|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
13893699|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13893700|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893701|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893702|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
13893703|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893704|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893705|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
13893706|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893707|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13893708|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893709|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
13893710|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893711|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13893712|NCT01908738|Lidocaine|lidocaine|mesh-list
13893713|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
13893714|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
13893715|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893716|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893717|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
13893718|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893719|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13893720|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13893721|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13893722|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13893723|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893724|NCT01904409|Rifaximin|rifaximin|mesh-list
13893725|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13893726|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893727|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13893728|NCT01903954|Ribavirin|ribavirin|mesh-list
13893729|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13893730|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
13893731|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893732|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
13893733|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893734|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
14028167|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028168|NCT02731950|Analgesics|analgesics|mesh-ancestor
14028169|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14028170|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
14028171|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14028172|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14028173|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028174|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14028175|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
14028176|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13893735|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
13893736|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893737|NCT01902381|Protective Agents|protective agents|mesh-ancestor
13893738|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893739|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
13893740|NCT01902381|Vitamins|vitamins|mesh-ancestor
13893741|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
13893742|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13893743|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893744|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893745|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893746|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893747|NCT01896531|Leucovorin|leucovorin|mesh-list
13893748|NCT01896531|Fluorouracil|fluorouracil|mesh-list
13893749|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
13893750|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
13893751|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893752|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893753|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893754|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893755|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
13893756|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893757|NCT01896531|Antidotes|antidotes|mesh-ancestor
13893758|NCT01896531|Protective Agents|protective agents|mesh-ancestor
13893759|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
13893760|NCT01896531|Vitamins|vitamins|mesh-ancestor
13893761|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
13893762|NCT01893190|Nimodipine|nimodipine|mesh-list
13893763|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13893764|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13893765|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13893766|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893767|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13893768|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893769|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
13893770|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13893771|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893772|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893773|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893774|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893775|NCT01877395|Vaccines|vaccines|mesh-list
13893776|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
13893777|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893778|NCT01874626|Ibuprofen|ibuprofen|mesh-list
13893779|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13893780|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13893781|NCT01874626|Analgesics|analgesics|mesh-ancestor
13893782|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
13893783|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893784|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893785|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893786|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893787|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13893788|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893789|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932213|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14932214|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
13893790|NCT01873703|Azacitidine|azacitidine|mesh-list
13893791|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893792|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
14932215|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932216|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932217|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14932218|NCT01443624|Hematinics|hematinics|mesh-ancestor
14932219|NCT01443676|Bevacizumab|bevacizumab|mesh-list
13893793|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893794|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893795|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893796|NCT01871415|Metformin|metformin|mesh-list
13893797|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13893798|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893799|NCT01870505|Letrozole|letrozole|mesh-list
13893800|NCT01870505|Exemestane|exemestane|mesh-list
14028177|NCT02731911|Dexamethasone|dexamethasone|mesh-list
13893801|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893802|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13893803|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13893804|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893805|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893806|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13893807|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
13893808|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893809|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893810|NCT01866930|Interferons|interferons|mesh-list
13893811|NCT01866930|Ribavirin|ribavirin|mesh-list
13893812|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893813|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
13893814|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893815|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
13893816|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893819|NCT01862224|Methotrexate|methotrexate|mesh-list
13893820|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13893821|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
13893822|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13893823|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893824|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893825|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
13893826|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893827|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893828|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
13893829|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893830|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13893831|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893832|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
13893833|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13893834|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13893835|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
13893836|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13893837|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
13893838|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893839|NCT01859962|Ribavirin|ribavirin|mesh-list
13893840|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
13893841|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893842|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
13893843|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893844|NCT01858883|Gemcitabine|gemcitabine|mesh-list
13893845|NCT01858883|Paclitaxel|paclitaxel|mesh-list
13893846|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13893847|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893848|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
13893849|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893850|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893851|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893852|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893853|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
13893854|NCT01858883|Antiviral Agents|antiviral agents|mesh-ancestor
13893855|NCT01858883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893856|NCT01858883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893857|NCT01858883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893858|NCT01858883|Immunologic Factors|immunologic factors|mesh-ancestor
13893859|NCT01858883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893860|NCT01847573|Halofuginone|halofuginone|mesh-list
13893861|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893862|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
13893863|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13893864|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13893865|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893866|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13893867|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893868|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893869|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893870|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893871|NCT01847573|Growth Substances|growth substances|mesh-ancestor
14028178|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13893872|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893873|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893874|NCT01846481|Cocaine|cocaine|mesh-list
14028179|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
13893875|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
13893876|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
13893877|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13893878|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893879|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
13893880|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893881|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13893882|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13893883|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13893884|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13893885|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893886|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
13893887|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893888|NCT01845649|Estradiol|estradiol|mesh-list
13893889|NCT01845649|Estrogens|estrogens|mesh-ancestor
13893890|NCT01845649|Hormones|hormones|mesh-ancestor
13893891|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893892|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893893|NCT01836432|Leucovorin|leucovorin|mesh-list
13893894|NCT01836432|Gemcitabine|gemcitabine|mesh-list
13893895|NCT01836432|Paclitaxel|paclitaxel|mesh-list
13893896|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13893897|NCT01836432|Fluorouracil|fluorouracil|mesh-list
13893898|NCT01836432|Capecitabine|capecitabine|mesh-list
13893899|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
13893900|NCT01836432|Irinotecan|irinotecan|mesh-list
13893901|NCT01836432|Folfirinox|folfirinox|mesh-list
13893902|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13893903|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893904|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
13893905|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
13893906|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
13893907|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893908|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13893909|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
13893910|NCT01836432|Antiviral Agents|antiviral agents|mesh-ancestor
13893911|NCT01836432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893912|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893913|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13893914|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
13893915|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893916|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13893917|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13893918|NCT01836432|Antidotes|antidotes|mesh-ancestor
13893919|NCT01836432|Protective Agents|protective agents|mesh-ancestor
13893920|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
13893921|NCT01836432|Vitamins|vitamins|mesh-ancestor
13893922|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
13893923|NCT01825980|Ritonavir|ritonavir|mesh-list
13893924|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13893925|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13893926|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
13893927|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893928|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893929|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13893930|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13893931|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
13893932|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893933|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13893934|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13893935|NCT01818921|CKD732|ckd732|mesh-list
13893936|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13893937|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13893938|NCT01818921|Growth Substances|growth substances|mesh-ancestor
13893939|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893940|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
13893941|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893942|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
13893943|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13893944|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13893945|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13893946|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13893947|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893948|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
13893949|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893950|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893951|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13893952|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893953|NCT01816139|Estradiol|estradiol|mesh-list
13893954|NCT01816139|Estrogens|estrogens|mesh-ancestor
13893955|NCT01816139|Hormones|hormones|mesh-ancestor
13893956|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893957|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893958|NCT01811576|Hormones|hormones|mesh-list
13893959|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13893960|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893961|NCT01810575|Alprostadil|alprostadil|mesh-list
13893962|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13893963|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
13893964|NCT01810575|Urological Agents|urological agents|mesh-ancestor
13893965|NCT01807546|ON 01910|on 01910|mesh-list
13893966|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893967|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13893968|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13893969|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893970|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
13893971|NCT01804829|Antibodies|antibodies|mesh-list
13893972|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
13893973|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13893974|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13893975|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
13893976|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
13893977|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893978|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13893979|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13893980|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
13893981|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13893982|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13893983|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13893984|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
13893985|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13893986|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13893987|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13893988|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
13893989|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13893990|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893991|NCT01795911|Interferons|interferons|mesh-list
13893992|NCT01795911|Ribavirin|ribavirin|mesh-list
13893993|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13893994|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
13893995|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13893996|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
13893997|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13893998|NCT01792050|Paclitaxel|paclitaxel|mesh-list
13893999|NCT01792050|Docetaxel|docetaxel|mesh-list
13894000|NCT01792050|Tryptophan|tryptophan|mesh-list
13894001|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13894002|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894003|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894004|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894005|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894006|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894007|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13894008|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
13894009|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13959064|NCT03165383|Bupivacaine|bupivacaine|mesh-list
13959065|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
13959066|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
13959067|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959068|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959069|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
13959070|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959071|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13959072|NCT03165383|Narcotics|narcotics|mesh-ancestor
13959073|NCT03165383|Analgesics|analgesics|mesh-ancestor
13959074|NCT03165591|Vaccines|vaccines|mesh-list
13959075|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
13959076|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959077|NCT03165500|Midazolam|midazolam|mesh-list
13959078|NCT03165500|Diazepam|diazepam|mesh-list
13959079|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
13959080|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13959081|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13894010|NCT01790100|Ribavirin|ribavirin|mesh-list
13894011|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
13894012|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894013|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
13894014|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894015|NCT01789736|Travoprost|travoprost|mesh-list
13894016|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13894017|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13894018|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13894019|NCT01785771|Exenatide|exenatide|mesh-list
13894020|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894021|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894022|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13894023|NCT01785771|Incretins|incretins|mesh-ancestor
13894024|NCT01785771|Hormones|hormones|mesh-ancestor
13894025|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894026|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
13894027|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13894028|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
13894029|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894030|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894031|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13894032|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
13894033|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
13894034|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13894035|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
13894036|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894037|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894038|NCT01784874|Vaccines|vaccines|mesh-list
13894039|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
13894040|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894041|NCT01782729|Tacrolimus|tacrolimus|mesh-list
13894042|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894043|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
13894044|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894045|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13894046|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894047|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894048|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
13894049|NCT01780844|Prednisone|prednisone|mesh-list
13894050|NCT01780844|Tacrolimus|tacrolimus|mesh-list
13894051|NCT01780844|Basiliximab|basiliximab|mesh-list
13894052|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894053|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
13894054|NCT01780844|Hormones|hormones|mesh-ancestor
13894055|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894056|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894057|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13894058|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894059|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894060|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
13894061|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13894062|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894063|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894064|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13894065|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13894066|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
13894067|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13894068|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894069|NCT01780428|Acetaminophen|acetaminophen|mesh-list
13894070|NCT01780428|Promethazine|promethazine|mesh-list
13894071|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
13894072|NCT01780428|Hydrocodone|hydrocodone|mesh-list
13894073|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13894074|NCT01780428|Analgesics|analgesics|mesh-ancestor
13894075|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
13894076|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894077|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894078|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
13894079|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13894080|NCT01780428|Narcotics|narcotics|mesh-ancestor
13894081|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13894082|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
13894083|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
14028180|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
13894084|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
13894085|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
13894086|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13894087|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
13894088|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
13894089|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894090|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894091|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13894092|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13894093|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13894094|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
13894095|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
13894096|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
13894097|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
13894098|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13894099|NCT01779947|Estradiol|estradiol|mesh-list
13894100|NCT01779947|Estrogens|estrogens|mesh-ancestor
13894101|NCT01779947|Hormones|hormones|mesh-ancestor
13894102|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894103|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894104|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13894105|NCT01779453|Atorvastatin|atorvastatin|mesh-list
13894106|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13894107|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13894108|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
13894109|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894110|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13894111|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13894112|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894113|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894114|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894115|NCT01777555|Levodopa|levodopa|mesh-list
13894116|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13894117|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13894118|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
13894119|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894120|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894121|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894122|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
13894123|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13894124|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13894125|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13894126|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13894127|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894128|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
13894129|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894130|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894131|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13894132|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894133|NCT01774578|Gemcitabine|gemcitabine|mesh-list
13894134|NCT01774578|Docetaxel|docetaxel|mesh-list
13894135|NCT01774578|Pemetrexed|pemetrexed|mesh-list
13894136|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13894137|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
13894138|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894139|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894140|NCT01774578|Antiviral Agents|antiviral agents|mesh-ancestor
13894141|NCT01774578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894142|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894143|NCT01774578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894144|NCT01774578|Immunologic Factors|immunologic factors|mesh-ancestor
13894145|NCT01774578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894146|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894147|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894148|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894149|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13894150|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13894151|NCT01773928|Vaccines|vaccines|mesh-list
13894152|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
13894153|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894154|NCT01773785|Docetaxel|docetaxel|mesh-list
13894155|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894156|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894157|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894158|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894159|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894160|NCT01768975|Dapansutrile|dapansutrile|mesh-list
13894161|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894188|NCT01758458|Interferons|interferons|mesh-list
13894189|NCT01758458|Aldesleukin|aldesleukin|mesh-list
13894190|NCT01758458|Interferon-beta|interferon-beta|mesh-list
13894191|NCT01758458|Interleukin-2|interleukin-2|mesh-list
13894192|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894193|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
13894194|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894195|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13894196|NCT01758458|Analgesics|analgesics|mesh-ancestor
13894197|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
13894198|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894199|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894200|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13894201|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13894202|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
13894203|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13894204|NCT01756924|Vancomycin|vancomycin|mesh-list
13894205|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
13894206|NCT01756924|Levofloxacin|levofloxacin|mesh-list
13894207|NCT01756924|Rifampin|rifampin|mesh-list
13894208|NCT01756924|Cefazolin|cefazolin|mesh-list
13894209|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
13894210|NCT01756924|Linezolid|linezolid|mesh-list
13894211|NCT01756924|Daptomycin|daptomycin|mesh-list
13894212|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13894213|NCT01756924|Oxacillin|oxacillin|mesh-list
13894214|NCT01756924|Nafcillin|nafcillin|mesh-list
13894215|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
13894216|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894217|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13894218|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
13894219|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13894220|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13894221|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894222|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894223|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894224|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13894225|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13894226|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13894227|NCT01756924|Renal Agents|renal agents|mesh-ancestor
13894228|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
13894229|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13894230|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14028181|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028182|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028183|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13894231|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14028184|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
13894232|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14028185|NCT02731911|Hormones|hormones|mesh-ancestor
13894233|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13894234|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13894235|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13894236|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13894237|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
13894238|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13894239|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13894240|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
13894241|NCT01756339|Solithromycin|solithromycin|mesh-list
13894242|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13894243|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894244|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13894245|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13894246|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894247|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894248|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894249|NCT01741155|Docetaxel|docetaxel|mesh-list
13894250|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894251|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894252|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894253|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894254|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894255|NCT01737905|Epinephrine|epinephrine|mesh-list
13894256|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13894257|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13894258|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
13894259|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894260|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894261|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894262|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13894263|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13894264|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
13894265|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894266|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13894267|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
13894268|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
13894269|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
13894270|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13894271|NCT01737892|Epinephrine|epinephrine|mesh-list
14028186|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028187|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028188|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028189|NCT02731664|Glucagon|glucagon|mesh-list
14028190|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14028191|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028192|NCT02731664|Hormones|hormones|mesh-ancestor
14028193|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028194|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028195|NCT02731664|Incretins|incretins|mesh-ancestor
14028196|NCT02731846|Fluticasone|fluticasone|mesh-list
14028197|NCT02731846|Xhance|xhance|mesh-list
14028198|NCT02731846|Albuterol|albuterol|mesh-list
14028199|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028200|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14028201|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
14028202|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028203|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028204|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14028205|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
14028206|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028207|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14028208|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
14028209|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14028210|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14028211|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14028212|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14028213|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028214|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028215|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028216|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
13894272|NCT01737892|Racepinephrine|racepinephrine|mesh-list
13894273|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
13894274|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13894275|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13894276|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
13894277|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894278|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894279|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894280|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13894281|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13894282|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
13894283|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894284|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13894285|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
13894286|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
13894287|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
13894288|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13894289|NCT01730027|Montelukast|montelukast|mesh-list
13894290|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13894291|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
13894292|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13894293|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
13894294|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894295|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894296|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13894297|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13894298|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894299|NCT01729403|Metformin|metformin|mesh-list
13894300|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894301|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894302|NCT01728753|Favipiravir|favipiravir|mesh-list
13894303|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
13894304|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894305|NCT01728064|Ubiquinone|ubiquinone|mesh-list
13894306|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
13894307|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894308|NCT01726946|Ribavirin|ribavirin|mesh-list
13894309|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
13894310|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894311|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
13894312|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894313|NCT01725152|Ganaxolone|ganaxolone|mesh-list
13894314|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
13894315|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894316|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894317|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894318|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
13894319|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
13894320|NCT01721733|Ubiquinone|ubiquinone|mesh-list
13894321|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
13894322|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894323|NCT01718158|Ribavirin|ribavirin|mesh-list
13894324|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13894325|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
13894326|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894327|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
13894328|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894329|NCT01718145|Ribavirin|ribavirin|mesh-list
13894330|NCT01718145|Asunaprevir|asunaprevir|mesh-list
13894331|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
13894332|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894333|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
13894334|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894335|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
13894336|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894337|NCT01714739|Nivolumab|nivolumab|mesh-list
13894338|NCT01714739|Ipilimumab|ipilimumab|mesh-list
13894339|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
13894340|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13894341|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894342|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14028217|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13894343|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894344|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
13894345|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894346|NCT01712451|Fluticasone|fluticasone|mesh-list
13894347|NCT01712451|Xhance|xhance|mesh-list
13894348|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13894349|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894350|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13894351|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
13894352|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894353|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894354|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13894355|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
13894356|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
13894357|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13894358|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13894359|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13894360|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13894361|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
13894362|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894363|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894364|NCT01712217|Crizotinib|crizotinib|mesh-list
13894365|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894366|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13894367|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894368|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894369|NCT01709214|Oxycodone|oxycodone|mesh-list
13894370|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13894371|NCT01709214|Narcotics|narcotics|mesh-ancestor
13894372|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13894373|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894374|NCT01709214|Analgesics|analgesics|mesh-ancestor
13894375|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
13894376|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894377|NCT01704365|Vaccines|vaccines|mesh-list
13894378|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
13894379|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894380|NCT01699737|Glimepiride|glimepiride|mesh-list
13894381|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13894382|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894383|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894384|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894385|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
13894386|NCT01699464|Timolol|timolol|mesh-list
13894387|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13894388|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13894389|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13894390|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13894391|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
13894392|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894393|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894394|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894395|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13894396|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13894397|NCT01698281|Dexamethasone|dexamethasone|mesh-list
13894398|NCT01698281|Doxorubicin|doxorubicin|mesh-list
13894399|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894400|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
13894401|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
13894402|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894403|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894404|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13894405|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
13894406|NCT01698281|Hormones|hormones|mesh-ancestor
13894407|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894408|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13894409|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894410|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13894411|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13894412|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13894413|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894414|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894415|NCT01697072|Cisplatin|cisplatin|mesh-list
13894416|NCT01697072|Capecitabine|capecitabine|mesh-list
13894417|NCT01697072|Epirubicin|epirubicin|mesh-list
13894418|NCT01697072|Rilotumumab|rilotumumab|mesh-list
13894419|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894420|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13894421|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
13894422|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894423|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13894424|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13894425|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13894426|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894427|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13894428|NCT01696435|Vitamin D|vitamin d|mesh-list
13894429|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
13894430|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
13894431|NCT01696435|Vitamins|vitamins|mesh-list
13894432|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
13894433|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894434|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13894435|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13894436|NCT01694277|Sunitinib|sunitinib|mesh-list
13894437|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894438|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13894439|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13894440|NCT01694277|Growth Substances|growth substances|mesh-ancestor
13894441|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894442|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
13894443|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13894444|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894445|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894446|NCT01691846|Metformin|metformin|mesh-list
13894447|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894448|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894449|NCT01689246|Methylene Blue|methylene blue|mesh-list
13894450|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894451|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894452|NCT01687985|Laxatives|laxatives|mesh-list
13894453|NCT01687985|Cathartics|cathartics|mesh-list
13894454|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13894455|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
13894456|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894457|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894458|NCT01685268|Prednisone|prednisone|mesh-list
13894459|NCT01685268|Prednisolone|prednisolone|mesh-list
13894460|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
13894461|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894462|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
13894463|NCT01685268|Hormones|hormones|mesh-ancestor
13894464|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894465|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894466|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13894467|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894468|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13894469|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894470|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894471|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
13894472|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13894473|NCT01685255|Tamoxifen|tamoxifen|mesh-list
13894474|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13894475|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
13894476|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894477|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894478|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13894479|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894480|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13894481|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13894482|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13894483|NCT01683084|Telmisartan|telmisartan|mesh-list
13894484|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13894485|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13894486|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13894487|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894488|NCT01679951|Methotrexate|methotrexate|mesh-list
13894489|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13894490|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
13894491|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13894492|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894493|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13894494|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
13894495|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894496|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894497|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
13894498|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894499|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13894500|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894501|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
13894502|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13894503|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13894504|NCT01677754|Memantine|memantine|mesh-list
13894505|NCT01677754|Rivastigmine|rivastigmine|mesh-list
13894506|NCT01677754|Donepezil|donepezil|mesh-list
13894507|NCT01677754|Galantamine|galantamine|mesh-list
13894508|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13894509|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894510|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894511|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
13894512|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894513|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894514|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
13894515|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13894516|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13894517|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
13894518|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13894519|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13894520|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13894521|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
13894522|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894523|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13894524|NCT01677754|Protective Agents|protective agents|mesh-ancestor
13894525|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
13894526|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13894527|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894528|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13894529|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13894530|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13894531|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13894532|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13894533|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
13894534|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894535|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894536|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894537|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
13894538|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894539|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
13894540|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13894541|NCT01669980|Vancomycin|vancomycin|mesh-list
13894542|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
13894543|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
13894544|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13894545|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894546|NCT01666977|Carboplatin|carboplatin|mesh-list
13894547|NCT01666977|Pemetrexed|pemetrexed|mesh-list
13894548|NCT01666977|Trebananib|trebananib|mesh-list
13894549|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894550|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894551|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894552|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13894553|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13894554|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13894555|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13894556|NCT01666977|Growth Substances|growth substances|mesh-ancestor
13894557|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894558|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
13959082|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959083|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959084|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14755125|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14755126|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755127|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
13959085|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13959086|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14755128|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
14755129|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755130|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14755131|NCT04338984|Narcotics|narcotics|mesh-ancestor
14755132|NCT04338984|Analgesics|analgesics|mesh-ancestor
14755133|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14755134|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14932220|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932221|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894559|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13894560|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
13894561|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894562|NCT01661634|Ularitide|ularitide|mesh-list
13894563|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13894564|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
13894565|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894566|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894567|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13894568|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
13894569|NCT01661634|Diuretics|diuretics|mesh-ancestor
13894570|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
13894571|NCT01661166|Fesoterodine|fesoterodine|mesh-list
13894572|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13894573|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13894574|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
13894575|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932222|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14932223|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14932224|NCT01443676|Growth Substances|growth substances|mesh-ancestor
14932225|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932226|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
13894576|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894577|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894578|NCT01661166|Urological Agents|urological agents|mesh-ancestor
13894579|NCT01660633|Melphalan|melphalan|mesh-list
13894580|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13894581|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
13894582|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894583|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894584|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13894585|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894586|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
13894587|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894588|NCT01658826|Valacyclovir|valacyclovir|mesh-list
13894589|NCT01658826|Pritelivir|pritelivir|mesh-list
13894590|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
13894591|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894592|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894593|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894594|NCT01658501|Metformin|metformin|mesh-list
13894595|NCT01658501|Liraglutide|liraglutide|mesh-list
13894596|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894597|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894598|NCT01658501|Incretins|incretins|mesh-ancestor
13894599|NCT01658501|Hormones|hormones|mesh-ancestor
13894600|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894601|NCT01652482|Leucovorin|leucovorin|mesh-list
13894602|NCT01652482|Fluorouracil|fluorouracil|mesh-list
13894603|NCT01652482|Irinotecan|irinotecan|mesh-list
13894604|NCT01652482|Cetuximab|cetuximab|mesh-list
13894605|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
13894606|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894607|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13894608|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894609|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894610|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
13894611|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894612|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13894613|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13894614|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894615|NCT01652482|Antidotes|antidotes|mesh-ancestor
14932227|NCT01443741|Insulin|insulin|mesh-list
14932228|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13894616|NCT01652482|Protective Agents|protective agents|mesh-ancestor
13894617|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
13894618|NCT01652482|Vitamins|vitamins|mesh-ancestor
13894619|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
13894620|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13894621|NCT01651871|Cetirizine|cetirizine|mesh-list
13894622|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13894623|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13894624|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13894625|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
13894626|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
13894627|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894628|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894629|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894630|NCT01649999|Peficitinib|peficitinib|mesh-list
13894631|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894632|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894633|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894634|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
13894635|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894636|NCT01643226|Riboflavin|riboflavin|mesh-list
13894637|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13894638|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
13894639|NCT01643226|Vitamins|vitamins|mesh-ancestor
13894640|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
13894641|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894642|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13894643|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
13894644|NCT01640080|Esketamine|esketamine|mesh-list
13894645|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
13894646|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13894647|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13894648|NCT01638533|Romidepsin|romidepsin|mesh-list
13894649|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894650|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13894651|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894652|NCT01632228|Bevacizumab|bevacizumab|mesh-list
13894653|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13894654|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894655|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13894656|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13894657|NCT01632228|Growth Substances|growth substances|mesh-ancestor
13894658|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894659|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
13894660|NCT01632137|Rebamipide|rebamipide|mesh-list
13894661|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13894662|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13894663|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
13894664|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894665|NCT01632137|Protective Agents|protective agents|mesh-ancestor
13894666|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894667|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894668|NCT01628094|Ritonavir|ritonavir|mesh-list
13894669|NCT01628094|Ribavirin|ribavirin|mesh-list
13894670|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13894671|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13894672|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
13894673|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894674|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894675|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13894676|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13894677|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
13894678|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894679|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13894680|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13894681|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
13894682|NCT01625234|Ensartinib|ensartinib|mesh-list
14932229|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14932230|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932231|NCT01443780|Selenium|selenium|mesh-list
13894683|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894684|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13894685|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894686|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894687|NCT01621243|Gemcitabine|gemcitabine|mesh-list
13894688|NCT01621243|Paclitaxel|paclitaxel|mesh-list
14028218|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13894689|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13894690|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13894691|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894692|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894693|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894694|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894695|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894696|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14028219|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028220|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028221|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14028222|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14028223|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14028224|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14028225|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028226|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028227|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028228|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14028229|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14028230|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
14028231|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14028232|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14028233|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
14028234|NCT02731560|Rituximab|rituximab|mesh-list
14028235|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14028236|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028237|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
14028238|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028239|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028240|NCT02731378|Iron|iron|mesh-list
14028241|NCT02731378|Dextrans|dextrans|mesh-list
14028242|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
14028243|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
14028244|NCT02731378|Trace Elements|trace elements|mesh-ancestor
14028245|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
14028246|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028247|NCT02731378|Hematinics|hematinics|mesh-ancestor
14028248|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
14028249|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
14028250|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
14028251|NCT02731430|Morphine|morphine|mesh-list
14028252|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14028253|NCT02731430|Narcotics|narcotics|mesh-ancestor
14028254|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028255|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028256|NCT02731430|Analgesics|analgesics|mesh-ancestor
14028257|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
14028258|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028259|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14028260|NCT02731534|Hematinics|hematinics|mesh-ancestor
14028261|NCT02731287|Timolol|timolol|mesh-list
14028262|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14028263|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14028264|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028265|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028266|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028267|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028268|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14028269|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14028270|NCT02731092|Lactoferrin|lactoferrin|mesh-list
14028271|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028272|NCT02731105|Clindamycin|clindamycin|mesh-list
14028273|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
14028274|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
14028275|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14028276|NCT02731105|Tretinoin|tretinoin|mesh-list
14028277|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14028278|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028279|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14028280|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028281|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028282|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028283|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
13894697|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
14028284|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028285|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13894698|NCT01621243|Antiviral Agents|antiviral agents|mesh-ancestor
13894699|NCT01621243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894700|NCT01621243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894701|NCT01621243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894702|NCT01621243|Immunologic Factors|immunologic factors|mesh-ancestor
13894703|NCT01621243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894704|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13894705|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894706|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894707|NCT01619332|Incretins|incretins|mesh-ancestor
13894708|NCT01619332|Hormones|hormones|mesh-ancestor
13894709|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894710|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13894711|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
13894712|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894713|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894714|NCT01617096|Dapivirine|dapivirine|mesh-list
13894715|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13894716|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13894717|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
13894718|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894719|NCT01616524|Interferons|interferons|mesh-list
13894720|NCT01616524|Ribavirin|ribavirin|mesh-list
13894721|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
13894722|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
13894723|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13894724|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894725|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
13894726|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894727|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
13894728|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894729|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
13894730|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894731|NCT01616303|Paclitaxel|paclitaxel|mesh-list
13894732|NCT01616303|Carboplatin|carboplatin|mesh-list
14932232|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
14932233|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932234|NCT01443780|Protective Agents|protective agents|mesh-ancestor
14932235|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932236|NCT01443780|Trace Elements|trace elements|mesh-ancestor
13894733|NCT01616303|Oregovomab|oregovomab|mesh-list
13894734|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13894735|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894736|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894737|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894738|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894739|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894740|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13894741|NCT01616199|Vemurafenib|vemurafenib|mesh-list
13894742|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894743|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13894744|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894745|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894746|NCT01610245|Oseltamivir|oseltamivir|mesh-list
14932237|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
14932238|NCT01443806|Oseltamivir|oseltamivir|mesh-list
14932239|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
14932240|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932241|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932242|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932243|NCT01443897|Vitamin D|vitamin d|mesh-list
14932244|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
14932245|NCT01443897|Vitamins|vitamins|mesh-list
14932246|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
13894747|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
13894748|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
14932247|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894749|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894750|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894751|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894752|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13894753|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13894754|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13894755|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
13894756|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894757|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13894758|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894759|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13894760|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894761|NCT01606566|Bleomycin|bleomycin|mesh-list
13894762|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13894763|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894764|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
13894765|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13894766|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894767|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894768|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894769|NCT01604889|Ipilimumab|ipilimumab|mesh-list
13894770|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13894771|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894772|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13894773|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894774|NCT01603407|Prednisone|prednisone|mesh-list
13894775|NCT01603407|Deflazacort|deflazacort|mesh-list
13894776|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894777|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
13894778|NCT01603407|Hormones|hormones|mesh-ancestor
13894779|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894780|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894781|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13894782|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894783|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894784|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
13894785|NCT01602393|Flurbiprofen|flurbiprofen|mesh-list
13894786|NCT01602393|Analgesics|analgesics|mesh-ancestor
13894787|NCT01602393|Sensory System Agents|sensory system agents|mesh-ancestor
13894788|NCT01602393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894789|NCT01602393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894790|NCT01602393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13894791|NCT01602393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13894792|NCT01602393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894793|NCT01602393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13894794|NCT01602393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13894795|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894796|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894797|NCT01594983|Fenofibrate|fenofibrate|mesh-list
13894798|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13894799|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
13894800|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894801|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13894802|NCT01594216|Exemestane|exemestane|mesh-list
13894803|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894804|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13894805|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13894806|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894807|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894808|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13894809|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
13894810|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894811|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894812|NCT01593228|Gemcitabine|gemcitabine|mesh-list
13894813|NCT01593228|Paclitaxel|paclitaxel|mesh-list
13894814|NCT01593228|Carboplatin|carboplatin|mesh-list
13894815|NCT01593228|Doxorubicin|doxorubicin|mesh-list
13894816|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13894817|NCT01593228|Irinotecan|irinotecan|mesh-list
13894818|NCT01593228|Topotecan|topotecan|mesh-list
13894819|NCT01593228|Iniparib|iniparib|mesh-list
13894820|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13894821|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894822|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894823|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894824|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894825|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894826|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13894827|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
13894828|NCT01593228|Antiviral Agents|antiviral agents|mesh-ancestor
13894829|NCT01593228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894830|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894831|NCT01593228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894832|NCT01593228|Immunologic Factors|immunologic factors|mesh-ancestor
13894833|NCT01593228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894834|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13894835|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13894836|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13894837|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14932248|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13894838|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13894839|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
13894840|NCT01591473|Poly I-C|poly i-c|mesh-list
13894841|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
13894842|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894843|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
13894844|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
13894845|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894846|NCT01591447|Solithromycin|solithromycin|mesh-list
13894847|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13894848|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894849|NCT01590719|Leucovorin|leucovorin|mesh-list
13894850|NCT01590719|Folic Acid|folic acid|mesh-list
13894851|NCT01590719|Fluorouracil|fluorouracil|mesh-list
13894852|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
13894853|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
13894854|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
13894855|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755144|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
14755145|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
14755146|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14938616|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13894856|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13894857|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894858|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13894859|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
13894860|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894861|NCT01590719|Antidotes|antidotes|mesh-ancestor
13894862|NCT01590719|Protective Agents|protective agents|mesh-ancestor
13894863|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
13894864|NCT01590719|Vitamins|vitamins|mesh-ancestor
13894865|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
13894866|NCT01590719|Hematinics|hematinics|mesh-ancestor
13894867|NCT01588535|Benzocaine|benzocaine|mesh-list
13894868|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
13894869|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
13894870|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13894871|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894872|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
13894873|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894874|NCT01587144|Lucanthone|lucanthone|mesh-list
13894875|NCT01587144|Temozolomide|temozolomide|mesh-list
13894876|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13894877|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
13894878|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894879|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894880|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
13894881|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13894882|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
13894883|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13894884|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894885|NCT01584531|ON 01910|on 01910|mesh-list
13894886|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894887|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13894888|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894889|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894890|NCT01582347|Buprenorphine|buprenorphine|mesh-list
13894891|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13894892|NCT01582347|Naloxone|naloxone|mesh-list
13894893|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13894894|NCT01582347|Narcotics|narcotics|mesh-ancestor
13894895|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13894896|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894897|NCT01582347|Analgesics|analgesics|mesh-ancestor
13894898|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
13894899|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894900|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13894901|NCT01582269|Lomustine|lomustine|mesh-list
13894902|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13894903|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
13894904|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894905|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894906|NCT01581203|Interferons|interferons|mesh-list
13894907|NCT01581203|Ribavirin|ribavirin|mesh-list
13894908|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
13894909|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
13894910|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13894911|NCT01581203|Asunaprevir|asunaprevir|mesh-list
13894912|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894913|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
13894914|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894915|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
13894916|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894917|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
13894918|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894919|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
13894920|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894921|NCT01581177|Albuterol|albuterol|mesh-list
13894922|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13894923|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
13894924|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13894925|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894926|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13894927|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
13894928|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
13894929|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13894930|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13894931|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13894932|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13894933|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
13894934|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13894935|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894936|NCT01581138|Ribavirin|ribavirin|mesh-list
13894937|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
13894938|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894939|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
13894940|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894941|NCT01580696|Molgramostim|molgramostim|mesh-list
13894942|NCT01580696|Vaccines|vaccines|mesh-list
13894943|NCT01580696|Sargramostim|sargramostim|mesh-list
13894944|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
13894945|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894946|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894947|NCT01578655|Prednisone|prednisone|mesh-list
13894948|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13894949|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
13894950|NCT01578655|Hormones|hormones|mesh-ancestor
13894951|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13894952|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894953|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13894954|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894955|NCT01577654|Folic Acid|folic acid|mesh-list
13894956|NCT01577654|Docetaxel|docetaxel|mesh-list
13894957|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
13894958|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894959|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
13894960|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
13894961|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
13894962|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894963|NCT01577654|Hematinics|hematinics|mesh-ancestor
13894964|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
13894965|NCT01577654|Vitamins|vitamins|mesh-ancestor
13894966|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
13894967|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894968|NCT01577173|Cetuximab|cetuximab|mesh-list
13894969|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13894970|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894971|NCT01573351|Interferons|interferons|mesh-list
13894972|NCT01573351|Ribavirin|ribavirin|mesh-list
13894973|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
13894974|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
13894975|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13894976|NCT01573351|Asunaprevir|asunaprevir|mesh-list
13894977|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894978|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
13894979|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13894980|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
13894981|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894982|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
13894983|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13894984|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
13894985|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13894986|NCT01567904|Semuloparin|semuloparin|mesh-list
13894987|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13894988|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13894989|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894990|NCT01567059|Cytarabine|cytarabine|mesh-list
13894991|NCT01567059|Decitabine|decitabine|mesh-list
13894992|NCT01567059|Azacitidine|azacitidine|mesh-list
13894993|NCT01567059|Tosedostat|tosedostat|mesh-list
13894994|NCT01567059|Glycine|glycine|mesh-list
13894995|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13894996|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
13894997|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13894998|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13894999|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
13895000|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895001|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895002|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
13895003|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895004|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895005|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
13895006|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895007|NCT01565655|Peficitinib|peficitinib|mesh-list
13895008|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895009|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895010|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895011|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
13895012|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895013|NCT01561768|Vaccines|vaccines|mesh-list
13895014|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
13895015|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895016|NCT01560104|Paclitaxel|paclitaxel|mesh-list
13895017|NCT01560104|Carboplatin|carboplatin|mesh-list
13895018|NCT01560104|Veliparib|veliparib|mesh-list
13895019|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13895020|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895021|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
13895022|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
13895023|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
13895024|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895025|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13895026|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959087|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13959088|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
13959089|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
13959090|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
13959091|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
13959092|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959093|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959094|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13959095|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959096|NCT03165500|Analgesics|analgesics|mesh-ancestor
13959097|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
13959098|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959099|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
13959100|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
13959101|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
13959102|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959103|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13959104|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13959105|NCT03165396|Propofol|propofol|mesh-list
13959106|NCT03165396|Sevoflurane|sevoflurane|mesh-list
13959107|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13959108|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959109|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959110|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13959111|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
13959112|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
13959113|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13959114|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13959115|NCT03165253|Amoxicillin|amoxicillin|mesh-list
13959116|NCT03165253|Clarithromycin|clarithromycin|mesh-list
13959117|NCT03165253|Omeprazole|omeprazole|mesh-list
13959118|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959119|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959120|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13959121|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959122|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13959123|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959124|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959125|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13959126|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13959127|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13959128|NCT03165123|Azithromycin|azithromycin|mesh-list
13959129|NCT03165123|Dexamethasone|dexamethasone|mesh-list
13959130|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959131|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
13959132|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
13959133|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959134|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959135|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959136|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
13959137|NCT03165123|Hormones|hormones|mesh-ancestor
13959138|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959139|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13959140|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959141|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959142|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028286|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14028287|NCT02731105|Analgesics|analgesics|mesh-ancestor
13959143|NCT03165240|Eplerenone|eplerenone|mesh-list
13959144|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13959145|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
13895027|NCT01559363|XL647|xl647|mesh-list
13895028|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895029|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13895030|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895031|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895032|NCT01557777|Navitoclax|navitoclax|mesh-list
13895033|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895034|NCT01555554|Propranolol|propranolol|mesh-list
13895035|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13895036|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13895037|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
13895038|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895039|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895040|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895041|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13895042|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13895043|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
13895044|NCT01554696|Methotrexate|methotrexate|mesh-list
13895045|NCT01554696|Peficitinib|peficitinib|mesh-list
13895046|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13895047|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
13895048|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13895049|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895050|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13895051|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
13895052|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895053|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895054|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895055|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895056|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13895057|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895058|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
13895059|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895060|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13895061|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13895062|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
13895063|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895064|NCT01539226|Dapivirine|dapivirine|mesh-list
13895065|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13895066|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13895067|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
13895068|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895069|NCT01536041|Montelukast|montelukast|mesh-list
13895070|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895071|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895072|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13895073|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
13895074|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895075|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895076|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13895077|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13895078|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895079|NCT01535508|Vitamin D|vitamin d|mesh-list
13895080|NCT01535508|Vitamins|vitamins|mesh-ancestor
13895081|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
13895082|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895083|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13895084|NCT01534403|Epratuzumab|epratuzumab|mesh-list
13895085|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895086|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895087|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
13895088|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13895089|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13895090|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895091|NCT01527916|Donepezil|donepezil|mesh-list
13895092|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13895093|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895094|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895095|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
13895096|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895097|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895098|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
14755147|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14938617|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
13895099|NCT01522469|Crenolanib|crenolanib|mesh-list
13895100|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895101|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
13895102|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
13895103|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895104|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895105|NCT01520545|Baclofen|baclofen|mesh-list
13895106|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13895107|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895108|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13895109|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895110|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13895111|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
13895112|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
13895113|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895114|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895115|NCT01519804|Paclitaxel|paclitaxel|mesh-list
13895116|NCT01519804|Carboplatin|carboplatin|mesh-list
13895117|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13895118|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895119|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
13895120|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
13895121|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
13895122|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895123|NCT01517776|Temozolomide|temozolomide|mesh-list
13895124|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13895125|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
13895126|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895127|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895128|NCT01516918|Ribavirin|ribavirin|mesh-list
13895129|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13895130|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
13895131|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895132|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
13895133|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895134|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
13895135|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13895136|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13895137|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
13895138|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895139|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13895140|NCT01516476|Liraglutide|liraglutide|mesh-list
13895141|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895142|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895143|NCT01516476|Incretins|incretins|mesh-ancestor
13895144|NCT01516476|Hormones|hormones|mesh-ancestor
13895145|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895146|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
13895147|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895148|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
13895149|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895150|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895151|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13895152|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
13895153|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895154|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895155|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13895156|NCT01516203|Rifampin|rifampin|mesh-list
13895157|NCT01516203|Isoniazid|isoniazid|mesh-list
13895158|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
13895159|NCT01516203|Ethambutol|ethambutol|mesh-list
13895160|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13895161|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
13895162|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13895163|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895164|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
13895165|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13895166|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895167|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895168|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13895169|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13895170|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13895171|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13895172|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13895173|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13895174|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13895175|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13895176|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
13895177|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13895178|NCT01516086|Fluticasone|fluticasone|mesh-list
13895179|NCT01516086|Xhance|xhance|mesh-list
14755148|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755149|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14755150|NCT04329832|Azithromycin|azithromycin|mesh-list
14755151|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
14755152|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755153|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895180|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895181|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14755154|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
14755155|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14755156|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14755157|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755158|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895182|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
13895183|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895184|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895185|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895186|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895187|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895188|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13895189|NCT01516073|Fluticasone|fluticasone|mesh-list
13895190|NCT01516073|Xhance|xhance|mesh-list
13895191|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895192|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895193|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
13895194|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895195|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895196|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14028288|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
14028289|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028290|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028291|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028292|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028293|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
14028294|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14169257|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169258|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14169259|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
14169260|NCT04843462|Esketamine|esketamine|mesh-list
14169261|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
14169262|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169263|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14169264|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169265|NCT04843449|Itraconazole|itraconazole|mesh-list
14169266|NCT04843449|Rifampin|rifampin|mesh-list
14169267|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
14169268|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169269|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14169270|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14169271|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169272|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169273|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14169274|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
14169275|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169276|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169277|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14169278|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14169279|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
14169280|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14169281|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
14169282|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14169283|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14169284|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14169285|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14755159|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895197|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895198|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895199|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13895200|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
13895201|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13895202|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895203|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13895204|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14471422|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471423|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
14471424|NCT02330172|Neostigmine|neostigmine|mesh-list
14471425|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13895205|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895206|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895207|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895208|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13895209|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13895210|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
13895211|NCT01510119|Everolimus|everolimus|mesh-list
13895212|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895213|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895214|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
13895215|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895216|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
13895217|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14471426|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471427|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471428|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
14471429|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471430|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471431|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14471432|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
14471433|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471434|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
14471435|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13895218|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13895219|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895220|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895221|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895222|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895223|NCT01508026|Valsartan|valsartan|mesh-list
13895224|NCT01508026|Nebivolol|nebivolol|mesh-list
13895225|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13895226|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13895227|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13895228|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895229|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
13895230|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13895231|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13895232|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13895233|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
13895234|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895235|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895236|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
13895237|NCT01501513|Laxatives|laxatives|mesh-ancestor
13895238|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13895239|NCT01499563|Risperidone|risperidone|mesh-list
13895240|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13895241|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
13895242|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895243|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895244|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895245|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14755160|NCT04323436|Spartalizumab|spartalizumab|mesh-list
13895246|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13895247|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13895248|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13895249|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13895250|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
13895251|NCT01498328|Bevacizumab|bevacizumab|mesh-list
13895252|NCT01498328|Rindopepimut|rindopepimut|mesh-list
13895253|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895254|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895255|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13895256|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13895257|NCT01498328|Growth Substances|growth substances|mesh-ancestor
13895258|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895259|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
13895260|NCT01497834|Asunaprevir|asunaprevir|mesh-list
13895261|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
13895262|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895263|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895264|NCT01497704|Apatinib|apatinib|mesh-list
13895265|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895266|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13895267|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895268|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895269|NCT01495247|Paclitaxel|paclitaxel|mesh-list
13895270|NCT01495247|Dactolisib|dactolisib|mesh-list
13895271|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13895272|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895273|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
13895274|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
13895275|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
13895276|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895277|NCT01495013|Glimepiride|glimepiride|mesh-list
13895278|NCT01495013|Atorvastatin|atorvastatin|mesh-list
13895279|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13895280|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13895281|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
13895282|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895283|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13895284|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13895285|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895286|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13895287|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895288|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895289|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895290|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
13895291|NCT01493505|Paclitaxel|paclitaxel|mesh-list
13895292|NCT01493505|Carboplatin|carboplatin|mesh-list
13895293|NCT01493505|Trebananib|trebananib|mesh-list
13895294|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13895295|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895296|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
13895297|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
13895298|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
13895299|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895300|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13895301|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13895302|NCT01493505|Growth Substances|growth substances|mesh-ancestor
13895303|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895304|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
13895305|NCT01489046|Tenofovir|tenofovir|mesh-list
13895306|NCT01489046|Lamivudine|lamivudine|mesh-list
13895307|NCT01489046|Efavirenz|efavirenz|mesh-list
13895308|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
13895309|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895310|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13895311|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13895312|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895313|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895314|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13895315|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13895316|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13895317|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13895318|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13895319|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13895320|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13895321|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13895322|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13895323|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028295|NCT02730949|Folic Acid|folic acid|mesh-list
13895324|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13895325|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895326|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895327|NCT01486849|Riluzole|riluzole|mesh-list
14755161|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14755162|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755163|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755164|NCT04323046|Nivolumab|nivolumab|mesh-list
14755165|NCT04323046|Ipilimumab|ipilimumab|mesh-list
14755166|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755167|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755168|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13895328|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
13895329|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13895330|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13895331|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895332|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895333|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895334|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13895335|NCT01486849|Protective Agents|protective agents|mesh-ancestor
13895336|NCT01484119|Cetirizine|cetirizine|mesh-list
13895337|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13895338|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13895339|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13895340|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
13895341|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
13895342|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895343|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895344|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895345|NCT01483742|Ritonavir|ritonavir|mesh-list
13895346|NCT01483742|Ribavirin|ribavirin|mesh-list
13895347|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13895348|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13895349|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13895350|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
13895351|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895352|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895353|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13895354|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13895355|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
13895356|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895357|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13895358|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13895359|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
13895360|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13895361|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
13895362|NCT01482403|Ribavirin|ribavirin|mesh-list
13895363|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
13895364|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895365|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
13895366|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895367|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
13895368|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895369|NCT01482390|Ribavirin|ribavirin|mesh-list
13895370|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13895371|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
13895372|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895373|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
13895374|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895375|NCT01481077|Latanoprost|latanoprost|mesh-list
13895376|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13895377|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13895378|NCT01481051|Latanoprost|latanoprost|mesh-list
13895379|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13895380|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13895381|NCT01480583|Alovudine|alovudine|mesh-list
13895382|NCT01480583|Trastuzumab|trastuzumab|mesh-list
13895383|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895384|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895385|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
13895386|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895387|NCT01480479|Temozolomide|temozolomide|mesh-list
13895388|NCT01480479|Molgramostim|molgramostim|mesh-list
13895389|NCT01480479|Rindopepimut|rindopepimut|mesh-list
13895390|NCT01480479|Sargramostim|sargramostim|mesh-list
13895391|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13895392|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
13895393|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895394|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895395|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
13895396|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895397|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895398|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
13895399|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13895400|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
13895401|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895402|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895403|NCT01476904|Epinephrine|epinephrine|mesh-list
13895404|NCT01476904|Racepinephrine|racepinephrine|mesh-list
13895405|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
13895406|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13895407|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13895408|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
13895409|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895410|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895411|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895412|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13895413|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895414|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
13895415|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895416|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895417|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895418|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
13895419|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
13895420|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13895421|NCT01474135|Travoprost|travoprost|mesh-list
13895422|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13895423|NCT01472198|Gemcitabine|gemcitabine|mesh-list
13895424|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13895425|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
13895426|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895427|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895428|NCT01472198|Antiviral Agents|antiviral agents|mesh-ancestor
13895429|NCT01472198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932249|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14932250|NCT01443936|Vaccines|vaccines|mesh-list
14932251|NCT01443936|Immunologic Factors|immunologic factors|mesh-ancestor
14932252|NCT01443936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932253|NCT01443988|Travoprost|travoprost|mesh-list
14932254|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932255|NCT01444001|Vaccines|vaccines|mesh-list
14932256|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14932257|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
13895430|NCT01472198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895431|NCT01472198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895432|NCT01472198|Immunologic Factors|immunologic factors|mesh-ancestor
13895433|NCT01472198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895434|NCT01470131|Dexamethasone|dexamethasone|mesh-list
13895435|NCT01470131|Bortezomib|bortezomib|mesh-list
13895436|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895437|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
13895438|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
13895439|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895440|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895441|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13895442|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
13895443|NCT01470131|Hormones|hormones|mesh-ancestor
13895444|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895445|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13895446|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959146|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959147|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959148|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13959149|NCT03165240|Diuretics|diuretics|mesh-ancestor
13959150|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
13959151|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13959152|NCT03165097|ACT-709478|act-709478|mesh-list
13959153|NCT03165097|Midazolam|midazolam|mesh-list
13959154|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13959155|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13959156|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959157|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959158|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13959159|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13959160|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13959161|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13959162|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
13959163|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
13959164|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
13959165|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
13959166|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959167|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959168|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13959169|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13959170|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13963310|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13963311|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
13963312|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963313|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963314|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13963315|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13963316|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13963317|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13963318|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963319|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963320|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
13963321|NCT00069238|Hormones|hormones|mesh-ancestor
13963322|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963323|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13963324|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13963325|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
13963326|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
13963327|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
13963328|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963329|NCT03145467|Acetaminophen|acetaminophen|mesh-list
13963330|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
13963331|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963332|NCT03145467|Analgesics|analgesics|mesh-ancestor
13963333|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
13963334|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963335|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963336|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
13963337|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13963338|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13963339|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
13963340|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963341|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895447|NCT01466374|Antibodies|antibodies|mesh-list
13895448|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
13895449|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13895450|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
13895451|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895452|NCT01466088|Donepezil|donepezil|mesh-list
13895453|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13895454|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028296|NCT02730949|Inositol|inositol|mesh-list
14028297|NCT02730949|Hematinics|hematinics|mesh-ancestor
14028298|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
14028299|NCT02730949|Vitamins|vitamins|mesh-ancestor
14028300|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
14028301|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028302|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
13895455|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895456|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
13895457|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895458|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895459|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
13895460|NCT01464437|Metformin|metformin|mesh-list
13895461|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895462|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895463|NCT01461915|Gemcitabine|gemcitabine|mesh-list
13895464|NCT01461915|Paclitaxel|paclitaxel|mesh-list
13895465|NCT01461915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13895466|NCT01461915|Heparin|heparin|mesh-list
13895467|NCT01461915|Calcium heparin|calcium heparin|mesh-list
13895468|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13895469|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895470|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
13895471|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
13895472|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
13895473|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895474|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13895475|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
13895476|NCT01461915|Antiviral Agents|antiviral agents|mesh-ancestor
13895477|NCT01461915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895478|NCT01461915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895479|NCT01461915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895480|NCT01461915|Immunologic Factors|immunologic factors|mesh-ancestor
13895481|NCT01461915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895482|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
13895483|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14028303|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
14028304|NCT02731040|Diphosphonates|diphosphonates|mesh-list
14028305|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14028306|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028307|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
14028308|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028309|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14028310|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028311|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028312|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
14028313|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028314|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028315|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14028316|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
14028317|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14028318|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028319|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028320|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14028321|NCT02730845|Analgesics|analgesics|mesh-ancestor
14028322|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
14028323|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028324|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14028325|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14028326|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13895484|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13895485|NCT01461317|Etrolizumab|etrolizumab|mesh-list
13895486|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13895487|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
13895488|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028327|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
13895489|NCT01460511|Epinephrine|epinephrine|mesh-list
13895490|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13895491|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13895492|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
13895493|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895494|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895495|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895496|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13895497|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895498|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
13895499|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895500|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895501|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895502|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
13895503|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
13895504|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13895505|NCT01459679|Riboflavin|riboflavin|mesh-list
13895506|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13895507|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13895508|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
13895509|NCT01459679|Vitamins|vitamins|mesh-ancestor
13895510|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
13895511|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895512|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13895513|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895514|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
13895515|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895516|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
13895517|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895518|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895519|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895520|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895521|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13895522|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
13895523|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895524|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895525|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13895526|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
13895527|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
13895528|NCT01457781|Protective Agents|protective agents|mesh-ancestor
13895529|NCT01455896|Exenatide|exenatide|mesh-list
13895530|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895531|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895532|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13895533|NCT01455896|Incretins|incretins|mesh-ancestor
13895534|NCT01455896|Hormones|hormones|mesh-ancestor
13895535|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895536|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13895537|NCT01455870|Exenatide|exenatide|mesh-list
13895538|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895539|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895540|NCT01455870|Incretins|incretins|mesh-ancestor
13895541|NCT01455870|Hormones|hormones|mesh-ancestor
13895542|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895543|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13895544|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
13895545|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895546|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895547|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13895548|NCT01455857|Exenatide|exenatide|mesh-list
13895549|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895550|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895551|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13895552|NCT01455857|Incretins|incretins|mesh-ancestor
13895553|NCT01455857|Hormones|hormones|mesh-ancestor
13895554|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895555|NCT01455597|Estradiol|estradiol|mesh-list
13895556|NCT01455597|Estrogens|estrogens|mesh-ancestor
13895557|NCT01455597|Hormones|hormones|mesh-ancestor
13895558|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895559|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895560|NCT01455090|Ribavirin|ribavirin|mesh-list
13895561|NCT01455090|Asunaprevir|asunaprevir|mesh-list
13895562|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
13895563|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895564|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
13895565|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895566|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
13895567|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895568|NCT01454089|Gemcitabine|gemcitabine|mesh-list
13895569|NCT01454089|Carboplatin|carboplatin|mesh-list
13895570|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895571|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13895572|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
13895573|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895574|NCT01454089|Antiviral Agents|antiviral agents|mesh-ancestor
13895575|NCT01454089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895576|NCT01454089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895577|NCT01454089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895578|NCT01454089|Immunologic Factors|immunologic factors|mesh-ancestor
13895579|NCT01454089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895580|NCT01452451|Exenatide|exenatide|mesh-list
13895581|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895582|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895583|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13895584|NCT01452451|Incretins|incretins|mesh-ancestor
13895585|NCT01452451|Hormones|hormones|mesh-ancestor
13895586|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895587|NCT01449591|Metronidazole|metronidazole|mesh-list
13895588|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895589|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13895590|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13895591|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13895592|NCT01449071|Epratuzumab|epratuzumab|mesh-list
13895593|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895594|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895595|NCT01445899|Ranibizumab|ranibizumab|mesh-list
13895596|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13895597|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13895598|NCT01445899|Growth Substances|growth substances|mesh-ancestor
13895599|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895600|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
13895601|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895602|NCT01445795|Ribavirin|ribavirin|mesh-list
13895603|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
13895604|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895605|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
13895606|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895607|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
13895608|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13895609|NCT01444365|Analgesics|analgesics|mesh-ancestor
13895610|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
13895611|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895612|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895613|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895614|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895615|NCT01443728|Vitamin D|vitamin d|mesh-list
13895616|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
13895617|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
13895618|NCT01443728|Vitamins|vitamins|mesh-list
13895619|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
13895620|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895621|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13895622|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13895623|NCT01442090|Everolimus|everolimus|mesh-list
13895624|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895625|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895626|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
13895627|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895628|NCT01437735|Montelukast|montelukast|mesh-list
13895629|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895630|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895631|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14028328|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028329|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028330|NCT02730923|Anastrozole|anastrozole|mesh-list
14028331|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028332|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028333|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14028334|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14028335|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028336|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028337|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13895632|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
13895633|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895634|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895635|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13895636|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13895637|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895638|NCT01436032|Ketorolac|ketorolac|mesh-list
13895639|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13895640|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13895641|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13895642|NCT01436032|Analgesics|analgesics|mesh-ancestor
13895643|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
13895644|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895645|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895646|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895647|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895648|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13895649|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895650|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895651|NCT01435369|Pidilizumab|pidilizumab|mesh-list
13895652|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895653|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895654|NCT01435226|Ribavirin|ribavirin|mesh-list
13895655|NCT01435226|Ledipasvir|ledipasvir|mesh-list
13895656|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
13895657|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895658|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
13895659|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895660|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
13895661|NCT01435044|Ribavirin|ribavirin|mesh-list
13895662|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
13895663|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895664|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
13895665|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895666|NCT01434498|Ribavirin|ribavirin|mesh-list
13895667|NCT01434498|Ledipasvir|ledipasvir|mesh-list
13895668|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
13895669|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895670|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
13895671|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895672|NCT01431820|Luliconazole|luliconazole|mesh-list
13895673|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13895674|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
13895675|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895676|NCT01425970|Interferons|interferons|mesh-list
13895677|NCT01425970|Ribavirin|ribavirin|mesh-list
13895678|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
13895679|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
13895680|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13895681|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895682|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
13895683|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895684|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
13895685|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895686|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
13895687|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895688|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
13895689|NCT01423149|Combretastatin|combretastatin|mesh-list
13895690|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13895691|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895692|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
13895693|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
13895694|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
13895695|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895696|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
13895697|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13895698|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895699|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895700|NCT01422148|Minocycline|minocycline|mesh-list
13895701|NCT01422148|Amiodarone|amiodarone|mesh-list
13895702|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13895703|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895704|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13895705|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
13895706|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13895707|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13895708|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895709|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13895710|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13895711|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13895712|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895713|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13895714|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13895715|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13895716|NCT01421056|Flurbiprofen|flurbiprofen|mesh-list
13895717|NCT01421056|Analgesics|analgesics|mesh-ancestor
13895718|NCT01421056|Sensory System Agents|sensory system agents|mesh-ancestor
13895719|NCT01421056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895720|NCT01421056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895721|NCT01421056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13895722|NCT01421056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13895723|NCT01421056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895724|NCT01421056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895725|NCT01421056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13895726|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895727|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895728|NCT01418222|Leucovorin|leucovorin|mesh-list
13895729|NCT01418222|Bevacizumab|bevacizumab|mesh-list
13895730|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895731|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895732|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13895733|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13895734|NCT01418222|Growth Substances|growth substances|mesh-ancestor
13895735|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895736|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
13895737|NCT01418222|Antidotes|antidotes|mesh-ancestor
13895738|NCT01418222|Protective Agents|protective agents|mesh-ancestor
13895739|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
13895740|NCT01418222|Vitamins|vitamins|mesh-ancestor
13895741|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
13895742|NCT01416402|Colchicine|colchicine|mesh-list
13895743|NCT01416402|Febuxostat|febuxostat|mesh-list
13895744|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
13895745|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895746|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
13895747|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
13895748|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
13895749|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895750|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895751|NCT01416064|Molindone|molindone|mesh-list
13895752|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13895753|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13895754|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13895755|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895756|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13895757|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13895758|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895759|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895760|NCT01414920|Incretins|incretins|mesh-ancestor
14755169|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755170|NCT04321395|Vigabatrin|vigabatrin|mesh-list
14755171|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
14755172|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895761|NCT01414920|Hormones|hormones|mesh-ancestor
13895762|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895763|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13895764|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
13895765|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895766|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755173|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755174|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
13895767|NCT01410695|Methotrexate|methotrexate|mesh-list
13895768|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13895769|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
13895770|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13895771|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895772|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13895773|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
14755175|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895774|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895775|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895776|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895777|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895778|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13895779|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895780|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
13895781|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895782|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13895783|NCT01410188|Latanoprost|latanoprost|mesh-list
13895784|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13895785|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13895786|NCT01408082|Azithromycin|azithromycin|mesh-list
13895787|NCT01408082|Dexamethasone|dexamethasone|mesh-list
13895788|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
13895789|NCT01408082|BB 1101|bb 1101|mesh-list
13895790|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895791|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
13895792|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
13895793|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895794|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895795|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13895796|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
13895797|NCT01408082|Hormones|hormones|mesh-ancestor
13895798|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895799|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13895800|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895801|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
13895802|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895803|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895804|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13895805|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895806|NCT01407003|Licogliflozin|licogliflozin|mesh-list
13895807|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13895808|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895809|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13895810|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895811|NCT01402401|Trastuzumab|trastuzumab|mesh-list
13895812|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895813|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895814|NCT01399684|Leucovorin|leucovorin|mesh-list
13895815|NCT01399684|Folic Acid|folic acid|mesh-list
13895816|NCT01399684|Bevacizumab|bevacizumab|mesh-list
13895817|NCT01399684|Fluorouracil|fluorouracil|mesh-list
13895818|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
13895819|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
13895820|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13895821|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895822|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13895823|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13895824|NCT01399684|Growth Substances|growth substances|mesh-ancestor
13895825|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895826|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
13895827|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
13895828|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895829|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13895830|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895831|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
13895832|NCT01399684|Antidotes|antidotes|mesh-ancestor
13895833|NCT01399684|Protective Agents|protective agents|mesh-ancestor
13895834|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
13895835|NCT01399684|Vitamins|vitamins|mesh-ancestor
13895836|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
13895837|NCT01399684|Hematinics|hematinics|mesh-ancestor
13895838|NCT01399580|Atrasentan|atrasentan|mesh-list
13895839|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895840|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13895841|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13895842|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895843|NCT01397968|Cenobamate|cenobamate|mesh-list
13895844|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
13895845|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13895846|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
13895847|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895848|NCT01397201|Fluticasone|fluticasone|mesh-list
13895849|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895850|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895851|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
13895852|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895853|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895854|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895855|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895856|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895857|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13895858|NCT01397162|Fluticasone|fluticasone|mesh-list
13895859|NCT01397162|Xhance|xhance|mesh-list
13895860|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895861|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895862|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
13895863|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895864|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895865|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895866|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895867|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895868|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13895869|NCT01396278|Fluticasone|fluticasone|mesh-list
13895870|NCT01396278|Xhance|xhance|mesh-list
13895871|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895872|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895873|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
13895874|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895875|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895876|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895877|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895878|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895879|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13895880|NCT01393639|Prednisone|prednisone|mesh-list
13895881|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13895882|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
13895883|NCT01393639|Hormones|hormones|mesh-ancestor
13895884|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895885|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895886|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13895887|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895888|NCT01390545|Veltuzumab|veltuzumab|mesh-list
13895889|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959171|NCT03165292|Topotecan|topotecan|mesh-list
13959172|NCT03165292|Thiotepa|thiotepa|mesh-list
13959173|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13959174|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959175|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959176|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959177|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959178|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13959179|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
13959180|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13959181|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13959182|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
13959183|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959184|NCT03165409|Nivolumab|nivolumab|mesh-list
13959185|NCT03165409|Ipilimumab|ipilimumab|mesh-list
13959186|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959187|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959188|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13959189|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959190|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
13959191|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13959192|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959193|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
13959194|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
13959195|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959196|NCT03164694|Carboplatin|carboplatin|mesh-list
13959197|NCT03164694|Pemetrexed|pemetrexed|mesh-list
13959198|NCT03164694|Apatinib|apatinib|mesh-list
13959199|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959200|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959201|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959202|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13959203|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13959204|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13959205|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
13959206|NCT03164590|Ketamine|ketamine|mesh-list
13959207|NCT03164590|Bupivacaine|bupivacaine|mesh-list
13895890|NCT01384383|Ledipasvir|ledipasvir|mesh-list
13895891|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
13895892|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895893|NCT01382654|Azelastine|azelastine|mesh-list
13895894|NCT01382654|Epinastine|epinastine|mesh-list
13895895|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13895896|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
13895897|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13895898|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895899|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13895900|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
13895901|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
13895902|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895903|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895904|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13895905|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13895906|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13895907|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
13895908|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
13895909|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895910|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13895911|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13895912|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13895913|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
13895914|NCT01379209|Sirolimus|sirolimus|mesh-list
13895915|NCT01379209|Methotrexate|methotrexate|mesh-list
13895916|NCT01379209|KRN 7000|krn 7000|mesh-list
13895917|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
13895918|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13895919|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
13895920|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13895921|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895922|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13895923|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
13895924|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895925|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13895926|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
13895927|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895928|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13895929|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13895930|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
13895931|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13895932|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13895933|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13895934|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13895935|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
13895936|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13895937|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895938|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
13895939|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13895940|NCT01378676|Riluzole|riluzole|mesh-list
13895941|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
13895942|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13895943|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13895944|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895945|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895946|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755176|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895947|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13895948|NCT01378676|Protective Agents|protective agents|mesh-ancestor
13895949|NCT01377662|Methylphenidate|methylphenidate|mesh-list
13895950|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13895951|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895952|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13895953|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13895954|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13895955|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895956|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
13895957|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895958|NCT01373086|Eplerenone|eplerenone|mesh-list
13895959|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13895960|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
13895961|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13895962|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895963|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13895964|NCT01373086|Diuretics|diuretics|mesh-ancestor
13895965|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
13895966|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13895967|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
13895968|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13895969|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
13895970|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895971|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
13895972|NCT01372475|Protective Agents|protective agents|mesh-ancestor
13895973|NCT01371578|Ribavirin|ribavirin|mesh-list
13895974|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13895975|NCT01371578|Ledipasvir|ledipasvir|mesh-list
13895976|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
13895977|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895978|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
13895979|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13895980|NCT01370512|Droxidopa|droxidopa|mesh-list
13895981|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
13895982|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13895983|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13895984|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13895985|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13895986|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13895987|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
13895988|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13895989|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13895990|NCT01369147|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13895991|NCT01369147|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13895992|NCT01369147|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13895993|NCT01369147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13895994|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13895995|NCT01369095|Citalopram|citalopram|mesh-list
13895996|NCT01369095|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13895997|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13895998|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13895999|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896000|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896001|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
13896002|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896003|NCT01369095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13896004|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
13896005|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13896006|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896007|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13896008|NCT01369095|Analgesics|analgesics|mesh-ancestor
13896009|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
13896010|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
13896011|NCT01366131|Paclitaxel|paclitaxel|mesh-list
13896012|NCT01366131|Bevacizumab|bevacizumab|mesh-list
13896013|NCT01366131|Carboplatin|carboplatin|mesh-list
13896014|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13896015|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896016|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896017|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896018|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896019|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896020|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13896021|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13896022|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13896023|NCT01366131|Growth Substances|growth substances|mesh-ancestor
13896024|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896025|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
13896026|NCT01366014|Oxycodone|oxycodone|mesh-list
13896027|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13896028|NCT01366014|Narcotics|narcotics|mesh-ancestor
13896029|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896030|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896031|NCT01366014|Analgesics|analgesics|mesh-ancestor
13896032|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
13896033|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896034|NCT01365195|Ketamine|ketamine|mesh-list
13896035|NCT01365195|Analgesics|analgesics|mesh-ancestor
13896036|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
13896037|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896038|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896039|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13896040|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13896041|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
13896042|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
13896043|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896044|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13896045|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13896046|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028338|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
14028339|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028340|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028341|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
14028342|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14028343|NCT02730715|Basiliximab|basiliximab|mesh-list
14028344|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
14028345|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028346|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14028347|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14028348|NCT02730689|Ezetimibe|ezetimibe|mesh-list
14028349|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14028350|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14028351|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
14028352|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028353|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14028354|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14028355|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028356|NCT02730533|Esomeprazole|esomeprazole|mesh-list
14028357|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14028358|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028359|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14028360|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028361|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028362|NCT02730676|Menthol|menthol|mesh-list
14028363|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
14028364|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028365|NCT02730624|Tazobactam|tazobactam|mesh-list
14028366|NCT02730624|Piperacillin|piperacillin|mesh-list
14028367|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14028368|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14028369|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028370|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14028371|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028372|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028373|NCT02730481|Paclitaxel|paclitaxel|mesh-list
14028374|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14028375|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028376|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
14028377|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
14028378|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
14028379|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028380|NCT02730572|Methylphenidate|methylphenidate|mesh-list
14028381|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14028382|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028383|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14028384|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14028385|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471436|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959208|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
13896047|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896048|NCT01361802|Ambroxol|ambroxol|mesh-list
13896049|NCT01361802|Expectorants|expectorants|mesh-ancestor
13896050|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
13896051|NCT01360853|Gemcitabine|gemcitabine|mesh-list
13896052|NCT01360853|ON 01910|on 01910|mesh-list
13896053|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13896054|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
13896055|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896056|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896057|NCT01360853|Antiviral Agents|antiviral agents|mesh-ancestor
13896058|NCT01360853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896059|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896060|NCT01360853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13896061|NCT01360853|Immunologic Factors|immunologic factors|mesh-ancestor
13896062|NCT01360853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896063|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896064|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
13896065|NCT01359566|Baclofen|baclofen|mesh-list
13896066|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13896067|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896068|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13896069|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896070|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13896071|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
13896072|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
13896073|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896074|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896075|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
13896076|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13896077|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13896078|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13896079|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896080|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896081|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
13896082|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896083|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896084|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13896085|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896086|NCT01357642|Epinephrine|epinephrine|mesh-list
13896087|NCT01357642|Racepinephrine|racepinephrine|mesh-list
13896088|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
13896089|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13896090|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14932258|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932259|NCT01444040|Travoprost|travoprost|mesh-list
14932260|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932261|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
14932262|NCT01444118|Vaccines|vaccines|mesh-list
14932263|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
13896091|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
13896092|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896093|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896094|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896095|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13896096|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13896097|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
13896098|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896099|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13896100|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
13896101|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
13896102|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
13896103|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13896104|NCT01356849|Atrasentan|atrasentan|mesh-list
13896105|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896106|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13959209|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
14932264|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896107|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13896108|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896109|NCT01356160|Ribavirin|ribavirin|mesh-list
13896110|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13896111|NCT01356160|Ledipasvir|ledipasvir|mesh-list
13896112|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
13896113|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896114|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
13896115|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896116|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
13896117|NCT01355393|Sargramostim|sargramostim|mesh-list
13896118|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
13896119|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896120|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
13896121|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896122|NCT01354717|Fluorouracil|fluorouracil|mesh-list
13896123|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
13896124|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896125|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13896126|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896127|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13896128|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
13896129|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896130|NCT01353248|Ribavirin|ribavirin|mesh-list
13896131|NCT01353248|Ledipasvir|ledipasvir|mesh-list
13896132|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
13896133|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896134|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
14755177|NCT04321330|Atezolizumab|atezolizumab|mesh-list
14755178|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755179|NCT04318548|Vaccines|vaccines|mesh-list
13896135|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896136|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
13896137|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14755180|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
14755181|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755182|NCT04311411|Liraglutide|liraglutide|mesh-list
14755183|NCT04311411|Tirzepatide|tirzepatide|mesh-list
14755184|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14755185|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896138|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
13896139|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896140|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896141|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13896142|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
13896143|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13896144|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13896145|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14755186|NCT04311411|Incretins|incretins|mesh-ancestor
14755187|NCT04311411|Hormones|hormones|mesh-ancestor
14755188|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755189|NCT04305496|Fulvestrant|fulvestrant|mesh-list
14755190|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13896146|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
13896147|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896148|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896149|NCT01348919|Dexamethasone|dexamethasone|mesh-list
13896150|NCT01348919|Lenalidomide|lenalidomide|mesh-list
13896151|NCT01348919|Delanzomib|delanzomib|mesh-list
13896152|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896153|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
13896154|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
13896155|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896156|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896157|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13896158|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
13896159|NCT01348919|Hormones|hormones|mesh-ancestor
13896160|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896161|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13896162|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896163|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
13896164|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14755191|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896165|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13896166|NCT01348919|Growth Substances|growth substances|mesh-ancestor
14755192|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13896167|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
13896168|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
13896169|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
13896170|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896171|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896172|NCT01345045|Pregabalin|pregabalin|mesh-list
13896173|NCT01345045|Analgesics|analgesics|mesh-ancestor
13896174|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
13896175|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896176|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896177|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
13896178|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13896179|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896180|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896181|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13896182|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13896183|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13896184|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896185|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13896186|NCT01344187|Riboflavin|riboflavin|mesh-list
13896187|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13896188|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
13896189|NCT01344187|Vitamins|vitamins|mesh-ancestor
13896190|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
13896191|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896192|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13896193|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
13896194|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13896195|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
13896196|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896197|NCT01339689|Ganaxolone|ganaxolone|mesh-list
13896198|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
13896199|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896200|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896201|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896202|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
13896203|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
13896204|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13896205|NCT01338883|Efavirenz|efavirenz|mesh-list
13896206|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
13896207|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13896208|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13896209|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896210|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896211|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
13896212|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896213|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13896214|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13896215|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13896216|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13896217|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13896218|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13896219|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13896220|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13896221|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13896222|NCT01337752|Dexamethasone|dexamethasone|mesh-list
13896223|NCT01337752|Bortezomib|bortezomib|mesh-list
13896224|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13896225|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896226|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
14755193|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14755194|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
14755195|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755196|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755197|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14755198|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14755199|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
13896227|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
13896228|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896229|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896230|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13896231|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
13896232|NCT01337752|Hormones|hormones|mesh-ancestor
13959210|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896233|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896234|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13896235|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896236|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
13896237|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
13896238|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13896239|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896240|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896241|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13896242|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13896243|NCT01337349|Protective Agents|protective agents|mesh-ancestor
13896244|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896245|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
13896246|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13896247|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
13896248|NCT01336686|Colchicine|colchicine|mesh-list
13896249|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
13896250|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13896251|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896252|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896253|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896254|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896255|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896256|NCT01336465|Etrolizumab|etrolizumab|mesh-list
13896257|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13896258|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
13896259|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896260|NCT01332812|Dexamethasone|dexamethasone|mesh-list
13896261|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
13896262|NCT01332812|BB 1101|bb 1101|mesh-list
13896263|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896264|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
13896265|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
13896266|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896267|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896268|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13896269|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
13896270|NCT01332812|Hormones|hormones|mesh-ancestor
13896271|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896272|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13896273|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896274|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
13896275|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896276|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896277|NCT01332656|Paclitaxel|paclitaxel|mesh-list
13896278|NCT01332656|Carboplatin|carboplatin|mesh-list
13896279|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13896280|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896281|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896282|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896283|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896284|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896285|NCT01331850|Ritonavir|ritonavir|mesh-list
13896286|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13896287|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
13896288|NCT01331850|Ribavirin|ribavirin|mesh-list
13896289|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13896290|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13896291|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
13896292|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896293|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896294|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13896295|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13896296|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
13896297|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896298|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13896299|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13896300|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
13896301|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896302|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
14028386|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896303|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13896304|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13896305|NCT01328808|Acetaminophen|acetaminophen|mesh-list
13896306|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13896307|NCT01328808|Analgesics|analgesics|mesh-ancestor
13896308|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
13896309|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896310|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896311|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
13896312|NCT01328093|Aripiprazole|aripiprazole|mesh-list
13896313|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
13896314|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13896315|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13896316|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13896317|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896318|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896319|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
13896320|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
13896321|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896322|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896323|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13896324|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13896325|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
13896326|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13896327|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13896328|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13896329|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13896330|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
13896331|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
13896332|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896333|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896334|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
13896335|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13896336|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896337|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896338|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13896339|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
13896340|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
13896341|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896342|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896343|NCT01318642|Gemcitabine|gemcitabine|mesh-list
13896344|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13896345|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
13896346|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896347|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896348|NCT01318642|Antiviral Agents|antiviral agents|mesh-ancestor
13896349|NCT01318642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896350|NCT01318642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896351|NCT01318642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13896352|NCT01318642|Immunologic Factors|immunologic factors|mesh-ancestor
13896353|NCT01318642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896354|NCT01318252|Latanoprost|latanoprost|mesh-list
13896355|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13896356|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13896357|NCT01314222|Pregabalin|pregabalin|mesh-list
13896358|NCT01314222|Analgesics|analgesics|mesh-ancestor
13896359|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
13896360|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896361|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896362|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
13896363|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13896364|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896365|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896366|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13896367|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13896368|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13896369|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896370|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13896371|NCT01313572|Adenosine|adenosine|mesh-list
13896372|NCT01313572|Analgesics|analgesics|mesh-ancestor
13896373|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
13896374|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896375|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896376|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13896377|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
13896378|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13896379|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
13896380|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
13896381|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896382|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896383|NCT01312454|Travoprost|travoprost|mesh-list
13896384|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13896385|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13896386|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13896387|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896388|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896389|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896390|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13896391|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13896392|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13896393|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896394|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896395|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896396|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896397|NCT01309945|Analgesics|analgesics|mesh-ancestor
13896398|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
13896399|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896400|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
13896401|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13896402|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
13896403|NCT01309932|Interferons|interferons|mesh-list
13896404|NCT01309932|Ribavirin|ribavirin|mesh-list
13896405|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
13896406|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
13896407|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13896408|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
13896409|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
13896410|NCT01309932|Asunaprevir|asunaprevir|mesh-list
13896411|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896412|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
13896413|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896414|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
13896415|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896416|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
13896417|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896418|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896419|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13896420|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13896421|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13896422|NCT01303783|Candesartan|candesartan|mesh-list
13896423|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
14028387|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
14028388|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028389|NCT02730442|Fluconazole|fluconazole|mesh-list
14932265|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932266|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932267|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14932268|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
14932269|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932270|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028390|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
14028391|NCT02730442|Clotrimazole|clotrimazole|mesh-list
14028392|NCT02730442|Miconazole|miconazole|mesh-list
14028393|NCT02730442|Olorofim|olorofim|mesh-list
14028394|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028395|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14028396|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14028397|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028398|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028399|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14028400|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
14932271|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14932272|NCT01444131|Nicotine|nicotine|mesh-list
14932273|NCT01444131|Varenicline|varenicline|mesh-list
14932274|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14932275|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
13896424|NCT01303783|Nifedipine|nifedipine|mesh-list
13896425|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13896426|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14028401|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896427|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13896428|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896429|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13896430|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896431|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13896432|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896433|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
13896434|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
13896435|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13896436|NCT01302249|Timolol|timolol|mesh-list
13896437|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13896438|NCT01302249|Latanoprost|latanoprost|mesh-list
13896439|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13896440|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13896441|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13896442|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
13896443|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896444|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896445|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896446|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13896447|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13896448|NCT01301157|Calcipotriene|calcipotriene|mesh-list
13896449|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
13896450|NCT01298687|Travoprost|travoprost|mesh-list
13896451|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13896452|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13896453|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13896454|NCT01297543|Sargramostim|sargramostim|mesh-list
13896455|NCT01297543|Lenograstim|lenograstim|mesh-list
13896456|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
13896457|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896458|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13896459|NCT01295060|Octreotide|octreotide|mesh-list
13896460|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13896461|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14755202|NCT04276233|Prednisone|prednisone|mesh-list
14755203|NCT04276233|Prednisolone|prednisolone|mesh-list
14755204|NCT04276233|Albuterol|albuterol|mesh-list
13896462|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959211|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959212|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
13959213|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959214|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13959215|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959216|NCT03164590|Analgesics|analgesics|mesh-ancestor
13959217|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13959218|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13959219|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13959220|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
13959221|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959222|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959223|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13959224|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13959225|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
13959226|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13959227|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13959228|NCT03164668|Menthol|menthol|mesh-list
13959229|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
13959230|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
13959231|NCT03164512|Cannabidiol|cannabidiol|mesh-list
13959232|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
13959233|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
14755205|NCT04276233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755206|NCT04276233|Glucocorticoids|glucocorticoids|mesh-ancestor
13896463|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
13896464|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896465|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896466|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896467|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896468|NCT01283594|Levodopa|levodopa|mesh-list
13896469|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13896470|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13896471|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
13896472|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896473|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896474|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896475|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
13896476|NCT01281462|Cephalosporins|cephalosporins|mesh-list
13896477|NCT01281462|Doripenem|doripenem|mesh-list
13896478|NCT01281462|Avibactam|avibactam|mesh-list
13896479|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13896480|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896481|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13896482|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896483|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896484|NCT01281254|Trebananib|trebananib|mesh-list
13896485|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13896486|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13896487|NCT01281254|Growth Substances|growth substances|mesh-ancestor
13896488|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896489|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
14755207|NCT04276233|Hormones|hormones|mesh-ancestor
14755208|NCT04276233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896490|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896491|NCT01280565|Dacarbazine|dacarbazine|mesh-list
13896492|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13896493|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
13896494|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896495|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896496|NCT01280331|Morphine|morphine|mesh-list
13896497|NCT01280331|Oxycodone|oxycodone|mesh-list
13896498|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13896499|NCT01280331|Narcotics|narcotics|mesh-ancestor
13896500|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896501|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896502|NCT01280331|Analgesics|analgesics|mesh-ancestor
13896503|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
13896504|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896505|NCT01279590|Atorvastatin|atorvastatin|mesh-list
13896506|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13896507|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13896508|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
13896509|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896510|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13896511|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13896512|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896513|NCT01278134|Ritonavir|ritonavir|mesh-list
13896514|NCT01278134|Ribavirin|ribavirin|mesh-list
13896515|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13896516|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13896517|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13896518|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
13896519|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896520|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896521|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13896522|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13896523|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
13896524|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896525|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13896526|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13896527|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
13896528|NCT01276587|Vitamin D|vitamin d|mesh-list
13896529|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
13896530|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
13896531|NCT01276587|Vitamins|vitamins|mesh-list
13896532|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
13896533|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896534|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13896535|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13896536|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13896537|NCT01275105|Phenylephrine|phenylephrine|mesh-list
13896538|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
13896539|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13896540|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13896541|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13896542|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13896543|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
13896544|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896545|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896546|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896547|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
13896548|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
13896549|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896550|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
13896551|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13896552|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
13896553|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13896554|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
13896555|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13896556|NCT01275105|Protective Agents|protective agents|mesh-ancestor
13896557|NCT01272791|Gemcitabine|gemcitabine|mesh-list
13896558|NCT01272791|Bavituximab|bavituximab|mesh-list
13896559|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13896560|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
13896561|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896562|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896563|NCT01272791|Antiviral Agents|antiviral agents|mesh-ancestor
13896564|NCT01272791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896565|NCT01272791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896566|NCT01272791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13896567|NCT01272791|Immunologic Factors|immunologic factors|mesh-ancestor
13896568|NCT01272791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896569|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13896570|NCT01271920|Trastuzumab|trastuzumab|mesh-list
13896571|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13896572|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896573|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13896574|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
13896575|NCT01271790|Ribavirin|ribavirin|mesh-list
13896576|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
13896577|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755209|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755210|NCT04276233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14755211|NCT04276233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755212|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
14755213|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755214|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14755215|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14755216|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
14755217|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
14755218|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14755219|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14755220|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13896578|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
13896579|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896580|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
13896581|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896582|NCT01270347|Levofloxacin|levofloxacin|mesh-list
13896583|NCT01270347|Ofloxacin|ofloxacin|mesh-list
13896584|NCT01270347|Tobramycin|tobramycin|mesh-list
13896585|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13896586|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13896587|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896588|NCT01270347|Renal Agents|renal agents|mesh-ancestor
13896589|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13896590|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13896591|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13896592|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896593|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896594|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896595|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13896596|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14755221|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13896597|NCT01269658|Azithromycin|azithromycin|mesh-list
13896598|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13896599|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13896600|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13896601|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896602|NCT01266525|Donepezil|donepezil|mesh-list
13896603|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13896604|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896605|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896606|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
13896607|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896608|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896609|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
13896610|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
13896611|NCT01265901|Sunitinib|sunitinib|mesh-list
13896612|NCT01265901|Molgramostim|molgramostim|mesh-list
13896613|NCT01265901|Sargramostim|sargramostim|mesh-list
13896614|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
13896615|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896616|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13896617|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13896618|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13896619|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
13896620|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896621|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896622|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13896623|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13896624|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13896625|NCT01265901|Growth Substances|growth substances|mesh-ancestor
13896626|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
13896627|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896628|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896629|NCT01262261|Buprenorphine|buprenorphine|mesh-list
13896630|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13896631|NCT01262261|Narcotics|narcotics|mesh-ancestor
13896632|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896633|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896634|NCT01262261|Analgesics|analgesics|mesh-ancestor
13896635|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
13896636|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896637|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13896638|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13896639|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
13896640|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896641|NCT01261312|Guadecitabine|guadecitabine|mesh-list
13896642|NCT01261312|Azacitidine|azacitidine|mesh-list
13896643|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896644|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13896645|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
13896646|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896647|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896648|NCT01260870|Paclitaxel|paclitaxel|mesh-list
13896649|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13896650|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896651|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896652|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896653|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896654|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896655|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13896656|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
13896657|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896658|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13896659|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13896660|NCT01256762|Paclitaxel|paclitaxel|mesh-list
13896661|NCT01256762|Bevacizumab|bevacizumab|mesh-list
13896662|NCT01256762|Imetelstat|imetelstat|mesh-list
13896663|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
13896664|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13896665|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896666|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896667|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896668|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896669|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896670|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13896671|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13896672|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13896673|NCT01256762|Growth Substances|growth substances|mesh-ancestor
13896674|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755222|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
14755223|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755224|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755225|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
13896675|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
13896676|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896677|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896678|NCT01255709|Epinephrine|epinephrine|mesh-list
13896679|NCT01255709|Racepinephrine|racepinephrine|mesh-list
13896680|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
13896681|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13896682|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13896683|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
13896684|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896685|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896686|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896687|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13896688|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13896689|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
13896690|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896691|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13896692|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
13896693|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
13896694|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
13896695|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13896696|NCT01254370|Travoprost|travoprost|mesh-list
13896697|NCT01254370|Latanoprost|latanoprost|mesh-list
13896698|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13896699|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13896700|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13896701|NCT01254136|Trastuzumab|trastuzumab|mesh-list
13896702|NCT01254136|Vinorelbine|vinorelbine|mesh-list
13896703|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13896704|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896705|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13896706|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896707|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896708|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896709|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896710|NCT01253603|Fluticasone|fluticasone|mesh-list
13896711|NCT01253603|Xhance|xhance|mesh-list
13896712|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
13896713|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896714|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13896715|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
13896716|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896717|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896718|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13896719|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
13896720|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028402|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028403|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14028404|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14028405|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14028406|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14028407|NCT02730364|Acetaminophen|acetaminophen|mesh-list
14028408|NCT02730364|Ascorbic Acid|ascorbic acid|mesh-list
14028409|NCT02730364|Pheniramine|pheniramine|mesh-list
14028410|NCT02730364|Phenylephrine|phenylephrine|mesh-list
14028411|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
14028412|NCT02730364|Vitamins|vitamins|mesh-ancestor
14028413|NCT02730364|Micronutrients|micronutrients|mesh-ancestor
14028414|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028415|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14028416|NCT02730364|Analgesics|analgesics|mesh-ancestor
14028417|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
14028418|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028419|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
14028420|NCT02730364|Antioxidants|antioxidants|mesh-ancestor
14028421|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028422|NCT02730364|Protective Agents|protective agents|mesh-ancestor
14028423|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13896721|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14028424|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
14028425|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
14028426|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
13896722|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14755226|NCT04275661|Ketamine|ketamine|mesh-list
13896723|NCT01253603|Growth Substances|growth substances|mesh-ancestor
13896724|NCT01252693|Goserelin|goserelin|mesh-list
13896725|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13896726|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896727|NCT01252628|Cetuximab|cetuximab|mesh-list
13896728|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13896729|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896730|NCT01248975|Montelukast|montelukast|mesh-list
13896731|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13896732|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
13896733|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13896734|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
13896735|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896736|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896737|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13896738|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13896739|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896740|NCT01243346|Crenolanib|crenolanib|mesh-list
13896741|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896742|NCT01243073|Imetelstat|imetelstat|mesh-list
13896743|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
13896744|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896745|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896746|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896747|NCT01242930|Niacinamide|niacinamide|mesh-list
13896748|NCT01242930|Lenalidomide|lenalidomide|mesh-list
13896749|NCT01242930|Imetelstat|imetelstat|mesh-list
13896750|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
13896751|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
13896752|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896753|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13896754|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13896755|NCT01242930|Growth Substances|growth substances|mesh-ancestor
13896756|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
13896757|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896758|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896759|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896760|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896761|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
13896762|NCT01242930|Vitamins|vitamins|mesh-ancestor
13896763|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
13896764|NCT01241214|Cetirizine|cetirizine|mesh-list
13896765|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13896766|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13896767|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13896768|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
13896769|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
13896770|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896771|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896772|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896773|NCT01240759|Metformin|metformin|mesh-list
13896774|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13896775|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896776|NCT01240512|Vitamin D|vitamin d|mesh-list
13896777|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
13896778|NCT01240512|Vitamins|vitamins|mesh-ancestor
13896779|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
13896780|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896781|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13896782|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13896783|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
13896784|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896785|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896786|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896787|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
13896788|NCT01235754|Testosterone|testosterone|mesh-list
13896789|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
13896790|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
13896791|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13896792|NCT01235754|Androgens|androgens|mesh-ancestor
13896793|NCT01235754|Hormones|hormones|mesh-ancestor
13896794|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896795|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028427|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13896796|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13896797|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896798|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
13896799|NCT01235039|Insulin|insulin|mesh-list
13896800|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
13896801|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13896802|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13896803|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896804|NCT01234779|Olanzapine|olanzapine|mesh-list
13896805|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
13896806|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
13896807|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028428|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
14028429|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
14028430|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14028431|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14028432|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14028433|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028434|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028435|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
14028436|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028437|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14028438|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
14028439|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
14028440|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14028441|NCT02730117|Cephalosporins|cephalosporins|mesh-list
14028442|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14028443|NCT02730117|Dobutamine|dobutamine|mesh-list
14028444|NCT02730117|Dopamine|dopamine|mesh-list
14028445|NCT02730117|Milrinone|milrinone|mesh-list
14028446|NCT02730117|Norepinephrine|norepinephrine|mesh-list
14028447|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14028448|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14028449|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14028450|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028451|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028452|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028453|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028454|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
14028455|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
14028456|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028457|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14028458|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14028459|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14028460|NCT02730117|Protective Agents|protective agents|mesh-ancestor
14028461|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
14028462|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14028463|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
14028464|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14028465|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14028466|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028467|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028468|NCT02730091|Letrozole|letrozole|mesh-list
14028469|NCT02730091|Vinorelbine|vinorelbine|mesh-list
14028470|NCT02730091|Anastrozole|anastrozole|mesh-list
14028471|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028472|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14028473|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14028474|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028475|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028476|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14028477|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
14028478|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028479|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896808|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896809|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13896810|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13896811|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13896812|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896813|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13896814|NCT01234779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13896815|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13896816|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896817|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896818|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13896819|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
13896820|NCT01234519|Doxorubicin|doxorubicin|mesh-list
13896821|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13896822|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896823|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13896824|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13896825|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896826|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896827|NCT01234038|Paclitaxel|paclitaxel|mesh-list
13896828|NCT01234038|Carboplatin|carboplatin|mesh-list
13896829|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13896830|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896831|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896832|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896833|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896834|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896835|NCT01234025|Prednisone|prednisone|mesh-list
13896836|NCT01234025|Docetaxel|docetaxel|mesh-list
13896837|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896838|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
13896839|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
13896840|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
13896841|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896842|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896843|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
14471437|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14471438|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14471439|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
14471440|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471441|NCT02331095|Warfarin|warfarin|mesh-list
14471442|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
14471443|NCT02331095|Atorvastatin|atorvastatin|mesh-list
14471444|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14471445|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14471446|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
14471447|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471448|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14471449|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14471450|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471451|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
13896844|NCT01234025|Hormones|hormones|mesh-ancestor
13896845|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13896846|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896847|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13896848|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
13896849|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896850|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
13896851|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896852|NCT01232595|Vancomycin|vancomycin|mesh-list
13896853|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13896854|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896855|NCT01231347|Gemcitabine|gemcitabine|mesh-list
13896856|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13896857|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13896858|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
13896859|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896860|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896861|NCT01231347|Antiviral Agents|antiviral agents|mesh-ancestor
13896862|NCT01231347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896863|NCT01231347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896864|NCT01231347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13896865|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
14471452|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14471453|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
14755227|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
13896866|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896867|NCT01230957|Vaccines|vaccines|mesh-list
13896868|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
13896869|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471454|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14471455|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
14471456|NCT02331108|Anesthetics|anesthetics|mesh-list
14471457|NCT02331108|Propofol|propofol|mesh-list
13896870|NCT01229982|Latanoprost|latanoprost|mesh-list
13896871|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13896872|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13896873|NCT01229644|Crenolanib|crenolanib|mesh-list
13896874|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896875|NCT01228383|Vaccines|vaccines|mesh-list
13896876|NCT01228383|Antibodies|antibodies|mesh-list
13896877|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13896878|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
13896879|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
13896880|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13896881|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13896882|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
13896883|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896884|NCT01226563|Calcium|calcium|mesh-list
13896885|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13896886|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896887|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
13896888|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896889|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13896890|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896891|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959234|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13959235|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
13959236|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959237|NCT03164421|Expectorants|expectorants|mesh-ancestor
13959238|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
13959239|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13959240|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
13959241|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959242|NCT03164421|Protective Agents|protective agents|mesh-ancestor
13959243|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959244|NCT03164421|Antidotes|antidotes|mesh-ancestor
13959245|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
13959246|NCT03164304|Analgesics|analgesics|mesh-ancestor
13959247|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
13959248|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959249|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959250|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
13959251|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959252|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13959253|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
13959254|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13959255|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13959256|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959257|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13959258|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
13959259|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13959260|NCT03164447|UB-421|ub-421|mesh-list
13959261|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13959262|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
13959263|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959264|NCT03164382|Sorafenib|sorafenib|mesh-list
13959265|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959266|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13959267|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959268|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959269|NCT03164291|Rifabutin|rifabutin|mesh-list
13959270|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959271|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959272|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13959273|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
13959274|NCT03164096|Bupivacaine|bupivacaine|mesh-list
13959275|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
13959276|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
13959277|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959278|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471458|NCT02331108|Sevoflurane|sevoflurane|mesh-list
13959279|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
14755228|NCT04275661|Analgesics|analgesics|mesh-ancestor
13896892|NCT01225393|Adalimumab|adalimumab|mesh-list
13896893|NCT01225393|Methotrexate|methotrexate|mesh-list
13896894|NCT01225393|Leflunomide|leflunomide|mesh-list
13896895|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13896896|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
13896897|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13896898|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896899|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13896900|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
13896901|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896902|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896903|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
13896904|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896905|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13896906|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13896907|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
13896908|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13896909|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13896910|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896911|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13896912|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
13896913|NCT01225380|Ribavirin|ribavirin|mesh-list
13896914|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
13896915|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896916|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
13896917|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896918|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
13896919|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896920|NCT01224795|Peramivir|peramivir|mesh-list
13896921|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
13896922|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896923|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896924|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896925|NCT01224262|Vaccines|vaccines|mesh-list
13896926|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
13896927|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896928|NCT01222702|Vancomycin|vancomycin|mesh-list
13896929|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
13896930|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13896931|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896932|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13896933|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896934|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896935|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13896936|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896937|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13896938|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896939|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896940|NCT01220947|Ritonavir|ritonavir|mesh-list
13896941|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13896942|NCT01220947|Lactams|lactams|mesh-list
13896943|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13896944|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13896945|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
13896946|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896947|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896948|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13896949|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13896950|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
13896951|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13896952|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13896953|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13896954|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13896955|NCT01220271|Temozolomide|temozolomide|mesh-list
13896956|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13896957|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
13896958|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896959|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13896960|NCT01207115|Naproxen|naproxen|mesh-list
13896961|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13896962|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13896963|NCT01207115|Analgesics|analgesics|mesh-ancestor
13896964|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
13896965|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896966|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896967|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13896968|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13896969|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
13896970|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13896971|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13896972|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896973|NCT01205061|Lidocaine|lidocaine|mesh-list
14755229|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
14755230|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755231|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755232|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14755233|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13896974|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
13896975|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
13896976|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896977|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896978|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
13896979|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896980|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13896981|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13896982|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13896983|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896984|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755234|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
14755235|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
14932276|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896985|NCT01205048|Lidocaine|lidocaine|mesh-list
14755236|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896986|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
13896987|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
13896988|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13896989|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13896990|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
13896991|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13896992|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13896993|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13896994|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13896995|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13896996|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13896997|NCT01204762|Entecavir|entecavir|mesh-list
13896998|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
13896999|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897000|NCT01204749|Paclitaxel|paclitaxel|mesh-list
13897001|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13897002|NCT01204749|Trebananib|trebananib|mesh-list
13897003|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
13897004|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13897005|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897006|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897007|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897008|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897009|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897010|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13897011|NCT01204749|Growth Substances|growth substances|mesh-ancestor
13897012|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897013|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
13897014|NCT01204099|Docetaxel|docetaxel|mesh-list
13897015|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897016|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897017|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897018|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897019|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897020|NCT01198834|Etodolac|etodolac|mesh-list
13897021|NCT01198834|Lidocaine|lidocaine|mesh-list
13897022|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
13897023|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
13897024|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897025|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897026|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
13897027|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897028|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13897029|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13897030|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13897031|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897032|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897033|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13897034|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13897035|NCT01198834|Analgesics|analgesics|mesh-ancestor
13897036|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897037|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897038|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13897039|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13897040|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897041|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
13897042|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897043|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897044|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897045|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897046|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897047|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897048|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897049|NCT01194960|Docetaxel|docetaxel|mesh-list
13897050|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897051|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897052|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897053|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897054|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897055|NCT01193361|Interferons|interferons|mesh-list
13897056|NCT01193361|Ribavirin|ribavirin|mesh-list
13897057|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
13897058|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
13897059|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13897060|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897061|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
13897062|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897063|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
13897064|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897065|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
13897066|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897067|NCT01193140|Temozolomide|temozolomide|mesh-list
13897068|NCT01193140|Veliparib|veliparib|mesh-list
13897069|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13897070|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
13897071|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897072|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897073|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13897074|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897075|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
13897076|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13897077|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897078|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897079|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13897080|NCT01192035|Ritonavir|ritonavir|mesh-list
13897081|NCT01192035|Lopinavir|lopinavir|mesh-list
13897082|NCT01192035|Nevirapine|nevirapine|mesh-list
13897083|NCT01192035|Efavirenz|efavirenz|mesh-list
13897084|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13897085|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13897086|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
13897087|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897088|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897089|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13897090|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13897091|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
13897092|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897093|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13897094|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13897095|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13897096|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13897097|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13897098|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13897099|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13897100|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13897101|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13897102|NCT01189396|Albuterol|albuterol|mesh-list
13897103|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13897104|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
13897105|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897106|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897107|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13897108|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
13897109|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
13897110|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13897111|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13897112|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13897113|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13897114|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
13897115|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897116|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897117|NCT01188187|Dexamethasone|dexamethasone|mesh-list
13897118|NCT01188187|Prednisone|prednisone|mesh-list
13897119|NCT01188187|Docetaxel|docetaxel|mesh-list
13897120|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897121|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
13897122|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
13897123|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897124|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897125|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13897126|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
13897127|NCT01188187|Hormones|hormones|mesh-ancestor
13897128|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897129|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13897130|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897131|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897132|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897133|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897134|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897135|NCT01186991|Paclitaxel|paclitaxel|mesh-list
13897136|NCT01186991|Bevacizumab|bevacizumab|mesh-list
13897137|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13897138|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13897139|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897140|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897141|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897142|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897143|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897144|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755237|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13897145|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13897146|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13897147|NCT01186991|Growth Substances|growth substances|mesh-ancestor
13897148|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897149|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
13897150|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
13897151|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13897152|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897153|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13897154|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897155|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897156|NCT01183949|Bortezomib|bortezomib|mesh-list
13897157|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897158|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13897159|NCT01180634|Levofloxacin|levofloxacin|mesh-list
13897160|NCT01180634|Ofloxacin|ofloxacin|mesh-list
13897161|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13897162|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897163|NCT01180634|Renal Agents|renal agents|mesh-ancestor
13897164|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897165|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897166|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897167|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897168|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897169|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897170|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13897171|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13897172|NCT01175785|Cyclosporine|cyclosporine|mesh-list
13897173|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
13897174|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
14755238|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13897175|NCT01175785|Fludarabine|fludarabine|mesh-list
13897176|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
13897177|NCT01175785|Cyclosporins|cyclosporins|mesh-list
13897178|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897179|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
13897180|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897181|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897182|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13897183|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
13897184|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897185|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897186|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13897187|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13897188|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
13897189|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897190|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
13897191|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897192|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
13897193|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13897194|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13897195|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13897196|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
13897197|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897198|NCT01174732|Albuterol|albuterol|mesh-list
13897199|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13897200|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
13897201|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897202|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897203|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13897204|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
13897205|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
13897206|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13897207|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13897208|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13897209|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13897210|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
13897211|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897212|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897213|NCT01173497|Irinotecan|irinotecan|mesh-list
13897214|NCT01173497|Iniparib|iniparib|mesh-list
13897215|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13897216|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897217|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897218|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897219|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897220|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13897221|NCT01171313|Carbidopa|carbidopa|mesh-list
13897222|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13897223|NCT01171313|Levodopa|levodopa|mesh-list
13897224|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13897225|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13897226|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
13897227|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897228|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897229|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897230|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13897231|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897232|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13897233|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
13897234|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
13897235|NCT01170650|Doxorubicin|doxorubicin|mesh-list
13897236|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13897237|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13897238|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897239|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897240|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897241|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897242|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897243|NCT01169259|Vitamin D|vitamin d|mesh-list
14755239|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755240|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755241|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14755242|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
14755243|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13897244|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
13897245|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
13897246|NCT01169259|Vitamins|vitamins|mesh-list
13897247|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
13897248|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897249|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13897250|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13897251|NCT01168713|Levofloxacin|levofloxacin|mesh-list
13897252|NCT01168713|Ofloxacin|ofloxacin|mesh-list
13897253|NCT01168713|Solithromycin|solithromycin|mesh-list
13897254|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13897255|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897256|NCT01168713|Renal Agents|renal agents|mesh-ancestor
13897257|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897258|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897259|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897260|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897261|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897262|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897263|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13897264|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13897265|NCT01168310|Fluticasone|fluticasone|mesh-list
13897266|NCT01168310|Xhance|xhance|mesh-list
13897267|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
13897268|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897269|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13897270|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
13897271|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897272|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897273|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13897274|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
13897275|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
13897276|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13897277|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13897278|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13897279|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13897280|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
13897281|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897282|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897283|NCT01167166|ON 01910|on 01910|mesh-list
13897284|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897285|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13897286|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897287|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897288|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
13897289|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13897290|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
13897291|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13897292|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897293|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13897294|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13897295|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13897296|NCT01160601|Paclitaxel|paclitaxel|mesh-list
13897297|NCT01160601|Carboplatin|carboplatin|mesh-list
13897298|NCT01160601|Bavituximab|bavituximab|mesh-list
13897299|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13897300|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897301|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897302|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
14755244|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897303|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897304|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897305|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13897306|NCT01159249|Vildagliptin|vildagliptin|mesh-list
13897307|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13897308|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897309|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13897310|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
13897311|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897312|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897313|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
13897314|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13897315|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897316|NCT01156415|S 20098|s 20098|mesh-list
13897317|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13897318|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897319|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897320|NCT01150695|Vaccines|vaccines|mesh-list
13897321|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
13897322|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897323|NCT01143246|Terlipressin|terlipressin|mesh-list
13897324|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13897325|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13897326|NCT01143064|Progesterone|progesterone|mesh-list
13897327|NCT01143064|Progestins|progestins|mesh-ancestor
14932277|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932278|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14932279|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14932280|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
14932281|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932282|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932283|NCT01444196|Desloratadine|desloratadine|mesh-list
14932284|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14932285|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
14932286|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932287|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932288|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932289|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14932290|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14932291|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
14932292|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
14932293|NCT01444248|Metformin|metformin|mesh-list
14932294|NCT01444248|Glimepiride|glimepiride|mesh-list
14932295|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14932296|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932297|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14932298|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932299|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
14932300|NCT01444339|Vaccines|vaccines|mesh-list
14932301|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14932302|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
13897328|NCT01143064|Hormones|hormones|mesh-ancestor
13897329|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897330|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897331|NCT01140217|Norethindrone|norethindrone|mesh-list
13897332|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
13897333|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13897334|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13897335|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13897336|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
13897337|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13897338|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897339|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13897340|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13897341|NCT01138163|Docetaxel|docetaxel|mesh-list
13897342|NCT01138163|Bavituximab|bavituximab|mesh-list
13897343|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897344|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897345|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897346|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897347|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897348|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13897349|NCT01137968|Bevacizumab|bevacizumab|mesh-list
13897350|NCT01137968|Imetelstat|imetelstat|mesh-list
13897351|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
13963342|NCT03145584|Bupivacaine|bupivacaine|mesh-list
14932303|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897352|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13897353|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897354|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13897355|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13897356|NCT01137968|Growth Substances|growth substances|mesh-ancestor
13897357|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897358|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
13897359|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897360|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897361|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13897362|NCT01137526|Donepezil|donepezil|mesh-list
13897363|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13897364|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897365|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897366|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
13897367|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897368|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897369|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
13897370|NCT01133990|Leucovorin|leucovorin|mesh-list
13897371|NCT01133990|Bevacizumab|bevacizumab|mesh-list
13897372|NCT01133990|Fluorouracil|fluorouracil|mesh-list
13897373|NCT01133990|Irinotecan|irinotecan|mesh-list
13897374|NCT01133990|Calcium|calcium|mesh-list
13897375|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
13897376|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13897377|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897378|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13897379|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13897380|NCT01133990|Growth Substances|growth substances|mesh-ancestor
13897381|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897382|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
13897383|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13897384|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
13897385|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897386|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13897387|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897388|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
13897389|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13897390|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897391|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897392|NCT01133990|Antidotes|antidotes|mesh-ancestor
13897393|NCT01133990|Protective Agents|protective agents|mesh-ancestor
13897394|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
13897395|NCT01133990|Vitamins|vitamins|mesh-ancestor
13897396|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
13897397|NCT01130142|Gemcitabine|gemcitabine|mesh-list
13897398|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13897399|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
13897400|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897401|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897402|NCT01130142|Antiviral Agents|antiviral agents|mesh-ancestor
13897403|NCT01130142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897404|NCT01130142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897405|NCT01130142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897406|NCT01130142|Immunologic Factors|immunologic factors|mesh-ancestor
13897407|NCT01130142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897408|NCT01129674|Olanzapine|olanzapine|mesh-list
13897409|NCT01129674|Risperidone|risperidone|mesh-list
13897410|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13897411|NCT01129674|Aripiprazole|aripiprazole|mesh-list
13897412|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13897413|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
13897414|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897415|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897416|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897417|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13897418|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13897419|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897420|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13897421|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13897422|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
13897423|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
13897424|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
14755245|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13897425|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897426|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13897427|NCT01129674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13897428|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13897429|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897430|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
13897431|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
13897432|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13897433|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13897434|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13897435|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13897436|NCT01129648|Allopurinol|allopurinol|mesh-list
13897437|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
13897438|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897439|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897440|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
13897441|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897442|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13897443|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
13897444|NCT01129648|Protective Agents|protective agents|mesh-ancestor
13897445|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897446|NCT01128530|Linezolid|linezolid|mesh-list
13897447|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897448|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897449|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13897450|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897451|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897452|NCT01128335|Tacrolimus|tacrolimus|mesh-list
13897453|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897454|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
13897455|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897456|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13897457|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897458|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897459|NCT01126970|Orlistat|orlistat|mesh-list
13897460|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897461|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897462|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13897463|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13897464|NCT01126190|Docetaxel|docetaxel|mesh-list
13897465|NCT01126190|Doxorubicin|doxorubicin|mesh-list
13897466|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897467|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897468|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897469|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897470|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897471|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13897472|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897473|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897474|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897475|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
13897476|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13897477|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13897478|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13897479|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897480|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897481|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
13897482|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897483|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897484|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13897485|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959280|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959281|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
13959282|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
13959283|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959284|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959285|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13959286|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959287|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959288|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959289|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959290|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959291|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
13959292|NCT03164109|Protective Agents|protective agents|mesh-ancestor
13959293|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
13963343|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
13897486|NCT01122784|Vaccines|vaccines|mesh-list
13897487|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
13897488|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897489|NCT01120470|Prednisone|prednisone|mesh-list
13897490|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897491|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
13897492|NCT01120470|Hormones|hormones|mesh-ancestor
13897493|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897494|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897495|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13897496|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897497|NCT01117584|Metformin|metformin|mesh-list
13897498|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
13897499|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13897500|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897501|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13897502|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897503|NCT01116141|Folic Acid|folic acid|mesh-list
13897504|NCT01116141|Methotrexate|methotrexate|mesh-list
13897505|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13897506|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
13897507|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13897508|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897509|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13897510|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
13897511|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897512|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897513|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
13897514|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897515|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13897516|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897517|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
13897518|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897519|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13897520|NCT01116141|Hematinics|hematinics|mesh-ancestor
13897521|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
13897522|NCT01116141|Vitamins|vitamins|mesh-ancestor
13897523|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
13897524|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13897525|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13897526|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13897527|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897528|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897529|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897530|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897531|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13897532|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
13897533|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13897534|NCT01114308|Buprenorphine|buprenorphine|mesh-list
13897535|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13897536|NCT01114308|Narcotics|narcotics|mesh-ancestor
13897537|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897538|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897539|NCT01114308|Analgesics|analgesics|mesh-ancestor
13897540|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
13897541|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897542|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13897543|NCT01113957|Doxorubicin|doxorubicin|mesh-list
13897544|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13897545|NCT01113957|Temozolomide|temozolomide|mesh-list
13897546|NCT01113957|Veliparib|veliparib|mesh-list
13897547|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13897548|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897549|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897550|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897551|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897552|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897553|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13897554|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
13897555|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13897556|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
13897557|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13897558|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
13897559|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897560|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897561|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13897562|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
13897563|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13897564|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13897565|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13897566|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
13897567|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897568|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897569|NCT01111955|Metformin|metformin|mesh-list
13897570|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13897571|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897572|NCT01111773|Lidocaine|lidocaine|mesh-list
13897573|NCT01111773|Tetracaine|tetracaine|mesh-list
13897574|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
13897575|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
13897576|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897577|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897578|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
13897579|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897580|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13897581|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13897582|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13897583|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897584|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897585|NCT01110902|S 20098|s 20098|mesh-list
13897586|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13897587|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897588|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897589|NCT01110889|S 20098|s 20098|mesh-list
13897590|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13897591|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897592|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897593|NCT01110746|Insulin|insulin|mesh-list
13897594|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13897595|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13897596|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897597|NCT01107496|Viloxazine|viloxazine|mesh-list
13897598|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13897599|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
13897600|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13897601|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13897602|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13897603|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897604|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897605|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
13897606|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897607|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897608|NCT01106989|Lidocaine|lidocaine|mesh-list
13897609|NCT01106989|Tetracaine|tetracaine|mesh-list
13897610|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
13897611|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
13897612|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897613|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897614|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
13897615|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897616|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13897617|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13897618|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13897619|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897620|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897621|NCT01106807|Adapalene|adapalene|mesh-list
13897622|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
13897623|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
13897624|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
13897625|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13897626|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13897627|NCT01106807|Analgesics|analgesics|mesh-ancestor
13897628|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
13897629|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897630|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897631|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897632|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897633|NCT01105624|Azithromycin|azithromycin|mesh-list
13897634|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13897635|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13897636|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897637|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897638|NCT01103349|Montelukast|montelukast|mesh-list
13897639|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13897640|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
13897641|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13897642|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
13897643|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897644|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897645|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13897646|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13897647|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897648|NCT01102660|Naproxen|naproxen|mesh-list
13897649|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13897650|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13897651|NCT01102660|Analgesics|analgesics|mesh-ancestor
13897652|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
13897653|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897654|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897655|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897656|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897657|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
13897658|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13897659|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897660|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897661|NCT01101594|Doxorubicin|doxorubicin|mesh-list
13897662|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13897663|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897664|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897665|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897666|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897667|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897668|NCT01098435|ALKS-33|alks-33|mesh-list
13897669|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13897670|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897671|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
13897672|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897673|NCT01097018|Capecitabine|capecitabine|mesh-list
13897674|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13897675|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
13897676|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897677|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897678|NCT01096966|Bupivacaine|bupivacaine|mesh-list
13897679|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
13897680|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
13897681|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897682|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897683|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
13897684|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897685|NCT01096862|Peficitinib|peficitinib|mesh-list
13897686|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897687|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897688|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897689|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
13897690|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897691|NCT01094262|Oxycodone|oxycodone|mesh-list
13897692|NCT01094262|Analgesics|analgesics|mesh-list
13897693|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13897694|NCT01094262|Narcotics|narcotics|mesh-ancestor
13897695|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897696|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897697|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
13897698|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897699|NCT01092143|Fluticasone|fluticasone|mesh-list
13897700|NCT01092143|Xhance|xhance|mesh-list
13897701|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897702|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13897703|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
13897704|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897705|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897706|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13897707|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
13897708|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
13897709|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13897710|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
13897711|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13897712|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897713|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13897714|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13897715|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
13897716|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897717|NCT01092065|Levodopa|levodopa|mesh-list
13897718|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13897719|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13897720|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
13897721|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897722|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897723|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897724|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13897725|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13897726|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897727|NCT01089790|Incretins|incretins|mesh-ancestor
13897728|NCT01089790|Hormones|hormones|mesh-ancestor
13897729|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897730|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13897731|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
13897732|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897733|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897734|NCT01087151|Rituximab|rituximab|mesh-list
13897735|NCT01087151|Navitoclax|navitoclax|mesh-list
13897736|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13897737|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897738|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
13897739|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897740|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897741|NCT01086748|Risperidone|risperidone|mesh-list
13897742|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13897743|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
13897744|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897745|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897746|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897747|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13897748|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13897749|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897750|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13897751|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13897752|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
13897753|NCT01086267|Cetuximab|cetuximab|mesh-list
13897754|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13897755|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897756|NCT01084330|Docetaxel|docetaxel|mesh-list
13897757|NCT01084330|Irinotecan|irinotecan|mesh-list
13897758|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897759|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897760|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897761|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897762|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897763|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13897764|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897765|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028480|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14028481|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
14028482|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
14028483|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
14028484|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028485|NCT02730026|Ketoprofen|ketoprofen|mesh-list
14028486|NCT02730026|Omeprazole|omeprazole|mesh-list
14028487|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14028488|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028489|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14028490|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028491|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028492|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14028493|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14028494|NCT02730026|Analgesics|analgesics|mesh-ancestor
14028495|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
14028496|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028497|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028498|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028499|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028500|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14028501|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14028502|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14028503|NCT02729961|Ceritinib|ceritinib|mesh-list
14028504|NCT02729961|Antibodies|antibodies|mesh-list
14755246|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
14755247|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14755248|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
14755249|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
14755250|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14028505|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
13897766|NCT01084161|Morphine|morphine|mesh-list
14028506|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14755251|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897767|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13897768|NCT01084161|Narcotics|narcotics|mesh-ancestor
13897769|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897770|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897771|NCT01084161|Analgesics|analgesics|mesh-ancestor
13897772|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
13897773|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897774|NCT01083615|Prednisone|prednisone|mesh-list
13897775|NCT01083615|Docetaxel|docetaxel|mesh-list
13897776|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897777|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
13897778|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
13897779|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
13897780|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897781|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13897782|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
13897783|NCT01083615|Hormones|hormones|mesh-ancestor
13897784|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897785|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897786|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13897787|NCT01082549|Gemcitabine|gemcitabine|mesh-list
13897788|NCT01082549|Carboplatin|carboplatin|mesh-list
13897789|NCT01082549|Iniparib|iniparib|mesh-list
13897790|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897791|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13897792|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
13897793|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897794|NCT01082549|Antiviral Agents|antiviral agents|mesh-ancestor
13897795|NCT01082549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897796|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897797|NCT01082549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897798|NCT01082549|Immunologic Factors|immunologic factors|mesh-ancestor
13897799|NCT01082549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897800|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13897801|NCT01082068|Letrozole|letrozole|mesh-list
13897802|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897803|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13897804|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13897805|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897806|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897807|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13897808|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
13897809|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897810|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897811|NCT01081782|Ceralifimod|ceralifimod|mesh-list
13897812|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13897813|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897814|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897815|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
13897816|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897817|NCT01080222|Ribavirin|ribavirin|mesh-list
13897818|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13897819|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
13897820|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897821|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
13897822|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897823|NCT01077297|Tezosentan|tezosentan|mesh-list
13897824|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
13897825|NCT01076764|Heparin|heparin|mesh-list
13897826|NCT01076764|Calcium heparin|calcium heparin|mesh-list
13897827|NCT01076764|Otamixaban|otamixaban|mesh-list
13897828|NCT01076764|Eptifibatide|eptifibatide|mesh-list
13897829|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
13897830|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13897831|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13897832|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897833|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13897834|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13897835|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
13897836|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13897837|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
13897838|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897839|NCT01074294|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
14932304|NCT01444352|Vaccines|vaccines|mesh-list
13897840|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897841|NCT01072981|Gemcitabine|gemcitabine|mesh-list
13897842|NCT01072981|Fluorouracil|fluorouracil|mesh-list
13897843|NCT01072981|Pancrelipase|pancrelipase|mesh-list
13897844|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
13897845|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14932305|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14932306|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
14932307|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932308|NCT01444469|Azithromycin|azithromycin|mesh-list
14932309|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14932310|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932311|NCT01444521|Irinotecan|irinotecan|mesh-list
14932312|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932313|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13897846|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
13897847|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897848|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897849|NCT01072981|Antiviral Agents|antiviral agents|mesh-ancestor
13897850|NCT01072981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897851|NCT01072981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897852|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897853|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897854|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13897855|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
14932314|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14932315|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932316|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932317|NCT01444547|Paclitaxel|paclitaxel|mesh-list
13897856|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13897857|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897858|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897859|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13897860|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13897861|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897862|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897863|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897864|NCT01071850|Metformin|metformin|mesh-list
13897865|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
13897866|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13897867|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897868|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13897869|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897870|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
13897871|NCT01071239|Busulfan|busulfan|mesh-list
13897872|NCT01071239|Fludarabine|fludarabine|mesh-list
13897873|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897874|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
13897875|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897876|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13897877|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13897878|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
13897879|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897880|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897881|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13897882|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
13897883|NCT01069692|Hematinics|hematinics|mesh-ancestor
13897884|NCT01068704|Letrozole|letrozole|mesh-list
13897885|NCT01068704|Lapatinib|lapatinib|mesh-list
13897886|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897887|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13897888|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13897889|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897890|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897891|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13897892|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
13897893|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13897894|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897895|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13897896|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
13897897|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13897898|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
13897899|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932318|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13897900|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932319|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13897901|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13897902|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
13897903|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
13897904|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13897905|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
13897906|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897907|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897908|NCT01065012|Udenafil|udenafil|mesh-list
13897909|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13897910|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13897911|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897912|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897913|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
13897914|NCT01064791|Tacrolimus|tacrolimus|mesh-list
13897915|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13897916|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
13897917|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897918|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13897919|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897920|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897921|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13897922|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13897923|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13897924|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
13897925|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897926|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897927|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
13897928|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13897929|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13897930|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13897931|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897932|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897933|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
13897934|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13897935|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897936|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13897937|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897938|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13897939|NCT01060579|Latanoprost|latanoprost|mesh-list
13897940|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13897941|NCT01057667|Ribavirin|ribavirin|mesh-list
13897942|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13897943|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
13897944|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897945|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
13897946|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897947|NCT01057147|Rebamipide|rebamipide|mesh-list
13897948|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13897949|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13897950|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13897951|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13897952|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
13897953|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897954|NCT01057147|Protective Agents|protective agents|mesh-ancestor
13897955|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897956|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897957|NCT01056393|Ibalizumab|ibalizumab|mesh-list
13897958|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13897959|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13897960|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13897961|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
13897962|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897963|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
13897964|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897965|NCT01055444|Lidocaine|lidocaine|mesh-list
13897966|NCT01055444|Tetracaine|tetracaine|mesh-list
13897967|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
13897968|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
13897969|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897970|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897971|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
13897972|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897973|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13897974|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13897975|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13897976|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13897977|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13897978|NCT01055106|Metronidazole|metronidazole|mesh-list
13897979|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13897980|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13897981|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13897982|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13897983|NCT01055015|Morphine|morphine|mesh-list
13897984|NCT01055015|Oxycodone|oxycodone|mesh-list
13897985|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13897986|NCT01055015|Narcotics|narcotics|mesh-ancestor
13897987|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13897988|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13897989|NCT01055015|Analgesics|analgesics|mesh-ancestor
13897990|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
13897991|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13897992|NCT01051414|Asunaprevir|asunaprevir|mesh-list
13897993|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
13897994|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13897995|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471459|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471460|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471461|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14471462|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14471463|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
14471464|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13959294|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13959295|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13959296|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959297|NCT03163914|Phenylephrine|phenylephrine|mesh-list
13959298|NCT03163914|Epinephrine|epinephrine|mesh-list
13959299|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
13959300|NCT03163914|Norepinephrine|norepinephrine|mesh-list
13959301|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13959302|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13959303|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
13959304|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959305|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959306|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959307|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13959308|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13959309|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
13959310|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959311|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13959312|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
13959313|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
13959314|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
13959315|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13959316|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13959317|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
13959318|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13959319|NCT03163914|Protective Agents|protective agents|mesh-ancestor
13959320|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
13959321|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13959322|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959323|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959324|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959325|NCT03163693|Analgesics|analgesics|mesh-ancestor
13959326|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
13959327|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959328|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13959329|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13959330|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13959331|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
13959332|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959333|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959334|NCT03163680|Omeprazole|omeprazole|mesh-list
13959335|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13959336|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959337|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13959338|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959339|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959340|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13959341|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13898002|NCT01046422|Metformin|metformin|mesh-list
13898003|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13898004|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898005|NCT01044381|Luliconazole|luliconazole|mesh-list
13898006|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
13898007|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898008|NCT01043029|Pioglitazone|pioglitazone|mesh-list
13898009|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13898010|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898011|NCT01042925|Paclitaxel|paclitaxel|mesh-list
13898012|NCT01042925|Trastuzumab|trastuzumab|mesh-list
13898013|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13898014|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898015|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898016|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898017|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898018|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898019|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13898020|NCT01038804|Docetaxel|docetaxel|mesh-list
13898021|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898022|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898023|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898024|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898025|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898026|NCT01038739|Mesalamine|mesalamine|mesh-list
13898027|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898028|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898029|NCT01038739|Analgesics|analgesics|mesh-ancestor
13898030|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
13898031|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898032|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898033|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898034|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898035|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
13898036|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13898037|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13898038|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898039|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898040|NCT01037179|Analgesics|analgesics|mesh-ancestor
13898041|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
13898042|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898043|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898044|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898045|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028507|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
14028508|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
14028509|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028510|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028511|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14028512|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028513|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028514|NCT02729662|Tolvaptan|tolvaptan|mesh-list
14028515|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14028516|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028517|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
14028518|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028519|NCT02729766|Empagliflozin|empagliflozin|mesh-list
14028520|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14028521|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028522|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14028523|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028524|NCT02729714|Suvorexant|suvorexant|mesh-list
14028525|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14028526|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14028527|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028528|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028529|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14028530|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028531|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028532|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13898046|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13898047|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13898048|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13898049|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
13898050|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
13898051|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898052|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898053|NCT01037166|Entecavir|entecavir|mesh-list
13898054|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
13898055|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898056|NCT01037062|Entecavir|entecavir|mesh-list
13898057|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
13898058|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898059|NCT01037036|Latanoprost|latanoprost|mesh-list
13898060|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13898061|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13898062|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13898063|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13898064|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898065|NCT01035879|Incretins|incretins|mesh-ancestor
13898066|NCT01035879|Hormones|hormones|mesh-ancestor
13898067|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898068|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13898069|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
13898070|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898071|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898072|NCT01035502|Idarubicin|idarubicin|mesh-list
13898073|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13898074|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898075|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13898076|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13898077|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898078|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898079|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13898080|NCT01033292|Iniparib|iniparib|mesh-list
13898081|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898082|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898083|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898084|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13898085|NCT01033123|Iniparib|iniparib|mesh-list
13898086|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898087|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898088|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898089|NCT01030432|Ribavirin|ribavirin|mesh-list
13898090|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13898091|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
13898092|NCT01030432|Asunaprevir|asunaprevir|mesh-list
13898093|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
13898094|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898095|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
13898096|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898097|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
13898098|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898099|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
13898100|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898101|NCT01029873|Cisplatin|cisplatin|mesh-list
13898102|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898103|NCT01027013|Rebamipide|rebamipide|mesh-list
13898104|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13898105|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13898106|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13898107|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898108|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
13898109|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898110|NCT01027013|Protective Agents|protective agents|mesh-ancestor
13898111|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898112|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898113|NCT01025648|Epinephrine|epinephrine|mesh-list
13898114|NCT01025648|Racepinephrine|racepinephrine|mesh-list
13898115|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
13898116|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13898117|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13898118|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
13898119|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898120|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898121|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898122|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13898123|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13898124|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
13898125|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898126|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13898127|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
13898128|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
13898129|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
13898130|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13898131|NCT01024101|Paclitaxel|paclitaxel|mesh-list
13898132|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13898133|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898134|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898135|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898136|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898137|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898138|NCT01024062|Paclitaxel|paclitaxel|mesh-list
13898139|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13898140|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898141|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898142|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898143|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898144|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898145|NCT01023880|Delanzomib|delanzomib|mesh-list
13898146|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
13898147|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
13898148|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898149|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898150|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
13898151|NCT01023295|Combretastatin|combretastatin|mesh-list
13898152|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13898153|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898154|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898155|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898156|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898157|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898158|NCT01023204|Paclitaxel|paclitaxel|mesh-list
13898159|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13898160|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898161|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898162|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898163|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898164|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898165|NCT01022801|Entecavir|entecavir|mesh-list
13898166|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
13898167|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898168|NCT01020565|Entecavir|entecavir|mesh-list
13898169|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
13898170|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898171|NCT01020097|Fluorides|fluorides|mesh-list
13898172|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
13898173|NCT01020097|Protective Agents|protective agents|mesh-ancestor
13898174|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898175|NCT01019187|Modafinil|modafinil|mesh-list
13898176|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13898177|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898178|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
13898179|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13898180|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13898181|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898182|NCT01018875|Donepezil|donepezil|mesh-list
13898183|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13898184|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898185|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898186|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
13898187|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898188|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898189|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
13898190|NCT01016808|Morphine|morphine|mesh-list
13898191|NCT01016808|Oxycodone|oxycodone|mesh-list
13898192|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13898193|NCT01016808|Narcotics|narcotics|mesh-ancestor
13898194|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898195|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898196|NCT01016808|Analgesics|analgesics|mesh-ancestor
13898197|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
13898198|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898199|NCT01014078|Azithromycin|azithromycin|mesh-list
13898200|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13898201|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13898202|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13898203|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898204|NCT01012895|Interferons|interferons|mesh-list
13898205|NCT01012895|Ribavirin|ribavirin|mesh-list
13898206|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
13898207|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
13898208|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13898209|NCT01012895|Asunaprevir|asunaprevir|mesh-list
13898210|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898211|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
13898212|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898213|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
13898214|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898215|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
13898216|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898217|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
13898218|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898219|NCT01009775|Docetaxel|docetaxel|mesh-list
13898220|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898221|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898222|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898223|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898224|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898225|NCT01009242|Methotrexate|methotrexate|mesh-list
13898226|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13898227|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
13898228|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13898229|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898230|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13898231|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
13898232|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898233|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898234|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
13898235|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898236|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13898237|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13898238|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
13898239|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898240|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13898241|NCT01007721|Fluticasone|fluticasone|mesh-list
13898242|NCT01007721|Xhance|xhance|mesh-list
13898243|NCT01007721|Montelukast|montelukast|mesh-list
13898244|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898245|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13898246|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
13898247|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898248|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898249|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13898250|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
13898251|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
13898252|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13898253|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13898254|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
13898255|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898256|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13898257|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13898258|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898259|NCT01007292|Rituximab|rituximab|mesh-list
13898260|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13898261|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898262|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
13898263|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898264|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898265|NCT01007097|Glimepiride|glimepiride|mesh-list
13898266|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898267|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13898268|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898269|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13898270|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
14932320|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898271|NCT01005108|Gabapentin|gabapentin|mesh-list
13898272|NCT01005108|Analgesics|analgesics|mesh-ancestor
13898273|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
14932321|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898274|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898275|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898276|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
13898277|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13898278|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13898279|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898280|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13898281|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13898282|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13898283|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898284|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898285|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
13898286|NCT01004081|Exemestane|exemestane|mesh-list
13898287|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898288|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13898289|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13898290|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898291|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898292|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13898293|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
13898294|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898295|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898296|NCT01002820|Ganaxolone|ganaxolone|mesh-list
13898297|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
13898298|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898299|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898300|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898301|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
13898302|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
13898303|NCT01002248|Dexamethasone|dexamethasone|mesh-list
13898304|NCT01002248|Bortezomib|bortezomib|mesh-list
13898305|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898306|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
13898307|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
13898308|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898309|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898310|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898311|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
13898312|NCT01002248|Hormones|hormones|mesh-ancestor
13898313|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898314|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13898315|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898316|NCT01001923|Fasinumab|fasinumab|mesh-list
13898317|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898318|NCT01001923|Analgesics|analgesics|mesh-ancestor
13898319|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
13898320|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898321|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755252|NCT04256317|Azacitidine|azacitidine|mesh-list
14755253|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755254|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
14755255|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755256|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755257|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755258|NCT04255433|Dulaglutide|dulaglutide|mesh-list
14755259|NCT04255433|Tirzepatide|tirzepatide|mesh-list
14755260|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14755261|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755262|NCT04255433|Incretins|incretins|mesh-ancestor
14755263|NCT04255433|Hormones|hormones|mesh-ancestor
14755264|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755265|NCT04249362|Durvalumab|durvalumab|mesh-list
14755266|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755267|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898322|NCT01001715|Fasinumab|fasinumab|mesh-list
13898323|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14755268|NCT04232553|Mirikizumab|mirikizumab|mesh-list
14755269|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14755270|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898324|NCT01001715|Analgesics|analgesics|mesh-ancestor
13898325|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
13898326|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898327|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898328|NCT01001338|Allopurinol|allopurinol|mesh-list
13898329|NCT01001338|Lesinurad|lesinurad|mesh-list
13898330|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
13898331|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898332|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898333|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
13898334|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898335|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13898336|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
13898337|NCT01001338|Protective Agents|protective agents|mesh-ancestor
13898338|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898339|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
13898340|NCT01001338|Renal Agents|renal agents|mesh-ancestor
13898341|NCT01001091|Dexamethasone|dexamethasone|mesh-list
13898342|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13898343|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13898344|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898345|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
13898346|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
13898347|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898348|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898349|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898350|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
13898351|NCT01001091|Hormones|hormones|mesh-ancestor
13898352|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898353|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13898354|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898355|NCT01000922|Insulin|insulin|mesh-list
13898356|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13898357|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
13898358|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13898359|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898360|NCT00994292|Darexaban|darexaban|mesh-list
13898361|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13898362|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
13898363|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13898364|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
13898365|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898366|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898367|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
13898368|NCT00993382|Amiodarone|amiodarone|mesh-list
13898369|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898370|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
13898371|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13898372|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13898373|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898374|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13898375|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13898376|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13898377|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898378|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13898379|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13898380|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13898381|NCT00992732|Valganciclovir|valganciclovir|mesh-list
13898382|NCT00992732|Ganciclovir|ganciclovir|mesh-list
13898383|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13898384|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
13898385|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
13898386|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898387|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13898388|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898389|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898390|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898391|NCT00992563|Ranibizumab|ranibizumab|mesh-list
13898392|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13898393|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13898394|NCT00992563|Growth Substances|growth substances|mesh-ancestor
13898395|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898396|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
13898397|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898398|NCT00991172|Fasinumab|fasinumab|mesh-list
13898399|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898400|NCT00991172|Analgesics|analgesics|mesh-ancestor
13898401|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
13898402|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898403|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898404|NCT00991068|Lidocaine|lidocaine|mesh-list
13898405|NCT00991068|Tetracaine|tetracaine|mesh-list
13898406|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
13898407|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
13898408|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898409|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898410|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
13898411|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898412|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898413|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13898414|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13898415|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13898416|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898417|NCT00990912|Carboplatin|carboplatin|mesh-list
13898418|NCT00990912|Irinotecan|irinotecan|mesh-list
13898419|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898420|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13898421|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13898422|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898423|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898424|NCT00990327|Adenosine|adenosine|mesh-list
13898425|NCT00990327|Analgesics|analgesics|mesh-ancestor
13898426|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
13898427|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898428|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898429|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898430|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
13898431|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13898432|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
13898433|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
13898434|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898435|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898436|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
13898437|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13898438|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13898439|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898440|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898441|NCT00987272|Analgesics|analgesics|mesh-ancestor
13898442|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
13898443|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898444|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898445|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898446|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898447|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13898448|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13898449|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13898450|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
13898451|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
13898452|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898453|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898454|NCT00986882|Ibuprofen|ibuprofen|mesh-list
13898455|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898456|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898457|NCT00986882|Analgesics|analgesics|mesh-ancestor
13898458|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
13898459|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898460|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898461|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14471465|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13898462|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14471466|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
13898463|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13898464|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898465|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898466|NCT00983814|Carbidopa|carbidopa|mesh-list
13898467|NCT00983814|Droxidopa|droxidopa|mesh-list
13898468|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13898469|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13898470|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
13898471|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898472|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898473|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898474|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13898475|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898476|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
13898477|NCT00982696|Mitogens|mitogens|mesh-list
13898478|NCT00982696|Enkephalin, Methionine|enkephalin, methionine|mesh-list
13898479|NCT00982696|Enkephalins|enkephalins|mesh-list
13898480|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
13898481|NCT00982696|Narcotics|narcotics|mesh-ancestor
13898482|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898483|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898484|NCT00982696|Analgesics|analgesics|mesh-ancestor
13898485|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
13898486|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898487|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898488|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898489|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898490|NCT00981617|ALKS-33|alks-33|mesh-list
13898491|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13898492|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898493|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
13898494|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898495|NCT00981357|Naproxen|naproxen|mesh-list
13898496|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898497|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898498|NCT00981357|Analgesics|analgesics|mesh-ancestor
13898499|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
13898500|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898501|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898502|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898503|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898504|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
13898505|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13898506|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898507|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898508|NCT00979251|Oseltamivir|oseltamivir|mesh-list
13898509|NCT00979251|Amantadine|amantadine|mesh-list
13898510|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
13898511|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898512|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898513|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898514|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13898515|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13898516|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
13898517|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898518|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898519|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898520|NCT00979251|Analgesics|analgesics|mesh-ancestor
13898521|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
13898522|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898523|NCT00978497|Ribavirin|ribavirin|mesh-list
13898524|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
13898525|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898526|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
13898527|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959342|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959343|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
13959344|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13959345|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13959346|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959347|NCT03164161|Endorphins|endorphins|mesh-list
13959348|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959349|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959350|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959351|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
13898528|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
13898529|NCT00978016|Baclofen|baclofen|mesh-list
13898530|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13898531|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898532|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898533|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13898534|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898535|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13898536|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898537|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13898538|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
13898539|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
13898540|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898541|NCT00975091|Entecavir|entecavir|mesh-list
13898542|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
13898543|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898544|NCT00973284|Mannitol|mannitol|mesh-list
13898545|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13898546|NCT00973284|Diuretics|diuretics|mesh-ancestor
13898547|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
13898548|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898549|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13898550|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
13898551|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898552|NCT00969722|Tretinoin|tretinoin|mesh-list
13898553|NCT00969722|Molgramostim|molgramostim|mesh-list
13898554|NCT00969722|Isotretinoin|isotretinoin|mesh-list
13898555|NCT00969722|Sargramostim|sargramostim|mesh-list
13898556|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
13898557|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898558|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898559|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
13898560|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
13898561|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
14028533|NCT02729870|Laxatives|laxatives|mesh-ancestor
14028534|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028535|NCT02729805|Ketamine|ketamine|mesh-list
14028536|NCT02729805|Analgesics|analgesics|mesh-ancestor
14028537|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
14028538|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028539|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028540|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14028541|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14028542|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
14028543|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
14028544|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028545|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14028546|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14028547|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028548|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028549|NCT02729935|Parecoxib|parecoxib|mesh-list
14028550|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14028551|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14028552|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028553|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028554|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14028555|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14028556|NCT02729935|Analgesics|analgesics|mesh-ancestor
14028557|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
14028558|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028559|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028560|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028561|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028562|NCT02729285|Ketorolac|ketorolac|mesh-list
14028563|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14028564|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14028565|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14028566|NCT02729285|Analgesics|analgesics|mesh-ancestor
14028567|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
14028568|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028569|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028570|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028571|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028572|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13898562|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13898563|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13898564|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13898565|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13898566|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898567|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
14932322|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
14932323|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
14932324|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932325|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
14932326|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14932327|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
14932328|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14932329|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
14932330|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932331|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898568|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898569|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898570|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13898571|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898572|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
13898573|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13898574|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13898575|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13898576|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13898577|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898578|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
13898579|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898580|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898581|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13898582|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898583|NCT00966953|Honokiol|honokiol|mesh-list
13898584|NCT00966953|Triclosan|triclosan|mesh-list
13898585|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13898586|NCT00966953|Fluorides|fluorides|mesh-list
13898587|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
13898588|NCT00966953|Protective Agents|protective agents|mesh-ancestor
13898589|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898590|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13898591|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898592|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13898593|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13898594|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
13898595|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898596|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13898597|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898598|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13898599|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898600|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898601|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898602|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898603|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13898604|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13898605|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13898606|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13898607|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13898608|NCT00963885|Lactams|lactams|mesh-list
13898609|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
13898610|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898611|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13898612|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
13898613|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
13898614|NCT00961675|Dexamethasone|dexamethasone|mesh-list
13898615|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
13898616|NCT00961675|Povidone|povidone|mesh-list
13898617|NCT00961675|BB 1101|bb 1101|mesh-list
13898618|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898619|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
13898620|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
13898621|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898622|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898623|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898624|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
13898625|NCT00961675|Hormones|hormones|mesh-ancestor
13898626|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898627|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13898628|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898629|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
14932332|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
13898630|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898631|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898632|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13898633|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898634|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13898635|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13898636|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13898637|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13898638|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
13898639|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
13898640|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13898641|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13898642|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13898643|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
13898644|NCT00959036|Methotrexate|methotrexate|mesh-list
13898645|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13898646|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
13898647|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13898648|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898649|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13898650|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
13898651|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898652|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898653|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
13898654|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898655|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13898656|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13898657|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
13898658|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898659|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13898660|NCT00957918|Nicotine|nicotine|mesh-list
13898661|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13898662|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
13898663|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898664|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898665|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13898666|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13898667|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
13898668|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898669|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898670|NCT00955981|Lesinurad|lesinurad|mesh-list
13898671|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
13898672|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898673|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
13898674|NCT00955981|Renal Agents|renal agents|mesh-ancestor
13898675|NCT00953420|Dexamethasone|dexamethasone|mesh-list
13898676|NCT00953420|Carboplatin|carboplatin|mesh-list
13898677|NCT00953420|Docetaxel|docetaxel|mesh-list
13898678|NCT00953420|Lenograstim|lenograstim|mesh-list
13898679|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898680|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
13898681|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
13898682|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898683|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898684|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898685|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
13898686|NCT00953420|Hormones|hormones|mesh-ancestor
13898687|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898688|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13898689|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898690|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898691|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
13898692|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
13898693|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898694|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13898695|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
13898696|NCT00950885|Melatonin|melatonin|mesh-list
13898697|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
13898698|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898699|NCT00950885|Protective Agents|protective agents|mesh-ancestor
13898700|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898701|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898702|NCT00948961|Poly I-C|poly i-c|mesh-list
13898703|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13898704|NCT00948961|Poly ICLC|poly iclc|mesh-list
13898705|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
13898706|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
13898707|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898708|NCT00948961|Laxatives|laxatives|mesh-ancestor
13898709|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898710|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
13898711|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898712|NCT00948909|Donepezil|donepezil|mesh-list
13898713|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13898714|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898715|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898716|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
13898717|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898718|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898719|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
13898720|NCT00948753|Maraviroc|maraviroc|mesh-list
13898721|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13898722|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
13898723|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898724|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13898725|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13898726|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
13898727|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898728|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13898729|NCT00948142|Linezolid|linezolid|mesh-list
13898730|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
13898731|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13898732|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898733|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13898734|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898735|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898736|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
13898737|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13898738|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898739|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
13898740|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
13898741|NCT00945802|Dexamethasone|dexamethasone|mesh-list
13898742|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
13898743|NCT00945802|BB 1101|bb 1101|mesh-list
13898744|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898745|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
14932333|NCT01444612|Heparin|heparin|mesh-list
14932334|NCT01444612|Calcium heparin|calcium heparin|mesh-list
14932335|NCT01444612|Enoxaparin|enoxaparin|mesh-list
14932336|NCT01444612|Dalteparin|dalteparin|mesh-list
14932337|NCT01444612|Tinzaparin|tinzaparin|mesh-list
14932338|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14932339|NCT01444612|PENTA|penta|mesh-list
14932340|NCT01444612|Fondaparinux|fondaparinux|mesh-list
14932341|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
14932342|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14932343|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14932344|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932345|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14932346|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
14932347|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14932348|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
14932349|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932350|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
13898746|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
13898747|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898748|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898749|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028573|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028574|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028575|NCT02729441|Ramipril|ramipril|mesh-list
14028576|NCT02729441|Perindopril|perindopril|mesh-list
14028577|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14028578|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
14028579|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028580|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028581|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14471467|NCT02331368|Lenalidomide|lenalidomide|mesh-list
13898750|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
13898751|NCT00945802|Hormones|hormones|mesh-ancestor
13959352|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
14932351|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932352|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13898752|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898753|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13898754|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028582|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
14028583|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028584|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028585|NCT02729467|Itraconazole|itraconazole|mesh-list
14028586|NCT02729467|Rifampin|rifampin|mesh-list
14028587|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
14028588|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028589|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14028590|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13898755|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
13898756|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898757|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898758|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13898759|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898760|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13898761|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13898762|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13898763|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13898764|NCT00945763|Ibuprofen|ibuprofen|mesh-list
13898765|NCT00945763|Meloxicam|meloxicam|mesh-list
13898766|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898767|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898768|NCT00945763|Analgesics|analgesics|mesh-ancestor
13898769|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
13898770|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898771|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898772|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898773|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898774|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13898775|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898776|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898777|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13898778|NCT00945646|Dexamethasone|dexamethasone|mesh-list
13898779|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898780|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
13898781|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
13898782|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898783|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898784|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898785|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
13898786|NCT00945646|Hormones|hormones|mesh-ancestor
13898787|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898788|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13898789|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898790|NCT00945269|Aldesleukin|aldesleukin|mesh-list
13898791|NCT00945269|Interleukin-2|interleukin-2|mesh-list
13898792|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
13898793|NCT00945269|Immunotoxins|immunotoxins|mesh-list
13898794|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898795|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898796|NCT00945269|Analgesics|analgesics|mesh-ancestor
13898797|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
13898798|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898799|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898800|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14028591|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028592|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898801|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13898802|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
13898803|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898804|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
13898805|NCT00944970|Adenosine|adenosine|mesh-list
13898806|NCT00944970|Binodenoson|binodenoson|mesh-list
13898807|NCT00944970|Analgesics|analgesics|mesh-ancestor
13898808|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
13898809|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028593|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14028594|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
14028595|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028596|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028597|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14028598|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14028599|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
14028600|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14028601|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
14028602|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14028603|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14028604|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14028605|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14028606|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14028607|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14028608|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14028609|NCT02729324|Protective Agents|protective agents|mesh-list
14028610|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
14028611|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169286|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14169287|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14169288|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14169289|NCT04843644|Propolis|propolis|mesh-list
13898810|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898811|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898812|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
13898813|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13898814|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
13898815|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
13898816|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898817|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898818|NCT00944892|Fasinumab|fasinumab|mesh-list
13898819|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898820|NCT00944892|Analgesics|analgesics|mesh-ancestor
13898821|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
13898822|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898823|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898824|NCT00944294|Adenosine|adenosine|mesh-list
14169290|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169291|NCT04843280|Coal Tar|coal tar|mesh-list
14169292|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
14169293|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
14169294|NCT04843098|Paclitaxel|paclitaxel|mesh-list
14169295|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169296|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169297|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169298|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
14169299|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
14169300|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169301|NCT04842825|Cetrorelix|cetrorelix|mesh-list
14169302|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14169303|NCT04842825|Hormones|hormones|mesh-ancestor
14169304|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169305|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898825|NCT00944294|Binodenoson|binodenoson|mesh-list
13898826|NCT00944294|Analgesics|analgesics|mesh-ancestor
13898827|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
13898828|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898829|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898830|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898831|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
13898832|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14028612|NCT02729064|Insulin|insulin|mesh-list
14028613|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14028614|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14028615|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028616|NCT02728869|Vaccines|vaccines|mesh-list
14028617|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
14028618|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028619|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14028620|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
14028621|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14028622|NCT02728856|Protective Agents|protective agents|mesh-ancestor
14028623|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028624|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028625|NCT02728947|Rotigotine|rotigotine|mesh-list
14028626|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
14028627|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
14028628|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028629|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028630|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028631|NCT02728934|Golimumab|golimumab|mesh-list
14028632|NCT02728934|Infliximab|infliximab|mesh-list
14028633|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028634|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028635|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028636|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14028637|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028638|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14028639|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
14028640|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028641|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14028642|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028643|NCT02728843|Deferiprone|deferiprone|mesh-list
14028644|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14028645|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
14028646|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
14028647|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028648|NCT02728518|Amikacin|amikacin|mesh-list
14028649|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14028650|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028651|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
14028652|NCT02728700|Sirolimus|sirolimus|mesh-list
14028653|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14028654|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028655|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14028656|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
14028657|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14028658|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028659|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028660|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028661|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
14028662|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14028663|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
14028664|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028665|NCT02728453|Empagliflozin|empagliflozin|mesh-list
14028666|NCT02728453|Glimepiride|glimepiride|mesh-list
14028667|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14028668|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028669|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14028670|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028671|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14028672|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14028673|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
14028674|NCT02728622|Tamoxifen|tamoxifen|mesh-list
14028675|NCT02728622|Paclitaxel|paclitaxel|mesh-list
14028676|NCT02728622|Doxorubicin|doxorubicin|mesh-list
14028677|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14028678|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14028679|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028680|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
14028681|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
14028682|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755271|NCT04232553|Analgesics|analgesics|mesh-ancestor
13898833|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
13898834|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
13898835|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898836|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898837|NCT00939276|Nepafenac|nepafenac|mesh-list
13898838|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898839|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898840|NCT00939276|Analgesics|analgesics|mesh-ancestor
13898841|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
13898842|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898843|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898844|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898845|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898846|NCT00938652|Gemcitabine|gemcitabine|mesh-list
13898847|NCT00938652|Carboplatin|carboplatin|mesh-list
13898848|NCT00938652|Iniparib|iniparib|mesh-list
13898849|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898850|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13898851|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
13898852|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898853|NCT00938652|Antiviral Agents|antiviral agents|mesh-ancestor
13898854|NCT00938652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898855|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898856|NCT00938652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13898857|NCT00938652|Immunologic Factors|immunologic factors|mesh-ancestor
13898858|NCT00938652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898859|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13898860|NCT00938587|Prednisone|prednisone|mesh-list
13898861|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898862|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
13898863|NCT00938587|Hormones|hormones|mesh-ancestor
13898864|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898865|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898866|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13898867|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898868|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
13898869|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13898870|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898871|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13898872|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13898873|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898874|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898875|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13898876|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
13898877|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13898878|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028683|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755272|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
14755273|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755274|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755275|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755276|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755277|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14755278|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14755279|NCT04230148|Triclabendazole|triclabendazole|mesh-list
14755280|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14755281|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
14755282|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14755283|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755284|NCT04228042|Infigratinib|infigratinib|mesh-list
14755285|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028684|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14028685|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14028686|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14028687|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028688|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14028689|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
14028690|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028691|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898879|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898880|NCT00934921|Ondansetron|ondansetron|mesh-list
13898881|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
13898882|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
13898883|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028692|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028693|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14028694|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14028695|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14932353|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14932354|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932355|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932356|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
14932357|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14932358|NCT01444807|Sorafenib|sorafenib|mesh-list
14932359|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932360|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13898884|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028696|NCT02728687|Mannitol|mannitol|mesh-list
14028697|NCT02728687|Menthol|menthol|mesh-list
13898885|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898886|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
13898887|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
13898888|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13898889|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
13898890|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028698|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14028699|NCT02728687|Diuretics|diuretics|mesh-ancestor
14028700|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
14028701|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028702|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
14028703|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028704|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
14028705|NCT02728466|Procyanidin|procyanidin|mesh-list
14028706|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
14028707|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028708|NCT02728466|Protective Agents|protective agents|mesh-ancestor
14028709|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028710|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14028711|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14028712|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028713|NCT02728531|Cytarabine|cytarabine|mesh-list
14028714|NCT02728531|Rituximab|rituximab|mesh-list
14028715|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14028716|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14028717|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028718|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
14028719|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028720|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14028721|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14028722|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
14028723|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028724|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
14028725|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028726|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14028727|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14028728|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
14028729|NCT02728492|Gemcitabine|gemcitabine|mesh-list
14028730|NCT02728492|Paclitaxel|paclitaxel|mesh-list
14028731|NCT02728492|Carboplatin|carboplatin|mesh-list
14028732|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14028733|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028734|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
13898891|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028735|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
14028736|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
14028737|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028738|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14028739|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
14028740|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
14028741|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028742|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028743|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14028744|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
14028745|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028746|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14028747|NCT02728440|Menotropins|menotropins|mesh-list
14028748|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14028749|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028750|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14028751|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
14028752|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
13898892|NCT00934921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13898893|NCT00934921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13898894|NCT00934921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898895|NCT00934921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13898896|NCT00934921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13898897|NCT00934180|Ondansetron|ondansetron|mesh-list
13898898|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
13898899|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
13898900|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898901|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898902|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13898903|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
13898904|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
13898905|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13898906|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
13898907|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898908|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028753|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
14028754|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
14028755|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028756|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028757|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
14028758|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028759|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
14028760|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
14028761|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
14028762|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028763|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028764|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
14028765|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755286|NCT04224987|Azithromycin|azithromycin|mesh-list
14755287|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755288|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755289|NCT04223752|Tazobactam|tazobactam|mesh-list
14755290|NCT04223752|Ceftolozane|ceftolozane|mesh-list
14028766|NCT02728037|Lidocaine|lidocaine|mesh-list
14028767|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
14028768|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
13898909|NCT00934180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13898910|NCT00934180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13898911|NCT00934180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13898912|NCT00934180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13898913|NCT00934180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13898914|NCT00929968|Fluticasone|fluticasone|mesh-list
13898915|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898916|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13898917|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
13898918|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898919|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028769|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
14028770|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028771|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028772|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
14028773|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028774|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898920|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13898921|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
13898922|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
14028775|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14028776|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14755291|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14028777|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14028778|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028779|NCT02728037|Analgesics|analgesics|mesh-ancestor
13898923|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13898924|NCT00928590|Timolol|timolol|mesh-list
13898925|NCT00928590|Travoprost|travoprost|mesh-list
13898926|NCT00928590|Cloprostenol|cloprostenol|mesh-list
13898927|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13898928|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13898929|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
13898930|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898931|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898932|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898933|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13898934|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13898935|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
13898936|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13898937|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
14028780|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
14028781|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14028782|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14028783|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
14028784|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14028785|NCT02728245|Dienogest|dienogest|mesh-list
14028786|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14028787|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
14028788|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14028789|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028790|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14028791|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13898938|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13898939|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13898940|NCT00927914|Ranirestat|ranirestat|mesh-list
13898941|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028792|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14028793|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14028794|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
14471468|NCT02331368|Melphalan|melphalan|mesh-list
14471469|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471470|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471471|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
14471472|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898942|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898943|NCT00927641|Ketoprofen|ketoprofen|mesh-list
14471473|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14471474|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471475|NCT02331368|Growth Substances|growth substances|mesh-ancestor
14471476|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
14471477|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14471478|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
14471479|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898944|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13898945|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13898946|NCT00927641|Analgesics|analgesics|mesh-ancestor
13898947|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
13898948|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13898949|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898950|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13898951|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13898952|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13898953|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13898954|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898955|NCT00925535|Rifabutin|rifabutin|mesh-list
13898956|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13898957|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13898958|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13898959|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
13898960|NCT00924833|Carvedilol|carvedilol|mesh-list
13898961|NCT00924833|Nebivolol|nebivolol|mesh-list
13898962|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13898963|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13898964|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
13898965|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963344|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
14028795|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028796|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028797|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028798|NCT02727712|Anesthetics|anesthetics|mesh-list
14028799|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028800|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028801|NCT02727647|Factor VIII|factor viii|mesh-list
14028802|NCT02727647|Coagulants|coagulants|mesh-ancestor
14028803|NCT02727881|Squalamine|squalamine|mesh-list
14028804|NCT02727881|Ranibizumab|ranibizumab|mesh-list
14028805|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14028806|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14028807|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14028808|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14028809|NCT02727881|Growth Substances|growth substances|mesh-ancestor
14028810|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028811|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
14028812|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028813|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14028814|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028815|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14028816|NCT02727881|Protective Agents|protective agents|mesh-ancestor
14028817|NCT02727738|Selenium|selenium|mesh-list
14028818|NCT02727738|Methimazole|methimazole|mesh-list
14028819|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
14028820|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028821|NCT02727738|Protective Agents|protective agents|mesh-ancestor
14028822|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898966|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898967|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898968|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13898969|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
13898970|NCT00924833|Protective Agents|protective agents|mesh-ancestor
13898971|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13898972|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13898973|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13898974|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
13898975|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13898976|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14028823|NCT02727738|Trace Elements|trace elements|mesh-ancestor
14028824|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
14028825|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
14028826|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
14028827|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028828|NCT02727907|Interferons|interferons|mesh-list
14028829|NCT02727907|Interferon-beta|interferon-beta|mesh-list
14028830|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
14028831|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028832|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
14028833|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028834|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
13898977|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13898978|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13898979|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13898980|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
13898981|NCT00920985|Gestodene|gestodene|mesh-list
13898982|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
13898983|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13898984|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13898985|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13898986|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14028835|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028836|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14028837|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
14028838|NCT02727621|Propofol|propofol|mesh-list
14028839|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14028840|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028841|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028842|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14028843|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
14028844|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
14028845|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14028846|NCT02727621|Analgesics|analgesics|mesh-ancestor
14028847|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
14028848|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028849|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14028850|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14028851|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14028852|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028853|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13898987|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13898988|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13898989|NCT00920985|Progestins|progestins|mesh-ancestor
13898990|NCT00920985|Hormones|hormones|mesh-ancestor
13898991|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13898992|NCT00920764|Atrasentan|atrasentan|mesh-list
13898993|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028854|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028855|NCT02727608|Eculizumab|eculizumab|mesh-list
14028856|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14028857|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14028858|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
14028859|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169306|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14169307|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
14169308|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14169309|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
14169310|NCT04843046|Pioglitazone|pioglitazone|mesh-list
14169311|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13898994|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13898995|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13898996|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13898997|NCT00917826|Valganciclovir|valganciclovir|mesh-list
14169312|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169313|NCT04843007|Pemetrexed|pemetrexed|mesh-list
14169314|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169315|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169316|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169317|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14169318|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14169319|NCT04842838|Paclitaxel|paclitaxel|mesh-list
14169320|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169321|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169322|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169323|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
14169324|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
14169325|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169326|NCT04842968|Methylene Blue|methylene blue|mesh-list
14169327|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169328|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169329|NCT04842682|Diazepam|diazepam|mesh-list
14471480|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14471481|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14479103|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14169330|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14169331|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
14169332|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
14169333|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
14169334|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169335|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169336|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169337|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14169338|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169339|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14169340|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14169341|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14169342|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14169343|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169344|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14169345|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
14169346|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
14169347|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
14169348|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
14169349|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169350|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169351|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
14169352|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14169353|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
14169354|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932361|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932362|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932363|NCT01444833|Candesartan|candesartan|mesh-list
14932364|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932365|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14932366|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13898998|NCT00917826|Ganciclovir|ganciclovir|mesh-list
14028860|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
14028861|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
14028862|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
14028863|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14028864|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14028865|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028866|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028867|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028868|NCT02727504|Dobutamine|dobutamine|mesh-list
14028869|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14028870|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
14028871|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
14028872|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028873|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028874|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14028875|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14028876|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14028877|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
14028878|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028879|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028880|NCT02727504|Protective Agents|protective agents|mesh-ancestor
14028881|NCT02727309|Apatinib|apatinib|mesh-list
13898999|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13899000|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
13899001|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
13899002|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028882|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028883|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14028884|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028885|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028886|NCT02727296|Propofol|propofol|mesh-list
14028887|NCT02727296|Sevoflurane|sevoflurane|mesh-list
14028888|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14028889|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028890|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028891|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14028892|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
14028893|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
14028894|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14028895|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14028896|NCT02727348|Anesthetics|anesthetics|mesh-list
13899003|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13899004|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899005|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899006|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899007|NCT00917293|Pyridoxal|pyridoxal|mesh-list
13899008|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
13899009|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
14028897|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028898|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028899|NCT02726919|Clobazam|clobazam|mesh-list
14028900|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
14028901|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14028902|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14028903|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028904|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471482|NCT02331680|Tolvaptan|tolvaptan|mesh-list
13899010|NCT00917293|Vitamins|vitamins|mesh-ancestor
13899011|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
13899012|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899013|NCT00914602|Levodopa|levodopa|mesh-list
13899014|NCT00914602|Carbidopa|carbidopa|mesh-list
13899015|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13899016|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13899017|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13899018|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
13899019|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899020|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899021|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899022|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13899023|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899024|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13899025|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
13899026|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
13899027|NCT00914290|Baclofen|baclofen|mesh-list
13899028|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13899029|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028905|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14028906|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14028907|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
14028908|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
14028909|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028910|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028911|NCT02727205|Rotigotine|rotigotine|mesh-list
14028912|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
14028913|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
14028914|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028915|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028916|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028917|NCT02726867|Lacosamide|lacosamide|mesh-list
14028918|NCT02726867|Ketamine|ketamine|mesh-list
14028919|NCT02726867|Levetiracetam|levetiracetam|mesh-list
14028920|NCT02726867|Phenobarbital|phenobarbital|mesh-list
14028921|NCT02726867|Analgesics|analgesics|mesh-ancestor
14028922|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
14028923|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028924|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028925|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14028926|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14028927|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
14028928|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
14028929|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14028930|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14028931|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14028932|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028933|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028934|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
14028935|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
14028936|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14028937|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14028938|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14028939|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14028940|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
14028941|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
14028942|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14028943|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14028944|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14028945|NCT02726984|Listerine|listerine|mesh-list
14028946|NCT02726984|Fluorides|fluorides|mesh-list
14028947|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
14028948|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
14028949|NCT02726984|Protective Agents|protective agents|mesh-ancestor
14471483|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14028950|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028951|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14028952|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14028953|NCT02726854|Apatinib|apatinib|mesh-list
14028954|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028955|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14028956|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028957|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028958|NCT02726828|Ketamine|ketamine|mesh-list
14028959|NCT02726828|Morphine|morphine|mesh-list
14028960|NCT02726828|Analgesics|analgesics|mesh-ancestor
14028961|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
14028962|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028963|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899030|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13899031|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899032|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13899033|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
13899034|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
13899035|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899036|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899037|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14028964|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14028965|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14028966|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
14028967|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
14028968|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899038|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
14028969|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14028970|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14028971|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14028972|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028973|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14028974|NCT02726828|Narcotics|narcotics|mesh-ancestor
14028975|NCT02726503|Lenvatinib|lenvatinib|mesh-list
14028976|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028977|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14028978|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14028979|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028980|NCT02726581|Dexamethasone|dexamethasone|mesh-list
14028981|NCT02726581|Nivolumab|nivolumab|mesh-list
14028982|NCT02726581|Pomalidomide|pomalidomide|mesh-list
14028983|NCT02726581|Elotuzumab|elotuzumab|mesh-list
14028984|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14028985|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
14028986|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
14028987|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14028988|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14028989|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14028990|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
14028991|NCT02726581|Hormones|hormones|mesh-ancestor
14028992|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14028993|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14028994|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14028995|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14028996|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14028997|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14028998|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
14028999|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14029000|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14029001|NCT02726581|Growth Substances|growth substances|mesh-ancestor
14029002|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
14029003|NCT02726555|Atorvastatin|atorvastatin|mesh-list
14029004|NCT02726555|Red yeast rice|red yeast rice|mesh-list
14029005|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14029006|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14029007|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
14471484|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471485|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
14471486|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471487|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
14471488|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14471489|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
14471490|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029008|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029009|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14029010|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14029011|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029012|NCT02726490|Metformin|metformin|mesh-list
14029013|NCT02726490|Glyburide|glyburide|mesh-list
14029014|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14029015|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899039|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899040|NCT00911963|Ribavirin|ribavirin|mesh-list
13899041|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13899042|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
13899043|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899044|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
13899045|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899046|NCT00911443|Interferons|interferons|mesh-list
13899047|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
13899048|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
13899049|NCT00911443|Dacarbazine|dacarbazine|mesh-list
13899050|NCT00911443|Thymalfasin|thymalfasin|mesh-list
14029016|NCT02726737|Lidocaine|lidocaine|mesh-list
14029017|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029018|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
14029019|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029020|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029021|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
14029022|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029023|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14029024|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14029025|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14029026|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029027|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899051|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899052|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
13899053|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899054|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
13899055|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899056|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13899057|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
13899058|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899059|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13899060|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
13899061|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13899062|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899063|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13899064|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
13899065|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899066|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899067|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899068|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899069|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13899070|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13899071|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13899072|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13899073|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
13899074|NCT00909649|Coagulants|coagulants|mesh-ancestor
13899075|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13899076|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13899077|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029028|NCT02726711|Trimethaphan|trimethaphan|mesh-list
14029029|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
14029030|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14029031|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14029032|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14029033|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
14029034|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755292|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755293|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755294|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14755295|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755296|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755297|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14755298|NCT04223752|Renal Agents|renal agents|mesh-ancestor
14755299|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13899078|NCT00909597|Pioglitazone|pioglitazone|mesh-list
14029035|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029036|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14029037|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14029038|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
14029039|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029040|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029041|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
13899079|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13899080|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899081|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899082|NCT00909597|Incretins|incretins|mesh-ancestor
13899083|NCT00909597|Hormones|hormones|mesh-ancestor
13899084|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959353|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029042|NCT02726646|Doxycycline|doxycycline|mesh-list
14029043|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14029044|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029045|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
14029046|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14029047|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14029048|NCT02726308|Dexamethasone|dexamethasone|mesh-list
14029049|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029050|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
14029051|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
14029052|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029053|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029054|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029055|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
14755300|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755301|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
14755302|NCT04207177|Tacrolimus|tacrolimus|mesh-list
14755303|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755304|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
14755305|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029056|NCT02726308|Hormones|hormones|mesh-ancestor
14029057|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14029058|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14029059|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029060|NCT02726269|Ofloxacin|ofloxacin|mesh-list
14029061|NCT02726269|Levofloxacin|levofloxacin|mesh-list
14029062|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14029063|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029064|NCT02726269|Renal Agents|renal agents|mesh-ancestor
14029065|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14029066|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14029067|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14029068|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029069|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029070|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029071|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14029072|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14029073|NCT02726126|Fentanyl|fentanyl|mesh-list
14029074|NCT02726126|Melatonin|melatonin|mesh-list
14029075|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14029076|NCT02726126|Narcotics|narcotics|mesh-ancestor
14029077|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029078|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959354|NCT03163966|Methotrexate|methotrexate|mesh-list
13959355|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14029079|NCT02726126|Analgesics|analgesics|mesh-ancestor
14029080|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
14029081|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029082|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13959356|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
13959357|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13959358|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959359|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13959360|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
13959361|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029083|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14029084|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
14029085|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
14029086|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
14169355|NCT04842487|Prednisone|prednisone|mesh-list
14755306|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14755307|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899085|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
13899086|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13899087|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899088|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13899089|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
14029087|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029088|NCT02726126|Protective Agents|protective agents|mesh-ancestor
14029089|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14029090|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
14029091|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029092|NCT02726035|Naltrexone|naltrexone|mesh-list
14029093|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14029094|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14029095|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029096|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
14029097|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169356|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
14169357|NCT04842487|Rituximab|rituximab|mesh-list
14169358|NCT04842487|Vincristine|vincristine|mesh-list
14169359|NCT04842487|Lenalidomide|lenalidomide|mesh-list
14169360|NCT04842487|Doxorubicin|doxorubicin|mesh-list
14169361|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14169362|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14169363|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
14169364|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169365|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169366|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14169367|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
14169368|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169369|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169370|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14169371|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14169372|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169373|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
14169374|NCT04842487|Hormones|hormones|mesh-ancestor
14169375|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169376|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14169377|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169378|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169379|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
14169380|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
13899090|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899091|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169381|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14169382|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14169383|NCT04842487|Growth Substances|growth substances|mesh-ancestor
13899092|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899093|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169384|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
14169385|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14169386|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14169387|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755308|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755309|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13899094|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
13899095|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14755310|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755311|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14755312|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
14755313|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755314|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029098|NCT02725736|Nifedipine|nifedipine|mesh-list
14029099|NCT02725736|Atosiban|atosiban|mesh-list
14029100|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14029101|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029102|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029103|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14029104|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029105|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14029106|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
14029107|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14029108|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
14029109|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14029110|NCT02725918|Pemetrexed|pemetrexed|mesh-list
14029111|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029112|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899096|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899097|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13899098|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
13899099|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899100|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899101|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471491|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471492|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14471493|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
14471494|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
14471495|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14471496|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
14471497|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899102|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029113|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029114|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14029115|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14029116|NCT02725541|Trastuzumab|trastuzumab|mesh-list
14029117|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14029118|NCT02725541|Maytansine|maytansine|mesh-list
14029119|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14029120|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029121|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14029122|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
14029123|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
14029124|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
14029125|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029126|NCT02725502|Linagliptin|linagliptin|mesh-list
14029127|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14029128|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029129|NCT02725502|Incretins|incretins|mesh-ancestor
14029130|NCT02725502|Hormones|hormones|mesh-ancestor
14755315|NCT04205136|Spironolactone|spironolactone|mesh-list
14755316|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13899103|NCT00906334|ON 01910|on 01910|mesh-list
13899104|NCT00906334|Glycine|glycine|mesh-list
13899105|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899106|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13899107|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899108|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899109|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
13899110|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899111|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899112|NCT00905606|Topiramate|topiramate|mesh-list
13899113|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
13899114|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899115|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899116|NCT00905567|Topiramate|topiramate|mesh-list
13899117|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
13899118|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899119|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899120|NCT00905346|Topiramate|topiramate|mesh-list
13899121|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
13899122|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899123|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899124|NCT00905164|Topiramate|topiramate|mesh-list
14755317|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
13899125|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
13899126|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899127|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899128|NCT00904943|Topiramate|topiramate|mesh-list
13899129|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
14029131|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14029132|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14029133|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14029134|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029135|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029136|NCT02725398|Scopolamine|scopolamine|mesh-list
14029137|NCT02725398|Bromides|bromides|mesh-list
14029138|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14029139|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
14029140|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14029141|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
14029142|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
14029143|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029144|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029145|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029146|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
14029147|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14029148|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
14029149|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029150|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029151|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14029152|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
14029153|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
14029154|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14029155|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
14029156|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029157|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029158|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14029159|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
14029160|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14029161|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
14029162|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029163|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029164|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14029165|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
14029166|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
13899130|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899131|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899132|NCT00902928|Enoxaparin|enoxaparin|mesh-list
13899133|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
13899134|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13899135|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13899136|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029167|NCT02725372|Protective Agents|protective agents|mesh-ancestor
14029168|NCT02725255|Albendazole|albendazole|mesh-list
14029169|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
14029170|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14029171|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029172|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
14029173|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13899137|NCT00902291|Gemcitabine|gemcitabine|mesh-list
13899138|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13899139|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
13899140|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899141|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899142|NCT00902291|Antiviral Agents|antiviral agents|mesh-ancestor
13899143|NCT00902291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899144|NCT00902291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899145|NCT00902291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899146|NCT00902291|Immunologic Factors|immunologic factors|mesh-ancestor
13899147|NCT00902291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899148|NCT00901979|Metformin|metformin|mesh-list
13899149|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13899150|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899151|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899152|NCT00901979|Incretins|incretins|mesh-ancestor
13899153|NCT00901979|Hormones|hormones|mesh-ancestor
13899154|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13899155|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13899156|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
13899157|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899158|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899159|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14029174|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14755318|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755319|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755320|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14755321|NCT04205136|Diuretics|diuretics|mesh-ancestor
14755322|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
14755327|NCT04194944|Carboplatin|carboplatin|mesh-list
14755328|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
14755329|NCT04194944|Pemetrexed|pemetrexed|mesh-list
14755330|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755331|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755332|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899160|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13899161|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
13899162|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13899163|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
13899164|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899165|NCT00900783|Valacyclovir|valacyclovir|mesh-list
13899166|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
13899167|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899168|NCT00894868|Vildagliptin|vildagliptin|mesh-list
13899169|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899170|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899171|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13899172|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
14755333|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755334|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14755335|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14755336|NCT04192903|Cisplatin|cisplatin|mesh-list
14755337|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755338|NCT04190550|Cytarabine|cytarabine|mesh-list
14755339|NCT04190550|Idarubicin|idarubicin|mesh-list
14755340|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755341|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
14755342|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899173|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932367|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938618|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899174|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899175|NCT00894530|Azithromycin|azithromycin|mesh-list
13899176|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13899177|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13899178|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899179|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899180|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13899181|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13899182|NCT00892970|Azithromycin|azithromycin|mesh-list
13899183|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13899184|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13899185|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899186|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899187|NCT00892762|Travoprost|travoprost|mesh-list
13899188|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13899189|NCT00892762|Latanoprost|latanoprost|mesh-list
13899190|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13899191|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899192|NCT00892203|Sumatriptan|sumatriptan|mesh-list
13899193|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13899194|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13899195|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13899196|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
13899197|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899198|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899199|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899200|NCT00890968|Triamcinolone|triamcinolone|mesh-list
13899201|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13899202|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13899203|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13899204|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13899205|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
13899206|NCT00890968|Hormones|hormones|mesh-ancestor
14029175|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
14029176|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
14029177|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
14029178|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029179|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029180|NCT02725424|Docetaxel|docetaxel|mesh-list
14029181|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
14029182|NCT02725424|Trastuzumab|trastuzumab|mesh-list
14029183|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029184|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
14029185|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
14029186|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
14029187|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029188|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14029189|NCT02725359|Tizanidine|tizanidine|mesh-list
14932368|NCT01444846|Ebselen|ebselen|mesh-list
14932369|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13899207|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13899208|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899209|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899210|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
13899211|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899212|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899213|NCT00890591|Amlodipine|amlodipine|mesh-list
14029190|NCT02725359|Bupivacaine|bupivacaine|mesh-list
14029191|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029192|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
14029193|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029194|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029195|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
14029196|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899214|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13899215|NCT00890591|Olmesartan|olmesartan|mesh-list
13899216|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13899217|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899218|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13899219|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899220|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899221|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14029197|NCT02725359|Analgesics|analgesics|mesh-ancestor
14029198|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
14029199|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14029200|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14029201|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
14029202|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
14029203|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14029204|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14029205|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14029206|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
14029207|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029208|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029209|NCT02725489|Durvalumab|durvalumab|mesh-list
14029210|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14029211|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029212|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
14029213|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029214|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
14029215|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029216|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029217|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
14029218|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029219|NCT02725242|Budesonide|budesonide|mesh-list
14029220|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
14755343|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755344|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
14755345|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755346|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755347|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
14755348|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755349|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14755350|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14755351|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755352|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029221|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029222|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14029223|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
14029224|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029225|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029226|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14029227|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
14029228|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
14755353|NCT04188548|Trastuzumab|trastuzumab|mesh-list
14755354|NCT04188548|Pertuzumab|pertuzumab|mesh-list
13899222|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899223|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
13899224|NCT00890591|Diuretics|diuretics|mesh-ancestor
13899225|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
13899226|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13899227|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13899228|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13899229|NCT00890305|Pidilizumab|pidilizumab|mesh-list
13899230|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13899231|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899232|NCT00890149|Ondansetron|ondansetron|mesh-list
13899233|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
13899234|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
13899235|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899236|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899237|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13899238|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
13899239|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
13899240|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13899241|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
13899242|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899243|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899244|NCT00890149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13899245|NCT00890149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899246|NCT00890149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899247|NCT00890149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899248|NCT00890149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13899249|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
13899250|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899251|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899252|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13899253|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13899254|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899255|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899256|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899257|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13899258|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13899259|NCT00889382|Paclitaxel|paclitaxel|mesh-list
13899260|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13899261|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899262|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
13899263|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
13899264|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
13899265|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755355|NCT04188548|Everolimus|everolimus|mesh-list
14755356|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14755357|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755358|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755359|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755360|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
14029229|NCT02725242|Hormones|hormones|mesh-ancestor
14029230|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14029231|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14029232|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14029233|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14029234|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
14029235|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029236|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029237|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
14029238|NCT02725164|Sevoflurane|sevoflurane|mesh-list
14029239|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13899266|NCT00888355|Losartan|losartan|mesh-list
13899267|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13899268|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14755361|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899269|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13899270|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13899271|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899272|NCT00887250|Losartan|losartan|mesh-list
13899273|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13899274|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899275|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13899276|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13899277|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029240|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14029241|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
14029242|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
14029243|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029244|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029245|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029246|NCT02725164|Analgesics|analgesics|mesh-ancestor
14029247|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
14029248|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029249|NCT02725099|Ticagrelor|ticagrelor|mesh-list
14029250|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14029251|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14029252|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14029253|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14029254|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
14029255|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029256|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029257|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029258|NCT02724904|Methotrexate|methotrexate|mesh-list
14029259|NCT02724904|Fludarabine|fludarabine|mesh-list
14029260|NCT02724904|Thiotepa|thiotepa|mesh-list
14029261|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14029262|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
14029263|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14029264|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029265|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029266|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
14029267|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029268|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029269|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
14029270|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029271|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14029272|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029273|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
14029274|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029275|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14029276|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14029277|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
14029278|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14029279|NCT02725112|Pregabalin|pregabalin|mesh-list
14029280|NCT02725112|Analgesics|analgesics|mesh-ancestor
14029281|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
14029282|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029283|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029284|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
14029285|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14029286|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029287|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029288|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14029289|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14029290|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14471498|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471499|NCT02332291|Citalopram|citalopram|mesh-list
14471500|NCT02332291|Bupropion|bupropion|mesh-list
14471501|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14471502|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14471503|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029291|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029292|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14029293|NCT02725060|Phenylephrine|phenylephrine|mesh-list
13899278|NCT00886600|Losartan|losartan|mesh-list
13899279|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13899280|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13899281|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899282|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13899283|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13899284|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899285|NCT00886600|Diuretics|diuretics|mesh-ancestor
13899286|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
13899287|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899288|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13899289|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899290|NCT00884715|Octreotide|octreotide|mesh-list
13899291|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13899292|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13899293|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029294|NCT02725060|Isoproterenol|isoproterenol|mesh-list
14029295|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
14029296|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14029297|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
14029298|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
14029299|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029300|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029301|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
14029302|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14029303|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
14029304|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
14029305|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14029306|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14029307|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14029308|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
14029309|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029310|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932370|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14932371|NCT01444846|Analgesics|analgesics|mesh-ancestor
14029311|NCT02725060|Protective Agents|protective agents|mesh-ancestor
14029312|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14029313|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14029314|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14029315|NCT02724761|Epinephrine|epinephrine|mesh-list
14029316|NCT02724761|Racepinephrine|racepinephrine|mesh-list
14029317|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
14029318|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14029319|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14029320|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
14029321|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029322|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029323|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029324|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14029325|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14029326|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
14029327|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899294|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
13899295|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13899296|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13899297|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13899298|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899299|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899300|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
14029328|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14029329|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
14029330|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
13899301|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899302|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899303|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14029331|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
14029332|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14029333|NCT02724618|Curcumin|curcumin|mesh-list
14029334|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14029335|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029336|NCT02724618|Analgesics|analgesics|mesh-ancestor
14029337|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
14029338|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029339|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029340|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029341|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029342|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029343|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899304|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029344|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029345|NCT02724332|Sirolimus|sirolimus|mesh-list
14029346|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14029347|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029348|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14029349|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029350|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
14029351|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029352|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
14029353|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029354|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
14029355|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14029356|NCT02724358|Estrogens|estrogens|mesh-ancestor
14029357|NCT02724358|Hormones|hormones|mesh-ancestor
14029358|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13899305|NCT00883896|Fezakinumab|fezakinumab|mesh-list
13899306|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
13899307|NCT00882440|Losartan|losartan|mesh-list
13899308|NCT00882440|Enalapril|enalapril|mesh-list
13899309|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13899310|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899311|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13899312|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13899313|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899314|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13899315|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
13899316|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899317|NCT00881452|Citric Acid|citric acid|mesh-list
13899318|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
13899319|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13899320|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
13899321|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
14029359|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029360|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14029361|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029362|NCT02724202|Curcumin|curcumin|mesh-list
14029363|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14029364|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029365|NCT02724202|Analgesics|analgesics|mesh-ancestor
14029366|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
13899322|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899323|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
13899324|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13899325|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
13899326|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899327|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899328|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13899329|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
13899330|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13899331|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13899332|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13899333|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
13899334|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899335|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899336|NCT00880217|Methylphenidate|methylphenidate|mesh-list
14029367|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029368|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029369|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029370|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029371|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029372|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029373|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029374|NCT02724150|Omeprazole|omeprazole|mesh-list
14029375|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14029376|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029377|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14029378|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029379|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029380|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
14029381|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14029382|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899337|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
13899338|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13899339|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899340|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13899341|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13899342|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899343|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899344|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
13899345|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899346|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13899347|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
13899348|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
13899349|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755362|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14755363|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755364|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755365|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14755366|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
14755367|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755368|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
14755369|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755370|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755371|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899350|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
13899351|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899352|NCT00875459|Insulin|insulin|mesh-list
13899353|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13899354|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899355|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899356|NCT00875108|Insulin|insulin|mesh-list
13899357|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13899358|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899359|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899360|NCT00872885|Morphine|morphine|mesh-list
13899361|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13899362|NCT00872885|Narcotics|narcotics|mesh-ancestor
13899363|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899364|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899365|NCT00872885|Analgesics|analgesics|mesh-ancestor
13899366|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
13899367|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899368|NCT00872430|Laxatives|laxatives|mesh-list
13899369|NCT00872430|Cathartics|cathartics|mesh-list
13899370|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13899371|NCT00872014|Sorafenib|sorafenib|mesh-list
13899372|NCT00872014|Trebananib|trebananib|mesh-list
13899373|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899374|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13899375|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899376|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899377|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13899378|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13899379|NCT00872014|Growth Substances|growth substances|mesh-ancestor
13899380|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899381|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
13899382|NCT00871936|Metformin|metformin|mesh-list
13899383|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899384|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899385|NCT00871481|Aldesleukin|aldesleukin|mesh-list
13899386|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
13899387|NCT00871481|Ipilimumab|ipilimumab|mesh-list
13899388|NCT00871481|Interleukin-2|interleukin-2|mesh-list
13899389|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13899390|NCT00871481|Antibodies|antibodies|mesh-list
13899391|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
13899392|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13899393|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899394|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
13899395|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899396|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13899397|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13899398|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
13899399|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899400|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899401|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13899402|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13899403|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13899404|NCT00871481|Analgesics|analgesics|mesh-ancestor
13899405|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
13899406|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029383|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029384|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029385|NCT02724098|Analgesics|analgesics|mesh-ancestor
14029386|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
14029387|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029388|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14029389|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14029390|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14029391|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14029392|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029393|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029394|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
14029395|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14029396|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029397|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14029398|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14029399|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029400|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029401|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029402|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14029403|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14029404|NCT02724293|Pregabalin|pregabalin|mesh-list
14029405|NCT02724293|Analgesics|analgesics|mesh-ancestor
14029406|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
14029407|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029408|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899407|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13899408|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14029409|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
14029410|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14029411|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029412|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029413|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14029414|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14029415|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14029416|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029417|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169388|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182912|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182913|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
14182914|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182915|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14182916|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13899409|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
13899410|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899411|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
14182917|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14182918|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899412|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13899413|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
13899414|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899415|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899416|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13899417|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
13899418|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
13899419|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13899420|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
13899421|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899422|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899423|NCT00870688|Valproic Acid|valproic acid|mesh-list
13899424|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
13899425|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899426|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899427|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
13899428|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899429|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899430|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
13899431|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899432|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029418|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14029419|NCT02724163|Cytarabine|cytarabine|mesh-list
14029420|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
14029421|NCT02724163|Busulfan|busulfan|mesh-list
14029422|NCT02724163|Fludarabine|fludarabine|mesh-list
14029423|NCT02724163|Daunorubicin|daunorubicin|mesh-list
14029424|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
13899433|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899434|NCT00870454|Pregabalin|pregabalin|mesh-list
13899435|NCT00870454|Analgesics|analgesics|mesh-ancestor
13899436|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
13899437|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899438|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899439|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
13899440|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13899441|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029425|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
14029426|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029427|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
14029428|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029429|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029430|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14029431|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
14029432|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029433|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029434|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14029435|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029436|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
14029437|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
14029438|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029439|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14029440|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14029441|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14029442|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029443|NCT02724163|Analgesics|analgesics|mesh-ancestor
14029444|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
14029445|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899442|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899443|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13899444|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13899445|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899446|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899447|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899448|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13899449|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
13899450|NCT00869661|Ribavirin|ribavirin|mesh-list
13899451|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
13899452|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899453|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
13899454|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899455|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
13899456|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899457|NCT00869336|Luliconazole|luliconazole|mesh-list
13899458|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
13899459|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899460|NCT00869128|Melatonin|melatonin|mesh-list
13899461|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
13899462|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899463|NCT00869128|Protective Agents|protective agents|mesh-ancestor
13899464|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899465|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029446|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14029447|NCT02723981|Vitamins|vitamins|mesh-list
14029448|NCT02723981|Vitamin K|vitamin k|mesh-list
14029449|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
14029450|NCT02723981|Dabigatran|dabigatran|mesh-list
14029451|NCT02723981|Anticoagulants|anticoagulants|mesh-list
14029452|NCT02723981|Clopidogrel|clopidogrel|mesh-list
14029453|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
14029454|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029455|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14029456|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14029457|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14029458|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14029459|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
14029460|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029461|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029462|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14029463|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
14029464|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14029465|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
14029466|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029467|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14029468|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14029469|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
14029470|NCT02723981|Coagulants|coagulants|mesh-ancestor
14029471|NCT02723903|Fluoxetine|fluoxetine|mesh-list
14029472|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14029473|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14029474|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029475|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029476|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029477|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
14029478|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029479|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14029480|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
14029481|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14029482|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14029483|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14029484|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029485|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
14029486|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14029487|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029488|NCT02723578|Pemetrexed|pemetrexed|mesh-list
14029489|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14029490|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029491|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029492|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029493|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14029494|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14029495|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14029496|NCT02723838|Gemcitabine|gemcitabine|mesh-list
14029497|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899466|NCT00864175|Docetaxel|docetaxel|mesh-list
13899467|NCT00864175|Trastuzumab|trastuzumab|mesh-list
14029498|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029499|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
14029500|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029501|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
14029502|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029503|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029504|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029505|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
14029506|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029507|NCT02723500|Xenon|xenon|mesh-list
14029508|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14029509|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
14029510|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
14169389|NCT04842292|Heparin|heparin|mesh-list
13899468|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899469|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
13899470|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
13899471|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
13899472|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899473|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13899474|NCT00863369|Gemcitabine|gemcitabine|mesh-list
13899475|NCT00863369|Rituximab|rituximab|mesh-list
13899476|NCT00863369|Bortezomib|bortezomib|mesh-list
13899477|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13899478|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899479|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
13899480|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899481|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13899482|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13899483|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
13899484|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899485|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
13899486|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899487|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899488|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899489|NCT00862524|Gemcitabine|gemcitabine|mesh-list
13899490|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13899491|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
13899492|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899493|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899494|NCT00862524|Antiviral Agents|antiviral agents|mesh-ancestor
13899495|NCT00862524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899496|NCT00862524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899497|NCT00862524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899498|NCT00862524|Immunologic Factors|immunologic factors|mesh-ancestor
13899499|NCT00862524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899500|NCT00861705|Paclitaxel|paclitaxel|mesh-list
13899501|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
13899502|NCT00861705|Bevacizumab|bevacizumab|mesh-list
13899503|NCT00861705|Carboplatin|carboplatin|mesh-list
13899504|NCT00861705|Doxorubicin|doxorubicin|mesh-list
13899505|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14029511|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029512|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029513|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
14029514|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14029515|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
14029516|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029517|NCT02723669|Expectorants|expectorants|mesh-ancestor
14029518|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
14029519|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14029520|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
14029521|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029522|NCT02723669|Protective Agents|protective agents|mesh-ancestor
14932372|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
14932373|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932374|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932375|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932376|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932377|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14932378|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14932379|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
14932380|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932381|NCT01444846|Protective Agents|protective agents|mesh-ancestor
14932382|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14932383|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932384|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14932385|NCT01444885|Amlodipine|amlodipine|mesh-list
14932386|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
14932387|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932388|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14932389|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932390|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899506|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13899507|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13899508|NCT00861705|Antibodies|antibodies|mesh-list
13899509|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
13899510|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13899511|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
13899512|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
13899513|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13899514|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899515|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
13899516|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
13899517|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
13899518|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899519|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899520|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
13899521|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899522|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13899523|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14169390|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
13899524|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
13899525|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13899526|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13899527|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13899528|NCT00861705|Growth Substances|growth substances|mesh-ancestor
13899529|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
13899530|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13899531|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13899532|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13899533|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899534|NCT00860288|Metformin|metformin|mesh-list
13899535|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13899536|NCT00860288|Vildagliptin|vildagliptin|mesh-list
13899537|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899538|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899539|NCT00860288|Incretins|incretins|mesh-ancestor
13899540|NCT00860288|Hormones|hormones|mesh-ancestor
13899541|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13899542|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13899543|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
13899544|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899545|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899546|NCT00859521|Levetiracetam|levetiracetam|mesh-list
13899547|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
14932391|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14932392|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932393|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
14932394|NCT01444976|Midazolam|midazolam|mesh-list
14932395|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
14932396|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899548|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
13899549|NCT00859430|Levetiracetam|levetiracetam|mesh-list
14932397|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899550|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
13899551|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
13959362|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959363|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
13959364|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959365|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13959366|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029523|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029524|NCT02723669|Antidotes|antidotes|mesh-ancestor
14029525|NCT02723513|Xenon|xenon|mesh-list
14029526|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14029527|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
14029528|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
14029529|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029530|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029531|NCT02723461|Oxytocin|oxytocin|mesh-list
14029532|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
14029533|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14755372|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755373|NCT04166773|Tirzepatide|tirzepatide|mesh-list
14755374|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14755375|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959367|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
13959368|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959369|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13959370|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
13959371|NCT03163589|Hematinics|hematinics|mesh-ancestor
13959372|NCT03163277|Emtricitabine|emtricitabine|mesh-list
13959373|NCT03163277|Maraviroc|maraviroc|mesh-list
13959374|NCT03163277|Darunavir|darunavir|mesh-list
13959375|NCT03163277|Cobicistat|cobicistat|mesh-list
13959376|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
14029534|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755376|NCT04166773|Incretins|incretins|mesh-ancestor
14755377|NCT04166773|Hormones|hormones|mesh-ancestor
14755378|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755379|NCT04158440|Paclitaxel|paclitaxel|mesh-list
14755380|NCT04158440|Docetaxel|docetaxel|mesh-list
14755381|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14755382|NCT04158440|Cisplatin|cisplatin|mesh-list
14932398|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13959377|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959378|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13959379|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14029535|NCT02723487|Bupivacaine|bupivacaine|mesh-list
14932399|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14029536|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029537|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
14029538|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029539|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029540|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
14029541|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029542|NCT02723448|Aclarubicin|aclarubicin|mesh-list
14029543|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
14029544|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14029545|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029546|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14029547|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14029548|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029549|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029550|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14029551|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
14029552|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029553|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14029554|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14029555|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14029556|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
14029557|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029558|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029559|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029560|NCT02723279|Urological Agents|urological agents|mesh-ancestor
14029561|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
13899552|NCT00858871|Sorafenib|sorafenib|mesh-list
13899553|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899554|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13899555|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899556|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899557|NCT00858702|Olmesartan|olmesartan|mesh-list
13899558|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13899559|NCT00858702|Diuretics|diuretics|mesh-list
13899560|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899561|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13899562|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13899563|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899564|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
13899565|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899566|NCT00857285|Losartan|losartan|mesh-list
13899567|NCT00857285|Olmesartan|olmesartan|mesh-list
13899568|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13899569|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14029562|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
14029563|NCT02723266|Protective Agents|protective agents|mesh-ancestor
14029564|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029565|NCT02723253|Raltitrexed|raltitrexed|mesh-list
14029566|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029567|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029568|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
14029569|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029570|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14029571|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029572|NCT02723383|Baclofen|baclofen|mesh-list
14029573|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14029574|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029575|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14029576|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029577|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14029578|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
14029579|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
14029580|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029581|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029582|NCT02723435|Midostaurin|midostaurin|mesh-list
14029583|NCT02723435|Staurosporine|staurosporine|mesh-list
14029584|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029585|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14029586|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029587|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029588|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
14029589|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13899570|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899571|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14029590|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899572|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13899573|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899574|NCT00855764|Paclitaxel|paclitaxel|mesh-list
13899575|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13899576|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899577|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
13899578|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
13899579|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
13899580|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899581|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
13899582|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13899583|NCT00854945|ON 01910|on 01910|mesh-list
13899584|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899585|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13899586|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899587|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899588|NCT00851045|Leucovorin|leucovorin|mesh-list
13899589|NCT00851045|Bevacizumab|bevacizumab|mesh-list
13899590|NCT00851045|Fluorouracil|fluorouracil|mesh-list
14029591|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
14029592|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
14029593|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029594|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14029595|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14029596|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14029597|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14029598|NCT02722811|Etanercept|etanercept|mesh-list
14029599|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14029600|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029601|NCT02722811|Analgesics|analgesics|mesh-ancestor
14029602|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
14029603|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029604|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029605|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029606|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029607|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029608|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029609|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
14029610|NCT02722538|Gemcitabine|gemcitabine|mesh-list
14029611|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029612|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
14029613|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029614|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029615|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
14029616|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029617|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029618|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029619|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
14029620|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029621|NCT02722746|Epinephrine|epinephrine|mesh-list
14029622|NCT02722746|Ropivacaine|ropivacaine|mesh-list
14029623|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029624|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
14029625|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029626|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029627|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
14029628|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029629|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14029630|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13899591|NCT00851045|Irinotecan|irinotecan|mesh-list
13899592|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13899593|NCT00851045|Calcium|calcium|mesh-list
13899594|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
13899595|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13899596|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899597|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13899598|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13899599|NCT00851045|Growth Substances|growth substances|mesh-ancestor
13899600|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899601|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
13899602|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13899603|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
13899604|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899605|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13899606|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899607|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
13899608|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13899609|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13899610|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899611|NCT00851045|Antidotes|antidotes|mesh-ancestor
13899612|NCT00851045|Protective Agents|protective agents|mesh-ancestor
13899613|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
13899614|NCT00851045|Vitamins|vitamins|mesh-ancestor
13899615|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
13899616|NCT00850577|Paclitaxel|paclitaxel|mesh-list
13899617|NCT00850577|Bevacizumab|bevacizumab|mesh-list
13899618|NCT00850577|Carboplatin|carboplatin|mesh-list
13899619|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13899620|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13899621|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899622|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
13899623|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
13899624|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
13899625|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899626|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13899627|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13899628|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13899629|NCT00850577|Growth Substances|growth substances|mesh-ancestor
13899630|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899631|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
13899632|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
13899633|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
13899634|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13899635|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13899636|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899637|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899638|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13899639|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13899640|NCT00849862|Levetiracetam|levetiracetam|mesh-list
13899641|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
13899642|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
13899643|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
13899644|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
13899645|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13899646|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13899647|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899648|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899649|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13899650|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13899651|NCT00849667|Farletuzumab|farletuzumab|mesh-list
13899652|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899653|NCT00849576|Insulin|insulin|mesh-list
13899654|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13899655|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
13899656|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899657|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899658|NCT00849485|Levetiracetam|levetiracetam|mesh-list
13899659|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
13899660|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
13899661|NCT00847405|Sumatriptan|sumatriptan|mesh-list
13899662|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13899663|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13899664|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13899665|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
13899666|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899667|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899668|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899669|NCT00847366|Tamoxifen|tamoxifen|mesh-list
13899670|NCT00847366|Trastuzumab|trastuzumab|mesh-list
13899671|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13899672|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899673|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13899674|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
13899675|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13899676|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899677|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13899678|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13899679|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14029631|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
14029632|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029633|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029634|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14029635|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14029636|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
14029637|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13899680|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13899681|NCT00846989|Latanoprost|latanoprost|mesh-list
13899682|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13899683|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13899684|NCT00846885|Sumatriptan|sumatriptan|mesh-list
13899685|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13899686|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13959380|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029638|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
14029639|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
14029640|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
14029641|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14029642|NCT02722616|Pancrelipase|pancrelipase|mesh-list
14029643|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029644|NCT02722772|Etanercept|etanercept|mesh-list
14029645|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14029646|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029647|NCT02722772|Analgesics|analgesics|mesh-ancestor
14029648|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
14029649|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029650|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029651|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029652|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029653|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029654|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029655|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
14029656|NCT02722733|Cytarabine|cytarabine|mesh-list
14932400|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14932401|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14932402|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14932403|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14029657|NCT02722733|Lenograstim|lenograstim|mesh-list
14029658|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14029659|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
14029660|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029661|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029662|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
14029663|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029664|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029665|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
14029666|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029667|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14479104|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
14029668|NCT02722694|Methotrexate|methotrexate|mesh-list
14029669|NCT02722694|Abatacept|abatacept|mesh-list
14029670|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14029671|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
14029672|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14029673|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029674|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029675|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
14029676|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029677|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029678|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
14029679|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029680|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14029681|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029682|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
14029683|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029684|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14029685|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14029686|NCT02722603|Gabapentin|gabapentin|mesh-list
14029687|NCT02722603|Tramadol|tramadol|mesh-list
14029688|NCT02722603|Analgesics|analgesics|mesh-ancestor
14029689|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
14029690|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029691|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029692|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
14029693|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14029694|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14029695|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029696|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14029697|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14029698|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14029699|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029700|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029701|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
14029702|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14029703|NCT02722603|Narcotics|narcotics|mesh-ancestor
14029704|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
14029705|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14029706|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
14029707|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14029708|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
14029709|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029710|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029711|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
14029712|NCT02722421|Efavirenz|efavirenz|mesh-list
14029713|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
14029714|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14029715|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14029716|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029717|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029718|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
14029719|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029720|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14029721|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14471504|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755383|NCT04158440|Carboplatin|carboplatin|mesh-list
14471505|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899687|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13899688|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
13899689|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899690|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899691|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899692|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
13899693|NCT00845299|Latanoprost|latanoprost|mesh-list
13899694|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
13899695|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13899696|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13899697|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13899698|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899699|NCT00845026|Olanzapine|olanzapine|mesh-list
14471506|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
14471507|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471508|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14471509|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
14755384|NCT04158440|Pemetrexed|pemetrexed|mesh-list
14755385|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14755386|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755387|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
14755388|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
14755389|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
14029722|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14029723|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14029724|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14029725|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14029726|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14029727|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
14029728|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14029729|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029730|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14029731|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14029732|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14029733|NCT02722369|Gemcitabine|gemcitabine|mesh-list
14029734|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
14029735|NCT02722369|Carboplatin|carboplatin|mesh-list
14029736|NCT02722369|Etoposide|etoposide|mesh-list
14029737|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029738|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029739|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
14029740|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029741|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
14029742|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029743|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029744|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14029745|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
14029746|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029747|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14029748|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13899700|NCT00845026|Risperidone|risperidone|mesh-list
13899701|NCT00845026|Aripiprazole|aripiprazole|mesh-list
13899702|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13899703|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
13899704|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899705|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899706|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899707|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13899708|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899709|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899710|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899711|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13899712|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
13899713|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
13899714|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
13899715|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899716|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13899717|NCT00845026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13899718|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14029749|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14029750|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
14029751|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14029752|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14029753|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169391|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14169392|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14169393|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169394|NCT04842383|Peppermint oil|peppermint oil|mesh-list
14169395|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
14169396|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
14169397|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169398|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169399|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471510|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14471511|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14755390|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899719|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899720|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
14471512|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
14755391|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471513|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13899721|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
13899722|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13899723|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13899724|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13899725|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14932404|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
14932405|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
14932406|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
14932407|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932408|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932409|NCT01445067|Calcitonin|calcitonin|mesh-list
14932410|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14932411|NCT01445067|Katacalcin|katacalcin|mesh-list
14029754|NCT02722356|Oxytocin|oxytocin|mesh-list
14029755|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
14029756|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14029757|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029758|NCT02722343|Tenofovir|tenofovir|mesh-list
14029759|NCT02722343|Emtricitabine|emtricitabine|mesh-list
14029760|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14029761|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
14029762|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029763|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14029764|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14029765|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029766|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029767|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14029768|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14029769|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
14029770|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029771|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
14029772|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029773|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
14029774|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
14029775|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14029776|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
14029777|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
14029778|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029779|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029780|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14029781|NCT02722096|Lidocaine|lidocaine|mesh-list
14029782|NCT02722096|Ropivacaine|ropivacaine|mesh-list
14029783|NCT02722096|Anesthetics|anesthetics|mesh-list
14029784|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029785|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029786|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029787|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
14029788|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029789|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14029790|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14029791|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14029792|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029793|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029794|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
14029795|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14029796|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029797|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14029798|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14029799|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029800|NCT02721888|Liraglutide|liraglutide|mesh-list
14029801|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14029802|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029803|NCT02721888|Incretins|incretins|mesh-ancestor
14029804|NCT02721888|Hormones|hormones|mesh-ancestor
14169400|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
14932412|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
14029805|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755392|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14755393|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14755394|NCT04158258|Bevacizumab|bevacizumab|mesh-list
14029809|NCT02721511|Furosemide|furosemide|mesh-list
13899736|NCT00843687|Risperidone|risperidone|mesh-list
13899737|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13899738|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
13899739|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899740|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899741|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899742|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14029810|NCT02721511|Diuretics|diuretics|mesh-ancestor
14029811|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
14029812|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029813|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14029814|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029815|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029816|NCT02721420|Piperaquine|piperaquine|mesh-list
14029817|NCT02721420|Artenimol|artenimol|mesh-list
14029818|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
14029819|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14029820|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14029821|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755395|NCT04158258|Trastuzumab|trastuzumab|mesh-list
14755396|NCT04158258|Pertuzumab|pertuzumab|mesh-list
14755397|NCT04158258|Capecitabine|capecitabine|mesh-list
14755398|NCT04158258|Atezolizumab|atezolizumab|mesh-list
14755399|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755400|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755401|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14755402|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14932413|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14029822|NCT02721368|Lidocaine|lidocaine|mesh-list
14029823|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029824|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
14029825|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029826|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029827|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
14029828|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029829|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14029830|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14029831|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14029832|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14029833|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932414|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932415|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14932416|NCT01445106|Nelfinavir|nelfinavir|mesh-list
14932417|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14932418|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14932419|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
14932420|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932421|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932422|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13899743|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899744|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899745|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899746|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13899747|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
13899748|NCT00841815|Amlodipine|amlodipine|mesh-list
13899749|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899750|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13899751|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899752|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899753|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13899754|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899755|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
13899756|NCT00841698|Paroxetine|paroxetine|mesh-list
13899757|NCT00841698|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13899758|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13899759|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899760|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029834|NCT02721329|Acetaminophen|acetaminophen|mesh-list
14471514|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14471515|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471516|NCT02332707|Ribavirin|ribavirin|mesh-list
14471517|NCT02332707|Grazoprevir|grazoprevir|mesh-list
14471518|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
14471519|NCT02332707|Ruzasvir|ruzasvir|mesh-list
14471520|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
14471521|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471522|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
14471523|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471524|NCT02332720|Ribavirin|ribavirin|mesh-list
14471525|NCT02332720|Grazoprevir|grazoprevir|mesh-list
14471526|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
14471527|NCT02332720|Ruzasvir|ruzasvir|mesh-list
14471528|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
14471529|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755403|NCT04158258|Growth Substances|growth substances|mesh-ancestor
14755404|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899761|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899762|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
13899763|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899764|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13899765|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
13899766|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899767|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13899768|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13899769|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899770|NCT00841659|Paroxetine|paroxetine|mesh-list
13899771|NCT00841659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13899772|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13899773|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899774|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899775|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899776|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
13899777|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899778|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13899779|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
13899780|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899781|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14029835|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029836|NCT02721329|Analgesics|analgesics|mesh-ancestor
14029837|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
14029838|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029839|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029840|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
14029841|NCT02721433|Denosumab|denosumab|mesh-list
14029842|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
14029843|NCT02721433|Pamidronate|pamidronate|mesh-list
14029844|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14029845|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029846|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
14029847|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14029848|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14029849|NCT02721043|Lenalidomide|lenalidomide|mesh-list
14029850|NCT02721043|Vaccines|vaccines|mesh-list
14029851|NCT02721043|Poly ICLC|poly iclc|mesh-list
14029852|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
14029853|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029854|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14029855|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14029856|NCT02721043|Growth Substances|growth substances|mesh-ancestor
14029857|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
14029858|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029859|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
14029860|NCT02721290|Ropivacaine|ropivacaine|mesh-list
14471530|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
14471531|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471532|NCT02332824|Candesartan|candesartan|mesh-list
14932423|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14932424|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
14029861|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029862|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
14029863|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029864|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029865|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
14029866|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029867|NCT02721082|Nicotine|nicotine|mesh-list
14029868|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14029869|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
14029870|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029871|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932425|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932426|NCT01445119|Carboplatin|carboplatin|mesh-list
14932427|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932428|NCT01445210|Ropivacaine|ropivacaine|mesh-list
13899782|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13899783|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899784|NCT00841542|Amlodipine|amlodipine|mesh-list
13899785|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899786|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13899787|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899788|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899789|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13899790|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899791|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
13899792|NCT00840879|Meloxicam|meloxicam|mesh-list
13899793|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13899794|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13899795|NCT00840879|Analgesics|analgesics|mesh-ancestor
13899796|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
13899797|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899798|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899799|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13899800|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13899801|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13899802|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13899803|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899804|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899805|NCT00840866|Cefprozil|cefprozil|mesh-list
13899806|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899807|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899808|NCT00840840|Amoxicillin|amoxicillin|mesh-list
13899809|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
13899810|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
14029872|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14029873|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14029874|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
14029875|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029876|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029877|NCT02721173|Clindamycin|clindamycin|mesh-list
14029878|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
14029879|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
14932429|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
14029880|NCT02721173|Adapalene|adapalene|mesh-list
14029881|NCT02721173|Tazarotene|tazarotene|mesh-list
14029882|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14029883|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029884|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14029885|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029886|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029887|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14029888|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029889|NCT02721173|Analgesics|analgesics|mesh-ancestor
14029890|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
13899811|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13899812|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899813|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899814|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13899815|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029891|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169401|NCT04842526|Irinotecan|irinotecan|mesh-list
14932430|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
14029892|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029893|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029894|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029895|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
14029896|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
14029897|NCT02721186|Piperaquine|piperaquine|mesh-list
14029898|NCT02721186|Primaquine|primaquine|mesh-list
14029899|NCT02721186|Artenimol|artenimol|mesh-list
14029900|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
14029901|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14029902|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14029903|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14029904|NCT02720978|Oxytocin|oxytocin|mesh-list
14029905|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
14029906|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14029907|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029908|NCT02720991|Misoprostol|misoprostol|mesh-list
14029909|NCT02720991|Mifepristone|mifepristone|mesh-list
14029910|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14029911|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
14029912|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14029913|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029914|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14029915|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029916|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
14029917|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14029918|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14029919|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14029920|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14029921|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
14029922|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14029923|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14029924|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
14029925|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14029926|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
14029927|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14029928|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14029929|NCT02720822|Morphine|morphine|mesh-list
14029930|NCT02720822|Laxatives|laxatives|mesh-list
14029931|NCT02720822|Cathartics|cathartics|mesh-list
14029932|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14029933|NCT02720822|Narcotics|narcotics|mesh-ancestor
14029934|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029935|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029936|NCT02720822|Analgesics|analgesics|mesh-ancestor
14029937|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
14029938|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029939|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14029940|NCT02720770|Hormones|hormones|mesh-list
14029941|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755405|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
14755406|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755407|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
14755408|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755409|NCT04157348|Benralizumab|benralizumab|mesh-list
14755410|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14755411|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
14755412|NCT04137120|Aflibercept|aflibercept|mesh-list
14755413|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14755414|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14755415|NCT04137120|Growth Substances|growth substances|mesh-ancestor
14755416|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899816|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899817|NCT00840632|Trandolapril|trandolapril|mesh-list
13899818|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13899819|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
13899820|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899821|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899822|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899823|NCT00840476|Meloxicam|meloxicam|mesh-list
13899824|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13899825|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13899826|NCT00840476|Analgesics|analgesics|mesh-ancestor
13899827|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
14029942|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029943|NCT02720926|Capecitabine|capecitabine|mesh-list
14029944|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
13899828|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899829|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899830|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13899831|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13899832|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13899833|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14029945|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14029946|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
14029947|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029948|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14029949|NCT02720965|Anesthetics|anesthetics|mesh-list
14029950|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
14029951|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029952|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029953|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
14029954|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029955|NCT02720783|Econazole|econazole|mesh-list
14029956|NCT02720783|Benzydamine|benzydamine|mesh-list
14029957|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029958|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
14029959|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899834|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899835|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899836|NCT00840411|Clarithromycin|clarithromycin|mesh-list
13899837|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899838|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899839|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13899840|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899841|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899842|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13899843|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13899844|NCT00840281|Cefprozil|cefprozil|mesh-list
13899845|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899846|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899847|NCT00840216|Clarithromycin|clarithromycin|mesh-list
13899848|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899849|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899850|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13899851|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899852|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899853|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13899854|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13899855|NCT00840203|Mesalamine|mesalamine|mesh-list
13899856|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13899857|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13899858|NCT00840203|Analgesics|analgesics|mesh-ancestor
13899859|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
13899860|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029960|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14029961|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14029962|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14029963|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029964|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14029965|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
14029966|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14029967|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029968|NCT02720692|Meloxicam|meloxicam|mesh-list
14029969|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14029970|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029971|NCT02720692|Analgesics|analgesics|mesh-ancestor
14029972|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
14029973|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029974|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029975|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14029976|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14029977|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14029978|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14029979|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169402|NCT04842526|Temozolomide|temozolomide|mesh-list
13899861|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029980|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14029981|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
14029982|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14029983|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029984|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029985|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14029986|NCT02720705|Analgesics|analgesics|mesh-ancestor
14029987|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
14029988|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14029989|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14029990|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14029991|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14029992|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14029993|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14029994|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169403|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13899862|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13899863|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13899864|NCT00840099|Amoxicillin|amoxicillin|mesh-list
13899865|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
13899866|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
13899867|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13899868|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899869|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899870|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13899871|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899872|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899873|NCT00840073|Trandolapril|trandolapril|mesh-list
13899874|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13899875|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
13899876|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899877|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899878|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13899879|NCT00839930|Cilostazol|cilostazol|mesh-list
13899880|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14169404|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14169405|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169406|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169407|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169408|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14169409|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
14169410|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
14169411|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14169412|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
14169413|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169414|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169415|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14169416|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
14169417|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14169418|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
14169419|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169420|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169421|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14169422|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
14169423|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
14169424|NCT04842331|Protective Agents|protective agents|mesh-ancestor
14169425|NCT04841980|Rifaximin|rifaximin|mesh-list
14169426|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14169427|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169428|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169429|NCT04841720|Metformin|metformin|mesh-list
14169430|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14169431|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169432|NCT04841668|Metformin|metformin|mesh-list
14169433|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14169434|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169435|NCT04842071|Listerine|listerine|mesh-list
14169436|NCT04842071|Fluorides|fluorides|mesh-list
14169437|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
14169438|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
14169439|NCT04842071|Protective Agents|protective agents|mesh-ancestor
14169440|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899881|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
13899882|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899883|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899884|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13899885|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
13899886|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13899887|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13899888|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899889|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13899890|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
13899891|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13899892|NCT00839930|Protective Agents|protective agents|mesh-ancestor
13899893|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14029995|NCT02720471|Anesthetics|anesthetics|mesh-list
14029996|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
14029997|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14029998|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14029999|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
14030000|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030001|NCT02720601|Capecitabine|capecitabine|mesh-list
14030002|NCT02720601|Irinotecan|irinotecan|mesh-list
14030003|NCT02720601|Camptothecin|camptothecin|mesh-list
14030004|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030005|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
14030006|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030007|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030008|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14030009|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14030010|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030011|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14030012|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14030013|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030014|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030015|NCT02720575|Vitamin D|vitamin d|mesh-list
14030016|NCT02720575|Vitamins|vitamins|mesh-ancestor
14030017|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
14030018|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030019|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14030020|NCT02720406|Ketamine|ketamine|mesh-list
14030021|NCT02720406|Analgesics|analgesics|mesh-ancestor
14030022|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
14030023|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030024|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030025|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14030026|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14030027|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
14030028|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
14030029|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030030|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14030031|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14030032|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030033|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030034|NCT02720367|Gemcitabine|gemcitabine|mesh-list
14030035|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030036|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
14030037|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030038|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030039|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
14030040|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030041|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030042|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030043|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
14030044|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030045|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
14030046|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
14030047|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030048|NCT02720094|Cabotegravir|cabotegravir|mesh-list
14030049|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14030050|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14030051|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030052|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030053|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14030054|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14030055|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
14030056|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030057|NCT02720341|Armin|armin|mesh-list
13899894|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13899895|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899896|NCT00838799|Pregabalin|pregabalin|mesh-list
13899897|NCT00838799|Analgesics|analgesics|mesh-ancestor
13899898|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
13899899|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13899900|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030058|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14030059|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030060|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030061|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
14030062|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030063|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030064|NCT02719756|Metformin|metformin|mesh-list
14030065|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
14030066|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14030067|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932431|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932432|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932433|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
14932434|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932435|NCT01445223|Ritonavir|ritonavir|mesh-list
14932436|NCT01445223|Lopinavir|lopinavir|mesh-list
14932437|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13899901|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
13899902|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13899903|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899904|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899905|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13899906|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13899907|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899908|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899909|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14030068|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14030069|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030070|NCT02719795|Ropivacaine|ropivacaine|mesh-list
14030071|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
14030072|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
14030073|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030074|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030075|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
14755417|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
14755418|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755419|NCT04123262|Tamoxifen|tamoxifen|mesh-list
14755420|NCT04123262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14755421|NCT04123262|Hormone Antagonists|hormone antagonists|mesh-ancestor
14755422|NCT04123262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755423|NCT04123262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755424|NCT04123262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14755425|NCT04123262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755426|NCT04123262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14755427|NCT04123262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13899910|NCT00838630|Cilostazol|cilostazol|mesh-list
13899911|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13899912|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
13899913|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932438|NCT01445223|Efavirenz|efavirenz|mesh-list
14932439|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14932440|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14932441|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
14932442|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932443|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471533|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
14471534|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
14471535|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14471536|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14471537|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14471538|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471539|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471540|NCT02332889|Decitabine|decitabine|mesh-list
14471541|NCT02332889|Poly ICLC|poly iclc|mesh-list
14471542|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14471543|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
14471544|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471545|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471546|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471547|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
14471548|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
14471549|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471550|NCT02332902|Everolimus|everolimus|mesh-list
14471551|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471552|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13899914|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899915|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13899916|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14471553|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
14471554|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471555|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13899917|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13899918|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14932444|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14932445|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14932446|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
14932447|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932448|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14030076|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471556|NCT02333045|Maraviroc|maraviroc|mesh-list
14755428|NCT04123262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13899919|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899920|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13899921|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
13899922|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13899923|NCT00838630|Protective Agents|protective agents|mesh-ancestor
13899924|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13899925|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13899926|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755429|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
14755430|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13899927|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
13899928|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13899929|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899930|NCT00838279|Lamotrigine|lamotrigine|mesh-list
13899931|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
13899932|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13899933|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899934|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899935|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13899936|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899937|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13899938|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899939|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14755431|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
14755432|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755433|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
14755434|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14755435|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14755436|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932449|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13899940|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899941|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13899942|NCT00838136|Lamotrigine|lamotrigine|mesh-list
13899943|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
13899944|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13899945|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899946|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899947|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14030077|NCT02719834|Acetaminophen|acetaminophen|mesh-list
14030078|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030079|NCT02719834|Analgesics|analgesics|mesh-ancestor
14030080|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
14030081|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030082|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030083|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
14030084|NCT02719808|Tenofovir|tenofovir|mesh-list
14030085|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
14030086|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030087|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14030088|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14030089|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030090|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030091|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14030092|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14030093|NCT02719574|Cytarabine|cytarabine|mesh-list
14030094|NCT02719574|Azacitidine|azacitidine|mesh-list
14030095|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13899948|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899949|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13899950|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13899951|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13899952|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13899953|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13899954|NCT00837265|Docetaxel|docetaxel|mesh-list
13899955|NCT00837265|Doxorubicin|doxorubicin|mesh-list
13899956|NCT00837265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13899957|NCT00837265|Tubulin Modulators|tubulin modulators|mesh-ancestor
13899958|NCT00837265|Antimitotic Agents|antimitotic agents|mesh-ancestor
13899959|NCT00837265|Mitosis Modulators|mitosis modulators|mesh-ancestor
14030096|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
14030097|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030098|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030099|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
14030100|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030101|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030102|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
14030103|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030104|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030105|NCT02719405|Caseins|caseins|mesh-list
14030106|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
14030107|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
14030108|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030109|NCT02719418|Tinzaparin|tinzaparin|mesh-list
14030110|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14030111|NCT02719418|Dalteparin|dalteparin|mesh-list
13899960|NCT00837265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899961|NCT00837265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14030112|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
14030113|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14030114|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14030115|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030116|NCT02719431|Warfarin|warfarin|mesh-list
14030117|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
14030118|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14030119|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
14030120|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030121|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
13899962|NCT00837265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13899963|NCT00837265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13899964|NCT00837265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899965|NCT00836901|Amoxicillin|amoxicillin|mesh-list
13899966|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13899967|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
13899968|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
13899969|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899970|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899971|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13899972|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13899973|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899974|NCT00836706|Clarithromycin|clarithromycin|mesh-list
13899975|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13899976|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13899977|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13899978|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030122|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14030123|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14030124|NCT02719210|Mannitol|mannitol|mesh-list
14030125|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14030126|NCT02719210|Diuretics|diuretics|mesh-ancestor
14030127|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
14030128|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899979|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899980|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13899981|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13899982|NCT00836472|Metformin|metformin|mesh-list
13899983|NCT00836472|Glyburide|glyburide|mesh-list
13899984|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13899985|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899986|NCT00836069|Paroxetine|paroxetine|mesh-list
14030129|NCT02719132|Metformin|metformin|mesh-list
14030130|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
14030131|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14030132|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030133|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14030134|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169441|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14169442|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169443|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
14169444|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14169445|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169446|NCT04841096|Metformin|metformin|mesh-list
14169447|NCT04841096|Glimepiride|glimepiride|mesh-list
14169448|NCT04841096|Vildagliptin|vildagliptin|mesh-list
13899987|NCT00836069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13899988|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13899989|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13899990|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13899991|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13899992|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
13899993|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13899994|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13899995|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
13899996|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169449|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14169450|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755437|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14755438|NCT04111926|Analgesics|analgesics|mesh-ancestor
14755439|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
14755440|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169451|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14169452|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755441|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14030135|NCT02718820|Docetaxel|docetaxel|mesh-list
14030136|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
14030137|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030138|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
13899997|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13899998|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14030139|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
14030140|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
14030141|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030142|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14030143|NCT02718950|Liraglutide|liraglutide|mesh-list
14030144|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14030145|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030146|NCT02718950|Incretins|incretins|mesh-ancestor
14030147|NCT02718950|Hormones|hormones|mesh-ancestor
14030148|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13899999|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900000|NCT00836056|Clindamycin|clindamycin|mesh-list
13900001|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
13900002|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
13900003|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900004|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030149|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
14030150|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14030151|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030152|NCT02718911|Durvalumab|durvalumab|mesh-list
14030153|NCT02718911|Tremelimumab|tremelimumab|mesh-list
14030154|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14030155|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030156|NCT02718755|Vidarabine|vidarabine|mesh-list
14030157|NCT02718755|Cytarabine|cytarabine|mesh-list
14030158|NCT02718755|Fludarabine|fludarabine|mesh-list
13900005|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13900006|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900007|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900008|NCT00836004|Clindamycin|clindamycin|mesh-list
13900009|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
13900010|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
13900011|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900012|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030159|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
14030160|NCT02718755|Asparaginase|asparaginase|mesh-list
14030161|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030162|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14932450|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14030163|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
14030164|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030165|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030166|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
14030167|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030168|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
14030169|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030170|NCT02718976|Lidocaine|lidocaine|mesh-list
14030171|NCT02718976|Epinephrine|epinephrine|mesh-list
14030172|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14030173|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
14030174|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
14030175|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030176|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030177|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
14030178|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030179|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14030180|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14932451|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14932452|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14932453|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14030181|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14030182|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14030183|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030184|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14030185|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14030186|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
14030187|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030188|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14030189|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14030190|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
14030191|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14030192|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
14030193|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
14030194|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
14030195|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14030196|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
14030197|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
14030198|NCT02718677|Factor VIII|factor viii|mesh-list
14030199|NCT02718677|Coagulants|coagulants|mesh-ancestor
14030200|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
14030201|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030202|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
14030203|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030204|NCT02718547|Timolol|timolol|mesh-list
14030205|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14030206|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14030207|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
14030208|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14030209|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14030210|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14030211|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
14030212|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030213|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030214|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030215|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14030216|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14030217|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14030218|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14030219|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14030220|NCT02718742|Paclitaxel|paclitaxel|mesh-list
14755442|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14030221|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13900013|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13900014|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900015|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900016|NCT00835991|Metformin|metformin|mesh-list
13900017|NCT00835991|Glyburide|glyburide|mesh-list
13900018|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900019|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900020|NCT00835796|Finasteride|finasteride|mesh-list
13900021|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13900022|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13900023|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900024|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900025|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
14030222|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14030223|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030224|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
14030225|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
14030226|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755443|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14755444|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
14755445|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755446|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755447|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
14755448|NCT04106219|Topotecan|topotecan|mesh-list
14755449|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755450|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
14755451|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755452|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755453|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14755454|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
14755455|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755456|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030227|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030228|NCT02718404|Analgesics|analgesics|mesh-list
14030229|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
14030230|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030231|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030232|NCT02718469|Vaccines|vaccines|mesh-list
14030233|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
14030234|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030235|NCT02718521|Isosorbide|isosorbide|mesh-list
14030236|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14030237|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14030238|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14030239|NCT02718521|Diuretics|diuretics|mesh-ancestor
14030240|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
14030241|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030242|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
14030243|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14030244|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030245|NCT02718482|Gemcitabine|gemcitabine|mesh-list
14030246|NCT02718482|Docetaxel|docetaxel|mesh-list
14030247|NCT02718482|Ifosfamide|ifosfamide|mesh-list
14030248|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
14030249|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030250|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
14030251|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030252|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030253|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
14030254|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900026|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900027|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900028|NCT00835796|Urological Agents|urological agents|mesh-ancestor
13900029|NCT00835705|Amoxicillin|amoxicillin|mesh-list
13900030|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13900031|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
13900032|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
13900033|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900034|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900035|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13900036|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900037|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900038|NCT00835692|Clarithromycin|clarithromycin|mesh-list
13900039|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900040|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900041|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13900042|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900043|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900044|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13900045|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13900046|NCT00835666|Finasteride|finasteride|mesh-list
13900047|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13900048|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13900049|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030255|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755457|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14030256|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030257|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
14030258|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030259|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
14755458|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13900050|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900051|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
13900052|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900053|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900054|NCT00835666|Urological Agents|urological agents|mesh-ancestor
13900055|NCT00835640|Fexofenadine|fexofenadine|mesh-list
13900056|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13900057|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13900058|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13900059|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
13900060|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
13900061|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900062|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900063|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900064|NCT00835614|Cefprozil|cefprozil|mesh-list
13900065|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900066|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900067|NCT00835588|Pantoprazole|pantoprazole|mesh-list
13900068|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13900069|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13900070|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13900071|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900072|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900073|NCT00835575|Mirtazapine|mirtazapine|mesh-list
13900074|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
13900075|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900076|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13900077|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
13900078|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
13900079|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900080|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900081|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900082|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13900083|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900084|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900085|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13900086|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13900087|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13900088|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
13900089|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13900090|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13900091|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
13900092|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13900093|NCT00835549|Cefdinir|cefdinir|mesh-list
13900094|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900095|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900096|NCT00835536|Ribavirin|ribavirin|mesh-list
13900097|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
13900098|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900099|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
13900100|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900101|NCT00835497|Metformin|metformin|mesh-list
13900102|NCT00835497|Glipizide|glipizide|mesh-list
13900103|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900104|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900105|NCT00835484|Cefdinir|cefdinir|mesh-list
13900106|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900107|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900108|NCT00835406|Alendronate|alendronate|mesh-list
13900109|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13900110|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900111|NCT00835367|Amlodipine|amlodipine|mesh-list
13900112|NCT00835367|Benazepril|benazepril|mesh-list
13900113|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900114|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13900115|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900116|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900117|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13900118|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900119|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
13900120|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13900121|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900122|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030260|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
14030261|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
14030262|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14030263|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
14030264|NCT02718599|Terlipressin|terlipressin|mesh-list
14030265|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14030266|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14030267|NCT02718261|Pantoprazole|pantoprazole|mesh-list
14030268|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14030269|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14030270|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14030271|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030272|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030273|NCT02717884|Cytarabine|cytarabine|mesh-list
14030274|NCT02717884|Tretinoin|tretinoin|mesh-list
14030275|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
14030276|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030277|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
14030278|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030279|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030280|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
14030281|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900123|NCT00835354|Cefprozil|cefprozil|mesh-list
13900124|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900125|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900126|NCT00835276|Fexofenadine|fexofenadine|mesh-list
13900127|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13900128|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13900129|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13900130|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
13900131|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
13900132|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900133|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030282|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030283|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
14030284|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030285|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
14030286|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14030287|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
14030288|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14030289|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14030290|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030291|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14030292|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14030293|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030294|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14030295|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
14030296|NCT02718079|Mannitol|mannitol|mesh-list
14030297|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14030298|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030299|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14030300|NCT02718079|Diuretics|diuretics|mesh-ancestor
14030301|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
14030302|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030303|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
14030304|NCT02718079|Expectorants|expectorants|mesh-ancestor
14030305|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
14030306|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14030307|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
14030308|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030309|NCT02718079|Protective Agents|protective agents|mesh-ancestor
14030310|NCT02718079|Antidotes|antidotes|mesh-ancestor
14030311|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13900134|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030312|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
14030313|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14030314|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030315|NCT02717923|Capecitabine|capecitabine|mesh-list
13900135|NCT00835263|Lamotrigine|lamotrigine|mesh-list
13900136|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
13900137|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13900138|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900139|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900140|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13900141|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900142|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13900143|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900144|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900145|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900146|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13900147|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13900148|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
13900149|NCT00835211|Coagulants|coagulants|mesh-ancestor
13900150|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13900151|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
13900152|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900153|NCT00835172|Glimepiride|glimepiride|mesh-list
13900154|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13900155|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900156|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900157|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900158|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
13900159|NCT00835146|Ribavirin|ribavirin|mesh-list
13900160|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
13900161|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900162|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
13900163|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900164|NCT00835081|Cefadroxil|cefadroxil|mesh-list
13900165|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900166|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030316|NCT02717923|Cetuximab|cetuximab|mesh-list
14030317|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030318|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
14030319|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030320|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030321|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14030322|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
14030323|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
14030324|NCT02717871|Levofloxacin|levofloxacin|mesh-list
14030325|NCT02717871|Ofloxacin|ofloxacin|mesh-list
14030326|NCT02717871|Gentamicins|gentamicins|mesh-list
14030327|NCT02717871|Cefazolin|cefazolin|mesh-list
14030328|NCT02717871|Tobramycin|tobramycin|mesh-list
14030329|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
14030330|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
14030331|NCT02717871|Besifloxacin|besifloxacin|mesh-list
14030332|NCT02717871|Prednisolone|prednisolone|mesh-list
14030333|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14030334|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
14030335|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14030336|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
14030337|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14755459|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755460|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755461|NCT04106115|Durvalumab|durvalumab|mesh-list
14030338|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14030339|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
14030340|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
14030341|NCT02717871|Mydriatics|mydriatics|mesh-list
14030342|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14030343|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
13900167|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13900168|NCT00835042|Moexipril|moexipril|mesh-list
13900169|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14030344|NCT02717871|Hormones|hormones|mesh-ancestor
14030345|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14030346|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030347|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14030348|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030349|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
14030350|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
14030351|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030352|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14030353|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14030354|NCT02717871|Protective Agents|protective agents|mesh-ancestor
14030355|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14030356|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030357|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14030358|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14030359|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030360|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030361|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14030362|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14030363|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14030364|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14030365|NCT02717871|Renal Agents|renal agents|mesh-ancestor
14030366|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14030367|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14030368|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
14030369|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14030370|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14030371|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
14030372|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030373|NCT02717858|Liraglutide|liraglutide|mesh-list
14030374|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14030375|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030376|NCT02717858|Incretins|incretins|mesh-ancestor
14030377|NCT02717858|Hormones|hormones|mesh-ancestor
14030378|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14030379|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14030380|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14030381|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030382|NCT02717819|Vitamin D|vitamin d|mesh-list
14030383|NCT02717819|Vitamins|vitamins|mesh-ancestor
14030384|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
14030385|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030386|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14030387|NCT02717780|Fentanyl|fentanyl|mesh-list
14030388|NCT02717780|Remifentanil|remifentanil|mesh-list
14030389|NCT02717780|Sevoflurane|sevoflurane|mesh-list
14030390|NCT02717780|Desflurane|desflurane|mesh-list
14030391|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14030392|NCT02717780|Narcotics|narcotics|mesh-ancestor
14030393|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030394|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030395|NCT02717780|Analgesics|analgesics|mesh-ancestor
14030396|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
14030397|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030398|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14030399|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14030400|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
14030401|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
14030402|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14030403|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14030404|NCT02717052|Ketamine|ketamine|mesh-list
13900170|NCT00835042|Diuretics|diuretics|mesh-ancestor
13900171|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
13900172|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900173|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13900174|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900175|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900176|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13900177|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900178|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900179|NCT00834990|Valproic Acid|valproic acid|mesh-list
13900180|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
13900181|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900182|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900183|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
14030405|NCT02717052|Esketamine|esketamine|mesh-list
14030406|NCT02717052|Analgesics|analgesics|mesh-ancestor
14030407|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
13900184|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900185|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900186|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
13900187|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900188|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900189|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900190|NCT00834977|Amlodipine|amlodipine|mesh-list
13900191|NCT00834977|Benazepril|benazepril|mesh-list
13900192|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900193|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13900194|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900195|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900196|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13900197|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900198|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
13900199|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13900200|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900201|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900202|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13900203|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13900204|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13900205|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900206|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900207|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900208|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900209|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13900210|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
13900211|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900212|NCT00834873|Carvedilol|carvedilol|mesh-list
14030408|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030409|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030410|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14030411|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14030412|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
14030413|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
14030414|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030415|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14030416|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14030417|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030418|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900213|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13900214|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13900215|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
13900216|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900217|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900218|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900219|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900220|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
13900221|NCT00834873|Protective Agents|protective agents|mesh-ancestor
13900222|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14030419|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
14030420|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14030421|NCT02717091|Gemcitabine|gemcitabine|mesh-list
14755462|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755463|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755464|NCT04102020|Azacitidine|azacitidine|mesh-list
13900223|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900224|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14030422|NCT02717091|Paclitaxel|paclitaxel|mesh-list
14030423|NCT02717091|Folfirinox|folfirinox|mesh-list
14030424|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14030425|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030426|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
14030427|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
13900225|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
14030428|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755465|NCT04102020|Venetoclax|venetoclax|mesh-list
14755466|NCT04102020|Cc-486|cc-486|mesh-list
14755467|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755468|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
14755469|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755470|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755471|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755472|NCT04094688|Vitamin D|vitamin d|mesh-list
14471557|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14471558|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14471559|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471560|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471561|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
14471562|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471563|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14471564|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14471565|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13900226|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13900227|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13900228|NCT00834795|Carvedilol|carvedilol|mesh-list
13900229|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13900230|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13900231|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
13900232|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900233|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900234|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900235|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900236|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
13900237|NCT00834795|Protective Agents|protective agents|mesh-ancestor
13900238|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13900239|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471566|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14471567|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14471568|NCT02333383|Adalimumab|adalimumab|mesh-list
14471569|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14471570|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14471571|NCT02334059|Ketamine|ketamine|mesh-list
14471572|NCT02334059|Analgesics|analgesics|mesh-ancestor
14471573|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
14030429|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030430|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030431|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
14030432|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
14030433|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030434|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030435|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030436|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
14030437|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169453|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
14169454|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14169455|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
14169456|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900240|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13900241|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
13900242|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13900243|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13900244|NCT00834756|Azithromycin|azithromycin|mesh-list
13900245|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900246|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900247|NCT00834743|Metformin|metformin|mesh-list
13900248|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900249|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900250|NCT00834717|Granisetron|granisetron|mesh-list
13900251|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
13900252|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
14169457|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169458|NCT04841369|Vaccines|vaccines|mesh-list
14169459|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
14169460|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169461|NCT04841343|Triamcinolone|triamcinolone|mesh-list
14169462|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169463|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
14169464|NCT04841343|Hormones|hormones|mesh-ancestor
14169465|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169466|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169467|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
14169468|NCT04841148|Palbociclib|palbociclib|mesh-list
14471574|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471575|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755473|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
14169469|NCT04841148|Avelumab|avelumab|mesh-list
14755474|NCT04094688|Leucovorin|leucovorin|mesh-list
14030438|NCT02716974|Docetaxel|docetaxel|mesh-list
14030439|NCT02716974|Leuprolide|leuprolide|mesh-list
14030440|NCT02716974|Bicalutamide|bicalutamide|mesh-list
14030441|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030442|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
14030443|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
14030444|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
14030445|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030446|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14030447|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
14030448|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030449|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900253|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900254|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900255|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13900256|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13900257|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
13900258|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900259|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900260|NCT00834639|Valproic Acid|valproic acid|mesh-list
13900261|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
13900262|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900263|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900264|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
14030450|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14030451|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
14030452|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
14030453|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14030454|NCT02716961|Gemcitabine|gemcitabine|mesh-list
14030455|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030456|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030457|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
14030458|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900265|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900266|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900267|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
13900268|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900269|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900270|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900271|NCT00834613|Metformin|metformin|mesh-list
13900272|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900273|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900274|NCT00834587|Metformin|metformin|mesh-list
13900275|NCT00834587|Glipizide|glipizide|mesh-list
13900276|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900277|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900278|NCT00834574|Cefdinir|cefdinir|mesh-list
13900279|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900280|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900281|NCT00834561|Lamotrigine|lamotrigine|mesh-list
13900282|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
13900283|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13900284|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900285|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900286|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13900287|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030459|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
14030460|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030461|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030462|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030463|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
14030464|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030465|NCT02716857|Oxycodone|oxycodone|mesh-list
14030466|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14030467|NCT02716857|Narcotics|narcotics|mesh-ancestor
14030468|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030469|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030470|NCT02716857|Analgesics|analgesics|mesh-ancestor
14030471|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
14030472|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900288|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13900289|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900290|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030473|NCT02716766|Capecitabine|capecitabine|mesh-list
13900291|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14030474|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
14030475|NCT02716766|Sorafenib|sorafenib|mesh-list
14030476|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030477|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
14030478|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030479|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030480|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14030481|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030482|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
14030483|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14471576|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14471577|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14471578|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
14471579|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
14471580|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471581|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13900292|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14030484|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030485|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
14030486|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14030487|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030488|NCT02716415|Menthol|menthol|mesh-list
14030489|NCT02716415|Petrolatum|petrolatum|mesh-list
14030490|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
14030491|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
14030492|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
14030493|NCT02716415|Emollients|emollients|mesh-ancestor
14030494|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
14030495|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14030496|NCT02716415|Protective Agents|protective agents|mesh-ancestor
14030497|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030498|NCT02716428|Ribavirin|ribavirin|mesh-list
14030499|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
14030500|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030501|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
14030502|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030503|NCT02716311|Cetuximab|cetuximab|mesh-list
14030504|NCT02716311|Afatinib|afatinib|mesh-list
14030505|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14030506|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030507|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14030508|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030509|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030510|NCT02716285|Peppermint oil|peppermint oil|mesh-list
14030511|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
14030512|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
14030513|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030514|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030515|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14030516|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
14030517|NCT02716129|Morphine|morphine|mesh-list
14030518|NCT02716129|Nalbuphine|nalbuphine|mesh-list
14030519|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14030520|NCT02716129|Narcotics|narcotics|mesh-ancestor
13900293|NCT00834535|Cefdinir|cefdinir|mesh-list
13900294|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900295|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959381|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959382|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13959383|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13959384|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13959385|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
13959386|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13959387|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13959388|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13959389|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
13959390|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13959391|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13959392|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
14030521|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030522|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030523|NCT02716129|Analgesics|analgesics|mesh-ancestor
14030524|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
14030525|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030526|NCT02716259|Fluorides|fluorides|mesh-list
14030527|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
14030528|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
14030529|NCT02716259|Protective Agents|protective agents|mesh-ancestor
14030530|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030531|NCT02716233|Pegaspargase|pegaspargase|mesh-list
14030532|NCT02716233|Asparaginase|asparaginase|mesh-list
14030533|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030534|NCT02716272|Nivolumab|nivolumab|mesh-list
14030535|NCT02716272|Ipilimumab|ipilimumab|mesh-list
14030536|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14030537|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030538|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14030539|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030540|NCT02716142|Misoprostol|misoprostol|mesh-list
14030541|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14030542|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
14030543|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030544|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030545|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14030546|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14030547|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
14030548|NCT02716038|Paclitaxel|paclitaxel|mesh-list
14030549|NCT02716038|Carboplatin|carboplatin|mesh-list
14030550|NCT02716038|Atezolizumab|atezolizumab|mesh-list
14030551|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14030552|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030553|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14030554|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14030555|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14030556|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030557|NCT02716090|Adapalene|adapalene|mesh-list
14030558|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
13900296|NCT00834522|Granisetron|granisetron|mesh-list
13900297|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
13900298|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
13900299|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900300|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900301|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13900302|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13900303|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
13900304|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900305|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900306|NCT00834444|Famciclovir|famciclovir|mesh-list
13900307|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
13900308|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900309|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13900310|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900311|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900312|NCT00834431|Famciclovir|famciclovir|mesh-list
13900313|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
13900314|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900315|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13900316|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900317|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030559|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
14030560|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14030561|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030562|NCT02716090|Analgesics|analgesics|mesh-ancestor
14030563|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
14030564|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030565|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030566|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14030567|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14030568|NCT02715869|Sevoflurane|sevoflurane|mesh-list
14030569|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13900318|NCT00834418|Leflunomide|leflunomide|mesh-list
14030570|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14030571|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
14030572|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
14030573|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030574|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030575|NCT02715687|Amiodarone|amiodarone|mesh-list
14030576|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14030577|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
14030578|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14030579|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14030580|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030581|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14030582|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13900319|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900320|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900321|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900322|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
13900323|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900324|NCT00834405|Leflunomide|leflunomide|mesh-list
13900325|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900326|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900327|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900328|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
14030583|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14030584|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030585|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14030586|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14030587|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14030588|NCT02715947|Methotrexate|methotrexate|mesh-list
14030589|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14030590|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
14030591|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030592|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030593|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030594|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
14030595|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030596|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030597|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
14030598|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030599|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14030600|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030601|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
14030602|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14030603|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14030604|NCT02715960|Vitamin A|vitamin a|mesh-list
14030605|NCT02715960|Tretinoin|tretinoin|mesh-list
14030606|NCT02715960|Acitretin|acitretin|mesh-list
14030607|NCT02715960|Vitamins|vitamins|mesh-ancestor
14030608|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
14030609|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030610|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030611|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
14030612|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
14169470|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
14169471|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14169472|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14169473|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169474|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900329|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900330|NCT00834340|Glimepiride|glimepiride|mesh-list
13900331|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13900332|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900333|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900334|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900335|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
13900336|NCT00834275|Cefadroxil|cefadroxil|mesh-list
13900337|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900338|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900339|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13900340|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13900341|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13900342|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900343|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900344|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900345|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900346|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13900347|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
13900348|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14932454|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14932455|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14932456|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14932457|NCT01445236|Cyclosporine|cyclosporine|mesh-list
14932458|NCT01445236|Tacrolimus|tacrolimus|mesh-list
13900349|NCT00834197|Mirtazapine|mirtazapine|mesh-list
13900350|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
13900351|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900352|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13900353|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
13900354|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
13900355|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030613|NCT02715492|Enoxaparin|enoxaparin|mesh-list
14030614|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
14030615|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14030616|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14030617|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030618|NCT02715531|Leucovorin|leucovorin|mesh-list
14030619|NCT02715531|Gemcitabine|gemcitabine|mesh-list
14030620|NCT02715531|Paclitaxel|paclitaxel|mesh-list
14030621|NCT02715531|Bevacizumab|bevacizumab|mesh-list
14030622|NCT02715531|Capecitabine|capecitabine|mesh-list
14030623|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
14030624|NCT02715531|Atezolizumab|atezolizumab|mesh-list
14030625|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14030626|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030627|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
14030628|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
14030629|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
14030630|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030631|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14030632|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14030633|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14030634|NCT02715531|Growth Substances|growth substances|mesh-ancestor
14030635|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030636|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
14030637|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030638|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
14030639|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
14932459|NCT01445236|Cyclosporins|cyclosporins|mesh-list
14932460|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932461|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
14932462|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932463|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14030640|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030641|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030642|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900356|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900357|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900358|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13900359|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900360|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900361|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13900362|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13900363|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13900364|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
13900365|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13900366|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13900367|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
13900368|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13900369|NCT00834132|Azithromycin|azithromycin|mesh-list
13900370|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900371|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900372|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13900373|NCT00834067|Moexipril|moexipril|mesh-list
13900374|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900375|NCT00834067|Diuretics|diuretics|mesh-ancestor
13900376|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
13900377|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030643|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
14030644|NCT02715531|Antidotes|antidotes|mesh-ancestor
14030645|NCT02715531|Protective Agents|protective agents|mesh-ancestor
14030646|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
14030647|NCT02715531|Vitamins|vitamins|mesh-ancestor
14030648|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
14030649|NCT02715479|Dolutegravir|dolutegravir|mesh-list
14030650|NCT02715479|BMS-955176|bms-955176|mesh-list
14030651|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14030652|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14030653|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030654|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030655|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14030656|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14030657|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
14030658|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030659|NCT02715336|Leuprolide|leuprolide|mesh-list
14030660|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14030661|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
14030662|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030663|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030664|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14030665|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030666|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14030667|NCT02714998|Methotrexate|methotrexate|mesh-list
14030668|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14030669|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
14030670|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030671|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030672|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030673|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
14030674|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030675|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030676|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
14030677|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030678|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14030679|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030680|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
14755475|NCT04094688|Bevacizumab|bevacizumab|mesh-list
14755476|NCT04094688|Fluorouracil|fluorouracil|mesh-list
14755477|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
14755478|NCT04094688|Irinotecan|irinotecan|mesh-list
14755479|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
14755480|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755481|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755482|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14755483|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14755484|NCT04094688|Growth Substances|growth substances|mesh-ancestor
14755485|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755486|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
14755487|NCT04094688|Vitamins|vitamins|mesh-ancestor
14030681|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755488|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
14755489|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14755490|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13900378|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13900379|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900380|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900381|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13900382|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900383|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900384|NCT00833937|Zolpidem|zolpidem|mesh-list
13900385|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13900386|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13900387|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900388|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900389|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13900390|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
13900391|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
13900392|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900393|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900394|NCT00833664|Terbinafine|terbinafine|mesh-list
14030682|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14030683|NCT02715024|Tamsulosin|tamsulosin|mesh-list
14030684|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
14030685|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14030686|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14030687|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14030688|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
14030689|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030690|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471582|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14471583|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471584|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471585|NCT02334215|Methadone|methadone|mesh-list
14471586|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14030691|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030692|NCT02715024|Urological Agents|urological agents|mesh-ancestor
14030693|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14030694|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14030695|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
14030696|NCT02715193|Volagidemab|volagidemab|mesh-list
14030697|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14030698|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030699|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
14030700|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14030701|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030702|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030703|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030704|NCT02715154|Analgesics|analgesics|mesh-ancestor
14030705|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
14030706|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030707|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14030708|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14030709|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14030710|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
14030711|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030712|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030713|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14030714|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
14030715|NCT02715232|Lynestrenol|lynestrenol|mesh-list
14030716|NCT02715232|Estradiol|estradiol|mesh-list
14030717|NCT02715232|Testosterone|testosterone|mesh-list
14030718|NCT02715232|Cyproterone|cyproterone|mesh-list
14030719|NCT02715232|Estrogens|estrogens|mesh-ancestor
14030720|NCT02715232|Hormones|hormones|mesh-ancestor
14030721|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14030722|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030723|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14471587|NCT02334215|Narcotics|narcotics|mesh-ancestor
14471588|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471589|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471590|NCT02334215|Analgesics|analgesics|mesh-ancestor
14471591|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
14471592|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471593|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
14471594|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
14471595|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
14030724|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
14030725|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030726|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14030727|NCT02715232|Androgens|androgens|mesh-ancestor
14030728|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14030729|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030730|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
14030731|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
14030732|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
14030733|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14030734|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14030735|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14030736|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14030737|NCT02715167|Budesonide|budesonide|mesh-list
14030738|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14030739|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14030740|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
14030741|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030742|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030743|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14030744|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
14030745|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
14030746|NCT02715167|Hormones|hormones|mesh-ancestor
14030747|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14030748|NCT02714959|Aldesleukin|aldesleukin|mesh-list
14030749|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030750|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14030751|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14030752|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
14030753|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030754|NCT02714894|Clozapine|clozapine|mesh-list
14030755|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14030756|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
14030757|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030758|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030759|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030760|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14030761|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14030762|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030763|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14030764|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
13900395|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
13900396|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900397|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900398|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900399|NCT00833586|Terbinafine|terbinafine|mesh-list
13900400|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
13900401|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900402|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900403|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900404|NCT00833521|Zolpidem|zolpidem|mesh-list
13900405|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13900406|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13900407|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030765|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
14030766|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
14030767|NCT02714634|Methotrexate|methotrexate|mesh-list
14030768|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14030769|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
14030770|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030771|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030772|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14030773|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
14030774|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900408|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900409|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13900410|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
13900411|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
13900412|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900413|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900414|NCT00833495|Prednisolone|prednisolone|mesh-list
13900415|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13900416|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
14030775|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030776|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
13900417|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13900418|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
13900419|NCT00833495|Prednisone|prednisone|mesh-list
13900420|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13900421|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
13900422|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900423|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
13900424|NCT00833495|Hormones|hormones|mesh-ancestor
13900425|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900426|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900427|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13900428|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030777|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030778|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14030779|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030780|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
14030781|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14030782|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14030783|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
14030784|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14030785|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14030786|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030787|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
14030788|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14030789|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
14030790|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030791|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14030792|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
14030793|NCT02714725|Propofol|propofol|mesh-list
14030794|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14030795|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14755491|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
14755492|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755493|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755494|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755495|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
14755496|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14755497|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755498|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900429|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
14030796|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030797|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14030798|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
14030799|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
14030800|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030801|NCT02714725|Analgesics|analgesics|mesh-ancestor
14030802|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
14030803|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030804|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14030805|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14030806|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14030807|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
14030808|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030809|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030810|NCT02714842|Diclofenac|diclofenac|mesh-list
14030811|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14030812|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030813|NCT02714842|Analgesics|analgesics|mesh-ancestor
14030814|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
14030815|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030816|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030817|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14030818|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14030819|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14030820|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030821|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030822|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14030823|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
13900430|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
13900431|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900432|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13900433|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14030824|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030825|NCT02714699|Diclofenac|diclofenac|mesh-list
13900434|NCT00833495|Protective Agents|protective agents|mesh-ancestor
14030826|NCT02714699|Scopolamine|scopolamine|mesh-list
14030827|NCT02714699|Bromides|bromides|mesh-list
14030828|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14030829|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14030830|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030831|NCT02714699|Analgesics|analgesics|mesh-ancestor
14030832|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
14030833|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030834|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030835|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14030836|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14030837|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14030838|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030839|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030840|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
14030841|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14030842|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
14030843|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
14030844|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14030845|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
14030846|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14030847|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
14030848|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030849|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14030850|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
14030851|NCT02714855|Apixaban|apixaban|mesh-list
14030852|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14030853|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
14030854|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14030855|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14030856|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030857|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030858|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
14030859|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
14030860|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
14030861|NCT02714543|Antioxidants|antioxidants|mesh-list
14030862|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900435|NCT00832507|Cicletanine|cicletanine|mesh-list
14030863|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14030864|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
14030865|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030866|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
14030867|NCT02714543|Protective Agents|protective agents|mesh-ancestor
14030868|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030869|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14030870|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030871|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14030872|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030873|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030874|NCT02714439|Proflavine|proflavine|mesh-list
14030875|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14030876|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030877|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
13900436|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13900437|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900438|NCT00832507|Diuretics|diuretics|mesh-ancestor
13900439|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
13900440|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900441|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13900442|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13900443|NCT00831051|Morphine|morphine|mesh-list
13900444|NCT00831051|Oxycodone|oxycodone|mesh-list
13900445|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13900446|NCT00831051|Narcotics|narcotics|mesh-ancestor
13900447|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900448|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900449|NCT00831051|Analgesics|analgesics|mesh-ancestor
13900450|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
13900451|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900452|NCT00830336|Azithromycin|azithromycin|mesh-list
13900453|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900454|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030878|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14030879|NCT02714166|Protective Agents|protective agents|mesh-ancestor
14030880|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900455|NCT00830258|Pravastatin|pravastatin|mesh-list
13900456|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13900457|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14030881|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
14030882|NCT02714231|Diclofenac|diclofenac|mesh-list
14030883|NCT02714231|Scopolamine|scopolamine|mesh-list
14030884|NCT02714231|Bromides|bromides|mesh-list
14030885|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14030886|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14030887|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030888|NCT02714231|Analgesics|analgesics|mesh-ancestor
14030889|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
14030890|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030891|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030892|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900458|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
13900459|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900460|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13900461|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13900462|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900463|NCT00830219|Ropinirole|ropinirole|mesh-list
13900464|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14030893|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14030894|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14030895|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900465|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13900466|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
13900467|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
13900468|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900469|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900470|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900471|NCT00830206|Azithromycin|azithromycin|mesh-list
13900472|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900473|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900474|NCT00830102|Fluticasone|fluticasone|mesh-list
13900475|NCT00830102|Xhance|xhance|mesh-list
13900476|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
13900477|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900478|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14030896|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030897|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
14030898|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14030899|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
14030900|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
14030901|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14030902|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
14030903|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14030904|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
14030905|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14030906|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14030907|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
14030908|NCT02714179|Acetaminophen|acetaminophen|mesh-list
14030909|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14030910|NCT02714179|Analgesics|analgesics|mesh-ancestor
14030911|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
14030912|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030913|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030914|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
14030915|NCT02714361|Vitamin D|vitamin d|mesh-list
14030916|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
14030917|NCT02714361|Vitamins|vitamins|mesh-ancestor
14030918|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
14030919|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030920|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14030921|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14030922|NCT02714036|Ibudilast|ibudilast|mesh-list
14030923|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14030924|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
14030925|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030926|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030927|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14030928|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
14471596|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13900479|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
13900480|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14030929|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14030930|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030931|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030932|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14030933|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
14030934|NCT02713945|Simvastatin|simvastatin|mesh-list
14030935|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14030936|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14030937|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
14030938|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030939|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14030940|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14030941|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169475|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169476|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169477|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169478|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14169479|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14169480|NCT04841434|Methotrexate|methotrexate|mesh-list
14169481|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14169482|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
14169483|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14169484|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169485|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14169486|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
14169487|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169488|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900481|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900482|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13900483|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
13900484|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
13900485|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13900486|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13900487|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13900488|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13900489|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
13900490|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900491|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900492|NCT00830024|Alprazolam|alprazolam|mesh-list
13900493|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14169489|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
14169490|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169491|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14169492|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755499|NCT04094688|Antidotes|antidotes|mesh-ancestor
14755500|NCT04094688|Protective Agents|protective agents|mesh-ancestor
14755501|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
14755502|NCT04092452|PF-06700841|pf-06700841|mesh-list
14755503|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755504|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755505|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755506|NCT04088409|Adalimumab|adalimumab|mesh-list
14932464|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932465|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932466|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
14932467|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932468|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14932469|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932470|NCT01445262|Levocetirizine|levocetirizine|mesh-list
14932471|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14932472|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14932473|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
14932474|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
14932475|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932476|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932477|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932478|NCT01445340|Romidepsin|romidepsin|mesh-list
14932479|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14932480|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932481|NCT01445379|Ipilimumab|ipilimumab|mesh-list
14030942|NCT02713841|Insulin|insulin|mesh-list
14030943|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14030944|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
14030945|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14030946|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030947|NCT02713893|Econazole|econazole|mesh-list
14030948|NCT02713893|Benzydamine|benzydamine|mesh-list
14030949|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14030950|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
14030951|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030952|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14030953|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14030954|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14030955|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030956|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14030957|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
14030958|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14030959|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030960|NCT02714010|Gefitinib|gefitinib|mesh-list
14030961|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030962|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14030963|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900494|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900495|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900496|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13900497|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900498|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900499|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
13900500|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
13900501|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900502|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900503|NCT00829998|Zaleplon|zaleplon|mesh-list
13900504|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
13900505|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13900506|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900507|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900508|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
13900509|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
13900510|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900511|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900512|NCT00829868|Zaleplon|zaleplon|mesh-list
13900513|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
13900514|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13900515|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900516|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900517|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
13900518|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
13900519|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900520|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900521|NCT00829790|Doxycycline|doxycycline|mesh-list
13900522|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900523|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900524|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
13900525|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13900526|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13900527|NCT00829764|Doxycycline|doxycycline|mesh-list
14030964|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030965|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
14030966|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14030967|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030968|NCT02714075|Zinc|zinc|mesh-list
14030969|NCT02714075|Iron|iron|mesh-list
14030970|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
14030971|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
14030972|NCT02714075|Citric Acid|citric acid|mesh-list
14030973|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
14030974|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
14030975|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14030976|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
14030977|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
14030978|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14030979|NCT02714075|Trace Elements|trace elements|mesh-ancestor
13900528|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900529|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14030980|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
14030981|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030982|NCT02714075|Astringents|astringents|mesh-ancestor
14030983|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
14030984|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
14030985|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14030986|NCT02714075|Protective Agents|protective agents|mesh-ancestor
14030987|NCT02713802|Propofol|propofol|mesh-list
14030988|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14030989|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14030990|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14030991|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14030992|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
14030993|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
14030994|NCT02713763|Sunitinib|sunitinib|mesh-list
14030995|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14030996|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14030997|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14030998|NCT02713763|Growth Substances|growth substances|mesh-ancestor
14030999|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900530|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
14031000|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
14031001|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14031002|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031003|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031004|NCT02713607|Doxycycline|doxycycline|mesh-list
14031005|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031006|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031007|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
14031008|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14031009|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14031010|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14031011|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14031012|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14031013|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031014|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031015|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14031016|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14031017|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14031018|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
14031019|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031020|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031021|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14031022|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14031023|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
14031024|NCT02713477|Insulin|insulin|mesh-list
14031025|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14031026|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
14031027|NCT02713477|Lixisenatide|lixisenatide|mesh-list
14031028|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14031029|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031030|NCT02713139|Metronidazole|metronidazole|mesh-list
14031031|NCT02713139|Clotrimazole|clotrimazole|mesh-list
14031032|NCT02713139|Miconazole|miconazole|mesh-list
14755507|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755508|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755509|NCT04086745|Adalimumab|adalimumab|mesh-list
14755510|NCT04086745|Etanercept|etanercept|mesh-list
14755511|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14031033|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031034|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031035|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14755512|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900531|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13900532|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13900533|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
13900534|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13900535|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900536|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13900537|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13900538|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900539|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900540|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
13900541|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031036|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14031037|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14031038|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
14031039|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14169493|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
14031040|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14031041|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031042|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031043|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14031044|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
14031045|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031046|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031047|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14031048|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14031049|NCT02713191|Fentanyl|fentanyl|mesh-list
14031050|NCT02713191|Midazolam|midazolam|mesh-list
14031051|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
14031052|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14031053|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031054|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031055|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031056|NCT02713191|Analgesics|analgesics|mesh-ancestor
14031057|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
14031058|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031059|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14031060|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14031061|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13900542|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13900543|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13900544|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900545|NCT00829686|Renal Agents|renal agents|mesh-ancestor
13900546|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900547|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
13900548|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13900549|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13900550|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
13900551|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13900552|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900553|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13900554|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13900555|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900556|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900557|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
13900558|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900559|NCT00829530|Ramipril|ramipril|mesh-list
13900560|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13900561|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900562|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900563|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900564|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900565|NCT00829504|Ropinirole|ropinirole|mesh-list
13900566|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13900567|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13900568|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
13900569|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
13900570|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900571|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900572|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900573|NCT00829452|Ramipril|ramipril|mesh-list
13900574|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13900575|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900576|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900577|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900578|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900579|NCT00829426|Alprazolam|alprazolam|mesh-list
13900580|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13900581|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900582|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900583|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13900584|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900585|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900586|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
13900587|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
13900588|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031062|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
14031063|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900589|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900590|NCT00829309|Pravastatin|pravastatin|mesh-list
13900591|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13900592|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13900593|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
13900594|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900595|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13900596|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14031064|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031065|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14031066|NCT02713191|Narcotics|narcotics|mesh-ancestor
14031067|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14031068|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14031069|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
14031070|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
14031071|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14031072|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14031073|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14031074|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
13900597|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900598|NCT00828321|Ramipril|ramipril|mesh-list
13900599|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13900600|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900601|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900602|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900603|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13900604|NCT00821977|Vildagliptin|vildagliptin|mesh-list
13900605|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900606|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900607|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13900608|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900609|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900610|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900611|NCT00821249|Dexamethasone|dexamethasone|mesh-list
13900612|NCT00821249|Filanesib|filanesib|mesh-list
13900613|NCT00821249|Lenograstim|lenograstim|mesh-list
13900614|NCT00821249|Sargramostim|sargramostim|mesh-list
13900615|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031075|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
14031076|NCT02713009|Vitamin D|vitamin d|mesh-list
14031077|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
14031078|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
14031079|NCT02713009|Vitamins|vitamins|mesh-list
14031080|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
14031081|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031082|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14031083|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14031084|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
14031085|NCT02713074|Povidone|povidone|mesh-list
14031086|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
13900616|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
14031087|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
14031088|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14031089|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900617|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
13900618|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900619|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900620|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13900621|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
13900622|NCT00821249|Hormones|hormones|mesh-ancestor
13900623|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031090|NCT02713087|Phenylephrine|phenylephrine|mesh-list
14031091|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
14031092|NCT02713087|Ephedrine|ephedrine|mesh-list
13900624|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13900625|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900626|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13900627|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
13900628|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
14031093|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14031094|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
14031095|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
14031096|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031097|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031098|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
14031099|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14031100|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
14031101|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14031102|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14031103|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14031104|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14031105|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
14031106|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031107|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031108|NCT02713087|Protective Agents|protective agents|mesh-ancestor
14031109|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14031110|NCT02712957|Naproxen|naproxen|mesh-list
14031111|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14031112|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031113|NCT02712957|Analgesics|analgesics|mesh-ancestor
14031114|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
14031115|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031116|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031117|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031118|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14031119|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
14031120|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14031121|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031122|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031123|NCT02712944|Testosterone|testosterone|mesh-list
14031124|NCT02712944|Androgens|androgens|mesh-ancestor
14031125|NCT02712944|Hormones|hormones|mesh-ancestor
14031126|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031127|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031128|NCT02712866|Vedolizumab|vedolizumab|mesh-list
14031129|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13900629|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
13900630|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900631|NCT00821002|Latanoprost|latanoprost|mesh-list
13900632|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13900633|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13900634|NCT00820924|Lapatinib|lapatinib|mesh-list
13900635|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900636|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13900637|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900638|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031130|NCT02712619|Metformin|metformin|mesh-list
14031131|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14031132|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031133|NCT02712671|Interferons|interferons|mesh-list
14031134|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
14031135|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031136|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
13900639|NCT00820846|Vaccines|vaccines|mesh-list
13900640|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
13900641|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900642|NCT00820300|Latanoprost|latanoprost|mesh-list
13900643|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14031137|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031138|NCT02712697|Prednisone|prednisone|mesh-list
14031139|NCT02712697|Hormones|hormones|mesh-list
14031140|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031141|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
14031142|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031143|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900644|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13900645|NCT00819169|Conatumumab|conatumumab|mesh-list
13900646|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13900647|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900648|NCT00818844|Nepafenac|nepafenac|mesh-list
13900649|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13900650|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13900651|NCT00818844|Analgesics|analgesics|mesh-ancestor
13900652|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
13900653|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900654|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031144|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14031145|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031146|NCT02712775|Minocycline|minocycline|mesh-list
14031147|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031148|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031149|NCT02712658|Terbutaline|terbutaline|mesh-list
14031150|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14031151|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
14031152|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031153|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031154|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14031155|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
14031156|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
14031157|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
14031158|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14031159|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14031160|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14031161|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14031162|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
14031163|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031164|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031165|NCT02712723|Letrozole|letrozole|mesh-list
14031166|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031167|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14031168|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14031169|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031170|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031171|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14031172|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
14031173|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031174|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031175|NCT02712801|Ritonavir|ritonavir|mesh-list
14031176|NCT02712801|Lopinavir|lopinavir|mesh-list
14031177|NCT02712801|Lamivudine|lamivudine|mesh-list
13900655|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900656|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13900657|NCT00818571|Vildagliptin|vildagliptin|mesh-list
13900658|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900659|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900660|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13900661|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900662|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900663|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900664|NCT00818493|Acetaminophen|acetaminophen|mesh-list
13900665|NCT00818493|Morphine|morphine|mesh-list
13900666|NCT00818493|Oxycodone|oxycodone|mesh-list
13900667|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13900668|NCT00818493|Narcotics|narcotics|mesh-ancestor
13900669|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900670|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900671|NCT00818493|Analgesics|analgesics|mesh-ancestor
13900672|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
13900673|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900674|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13900675|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
14932482|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932483|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900676|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
14031178|NCT02712801|Zidovudine|zidovudine|mesh-list
14031179|NCT02712801|Nevirapine|nevirapine|mesh-list
14031180|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14031181|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14031182|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
14031183|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031184|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031185|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14031186|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14031187|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
14031188|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031189|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14031190|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14031191|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14031192|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14031193|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
14031194|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14031195|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14031196|NCT02712528|Sufentanil|sufentanil|mesh-list
14031197|NCT02712528|Remifentanil|remifentanil|mesh-list
14031198|NCT02712528|Sevoflurane|sevoflurane|mesh-list
14031199|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14031200|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14031201|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
14031202|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
14031203|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031204|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031205|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14031206|NCT02712528|Narcotics|narcotics|mesh-ancestor
14031207|NCT02712528|Analgesics|analgesics|mesh-ancestor
14031208|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
14031209|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031210|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14031211|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14031212|NCT02712502|Amoxicillin|amoxicillin|mesh-list
14031213|NCT02712502|Levofloxacin|levofloxacin|mesh-list
14031214|NCT02712502|Ofloxacin|ofloxacin|mesh-list
14031215|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
14031216|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
14031217|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14031218|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031219|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031220|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14031221|NCT02712502|Renal Agents|renal agents|mesh-ancestor
14031222|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14031223|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755513|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755514|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14755515|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14755516|NCT04086745|Analgesics|analgesics|mesh-ancestor
14755517|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
14755518|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755519|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755520|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14755521|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755522|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
14755523|NCT04081831|Aspirin|aspirin|mesh-list
14755524|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14755525|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14755526|NCT04081831|Analgesics|analgesics|mesh-ancestor
14755527|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
14755528|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755529|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755530|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755531|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755532|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14755533|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14755534|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755535|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14755536|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14755537|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755538|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
14755539|NCT04071236|Avelumab|avelumab|mesh-list
14031224|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031225|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031226|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031227|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14932484|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14932485|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932486|NCT01445392|Pemetrexed|pemetrexed|mesh-list
14932487|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14932488|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932489|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932490|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932491|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14932492|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14932493|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
14932494|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932495|NCT01445405|Cetuximab|cetuximab|mesh-list
14932496|NCT01445405|Bortezomib|bortezomib|mesh-list
14932497|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932498|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932499|NCT01445418|Carboplatin|carboplatin|mesh-list
13900677|NCT00817986|Baclofen|baclofen|mesh-list
13900678|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13900679|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932500|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932501|NCT01445431|Mineral Oil|mineral oil|mesh-list
14932502|NCT01445431|Emollients|emollients|mesh-ancestor
14932503|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
14932504|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
14932505|NCT01445522|Veliparib|veliparib|mesh-list
14031228|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14031229|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14031230|NCT02712346|Ambrisentan|ambrisentan|mesh-list
14031231|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14031232|NCT02712476|Furosemide|furosemide|mesh-list
14031233|NCT02712476|Mannitol|mannitol|mesh-list
14031234|NCT02712476|Diuretics|diuretics|mesh-ancestor
14755540|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14755541|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14755542|NCT04071236|Peposertib|peposertib|mesh-list
14755543|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755544|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755545|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
14755546|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755547|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755548|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755549|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755550|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
14755551|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755552|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755553|NCT04047251|Topotecan|topotecan|mesh-list
14755554|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14755555|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755556|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755557|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932506|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932507|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
14932508|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932509|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932510|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14932511|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
14932512|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932513|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932514|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13900680|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13900681|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900682|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13900683|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
13900684|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
13900685|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900686|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900687|NCT00817362|Trastuzumab|trastuzumab|mesh-list
13900688|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13900689|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900690|NCT00814372|Metformin|metformin|mesh-list
13900691|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14755558|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755559|NCT04032964|Doxorubicin|doxorubicin|mesh-list
13900692|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900693|NCT00814294|Insulin|insulin|mesh-list
14031235|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
14932515|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14932516|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932517|NCT01445561|Interleukin-2|interleukin-2|mesh-list
14031236|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031237|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14031238|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031239|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031240|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14932518|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932519|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14932520|NCT01445561|Analgesics|analgesics|mesh-ancestor
14932521|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
14932522|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031241|NCT02712125|Isosorbide|isosorbide|mesh-list
14031242|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14031243|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14031244|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14031245|NCT02712125|Diuretics|diuretics|mesh-ancestor
14031246|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
14031247|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031248|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
14932523|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031249|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14031250|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031251|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14031252|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
14031253|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031254|NCT02712203|Vaccines|vaccines|mesh-list
14031255|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
14932524|NCT01445587|Bortezomib|bortezomib|mesh-list
14932525|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932526|NCT01445600|Retapamulin|retapamulin|mesh-list
14932527|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14932528|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932529|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
14932530|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14932531|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932532|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932533|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14932534|NCT01445639|Analgesics|analgesics|mesh-ancestor
13900694|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13900695|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900696|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900697|NCT00813956|Gemcitabine|gemcitabine|mesh-list
13900698|NCT00813956|Carboplatin|carboplatin|mesh-list
13900699|NCT00813956|Iniparib|iniparib|mesh-list
13900700|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900701|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13900702|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
13900703|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900704|NCT00813956|Antiviral Agents|antiviral agents|mesh-ancestor
13900705|NCT00813956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900706|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900707|NCT00813956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900708|NCT00813956|Immunologic Factors|immunologic factors|mesh-ancestor
13900709|NCT00813956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900710|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13900711|NCT00813605|Conatumumab|conatumumab|mesh-list
13900712|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13900713|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900714|NCT00813163|Irinotecan|irinotecan|mesh-list
13900715|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13900716|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13900717|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900718|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900719|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900720|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
14031256|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031257|NCT02712307|Penicillins|penicillins|mesh-list
14031258|NCT02712307|Penicillin V|penicillin v|mesh-list
14031259|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031260|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031261|NCT02712151|Ropivacaine|ropivacaine|mesh-list
14031262|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
14932535|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
13900721|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900722|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13900723|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900724|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900725|NCT00810732|Nifedipine|nifedipine|mesh-list
13900726|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
13900727|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13900728|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900729|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900730|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13900731|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900732|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
13900733|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
13900734|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13900735|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13900736|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13900737|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13900738|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
13900739|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900740|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900741|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13900742|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
13900743|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13900744|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13900745|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13900746|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
13900747|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900748|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900749|NCT00807612|Paclitaxel|paclitaxel|mesh-list
13900750|NCT00807612|Carboplatin|carboplatin|mesh-list
13900751|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13900752|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13900753|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900754|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
13900755|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
13900756|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
13900757|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900758|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
13900759|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900760|NCT00806403|Reteplase|reteplase|mesh-list
13900761|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13900762|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13900763|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900764|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
13900765|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
13900766|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
13900767|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900768|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900769|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13900770|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13900771|NCT00805805|Growth Substances|growth substances|mesh-ancestor
13900772|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900773|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
13900774|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900775|NCT00805350|SR 46349B|sr 46349b|mesh-list
13900776|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13900777|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13900778|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900779|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13900780|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13900781|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
13900782|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900783|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900784|NCT00803114|Morphine|morphine|mesh-list
13900785|NCT00803114|Narcotics|narcotics|mesh-list
13900786|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13900787|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900788|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900789|NCT00803114|Analgesics|analgesics|mesh-ancestor
13900790|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
13900791|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900792|NCT00799292|Vasopressins|vasopressins|mesh-list
13900793|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
13900794|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
13900795|NCT00799292|Coagulants|coagulants|mesh-ancestor
13900796|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13900797|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14031263|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
14031264|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031265|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031266|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
13900798|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
13900799|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900800|NCT00796289|Citric Acid|citric acid|mesh-list
13900801|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
13900802|NCT00796289|Clomiphene|clomiphene|mesh-list
13900803|NCT00796289|Enclomiphene|enclomiphene|mesh-list
13900804|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
13900805|NCT00796289|Hormones|hormones|mesh-list
13900806|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14031267|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169494|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169495|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14169496|NCT04841265|Vitamin D|vitamin d|mesh-list
14169497|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
14169498|NCT04841265|Vitamins|vitamins|mesh-ancestor
14169499|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
14169500|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169501|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14169502|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14169503|NCT04840862|Rifabutin|rifabutin|mesh-list
13900807|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
13900808|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13900809|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
14169504|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14169505|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169506|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14169507|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
14169508|NCT04841018|Dexamethasone|dexamethasone|mesh-list
13900810|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
13900811|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900812|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900813|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900814|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13900815|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
13900816|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14169509|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
14169510|NCT04841018|BB 1101|bb 1101|mesh-list
14169511|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169512|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
14169513|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
13900817|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
13900818|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14169514|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169515|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169516|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471597|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
14471598|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14471599|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14755560|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14755561|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755562|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13900819|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13900820|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14169517|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
14169518|NCT04841018|Hormones|hormones|mesh-ancestor
13900821|NCT00794677|Ezetimibe|ezetimibe|mesh-list
13900822|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13900823|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13900824|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
13900825|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900826|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13959393|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14169519|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169520|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14755563|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755564|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959394|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471600|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14031268|NCT02711865|Antibodies|antibodies|mesh-list
14031269|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
14031270|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031271|NCT02711904|Remifentanil|remifentanil|mesh-list
14031272|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14031273|NCT02711904|Narcotics|narcotics|mesh-ancestor
14031274|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031275|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031276|NCT02711904|Analgesics|analgesics|mesh-ancestor
14031277|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
14031278|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031279|NCT02711969|Apatinib|apatinib|mesh-list
14031280|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031281|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14031282|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031283|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900827|NCT00792727|Ketoprofen|ketoprofen|mesh-list
13900828|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13900829|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13900830|NCT00792727|Analgesics|analgesics|mesh-ancestor
13900831|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
13900832|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900833|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900834|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900835|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13900836|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13900837|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900838|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900839|NCT00791154|Carboplatin|carboplatin|mesh-list
13900840|NCT00791154|Etoposide|etoposide|mesh-list
13900841|NCT00791154|Rilotumumab|rilotumumab|mesh-list
13900842|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900843|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13900844|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13900845|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13900846|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900847|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900848|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13900849|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
13900850|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13900851|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900852|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900853|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900854|NCT00789633|Gemcitabine|gemcitabine|mesh-list
13900855|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14031284|NCT02711943|Levofloxacin|levofloxacin|mesh-list
14031285|NCT02711943|Ofloxacin|ofloxacin|mesh-list
14031286|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14031287|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031288|NCT02711943|Renal Agents|renal agents|mesh-ancestor
14932536|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932537|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14932538|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14932539|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14932540|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
14932541|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932542|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932543|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14932544|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14932545|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14031289|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031290|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14031291|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14031292|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031293|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031294|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031295|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14031296|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14031297|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
14031298|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14031299|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14031300|NCT02711982|Prednisolone|prednisolone|mesh-list
14031301|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
14932546|NCT01445743|Vaccines|vaccines|mesh-list
14031302|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14031303|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
14031304|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031305|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
13900856|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
13900857|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900858|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900859|NCT00789633|Antiviral Agents|antiviral agents|mesh-ancestor
13900860|NCT00789633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900861|NCT00789633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900862|NCT00789633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900863|NCT00789633|Immunologic Factors|immunologic factors|mesh-ancestor
13900864|NCT00789633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900865|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
13900866|NCT00788541|Anecortave|anecortave|mesh-list
13900867|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13900868|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13900869|NCT00788541|Growth Substances|growth substances|mesh-ancestor
13900870|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900871|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
13900872|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900873|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900874|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13900875|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
14031306|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
14031307|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031308|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031309|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031310|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
14031311|NCT02711982|Hormones|hormones|mesh-ancestor
14031312|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031313|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14031314|NCT02711982|Protective Agents|protective agents|mesh-ancestor
14031315|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13900876|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900877|NCT00785226|Sorafenib|sorafenib|mesh-list
13900878|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900879|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13900880|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900881|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900882|NCT00782431|Vaccines|vaccines|mesh-list
13900883|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
13900884|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900885|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13900886|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900887|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13900888|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900889|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900890|NCT00776373|Cytarabine|cytarabine|mesh-list
13900891|NCT00776373|Sirolimus|sirolimus|mesh-list
13900892|NCT00776373|Etoposide|etoposide|mesh-list
14031316|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031317|NCT02711891|Loperamide|loperamide|mesh-list
14031318|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
14031319|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031320|NCT02711917|Propofol|propofol|mesh-list
14031321|NCT02711917|Etomidate|etomidate|mesh-list
14031322|NCT02711917|Rocuronium|rocuronium|mesh-list
14031323|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14031324|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031325|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031326|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14031327|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
14031328|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
14031329|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14031330|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13900893|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13900894|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900895|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13900896|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14031331|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14031332|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031333|NCT02711735|Vaccines|vaccines|mesh-list
13900897|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959395|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031334|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
14932547|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
14031335|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031336|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
14031337|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14031338|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14031339|NCT02711449|Prednisolone|prednisolone|mesh-list
14031340|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
14031341|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13900898|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900899|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13900900|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
13900901|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
13900902|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13900903|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13900904|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
13900905|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900906|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13900907|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13900908|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
13900909|NCT00774761|Fluticasone|fluticasone|mesh-list
13900910|NCT00774761|Xhance|xhance|mesh-list
13900911|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
13900912|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900913|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13900914|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
13900915|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900916|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900917|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13900918|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
13900919|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
13900920|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13900921|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13900922|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13900923|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14031342|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
14031343|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031344|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
14031345|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
14031346|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031347|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031348|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031349|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
14031350|NCT02711449|Hormones|hormones|mesh-ancestor
14031351|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900924|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
13900925|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13900926|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900927|NCT00772785|Buprenorphine|buprenorphine|mesh-list
13900928|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13900929|NCT00772785|Narcotics|narcotics|mesh-ancestor
13900930|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900931|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900932|NCT00772785|Analgesics|analgesics|mesh-ancestor
14031352|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14031353|NCT02711449|Protective Agents|protective agents|mesh-ancestor
14031354|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14031355|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031356|NCT02711592|Analgesics|analgesics|mesh-list
14031357|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
14031358|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031359|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031360|NCT02711410|Clopidogrel|clopidogrel|mesh-list
14031361|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14031362|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14031363|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14031364|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14031365|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
14031366|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031367|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031368|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031369|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14031370|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
14031371|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14031372|NCT02711670|Diuretics|diuretics|mesh-ancestor
13900933|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
14031373|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
14031374|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031375|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14031376|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031377|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031378|NCT02711579|Celecoxib|celecoxib|mesh-list
14031379|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14031380|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031381|NCT02711579|Analgesics|analgesics|mesh-ancestor
14031382|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
14031383|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031384|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031385|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932548|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932549|NCT01445756|Lidocaine|lidocaine|mesh-list
13900934|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900935|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13900936|NCT00772343|Vaccines|vaccines|mesh-list
13900937|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
13900938|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900939|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13900940|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
13900941|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13900942|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13900943|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13900944|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900945|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900946|NCT00770848|Prednisone|prednisone|mesh-list
13900947|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
13900948|NCT00770848|Rilotumumab|rilotumumab|mesh-list
13900949|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13900950|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13900951|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
13900952|NCT00770848|Hormones|hormones|mesh-ancestor
13900953|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900954|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900955|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13900956|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900957|NCT00770848|Analgesics|analgesics|mesh-ancestor
13900958|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
13900959|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900960|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13900961|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13900962|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900963|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900964|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13900965|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
13900966|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13900967|NCT00770081|Vildagliptin|vildagliptin|mesh-list
13900968|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900969|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900970|NCT00770081|Incretins|incretins|mesh-ancestor
13900971|NCT00770081|Hormones|hormones|mesh-ancestor
13900972|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900973|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13900974|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
14932550|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
14932551|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
14932552|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932553|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932554|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
14932555|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900975|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13900976|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13900977|NCT00769795|Goserelin|goserelin|mesh-list
13900978|NCT00769795|Bicalutamide|bicalutamide|mesh-list
13900979|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13900980|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13900981|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
13900982|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
13900983|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13900984|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900985|NCT00768482|Buprenorphine|buprenorphine|mesh-list
13900986|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14932556|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14932557|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14932558|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14932559|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13900987|NCT00768482|Narcotics|narcotics|mesh-ancestor
13900988|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13900989|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900990|NCT00768482|Analgesics|analgesics|mesh-ancestor
13900991|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
13900992|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13900993|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13900994|NCT00765830|Vildagliptin|vildagliptin|mesh-list
13900995|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13900996|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13900997|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13900998|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
13900999|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901000|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901001|NCT00765804|Dexamethasone|dexamethasone|mesh-list
13901002|NCT00765804|Citric Acid|citric acid|mesh-list
13901003|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
13901004|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13901005|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13901006|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13901007|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901008|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
13901009|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
13901010|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901011|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901012|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901013|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
13901014|NCT00765804|Hormones|hormones|mesh-ancestor
13901015|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901016|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13901017|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901018|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901019|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
13901020|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13901021|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
13901022|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
13901023|NCT00765700|Ketoprofen|ketoprofen|mesh-list
13901024|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13901025|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13901026|NCT00765700|Analgesics|analgesics|mesh-ancestor
13901027|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
13901028|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901029|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901030|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901031|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13901032|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13901033|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901034|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901035|NCT00765323|Octreotide|octreotide|mesh-list
13901036|NCT00765323|Somatostatin|somatostatin|mesh-list
13901037|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901038|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13901039|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901040|NCT00765323|Hormones|hormones|mesh-ancestor
13901041|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901042|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901043|NCT00764634|Vaccines|vaccines|mesh-list
13901044|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
13901045|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901046|NCT00763555|Calcitriol|calcitriol|mesh-list
13901047|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13901048|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901049|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13901050|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901051|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901052|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13901053|NCT00763555|Vitamins|vitamins|mesh-ancestor
13901054|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
13901055|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13901056|NCT00763503|Calcitriol|calcitriol|mesh-list
13901057|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13901058|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901059|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13901060|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901061|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901062|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13901063|NCT00763503|Vitamins|vitamins|mesh-ancestor
13901064|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
13901065|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13901066|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13901067|NCT00761709|Latanoprost|latanoprost|mesh-list
14031386|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14031387|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14031388|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14031389|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031390|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031391|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
14031392|NCT02711683|Donepezil|donepezil|mesh-list
14031393|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14031394|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031395|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031396|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
14031397|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031398|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031399|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
14031400|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14031401|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14031402|NCT02711683|Protective Agents|protective agents|mesh-ancestor
14031403|NCT02711176|Amoxicillin|amoxicillin|mesh-list
14031404|NCT02711176|Clarithromycin|clarithromycin|mesh-list
14031405|NCT02711176|Tinidazole|tinidazole|mesh-list
14031406|NCT02711176|Esomeprazole|esomeprazole|mesh-list
14031407|NCT02711176|Lansoprazole|lansoprazole|mesh-list
14031408|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031409|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031410|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14031411|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031412|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14031413|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031414|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031415|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14031416|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14031417|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14031418|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
14031419|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14031420|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14031421|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14031422|NCT02711189|Oxytocin|oxytocin|mesh-list
14031423|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
14031424|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14031425|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031426|NCT02711202|Sirolimus|sirolimus|mesh-list
14031427|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
14031428|NCT02711202|Infliximab|infliximab|mesh-list
13901068|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13901069|NCT00760539|Timolol|timolol|mesh-list
13901070|NCT00760539|Travoprost|travoprost|mesh-list
13901071|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13901072|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13901073|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13901074|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13901075|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
13901076|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901077|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901078|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031429|NCT02711202|Tacrolimus|tacrolimus|mesh-list
14031430|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14031431|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
14031432|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901079|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13901080|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14031433|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14031434|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901081|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13901082|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901083|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031435|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031436|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031437|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031438|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14031439|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031440|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
14031441|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14031442|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031443|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14031444|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14031445|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
14031446|NCT02711228|Antibodies|antibodies|mesh-list
14031447|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
14031448|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14031449|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14031450|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
14031451|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031452|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14031453|NCT02711215|Mirtazapine|mirtazapine|mesh-list
14031454|NCT02711215|Citalopram|citalopram|mesh-list
14031455|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13901084|NCT00760344|Incretins|incretins|mesh-ancestor
13901085|NCT00760344|Hormones|hormones|mesh-ancestor
13901086|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901087|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13901088|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
13901089|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901090|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901091|NCT00759135|Finasteride|finasteride|mesh-list
14031456|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14031457|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14031458|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031459|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031460|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031461|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
14031462|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031463|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14031464|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
14031465|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14031466|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031467|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14031468|NCT02711215|Analgesics|analgesics|mesh-ancestor
14031469|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
14031470|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
13901092|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13901093|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13901094|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901095|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901096|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
14031471|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14031472|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
14031473|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
14031474|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14031475|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14031476|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031477|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14031478|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14031479|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14031480|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
14031481|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14031482|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14031483|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14031484|NCT02711358|Indomethacin|indomethacin|mesh-list
14031485|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13901097|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901098|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901099|NCT00759135|Urological Agents|urological agents|mesh-ancestor
13901100|NCT00758966|Naltrexone|naltrexone|mesh-list
14031486|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031487|NCT02711358|Analgesics|analgesics|mesh-ancestor
14031488|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
14031489|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031490|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031491|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031492|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14031493|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
14031494|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
14031495|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14031496|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14031497|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031498|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031499|NCT02711267|Acyclovir|acyclovir|mesh-list
14031500|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
14031501|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901101|NCT00758966|Fluoxetine|fluoxetine|mesh-list
13901102|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13901103|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13901104|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901105|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
13901106|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901107|NCT00758966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13901108|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13901109|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901110|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901111|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901112|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
14031502|NCT02711280|Propofol|propofol|mesh-list
14031503|NCT02711280|Sevoflurane|sevoflurane|mesh-list
14031504|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14031505|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031506|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031507|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14031508|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
14031509|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
14031510|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14031511|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14031512|NCT02711241|Dipyrone|dipyrone|mesh-list
14031513|NCT02711241|Papaverine|papaverine|mesh-list
14031514|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14031515|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031516|NCT02711241|Analgesics|analgesics|mesh-ancestor
14031517|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
14031518|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031519|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031520|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031521|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14031522|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
14031523|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14031524|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031525|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031526|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
14031527|NCT02711241|Urological Agents|urological agents|mesh-ancestor
14031528|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
14031529|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14031530|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031531|NCT02711007|Apatinib|apatinib|mesh-list
14031532|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031533|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14031534|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031535|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031536|NCT02710877|Sufentanil|sufentanil|mesh-list
14031537|NCT02710877|Dsuvia|dsuvia|mesh-list
14031538|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
14031539|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
14031540|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
14031541|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031542|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031543|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
14031544|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031545|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14031546|NCT02710877|Narcotics|narcotics|mesh-ancestor
14031547|NCT02710877|Analgesics|analgesics|mesh-ancestor
14031548|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14031549|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14031550|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
14932560|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932561|NCT01445860|Simvastatin|simvastatin|mesh-list
14932562|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14932563|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14932564|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
14932565|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932566|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14932567|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14932568|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932569|NCT01445938|Lumefantrine|lumefantrine|mesh-list
13901113|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13901114|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
14932570|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
14932571|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14932572|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14932573|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901115|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13901116|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13901117|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13901118|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901119|NCT00758953|Danazol|danazol|mesh-list
14932574|NCT01445964|Atenolol|atenolol|mesh-list
14932575|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14932576|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932577|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
14932578|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
14932579|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932580|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901120|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13901121|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
13901122|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901123|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901124|NCT00758563|Triclosan|triclosan|mesh-list
13901125|NCT00758563|Fluorides|fluorides|mesh-list
13901126|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
13901127|NCT00758563|Protective Agents|protective agents|mesh-ancestor
13901128|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901129|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13901130|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901131|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13901132|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13901133|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
13901134|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901135|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13901136|NCT00758290|Triclosan|triclosan|mesh-list
13901137|NCT00758290|Fluorides|fluorides|mesh-list
13901138|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
13901139|NCT00758290|Protective Agents|protective agents|mesh-ancestor
13901140|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901141|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13901142|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901143|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13901144|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13901145|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
13901146|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901147|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13901148|NCT00755287|Metformin|metformin|mesh-list
13901149|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
13901150|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13901151|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901152|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901153|NCT00755287|Incretins|incretins|mesh-ancestor
13901154|NCT00755287|Hormones|hormones|mesh-ancestor
13901155|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901156|NCT00754988|Metformin|metformin|mesh-list
13901157|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13901158|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13901159|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901160|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901161|NCT00754988|Incretins|incretins|mesh-ancestor
13901162|NCT00754988|Hormones|hormones|mesh-ancestor
13901163|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901164|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13901165|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
13901166|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932581|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14932582|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14932583|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14932584|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14932585|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932586|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932587|NCT01446094|Regadenoson|regadenoson|mesh-list
14932588|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14932589|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14932590|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
13901167|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031551|NCT02710656|Paclitaxel|paclitaxel|mesh-list
14031552|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14031553|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031554|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
14031555|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
14031556|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
14031557|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169521|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169522|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
14169523|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169524|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169525|NCT04840992|Vaccines|vaccines|mesh-list
14169526|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
14169527|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169528|NCT04840550|Lansoprazole|lansoprazole|mesh-list
14169529|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
14169530|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14169531|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169532|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14169533|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169534|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901168|NCT00754221|Reboxetine|reboxetine|mesh-list
13901169|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
13901170|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13901171|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13901172|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13901173|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901174|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901175|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
14169535|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
14169536|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14169537|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182919|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182920|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14182921|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
14182922|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
14182923|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14182924|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
14182925|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182926|NCT04732000|Expectorants|expectorants|mesh-ancestor
14182927|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
14182928|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14182929|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
14182930|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182931|NCT04732000|Protective Agents|protective agents|mesh-ancestor
14182932|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182933|NCT04732000|Antidotes|antidotes|mesh-ancestor
14182934|NCT04731727|Riboflavin|riboflavin|mesh-list
14182935|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
14182936|NCT04731727|Vitamins|vitamins|mesh-ancestor
14182937|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
14932591|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
13901176|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031558|NCT02710539|Amlodipine|amlodipine|mesh-list
14031559|NCT02710539|Perindopril|perindopril|mesh-list
14031560|NCT02710539|Indapamide|indapamide|mesh-list
14031561|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14031562|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14031563|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031564|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901177|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901178|NCT00752570|Trebananib|trebananib|mesh-list
14031565|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14031566|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031567|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
14031568|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14031569|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
14031570|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767202|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901179|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13901180|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13901181|NCT00752570|Growth Substances|growth substances|mesh-ancestor
13901182|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901183|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
13901184|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901185|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
13901186|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13901187|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13901188|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13901189|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901190|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901191|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901192|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901193|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901194|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13901195|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901196|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
13901197|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13901198|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13901199|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13901200|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901201|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901202|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901203|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901204|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901205|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13901206|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901207|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
13901208|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13901209|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13901210|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13901211|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901212|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901213|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901214|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901215|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901216|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13901217|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901218|NCT00751803|Eletriptan|eletriptan|mesh-list
13901219|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13901220|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
13901221|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901222|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901223|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901224|NCT00751231|Clopidogrel|clopidogrel|mesh-list
13901225|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13901226|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13901227|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13901228|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13901229|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
13901230|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901231|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901232|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901233|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
14031571|NCT02710539|Diuretics|diuretics|mesh-ancestor
14031572|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
14031573|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14031574|NCT02710604|Tenofovir|tenofovir|mesh-list
14031575|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
14031576|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
14031577|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031578|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14031579|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14031580|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031581|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031582|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14031583|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14031584|NCT02710552|Amlodipine|amlodipine|mesh-list
14031585|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
14031586|NCT02710552|Perindopril|perindopril|mesh-list
14031587|NCT02710552|Indapamide|indapamide|mesh-list
14031588|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13901234|NCT00750633|Dexamethasone|dexamethasone|mesh-list
14031589|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031590|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901235|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13901236|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13901237|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901238|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
13901239|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
13901240|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901241|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901242|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901243|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
13901244|NCT00750633|Hormones|hormones|mesh-ancestor
13901245|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901246|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13901247|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901248|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13901249|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901250|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13901251|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13901252|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901253|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901254|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
13901255|NCT00750295|Hematinics|hematinics|mesh-ancestor
13901256|NCT00750243|Naproxen|naproxen|mesh-list
13901257|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13901258|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13901259|NCT00750243|Analgesics|analgesics|mesh-ancestor
13901260|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
13901261|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901262|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901263|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901264|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13901265|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
13901266|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13901267|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901268|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901269|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
13901270|NCT00749632|Oxybutynin|oxybutynin|mesh-list
13901271|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
13901272|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
13901273|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031591|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14031592|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031593|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
14031594|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14031595|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
14755565|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755566|NCT04029454|Vaccines|vaccines|mesh-list
14755567|NCT04029454|Immunologic Factors|immunologic factors|mesh-ancestor
14755568|NCT04029454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031596|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031597|NCT02710552|Diuretics|diuretics|mesh-ancestor
14031598|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
14031599|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14031600|NCT02710448|Metformin|metformin|mesh-list
14031601|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14031602|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901274|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901275|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13901276|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13901277|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901278|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901279|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901280|NCT00749632|Urological Agents|urological agents|mesh-ancestor
13901281|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13901282|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901283|NCT00749632|Renal Agents|renal agents|mesh-ancestor
14031603|NCT02710409|Vaccines|vaccines|mesh-list
14031604|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
14031605|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031606|NCT02710396|Paclitaxel|paclitaxel|mesh-list
14031607|NCT02710396|Carboplatin|carboplatin|mesh-list
14031608|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
14031609|NCT02710396|Pemetrexed|pemetrexed|mesh-list
14031610|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14031611|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031612|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
14031613|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
14031614|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
14031615|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031616|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14031617|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031618|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14031619|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14031620|NCT02710266|Gabexate|gabexate|mesh-list
14031621|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
14031622|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14031623|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
14031624|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031625|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031626|NCT02710305|Lidocaine|lidocaine|mesh-list
14031627|NCT02710305|Scopolamine|scopolamine|mesh-list
14031628|NCT02710305|Bromides|bromides|mesh-list
14031629|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14031630|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
14031631|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
14031632|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031633|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031634|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
14755569|NCT04025359|Dronabinol|dronabinol|mesh-list
13901284|NCT00747318|Fluticasone|fluticasone|mesh-list
13901285|NCT00747318|Xhance|xhance|mesh-list
13901286|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
13901287|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901288|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13901289|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
13901290|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901291|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901292|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13901293|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
13901294|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
13901295|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13901296|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14755570|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
13901297|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13901298|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14031635|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901299|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
13901300|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901301|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901302|NCT00745316|Adenosine|adenosine|mesh-list
13901303|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
13901304|NCT00745316|Analgesics|analgesics|mesh-ancestor
13901305|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
13901306|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901307|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901308|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13901309|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
13901310|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13901311|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
13901312|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
13901313|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901314|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901315|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13901316|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14031636|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14031637|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14031638|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14031639|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031640|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031641|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
14031642|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14031643|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
14031644|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
14031645|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031646|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
14031647|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14031648|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
14031649|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031650|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14031651|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
14031652|NCT02710318|Vaccines|vaccines|mesh-list
14031653|NCT02710318|Immunologic Factors|immunologic factors|mesh-ancestor
14031654|NCT02710318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031655|NCT02710110|Capsaicin|capsaicin|mesh-list
14031656|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
14031657|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14031658|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
14031659|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031660|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031661|NCT02710162|Capsaicin|capsaicin|mesh-list
14031662|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
14031663|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14031664|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
14031665|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031666|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031667|NCT02709863|Propofol|propofol|mesh-list
14031668|NCT02709863|Sevoflurane|sevoflurane|mesh-list
14031669|NCT02709863|Desflurane|desflurane|mesh-list
14031670|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14031671|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031672|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031673|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14031674|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
14031675|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
14031676|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14031677|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14031678|NCT02709902|Adapalene|adapalene|mesh-list
14031679|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14031680|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
13901317|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13901318|NCT00744926|Incretins|incretins|mesh-ancestor
13901319|NCT00744926|Hormones|hormones|mesh-ancestor
13901320|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901321|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901322|NCT00744367|Metformin|metformin|mesh-list
13901323|NCT00744367|Pioglitazone|pioglitazone|mesh-list
14031681|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
14031682|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14031683|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031684|NCT02709902|Analgesics|analgesics|mesh-ancestor
14031685|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
14031686|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901324|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13901325|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901326|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031687|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031688|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031689|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14031690|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
14031691|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14031692|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14031693|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031694|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
14031695|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
14031696|NCT02709720|Cisplatin|cisplatin|mesh-list
14031697|NCT02709720|Vinorelbine|vinorelbine|mesh-list
14031698|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901327|NCT00744367|Incretins|incretins|mesh-ancestor
13901328|NCT00744367|Hormones|hormones|mesh-ancestor
13901329|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901330|NCT00744276|Danazol|danazol|mesh-list
13901331|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13901332|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
13901333|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901334|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901335|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13901336|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901337|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13901338|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901339|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031699|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14031700|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14031701|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
14031702|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14031703|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031704|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
14031705|NCT02709668|Vitamins|vitamins|mesh-ancestor
14031706|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
14031707|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959396|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959397|NCT03163238|Analgesics|analgesics|mesh-ancestor
13959398|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
13959399|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959400|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13959401|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13959402|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13959403|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
13959404|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959405|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959406|NCT03163420|Diclofenac|diclofenac|mesh-list
13959407|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13959408|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959409|NCT03163420|Analgesics|analgesics|mesh-ancestor
13959410|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
14031708|NCT02709616|Vaccines|vaccines|mesh-list
14031709|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
14031710|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031711|NCT02709590|Diclofenac|diclofenac|mesh-list
14031712|NCT02709590|Lidocaine|lidocaine|mesh-list
14031713|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
14031714|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
14031715|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031716|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031717|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
14031718|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031719|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14031720|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14031721|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14031722|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031723|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031724|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14031725|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031726|NCT02709590|Analgesics|analgesics|mesh-ancestor
13959411|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959412|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031727|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901340|NCT00743925|Atorvastatin|atorvastatin|mesh-list
13901341|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
13901342|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13901343|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13901344|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
13901345|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901346|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13901347|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13901348|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901349|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
13901350|NCT00743795|Ribavirin|ribavirin|mesh-list
13901351|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13901352|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
13901353|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901354|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
13901355|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901356|NCT00743002|Metformin|metformin|mesh-list
13901357|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901358|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901359|NCT00741715|Atorvastatin|atorvastatin|mesh-list
13901360|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13901361|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13901362|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
13901363|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901364|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13901365|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13901366|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901367|NCT00739349|Cyclosporine|cyclosporine|mesh-list
13901368|NCT00739349|Cyclosporins|cyclosporins|mesh-list
14031728|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14031729|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14031730|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031731|NCT02709603|Scopolamine|scopolamine|mesh-list
14031732|NCT02709603|Bromides|bromides|mesh-list
14031733|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14031734|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
14031735|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14031736|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
14031737|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
14031738|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031739|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031740|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031741|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
14031742|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14031743|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
14031744|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031745|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031746|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14031747|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
14031748|NCT02709564|Misoprostol|misoprostol|mesh-list
14031749|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14031750|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
14031751|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14031752|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031753|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14031754|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031755|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
14031756|NCT02709265|Amikacin|amikacin|mesh-list
14031757|NCT02709265|Fosfomycin|fosfomycin|mesh-list
14031758|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031759|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031760|NCT02709304|Lidocaine|lidocaine|mesh-list
14031761|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
14031762|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
14031763|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031764|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031765|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
14031766|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031767|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14031768|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14031769|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14031770|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14755571|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031771|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031772|NCT02709473|Remifentanil|remifentanil|mesh-list
13901369|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031773|NCT02709473|Propofol|propofol|mesh-list
14031774|NCT02709473|Rocuronium|rocuronium|mesh-list
14031775|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14031776|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031777|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031778|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13901370|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901371|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13901372|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
13901373|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901374|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
13901375|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901376|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
13901377|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13901378|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13901379|NCT00738582|Pemetrexed|pemetrexed|mesh-list
13901380|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901381|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901382|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901383|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13901384|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13901385|NCT00738387|Docetaxel|docetaxel|mesh-list
13901386|NCT00738387|Vadimezan|vadimezan|mesh-list
13901387|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901388|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
13901389|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
13901390|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14031779|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
14031780|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
14031781|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14031782|NCT02709473|Narcotics|narcotics|mesh-ancestor
14031783|NCT02709473|Analgesics|analgesics|mesh-ancestor
14031784|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
14031785|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031786|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14031787|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14031788|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14031789|NCT02709187|Candesartan|candesartan|mesh-list
14031790|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
14031791|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14031792|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14031793|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14031794|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
14031795|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031796|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14031797|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14031798|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031799|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14031800|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14031801|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14031802|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
14031803|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14031804|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031805|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031806|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031807|NCT02709200|Analgesics|analgesics|mesh-ancestor
14031808|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
14031809|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031810|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14031811|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14031812|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14031813|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
14031814|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031815|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031816|NCT02709382|Tazobactam|tazobactam|mesh-list
14031817|NCT02709382|Cefepime|cefepime|mesh-list
14031818|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031819|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031820|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14031821|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031822|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031823|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
14031824|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13901391|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031825|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
14031826|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031827|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
14031828|NCT02709525|Protective Agents|protective agents|mesh-ancestor
14031829|NCT02708992|Azithromycin|azithromycin|mesh-list
14031830|NCT02708992|Cefixime|cefixime|mesh-list
14031831|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14031832|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031833|NCT02709031|Cicletanine|cicletanine|mesh-list
14031834|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14031835|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14031836|NCT02709031|Diuretics|diuretics|mesh-ancestor
14031837|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
14031838|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169538|NCT04840511|Lidocaine|lidocaine|mesh-list
14755572|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14755573|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14755574|NCT04025359|Analgesics|analgesics|mesh-ancestor
13901392|NCT00734461|Naltrexone|naltrexone|mesh-list
14169539|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
14169540|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
14169541|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169542|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169543|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
14169544|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169545|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14169546|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14169547|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14169548|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169549|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169550|NCT04840745|Leuprolide|leuprolide|mesh-list
14169551|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14169552|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
14169553|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14169554|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169555|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14169556|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169557|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
14169558|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14169559|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169560|NCT04840238|Vitamins|vitamins|mesh-ancestor
14169561|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
14169562|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14169563|NCT04840290|Paclitaxel|paclitaxel|mesh-list
14169564|NCT04840290|Carboplatin|carboplatin|mesh-list
14169565|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169566|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169567|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169568|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
14169569|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
14169570|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169571|NCT04840342|Amlodipine|amlodipine|mesh-list
14169572|NCT04840342|Eplerenone|eplerenone|mesh-list
14169573|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14169574|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14169575|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169576|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169577|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13901393|NCT00734461|Oxycodone|oxycodone|mesh-list
13901394|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13901395|NCT00734461|Narcotics|narcotics|mesh-ancestor
13901396|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13901397|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901398|NCT00734461|Analgesics|analgesics|mesh-ancestor
13901399|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
13901400|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901401|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14169578|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169579|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
14169580|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14169581|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
14169582|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169583|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14767203|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
13901402|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13901403|NCT00734435|Zonisamide|zonisamide|mesh-list
14031839|NCT02708836|Anesthetics|anesthetics|mesh-list
14031840|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031841|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031842|NCT02708628|Heparin|heparin|mesh-list
14031843|NCT02708628|Allantoin|allantoin|mesh-list
14031844|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
14031845|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14031846|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14031847|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031848|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
14031849|NCT02708693|Triamcinolone|triamcinolone|mesh-list
14031850|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14031851|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13901404|NCT00734435|Olanzapine|olanzapine|mesh-list
13901405|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
13901406|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
13901407|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901408|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901409|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901410|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14031852|NCT02708693|Lidocaine|lidocaine|mesh-list
14031853|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14031854|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
14031855|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
14031856|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031857|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031858|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
14031859|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031860|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14031861|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14031862|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14031863|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031864|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031865|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14031866|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
14031867|NCT02708693|Hormones|hormones|mesh-ancestor
14031868|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031869|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14031870|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
14031871|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031872|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
14031873|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14031874|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
14031875|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031876|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
14031877|NCT02708706|Protective Agents|protective agents|mesh-ancestor
14031878|NCT02708680|Atezolizumab|atezolizumab|mesh-list
14031879|NCT02708680|Entinostat|entinostat|mesh-list
14031880|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031881|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14031882|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031883|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031884|NCT02708511|Copper|copper|mesh-list
14031885|NCT02708511|Trace Elements|trace elements|mesh-ancestor
14031886|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
14031887|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031888|NCT02708394|Olanzapine|olanzapine|mesh-list
14031889|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
14031890|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
14031891|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031892|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031893|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031894|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14031895|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14031896|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031897|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14031898|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14031899|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14031900|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031901|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031902|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031903|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
14031904|NCT02708160|Fluorides|fluorides|mesh-list
13901411|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13901412|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031905|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
14031906|NCT02708160|Protective Agents|protective agents|mesh-ancestor
14031907|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031908|NCT02708446|Misoprostol|misoprostol|mesh-list
14031909|NCT02708446|Mifepristone|mifepristone|mesh-list
14031910|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14031911|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
14031912|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14031913|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031914|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14031915|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14031916|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
14031917|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14031918|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14031919|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14031920|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14031921|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
14031922|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14031923|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14031924|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
14031925|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14031926|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
14031927|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14031928|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14031929|NCT02708251|Lidocaine|lidocaine|mesh-list
14031930|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
14031931|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
14031932|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
13901413|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13901414|NCT00734435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13901415|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13901416|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901417|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901418|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901419|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
13901420|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
13901421|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14031933|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031934|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031935|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
14031936|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031937|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14031938|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14031939|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14031940|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14755575|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
14755576|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901422|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13901423|NCT00734292|Fluticasone|fluticasone|mesh-list
13901424|NCT00734292|Xhance|xhance|mesh-list
13901425|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
13901426|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901427|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13901428|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
13901429|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901430|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901431|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13901432|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
13901433|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
14755577|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14755578|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13901434|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13901435|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13901436|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13901437|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14755579|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755580|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755581|NCT04025359|Hormones|hormones|mesh-ancestor
14755582|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755583|NCT04020913|Hormones|hormones|mesh-list
14755584|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901438|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
13901439|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755585|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755586|NCT04017247|Oxytocin|oxytocin|mesh-list
14755587|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
13901440|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901441|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
13901442|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
13901443|NCT00734253|Vitamins|vitamins|mesh-ancestor
13901444|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
13901445|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901446|NCT00730665|Esomeprazole|esomeprazole|mesh-list
13901447|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13901448|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901449|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13901450|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901451|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901452|NCT00728351|Metformin|metformin|mesh-list
13901453|NCT00728351|Vildagliptin|vildagliptin|mesh-list
13901454|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901455|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901456|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13901457|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
13901458|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901459|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901460|NCT00728091|Satavaptan|satavaptan|mesh-list
13901461|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13901462|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901463|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
13901464|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901465|NCT00726336|Tenofovir|tenofovir|mesh-list
13901466|NCT00726336|Dolutegravir|dolutegravir|mesh-list
13901467|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
13901468|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901469|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13901470|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13901471|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901472|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901473|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13901474|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13901475|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13901476|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13901477|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
13901478|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
14755588|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14755589|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755590|NCT04004819|Rituximab|rituximab|mesh-list
14755591|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755592|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755593|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
14755594|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755595|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755596|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
14755597|NCT04004078|Clotrimazole|clotrimazole|mesh-list
14755598|NCT04004078|Miconazole|miconazole|mesh-list
13901479|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031941|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031942|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
14031943|NCT02708459|Morphine|morphine|mesh-list
14031944|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14031945|NCT02708459|Narcotics|narcotics|mesh-ancestor
14031946|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031947|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031948|NCT02708459|Analgesics|analgesics|mesh-ancestor
14031949|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
14031950|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031951|NCT02708173|Vaccines|vaccines|mesh-list
14031952|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
14031953|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031954|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
14031955|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14031956|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031957|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031958|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14031959|NCT02707809|Analgesics|analgesics|mesh-ancestor
14755599|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901480|NCT00725881|Protective Agents|protective agents|mesh-ancestor
13901481|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031960|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
14031961|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031962|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14031963|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13901482|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13901483|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901484|NCT00724841|Temozolomide|temozolomide|mesh-list
13901485|NCT00724841|Obatoclax|obatoclax|mesh-list
13901486|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13901487|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
13901488|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901489|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031964|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14031965|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
14031966|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14031967|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031968|NCT02707900|Vorinostat|vorinostat|mesh-list
14031969|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031970|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14031971|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031972|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031973|NCT02707874|Ropivacaine|ropivacaine|mesh-list
14031974|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
14031975|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
14031976|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14031977|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031978|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
14031979|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14031980|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
14031981|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14031982|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
14031983|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14031984|NCT02707913|Amlodipine|amlodipine|mesh-list
14031985|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14031986|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14031987|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14031988|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031989|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14031990|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14031991|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
14031992|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
14031993|NCT02707666|Pemetrexed|pemetrexed|mesh-list
14031994|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14031995|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14031996|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14031997|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14031998|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14031999|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14032000|NCT02707653|Misoprostol|misoprostol|mesh-list
14755600|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14755601|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14755602|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14755603|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755604|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755605|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14755606|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
14755607|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755608|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755609|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14755610|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14755611|NCT04001621|Capecitabine|capecitabine|mesh-list
13901490|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901491|NCT00724698|Desloratadine|desloratadine|mesh-list
13901492|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13901493|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901494|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901495|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901496|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755612|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13901497|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13901498|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13901499|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
13901500|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
13901501|NCT00722917|Pioglitazone|pioglitazone|mesh-list
13901502|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901503|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901504|NCT00722592|Doxorubicin|doxorubicin|mesh-list
13901505|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13901506|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13901507|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901508|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13901509|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13901510|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901511|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901512|NCT00722358|Asunaprevir|asunaprevir|mesh-list
13901513|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
13901514|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901515|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901516|NCT00721760|Enoxaparin|enoxaparin|mesh-list
13901517|NCT00721760|Semuloparin|semuloparin|mesh-list
13901518|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
13901519|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
13901520|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13901521|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13901522|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901523|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13901524|NCT00721695|Mydriatics|mydriatics|mesh-list
13901525|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
13901526|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901527|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901528|NCT00719550|Capecitabine|capecitabine|mesh-list
13901529|NCT00719550|Epirubicin|epirubicin|mesh-list
13901530|NCT00719550|Rilotumumab|rilotumumab|mesh-list
13901531|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901532|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13901533|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
13901534|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032001|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14032002|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
14032003|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14032004|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032005|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14032006|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14032007|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
14032008|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14032009|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
14032010|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032011|NCT02707458|Probucol|probucol|mesh-list
14032012|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14032013|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14032014|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
14032015|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032016|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14755613|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
14755614|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755615|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755616|NCT03994796|Entrectinib|entrectinib|mesh-list
14755617|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755618|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755619|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755620|NCT03994627|Olaratumab|olaratumab|mesh-list
14755621|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767204|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032017|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
14032018|NCT02707458|Protective Agents|protective agents|mesh-ancestor
14032019|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032020|NCT02707484|Thalidomide|thalidomide|mesh-list
14032021|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032022|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
14032023|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901535|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13901536|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13901537|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13901538|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901539|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13901540|NCT00718224|Enoxaparin|enoxaparin|mesh-list
13901541|NCT00718224|Semuloparin|semuloparin|mesh-list
13901542|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
13901543|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13901544|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13901545|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032024|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
14032025|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14032026|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032027|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14032028|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14032029|NCT02707484|Growth Substances|growth substances|mesh-ancestor
14032030|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
14032031|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032032|NCT02707445|Clopidogrel|clopidogrel|mesh-list
14032033|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14032034|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14032035|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14032036|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14032037|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
14032038|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14032039|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032040|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032041|NCT02707393|Cyclosporine|cyclosporine|mesh-list
14032042|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
14032043|NCT02707393|Fludarabine|fludarabine|mesh-list
14032044|NCT02707393|Melphalan|melphalan|mesh-list
14032045|NCT02707393|Thiotepa|thiotepa|mesh-list
14032046|NCT02707393|Cyclosporins|cyclosporins|mesh-list
14032047|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
14032048|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032049|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032050|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032051|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
14032052|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032053|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032054|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
14032055|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032056|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14032057|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032058|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14032059|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14032060|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14032061|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
14032062|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14032063|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14032064|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
14032065|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13901546|NCT00717457|Exenatide|exenatide|mesh-list
13901547|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13901548|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901549|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901550|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13901551|NCT00717457|Incretins|incretins|mesh-ancestor
13901552|NCT00717457|Hormones|hormones|mesh-ancestor
14032066|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
14032067|NCT02707588|Cetuximab|cetuximab|mesh-list
14032068|NCT02707588|Antibodies|antibodies|mesh-list
14032069|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
14032070|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
14032071|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032072|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032073|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032074|NCT02707575|Ranibizumab|ranibizumab|mesh-list
14032075|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14032076|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14032077|NCT02707575|Growth Substances|growth substances|mesh-ancestor
14032078|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755622|NCT03974594|Trifluridine|trifluridine|mesh-list
13901553|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901554|NCT00716534|Paclitaxel|paclitaxel|mesh-list
13901555|NCT00716534|Carboplatin|carboplatin|mesh-list
13901556|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13901557|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032079|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
14032080|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032081|NCT02707328|Gemcitabine|gemcitabine|mesh-list
14032082|NCT02707328|Paclitaxel|paclitaxel|mesh-list
13901558|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
13901559|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
13901560|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
13901561|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901562|NCT00714597|Enoxaparin|enoxaparin|mesh-list
13901563|NCT00714597|Semuloparin|semuloparin|mesh-list
13901564|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
14032083|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14032084|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032085|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
14032086|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
14032087|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
14032088|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032089|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032090|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
14032091|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
14032092|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032093|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032094|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032095|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
14032096|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032097|NCT02707315|Gemcitabine|gemcitabine|mesh-list
14032098|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032099|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
14032100|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032101|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901565|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
13901566|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13901567|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13901568|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901569|NCT00713518|Ranibizumab|ranibizumab|mesh-list
13901570|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13901571|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13901572|NCT00713518|Growth Substances|growth substances|mesh-ancestor
13901573|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901574|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
13901575|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032102|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
14032103|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032104|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032105|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032106|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
14032107|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032108|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14032109|NCT02706977|Carbidopa|carbidopa|mesh-list
14032110|NCT02706977|Levodopa|levodopa|mesh-list
14032111|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14032112|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
13901576|NCT00713401|Esmolol|esmolol|mesh-list
13901577|NCT00713401|Tecadenoson|tecadenoson|mesh-list
13901578|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13901579|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14032113|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032114|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14032115|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14032116|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
14032117|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
14032118|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14032119|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032120|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14032121|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032122|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14032123|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
14032124|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14032125|NCT02707081|Lidocaine|lidocaine|mesh-list
14032126|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032127|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
14032128|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032129|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032130|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
14032131|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901580|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13901581|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
14032132|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14032133|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14032134|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14032135|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14032136|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032137|NCT02707263|Heparin|heparin|mesh-list
14032138|NCT02707263|Calcium heparin|calcium heparin|mesh-list
14032139|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
14032140|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14032141|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14032142|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032143|NCT02707224|Candesartan|candesartan|mesh-list
14032144|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
14032145|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14032146|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14032147|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14032148|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
14032149|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032150|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14032151|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14032152|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032153|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14032154|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14032155|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14032156|NCT02707159|Gemcitabine|gemcitabine|mesh-list
14032157|NCT02707159|Paclitaxel|paclitaxel|mesh-list
14032158|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14032159|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14032160|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032161|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
14032162|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
14032163|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
14032164|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032165|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032166|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
14032167|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
14032168|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032169|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032170|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032171|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
14032172|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032173|NCT02707211|Antibodies|antibodies|mesh-list
14032174|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
14032175|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
14032176|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169584|NCT04840342|Diuretics|diuretics|mesh-ancestor
14169585|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
14169586|NCT04839913|Antibodies|antibodies|mesh-list
14169587|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
14169588|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169589|NCT04840004|Aprepitant|aprepitant|mesh-list
14169590|NCT04840004|Antiemetics|antiemetics|mesh-ancestor
14169591|NCT04840004|Autonomic Agents|autonomic agents|mesh-ancestor
14169592|NCT04840004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169593|NCT04840004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169594|NCT04840004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169595|NCT04840004|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14169596|NCT04840004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169597|NCT04840004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169598|NCT04839666|Propofol|propofol|mesh-list
14169599|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14169600|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169601|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169602|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14169603|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
14169604|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
14169605|NCT04839731|Fluorouracil|fluorouracil|mesh-list
14169606|NCT04839731|Calcipotriene|calcipotriene|mesh-list
14169607|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
14169608|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169609|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14169610|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169611|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14169612|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
14169613|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169614|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
14032177|NCT02707250|Meperidine|meperidine|mesh-list
14032178|NCT02707250|Bupivacaine|bupivacaine|mesh-list
14032179|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032180|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
14032181|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032182|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032183|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
14032184|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032185|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14032186|NCT02707250|Narcotics|narcotics|mesh-ancestor
14032187|NCT02707250|Analgesics|analgesics|mesh-ancestor
14032188|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14032189|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
14032190|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032191|NCT02707016|Sevoflurane|sevoflurane|mesh-list
14032192|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13901582|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901583|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901584|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901585|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13901586|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
13901587|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
13901588|NCT00712699|Adderall|adderall|mesh-list
13901589|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13901590|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901591|NCT00711555|Dexamethasone|dexamethasone|mesh-list
13901592|NCT00711555|Ondansetron|ondansetron|mesh-list
13901593|NCT00711555|Aprepitant|aprepitant|mesh-list
13901594|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901595|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
13901596|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
13901597|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901598|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901599|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901600|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
13901601|NCT00711555|Hormones|hormones|mesh-ancestor
13901602|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901603|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13901604|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901605|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
13901606|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
13901607|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13901608|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
13901609|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901610|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901611|NCT00711555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13901612|NCT00711555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13901613|NCT00711555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13901614|NCT00711555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13901615|NCT00711555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13901616|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13901617|NCT00710580|Etanercept|etanercept|mesh-list
14032193|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14032194|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
14032195|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
14032196|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032197|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032198|NCT02706704|Adalimumab|adalimumab|mesh-list
14032199|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14032200|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032201|NCT02706769|Acetaminophen|acetaminophen|mesh-list
14032202|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14032203|NCT02706769|Analgesics|analgesics|mesh-ancestor
14032204|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
14032205|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032206|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032207|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
14032208|NCT02706678|Tacrolimus|tacrolimus|mesh-list
14032209|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032210|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
14032211|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032212|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14032213|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032214|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032215|NCT02706860|Atorvastatin|atorvastatin|mesh-list
14032216|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14032217|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14032218|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
14032219|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032220|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14032221|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14032222|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032223|NCT02706470|Cyclosporine|cyclosporine|mesh-list
14032224|NCT02706470|Cyclosporins|cyclosporins|mesh-list
14032225|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
14032226|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032227|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032228|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032229|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
14032230|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032231|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
14032232|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032233|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
14032234|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032235|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14032236|NCT02706470|Progestins|progestins|mesh-ancestor
14032237|NCT02706470|Hormones|hormones|mesh-ancestor
14032238|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032239|NCT02706535|Itraconazole|itraconazole|mesh-list
14032240|NCT02706535|Rifampin|rifampin|mesh-list
14032241|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
14032242|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901618|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13901619|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13901620|NCT00710580|Analgesics|analgesics|mesh-ancestor
13901621|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
13901622|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901623|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901624|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901625|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13901626|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901627|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13901628|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
13901629|NCT00709904|Semuloparin|semuloparin|mesh-list
13901630|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13901631|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13901632|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13901633|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901634|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
14032243|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14032244|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14032245|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901635|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
13901636|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
13901637|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13901638|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13901639|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
13901640|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901641|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901642|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901643|NCT00709371|Zonisamide|zonisamide|mesh-list
13901644|NCT00709371|Bupropion|bupropion|mesh-list
13901645|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13901646|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
13901647|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13901648|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13901649|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13901650|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901651|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901652|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
14032246|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032247|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14032248|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
14032249|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032250|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032251|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14032252|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14032253|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
14032254|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13901653|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901654|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901655|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13901656|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13901657|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901658|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
13901659|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13901660|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13901661|NCT00708292|Dexamethasone|dexamethasone|mesh-list
13901662|NCT00708292|Bortezomib|bortezomib|mesh-list
13901663|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901664|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
13901665|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
14032255|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
14032256|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14032257|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14032258|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14032259|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14032260|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14032261|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14032262|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14032263|NCT02706509|Tramadol|tramadol|mesh-list
14032264|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13901666|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901667|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901668|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901669|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
13901670|NCT00708292|Hormones|hormones|mesh-ancestor
14032265|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032266|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14032267|NCT02706509|Narcotics|narcotics|mesh-ancestor
14032268|NCT02706509|Analgesics|analgesics|mesh-ancestor
14032269|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
14032270|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032271|NCT02706236|Pancrelipase|pancrelipase|mesh-list
14032272|NCT02706236|Pancreatin|pancreatin|mesh-list
14032273|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14032274|NCT05265676|Enoxaparin|enoxaparin|mesh-list
14032275|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
14032276|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
14032277|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14032278|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14032279|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032280|NCT05265546|Psilocybin|psilocybin|mesh-list
14032281|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
14032282|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032283|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14032284|NCT05265442|Methadone|methadone|mesh-list
14032285|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14032286|NCT05265442|Narcotics|narcotics|mesh-ancestor
13901671|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901672|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13901673|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901674|NCT00707889|Leucovorin|leucovorin|mesh-list
13901675|NCT00707889|Folic Acid|folic acid|mesh-list
13901676|NCT00707889|Bevacizumab|bevacizumab|mesh-list
13901677|NCT00707889|Fluorouracil|fluorouracil|mesh-list
14032287|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032288|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032289|NCT05265442|Analgesics|analgesics|mesh-ancestor
14032290|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
14032291|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032292|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
14032293|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14032294|NCT05265299|Aspirin|aspirin|mesh-list
14032295|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14032296|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14032297|NCT05265299|Analgesics|analgesics|mesh-ancestor
14032298|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
14032299|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901678|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
13901679|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
13901680|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13901681|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032300|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901682|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13901683|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13901684|NCT00707889|Growth Substances|growth substances|mesh-ancestor
13901685|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901686|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
13901687|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
13901688|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901689|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13901690|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032301|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14032302|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032303|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14032304|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14032305|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032306|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14032307|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14032308|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032309|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
14032310|NCT05265286|Factor VIII|factor viii|mesh-list
14032311|NCT05265286|Coagulants|coagulants|mesh-ancestor
14032312|NCT05265065|Vaccines|vaccines|mesh-list
14032313|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
14032314|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032315|NCT05264974|Vaccines|vaccines|mesh-list
14032316|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
14032317|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032318|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14032319|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
14032320|NCT05264922|Coagulants|coagulants|mesh-ancestor
14032321|NCT05264883|Azacitidine|azacitidine|mesh-list
14032322|NCT05264883|Decitabine|decitabine|mesh-list
14032323|NCT05264883|Venetoclax|venetoclax|mesh-list
14032324|NCT05264883|Aclarubicin|aclarubicin|mesh-list
14032325|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032326|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
14032327|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032328|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032329|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032330|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14032331|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14032332|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14032333|NCT05264805|Bupivacaine|bupivacaine|mesh-list
14032334|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032335|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
14032336|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032337|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032338|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
14032339|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169615|NCT04839653|Vancomycin|vancomycin|mesh-list
14169616|NCT04839653|Gentamicins|gentamicins|mesh-list
14169617|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
14169618|NCT04839653|Polymyxins|polymyxins|mesh-list
14169619|NCT04839653|Cefotaxime|cefotaxime|mesh-list
14169620|NCT04839653|Cefoxitin|cefoxitin|mesh-list
14169621|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14169622|NCT04839653|Polymyxin B|polymyxin b|mesh-list
14169623|NCT04839653|Amphotericin B|amphotericin b|mesh-list
14169624|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14169625|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169626|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14169627|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169628|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901691|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
13901692|NCT00707889|Antidotes|antidotes|mesh-ancestor
13901693|NCT00707889|Protective Agents|protective agents|mesh-ancestor
13901694|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
13901695|NCT00707889|Vitamins|vitamins|mesh-ancestor
13901696|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
13901697|NCT00707889|Hematinics|hematinics|mesh-ancestor
13901698|NCT00707304|Lactoferrin|lactoferrin|mesh-list
13901699|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
13901700|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901701|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901702|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
13901703|NCT00704483|Sevelamer|sevelamer|mesh-list
13901704|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
14169629|NCT04839653|Amebicides|amebicides|mesh-ancestor
14169630|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14169631|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14169632|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
14169633|NCT04839536|Sevoflurane|sevoflurane|mesh-list
14032340|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14032341|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
13901705|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
13901706|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901707|NCT00704483|Hematinics|hematinics|mesh-ancestor
13901708|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
13901709|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13901710|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901711|NCT00701883|Atorvastatin|atorvastatin|mesh-list
13901712|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13901713|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13901714|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
14032342|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032343|NCT05264506|Estradiol|estradiol|mesh-list
14032344|NCT05264506|Estrogens|estrogens|mesh-ancestor
14032345|NCT05264506|Hormones|hormones|mesh-ancestor
14032346|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032347|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032348|NCT05264493|Naloxone|naloxone|mesh-list
14032349|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14032350|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032351|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
14032352|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032353|NCT05264142|Voriconazole|voriconazole|mesh-list
14032354|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
14032355|NCT05264142|Omeprazole|omeprazole|mesh-list
14032356|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14032357|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14032358|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14032359|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755623|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
14755624|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755625|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
14755626|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755627|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
14755628|NCT03964688|Vitamins|vitamins|mesh-ancestor
14755629|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
14755630|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932592|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901715|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032360|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032361|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
14032362|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032363|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14032364|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14032365|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14032366|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
14032367|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901716|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13901717|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13901718|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901719|NCT00698789|Metformin|metformin|mesh-list
13901720|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901721|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901722|NCT00698230|Metformin|metformin|mesh-list
13901723|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901724|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901725|NCT00697099|Enoxaparin|enoxaparin|mesh-list
13901726|NCT00697099|Semuloparin|semuloparin|mesh-list
13901727|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
13901728|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
13901729|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13901730|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13901731|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901732|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
13901733|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
13901734|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13901735|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901736|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901737|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901738|NCT00694928|Clindamycin|clindamycin|mesh-list
13901739|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
13901740|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
14755631|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
14032368|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032369|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14032370|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14032371|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14032372|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032373|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14032374|NCT05264142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14032375|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14032376|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14032377|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14032378|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
14032379|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14032380|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
14032381|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14032382|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14032383|NCT05264077|Midazolam|midazolam|mesh-list
14032384|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
14032385|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14032386|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032387|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032388|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14032389|NCT05264077|Analgesics|analgesics|mesh-ancestor
14032390|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
14032391|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032392|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14032393|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14032394|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14032395|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
14032396|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14032397|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032398|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14032399|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14032400|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14032401|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14032402|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14032403|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
14032404|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
14032405|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
14032406|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
14032407|NCT05264025|Fexofenadine|fexofenadine|mesh-list
14032408|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14032409|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14032410|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14032411|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
14032412|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
14032413|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14032414|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032415|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032416|NCT05263986|Adagrasib|adagrasib|mesh-list
14032417|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032418|NCT05263947|Bevacizumab|bevacizumab|mesh-list
14032419|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032420|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032421|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14032422|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14032423|NCT05263947|Growth Substances|growth substances|mesh-ancestor
13901741|NCT00694928|Butoconazole|butoconazole|mesh-list
13901742|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13901743|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901744|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13901745|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901746|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901747|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
13901748|NCT00694382|Semuloparin|semuloparin|mesh-list
13901749|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13901750|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13901751|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13901752|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901753|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
13901754|NCT00694135|Dexamethasone|dexamethasone|mesh-list
14032424|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032425|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
13901755|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
14032426|NCT05263921|Ritonavir|ritonavir|mesh-list
13901756|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13901757|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13901758|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13901759|NCT00694135|BB 1101|bb 1101|mesh-list
13901760|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14032427|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14032428|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14032429|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
14032430|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032431|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032432|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14032433|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14032434|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
14032435|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032436|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14032437|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14032438|NCT05263908|Ritonavir|ritonavir|mesh-list
14032439|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14032440|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13901761|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
13901762|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
13901763|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901764|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901765|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901766|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
13901767|NCT00694135|Hormones|hormones|mesh-ancestor
13901768|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032441|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
14032442|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032443|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032444|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14032445|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14032446|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
14032447|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032448|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14032449|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14032450|NCT05263882|Gemcitabine|gemcitabine|mesh-list
14032451|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032452|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
14032453|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032454|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032455|NCT05263882|Antiviral Agents|antiviral agents|mesh-ancestor
14032456|NCT05263882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032457|NCT05263882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032458|NCT05263882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032459|NCT05263882|Immunologic Factors|immunologic factors|mesh-ancestor
14032460|NCT05263882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032461|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14032462|NCT05263778|Ezetimibe|ezetimibe|mesh-list
14032463|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14032464|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14032465|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
14032466|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032467|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14032468|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032469|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14032470|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032471|NCT05263700|FAPI-46|fapi-46|mesh-list
14032472|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14032473|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032474|NCT05260684|Trametinib|trametinib|mesh-list
14032475|NCT05260684|Vemurafenib|vemurafenib|mesh-list
14032476|NCT05260684|Dabrafenib|dabrafenib|mesh-list
14032477|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032478|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14032479|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032480|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032481|NCT05260619|Lenalidomide|lenalidomide|mesh-list
14032482|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
14032483|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032484|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14032485|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14032486|NCT05260619|Growth Substances|growth substances|mesh-ancestor
14032487|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
13901769|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13901770|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901771|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
13901772|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901773|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901774|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
13901775|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13901776|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
13901777|NCT00692484|Povidone|povidone|mesh-list
13901778|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13901779|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901780|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
13901781|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
13901782|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
13901783|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
14032488|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032489|NCT05260554|Fosfomycin|fosfomycin|mesh-list
14032490|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14032491|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032492|NCT05260541|Pramoxine|pramoxine|mesh-list
14032493|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
13901784|NCT00692445|Mecamylamine|mecamylamine|mesh-list
13901785|NCT00692445|Dexetimide|dexetimide|mesh-list
13901786|NCT00692445|Citalopram|citalopram|mesh-list
13901787|NCT00692445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13901788|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13901789|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13901790|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901791|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901792|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
13901793|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901794|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13901795|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
13901796|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13901797|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13901798|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13901799|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
13901800|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
13901801|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032494|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
13901802|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13901803|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13901804|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901805|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13901806|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
13901807|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
13901808|NCT00691964|Etanercept|etanercept|mesh-list
13901809|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13901810|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13901811|NCT00691964|Analgesics|analgesics|mesh-ancestor
13901812|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
14032495|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13901813|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901814|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901815|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901816|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032496|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032497|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
14032498|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169634|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14169635|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14169636|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
14169637|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
14169638|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169639|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169640|NCT04839549|Fluorometholone|fluorometholone|mesh-list
14932593|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932594|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932595|NCT01446107|Fluorides|fluorides|mesh-list
14932596|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
14932597|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
14932598|NCT01446107|Protective Agents|protective agents|mesh-ancestor
14932599|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932600|NCT01446120|Insulin|insulin|mesh-list
14932601|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14932602|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
13901817|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901818|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13901819|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
13901820|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
13901821|NCT00691717|Anecortave|anecortave|mesh-list
13901822|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13901823|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13901824|NCT00691717|Growth Substances|growth substances|mesh-ancestor
13901825|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901826|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
13901827|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901828|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169641|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169642|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169643|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
14169644|NCT04839549|Hormones|hormones|mesh-ancestor
14169645|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169646|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14169647|NCT04839627|Progesterone|progesterone|mesh-list
14169648|NCT04839627|Progestins|progestins|mesh-ancestor
14169649|NCT04839627|Hormones|hormones|mesh-ancestor
14169650|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169651|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169652|NCT04839445|Anesthetics|anesthetics|mesh-list
14169653|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169654|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169655|NCT04839224|Phenylephrine|phenylephrine|mesh-list
14169656|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
14169657|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14169658|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
14169659|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
14169660|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169661|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169662|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
14169663|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13901829|NCT00690456|Metformin|metformin|mesh-list
13901830|NCT00690456|Rimonabant|rimonabant|mesh-list
13901831|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901832|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901833|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13901834|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14169664|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
14169665|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
14169666|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14169667|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14169668|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14169669|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
14169670|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169671|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901835|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13901836|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169672|NCT04839224|Protective Agents|protective agents|mesh-ancestor
14932603|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
14032499|NCT05260255|Vitamin D|vitamin d|mesh-list
14032500|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
14032501|NCT05260255|Vitamins|vitamins|mesh-ancestor
14032502|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
14032503|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032504|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14032505|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14032506|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
14032507|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14032508|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14032509|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
14032510|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14032511|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032512|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032513|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
14032514|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
14032515|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032516|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
14032517|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14032518|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
13901837|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901838|NCT00690456|Hormones|hormones|mesh-ancestor
13901839|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13901840|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
13901841|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901842|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
13901843|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901844|NCT00687882|Anticoagulants|anticoagulants|mesh-list
13901845|NCT00687687|Paclitaxel|paclitaxel|mesh-list
13901846|NCT00687687|Carboplatin|carboplatin|mesh-list
13901847|NCT00687687|Iniparib|iniparib|mesh-list
13901848|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13901849|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901850|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
13901851|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
13901852|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
13901853|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901854|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13901855|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959413|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959414|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959415|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13959416|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959417|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963345|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032519|NCT05259839|Dexamethasone|dexamethasone|mesh-list
14032520|NCT05259839|Lenalidomide|lenalidomide|mesh-list
14032521|NCT05259839|Daratumumab|daratumumab|mesh-list
14032522|NCT05259839|Pomalidomide|pomalidomide|mesh-list
14032523|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14032524|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
14032525|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
14032526|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032527|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032528|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14032529|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
14032530|NCT05259839|Hormones|hormones|mesh-ancestor
14032531|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032532|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14032533|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032534|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
14032535|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14032536|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14032537|NCT05259839|Growth Substances|growth substances|mesh-ancestor
14032538|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
14032539|NCT05259800|Peppermint oil|peppermint oil|mesh-list
14032540|NCT05259800|Mineral Oil|mineral oil|mesh-list
14032541|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
14032542|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
13963346|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963347|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
14032543|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032544|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032545|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14032546|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
14032547|NCT05259800|Emollients|emollients|mesh-ancestor
13901856|NCT00684918|Obatoclax|obatoclax|mesh-list
13901857|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901858|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901859|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
13901860|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901861|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
13901862|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901863|NCT00682981|Carboplatin|carboplatin|mesh-list
13901864|NCT00682981|Etoposide|etoposide|mesh-list
14932604|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
14932605|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13901865|NCT00682981|Obatoclax|obatoclax|mesh-list
13901866|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901867|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13901868|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13901869|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13901870|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901871|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901872|NCT00680784|Ketoprofen|ketoprofen|mesh-list
13901873|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13901874|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13901875|NCT00680784|Analgesics|analgesics|mesh-ancestor
13901876|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
13901877|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901878|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901879|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901880|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13901881|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13901882|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901883|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901884|NCT00680472|Ketoprofen|ketoprofen|mesh-list
13901885|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13901886|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13901887|NCT00680472|Analgesics|analgesics|mesh-ancestor
13901888|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
13901889|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901890|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901891|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13901892|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13901893|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13901894|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901895|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901896|NCT00680342|Silymarin|silymarin|mesh-list
13901897|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
13901898|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901899|NCT00680342|Protective Agents|protective agents|mesh-ancestor
13901900|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901901|NCT00679731|Methotrexate|methotrexate|mesh-list
13901902|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13901903|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
13901904|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13901905|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901906|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13901907|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
13901908|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901909|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13901910|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
13901911|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901912|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13901913|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13901914|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
13901915|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13901916|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13901917|NCT00679588|Enoxaparin|enoxaparin|mesh-list
13901918|NCT00679588|Semuloparin|semuloparin|mesh-list
13901919|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
13901920|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
13901921|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13901922|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13901923|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901924|NCT00678119|Sunitinib|sunitinib|mesh-list
13901925|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032548|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
14032549|NCT05259787|Propofol|propofol|mesh-list
14032550|NCT05259787|Etomidate|etomidate|mesh-list
14032551|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14032552|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932606|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932607|NCT01446211|Gusperimus|gusperimus|mesh-list
14932608|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
14932609|NCT01446211|Methotrexate|methotrexate|mesh-list
14932610|NCT01446211|Azathioprine|azathioprine|mesh-list
14932611|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
14932612|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932613|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
14932614|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932615|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932616|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14932617|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
14932618|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932619|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932620|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14932621|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14932622|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
14032553|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032554|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14032555|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
14032556|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
14032557|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
14032558|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14032559|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032560|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
14032561|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
14032562|NCT05244031|Narcotics|narcotics|mesh-ancestor
14032563|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032564|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032565|NCT05244031|Analgesics|analgesics|mesh-ancestor
14032566|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
14032567|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032568|NCT05243550|Mitomycins|mitomycins|mesh-list
14032569|NCT05243550|Mitomycin|mitomycin|mesh-list
14032570|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14032571|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032572|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
14032573|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932623|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14932624|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13901926|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13901927|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13901928|NCT00678119|Growth Substances|growth substances|mesh-ancestor
13901929|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901930|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
13901931|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13901932|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901933|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901934|NCT00677079|Iniparib|iniparib|mesh-list
13901935|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13901936|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901937|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901938|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959418|NCT03163407|Norepinephrine|norepinephrine|mesh-list
13959419|NCT03163407|Ephedrine|ephedrine|mesh-list
14032574|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14032575|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032576|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14932625|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
14032577|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032578|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032579|NCT05237947|Vaccines|vaccines|mesh-list
14032580|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
14032581|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032582|NCT05236647|Morphine|morphine|mesh-list
14032583|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14032584|NCT05236647|Narcotics|narcotics|mesh-ancestor
14032585|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032586|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032587|NCT05236647|Analgesics|analgesics|mesh-ancestor
14032588|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
14032589|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032590|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14032591|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14032592|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901939|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
13901940|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13901941|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
13901942|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13901943|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
13901944|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901945|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901946|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
13901947|NCT00676832|Prednisolone|prednisolone|mesh-list
13901948|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13901949|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
13901950|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13901951|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
13901952|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13901953|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
13901954|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14032593|NCT05233696|Paclitaxel|paclitaxel|mesh-list
14032594|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14032595|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
14032596|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14032597|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032598|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14032599|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14032600|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14032601|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032602|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471601|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479105|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14032603|NCT05227833|Pantoprazole|pantoprazole|mesh-list
14032604|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14032605|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14032606|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14032607|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032608|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032609|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14032610|NCT05225545|Iron|iron|mesh-list
14032611|NCT05225545|Trace Elements|trace elements|mesh-ancestor
14032612|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
14032613|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032614|NCT05222971|Durvalumab|durvalumab|mesh-list
14032615|NCT05222971|Olaparib|olaparib|mesh-list
14032616|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032617|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032618|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14032619|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032620|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032621|NCT05219487|Risdiplam|risdiplam|mesh-list
14032622|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14032623|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032624|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901955|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
13901956|NCT00676832|Hormones|hormones|mesh-ancestor
13901957|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032625|NCT05218733|Fentanyl|fentanyl|mesh-list
14032626|NCT05218733|Morphine|morphine|mesh-list
14032627|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
14032628|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032629|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032630|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14032631|NCT05218733|Narcotics|narcotics|mesh-ancestor
14032632|NCT05218733|Analgesics|analgesics|mesh-ancestor
14032633|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
14032634|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032635|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14032636|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14032637|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
14032638|NCT05213104|Flecainide|flecainide|mesh-list
14032639|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14032640|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14032641|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14032642|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14755632|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755633|NCT03964688|Protective Agents|protective agents|mesh-ancestor
14755634|NCT03961165|Scopolamine|scopolamine|mesh-list
14755635|NCT03961165|Bromides|bromides|mesh-list
14767205|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13901958|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901959|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13901960|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032643|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032644|NCT05209711|Lidocaine|lidocaine|mesh-list
14032645|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032646|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
14032647|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032648|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032649|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
14032650|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032651|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14032652|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14032653|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14032654|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14032655|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032656|NCT05209490|Iodine|iodine|mesh-list
13901961|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
13901962|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
14032657|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14471602|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471603|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
14471604|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471605|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471606|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14032658|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032659|NCT05209490|Trace Elements|trace elements|mesh-ancestor
14032660|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
14032661|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032662|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
14032663|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
14032664|NCT05207358|Rituximab|rituximab|mesh-list
14032665|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032666|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
14032667|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032668|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032669|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14032670|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
14032671|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032672|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032673|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14032674|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032675|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14032676|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14032677|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
14032678|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14032679|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755636|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14755637|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
14755638|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
14755639|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
14755640|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755641|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032680|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755642|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14755643|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14755644|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
14755645|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901963|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901964|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13901965|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13901966|NCT00676832|Protective Agents|protective agents|mesh-ancestor
13901967|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
13901968|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13901969|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13901970|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13901971|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901972|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
13901973|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13901974|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13901975|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13901976|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
13901977|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
13901978|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901979|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13901980|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901981|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
13901982|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13901983|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13901984|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
13901985|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13901986|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13901987|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13901988|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
13901989|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
13901990|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13901991|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901992|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13901993|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755646|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032681|NCT05205473|Lidocaine|lidocaine|mesh-list
14032682|NCT05205473|Anesthetics|anesthetics|mesh-list
14032683|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032684|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032685|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032686|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
14032687|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032688|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14032689|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14032690|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14032691|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14032692|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032693|NCT05201846|Insulin|insulin|mesh-list
14032694|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14032695|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14032696|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032697|NCT05199285|Nivolumab|nivolumab|mesh-list
14032698|NCT05199285|Ipilimumab|ipilimumab|mesh-list
14755647|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14755648|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
14755649|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14755650|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
14755651|NCT03958877|Interferons|interferons|mesh-list
14755652|NCT03958877|Interferon-beta|interferon-beta|mesh-list
14032699|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032700|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032701|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14032702|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169673|NCT04839471|Afatinib|afatinib|mesh-list
14169674|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169675|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14169676|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169677|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169678|NCT04839328|Hemay005|hemay005|mesh-list
14169679|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
14169680|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14169681|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14169682|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169683|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169684|NCT04839198|Nicotine|nicotine|mesh-list
14169685|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14169686|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
14169687|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169688|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169689|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14169690|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14169691|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
13901994|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13901995|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13901996|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13901997|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
13901998|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
13901999|NCT00673062|Ephedrine|ephedrine|mesh-list
13902000|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902001|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
13902002|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902003|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902004|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902005|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902006|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
13902007|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14169692|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169693|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169694|NCT04839237|Metformin|metformin|mesh-list
14169695|NCT04839237|Liraglutide|liraglutide|mesh-list
14169696|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14169697|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169698|NCT04839237|Incretins|incretins|mesh-ancestor
14169699|NCT04839237|Hormones|hormones|mesh-ancestor
13902008|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14169700|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755653|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755654|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
13902009|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
13902010|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14767206|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14032708|NCT05194189|Ascorbic Acid|ascorbic acid|mesh-list
14032709|NCT05194189|Vitamins|vitamins|mesh-ancestor
14032710|NCT05194189|Micronutrients|micronutrients|mesh-ancestor
14032711|NCT05194189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032712|NCT05194189|Antioxidants|antioxidants|mesh-ancestor
14032713|NCT05194189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032714|NCT05194189|Protective Agents|protective agents|mesh-ancestor
14032715|NCT05189457|Docetaxel|docetaxel|mesh-list
14032716|NCT05189457|Leuprolide|leuprolide|mesh-list
14032717|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14032718|NCT05189457|Hormones|hormones|mesh-list
14032719|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14032720|NCT05189457|Relugolix|relugolix|mesh-list
14032721|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032722|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14032723|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
14032724|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14032725|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032726|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032727|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032728|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14032729|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
14032730|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14032731|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14032732|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
14032733|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14032734|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
14032735|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14032736|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
14755655|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755656|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
14755657|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755658|NCT03957876|Cytarabine|cytarabine|mesh-list
14755659|NCT03957876|Daunorubicin|daunorubicin|mesh-list
14755660|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032737|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
14032738|NCT05181462|Gemcitabine|gemcitabine|mesh-list
14032739|NCT05181462|Carboplatin|carboplatin|mesh-list
14032740|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032741|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032742|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
14032743|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032744|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
14032745|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032746|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032747|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032748|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
14032749|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032750|NCT05180708|Sirolimus|sirolimus|mesh-list
14032751|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14032752|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032753|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14032754|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032755|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
14032756|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14032757|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
14032758|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032759|NCT05174598|Calcitriol|calcitriol|mesh-list
14032760|NCT05174598|Calcipotriene|calcipotriene|mesh-list
14032761|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14032762|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14032763|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032764|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14032765|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14032766|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032767|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14755661|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
14032768|NCT05174598|Vitamins|vitamins|mesh-ancestor
13902011|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902012|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902013|NCT00672997|Timolol|timolol|mesh-list
13902014|NCT00672997|Travoprost|travoprost|mesh-list
13902015|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13902016|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13902017|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13902018|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14032769|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
14032770|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14032771|NCT05157841|Bupivacaine|bupivacaine|mesh-list
14032772|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032773|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
14032774|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032775|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032776|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
14032777|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032778|NCT05151848|Adalimumab|adalimumab|mesh-list
13902019|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902020|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902021|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902022|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902023|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13902024|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14032779|NCT05151848|Tofacitinib|tofacitinib|mesh-list
14032780|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14032781|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032782|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14032783|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032784|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032785|NCT05139030|Bupivacaine|bupivacaine|mesh-list
14032786|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032787|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
14032788|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032789|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032790|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
14032791|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032792|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
14032793|NCT05134688|Analgesics|analgesics|mesh-ancestor
14032794|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
14032795|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902025|NCT00672412|Lamivudine|lamivudine|mesh-list
13902026|NCT00672412|Zidovudine|zidovudine|mesh-list
13902027|NCT00672412|Nevirapine|nevirapine|mesh-list
14032796|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032797|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
14032798|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032799|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14032800|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
14032801|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14032802|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14032803|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032804|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14032805|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
13902028|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13902029|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13902030|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902031|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902032|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
14932626|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
14932627|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932628|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14932629|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14932630|NCT01446211|Hormones|hormones|mesh-ancestor
14932631|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032806|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14032807|NCT05132699|Cannabidiol|cannabidiol|mesh-list
14032808|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14032809|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
14032810|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
14032811|NCT05132504|Folfirinox|folfirinox|mesh-list
14032812|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032813|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032814|NCT05121246|Palivizumab|palivizumab|mesh-list
14032815|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
14032816|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032817|NCT05118776|Bevacizumab|bevacizumab|mesh-list
14032818|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032819|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902033|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902034|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13902035|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13902036|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
13902037|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13902038|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13902039|NCT00672386|Metformin|metformin|mesh-list
13902040|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13902041|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032820|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14032821|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14032822|NCT05118776|Growth Substances|growth substances|mesh-ancestor
13902042|NCT00670033|Travoprost|travoprost|mesh-list
13902043|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13902044|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14032823|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032824|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
14032825|NCT05107765|Pioglitazone|pioglitazone|mesh-list
14032826|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14032827|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032828|NCT05087589|Tofacitinib|tofacitinib|mesh-list
14032829|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14032830|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032831|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032832|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
14032833|NCT05081193|Testosterone|testosterone|mesh-list
14032834|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
14032835|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
14032836|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14032837|NCT05081193|Androgens|androgens|mesh-ancestor
14032838|NCT05081193|Hormones|hormones|mesh-ancestor
14032839|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14032840|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032841|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14032842|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932632|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13902045|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13902046|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
13902047|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13902048|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902049|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
13902050|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902051|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902052|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902053|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902054|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
13902055|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13902056|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
13902057|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902058|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902059|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13902060|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902061|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13902062|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
14032843|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
14032844|NCT05079061|Misoprostol|misoprostol|mesh-list
14032845|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14032846|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
14032847|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14032848|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032849|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14032850|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14032851|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
14032852|NCT05069545|Insulin|insulin|mesh-list
14032853|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14032854|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
13902063|NCT00667953|Temozolomide|temozolomide|mesh-list
13902064|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
13902065|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13902066|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
14932633|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14932634|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14932635|NCT01446211|Protective Agents|protective agents|mesh-ancestor
14932636|NCT01446224|Bevacizumab|bevacizumab|mesh-list
14932637|NCT01446224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13902067|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902068|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902069|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13902070|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902071|NCT00666497|Azacitidine|azacitidine|mesh-list
13902072|NCT00666497|Mocetinostat|mocetinostat|mesh-list
13902073|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13902074|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
13902075|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902076|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902077|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902078|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13902079|NCT00663767|Celecoxib|celecoxib|mesh-list
13902080|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14932638|NCT01446224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932639|NCT01446224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14932640|NCT01446224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13902081|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13902082|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13902083|NCT00663767|Analgesics|analgesics|mesh-ancestor
13902084|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
13902085|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902086|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032855|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14032856|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032857|NCT05064085|Capecitabine|capecitabine|mesh-list
14032858|NCT05064085|Cemiplimab|cemiplimab|mesh-list
14032859|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032860|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
14032861|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032862|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032863|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032864|NCT05062044|Folic Acid|folic acid|mesh-list
14032865|NCT05062044|Hematinics|hematinics|mesh-ancestor
14471607|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471608|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
13902087|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13902088|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13902089|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13902090|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902091|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902092|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
13902093|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13902094|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902095|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
13902096|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902097|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471609|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14471610|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14471611|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14471612|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471613|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471614|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
14032866|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
14032867|NCT05062044|Vitamins|vitamins|mesh-ancestor
14932641|NCT01446224|Growth Substances|growth substances|mesh-ancestor
14032868|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
14032869|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169701|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
14169702|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14169703|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169704|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
14471615|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471616|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471617|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14471618|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471619|NCT02334527|Palbociclib|palbociclib|mesh-list
14471620|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471621|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14471622|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471623|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471624|NCT02334800|Palbociclib|palbociclib|mesh-list
14471625|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471626|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14471627|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471628|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471629|NCT02334813|Dexamethasone|dexamethasone|mesh-list
14169705|NCT04838704|Methotrexate|methotrexate|mesh-list
14169706|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14169707|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
14169708|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14169709|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169710|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14169711|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
14169712|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169713|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169714|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
14169715|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169716|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14169717|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14169718|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
14169719|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169720|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14169721|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14169722|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14169723|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
14471630|NCT02334813|Prednisone|prednisone|mesh-list
13902098|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902099|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
14169724|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14169725|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169726|NCT04838665|Phenylephrine|phenylephrine|mesh-list
14169727|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
14169728|NCT04838665|Tropicamide|tropicamide|mesh-list
14169729|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
14169730|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14169731|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
14169732|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
14169733|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169734|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169735|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
14169736|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14169737|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
13902100|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
13902101|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13902102|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
13902103|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902104|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902105|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13902106|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902107|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13902108|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902109|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
13902110|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13902111|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902112|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
13902113|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902114|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169738|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
14169739|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14169740|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14032870|NCT05057689|Fentanyl|fentanyl|mesh-list
14032871|NCT05057689|Midazolam|midazolam|mesh-list
14032872|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
14032873|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14032874|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032875|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032876|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14032877|NCT05057689|Analgesics|analgesics|mesh-ancestor
14932642|NCT01446224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932643|NCT01446224|Growth Inhibitors|growth inhibitors|mesh-ancestor
13902115|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902116|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902117|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
13902118|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13902119|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
13902120|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902121|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932644|NCT01446276|Resveratrol|resveratrol|mesh-list
14932645|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
14932646|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932647|NCT01446276|Protective Agents|protective agents|mesh-ancestor
14932648|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932649|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932650|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14932651|NCT01446328|Olanzapine|olanzapine|mesh-list
14932652|NCT01446328|Aripiprazole|aripiprazole|mesh-list
14932653|NCT01446328|Amisulpride|amisulpride|mesh-list
14932654|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
14932655|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
14932656|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932657|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902122|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13902123|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902124|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13902125|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902126|NCT00662597|Paclitaxel|paclitaxel|mesh-list
13902127|NCT00662597|Carboplatin|carboplatin|mesh-list
13902128|NCT00662597|Vadimezan|vadimezan|mesh-list
13902129|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13902130|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902131|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
13902132|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
13902133|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
13902134|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902135|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
13902136|NCT00662506|Temozolomide|temozolomide|mesh-list
13902137|NCT00662506|Cediranib|cediranib|mesh-list
13902138|NCT00662506|Maleic acid|maleic acid|mesh-list
13902139|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13902140|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14932658|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14932659|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14932660|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14932661|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932662|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14932663|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14932664|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14932665|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932666|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932667|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932668|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
14932669|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
14932670|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
14932671|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
13902141|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
14032878|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
14032879|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032880|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14032881|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14032882|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14032883|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
14032884|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14032885|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932672|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14932673|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14032886|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14032887|NCT05057689|Narcotics|narcotics|mesh-ancestor
14032888|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14032889|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14032890|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
14032891|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
14032892|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14032893|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14032894|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14032895|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
14032896|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
14032897|NCT05054179|Ropivacaine|ropivacaine|mesh-list
13902142|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902143|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902144|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902145|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13902146|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13902147|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
13902148|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
13902149|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902150|NCT00660881|Epratuzumab|epratuzumab|mesh-list
13902151|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932674|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14932675|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14932676|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14932677|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14932678|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14932679|NCT01446445|Valganciclovir|valganciclovir|mesh-list
14932680|NCT01446445|Ganciclovir|ganciclovir|mesh-list
14932681|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14932682|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
14932683|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932684|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14932685|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932686|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932687|NCT01446458|Folfirinox|folfirinox|mesh-list
14932688|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032898|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
14032899|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
14032900|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14032901|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032902|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
14032903|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14032904|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
14032905|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14032906|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032907|NCT05050318|Vaccines|vaccines|mesh-list
14032908|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
14032909|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032910|NCT05048238|Tofacitinib|tofacitinib|mesh-list
14032911|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14032912|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032913|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032914|NCT05047601|Ritonavir|ritonavir|mesh-list
14932689|NCT01446484|Cyclosporine|cyclosporine|mesh-list
14932690|NCT01446484|Sirolimus|sirolimus|mesh-list
13902152|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902153|NCT00659191|Cabotegravir|cabotegravir|mesh-list
13902154|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13902155|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13902156|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902157|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902158|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13902159|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13902160|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
13902161|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902162|NCT00659061|Micronutrients|micronutrients|mesh-list
13902163|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932691|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
13902164|NCT00658762|Paroxetine|paroxetine|mesh-list
13902165|NCT00658762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13902166|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14932692|NCT01446484|Everolimus|everolimus|mesh-list
13902167|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14032915|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14032916|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14932693|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
14932694|NCT01446484|Tacrolimus|tacrolimus|mesh-list
13902168|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902169|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902170|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
14032917|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
14032918|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032919|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032920|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14032921|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14032922|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
14032923|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032924|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14032925|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14032926|NCT05044117|Capecitabine|capecitabine|mesh-list
14032927|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032928|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
14032929|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032930|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032931|NCT05041335|Heparin|heparin|mesh-list
14032932|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
13902171|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902172|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13902173|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902174|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902175|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13902176|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13902177|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902178|NCT00658372|Paroxetine|paroxetine|mesh-list
13902179|NCT00658372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13902180|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902181|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902182|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902183|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902184|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
13902185|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902186|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13902187|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902188|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902189|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13902190|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13902191|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902192|NCT00658047|Methotrexate|methotrexate|mesh-list
13902193|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13902194|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
13902195|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13902196|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902197|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13902198|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
13902199|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902200|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902201|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
13902202|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902203|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13902204|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13902205|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
13902206|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767207|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
14032933|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14032934|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14032935|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032936|NCT05029466|Psilocybin|psilocybin|mesh-list
14032937|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
14032938|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032939|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14032940|NCT05024006|Interferons|interferons|mesh-list
14032941|NCT05024006|Ritonavir|ritonavir|mesh-list
14032942|NCT05024006|Lopinavir|lopinavir|mesh-list
14032943|NCT05024006|Interferon-beta|interferon-beta|mesh-list
14032944|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
14032945|NCT05024006|Remdesivir|remdesivir|mesh-list
14032946|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
14032947|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
14032948|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032949|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
14032950|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032951|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14032952|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14032953|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
14032954|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032955|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032956|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14032957|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14032958|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14032959|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14032960|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
14032961|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14032962|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14032963|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032964|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
14032965|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032966|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14032967|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
14032968|NCT05019703|Atezolizumab|atezolizumab|mesh-list
14032969|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14032970|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032971|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
14032972|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032973|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
14032974|NCT05000216|Methotrexate|methotrexate|mesh-list
14032975|NCT05000216|Vaccines|vaccines|mesh-list
14032976|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
14032977|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14032978|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14032979|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
13902207|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13902208|NCT00658008|Paroxetine|paroxetine|mesh-list
13902209|NCT00658008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13902210|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902211|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902212|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902213|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902214|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
13902215|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902216|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14032980|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14032981|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14032982|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
14032983|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14032984|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14032985|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
14032986|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14032987|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14032988|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13902217|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902218|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902219|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13902220|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13902221|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902222|NCT00657501|Testosterone|testosterone|mesh-list
13902223|NCT00657501|Androgens|androgens|mesh-ancestor
13902224|NCT00657501|Hormones|hormones|mesh-ancestor
13902225|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902226|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902227|NCT00657189|Sifalimumab|sifalimumab|mesh-list
13902228|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13902229|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
13902230|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902231|NCT00656539|Azithromycin|azithromycin|mesh-list
13902232|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902233|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902234|NCT00656357|Cocaine|cocaine|mesh-list
13902235|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
13902236|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
13902237|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902238|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902239|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
13902240|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902241|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13902242|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13902243|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902244|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902245|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902246|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
13902247|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902248|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
13902249|NCT00654992|Hematinics|hematinics|mesh-ancestor
13902250|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13902251|NCT00654706|Sertindole|sertindole|mesh-list
13902252|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902253|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902254|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13902255|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14032989|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14032990|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14032991|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14032992|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14032993|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
14032994|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14032995|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14032996|NCT04993027|Vancomycin|vancomycin|mesh-list
14032997|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14032998|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902256|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902257|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902258|NCT00650949|Carboplatin|carboplatin|mesh-list
13902259|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902260|NCT00650832|Darunavir|darunavir|mesh-list
13902261|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13902262|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14032999|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
14033000|NCT04983238|Trastuzumab|trastuzumab|mesh-list
14033001|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033002|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033003|NCT04983238|Antidotes|antidotes|mesh-ancestor
14033004|NCT04983238|Protective Agents|protective agents|mesh-ancestor
14033005|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033006|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
14033007|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033008|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
14033009|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14033010|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033011|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
14033012|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
14033013|NCT04982614|Vaccines|vaccines|mesh-list
14033014|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
14033015|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755662|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755663|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755664|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
14755665|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755666|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755667|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
14755668|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755669|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14755670|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14033025|NCT04956146|Carboplatin|carboplatin|mesh-list
14033026|NCT04956146|Pemetrexed|pemetrexed|mesh-list
14033027|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033028|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033029|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033030|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14033031|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14033032|NCT04942067|Dexamethasone|dexamethasone|mesh-list
14033033|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
14033034|NCT04942067|Lenalidomide|lenalidomide|mesh-list
14033035|NCT04942067|Daratumumab|daratumumab|mesh-list
14033036|NCT04942067|Pomalidomide|pomalidomide|mesh-list
14033037|NCT04942067|BB 1101|bb 1101|mesh-list
14033038|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033039|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
14033040|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
14033041|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033042|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033043|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14033044|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
14033045|NCT04942067|Hormones|hormones|mesh-ancestor
14033046|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033047|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033048|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033049|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
14033050|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902263|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
13902264|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902265|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033051|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902266|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14033052|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
14033053|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14033054|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14033055|NCT04942067|Growth Substances|growth substances|mesh-ancestor
14033056|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
14033057|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14033058|NCT04937062|Glycerol|glycerol|mesh-list
14033059|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14033060|NCT04937062|Protective Agents|protective agents|mesh-ancestor
14033061|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033062|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033063|NCT04932980|Aflibercept|aflibercept|mesh-list
14033064|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14033065|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14033066|NCT04932980|Growth Substances|growth substances|mesh-ancestor
14033067|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033068|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
14033069|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033070|NCT04931368|Rituximab|rituximab|mesh-list
14033071|NCT04931368|Methotrexate|methotrexate|mesh-list
14033072|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033073|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033074|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
14033075|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033076|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033077|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14033078|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
14033079|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14033080|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14033081|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
14033082|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033083|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14033084|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033085|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14033086|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033087|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14932695|NCT01446484|Cyclosporins|cyclosporins|mesh-list
14932696|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932697|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
13902267|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13902268|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
14932698|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932699|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14932700|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932701|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902269|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902270|NCT00650702|Latanoprost|latanoprost|mesh-list
13902271|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13902272|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13902273|NCT00649025|Fluticasone|fluticasone|mesh-list
13902274|NCT00649025|Xhance|xhance|mesh-list
13902275|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932702|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
14932703|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902276|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902277|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
14932704|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14932705|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932706|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932707|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14932708|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14932709|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
14932710|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14932711|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932712|NCT01446497|Timolol|timolol|mesh-list
14932713|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14932714|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14932715|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14932716|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
14932717|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902278|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902279|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902280|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902281|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902282|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
13902283|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13902284|NCT00647231|Ketoprofen|ketoprofen|mesh-list
13902285|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13902286|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13902287|NCT00647231|Analgesics|analgesics|mesh-ancestor
13902288|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
13902289|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902290|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902291|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13902292|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13902293|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13902294|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902295|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902296|NCT00646542|Vildagliptin|vildagliptin|mesh-list
13902297|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13902298|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902299|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13902300|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
13902301|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902302|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902303|NCT00645177|Paclitaxel|paclitaxel|mesh-list
13902304|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13902305|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902306|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
13902307|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
13902308|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
13902309|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902310|NCT00643383|Acetaminophen|acetaminophen|mesh-list
13902311|NCT00643383|Tramadol|tramadol|mesh-list
13902312|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13902313|NCT00643383|Analgesics|analgesics|mesh-ancestor
13902314|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
13902315|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902316|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902317|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
13902318|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13902319|NCT00643383|Narcotics|narcotics|mesh-ancestor
13902320|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902321|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13902322|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902323|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
13902324|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902325|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902326|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902327|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902328|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
14033114|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
14033115|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033116|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
14033117|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033118|NCT04899791|Protective Agents|protective agents|mesh-ancestor
14033119|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033120|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14169741|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14169742|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
14169743|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169744|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169745|NCT04838665|Protective Agents|protective agents|mesh-ancestor
14169746|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14169747|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13902329|NCT00642148|Hormones|hormones|mesh-ancestor
13959420|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13902330|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902331|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
13902332|NCT00641732|Enoxaparin|enoxaparin|mesh-list
13902333|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
14932718|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932719|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932720|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14932721|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932722|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14932723|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14932724|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14932725|NCT01446523|Lactulose|lactulose|mesh-list
14932726|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14932727|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14932728|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
14932729|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932730|NCT01446679|Atorvastatin|atorvastatin|mesh-list
14932731|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14932732|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14932733|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
14932734|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932735|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14932736|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14932737|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932738|NCT01446731|Docetaxel|docetaxel|mesh-list
13902334|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
13902335|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14932739|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932740|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
14932741|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
14932742|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
14932743|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932744|NCT01446783|Mecasermin|mecasermin|mesh-list
14932745|NCT01446783|Growth Substances|growth substances|mesh-ancestor
14932746|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938619|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938620|NCT01482559|Dopamine|dopamine|mesh-list
14938621|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14938622|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
14938623|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
14938624|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938625|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938626|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
14938627|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938628|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938629|NCT01482559|Protective Agents|protective agents|mesh-ancestor
14938630|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
14938631|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14938632|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
14938633|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938634|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
14938635|NCT01482624|Protective Agents|protective agents|mesh-ancestor
13902336|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13902337|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902338|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13902339|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
13902340|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13902341|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
13902342|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902343|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13902344|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902345|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
13902346|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902347|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902348|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902349|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902350|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13902351|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902352|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13902353|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902354|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959421|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14755671|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755672|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755673|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
14755674|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13902355|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902356|NCT00637130|Travoprost|travoprost|mesh-list
13902357|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13902358|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13902359|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13959422|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
13959423|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959424|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959425|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959426|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
13959427|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
13959428|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959429|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13959430|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13959431|NCT03163381|Apatinib|apatinib|mesh-list
13959432|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959433|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13959434|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959435|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959436|NCT03163576|Niacin|niacin|mesh-list
13959437|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14033121|NCT04891419|Lidocaine|lidocaine|mesh-list
14033122|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
14033123|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
14033124|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033125|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033126|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
14033127|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033128|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14033129|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14033130|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14033131|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14033132|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033133|NCT04887506|Prednisone|prednisone|mesh-list
14033134|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
14033135|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033136|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
14033137|NCT04887506|Hormones|hormones|mesh-ancestor
14033138|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033139|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033140|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033141|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033142|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14033143|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033144|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033145|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
14033146|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14033147|NCT04882293|Atorvastatin|atorvastatin|mesh-list
14033148|NCT04882293|Fenofibrate|fenofibrate|mesh-list
14033149|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14033150|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14033151|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
14033152|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033153|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14169748|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
14755675|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902360|NCT00637052|Filanesib|filanesib|mesh-list
13902361|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
13902362|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
13902363|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902364|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902365|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
14033154|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14033155|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033156|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
14033157|NCT04869137|Lenvatinib|lenvatinib|mesh-list
14033158|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033159|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033160|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033161|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033162|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033163|NCT04863248|Docetaxel|docetaxel|mesh-list
14033164|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033165|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
14033166|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
13902366|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13902367|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13902368|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902369|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
13902370|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
13902371|NCT00635505|Albuterol|albuterol|mesh-list
13902372|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902373|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
13902374|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902375|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902376|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902377|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902378|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
13902379|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13902380|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13902381|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902382|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13902383|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
14033167|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
14033168|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033169|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14033170|NCT04862962|Ezetimibe|ezetimibe|mesh-list
14033171|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14033172|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14033173|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
14033174|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033175|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14033176|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14033177|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033178|NCT04848714|Antivenins|antivenins|mesh-list
14033179|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
14033180|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033181|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
14033182|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14033183|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
14033184|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033185|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
14033186|NCT04839692|Protective Agents|protective agents|mesh-ancestor
14033187|NCT04829422|Lazertinib|lazertinib|mesh-list
14033188|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033189|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033190|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033191|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
14033192|NCT04813016|Tramadol|tramadol|mesh-list
13902384|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902385|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902386|NCT00635193|Doxorubicin|doxorubicin|mesh-list
13902387|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13902388|NCT00635193|Volociximab|volociximab|mesh-list
13902389|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13902390|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13902391|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902392|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13902393|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13902394|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902395|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902396|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13902397|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13902398|NCT00635193|Growth Substances|growth substances|mesh-ancestor
13902399|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033193|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14033194|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033195|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033196|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14033197|NCT04813016|Analgesics|analgesics|mesh-ancestor
14033198|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
14033199|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755676|NCT03940703|Osimertinib|osimertinib|mesh-list
14755677|NCT03940703|Tepotinib|tepotinib|mesh-list
14755678|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033200|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14033201|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14033202|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14033203|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14033204|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033205|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033206|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14033207|NCT04813016|Narcotics|narcotics|mesh-ancestor
14033208|NCT04800822|Cetuximab|cetuximab|mesh-list
14033209|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033210|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033211|NCT04789928|Gentamicins|gentamicins|mesh-list
14033212|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14033213|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033214|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14033215|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033216|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033217|NCT04767594|Palbociclib|palbociclib|mesh-list
14033218|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033219|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033220|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033221|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033222|NCT04762069|Lomustine|lomustine|mesh-list
14033223|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14033224|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
14033225|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033226|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033227|NCT04757636|Aflibercept|aflibercept|mesh-list
14033228|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14033229|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14033230|NCT04757636|Growth Substances|growth substances|mesh-ancestor
14033231|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033232|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
14033233|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033234|NCT04757610|Ranibizumab|ranibizumab|mesh-list
14755679|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13902400|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
13902401|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
14033235|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14033236|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14033237|NCT04757610|Growth Substances|growth substances|mesh-ancestor
14033238|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033239|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
14033240|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033241|NCT04752696|Leucovorin|leucovorin|mesh-list
14033242|NCT04752696|Fluorouracil|fluorouracil|mesh-list
14033243|NCT04752696|Irinotecan|irinotecan|mesh-list
14033244|NCT04752696|Onvansertib|onvansertib|mesh-list
13902402|NCT00634829|Albuterol|albuterol|mesh-list
13902403|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902404|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
13902405|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902406|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033245|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
14033246|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033247|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14033248|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033249|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033250|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
14033251|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033252|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14033253|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14033254|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033255|NCT04752696|Antidotes|antidotes|mesh-ancestor
14033256|NCT04752696|Protective Agents|protective agents|mesh-ancestor
14033257|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
14033258|NCT04752696|Vitamins|vitamins|mesh-ancestor
14033259|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
14033260|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033261|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14033262|NCT04747847|Atorvastatin|atorvastatin|mesh-list
14033263|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14033264|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14033265|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
14033266|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033267|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14033268|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14033269|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033270|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033271|NCT04743804|Ravulizumab|ravulizumab|mesh-list
14033272|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14033273|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033274|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
13902407|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902408|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902409|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
14033275|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033276|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
14033277|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13902410|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13902411|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13902412|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902413|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13902414|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902415|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902416|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902417|NCT00634517|Albuterol|albuterol|mesh-list
13902418|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902419|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
13902420|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033278|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033279|NCT04736173|Paclitaxel|paclitaxel|mesh-list
14033280|NCT04736173|Carboplatin|carboplatin|mesh-list
14033281|NCT04736173|Pemetrexed|pemetrexed|mesh-list
14033282|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14033283|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033284|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
13902421|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902422|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13959438|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
14033285|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
14033286|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
14169749|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
14033287|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033288|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033289|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14033290|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14033291|NCT04730635|Donepezil|donepezil|mesh-list
14033292|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14033293|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033294|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033295|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
13902423|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902424|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
13902425|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13902426|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13902427|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902428|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13902429|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902430|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902431|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902432|NCT00633997|Vildagliptin|vildagliptin|mesh-list
13902433|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13902434|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902435|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13902436|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
13902437|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902438|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755680|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902439|NCT00631111|Aspirin|aspirin|mesh-list
13902440|NCT00631111|Ascorbic Acid|ascorbic acid|mesh-list
13902441|NCT00631111|Ibuprofen|ibuprofen|mesh-list
13902442|NCT00631111|Vitamins|vitamins|mesh-ancestor
14033296|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033297|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033298|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
14755681|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755682|NCT03940196|Paclitaxel|paclitaxel|mesh-list
14755683|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14755684|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14033303|NCT04712071|Ketamine|ketamine|mesh-list
14033304|NCT04712071|Analgesics|analgesics|mesh-ancestor
14033305|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
14033306|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033307|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033308|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14033309|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14033310|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
14033311|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
14033312|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033313|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14033314|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14033315|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902443|NCT00631111|Micronutrients|micronutrients|mesh-ancestor
13902444|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902445|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14033316|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033317|NCT04706741|Prednisone|prednisone|mesh-list
14033318|NCT04706741|Prednisolone|prednisolone|mesh-list
14033319|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033320|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
14033321|NCT04706741|Hormones|hormones|mesh-ancestor
13902446|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13902447|NCT00631111|Analgesics|analgesics|mesh-ancestor
13902448|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
13902449|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902450|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13902451|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13902452|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13902453|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13902454|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033322|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902455|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13902456|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14033323|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033324|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13902457|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902458|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
13902459|NCT00631111|Antioxidants|antioxidants|mesh-ancestor
13902460|NCT00631111|Protective Agents|protective agents|mesh-ancestor
13902461|NCT00630799|Leuprolide|leuprolide|mesh-list
13902462|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13902463|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
13902464|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13902465|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902466|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13902467|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902468|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
13902469|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902470|NCT00630552|Conatumumab|conatumumab|mesh-list
13902471|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13902472|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902473|NCT00630201|Buprenorphine|buprenorphine|mesh-list
13902474|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13902475|NCT00630201|Narcotics|narcotics|mesh-ancestor
13902476|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902477|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902478|NCT00630201|Analgesics|analgesics|mesh-ancestor
13902479|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
13902480|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902481|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13902482|NCT00629980|Azithromycin|azithromycin|mesh-list
14033325|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169750|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
14169751|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14169752|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
14169753|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14169754|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
14169755|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169756|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169757|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
14169758|NCT04838860|Siltuximab|siltuximab|mesh-list
14169759|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169760|NCT04838288|Tacrolimus|tacrolimus|mesh-list
14169761|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14169762|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
14169763|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169764|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13902483|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902484|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902485|NCT00629941|Azithromycin|azithromycin|mesh-list
13902486|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902487|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169765|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169766|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182938|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182939|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14182940|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
14182941|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
14182942|NCT04731740|Lenvatinib|lenvatinib|mesh-list
14182943|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182944|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182945|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182946|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182947|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182948|NCT04731948|Vitamins|vitamins|mesh-list
14182949|NCT04731948|Folic Acid|folic acid|mesh-list
14182950|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
14182951|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
14182952|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
14182953|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
14182954|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182955|NCT04731948|Hematinics|hematinics|mesh-ancestor
14182956|NCT04731909|Cisplatin|cisplatin|mesh-list
14182957|NCT04731909|Carboplatin|carboplatin|mesh-list
14755685|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755686|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
14755687|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
14755688|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755689|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902488|NCT00629590|Azithromycin|azithromycin|mesh-list
13902489|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902490|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182958|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182959|NCT04731766|Listerine|listerine|mesh-list
13902491|NCT00629551|Paroxetine|paroxetine|mesh-list
13902492|NCT00629551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13902493|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902494|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902495|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902496|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902497|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
13902498|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902499|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13902500|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902501|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14033326|NCT04705844|Adalimumab|adalimumab|mesh-list
14033327|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033328|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033329|NCT04704505|Androgens|androgens|mesh-list
14033330|NCT04704505|Hormones|hormones|mesh-ancestor
14033331|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033332|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033333|NCT04704024|Tenofovir|tenofovir|mesh-list
14033334|NCT04704024|Lamivudine|lamivudine|mesh-list
14033335|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
14033336|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033337|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14033338|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14033339|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033340|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033341|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14033342|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14033343|NCT04688814|Morphine|morphine|mesh-list
14033344|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14033345|NCT04688814|Narcotics|narcotics|mesh-ancestor
14033346|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033347|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033348|NCT04688814|Analgesics|analgesics|mesh-ancestor
14033349|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
14033350|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033351|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
14033352|NCT04678336|Fludarabine|fludarabine|mesh-list
14033353|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033354|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
14033355|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033356|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033357|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14033358|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
14033359|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033360|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902502|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13902503|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13902504|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902505|NCT00626704|Doxorubicin|doxorubicin|mesh-list
13902506|NCT00626704|Conatumumab|conatumumab|mesh-list
13902507|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13902508|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033361|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14033362|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
14033363|NCT04674813|Fludarabine|fludarabine|mesh-list
14033364|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033365|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
14033366|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033367|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033368|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14033369|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
14033370|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033371|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033372|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14033373|NCT04663555|Dexamethasone|dexamethasone|mesh-list
14033374|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033375|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
14033376|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
13902509|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13902510|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13902511|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902512|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902513|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13902514|NCT00626106|Fulvestrant|fulvestrant|mesh-list
13902515|NCT00626106|Exemestane|exemestane|mesh-list
13902516|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13902517|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13902518|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902519|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13902520|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13902521|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
13902522|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902523|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902524|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13902525|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13902526|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902527|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902528|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
14033377|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033378|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033379|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14033380|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
14033381|NCT04663555|Hormones|hormones|mesh-ancestor
14033382|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033383|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033384|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033385|NCT04656652|Docetaxel|docetaxel|mesh-list
14033386|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033387|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
14033388|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
14033389|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
14033390|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033391|NCT04649489|Bevacizumab|bevacizumab|mesh-list
14033392|NCT04649489|Atezolizumab|atezolizumab|mesh-list
14033393|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14033394|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033395|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033396|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14033397|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14033398|NCT04649489|Growth Substances|growth substances|mesh-ancestor
14033399|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033400|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
14033401|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
14033402|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
14033403|NCT04645719|Analgesics|analgesics|mesh-ancestor
14033404|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
14033405|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033406|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033407|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
14033408|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033409|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14033410|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
14033411|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14033412|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14033413|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902529|NCT00625833|Reboxetine|reboxetine|mesh-list
13902530|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902531|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902532|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13902533|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902534|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902535|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902536|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902537|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033414|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14033415|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
13902538|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902539|NCT00625664|Gemcitabine|gemcitabine|mesh-list
13902540|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902541|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13902542|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
13902543|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902544|NCT00625664|Antiviral Agents|antiviral agents|mesh-ancestor
14033416|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14033417|NCT04641273|Pregabalin|pregabalin|mesh-list
14033418|NCT04641273|Analgesics|analgesics|mesh-ancestor
14033419|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
14033420|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033421|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033422|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
14033423|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14033424|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14033425|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033426|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14033427|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14033428|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14033429|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033430|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14033431|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
14033432|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033433|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033434|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14033435|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033436|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
14033437|NCT04579523|Fludarabine|fludarabine|mesh-list
14033438|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
14033439|NCT04579523|Daratumumab|daratumumab|mesh-list
14033440|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14033441|NCT04579523|Antibodies|antibodies|mesh-list
14033442|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
14033443|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14033444|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033445|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
14033446|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033447|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033448|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14033449|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
14033450|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033451|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033452|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14033453|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14033454|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
14033455|NCT04570644|Ibuprofen|ibuprofen|mesh-list
14033456|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
14033457|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14033458|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14033459|NCT04570644|Analgesics|analgesics|mesh-ancestor
14033460|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
14033461|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033462|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033463|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033464|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033465|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14033466|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033467|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033468|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14033469|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
14033470|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14033471|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902545|NCT00625664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902546|NCT00625664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033472|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14033473|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14033474|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
14033475|NCT04570085|Caffeine|caffeine|mesh-list
14033476|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14033477|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033478|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13902547|NCT00625664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13902548|NCT00625664|Immunologic Factors|immunologic factors|mesh-ancestor
13902549|NCT00625664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902550|NCT00625651|Bevacizumab|bevacizumab|mesh-list
13902551|NCT00625651|Conatumumab|conatumumab|mesh-list
13902552|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033479|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033480|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033481|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14033482|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14033483|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
14033484|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033485|NCT04565236|Factor VIII|factor viii|mesh-list
14033486|NCT04565236|Coagulants|coagulants|mesh-ancestor
14033487|NCT04558216|Rifampin|rifampin|mesh-list
14033488|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14033489|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
14033490|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14033491|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033492|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
14033493|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14033494|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033495|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033496|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14033497|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14033498|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14033499|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14033500|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14033501|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14033502|NCT04546113|Ropivacaine|ropivacaine|mesh-list
14033503|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
14033504|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
14033505|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033506|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033507|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
14033508|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033509|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
14033510|NCT04539262|Remdesivir|remdesivir|mesh-list
14033511|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
14033512|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033513|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
14033514|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033515|NCT04528329|Dexamethasone|dexamethasone|mesh-list
14033516|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
14033517|NCT04528329|BB 1101|bb 1101|mesh-list
14033518|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033519|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
14033520|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
14033521|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033522|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033523|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14033524|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
14033525|NCT04528329|Hormones|hormones|mesh-ancestor
14033526|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033527|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033528|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033529|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
14033530|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033531|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033532|NCT04527757|Anesthetics|anesthetics|mesh-list
14169767|NCT04838301|Pregnanolone|pregnanolone|mesh-list
14479106|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902553|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902554|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13902555|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13902556|NCT00625651|Growth Substances|growth substances|mesh-ancestor
14033533|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033534|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033535|NCT04519164|Eplerenone|eplerenone|mesh-list
14033536|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
14033537|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14033538|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
14033539|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033540|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033541|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14033542|NCT04519164|Diuretics|diuretics|mesh-ancestor
14033543|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
14033544|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14033545|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14033546|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14033547|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033548|NCT04517747|Ramucirumab|ramucirumab|mesh-list
14033549|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033550|NCT04511039|Trifluridine|trifluridine|mesh-list
14033551|NCT04511039|Talazoparib|talazoparib|mesh-list
14033552|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14033553|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033554|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902557|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902558|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
13902559|NCT00625326|Calcipotriene|calcipotriene|mesh-list
13902560|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
13902561|NCT00624858|Naltrexone|naltrexone|mesh-list
13902562|NCT00624858|Bupropion|bupropion|mesh-list
13902563|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13902564|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13902565|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902566|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
13902567|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902568|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13902569|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902570|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902571|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13902572|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902573|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902574|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902575|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
13902576|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902577|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13902578|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13902579|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902580|NCT00624351|Epratuzumab|epratuzumab|mesh-list
13902581|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13902582|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902583|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
13902584|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033555|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033556|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
14033557|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
14033558|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033559|NCT04502602|Niraparib|niraparib|mesh-list
14033560|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14755690|NCT03933202|Cladribine|cladribine|mesh-list
14755691|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755692|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13902585|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14755693|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
14755694|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755695|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
14755696|NCT03927378|Ketamine|ketamine|mesh-list
14755697|NCT03927378|Esketamine|esketamine|mesh-list
14755698|NCT03927378|Analgesics|analgesics|mesh-ancestor
14755699|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
14755700|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755701|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755702|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14755703|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14755704|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
14755705|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
14755706|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902586|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13902587|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902588|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902589|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
13902590|NCT00620256|Timolol|timolol|mesh-list
13902591|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13902592|NCT00620256|Latanoprost|latanoprost|mesh-list
13902593|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13902594|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13902595|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13902596|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902597|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902598|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902599|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902600|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13902601|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13902602|NCT00618098|Thrombin|thrombin|mesh-list
13902603|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
14033561|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033562|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033563|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471631|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14471632|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
14471633|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
14471634|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471635|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471636|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471637|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
14033564|NCT04495868|Lidocaine|lidocaine|mesh-list
14033565|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
14033566|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
14033567|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033568|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033569|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
14033570|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033571|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14033572|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14033573|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14033574|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14033575|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169768|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
14169769|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169770|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169771|NCT04838145|Ribavirin|ribavirin|mesh-list
14169772|NCT04838145|Pleconaril|pleconaril|mesh-list
14755707|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14755708|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14755709|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755710|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755711|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
14755712|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14755713|NCT03925402|Ertapenem|ertapenem|mesh-list
14755714|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902604|NCT00618098|Coagulants|coagulants|mesh-ancestor
14471638|NCT02334813|Hormones|hormones|mesh-ancestor
14033576|NCT04477512|Prednisone|prednisone|mesh-list
14033577|NCT04477512|Nivolumab|nivolumab|mesh-list
14033578|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
14033579|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033580|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
14033581|NCT04477512|Hormones|hormones|mesh-ancestor
14033582|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033583|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033584|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033585|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902605|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13902606|NCT00616811|Vildagliptin|vildagliptin|mesh-list
13902607|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14033586|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033587|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14033588|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033589|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14033590|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755715|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755716|NCT03896503|Topotecan|topotecan|mesh-list
13902608|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033591|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
14033592|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14033593|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
14033594|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033595|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033596|NCT04470674|Carboplatin|carboplatin|mesh-list
14033597|NCT04470674|Pemetrexed|pemetrexed|mesh-list
14033598|NCT04470674|Durvalumab|durvalumab|mesh-list
14033599|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033600|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033601|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033602|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14033603|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14033604|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033605|NCT04458259|Axitinib|axitinib|mesh-list
14033606|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033607|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033608|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033609|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033610|NCT04457466|Mitogens|mitogens|mesh-list
14033611|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
14033612|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033613|NCT04457245|Fluorides|fluorides|mesh-list
14033614|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
14033615|NCT04457245|Protective Agents|protective agents|mesh-ancestor
13902609|NCT00616811|Incretins|incretins|mesh-ancestor
13902610|NCT00616811|Hormones|hormones|mesh-ancestor
13902611|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902612|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13902613|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
13902614|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033616|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033617|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
14033618|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
14033619|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
14033620|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033621|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033622|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
14033623|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033624|NCT04411654|Sirolimus|sirolimus|mesh-list
14033625|NCT04411654|Prednisone|prednisone|mesh-list
14033626|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
14033627|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14033628|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14755717|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14033629|NCT04411654|Prednisolone|prednisolone|mesh-list
14033630|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
14033631|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14755718|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755719|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755720|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755721|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755722|NCT03896477|Vaccines|vaccines|mesh-list
14755723|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14755724|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
14755725|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755726|NCT03893175|Acetaminophen|acetaminophen|mesh-list
13902615|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902616|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
13902617|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13902618|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902619|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902620|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902621|NCT00616330|Clindamycin|clindamycin|mesh-list
13902622|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
13902623|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
13902624|NCT00616330|Butoconazole|butoconazole|mesh-list
13902625|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902626|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902627|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13902628|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902629|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902630|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
13902631|NCT00616148|Cenobamate|cenobamate|mesh-list
13902632|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
13902633|NCT00615251|Progesterone|progesterone|mesh-list
13902634|NCT00615251|Progestins|progestins|mesh-ancestor
13902635|NCT00615251|Hormones|hormones|mesh-ancestor
13902636|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902637|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902638|NCT00614601|Vaccines|vaccines|mesh-list
13902639|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
13902640|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902641|NCT00613002|Testosterone|testosterone|mesh-list
13902642|NCT00613002|Androgens|androgens|mesh-ancestor
13902643|NCT00613002|Hormones|hormones|mesh-ancestor
13902644|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902645|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902646|NCT00612820|Fluticasone|fluticasone|mesh-list
13902647|NCT00612820|Xhance|xhance|mesh-list
13902648|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
13902649|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13902650|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902651|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
13902652|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902653|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902654|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902655|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902656|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
13902657|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13902658|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13902659|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13902660|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902661|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902662|NCT00612742|Testosterone|testosterone|mesh-list
13902663|NCT00612742|Androgens|androgens|mesh-ancestor
14033632|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
14033633|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13902664|NCT00612742|Hormones|hormones|mesh-ancestor
13902665|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902666|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902667|NCT00612170|Reboxetine|reboxetine|mesh-list
13902668|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902669|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902670|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13902671|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902672|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14033634|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
14033635|NCT04411654|Hormones|hormones|mesh-ancestor
14033636|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033637|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033638|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033639|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033640|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14033641|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033642|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14033643|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
14033644|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033645|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
14755727|NCT03893175|Ibuprofen|ibuprofen|mesh-list
14755728|NCT03893175|Oxycodone|oxycodone|mesh-list
14755729|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14755730|NCT03893175|Analgesics|analgesics|mesh-ancestor
13902673|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033646|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
14033647|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
14033648|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033649|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14033650|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14033651|NCT04411654|Protective Agents|protective agents|mesh-ancestor
14033652|NCT04408625|Sirolimus|sirolimus|mesh-list
13902674|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902675|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902676|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902677|NCT00612118|Azelastine|azelastine|mesh-list
13902678|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
13902679|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13902680|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
13902681|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902682|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902683|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902684|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
13902685|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
13902686|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902687|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902688|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13902689|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14033653|NCT04408625|Prednisone|prednisone|mesh-list
14033654|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
14033655|NCT04408625|Rituximab|rituximab|mesh-list
14033656|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033657|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033658|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
14033659|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033660|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755731|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
14755732|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902690|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13902691|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
13902692|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
14033661|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033662|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
14033663|NCT04408625|Hormones|hormones|mesh-ancestor
14033664|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033665|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033666|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14033667|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033668|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14033669|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
14033670|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033671|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
14033672|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
14033673|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033674|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14033675|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14033676|NCT04408625|Protective Agents|protective agents|mesh-ancestor
14033677|NCT04403165|Norepinephrine|norepinephrine|mesh-list
14033678|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14033679|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14033680|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
14033681|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033682|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033683|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033684|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
14033685|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
14033686|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033687|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14033688|NCT04393311|Urinastatin|urinastatin|mesh-list
14033689|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14033690|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14033691|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
14033692|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033693|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033694|NCT04385303|Lorecivivint|lorecivivint|mesh-list
14033695|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033696|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
14033697|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033698|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033699|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033700|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033701|NCT04360044|Dronabinol|dronabinol|mesh-list
13902693|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902694|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13902695|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13902696|NCT00609323|Lidocaine|lidocaine|mesh-list
13902697|NCT00609323|Tetracaine|tetracaine|mesh-list
13902698|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
13902699|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
13902700|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902701|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902702|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
13902703|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902704|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13902705|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13902706|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13902707|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902708|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902709|NCT00607256|Reboxetine|reboxetine|mesh-list
13902710|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902711|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902712|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13902713|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902714|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902715|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902716|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
13902717|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902718|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902719|NCT00606697|Vofopitant|vofopitant|mesh-list
13902720|NCT00606697|Vestipitant|vestipitant|mesh-list
14033702|NCT04360044|Cannabidiol|cannabidiol|mesh-list
13902721|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14033703|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
14033704|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
13902722|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902723|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902724|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902725|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
13902726|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
13902727|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902728|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13902729|NCT00603616|Rifaximin|rifaximin|mesh-list
14033705|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033706|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14033707|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13902730|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902731|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902732|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14033708|NCT04360044|Analgesics|analgesics|mesh-ancestor
14033709|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
14471639|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471640|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14471641|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033710|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033711|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14471642|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
14471643|NCT02335294|Morphine|morphine|mesh-list
14471644|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14471645|NCT02335294|Narcotics|narcotics|mesh-ancestor
14471646|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471647|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471648|NCT02335294|Analgesics|analgesics|mesh-ancestor
13902733|NCT00603577|Xaliproden|xaliproden|mesh-list
13902734|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13902735|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13902736|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
13902737|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902738|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902739|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033712|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14033713|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033714|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033715|NCT04360044|Hormones|hormones|mesh-ancestor
14033716|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033717|NCT04356339|Interferons|interferons|mesh-list
14033718|NCT04356339|Interferon-beta|interferon-beta|mesh-list
14033719|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
14033720|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033721|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
14033722|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033723|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
14033724|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033725|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14033726|NCT04353414|Bupivacaine|bupivacaine|mesh-list
14033727|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
14033728|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
14033729|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471649|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
14471650|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902740|NCT00602745|Fluorouracil|fluorouracil|mesh-list
13902741|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
13902742|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902743|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13902744|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902745|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13902746|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
13902747|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033730|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471651|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14033731|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
14033732|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033733|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
14033734|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033735|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033736|NCT04331717|Leuprolide|leuprolide|mesh-list
14033737|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14033738|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
14033739|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14033740|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033741|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033742|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033743|NCT04331145|Ticagrelor|ticagrelor|mesh-list
14033744|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14033745|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14033746|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14033747|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14033748|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
14033749|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033750|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033751|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033752|NCT04325802|Naltrexone|naltrexone|mesh-list
14033753|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14033754|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14033755|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033756|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
14033757|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033758|NCT04318704|Ifenprodil|ifenprodil|mesh-list
14033759|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14033760|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14033761|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
14033762|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033763|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033764|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033765|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
14033766|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14033767|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14033768|NCT04313088|Eluxadoline|eluxadoline|mesh-list
14033769|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14033770|NCT04302896|Tenofovir|tenofovir|mesh-list
14033771|NCT04302896|Lamivudine|lamivudine|mesh-list
14033772|NCT04302896|Emtricitabine|emtricitabine|mesh-list
14033773|NCT04302896|Dolutegravir|dolutegravir|mesh-list
14033774|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14033775|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
14033776|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033777|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14033778|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14033779|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033780|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033781|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14033782|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14033783|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14033784|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14033785|NCT04298099|Ropivacaine|ropivacaine|mesh-list
14033786|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
14033787|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
14033788|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033789|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033790|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
14033791|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932747|NCT01446900|Rituximab|rituximab|mesh-list
14033792|NCT04291820|Anesthetics|anesthetics|mesh-list
14932748|NCT01446900|Cladribine|cladribine|mesh-list
14938636|NCT01482728|Dasatinib|dasatinib|mesh-list
14033793|NCT04291820|Sevoflurane|sevoflurane|mesh-list
14033794|NCT04291820|Desflurane|desflurane|mesh-list
14033795|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033796|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033797|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14033798|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14033799|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
14033800|NCT04278781|Ivosidenib|ivosidenib|mesh-list
14033801|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033802|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033803|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033804|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
14033805|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
14033806|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14033807|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14033808|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033809|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033810|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033811|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169773|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
14169774|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169775|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
14169776|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169777|NCT04838132|Ropivacaine|ropivacaine|mesh-list
14169778|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
14169779|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
14169780|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169781|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169782|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
14169783|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169784|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14169785|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14169786|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169787|NCT04837924|Acetaminophen|acetaminophen|mesh-list
14169788|NCT04837924|Tramadol|tramadol|mesh-list
14169789|NCT04837924|Analgesics|analgesics|mesh-list
14169790|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
14169791|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14471652|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14471653|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14471654|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471655|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471656|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471657|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471658|NCT02335346|Analgesics|analgesics|mesh-ancestor
14471659|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
14471660|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471661|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
14471662|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14471663|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
14169792|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
14471664|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14471665|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14471666|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471667|NCT02335983|Dexamethasone|dexamethasone|mesh-list
14169793|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169794|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169795|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
14169796|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14169797|NCT04837924|Narcotics|narcotics|mesh-ancestor
14169798|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169799|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
14471668|NCT02335983|Lenalidomide|lenalidomide|mesh-list
14169800|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
14471669|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033812|NCT04259658|Calcium|calcium|mesh-list
14033813|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14033814|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033815|NCT04256824|Triclosan|triclosan|mesh-list
14033816|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14033817|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033818|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14033819|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14033820|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
14033821|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033822|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14033823|NCT04251065|Daratumumab|daratumumab|mesh-list
14033824|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033825|NCT04246541|Acetaminophen|acetaminophen|mesh-list
14033826|NCT04246541|Ketorolac|ketorolac|mesh-list
14033827|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14033828|NCT04246541|Oxycodone|oxycodone|mesh-list
14033829|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14033830|NCT04246541|Analgesics|analgesics|mesh-ancestor
14033831|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
14033832|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033833|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033834|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
14033835|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14033836|NCT04246541|Narcotics|narcotics|mesh-ancestor
14033837|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033838|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14033839|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14033840|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033841|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14033842|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033843|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033844|NCT04242238|Avelumab|avelumab|mesh-list
14033845|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033846|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033852|NCT04231539|Nicotine|nicotine|mesh-list
14033853|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14033854|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
14033855|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033856|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033857|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14033858|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14033859|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
14033860|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033861|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033862|NCT04230681|Fentanyl|fentanyl|mesh-list
14033863|NCT04230681|Hydromorphone|hydromorphone|mesh-list
14033864|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14033865|NCT04230681|Narcotics|narcotics|mesh-ancestor
14033866|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033867|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033868|NCT04230681|Analgesics|analgesics|mesh-ancestor
14033869|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
14033870|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033871|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14033872|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14033873|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
14033874|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
13902775|NCT00602602|Gemcitabine|gemcitabine|mesh-list
13902776|NCT00602602|Bevacizumab|bevacizumab|mesh-list
13902777|NCT00602602|Fluorouracil|fluorouracil|mesh-list
13902778|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
14033875|NCT04225767|Calcium|calcium|mesh-list
14033876|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14033877|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902779|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14033878|NCT04214288|Fulvestrant|fulvestrant|mesh-list
14033879|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14033880|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033881|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14033882|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14033883|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
14033884|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033885|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033886|NCT04191382|Letrozole|letrozole|mesh-list
14033887|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033888|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14033889|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14033890|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033891|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033892|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13902780|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902781|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13902782|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13902783|NCT00602602|Growth Substances|growth substances|mesh-ancestor
13902784|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033893|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
14033894|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14033895|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033896|NCT04188392|Pimavanserin|pimavanserin|mesh-list
14033897|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14033898|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14033899|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14033900|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14033901|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033902|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033903|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14033904|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14033905|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14033906|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
13902785|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
13902786|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13902787|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
13902788|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902789|NCT00602602|Antiviral Agents|antiviral agents|mesh-ancestor
14033907|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033908|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033909|NCT04184609|Bromides|bromides|mesh-list
14033910|NCT04184609|Albuterol|albuterol|mesh-list
14033911|NCT04184609|Ipratropium|ipratropium|mesh-list
14033912|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
14033913|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14033914|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
13902790|NCT00602602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902791|NCT00602602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902792|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13902793|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
13902794|NCT00602576|Temozolomide|temozolomide|mesh-list
13902795|NCT00602576|Sorafenib|sorafenib|mesh-list
13902796|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13902797|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
13902798|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902799|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902800|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033915|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033916|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033917|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13902801|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902802|NCT00602329|Leucovorin|leucovorin|mesh-list
13902803|NCT00602329|Bevacizumab|bevacizumab|mesh-list
13902804|NCT00602329|Fluorouracil|fluorouracil|mesh-list
13902805|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
14033918|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
14033919|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
14033920|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14033921|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14033922|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13902806|NCT00602329|Calcium|calcium|mesh-list
13902807|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
13902808|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13902809|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902810|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13902811|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13902812|NCT00602329|Growth Substances|growth substances|mesh-ancestor
13902813|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902814|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
13902815|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13902816|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
13902817|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902818|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13902819|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13902820|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
13902821|NCT00602329|Antidotes|antidotes|mesh-ancestor
13902822|NCT00602329|Protective Agents|protective agents|mesh-ancestor
13902823|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
13902824|NCT00602329|Vitamins|vitamins|mesh-ancestor
13902825|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
13902826|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13902827|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13902828|NCT00598312|Leuprolide|leuprolide|mesh-list
13902829|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13902830|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
13902831|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13902832|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902833|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13902834|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902835|NCT00595699|Citalopram|citalopram|mesh-list
13902836|NCT00595699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13902837|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902838|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902839|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902840|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902841|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
13902842|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902843|NCT00595699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13902844|NCT00595699|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902845|NCT00595699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902846|NCT00595426|Warfarin|warfarin|mesh-list
13902847|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
13902848|NCT00594984|Irinotecan|irinotecan|mesh-list
13902849|NCT00594984|Cetuximab|cetuximab|mesh-list
13902850|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13902851|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13902852|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902853|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902854|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902855|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13902856|NCT00589875|Valacyclovir|valacyclovir|mesh-list
13902857|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
13902858|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902859|NCT00589823|Fentanyl|fentanyl|mesh-list
13902860|NCT00589823|Morphine|morphine|mesh-list
13902861|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13902862|NCT00589823|Narcotics|narcotics|mesh-ancestor
13902863|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902864|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902865|NCT00589823|Analgesics|analgesics|mesh-ancestor
13902866|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
13902867|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902868|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13902869|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13902870|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
13902871|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
13902872|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14033923|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14033924|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14033925|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033926|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033927|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14033928|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
13902873|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13902874|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13902875|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14033929|NCT04181996|Colchicine|colchicine|mesh-list
14033930|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
13902876|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033931|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14033932|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
14033933|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
14033934|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
14033935|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033936|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033937|NCT04180943|Bupivacaine|bupivacaine|mesh-list
14033938|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
14033939|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
14033940|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033941|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033942|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
14033943|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033944|NCT04175626|Sirolimus|sirolimus|mesh-list
14033945|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755733|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755734|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
13902877|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902878|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902879|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13902880|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902881|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902882|NCT00583830|Paclitaxel|paclitaxel|mesh-list
13902883|NCT00583830|Carboplatin|carboplatin|mesh-list
13902884|NCT00583830|Mapatumumab|mapatumumab|mesh-list
13902885|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13902886|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14755735|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14755736|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755737|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755738|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14755739|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755740|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755741|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14755742|NCT03893175|Narcotics|narcotics|mesh-ancestor
14033946|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14033947|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14033948|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033949|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
14033950|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14033951|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
14033952|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033953|NCT04170946|Talazoparib|talazoparib|mesh-list
14033954|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14033955|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033956|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033957|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033963|NCT04146571|Ensartinib|ensartinib|mesh-list
14033964|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14033965|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14033966|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14033967|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033968|NCT04126473|Ivacaftor|ivacaftor|mesh-list
14033969|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14033970|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13902887|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902888|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
13902889|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
13902890|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
14033971|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033972|NCT04120870|Ketamine|ketamine|mesh-list
13902891|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902892|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
13902893|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902894|NCT00583674|Cisplatin|cisplatin|mesh-list
13902895|NCT00583674|Capecitabine|capecitabine|mesh-list
13902896|NCT00583674|Trebananib|trebananib|mesh-list
13902897|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902898|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13902899|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
14033973|NCT04120870|Etomidate|etomidate|mesh-list
14033974|NCT04120870|Analgesics|analgesics|mesh-ancestor
14033975|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
14033976|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14033977|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033978|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14033979|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14033980|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
14033981|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
14033982|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14033983|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14033984|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14033985|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033986|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033987|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14033988|NCT04116112|Hydralazine|hydralazine|mesh-list
14033989|NCT04116112|Labetalol|labetalol|mesh-list
14033990|NCT04116112|Nicardipine|nicardipine|mesh-list
14033991|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14033992|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
13902900|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902901|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13902902|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13902903|NCT00583674|Growth Substances|growth substances|mesh-ancestor
13902904|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902905|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
13902906|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
13902907|NCT00583609|Laxatives|laxatives|mesh-ancestor
13902908|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959439|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959440|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13959441|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
13959442|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
13959443|NCT03163576|Vitamins|vitamins|mesh-ancestor
13959444|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
13959445|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959446|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
13959447|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
13959448|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959449|NCT03163173|Protective Agents|protective agents|mesh-ancestor
13959450|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959451|NCT03163212|Lactoferrin|lactoferrin|mesh-list
14033993|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14033994|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14033995|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
14033996|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14033997|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14033998|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14033999|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
14034000|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
14034001|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034002|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14034003|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14034004|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14034005|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034006|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14034007|NCT04083950|Aspirin|aspirin|mesh-list
14034008|NCT04083950|Vaccines|vaccines|mesh-list
14034009|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
14034010|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034011|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14034012|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14034013|NCT04083950|Analgesics|analgesics|mesh-ancestor
13902909|NCT00581477|Droxidopa|droxidopa|mesh-list
13902910|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13902911|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13902912|NCT00580216|Biotin|biotin|mesh-list
13902913|NCT00580216|Warfarin|warfarin|mesh-list
13902914|NCT00580216|Idraparinux|idraparinux|mesh-list
13902915|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
13902916|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
13902917|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13902918|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
13902919|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13902920|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
13902921|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902922|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902923|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
13902924|NCT00580216|Vitamins|vitamins|mesh-ancestor
13902925|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
14755743|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034014|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
14034015|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034016|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034017|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034018|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14034019|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14034020|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034021|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14034022|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14034023|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034024|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
14034025|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
14034026|NCT04083183|Sirolimus|sirolimus|mesh-list
14034027|NCT04083183|Vidarabine|vidarabine|mesh-list
14755744|NCT03875235|Durvalumab|durvalumab|mesh-list
14755745|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755746|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902926|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902927|NCT00580125|Aripiprazole|aripiprazole|mesh-list
13902928|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
13902929|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13902930|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13902931|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13902932|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13902933|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902934|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
13902935|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
13902936|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13902937|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902938|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13902939|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13902940|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
13902941|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13902942|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13902943|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13902944|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13902945|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
14034028|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
14034029|NCT04083183|Fludarabine|fludarabine|mesh-list
14034030|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
14034031|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14034032|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
14034033|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14034034|NCT04083183|Antibodies|antibodies|mesh-list
14034035|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
14034036|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14034037|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
14034038|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14034039|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14034040|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034041|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
14034042|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034043|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034044|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14034045|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
13902946|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13902947|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902948|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902949|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14169801|NCT04838080|Vaccines|vaccines|mesh-list
13902950|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13902951|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13902952|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902953|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902954|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
13902955|NCT00579020|Dexamethasone|dexamethasone|mesh-list
14932749|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14932750|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932751|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
14932752|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932753|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932754|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14932755|NCT01446926|Vaccines|vaccines|mesh-list
14932756|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13902956|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
13902957|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13902958|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13902959|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13902960|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13902961|NCT00579020|BB 1101|bb 1101|mesh-list
13902962|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13902963|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
13902964|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
14034046|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034047|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034048|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14034049|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14034050|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
14034051|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14034052|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14034053|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
14034054|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034055|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034056|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034057|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
14034058|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
14034059|NCT04079881|Insulin|insulin|mesh-list
14034060|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14034061|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14034062|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034063|NCT04075526|Vancomycin|vancomycin|mesh-list
14034064|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
14034065|NCT04075526|Povidone|povidone|mesh-list
14034066|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902965|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902966|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902967|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13902968|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
13902969|NCT00579020|Hormones|hormones|mesh-ancestor
13902970|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902971|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13902972|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902973|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
13902974|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932757|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
14932758|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932759|NCT01446952|Vitamin E|vitamin e|mesh-list
14932760|NCT01446952|Tocopherols|tocopherols|mesh-list
14034067|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034068|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
14034069|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
14034070|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14034071|NCT04073615|Trifluridine|trifluridine|mesh-list
14034072|NCT04073615|Apatinib|apatinib|mesh-list
14034073|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034074|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14034075|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034076|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034077|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
14034078|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
14932761|NCT01446952|Tocotrienols|tocotrienols|mesh-list
14932762|NCT01446952|Vitamins|vitamins|mesh-ancestor
14932763|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
14034079|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034080|NCT04071119|Oxytocin|oxytocin|mesh-list
14932764|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034081|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
14932765|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
14034082|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14034083|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034084|NCT04050280|Cytarabine|cytarabine|mesh-list
14034085|NCT04050280|Cladribine|cladribine|mesh-list
14034086|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
14034087|NCT04050280|Sargramostim|sargramostim|mesh-list
14034088|NCT04050280|Lenograstim|lenograstim|mesh-list
14034089|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14034090|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
14034091|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034092|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034093|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
14034094|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034095|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034096|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
14034097|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034098|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14034099|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14034100|NCT04032067|Finasteride|finasteride|mesh-list
14034101|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14034102|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14034103|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034104|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034105|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
14034106|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034107|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034108|NCT04032067|Urological Agents|urological agents|mesh-ancestor
14034109|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
14034110|NCT04005599|Remifentanil|remifentanil|mesh-list
14034111|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14034112|NCT04005599|Narcotics|narcotics|mesh-ancestor
14938637|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13902975|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13902976|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13902977|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13902978|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13902979|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13902980|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13902981|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
13902982|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13902983|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13902984|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13902985|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13902986|NCT00578955|Azithromycin|azithromycin|mesh-list
13902987|NCT00578955|Dexamethasone|dexamethasone|mesh-list
14034113|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034114|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034115|NCT04005599|Analgesics|analgesics|mesh-ancestor
14034116|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
14034117|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034118|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
13902988|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
13902989|NCT00578955|BB 1101|bb 1101|mesh-list
13902990|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13902991|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
13902992|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
13902993|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13902994|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13902995|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13902996|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
13902997|NCT00578955|Hormones|hormones|mesh-ancestor
13902998|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13902999|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13903000|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903001|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
13903002|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903003|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903004|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13903005|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903006|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
13903007|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13903008|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13903009|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903010|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14034119|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14034120|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
14034121|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14034122|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034123|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034124|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14034125|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
14034126|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14034127|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14034128|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14034129|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034130|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034131|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14034132|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034133|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034134|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
14034135|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034136|NCT03988257|Ascorbic Acid|ascorbic acid|mesh-list
14034137|NCT03988257|Vitamins|vitamins|mesh-ancestor
14034138|NCT03988257|Micronutrients|micronutrients|mesh-ancestor
14034139|NCT03988257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034140|NCT03988257|Antioxidants|antioxidants|mesh-ancestor
14034141|NCT03988257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034142|NCT03988257|Protective Agents|protective agents|mesh-ancestor
14034143|NCT03978598|Etonogestrel|etonogestrel|mesh-list
14034144|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14034145|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
14034146|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14034147|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034148|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14169802|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
14169803|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169804|NCT04837664|Nystatin|nystatin|mesh-list
13903011|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13903012|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903013|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903014|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903015|NCT00578474|Ofloxacin|ofloxacin|mesh-list
13903016|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13903017|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13903018|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903019|NCT00578474|Renal Agents|renal agents|mesh-ancestor
14169805|NCT04837664|Curcumin|curcumin|mesh-list
14169806|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14169807|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14169808|NCT04837664|Analgesics|analgesics|mesh-ancestor
14169809|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
14169810|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169811|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169812|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169813|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169814|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169815|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169816|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169817|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14169818|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169819|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
14169820|NCT04837664|Ionophores|ionophores|mesh-ancestor
14169821|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169822|NCT04837651|Antibodies|antibodies|mesh-list
14169823|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
14169824|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903020|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13903021|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13903022|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14034149|NCT03950674|Folic Acid|folic acid|mesh-list
14034150|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
14034151|NCT03950674|Hydroxocobalamin|hydroxocobalamin|mesh-list
14034152|NCT03950674|Dexamethasone|dexamethasone|mesh-list
14034153|NCT03950674|Carboplatin|carboplatin|mesh-list
14034154|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
14034155|NCT03950674|Pemetrexed|pemetrexed|mesh-list
14034156|NCT03950674|Vitamins|vitamins|mesh-ancestor
14034157|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
14034158|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903023|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903024|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903025|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903026|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13903027|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13903028|NCT00577148|Rimonabant|rimonabant|mesh-list
13903029|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13903030|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13903031|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13903032|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903033|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903034|NCT00577148|Hormones|hormones|mesh-ancestor
13903035|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903036|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903037|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
13903038|NCT00576810|Cathartics|cathartics|mesh-ancestor
13903039|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13903040|NCT00576667|Rimonabant|rimonabant|mesh-list
13903041|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13903042|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14034159|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034160|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034161|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
14034162|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
13903043|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13903044|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903045|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903046|NCT00576667|Hormones|hormones|mesh-ancestor
13903047|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903048|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903049|NCT00576537|Vaccines|vaccines|mesh-list
13903050|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
14034163|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034164|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14034165|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
14034166|NCT03950674|Hormones|hormones|mesh-ancestor
14034167|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034168|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034169|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14034170|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034171|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034172|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14034173|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14034174|NCT03950674|Hematinics|hematinics|mesh-ancestor
14755747|NCT03862157|Azacitidine|azacitidine|mesh-list
14755748|NCT03862157|Venetoclax|venetoclax|mesh-list
14755749|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14755750|NCT03862157|Pevonedistat|pevonedistat|mesh-list
14755751|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755752|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
14755753|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755754|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755755|NCT03859973|BI 425809|bi 425809|mesh-list
14755756|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
14755757|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
14755758|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755759|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755760|NCT03853044|Prednisone|prednisone|mesh-list
13903051|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755761|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
14755762|NCT03853044|Doxorubicin|doxorubicin|mesh-list
14755763|NCT03853044|Vincristine|vincristine|mesh-list
14755764|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755765|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
14755766|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755767|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903052|NCT00576342|Timolol|timolol|mesh-list
13903053|NCT00576342|Dorzolamide|dorzolamide|mesh-list
13903054|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14755768|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14755769|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
14755770|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755771|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755772|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14755773|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14755774|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13903055|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13903056|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14932766|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932767|NCT01446952|Protective Agents|protective agents|mesh-ancestor
14932768|NCT01446978|Vaccines|vaccines|mesh-list
14932769|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
14932770|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932771|NCT01447043|Ranibizumab|ranibizumab|mesh-list
14932772|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14932773|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14932774|NCT01447043|Growth Substances|growth substances|mesh-ancestor
14932775|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932776|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
14932777|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932778|NCT01447069|Albuterol|albuterol|mesh-list
14932779|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14932780|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
14932781|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932782|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755775|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755776|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755777|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755778|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
14755779|NCT03853044|Hormones|hormones|mesh-ancestor
14755780|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14932783|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13903057|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13903058|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
13903059|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903060|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903061|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903062|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13903063|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13903064|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13903065|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903066|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13903067|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
13903068|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903069|NCT00570752|Atorvastatin|atorvastatin|mesh-list
14034175|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
14755781|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14932784|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
14034176|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14034177|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14034178|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034179|NCT03931408|Gentamicins|gentamicins|mesh-list
14034180|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034181|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034182|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14034183|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034184|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034185|NCT03927274|Topotecan|topotecan|mesh-list
14034186|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14034187|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14034188|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034189|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034190|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034191|NCT03922945|Topiramate|topiramate|mesh-list
14034192|NCT03922945|Phentermine|phentermine|mesh-list
14034193|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
14034194|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14034195|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034196|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14034197|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
14034198|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14034199|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
14034200|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
14034201|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034202|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
14034203|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034204|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034205|NCT03919292|Valproic Acid|valproic acid|mesh-list
13903070|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13903071|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13903072|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
13903073|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903074|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13903075|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13903076|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903077|NCT00569387|Vaccines|vaccines|mesh-list
13903078|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
14034206|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
14034207|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034208|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903079|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903080|NCT00566202|Citalopram|citalopram|mesh-list
14034209|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
14034210|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034211|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034212|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
14034213|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14034214|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034215|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14034216|NCT03902951|Leuprolide|leuprolide|mesh-list
14034217|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
14034218|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14034219|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
14034220|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14034221|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034222|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034223|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034224|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14034225|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034226|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034227|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
14034228|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034229|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14034230|NCT03896685|Linezolid|linezolid|mesh-list
14034231|NCT03896685|Bedaquiline|bedaquiline|mesh-list
14034232|NCT03896685|Clofazimine|clofazimine|mesh-list
14034233|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034234|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034235|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14034236|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169825|NCT04837131|Ixazomib|ixazomib|mesh-list
14932785|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
13903081|NCT00566202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14034237|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034238|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
14034239|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034240|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
14034241|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14034242|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14034243|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14034244|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
14034245|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034246|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14034247|NCT03875573|Durvalumab|durvalumab|mesh-list
14034248|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14034249|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034250|NCT03871491|Azithromycin|azithromycin|mesh-list
14034251|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034252|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034253|NCT03868839|Telmisartan|telmisartan|mesh-list
14034254|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14034255|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14034256|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14034257|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034258|NCT03864042|Losartan|losartan|mesh-list
14034259|NCT03864042|Midazolam|midazolam|mesh-list
14034260|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
14034261|NCT03864042|Caffeine|caffeine|mesh-list
14034262|NCT03864042|Modafinil|modafinil|mesh-list
14034263|NCT03864042|Bupropion|bupropion|mesh-list
14034264|NCT03864042|Omeprazole|omeprazole|mesh-list
14034265|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14034266|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14034267|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14034268|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034269|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034270|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14034271|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14034272|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14034273|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14034274|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
14034275|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
14034276|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
14755782|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14755783|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
14755784|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
14755785|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755786|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14755787|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
13903082|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13903083|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903084|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755788|NCT03847857|Coagulants|coagulants|mesh-ancestor
14755789|NCT03843645|Anesthetics|anesthetics|mesh-list
14755790|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14755791|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755792|NCT03837899|Durvalumab|durvalumab|mesh-list
14755793|NCT03837899|Tremelimumab|tremelimumab|mesh-list
14755794|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14755795|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903085|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903086|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
13903087|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903088|NCT00566202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14471670|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
14471671|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
14471672|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471673|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471674|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471675|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
14471676|NCT02335983|Hormones|hormones|mesh-ancestor
14471677|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471678|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14471679|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471680|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
14471681|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14471682|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14755796|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034277|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
14034278|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034279|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034280|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14034281|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14034282|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
14034283|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14034284|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14034285|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034286|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14034287|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14034288|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14034289|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14034290|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14034291|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14034292|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14034293|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14034294|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14034295|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14034296|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14034297|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
14034298|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14034299|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
14034300|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14034301|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14034302|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034303|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
14034304|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14034305|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14034306|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14932786|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14932787|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14932788|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14932789|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14932790|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
14932791|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903089|NCT00566202|Antidepressive Agents|antidepressive agents|mesh-ancestor
13903090|NCT00566202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13903091|NCT00564421|Epinastine|epinastine|mesh-list
13903092|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13903093|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
13903094|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
13903095|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903096|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903097|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903098|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14034307|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14034308|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14034309|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
14034310|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
14034311|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14034312|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14034313|NCT03862495|Azithromycin|azithromycin|mesh-list
14034314|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034315|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034316|NCT03859427|Dexamethasone|dexamethasone|mesh-list
14034317|NCT03859427|Lenalidomide|lenalidomide|mesh-list
14034318|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034319|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
14034320|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
14034321|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932792|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903099|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13903100|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13903101|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
13903102|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903103|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903104|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903105|NCT00564226|Urological Agents|urological agents|mesh-ancestor
13903106|NCT00563563|Naltrexone|naltrexone|mesh-list
13903107|NCT00563563|Bupropion|bupropion|mesh-list
13903108|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13903109|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14034322|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034323|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14034324|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
14034325|NCT03859427|Hormones|hormones|mesh-ancestor
14034326|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034327|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034328|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034329|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
14034330|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14034331|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14034332|NCT03859427|Growth Substances|growth substances|mesh-ancestor
14034333|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
14034334|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14034335|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
14034336|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034337|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
14034338|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034339|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034340|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14034341|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034342|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034343|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
14034344|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034345|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14034346|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034347|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034348|NCT03842085|Antibodies|antibodies|mesh-list
14034349|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13903110|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903111|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
13903112|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903113|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13903114|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
13903115|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14034350|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14034351|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
14034352|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034353|NCT03837353|Docetaxel|docetaxel|mesh-list
14034354|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034355|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
14034356|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
14034357|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
14034358|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034359|NCT03821246|Atezolizumab|atezolizumab|mesh-list
14034360|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14034361|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034362|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
14034363|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034364|NCT03815019|Megestrol|megestrol|mesh-list
14034365|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
14034366|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14034367|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14034368|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14034369|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
14034370|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14034371|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034372|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14034373|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14034374|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13903116|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13903117|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13903118|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903119|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903120|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
13903121|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903122|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13903123|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13903124|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903125|NCT00563459|Topiramate|topiramate|mesh-list
13903126|NCT00563459|Levetiracetam|levetiracetam|mesh-list
13903127|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
13903128|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13903129|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182960|NCT04731766|Fluorides|fluorides|mesh-list
14471683|NCT02335983|Growth Substances|growth substances|mesh-ancestor
13903130|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
13903131|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13903132|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
13903133|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903134|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
13903135|NCT00562497|Prednisone|prednisone|mesh-list
14471684|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
14471685|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
14932793|NCT01447095|Epoprostenol|epoprostenol|mesh-list
14932794|NCT01447095|Tezosentan|tezosentan|mesh-list
14932795|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932796|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14932797|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
14932798|NCT01447160|Cortisone|cortisone|mesh-list
14932799|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932800|NCT01447173|Vitamin D|vitamin d|mesh-list
14471686|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14034375|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471687|NCT02336074|Vorinostat|vorinostat|mesh-list
13903136|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
13903137|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903138|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
13903139|NCT00562497|Hormones|hormones|mesh-ancestor
13903140|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903141|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903142|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14471688|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932801|NCT01447173|Vitamins|vitamins|mesh-ancestor
14932802|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
14932803|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932804|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14932805|NCT01447212|Hydromorphone|hydromorphone|mesh-list
14932806|NCT01447212|Heroin|heroin|mesh-list
14932807|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14932808|NCT01447212|Narcotics|narcotics|mesh-ancestor
14932809|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932810|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932811|NCT01447212|Analgesics|analgesics|mesh-ancestor
14932812|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
14932813|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932814|NCT01447355|Vitamin D|vitamin d|mesh-list
14932815|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
13903143|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903144|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
13903145|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
13903146|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903147|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13903148|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13903149|NCT00562497|Protective Agents|protective agents|mesh-ancestor
13903150|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
13903151|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903152|NCT00561743|Dexamethasone|dexamethasone|mesh-list
13903153|NCT00561743|Doxorubicin|doxorubicin|mesh-list
13903154|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13903155|NCT00561743|Bortezomib|bortezomib|mesh-list
13903156|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903157|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
13903158|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
13903159|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903160|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903161|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13903162|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
13903163|NCT00561743|Hormones|hormones|mesh-ancestor
13903164|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903165|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13903166|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903167|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13903168|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13903169|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13903170|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903171|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903172|NCT00560183|Morphine|morphine|mesh-list
13903173|NCT00560183|Oxycodone|oxycodone|mesh-list
13903174|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13903175|NCT00560183|Narcotics|narcotics|mesh-ancestor
13903176|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13903177|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903178|NCT00560183|Analgesics|analgesics|mesh-ancestor
13903179|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
13903180|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903181|NCT00559247|Asunaprevir|asunaprevir|mesh-list
13903182|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
13903183|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903184|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903185|NCT00558207|Gemcitabine|gemcitabine|mesh-list
13903186|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755797|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
14755798|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755799|NCT03826303|Ethanol|ethanol|mesh-list
14755800|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14755801|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755802|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14755803|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755804|NCT03820726|Nintedanib|nintedanib|mesh-list
14755805|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755806|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13903187|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
13959452|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932816|NCT01447355|Vitamins|vitamins|mesh-ancestor
14932817|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
14932818|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932819|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14932820|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13903188|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903189|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903190|NCT00558207|Antiviral Agents|antiviral agents|mesh-ancestor
13903191|NCT00558207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903192|NCT00558207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903193|NCT00558207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903194|NCT00558207|Immunologic Factors|immunologic factors|mesh-ancestor
13903195|NCT00558207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903196|NCT00558038|Lactulose|lactulose|mesh-list
13903197|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13903198|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
13903199|NCT00557973|Baclofen|baclofen|mesh-list
13903200|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13903201|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903202|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13903203|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903204|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13903205|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
13903206|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
13903207|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903208|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903209|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
13903210|NCT00557401|Baclofen|baclofen|mesh-list
13903211|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13903212|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932821|NCT01447368|Cinacalcet|cinacalcet|mesh-list
14932822|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14932823|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932824|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14932825|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
14932826|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14932827|NCT01447394|Interferons|interferons|mesh-list
14932828|NCT01447394|Ribavirin|ribavirin|mesh-list
14932829|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
14932830|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
14034376|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
14034377|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14034378|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
14034379|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
13903213|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13903214|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034380|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14034381|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13903215|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13903216|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
13903217|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
13903218|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903219|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903220|NCT00557128|Lisinopril|lisinopril|mesh-list
13903221|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13903222|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
13903223|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903224|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903225|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13903226|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13903227|NCT00557128|Protective Agents|protective agents|mesh-ancestor
14034382|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14034383|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034384|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034385|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
14034386|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034387|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034388|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
14034389|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
14034390|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034391|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
14034392|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034393|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034394|NCT03792256|Cytarabine|cytarabine|mesh-list
14034395|NCT03792256|Prednisone|prednisone|mesh-list
14034396|NCT03792256|Prednisolone|prednisolone|mesh-list
14034397|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
14034398|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14034399|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14034400|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14034401|NCT03792256|Doxorubicin|doxorubicin|mesh-list
14034402|NCT03792256|Methotrexate|methotrexate|mesh-list
14034403|NCT03792256|Vincristine|vincristine|mesh-list
14034404|NCT03792256|Palbociclib|palbociclib|mesh-list
14034405|NCT03792256|Pegaspargase|pegaspargase|mesh-list
14034406|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14034407|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034408|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14034409|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14034410|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034411|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034412|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903228|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903229|NCT00556920|Carvedilol|carvedilol|mesh-list
13903230|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13903231|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13903232|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
13903233|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903234|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903235|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903236|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13903237|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
13903238|NCT00556920|Protective Agents|protective agents|mesh-ancestor
13903239|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13903240|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903241|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13903242|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
14034413|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
14034414|NCT03792256|Hormones|hormones|mesh-ancestor
14034415|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034416|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034417|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034418|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14034419|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
14034420|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14034421|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14034422|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
14034423|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
13903243|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14034424|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14034425|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034426|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
14034427|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034428|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14034429|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
14034430|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034431|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14034432|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14034433|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14034434|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14034435|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14034436|NCT03787095|Cemiplimab|cemiplimab|mesh-list
14034437|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903244|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13903245|NCT00555789|Tacrolimus|tacrolimus|mesh-list
13903246|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903247|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
13903248|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903249|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13903250|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903251|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903252|NCT00555035|Dolutegravir|dolutegravir|mesh-list
13903253|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13903254|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13903255|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903256|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903257|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13903258|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13903259|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
13903260|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903261|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
13903262|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13903263|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13903264|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
13903265|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903266|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903267|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903268|NCT00553657|Urological Agents|urological agents|mesh-ancestor
13903269|NCT00553306|Aldesleukin|aldesleukin|mesh-list
13903270|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
13903271|NCT00553306|Interleukin-2|interleukin-2|mesh-list
13903272|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903273|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
13903274|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903275|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034438|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034439|NCT03779295|Clindamycin|clindamycin|mesh-list
14034440|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
14034441|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
14034442|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034443|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034444|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14034445|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034446|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034447|NCT03769155|Nivolumab|nivolumab|mesh-list
14034448|NCT03769155|Ipilimumab|ipilimumab|mesh-list
14034449|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14034450|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034451|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14034452|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034453|NCT03765788|Prednisolone|prednisolone|mesh-list
14034454|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034455|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
14034456|NCT03765788|Hormones|hormones|mesh-ancestor
14034457|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034458|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034459|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034460|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034461|NCT03765567|Vancomycin|vancomycin|mesh-list
14034462|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034463|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034464|NCT03762109|Dantrolene|dantrolene|mesh-list
14034465|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14034466|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034467|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14034468|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034469|NCT03746951|Ropivacaine|ropivacaine|mesh-list
14034470|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
14471689|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14471690|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471691|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471692|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14471693|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
14471694|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471695|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14471696|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14471697|NCT02336165|Bevacizumab|bevacizumab|mesh-list
14471698|NCT02336165|Durvalumab|durvalumab|mesh-list
13903276|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13903277|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
13903278|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903279|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755807|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755808|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903280|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13903281|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13903282|NCT00553306|Analgesics|analgesics|mesh-ancestor
13903283|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
13903284|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903285|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13903286|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13903287|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
13903288|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903289|NCT00552708|Lisinopril|lisinopril|mesh-list
14034471|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
14034472|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034473|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034474|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
14034475|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034476|NCT03746769|Gastrins|gastrins|mesh-list
14034477|NCT03746769|Hormones|hormones|mesh-ancestor
13903290|NCT00552708|Carvedilol|carvedilol|mesh-list
14034478|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034479|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034480|NCT03699631|Methotrexate|methotrexate|mesh-list
14034481|NCT03699631|Tacrolimus|tacrolimus|mesh-list
14034482|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14034483|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
14034484|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14932831|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14932832|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034485|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034486|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14034487|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
14034488|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034489|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034490|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14034491|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034492|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14034493|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034494|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
14034495|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034496|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14034497|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14034498|NCT03693781|Colchicine|colchicine|mesh-list
14034499|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
14755809|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
14755810|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
14755811|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755812|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755813|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14932833|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
14034500|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034501|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
14034502|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
14034503|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
14755814|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755815|NCT03803761|Fulvestrant|fulvestrant|mesh-list
14755816|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14932834|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932835|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
13903291|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13903292|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
13903293|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903294|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903295|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13903296|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13903297|NCT00552708|Protective Agents|protective agents|mesh-ancestor
13903298|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903299|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13903300|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13903301|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
13903302|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903303|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
13903304|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13903305|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903306|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13903307|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
13903308|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13903309|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13903310|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
13903311|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13903312|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13903313|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903314|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903315|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
13903316|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13903317|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13903318|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903319|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903320|NCT00549510|Lisinopril|lisinopril|mesh-list
13903321|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13903322|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
13903323|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903324|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755817|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034504|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034505|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169826|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169827|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
14169828|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169829|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755818|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14755819|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14755820|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
14755821|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755822|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755823|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
14755824|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755825|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169830|NCT04837014|Acetaminophen|acetaminophen|mesh-list
14169831|NCT04837014|Naproxen|naproxen|mesh-list
14169832|NCT04837014|Hydromorphone|hydromorphone|mesh-list
14169833|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14169834|NCT04837014|Analgesics|analgesics|mesh-ancestor
14169835|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
14169836|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169837|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169838|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
14169839|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14169840|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169841|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14169842|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
14169843|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14169844|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169845|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169846|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14169847|NCT04837014|Narcotics|narcotics|mesh-ancestor
14169848|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169849|NCT04837170|Ketamine|ketamine|mesh-list
14169850|NCT04837170|Esketamine|esketamine|mesh-list
14169851|NCT04837170|Analgesics|analgesics|mesh-ancestor
14169852|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
14169853|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767208|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14767209|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
14767210|NCT00629213|Acarbose|acarbose|mesh-list
14767211|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14767212|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767213|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903325|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13903326|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13903327|NCT00549510|Protective Agents|protective agents|mesh-ancestor
13959453|NCT03163121|Vaccines|vaccines|mesh-list
14169854|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034506|NCT03690986|Nivolumab|nivolumab|mesh-list
14034507|NCT03690986|Ipilimumab|ipilimumab|mesh-list
14034508|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903328|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903329|NCT00547651|Topotecan|topotecan|mesh-list
13903330|NCT00547651|Amrubicin|amrubicin|mesh-list
14034509|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034510|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14034511|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034512|NCT03685747|Vancomycin|vancomycin|mesh-list
14034513|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034514|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034515|NCT03674827|Vaccines|vaccines|mesh-list
14034516|NCT03674827|Immunologic Factors|immunologic factors|mesh-list
14034517|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034518|NCT03650114|Ofatumumab|ofatumumab|mesh-list
14034519|NCT03650114|Vaccines|vaccines|mesh-list
14034520|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14034521|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14034522|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
14034523|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034524|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034525|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14034526|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
14034527|NCT03640949|Vasopressins|vasopressins|mesh-list
14034528|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
14034529|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903331|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13903332|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13903333|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903334|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903335|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903336|NCT00547066|Veltuzumab|veltuzumab|mesh-list
13903337|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903338|NCT00546793|Veltuzumab|veltuzumab|mesh-list
13903339|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903340|NCT00546780|Bortezomib|bortezomib|mesh-list
13903341|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903342|NCT00546273|Vaccines|vaccines|mesh-list
13903343|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
13903344|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903345|NCT00544960|Docetaxel|docetaxel|mesh-list
13903346|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903347|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
13903348|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
13903349|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
13903350|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903351|NCT00544466|Fludarabine|fludarabine|mesh-list
13903352|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
13903353|NCT00544466|Melphalan|melphalan|mesh-list
13903354|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903355|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14034530|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
13903356|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
14034531|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
13903357|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903358|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903359|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
13903360|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903361|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13903362|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
13903363|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13903364|NCT00544115|Cyclosporine|cyclosporine|mesh-list
13903365|NCT00544115|Sirolimus|sirolimus|mesh-list
13903366|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
13903367|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
13903368|NCT00544115|Melphalan|melphalan|mesh-list
13903369|NCT00544115|Busulfan|busulfan|mesh-list
13903370|NCT00544115|Methotrexate|methotrexate|mesh-list
13903371|NCT00544115|Fludarabine|fludarabine|mesh-list
13903372|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
13903373|NCT00544115|Etoposide|etoposide|mesh-list
13903374|NCT00544115|Tacrolimus|tacrolimus|mesh-list
13903375|NCT00544115|Cyclosporins|cyclosporins|mesh-list
13903376|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903377|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
13903378|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903379|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903380|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14034532|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034533|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034534|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14034535|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
14034536|NCT03640949|Hormones|hormones|mesh-ancestor
13903381|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
14932836|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932837|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
14932838|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903382|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903383|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903384|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13903385|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13903386|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
14034537|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034538|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14034539|NCT03640949|Protective Agents|protective agents|mesh-ancestor
14034540|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
14034541|NCT03640949|Coagulants|coagulants|mesh-ancestor
14034542|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14034543|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14034544|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
14034545|NCT03621761|Modafinil|modafinil|mesh-list
14034546|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14034547|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932839|NCT01447485|Valsartan|valsartan|mesh-list
14932840|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932841|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14932842|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14932843|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932844|NCT01447550|Bosentan|bosentan|mesh-list
14932845|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932846|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14932847|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932848|NCT01447563|Clopidogrel|clopidogrel|mesh-list
14932849|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14932850|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14034548|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14034549|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13903387|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13903388|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13903389|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
13903390|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
13903391|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903392|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13903393|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13903394|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13903395|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13903396|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13903397|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13903398|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
13903399|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903400|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13903401|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13903402|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
13903403|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13903404|NCT00543582|Azacitidine|azacitidine|mesh-list
13903405|NCT00543582|Mocetinostat|mocetinostat|mesh-list
13903406|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13903407|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
13903408|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903409|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903410|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903411|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13903412|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
13903413|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903414|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
13903415|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903416|NCT00542724|Insulin|insulin|mesh-list
13903417|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14034550|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14034551|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034552|NCT03619551|Busulfan|busulfan|mesh-list
14034553|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
14034554|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034555|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034556|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
14034557|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034558|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14034559|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034560|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14034561|NCT03616886|Paclitaxel|paclitaxel|mesh-list
14034562|NCT03616886|Carboplatin|carboplatin|mesh-list
14034563|NCT03616886|Durvalumab|durvalumab|mesh-list
14034564|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14034565|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034566|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
14034567|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
14034568|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
14034569|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034570|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14034571|NCT03616574|Trifluridine|trifluridine|mesh-list
14034572|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
14034573|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034574|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
14034575|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034576|NCT03615508|Phenylephrine|phenylephrine|mesh-list
14034577|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
13903418|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14034578|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14034579|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
14034580|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
14034581|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034582|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034583|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
14034584|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14034585|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
14034586|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
13903419|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903420|NCT00542633|Insulin|insulin|mesh-list
13903421|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13903422|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13903423|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903424|NCT00540358|Gemcitabine|gemcitabine|mesh-list
13903425|NCT00540358|Carboplatin|carboplatin|mesh-list
13903426|NCT00540358|Iniparib|iniparib|mesh-list
13903427|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903428|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13903429|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
13903430|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903431|NCT00540358|Antiviral Agents|antiviral agents|mesh-ancestor
13903432|NCT00540358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903433|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903434|NCT00540358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903435|NCT00540358|Immunologic Factors|immunologic factors|mesh-ancestor
13903436|NCT00540358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903437|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13959454|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
13959455|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959456|NCT03162861|Anesthetics|anesthetics|mesh-list
13959457|NCT03162861|Propofol|propofol|mesh-list
13959458|NCT03162861|Sevoflurane|sevoflurane|mesh-list
13959459|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959460|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959461|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13959462|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13959463|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
14034587|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14034588|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14034589|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13959464|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13959465|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13959466|NCT03162653|Allopurinol|allopurinol|mesh-list
14034590|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
14034591|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034592|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034593|NCT03615508|Protective Agents|protective agents|mesh-ancestor
14034594|NCT03612791|Atezolizumab|atezolizumab|mesh-list
14034595|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034596|NCT03609840|Thiotepa|thiotepa|mesh-list
14034597|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
14034598|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
13959467|NCT03162653|Mannitol|mannitol|mesh-list
14034599|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
14755826|NCT03787251|Apatinib|apatinib|mesh-list
14755827|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755828|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755829|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755830|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755831|NCT03761173|Anticoagulants|anticoagulants|mesh-list
14034600|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034601|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14034602|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034603|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
14034604|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034605|NCT03606642|Aspirin|aspirin|mesh-list
14034606|NCT03606642|Clopidogrel|clopidogrel|mesh-list
14034607|NCT03606642|Ticagrelor|ticagrelor|mesh-list
14034608|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14034609|NCT03606642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14034610|NCT03606642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14034611|NCT03606642|Analgesics|analgesics|mesh-ancestor
14034612|NCT03606642|Sensory System Agents|sensory system agents|mesh-ancestor
14034613|NCT03606642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034614|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034615|NCT03606642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034616|NCT03606642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034617|NCT03606642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14034618|NCT03606642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14034619|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034620|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14034621|NCT03606642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14034622|NCT03606642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034623|NCT03606642|Antipyretics|antipyretics|mesh-ancestor
14034624|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14034625|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14034626|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13903438|NCT00539721|Ondansetron|ondansetron|mesh-list
13903439|NCT00539721|Rolapitant|rolapitant|mesh-list
13903440|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
13903441|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
13903442|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903443|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903444|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13903445|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
13903446|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
13903447|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13903448|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
13903449|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903450|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903451|NCT00539721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14755832|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13903452|NCT00539721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13959468|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
14034627|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
14034628|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034629|NCT03586687|Triamcinolone|triamcinolone|mesh-list
14034630|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034631|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
14034632|NCT03586687|Hormones|hormones|mesh-ancestor
14034633|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034634|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034635|NCT03573024|Azacitidine|azacitidine|mesh-list
14034636|NCT03573024|Venetoclax|venetoclax|mesh-list
14034637|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14034638|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
13903453|NCT00539721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13903454|NCT00539721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13903455|NCT00539721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13903456|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13903457|NCT00537043|Carvedilol|carvedilol|mesh-list
13903458|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13903459|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14034639|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034640|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034641|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034642|NCT03570437|Paclitaxel|paclitaxel|mesh-list
14034643|NCT03570437|Olaparib|olaparib|mesh-list
14034644|NCT03570437|Cediranib|cediranib|mesh-list
14034645|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14034646|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034647|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
14034648|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
14034649|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
14034650|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034651|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14034652|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034653|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14034654|NCT03532880|Olaparib|olaparib|mesh-list
14034655|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14034656|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034657|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034658|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034659|NCT03502070|Tobramycin|tobramycin|mesh-list
14034660|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034661|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034662|NCT03485911|Berotralstat|berotralstat|mesh-list
14034663|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034664|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034665|NCT03481660|Aflibercept|aflibercept|mesh-list
14034666|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14034667|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14034668|NCT03481660|Growth Substances|growth substances|mesh-ancestor
14034669|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034670|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
14034671|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034672|NCT03459846|Durvalumab|durvalumab|mesh-list
14034673|NCT03459846|Olaparib|olaparib|mesh-list
14034674|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14034675|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034676|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14034677|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034678|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034679|NCT03452137|Atezolizumab|atezolizumab|mesh-list
14034680|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034681|NCT03403634|Interferons|interferons|mesh-list
14034682|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
14034683|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
14034684|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14034685|NCT03403634|Celecoxib|celecoxib|mesh-list
14034686|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
14034687|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034688|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
14034689|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034690|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
14034691|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034692|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14034693|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13903460|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14034694|NCT03403634|Analgesics|analgesics|mesh-ancestor
14034695|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
14034696|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034697|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034698|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903461|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903462|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903463|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903464|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13903465|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
13903466|NCT00537043|Protective Agents|protective agents|mesh-ancestor
13903467|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13903468|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034699|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14034700|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14034701|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034702|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034703|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14034704|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
14034705|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14034706|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471699|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471700|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471701|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14034710|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
14034711|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14034712|NCT03369301|Antibodies|antibodies|mesh-list
14034713|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
14034714|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034715|NCT03359538|Sirolimus|sirolimus|mesh-list
14034716|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034717|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034718|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14034719|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034720|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
14034721|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034722|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
14034723|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034724|NCT03342456|Amoxicillin|amoxicillin|mesh-list
14034725|NCT03342456|Doxycycline|doxycycline|mesh-list
14034726|NCT03342456|Furazolidone|furazolidone|mesh-list
14034727|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
14034728|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034729|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034730|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034731|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
14034732|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14034733|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14034734|NCT03342456|Diuretics|diuretics|mesh-ancestor
14034735|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
14034736|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034737|NCT03342456|Expectorants|expectorants|mesh-ancestor
14034738|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
14034739|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14034740|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14034741|NCT03342456|Renal Agents|renal agents|mesh-ancestor
14034742|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14034743|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14034744|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903469|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13903470|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
13903471|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13903472|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13903473|NCT00535366|Fluticasone|fluticasone|mesh-list
14034745|NCT03332095|Tenofovir|tenofovir|mesh-list
14034746|NCT03332095|Lamivudine|lamivudine|mesh-list
14034747|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14034748|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
14034749|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034750|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14034751|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14034752|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034753|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034754|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14755833|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14755834|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14755835|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14034758|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
14034759|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13903474|NCT00535366|Ciclesonide|ciclesonide|mesh-list
13903475|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
13903476|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13903477|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903478|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13903479|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
14034760|NCT03322280|Estrogens|estrogens|mesh-ancestor
14034761|NCT03322280|Hormones|hormones|mesh-ancestor
14755836|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14755837|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
14755838|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755839|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755840|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755841|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
14767214|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14034762|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034763|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034764|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14471702|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471703|NCT02336165|Growth Substances|growth substances|mesh-ancestor
14471704|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471705|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
14471706|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
14471707|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471708|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
14471709|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471710|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471711|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14471712|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14034765|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034766|NCT03318952|Lidocaine|lidocaine|mesh-list
14034767|NCT03318952|Carticaine|carticaine|mesh-list
14034768|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-ancestor
14034769|NCT03318952|Anesthetics|anesthetics|mesh-ancestor
14034770|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034771|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034772|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
14034773|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034774|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14034775|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14034776|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14034777|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034778|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034779|NCT03277495|Nicotine|nicotine|mesh-list
14034780|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14034781|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
14034782|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034783|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903480|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903481|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903482|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13903483|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
13903484|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
13903485|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13903486|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
13903487|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13903488|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
13903489|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903490|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903491|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13903492|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13903493|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14034784|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14034785|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14034786|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
14034787|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034788|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034789|NCT03246529|Lenograstim|lenograstim|mesh-list
14034790|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14755842|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755843|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755844|NCT03749070|Silymarin|silymarin|mesh-list
14755845|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
14755846|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755847|NCT03749070|Protective Agents|protective agents|mesh-ancestor
14755848|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755849|NCT03747419|Avelumab|avelumab|mesh-list
14755850|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755851|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755852|NCT03732677|Gemcitabine|gemcitabine|mesh-list
14755853|NCT03732677|Durvalumab|durvalumab|mesh-list
14755854|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755855|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755856|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
14755857|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755858|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
14755859|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755860|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034791|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
14034792|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034793|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14034794|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
14034795|NCT03201419|Coagulants|coagulants|mesh-ancestor
14034796|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14034797|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
14034798|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034799|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
14034800|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
14034801|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169855|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14169856|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14169857|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
14169858|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
14169859|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471713|NCT02336438|Cathartics|cathartics|mesh-ancestor
14471714|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14755861|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755862|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
14755863|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755864|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755865|NCT03706365|Prednisone|prednisone|mesh-list
14755866|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
14755867|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755868|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
14471715|NCT02336451|Ceritinib|ceritinib|mesh-list
14471716|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471717|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14471718|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471719|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471720|NCT02336594|Verinurad|verinurad|mesh-list
14471721|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
14471722|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755869|NCT03706365|Hormones|hormones|mesh-ancestor
14755870|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755871|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755872|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14755873|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755874|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14755875|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755876|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755877|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
14755878|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14755879|NCT03673956|Vancomycin|vancomycin|mesh-list
14755880|NCT03673956|Levofloxacin|levofloxacin|mesh-list
14755881|NCT03673956|Ofloxacin|ofloxacin|mesh-list
14755882|NCT03673956|Tobramycin|tobramycin|mesh-list
14755883|NCT03673956|Mupirocin|mupirocin|mesh-list
14755884|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14755885|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169860|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14471723|NCT02336607|Metoprolol|metoprolol|mesh-list
14755886|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14034802|NCT05345327|Metformin|metformin|mesh-list
14034803|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
14034804|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14932851|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14932852|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14932853|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
14932854|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932855|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932856|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932857|NCT01447589|Nelfinavir|nelfinavir|mesh-list
14932858|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14932859|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14932860|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
14932861|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932862|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903494|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
13903495|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
13903496|NCT00535366|Hormones|hormones|mesh-ancestor
13903497|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903498|NCT00534027|Conatumumab|conatumumab|mesh-list
13903499|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903500|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903501|NCT00532311|Atorvastatin|atorvastatin|mesh-list
14034805|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034806|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14034807|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471724|NCT02336607|Felodipine|felodipine|mesh-list
13903502|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13903503|NCT00532311|Simvastatin|simvastatin|mesh-list
13903504|NCT00532311|Pravastatin|pravastatin|mesh-list
13903505|NCT00532311|Lovastatin|lovastatin|mesh-list
13903506|NCT00532311|L 647318|l 647318|mesh-list
13903507|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
13903508|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14034808|NCT05345249|Ropivacaine|ropivacaine|mesh-list
14034809|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
14034810|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
14034811|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13903509|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14471725|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13903510|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13903511|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
13903512|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903513|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13903514|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903515|NCT00532038|Ketoprofen|ketoprofen|mesh-list
13903516|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13903517|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13903518|NCT00532038|Analgesics|analgesics|mesh-ancestor
13903519|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
13903520|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903521|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903522|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755887|NCT03673956|Renal Agents|renal agents|mesh-ancestor
14755888|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14755889|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755890|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755891|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755892|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755893|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14471726|NCT02336607|Lisinopril|lisinopril|mesh-list
14471727|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14471728|NCT02336607|Diuretics|diuretics|mesh-ancestor
14755894|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14755895|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14755896|NCT03672630|Azithromycin|azithromycin|mesh-list
14471729|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
14034812|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034813|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
14034814|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034815|NCT05345236|Aflibercept|aflibercept|mesh-list
14034816|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14034817|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14034818|NCT05345236|Growth Substances|growth substances|mesh-ancestor
14034819|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034820|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
14034821|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034822|NCT05345210|Amoxicillin|amoxicillin|mesh-list
14034823|NCT05345210|Clarithromycin|clarithromycin|mesh-list
14034824|NCT05345210|Tetracycline|tetracycline|mesh-list
14034825|NCT05345210|Furazolidone|furazolidone|mesh-list
14034826|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034827|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034828|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14034829|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034830|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034831|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14182961|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
14755897|NCT03672630|Rifampin|rifampin|mesh-list
14755898|NCT03672630|Ethambutol|ethambutol|mesh-list
13903523|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903524|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13903525|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903526|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903527|NCT00531622|Citalopram|citalopram|mesh-list
13903528|NCT00531622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13903529|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14471730|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471731|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14471732|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14471733|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471734|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14471735|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
14471736|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
14471737|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471738|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14471739|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14471740|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14034832|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14034833|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14034834|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14034835|NCT05345210|Renal Agents|renal agents|mesh-ancestor
14034836|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14034837|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14034838|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14034839|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13903530|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903531|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903532|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903533|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
13903534|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903535|NCT00531622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13903536|NCT00531622|Antidepressive Agents|antidepressive agents|mesh-ancestor
13903537|NCT00531622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13903538|NCT00530062|Albuterol|albuterol|mesh-list
13903539|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14034840|NCT05345171|Prednisolone|prednisolone|mesh-list
14034841|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034842|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
14034843|NCT05345171|Hormones|hormones|mesh-ancestor
14034844|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034845|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034846|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034847|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034848|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
14034849|NCT05345132|Nifedipine|nifedipine|mesh-list
14034850|NCT05345132|Analgesics|analgesics|mesh-ancestor
14034851|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
14034852|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034853|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034854|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
14034855|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471741|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
14471742|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471743|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14471744|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
14471745|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471746|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14471747|NCT02336607|Protective Agents|protective agents|mesh-ancestor
14932863|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13903540|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
14034856|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14034857|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
14034858|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14034859|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14034860|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034861|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14034862|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
14034863|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14034864|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
14034865|NCT05345119|Sirolimus|sirolimus|mesh-list
14034866|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
14034867|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14034868|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14034869|NCT05345119|Prednisolone|prednisolone|mesh-list
13903541|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903542|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903543|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13903544|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
13903545|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
13903546|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13903547|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13903548|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13903549|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13903550|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
13903551|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903552|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903553|NCT00529503|Rituximab|rituximab|mesh-list
14034870|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
14034871|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14034872|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
14034873|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14034874|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034875|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14471748|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13903554|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
13903555|NCT00529503|Carboplatin|carboplatin|mesh-list
13903556|NCT00529503|Etoposide|etoposide|mesh-list
13903557|NCT00529503|Ifosfamide|ifosfamide|mesh-list
13903558|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903559|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903560|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
13903561|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903562|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14471749|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14471750|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
14471751|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14471752|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14471753|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755899|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13903563|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13903564|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14034876|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903565|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14034877|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
14034878|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034879|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
14034880|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034881|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034882|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
14034883|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
13903566|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903567|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903568|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13903569|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
13903570|NCT00529178|Pravastatin|pravastatin|mesh-list
13903571|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13903572|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13903573|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
13903574|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903575|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13903576|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13903577|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903578|NCT00529152|Deferiprone|deferiprone|mesh-list
13903579|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13903580|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
13903581|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
13903582|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903583|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
13903584|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13903585|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13903586|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903587|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903588|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
13903589|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903590|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903591|NCT00528333|Cytarabine|cytarabine|mesh-list
13903592|NCT00528333|Lintuzumab|lintuzumab|mesh-list
13903593|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13903594|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
13903595|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903596|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903597|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
13903598|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903599|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903600|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
13903601|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903602|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14034884|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034885|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14034886|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
14034887|NCT05345119|Hormones|hormones|mesh-ancestor
14034888|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034889|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14034890|NCT05345119|Protective Agents|protective agents|mesh-ancestor
14034891|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034896|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14034897|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034898|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14034899|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034900|NCT05344911|Remifentanil|remifentanil|mesh-list
14034901|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14034902|NCT05344911|Narcotics|narcotics|mesh-ancestor
14034903|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13903603|NCT00526227|Clotrimazole|clotrimazole|mesh-list
13903604|NCT00526227|Miconazole|miconazole|mesh-list
13903605|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13903606|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903607|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
13903608|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13903609|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13903610|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14034904|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034905|NCT05344911|Analgesics|analgesics|mesh-ancestor
14034906|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
14034907|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034908|NCT05344833|Lenalidomide|lenalidomide|mesh-list
14034909|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
14034910|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034911|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13903611|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903612|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13903613|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
13903614|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903615|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903616|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13903617|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13903618|NCT00525941|Indiplon|indiplon|mesh-list
13903619|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13903620|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13903621|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903622|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
13903623|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
13903624|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903625|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903626|NCT00525330|Metformin|metformin|mesh-list
13903627|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13903628|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903629|NCT00524277|Molgramostim|molgramostim|mesh-list
13903630|NCT00524277|Vaccines|vaccines|mesh-list
13903631|NCT00524277|Sargramostim|sargramostim|mesh-list
14034912|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471754|NCT02336815|Dexamethasone|dexamethasone|mesh-list
14471755|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903632|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
13903633|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903634|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903635|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13903636|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14755900|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755901|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13903637|NCT00523042|Insulin|insulin|mesh-list
13903638|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13903639|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
14755902|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
14755903|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
14755904|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13903640|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13903641|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903642|NCT00522834|Paclitaxel|paclitaxel|mesh-list
13903643|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13903644|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903645|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
13903646|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
13903647|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
13903648|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903649|NCT00522145|XL647|xl647|mesh-list
13903650|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034913|NCT05344833|Growth Substances|growth substances|mesh-ancestor
14034914|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
14034915|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034916|NCT05344742|Paclitaxel|paclitaxel|mesh-list
14034917|NCT05344742|Capecitabine|capecitabine|mesh-list
14034918|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
14034919|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14034920|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034921|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
14034922|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
14034923|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
14034924|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034925|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14034926|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
14034927|NCT05344742|Analgesics|analgesics|mesh-ancestor
14034928|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
14034929|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034930|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034931|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14034932|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14755905|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755906|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755907|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14755908|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14755909|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14755910|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14755911|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14755912|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14755913|NCT03669614|Gallium citrate|gallium citrate|mesh-list
14755914|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755915|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14755916|NCT03667482|Cetuximab|cetuximab|mesh-list
14755917|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755918|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755919|NCT03661411|Aspirin|aspirin|mesh-list
14755920|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14755921|NCT03661411|Clopidogrel|clopidogrel|mesh-list
14755922|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14755923|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14932864|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14932865|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
14932866|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932867|NCT01447654|Losartan|losartan|mesh-list
14932868|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14755924|NCT03661411|Analgesics|analgesics|mesh-ancestor
14755925|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
13903651|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13903652|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903653|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903654|NCT00520923|Olanzapine|olanzapine|mesh-list
13903655|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
13903656|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
13903657|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034933|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471756|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
14471757|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
14471758|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471759|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471760|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471761|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
14471762|NCT02336815|Hormones|hormones|mesh-ancestor
14471763|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471764|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034934|NCT05344625|Ketamine|ketamine|mesh-list
14471765|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471766|NCT02336958|Ropivacaine|ropivacaine|mesh-list
14471767|NCT02336958|Prilocaine|prilocaine|mesh-list
14471768|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
14471769|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
14471770|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471771|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471772|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
14471773|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471774|NCT02337478|Vincristine|vincristine|mesh-list
14471775|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14471776|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471777|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
14471778|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
14471779|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
14471780|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471781|NCT02337491|Bevacizumab|bevacizumab|mesh-list
14471782|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
14755926|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14755927|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755928|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14755929|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755930|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13903658|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903659|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13903660|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13903661|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13903662|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13903663|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14755931|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14755932|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755933|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14755934|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14755935|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755936|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
14755937|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14755938|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14755939|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14755940|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
14755941|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14755942|NCT03651011|Aflibercept|aflibercept|mesh-list
14755943|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14755944|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14755945|NCT03651011|Growth Substances|growth substances|mesh-ancestor
14755946|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755947|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
14755948|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755949|NCT03646604|Upadacitinib|upadacitinib|mesh-list
14755950|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14755951|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755952|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755953|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903664|NCT00520923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13903665|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13903666|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903667|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903668|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903669|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
13903670|NCT00519142|Mitiglinide|mitiglinide|mesh-list
14471783|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903671|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13903672|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903673|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13903674|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
13903675|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
13903676|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034935|NCT05344625|Analgesics|analgesics|mesh-ancestor
14034936|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
13903677|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
13903678|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903679|NCT00517153|Miglustat|miglustat|mesh-list
13903680|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903681|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903682|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13903683|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13903684|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
13903685|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903686|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14182962|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
13903687|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14471784|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903688|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903689|NCT00517049|Rituximab|rituximab|mesh-list
13903690|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903691|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903692|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
13903693|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903694|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903695|NCT00514371|Bortezomib|bortezomib|mesh-list
13903696|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903697|NCT00514267|Prednisone|prednisone|mesh-list
13903698|NCT00514267|Docetaxel|docetaxel|mesh-list
14755954|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14755955|NCT03641326|Sunitinib|sunitinib|mesh-list
14755956|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755957|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14755958|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471785|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14471786|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471787|NCT02337491|Growth Substances|growth substances|mesh-ancestor
14471788|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471789|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
14471790|NCT02337530|Carboplatin|carboplatin|mesh-list
14471791|NCT02337530|Pemetrexed|pemetrexed|mesh-list
14471792|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471793|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471794|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471795|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14471796|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14471797|NCT02337907|Donepezil|donepezil|mesh-list
14471798|NCT02337907|BI 409306|bi 409306|mesh-list
14471799|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14471800|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471801|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471802|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
14471803|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034937|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471804|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903699|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034938|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034939|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14034940|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14034941|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
14034942|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
14034943|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034944|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13903700|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
13903701|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
13903702|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
13903703|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903704|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903705|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
13903706|NCT00514267|Hormones|hormones|mesh-ancestor
13903707|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903708|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903709|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13903710|NCT00512317|Ganaxolone|ganaxolone|mesh-list
13903711|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
13903712|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903713|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903714|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903715|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
14034945|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14034946|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034947|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034948|NCT05344495|Dexamethasone|dexamethasone|mesh-list
14034949|NCT05344495|Dexamethasone acetate|dexamethasone acetate|mesh-list
14034950|NCT05344495|Midazolam|midazolam|mesh-list
14034951|NCT05344495|Bupivacaine|bupivacaine|mesh-list
14471805|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
14471806|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14471807|NCT02337933|Ursolic acid|ursolic acid|mesh-list
14471808|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903716|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
13903717|NCT00511459|Paclitaxel|paclitaxel|mesh-list
14034952|NCT05344495|BB 1101|bb 1101|mesh-list
14471809|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903718|NCT00511459|Bevacizumab|bevacizumab|mesh-list
13903719|NCT00511459|Trebananib|trebananib|mesh-list
13903720|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14471810|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14471811|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471812|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14471813|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471814|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14471815|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14471816|NCT02337933|Analgesics|analgesics|mesh-ancestor
14471817|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
14471818|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034953|NCT05344495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14034954|NCT05344495|Antiemetics|antiemetics|mesh-ancestor
14471819|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034955|NCT05344495|Autonomic Agents|autonomic agents|mesh-ancestor
14471820|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14471821|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14471822|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
14471823|NCT02337946|Leucovorin|leucovorin|mesh-list
14471824|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
14471825|NCT02337946|Fluorouracil|fluorouracil|mesh-list
14755959|NCT03641326|Growth Substances|growth substances|mesh-ancestor
13903721|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903722|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
13903723|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
13903724|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
13903725|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903726|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903727|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13903728|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13903729|NCT00511459|Growth Substances|growth substances|mesh-ancestor
13903730|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903731|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
13903732|NCT00511043|Vatalanib|vatalanib|mesh-list
13903733|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13903734|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903735|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903736|NCT00508989|Niacin|niacin|mesh-list
13903737|NCT00508989|Acetylcholine|acetylcholine|mesh-list
13903738|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13903739|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
13903740|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903741|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13903742|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
13903743|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
13903744|NCT00508989|Vitamins|vitamins|mesh-ancestor
13903745|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
13903746|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903747|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13903748|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
13903749|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903750|NCT00508625|Paclitaxel|paclitaxel|mesh-list
14034956|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14034957|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903751|NCT00508625|Bevacizumab|bevacizumab|mesh-list
13903752|NCT00508625|Carboplatin|carboplatin|mesh-list
13903753|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13903754|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903755|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
13903756|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
13903757|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
13903758|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903759|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903760|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13903761|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14755960|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755961|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
14755962|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755963|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755964|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755965|NCT03637062|Progesterone|progesterone|mesh-list
14755966|NCT03637062|Progestins|progestins|mesh-ancestor
14755967|NCT03637062|Hormones|hormones|mesh-ancestor
14755968|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755969|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755970|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
14034958|NCT05344495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14034959|NCT05344495|Glucocorticoids|glucocorticoids|mesh-ancestor
14034960|NCT05344495|Hormones|hormones|mesh-ancestor
14034961|NCT05344495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14034962|NCT05344495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14034963|NCT05344495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034964|NCT05344495|Protease Inhibitors|protease inhibitors|mesh-ancestor
13903762|NCT00508625|Growth Substances|growth substances|mesh-ancestor
14932869|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932870|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14034965|NCT05344495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932871|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13903763|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903764|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
13903765|NCT00508066|Bupivacaine|bupivacaine|mesh-list
13903766|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
13903767|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
13903768|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13903769|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903770|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
13903771|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903772|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13903773|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13903774|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13903775|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903776|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903777|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903778|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903779|NCT00507936|Analgesics|analgesics|mesh-ancestor
13903780|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
13903781|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932872|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932873|NCT01447797|Irbesartan|irbesartan|mesh-list
13903782|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
13903783|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13903784|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
13903785|NCT00501709|Abatacept|abatacept|mesh-list
14182963|NCT04731766|Protective Agents|protective agents|mesh-ancestor
14932874|NCT01447797|Atorvastatin|atorvastatin|mesh-list
14932875|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14932876|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14932877|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
14932878|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034966|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034967|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
14034968|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
14034969|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14034970|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
14034971|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14034972|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14034973|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14034974|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14034975|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14034976|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14471826|NCT02337946|Panitumumab|panitumumab|mesh-list
14034977|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
14471827|NCT02337946|Calcium|calcium|mesh-list
14932879|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14932880|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14932881|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932882|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14932883|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14932884|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14932885|NCT01447862|Ibutilide|ibutilide|mesh-list
14932886|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14932887|NCT01447875|Propofol|propofol|mesh-list
14932888|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14932889|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932890|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932891|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14755971|NCT03633110|Nivolumab|nivolumab|mesh-list
14755972|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14755973|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755974|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14755975|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755976|NCT03628066|Letrozole|letrozole|mesh-list
14755977|NCT03628066|Palbociclib|palbociclib|mesh-list
14755978|NCT03628066|Goserelin|goserelin|mesh-list
14932892|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
14932893|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
14932894|NCT01447979|Pancrelipase|pancrelipase|mesh-list
14932895|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14932896|NCT01447992|Pancrelipase|pancrelipase|mesh-list
14932897|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14932898|NCT01448018|Ranibizumab|ranibizumab|mesh-list
14932899|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14932900|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14932901|NCT01448018|Growth Substances|growth substances|mesh-ancestor
14932902|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903786|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13903787|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13903788|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903789|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903790|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
13903791|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903792|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903793|NCT00498836|Sorafenib|sorafenib|mesh-list
13903794|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903795|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13903796|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903797|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903798|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
13903799|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13903800|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
13903801|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903802|NCT00495885|Volinanserin|volinanserin|mesh-list
13903803|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13903804|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
13903805|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903806|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903807|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034978|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
14034979|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
14034980|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034981|NCT05344469|Interferons|interferons|mesh-list
14034982|NCT05344469|Interferon-beta|interferon-beta|mesh-list
14034983|NCT05344469|Ofatumumab|ofatumumab|mesh-list
14034984|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
14034985|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
14034986|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14034987|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
14034988|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14034989|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14034990|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
14034991|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14034992|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14034993|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14034994|NCT05344443|Lemborexant|lemborexant|mesh-list
14034995|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14034996|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14034997|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14034998|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14034999|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14035000|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035001|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035002|NCT05344417|Iodine|iodine|mesh-list
14035003|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14035004|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035005|NCT05344417|Trace Elements|trace elements|mesh-ancestor
14035006|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
14035007|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903808|NCT00495131|Interferons|interferons|mesh-list
13903809|NCT00495131|Ribavirin|ribavirin|mesh-list
13903810|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
13903811|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
13903812|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13903813|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903814|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
13903815|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903816|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
13903817|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903818|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
13903819|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903820|NCT00491738|Bevacizumab|bevacizumab|mesh-list
13903821|NCT00491738|Sunitinib|sunitinib|mesh-list
13903822|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903823|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903824|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13903825|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13903826|NCT00491738|Growth Substances|growth substances|mesh-ancestor
13903827|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903828|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
13903829|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13903830|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903831|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903832|NCT00489203|Beclomethasone|beclomethasone|mesh-list
13903833|NCT00489203|Methotrexate|methotrexate|mesh-list
13903834|NCT00489203|Tacrolimus|tacrolimus|mesh-list
13903835|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13903836|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
14471828|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
13903837|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13903838|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903839|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13903840|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
13903841|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035020|NCT05344365|Iloperidone|iloperidone|mesh-list
14035021|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14035022|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14035023|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035024|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035025|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14035026|NCT05344248|Antibodies|antibodies|mesh-list
14035027|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14035028|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
14035029|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035030|NCT05344209|Sargramostim|sargramostim|mesh-list
14035031|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
14035032|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035033|NCT05344027|Mitotane|mitotane|mesh-list
14035034|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14035035|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035036|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
14035037|NCT05343806|Nifedipine|nifedipine|mesh-list
14035038|NCT05343806|Analgesics|analgesics|mesh-ancestor
14035039|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
14035040|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035041|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035042|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
14035043|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035044|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13903842|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903843|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
13903844|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903845|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13903846|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13903847|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
13903848|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903849|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13903850|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13903851|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903852|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
13903853|NCT00489203|Hormones|hormones|mesh-ancestor
13903854|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903855|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13903856|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
14035045|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
14035046|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14035047|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14035048|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035049|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14035050|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
14035051|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14035052|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
14035053|NCT05343767|Metformin|metformin|mesh-list
14035054|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14035055|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035056|NCT05343728|Hemostatics|hemostatics|mesh-list
14035057|NCT05343728|Coagulants|coagulants|mesh-ancestor
14035058|NCT05343702|Rocuronium|rocuronium|mesh-list
14035059|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14035060|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14035061|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13903857|NCT00488839|Baclofen|baclofen|mesh-list
13903858|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13903859|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903860|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14035062|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035063|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035064|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14035065|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
14035066|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14035067|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14035068|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035069|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035070|NCT05343637|Urological Agents|urological agents|mesh-ancestor
14932903|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
14932904|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932905|NCT01448031|Esomeprazole|esomeprazole|mesh-list
14035071|NCT05343572|Plerixafor|plerixafor|mesh-list
14035072|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14035073|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14035074|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
14035075|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035076|NCT05343546|Copper|copper|mesh-list
14035077|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
14035078|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14035079|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
14035080|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14035081|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035082|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14035083|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14035084|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14035085|NCT05343546|Trace Elements|trace elements|mesh-ancestor
14035086|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
14035087|NCT05343507|Ketamine|ketamine|mesh-list
14035088|NCT05343507|Analgesics|analgesics|mesh-ancestor
14035089|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
14035090|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903861|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903862|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13903863|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
13903864|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
13903865|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903866|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903867|NCT00488267|Ketoprofen|ketoprofen|mesh-list
13903868|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13903869|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13903870|NCT00488267|Analgesics|analgesics|mesh-ancestor
13903871|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
13903872|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903873|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903874|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903875|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903876|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13903877|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903878|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903879|NCT00486512|Aspirin|aspirin|mesh-list
13903880|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
13903881|NCT00486512|Calcitriol|calcitriol|mesh-list
13903882|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
13903883|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
13903884|NCT00486512|Calcium|calcium|mesh-list
13903885|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13903886|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903887|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13903888|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13903889|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13903890|NCT00486512|Analgesics|analgesics|mesh-ancestor
14035091|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035092|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14035093|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14035094|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
14035095|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
14035096|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035097|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14035098|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14932906|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14932907|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14932908|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14932909|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035099|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035100|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035101|NCT05343481|Nivolumab|nivolumab|mesh-list
14035102|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035103|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035104|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14035105|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035106|NCT05343455|Doxycycline|doxycycline|mesh-list
14035107|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14035108|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035109|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
14035110|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14035111|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13903891|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
13903892|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903893|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903894|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13903895|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13903896|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13903897|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903898|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13903899|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13903900|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903901|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
13903902|NCT00486512|Antacids|antacids|mesh-ancestor
14471829|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14471830|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471831|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14471832|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471833|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
14471834|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471835|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14471836|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14035112|NCT05343429|Aspirin|aspirin|mesh-list
14035113|NCT05343429|Benzydamine|benzydamine|mesh-list
14035114|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14471837|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
14471838|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471839|NCT02337946|Antidotes|antidotes|mesh-ancestor
14471840|NCT02337946|Protective Agents|protective agents|mesh-ancestor
14471841|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
14471842|NCT02337946|Vitamins|vitamins|mesh-ancestor
14471843|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
13903903|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13903904|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13903905|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903906|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13903907|NCT00486512|Vitamins|vitamins|mesh-ancestor
13903908|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
13903909|NCT00486200|Valacyclovir|valacyclovir|mesh-list
13903910|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
14471844|NCT02338076|Petrolatum|petrolatum|mesh-list
14471845|NCT02338076|Emollients|emollients|mesh-ancestor
13903911|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903912|NCT00485563|Folic Acid|folic acid|mesh-list
13903913|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
13903914|NCT00485563|Interferons|interferons|mesh-list
13903915|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
13903916|NCT00485563|Interleukin-2|interleukin-2|mesh-list
13903917|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
13903918|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903919|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
14035115|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035116|NCT05343429|Analgesics|analgesics|mesh-ancestor
14035117|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
14035118|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035119|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035120|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035121|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14035122|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14035123|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14471846|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
14471847|NCT02338193|Metformin|metformin|mesh-list
13903920|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903921|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
13903922|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903923|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13903924|NCT00485563|Analgesics|analgesics|mesh-ancestor
13903925|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
13903926|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903927|NCT00485563|Hematinics|hematinics|mesh-ancestor
13903928|NCT00485563|Vitamins|vitamins|mesh-ancestor
13903929|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
13903930|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13903931|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13903932|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
13903933|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
13903934|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13903935|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903936|NCT00484419|Incretins|incretins|mesh-ancestor
13903937|NCT00484419|Hormones|hormones|mesh-ancestor
13903938|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13903939|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13903940|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
13903941|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13903942|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903943|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13903944|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13903945|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
13903946|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13959469|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959470|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959471|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
13959472|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959473|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13959474|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
13959475|NCT03162653|Protective Agents|protective agents|mesh-ancestor
13959476|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959477|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13959478|NCT03162653|Diuretics|diuretics|mesh-ancestor
13959479|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
13959480|NCT03162731|Nivolumab|nivolumab|mesh-list
13959481|NCT03162731|Ipilimumab|ipilimumab|mesh-list
13959482|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959483|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959484|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13959485|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959486|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
13959487|NCT03162588|Hematinics|hematinics|mesh-ancestor
13959488|NCT03162406|Vitamin D|vitamin d|mesh-list
13959489|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
13959490|NCT03162406|Vitamins|vitamins|mesh-ancestor
13959491|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
13959492|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959493|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13959494|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14035124|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035125|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14035126|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14035127|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035128|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
14035129|NCT05343338|Sivelestat|sivelestat|mesh-list
14035130|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14035131|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
14035132|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035133|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035134|NCT05343325|Paclitaxel|paclitaxel|mesh-list
14035135|NCT05343325|Cisplatin|cisplatin|mesh-list
14035136|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14035137|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14035138|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035139|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
14035140|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
14035141|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
14035142|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035143|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14035144|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
14035145|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14035146|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14035147|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035148|NCT05343299|Lidocaine|lidocaine|mesh-list
13959495|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
13959496|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13903947|NCT00483977|Oxycodone|oxycodone|mesh-list
13903948|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13903949|NCT00483977|Narcotics|narcotics|mesh-ancestor
13903950|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471848|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
14471849|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13903951|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903952|NCT00483977|Analgesics|analgesics|mesh-ancestor
13903953|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
13903954|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13903955|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
13903956|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13903957|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
13903958|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13903959|NCT00481325|Citalopram|citalopram|mesh-list
13903960|NCT00481325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13903961|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13903962|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13903963|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903964|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13903965|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
13903966|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903967|NCT00481325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13903968|NCT00481325|Antidepressive Agents|antidepressive agents|mesh-ancestor
13903969|NCT00481325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13903970|NCT00480831|Paclitaxel|paclitaxel|mesh-list
13903971|NCT00480831|Bevacizumab|bevacizumab|mesh-list
13903972|NCT00480831|Carboplatin|carboplatin|mesh-list
13903973|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13903974|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903975|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
13903976|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
13903977|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
13903978|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903979|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13903980|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13903981|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13903982|NCT00480831|Growth Substances|growth substances|mesh-ancestor
13903983|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903984|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
13903985|NCT00479817|Paclitaxel|paclitaxel|mesh-list
13903986|NCT00479817|Trebananib|trebananib|mesh-list
13903987|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13903988|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13903989|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
13903990|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
13903991|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
13903992|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13903993|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13903994|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13903995|NCT00479817|Growth Substances|growth substances|mesh-ancestor
13903996|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13903997|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
13903998|NCT00479258|Insulin|insulin|mesh-list
13903999|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13904000|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904001|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904002|NCT00478972|Rimonabant|rimonabant|mesh-list
13904003|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13904004|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13904005|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13904006|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904007|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904008|NCT00478972|Hormones|hormones|mesh-ancestor
13904009|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904010|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904011|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13904012|NCT00478595|Rimonabant|rimonabant|mesh-list
13904013|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13904014|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13904015|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13904016|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035149|NCT05343299|Ropivacaine|ropivacaine|mesh-list
14755979|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755980|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14755981|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14755982|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755983|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755984|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14755985|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
13904017|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035150|NCT05343299|Anesthetics|anesthetics|mesh-list
14035151|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
14035152|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035153|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035154|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
14035155|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035156|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14035157|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14035158|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14035159|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14035160|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035161|NCT05343260|Propofol|propofol|mesh-list
14035162|NCT05343260|Sevoflurane|sevoflurane|mesh-list
14035163|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14035164|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035165|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035166|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13904018|NCT00478595|Hormones|hormones|mesh-ancestor
13904019|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904020|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904021|NCT00478179|Bupivacaine|bupivacaine|mesh-list
13904022|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
13904023|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
13904024|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904025|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904026|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
13904027|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904028|NCT00477529|Docetaxel|docetaxel|mesh-list
13904029|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904030|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
13904031|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
13904032|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
13904033|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904034|NCT00474188|Dexamethasone|dexamethasone|mesh-list
13904035|NCT00474188|Lenalidomide|lenalidomide|mesh-list
13904036|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035167|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
14035168|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
14035169|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14035170|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14035171|NCT05343169|Naloxone|naloxone|mesh-list
14035172|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13904037|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
13904038|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
13904039|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904040|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904041|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13904042|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
13904043|NCT00474188|Hormones|hormones|mesh-ancestor
13904044|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904045|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13904046|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904047|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
13904048|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13904049|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13904050|NCT00474188|Growth Substances|growth substances|mesh-ancestor
13904051|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904052|NCT00472693|Bevacizumab|bevacizumab|mesh-list
14035173|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035174|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
14035175|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035176|NCT05343156|Dexamethasone|dexamethasone|mesh-list
14035177|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14035178|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035179|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
14035180|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
14035181|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035182|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035183|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13904053|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13904054|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904055|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904056|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13904057|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13904058|NCT00472693|Growth Substances|growth substances|mesh-ancestor
13904059|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904060|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904061|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13904062|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13904063|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
14035184|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
14035185|NCT05343156|Hormones|hormones|mesh-ancestor
14035186|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14035187|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14035188|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035189|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14471850|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471851|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13904064|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904065|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904066|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13904067|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
13904068|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13904069|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13904070|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13904071|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
13904072|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904073|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904074|NCT00468442|Sirolimus|sirolimus|mesh-list
13904075|NCT00468442|Rituximab|rituximab|mesh-list
13904076|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13904077|NCT00468442|Daclizumab|daclizumab|mesh-list
13904078|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471852|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471853|NCT02338362|Fluticasone|fluticasone|mesh-list
14471854|NCT02338362|Xhance|xhance|mesh-list
14035195|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
14035196|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14035197|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035198|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14035199|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471855|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035200|NCT05343013|Trifluridine|trifluridine|mesh-list
14035201|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
14035202|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035203|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
14035204|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035205|NCT05342974|Misoprostol|misoprostol|mesh-list
14035206|NCT05342974|Atorvastatin|atorvastatin|mesh-list
14035207|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14035208|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14035209|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
14035210|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035211|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14035212|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14035213|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035214|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14035215|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
14035216|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14035217|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471856|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13904079|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904080|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
13904081|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904082|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904083|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904084|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904085|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13904086|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
13904087|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904088|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
13904089|NCT00468403|Abatacept|abatacept|mesh-list
13904090|NCT00468403|Tacrolimus|tacrolimus|mesh-list
13904091|NCT00468403|Basiliximab|basiliximab|mesh-list
13904092|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904093|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
13904094|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904095|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13904096|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904097|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904098|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13904099|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904100|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13904101|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
13904102|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904103|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904104|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13904105|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904106|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
13904107|NCT00468273|Antibodies|antibodies|mesh-list
13904108|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
13904109|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13904110|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13904111|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
13904112|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904113|NCT00468117|Etanercept|etanercept|mesh-list
13904114|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13904115|NCT00468117|Basiliximab|basiliximab|mesh-list
13904116|NCT00468117|Daclizumab|daclizumab|mesh-list
13904117|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13904118|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13904119|NCT00468117|Analgesics|analgesics|mesh-ancestor
14035218|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14035219|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14035220|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
14035221|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
14035222|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13904120|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
13904121|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904122|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904123|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904124|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904125|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13904126|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904127|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
13904128|NCT00468039|Metformin|metformin|mesh-list
13904129|NCT00468039|Vildagliptin|vildagliptin|mesh-list
13904130|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904131|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904132|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13904133|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
13904134|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904135|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904136|NCT00467402|S 20098|s 20098|mesh-list
13904137|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13904138|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904139|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904140|NCT00467025|Sorafenib|sorafenib|mesh-list
13904141|NCT00467025|Trebananib|trebananib|mesh-list
13904142|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904143|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13904144|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904145|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035223|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904146|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13904147|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13904148|NCT00467025|Growth Substances|growth substances|mesh-ancestor
13904149|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904150|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904151|NCT00465959|Trospium chloride|trospium chloride|mesh-list
13904152|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
13904153|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
13904154|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904155|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904156|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13904157|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13904158|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
13904159|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904160|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904161|NCT00465959|Urological Agents|urological agents|mesh-ancestor
13904162|NCT00465803|Timolol|timolol|mesh-list
13904163|NCT00465803|Travoprost|travoprost|mesh-list
13904164|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13904165|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13904166|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13904167|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13904168|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
13904169|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904170|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904171|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904172|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13904173|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13904174|NCT00465517|Ganaxolone|ganaxolone|mesh-list
13904175|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
13904176|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904177|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904178|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904179|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
13904180|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
14035224|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035225|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035226|NCT05342870|Analgesics|analgesics|mesh-ancestor
13904181|NCT00464633|Alvocidib|alvocidib|mesh-list
13904182|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904183|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904184|NCT00464633|Growth Substances|growth substances|mesh-ancestor
13904185|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904186|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13904187|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904188|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904189|NCT00464555|Sirolimus|sirolimus|mesh-list
13904190|NCT00464555|Lisofylline|lisofylline|mesh-list
13904191|NCT00464555|Tacrolimus|tacrolimus|mesh-list
13904192|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13904193|NCT00464555|Basiliximab|basiliximab|mesh-list
13904194|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904195|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
13904196|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904197|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13904198|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904199|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904200|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904201|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035227|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
14035228|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035229|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14035230|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14035231|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14035232|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
14035233|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035234|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035235|NCT05342857|Aflibercept|aflibercept|mesh-list
13904202|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13904203|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904204|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
13904205|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13904206|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13904207|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13904208|NCT00464555|Analgesics|analgesics|mesh-ancestor
13904209|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
13904210|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904211|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904212|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904213|NCT00464243|Volinanserin|volinanserin|mesh-list
13904214|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13904215|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
13904216|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904217|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904218|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035236|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14035237|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14035238|NCT05342857|Growth Substances|growth substances|mesh-ancestor
14035239|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035240|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
14035241|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035242|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
14035243|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14035244|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035245|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035246|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035247|NCT05342844|Analgesics|analgesics|mesh-ancestor
14035248|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
14035249|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035250|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14035251|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14035252|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14035253|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
14035254|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904219|NCT00464061|Volinanserin|volinanserin|mesh-list
13904220|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13904221|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
14035255|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035256|NCT05342818|Ondansetron|ondansetron|mesh-list
14035257|NCT05342818|Metoclopramide|metoclopramide|mesh-list
14035258|NCT05342818|Neostigmine|neostigmine|mesh-list
14035259|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
14035260|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
14035261|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035262|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035263|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14035264|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
14035265|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
14035266|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14035267|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
14035268|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035269|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035270|NCT05342818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14035271|NCT05342818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14035272|NCT05342818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035273|NCT05342818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14035274|NCT05342818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14035275|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14035276|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035277|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
13904222|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904223|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904224|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904225|NCT00463242|S 20098|s 20098|mesh-list
13904226|NCT00463242|Paroxetine|paroxetine|mesh-list
13904227|NCT00463242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14035278|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14035279|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14035280|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14035281|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
14035282|NCT05342792|Capecitabine|capecitabine|mesh-list
14035283|NCT05342792|Antibodies|antibodies|mesh-list
13904228|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13904229|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13904230|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904231|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904232|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
13904233|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904234|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13904235|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
13904236|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13904237|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13904238|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13904239|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904240|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13904241|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904242|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
13904243|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
13904244|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13904245|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
13904246|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904247|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14035284|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
14035285|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035286|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14035287|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
14035288|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035289|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035290|NCT05342662|Methamphetamine|methamphetamine|mesh-list
14035291|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14035292|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035293|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
14035294|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
14035295|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035296|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
14035297|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035298|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035299|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
14035300|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14035301|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14035302|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14035303|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14035304|NCT05331911|Propofol|propofol|mesh-list
14035305|NCT05331911|Sevoflurane|sevoflurane|mesh-list
14035306|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
14035307|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035308|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035309|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14035310|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14035311|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
14035312|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14035313|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14035314|NCT05331027|Sevoflurane|sevoflurane|mesh-list
14035315|NCT05331027|Desflurane|desflurane|mesh-list
14035316|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14035317|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14035318|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
14035319|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
14035320|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035321|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035322|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
14035323|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14035324|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
14035325|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471857|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
14471858|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471859|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904248|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13904249|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13904250|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904251|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904252|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13904253|NCT00460941|Incretins|incretins|mesh-ancestor
13904254|NCT00460941|Hormones|hormones|mesh-ancestor
13904255|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471860|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14471861|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
14035331|NCT05329779|Pregnanolone|pregnanolone|mesh-list
14035332|NCT05329779|Brexanolone|brexanolone|mesh-list
14035333|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
14035334|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035335|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035336|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
14035337|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035338|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904256|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904257|NCT00460317|Paclitaxel|paclitaxel|mesh-list
14755986|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14755987|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14755988|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14755989|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14755990|NCT03609216|Gemcitabine|gemcitabine|mesh-list
14755991|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14755992|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14755993|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
14755994|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14755995|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
14755996|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14755997|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14755998|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14755999|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
14756000|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756001|NCT03604406|Vaccines|vaccines|mesh-list
14756002|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
13904258|NCT00460317|Carboplatin|carboplatin|mesh-list
13904259|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
13904260|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13904261|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904262|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
13904263|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
13904264|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
13904265|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904266|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13904267|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904268|NCT00459745|Fenofibrate|fenofibrate|mesh-list
13904269|NCT00459745|Pravastatin|pravastatin|mesh-list
13904270|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13904271|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
13904272|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904273|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13904274|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13904275|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13904276|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904277|NCT00459277|Fentanyl|fentanyl|mesh-list
13904278|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13904279|NCT00459277|Narcotics|narcotics|mesh-ancestor
13904280|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904281|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904282|NCT00459277|Analgesics|analgesics|mesh-ancestor
13904283|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
13904284|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904285|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13904286|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13904287|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
13904288|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
13904289|NCT00458978|Cediranib|cediranib|mesh-list
13904290|NCT00458978|Maleic acid|maleic acid|mesh-list
13904291|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904292|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904293|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035339|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
14756003|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756004|NCT03568097|Avelumab|avelumab|mesh-list
14756005|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756006|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756007|NCT03567720|Paclitaxel|paclitaxel|mesh-list
14756008|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
14756009|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756010|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904294|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13904295|NCT00458601|Temozolomide|temozolomide|mesh-list
13904296|NCT00458601|Molgramostim|molgramostim|mesh-list
13904297|NCT00458601|Rindopepimut|rindopepimut|mesh-list
13904298|NCT00458601|Sargramostim|sargramostim|mesh-list
13904299|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13904300|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
13904301|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756011|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756012|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
13904302|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904303|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
14035340|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
14756013|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756014|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756015|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756016|NCT03557788|Rifaximin|rifaximin|mesh-list
14756017|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14756018|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471862|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
14471863|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14471864|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
13904304|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904305|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904306|NCT00458276|Tezosentan|tezosentan|mesh-list
13904307|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
13904308|NCT00457457|Tamsulosin|tamsulosin|mesh-list
13904309|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13904310|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13904311|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13904312|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
13904313|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904314|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904315|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904316|NCT00457457|Urological Agents|urological agents|mesh-ancestor
13904317|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
13904318|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904319|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13904320|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904321|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904322|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14035341|NCT05329155|Heparin|heparin|mesh-list
14035342|NCT05329155|Calcium heparin|calcium heparin|mesh-list
14035343|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
14035344|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14471865|NCT02338713|Antacids|antacids|mesh-ancestor
14471866|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035345|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14035346|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471867|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471868|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
14471869|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14471870|NCT02338973|Interferons|interferons|mesh-list
14471871|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
14471872|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471873|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
14471874|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471875|NCT02338999|Pioglitazone|pioglitazone|mesh-list
14471876|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14471877|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471878|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
14471879|NCT02339038|Ledipasvir|ledipasvir|mesh-list
14471880|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
14471881|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471882|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
14471883|NCT02339155|Promethazine|promethazine|mesh-list
14756019|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14756020|NCT03557385|Adenosine|adenosine|mesh-list
14756021|NCT03557385|Analgesics|analgesics|mesh-ancestor
14471884|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14471885|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14471886|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14471887|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471888|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
14471889|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
14471890|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
14471891|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471892|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
14471893|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
13904323|NCT00455156|ST 1435|st 1435|mesh-list
13904324|NCT00455156|Estradiol|estradiol|mesh-list
13904325|NCT00455156|Estrogens|estrogens|mesh-ancestor
13904326|NCT00455156|Hormones|hormones|mesh-ancestor
13904327|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904328|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904329|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13904330|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
13904331|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13904332|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13904333|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13904334|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13904335|NCT00453531|Acetylcholine|acetylcholine|mesh-list
13904336|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
13904337|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13904338|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
13904339|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904340|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904341|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904342|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
13904343|NCT00451152|Anecortave|anecortave|mesh-list
13904344|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13904345|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13904346|NCT00451152|Growth Substances|growth substances|mesh-ancestor
13904347|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904348|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904349|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904350|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904351|NCT00450970|Satraplatin|satraplatin|mesh-list
13904352|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904353|NCT00449605|Metformin|metformin|mesh-list
13904354|NCT00449605|Glimepiride|glimepiride|mesh-list
13904355|NCT00449605|Rimonabant|rimonabant|mesh-list
13904356|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904357|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904358|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13904359|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904360|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
13904361|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13904362|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13904363|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13904364|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904365|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904366|NCT00449605|Hormones|hormones|mesh-ancestor
13904367|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904368|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
13904369|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904370|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904371|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13904372|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13904373|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904374|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904375|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904376|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13904377|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13904378|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13904379|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13904380|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904381|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904382|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904383|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14471894|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14471895|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14471896|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
14471897|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
14471898|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471899|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471900|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14471901|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
14471902|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
14471903|NCT02339246|Tacrolimus|tacrolimus|mesh-list
14471904|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14471905|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
14471906|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471907|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14471908|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471909|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904384|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
13904385|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14471910|NCT02339415|Edoxaban|edoxaban|mesh-list
14471911|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14471912|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
14035368|NCT05325099|Azacitidine|azacitidine|mesh-list
14035369|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14035370|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
14035371|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035372|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035373|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035374|NCT05321160|Ketamine|ketamine|mesh-list
14035375|NCT05321160|Sevoflurane|sevoflurane|mesh-list
14035376|NCT05321160|Esketamine|esketamine|mesh-list
14035377|NCT05321160|Analgesics|analgesics|mesh-ancestor
14035378|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
13904386|NCT00447564|Buprenorphine|buprenorphine|mesh-list
13904387|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13904388|NCT00447564|Narcotics|narcotics|mesh-ancestor
13904389|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904390|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904391|NCT00447564|Analgesics|analgesics|mesh-ancestor
13904392|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
13904393|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904394|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13904395|NCT00445198|Navitoclax|navitoclax|mesh-list
13904396|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904397|NCT00443287|Cilostazol|cilostazol|mesh-list
13904398|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
13904399|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13904400|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
13904401|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904402|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904403|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13904404|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
13904405|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13904406|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13904407|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904408|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13904409|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
13904410|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13904411|NCT00443287|Protective Agents|protective agents|mesh-ancestor
13904412|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13904413|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13904414|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904415|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
13904416|NCT00442104|Ganaxolone|ganaxolone|mesh-list
13904417|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
13904418|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035379|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035380|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035381|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14035382|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14035383|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
14035384|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
14035385|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035386|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14035387|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14035388|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471913|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13904419|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904420|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904421|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
13904422|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
13904423|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
13904424|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
13904425|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13904426|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904427|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904428|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
13904429|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13904430|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035389|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035390|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14035391|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14035392|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
14035393|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14756022|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
14756023|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756024|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756025|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14756026|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
14756027|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14756028|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
14035401|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
14471914|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
14471915|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471916|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471917|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
14471918|NCT02339506|Cosyntropin|cosyntropin|mesh-list
14471919|NCT02339506|Hormones|hormones|mesh-ancestor
14471920|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14471921|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471922|NCT02339558|Nivolumab|nivolumab|mesh-list
14756029|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
14932910|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932911|NCT01448070|Insulin|insulin|mesh-list
14932912|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13904431|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904432|NCT00441896|Ganaxolone|ganaxolone|mesh-list
13904433|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
13904434|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904435|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904436|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904437|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
13904438|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
13904439|NCT00440531|Vaccines|vaccines|mesh-list
13904440|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
13904441|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904442|NCT00440388|Rituximab|rituximab|mesh-list
13904443|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904444|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904445|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
13904446|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904447|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904448|NCT00439738|Amlodipine|amlodipine|mesh-list
13904449|NCT00439738|Valsartan|valsartan|mesh-list
13904450|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13904451|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13904452|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13904453|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14035402|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14035403|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035404|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035405|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035406|NCT05305248|Analgesics|analgesics|mesh-ancestor
14035407|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
14035408|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035409|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14035410|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14035411|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14035412|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
14035413|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035414|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035415|NCT05305105|Psilocybin|psilocybin|mesh-list
14035416|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
14035417|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035418|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14035419|NCT05288023|Azithromycin|azithromycin|mesh-list
14035420|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14035421|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471923|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471924|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471925|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14471926|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471927|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14471928|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14471929|NCT02339584|Brinzolamide|brinzolamide|mesh-list
14471930|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14471931|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14471932|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14471933|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14471934|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14471935|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
14471936|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471937|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471938|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471939|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14471940|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479107|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479108|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
14479109|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14479110|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14479111|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
14479112|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479113|NCT02464033|Vitamin D|vitamin d|mesh-list
14479114|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
14479115|NCT02464033|Etanercept|etanercept|mesh-list
14479116|NCT02464033|Vitamins|vitamins|mesh-ancestor
14479117|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
14479118|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479119|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14479120|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14471941|NCT02340000|Amoxicillin|amoxicillin|mesh-list
14471942|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
14471943|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
14471944|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14035460|NCT05278351|Irinotecan|irinotecan|mesh-list
14035461|NCT05278351|Cetuximab|cetuximab|mesh-list
14035462|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14035463|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14035464|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035465|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035466|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035467|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035468|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
14035469|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14035470|NCT05272787|Protective Agents|protective agents|mesh-ancestor
14035471|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035472|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
14035473|NCT05268419|Ethanol|ethanol|mesh-list
14035474|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14035475|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035476|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035477|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035478|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14035479|NCT05267873|Vortioxetine|vortioxetine|mesh-list
14035480|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14035481|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14035482|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14035483|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035484|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904454|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904455|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13904456|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904457|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
13904458|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13904459|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13904460|NCT00439738|Diuretics|diuretics|mesh-ancestor
13904461|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
13904462|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13904463|NCT00437112|Insulin|insulin|mesh-list
13904464|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13904465|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
14035485|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035486|NCT05267873|Analgesics|analgesics|mesh-ancestor
14035487|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
13904466|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904467|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904468|NCT00436683|Sevelamer|sevelamer|mesh-list
13904469|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
13904470|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
13904471|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035488|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035489|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
14035490|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14035491|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
14035492|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14035493|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14035494|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035495|NCT05267873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14035496|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
14035497|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14035498|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14035499|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14035500|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14035501|NCT05251233|Pantoprazole|pantoprazole|mesh-list
14035502|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14035503|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14035504|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14035505|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035506|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471945|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14471946|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14471947|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14932913|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904472|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13904473|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
13904474|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904475|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
14035507|NCT05249959|Rituximab|rituximab|mesh-list
14035508|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14035509|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14035510|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035511|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904476|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904477|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904478|NCT00434850|Gusperimus|gusperimus|mesh-list
13904479|NCT00434850|Sirolimus|sirolimus|mesh-list
13904480|NCT00434850|Etanercept|etanercept|mesh-list
13904481|NCT00434850|Tacrolimus|tacrolimus|mesh-list
13904482|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13904483|NCT00434850|Basiliximab|basiliximab|mesh-list
13904484|NCT00434850|Daclizumab|daclizumab|mesh-list
13904485|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904486|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
13904487|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904488|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13904489|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904490|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904491|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904492|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904493|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13904494|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904495|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
13904496|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13904497|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13904498|NCT00434850|Analgesics|analgesics|mesh-ancestor
13904499|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
13904500|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904501|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904502|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904503|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14035512|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
14035513|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035514|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14035515|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14035516|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
14035517|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035518|NCT05247320|Sotalol|sotalol|mesh-list
14035519|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14035520|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14035521|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
14035522|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035523|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035524|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035525|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14035526|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
14035527|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
14035528|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035529|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
14035530|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904504|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904505|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13904506|NCT00434850|Protective Agents|protective agents|mesh-ancestor
13904507|NCT00434811|Sirolimus|sirolimus|mesh-list
14035531|NCT05244538|Remifentanil|remifentanil|mesh-list
14035532|NCT05244538|Propofol|propofol|mesh-list
14035533|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13904508|NCT00434811|Etanercept|etanercept|mesh-list
13904509|NCT00434811|Tacrolimus|tacrolimus|mesh-list
13904510|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13904511|NCT00434811|Basiliximab|basiliximab|mesh-list
13904512|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904513|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
13904514|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904515|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13904516|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904517|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904518|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904519|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904520|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13904521|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904522|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
13904523|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13904524|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13904525|NCT00434811|Analgesics|analgesics|mesh-ancestor
13904526|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
13904527|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904528|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904529|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904530|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13904531|NCT00434226|Paclitaxel|paclitaxel|mesh-list
13904532|NCT00434226|Bevacizumab|bevacizumab|mesh-list
13904533|NCT00434226|Carboplatin|carboplatin|mesh-list
13904534|NCT00434226|Sunitinib|sunitinib|mesh-list
13904535|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13904536|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904537|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
13904538|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
13904539|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
14035534|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035535|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035536|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14035537|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
14035538|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
14035539|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14035540|NCT05244538|Narcotics|narcotics|mesh-ancestor
14035541|NCT05244538|Analgesics|analgesics|mesh-ancestor
14035542|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
14035543|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035544|NCT05229445|Insulin|insulin|mesh-list
14035545|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14035546|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904540|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904541|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904542|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13904543|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13904544|NCT00434226|Growth Substances|growth substances|mesh-ancestor
13904545|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904546|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904547|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13904548|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932914|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932915|NCT01448096|Rituximab|rituximab|mesh-list
14932916|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471948|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471949|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471950|NCT02340156|Temozolomide|temozolomide|mesh-list
14471951|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14471952|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
14471953|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471954|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471955|NCT02340520|Theophylline|theophylline|mesh-list
14471956|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14471957|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
14471958|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14471959|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471960|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14471961|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
14471962|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14471963|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14471964|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471965|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
14471966|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14471967|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14471968|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
14471969|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471970|NCT02340819|Teduglutide|teduglutide|mesh-list
14756030|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756031|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756032|NCT03557008|Metronidazole|metronidazole|mesh-list
14756033|NCT03557008|Vancomycin|vancomycin|mesh-list
14932917|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14932918|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
14932919|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756034|NCT03557008|Neomycin|neomycin|mesh-list
14756035|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035562|NCT05224141|Carboplatin|carboplatin|mesh-list
14035563|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
14035564|NCT05224141|Etoposide|etoposide|mesh-list
14035565|NCT05224141|Atezolizumab|atezolizumab|mesh-list
14756036|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14756037|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14756038|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14756039|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14756040|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756041|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035566|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035567|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035568|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14035569|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756042|NCT03524092|Mirikizumab|mirikizumab|mesh-list
14035570|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14035571|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035572|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035573|NCT05215951|Osimertinib|osimertinib|mesh-list
14035574|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035575|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14035576|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035577|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035578|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
14035579|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035580|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471971|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14756043|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14932920|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14932921|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
14756044|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756045|NCT03524092|Analgesics|analgesics|mesh-ancestor
14756046|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
14756047|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756048|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756049|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756050|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756051|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14756052|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14756053|NCT03519945|Mirikizumab|mirikizumab|mesh-list
14756054|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14756055|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14471972|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14471973|NCT02340819|Protective Agents|protective agents|mesh-ancestor
14471974|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471975|NCT02340949|Leucovorin|leucovorin|mesh-list
14471976|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
14471977|NCT02340949|Aflibercept|aflibercept|mesh-list
13959497|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959498|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14471978|NCT02340949|Fluorouracil|fluorouracil|mesh-list
14471979|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14471980|NCT02340949|Antidotes|antidotes|mesh-ancestor
14471981|NCT02340949|Protective Agents|protective agents|mesh-ancestor
14471982|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471983|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
14471984|NCT02340949|Vitamins|vitamins|mesh-ancestor
14471985|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
13959499|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959500|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959501|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959502|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959503|NCT03162432|Vitamin D|vitamin d|mesh-list
13959504|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
13959505|NCT03162432|Vitamins|vitamins|mesh-ancestor
13959506|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
14471986|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14471987|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14471988|NCT02340949|Growth Substances|growth substances|mesh-ancestor
14471989|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
14756056|NCT03519945|Analgesics|analgesics|mesh-ancestor
13959507|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14471990|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
14756057|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
14035601|NCT05208307|Dexamethasone|dexamethasone|mesh-list
14035602|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
14035603|NCT05208307|Pomalidomide|pomalidomide|mesh-list
14035604|NCT05208307|Ichthammol|ichthammol|mesh-list
14035605|NCT05208307|BB 1101|bb 1101|mesh-list
14035606|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035607|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
14035608|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
14035609|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035610|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035611|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14035612|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
14035613|NCT05208307|Hormones|hormones|mesh-ancestor
14035614|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14035615|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14035616|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035617|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
14035618|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035619|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035620|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
14035621|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14035622|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14035623|NCT05208307|Growth Substances|growth substances|mesh-ancestor
14035624|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
14035625|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
14035626|NCT05198791|Eplerenone|eplerenone|mesh-list
14035627|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14035628|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
14035629|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14035630|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035631|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14035632|NCT05198791|Diuretics|diuretics|mesh-ancestor
14035633|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
14035634|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14035635|NCT05193071|Aspirin|aspirin|mesh-list
14035636|NCT05193071|Clopidogrel|clopidogrel|mesh-list
14035637|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14035638|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035639|NCT05193071|Analgesics|analgesics|mesh-ancestor
14035640|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
14035641|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035642|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035643|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035644|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904582|NCT00431873|Mocetinostat|mocetinostat|mesh-list
14035645|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14035646|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14035647|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035648|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14035649|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14035650|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904583|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13904584|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904585|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904586|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13904587|NCT00430950|Olmesartan|olmesartan|mesh-list
13904588|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13904589|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13904590|NCT00430950|Diuretics|diuretics|mesh-ancestor
13904591|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
14035651|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
14035652|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14035653|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14035654|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13904592|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904593|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14035655|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
14035656|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14471991|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14471992|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14471993|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14471994|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
14471995|NCT02340962|Interferons|interferons|mesh-list
14471996|NCT02340962|Ribavirin|ribavirin|mesh-list
14471997|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
14035664|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
14035665|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
14035666|NCT05176470|Fludarabine|fludarabine|mesh-list
14035667|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14035668|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
14035669|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035670|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14035671|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14035672|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
14932922|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14932923|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932924|NCT01448174|Atorvastatin|atorvastatin|mesh-list
14932925|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14932926|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13904594|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13904595|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904596|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13904597|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13904598|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14035673|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035674|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035675|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14035676|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14471998|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
14471999|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472000|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
14035680|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
14035681|NCT05167409|Cetuximab|cetuximab|mesh-list
14035682|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035683|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035684|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
14035685|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14035686|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14035687|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035688|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
14035689|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904599|NCT00430508|Olmesartan|olmesartan|mesh-list
13904600|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13904601|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13904602|NCT00430508|Diuretics|diuretics|mesh-ancestor
13904603|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
13904604|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904605|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14035690|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035691|NCT05156281|Teriflunomide|teriflunomide|mesh-list
14932927|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
13904606|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932928|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472001|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932929|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14932930|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14932931|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035692|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14035693|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035694|NCT05156281|Analgesics|analgesics|mesh-ancestor
14035695|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
14035696|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035697|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035698|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035699|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14035700|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14035701|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
14472002|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
14472003|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472004|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
14472005|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472006|NCT02340975|Durvalumab|durvalumab|mesh-list
14472007|NCT02340975|Tremelimumab|tremelimumab|mesh-list
14472008|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14472009|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035710|NCT05152628|Tacrolimus|tacrolimus|mesh-list
14035711|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14035712|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
14035713|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035714|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14035715|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035716|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472010|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472011|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
14472012|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472013|NCT02341144|Ropivacaine|ropivacaine|mesh-list
14472014|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
14472015|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
14035723|NCT05147220|Teriflunomide|teriflunomide|mesh-list
14035724|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14035725|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035726|NCT05147220|Analgesics|analgesics|mesh-ancestor
14035727|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
14035728|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035729|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035730|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035731|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14035732|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14035733|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
13904607|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904608|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13904609|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14756058|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756059|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756060|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756061|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756062|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14756063|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14756064|NCT03491059|Nicotine|nicotine|mesh-list
14756065|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14756066|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
14756067|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756068|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756069|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14756070|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14756071|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
14756072|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756073|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767215|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767216|NCT00629226|Cetuximab|cetuximab|mesh-list
14767217|NCT00629226|Bortezomib|bortezomib|mesh-list
14767218|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767219|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904610|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
13904611|NCT00430092|Difluprednate|difluprednate|mesh-list
13904612|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
13904613|NCT00430092|Hormones|hormones|mesh-ancestor
13904614|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904615|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904616|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767220|NCT00629252|Risperidone|risperidone|mesh-list
14035734|NCT05144009|Rituximab|rituximab|mesh-list
14035735|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14035736|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035737|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904617|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
13904618|NCT00429923|Difluprednate|difluprednate|mesh-list
13904619|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
13904620|NCT00429923|Hormones|hormones|mesh-ancestor
13904621|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904622|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904623|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904624|NCT00427856|Rituximab|rituximab|mesh-list
13904625|NCT00427856|Obatoclax|obatoclax|mesh-list
14035738|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
14035739|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035740|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14035741|NCT05141682|Azacitidine|azacitidine|mesh-list
14035742|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14035743|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
14035744|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904626|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904627|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904628|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
13904629|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904630|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904631|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904632|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904633|NCT00427440|Rilotumumab|rilotumumab|mesh-list
13904634|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13904635|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904636|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904637|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
13904638|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904639|NCT00427154|Insulin|insulin|mesh-list
13904640|NCT00427154|Metformin|metformin|mesh-list
13904641|NCT00427154|Glimepiride|glimepiride|mesh-list
13904642|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
13904643|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13904644|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904645|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904646|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13904647|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904648|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
13904649|NCT00425100|Fesoterodine|fesoterodine|mesh-list
13904650|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13904651|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13904652|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
13904653|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904654|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904655|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904656|NCT00425100|Urological Agents|urological agents|mesh-ancestor
14035745|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035746|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035747|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14035748|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
14035749|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904657|NCT00424697|Lorazepam|lorazepam|mesh-list
13904658|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
13904659|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
13904660|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
13904661|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904662|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904663|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13904664|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13904665|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904666|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13904667|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13904668|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13904669|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
13904670|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
13904671|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904672|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904673|NCT00422019|Rilotumumab|rilotumumab|mesh-list
13904674|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13904675|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035750|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13904676|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904677|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
13904678|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904679|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13904680|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
13904681|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
14035751|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
14932932|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14932933|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
14932934|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932935|NCT01448252|Vaccines|vaccines|mesh-list
13904682|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904683|NCT00417209|Fluorouracil|fluorouracil|mesh-list
13904684|NCT00417209|Capecitabine|capecitabine|mesh-list
13904685|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
13904686|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904687|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13904688|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904689|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904690|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
13904691|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904692|NCT00417118|Citalopram|citalopram|mesh-list
13904693|NCT00417118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13904694|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13904695|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13904696|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904697|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904698|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
13904699|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904700|NCT00417118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13904701|NCT00417118|Antidepressive Agents|antidepressive agents|mesh-ancestor
13904702|NCT00417118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13904703|NCT00415623|Amlodipine|amlodipine|mesh-list
13904704|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13904705|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13904706|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13904707|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904708|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13904709|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904710|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
13904711|NCT00415142|Citalopram|citalopram|mesh-list
13904712|NCT00415142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13904713|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13904714|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13904715|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904716|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904717|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
13904718|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904719|NCT00415142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13904720|NCT00415142|Antidepressive Agents|antidepressive agents|mesh-ancestor
13904721|NCT00415142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13904722|NCT00413114|Obatoclax|obatoclax|mesh-list
13904723|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904724|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904725|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13904726|NCT00412932|Olmesartan|olmesartan|mesh-list
13904727|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13904728|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13904729|NCT00412932|Diuretics|diuretics|mesh-ancestor
13904730|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
13904731|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904732|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13904733|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13904734|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904735|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13904736|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13904737|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
13904738|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904739|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904740|NCT00411892|Insulin|insulin|mesh-list
13904741|NCT00411892|Pioglitazone|pioglitazone|mesh-list
13904742|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14035752|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035753|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035754|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14035755|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13904743|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904744|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904745|NCT00411528|Prednisone|prednisone|mesh-list
13904746|NCT00411528|Docetaxel|docetaxel|mesh-list
13904747|NCT00411528|Epothilone B|epothilone b|mesh-list
13904748|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904749|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
13904750|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
13904751|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
13904752|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904753|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904754|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
13904755|NCT00411528|Hormones|hormones|mesh-ancestor
13904756|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904757|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904758|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14035756|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14035757|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
14035758|NCT05136846|Paclitaxel|paclitaxel|mesh-list
14035759|NCT05136846|Carboplatin|carboplatin|mesh-list
14035760|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14035761|NCT05136846|Durvalumab|durvalumab|mesh-list
14035762|NCT05136846|Papaverine|papaverine|mesh-list
14035763|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
14035764|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14035765|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
14035766|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14035767|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035768|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14035769|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14035770|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14035771|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904759|NCT00411385|Interferons|interferons|mesh-list
13904760|NCT00411385|Ribavirin|ribavirin|mesh-list
13904761|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
13904762|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
13904763|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13904764|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904765|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
13904766|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904767|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
13904768|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904769|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
13904770|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904771|NCT00411242|S 20098|s 20098|mesh-list
13904772|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13904773|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904774|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904775|NCT00411099|S 20098|s 20098|mesh-list
13904776|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13904777|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13904778|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904779|NCT00407303|Bortezomib|bortezomib|mesh-list
13904780|NCT00407303|Obatoclax|obatoclax|mesh-list
13904781|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904782|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035772|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035773|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
14035774|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035775|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14035776|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035777|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
14035778|NCT05136846|Urological Agents|urological agents|mesh-ancestor
14035779|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
14035780|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14035781|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035782|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035783|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756074|NCT03485209|Carboplatin|carboplatin|mesh-list
14035784|NCT05134363|Analgesics|analgesics|mesh-ancestor
14756075|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
13904783|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904784|NCT00406809|Navitoclax|navitoclax|mesh-list
13904785|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904786|NCT00406588|Levodopa|levodopa|mesh-list
13904787|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13904788|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13904789|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
13904790|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904791|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904792|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904793|NCT00405951|Docetaxel|docetaxel|mesh-list
13904794|NCT00405951|Obatoclax|obatoclax|mesh-list
13904795|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904796|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
13904797|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
13904798|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
13904799|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904800|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904801|NCT00405743|Cytarabine|cytarabine|mesh-list
13904802|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13904803|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
13904804|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904805|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035785|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
14035786|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035787|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14035788|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14035789|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14035790|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
14035791|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035792|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472016|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472017|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472018|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
14472019|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472020|NCT02341417|Cinacalcet|cinacalcet|mesh-list
14472021|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14472022|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472023|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14472024|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
14035808|NCT05078866|Vaccines|vaccines|mesh-list
14035809|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
13904806|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
13904807|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904808|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904809|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
13904810|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904811|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
13904812|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13904813|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035810|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035811|NCT05078060|Vaccines|vaccines|mesh-list
14035812|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
14035813|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035814|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
14035815|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035816|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035817|NCT05073003|Vaccines|vaccines|mesh-list
14035818|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
14035819|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035820|NCT05065372|Metformin|metformin|mesh-list
14035821|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14035822|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035823|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
14035824|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035825|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035826|NCT05058924|Aspirin|aspirin|mesh-list
14035827|NCT05058924|Heparin|heparin|mesh-list
13904814|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14035828|NCT05058924|Calcium heparin|calcium heparin|mesh-list
14035829|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14756076|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
14472025|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472026|NCT02341456|Paclitaxel|paclitaxel|mesh-list
14472027|NCT02341456|Carboplatin|carboplatin|mesh-list
14472028|NCT02341456|Adavosertib|adavosertib|mesh-list
13904815|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
14035830|NCT05058924|Tinzaparin|tinzaparin|mesh-list
14035831|NCT05058924|Dalteparin|dalteparin|mesh-list
14035832|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14035833|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14035834|NCT05058924|Analgesics|analgesics|mesh-ancestor
14035835|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
14035836|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14035837|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904816|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904817|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904818|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904819|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904820|NCT00403169|Lenalidomide|lenalidomide|mesh-list
13904821|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
14035838|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14035839|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14035840|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14035841|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14035842|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035843|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14035844|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14035845|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035846|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
14035847|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
14472029|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14472030|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472031|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14472032|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
14472033|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14035853|NCT05042531|Azacitidine|azacitidine|mesh-list
14035854|NCT05042531|Dasatinib|dasatinib|mesh-list
14035855|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14035856|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
14035857|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035858|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035859|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035860|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14035861|NCT05042440|Factor VIII|factor viii|mesh-list
14035862|NCT05042440|BAX 855|bax 855|mesh-list
14035863|NCT05042440|Coagulants|coagulants|mesh-ancestor
14472034|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472035|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472036|NCT02341482|Itraconazole|itraconazole|mesh-list
14472037|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
14472038|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472039|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14472040|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14472041|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472042|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472043|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14472044|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
14472045|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756077|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756078|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756079|NCT03474107|Paclitaxel|paclitaxel|mesh-list
14756080|NCT03474107|Docetaxel|docetaxel|mesh-list
14472046|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904822|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472047|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14472048|NCT02342015|Atorvastatin|atorvastatin|mesh-list
14472049|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14472050|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14472051|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
14035880|NCT05029921|Ustekinumab|ustekinumab|mesh-list
14035881|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
14756081|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756082|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756083|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756084|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756085|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756086|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756087|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
14756088|NCT03463993|Oxytocin|oxytocin|mesh-list
14756089|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
13904823|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13904824|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13904825|NCT00403169|Growth Substances|growth substances|mesh-ancestor
13904826|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904827|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904828|NCT00402428|Interferons|interferons|mesh-list
13904829|NCT00402428|Ribavirin|ribavirin|mesh-list
13904830|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
13904831|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
14756090|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14756091|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472052|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472053|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14472054|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14472055|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472056|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14472057|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
14472058|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14472059|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
14472060|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14472061|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472062|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14472063|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14472064|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472065|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
14756092|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14756093|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14756094|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756095|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
14756096|NCT03463993|Coagulants|coagulants|mesh-ancestor
14756097|NCT03422822|Abrocitinib|abrocitinib|mesh-list
14756098|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14756099|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756100|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756101|NCT03421756|Sirolimus|sirolimus|mesh-list
14756102|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
14756103|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13904832|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13904833|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904834|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
13904835|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904836|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
13904837|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904838|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
13904839|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904840|NCT00401570|Gemcitabine|gemcitabine|mesh-list
14472066|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14472067|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
14472068|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472069|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
14472070|NCT02342223|Protective Agents|protective agents|mesh-ancestor
14472071|NCT02342327|Menthol|menthol|mesh-list
14472072|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
14035914|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
14035915|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14035916|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14035917|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14035918|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
14472073|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
14472074|NCT02342379|Bevacizumab|bevacizumab|mesh-list
14472075|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904841|NCT00401570|Volociximab|volociximab|mesh-list
13904842|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756104|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756105|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756106|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904843|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
14472076|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472077|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14472078|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14035927|NCT05016518|Propofol|propofol|mesh-list
14035928|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14035929|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035930|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035931|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14035932|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
14035933|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
14472079|NCT02342379|Growth Substances|growth substances|mesh-ancestor
14472080|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472081|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
14035937|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
14035938|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14035939|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472082|NCT02342418|Tedizolid|tedizolid|mesh-list
14472083|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
14472084|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14472085|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472086|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
14472087|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14472088|NCT02342639|Rifaximin|rifaximin|mesh-list
14472089|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14472090|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472091|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14472092|NCT02342704|Natalizumab|natalizumab|mesh-list
14035951|NCT05001880|Bevacizumab|bevacizumab|mesh-list
14035952|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14035953|NCT05001880|Carboplatin|carboplatin|mesh-list
14035954|NCT05001880|Pemetrexed|pemetrexed|mesh-list
14035955|NCT05001880|Atezolizumab|atezolizumab|mesh-list
14035956|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
14035957|NCT05001880|Antibodies|antibodies|mesh-list
14035958|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
14035959|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14035960|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
14035961|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035962|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14035963|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14035964|NCT05001880|Growth Substances|growth substances|mesh-ancestor
14035965|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035966|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
14035967|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
14035968|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035969|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035970|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14035971|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14035972|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14035973|NCT04997811|Valproic Acid|valproic acid|mesh-list
14035974|NCT04997811|Bezafibrate|bezafibrate|mesh-list
14035975|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
14035976|NCT04997811|Danazol|danazol|mesh-list
14035977|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
14035978|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14035979|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14035980|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
14035981|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14035982|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035983|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
14035984|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13904844|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904845|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904846|NCT00401570|Antiviral Agents|antiviral agents|mesh-ancestor
13904847|NCT00401570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13904848|NCT00401570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904849|NCT00401570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13904850|NCT00401570|Immunologic Factors|immunologic factors|mesh-ancestor
13904851|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14035985|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14035986|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14035987|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14035988|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14472093|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14472094|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
13904852|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13904853|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13904854|NCT00401570|Growth Substances|growth substances|mesh-ancestor
13904855|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
13904856|NCT00401388|Allopurinol|allopurinol|mesh-list
13904857|NCT00401388|Antiemetics|antiemetics|mesh-list
13904858|NCT00401388|Loperamide|loperamide|mesh-list
13904859|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
14932936|NCT01448252|Immunologic Factors|immunologic factors|mesh-ancestor
14932937|NCT01448252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932938|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14932939|NCT01448291|Etonogestrel|etonogestrel|mesh-list
14932940|NCT01448291|NuvaRing|nuvaring|mesh-list
14932941|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
14932942|NCT01448291|Estradiol|estradiol|mesh-list
14932943|NCT01448291|Estrogens|estrogens|mesh-ancestor
14932944|NCT01448291|Hormones|hormones|mesh-ancestor
14035989|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14035990|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
14035991|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14035992|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14035993|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14035994|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14035995|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14035996|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14035997|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14035998|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
14035999|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036000|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14036001|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
14036002|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14036003|NCT04978259|Remdesivir|remdesivir|mesh-list
14036004|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
14036005|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036006|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
14036007|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036008|NCT04975919|Decitabine|decitabine|mesh-list
14036009|NCT04975919|Venetoclax|venetoclax|mesh-list
14036010|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14036011|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
14932945|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14932946|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932947|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14932948|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14932949|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13904860|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
13904861|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904862|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904863|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
13904864|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904865|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13904866|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
13904867|NCT00401388|Protective Agents|protective agents|mesh-ancestor
13904868|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904869|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13904870|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
13904871|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036012|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036013|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036014|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036015|NCT04970901|Gemcitabine|gemcitabine|mesh-list
14036016|NCT04970901|Lenalidomide|lenalidomide|mesh-list
14036017|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14036018|NCT04970901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14036019|NCT04970901|Antimetabolites|antimetabolites|mesh-ancestor
14036020|NCT04970901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036021|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036022|NCT04970901|Antiviral Agents|antiviral agents|mesh-ancestor
14036023|NCT04970901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036024|NCT04970901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904872|NCT00401011|Dexamethasone|dexamethasone|mesh-list
13904873|NCT00401011|Bortezomib|bortezomib|mesh-list
14036025|NCT04970901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14036026|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
14036027|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904874|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932950|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14036028|NCT04970901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14036029|NCT04970901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14036030|NCT04970901|Growth Substances|growth substances|mesh-ancestor
14036031|NCT04970901|Growth Inhibitors|growth inhibitors|mesh-ancestor
14036032|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14036033|NCT04965090|Lazertinib|lazertinib|mesh-list
14036034|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13904875|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
13904876|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
13904877|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904878|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904879|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13904880|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
13904881|NCT00401011|Hormones|hormones|mesh-ancestor
13904882|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13904883|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13904884|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904885|NCT00398879|Capecitabine|capecitabine|mesh-list
13904886|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13904887|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
13904888|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904889|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904890|NCT00397293|Topotecan|topotecan|mesh-list
13904891|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13904892|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13904893|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904894|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904895|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904896|NCT00397254|Rizatriptan|rizatriptan|mesh-list
13904897|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13904898|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
13904899|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904900|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904901|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904902|NCT00396357|Metformin|metformin|mesh-list
13904903|NCT00396357|Vildagliptin|vildagliptin|mesh-list
13904904|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13904905|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904906|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13904907|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
13904908|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904909|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904910|NCT00394563|Tanezumab|tanezumab|mesh-list
13904911|NCT00394563|Analgesics|analgesics|mesh-ancestor
13904912|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
13904913|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904914|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904915|NCT00394199|Fluticasone|fluticasone|mesh-list
13904916|NCT00394199|Xhance|xhance|mesh-list
14036035|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036036|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472095|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472096|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14472097|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472098|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472099|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
14472100|NCT02342886|Rifampin|rifampin|mesh-list
14472101|NCT02342886|Isoniazid|isoniazid|mesh-list
14472102|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
14472103|NCT02342886|Ethambutol|ethambutol|mesh-list
14472104|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14472105|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472106|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14472107|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14472108|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472109|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472110|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472111|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14472112|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
14472113|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
14472114|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14036057|NCT04957758|Varenicline|varenicline|mesh-list
14036058|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14036059|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14036060|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
14036061|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036062|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036063|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036064|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
14036065|NCT04956640|Cetuximab|cetuximab|mesh-list
14036066|NCT04956640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14036067|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14036068|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036069|NCT04956640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14036070|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13904917|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
13904918|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904919|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13904920|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
13904921|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904922|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904923|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13904924|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
13904925|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
13904926|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13904927|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13904928|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13904929|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13904930|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
13904931|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904932|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904933|NCT00394121|Fluticasone|fluticasone|mesh-list
13904934|NCT00394121|Xhance|xhance|mesh-list
13904935|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
13904936|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13904937|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13904938|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
13904939|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904940|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904941|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13904942|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
13904943|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
13904944|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13904945|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13904946|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13904947|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13904948|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
13904949|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904950|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904951|NCT00393991|Fluticasone|fluticasone|mesh-list
13904952|NCT00393991|Xhance|xhance|mesh-list
13904953|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
13904954|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036071|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036072|NCT04934904|Ropivacaine|ropivacaine|mesh-list
14036073|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
14036074|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
14036075|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14036076|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036077|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
14036078|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472115|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14472116|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14472117|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14472118|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14472119|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14472120|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14472121|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14472122|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14472123|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
14472124|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14472125|NCT02343081|Temozolomide|temozolomide|mesh-list
14472126|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14472127|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
14472128|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472129|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472130|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
13904955|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13904956|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
14472131|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
14472132|NCT02343406|Temozolomide|temozolomide|mesh-list
14472133|NCT02343406|Lomustine|lomustine|mesh-list
14472134|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14472135|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
14472136|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472137|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472138|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
14472139|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
14472140|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14472141|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
14472142|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472143|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472144|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14472145|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
14472146|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14472147|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14472148|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14472149|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472150|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472151|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472152|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14472153|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14472154|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14036121|NCT04929041|Paclitaxel|paclitaxel|mesh-list
14036122|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14036123|NCT04929041|Carboplatin|carboplatin|mesh-list
14036124|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
14036125|NCT04929041|Nivolumab|nivolumab|mesh-list
14036126|NCT04929041|Pemetrexed|pemetrexed|mesh-list
14036127|NCT04929041|Ipilimumab|ipilimumab|mesh-list
14036128|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14036129|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036130|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036131|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036132|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036133|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036134|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14036135|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14036136|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036137|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13904957|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904958|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904959|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13904960|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
13904961|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
13904962|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13904963|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13904964|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13904965|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13904966|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
13904967|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13904968|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904969|NCT00393952|Fluticasone|fluticasone|mesh-list
13904970|NCT00393952|Xhance|xhance|mesh-list
13904971|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
13904972|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036138|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13904973|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13904974|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
13904975|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13904976|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13904977|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13904978|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
13904979|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
13904980|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13904981|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14036157|NCT04915248|Dexamethasone|dexamethasone|mesh-list
13904982|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13904983|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13904984|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
13904985|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036158|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
14036159|NCT04915248|Bortezomib|bortezomib|mesh-list
14036160|NCT04915248|Daratumumab|daratumumab|mesh-list
14036161|NCT04915248|BB 1101|bb 1101|mesh-list
14036162|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14036163|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932951|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14932952|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14932953|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14932954|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
14932955|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932956|NCT01448330|Aspirin|aspirin|mesh-list
14932957|NCT01448330|Clopidogrel|clopidogrel|mesh-list
14932958|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14932959|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14932960|NCT01448330|Analgesics|analgesics|mesh-ancestor
14932961|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
14932962|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14932963|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932964|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036164|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
14036165|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
14036166|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036167|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036168|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14036169|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
14036170|NCT04915248|Hormones|hormones|mesh-ancestor
14036171|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036172|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14036173|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036174|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
14036175|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036176|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036177|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
14472155|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
14472156|NCT02343575|Valproic Acid|valproic acid|mesh-list
14472157|NCT02343575|Haloperidol|haloperidol|mesh-list
14472158|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
14472159|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
14472160|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
14472161|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472162|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036186|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14036187|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14036188|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036189|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036190|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14036191|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14932965|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13904986|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904987|NCT00393068|Paclitaxel|paclitaxel|mesh-list
13904988|NCT00393068|Bevacizumab|bevacizumab|mesh-list
13904989|NCT00393068|Carboplatin|carboplatin|mesh-list
13904990|NCT00393068|Fluorouracil|fluorouracil|mesh-list
13904991|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13904992|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13904993|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13904994|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
13904995|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
13904996|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
14472163|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14036192|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904997|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13904998|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13904999|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905000|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14932966|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14932967|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14932968|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932969|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14932970|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14932971|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932972|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
14932973|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13905001|NCT00393068|Growth Substances|growth substances|mesh-ancestor
13905002|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905003|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905004|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
13905005|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905006|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905007|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
13905008|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905009|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905010|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
13905011|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13905012|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905013|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13905014|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13905015|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905016|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905017|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905018|NCT00391209|Insulin|insulin|mesh-list
13905019|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13905020|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905021|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905022|NCT00389779|Guanfacine|guanfacine|mesh-list
13905023|NCT00389779|Darusentan|darusentan|mesh-list
13905024|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14036193|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
14036194|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036195|NCT04907539|Denosumab|denosumab|mesh-list
14036196|NCT04907539|Nivolumab|nivolumab|mesh-list
14036197|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14036198|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036199|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14036200|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036201|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14036202|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472164|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14472165|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14472166|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472167|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14472168|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14472169|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
14472170|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472171|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472172|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14472173|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
14472174|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472175|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
14472176|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
14472177|NCT02343939|Cytarabine|cytarabine|mesh-list
13905025|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14472178|NCT02343939|Azacitidine|azacitidine|mesh-list
14472179|NCT02343939|Decitabine|decitabine|mesh-list
14472180|NCT02343939|Daunorubicin|daunorubicin|mesh-list
13905026|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13905027|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13905028|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
13905029|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905030|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905031|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905032|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13905033|NCT00389675|Guanfacine|guanfacine|mesh-list
13905034|NCT00389675|Darusentan|darusentan|mesh-list
13905035|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13905036|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13905037|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13905038|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13905039|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
13905040|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905041|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905042|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905043|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13905044|NCT00389155|Gemcitabine|gemcitabine|mesh-list
14472181|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14472182|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
14036220|NCT04895410|Dexamethasone|dexamethasone|mesh-list
14036221|NCT04895410|Daratumumab|daratumumab|mesh-list
14036222|NCT04895410|Pomalidomide|pomalidomide|mesh-list
14036223|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036224|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
13905045|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905046|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
13905047|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905048|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905049|NCT00389155|Antiviral Agents|antiviral agents|mesh-ancestor
13905050|NCT00389155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905051|NCT00389155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905052|NCT00389155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905053|NCT00389155|Immunologic Factors|immunologic factors|mesh-ancestor
13905054|NCT00389155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905055|NCT00388960|Etoposide|etoposide|mesh-list
13905056|NCT00388960|Amrubicin|amrubicin|mesh-list
13905057|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905058|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905059|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13905060|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13905061|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905062|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905063|NCT00387907|Trastuzumab|trastuzumab|mesh-list
13905064|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905065|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905066|NCT00385515|Meclocycline|meclocycline|mesh-list
13905067|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13905068|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905069|NCT00384904|Ritonavir|ritonavir|mesh-list
13905070|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13905071|NCT00384904|Tenofovir|tenofovir|mesh-list
14036225|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
14036226|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036227|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036228|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14036229|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
14036230|NCT04895410|Hormones|hormones|mesh-ancestor
14036231|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036232|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14036233|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036234|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
14036235|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14036236|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14036237|NCT04895410|Growth Substances|growth substances|mesh-ancestor
14036238|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
14036239|NCT04891068|Azacitidine|azacitidine|mesh-list
13905072|NCT00384904|Famotidine|famotidine|mesh-list
13905073|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13905074|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13905075|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
14036240|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905076|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959508|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14756107|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
14036241|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
14036242|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036243|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036244|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472183|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472184|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472185|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
14472186|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472187|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472188|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
14472189|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472190|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905077|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905078|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13905079|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13905080|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
13905081|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905082|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14472191|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14472192|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14036255|NCT04887831|Gemcitabine|gemcitabine|mesh-list
14036256|NCT04887831|Carboplatin|carboplatin|mesh-list
14036257|NCT04887831|Avelumab|avelumab|mesh-list
14036258|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036259|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14036260|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
14036261|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036262|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
14036263|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036264|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036265|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14036266|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
14036267|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036268|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14472193|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14472194|NCT02344004|Amikacin|amikacin|mesh-list
14472195|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14472196|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472197|NCT02344225|Ibuprofen|ibuprofen|mesh-list
14472198|NCT02344225|Ketorolac|ketorolac|mesh-list
14036275|NCT04878432|Azacitidine|azacitidine|mesh-list
14036276|NCT04878432|Decitabine|decitabine|mesh-list
14036277|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905083|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13905084|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13905085|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13905086|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13905087|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13905088|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13905089|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
13905090|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
13905091|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905092|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905093|NCT00384150|Galiximab|galiximab|mesh-list
13905094|NCT00384150|Rituximab|rituximab|mesh-list
13905095|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905096|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905097|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
14036278|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
13905098|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905099|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14036279|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472199|NCT02344225|Caffeine|caffeine|mesh-list
14932974|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14932975|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14932976|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
14932977|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14932978|NCT01448395|Avibactam|avibactam|mesh-list
14932979|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13905100|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905101|NCT00383578|Metformin|metformin|mesh-list
13905102|NCT00383578|Vildagliptin|vildagliptin|mesh-list
13905103|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905104|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905105|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13905106|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905107|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905108|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959509|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13959510|NCT03162562|Oregovomab|oregovomab|mesh-list
13959511|NCT03162562|Poly ICLC|poly iclc|mesh-list
13959512|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
13959513|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
13959514|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959515|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959516|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959517|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
13959518|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
13959519|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959520|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959521|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13959522|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13959523|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
13959524|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13959525|NCT03162224|Durvalumab|durvalumab|mesh-list
13959526|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959527|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959528|NCT03162185|Citalopram|citalopram|mesh-list
13959529|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13959530|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13959531|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13959532|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959533|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959534|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
13959535|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959536|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13959537|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
13959538|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13959539|NCT03162120|Metoprolol|metoprolol|mesh-list
13959540|NCT03162120|Flecainide|flecainide|mesh-list
13959541|NCT03162120|Ranolazine|ranolazine|mesh-list
13959542|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13959543|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13959544|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
13959545|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
13959546|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959547|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959548|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13959549|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13959550|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13959551|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
13959552|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959553|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959554|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13959555|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13959556|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13959557|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13959558|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13959559|NCT03161977|Mannitol|mannitol|mesh-list
13959560|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13959561|NCT03161977|Diuretics|diuretics|mesh-ancestor
13959562|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
13959563|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963348|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963349|NCT03145194|Ticagrelor|ticagrelor|mesh-list
13963350|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13963351|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14036280|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036281|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036282|NCT04869943|Exemestane|exemestane|mesh-list
14036283|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036284|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14036285|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14036286|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036287|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036288|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14036289|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
14036290|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036291|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932980|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932981|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905109|NCT00383513|Epratuzumab|epratuzumab|mesh-list
13905110|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905111|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905112|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13905113|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13905114|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
13905115|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036292|NCT04848753|Paclitaxel|paclitaxel|mesh-list
14036293|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14036294|NCT04848753|Cisplatin|cisplatin|mesh-list
14036295|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14036296|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036297|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036298|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036299|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036300|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472200|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
14472201|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472202|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14472203|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14472204|NCT02344225|Analgesics|analgesics|mesh-ancestor
14472205|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
14472206|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472207|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472208|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14472209|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472210|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14472211|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472212|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14472213|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14472214|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14472215|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14472216|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
14472217|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472218|NCT02344238|Riboflavin|riboflavin|mesh-list
14472219|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
14472220|NCT02344238|Vitamins|vitamins|mesh-ancestor
14472221|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
14472222|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472223|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14472224|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
14472225|NCT02344316|Melatonin|melatonin|mesh-list
14472226|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
14472227|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472228|NCT02344316|Protective Agents|protective agents|mesh-ancestor
14472229|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472230|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472231|NCT02344342|Diuretics|diuretics|mesh-list
14472232|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
14767221|NCT00629252|Sertindole|sertindole|mesh-list
14767222|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14036336|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
14036337|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
14036338|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036339|NCT04827745|Blinatumomab|blinatumomab|mesh-list
14036340|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036341|NCT04820309|Xanomeline|xanomeline|mesh-list
13905116|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036342|NCT04820309|Trospium chloride|trospium chloride|mesh-list
14036343|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
14767223|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
14036344|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
14036345|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036346|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036347|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14036348|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14036349|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
14036350|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036351|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036352|NCT04820309|Urological Agents|urological agents|mesh-ancestor
14036353|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14036354|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14036355|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14036356|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14472233|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472234|NCT02344628|Azithromycin|azithromycin|mesh-list
14472235|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14472236|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472237|NCT02345161|Budesonide|budesonide|mesh-list
14472238|NCT02345161|Albuterol|albuterol|mesh-list
14036363|NCT04811625|Aspirin|aspirin|mesh-list
14036364|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14036365|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14036366|NCT04811625|Analgesics|analgesics|mesh-ancestor
14036367|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
14036368|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13905117|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13905118|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13905119|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14036369|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036370|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036371|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14036372|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14036373|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14036374|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036375|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14036376|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14036377|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036378|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
14472239|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
14472240|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14472241|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14472242|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14472243|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
14472244|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472245|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472246|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14472247|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
14472248|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
14472249|NCT02345161|Hormones|hormones|mesh-ancestor
14036396|NCT04788615|Interferons|interferons|mesh-list
14036397|NCT04788615|Interferon-beta|interferon-beta|mesh-list
14036398|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
14036399|NCT04788615|Teriflunomide|teriflunomide|mesh-list
14036400|NCT04788615|Ofatumumab|ofatumumab|mesh-list
14036401|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
14036402|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13905120|NCT00382811|Carboplatin|carboplatin|mesh-list
13905121|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905122|NCT00382460|Pravastatin|pravastatin|mesh-list
13905123|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13905124|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13905125|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
13905126|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905127|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13905128|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13905129|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905130|NCT00382096|Metformin|metformin|mesh-list
14036403|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
14036404|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036405|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
13905131|NCT00382096|Vildagliptin|vildagliptin|mesh-list
13905132|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905133|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905134|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13905135|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905136|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905137|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905138|NCT00380159|Lamivudine|lamivudine|mesh-list
13905139|NCT00380159|Emtricitabine|emtricitabine|mesh-list
13905140|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
13905141|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13905142|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13905143|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036406|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036407|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
14036408|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036409|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14036410|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
14036411|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14036412|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14036413|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14036414|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14036415|NCT04788615|Analgesics|analgesics|mesh-ancestor
14036416|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
14036417|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036418|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036419|NCT04768296|Topotecan|topotecan|mesh-list
14036420|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14036421|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14036422|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036423|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036424|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756108|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756109|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
14756110|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756111|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756112|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
14756113|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756114|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905144|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905145|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
13905146|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905147|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13905148|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13905149|NCT00379990|Prednisolone|prednisolone|mesh-list
13905150|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905151|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
13905152|NCT00379990|Hormones|hormones|mesh-ancestor
13905153|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13905154|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905155|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13905156|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905157|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13905158|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
13905159|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905160|NCT00375791|Dexamethasone|dexamethasone|mesh-list
13905161|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905162|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
13905163|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
14756115|NCT03412266|Cytarabine|cytarabine|mesh-list
14756116|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
14756117|NCT03412266|Busulfan|busulfan|mesh-list
14756118|NCT03412266|Semustine|semustine|mesh-list
14756119|NCT03412266|Fludarabine|fludarabine|mesh-list
14756120|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14756121|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756122|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
14756123|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756124|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756125|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756126|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
13905164|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756127|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756128|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905165|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905166|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13905167|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
13905168|NCT00375791|Hormones|hormones|mesh-ancestor
14472250|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472251|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14472252|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14472253|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14472254|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
14756129|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756130|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756131|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
14756132|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
14756133|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756134|NCT03411031|Thalidomide|thalidomide|mesh-list
14932982|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14932983|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14932984|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
14932985|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14932986|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14938638|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938639|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938640|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938641|NCT01482754|Rituximab|rituximab|mesh-list
14938642|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756135|NCT03411031|Dexamethasone|dexamethasone|mesh-list
14756136|NCT03411031|Lenalidomide|lenalidomide|mesh-list
14938643|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905169|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13905170|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13905171|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905172|NCT00375193|Amrubicin|amrubicin|mesh-list
13905173|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905174|NCT00374296|Mocetinostat|mocetinostat|mesh-list
13905175|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13905176|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905177|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905178|NCT00374166|Paroxetine|paroxetine|mesh-list
13905179|NCT00374166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13905180|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13905181|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13905182|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905183|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905184|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
13905185|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756137|NCT03411031|Elotuzumab|elotuzumab|mesh-list
14756138|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14932987|NCT01448499|Clozapine|clozapine|mesh-list
14932988|NCT01448499|Amisulpride|amisulpride|mesh-list
14932989|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14932990|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
13905186|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13905187|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
13905188|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13905189|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13905190|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13905191|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905192|NCT00372944|Capecitabine|capecitabine|mesh-list
13905193|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905194|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
13905195|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905196|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905197|NCT00372437|Gemcitabine|gemcitabine|mesh-list
13905198|NCT00372437|Mocetinostat|mocetinostat|mesh-list
14472255|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472256|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472257|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
14472258|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14472259|NCT02345226|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14472260|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14472261|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14472262|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14472263|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14932991|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959564|NCT03161652|Ranibizumab|ranibizumab|mesh-list
14932992|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14932993|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14932994|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14932995|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14932996|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14932997|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14932998|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
14932999|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
14933000|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14933001|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
14933002|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14933003|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
14933004|NCT01448538|Bevacizumab|bevacizumab|mesh-list
14933005|NCT01448538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933006|NCT01448538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933007|NCT01448538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14933008|NCT01448538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14933009|NCT01448538|Growth Substances|growth substances|mesh-ancestor
14933010|NCT01448538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933011|NCT01448538|Growth Inhibitors|growth inhibitors|mesh-ancestor
14933012|NCT01448642|Atorvastatin|atorvastatin|mesh-list
14933013|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14933014|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14933015|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
14933016|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933017|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14933018|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14933019|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933020|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14933021|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14933022|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14933023|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933024|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933025|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14933026|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14933027|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14933028|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
14933029|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933030|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933031|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14933032|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14933033|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
14472264|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472265|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
13905199|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905200|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
13905201|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905202|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905203|NCT00372437|Antiviral Agents|antiviral agents|mesh-ancestor
13905204|NCT00372437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905205|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905206|NCT00372437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905207|NCT00372437|Immunologic Factors|immunologic factors|mesh-ancestor
13905208|NCT00372437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472266|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472267|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14472268|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13905209|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13905210|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13905211|NCT00370383|Satraplatin|satraplatin|mesh-list
13905212|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905213|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905214|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905215|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905216|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13905217|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
13905218|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905219|NCT00369070|Paclitaxel|paclitaxel|mesh-list
13905220|NCT00369070|Bevacizumab|bevacizumab|mesh-list
14036498|NCT04739800|Paclitaxel|paclitaxel|mesh-list
14036499|NCT04739800|Doxorubicin|doxorubicin|mesh-list
14933034|NCT01448733|Clindamycin|clindamycin|mesh-list
14933035|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
14933036|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
14036500|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14036501|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14036502|NCT04739800|Durvalumab|durvalumab|mesh-list
14036503|NCT04739800|Topotecan|topotecan|mesh-list
14036504|NCT04739800|Olaparib|olaparib|mesh-list
14036505|NCT04739800|Cediranib|cediranib|mesh-list
14036506|NCT04739800|Maleic acid|maleic acid|mesh-list
14036507|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
14036508|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14036509|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
14036510|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14036511|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036512|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036513|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036514|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036515|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036516|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14036517|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14036518|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14036519|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036520|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756139|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
14756140|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
14756141|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756142|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756143|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14756144|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
14756145|NCT03411031|Hormones|hormones|mesh-ancestor
14756146|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756147|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14756148|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756149|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
14756150|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14933037|NCT01448733|Tretinoin|tretinoin|mesh-list
13905221|NCT00369070|Carboplatin|carboplatin|mesh-list
13905222|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
14036521|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
14036522|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472269|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
14472270|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
14472271|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472272|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14472273|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14472274|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905223|NCT00369070|Imetelstat|imetelstat|mesh-list
13905224|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905225|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905226|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
13905227|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
13905228|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036523|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14036524|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14036525|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905229|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905230|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905231|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905232|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905233|NCT00369070|Growth Substances|growth substances|mesh-ancestor
13905234|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905235|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905236|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905237|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905238|NCT00367887|Ribavirin|ribavirin|mesh-list
13905239|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
13905240|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
13905241|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
13905242|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
13905243|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036526|NCT04739358|Tepotinib|tepotinib|mesh-list
14036527|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036528|NCT04735861|Bevacizumab|bevacizumab|mesh-list
14036529|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14036530|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036531|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14036532|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14036533|NCT04735861|Growth Substances|growth substances|mesh-ancestor
14036534|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036535|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
14036536|NCT04734210|Betamethasone|betamethasone|mesh-list
14036537|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
14036538|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14036539|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
14036540|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14036541|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036542|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
14036543|NCT04734210|Hormones|hormones|mesh-ancestor
14036544|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036545|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036546|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14756151|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14756152|NCT03411031|Growth Substances|growth substances|mesh-ancestor
14756153|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14756154|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756155|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
14036547|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
14036548|NCT04725188|Docetaxel|docetaxel|mesh-list
14036549|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
14036550|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036551|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036552|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036553|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036554|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756156|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13905244|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
13905245|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905246|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905247|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
13905248|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905249|NCT00366795|Satavaptan|satavaptan|mesh-list
13905250|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13905251|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905252|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
13905253|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905254|NCT00366704|Risperidone|risperidone|mesh-list
13905255|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13905256|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
13905257|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905258|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905259|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905260|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13905261|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13905262|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13905263|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13905264|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13905265|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
13905266|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
13905267|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905268|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
13905269|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905270|NCT00364780|XL647|xl647|mesh-list
13905271|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905272|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905273|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905274|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905275|NCT00364546|Tapentadol|tapentadol|mesh-list
13905276|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13905277|NCT00364546|Narcotics|narcotics|mesh-ancestor
13905278|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13905279|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905280|NCT00364546|Analgesics|analgesics|mesh-ancestor
13905281|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
13905282|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13905283|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13905284|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13905285|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13905286|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905287|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
13905288|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905289|NCT00364247|Tapentadol|tapentadol|mesh-list
13905290|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13905291|NCT00364247|Narcotics|narcotics|mesh-ancestor
13905292|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13905293|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905294|NCT00364247|Analgesics|analgesics|mesh-ancestor
13905295|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
13905296|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13905297|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13905298|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13905299|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13905300|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905301|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
13905302|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905303|NCT00363636|Galiximab|galiximab|mesh-list
13905304|NCT00363636|Rituximab|rituximab|mesh-list
13905305|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905306|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905307|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
14036555|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14036556|NCT04717700|Dexamethasone|dexamethasone|mesh-list
14036557|NCT04717700|Lenalidomide|lenalidomide|mesh-list
14036558|NCT04717700|Bortezomib|bortezomib|mesh-list
14036559|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036560|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
14036561|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
14036562|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036563|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036564|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13905308|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905309|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13905310|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905311|NCT00361582|Tapentadol|tapentadol|mesh-list
13905312|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14756157|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756158|NCT03404193|Decitabine|decitabine|mesh-list
14756159|NCT03404193|Venetoclax|venetoclax|mesh-list
13905313|NCT00361582|Narcotics|narcotics|mesh-ancestor
13905314|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13905315|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905316|NCT00361582|Analgesics|analgesics|mesh-ancestor
13905317|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
13905318|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13905319|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13905320|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13905321|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13905322|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905323|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
13905324|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905325|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
13905326|NCT00360867|Imetelstat|imetelstat|mesh-list
13905327|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905328|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905329|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905330|NCT00360035|Obatoclax|obatoclax|mesh-list
13905331|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905332|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905333|NCT00359450|Taxane|taxane|mesh-list
13905334|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905335|NCT00359437|Satavaptan|satavaptan|mesh-list
13905336|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13905337|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905338|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
13905339|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905340|NCT00359086|Mocetinostat|mocetinostat|mesh-list
13905341|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13905342|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905343|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905344|NCT00358982|Mocetinostat|mocetinostat|mesh-list
13905345|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13905346|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905347|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905348|NCT00358878|Satavaptan|satavaptan|mesh-list
13905349|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14036565|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
14036566|NCT04717700|Hormones|hormones|mesh-ancestor
14036567|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036568|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14036569|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036570|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
14036571|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14036572|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14036573|NCT04717700|Growth Substances|growth substances|mesh-ancestor
14036574|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
14472275|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472276|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14472277|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14472278|NCT02345330|Interleukin-12|interleukin-12|mesh-list
14756160|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756161|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
14756162|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756163|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756164|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472279|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13905350|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905351|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
13905352|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905353|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13905354|NCT00356681|Niacinamide|niacinamide|mesh-list
13905355|NCT00356681|Paclitaxel|paclitaxel|mesh-list
13905356|NCT00356681|Bevacizumab|bevacizumab|mesh-list
13905357|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
14036588|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14036589|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14036590|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036591|NCT04686279|Tenofovir|tenofovir|mesh-list
14036592|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
14036593|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036594|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14036595|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14036596|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036597|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036598|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14036599|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14036600|NCT04685135|Docetaxel|docetaxel|mesh-list
14036601|NCT04685135|Adagrasib|adagrasib|mesh-list
13905358|NCT00356681|Imetelstat|imetelstat|mesh-list
13905359|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905360|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905361|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
13905362|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
13905363|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036602|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036603|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036604|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036605|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036606|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756165|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
14756166|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756167|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905364|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905365|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905366|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905367|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905368|NCT00356681|Growth Substances|growth substances|mesh-ancestor
13905369|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905370|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905371|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905372|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905373|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
14756168|NCT03365752|Anesthetics|anesthetics|mesh-list
14756169|NCT03365752|Mepivacaine|mepivacaine|mesh-list
14756170|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
14472280|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
14472281|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472282|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14472283|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14472284|NCT02345330|Growth Substances|growth substances|mesh-ancestor
14036618|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14036619|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
14036620|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
14036621|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036622|NCT04665843|Atezolizumab|atezolizumab|mesh-list
14036623|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905374|NCT00356681|Vitamins|vitamins|mesh-ancestor
13905375|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
13905376|NCT00356109|Insulin|insulin|mesh-list
13905377|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13905378|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
13905379|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905380|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905381|NCT00355849|Insulin|insulin|mesh-list
13905382|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13905383|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
13905384|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905385|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905386|NCT00355355|Talaporfin|talaporfin|mesh-list
13905387|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472285|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905388|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13905389|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
13905390|NCT00353574|Darusentan|darusentan|mesh-list
13905391|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13905392|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905393|NCT00353457|Capecitabine|capecitabine|mesh-list
14036630|NCT04659174|Xanomeline|xanomeline|mesh-list
14036631|NCT04659174|Trospium chloride|trospium chloride|mesh-list
14036632|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
14036633|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
14036634|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036635|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036636|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14036637|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14036638|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
14036639|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036640|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036641|NCT04659174|Urological Agents|urological agents|mesh-ancestor
13905394|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
13905395|NCT00353457|Cetuximab|cetuximab|mesh-list
13905396|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905397|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
13905398|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905399|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905400|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905401|NCT00352560|Irbesartan|irbesartan|mesh-list
13905402|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13905403|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13905404|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13905405|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905406|NCT00345748|Abatacept|abatacept|mesh-list
13905407|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13905408|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905409|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905410|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905411|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
13905412|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905413|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14036642|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14036643|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14036644|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14036645|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14472286|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472287|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
14472288|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14472289|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14472290|NCT02346240|Etanercept|etanercept|mesh-list
14472291|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
14472292|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14472293|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14472294|NCT02346240|Analgesics|analgesics|mesh-ancestor
14472295|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
14472296|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472297|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472298|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905414|NCT00345618|Biotin|biotin|mesh-list
13905415|NCT00345618|Enoxaparin|enoxaparin|mesh-list
13905416|NCT00345618|Warfarin|warfarin|mesh-list
14756171|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
13905417|NCT00345618|Idraparinux|idraparinux|mesh-list
13905418|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
13905419|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
14472299|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472300|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14472301|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905420|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13905421|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13905422|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905423|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13905424|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
13905425|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13905426|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905427|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905428|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
13905429|NCT00345618|Vitamins|vitamins|mesh-ancestor
13905430|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
14472302|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
14472303|NCT02346370|Docetaxel|docetaxel|mesh-list
14472304|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472305|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
14472306|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
14472307|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
14472308|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472309|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
14036671|NCT04630730|Gemcitabine|gemcitabine|mesh-list
14036672|NCT04630730|Atezolizumab|atezolizumab|mesh-list
14036673|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
14036674|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036675|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14036676|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
14036677|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036678|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
14036679|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036680|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036681|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14036682|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
14036683|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036684|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14036685|NCT04624243|Risperidone|risperidone|mesh-list
14036686|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14036687|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
14036688|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036689|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036690|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036691|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14036692|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14036693|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14036694|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14036695|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14036696|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
14036697|NCT04622839|Acetaminophen|acetaminophen|mesh-list
14036698|NCT04622839|Ibuprofen|ibuprofen|mesh-list
14036699|NCT04622839|Diclofenac|diclofenac|mesh-list
14036700|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14036701|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14036702|NCT04622839|Analgesics|analgesics|mesh-ancestor
14036703|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
14036704|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036705|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036706|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036707|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14036708|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14036709|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036710|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036711|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
14472310|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14472311|NCT02346721|Velpatasvir|velpatasvir|mesh-list
13905431|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905432|NCT00344045|Acetaminophen|acetaminophen|mesh-list
13905433|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13905434|NCT00344045|Analgesics|analgesics|mesh-ancestor
13905435|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
13905436|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13905437|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905438|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
14472312|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
13905439|NCT00343109|Sargramostim|sargramostim|mesh-list
14472313|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472314|NCT02346903|Capsaicin|capsaicin|mesh-list
14472315|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
14472316|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14756172|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756173|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756174|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
14756175|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
14933038|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14036722|NCT04594551|Vaccines|vaccines|mesh-list
14036723|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
13905440|NCT00343109|Vaccines|vaccines|mesh-list
13905441|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
13905442|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905443|NCT00338104|Insulin|insulin|mesh-list
13905444|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13905445|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
13905446|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905447|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905448|NCT00337532|Paclitaxel|paclitaxel|mesh-list
13905449|NCT00337532|Cisplatin|cisplatin|mesh-list
13905450|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905451|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905452|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
13905453|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
13905454|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
13905455|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905456|NCT00337454|Dasatinib|dasatinib|mesh-list
13905457|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036724|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14036725|NCT04594551|Antibodies|antibodies|mesh-list
14036726|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
14036727|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036728|NCT04593680|Tenofovir|tenofovir|mesh-list
14036729|NCT04593680|Emtricitabine|emtricitabine|mesh-list
14036730|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
14036731|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036732|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14036733|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14036734|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036735|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036736|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14036737|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14036738|NCT04591808|Perindopril|perindopril|mesh-list
14036739|NCT04591808|Atorvastatin|atorvastatin|mesh-list
14036740|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14036741|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14036742|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
14036743|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036744|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14036745|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14036746|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036747|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14036748|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
14036749|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14036750|NCT04590963|Cetuximab|cetuximab|mesh-list
13905458|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905459|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905460|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905461|NCT00333502|Camptothecin|camptothecin|mesh-list
13905462|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14036751|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14036752|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036753|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
14036754|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14036755|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14036756|NCT04590417|Estradiol|estradiol|mesh-list
13905463|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905464|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13905465|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13905466|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036757|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14036758|NCT04590417|Cyproterone|cyproterone|mesh-list
14036759|NCT04590417|Estrogens|estrogens|mesh-ancestor
13905467|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905468|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
13905469|NCT00333216|Anecortave|anecortave|mesh-list
14036760|NCT04590417|Hormones|hormones|mesh-ancestor
14036761|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472317|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
14036762|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036763|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14036764|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
14036765|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14036766|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14036767|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
14036768|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
14036769|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036770|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13905470|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905471|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905472|NCT00333216|Growth Substances|growth substances|mesh-ancestor
13905473|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905474|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905475|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905476|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933039|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14933040|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933041|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14933042|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933043|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036771|NCT04571944|Suvorexant|suvorexant|mesh-list
14036772|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14036773|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14036774|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14036775|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036776|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14036777|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036778|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905477|NCT00332956|Vaccines|vaccines|mesh-list
13905478|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
13905479|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905480|NCT00332748|Taxane|taxane|mesh-list
13905481|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905482|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
13905483|NCT00332657|Anecortave|anecortave|mesh-list
13905484|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905485|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905486|NCT00332657|Growth Substances|growth substances|mesh-ancestor
13905487|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905488|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905489|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905490|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905491|NCT00330473|Insulin|insulin|mesh-list
13905492|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14472318|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472319|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472320|NCT02346916|Capsaicin|capsaicin|mesh-list
14933044|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
13905493|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905494|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905495|NCT00330369|Darusentan|darusentan|mesh-list
13905496|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13905497|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905498|NCT00327743|Capecitabine|capecitabine|mesh-list
13905499|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905500|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
13905501|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905502|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905503|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
13905504|NCT00326287|Linezolid|linezolid|mesh-list
13905505|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
13905506|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14472321|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
14933045|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933046|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
14933047|NCT01448746|Heparin|heparin|mesh-list
14933048|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14933049|NCT01448746|Tinzaparin|tinzaparin|mesh-list
14933050|NCT01448746|Dalteparin|dalteparin|mesh-list
14933051|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
14933052|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13905507|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13905508|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905509|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14933053|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14472322|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
14472323|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
14472324|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472325|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472326|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
14472327|NCT02347072|Bromides|bromides|mesh-list
14036790|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
14036791|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
14036792|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
14036793|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14036794|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036795|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
14036796|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
14036797|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036798|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036799|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14036800|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
14036801|NCT04548999|Hormones|hormones|mesh-ancestor
14036802|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036803|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14036804|NCT04548999|Protective Agents|protective agents|mesh-ancestor
14036805|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
14036806|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
14036807|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14036808|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756176|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756177|NCT03364036|Cladribine|cladribine|mesh-list
14756178|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756179|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756180|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
14756181|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756182|NCT03363464|Empagliflozin|empagliflozin|mesh-list
13905510|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905511|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905512|NCT00325650|Rimonabant|rimonabant|mesh-list
13905513|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13905514|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13905515|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13905516|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905517|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905518|NCT00325650|Hormones|hormones|mesh-ancestor
13905519|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13905520|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472328|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
14472329|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
14472330|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14036819|NCT04545554|Vitamin D|vitamin d|mesh-list
14036820|NCT04545554|Calcium|calcium|mesh-list
14036821|NCT04545554|Vitamins|vitamins|mesh-ancestor
14036822|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
14036823|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036824|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14036825|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14472331|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
14472332|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472333|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472334|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14472335|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
13905521|NCT00325364|Insulin|insulin|mesh-list
13905522|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13905523|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905524|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905525|NCT00324220|Mocetinostat|mocetinostat|mesh-list
13905526|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13905527|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905528|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905529|NCT00323037|Carvedilol|carvedilol|mesh-list
13905530|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13905531|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14472336|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14472337|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14036833|NCT04537208|Vaccines|vaccines|mesh-list
13905532|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
13959565|NCT03161652|Dopamine|dopamine|mesh-list
14036834|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
14756183|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14036835|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036836|NCT04530565|Cytarabine|cytarabine|mesh-list
14036837|NCT04530565|Dexamethasone|dexamethasone|mesh-list
14036838|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
14036839|NCT04530565|Prednisone|prednisone|mesh-list
14036840|NCT04530565|Cortisone|cortisone|mesh-list
14036841|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
14036842|NCT04530565|Doxorubicin|doxorubicin|mesh-list
14036843|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14036844|NCT04530565|Methotrexate|methotrexate|mesh-list
14036845|NCT04530565|Vincristine|vincristine|mesh-list
14036846|NCT04530565|Dasatinib|dasatinib|mesh-list
14036847|NCT04530565|Blinatumomab|blinatumomab|mesh-list
14036848|NCT04530565|Ponatinib|ponatinib|mesh-list
14036849|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14036850|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
14036851|NCT04530565|Antibodies|antibodies|mesh-list
13905533|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905534|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905535|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905536|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13905537|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
13905538|NCT00323037|Protective Agents|protective agents|mesh-ancestor
13905539|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13905540|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13905541|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13905542|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
13905543|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13905544|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14036852|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
14036853|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14036854|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14036855|NCT04530565|BB 1101|bb 1101|mesh-list
14036856|NCT04530565|Mesna|mesna|mesh-list
14036857|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14036858|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
14036859|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036860|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14036861|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14036862|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
14036863|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036864|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036865|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14036866|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036867|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
14036868|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
14036869|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036870|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14036871|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
14036872|NCT04530565|Hormones|hormones|mesh-ancestor
14036873|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14036874|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14756184|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14756185|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756186|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14756187|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756188|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
14756189|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756190|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
14756191|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933054|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905545|NCT00322257|Insulin|insulin|mesh-list
14036875|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905546|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13905547|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
13905548|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
13905549|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905550|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036876|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036877|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14036878|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14036879|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14036880|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14036881|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
14756192|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959566|NCT03161652|Sulpiride|sulpiride|mesh-list
14036882|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14756193|NCT03290287|Bromides|bromides|mesh-list
13905551|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14036883|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14036884|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
14036885|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14036886|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13905552|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905553|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905554|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905555|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905556|NCT00321308|Pemetrexed|pemetrexed|mesh-list
13905557|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905558|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905559|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905560|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13905561|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13905562|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
13905563|NCT00320203|Anecortave|anecortave|mesh-list
13905564|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905565|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905566|NCT00320203|Growth Substances|growth substances|mesh-ancestor
13905567|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905568|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905569|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905570|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905571|NCT00319969|Topotecan|topotecan|mesh-list
13905572|NCT00319969|Amrubicin|amrubicin|mesh-list
13905573|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13905574|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13905575|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905576|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905577|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905578|NCT00318656|Metformin|metformin|mesh-list
13905579|NCT00318656|Glimepiride|glimepiride|mesh-list
13905580|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
13905581|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905582|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905583|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13905584|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905585|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
14036887|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14036888|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
14036889|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14036890|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14036891|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036892|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036893|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036894|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14036895|NCT04530565|Protective Agents|protective agents|mesh-ancestor
14036896|NCT04527991|Paclitaxel|paclitaxel|mesh-list
14036897|NCT04527991|Docetaxel|docetaxel|mesh-list
14036898|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14036899|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036900|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036901|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036902|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
13905586|NCT00317486|Bosentan|bosentan|mesh-list
13905587|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13905588|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14036903|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036904|NCT04524611|Ustekinumab|ustekinumab|mesh-list
14036905|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14036906|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
14036907|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
14036908|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472338|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13905589|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905590|NCT00317395|Heparin|heparin|mesh-list
13905591|NCT00317395|Calcium heparin|calcium heparin|mesh-list
13905592|NCT00317395|Otamixaban|otamixaban|mesh-list
13905593|NCT00317395|Eptifibatide|eptifibatide|mesh-list
13905594|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
13905595|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13905596|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13905597|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472339|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472340|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905598|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14472341|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036913|NCT04477759|Atezolizumab|atezolizumab|mesh-list
14036914|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472342|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
14472343|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14472344|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
14472345|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
14472346|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14036920|NCT04466618|Heparin|heparin|mesh-list
14036921|NCT04466618|Calcium heparin|calcium heparin|mesh-list
14036922|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14036923|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
14036924|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14036925|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14036926|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036927|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14036928|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14036929|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14036930|NCT04461587|Pirfenidone|pirfenidone|mesh-list
14036931|NCT04461587|Analgesics|analgesics|mesh-ancestor
14036932|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
14036933|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14036934|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036935|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14036936|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14036937|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14036938|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14036939|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036940|NCT04457089|Simvastatin|simvastatin|mesh-list
14036941|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13905599|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13905600|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
13905601|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13905602|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905603|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959567|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13959568|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13959569|NCT03161652|Growth Substances|growth substances|mesh-ancestor
13959570|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959571|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
13959572|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959573|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13959574|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
13959575|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
13959576|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959577|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
13959578|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959579|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959580|NCT03161652|Protective Agents|protective agents|mesh-ancestor
13959581|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13959582|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13959583|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959584|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14036942|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14036943|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
14036944|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14036945|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14036946|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14036947|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14036948|NCT04454658|Navitoclax|navitoclax|mesh-list
14036949|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472347|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13959585|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13959586|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13959587|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
13959588|NCT03161353|Tamoxifen|tamoxifen|mesh-list
14472348|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
14472349|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
14472350|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14472351|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
14472352|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13905604|NCT00315757|Bortezomib|bortezomib|mesh-list
13905605|NCT00315757|Mapatumumab|mapatumumab|mesh-list
13905606|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13905607|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905608|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
13905609|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905610|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
13905611|NCT00315640|Anecortave|anecortave|mesh-list
13905612|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905613|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905614|NCT00315640|Growth Substances|growth substances|mesh-ancestor
13905615|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905616|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905617|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905618|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905619|NCT00313794|Tremelimumab|tremelimumab|mesh-list
13905620|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905621|NCT00313768|Paclitaxel|paclitaxel|mesh-list
13905622|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13905623|NCT00313768|Bevacizumab|bevacizumab|mesh-list
13905624|NCT00313768|Carboplatin|carboplatin|mesh-list
13905625|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905626|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905627|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
13905628|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
13905629|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
13905630|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905631|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905632|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905633|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905634|NCT00313768|Growth Substances|growth substances|mesh-ancestor
13905635|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905636|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905637|NCT00313248|Sagopilone|sagopilone|mesh-list
13905638|NCT00313248|Epothilones|epothilones|mesh-list
13905639|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905640|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
13905641|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
13905642|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
13905643|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905644|NCT00313222|Bosentan|bosentan|mesh-list
14933055|NCT01448772|Dronabinol|dronabinol|mesh-list
14933056|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
14933057|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933058|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14933059|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933060|NCT01448772|Analgesics|analgesics|mesh-ancestor
14472353|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472354|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14472355|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
14472356|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14756194|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
14756195|NCT03289962|Atezolizumab|atezolizumab|mesh-list
14756196|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756197|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
14756198|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756199|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756200|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14756201|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
14756202|NCT03255174|Coagulants|coagulants|mesh-ancestor
14756203|NCT03254654|Apatinib|apatinib|mesh-list
14756204|NCT03254654|Vinorelbine|vinorelbine|mesh-list
14756205|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756206|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14756207|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756208|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933061|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
14472357|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14756209|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905645|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13905646|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14756210|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
14933062|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472358|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14472359|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472360|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472361|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472362|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14472363|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14472364|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14472365|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
14472366|NCT02347098|Atorvastatin|atorvastatin|mesh-list
14472367|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14472368|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14472369|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14472370|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
14472371|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472372|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14472373|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472374|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14472375|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
14472376|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036983|NCT04416737|Insulin|insulin|mesh-list
14036984|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14036985|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14036986|NCT04409860|Paclitaxel|paclitaxel|mesh-list
14036987|NCT04409860|Cisplatin|cisplatin|mesh-list
14036988|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14036989|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14036990|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
14036991|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
14036992|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
14036993|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472377|NCT02347332|Methotrexate|methotrexate|mesh-list
14472378|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14472379|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
14472380|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14472381|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472382|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14472383|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
14472384|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037002|NCT04394858|Temozolomide|temozolomide|mesh-list
14037003|NCT04394858|Olaparib|olaparib|mesh-list
14037004|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14037005|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14037006|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
14037007|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037008|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037009|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037010|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
14037011|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14037012|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
14037013|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472385|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472386|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
14472387|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472388|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14472389|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472390|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
14472391|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472392|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14472393|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
14472394|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13905647|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905648|NCT00313196|Bosentan|bosentan|mesh-list
13905649|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13905650|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13905651|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905652|NCT00312975|Tremelimumab|tremelimumab|mesh-list
13905653|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905654|NCT00312091|Lamivudine|lamivudine|mesh-list
13905655|NCT00312091|Nevirapine|nevirapine|mesh-list
13905656|NCT00312091|Stavudine|stavudine|mesh-list
13905657|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13905658|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13905659|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905660|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472395|NCT02347345|Ledipasvir|ledipasvir|mesh-list
14472396|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
14472397|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472398|NCT02347605|Nicotine|nicotine|mesh-list
14037028|NCT04363801|Capecitabine|capecitabine|mesh-list
14037029|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
14037030|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14037031|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
14037032|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037033|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037034|NCT04349306|Rasburicase|rasburicase|mesh-list
14037035|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
14037036|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14037037|NCT04345913|Halichondrin B|halichondrin b|mesh-list
14037038|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
14037039|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
14037040|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
14037041|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037042|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472399|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14472400|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
14472401|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472402|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472403|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14472404|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13905661|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
13905662|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905663|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13905664|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14472405|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
14472406|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472407|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472408|NCT02347631|Dipivefrin|dipivefrin|mesh-list
14472409|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14472410|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472411|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472412|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472413|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472414|NCT02347657|Ivacaftor|ivacaftor|mesh-list
14472415|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14472416|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14472417|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472418|NCT02347813|Pioglitazone|pioglitazone|mesh-list
14472419|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14472420|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479121|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14479122|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479123|NCT02464033|Analgesics|analgesics|mesh-ancestor
14479124|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
14479125|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13905665|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13905666|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13905667|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
13905668|NCT00311090|Idraparinux|idraparinux|mesh-list
13905669|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
13905670|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13905671|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
13905672|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13905673|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905674|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905675|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905676|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
14479126|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14037071|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
14037072|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
14037073|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14037074|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14037075|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14037076|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037077|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037078|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756211|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756212|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
13905677|NCT00310830|Bosentan|bosentan|mesh-list
14756213|NCT03253263|Mecasermin|mecasermin|mesh-list
13905678|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13959589|NCT03161353|Carboplatin|carboplatin|mesh-list
14756214|NCT03253263|Growth Substances|growth substances|mesh-ancestor
14756215|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756216|NCT03205163|Factor VIII|factor viii|mesh-list
14756217|NCT03205163|Coagulants|coagulants|mesh-ancestor
14756218|NCT03150693|Cytarabine|cytarabine|mesh-list
14756219|NCT03150693|Dexamethasone|dexamethasone|mesh-list
14756220|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
14756221|NCT03150693|Rituximab|rituximab|mesh-list
14756222|NCT03150693|Doxorubicin|doxorubicin|mesh-list
14756223|NCT03150693|Methotrexate|methotrexate|mesh-list
14756224|NCT03150693|Vincristine|vincristine|mesh-list
13905679|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13905680|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905681|NCT00309179|Cetuximab|cetuximab|mesh-list
14756225|NCT03150693|Daunorubicin|daunorubicin|mesh-list
14756226|NCT03150693|Asparaginase|asparaginase|mesh-list
14756227|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
13905682|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13905683|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905684|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
13905685|NCT00307398|Anecortave|anecortave|mesh-list
13905686|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905687|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905688|NCT00307398|Growth Substances|growth substances|mesh-ancestor
13905689|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905690|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905691|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905692|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13905693|NCT00305656|Cediranib|cediranib|mesh-list
13905694|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905695|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905696|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905697|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905698|NCT00305188|Leucovorin|leucovorin|mesh-list
13905699|NCT00305188|Fluorouracil|fluorouracil|mesh-list
13905700|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
13905701|NCT00305188|Xaliproden|xaliproden|mesh-list
13905702|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
13905703|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905704|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905705|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905706|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905707|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
13905708|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905709|NCT00305188|Antidotes|antidotes|mesh-ancestor
13905710|NCT00305188|Protective Agents|protective agents|mesh-ancestor
13905711|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
13905712|NCT00305188|Vitamins|vitamins|mesh-ancestor
14756228|NCT03150693|Thioguanine|thioguanine|mesh-list
14756229|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14756230|NCT03150693|Pegaspargase|pegaspargase|mesh-list
14756231|NCT03150693|Allopurinol|allopurinol|mesh-list
14756232|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756233|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
14756234|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756235|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472421|NCT02348008|Bevacizumab|bevacizumab|mesh-list
14472422|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
14472423|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14472424|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472425|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14472426|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14472427|NCT02348008|Growth Substances|growth substances|mesh-ancestor
14472428|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472429|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
14472430|NCT02348203|Aspirin|aspirin|mesh-list
14472431|NCT02348203|Zileuton|zileuton|mesh-list
14472432|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14472433|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14037117|NCT04302025|Atezolizumab|atezolizumab|mesh-list
14037118|NCT04302025|Vemurafenib|vemurafenib|mesh-list
14037119|NCT04302025|Pralsetinib|pralsetinib|mesh-list
14037120|NCT04302025|Entrectinib|entrectinib|mesh-list
14037121|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905713|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
13905714|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14037122|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14037123|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756236|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756237|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
14938644|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
14037124|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037125|NCT04292223|Pimavanserin|pimavanserin|mesh-list
14037126|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14037127|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14037128|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14037129|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14037130|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14037131|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037132|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13905715|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13905716|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
13905717|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905718|NCT00303498|Sitaxsentan|sitaxsentan|mesh-list
14037133|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14037134|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14037135|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
14037136|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14037137|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905719|NCT00303498|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13905720|NCT00303498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905721|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
13905722|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905723|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
13905724|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13905725|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13905726|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905727|NCT00301262|Urological Agents|urological agents|mesh-ancestor
13905728|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13905729|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13905730|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13905731|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13905732|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905733|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13905734|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13905735|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13905736|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
13905737|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756238|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756239|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756240|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756241|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756242|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
14756243|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
14756244|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756245|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14756246|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
14756247|NCT03150693|Hormones|hormones|mesh-ancestor
14756248|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13905738|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905739|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13905740|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13905741|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
13905742|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
13905743|NCT00299507|Anecortave|anecortave|mesh-list
13905744|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13905745|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13905746|NCT00299507|Growth Substances|growth substances|mesh-ancestor
13905747|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756249|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14756250|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756251|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756252|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756253|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756254|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756255|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14756256|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
14756257|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14756258|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905748|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
13905749|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905750|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14472434|NCT02348203|Analgesics|analgesics|mesh-ancestor
13905751|NCT00299325|Rimonabant|rimonabant|mesh-list
13905752|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13905753|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13905754|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13905755|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905756|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905757|NCT00299325|Hormones|hormones|mesh-ancestor
13905758|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13905759|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905760|NCT00298987|Dasatinib|dasatinib|mesh-list
13905761|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905762|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905763|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905764|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905765|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
13905766|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905767|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905768|NCT00297310|Tacrolimus|tacrolimus|mesh-list
13905769|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905770|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
13905771|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905772|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13905773|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905774|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905775|NCT00297089|Pemetrexed|pemetrexed|mesh-list
13905776|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905777|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905778|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905779|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13905780|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13905781|NCT00292396|Antibodies|antibodies|mesh-list
13905782|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13905783|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
13905784|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905785|NCT00289640|Ipilimumab|ipilimumab|mesh-list
13905786|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756259|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
14756260|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
14756261|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14756262|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14756263|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
14756264|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756265|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14472435|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
14472436|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472437|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472438|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14472439|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472440|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14472441|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14472442|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472443|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14472444|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14472445|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472446|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
14472447|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14472448|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14472449|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
14472450|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472451|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
14472452|NCT02348216|Fludarabine|fludarabine|mesh-list
14472453|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472454|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
14037189|NCT04229615|Apatinib|apatinib|mesh-list
14037190|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037191|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14037192|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037193|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472455|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472456|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472457|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14472458|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
14756266|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
14037199|NCT04210349|Vaccines|vaccines|mesh-list
13905787|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905788|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13905789|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905790|NCT00287547|Abatacept|abatacept|mesh-list
13905791|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13905792|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905793|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905794|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905795|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
13905796|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905797|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13905798|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
13905799|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905800|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905801|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13905802|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
13905803|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14037200|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
14037201|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472459|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472460|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472461|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13905804|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905805|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
13905806|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
13905807|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13905808|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
14472462|NCT02348385|Amphetamine|amphetamine|mesh-list
14472463|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
14472464|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14472465|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472466|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
14472467|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
14472468|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472469|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
14472470|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933063|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14037215|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14037216|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037217|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037218|NCT04191304|Benralizumab|benralizumab|mesh-list
14037219|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14037220|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14037221|NCT04186871|Abatacept|abatacept|mesh-list
14037222|NCT04186871|Branebrutinib|branebrutinib|mesh-list
14037223|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14037224|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933064|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14933065|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933066|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933067|NCT01448772|Hormones|hormones|mesh-ancestor
14933068|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933069|NCT01448798|Thrombin|thrombin|mesh-list
14933070|NCT01448798|Hemostatics|hemostatics|mesh-list
14933071|NCT01448798|Coagulants|coagulants|mesh-ancestor
14933072|NCT01448837|Timolol|timolol|mesh-list
14756267|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756268|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756269|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
14756270|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14756271|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
14756272|NCT03150693|Protective Agents|protective agents|mesh-ancestor
14756273|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
13905809|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905810|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905811|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13905812|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
13905813|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13905814|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905815|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
13905816|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
13905817|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13905818|NCT00284128|Losartan|losartan|mesh-list
13905819|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13905820|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13905821|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13905822|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13905823|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905824|NCT00282867|Insulin|insulin|mesh-list
13905825|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905826|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905827|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
13905828|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905829|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905830|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13905831|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
13905832|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13905833|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905834|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
13905835|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
13905836|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13905837|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
13905838|NCT00273650|Vitamins|vitamins|mesh-ancestor
13905839|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
13905840|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905841|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
13905842|NCT00267592|Temozolomide|temozolomide|mesh-list
13905843|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13905844|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
13905845|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905846|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905847|NCT00267280|Atorvastatin|atorvastatin|mesh-list
14037225|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037226|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14037227|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
14037228|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037229|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14037230|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14037231|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037232|NCT04177693|Letrozole|letrozole|mesh-list
14037233|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14037234|NCT04177693|Clomiphene|clomiphene|mesh-list
14037235|NCT04177693|Enclomiphene|enclomiphene|mesh-list
14037236|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
14037237|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037238|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037239|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14037240|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14037241|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037242|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14037243|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
14037244|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14037245|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037246|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14037247|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
14037248|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14037249|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14037250|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14037251|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
14756274|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13905848|NCT00267280|Simvastatin|simvastatin|mesh-list
13905849|NCT00267280|Torcetrapib|torcetrapib|mesh-list
13905850|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13905851|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14933073|NCT01448837|Bimatoprost|bimatoprost|mesh-list
14933074|NCT01448837|Latanoprost|latanoprost|mesh-list
14933075|NCT01448837|Cloprostenol|cloprostenol|mesh-list
14933076|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14933077|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13905852|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
13905853|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905854|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13905855|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13905856|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905857|NCT00265655|Satraplatin|satraplatin|mesh-list
13905858|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905859|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
13905860|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13905861|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13905862|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905863|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13905864|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13905865|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13905866|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13905867|NCT00263341|Estrogens|estrogens|mesh-ancestor
13905868|NCT00263341|Hormones|hormones|mesh-ancestor
13905869|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13905870|NCT00263042|Rimonabant|rimonabant|mesh-list
14037252|NCT04177693|Protective Agents|protective agents|mesh-ancestor
14037253|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14037254|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14037255|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14472471|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472472|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472473|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14472474|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14472475|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14756275|NCT03145766|Antibodies|antibodies|mesh-list
14756276|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
14756277|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756278|NCT03127592|Etodolac|etodolac|mesh-list
14756279|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
14756280|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14756281|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
14756282|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14756283|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14756284|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756285|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14756286|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756287|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14037274|NCT04142086|Vaccines|vaccines|mesh-list
14037275|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
14037276|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472476|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14472477|NCT02348489|Guadecitabine|guadecitabine|mesh-list
14472478|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472479|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14472480|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14472481|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14472482|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472483|NCT02348723|Warfarin|warfarin|mesh-list
14472484|NCT02348723|Dabigatran|dabigatran|mesh-list
14472485|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
14472486|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
14472487|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14472488|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
14472489|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472490|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472491|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
14472492|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14472493|NCT02348775|Glycine|glycine|mesh-list
14472494|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
14472495|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472496|NCT02348775|Expectorants|expectorants|mesh-ancestor
14756288|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472497|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14037299|NCT04137887|Vaccines|vaccines|mesh-list
14037300|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
14037301|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037302|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
14037303|NCT04109482|Fludarabine|fludarabine|mesh-list
14037304|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14037305|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
14037306|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037307|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14037308|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14037309|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
14037310|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037311|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037312|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14037313|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
14037314|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13905871|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13905872|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13905873|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13905874|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905875|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905876|NCT00263042|Hormones|hormones|mesh-ancestor
13905877|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13905878|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905879|NCT00262990|Doxorubicin|doxorubicin|mesh-list
13905880|NCT00262990|Epothilone B|epothilone b|mesh-list
13905881|NCT00262990|Epothilones|epothilones|mesh-list
13905882|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13905883|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905884|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13905885|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13905886|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905887|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905888|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
13905889|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
13905890|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
13905891|NCT00260156|Vildagliptin|vildagliptin|mesh-list
13905892|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13905893|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905894|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13905895|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905896|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905897|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905898|NCT00260078|Ritonavir|ritonavir|mesh-list
13905899|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13905900|NCT00260078|Darunavir|darunavir|mesh-list
13905901|NCT00260078|Tenofovir|tenofovir|mesh-list
13905902|NCT00260078|Nevirapine|nevirapine|mesh-list
13905903|NCT00260078|Efavirenz|efavirenz|mesh-list
13905904|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13905905|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13905906|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905907|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905908|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905909|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13905910|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13905911|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
14037315|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14037316|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037317|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14037318|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037319|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14472498|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14472499|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
14472500|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472501|NCT02348775|Protective Agents|protective agents|mesh-ancestor
14472502|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472503|NCT02348775|Antidotes|antidotes|mesh-ancestor
14472504|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
14472505|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169861|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13905912|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905913|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13905914|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13905915|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14472506|NCT02348918|Bevacizumab|bevacizumab|mesh-list
14472507|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14472508|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472509|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14472510|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14472511|NCT02348918|Growth Substances|growth substances|mesh-ancestor
14472512|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037336|NCT04088188|Gemcitabine|gemcitabine|mesh-list
14037337|NCT04088188|Cisplatin|cisplatin|mesh-list
14037338|NCT04088188|Ivosidenib|ivosidenib|mesh-list
14037339|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037340|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14037341|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
14037342|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037343|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
14037344|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14037345|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037346|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14037347|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
14037348|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905916|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13905917|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13905918|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14472513|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
14472514|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
14472515|NCT02349048|Simeprevir|simeprevir|mesh-list
14472516|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
14472517|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14037354|NCT04075513|Insulin|insulin|mesh-list
14037355|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14037356|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
14037357|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
14037358|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037359|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037360|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
14037361|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14037362|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14037363|NCT04074187|Prednisolone|prednisolone|mesh-list
14037364|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
14037365|NCT04074187|Rituximab|rituximab|mesh-list
14037366|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14037367|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
14037368|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14037369|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14037370|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037371|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
14037372|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037373|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14037374|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14037375|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
14037376|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
14037377|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14037378|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14037379|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
14037380|NCT04074187|Hormones|hormones|mesh-ancestor
14037381|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14037382|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14037383|NCT04074187|Protective Agents|protective agents|mesh-ancestor
14037384|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14472518|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
14472519|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472520|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472521|NCT02349061|Ustekinumab|ustekinumab|mesh-list
14472522|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
14472523|NCT02349152|Fentanyl|fentanyl|mesh-list
14472524|NCT02349152|Remifentanil|remifentanil|mesh-list
13905919|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13905920|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14472525|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14472526|NCT02349152|Narcotics|narcotics|mesh-ancestor
14472527|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472528|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472529|NCT02349152|Analgesics|analgesics|mesh-ancestor
14472530|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
14472531|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472532|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14472533|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14472534|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
14472535|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
14472536|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
14472537|NCT02349178|Etoposide|etoposide|mesh-list
14037405|NCT04017546|Venetoclax|venetoclax|mesh-list
14037406|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037407|NCT04007991|Ecopipam|ecopipam|mesh-list
14037408|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14037409|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14037410|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14037411|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037412|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14037413|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14037414|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
14037415|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14037416|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037417|NCT04003818|Teicoplanin|teicoplanin|mesh-list
13905921|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13905922|NCT00257205|Temozolomide|temozolomide|mesh-list
13905923|NCT00257205|Dacarbazine|dacarbazine|mesh-list
13905924|NCT00257205|Tremelimumab|tremelimumab|mesh-list
13905925|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13905926|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
13905927|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905928|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905929|NCT00255099|Etravirine|etravirine|mesh-list
13905930|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13905931|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13905932|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905933|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905934|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
13905935|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13905936|NCT00254904|Gemcitabine|gemcitabine|mesh-list
13905937|NCT00254904|Cisplatin|cisplatin|mesh-list
13905938|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905939|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905940|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
13905941|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905942|NCT00254904|Antiviral Agents|antiviral agents|mesh-ancestor
13905943|NCT00254904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14037418|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14037419|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14037420|NCT04003805|Nicotine|nicotine|mesh-list
14037421|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14037422|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
14037423|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14037424|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905944|NCT00254904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905945|NCT00254904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905946|NCT00254904|Immunologic Factors|immunologic factors|mesh-ancestor
13905947|NCT00254904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905948|NCT00254891|Paclitaxel|paclitaxel|mesh-list
13905949|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13905950|NCT00254891|Carboplatin|carboplatin|mesh-list
13905951|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905952|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037425|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14037426|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14037427|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
14037428|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14037429|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472538|NCT02349178|Clofarabine|clofarabine|mesh-list
14472539|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472540|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
14472541|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905953|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
14472542|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472543|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13905954|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
14472544|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
13905955|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
14479127|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14037437|NCT03994601|Nivolumab|nivolumab|mesh-list
14037438|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14037439|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037440|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14037441|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472545|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472546|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472547|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14472548|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14472549|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14472550|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14472551|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472552|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14472553|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
14472554|NCT02349295|Ixekizumab|ixekizumab|mesh-list
14472555|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
14472556|NCT02349451|Adalimumab|adalimumab|mesh-list
14472557|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14472558|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472559|NCT02349477|Gabapentin|gabapentin|mesh-list
14472560|NCT02349477|Analgesics|analgesics|mesh-ancestor
14472561|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
14472562|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472563|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905956|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905957|NCT00254579|Tremelimumab|tremelimumab|mesh-list
13905958|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905959|NCT00253968|SR 46349B|sr 46349b|mesh-list
13905960|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13905961|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13905962|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905963|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13905964|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13905965|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
13905966|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13905967|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905968|NCT00252005|Apixaban|apixaban|mesh-list
13905969|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13905970|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
13905971|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14472564|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
14472565|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14472566|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14472567|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472568|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14472569|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14472570|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14472571|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472572|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472573|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
14472574|NCT02349542|Bupivacaine|bupivacaine|mesh-list
14472575|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14472576|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
14472577|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472578|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472579|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
14472580|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472581|NCT02349633|Palbociclib|palbociclib|mesh-list
13905972|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
13905973|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905974|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905975|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
13905976|NCT00250822|Gemcitabine|gemcitabine|mesh-list
13905977|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
13905978|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13905979|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
13905980|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905981|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905982|NCT00250822|Antiviral Agents|antiviral agents|mesh-ancestor
13905983|NCT00250822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472582|NCT02349633|Avelumab|avelumab|mesh-list
14472583|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472584|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13905984|NCT00250822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472585|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13905985|NCT00250822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13905986|NCT00250822|Immunologic Factors|immunologic factors|mesh-ancestor
13905987|NCT00250822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13905988|NCT00243906|Plasminogen|plasminogen|mesh-list
13905989|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13905990|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13905991|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13905992|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13905993|NCT00243867|Paclitaxel|paclitaxel|mesh-list
13905994|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13905995|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13905996|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
13905997|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
13905998|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
13905999|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906000|NCT00239694|Vaccines|vaccines|mesh-list
13906001|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13906002|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
13906003|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472586|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472587|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14472588|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
14472589|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14472590|NCT02350309|Lemborexant|lemborexant|mesh-list
14472591|NCT02350309|Flurazepam|flurazepam|mesh-list
14472592|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14472593|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14037491|NCT03958799|Vaccines|vaccines|mesh-list
14037492|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
14037493|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472594|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906004|NCT00232752|Sirolimus|sirolimus|mesh-list
13906005|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13906006|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906007|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13906008|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906009|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
13906010|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906011|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
13906012|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906013|NCT00232141|Pregabalin|pregabalin|mesh-list
13906014|NCT00232141|Analgesics|analgesics|mesh-ancestor
13906015|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
13906016|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906017|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906018|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
13906019|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13906020|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13906021|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906022|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13906023|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13906024|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13906025|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13906026|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13906027|NCT00231257|Sirolimus|sirolimus|mesh-list
13906028|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13906029|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906030|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13906031|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906032|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
13906033|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906034|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
13906035|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906036|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
13906037|NCT00231153|Povidone|povidone|mesh-list
13906038|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
13906039|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
13906040|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14933078|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
13906041|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906042|NCT00229008|Linezolid|linezolid|mesh-list
13906043|NCT00229008|Ceftazidime|ceftazidime|mesh-list
14472595|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13906044|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
13906045|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14472596|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14472597|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472598|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472599|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14472600|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14472601|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14472602|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
14472603|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
14472604|NCT02350478|Linagliptin|linagliptin|mesh-list
14472605|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14472606|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472607|NCT02350478|Incretins|incretins|mesh-ancestor
14472608|NCT02350478|Hormones|hormones|mesh-ancestor
14472609|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472610|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14472611|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
14472612|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472613|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472614|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
14472615|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14472616|NCT02350569|Ledipasvir|ledipasvir|mesh-list
14037519|NCT03951142|Losartan|losartan|mesh-list
13906046|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13906047|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906048|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13906049|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906050|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906051|NCT00228176|Rimonabant|rimonabant|mesh-list
13906052|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13906053|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
13906054|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14037520|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14037521|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14037522|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14037523|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14933079|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933080|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933081|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933082|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14933083|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906055|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13906056|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906057|NCT00228176|Hormones|hormones|mesh-ancestor
13906058|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906059|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906060|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
13906061|NCT00224003|Hematinics|hematinics|mesh-ancestor
13906062|NCT00219297|Epothilone B|epothilone b|mesh-list
13906063|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906064|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
13906065|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
13906066|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
14933084|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14933085|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13906067|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037524|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037525|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
14037526|NCT03945591|Bortezomib|bortezomib|mesh-list
14037527|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14037528|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
14037529|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037530|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906068|NCT00216593|Galantamine|galantamine|mesh-list
13906069|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13906070|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906071|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906072|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
13906073|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13906074|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906075|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13906076|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
14037531|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14472617|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
14037532|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
14037533|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037534|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037535|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14037536|NCT03943875|Vaccines|vaccines|mesh-list
14037537|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
14037538|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472618|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906077|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906078|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
13906079|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
13906080|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
13906081|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906082|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
13906083|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906084|NCT00214968|Modafinil|modafinil|mesh-list
13906085|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13906086|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906087|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
13906088|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13906089|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906090|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906091|NCT00210964|Linezolid|linezolid|mesh-list
14472619|NCT02351037|Azacitidine|azacitidine|mesh-list
14472620|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14472621|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
14472622|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472623|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472624|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472625|NCT02351115|Alprazolam|alprazolam|mesh-list
14472626|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14472627|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472628|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472629|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14472630|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14472631|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14472632|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
13906092|NCT00210964|Ceftazidime|ceftazidime|mesh-list
13906093|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
13906094|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
13906095|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13906096|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906097|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13906098|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472633|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
14037555|NCT03930446|Ethanol|ethanol|mesh-list
14037556|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14037557|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906099|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959590|NCT03161353|Docetaxel|docetaxel|mesh-list
13959591|NCT03161353|Trastuzumab|trastuzumab|mesh-list
13959592|NCT03161353|Letrozole|letrozole|mesh-list
13959593|NCT03161353|Pertuzumab|pertuzumab|mesh-list
13959594|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959595|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
13959596|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
13959597|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
13959598|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959599|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959600|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13959601|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13959602|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959603|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14037558|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14037559|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037560|NCT03926130|Mirikizumab|mirikizumab|mesh-list
14037561|NCT03926130|Ustekinumab|ustekinumab|mesh-list
14037562|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
14037563|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14037564|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14037565|NCT03926130|Analgesics|analgesics|mesh-ancestor
14037566|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
13959604|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
14037567|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959605|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14037568|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037569|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14037570|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14037571|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14037572|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14037573|NCT03916601|Insulin|insulin|mesh-list
14037574|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14037575|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
14037576|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
14037577|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14037578|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037579|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906100|NCT00198276|Bleomycin|bleomycin|mesh-list
13906101|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13906102|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906103|NCT00198263|Bleomycin|bleomycin|mesh-list
13906104|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13906105|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906106|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
13906107|NCT00196339|Cyproterone|cyproterone|mesh-list
13906108|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
13906109|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
13906110|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906111|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906112|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472634|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472635|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472636|NCT02351167|Nicotine|nicotine|mesh-list
14472637|NCT02351167|Varenicline|varenicline|mesh-list
14472638|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13906113|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13906114|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
13906115|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13906116|NCT00179400|Pioglitazone|pioglitazone|mesh-list
13906117|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906118|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933086|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
14933087|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14933088|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
14933089|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14933090|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14933091|NCT01448993|Azithromycin|azithromycin|mesh-list
14933092|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14933093|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933094|NCT01449045|Lumefantrine|lumefantrine|mesh-list
14933095|NCT01449045|Artemether|artemether|mesh-list
14933096|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14933097|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
14933098|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13906119|NCT00174837|Tirapazamine|tirapazamine|mesh-list
14472639|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
14472640|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472641|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906120|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906121|NCT00162292|Methotrexate|methotrexate|mesh-list
13906122|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13906123|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
13906124|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13906125|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906126|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13906127|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
13906128|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906129|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472642|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14472643|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14472644|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14472645|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472646|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472647|NCT02351700|Ibuprofen|ibuprofen|mesh-list
14472648|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14472649|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14472650|NCT02351700|Analgesics|analgesics|mesh-ancestor
14933099|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13906130|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
13906131|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933100|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472651|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
14472652|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472653|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472654|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14472655|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906132|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13906133|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906134|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
14472656|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14472657|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472658|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472659|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
13906135|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906136|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906137|NCT00162279|Abatacept|abatacept|mesh-list
13906138|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13906139|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906140|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472660|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
14472661|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14472662|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472663|NCT02351934|Celecoxib|celecoxib|mesh-list
14037611|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14037612|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14037613|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037614|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037615|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756289|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14756290|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756291|NCT03127592|Analgesics|analgesics|mesh-ancestor
14756292|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
14756293|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756294|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756295|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14756296|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14756297|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756298|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756299|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
13906141|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906142|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
13906143|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906144|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906145|NCT00157339|Insulin|insulin|mesh-list
13906146|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13906147|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906148|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906149|NCT00151398|Donepezil|donepezil|mesh-list
13906150|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13906151|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906152|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906153|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
13906154|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13906155|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906156|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
13906157|NCT00145431|Atorvastatin|atorvastatin|mesh-list
13906158|NCT00145431|Torcetrapib|torcetrapib|mesh-list
13906159|NCT00145431|Fenofibrate|fenofibrate|mesh-list
13906160|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13906161|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13906162|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
13906163|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906164|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13906165|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13906166|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906167|NCT00141284|Lamivudine|lamivudine|mesh-list
13906168|NCT00141284|Zidovudine|zidovudine|mesh-list
13906169|NCT00141284|Nelfinavir|nelfinavir|mesh-list
13906170|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906171|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906172|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472664|NCT02351934|Furosemide|furosemide|mesh-list
13906173|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906174|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
13906175|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906176|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906177|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906178|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
13906179|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906180|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906181|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906182|NCT00138762|Atorvastatin|atorvastatin|mesh-list
13906183|NCT00138762|Torcetrapib|torcetrapib|mesh-list
13906184|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13906185|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13906186|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
13906187|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906188|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13906189|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13906190|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906191|NCT00135421|Citalopram|citalopram|mesh-list
13906192|NCT00135421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13906193|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13906194|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13906195|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906196|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13906197|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
13906198|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906199|NCT00135421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13906200|NCT00135421|Antidepressive Agents|antidepressive agents|mesh-ancestor
14756300|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
14756301|NCT03116425|Vitamins|vitamins|mesh-ancestor
14756302|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
14756303|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756304|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
14756305|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14756306|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14756307|NCT03110822|Prednisolone|prednisolone|mesh-list
14756308|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
14756309|NCT03110822|Lenalidomide|lenalidomide|mesh-list
14756310|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14756311|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
14756312|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
14756313|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756314|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14756315|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14037645|NCT03903016|Insulin|insulin|mesh-list
14037646|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14037647|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
14037648|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037649|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472665|NCT02351934|Gabapentin|gabapentin|mesh-list
14472666|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14472667|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14472668|NCT02351934|Analgesics|analgesics|mesh-ancestor
14472669|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
14037655|NCT03892642|Avelumab|avelumab|mesh-list
14037656|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14037657|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037658|NCT03891355|Dexamethasone|dexamethasone|mesh-list
14037659|NCT03891355|Lenalidomide|lenalidomide|mesh-list
14037660|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14037661|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
14037662|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
14037663|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14037664|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037665|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14037666|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
14037667|NCT03891355|Hormones|hormones|mesh-ancestor
14037668|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14037669|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14037670|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037671|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
14037672|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14037673|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14037674|NCT03891355|Growth Substances|growth substances|mesh-ancestor
14756316|NCT03110822|Growth Substances|growth substances|mesh-ancestor
14756317|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
13906201|NCT00135421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13906202|NCT00135395|Ritonavir|ritonavir|mesh-list
13906203|NCT00135395|Lopinavir|lopinavir|mesh-list
13906204|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906205|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906206|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14037675|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
14756318|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756319|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756320|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
13906207|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906208|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906209|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906210|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906211|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906212|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
13906213|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906214|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13906215|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906216|NCT00135382|Efavirenz|efavirenz|mesh-list
13906217|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906218|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906219|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906220|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906221|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
13906222|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906223|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13906224|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906225|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13906226|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13906227|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906228|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13906229|NCT00135369|Lamivudine|lamivudine|mesh-list
13906230|NCT00135369|Efavirenz|efavirenz|mesh-list
13906231|NCT00135369|Stavudine|stavudine|mesh-list
13906232|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906233|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906234|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906235|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906236|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
13906237|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906238|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906239|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906240|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13906241|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906242|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14756321|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
14756322|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756323|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14472670|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472671|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472672|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14472673|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472674|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14472675|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14472676|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472677|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472678|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
14472679|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14472680|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14472681|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472682|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14472683|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14472684|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14472685|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472686|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
13906243|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13906244|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906245|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13906246|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
13906247|NCT00135343|Ritonavir|ritonavir|mesh-list
13906248|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906249|NCT00135343|Efavirenz|efavirenz|mesh-list
13906250|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906251|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906252|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906253|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906254|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906255|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906256|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906257|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
13906258|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906259|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13906260|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906261|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906262|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906263|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14472687|NCT02351934|Diuretics|diuretics|mesh-ancestor
14037710|NCT03861702|Irinotecan|irinotecan|mesh-list
14037711|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14037712|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14037713|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037714|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037715|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472688|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
14472689|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14472690|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14472691|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
14472692|NCT02351960|Lansoprazole|lansoprazole|mesh-list
14472693|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14472694|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14472695|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14472696|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472697|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472698|NCT02352259|Bleomycin|bleomycin|mesh-list
14472699|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14037730|NCT03822507|Cinacalcet|cinacalcet|mesh-list
14037731|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14037732|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037733|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
13906264|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13906265|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14037734|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
14037735|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14037736|NCT03816358|Gemcitabine|gemcitabine|mesh-list
14037737|NCT03816358|Nivolumab|nivolumab|mesh-list
14037738|NCT03816358|Ipilimumab|ipilimumab|mesh-list
14037739|NCT03816358|Maytansine|maytansine|mesh-list
14037740|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14037741|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
14037742|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037743|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037744|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
14037745|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14037746|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037747|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14037748|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
14037749|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037750|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14037751|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14037752|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14037753|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14037754|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14037755|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14472700|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472701|NCT02352363|Levodopa|levodopa|mesh-list
14472702|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14756324|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
13906266|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906267|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14472703|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14472704|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
14472705|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472706|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906268|NCT00134264|Atorvastatin|atorvastatin|mesh-list
13906269|NCT00134264|Torcetrapib|torcetrapib|mesh-list
13906270|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13906271|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13906272|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
13906273|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906274|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13906275|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13906276|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906277|NCT00134238|Atorvastatin|atorvastatin|mesh-list
13906278|NCT00134238|Torcetrapib|torcetrapib|mesh-list
13906279|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13906280|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13906281|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
14472707|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472708|NCT02352831|Capecitabine|capecitabine|mesh-list
14472709|NCT02352831|Tosedostat|tosedostat|mesh-list
14472710|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14472711|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
14472712|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472713|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472714|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472715|NCT02352844|Everolimus|everolimus|mesh-list
14472716|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472717|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472718|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
14472719|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472720|NCT02352922|Bupivacaine|bupivacaine|mesh-list
14472721|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
14472722|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
14472723|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472724|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472725|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
14472726|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906282|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906283|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13906284|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13906285|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906286|NCT00131924|Estrogens|estrogens|mesh-list
13906287|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
13906288|NCT00131924|Hormones|hormones|mesh-ancestor
13906289|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906290|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906291|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
13906292|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
13906293|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13906294|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
13906295|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906296|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13906297|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13906298|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13906299|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906300|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906301|NCT00127634|Insulin|insulin|mesh-list
13906302|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13906303|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
13906304|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906305|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906306|NCT00126984|Vaccines|vaccines|mesh-list
13906307|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
13906308|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906309|NCT00125970|Vaccines|vaccines|mesh-list
13906310|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
13906311|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906312|NCT00120393|Ritonavir|ritonavir|mesh-list
13906313|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906314|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14037783|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14037784|NCT03802487|Charcoal|charcoal|mesh-list
14037785|NCT03802487|Antidotes|antidotes|mesh-ancestor
14037786|NCT03802487|Protective Agents|protective agents|mesh-ancestor
14037787|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037788|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14037789|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037790|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037791|NCT03800836|Paclitaxel|paclitaxel|mesh-list
14037792|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14037793|NCT03800836|Atezolizumab|atezolizumab|mesh-list
14037794|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14037795|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906315|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906316|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906317|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906318|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906319|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906320|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906321|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
13906322|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906323|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13906324|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906325|NCT00120042|Misoprostol|misoprostol|mesh-list
14472727|NCT02352974|Vitamin D|vitamin d|mesh-list
13906326|NCT00120042|Oxytocin|oxytocin|mesh-list
13906327|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
13906328|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13906329|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906330|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13906331|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
13906332|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13906333|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13906334|NCT00119366|Iodine|iodine|mesh-list
13906335|NCT00119366|Cyclosporine|cyclosporine|mesh-list
14037796|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
14037797|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
14037798|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
14037799|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037800|NCT03798080|Insulin|insulin|mesh-list
14037801|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14037802|NCT03798080|Metformin|metformin|mesh-list
14037803|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
14037804|NCT03798080|Lixisenatide|lixisenatide|mesh-list
14037805|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037806|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037807|NCT03794336|Aspirin|aspirin|mesh-list
14037808|NCT03794336|Metformin|metformin|mesh-list
14037809|NCT03794336|Alogliptin|alogliptin|mesh-list
14037810|NCT03794336|Acarbose|acarbose|mesh-list
14037811|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037812|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037813|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14037814|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14037815|NCT03794336|Analgesics|analgesics|mesh-ancestor
14037816|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
14037817|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14037818|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14037819|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14037820|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14037821|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14037822|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037823|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14037824|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14037825|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037826|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
14037827|NCT03794336|Incretins|incretins|mesh-ancestor
14037828|NCT03794336|Hormones|hormones|mesh-ancestor
14037829|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472728|NCT02352974|Vitamins|vitamins|mesh-ancestor
14037830|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14037831|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
14037832|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14756325|NCT03110822|Hormones|hormones|mesh-ancestor
14756326|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756327|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14756328|NCT03110822|Protective Agents|protective agents|mesh-ancestor
14756329|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13906336|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
13906337|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13906338|NCT00119366|Fludarabine|fludarabine|mesh-list
13906339|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
13906340|NCT00119366|Antibodies|antibodies|mesh-list
13906341|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
13906342|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13906343|NCT00119366|Cyclosporins|cyclosporins|mesh-list
13906344|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
13906345|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906346|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756330|NCT03106987|Olaparib|olaparib|mesh-list
14756331|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14756332|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756333|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472729|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
14472730|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472731|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14472732|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
14472733|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14472734|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472735|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472736|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14472737|NCT02353169|Analgesics|analgesics|mesh-ancestor
14472738|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
14472739|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472740|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14472741|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14472742|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14472743|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472744|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472745|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472746|NCT02353299|Zolpidem|zolpidem|mesh-list
14472747|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14472748|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14472749|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472750|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472751|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14472752|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
14472753|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
14756334|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037868|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13906347|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13906348|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
14756335|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
14756336|NCT03105843|Miotics|miotics|mesh-ancestor
14756337|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
13906349|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906350|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906351|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906352|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
13906353|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906354|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
13906355|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906356|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13906357|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13906358|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13906359|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
13906360|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13906361|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13906362|NCT00119366|Trace Elements|trace elements|mesh-ancestor
13906363|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
13906364|NCT00117650|Etoposide|etoposide|mesh-list
13906365|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
13906366|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14037869|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14037870|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037871|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037872|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756338|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756339|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756340|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14756341|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14756342|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14756343|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14756344|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14756345|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
14756346|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756347|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756348|NCT03103750|Calcitriol|calcitriol|mesh-list
14756349|NCT03103750|Amphetamine|amphetamine|mesh-list
14756350|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
14756351|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14756352|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756353|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14756354|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14756355|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037898|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
14037899|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14037900|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037901|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
14037902|NCT03767543|Lixisenatide|lixisenatide|mesh-list
14037903|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037904|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037905|NCT03761134|Metformin|metformin|mesh-list
14037906|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14037907|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037908|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037909|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14037910|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037911|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
13906367|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906368|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13906369|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13906370|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906371|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906372|NCT00116415|Lamivudine|lamivudine|mesh-list
13906373|NCT00116415|Efavirenz|efavirenz|mesh-list
13906374|NCT00116415|Didanosine|didanosine|mesh-list
13906375|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906376|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906377|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906378|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906379|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
13906380|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906381|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906382|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906383|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13906384|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906385|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13906386|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13906387|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906388|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13906389|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
13906390|NCT00116298|Lamivudine|lamivudine|mesh-list
13906391|NCT00116298|Efavirenz|efavirenz|mesh-list
13906392|NCT00116298|Stavudine|stavudine|mesh-list
13906393|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906394|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906395|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037912|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037913|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037914|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14037915|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14037916|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037917|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037918|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472754|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472755|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472756|NCT02353754|Morphine|morphine|mesh-list
14472757|NCT02353754|Bupivacaine|bupivacaine|mesh-list
14472758|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
14472759|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
14472760|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472761|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472762|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
14472763|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472764|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14472765|NCT02353754|Narcotics|narcotics|mesh-ancestor
14472766|NCT02353754|Analgesics|analgesics|mesh-ancestor
14472767|NCT02353780|Etanercept|etanercept|mesh-list
14472768|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14472769|NCT02353780|Abatacept|abatacept|mesh-list
14037935|NCT03743636|Niacinamide|niacinamide|mesh-list
14037936|NCT03743636|Niacin|niacin|mesh-list
14037937|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
14037938|NCT03743636|Resveratrol|resveratrol|mesh-list
14037939|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
14037940|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037941|NCT03743636|Protective Agents|protective agents|mesh-ancestor
13906396|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906397|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
13906398|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906399|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906400|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906401|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13906402|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906403|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13906404|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13906405|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906406|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13906407|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
13906408|NCT00116116|Lamivudine|lamivudine|mesh-list
13906409|NCT00116116|Efavirenz|efavirenz|mesh-list
13906410|NCT00116116|Stavudine|stavudine|mesh-list
13906411|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906412|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906413|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906414|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906415|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
13906416|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906417|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14037942|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037943|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14037944|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14037945|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
14756356|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14933101|NCT01449110|Resveratrol|resveratrol|mesh-list
14933102|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
14933103|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933104|NCT01449110|Protective Agents|protective agents|mesh-ancestor
13906418|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14037946|NCT03743636|Vitamins|vitamins|mesh-ancestor
14756357|NCT03103750|Vitamins|vitamins|mesh-ancestor
14756358|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
14756359|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14756360|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14756361|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
14756362|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
14756363|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756364|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
14756365|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756366|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
14756367|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14933105|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906419|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13906420|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906421|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13906422|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13906423|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906424|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13906425|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
13906426|NCT00115050|Darunavir|darunavir|mesh-list
13906427|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906428|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906429|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906430|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906431|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906432|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906433|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906434|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
13906435|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906436|NCT00113438|Paclitaxel|paclitaxel|mesh-list
13906437|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
13906438|NCT00113438|Combretastatin|combretastatin|mesh-list
14037947|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
14037948|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14037949|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
14037950|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14037951|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
14756368|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14756369|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14756370|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14756371|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14756372|NCT03103087|Norethindrone|norethindrone|mesh-list
14756373|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
14756374|NCT03103087|Estradiol|estradiol|mesh-list
14756375|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14756376|NCT03103087|Relugolix|relugolix|mesh-list
14756377|NCT03103087|Estrogens|estrogens|mesh-ancestor
13906439|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13906440|NCT00113438|Carboplatin|carboplatin|mesh-list
13906441|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13906442|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906443|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
13906444|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
13906445|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
13906446|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906447|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13906448|NCT00110422|Irbesartan|irbesartan|mesh-list
13906449|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906450|NCT00110422|Diuretics|diuretics|mesh-ancestor
13906451|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
13906452|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906453|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13906454|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13906455|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906456|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13906457|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13906458|NCT00109681|Iloprost|iloprost|mesh-list
13906459|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13906460|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
13906461|NCT00109538|Lonafarnib|lonafarnib|mesh-list
13906462|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906463|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906464|NCT00108810|Ketoprofen|ketoprofen|mesh-list
13906465|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13906466|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13906467|NCT00108810|Analgesics|analgesics|mesh-ancestor
13906468|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
14756378|NCT03103087|Hormones|hormones|mesh-ancestor
14756379|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756380|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756381|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14756382|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
14756383|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14756384|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14756385|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14756386|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14756387|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13906469|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906470|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906471|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13906472|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906473|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13906474|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906475|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756388|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
14037965|NCT03739554|Venetoclax|venetoclax|mesh-list
14037966|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472770|NCT02353780|Infliximab|infliximab|mesh-list
14472771|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
14472772|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14472773|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14472774|NCT02353780|Analgesics|analgesics|mesh-ancestor
14472775|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
14472776|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472777|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472778|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13906476|NCT00106808|Pioglitazone|pioglitazone|mesh-list
13906477|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906478|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906479|NCT00106626|Pemetrexed|pemetrexed|mesh-list
13906480|NCT00106626|Vorinostat|vorinostat|mesh-list
13906481|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906482|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906483|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906484|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13906485|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906486|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13906487|NCT00106340|Metformin|metformin|mesh-list
14472779|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472780|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14472781|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14037979|NCT03728881|Vaccines|vaccines|mesh-list
14037980|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
14037981|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037982|NCT03719768|Avelumab|avelumab|mesh-list
14037983|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14037984|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037985|NCT03718767|Nivolumab|nivolumab|mesh-list
14037986|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14037987|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14037988|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14037989|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14037990|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
14037991|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14037992|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037993|NCT03699319|Leucovorin|leucovorin|mesh-list
14037994|NCT03699319|Folic Acid|folic acid|mesh-list
14037995|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
13906488|NCT00106340|Glimepiride|glimepiride|mesh-list
13906489|NCT00106340|Vildagliptin|vildagliptin|mesh-list
13906490|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906491|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906492|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13906493|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906494|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
14037996|NCT03699319|Irinotecan|irinotecan|mesh-list
14037997|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
14037998|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14037999|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038000|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14038001|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14038002|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14038003|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038004|NCT03699319|Antidotes|antidotes|mesh-ancestor
14038005|NCT03699319|Protective Agents|protective agents|mesh-ancestor
14038006|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
14038007|NCT03699319|Vitamins|vitamins|mesh-ancestor
14038008|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
14038009|NCT03699319|Hematinics|hematinics|mesh-ancestor
14038010|NCT03681158|Valproic Acid|valproic acid|mesh-list
14038011|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
14038012|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906495|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14038013|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038014|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
14038015|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14038016|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038017|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
14038018|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14038019|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14038020|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14038021|NCT03670056|Nivolumab|nivolumab|mesh-list
14038022|NCT03670056|Ipilimumab|ipilimumab|mesh-list
14038023|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038024|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038025|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14038026|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038027|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
14038028|NCT03666000|Fludarabine|fludarabine|mesh-list
14038029|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14038030|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
13906496|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906497|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906498|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906499|NCT00103831|Taxane|taxane|mesh-list
13906500|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906501|NCT00102466|Metformin|metformin|mesh-list
13906502|NCT00102466|Vildagliptin|vildagliptin|mesh-list
13906503|NCT00102466|Gliclazide|gliclazide|mesh-list
13906504|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906505|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906506|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13906507|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906508|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906509|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906510|NCT00101595|Dasatinib|dasatinib|mesh-list
13906511|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906512|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13906513|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14038031|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906514|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906515|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
13906516|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906517|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13906518|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
13906519|NCT00099853|Pioglitazone|pioglitazone|mesh-list
13906520|NCT00099853|Vildagliptin|vildagliptin|mesh-list
13906521|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906522|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906523|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13906524|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906525|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906526|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906527|NCT00097357|Enoxaparin|enoxaparin|mesh-list
13906528|NCT00097357|Warfarin|warfarin|mesh-list
13906529|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
14038032|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14038033|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14038034|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
14169862|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472782|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
14472783|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14472784|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472785|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472786|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
14472787|NCT02353806|Amlodipine|amlodipine|mesh-list
14472788|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14472789|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14472790|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14756389|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
14038035|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038036|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038037|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14038038|NCT03664882|Fexofenadine|fexofenadine|mesh-list
14038039|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14038040|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14038041|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14038042|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
14038043|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
14038044|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472791|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472792|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14472793|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472794|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
14472795|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
14472796|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14472797|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14472798|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13906530|NCT00097357|Apixaban|apixaban|mesh-list
13906531|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
13906532|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13906533|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13906534|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906535|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13906536|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
13906537|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14472799|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14472800|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472801|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
14472802|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472803|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472804|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14472805|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472806|NCT02354092|Anesthetics|anesthetics|mesh-list
14472807|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
14472808|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472809|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472810|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
14472811|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472812|NCT02354222|Canagliflozin|canagliflozin|mesh-list
14472813|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14472814|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472815|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906538|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906539|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906540|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13906541|NCT00095550|Irbesartan|irbesartan|mesh-list
13906542|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906543|NCT00095550|Diuretics|diuretics|mesh-ancestor
13906544|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
13906545|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906546|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13906547|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13906548|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906549|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13906550|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13906551|NCT00095394|Irbesartan|irbesartan|mesh-list
13906552|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906553|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13906554|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13906555|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906556|NCT00095290|Ramipril|ramipril|mesh-list
13906557|NCT00095290|Irbesartan|irbesartan|mesh-list
13906558|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14038045|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038046|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906559|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906560|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906561|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906562|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906563|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14756390|NCT03102047|Durvalumab|durvalumab|mesh-list
14756391|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038062|NCT03653507|Capecitabine|capecitabine|mesh-list
14038063|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
14038064|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14038065|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
14038066|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756392|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767224|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13906564|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13906565|NCT00093132|Satraplatin|satraplatin|mesh-list
13906566|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906567|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
13906568|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13906569|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906570|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13906571|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
13906572|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13906573|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906574|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906575|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906576|NCT00086723|Captopril|captopril|mesh-list
13906577|NCT00086723|Plasminogen|plasminogen|mesh-list
13906578|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13906579|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13906580|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13906581|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906582|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13906583|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906584|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906585|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906586|NCT00086671|Antibodies|antibodies|mesh-list
13906587|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13906588|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
13906589|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906590|NCT00084344|Afimoxifene|afimoxifene|mesh-list
13906591|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906592|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13906593|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
13906594|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906595|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906596|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13906597|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13906598|NCT00084253|Ritonavir|ritonavir|mesh-list
13906599|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906600|NCT00084253|Lamivudine|lamivudine|mesh-list
13906601|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906602|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906603|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
14038067|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472816|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906604|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472817|NCT02354235|Canagliflozin|canagliflozin|mesh-list
14472818|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14472819|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472820|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14472821|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472822|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
14472823|NCT02354339|Antacids|antacids|mesh-ancestor
13906605|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906606|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906607|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906608|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
13906609|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906610|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13906611|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906612|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906613|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906614|NCT00083941|Interleukin-2|interleukin-2|mesh-list
13906615|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906616|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13906617|NCT00083941|Analgesics|analgesics|mesh-ancestor
13906618|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
13906619|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906620|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906621|NCT00083759|Natalizumab|natalizumab|mesh-list
13906622|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
13906623|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906624|NCT00081510|Anastrozole|anastrozole|mesh-list
13906625|NCT00081510|Lonafarnib|lonafarnib|mesh-list
13906626|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13906627|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906628|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13906629|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14472824|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472825|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14472826|NCT02354352|Eplerenone|eplerenone|mesh-list
13906630|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906631|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906632|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13906633|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
13906634|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472827|NCT02354352|Spironolactone|spironolactone|mesh-list
14472828|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14472829|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
14472830|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472831|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472832|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14472833|NCT02354352|Diuretics|diuretics|mesh-ancestor
14038080|NCT03630809|Vaccines|vaccines|mesh-list
14038081|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
14038082|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472834|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
14472835|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14472836|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
14472837|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14472838|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472839|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472840|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756393|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
14756394|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
14756395|NCT03083678|Afatinib|afatinib|mesh-list
14756396|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756397|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14472841|NCT02354378|Analgesics|analgesics|mesh-ancestor
14472842|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
14472843|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472844|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14038094|NCT03589326|Cytarabine|cytarabine|mesh-list
14756398|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756399|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756400|NCT03073980|Acetaminophen|acetaminophen|mesh-list
14756401|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756402|NCT03073980|Analgesics|analgesics|mesh-ancestor
14756403|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
14756404|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756405|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756406|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
14756407|NCT03071926|Doxorubicin|doxorubicin|mesh-list
14756408|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14756409|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756410|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038095|NCT03589326|Dexamethasone|dexamethasone|mesh-list
14038096|NCT03589326|Prednisone|prednisone|mesh-list
14038097|NCT03589326|Methotrexate|methotrexate|mesh-list
14038098|NCT03589326|Vincristine|vincristine|mesh-list
14038099|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
14038100|NCT03589326|Ponatinib|ponatinib|mesh-list
14038101|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14038102|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
14038103|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
14038104|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14038105|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038106|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14038107|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
14038108|NCT03589326|Hormones|hormones|mesh-ancestor
14038109|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14038110|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14038111|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038112|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13906635|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906636|NCT00080106|Vaccines|vaccines|mesh-list
13906637|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
13906638|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906639|NCT00079482|Cytarabine|cytarabine|mesh-list
13906640|NCT00079482|Etoposide|etoposide|mesh-list
13906641|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
13906642|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14038113|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
14038114|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14038115|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14038116|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
14038117|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038118|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
14038119|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14038120|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14038121|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14038122|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
14038123|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14038124|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14038125|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
13906643|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906644|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13906645|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13906646|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906647|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906648|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13906649|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
13906650|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
13906651|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906652|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906653|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
13906654|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906655|NCT00079482|Analgesics|analgesics|mesh-ancestor
14038126|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14038127|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14038128|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
14038129|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
14038130|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14038131|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14038132|NCT03583658|Ambroxol|ambroxol|mesh-list
14038133|NCT03583658|Expectorants|expectorants|mesh-ancestor
14038134|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
14038135|NCT03555968|Dronabinol|dronabinol|mesh-list
14038136|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
14038137|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038138|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14038139|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14038140|NCT03555968|Analgesics|analgesics|mesh-ancestor
13906656|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
13906657|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14038141|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
14038142|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906658|NCT00073866|Celecoxib|celecoxib|mesh-list
13906659|NCT00073866|Docetaxel|docetaxel|mesh-list
13906660|NCT00073866|Irinotecan|irinotecan|mesh-list
13906661|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038143|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14038144|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14038145|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14038146|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038147|NCT03555968|Hormones|hormones|mesh-ancestor
14038148|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472845|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14472846|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13906662|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
13906663|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
13906664|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
13906665|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906666|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13906667|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13906668|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906669|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13906670|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13906671|NCT00073866|Analgesics|analgesics|mesh-ancestor
13906672|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
13906673|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906674|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906675|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13906676|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906677|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13906678|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13906679|NCT00071461|Bosentan|bosentan|mesh-list
13906680|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906681|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13906682|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906683|NCT00070590|Bosentan|bosentan|mesh-list
13906684|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13906685|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13906686|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472847|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472848|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472849|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472850|NCT02354508|Pasireotide|pasireotide|mesh-list
14472851|NCT02354508|Hormones|hormones|mesh-ancestor
14472852|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959606|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959607|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13959608|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13959609|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13959610|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13959611|NCT03161509|Acetaminophen|acetaminophen|mesh-list
13959612|NCT03161509|Lamotrigine|lamotrigine|mesh-list
13959613|NCT03161509|Carbamazepine|carbamazepine|mesh-list
13959614|NCT03161509|Phenytoin|phenytoin|mesh-list
13959615|NCT03161509|Valproic Acid|valproic acid|mesh-list
13959616|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
13959617|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959618|NCT03161509|Analgesics|analgesics|mesh-ancestor
13959619|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
13959620|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959621|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959622|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
13959623|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13959624|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13959625|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959626|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13959627|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13959628|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13959629|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14038158|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
14038159|NCT03547973|Avelumab|avelumab|mesh-list
14038160|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959630|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13959631|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13959632|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959633|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
14038161|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13906687|NCT00069745|Prednisone|prednisone|mesh-list
13906688|NCT00069745|Satraplatin|satraplatin|mesh-list
13906689|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13906690|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
13906691|NCT00069745|Hormones|hormones|mesh-ancestor
13906692|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14038162|NCT03529123|Insulin|insulin|mesh-list
14038163|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14038164|NCT03529123|Metformin|metformin|mesh-list
14038165|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
14038166|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
14038167|NCT03529123|Lixisenatide|lixisenatide|mesh-list
14038168|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14038169|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472853|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472854|NCT02354534|Artesunate|artesunate|mesh-list
14472855|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
13906693|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472856|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14472857|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14472858|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906694|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13906695|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906696|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906697|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906698|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906699|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906700|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906701|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906702|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906703|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906704|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
13906705|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906706|NCT00065728|Anecortave|anecortave|mesh-list
13906707|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13906708|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13906709|NCT00065728|Growth Substances|growth substances|mesh-ancestor
13906710|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906711|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
13906712|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906713|NCT00064714|Exenatide|exenatide|mesh-list
13906714|NCT00064714|Daclizumab|daclizumab|mesh-list
14472859|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472860|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
14472861|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
13906715|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13906716|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906717|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906718|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13906719|NCT00064714|Incretins|incretins|mesh-ancestor
13906720|NCT00064714|Hormones|hormones|mesh-ancestor
13906721|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14472862|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14472863|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
14472864|NCT02354586|Niraparib|niraparib|mesh-list
14472865|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14472866|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472867|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472868|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038183|NCT03514732|Melatonin|melatonin|mesh-list
14038184|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
14038185|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038186|NCT03514732|Protective Agents|protective agents|mesh-ancestor
14038187|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038188|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472869|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14472870|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
14472871|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472872|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
14472873|NCT02354690|Fludarabine|fludarabine|mesh-list
14472874|NCT02354690|Interleukin-2|interleukin-2|mesh-list
14472875|NCT02354690|Vemurafenib|vemurafenib|mesh-list
14472876|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472877|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
14472878|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906722|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
13906723|NCT00058266|Genistein|genistein|mesh-list
14472879|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14472880|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14472881|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
14472882|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472883|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472884|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14472885|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14472886|NCT02354690|Analgesics|analgesics|mesh-ancestor
14038206|NCT03498313|Estradiol|estradiol|mesh-list
14038207|NCT03498313|Progesterone|progesterone|mesh-list
14038208|NCT03498313|Estrogens|estrogens|mesh-ancestor
14038209|NCT03498313|Hormones|hormones|mesh-ancestor
14038210|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14038211|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038212|NCT03498313|Progestins|progestins|mesh-ancestor
14038213|NCT03492099|Buprenorphine|buprenorphine|mesh-list
14038214|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14038215|NCT03492099|Narcotics|narcotics|mesh-ancestor
14038216|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14038217|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038218|NCT03492099|Analgesics|analgesics|mesh-ancestor
14038219|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
14038220|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14038221|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14038222|NCT03485547|Venetoclax|venetoclax|mesh-list
14038223|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906724|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13906725|NCT00058266|Protective Agents|protective agents|mesh-ancestor
13906726|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906727|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906728|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13906729|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906730|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906731|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
13906732|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13906733|NCT00058266|Estrogens|estrogens|mesh-ancestor
13906734|NCT00058266|Hormones|hormones|mesh-ancestor
13906735|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906736|NCT00057993|Trastuzumab|trastuzumab|mesh-list
13906737|NCT00057993|Exemestane|exemestane|mesh-list
13906738|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13906739|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038224|NCT03481959|Methylphenidate|methylphenidate|mesh-list
14038225|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14038226|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038227|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14038228|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14038229|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14038230|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038231|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
14038232|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14038233|NCT03479502|Doxycycline|doxycycline|mesh-list
14038234|NCT03479502|Prednisone|prednisone|mesh-list
14038235|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
14038236|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14038237|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14038238|NCT03479502|Prednisolone|prednisolone|mesh-list
14038239|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
14038240|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14038241|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
14038242|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14038243|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
14038244|NCT03479502|Hormones|hormones|mesh-ancestor
13906740|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13906741|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13906742|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906743|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906744|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13906745|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
13906746|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906747|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906748|NCT00057980|Celecoxib|celecoxib|mesh-list
14038245|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14038246|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038247|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13906749|NCT00057980|Epirubicin|epirubicin|mesh-list
13906750|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13906751|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13906752|NCT00057980|Analgesics|analgesics|mesh-ancestor
13906753|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
13906754|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906755|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906756|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13906757|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906758|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13906759|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13906760|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906761|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906762|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13906763|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906764|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13906765|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13906766|NCT00057473|Carboplatin|carboplatin|mesh-list
13906767|NCT00057473|Irinotecan|irinotecan|mesh-list
13906768|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038248|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038249|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
14038250|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
14038251|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906769|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13906770|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13906771|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906772|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906773|NCT00055575|Scopolamine|scopolamine|mesh-list
13906774|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13906775|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13906776|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
13906777|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
14038252|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14038253|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14038254|NCT03479502|Protective Agents|protective agents|mesh-ancestor
14038255|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14038256|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14038257|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
13906778|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906779|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906780|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13906781|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
13906782|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13906783|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
13906784|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13906785|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906786|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13906787|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
13906788|NCT00052598|Aldesleukin|aldesleukin|mesh-list
13906789|NCT00052598|Interleukin-2|interleukin-2|mesh-list
13906790|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038258|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14038259|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14472887|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
14472888|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472889|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14472890|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472891|NCT02354833|Phenylephrine|phenylephrine|mesh-list
14472892|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
14472893|NCT02354833|Norepinephrine|norepinephrine|mesh-list
14472894|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14472895|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
14472896|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
14472897|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472898|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906791|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13906792|NCT00052598|Analgesics|analgesics|mesh-ancestor
13906793|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
13906794|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906795|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906796|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14472899|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
14472900|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14472901|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
14472902|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
13906797|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14472903|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14472904|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14472905|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14038280|NCT03462069|Empagliflozin|empagliflozin|mesh-list
14038281|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14038282|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14038283|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038284|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14038285|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906798|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
13906799|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14038286|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
14038287|NCT03462017|Acetylcholine|acetylcholine|mesh-list
14038288|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
14038289|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14038290|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14038291|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14038292|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038293|NCT03462017|Urological Agents|urological agents|mesh-ancestor
14038294|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14038295|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
14038296|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14038297|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472906|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472907|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472908|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472909|NCT02354833|Protective Agents|protective agents|mesh-ancestor
14472910|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
14472911|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14472912|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472913|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472914|NCT02354976|Fenofibrate|fenofibrate|mesh-list
14472915|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14472916|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
14038309|NCT03448042|Trastuzumab|trastuzumab|mesh-list
14038310|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038311|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472917|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472918|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14472919|NCT02355028|Ranibizumab|ranibizumab|mesh-list
14472920|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14472921|NCT02355028|Acrizanib|acrizanib|mesh-list
14472922|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14472923|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14472924|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14472925|NCT02355028|Growth Substances|growth substances|mesh-ancestor
14472926|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038322|NCT03436498|Insulin|insulin|mesh-list
14038323|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14038324|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
14038325|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
13906800|NCT00052520|Aldesleukin|aldesleukin|mesh-list
13906801|NCT00052520|Interleukin-2|interleukin-2|mesh-list
13906802|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906803|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13906804|NCT00052520|Analgesics|analgesics|mesh-ancestor
13906805|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
13906806|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13906807|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906808|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906809|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906810|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
13906811|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906812|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
13906813|NCT00051129|Anecortave|anecortave|mesh-list
13906814|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13906815|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13906816|NCT00051129|Growth Substances|growth substances|mesh-ancestor
13906817|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906818|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
13906819|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906820|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13906821|NCT00051038|Entecavir|entecavir|mesh-list
13906822|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
14472927|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14472928|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14472929|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14472930|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14472931|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472932|NCT02355158|Clonidine|clonidine|mesh-list
14038326|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14038327|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14038328|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038329|NCT03435952|Doxycycline|doxycycline|mesh-list
14038330|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
14038331|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038332|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038333|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14038334|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14038335|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
14038336|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14038337|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14038338|NCT03421652|Nivolumab|nivolumab|mesh-list
14038339|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038340|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038341|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14038342|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038343|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14038344|NCT03414723|Ramipril|ramipril|mesh-list
14038345|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14038346|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
14038347|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906823|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906824|NCT00050102|Ipilimumab|ipilimumab|mesh-list
13906825|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038348|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038349|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14038350|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14038351|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14038352|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472933|NCT02355158|Analgesics|analgesics|mesh-ancestor
14472934|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
14472935|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472936|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472937|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14472938|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
14472939|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
14472940|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14472941|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14472942|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14472943|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14472944|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472945|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472946|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
14472947|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472948|NCT02355665|Nicotine|nicotine|mesh-list
14472949|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14472950|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
14038371|NCT03409276|Vaccines|vaccines|mesh-list
14472951|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933106|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906826|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906827|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13906828|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906829|NCT00049959|Verteporfin|verteporfin|mesh-list
13906830|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13906831|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
13906832|NCT00036608|Entecavir|entecavir|mesh-list
13906833|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
13906834|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906835|NCT00035789|Entecavir|entecavir|mesh-list
13906836|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
13906837|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906838|NCT00035633|Entecavir|entecavir|mesh-list
13906839|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
13906840|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906841|NCT00035568|Metformin|metformin|mesh-list
13906842|NCT00035568|Glyburide|glyburide|mesh-list
13906843|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14038372|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
14038373|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906844|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906845|NCT00035542|Metformin|metformin|mesh-list
13906846|NCT00035542|Glyburide|glyburide|mesh-list
13906847|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13906848|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906849|NCT00035529|Abatacept|abatacept|mesh-list
13906850|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13906851|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906852|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906853|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906854|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
13906855|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906856|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13906857|NCT00031512|Pleconaril|pleconaril|mesh-list
13906858|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
13906859|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14038374|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
14038375|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14038376|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906860|NCT00028639|Bortezomib|bortezomib|mesh-list
13906861|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906862|NCT00028301|Ritonavir|ritonavir|mesh-list
13906863|NCT00028301|Lopinavir|lopinavir|mesh-list
13906864|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906865|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906866|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906867|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906868|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906869|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906870|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906871|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14038377|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
14038378|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14038379|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14038380|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14038381|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13906872|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
13906873|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906874|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13906875|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906876|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906877|NCT00028067|Nelfinavir|nelfinavir|mesh-list
13906878|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906879|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906880|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906881|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906882|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906883|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906884|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906885|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
13906886|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14038385|NCT03391193|Vaccines|vaccines|mesh-list
14038386|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
14038387|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472952|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472953|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14472954|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14472955|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
14472956|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472957|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038394|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14038395|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14038396|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14038397|NCT03387657|Diuretics|diuretics|mesh-ancestor
14038398|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
14038399|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038400|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13906887|NCT00013897|Lamivudine|lamivudine|mesh-list
14038401|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13906888|NCT00013897|Zidovudine|zidovudine|mesh-list
13906889|NCT00013897|Efavirenz|efavirenz|mesh-list
14038402|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038403|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14038404|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14472958|NCT02355821|Bisoprolol|bisoprolol|mesh-list
14472959|NCT02355821|Moxonidine|moxonidine|mesh-list
14472960|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14472961|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
14472962|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
14472963|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472964|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472965|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14472966|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14472967|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14472968|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
13906890|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
13906891|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13906892|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906893|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906894|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906895|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906896|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
13906897|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906898|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906899|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906900|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
13906901|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13906902|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906903|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13906904|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13906905|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906906|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13906907|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13906908|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13906909|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
13906910|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
13906911|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13906912|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
14756411|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756412|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756413|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756414|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756415|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14756416|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14756417|NCT03049735|Norethindrone|norethindrone|mesh-list
13906913|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906914|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13906915|NCT00006225|Protective Agents|protective agents|mesh-ancestor
13906916|NCT00005918|Lamivudine|lamivudine|mesh-list
13906917|NCT00005918|Efavirenz|efavirenz|mesh-list
13906918|NCT00005918|Stavudine|stavudine|mesh-list
13906919|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13906920|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13906921|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906922|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906923|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
13906924|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906925|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906926|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906927|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13906928|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13906929|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13906930|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13906931|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13906932|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14756418|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
13906933|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
14756419|NCT03049735|Estradiol|estradiol|mesh-list
14756420|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14756421|NCT03049735|Relugolix|relugolix|mesh-list
14756422|NCT03049735|Estrogens|estrogens|mesh-ancestor
14756423|NCT03049735|Hormones|hormones|mesh-ancestor
14756424|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906934|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
14472969|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472970|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472971|NCT02355886|Gabapentin|gabapentin|mesh-list
14472972|NCT02355886|Analgesics|analgesics|mesh-ancestor
14472973|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
14472974|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14472975|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038420|NCT03345784|Cisplatin|cisplatin|mesh-list
14038421|NCT03345784|Adavosertib|adavosertib|mesh-list
14038422|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038423|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14038424|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038425|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14038426|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13906935|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906936|NCT00005788|Aldesleukin|aldesleukin|mesh-list
13906937|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906938|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13906939|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13906940|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
13906941|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13906942|NCT00005608|Leucovorin|leucovorin|mesh-list
13906943|NCT00005608|Tegafur|tegafur|mesh-list
13906944|NCT00005608|Calcium|calcium|mesh-list
13906945|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
13906946|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13906947|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906948|NCT00005608|Antidotes|antidotes|mesh-ancestor
13906949|NCT00005608|Protective Agents|protective agents|mesh-ancestor
13906950|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
13906951|NCT00005608|Vitamins|vitamins|mesh-ancestor
13906952|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
13906953|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13906954|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
13906955|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906956|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906957|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
13906958|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906959|NCT00004916|Paclitaxel|paclitaxel|mesh-list
13906960|NCT00004916|Ifosfamide|ifosfamide|mesh-list
13906961|NCT00004916|Teniposide|teniposide|mesh-list
13906962|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13906963|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906964|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
13906965|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
13906966|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
13906967|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13906968|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13906969|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
13906970|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13906971|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13906972|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13906973|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13906974|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13906975|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
13906976|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13906977|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906978|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13906979|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13906980|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13906981|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
13906982|NCT00004914|Hematinics|hematinics|mesh-ancestor
13906983|NCT00004912|Megestrol|megestrol|mesh-list
13906984|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
13906985|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13906986|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14038427|NCT03332303|Estradiol|estradiol|mesh-list
14038428|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14038429|NCT03332303|Estrogens|estrogens|mesh-ancestor
14472976|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
14038430|NCT03332303|Hormones|hormones|mesh-ancestor
14038431|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14038432|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038433|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14038434|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
14038435|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14038436|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14472977|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14472978|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14472979|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472980|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14472981|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14472982|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14472983|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14472984|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14472985|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
14038446|NCT03312907|Rituximab|rituximab|mesh-list
14038447|NCT03312907|Belimumab|belimumab|mesh-list
14038448|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14038449|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038450|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038451|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
14038452|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038453|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479128|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479129|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14479130|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
14479131|NCT02464059|Vitamin D|vitamin d|mesh-list
14479132|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
14479133|NCT02464059|Vitamins|vitamins|mesh-ancestor
14479134|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
14479135|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479136|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14479137|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13906987|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13906988|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
13906989|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13906990|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13906991|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13906992|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13906993|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13906994|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13906995|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
13906996|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13906997|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
13906998|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13906999|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
13907000|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907001|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907002|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907003|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
13907004|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907005|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907006|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907007|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
13907008|NCT00004907|Busulfan|busulfan|mesh-list
13907009|NCT00004907|Etoposide|etoposide|mesh-list
13907010|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907011|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
13907012|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907013|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907014|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907015|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
13907016|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907017|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479138|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
14479139|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
14479140|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
14472986|NCT02355977|Minocycline|minocycline|mesh-list
14472987|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14472988|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14472989|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
14472990|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13907018|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907019|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13907020|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907021|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907022|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907023|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
13907024|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907025|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
13907026|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907027|NCT00004899|Etoposide|etoposide|mesh-list
13907028|NCT00004899|Busulfan|busulfan|mesh-list
13907029|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14472991|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
14472992|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14472993|NCT02356198|Hydromorphone|hydromorphone|mesh-list
14472994|NCT02356198|Bupivacaine|bupivacaine|mesh-list
13907030|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907031|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907032|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907033|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907034|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907035|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
14472995|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
13907036|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907037|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
13907038|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14472996|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
14472997|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14472998|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14472999|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
14473000|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473001|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14473002|NCT02356198|Narcotics|narcotics|mesh-ancestor
14473003|NCT02356198|Analgesics|analgesics|mesh-ancestor
14473004|NCT02356562|Ritonavir|ritonavir|mesh-list
14473005|NCT02356562|Ribavirin|ribavirin|mesh-list
14473006|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
13907039|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907040|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907041|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
13907042|NCT00004898|Etoposide|etoposide|mesh-list
13907043|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907044|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
13907045|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907046|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907047|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907048|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
13907049|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907050|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907051|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907052|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13907053|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907054|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907055|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473007|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14473008|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14473009|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
14473010|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907056|NCT00004897|Leucovorin|leucovorin|mesh-list
13907057|NCT00004897|Interferons|interferons|mesh-list
13907058|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
13907059|NCT00004897|Fluorouracil|fluorouracil|mesh-list
13907060|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
13907061|NCT00004897|Calcium|calcium|mesh-list
13907062|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
13907063|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907064|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13907065|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907066|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
14473011|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473012|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14473013|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14473014|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
14473015|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473016|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14473017|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14473018|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
14473019|NCT02356588|Sufentanil|sufentanil|mesh-list
14473020|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14473021|NCT02356588|Narcotics|narcotics|mesh-ancestor
14473022|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473023|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473024|NCT02356588|Analgesics|analgesics|mesh-ancestor
14473025|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
14473026|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473027|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14473028|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14473029|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
14473030|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
14933107|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13959634|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473031|NCT02357147|Pemetrexed|pemetrexed|mesh-list
13907067|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907068|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13907069|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14933108|NCT01449123|Mannitol|mannitol|mesh-list
13907070|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
13907071|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
13907072|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907073|NCT00004897|Antidotes|antidotes|mesh-ancestor
13907074|NCT00004897|Protective Agents|protective agents|mesh-ancestor
13907075|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
13907076|NCT00004897|Vitamins|vitamins|mesh-ancestor
13907077|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
13907078|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
13907079|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907080|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907081|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
13907082|NCT00004896|Busulfan|busulfan|mesh-list
13907083|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907084|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
13907085|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907086|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907087|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907088|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
13907089|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907090|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907091|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907092|NCT00004895|Octreotide|octreotide|mesh-list
13907093|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907094|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13907095|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907096|NCT00004584|Ritonavir|ritonavir|mesh-list
13907097|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13907098|NCT00004584|Saquinavir|saquinavir|mesh-list
13907099|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13907100|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13907101|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907102|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907103|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907104|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907105|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907106|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
13907107|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907108|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13907109|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13907110|NCT00004231|Leucovorin|leucovorin|mesh-list
13907111|NCT00004231|Interferons|interferons|mesh-list
13907112|NCT00004231|Cytarabine|cytarabine|mesh-list
13907113|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
13907114|NCT00004231|Aldesleukin|aldesleukin|mesh-list
14473032|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473033|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473034|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473035|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14473036|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14473037|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
14473038|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13907115|NCT00004231|Prednisone|prednisone|mesh-list
14473039|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
14473040|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473041|NCT02357290|Expectorants|expectorants|mesh-ancestor
14473042|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
14473043|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14473044|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
14933109|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13907116|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
13907117|NCT00004231|Busulfan|busulfan|mesh-list
13907118|NCT00004231|Doxorubicin|doxorubicin|mesh-list
14473045|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907119|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13907120|NCT00004231|Methotrexate|methotrexate|mesh-list
13907121|NCT00004231|Vincristine|vincristine|mesh-list
13907122|NCT00004231|Teniposide|teniposide|mesh-list
13907123|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
13907124|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907125|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
13907126|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907127|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907128|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907129|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
13907130|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907131|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907132|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907133|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13907134|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907135|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907136|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907137|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907138|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
13907139|NCT00004231|Hormones|hormones|mesh-ancestor
13907140|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13907141|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13907142|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13907143|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
13907144|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13907145|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13907146|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
13907147|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
13907148|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13907149|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907150|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
13907151|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907152|NCT00004231|Antidotes|antidotes|mesh-ancestor
13907153|NCT00004231|Protective Agents|protective agents|mesh-ancestor
13907154|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
14473046|NCT02357290|Protective Agents|protective agents|mesh-ancestor
14473047|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473048|NCT02357290|Antidotes|antidotes|mesh-ancestor
14473049|NCT02357342|Sirolimus|sirolimus|mesh-list
13907155|NCT00004231|Vitamins|vitamins|mesh-ancestor
13907156|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
13907157|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13907158|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
13907159|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
13907160|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
13907161|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907162|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907163|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
13907164|NCT00004230|Captopril|captopril|mesh-list
13907165|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907166|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
13907167|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907168|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907169|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907170|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
13907171|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907172|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907173|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14473050|NCT02357342|Aflibercept|aflibercept|mesh-list
14473051|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907174|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13907175|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
14473052|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13907176|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907177|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13907178|NCT00004182|Irinotecan|irinotecan|mesh-list
14473053|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14473054|NCT02357342|Growth Substances|growth substances|mesh-ancestor
14473055|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473056|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
14473057|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14473058|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756425|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756426|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14756427|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
14756428|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14756429|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14756430|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13907179|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13907180|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907181|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473059|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14473060|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
14473061|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14473062|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
14473063|NCT02357368|Copper|copper|mesh-list
14473064|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14473065|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
14473066|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
14473067|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
14473068|NCT02357368|Etonogestrel|etonogestrel|mesh-list
14473069|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14473070|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907182|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907183|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907184|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
13907185|NCT00004181|Busulfan|busulfan|mesh-list
13907186|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907187|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
13907188|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907189|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907190|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907191|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
13907192|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907193|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907194|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907195|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
13907196|NCT00004175|Docetaxel|docetaxel|mesh-list
14473071|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14473072|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14473073|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14473074|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14473075|NCT02357368|Trace Elements|trace elements|mesh-ancestor
14473076|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
14473077|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14473078|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14473079|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14038598|NCT03180034|Vaccines|vaccines|mesh-list
14038599|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
14038600|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473080|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473081|NCT02357459|Triamcinolone|triamcinolone|mesh-list
14473082|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14473083|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14473084|NCT02357459|FX006|fx006|mesh-list
14473085|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14473086|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14473087|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
14473088|NCT02357459|Hormones|hormones|mesh-ancestor
14473089|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473090|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473091|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14473092|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
14473093|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473094|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473095|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14473096|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14756431|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14756432|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14756433|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
14756434|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
13907197|NCT00004175|Doxorubicin|doxorubicin|mesh-list
13907198|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13907199|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907200|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
13907201|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907202|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907203|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907204|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
13907205|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907206|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907207|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907208|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756435|NCT03044613|Paclitaxel|paclitaxel|mesh-list
14756436|NCT03044613|Carboplatin|carboplatin|mesh-list
14756437|NCT03044613|Nivolumab|nivolumab|mesh-list
14756438|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756439|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756440|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756441|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756442|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756443|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756444|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756445|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13907209|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
13907210|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
13907211|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13907212|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907213|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907214|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473097|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14473098|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14473099|NCT02357706|Acetaminophen|acetaminophen|mesh-list
14473100|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14473101|NCT02357706|Analgesics|analgesics|mesh-ancestor
14473102|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
14473103|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756446|NCT03028519|Vitamin D|vitamin d|mesh-list
13907215|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
13907216|NCT00004172|Ifosfamide|ifosfamide|mesh-list
14473104|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473105|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
14473106|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14038616|NCT03148756|Dalbavancin|dalbavancin|mesh-list
14038617|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14038618|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473107|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473108|NCT02357836|Itraconazole|itraconazole|mesh-list
14473109|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
14473110|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473111|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14473112|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14473113|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473114|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756447|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
14756448|NCT03028519|Vitamins|vitamins|mesh-ancestor
13907217|NCT00004172|Thiotepa|thiotepa|mesh-list
13907218|NCT00004172|Carboplatin|carboplatin|mesh-list
13907219|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907220|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
13907221|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907222|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907223|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907224|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
13907225|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907226|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907227|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907228|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
13907229|NCT00004171|Busulfan|busulfan|mesh-list
13907230|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907231|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
13907232|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907233|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907234|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907235|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
13907236|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907237|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907238|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907239|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
13907240|NCT00004169|Carboplatin|carboplatin|mesh-list
13907241|NCT00004169|Etoposide|etoposide|mesh-list
13907242|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907243|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
13907244|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907245|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907246|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907247|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
13907248|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907249|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907250|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907251|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13907252|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907253|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907254|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907255|NCT00004166|Amifostine|amifostine|mesh-list
13907256|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13907257|NCT00004166|Protective Agents|protective agents|mesh-ancestor
13907258|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907259|NCT00004165|Melphalan|melphalan|mesh-list
13907260|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
13907261|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907262|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907263|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
13907264|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907265|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907266|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907267|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907268|NCT00004106|Temozolomide|temozolomide|mesh-list
13907269|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907270|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
13907271|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907272|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907273|NCT00004096|Carboplatin|carboplatin|mesh-list
13907274|NCT00004096|Vinorelbine|vinorelbine|mesh-list
13907275|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907276|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13907277|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473115|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14473116|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
14473117|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473118|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473119|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14473120|NCT02357901|Buprenorphine|buprenorphine|mesh-list
14473121|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14473122|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14473123|NCT02357901|Narcotics|narcotics|mesh-ancestor
14473124|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473125|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473126|NCT02357901|Analgesics|analgesics|mesh-ancestor
13907278|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
13907279|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
13907280|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907281|NCT00004093|Gemcitabine|gemcitabine|mesh-list
13907282|NCT00004093|Paclitaxel|paclitaxel|mesh-list
13907283|NCT00004093|Vinorelbine|vinorelbine|mesh-list
13907284|NCT00004093|Carboplatin|carboplatin|mesh-list
13907285|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13907286|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907287|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
13907288|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
13907289|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
13907290|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907291|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14473127|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
14473128|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473129|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14473130|NCT02357979|Fluorides|fluorides|mesh-list
14473131|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
14473132|NCT02357979|Protective Agents|protective agents|mesh-ancestor
14473133|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473134|NCT02358044|Ribavirin|ribavirin|mesh-list
14473135|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
14473136|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14473137|NCT02358044|Grazoprevir|grazoprevir|mesh-list
14473138|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
14473139|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473140|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
14473141|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473142|NCT02358343|Sertraline|sertraline|mesh-list
14473143|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
14473144|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14473145|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14473146|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14038661|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
14038662|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14038663|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
14038664|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14038665|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038666|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14038667|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
14038668|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14038669|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
14038670|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038671|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14038672|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14038673|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
14038674|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
14038675|NCT03079102|Protective Agents|protective agents|mesh-ancestor
14473147|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14473148|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473149|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473150|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
14473151|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473152|NCT02358369|Timolol|timolol|mesh-list
14473153|NCT02358369|Bimatoprost|bimatoprost|mesh-list
14473154|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14473155|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14473156|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14473157|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14473158|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
14473159|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473160|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473161|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473162|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14473163|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14473164|NCT02358473|Docetaxel|docetaxel|mesh-list
14473165|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
14473166|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473167|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473168|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473169|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473170|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473171|NCT02358668|PAZ320|paz320|mesh-list
13907292|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
14473172|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14933110|NCT01449123|Diuretics|diuretics|mesh-ancestor
14933111|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
14933112|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933113|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14933114|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473173|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473174|NCT02358863|Leucovorin|leucovorin|mesh-list
14473175|NCT02358863|Cisplatin|cisplatin|mesh-list
14473176|NCT02358863|Docetaxel|docetaxel|mesh-list
14473177|NCT02358863|Capecitabine|capecitabine|mesh-list
14473178|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
14473179|NCT02358863|Irinotecan|irinotecan|mesh-list
14473180|NCT02358863|Epirubicin|epirubicin|mesh-list
13907293|NCT00004093|Antiviral Agents|antiviral agents|mesh-ancestor
13907294|NCT00004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907295|NCT00004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907296|NCT00004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907297|NCT00004093|Immunologic Factors|immunologic factors|mesh-ancestor
13907298|NCT00004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907299|NCT00002479|Tretinoin|tretinoin|mesh-list
13907300|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907301|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
13907302|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
13907303|NCT00002429|Lamivudine|lamivudine|mesh-list
13907304|NCT00002429|Zidovudine|zidovudine|mesh-list
13907305|NCT00002429|Stavudine|stavudine|mesh-list
13907306|NCT00002429|Didanosine|didanosine|mesh-list
14473181|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473182|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473183|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473184|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473185|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473186|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756449|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
14756450|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756451|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14756452|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14756453|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
14756454|NCT03012971|Morphine|morphine|mesh-list
13907307|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
13907308|NCT00002429|Nelfinavir|nelfinavir|mesh-list
13907309|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14756455|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14756456|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756457|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756458|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756459|NCT03012971|Analgesics|analgesics|mesh-ancestor
14756460|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
14756461|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907310|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907311|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907312|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907313|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
13907314|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907315|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14473187|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
14756462|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14756463|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14756464|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14756465|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
14756466|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756467|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756468|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14756469|NCT03012971|Narcotics|narcotics|mesh-ancestor
14756470|NCT03006172|Metformin|metformin|mesh-list
14756471|NCT03006172|Trastuzumab|trastuzumab|mesh-list
14756472|NCT03006172|Pertuzumab|pertuzumab|mesh-list
14473188|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14473189|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14473190|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473191|NCT02358863|Antidotes|antidotes|mesh-ancestor
14473192|NCT02358863|Protective Agents|protective agents|mesh-ancestor
14473193|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907316|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14473194|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
13907317|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
14473195|NCT02358863|Vitamins|vitamins|mesh-ancestor
14473196|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
14473197|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13907318|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13907319|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13907320|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907321|NCT00002411|Lamivudine|lamivudine|mesh-list
13907322|NCT00002411|Zidovudine|zidovudine|mesh-list
13907323|NCT00002411|Stavudine|stavudine|mesh-list
13907324|NCT00002411|Didanosine|didanosine|mesh-list
13907325|NCT00002411|Nelfinavir|nelfinavir|mesh-list
14933115|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
14933116|NCT01449188|Ondansetron|ondansetron|mesh-list
14933117|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14933118|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933119|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14933120|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14933121|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933122|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933123|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933124|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933125|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
14933126|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
14933127|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933128|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933129|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
13907326|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13907327|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14473198|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14038716|NCT03064126|Paclitaxel|paclitaxel|mesh-list
14038717|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14038718|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14038719|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933130|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
13907328|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907329|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907330|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
13907331|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907332|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907333|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907334|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
13907335|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13907336|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13907337|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907338|NCT00002371|Lamivudine|lamivudine|mesh-list
13907339|NCT00002371|Zidovudine|zidovudine|mesh-list
13907340|NCT00002371|Stavudine|stavudine|mesh-list
13907341|NCT00002371|Indinavir|indinavir|mesh-list
13907342|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13907343|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907344|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907345|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907346|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
13907347|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907348|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907349|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907350|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
13907351|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14038720|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14038721|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473199|NCT02358889|Ranibizumab|ranibizumab|mesh-list
13959635|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
14473200|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
14473201|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14473202|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14473203|NCT02358889|Growth Substances|growth substances|mesh-ancestor
14473204|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473205|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14473206|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473207|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
14473208|NCT02359006|Minocycline|minocycline|mesh-list
14473209|NCT02359006|Tetracycline|tetracycline|mesh-list
14038722|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14038723|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473210|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14473211|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473212|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14473213|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473214|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473215|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
14473216|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473217|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473218|NCT02359058|Capecitabine|capecitabine|mesh-list
13907352|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13907353|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907354|NCT00002246|Stavudine|stavudine|mesh-list
13907355|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
13907356|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907357|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13907358|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907359|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907360|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
13907361|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907362|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907363|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907364|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13907365|NCT00002240|Nelfinavir|nelfinavir|mesh-list
13907366|NCT00002240|Stavudine|stavudine|mesh-list
13907367|NCT00002240|Didanosine|didanosine|mesh-list
13907368|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13907369|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13907370|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907371|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907372|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907373|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907374|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907375|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
13907376|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907377|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
13907378|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13907379|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907380|NCT00002224|Stavudine|stavudine|mesh-list
13907381|NCT00002224|Didanosine|didanosine|mesh-list
13907382|NCT00002224|Nelfinavir|nelfinavir|mesh-list
14933131|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14933132|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
14933133|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933134|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14933135|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14933136|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933137|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14933138|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14933139|NCT01449253|Bosentan|bosentan|mesh-list
14933140|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
14933141|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14933142|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13907383|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
13907384|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907385|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13907386|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907387|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907388|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
13907389|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907390|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907391|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907392|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13907393|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13907394|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907395|NCT00002207|Stavudine|stavudine|mesh-list
13907396|NCT00002207|Didanosine|didanosine|mesh-list
13907397|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
13907398|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907399|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13907400|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907401|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907402|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
14473219|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
14933143|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14933144|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473220|NCT02359058|Ramucirumab|ramucirumab|mesh-list
14473221|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473222|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14473223|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
14038738|NCT03031821|Metformin|metformin|mesh-list
13907403|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907404|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907405|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907406|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
13907407|NCT03532620|Atorvastatin|atorvastatin|mesh-list
14756473|NCT03006172|Letrozole|letrozole|mesh-list
14756474|NCT03006172|Fulvestrant|fulvestrant|mesh-list
14756475|NCT03006172|Palbociclib|palbociclib|mesh-list
14756476|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14756477|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756478|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756479|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756480|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14756481|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14756482|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756483|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756484|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13907408|NCT03532620|Pitavastatin|pitavastatin|mesh-list
13907409|NCT03532620|Calcium|calcium|mesh-list
13907410|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13907411|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907412|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13907413|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13907414|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13907415|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
13907416|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907417|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13907418|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13907419|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907420|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13907421|NCT03532516|Brivaracetam|brivaracetam|mesh-list
13907422|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
13907423|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13907424|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13907425|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13907426|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13907427|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907428|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907429|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907430|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13907431|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
13907432|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13907433|NCT03532464|Azithromycin|azithromycin|mesh-list
13907434|NCT03532464|Doxycycline|doxycycline|mesh-list
13907435|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13907436|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907437|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
13907438|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13907439|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14756485|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
14756486|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756487|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14756488|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14756489|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14756490|NCT02992522|Lenalidomide|lenalidomide|mesh-list
14756491|NCT02992522|Venetoclax|venetoclax|mesh-list
14756492|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
14756493|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
13907440|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13907441|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13907442|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907443|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959636|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14038739|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14473224|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473225|NCT02359110|Gabapentin|gabapentin|mesh-list
14473226|NCT02359110|Analgesics|analgesics|mesh-ancestor
14473227|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
14473228|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907444|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907445|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
13907446|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907447|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13907448|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13907449|NCT03532399|Bivalirudin|bivalirudin|mesh-list
13907450|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
13907451|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13907452|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907453|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907454|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907455|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
13959637|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13959638|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13959639|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13959640|NCT03161457|Rituximab|rituximab|mesh-list
13959641|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959642|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959643|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
13959644|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959645|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959646|NCT03161522|Fluorouracil|fluorouracil|mesh-list
13959647|NCT03161522|Capecitabine|capecitabine|mesh-list
13959648|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
13959649|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959650|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13959651|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959652|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13959653|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
14038740|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473229|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473230|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
14473231|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14473232|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14038745|NCT03026062|Durvalumab|durvalumab|mesh-list
14038746|NCT03026062|Ipilimumab|ipilimumab|mesh-list
14038747|NCT03026062|Tremelimumab|tremelimumab|mesh-list
14038748|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
14038749|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14038750|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
14038751|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038752|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038753|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
14038754|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14038755|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14038756|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473233|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473234|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14473235|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13959654|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959655|NCT03161340|Sirolimus|sirolimus|mesh-list
13959656|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959657|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959658|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13959659|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959660|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
13959661|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13959662|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
13959663|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959664|NCT03161210|Anesthetics|anesthetics|mesh-list
14473236|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14473237|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473238|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756494|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756495|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14756496|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14756497|NCT02992522|Growth Substances|growth substances|mesh-ancestor
14756498|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
14756499|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473239|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
14473240|NCT02359305|Acetaminophen|acetaminophen|mesh-list
14473241|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756500|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959665|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907456|NCT03532178|Rocuronium|rocuronium|mesh-list
13907457|NCT03532178|Succinylcholine|succinylcholine|mesh-list
13907458|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13907459|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13907460|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13907461|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907462|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907463|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
13907464|NCT03532087|Denosumab|denosumab|mesh-list
13907465|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13907466|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473242|NCT02359305|Analgesics|analgesics|mesh-ancestor
14473243|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
14473244|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907467|NCT03532035|Brincidofovir|brincidofovir|mesh-list
13907468|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
13907469|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907470|NCT03531970|Dexamethasone|dexamethasone|mesh-list
13907471|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
13907472|NCT03531970|Lidocaine|lidocaine|mesh-list
13907473|NCT03531970|Epinephrine|epinephrine|mesh-list
13907474|NCT03531970|BB 1101|bb 1101|mesh-list
13907475|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907476|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
13907477|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
13907478|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907479|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907480|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907481|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
13907482|NCT03531970|Hormones|hormones|mesh-ancestor
13907483|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13907484|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13907485|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907486|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
13907487|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473245|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473246|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
14473247|NCT02359435|Amoxicillin|amoxicillin|mesh-list
14473248|NCT02359435|Metronidazole|metronidazole|mesh-list
14473249|NCT02359435|Clarithromycin|clarithromycin|mesh-list
14473250|NCT02359435|Pantoprazole|pantoprazole|mesh-list
14473251|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14473252|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473253|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14038776|NCT02966756|Venetoclax|venetoclax|mesh-list
14038777|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038778|NCT02964013|Carboplatin|carboplatin|mesh-list
14038779|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
14038780|NCT02964013|Etoposide|etoposide|mesh-list
14038781|NCT02964013|Pemetrexed|pemetrexed|mesh-list
14038782|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038783|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038784|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756501|NCT02990338|Dexamethasone|dexamethasone|mesh-list
14756502|NCT02990338|Pomalidomide|pomalidomide|mesh-list
14756503|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756504|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
13907488|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907489|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
13907490|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
13907491|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907492|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
13907493|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13907494|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14756505|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
14756506|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756507|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756508|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907495|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14038785|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907496|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14038786|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14038787|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473254|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14756509|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
13907497|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13907498|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13907499|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
13907500|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907501|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13907502|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13907503|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13907504|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
13907505|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
13907506|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
13907507|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13907508|NCT03531931|Apatinib|apatinib|mesh-list
13907509|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907510|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13907511|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907512|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907513|NCT03531918|Cytarabine|cytarabine|mesh-list
13907514|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14038788|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038789|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14038790|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14473255|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14473256|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473257|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473258|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14473259|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14473260|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14473261|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14473262|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14473263|NCT02359552|Rasagiline|rasagiline|mesh-list
14473264|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14473265|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473266|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038803|NCT02932618|Factor VIII|factor viii|mesh-list
14038804|NCT02932618|Coagulants|coagulants|mesh-ancestor
14038805|NCT02916316|Doxorubicin|doxorubicin|mesh-list
14038806|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14038807|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14038808|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038809|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14038810|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14038811|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14038812|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756510|NCT02990338|Hormones|hormones|mesh-ancestor
14756511|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756512|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14756513|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756514|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
14756515|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14756516|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13907515|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
13907516|NCT03531918|Cladribine|cladribine|mesh-list
13907517|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
14756517|NCT02990338|Growth Substances|growth substances|mesh-ancestor
14756518|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
14756519|NCT02978612|Capecitabine|capecitabine|mesh-list
14756520|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756521|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
14756522|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756523|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756524|NCT02975882|Sirolimus|sirolimus|mesh-list
14756525|NCT02975882|Irinotecan|irinotecan|mesh-list
14756526|NCT02975882|Camptothecin|camptothecin|mesh-list
14756527|NCT02975882|Temozolomide|temozolomide|mesh-list
14756528|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14756529|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756530|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756531|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473267|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14473268|NCT02359552|Protective Agents|protective agents|mesh-ancestor
14473269|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907518|NCT03531918|Calicheamicins|calicheamicins|mesh-list
13907519|NCT03531918|Sargramostim|sargramostim|mesh-list
13907520|NCT03531918|Lenograstim|lenograstim|mesh-list
13907521|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14473270|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
13907522|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
13907523|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907524|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473271|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473272|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473273|NCT02359877|Interferons|interferons|mesh-list
14473274|NCT02359877|Interferon-beta|interferon-beta|mesh-list
14473275|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
14473276|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473277|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
14473278|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473279|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
14473280|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473281|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14473282|NCT02359903|Infliximab|infliximab|mesh-list
14473283|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14473284|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14473285|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14473286|NCT02360098|Anesthetics|anesthetics|mesh-list
14473287|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473288|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473289|NCT02360124|Fluorides|fluorides|mesh-list
14473290|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
14473291|NCT02360124|Protective Agents|protective agents|mesh-ancestor
14473292|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473293|NCT02360215|Memantine|memantine|mesh-list
14473294|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14473295|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14473296|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
14473297|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473298|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473299|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473300|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14473301|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13907525|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
13907526|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907527|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907528|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
13907529|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907530|NCT03531918|Analgesics|analgesics|mesh-ancestor
13907531|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
13907532|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907533|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907534|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907535|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907536|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13907537|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13907538|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13907539|NCT03531762|Tepotinib|tepotinib|mesh-list
14473302|NCT02360280|Midazolam|midazolam|mesh-list
14473303|NCT02360280|Ketamine|ketamine|mesh-list
14473304|NCT02360280|Analgesics|analgesics|mesh-ancestor
14473305|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
14473306|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473307|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473308|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14473309|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14473310|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
13907540|NCT03531762|Omeprazole|omeprazole|mesh-list
14473311|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
14473312|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907541|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13907542|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907543|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13907544|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473313|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14473314|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14473315|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473316|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473317|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14473318|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14473319|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14473320|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14473321|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14473322|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
14473323|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
14473324|NCT02360319|Aripiprazole|aripiprazole|mesh-list
14473325|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
14473326|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
14473327|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14473328|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14473329|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473330|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473331|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
14473332|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
14473333|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473334|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473335|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13907545|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907546|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907547|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
13907548|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
13907549|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907550|NCT03531749|Protective Agents|protective agents|mesh-ancestor
13907551|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907552|NCT03531749|Vitamins|vitamins|mesh-ancestor
13907553|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
13907554|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
13907555|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13907556|NCT03531645|Fulvestrant|fulvestrant|mesh-list
13907557|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13907558|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907559|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13907560|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13907561|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
13907562|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13907563|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907564|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13907565|NCT03531437|Gestodene|gestodene|mesh-list
13907566|NCT03531437|Estradiol|estradiol|mesh-list
13907567|NCT03531437|Estrogens|estrogens|mesh-ancestor
13907568|NCT03531437|Hormones|hormones|mesh-ancestor
13907569|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13907570|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907571|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13907572|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
13907573|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13907574|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13907575|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13907576|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13907577|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13907578|NCT03531437|Progestins|progestins|mesh-ancestor
14473336|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14473337|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
14473338|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14473339|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14473340|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13907579|NCT03531372|Antacids|antacids|mesh-list
13907580|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907581|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907582|NCT03531359|Midazolam|midazolam|mesh-list
13907583|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13907584|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14473341|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14473342|NCT02360397|Ranolazine|ranolazine|mesh-list
14473343|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14473344|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14473345|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473346|NCT02360475|Vaccines|vaccines|mesh-list
14473347|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
14473348|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473349|NCT02360631|Varenicline|varenicline|mesh-list
14473350|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14473351|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14933145|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933146|NCT01449253|Urological Agents|urological agents|mesh-ancestor
14933147|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13907585|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907586|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907587|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13907588|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13907589|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13907590|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13907591|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
13907592|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
13907593|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
13907594|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
13907595|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907596|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907597|NCT03531294|Aflibercept|aflibercept|mesh-list
14933148|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14933149|NCT01449344|Cytarabine|cytarabine|mesh-list
14933150|NCT01449344|Dexamethasone|dexamethasone|mesh-list
14933151|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
14933152|NCT01449344|Rituximab|rituximab|mesh-list
13907598|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13907599|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13907600|NCT03531294|Growth Substances|growth substances|mesh-ancestor
13907601|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907602|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
13907603|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907604|NCT03531281|Sirolimus|sirolimus|mesh-list
13907605|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
13907606|NCT03531281|Etoposide|etoposide|mesh-list
13907607|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
13907608|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
13907609|NCT03531281|Tacrolimus|tacrolimus|mesh-list
13907610|NCT03531281|Mitogens|mitogens|mesh-list
13907611|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907612|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
13907613|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907614|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907615|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907616|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
13907617|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907618|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907619|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907620|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13907621|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13907622|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13907623|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907624|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13907625|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13907626|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907627|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13907628|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
13907629|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
13907630|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
13907631|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
13907632|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
13907633|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473352|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
13907634|NCT03531073|Methotrexate|methotrexate|mesh-list
14473353|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933153|NCT01449344|Bortezomib|bortezomib|mesh-list
14473354|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933154|NCT01449344|BB 1101|bb 1101|mesh-list
13907635|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13907636|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
14473355|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473356|NCT02360774|Canagliflozin|canagliflozin|mesh-list
14473357|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14473358|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473359|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14473360|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473361|NCT02360995|Triclosan|triclosan|mesh-list
14473362|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
13907637|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13907638|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907639|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13907640|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
13907641|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907642|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907643|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
13907644|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907645|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13907646|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907647|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
13907648|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907649|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13907650|NCT03531047|Riboflavin|riboflavin|mesh-list
13907651|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
13907652|NCT03531047|Vitamins|vitamins|mesh-ancestor
13907653|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
13907654|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907655|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13907656|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
13907657|NCT03530800|Dronabinol|dronabinol|mesh-list
13907658|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
13907659|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907660|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13907661|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13907662|NCT03530800|Analgesics|analgesics|mesh-ancestor
13907663|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
13907664|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907665|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13907666|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13907667|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907668|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907669|NCT03530800|Hormones|hormones|mesh-ancestor
13907670|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13907671|NCT03530670|Midazolam|midazolam|mesh-list
13907672|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13907673|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13907674|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907675|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907676|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13907677|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14473363|NCT02360995|Fluorides|fluorides|mesh-list
14473364|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
14473365|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
14473366|NCT02360995|Protective Agents|protective agents|mesh-ancestor
14473367|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473368|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14473369|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473370|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13907678|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13907679|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13907680|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
13907681|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
13907682|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
13907683|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
13907684|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907685|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959666|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959667|NCT03161574|Fluorouracil|fluorouracil|mesh-list
13959668|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
14473371|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14473372|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
13959669|NCT03161574|Irinotecan|irinotecan|mesh-list
13907686|NCT03530488|Lidocaine|lidocaine|mesh-list
13907687|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
13907688|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
13907689|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907690|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907691|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
13907692|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473373|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473374|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14473375|NCT02361476|Clonidine|clonidine|mesh-list
14473376|NCT02361476|Analgesics|analgesics|mesh-ancestor
14473377|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
14473378|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907693|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13907694|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13907695|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13907696|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13907697|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907698|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
13907699|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
13907700|NCT03530462|Rituximab|rituximab|mesh-list
13907701|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
13907702|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13907703|NCT03530462|Antibodies|antibodies|mesh-list
13907704|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
13907705|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13907706|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907707|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
13907708|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907709|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907710|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907711|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
13907712|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907713|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907714|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907715|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13907716|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907717|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
13907718|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
13907719|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907720|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14473379|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473380|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14473381|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
14473382|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
14473383|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14473384|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14473385|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14473386|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
14473387|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473388|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473389|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
14473390|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
14473391|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473392|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473393|NCT02362269|Vitamin D|vitamin d|mesh-list
14473394|NCT02362269|Vitamins|vitamins|mesh-ancestor
14473395|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
14473396|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473397|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14473398|NCT02362321|Dexamethasone|dexamethasone|mesh-list
14473399|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14473400|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
14473401|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
14473402|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473403|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473404|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14038972|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
14038973|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14038974|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473405|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
14473406|NCT02362321|Hormones|hormones|mesh-ancestor
14473407|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473408|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14473409|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933155|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14473410|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
14933156|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
14933157|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
14933158|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933159|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933160|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933161|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
13907721|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
13907722|NCT03530462|Hormones|hormones|mesh-ancestor
13907723|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13907724|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13907725|NCT03530462|Protective Agents|protective agents|mesh-ancestor
13907726|NCT03530436|Curcumin|curcumin|mesh-list
13907727|NCT03530436|Turmeric extract|turmeric extract|mesh-list
13907728|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13907729|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13907730|NCT03530436|Analgesics|analgesics|mesh-ancestor
13907731|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
13907732|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907733|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907734|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907735|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907736|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907737|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907738|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907739|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
13907740|NCT03530436|Protective Agents|protective agents|mesh-ancestor
13907741|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
13907742|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13907743|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907744|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907745|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13907746|NCT03530371|Analgesics|analgesics|mesh-ancestor
13907747|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
13907748|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907749|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13907750|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13907751|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13907752|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
13907753|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907754|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907755|NCT03530319|Azithromycin|azithromycin|mesh-list
13907756|NCT03530319|Doxycycline|doxycycline|mesh-list
13907757|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13907758|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907759|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
13907760|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13907761|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13907762|NCT03530280|Pregabalin|pregabalin|mesh-list
13907763|NCT03530280|Bupivacaine|bupivacaine|mesh-list
13907764|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
13907765|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
13907766|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907767|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907768|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
13907769|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907770|NCT03530280|Analgesics|analgesics|mesh-ancestor
13907771|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
13907772|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13907773|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13907774|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907775|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13907776|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13907777|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13907778|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13907786|NCT03530228|Esomeprazole|esomeprazole|mesh-list
13907787|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13907788|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907789|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13907790|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907791|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907792|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
13907793|NCT03530189|Insulin|insulin|mesh-list
13907794|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13907795|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907796|NCT03530176|Listerine|listerine|mesh-list
14473411|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14473412|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
14473413|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14038985|NCT02759419|Riociguat|riociguat|mesh-list
14038986|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
14038987|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038988|NCT02752035|Azacitidine|azacitidine|mesh-list
14038989|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14038990|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
14038991|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14038992|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14038993|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473414|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473415|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14473416|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14473417|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14038998|NCT02699840|Vaccines|vaccines|mesh-list
14038999|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
14039000|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473418|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14473419|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
14473420|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14473421|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14473422|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14473423|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473424|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473425|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
14473426|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14473427|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
14473428|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473429|NCT02362425|Expectorants|expectorants|mesh-ancestor
14473430|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
14473431|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14473432|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
14473433|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473434|NCT02362425|Protective Agents|protective agents|mesh-ancestor
14473435|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473436|NCT02362425|Antidotes|antidotes|mesh-ancestor
14473437|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
14039021|NCT02626455|Prednisone|prednisone|mesh-list
14039022|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
14039023|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14933162|NCT01449344|Hormones|hormones|mesh-ancestor
14933163|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14039024|NCT02626455|Rituximab|rituximab|mesh-list
14039025|NCT02626455|Doxorubicin|doxorubicin|mesh-list
13907797|NCT03530176|Fluorides|fluorides|mesh-list
13907798|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
13907799|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
13907800|NCT03530176|Protective Agents|protective agents|mesh-ancestor
13907801|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907802|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13907803|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13907804|NCT03530150|Pirfenidone|pirfenidone|mesh-list
13907805|NCT03530150|Analgesics|analgesics|mesh-ancestor
13907806|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
13907807|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14039026|NCT02626455|Vincristine|vincristine|mesh-list
14039027|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14039028|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
14039029|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039030|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14039031|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907808|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907809|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14039032|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
14039033|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039034|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14039035|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14039036|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14039037|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14039038|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14039039|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14039040|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14039041|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14473438|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13907810|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13907811|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907812|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907813|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907814|NCT03530085|Fludarabine|fludarabine|mesh-list
13907815|NCT03530085|Busulfan|busulfan|mesh-list
13907816|NCT03530085|Decitabine|decitabine|mesh-list
13907817|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907818|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13907819|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
13907820|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907821|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13907822|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
13907823|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907824|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
13907825|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907826|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13907827|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907828|NCT03530033|Lidocaine|lidocaine|mesh-list
13907829|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
13907830|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
13907831|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907832|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907833|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
13907834|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907835|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13907836|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13907837|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13907838|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13907839|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907840|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
13907841|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
13907842|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13907843|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907844|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907845|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
13907846|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13907847|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907848|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907849|NCT03530007|Ondansetron|ondansetron|mesh-list
13907850|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
13907851|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
13907852|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907853|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907854|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907855|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
13907856|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
13907857|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13907858|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
13907859|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907860|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907861|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13907862|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13907863|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907864|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13907865|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13907866|NCT03529955|Apremilast|apremilast|mesh-list
13907867|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13907868|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13907869|NCT03529955|Analgesics|analgesics|mesh-ancestor
13907870|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
13907871|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959670|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
13907872|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907873|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907874|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907875|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13907876|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13907877|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907878|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907879|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
13907880|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13907881|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13907882|NCT03529929|Prednisolone|prednisolone|mesh-list
13907883|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
13907884|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13907885|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
13907886|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907887|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
13907888|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
13907889|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907890|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907891|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13907892|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
14039042|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
14039043|NCT02626455|Hormones|hormones|mesh-ancestor
14039044|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14039045|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14039046|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14039047|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
14039048|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
14039049|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473439|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473440|NCT02363270|Ketamine|ketamine|mesh-list
14473441|NCT02363270|Analgesics|analgesics|mesh-ancestor
14473442|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
14473443|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473444|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473445|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14473446|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14473447|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
14473448|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
14473449|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473450|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14473451|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14473452|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473453|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473454|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
14473455|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
14473456|NCT02363283|Immunotoxins|immunotoxins|mesh-list
14039068|NCT02584426|Cefazolin|cefazolin|mesh-list
14039069|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14039070|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473457|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14473458|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
14473459|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039074|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
14039075|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14039076|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473460|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473461|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473462|NCT02363478|Buspirone|buspirone|mesh-list
14473463|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14473464|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14473465|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473466|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473467|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14473468|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14473469|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
14473470|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473471|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473472|NCT02363621|Ranibizumab|ranibizumab|mesh-list
14473473|NCT02363621|Aflibercept|aflibercept|mesh-list
14473474|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14473475|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14473476|NCT02363621|Growth Substances|growth substances|mesh-ancestor
14473477|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473478|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
14473479|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473480|NCT02363738|Infliximab|infliximab|mesh-list
14473481|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
14473482|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14473483|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907893|NCT03529929|Hormones|hormones|mesh-ancestor
13907894|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13907895|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13907896|NCT03529929|Protective Agents|protective agents|mesh-ancestor
13907897|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13907898|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907899|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
13907900|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13907901|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907902|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907903|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13907904|NCT03529643|Analgesics|analgesics|mesh-ancestor
13907905|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
13907906|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907907|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13907908|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14479141|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479142|NCT02464176|Dexamethasone|dexamethasone|mesh-list
14479143|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
14039104|NCT02480803|Levodopa|levodopa|mesh-list
14039105|NCT02480803|Carbidopa|carbidopa|mesh-list
13907909|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13907910|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
13907911|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907912|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907913|NCT03529487|Phenylephrine|phenylephrine|mesh-list
13907914|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
13907915|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13907916|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13907917|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
13907918|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13907919|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907920|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907921|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
13907922|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
13907923|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907924|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
13907925|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13907926|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
13907927|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13907928|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
13907929|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13907930|NCT03529487|Protective Agents|protective agents|mesh-ancestor
13907931|NCT03529448|Temozolomide|temozolomide|mesh-list
13907932|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13907933|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
13907934|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039106|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14039107|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14039108|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14039109|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
14039110|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14039111|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039112|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039113|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14039114|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14039115|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14039116|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
14039117|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
13907935|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907936|NCT03529422|Durvalumab|durvalumab|mesh-list
13907937|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13907938|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907939|NCT03529331|Acetaminophen|acetaminophen|mesh-list
13907940|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
13907941|NCT03529331|Morphine|morphine|mesh-list
13907942|NCT03529331|Oxycodone|oxycodone|mesh-list
13907943|NCT03529331|Hydrocodone|hydrocodone|mesh-list
13907944|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13907945|NCT03529331|Narcotics|narcotics|mesh-ancestor
13907946|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907947|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907948|NCT03529331|Analgesics|analgesics|mesh-ancestor
13907949|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
13907950|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907951|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13907952|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
13907953|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
13907954|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
13907955|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13907956|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13907957|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13907958|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13907959|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
13907960|NCT03529266|Coagulants|coagulants|mesh-ancestor
13907961|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13907962|NCT03529253|Calcium|calcium|mesh-list
13907963|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14473484|NCT02363803|Lidocaine|lidocaine|mesh-list
14473485|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
14473486|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
14473487|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473488|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473489|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
14473490|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473491|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14473492|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14473493|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14473494|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14473495|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473496|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
14473497|NCT02363946|Promethazine|promethazine|mesh-list
14473498|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13907964|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473499|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13907965|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14473500|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907966|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13907967|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
14039176|NCT02415153|Pomalidomide|pomalidomide|mesh-list
14039177|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
14039178|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039179|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14039180|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14039181|NCT02415153|Growth Substances|growth substances|mesh-ancestor
14039182|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
14039183|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473501|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473502|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
14473503|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
14473504|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
13907968|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13907969|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13907970|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13907971|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13907972|NCT03529201|Fentanyl|fentanyl|mesh-list
13907973|NCT03529201|Oxycodone|oxycodone|mesh-list
13907974|NCT03529201|Sevoflurane|sevoflurane|mesh-list
13907975|NCT03529201|Rocuronium|rocuronium|mesh-list
13907976|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13907977|NCT03529201|Narcotics|narcotics|mesh-ancestor
13907978|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13907979|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473505|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14039189|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
14039190|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13907980|NCT03529201|Analgesics|analgesics|mesh-ancestor
13907981|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
13907982|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13907983|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13907984|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13907985|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
13907986|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
13907987|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13907988|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13907989|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13907990|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13907991|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14473506|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
14473507|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
14473508|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14473509|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14473510|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
14473511|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
14473512|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473513|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473514|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14473515|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
14473516|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
14473517|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
14473518|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14473519|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13907992|NCT03529175|Gemcitabine|gemcitabine|mesh-list
13907993|NCT03529175|Paclitaxel|paclitaxel|mesh-list
14039191|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14039192|NCT02386839|Mecasermin|mecasermin|mesh-list
14039193|NCT02386839|Growth Substances|growth substances|mesh-ancestor
14039194|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473520|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
14473521|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473522|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473523|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14473524|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
14473525|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473526|NCT02364947|Nalmefene|nalmefene|mesh-list
14473527|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14473528|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473529|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
14473530|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473531|NCT02364999|Paclitaxel|paclitaxel|mesh-list
13907994|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13907995|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14473532|NCT02364999|Bevacizumab|bevacizumab|mesh-list
14473533|NCT02364999|Carboplatin|carboplatin|mesh-list
14473534|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14473535|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473536|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473537|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473538|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473539|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473540|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473541|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14473542|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14473543|NCT02364999|Growth Substances|growth substances|mesh-ancestor
14473544|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473545|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
14039218|NCT02330926|Ibuprofen|ibuprofen|mesh-list
14039219|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14039220|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14039221|NCT02330926|Analgesics|analgesics|mesh-ancestor
14039222|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
14039223|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14039224|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039225|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14039226|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14039227|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14039228|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14039229|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039230|NCT02274285|Vaccines|vaccines|mesh-list
14039231|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
14039232|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473546|NCT02365285|Heparin|heparin|mesh-list
14473547|NCT02365285|Galantamine|galantamine|mesh-list
14473548|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14473549|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
13907996|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13907997|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
13907998|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
13907999|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
13908000|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908001|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13908002|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
13908003|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
13908004|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908005|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473550|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14473551|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14473552|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473553|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14473554|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14473555|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14473556|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14473557|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473558|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
14473559|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473560|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473561|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14473562|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
14473563|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473564|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
14473565|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14473566|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14473567|NCT02365558|Omeprazole|omeprazole|mesh-list
14473568|NCT02365558|Evacetrapib|evacetrapib|mesh-list
14473569|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14473570|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14473571|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14473572|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473573|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473574|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13908006|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908007|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
13908008|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933164|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14933165|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933166|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
13908009|NCT03529149|Diltiazem|diltiazem|mesh-list
13908010|NCT03529149|Urapidil|urapidil|mesh-list
13908011|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13908012|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13908013|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908014|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908015|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13908016|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473575|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14473576|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
14473577|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13908017|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
13908018|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13908019|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
13908020|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908021|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13908022|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13908023|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13908024|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14473578|NCT02365584|Lanreotide|lanreotide|mesh-list
14473579|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473580|NCT02365870|Rotigotine|rotigotine|mesh-list
14473581|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
14473582|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
14473583|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473584|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473585|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473586|NCT02365961|Clonidine|clonidine|mesh-list
14473587|NCT02365961|Epinephrine|epinephrine|mesh-list
14473588|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14473589|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14473590|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14473591|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473592|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756532|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756533|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756534|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
14756535|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14756536|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756537|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756538|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
14756539|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756540|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
14756541|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756542|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13908033|NCT03529097|Dipyrone|dipyrone|mesh-list
13908034|NCT03529097|Diclofenac|diclofenac|mesh-list
14756543|NCT02975310|Anesthetics|anesthetics|mesh-list
14756544|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756545|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756546|NCT02968212|Clofazimine|clofazimine|mesh-list
14756547|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756548|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
14756549|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14756550|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756551|NCT02960230|Nivolumab|nivolumab|mesh-list
14756552|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756553|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756554|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13908035|NCT03529097|Morphine|morphine|mesh-list
13908036|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13908037|NCT03529097|Narcotics|narcotics|mesh-ancestor
13908038|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908039|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908040|NCT03529097|Analgesics|analgesics|mesh-ancestor
13908041|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
13908042|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908043|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13908044|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908045|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908046|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908047|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13908048|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908049|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908050|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
13908051|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13908052|NCT03529084|Gefitinib|gefitinib|mesh-list
13908053|NCT03529084|Nazartinib|nazartinib|mesh-list
13908054|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908055|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13908056|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908057|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908058|NCT03529032|Methadone|methadone|mesh-list
13908059|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13908060|NCT03529032|Narcotics|narcotics|mesh-ancestor
13908061|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908062|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908063|NCT03529032|Analgesics|analgesics|mesh-ancestor
13908064|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
13908065|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908066|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
13908067|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
13908068|NCT03528967|Aspirin|aspirin|mesh-list
13908069|NCT03528967|Enoxaparin|enoxaparin|mesh-list
13908070|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13908071|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908072|NCT03528967|Analgesics|analgesics|mesh-ancestor
13908073|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
14756555|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756556|NCT02957032|Cytarabine|cytarabine|mesh-list
14473593|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473594|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14473595|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14473596|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
13908074|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908075|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908076|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908077|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908078|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13908079|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13908080|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908081|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13908082|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13908083|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908084|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
13908085|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
14473597|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473598|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14473599|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
13908086|NCT03528954|Propofol|propofol|mesh-list
14473600|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
13908087|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14756557|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13908088|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908089|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908090|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13908091|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
13908092|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
13908093|NCT03528941|Lamivudine|lamivudine|mesh-list
13908094|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13908095|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13908096|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908097|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908098|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
13908099|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908100|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13908101|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13959671|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959672|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13959673|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959674|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14473601|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
14473602|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14473603|NCT02365961|Analgesics|analgesics|mesh-ancestor
14473604|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
14473605|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14039313|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14473606|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
14473607|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14473608|NCT02366091|Methotrexate|methotrexate|mesh-list
14473609|NCT02366091|Colchicine|colchicine|mesh-list
14473610|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14473611|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
14473612|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14473613|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473614|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14473615|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
14473616|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473617|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473618|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
14473619|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473620|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14473621|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14039330|NCT02120469|Everolimus|everolimus|mesh-list
14039331|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14039332|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14039333|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
14039334|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473622|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
14473623|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14473624|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14473625|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
14473626|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473627|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473628|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473629|NCT02366130|Denosumab|denosumab|mesh-list
14473630|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14473631|NCT02366130|Hormones|hormones|mesh-list
14473632|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473633|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473634|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14473635|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473636|NCT02366143|Paclitaxel|paclitaxel|mesh-list
14473637|NCT02366143|Bevacizumab|bevacizumab|mesh-list
14473638|NCT02366143|Carboplatin|carboplatin|mesh-list
14473639|NCT02366143|Atezolizumab|atezolizumab|mesh-list
14473640|NCT02366143|Antibodies|antibodies|mesh-list
14473641|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14473642|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14473643|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473644|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473645|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473646|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473647|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473648|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14039362|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
14039363|NCT02101853|Leucovorin|leucovorin|mesh-list
14039364|NCT02101853|Folic Acid|folic acid|mesh-list
14039365|NCT02101853|Cytarabine|cytarabine|mesh-list
14756558|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
14756559|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908102|NCT03528915|Rifamycins|rifamycins|mesh-list
13908103|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
13908104|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13908105|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908106|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908107|NCT03528824|Diclofenac|diclofenac|mesh-list
13908108|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13908109|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908110|NCT03528824|Analgesics|analgesics|mesh-ancestor
13908111|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
13908112|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908113|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039366|NCT02101853|Dexamethasone|dexamethasone|mesh-list
14039367|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
14039368|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
14039369|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14039370|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14039371|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14039372|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
14039373|NCT02101853|Methotrexate|methotrexate|mesh-list
14039374|NCT02101853|Etoposide|etoposide|mesh-list
14039375|NCT02101853|Vincristine|vincristine|mesh-list
14039376|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
14039377|NCT02101853|Asparaginase|asparaginase|mesh-list
14039378|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
14039379|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
14039380|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
14039381|NCT02101853|Pegaspargase|pegaspargase|mesh-list
14039382|NCT02101853|Thioguanine|thioguanine|mesh-list
14039383|NCT02101853|Blinatumomab|blinatumomab|mesh-list
14039384|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14039385|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
14039386|NCT02101853|Antibodies|antibodies|mesh-list
14039387|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
14039388|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14039389|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14039390|NCT02101853|BB 1101|bb 1101|mesh-list
14039391|NCT02101853|Calcium|calcium|mesh-list
14039392|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
14039393|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
14039394|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14039395|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
14039396|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039397|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14039398|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14039399|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
14473649|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14756560|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473650|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14473651|NCT02366143|Growth Substances|growth substances|mesh-ancestor
14473652|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473653|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
14473654|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
14473655|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14473656|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473657|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473658|NCT02366468|Ranibizumab|ranibizumab|mesh-list
14473659|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14473660|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14473661|NCT02366468|Growth Substances|growth substances|mesh-ancestor
14479144|NCT02464176|Epinephrine|epinephrine|mesh-list
14756561|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
14756562|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933167|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908114|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908115|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14039400|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039401|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14039402|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756563|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756564|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
14756565|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756566|NCT02954991|Nivolumab|nivolumab|mesh-list
14756567|NCT02954991|Mocetinostat|mocetinostat|mesh-list
14756568|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933168|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933169|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933170|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
14933171|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933172|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14933173|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
14933174|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
14933175|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933176|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14933177|NCT01449357|Zalutumumab|zalutumumab|mesh-list
14933178|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933179|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933180|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
14756569|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756570|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14756571|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756572|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14756573|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756574|NCT02947516|Liver Extracts|liver extracts|mesh-list
14756575|NCT02947516|Hematinics|hematinics|mesh-ancestor
14756576|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
14756577|NCT02932956|Fludarabine|fludarabine|mesh-list
14756578|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
14756579|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756580|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
14756581|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039403|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14039404|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
14039405|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
14039406|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14039407|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14039408|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
14039409|NCT02101853|Hormones|hormones|mesh-ancestor
14039410|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14039411|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13908116|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13908117|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908118|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908119|NCT03528785|Leucovorin|leucovorin|mesh-list
13908120|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
13908121|NCT03528785|Irinotecan|irinotecan|mesh-list
13908122|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
14039412|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
14039413|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14039414|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14039415|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14039416|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14039417|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
14039418|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14039419|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14933181|NCT01449435|Miotics|miotics|mesh-ancestor
13908123|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908124|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13908125|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13908126|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908127|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908128|NCT03528785|Antidotes|antidotes|mesh-ancestor
13908129|NCT03528785|Protective Agents|protective agents|mesh-ancestor
13908130|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908131|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
13908132|NCT03528785|Vitamins|vitamins|mesh-ancestor
13908133|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
13908134|NCT03528772|Minoxidil|minoxidil|mesh-list
13908135|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
13908136|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13908137|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
13908138|NCT03528616|Propranolol|propranolol|mesh-list
14933182|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
13908139|NCT03528616|Digoxin|digoxin|mesh-list
13908140|NCT03528616|Adenosine|adenosine|mesh-list
13908141|NCT03528616|Amiodarone|amiodarone|mesh-list
13908142|NCT03528616|Flecainide|flecainide|mesh-list
13908143|NCT03528616|Procainamide|procainamide|mesh-list
13908144|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13908145|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13908146|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
13908147|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908148|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908149|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908150|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14039420|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
14039421|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
14039422|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14039423|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14039424|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14039425|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14039426|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14039427|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
14039428|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14039429|NCT02101853|Antidotes|antidotes|mesh-ancestor
13908151|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13908152|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
13908153|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13908154|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908155|NCT03528616|Protective Agents|protective agents|mesh-ancestor
13908156|NCT03528616|Analgesics|analgesics|mesh-ancestor
13908157|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
13908158|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908159|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13908160|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
13908161|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
13908162|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13908163|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908164|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13908165|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13908166|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13908167|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13908168|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14039430|NCT02101853|Protective Agents|protective agents|mesh-ancestor
14039431|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
14039432|NCT02101853|Vitamins|vitamins|mesh-ancestor
14039433|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
14039434|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
14039435|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
14039436|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
13908169|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13908170|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13908171|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
13908172|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13908173|NCT03528564|Hematinics|hematinics|mesh-ancestor
13908174|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
13908175|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13908176|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908177|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
13908178|NCT03528421|Fludarabine|fludarabine|mesh-list
13908179|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14039437|NCT02101853|Hematinics|hematinics|mesh-ancestor
14039438|NCT02101853|Analgesics|analgesics|mesh-ancestor
14039439|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
14039440|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
14039441|NCT02091960|Trastuzumab|trastuzumab|mesh-list
14039442|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908180|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
13908181|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039443|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14039444|NCT02078427|BAX 855|bax 855|mesh-list
14039445|NCT02078427|Coagulants|coagulants|mesh-ancestor
14039446|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14039447|NCT02046434|Glycerol|glycerol|mesh-list
14039448|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14039449|NCT02046434|Protective Agents|protective agents|mesh-ancestor
13908182|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908183|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13908184|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
13908185|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908186|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908187|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13908188|NCT03528070|Tranilast|tranilast|mesh-list
13908189|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13908190|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908191|NCT03528070|Analgesics|analgesics|mesh-ancestor
14039450|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039451|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473662|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908192|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
13908193|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908194|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908195|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908196|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908197|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13908198|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908199|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908200|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13908201|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13908202|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
14473663|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
14473664|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473665|NCT02366663|Cytarabine|cytarabine|mesh-list
14473666|NCT02366663|Rituximab|rituximab|mesh-list
14473667|NCT02366663|Etoposide|etoposide|mesh-list
14473668|NCT02366663|Melphalan|melphalan|mesh-list
14473669|NCT02366663|Carmustine|carmustine|mesh-list
14473670|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473671|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908203|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
13908204|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908205|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13908206|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13908207|NCT03528057|Hemostatics|hemostatics|mesh-list
13908208|NCT03528057|Coagulants|coagulants|mesh-ancestor
13908209|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
13908210|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
13908211|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908212|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908213|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908214|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14473672|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
14473673|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473674|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14473675|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14473676|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14473677|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14473678|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473679|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473680|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13908215|NCT03527836|Lidocaine|lidocaine|mesh-list
13908216|NCT03527836|Bupivacaine|bupivacaine|mesh-list
13908217|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
13908218|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
13908219|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908220|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908221|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
13908222|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908223|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14473681|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
14473682|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
14473683|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473684|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14473685|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14473686|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
14473687|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14473688|NCT02366689|Triclosan|triclosan|mesh-list
14473689|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
13908224|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13908225|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13908226|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908227|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908228|NCT03527732|Ivermectin|ivermectin|mesh-list
13908229|NCT03527732|Albendazole|albendazole|mesh-list
13908230|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13908231|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908232|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
13908233|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
13908234|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13908235|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13908236|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
13908237|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
13908238|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
13908239|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908240|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908241|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
13908242|NCT03527628|Dacarbazine|dacarbazine|mesh-list
13908243|NCT03527628|Doxorubicin|doxorubicin|mesh-list
13908244|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13908245|NCT03527628|Bleomycin|bleomycin|mesh-list
13908246|NCT03527628|Vinblastine|vinblastine|mesh-list
13908247|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13908248|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908249|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
13908250|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908251|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908252|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13908253|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
13908254|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908255|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908256|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13908257|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13908258|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756582|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908259|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13908260|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908261|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13908262|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
13908263|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
13908264|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
13908265|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908266|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
13908267|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13908268|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
13908269|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908270|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908271|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13908272|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
13908273|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13908274|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
13908275|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908276|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908277|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13908278|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
13908279|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
13908280|NCT03527381|Protective Agents|protective agents|mesh-ancestor
13908281|NCT03527355|Vaccines|vaccines|mesh-list
13908282|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
13908283|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473690|NCT02366689|Fluorides|fluorides|mesh-list
14756583|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756584|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
14473691|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
14473692|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
14473693|NCT02366689|Protective Agents|protective agents|mesh-ancestor
14473694|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473695|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14473696|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473697|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14473698|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14473699|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
14473700|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473701|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14473702|NCT02366767|Insulin|insulin|mesh-list
14473703|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14473704|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473705|NCT02366871|Enoxaparin|enoxaparin|mesh-list
14473706|NCT02366871|Apixaban|apixaban|mesh-list
14473707|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
14473708|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14473709|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14473710|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473711|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14473712|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
14473713|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14473714|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
14473715|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473716|NCT02367131|Empagliflozin|empagliflozin|mesh-list
14473717|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14473718|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473719|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14473720|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473721|NCT02367352|Paclitaxel|paclitaxel|mesh-list
14473722|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14473723|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473724|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473725|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473726|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473727|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473728|NCT02367599|Vitamin D|vitamin d|mesh-list
14473729|NCT02367599|Vitamins|vitamins|mesh-ancestor
14473730|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
14473731|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473732|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14473733|NCT02367781|Paclitaxel|paclitaxel|mesh-list
14473734|NCT02367781|Carboplatin|carboplatin|mesh-list
14473735|NCT02367781|Pemetrexed|pemetrexed|mesh-list
14473736|NCT02367781|Atezolizumab|atezolizumab|mesh-list
14473737|NCT02367781|Antibodies|antibodies|mesh-list
14473738|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14473739|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14473740|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473741|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473742|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473743|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473744|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959675|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
13959676|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959677|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13959678|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959679|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959680|NCT03160872|Hormones|hormones|mesh-list
13959681|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959682|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959683|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13959684|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13959685|NCT03161132|Doxorubicin|doxorubicin|mesh-list
13959686|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13959687|NCT03161132|Olaparib|olaparib|mesh-list
13959688|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13908289|NCT03527251|Ipilimumab|ipilimumab|mesh-list
13908290|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908291|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908292|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13908293|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908294|NCT03527147|Rituximab|rituximab|mesh-list
13908295|NCT03527147|Magrolimab|magrolimab|mesh-list
13908296|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
13908297|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908298|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908299|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
13908300|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908301|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908302|NCT03527134|Amantadine|amantadine|mesh-list
13908303|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13908304|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14933183|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908305|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
13908306|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908307|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
13908308|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473745|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
14473746|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473747|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473748|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14473749|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14473750|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
14473751|NCT02367833|NuvaRing|nuvaring|mesh-list
14473752|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
14473753|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14473754|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14473755|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473756|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14473757|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14473758|NCT02367859|Trametinib|trametinib|mesh-list
14473759|NCT02367859|Dabrafenib|dabrafenib|mesh-list
14473760|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473761|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14473762|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473763|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473764|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
14473765|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473766|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473767|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
14473768|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
14473769|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
14473770|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14473771|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14473772|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473773|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473774|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473775|NCT02368314|Enoxaparin|enoxaparin|mesh-list
14473776|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
14473777|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
14473778|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14473779|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14473780|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473781|NCT02368431|Zonisamide|zonisamide|mesh-list
14473782|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
14473783|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14473784|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14473785|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473786|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14473787|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473788|NCT02368457|Tocopherols|tocopherols|mesh-list
14473789|NCT02368457|Vitamin E|vitamin e|mesh-list
14473790|NCT02368457|Tocotrienols|tocotrienols|mesh-list
14473791|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
14473792|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
14473793|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14473794|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473795|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473796|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14473797|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14473798|NCT02368457|Protective Agents|protective agents|mesh-ancestor
14933184|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933185|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14933186|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14933187|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
14933188|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14933189|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14933190|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
14933191|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933192|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908309|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908310|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908311|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908312|NCT03527134|Analgesics|analgesics|mesh-ancestor
13908313|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
13908314|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933193|NCT01449448|Triamcinolone|triamcinolone|mesh-list
14933194|NCT01449448|Ketorolac|ketorolac|mesh-list
14933195|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908315|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14473799|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473800|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
14473801|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14473802|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
14473803|NCT02368457|Vitamins|vitamins|mesh-ancestor
14473804|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
14473805|NCT02369068|Triamcinolone|triamcinolone|mesh-list
14473806|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14473807|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14473808|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14473809|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14473810|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
14039625|NCT01743651|Baclofen|baclofen|mesh-list
14039626|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14039627|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039628|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14039629|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14039630|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14039631|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
13908316|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13908317|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14039632|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
14039633|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14039634|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473811|NCT02369068|Hormones|hormones|mesh-ancestor
14473812|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473813|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473814|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14473815|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
14473816|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473817|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14473818|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473819|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14473820|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14473821|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
14473822|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473823|NCT02369159|Oseltamivir|oseltamivir|mesh-list
14473824|NCT02369159|Peramivir|peramivir|mesh-list
13908318|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
13908319|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908320|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13908321|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13908322|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908323|NCT03527043|Citalopram|citalopram|mesh-list
13908324|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13908325|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13908326|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908327|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908328|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908329|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
13908330|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908331|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13908332|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
13908333|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908334|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
13908335|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908336|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908337|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
13908338|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13908339|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908340|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
13908341|NCT03526575|Zaleplon|zaleplon|mesh-list
13908342|NCT03526575|Zolpidem|zolpidem|mesh-list
13908343|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13908344|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13908345|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908346|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908347|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13908348|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
13908349|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
13908350|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908351|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908352|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
13908353|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
13908354|NCT03526536|Insulin|insulin|mesh-list
14473825|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
14933196|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
14933197|NCT01449448|Hormones|hormones|mesh-ancestor
14933198|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473826|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473827|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473828|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473829|NCT02369172|Bupropion|bupropion|mesh-list
14473830|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14473831|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
14473832|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14473833|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14473834|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14473835|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14933199|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933200|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473836|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473837|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
14473838|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473839|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473840|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14473841|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14473842|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473843|NCT02369211|Acetaminophen|acetaminophen|mesh-list
14473844|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14473845|NCT02369211|Analgesics|analgesics|mesh-ancestor
14473846|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
14473847|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473848|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473849|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
14473850|NCT02369341|Vaccines|vaccines|mesh-list
14473851|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
14473852|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473853|NCT02369484|Afatinib|afatinib|mesh-list
14473854|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473855|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14473856|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473857|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473858|NCT02369510|Epinephrine|epinephrine|mesh-list
14473859|NCT02369510|Racepinephrine|racepinephrine|mesh-list
14473860|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
14473861|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14473862|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14473863|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
14473864|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473865|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473866|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473867|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13908355|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13908356|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13908357|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908358|NCT03526445|Glucagon|glucagon|mesh-list
13908359|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933201|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933202|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933203|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933204|NCT01449448|Analgesics|analgesics|mesh-ancestor
14933205|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
14933206|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933207|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933208|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14933209|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
14933210|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14473868|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14473869|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
14473870|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473871|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14473872|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
14473873|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
14473874|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
14473875|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14473876|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14473877|NCT02369835|Eusol|eusol|mesh-list
14473878|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14473879|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
14473880|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473881|NCT02369874|Durvalumab|durvalumab|mesh-list
14473882|NCT02369874|Tremelimumab|tremelimumab|mesh-list
14473883|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14473884|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14473885|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473886|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
14473887|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473888|NCT02369900|Esmolol|esmolol|mesh-list
13908360|NCT03526445|Hormones|hormones|mesh-ancestor
13908361|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13908362|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908363|NCT03526419|Bupivacaine|bupivacaine|mesh-list
13908364|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
13908365|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
13908366|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908367|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908368|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
13908369|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908370|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13908371|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13908372|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14473889|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14473890|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14473891|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
13908373|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
13908374|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908375|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13908376|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13908377|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908378|NCT03526315|Fluorides|fluorides|mesh-list
13908379|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
13908380|NCT03526315|Protective Agents|protective agents|mesh-ancestor
13908381|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908382|NCT03526276|Fluorides|fluorides|mesh-list
13908383|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
13908384|NCT03526276|Protective Agents|protective agents|mesh-ancestor
13908385|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908386|NCT03526224|Teriflunomide|teriflunomide|mesh-list
13908387|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13908388|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
13908389|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908390|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
13908391|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908392|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13908393|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908394|NCT03526224|Analgesics|analgesics|mesh-ancestor
13908395|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
13908396|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908397|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908398|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908399|NCT03526185|Nivolumab|nivolumab|mesh-list
13908400|NCT03526185|Ipilimumab|ipilimumab|mesh-list
13908401|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908402|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908403|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13908404|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908405|NCT03526159|Gentamicins|gentamicins|mesh-list
13908406|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13908407|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908408|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13908409|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908410|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908411|NCT03526107|Theobromine|theobromine|mesh-list
13908412|NCT03526107|Caffeine|caffeine|mesh-list
13908413|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13908414|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908415|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14473892|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473893|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473894|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473895|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14473896|NCT02370095|Treprostinil|treprostinil|mesh-list
14756585|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756586|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756587|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756588|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756589|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
14756590|NCT02909361|Fulvestrant|fulvestrant|mesh-list
14756591|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14756592|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756593|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14756594|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14756595|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
14756596|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756597|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756598|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14756599|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14756600|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756601|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
14756602|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
14756603|NCT02897050|Docetaxel|docetaxel|mesh-list
14756604|NCT02897050|Fluorouracil|fluorouracil|mesh-list
13908416|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473897|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14473898|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14473899|NCT02370238|Paclitaxel|paclitaxel|mesh-list
14473900|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13908417|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908418|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13908419|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14473901|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473902|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
14473903|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473904|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473905|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473906|NCT02370498|Paclitaxel|paclitaxel|mesh-list
14473907|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14473908|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473909|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
13908420|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
13908421|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908422|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13908423|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
13908424|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908425|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13908426|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
13908427|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
13908428|NCT03526042|Losartan|losartan|mesh-list
13908429|NCT03526042|Enalapril|enalapril|mesh-list
13908430|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
13908431|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13908432|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
13908433|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13908434|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13908435|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13908436|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908437|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
13908438|NCT03525925|Nivolumab|nivolumab|mesh-list
13908439|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908440|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908441|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13908442|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908443|NCT03525912|Ketamine|ketamine|mesh-list
13908444|NCT03525912|Analgesics|analgesics|mesh-list
13908445|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
13908446|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908447|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908448|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13908449|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13908450|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
13908451|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
13908452|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908453|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13908454|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13908455|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908456|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908457|NCT03525821|Ketamine|ketamine|mesh-list
13908458|NCT03525821|Analgesics|analgesics|mesh-ancestor
13908459|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
13908460|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908461|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908462|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13908463|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13908464|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
13908465|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
13908466|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908467|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13908468|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13908469|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908470|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908471|NCT03525795|Ipilimumab|ipilimumab|mesh-list
13908472|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
13908473|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908474|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473910|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
14473911|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
14473912|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473913|NCT02370615|Itraconazole|itraconazole|mesh-list
14473914|NCT02370615|Digoxin|digoxin|mesh-list
14473915|NCT02370615|Midazolam|midazolam|mesh-list
14473916|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
14473917|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14473918|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14473919|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14473920|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908475|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13908476|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908477|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908478|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
13908479|NCT03525730|Valproic Acid|valproic acid|mesh-list
13908480|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
13908481|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13908482|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13908483|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908484|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13908485|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908486|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908487|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
13908488|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
13908489|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908490|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908491|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
13908492|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13908493|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908494|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908495|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13908496|NCT03525652|Vaccines|vaccines|mesh-list
13908497|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
14473921|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14473922|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14473923|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908498|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959689|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959690|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13959691|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959692|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959693|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959694|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13959695|NCT03161041|Bevacizumab|bevacizumab|mesh-list
13959696|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
13959697|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959698|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473924|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14473925|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
14473926|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
14473927|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
14473928|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
13959699|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13959700|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13959701|NCT03161041|Growth Substances|growth substances|mesh-ancestor
13959702|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959703|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
14473929|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473930|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473931|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
14473932|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473933|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14473934|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14473935|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473936|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14473937|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
14473938|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473939|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14473940|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13959704|NCT03160911|Hemostatics|hemostatics|mesh-list
13959705|NCT03160911|Coagulants|coagulants|mesh-ancestor
13959706|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
14473941|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14473942|NCT02370615|Protective Agents|protective agents|mesh-ancestor
14479145|NCT02464176|Bupivacaine|bupivacaine|mesh-list
14473943|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
14473944|NCT02370693|Bortezomib|bortezomib|mesh-list
13908499|NCT03525574|Ivacaftor|ivacaftor|mesh-list
13908500|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13908501|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908502|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908503|NCT03525561|Acetazolamide|acetazolamide|mesh-list
13908504|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
13908505|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13908506|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908507|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908508|NCT03525561|Diuretics|diuretics|mesh-ancestor
14473945|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14473946|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14473947|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14473948|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
14473949|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14473950|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473951|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473952|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473953|NCT02370784|Atorvastatin|atorvastatin|mesh-list
14473954|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14473955|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13908509|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
13908510|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908511|NCT03525522|Betamethasone|betamethasone|mesh-list
13908512|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13908513|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908514|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
13908515|NCT03525522|Hormones|hormones|mesh-ancestor
13908516|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14473956|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
14473957|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473958|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14473959|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14473960|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473961|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
13908517|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908518|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13908519|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
13908520|NCT03525509|Morphine|morphine|mesh-list
13908521|NCT03525509|Methadone|methadone|mesh-list
13908522|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13908523|NCT03525509|Narcotics|narcotics|mesh-ancestor
13908524|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908525|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908526|NCT03525509|Analgesics|analgesics|mesh-ancestor
13908527|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
13908528|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933211|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14933212|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908529|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
13908530|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
13908531|NCT03525379|Resveratrol|resveratrol|mesh-list
14756605|NCT02897050|Capecitabine|capecitabine|mesh-list
14756606|NCT02897050|Epirubicin|epirubicin|mesh-list
14756607|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756608|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
14756609|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756610|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756611|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756612|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
14756613|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756614|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756615|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756616|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756617|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756618|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756619|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
14756620|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756621|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14933213|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
13908532|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
13908533|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933214|NCT01449552|Coagulants|coagulants|mesh-ancestor
14933215|NCT01449565|Naltrexone|naltrexone|mesh-list
14933216|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14933217|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14933218|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933219|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
14933220|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908534|NCT03525379|Protective Agents|protective agents|mesh-ancestor
13908535|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908536|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908537|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13908538|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
13908539|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13908540|NCT03525028|Metformin|metformin|mesh-list
13908541|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13908542|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908543|NCT03525002|Bromocriptine|bromocriptine|mesh-list
13908544|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13908545|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13908546|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
13908547|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13908548|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908549|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
13908550|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
14473962|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14473963|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473964|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14473965|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473966|NCT02371252|Alendronate|alendronate|mesh-list
14473967|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14473968|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473969|NCT02371616|Listerine|listerine|mesh-list
14473970|NCT02371616|Calcium|calcium|mesh-list
14473971|NCT02371616|Fluorides|fluorides|mesh-list
14473972|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
14473973|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
14473974|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14473975|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473976|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
14473977|NCT02371616|Protective Agents|protective agents|mesh-ancestor
14473978|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14473979|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14473980|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
14473981|NCT02371629|Bromides|bromides|mesh-list
14473982|NCT02371629|Albuterol|albuterol|mesh-list
14756622|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756623|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756624|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14473983|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
14473984|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14473985|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
14473986|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14473987|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14473988|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14473989|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
14473990|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
14473991|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14473992|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14473993|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14473994|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14473995|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
14473996|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14473997|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14473998|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14473999|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14474000|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14474001|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
14474002|NCT02371746|Travoprost|travoprost|mesh-list
14474003|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14474004|NCT02371759|Anesthetics|anesthetics|mesh-list
14474005|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756625|NCT02871297|Vortioxetine|vortioxetine|mesh-list
14756626|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
14756627|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14756628|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14474006|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474007|NCT02371850|Nicotine|nicotine|mesh-list
14474008|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14474009|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
14474010|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474011|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474012|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14474013|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14474014|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
14474015|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474016|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474017|NCT02371980|Vortioxetine|vortioxetine|mesh-list
14474018|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
14474019|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908551|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908552|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908553|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
13908554|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13908555|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908556|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908557|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908558|NCT03524950|Analgesics|analgesics|mesh-ancestor
13908559|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
13908560|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908561|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13908562|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14474020|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14474021|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14474022|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908563|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13908564|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
13908565|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908566|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908567|NCT03524937|Melatonin|melatonin|mesh-list
13908568|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
13908569|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908570|NCT03524937|Protective Agents|protective agents|mesh-ancestor
13908571|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908572|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908573|NCT03524872|Analgesics|analgesics|mesh-list
13908574|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908575|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
13908576|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908577|NCT03524846|Vitamins|vitamins|mesh-list
13908578|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
13908579|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
13908580|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908581|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
13908582|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908583|NCT03524846|Protective Agents|protective agents|mesh-ancestor
13908584|NCT03524833|Amoxicillin|amoxicillin|mesh-list
13908585|NCT03524833|Metronidazole|metronidazole|mesh-list
13908586|NCT03524833|Lansoprazole|lansoprazole|mesh-list
13908587|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
14474023|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474024|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14474025|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14474026|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474027|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474028|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474029|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
14474030|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14474031|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14474032|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14474033|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14474034|NCT02372006|Afatinib|afatinib|mesh-list
14474035|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908588|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13908589|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908590|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13908591|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14474036|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14474037|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908592|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14474038|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474039|NCT02372253|Verapamil|verapamil|mesh-list
14474040|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14474041|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14039867|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14039868|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14039869|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14039870|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14039871|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14039872|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14039873|NCT00981656|Fluorouracil|fluorouracil|mesh-list
14039874|NCT00981656|Mitomycins|mitomycins|mesh-list
14039875|NCT00981656|Mitomycin|mitomycin|mesh-list
14039876|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14039877|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
14039878|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039879|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14039880|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14039881|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
14039882|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039883|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14039884|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
14039885|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14039886|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474042|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474043|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474044|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14474045|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474046|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14474047|NCT02372383|Azithromycin|azithromycin|mesh-list
14474048|NCT02372383|Rifampin|rifampin|mesh-list
14474049|NCT02372383|Ethambutol|ethambutol|mesh-list
14474050|NCT02372383|Pancrelipase|pancrelipase|mesh-list
14474051|NCT02372383|Pancreatin|pancreatin|mesh-list
13908593|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13908594|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13908595|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908596|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474052|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14474053|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474054|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14474055|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
14474056|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
14474057|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14474058|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474059|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474060|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14474061|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14474062|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14474063|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14474064|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14474065|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14474066|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474067|NCT02372799|Fluoxetine|fluoxetine|mesh-list
14474068|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14474069|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14474070|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14474071|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474072|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474073|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474074|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
14756629|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14039924|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
14039925|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14039926|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
14039927|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14039928|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908597|NCT03524820|Cetuximab|cetuximab|mesh-list
13908598|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908599|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908600|NCT03524508|Fluorouracil|fluorouracil|mesh-list
13908601|NCT03524508|Irinotecan|irinotecan|mesh-list
13908602|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
14039929|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14039930|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
14039931|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14039932|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
14039933|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039934|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14039935|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14039936|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
14039937|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
14039938|NCT00848731|Protective Agents|protective agents|mesh-ancestor
14039939|NCT00838526|Rabeprazole|rabeprazole|mesh-list
14039940|NCT00838526|Ranitidine|ranitidine|mesh-list
14039941|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14039942|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14039943|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14039944|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14039945|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14039946|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039947|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14039948|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
14039949|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
14039950|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14039951|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474075|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474076|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14039954|NCT00716066|Cytarabine|cytarabine|mesh-list
14039955|NCT00716066|Prednisone|prednisone|mesh-list
14039956|NCT00716066|Cortisone|cortisone|mesh-list
14039957|NCT00716066|Etoposide|etoposide|mesh-list
14039958|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
14039959|NCT00716066|Melphalan|melphalan|mesh-list
14039960|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
14039961|NCT00716066|Carmustine|carmustine|mesh-list
14039962|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
14039963|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14039964|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
14039965|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14039966|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14039967|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
14039968|NCT00716066|Hormones|hormones|mesh-ancestor
14039969|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14039970|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14039971|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14039972|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14039973|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14039974|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14039975|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14039976|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14039977|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14039978|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14039979|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
14039980|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
14039981|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14039982|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14039983|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
14039984|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14039985|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
14039986|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14039987|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
14039988|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
14039989|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
14039990|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14039991|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14039992|NCT00627250|Amantadine|amantadine|mesh-list
14039993|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14039994|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14039995|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
14039996|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14039997|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
14039998|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14039999|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040000|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040001|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14040002|NCT00627250|Analgesics|analgesics|mesh-ancestor
14040003|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
14040004|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040005|NCT00454285|Amoxicillin|amoxicillin|mesh-list
13908603|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908604|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13908605|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908606|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908607|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
13908608|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908609|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13908610|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13908611|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908617|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
13908618|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
13908619|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908620|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
13908621|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908622|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908623|NCT03524274|Antibodies|antibodies|mesh-list
13908624|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13908625|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
13908626|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908627|NCT03524261|Antibodies|antibodies|mesh-list
13908628|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13908629|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
13908630|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908631|NCT03524079|Ajmaline|ajmaline|mesh-list
13908632|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13908633|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13908634|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13908635|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908636|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959707|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959708|NCT03161106|Lactulose|lactulose|mesh-list
13959709|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959710|NCT03160807|Levofloxacin|levofloxacin|mesh-list
13959711|NCT03160807|Ofloxacin|ofloxacin|mesh-list
13959712|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13959713|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959714|NCT03160807|Renal Agents|renal agents|mesh-ancestor
13959715|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959716|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13959717|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959718|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959719|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959720|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959721|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13959722|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13959723|NCT03160729|Dexamethasone|dexamethasone|mesh-list
13959724|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959725|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
13959726|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
13959727|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959728|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959729|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959730|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
13959731|NCT03160729|Hormones|hormones|mesh-ancestor
13959732|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959733|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13959734|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959735|NCT03160404|Zolpidem|zolpidem|mesh-list
13959736|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13959737|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13959738|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959739|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959740|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13959741|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
13959742|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
13959743|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959744|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959745|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
13959746|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14040006|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14040007|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040008|NCT00452023|Interferons|interferons|mesh-list
14756630|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756631|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756632|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14756633|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14756634|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14040009|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
14040010|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
14040011|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14040012|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040013|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
14040014|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040015|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
14040016|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908637|NCT03523975|Rituximab|rituximab|mesh-list
13908638|NCT03523975|Lenalidomide|lenalidomide|mesh-list
13908639|NCT03523975|Venetoclax|venetoclax|mesh-list
13908640|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908641|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908642|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
13908643|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908644|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908645|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13908646|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13908647|NCT03523975|Growth Substances|growth substances|mesh-ancestor
13908648|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
13908649|NCT03523832|Celecoxib|celecoxib|mesh-list
14040017|NCT00405613|Aspirin|aspirin|mesh-list
14040018|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14040019|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908650|NCT03523832|Pregabalin|pregabalin|mesh-list
13908651|NCT03523832|Analgesics|analgesics|mesh-ancestor
13908652|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
13908653|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908654|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908655|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
13908656|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13908657|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908658|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908659|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13908660|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13908661|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13908662|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756635|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756636|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756637|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
14756638|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14756639|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14756640|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14756641|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14756642|NCT02865551|Anesthetics|anesthetics|mesh-list
14756643|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756644|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756645|NCT02864953|Glyburide|glyburide|mesh-list
14756646|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14756647|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908663|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908664|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13908665|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908666|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908667|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908668|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13908669|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14040020|NCT00405613|Analgesics|analgesics|mesh-ancestor
14040021|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
14040022|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756648|NCT02821507|Sirolimus|sirolimus|mesh-list
14756649|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
14040023|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933221|NCT01449578|Pramipexole|pramipexole|mesh-list
13908670|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908671|NCT03523754|Isosorbide|isosorbide|mesh-list
14040024|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040025|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040026|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14040027|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14040028|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040029|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14040030|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14040031|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040032|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
14474077|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
14474078|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14474079|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14474080|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14474081|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474082|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14474083|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14474084|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14474085|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14474086|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474087|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14474088|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
14474089|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474090|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
14474091|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14474092|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14474093|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14040050|NCT00126672|Sirolimus|sirolimus|mesh-list
14040051|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14040052|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040053|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14040054|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040055|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
14040056|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040057|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
14040058|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474094|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908672|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13908673|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13908674|NCT03523754|Misoprostol|misoprostol|mesh-list
13908675|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13908676|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
13908677|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13908678|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908679|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13908680|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13908681|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
13908682|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13908683|NCT03523754|Diuretics|diuretics|mesh-ancestor
13908684|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
13908685|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
13908686|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13908687|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908688|NCT03523741|Clozapine|clozapine|mesh-list
13908689|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13908690|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
13908691|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908692|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908693|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908694|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13908695|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13908696|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908697|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908698|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
13908699|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
13908700|NCT03523650|Propranolol|propranolol|mesh-list
13908701|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13908702|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13908703|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
13908704|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908705|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474095|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474096|NCT02373137|Ofloxacin|ofloxacin|mesh-list
14474097|NCT02373137|Prednisolone|prednisolone|mesh-list
13908706|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474098|NCT02373137|Phenylephrine|phenylephrine|mesh-list
14474099|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
14474100|NCT02373137|Tropicamide|tropicamide|mesh-list
14474101|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474102|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
14474103|NCT02373137|Hormones|hormones|mesh-ancestor
14474104|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14474105|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474106|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14474107|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474108|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
14474109|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474110|NCT02373137|Protective Agents|protective agents|mesh-ancestor
14474111|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14474112|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
14474113|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
14474114|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14474115|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
14474116|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
14474117|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14474118|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14474119|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14474120|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
14474121|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474122|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474123|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14474124|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14474125|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
14474126|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14474127|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474128|NCT02373137|Renal Agents|renal agents|mesh-ancestor
14474129|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14474130|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14474131|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14474132|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474133|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14474134|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14474135|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
14474136|NCT02373202|Mizoribine|mizoribine|mesh-list
14474137|NCT02373202|Bucillamine|bucillamine|mesh-list
14474138|NCT02373202|Tacrolimus|tacrolimus|mesh-list
14474139|NCT02373202|Leflunomide|leflunomide|mesh-list
14474140|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14474141|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
14474142|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908707|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13908708|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13908709|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
14474143|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14474144|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474145|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474146|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474147|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14474148|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14474149|NCT02373202|Analgesics|analgesics|mesh-ancestor
13908710|NCT03523572|Nivolumab|nivolumab|mesh-list
13908711|NCT03523572|Trastuzumab|trastuzumab|mesh-list
13908712|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908713|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908714|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13908715|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908716|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
13908717|NCT03523455|Hematinics|hematinics|mesh-ancestor
13908718|NCT03523429|Blinatumomab|blinatumomab|mesh-list
13908719|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908720|NCT03523390|Avelumab|avelumab|mesh-list
13908721|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908722|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908723|NCT03523273|Liraglutide|liraglutide|mesh-list
13908724|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13908725|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908726|NCT03523273|Incretins|incretins|mesh-ancestor
13908727|NCT03523273|Hormones|hormones|mesh-ancestor
13908728|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756650|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908729|NCT03523221|Dexamethasone|dexamethasone|mesh-list
14474150|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
13908730|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13908731|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
13908732|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
13908733|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908734|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908735|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13908736|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
13908737|NCT03523221|Hormones|hormones|mesh-ancestor
13908738|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13908739|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13908740|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474151|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908741|NCT03522987|Citalopram|citalopram|mesh-list
13908742|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13908743|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13908744|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908745|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908746|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908747|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
13908748|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756651|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
14756652|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908749|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13908750|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
13908751|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14474152|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474153|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474154|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474155|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13908752|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
13908753|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13908754|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13908755|NCT03522961|Renal Agents|renal agents|mesh-ancestor
14474156|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14474157|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474158|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
14474159|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14474160|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14474161|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
14474162|NCT02373202|Protective Agents|protective agents|mesh-ancestor
14474163|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
13908756|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13908757|NCT03522935|Elafin|elafin|mesh-list
13908758|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
13908759|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908760|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908761|NCT03522922|Ascorbic Acid|ascorbic acid|mesh-list
13908762|NCT03522922|Vitamins|vitamins|mesh-ancestor
13908763|NCT03522922|Micronutrients|micronutrients|mesh-ancestor
13908764|NCT03522922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908765|NCT03522922|Antioxidants|antioxidants|mesh-ancestor
13908766|NCT03522922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908767|NCT03522922|Protective Agents|protective agents|mesh-ancestor
13908768|NCT03522831|Albuterol|albuterol|mesh-list
13908769|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13908770|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
14474164|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14474165|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474166|NCT02373813|Folic Acid|folic acid|mesh-list
14474167|NCT02373813|Etanercept|etanercept|mesh-list
14474168|NCT02373813|Methotrexate|methotrexate|mesh-list
14474169|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14474170|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
14474171|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14474172|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474173|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14474174|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
14474175|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474176|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474177|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474178|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474179|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14474180|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756653|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474181|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
13908771|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908772|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908773|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13908774|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
14474182|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474183|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14474184|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14474185|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14474186|NCT02373813|Analgesics|analgesics|mesh-ancestor
14474187|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
14474188|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474189|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474190|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474191|NCT02373813|Hematinics|hematinics|mesh-ancestor
14474192|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
14474193|NCT02373813|Vitamins|vitamins|mesh-ancestor
14474194|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
14474195|NCT02374060|Dexamethasone|dexamethasone|mesh-list
14474196|NCT02374060|Triamcinolone|triamcinolone|mesh-list
14474197|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14474198|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14474199|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14474200|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474201|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
14474202|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
14474203|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474204|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474205|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474206|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
14474207|NCT02374060|Hormones|hormones|mesh-ancestor
14474208|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14474209|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14474210|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474211|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14474212|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
14474213|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474214|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474215|NCT02374099|Azacitidine|azacitidine|mesh-list
14474216|NCT02374099|Fulvestrant|fulvestrant|mesh-list
13908775|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
13908776|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13908777|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13908778|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13908779|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13908780|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
13908781|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908782|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474217|NCT02374099|Cc-486|cc-486|mesh-list
14474218|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14474219|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
14474220|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474221|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474222|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474223|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14474224|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14474225|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14474226|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
14474227|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14474228|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474229|NCT02374164|Febuxostat|febuxostat|mesh-list
14474230|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
14474231|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474232|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
14474233|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14474234|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14474235|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474236|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
14474237|NCT02374398|Coagulants|coagulants|mesh-ancestor
14474238|NCT02374957|Cilostazol|cilostazol|mesh-list
14474239|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14474240|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
14474241|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474242|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474243|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14474244|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
13908783|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
13908784|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13908785|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908786|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908787|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908788|NCT03522688|Analgesics|analgesics|mesh-ancestor
13908789|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
13908790|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908791|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13908792|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14474245|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14169863|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169864|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
14169865|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169866|NCT04837261|Propranolol|propranolol|mesh-list
14169867|NCT04837261|Amiodarone|amiodarone|mesh-list
14169868|NCT04837261|Flecainide|flecainide|mesh-list
14169869|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14169870|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14169871|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
14169872|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169873|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169874|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169875|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14169876|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14169877|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
14169878|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14169879|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169880|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14169881|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14169882|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14169883|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169884|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14169885|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14169886|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14169887|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14474246|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14474247|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474248|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14474249|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
14474250|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14474251|NCT02374957|Protective Agents|protective agents|mesh-ancestor
14474252|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14474253|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14474254|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474255|NCT02375724|Bromides|bromides|mesh-list
14169888|NCT04836962|Dexamethasone|dexamethasone|mesh-list
14169889|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169890|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
14169891|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
14169892|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169893|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169894|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169895|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
14169896|NCT04836962|Hormones|hormones|mesh-ancestor
14169897|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169898|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14169899|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169900|NCT04836806|Cetirizine|cetirizine|mesh-list
14169901|NCT04836806|Famotidine|famotidine|mesh-list
14169902|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14169903|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169904|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14474256|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
14474257|NCT02375971|Ranibizumab|ranibizumab|mesh-list
14756654|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756655|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
14756656|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756657|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756658|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756659|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14756660|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756661|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13908793|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13908794|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
13908795|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908796|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908797|NCT03522649|Leucovorin|leucovorin|mesh-list
13908798|NCT03522649|Fluorouracil|fluorouracil|mesh-list
13908799|NCT03522649|Irinotecan|irinotecan|mesh-list
13908800|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
13908801|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908802|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13908803|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908804|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908805|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
13908806|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908807|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13908808|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13908809|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040192|NCT03176498|Aspirin|aspirin|mesh-list
14040193|NCT03176498|Atorvastatin|atorvastatin|mesh-list
14040194|NCT03176498|Calcium|calcium|mesh-list
14040195|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14040196|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040197|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14040198|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14040199|NCT03176498|Analgesics|analgesics|mesh-ancestor
14040200|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
14040201|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040202|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040203|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040204|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14040205|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14040206|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040207|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14040208|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14040209|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040210|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
14040211|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14040212|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14040213|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
14040214|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14040215|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14040216|NCT03172780|Diclofenac|diclofenac|mesh-list
14040217|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14040218|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14040219|NCT03172780|Analgesics|analgesics|mesh-ancestor
14040220|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
14040221|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040222|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040223|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040224|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908810|NCT03522649|Antidotes|antidotes|mesh-ancestor
13908811|NCT03522649|Protective Agents|protective agents|mesh-ancestor
13908812|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
13908813|NCT03522649|Vitamins|vitamins|mesh-ancestor
13908814|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
14040225|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14040226|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040227|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040228|NCT03169972|Factor VIII|factor viii|mesh-list
14040229|NCT03169972|BAX 855|bax 855|mesh-list
14040230|NCT03169972|Coagulants|coagulants|mesh-ancestor
14040231|NCT03158064|Durvalumab|durvalumab|mesh-list
14040232|NCT03158064|Tremelimumab|tremelimumab|mesh-list
14040233|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040234|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040235|NCT03151304|Azacitidine|azacitidine|mesh-list
14040236|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040237|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
14040238|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040239|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040240|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040241|NCT03148418|Atezolizumab|atezolizumab|mesh-list
14040242|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040243|NCT03134196|Valacyclovir|valacyclovir|mesh-list
13908815|NCT03522532|Zinc|zinc|mesh-list
14474258|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13908816|NCT03522532|Trace Elements|trace elements|mesh-ancestor
14040244|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
14040245|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040246|NCT03128034|Cyclosporine|cyclosporine|mesh-list
14040247|NCT03128034|Sirolimus|sirolimus|mesh-list
14040248|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
14040249|NCT03128034|Fludarabine|fludarabine|mesh-list
14040250|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
14040251|NCT03128034|Cyclosporins|cyclosporins|mesh-list
14040252|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040253|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040254|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
14040255|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040256|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040257|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
14040258|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040259|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040260|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
14040261|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040262|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14040263|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040264|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14040265|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14040266|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14040267|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
14040268|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14040269|NCT03113409|Naltrexone|naltrexone|mesh-list
14040270|NCT03113409|Buprenorphine|buprenorphine|mesh-list
14040271|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14040272|NCT03113409|Narcotics|narcotics|mesh-ancestor
14040273|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14040274|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040275|NCT03113409|Analgesics|analgesics|mesh-ancestor
14040276|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
14040277|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040278|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14040279|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14040280|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
14040281|NCT03096275|Hormones|hormones|mesh-ancestor
14040282|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040283|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908817|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
13908818|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908819|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
13908820|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
13908821|NCT03522428|Vitamins|vitamins|mesh-ancestor
13908822|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
13908823|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908824|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
13908825|NCT03522428|Hematinics|hematinics|mesh-ancestor
13908826|NCT03522415|Methotrexate|methotrexate|mesh-list
13908827|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13908828|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
13908829|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13908830|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908831|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040284|NCT03094052|Trastuzumab|trastuzumab|mesh-list
14040285|NCT03094052|Atropine|atropine|mesh-list
14040286|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
14040287|NCT03094052|Loperamide|loperamide|mesh-list
14040288|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
14040289|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
14040290|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040291|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040292|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14040293|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14040294|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14040295|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
14040296|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040297|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040298|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14040299|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14040300|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
14040301|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
14040302|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13908832|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
14040303|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14040304|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
14040305|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14040306|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040307|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14040308|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14040309|NCT03094052|Narcotics|narcotics|mesh-ancestor
14040310|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14040311|NCT03094052|Analgesics|analgesics|mesh-ancestor
14040312|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
14040313|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
13908833|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908834|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908835|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
13908836|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474259|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14474260|NCT02375971|Growth Substances|growth substances|mesh-ancestor
14474261|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474262|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
14474263|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474264|NCT02376010|Warfarin|warfarin|mesh-list
13908837|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13908838|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908839|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
14040314|NCT03089905|Remifentanil|remifentanil|mesh-list
14040315|NCT03089905|Sevoflurane|sevoflurane|mesh-list
14040316|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14040317|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14040318|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908840|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13908841|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13908842|NCT03522402|Sevoflurane|sevoflurane|mesh-list
14040319|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14040320|NCT03089905|Analgesics|analgesics|mesh-ancestor
14040321|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
14040322|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040323|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14040324|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14040325|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14040326|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
14040327|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14040328|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040329|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14474265|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
14474266|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
14474267|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14474268|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
14474269|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14474270|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
14474271|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474272|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474273|NCT02376166|Metformin|metformin|mesh-list
14474274|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14474275|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933222|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
14933223|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933224|NCT01449578|Protective Agents|protective agents|mesh-ancestor
14933225|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933226|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14933227|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14040330|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14040331|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
14040332|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
14040333|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14040334|NCT03089905|Narcotics|narcotics|mesh-ancestor
14040335|NCT03084471|Durvalumab|durvalumab|mesh-list
14040336|NCT03084471|Tremelimumab|tremelimumab|mesh-list
14040337|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14040338|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040339|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040340|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
14040341|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040342|NCT03074513|Bevacizumab|bevacizumab|mesh-list
14040343|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14040344|NCT03074513|Atezolizumab|atezolizumab|mesh-list
14933228|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
14933229|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
14933230|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933231|NCT01449617|Aspirin|aspirin|mesh-list
14933232|NCT01449617|Clopidogrel|clopidogrel|mesh-list
14933233|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933234|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908843|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13908844|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14040345|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
14040346|NCT03074513|Antibodies|antibodies|mesh-list
14040347|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
14040348|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14040349|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
14040350|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040351|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14040352|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14040353|NCT03074513|Growth Substances|growth substances|mesh-ancestor
14040354|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040355|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
14040356|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
14040357|NCT03039036|Misoprostol|misoprostol|mesh-list
14040358|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14040359|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
14040360|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13908845|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
13908846|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
13908847|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908848|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959747|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13959748|NCT03160651|Prednisolone|prednisolone|mesh-list
14040361|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040362|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14040363|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14040364|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
14040365|NCT03026517|Phenformin|phenformin|mesh-list
14040366|NCT03026517|Trametinib|trametinib|mesh-list
14040367|NCT03026517|Dabrafenib|dabrafenib|mesh-list
14040368|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040369|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040370|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040371|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040372|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14040373|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959749|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
14040374|NCT03007979|Letrozole|letrozole|mesh-list
14040375|NCT03007979|Fulvestrant|fulvestrant|mesh-list
14040376|NCT03007979|Palbociclib|palbociclib|mesh-list
14040377|NCT03007979|Goserelin|goserelin|mesh-list
14933235|NCT01449617|Analgesics|analgesics|mesh-ancestor
13908849|NCT03522298|GDC-0084|gdc-0084|mesh-list
13908850|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908851|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908852|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
13908853|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13908854|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
13908855|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13908856|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
13908857|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908858|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908859|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
13908860|NCT03522207|Trazodone|trazodone|mesh-list
13908861|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14474276|NCT02376257|Cycloserine|cycloserine|mesh-list
14474277|NCT02376257|Modafinil|modafinil|mesh-list
14474278|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14474279|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474280|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14474281|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14474282|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13908862|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13908863|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908864|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040378|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040379|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14040380|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14040381|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040382|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040383|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14040384|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
14040385|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040386|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040387|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14040388|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14040389|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040390|NCT02997605|Prednisone|prednisone|mesh-list
14040391|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
14040392|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
14040393|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040394|NCT02997605|Hormones|hormones|mesh-ancestor
14040395|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040396|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040397|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14040398|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040399|NCT02988297|RNS60|rns60|mesh-list
14040400|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14040401|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14040402|NCT02988297|Analgesics|analgesics|mesh-ancestor
14040403|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
14040404|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040405|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040406|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040407|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040408|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14040411|NCT02967692|Trametinib|trametinib|mesh-list
14040412|NCT02967692|Dabrafenib|dabrafenib|mesh-list
14474283|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474284|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14474285|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474286|NCT02376257|Renal Agents|renal agents|mesh-ancestor
14474287|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14474288|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
14474289|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14474290|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
14474291|NCT02376283|Clopidogrel|clopidogrel|mesh-list
14474292|NCT02376283|Ticagrelor|ticagrelor|mesh-list
14474293|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14474294|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14474295|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14474296|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14474297|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13908865|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14040413|NCT02967692|Spartalizumab|spartalizumab|mesh-list
14040414|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040415|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040416|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040417|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040418|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14040419|NCT02962063|Paclitaxel|paclitaxel|mesh-list
14040420|NCT02962063|Carboplatin|carboplatin|mesh-list
14040421|NCT02962063|Durvalumab|durvalumab|mesh-list
14040422|NCT02962063|Tremelimumab|tremelimumab|mesh-list
14040423|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14040424|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040425|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040426|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040427|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
14040428|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040429|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040430|NCT02955940|Capecitabine|capecitabine|mesh-list
14040431|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040432|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
14040433|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040434|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040435|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
14040436|NCT02953340|Docetaxel|docetaxel|mesh-list
14040437|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040438|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
14040439|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040440|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040441|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14040442|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
14040443|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040444|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040445|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14040446|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040447|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040448|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
14474298|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
14474299|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474300|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474301|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474302|NCT02376790|Etanercept|etanercept|mesh-list
14474303|NCT02376790|Methotrexate|methotrexate|mesh-list
14474304|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14474305|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
14474306|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14474307|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474308|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14474309|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
14474310|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474311|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474312|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474313|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474314|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14474315|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13908866|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13908867|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13908868|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908869|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908870|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908871|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
13908872|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14474316|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
14474317|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474318|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14474319|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14474320|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908873|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
13908874|NCT03522194|Propofol|propofol|mesh-list
13908875|NCT03522194|Sevoflurane|sevoflurane|mesh-list
13908876|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13908877|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908878|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908879|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13908880|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
13908881|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
13908882|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13908883|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13908884|NCT03522181|Insulin|insulin|mesh-list
13908885|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13908886|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13908887|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474321|NCT02376790|Analgesics|analgesics|mesh-ancestor
14474322|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
14474323|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474324|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474325|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474326|NCT02377752|Doxorubicin|doxorubicin|mesh-list
14474327|NCT02377752|Olaratumab|olaratumab|mesh-list
14474328|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14474329|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474330|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14474331|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13908888|NCT03522168|Risperidone|risperidone|mesh-list
13908889|NCT03522168|Aripiprazole|aripiprazole|mesh-list
13908890|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13908891|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
13908892|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908893|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908894|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908895|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13908896|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13908897|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908898|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908899|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13908900|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
13908901|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
13908902|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
13908903|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13908904|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13908905|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13908906|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14474332|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474333|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756662|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
14756663|NCT02640664|Ranibizumab|ranibizumab|mesh-list
14040461|NCT02891603|Sirolimus|sirolimus|mesh-list
14040462|NCT02891603|Tacrolimus|tacrolimus|mesh-list
14040463|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040464|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
14040465|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756664|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14040466|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14040467|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040468|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040469|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14040470|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474334|NCT02378480|Linezolid|linezolid|mesh-list
14474335|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14474336|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474337|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14474338|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474339|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040471|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14040472|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040473|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
14474340|NCT02378506|Etanercept|etanercept|mesh-list
14474341|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14474342|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14474343|NCT02378506|Analgesics|analgesics|mesh-ancestor
13908907|NCT03522077|Hemostatics|hemostatics|mesh-list
14474344|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
14756665|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14040474|NCT02874430|Metformin|metformin|mesh-list
14040475|NCT02874430|Doxycycline|doxycycline|mesh-list
14040476|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14040477|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040478|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14040479|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040480|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
14040481|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14040482|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14040483|NCT02870920|Durvalumab|durvalumab|mesh-list
14040484|NCT02870920|Tremelimumab|tremelimumab|mesh-list
14040485|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040486|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040487|NCT02855944|Gemcitabine|gemcitabine|mesh-list
14040488|NCT02855944|Paclitaxel|paclitaxel|mesh-list
14040489|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14040490|NCT02855944|Cisplatin|cisplatin|mesh-list
14040491|NCT02855944|Carboplatin|carboplatin|mesh-list
14040492|NCT02855944|Rucaparib|rucaparib|mesh-list
14040493|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14040494|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040495|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040496|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040497|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
14040498|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040499|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040500|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
13908908|NCT03522077|Coagulants|coagulants|mesh-ancestor
13908909|NCT03522051|Calcium|calcium|mesh-list
13908910|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13908911|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908912|NCT03521960|Buspirone|buspirone|mesh-list
13908913|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13908914|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13908915|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908916|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908917|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13908918|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13908919|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
13908920|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908921|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908922|NCT03521895|Aflibercept|aflibercept|mesh-list
13908923|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14040501|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
14040502|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040503|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040504|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040505|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
14040506|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040507|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14040508|NCT02851407|Defibrotide|defibrotide|mesh-list
14040509|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14040510|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14040511|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040512|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14040513|NCT02851290|Anesthetics|anesthetics|mesh-list
14040514|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14040515|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040516|NCT02817633|Carboplatin|carboplatin|mesh-list
14040517|NCT02817633|Docetaxel|docetaxel|mesh-list
14040518|NCT02817633|Nivolumab|nivolumab|mesh-list
14474345|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474346|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933236|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
13908924|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13908925|NCT03521895|Growth Substances|growth substances|mesh-ancestor
13908926|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908927|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
13908928|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908929|NCT03521726|Amoxicillin|amoxicillin|mesh-list
13908930|NCT03521726|Rabeprazole|rabeprazole|mesh-list
13908931|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14040519|NCT02817633|Pemetrexed|pemetrexed|mesh-list
13908932|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040520|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040521|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040522|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040523|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
13908933|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13908934|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13908935|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13908936|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040524|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040525|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040526|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14040527|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040528|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14040529|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14040530|NCT02803203|Bevacizumab|bevacizumab|mesh-list
14040531|NCT02803203|Osimertinib|osimertinib|mesh-list
13908937|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908938|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
13908939|NCT03521713|Hematinics|hematinics|mesh-ancestor
13908940|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13908941|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13908942|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13908943|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
14040532|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040533|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040534|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14040535|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14040536|NCT02803203|Growth Substances|growth substances|mesh-ancestor
14040537|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040538|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
14040539|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040540|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040541|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040542|NCT02780024|Metformin|metformin|mesh-list
14040543|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14040544|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040545|NCT02737436|Oxytocin|oxytocin|mesh-list
14040546|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
14040547|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14040548|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040549|NCT02727998|Midazolam|midazolam|mesh-list
13908944|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908945|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13908946|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13908947|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908948|NCT03521492|Vitamin D|vitamin d|mesh-list
13908949|NCT03521492|Calcium|calcium|mesh-list
13908950|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
13908951|NCT03521492|Hormones|hormones|mesh-list
14040550|NCT02727998|Ketamine|ketamine|mesh-list
14040551|NCT02727998|Analgesics|analgesics|mesh-ancestor
14040552|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
14040553|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040554|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040555|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14040556|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14040557|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
14040558|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
14040559|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908952|NCT03521492|Vitamins|vitamins|mesh-ancestor
13908953|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
13908954|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908955|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13908956|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13908957|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13908958|NCT03521414|Sevoflurane|sevoflurane|mesh-list
13908959|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13908960|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13908961|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
13908962|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
13908963|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908964|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908965|NCT03521245|Trastuzumab|trastuzumab|mesh-list
13908966|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13908967|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13908968|NCT03521219|Apatinib|apatinib|mesh-list
13908969|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040560|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13908970|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040561|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14040562|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14040563|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040564|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14040565|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14040566|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14040567|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14040568|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14040569|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
14040570|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
14040571|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
14040572|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040573|NCT02715609|Copper|copper|mesh-list
14040574|NCT02715609|Temozolomide|temozolomide|mesh-list
14040575|NCT02715609|Disulfiram|disulfiram|mesh-list
14040576|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14040577|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
14040578|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040579|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040580|NCT02715609|Trace Elements|trace elements|mesh-ancestor
14040581|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
14040582|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040583|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14040584|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14040585|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040586|NCT02713997|Etanercept|etanercept|mesh-list
14040587|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
13908971|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13908972|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908973|NCT03521167|Acetaminophen|acetaminophen|mesh-list
14040588|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
14933237|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933238|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908974|NCT03521167|Lidocaine|lidocaine|mesh-list
13908975|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
13908976|NCT03521167|Ketamine|ketamine|mesh-list
13908977|NCT03521167|Gabapentin|gabapentin|mesh-list
13908978|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
13908979|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
13908980|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13908981|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13908982|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
13908983|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13908984|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13908985|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13908986|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13908987|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13908988|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13908989|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13908990|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13908991|NCT03521167|Analgesics|analgesics|mesh-ancestor
13908992|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13908993|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13908994|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13908995|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
13908996|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13908997|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13908998|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13908999|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
14040589|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933239|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933240|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933241|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14933242|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14933243|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933244|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14933245|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14933246|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933247|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
14933248|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14933249|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14933250|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14933251|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
14933252|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14040590|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14040591|NCT02713997|Analgesics|analgesics|mesh-ancestor
14040592|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
14040593|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040594|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040595|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040596|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040597|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14040598|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040599|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
14040600|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14040601|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14040602|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
14040603|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040604|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040605|NCT02684058|Carboplatin|carboplatin|mesh-list
14040606|NCT02684058|Vincristine|vincristine|mesh-list
14040607|NCT02684058|Trametinib|trametinib|mesh-list
14040608|NCT02684058|Dabrafenib|dabrafenib|mesh-list
14040609|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040610|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14474347|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756666|NCT02640664|Growth Substances|growth substances|mesh-ancestor
14756667|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474348|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474349|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474350|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14474351|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
14474352|NCT02378714|Varenicline|varenicline|mesh-list
14474353|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14474354|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14474355|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
13909000|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13909001|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13909002|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
13909003|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13909004|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13909005|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13909006|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
14474356|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474357|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474358|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474359|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
14474360|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14474361|NCT02378935|Velpatasvir|velpatasvir|mesh-list
14474362|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
14474363|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474364|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
13909007|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
13909008|NCT03521063|Budesonide|budesonide|mesh-list
13909009|NCT03521063|Poractant alfa|poractant alfa|mesh-list
13909010|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13909011|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13909012|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
14040611|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
14479146|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14040612|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040613|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
14040614|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040615|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040616|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040617|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
14040618|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14040619|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040620|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
14040621|NCT02643420|Docetaxel|docetaxel|mesh-list
14040622|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040623|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
14040624|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040625|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040626|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14040627|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
14040628|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909013|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909014|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909015|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13909016|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
13909017|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
13909018|NCT03521063|Hormones|hormones|mesh-ancestor
13909019|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909020|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
13909021|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
13909022|NCT03521024|Ether|ether|mesh-list
13909023|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
13909024|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13909025|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909026|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909027|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
14040629|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040630|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14040631|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040632|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040633|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14040634|NCT02643303|Durvalumab|durvalumab|mesh-list
14040635|NCT02643303|Tremelimumab|tremelimumab|mesh-list
13909028|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13909029|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909030|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909031|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14040636|NCT02643303|Poly ICLC|poly iclc|mesh-list
14040637|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040638|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040639|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
14040640|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
13909032|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
14040641|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040642|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
14040643|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14040644|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14040645|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040646|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
14040647|NCT02606045|Coagulants|coagulants|mesh-ancestor
14040648|NCT02601586|Oxycodone|oxycodone|mesh-list
14040649|NCT02601586|Levodopa|levodopa|mesh-list
14040650|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14040651|NCT02601586|Narcotics|narcotics|mesh-ancestor
14040652|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14040653|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040654|NCT02601586|Analgesics|analgesics|mesh-ancestor
14040655|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
14040656|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040657|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13909033|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
13909034|NCT03520985|Dexamethasone|dexamethasone|mesh-list
13909035|NCT03520985|Pomalidomide|pomalidomide|mesh-list
13909036|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040658|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14040659|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
14040660|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909037|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
13909038|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
13909039|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040661|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040662|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
14040663|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
14040664|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040665|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040666|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040667|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040668|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040669|NCT02549209|Paclitaxel|paclitaxel|mesh-list
14040670|NCT02549209|Carboplatin|carboplatin|mesh-list
14040671|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
14040672|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13909040|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909041|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13909042|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
13909043|NCT03520985|Hormones|hormones|mesh-ancestor
13909044|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909045|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13909046|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909047|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
13909048|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13909049|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14040673|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040674|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040675|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040676|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14040677|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040678|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040679|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
14040680|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14040681|NCT02549170|Antibodies|antibodies|mesh-list
14040682|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
14040683|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
14040684|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14040685|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
14040686|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040687|NCT02509546|Adenosine|adenosine|mesh-list
14040688|NCT02509546|Analgesics|analgesics|mesh-ancestor
14040689|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
14040690|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040691|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040692|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14040693|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
14040694|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14040695|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
14040696|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
14040697|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14040698|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040699|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
14933253|NCT01449799|Fluticasone|fluticasone|mesh-list
14933254|NCT01449799|Xhance|xhance|mesh-list
14933255|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933256|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14933257|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
14933258|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933259|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933260|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14933261|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14933262|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14933263|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14933264|NCT01449825|Bevacizumab|bevacizumab|mesh-list
13909050|NCT03520985|Growth Substances|growth substances|mesh-ancestor
14040700|NCT02496676|Analgesics|analgesics|mesh-ancestor
14040701|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
14040702|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040703|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040704|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
14040705|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14040706|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14040707|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
14040708|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14040709|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14040710|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909051|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
14169905|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
14933265|NCT01449825|Sunitinib|sunitinib|mesh-list
14933266|NCT01449825|Sorafenib|sorafenib|mesh-list
14040711|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14040712|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
14040713|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13909052|NCT03520946|Ramucirumab|ramucirumab|mesh-list
13909053|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909054|NCT03520595|Diclofenac|diclofenac|mesh-list
13909055|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13909056|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13909057|NCT03520595|Analgesics|analgesics|mesh-ancestor
13909058|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
13909059|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040714|NCT02494141|Curcumin|curcumin|mesh-list
14040715|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14040716|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14040717|NCT02494141|Analgesics|analgesics|mesh-ancestor
14040718|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
14040719|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909060|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909061|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13909062|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909063|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13909064|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909065|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040720|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040721|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040722|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040723|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040724|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040725|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040726|NCT02478099|Atezolizumab|atezolizumab|mesh-list
14040727|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040728|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
14040729|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14040730|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040731|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040732|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040733|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040734|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040735|NCT02453984|Atezolizumab|atezolizumab|mesh-list
14040736|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040737|NCT02412618|Misoprostol|misoprostol|mesh-list
14040738|NCT02412618|Mifepristone|mifepristone|mesh-list
14040739|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14040740|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
14040741|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14040742|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040743|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14040744|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14040745|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
14040746|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14040747|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14040748|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14040749|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14040750|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
14040751|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14040752|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14040753|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
14040754|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040755|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
13909066|NCT03520569|Octreotide|octreotide|mesh-list
13909067|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14040756|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14040757|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14474365|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14474366|NCT02378961|Velpatasvir|velpatasvir|mesh-list
14474367|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
14474368|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474369|NCT02379091|Leucovorin|leucovorin|mesh-list
14474370|NCT02379091|Folic Acid|folic acid|mesh-list
14474371|NCT02379091|Methotrexate|methotrexate|mesh-list
13909068|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14040758|NCT02402660|Vitamin A|vitamin a|mesh-list
14040759|NCT02402660|Retinol acetate|retinol acetate|mesh-list
14474372|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
13909069|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040760|NCT02402660|Vitamins|vitamins|mesh-ancestor
14040761|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
14040762|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040763|NCT02402660|Protective Agents|protective agents|mesh-ancestor
14040764|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14040765|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040766|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14040767|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
14040768|NCT02351180|Beclomethasone|beclomethasone|mesh-list
14040769|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474373|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14474374|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
14474375|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14474376|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474377|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13909070|NCT03520543|Clonidine|clonidine|mesh-list
13909071|NCT03520543|Yohimbine|yohimbine|mesh-list
13909072|NCT03520543|Analgesics|analgesics|mesh-ancestor
13909073|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
13909074|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909075|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040770|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
14040771|NCT02351180|Hormones|hormones|mesh-ancestor
14040772|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040773|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040774|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14040775|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
14040776|NCT02327403|Abatacept|abatacept|mesh-list
14040777|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14040778|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040779|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040780|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040781|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
14040782|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040783|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040784|NCT02313389|Rituximab|rituximab|mesh-list
14040785|NCT02313389|Methotrexate|methotrexate|mesh-list
14040786|NCT02313389|Temozolomide|temozolomide|mesh-list
14040787|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14474378|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
14933267|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933268|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909076|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13909077|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
13909078|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
13909079|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13909080|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13909081|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13909082|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
13909083|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909084|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909085|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
13909086|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13909087|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13909088|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13909089|NCT03520543|Urological Agents|urological agents|mesh-ancestor
13959750|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13959751|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
13959752|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959753|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
13959754|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
13959755|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959756|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909090|NCT03520478|Bicalutamide|bicalutamide|mesh-list
13909091|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
13909092|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
13909093|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909094|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909095|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909096|NCT03520439|Mifepristone|mifepristone|mesh-list
13909097|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13909098|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
13909099|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13909100|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909101|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13909102|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13909103|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13909104|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
13909105|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13909106|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13909107|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
13909108|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909109|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
13909110|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14040788|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040789|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
14040790|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040791|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040792|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14040793|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
14040794|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14040795|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040796|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
14040797|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909111|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13909112|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14040798|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
14040799|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040800|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14040801|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040802|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14040803|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14040804|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
14040805|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
14040806|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040807|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040808|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
14040809|NCT02306161|Ifosfamide|ifosfamide|mesh-list
14040810|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
14040811|NCT02306161|Doxorubicin|doxorubicin|mesh-list
14040812|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14040813|NCT02306161|Etoposide|etoposide|mesh-list
14040814|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
14040815|NCT02306161|Vincristine|vincristine|mesh-list
14040816|NCT02306161|Daunorubicin|daunorubicin|mesh-list
14040817|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
14040818|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14040819|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040820|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
14756668|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
14756669|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756670|NCT02607215|Vinorelbine|vinorelbine|mesh-list
14756671|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756672|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756673|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040821|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909113|NCT03520257|Apatinib|apatinib|mesh-list
13909114|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909115|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13909116|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909117|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909118|NCT03520062|Liraglutide|liraglutide|mesh-list
13909119|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14040822|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040823|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14040824|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
14040825|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040826|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040827|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14040828|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14040829|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14040830|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14040831|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040832|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14040833|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
14040834|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
14040835|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
14040836|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
14040837|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
14169906|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
14169907|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169908|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169909|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169910|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14169911|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14169912|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14169913|NCT04836728|Paclitaxel|paclitaxel|mesh-list
14169914|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14169915|NCT04836728|Carboplatin|carboplatin|mesh-list
14169916|NCT04836728|Pemetrexed|pemetrexed|mesh-list
14169917|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14169918|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169919|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169920|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169921|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
14169922|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
14169923|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169924|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169925|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14169926|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14169927|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
14169928|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169929|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
14169930|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
14169931|NCT04836637|Calcium|calcium|mesh-list
14169932|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14169933|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169934|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14169935|NCT04836637|Antacids|antacids|mesh-ancestor
14169936|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169937|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169938|NCT04836819|Lidocaine|lidocaine|mesh-list
14169939|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
14169940|NCT04836819|Ketamine|ketamine|mesh-list
14169941|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
14169942|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
14169943|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169944|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169945|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
14169946|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169947|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14169948|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14169949|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14169950|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169951|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169952|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13909120|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909121|NCT03520062|Incretins|incretins|mesh-ancestor
13909122|NCT03520062|Hormones|hormones|mesh-ancestor
13909123|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909124|NCT03520049|Oseltamivir|oseltamivir|mesh-list
13909125|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
13909126|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909127|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909128|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909129|NCT03519906|Metoprolol|metoprolol|mesh-list
13909130|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13909131|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13909132|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
13909133|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
13909134|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909135|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909136|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13909137|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13909138|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13909139|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
13909140|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909141|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909142|NCT03519893|Losartan|losartan|mesh-list
13909143|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13909144|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13909145|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13909146|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13909147|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909148|NCT03519776|Progesterone|progesterone|mesh-list
13909149|NCT03519776|Progestins|progestins|mesh-ancestor
13909150|NCT03519776|Hormones|hormones|mesh-ancestor
13909151|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909152|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909153|NCT03519750|Melatonin|melatonin|mesh-list
13909154|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
13909155|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909156|NCT03519750|Protective Agents|protective agents|mesh-ancestor
13909157|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909158|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909159|NCT03519724|Neostigmine|neostigmine|mesh-list
13909160|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14474379|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474380|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474381|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474382|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474383|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14474384|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040844|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14040845|NCT02296125|Gefitinib|gefitinib|mesh-list
14040846|NCT02296125|Osimertinib|osimertinib|mesh-list
14040847|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040848|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040849|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040850|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040851|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
14040852|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14040853|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
14040854|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040855|NCT02273375|Durvalumab|durvalumab|mesh-list
14040856|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040857|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040858|NCT02255799|Donepezil|donepezil|mesh-list
14040859|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14040860|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040861|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040862|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
14040863|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14040864|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040865|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
14040866|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
14040867|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14040868|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040869|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
14040870|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14040871|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040872|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14040873|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14040874|NCT02145143|Vemurafenib|vemurafenib|mesh-list
14040875|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040876|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040877|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040878|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040879|NCT02131493|Gemcitabine|gemcitabine|mesh-list
14040880|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040881|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
14040882|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040883|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040884|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
14040885|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040886|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040887|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040888|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
14040889|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040890|NCT02115295|Cytarabine|cytarabine|mesh-list
14040891|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14040892|NCT02115295|Venetoclax|venetoclax|mesh-list
14040893|NCT02115295|Idarubicin|idarubicin|mesh-list
14040894|NCT02115295|Cladribine|cladribine|mesh-list
14040895|NCT02115295|Midostaurin|midostaurin|mesh-list
14040896|NCT02115295|Staurosporine|staurosporine|mesh-list
14040897|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14040898|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
14040899|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040900|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040901|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
14040902|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040903|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14040904|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
14040905|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040906|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14040907|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13909161|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909162|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909163|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
13909164|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909165|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909166|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13909167|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
13909168|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909169|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
14040908|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14040909|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040910|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040911|NCT02108964|Nazartinib|nazartinib|mesh-list
14040912|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040913|NCT02096159|Trimethoprim|trimethoprim|mesh-list
14040914|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14040915|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
14040916|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14756674|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756675|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756676|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909170|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13909171|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040917|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14040918|NCT02096159|Renal Agents|renal agents|mesh-ancestor
14756677|NCT02589353|Acarbose|acarbose|mesh-list
13909172|NCT03519646|Eliglustat|eliglustat|mesh-list
13909173|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909174|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909175|NCT03519633|Neostigmine|neostigmine|mesh-list
13909176|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13909177|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909178|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909179|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
13909180|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909181|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909182|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13909183|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
13909184|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909185|NCT03519568|Vaccines|vaccines|mesh-list
13909186|NCT03519568|Immunologic Factors|immunologic factors|mesh-ancestor
13909187|NCT03519568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909188|NCT03519542|Sunitinib|sunitinib|mesh-list
13909189|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909190|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13909191|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13909192|NCT03519542|Growth Substances|growth substances|mesh-ancestor
13909193|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909194|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
13909195|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13909196|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909197|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909198|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
13909199|NCT03519412|Temozolomide|temozolomide|mesh-list
13909200|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13909201|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909202|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909203|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
13909204|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909205|NCT03519386|Travoprost|travoprost|mesh-list
13909206|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13909207|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13909208|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14756678|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14756679|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756680|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756681|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14756682|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040919|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
14040920|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14040921|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14040922|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14040923|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040924|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040925|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14040926|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14040927|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14040928|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14040929|NCT02079740|Trametinib|trametinib|mesh-list
14040930|NCT02079740|Navitoclax|navitoclax|mesh-list
14040931|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040932|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040933|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040934|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040935|NCT01989598|Trametinib|trametinib|mesh-list
14040936|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040937|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14040938|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040939|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040940|NCT01939275|Copper|copper|mesh-list
14040941|NCT01939275|Trastuzumab|trastuzumab|mesh-list
14040942|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14040943|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040944|NCT01939275|Trace Elements|trace elements|mesh-ancestor
14040945|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
14040946|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040947|NCT01831076|Tamoxifen|tamoxifen|mesh-list
14040948|NCT01831076|Exemestane|exemestane|mesh-list
14756683|NCT02588248|Peppermint oil|peppermint oil|mesh-list
14756684|NCT02588248|Menthol|menthol|mesh-list
14040949|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14040950|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
14040951|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040952|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040953|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14040954|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040955|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14040956|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14040957|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14040958|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14040959|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14040960|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14040961|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14040962|NCT01625611|Naltrexone|naltrexone|mesh-list
14040963|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14040964|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14040965|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040966|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
14040967|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040968|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
14040969|NCT01595581|Testosterone|testosterone|mesh-list
14040970|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
14040971|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
14040972|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14040973|NCT01595581|Androgens|androgens|mesh-ancestor
14040974|NCT01595581|Hormones|hormones|mesh-ancestor
14040975|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040976|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040977|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14040978|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14040979|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
14040980|NCT01542021|Androgens|androgens|mesh-list
14040981|NCT01542021|Hormones|hormones|mesh-ancestor
14040982|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040983|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040984|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14040985|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
14040986|NCT01455389|Promethazine|promethazine|mesh-list
14040987|NCT01455389|Dexamethasone|dexamethasone|mesh-list
14040988|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14040989|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14040990|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
13909216|NCT03519152|Diclofenac|diclofenac|mesh-list
13909217|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13909218|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13909219|NCT03519152|Analgesics|analgesics|mesh-ancestor
13909220|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
13909221|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909222|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909223|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13909224|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909225|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13909226|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909227|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909228|NCT03519061|Budesonide|budesonide|mesh-list
13909229|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13909230|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13909231|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
13909232|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909233|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909234|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13909235|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
13909236|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
13909237|NCT03519061|Hormones|hormones|mesh-ancestor
13909238|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040991|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
14040992|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14040993|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14040994|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14040995|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
14040996|NCT01455389|Hormones|hormones|mesh-ancestor
14040997|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14040998|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13909239|NCT03519022|Cocaine|cocaine|mesh-list
13909240|NCT03519022|Methylphenidate|methylphenidate|mesh-list
14040999|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041000|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14041001|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041002|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041003|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14041004|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14041005|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041006|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
14041007|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
14041008|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
14041009|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14041010|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
14041011|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
14041012|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041013|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14041014|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
14041015|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
14041016|NCT01453140|Sirolimus|sirolimus|mesh-list
14041017|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
14041018|NCT01453140|Interleukin-2|interleukin-2|mesh-list
14041019|NCT01453140|Azacitidine|azacitidine|mesh-list
14041020|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041021|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
14041022|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041023|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041024|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041025|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
14041026|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041027|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041028|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14041029|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14041030|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041031|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14041032|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
14041033|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041034|NCT01453140|Analgesics|analgesics|mesh-ancestor
14041035|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
14041036|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041037|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14041038|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
14041039|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909241|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13909242|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909243|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14041040|NCT01408641|Topiramate|topiramate|mesh-list
14041041|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
14041042|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14041043|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041044|NCT01246310|Inositol|inositol|mesh-list
14041045|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
14041046|NCT01246310|Vitamins|vitamins|mesh-ancestor
14041047|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
14041048|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041049|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
14041050|NCT01203722|Sirolimus|sirolimus|mesh-list
14041051|NCT01203722|Fludarabine|fludarabine|mesh-list
13909244|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13909245|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13909246|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909247|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
13909248|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909249|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
13909250|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
13909251|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909252|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
13909253|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909254|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13909255|NCT03518801|Cannabidiol|cannabidiol|mesh-list
13909256|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
13959757|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959758|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
14041052|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
14041053|NCT01203722|Tacrolimus|tacrolimus|mesh-list
14041054|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041055|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041056|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909257|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13909258|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13909259|NCT03518528|Estradiol|estradiol|mesh-list
13909260|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13909261|NCT03518528|Estrogens|estrogens|mesh-ancestor
13909262|NCT03518528|Hormones|hormones|mesh-ancestor
13909263|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909264|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909265|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13909266|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
13909267|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13909268|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13909269|NCT03518502|Sorafenib|sorafenib|mesh-list
13909270|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909271|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13909272|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909273|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909274|NCT03518489|Lappaconitine|lappaconitine|mesh-list
13909275|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13909276|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13909277|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13909278|NCT03518489|Analgesics|analgesics|mesh-ancestor
13909279|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
13909280|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909281|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909282|NCT03518320|Gemcitabine|gemcitabine|mesh-list
13909283|NCT03518320|Nivolumab|nivolumab|mesh-list
13909284|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13909285|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
13909286|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909287|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909288|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
13909289|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909290|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909291|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909292|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
13909293|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909294|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041057|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
14041058|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041059|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14041060|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041061|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041062|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041063|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
14041064|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14041065|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14041066|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14041067|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
14041068|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14041069|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041070|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
14041071|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
14041072|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14041073|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041074|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14041075|NCT01029717|Minocycline|minocycline|mesh-list
14041076|NCT01029717|Rifampin|rifampin|mesh-list
14041077|NCT01029717|Heparin|heparin|mesh-list
14041078|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909295|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13909296|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
13909297|NCT03518112|Leucovorin|leucovorin|mesh-list
13909298|NCT03518112|Folic Acid|folic acid|mesh-list
13909299|NCT03518112|Cytarabine|cytarabine|mesh-list
13909300|NCT03518112|Dexamethasone|dexamethasone|mesh-list
13909301|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
13909302|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
13909303|NCT03518112|Rituximab|rituximab|mesh-list
14041079|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14041080|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
14474385|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
14756685|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
13909304|NCT03518112|Methotrexate|methotrexate|mesh-list
13909305|NCT03518112|Vincristine|vincristine|mesh-list
13909306|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
13909307|NCT03518112|Blinatumomab|blinatumomab|mesh-list
14041081|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
14041082|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14041083|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14041084|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041085|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
14041086|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14041087|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041088|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14041089|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14041090|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14041091|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14041092|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14041093|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14041094|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14041095|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
14041096|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041097|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
14041098|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041099|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041100|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041101|NCT00700076|Ketamine|ketamine|mesh-list
14041102|NCT00700076|Analgesics|analgesics|mesh-ancestor
13909308|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13909309|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
13909310|NCT03518112|Antibodies|antibodies|mesh-list
13909311|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
13909312|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13909313|NCT03518112|Lenograstim|lenograstim|mesh-list
13909314|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13909315|NCT03518112|BB 1101|bb 1101|mesh-list
14041103|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
14041104|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041105|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041106|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14041107|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14041108|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
14041109|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
14041110|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041111|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14041112|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14041113|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041114|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909316|NCT03518112|Calcium|calcium|mesh-list
13909317|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
13909318|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909319|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
13909320|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909321|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909322|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909323|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
13909324|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909325|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909326|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13909327|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13909328|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
14474386|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474387|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13909329|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
13909330|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909331|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13909332|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
13909333|NCT03518112|Hormones|hormones|mesh-ancestor
14041115|NCT00679783|Olaparib|olaparib|mesh-list
14041116|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14041117|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041118|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041119|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041120|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
14041121|NCT00653068|Leucovorin|leucovorin|mesh-list
14041122|NCT00653068|Folic Acid|folic acid|mesh-list
14041123|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
13909334|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909335|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13909336|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
14474388|NCT02379091|Antidotes|antidotes|mesh-ancestor
14756686|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14933269|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13909337|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909338|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13909339|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13909340|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13909341|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
13909342|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13909343|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13909344|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
13909345|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
13909346|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13909347|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13909348|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
13909349|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041124|NCT00653068|Thiotepa|thiotepa|mesh-list
14041125|NCT00653068|Cisplatin|cisplatin|mesh-list
14041126|NCT00653068|Carboplatin|carboplatin|mesh-list
14041127|NCT00653068|Methotrexate|methotrexate|mesh-list
14041128|NCT00653068|Etoposide|etoposide|mesh-list
14041129|NCT00653068|Vincristine|vincristine|mesh-list
14041130|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
14041131|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
14041132|NCT00653068|Lenograstim|lenograstim|mesh-list
14041133|NCT00653068|Calcium|calcium|mesh-list
14041134|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
14041135|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041136|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
14041137|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041138|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041139|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041140|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
14041141|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041142|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041143|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14041144|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14041145|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14041146|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14041147|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
14041148|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14041149|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14041150|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
14041151|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
14041152|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041153|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14041154|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14041155|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041156|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14041157|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14041158|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14041159|NCT00653068|Antidotes|antidotes|mesh-ancestor
14041160|NCT00653068|Protective Agents|protective agents|mesh-ancestor
14041161|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
14041162|NCT00653068|Vitamins|vitamins|mesh-ancestor
14041163|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
14041164|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041165|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041166|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
14041167|NCT00653068|Hematinics|hematinics|mesh-ancestor
14041168|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
14041169|NCT00601900|Tamoxifen|tamoxifen|mesh-list
14041170|NCT00601900|Bevacizumab|bevacizumab|mesh-list
14041171|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14041172|NCT00601900|Letrozole|letrozole|mesh-list
14474389|NCT02379091|Protective Agents|protective agents|mesh-ancestor
14041173|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
14041174|NCT00601900|Antibodies|antibodies|mesh-list
14474390|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
14474391|NCT02379091|Vitamins|vitamins|mesh-ancestor
14474392|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
14474393|NCT02379091|Hematinics|hematinics|mesh-ancestor
14474394|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14474395|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
14474396|NCT02379195|Fludarabine|fludarabine|mesh-list
14474397|NCT02379195|Interleukin-2|interleukin-2|mesh-list
14474398|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14474399|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
14479147|NCT02464176|BB 1101|bb 1101|mesh-list
14041175|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
14041176|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14041177|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
14041178|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041179|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13909350|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13909351|NCT03518112|Antidotes|antidotes|mesh-ancestor
13909352|NCT03518112|Protective Agents|protective agents|mesh-ancestor
13909353|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
13909354|NCT03518112|Vitamins|vitamins|mesh-ancestor
13909355|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
13909356|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041180|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14041181|NCT00601900|Growth Substances|growth substances|mesh-ancestor
14041182|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041183|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
14041184|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
14041185|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041186|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14041187|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14041188|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041189|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14041190|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
14041191|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041192|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041193|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14041194|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14041195|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14041196|NCT00482157|Vitamin D|vitamin d|mesh-list
14041197|NCT00482157|Calcitriol|calcitriol|mesh-list
14041198|NCT00482157|Vitamins|vitamins|mesh-ancestor
14041199|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
14041200|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041201|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14041202|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14041203|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14041204|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14041205|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041206|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14041207|NCT00193479|Prednisone|prednisone|mesh-list
14041208|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
14041209|NCT00193479|Rituximab|rituximab|mesh-list
14041210|NCT00193479|Vincristine|vincristine|mesh-list
14041211|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
14041212|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041213|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
14041214|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041215|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041216|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041217|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
14041218|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041219|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041220|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14041221|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041222|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041223|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
14041224|NCT00193479|Hormones|hormones|mesh-ancestor
14041225|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041226|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041227|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041228|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041229|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041230|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
13909357|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
13909358|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
13909359|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
13909360|NCT03518112|Hematinics|hematinics|mesh-ancestor
13909361|NCT03518021|Naloxone|naloxone|mesh-list
13909362|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13909363|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909364|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
13909365|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909366|NCT03517995|Sulforaphane|sulforaphane|mesh-list
13909367|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13909368|NCT03517995|Protective Agents|protective agents|mesh-ancestor
13909369|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909370|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909371|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
13909372|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13909373|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909374|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13909375|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
13909376|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13909377|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909378|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909379|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909380|NCT03517943|Loratadine|loratadine|mesh-list
13909381|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
13909382|NCT03517943|Ephedrine|ephedrine|mesh-list
13909383|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
13909384|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
13909385|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13909386|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13909387|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13909388|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
13909389|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
13909390|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909391|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909392|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909393|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13909394|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
13909395|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909396|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13909397|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
14041231|NCT00193479|Analgesics|analgesics|mesh-ancestor
14041232|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
14474400|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041233|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041234|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14041235|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14041236|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041237|NCT00193427|Gemcitabine|gemcitabine|mesh-list
14041238|NCT00193427|Carboplatin|carboplatin|mesh-list
14474401|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474402|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041239|NCT00193427|Docetaxel|docetaxel|mesh-list
13909398|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
13909399|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13909400|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13909401|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
14041240|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041241|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14041242|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
14041243|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041244|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
14041245|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041246|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041247|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041248|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
14041249|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041250|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041251|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041252|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14041253|NCT00193414|Gemcitabine|gemcitabine|mesh-list
14041254|NCT00193414|Pemetrexed|pemetrexed|mesh-list
14041255|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14041256|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
14041257|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041258|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041259|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
14041260|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041261|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041262|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041263|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
14041264|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909402|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
13909403|NCT03517930|Loratadine|loratadine|mesh-list
13909404|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
13909405|NCT03517930|Ephedrine|ephedrine|mesh-list
13909406|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
13909407|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
13909408|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14041265|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14041266|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14041267|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
14041268|NCT00085735|Lomustine|lomustine|mesh-list
14041269|NCT00085735|Cisplatin|cisplatin|mesh-list
14041270|NCT00085735|Vincristine|vincristine|mesh-list
14041271|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909409|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14041272|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
14041273|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041274|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041275|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041276|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
14041277|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041278|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041279|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14041280|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041281|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041282|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041283|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
14041284|NCT00003042|Tamoxifen|tamoxifen|mesh-list
14041285|NCT00003042|Paclitaxel|paclitaxel|mesh-list
14041286|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
14041287|NCT00003042|Doxorubicin|doxorubicin|mesh-list
14041288|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14041289|NCT00003042|Melphalan|melphalan|mesh-list
14041290|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041291|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041292|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041293|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041294|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14041295|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041296|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041297|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
14041298|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041299|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041300|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909410|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14041301|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
14041302|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13909411|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
14041303|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14041304|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14041305|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14041306|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474403|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
13909412|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
13909413|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909414|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909415|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909416|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13909417|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
13909418|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909419|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13909420|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
13909421|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
13909422|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13909423|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13909424|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
13909425|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
13909426|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14756687|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
14756688|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
14756689|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756690|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909427|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13909428|NCT03517683|Methamphetamine|methamphetamine|mesh-list
13909429|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13909430|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909431|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
13909432|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
13909433|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909434|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
13909435|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909436|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909437|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
13909438|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13909439|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13909440|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13909441|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13909442|NCT03517670|Milrinone|milrinone|mesh-list
13909443|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13909444|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13909445|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
13909446|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13909447|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13909448|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909449|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909450|NCT03517670|Protective Agents|protective agents|mesh-ancestor
13909451|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474404|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474405|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474406|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14474407|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14474408|NCT02379195|Analgesics|analgesics|mesh-ancestor
14474409|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
14474410|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474411|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
14474412|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756691|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13909452|NCT03517631|Busulfan|busulfan|mesh-list
13909453|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
13909454|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909455|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909456|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
13909457|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909458|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909459|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909460|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13909461|NCT03517618|Leucovorin|leucovorin|mesh-list
13909462|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909463|NCT03517618|Antidotes|antidotes|mesh-ancestor
14474413|NCT02379221|Lidocaine|lidocaine|mesh-list
14474414|NCT02379221|Epinephrine|epinephrine|mesh-list
14756692|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
14756693|NCT02584309|Doxorubicin|doxorubicin|mesh-list
14756694|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14756695|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
14756696|NCT02584309|Razoxane|razoxane|mesh-list
14756697|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756698|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756699|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756700|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756701|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756702|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756703|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14756704|NCT02584309|Protective Agents|protective agents|mesh-ancestor
14756705|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756706|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756707|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756708|NCT02521493|Cytarabine|cytarabine|mesh-list
14756709|NCT02521493|Etoposide|etoposide|mesh-list
14756710|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
14756711|NCT02521493|Daunorubicin|daunorubicin|mesh-list
14756712|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
14756713|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
14756714|NCT02521493|Asparaginase|asparaginase|mesh-list
14756715|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
14756716|NCT02521493|Thioguanine|thioguanine|mesh-list
14756717|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
14041307|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14041308|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
14041309|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041310|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041311|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14041312|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14041313|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14474415|NCT02379221|Benzocaine|benzocaine|mesh-list
14474416|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
14474417|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
14474418|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474419|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474420|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
14474421|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474422|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14474423|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14756718|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756719|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756720|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756721|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13909464|NCT03517618|Protective Agents|protective agents|mesh-ancestor
13909465|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
13909466|NCT03517618|Vitamins|vitamins|mesh-ancestor
13909467|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
13909468|NCT03517462|Ivermectin|ivermectin|mesh-list
13909469|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13909470|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909471|NCT03517423|Brivaracetam|brivaracetam|mesh-list
13909472|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
13909473|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
13909474|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13909475|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13909476|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13909477|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13909478|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909479|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
13909480|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756722|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909481|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041314|NCT00002874|Bicalutamide|bicalutamide|mesh-list
14041315|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
14041316|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
14041317|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041318|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041319|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041320|NCT02706158|Vitamin D|vitamin d|mesh-list
14041321|NCT02706158|Calcium|calcium|mesh-list
14041322|NCT02706158|Vitamins|vitamins|mesh-ancestor
14041323|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
14041324|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041325|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14041326|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14041327|NCT02706119|Insulin|insulin|mesh-list
14041328|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14041329|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
14041330|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14041331|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041332|NCT02705859|Trastuzumab|trastuzumab|mesh-list
14041333|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041334|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041335|NCT02705950|Baclofen|baclofen|mesh-list
14041336|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14041337|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041338|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14041339|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041340|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14041341|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
14041342|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
14041343|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041344|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041345|NCT02705872|Sufentanil|sufentanil|mesh-list
14041346|NCT02705872|Dsuvia|dsuvia|mesh-list
14041347|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
14041348|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14041349|NCT02705872|Narcotics|narcotics|mesh-ancestor
14041350|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041351|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041352|NCT02705872|Analgesics|analgesics|mesh-ancestor
14041353|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
14041354|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041355|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14041356|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14041357|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
14041358|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
14041359|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
14041360|NCT02706054|Meloxicam|meloxicam|mesh-list
14041361|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14041362|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041363|NCT02706054|Analgesics|analgesics|mesh-ancestor
14041364|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
14041365|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041366|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041367|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041368|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041369|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14041370|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14041371|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041372|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041373|NCT02706015|Dipyrone|dipyrone|mesh-list
14041374|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
14041375|NCT02706015|Caffeine|caffeine|mesh-list
14041376|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14041377|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041378|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14041379|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041380|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041381|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14041382|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14041383|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
14041384|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041385|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14041386|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041387|NCT02706015|Analgesics|analgesics|mesh-ancestor
14041388|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
14041389|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041390|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041391|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041392|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
13909482|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13909483|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909484|NCT03517176|Gemcitabine|gemcitabine|mesh-list
13909485|NCT03517176|Paclitaxel|paclitaxel|mesh-list
13909486|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13909487|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909488|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
13909489|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
13909490|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
13909491|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909492|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13909493|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
13909494|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
13909495|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909496|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909497|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909498|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
13909499|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909500|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
14041393|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14041394|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
14041395|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
14041396|NCT02705976|Warfarin|warfarin|mesh-list
14041397|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
14041398|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
14041399|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041400|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041401|NCT02705989|Branebrutinib|branebrutinib|mesh-list
14041402|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14041403|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041404|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041405|NCT02706067|Orlistat|orlistat|mesh-list
14041406|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041407|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041408|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14041409|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14041410|NCT02705768|Carbamazepine|carbamazepine|mesh-list
14041411|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
14041412|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
14041413|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
14041414|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14041415|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041416|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041417|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14041418|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041419|NCT02705768|Analgesics|analgesics|mesh-ancestor
14041420|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
14041421|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041422|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14041423|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14041424|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909501|NCT03517137|Dacarbazine|dacarbazine|mesh-list
14041425|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14041426|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14041427|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14041428|NCT02705729|Methamphetamine|methamphetamine|mesh-list
14041429|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14041430|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041431|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
14041432|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
14041433|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041434|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
14041435|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041436|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041437|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14041438|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14041439|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14041440|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14041441|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14169953|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14169954|NCT04836819|Analgesics|analgesics|mesh-ancestor
14169955|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14169956|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14169957|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14169958|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
14169959|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169960|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14169961|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14169962|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
14169963|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14169964|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14169965|NCT04836780|Dexamethasone|dexamethasone|mesh-list
14169966|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14169967|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
14169968|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
14169969|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169970|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909502|NCT03517137|Etoposide|etoposide|mesh-list
13909503|NCT03517137|Doxorubicin|doxorubicin|mesh-list
13909504|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13909505|NCT03517137|Vinblastine|vinblastine|mesh-list
13909506|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13909507|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909508|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
13909509|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909510|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909511|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909512|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
13909513|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909514|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169971|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169972|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
14169973|NCT04836780|Hormones|hormones|mesh-ancestor
14169974|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169975|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14169976|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169977|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
14169978|NCT04836507|Fludarabine|fludarabine|mesh-list
14169979|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14169980|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
14169981|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169982|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909515|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13909516|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13909517|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13909518|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13909519|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909520|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13909521|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
13909522|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
13909523|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
13909524|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13909525|NCT03517033|Nebivolol|nebivolol|mesh-list
13909526|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13909527|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
13909528|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14041442|NCT02705534|Ribavirin|ribavirin|mesh-list
14041443|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
14041444|NCT02705534|Ledipasvir|ledipasvir|mesh-list
14041445|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
14041446|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041447|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
14041448|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041449|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14041450|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14041451|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14041452|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
14041453|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041454|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14041455|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14041456|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041457|NCT02705573|Mannitol|mannitol|mesh-list
14041458|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14041459|NCT02705573|Diuretics|diuretics|mesh-ancestor
14041460|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
14041461|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041462|NCT02705508|Gemcitabine|gemcitabine|mesh-list
14041463|NCT02705508|Etoposide|etoposide|mesh-list
14041464|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
14041465|NCT02705508|Pegaspargase|pegaspargase|mesh-list
14041466|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14041467|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
14041468|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041469|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041470|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
14041471|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041472|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041473|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041474|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
14041475|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041476|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041477|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14041478|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14474424|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14474425|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474426|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474427|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14474428|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14474429|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
14474430|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474431|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14474432|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14474433|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
14474434|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14474435|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
14474436|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
14474437|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
14474438|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14474439|NCT02379247|Paclitaxel|paclitaxel|mesh-list
14474440|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13909529|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13909530|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13909531|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
13909532|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909533|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909534|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909535|NCT03517020|Nebivolol|nebivolol|mesh-list
13909536|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13909537|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
13909538|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13909539|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13909540|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13909541|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
13909542|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909543|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909544|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959759|NCT03160651|Hormones|hormones|mesh-ancestor
13959760|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959761|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14041479|NCT02705482|Durvalumab|durvalumab|mesh-list
13959762|NCT03160651|Protective Agents|protective agents|mesh-ancestor
13909545|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
13909546|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13909547|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474441|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474442|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
14474443|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041480|NCT02705482|Tremelimumab|tremelimumab|mesh-list
14041481|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13909548|NCT03516968|Vitamins|vitamins|mesh-ancestor
14474444|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
14474445|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479148|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479149|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
14479150|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
14479151|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909549|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
14041482|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041483|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
14041484|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041485|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041486|NCT02705664|Amorolfine|amorolfine|mesh-list
14041487|NCT02705664|Bifonazole|bifonazole|mesh-list
14041488|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
14041489|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041490|NCT02705378|Naloxegol|naloxegol|mesh-list
14041491|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14041492|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041493|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
14041494|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041495|NCT02705638|Rituximab|rituximab|mesh-list
14041496|NCT02705638|Lenalidomide|lenalidomide|mesh-list
14041497|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041498|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041499|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
14041500|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041501|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041502|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14041503|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14041504|NCT02705638|Growth Substances|growth substances|mesh-ancestor
14041505|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
14041506|NCT02705651|Somatostatin|somatostatin|mesh-list
14041507|NCT02705651|Hormones|hormones|mesh-ancestor
14041508|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041509|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041510|NCT02705287|Vitamin D|vitamin d|mesh-list
14041511|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
14041512|NCT02705287|Vitamins|vitamins|mesh-list
14041513|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
14041514|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041515|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14041516|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14041517|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14041518|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14041519|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041520|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14041521|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
14041522|NCT02705053|Insulin|insulin|mesh-list
14041523|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14041524|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041525|NCT02705274|Bevacizumab|bevacizumab|mesh-list
14041526|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041527|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909550|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13909551|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13909552|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13909553|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13909554|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
13909555|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909556|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13909557|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13909558|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909559|NCT03516903|Folic Acid|folic acid|mesh-list
13909560|NCT03516903|Methotrexate|methotrexate|mesh-list
13909561|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14041528|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14041529|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14041530|NCT02705274|Growth Substances|growth substances|mesh-ancestor
14041531|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041532|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
14041533|NCT02705196|Gemcitabine|gemcitabine|mesh-list
14041534|NCT02705196|Paclitaxel|paclitaxel|mesh-list
14041535|NCT02705196|Atezolizumab|atezolizumab|mesh-list
14041536|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041537|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041538|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041539|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041540|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
14041541|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909562|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
13909563|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13909564|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909565|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13909566|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
14041542|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14474446|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
14474447|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14474448|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
14474449|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474450|NCT02379637|Expectorants|expectorants|mesh-ancestor
14474451|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
14474452|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14474453|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
14474454|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909567|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909568|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909569|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
13909570|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041543|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
14041544|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
14041545|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041546|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756723|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756724|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756725|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
14756726|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
14756727|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756728|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756729|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
14756730|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756731|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756732|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14756733|NCT02521493|Analgesics|analgesics|mesh-ancestor
13909571|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13909572|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909573|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
13909574|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909575|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13909576|NCT03516903|Hematinics|hematinics|mesh-ancestor
13909577|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
13909578|NCT03516903|Vitamins|vitamins|mesh-ancestor
13909579|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
13909580|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
13909581|NCT03516812|Olaparib|olaparib|mesh-list
13909582|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14041547|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041548|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
14474455|NCT02379637|Protective Agents|protective agents|mesh-ancestor
14474456|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474457|NCT02379637|Antidotes|antidotes|mesh-ancestor
14474458|NCT02379858|Alvimopan|alvimopan|mesh-list
14474459|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474460|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14474461|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14474462|NCT02380287|Antibodies|antibodies|mesh-list
14474463|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14474464|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
14474465|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474466|NCT02380742|Lidocaine|lidocaine|mesh-list
13909583|NCT03516812|Testosterone|testosterone|mesh-list
14474467|NCT02380742|Prilocaine|prilocaine|mesh-list
14474468|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14474469|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
14041549|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041550|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14041551|NCT02705014|Hormones|hormones|mesh-list
14041552|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041553|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041554|NCT02704962|Olanzapine|olanzapine|mesh-list
14041555|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
14041556|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
14041557|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041558|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041559|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14041560|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14041561|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14041562|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041563|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14041564|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14041565|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14041566|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14041567|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041568|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041569|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
14041570|NCT02704715|Anesthetics|anesthetics|mesh-list
13909584|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
13909585|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
13909586|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13909587|NCT03516812|Androgens|androgens|mesh-ancestor
13909588|NCT03516812|Hormones|hormones|mesh-ancestor
13909589|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909590|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474470|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
14474471|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474472|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474473|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
14474474|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474475|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14474476|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14474477|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14474478|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474479|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041571|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041572|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041573|NCT02704624|Vitamin D|vitamin d|mesh-list
14041574|NCT02704624|Vitamins|vitamins|mesh-ancestor
14041575|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
14041576|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041577|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14041578|NCT02704754|Suvorexant|suvorexant|mesh-list
14041579|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14041580|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14041581|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041582|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041583|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14041584|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041585|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041586|NCT02704923|Atropine|atropine|mesh-list
14041587|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14041588|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14041589|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14041590|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14041591|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14041592|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
14041593|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041594|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041595|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14041596|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
14474480|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14474481|NCT02382016|Macitentan|macitentan|mesh-list
14474482|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13909591|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041597|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
14041598|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
14041599|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14041600|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14474483|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14474484|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474485|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14474486|NCT02382276|Nalmefene|nalmefene|mesh-list
14474487|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13909592|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909593|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
13909594|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909595|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756734|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
14756735|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756736|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
14756737|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
14756738|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756739|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756740|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756741|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
14756742|NCT02512926|Etoposide|etoposide|mesh-list
14756743|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14474488|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474489|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
14474490|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474491|NCT02382640|Febuxostat|febuxostat|mesh-list
14474492|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
14474493|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474494|NCT02382848|Prazosin|prazosin|mesh-list
14474495|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14474496|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14474497|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14474498|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14474499|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
14474500|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474501|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474502|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474503|NCT02383043|Cocaine|cocaine|mesh-list
14474504|NCT02383043|Amphetamine|amphetamine|mesh-list
14756744|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
13909596|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
13909597|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13909598|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909599|NCT03516747|Hormones|hormones|mesh-list
13909600|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
13909601|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909602|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909603|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13909604|NCT03516669|Amoxicillin|amoxicillin|mesh-list
13909605|NCT03516669|Clarithromycin|clarithromycin|mesh-list
13909606|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13909607|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909608|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13909609|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909610|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909611|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13909612|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13909613|NCT03516656|Heparin|heparin|mesh-list
13909614|NCT03516656|Calcium heparin|calcium heparin|mesh-list
13909615|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
13909616|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13909617|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13909618|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909619|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
13909620|NCT03516630|Trazodone|trazodone|mesh-list
14041601|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
14041602|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474505|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
14041603|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041604|NCT02704598|Warfarin|warfarin|mesh-list
14041605|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
14041606|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
14041607|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14041608|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
14041609|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14474506|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14756745|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756746|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041610|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
14041611|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041612|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041613|NCT02704767|Apatinib|apatinib|mesh-list
14041614|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14041615|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041616|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14041617|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041618|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041619|NCT02704780|Misoprostol|misoprostol|mesh-list
14041620|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14041621|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
14041622|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14041623|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041624|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14041625|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14041626|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
14041627|NCT02704546|Methylphenidate|methylphenidate|mesh-list
14041628|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14041629|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041630|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13909621|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13909622|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909623|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13909624|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13909625|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909626|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909627|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909628|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909629|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13909630|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13909631|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909632|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13909633|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13909634|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13909635|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13909636|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909637|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
13909638|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13909639|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
13909640|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
13909641|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
13909642|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13909643|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909644|NCT03516604|Citalopram|citalopram|mesh-list
13909645|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13909646|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14041631|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14474507|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474508|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
14041632|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14041633|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041634|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
14041635|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041636|NCT02704481|Misoprostol|misoprostol|mesh-list
14041637|NCT02704481|Mifepristone|mifepristone|mesh-list
14041638|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14041639|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
14474509|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
14474510|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474511|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
14041640|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14041641|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041642|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14041643|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14041644|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
14041645|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14041646|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14041647|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14041648|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14041649|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
14041650|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14041651|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14041652|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
14041653|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041654|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
14041655|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14041656|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14041657|NCT02704494|Losartan|losartan|mesh-list
14041658|NCT02704494|Resveratrol|resveratrol|mesh-list
14041659|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14041660|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14041661|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13909647|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13909648|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909649|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909650|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
14041662|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14041663|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041664|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
14041665|NCT02704494|Protective Agents|protective agents|mesh-ancestor
14041666|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041667|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041668|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14041669|NCT02704520|Leucovorin|leucovorin|mesh-list
14041670|NCT02704520|Folic Acid|folic acid|mesh-list
14041671|NCT02704520|Fluorouracil|fluorouracil|mesh-list
14041672|NCT02704520|Capecitabine|capecitabine|mesh-list
14041673|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
13909651|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909652|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13909653|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
13909654|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13909655|NCT03516526|Natalizumab|natalizumab|mesh-list
13909656|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
13909657|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909658|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13909659|NCT03516500|Hematinics|hematinics|mesh-ancestor
13909660|NCT03516214|Trametinib|trametinib|mesh-list
13909661|NCT03516214|Nazartinib|nazartinib|mesh-list
13909662|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909663|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13909664|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909665|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909666|NCT03516188|Antacids|antacids|mesh-list
14041674|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
13909667|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756747|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756748|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
14756749|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756750|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756751|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756752|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756753|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756754|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756755|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756756|NCT02512497|Vidarabine|vidarabine|mesh-list
14756757|NCT02512497|Fludarabine|fludarabine|mesh-list
14756758|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
14756759|NCT02512497|Busulfan|busulfan|mesh-list
13909668|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13909669|NCT03515837|Carboplatin|carboplatin|mesh-list
14041675|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909670|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
13909671|NCT03515837|Pemetrexed|pemetrexed|mesh-list
14756760|NCT02512497|Romidepsin|romidepsin|mesh-list
14756761|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
13909672|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14474512|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474513|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474514|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14474515|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14474516|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14474517|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474518|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14474519|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
14474520|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
14474521|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474522|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
14474523|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14474524|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
14474525|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14474526|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14474527|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
14474528|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474529|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14474530|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14474531|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474532|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474533|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
14474534|NCT02383589|Rituximab|rituximab|mesh-list
13909673|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909674|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13909675|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909676|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909677|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13909678|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14041676|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
14041677|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041678|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14041679|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041680|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041681|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
14041682|NCT02704520|Antidotes|antidotes|mesh-ancestor
14041683|NCT02704520|Protective Agents|protective agents|mesh-ancestor
14041684|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
14041685|NCT02704520|Vitamins|vitamins|mesh-ancestor
14041686|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
14041687|NCT02704520|Hematinics|hematinics|mesh-ancestor
14041688|NCT02704208|Nicotine|nicotine|mesh-list
14041689|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14041690|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
14041691|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041692|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041693|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14041694|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14041695|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
14041696|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041697|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041698|NCT02704507|Triamcinolone|triamcinolone|mesh-list
14041699|NCT02704507|Tretinoin|tretinoin|mesh-list
14041700|NCT02704507|Emollients|emollients|mesh-list
14041701|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041702|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
14041703|NCT02704507|Hormones|hormones|mesh-ancestor
14041704|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041705|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909679|NCT03515798|Paclitaxel|paclitaxel|mesh-list
13909680|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13909681|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
13909682|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
13909683|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13909684|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909685|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
13909686|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
13909687|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
13909688|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041706|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041707|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
14474535|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756762|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14041708|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
14041709|NCT02703857|Cefoxitin|cefoxitin|mesh-list
14041710|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14041711|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041712|NCT02704052|Enoxaparin|enoxaparin|mesh-list
14041713|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
14041714|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
14041715|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13909689|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909690|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
13909691|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909692|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909693|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909694|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
13909695|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13909696|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14474536|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474537|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
14474538|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474539|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474540|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14474541|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14474542|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
14474543|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14474544|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909697|NCT03515772|Darunavir|darunavir|mesh-list
13909698|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13909699|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13909700|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
13909701|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909702|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909703|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13909704|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13909705|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
14041716|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14041717|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041718|NCT02703896|Esomeprazole|esomeprazole|mesh-list
14041719|NCT02703896|Omeprazole|omeprazole|mesh-list
14041720|NCT02703896|Pantoprazole|pantoprazole|mesh-list
14041721|NCT02703896|Lansoprazole|lansoprazole|mesh-list
14041722|NCT02703896|Famotidine|famotidine|mesh-list
14041723|NCT02703896|Ranitidine|ranitidine|mesh-list
14041724|NCT02703896|Cimetidine|cimetidine|mesh-list
14041725|NCT02703896|Nizatidine|nizatidine|mesh-list
14041726|NCT02703896|Lafutidine|lafutidine|mesh-list
14041727|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14474545|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474546|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474547|NCT02383758|Bisacodyl|bisacodyl|mesh-list
14474548|NCT02383758|Glycerol|glycerol|mesh-list
14041728|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14041729|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13909706|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909707|NCT03515707|Etoposide|etoposide|mesh-list
13909708|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
13909709|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
13909710|NCT03515707|Busulfan|busulfan|mesh-list
13909711|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13909712|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909713|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13909714|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14041730|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041731|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041732|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14041733|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
14041734|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
14041735|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041736|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041737|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14041738|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14041739|NCT02704013|Oxybutynin|oxybutynin|mesh-list
14041740|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
14041741|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
14041742|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041743|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909715|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041744|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14041745|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14756763|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909716|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909717|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
13909718|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909719|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
13909720|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909721|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909722|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14041746|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
14041747|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041748|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041749|NCT02704013|Urological Agents|urological agents|mesh-ancestor
14041750|NCT02703961|Cisplatin|cisplatin|mesh-list
14041751|NCT02703961|Docetaxel|docetaxel|mesh-list
14041752|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041753|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041754|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041755|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
13909723|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
13909724|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
13909725|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
13909726|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
13909727|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
13909728|NCT03515668|Methylphenidate|methylphenidate|mesh-list
13909729|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13909730|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909731|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13909732|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13909733|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13909734|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909735|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
13909736|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041756|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041757|NCT02703649|Letrozole|letrozole|mesh-list
14041758|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041759|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14041760|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14041761|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041762|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041763|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14041764|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
14041765|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041766|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909737|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
13909738|NCT03515629|Cemiplimab|cemiplimab|mesh-list
13909739|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13909740|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909741|NCT03515577|Edetic Acid|edetic acid|mesh-list
13909742|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13909743|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
13909744|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
13909745|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909746|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
13909747|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13909748|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13909749|NCT03515538|Cisplatin|cisplatin|mesh-list
13909750|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959763|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13959764|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959765|NCT03160339|Vaccines|vaccines|mesh-list
13959766|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
13959767|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959768|NCT03160248|Apremilast|apremilast|mesh-list
13959769|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13959770|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959771|NCT03160248|Analgesics|analgesics|mesh-ancestor
13959772|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
13959773|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959774|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041770|NCT02703571|Trametinib|trametinib|mesh-list
14041771|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959775|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041772|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14041773|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041774|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041775|NCT02703740|Lidocaine|lidocaine|mesh-list
14041776|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
14041777|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
14041778|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
14041779|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041780|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041781|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
13909751|NCT03515382|Itraconazole|itraconazole|mesh-list
13909752|NCT03515382|Voriconazole|voriconazole|mesh-list
13909753|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
13909754|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909755|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13909756|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13909757|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909758|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909759|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13909760|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
13909761|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909762|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909763|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13909764|NCT03515369|Liver Extracts|liver extracts|mesh-list
13909765|NCT03515369|Hematinics|hematinics|mesh-ancestor
13909766|NCT03515213|Fenofibrate|fenofibrate|mesh-list
13909767|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13909768|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
13909769|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909770|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13909771|NCT03515200|Cytarabine|cytarabine|mesh-list
14041782|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041783|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14041784|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14041785|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14041786|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14041787|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041788|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14041789|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
14041790|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
14041791|NCT02703740|Protective Agents|protective agents|mesh-ancestor
14041792|NCT02703363|Minocycline|minocycline|mesh-list
14041793|NCT02703363|Celecoxib|celecoxib|mesh-list
14041794|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14041795|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041796|NCT02703363|Analgesics|analgesics|mesh-ancestor
14041797|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
14041798|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041799|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909772|NCT03515200|Dexamethasone|dexamethasone|mesh-list
13909773|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
13909774|NCT03515200|Doxorubicin|doxorubicin|mesh-list
13909775|NCT03515200|Methotrexate|methotrexate|mesh-list
14041800|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041801|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041802|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14041803|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14041804|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041805|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041806|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14041807|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041808|NCT02703376|Prednisone|prednisone|mesh-list
14041809|NCT02703376|Prednisolone|prednisolone|mesh-list
14041810|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041811|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
14041812|NCT02703376|Hormones|hormones|mesh-ancestor
14041813|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041814|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041815|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041816|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041817|NCT02703610|Acetaminophen|acetaminophen|mesh-list
14041818|NCT02703610|Ibuprofen|ibuprofen|mesh-list
14041819|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14041820|NCT02703610|Oxycodone|oxycodone|mesh-list
13909776|NCT03515200|Bortezomib|bortezomib|mesh-list
14041821|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041822|NCT02703610|Analgesics|analgesics|mesh-ancestor
14041823|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
14041824|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041825|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041826|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
14041827|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14041828|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041829|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041830|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14041831|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041832|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041833|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14041834|NCT02703610|Narcotics|narcotics|mesh-ancestor
14041835|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041836|NCT02703415|Tramadol|tramadol|mesh-list
14041837|NCT02703415|Bupivacaine|bupivacaine|mesh-list
14041838|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
14041839|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
14041840|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041841|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041842|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
14041843|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041844|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14041845|NCT02703415|Narcotics|narcotics|mesh-ancestor
14041846|NCT02703415|Analgesics|analgesics|mesh-ancestor
14041847|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
14041848|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14041849|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041850|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
14041851|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14041852|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
14041853|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
14041854|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041855|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909777|NCT03515200|Dasatinib|dasatinib|mesh-list
13909778|NCT03515200|Palbociclib|palbociclib|mesh-list
13909779|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13909780|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
13909781|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
13909782|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909783|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909784|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13909785|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
13909786|NCT03515200|Hormones|hormones|mesh-ancestor
13909787|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909788|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13909789|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909790|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13909791|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13909792|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13909793|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909794|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041856|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041857|NCT02703233|Analgesics|analgesics|mesh-ancestor
14041858|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
14041859|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041860|NCT02703272|Dexamethasone|dexamethasone|mesh-list
14041861|NCT02703272|Rituximab|rituximab|mesh-list
14041862|NCT02703272|Carboplatin|carboplatin|mesh-list
14041863|NCT02703272|Etoposide|etoposide|mesh-list
14041864|NCT02703272|Vincristine|vincristine|mesh-list
14041865|NCT02703272|Ifosfamide|ifosfamide|mesh-list
14041866|NCT02703272|Idarubicin|idarubicin|mesh-list
14041867|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041868|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
14041869|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
14041870|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041871|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041872|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14041873|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
14041874|NCT02703272|Hormones|hormones|mesh-ancestor
13959776|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041875|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041876|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041877|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041878|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14041879|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
14041880|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041881|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14041882|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14041883|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14041884|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041885|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041886|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
14041887|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
14041888|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
14041889|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041890|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
14041891|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14041892|NCT02703194|Prednisone|prednisone|mesh-list
14041893|NCT02703194|Prednisolone|prednisolone|mesh-list
14041894|NCT02703194|Leflunomide|leflunomide|mesh-list
14041895|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041896|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
14041897|NCT02703194|Hormones|hormones|mesh-ancestor
14041898|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041899|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041900|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041901|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041902|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041903|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041904|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041905|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
14041906|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
14041907|NCT02702960|Prednisone|prednisone|mesh-list
14041908|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
14041909|NCT02702960|Fludarabine|fludarabine|mesh-list
14041910|NCT02702960|Tacrolimus|tacrolimus|mesh-list
14041911|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14041912|NCT02702960|Mesna|mesna|mesh-list
14041913|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14041914|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
14041915|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041916|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041917|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14041918|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
14041919|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756764|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756765|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
13909795|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13909796|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
13909797|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13909798|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756766|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756767|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756768|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
14756769|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756770|NCT02512497|Antiviral Agents|antiviral agents|mesh-ancestor
14756771|NCT02512497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909799|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
13909800|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
13909801|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13909802|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909803|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
13909804|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909805|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13909806|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
13909807|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909808|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13909809|NCT03515187|Bromides|bromides|mesh-list
13909810|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13909811|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13909812|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
13909813|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
13909814|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13909815|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
13909816|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909817|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
13909818|NCT03515187|Protective Agents|protective agents|mesh-ancestor
13909819|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
13909820|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
14041920|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14041921|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14041922|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041923|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
14041924|NCT02702960|Hormones|hormones|mesh-ancestor
14041925|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14041926|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14041927|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14041928|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041929|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13909821|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909822|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13909823|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909824|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909825|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
13909826|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13909827|NCT03514979|Vaccines|vaccines|mesh-list
14041930|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14041931|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
14041932|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14041933|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041934|NCT02702960|Protective Agents|protective agents|mesh-ancestor
14041935|NCT02703051|Lenograstim|lenograstim|mesh-list
14041936|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14041937|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
14041938|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041939|NCT02703090|Remifentanil|remifentanil|mesh-list
14041940|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14041941|NCT02703090|Narcotics|narcotics|mesh-ancestor
14041942|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041943|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041944|NCT02703090|Analgesics|analgesics|mesh-ancestor
14041945|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
14041946|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041947|NCT02702843|Xenon|xenon|mesh-list
14041948|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14041949|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
14041950|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
14041951|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14041952|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041953|NCT02702817|Naproxen|naproxen|mesh-list
14041954|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14041955|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14041956|NCT02702817|Analgesics|analgesics|mesh-ancestor
14041957|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
14041958|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14041959|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041960|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14041961|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14041962|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
14041963|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14041964|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041965|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041966|NCT02702700|Verteporfin|verteporfin|mesh-list
14041967|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14041968|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
14041969|NCT02702674|Propranolol|propranolol|mesh-list
14474549|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14474550|NCT02383758|Protective Agents|protective agents|mesh-ancestor
14474551|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474552|NCT02383758|Cathartics|cathartics|mesh-ancestor
13909828|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
13909829|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909830|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
13909831|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909832|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
13909833|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909834|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909835|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909836|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
13909837|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041970|NCT02702674|Oxytocin|oxytocin|mesh-list
14041971|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
14041972|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14041973|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041974|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14041975|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14041976|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
14041977|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14041978|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041979|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14041980|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14041981|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
14041982|NCT02702739|Ribavirin|ribavirin|mesh-list
13909838|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909839|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13909840|NCT03514810|Ketoprofen|ketoprofen|mesh-list
13909841|NCT03514810|Sertraline|sertraline|mesh-list
13909842|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
14041983|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
14041984|NCT02702739|Simeprevir|simeprevir|mesh-list
14041985|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
14041986|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14041987|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
14041988|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14041989|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
14041990|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14041991|NCT02702622|Provitamins|provitamins|mesh-list
14041992|NCT02702622|Beta Carotene|beta carotene|mesh-list
14041993|NCT02702622|Vitamins|vitamins|mesh-ancestor
14041994|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
14041995|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14041996|NCT02702661|Anesthetics|anesthetics|mesh-list
14041997|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
14041998|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
14041999|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042000|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042001|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
14042002|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042003|NCT02702778|Prednisone|prednisone|mesh-list
14042004|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042005|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
13909843|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13909844|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13909845|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13909846|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13909847|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909848|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042006|NCT02702778|Hormones|hormones|mesh-ancestor
14042007|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042008|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042009|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14042010|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042011|NCT02702492|Niacin|niacin|mesh-list
14042012|NCT02702492|Nivolumab|nivolumab|mesh-list
14042013|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14042014|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042015|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14042016|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042017|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14042018|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
14042019|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14042020|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
14042021|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
14042022|NCT02702492|Vitamins|vitamins|mesh-ancestor
14042023|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
14042024|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169983|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14169984|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
14169985|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169986|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169987|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14169988|NCT04836078|Chitosan|chitosan|mesh-list
14169989|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14169990|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14169991|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
14169992|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169993|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14169994|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
13909849|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
14169995|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
14169996|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
14042025|NCT02702206|Triamcinolone|triamcinolone|mesh-list
14042026|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
14042027|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042028|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
14042029|NCT02702206|Hormones|hormones|mesh-ancestor
14042030|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042031|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042032|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
14042033|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14042034|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
14042035|NCT02702206|Protective Agents|protective agents|mesh-ancestor
14042036|NCT02702323|Apatinib|apatinib|mesh-list
14042037|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042038|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14042039|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042040|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042041|NCT02702349|Penicillins|penicillins|mesh-list
14042042|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14042043|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042044|NCT02702076|Apomorphine|apomorphine|mesh-list
14042045|NCT02702076|Emetics|emetics|mesh-ancestor
14042046|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042047|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
14042048|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042049|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042050|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
14042051|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
13909850|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909851|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13909852|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13909853|NCT03514810|Analgesics|analgesics|mesh-ancestor
13909854|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
13909855|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909856|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042052|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042053|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042054|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
14042055|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14042056|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14042057|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042058|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
14042059|NCT02702128|Coagulants|coagulants|mesh-ancestor
14042060|NCT02701933|Ketamine|ketamine|mesh-list
14042061|NCT02701933|Analgesics|analgesics|mesh-ancestor
14042062|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
14042063|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042064|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042065|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14042066|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14042067|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
14042068|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
14042069|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042070|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14042071|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14042072|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042073|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042074|NCT02701673|Pyridoxine|pyridoxine|mesh-list
14042075|NCT02701673|Gemcitabine|gemcitabine|mesh-list
14042076|NCT02701673|Azacitidine|azacitidine|mesh-list
14042077|NCT02701673|Melphalan|melphalan|mesh-list
14042078|NCT02701673|Busulfan|busulfan|mesh-list
14042079|NCT02701673|Belinostat|belinostat|mesh-list
14042080|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13909857|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909858|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13909859|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909860|NCT03514771|Valacyclovir|valacyclovir|mesh-list
13909861|NCT03514771|Isotretinoin|isotretinoin|mesh-list
13909862|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
13909863|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909864|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474553|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042081|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
14042082|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042083|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042084|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
14042085|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474554|NCT02383758|Laxatives|laxatives|mesh-ancestor
14474555|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14042086|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042087|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14042088|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
14042089|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042090|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14042091|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
14042092|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14042093|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
14042094|NCT02701673|Vitamins|vitamins|mesh-ancestor
14042095|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
14042096|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14474556|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14474557|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909871|NCT03514667|Curcumin|curcumin|mesh-list
13909872|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13909873|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13909874|NCT03514667|Analgesics|analgesics|mesh-ancestor
13909875|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
13909876|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909877|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909878|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13909879|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909880|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909881|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909882|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909883|NCT03514589|Cosyntropin|cosyntropin|mesh-list
13909884|NCT03514589|Hormones|hormones|mesh-ancestor
13909885|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909886|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909887|NCT03514576|Pasireotide|pasireotide|mesh-list
13909888|NCT03514576|Hormones|hormones|mesh-ancestor
13909889|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909890|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909891|NCT03514550|Propofol|propofol|mesh-list
13909892|NCT03514550|Sevoflurane|sevoflurane|mesh-list
13909893|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14042097|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14042098|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14042099|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042100|NCT02701595|Amoxicillin|amoxicillin|mesh-list
14042101|NCT02701595|Vancomycin|vancomycin|mesh-list
14042102|NCT02701595|Gentamicins|gentamicins|mesh-list
14042103|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
14042104|NCT02701595|Penicillins|penicillins|mesh-list
14042105|NCT02701595|Penicillin G|penicillin g|mesh-list
14042106|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
13909894|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909895|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909896|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13909897|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
13909898|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
13909899|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13909900|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13909901|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13909902|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909903|NCT03514381|Doxorubicin|doxorubicin|mesh-list
13909904|NCT03514381|Ifosfamide|ifosfamide|mesh-list
13909905|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13909906|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909907|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13909908|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13909909|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042107|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
14042108|NCT02701595|Netilmicin|netilmicin|mesh-list
14042109|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14042110|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474558|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14474559|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474560|NCT02383966|Carboplatin|carboplatin|mesh-list
14474561|NCT02383966|Fluorouracil|fluorouracil|mesh-list
14474562|NCT02383966|Cetuximab|cetuximab|mesh-list
14474563|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474564|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
14042111|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14042112|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042113|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042114|NCT02701608|Levofloxacin|levofloxacin|mesh-list
14042115|NCT02701608|Ofloxacin|ofloxacin|mesh-list
14042116|NCT02701608|Rifampin|rifampin|mesh-list
14042117|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
14042118|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14042119|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042120|NCT02701608|Renal Agents|renal agents|mesh-ancestor
14042121|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14756772|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
14756773|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756774|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756775|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756776|NCT02451358|Vaccines|vaccines|mesh-list
14756777|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
14756778|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756779|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
14756780|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
14756781|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756782|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
13909910|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909911|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13909912|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
13909913|NCT03514342|Ropivacaine|ropivacaine|mesh-list
14474565|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474566|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14474567|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13909914|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
13909915|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
13909916|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909917|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909918|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
13909919|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909920|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
13909921|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13909922|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909923|NCT03514108|Metformin|metformin|mesh-list
13909924|NCT03514108|Hydralazine|hydralazine|mesh-list
13909925|NCT03514108|Isosorbide|isosorbide|mesh-list
13909926|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14042122|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14042123|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14042124|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042125|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042126|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042127|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14042128|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14042129|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14042130|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
14042131|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
14042132|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14042133|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14042134|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13909927|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14474568|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
14474569|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474570|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14474571|NCT02384044|Listerine|listerine|mesh-list
14474572|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
14474573|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
14474574|NCT02384044|Protective Agents|protective agents|mesh-ancestor
14474575|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474576|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14474577|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474578|NCT02384070|Aspirin|aspirin|mesh-list
14474579|NCT02384070|Bivalirudin|bivalirudin|mesh-list
14474580|NCT02384070|Clopidogrel|clopidogrel|mesh-list
14474581|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14474582|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14756783|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042135|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14042136|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14042137|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14042138|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14042139|NCT02701348|Letrozole|letrozole|mesh-list
14042140|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14756784|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756785|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756786|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
14756787|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756788|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756789|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756790|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756791|NCT02403310|Cytarabine|cytarabine|mesh-list
14756792|NCT02403310|Daunorubicin|daunorubicin|mesh-list
14042141|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909928|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13909929|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909930|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13909931|NCT03514108|Diuretics|diuretics|mesh-ancestor
13909932|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
13909933|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
13909934|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14042142|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14042143|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042144|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042145|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14042146|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
14042147|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13909935|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909936|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13909937|NCT03514030|Antibodies|antibodies|mesh-list
13909938|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
14474583|NCT02384070|Analgesics|analgesics|mesh-ancestor
14474584|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
14474585|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474586|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474587|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474588|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474589|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13909939|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909940|NCT03513874|Metformin|metformin|mesh-list
13909941|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14042148|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042149|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
14474590|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14756793|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756794|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
14756795|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756796|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933270|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13909942|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474591|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474592|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14474593|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13909943|NCT03513822|Midazolam|midazolam|mesh-list
13909944|NCT03513822|Ketamine|ketamine|mesh-list
14474594|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13909945|NCT03513822|Analgesics|analgesics|mesh-ancestor
13909946|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
13909947|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13909948|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909949|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13909950|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13909951|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
13909952|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
13909953|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909954|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13909955|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13909956|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909957|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909958|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13909959|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13909960|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13909961|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13909962|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14042150|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14042151|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
14042152|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
14042153|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042154|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042155|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042156|NCT02701478|Analgesics|analgesics|mesh-ancestor
14042157|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
14042158|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042159|NCT02701517|Cyclosporine|cyclosporine|mesh-list
14042160|NCT02701517|Methotrexate|methotrexate|mesh-list
14042161|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
14042162|NCT02701517|Cyclosporins|cyclosporins|mesh-list
14042163|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14042164|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
14042165|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14042166|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042167|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14042168|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
14042169|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909963|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
13909964|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
13959777|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13959778|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14042170|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042171|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
13959779|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959780|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959781|NCT03160001|Niclosamide|niclosamide|mesh-list
13959782|NCT03160001|Etanercept|etanercept|mesh-list
13959783|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13959784|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959785|NCT03160001|Analgesics|analgesics|mesh-ancestor
13959786|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
13959787|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959788|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959789|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959790|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959791|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959792|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13959793|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
13959794|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
13959795|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13959796|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
13959797|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13959798|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959799|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
13959800|NCT03160040|Minocycline|minocycline|mesh-list
13959801|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959802|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959803|NCT03160261|Exenatide|exenatide|mesh-list
13959804|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13959805|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959806|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13959807|NCT03160261|Incretins|incretins|mesh-ancestor
14042172|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933271|NCT01449825|Growth Substances|growth substances|mesh-ancestor
14042173|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13909965|NCT03513601|Rituximab|rituximab|mesh-list
13909966|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13909967|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909968|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
13909969|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13909970|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909971|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
13909972|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13909973|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13909974|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
13909975|NCT03513549|Loxapine|loxapine|mesh-list
13909976|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13909977|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13909978|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13909979|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042174|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14042175|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
14042176|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042177|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14042178|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
14042179|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042180|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14042181|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14042182|NCT02701309|Iron|iron|mesh-list
14042183|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
14042184|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
14042185|NCT02701309|Trace Elements|trace elements|mesh-ancestor
14042186|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
14042187|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042188|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14042189|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
14042190|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042191|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042192|NCT02701179|Lidocaine|lidocaine|mesh-list
14042193|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14042194|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042195|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
14042196|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042197|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042198|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
14042199|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042200|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14042201|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14042202|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13909980|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13909981|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13909982|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
13909983|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13909984|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909985|NCT03513484|Azacitidine|azacitidine|mesh-list
13909986|NCT03513484|Nintedanib|nintedanib|mesh-list
13909987|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13909988|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
13909989|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13909990|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13909991|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042203|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042204|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042205|NCT02701127|Niacinamide|niacinamide|mesh-list
14042206|NCT02701127|Niacin|niacin|mesh-list
14042207|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
14042208|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
14042209|NCT02701127|Vitamins|vitamins|mesh-ancestor
14042210|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
13909992|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13909993|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13909994|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909995|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13909996|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13909997|NCT03513432|Ethanol|ethanol|mesh-list
14042211|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042212|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14042213|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
14042214|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042215|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13909998|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13909999|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910000|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910001|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910002|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
13910003|NCT03513406|Neostigmine|neostigmine|mesh-list
13910004|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13910005|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910006|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910007|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
13910008|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910009|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910010|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13910011|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
13910012|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910013|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13910014|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13910015|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13910016|NCT03513393|Velpatasvir|velpatasvir|mesh-list
13910017|NCT03513393|Omeprazole|omeprazole|mesh-list
13910018|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13910019|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910020|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13910021|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910022|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910023|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
13910024|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910025|NCT03513328|Thiotepa|thiotepa|mesh-list
13910026|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13910027|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
13910028|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042216|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
14042217|NCT02701166|Bezafibrate|bezafibrate|mesh-list
14042218|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14042219|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
14042220|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042221|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14042222|NCT02700893|Atropine|atropine|mesh-list
14042223|NCT02700893|Sufentanil|sufentanil|mesh-list
14042224|NCT02700893|Propofol|propofol|mesh-list
14042225|NCT02700893|Atracurium|atracurium|mesh-list
14042226|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14042227|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042228|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042229|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14042230|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
14042231|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
14042232|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14042233|NCT02700893|Narcotics|narcotics|mesh-ancestor
14042234|NCT02700893|Analgesics|analgesics|mesh-ancestor
14042235|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
14042236|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042237|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14474595|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
14474596|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14474597|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13910029|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910030|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13910031|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13910032|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
13910033|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910034|NCT03513276|Epinephrine|epinephrine|mesh-list
13910035|NCT03513276|Racepinephrine|racepinephrine|mesh-list
14042238|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14474598|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14042239|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14042240|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
14042241|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14042242|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
14042243|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
14756797|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
14756798|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756799|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756800|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
14042244|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
14042245|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14042246|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14042247|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
14042248|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042249|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042250|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14042251|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14042252|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14042253|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14042254|NCT02700906|Lidocaine|lidocaine|mesh-list
14042255|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042256|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
14042257|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042258|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042259|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
14042260|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042261|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14042262|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14042263|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14042264|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042265|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042266|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
14042267|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14042268|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042269|NCT02700568|Axitinib|axitinib|mesh-list
14042270|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042271|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14042272|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042273|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042274|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13910036|NCT03513276|Ropivacaine|ropivacaine|mesh-list
13910037|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
13910038|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
13910039|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
13910040|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910041|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910042|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
13910043|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910044|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13910045|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13910046|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910047|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042275|NCT02700711|Methylphenidate|methylphenidate|mesh-list
14042276|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14042277|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042278|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14042279|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14042280|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042281|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042282|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
14042283|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042284|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14042285|NCT02700711|Analgesics|analgesics|mesh-ancestor
14042286|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
14042287|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042288|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
13910048|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910049|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14042289|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14042290|NCT02700685|Methylphenidate|methylphenidate|mesh-list
14042291|NCT02700685|Pycnogenols|pycnogenols|mesh-list
14042292|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14042293|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042294|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14042295|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14042296|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910050|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13910051|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
13910052|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13910053|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
13910054|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
14042297|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042298|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
14042299|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042300|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14042301|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
14042302|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
14042303|NCT02700685|Protective Agents|protective agents|mesh-ancestor
14042304|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14042305|NCT02700763|Dabrafenib|dabrafenib|mesh-list
14042306|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042307|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14042308|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042309|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169997|NCT04836078|Coagulants|coagulants|mesh-ancestor
14169998|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
14169999|NCT04836156|Carboplatin|carboplatin|mesh-list
14170000|NCT04836156|Docetaxel|docetaxel|mesh-list
14170001|NCT04836156|Epirubicin|epirubicin|mesh-list
14170002|NCT04836156|Phenobarbital|phenobarbital|mesh-list
14170003|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170004|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
14170005|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170006|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170007|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14170008|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
14170009|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170010|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933272|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933273|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
14933274|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13910055|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
13910056|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13910057|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
13910058|NCT03513211|Itraconazole|itraconazole|mesh-list
14042310|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
14042311|NCT02700347|Allopurinol|allopurinol|mesh-list
14042312|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
14042313|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042314|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042315|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
14042316|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042317|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14042318|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
14042319|NCT02700347|Protective Agents|protective agents|mesh-ancestor
14042320|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042321|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
14042322|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14042323|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042324|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
14042325|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
14042326|NCT02700217|Remifentanil|remifentanil|mesh-list
14042327|NCT02700217|Heroin|heroin|mesh-list
14042328|NCT02700217|Bupivacaine|bupivacaine|mesh-list
14042329|NCT02700217|Propofol|propofol|mesh-list
14042330|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042331|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
14042332|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042333|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042334|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
14042335|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042336|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14042337|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14042338|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
14042339|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14042340|NCT02700217|Narcotics|narcotics|mesh-ancestor
14042341|NCT02700217|Analgesics|analgesics|mesh-ancestor
14042342|NCT02701205|Etanercept|etanercept|mesh-list
14042343|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14042344|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042345|NCT02701205|Analgesics|analgesics|mesh-ancestor
14042346|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
14042347|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042348|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042349|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042350|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042351|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042352|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14042353|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
14042354|NCT02700087|Famotidine|famotidine|mesh-list
14042355|NCT02700087|Ranitidine|ranitidine|mesh-list
14042356|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14042357|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14042358|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042359|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14042360|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
14042361|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
14042362|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042363|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042364|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042365|NCT02700048|Naloxone|naloxone|mesh-list
14042366|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14042367|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042368|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
14042369|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042370|NCT02699879|Pirfenidone|pirfenidone|mesh-list
14042371|NCT02699879|Analgesics|analgesics|mesh-ancestor
13910059|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
13910060|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13910061|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13910062|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910063|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910064|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910065|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13910066|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
13910067|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13910068|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13910069|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14042372|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
14042373|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042374|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474599|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
13910070|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
14042375|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14042376|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042377|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042378|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042379|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042380|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
14042381|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
14042382|NCT02699827|Analgesics|analgesics|mesh-ancestor
14042383|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
14042384|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042385|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042386|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
14042387|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042388|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14042389|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
13910071|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13910072|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910073|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13910074|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14042390|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14042391|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042392|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042393|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14042394|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
14042395|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14474600|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910075|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13910076|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13910077|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13910078|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13910079|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910080|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910081|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910082|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910083|NCT03513055|Insulin|insulin|mesh-list
13910084|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13910085|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910086|NCT03512990|Bupivacaine|bupivacaine|mesh-list
14474601|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
14474602|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14474603|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14474604|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
14474605|NCT02384200|Vancomycin|vancomycin|mesh-list
14474606|NCT02384200|Gentamicins|gentamicins|mesh-list
14474607|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
14474608|NCT02384200|Ampicillin|ampicillin|mesh-list
14474609|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
14474610|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14474611|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474612|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14474613|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474614|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474615|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14474616|NCT02384200|Renal Agents|renal agents|mesh-ancestor
14474617|NCT02384395|Lamivudine|lamivudine|mesh-list
14756801|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756802|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14756803|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756804|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756805|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767225|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767226|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767227|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14767228|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14474618|NCT02384395|Abacavir|abacavir|mesh-list
14474619|NCT02384395|Dolutegravir|dolutegravir|mesh-list
14756806|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14042396|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042397|NCT02699723|Itraconazole|itraconazole|mesh-list
14042398|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
14042399|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
14474620|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14474621|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13910087|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
13910088|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
13910089|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910090|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910091|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
14474622|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474623|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474624|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
14474625|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474626|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14474627|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14474628|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14474629|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14474630|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14474631|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14474632|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474633|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14474634|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474635|NCT02385097|Ropivacaine|ropivacaine|mesh-list
14474636|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
14474637|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042400|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042401|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14042402|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14042403|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042404|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042405|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14042406|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
14042407|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042408|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042409|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14042410|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910092|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910093|NCT03512873|Tranilast|tranilast|mesh-list
13910094|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13910095|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13910096|NCT03512873|Analgesics|analgesics|mesh-ancestor
13910097|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
13910098|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910099|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910100|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13910101|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474638|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
14474639|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474640|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910102|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13910103|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910104|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910105|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13910106|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13910107|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
13910108|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
13910109|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910110|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13910111|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13910112|NCT03512860|Valproic Acid|valproic acid|mesh-list
13910113|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
13910114|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910115|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910116|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
13910117|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910118|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042411|NCT02699645|Amlodipine|amlodipine|mesh-list
13910119|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
13910120|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13910121|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910122|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13910123|NCT03512834|Paclitaxel|paclitaxel|mesh-list
13910124|NCT03512834|Avelumab|avelumab|mesh-list
13910125|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13910126|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910127|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
14042412|NCT02699645|Telmisartan|telmisartan|mesh-list
14042413|NCT02699645|Indapamide|indapamide|mesh-list
14042414|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14042415|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14042416|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042417|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042418|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14042419|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042420|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
14042421|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14042422|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13910128|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
13910129|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
13910130|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910131|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910132|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13910133|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14474641|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
14474642|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910134|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910135|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13910136|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13910137|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042423|NCT02699645|Diuretics|diuretics|mesh-ancestor
14042424|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
14042425|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14042426|NCT02700022|Prednisone|prednisone|mesh-list
14042427|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
14042428|NCT02700022|Doxorubicin|doxorubicin|mesh-list
14474643|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14474644|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14474645|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14474646|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14474647|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14474648|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14474649|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474650|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474651|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474652|NCT02385669|Ipilimumab|ipilimumab|mesh-list
14474653|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14474654|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474655|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14042429|NCT02700022|Etoposide|etoposide|mesh-list
14042430|NCT02700022|Vincristine|vincristine|mesh-list
14933275|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933276|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933277|NCT01449877|Trimethoprim|trimethoprim|mesh-list
14933278|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14933279|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
14933280|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14933281|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933282|NCT01449877|Renal Agents|renal agents|mesh-ancestor
14042431|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14042432|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
14042433|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474656|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474657|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
14474658|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14474659|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14474660|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474661|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
14474662|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474663|NCT02385799|Sertraline|sertraline|mesh-list
14756807|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
13910138|NCT03512756|Gemcitabine|gemcitabine|mesh-list
13910139|NCT03512756|Sirolimus|sirolimus|mesh-list
13910140|NCT03512756|Capecitabine|capecitabine|mesh-list
13910141|NCT03512756|Phenytoin|phenytoin|mesh-list
14474664|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
14474665|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14474666|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14474667|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14474668|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14756808|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
14756809|NCT02389036|Tobramycin|tobramycin|mesh-list
14756810|NCT02389036|Colistin|colistin|mesh-list
14756811|NCT02389036|Nystatin|nystatin|mesh-list
14756812|NCT02389036|Cefotaxime|cefotaxime|mesh-list
14756813|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756814|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14756815|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756816|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756817|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756818|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756819|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14756820|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14756821|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
14756822|NCT02389036|Ionophores|ionophores|mesh-ancestor
14756823|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910142|NCT03512756|Methoxsalen|methoxsalen|mesh-list
13910143|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13910144|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
13910145|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910146|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910147|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
13910148|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910149|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910150|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13910151|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
13910152|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910153|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910154|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13910155|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
13910156|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
13910157|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13910158|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13910159|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910160|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13910161|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13910162|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13910163|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
13910164|NCT03512574|Pregabalin|pregabalin|mesh-list
13910165|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
13910166|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13910167|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910168|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910169|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13910170|NCT03512574|Analgesics|analgesics|mesh-ancestor
13910171|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
13910172|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959808|NCT03160261|Hormones|hormones|mesh-ancestor
14756824|NCT02375204|Paclitaxel|paclitaxel|mesh-list
14756825|NCT02375204|Etoposide|etoposide|mesh-list
14756826|NCT02375204|Carboplatin|carboplatin|mesh-list
14042434|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042435|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14042436|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
14042437|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042438|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042439|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14042440|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14042441|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14042442|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14042443|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042444|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042445|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
14042446|NCT02700022|Hormones|hormones|mesh-ancestor
14042447|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042448|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14042449|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14042450|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14042451|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14042452|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14042453|NCT02699658|Levofloxacin|levofloxacin|mesh-list
14042454|NCT02699658|Ofloxacin|ofloxacin|mesh-list
14042455|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14042456|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042457|NCT02699658|Renal Agents|renal agents|mesh-ancestor
14042458|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910173|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13910174|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13910175|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13910176|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910177|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910178|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910179|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
13910180|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13910181|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910182|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13910183|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13910184|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13910185|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13910186|NCT03512548|Itraconazole|itraconazole|mesh-list
13910187|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
13910188|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910189|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13910190|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14474669|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474670|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474671|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
14474672|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474673|NCT02386098|Ritonavir|ritonavir|mesh-list
14474674|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13910191|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910192|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910193|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13910194|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
13910195|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042459|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14042460|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14042461|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042462|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042463|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042464|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14042465|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14042466|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
13910196|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042467|NCT02699801|Propofol|propofol|mesh-list
14474675|NCT02386098|Tenofovir|tenofovir|mesh-list
14474676|NCT02386098|Dolutegravir|dolutegravir|mesh-list
14474677|NCT02386098|BMS-955176|bms-955176|mesh-list
14474678|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14474679|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14474680|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
14474681|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474682|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474683|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14474684|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14474685|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
14474686|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474687|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14474688|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14474689|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13910197|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13910198|NCT03512496|Caffeine|caffeine|mesh-list
13910199|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13910200|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910201|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13910202|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910203|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910204|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13910205|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13910206|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
14042468|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14042469|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933283|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
14042470|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042471|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14042472|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
14042473|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
14042474|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042475|NCT02699801|Analgesics|analgesics|mesh-ancestor
14042476|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
14042477|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042478|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14042479|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14042480|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14042481|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14042482|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042483|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042484|NCT02699710|Folic Acid|folic acid|mesh-list
14042485|NCT02699710|Methotrexate|methotrexate|mesh-list
14042486|NCT02699710|Rabeprazole|rabeprazole|mesh-list
14042487|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14042488|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
14042489|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14042490|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756827|NCT02375204|Ifosfamide|ifosfamide|mesh-list
13910207|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756828|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
14756829|NCT02375204|Lenograstim|lenograstim|mesh-list
14756830|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756831|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756832|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756833|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756834|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756835|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756836|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13910208|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13910209|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
13910210|NCT03512405|Blinatumomab|blinatumomab|mesh-list
13910211|NCT03512405|Antibodies|antibodies|mesh-list
13910212|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
14756837|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756838|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756839|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14756840|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
13910213|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13910214|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
13910215|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13910216|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
14042491|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14042492|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
14042493|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042494|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042495|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
14042496|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042497|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14042498|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14042499|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
14042500|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042501|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14042502|NCT02699710|Hematinics|hematinics|mesh-ancestor
14042503|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
14042504|NCT02699710|Vitamins|vitamins|mesh-ancestor
13910217|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910218|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910219|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13959809|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959810|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
13959811|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13959812|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
13963352|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13963353|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13963354|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
14042505|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
14042506|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14042507|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042508|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14042509|NCT02699437|Antibodies|antibodies|mesh-list
14042510|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
14042511|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
14042512|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042513|NCT02699281|Palmidrol|palmidrol|mesh-list
14042514|NCT02699281|Analgesics|analgesics|mesh-ancestor
14042515|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
14042516|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963355|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963356|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963357|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963358|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
14042517|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042518|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14042519|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042520|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042521|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042522|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
14042523|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042524|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14042525|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14042526|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042527|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042528|NCT02699281|Hormones|hormones|mesh-ancestor
14042529|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963359|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042530|NCT02699385|Domperidone|domperidone|mesh-list
14042531|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
14042532|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
14042533|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042534|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910220|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
13910221|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13910222|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910223|NCT03512171|Amphetamine|amphetamine|mesh-list
13910224|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
13910225|NCT03512171|Fallypride|fallypride|mesh-list
13910226|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13910227|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910228|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
13910229|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
13910230|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910231|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
13910232|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910233|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910234|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910235|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13910236|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13910237|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910238|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13910239|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13910240|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13910241|NCT03511976|Methylphenidate|methylphenidate|mesh-list
13910242|NCT03511976|Amphetamine|amphetamine|mesh-list
13910243|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13910244|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910245|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14042535|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042536|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14042537|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
14042538|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042539|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042540|NCT02699528|Methylphenidate|methylphenidate|mesh-list
14042541|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14042542|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042543|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14042544|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14042545|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042546|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042547|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
14042548|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042549|NCT02699008|Clopidogrel|clopidogrel|mesh-list
14042550|NCT02699008|Ticagrelor|ticagrelor|mesh-list
14042551|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14042552|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14933284|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14042553|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14042554|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14042555|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
14042556|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042557|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042558|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042559|NCT02699138|Trazodone|trazodone|mesh-list
14042560|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14042561|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14933285|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14042562|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042563|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910246|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13910247|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910248|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910249|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
13910250|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042564|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14042565|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14042566|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14042567|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042568|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042569|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042570|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
14042571|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14042572|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
14042573|NCT02698891|Paclitaxel|paclitaxel|mesh-list
14042574|NCT02698891|Cyclophosphamide|cyclophosphamide|mesh-list
14042575|NCT02698891|Doxorubicin|doxorubicin|mesh-list
14042576|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14042577|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042578|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
14042579|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
14042580|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
14042581|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910251|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
13910252|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
13910253|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910254|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910255|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13910256|NCT03511846|Capsaicin|capsaicin|mesh-list
13910257|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
13910258|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
13910259|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
13910260|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910261|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910262|NCT03511833|Ketamine|ketamine|mesh-list
13910263|NCT03511833|Morphine|morphine|mesh-list
13910264|NCT03511833|Analgesics|analgesics|mesh-ancestor
13910265|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
13910266|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910267|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910268|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13910269|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13910270|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
13910271|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
13910272|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910273|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13910274|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14042582|NCT02698891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14042583|NCT02698891|Immunologic Factors|immunologic factors|mesh-ancestor
14042584|NCT02698891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042585|NCT02698891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042586|NCT02698891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14042587|NCT02698891|Alkylating Agents|alkylating agents|mesh-ancestor
14042588|NCT02698891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14042589|NCT02698891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14042590|NCT02698891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14042591|NCT02698891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14042592|NCT02698891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042593|NCT02698982|Anesthetics|anesthetics|mesh-list
14042594|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756841|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756842|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756843|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
14756844|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
14042595|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042596|NCT02698969|Atropine|atropine|mesh-list
14042597|NCT02698969|Fentanyl|fentanyl|mesh-list
14042598|NCT02698969|Propofol|propofol|mesh-list
14042599|NCT02698969|Sevoflurane|sevoflurane|mesh-list
14042600|NCT02698969|Rocuronium|rocuronium|mesh-list
14042601|NCT02698969|Neostigmine|neostigmine|mesh-list
13910275|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959813|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
13910276|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910277|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13910278|NCT03511833|Narcotics|narcotics|mesh-ancestor
13910279|NCT03511820|Amphotericin B|amphotericin b|mesh-list
13910280|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13910281|NCT03511820|Amebicides|amebicides|mesh-ancestor
14042602|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14042603|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042604|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042605|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14042606|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
14042607|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
14042608|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14042609|NCT02698969|Narcotics|narcotics|mesh-ancestor
14042610|NCT02698969|Analgesics|analgesics|mesh-ancestor
14042611|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
14042612|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042613|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14042614|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14042615|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14042616|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14042617|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14042618|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14042619|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14042620|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14042621|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
14042622|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14042623|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
14042624|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
14042625|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
14042626|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14042627|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14042628|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
14042629|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910282|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13910283|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13910284|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910285|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910286|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
13910287|NCT03511768|Octreotide|octreotide|mesh-list
13910288|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910289|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13910290|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910291|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
13910292|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910293|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910294|NCT03511703|Apatinib|apatinib|mesh-list
13910295|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910296|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13910297|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910298|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910299|NCT03511560|Tacrolimus|tacrolimus|mesh-list
13910300|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13910301|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
13910302|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910303|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13910304|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910305|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910306|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
13910307|NCT03511391|Nivolumab|nivolumab|mesh-list
13910308|NCT03511391|Atezolizumab|atezolizumab|mesh-list
14042630|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042631|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14042632|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042633|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14170011|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14170012|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
14170013|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
14170014|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
14170015|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14170016|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13910309|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13910310|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170017|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13910311|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910312|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910313|NCT03511261|Curcumin|curcumin|mesh-list
13910314|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13910315|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13910316|NCT03511261|Analgesics|analgesics|mesh-ancestor
13910317|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
13910318|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910319|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910320|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13910321|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13910322|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910323|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910324|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910325|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
13910326|NCT03511222|Nivolumab|nivolumab|mesh-list
13910327|NCT03511222|Vorolanib|vorolanib|mesh-list
13910328|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910329|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910330|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13910331|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910332|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13910333|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910334|NCT03511183|Bevacizumab|bevacizumab|mesh-list
13910335|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910336|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910337|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13910338|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13910339|NCT03511183|Growth Substances|growth substances|mesh-ancestor
13910340|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910341|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
13910342|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13910343|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
13910344|NCT03510975|Coagulants|coagulants|mesh-ancestor
13910345|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13910346|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
13910347|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910348|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
13910349|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13910350|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910351|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
13910352|NCT03510871|Nivolumab|nivolumab|mesh-list
13910353|NCT03510871|Ipilimumab|ipilimumab|mesh-list
13910354|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14042634|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
14042635|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14042636|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042637|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042638|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042639|NCT02698930|Analgesics|analgesics|mesh-ancestor
14042640|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
14042641|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042642|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14042643|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14042644|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14042645|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
14042646|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042647|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042648|NCT02698995|Acetaminophen|acetaminophen|mesh-list
14042649|NCT02698995|Dexamethasone|dexamethasone|mesh-list
14042650|NCT02698995|Lidocaine|lidocaine|mesh-list
14042651|NCT02698995|Morphine|morphine|mesh-list
14042652|NCT02698995|Ropivacaine|ropivacaine|mesh-list
14042653|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042654|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
14042655|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
14042656|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042657|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042658|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042659|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
14933286|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14933287|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933288|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933289|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14933290|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13959814|NCT03160079|Blinatumomab|blinatumomab|mesh-list
13959815|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959816|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959817|NCT03159741|Glucagon|glucagon|mesh-list
13959818|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13959819|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959820|NCT03159741|Hormones|hormones|mesh-ancestor
13959821|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959822|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959823|NCT03159741|Incretins|incretins|mesh-ancestor
13959824|NCT03159845|Levofloxacin|levofloxacin|mesh-list
13959825|NCT03159845|Ofloxacin|ofloxacin|mesh-list
14042660|NCT02698995|Hormones|hormones|mesh-ancestor
14042661|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042662|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14042663|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042664|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042665|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
14042666|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042667|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
14042668|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14042669|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14042670|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14042671|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042672|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042673|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14042674|NCT02698995|Narcotics|narcotics|mesh-ancestor
14933291|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14933292|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14933293|NCT01450046|Vitamin E|vitamin e|mesh-list
14042675|NCT02698995|Analgesics|analgesics|mesh-ancestor
14042676|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042677|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
14042678|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
14042679|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14042680|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
14042681|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042682|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
14042683|NCT02698813|Protective Agents|protective agents|mesh-ancestor
14042684|NCT02698553|Bupropion|bupropion|mesh-list
14042685|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14933294|NCT01450046|Tocopherols|tocopherols|mesh-list
14933295|NCT01450046|Tocotrienols|tocotrienols|mesh-list
14474690|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14474691|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14474692|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14474693|NCT02386319|Melatonin|melatonin|mesh-list
14474694|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
14474695|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474696|NCT02386319|Protective Agents|protective agents|mesh-ancestor
14474697|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474698|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910355|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910356|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13910357|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910358|NCT03510793|Anesthetics|anesthetics|mesh-list
13910359|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910360|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756845|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756846|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756847|NCT02349906|Treosulfan|treosulfan|mesh-list
14756848|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14042686|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
14042687|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14042688|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14042689|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14042690|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042691|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042692|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
14042693|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042694|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042695|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14042696|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14042697|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042698|NCT02698514|Sevoflurane|sevoflurane|mesh-list
14042699|NCT02698514|Desflurane|desflurane|mesh-list
14042700|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14042701|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14042702|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
14042703|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
14042704|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756849|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
14756850|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756851|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756852|NCT02341911|Gemcitabine|gemcitabine|mesh-list
14756853|NCT02341911|Carboplatin|carboplatin|mesh-list
14756854|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756855|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14756856|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
14767229|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910375|NCT03510611|Ensartinib|ensartinib|mesh-list
13910376|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910377|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13910378|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910379|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910380|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
13910381|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13910382|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910383|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910384|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
13910385|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910386|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910387|NCT03510533|Autoantibodies|autoantibodies|mesh-list
14933296|NCT01450046|Vitamins|vitamins|mesh-ancestor
14933297|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
14933298|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933299|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
14933300|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933301|NCT01450046|Protective Agents|protective agents|mesh-ancestor
13910388|NCT03510533|alpha-MSH|alpha-msh|mesh-list
13910389|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
13910390|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910391|NCT03510533|Hormones|hormones|mesh-ancestor
13910392|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959826|NCT03159845|Fluconazole|fluconazole|mesh-list
13959827|NCT03159845|Acyclovir|acyclovir|mesh-list
13959828|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
14042705|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042706|NCT02698527|Lidocaine|lidocaine|mesh-list
14042707|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042708|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
14042709|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042710|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042711|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
14042712|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042713|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14042714|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14042715|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14042716|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042717|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959829|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13959830|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959831|NCT03159845|Renal Agents|renal agents|mesh-ancestor
13959832|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959833|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13959834|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959835|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959836|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959837|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042718|NCT02698748|Chloroquine|chloroquine|mesh-list
14042719|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14042720|NCT02698748|Amebicides|amebicides|mesh-ancestor
13959838|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13959839|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13959840|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
13959841|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13959842|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13959843|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
13959844|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13959845|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959846|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13959847|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13959848|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
13959849|NCT03159845|Astringents|astringents|mesh-ancestor
13959850|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
14042721|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14042722|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14933302|NCT01450111|Lacosamide|lacosamide|mesh-list
14933303|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
14933304|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14933305|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14933306|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13959851|NCT03159598|Urethane|urethane|mesh-list
13959852|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756857|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756858|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
14042723|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042724|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
14042725|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14042726|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14042727|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042728|NCT02698748|Analgesics|analgesics|mesh-ancestor
14042729|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
14042730|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042731|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042732|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042733|NCT02698748|Filaricides|filaricides|mesh-ancestor
14756859|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910393|NCT03510416|Apatinib|apatinib|mesh-list
13910394|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910395|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13910396|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910397|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910398|NCT03510351|Tazobactam|tazobactam|mesh-list
13910399|NCT03510351|Ceftolozane|ceftolozane|mesh-list
13910400|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14042734|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
14042735|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
14042736|NCT02698267|Itraconazole|itraconazole|mesh-list
14042737|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
14042738|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042739|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14042740|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14042741|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042742|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042743|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14042744|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
14042745|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042746|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042747|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14042748|NCT02698254|Bevacizumab|bevacizumab|mesh-list
14042749|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14042750|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
14042751|NCT02698254|Antibodies|antibodies|mesh-list
14042752|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
14042753|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14042754|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
14042755|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042756|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14042757|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14042758|NCT02698254|Growth Substances|growth substances|mesh-ancestor
14042759|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042760|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
14042761|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
14042762|NCT02698280|Bevacizumab|bevacizumab|mesh-list
14042763|NCT02698280|Nimustine|nimustine|mesh-list
14042764|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14042765|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042766|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14042767|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14042768|NCT02698280|Growth Substances|growth substances|mesh-ancestor
14042769|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042770|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
14042771|NCT02698124|Decitabine|decitabine|mesh-list
14042772|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14042773|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
14042774|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042775|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042776|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042777|NCT02698306|Dexamethasone|dexamethasone|mesh-list
14042778|NCT02698306|Diclofenac|diclofenac|mesh-list
14042779|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042780|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
14042781|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
14042782|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042783|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042784|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042785|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
14042786|NCT02698306|Hormones|hormones|mesh-ancestor
13910401|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910402|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910403|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13910404|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042787|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042788|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14042789|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042790|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14042791|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14042792|NCT02698306|Analgesics|analgesics|mesh-ancestor
14042793|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
13910405|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910406|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13910407|NCT03510351|Renal Agents|renal agents|mesh-ancestor
13910408|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
13910409|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
13910410|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13910411|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13910412|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910413|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910414|NCT03510338|Urological Agents|urological agents|mesh-ancestor
13910415|NCT03510325|Olanzapine|olanzapine|mesh-list
13910416|NCT03510325|Risperidone|risperidone|mesh-list
13910417|NCT03510325|Aripiprazole|aripiprazole|mesh-list
13910418|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13910419|NCT03510325|Amisulpride|amisulpride|mesh-list
13910420|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13910421|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
13910422|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910423|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910424|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910425|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13910426|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13910427|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910428|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14042794|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756860|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756861|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756862|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
14756863|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042795|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14042796|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042797|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042798|NCT02698098|Methadone|methadone|mesh-list
14042799|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14042800|NCT02698098|Narcotics|narcotics|mesh-ancestor
14042801|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14756864|NCT02336750|Aprepitant|aprepitant|mesh-list
14756865|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
13910429|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14042802|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042803|NCT02698098|Analgesics|analgesics|mesh-ancestor
14042804|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
14042805|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042806|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
14042807|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
14042808|NCT02698228|Morphine|morphine|mesh-list
14042809|NCT02698228|Bupivacaine|bupivacaine|mesh-list
14042810|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042811|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
14042812|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042813|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042814|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
14042815|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042816|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14042817|NCT02698228|Narcotics|narcotics|mesh-ancestor
14042818|NCT02698228|Analgesics|analgesics|mesh-ancestor
14042819|NCT02697955|Epinephrine|epinephrine|mesh-list
14756866|NCT02336750|Mirtazapine|mirtazapine|mesh-list
14756867|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
14756868|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
13910430|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
14042820|NCT02697955|Bupivacaine|bupivacaine|mesh-list
14042821|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
14042822|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
14756869|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14756870|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042823|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042824|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042825|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
14042826|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042827|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14042828|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14042829|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
14042830|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933307|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933308|NCT01450124|Boswellic acid|boswellic acid|mesh-list
14042831|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042832|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14042833|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14042834|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
14042835|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14042836|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
14042837|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
14042838|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
14042839|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14042840|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14042841|NCT02697851|Cobicistat|cobicistat|mesh-list
14042842|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
14042843|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14042844|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14042845|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14042846|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14042847|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
14042848|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14042849|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042850|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14042851|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14042852|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14042853|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14042854|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14042855|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
14042856|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042857|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042858|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14042859|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14042860|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
14042861|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14042862|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14042863|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14042864|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14042865|NCT02697851|Estrogens|estrogens|mesh-ancestor
14042866|NCT02697851|Hormones|hormones|mesh-ancestor
14042867|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042868|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14933309|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933310|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933311|NCT01450124|Analgesics|analgesics|mesh-ancestor
14933312|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
14933313|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933314|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933315|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933316|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933317|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
14933318|NCT01450163|Pregabalin|pregabalin|mesh-list
14042869|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14933319|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910431|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
13910432|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
13910433|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910434|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910435|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13910436|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13910437|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910438|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
13910439|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
13910440|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13910441|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13910442|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14474699|NCT02387164|Vitamin D|vitamin d|mesh-list
14474700|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
14042870|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14042871|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14042872|NCT02697877|Regadenoson|regadenoson|mesh-list
14042873|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14042874|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14042875|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
14042876|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
14042877|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042878|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042879|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042880|NCT02697929|Neostigmine|neostigmine|mesh-list
14042881|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14042882|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042883|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042884|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
14042885|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042886|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042887|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14042888|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
14042889|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042890|NCT02697838|Paclitaxel|paclitaxel|mesh-list
14042891|NCT02697838|Apatinib|apatinib|mesh-list
14042892|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14474701|NCT02387164|Vitamins|vitamins|mesh-ancestor
14756871|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910443|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13910444|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13910445|NCT03510221|Antioxidants|antioxidants|mesh-list
13910446|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910447|NCT03510221|Protective Agents|protective agents|mesh-ancestor
13910448|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042893|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042894|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
14042895|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
14042896|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
14042897|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042898|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14042899|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042900|NCT05324852|Midazolam|midazolam|mesh-list
14042901|NCT05324852|Loxapine|loxapine|mesh-list
14042902|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14042903|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14042904|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910449|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13910450|NCT03510208|Panitumumab|panitumumab|mesh-list
13910451|NCT03510208|Antibodies|antibodies|mesh-list
13910452|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
13910453|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14756872|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14042905|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042906|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14042907|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14042908|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14042909|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14042910|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
14474702|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
14474703|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474704|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14474705|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14474706|NCT02387216|Docetaxel|docetaxel|mesh-list
14042911|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
14042912|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
14042913|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
14042914|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042915|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042916|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14042917|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14042918|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
14042919|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
14042920|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14042921|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14042922|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14042923|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042924|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042925|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
14042926|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042927|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042928|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14042929|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042930|NCT05324800|Turmeric extract|turmeric extract|mesh-list
14042931|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
14756873|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14756874|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756875|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
14756876|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14756877|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13910454|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
13910455|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910456|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756878|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
14756879|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
14756880|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14042932|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042933|NCT05324800|Protective Agents|protective agents|mesh-ancestor
14042934|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042935|NCT05324774|Aflibercept|aflibercept|mesh-list
14042936|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14042937|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14042938|NCT05324774|Growth Substances|growth substances|mesh-ancestor
14042939|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756881|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14756882|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910457|NCT03510078|Insulin|insulin|mesh-list
13910458|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13910459|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910460|NCT03510013|Sevoflurane|sevoflurane|mesh-list
14042940|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
14042941|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042942|NCT05324761|Pregabalin|pregabalin|mesh-list
14042943|NCT05324761|Gabapentin|gabapentin|mesh-list
14042944|NCT05324761|Analgesics|analgesics|mesh-ancestor
14042945|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
14042946|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042947|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042948|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
14042949|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14042950|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14042951|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910461|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
14042952|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13910462|NCT03510013|Anesthetics|anesthetics|mesh-list
14042953|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14042954|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14042955|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14042956|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14042957|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14042958|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14042959|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14042960|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
14042961|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
14042962|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14042963|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14042964|NCT05324748|Prednisolone|prednisolone|mesh-list
14042965|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
14042966|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14042967|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
14042968|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14042969|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
14042970|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
14042971|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14042972|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14042973|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14042974|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
14042975|NCT05324748|Hormones|hormones|mesh-ancestor
14042976|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042977|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14042978|NCT05324748|Protective Agents|protective agents|mesh-ancestor
14042979|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14042980|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14042981|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
14042982|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14042983|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14042984|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14042985|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14042986|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14042987|NCT05324735|Protective Agents|protective agents|mesh-ancestor
14042988|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910463|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13910464|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
13910465|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910466|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910467|NCT03510000|Empagliflozin|empagliflozin|mesh-list
13910468|NCT03510000|Pancrelipase|pancrelipase|mesh-list
13910469|NCT03510000|Hormones|hormones|mesh-list
13910470|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14042989|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
14042990|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14042991|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
14042992|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
13910471|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910472|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13910473|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910474|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14042993|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14042994|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14042995|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14042996|NCT05324618|Tacrolimus|tacrolimus|mesh-list
14042997|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14042998|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
14042999|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043000|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14043001|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043002|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756883|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13910475|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910476|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
13910477|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13910478|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13910479|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043003|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14756884|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14756885|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14170018|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170019|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
14756886|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
14756887|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13910480|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13910481|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13910482|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
14474707|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474708|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14474709|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14474710|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14474711|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474712|NCT02387294|Vaccines|vaccines|mesh-list
14043004|NCT05324592|Aflibercept|aflibercept|mesh-list
14043005|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14043006|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14043007|NCT05324592|Growth Substances|growth substances|mesh-ancestor
14043008|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043009|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
14043010|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043011|NCT05324501|Lomustine|lomustine|mesh-list
14043012|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14043013|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
14043014|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474713|NCT02387294|Immunologic Factors|immunologic factors|mesh-ancestor
14474714|NCT02387294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474715|NCT02387359|Plecanatide|plecanatide|mesh-list
14474716|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14474717|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
14474718|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474719|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474720|NCT02387372|Tazobactam|tazobactam|mesh-list
14474721|NCT02387372|Ceftolozane|ceftolozane|mesh-list
14474722|NCT02387372|Cephalosporins|cephalosporins|mesh-list
13910483|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910484|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910485|NCT03509831|Irsogladine|irsogladine|mesh-list
14043015|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043016|NCT05324462|Xultophy|xultophy|mesh-list
14043017|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14043018|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043019|NCT05324462|Incretins|incretins|mesh-ancestor
14043020|NCT05324462|Hormones|hormones|mesh-ancestor
14043021|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043022|NCT05324449|Cannabidiol|cannabidiol|mesh-list
14043023|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
14043024|NCT05324423|Colchicine|colchicine|mesh-list
14043025|NCT05324423|Febuxostat|febuxostat|mesh-list
14043026|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
14043027|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043028|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
14043029|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
14043030|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
14043031|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910486|NCT03509831|Nizatidine|nizatidine|mesh-list
14756888|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14756889|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
13910487|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910488|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13910489|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910490|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13910491|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
13910492|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
13910493|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043032|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474723|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14474724|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
14474725|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14756890|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14756891|NCT02307812|Paclitaxel|paclitaxel|mesh-list
14756892|NCT02307812|Ramucirumab|ramucirumab|mesh-list
14756893|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756894|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756895|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756896|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756897|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756898|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756899|NCT02268175|Prednisone|prednisone|mesh-list
14756900|NCT02268175|Leuprolide|leuprolide|mesh-list
13910494|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910495|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043033|NCT05324384|Sirolimus|sirolimus|mesh-list
14043034|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14043035|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043036|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14043037|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910496|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14933320|NCT01450163|Analgesics|analgesics|mesh-ancestor
14933321|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
14933322|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933323|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933324|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
14933325|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14933326|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14933327|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043038|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
14043039|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043040|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
14043041|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043042|NCT05324358|Ketorolac|ketorolac|mesh-list
14043043|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14043044|NCT05324358|Morphine|morphine|mesh-list
14043045|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14043046|NCT05324358|Narcotics|narcotics|mesh-ancestor
14043047|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043048|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043049|NCT05324358|Analgesics|analgesics|mesh-ancestor
14043050|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
14043051|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043052|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14043053|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14043054|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043055|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043056|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14043057|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043058|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043059|NCT05324332|Edetic Acid|edetic acid|mesh-list
14043060|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14043061|NCT05324332|Anticoagulants|anticoagulants|mesh-ancestor
14043062|NCT05324332|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14043063|NCT05324332|Chelating Agents|chelating agents|mesh-ancestor
14043064|NCT05324332|Sequestering Agents|sequestering agents|mesh-ancestor
14043065|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043066|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14933328|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13910497|NCT03509831|Protective Agents|protective agents|mesh-ancestor
13910498|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13910499|NCT03509740|Acetaminophen|acetaminophen|mesh-list
13910500|NCT03509740|Tramadol|tramadol|mesh-list
13910501|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13910502|NCT03509740|Analgesics|analgesics|mesh-ancestor
13910503|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
13910504|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910505|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910506|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
13910507|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13910508|NCT03509740|Narcotics|narcotics|mesh-ancestor
13910509|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910510|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
13910511|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
13910512|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910513|NCT03509714|Protective Agents|protective agents|mesh-ancestor
13910514|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910515|NCT03509714|Vitamins|vitamins|mesh-ancestor
13910516|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
13910517|NCT03509701|Antibodies|antibodies|mesh-list
13910518|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
13910519|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910520|NCT03509688|Entecavir|entecavir|mesh-list
13910521|NCT03509688|Resveratrol|resveratrol|mesh-list
13910522|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
13910523|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910524|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
13910525|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910526|NCT03509688|Protective Agents|protective agents|mesh-ancestor
13910527|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043080|NCT05323981|Pertuzumab|pertuzumab|mesh-list
14043081|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043082|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043083|NCT05323955|Trastuzumab|trastuzumab|mesh-list
14043084|NCT05323955|Pertuzumab|pertuzumab|mesh-list
13910528|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910529|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13910530|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
13910531|NCT03509662|Thiamine|thiamine|mesh-list
14043085|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14043086|NCT05323955|Maytansine|maytansine|mesh-list
13910532|NCT03509662|Vitamins|vitamins|mesh-ancestor
13910533|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
14474726|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474727|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14474728|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474729|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474730|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14043087|NCT05323955|Tucatinib|tucatinib|mesh-list
14043088|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043089|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043090|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14043091|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
14043092|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
14043093|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
14043094|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043095|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14043096|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043097|NCT05323812|Edaravone|edaravone|mesh-list
14043098|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14043099|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
14043100|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043101|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14043102|NCT05323812|Protective Agents|protective agents|mesh-ancestor
14043103|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043104|NCT05323786|Anesthetics|anesthetics|mesh-list
14043105|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043106|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043107|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
14043108|NCT05323721|Piperaquine|piperaquine|mesh-list
14043109|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
14043110|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14043111|NCT05323721|Amodiaquine|amodiaquine|mesh-list
14043112|NCT05323721|Artenimol|artenimol|mesh-list
14756901|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
13910534|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910535|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
13910536|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756902|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13910537|NCT03509662|Protective Agents|protective agents|mesh-ancestor
13910538|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
13910539|NCT03509584|Nivolumab|nivolumab|mesh-list
13910540|NCT03509584|Ipilimumab|ipilimumab|mesh-list
14043113|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
14043114|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13910541|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910542|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910543|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13910544|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910545|NCT03509545|Torsemide|torsemide|mesh-list
13910546|NCT03509545|Furosemide|furosemide|mesh-list
13910547|NCT03509545|Diuretics|diuretics|mesh-ancestor
13910548|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
13910549|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910550|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13910551|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910552|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910553|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13910554|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
13910555|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13910556|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910557|NCT03509298|Antibodies|antibodies|mesh-list
14043115|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14474731|NCT02387372|Renal Agents|renal agents|mesh-ancestor
14756903|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
14756904|NCT02268175|Hormones|hormones|mesh-ancestor
14756905|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14756906|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756907|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14756908|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756909|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14756910|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
14756911|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14756912|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14756913|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756914|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756915|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
14756916|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14474732|NCT02387554|Losartan|losartan|mesh-list
14474733|NCT02387554|Amlodipine|amlodipine|mesh-list
14474734|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
14474735|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14474736|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14474737|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474738|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474739|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14474740|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474741|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
14474742|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14474743|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14474744|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14474745|NCT02387554|Diuretics|diuretics|mesh-ancestor
14756926|NCT02178709|Leucovorin|leucovorin|mesh-list
13910558|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13910559|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
13910560|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910561|NCT03509285|Cenobamate|cenobamate|mesh-list
13910562|NCT03509285|Alprazolam|alprazolam|mesh-list
13910563|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13910564|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933329|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14933330|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14933331|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933332|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14933333|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14933334|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
14933335|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14933336|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14933337|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933338|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13910565|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910566|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13910567|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13910568|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13910569|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
13910570|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
13910571|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910572|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910573|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
13910574|NCT03509246|Doxorubicin|doxorubicin|mesh-list
13910575|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13910576|NCT03509246|Bortezomib|bortezomib|mesh-list
13910577|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13910578|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910579|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13910580|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14043116|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043117|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14043118|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043119|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043120|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13910581|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910582|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910583|NCT03509168|Misoprostol|misoprostol|mesh-list
13910584|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13910585|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
13910586|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13910587|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043121|NCT05323721|Renal Agents|renal agents|mesh-ancestor
14043122|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
14043123|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043124|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043125|NCT05323617|Cyclosporine|cyclosporine|mesh-list
14043126|NCT05323617|Cyclosporins|cyclosporins|mesh-list
14043127|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14043128|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043129|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043130|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043131|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
14043132|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043133|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
14043134|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043135|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474746|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
13910588|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14043136|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043137|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14756927|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
13910589|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910590|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
14756928|NCT02178709|Irinotecan|irinotecan|mesh-list
14756929|NCT02178709|Folfirinox|folfirinox|mesh-list
14756930|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756931|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14756932|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14756933|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756934|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756935|NCT02178709|Antidotes|antidotes|mesh-ancestor
14756936|NCT02178709|Protective Agents|protective agents|mesh-ancestor
14043138|NCT05323565|Dexamethasone|dexamethasone|mesh-list
14933339|NCT01450176|Analgesics|analgesics|mesh-ancestor
14933340|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
13910591|NCT03509142|Sirolimus|sirolimus|mesh-list
13910592|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910593|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910594|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13910595|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910596|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
13910597|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13910598|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
13910599|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910600|NCT03509051|Vaccines|vaccines|mesh-list
13910601|NCT03509051|Immunologic Factors|immunologic factors|mesh-ancestor
13910602|NCT03509051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910603|NCT03508999|Metronidazole|metronidazole|mesh-list
13910604|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910605|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910606|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13910607|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13910608|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13910609|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13910610|NCT03508921|Trimethoprim|trimethoprim|mesh-list
13910611|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
13910612|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13910613|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13910614|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910615|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
13910616|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13910617|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910618|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910619|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13910620|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910621|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910622|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
13910623|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910624|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13910625|NCT03508921|Renal Agents|renal agents|mesh-ancestor
13910626|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
13910627|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13910628|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13910629|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13910630|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910631|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13910632|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13910633|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13910634|NCT03508895|Caseins|caseins|mesh-list
13910635|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
13910636|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
13910637|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910638|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
13910639|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13910640|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13910641|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13910642|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910643|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910644|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
13910645|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910646|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910647|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13910648|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910649|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13910650|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13910651|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14043139|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
14933341|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910652|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13910653|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13910654|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13910655|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13910656|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910657|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910658|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910659|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043140|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043141|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
14043142|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
14043143|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043144|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043145|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14043146|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
14043147|NCT05323565|Hormones|hormones|mesh-ancestor
14043148|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043149|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14043150|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043151|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043152|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14043153|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474747|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14474748|NCT02387580|Artefenomel|artefenomel|mesh-list
14474749|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
14474750|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14474751|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14474752|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474753|NCT02387710|Tiagabine|tiagabine|mesh-list
14474754|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
14474755|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
14933342|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933343|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933344|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933345|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14933346|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14933347|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14933348|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
14933349|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
14933350|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933351|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933352|NCT01450215|Lenalidomide|lenalidomide|mesh-list
14043154|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14043155|NCT05323565|Analgesics|analgesics|mesh-ancestor
14043156|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
14043157|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14043158|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14043159|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14043160|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
14043161|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043162|NCT05323487|Bumetanide|bumetanide|mesh-list
14043163|NCT05323487|Diuretics|diuretics|mesh-ancestor
14043164|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
14043165|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043166|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14043167|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14043168|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043169|NCT05323435|Vaccines|vaccines|mesh-list
14043170|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
14043171|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043172|NCT05323422|Ketamine|ketamine|mesh-list
14043173|NCT05323422|Analgesics|analgesics|mesh-ancestor
14043174|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
14043175|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043176|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043177|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14043178|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14043179|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
14043180|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
14043181|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043182|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14043183|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14043184|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043185|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043186|NCT05323396|Metronidazole|metronidazole|mesh-list
14043187|NCT05323396|Albendazole|albendazole|mesh-list
14043188|NCT05323396|Praziquantel|praziquantel|mesh-list
14043189|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
14043190|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14756937|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756938|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
14756939|NCT02178709|Vitamins|vitamins|mesh-ancestor
14756940|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
14756941|NCT02117791|Riociguat|riociguat|mesh-list
14756942|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
14043191|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14043192|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14043193|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
14043194|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
14043195|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14043196|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
14043197|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
14043198|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
14043199|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474756|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14474757|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14756943|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756944|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
14756945|NCT02066220|Lomustine|lomustine|mesh-list
14043200|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756946|NCT02066220|Cisplatin|cisplatin|mesh-list
14043201|NCT05323214|Fentanyl|fentanyl|mesh-list
14474758|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474759|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
13910660|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13910661|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910662|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
13910663|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13910664|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959853|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13959854|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
13959855|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
13959856|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959857|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959858|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13959859|NCT03159754|Metronidazole|metronidazole|mesh-list
13959860|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
13959861|NCT03159754|Tazobactam|tazobactam|mesh-list
13959862|NCT03159754|Piperacillin|piperacillin|mesh-list
13959863|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13959864|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959865|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14474760|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959866|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13959867|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13959868|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13959869|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959870|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043202|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
14043203|NCT05323214|Analgesics|analgesics|mesh-list
14043204|NCT05323214|Bupivacaine|bupivacaine|mesh-list
14043205|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
14043206|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
14043207|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043208|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043209|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
14043210|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043211|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14043212|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14043213|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14043214|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14043215|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14043216|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
14043217|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043218|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043219|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14043220|NCT05323214|Narcotics|narcotics|mesh-ancestor
14043221|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14043222|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14043223|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
14043224|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
14043225|NCT05323201|Fludarabine|fludarabine|mesh-list
14043226|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043227|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
14043228|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043229|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043230|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14043231|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
14043232|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043233|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043234|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14043235|NCT05323175|Ropivacaine|ropivacaine|mesh-list
14043236|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
14043237|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
14043238|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043239|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043240|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
14043241|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043242|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
14043243|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14043244|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14043245|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043246|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
14043247|NCT05323149|Coagulants|coagulants|mesh-ancestor
14043248|NCT05323019|Ketamine|ketamine|mesh-list
14043249|NCT05323019|Esketamine|esketamine|mesh-list
13910665|NCT03508817|Atropine|atropine|mesh-list
13910666|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13910667|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14043250|NCT05323019|Analgesics|analgesics|mesh-ancestor
14043251|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
14043252|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043253|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043254|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14043255|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14043256|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
14043257|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
14043258|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043259|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14043260|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14043261|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043262|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043263|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
14043264|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14170020|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14170021|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170022|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14170023|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14170024|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170025|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
14170026|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
14170027|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14170028|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14170029|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14182964|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182965|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14182966|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182967|NCT04731558|Enoxaparin|enoxaparin|mesh-list
13910668|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13910669|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13910670|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13910671|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
13910672|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474761|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474762|NCT02387762|Methotrexate|methotrexate|mesh-list
13910673|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910674|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14182968|NCT04731558|Dalteparin|dalteparin|mesh-list
14756947|NCT02066220|Carboplatin|carboplatin|mesh-list
14756948|NCT02066220|Vincristine|vincristine|mesh-list
14756949|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14756950|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
14756951|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910675|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
13910676|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
13910677|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
13910678|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14474763|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
14474764|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14474765|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
14474766|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14474767|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474768|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14474769|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
14474770|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910679|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13910680|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
13910681|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910682|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182969|NCT04731558|Tinzaparin|tinzaparin|mesh-list
14474771|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474772|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14756952|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13910683|NCT03508804|Lidocaine|lidocaine|mesh-list
14182970|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14182971|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
14182972|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14474773|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910684|NCT03508804|Prilocaine|prilocaine|mesh-list
14182973|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14474774|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14043265|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
14474775|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14474776|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
14474777|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474778|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14043270|NCT05322889|Telmisartan|telmisartan|mesh-list
14043271|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14043272|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14043273|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14043274|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043275|NCT05322720|Paclitaxel|paclitaxel|mesh-list
14043276|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14043277|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14043278|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043279|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14043280|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
14043281|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14043282|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043283|NCT05322707|Budesonide|budesonide|mesh-list
14043284|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
14043285|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14043286|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043287|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14043288|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
14043289|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043290|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043291|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14043292|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
14043293|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
14043294|NCT05322707|Hormones|hormones|mesh-ancestor
14043295|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043296|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14043297|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14043298|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14043299|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
14043300|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043301|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043302|NCT05322681|Pregabalin|pregabalin|mesh-list
14043303|NCT05322681|Analgesics|analgesics|mesh-ancestor
14043304|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
14043305|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043306|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043307|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
14043308|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14043309|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14043310|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043311|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14043312|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14043313|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043314|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043315|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043316|NCT05322603|Diclofenac|diclofenac|mesh-list
14043317|NCT05322603|Morphine|morphine|mesh-list
14043318|NCT05322603|Analgesics|analgesics|mesh-list
14043319|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
14043320|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14043321|NCT05322603|Narcotics|narcotics|mesh-ancestor
14043322|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474779|NCT02387801|Ixekizumab|ixekizumab|mesh-list
14474780|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474781|NCT02387957|Bevacizumab|bevacizumab|mesh-list
14474782|NCT02387957|Ranibizumab|ranibizumab|mesh-list
14474783|NCT02387957|Aflibercept|aflibercept|mesh-list
14474784|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14474785|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474786|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14474787|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14933353|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
14043323|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043324|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
14043325|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043326|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14043327|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043328|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043329|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14043330|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043331|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043332|NCT05322577|Nivolumab|nivolumab|mesh-list
14043333|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
14043334|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043335|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043336|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14043337|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043338|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
14043339|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14043340|NCT05322564|Narcotics|narcotics|mesh-ancestor
14043341|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043342|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043343|NCT05322564|Analgesics|analgesics|mesh-ancestor
14043344|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
14043345|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043346|NCT05322538|Vitamin D|vitamin d|mesh-list
14043347|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
14043348|NCT05322538|Vitamins|vitamins|mesh-list
14043349|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14043350|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
14043351|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043352|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14043353|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14043354|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14043355|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14043356|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043357|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043358|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043359|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043360|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14043361|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14043362|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
14043363|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043364|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043365|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13910685|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13910686|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
13910687|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
13910688|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910689|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910690|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
13910691|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043366|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14043367|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
14043368|NCT05321394|Ritonavir|ritonavir|mesh-list
14043369|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14043370|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14043371|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
14043372|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043373|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043374|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14043375|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14474788|NCT02387957|Growth Substances|growth substances|mesh-ancestor
14474789|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474790|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
14043376|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
14043377|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043378|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14043379|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14043380|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
14043381|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14043382|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14043383|NCT05317624|Prednisolone|prednisolone|mesh-list
14043384|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
14043385|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14043386|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
14043387|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043388|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
14043389|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
14043390|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043391|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043392|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14043393|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
14474791|NCT02387983|Posaconazole|posaconazole|mesh-list
14474792|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
14474793|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474794|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14474795|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14474796|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14474797|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14474798|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14474799|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474800|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474801|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14474802|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
14474803|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14474804|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474805|NCT02388165|Vaccines|vaccines|mesh-list
14474806|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
14474807|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474808|NCT02388191|Naproxen|naproxen|mesh-list
13910692|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13910693|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13910694|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13910695|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910696|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910697|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13910698|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
13910699|NCT03508726|Vitamins|vitamins|mesh-ancestor
13910700|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
13910701|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910702|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
13910703|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910704|NCT03508726|Protective Agents|protective agents|mesh-ancestor
14043394|NCT05317624|Hormones|hormones|mesh-ancestor
14043395|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043396|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14043397|NCT05317624|Protective Agents|protective agents|mesh-ancestor
14043398|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14043399|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910705|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
13910706|NCT03508635|Prednisone|prednisone|mesh-list
13910707|NCT03508635|Cortisone|cortisone|mesh-list
13910708|NCT03508635|Mifepristone|mifepristone|mesh-list
13910709|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13910710|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
13910711|NCT03508635|Hormones|hormones|mesh-ancestor
14043400|NCT05309655|Adenosine|adenosine|mesh-list
14043401|NCT05309655|Analgesics|analgesics|mesh-ancestor
14043402|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
14043403|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043404|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043405|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14043406|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
14043407|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14043408|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
14043409|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
14043410|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043411|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043412|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
14043413|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14043414|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14043415|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043416|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
14043417|NCT05309525|Coagulants|coagulants|mesh-ancestor
14043418|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14043419|NCT05308446|Nivolumab|nivolumab|mesh-list
14043420|NCT05308446|Cetuximab|cetuximab|mesh-list
14933354|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043421|NCT05308446|Antibodies|antibodies|mesh-list
14043422|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
14043423|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14043424|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
14043425|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043426|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043427|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14043428|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933355|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14933356|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14933357|NCT01450215|Growth Substances|growth substances|mesh-ancestor
14933358|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
14933359|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933360|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14933361|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910712|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14474809|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14474810|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14474811|NCT02388191|Analgesics|analgesics|mesh-ancestor
14474812|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
14474813|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910713|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910714|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13910715|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910716|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13910717|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
13910718|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13910719|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13910720|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13910721|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13910722|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
13910723|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13910724|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13910725|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
13910726|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
13910727|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13910728|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13910729|NCT03508440|Prednisone|prednisone|mesh-list
13910730|NCT03508440|Prednisolone|prednisolone|mesh-list
13910731|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13910732|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
14933362|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14933363|NCT01450345|Pregabalin|pregabalin|mesh-list
14933364|NCT01450345|Analgesics|analgesics|mesh-ancestor
13910733|NCT03508440|Hormones|hormones|mesh-ancestor
13910734|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13910735|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910736|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13910737|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043429|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14043430|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043431|NCT05305313|Propofol|propofol|mesh-list
14933365|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
14933366|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933367|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933368|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
14933369|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14933370|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14933371|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933372|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14933373|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14933374|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14933375|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043432|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14043433|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043434|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043435|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14043436|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
14043437|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
14043438|NCT05304585|Dactinomycin|dactinomycin|mesh-list
14043439|NCT05304585|Cactinomycin|cactinomycin|mesh-list
14043440|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
14043441|NCT05304585|Vincristine|vincristine|mesh-list
14043442|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043443|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
14043444|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043445|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043446|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14043447|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
14043448|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043449|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043450|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14043451|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14043452|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14043453|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
14043454|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14043455|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14043456|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170030|NCT04836143|Mitogens|mitogens|mesh-list
14043457|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14043458|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14043459|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043460|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14043461|NCT05300594|Vitamins|vitamins|mesh-list
14043462|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
14043463|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043464|NCT05300451|Daratumumab|daratumumab|mesh-list
14043465|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043466|NCT05300152|Antibodies|antibodies|mesh-list
14043467|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
14043468|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
14043469|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043470|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14043471|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
14043472|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043473|NCT05297851|Riboflavin|riboflavin|mesh-list
14043474|NCT05297851|Niacinamide|niacinamide|mesh-list
14043475|NCT05297851|Niacin|niacin|mesh-list
14043476|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
14043477|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
14043478|NCT05297851|Vitamins|vitamins|mesh-ancestor
14043479|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
14043480|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043481|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14474814|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474815|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14474816|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474817|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
14474818|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14474819|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910738|NCT03508102|Remifentanil|remifentanil|mesh-list
13910739|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13910740|NCT03508102|Narcotics|narcotics|mesh-ancestor
13910741|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910742|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910743|NCT03508102|Analgesics|analgesics|mesh-ancestor
13910744|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
13910745|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910746|NCT03507842|Cytarabine|cytarabine|mesh-list
13910747|NCT03507842|Daunorubicin|daunorubicin|mesh-list
13910748|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13910749|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
13910750|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910751|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910752|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
13910753|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910754|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767230|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13910755|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
14043482|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
14043483|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14043484|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
13910756|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910757|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13910758|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14474820|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474821|NCT02388321|Fentanyl|fentanyl|mesh-list
14474822|NCT02388321|Ketamine|ketamine|mesh-list
14474823|NCT02388321|Analgesics|analgesics|mesh-ancestor
14474824|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
14474825|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474826|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474827|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14474828|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13910759|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13910760|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910761|NCT03507829|Insulin|insulin|mesh-list
14474829|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
14474830|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
14474831|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043485|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043486|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14043487|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
14756953|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14756954|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
14043488|NCT05295394|Lamivudine|lamivudine|mesh-list
14043489|NCT05295394|Dolutegravir|dolutegravir|mesh-list
14043490|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14043491|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14043492|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043493|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043494|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
14043495|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043496|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14043497|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14043498|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14043499|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14043500|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
14043501|NCT05273632|Oxytocin|oxytocin|mesh-list
14043502|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
14043503|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14043504|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043505|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14043506|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14043507|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043508|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
14043509|NCT05273632|Coagulants|coagulants|mesh-ancestor
14043510|NCT05266846|Bevacizumab|bevacizumab|mesh-list
14043511|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
14043512|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043513|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043514|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14043515|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14043516|NCT05266846|Growth Substances|growth substances|mesh-ancestor
14043517|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043518|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
14043519|NCT05261139|Ritonavir|ritonavir|mesh-list
14043520|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14043521|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14043522|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
14043523|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043524|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474832|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14756955|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910762|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13910763|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
14043525|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14043526|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14474833|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14043527|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
14043528|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043529|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14043530|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14043531|NCT05257629|Nicotine|nicotine|mesh-list
14043532|NCT05257629|Varenicline|varenicline|mesh-list
14043533|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14043534|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
14043535|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043536|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043537|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14043538|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14043539|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
14043540|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043541|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043542|NCT05249426|Cetuximab|cetuximab|mesh-list
14043543|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043544|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170031|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
14170032|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
14170033|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170034|NCT04836143|Growth Substances|growth substances|mesh-ancestor
14170035|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170036|NCT04836299|Ivermectin|ivermectin|mesh-list
14170037|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14474834|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474835|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474836|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14474837|NCT02388321|Narcotics|narcotics|mesh-ancestor
14474838|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14479152|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479153|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479154|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
14479155|NCT02464176|Hormones|hormones|mesh-ancestor
14479156|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479157|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14933376|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14170038|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170039|NCT04835870|Prednisone|prednisone|mesh-list
14170040|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
14170041|NCT04835870|Rituximab|rituximab|mesh-list
14170042|NCT04835870|Doxorubicin|doxorubicin|mesh-list
14170043|NCT04835870|Vincristine|vincristine|mesh-list
14170044|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
14170045|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170046|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
14170047|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170048|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170049|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14170050|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
14170051|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170052|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170053|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14170054|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170055|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14170056|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14170057|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14170058|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170059|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170060|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
14170061|NCT04835870|Hormones|hormones|mesh-ancestor
14170062|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170063|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14170064|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14170065|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
14170066|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
14170067|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
14170068|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170069|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14170070|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
14170071|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170072|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170073|NCT04835623|Cyclosporine|cyclosporine|mesh-list
14170074|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14933377|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14043545|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
14043546|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043547|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043548|NCT05228041|Benralizumab|benralizumab|mesh-list
14043549|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14043550|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
14043551|NCT05210062|Succinylcholine|succinylcholine|mesh-list
14043552|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14043553|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14043554|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14043555|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043556|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043557|NCT05205447|Itraconazole|itraconazole|mesh-list
14043558|NCT05205447|Carbamazepine|carbamazepine|mesh-list
14043559|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
14043560|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043561|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14043562|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14043563|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043564|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043565|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14043566|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
14043567|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043568|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043569|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14043570|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
14043571|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
14043572|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043573|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043574|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043575|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14043576|NCT05205447|Analgesics|analgesics|mesh-ancestor
14043577|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
14043578|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474839|NCT02388724|Lansoprazole|lansoprazole|mesh-list
14474840|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
14474841|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14474842|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474843|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14474844|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474845|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474846|NCT02388737|Lansoprazole|lansoprazole|mesh-list
14474847|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
14474848|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14474849|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474850|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14474851|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474852|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474853|NCT02388997|Omalizumab|omalizumab|mesh-list
14474854|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14474855|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14474856|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
14474857|NCT02389088|Letrozole|letrozole|mesh-list
14474858|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474859|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13910764|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
13910765|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
13910766|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
13910767|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13910768|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910769|NCT03507751|Meropenem|meropenem|mesh-list
14043579|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14043580|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474860|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13910770|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910771|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910772|NCT03507699|Nivolumab|nivolumab|mesh-list
13910773|NCT03507699|Ipilimumab|ipilimumab|mesh-list
13910774|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910775|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910776|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13910777|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910778|NCT03507634|Lidocaine|lidocaine|mesh-list
14474861|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910779|NCT03507634|Fentanyl|fentanyl|mesh-list
13910780|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
14043581|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14043582|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14043583|NCT05196932|Antibodies|antibodies|mesh-list
14043584|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
14043585|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043586|NCT05182658|Empagliflozin|empagliflozin|mesh-list
14043587|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14043588|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043589|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13910781|NCT03507634|Remifentanil|remifentanil|mesh-list
13910782|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
13910783|NCT03507634|Anesthetics|anesthetics|mesh-list
13910784|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
13910785|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043590|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043591|NCT05180474|Antibodies|antibodies|mesh-list
14043592|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14043593|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
14043594|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756956|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756957|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14756958|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14756959|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
14756960|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
14756961|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
14756962|NCT02065765|Ramucirumab|ramucirumab|mesh-list
14756963|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756964|NCT01991457|Fludarabine|fludarabine|mesh-list
14756965|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756966|NCT01969643|Trastuzumab|trastuzumab|mesh-list
14756967|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043607|NCT05151744|Ranibizumab|ranibizumab|mesh-list
14043608|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14043609|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14043610|NCT05151744|Growth Substances|growth substances|mesh-ancestor
14043611|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043612|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
14043613|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043614|NCT05151731|Ranibizumab|ranibizumab|mesh-list
14043615|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14043616|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14043617|NCT05151731|Growth Substances|growth substances|mesh-ancestor
14043618|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043619|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
14043620|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043621|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14043622|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14043623|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910786|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910787|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
13910788|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910789|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13910790|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13910791|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13910792|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13910793|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910794|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13910795|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13910796|NCT03507634|Analgesics|analgesics|mesh-ancestor
13910797|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13910798|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13910799|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13910800|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910801|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910802|NCT03507634|Narcotics|narcotics|mesh-ancestor
13910803|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13910804|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13910805|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
13910806|NCT03507608|Flutamide|flutamide|mesh-list
13910807|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
13910808|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
13910809|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043624|NCT05136690|Nicotine|nicotine|mesh-list
14756968|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910810|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910811|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13910812|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910813|NCT03507556|Metronidazole|metronidazole|mesh-list
13910814|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
13910815|NCT03507556|Minocycline|minocycline|mesh-list
13910816|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
14043625|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14043626|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
14043627|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043628|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043629|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14043630|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14043631|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
14043632|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043633|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043634|NCT05130268|Dronedarone|dronedarone|mesh-list
14043635|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13910817|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910818|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13910819|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13910820|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13910821|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13910822|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13910823|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910824|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910825|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910826|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13910827|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13910828|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
13910829|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
13910830|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13910831|NCT03507556|Protective Agents|protective agents|mesh-ancestor
13910832|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910833|NCT03507465|Capecitabine|capecitabine|mesh-list
13910834|NCT03507465|Letrozole|letrozole|mesh-list
13910835|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13910836|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
13910837|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910838|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910839|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14474862|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910840|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13910841|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910842|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13910843|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
13910844|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13910845|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910846|NCT03507426|Ketamine|ketamine|mesh-list
13910847|NCT03507426|Analgesics|analgesics|mesh-ancestor
13910848|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
13910849|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910850|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910851|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13910852|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13910853|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
13910854|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
14043636|NCT05115513|Dronabinol|dronabinol|mesh-list
14474863|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14043637|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
14043638|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043639|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043640|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14043641|NCT05115513|Analgesics|analgesics|mesh-ancestor
14043642|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
14043643|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043644|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14043645|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14043646|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043647|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043648|NCT05115513|Hormones|hormones|mesh-ancestor
14043649|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043650|NCT05113940|Midazolam|midazolam|mesh-list
13910855|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910856|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14043651|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14043652|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14043653|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043654|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043655|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14043656|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043657|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043658|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14043659|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
14043660|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
14043661|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
14043662|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
14043663|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043664|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043665|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14043666|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
14043667|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043668|NCT05096169|Citric Acid|citric acid|mesh-list
14043669|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
14043670|NCT05096169|Clomiphene|clomiphene|mesh-list
14043671|NCT05096169|Enclomiphene|enclomiphene|mesh-list
14043672|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
14474864|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
14474865|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14474866|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474867|NCT02389361|Acetaminophen|acetaminophen|mesh-list
14474868|NCT02389361|Tramadol|tramadol|mesh-list
14474869|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14474870|NCT02389361|Analgesics|analgesics|mesh-ancestor
14474871|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
14474872|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474873|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474874|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
14474875|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14756969|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
13910857|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13910858|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910859|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910860|NCT03507413|Metformin|metformin|mesh-list
13910861|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13910862|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910863|NCT03507387|Phenylephrine|phenylephrine|mesh-list
13910864|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
13910865|NCT03507387|Bupivacaine|bupivacaine|mesh-list
13910866|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
13910867|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
13910868|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910869|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910870|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
14043673|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
14043674|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14043675|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
14474876|NCT02389361|Narcotics|narcotics|mesh-ancestor
14043676|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
14043677|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043678|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14043679|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
14474877|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13910871|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910872|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13910873|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
13910874|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
13910875|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
13910876|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13910877|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
13910878|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
13910879|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13910880|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13910881|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13910882|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
13910883|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910884|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910885|NCT03507387|Protective Agents|protective agents|mesh-ancestor
14043680|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14474878|NCT02389374|Chloroquine|chloroquine|mesh-list
14474879|NCT02389374|Lumefantrine|lumefantrine|mesh-list
14474880|NCT02389374|Artemether|artemether|mesh-list
14474881|NCT02389374|Primaquine|primaquine|mesh-list
14474882|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14474883|NCT02389374|Amebicides|amebicides|mesh-ancestor
14474884|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14474885|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14474886|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14474887|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
14474888|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14474889|NCT02389452|Hylan|hylan|mesh-list
14474890|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
14474891|NCT02389452|Protective Agents|protective agents|mesh-ancestor
14474892|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474893|NCT02389738|Temozolomide|temozolomide|mesh-list
14043681|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043682|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14043683|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
14043684|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14043685|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14043686|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14043687|NCT05076149|Ivacaftor|ivacaftor|mesh-list
14043688|NCT05076149|Elexacaftor|elexacaftor|mesh-list
14043689|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14043690|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14043691|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043692|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14043693|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14170075|NCT04835623|Cyclosporins|cyclosporins|mesh-list
14170076|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170077|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170078|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170079|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
14170080|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170081|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
14170082|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170083|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
14170084|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170085|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14170086|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14170087|NCT04835922|Anesthetics|anesthetics|mesh-list
14474894|NCT02389738|Regadenoson|regadenoson|mesh-list
14474895|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14474896|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
13910886|NCT03507348|Rituximab|rituximab|mesh-list
13910887|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910888|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910889|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
13910890|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910891|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959871|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959872|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13959873|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13959874|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13959875|NCT03159702|Fludarabine|fludarabine|mesh-list
13959876|NCT03159702|Melphalan|melphalan|mesh-list
13959877|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474897|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474898|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474899|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14474900|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14474901|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
14474902|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
14043694|NCT05063656|Gabapentin|gabapentin|mesh-list
14043695|NCT05063656|Analgesics|analgesics|mesh-ancestor
14043696|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
14043697|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043698|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043699|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
14043700|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14043701|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043702|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474903|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959878|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959879|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043703|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043704|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14043705|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14043706|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043707|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043708|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
14043709|NCT05059860|Insulin|insulin|mesh-list
14043710|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14043711|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043712|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14043713|NCT05055128|Lansoprazole|lansoprazole|mesh-list
14043714|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
14043715|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14043716|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13959880|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
13959881|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959882|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14474904|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474905|NCT02389764|Nintedanib|nintedanib|mesh-list
14474906|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474907|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14474908|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474909|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474910|NCT02389816|Vortioxetine|vortioxetine|mesh-list
14474911|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
14043717|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14043718|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043719|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043720|NCT05048498|Azacitidine|azacitidine|mesh-list
14043721|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13959883|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
14043722|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
14043723|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910892|NCT03507244|Dexamethasone|dexamethasone|mesh-list
13910893|NCT03507244|Pemetrexed|pemetrexed|mesh-list
13910894|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13910895|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
13910896|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
13910897|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910898|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910899|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910900|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
13910901|NCT03507244|Hormones|hormones|mesh-ancestor
13910902|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13910903|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13910904|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910905|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910906|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910907|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13910908|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13910909|NCT03507231|Vaccines|vaccines|mesh-list
13910910|NCT03507231|Immunologic Factors|immunologic factors|mesh-ancestor
13910911|NCT03507231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043724|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043725|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043726|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14043727|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14043728|NCT05036226|Metformin|metformin|mesh-list
14043729|NCT05036226|Sirolimus|sirolimus|mesh-list
14043730|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
14043731|NCT05036226|Nelfinavir|nelfinavir|mesh-list
14043732|NCT05036226|Dasatinib|dasatinib|mesh-list
14043733|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14043734|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043735|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14043736|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043737|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14043738|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043739|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
14043740|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043741|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
14043742|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
14043743|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13910912|NCT03507166|Trastuzumab|trastuzumab|mesh-list
14043744|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14043745|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043746|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043747|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043748|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14043749|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14043750|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14043751|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
14043752|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14043753|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14043754|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
14043755|NCT05035862|Interferons|interferons|mesh-list
14043756|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
14043757|NCT05035862|Prednisone|prednisone|mesh-list
14043758|NCT05035862|Albuterol|albuterol|mesh-list
14043759|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043760|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
14043761|NCT05035862|Hormones|hormones|mesh-ancestor
14043762|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043763|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043764|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14043765|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043766|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
14043767|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043768|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14043769|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
14043770|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043771|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14043772|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14043773|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
14043774|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14043775|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14043776|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14043777|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14043778|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
14043779|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043780|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756970|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14756971|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
14756972|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14756973|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756974|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14756975|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14756976|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14756977|NCT01905046|Metformin|metformin|mesh-list
13910913|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910914|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910915|NCT03507127|Varenicline|varenicline|mesh-list
13910916|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13910917|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13910918|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
13910919|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13910920|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910921|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910922|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
13910923|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13910924|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13910925|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
13910926|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13910927|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910928|NCT03506919|Allopurinol|allopurinol|mesh-list
13910929|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
13910930|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756978|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14756979|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043791|NCT05004116|Irinotecan|irinotecan|mesh-list
14043792|NCT05004116|Temozolomide|temozolomide|mesh-list
14043793|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13910931|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910932|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
13910933|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13910934|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13910935|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
14043794|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14043795|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043796|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043797|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043798|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14043799|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
13910936|NCT03506919|Protective Agents|protective agents|mesh-ancestor
13910937|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910938|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
13910939|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13910940|NCT03506841|Protective Agents|protective agents|mesh-ancestor
13910941|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910942|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
13910943|NCT03506828|Phenol|phenol|mesh-list
13910944|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13910945|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910946|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
13910947|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13910948|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13910949|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
13910950|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13910951|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
13910952|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14474912|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13910953|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
13910954|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043800|NCT05000658|Dexamethasone|dexamethasone|mesh-list
14043801|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14043802|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043803|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
14043804|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
14043805|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043806|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043807|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14043808|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
14043809|NCT05000658|Hormones|hormones|mesh-ancestor
14043810|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043811|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14043812|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043813|NCT04994808|Fludarabine|fludarabine|mesh-list
14043814|NCT04994808|Clofarabine|clofarabine|mesh-list
14043815|NCT04994808|Treosulfan|treosulfan|mesh-list
14043816|NCT04994808|Busulfan|busulfan|mesh-list
14043817|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043818|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14043819|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
14043820|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043821|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043822|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
14043823|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043824|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14043825|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
14043826|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14043827|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
14043828|NCT04989803|Fludarabine|fludarabine|mesh-list
14043829|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043830|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
14043831|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043832|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043833|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14043834|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
14043835|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043836|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043837|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14043838|NCT04969510|Pramoxine|pramoxine|mesh-list
14043839|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
14043840|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
14043841|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043842|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043843|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
14043844|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043845|NCT04965272|Cariprazine|cariprazine|mesh-list
14043846|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13910955|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910956|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
13910957|NCT03506802|Aldesleukin|aldesleukin|mesh-list
13910958|NCT03506802|Plerixafor|plerixafor|mesh-list
13910959|NCT03506802|Lenalidomide|lenalidomide|mesh-list
13910960|NCT03506802|Melphalan|melphalan|mesh-list
13910961|NCT03506802|Interleukin-2|interleukin-2|mesh-list
13910962|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
13910963|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13910964|NCT03506802|Lenograstim|lenograstim|mesh-list
13910965|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13910966|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
14043847|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043848|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933378|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933379|NCT01450384|Pemetrexed|pemetrexed|mesh-list
14933380|NCT01450384|Sorafenib|sorafenib|mesh-list
14933381|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910967|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933382|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13910968|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13910969|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13910970|NCT03506802|Growth Substances|growth substances|mesh-ancestor
13910971|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
13910972|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910973|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13910974|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
13910975|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13910976|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13910977|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13910978|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13910979|NCT03506802|Analgesics|analgesics|mesh-ancestor
13910980|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
13910981|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910982|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13910983|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13910984|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
13910985|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13910986|NCT03506789|Dexamethasone|dexamethasone|mesh-list
13910987|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13910988|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
13910989|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
13910990|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13910991|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13910992|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13910993|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
13910994|NCT03506789|Hormones|hormones|mesh-ancestor
13910995|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13910996|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13910997|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13910998|NCT03506763|Diclofenac|diclofenac|mesh-list
13910999|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14043849|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043850|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043851|NCT04961593|Caspofungin|caspofungin|mesh-list
14043852|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
14043853|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043854|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043855|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043856|NCT04961580|Ceftazidime|ceftazidime|mesh-list
13911000|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13911001|NCT03506763|Analgesics|analgesics|mesh-ancestor
13911002|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
14043857|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14043858|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14043859|NCT04958772|Lenograstim|lenograstim|mesh-list
14043860|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14043861|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
14043862|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043863|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
14043864|NCT04954989|Hematinics|hematinics|mesh-ancestor
14043865|NCT04937738|Leucovorin|leucovorin|mesh-list
14043866|NCT04937738|Docetaxel|docetaxel|mesh-list
14043867|NCT04937738|Fluorouracil|fluorouracil|mesh-list
14043868|NCT04937738|Capecitabine|capecitabine|mesh-list
14043869|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
14043870|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043871|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
14043872|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
14043873|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
14043874|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043875|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
14043876|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14043877|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043878|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
14043879|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911003|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911004|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911005|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911006|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911007|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13911008|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911009|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043880|NCT04937738|Antidotes|antidotes|mesh-ancestor
14043881|NCT04937738|Protective Agents|protective agents|mesh-ancestor
14043882|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
14043883|NCT04937738|Vitamins|vitamins|mesh-ancestor
14043884|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
14043885|NCT04927975|Upadacitinib|upadacitinib|mesh-list
14043886|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14043887|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14043888|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043889|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043890|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043891|NCT04924621|Midazolam|midazolam|mesh-list
14043892|NCT04924621|Sufentanil|sufentanil|mesh-list
14043893|NCT04924621|Propofol|propofol|mesh-list
14756980|NCT01855867|Tenofovir|tenofovir|mesh-list
14756981|NCT01855867|Emtricitabine|emtricitabine|mesh-list
14756982|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
14043894|NCT04924621|Tetracaine|tetracaine|mesh-list
14043895|NCT04924621|Rocuronium|rocuronium|mesh-list
13911010|NCT03506620|Ropivacaine|ropivacaine|mesh-list
13911011|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911012|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
13911013|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911014|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911015|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
13911016|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911017|NCT03506542|Mitomycins|mitomycins|mesh-list
13911018|NCT03506542|Mitomycin|mitomycin|mesh-list
13911019|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13911020|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911021|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
14043896|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14043897|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043898|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043899|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14043900|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
14043901|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
13911022|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911023|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13911024|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911025|NCT03506516|Ethanol|ethanol|mesh-list
13911026|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13911027|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911028|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911029|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911030|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
13911031|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13911032|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
13911033|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
13911034|NCT03506399|Estradiol|estradiol|mesh-list
13911035|NCT03506399|Estrogens|estrogens|mesh-ancestor
13911036|NCT03506399|Hormones|hormones|mesh-ancestor
13911037|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911038|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911039|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13911040|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13911041|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13911042|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13911043|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13911044|NCT03506373|Ixazomib|ixazomib|mesh-list
13911045|NCT03506373|Glycine|glycine|mesh-list
14043902|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14043903|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14043904|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043905|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14043906|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
14043907|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
14043908|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14043909|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043910|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14043911|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14043912|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14043913|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043914|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14043915|NCT04924621|Narcotics|narcotics|mesh-ancestor
14043916|NCT04924621|Analgesics|analgesics|mesh-ancestor
14043917|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
14043918|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911046|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756983|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911047|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911048|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
13911049|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911050|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
13911051|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911052|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911053|NCT03506256|Norfloxacin|norfloxacin|mesh-list
13911054|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13911055|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911056|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13911057|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13911058|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911059|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911060|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911061|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13911062|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14043931|NCT04909073|Afatinib|afatinib|mesh-list
14043932|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043933|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14043934|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14756984|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14756985|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14756986|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911063|NCT03506178|Phenylephrine|phenylephrine|mesh-list
14756987|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14756988|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14756989|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14756990|NCT01754857|Rituximab|rituximab|mesh-list
14756991|NCT01754857|Lenalidomide|lenalidomide|mesh-list
14756992|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14756993|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14756994|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14756995|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
14756996|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14756997|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14756998|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14756999|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14757000|NCT01754857|Growth Substances|growth substances|mesh-ancestor
14043935|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043936|NCT04903197|Lenalidomide|lenalidomide|mesh-list
14043937|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
14043938|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043939|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14043940|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14043941|NCT04903197|Growth Substances|growth substances|mesh-ancestor
14043942|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
14043943|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043944|NCT04899232|Antithrombins|antithrombins|mesh-list
14043945|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
14043946|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14043947|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
14043948|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043949|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043950|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
14043951|NCT04897919|Lumefantrine|lumefantrine|mesh-list
14043952|NCT04897919|Artemether|artemether|mesh-list
14043953|NCT04897919|Piperaquine|piperaquine|mesh-list
14043954|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14043955|NCT04897919|Artenimol|artenimol|mesh-list
14043956|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
14043957|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14043958|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14043959|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911064|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
13911065|NCT03506178|Menthol|menthol|mesh-list
13911066|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
13911067|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
13911068|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13911069|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13911070|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
13911071|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911072|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911073|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911074|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
13911075|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
13911076|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911077|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
13911078|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13911079|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911080|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13911081|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
13911082|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13911083|NCT03506178|Protective Agents|protective agents|mesh-ancestor
13911084|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13911085|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13911086|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911087|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
14474913|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14474914|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14474915|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14043960|NCT04872790|Prednisone|prednisone|mesh-list
14043961|NCT04872790|Cortisone|cortisone|mesh-list
14043962|NCT04872790|Rituximab|rituximab|mesh-list
14043963|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14043964|NCT04872790|Methotrexate|methotrexate|mesh-list
14043965|NCT04872790|Dasatinib|dasatinib|mesh-list
14043966|NCT04872790|Venetoclax|venetoclax|mesh-list
14043967|NCT04872790|Antibodies|antibodies|mesh-list
14043968|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
14043969|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14043970|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
14043971|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043972|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14043973|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14043974|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14043975|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
14043976|NCT04872790|Hormones|hormones|mesh-ancestor
14043977|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14043978|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13911088|NCT03506061|Ivacaftor|ivacaftor|mesh-list
13911089|NCT03506061|Elexacaftor|elexacaftor|mesh-list
13911090|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13911091|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911092|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911093|NCT03506048|Lenvatinib|lenvatinib|mesh-list
13911094|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911095|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13911096|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911097|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043979|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14043980|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
14043981|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14043982|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14043983|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
14043984|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14043985|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14043986|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14043987|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14043988|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14043989|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13911098|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13911099|NCT03506009|Argatroban|argatroban|mesh-list
13911100|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14043990|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170088|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170089|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170090|NCT04835896|Paclitaxel|paclitaxel|mesh-list
13911101|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14170091|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14170092|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757001|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
14043991|NCT04865042|Gabapentin|gabapentin|mesh-list
14043992|NCT04865042|Analgesics|analgesics|mesh-ancestor
14043993|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
14043994|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14043995|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14043996|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
14043997|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14043998|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14043999|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044000|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044001|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14044002|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14044003|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044004|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044005|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
14044006|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14044007|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
14044008|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14044009|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14044010|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14044011|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911102|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911103|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
13911104|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14044012|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044013|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
14044014|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044015|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044016|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14044017|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044018|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
14044019|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
14044020|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044021|NCT04853251|Ranibizumab|ranibizumab|mesh-list
13911105|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
13911106|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911107|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
13911108|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13911109|NCT03505788|Acetazolamide|acetazolamide|mesh-list
13911110|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
13911111|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13911112|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044022|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044023|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13911113|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911114|NCT03505788|Diuretics|diuretics|mesh-ancestor
13911115|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
13911116|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911117|NCT03505736|Adenosine|adenosine|mesh-list
13911118|NCT03505736|Regadenoson|regadenoson|mesh-list
13911119|NCT03505736|Analgesics|analgesics|mesh-ancestor
13911120|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
13911121|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911122|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911123|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13911124|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
13911125|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13911126|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
13911127|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
13911128|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911129|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911130|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
13959884|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13959885|NCT03159559|Aspirin|aspirin|mesh-list
13959886|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13959887|NCT03159559|Alprostadil|alprostadil|mesh-list
14044024|NCT04853251|Growth Substances|growth substances|mesh-ancestor
14044025|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044026|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044027|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044028|NCT04851301|Naloxone|naloxone|mesh-list
14044029|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14044030|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044031|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
13959888|NCT03159559|Clopidogrel|clopidogrel|mesh-list
13959889|NCT03159559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13959890|NCT03159559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959891|NCT03159559|Analgesics|analgesics|mesh-ancestor
13959892|NCT03159559|Sensory System Agents|sensory system agents|mesh-ancestor
14044032|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044033|NCT04821310|Pantoprazole|pantoprazole|mesh-list
14044034|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14044035|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044036|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14044037|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044038|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044039|NCT04808531|Oxycodone|oxycodone|mesh-list
14044040|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14044041|NCT04808531|Narcotics|narcotics|mesh-ancestor
14044042|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044043|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044044|NCT04808531|Analgesics|analgesics|mesh-ancestor
14044045|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
14044046|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044047|NCT04804644|Memantine|memantine|mesh-list
14044048|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14044049|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14044050|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
14044051|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044052|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044053|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959893|NCT03159559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959894|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959895|NCT03159559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13959896|NCT03159559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959897|NCT03159559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13959898|NCT03159559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13959899|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959900|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13959901|NCT03159559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13959902|NCT03159559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959903|NCT03159559|Antipyretics|antipyretics|mesh-ancestor
13959904|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14044054|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14044055|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14044056|NCT04803084|TEMPO|tempo|mesh-list
14044057|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
14044058|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044059|NCT04803084|Protective Agents|protective agents|mesh-ancestor
14044060|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044061|NCT04801849|Vitamin E|vitamin e|mesh-list
14044062|NCT04801849|Tocopherols|tocopherols|mesh-list
14044063|NCT04801849|Tocotrienols|tocotrienols|mesh-list
14044064|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
14044065|NCT04801849|Vitamins|vitamins|mesh-ancestor
14044066|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
14044067|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044068|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
14044069|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044070|NCT04801849|Protective Agents|protective agents|mesh-ancestor
14044071|NCT04770623|Docetaxel|docetaxel|mesh-list
14044072|NCT04770623|Irinotecan|irinotecan|mesh-list
13911131|NCT03505528|Paclitaxel|paclitaxel|mesh-list
13911132|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13911133|NCT03505528|Phenelzine|phenelzine|mesh-list
13911134|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13911135|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911136|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911137|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
13911138|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
13911139|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911140|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
14474916|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474917|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14474918|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14474919|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474920|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474921|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474922|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
14474923|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14044073|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044074|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044075|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044076|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044077|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044078|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14044079|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14044080|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044081|NCT04769414|Gemcitabine|gemcitabine|mesh-list
14474924|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14474925|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14474926|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14044082|NCT04769414|Fluorouracil|fluorouracil|mesh-list
14474927|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
14474928|NCT02389829|Promethazine|promethazine|mesh-list
14474929|NCT02389829|Hydromorphone|hydromorphone|mesh-list
14044083|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14044084|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
14044085|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044086|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044087|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
14044088|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044089|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044090|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044091|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
14044092|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044093|NCT04766008|Metformin|metformin|mesh-list
14044094|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14044095|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474930|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
14474931|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14474932|NCT02389829|Narcotics|narcotics|mesh-ancestor
14474933|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14474934|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911141|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13911142|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13911143|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911144|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
13911145|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14044096|NCT04760132|Vaccines|vaccines|mesh-list
14044097|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
14170093|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911146|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13911147|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911148|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
13911149|NCT03505502|Coagulants|coagulants|mesh-ancestor
13911150|NCT03505489|Mannitol|mannitol|mesh-list
13911151|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
13911152|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13911153|NCT03505489|Diuretics|diuretics|mesh-ancestor
13911154|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
14044098|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044099|NCT04752566|Eculizumab|eculizumab|mesh-list
14044100|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14044101|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044102|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
14044103|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044104|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
14044105|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044106|NCT04743505|Osimertinib|osimertinib|mesh-list
14044107|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911155|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911156|NCT03505489|Miotics|miotics|mesh-ancestor
13911157|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
13911158|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911159|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13911160|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
13911161|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911162|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14044108|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14044109|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044110|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044111|NCT04741139|Acetaminophen|acetaminophen|mesh-list
14044112|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
14044113|NCT04741139|Promethazine|promethazine|mesh-list
14044114|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14044115|NCT04741139|Analgesics|analgesics|mesh-ancestor
14044116|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
14044117|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044118|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044119|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
14044120|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14044121|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14044122|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044123|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
14044124|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
14044125|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
14044126|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
14044127|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044128|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14044129|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
14044130|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
14044131|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044132|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044133|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14044134|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
14044135|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
14044136|NCT04734197|Cyclosporine|cyclosporine|mesh-list
14044137|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
14044138|NCT04734197|Betamethasone|betamethasone|mesh-list
14044139|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
14044140|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14044141|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
14044142|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14044143|NCT04734197|Lifitegrast|lifitegrast|mesh-list
14044144|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14044145|NCT04734197|Cyclosporins|cyclosporins|mesh-list
14044146|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13911163|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13911164|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
14044147|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14474935|NCT02389829|Analgesics|analgesics|mesh-ancestor
13911165|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911166|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933383|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933384|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14933385|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14933386|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14933387|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
14933388|NCT01450410|Niacin|niacin|mesh-list
14933389|NCT01450410|Niacinamide|niacinamide|mesh-list
14933390|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
14933391|NCT01450410|Vitamins|vitamins|mesh-ancestor
14933392|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
14933393|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474936|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
14474937|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474938|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14474939|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14474940|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
14474941|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
13911167|NCT03505411|Melatonin|melatonin|mesh-list
13911168|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
13911169|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911170|NCT03505411|Protective Agents|protective agents|mesh-ancestor
13911171|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911172|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911173|NCT03505255|Neostigmine|neostigmine|mesh-list
13911174|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13911175|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911176|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911177|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
13911178|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911179|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911180|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13911181|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
13911182|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911183|NCT03505151|BI 409306|bi 409306|mesh-list
13911184|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14044148|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044149|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044150|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
14044151|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044152|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
14044153|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044154|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
14044155|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044156|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14044157|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044158|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
14044159|NCT04734197|Hormones|hormones|mesh-ancestor
14044160|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933394|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14933395|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
14474942|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
14474943|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
14474944|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044161|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14044162|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911185|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911186|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911187|NCT03505047|Copper|copper|mesh-list
13911188|NCT03505047|Trace Elements|trace elements|mesh-ancestor
13911189|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
13911190|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911191|NCT03505008|Adalimumab|adalimumab|mesh-list
14044163|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14044164|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044165|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14044166|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
14044167|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14044168|NCT04733144|Dexamethasone|dexamethasone|mesh-list
14044169|NCT04733144|Prednisolone|prednisolone|mesh-list
14044170|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044171|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
14044172|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
14044173|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044174|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044175|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044176|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
14044177|NCT04733144|Hormones|hormones|mesh-ancestor
14044178|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044179|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14044180|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044181|NCT04724720|Famotidine|famotidine|mesh-list
14044182|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14044183|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044184|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13911192|NCT03505008|Methotrexate|methotrexate|mesh-list
13911193|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13911194|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
13911195|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13911196|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911197|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13911198|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
13911199|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044185|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
14044186|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
14044187|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044188|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044189|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044192|NCT04695340|Psyllium|psyllium|mesh-list
14044193|NCT04695340|Cathartics|cathartics|mesh-ancestor
14044194|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044195|NCT04682405|Melphalan|melphalan|mesh-list
14044196|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14044197|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
14044198|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044199|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044200|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14044201|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044202|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
14044203|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911200|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044204|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14474945|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14044205|NCT04668144|Cangrelor|cangrelor|mesh-list
14044206|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14044207|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14044208|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14044209|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14044210|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
14044211|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044212|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044213|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044214|NCT04666129|Prednisone|prednisone|mesh-list
14044215|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
14044216|NCT04666129|Docetaxel|docetaxel|mesh-list
14044217|NCT04666129|Relugolix|relugolix|mesh-list
14044218|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044219|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044220|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044221|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044222|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044223|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044224|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
14044225|NCT04666129|Hormones|hormones|mesh-ancestor
14044226|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044227|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911201|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
13911202|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911203|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13911204|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911205|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
13911206|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911207|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13911208|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911209|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
13911210|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13911211|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911212|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13911213|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13911214|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911215|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911216|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911217|NCT03504956|Metoprolol|metoprolol|mesh-list
13911218|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13911219|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13911220|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14044228|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14044229|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
14044230|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
14044231|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044232|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044233|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14044234|NCT04666129|Protective Agents|protective agents|mesh-ancestor
14044235|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
14044236|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
14044237|NCT04665570|Metformin|metformin|mesh-list
14044238|NCT04665570|Acarbose|acarbose|mesh-list
14044239|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14044240|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044241|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14044242|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044243|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044244|NCT04662944|Ranibizumab|ranibizumab|mesh-list
14044245|NCT04662944|Aflibercept|aflibercept|mesh-list
14044246|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044247|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044248|NCT04662944|Growth Substances|growth substances|mesh-ancestor
14044249|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044250|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044251|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911221|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
13911222|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
14044252|NCT04662515|Warfarin|warfarin|mesh-list
14044253|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
14044254|NCT04662515|Dabigatran|dabigatran|mesh-list
14044255|NCT04662515|Apixaban|apixaban|mesh-list
14044256|NCT04662515|Edoxaban|edoxaban|mesh-list
14044257|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
14044258|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14044259|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
14044260|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14044261|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
14044262|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044263|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170094|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
14170095|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
14170096|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170097|NCT04835350|Pancrelipase|pancrelipase|mesh-list
14170098|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170099|NCT04835259|Selenium|selenium|mesh-list
13911223|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911224|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911225|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13911226|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13911227|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
13911228|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911229|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911230|NCT03504865|Bupivacaine|bupivacaine|mesh-list
13911231|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911232|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
13911233|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911234|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911235|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
13911236|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911237|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
13911238|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13911239|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13911240|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
13911241|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911242|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13911243|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13911244|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13911245|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911246|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13911247|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911248|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13911249|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911250|NCT03504644|Vincristine|vincristine|mesh-list
13911251|NCT03504644|Venetoclax|venetoclax|mesh-list
13911252|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13911253|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911254|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
14933396|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933397|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14170100|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
14170101|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170102|NCT04835259|Protective Agents|protective agents|mesh-ancestor
14170103|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170104|NCT04835259|Trace Elements|trace elements|mesh-ancestor
14170105|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
14170106|NCT04835233|Methyldopa|methyldopa|mesh-list
14170107|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14170108|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
14170109|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
14170110|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170111|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170112|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14170113|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14933398|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
13911255|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
13911256|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
13911257|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911258|NCT03504566|Empagliflozin|empagliflozin|mesh-list
13911259|NCT03504566|Linagliptin|linagliptin|mesh-list
14170114|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14170115|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170116|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911260|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
13911261|NCT03504566|Telmisartan|telmisartan|mesh-list
13911262|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14044264|NCT04660097|Etoposide|etoposide|mesh-list
14044265|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
14044266|NCT04660097|Durvalumab|durvalumab|mesh-list
14044267|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14044268|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044269|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757002|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14757003|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
14757004|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757005|NCT01721746|Paclitaxel|paclitaxel|mesh-list
14757006|NCT01721746|Carboplatin|carboplatin|mesh-list
14757007|NCT01721746|Nivolumab|nivolumab|mesh-list
14757008|NCT01721746|Dacarbazine|dacarbazine|mesh-list
13911263|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14044270|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14044271|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14044272|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044273|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044274|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044275|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
14044276|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044277|NCT04658849|Pioglitazone|pioglitazone|mesh-list
14044278|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14044279|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044280|NCT04656301|Psilocybin|psilocybin|mesh-list
14044281|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
14044282|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044283|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044284|NCT04648540|Acetaminophen|acetaminophen|mesh-list
14044285|NCT04648540|Celecoxib|celecoxib|mesh-list
14044286|NCT04648540|Ketorolac|ketorolac|mesh-list
14044287|NCT04648540|Lidocaine|lidocaine|mesh-list
14044288|NCT04648540|Pregabalin|pregabalin|mesh-list
14044289|NCT04648540|Fentanyl|fentanyl|mesh-list
14044290|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
14044291|NCT04648540|Morphine|morphine|mesh-list
14044292|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
14044293|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
14044294|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044295|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044296|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
14044297|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044298|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14474946|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
13911264|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13911265|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911266|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13911267|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13911268|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911269|NCT03504566|Incretins|incretins|mesh-ancestor
13911270|NCT03504566|Hormones|hormones|mesh-ancestor
13911271|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911272|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13911273|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
13911274|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911275|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
13911276|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13911277|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
14044299|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14474947|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
14474948|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474949|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474950|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14474951|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
14474952|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
14474953|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14474954|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14474955|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044300|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14044301|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14044302|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044303|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14757009|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044304|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14044305|NCT04648540|Analgesics|analgesics|mesh-ancestor
14044306|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14044307|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14044308|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14044309|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14044310|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044311|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14044312|NCT04648540|Narcotics|narcotics|mesh-ancestor
14044313|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14044314|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14044315|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
14044316|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
14044317|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
14044318|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14044319|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14044320|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14044321|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14044322|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044323|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14044324|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044325|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044326|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14044327|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14044328|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044329|NCT04622319|Trastuzumab|trastuzumab|mesh-list
14044330|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14044331|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044332|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044333|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044334|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044335|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044336|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044337|NCT04609046|Rituximab|rituximab|mesh-list
14044338|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14044339|NCT04609046|Nivolumab|nivolumab|mesh-list
14044340|NCT04609046|Methotrexate|methotrexate|mesh-list
14044341|NCT04609046|Lenalidomide|lenalidomide|mesh-list
14044342|NCT04609046|Antibodies|antibodies|mesh-list
14044343|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
14044344|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14044345|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
14044346|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044347|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044348|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044349|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14044350|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
14044351|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14044352|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14044353|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
14044354|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044355|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
14044356|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044357|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14044358|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044359|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14044360|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14044361|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044362|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044363|NCT04609046|Growth Substances|growth substances|mesh-ancestor
14044364|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044365|NCT04592913|Durvalumab|durvalumab|mesh-list
14044366|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044367|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044368|NCT04588259|Insulin|insulin|mesh-list
14044369|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14044370|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
14044371|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
14044372|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14044373|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14044374|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044375|NCT04556617|Prednisone|prednisone|mesh-list
14044376|NCT04556617|Olaparib|olaparib|mesh-list
14044377|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
14044378|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044379|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
14044380|NCT04556617|Hormones|hormones|mesh-ancestor
14044381|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044382|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044383|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14044384|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044385|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14044386|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044387|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044388|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14044389|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
14044390|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14044391|NCT04555798|Meropenem|meropenem|mesh-list
14044392|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14044393|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044394|NCT04546633|Lumefantrine|lumefantrine|mesh-list
14044395|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
14044396|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14044397|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14044398|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044399|NCT04521647|Nicotine|nicotine|mesh-list
14044400|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14044401|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
14044402|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044403|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044404|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14474956|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14474957|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
13911278|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13911279|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13911280|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13911281|NCT03504527|Budesonide|budesonide|mesh-list
13911282|NCT03504527|Bromides|bromides|mesh-list
13911283|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
13911284|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911285|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13911286|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
13911287|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044405|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14044406|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
14044407|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044408|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044409|NCT04513717|Leuprolide|leuprolide|mesh-list
14044410|NCT04513717|Goserelin|goserelin|mesh-list
14044411|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14044412|NCT04513717|Flutamide|flutamide|mesh-list
14044413|NCT04513717|Bicalutamide|bicalutamide|mesh-list
14044414|NCT04513717|Tryptophan|tryptophan|mesh-list
14044415|NCT04513717|Buserelin|buserelin|mesh-list
14044416|NCT04513717|Hormones|hormones|mesh-list
14044417|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044418|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044419|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14044420|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
14933399|NCT01450462|Vitamin D|vitamin d|mesh-list
14933400|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
14933401|NCT01450462|Vitamins|vitamins|mesh-ancestor
14044421|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14044422|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14044423|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044424|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
14044425|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
14044426|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
14044427|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14474968|NCT02389959|Bevacizumab|bevacizumab|mesh-list
14933402|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
13911288|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474969|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933403|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044428|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
14044429|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14474970|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14474971|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14474972|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14474973|NCT02389959|Growth Substances|growth substances|mesh-ancestor
14474974|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474975|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
14474976|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
14474977|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14474978|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14474979|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14474980|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
13911289|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13911290|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911291|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
13911292|NCT03504527|Hormones|hormones|mesh-ancestor
13911293|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911294|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
13911295|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13911296|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
13911297|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911298|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911299|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
13911300|NCT03504501|Lamotrigine|lamotrigine|mesh-list
13911301|NCT03504501|Lovastatin|lovastatin|mesh-list
13911302|NCT03504501|L 647318|l 647318|mesh-list
13911303|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
13911304|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
13911305|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13911306|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911307|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911308|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13911309|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911310|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13911311|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13911312|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911313|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13911314|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13911315|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13911316|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13911317|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
13911318|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13911319|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13911320|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911321|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13911322|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911323|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911324|NCT03504475|Paroxetine|paroxetine|mesh-list
13911325|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13911326|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13911327|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911328|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911329|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911330|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
13911331|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911332|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13911333|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
13911334|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13911335|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13911336|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13911337|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911338|NCT03504345|Progesterone|progesterone|mesh-list
13911339|NCT03504345|Progestins|progestins|mesh-ancestor
13911340|NCT03504345|Hormones|hormones|mesh-ancestor
13911341|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911342|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911343|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
13911344|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13911345|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911346|NCT03504280|Vitamins|vitamins|mesh-ancestor
13911347|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
13911348|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14044430|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14044431|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
14044432|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044433|NCT04493619|Carboplatin|carboplatin|mesh-list
14044434|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044435|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14044436|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14044437|NCT04464265|Propofol|propofol|mesh-list
14044438|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14044439|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044440|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044441|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14044442|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
14044443|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
14044444|NCT04430894|Dexamethasone|dexamethasone|mesh-list
14044445|NCT04430894|Lenalidomide|lenalidomide|mesh-list
14044446|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044447|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
14044448|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
14044449|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044450|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044451|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044452|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
14044453|NCT04430894|Hormones|hormones|mesh-ancestor
14044454|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044455|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14044456|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044457|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
14044458|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044459|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044460|NCT04430894|Growth Substances|growth substances|mesh-ancestor
14044461|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044462|NCT04409834|Heparin|heparin|mesh-list
14044463|NCT04409834|Calcium heparin|calcium heparin|mesh-list
14044464|NCT04409834|Enoxaparin|enoxaparin|mesh-list
14044465|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
14044466|NCT04409834|Clopidogrel|clopidogrel|mesh-list
14044467|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14044468|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14044469|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14044470|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14044471|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
14044472|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044473|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044474|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044475|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
14044476|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14044477|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14044478|NCT04399356|Niclosamide|niclosamide|mesh-list
14044479|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
14044480|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14044481|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
14044482|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14044483|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044484|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
14044485|NCT04397003|Durvalumab|durvalumab|mesh-list
14044486|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044487|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767231|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13911349|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
13911350|NCT03504241|Sirolimus|sirolimus|mesh-list
13911351|NCT03504241|Prednisone|prednisone|mesh-list
13911352|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
13911353|NCT03504241|Abatacept|abatacept|mesh-list
13911354|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911355|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
13911356|NCT03504241|Hormones|hormones|mesh-ancestor
13911357|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911358|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911359|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13911360|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044489|NCT04391049|Paclitaxel|paclitaxel|mesh-list
14044490|NCT04391049|Carboplatin|carboplatin|mesh-list
14044491|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13911361|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14044492|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044493|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044494|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14474981|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14474982|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474983|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14474984|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
14474985|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
14474986|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
14474987|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13911362|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13911363|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
13911364|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13911365|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911366|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911367|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911368|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
13911369|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911370|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
14044495|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044496|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044497|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044498|NCT04385368|Durvalumab|durvalumab|mesh-list
14044499|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044500|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044501|NCT04384484|Gemcitabine|gemcitabine|mesh-list
14044502|NCT04384484|Rituximab|rituximab|mesh-list
14044503|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14044504|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
14044505|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044506|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044507|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
14044508|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044509|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044510|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14044511|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
14044512|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044513|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
14044514|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044515|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044516|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044517|NCT04382885|Cariprazine|cariprazine|mesh-list
14044518|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14044519|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14044520|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044521|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044522|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044523|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14044524|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044525|NCT04360681|Lofexidine|lofexidine|mesh-list
14044526|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14044527|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14044528|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044529|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
14044530|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044531|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14044532|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14044533|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14044534|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
14044535|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044536|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170117|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170118|NCT04834986|Lenvatinib|lenvatinib|mesh-list
14170119|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170120|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170121|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170122|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170123|NCT04835064|Gemcitabine|gemcitabine|mesh-list
14170124|NCT04835064|Paclitaxel|paclitaxel|mesh-list
14170125|NCT04835064|Folfirinox|folfirinox|mesh-list
14170126|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14170127|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170128|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
14170129|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
14170130|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044537|NCT04355832|Glucagon|glucagon|mesh-list
14044538|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14044539|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14044540|NCT04355832|Hormones|hormones|mesh-ancestor
14044541|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044542|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044543|NCT04355832|Incretins|incretins|mesh-ancestor
14044544|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
14044545|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14044546|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14044547|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044548|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
14044549|NCT04349982|Coagulants|coagulants|mesh-ancestor
14044550|NCT04340947|Nicotine|nicotine|mesh-list
14044551|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14044552|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
14044553|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044554|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044555|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14933404|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14933405|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14933406|NCT01450514|Pipamperone|pipamperone|mesh-list
14933407|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14933408|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
14933409|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933410|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933411|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933412|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14933413|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14933414|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933415|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14933416|NCT01450566|Lidocaine|lidocaine|mesh-list
14933417|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
14933418|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
14933419|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933420|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933421|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
14933422|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933423|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13911371|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14474988|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14474989|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
13911372|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14044556|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13911373|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911374|NCT03504202|Trimetazidine|trimetazidine|mesh-list
13911375|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
13911376|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
13911377|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911378|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911379|NCT03504072|Etanercept|etanercept|mesh-list
13911380|NCT03504072|Tofacitinib|tofacitinib|mesh-list
13911381|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13911382|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13911383|NCT03504072|Analgesics|analgesics|mesh-ancestor
14044557|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
14044558|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044559|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044560|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
14044561|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
14044562|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14044563|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14044564|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044565|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044566|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044567|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044568|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
14044569|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911384|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
13911385|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911386|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044570|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044571|NCT04315350|Prednisolone|prednisolone|mesh-list
14933424|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14044572|NCT04315350|Curcumin|curcumin|mesh-list
13911387|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911388|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911389|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14474990|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14474991|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474992|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
14044573|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044574|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
14044575|NCT04315350|Hormones|hormones|mesh-ancestor
14044576|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044577|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044578|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14044579|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044580|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044581|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14044582|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14044583|NCT04315350|Analgesics|analgesics|mesh-ancestor
14044584|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
14044585|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044586|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044587|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044588|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
14044589|NCT04314219|Methotrexate|methotrexate|mesh-list
14044590|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044591|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
14044592|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044593|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044594|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14474993|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13911390|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911391|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
13911392|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14933425|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14933426|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14933427|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933428|NCT01450774|Beclomethasone|beclomethasone|mesh-list
14933429|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
14933430|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14933431|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
14933432|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933433|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933434|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14044595|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
14044596|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044597|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044598|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14044599|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14044600|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
14044601|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14044602|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14044603|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
14933435|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
14933436|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14933437|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14933438|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13911393|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911394|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911395|NCT03504046|Pancrelipase|pancrelipase|mesh-list
13911396|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13911397|NCT03504033|Desflurane|desflurane|mesh-list
13911398|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13911399|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
13911400|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
13911401|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044604|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
14044605|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044606|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14044607|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14044608|NCT04309552|Alovudine|alovudine|mesh-list
13911402|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474994|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14474995|NCT02390219|Ivacaftor|ivacaftor|mesh-list
13911403|NCT03503994|Beclomethasone|beclomethasone|mesh-list
13911404|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911405|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
13911406|NCT03503994|Hormones|hormones|mesh-ancestor
13911407|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911408|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911409|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13911410|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
13959905|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13959906|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13959907|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
13959908|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959909|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
13959910|NCT03159559|Urological Agents|urological agents|mesh-ancestor
13959911|NCT03159403|Oritavancin|oritavancin|mesh-list
13959912|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959913|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959914|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
13959915|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13959916|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
13959917|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959918|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959919|NCT03159078|Imipenem|imipenem|mesh-list
13959920|NCT03159078|Polymyxins|polymyxins|mesh-list
13959921|NCT03159078|Polymyxin B|polymyxin b|mesh-list
13959922|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13959923|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959924|NCT03159234|Epinephrine|epinephrine|mesh-list
13959925|NCT03159234|Racepinephrine|racepinephrine|mesh-list
13959926|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
13959927|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13959928|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14044609|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
14044610|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044611|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
14044612|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14044613|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14044614|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044615|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
14044616|NCT04304625|Coagulants|coagulants|mesh-ancestor
14044617|NCT04298541|Edotreotide|edotreotide|mesh-list
14044618|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14044619|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044620|NCT04294654|Vortioxetine|vortioxetine|mesh-list
14044621|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
14044622|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044623|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14044624|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14044625|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044626|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044627|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14044628|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14044629|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14044630|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044631|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044632|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
14044633|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14044634|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14044635|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14044636|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14044637|NCT04288206|Cefazolin|cefazolin|mesh-list
14044638|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14044639|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044640|NCT04278625|Acetaminophen|acetaminophen|mesh-list
14044641|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14044642|NCT04278625|Analgesics|analgesics|mesh-ancestor
14044643|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
14044644|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044645|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044646|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
14044647|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
14044648|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14044649|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
14044650|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13959929|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14044651|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
14044652|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044653|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044654|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
13911411|NCT03503942|Metformin|metformin|mesh-list
13911412|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13911413|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911414|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
13911415|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911416|NCT03503786|Paclitaxel|paclitaxel|mesh-list
13911417|NCT03503786|Carboplatin|carboplatin|mesh-list
13911418|NCT03503786|Avelumab|avelumab|mesh-list
13911419|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13911420|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911421|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911422|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
13911423|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
13911424|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911425|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911426|NCT03503604|Leucovorin|leucovorin|mesh-list
13911427|NCT03503604|Gemcitabine|gemcitabine|mesh-list
13911428|NCT03503604|Paclitaxel|paclitaxel|mesh-list
13911429|NCT03503604|Carboplatin|carboplatin|mesh-list
13911430|NCT03503604|Fluorouracil|fluorouracil|mesh-list
13911431|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
13911432|NCT03503604|Irinotecan|irinotecan|mesh-list
13911433|NCT03503604|Bevacizumab|bevacizumab|mesh-list
13911434|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13911435|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911436|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911437|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
13911438|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
13911439|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911440|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13911441|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
13911442|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
13911443|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911444|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911445|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911446|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
13911447|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911448|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13911449|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13911450|NCT03503604|Antidotes|antidotes|mesh-ancestor
13911451|NCT03503604|Protective Agents|protective agents|mesh-ancestor
14933439|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
14933440|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933441|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911452|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
13911453|NCT03503604|Vitamins|vitamins|mesh-ancestor
13911454|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
13911455|NCT03503604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911456|NCT03503604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13911457|NCT03503604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13911458|NCT03503604|Growth Substances|growth substances|mesh-ancestor
13911459|NCT03503604|Growth Inhibitors|growth inhibitors|mesh-ancestor
14757010|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757011|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
14757012|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044655|NCT04210310|Oxytocin|oxytocin|mesh-list
14044656|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
14044657|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14044658|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044659|NCT04205812|Paclitaxel|paclitaxel|mesh-list
14044660|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14044661|NCT04205812|Carboplatin|carboplatin|mesh-list
14044662|NCT04205812|Pemetrexed|pemetrexed|mesh-list
14044663|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044664|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044665|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044666|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044667|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14757013|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
14184184|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757014|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757015|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911466|NCT03503409|Ivosidenib|ivosidenib|mesh-list
14757016|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14767232|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
14044668|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044669|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044670|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14044671|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14044672|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
14044673|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044674|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044675|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14044676|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14044677|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044678|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044679|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14044680|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14044681|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14044682|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14044683|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044684|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
14044685|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14044686|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
14044687|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14044688|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14044689|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14044690|NCT04147013|Celecoxib|celecoxib|mesh-list
14044691|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14044692|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14044693|NCT04147013|Analgesics|analgesics|mesh-ancestor
14044694|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
14044695|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044696|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044697|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911467|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911468|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911469|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044698|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044699|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14757017|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14757018|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
14757019|NCT01716312|Omalizumab|omalizumab|mesh-list
14757020|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14757021|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14757022|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14757023|NCT01705977|Belimumab|belimumab|mesh-list
14757024|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911470|NCT03503227|Aspirin|aspirin|mesh-list
14044700|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14044701|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044702|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044703|NCT04134260|Hormones|hormones|mesh-list
14044704|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044705|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044706|NCT04126317|Aflibercept|aflibercept|mesh-list
14044707|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14474996|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14474997|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14474998|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14474999|NCT02391337|Digoxin|digoxin|mesh-list
14475000|NCT02391337|Bisoprolol|bisoprolol|mesh-list
14475001|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14475002|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14475003|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757025|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
13911471|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
13911472|NCT03503227|Prednisolone|prednisolone|mesh-list
13911473|NCT03503227|Salicylates|salicylates|mesh-list
13911474|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911475|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
13911476|NCT03503227|Hormones|hormones|mesh-ancestor
13911477|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911478|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911479|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13911480|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911481|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475004|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475005|NCT02391337|Protective Agents|protective agents|mesh-ancestor
14475006|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475007|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14475008|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
14475009|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
14475010|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475011|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14044708|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044709|NCT04126317|Growth Substances|growth substances|mesh-ancestor
14044710|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044711|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044712|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044713|NCT04126070|Docetaxel|docetaxel|mesh-list
14044714|NCT04126070|Nivolumab|nivolumab|mesh-list
14044715|NCT04126070|Leuprolide|leuprolide|mesh-list
13911482|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911483|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
13911484|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
14475012|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14475013|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14475014|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
14475015|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475016|NCT02391545|Rituximab|rituximab|mesh-list
13911485|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
14044716|NCT04126070|Goserelin|goserelin|mesh-list
14044717|NCT04126070|Androgens|androgens|mesh-list
14044718|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044719|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044720|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044721|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044722|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044723|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044724|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14044725|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14044726|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
14044727|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14044728|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044729|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14044730|NCT04126070|Hormones|hormones|mesh-ancestor
14044731|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044732|NCT04108156|Ranibizumab|ranibizumab|mesh-list
14044733|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044734|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044735|NCT04108156|Growth Substances|growth substances|mesh-ancestor
14044736|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044737|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044738|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044739|NCT04084951|Nivolumab|nivolumab|mesh-list
14044740|NCT04084951|Ipilimumab|ipilimumab|mesh-list
14044741|NCT04084951|Atezolizumab|atezolizumab|mesh-list
14044742|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044743|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044744|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14044745|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044746|NCT04076059|Androgens|androgens|mesh-list
14475017|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
13911486|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13911487|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13911488|NCT03503227|Analgesics|analgesics|mesh-ancestor
13911489|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
13911490|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911491|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14475018|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475019|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475020|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
13911492|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911493|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911494|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13911495|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13911496|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13911497|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
13911498|NCT03503201|Chromium|chromium|mesh-list
13911499|NCT03503201|Trace Elements|trace elements|mesh-ancestor
13911500|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
14044747|NCT04076059|Hormones|hormones|mesh-ancestor
14475021|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044748|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044749|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044750|NCT04064697|Valganciclovir|valganciclovir|mesh-list
14044751|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
14044752|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044753|NCT04062669|Vaccines|vaccines|mesh-list
14044754|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
14044755|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044756|NCT04052620|Diclofenac|diclofenac|mesh-list
14044757|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14044758|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14044759|NCT04052620|Analgesics|analgesics|mesh-ancestor
14044760|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
14044761|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044762|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044763|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044764|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044765|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14044766|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044767|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170131|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170132|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14170133|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
14170134|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
14170135|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170136|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170137|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170138|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
14170139|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170140|NCT04835116|Acetaminophen|acetaminophen|mesh-list
14170141|NCT04835116|Tramadol|tramadol|mesh-list
14170142|NCT04835116|Analgesics|analgesics|mesh-list
14170143|NCT04835116|Orphenadrine|orphenadrine|mesh-list
14475022|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475023|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
14475024|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
14475025|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
14475026|NCT02391714|Povidone|povidone|mesh-list
14475027|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14475028|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475029|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
14475030|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
14475031|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
14475032|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14475033|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
14170144|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
14170145|NCT04835116|Bupivacaine|bupivacaine|mesh-list
14170146|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
14170147|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
14170148|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170149|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170150|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
14170151|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170152|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14170153|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
14170154|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14170155|NCT04835116|Narcotics|narcotics|mesh-ancestor
14170156|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14170157|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14170158|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14170159|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14170160|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
14170161|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
14170162|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14170163|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14170164|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
14170165|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170166|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170167|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
14170168|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14170169|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170170|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
14170171|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475034|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
14170172|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14170173|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
14475035|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475036|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475037|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475038|NCT02391714|Analgesics|analgesics|mesh-ancestor
14475039|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
13911501|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911502|NCT03503136|Cisplatin|cisplatin|mesh-list
13911503|NCT03503136|Docetaxel|docetaxel|mesh-list
13911504|NCT03503136|Fluorouracil|fluorouracil|mesh-list
14044768|NCT04048278|Lidocaine|lidocaine|mesh-list
14044769|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
14044770|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
14044771|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044772|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044773|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
14475040|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475041|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
14475042|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14475043|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14475044|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475045|NCT02392104|Warfarin|warfarin|mesh-list
14475046|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
13911505|NCT03503136|Capecitabine|capecitabine|mesh-list
14475047|NCT02392208|Telavancin|telavancin|mesh-list
14475048|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14475049|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475050|NCT02392234|Ivacaftor|ivacaftor|mesh-list
14475051|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14475052|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14475053|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475054|NCT02392286|Prednisone|prednisone|mesh-list
14475055|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
14475056|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475057|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
14475058|NCT02392286|Hormones|hormones|mesh-ancestor
14475059|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911506|NCT03503136|Nedaplatin|nedaplatin|mesh-list
13911507|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911508|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911509|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
13911510|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
13911511|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911512|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
13911513|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13911514|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911515|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
13911516|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911517|NCT03503058|Chloroquine|chloroquine|mesh-list
13911518|NCT03503058|Amebicides|amebicides|mesh-ancestor
13911519|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13911520|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13911521|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911522|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
13911523|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911524|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13911525|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911526|NCT03502889|Ropivacaine|ropivacaine|mesh-list
13911527|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911528|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
14044774|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044775|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14044776|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14044777|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14044778|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14044779|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044780|NCT04037254|Niraparib|niraparib|mesh-list
14044781|NCT04037254|Hormones|hormones|mesh-list
14044782|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14044783|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14044784|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14044785|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044786|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14044787|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044788|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044789|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044790|NCT04015180|Aflibercept|aflibercept|mesh-list
14044791|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044792|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044793|NCT04015180|Growth Substances|growth substances|mesh-ancestor
14044794|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044795|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044796|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044797|NCT04009681|Antibodies|antibodies|mesh-list
14044798|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
14044799|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044800|NCT04005352|Aflibercept|aflibercept|mesh-list
14044801|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044802|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044803|NCT04005352|Growth Substances|growth substances|mesh-ancestor
14044804|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044805|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044806|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044807|NCT03969420|Cytarabine|cytarabine|mesh-list
14044808|NCT03969420|Alvocidib|alvocidib|mesh-list
14044809|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14044810|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
14044811|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044812|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044813|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
14044814|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044815|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044816|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
14044817|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044818|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044819|NCT03969420|Growth Substances|growth substances|mesh-ancestor
14044820|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14044821|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044822|NCT03962062|Moxidectin|moxidectin|mesh-list
14044823|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
13911529|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911530|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911531|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
13911532|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911533|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
13911534|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13911535|NCT03502746|Nivolumab|nivolumab|mesh-list
13911536|NCT03502746|Ramucirumab|ramucirumab|mesh-list
13911537|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911538|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044824|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14475060|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475061|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14475062|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475063|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
14044825|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044826|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
14044827|NCT03954041|Glyburide|glyburide|mesh-list
14044828|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14044829|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044830|NCT03950037|Albendazole|albendazole|mesh-list
14475064|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
14475065|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911539|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14475066|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475067|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14475068|NCT02392286|Protective Agents|protective agents|mesh-ancestor
14475069|NCT02392507|Paclitaxel|paclitaxel|mesh-list
13911540|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911541|NCT03502642|Morphine|morphine|mesh-list
13911542|NCT03502642|Ropivacaine|ropivacaine|mesh-list
14475070|NCT02392507|Carboplatin|carboplatin|mesh-list
14475071|NCT02392507|Necitumumab|necitumumab|mesh-list
14475072|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14475073|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475074|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044831|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
14044832|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14044833|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044834|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
14044835|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14475075|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
14475076|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475077|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911543|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
13911544|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911545|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911546|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13911547|NCT03502642|Narcotics|narcotics|mesh-ancestor
13911548|NCT03502642|Analgesics|analgesics|mesh-ancestor
13911549|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
13911550|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911551|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911552|NCT03502551|Ketamine|ketamine|mesh-list
13911553|NCT03502551|Analgesics|analgesics|mesh-ancestor
13911554|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
13911555|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044836|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14044837|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044838|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044839|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475078|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475079|NCT02392559|Evolocumab|evolocumab|mesh-list
14475080|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14475081|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14475082|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
14475083|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475084|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14044840|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044841|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044842|NCT03944772|Carboplatin|carboplatin|mesh-list
14044843|NCT03944772|Etoposide|etoposide|mesh-list
14044844|NCT03944772|Pemetrexed|pemetrexed|mesh-list
14044845|NCT03944772|Durvalumab|durvalumab|mesh-list
14044846|NCT03944772|Gefitinib|gefitinib|mesh-list
14044847|NCT03944772|Osimertinib|osimertinib|mesh-list
14044848|NCT03944772|Necitumumab|necitumumab|mesh-list
14044849|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044850|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044851|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14475085|NCT02392611|Fulvestrant|fulvestrant|mesh-list
14475086|NCT02392611|Exemestane|exemestane|mesh-list
14475087|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14475088|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475089|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14475090|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14475091|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
14475092|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475093|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475094|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14475095|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14475096|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475097|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475098|NCT02392624|Omalizumab|omalizumab|mesh-list
14475099|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14475100|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14475101|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
14757026|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757027|NCT01661400|Thalidomide|thalidomide|mesh-list
14757028|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
14757029|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757030|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
14044852|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14044853|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044854|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044855|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14044856|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14044857|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044858|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14044859|NCT03941860|Lenalidomide|lenalidomide|mesh-list
14044860|NCT03941860|Ixazomib|ixazomib|mesh-list
14044861|NCT03941860|Glycine|glycine|mesh-list
14044862|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
14044863|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044864|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044865|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044866|NCT03941860|Growth Substances|growth substances|mesh-ancestor
14044867|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044868|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044869|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044870|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
14044871|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044872|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
14044873|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911556|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911557|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13911558|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13911559|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
13911560|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
13911561|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911562|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13911563|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13911564|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475102|NCT02393209|Docetaxel|docetaxel|mesh-list
14475103|NCT02393209|Serabelisib|serabelisib|mesh-list
14475104|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475105|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
14475106|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14475107|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475108|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475109|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475110|NCT02393339|Acetaminophen|acetaminophen|mesh-list
14475111|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475112|NCT02393339|Analgesics|analgesics|mesh-ancestor
14475113|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
14475114|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475115|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044874|NCT03936309|Lidocaine|lidocaine|mesh-list
14044875|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
14044876|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
14475116|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
14475117|NCT02393378|Folic Acid|folic acid|mesh-list
14475118|NCT02393378|Adalimumab|adalimumab|mesh-list
14475119|NCT02393378|Methotrexate|methotrexate|mesh-list
14475120|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14044877|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14044878|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044879|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
14044880|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044881|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14044882|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14044883|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14044884|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14044885|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044886|NCT03934307|Irbesartan|irbesartan|mesh-list
14044887|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14044888|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14044889|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14044890|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044891|NCT03933449|Paclitaxel|paclitaxel|mesh-list
14044892|NCT03933449|Docetaxel|docetaxel|mesh-list
14044893|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
14044894|NCT03933449|Irinotecan|irinotecan|mesh-list
14044895|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044896|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044897|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044898|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044899|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044900|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044901|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044902|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14044903|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14044904|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044905|NCT03927690|Ranibizumab|ranibizumab|mesh-list
14044906|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14044907|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14044908|NCT03927690|Growth Substances|growth substances|mesh-ancestor
14044909|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475121|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
14475122|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14475123|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475124|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14475125|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
14475126|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475127|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475128|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475129|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475130|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14044910|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
14044911|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044912|NCT03921242|Metformin|metformin|mesh-list
14044913|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14044914|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14044915|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14044916|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044917|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044918|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
14044919|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044920|NCT03915496|Abrocitinib|abrocitinib|mesh-list
14044921|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14044922|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911565|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911566|NCT03502434|Petrolatum|petrolatum|mesh-list
13911567|NCT03502434|Emollients|emollients|mesh-ancestor
13911568|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
13911569|NCT03502421|Ketamine|ketamine|mesh-list
13911570|NCT03502421|Analgesics|analgesics|mesh-ancestor
13911571|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
13911572|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911573|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044923|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044924|NCT03890666|Albuterol|albuterol|mesh-list
14044925|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14475131|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14475132|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
13911574|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14044926|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
14044927|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044928|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044929|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13911575|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13911576|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
13911577|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
13911578|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911579|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13911580|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13911581|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911582|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911583|NCT03502395|Lidocaine|lidocaine|mesh-list
13911584|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911585|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
14044930|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
14044931|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
14044932|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14044933|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14044934|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14044935|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14044936|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
14044937|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14044938|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044939|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14044940|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044941|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
14044942|NCT03844061|Rituximab|rituximab|mesh-list
14044943|NCT03844061|Belimumab|belimumab|mesh-list
14044944|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044945|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044946|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
14044947|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044948|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044949|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14044950|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14044951|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
14044952|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14044953|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14044954|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044955|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044956|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044957|NCT03838263|Cisplatin|cisplatin|mesh-list
14044958|NCT03838263|Nivolumab|nivolumab|mesh-list
14044959|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911586|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911587|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911588|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
13911589|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911590|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13911591|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13911592|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13911593|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911594|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911595|NCT03502356|Azithromycin|azithromycin|mesh-list
14475133|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475134|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14475135|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475136|NCT02393378|Hematinics|hematinics|mesh-ancestor
13911596|NCT03502356|Cefazolin|cefazolin|mesh-list
14044960|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14044961|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14044962|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044963|NCT03801876|Paclitaxel|paclitaxel|mesh-list
14044964|NCT03801876|Docetaxel|docetaxel|mesh-list
14044965|NCT03801876|Carboplatin|carboplatin|mesh-list
13911597|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13911598|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911599|NCT03502343|Gemcitabine|gemcitabine|mesh-list
14044966|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14044967|NCT03801876|Fluorouracil|fluorouracil|mesh-list
13911600|NCT03502343|Paclitaxel|paclitaxel|mesh-list
13911601|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044968|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14044969|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14044970|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
14044971|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
14044972|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
14044973|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044974|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
14044975|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13911602|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911603|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911604|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
13911605|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
13911606|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911607|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13911608|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
13911609|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
13911610|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911611|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911612|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911613|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
14044976|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14044977|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
14044978|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044979|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
14044980|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13911614|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911615|NCT03502291|Vaccines|vaccines|mesh-list
13911616|NCT03502291|Immunologic Factors|immunologic factors|mesh-ancestor
13911617|NCT03502291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959930|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13959931|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959932|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959933|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14044981|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044982|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14044983|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044984|NCT03771651|Aspirin|aspirin|mesh-list
14044985|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14044986|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14044987|NCT03771651|Analgesics|analgesics|mesh-ancestor
14044988|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
14044989|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14044990|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14044991|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14044992|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14044993|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14044994|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14044995|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14044996|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14170174|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
14933442|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933443|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
14933444|NCT01450774|Hormones|hormones|mesh-ancestor
14933445|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933446|NCT01450865|Flupirtine|flupirtine|mesh-list
14933447|NCT01450865|Analgesics|analgesics|mesh-ancestor
14933448|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
14933449|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933450|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933451|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
14933452|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
13959934|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14757031|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757032|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14757033|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14757034|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
14757035|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757036|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757037|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14757038|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
14044997|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14044998|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14044999|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
14045000|NCT03747042|Letrozole|letrozole|mesh-list
14045001|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045002|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14045003|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14045004|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045005|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045006|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14045007|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
14045008|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045009|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045010|NCT03739203|Cariprazine|cariprazine|mesh-list
14045011|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14045012|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14045013|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045014|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045015|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14045016|NCT03738215|Cariprazine|cariprazine|mesh-list
14045017|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14045018|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14045019|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045020|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045021|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14045022|NCT03735901|Levodopa|levodopa|mesh-list
14045023|NCT03735901|Carbidopa|carbidopa|mesh-list
14045024|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14045025|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14045026|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
14045027|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045028|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045029|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045030|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14045031|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045032|NCT03725007|Upadacitinib|upadacitinib|mesh-list
14045033|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14045034|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045035|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045036|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045037|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045038|NCT03711448|Prednisone|prednisone|mesh-list
13911618|NCT03502135|Phenylephrine|phenylephrine|mesh-list
13911619|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
13911620|NCT03502135|Tetracaine|tetracaine|mesh-list
13911621|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911622|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
13911623|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911624|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045039|NCT03711448|Ustekinumab|ustekinumab|mesh-list
14045040|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045041|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
14045042|NCT03711448|Hormones|hormones|mesh-ancestor
14045043|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045044|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911625|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
13911626|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911627|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13911628|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13911629|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
13911630|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911631|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911632|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
14045045|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14045046|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045047|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
14045048|NCT03703856|Memantine|memantine|mesh-list
14045049|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14045050|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13911633|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
13911634|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
13911635|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13911636|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911637|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13911638|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
13911639|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13911640|NCT03502135|Protective Agents|protective agents|mesh-ancestor
13911641|NCT03502018|Bupivacaine|bupivacaine|mesh-list
13911642|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911643|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
13911644|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911645|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911646|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
13911647|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911648|NCT03502005|Tenofovir|tenofovir|mesh-list
14045051|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
14045052|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045053|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045054|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045055|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14045056|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14045057|NCT03699995|Lidocaine|lidocaine|mesh-list
14045058|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
14045059|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
14045060|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045061|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045062|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
14045063|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045064|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14045065|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13911649|NCT03502005|Emtricitabine|emtricitabine|mesh-list
14045066|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14045067|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14045068|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045069|NCT03689946|Listerine|listerine|mesh-list
14045070|NCT03689946|Evolocumab|evolocumab|mesh-list
14045071|NCT03689946|Fluorides|fluorides|mesh-list
14045072|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
14045073|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
14045074|NCT03689946|Protective Agents|protective agents|mesh-ancestor
14045075|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045076|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14045077|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045078|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14045079|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14045080|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
14045081|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045082|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14045083|NCT03664180|Heparin|heparin|mesh-list
14045084|NCT03664180|Calcium heparin|calcium heparin|mesh-list
14045085|NCT03664180|Enoxaparin|enoxaparin|mesh-list
14045086|NCT03664180|Hirudins|hirudins|mesh-list
14045087|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
14045088|NCT03664180|Bivalirudin|bivalirudin|mesh-list
14045089|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
14045090|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14045091|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14045092|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045093|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
14045094|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14045095|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
14045096|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170175|NCT04834908|Immune Sera|immune sera|mesh-list
14170176|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
14170177|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170178|NCT04834791|Letrozole|letrozole|mesh-list
14170179|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170180|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14170181|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14170182|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170183|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170184|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14170185|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
14170186|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170187|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170188|NCT04834960|Vaccines|vaccines|mesh-list
14170189|NCT04834960|Immunologic Factors|immunologic factors|mesh-ancestor
14170190|NCT04834960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170191|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14170192|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170193|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170194|NCT04834440|Ropivacaine|ropivacaine|mesh-list
14170195|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
14170196|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
14170197|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170198|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170199|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
14170200|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170201|NCT04834752|Esomeprazole|esomeprazole|mesh-list
14170202|NCT04834752|Omeprazole|omeprazole|mesh-list
14170203|NCT04834752|Rabeprazole|rabeprazole|mesh-list
14170204|NCT04834752|Pantoprazole|pantoprazole|mesh-list
14170205|NCT04834752|Lansoprazole|lansoprazole|mesh-list
14170206|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
14170207|NCT04834752|Famotidine|famotidine|mesh-list
14170208|NCT04834752|Ranitidine|ranitidine|mesh-list
14170209|NCT04834752|Cimetidine|cimetidine|mesh-list
14170210|NCT04834752|Nizatidine|nizatidine|mesh-list
14170211|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14170212|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170213|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14170214|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170215|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170216|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14170217|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
14170218|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
14475137|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
14475138|NCT02393378|Vitamins|vitamins|mesh-ancestor
14475139|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
14475140|NCT02393547|Varenicline|varenicline|mesh-list
14475141|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14475142|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14475143|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
14475144|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475145|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475146|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475147|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
14475148|NCT02393677|Ropivacaine|ropivacaine|mesh-list
13911650|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
13911651|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
13911652|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911653|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13911654|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13911655|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911656|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911657|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13911658|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13911659|NCT03501966|Acetazolamide|acetazolamide|mesh-list
13911660|NCT03501966|Diuretics|diuretics|mesh-list
13911661|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
13911662|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911663|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
14475149|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13911664|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13911665|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911666|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911667|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13911668|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911669|NCT03501680|Insulin|insulin|mesh-list
13911670|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13911671|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911672|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
13911673|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911674|NCT03501498|Loperamide|loperamide|mesh-list
13911675|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
13911676|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14045097|NCT03612713|Oxycodone|oxycodone|mesh-list
14045098|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14045099|NCT03612713|Narcotics|narcotics|mesh-ancestor
14045100|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045101|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045102|NCT03612713|Analgesics|analgesics|mesh-ancestor
14045103|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
14045104|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911677|NCT03501459|Rituximab|rituximab|mesh-list
13911678|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911679|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911680|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
14045105|NCT03601923|Niraparib|niraparib|mesh-list
14045106|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14045107|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045108|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045109|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045110|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
14045111|NCT03600909|Busulfan|busulfan|mesh-list
14045112|NCT03600909|Fludarabine|fludarabine|mesh-list
14045113|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14045114|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
14045115|NCT03600909|Sargramostim|sargramostim|mesh-list
14045116|NCT03600909|Lenograstim|lenograstim|mesh-list
14045117|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045118|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
14045119|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045120|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045121|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14045122|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
14045123|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045124|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045125|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14045126|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14045127|NCT03587142|Buspirone|buspirone|mesh-list
14045128|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14045129|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14045130|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045131|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045132|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14045133|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14757039|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757040|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757041|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14757042|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13911681|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045134|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
14045135|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045136|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045137|NCT03573297|Cariprazine|cariprazine|mesh-list
14475150|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045138|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14045139|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14045140|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475151|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475152|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475153|NCT02393677|Analgesics|analgesics|mesh-ancestor
14475154|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
14475155|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757043|NCT01661400|Growth Substances|growth substances|mesh-ancestor
14045141|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045142|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14045143|NCT03563560|Cytarabine|cytarabine|mesh-list
14045144|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
14045145|NCT03563560|Alvocidib|alvocidib|mesh-list
14045146|NCT03563560|Daunorubicin|daunorubicin|mesh-list
14045147|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14045148|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
14045149|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045150|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045151|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
14045152|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045153|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045154|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
14045155|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045156|NCT03563560|Analgesics|analgesics|mesh-ancestor
14045157|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
14045158|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045159|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14045160|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045161|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045162|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
14045163|NCT03563560|Growth Substances|growth substances|mesh-ancestor
13911682|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911683|NCT03501433|Niacinamide|niacinamide|mesh-list
13911684|NCT03501433|Niacin|niacin|mesh-list
13911685|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
14475156|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14475157|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14475158|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14475159|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
14475160|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475161|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475162|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
14475163|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
14475164|NCT02393755|Capecitabine|capecitabine|mesh-list
14475165|NCT02393755|Nintedanib|nintedanib|mesh-list
14475166|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14475167|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
14475168|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475169|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475170|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14475171|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475172|NCT02394340|Luliconazole|luliconazole|mesh-list
14475173|NCT02394340|Omeprazole|omeprazole|mesh-list
14475174|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14475175|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13911686|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
13911687|NCT03501433|Vitamins|vitamins|mesh-ancestor
14045164|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045165|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14045166|NCT03551691|Omeprazole|omeprazole|mesh-list
14045167|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14045168|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14045169|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14045170|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045171|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911688|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
13911689|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911690|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13911691|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
13911692|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911693|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13911694|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
13911695|NCT03501251|Albendazole|albendazole|mesh-list
13911696|NCT03501251|Moxidectin|moxidectin|mesh-list
13911697|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
13911698|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13911699|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911700|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
13911701|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13911702|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13911703|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911704|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14045172|NCT03548805|Mitomycins|mitomycins|mesh-list
14045173|NCT03548805|Mitomycin|mitomycin|mesh-list
14475176|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13911705|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
13911706|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911707|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475177|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475178|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475179|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
14475180|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475181|NCT02394457|Cosyntropin|cosyntropin|mesh-list
14475182|NCT02394457|Hormones|hormones|mesh-ancestor
14475183|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475184|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475185|NCT02394730|Vorapaxar|vorapaxar|mesh-list
14475186|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14475187|NCT02394769|Aspirin|aspirin|mesh-list
14045174|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14045175|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045176|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
14045177|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045178|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14045179|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045180|NCT03535116|Ketorolac|ketorolac|mesh-list
14045181|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14045182|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14045183|NCT03535116|Analgesics|analgesics|mesh-ancestor
14045184|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
14045185|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045186|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045187|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045188|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045189|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14045190|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045191|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045192|NCT03471143|Betadex|betadex|mesh-list
14045193|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
14045194|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475188|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14475189|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475190|NCT02394769|Analgesics|analgesics|mesh-ancestor
14475191|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
14045199|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
14045200|NCT03434366|Ketamine|ketamine|mesh-list
14045201|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14045202|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045203|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045204|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14045205|NCT03434366|Analgesics|analgesics|mesh-ancestor
14045206|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
14045207|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045208|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14475192|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475193|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475194|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475195|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911708|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
13911709|NCT03501212|Anesthetics|anesthetics|mesh-list
13911710|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
13911711|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911712|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911713|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
13911714|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911715|NCT03501056|Antibodies|antibodies|mesh-list
13911716|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13911717|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
13911718|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045209|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14045210|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14045211|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
14045212|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475196|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13911719|NCT03500913|Hormones|hormones|mesh-list
13911720|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911721|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911722|NCT03500900|Vildagliptin|vildagliptin|mesh-list
13911723|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13911724|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911725|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13911726|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
14045213|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045214|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14045215|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14045216|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
14045217|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
14045218|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13911727|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911728|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911729|NCT03500874|Leucovorin|leucovorin|mesh-list
14045219|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14045220|NCT03424005|Gemcitabine|gemcitabine|mesh-list
14045221|NCT03424005|Paclitaxel|paclitaxel|mesh-list
14045222|NCT03424005|Bevacizumab|bevacizumab|mesh-list
14045223|NCT03424005|Carboplatin|carboplatin|mesh-list
14045224|NCT03424005|Capecitabine|capecitabine|mesh-list
14045225|NCT03424005|Atezolizumab|atezolizumab|mesh-list
14045226|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045227|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045228|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
13911730|NCT03500874|Fluorouracil|fluorouracil|mesh-list
13911731|NCT03500874|Floxuridine|floxuridine|mesh-list
13911732|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
13911733|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
13911734|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911735|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13911736|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911737|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911738|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
13911739|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911740|NCT03500874|Antidotes|antidotes|mesh-ancestor
13911741|NCT03500874|Protective Agents|protective agents|mesh-ancestor
13911742|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
13911743|NCT03500874|Vitamins|vitamins|mesh-ancestor
14045229|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14045230|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14045231|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045232|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045233|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14045234|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14045235|NCT03424005|Growth Substances|growth substances|mesh-ancestor
14045236|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045237|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
14045238|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14045239|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
14045240|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
14045241|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045242|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045243|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911744|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
13911745|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
13911746|NCT03500848|Sirolimus|sirolimus|mesh-list
13911747|NCT03500848|Tacrolimus|tacrolimus|mesh-list
13911748|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911749|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
14045244|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
14045245|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14045246|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14045247|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045248|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
14045249|NCT03417154|Nivolumab|nivolumab|mesh-list
14045250|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045251|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
14045252|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045253|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045254|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14045255|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
14045256|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045257|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911750|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911751|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13911752|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911753|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911754|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13911755|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045258|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14045259|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045260|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14045261|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
14933453|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14933454|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14933455|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933456|NCT01450956|Sevoflurane|sevoflurane|mesh-list
14933457|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14933458|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14933459|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
14933460|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
13911756|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13911757|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
13911758|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13911759|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911760|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
13911761|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
13911762|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13911763|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
13911764|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911765|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911766|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13911767|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911768|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13911769|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
13911770|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911771|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933461|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933462|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933463|NCT01450995|Sumatriptan|sumatriptan|mesh-list
14933464|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14933465|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14933466|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14933467|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
14933468|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933469|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933470|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933471|NCT01451060|Ephedrine|ephedrine|mesh-list
14045262|NCT03405792|Temozolomide|temozolomide|mesh-list
14045263|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045264|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045265|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14045266|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
14045267|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045268|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
13911772|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13911773|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
13911774|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
13911775|NCT03500783|Protective Agents|protective agents|mesh-ancestor
13911776|NCT03500653|Curcumin|curcumin|mesh-list
13911777|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13911778|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475197|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14475198|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475199|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14933472|NCT01451060|Metaraminol|metaraminol|mesh-list
14933473|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14933474|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933475|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
14933476|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
14933477|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933478|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13911779|NCT03500653|Analgesics|analgesics|mesh-ancestor
13911780|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
14045269|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045270|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045271|NCT03330405|Avelumab|avelumab|mesh-list
14045272|NCT03330405|Talazoparib|talazoparib|mesh-list
14045273|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14045274|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045275|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045276|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
14045277|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045278|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14045279|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045280|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045281|NCT03244059|Belimumab|belimumab|mesh-list
14045282|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045283|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
14045284|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045285|NCT03207867|Spartalizumab|spartalizumab|mesh-list
14045286|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14045287|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045288|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045289|NCT03182244|Cytarabine|cytarabine|mesh-list
14045290|NCT03182244|Fludarabine|fludarabine|mesh-list
14045291|NCT03182244|Etoposide|etoposide|mesh-list
14045292|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
14045293|NCT03182244|Sargramostim|sargramostim|mesh-list
14475200|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14475201|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475202|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
14475203|NCT02394951|Pregabalin|pregabalin|mesh-list
14475204|NCT02394951|Analgesics|analgesics|mesh-ancestor
14475205|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
14475206|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475207|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475208|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
14475209|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14757044|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
14045294|NCT03182244|Lenograstim|lenograstim|mesh-list
14045295|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045296|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14475210|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911781|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911782|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911783|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911784|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911785|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911786|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911787|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959935|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
13959936|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959937|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13959938|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
13959939|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
13959940|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
13959941|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13959942|NCT03158935|Aldesleukin|aldesleukin|mesh-list
13959943|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
13959944|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
13959945|NCT03158935|Fludarabine|fludarabine|mesh-list
13959946|NCT03158935|Interleukin-2|interleukin-2|mesh-list
13959947|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13959948|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
13959949|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959950|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959951|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13959952|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
13959953|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959954|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959955|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13959956|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13959957|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13959958|NCT03158935|Analgesics|analgesics|mesh-ancestor
13959959|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
13959960|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045297|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
14170219|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757045|NCT01503606|Clarithromycin|clarithromycin|mesh-list
14045298|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045299|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045300|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
14045301|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045302|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045303|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14045304|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045305|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045306|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
14045307|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045308|NCT03182244|Analgesics|analgesics|mesh-ancestor
14045309|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
14045310|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045311|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14045312|NCT03170960|Atezolizumab|atezolizumab|mesh-list
13911788|NCT03500445|Dexamethasone|dexamethasone|mesh-list
13911789|NCT03500445|Lenalidomide|lenalidomide|mesh-list
13911790|NCT03500445|Daratumumab|daratumumab|mesh-list
13911791|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911792|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
13911793|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
13911794|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911795|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911796|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14045313|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045314|NCT03131219|Ravulizumab|ravulizumab|mesh-list
14045315|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14045316|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045317|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
14045318|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045319|NCT03075527|Durvalumab|durvalumab|mesh-list
14045320|NCT03075527|Tremelimumab|tremelimumab|mesh-list
14045321|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045322|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045323|NCT03070886|Docetaxel|docetaxel|mesh-list
14045324|NCT03070886|Leuprolide|leuprolide|mesh-list
14045325|NCT03070886|Goserelin|goserelin|mesh-list
14045326|NCT03070886|Bicalutamide|bicalutamide|mesh-list
14045327|NCT03070886|Flutamide|flutamide|mesh-list
14045328|NCT03070886|Nilutamide|nilutamide|mesh-list
14045329|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045330|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
14045331|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
14045332|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
14045333|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045334|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14045335|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
14045336|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14045337|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045338|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14045339|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
14045340|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
14045341|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045342|NCT03064867|Rituximab|rituximab|mesh-list
14045343|NCT03064867|Carboplatin|carboplatin|mesh-list
14045344|NCT03064867|Etoposide|etoposide|mesh-list
14045345|NCT03064867|Ifosfamide|ifosfamide|mesh-list
14045346|NCT03064867|Venetoclax|venetoclax|mesh-list
14045347|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045348|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045349|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
14045350|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045351|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045352|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045353|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14045354|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13911797|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
13911798|NCT03500445|Hormones|hormones|mesh-ancestor
13911799|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911800|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13911801|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911802|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
14045355|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045356|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045357|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14479158|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045358|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
14045359|NCT03056755|Letrozole|letrozole|mesh-list
14045360|NCT03056755|Fulvestrant|fulvestrant|mesh-list
14045361|NCT03056755|Leuprolide|leuprolide|mesh-list
14045362|NCT03056755|Goserelin|goserelin|mesh-list
14045363|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045364|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14045365|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14045366|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045367|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045368|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14045369|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14045370|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045371|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045372|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14045373|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14045374|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14045375|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
14045376|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14045377|NCT03049189|Everolimus|everolimus|mesh-list
14045378|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14045379|NCT03049189|Edotreotide|edotreotide|mesh-list
14045380|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045381|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045382|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
14045383|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045384|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14045385|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045386|NCT03014648|Atezolizumab|atezolizumab|mesh-list
14045387|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757046|NCT01503606|Cefazolin|cefazolin|mesh-list
14757047|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757048|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757049|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14757050|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757051|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757052|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14757053|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14757054|NCT01293682|Calcitriol|calcitriol|mesh-list
14757055|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14757056|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757057|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14933479|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
14045401|NCT02814916|Dalbavancin|dalbavancin|mesh-list
14045402|NCT02814916|Teicoplanin|teicoplanin|mesh-list
14045403|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14045404|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045405|NCT02756611|Venetoclax|venetoclax|mesh-list
14045406|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045407|NCT02740335|Protein C|protein c|mesh-list
14045408|NCT02740335|Protein S|protein s|mesh-list
14045409|NCT02740335|Thrombin|thrombin|mesh-list
14045410|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
13911803|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13911804|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13911805|NCT03500445|Growth Substances|growth substances|mesh-ancestor
13911806|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
13911807|NCT03500432|Lidocaine|lidocaine|mesh-list
14933480|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933481|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933482|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14933483|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14933484|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14933485|NCT01451086|Vaccines|vaccines|mesh-list
14933486|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
14933487|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933488|NCT01451229|Higenamine|higenamine|mesh-list
13911808|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
13911809|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
13911810|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911811|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911812|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
14045411|NCT02740335|Coagulants|coagulants|mesh-ancestor
13959961|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14045412|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
14045413|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14045414|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14479159|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
14933489|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14933490|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14933491|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
13911813|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911814|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13911815|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13911816|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13911817|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911818|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911819|NCT03500367|Sirolimus|sirolimus|mesh-list
13911820|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13911821|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911822|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13911823|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911824|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
13911825|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911826|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
13911827|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911828|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
13911829|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
13911830|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911831|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911832|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911833|NCT03500133|Cytarabine|cytarabine|mesh-list
13911834|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
13911835|NCT03500133|Cisplatin|cisplatin|mesh-list
13911836|NCT03500133|Etoposide|etoposide|mesh-list
13911837|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911838|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13911839|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
13911840|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911841|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
13911842|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911843|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13911844|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
13911845|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911846|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045415|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045416|NCT02724878|Bevacizumab|bevacizumab|mesh-list
14045417|NCT02724878|Atezolizumab|atezolizumab|mesh-list
14045418|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045419|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045420|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14045421|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14045422|NCT02724878|Growth Substances|growth substances|mesh-ancestor
14045423|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045424|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
14045425|NCT02723955|Gemcitabine|gemcitabine|mesh-list
14045426|NCT02723955|Paclitaxel|paclitaxel|mesh-list
14045427|NCT02723955|Docetaxel|docetaxel|mesh-list
14045428|NCT02723955|Carboplatin|carboplatin|mesh-list
14045429|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
14045430|NCT02723955|Fluorouracil|fluorouracil|mesh-list
14757058|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757059|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757060|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14757061|NCT01293682|Vitamins|vitamins|mesh-ancestor
14757062|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
14757063|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14757064|NCT01253161|Pasireotide|pasireotide|mesh-list
14757065|NCT01253161|Hormones|hormones|mesh-ancestor
14757066|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933492|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045431|NCT02723955|Pemetrexed|pemetrexed|mesh-list
14045432|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045433|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045434|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
14045435|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
14045436|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
14045437|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045438|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14045439|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
14045440|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
14045441|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045442|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045443|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045444|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
14045445|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045446|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13911847|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13911848|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13911849|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911850|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911851|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
13911852|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
13911853|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911854|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14045447|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14045448|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14045449|NCT02720068|Leucovorin|leucovorin|mesh-list
14045450|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
14045451|NCT02720068|Fluorouracil|fluorouracil|mesh-list
14045452|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
14045453|NCT02720068|Irinotecan|irinotecan|mesh-list
14045454|NCT02720068|Lenvatinib|lenvatinib|mesh-list
14045455|NCT02720068|Calcium|calcium|mesh-list
14045456|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
13911855|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
13911856|NCT03500133|Hormones|hormones|mesh-ancestor
13911857|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13911858|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13911859|NCT03500133|Protective Agents|protective agents|mesh-ancestor
13911860|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
13911861|NCT03500120|Captopril|captopril|mesh-list
13911862|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13911863|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
13911864|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911865|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911866|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13911867|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911868|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
13911869|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13911870|NCT03499886|Ketamine|ketamine|mesh-list
13911871|NCT03499886|Analgesics|analgesics|mesh-ancestor
13911872|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
13911873|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13911874|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911875|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13911876|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13911877|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
13911878|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
13911879|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911880|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13911881|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13911882|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045457|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14045458|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045459|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045460|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045461|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
14045462|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045463|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14045464|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045465|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
14045466|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14045467|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045468|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045469|NCT02720068|Antidotes|antidotes|mesh-ancestor
14045470|NCT02720068|Protective Agents|protective agents|mesh-ancestor
14045471|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
14045472|NCT02720068|Vitamins|vitamins|mesh-ancestor
14045473|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
14045474|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045475|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
14045476|NCT02693535|Nivolumab|nivolumab|mesh-list
14045477|NCT02693535|Trastuzumab|trastuzumab|mesh-list
14045478|NCT02693535|Ipilimumab|ipilimumab|mesh-list
13911883|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911884|NCT03499743|Celecoxib|celecoxib|mesh-list
13911885|NCT03499743|Scopolamine|scopolamine|mesh-list
13911886|NCT03499743|Bromides|bromides|mesh-list
13911887|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13911888|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13911889|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13911890|NCT03499743|Analgesics|analgesics|mesh-ancestor
13911891|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
13911892|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045479|NCT02693535|Pertuzumab|pertuzumab|mesh-list
14045480|NCT02693535|Atezolizumab|atezolizumab|mesh-list
14045481|NCT02693535|Sunitinib|sunitinib|mesh-list
14045482|NCT02693535|Olaparib|olaparib|mesh-list
14045483|NCT02693535|Palbociclib|palbociclib|mesh-list
14045484|NCT02693535|Afatinib|afatinib|mesh-list
14045485|NCT02693535|Vemurafenib|vemurafenib|mesh-list
14045486|NCT02693535|Crizotinib|crizotinib|mesh-list
14045487|NCT02693535|Talazoparib|talazoparib|mesh-list
14045488|NCT02693535|Tucatinib|tucatinib|mesh-list
14045489|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14045490|NCT02693535|Entrectinib|entrectinib|mesh-list
14045491|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045492|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045493|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14045494|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045495|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
14045496|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045497|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14045498|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14045499|NCT02693535|Growth Substances|growth substances|mesh-ancestor
14045500|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
14045501|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045502|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045503|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13911893|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911894|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13911895|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13911896|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13911897|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13911898|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911899|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911900|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
13911901|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14045504|NCT02692313|Epinephrine|epinephrine|mesh-list
14045505|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14045506|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14045507|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
14045508|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170220|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911902|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
13911903|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
13911904|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13911905|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
13911906|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13911907|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
13911908|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911909|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13911910|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
13911911|NCT03499730|Midazolam|midazolam|mesh-list
13911912|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13911913|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13911914|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911915|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045509|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045510|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045511|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14045512|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14045513|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
14045514|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045515|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14045516|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911916|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13911917|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13911918|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13911919|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13911920|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
13911921|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
13911922|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
13911923|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
13911924|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911925|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911926|NCT03499639|Ritonavir|ritonavir|mesh-list
13911927|NCT03499639|Ribavirin|ribavirin|mesh-list
13911928|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13911929|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13911930|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
13911931|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045517|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
14045518|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
14045519|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14045520|NCT02666105|Exemestane|exemestane|mesh-list
14045521|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045522|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14045523|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14045524|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045525|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045526|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14045527|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
14045528|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045529|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045530|NCT02641873|Leucovorin|leucovorin|mesh-list
14045531|NCT02641873|Bevacizumab|bevacizumab|mesh-list
14045532|NCT02641873|Irinotecan|irinotecan|mesh-list
14045533|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
14045534|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045535|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045536|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13911932|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911933|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13911934|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13911935|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
13911936|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911937|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13911938|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13911939|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
13911940|NCT03499457|Amoxicillin|amoxicillin|mesh-list
13911941|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13911942|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911943|NCT03499444|Rucaparib|rucaparib|mesh-list
13911944|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13911945|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479160|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911946|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045537|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14045538|NCT02641873|Growth Substances|growth substances|mesh-ancestor
14045539|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045540|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
14045541|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14045542|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045543|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045544|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045545|NCT02641873|Antidotes|antidotes|mesh-ancestor
14045546|NCT02641873|Protective Agents|protective agents|mesh-ancestor
14045547|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
14045548|NCT02641873|Vitamins|vitamins|mesh-ancestor
14045549|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
14045550|NCT02629120|Sirolimus|sirolimus|mesh-list
14045551|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
14045552|NCT02629120|Busulfan|busulfan|mesh-list
14045553|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
14045554|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045555|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
14045556|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045557|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045558|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14045559|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
14045560|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045561|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045562|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14045563|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14045564|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045565|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14045566|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
14045567|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045568|NCT02608268|Decitabine|decitabine|mesh-list
14045569|NCT02608268|Spartalizumab|spartalizumab|mesh-list
14045570|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14045571|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
14045572|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045573|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045574|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045575|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14045576|NCT02605993|Ravulizumab|ravulizumab|mesh-list
14045577|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14045578|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045579|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
14045580|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170221|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14170222|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14170223|NCT04834674|Apatinib|apatinib|mesh-list
14170224|NCT04834674|Antibodies|antibodies|mesh-list
14170225|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
14475211|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475212|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14475213|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13911947|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911948|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
13911949|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13911950|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
13911951|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13911952|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911953|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13911954|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13911955|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13911956|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
13911957|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14170226|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475214|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14767233|NCT00629278|Tamoxifen|tamoxifen|mesh-list
14170227|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045581|NCT02598726|Curcumin|curcumin|mesh-list
14045582|NCT02598726|Piperine|piperine|mesh-list
14045583|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14045584|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14045585|NCT02598726|Analgesics|analgesics|mesh-ancestor
14045586|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
14045587|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045588|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045589|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045590|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045591|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045592|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13911958|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
13911959|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911960|NCT03499249|Expectorants|expectorants|mesh-ancestor
13911961|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
13911962|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13911963|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
13911964|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045593|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045594|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14045595|NCT02562235|Riociguat|riociguat|mesh-list
14045596|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
14045597|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045598|NCT02553460|Leucovorin|leucovorin|mesh-list
14045599|NCT02553460|Cytarabine|cytarabine|mesh-list
14045600|NCT02553460|Dexamethasone|dexamethasone|mesh-list
14045601|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
14045602|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
14045603|NCT02553460|Methotrexate|methotrexate|mesh-list
14045604|NCT02553460|Etoposide|etoposide|mesh-list
14045605|NCT02553460|Vincristine|vincristine|mesh-list
14045606|NCT02553460|Bortezomib|bortezomib|mesh-list
14045607|NCT02553460|Asparaginase|asparaginase|mesh-list
14045608|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
14045609|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
14045610|NCT02553460|Vorinostat|vorinostat|mesh-list
14045611|NCT02553460|Pegaspargase|pegaspargase|mesh-list
14045612|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
14045613|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045614|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
14045615|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045616|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045617|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14045618|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
14045619|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045620|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045621|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14045622|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045623|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
14045624|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
14045625|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045626|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14045627|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
14045628|NCT02553460|Hormones|hormones|mesh-ancestor
14045629|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045630|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14045631|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14045632|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
14045633|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14045634|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14045635|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
14045636|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
13911965|NCT03499249|Protective Agents|protective agents|mesh-ancestor
13911966|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911967|NCT03499249|Antidotes|antidotes|mesh-ancestor
13911968|NCT03499223|Ranibizumab|ranibizumab|mesh-list
13911969|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13911970|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13911971|NCT03499223|Growth Substances|growth substances|mesh-ancestor
13911972|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911973|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
13911974|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13911975|NCT03499184|Metronidazole|metronidazole|mesh-list
13911976|NCT03499184|Amoxicillin|amoxicillin|mesh-list
13911977|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911978|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14045637|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045638|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14045639|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14045640|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045641|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14045642|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045643|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
14045644|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045645|NCT02553460|Antidotes|antidotes|mesh-ancestor
14045646|NCT02553460|Protective Agents|protective agents|mesh-ancestor
14045647|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
14045648|NCT02553460|Vitamins|vitamins|mesh-ancestor
14045649|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
14475215|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475216|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475217|NCT02395055|Adalimumab|adalimumab|mesh-list
13911979|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13911980|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13911981|NCT03499171|Citalopram|citalopram|mesh-list
13911982|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13911983|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13911984|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13911985|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13911986|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13911987|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
13911988|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911989|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13911990|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
13911991|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13911992|NCT03499132|Anesthetics|anesthetics|mesh-list
13911993|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13911994|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13911995|NCT03499106|Itraconazole|itraconazole|mesh-list
13911996|NCT03499106|Praliciguat|praliciguat|mesh-list
13911997|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
13911998|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13911999|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14045650|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
14045651|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
14045652|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
14045653|NCT02553460|Analgesics|analgesics|mesh-ancestor
14045654|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
14045655|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14045656|NCT02522715|Prednisone|prednisone|mesh-list
14045657|NCT02522715|Cortisone|cortisone|mesh-list
14475218|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475219|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475220|NCT02395081|Vitamin D|vitamin d|mesh-list
14475221|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
14475222|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
14475223|NCT02395081|Vitamins|vitamins|mesh-list
14475224|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
13912000|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13912001|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912002|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912003|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13912004|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
13912005|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13912006|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912007|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13912008|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
13912009|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
13912010|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912011|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
13912012|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912013|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912014|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912015|NCT03498820|Remifentanil|remifentanil|mesh-list
14045658|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045659|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
14045660|NCT02522715|Hormones|hormones|mesh-ancestor
14045661|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045662|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045663|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14045664|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045665|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
14045666|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045667|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045668|NCT02487095|Topotecan|topotecan|mesh-list
14045669|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14045670|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045671|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045672|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045673|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045674|NCT02471911|Dexamethasone|dexamethasone|mesh-list
14045675|NCT02471911|Rituximab|rituximab|mesh-list
14045676|NCT02471911|Carboplatin|carboplatin|mesh-list
14045677|NCT02471911|Etoposide|etoposide|mesh-list
14045678|NCT02471911|Ifosfamide|ifosfamide|mesh-list
14045679|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045680|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
14045681|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
14045682|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045683|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045684|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14045685|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
13912016|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13912017|NCT03498820|Narcotics|narcotics|mesh-ancestor
13912018|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912019|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912020|NCT03498820|Analgesics|analgesics|mesh-ancestor
13912021|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
13912022|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959962|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13959963|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
13959964|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13959965|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
13959966|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
14045686|NCT02471911|Hormones|hormones|mesh-ancestor
14045687|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045688|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14045689|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045690|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045691|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
14045692|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13959967|NCT03158584|Morphine|morphine|mesh-list
13959968|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13959969|NCT03158584|Narcotics|narcotics|mesh-ancestor
13959970|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13959971|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959972|NCT03158584|Analgesics|analgesics|mesh-ancestor
13959973|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
13959974|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13959975|NCT03158805|Liraglutide|liraglutide|mesh-list
14045693|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045694|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14045695|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045696|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045697|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045698|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14045699|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
14045700|NCT02432417|Chloroquine|chloroquine|mesh-list
14045701|NCT02432417|Amebicides|amebicides|mesh-ancestor
14045702|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14045703|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14045704|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045705|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
14045706|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475225|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475226|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14475227|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14475228|NCT02395172|Docetaxel|docetaxel|mesh-list
13912023|NCT03498703|Azathioprine|azathioprine|mesh-list
13912024|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
13912025|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912026|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912027|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912028|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912029|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
13912030|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912031|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912032|NCT03498534|Isoniazid|isoniazid|mesh-list
13912033|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
13912034|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912035|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912036|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13912037|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13912038|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
13912039|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912040|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13912041|NCT03498456|Amoxicillin|amoxicillin|mesh-list
13912042|NCT03498456|Clarithromycin|clarithromycin|mesh-list
13912043|NCT03498456|Lansoprazole|lansoprazole|mesh-list
13912044|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
13912045|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912046|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912047|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13912048|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912049|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912050|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13912051|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13912052|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13912053|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912054|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13912055|NCT03498417|Antibodies|antibodies|mesh-list
13912056|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
14475229|NCT02395172|Avelumab|avelumab|mesh-list
14475230|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475231|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
14475232|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
14475233|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475234|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475235|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475236|NCT02395627|Tamoxifen|tamoxifen|mesh-list
14475237|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
14475238|NCT02395627|Vorinostat|vorinostat|mesh-list
14475239|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475240|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475241|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14475242|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
14475243|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475244|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475245|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14475246|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14475247|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14045733|NCT02407119|Amoxicillin|amoxicillin|mesh-list
14045734|NCT02407119|Clarithromycin|clarithromycin|mesh-list
13912057|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045735|NCT02407119|Omeprazole|omeprazole|mesh-list
14045736|NCT02407119|Rabeprazole|rabeprazole|mesh-list
14045737|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14045738|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14045739|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045740|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14045741|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912058|NCT03498326|Gemcitabine|gemcitabine|mesh-list
13912059|NCT03498326|Celecoxib|celecoxib|mesh-list
14045742|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912060|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912061|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
13912062|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912063|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912064|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
13912065|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045743|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045744|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14045745|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14045746|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14045747|NCT02377271|Bosentan|bosentan|mesh-list
14045748|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14045749|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13912066|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912067|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912068|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
13912069|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912070|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13912071|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912072|NCT03498326|Analgesics|analgesics|mesh-ancestor
13912073|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
13912074|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912075|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912076|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045750|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045751|NCT02364713|Gemcitabine|gemcitabine|mesh-list
14045752|NCT02364713|Paclitaxel|paclitaxel|mesh-list
14045753|NCT02364713|Bevacizumab|bevacizumab|mesh-list
14045754|NCT02364713|Doxorubicin|doxorubicin|mesh-list
14045755|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14045756|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14045757|NCT02364713|Topotecan|topotecan|mesh-list
14045758|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14045759|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
14045760|NCT02364713|Antibodies|antibodies|mesh-list
14045761|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
14045762|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14045763|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
14045764|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14045765|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045766|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
14045767|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
14045768|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
14045769|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045770|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14045771|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14045772|NCT02364713|Growth Substances|growth substances|mesh-ancestor
14045773|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045774|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
14045775|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
14045776|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14045777|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
14045778|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
14045779|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045780|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045781|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045782|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14045783|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14045784|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14045785|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14045786|NCT02358395|Sorafenib|sorafenib|mesh-list
14045787|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045788|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045789|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045790|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045791|NCT02354898|Sorafenib|sorafenib|mesh-list
13912077|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13912078|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14045792|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045793|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045794|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045795|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475248|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14475249|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14475250|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475251|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475252|NCT02395653|Fentanyl|fentanyl|mesh-list
14045796|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
14045797|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14045798|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
14045799|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14045800|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045801|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14045802|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14045803|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14045804|NCT02347917|Pemetrexed|pemetrexed|mesh-list
14045805|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045806|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045807|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045808|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14045809|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14045810|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
14045811|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045812|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045813|NCT02303795|Warfarin|warfarin|mesh-list
14045814|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
14045815|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
14045816|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14045817|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
14045818|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14045819|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
14045820|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045821|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045822|NCT02185560|Sorafenib|sorafenib|mesh-list
14045823|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045824|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045825|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045826|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045827|NCT02178566|Treprostinil|treprostinil|mesh-list
14045828|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14045829|NCT02167763|Copper|copper|mesh-list
14045830|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
14045831|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14045832|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045833|NCT02167763|Trace Elements|trace elements|mesh-ancestor
14475253|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13912086|NCT03498261|Gabapentin|gabapentin|mesh-list
13912087|NCT03498261|Analgesics|analgesics|mesh-ancestor
13912088|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
13912089|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912090|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912091|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
13912092|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13912093|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13912094|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912095|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13912096|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13912097|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13912098|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045834|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
14045835|NCT02099058|Nivolumab|nivolumab|mesh-list
14045836|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14045837|NCT02099058|Osimertinib|osimertinib|mesh-list
13912099|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912100|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
13912101|NCT03498248|Lenograstim|lenograstim|mesh-list
13912102|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13912103|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
13912104|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912105|NCT03498235|Propofol|propofol|mesh-list
13912106|NCT03498235|Sevoflurane|sevoflurane|mesh-list
13912107|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14045838|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13912108|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933493|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933494|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912109|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912110|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13912111|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
13912112|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
13912113|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13912114|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13912115|NCT03498222|Carboplatin|carboplatin|mesh-list
13912116|NCT03498222|Pemetrexed|pemetrexed|mesh-list
13912117|NCT03498222|Atezolizumab|atezolizumab|mesh-list
13912118|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912119|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912120|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912121|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14045839|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14045840|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045841|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14045842|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045843|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045844|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045845|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
14045846|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045847|NCT02043678|Prednisone|prednisone|mesh-list
14045848|NCT02043678|Prednisolone|prednisolone|mesh-list
14045849|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14045850|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045851|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
14045852|NCT02043678|Hormones|hormones|mesh-ancestor
14045853|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045854|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045855|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14045856|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045857|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14045858|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14045859|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14045860|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045861|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045862|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14045863|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14045864|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14045865|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14045866|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
14045867|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045868|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045869|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14045870|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14045871|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
14045872|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14045873|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14045874|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
14045875|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14045876|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14045877|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14045878|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045879|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045880|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14045881|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14045882|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14045883|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14045884|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
14045885|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045886|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045887|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14045888|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14045889|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
14045890|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14045891|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14045892|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
14933495|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14045893|NCT01972035|Valacyclovir|valacyclovir|mesh-list
14045894|NCT01972035|Valganciclovir|valganciclovir|mesh-list
14045895|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
14045896|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045897|NCT01955980|Budesonide|budesonide|mesh-list
14045898|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045899|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14045900|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
14933496|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933497|NCT01451229|Analgesics|analgesics|mesh-ancestor
14933498|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
14933499|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045901|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045902|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045903|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14045904|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
14045905|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
14045906|NCT01955980|Hormones|hormones|mesh-ancestor
14045907|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045908|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
14045909|NCT01953900|Fludarabine|fludarabine|mesh-list
14045910|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14045911|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
14045912|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045913|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14045914|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14045915|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
14045916|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045917|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045918|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14045919|NCT01946711|Budesonide|budesonide|mesh-list
14045920|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14045921|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14045922|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
14933500|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912122|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13912123|NCT03498170|Itraconazole|itraconazole|mesh-list
13912124|NCT03498170|Acumapimod|acumapimod|mesh-list
13912125|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
13912126|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912127|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13912128|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13912129|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912130|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045923|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14045924|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045925|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14045926|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
14045927|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
14045928|NCT01946711|Hormones|hormones|mesh-ancestor
14045929|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933501|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933502|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13912131|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13912132|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
13912133|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13912134|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912135|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13912136|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13912137|NCT03498131|Melatonin|melatonin|mesh-list
13912138|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
13912139|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912140|NCT03498131|Protective Agents|protective agents|mesh-ancestor
13912141|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912142|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912143|NCT03498118|Bupivacaine|bupivacaine|mesh-list
13912144|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
13912145|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
13912146|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912147|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912148|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
13912149|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912150|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
14045930|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14045931|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14045932|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912151|NCT03498092|Bupivacaine|bupivacaine|mesh-list
13912152|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
13912153|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
13912154|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912155|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912156|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
13912157|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912158|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13912159|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912160|NCT03498092|Analgesics|analgesics|mesh-ancestor
13912161|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13912162|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13912163|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13912164|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
13912165|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912166|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912167|NCT03497988|Oxytocin|oxytocin|mesh-list
14045933|NCT01864746|Palbociclib|palbociclib|mesh-list
14045934|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045935|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045936|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045937|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045938|NCT01858896|Glucagon|glucagon|mesh-list
14045939|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14045940|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14045941|NCT01858896|Hormones|hormones|mesh-ancestor
14045942|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14045943|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045944|NCT01858896|Incretins|incretins|mesh-ancestor
14045945|NCT01740427|Letrozole|letrozole|mesh-list
14045946|NCT01740427|Palbociclib|palbociclib|mesh-list
14045947|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045948|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14045949|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14045950|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045951|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045952|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14045953|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
14045954|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13912168|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
13912169|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912170|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912171|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
13912172|NCT03497923|Analgesics|analgesics|mesh-ancestor
13912173|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
13912174|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912175|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045955|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045956|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045957|NCT01723202|Trametinib|trametinib|mesh-list
14045958|NCT01723202|Dabrafenib|dabrafenib|mesh-list
14045959|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045960|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14045961|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045962|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045963|NCT01680965|Ofatumumab|ofatumumab|mesh-list
14045964|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045965|NCT01678027|Clarithromycin|clarithromycin|mesh-list
14045966|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14045967|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14045968|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14045969|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14045970|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045971|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14045972|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14045973|NCT01672255|Fluoxetine|fluoxetine|mesh-list
14045974|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14045975|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14045976|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14045977|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045978|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912176|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
13912177|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912178|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13912179|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
13912180|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13912181|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13912182|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912183|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13912184|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
13912185|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912186|NCT03497767|Osimertinib|osimertinib|mesh-list
13912187|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912188|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13912189|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912190|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045979|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
14045980|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045981|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14045982|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
14045983|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14045984|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14045985|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14045986|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933503|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14933504|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14933505|NCT01451229|Protective Agents|protective agents|mesh-ancestor
14045987|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14045988|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14933506|NCT01451268|Panobinostat|panobinostat|mesh-list
14933507|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933508|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13912191|NCT03497715|Ibuprofen|ibuprofen|mesh-list
13912192|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13912193|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912194|NCT03497715|Analgesics|analgesics|mesh-ancestor
13912195|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
13912196|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912197|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912198|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912199|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912200|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13912201|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912202|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912203|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
13912204|NCT03497702|Docetaxel|docetaxel|mesh-list
13912205|NCT03497702|Doxorubicin|doxorubicin|mesh-list
13912206|NCT03497702|Letrozole|letrozole|mesh-list
13912207|NCT03497702|Leuprolide|leuprolide|mesh-list
13912208|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912209|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
13912210|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912211|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912212|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13912213|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
13912214|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912215|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14045989|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14045990|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14045991|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14045992|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13912216|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13912217|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
13912218|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
13912219|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
13912220|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13912221|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13912222|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13912223|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912224|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13912225|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13912226|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13912227|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
13912228|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13912229|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13912230|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
13912231|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912232|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13912233|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13912234|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14045993|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14045994|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14045995|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14045996|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
14045997|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14045998|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14045999|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14046000|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14046001|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
14046002|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14046003|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14046004|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
14046005|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14046006|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14046007|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14046008|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046009|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046010|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14046011|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14046012|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14046013|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14046014|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046015|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046016|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046017|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14046018|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14046019|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
14046020|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14046021|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14046022|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
14046023|NCT01592370|Dexamethasone|dexamethasone|mesh-list
14046024|NCT01592370|Nivolumab|nivolumab|mesh-list
14046025|NCT01592370|Ipilimumab|ipilimumab|mesh-list
14046026|NCT01592370|Daratumumab|daratumumab|mesh-list
14046027|NCT01592370|Pomalidomide|pomalidomide|mesh-list
14046028|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046029|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
14046030|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
14046031|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046032|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046033|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14046034|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
14046035|NCT01592370|Hormones|hormones|mesh-ancestor
14046036|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046037|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13959976|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046038|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475254|NCT02395653|Narcotics|narcotics|mesh-ancestor
14046039|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475255|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475256|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475257|NCT02395653|Analgesics|analgesics|mesh-ancestor
14475258|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
14475259|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475260|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14475261|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14757067|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757068|NCT01192568|Oxybutynin|oxybutynin|mesh-list
14757069|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
14757070|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
14757071|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912235|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13912236|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13912237|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13912238|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
13912239|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912240|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912241|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912242|NCT03497364|Bupivacaine|bupivacaine|mesh-list
13912243|NCT03497364|Ropivacaine|ropivacaine|mesh-list
13912244|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
13912245|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
13912246|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912247|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912248|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
13912249|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912250|NCT03497351|Nicardipine|nicardipine|mesh-list
13912251|NCT03497351|Urapidil|urapidil|mesh-list
13912252|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13912253|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13912254|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13912255|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912256|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13912257|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912258|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
13912259|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13912260|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
13912261|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912262|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13912263|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13912264|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13912265|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046040|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14046041|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046042|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
14046043|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14046044|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14046045|NCT01592370|Growth Substances|growth substances|mesh-ancestor
14046046|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
14046047|NCT01526603|Carboplatin|carboplatin|mesh-list
13959977|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959978|NCT03158805|Incretins|incretins|mesh-ancestor
13959979|NCT03158805|Hormones|hormones|mesh-ancestor
13959980|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046048|NCT01526603|Etoposide|etoposide|mesh-list
14046049|NCT01526603|Melphalan|melphalan|mesh-list
14046050|NCT01526603|Tretinoin|tretinoin|mesh-list
14046051|NCT01526603|Isotretinoin|isotretinoin|mesh-list
14046052|NCT01526603|Sargramostim|sargramostim|mesh-list
14046053|NCT01526603|Lenograstim|lenograstim|mesh-list
14046054|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046055|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14046056|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14046057|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14046058|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046059|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046060|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14046061|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
14046062|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14046063|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046064|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
14046065|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046066|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14046067|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
14046068|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046069|NCT01475123|Nicorandil|nicorandil|mesh-list
13959981|NCT03158610|Capecitabine|capecitabine|mesh-list
13959982|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13959983|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
14046070|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13959984|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046071|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14046072|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
13912294|NCT03496870|Levodopa|levodopa|mesh-list
13912295|NCT03496870|Carbidopa|carbidopa|mesh-list
13912296|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13912297|NCT03496870|Opicapone|opicapone|mesh-list
13912298|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13912299|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13912300|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
13912301|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912302|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912303|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912304|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13912305|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912306|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14046073|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
14046074|NCT01475123|Vitamins|vitamins|mesh-ancestor
14046075|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
14046076|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046077|NCT01207011|Docetaxel|docetaxel|mesh-list
14046078|NCT01207011|Amrubicin|amrubicin|mesh-list
14046079|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046080|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14046081|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14046082|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14046083|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912307|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
13912308|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
13912309|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13912310|NCT03496831|Adalimumab|adalimumab|mesh-list
13912311|NCT03496831|Etanercept|etanercept|mesh-list
13912312|NCT03496831|Golimumab|golimumab|mesh-list
13912313|NCT03496831|Abatacept|abatacept|mesh-list
14046084|NCT01176461|Nivolumab|nivolumab|mesh-list
14046085|NCT01176461|Vaccines|vaccines|mesh-list
14046086|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
14046087|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046088|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14046089|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046090|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14046091|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046092|NCT01165632|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14046093|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046094|NCT01165632|Dopamine Agents|dopamine agents|mesh-ancestor
14046095|NCT01165632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046096|NCT01165632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912314|NCT03496831|Infliximab|infliximab|mesh-list
13912315|NCT03496831|Ustekinumab|ustekinumab|mesh-list
13912316|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912317|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
13912318|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912319|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912320|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912321|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
13912322|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912323|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13912324|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912325|NCT03496831|Analgesics|analgesics|mesh-ancestor
13912326|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
13912327|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912328|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912329|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13912330|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912331|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13912332|NCT03496779|Gemcitabine|gemcitabine|mesh-list
13912333|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13912334|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13912335|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912336|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
13912337|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912338|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912339|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
13912340|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912341|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912342|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912343|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
14046097|NCT01003964|Gemcitabine|gemcitabine|mesh-list
14046098|NCT01003964|Cisplatin|cisplatin|mesh-list
14046099|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912344|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912345|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912346|NCT03496766|Tipifarnib|tipifarnib|mesh-list
13912347|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912348|NCT03496740|Bupivacaine|bupivacaine|mesh-list
13912349|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046100|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14046101|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
14046102|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046103|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
14046104|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046105|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046106|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046107|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
14046108|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046109|NCT00980954|Paclitaxel|paclitaxel|mesh-list
14046110|NCT00980954|Carboplatin|carboplatin|mesh-list
14046111|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14046112|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046113|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
14046114|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14046115|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14046116|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170228|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170229|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170230|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182974|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912350|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
13912351|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182975|NCT04731363|Erythritol|erythritol|mesh-list
14182976|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
14182977|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
14182978|NCT04731376|Testosterone|testosterone|mesh-list
14182979|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
14182980|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
14182981|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14182982|NCT04731376|Androgens|androgens|mesh-ancestor
14182983|NCT04731376|Hormones|hormones|mesh-ancestor
14182984|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182985|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182986|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14182987|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182988|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
14182989|NCT04731116|Cannabidiol|cannabidiol|mesh-list
14182990|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
14182991|NCT04731038|Paclitaxel|paclitaxel|mesh-list
14182992|NCT04731038|Carboplatin|carboplatin|mesh-list
14182993|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14182994|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182995|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14182996|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14182997|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14182998|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182999|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14183000|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
14183001|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14183002|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183003|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
14183004|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14183005|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475262|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
13912352|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912353|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
13912354|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912355|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13912356|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13912357|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046117|NCT00890266|Riboflavin|riboflavin|mesh-list
14046118|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
14046119|NCT00890266|Vitamins|vitamins|mesh-ancestor
14046120|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
14046121|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046122|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14046123|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046124|NCT00711269|Risperidone|risperidone|mesh-list
13912358|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912359|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
13912360|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912361|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912362|NCT03496519|Durvalumab|durvalumab|mesh-list
13912363|NCT03496519|Trabectedin|trabectedin|mesh-list
13912364|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13912365|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912366|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912367|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
14046125|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14046126|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14046127|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
14046128|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046129|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046130|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046131|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14046132|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14046133|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046134|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14046135|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14046136|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
14046137|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14046138|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14046139|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14046140|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046141|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14046142|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14046143|NCT00694850|Riociguat|riociguat|mesh-list
14046144|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
14046145|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046146|NCT00411138|Paclitaxel|paclitaxel|mesh-list
14046147|NCT00411138|Carboplatin|carboplatin|mesh-list
14046148|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14046149|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046150|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
14046151|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
14046152|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
14046153|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046154|NCT00291525|Warfarin|warfarin|mesh-list
14046155|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
14046156|NCT00286169|Amrubicin|amrubicin|mesh-list
14046157|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046158|NCT00188539|Anesthetics|anesthetics|mesh-list
14046159|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046160|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046161|NCT00152477|Paclitaxel|paclitaxel|mesh-list
14046162|NCT00152477|Carboplatin|carboplatin|mesh-list
14046163|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14046164|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046165|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
14046166|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
14046167|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
14046168|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046169|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14046170|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14046171|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046172|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
14046173|NCT02697630|Entinostat|entinostat|mesh-list
14046174|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14046175|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046176|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14046177|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757072|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757073|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14757074|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14757075|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
14757076|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912368|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912369|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13912370|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
13912371|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912372|NCT03496506|Selexipag|selexipag|mesh-list
13912373|NCT03496506|Clopidogrel|clopidogrel|mesh-list
13912374|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13912375|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14757077|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757078|NCT01192568|Urological Agents|urological agents|mesh-ancestor
14757079|NCT01084252|Dexamethasone|dexamethasone|mesh-list
14757080|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
14757081|NCT01084252|BB 1101|bb 1101|mesh-list
14757082|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14757083|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
14757084|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
14757085|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046178|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046179|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14046180|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046181|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046182|NCT02697253|Incretins|incretins|mesh-ancestor
14046183|NCT02697253|Hormones|hormones|mesh-ancestor
14046184|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046185|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14046186|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
14046187|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046188|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046189|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14046190|NCT02697162|Octenidine|octenidine|mesh-list
14046191|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046192|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14046193|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14046194|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14046195|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14046196|NCT02697331|Progesterone|progesterone|mesh-list
14046197|NCT02697331|Progestins|progestins|mesh-ancestor
14046198|NCT02697331|Hormones|hormones|mesh-ancestor
14046199|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046200|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046201|NCT02697370|Factor VIII|factor viii|mesh-list
13912376|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13912377|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13912378|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
13912379|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912380|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912381|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912382|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13912383|NCT03496389|Acetaminophen|acetaminophen|mesh-list
13912384|NCT03496389|Gabapentin|gabapentin|mesh-list
13912385|NCT03496389|Tramadol|tramadol|mesh-list
13912386|NCT03496389|Analgesics|analgesics|mesh-ancestor
13912387|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
13912388|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912389|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912390|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
13912391|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13912392|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13912393|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912394|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13912395|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13912396|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13912397|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046202|NCT02697370|Coagulants|coagulants|mesh-ancestor
14046203|NCT02697045|Aripiprazole|aripiprazole|mesh-list
14046204|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
14046205|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14046206|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14046207|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14046208|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046209|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046210|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
14046211|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
13912398|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046212|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046213|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046214|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14046215|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14046216|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
14046217|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14046218|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14046219|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14046220|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14046221|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
14046222|NCT02697058|Leucovorin|leucovorin|mesh-list
14046223|NCT02697058|Fluorouracil|fluorouracil|mesh-list
14046224|NCT02697058|Calcium|calcium|mesh-list
14046225|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
14046226|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14046227|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046228|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14046229|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
14046230|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046231|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14046232|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046233|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046234|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
14046235|NCT02697058|Antidotes|antidotes|mesh-ancestor
14046236|NCT02697058|Protective Agents|protective agents|mesh-ancestor
14046237|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
14046238|NCT02697058|Vitamins|vitamins|mesh-ancestor
14046239|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
14046240|NCT02697318|Timolol|timolol|mesh-list
14046241|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14046242|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14046243|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14046244|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14046245|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046246|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046247|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046248|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046249|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046250|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14046251|NCT02697344|Acetic Acid|acetic acid|mesh-list
14046252|NCT02697344|Dexamethasone|dexamethasone|mesh-list
14046253|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
14046254|NCT02697344|Lenalidomide|lenalidomide|mesh-list
14046255|NCT02697344|Retinol acetate|retinol acetate|mesh-list
14046256|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
14046257|NCT02697344|Gossypol|gossypol|mesh-list
14046258|NCT02697344|BB 1101|bb 1101|mesh-list
14046259|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046260|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
14046261|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
14046262|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046263|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046264|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14046265|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
14046266|NCT02697344|Hormones|hormones|mesh-ancestor
14046267|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046268|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14046269|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046270|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
14046271|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14046272|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14046273|NCT02697344|Growth Substances|growth substances|mesh-ancestor
14046274|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
14046275|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
14046276|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046277|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046278|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14046279|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046280|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14046281|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14046282|NCT02697344|Protective Agents|protective agents|mesh-ancestor
14046283|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14046284|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
14046285|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14046286|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14046287|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14046288|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14046289|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14046290|NCT02697032|Bicalutamide|bicalutamide|mesh-list
14046291|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
14046292|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
14046293|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046294|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046295|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046296|NCT02696837|Rocuronium|rocuronium|mesh-list
14046297|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14046298|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14046299|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14046300|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046301|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046302|NCT02696928|Lumefantrine|lumefantrine|mesh-list
14046303|NCT02696928|Primaquine|primaquine|mesh-list
14046304|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
14046305|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14046306|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14046307|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046308|NCT02696720|Lidocaine|lidocaine|mesh-list
14046309|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046310|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
14046311|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046312|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046313|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
14046314|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046315|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046316|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14046317|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14046318|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046319|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046320|NCT02696694|Progesterone|progesterone|mesh-list
14046321|NCT02696694|Progestins|progestins|mesh-ancestor
14046322|NCT02696694|Hormones|hormones|mesh-ancestor
14046323|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046324|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046325|NCT02696993|Nivolumab|nivolumab|mesh-list
14046326|NCT02696993|Ipilimumab|ipilimumab|mesh-list
14046327|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14046328|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046329|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14046330|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046331|NCT02696941|Metformin|metformin|mesh-list
14046332|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14046333|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046334|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046335|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046336|NCT02696954|Lumefantrine|lumefantrine|mesh-list
14046337|NCT02696954|Artemether|artemether|mesh-list
14046338|NCT02696954|Primaquine|primaquine|mesh-list
14046339|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14046340|NCT02696954|Amodiaquine|amodiaquine|mesh-list
14046341|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
14046342|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14046343|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14046344|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046345|NCT02696733|Cephalosporins|cephalosporins|mesh-list
14046346|NCT02696733|Lidocaine|lidocaine|mesh-list
14046347|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046348|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
14046349|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046350|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046351|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
14046352|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046353|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046354|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14046355|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14046356|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046357|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046358|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14046359|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046360|NCT02696915|Fentanyl|fentanyl|mesh-list
14046361|NCT02696915|Bupivacaine|bupivacaine|mesh-list
14046362|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046363|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
14046364|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046365|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046366|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
14046367|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046368|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14046369|NCT02696915|Narcotics|narcotics|mesh-ancestor
14046370|NCT02696915|Analgesics|analgesics|mesh-ancestor
14046371|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14046372|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14046373|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
14046374|NCT02696564|Losartan|losartan|mesh-list
14046375|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046376|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14046377|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14046378|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14046379|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046380|NCT02696590|Vitamin D|vitamin d|mesh-list
14046381|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
14046382|NCT02696590|Vitamins|vitamins|mesh-ancestor
14046383|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
14046384|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046385|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14046386|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14046387|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
14046388|NCT02696512|Minocycline|minocycline|mesh-list
14046389|NCT02696512|Lamotrigine|lamotrigine|mesh-list
14046390|NCT02696512|Flumazenil|flumazenil|mesh-list
14046391|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14046392|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046393|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
14046394|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14757086|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757087|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757088|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
14757089|NCT01084252|Hormones|hormones|mesh-ancestor
14757090|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046395|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046396|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046397|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14046398|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046399|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14046400|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14046401|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046402|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14046403|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14046404|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
14046405|NCT02696512|Protective Agents|protective agents|mesh-ancestor
14046406|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
14046407|NCT02696512|Vitamins|vitamins|mesh-ancestor
14046408|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
14046409|NCT02696512|Antidotes|antidotes|mesh-ancestor
14046410|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
14046411|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
14046412|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046413|NCT02696577|Aspirin|aspirin|mesh-list
14046414|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14046415|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14046416|NCT02696577|Analgesics|analgesics|mesh-ancestor
14046417|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
14046418|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046419|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046420|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046421|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046422|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14046423|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14046424|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046425|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14046426|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14046427|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046428|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
14757091|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14757092|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046429|NCT02696642|Maytansine|maytansine|mesh-list
14933509|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046430|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14046431|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046432|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
14046433|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
14046434|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
14046435|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046436|NCT02696460|Lidocaine|lidocaine|mesh-list
14046437|NCT02696460|Prilocaine|prilocaine|mesh-list
14046438|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14046439|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046440|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
14046441|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046442|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046443|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
14046444|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046445|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046446|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14046447|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14046448|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046449|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046450|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14046451|NCT02696330|Enoxaparin|enoxaparin|mesh-list
14046452|NCT02696330|Clopidogrel|clopidogrel|mesh-list
14046453|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14046454|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14046455|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14046456|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14046457|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
14046458|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046459|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046460|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046461|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
14046462|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14046463|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14046464|NCT02696369|Lidocaine|lidocaine|mesh-list
14046465|NCT02696369|Epinephrine|epinephrine|mesh-list
14046466|NCT02696369|Racepinephrine|racepinephrine|mesh-list
14046467|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
14046468|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046469|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
14046470|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046471|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046472|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
14046473|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046474|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046475|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14046476|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14046477|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046478|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046479|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14046480|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14046481|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046482|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046483|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14046484|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14046485|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
14046486|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14046487|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
14046488|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
14046489|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
14046490|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14046491|NCT02696096|Buprenorphine|buprenorphine|mesh-list
14046492|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14046493|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14046494|NCT02696096|Narcotics|narcotics|mesh-ancestor
14046495|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046496|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046497|NCT02696096|Analgesics|analgesics|mesh-ancestor
14046498|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
14046499|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046500|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14170231|NCT04834427|Ketamine|ketamine|mesh-list
14170232|NCT04834427|Esketamine|esketamine|mesh-list
14170233|NCT04834427|Analgesics|analgesics|mesh-ancestor
14170234|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
14170235|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046501|NCT02696122|Anesthetics|anesthetics|mesh-list
14046502|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046503|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046504|NCT02696148|Liraglutide|liraglutide|mesh-list
14046505|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046506|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046507|NCT02696148|Incretins|incretins|mesh-ancestor
14046508|NCT02696148|Hormones|hormones|mesh-ancestor
14046509|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046510|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
14046511|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14046512|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14046513|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046514|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
14046515|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046516|NCT02695810|Metformin|metformin|mesh-list
14046517|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
14046518|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046519|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046520|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14046521|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046522|NCT02695797|Prednisolone|prednisolone|mesh-list
14046523|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046524|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
14046525|NCT02695797|Hormones|hormones|mesh-ancestor
14046526|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046527|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046528|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14046529|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046530|NCT02695654|Clonidine|clonidine|mesh-list
14046531|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
14046532|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046533|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
14046534|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046535|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046536|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
14046537|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046538|NCT02695654|Analgesics|analgesics|mesh-ancestor
14046539|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14046540|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
14046541|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
14046542|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14046543|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14046544|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14046545|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046546|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046547|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046548|NCT02695771|Gemcitabine|gemcitabine|mesh-list
14046549|NCT02695771|Mitomycins|mitomycins|mesh-list
14046550|NCT02695771|Mitomycin|mitomycin|mesh-list
14046551|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14046552|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
14046553|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046554|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046555|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
14046556|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046557|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046558|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046559|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
14046560|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046561|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14046562|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
14046563|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14046564|NCT02695862|Terlipressin|terlipressin|mesh-list
14046565|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14046566|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14046567|NCT02695758|Bupivacaine|bupivacaine|mesh-list
14046568|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046569|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
14046570|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046571|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046572|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
14046573|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046574|NCT02695563|Lactoferrin|lactoferrin|mesh-list
14046575|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046576|NCT02695459|Everolimus|everolimus|mesh-list
14046577|NCT02695459|Cisplatin|cisplatin|mesh-list
14046578|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046579|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046580|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
14046581|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046582|NCT02695641|Bevacizumab|bevacizumab|mesh-list
14046583|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14046584|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046585|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14046586|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14046587|NCT02695641|Growth Substances|growth substances|mesh-ancestor
14046588|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046589|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
14046590|NCT02695745|Celecoxib|celecoxib|mesh-list
14046591|NCT02695745|Capsaicin|capsaicin|mesh-list
14046592|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14046593|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14046594|NCT02695745|Analgesics|analgesics|mesh-ancestor
14046595|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
14046596|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046597|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046598|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046599|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046600|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14046601|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14046602|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046603|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046604|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
14046605|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046606|NCT02695732|Carvedilol|carvedilol|mesh-list
14046607|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14046608|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14046609|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046610|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046611|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046612|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046613|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14046614|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
14046615|NCT02695732|Protective Agents|protective agents|mesh-ancestor
14046616|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14046617|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046618|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14046619|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
14046620|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14046621|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14046622|NCT02695381|Etodolac|etodolac|mesh-list
14046623|NCT02695381|Lidocaine|lidocaine|mesh-list
14046624|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046625|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
14046626|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046627|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046628|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
14046629|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046630|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046631|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14046632|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14046633|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046634|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046635|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14046636|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14046637|NCT02695381|Analgesics|analgesics|mesh-ancestor
14046638|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046639|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046640|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14046641|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14046642|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046643|NCT02695355|Methylphenidate|methylphenidate|mesh-list
14046644|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14046645|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046646|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14046647|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14046648|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046649|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046650|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
14046651|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046652|NCT02695212|Apremilast|apremilast|mesh-list
14046653|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14046654|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14046655|NCT02695212|Analgesics|analgesics|mesh-ancestor
14046656|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
14046657|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046658|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046659|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046660|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046661|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14046662|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14046663|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046664|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046665|NCT02695004|Donepezil|donepezil|mesh-list
14046666|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14046667|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046668|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046669|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
14046670|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046671|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046672|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
14046673|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
14046674|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046675|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046676|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
14046677|NCT02694809|Estrogens|estrogens|mesh-list
14046678|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14046679|NCT02694809|Hormones|hormones|mesh-ancestor
14046680|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046681|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046682|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14046683|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14046684|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
14046685|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14046686|NCT02694692|Vaccines|vaccines|mesh-list
14046687|NCT02694692|Immunologic Factors|immunologic factors|mesh-ancestor
14046688|NCT02694692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046689|NCT02694848|Aspirin|aspirin|mesh-list
14046690|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14046691|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912399|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
13912400|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13912401|NCT03496389|Narcotics|narcotics|mesh-ancestor
13912402|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912403|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
13912404|NCT03496246|Vitamin D|vitamin d|mesh-list
13912405|NCT03496246|Calcifediol|calcifediol|mesh-list
13912406|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14933510|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933511|NCT01451294|Phenylephrine|phenylephrine|mesh-list
14933512|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
14933513|NCT01451294|Ephedrine|ephedrine|mesh-list
14933514|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14933515|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
14933516|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
13912407|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
13912408|NCT03496246|Calcium|calcium|mesh-list
13912409|NCT03496246|Vitamins|vitamins|mesh-ancestor
14933517|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912410|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
13912411|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046692|NCT02694848|Analgesics|analgesics|mesh-ancestor
14046693|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
14046694|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046695|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046696|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046697|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046698|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14046699|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14046700|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046701|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14046702|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14046703|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046704|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
14046705|NCT02694588|Infliximab|infliximab|mesh-list
14046706|NCT02694588|Vedolizumab|vedolizumab|mesh-list
14046707|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046708|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14046709|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046710|NCT02694653|Acetaminophen|acetaminophen|mesh-list
14046711|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14046712|NCT02694653|Analgesics|analgesics|mesh-ancestor
14046713|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
14046714|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046715|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046716|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
14046717|NCT02694458|Vancomycin|vancomycin|mesh-list
14046718|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14046719|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046720|NCT02694289|Metformin|metformin|mesh-list
14046721|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046722|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046723|NCT02694263|Pioglitazone|pioglitazone|mesh-list
14046724|NCT02694263|Glimepiride|glimepiride|mesh-list
14046725|NCT02694263|Canagliflozin|canagliflozin|mesh-list
14046726|NCT02694263|Repaglinide|repaglinide|mesh-list
14046727|NCT02694263|Gliclazide|gliclazide|mesh-list
14046728|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14046729|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046730|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046731|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046732|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
14046733|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14046734|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170236|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170237|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14170238|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14170239|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
14170240|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
14170241|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170242|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14170243|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14170244|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170245|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170246|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
14170247|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14170248|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14170249|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170250|NCT04834375|Dexamethasone|dexamethasone|mesh-list
14170251|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
14170252|NCT04834375|BB 1101|bb 1101|mesh-list
14170253|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170254|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
14170255|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
14170256|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170257|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170258|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170259|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
14170260|NCT04834375|Hormones|hormones|mesh-ancestor
14170261|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170262|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14170263|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170264|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
14170265|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170266|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170267|NCT04834310|Clindamycin|clindamycin|mesh-list
14170268|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
14046735|NCT02694146|Hylan|hylan|mesh-list
14046736|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
14046737|NCT02694146|Protective Agents|protective agents|mesh-ancestor
14046738|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046739|NCT02693769|Fluticasone|fluticasone|mesh-list
14046740|NCT02693769|Xhance|xhance|mesh-list
14046741|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
14046742|NCT02693769|Bromides|bromides|mesh-list
14046743|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
14046744|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046745|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14046746|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
14046747|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046748|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046749|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14046750|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
14046751|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046752|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14046753|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14046754|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14046755|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14046756|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
14046757|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046758|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046759|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
14046760|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14046761|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14046762|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14046763|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
14046764|NCT02694224|Paclitaxel|paclitaxel|mesh-list
14046765|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
14046766|NCT02694224|Epirubicin|epirubicin|mesh-list
14046767|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14046768|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046769|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
14046770|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
14046771|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
14046772|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046773|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046774|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
14046775|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046776|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046777|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14757093|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
14757094|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046778|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
14046779|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14046780|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14046781|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14046782|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14046783|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046784|NCT02693951|Cefotiam|cefotiam|mesh-list
14046785|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14046786|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046787|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14046788|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
14046789|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046790|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
14046791|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14046792|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
14046793|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046794|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
14046795|NCT02693808|Protective Agents|protective agents|mesh-ancestor
14046796|NCT02693574|Amoxicillin|amoxicillin|mesh-list
14046797|NCT02693574|Clarithromycin|clarithromycin|mesh-list
14046798|NCT02693574|Levofloxacin|levofloxacin|mesh-list
14046799|NCT02693574|Ofloxacin|ofloxacin|mesh-list
14046800|NCT02693574|Esomeprazole|esomeprazole|mesh-list
14046801|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14046802|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046803|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14046804|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14046805|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14046806|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046807|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046808|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14046809|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14767234|NCT00629278|Docetaxel|docetaxel|mesh-list
14046810|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14046811|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14046812|NCT02693574|Renal Agents|renal agents|mesh-ancestor
14046813|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14046814|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14046815|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046816|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13912412|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13912413|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13912414|NCT03496233|Grazoprevir|grazoprevir|mesh-list
13912415|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14046817|NCT02693470|Ustekinumab|ustekinumab|mesh-list
14046818|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046819|NCT02693444|Lidocaine|lidocaine|mesh-list
14046820|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046821|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
14046822|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046823|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046824|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
14046825|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046826|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14046827|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13912416|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
13912417|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912418|NCT03495804|Mannitol|mannitol|mesh-list
13912419|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14046828|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14757095|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757096|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
14757097|NCT00887536|Bevacizumab|bevacizumab|mesh-list
14757098|NCT00887536|Docetaxel|docetaxel|mesh-list
14757099|NCT00887536|Doxorubicin|doxorubicin|mesh-list
14046829|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046830|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046831|NCT02693184|Vitamin D|vitamin d|mesh-list
14046832|NCT02693184|Calcium|calcium|mesh-list
14046833|NCT02693184|Vitamins|vitamins|mesh-ancestor
14046834|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
14046835|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046836|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14046837|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14046838|NCT02693288|Anesthetics|anesthetics|mesh-list
14046839|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046840|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046841|NCT02693392|Metformin|metformin|mesh-list
14046842|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14046843|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046844|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
14046845|NCT02693483|Povidone|povidone|mesh-list
14046846|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
14046847|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
14046848|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14046849|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046850|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13912420|NCT03495804|Diuretics|diuretics|mesh-ancestor
13912421|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
14046851|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
14046852|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757100|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757101|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
14757102|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912422|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757103|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046853|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
14046854|NCT02693210|Rituximab|rituximab|mesh-list
14046855|NCT02693210|Methotrexate|methotrexate|mesh-list
14046856|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046857|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
14046858|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046859|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046860|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14046861|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
14046862|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046863|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046864|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14046865|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14046866|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14046867|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
14046868|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14046869|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14046870|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
14046871|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
14046872|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046873|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14046874|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14046875|NCT02692989|Anesthetics|anesthetics|mesh-list
14046876|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046877|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046878|NCT02692963|Vaccines|vaccines|mesh-list
14046879|NCT02692963|Immunologic Factors|immunologic factors|mesh-ancestor
14046880|NCT02692963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046881|NCT02692976|Vaccines|vaccines|mesh-list
14046882|NCT02692976|Immunologic Factors|immunologic factors|mesh-ancestor
14046883|NCT02692976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046884|NCT02692599|Vaccines|vaccines|mesh-list
14046885|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
14046886|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170269|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
14170270|NCT04834310|Cefazolin|cefazolin|mesh-list
14170271|NCT04834310|Cephalexin|cephalexin|mesh-list
14170272|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14170273|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170274|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14170275|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170276|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912423|NCT03495765|Ranibizumab|ranibizumab|mesh-list
13912424|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13912425|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13912426|NCT03495765|Growth Substances|growth substances|mesh-ancestor
13912427|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912428|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
13912429|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912430|NCT03495739|Dabigatran|dabigatran|mesh-list
13912431|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
13912432|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13912433|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
13912434|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912435|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912436|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
13912437|NCT03495713|Nivolumab|nivolumab|mesh-list
13912438|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912439|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912440|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13912441|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912442|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13912443|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912444|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912445|NCT03495466|Anesthetics|anesthetics|mesh-list
13912446|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912447|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912448|NCT03495232|Cimetidine|cimetidine|mesh-list
13912449|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13912450|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912451|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14170277|NCT04833959|Panitumumab|panitumumab|mesh-list
14170278|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170279|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046887|NCT02692534|Cocaine|cocaine|mesh-list
14046888|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
14046889|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
14046890|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14046891|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046892|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
14046893|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046894|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14046895|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14046896|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14046897|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14046898|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046899|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
14046900|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14046901|NCT02692339|Dexamethasone|dexamethasone|mesh-list
14046902|NCT02692339|Lenalidomide|lenalidomide|mesh-list
14046903|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046904|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
14046905|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
14046906|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046907|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046908|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14046909|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
14046910|NCT02692339|Hormones|hormones|mesh-ancestor
14046911|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046912|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14046913|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046914|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
14046915|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14046916|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14046917|NCT02692339|Growth Substances|growth substances|mesh-ancestor
14046918|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
14046919|NCT02692248|Gemcitabine|gemcitabine|mesh-list
14046920|NCT02692248|Dexamethasone|dexamethasone|mesh-list
14046921|NCT02692248|Rituximab|rituximab|mesh-list
14046922|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
14046923|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046924|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
14046925|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
14046926|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046927|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046928|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14046929|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
14046930|NCT02692248|Hormones|hormones|mesh-ancestor
14046931|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14046932|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14046933|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046934|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14046935|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
14046936|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046937|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14046938|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
14046939|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046940|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
14046941|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046942|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046943|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14046944|NCT02692365|Manganese|manganese|mesh-list
14046945|NCT02692365|Trace Elements|trace elements|mesh-ancestor
14046946|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
14046947|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046948|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
14046949|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14046950|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046951|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14046952|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
14046953|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14046954|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046955|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046956|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046957|NCT02691910|Chloroquine|chloroquine|mesh-list
14046958|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14046959|NCT02691910|Primaquine|primaquine|mesh-list
14046960|NCT02691910|Amebicides|amebicides|mesh-ancestor
14046961|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14046962|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14046963|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14046964|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
14046965|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14046966|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14046967|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14046968|NCT02691910|Analgesics|analgesics|mesh-ancestor
14046969|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
14046970|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046971|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046972|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046973|NCT02691910|Filaricides|filaricides|mesh-ancestor
14046974|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
14046975|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
14046976|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
14046977|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14046978|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14046979|NCT02691871|Docetaxel|docetaxel|mesh-list
14046980|NCT02691871|Apatinib|apatinib|mesh-list
14046981|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14046982|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
14046983|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
14046984|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
14046985|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046986|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14046987|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14046988|NCT02691754|Acetaminophen|acetaminophen|mesh-list
14046989|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14046990|NCT02691754|Analgesics|analgesics|mesh-ancestor
14046991|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
14046992|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14046993|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14046994|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
14046995|NCT02691897|Melatonin|melatonin|mesh-list
14046996|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
14046997|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14046998|NCT02691897|Protective Agents|protective agents|mesh-ancestor
14046999|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047000|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047001|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
14047002|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14047003|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14047004|NCT02691780|Sorafenib|sorafenib|mesh-list
14047005|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047006|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047007|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047008|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047009|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14047010|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14047011|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
14047012|NCT02691793|Sunitinib|sunitinib|mesh-list
14047013|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047014|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14047015|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14047016|NCT02691793|Growth Substances|growth substances|mesh-ancestor
14047017|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047018|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
14047019|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047020|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047021|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047022|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14047023|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14047024|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14047025|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14047026|NCT02691325|Charcoal|charcoal|mesh-list
14047027|NCT02691325|Nemiralisib|nemiralisib|mesh-list
14047028|NCT02691325|Antidotes|antidotes|mesh-ancestor
14047029|NCT02691325|Protective Agents|protective agents|mesh-ancestor
14047030|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047031|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047032|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047033|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047034|NCT02691403|Bupivacaine|bupivacaine|mesh-list
14047035|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
14047036|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
14047037|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
14047038|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047039|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047040|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
14047041|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047042|NCT02691442|Epinephrine|epinephrine|mesh-list
14047043|NCT02691442|Ropivacaine|ropivacaine|mesh-list
14047044|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
14047045|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
14047046|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
14047047|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047048|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047049|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
14047050|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047051|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14047052|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14047053|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14047054|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047055|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047056|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14047057|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14047058|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
14047059|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14047060|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14047061|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
14047062|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
14047063|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14047064|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
14933518|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933519|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
14933520|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14933521|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
14933522|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
14933523|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14933524|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13912452|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
13912453|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
14047065|NCT02691156|Bilirubin|bilirubin|mesh-list
14047066|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
14047067|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047068|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
14047069|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047070|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047071|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
13912454|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912455|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912456|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047072|NCT02691156|Protective Agents|protective agents|mesh-ancestor
14047073|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
14047074|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14047075|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912457|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13912458|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13912459|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912460|NCT03495206|Edaravone|edaravone|mesh-list
13912461|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13912462|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
13912463|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912464|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13912465|NCT03495206|Protective Agents|protective agents|mesh-ancestor
13912466|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912467|NCT03495063|Caffeine|caffeine|mesh-list
13912468|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13912469|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912470|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13912471|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047076|NCT02691195|Ropivacaine|ropivacaine|mesh-list
14047077|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
14047078|NCT02691195|Anesthetics|anesthetics|mesh-list
14047079|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047080|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047081|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
14047082|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047083|NCT02691078|Octreotide|octreotide|mesh-list
14047084|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047085|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047086|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047087|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
14047088|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
14047089|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047090|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047091|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14047092|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14047093|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
14047094|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047095|NCT02690987|Exenatide|exenatide|mesh-list
14047096|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14047097|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047098|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14047099|NCT02690987|Incretins|incretins|mesh-ancestor
14047100|NCT02690987|Hormones|hormones|mesh-ancestor
14047101|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047102|NCT02690922|Dexamethasone|dexamethasone|mesh-list
14047103|NCT02690922|Prednisone|prednisone|mesh-list
14047104|NCT02690922|Methotrexate|methotrexate|mesh-list
14047105|NCT02690922|Dasatinib|dasatinib|mesh-list
14047106|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047107|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
14047108|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
14047109|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047110|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047111|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047112|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
14047113|NCT02690922|Hormones|hormones|mesh-ancestor
14047114|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047115|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047116|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047117|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14047118|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
14047119|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14047120|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14047121|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
14047122|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047123|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475263|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
14475264|NCT02395692|Temozolomide|temozolomide|mesh-list
14047124|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047125|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14047126|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047127|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
14047128|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047129|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14047130|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047131|NCT02690883|Exenatide|exenatide|mesh-list
14047132|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14047133|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047134|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14047135|NCT02690883|Incretins|incretins|mesh-ancestor
14047136|NCT02690883|Hormones|hormones|mesh-ancestor
14047137|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170280|NCT04834115|Ivermectin|ivermectin|mesh-list
14170281|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14170282|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170283|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
14170284|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170285|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170286|NCT04834206|Docetaxel|docetaxel|mesh-list
14170287|NCT04834206|Fluorouracil|fluorouracil|mesh-list
14170288|NCT04834206|Nedaplatin|nedaplatin|mesh-list
14170289|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170290|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14170291|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14170292|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475265|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14047138|NCT02690844|Clonazepam|clonazepam|mesh-list
14047139|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
14047140|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
14047141|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
14047142|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047143|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047144|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047145|NCT02690870|Tamoxifen|tamoxifen|mesh-list
14047146|NCT02690870|Clomiphene|clomiphene|mesh-list
14047147|NCT02690870|Enclomiphene|enclomiphene|mesh-list
14047148|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
14047149|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14047150|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
14047151|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047152|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047153|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047154|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047155|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14047156|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14047157|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14047158|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14047159|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
14047160|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14047161|NCT02690792|Vitamin E|vitamin e|mesh-list
14047162|NCT02690792|Vitamins|vitamins|mesh-ancestor
14047163|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
14047164|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047165|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
14047166|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047167|NCT02690792|Protective Agents|protective agents|mesh-ancestor
14047168|NCT02690506|Pregabalin|pregabalin|mesh-list
14047169|NCT02690506|Analgesics|analgesics|mesh-ancestor
14047170|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
14047171|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047172|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047173|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
14047174|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14047175|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14047176|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047177|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14047178|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14047179|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14047180|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047181|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14047182|NCT02690389|Flumazenil|flumazenil|mesh-list
14047183|NCT02690389|Antidotes|antidotes|mesh-ancestor
14047184|NCT02690389|Protective Agents|protective agents|mesh-ancestor
14047185|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047186|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
14047187|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
14047188|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047189|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047190|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14047191|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14047192|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047193|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
14047194|NCT02690480|Fulvestrant|fulvestrant|mesh-list
14047195|NCT02690480|Palbociclib|palbociclib|mesh-list
14047196|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047197|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047198|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14047199|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14047200|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
14047201|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047202|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047203|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047204|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047205|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047206|NCT02689999|Rabeprazole|rabeprazole|mesh-list
14047207|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14047208|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047209|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14047210|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047211|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047212|NCT02690064|Vitamins|vitamins|mesh-list
14047213|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
14047214|NCT02690064|Vitamin E|vitamin e|mesh-list
14047215|NCT02690064|Tocopherols|tocopherols|mesh-list
14047216|NCT02690064|Tocotrienols|tocotrienols|mesh-list
14047217|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
14047218|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
14047219|NCT02690064|Ubiquinone|ubiquinone|mesh-list
14047220|NCT02690064|Resveratrol|resveratrol|mesh-list
14047221|NCT02690064|Antioxidants|antioxidants|mesh-list
14047222|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
14047223|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047224|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047225|NCT02690064|Protective Agents|protective agents|mesh-ancestor
14047226|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047227|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14047228|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
14047229|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
14047230|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14047231|NCT02690038|Antibodies|antibodies|mesh-list
14047232|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
14047233|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14047234|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
14047235|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047236|NCT02690103|Ribavirin|ribavirin|mesh-list
14047237|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
14047238|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047239|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
14047240|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047241|NCT02690155|Vitamin K|vitamin k|mesh-list
14047242|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
14047243|NCT02690155|Vitamins|vitamins|mesh-ancestor
14047244|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
14047245|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047246|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14047247|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
14047248|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14047249|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
14047250|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047251|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047252|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
14047253|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14047254|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14047255|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
14047256|NCT02690155|Coagulants|coagulants|mesh-ancestor
14047257|NCT02690129|Progesterone|progesterone|mesh-list
14047258|NCT02690129|Progestins|progestins|mesh-ancestor
14047259|NCT02690129|Hormones|hormones|mesh-ancestor
14047260|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047261|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047262|NCT02689960|Prednisone|prednisone|mesh-list
14047263|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047264|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
14047265|NCT02689960|Hormones|hormones|mesh-ancestor
14047266|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047267|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047268|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047269|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047270|NCT02689882|Niacinamide|niacinamide|mesh-list
14047271|NCT02689882|Niacin|niacin|mesh-list
14047272|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
14047273|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
14047274|NCT02689882|Vitamins|vitamins|mesh-ancestor
14047275|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
14047276|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047277|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14047278|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
14047279|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047280|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14047281|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
14047282|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
14047283|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
14047284|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047285|NCT02690012|Cathartics|cathartics|mesh-ancestor
14047286|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047287|NCT02690012|Antacids|antacids|mesh-ancestor
14047288|NCT02689986|Rituximab|rituximab|mesh-list
14047289|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14047290|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14047291|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047292|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
14047293|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047294|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047295|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14047296|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
14047297|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047298|NCT02689921|Trastuzumab|trastuzumab|mesh-list
14047299|NCT02689921|Pertuzumab|pertuzumab|mesh-list
14047300|NCT02689921|Letrozole|letrozole|mesh-list
14047301|NCT02689921|Anastrozole|anastrozole|mesh-list
14047302|NCT02689921|Leuprolide|leuprolide|mesh-list
14047303|NCT02689921|Exemestane|exemestane|mesh-list
14047304|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14047305|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047306|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14047307|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14047308|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047309|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047310|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14047311|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
14047312|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047313|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047314|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047315|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14047316|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
14047317|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14047318|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14047319|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
14047320|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047321|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
14047322|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14933525|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14933526|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
14933527|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933528|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933529|NCT01451294|Protective Agents|protective agents|mesh-ancestor
14047323|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14047324|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14047325|NCT02689856|Lidocaine|lidocaine|mesh-list
14047326|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
14047327|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
14047328|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047329|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047330|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
14933530|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14933531|NCT01451320|Plasminogen|plasminogen|mesh-list
14933532|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14933533|NCT01451320|Streptokinase|streptokinase|mesh-list
14047331|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047332|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14047333|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14047334|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14047335|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14047336|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047337|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047338|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
14047339|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14047340|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047341|NCT02689843|Metformin|metformin|mesh-list
14047342|NCT02689843|Pioglitazone|pioglitazone|mesh-list
14047343|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
14047344|NCT02689843|Spironolactone|spironolactone|mesh-list
14047345|NCT02689843|Cyproterone|cyproterone|mesh-list
14047346|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14047347|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047348|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14047349|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
14047350|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047351|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14047352|NCT02689843|Diuretics|diuretics|mesh-ancestor
14047353|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
14047354|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
14047355|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047356|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14047357|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
14933534|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14047358|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14047359|NCT02689726|Imiquimod|imiquimod|mesh-list
14047360|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14047361|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
14047362|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047363|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047364|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
14047365|NCT02689388|Anesthetics|anesthetics|mesh-list
14047366|NCT02689388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047367|NCT02689388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047368|NCT02689713|Voriconazole|voriconazole|mesh-list
14047369|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
14047370|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047371|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14047372|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14047373|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047374|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047375|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14047376|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
14047377|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047378|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047379|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14047380|NCT02689778|Pirfenidone|pirfenidone|mesh-list
14047381|NCT02689778|Analgesics|analgesics|mesh-ancestor
14047382|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
14047383|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047384|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047385|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14047386|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14047387|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047388|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047389|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047390|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14047391|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14047392|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047393|NCT02689362|Incretins|incretins|mesh-ancestor
14047394|NCT02689362|Hormones|hormones|mesh-ancestor
14047395|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047396|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14757104|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14757105|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
14757106|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757107|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757108|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13912472|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912473|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13912474|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13912475|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
13912476|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912477|NCT03495024|Varenicline|varenicline|mesh-list
13912478|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13912479|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13912480|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
13912481|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912482|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912483|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13959985|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959986|NCT03158792|Enoxaparin|enoxaparin|mesh-list
13959987|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
13959988|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
13959989|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13959990|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13959991|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963360|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14047397|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
14047398|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047399|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047400|NCT02689596|Oxytocin|oxytocin|mesh-list
14047401|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
14047402|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14047403|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047404|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14047405|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14047406|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047407|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
14047411|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14047412|NCT02689401|Hematinics|hematinics|mesh-ancestor
14047413|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14047414|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14047415|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14047416|NCT02689141|Ofatumumab|ofatumumab|mesh-list
14047417|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14047418|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
14047419|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047420|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170293|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170294|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
14170295|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14170296|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170297|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
14170298|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170299|NCT04833907|Prednisolone|prednisolone|mesh-list
14170300|NCT04833907|Levetiracetam|levetiracetam|mesh-list
14170301|NCT04833907|Prednisolone phosphate|prednisolone phosphate|mesh-list
14170302|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170303|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
14170304|NCT04833907|Hormones|hormones|mesh-ancestor
14170305|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170306|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170307|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14170308|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170309|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
14170310|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
14170311|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
14170312|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14170313|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170314|NCT04833738|Triamcinolone|triamcinolone|mesh-list
14170315|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14170316|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14170317|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
14170318|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14170319|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170320|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
14170321|NCT04833738|Hormones|hormones|mesh-ancestor
14170322|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170323|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170324|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170325|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
14170326|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170327|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170328|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14170329|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
14170330|NCT04833738|Protective Agents|protective agents|mesh-ancestor
14170331|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14170332|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170333|NCT04833777|Lidocaine|lidocaine|mesh-list
14170334|NCT04833777|Bupivacaine|bupivacaine|mesh-list
14170335|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
14170336|NCT04833777|Anesthetics|anesthetics|mesh-list
14170337|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170338|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170339|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
14170340|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170341|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14170342|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14170343|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14047421|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
14047422|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
14047423|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
14047424|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047425|NCT02689180|Furosemide|furosemide|mesh-list
14047426|NCT02689180|Diuretics|diuretics|mesh-ancestor
14047427|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
14047428|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047429|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14047430|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14047431|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047432|NCT02689245|Tenofovir|tenofovir|mesh-list
14047433|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
14047434|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047435|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14047436|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14047437|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047438|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047439|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14047440|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14047441|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14047442|NCT02689336|Temozolomide|temozolomide|mesh-list
14047443|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047444|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047445|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047446|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047447|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14047448|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
14047449|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
14047450|NCT02689284|Margetuximab|margetuximab|mesh-list
14047451|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14047452|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047453|NCT02689089|Rifapentine|rifapentine|mesh-list
14047454|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14047455|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
14047456|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14047457|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047458|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
14047459|NCT02689024|Acetaminophen|acetaminophen|mesh-list
14047460|NCT02689024|Dipyrone|dipyrone|mesh-list
14047461|NCT02689024|Ibuprofen|ibuprofen|mesh-list
14047462|NCT02689024|Diclofenac|diclofenac|mesh-list
14047463|NCT02689024|Naproxen|naproxen|mesh-list
14047464|NCT02689024|Fentanyl|fentanyl|mesh-list
14047465|NCT02689024|Morphine|morphine|mesh-list
14047466|NCT02689024|Bupivacaine|bupivacaine|mesh-list
14047467|NCT02689024|Ropivacaine|ropivacaine|mesh-list
14047468|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
14047469|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
14047470|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
14047471|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047472|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912484|NCT03494972|Tetracycline|tetracycline|mesh-list
13912485|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912486|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912487|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13912488|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912489|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912490|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
13912491|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13912492|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912493|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047473|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
14047474|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047475|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14047476|NCT02689024|Narcotics|narcotics|mesh-ancestor
14757109|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14757110|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14047477|NCT02689024|Analgesics|analgesics|mesh-ancestor
14047478|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14047479|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14047480|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
14047481|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14047482|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
14047483|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14047484|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047485|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047486|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14047487|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047488|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047489|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
14047490|NCT02689037|Aspirin|aspirin|mesh-list
14047491|NCT02689037|Clopidogrel|clopidogrel|mesh-list
14047492|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14047493|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14047494|NCT02689037|Analgesics|analgesics|mesh-ancestor
14047495|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
14047496|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047497|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047498|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047499|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047500|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14047501|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14047502|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047503|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14047504|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14047505|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047506|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
14047507|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14047508|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14047509|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14047510|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
14047511|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047512|NCT02688803|Paclitaxel|paclitaxel|mesh-list
14047513|NCT02688803|Docetaxel|docetaxel|mesh-list
14047514|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14047515|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
14047516|NCT02688803|Doxorubicin|doxorubicin|mesh-list
14047517|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14047518|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14047519|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047520|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
14047521|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
14047522|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
14047523|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047524|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047525|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
14047526|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047527|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047528|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14047529|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
14047530|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14047531|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14047532|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14047533|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14047534|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047535|NCT02688738|Doxycycline|doxycycline|mesh-list
14047536|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14047537|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047538|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
14047539|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14047540|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14047541|NCT02688881|Sirolimus|sirolimus|mesh-list
14047542|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14047543|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047544|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14047545|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047546|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
14047547|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047548|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
14767235|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
14047549|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047550|NCT02688465|Apomorphine|apomorphine|mesh-list
14047551|NCT02688465|Emetics|emetics|mesh-ancestor
14047552|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047553|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
14047554|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047555|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047556|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
14047557|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
14047558|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047559|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047560|NCT02688907|Adavosertib|adavosertib|mesh-list
14047561|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047562|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047563|NCT02688530|Dexamethasone|dexamethasone|mesh-list
14047564|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
14047565|NCT02688530|BB 1101|bb 1101|mesh-list
14047566|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047567|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
14047568|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
14047569|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047570|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047571|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047572|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
14047573|NCT02688530|Hormones|hormones|mesh-ancestor
14047574|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047575|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047576|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047577|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
14047578|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047579|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047580|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14047581|NCT02688634|Amoxicillin|amoxicillin|mesh-list
14047582|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047583|NCT02688491|Sunitinib|sunitinib|mesh-list
14047584|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047585|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14047586|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14047587|NCT02688491|Growth Substances|growth substances|mesh-ancestor
14047588|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047589|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
14047590|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047591|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047592|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047593|NCT02688595|Anesthetics|anesthetics|mesh-list
14047594|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047595|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047596|NCT02688400|Celecoxib|celecoxib|mesh-list
14047597|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
14047598|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14047599|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14047600|NCT02688400|Analgesics|analgesics|mesh-ancestor
14047601|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
14047602|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047603|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047604|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047605|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047606|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14047607|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14047608|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047609|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047610|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
14047611|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14047612|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14047613|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
14047614|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047615|NCT02688361|Expectorants|expectorants|mesh-ancestor
14047616|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
14047617|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14047618|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
14047619|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047620|NCT02688361|Protective Agents|protective agents|mesh-ancestor
14047621|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047622|NCT02688361|Antidotes|antidotes|mesh-ancestor
14047623|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
14047624|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14047625|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14047626|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047627|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
14047628|NCT02688127|Coagulants|coagulants|mesh-ancestor
14047629|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
14047630|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
14047631|NCT02688374|Nicotine|nicotine|mesh-list
14047632|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14047633|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
14047634|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047635|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047636|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14047637|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14047638|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
14047639|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047640|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047641|NCT02688088|Midazolam|midazolam|mesh-list
14047642|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
14047643|NCT02688088|Caffeine|caffeine|mesh-list
14047644|NCT02688088|Warfarin|warfarin|mesh-list
14047645|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14047646|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14047647|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047648|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047649|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14047650|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14047651|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14047652|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14047653|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
14047654|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
14047655|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
14047656|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
14047657|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047658|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047659|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
14047660|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14047661|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14047662|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047663|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14047664|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14047665|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
14047666|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
14047667|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
14047668|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14047669|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14047670|NCT02688322|Sulbactam|sulbactam|mesh-list
14047671|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14047672|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047673|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14047674|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047675|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047676|NCT02687984|Risperidone|risperidone|mesh-list
14047677|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14047678|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
14047679|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14047680|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047681|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047682|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14047683|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14047684|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047685|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14047686|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14047687|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
14047688|NCT02687971|Miltefosine|miltefosine|mesh-list
14047689|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
14047690|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047691|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047692|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14047693|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14047694|NCT02688023|Leucovorin|leucovorin|mesh-list
14047695|NCT02688023|Fluorouracil|fluorouracil|mesh-list
14047696|NCT02688023|Capecitabine|capecitabine|mesh-list
14047697|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
14047698|NCT02688023|Irinotecan|irinotecan|mesh-list
14757111|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14047699|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
14047700|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047701|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14047702|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047703|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047704|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
14047705|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047706|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14047707|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14047708|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047709|NCT02688023|Antidotes|antidotes|mesh-ancestor
14047710|NCT02688023|Protective Agents|protective agents|mesh-ancestor
14047711|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
14047712|NCT02688023|Vitamins|vitamins|mesh-ancestor
14047713|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
14047714|NCT02687724|Golimumab|golimumab|mesh-list
14047715|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14047716|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047717|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047718|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
14047719|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047720|NCT02687958|Everolimus|everolimus|mesh-list
14047721|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047722|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047723|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
14047724|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047725|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
14047726|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14047727|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047728|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047729|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14047730|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14047731|NCT02687841|Protective Agents|protective agents|mesh-ancestor
14047732|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047733|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
14047734|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14047735|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
14047736|NCT02687906|Meropenem|meropenem|mesh-list
14047737|NCT02687906|Vaborbactam|vaborbactam|mesh-list
14047738|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
14047739|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14047740|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047741|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047742|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047743|NCT02687932|Valsartan|valsartan|mesh-list
14047744|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14047745|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14047746|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14047747|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14047748|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047749|NCT02687867|Vitamin K|vitamin k|mesh-list
14047750|NCT02687867|Dabigatran|dabigatran|mesh-list
14047751|NCT02687867|Vitamins|vitamins|mesh-ancestor
14047752|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
14047753|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047754|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
14047755|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14047756|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
14047757|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047758|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047759|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
14047760|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14047761|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14047762|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
14047763|NCT02687867|Coagulants|coagulants|mesh-ancestor
14047764|NCT02687854|Vitamin K|vitamin k|mesh-list
14047765|NCT02687854|Apixaban|apixaban|mesh-list
14047766|NCT02687854|Vitamins|vitamins|mesh-ancestor
14047767|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
14047768|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047769|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14047770|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
14047771|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14047772|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
14047773|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047774|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047775|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
14047776|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14047777|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14047778|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
14047779|NCT02687854|Coagulants|coagulants|mesh-ancestor
14170344|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170345|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170346|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
14170347|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170348|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170349|NCT04833218|Propranolol|propranolol|mesh-list
14170350|NCT04833218|Clonidine|clonidine|mesh-list
14170351|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14170352|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14170353|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170354|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170355|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170356|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170357|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14170358|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14170359|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14170360|NCT04833218|Analgesics|analgesics|mesh-ancestor
14170361|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
14170362|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170363|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
14170364|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
14170365|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14170366|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14170367|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14170368|NCT04833114|Carboplatin|carboplatin|mesh-list
14170369|NCT04833114|Etoposide|etoposide|mesh-list
14170370|NCT04833114|Rituximab|rituximab|mesh-list
14170371|NCT04833114|Ifosfamide|ifosfamide|mesh-list
14170372|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170373|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14170374|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14170375|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14170376|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170377|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170378|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170379|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
14170380|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170381|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170382|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14170383|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
14170384|NCT04833387|Antibodies|antibodies|mesh-list
14170385|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
14170386|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170387|NCT04833374|Prednisone|prednisone|mesh-list
14170388|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
14170389|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14170390|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14170391|NCT04833374|Prednisolone|prednisolone|mesh-list
14170392|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
14170393|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14170394|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
14170395|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170396|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
14170397|NCT04833374|Hormones|hormones|mesh-ancestor
14170398|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170399|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170400|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14170401|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170402|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
14170403|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
14170404|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170405|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170406|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14170407|NCT04833374|Protective Agents|protective agents|mesh-ancestor
14170408|NCT04833101|Vaccines|vaccines|mesh-list
14170409|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
14170410|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170411|NCT04833036|Irinotecan|irinotecan|mesh-list
14475266|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
14475267|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475268|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170412|NCT04833036|Cetuximab|cetuximab|mesh-list
14170413|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14170414|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14475269|NCT02396147|Relugolix|relugolix|mesh-list
14047780|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14047781|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047782|NCT02687347|Morphine|morphine|mesh-list
14047783|NCT02687347|Methadone|methadone|mesh-list
14047784|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14047785|NCT02687347|Narcotics|narcotics|mesh-ancestor
14047786|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047787|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047788|NCT02687347|Analgesics|analgesics|mesh-ancestor
14047789|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
14047790|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912494|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13912495|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13912496|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047791|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
14047792|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
14047793|NCT02687425|Pioglitazone|pioglitazone|mesh-list
14047794|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
14047795|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14047796|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047797|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047798|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14047799|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047800|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047801|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
14047802|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047803|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
14047804|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14047805|NCT02687256|Heparin|heparin|mesh-list
14047806|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
14047807|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14047808|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14047809|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047810|NCT02687269|Ranolazine|ranolazine|mesh-list
14047811|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14047812|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14047813|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047814|NCT02687204|Enoxaparin|enoxaparin|mesh-list
14047815|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
14047816|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
14047817|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14047818|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14757112|NCT00887536|Growth Substances|growth substances|mesh-ancestor
14047819|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047820|NCT02686983|Betamethasone|betamethasone|mesh-list
14047821|NCT02686983|Anesthetics|anesthetics|mesh-list
14047822|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
14047823|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047824|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047825|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
14757113|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
14757114|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
14757115|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
14757116|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
14757117|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14757118|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14757119|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14757120|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757121|NCT00867321|Bevacizumab|bevacizumab|mesh-list
14757122|NCT00867321|Sorafenib|sorafenib|mesh-list
14757123|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912497|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912498|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912499|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13912500|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
13912501|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912502|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912503|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13912504|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13912505|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13912506|NCT03494686|Anesthetics|anesthetics|mesh-list
14047826|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047827|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047828|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
14047829|NCT02686983|Hormones|hormones|mesh-ancestor
14757124|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757125|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14047830|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047831|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14047832|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
14047833|NCT02687178|Canrenone|canrenone|mesh-list
14047834|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14047835|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
14047836|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047837|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047838|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14047839|NCT02687178|Diuretics|diuretics|mesh-ancestor
14047840|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
14047841|NCT02687009|Niclosamide|niclosamide|mesh-list
14047842|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
14047843|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14757126|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14757127|NCT00867321|Growth Substances|growth substances|mesh-ancestor
14757128|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757129|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
14757130|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14757131|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757132|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757133|NCT00728754|Ethanol|ethanol|mesh-list
14757134|NCT00728754|Povidone-Iodine|povidone-iodine|mesh-list
14757135|NCT00728754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14757136|NCT00728754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912507|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047844|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
14047845|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14047846|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047847|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
14047848|NCT02687100|Beclomethasone|beclomethasone|mesh-list
14047849|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047850|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
14047851|NCT02687100|Hormones|hormones|mesh-ancestor
14047852|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047853|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047854|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14047855|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
14047856|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
14047857|NCT02686905|Vitamin D|vitamin d|mesh-list
14047858|NCT02686905|Vitamins|vitamins|mesh-list
14047859|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
14047860|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
14047861|NCT02686905|Calcium|calcium|mesh-list
14047862|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
14047863|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047864|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14047865|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14047866|NCT02686905|Hematinics|hematinics|mesh-ancestor
14047867|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
14047868|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
14047869|NCT02686593|Clofarabine|clofarabine|mesh-list
14047870|NCT02686593|Analgesics|analgesics|mesh-ancestor
14047871|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
14047872|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047873|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047874|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047875|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14047876|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14047877|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047878|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047879|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14047880|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
14047881|NCT02686619|Cyclosporine|cyclosporine|mesh-list
14047882|NCT02686619|Sirolimus|sirolimus|mesh-list
13912508|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912509|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
13912510|NCT03494517|Analgesics|analgesics|mesh-ancestor
13912511|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
13912512|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912513|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912514|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
13912515|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047883|NCT02686619|Prednisolone|prednisolone|mesh-list
14047884|NCT02686619|Cyclosporins|cyclosporins|mesh-list
14047885|NCT02686619|Daclizumab|daclizumab|mesh-list
14047886|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047887|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047888|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047889|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
14047890|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047891|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
14047892|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047893|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
14047894|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14047895|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14047896|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14170415|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912516|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13912517|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
13912518|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13912519|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13912520|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912521|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13912522|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
13912523|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912524|NCT03494426|Pregabalin|pregabalin|mesh-list
13912525|NCT03494426|Tramadol|tramadol|mesh-list
13912526|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
13912527|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
13912528|NCT03494426|Analgesics|analgesics|mesh-ancestor
13912529|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
13912530|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912531|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912532|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
13912533|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13912534|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13912535|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912536|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13912537|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13912538|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13912539|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912540|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13912541|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13912542|NCT03494426|Narcotics|narcotics|mesh-ancestor
13912543|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
13912544|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
13912545|NCT03494387|Antioxidants|antioxidants|mesh-list
13912546|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
13912547|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912548|NCT03494387|Expectorants|expectorants|mesh-ancestor
13912549|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
13912550|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13912551|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912552|NCT03494387|Protective Agents|protective agents|mesh-ancestor
13912553|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912554|NCT03494387|Vitamins|vitamins|mesh-ancestor
13912555|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
13912556|NCT03494322|Cetuximab|cetuximab|mesh-list
13912557|NCT03494322|Avelumab|avelumab|mesh-list
13912558|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912559|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912560|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13912561|NCT03494257|Brinzolamide|brinzolamide|mesh-list
13912562|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13912563|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13912564|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13912565|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13912566|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
13912567|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912568|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912569|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912570|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13912571|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912572|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
14047897|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14047898|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047899|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047900|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
14047901|NCT02686619|Hormones|hormones|mesh-ancestor
14047902|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047903|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047904|NCT02686710|Propofol|propofol|mesh-list
14047905|NCT02686710|Sevoflurane|sevoflurane|mesh-list
14047906|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14047907|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14047908|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047909|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14047910|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
14047911|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
14047912|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14047913|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14047914|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14047915|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
14047916|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14047917|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
14047918|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047919|NCT02686645|Metronidazole|metronidazole|mesh-list
14047920|NCT02686645|Vancomycin|vancomycin|mesh-list
14047921|NCT02686645|Loperamide|loperamide|mesh-list
14047922|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
14047923|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047924|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14047925|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14047926|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14047927|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047928|NCT02686853|Amphotericin B|amphotericin b|mesh-list
14047929|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14047930|NCT02686853|Amebicides|amebicides|mesh-ancestor
14047931|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14047932|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14047933|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047934|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14047935|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
14047936|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14047937|NCT02686840|Misoprostol|misoprostol|mesh-list
14047938|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14047939|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
14047940|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14047941|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047942|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14047943|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047944|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
14047945|NCT02686827|Vitamin D|vitamin d|mesh-list
14047946|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
14047947|NCT02686827|Vitamins|vitamins|mesh-ancestor
14047948|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
14047949|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047950|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14047951|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14047952|NCT02686476|Empagliflozin|empagliflozin|mesh-list
14047953|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14047954|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047955|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14047956|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047957|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
14047958|NCT02686385|Prednisolone|prednisolone|mesh-list
14047959|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14047960|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047961|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
14047962|NCT02686385|Hormones|hormones|mesh-ancestor
14047963|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047964|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047965|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047966|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047967|NCT02686385|Protective Agents|protective agents|mesh-ancestor
14047968|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
14047969|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14047970|NCT02686385|Expectorants|expectorants|mesh-ancestor
14047971|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
14047972|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14047973|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
14475270|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
14047974|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047975|NCT02686385|Antidotes|antidotes|mesh-ancestor
14047976|NCT02686151|Dexamethasone|dexamethasone|mesh-list
14047977|NCT02686151|Letrozole|letrozole|mesh-list
14047978|NCT02686151|Polygeline|polygeline|mesh-list
14047979|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14047980|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
14047981|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
14047982|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14047983|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14047984|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14047985|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
14047986|NCT02686151|Hormones|hormones|mesh-ancestor
14047987|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14047988|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14047989|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14047990|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14047991|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14047992|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14047993|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14047994|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14047995|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
14047996|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
14047997|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
14047998|NCT02686242|Anesthetics|anesthetics|mesh-list
14047999|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048000|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048001|NCT02686086|Albuterol|albuterol|mesh-list
14048002|NCT02686086|Ipratropium|ipratropium|mesh-list
14048003|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14048004|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
14048005|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048006|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048007|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14048008|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
14048009|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
14048010|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048011|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14048012|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14048013|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14048014|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
14048015|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048016|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048017|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14048018|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
14048019|NCT02686177|Metformin|metformin|mesh-list
14048020|NCT02686177|Liraglutide|liraglutide|mesh-list
14048021|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14048022|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048023|NCT02686177|Incretins|incretins|mesh-ancestor
14048024|NCT02686177|Hormones|hormones|mesh-ancestor
14048025|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048026|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
14048027|NCT02686047|Hylan|hylan|mesh-list
14048028|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14048029|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
14048030|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048031|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
14048032|NCT02686047|Protective Agents|protective agents|mesh-ancestor
14048033|NCT02685852|Exenatide|exenatide|mesh-list
14048034|NCT02685852|Acarbose|acarbose|mesh-list
14048035|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14048036|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048037|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14048038|NCT02685852|Incretins|incretins|mesh-ancestor
14048039|NCT02685852|Hormones|hormones|mesh-ancestor
13912573|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
13912574|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912575|NCT03493841|Protective Agents|protective agents|mesh-ancestor
13912576|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912577|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
13912578|NCT03493841|Vitamins|vitamins|mesh-ancestor
13912579|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
13912580|NCT03493685|Irbesartan|irbesartan|mesh-list
13912581|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13912582|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13912583|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14048040|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048041|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14048042|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048043|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170416|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170417|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170418|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170419|NCT04833023|Olanzapine|olanzapine|mesh-list
14170420|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
14170421|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
14170422|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170423|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170424|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170425|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14170426|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14170427|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170428|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14170429|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14170430|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14170431|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170432|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170433|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170434|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
14170435|NCT04833296|Ropivacaine|ropivacaine|mesh-list
14170436|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
14170437|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
14170438|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170439|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170440|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
14170441|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170442|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
14170443|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14170444|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
14170445|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14170446|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170447|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14183006|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183007|NCT04730973|Evolocumab|evolocumab|mesh-list
14183008|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14183009|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14183010|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
14183011|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183012|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14183013|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14183014|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183015|NCT04730895|Tretinoin|tretinoin|mesh-list
14183016|NCT04730895|Isotretinoin|isotretinoin|mesh-list
14183017|NCT04730895|Vaccines|vaccines|mesh-list
14183018|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
14183019|NCT04730895|Paraproteins|paraproteins|mesh-list
14183020|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
14183021|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183022|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183023|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
14183024|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
14183025|NCT04730999|Bevacizumab|bevacizumab|mesh-list
14183026|NCT04730999|Carboplatin|carboplatin|mesh-list
14183027|NCT04730999|Etoposide|etoposide|mesh-list
14183028|NCT04730999|Atezolizumab|atezolizumab|mesh-list
14183029|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14183030|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183031|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14183032|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14183033|NCT04730999|Growth Substances|growth substances|mesh-ancestor
14183034|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183035|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
14183036|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14183037|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14183038|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14183039|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183040|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183041|NCT04730362|Propofol|propofol|mesh-list
14757137|NCT00728754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183042|NCT04730362|Sevoflurane|sevoflurane|mesh-list
14048044|NCT02686021|Dipyrone|dipyrone|mesh-list
14048045|NCT02686021|Ibuprofen|ibuprofen|mesh-list
14048046|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048047|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048048|NCT02686021|Analgesics|analgesics|mesh-ancestor
14048049|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
14048050|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048051|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048052|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048053|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048054|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14048055|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048056|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048057|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
14048058|NCT02685748|Aspirin|aspirin|mesh-list
14048059|NCT02685748|Pantoprazole|pantoprazole|mesh-list
14048060|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048061|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048062|NCT02685748|Analgesics|analgesics|mesh-ancestor
14048063|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
14048064|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048065|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048066|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048067|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048068|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14048069|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14048070|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048071|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13912584|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912585|NCT03493568|Dolutegravir|dolutegravir|mesh-list
13912586|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13912587|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13912588|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13912589|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912590|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912591|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13912592|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14048072|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14048073|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048074|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
14048075|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14048076|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048077|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14048078|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14048079|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14048080|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048081|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
14048082|NCT02685969|Flutemetamol|flutemetamol|mesh-list
14048083|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14048084|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048085|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
14048086|NCT02685657|Docetaxel|docetaxel|mesh-list
14048087|NCT02685657|Doxorubicin|doxorubicin|mesh-list
14048088|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048089|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
14048090|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048091|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048092|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048093|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
14048094|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048095|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048096|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14048097|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
14048098|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
14048099|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14048100|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14048101|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14048102|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14048103|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048104|NCT02685774|Metformin|metformin|mesh-list
14048105|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14048106|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048107|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
14048108|NCT02685670|Fludarabine|fludarabine|mesh-list
14048109|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048110|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
14048111|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048112|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048113|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048114|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
14048115|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048116|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048117|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14048118|NCT02686008|Olaparib|olaparib|mesh-list
14048119|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14048120|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048121|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048122|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048123|NCT02685618|Iloprost|iloprost|mesh-list
14048124|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14048125|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
14048126|NCT02685397|Leuprolide|leuprolide|mesh-list
14048127|NCT02685397|Goserelin|goserelin|mesh-list
14048128|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14048129|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14048130|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
14048131|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048132|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048133|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14048134|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048135|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
14048136|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14048137|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
14048138|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14048139|NCT02685345|Firuglipel|firuglipel|mesh-list
14048140|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14048141|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048142|NCT02685462|Digoxin|digoxin|mesh-list
14048143|NCT02685462|Caffeine|caffeine|mesh-list
14048144|NCT02685462|Atorvastatin|atorvastatin|mesh-list
14048145|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14757138|NCT00728754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757139|NCT00723944|Ethanol|ethanol|mesh-list
14757140|NCT00723944|Povidone-Iodine|povidone-iodine|mesh-list
14048146|NCT02685462|Simvastatin|simvastatin|mesh-list
14048147|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14048148|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14048149|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
14048150|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048151|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14048152|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14048153|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048154|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14048155|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048156|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14048157|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14048158|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14048159|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
14048160|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048161|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14048162|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14048163|NCT02685462|Protective Agents|protective agents|mesh-ancestor
14048164|NCT02685306|Paclitaxel|paclitaxel|mesh-list
14757141|NCT00723944|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14048165|NCT02685306|Taxane|taxane|mesh-list
14048166|NCT02685306|Bavituximab|bavituximab|mesh-list
14048167|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14048168|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048169|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
14757142|NCT00723944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757143|NCT00723944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757144|NCT00723944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757145|NCT00565851|Gemcitabine|gemcitabine|mesh-list
14757146|NCT00565851|Paclitaxel|paclitaxel|mesh-list
14757147|NCT00565851|Docetaxel|docetaxel|mesh-list
14757148|NCT00565851|Bevacizumab|bevacizumab|mesh-list
14048170|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
14757149|NCT00565851|Carboplatin|carboplatin|mesh-list
14048171|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
14048172|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048173|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14048174|NCT02685449|Insulin|insulin|mesh-list
14048175|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14048176|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
14048177|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
14048178|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
14048179|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14048180|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048181|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14048182|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14048183|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
14048184|NCT02685605|Temozolomide|temozolomide|mesh-list
14048185|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048186|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
14048187|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048188|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048189|NCT02685228|Gemcitabine|gemcitabine|mesh-list
14048190|NCT02685228|Decitabine|decitabine|mesh-list
14048191|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14048192|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
14048193|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048194|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048195|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
14048196|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048197|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048198|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048199|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
14048200|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048201|NCT02685163|Antioxidants|antioxidants|mesh-list
14048202|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048203|NCT02685163|Protective Agents|protective agents|mesh-ancestor
14048204|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048205|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14048206|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048207|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048208|NCT02685111|Lenograstim|lenograstim|mesh-list
14048209|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14048210|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
14048211|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048212|NCT02685150|Omeprazole|omeprazole|mesh-list
14757150|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14757151|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14757152|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
14757153|NCT00565851|Antibodies|antibodies|mesh-list
14048213|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14048214|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14048215|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048216|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048217|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048218|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
14048219|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14048220|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14048221|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475271|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
14475272|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048222|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
14048223|NCT02684812|Coagulants|coagulants|mesh-ancestor
14048224|NCT02684786|Lidocaine|lidocaine|mesh-list
14048225|NCT02684786|Reserpine|reserpine|mesh-list
14048226|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048227|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
14048228|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048229|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048230|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
14048231|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048232|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14048233|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14475273|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048234|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14048235|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14048236|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048237|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14048238|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14048239|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14048240|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14048241|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14048242|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14048243|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14048244|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048245|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
14048246|NCT02684799|Omeprazole|omeprazole|mesh-list
14048247|NCT02684799|Famotidine|famotidine|mesh-list
14048248|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14048249|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048250|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14048251|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048252|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048253|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14048254|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
14048255|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
14048256|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048257|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048258|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14048259|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14048260|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14048261|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
14048262|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048263|NCT02685176|Charcoal|charcoal|mesh-list
14048264|NCT02685176|Antidotes|antidotes|mesh-ancestor
14048265|NCT02685176|Protective Agents|protective agents|mesh-ancestor
14048266|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048267|NCT02685085|Misoprostol|misoprostol|mesh-list
14048268|NCT02685085|Dinoprostone|dinoprostone|mesh-list
14048269|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14048270|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
14048271|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048272|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048273|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14048274|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048275|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
14048276|NCT02685059|Paclitaxel|paclitaxel|mesh-list
14048277|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
14048278|NCT02685059|Durvalumab|durvalumab|mesh-list
14048279|NCT02685059|Epirubicin|epirubicin|mesh-list
14048280|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14048281|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048282|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14048283|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14048284|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14048285|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048286|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048287|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
14048288|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048289|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048290|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048291|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
14048292|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14048293|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14048294|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14048295|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14048296|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14048297|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048298|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
14048299|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048300|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048301|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
14048302|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048303|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14048304|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048305|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048306|NCT02684708|Prednisone|prednisone|mesh-list
14048307|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
14048308|NCT02684708|Dacarbazine|dacarbazine|mesh-list
14475274|NCT02396316|Aflibercept|aflibercept|mesh-list
14048309|NCT02684708|Vincristine|vincristine|mesh-list
14048310|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048311|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
14048312|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048313|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14757154|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
14048314|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048315|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
14048316|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048317|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048318|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14048319|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048320|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
14048321|NCT02684708|Hormones|hormones|mesh-ancestor
14048322|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048323|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14048324|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14048325|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14048326|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14048327|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14048328|NCT02684487|Vitamin D|vitamin d|mesh-list
14048329|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
14048330|NCT02684487|Vitamins|vitamins|mesh-ancestor
14048331|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
14048332|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048333|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14048334|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14048335|NCT02684409|Sumatriptan|sumatriptan|mesh-list
14048336|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14048337|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14048338|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14048339|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
14048340|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048341|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048342|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048343|NCT02684474|HBOC 201|hboc 201|mesh-list
14048344|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
14048345|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
14048346|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14048347|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14048348|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048349|NCT02684669|Naloxone|naloxone|mesh-list
14048350|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14048351|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048352|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
14048353|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048354|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
14048355|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
14048356|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14048357|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048358|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048359|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048360|NCT02684019|Analgesics|analgesics|mesh-ancestor
14048361|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
14048362|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048363|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14048364|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14048365|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14048366|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14048367|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048368|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048369|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
14048370|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14048371|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
14048372|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14048373|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14048374|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14048375|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
14048376|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14475275|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14475276|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14475277|NCT02396316|Growth Substances|growth substances|mesh-ancestor
14475278|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048384|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
14048385|NCT02684071|Methotrexate|methotrexate|mesh-list
14048386|NCT02684071|Topotecan|topotecan|mesh-list
14048387|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048388|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
14048389|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048390|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048391|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048392|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
14048393|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048394|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048395|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14048396|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14048397|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
14048398|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048399|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14048400|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
14048401|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
14048402|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048403|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14048404|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14048405|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14048406|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14170448|NCT04832880|Remdesivir|remdesivir|mesh-list
14170449|NCT04832880|Dexamethasone|dexamethasone|mesh-list
14170450|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170451|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
14170452|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
14170453|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170454|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170455|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170456|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
14170457|NCT04832880|Hormones|hormones|mesh-ancestor
14170458|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170459|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14170460|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170461|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
14170462|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170463|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
14170464|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170465|NCT04832945|Ivermectin|ivermectin|mesh-list
14170466|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13912593|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
13912594|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912595|NCT03493503|Albuterol|albuterol|mesh-list
13912596|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13912597|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
14170467|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170468|NCT04832776|Bevacizumab|bevacizumab|mesh-list
14170469|NCT04832776|Cetuximab|cetuximab|mesh-list
14170470|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170471|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170472|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14170473|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14170474|NCT04832776|Growth Substances|growth substances|mesh-ancestor
14170475|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170476|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
14170477|NCT04832399|Natalizumab|natalizumab|mesh-list
14170478|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
14170479|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170480|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
14170481|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14170482|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
14170483|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912598|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912599|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912600|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13912601|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
13912602|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
13912603|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912604|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13912605|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13912606|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13912607|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170484|NCT04832009|Protective Agents|protective agents|mesh-ancestor
14170485|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048407|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
14048408|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14048409|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048410|NCT02684084|Dexamethasone|dexamethasone|mesh-list
14048411|NCT02684084|Ranibizumab|ranibizumab|mesh-list
14048412|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048413|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
14048414|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
14048415|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048416|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048417|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048418|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
14048419|NCT02684084|Hormones|hormones|mesh-ancestor
14048420|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048421|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14048422|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048423|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14048424|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14048425|NCT02684084|Growth Substances|growth substances|mesh-ancestor
14048426|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
14048427|NCT02684305|Oxytocin|oxytocin|mesh-list
14048428|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
14048429|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048430|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048431|NCT02684318|Olaparib|olaparib|mesh-list
14048432|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14048433|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048434|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048435|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048436|NCT02684123|Apremilast|apremilast|mesh-list
14048437|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048438|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048439|NCT02684123|Analgesics|analgesics|mesh-ancestor
14048440|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
14048441|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048442|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048443|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048444|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048445|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14048446|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14048447|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048448|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048449|NCT02683837|Remifentanil|remifentanil|mesh-list
14048450|NCT02683837|Sevoflurane|sevoflurane|mesh-list
14048451|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14048452|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14048453|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
14048454|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
14048455|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048456|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048457|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14048458|NCT02683837|Narcotics|narcotics|mesh-ancestor
14048459|NCT02683837|Analgesics|analgesics|mesh-ancestor
14048460|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
14048461|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048462|NCT02683759|Curcumin|curcumin|mesh-list
14048463|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048464|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048465|NCT02683759|Analgesics|analgesics|mesh-ancestor
14048466|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
14048467|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048468|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048469|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048470|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048471|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048472|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048473|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048474|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14048475|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
14048476|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048477|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
14048478|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048479|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
14475279|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
14475280|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048480|NCT02683733|Curcumin|curcumin|mesh-list
14048481|NCT02683733|Mesalamine|mesalamine|mesh-list
14048482|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048483|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048484|NCT02683733|Analgesics|analgesics|mesh-ancestor
14048485|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
14048486|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048487|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048488|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048489|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048490|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048491|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048492|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048493|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
14048494|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14048495|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048496|NCT02683655|Apatinib|apatinib|mesh-list
14048497|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048498|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14048499|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048500|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048501|NCT02683564|Infliximab|infliximab|mesh-list
14048502|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
14048503|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048504|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048505|NCT02683603|Imipenem|imipenem|mesh-list
14048506|NCT02683603|Colistin|colistin|mesh-list
14048507|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14048508|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048509|NCT02683369|Iron|iron|mesh-list
14048510|NCT02683369|Trace Elements|trace elements|mesh-ancestor
14048511|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
14048512|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048513|NCT02682953|Plerixafor|plerixafor|mesh-list
14048514|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14048515|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14048516|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
14048517|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048518|NCT02683031|Ionophores|ionophores|mesh-list
14048519|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14048520|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048521|NCT02683213|Fluoxetine|fluoxetine|mesh-list
14048522|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14048523|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14048524|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14048525|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048526|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048527|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
14048528|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048529|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14048530|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
14048531|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14048532|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14048533|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14048534|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048535|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
14048536|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14048537|NCT02683005|Ledipasvir|ledipasvir|mesh-list
14475281|NCT02396511|Bevacizumab|bevacizumab|mesh-list
14048538|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
14048539|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048540|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14048541|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14048542|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
14048543|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048544|NCT02683070|Tramadol|tramadol|mesh-list
14048545|NCT02683070|Ropivacaine|ropivacaine|mesh-list
14048546|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048547|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
14048548|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048549|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048550|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
14048551|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048552|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14048553|NCT02683070|Narcotics|narcotics|mesh-ancestor
14048554|NCT02683070|Analgesics|analgesics|mesh-ancestor
14048555|NCT02682927|Fenfluramine|fenfluramine|mesh-list
14048556|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14048557|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14048558|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14048559|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048560|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048561|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
14048562|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048563|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
14048564|NCT02683291|Sirolimus|sirolimus|mesh-list
14048565|NCT02683291|Prednisone|prednisone|mesh-list
14475282|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475283|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475284|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14475285|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14475286|NCT02396511|Growth Substances|growth substances|mesh-ancestor
14475287|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475288|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
14475289|NCT02396537|Lidocaine|lidocaine|mesh-list
14475290|NCT02396537|Midazolam|midazolam|mesh-list
14048566|NCT02683291|Tacrolimus|tacrolimus|mesh-list
14048567|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
14048568|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14048569|NCT02683291|Basiliximab|basiliximab|mesh-list
14048570|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048571|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
14048572|NCT02683291|Hormones|hormones|mesh-ancestor
14048573|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048574|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048575|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14048576|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048577|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048578|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
14048579|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14048580|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048581|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048582|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14048583|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14048584|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
14048585|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14048586|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048587|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
14475291|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
13912608|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048588|NCT02682862|Bromides|bromides|mesh-list
14048589|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
14048590|NCT02682862|Olodaterol|olodaterol|mesh-list
14048591|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14048592|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
14048593|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048594|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048595|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14048596|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14048597|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
14048598|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14048599|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
13912609|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912610|NCT03493490|Diclofenac|diclofenac|mesh-list
14933535|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13912611|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13912612|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912613|NCT03493490|Analgesics|analgesics|mesh-ancestor
13912614|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
14048600|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048601|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048602|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
14048603|NCT02682693|Denosumab|denosumab|mesh-list
14048604|NCT02682693|Paclitaxel|paclitaxel|mesh-list
14048605|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
14048606|NCT02682693|Carboplatin|carboplatin|mesh-list
14048607|NCT02682693|Trastuzumab|trastuzumab|mesh-list
14048608|NCT02682693|Epirubicin|epirubicin|mesh-list
14048609|NCT02682693|Pertuzumab|pertuzumab|mesh-list
14475292|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
14757155|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14757156|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
14048610|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14048611|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048612|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
14048613|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
14048614|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
14048615|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048616|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048617|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
14048618|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048619|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048620|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048621|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
14048622|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14048623|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14048624|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14048625|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14048626|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13912615|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048627|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048628|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14048629|NCT02682680|Ezetimibe|ezetimibe|mesh-list
14048630|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14048631|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14048632|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14048633|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
14048634|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048635|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14048636|NCT02682758|Xenon|xenon|mesh-list
14048637|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
14048638|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048639|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048640|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14048641|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
14048642|NCT02682524|Aceclofenac|aceclofenac|mesh-list
14048643|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048644|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048645|NCT02682524|Analgesics|analgesics|mesh-ancestor
14048646|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
14048647|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048648|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048649|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048650|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048651|NCT02682511|Ifetroban|ifetroban|mesh-list
14048652|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14048653|NCT02682485|Metronidazole|metronidazole|mesh-list
14048654|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
14048655|NCT02682485|Neomycin|neomycin|mesh-list
14048656|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048657|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14048658|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14048659|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14048660|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14048661|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14048662|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048663|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048664|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048665|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14048666|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14048667|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14048668|NCT02682186|Ropivacaine|ropivacaine|mesh-list
14048669|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
13912616|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912617|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912618|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912619|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13912620|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912621|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912622|NCT03493412|Verapamil|verapamil|mesh-list
13912623|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13912624|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13912625|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13912626|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048670|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
14170486|NCT04832009|Vitamins|vitamins|mesh-ancestor
14048671|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048672|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048673|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
14048674|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048675|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
14048676|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
14048677|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14048678|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14048679|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048680|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048681|NCT02682147|Urological Agents|urological agents|mesh-ancestor
14048682|NCT02682134|Dexamethasone|dexamethasone|mesh-list
14048683|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
14048684|NCT02682134|Lidocaine|lidocaine|mesh-list
14048685|NCT02682134|BB 1101|bb 1101|mesh-list
14048686|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048687|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
14048688|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
14048689|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048690|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048691|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048692|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
14048693|NCT02682134|Hormones|hormones|mesh-ancestor
14048694|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048695|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14048696|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048697|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
14048698|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048699|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048700|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048701|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
14048702|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048703|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
14048704|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14048705|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14048706|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14048707|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170487|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
14170488|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14170489|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14170490|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14170491|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
14170492|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14170493|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14170494|NCT04832269|Prednisolone|prednisolone|mesh-list
14170495|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
14757157|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14757158|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757159|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
14757160|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
13912627|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13912628|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912629|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
13912630|NCT03493269|Midazolam|midazolam|mesh-list
13912631|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13912632|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13912633|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912634|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912635|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13912636|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13912637|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13912638|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13912639|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
13912640|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
13912641|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
13912642|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
13912643|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912644|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912645|NCT03493165|Everolimus|everolimus|mesh-list
13912646|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912647|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912648|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
14170496|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14170497|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
14048708|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14048709|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
14048710|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14048711|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048712|NCT02682459|Lisinopril|lisinopril|mesh-list
14475293|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475294|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475295|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
14048713|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14048714|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
14048715|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048716|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048717|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14048718|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14048719|NCT02682459|Protective Agents|protective agents|mesh-ancestor
14048720|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048721|NCT02682225|Ketamine|ketamine|mesh-list
14048722|NCT02682225|Esketamine|esketamine|mesh-list
14048723|NCT02682225|Analgesics|analgesics|mesh-ancestor
14048724|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
14048725|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048726|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048727|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14048728|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14048729|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
14048730|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
14048731|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048732|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14048733|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14048734|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048735|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048736|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
14048737|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14048738|NCT02682121|Metformin|metformin|mesh-list
14048739|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14048740|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048741|NCT02682017|Fucoidan|fucoidan|mesh-list
14048742|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14048743|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048744|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
14048745|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048746|NCT02682082|Bupivacaine|bupivacaine|mesh-list
14048747|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048748|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
14048749|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048750|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048751|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
14048752|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048753|NCT02681848|Nicotine|nicotine|mesh-list
14048754|NCT02681848|Varenicline|varenicline|mesh-list
14048755|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14048756|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
14048757|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048758|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048759|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14048760|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14048761|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
14475296|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475297|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14048762|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170498|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048763|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048764|NCT02681887|Melatonin|melatonin|mesh-list
14048765|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
14048766|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048767|NCT02681887|Protective Agents|protective agents|mesh-ancestor
14048768|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048769|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048770|NCT02681913|Adenosine|adenosine|mesh-list
14048771|NCT02681913|Analgesics|analgesics|mesh-ancestor
14048772|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
14048773|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048774|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048775|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14048776|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
14048777|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14048778|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
14048779|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
14048780|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048781|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048782|NCT02681783|Aflibercept|aflibercept|mesh-list
14048783|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14048784|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14048785|NCT02681783|Growth Substances|growth substances|mesh-ancestor
14048786|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048787|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
14048788|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048789|NCT02681679|Bromfenac|bromfenac|mesh-list
14048790|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14048791|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14048792|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048793|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048794|NCT02681679|Analgesics|analgesics|mesh-ancestor
14048795|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
14048796|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048797|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048798|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048799|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048800|NCT02681562|Olaparib|olaparib|mesh-list
14048801|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14048802|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048803|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048804|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048805|NCT02681705|Temozolomide|temozolomide|mesh-list
14048806|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14048807|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
14048808|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048809|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048810|NCT02681653|Atorvastatin|atorvastatin|mesh-list
14048811|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14048812|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14048813|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
14048814|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048815|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14048816|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14048817|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048818|NCT02681471|Mannitol|mannitol|mesh-list
14048819|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14048820|NCT02681471|Diuretics|diuretics|mesh-ancestor
14048821|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
14048822|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048823|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14048824|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
14048825|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
14048826|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14048827|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048828|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048829|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
14048830|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14048831|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14048832|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14048833|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048834|NCT02681796|Bupivacaine|bupivacaine|mesh-list
14048835|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048836|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
14048837|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048838|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048839|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
14048840|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048841|NCT02681198|Lofexidine|lofexidine|mesh-list
14048842|NCT02681198|Paroxetine|paroxetine|mesh-list
14048843|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14048844|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14048845|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14048846|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048847|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048848|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
14048849|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048850|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14048851|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
14048852|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14048853|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14048854|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14048855|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048856|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14048857|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14048858|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
14048859|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048860|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14048861|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14048862|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14048863|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
14048864|NCT02681263|Temocillin|temocillin|mesh-list
14048865|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14048866|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048867|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
14048868|NCT02681211|Promethazine|promethazine|mesh-list
14048869|NCT02681211|Ketorolac|ketorolac|mesh-list
14048870|NCT02681211|Metoclopramide|metoclopramide|mesh-list
14048871|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14048872|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14048873|NCT02681211|Analgesics|analgesics|mesh-ancestor
14048874|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
14048875|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048876|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048877|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048878|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14048879|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14048880|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048881|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048882|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14048883|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14048884|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048885|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048886|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
14048887|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
14048888|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
14048889|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048890|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14048891|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
14048892|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
14048893|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048894|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14048895|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
14048896|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
14048897|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14048898|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14048899|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
14048900|NCT02680977|Levodopa|levodopa|mesh-list
14048901|NCT02680977|Benserazide|benserazide|mesh-list
14048902|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14048903|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14048904|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
14475298|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14475299|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14475300|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757161|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
14757162|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048905|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14048906|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048907|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048908|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048909|NCT02680938|Oxytocin|oxytocin|mesh-list
14048910|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
14048911|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048912|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048913|NCT02680951|Cytarabine|cytarabine|mesh-list
13912649|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048914|NCT02680951|Fludarabine|fludarabine|mesh-list
14048915|NCT02680951|Dasatinib|dasatinib|mesh-list
14048916|NCT02680951|Idarubicin|idarubicin|mesh-list
14048917|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048918|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14048919|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
14048920|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048921|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048922|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
14048923|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048924|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
14048925|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048926|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14048927|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048928|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14048929|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14048930|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14048931|NCT02680717|Clobetasol|clobetasol|mesh-list
14048932|NCT02680717|Calcipotriene|calcipotriene|mesh-list
14048933|NCT02680717|Tacrolimus|tacrolimus|mesh-list
14048934|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14048935|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
14048936|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048937|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14048938|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048939|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048940|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048941|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
14048942|NCT02680717|Hormones|hormones|mesh-ancestor
14048943|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048944|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14048945|NCT02680795|Belinostat|belinostat|mesh-list
14048946|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048947|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14048948|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14048949|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048950|NCT02680600|Cefepime|cefepime|mesh-list
14048951|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14048952|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14048953|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14048954|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
14048955|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14048956|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14475301|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475302|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14475303|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14475304|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14475305|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14475306|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475307|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14475308|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
14475309|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
14475310|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
14475311|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475312|NCT02396732|Aspirin|aspirin|mesh-list
14475313|NCT02396732|Enoxaparin|enoxaparin|mesh-list
14475314|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13959992|NCT03158389|Sirolimus|sirolimus|mesh-list
13959993|NCT03158389|Atezolizumab|atezolizumab|mesh-list
13959994|NCT03158389|Palbociclib|palbociclib|mesh-list
13959995|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13959996|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13959997|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13959998|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13959999|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14048957|NCT02680548|Prednisolone|prednisolone|mesh-list
14048958|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
14048959|NCT02680548|Bupivacaine|bupivacaine|mesh-list
14048960|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14048961|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
14048962|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048963|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
14048964|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048965|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048966|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
14048967|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048968|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14048969|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
14048970|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
14048971|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14048972|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
14048973|NCT02680548|Hormones|hormones|mesh-ancestor
14048974|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14048975|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14048976|NCT02680548|Protective Agents|protective agents|mesh-ancestor
14048977|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14048978|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14048979|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
14048980|NCT02680626|Ropivacaine|ropivacaine|mesh-list
14048981|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
14048982|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
14048983|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14048984|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14048985|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
14048986|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14048987|NCT02680626|Analgesics|analgesics|mesh-ancestor
14048988|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14048989|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
14048990|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14048991|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14048992|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14048993|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14048994|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
14048995|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14048996|NCT02680808|Olorofim|olorofim|mesh-list
14048997|NCT02680808|Midazolam|midazolam|mesh-list
14048998|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14048999|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14049000|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049001|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049002|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14049003|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14049004|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14049005|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14049006|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
14049007|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
14049008|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
14049009|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
14049010|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049011|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049012|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
14049013|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170499|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
14170500|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
14170501|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170502|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170503|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170504|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
14170505|NCT04832269|Hormones|hormones|mesh-ancestor
14170506|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170507|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14170508|NCT04832269|Protective Agents|protective agents|mesh-ancestor
14049014|NCT02680379|Minocycline|minocycline|mesh-list
14049015|NCT02680379|Lovastatin|lovastatin|mesh-list
14049016|NCT02680379|L 647318|l 647318|mesh-list
14049017|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
14049018|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14049019|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049020|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14049021|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14049022|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
14049023|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049024|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14049025|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14049026|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049027|NCT02680119|Esomeprazole|esomeprazole|mesh-list
14049028|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14049029|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14049030|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14049031|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049032|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049033|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
14049034|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14049035|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049036|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14049037|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14049038|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049039|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049040|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049041|NCT02680132|Esomeprazole|esomeprazole|mesh-list
14049042|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14049043|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14049044|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14049045|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049046|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049047|NCT02679963|Olaparib|olaparib|mesh-list
14049048|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14049049|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049050|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049051|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049052|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
14049053|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14049054|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
14049055|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049056|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
14049057|NCT02679924|Protective Agents|protective agents|mesh-ancestor
14049058|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14049059|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14049060|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14049061|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
14049062|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049063|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14049064|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14049065|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049066|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
14049067|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
14049068|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
14049069|NCT02679833|Vitamins|vitamins|mesh-ancestor
14049070|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
14049071|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049072|NCT02679833|Hematinics|hematinics|mesh-ancestor
14049073|NCT02679820|Copper|copper|mesh-list
14049074|NCT02679820|Trace Elements|trace elements|mesh-ancestor
14049075|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
14049076|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049077|NCT02679339|Lidocaine|lidocaine|mesh-list
14049078|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
14049079|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
14049080|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049081|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757163|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14475315|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475316|NCT02396732|Analgesics|analgesics|mesh-ancestor
14049082|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
14049083|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912650|NCT03493152|Everolimus|everolimus|mesh-list
14933536|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933537|NCT01451333|Efavirenz|efavirenz|mesh-list
14933538|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14933539|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14933540|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933541|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475317|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
14475318|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475319|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475320|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475321|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475322|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14475323|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14475324|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049084|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14049085|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14049086|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14049087|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049088|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049089|NCT02679456|Fluconazole|fluconazole|mesh-list
14049090|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
14049091|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
14933542|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
14933543|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933544|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14933545|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14933546|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14933547|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14933548|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14049092|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049093|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14049094|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14049095|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049096|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049097|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14049098|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
14049099|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049100|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049101|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14049102|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14475325|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14475326|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14475327|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475328|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
14475329|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
14049103|NCT02679261|Atorvastatin|atorvastatin|mesh-list
14049104|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14049105|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14049106|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
14475330|NCT02396758|Plasminogen|plasminogen|mesh-list
14475331|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14475332|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14475333|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14475334|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475335|NCT02396953|Lanreotide|lanreotide|mesh-list
14475336|NCT02396953|Somatostatin|somatostatin|mesh-list
14475337|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475338|NCT02396953|Hormones|hormones|mesh-ancestor
13912651|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912652|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912653|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
13912654|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912655|NCT03493087|Vitamin K|vitamin k|mesh-list
13912656|NCT03493087|Vitamins|vitamins|mesh-ancestor
13912657|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
13912658|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912659|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13912660|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13963361|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475339|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475340|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475341|NCT02397096|Ritonavir|ritonavir|mesh-list
14475342|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14475343|NCT02397096|Tenofovir|tenofovir|mesh-list
14475344|NCT02397096|Lamivudine|lamivudine|mesh-list
14475345|NCT02397096|Cobicistat|cobicistat|mesh-list
14475346|NCT02397096|Elvitegravir|elvitegravir|mesh-list
14049107|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049108|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14049109|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14049110|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049111|NCT02678975|Copper|copper|mesh-list
14049112|NCT02678975|Temozolomide|temozolomide|mesh-list
14049113|NCT02678975|Lomustine|lomustine|mesh-list
14049114|NCT02678975|Disulfiram|disulfiram|mesh-list
14049115|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
14049116|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14049117|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049118|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049119|NCT02678975|Trace Elements|trace elements|mesh-ancestor
14049120|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
14049121|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049122|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14049123|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14049124|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049125|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14049126|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14049127|NCT02679131|Belinostat|belinostat|mesh-list
14049128|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049129|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14049130|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049131|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049132|NCT02679092|Misoprostol|misoprostol|mesh-list
14049133|NCT02679092|Mifepristone|mifepristone|mesh-list
14049134|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14049135|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
14049136|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049137|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049138|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14049139|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14049140|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
14049141|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14049142|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14049143|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14049144|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14475347|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14933549|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13912661|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912662|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
13912663|NCT03493087|Coagulants|coagulants|mesh-ancestor
13912664|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
13912665|NCT03493061|Irinotecan|irinotecan|mesh-list
13912666|NCT03493061|Floxuridine|floxuridine|mesh-list
13912667|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912668|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13912669|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13912670|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912671|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912672|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912673|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
13912674|NCT03493048|Leucovorin|leucovorin|mesh-list
13912675|NCT03493048|Fluorouracil|fluorouracil|mesh-list
13912676|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
13912677|NCT03493048|Irinotecan|irinotecan|mesh-list
13912678|NCT03493048|Cetuximab|cetuximab|mesh-list
13912679|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
13912680|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912681|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912682|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912683|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912684|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
14475348|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
13912685|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912686|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14049145|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
14049146|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14049147|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14049148|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
14049149|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049150|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
14049151|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14049152|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14049153|NCT02679040|Trastuzumab|trastuzumab|mesh-list
14049154|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14049155|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049156|NCT02678949|Fluticasone|fluticasone|mesh-list
14049157|NCT02678949|Xhance|xhance|mesh-list
14049158|NCT02678949|Albuterol|albuterol|mesh-list
14049159|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14049160|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14049161|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
14049162|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049163|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049164|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14049165|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
14049166|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
14049167|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14049168|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
14049169|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049170|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14049171|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14049172|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14049173|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
14049174|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049175|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049185|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14049186|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14049187|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049188|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
14049189|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14049190|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049191|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049192|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14049193|NCT02678728|Analgesics|analgesics|mesh-ancestor
14049194|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
14049195|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049196|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14049197|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14049198|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14049199|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
14049200|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049201|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170509|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14170510|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170511|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
14170512|NCT04832100|Pregabalin|pregabalin|mesh-list
14170513|NCT04832100|Imipramine|imipramine|mesh-list
14170514|NCT04832100|Analgesics|analgesics|mesh-ancestor
14170515|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
14170516|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170517|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170518|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
14170519|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14170520|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170521|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170522|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14170523|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14170524|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14049202|NCT02678780|Lenvatinib|lenvatinib|mesh-list
14049203|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049204|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14049205|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049206|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049207|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14049208|NCT02678767|Hematinics|hematinics|mesh-ancestor
14049209|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14049210|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14049211|NCT02678520|Goserelin|goserelin|mesh-list
14049212|NCT02678520|Bicalutamide|bicalutamide|mesh-list
14049213|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049214|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049215|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14049216|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049217|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
14049218|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
14049219|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14049220|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14049221|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14049222|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049223|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049224|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14049225|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049226|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049227|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14049228|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049229|NCT02678650|Anesthetics|anesthetics|mesh-list
14049230|NCT02678650|Propofol|propofol|mesh-list
14049231|NCT02678650|Isoflurane|isoflurane|mesh-list
14049232|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049233|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049234|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14049235|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14049236|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
14049237|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14049238|NCT02678338|Magrolimab|magrolimab|mesh-list
14049239|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14049240|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049241|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
14049242|NCT02678507|Narcotics|narcotics|mesh-ancestor
14049243|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049244|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049245|NCT02678507|Analgesics|analgesics|mesh-ancestor
14049246|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
14049247|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049248|NCT02678598|Micafungin|micafungin|mesh-list
14049249|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
14049250|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049251|NCT02678364|Vitamin D|vitamin d|mesh-list
14049252|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
14049253|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14049254|NCT02678364|Calcifediol|calcifediol|mesh-list
14049255|NCT02678364|Vitamins|vitamins|mesh-ancestor
14049256|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
14049257|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049258|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14049259|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14049260|NCT02678585|Lidocaine|lidocaine|mesh-list
14049261|NCT02678585|Nalbuphine|nalbuphine|mesh-list
14049262|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
14049263|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
14049264|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049265|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049266|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
14049267|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049268|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14049269|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14049270|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14049271|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049272|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049273|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14049274|NCT02678585|Narcotics|narcotics|mesh-ancestor
14049275|NCT02678585|Analgesics|analgesics|mesh-ancestor
14757164|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14757165|NCT00565851|Growth Substances|growth substances|mesh-ancestor
13912687|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14049276|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
14049277|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14049278|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14049279|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049280|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
14049281|NCT02678208|Coagulants|coagulants|mesh-ancestor
14049282|NCT02678260|Spartalizumab|spartalizumab|mesh-list
14049283|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14049284|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049285|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049286|NCT02678195|Amoxicillin|amoxicillin|mesh-list
14049287|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14049288|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049289|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
14049290|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14049291|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14049292|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049293|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
14049294|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
14049295|NCT02678221|Aspirin|aspirin|mesh-list
14049296|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
14049297|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14049298|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14049299|NCT02678221|Analgesics|analgesics|mesh-ancestor
14049300|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
14049301|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049302|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049303|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14049304|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049305|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14049306|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14049307|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049308|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14049309|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14049310|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049311|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
14049312|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
14049313|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14049314|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14049315|NCT02678221|Urological Agents|urological agents|mesh-ancestor
14049316|NCT02678234|Acetaminophen|acetaminophen|mesh-list
14049317|NCT02678234|Ascorbic Acid|ascorbic acid|mesh-list
14049318|NCT02678234|Phenylephrine|phenylephrine|mesh-list
14049319|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
14049320|NCT02678234|Vitamins|vitamins|mesh-ancestor
14049321|NCT02678234|Micronutrients|micronutrients|mesh-ancestor
14049322|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049323|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14049324|NCT02678234|Analgesics|analgesics|mesh-ancestor
14049325|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
14049326|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049327|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
14049328|NCT02678234|Antioxidants|antioxidants|mesh-ancestor
14049329|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049330|NCT02678234|Protective Agents|protective agents|mesh-ancestor
14049331|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14049332|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
14049333|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
14049334|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
14757166|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912688|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912689|NCT03493048|Antidotes|antidotes|mesh-ancestor
13912690|NCT03493048|Protective Agents|protective agents|mesh-ancestor
13912691|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
13912692|NCT03493048|Vitamins|vitamins|mesh-ancestor
13912693|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
13912694|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912695|NCT03492996|Delpazolid|delpazolid|mesh-list
13912696|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912697|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912698|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13912699|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049335|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14049336|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
14049337|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
14049338|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14049339|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14049340|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14049341|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14049342|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049343|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
14049344|NCT02678117|Pregabalin|pregabalin|mesh-list
14049345|NCT02678117|Analgesics|analgesics|mesh-ancestor
14049346|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
14049347|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049348|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049349|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
14049350|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14049351|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049352|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049353|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14049354|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14049355|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14049356|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049357|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14049358|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
14049359|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14049360|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
14049361|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049362|NCT02678182|Capecitabine|capecitabine|mesh-list
14049363|NCT02678182|Trastuzumab|trastuzumab|mesh-list
14049364|NCT02678182|Durvalumab|durvalumab|mesh-list
14049365|NCT02678182|Ramucirumab|ramucirumab|mesh-list
14049366|NCT02678182|Rucaparib|rucaparib|mesh-list
14475349|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14475350|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475351|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475352|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14475353|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14475354|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
14475355|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475356|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14475357|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14475358|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14475359|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14475360|NCT02397265|Insulin|insulin|mesh-list
14475361|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14475362|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475363|NCT02397291|Inositol|inositol|mesh-list
14049367|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14049368|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
14049369|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049370|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049371|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14049372|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14049373|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049374|NCT02678052|Vedolizumab|vedolizumab|mesh-list
14049375|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14049376|NCT02677597|Paclitaxel|paclitaxel|mesh-list
14049377|NCT02677597|Cisplatin|cisplatin|mesh-list
14049378|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14049379|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049380|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
14049381|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
14049382|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
14049383|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049384|NCT02677584|Caffeine|caffeine|mesh-list
14049385|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
14049386|NCT02677584|Citric Acid|citric acid|mesh-list
14049387|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
14049388|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
14049389|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14049390|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
14049391|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
14049392|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049393|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14049394|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049395|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14049396|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049397|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14049398|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14049399|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
14049400|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049401|NCT02677571|Morphine|morphine|mesh-list
14049402|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
14049403|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14049404|NCT02677571|Narcotics|narcotics|mesh-ancestor
14049405|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049406|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049407|NCT02677571|Analgesics|analgesics|mesh-ancestor
14049408|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
14049409|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049410|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
14049411|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
14049412|NCT02677532|Acetaminophen|acetaminophen|mesh-list
14049413|NCT02677532|Sufentanil|sufentanil|mesh-list
14049414|NCT02677532|Morphine|morphine|mesh-list
14049415|NCT02677532|Dsuvia|dsuvia|mesh-list
14049416|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
14049417|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14049418|NCT02677532|Narcotics|narcotics|mesh-ancestor
14049419|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049420|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049421|NCT02677532|Analgesics|analgesics|mesh-ancestor
14049422|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
14049423|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049424|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14049425|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
14049426|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
14049427|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
14049428|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14049429|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14049430|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
14049431|NCT02677519|Methylphenidate|methylphenidate|mesh-list
14049432|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14049433|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049434|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14049435|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14049436|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049437|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049438|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
14049439|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049440|NCT02677415|Anesthetics|anesthetics|mesh-list
14049441|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
14049442|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049443|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049444|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
14049445|NCT02677376|Listerine|listerine|mesh-list
14049446|NCT02677376|Fluorides|fluorides|mesh-list
14049447|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
14049448|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
14049449|NCT02677376|Protective Agents|protective agents|mesh-ancestor
14049450|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049451|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14049452|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049453|NCT02677155|Rituximab|rituximab|mesh-list
14049454|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
14049455|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14049456|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049457|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
14049458|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049459|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049460|NCT02677051|Sulforaphane|sulforaphane|mesh-list
14049461|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14049462|NCT02677051|Protective Agents|protective agents|mesh-ancestor
14049463|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049464|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049465|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
14049466|NCT02677181|Methotrexate|methotrexate|mesh-list
14049467|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
14049468|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14049469|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
14049470|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049471|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049472|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14049473|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
14049474|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049475|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475364|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
14049476|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14049477|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049478|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14049479|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14049480|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
14049481|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049482|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14049483|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14049484|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14049485|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
14049486|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14049487|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049488|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14049489|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14049490|NCT02677259|Estradiol|estradiol|mesh-list
14049491|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14049492|NCT02677259|Progesterone|progesterone|mesh-list
14049493|NCT02677259|Estrogens|estrogens|mesh-ancestor
14049494|NCT02677259|Hormones|hormones|mesh-ancestor
14049495|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049496|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049497|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14049498|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
14049499|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049500|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14049501|NCT02677259|Progestins|progestins|mesh-ancestor
14049502|NCT02677246|Denosumab|denosumab|mesh-list
14049503|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14049504|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049505|NCT02677077|Natalizumab|natalizumab|mesh-list
14049506|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
14049507|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049508|NCT02676986|Exemestane|exemestane|mesh-list
14049509|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049510|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14049511|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14049512|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049513|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049514|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14049515|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
14049516|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049517|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049518|NCT02676934|Anesthetics|anesthetics|mesh-list
14049519|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049520|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170525|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170526|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14170527|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14170528|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
14170529|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14170530|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14170531|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170532|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170533|NCT04832204|Apatinib|apatinib|mesh-list
14170534|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170535|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170536|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170537|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170538|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14170539|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14170540|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170541|NCT04831593|Anesthetics|anesthetics|mesh-list
14170542|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170543|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170544|NCT04831736|Ketamine|ketamine|mesh-list
14170545|NCT04831736|Analgesics|analgesics|mesh-ancestor
14170546|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
14049521|NCT02676622|Aldesleukin|aldesleukin|mesh-list
14049522|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
14049523|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
14049524|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14049525|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
14049526|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049527|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049528|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14049529|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
14049530|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049531|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049532|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14049533|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14049534|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14049535|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
14049536|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049537|NCT02676674|Vitamin D|vitamin d|mesh-list
14049538|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
14049539|NCT02676674|Vitamins|vitamins|mesh-ancestor
14049540|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
14049541|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049542|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14049543|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14049544|NCT02676609|Insulin|insulin|mesh-list
14049545|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14049546|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049547|NCT02676739|Adderall|adderall|mesh-list
14049548|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13912700|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912701|NCT03492970|Melatonin|melatonin|mesh-list
13912702|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
13912703|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912704|NCT03492970|Protective Agents|protective agents|mesh-ancestor
13912705|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912706|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049549|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049550|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
14049551|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14049552|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049553|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
14049554|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14049555|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
14049556|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049557|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049558|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14049559|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
14049560|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
14049561|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14049562|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
13912707|NCT03492931|Ticagrelor|ticagrelor|mesh-list
13912708|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13912709|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13912710|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13912711|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13912712|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
13912713|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912714|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912715|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912716|NCT03492866|Gentamicins|gentamicins|mesh-list
13912717|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912718|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912719|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13912720|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912721|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912722|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
13912723|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13912724|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13912725|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912726|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
13912727|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
13912728|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13912729|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
13912730|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13912731|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
14049563|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049564|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049565|NCT02676154|Fesoterodine|fesoterodine|mesh-list
14049566|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14049567|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14049568|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
14049569|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049570|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049571|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049572|NCT02676154|Urological Agents|urological agents|mesh-ancestor
14049573|NCT02676310|Bimatoprost|bimatoprost|mesh-list
14049574|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14049575|NCT02676323|Leucovorin|leucovorin|mesh-list
14049576|NCT02676323|Cytarabine|cytarabine|mesh-list
14049577|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
14049578|NCT02676323|Methotrexate|methotrexate|mesh-list
14049579|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
14049580|NCT02676323|Fludarabine|fludarabine|mesh-list
14049581|NCT02676323|Panobinostat|panobinostat|mesh-list
14049582|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
14049583|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049584|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14049585|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
14049586|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049587|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14049588|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
14049589|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049590|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049591|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14049592|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049593|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14049594|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14049595|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
14049596|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049597|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14049598|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
14049599|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049600|NCT02676323|Antidotes|antidotes|mesh-ancestor
14049601|NCT02676323|Protective Agents|protective agents|mesh-ancestor
14049602|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
14049603|NCT02676323|Vitamins|vitamins|mesh-ancestor
14049604|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
14049605|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14049606|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14049607|NCT02676336|Iodine|iodine|mesh-list
14049608|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
14049609|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14049610|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049611|NCT02676336|Trace Elements|trace elements|mesh-ancestor
14049612|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
14049613|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049614|NCT02675868|Phenylephrine|phenylephrine|mesh-list
14049615|NCT02675868|Vasopressins|vasopressins|mesh-list
14049616|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
14049617|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
14049618|NCT02675868|Norepinephrine|norepinephrine|mesh-list
14049619|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14049620|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
14049621|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
14049622|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049623|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049624|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
14049625|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14049626|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
14049627|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
14049628|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14049629|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14049630|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14049631|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
14049632|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049633|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049634|NCT02675868|Protective Agents|protective agents|mesh-ancestor
14049635|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
14049636|NCT02675868|Coagulants|coagulants|mesh-ancestor
14049637|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14049638|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
14049639|NCT02676011|Atropine|atropine|mesh-list
14049640|NCT02676011|Succinylcholine|succinylcholine|mesh-list
14049641|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14049642|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14049643|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14049644|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
14049645|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049646|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049647|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14049648|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
14049649|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
14049650|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
14049651|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14049652|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14049653|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
14049654|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049655|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049656|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
13912732|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912733|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912734|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912735|NCT03492736|Melatonin|melatonin|mesh-list
13912736|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
13912737|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912738|NCT03492736|Protective Agents|protective agents|mesh-ancestor
13912739|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912740|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13912741|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
13912742|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14049657|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14049658|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14049659|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
14049660|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14049661|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
14049662|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049663|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049664|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14049665|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
14049666|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
14049667|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14049668|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
14049669|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049670|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049671|NCT02675647|Heparin|heparin|mesh-list
14049672|NCT02675647|Protamines|protamines|mesh-list
14049673|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
14049674|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14049675|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14049676|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049677|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
14049678|NCT02675647|Coagulants|coagulants|mesh-ancestor
14049679|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14049680|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
14049681|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14049682|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
14049683|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049684|NCT02675530|Ketamine|ketamine|mesh-list
14049685|NCT02675530|Analgesics|analgesics|mesh-ancestor
14049686|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
14049687|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049688|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049689|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14049690|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14049691|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
14049692|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
14049693|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049694|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14049695|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14049696|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049697|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049698|NCT02675400|Methylphenidate|methylphenidate|mesh-list
14049699|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14049700|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14049701|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049702|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14049703|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14049704|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049705|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049706|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
14049707|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049708|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14049709|NCT02675309|Simvastatin|simvastatin|mesh-list
14049710|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14049711|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14049712|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
14049713|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049714|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14049715|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14049716|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049717|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14049718|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14049719|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
14049720|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
14049721|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049722|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049723|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049724|NCT02675387|Lidocaine|lidocaine|mesh-list
14049725|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
14049726|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
14049727|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049728|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049729|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
14049730|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049731|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14049732|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14049733|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14049734|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049735|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049736|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14049737|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14049738|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049739|NCT02675335|Incretins|incretins|mesh-ancestor
14049740|NCT02675335|Hormones|hormones|mesh-ancestor
14049741|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049742|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14049743|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
14049744|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049745|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049746|NCT02675205|Aspirin|aspirin|mesh-list
14049747|NCT02675205|Clopidogrel|clopidogrel|mesh-list
14049748|NCT02675205|Ticagrelor|ticagrelor|mesh-list
14049749|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14049750|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14049751|NCT02675205|Analgesics|analgesics|mesh-ancestor
14049752|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
14049753|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049754|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049755|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14049756|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049757|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14049758|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14049759|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049760|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14049761|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14049762|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049763|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
14049764|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14049765|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14049766|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14049767|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
14049768|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170547|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170548|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170549|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14170550|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14170551|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
14170552|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
14170553|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049769|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
14049770|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14049771|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14049772|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
14049773|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049774|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14049775|NCT02675153|Sirolimus|sirolimus|mesh-list
14049776|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14049777|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049778|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14049779|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049780|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
14049781|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14049782|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
14049783|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049784|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
14049785|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14049786|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049787|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049788|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14049789|NCT02675049|Analgesics|analgesics|mesh-ancestor
14049790|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
14049791|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049792|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14049793|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14049794|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14049795|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
14049796|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049797|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049798|NCT02675140|Vitamins|vitamins|mesh-list
14049799|NCT02675140|Vitamin A|vitamin a|mesh-list
14049800|NCT02675140|Albendazole|albendazole|mesh-list
14049801|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
14049802|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
14049803|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049804|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
14049805|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049806|NCT02675140|Protective Agents|protective agents|mesh-ancestor
14049807|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14049808|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049809|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
14049810|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14049811|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049812|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
14049813|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14049814|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14049815|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14049816|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14049817|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14049818|NCT02675023|Adalimumab|adalimumab|mesh-list
14049819|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14049820|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049821|NCT02674906|Heparin|heparin|mesh-list
14049822|NCT02674906|Calcium heparin|calcium heparin|mesh-list
14049823|NCT02674906|Anticoagulants|anticoagulants|mesh-list
14049824|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049825|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14049826|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14049827|NCT02674997|Factor VIII|factor viii|mesh-list
14049828|NCT02674997|Coagulants|coagulants|mesh-ancestor
14049829|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
14049830|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
14049831|NCT02674737|Tramadol|tramadol|mesh-list
14049832|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14049833|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049834|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049835|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14049836|NCT02674737|Analgesics|analgesics|mesh-ancestor
14049837|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
14049838|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049839|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14049840|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14049841|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14049842|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
14049843|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049844|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049845|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14049846|NCT02674737|Narcotics|narcotics|mesh-ancestor
14049847|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14049848|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912743|NCT03492710|Antibodies|antibodies|mesh-list
13912744|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
13912745|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912746|NCT03492671|Gemcitabine|gemcitabine|mesh-list
13912747|NCT03492671|Paclitaxel|paclitaxel|mesh-list
13912748|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13912749|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912750|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
13912751|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
13912752|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
13912753|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912754|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912755|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
13912756|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
13912757|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912758|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912759|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912760|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
13912761|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912762|NCT03492658|Methotrexate|methotrexate|mesh-list
13912763|NCT03492658|Abatacept|abatacept|mesh-list
13912764|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13912765|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
13912766|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13912767|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912768|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912769|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
13912770|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912771|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912772|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
13912773|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912774|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14757167|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
14757168|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
14757169|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14757170|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
14757171|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
14757172|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757173|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757174|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757175|NCT00467142|Leucovorin|leucovorin|mesh-list
14757176|NCT00467142|Bevacizumab|bevacizumab|mesh-list
14757177|NCT00467142|Fluorouracil|fluorouracil|mesh-list
14757178|NCT00467142|Irinotecan|irinotecan|mesh-list
14757179|NCT00467142|Calcium|calcium|mesh-list
14757180|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
14757181|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14757182|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912775|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912776|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
13912777|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912778|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13912779|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13912780|NCT03492632|Hormones|hormones|mesh-list
13912781|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13912782|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912783|NCT03492593|Beta Carotene|beta carotene|mesh-list
13912784|NCT03492593|Lycopene|lycopene|mesh-list
13912785|NCT03492593|Carotenoids|carotenoids|mesh-list
13912786|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912787|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
13912788|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912789|NCT03492593|Protective Agents|protective agents|mesh-ancestor
13912790|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912791|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13912792|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13912793|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912794|NCT03492593|Provitamins|provitamins|mesh-ancestor
13912795|NCT03492593|Vitamins|vitamins|mesh-ancestor
14757183|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13912796|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
13912797|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
13912798|NCT03492580|Empagliflozin|empagliflozin|mesh-list
14049849|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14049850|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14049851|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049852|NCT02674893|Liraglutide|liraglutide|mesh-list
14049853|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14049854|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049855|NCT02674893|Incretins|incretins|mesh-ancestor
14049856|NCT02674893|Hormones|hormones|mesh-ancestor
14049857|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475365|NCT02397291|Vitamins|vitamins|mesh-ancestor
14475366|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
14475367|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475368|NCT02397408|Choline|choline|mesh-list
14475369|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
14475370|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14475371|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
14475372|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475373|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475374|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14475375|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
14475376|NCT02397694|Dolutegravir|dolutegravir|mesh-list
14475377|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14475378|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14475379|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475380|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049874|NCT02674581|Fostemsavir|fostemsavir|mesh-list
14049875|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14049876|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14049877|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
14049878|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049879|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14049880|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14049881|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049882|NCT02674295|Esketamine|esketamine|mesh-list
14049883|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
14049884|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14049885|NCT02674308|Vedolizumab|vedolizumab|mesh-list
14049886|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14049887|NCT02674555|Naquotinib|naquotinib|mesh-list
14049888|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049889|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14049890|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049891|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049892|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
14049893|NCT02674243|Povidone|povidone|mesh-list
14049894|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14049895|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
14049896|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
14049897|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14049898|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049899|NCT02674139|Copper|copper|mesh-list
14049900|NCT02674139|Trace Elements|trace elements|mesh-ancestor
14049901|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
14049902|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049903|NCT02673931|Exenatide|exenatide|mesh-list
14049904|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14049905|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049906|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14049907|NCT02673931|Incretins|incretins|mesh-ancestor
14049908|NCT02673931|Hormones|hormones|mesh-ancestor
14933550|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
14933551|NCT01451489|Tacrolimus|tacrolimus|mesh-list
14933552|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14049909|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049910|NCT02674113|Bupivacaine|bupivacaine|mesh-list
14049911|NCT02674113|Anesthetics|anesthetics|mesh-list
14049912|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
14049913|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049914|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049915|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
14049916|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049917|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14049918|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14049919|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
14049920|NCT02674191|Clindamycin|clindamycin|mesh-list
14049921|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
14049922|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
14475381|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14933553|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
14049923|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
14049924|NCT02674191|Mepivacaine|mepivacaine|mesh-list
14049925|NCT02674191|Benzocaine|benzocaine|mesh-list
14049926|NCT02674191|Povidone|povidone|mesh-list
14049927|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14049928|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14049929|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14049930|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14049931|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049932|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
14049933|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
14049934|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14049935|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
14049936|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
14049937|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049938|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049939|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
14049940|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049941|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14049942|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14049943|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14049944|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049945|NCT02673866|Pregabalin|pregabalin|mesh-list
14049946|NCT02673866|Analgesics|analgesics|mesh-ancestor
14049947|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
14049948|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14049949|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049950|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
14049951|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14049952|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14049953|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049954|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14049955|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14049956|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14049957|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14049958|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14049959|NCT02673840|Ketotifen|ketotifen|mesh-list
14049960|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
14049961|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
14049962|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14049963|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
14049964|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
14049965|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14049966|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14049967|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049968|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14049969|NCT02673814|Durvalumab|durvalumab|mesh-list
14049970|NCT02673814|Bavituximab|bavituximab|mesh-list
14049971|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14049972|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049973|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14049974|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14049975|NCT02673606|Estradiol|estradiol|mesh-list
14049976|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14049977|NCT02673606|Estrogens|estrogens|mesh-ancestor
14049978|NCT02673606|Hormones|hormones|mesh-ancestor
14049979|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049980|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049981|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14049982|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
14049983|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049984|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14049985|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14049986|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
14049987|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14049988|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
14049989|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14049990|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049991|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14049992|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14049993|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14049994|NCT02673463|Spironolactone|spironolactone|mesh-list
14049995|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14475382|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14049996|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
14049997|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14049998|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14049999|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14050000|NCT02673463|Diuretics|diuretics|mesh-ancestor
14050001|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
14170554|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14170555|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14170556|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170557|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170558|NCT04831528|Bevacizumab|bevacizumab|mesh-list
14170559|NCT04831528|Trastuzumab|trastuzumab|mesh-list
14170560|NCT04831528|Cetuximab|cetuximab|mesh-list
14170561|NCT04831528|Pertuzumab|pertuzumab|mesh-list
14170562|NCT04831528|Lapatinib|lapatinib|mesh-list
14170563|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170564|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170565|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14170566|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14170567|NCT04831528|Growth Substances|growth substances|mesh-ancestor
14170568|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170569|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
14170570|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170571|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170572|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170573|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
14170574|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170575|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
14170576|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
14170577|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170578|NCT04831320|Paclitaxel|paclitaxel|mesh-list
14170579|NCT04831320|Nivolumab|nivolumab|mesh-list
14170580|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14170581|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170582|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
14170583|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
14170584|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
14170585|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170586|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170587|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14170588|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
14170589|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14170590|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757184|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14757185|NCT00467142|Growth Substances|growth substances|mesh-ancestor
14757186|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757187|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
14757188|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14170591|NCT04831047|Phenylephrine|phenylephrine|mesh-list
14170592|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
14170593|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14170594|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14170595|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14170596|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14170597|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170598|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170599|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170600|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170601|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
14170602|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
14050002|NCT02673359|Progesterone|progesterone|mesh-list
14050003|NCT02673359|Progestins|progestins|mesh-ancestor
14050004|NCT02673359|Hormones|hormones|mesh-ancestor
14050005|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050006|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050007|NCT02673229|Bacitracin|bacitracin|mesh-list
14050008|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14050009|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050010|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14050011|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
14050012|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14050013|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14050014|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14050015|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050016|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050017|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
14050018|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14050019|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050020|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14050021|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050022|NCT02672839|Betadex|betadex|mesh-list
14050023|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
14050024|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050025|NCT02672917|Folfirinox|folfirinox|mesh-list
14050026|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050027|NCT02672995|Bevacizumab|bevacizumab|mesh-list
14050028|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14050029|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050030|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14050031|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14050032|NCT02672995|Growth Substances|growth substances|mesh-ancestor
14050033|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050034|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
14050035|NCT02672709|Apixaban|apixaban|mesh-list
14050036|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14050037|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
14050038|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14050039|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
14050040|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050041|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050042|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
14050043|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14050044|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050045|NCT02672527|Dexamethasone|dexamethasone|mesh-list
14050046|NCT02672527|Trabectedin|trabectedin|mesh-list
14050047|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050048|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
14050049|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
14050050|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050051|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050052|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050053|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
14050054|NCT02672527|Hormones|hormones|mesh-ancestor
14050055|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050056|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050057|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050058|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050059|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
14050060|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050061|NCT02672566|Enoxaparin|enoxaparin|mesh-list
14050062|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
14050063|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14050064|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14050065|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050066|NCT02672488|Metformin|metformin|mesh-list
14050067|NCT02672488|Sorafenib|sorafenib|mesh-list
14050068|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14050069|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050070|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050071|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14050072|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183043|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
14757189|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
14757190|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757191|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14050073|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050074|NCT02672475|Paclitaxel|paclitaxel|mesh-list
14050075|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14050076|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14050077|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050078|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
14050079|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
14050080|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
14050081|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050082|NCT02672345|Sevoflurane|sevoflurane|mesh-list
14050083|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14050084|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14050085|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
14050086|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
14050087|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050088|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050089|NCT02672358|Trametinib|trametinib|mesh-list
14050090|NCT02672358|Dabrafenib|dabrafenib|mesh-list
14050091|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050092|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14050093|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050094|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050095|NCT02672202|Pregabalin|pregabalin|mesh-list
14050096|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14050097|NCT02672202|Analgesics|analgesics|mesh-ancestor
14050098|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
14050099|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050100|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050101|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
14050102|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14050103|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050104|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050105|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14050106|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14050107|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14050108|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050109|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14050110|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14050111|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14050112|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14050113|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
14050114|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
14050115|NCT02672241|Temozolomide|temozolomide|mesh-list
14050116|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
14050117|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050118|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
14050119|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050120|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050121|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14050122|NCT02672098|Carboplatin|carboplatin|mesh-list
14050123|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050124|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14050125|NCT02671864|Incretins|incretins|mesh-list
14050126|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050127|NCT02671864|Hormones|hormones|mesh-ancestor
14050128|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170603|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170604|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
14170605|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14170606|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14170607|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14170608|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
14170609|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14170610|NCT04831047|Protective Agents|protective agents|mesh-ancestor
14170611|NCT04831255|Triamcinolone|triamcinolone|mesh-list
14170612|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14170613|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14170614|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14170615|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170616|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
14170617|NCT04831255|Hormones|hormones|mesh-ancestor
14170618|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475383|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
14767236|NCT00629278|Doxorubicin|doxorubicin|mesh-list
14050129|NCT02671851|Acetaminophen|acetaminophen|mesh-list
14050130|NCT02671851|Dipyrone|dipyrone|mesh-list
14050131|NCT02671851|Fentanyl|fentanyl|mesh-list
14050132|NCT02671851|Tramadol|tramadol|mesh-list
14050133|NCT02671851|Bupivacaine|bupivacaine|mesh-list
14050134|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
14050135|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
14050136|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050137|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050138|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
14050139|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050140|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14050141|NCT02671851|Narcotics|narcotics|mesh-ancestor
14050142|NCT02671851|Analgesics|analgesics|mesh-ancestor
14050143|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14050144|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14050145|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
14050146|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14050147|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
14050148|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14050149|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050150|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050151|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
14050152|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14050153|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
14050154|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
14050155|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050156|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050157|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14050158|NCT02671578|Analgesics|analgesics|mesh-ancestor
14050159|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
14050160|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050161|NCT02671695|Amlodipine|amlodipine|mesh-list
14050162|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14050163|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14050164|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050165|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050166|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14050167|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050168|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
14050169|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
14050170|NCT02671708|Busulfan|busulfan|mesh-list
14050171|NCT02671708|Idarubicin|idarubicin|mesh-list
14050172|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050173|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
14050174|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050175|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050176|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050177|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
14050178|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050179|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050180|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14050181|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14050182|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14050183|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14050184|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050185|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
14050186|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14050187|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
14050188|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050189|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
14050190|NCT02671565|Protective Agents|protective agents|mesh-ancestor
14050191|NCT02671383|Lopinavir|lopinavir|mesh-list
14050192|NCT02671383|Darunavir|darunavir|mesh-list
14050193|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14050194|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14050195|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
14050196|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050197|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050198|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14050199|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14050200|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
14050201|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050202|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14050203|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14475384|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050204|NCT02671318|Sirolimus|sirolimus|mesh-list
14050205|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14050206|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050207|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14050208|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050209|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
14050210|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050211|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
14050212|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050213|NCT02671227|Bupivacaine|bupivacaine|mesh-list
14050214|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
14050215|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
14050216|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050217|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050218|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
14050219|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050220|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
14050221|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14050222|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14050223|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14050224|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050225|NCT02671084|Sevoflurane|sevoflurane|mesh-list
14475385|NCT02397837|Pramipexole|pramipexole|mesh-list
14475386|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
14475387|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475388|NCT02397837|Protective Agents|protective agents|mesh-ancestor
14475389|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475390|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14050226|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14050227|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14050228|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
14050229|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
14050230|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050231|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050232|NCT02671175|Piperaquine|piperaquine|mesh-list
14050233|NCT02671175|Artenimol|artenimol|mesh-list
14050234|NCT02671175|Artemisinins|artemisinins|mesh-list
14050235|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
14050236|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14050237|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14050238|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050239|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14050240|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14050241|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14050242|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
14050243|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050244|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14050245|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14050246|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050247|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
14050248|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
14050249|NCT02670954|Tramadol|tramadol|mesh-list
14050250|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14050251|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050252|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050253|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14050254|NCT02670954|Analgesics|analgesics|mesh-ancestor
14050255|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
14050256|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050257|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14050258|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14050259|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14050260|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
14050261|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14050262|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050263|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14050264|NCT02670954|Narcotics|narcotics|mesh-ancestor
14050265|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14050266|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050267|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050268|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14050269|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050270|NCT02670707|Cytarabine|cytarabine|mesh-list
14050271|NCT02670707|Prednisone|prednisone|mesh-list
14050272|NCT02670707|Vinblastine|vinblastine|mesh-list
14050273|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050274|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
14050275|NCT02670707|Hormones|hormones|mesh-ancestor
14050276|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050277|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050278|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050279|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050280|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14050281|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
14050282|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050283|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
14050284|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050285|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050286|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
14050287|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14050288|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
14050289|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14050290|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14050291|NCT02670564|Busulfan|busulfan|mesh-list
14050292|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
14050293|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050294|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050295|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
14050296|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050297|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050298|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050299|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14050300|NCT02670655|Lidocaine|lidocaine|mesh-list
14050301|NCT02670655|Prilocaine|prilocaine|mesh-list
14050302|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14050303|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
14050304|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
14050305|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050306|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050307|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
14050308|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050309|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14050310|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14050311|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14050312|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050313|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050314|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14050315|NCT02670759|Bupivacaine|bupivacaine|mesh-list
14050316|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
14050317|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
14050318|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050319|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050320|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
14050321|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050322|NCT02670785|Estradiol|estradiol|mesh-list
14050323|NCT02670785|Estrogens|estrogens|mesh-ancestor
14050324|NCT02670785|Hormones|hormones|mesh-ancestor
14050325|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050326|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050327|NCT02670616|Prednisolone|prednisolone|mesh-list
14050328|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
14050329|NCT02670616|Rituximab|rituximab|mesh-list
14050330|NCT02670616|Doxorubicin|doxorubicin|mesh-list
14050331|NCT02670616|Vincristine|vincristine|mesh-list
14050332|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050333|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
14050334|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050335|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050336|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050337|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
14933554|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933555|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912799|NCT03492580|Canagliflozin|canagliflozin|mesh-list
13912800|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
13912801|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13912802|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
13912803|NCT03492580|Glucagon|glucagon|mesh-list
13912804|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13912805|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912806|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13912807|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050338|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050339|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050340|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14050341|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14050342|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14050343|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14050344|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14050345|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050346|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14050347|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
14050348|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
14050349|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
14050350|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050351|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
14050352|NCT02670616|Hormones|hormones|mesh-ancestor
14050353|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050354|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050355|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14050356|NCT02670772|Tenofovir|tenofovir|mesh-list
14050357|NCT02670772|Stavudine|stavudine|mesh-list
14050358|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
14050359|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050360|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14050361|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14050362|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050363|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050364|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14050365|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14050366|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
14050367|NCT02670642|Esomeprazole|esomeprazole|mesh-list
14050368|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14050369|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050370|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14050371|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933556|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14933557|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
14933558|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933559|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050372|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050373|NCT02670317|Prednisone|prednisone|mesh-list
14050374|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
14050375|NCT02670317|Doxorubicin|doxorubicin|mesh-list
14050376|NCT02670317|Vincristine|vincristine|mesh-list
14050377|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
14050378|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050379|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
14050380|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050381|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050382|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050383|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
14050384|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050385|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050386|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14050387|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14050388|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14050389|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14050390|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050391|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050392|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
14050393|NCT02670317|Hormones|hormones|mesh-ancestor
14050394|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050395|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050396|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14050397|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
14050398|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
14050399|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
14050400|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14050401|NCT02670434|Pitavastatin|pitavastatin|mesh-list
14050402|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14050403|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14050404|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14050405|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
14767237|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14933560|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14050406|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050407|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050408|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14050409|NCT02670304|Aspirin|aspirin|mesh-list
14050410|NCT02670304|Letrozole|letrozole|mesh-list
14050411|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14050412|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14050413|NCT02670304|Analgesics|analgesics|mesh-ancestor
14050414|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
14050415|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050416|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050417|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050418|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050419|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14050420|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14050421|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050422|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14050423|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14050424|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050425|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
14050426|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050427|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14050428|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14050429|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14050430|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
14050431|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050432|NCT02670018|Metformin|metformin|mesh-list
14050433|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14050434|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170619|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170620|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170621|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
14170622|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170623|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170624|NCT04831294|Cannabidiol|cannabidiol|mesh-list
14170625|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
14170626|NCT04830982|Diazoxide|diazoxide|mesh-list
14170627|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14170628|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
14170629|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
14170630|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14170631|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14170632|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170633|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
14170634|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14170635|NCT04830878|Methotrexate|methotrexate|mesh-list
14170636|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14170637|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
14170638|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14170639|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170640|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14170641|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
14170642|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170643|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170644|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
14170645|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170646|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14170647|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170648|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
14170649|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170650|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14183044|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183045|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183046|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14183047|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14183048|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
14183049|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14183050|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14183051|NCT04730622|Mitogens|mitogens|mesh-list
14183052|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14183053|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183054|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
14183055|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14183056|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050435|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14050436|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14050437|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14050438|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
14050439|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050440|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14050441|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14050442|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050443|NCT02670096|Acetazolamide|acetazolamide|mesh-list
14050444|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
14050445|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14050446|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050447|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050448|NCT02670096|Diuretics|diuretics|mesh-ancestor
14050449|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
14050450|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050451|NCT02670135|Triclosan|triclosan|mesh-list
14050452|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14050453|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050454|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14050455|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14050456|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
14050457|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050458|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14050459|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
14050460|NCT02670109|Busulfan|busulfan|mesh-list
14050461|NCT02670109|Carmustine|carmustine|mesh-list
14757192|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757193|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
14757194|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14757195|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14757196|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757197|NCT00467142|Antidotes|antidotes|mesh-ancestor
14757198|NCT00467142|Protective Agents|protective agents|mesh-ancestor
14757199|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
14757200|NCT00467142|Vitamins|vitamins|mesh-ancestor
14757201|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
14757202|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14757203|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14757204|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14757205|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757206|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933561|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14050462|NCT02670109|Carboplatin|carboplatin|mesh-list
14050463|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050464|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
14050465|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050466|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050467|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050468|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
14050469|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050470|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050471|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14050472|NCT02669953|Aflibercept|aflibercept|mesh-list
14050473|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14050474|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14050475|NCT02669953|Growth Substances|growth substances|mesh-ancestor
14050476|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050477|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
14050478|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050479|NCT02669901|Naloxone|naloxone|mesh-list
14050480|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14050481|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050482|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
14050483|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050484|NCT02669719|Carboplatin|carboplatin|mesh-list
14050485|NCT02669719|Pemetrexed|pemetrexed|mesh-list
14050486|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933562|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050487|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050488|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050489|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14050490|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14050491|NCT02669732|Firuglipel|firuglipel|mesh-list
14050492|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14050493|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050494|NCT02669706|Pentamidine|pentamidine|mesh-list
14050495|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
14050496|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050497|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14050498|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14050499|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14050500|NCT02669641|Choline|choline|mesh-list
14050501|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
14050502|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14050503|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
14050504|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050505|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050506|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14050507|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
14050508|NCT02669589|Heparin|heparin|mesh-list
14050509|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
14050510|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050511|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14050512|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14050513|NCT02669459|Imiquimod|imiquimod|mesh-list
14050514|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14050515|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
14050516|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050517|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050518|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
14050519|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
14050520|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14050521|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14050522|NCT02669303|Prednisolone|prednisolone|mesh-list
14050523|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
14050524|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14050525|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
14050526|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050527|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
14050528|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
14050529|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050530|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050531|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050532|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
14050533|NCT02669303|Hormones|hormones|mesh-ancestor
14050534|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050535|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14050536|NCT02669303|Protective Agents|protective agents|mesh-ancestor
14050537|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050538|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050539|NCT02669238|Etonogestrel|etonogestrel|mesh-list
14050540|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14050541|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
14050542|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14050543|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050544|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14050545|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14050546|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
14050547|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14050548|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
14050549|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050550|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
14050551|NCT02669368|Rocuronium|rocuronium|mesh-list
14050552|NCT02669368|Analgesics|analgesics|mesh-ancestor
14050553|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
14050554|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050555|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050556|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
14050557|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050558|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14050559|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
14050560|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14050561|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050562|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050563|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14050564|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
14050565|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14050566|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14050567|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14050568|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14050569|NCT02669030|Suvorexant|suvorexant|mesh-list
14050570|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14050571|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14050572|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050573|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050574|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14050575|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14050576|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050577|NCT02669004|Morphine|morphine|mesh-list
14050578|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14050579|NCT02669004|Narcotics|narcotics|mesh-ancestor
14475391|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14475392|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
14475393|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
14475394|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475395|NCT02397889|Midazolam|midazolam|mesh-list
14050580|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050581|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050582|NCT02669004|Analgesics|analgesics|mesh-ancestor
14050583|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
14050584|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050585|NCT02668666|Tamoxifen|tamoxifen|mesh-list
14050586|NCT02668666|Palbociclib|palbociclib|mesh-list
14050587|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14050588|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
14050589|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050590|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050591|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050592|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050593|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14050594|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14050595|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14050596|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14050597|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050598|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050599|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14050600|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14050601|NCT02668796|Estradiol|estradiol|mesh-list
14050602|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14050603|NCT02668796|Estrogens|estrogens|mesh-ancestor
14050604|NCT02668796|Hormones|hormones|mesh-ancestor
14050605|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050606|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050607|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14050608|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
14050609|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14050610|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14050611|NCT02668861|Vitamin D|vitamin d|mesh-list
14050612|NCT02668861|Budesonide|budesonide|mesh-list
14050613|NCT02668861|Vitamins|vitamins|mesh-ancestor
14050614|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
14050615|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050616|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14050617|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050618|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14050619|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
14050620|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050621|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14050622|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
14050623|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
14050624|NCT02668861|Hormones|hormones|mesh-ancestor
14475396|NCT02397889|Ketamine|ketamine|mesh-list
14933563|NCT01451515|Cytarabine|cytarabine|mesh-list
14475397|NCT02397889|Analgesics|analgesics|mesh-ancestor
14050625|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050626|NCT02668926|Amphetamine|amphetamine|mesh-list
14050627|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14050628|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
14050629|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14050630|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050631|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
14050632|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
14050633|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050634|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
14050635|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14050636|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050637|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
14050638|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14050639|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14050640|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050641|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14050642|NCT02668679|Hormones|hormones|mesh-list
14050643|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050644|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050645|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14050646|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14050647|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050648|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
14050649|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14050650|NCT02668536|Protective Agents|protective agents|mesh-ancestor
14050651|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050652|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14050653|NCT02668289|Anesthetics|anesthetics|mesh-list
14050654|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050655|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170651|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
14170652|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14170653|NCT04830943|Protective Agents|protective agents|mesh-ancestor
14170654|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170655|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
14170656|NCT04830813|Chiauranib|chiauranib|mesh-list
14170657|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170658|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170659|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170660|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170661|NCT04830579|Etoricoxib|etoricoxib|mesh-list
14170662|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14170663|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14170664|NCT04830579|Analgesics|analgesics|mesh-ancestor
14170665|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
14170666|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170667|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170668|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170669|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170670|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14170671|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14170672|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170673|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170674|NCT04830462|Rifampin|rifampin|mesh-list
14170675|NCT04830462|Isoniazid|isoniazid|mesh-list
14170676|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14170677|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
14170678|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14170679|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170680|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
14170681|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14170682|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170683|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170684|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14170685|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14170686|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14170687|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14170688|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14170689|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14170690|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14475398|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
14475399|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475400|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475401|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14475402|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14475403|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
14475404|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
14475405|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475406|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14757207|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757208|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757209|NCT00071708|Analgesics|analgesics|mesh-ancestor
14050656|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
14050657|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14050658|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14757210|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
14757211|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757212|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
14757213|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14757214|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
14050659|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14050660|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14050661|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050662|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050663|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
14050664|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14050665|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050666|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14050667|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050668|NCT02668588|Octreotide|octreotide|mesh-list
14050669|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050670|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050671|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050672|NCT02667886|Axitinib|axitinib|mesh-list
14050673|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050674|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14050675|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050676|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050677|NCT02668016|Atorvastatin|atorvastatin|mesh-list
14050678|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14050679|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14050680|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14050681|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
14050682|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050683|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14050684|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050685|NCT02668159|Vitamin D|vitamin d|mesh-list
14050686|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
14050687|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
14050688|NCT02668159|Vitamins|vitamins|mesh-list
14050689|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
14050690|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050691|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14050692|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14050693|NCT02668172|Pasireotide|pasireotide|mesh-list
14050694|NCT02668172|Hormones|hormones|mesh-ancestor
14050695|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050696|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050697|NCT02667925|Cisplatin|cisplatin|mesh-list
14050698|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050699|NCT02668094|Lidocaine|lidocaine|mesh-list
14050700|NCT02668094|Pregabalin|pregabalin|mesh-list
14050701|NCT02668094|Propofol|propofol|mesh-list
14050702|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
14050703|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
14050704|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050705|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050706|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
14050707|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050708|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14050709|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14050710|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14757215|NCT05342636|Paclitaxel|paclitaxel|mesh-list
14757216|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
14933564|NCT01451515|Dexamethasone|dexamethasone|mesh-list
14933565|NCT01451515|Prednisone|prednisone|mesh-list
14475407|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14475408|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475409|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475410|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14475411|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14475412|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14475413|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14475414|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475415|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
14475416|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
14475417|NCT02397954|Ranibizumab|ranibizumab|mesh-list
13912808|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050711|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050712|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050713|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14050714|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14050715|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
14050716|NCT02668094|Analgesics|analgesics|mesh-ancestor
14050717|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
14050718|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14050719|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14050720|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14050721|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14050722|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14050723|NCT02667730|Acetaminophen|acetaminophen|mesh-list
14050724|NCT02667730|Celecoxib|celecoxib|mesh-list
14050725|NCT02667730|Naproxen|naproxen|mesh-list
14050726|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14050727|NCT02667730|Analgesics|analgesics|mesh-ancestor
14050728|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
14050729|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050730|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050731|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
14050732|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14050733|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050734|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050735|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14050736|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14050737|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050738|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050739|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
14050740|NCT02667743|Paclitaxel|paclitaxel|mesh-list
14050741|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14050742|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14050743|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050744|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
14050745|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
14050746|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
14050747|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050748|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
14050749|NCT02667561|Testosterone|testosterone|mesh-list
13912809|NCT03492580|Hormones|hormones|mesh-ancestor
13912810|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13912811|NCT03492580|Incretins|incretins|mesh-ancestor
13912812|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
13912813|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912814|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13912815|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13912816|NCT03492489|Cemiplimab|cemiplimab|mesh-list
13912817|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912818|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912819|NCT03492463|Nicotine|nicotine|mesh-list
13912820|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13912821|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
13912822|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912823|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912824|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13912825|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13912826|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
13912827|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912828|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912829|NCT03492437|Tepotinib|tepotinib|mesh-list
13912830|NCT03492437|Dabigatran|dabigatran|mesh-list
13912831|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
14475418|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14475419|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14050750|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
14050751|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
14050752|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14050753|NCT02667561|Androgens|androgens|mesh-ancestor
14050754|NCT02667561|Hormones|hormones|mesh-ancestor
14050755|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050756|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050757|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050758|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050759|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
14050760|NCT02667535|Isosorbide|isosorbide|mesh-list
14050761|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14050762|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14050763|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14050764|NCT02667535|Diuretics|diuretics|mesh-ancestor
14050765|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
14050766|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050767|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
14050768|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14757217|NCT05342636|Irinotecan|irinotecan|mesh-list
14757218|NCT05342636|Lenvatinib|lenvatinib|mesh-list
14050769|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050770|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
14050771|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14050772|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14050773|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
14050774|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14050775|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050776|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050777|NCT02667470|Urological Agents|urological agents|mesh-ancestor
14050778|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
14050779|NCT02667197|Narcotics|narcotics|mesh-ancestor
14050780|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050781|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050782|NCT02667197|Analgesics|analgesics|mesh-ancestor
14050783|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
14050784|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050785|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
14050786|NCT02667262|Narcotics|narcotics|mesh-ancestor
14050787|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050788|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757219|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
14757220|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14757221|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757222|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
14757223|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
14757224|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
14757225|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757226|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14757227|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14757228|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14050789|NCT02667262|Analgesics|analgesics|mesh-ancestor
14050790|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
14170691|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14933566|NCT01451515|Prednisolone|prednisolone|mesh-list
14933567|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
14933568|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
14933569|NCT01451515|Doxorubicin|doxorubicin|mesh-list
14933570|NCT01451515|Methotrexate|methotrexate|mesh-list
14933571|NCT01451515|Etoposide|etoposide|mesh-list
14933572|NCT01451515|Vincristine|vincristine|mesh-list
14933573|NCT01451515|Daunorubicin|daunorubicin|mesh-list
14933574|NCT01451515|Asparaginase|asparaginase|mesh-list
14050791|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050792|NCT02667223|Bococizumab|bococizumab|mesh-list
14050793|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14050794|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14050795|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
14050796|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050797|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14050798|NCT02667353|Anesthetics|anesthetics|mesh-list
14050799|NCT02667353|Etomidate|etomidate|mesh-list
14050800|NCT02667353|Succinylcholine|succinylcholine|mesh-list
14050801|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050802|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050803|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14050804|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14050805|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
14050806|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14050807|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14050808|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14050809|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050810|NCT02667496|Sargramostim|sargramostim|mesh-list
14050811|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
14050812|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050813|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
14050814|NCT02666898|Fludarabine|fludarabine|mesh-list
14050815|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
14050816|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14050817|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
14050818|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050819|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14050820|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14050821|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
14050822|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050823|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050824|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14050825|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14050826|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
14050827|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14050828|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14050829|NCT02666703|Prednisolone|prednisolone|mesh-list
14050830|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
14050831|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14050832|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
14050833|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050834|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
14050835|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
14050836|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050837|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050838|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050839|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
14050840|NCT02666703|Hormones|hormones|mesh-ancestor
14050841|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050842|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14050843|NCT02666703|Protective Agents|protective agents|mesh-ancestor
14050844|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050845|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050846|NCT02667054|Anesthetics|anesthetics|mesh-list
14050847|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
14050848|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050849|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050850|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
14050851|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050852|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14050853|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14933575|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
14050854|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933576|NCT01451515|Clofarabine|clofarabine|mesh-list
14933577|NCT01451515|Pegaspargase|pegaspargase|mesh-list
14933578|NCT01451515|Thioguanine|thioguanine|mesh-list
14933579|NCT01451515|Antimetabolites|antimetabolites|mesh-list
14050855|NCT02666716|Fluconazole|fluconazole|mesh-list
14050856|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
14050857|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050858|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14050859|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14050860|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050861|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050862|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14050863|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
14050864|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050865|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050866|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14050867|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14170692|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
14170693|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14170694|NCT04831099|Testosterone|testosterone|mesh-list
14170695|NCT04831099|Androgens|androgens|mesh-ancestor
14170696|NCT04831099|Hormones|hormones|mesh-ancestor
14170697|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170698|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170699|NCT04831229|Menthol|menthol|mesh-list
14170700|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
14170701|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
14170702|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14170703|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
14170704|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170705|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
14170706|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14170707|NCT04830410|Levan|levan|mesh-list
14170708|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170709|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
14170710|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
14170711|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170712|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170713|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170714|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
14170715|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
14170716|NCT04829799|Ketorolac|ketorolac|mesh-list
14170717|NCT04829799|Lidocaine|lidocaine|mesh-list
14170718|NCT04829799|Phenylephrine|phenylephrine|mesh-list
14170719|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
14170720|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
14170721|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
14170722|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170723|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170724|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
14170725|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170726|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14170727|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14170728|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14170729|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170730|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170731|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14170732|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14170733|NCT04829799|Analgesics|analgesics|mesh-ancestor
14170734|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170735|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170736|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14170737|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170738|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14170739|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
14170740|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
14170741|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
14170742|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14170743|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
14170744|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14170745|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14170746|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14170747|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14170748|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170749|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170750|NCT04829799|Protective Agents|protective agents|mesh-ancestor
14933580|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14170751|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14170752|NCT04829773|Midazolam|midazolam|mesh-list
14050868|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14050869|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14050870|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050871|NCT02666768|Interferons|interferons|mesh-list
14050872|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
14050873|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050874|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
14050875|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050876|NCT02666651|Tolvaptan|tolvaptan|mesh-list
14050877|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14050878|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050879|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
14050880|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050881|NCT02666534|Lidocaine|lidocaine|mesh-list
14050882|NCT02666534|Prilocaine|prilocaine|mesh-list
14050883|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14050884|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14050885|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14050886|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
14050887|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
14050888|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050889|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050890|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
14050891|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050892|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14050893|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14050894|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14050895|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14050896|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050897|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14050898|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
14050899|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14050900|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
14050901|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
14050902|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050903|NCT02666170|Protective Agents|protective agents|mesh-ancestor
14050904|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050905|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
14050906|NCT02666170|Vitamins|vitamins|mesh-ancestor
14050907|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
14050908|NCT02666209|Dexamethasone|dexamethasone|mesh-list
14050909|NCT02666209|Lenalidomide|lenalidomide|mesh-list
14050910|NCT02666209|Bortezomib|bortezomib|mesh-list
14050911|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050912|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
14050913|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
14050914|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050915|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050916|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050917|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
14050918|NCT02666209|Hormones|hormones|mesh-ancestor
14050919|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050920|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050921|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050922|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
14050923|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14050924|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14050925|NCT02666209|Growth Substances|growth substances|mesh-ancestor
14050926|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
14050927|NCT02666365|Cefazolin|cefazolin|mesh-list
14050928|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14050929|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050930|NCT02666443|Dexamethasone|dexamethasone|mesh-list
14050931|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
14050932|NCT02666443|BB 1101|bb 1101|mesh-list
14050933|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050934|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
14050935|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
14050936|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050937|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050938|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14050939|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
14050940|NCT02666443|Hormones|hormones|mesh-ancestor
14050941|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050942|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14050943|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14050944|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
14050945|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050946|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050947|NCT02666417|Iron|iron|mesh-list
14050948|NCT02666417|Trace Elements|trace elements|mesh-ancestor
14050949|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
14050950|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050951|NCT02666092|Antibodies|antibodies|mesh-list
14050952|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
14050953|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050954|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
14050955|NCT02666157|Apixaban|apixaban|mesh-list
14050956|NCT02666157|Dabigatran|dabigatran|mesh-list
14050957|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14050958|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
14050959|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14050960|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
14050961|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14050962|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050963|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
14050964|NCT02666053|Fostemsavir|fostemsavir|mesh-list
14050965|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14050966|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14050967|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
14050968|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14050969|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14050970|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14050971|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14050972|NCT02666040|Anesthetics|anesthetics|mesh-list
14050973|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050974|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050975|NCT02665806|Fluticasone|fluticasone|mesh-list
14050976|NCT02665806|Ciclesonide|ciclesonide|mesh-list
14050977|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14050978|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14050979|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
14050980|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14050981|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050982|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14050983|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
14050984|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
14050985|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14050986|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
14050987|NCT02665806|Hormones|hormones|mesh-ancestor
14050988|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14050989|NCT02666001|Fostemsavir|fostemsavir|mesh-list
14050990|NCT02666001|Buprenorphine|buprenorphine|mesh-list
14050991|NCT02666001|Methadone|methadone|mesh-list
14050992|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14050993|NCT02666001|Narcotics|narcotics|mesh-ancestor
14050994|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14050995|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14050996|NCT02666001|Analgesics|analgesics|mesh-ancestor
14050997|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
14050998|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933581|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
14933582|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933583|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933584|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14933585|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
14050999|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14051000|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
14051001|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
14051002|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14051003|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14051004|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
14051005|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051006|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14051007|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14051008|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051009|NCT02665936|Dexamethasone|dexamethasone|mesh-list
14051010|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
14051011|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
14051012|NCT02665936|BB 1101|bb 1101|mesh-list
14051013|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051014|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
14051015|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
14051016|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051017|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051018|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051019|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
14051020|NCT02665936|Hormones|hormones|mesh-ancestor
14051021|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051022|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051023|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051024|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
14051025|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051026|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051027|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
14051028|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
14051029|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051030|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
14051031|NCT02665871|Vaccines|vaccines|mesh-list
14051032|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
14051033|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051034|NCT02665845|Mesalamine|mesalamine|mesh-list
14051035|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14051036|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051037|NCT02665845|Analgesics|analgesics|mesh-ancestor
14051038|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
14051039|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051040|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051041|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051042|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051043|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
14051044|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14051045|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051046|NCT02665832|Amlodipine|amlodipine|mesh-list
14051047|NCT02665832|Olmesartan|olmesartan|mesh-list
14051048|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14051049|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14051050|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14051051|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14051052|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051053|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14051054|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051055|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
14051056|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14051057|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14051058|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
14051059|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14051060|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14051061|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051062|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14051063|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14051064|NCT02666014|Neostigmine|neostigmine|mesh-list
14051065|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14051066|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051067|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051068|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
14051069|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051070|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051071|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14051072|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
14051073|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051074|NCT02665702|Cisplatin|cisplatin|mesh-list
14051075|NCT02665702|Vinorelbine|vinorelbine|mesh-list
14051076|NCT02665702|Endostar protein|endostar protein|mesh-list
14051077|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051078|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14051079|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
14051080|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14051081|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14051082|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051083|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14051084|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14051085|NCT02665702|Growth Substances|growth substances|mesh-ancestor
14051086|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051087|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
14051088|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
14051089|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051090|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051091|NCT02665637|Trastuzumab|trastuzumab|mesh-list
14051092|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051093|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051094|NCT02665533|Dexamethasone|dexamethasone|mesh-list
14051095|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
14051096|NCT02665533|Diclofenac|diclofenac|mesh-list
14051097|NCT02665533|Codeine|codeine|mesh-list
14051098|NCT02665533|BB 1101|bb 1101|mesh-list
14051099|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051100|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
14051101|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
14051102|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051103|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051104|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475420|NCT02397954|Growth Substances|growth substances|mesh-ancestor
14475421|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475422|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
14475423|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051105|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
14051106|NCT02665533|Hormones|hormones|mesh-ancestor
14051107|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051108|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051109|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051110|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
14051111|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051112|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051113|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14051114|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051115|NCT02665533|Analgesics|analgesics|mesh-ancestor
14051116|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
14051117|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051118|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14051119|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14051120|NCT02665533|Narcotics|narcotics|mesh-ancestor
14051121|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051122|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
14051123|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
14051124|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
14051125|NCT02665624|Sennosides|sennosides|mesh-list
14051126|NCT02665624|Senna Extract|senna extract|mesh-list
14051127|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14051128|NCT02665624|Calcium|calcium|mesh-list
14051129|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14051130|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051131|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14051132|NCT02665624|Laxatives|laxatives|mesh-ancestor
14051133|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051134|NCT02665624|Cathartics|cathartics|mesh-ancestor
14051135|NCT02665351|Peramivir|peramivir|mesh-list
14051136|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
14051137|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051138|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051139|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051140|NCT02665416|Bevacizumab|bevacizumab|mesh-list
14051141|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051142|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051143|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14051144|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14051145|NCT02665416|Growth Substances|growth substances|mesh-ancestor
14051146|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051147|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
14051148|NCT02665208|Nicotine|nicotine|mesh-list
14051149|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14051150|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
14051151|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051152|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051153|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14051154|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14051155|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
14051156|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051157|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170753|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14170754|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14170755|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170756|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170757|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14051158|NCT02665039|Gemcitabine|gemcitabine|mesh-list
14051159|NCT02665039|Carboplatin|carboplatin|mesh-list
14051160|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051161|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14051162|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
14051163|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051164|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
14051165|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051166|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051167|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051168|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
14051169|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051170|NCT02664857|Vitamin D|vitamin d|mesh-list
14051171|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
14051172|NCT02664857|Vitamins|vitamins|mesh-list
14051173|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
14051174|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051175|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14051176|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14051177|NCT02664649|Apixaban|apixaban|mesh-list
14051178|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
14051179|NCT02664649|Anticoagulants|anticoagulants|mesh-list
14051180|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
14051181|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14051182|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
14051183|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051184|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051185|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
14051186|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14051187|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14051188|NCT02664493|Prednisolone|prednisolone|mesh-list
14051189|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
14051190|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14051191|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
14051192|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051193|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
14051194|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
14051195|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051196|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051197|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051198|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
14051199|NCT02664493|Hormones|hormones|mesh-ancestor
14051200|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051201|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14051202|NCT02664493|Protective Agents|protective agents|mesh-ancestor
14051203|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051204|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051205|NCT02664116|Diclofenac|diclofenac|mesh-list
14051206|NCT02664116|Ketorolac|ketorolac|mesh-list
14051207|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14051208|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14051209|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051210|NCT02664116|Analgesics|analgesics|mesh-ancestor
14051211|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
14051212|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051213|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051214|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051215|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051216|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14051217|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051218|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051219|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
14051220|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14051221|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
14051222|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051223|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051224|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14051225|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14051226|NCT02664441|Exenatide|exenatide|mesh-list
14051227|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14051228|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051229|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14051230|NCT02664441|Incretins|incretins|mesh-ancestor
14051231|NCT02664441|Hormones|hormones|mesh-ancestor
14051232|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051233|NCT02664142|Anesthetics|anesthetics|mesh-list
14170758|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14051234|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051235|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051236|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14051237|NCT02664168|Laxatives|laxatives|mesh-ancestor
14051238|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051239|NCT02663960|Citric Acid|citric acid|mesh-list
14051240|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
14051241|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
14051242|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14051243|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
14051244|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
14051245|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051246|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
14051247|NCT02664103|Capecitabine|capecitabine|mesh-list
14051248|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051249|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
14051250|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051251|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051252|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14051253|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
14051254|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051255|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051256|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14051257|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14051258|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
14051259|NCT02663999|Diazepam|diazepam|mesh-list
14051260|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14051261|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
14051262|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
14051263|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
14051264|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051265|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051266|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051267|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14051268|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051269|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14051270|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14051271|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14051272|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14051273|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14051274|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14051275|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
14051276|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
14051277|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
14051278|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
14051279|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051280|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051281|NCT02664012|Menthol|menthol|mesh-list
14051282|NCT02664012|Nicotine|nicotine|mesh-list
14051283|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14051284|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
14051285|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051286|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051287|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14051288|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14051289|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
14051290|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051291|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051292|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
14051293|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
14051294|NCT02663713|Clopidogrel|clopidogrel|mesh-list
14051295|NCT02663713|Ticagrelor|ticagrelor|mesh-list
14051296|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14051297|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14051298|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14051299|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14051300|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
14051301|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051302|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051303|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051304|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
14051305|NCT02663830|Clomiphene|clomiphene|mesh-list
14051306|NCT02663830|Enclomiphene|enclomiphene|mesh-list
14475424|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14051307|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
14051308|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051309|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
14051310|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14051311|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14051312|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051313|NCT02663830|Urological Agents|urological agents|mesh-ancestor
14051314|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14051315|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
14051316|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051317|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051318|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14051319|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
14051320|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14051321|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14051322|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14051323|NCT02663700|Artesunate|artesunate|mesh-list
14051324|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
14051325|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14051326|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14051327|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051328|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051329|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
14051330|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
14051331|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14051332|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
14051333|NCT02663596|Vancomycin|vancomycin|mesh-list
14051334|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14051335|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051336|NCT02663570|Melatonin|melatonin|mesh-list
14051337|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
14051338|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051339|NCT02663570|Protective Agents|protective agents|mesh-ancestor
14051340|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051341|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051342|NCT02663440|Temozolomide|temozolomide|mesh-list
14051343|NCT02663440|Molgramostim|molgramostim|mesh-list
14051344|NCT02663440|Sargramostim|sargramostim|mesh-list
14051345|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14051346|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
14051347|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051348|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051349|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
14051350|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051351|NCT02663323|Sirolimus|sirolimus|mesh-list
14051352|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14051353|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051354|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14051355|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051356|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
14757229|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757230|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
14757231|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757232|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14757233|NCT05342597|Edaravone|edaravone|mesh-list
14757234|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14051357|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051358|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
14051359|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051360|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
14051361|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14051362|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14051363|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051364|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
14051365|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051366|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051367|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
14051368|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051369|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051370|NCT02663284|Ropivacaine|ropivacaine|mesh-list
14051371|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
14051372|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
14051373|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051374|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051375|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
14051376|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051377|NCT02663141|Bevacizumab|bevacizumab|mesh-list
14051378|NCT02663141|Losartan|losartan|mesh-list
14051379|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051380|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051381|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14051382|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14051383|NCT02663141|Growth Substances|growth substances|mesh-ancestor
14051384|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051385|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
14051386|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14051387|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14051388|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14051389|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14051390|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170759|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14170760|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14170761|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
14170762|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
14170763|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
14170764|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
14170765|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170766|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170767|NCT04829760|Psyllium|psyllium|mesh-list
14170768|NCT04829760|Cathartics|cathartics|mesh-ancestor
14170769|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170770|NCT04829695|Artesunate|artesunate|mesh-list
14170771|NCT04829695|Lumefantrine|lumefantrine|mesh-list
14170772|NCT04829695|Artemether|artemether|mesh-list
14170773|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14170774|NCT04829695|Amodiaquine|amodiaquine|mesh-list
14170775|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
14170776|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14170777|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14170778|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170779|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170780|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
14170781|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
14170782|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14170783|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
14170784|NCT04829435|Rasburicase|rasburicase|mesh-list
14170785|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
14170786|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170787|NCT04829487|Vitamin D|vitamin d|mesh-list
14170788|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
14170789|NCT04829487|Vitamins|vitamins|mesh-ancestor
14170790|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
14170791|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170792|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14170793|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14170794|NCT04829344|Carticaine|carticaine|mesh-list
14170795|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
14170796|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
14170797|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170798|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170799|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
14170800|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170801|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
14170802|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14170803|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170804|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170805|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
14170806|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170807|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912832|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13912833|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
13912834|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912835|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912836|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
13912837|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912838|NCT03492385|Ticagrelor|ticagrelor|mesh-list
13912839|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13912840|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13912841|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13912842|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13912843|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
14170808|NCT04829097|Temozolomide|temozolomide|mesh-list
14170809|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14051391|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14051392|NCT02663050|Diclofenac|diclofenac|mesh-list
14051393|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14051394|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051395|NCT02663050|Analgesics|analgesics|mesh-ancestor
14051396|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
14051397|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051398|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051399|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051400|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051401|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14051402|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051403|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051404|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
14051405|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14051406|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14051407|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14051408|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14051409|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051410|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
14051411|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051412|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051413|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14051414|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051415|NCT02662959|Irinotecan|irinotecan|mesh-list
14051416|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14051417|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14051418|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051419|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051420|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051421|NCT02662894|Valsartan|valsartan|mesh-list
14051422|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14051423|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14051424|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14051425|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
14051426|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051427|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14051428|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14051429|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051430|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14051431|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14051432|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14051433|NCT02662855|Favipiravir|favipiravir|mesh-list
14051434|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
14051435|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051436|NCT02662647|Cytarabine|cytarabine|mesh-list
14051437|NCT02662647|Decitabine|decitabine|mesh-list
14051438|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
14051439|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912844|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13912845|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912846|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912847|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
13912848|NCT03492255|Prednisone|prednisone|mesh-list
13912849|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
13912850|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
13912851|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912852|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
13912853|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912854|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13912855|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13912856|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
14051440|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
14051441|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051442|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912857|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912858|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912859|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13912860|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912861|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
13912862|NCT03492255|Hormones|hormones|mesh-ancestor
13960000|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051443|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
14051444|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051445|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051446|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
14051447|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051448|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051449|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14051450|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14051451|NCT02662660|Acetaminophen|acetaminophen|mesh-list
14051452|NCT02662660|Dipyrone|dipyrone|mesh-list
14051453|NCT02662660|Bupivacaine|bupivacaine|mesh-list
14051454|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
14051455|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
14051456|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
14051457|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051458|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051459|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
14051460|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051461|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051462|NCT02662660|Analgesics|analgesics|mesh-ancestor
14051463|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
14051464|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14051465|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051466|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051467|NCT02662725|Ipilimumab|ipilimumab|mesh-list
14051468|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051469|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051470|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14051471|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051472|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
14051473|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14051474|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14051475|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14051476|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14051477|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051478|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
14051479|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051480|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051481|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14051482|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051483|NCT02662504|Cisplatin|cisplatin|mesh-list
14051484|NCT02662504|Pemetrexed|pemetrexed|mesh-list
14051485|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14051486|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051487|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051488|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051489|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14051490|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14051491|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
14051492|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14051493|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
14051494|NCT02662491|Vitamin D|vitamin d|mesh-list
14051495|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
14051496|NCT02662491|Vitamins|vitamins|mesh-list
14051497|NCT02662491|Calcium|calcium|mesh-list
14051498|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
14051499|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051500|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14051501|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14051502|NCT02662426|Oseltamivir|oseltamivir|mesh-list
14051503|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
14051504|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051505|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051506|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051507|NCT02662348|Aldesleukin|aldesleukin|mesh-list
14051508|NCT02662348|Interleukin-2|interleukin-2|mesh-list
14051509|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051510|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051511|NCT02662348|Analgesics|analgesics|mesh-ancestor
14051512|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
14051513|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051514|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051515|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14051516|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14051517|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
14051518|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051519|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14051520|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051521|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051522|NCT02662283|Acteoside|acteoside|mesh-list
14051523|NCT02662283|Prednisolone|prednisolone|mesh-list
14051524|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051525|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
14051526|NCT02662283|Hormones|hormones|mesh-ancestor
14051527|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051528|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051529|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051530|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051531|NCT02662283|Protective Agents|protective agents|mesh-ancestor
14051532|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051533|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14051534|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
14051535|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051536|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
14051537|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
14051538|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051539|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
14051540|NCT02662296|Idelalisib|idelalisib|mesh-list
14051541|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051542|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051543|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051544|NCT02662309|Atezolizumab|atezolizumab|mesh-list
14051545|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051546|NCT02662374|Nystatin|nystatin|mesh-list
14051547|NCT02662374|Calcium|calcium|mesh-list
14051548|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14051549|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051550|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757235|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
14757236|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757237|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14757238|NCT05342597|Protective Agents|protective agents|mesh-ancestor
14757239|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757240|NCT05342584|Cytarabine|cytarabine|mesh-list
14757241|NCT05342584|Daunorubicin|daunorubicin|mesh-list
14757242|NCT05342584|Venetoclax|venetoclax|mesh-list
14757243|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14051551|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051552|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
14051553|NCT02662374|Ionophores|ionophores|mesh-ancestor
14051554|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14051555|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051556|NCT02661932|Letrozole|letrozole|mesh-list
14051557|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051558|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14051559|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14051560|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051561|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051562|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14051563|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
14051564|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051565|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051566|NCT02661893|Rifampin|rifampin|mesh-list
14051567|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14051568|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
14051569|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14051570|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051571|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
14051572|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14051573|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051574|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051575|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14051576|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14051577|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14051578|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14051579|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14051580|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14051581|NCT02661711|Aflibercept|aflibercept|mesh-list
14051582|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14051583|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14051584|NCT02661711|Growth Substances|growth substances|mesh-ancestor
14757244|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
14051585|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051586|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
14051587|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051588|NCT02661789|Goserelin|goserelin|mesh-list
14757245|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051589|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051590|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051591|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
14051592|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
14051593|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051594|NCT02661373|Cobicistat|cobicistat|mesh-list
14051595|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14051596|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14051597|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
14051598|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051599|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14051600|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14051601|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051602|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051603|NCT02661503|Dexamethasone|dexamethasone|mesh-list
14051604|NCT02661503|Prednisone|prednisone|mesh-list
14051605|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
14051606|NCT02661503|Dacarbazine|dacarbazine|mesh-list
14051607|NCT02661503|Doxorubicin|doxorubicin|mesh-list
14051608|NCT02661503|Etoposide|etoposide|mesh-list
14051609|NCT02661503|Vincristine|vincristine|mesh-list
14051610|NCT02661503|Bleomycin|bleomycin|mesh-list
14051611|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14051612|NCT02661503|Procarbazine|procarbazine|mesh-list
14051613|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051614|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
14051615|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051616|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051617|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14051618|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
14051619|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051620|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051621|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14051622|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051623|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
14051624|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
14051625|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051626|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051627|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
14051628|NCT02661503|Hormones|hormones|mesh-ancestor
14051629|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051630|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051631|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14051632|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14051633|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14051634|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051635|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14051636|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
14051637|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
14051638|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
14051639|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170810|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
14170811|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170812|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170813|NCT04829019|Osimertinib|osimertinib|mesh-list
14170814|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170815|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14170816|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170817|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170818|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
14170819|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14170820|NCT04828824|Norgestimate|norgestimate|mesh-list
14170821|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14170822|NCT04828824|Estradiol|estradiol|mesh-list
14170823|NCT04828824|Estrogens|estrogens|mesh-ancestor
14170824|NCT04828824|Hormones|hormones|mesh-ancestor
14170825|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170826|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170827|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14170828|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
14051640|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
14051641|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14051642|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051643|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14051644|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14051645|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051646|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051647|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051648|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14051649|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14051650|NCT02661347|Risperidone|risperidone|mesh-list
14051651|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14051652|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
14051653|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051654|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051655|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051656|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14051657|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14051658|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051659|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14051660|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14051661|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
14051662|NCT02661477|Interferons|interferons|mesh-list
14051663|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
14051664|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
14051665|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051666|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
14051667|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051668|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
14051669|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051670|NCT02661152|Nimorazole|nimorazole|mesh-list
14051671|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14051672|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14051673|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14051674|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051675|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
14051676|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14051677|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051678|NCT02661191|Vitamins|vitamins|mesh-ancestor
14051679|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
14051680|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14051681|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
14051682|NCT02661100|Poly ICLC|poly iclc|mesh-list
14051683|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051684|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051685|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
14051686|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
14051687|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051688|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
14051689|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
14051690|NCT02661035|Fludarabine|fludarabine|mesh-list
14051691|NCT02661035|Allopurinol|allopurinol|mesh-list
14051692|NCT02661035|Tacrolimus|tacrolimus|mesh-list
14051693|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14051694|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051695|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
14051696|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051697|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051698|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14051699|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
14051700|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051701|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051702|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14051703|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
14051704|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14051705|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051706|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14051707|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14051708|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
14051709|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14051710|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051711|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
14051712|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14051713|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
14051714|NCT02661035|Protective Agents|protective agents|mesh-ancestor
14051715|NCT02660840|Flupenthixol|flupenthixol|mesh-list
14051716|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14051717|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14051718|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14051719|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051720|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051721|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14051722|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14051723|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
14051724|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051725|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051726|NCT02660905|Tenofovir|tenofovir|mesh-list
14051727|NCT02660905|Emtricitabine|emtricitabine|mesh-list
14051728|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
14051729|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14051730|NCT02660905|Rilpivirine|rilpivirine|mesh-list
14051731|NCT02660905|Ledipasvir|ledipasvir|mesh-list
14051732|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
14051733|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051734|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14051735|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14051736|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051737|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051738|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14051739|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14051740|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
14051741|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14051742|NCT02660736|Incretins|incretins|mesh-ancestor
14051743|NCT02660736|Hormones|hormones|mesh-ancestor
14051744|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051745|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051746|NCT02660866|Vorapaxar|vorapaxar|mesh-list
14051747|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14051748|NCT02660762|Cytarabine|cytarabine|mesh-list
14051749|NCT02660762|Dexamethasone|dexamethasone|mesh-list
14051750|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
14051751|NCT02660762|Prednisone|prednisone|mesh-list
14051752|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
14051753|NCT02660762|Methotrexate|methotrexate|mesh-list
14051754|NCT02660762|Etoposide|etoposide|mesh-list
14051755|NCT02660762|Vincristine|vincristine|mesh-list
14051756|NCT02660762|Daunorubicin|daunorubicin|mesh-list
14051757|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
14051758|NCT02660762|Pegaspargase|pegaspargase|mesh-list
14051759|NCT02660762|Thioguanine|thioguanine|mesh-list
14051760|NCT02660762|BB 1101|bb 1101|mesh-list
14051761|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051762|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
14051763|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051764|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051765|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14051766|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
14051767|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051768|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051769|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14051770|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051771|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
14051772|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
13912863|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13912864|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13912865|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13912866|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13912867|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
14757246|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757247|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
14757248|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757249|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757250|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
14757251|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757252|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14757253|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13912868|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912869|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912870|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912871|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
14051773|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051774|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051775|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
14051776|NCT02660762|Hormones|hormones|mesh-ancestor
14757254|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14757255|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757256|NCT05342558|Fluticasone|fluticasone|mesh-list
14757257|NCT05342558|Xhance|xhance|mesh-list
14757258|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051777|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051778|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051779|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
14051780|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051781|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14051782|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
14051783|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14051784|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14051785|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
14051786|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14051787|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14051788|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14051789|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14051790|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14051791|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14051792|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
14051793|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051794|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14051795|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14051796|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14051797|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14051798|NCT02660684|Cyclosporine|cyclosporine|mesh-list
14051799|NCT02660684|Methotrexate|methotrexate|mesh-list
14051800|NCT02660684|Tacrolimus|tacrolimus|mesh-list
14051801|NCT02660684|Cyclosporins|cyclosporins|mesh-list
14051802|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14051803|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
14051804|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14051805|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051806|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14051807|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
14051808|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051809|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051810|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
14051811|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051812|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14051813|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051814|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
14051815|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051816|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14051817|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14051818|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
14051819|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051820|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
14051821|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14051822|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051823|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051824|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051825|NCT02660658|Analgesics|analgesics|mesh-ancestor
14051826|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
14051827|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051828|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14051829|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14051830|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14051831|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
14051832|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051833|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051834|NCT02660502|Insulin|insulin|mesh-list
14051835|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14051836|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
14051837|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14051838|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051839|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
14051840|NCT02660606|Narcotics|narcotics|mesh-ancestor
14051841|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051842|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051843|NCT02660606|Analgesics|analgesics|mesh-ancestor
14051844|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
14051845|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051846|NCT02660346|Vancomycin|vancomycin|mesh-list
14933586|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051847|NCT02660346|Daptomycin|daptomycin|mesh-list
14051848|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14051849|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14051850|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051851|NCT02660255|Cannabidiol|cannabidiol|mesh-list
14051852|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
14051853|NCT02660177|Dipyrone|dipyrone|mesh-list
14051854|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14051855|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051856|NCT02660177|Analgesics|analgesics|mesh-ancestor
14051857|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
14051858|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051859|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051860|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051861|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051862|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
14051863|NCT02660008|Glucagon|glucagon|mesh-list
14051864|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14051865|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051866|NCT02660008|Hormones|hormones|mesh-ancestor
14051867|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051868|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051869|NCT02660008|Incretins|incretins|mesh-ancestor
14051870|NCT02660060|Pramipexole|pramipexole|mesh-list
14051871|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
14051872|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051873|NCT02660060|Protective Agents|protective agents|mesh-ancestor
14051874|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051875|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14051876|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14051877|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
14051878|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
14051879|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051880|NCT02660047|Liraglutide|liraglutide|mesh-list
14051881|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14051882|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051883|NCT02660047|Incretins|incretins|mesh-ancestor
14051884|NCT02660047|Hormones|hormones|mesh-ancestor
14051885|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051886|NCT02659683|Esomeprazole|esomeprazole|mesh-list
14051887|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14051888|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051889|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14051890|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051891|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051892|NCT02659761|Lamivudine|lamivudine|mesh-list
14051893|NCT02659761|Abacavir|abacavir|mesh-list
14051894|NCT02659761|Dolutegravir|dolutegravir|mesh-list
14051895|NCT02659761|Triumeq|triumeq|mesh-list
14051896|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14051897|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14051898|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051899|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051900|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
14051901|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051902|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14051903|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14051904|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14051905|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14051906|NCT02659917|Methamphetamine|methamphetamine|mesh-list
14051907|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14051908|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051909|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
14051910|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
14051911|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051912|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
14051913|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14051914|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051915|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
14051916|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14051917|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14051918|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14051919|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14051920|NCT02659657|Interleukin-2|interleukin-2|mesh-list
14051921|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051922|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051923|NCT02659657|Analgesics|analgesics|mesh-ancestor
14051924|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
14051925|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051926|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051927|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14051928|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
14051929|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051930|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14051931|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14051932|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051933|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14051934|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14051935|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14051936|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051937|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
14051938|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170829|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14170830|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14170831|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14170832|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14170833|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14170834|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14170835|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170836|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14170837|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14170838|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170839|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170840|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170841|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14183057|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183058|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183059|NCT04730609|Analgesics|analgesics|mesh-ancestor
14183060|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
14183061|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183062|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14183063|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14183064|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14183065|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183066|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183067|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183068|NCT04730544|Nivolumab|nivolumab|mesh-list
14183069|NCT04730544|Ipilimumab|ipilimumab|mesh-list
14183070|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14183071|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183072|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14183073|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183074|NCT04730531|Epinephrine|epinephrine|mesh-list
14183075|NCT04730531|Bupivacaine|bupivacaine|mesh-list
14183076|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
14183077|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
14183078|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183079|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183080|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
14183081|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183082|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14183083|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14183084|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183085|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183086|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183087|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14183088|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14183089|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
14183090|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14183091|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
14183092|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
14183093|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
14183094|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14183095|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
14183096|NCT04730596|Ketamine|ketamine|mesh-list
14183097|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14183098|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183099|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183100|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051939|NCT02659384|Aspirin|aspirin|mesh-list
14051940|NCT02659384|Bevacizumab|bevacizumab|mesh-list
14051941|NCT02659384|Atezolizumab|atezolizumab|mesh-list
14051942|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14051943|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051944|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14051945|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14051946|NCT02659384|Growth Substances|growth substances|mesh-ancestor
14051947|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051948|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
14051949|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14051950|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14051951|NCT02659384|Analgesics|analgesics|mesh-ancestor
14051952|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
14051953|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051954|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051955|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14051956|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14051957|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14051958|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051959|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14051960|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14051961|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14051962|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
14051963|NCT02659306|Metformin|metformin|mesh-list
14051964|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14051965|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051966|NCT02659254|Sirolimus|sirolimus|mesh-list
14051967|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14051968|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14051969|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14051970|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051971|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
14051972|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14051973|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
14051974|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051975|NCT02659228|Anesthetics|anesthetics|mesh-list
14051976|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
14051977|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14051978|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051979|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
14051980|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14051981|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14051982|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14051983|NCT02659293|Dexamethasone|dexamethasone|mesh-list
14051984|NCT02659293|Lenalidomide|lenalidomide|mesh-list
14051985|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14051986|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
14051987|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
14051988|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14051989|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14051990|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14051991|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
14051992|NCT02659293|Hormones|hormones|mesh-ancestor
14051993|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14051994|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14051995|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14051996|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
14051997|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14051998|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14051999|NCT02659293|Growth Substances|growth substances|mesh-ancestor
14052000|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
14052001|NCT02659085|Ketamine|ketamine|mesh-list
14052002|NCT02659085|Analgesics|analgesics|mesh-ancestor
14052003|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
14052004|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052005|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052006|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14052007|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14052008|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
14052009|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
14052010|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052011|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14052012|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14052013|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052014|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052015|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
14052016|NCT02659033|Cefotaxime|cefotaxime|mesh-list
14052017|NCT02659033|Cefoxitin|cefoxitin|mesh-list
14052018|NCT02659033|Cephalosporins|cephalosporins|mesh-list
14052019|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14052020|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052021|NCT02658864|Lafutidine|lafutidine|mesh-list
14052022|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14052023|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14052024|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14052025|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
14052026|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
14052027|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052028|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052029|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052030|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
14052031|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14052032|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14052033|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052034|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14052035|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14052036|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052037|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052038|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052039|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14052040|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
14052041|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14052042|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052043|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14052044|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14052045|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14052046|NCT02658838|Heparin|heparin|mesh-list
14052047|NCT02658838|Calcium heparin|calcium heparin|mesh-list
14052048|NCT02658838|Enoxaparin|enoxaparin|mesh-list
14052049|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14052050|NCT02658838|Tinzaparin|tinzaparin|mesh-list
14052051|NCT02658838|Dalteparin|dalteparin|mesh-list
14052052|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
14052053|NCT02658838|Ticagrelor|ticagrelor|mesh-list
14052054|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14052055|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
14052056|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14052057|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14052058|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052059|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14052060|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14052061|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14052062|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
14052063|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052064|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052065|NCT02658799|Diclofenac|diclofenac|mesh-list
14052066|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14052067|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14052068|NCT02658799|Analgesics|analgesics|mesh-ancestor
14052069|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
14052070|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052071|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052072|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14052073|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052074|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14052075|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052076|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052077|NCT02658773|Lidocaine|lidocaine|mesh-list
14052078|NCT02658773|Prilocaine|prilocaine|mesh-list
14052079|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14052080|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
14052081|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
14052082|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052083|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052084|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
14052085|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052086|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14052087|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14052088|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14052089|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14052090|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052091|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14052092|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
14052093|NCT02658760|Bupivacaine|bupivacaine|mesh-list
14052094|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
14052095|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
14052096|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052097|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052098|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
14052099|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052100|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14052101|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14052102|NCT02658760|Analgesics|analgesics|mesh-ancestor
14052103|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14052104|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14052105|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14052106|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
14052107|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052108|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052109|NCT02658721|Diclofenac|diclofenac|mesh-list
14052110|NCT02658721|Lidocaine|lidocaine|mesh-list
14052111|NCT02658721|Atropine|atropine|mesh-list
14052112|NCT02658721|Ephedrine|ephedrine|mesh-list
14052113|NCT02658721|Fentanyl|fentanyl|mesh-list
14052114|NCT02658721|Midazolam|midazolam|mesh-list
14052115|NCT02658721|Tramadol|tramadol|mesh-list
14052116|NCT02658721|Ondansetron|ondansetron|mesh-list
14052117|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
14052118|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
14052119|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052120|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052121|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
14052122|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052123|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14052124|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14052125|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14052126|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14052127|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052128|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14052129|NCT02658721|Narcotics|narcotics|mesh-ancestor
14052130|NCT02658721|Analgesics|analgesics|mesh-ancestor
14052131|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14052132|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14052133|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
14052134|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14052135|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14052136|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14052137|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14052138|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
14052139|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
14052140|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052141|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
14052142|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
14052143|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14052144|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
14052145|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
14052146|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14052147|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
14052148|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14052149|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14052150|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14052151|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14052152|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052153|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14052154|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052155|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14052156|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14052157|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
14052158|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
14052159|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
14052160|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14052161|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14052162|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
14052163|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14052164|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
14052165|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14052166|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14052167|NCT02658422|Montelukast|montelukast|mesh-list
14052168|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14052169|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14052170|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14052171|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052172|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052173|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052174|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14052175|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14052176|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052177|NCT02658526|Anesthetics|anesthetics|mesh-list
14052178|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052179|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052180|NCT02658435|Tafenoquine|tafenoquine|mesh-list
14052181|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
14052182|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14052183|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14052184|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052185|NCT02658409|Vaccines|vaccines|mesh-list
14052186|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
14475425|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14475426|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
14933587|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052187|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052188|NCT02658188|Gabapentin|gabapentin|mesh-list
14052189|NCT02658188|Analgesics|analgesics|mesh-ancestor
14052190|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
14052191|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052192|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052193|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
14052194|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14052195|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14052196|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052197|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14052198|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14052199|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14052200|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052201|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052202|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
14052203|NCT02658396|Bortezomib|bortezomib|mesh-list
14052204|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052205|NCT02658214|Leucovorin|leucovorin|mesh-list
14052206|NCT02658214|Folic Acid|folic acid|mesh-list
14052207|NCT02658214|Gemcitabine|gemcitabine|mesh-list
14052208|NCT02658214|Paclitaxel|paclitaxel|mesh-list
14052209|NCT02658214|Etoposide|etoposide|mesh-list
14052210|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14052211|NCT02658214|Carboplatin|carboplatin|mesh-list
14052212|NCT02658214|Fluorouracil|fluorouracil|mesh-list
14052213|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
14052214|NCT02658214|Durvalumab|durvalumab|mesh-list
14052215|NCT02658214|Tremelimumab|tremelimumab|mesh-list
14052216|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
14052217|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14052218|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052219|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
14052220|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
14052221|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
14052222|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052223|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14052224|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
14052225|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
14052226|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052227|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052228|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14052229|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
14052230|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052231|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14052232|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14052233|NCT02658214|Antidotes|antidotes|mesh-ancestor
14052234|NCT02658214|Protective Agents|protective agents|mesh-ancestor
14052235|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
14052236|NCT02658214|Vitamins|vitamins|mesh-ancestor
14052237|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
14052238|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14052239|NCT02658214|Hematinics|hematinics|mesh-ancestor
14052240|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14052241|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14052242|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
14052243|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052244|NCT02658253|Antacids|antacids|mesh-ancestor
14052245|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052246|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14052247|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
14052248|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14052249|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052250|NCT02658292|Naftifine|naftifine|mesh-list
14052251|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
14052252|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170842|NCT04828525|Dexamethasone|dexamethasone|mesh-list
14170843|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14170844|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
14170845|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
14170846|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170847|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170848|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14170849|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
14170850|NCT04828525|Hormones|hormones|mesh-ancestor
14170851|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170852|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14170853|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170854|NCT04828642|Vitamins|vitamins|mesh-list
14170855|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
14170856|NCT04828642|Vitamin E|vitamin e|mesh-list
14170857|NCT04828642|Tocopherols|tocopherols|mesh-list
14170858|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
14170859|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170860|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
14170861|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170862|NCT04828642|Protective Agents|protective agents|mesh-ancestor
14170863|NCT04828694|Naltrexone|naltrexone|mesh-list
14170864|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14170865|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14170866|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170867|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
14170868|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170869|NCT04828564|Ribavirin|ribavirin|mesh-list
14170870|NCT04828564|Favipiravir|favipiravir|mesh-list
14170871|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
14170872|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170873|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
14170874|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170875|NCT04828135|Xenon|xenon|mesh-list
14170876|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14933588|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14933589|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912872|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
13912873|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912874|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912875|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13912876|NCT03492255|Protective Agents|protective agents|mesh-ancestor
13912877|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13912878|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912879|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912880|NCT03492138|Dexamethasone|dexamethasone|mesh-list
13912881|NCT03492138|Ixazomib|ixazomib|mesh-list
13912882|NCT03492138|TIC10 compound|tic10 compound|mesh-list
13912883|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13912884|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
13912885|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
13912886|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912887|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912888|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912889|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
13912890|NCT03492138|Hormones|hormones|mesh-ancestor
13912891|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14170877|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
14170878|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
14170879|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170880|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170881|NCT04828031|Vitamin D|vitamin d|mesh-list
14170882|NCT04828031|Vitamins|vitamins|mesh-ancestor
14933590|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
14052253|NCT02657603|Lidocaine|lidocaine|mesh-list
14052254|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
14052255|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
14052256|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052257|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052258|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
14052259|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052260|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14052261|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14052262|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14052263|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14052264|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052265|NCT02657616|Vitamin K|vitamin k|mesh-list
14052266|NCT02657616|Anticoagulants|anticoagulants|mesh-list
14052267|NCT02657616|Vitamins|vitamins|mesh-ancestor
14052268|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
14052269|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052270|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14052271|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14052272|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052273|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
14052274|NCT02657616|Coagulants|coagulants|mesh-ancestor
14052275|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
14052276|NCT02657694|Ledipasvir|ledipasvir|mesh-list
14052277|NCT02657694|Velpatasvir|velpatasvir|mesh-list
14052278|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
14052279|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052280|NCT02657460|Cisplatin|cisplatin|mesh-list
14052281|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052282|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14052283|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
14052284|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
14052285|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052286|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
14052287|NCT02657512|Charcoal|charcoal|mesh-list
14052288|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14052289|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
14052290|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14052291|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
14052292|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052293|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052294|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
14052295|NCT02657512|Antidotes|antidotes|mesh-ancestor
14052296|NCT02657512|Protective Agents|protective agents|mesh-ancestor
14052297|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052298|NCT02657486|Infigratinib|infigratinib|mesh-list
14052299|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052300|NCT02657343|Trastuzumab|trastuzumab|mesh-list
14052301|NCT02657343|Fulvestrant|fulvestrant|mesh-list
14052302|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14052303|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052304|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14052305|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14052306|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14052307|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052308|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052309|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052310|NCT02657291|Ropivacaine|ropivacaine|mesh-list
14052311|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
14052312|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
14052313|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052314|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052315|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
14052316|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052317|NCT02657473|Tobramycin|tobramycin|mesh-list
14052318|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14052319|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14052320|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052321|NCT02657187|Rocuronium|rocuronium|mesh-list
14052322|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14052323|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14052324|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14052325|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052326|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052327|NCT02657213|Insulin|insulin|mesh-list
14052328|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14933591|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
14933592|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052329|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14052330|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052331|NCT02657161|Vaccines|vaccines|mesh-list
14052332|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
14052333|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052334|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
14052335|NCT02657148|Etonogestrel|etonogestrel|mesh-list
14052336|NCT02657148|Desogestrel|desogestrel|mesh-list
14052337|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14052338|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052339|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14052340|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14052341|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14052342|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14052343|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14052344|NCT02657148|Progestins|progestins|mesh-ancestor
14052345|NCT02657148|Hormones|hormones|mesh-ancestor
14052346|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052347|NCT02657096|Hybenx|hybenx|mesh-list
14052348|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
14052349|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
14052350|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052351|NCT02656901|Anesthetics|anesthetics|mesh-list
14052352|NCT02656901|Sevoflurane|sevoflurane|mesh-list
14052353|NCT02656901|Desflurane|desflurane|mesh-list
14052354|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052355|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052356|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14052357|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14052358|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
14052359|NCT02656979|Latanoprost|latanoprost|mesh-list
14052360|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14052361|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14052362|NCT02656810|Teriparatide|teriparatide|mesh-list
14052363|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14052364|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052365|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14052366|NCT02656771|Metronidazole|metronidazole|mesh-list
14052367|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052368|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14052369|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14052370|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14052371|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14052372|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052373|NCT02656511|Tenofovir|tenofovir|mesh-list
14052374|NCT02656511|Emtricitabine|emtricitabine|mesh-list
14052375|NCT02656511|Dolutegravir|dolutegravir|mesh-list
14052376|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
14052377|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052378|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14052379|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14052380|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052381|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052382|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14052383|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14052384|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14052385|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14052386|NCT02656589|Capecitabine|capecitabine|mesh-list
14052387|NCT02656589|Trastuzumab|trastuzumab|mesh-list
14052388|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14052389|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
14052390|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052391|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052392|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14052393|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
14052394|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
14052395|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14052396|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14052397|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052398|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
14052399|NCT02656472|Coagulants|coagulants|mesh-ancestor
14933593|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14052400|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
14052401|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052402|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14052403|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052404|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052405|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052406|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052407|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052408|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14052409|NCT02656251|Ethanol|ethanol|mesh-list
14052410|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
14052411|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14052412|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14052413|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052414|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052415|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052416|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
14052417|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
14052418|NCT02656121|Vitamin D|vitamin d|mesh-list
14052419|NCT02656121|Clomiphene|clomiphene|mesh-list
14052420|NCT02656121|Vitamins|vitamins|mesh-ancestor
14052421|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
14052422|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052423|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14052424|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14052425|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052426|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052427|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14052428|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
14052429|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14052430|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14052431|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14052432|NCT02656342|Cycloserine|cycloserine|mesh-list
14052433|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14052434|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052435|NCT02656342|Renal Agents|renal agents|mesh-ancestor
14052436|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14052437|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
14757259|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14757260|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
14757261|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757262|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757263|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14757264|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
14757265|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
14757266|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14757267|NCT05342532|Amoxicillin|amoxicillin|mesh-list
13912892|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14052438|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14052439|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
14052440|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052441|NCT02656095|Heparin|heparin|mesh-list
14052442|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
14052443|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14052444|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14052445|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052446|NCT02656082|Etanercept|etanercept|mesh-list
14052447|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14052448|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14052449|NCT02656082|Analgesics|analgesics|mesh-ancestor
14052450|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
14052451|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052452|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052453|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14052454|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052455|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14052456|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912893|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912894|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
13912895|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912896|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912897|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
13912898|NCT03492047|Paclitaxel|paclitaxel|mesh-list
13912899|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13912900|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13912901|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912902|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
14052457|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
14052458|NCT02656017|Metformin|metformin|mesh-list
14052459|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14052460|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170883|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
14170884|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170885|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14170886|NCT04828083|Lidocaine|lidocaine|mesh-list
14170887|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
14170888|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
14170889|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170890|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757268|NCT05342532|Clarithromycin|clarithromycin|mesh-list
14757269|NCT05342532|Omeprazole|omeprazole|mesh-list
14757270|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757271|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757272|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14757273|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757274|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14170891|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
14170892|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170893|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14170894|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14170895|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14170896|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170897|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170898|NCT04828057|Timolol|timolol|mesh-list
14170899|NCT04828057|Bimatoprost|bimatoprost|mesh-list
14170900|NCT04828057|Travoprost|travoprost|mesh-list
14170901|NCT04828057|Latanoprost|latanoprost|mesh-list
14170902|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14170903|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14170904|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170905|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170906|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170907|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170908|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14170909|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14170910|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14170911|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14170912|NCT04828226|Clonidine|clonidine|mesh-list
14170913|NCT04828226|Analgesics|analgesics|mesh-ancestor
14170914|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
14170915|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170916|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170917|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14170918|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
14170919|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
14170920|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14170921|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14170922|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14170923|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170924|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757275|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757276|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757277|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14757278|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14757279|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14757280|NCT05342519|Sirolimus|sirolimus|mesh-list
14757281|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757282|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757283|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14757284|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757285|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
14757286|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757287|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
14757288|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767238|NCT00629278|Fluorouracil|fluorouracil|mesh-list
14767239|NCT00629278|Trastuzumab|trastuzumab|mesh-list
14767240|NCT00629278|Epirubicin|epirubicin|mesh-list
14767241|NCT00629278|Hormones|hormones|mesh-list
14767242|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14767243|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170925|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767244|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14767245|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
13912903|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
13912904|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
13912905|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912906|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
13912907|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052461|NCT02655692|Ketamine|ketamine|mesh-list
14052462|NCT02655692|Analgesics|analgesics|mesh-ancestor
14052463|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
14052464|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052465|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052466|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14757289|NCT05342467|Dinoprostone|dinoprostone|mesh-list
14052467|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14052468|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
14052469|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
14052470|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052471|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14052472|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14052473|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052474|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052475|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14052476|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14052477|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052478|NCT02655757|Incretins|incretins|mesh-ancestor
14052479|NCT02655757|Hormones|hormones|mesh-ancestor
14052480|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052481|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14052482|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
14052483|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052484|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052485|NCT02655770|Liraglutide|liraglutide|mesh-list
14052486|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14052487|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052488|NCT02655770|Incretins|incretins|mesh-ancestor
14052489|NCT02655770|Hormones|hormones|mesh-ancestor
14052490|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052491|NCT02655874|Vaccines|vaccines|mesh-list
14052492|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
14052493|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052494|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
14052495|NCT02655913|Vitamins|vitamins|mesh-ancestor
14052496|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
14052497|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052498|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
14052499|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052500|NCT02655913|Protective Agents|protective agents|mesh-ancestor
14052501|NCT02655822|Atezolizumab|atezolizumab|mesh-list
14052502|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052503|NCT02655965|Clonidine|clonidine|mesh-list
14052504|NCT02655965|Ropivacaine|ropivacaine|mesh-list
14052505|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
14052506|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
14052507|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052508|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052509|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
14052510|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052511|NCT02655965|Analgesics|analgesics|mesh-ancestor
14052512|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14052513|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
14052514|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
14052515|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14052516|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14052517|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14052518|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
13912908|NCT03492047|Expectorants|expectorants|mesh-ancestor
13912909|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
13912910|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13912911|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
13912912|NCT03492047|Protective Agents|protective agents|mesh-ancestor
13912913|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912914|NCT03492047|Antidotes|antidotes|mesh-ancestor
13912915|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
14052519|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052520|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912916|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
14052521|NCT02655705|Cyclosporine|cyclosporine|mesh-list
14757290|NCT05342467|Gemeprost|gemeprost|mesh-list
14052522|NCT02655705|Methotrexate|methotrexate|mesh-list
14052523|NCT02655705|Cyclosporins|cyclosporins|mesh-list
14052524|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14052525|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
14052526|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14052527|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052528|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14052529|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
14052530|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052531|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052532|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
14052533|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052534|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14052535|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14052536|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
14052537|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052538|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14052539|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
14052540|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052541|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14052542|NCT02655614|Midazolam|midazolam|mesh-list
14052543|NCT02655614|Caffeine|caffeine|mesh-list
14052544|NCT02655614|Rabeprazole|rabeprazole|mesh-list
14052545|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14052546|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14052547|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052548|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052549|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14052550|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14052551|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14052552|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14052553|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
14052554|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
14052555|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
14052556|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
14052557|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052558|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052559|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14052560|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14052561|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052562|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14052563|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14052564|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
14052565|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14052566|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14052567|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14052568|NCT02655601|Manganese|manganese|mesh-list
14052569|NCT02655601|Temozolomide|temozolomide|mesh-list
14052570|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14052571|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
14052572|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052573|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052574|NCT02655601|Trace Elements|trace elements|mesh-ancestor
14052575|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
14052576|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052577|NCT02655562|Montelukast|montelukast|mesh-list
14052578|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14052579|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
14052580|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14052581|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052582|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052583|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052584|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14052585|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14052586|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052587|NCT02655536|Bevacizumab|bevacizumab|mesh-list
14052588|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14052589|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14052590|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052591|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14052592|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14052593|NCT02655536|Growth Substances|growth substances|mesh-ancestor
14052594|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052595|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
14052596|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14052597|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052598|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052599|NCT02655380|Ketamine|ketamine|mesh-list
14052600|NCT02655380|Remifentanil|remifentanil|mesh-list
14052601|NCT02655380|Analgesics|analgesics|mesh-ancestor
14052602|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
14052603|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052604|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052605|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14052606|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14052607|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
14052608|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
14052609|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052610|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14052611|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14052612|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052613|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052614|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14052615|NCT02655380|Narcotics|narcotics|mesh-ancestor
14052616|NCT02655458|Lenalidomide|lenalidomide|mesh-list
14052617|NCT02655458|Elotuzumab|elotuzumab|mesh-list
14052618|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
14052619|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052620|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14052621|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14052622|NCT02655458|Growth Substances|growth substances|mesh-ancestor
14052623|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
14052624|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052625|NCT02655471|Zidovudine|zidovudine|mesh-list
14052626|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
14052627|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
14052628|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052629|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14052630|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14052631|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052632|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
14052633|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052634|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14052635|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14052636|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14052637|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14052638|NCT02655315|Deferiprone|deferiprone|mesh-list
14052639|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14052640|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
14052641|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
14052642|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052643|NCT02655276|Glycine|glycine|mesh-list
14052644|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
14052645|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052646|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052647|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052648|NCT02655198|Fenfluramine|fenfluramine|mesh-list
14052649|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14052650|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14052651|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14052652|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052653|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052654|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
14052655|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052656|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14052657|NCT02655146|Progesterone|progesterone|mesh-list
14052658|NCT02655146|Estradiol|estradiol|mesh-list
14052659|NCT02655146|Progestins|progestins|mesh-ancestor
14052660|NCT02655146|Hormones|hormones|mesh-ancestor
14052661|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052662|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052663|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
14052664|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14052665|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
14052666|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14052667|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14052668|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14052669|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052670|NCT02655146|Estrogens|estrogens|mesh-ancestor
14052671|NCT02654847|Norepinephrine|norepinephrine|mesh-list
14052672|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14052673|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14052674|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
14052675|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052676|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052677|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052678|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
14052679|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
14052680|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052681|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14052682|NCT02655029|Amlodipine|amlodipine|mesh-list
14052683|NCT02655029|Perindopril|perindopril|mesh-list
14052684|NCT02655029|Indapamide|indapamide|mesh-list
14052685|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14052686|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14052687|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14052688|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052689|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14052690|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052691|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
14052692|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14052693|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
14052694|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052695|NCT02655029|Diuretics|diuretics|mesh-ancestor
14052696|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
14052697|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14052698|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
14052699|NCT02654834|Anesthetics|anesthetics|mesh-list
14052700|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052701|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052702|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14052703|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
14052704|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14052705|NCT02654834|Analgesics|analgesics|mesh-ancestor
14052706|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
14052707|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052708|NCT02654743|Sulforaphane|sulforaphane|mesh-list
14052709|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14052710|NCT02654743|Protective Agents|protective agents|mesh-ancestor
14052711|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052712|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052713|NCT02654561|Heparin|heparin|mesh-list
14052714|NCT02654561|Calcium heparin|calcium heparin|mesh-list
14052715|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
14052716|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14052717|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14052718|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052719|NCT02654665|Liraglutide|liraglutide|mesh-list
14052720|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14052721|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052722|NCT02654665|Incretins|incretins|mesh-ancestor
14052723|NCT02654665|Hormones|hormones|mesh-ancestor
14052724|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052725|NCT02654730|Piperaquine|piperaquine|mesh-list
14052726|NCT02654730|Primaquine|primaquine|mesh-list
14052727|NCT02654730|Artenimol|artenimol|mesh-list
14052728|NCT02654730|Artemisinins|artemisinins|mesh-list
14052729|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
14052730|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14052731|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14052732|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052733|NCT02654678|Enalapril|enalapril|mesh-list
14052734|NCT02654678|Enalaprilat|enalaprilat|mesh-list
14052735|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14052736|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
14052737|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052738|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052739|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14052740|NCT02654704|Vaccines|vaccines|mesh-list
14052741|NCT02654704|Immunologic Factors|immunologic factors|mesh-ancestor
14052742|NCT02654704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052743|NCT02654587|Docetaxel|docetaxel|mesh-list
14052744|NCT02654587|Pemetrexed|pemetrexed|mesh-list
14052745|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052746|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14052747|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14052748|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14052749|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052750|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052751|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14052752|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14052753|NCT02654405|Butyric Acid|butyric acid|mesh-list
14052754|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
14052755|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
14052756|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757291|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
14757292|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757293|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757294|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14757295|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
14757296|NCT05342389|Apatinib|apatinib|mesh-list
14757297|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052757|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052758|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052759|NCT02654379|Rituximab|rituximab|mesh-list
14052760|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14052761|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052762|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
14052763|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052764|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170926|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
14170927|NCT04827966|Listerine|listerine|mesh-list
14170928|NCT04827966|Calcium|calcium|mesh-list
14170929|NCT04827966|Fluorides|fluorides|mesh-list
14170930|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
14170931|NCT04827966|Caseins|caseins|mesh-list
14170932|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14170933|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170934|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14170935|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
14170936|NCT04827966|Protective Agents|protective agents|mesh-ancestor
14170937|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14170938|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170939|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
14170940|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
14170941|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170942|NCT04828395|Paclitaxel|paclitaxel|mesh-list
14170943|NCT04828395|Etoposide|etoposide|mesh-list
14170944|NCT04828395|Cisplatin|cisplatin|mesh-list
14170945|NCT04828395|Carboplatin|carboplatin|mesh-list
14170946|NCT04828395|Pemetrexed|pemetrexed|mesh-list
14170947|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14170948|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170949|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
14170950|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
14170951|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
14757298|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13912917|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912918|NCT03491969|Protective Agents|protective agents|mesh-ancestor
13912919|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170952|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170953|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14170954|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14170955|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14170956|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14170957|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14170958|NCT04827784|Anesthetics|anesthetics|mesh-list
14170959|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
14170960|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14170961|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170962|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
14757299|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912920|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
13912921|NCT03491969|Vitamins|vitamins|mesh-ancestor
13912922|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
13912923|NCT03491904|Fasinumab|fasinumab|mesh-list
13912924|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13912925|NCT03491904|Analgesics|analgesics|mesh-ancestor
13912926|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
13912927|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13912928|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912929|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
14170963|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475427|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475428|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475429|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14052765|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
14052766|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14052767|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14052768|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052769|NCT02654093|Vitamins|vitamins|mesh-ancestor
14052770|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
14052771|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14052772|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14052773|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052774|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052775|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14052776|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14052777|NCT02654106|Temozolomide|temozolomide|mesh-list
14052778|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14052779|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
14052780|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052781|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052782|NCT02654119|Paclitaxel|paclitaxel|mesh-list
14052783|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
14052784|NCT02654119|Trastuzumab|trastuzumab|mesh-list
14052785|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14052786|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14052787|NCT02654119|Antibodies|antibodies|mesh-list
14052788|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
14052789|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14052790|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14052791|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052792|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14052793|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14052794|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14052795|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052796|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14052797|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
14052798|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052799|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052800|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14052801|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
14052802|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14052803|NCT02654171|Ziresovir|ziresovir|mesh-list
14052804|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
14052805|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052806|NCT02654288|Gemcitabine|gemcitabine|mesh-list
14052807|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14052808|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
14052809|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052810|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052811|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
14052812|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052813|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052814|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14052815|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
14052816|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052817|NCT02654041|Methimazole|methimazole|mesh-list
14052818|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
14052819|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052820|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052821|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052822|NCT02653898|Artesunate|artesunate|mesh-list
14052823|NCT02653898|Piperaquine|piperaquine|mesh-list
14052824|NCT02653898|Primaquine|primaquine|mesh-list
14052825|NCT02653898|Artenimol|artenimol|mesh-list
14052826|NCT02653898|Mefloquine|mefloquine|mesh-list
14052827|NCT02653898|Permethrin|permethrin|mesh-list
14052828|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
14052829|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14052830|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14052831|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052832|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052833|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
14052834|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
14052835|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14475430|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
14475431|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14052836|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
14052837|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052838|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052839|NCT02653833|Tadalafil|tadalafil|mesh-list
14052840|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
14052841|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14052842|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14052843|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052844|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052845|NCT02653833|Urological Agents|urological agents|mesh-ancestor
14052846|NCT02653703|Ethanol|ethanol|mesh-list
14052847|NCT02653703|Menthol|menthol|mesh-list
14052848|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13912930|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13912931|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
13912932|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912933|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
13912934|NCT03491761|Protective Agents|protective agents|mesh-ancestor
13912935|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
13912936|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
13912937|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14052849|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052850|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052851|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052852|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
14052853|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
14052854|NCT02653742|Ketorolac|ketorolac|mesh-list
14052855|NCT02653742|Fentanyl|fentanyl|mesh-list
14052856|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14052857|NCT02653742|Narcotics|narcotics|mesh-ancestor
14052858|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052859|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052860|NCT02653742|Analgesics|analgesics|mesh-ancestor
14052861|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
14052862|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052863|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14052864|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14052865|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
14052866|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
14052867|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14052868|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14052869|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14052870|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052871|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14052872|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052873|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052874|NCT02653963|Triamcinolone|triamcinolone|mesh-list
14052875|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14052876|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
14052877|NCT02653963|Hormones|hormones|mesh-ancestor
14052878|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052879|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052880|NCT02653651|Lidocaine|lidocaine|mesh-list
14052881|NCT02653651|Ketamine|ketamine|mesh-list
14052882|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
14052883|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
14052884|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052885|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052886|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
14052887|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052888|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14052889|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14052890|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14052891|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14052892|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912938|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912939|NCT03491709|Cetuximab|cetuximab|mesh-list
13912940|NCT03491709|Antibodies|antibodies|mesh-list
13912941|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13912942|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
13912943|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912944|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13912945|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912946|NCT03491696|Metyrapone|metyrapone|mesh-list
14052893|NCT02653651|Analgesics|analgesics|mesh-ancestor
14052894|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14052895|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14052896|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
14052897|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14052898|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14052899|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052900|NCT02653638|Indomethacin|indomethacin|mesh-list
14052901|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14052902|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14052903|NCT02653638|Analgesics|analgesics|mesh-ancestor
14052904|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
14052905|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14052906|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052907|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14052908|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052909|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
14052910|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
14052911|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14052912|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14052913|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052914|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052915|NCT02653235|Vaccines|vaccines|mesh-list
14052916|NCT02653235|Immunologic Factors|immunologic factors|mesh-ancestor
14052917|NCT02653235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052918|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
14052919|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14052920|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14052921|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052922|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
14052923|NCT02653261|Coagulants|coagulants|mesh-ancestor
14052924|NCT02653196|Cyclosporine|cyclosporine|mesh-list
14052925|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
14052926|NCT02653196|Fludarabine|fludarabine|mesh-list
14052927|NCT02653196|Etoposide|etoposide|mesh-list
14052928|NCT02653196|Melphalan|melphalan|mesh-list
14052929|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
14052930|NCT02653196|Thiotepa|thiotepa|mesh-list
14052931|NCT02653196|Tacrolimus|tacrolimus|mesh-list
14052932|NCT02653196|Cyclosporins|cyclosporins|mesh-list
14052933|NCT02653196|Mitogens|mitogens|mesh-list
14052934|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14052935|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052936|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14052937|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
14052938|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052939|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14052940|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14052941|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14052942|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052943|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14052944|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
14052945|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14052946|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14052947|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14052948|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14052949|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14052950|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
14052951|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14052952|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14052953|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
14052954|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14052955|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
14052956|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14052957|NCT02653209|Pioglitazone|pioglitazone|mesh-list
14052958|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14052959|NCT02653209|Canagliflozin|canagliflozin|mesh-list
14052960|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14052961|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052962|NCT02653209|Incretins|incretins|mesh-ancestor
14052963|NCT02653209|Hormones|hormones|mesh-ancestor
14052964|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052965|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14052966|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
14052967|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052968|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052969|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14052970|NCT02653339|Loratadine|loratadine|mesh-list
14052971|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
14052972|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
14052973|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14052974|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14052975|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14052976|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
14052977|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
14052978|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14052979|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052980|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052981|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14052982|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14052983|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14052984|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14052985|NCT02653131|Incretins|incretins|mesh-ancestor
14052986|NCT02653131|Hormones|hormones|mesh-ancestor
14052987|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052988|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
14052989|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14052990|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757300|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757301|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
14757302|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14757303|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14052991|NCT02653027|Ivacaftor|ivacaftor|mesh-list
14052992|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14052993|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14052994|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14052995|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14052996|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
14052997|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
14052998|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14052999|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053000|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14053001|NCT02653014|Diuretics|diuretics|mesh-ancestor
14053002|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
14053003|NCT02653014|Hormones|hormones|mesh-ancestor
14053004|NCT02652793|Lamivudine|lamivudine|mesh-list
14053005|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14053006|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14053007|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14053008|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053009|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053010|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
14053011|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053012|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13912947|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
13912948|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912949|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912950|NCT03491631|Apatinib|apatinib|mesh-list
13912951|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912952|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13912953|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912954|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960001|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13960002|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
13960003|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960004|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
13960005|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933594|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
14933595|NCT01451515|Hormones|hormones|mesh-ancestor
14933596|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933597|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14933598|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14053013|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14053014|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14053015|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14053016|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
14053017|NCT02652884|Betamethasone|betamethasone|mesh-list
14053018|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
14053019|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053020|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
14053021|NCT02652884|Hormones|hormones|mesh-ancestor
14053022|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053023|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053024|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14757304|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757305|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757306|NCT05342376|Analgesics|analgesics|mesh-ancestor
14757307|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
14757308|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757309|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14757310|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14757311|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14757312|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
14757313|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767246|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14053025|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
14053026|NCT02652871|Cytarabine|cytarabine|mesh-list
14053027|NCT02652871|Idarubicin|idarubicin|mesh-list
14053028|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14053029|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
14053030|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053031|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053032|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
14053033|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053034|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053035|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
14053036|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053037|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14053038|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14053039|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14053040|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053041|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14053042|NCT02652650|Norethindrone|norethindrone|mesh-list
14053043|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
14053044|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14053045|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14053046|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14053047|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
14053048|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14053049|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053050|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14053051|NCT02652650|Estrogens|estrogens|mesh-ancestor
14053052|NCT02652650|Hormones|hormones|mesh-ancestor
14053053|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053054|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14053055|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
14053056|NCT02652806|Hematinics|hematinics|mesh-ancestor
14053057|NCT02652585|Naltrexone|naltrexone|mesh-list
14053058|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14053059|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14053060|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475432|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14475433|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14475434|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
14475435|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475436|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475437|NCT02399085|Lenalidomide|lenalidomide|mesh-list
14475438|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
14475439|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053061|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
14053062|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053063|NCT02652637|Metronidazole|metronidazole|mesh-list
14053064|NCT02652637|Neomycin|neomycin|mesh-list
14053065|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053066|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14053067|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14053068|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14053069|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14053070|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053071|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053072|NCT02652728|Enalapril|enalapril|mesh-list
14053073|NCT02652728|Enalaprilat|enalaprilat|mesh-list
14053074|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14053075|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
14053076|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053077|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053078|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14053079|NCT02652598|Tolcapone|tolcapone|mesh-list
14053080|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14053081|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14053082|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14053083|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053084|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053085|NCT02652741|Enalapril|enalapril|mesh-list
14053086|NCT02652741|Enalaprilat|enalaprilat|mesh-list
14053087|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14053088|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
14053089|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053090|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053091|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14475440|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14475441|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14475442|NCT02399085|Growth Substances|growth substances|mesh-ancestor
14475443|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
14475444|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475445|NCT02399163|Fluorides|fluorides|mesh-list
14475446|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
14475447|NCT02399163|Protective Agents|protective agents|mesh-ancestor
14475448|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053092|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
14053093|NCT02652507|Ketamine|ketamine|mesh-list
14053094|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14053095|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053096|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053097|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14053098|NCT02652507|Analgesics|analgesics|mesh-ancestor
14053099|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
14053100|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053101|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13912955|NCT03491579|Cytarabine|cytarabine|mesh-list
13912956|NCT03491579|Cladribine|cladribine|mesh-list
14053102|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14053103|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14053104|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
14053105|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053106|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053107|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14053108|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14053109|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
14053110|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
14053111|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14053112|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14053113|NCT02652273|Abatacept|abatacept|mesh-list
14053114|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14053115|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053116|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475449|NCT02399345|Ritonavir|ritonavir|mesh-list
14475450|NCT02399345|Ribavirin|ribavirin|mesh-list
13912957|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13912958|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
13912959|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912960|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912961|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
13912962|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912963|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13912964|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
14053117|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053118|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
14053119|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053120|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14170964|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
14170965|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14170966|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14170967|NCT04827446|Methamphetamine|methamphetamine|mesh-list
14170968|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14170969|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170970|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
14170971|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
14170972|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170973|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
14170974|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170975|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170976|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170977|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14170978|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14170979|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170980|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14170981|NCT04827134|Triumeq|triumeq|mesh-list
14170982|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14170983|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14170984|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
14170985|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14170986|NCT04827147|Methamphetamine|methamphetamine|mesh-list
14170987|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14170988|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14170989|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
14170990|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
14170991|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14170992|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
14170993|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14170994|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14170995|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
14170996|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14170997|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14170998|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14170999|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14183101|NCT04730596|Analgesics|analgesics|mesh-ancestor
14183102|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
14183103|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183104|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14183105|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14183106|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14183107|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183108|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183109|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183110|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14183111|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14183112|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
14183113|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
14183114|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14183115|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14183116|NCT04730674|Tetracycline|tetracycline|mesh-list
14183117|NCT04730674|Lidocaine|lidocaine|mesh-list
14183118|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
14183119|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
13912965|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13912966|NCT03491540|Gentamicins|gentamicins|mesh-list
13912967|NCT03491540|Ornidazole|ornidazole|mesh-list
13912968|NCT03491540|Sennosides|sennosides|mesh-list
13912969|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13912970|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912971|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13912972|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13912973|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912974|NCT03491540|Laxatives|laxatives|mesh-ancestor
13912975|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13912976|NCT03491540|Amebicides|amebicides|mesh-ancestor
13912977|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13912978|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13912979|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13912980|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
14053121|NCT02652312|Diclofenac|diclofenac|mesh-list
14053122|NCT02652312|Fentanyl|fentanyl|mesh-list
14053123|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
14053124|NCT02652312|Ondansetron|ondansetron|mesh-list
14053125|NCT02652312|Propofol|propofol|mesh-list
14053126|NCT02652312|Desflurane|desflurane|mesh-list
14053127|NCT02652312|Atracurium|atracurium|mesh-list
14053128|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14053129|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053130|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053131|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14053132|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
14053133|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
14757314|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757315|NCT05342272|Lactoferrin|lactoferrin|mesh-list
14757316|NCT05342272|Betaine|betaine|mesh-list
14757317|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757318|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053134|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14053135|NCT02652312|Analgesics|analgesics|mesh-ancestor
14053136|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
14053137|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053138|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14053139|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14053140|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14053141|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
14053142|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053143|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053144|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14053145|NCT02652312|Narcotics|narcotics|mesh-ancestor
14053146|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14053147|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
14053148|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
14053149|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053150|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
14053151|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14053152|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14053153|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
14053154|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14053155|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14053156|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14053157|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14053158|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14053159|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053160|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14053161|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14053162|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053163|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14053164|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14053165|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14053166|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14053167|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14053168|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14053169|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
14053170|NCT02652325|Iodine|iodine|mesh-list
14053171|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
14053172|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
14053173|NCT02652325|Povidone|povidone|mesh-list
14053174|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14053175|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053176|NCT02652325|Trace Elements|trace elements|mesh-ancestor
14053177|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
14053178|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053179|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
14053180|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
14053181|NCT02652234|Endostar protein|endostar protein|mesh-list
14053182|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14053183|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14053184|NCT02652234|Growth Substances|growth substances|mesh-ancestor
14053185|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053186|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
14053187|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053188|NCT02652065|Acetylcholine|acetylcholine|mesh-list
14053189|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
14053190|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14757319|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
14053191|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
14053192|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053193|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053194|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053195|NCT02652091|Interferons|interferons|mesh-list
14053196|NCT02652091|Interferon-beta|interferon-beta|mesh-list
14053197|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
14053198|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053199|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
14053200|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053201|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
14053202|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053203|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14053204|NCT02651870|Amlodipine|amlodipine|mesh-list
14053205|NCT02651870|Candesartan|candesartan|mesh-list
14053206|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14053207|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14053208|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14053209|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053210|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14053211|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053212|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
14053213|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14053214|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14053215|NCT02651792|Meperidine|meperidine|mesh-list
14053216|NCT02651792|Ketamine|ketamine|mesh-list
14053217|NCT02651792|Propofol|propofol|mesh-list
14053218|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14053219|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053220|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053221|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14053222|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
14053223|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
14053224|NCT02651792|Analgesics|analgesics|mesh-ancestor
14053225|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
14053226|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053227|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14053228|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14053229|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14053230|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053231|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053232|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14053233|NCT02651792|Narcotics|narcotics|mesh-ancestor
14475451|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
14475452|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14475453|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14053234|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14053235|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
14053236|NCT02651753|Atorvastatin|atorvastatin|mesh-list
14053237|NCT02651753|Fenofibrate|fenofibrate|mesh-list
14053238|NCT02651753|Calcium|calcium|mesh-list
14053239|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14053240|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053241|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14053242|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14053243|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14053244|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
14053245|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053246|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14053247|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14053248|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053249|NCT02651610|Paclitaxel|paclitaxel|mesh-list
14053250|NCT02651610|Docetaxel|docetaxel|mesh-list
14053251|NCT02651610|Taxane|taxane|mesh-list
14053252|NCT02651610|Bavituximab|bavituximab|mesh-list
14053253|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14053254|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053255|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14053256|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14053257|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171000|NCT04826822|Dexamethasone|dexamethasone|mesh-list
14475454|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
14475455|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475456|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475457|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14475458|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14757320|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14757321|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
14757322|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053258|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053259|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14053260|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
14053261|NCT02651623|Sertraline|sertraline|mesh-list
14053262|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14053263|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053264|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14053265|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14053266|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053267|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053268|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053269|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053270|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
14053271|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14053272|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14053273|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14053274|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14053275|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053276|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
14053277|NCT02651727|Gemcitabine|gemcitabine|mesh-list
14053278|NCT02651727|Paclitaxel|paclitaxel|mesh-list
14053279|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14053280|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14053281|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053282|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
14053283|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
14053284|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
14053285|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053286|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14053287|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
14053288|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
14053289|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053290|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053291|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053292|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
14053293|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053294|NCT02651519|Ropivacaine|ropivacaine|mesh-list
14053295|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
14053296|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
14053297|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053298|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053299|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
14053300|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053301|NCT02651662|Cemiplimab|cemiplimab|mesh-list
14053302|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14053303|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053304|NCT02651844|Mifepristone|mifepristone|mesh-list
14053305|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14053306|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
14053307|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14053308|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053309|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14053310|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14053311|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14053312|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
14053313|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14053314|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14053315|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
14053316|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053317|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
14053318|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14053319|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14053320|NCT02651636|Folic Acid|folic acid|mesh-list
14053321|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
14053322|NCT02651636|Inositol|inositol|mesh-list
14053323|NCT02651636|Hematinics|hematinics|mesh-ancestor
14053324|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
14053325|NCT02651636|Vitamins|vitamins|mesh-ancestor
14053326|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
14053327|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053328|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
14053329|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053330|NCT02651636|Protective Agents|protective agents|mesh-ancestor
14053331|NCT02651441|Gemcitabine|gemcitabine|mesh-list
14053332|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053333|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14053334|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
14053335|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053336|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
14053337|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053338|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053339|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053340|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
14053341|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053342|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
14053343|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14053344|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14053345|NCT02651350|Prednisolone|prednisolone|mesh-list
14053346|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
14053347|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14053348|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
14053349|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053350|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
14053351|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
14053352|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053353|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053354|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475459|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
14475460|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053355|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
14053356|NCT02651350|Hormones|hormones|mesh-ancestor
14053357|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053358|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14053359|NCT02651350|Protective Agents|protective agents|mesh-ancestor
14053360|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14053361|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053362|NCT02651324|Ketamine|ketamine|mesh-list
14053363|NCT02651324|Analgesics|analgesics|mesh-ancestor
14053364|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
14053365|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053366|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053367|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14053368|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14053369|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
14053370|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
14053371|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053372|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14053373|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14053374|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053375|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053376|NCT02651311|Ibuprofen|ibuprofen|mesh-list
14053377|NCT02651311|Fentanyl|fentanyl|mesh-list
14053378|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14053379|NCT02651311|Narcotics|narcotics|mesh-ancestor
14053380|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053381|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053382|NCT02651311|Analgesics|analgesics|mesh-ancestor
14053383|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
14053384|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053385|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14053386|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14053387|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
14053388|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
14053389|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14053390|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14053391|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475461|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14475462|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14475463|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
14475464|NCT02399475|Hormones|hormones|mesh-list
14475465|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
14475466|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475467|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475468|NCT02399917|Azacitidine|azacitidine|mesh-list
14475469|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14053392|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14053393|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14053394|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053395|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053396|NCT02651168|Aflibercept|aflibercept|mesh-list
14053397|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14053398|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14053399|NCT02651168|Growth Substances|growth substances|mesh-ancestor
14053400|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053401|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
14053402|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053403|NCT02651207|Lidocaine|lidocaine|mesh-list
14053404|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
14053405|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
14053406|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
14053407|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
14053408|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053409|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053410|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
14053411|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053412|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14053413|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14053414|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14053415|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14053416|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053417|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14053418|NCT02651038|Micafungin|micafungin|mesh-list
14053419|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
14053420|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053421|NCT02650752|Capecitabine|capecitabine|mesh-list
14053422|NCT02650752|Lapatinib|lapatinib|mesh-list
14053423|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14053424|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
14053425|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053426|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053427|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14053428|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053429|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
14053430|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14053431|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14053432|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053433|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
14053434|NCT02650791|Coagulants|coagulants|mesh-ancestor
14053435|NCT02650713|Atezolizumab|atezolizumab|mesh-list
14053436|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171001|NCT04826822|Spironolactone|spironolactone|mesh-list
14171002|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171003|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
14171004|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
14171005|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171006|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171007|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171008|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
14171009|NCT04826822|Hormones|hormones|mesh-ancestor
14171010|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171011|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14171012|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171013|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14171014|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
14171015|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14171016|NCT04826822|Diuretics|diuretics|mesh-ancestor
14171017|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
14171018|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14171019|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14171020|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171021|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171022|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14171023|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14171024|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171025|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
14171026|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171027|NCT04826679|Paclitaxel|paclitaxel|mesh-list
14171028|NCT04826679|Cisplatin|cisplatin|mesh-list
14171029|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14171030|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053437|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
14053438|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14053439|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14053440|NCT02650609|Prednisolone|prednisolone|mesh-list
14053441|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
14053442|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14053443|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
14053444|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053445|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
14053446|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
14053447|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053448|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053449|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053450|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
14053451|NCT02650609|Hormones|hormones|mesh-ancestor
14053452|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053453|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14053454|NCT02650609|Protective Agents|protective agents|mesh-ancestor
14933599|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14933600|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14933601|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933602|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14933603|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
14933604|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14933605|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14933606|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
14933607|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14933608|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13912981|NCT03491527|Pemetrexed|pemetrexed|mesh-list
13912982|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13912983|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053455|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14053456|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053457|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
14053458|NCT02650635|Lenograstim|lenograstim|mesh-list
14053459|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053460|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
14053461|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053462|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14053463|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14053464|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
14053465|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053466|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053467|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14053468|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14053469|NCT02650596|Liraglutide|liraglutide|mesh-list
14053470|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053471|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053472|NCT02650596|Incretins|incretins|mesh-ancestor
14053473|NCT02650596|Hormones|hormones|mesh-ancestor
14053474|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053475|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14053476|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053477|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14053478|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053479|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053480|NCT02650427|Incretins|incretins|mesh-ancestor
14933609|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13912984|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912985|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13912986|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13912987|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13912988|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
13912989|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
13912990|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
13912991|NCT03491475|Ajmaline|ajmaline|mesh-list
13912992|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13960006|NCT03158376|Gabapentin|gabapentin|mesh-list
14053481|NCT02650427|Hormones|hormones|mesh-ancestor
14053482|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053483|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14053484|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
14053485|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053486|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053487|NCT02650479|Exenatide|exenatide|mesh-list
14053488|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
14053489|NCT02650479|Palonosetron|palonosetron|mesh-list
14053490|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14053491|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053492|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14053493|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14053494|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053495|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053496|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053497|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053498|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053499|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14053500|NCT02650479|Incretins|incretins|mesh-ancestor
14053501|NCT02650479|Hormones|hormones|mesh-ancestor
14053502|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053503|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
14053504|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
14053505|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053506|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053507|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14053508|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14053509|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
14053510|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053511|NCT02650544|Mirtazapine|mirtazapine|mesh-list
14053512|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
14053513|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14053514|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14053515|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
14053516|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
14053517|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053518|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053519|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053520|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14053521|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14053522|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053523|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14053524|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14053525|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14053526|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
14053527|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14053528|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14053529|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
14053530|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14053531|NCT02650245|Lactulose|lactulose|mesh-list
14053532|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053533|NCT02650206|Liraglutide|liraglutide|mesh-list
14053534|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053535|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053536|NCT02650206|Incretins|incretins|mesh-ancestor
14053537|NCT02650206|Hormones|hormones|mesh-ancestor
14053538|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053539|NCT02650102|Olanzapine|olanzapine|mesh-list
14053540|NCT02650102|Risperidone|risperidone|mesh-list
14053541|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14053542|NCT02650102|Aripiprazole|aripiprazole|mesh-list
14053543|NCT02650102|Ziprasidone|ziprasidone|mesh-list
14053544|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14053545|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
14053546|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053547|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053548|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053549|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14053550|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14053551|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053552|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14053553|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14053554|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
14053555|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
14053556|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
14053557|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053558|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053559|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14053560|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14053561|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14053562|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
14053563|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
14053564|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14053565|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14053566|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14053567|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14053568|NCT02649920|Dinoprostone|dinoprostone|mesh-list
14053569|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
14053570|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14053571|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053572|NCT02649998|Furosemide|furosemide|mesh-list
14053573|NCT02649998|Isosorbide|isosorbide|mesh-list
14053574|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14053575|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14053576|NCT02649998|Diuretics|diuretics|mesh-ancestor
14053577|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
14053578|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053579|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14053580|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14053581|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053582|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14053583|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
14053584|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14053585|NCT02649751|Roscovitine|roscovitine|mesh-list
14053586|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053587|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
14053588|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053589|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14053590|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053591|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053592|NCT02649686|Trastuzumab|trastuzumab|mesh-list
14053593|NCT02649686|Durvalumab|durvalumab|mesh-list
14053594|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14053595|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053596|NCT02649829|Vaccines|vaccines|mesh-list
14053597|NCT02649829|Immunologic Factors|immunologic factors|mesh-ancestor
14053598|NCT02649829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053599|NCT02649673|Topotecan|topotecan|mesh-list
14053600|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14757323|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14757324|NCT05342194|Gemcitabine|gemcitabine|mesh-list
14757325|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
14757326|NCT05342194|Lenvatinib|lenvatinib|mesh-list
14757327|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757328|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14757329|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
14757330|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053601|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14053602|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757331|NCT05342194|Antiviral Agents|antiviral agents|mesh-ancestor
14933610|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
14053603|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053604|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053605|NCT02649582|Temozolomide|temozolomide|mesh-list
14053606|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14053607|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
14053608|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053609|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053610|NCT02649530|LGK974|lgk974|mesh-list
14053611|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053612|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053613|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14053614|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14053615|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
14053616|NCT02649504|Dexamethasone|dexamethasone|mesh-list
14053617|NCT02649504|Rituximab|rituximab|mesh-list
13912993|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13912994|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13912995|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13912996|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13912997|NCT03491410|Aspirin|aspirin|mesh-list
13912998|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14053618|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053619|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
14053620|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
14053621|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053622|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053623|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053624|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
14053625|NCT02649504|Hormones|hormones|mesh-ancestor
14053626|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053627|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14053628|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053629|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14053630|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
14053631|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14053632|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14053633|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14053634|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
14053635|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14053636|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053637|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053638|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053639|NCT02649478|Fluticasone|fluticasone|mesh-list
14053640|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14053641|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14053642|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053643|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14053644|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
14053645|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053646|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053647|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14053648|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
14053649|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14053650|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14053651|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13912999|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13913000|NCT03491410|Analgesics|analgesics|mesh-ancestor
13913001|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
13913002|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913003|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053652|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14053653|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14053654|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
14053655|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053656|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053657|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
14053658|NCT02649478|Hormones|hormones|mesh-ancestor
14053659|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053660|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
14053661|NCT02649465|Glimepiride|glimepiride|mesh-list
14053662|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
14053663|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14053664|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053665|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053666|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053667|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
14053668|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14053669|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757332|NCT05342194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913004|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053670|NCT02649179|Ropivacaine|ropivacaine|mesh-list
14053671|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
14053672|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
14053673|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053674|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053675|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
14053676|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053677|NCT02649335|Propranolol|propranolol|mesh-list
14053678|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14053679|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14053680|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
14053681|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053682|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053683|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053684|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14053685|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14053686|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
14053687|NCT02649413|Prednisone|prednisone|mesh-list
14053688|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053689|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
14053690|NCT02649413|Hormones|hormones|mesh-ancestor
14053691|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053692|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053693|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14053694|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053695|NCT02649140|Acetic Acid|acetic acid|mesh-list
14053696|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14053697|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053698|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
14053699|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14053700|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053701|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053702|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14053703|NCT02648958|Analgesics|analgesics|mesh-ancestor
14053704|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
14053705|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053706|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14053707|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14053708|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14053709|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
14053710|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053711|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913005|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913006|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13913007|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13913008|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913009|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13913010|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14053712|NCT02648854|Metformin|metformin|mesh-list
14933611|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913011|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475470|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
14475471|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475472|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475473|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475474|NCT02400333|Ticagrelor|ticagrelor|mesh-list
14475475|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14475476|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14475477|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14475478|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14475479|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
14475480|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475481|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475482|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475483|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
14475484|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
14933612|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
14933613|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
14933614|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
14053713|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053714|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053715|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
14053716|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14053717|NCT02649075|Antibodies|antibodies|mesh-list
14053718|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
14053719|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053720|NCT02648906|Choline|choline|mesh-list
14053721|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
14053722|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14053723|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
14053724|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053725|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053726|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14053727|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
14171031|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171032|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
14171033|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171034|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171035|NCT04826198|Olaparib|olaparib|mesh-list
14171036|NCT04826198|Niraparib|niraparib|mesh-list
14171037|NCT04826198|Rucaparib|rucaparib|mesh-list
14171038|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14171039|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171040|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171041|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171042|NCT04826562|Lamivudine|lamivudine|mesh-list
14171043|NCT04826562|Dolutegravir|dolutegravir|mesh-list
14171044|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14171045|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14171046|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171047|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171048|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
14171049|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171050|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14171051|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14171052|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14171053|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14171054|NCT04826406|Apatinib|apatinib|mesh-list
14171055|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171056|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14171057|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171058|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171059|NCT04826432|Pasireotide|pasireotide|mesh-list
14171060|NCT04826432|Hormones|hormones|mesh-ancestor
14171061|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171062|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171063|NCT04826497|Nicorandil|nicorandil|mesh-list
14171064|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14171065|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14171066|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
14171067|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
14171068|NCT04826497|Vitamins|vitamins|mesh-ancestor
14171069|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
14171070|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475485|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171071|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
14171072|NCT04826510|Perospirone|perospirone|mesh-list
14053728|NCT02649101|Thalidomide|thalidomide|mesh-list
14053729|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053730|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
14053731|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053732|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
14053733|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14053734|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053735|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14053736|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14053737|NCT02649101|Growth Substances|growth substances|mesh-ancestor
14053738|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
14053739|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053740|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14053741|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053742|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053743|NCT02648425|Leucovorin|leucovorin|mesh-list
14053744|NCT02648425|Cisplatin|cisplatin|mesh-list
14053745|NCT02648425|Fluorouracil|fluorouracil|mesh-list
14053746|NCT02648425|Capecitabine|capecitabine|mesh-list
14053747|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053748|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
14053749|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053750|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14053751|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14053752|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
14053753|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053754|NCT02648425|Antidotes|antidotes|mesh-ancestor
14053755|NCT02648425|Protective Agents|protective agents|mesh-ancestor
14053756|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
14053757|NCT02648425|Vitamins|vitamins|mesh-ancestor
14053758|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
14053759|NCT02648711|Leucovorin|leucovorin|mesh-list
14053760|NCT02648711|Bevacizumab|bevacizumab|mesh-list
14053761|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
14053762|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14053763|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053764|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14053765|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14053766|NCT02648711|Growth Substances|growth substances|mesh-ancestor
14053767|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053768|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
14053769|NCT02648711|Antidotes|antidotes|mesh-ancestor
14053770|NCT02648711|Protective Agents|protective agents|mesh-ancestor
14053771|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
14053772|NCT02648711|Vitamins|vitamins|mesh-ancestor
14053773|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
14053774|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
14053775|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
14053776|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14053777|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14053778|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053779|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053780|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053781|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14053782|NCT02648503|Atropine|atropine|mesh-list
14053783|NCT02648503|Rocuronium|rocuronium|mesh-list
14053784|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14053785|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14053786|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14053787|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
14053788|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053789|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053790|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14053791|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
14053792|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
14053793|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
14053794|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14053795|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14053796|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
14053797|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053798|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053799|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14053800|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14053801|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14053802|NCT02648490|Acetaminophen|acetaminophen|mesh-list
14053803|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
14053804|NCT02648490|Promethazine|promethazine|mesh-list
14053805|NCT02648490|Dexamethasone|dexamethasone|mesh-list
14053806|NCT02648490|Cetuximab|cetuximab|mesh-list
14053807|NCT02648490|Ondansetron|ondansetron|mesh-list
14053808|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053809|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
14053810|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
14053811|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053812|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053813|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053814|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
14053815|NCT02648490|Hormones|hormones|mesh-ancestor
14053816|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053817|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14053818|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053819|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14053820|NCT02648490|Analgesics|analgesics|mesh-ancestor
14053821|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
14053822|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
14053823|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
14053824|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
14053825|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14053826|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
14053827|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053828|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053829|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14053830|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14053831|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053832|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14053833|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14053834|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14053835|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14053836|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
14053837|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
14053838|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14053839|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
14053840|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
14053841|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14053842|NCT02648490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14053843|NCT02648633|Nivolumab|nivolumab|mesh-list
14053844|NCT02648633|Valproic Acid|valproic acid|mesh-list
14053845|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14053846|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053847|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14053848|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053849|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
14053850|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053851|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
14053852|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053853|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053854|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
14053855|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14053856|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053857|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14757333|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757334|NCT05342194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757335|NCT05342194|Immunologic Factors|immunologic factors|mesh-ancestor
14757336|NCT05342194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757337|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14757338|NCT05341999|Ibuprofen|ibuprofen|mesh-list
14757339|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14757340|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757341|NCT05341999|Analgesics|analgesics|mesh-ancestor
14757342|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
14757343|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757344|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053858|NCT02648659|Amoxicillin|amoxicillin|mesh-list
14053859|NCT02648659|Metronidazole|metronidazole|mesh-list
14053860|NCT02648659|Clarithromycin|clarithromycin|mesh-list
14053861|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14053862|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14053863|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14053864|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14053865|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14053866|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053867|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053868|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14053869|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14053870|NCT02648412|Ketamine|ketamine|mesh-list
14053871|NCT02648412|Analgesics|analgesics|mesh-ancestor
14053872|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
14053873|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757345|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14757346|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14757347|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14757348|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475486|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475487|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475488|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
14475489|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
14475490|NCT02400437|Dexamethasone|dexamethasone|mesh-list
14475491|NCT02400437|Rituximab|rituximab|mesh-list
14475492|NCT02400437|Ixazomib|ixazomib|mesh-list
14757349|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757350|NCT05341856|Isosorbide|isosorbide|mesh-list
14757351|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14757352|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14757353|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14757354|NCT05341856|Diuretics|diuretics|mesh-ancestor
14757355|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
14933615|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14053874|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053875|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14053876|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14053877|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
14053878|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
14053879|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053880|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14053881|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14053882|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053883|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053884|NCT02648048|Pirfenidone|pirfenidone|mesh-list
14053885|NCT02648048|Analgesics|analgesics|mesh-ancestor
14053886|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
14053887|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053888|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053889|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14053890|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14053891|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053892|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14053893|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053894|NCT02647892|Lidocaine|lidocaine|mesh-list
14933616|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14933617|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933618|NCT01451593|Phenytoin|phenytoin|mesh-list
14933619|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
14933620|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14933621|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14933622|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14933623|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933624|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14053895|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
14053896|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
14053897|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053898|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053899|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
14053900|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053901|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14053902|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14053903|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14053904|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14053905|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053906|NCT02647827|Metformin|metformin|mesh-list
14053907|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053908|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171073|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
14171074|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475493|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475494|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
14475495|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
14475496|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475497|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475498|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053909|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14053910|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14053911|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053912|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14053913|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053914|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
14053915|NCT02647671|Calcium|calcium|mesh-list
14053916|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14053917|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053918|NCT02647671|Antacids|antacids|mesh-ancestor
14053919|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053920|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053921|NCT02647567|Caffeine|caffeine|mesh-list
14053922|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14053923|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053924|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14053925|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053926|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053927|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14053928|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14053929|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
14053930|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14053931|NCT02647385|Lidocaine|lidocaine|mesh-list
14053932|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
14053933|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
14053934|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14053935|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053936|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
14053937|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14053938|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14053939|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14053940|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14053941|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14053942|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053943|NCT02647515|Ranibizumab|ranibizumab|mesh-list
14053944|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14053945|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14053946|NCT02647515|Growth Substances|growth substances|mesh-ancestor
14053947|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053948|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
14053949|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053950|NCT02647424|Letrozole|letrozole|mesh-list
14053951|NCT02647424|Clomiphene|clomiphene|mesh-list
14053952|NCT02647424|Enclomiphene|enclomiphene|mesh-list
14053953|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
14053954|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053955|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14053956|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14053957|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053958|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053959|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14053960|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
14053961|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14053962|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053963|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14053964|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
14053965|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14053966|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14053967|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14053968|NCT02647632|Ribavirin|ribavirin|mesh-list
14053969|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
14053970|NCT02647632|Grazoprevir|grazoprevir|mesh-list
14053971|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
14053972|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053973|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
14053974|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757356|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757357|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
14757358|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14757359|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757360|NCT05341843|Sertraline|sertraline|mesh-list
14053975|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14053976|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14053977|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
14053978|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14053979|NCT02647489|Antacids|antacids|mesh-ancestor
14053980|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053981|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14053982|NCT02647554|Urinastatin|urinastatin|mesh-list
14053983|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
14053984|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14053985|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
14053986|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14053987|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14053988|NCT02647190|Asparaginase|asparaginase|mesh-list
14053989|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14053990|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
14053991|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14053992|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14053993|NCT02647255|Prednisolone|prednisolone|mesh-list
14053994|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
14053995|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14053996|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
14053997|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14053998|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
14053999|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
14054000|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054001|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054002|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054003|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
14054004|NCT02647255|Hormones|hormones|mesh-ancestor
14054005|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054006|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14054007|NCT02647255|Protective Agents|protective agents|mesh-ancestor
14054008|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054009|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054010|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
14054011|NCT02647268|Oxytocin|oxytocin|mesh-list
14054012|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
14054013|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054014|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054015|NCT02647268|Analgesics|analgesics|mesh-ancestor
14054016|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
14054017|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054018|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
14054019|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054020|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14054021|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
14054022|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14054023|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054024|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054025|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14054026|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
14171075|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171076|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171077|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
14171078|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14171079|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171080|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757361|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
14757362|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14757363|NCT05341843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14757364|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14757365|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757366|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757367|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757368|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
14757369|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757370|NCT05341817|Letrozole|letrozole|mesh-list
14757371|NCT05341817|Mifepristone|mifepristone|mesh-list
14757372|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757373|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14757374|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14757375|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757376|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757377|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14757378|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
14757379|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14757380|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757381|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14757382|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
14757383|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757384|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14757385|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14757386|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14757387|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
14757388|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14757389|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14757390|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
14757391|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14757392|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14054027|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14054028|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14054029|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14054030|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054031|NCT02647047|Acetaminophen|acetaminophen|mesh-list
14054032|NCT02647047|Ketorolac|ketorolac|mesh-list
14054033|NCT02647047|Sufentanil|sufentanil|mesh-list
14054034|NCT02647047|Ropivacaine|ropivacaine|mesh-list
14054035|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
14054036|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
13913012|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
13913013|NCT03491371|Apatinib|apatinib|mesh-list
14054037|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757405|NCT05341583|Ensartinib|ensartinib|mesh-list
14757406|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757407|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14757408|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913014|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913015|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13913016|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913017|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913018|NCT03491345|Avelumab|avelumab|mesh-list
13913019|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13913020|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913021|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
13913022|NCT03491098|Prednisolone|prednisolone|mesh-list
13913023|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14054038|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757409|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757410|NCT05341401|Prednisolone|prednisolone|mesh-list
14757411|NCT05341401|Budesonide|budesonide|mesh-list
14757412|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054039|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
14054040|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054041|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14054042|NCT02647047|Analgesics|analgesics|mesh-ancestor
14054043|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
14054044|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14054045|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054046|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054047|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14054048|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054049|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054050|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14054051|NCT02647047|Narcotics|narcotics|mesh-ancestor
14054052|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14054053|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054054|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
14054055|NCT02646800|Micafungin|micafungin|mesh-list
14054056|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
14054057|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054058|NCT02646774|Micafungin|micafungin|mesh-list
14054059|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
14054060|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054061|NCT02647086|Metoprolol|metoprolol|mesh-list
14054062|NCT02647086|Midazolam|midazolam|mesh-list
14054063|NCT02647086|Caffeine|caffeine|mesh-list
14054064|NCT02647086|Omeprazole|omeprazole|mesh-list
14054065|NCT02647086|Warfarin|warfarin|mesh-list
14054066|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14054067|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14054068|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054069|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054070|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14054071|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14054072|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14054073|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054074|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
14054075|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
14054076|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
14054077|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
14054078|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054079|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054080|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
14054081|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14054082|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054083|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14054084|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054085|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14054086|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14054087|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14054088|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14054089|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
14054090|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14054091|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14054092|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
14054093|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
14054094|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054095|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14054096|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14054097|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14054098|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
14054099|NCT02646904|Beclomethasone|beclomethasone|mesh-list
14054100|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054101|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
14054102|NCT02646904|Hormones|hormones|mesh-ancestor
14054103|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054104|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054105|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14054106|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
14054107|NCT02646709|Ketamine|ketamine|mesh-list
14054108|NCT02646709|Rocuronium|rocuronium|mesh-list
14054109|NCT02646709|Analgesics|analgesics|mesh-ancestor
14054110|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
14054111|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171081|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14054112|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054113|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14054114|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054115|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
14054116|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
14054117|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054118|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14054119|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14054120|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054121|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054122|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14054123|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14054124|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14054125|NCT02646735|Fulvestrant|fulvestrant|mesh-list
14054126|NCT02646735|Exemestane|exemestane|mesh-list
14054127|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054128|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054129|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14054130|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14054131|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
14054132|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054133|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054134|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14054135|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14054136|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054137|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054138|NCT02646683|Vedolizumab|vedolizumab|mesh-list
14054139|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054140|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14054141|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14054142|NCT02646397|Fosinopril|fosinopril|mesh-list
14054143|NCT02646397|Benidipine|benidipine|mesh-list
14054144|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14054145|NCT02646397|Diuretics|diuretics|mesh-ancestor
14054146|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
14054147|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054148|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14054149|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054150|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054151|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14054152|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14054153|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054154|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14054155|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14054156|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
14054157|NCT02646592|Alfentanil|alfentanil|mesh-list
14054158|NCT02646592|Propofol|propofol|mesh-list
14054159|NCT02646592|Sevoflurane|sevoflurane|mesh-list
14054160|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14054161|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054162|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054163|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054164|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
14054165|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
14054166|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14054167|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14054168|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14054169|NCT02646592|Narcotics|narcotics|mesh-ancestor
14054170|NCT02646592|Analgesics|analgesics|mesh-ancestor
14054171|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
14054172|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054173|NCT02646670|Ranibizumab|ranibizumab|mesh-list
14054174|NCT02646670|Aflibercept|aflibercept|mesh-list
14054175|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14054176|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14054177|NCT02646670|Growth Substances|growth substances|mesh-ancestor
14054178|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054179|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
14054180|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054181|NCT02646657|Vedolizumab|vedolizumab|mesh-list
14054182|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054183|NCT02646540|Metolazone|metolazone|mesh-list
14054184|NCT02646540|Furosemide|furosemide|mesh-list
14054185|NCT02646540|Tolvaptan|tolvaptan|mesh-list
14054186|NCT02646540|Diuretics|diuretics|mesh-list
14054187|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
14054188|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054189|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14054190|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054191|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054192|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14054193|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14054194|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14054195|NCT02646111|Ribavirin|ribavirin|mesh-list
14054196|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
14054197|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054198|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
14054199|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054200|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
14054201|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14054202|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054203|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
14054204|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14054205|NCT02646137|Estrogens|estrogens|mesh-ancestor
14054206|NCT02646137|Hormones|hormones|mesh-ancestor
14054207|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054208|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054209|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054210|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054211|NCT02646319|Sirolimus|sirolimus|mesh-list
14054212|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14054213|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054214|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14054215|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054216|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
14054217|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14054218|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
14054219|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054220|NCT02646267|Warfarin|warfarin|mesh-list
14054221|NCT02646267|Dabigatran|dabigatran|mesh-list
14054222|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
14054223|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
14054224|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14054225|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
14054226|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054227|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054228|NCT02646189|Interferons|interferons|mesh-list
14054229|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
14054230|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
14054231|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14054232|NCT02646189|REP 2139|rep 2139|mesh-list
14054233|NCT02646189|Thymalfasin|thymalfasin|mesh-list
14054234|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054235|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
14054236|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054237|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
14054238|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054239|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14054240|NCT02646072|Ketorolac|ketorolac|mesh-list
14054241|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14054242|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14054243|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14054244|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14054245|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14054246|NCT02646072|Analgesics|analgesics|mesh-ancestor
14054247|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
14054248|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757413|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
14757414|NCT05341401|Hormones|hormones|mesh-ancestor
14757415|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14757416|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757417|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14757418|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757419|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
14757420|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757421|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14757422|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14757423|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
14757424|NCT05341375|Anesthetics|anesthetics|mesh-list
14757425|NCT05341375|Esketamine|esketamine|mesh-list
14757426|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054249|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054250|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054251|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054252|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14054253|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054254|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054255|NCT02645747|Aflibercept|aflibercept|mesh-list
14054256|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14054257|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14054258|NCT02645747|Growth Substances|growth substances|mesh-ancestor
14054259|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054260|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
14054261|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054262|NCT02645864|Irinotecan|irinotecan|mesh-list
14054263|NCT02645864|Apatinib|apatinib|mesh-list
14054264|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14054265|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14054266|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054267|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054268|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054269|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14054270|NCT02645994|Anesthetics|anesthetics|mesh-list
14054271|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054272|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054273|NCT02645734|Bevacizumab|bevacizumab|mesh-list
14054274|NCT02645734|Aflibercept|aflibercept|mesh-list
14054275|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14054276|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054277|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14054278|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14054279|NCT02645734|Growth Substances|growth substances|mesh-ancestor
14054280|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054281|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14054282|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
14054283|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14054284|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14054285|NCT02645565|Prednisolone|prednisolone|mesh-list
14054286|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
14054287|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
14054288|NCT02645565|Azathioprine|azathioprine|mesh-list
14054289|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14054290|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
14054291|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14054292|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
14054293|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054294|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054295|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14054296|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
14054297|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054298|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054299|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14054300|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054301|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
14054302|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
14054303|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054304|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054305|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
14054306|NCT02645565|Hormones|hormones|mesh-ancestor
14054307|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054308|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14054309|NCT02645565|Protective Agents|protective agents|mesh-ancestor
14054310|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054311|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
14054312|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14054313|NCT02645903|Morphine|morphine|mesh-list
14054314|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054315|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054316|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14054317|NCT02645903|Narcotics|narcotics|mesh-ancestor
14054318|NCT02645903|Analgesics|analgesics|mesh-ancestor
14054319|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
14054320|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054321|NCT02645981|Sorafenib|sorafenib|mesh-list
14054322|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475499|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
14171082|NCT04825938|Paclitaxel|paclitaxel|mesh-list
14054323|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14054324|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054325|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054326|NCT02646020|Loratadine|loratadine|mesh-list
14054327|NCT02646020|Aprepitant|aprepitant|mesh-list
14054328|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
14054329|NCT02646020|Desloratadine|desloratadine|mesh-list
14054330|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
14054331|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
14054332|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054333|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054334|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054335|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14054336|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054337|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054338|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14054339|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
14054340|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14054341|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14054342|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
14054343|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
14054344|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
14054345|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054346|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14171083|NCT04825938|Carboplatin|carboplatin|mesh-list
14171084|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14171085|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171086|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171087|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
14171088|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171089|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171090|NCT04826016|Paclitaxel|paclitaxel|mesh-list
14171091|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14171092|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171093|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171094|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
14171095|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171096|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171097|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14171098|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
14171099|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171100|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171101|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14757427|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757428|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
14757429|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14757430|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
14757431|NCT05341349|Nivolumab|nivolumab|mesh-list
14757432|NCT05341349|Ipilimumab|ipilimumab|mesh-list
14757433|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933625|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14933626|NCT01451658|Propranolol|propranolol|mesh-list
14933627|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14171102|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171103|NCT04826133|Calcitriol|calcitriol|mesh-list
14171104|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14171105|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14171106|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171107|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14171108|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14171109|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171110|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14171111|NCT04826133|Vitamins|vitamins|mesh-ancestor
14171112|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
14171113|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14171114|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
14171115|NCT04825496|Fludarabine|fludarabine|mesh-list
14171116|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14171117|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
14171118|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171119|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14757434|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171120|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14171121|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
14054347|NCT02645656|Curcumin|curcumin|mesh-list
14054348|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14054349|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14054350|NCT02645656|Analgesics|analgesics|mesh-ancestor
14054351|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
14054352|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054353|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054354|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054355|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054356|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054357|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054358|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054359|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
14054360|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14054361|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14054362|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054363|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
14054364|NCT02645552|Coagulants|coagulants|mesh-ancestor
14054365|NCT02645370|Topiramate|topiramate|mesh-list
14054366|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
14054367|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14054368|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054369|NCT02645461|Palmidrol|palmidrol|mesh-list
14054370|NCT02645461|Riluzole|riluzole|mesh-list
14054371|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
14054372|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14054373|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14054374|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054375|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054376|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054377|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14054378|NCT02645461|Protective Agents|protective agents|mesh-ancestor
14054379|NCT02645461|Analgesics|analgesics|mesh-ancestor
14054380|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
14054381|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054382|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14054383|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14054384|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054385|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054386|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
14054387|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054388|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14054389|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14054390|NCT02645461|Hormones|hormones|mesh-ancestor
14054391|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054392|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14054393|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14054394|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14054395|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
14054396|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054397|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14054398|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14054399|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054400|NCT02645240|Heparin|heparin|mesh-list
14054401|NCT02645240|Calcium heparin|calcium heparin|mesh-list
14054402|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14054403|NCT02645240|Tinzaparin|tinzaparin|mesh-list
14054404|NCT02645240|Dalteparin|dalteparin|mesh-list
14054405|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
14054406|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14054407|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14054408|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054409|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14054410|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054411|NCT02645266|Aflibercept|aflibercept|mesh-list
14054412|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14054413|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14054414|NCT02645266|Growth Substances|growth substances|mesh-ancestor
14054415|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054416|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
14054417|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054418|NCT02645279|Midazolam|midazolam|mesh-list
14054419|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14054420|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14054421|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054422|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054423|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14054424|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14054425|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14054426|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054427|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
14054428|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
14054429|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
14054430|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
14054431|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054432|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054433|NCT02645058|Analgesics|analgesics|mesh-list
14054434|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054435|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
14054436|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054437|NCT02645032|Vaccines|vaccines|mesh-list
14054438|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
14054439|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054440|NCT02644967|Pembrolizumab|pembrolizumab|mesh-list
14054441|NCT02644967|Ipilimumab|ipilimumab|mesh-list
14054442|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14054443|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054444|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14054445|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054446|NCT02644980|Anesthetics|anesthetics|mesh-list
14054447|NCT02644980|Propofol|propofol|mesh-list
14054448|NCT02644980|Etomidate|etomidate|mesh-list
14054449|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054450|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054451|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14054452|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054453|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
14054454|NCT02644954|Metformin|metformin|mesh-list
14054455|NCT02644954|Calcipotriene|calcipotriene|mesh-list
14054456|NCT02644954|Coal Tar|coal tar|mesh-list
14054457|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13913024|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
13913025|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13913026|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
13913027|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14054458|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054459|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054460|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
14054461|NCT02644785|Protamines|protamines|mesh-list
14054462|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
14054463|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054464|NCT02644785|Coagulants|coagulants|mesh-ancestor
14054465|NCT02644694|Dexamethasone|dexamethasone|mesh-list
14054466|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14054467|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14054468|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054469|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
14054470|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
14054471|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054472|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054473|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054474|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
14054475|NCT02644694|Hormones|hormones|mesh-ancestor
14054476|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054477|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054478|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913028|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
13913029|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913030|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
13913031|NCT03491098|Hormones|hormones|mesh-ancestor
13913032|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913033|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913034|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13913035|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913036|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
13913037|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
13913038|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913039|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913040|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13913041|NCT03491098|Protective Agents|protective agents|mesh-ancestor
14054479|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14054480|NCT02644707|Selenium|selenium|mesh-list
14054481|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
14054482|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054483|NCT02644707|Protective Agents|protective agents|mesh-ancestor
14054484|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054485|NCT02644707|Trace Elements|trace elements|mesh-ancestor
14054486|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
14054487|NCT02644720|Dexamethasone|dexamethasone|mesh-list
14054488|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054489|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
14054490|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
14054491|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054492|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054493|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054494|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
14054495|NCT02644720|Hormones|hormones|mesh-ancestor
14054496|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054497|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054498|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054499|NCT02644863|Paclitaxel|paclitaxel|mesh-list
14054500|NCT02644863|Cisplatin|cisplatin|mesh-list
14054501|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14054502|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054503|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14054504|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14054505|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14054506|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054507|NCT02644629|Ketamine|ketamine|mesh-list
14054508|NCT02644629|Analgesics|analgesics|mesh-ancestor
14054509|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
14054510|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054511|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054512|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14054513|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054514|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
14054515|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
14054516|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054517|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14054518|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14054519|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054520|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054521|NCT02644915|Edaravone|edaravone|mesh-list
14054522|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14054523|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
14054524|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054525|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14054526|NCT02644915|Protective Agents|protective agents|mesh-ancestor
14054527|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054528|NCT02644811|Anesthetics|anesthetics|mesh-list
14054529|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054530|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054531|NCT02644616|Torsemide|torsemide|mesh-list
14054532|NCT02644616|Tolvaptan|tolvaptan|mesh-list
14054533|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14054534|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054535|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
14054536|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054537|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14054538|NCT02644616|Diuretics|diuretics|mesh-ancestor
14054539|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14054540|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054541|NCT02644499|Folic Acid|folic acid|mesh-list
14757435|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14757436|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757437|NCT05341323|Ketamine|ketamine|mesh-list
14757438|NCT05341323|Bupivacaine|bupivacaine|mesh-list
14054542|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
14054543|NCT02644499|Prednisolone|prednisolone|mesh-list
14054544|NCT02644499|Methotrexate|methotrexate|mesh-list
14054545|NCT02644499|Leflunomide|leflunomide|mesh-list
14054546|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
14054547|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14054548|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
14054549|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054550|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054551|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14054552|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
14054553|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054554|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054555|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054556|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054557|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14054558|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14054559|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
14054560|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054561|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14054562|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054563|NCT02644499|Hormones|hormones|mesh-ancestor
14054564|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054565|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054566|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
14054567|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14054568|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14054569|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054570|NCT02644499|Hematinics|hematinics|mesh-ancestor
14054571|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
14054572|NCT02644499|Vitamins|vitamins|mesh-ancestor
14054573|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
14054574|NCT02644590|Melatonin|melatonin|mesh-list
14054575|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
14054576|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054577|NCT02644590|Protective Agents|protective agents|mesh-ancestor
14054578|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054579|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054580|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14054581|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
14054582|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054583|NCT02644551|Ciclopirox|ciclopirox|mesh-list
14054584|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
14054585|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054586|NCT02644395|Amlodipine|amlodipine|mesh-list
14054587|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
14054588|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14054589|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14054590|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757439|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
14757440|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
14757441|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757442|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757443|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
14757444|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757445|NCT05341323|Analgesics|analgesics|mesh-ancestor
14757446|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14757447|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054591|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757448|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
14757449|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14757450|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14054592|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14054593|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054594|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
14054595|NCT02644395|Diuretics|diuretics|mesh-ancestor
14054596|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
14054597|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14054598|NCT02644304|Cabergoline|cabergoline|mesh-list
14054599|NCT02644304|Clomiphene|clomiphene|mesh-list
14054600|NCT02644304|Enclomiphene|enclomiphene|mesh-list
14054601|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
14054602|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054603|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14054604|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
14054605|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913042|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
13913043|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13913044|NCT03491085|Amoxicillin|amoxicillin|mesh-list
13913045|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
13913046|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
13913047|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13913048|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14054606|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054607|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14054608|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
14054609|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054610|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14054611|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14054612|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14054613|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14054614|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
14054615|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
14054616|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054617|NCT02644408|Megestrol|megestrol|mesh-list
14054618|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14054619|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14054620|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14054621|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
14054622|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054623|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054624|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14054625|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14054626|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14054627|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054628|NCT02644486|Irbesartan|irbesartan|mesh-list
14054629|NCT02644486|Sevelamer|sevelamer|mesh-list
14054630|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14054631|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14054632|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14054633|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054634|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
14054635|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
14054636|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
14054637|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14054638|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14054639|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054640|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
14054641|NCT02644473|Coagulants|coagulants|mesh-ancestor
14054642|NCT02644577|Metformin|metformin|mesh-list
14054643|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14054644|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054645|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13913049|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913050|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13913051|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054646|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054647|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14054648|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
14054649|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913052|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913053|NCT03491072|Fentanyl|fentanyl|mesh-list
13913054|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13913055|NCT03491072|Narcotics|narcotics|mesh-ancestor
13913056|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913057|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913058|NCT03491072|Analgesics|analgesics|mesh-ancestor
13913059|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
13913060|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913061|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13913062|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13913063|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
13913064|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
13913065|NCT03490994|Warfarin|warfarin|mesh-list
14054650|NCT02644421|Lidocaine|lidocaine|mesh-list
14054651|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
14054652|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
14054653|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054654|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054655|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
14054656|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054657|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14054658|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14054659|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14054660|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054661|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054662|NCT02644252|Tocotrienols|tocotrienols|mesh-list
14054663|NCT02644252|Vitamin E|vitamin e|mesh-list
14054664|NCT02644252|Tocopherols|tocopherols|mesh-list
14054665|NCT02644252|Carboplatin|carboplatin|mesh-list
14054666|NCT02644252|Vinorelbine|vinorelbine|mesh-list
14054667|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054668|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14054669|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14757451|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757452|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757453|NCT05341193|Gemcitabine|gemcitabine|mesh-list
14757454|NCT05341193|Bevacizumab|bevacizumab|mesh-list
14757455|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14757456|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757457|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14757458|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14757459|NCT05341193|Growth Substances|growth substances|mesh-ancestor
14757460|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757461|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
14757462|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14757463|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
14757464|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757465|NCT05341193|Antiviral Agents|antiviral agents|mesh-ancestor
14757466|NCT05341193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757467|NCT05341193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757468|NCT05341193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14757469|NCT05341193|Immunologic Factors|immunologic factors|mesh-ancestor
14054670|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14054671|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14054672|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054673|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
14054674|NCT02644252|Protective Agents|protective agents|mesh-ancestor
14054675|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054676|NCT02644252|Vitamins|vitamins|mesh-ancestor
14054677|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
14054678|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
14054679|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
14054680|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054681|NCT02644226|Sevoflurane|sevoflurane|mesh-list
14054682|NCT02644226|Desflurane|desflurane|mesh-list
14054683|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14054684|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13913066|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
14054685|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
14054686|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
14054687|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767247|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767248|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767249|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
14767250|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767251|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767252|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14767253|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
14767254|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14767255|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14767256|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14767257|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14767258|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767259|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
14054688|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054689|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14054690|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14054691|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054692|NCT02644044|Methotrexate|methotrexate|mesh-list
14054693|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14054694|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
14054695|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054696|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054697|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14054698|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
14054699|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054700|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054701|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054702|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054703|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14054704|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14054705|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
14054706|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054707|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14054708|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
14054709|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14054710|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
14054711|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913067|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
13913068|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13913069|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
13913070|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13913071|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
13913072|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913073|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913074|NCT03490825|Melatonin|melatonin|mesh-list
13913075|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
13913076|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913077|NCT03490825|Protective Agents|protective agents|mesh-ancestor
14054712|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14054713|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054714|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054715|NCT02644291|Mebendazole|mebendazole|mesh-list
14054716|NCT02644291|Piperazine|piperazine|mesh-list
14054717|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
14054718|NCT02644291|DMP 777|dmp 777|mesh-list
14054719|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
14054720|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
14054721|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14054722|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054723|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14054724|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14054725|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14054726|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054727|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054728|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171122|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054729|NCT02644057|Dobutamine|dobutamine|mesh-list
14054730|NCT02644057|Milrinone|milrinone|mesh-list
14054731|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14054732|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
14054733|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
14054734|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054735|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054736|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14054737|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14054738|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14054739|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14054740|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054741|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054742|NCT02644057|Protective Agents|protective agents|mesh-ancestor
14054743|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14054744|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
14054745|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14054746|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14054747|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054748|NCT02643914|Nicotine|nicotine|mesh-list
14054749|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14054750|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
14054751|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054752|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054753|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14054754|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13913078|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913079|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913080|NCT03490708|Tranilast|tranilast|mesh-list
13913081|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13913082|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13913083|NCT03490708|Analgesics|analgesics|mesh-ancestor
13913084|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
13913085|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913086|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913087|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913088|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913089|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13913090|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913091|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913092|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13913093|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13913094|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
13913095|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
13913096|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913097|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13913098|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13913099|NCT03490617|Misoprostol|misoprostol|mesh-list
13913100|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14054755|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
14054756|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054757|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054758|NCT02643563|Epinephrine|epinephrine|mesh-list
14054759|NCT02643563|Bupivacaine|bupivacaine|mesh-list
14054760|NCT02643563|Ropivacaine|ropivacaine|mesh-list
14054761|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
14054762|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
14054763|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054764|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933628|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14933629|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
14054765|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
14054766|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054767|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14054768|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14054769|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
14054770|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054771|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054772|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14054773|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14054774|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
14054775|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14054776|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
14054777|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
13913101|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
13913102|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13913103|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757473|NCT05341167|Phenylephrine|phenylephrine|mesh-list
14757474|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
14757475|NCT05341167|Norepinephrine|norepinephrine|mesh-list
13913104|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913105|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913106|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
13913107|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
13913108|NCT03490539|Azathioprine|azathioprine|mesh-list
13913109|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13913110|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913111|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13913112|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
13913113|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13913114|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913115|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913116|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913117|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
13913118|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913119|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913120|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
13913121|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913122|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913123|NCT03490487|Prednisolone|prednisolone|mesh-list
13913124|NCT03490487|Carbamazepine|carbamazepine|mesh-list
13913125|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
13913126|NCT03490487|Levetiracetam|levetiracetam|mesh-list
13913127|NCT03490487|Valproic Acid|valproic acid|mesh-list
13913128|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
13913129|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913130|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
13913131|NCT03490487|Hormones|hormones|mesh-ancestor
13913132|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913133|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913134|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13913135|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913136|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054778|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
14054779|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14054780|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14054781|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14054782|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14054783|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
14054784|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054785|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14054786|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14054787|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054788|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
14054789|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14054790|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054791|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
13913137|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
13913138|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913139|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913140|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
13913141|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913142|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
13913143|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13913144|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913145|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13913146|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13913147|NCT03490487|Analgesics|analgesics|mesh-ancestor
13913148|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
13913149|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13913150|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913151|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13913152|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13913153|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14054792|NCT02643823|Methotrexate|methotrexate|mesh-list
14054793|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
13913154|NCT03490396|Povidone|povidone|mesh-list
13913155|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
13913156|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13913157|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
14757476|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13913158|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054794|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14054795|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
14054796|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054797|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054798|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14054799|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
14054800|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054801|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054802|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
14054803|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054804|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14054805|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14054806|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
14054807|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14054808|NCT02643719|Topiramate|topiramate|mesh-list
14054809|NCT02643719|Naproxen|naproxen|mesh-list
14054810|NCT02643719|Sumatriptan|sumatriptan|mesh-list
14054811|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14054812|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14054813|NCT02643719|Analgesics|analgesics|mesh-ancestor
14054814|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
14054815|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054816|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054817|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054818|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054819|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
14054820|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14054821|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054822|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054823|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
14054824|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14054825|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14054826|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14054827|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14054828|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
14054829|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054830|NCT02643732|Methylphenidate|methylphenidate|mesh-list
14054831|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14933630|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933631|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933632|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933633|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14933634|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14933635|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
14933636|NCT01451710|Prednisone|prednisone|mesh-list
14933637|NCT01451710|Prednisolone|prednisolone|mesh-list
14054832|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054833|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14054834|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14054835|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054836|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054837|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
13913159|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
13913160|NCT03490396|Protective Agents|protective agents|mesh-ancestor
13913161|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
13913162|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
13913163|NCT03490344|Lenalidomide|lenalidomide|mesh-list
14054838|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054839|NCT02643550|Cetuximab|cetuximab|mesh-list
14054840|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14054841|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054842|NCT02643602|Theophylline|theophylline|mesh-list
14933638|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14933639|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
14933640|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14933641|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
13913164|NCT03490344|Daratumumab|daratumumab|mesh-list
13913165|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
13913166|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913167|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13913168|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13913169|NCT03490344|Growth Substances|growth substances|mesh-ancestor
13913170|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
14054843|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14054844|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
14054845|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054846|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054847|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14054848|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
14054849|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14054850|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054851|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054852|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
14054853|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14054854|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14054855|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
14054856|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054857|NCT02643433|Vaccines|vaccines|mesh-list
14054858|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
14054859|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054860|NCT02643407|Docetaxel|docetaxel|mesh-list
14054861|NCT02643407|Nedaplatin|nedaplatin|mesh-list
14054862|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054863|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
14054864|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
14054865|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
14054866|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054867|NCT02643329|Gliclazide|gliclazide|mesh-list
14054868|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14054869|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054870|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
14054871|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14054872|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054873|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054874|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14054875|NCT02643017|Analgesics|analgesics|mesh-ancestor
14054876|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
14054877|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054878|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14054879|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14054880|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14054881|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14054882|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14054883|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054884|NCT02643173|Anesthetics|anesthetics|mesh-list
14054885|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
14054886|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054887|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054888|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
14054889|NCT02643147|Furosemide|furosemide|mesh-list
14054890|NCT02643147|Diuretics|diuretics|mesh-list
14054891|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14054892|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
14054893|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054894|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054895|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054896|NCT02643186|Misoprostol|misoprostol|mesh-list
14054897|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14054898|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
14054899|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054900|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054901|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14054902|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054903|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
14054904|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
14054905|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14054906|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
14054907|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14054908|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
14054909|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054910|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054911|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
14054912|NCT02642900|Nystatin|nystatin|mesh-list
14054913|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14054914|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14054915|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
14054916|NCT02642900|Ionophores|ionophores|mesh-ancestor
14054917|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14054918|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054919|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
14054920|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
14054921|NCT02642861|Calcium|calcium|mesh-list
14054922|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14054923|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054924|NCT02642861|Antacids|antacids|mesh-ancestor
14054925|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054926|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054927|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14054928|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
14054929|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14054930|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14054931|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14054932|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054933|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14054934|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054935|NCT02642913|Sorafenib|sorafenib|mesh-list
14054936|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14054937|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14054938|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14054939|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054940|NCT02642874|Methocarbamol|methocarbamol|mesh-list
14054941|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
14054942|NCT02642874|Calcium|calcium|mesh-list
14054943|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14054944|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054945|NCT02642874|Antacids|antacids|mesh-ancestor
14054946|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054947|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14054948|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14054949|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14054950|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054951|NCT02642939|Mifepristone|mifepristone|mesh-list
14054952|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14054953|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
14054954|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14054955|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054956|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14054957|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14054958|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14054959|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
14054960|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14054961|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14054962|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
14054963|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14054964|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
14054965|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14054966|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14054967|NCT02642718|Ketorolac|ketorolac|mesh-list
14054968|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14054969|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14054970|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14054971|NCT02642718|Analgesics|analgesics|mesh-ancestor
14054972|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
14054973|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054974|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757477|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
14757478|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
14757479|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757480|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757481|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
14757482|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14757483|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
14757484|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
14054975|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14054976|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14054977|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14054978|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933642|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14933643|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
14933644|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933645|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
14933646|NCT01451710|Hormones|hormones|mesh-ancestor
14054979|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054980|NCT02642640|Melatonin|melatonin|mesh-list
14054981|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
14054982|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14054983|NCT02642640|Protective Agents|protective agents|mesh-ancestor
14054984|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054985|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14054986|NCT02642523|Insulin|insulin|mesh-list
14054987|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14054988|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14054989|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14054990|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054991|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
14054992|NCT02642497|Ketamine|ketamine|mesh-list
14054993|NCT02642497|Analgesics|analgesics|mesh-ancestor
14054994|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
14054995|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14054996|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14054997|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14054998|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14054999|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
14475500|NCT02400437|Hormones|hormones|mesh-ancestor
14475501|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475502|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14475503|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475504|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475505|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
14475506|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475507|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
14475508|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475509|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475510|NCT02400580|Acetaminophen|acetaminophen|mesh-list
14055000|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
14055001|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055002|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14055003|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14055004|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055005|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055006|NCT02642484|Gabapentin|gabapentin|mesh-list
14055007|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
14055008|NCT02642484|Calcium|calcium|mesh-list
14055009|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14055010|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055011|NCT02642484|Analgesics|analgesics|mesh-ancestor
14055012|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
14055013|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055014|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
14055015|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14055016|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14055017|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055018|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14055019|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14055020|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14055021|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055022|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055023|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
14055024|NCT02642484|Antacids|antacids|mesh-ancestor
14055025|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055026|NCT02642419|Aspirin|aspirin|mesh-list
14055027|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
14055028|NCT02642419|Clopidogrel|clopidogrel|mesh-list
14055029|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13913171|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913172|NCT03490279|Lactoferrin|lactoferrin|mesh-list
13913173|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913174|NCT03490123|Azithromycin|azithromycin|mesh-list
13913175|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13913176|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913177|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
13913178|NCT03490097|Simvastatin|simvastatin|mesh-list
13913179|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13913180|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13913181|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
13913182|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913183|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13913184|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13913185|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913186|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
13913187|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913188|NCT03490019|Metformin|metformin|mesh-list
13913189|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13913190|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913191|NCT03489928|Misoprostol|misoprostol|mesh-list
14055030|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14055031|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14055032|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055033|NCT02642419|Analgesics|analgesics|mesh-ancestor
14055034|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
14055035|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055036|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055037|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055038|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055039|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14055040|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14055041|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055042|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14055043|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055044|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
14055045|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14055046|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14055047|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14055048|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
14055049|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055050|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14055051|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
14055052|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14055053|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
14055054|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
14055055|NCT02642380|Dexamethasone|dexamethasone|mesh-list
14055056|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
14055057|NCT02642380|BB 1101|bb 1101|mesh-list
14055058|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055059|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
14055060|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
14055061|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055062|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055063|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055064|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
14055065|NCT02642380|Hormones|hormones|mesh-ancestor
14055066|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14055067|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14055068|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055069|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
14055070|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055071|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055072|NCT02642601|Indomethacin|indomethacin|mesh-list
14055073|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14055074|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055075|NCT02642601|Analgesics|analgesics|mesh-ancestor
14055076|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
14055077|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055078|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055079|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055080|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055081|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
14055082|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
14055083|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14055084|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14055085|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055086|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055087|NCT02642367|Rocuronium|rocuronium|mesh-list
14055088|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14055089|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14055090|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14055091|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055092|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055093|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
14055094|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
14055095|NCT02642146|Calcium|calcium|mesh-list
14055096|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
14055097|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14055098|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055099|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055100|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055101|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055102|NCT02642250|Metronidazole|metronidazole|mesh-list
14055103|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055104|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14055105|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14055106|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14933647|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933648|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933649|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14933650|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933651|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
14933652|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
14933653|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933654|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171123|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171124|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14757485|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14757486|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14171128|NCT04824924|Venetoclax|venetoclax|mesh-list
14171129|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171130|NCT04825093|Vitamin D|vitamin d|mesh-list
14171131|NCT04825093|Vitamins|vitamins|mesh-ancestor
14171132|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
14171133|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171134|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14171135|NCT04824638|Vaccines|vaccines|mesh-list
14171136|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
14171137|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171138|NCT04824586|Insulin|insulin|mesh-list
14171139|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14171140|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14171141|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183120|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183121|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183122|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
14183123|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183124|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14183125|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14183126|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14183127|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913192|NCT03489928|Dinoprostone|dinoprostone|mesh-list
13913193|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13913194|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
13913195|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13913196|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913197|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913198|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913199|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
13913200|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13913201|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13913202|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913203|NCT03489837|Dipropizine|dipropizine|mesh-list
13913204|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
13913205|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
14055107|NCT02642263|Carbetocin|carbetocin|mesh-list
14055108|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
14055109|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14055110|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055111|NCT02641990|Exenatide|exenatide|mesh-list
14055112|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14055113|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055114|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14055115|NCT02641990|Incretins|incretins|mesh-ancestor
14055116|NCT02641990|Hormones|hormones|mesh-ancestor
14055117|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14055118|NCT02642003|Sargramostim|sargramostim|mesh-list
14055119|NCT02642003|Lenograstim|lenograstim|mesh-list
14055120|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
14055121|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055122|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14055123|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
14055124|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14055125|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933655|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13913206|NCT03489798|Alprostadil|alprostadil|mesh-list
13913207|NCT03489798|Misoprostol|misoprostol|mesh-list
13913208|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13913209|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
14055126|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055127|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055128|NCT02641938|Analgesics|analgesics|mesh-ancestor
14055129|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
14055130|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055131|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14055132|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14055133|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14055134|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
14055135|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055136|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055137|NCT02641847|Gemcitabine|gemcitabine|mesh-list
14055138|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
14055139|NCT02641847|Docetaxel|docetaxel|mesh-list
14055140|NCT02641847|Doxorubicin|doxorubicin|mesh-list
14055141|NCT02641847|Epirubicin|epirubicin|mesh-list
14055142|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14055143|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
14055144|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055145|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055146|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14055147|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
14055148|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055149|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055150|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14055151|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14055152|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
14055153|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
14055154|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055155|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055156|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
14055157|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14055158|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14055159|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14757487|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14757488|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
14757489|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757490|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913210|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13913211|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913212|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913213|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913214|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
13913215|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13913216|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
13913217|NCT03489798|Urological Agents|urological agents|mesh-ancestor
13960007|NCT03158376|Analgesics|analgesics|mesh-ancestor
13960008|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
13960009|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055160|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14171142|NCT04824599|Ropivacaine|ropivacaine|mesh-list
14055161|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14055162|NCT02641899|Acetaminophen|acetaminophen|mesh-list
14055163|NCT02641899|Exenatide|exenatide|mesh-list
14055164|NCT02641899|Digoxin|digoxin|mesh-list
14055165|NCT02641899|Lisinopril|lisinopril|mesh-list
14055166|NCT02641899|Warfarin|warfarin|mesh-list
14055167|NCT02641899|Atorvastatin|atorvastatin|mesh-list
14055168|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14055169|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14055170|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
14055171|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055172|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14055173|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14055174|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055175|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055176|NCT02641899|Analgesics|analgesics|mesh-ancestor
14055177|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
14055178|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055179|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055180|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
14055181|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
14757491|NCT05341167|Protective Agents|protective agents|mesh-ancestor
14757492|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
14757493|NCT05341154|Ketamine|ketamine|mesh-list
14757494|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14757495|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757496|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757497|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757498|NCT05341154|Analgesics|analgesics|mesh-ancestor
14757499|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
14757500|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757501|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14055182|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14055183|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14055184|NCT02641899|Protective Agents|protective agents|mesh-ancestor
14055185|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14055186|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14055187|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14055188|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14055189|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14055190|NCT02641899|Incretins|incretins|mesh-ancestor
14055191|NCT02641899|Hormones|hormones|mesh-ancestor
14055192|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14055193|NCT02641821|Nifedipine|nifedipine|mesh-list
14055194|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14055195|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055196|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055197|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14055198|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055199|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
14055200|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
14055201|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14055202|NCT02641782|Aldesleukin|aldesleukin|mesh-list
14055203|NCT02641782|Interleukin-2|interleukin-2|mesh-list
14055204|NCT02641782|Tretinoin|tretinoin|mesh-list
14055205|NCT02641782|Dinutuximab|dinutuximab|mesh-list
14055206|NCT02641782|Isotretinoin|isotretinoin|mesh-list
14055207|NCT02641782|Antibodies|antibodies|mesh-list
14055208|NCT02641782|Sargramostim|sargramostim|mesh-list
14055209|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
14055210|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055211|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055212|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055213|NCT02641782|Analgesics|analgesics|mesh-ancestor
14055214|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
14055215|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055216|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
14055217|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
14055218|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14055219|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14055220|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
14055221|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055222|NCT02641652|Sertraline|sertraline|mesh-list
14933656|NCT01451710|Protective Agents|protective agents|mesh-ancestor
14055223|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
14055224|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14055225|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14171143|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
14933657|NCT01451788|Thrombin|thrombin|mesh-list
14055226|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14055227|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055228|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055229|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055230|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
14055231|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055232|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
14055233|NCT02641639|Combretastatin|combretastatin|mesh-list
14055234|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14055235|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055236|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
14055237|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
14933658|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
14933659|NCT01451788|Coagulants|coagulants|mesh-ancestor
14933660|NCT01451840|Lidocaine|lidocaine|mesh-list
14933661|NCT01451840|Remifentanil|remifentanil|mesh-list
14933662|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
14933663|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
14933664|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933665|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933666|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
14933667|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933668|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14933669|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14933670|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14933671|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055238|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
14055239|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055240|NCT02641457|Ranibizumab|ranibizumab|mesh-list
14055241|NCT02641457|Aflibercept|aflibercept|mesh-list
14055242|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14055243|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14055244|NCT02641457|Growth Substances|growth substances|mesh-ancestor
14055245|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055246|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
14055247|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055248|NCT02641210|Albendazole|albendazole|mesh-list
14055249|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
14055250|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14055251|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055252|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
14055253|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14055254|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14055255|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
14055256|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
14055257|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
14055258|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055259|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055260|NCT02641431|Ajmaline|ajmaline|mesh-list
14055261|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14055262|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14055263|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14055264|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055265|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055266|NCT02641301|Morphine|morphine|mesh-list
14055267|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14055268|NCT02641301|Narcotics|narcotics|mesh-ancestor
14055269|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757502|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14757503|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14757504|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
14757505|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757506|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757507|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14757508|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14757509|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
14757510|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
14938645|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757511|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14757512|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13913218|NCT03489668|Metformin|metformin|mesh-list
13913219|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13913220|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913221|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
13913222|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13913223|NCT03489629|Minocycline|minocycline|mesh-list
13913224|NCT03489629|Trimethoprim|trimethoprim|mesh-list
13913225|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
13913226|NCT03489629|Mupirocin|mupirocin|mesh-list
14055270|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055271|NCT02641301|Analgesics|analgesics|mesh-ancestor
14055272|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
14055273|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055274|NCT02641314|Celecoxib|celecoxib|mesh-list
14055275|NCT02641314|Propranolol|propranolol|mesh-list
14055276|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055277|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055278|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055279|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14055280|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055281|NCT02641314|Analgesics|analgesics|mesh-ancestor
14055282|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
14055283|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055284|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055285|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14055286|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14757513|NCT05341115|Leuprolide|leuprolide|mesh-list
14757514|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13913227|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13913228|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13913229|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913230|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
13913231|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14757515|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
14757516|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757517|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757518|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14757519|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757520|NCT05341076|Oxytocin|oxytocin|mesh-list
14757521|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
14757522|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757523|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757524|NCT05340985|Vitamin D|vitamin d|mesh-list
13913232|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13913233|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13913234|NCT03489629|Renal Agents|renal agents|mesh-ancestor
13913235|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
13913236|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13913237|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13913238|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13913239|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913240|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055287|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055288|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14055289|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14055290|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
14055291|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055292|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14055293|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14055294|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
14055295|NCT02641288|Ropivacaine|ropivacaine|mesh-list
14055296|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
14055297|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
14055298|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913241|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13913242|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13913243|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14055299|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055300|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
14055301|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055302|NCT02641340|Fentanyl|fentanyl|mesh-list
14055303|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14055304|NCT02641340|Narcotics|narcotics|mesh-ancestor
14055305|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055306|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055307|NCT02641340|Analgesics|analgesics|mesh-ancestor
14055308|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
14055309|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055310|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14055311|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14055312|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
14055313|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
14055314|NCT02641132|Mitomycins|mitomycins|mesh-list
14055315|NCT02641132|Mitomycin|mitomycin|mesh-list
14055316|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14055317|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055318|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
14055319|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055320|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14055321|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055322|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
14055323|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055324|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14055325|NCT02640989|Vaccines|vaccines|mesh-list
14055326|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
14055327|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055328|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14055329|NCT02640976|Cetrorelix|cetrorelix|mesh-list
14055330|NCT02640976|Menotropins|menotropins|mesh-list
14055331|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14055332|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055333|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14055334|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
14055335|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
14055336|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14055337|NCT02640846|Simendan|simendan|mesh-list
14055338|NCT02640846|Milrinone|milrinone|mesh-list
14055339|NCT02640846|Norepinephrine|norepinephrine|mesh-list
14055340|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14055341|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14055342|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
14055343|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055344|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055345|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055346|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
14055347|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
14055348|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055349|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14055350|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14055351|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
14055352|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14055353|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14055354|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055355|NCT02640846|Protective Agents|protective agents|mesh-ancestor
14055356|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14055357|NCT02640898|Docetaxel|docetaxel|mesh-list
14055358|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055359|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14055360|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14055361|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14055362|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055363|NCT02641054|Levodopa|levodopa|mesh-list
14055364|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14055365|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14055366|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
14055367|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055368|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055369|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055370|NCT02640833|Venetoclax|venetoclax|mesh-list
14055371|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055372|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14055373|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
14055374|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055375|NCT02640794|Aspirin|aspirin|mesh-list
14055376|NCT02640794|Clopidogrel|clopidogrel|mesh-list
14055377|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14055378|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055379|NCT02640794|Analgesics|analgesics|mesh-ancestor
14055380|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
14055381|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055382|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055383|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055384|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055385|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14055386|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14055387|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055388|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14055389|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14055390|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055391|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
14055392|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14055393|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14055394|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14055395|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
14055396|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055397|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
14055398|NCT02640417|Vitamins|vitamins|mesh-ancestor
14055399|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
14055400|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055401|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
14055402|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14055403|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14055404|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055405|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
14055406|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
14055407|NCT02640495|Artesunate|artesunate|mesh-list
14055408|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
14055409|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14055410|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14055411|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933672|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933673|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14933674|NCT01451840|Narcotics|narcotics|mesh-ancestor
14933675|NCT01451840|Analgesics|analgesics|mesh-ancestor
14933676|NCT01451853|Ebselen|ebselen|mesh-list
14933677|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933678|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933679|NCT01451853|Analgesics|analgesics|mesh-ancestor
14933680|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
14933681|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933682|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933683|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933684|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933685|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913244|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13913245|NCT03489616|Pemetrexed|pemetrexed|mesh-list
13913246|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913247|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055412|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055413|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
14055414|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
14055415|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14055416|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
14055417|NCT02640508|Lenvatinib|lenvatinib|mesh-list
14055418|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055419|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14055420|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055421|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055422|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
13913248|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913249|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13913250|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13913251|NCT03489395|Edoxaban|edoxaban|mesh-list
13913252|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13913253|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
13913254|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13913255|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
13913256|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913257|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913258|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
14055423|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171144|NCT04824599|Anesthetics|anesthetics|mesh-list
14171145|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171146|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171147|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
14171148|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171149|NCT04824898|Simvastatin|simvastatin|mesh-list
14171150|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14171151|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14171152|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
14171153|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171154|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14171155|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14171156|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171157|NCT04824937|Talazoparib|talazoparib|mesh-list
13913259|NCT03489317|Metformin|metformin|mesh-list
13913260|NCT03489317|Amlodipine|amlodipine|mesh-list
13913261|NCT03489317|Simvastatin|simvastatin|mesh-list
14171158|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14171159|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171160|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171161|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171162|NCT04824612|Triamcinolone|triamcinolone|mesh-list
14171163|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14171164|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14171165|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14171166|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171167|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
14171168|NCT04824612|Hormones|hormones|mesh-ancestor
14171169|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171170|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171171|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14171172|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
14171173|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171174|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933686|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913262|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14055424|NCT02640534|Metformin|metformin|mesh-list
14055425|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14055426|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055427|NCT02640365|Leucovorin|leucovorin|mesh-list
14055428|NCT02640365|Bevacizumab|bevacizumab|mesh-list
14055429|NCT02640365|Irinotecan|irinotecan|mesh-list
14055430|NCT02640365|Camptothecin|camptothecin|mesh-list
14055431|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14055432|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055433|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14055434|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14055435|NCT02640365|Growth Substances|growth substances|mesh-ancestor
14055436|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055437|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
14055438|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14055439|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14055440|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055441|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055442|NCT02640365|Antidotes|antidotes|mesh-ancestor
14055443|NCT02640365|Protective Agents|protective agents|mesh-ancestor
14055444|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
14055445|NCT02640365|Vitamins|vitamins|mesh-ancestor
14055446|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
14055447|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14055448|NCT02640222|Vitamin K|vitamin k|mesh-list
14055449|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
14055450|NCT02640222|Apixaban|apixaban|mesh-list
14055451|NCT02640222|Dabigatran|dabigatran|mesh-list
14055452|NCT02640222|Vitamins|vitamins|mesh-ancestor
14055453|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
14055454|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055455|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14055456|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
14055457|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14055458|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
14055459|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055460|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055461|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
14055462|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14055463|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14055464|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
14055465|NCT02640222|Coagulants|coagulants|mesh-ancestor
14055466|NCT02640313|Choline|choline|mesh-list
14055467|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
14055468|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14055469|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
14055470|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055471|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055472|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14055473|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
14055474|NCT02640300|Clozapine|clozapine|mesh-list
14055475|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14055476|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
14055477|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055478|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055479|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055480|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14055481|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14055482|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055483|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14055484|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
14055485|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
14055486|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
14055487|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14055488|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
14055489|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055490|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
14055491|NCT02640144|Protective Agents|protective agents|mesh-ancestor
14055492|NCT02640118|Lixisenatide|lixisenatide|mesh-list
14055493|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14055494|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055495|NCT02639858|Docetaxel|docetaxel|mesh-list
14055496|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055497|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
14055498|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
14055499|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
14055500|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055501|NCT02639767|Pemetrexed|pemetrexed|mesh-list
14055502|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055503|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055504|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055505|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14055506|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14055507|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
14055508|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14055509|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14055510|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055511|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
14055512|NCT02639819|Coagulants|coagulants|mesh-ancestor
14055513|NCT02639806|Lidocaine|lidocaine|mesh-list
14055514|NCT02639806|Sevoflurane|sevoflurane|mesh-list
14055515|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
14055516|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
14055517|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055518|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055519|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
14055520|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055521|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14055522|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14055523|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14055524|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055525|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055526|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14055527|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14055528|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
14055529|NCT02639741|Vitamins|vitamins|mesh-list
14055530|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
14055531|NCT02639741|Melatonin|melatonin|mesh-list
14055532|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
14055533|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055534|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
14055535|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055536|NCT02639741|Protective Agents|protective agents|mesh-ancestor
14055537|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055538|NCT02639650|Dactinomycin|dactinomycin|mesh-list
14055539|NCT02639650|Paclitaxel|paclitaxel|mesh-list
14055540|NCT02639650|Etoposide|etoposide|mesh-list
14055541|NCT02639650|Vincristine|vincristine|mesh-list
14055542|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
14055543|NCT02639650|Carboplatin|carboplatin|mesh-list
14055544|NCT02639650|Methotrexate|methotrexate|mesh-list
14055545|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14055546|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055547|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
14055548|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
14055549|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
14055550|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055551|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14055552|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
14055553|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055554|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055555|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14055556|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
14055557|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14055558|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14055559|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
14055560|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13913263|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913264|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13913265|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13913266|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913267|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913268|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13913269|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
13913270|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13913271|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13913272|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
13913273|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13913274|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14171175|NCT04824911|Aspirin|aspirin|mesh-list
13913275|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913276|NCT03489265|Eluxadoline|eluxadoline|mesh-list
14055561|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14055562|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
14055563|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
14055564|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055565|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14055566|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14055567|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14055568|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14055569|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14055570|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055571|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14055572|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14055573|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
14055574|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14055575|NCT02639533|Pregabalin|pregabalin|mesh-list
14055576|NCT02639533|Analgesics|analgesics|mesh-ancestor
14055577|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
14055578|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055579|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055580|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
14055581|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14055582|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055583|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055584|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14055585|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14055586|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14055587|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055588|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14055589|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
14055590|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14055591|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14055592|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055593|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
14055594|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
14055595|NCT02639598|Topiramate|topiramate|mesh-list
14055596|NCT02639598|Flunarizine|flunarizine|mesh-list
14055597|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
14055598|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14055599|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055600|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14055601|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055602|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055603|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14055604|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14055605|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
14055606|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
14055607|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055608|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
14055609|NCT02639520|Fosfomycin|fosfomycin|mesh-list
14055610|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14055611|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055612|NCT02639143|Clopidogrel|clopidogrel|mesh-list
14055613|NCT02639143|Ticagrelor|ticagrelor|mesh-list
14055614|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14055615|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14055616|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14055617|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14055618|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
14055619|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055620|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055621|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913277|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913278|NCT03489239|Tenofovir|tenofovir|mesh-list
13913279|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
13913280|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913281|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13913282|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14055622|NCT02639065|Durvalumab|durvalumab|mesh-list
14055623|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14055624|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055625|NCT02639234|Nivolumab|nivolumab|mesh-list
14055626|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14055627|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055628|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14055629|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055630|NCT02639039|Cortisone|cortisone|mesh-list
14055631|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055632|NCT02639091|Pemetrexed|pemetrexed|mesh-list
14055633|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055634|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055635|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055636|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14055637|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14171176|NCT04824911|Clopidogrel|clopidogrel|mesh-list
14171177|NCT04824911|Atorvastatin|atorvastatin|mesh-list
14171178|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14171179|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14171180|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171181|NCT04824911|Analgesics|analgesics|mesh-ancestor
14171182|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
14171183|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171184|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171185|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171186|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14171187|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14171188|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14171189|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171190|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14171191|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14171192|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171193|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
14171194|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14171195|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14171196|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
14171197|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14171198|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14171199|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14171200|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14171201|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14171202|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
14171203|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171204|NCT04824352|Apatinib|apatinib|mesh-list
14171205|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171206|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14171207|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171208|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171209|NCT04824404|Buprenorphine|buprenorphine|mesh-list
14171210|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14171211|NCT04824404|Narcotics|narcotics|mesh-ancestor
14171212|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171213|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171214|NCT04824404|Analgesics|analgesics|mesh-ancestor
14171215|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
14171216|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171217|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14171218|NCT04824261|Clotrimazole|clotrimazole|mesh-list
14171219|NCT04824261|Miconazole|miconazole|mesh-list
14171220|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14171221|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171222|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
14171223|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14171224|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14171225|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171226|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171227|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14171228|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
14171229|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171230|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171231|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14933687|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
14938646|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055638|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14055639|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14055640|NCT02638922|Trisequens|trisequens|mesh-list
14055641|NCT02638922|Norethindrone|norethindrone|mesh-list
14055642|NCT02638922|Estradiol|estradiol|mesh-list
14055643|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14055644|NCT02638922|Estrogens|estrogens|mesh-ancestor
14055645|NCT02638922|Hormones|hormones|mesh-ancestor
14055646|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14055647|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055648|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14055649|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
14055650|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14055651|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14055652|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14055653|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14055654|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14055655|NCT02638909|Ceritinib|ceritinib|mesh-list
14055656|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055657|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14055658|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055659|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055660|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
14055661|NCT02638896|Celecoxib|celecoxib|mesh-list
14055662|NCT02638896|Etanercept|etanercept|mesh-list
14055663|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14055664|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055665|NCT02638896|Analgesics|analgesics|mesh-ancestor
14055666|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
14055667|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055668|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055669|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055670|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055671|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14055672|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14055673|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055674|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055675|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055676|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14055677|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
14055678|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055679|NCT02638870|Amitriptyline|amitriptyline|mesh-list
14055680|NCT02638870|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14055681|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14055682|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
14055683|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14055684|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055685|NCT02638870|Analgesics|analgesics|mesh-ancestor
14055686|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
14055687|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055688|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055689|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14055690|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14055691|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055692|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055693|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
14055694|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055695|NCT02638870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14055696|NCT02638870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14055697|NCT02638870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055698|NCT02638857|Epirubicin|epirubicin|mesh-list
14055699|NCT02638857|Mitomycins|mitomycins|mesh-list
14055700|NCT02638857|Mitomycin|mitomycin|mesh-list
14055701|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
14055702|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14055703|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055704|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14055705|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14055706|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055707|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055708|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
14055709|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14055710|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
14055711|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14757525|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
14055712|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055713|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055714|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055715|NCT02638545|Analgesics|analgesics|mesh-ancestor
14055716|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
14055717|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055718|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14055719|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14055720|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14055721|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
14055722|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055723|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757526|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
14757527|NCT05340985|Calcifediol|calcifediol|mesh-list
14757528|NCT05340985|Vitamins|vitamins|mesh-list
14757529|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
14055728|NCT02638831|Ketorolac|ketorolac|mesh-list
14055729|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14055730|NCT02638831|Ketoprofen|ketoprofen|mesh-list
14055731|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14055732|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14055733|NCT02638831|Analgesics|analgesics|mesh-ancestor
14055734|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
14055735|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055736|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055737|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14055738|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055739|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14055740|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055741|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757530|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
14757531|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
14757532|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757533|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14757534|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14757535|NCT05340985|Provitamins|provitamins|mesh-ancestor
14757536|NCT05340946|Anesthetics|anesthetics|mesh-list
14757537|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757538|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171232|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14171233|NCT04824391|Vaccines|vaccines|mesh-list
14171234|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
14171235|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171236|NCT04823962|Molgramostim|molgramostim|mesh-list
14171237|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171238|NCT04824053|Selenium|selenium|mesh-list
14171239|NCT04824053|Caseins|caseins|mesh-list
14171240|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
14171241|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171242|NCT04824053|Protective Agents|protective agents|mesh-ancestor
14757539|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
13913283|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913284|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913285|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13913286|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13913287|NCT03489161|Buprenorphine|buprenorphine|mesh-list
13913288|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13913289|NCT03489161|Narcotics|narcotics|mesh-ancestor
13913290|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913291|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913292|NCT03489161|Analgesics|analgesics|mesh-ancestor
13913293|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
13913294|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913295|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13913296|NCT03489044|Levetiracetam|levetiracetam|mesh-list
13913297|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
14055742|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
14055743|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
14055744|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055745|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14055746|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055747|NCT02638519|Xenon|xenon|mesh-list
14055748|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14055749|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
14055750|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
14055751|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055752|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055753|NCT02638506|Fentanyl|fentanyl|mesh-list
14055754|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14055755|NCT02638506|Narcotics|narcotics|mesh-ancestor
14055756|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055757|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055758|NCT02638506|Analgesics|analgesics|mesh-ancestor
14055759|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
14055760|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055761|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14055762|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14055763|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
14055764|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
14055765|NCT02638389|Sirolimus|sirolimus|mesh-list
14055766|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14055767|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055768|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14055769|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055770|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
14055771|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14055772|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
14055773|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055774|NCT02638428|Cytarabine|cytarabine|mesh-list
14055775|NCT02638428|Carboplatin|carboplatin|mesh-list
14933688|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933689|NCT01451853|Protective Agents|protective agents|mesh-ancestor
14933690|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14933691|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933692|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14933693|NCT01451879|Miglustat|miglustat|mesh-list
14933694|NCT01451879|Rituximab|rituximab|mesh-list
14933695|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933696|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933697|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
14933698|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933699|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933700|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933701|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933702|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14933703|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14933704|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
14055776|NCT02638428|Trastuzumab|trastuzumab|mesh-list
14055777|NCT02638428|Fludarabine|fludarabine|mesh-list
14055778|NCT02638428|Etoposide|etoposide|mesh-list
14055779|NCT02638428|Everolimus|everolimus|mesh-list
14055780|NCT02638428|Sorafenib|sorafenib|mesh-list
14055781|NCT02638428|Ifosfamide|ifosfamide|mesh-list
14055782|NCT02638428|Dasatinib|dasatinib|mesh-list
14055783|NCT02638428|Axitinib|axitinib|mesh-list
14055784|NCT02638428|Vemurafenib|vemurafenib|mesh-list
14055785|NCT02638428|Crizotinib|crizotinib|mesh-list
14055786|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055787|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14055788|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14055789|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
14055790|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055791|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14055792|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
14055793|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055794|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14055795|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14055796|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14055797|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055798|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
14055799|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055800|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14055801|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14933705|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055802|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
14055803|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
14055804|NCT02638233|Ledipasvir|ledipasvir|mesh-list
14055805|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
14055806|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055807|NCT02638376|Riboflavin|riboflavin|mesh-list
14055808|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14055809|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14055810|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
14055811|NCT02638376|Vitamins|vitamins|mesh-ancestor
14055812|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
14055813|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055814|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14055815|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14055816|NCT02638584|Rabeprazole|rabeprazole|mesh-list
14055817|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14055818|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055819|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14055820|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055821|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055822|NCT02638415|Carvedilol|carvedilol|mesh-list
14055823|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14055824|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14055825|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
14055826|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055827|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055828|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055829|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14055830|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
14055831|NCT02638415|Protective Agents|protective agents|mesh-ancestor
14055832|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14055833|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055834|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14055835|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
14055836|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14055837|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14055838|NCT02638285|Clomiphene|clomiphene|mesh-list
14055839|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14055840|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
14055841|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14055842|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055843|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14055844|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
14055845|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14055846|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14055847|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14055848|NCT02638064|Surgiflo|surgiflo|mesh-list
14055849|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
14055850|NCT02638064|Coagulants|coagulants|mesh-ancestor
14055851|NCT02638142|Furosemide|furosemide|mesh-list
14055852|NCT02638142|Diuretics|diuretics|mesh-ancestor
14055853|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
14055854|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055855|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14055856|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055857|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055858|NCT02638116|Omeprazole|omeprazole|mesh-list
14055859|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14055860|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055861|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14055862|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055863|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055864|NCT02637973|Empagliflozin|empagliflozin|mesh-list
14055865|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14055866|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055867|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14055868|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055869|NCT02637830|Fluorides|fluorides|mesh-list
14055870|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
14055871|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
14055872|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
14757540|NCT05340803|Midazolam|midazolam|mesh-list
14757541|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
14757542|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13913298|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
13913299|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
13913300|NCT03489005|Zamicastat|zamicastat|mesh-list
13913301|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13913302|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913303|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13913304|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13913305|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913306|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913307|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913308|NCT03488888|Bupivacaine|bupivacaine|mesh-list
13913309|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
13913310|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
13913311|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913312|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913313|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
13913314|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913315|NCT03488810|Hormones|hormones|mesh-list
13913316|NCT03488810|Androgens|androgens|mesh-list
13913317|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
14055873|NCT02637830|Protective Agents|protective agents|mesh-ancestor
14055874|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055875|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
14055876|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14055877|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14055878|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
14055879|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
14055880|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055881|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055882|NCT02637726|Remifentanil|remifentanil|mesh-list
14055883|NCT02637726|Propofol|propofol|mesh-list
14055884|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14055885|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055886|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055887|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14055888|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
14055889|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
14055890|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14055891|NCT02637726|Narcotics|narcotics|mesh-ancestor
14055892|NCT02637726|Analgesics|analgesics|mesh-ancestor
14055893|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
14055894|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14055895|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
14055896|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14055897|NCT02637700|Antibodies|antibodies|mesh-list
14055898|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
14055899|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14055900|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
14055901|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055902|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14055903|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
14055904|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055905|NCT02637466|Vortioxetine|vortioxetine|mesh-list
14055906|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
14055907|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14055908|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14055909|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14055910|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14055911|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055912|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14055913|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14055914|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055915|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055916|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055917|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
14055918|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14055919|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14055920|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14055921|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14055922|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
14938647|NCT01482897|Prednisolone|prednisolone|mesh-list
13913318|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
14055923|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14055924|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
14055925|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055926|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
14055927|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055928|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14055929|NCT02637284|BPC 157|bpc 157|mesh-list
14055930|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14055931|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055932|NCT02637375|Paclitaxel|paclitaxel|mesh-list
14055933|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
14055934|NCT02637375|Doxorubicin|doxorubicin|mesh-list
14055935|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14055936|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055937|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
14055938|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
14055939|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
14055940|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055941|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14055942|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
14055943|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055944|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14055945|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14055946|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
14055947|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14055948|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14055949|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14055950|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14055951|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055952|NCT02637167|Rifaximin|rifaximin|mesh-list
14757543|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757544|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757545|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757546|NCT05340803|Analgesics|analgesics|mesh-ancestor
14757547|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
14757548|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757549|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14757550|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14757551|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14757552|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
14757553|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757554|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757555|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14757556|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14757557|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14757558|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14757559|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14757560|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
14757561|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
14757562|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
14757563|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
14757564|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14055953|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14055954|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055955|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14055956|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
14055957|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14055958|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14055959|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055960|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14055961|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14055962|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14055963|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14055964|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055965|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055966|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14055967|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14055968|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14055969|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14055970|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14055971|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
14055972|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14055973|NCT02637128|Artesunate|artesunate|mesh-list
14055974|NCT02637128|Lumefantrine|lumefantrine|mesh-list
14757565|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
14055975|NCT02637128|Artemether|artemether|mesh-list
14055976|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14055977|NCT02637128|Amodiaquine|amodiaquine|mesh-list
14055978|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
14055979|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14055980|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14055981|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055982|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14055983|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
14055984|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
14055985|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14055986|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
14171243|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171244|NCT04824053|Trace Elements|trace elements|mesh-ancestor
14171245|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
14171246|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
14171247|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
14171248|NCT04823390|Fentanyl|fentanyl|mesh-list
14171249|NCT04823390|Midazolam|midazolam|mesh-list
14171250|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14171251|NCT04823390|Narcotics|narcotics|mesh-ancestor
14171252|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171253|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171254|NCT04823390|Analgesics|analgesics|mesh-ancestor
14171255|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
14171256|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171257|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14171258|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14171259|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
14171260|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
14171261|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14171262|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14171263|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14171264|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14171265|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
14171266|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
14171267|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171268|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171269|NCT04823442|Bisoprolol|bisoprolol|mesh-list
14171270|NCT04823442|Mirabegron|mirabegron|mesh-list
14171271|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14171272|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14171273|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14171274|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171275|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171276|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171277|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171278|NCT04823442|Urological Agents|urological agents|mesh-ancestor
14171279|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14171280|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
14171281|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
14171282|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171283|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14171284|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14171285|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14171286|NCT04823468|Cisplatin|cisplatin|mesh-list
14171287|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171288|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
14171289|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171290|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171291|NCT04823403|Nivolumab|nivolumab|mesh-list
14171292|NCT04823403|Ipilimumab|ipilimumab|mesh-list
14171293|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14171294|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171295|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14171296|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171297|NCT04823156|Calcium|calcium|mesh-list
14171298|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14171299|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171300|NCT04823260|Niacinamide|niacinamide|mesh-list
14171301|NCT04823260|Niacin|niacin|mesh-list
14171302|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
14171303|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
14171304|NCT04823260|Vitamins|vitamins|mesh-ancestor
14171305|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
14171306|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171307|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14171308|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
14055987|NCT02636816|Carbetocin|carbetocin|mesh-list
14055988|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
14055989|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14055990|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14055991|NCT02636803|Albendazole|albendazole|mesh-list
14055992|NCT02636803|Oxfendazole|oxfendazole|mesh-list
14055993|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
14055994|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14055995|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14055996|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
14055997|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14055998|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14055999|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
14056000|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
14056001|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
14056002|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056003|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056004|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
14056005|NCT02636829|Calcium|calcium|mesh-list
14757566|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14056006|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14056007|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475511|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475512|NCT02400580|Analgesics|analgesics|mesh-ancestor
14475513|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
14475514|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475515|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475516|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
14056008|NCT02636842|Aripiprazole|aripiprazole|mesh-list
14056009|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
14056010|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
14056011|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056012|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14056013|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056014|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056015|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056016|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
14056017|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
14056018|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056019|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056020|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14056021|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14056022|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
14056023|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14056024|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14056025|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14056026|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14056027|NCT02636426|Sorafenib|sorafenib|mesh-list
14056028|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056029|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14056030|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056031|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056032|NCT02636491|Insulin|insulin|mesh-list
14056033|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14056034|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14056035|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056036|NCT02636231|Endostatins|endostatins|mesh-list
14056037|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14056038|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14056039|NCT02636231|Growth Substances|growth substances|mesh-ancestor
14056040|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056041|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
14056042|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056043|NCT02636218|Ketamine|ketamine|mesh-list
14056044|NCT02636218|Analgesics|analgesics|mesh-ancestor
14056045|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
14056046|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056047|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056048|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14056049|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14056050|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
14056051|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
14475517|NCT02400749|Apremilast|apremilast|mesh-list
14475518|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14475519|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475520|NCT02400749|Analgesics|analgesics|mesh-ancestor
14056052|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056053|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14056054|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14056055|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056056|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056057|NCT02636348|Vitamin D|vitamin d|mesh-list
14056058|NCT02636348|Calcium|calcium|mesh-list
14056059|NCT02636348|Vitamins|vitamins|mesh-ancestor
14056060|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
14056061|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056062|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14056063|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14056064|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14056065|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
14056066|NCT02636387|Coagulants|coagulants|mesh-ancestor
14056067|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14056068|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
14056069|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056070|NCT02636101|Betamethasone|betamethasone|mesh-list
14056071|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
14056072|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14056073|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
14056074|NCT02636101|Calcipotriene|calcipotriene|mesh-list
14056075|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14056076|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056077|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
14056078|NCT02636101|Hormones|hormones|mesh-ancestor
14056079|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056080|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056081|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14056082|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
14056083|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14056084|NCT02636088|Cetuximab|cetuximab|mesh-list
14056085|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14056086|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056087|NCT02635841|Deferiprone|deferiprone|mesh-list
14056088|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14056089|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
14056090|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
14056091|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056092|NCT02635802|Lidocaine|lidocaine|mesh-list
14056093|NCT02635802|Midazolam|midazolam|mesh-list
14056094|NCT02635802|Remifentanil|remifentanil|mesh-list
14056095|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
14056096|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
14056097|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056098|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056099|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
14056100|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056101|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14056102|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14056103|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14056104|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14056105|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056106|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14056107|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14056108|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14056109|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056110|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056111|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14056112|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
14056113|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
14056114|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
14056115|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056116|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14056117|NCT02635802|Narcotics|narcotics|mesh-ancestor
14056118|NCT02635802|Analgesics|analgesics|mesh-ancestor
14056119|NCT02635971|Gemcitabine|gemcitabine|mesh-list
14056120|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
14056121|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14056122|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
14056123|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056124|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757567|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14767260|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14056125|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
14056126|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056127|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056128|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14056129|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
14056130|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056131|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14056132|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14056133|NCT02635607|Ganirelix|ganirelix|mesh-list
14056134|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
14056135|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14056136|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
14056137|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14056138|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056139|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14056140|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14056141|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056142|NCT02635607|Hormones|hormones|mesh-ancestor
14056143|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056144|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
14056145|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
14056146|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14056147|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056148|NCT02635750|Donepezil|donepezil|mesh-list
14056149|NCT02635750|BI 409306|bi 409306|mesh-list
14056150|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14056151|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056152|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056153|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
14056154|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056155|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056156|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
14056157|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14056158|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
14056159|NCT02635867|Calcium|calcium|mesh-list
14056160|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14056161|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056162|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14056163|NCT02635893|Cycloserine|cycloserine|mesh-list
14056164|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14056165|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056166|NCT02635893|Renal Agents|renal agents|mesh-ancestor
14056167|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14056168|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
14056169|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14056170|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
14056171|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056172|NCT02635555|Phenylephrine|phenylephrine|mesh-list
14056173|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
14056174|NCT02635555|Ephedrine|ephedrine|mesh-list
14056175|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14056176|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
14056177|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
14056178|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056179|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056180|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
14056181|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14056182|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
14056183|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
14056184|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14056185|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14056186|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14056187|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
14056188|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475521|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
14475522|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475523|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056189|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056190|NCT02635555|Protective Agents|protective agents|mesh-ancestor
14056191|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14056192|NCT02635243|Glucagon|glucagon|mesh-list
14056193|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056194|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14056195|NCT02635243|Hormones|hormones|mesh-ancestor
14056196|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056197|NCT02635334|Montelukast|montelukast|mesh-list
14056198|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14056199|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
14056200|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14056201|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
14056202|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056203|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056204|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14056205|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14056206|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056207|NCT02635230|Aspirin|aspirin|mesh-list
14056208|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14056209|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14056210|NCT02635230|Analgesics|analgesics|mesh-ancestor
14056211|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
14056212|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056213|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056214|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056215|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14056216|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14056217|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14056218|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056219|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14056220|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14056221|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056222|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
14056223|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
14056224|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056225|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14056226|NCT02635282|Fentanyl|fentanyl|mesh-list
14056227|NCT02635282|Midazolam|midazolam|mesh-list
14056228|NCT02635282|Ketamine|ketamine|mesh-list
14056229|NCT02635282|Analgesics|analgesics|mesh-ancestor
14056230|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
14056231|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056232|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056233|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14056234|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14056235|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
14056236|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
14056237|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056238|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14056239|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14056240|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056241|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056242|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14056243|NCT02635282|Narcotics|narcotics|mesh-ancestor
14056244|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14056245|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14056246|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14056247|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056248|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475524|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475525|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475526|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14475527|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14475528|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479293|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14056249|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
14056250|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
14171309|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171310|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14171311|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
14171312|NCT04822909|Thalidomide|thalidomide|mesh-list
14171313|NCT04822909|Apremilast|apremilast|mesh-list
14171314|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14171315|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171316|NCT04822909|Analgesics|analgesics|mesh-ancestor
14171317|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
14171318|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913319|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913320|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913321|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
13913322|NCT03488719|Metoprolol|metoprolol|mesh-list
13913323|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13913324|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13913325|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
13913326|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
13913327|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913328|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913329|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13913330|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14171319|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171320|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171321|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14171322|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14171323|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14171324|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171325|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171326|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14171327|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
14171328|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
14171329|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14171330|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171331|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14171332|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14171333|NCT04822909|Growth Substances|growth substances|mesh-ancestor
14171334|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
14171335|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183128|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183129|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14183130|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183131|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14183132|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183133|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
14183134|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14183135|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183136|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
14183137|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14183138|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183139|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183140|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183141|NCT04730375|Analgesics|analgesics|mesh-ancestor
14183142|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
14183143|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183144|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14183145|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14183146|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14183147|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183148|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183149|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183150|NCT04730245|Rifaximin|rifaximin|mesh-list
14183151|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14183152|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183153|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183154|NCT04730219|Paclitaxel|paclitaxel|mesh-list
14475529|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475530|NCT02401048|Durvalumab|durvalumab|mesh-list
14475531|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13913331|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13913332|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
14475532|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475533|NCT02401230|Tenofovir|tenofovir|mesh-list
14475534|NCT02401230|Emtricitabine|emtricitabine|mesh-list
14475535|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14475536|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
14475537|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475538|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14475539|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14475540|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475541|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475542|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14475543|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14475544|NCT02401256|Efavirenz|efavirenz|mesh-list
14475545|NCT02401256|Bupropion|bupropion|mesh-list
14475546|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14056251|NCT02635074|Cytarabine|cytarabine|mesh-list
14056252|NCT02635074|Idarubicin|idarubicin|mesh-list
14056253|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14056254|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
14056255|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056256|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056257|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
14056258|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056259|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14056260|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
14056261|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056262|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14475547|NCT02401256|Montelukast|montelukast|mesh-list
14475548|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14475549|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14475550|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
14475551|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475552|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14475553|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14056263|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14056264|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14056265|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056266|NCT02635191|Amoxicillin|amoxicillin|mesh-list
14056267|NCT02635191|Metronidazole|metronidazole|mesh-list
14056268|NCT02635191|Clarithromycin|clarithromycin|mesh-list
14056269|NCT02635191|Esomeprazole|esomeprazole|mesh-list
14056270|NCT02635191|Omeprazole|omeprazole|mesh-list
14056271|NCT02635191|Rabeprazole|rabeprazole|mesh-list
14056272|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14056273|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056274|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14056275|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14056276|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14056277|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14056278|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14475554|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475555|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14475556|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
14475557|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475558|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14475559|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14475560|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14475561|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
14475562|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475563|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757568|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14757569|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
14757570|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757571|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
14757572|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14757573|NCT05340764|Infliximab|infliximab|mesh-list
14757574|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
14757575|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757576|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14757577|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
14757578|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14757579|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056279|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056280|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479294|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475564|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14475565|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14475566|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14475567|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14475568|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14475569|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
14475570|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475571|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14056281|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14056282|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14056283|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14056284|NCT02635061|Nivolumab|nivolumab|mesh-list
14056285|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14056286|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056287|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14056288|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056289|NCT02634970|Ranibizumab|ranibizumab|mesh-list
14056290|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14056291|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14475572|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14757580|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757581|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757582|NCT05340725|Analgesics|analgesics|mesh-ancestor
14056292|NCT02634970|Growth Substances|growth substances|mesh-ancestor
14056293|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056294|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
14056295|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056296|NCT02634723|Factor VIII|factor viii|mesh-list
14056297|NCT02634723|Coagulants|coagulants|mesh-ancestor
14056298|NCT02634541|Adalimumab|adalimumab|mesh-list
14056299|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056300|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14056301|NCT02634489|Tamsulosin|tamsulosin|mesh-list
14056302|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
14056303|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14056304|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14056305|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14056306|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
14056307|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056308|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056309|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056310|NCT02634489|Urological Agents|urological agents|mesh-ancestor
14056311|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14056312|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14056313|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
14056314|NCT02634476|Ethanol|ethanol|mesh-list
14056315|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14056316|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056317|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056318|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056319|NCT02634528|Insulin|insulin|mesh-list
14056320|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14056321|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
14056322|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
14056323|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
14056324|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14056325|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056326|NCT02634463|Olanzapine|olanzapine|mesh-list
14056327|NCT02634463|Risperidone|risperidone|mesh-list
14056328|NCT02634463|Aripiprazole|aripiprazole|mesh-list
14056329|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14056330|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14056331|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
14757583|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
14757584|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757585|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14757586|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14757587|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14056332|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056333|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056334|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056335|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14056336|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14171336|NCT04823065|Scopolamine|scopolamine|mesh-list
14056337|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056338|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056339|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14056340|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
14056341|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
14056342|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
14056343|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056344|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14056345|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14056346|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14056347|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14056348|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
14056349|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
14056350|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14056351|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14056352|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14056353|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14056354|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
14056355|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14056356|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
14056357|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14056358|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056359|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14056360|NCT02634294|Interferons|interferons|mesh-list
14056361|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
14056362|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
14056363|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14056364|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056365|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
14056366|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933706|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14933707|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14933708|NCT01451905|Liraglutide|liraglutide|mesh-list
14475573|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14475574|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14475575|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
14475576|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475577|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14056367|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
14056368|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056369|NCT02634515|Insulin|insulin|mesh-list
14056370|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14475578|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14475579|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14475580|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14475581|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14475582|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14475583|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14475584|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475585|NCT02401529|Acetaminophen|acetaminophen|mesh-list
14475586|NCT02401529|Dexamethasone|dexamethasone|mesh-list
14475587|NCT02401529|Prednisolone|prednisolone|mesh-list
14475588|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475589|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
14475590|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
14475591|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475592|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475593|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475594|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
14475595|NCT02401529|Hormones|hormones|mesh-ancestor
14475596|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475597|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14475598|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475599|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475600|NCT02401529|Analgesics|analgesics|mesh-ancestor
14475601|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
14475602|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
14475603|NCT02401542|Docetaxel|docetaxel|mesh-list
14475604|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475605|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14475606|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14475607|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14056371|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14056372|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056373|NCT02634281|Varenicline|varenicline|mesh-list
14475608|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475609|NCT02402062|Sunitinib|sunitinib|mesh-list
14475610|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475611|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14475612|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14475613|NCT02402062|Growth Substances|growth substances|mesh-ancestor
14056374|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14056375|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14056376|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
14056377|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056378|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056379|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056380|NCT02634255|Fentanyl|fentanyl|mesh-list
14056381|NCT02634255|Propofol|propofol|mesh-list
14056382|NCT02634255|Rocuronium|rocuronium|mesh-list
14056383|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14056384|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056385|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056386|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14056387|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
14056388|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
14056389|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14056390|NCT02634255|Narcotics|narcotics|mesh-ancestor
14056391|NCT02634255|Analgesics|analgesics|mesh-ancestor
14056392|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
14056393|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475614|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757588|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
14757589|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056394|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14056395|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14056396|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14056397|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14056398|NCT02634034|Pitavastatin|pitavastatin|mesh-list
14056399|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14056400|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14056401|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14056402|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
14056403|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056404|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056405|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14056406|NCT02634203|Riociguat|riociguat|mesh-list
14056407|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
14056408|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056409|NCT02634021|Midazolam|midazolam|mesh-list
14056410|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
14056411|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14056412|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056413|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056414|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14056415|NCT02634021|Analgesics|analgesics|mesh-ancestor
14056416|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
14056417|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056418|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14056419|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14056420|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14056421|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14056422|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056423|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056424|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14056425|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14056426|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056427|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056428|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14056429|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
14056430|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
14056431|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
14056432|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
14757590|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757591|NCT05340673|Petrolatum|petrolatum|mesh-list
14757592|NCT05340673|Mineral Oil|mineral oil|mesh-list
14757593|NCT05340673|Emollients|emollients|mesh-ancestor
14757594|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
14757595|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
14757596|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
14056433|NCT02633969|Indomethacin|indomethacin|mesh-list
14056434|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14056435|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14056436|NCT02633969|Analgesics|analgesics|mesh-ancestor
14475615|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
14475616|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14475617|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475618|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475619|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
14475620|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14475621|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14475622|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475623|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
14475624|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475625|NCT02402933|Glucagon|glucagon|mesh-list
14475626|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14475627|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475628|NCT02402933|Hormones|hormones|mesh-ancestor
14475629|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475630|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475631|NCT02402933|Incretins|incretins|mesh-ancestor
14056437|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
14056438|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056439|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056440|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056441|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14056442|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
14056443|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
14056444|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14056445|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14056446|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056447|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056448|NCT02634008|Ritonavir|ritonavir|mesh-list
14056449|NCT02634008|Ribavirin|ribavirin|mesh-list
14475632|NCT02403271|Durvalumab|durvalumab|mesh-list
14475633|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475634|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475635|NCT02403635|Midazolam|midazolam|mesh-list
14475636|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14475637|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14475638|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475639|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475640|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14475641|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14475642|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475643|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14475644|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
14475645|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
14475646|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
14475647|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
14475648|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475649|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475650|NCT02403674|Tenofovir|tenofovir|mesh-list
14475651|NCT02403674|Lamivudine|lamivudine|mesh-list
14475652|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14475653|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
14475654|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475655|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14475656|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14475657|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475658|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475659|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14475660|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14475661|NCT02403778|Ipilimumab|ipilimumab|mesh-list
14475662|NCT02403778|Tretinoin|tretinoin|mesh-list
14475663|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475664|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475665|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14475666|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475667|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
14475668|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475669|NCT02403830|Morphine|morphine|mesh-list
14475670|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
14475671|NCT02403830|Ticagrelor|ticagrelor|mesh-list
14056450|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14171337|NCT04823065|Loperamide|loperamide|mesh-list
14475672|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14933709|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14933710|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933711|NCT01451905|Incretins|incretins|mesh-ancestor
14056451|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14056452|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
14056453|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056454|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056455|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14056456|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14056457|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
14475673|NCT02403830|Narcotics|narcotics|mesh-ancestor
14475674|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475675|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475676|NCT02403830|Analgesics|analgesics|mesh-ancestor
14475677|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
14475678|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475679|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14475680|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14056458|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056459|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14056460|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14475681|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14475682|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14475683|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
14475684|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475685|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475686|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14475687|NCT02403895|Paclitaxel|paclitaxel|mesh-list
14475688|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14475689|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475690|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
14475691|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
14475692|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475693|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475694|NCT02403986|Lidocaine|lidocaine|mesh-list
14475695|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
14056461|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
14056462|NCT02633930|Amoxicillin|amoxicillin|mesh-list
14056463|NCT02633930|Clarithromycin|clarithromycin|mesh-list
14056464|NCT02633930|Lansoprazole|lansoprazole|mesh-list
14056465|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
14056466|NCT02633930|Bismuth|bismuth|mesh-list
14056467|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14056468|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056469|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14056470|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056471|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056472|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14056473|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14056474|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14056475|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14056476|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14056477|NCT02633930|Antacids|antacids|mesh-ancestor
14056478|NCT02633995|Anesthetics|anesthetics|mesh-list
14056479|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056480|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056481|NCT02633878|Progesterone|progesterone|mesh-list
14056482|NCT02633878|Progestins|progestins|mesh-ancestor
14056483|NCT02633878|Hormones|hormones|mesh-ancestor
14056484|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056485|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056486|NCT02633696|Silybin|silybin|mesh-list
14056487|NCT02633696|Silymarin|silymarin|mesh-list
14056488|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
14056489|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475696|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
14757597|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757598|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757599|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14757600|NCT05340582|Acetaminophen|acetaminophen|mesh-list
14757601|NCT05340582|Ibuprofen|ibuprofen|mesh-list
14757602|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757603|NCT05340582|Analgesics|analgesics|mesh-ancestor
14757604|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
14933712|NCT01451905|Hormones|hormones|mesh-ancestor
14056490|NCT02633696|Protective Agents|protective agents|mesh-ancestor
14056491|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056492|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14056493|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056494|NCT02633683|Gabapentin|gabapentin|mesh-list
14056495|NCT02633683|Analgesics|analgesics|mesh-ancestor
14056496|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
14056497|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056498|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056499|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
14056500|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14056501|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056502|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056503|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056504|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14056505|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14056506|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056507|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056508|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
14056509|NCT02633813|Naftifine|naftifine|mesh-list
14056510|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
14056511|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056512|NCT02633852|Aflibercept|aflibercept|mesh-list
14056513|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14056514|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14056515|NCT02633852|Growth Substances|growth substances|mesh-ancestor
14056516|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056517|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
14056518|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056519|NCT02633774|Propafenone|propafenone|mesh-list
14056520|NCT02633774|Apixaban|apixaban|mesh-list
14056521|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14056522|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
14056523|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14056524|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
14056525|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056526|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056527|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
14056528|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14056529|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14056530|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14056531|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14056532|NCT02633709|Itraconazole|itraconazole|mesh-list
14056533|NCT02633709|Risdiplam|risdiplam|mesh-list
14056534|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
14056535|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056536|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14056537|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14056538|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056539|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056540|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14056541|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
14056542|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056543|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056544|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14056545|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14056546|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056547|NCT02633657|Gabapentin|gabapentin|mesh-list
14056548|NCT02633657|Analgesics|analgesics|mesh-ancestor
14056549|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
14056550|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056551|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056552|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
14056553|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14056554|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056555|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056556|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056557|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14056558|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14056559|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056560|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056561|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
14475697|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056562|NCT02633761|Misoprostol|misoprostol|mesh-list
14475698|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475699|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
14475700|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475701|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14475702|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14475703|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14475704|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757605|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757606|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757607|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
14757608|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14757609|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14757610|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14757611|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14757612|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757613|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757614|NCT05340530|Meropenem|meropenem|mesh-list
14757615|NCT05340530|Avibactam|avibactam|mesh-list
14757616|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14933713|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933714|NCT01451918|Resveratrol|resveratrol|mesh-list
14933715|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
14933716|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933717|NCT01451918|Protective Agents|protective agents|mesh-ancestor
13913333|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913334|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913335|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
13913336|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13913337|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913338|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
13913339|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
13913340|NCT03488485|Ledipasvir|ledipasvir|mesh-list
13913341|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913342|NCT03488316|Calcium|calcium|mesh-list
13913343|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13913344|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913345|NCT03488251|Gemcitabine|gemcitabine|mesh-list
13913346|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913347|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
13913348|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475705|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475706|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
14475707|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
14475708|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475709|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14475710|NCT02404103|Flunisolide|flunisolide|mesh-list
14475711|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475712|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14475713|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
14475714|NCT02404168|Lamotrigine|lamotrigine|mesh-list
14475715|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
14475716|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14475717|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14475718|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475719|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14475720|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475721|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14475722|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14475723|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475724|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475725|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14475726|NCT02404220|Dexamethasone|dexamethasone|mesh-list
14475727|NCT02404220|Vincristine|vincristine|mesh-list
14475728|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475729|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
14475730|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
14475731|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475732|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475733|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475734|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
14475735|NCT02404220|Hormones|hormones|mesh-ancestor
14757617|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056563|NCT02633761|Mifepristone|mifepristone|mesh-list
14056564|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14056565|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
14056566|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14056567|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056568|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14056569|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14056570|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
14056571|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14056572|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14056573|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14056574|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14056575|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
14056576|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14056577|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14056578|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
14056579|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056580|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
14056581|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14056582|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14056583|NCT02633839|Carbidopa|carbidopa|mesh-list
14056584|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14056585|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14056586|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
14056587|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056588|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056589|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056590|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14056591|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056592|NCT02633579|Erythromycin|erythromycin|mesh-list
14056593|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
14056594|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14056595|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
14056596|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
14056597|NCT02633579|Atropine|atropine|mesh-list
14475736|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475737|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14757618|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14757619|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056598|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14056599|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14056600|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14056601|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
14056602|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056603|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056604|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14056605|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
14056606|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
14056607|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
14056608|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14056609|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14056610|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
14056611|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056612|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056613|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14056614|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056615|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757620|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757621|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
14757622|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14757623|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
14757624|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757625|NCT05340504|Expectorants|expectorants|mesh-ancestor
14757626|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
14757627|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14757628|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
14757629|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757630|NCT05340504|Protective Agents|protective agents|mesh-ancestor
14757631|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933718|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933719|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933720|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14933721|NCT01452009|Travoprost|travoprost|mesh-list
14933722|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14933723|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14933724|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14938648|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14938649|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
14938650|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14938651|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
14938652|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14938653|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
14938654|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056616|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14056617|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475738|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757632|NCT05340504|Antidotes|antidotes|mesh-ancestor
14757633|NCT05340465|Iron|iron|mesh-list
14757634|NCT05340465|Dextrans|dextrans|mesh-list
14757635|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
14056618|NCT02633618|Neurotropin|neurotropin|mesh-list
14056619|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14056620|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
14056621|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056622|NCT02633618|Analgesics|analgesics|mesh-ancestor
14056623|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
14056624|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056625|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
14056626|NCT02633384|Sorbitol|sorbitol|mesh-list
14056627|NCT02633384|SMOFlipid|smoflipid|mesh-list
14056628|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14056629|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14056630|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14056631|NCT02633384|Cathartics|cathartics|mesh-ancestor
14056632|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14056633|NCT02633462|Inositol|inositol|mesh-list
14056634|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
14056635|NCT02633462|Vitamins|vitamins|mesh-ancestor
14056636|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
14056637|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171338|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
14171339|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14171340|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171341|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14171342|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
14171343|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
14171344|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171345|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171346|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
14171347|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14171348|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
14171349|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171350|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475739|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14475740|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
14475741|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
14475742|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475743|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475744|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14475745|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14475746|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
14475747|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475748|NCT02404441|Spartalizumab|spartalizumab|mesh-list
14475749|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14475750|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757636|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14757637|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
14757638|NCT05340465|Trace Elements|trace elements|mesh-ancestor
14757639|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
14757640|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757641|NCT05340465|Hematinics|hematinics|mesh-ancestor
14938655|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
14171351|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14171352|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
14171353|NCT04822649|Adenosine|adenosine|mesh-list
14171354|NCT04822649|Analgesics|analgesics|mesh-ancestor
14171355|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
14938656|NCT01482897|Hormones|hormones|mesh-ancestor
14757642|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14757643|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14757644|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
14757645|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
14757646|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
13913349|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056638|NCT02633202|Cisplatin|cisplatin|mesh-list
14056639|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056640|NCT02633176|Docetaxel|docetaxel|mesh-list
14056641|NCT02633176|Capecitabine|capecitabine|mesh-list
14056642|NCT02633176|Cetuximab|cetuximab|mesh-list
14056643|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056644|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
14056645|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
14056646|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
14056647|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056648|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14056649|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
14056650|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14056651|NCT02633189|Bevacizumab|bevacizumab|mesh-list
14056652|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14056653|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14056654|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913350|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
13913351|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913352|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913353|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913354|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
13913355|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913356|NCT03488186|Lansoprazole|lansoprazole|mesh-list
13913357|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
13913358|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913359|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913360|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13913361|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913362|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913363|NCT03488173|Lansoprazole|lansoprazole|mesh-list
13913364|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
13913365|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913366|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913367|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13913368|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913369|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913370|NCT03488147|Esomeprazole|esomeprazole|mesh-list
13913371|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913372|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913373|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13913374|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913375|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960010|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960011|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
13960012|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13960013|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056655|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14056656|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14056657|NCT02633189|Growth Substances|growth substances|mesh-ancestor
14056658|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056659|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14056660|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14056661|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056662|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056663|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
14056664|NCT02632916|Denosumab|denosumab|mesh-list
14056665|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14056666|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056667|NCT02633514|Etoposide|etoposide|mesh-list
14056668|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056669|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14056670|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14056671|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14056672|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056673|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056674|NCT02633007|Levodopa|levodopa|mesh-list
14056675|NCT02633007|Carbidopa|carbidopa|mesh-list
14056676|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14056677|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14056678|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
14056679|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056680|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056681|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056682|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14056683|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056684|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
14056685|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14933725|NCT01452100|Prednisone|prednisone|mesh-list
14933726|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933727|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
14056686|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056687|NCT02632877|Pirfenidone|pirfenidone|mesh-list
14056688|NCT02632877|Ketanserin|ketanserin|mesh-list
14056689|NCT02632877|Analgesics|analgesics|mesh-ancestor
14056690|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
14056691|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056692|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475751|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14475752|NCT02404493|Decanoic acid|decanoic acid|mesh-list
14475753|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
14475754|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475755|NCT02404610|Propofol|propofol|mesh-list
14475756|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14475757|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475758|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056693|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14056694|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14056695|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056696|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14056697|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056698|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14056699|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14056700|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14056701|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
14475759|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14475760|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
14475761|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
14479161|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479162|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
14479163|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
14479164|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479165|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
14479166|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14479167|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14757655|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14757656|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14757657|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757658|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933728|NCT01452100|Hormones|hormones|mesh-ancestor
14938779|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479168|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
14056702|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479169|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056703|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056704|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14056705|NCT02632760|Hematinics|hematinics|mesh-ancestor
14056706|NCT02632565|Lidocaine|lidocaine|mesh-list
14056707|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
14056708|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
14056709|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056710|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056711|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
14056712|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056713|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14056714|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14056715|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14056716|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14056717|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056718|NCT02632578|Vaccines|vaccines|mesh-list
14056719|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
14056720|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056721|NCT02632474|Tenofovir|tenofovir|mesh-list
14056722|NCT02632474|Lamivudine|lamivudine|mesh-list
14056723|NCT02632474|Efavirenz|efavirenz|mesh-list
14056724|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
14056725|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056726|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14056727|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14056728|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056729|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056730|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14056731|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14056732|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14056733|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14056734|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14056735|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14056736|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14056737|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14056738|NCT02632331|Gabapentin|gabapentin|mesh-list
14056739|NCT02632331|Analgesics|analgesics|mesh-ancestor
14056740|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
14056741|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056742|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056743|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
14056744|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14056745|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14056746|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056747|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056748|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14056749|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14056750|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056751|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056752|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
14056753|NCT02632019|Gemcitabine|gemcitabine|mesh-list
14056754|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14056755|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
14056756|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056757|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056758|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
14056759|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056760|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056761|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14056762|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
14056763|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056764|NCT02632279|Tryptophan|tryptophan|mesh-list
14056765|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14056766|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
14056767|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14056768|NCT02632305|Gemcitabine|gemcitabine|mesh-list
14056769|NCT02632305|Paclitaxel|paclitaxel|mesh-list
14056770|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14056771|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056772|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
14056773|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
14056774|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
14056775|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056776|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14056777|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
14056778|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
14056779|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056780|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056781|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14056782|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
14056783|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056784|NCT02632032|Insulin|insulin|mesh-list
14056785|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14056786|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14056787|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056788|NCT02631993|Furocoumarins|furocoumarins|mesh-list
14056789|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
14056790|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14056791|NCT02632136|Bupivacaine|bupivacaine|mesh-list
14056792|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
14056793|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
14056794|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056795|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056796|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
14056797|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056798|NCT02632071|Paclitaxel|paclitaxel|mesh-list
14056799|NCT02632071|Ricolinostat|ricolinostat|mesh-list
14056800|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14056801|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056802|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
14056803|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
14056804|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
14056805|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056806|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14056807|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056808|NCT02631928|Insulin|insulin|mesh-list
14056809|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14056810|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
14056811|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14056812|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056813|NCT02631759|Levetiracetam|levetiracetam|mesh-list
14056814|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
14056815|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
14056816|NCT02631694|Propranolol|propranolol|mesh-list
14056817|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14056818|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14056819|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
14056820|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056821|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056822|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056823|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14056824|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14056825|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
14056826|NCT02631616|Somatostatin|somatostatin|mesh-list
14056827|NCT02631616|Hormones|hormones|mesh-ancestor
14056828|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056829|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056830|NCT02631668|Ascorbic Acid|ascorbic acid|mesh-list
14056831|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
14475762|NCT02404805|Dolutegravir|dolutegravir|mesh-list
14475763|NCT02404805|Simeprevir|simeprevir|mesh-list
14475764|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14475765|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14475766|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475767|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475768|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14475769|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14475770|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
14475771|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475772|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
14475773|NCT02405780|Adalimumab|adalimumab|mesh-list
14475774|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056832|NCT02631668|Vitamins|vitamins|mesh-ancestor
14056833|NCT02631668|Micronutrients|micronutrients|mesh-ancestor
14056834|NCT02631668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938780|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14056835|NCT02631668|Antioxidants|antioxidants|mesh-ancestor
14056836|NCT02631668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056837|NCT02631668|Protective Agents|protective agents|mesh-ancestor
14475775|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475776|NCT02406248|Ticagrelor|ticagrelor|mesh-list
14056838|NCT02631668|Hematinics|hematinics|mesh-ancestor
14475777|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14475778|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14475779|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14475780|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14475781|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
14475782|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475783|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475784|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475785|NCT02406261|Midazolam|midazolam|mesh-list
14475786|NCT02406261|Donepezil|donepezil|mesh-list
14475787|NCT02406261|Simvastatin|simvastatin|mesh-list
14475788|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14475789|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14475790|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056839|NCT02631603|Prednisolone|prednisolone|mesh-list
14056840|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056841|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
14056842|NCT02631603|Hormones|hormones|mesh-ancestor
14056843|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056844|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056845|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14056846|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171356|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171357|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171358|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14171359|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
14171360|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14171361|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
14171362|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
14171363|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475791|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475792|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14475793|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14475794|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14171364|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171365|NCT04822415|Mepivacaine|mepivacaine|mesh-list
14171366|NCT04822415|Carticaine|carticaine|mesh-list
14171367|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
14171368|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
14171369|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171370|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171371|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
14171372|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171373|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
14171374|NCT04822064|Ketamine|ketamine|mesh-list
14171375|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
14171376|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14171377|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171378|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171379|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171380|NCT04822064|Analgesics|analgesics|mesh-ancestor
14171381|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
14171382|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171383|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14171384|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14171385|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14171386|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171387|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171388|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171389|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14171390|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14171391|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
14171392|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
14171393|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14171394|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14171395|NCT04822012|Antibodies|antibodies|mesh-list
14171396|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
14171397|NCT04822012|Progesterone|progesterone|mesh-list
14171398|NCT04822012|Estrogens|estrogens|mesh-list
14171399|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
14171400|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171401|NCT04822012|Progestins|progestins|mesh-ancestor
14938781|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14171402|NCT04822012|Hormones|hormones|mesh-ancestor
14475795|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14475796|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
14475797|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
14475798|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
14475799|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
14475800|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475801|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475802|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14475803|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14475804|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
14475805|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14475806|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14475807|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475808|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14475809|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
14475810|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
14475811|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14475812|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14475813|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475814|NCT02406443|Incretins|incretins|mesh-ancestor
14475815|NCT02406443|Hormones|hormones|mesh-ancestor
14757659|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14056847|NCT02631499|Epirubicin|epirubicin|mesh-list
14056848|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
14056849|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14056850|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056851|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14056852|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14056853|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056854|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056855|NCT02631473|Ritonavir|ritonavir|mesh-list
14056856|NCT02631473|Lopinavir|lopinavir|mesh-list
14056857|NCT02631473|Efavirenz|efavirenz|mesh-list
14056858|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14056859|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14056860|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
14056861|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056862|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056863|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14056864|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14056865|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
13913376|NCT03487939|Fluorouracil|fluorouracil|mesh-list
13913377|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
13913378|NCT03487939|Irinotecan|irinotecan|mesh-list
13913379|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
13913380|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757660|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757661|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757662|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14757663|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913381|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913382|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913383|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913384|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
13913385|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913386|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13913387|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14056866|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056867|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14056868|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14056869|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14056870|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14475816|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14757664|NCT05340413|Olaparib|olaparib|mesh-list
14757665|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14757666|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767261|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933729|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933730|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933731|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14933732|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933733|NCT01452113|Vildagliptin|vildagliptin|mesh-list
14933734|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14933735|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933736|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14933737|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
14933738|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475817|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14056871|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14056872|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14056873|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14056874|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14056875|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14056876|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
14056877|NCT02631252|Etoposide|etoposide|mesh-list
14056878|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
14056879|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14056880|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056881|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14056882|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14056883|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056884|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056885|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
14056886|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14056887|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14056888|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056889|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14056890|NCT02631252|Analgesics|analgesics|mesh-ancestor
14056891|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
14056892|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056893|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056894|NCT02631460|Carboplatin|carboplatin|mesh-list
14056895|NCT02631460|Pemetrexed|pemetrexed|mesh-list
14056896|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056897|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056898|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056899|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14056900|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14056901|NCT02631408|Vancomycin|vancomycin|mesh-list
14056902|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14056903|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14056904|NCT02631239|Dexamethasone|dexamethasone|mesh-list
14056905|NCT02631239|Methotrexate|methotrexate|mesh-list
14056906|NCT02631239|Etoposide|etoposide|mesh-list
14056907|NCT02631239|Pegaspargase|pegaspargase|mesh-list
14056908|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056909|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
14056910|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
14056911|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056912|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056913|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14056914|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
14056915|NCT02631239|Hormones|hormones|mesh-ancestor
14056916|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14056917|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14056918|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14056919|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14056920|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
14056921|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14056922|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14056923|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
14056924|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056925|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14056926|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056927|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14056928|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14056929|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
14056930|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14056931|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14056932|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14475818|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
14056933|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14056934|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14056935|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
14056936|NCT02631135|Remifentanil|remifentanil|mesh-list
14056937|NCT02631135|Propofol|propofol|mesh-list
14056938|NCT02631135|Rocuronium|rocuronium|mesh-list
14056939|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14056940|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14056941|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056942|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14056943|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
14056944|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
14056945|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14056946|NCT02631135|Analgesics|analgesics|mesh-ancestor
14056947|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
14056948|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056949|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14056950|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14056951|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14056952|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
14056953|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056954|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056955|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14056956|NCT02631135|Narcotics|narcotics|mesh-ancestor
14056957|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14056958|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14056959|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14056960|NCT02631031|Valsartan|valsartan|mesh-list
14056961|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14056962|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14056963|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14056964|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056965|NCT02630862|Aspirin|aspirin|mesh-list
14056966|NCT02630862|Dipyridamole|dipyridamole|mesh-list
14056967|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14056968|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14056969|NCT02630862|Analgesics|analgesics|mesh-ancestor
14056970|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
14056971|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14056972|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056973|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14056974|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14056975|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14056976|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14056977|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056978|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14056979|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14056980|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056981|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
14056982|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14056983|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
14056984|NCT02631174|Antithrombins|antithrombins|mesh-list
14056985|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
14056986|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14056987|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
14056988|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14056989|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056990|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
14475819|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475820|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475821|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14475822|NCT02406586|Carvedilol|carvedilol|mesh-list
14475823|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14475824|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14475825|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14475826|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
14475827|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475828|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475829|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475830|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14475831|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
14056991|NCT02630888|Memantine|memantine|mesh-list
14056992|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14056993|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14757667|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757668|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757669|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
14757670|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14757671|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475832|NCT02406586|Protective Agents|protective agents|mesh-ancestor
14475833|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14475834|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14475835|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14475836|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
14757672|NCT05340309|Atezolizumab|atezolizumab|mesh-list
14757673|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14757674|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757675|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
14757676|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913388|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913389|NCT03487874|Ropivacaine|ropivacaine|mesh-list
13913390|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
14757677|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14056994|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
14056995|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14056996|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14056997|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14056998|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14056999|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14057000|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
14057001|NCT02631109|Doxorubicin|doxorubicin|mesh-list
14057002|NCT02631109|Etoposide|etoposide|mesh-list
14757678|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757679|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757680|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14757681|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757682|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757683|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14757684|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933739|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933740|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14933741|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14933742|NCT01452217|Secretin|secretin|mesh-list
14933743|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933744|NCT01452217|Hormones|hormones|mesh-ancestor
13913391|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
14057003|NCT02631109|Pegaspargase|pegaspargase|mesh-list
14057004|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057005|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057006|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14057007|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14057008|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057009|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057010|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057011|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057012|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
14057013|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
14057014|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057015|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057016|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057017|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
14057018|NCT02631109|Hormones|hormones|mesh-ancestor
14057019|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057020|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13913392|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913393|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913394|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
13913395|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913396|NCT03487809|Budesonide|budesonide|mesh-list
13913397|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913398|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13913399|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
14057021|NCT02631109|Protective Agents|protective agents|mesh-ancestor
14475837|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14475838|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14475839|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14757685|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757686|NCT05340205|Misoprostol|misoprostol|mesh-list
14757687|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
14757688|NCT05340205|Oxytocin|oxytocin|mesh-list
14757689|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
14757690|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757691|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757692|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14757693|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14757694|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757695|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
14757696|NCT05340205|Coagulants|coagulants|mesh-ancestor
14757697|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14757698|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
14757699|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14757700|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757701|NCT05340192|Octreotide|octreotide|mesh-list
14757702|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757703|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14757704|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057022|NCT02630823|Paclitaxel|paclitaxel|mesh-list
14057023|NCT02630823|Carboplatin|carboplatin|mesh-list
14057024|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
14057025|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057026|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057027|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057028|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057029|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057030|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057031|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057032|NCT02630511|Mannitol|mannitol|mesh-list
14057033|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
14057034|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14057035|NCT02630511|Diuretics|diuretics|mesh-ancestor
14057036|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
14757705|NCT05340153|Lumefantrine|lumefantrine|mesh-list
14757706|NCT05340153|Artemether|artemether|mesh-list
14757707|NCT05340153|Piperaquine|piperaquine|mesh-list
14757708|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14757709|NCT05340153|Artenimol|artenimol|mesh-list
14757710|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
14757711|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14757712|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14757713|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757714|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14757715|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14757716|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767262|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767263|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14767264|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
14767265|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14767266|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14767267|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14767268|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14767269|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14057037|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057038|NCT02630511|Miotics|miotics|mesh-ancestor
14475840|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14475841|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14475842|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14475843|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475844|NCT02406586|Analgesics|analgesics|mesh-ancestor
14475845|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
14475846|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767270|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
14057039|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
14057040|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057041|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14057042|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14057043|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057044|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14767271|NCT00629304|Antithrombins|antithrombins|mesh-list
14767272|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14938782|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057045|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14057046|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
14757717|NCT05339802|Linezolid|linezolid|mesh-list
14757718|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14057047|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057048|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057049|NCT02630485|Inositol|inositol|mesh-list
14057050|NCT02630485|Letrozole|letrozole|mesh-list
14057051|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057052|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14057053|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14057054|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057055|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057056|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14057057|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
14057058|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057059|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057060|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
14057061|NCT02630485|Vitamins|vitamins|mesh-ancestor
14057062|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
14057063|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
14057064|NCT02630628|Tacrolimus|tacrolimus|mesh-list
14057065|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057066|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
14057067|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057068|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14057069|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057070|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057071|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057072|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057073|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14057074|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
14933745|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933746|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933747|NCT01452243|Vitamin D|vitamin d|mesh-list
14057075|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14057076|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057077|NCT02630420|Cetuximab|cetuximab|mesh-list
14057078|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057079|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057080|NCT02630394|Azithromycin|azithromycin|mesh-list
14057081|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14057082|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057083|NCT02630069|Choline|choline|mesh-list
14933748|NCT01452243|Calcium|calcium|mesh-list
14933749|NCT01452243|Vitamins|vitamins|mesh-ancestor
14933750|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
14933751|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933752|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14057084|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14057085|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
14057086|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14057087|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
14057088|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057089|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057090|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14057091|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
14757719|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757720|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14757721|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757722|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757723|NCT05339646|Ritonavir|ritonavir|mesh-list
14757724|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14757725|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14757726|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
14757727|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757728|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757729|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14757730|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14757731|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
14757732|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757733|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14057100|NCT02630303|Coal Tar|coal tar|mesh-list
14057101|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
14057102|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
14057103|NCT02630264|Paclitaxel|paclitaxel|mesh-list
14057104|NCT02630264|Endostatins|endostatins|mesh-list
14057105|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057106|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057107|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057108|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057109|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057110|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057111|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14057112|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14057113|NCT02630264|Growth Substances|growth substances|mesh-ancestor
14057114|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057115|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
14057116|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
14057117|NCT02630290|Ropivacaine|ropivacaine|mesh-list
14057118|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14057119|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057120|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057121|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14057122|NCT02630290|Analgesics|analgesics|mesh-ancestor
14057123|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
14057124|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057125|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14057126|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14057127|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14057128|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
14057129|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057130|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057131|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
14057132|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
14057133|NCT02630160|Epinephrine|epinephrine|mesh-list
14057134|NCT02630160|Bupivacaine|bupivacaine|mesh-list
14057135|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
14057136|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
14057137|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057138|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057139|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
14057140|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057141|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14057142|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14057143|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
14057144|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057145|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757734|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14757735|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
14757736|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14757737|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14757738|NCT05339542|Prednisolone|prednisolone|mesh-list
14757739|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
14757740|NCT05339542|Lidocaine|lidocaine|mesh-list
14757741|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14757742|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
14757743|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14757744|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
14057146|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14057147|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14057148|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
14757745|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757746|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057149|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14057150|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057151|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
14057152|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
14057153|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14057154|NCT02630277|Aflibercept|aflibercept|mesh-list
14057155|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14057156|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14057157|NCT02630277|Growth Substances|growth substances|mesh-ancestor
14057158|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057159|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
14057160|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057161|NCT02630199|Paclitaxel|paclitaxel|mesh-list
14057162|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057163|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057164|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057165|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057166|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057167|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057168|NCT02630108|Epirubicin|epirubicin|mesh-list
14057169|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
14057170|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057171|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057172|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14057173|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14057174|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057175|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057176|NCT02630121|Phenylephrine|phenylephrine|mesh-list
14057177|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
14057178|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14057179|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14057180|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
14057181|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057182|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057183|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057184|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
14057185|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
14057186|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057187|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
14057188|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14057189|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057190|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14057191|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
14057192|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14057193|NCT02630121|Protective Agents|protective agents|mesh-ancestor
14057194|NCT02630095|Nadroparin|nadroparin|mesh-list
14057195|NCT02630095|Warfarin|warfarin|mesh-list
14057196|NCT02630095|Calcium|calcium|mesh-list
14057197|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14057198|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057199|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
14057200|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14057201|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14057202|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057203|NCT02630004|Melatonin|melatonin|mesh-list
14057204|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
14057205|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057206|NCT02630004|Protective Agents|protective agents|mesh-ancestor
14057207|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057208|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057209|NCT02629848|Paclitaxel|paclitaxel|mesh-list
14057210|NCT02629848|Carboplatin|carboplatin|mesh-list
14057211|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
14057212|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057213|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057214|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057215|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057216|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057217|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057218|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14057219|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057220|NCT02629835|Dexamethasone|dexamethasone|mesh-list
14057221|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
14057222|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14057223|NCT02629835|BB 1101|bb 1101|mesh-list
14057224|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057225|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
14057226|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
14057227|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057228|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057229|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475847|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475848|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475849|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
14475850|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14475851|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057230|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
14057231|NCT02629835|Hormones|hormones|mesh-ancestor
14057232|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057233|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14057234|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057235|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
14057236|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057237|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171403|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171404|NCT04822038|Vitamin D|vitamin d|mesh-list
14171405|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
14171406|NCT04822038|Vitamins|vitamins|mesh-ancestor
14171407|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
14171408|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171409|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14171410|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14171411|NCT04821856|Cannabidiol|cannabidiol|mesh-list
14171412|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
14171413|NCT04821947|Bupivacaine|bupivacaine|mesh-list
14171414|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
14171415|NCT04821947|Anesthetics|anesthetics|mesh-list
14171416|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171417|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171418|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
14171419|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171420|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
14171421|NCT04822090|Antibodies|antibodies|mesh-list
14171422|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
14171423|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14171424|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14171425|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
14171426|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171427|NCT04821843|Paclitaxel|paclitaxel|mesh-list
14171428|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
14171429|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14171430|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171431|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171432|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
14475852|NCT02406885|Apixaban|apixaban|mesh-list
14757747|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
14475853|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14475854|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
14475855|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14475856|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
14475857|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475858|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475859|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
14475860|NCT02407223|Ustekinumab|ustekinumab|mesh-list
14475861|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475862|NCT02407704|Lorazepam|lorazepam|mesh-list
14475863|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14475864|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14475865|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14475866|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14475867|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475868|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475869|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475870|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14475871|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
14475872|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475873|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
14475874|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
14475875|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
14475876|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757748|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757749|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14757750|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14757751|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14757752|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14757753|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757754|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14757755|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
14757756|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
14057238|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14057239|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057240|NCT02629744|Etrolizumab|etrolizumab|mesh-list
14057241|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057242|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
14057243|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057244|NCT02629718|Paclitaxel|paclitaxel|mesh-list
14057245|NCT02629718|Carboplatin|carboplatin|mesh-list
14057246|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057247|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057248|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057249|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057250|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057251|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057252|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
14057253|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14057254|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
14057255|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057256|NCT02629536|Expectorants|expectorants|mesh-ancestor
14057257|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057258|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14057259|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
14057260|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057261|NCT02629536|Protective Agents|protective agents|mesh-ancestor
14057262|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057263|NCT02629536|Antidotes|antidotes|mesh-ancestor
14057264|NCT02629523|Afatinib|afatinib|mesh-list
14057265|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057266|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14757757|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757758|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
14933753|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14933754|NCT01452256|Propofol|propofol|mesh-list
14933755|NCT01452256|Desflurane|desflurane|mesh-list
14933756|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13913400|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913401|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913402|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13913403|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
13913404|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
13913405|NCT03487809|Hormones|hormones|mesh-ancestor
13913406|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913407|NCT03487783|Aripiprazole|aripiprazole|mesh-list
13913408|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13913409|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
13913410|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13913411|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13913412|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13913413|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913414|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913415|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
13913416|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
13913417|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913418|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913419|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14057267|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057268|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057269|NCT02629627|Metformin|metformin|mesh-list
14933757|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057270|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14057271|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057272|NCT02629575|Sirolimus|sirolimus|mesh-list
14057273|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14057274|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057275|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057276|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057277|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
14057278|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057279|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
14057280|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057281|NCT02629224|Gabapentin|gabapentin|mesh-list
14057282|NCT02629224|Analgesics|analgesics|mesh-ancestor
14057283|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
14757759|NCT05339542|Hormones|hormones|mesh-ancestor
14757760|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14757761|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14757762|NCT05339542|Protective Agents|protective agents|mesh-ancestor
14757763|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14757764|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757765|NCT05339529|Glycine|glycine|mesh-list
14757766|NCT05339529|Thymalfasin|thymalfasin|mesh-list
14757767|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
14757768|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757769|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757770|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757771|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14757772|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
14057284|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057285|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057286|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
14057287|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14057288|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14057289|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057290|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14057291|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14057292|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14057293|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057294|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057295|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
14057296|NCT02629315|Formaldehyde|formaldehyde|mesh-list
14057297|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
14057298|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057299|NCT02629042|Prednisolone|prednisolone|mesh-list
14057300|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057301|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057302|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
14057303|NCT02629042|Hormones|hormones|mesh-ancestor
14475877|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475878|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14475879|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14475880|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14475881|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14475882|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
14475883|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
14475884|NCT02408016|Aldesleukin|aldesleukin|mesh-list
14475885|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
14475886|NCT02408016|Interleukin-2|interleukin-2|mesh-list
14475887|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14475888|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
14475889|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475890|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475891|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14475892|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
14475893|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475894|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757777|NCT05339386|Xenon|xenon|mesh-list
14757778|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14757779|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
14757780|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
14757781|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757782|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757783|NCT05339373|Aceclofenac|aceclofenac|mesh-list
14475895|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14475896|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14475897|NCT02408016|Analgesics|analgesics|mesh-ancestor
14757784|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14057304|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057305|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14057306|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057307|NCT02629146|Fentanyl|fentanyl|mesh-list
14057308|NCT02629146|Midazolam|midazolam|mesh-list
14057309|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14057310|NCT02629146|Narcotics|narcotics|mesh-ancestor
14057311|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057312|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057313|NCT02629146|Analgesics|analgesics|mesh-ancestor
14057314|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
14057315|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057316|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14057317|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14057318|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
14057319|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
14057320|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14057321|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14057322|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14057323|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14057324|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
14057325|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
14057326|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057327|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057328|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
14057329|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14057330|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
14057331|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057332|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
14057333|NCT02629380|Protective Agents|protective agents|mesh-ancestor
14057334|NCT02628704|Dexamethasone|dexamethasone|mesh-list
14057335|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057336|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
14057337|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
14057338|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057339|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057340|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057341|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
14057342|NCT02628704|Hormones|hormones|mesh-ancestor
14057343|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057344|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14057345|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057346|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
14057347|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057348|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
14057349|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14057350|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14057351|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057352|NCT02628847|Urological Agents|urological agents|mesh-ancestor
14057353|NCT02628951|Paclitaxel|paclitaxel|mesh-list
14057354|NCT02628951|Ramucirumab|ramucirumab|mesh-list
14057355|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057356|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057357|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057358|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
14757785|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757786|NCT05339373|Analgesics|analgesics|mesh-ancestor
14757787|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
14757788|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057359|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171433|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
14475898|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
14475899|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475900|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14475901|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14475902|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
14475903|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14475904|NCT02408068|Dexamethasone|dexamethasone|mesh-list
14475905|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
14475906|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14475907|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14475908|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14757789|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757790|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14757791|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14757792|NCT05339334|Ritonavir|ritonavir|mesh-list
14757793|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14757794|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14757795|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
14757796|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757797|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757798|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14057360|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057361|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14057362|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
14057363|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057364|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
14057365|NCT02628860|Hematinics|hematinics|mesh-ancestor
14057366|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14057367|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14057368|NCT02628665|Trioxsalen|trioxsalen|mesh-list
14057369|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
14057370|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057371|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
14057372|NCT02628613|Paclitaxel|paclitaxel|mesh-list
14057373|NCT02628613|Vinorelbine|vinorelbine|mesh-list
14057374|NCT02628613|Epirubicin|epirubicin|mesh-list
14057375|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057376|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057377|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057378|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057379|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057380|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057381|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057382|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14057383|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14057384|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057385|NCT02628587|Clopidogrel|clopidogrel|mesh-list
14057386|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14057387|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14057388|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14057389|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14057390|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
14057391|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057392|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057393|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057394|NCT02628574|Gemcitabine|gemcitabine|mesh-list
14057395|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
14057396|NCT02628574|Nivolumab|nivolumab|mesh-list
14057397|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14057398|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
14057399|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057400|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057401|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
14057402|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057403|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057404|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057405|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
14057406|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057407|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057408|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14057409|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
14057410|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14057411|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14057412|NCT02628392|Firuglipel|firuglipel|mesh-list
14057413|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14057414|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057415|NCT02628392|Incretins|incretins|mesh-ancestor
14057416|NCT02628392|Hormones|hormones|mesh-ancestor
14057417|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057418|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14057419|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
14057420|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057421|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057422|NCT02628522|Lidocaine|lidocaine|mesh-list
14057423|NCT02628522|Epinephrine|epinephrine|mesh-list
14057424|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
14057425|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
14057426|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057427|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057428|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
14057429|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057430|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14057431|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14057432|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14057433|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14057434|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057435|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14057436|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14057437|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
14057438|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057439|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14057440|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14057441|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
14057442|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14057443|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057444|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
14057445|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
14057446|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14057447|NCT02628197|Vitamin D|vitamin d|mesh-list
14057448|NCT02628197|Calcium|calcium|mesh-list
14057449|NCT02628197|Vitamins|vitamins|mesh-ancestor
14057450|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
14057451|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057452|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14057453|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14171434|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171435|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14171436|NCT04821817|Rocuronium|rocuronium|mesh-list
14171437|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14171438|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14171439|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14171440|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171441|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171442|NCT04821778|Paclitaxel|paclitaxel|mesh-list
14171443|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
14171444|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14171445|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171446|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171447|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
14171448|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171449|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171450|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14171451|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
14171452|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171453|NCT04821765|Paclitaxel|paclitaxel|mesh-list
14171454|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14171455|NCT04821765|Antibodies|antibodies|mesh-list
14171456|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14171457|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171458|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171459|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
14171460|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171461|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171462|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
14171463|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171464|NCT04821323|Indomethacin|indomethacin|mesh-list
14171465|NCT04821323|Mannitol|mannitol|mesh-list
14171466|NCT04821323|Lactulose|lactulose|mesh-list
14171467|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14171468|NCT04821323|Diuretics|diuretics|mesh-ancestor
14171469|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
14171470|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171471|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14171472|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171473|NCT04821323|Analgesics|analgesics|mesh-ancestor
14171474|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
14171475|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171476|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171477|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14171478|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
14171479|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
14057454|NCT02628002|Regadenoson|regadenoson|mesh-list
14057455|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14057456|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14057457|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
14057458|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
14057459|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14475909|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475910|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
14475911|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
14475912|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057460|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057461|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057462|NCT02627846|Lidocaine|lidocaine|mesh-list
14057463|NCT02627846|Epinephrine|epinephrine|mesh-list
14057464|NCT02627846|Racepinephrine|racepinephrine|mesh-list
14057465|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14475913|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057466|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
14057467|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
14057468|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
14057469|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
14057470|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057471|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057472|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
14057473|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057474|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14057475|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14057476|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14057477|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14057478|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057479|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14057480|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14057481|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
14057482|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057483|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14057484|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14057485|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
14057486|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14057487|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057488|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
14057489|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
14057490|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14057491|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14057492|NCT02628132|Paclitaxel|paclitaxel|mesh-list
14057493|NCT02628132|Durvalumab|durvalumab|mesh-list
14057494|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057495|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057496|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057497|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057498|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057499|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057500|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057501|NCT02628080|Atovaquone|atovaquone|mesh-list
14057502|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057503|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
14057504|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14057505|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14057506|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057507|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057508|NCT02627989|Diflucortolone|diflucortolone|mesh-list
14057509|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
14057510|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057511|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
14057512|NCT02627989|Hormones|hormones|mesh-ancestor
14057513|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475914|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057514|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057515|NCT02627950|Metoclopramide|metoclopramide|mesh-list
14057516|NCT02627950|Ticagrelor|ticagrelor|mesh-list
14475915|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
14057517|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14057518|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14057519|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14057520|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14057521|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
14057522|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057523|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057524|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057525|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
14057526|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
14057527|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057528|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057529|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14057530|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14057531|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
14057532|NCT02627807|Gemcitabine|gemcitabine|mesh-list
14057533|NCT02627807|Cisplatin|cisplatin|mesh-list
14057534|NCT02627807|Docetaxel|docetaxel|mesh-list
14057535|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057536|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14057537|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
14057538|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057539|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
14057540|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057541|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057542|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057543|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
14057544|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057545|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057546|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057547|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057548|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
14057549|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14057550|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
14057551|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057552|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057553|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14057554|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057555|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
14057556|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14057557|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
14057558|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057559|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057560|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
14057561|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
14057562|NCT02627573|Busulfan|busulfan|mesh-list
14057563|NCT02627573|Fludarabine|fludarabine|mesh-list
14057564|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
14757799|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14757800|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
14757801|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913420|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13913421|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
13913422|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13913423|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13913424|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13913425|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13913426|NCT03487770|Aripiprazole|aripiprazole|mesh-list
13913427|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13913428|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
13913429|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13913430|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13913431|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14057565|NCT02627573|Tacrolimus|tacrolimus|mesh-list
13913432|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913433|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913434|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
13913435|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
13913436|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913437|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913438|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14057566|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
14057567|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057568|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
14057569|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057570|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14057571|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14057572|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
14057573|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057574|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057575|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14057576|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14057577|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
14057578|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14057579|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057580|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057581|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14057582|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
14057583|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14475916|NCT02408068|Hormones|hormones|mesh-ancestor
14475917|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475918|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14475919|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757802|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14757803|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14757804|NCT05339295|Levofloxacin|levofloxacin|mesh-list
14757805|NCT05339295|Ofloxacin|ofloxacin|mesh-list
14757806|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14757807|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757808|NCT05339295|Renal Agents|renal agents|mesh-ancestor
14757809|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757810|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14757811|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14757812|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757813|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757814|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757815|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14757816|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13913439|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14475920|NCT02408120|Insulin|insulin|mesh-list
13913440|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
14475921|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14475922|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
14475923|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
13913441|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13913442|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13913443|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13913444|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13913445|NCT03487562|Amoxicillin|amoxicillin|mesh-list
14475924|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
14475925|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14475926|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14475927|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475928|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
14475929|NCT02408445|Testosterone|testosterone|mesh-list
14475930|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
14475931|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
14475932|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14475933|NCT02408445|Androgens|androgens|mesh-ancestor
13913446|NCT03487562|Clarithromycin|clarithromycin|mesh-list
13913447|NCT03487562|Lansoprazole|lansoprazole|mesh-list
13913448|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
13913449|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13913450|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913451|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13913452|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913453|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913454|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13913455|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13913456|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913457|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913458|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13913459|NCT03487406|Aspirin|aspirin|mesh-list
13913460|NCT03487406|Ticagrelor|ticagrelor|mesh-list
13913461|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13913462|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13913463|NCT03487406|Analgesics|analgesics|mesh-ancestor
13913464|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
13913465|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913466|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913467|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913468|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913469|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13913470|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13913471|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913472|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13913473|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13913474|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913475|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
13913476|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13913477|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13913478|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13913479|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
13913480|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913481|NCT03487354|Misoprostol|misoprostol|mesh-list
13913482|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13913483|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
13913484|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13913485|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913486|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913487|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913488|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
13913489|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13913490|NCT03487211|Citalopram|citalopram|mesh-list
13913491|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13913492|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13913493|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913494|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913495|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913496|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
13913497|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913498|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13913499|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
13913500|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13913501|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475934|NCT02408445|Hormones|hormones|mesh-ancestor
14475935|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057584|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057585|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
14057586|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14057587|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13913502|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13913503|NCT03487211|Analgesics|analgesics|mesh-ancestor
13913504|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
13913505|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
13913506|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
13913507|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
13913508|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913509|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913510|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913511|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
13913512|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
13913513|NCT03487172|Mannitol|mannitol|mesh-list
13913514|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13913515|NCT03487172|Diuretics|diuretics|mesh-ancestor
13913516|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
13913517|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933758|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933759|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14933760|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
14933761|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
14933762|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14933763|NCT01452334|BMS-936559|bms-936559|mesh-list
14933764|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14933765|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913518|NCT03487133|Dexamethasone|dexamethasone|mesh-list
14057588|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057589|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
14057590|NCT02627560|Coagulants|coagulants|mesh-ancestor
14057591|NCT02627521|Ticagrelor|ticagrelor|mesh-list
14057592|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14057593|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14057594|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14057595|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14057596|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
14057597|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057598|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057599|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057600|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
14057601|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14057602|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14057603|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
14057604|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14057605|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14057606|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057607|NCT02627469|Listerine|listerine|mesh-list
14057608|NCT02627469|Fluorides|fluorides|mesh-list
14057609|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
14057610|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
14057611|NCT02627469|Protective Agents|protective agents|mesh-ancestor
14057612|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057613|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14057614|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057615|NCT02627417|Dapsone|dapsone|mesh-list
14057616|NCT02627417|Prednisone|prednisone|mesh-list
14757817|NCT05339256|Buprenorphine|buprenorphine|mesh-list
13913519|NCT03487133|Bortezomib|bortezomib|mesh-list
14057617|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14757818|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14757819|NCT05339256|Narcotics|narcotics|mesh-ancestor
14757820|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757821|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757822|NCT05339256|Analgesics|analgesics|mesh-ancestor
14757823|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
14757824|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757825|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14757826|NCT05339217|Aldesleukin|aldesleukin|mesh-list
14757827|NCT05339217|Interleukin-2|interleukin-2|mesh-list
14757828|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933766|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14933767|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14757829|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13913520|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057618|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
14057619|NCT02627417|Hormones|hormones|mesh-ancestor
14757830|NCT05339217|Analgesics|analgesics|mesh-ancestor
14757831|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
14757832|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057620|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057621|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057622|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14057623|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057624|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057625|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
14057626|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14057627|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14757833|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757834|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14757835|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14757836|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
14757837|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057628|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14057629|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057630|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057631|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
14057632|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14057633|NCT02627430|Talazoparib|talazoparib|mesh-list
14057634|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14057635|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057636|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057637|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057638|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
14057639|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14057640|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
14057641|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14057642|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
14057643|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057644|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057645|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
14057646|NCT02627222|Vitamin A|vitamin a|mesh-list
14057647|NCT02627222|Provitamins|provitamins|mesh-list
14057648|NCT02627222|Vitamins|vitamins|mesh-ancestor
14057649|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
14057650|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057651|NCT02627027|Metformin|metformin|mesh-list
14057652|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13913521|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
13913522|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
13913523|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913524|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057653|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057654|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
14057655|NCT02627248|Docetaxel|docetaxel|mesh-list
14057656|NCT02627248|Epirubicin|epirubicin|mesh-list
14057657|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057658|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
14057659|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057660|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14057661|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14057662|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
14057663|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057664|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057665|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14057666|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057667|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057668|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057669|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057670|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14057671|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14057672|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057673|NCT02626936|Insulin|insulin|mesh-list
14757838|NCT05339113|FAPI-46|fapi-46|mesh-list
13913525|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913526|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
13913527|NCT03487133|Hormones|hormones|mesh-ancestor
13913528|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913529|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13913530|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913531|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
13913532|NCT03487107|Yimitasvir|yimitasvir|mesh-list
14057674|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14757839|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14057675|NCT02626936|Glucagon|glucagon|mesh-list
14057676|NCT02626936|Hormones|hormones|mesh-list
14057677|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14057678|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057679|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057680|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057681|NCT02626754|Sunitinib|sunitinib|mesh-list
14057682|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057683|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14057684|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14057685|NCT02626754|Growth Substances|growth substances|mesh-ancestor
14057686|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057687|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
14057688|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14057689|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057690|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057691|NCT02626845|Rituximab|rituximab|mesh-list
14057692|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057693|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057694|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
14057695|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057696|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14171480|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14171481|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14171482|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171483|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171484|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171485|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
14171486|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14171487|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
14171488|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171489|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
14171490|NCT04821804|Protective Agents|protective agents|mesh-ancestor
14171491|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
14171492|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171493|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171494|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
14171495|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171496|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171497|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
14171498|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14171499|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14171500|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14171501|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171502|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14171503|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14171504|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171505|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171506|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171507|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14171508|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
14171509|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14171510|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171511|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14171512|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14171513|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14171514|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14171515|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
14933768|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
14933769|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933770|NCT01452477|Tanshinone|tanshinone|mesh-list
14933771|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933772|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14171516|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14171517|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14171518|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171519|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171520|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
14171521|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14171522|NCT04821193|Disinfectants|disinfectants|mesh-list
14171523|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14171524|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14938783|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14057697|NCT02626364|Crenolanib|crenolanib|mesh-list
14057698|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057699|NCT02626559|Bupivacaine|bupivacaine|mesh-list
14057700|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
14057701|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
14057702|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057703|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057704|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
14057705|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057706|NCT02626247|Vitamin A|vitamin a|mesh-list
14057707|NCT02626247|Vitamins|vitamins|mesh-ancestor
14057708|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
14057709|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475936|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475937|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14475938|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057710|NCT02626169|Clopidogrel|clopidogrel|mesh-list
14057711|NCT02626169|Ticagrelor|ticagrelor|mesh-list
14057712|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14057713|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14057714|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14057715|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14057716|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
14057717|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057718|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057719|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057720|NCT02626208|ST 1435|st 1435|mesh-list
14057721|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
14057722|NCT02626208|Estradiol|estradiol|mesh-list
14057723|NCT02626208|Estrogens|estrogens|mesh-ancestor
14057724|NCT02626208|Hormones|hormones|mesh-ancestor
14057725|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057726|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057727|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14057728|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14057729|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14057730|NCT02626234|Digoxin|digoxin|mesh-list
14057731|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14057732|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14057733|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14057734|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
14057735|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057736|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14057737|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14057738|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057739|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14057740|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14057741|NCT02626234|Protective Agents|protective agents|mesh-ancestor
14057742|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057743|NCT02626481|Dexamethasone|dexamethasone|mesh-list
14057744|NCT02626481|Daratumumab|daratumumab|mesh-list
14057745|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057746|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
14057747|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
14057748|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057749|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057750|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057751|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
14057752|NCT02626481|Hormones|hormones|mesh-ancestor
14057753|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057754|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14057755|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057756|NCT02626065|Nivolumab|nivolumab|mesh-list
14057757|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057758|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057759|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14057760|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057761|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
14057762|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057763|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057764|NCT02626104|Lactoferrin|lactoferrin|mesh-list
14057765|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057766|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
14057767|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14057768|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14057769|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475939|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
14475940|NCT02408523|Lacosamide|lacosamide|mesh-list
14475941|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14475942|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
14475943|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14057770|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
14057771|NCT02625948|Coagulants|coagulants|mesh-ancestor
14057772|NCT02625753|Acetaminophen|acetaminophen|mesh-list
14057773|NCT02625753|Codeine|codeine|mesh-list
14057774|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14057775|NCT02625753|Analgesics|analgesics|mesh-ancestor
14057776|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
14057777|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057778|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057779|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
14057780|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14057781|NCT02625753|Narcotics|narcotics|mesh-ancestor
14057782|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057783|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
14057784|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
14057785|NCT02625779|Valproic Acid|valproic acid|mesh-list
14057786|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
14057787|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057788|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057789|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
14057790|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057791|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057792|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
14057793|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14057794|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057795|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14057796|NCT02625805|Methylphenidate|methylphenidate|mesh-list
14057797|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14057798|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057799|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14057800|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14057801|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14057802|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057803|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
14057804|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057805|NCT02625740|Paclitaxel|paclitaxel|mesh-list
14057806|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14057807|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057808|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057809|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057810|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057811|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057812|NCT02625519|Hormones|hormones|mesh-list
14057813|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14057814|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057815|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057816|NCT02625636|Glucagon|glucagon|mesh-list
14057817|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14057818|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057819|NCT02625636|Hormones|hormones|mesh-ancestor
14057820|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057821|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057822|NCT02625636|Incretins|incretins|mesh-ancestor
14057823|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
14057824|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14057825|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
14057826|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057827|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
14057828|NCT02625727|Protective Agents|protective agents|mesh-ancestor
14057829|NCT02625506|Tramadol|tramadol|mesh-list
14057830|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
14057831|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14057832|NCT02625506|Narcotics|narcotics|mesh-ancestor
14057833|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057834|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057835|NCT02625506|Analgesics|analgesics|mesh-ancestor
14057836|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
14057837|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057838|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
14475944|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14057839|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
14057840|NCT02625558|Riociguat|riociguat|mesh-list
14057841|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
14057842|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057843|NCT02625415|Vitamins|vitamins|mesh-list
14057844|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
14057845|NCT02625415|Pyridoxal|pyridoxal|mesh-list
14057846|NCT02625415|Pyridoxine|pyridoxine|mesh-list
14057847|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
14057848|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
14057849|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057850|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
14057851|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057852|NCT02625454|Acetaminophen|acetaminophen|mesh-list
14057853|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14057854|NCT02625454|Analgesics|analgesics|mesh-ancestor
14057855|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
14057856|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057857|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057858|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
14057859|NCT02625103|Clozapine|clozapine|mesh-list
14057860|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14057861|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
14057862|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14057863|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057864|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057865|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14057866|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14057867|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057868|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14057869|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
14057870|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
14057871|NCT02625376|Resveratrol|resveratrol|mesh-list
14057872|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
14057873|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057874|NCT02625376|Protective Agents|protective agents|mesh-ancestor
14057875|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057876|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057877|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14057878|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14057879|NCT02625168|Afatinib|afatinib|mesh-list
14057880|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057881|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14057882|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057883|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057884|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
14057885|NCT02625337|Trametinib|trametinib|mesh-list
14057886|NCT02625337|Dabrafenib|dabrafenib|mesh-list
14057887|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14057888|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057889|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14057890|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057891|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057892|NCT02624999|Cisplatin|cisplatin|mesh-list
14057893|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057894|NCT02624856|Dexamethasone|dexamethasone|mesh-list
14057895|NCT02624856|Bupivacaine|bupivacaine|mesh-list
14057896|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14057897|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
14057898|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
14057899|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057900|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057901|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14057902|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
14057903|NCT02624856|Hormones|hormones|mesh-ancestor
14057904|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057905|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14057906|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057907|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
14057908|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
14057909|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14057910|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
14057911|NCT02624973|Tamoxifen|tamoxifen|mesh-list
14057912|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
14057913|NCT02624973|Docetaxel|docetaxel|mesh-list
14057914|NCT02624973|Trastuzumab|trastuzumab|mesh-list
14057915|NCT02624973|Letrozole|letrozole|mesh-list
14057916|NCT02624973|Epirubicin|epirubicin|mesh-list
14057917|NCT02624973|Olaparib|olaparib|mesh-list
14057918|NCT02624973|Palbociclib|palbociclib|mesh-list
14057919|NCT02624973|Pertuzumab|pertuzumab|mesh-list
14057920|NCT02624973|Goserelin|goserelin|mesh-list
14057921|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057922|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
14057923|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057924|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14057925|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14057926|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
14057927|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057928|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057929|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14057930|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
14057931|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
14057932|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057933|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14757840|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757841|NCT05339087|Riociguat|riociguat|mesh-list
14057934|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14057935|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14057936|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057937|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14057938|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
14057939|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14057940|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14057941|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14057942|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14057943|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14057944|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14057945|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14057946|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14057947|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14057948|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14057949|NCT02624817|Glyburide|glyburide|mesh-list
14057950|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14057951|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057952|NCT02624908|Canagliflozin|canagliflozin|mesh-list
14057953|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14057954|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057955|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14057956|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171525|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171526|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
14171527|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
14171528|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
14171529|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
14171530|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171531|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14171532|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
14171533|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
14171534|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171535|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171536|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171537|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14171538|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
14171539|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14171540|NCT04820933|Tenofovir|tenofovir|mesh-list
14171541|NCT04820933|Emtricitabine|emtricitabine|mesh-list
14171542|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
14171543|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171544|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14171545|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14171546|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171547|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171548|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14171549|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14171550|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
14171551|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14171552|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183155|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14183156|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183157|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
14183158|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
14183159|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
14057957|NCT02624726|Leucovorin|leucovorin|mesh-list
14057958|NCT02624726|Fluorouracil|fluorouracil|mesh-list
14057959|NCT02624726|Irinotecan|irinotecan|mesh-list
14057960|NCT02624726|Aflibercept|aflibercept|mesh-list
14057961|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
14057962|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
14057963|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14057964|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14057965|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14057966|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14057967|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
14057968|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057969|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14057970|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14057971|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14057972|NCT02624726|Antidotes|antidotes|mesh-ancestor
14057973|NCT02624726|Protective Agents|protective agents|mesh-ancestor
14057974|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
14057975|NCT02624726|Vitamins|vitamins|mesh-ancestor
14057976|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
14057977|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14057978|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14057979|NCT02624726|Growth Substances|growth substances|mesh-ancestor
14057980|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
14057981|NCT02624830|Glyburide|glyburide|mesh-list
14057982|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14057983|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057984|NCT02624661|Glycerol|glycerol|mesh-list
14057985|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14057986|NCT02624661|Protective Agents|protective agents|mesh-ancestor
14057987|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057988|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
14057989|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14057990|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14057991|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14057992|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
14057993|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14057994|NCT02624505|Albuterol|albuterol|mesh-list
14057995|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14057996|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
14057997|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14057998|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14057999|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14058000|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
14058001|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
14058002|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14058003|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14058004|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14058005|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14058006|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058007|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058008|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058009|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
14058010|NCT02624479|Antidotes|antidotes|mesh-ancestor
14058011|NCT02624479|Protective Agents|protective agents|mesh-ancestor
14058012|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933773|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933774|NCT01452477|Analgesics|analgesics|mesh-ancestor
14933775|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
14933776|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933777|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933778|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933779|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933780|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
14933781|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14933782|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933783|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14933784|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
14933785|NCT01452542|Eliglustat|eliglustat|mesh-list
14933786|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933787|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933788|NCT01452568|Aspirin|aspirin|mesh-list
14933789|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
14058013|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
14058014|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058015|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
14933790|NCT01452568|Salicylates|salicylates|mesh-list
14933791|NCT01452568|Warfarin|warfarin|mesh-list
14933792|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933793|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933794|NCT01452568|Analgesics|analgesics|mesh-ancestor
14933795|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
14933796|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913533|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
14058016|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058017|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058018|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
14058019|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
14058020|NCT02624544|Desonide|desonide|mesh-list
14058021|NCT02624544|Esomeprazole|esomeprazole|mesh-list
14058022|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14058023|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058024|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14058025|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058026|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058027|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14058028|NCT02624570|Midostaurin|midostaurin|mesh-list
14058029|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058030|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14058031|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058032|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058033|NCT02624453|Fluconazole|fluconazole|mesh-list
14058034|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14058035|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
14058036|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058037|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14058038|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14058039|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058040|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058041|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14058042|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
13913534|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913535|NCT03487042|Bimatoprost|bimatoprost|mesh-list
13913536|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13913537|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13913538|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14058043|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058044|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058045|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14058046|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14058047|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
14757842|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
14757843|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757844|NCT05339074|Ketamine|ketamine|mesh-list
14757845|NCT05339074|Analgesics|analgesics|mesh-ancestor
14058048|NCT02624388|Genistein|genistein|mesh-list
14058049|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14058050|NCT02624388|Protective Agents|protective agents|mesh-ancestor
14058051|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757846|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
14757847|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757848|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757849|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14757850|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14757851|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
14757852|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
13913539|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
13913540|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13913541|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13913542|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
13913543|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913544|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933797|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933798|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933799|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933800|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14933801|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13913545|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913546|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
13913547|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
13913548|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913549|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
13913550|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13913551|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
13913552|NCT03487016|Gemcitabine|gemcitabine|mesh-list
13913553|NCT03487016|Paclitaxel|paclitaxel|mesh-list
13913554|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
13913555|NCT03487016|Irinotecan|irinotecan|mesh-list
13913556|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13913557|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913558|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
13913559|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
13913560|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
13913561|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913562|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913563|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
14058052|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058053|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14058054|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058055|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058056|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
14058057|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14058058|NCT02624388|Estrogens|estrogens|mesh-ancestor
14058059|NCT02624388|Hormones|hormones|mesh-ancestor
14058060|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058061|NCT02624531|Cisplatin|cisplatin|mesh-list
14058062|NCT02624531|Taxane|taxane|mesh-list
14058063|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058064|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
14058065|NCT02624401|Ketamine|ketamine|mesh-list
14058066|NCT02624401|Propofol|propofol|mesh-list
14058067|NCT02624401|Sevoflurane|sevoflurane|mesh-list
14058068|NCT02624401|Esketamine|esketamine|mesh-list
14058069|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14058070|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058071|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058072|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14058073|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
14058074|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
14058075|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14058076|NCT02624401|Analgesics|analgesics|mesh-ancestor
14058077|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
14058078|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058079|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14058080|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14058081|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14058082|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058083|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058084|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058085|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14058086|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14058087|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14058088|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14058089|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14058090|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
14058091|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14058092|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
14058093|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14058094|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058095|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
14058096|NCT02624310|Droxidopa|droxidopa|mesh-list
14058097|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14058098|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13913564|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
14058099|NCT02624440|Clarithromycin|clarithromycin|mesh-list
14058100|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14058101|NCT02624440|Trimethoprim|trimethoprim|mesh-list
14058102|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
14058103|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058104|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058105|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14058106|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058107|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058108|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14058109|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14058110|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14058111|NCT02624440|Renal Agents|renal agents|mesh-ancestor
14058112|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
14058113|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14058114|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14058115|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14058116|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14058117|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14058118|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
14058119|NCT02624063|Simeprevir|simeprevir|mesh-list
14058120|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
14058121|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058122|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
14058123|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058124|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058125|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
14058126|NCT02624141|Hematinics|hematinics|mesh-ancestor
14058127|NCT02623881|Progesterone|progesterone|mesh-list
14058128|NCT02623881|Progestins|progestins|mesh-ancestor
14058129|NCT02623881|Hormones|hormones|mesh-ancestor
14058130|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058131|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058132|NCT02624089|Ropivacaine|ropivacaine|mesh-list
14058133|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
14058134|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
14058135|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058136|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058137|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
14058138|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058139|NCT02623816|Omeprazole|omeprazole|mesh-list
14058140|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14058141|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058142|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14058143|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058144|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058145|NCT02623920|Rituximab|rituximab|mesh-list
14058146|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14058147|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14058148|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058149|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058150|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
13913565|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913566|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913567|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913568|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
14058151|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058152|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14058153|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14058154|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
14058155|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913569|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913570|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13913571|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13913572|NCT03487003|Bromides|bromides|mesh-list
13913573|NCT03487003|Rocuronium|rocuronium|mesh-list
13913574|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
13913575|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13913576|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13913577|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13913578|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913579|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913580|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
13913581|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
13913582|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058156|NCT02623751|Exemestane|exemestane|mesh-list
14058157|NCT02623751|Entinostat|entinostat|mesh-list
14058158|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058159|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14058160|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14058161|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058162|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058163|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14058164|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
14058165|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058166|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058167|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14058168|NCT02623621|Bevacizumab|bevacizumab|mesh-list
14058169|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058170|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058171|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14058172|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14058173|NCT02623621|Growth Substances|growth substances|mesh-ancestor
14058174|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058175|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
13913583|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913584|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13913585|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913586|NCT03486925|Oxytocin|oxytocin|mesh-list
13913587|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
13913588|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13913589|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058176|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14058177|NCT02623738|Latanoprost|latanoprost|mesh-list
14058178|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14058179|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
14058180|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14058181|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
14058182|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058183|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14058184|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14058185|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
14058186|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058187|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058188|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14058189|NCT02623673|Dexamethasone|dexamethasone|mesh-list
14058190|NCT02623673|Bevacizumab|bevacizumab|mesh-list
14058191|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058192|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058193|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14058194|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14058195|NCT02623673|Growth Substances|growth substances|mesh-ancestor
14058196|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058197|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14058198|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14058199|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
14058200|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
14058201|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058202|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058203|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
14058204|NCT02623673|Hormones|hormones|mesh-ancestor
14058205|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058206|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14058207|NCT02623569|Atenolol|atenolol|mesh-list
14058208|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14058209|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14058210|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
14058211|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
14058212|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058213|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058214|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14058215|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14058216|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14058217|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058218|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913590|NCT03486626|Metformin|metformin|mesh-list
13913591|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13913592|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913593|NCT03486561|Ranolazine|ranolazine|mesh-list
13913594|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13913595|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058219|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058220|NCT02623595|Molgramostim|molgramostim|mesh-list
14058221|NCT02623595|Sargramostim|sargramostim|mesh-list
14058222|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
14058223|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058224|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058225|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
14058226|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14058227|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058228|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
14058229|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14058230|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058231|NCT02623504|Carbamazepine|carbamazepine|mesh-list
14058232|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
14058233|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
14058234|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14058235|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058236|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058237|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14058238|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14058239|NCT02623504|Analgesics|analgesics|mesh-ancestor
14058240|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
14058241|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058242|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14058243|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058244|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058245|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14058246|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14058247|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
14058248|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14058249|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058250|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
14058251|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14058252|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
14058253|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058254|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14058255|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14058256|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
14058257|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058258|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058259|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14058260|NCT02623205|Citalopram|citalopram|mesh-list
14058261|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14058262|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14058263|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058264|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058265|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058266|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
14058267|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058268|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14058269|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
14058270|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14058271|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
14058272|NCT02623062|Antacids|antacids|mesh-ancestor
14058273|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058274|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058275|NCT02623127|Sunitinib|sunitinib|mesh-list
14058276|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058277|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14058278|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14058279|NCT02623127|Growth Substances|growth substances|mesh-ancestor
14058280|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058281|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
14058282|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14058283|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058284|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171553|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
14171554|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
14171555|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171556|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171557|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
14757853|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757854|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14757855|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14757856|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913596|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913597|NCT03486548|Dexamethasone|dexamethasone|mesh-list
13913598|NCT03486548|Lidocaine|lidocaine|mesh-list
13913599|NCT03486548|Bupivacaine|bupivacaine|mesh-list
13913600|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913601|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
13913602|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
13913603|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913604|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913605|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913606|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
13913607|NCT03486548|Hormones|hormones|mesh-ancestor
13913608|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058285|NCT02623036|Enalapril|enalapril|mesh-list
14058286|NCT02623036|Lisinopril|lisinopril|mesh-list
14058287|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14058288|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
14058289|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058290|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058291|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14058292|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14058293|NCT02623036|Protective Agents|protective agents|mesh-ancestor
14058294|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058295|NCT02623049|Anticoagulants|anticoagulants|mesh-list
14058296|NCT02623231|Citalopram|citalopram|mesh-list
14058297|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14058298|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14058299|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058300|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058301|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058302|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
14058303|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058304|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14058305|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
14058306|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14058307|NCT02623153|Docetaxel|docetaxel|mesh-list
14058308|NCT02623153|Capecitabine|capecitabine|mesh-list
14058309|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
14058310|NCT02623153|Tegafur|tegafur|mesh-list
14058311|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058312|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
14058313|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
14058314|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
14058315|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058316|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14058317|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
14058318|NCT02623114|Methylphenidate|methylphenidate|mesh-list
14058319|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14058320|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14058321|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058322|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14058323|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14058324|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058325|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058326|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
14058327|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058328|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14058329|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058330|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
14058331|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14058332|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14058333|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058334|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058335|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058336|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058337|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14058338|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14058339|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14058340|NCT02622906|Pasireotide|pasireotide|mesh-list
14058341|NCT02622906|Hormones|hormones|mesh-ancestor
14058342|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058343|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058344|NCT02622854|Insulin|insulin|mesh-list
14058345|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14058346|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058347|NCT02622503|Rituximab|rituximab|mesh-list
14058348|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058349|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058350|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
14058351|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058352|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14058353|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14058354|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14058355|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
14058356|NCT02622555|Mirabegron|mirabegron|mesh-list
14058357|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14058358|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14058359|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14058360|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058361|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058362|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058363|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058364|NCT02622555|Urological Agents|urological agents|mesh-ancestor
14058365|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
14058366|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
14058367|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058368|NCT02622672|Vitamins|vitamins|mesh-ancestor
14058369|NCT02622802|Acetaminophen|acetaminophen|mesh-list
14058370|NCT02622802|Azithromycin|azithromycin|mesh-list
14058371|NCT02622802|Erythromycin|erythromycin|mesh-list
14058372|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
14058373|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14058374|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
14058375|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14058376|NCT02622802|Analgesics|analgesics|mesh-ancestor
14058377|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
14058378|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058379|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058380|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
14058381|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058382|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058383|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058384|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14058385|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058386|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058387|NCT02622477|Pirfenidone|pirfenidone|mesh-list
14058388|NCT02622477|Analgesics|analgesics|mesh-ancestor
14058389|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
14058390|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058391|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058392|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14058393|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14757857|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757858|NCT05339022|Coal Tar|coal tar|mesh-list
14757859|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
14757860|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
14058394|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14058395|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14058396|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058397|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14058398|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14058399|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058400|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
14058401|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14058402|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058403|NCT02622334|Latanoprost|latanoprost|mesh-list
14058404|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14058405|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14058406|NCT02622386|Riboflavin|riboflavin|mesh-list
14058407|NCT02622386|Vitamins|vitamins|mesh-ancestor
14058408|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
14058409|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058410|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
14058411|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14058412|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
14058413|NCT02622126|Atropine|atropine|mesh-list
14058414|NCT02622126|Ephedrine|ephedrine|mesh-list
14058415|NCT02622126|Morphine|morphine|mesh-list
14058416|NCT02622126|Bupivacaine|bupivacaine|mesh-list
14058417|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
14058418|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
14058419|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058420|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058421|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
14058422|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058423|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14058424|NCT02622126|Narcotics|narcotics|mesh-ancestor
14058425|NCT02622126|Analgesics|analgesics|mesh-ancestor
14058426|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14058427|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14058428|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14058429|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
14058430|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14058431|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
14058432|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
14058433|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
14058434|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14058435|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14058436|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
14058437|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058438|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058439|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14058440|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
14058441|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14058442|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058443|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
14058444|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
14058445|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14058446|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
14058447|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058448|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058449|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14058450|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
14058451|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
14058452|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14058453|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
14058454|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058455|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058456|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14058457|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14058458|NCT02622022|Morphine|morphine|mesh-list
14058459|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14058460|NCT02622022|Narcotics|narcotics|mesh-ancestor
14058461|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933802|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933803|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13913609|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13913610|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913611|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
13913612|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
13913613|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913614|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
13913615|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13913616|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13913617|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13913618|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913619|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913620|NCT03486509|Afatinib|afatinib|mesh-list
13913621|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913622|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13913623|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058462|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058463|NCT02622022|Analgesics|analgesics|mesh-ancestor
14058464|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
14058465|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058466|NCT02621957|Pravastatin|pravastatin|mesh-list
14058467|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14058468|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14058469|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
14058470|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058471|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14058472|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14058473|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058474|NCT02621970|Cisplatin|cisplatin|mesh-list
14058475|NCT02621970|Docetaxel|docetaxel|mesh-list
14058476|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058477|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
14058478|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
14058479|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
14058480|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058481|NCT02621944|Melatonin|melatonin|mesh-list
14058482|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
14058483|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058484|NCT02621944|Protective Agents|protective agents|mesh-ancestor
14058485|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058486|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058487|NCT02621905|Itraconazole|itraconazole|mesh-list
14058488|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14058489|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
14058490|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058491|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14058492|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14058493|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058494|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058495|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14058496|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
14058497|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058498|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058499|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14058500|NCT02621827|Calcifediol|calcifediol|mesh-list
14058501|NCT02621827|Vitamins|vitamins|mesh-ancestor
14058502|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
14058503|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058504|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14171558|NCT04820205|Ketamine|ketamine|mesh-list
14475945|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14475946|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475947|NCT02408965|Methylergonovine|methylergonovine|mesh-list
14475948|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
14475949|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14475950|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475951|NCT02409680|Aspirin|aspirin|mesh-list
14475952|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14475953|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933804|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14933805|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171559|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
14171560|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14171561|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171562|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171563|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171564|NCT04820205|Analgesics|analgesics|mesh-ancestor
14171565|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
14171566|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171567|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14171568|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14171569|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14171570|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171571|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171572|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171573|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14171574|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14171575|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
14171576|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
14171577|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14171578|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14171579|NCT04820439|Pertuzumab|pertuzumab|mesh-list
14171580|NCT04820439|Antibodies|antibodies|mesh-list
14933806|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
14058505|NCT02621554|Resveratrol|resveratrol|mesh-list
14058506|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
14058507|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058508|NCT02621554|Protective Agents|protective agents|mesh-ancestor
14058509|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058510|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058511|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14058512|NCT02621515|Nivolumab|nivolumab|mesh-list
14058513|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058514|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058515|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14058516|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058517|NCT02621385|Midazolam|midazolam|mesh-list
14058518|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14058519|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14058520|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058521|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058522|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14058523|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14058524|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14475954|NCT02409680|Analgesics|analgesics|mesh-ancestor
14475955|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
14475956|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14475957|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475958|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14058525|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14058526|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
14058527|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
14058528|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
14058529|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
14058530|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058531|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058532|NCT02621489|Metformin|metformin|mesh-list
14058533|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
14058534|NCT02621489|Exenatide|exenatide|mesh-list
14058535|NCT02621489|Biguanides|biguanides|mesh-list
14058536|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14058537|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058538|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14058539|NCT02621489|Incretins|incretins|mesh-ancestor
14058540|NCT02621489|Hormones|hormones|mesh-ancestor
14058541|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058553|NCT02621359|Doxycycline|doxycycline|mesh-list
14058554|NCT02621359|Levofloxacin|levofloxacin|mesh-list
14058555|NCT02621359|Ofloxacin|ofloxacin|mesh-list
14058556|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
14058557|NCT02621359|Omeprazole|omeprazole|mesh-list
14058558|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14058559|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058560|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14058561|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058562|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058563|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058564|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058565|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
14475959|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14475960|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14475961|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14475962|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757868|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
14058566|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14058567|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14058568|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14058569|NCT02621359|Renal Agents|renal agents|mesh-ancestor
14058570|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14058571|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14058572|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058573|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14058574|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14058575|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14058576|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14058577|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13913624|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913625|NCT03486496|Gefitinib|gefitinib|mesh-list
13913626|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913627|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13913628|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913629|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913630|NCT03486457|Tofacitinib|tofacitinib|mesh-list
13913631|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14058578|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058579|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058580|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
14058581|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058582|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14058583|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14058584|NCT02621320|Vitamin D|vitamin d|mesh-list
14058585|NCT02621320|Vitamins|vitamins|mesh-ancestor
14058586|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
14058587|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058588|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14058589|NCT02621255|Bupivacaine|bupivacaine|mesh-list
14058590|NCT02621255|Anesthetics|anesthetics|mesh-list
14058591|NCT02621255|Sevoflurane|sevoflurane|mesh-list
14058592|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
14058593|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058594|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058595|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
14058596|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058597|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14058598|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14058599|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
14058600|NCT02621112|Imiquimod|imiquimod|mesh-list
14058601|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14058602|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
14058603|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058604|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058605|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
14058606|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
14058607|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058608|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
14058609|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14058610|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14058611|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058612|NCT02620995|Urological Agents|urological agents|mesh-ancestor
14058613|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
14058614|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14058615|NCT02620800|Leucovorin|leucovorin|mesh-list
14058616|NCT02620800|Paclitaxel|paclitaxel|mesh-list
14058617|NCT02620800|Bevacizumab|bevacizumab|mesh-list
14058618|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
14058619|NCT02620800|Calcium|calcium|mesh-list
14058620|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
14058621|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14058622|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058623|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
14058624|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
14058625|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
14058626|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058627|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058628|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14058629|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14058630|NCT02620800|Growth Substances|growth substances|mesh-ancestor
14058631|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058632|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14767273|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
14058633|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14058634|NCT02620800|Antidotes|antidotes|mesh-ancestor
14058635|NCT02620800|Protective Agents|protective agents|mesh-ancestor
14058636|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
14058637|NCT02620800|Vitamins|vitamins|mesh-ancestor
14058638|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
14058639|NCT02620813|Tretinoin|tretinoin|mesh-list
14058640|NCT02620813|Isotretinoin|isotretinoin|mesh-list
14058641|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14058642|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058643|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
14058644|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
14058645|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14058646|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14058647|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058648|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
14058649|NCT02620748|Coagulants|coagulants|mesh-ancestor
14058650|NCT02620839|Cisplatin|cisplatin|mesh-list
14058651|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058652|NCT02620761|Fenoldopam|fenoldopam|mesh-list
14058653|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14058654|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
14058655|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
14058656|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
14058657|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058658|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058659|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058660|NCT02620605|Cabergoline|cabergoline|mesh-list
14058661|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14058662|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14058663|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
14058664|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
14058665|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058666|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058667|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058668|NCT02620618|Infliximab|infliximab|mesh-list
14058669|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
14058670|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058671|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913632|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913633|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913634|NCT03486353|Azacitidine|azacitidine|mesh-list
13913635|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913636|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
13913637|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913638|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913639|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058672|NCT02620566|Bupivacaine|bupivacaine|mesh-list
14058673|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
14058674|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
14058675|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058676|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058677|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
14058678|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058679|NCT02620501|Lidocaine|lidocaine|mesh-list
14058680|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
14058681|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
14058682|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058683|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058684|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
14058685|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058686|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14058687|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14058688|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14058689|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058690|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058691|NCT02620631|Morphine|morphine|mesh-list
14058692|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14058693|NCT02620631|Narcotics|narcotics|mesh-ancestor
14058694|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058695|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058696|NCT02620631|Analgesics|analgesics|mesh-ancestor
14058697|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
14058698|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058699|NCT02620423|Leucovorin|leucovorin|mesh-list
14757869|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058700|NCT02620423|Gemcitabine|gemcitabine|mesh-list
14757870|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058701|NCT02620423|Fluorouracil|fluorouracil|mesh-list
14058702|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
14058703|NCT02620423|Irinotecan|irinotecan|mesh-list
14058704|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14058705|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
14058706|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058707|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058708|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
14058709|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058710|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058711|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14058712|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
14058713|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058714|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14058715|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14058716|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14058717|NCT02620423|Antidotes|antidotes|mesh-ancestor
14058718|NCT02620423|Protective Agents|protective agents|mesh-ancestor
14058719|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
14058720|NCT02620423|Vitamins|vitamins|mesh-ancestor
14058721|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
14058722|NCT02620150|Citalopram|citalopram|mesh-list
14058723|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14058724|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14058725|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058726|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058727|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058728|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
14058729|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058730|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14058731|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
14058732|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14058733|NCT02620163|Amlodipine|amlodipine|mesh-list
14058734|NCT02620163|Telmisartan|telmisartan|mesh-list
14058735|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
14058736|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14058737|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14058738|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14058739|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058740|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058741|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14058742|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058743|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
14058744|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14058745|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14058746|NCT02620163|Diuretics|diuretics|mesh-ancestor
14058747|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
14058748|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14058749|NCT02620189|Adalimumab|adalimumab|mesh-list
14058750|NCT02620189|Etanercept|etanercept|mesh-list
14058751|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
14058752|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14058753|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14058754|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14058755|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14058756|NCT02620189|Analgesics|analgesics|mesh-ancestor
14058757|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
14058758|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058759|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058760|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058761|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14058762|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
14058763|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14058764|NCT02620124|Hormones|hormones|mesh-list
14058765|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058766|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058767|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
14058768|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14058769|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
14058770|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14058771|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14058772|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14058773|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058774|NCT02620215|Dinoprostone|dinoprostone|mesh-list
14058775|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
14058776|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14058777|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058778|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
14058779|NCT02620345|Progestins|progestins|mesh-ancestor
14058780|NCT02620345|Hormones|hormones|mesh-ancestor
14058781|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058782|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058783|NCT02620293|Emollients|emollients|mesh-list
14058784|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
14058785|NCT02619981|Lidocaine|lidocaine|mesh-list
14058786|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
14058787|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
14058788|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058789|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058790|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
14058791|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058792|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14058793|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14058794|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14058795|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14058796|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058797|NCT02620280|Paclitaxel|paclitaxel|mesh-list
14058798|NCT02620280|Carboplatin|carboplatin|mesh-list
14058799|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14058800|NCT02620280|Atezolizumab|atezolizumab|mesh-list
14058801|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14058802|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058803|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
14058804|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
14058805|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
14058806|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058807|NCT02620046|Vedolizumab|vedolizumab|mesh-list
14058808|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058809|NCT02619929|Vinorelbine|vinorelbine|mesh-list
14058810|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14058811|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058812|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14058813|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14058814|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14058815|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058816|NCT02619994|Levofloxacin|levofloxacin|mesh-list
14058817|NCT02619994|Ofloxacin|ofloxacin|mesh-list
14058818|NCT02619994|Linezolid|linezolid|mesh-list
14058819|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
14058820|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14058821|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058822|NCT02619994|Renal Agents|renal agents|mesh-ancestor
14058823|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058824|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14058825|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14058826|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058827|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058828|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058829|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14058830|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14058831|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14058832|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
14171581|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14171582|NCT04820439|Mitogens|mitogens|mesh-list
14171583|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
14171584|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171585|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171586|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171587|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14171588|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058833|NCT02620306|Losartan|losartan|mesh-list
14058834|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14058835|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14058836|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14058837|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14058838|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058839|NCT02620072|Insulin|insulin|mesh-list
14058840|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14058841|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058842|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
14058843|NCT02620007|Rifaximin|rifaximin|mesh-list
14058844|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058845|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058846|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14058847|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14058848|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058849|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058850|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058851|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14058852|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14058853|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058854|NCT02619773|Mupirocin|mupirocin|mesh-list
14058855|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058856|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058857|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14058858|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058859|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058860|NCT02619786|Colistin|colistin|mesh-list
14058861|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058862|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058863|NCT02619669|Letrozole|letrozole|mesh-list
14058864|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058865|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14058866|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14058867|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058868|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058869|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14058870|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
14058871|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14757881|NCT05338866|Capecitabine|capecitabine|mesh-list
14757882|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14757883|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
14757884|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757885|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757886|NCT05338801|Menthol|menthol|mesh-list
14058872|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058873|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
14058874|NCT02619513|Ropivacaine|ropivacaine|mesh-list
14058875|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14058876|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058877|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058878|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14058879|NCT02619513|Analgesics|analgesics|mesh-ancestor
14058880|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
14058881|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058882|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14058883|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14058884|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14058885|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058886|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058887|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757887|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
14757888|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14767274|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058888|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
14058889|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
14058890|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
14058891|NCT02619747|Antacids|antacids|mesh-ancestor
13913640|NCT03486236|Ivacaftor|ivacaftor|mesh-list
13913641|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13913642|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913643|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913644|NCT03486184|Cystatins|cystatins|mesh-list
14933807|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
14058892|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058893|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058894|NCT02619448|Paclitaxel|paclitaxel|mesh-list
14058895|NCT02619448|Carboplatin|carboplatin|mesh-list
14058896|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14058897|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058898|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14058899|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14058900|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14058901|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058902|NCT02619578|Remifentanil|remifentanil|mesh-list
14058903|NCT02619578|Propofol|propofol|mesh-list
14058904|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
14058905|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14058906|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058907|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058908|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14058909|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
14058910|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
14058911|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14058912|NCT02619578|Narcotics|narcotics|mesh-ancestor
14058913|NCT02619578|Analgesics|analgesics|mesh-ancestor
14058914|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
14058915|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058916|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14058917|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14058918|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14058919|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14058920|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14058921|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
14058922|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058923|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058924|NCT02619526|Carvedilol|carvedilol|mesh-list
14058925|NCT02619526|Nebivolol|nebivolol|mesh-list
14058926|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14058927|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14058928|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
14058929|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058930|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058931|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058932|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14058933|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
14058934|NCT02619526|Protective Agents|protective agents|mesh-ancestor
14058935|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14058936|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14933808|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933809|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
14933810|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
13913645|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13913646|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
13913647|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913648|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913649|NCT03486119|Nivolumab|nivolumab|mesh-list
13913650|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13913651|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913652|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13913653|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913654|NCT03486106|Propofol|propofol|mesh-list
13913655|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13913656|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058937|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14058938|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
14933811|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
14933812|NCT01452607|Ebselen|ebselen|mesh-list
14058939|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14058940|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14058941|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14058942|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14058943|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14058944|NCT02619201|Ondansetron|ondansetron|mesh-list
14058945|NCT02619201|Metoclopramide|metoclopramide|mesh-list
14058946|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
14058947|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
14058948|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14058949|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058950|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14058951|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
14058952|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
14058953|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14058954|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
14058955|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14058956|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058957|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14058958|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14058959|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14058960|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14058961|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14058962|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14058963|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14058964|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
14058965|NCT02619162|Letrozole|letrozole|mesh-list
14058966|NCT02619162|Nintedanib|nintedanib|mesh-list
14058967|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058968|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14058969|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14058970|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058971|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475963|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14475964|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14475965|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475966|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
14475967|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14475968|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14475969|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475970|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14475971|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475972|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14058972|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14058973|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
14058974|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14058975|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058976|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14058977|NCT02619266|Megestrol|megestrol|mesh-list
14058978|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
14058979|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14058980|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14058981|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14058982|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
14058983|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14058984|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14058985|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14058986|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14058987|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14058988|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14058989|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
14058990|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14058991|NCT02619149|Tazobactam|tazobactam|mesh-list
14058992|NCT02619149|Piperacillin|piperacillin|mesh-list
14058993|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14058994|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14058995|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14058996|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14058997|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14058998|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14058999|NCT02619019|Dexamethasone|dexamethasone|mesh-list
14059000|NCT02619019|Meperidine|meperidine|mesh-list
14059001|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475973|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
14475974|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059002|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
14059003|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
14059004|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059005|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059006|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059007|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
14059008|NCT02619019|Hormones|hormones|mesh-ancestor
14059009|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059010|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14059011|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059012|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14059013|NCT02619019|Narcotics|narcotics|mesh-ancestor
14059014|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059015|NCT02619019|Analgesics|analgesics|mesh-ancestor
14059016|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
14059017|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14059018|NCT02619032|Fentanyl|fentanyl|mesh-list
14059019|NCT02619032|Remifentanil|remifentanil|mesh-list
14059020|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14059021|NCT02619032|Narcotics|narcotics|mesh-ancestor
14059022|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059023|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059024|NCT02619032|Analgesics|analgesics|mesh-ancestor
14059025|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
14059026|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059027|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14059028|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14059029|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
14059030|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
14059031|NCT02618876|Nalbuphine|nalbuphine|mesh-list
14059032|NCT02618876|Bupivacaine|bupivacaine|mesh-list
14059033|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
14059034|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
14059035|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059036|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059037|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
14059038|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059039|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14059040|NCT02618876|Narcotics|narcotics|mesh-ancestor
14059041|NCT02618876|Analgesics|analgesics|mesh-ancestor
14059042|NCT02618824|Tryptophan|tryptophan|mesh-list
14059043|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14059044|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
14059045|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14059046|NCT02618668|Ketamine|ketamine|mesh-list
14059047|NCT02618668|Propofol|propofol|mesh-list
14059048|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14059049|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059050|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059051|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14059052|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
14059053|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
14059054|NCT02618668|Analgesics|analgesics|mesh-ancestor
14059055|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
14059056|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059057|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14059058|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14059059|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14059060|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059061|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059062|NCT02618577|Edoxaban|edoxaban|mesh-list
14059063|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14059064|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
14059065|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14059066|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
14059067|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059068|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059069|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
14059070|NCT02618395|Hydrocodone|hydrocodone|mesh-list
14059071|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14059072|NCT02618395|Narcotics|narcotics|mesh-ancestor
14059073|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059074|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059075|NCT02618395|Analgesics|analgesics|mesh-ancestor
14059076|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
14059077|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059078|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
14059079|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
14059080|NCT02618564|Sennosides|sennosides|mesh-list
14059081|NCT02618564|Laxatives|laxatives|mesh-ancestor
14059082|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059083|NCT02618720|Ornidazole|ornidazole|mesh-list
14059084|NCT02618720|Amebicides|amebicides|mesh-ancestor
14059085|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14059086|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14059087|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059088|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14059089|NCT02618603|Triamcinolone|triamcinolone|mesh-list
14059090|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14059091|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14059092|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
14059093|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14059094|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14059095|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14059096|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14059097|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14059098|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059099|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
14059100|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059101|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059102|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059103|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
14059104|NCT02618603|Hormones|hormones|mesh-ancestor
14059105|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059106|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14059107|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
14059108|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059109|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14059110|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059111|NCT02618356|Raltitrexed|raltitrexed|mesh-list
14059112|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14059113|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
14059114|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059115|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059116|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14757889|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14757890|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059117|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171589|NCT04820036|Insulin|insulin|mesh-list
14171590|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14171591|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171592|NCT04819971|Docetaxel|docetaxel|mesh-list
14171593|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
14171594|NCT04819971|Trastuzumab|trastuzumab|mesh-list
14171595|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171596|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171597|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
14171598|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171599|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171600|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14171601|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
14171602|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14171603|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171604|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14171605|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14171606|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171607|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171608|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171609|NCT04820010|Insulin|insulin|mesh-list
14171610|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14171611|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171612|NCT04819776|Iloperidone|iloperidone|mesh-list
14171613|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14171614|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14475975|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14059118|NCT02618499|Oxytocin|oxytocin|mesh-list
14059119|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
14059120|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14059121|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059122|NCT02618317|Minocycline|minocycline|mesh-list
14059123|NCT02618317|Heparin|heparin|mesh-list
14059124|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
14059125|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059126|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14059127|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14059128|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14059129|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059130|NCT02618096|Oxytocin|oxytocin|mesh-list
14059131|NCT02618096|Dinoprostone|dinoprostone|mesh-list
14059132|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
14059133|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14059134|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059135|NCT02618733|Clopidogrel|clopidogrel|mesh-list
14059136|NCT02618733|Ticagrelor|ticagrelor|mesh-list
14059137|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14059138|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14059139|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14059140|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14059141|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
14059142|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059143|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059144|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059145|NCT02618057|Levofloxacin|levofloxacin|mesh-list
14059146|NCT02618057|Ofloxacin|ofloxacin|mesh-list
14059147|NCT02618057|Prednisolone|prednisolone|mesh-list
14059148|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059149|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
14059150|NCT02618057|Hormones|hormones|mesh-ancestor
14059151|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059152|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059153|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14059154|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059155|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14059156|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059157|NCT02618057|Renal Agents|renal agents|mesh-ancestor
14059158|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14059159|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14059160|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14059161|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059162|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059163|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14059164|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14059165|NCT02617862|Anesthetics|anesthetics|mesh-list
14059166|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059167|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059168|NCT02617849|Paclitaxel|paclitaxel|mesh-list
14059169|NCT02617849|Carboplatin|carboplatin|mesh-list
14059170|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
14059171|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14933813|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933814|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933815|NCT01452607|Analgesics|analgesics|mesh-ancestor
14933816|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
13913657|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913658|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13913659|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
13913660|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
13913661|NCT03486080|Lenograstim|lenograstim|mesh-list
13913662|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13913663|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
13913664|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913665|NCT03485846|Ritonavir|ritonavir|mesh-list
13913666|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13913667|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13913668|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
13913669|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059172|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913670|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059173|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
14059174|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
14059175|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
14059176|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059177|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14059178|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
14059179|NCT02617680|Desflurane|desflurane|mesh-list
14059180|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14059181|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
14059182|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059183|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059184|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14059185|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
14059186|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14059187|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
14059188|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059189|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059190|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14757891|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757892|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14757893|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14757894|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14757895|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
14757896|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757897|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14757898|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14059191|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
14059192|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
14059193|NCT02617680|Protective Agents|protective agents|mesh-ancestor
14059194|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14059195|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
14059196|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
14059197|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059198|NCT02617810|Midazolam|midazolam|mesh-list
14059199|NCT02617810|Warfarin|warfarin|mesh-list
14059200|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14059201|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14059202|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059203|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757899|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757900|NCT05338671|Anesthetics|anesthetics|mesh-list
14757901|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
14757902|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757903|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757904|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
14757905|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757906|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
14059204|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14059205|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14059206|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14059207|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14059208|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
14059209|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
14059210|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
13913671|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13913672|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13913673|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
14059211|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
14059212|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059213|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059214|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
14059215|NCT02617771|Vitamin D|vitamin d|mesh-list
14059216|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
14059217|NCT02617771|Vitamins|vitamins|mesh-ancestor
14059218|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
14059219|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059220|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14059221|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14757907|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13913674|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913675|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13913676|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13913677|NCT03485703|Azithromycin|azithromycin|mesh-list
13913678|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13913679|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059222|NCT02617459|Betaxolol|betaxolol|mesh-list
14757908|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059223|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14059224|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14059225|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13913680|NCT03485625|Acetaminophen|acetaminophen|mesh-list
13913681|NCT03485625|Ketorolac|ketorolac|mesh-list
13913682|NCT03485625|Lidocaine|lidocaine|mesh-list
13913683|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
13913684|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
13913685|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913686|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913687|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
13913688|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913689|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13913690|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13913691|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13913692|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913693|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913694|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14059226|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
14059227|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
14059228|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913695|NCT03485625|Analgesics|analgesics|mesh-ancestor
13913696|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
13913697|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13913698|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913699|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913700|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13913701|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14475976|NCT02410278|Montelukast|montelukast|mesh-list
14475977|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13913704|NCT03485534|Tenofovir|tenofovir|mesh-list
13913705|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
14059229|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059230|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14933817|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933818|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059231|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14059232|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14059233|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
14059234|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059235|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059236|NCT02617758|Fentanyl|fentanyl|mesh-list
14059237|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14059238|NCT02617758|Narcotics|narcotics|mesh-ancestor
14059239|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059240|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059241|NCT02617758|Analgesics|analgesics|mesh-ancestor
14059242|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
14059243|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059244|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14059245|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14059246|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
14059247|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
14059248|NCT02617654|Liraglutide|liraglutide|mesh-list
14059249|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14059250|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059251|NCT02617654|Incretins|incretins|mesh-ancestor
14059252|NCT02617654|Hormones|hormones|mesh-ancestor
14059253|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059254|NCT02617485|Prednisone|prednisone|mesh-list
14059255|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
14059256|NCT02617485|Rituximab|rituximab|mesh-list
14059257|NCT02617485|Doxorubicin|doxorubicin|mesh-list
14059258|NCT02617485|Vincristine|vincristine|mesh-list
14059259|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14059260|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
14059261|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059262|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059263|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14059264|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
14059265|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475978|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
13913706|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913707|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13913708|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14059266|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059267|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14059268|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14059269|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14059270|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14059271|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14059272|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059273|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059274|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
14059275|NCT02617485|Hormones|hormones|mesh-ancestor
14059276|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14757909|NCT05338632|Naloxone|naloxone|mesh-list
14757910|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14757911|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059277|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14059278|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14059279|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
14059280|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
14059281|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
14059282|NCT02617121|Gabapentin|gabapentin|mesh-list
14059283|NCT02617121|Ramosetron|ramosetron|mesh-list
14059284|NCT02617121|Analgesics|analgesics|mesh-ancestor
14059285|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
14059286|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059287|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059288|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
14059289|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14059290|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14059291|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059292|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14059293|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14059294|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14059295|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059296|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059297|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
14059298|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
14059299|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
14059300|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059301|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14059302|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
14059303|NCT02617199|Fentanyl|fentanyl|mesh-list
14059304|NCT02617199|Analgesics|analgesics|mesh-list
14059305|NCT02617199|Ropivacaine|ropivacaine|mesh-list
14059306|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
14059307|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059308|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059309|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
14059310|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
14059311|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059312|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14059313|NCT02617199|Narcotics|narcotics|mesh-ancestor
14059314|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14059315|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14059316|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
14059317|NCT02617290|Clopidogrel|clopidogrel|mesh-list
14059318|NCT02617290|Ticagrelor|ticagrelor|mesh-list
14059319|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14059320|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14059321|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14059322|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14059323|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
14059324|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059325|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059326|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059327|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
14059328|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14059329|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14059330|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059331|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
14059332|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059333|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059334|NCT02617017|Buspirone|buspirone|mesh-list
14059335|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14059336|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14059337|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757912|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
14757913|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757914|NCT05338619|Lazertinib|lazertinib|mesh-list
14757915|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14757916|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757917|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757918|NCT05338606|Bimatoprost|bimatoprost|mesh-list
14757919|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14757920|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
14757921|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14757922|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14757923|NCT05338541|Etoposide|etoposide|mesh-list
14757924|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14757925|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933819|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933820|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913709|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913710|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913711|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13913712|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13913713|NCT03485482|Bisoprolol|bisoprolol|mesh-list
13913714|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14757926|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14757927|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14059338|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059339|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14059340|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14059341|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
14757928|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757929|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767275|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767276|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
14059342|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059343|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059344|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
14059345|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14059346|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059347|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14059348|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14059349|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059350|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059351|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059352|NCT02616770|Perflubron|perflubron|mesh-list
14059353|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14059354|NCT02616692|Sorafenib|sorafenib|mesh-list
14059355|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059356|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14059357|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059358|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059359|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
14059360|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14059361|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059362|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14059363|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059364|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
14059365|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14059366|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059367|NCT02616822|Resveratrol|resveratrol|mesh-list
14059368|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
14767277|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14933821|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13913715|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
13913716|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
13913717|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913718|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913719|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13913720|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13913721|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13913722|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
13913723|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913724|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913725|NCT03485456|Tobramycin|tobramycin|mesh-list
13913726|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757930|NCT05338502|Omeprazole|omeprazole|mesh-list
14757931|NCT05338502|Ranitidine|ranitidine|mesh-list
14757932|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14757933|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14757934|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14757935|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14757936|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757937|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757938|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14757939|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
14757940|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
14757941|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757942|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757943|NCT05338489|Itraconazole|itraconazole|mesh-list
14757944|NCT05338489|Rifampin|rifampin|mesh-list
14757945|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
14757946|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757947|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14757948|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13913727|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913728|NCT03485417|Aripiprazole|aripiprazole|mesh-list
13913729|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14757949|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14757950|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757951|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14757952|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
14757953|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14757954|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913730|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
14059369|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059370|NCT02616822|Protective Agents|protective agents|mesh-ancestor
14059371|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059372|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059373|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14059374|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
14059375|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14059376|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14059377|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059378|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
14059379|NCT02616731|Coagulants|coagulants|mesh-ancestor
14171615|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171616|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913731|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13913732|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13913733|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13913734|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913735|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913736|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
13913737|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
13913738|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913739|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171617|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14171618|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
14171619|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14171620|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171621|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171622|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171623|NCT04820101|Analgesics|analgesics|mesh-ancestor
14171624|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
14757955|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13913740|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13913741|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13913742|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
13913743|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13913744|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13913745|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13913746|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13913747|NCT03485404|Vitamins|vitamins|mesh-list
13913748|NCT03485404|Folic Acid|folic acid|mesh-list
13913749|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
13913750|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
13913751|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
13913752|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059380|NCT02616874|Romidepsin|romidepsin|mesh-list
14059381|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14059382|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059383|NCT02616861|Praliciguat|praliciguat|mesh-list
14059384|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14059385|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
14059386|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059387|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059388|NCT02616848|Everolimus|everolimus|mesh-list
14059389|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059390|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14059391|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
14059392|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059393|NCT02616640|Dexamethasone|dexamethasone|mesh-list
14059394|NCT02616640|Durvalumab|durvalumab|mesh-list
14059395|NCT02616640|Pomalidomide|pomalidomide|mesh-list
14059396|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059397|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
14059398|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
14059399|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059400|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059401|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059402|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
14059403|NCT02616640|Hormones|hormones|mesh-ancestor
14059404|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059405|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14059406|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059407|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14059408|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
14059409|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14059410|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14059411|NCT02616640|Growth Substances|growth substances|mesh-ancestor
14475979|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14475980|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
14475981|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475982|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475983|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14475984|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14475985|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14475986|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
14475987|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14475988|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
14475989|NCT02410382|Dexamethasone|dexamethasone|mesh-list
14475990|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14475991|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
14475992|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
14059412|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
14059413|NCT02616354|Imipenem|imipenem|mesh-list
14059414|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14059415|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059416|NCT02616367|Bupivacaine|bupivacaine|mesh-list
14059417|NCT02616367|Ropivacaine|ropivacaine|mesh-list
14059418|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
14059419|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
14059420|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059421|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059422|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
14059423|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059424|NCT02616289|Emollients|emollients|mesh-list
14059425|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
14059426|NCT02616497|Aspirin|aspirin|mesh-list
14059427|NCT02616497|Triflusal|triflusal|mesh-list
14059428|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14059429|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14059430|NCT02616497|Analgesics|analgesics|mesh-ancestor
14059431|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
14059432|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059433|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059434|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059435|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059436|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14059437|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14059438|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059439|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14059440|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14059441|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059442|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
14059443|NCT02616419|Lidocaine|lidocaine|mesh-list
14059444|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
14059445|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
14059446|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059447|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059448|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
14059449|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059450|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14059451|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14059452|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14059453|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14059454|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059455|NCT02616315|Naltrexone|naltrexone|mesh-list
14059456|NCT02616315|Bupropion|bupropion|mesh-list
14059457|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14059458|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14059459|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059460|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
14059461|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059462|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14059463|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
14059464|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14059465|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14059466|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14059467|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14059468|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059469|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
14059470|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059471|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14059472|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14059473|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059474|NCT02616003|Liraglutide|liraglutide|mesh-list
14059475|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14059476|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059477|NCT02616003|Incretins|incretins|mesh-ancestor
14059478|NCT02616003|Hormones|hormones|mesh-ancestor
14059479|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059480|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
14059481|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
14059482|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14059483|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14059484|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059485|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059486|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059487|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059488|NCT02615977|Ethanol|ethanol|mesh-list
14059489|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14059490|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059491|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059492|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059493|NCT02616068|Loxoprofen|loxoprofen|mesh-list
14059494|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14059495|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14059496|NCT02616068|Analgesics|analgesics|mesh-ancestor
14059497|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
14059498|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059499|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059500|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059501|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059502|NCT02615873|Levodopa|levodopa|mesh-list
14059503|NCT02615873|Carbidopa|carbidopa|mesh-list
14059504|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14059505|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14059506|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14059507|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
14059508|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059509|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059510|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059511|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14059512|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059513|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14059514|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
14059515|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
14059516|NCT02615847|Memantine|memantine|mesh-list
14059517|NCT02615847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14059518|NCT02615847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14059519|NCT02615847|Dopamine Agents|dopamine agents|mesh-ancestor
14059520|NCT02615847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059521|NCT02615847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059522|NCT02615847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059523|NCT02615847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14059524|NCT02615847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14059525|NCT02615912|Castor Oil|castor oil|mesh-list
14059526|NCT02615912|Cathartics|cathartics|mesh-ancestor
14059527|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059528|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14059529|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
14059530|NCT02615639|Entecavir|entecavir|mesh-list
14059531|NCT02615639|Telbivudine|telbivudine|mesh-list
14059532|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
14059533|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14059534|NCT02615639|Vaccines|vaccines|mesh-list
14059535|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
14059536|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059537|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
14059538|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059539|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14059540|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059541|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059542|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059543|NCT02615730|Paclitaxel|paclitaxel|mesh-list
14059544|NCT02615730|GSK2636771|gsk2636771|mesh-list
14059545|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14059546|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059547|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
14059548|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
14059549|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
14059550|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059551|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14059552|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059553|NCT02615782|Tadalafil|tadalafil|mesh-list
14059554|NCT02615782|Tamsulosin|tamsulosin|mesh-list
14059555|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
14059556|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14059557|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14059558|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059559|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059560|NCT02615782|Urological Agents|urological agents|mesh-ancestor
14059561|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14059562|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14059563|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14059564|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
14059565|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059566|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059567|NCT02615496|Aflibercept|aflibercept|mesh-list
14059568|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14059569|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14059570|NCT02615496|Growth Substances|growth substances|mesh-ancestor
14059571|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059572|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
14059573|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059574|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
14059575|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
14059576|NCT02615561|Vitamins|vitamins|mesh-ancestor
14059577|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
14059578|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059579|NCT02615691|Factor VIII|factor viii|mesh-list
14059580|NCT02615691|BAX 855|bax 855|mesh-list
14059581|NCT02615691|Coagulants|coagulants|mesh-ancestor
14059582|NCT02615574|Interferons|interferons|mesh-list
14059583|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14059584|NCT02615574|Celecoxib|celecoxib|mesh-list
14059585|NCT02615574|Vaccines|vaccines|mesh-list
14059586|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
14059587|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059588|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059589|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
14059590|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059591|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14059592|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14059593|NCT02615574|Analgesics|analgesics|mesh-ancestor
14059594|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
14059595|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059596|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059597|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059598|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14059599|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14059600|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059601|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059602|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
14059603|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14059604|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14059605|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059606|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
14059607|NCT02615366|Coagulants|coagulants|mesh-ancestor
14059608|NCT02615223|Bicalutamide|bicalutamide|mesh-list
14059609|NCT02615223|Hormones|hormones|mesh-list
14059610|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14059611|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059612|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059613|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
14059614|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
14059615|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059616|NCT02615288|Vitamin D|vitamin d|mesh-list
14059617|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
14059618|NCT02615288|Vitamins|vitamins|mesh-ancestor
14059619|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
14059620|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059621|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14059622|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14059623|NCT02615041|Meropenem|meropenem|mesh-list
14059624|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14059625|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059626|NCT02615340|Melatonin|melatonin|mesh-list
14059627|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
14059628|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059629|NCT02615340|Protective Agents|protective agents|mesh-ancestor
14059630|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059631|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757956|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14059632|NCT02615301|Vitamin D|vitamin d|mesh-list
14059633|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
14059634|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
14059635|NCT02615301|Vitamins|vitamins|mesh-list
14059636|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
14059637|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059638|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14059639|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14059640|NCT02615080|Pemirolast|pemirolast|mesh-list
14059641|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
14059642|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
14059643|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059644|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059645|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059646|NCT02615106|Endostar protein|endostar protein|mesh-list
14059647|NCT02615106|Endostatins|endostatins|mesh-list
14059648|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14059649|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14059650|NCT02615106|Growth Substances|growth substances|mesh-ancestor
14059651|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059652|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
14059653|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171625|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171626|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14171627|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14171628|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14171629|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171630|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171631|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171632|NCT04819867|Propolis|propolis|mesh-list
14171633|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171634|NCT04819503|Anesthetics|anesthetics|mesh-list
14171635|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171636|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171637|NCT04819438|Riluzole|riluzole|mesh-list
14171638|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
14171639|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14171640|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14171641|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171642|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171643|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171644|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14171645|NCT04819438|Protective Agents|protective agents|mesh-ancestor
14171646|NCT04819828|Diclofenac|diclofenac|mesh-list
14171647|NCT04819828|Tamsulosin|tamsulosin|mesh-list
14171648|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14171649|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171650|NCT04819828|Analgesics|analgesics|mesh-ancestor
14171651|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
14171652|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171653|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171654|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171655|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14171656|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14171657|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171658|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171659|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14171660|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14171661|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14475993|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14757957|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
14757958|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14757959|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
14757960|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14475994|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14475995|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14475996|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
14475997|NCT02410382|Hormones|hormones|mesh-ancestor
14475998|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14475999|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476000|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476001|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
14476002|NCT02410707|Propofol|propofol|mesh-list
14476003|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14476004|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476005|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757961|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14757962|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14476006|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14476007|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
14059654|NCT02615262|Dexamethasone|dexamethasone|mesh-list
14059655|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059656|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
14059657|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
14059658|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059659|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059660|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059661|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
14059662|NCT02615262|Hormones|hormones|mesh-ancestor
14059663|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059664|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14059665|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059666|NCT02614937|Squalamine|squalamine|mesh-list
14059667|NCT02614937|Ranibizumab|ranibizumab|mesh-list
14059668|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14059669|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14059670|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14059671|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14059672|NCT02614937|Growth Substances|growth substances|mesh-ancestor
14059673|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059674|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
14059675|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059676|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14059677|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059678|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14059679|NCT02614937|Protective Agents|protective agents|mesh-ancestor
14059680|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14059681|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14059682|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14059683|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
14059684|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059685|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059686|NCT02614612|Prednisone|prednisone|mesh-list
14059687|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
14059688|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14059689|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14059690|NCT02614612|Prednisolone|prednisolone|mesh-list
14059691|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
14059692|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14059693|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
14059694|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059695|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
14059696|NCT02614612|Hormones|hormones|mesh-ancestor
14059697|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059698|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757963|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14757964|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14059699|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14059700|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059701|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
14059702|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
14059703|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059704|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059705|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14059706|NCT02614612|Protective Agents|protective agents|mesh-ancestor
14059707|NCT02614833|Paclitaxel|paclitaxel|mesh-list
14059708|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14059709|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059710|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
14059711|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
13913753|NCT03485404|Hematinics|hematinics|mesh-ancestor
13913754|NCT03485300|Warfarin|warfarin|mesh-list
13913755|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
13913756|NCT03485274|Vortioxetine|vortioxetine|mesh-list
13913757|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
13913758|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13913759|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13913760|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13913761|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913762|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913763|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13913764|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13913765|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913766|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913767|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059712|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
14059713|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059714|NCT02614482|Fesoterodine|fesoterodine|mesh-list
14059715|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14059716|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14059717|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
14059718|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059719|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059720|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059721|NCT02614482|Urological Agents|urological agents|mesh-ancestor
14059722|NCT02614456|Interferons|interferons|mesh-list
14059723|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
14059724|NCT02614456|Nivolumab|nivolumab|mesh-list
14059725|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14059726|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059727|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14059728|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059729|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
14059730|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059731|NCT02614352|Candesartan|candesartan|mesh-list
14059732|NCT02614352|Atorvastatin|atorvastatin|mesh-list
14059733|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14059734|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14059735|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
14059736|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059737|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14059738|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14059739|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059740|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14059741|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14059742|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14059743|NCT02614339|Metformin|metformin|mesh-list
14059744|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14059745|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059746|NCT02614534|Mitomycins|mitomycins|mesh-list
14059747|NCT02614534|Mitomycin|mitomycin|mesh-list
14059748|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14059749|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059750|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
14059751|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059752|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14059753|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059754|NCT02614404|Piperaquine|piperaquine|mesh-list
14059755|NCT02614404|Artenimol|artenimol|mesh-list
14059756|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
14059757|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059758|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14059759|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059760|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059761|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
14059762|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14059763|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14059764|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059765|NCT02614118|Acetaminophen|acetaminophen|mesh-list
14059766|NCT02614118|Ketorolac|ketorolac|mesh-list
14059767|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14059768|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14059769|NCT02614118|Analgesics|analgesics|mesh-ancestor
14059770|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
14059771|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059772|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059773|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
14059774|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14059775|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059776|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059777|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14059778|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059779|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059780|NCT02614248|Protective Agents|protective agents|mesh-list
14059781|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059782|NCT02614508|Ofatumumab|ofatumumab|mesh-list
14059783|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14059784|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059785|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
14059786|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059787|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
14059788|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14059789|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14059790|NCT02613715|Ethanol|ethanol|mesh-list
14059791|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14059792|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059793|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059794|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059795|NCT02613585|Permethrin|permethrin|mesh-list
14059796|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059797|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059798|NCT02613676|Bilirubin|bilirubin|mesh-list
14059799|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
14059800|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059801|NCT02613676|Protective Agents|protective agents|mesh-ancestor
14059802|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059803|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
14059804|NCT02613494|Scopolamine|scopolamine|mesh-list
14059805|NCT02613494|Bromides|bromides|mesh-list
14059806|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14059807|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
14059808|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14059809|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14059810|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14059811|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
14059812|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059813|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059814|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059815|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
14059816|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
14059817|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059818|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059819|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
14059820|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
14059821|NCT02613455|Triamcinolone|triamcinolone|mesh-list
14059822|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14059823|NCT02613455|Lidocaine|lidocaine|mesh-list
14059824|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
14059825|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
14059826|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059827|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059828|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
14059829|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059830|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14059831|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14059832|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14059833|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14059834|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059835|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059836|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
14059837|NCT02613455|Hormones|hormones|mesh-ancestor
14059838|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059839|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14059840|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
14171662|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171663|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171664|NCT04819828|Urological Agents|urological agents|mesh-ancestor
14171665|NCT04818931|Cefazolin|cefazolin|mesh-list
14171666|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14171667|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171668|NCT04819204|Cetrorelix|cetrorelix|mesh-list
14171669|NCT04819204|Testosterone|testosterone|mesh-list
14171670|NCT04819204|Androgens|androgens|mesh-ancestor
14171671|NCT04819204|Hormones|hormones|mesh-ancestor
14171672|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171673|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171674|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14171675|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
14171676|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14171677|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
14171678|NCT04819217|Charcoal|charcoal|mesh-list
14171679|NCT04819217|Antidotes|antidotes|mesh-ancestor
14757965|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14757966|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14171680|NCT04819217|Protective Agents|protective agents|mesh-ancestor
14757967|NCT05338476|Midazolam|midazolam|mesh-list
14171681|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059841|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14059842|NCT02613247|Hylan|hylan|mesh-list
14059843|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
14059844|NCT02613247|Protective Agents|protective agents|mesh-ancestor
14059845|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059846|NCT02613130|Fluorides|fluorides|mesh-list
14059847|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
14059848|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
14059849|NCT02613130|Protective Agents|protective agents|mesh-ancestor
14059850|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059851|NCT02613091|Clemastine|clemastine|mesh-list
14059852|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
14059853|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
14059854|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14059855|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
14059856|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
14059857|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059858|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059859|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059860|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14059861|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14059862|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
14059863|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14059864|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14059865|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14059866|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059867|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059868|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
14059869|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14059870|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059871|NCT02613052|Propofol|propofol|mesh-list
14059872|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14059873|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059874|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059875|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14059876|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
14059877|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
14059878|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
14059879|NCT02613013|Pilocarpine|pilocarpine|mesh-list
14059880|NCT02613013|Miotics|miotics|mesh-ancestor
14059881|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
14059882|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059883|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913768|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
13913769|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13913770|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13913771|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13913772|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14059884|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14059885|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14059886|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
14059887|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059888|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059889|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
14059890|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
14059891|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059892|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
14059893|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
14059894|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
14059895|NCT02613039|Estrogens|estrogens|mesh-list
14059896|NCT02613039|Progestins|progestins|mesh-list
14059897|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14059898|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059899|NCT02613039|Hormones|hormones|mesh-ancestor
14059900|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14059901|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14059902|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
13913773|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13913774|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13913775|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913776|NCT03485118|Rituximab|rituximab|mesh-list
13913777|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14059903|NCT02613026|Docetaxel|docetaxel|mesh-list
14059904|NCT02613026|Pirarubicin|pirarubicin|mesh-list
14059905|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14059906|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
14059907|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059908|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059909|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14059910|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
14059911|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059912|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14059913|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14059914|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
14059915|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
14059916|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
14059917|NCT02612896|Praziquantel|praziquantel|mesh-list
14059918|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
14059919|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14059920|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059921|NCT02612792|Atorvastatin|atorvastatin|mesh-list
14059922|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14059923|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14059924|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
14059925|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059926|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14059927|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14059928|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059929|NCT02612545|Piperaquine|piperaquine|mesh-list
14059930|NCT02612545|Artenimol|artenimol|mesh-list
14059931|NCT02612545|Mefloquine|mefloquine|mesh-list
14059932|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
14059933|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14059934|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14059935|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14059936|NCT02612480|Aspirin|aspirin|mesh-list
14059937|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
14059938|NCT02612480|Clopidogrel|clopidogrel|mesh-list
14059939|NCT02612480|Ticagrelor|ticagrelor|mesh-list
14059940|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14059941|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14059942|NCT02612480|Analgesics|analgesics|mesh-ancestor
14059943|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
14059944|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059945|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059946|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14059947|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14059948|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14059949|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14059950|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059951|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14059952|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14059953|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059954|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
14059955|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14059956|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14059957|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14059958|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
14059959|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059960|NCT02612701|Nicotine|nicotine|mesh-list
14059961|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14059962|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
14059963|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059964|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059965|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14059966|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14059967|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
14059968|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059969|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059970|NCT02612649|Ramosetron|ramosetron|mesh-list
14059971|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
14059972|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
14059973|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059974|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059975|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14059976|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14059977|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
14059978|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14059979|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059980|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14059981|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14059982|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14059983|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
14059984|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14059985|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14059986|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14059987|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14059988|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
14059989|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14059990|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14059991|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14059992|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14059993|NCT02612363|Analgesics|analgesics|mesh-ancestor
14059994|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
14059995|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14059996|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14059997|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14059998|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14059999|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
14060000|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060001|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060002|NCT02612272|Ketorolac|ketorolac|mesh-list
14060003|NCT02612272|Betamethasone|betamethasone|mesh-list
14060004|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060005|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060006|NCT02612272|Analgesics|analgesics|mesh-ancestor
14060007|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
14060008|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060009|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060010|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060011|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060012|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060013|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060014|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060015|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
14060016|NCT02612272|Hormones|hormones|mesh-ancestor
14060017|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060018|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14060019|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
14060020|NCT02612298|Metoprolol|metoprolol|mesh-list
14060021|NCT02612298|Arotinolol|arotinolol|mesh-list
14060022|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14060023|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14060024|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
14060025|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
13913778|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913779|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
14060026|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060027|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060028|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14060029|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14476008|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
14476009|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13913780|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913781|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13913782|NCT03485092|Empagliflozin|empagliflozin|mesh-list
13913783|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13913784|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913785|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13913786|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913787|NCT03484962|Antibodies|antibodies|mesh-list
13913788|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13913789|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
13913790|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913791|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
13913792|NCT03484845|Lactoferrin|lactoferrin|mesh-list
13913793|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913794|NCT03484845|Trace Elements|trace elements|mesh-ancestor
13913795|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
13913796|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476010|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060030|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14060031|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14060032|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060033|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060034|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14060035|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
14060036|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14060037|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060038|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060039|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060040|NCT02612181|Analgesics|analgesics|mesh-ancestor
14060041|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
14060042|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060043|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14060044|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14060045|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14060046|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
14060047|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060048|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060049|NCT02612259|Tryptophan|tryptophan|mesh-list
14060050|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14060051|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
14060052|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14060053|NCT02612233|Pregabalin|pregabalin|mesh-list
14060054|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14060055|NCT02612233|Analgesics|analgesics|mesh-ancestor
14060056|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
14060057|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060058|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060059|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
14060060|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14060061|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14060062|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060063|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14060064|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14060065|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14060066|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060067|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14060068|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14060069|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14060070|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060071|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
14060072|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
14060073|NCT02612207|Bilirubin|bilirubin|mesh-list
14060074|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
14060075|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060076|NCT02612207|Protective Agents|protective agents|mesh-ancestor
14060077|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060078|NCT02612116|Ticagrelor|ticagrelor|mesh-list
14060079|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14060080|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14060081|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14060082|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14060083|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
14060084|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060085|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060086|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060087|NCT02611973|Aspirin|aspirin|mesh-list
14060088|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
14060089|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060090|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060091|NCT02611973|Analgesics|analgesics|mesh-ancestor
14060092|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
14060093|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060094|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060095|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060096|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060097|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14060098|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060099|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060100|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14060101|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060102|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060103|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
14060104|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060105|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
14060106|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14060107|NCT02612220|Hemostatics|hemostatics|mesh-list
14060108|NCT02612220|Coagulants|coagulants|mesh-ancestor
14060109|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14060110|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
14060111|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14060112|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060113|NCT02611921|Ketamine|ketamine|mesh-list
14060114|NCT02611921|Analgesics|analgesics|mesh-ancestor
14060115|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
14060116|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060117|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060118|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14060119|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14060120|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
14060121|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
14060122|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060123|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14060124|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14060125|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060126|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060127|NCT02611700|Paclitaxel|paclitaxel|mesh-list
14060128|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14060129|NCT02611700|Cisplatin|cisplatin|mesh-list
14060130|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
14060131|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14060132|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060133|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060134|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060135|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060136|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060137|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14060138|NCT02611596|Ranolazine|ranolazine|mesh-list
14060139|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14060140|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14060141|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060142|NCT02611635|Warfarin|warfarin|mesh-list
14060143|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
14060144|NCT02611635|Dabigatran|dabigatran|mesh-list
14060145|NCT02611635|Apixaban|apixaban|mesh-list
14060146|NCT02611635|Edoxaban|edoxaban|mesh-list
14060147|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
14060148|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14060149|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
14060150|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14060151|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
14060152|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060153|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060154|NCT02611804|Diclofenac|diclofenac|mesh-list
14060155|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060156|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060157|NCT02611804|Analgesics|analgesics|mesh-ancestor
14060158|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
14060159|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060160|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060161|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060162|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060163|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060164|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060165|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171682|NCT04819243|Atezolizumab|atezolizumab|mesh-list
14171683|NCT04819243|Talazoparib|talazoparib|mesh-list
14171684|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171685|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14171686|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171687|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171688|NCT04818723|Montelukast|montelukast|mesh-list
14171689|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14171690|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
14171691|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14171692|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
14184185|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14060166|NCT02611492|Cytarabine|cytarabine|mesh-list
14060167|NCT02611492|Dexamethasone|dexamethasone|mesh-list
14060168|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14060169|NCT02611492|Methotrexate|methotrexate|mesh-list
14060170|NCT02611492|Vincristine|vincristine|mesh-list
14060171|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
14060172|NCT02611492|Sargramostim|sargramostim|mesh-list
14060173|NCT02611492|Lenograstim|lenograstim|mesh-list
14060174|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060175|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
14060176|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
14060177|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060178|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060179|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14060180|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
14060181|NCT02611492|Hormones|hormones|mesh-ancestor
14060182|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060183|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14060184|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060185|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14060186|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
14060187|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14060188|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14060189|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
14060190|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060191|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
14060192|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060193|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14060194|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14060195|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
14060196|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060197|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14060198|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14060199|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060200|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060201|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060202|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14060203|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
14060204|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060205|NCT02611518|Metformin|metformin|mesh-list
14060206|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14060207|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14060208|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060209|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14060210|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14060211|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
14060212|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060213|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14060214|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14060215|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060216|NCT02611505|Esketamine|esketamine|mesh-list
14060217|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
14060218|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14060219|NCT02611336|Tadalafil|tadalafil|mesh-list
14060220|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
14060221|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14060222|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14060223|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060224|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060225|NCT02611336|Urological Agents|urological agents|mesh-ancestor
14060226|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14060227|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060228|NCT02611258|Tadalafil|tadalafil|mesh-list
14060229|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
14060230|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14060231|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14060232|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060233|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060234|NCT02611258|Urological Agents|urological agents|mesh-ancestor
14060235|NCT02611466|Naproxen|naproxen|mesh-list
14060236|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060237|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060238|NCT02611466|Analgesics|analgesics|mesh-ancestor
14060239|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
14060240|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060241|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060242|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060243|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060244|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
14060245|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060246|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060247|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060248|NCT02610920|Iron|iron|mesh-list
14060249|NCT02610920|Trace Elements|trace elements|mesh-ancestor
14060250|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
14060251|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060252|NCT02610933|Vitamin K|vitamin k|mesh-list
14476011|NCT02410707|Analgesics|analgesics|mesh-ancestor
14476012|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
14476013|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476014|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
14476015|NCT02410772|Rifapentine|rifapentine|mesh-list
14476016|NCT02410772|Rifampin|rifampin|mesh-list
14476017|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14476018|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476019|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14060253|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
14060254|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
14060255|NCT02610933|Vitamins|vitamins|mesh-ancestor
14060256|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
14060257|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476020|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14476021|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476022|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476023|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476024|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14476025|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
14476026|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
14476027|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14476028|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14476029|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14476030|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14476031|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14476032|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14757968|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14060258|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14060259|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
14060260|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14060261|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
14060262|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060263|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060264|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
14060265|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14060266|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060267|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
14060268|NCT02610933|Coagulants|coagulants|mesh-ancestor
14060269|NCT02610881|Iron|iron|mesh-list
14060270|NCT02610881|Trace Elements|trace elements|mesh-list
14060271|NCT02610881|Folic Acid|folic acid|mesh-list
14060272|NCT02610881|Micronutrients|micronutrients|mesh-list
14060273|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060274|NCT02610881|Hematinics|hematinics|mesh-ancestor
14060275|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
14060276|NCT02610881|Vitamins|vitamins|mesh-ancestor
14060277|NCT02610712|Ketamine|ketamine|mesh-list
14060278|NCT02610712|Analgesics|analgesics|mesh-ancestor
14060279|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
14060280|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060281|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060282|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14060283|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14757969|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14757970|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14757971|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757972|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14757973|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14757974|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14757975|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14060284|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
14060285|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
14060286|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060287|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14060288|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14757976|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
14060289|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060290|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060291|NCT02610829|Vitamin E|vitamin e|mesh-list
14060292|NCT02610829|Tocopherols|tocopherols|mesh-list
14060293|NCT02610829|Tocotrienols|tocotrienols|mesh-list
14060294|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
14060295|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
14060296|NCT02610829|Vitamins|vitamins|mesh-ancestor
14060297|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
14060298|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060299|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
14060300|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060301|NCT02610829|Protective Agents|protective agents|mesh-ancestor
14060302|NCT02610686|Chloroquine|chloroquine|mesh-list
14060303|NCT02610686|Amebicides|amebicides|mesh-ancestor
14060304|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14060305|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14060306|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060307|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
14060308|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060309|NCT02610647|Anesthetics|anesthetics|mesh-list
14060310|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060311|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060312|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14060313|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757977|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
14757978|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
14757979|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
14757980|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757981|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757982|NCT05338450|Clemastine|clemastine|mesh-list
14757983|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
14757984|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
14757985|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14476033|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14476034|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14476035|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
14476036|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
14476037|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14757986|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
14757987|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
14757988|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14757989|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933822|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14060314|NCT02610556|Cisplatin|cisplatin|mesh-list
14060315|NCT02610556|Docetaxel|docetaxel|mesh-list
14060316|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060317|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060318|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060319|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060320|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060321|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
14060322|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14060323|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
14060324|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060325|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
14060326|NCT02610504|Protective Agents|protective agents|mesh-ancestor
14060327|NCT02610348|Vaccines|vaccines|mesh-list
14757990|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14757991|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14757992|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14060328|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14060329|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
14060330|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060331|NCT02610153|Vitamin K|vitamin k|mesh-list
14060332|NCT02610153|Vitamins|vitamins|mesh-ancestor
14060333|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
14060334|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060335|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14476038|NCT02411292|Enoxaparin|enoxaparin|mesh-list
14476039|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
14757993|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14757994|NCT05338398|Benzydamine|benzydamine|mesh-list
14060336|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060337|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933823|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
14060338|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
14060339|NCT02610153|Coagulants|coagulants|mesh-ancestor
14060340|NCT02610010|Cisplatin|cisplatin|mesh-list
14060341|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060342|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
14060343|NCT02610088|Gliclazide|gliclazide|mesh-list
14060344|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14060345|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060346|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14060347|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060348|NCT02610127|Factor VIII|factor viii|mesh-list
14060349|NCT02610127|Coagulants|coagulants|mesh-ancestor
14060350|NCT02610075|Adavosertib|adavosertib|mesh-list
14060351|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060352|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060353|NCT02609932|Interferons|interferons|mesh-list
14060354|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
14060355|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060356|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
14060357|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060358|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
14060359|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
14060360|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14060361|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14060362|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
14060363|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060364|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060365|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060366|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060367|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14060368|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060369|NCT02609997|Dexamethasone|dexamethasone|mesh-list
14060370|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
14060371|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060372|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
14060373|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
14060374|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060375|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060376|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14060377|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
14060378|NCT02609997|Hormones|hormones|mesh-ancestor
14060379|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060380|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14060381|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060382|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
14060383|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
14060384|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060385|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
14060386|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14060387|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
14060388|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
14060389|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060390|NCT02609802|Sevoflurane|sevoflurane|mesh-list
14060391|NCT02609802|Desflurane|desflurane|mesh-list
14060392|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14060393|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14060394|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
14060395|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
14060396|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060397|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060398|NCT02609646|Vancomycin|vancomycin|mesh-list
14060399|NCT02609646|Meropenem|meropenem|mesh-list
14060400|NCT02609646|Tazobactam|tazobactam|mesh-list
14060401|NCT02609646|Linezolid|linezolid|mesh-list
14060402|NCT02609646|Piperacillin|piperacillin|mesh-list
14060403|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14060404|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14060405|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060406|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14060407|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060408|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060409|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14060410|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
14060411|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060412|NCT02609490|Olmesartan|olmesartan|mesh-list
14060413|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14060414|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14060415|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14060416|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14060417|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14060418|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171693|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171694|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171695|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14171696|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14171697|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171698|NCT04818736|Vaccines|vaccines|mesh-list
14171699|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
14171700|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183160|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183161|NCT04730297|Acetaminophen|acetaminophen|mesh-list
14183162|NCT04730297|Ibuprofen|ibuprofen|mesh-list
14183163|NCT04730297|Codeine|codeine|mesh-list
14183164|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14183165|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183166|NCT04730297|Analgesics|analgesics|mesh-ancestor
14183167|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
14183168|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183169|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183170|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14183171|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14183172|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14183173|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183174|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183175|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
14183176|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14183177|NCT04730297|Narcotics|narcotics|mesh-ancestor
14183178|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183179|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
14183180|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
14184186|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
14184187|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14184188|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
14184189|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
14184190|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184191|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14184192|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184193|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184194|NCT04721899|Vitamin D|vitamin d|mesh-list
14184195|NCT04721899|Vitamins|vitamins|mesh-ancestor
14184196|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
14184197|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184198|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14184199|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
14184200|NCT04721964|Trace Elements|trace elements|mesh-ancestor
14184201|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
14184202|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184203|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
14184204|NCT04721795|Atorvastatin|atorvastatin|mesh-list
14184205|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14184206|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14184207|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
14184208|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184209|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14184210|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14184211|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184212|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184213|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184214|NCT04721704|Amoxicillin|amoxicillin|mesh-list
14184215|NCT04721704|Metronidazole|metronidazole|mesh-list
14184216|NCT04721704|Clarithromycin|clarithromycin|mesh-list
14184217|NCT04721704|Omeprazole|omeprazole|mesh-list
14184218|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184219|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184220|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14184221|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14184222|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14184223|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14184224|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14476040|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14184225|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184226|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060419|NCT02609711|Candesartan|candesartan|mesh-list
14060420|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
14060421|NCT02609711|Atorvastatin|atorvastatin|mesh-list
14060422|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14060423|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14060424|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
14060425|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060426|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14060427|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14060428|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060429|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14060430|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14060431|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14060432|NCT02609698|Aspirin|aspirin|mesh-list
14060433|NCT02609698|Clopidogrel|clopidogrel|mesh-list
14060434|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060435|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060436|NCT02609698|Analgesics|analgesics|mesh-ancestor
14060437|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
14060438|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060439|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060440|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060441|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060442|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14060443|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060444|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060445|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14060446|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060447|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060448|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
14060449|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14060450|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14060451|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14060452|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
14060453|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060454|NCT02609477|Phentermine|phentermine|mesh-list
14060455|NCT02609477|Istradefylline|istradefylline|mesh-list
14060456|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14060457|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060458|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
14060459|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14060460|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
14060461|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
14060462|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060463|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
14060464|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060465|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060466|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14060467|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14060468|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14060469|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
14060470|NCT02609386|Zinc|zinc|mesh-list
14060471|NCT02609386|Indomethacin|indomethacin|mesh-list
14060472|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
14060473|NCT02609386|Omeprazole|omeprazole|mesh-list
14060474|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14060475|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14060476|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
14060477|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060478|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060479|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14060480|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
14060481|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060482|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060483|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14060484|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
14060485|NCT02609386|Trace Elements|trace elements|mesh-ancestor
14060486|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14060487|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14060488|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060489|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060490|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14476041|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060491|NCT02609386|Analgesics|analgesics|mesh-ancestor
14060492|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
14476042|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060493|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060494|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060495|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
14060496|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
14060497|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14060498|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060499|NCT02609230|TIC10 compound|tic10 compound|mesh-list
14060500|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060501|NCT02609087|Propofol|propofol|mesh-list
14060502|NCT02609087|Sevoflurane|sevoflurane|mesh-list
14060503|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14060504|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060505|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060506|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14060507|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
14060508|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
14060509|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14060510|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14060511|NCT02608944|Adenosine|adenosine|mesh-list
14060512|NCT02608944|Regadenoson|regadenoson|mesh-list
14060513|NCT02608944|Analgesics|analgesics|mesh-ancestor
14060514|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
14060515|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060516|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060517|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14060518|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
14060519|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14060520|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
14060521|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
14060522|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060523|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060524|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14060525|NCT02609152|Esmolol|esmolol|mesh-list
14060526|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14060527|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14060528|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14060529|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
14060530|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060531|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060532|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060533|NCT02608918|BMS-955176|bms-955176|mesh-list
14060534|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14060535|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14060536|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
14060537|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060538|NCT02609061|Alendronate|alendronate|mesh-list
14060539|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14060540|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060541|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14060542|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
14060543|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060544|NCT02609334|Pemirolast|pemirolast|mesh-list
14060545|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
14060546|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
14060547|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060548|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060549|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060550|NCT02608931|Dronabinol|dronabinol|mesh-list
14060551|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
14060552|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060553|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14060554|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060555|NCT02608931|Analgesics|analgesics|mesh-ancestor
14060556|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
14060557|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060558|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14060559|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14060560|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060561|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060562|NCT02608931|Hormones|hormones|mesh-ancestor
14060563|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060564|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14060565|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14060566|NCT02608710|Verinurad|verinurad|mesh-list
14060567|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
14060568|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060569|NCT02608736|Valproic Acid|valproic acid|mesh-list
14060570|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
14060571|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060572|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060573|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
14060574|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060575|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060576|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
14060577|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14060578|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060579|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14060580|NCT02608788|Ketorolac|ketorolac|mesh-list
14060581|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060582|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060583|NCT02608788|Analgesics|analgesics|mesh-ancestor
14060584|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
14060585|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060586|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060587|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060588|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060589|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060590|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060591|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060592|NCT02608619|Choline|choline|mesh-list
14060593|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
14060594|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14060595|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
14060596|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060597|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14060598|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14060599|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
14060600|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
14060601|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14060602|NCT02608658|Antibodies|antibodies|mesh-list
14060603|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
14060604|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060605|NCT02608606|Tacrolimus|tacrolimus|mesh-list
14060606|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14060607|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
14060608|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060609|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14060610|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060611|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060612|NCT02608437|Ipilimumab|ipilimumab|mesh-list
14060613|NCT02608437|Guadecitabine|guadecitabine|mesh-list
14060614|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14060615|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060616|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14060617|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060618|NCT02608242|Amlodipine|amlodipine|mesh-list
14060619|NCT02608242|Telmisartan|telmisartan|mesh-list
14060620|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14060621|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14060622|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14060623|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14060624|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14060625|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060626|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14060627|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060628|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
14060629|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14060630|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14060631|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
14060632|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14060633|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14060634|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060635|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14060636|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14060637|NCT02608320|Fentanyl|fentanyl|mesh-list
14060638|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14060639|NCT02608320|Narcotics|narcotics|mesh-ancestor
14060640|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060641|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060642|NCT02608320|Analgesics|analgesics|mesh-ancestor
14060643|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
14060644|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060645|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14060646|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14060647|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
14060648|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
14060649|NCT02608216|Paclitaxel|paclitaxel|mesh-list
14060650|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14060651|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060652|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060653|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060654|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060655|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060656|NCT02608164|Vitamin D|vitamin d|mesh-list
14060657|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
14060658|NCT02608164|Vitamins|vitamins|mesh-ancestor
14060659|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
14060660|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060661|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14060662|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14060663|NCT02608112|Methotrexate|methotrexate|mesh-list
14060664|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14060665|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
14933824|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933825|NCT01452607|Protective Agents|protective agents|mesh-ancestor
14933826|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14933827|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933828|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14933829|NCT01452633|Bupivacaine|bupivacaine|mesh-list
14933830|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
14933831|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
13913797|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13913798|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
13913799|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
13913800|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
13913801|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913802|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913803|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
13913804|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913805|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13913806|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
13913807|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13913808|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13913809|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913810|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
14060666|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14060667|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060668|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14060669|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
14060670|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060671|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060672|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
14060673|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060674|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14060675|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14060676|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
14060677|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060678|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14060679|NCT02607904|Cannabidiol|cannabidiol|mesh-list
14060680|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
14060681|NCT02607943|Insulin|insulin|mesh-list
14933832|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060682|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14060683|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
14060684|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14060685|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060686|NCT02607891|Cannabidiol|cannabidiol|mesh-list
14060687|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
14060688|NCT02607982|Paclitaxel|paclitaxel|mesh-list
14060689|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
14060690|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14060691|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060692|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060693|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060694|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060695|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171701|NCT04818749|Dexamethasone|dexamethasone|mesh-list
14171702|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
14171703|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
14171704|NCT04818749|BB 1101|bb 1101|mesh-list
14171705|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171706|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
14171707|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
14171708|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171709|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171710|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171711|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
14171712|NCT04818749|Hormones|hormones|mesh-ancestor
14171713|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171714|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14171715|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171716|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
14171717|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171718|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171719|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14171720|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171721|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171722|NCT04818749|Analgesics|analgesics|mesh-ancestor
14171723|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
14171724|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14476043|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14476044|NCT02411448|Gefitinib|gefitinib|mesh-list
14476045|NCT02411448|Osimertinib|osimertinib|mesh-list
14476046|NCT02411448|Ramucirumab|ramucirumab|mesh-list
14476047|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171725|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14171726|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14171727|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171728|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171729|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14171730|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14171731|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14171732|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
14171733|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171734|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14171735|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14171736|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171737|NCT04817826|Durvalumab|durvalumab|mesh-list
14171738|NCT04817826|Tremelimumab|tremelimumab|mesh-list
14171739|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14171740|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171741|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14171742|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171743|NCT04817982|Dexamethasone|dexamethasone|mesh-list
14171744|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
14171745|NCT04817982|Lidocaine|lidocaine|mesh-list
14171746|NCT04817982|BB 1101|bb 1101|mesh-list
14171747|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171748|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
14171749|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
14183181|NCT04730258|Azacitidine|azacitidine|mesh-list
14183182|NCT04730258|Decitabine|decitabine|mesh-list
14183183|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14183184|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
14183185|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183186|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183187|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183188|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
14183189|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14183190|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
14060696|NCT02608034|Itraconazole|itraconazole|mesh-list
14060697|NCT02608034|Rifampin|rifampin|mesh-list
14060698|NCT02608034|Vemurafenib|vemurafenib|mesh-list
14060699|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
14060700|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060701|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14060702|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14060703|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060704|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060705|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14060706|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
14060707|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060708|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060709|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14060710|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14060711|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
14060712|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14060713|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
14060714|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14060715|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13913811|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913812|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913813|NCT03484650|Lidocaine|lidocaine|mesh-list
13913814|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
13913815|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
13913816|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913817|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913818|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
13913819|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060716|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14060717|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14060718|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14060719|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14060720|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14060721|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060722|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14060723|NCT02608073|Capecitabine|capecitabine|mesh-list
14060724|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060725|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14060726|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
14060727|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060728|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
14060729|NCT02608060|Hematinics|hematinics|mesh-ancestor
14060730|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
14060731|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14060732|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060733|NCT02607657|Eplerenone|eplerenone|mesh-list
14060734|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14060735|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
14060736|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060737|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060738|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14060739|NCT02607657|Diuretics|diuretics|mesh-ancestor
14060740|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
14060741|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14060742|NCT02607748|Listerine|listerine|mesh-list
14060743|NCT02607748|Fluorides|fluorides|mesh-list
14060744|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
14060745|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
13913820|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13913821|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13913822|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13913823|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14933833|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933834|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
14933835|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933836|NCT01452659|Relugolix|relugolix|mesh-list
14933837|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
14933838|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
14933839|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060746|NCT02607748|Protective Agents|protective agents|mesh-ancestor
14060747|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933840|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933841|NCT01452685|Leuprolide|leuprolide|mesh-list
14933842|NCT01452685|Relugolix|relugolix|mesh-list
14933843|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14060748|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14060749|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060750|NCT02607696|Zolpidem|zolpidem|mesh-list
14060751|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14060752|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14060753|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060754|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060755|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14060756|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
14060757|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
14060758|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060759|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060760|NCT02607774|Midazolam|midazolam|mesh-list
14060761|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14060762|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14060763|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060764|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060765|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14060766|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14060767|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14060768|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14060769|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
14060770|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
14060771|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
14060772|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
14060773|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060774|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060775|NCT02607579|Ropivacaine|ropivacaine|mesh-list
14060776|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
14060777|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
14060778|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060779|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060780|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
14060781|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060782|NCT02607540|Cisplatin|cisplatin|mesh-list
14060783|NCT02607540|Fluorouracil|fluorouracil|mesh-list
14060784|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060785|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
14060786|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060787|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14060788|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14060789|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
14060790|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060791|NCT02607410|Insulin|insulin|mesh-list
14060792|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14060793|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14060794|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
14060795|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
14060796|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
14060797|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
14060798|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14060799|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14060800|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060801|NCT02607410|Incretins|incretins|mesh-ancestor
14060802|NCT02607410|Hormones|hormones|mesh-ancestor
14060803|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060804|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
14060805|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060806|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060807|NCT02607436|Aspirin|aspirin|mesh-list
14060808|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
14060809|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060810|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933844|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
14933845|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14933846|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933847|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14933848|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933849|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
14933850|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
14060811|NCT02607436|Analgesics|analgesics|mesh-ancestor
14938784|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14060812|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
14060813|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060814|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060815|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060816|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060817|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14060818|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060819|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060820|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14060821|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060822|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933851|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14933852|NCT01452698|Lansoprazole|lansoprazole|mesh-list
14933853|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
14933854|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14060823|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
14060824|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14060825|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
14060826|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060827|NCT02607592|Pemetrexed|pemetrexed|mesh-list
14060828|NCT02607592|Nedaplatin|nedaplatin|mesh-list
14060829|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060830|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060831|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060832|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14060833|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14060834|NCT02607488|Lidocaine|lidocaine|mesh-list
14060835|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
14060836|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
14060837|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060838|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060839|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
14060840|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060841|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14060842|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14060843|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14060844|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14060845|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060846|NCT02607423|Gemcitabine|gemcitabine|mesh-list
14060847|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
14060848|NCT02607423|Cisplatin|cisplatin|mesh-list
14060849|NCT02607423|Docetaxel|docetaxel|mesh-list
14060850|NCT02607423|Pemetrexed|pemetrexed|mesh-list
14060851|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14060852|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060853|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14060854|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
14060855|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060856|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
14060857|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060858|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060859|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14060860|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
14060861|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060862|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060863|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060864|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060865|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14060866|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14060867|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14060868|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14060869|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14060870|NCT02607293|Hormones|hormones|mesh-ancestor
14060871|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14060872|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060873|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
14060874|NCT02607371|Apixaban|apixaban|mesh-list
14060875|NCT02607371|Edoxaban|edoxaban|mesh-list
14060876|NCT02607371|Dabigatran|dabigatran|mesh-list
14060877|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14060878|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
14060879|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14060880|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
14060881|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171750|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060882|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060883|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
14060884|NCT02607332|Paclitaxel|paclitaxel|mesh-list
14060885|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14060886|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060887|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060888|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060889|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060890|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060891|NCT02607072|Aspirin|aspirin|mesh-list
14060892|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14060893|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060894|NCT02607072|Analgesics|analgesics|mesh-ancestor
14060895|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
14060896|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060897|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060898|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14060899|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14060900|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14060901|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060902|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060903|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14060904|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14060905|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060906|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
14060907|NCT02607202|Gemcitabine|gemcitabine|mesh-list
14060908|NCT02607202|Paclitaxel|paclitaxel|mesh-list
14060909|NCT02607202|Carboplatin|carboplatin|mesh-list
14060910|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14060911|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14060912|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
14060913|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
14060914|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
14060915|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060916|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14060917|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
14060918|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
14060919|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060920|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14060921|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14060922|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
14060923|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060924|NCT02607111|Dalteparin|dalteparin|mesh-list
14060925|NCT02607111|Tinzaparin|tinzaparin|mesh-list
14060926|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14060927|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
14060928|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14060929|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14060930|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060931|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
14060932|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14060933|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060934|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060935|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14060936|NCT02607163|Analgesics|analgesics|mesh-ancestor
14060937|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
14060938|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060939|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14060940|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14060941|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14060942|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
14060943|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060944|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060945|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
14060946|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
14060947|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060948|NCT02606773|Protective Agents|protective agents|mesh-ancestor
14060949|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060950|NCT02606773|Vitamins|vitamins|mesh-ancestor
14060951|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
14060952|NCT02606864|Nifurtimox|nifurtimox|mesh-list
14060953|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14060954|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14060955|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14060956|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060957|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
14060958|NCT02606994|Lidocaine|lidocaine|mesh-list
14060959|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
14060960|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
14060961|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14060962|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060963|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
14060964|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14060965|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14060966|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14060967|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14060968|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14060969|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060970|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14060971|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14060972|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
14060973|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
14060974|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14060975|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14060976|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
14060977|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
14060978|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060979|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14060980|NCT02606981|Vitamins|vitamins|mesh-list
14060981|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
14060982|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
14060983|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060984|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
14060985|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060986|NCT02606981|Protective Agents|protective agents|mesh-ancestor
14060987|NCT02606617|Mosapride|mosapride|mesh-list
14060988|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14060989|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14060990|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
14060991|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14060992|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14060993|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14060994|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
14060995|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14060996|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14060997|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
14060998|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
14060999|NCT02606409|Propofol|propofol|mesh-list
14061000|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14061001|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061002|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061003|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14061004|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
14061005|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
14061006|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061007|NCT02606409|Analgesics|analgesics|mesh-ancestor
14061008|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
14061009|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061010|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14061011|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14061012|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14061013|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
14061014|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061015|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476048|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938785|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
14061016|NCT02606448|Bupivacaine|bupivacaine|mesh-list
14476049|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061017|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
14061018|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
14061019|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061020|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061021|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
14061022|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061023|NCT02606552|Aspirin|aspirin|mesh-list
14061024|NCT02606552|Clopidogrel|clopidogrel|mesh-list
14061025|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061026|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061027|NCT02606552|Analgesics|analgesics|mesh-ancestor
14061028|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
14061029|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061030|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061031|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061032|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061033|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14061034|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14061035|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061036|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14061037|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14757995|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14757996|NCT05338320|Fentanyl|fentanyl|mesh-list
14757997|NCT05338320|Morphine|morphine|mesh-list
14757998|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
14757999|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061038|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061039|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
14061040|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14061041|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14061042|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14061043|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
14061044|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061045|NCT02606539|Leucovorin|leucovorin|mesh-list
14061046|NCT02606539|Folic Acid|folic acid|mesh-list
14061047|NCT02606539|Methotrexate|methotrexate|mesh-list
14061048|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
14061049|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14061050|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
14061051|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14061052|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061053|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14061054|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
14061055|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061056|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061057|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
14061058|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061059|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14061060|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14061061|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
14061062|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061063|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14061064|NCT02606539|Antidotes|antidotes|mesh-ancestor
14061065|NCT02606539|Protective Agents|protective agents|mesh-ancestor
14061066|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
14061067|NCT02606539|Vitamins|vitamins|mesh-ancestor
14061068|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
14061069|NCT02606539|Hematinics|hematinics|mesh-ancestor
14061070|NCT02606383|Ketoconazole|ketoconazole|mesh-list
14061071|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
14061072|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061073|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14061074|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14061075|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061076|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061077|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14061078|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
14061079|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061080|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061081|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14061082|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
14061083|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14061084|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061085|NCT02606266|Valganciclovir|valganciclovir|mesh-list
14061086|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
14061087|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171751|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171752|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171753|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
14171754|NCT04817982|Hormones|hormones|mesh-ancestor
14171755|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171756|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14171757|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171758|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
14171759|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171760|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171761|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
14171762|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
14171763|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171764|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
14171765|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14171766|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14171767|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14171768|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14171769|NCT04818099|Vortioxetine|vortioxetine|mesh-list
14171770|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
14171771|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14171772|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14171773|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14171774|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171775|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171776|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14171777|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14171778|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14171779|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171780|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171781|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
14171782|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14171783|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14171784|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14171785|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14171786|NCT04817969|Cimetidine|cimetidine|mesh-list
14171787|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14171788|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171789|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14171790|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
14171791|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
14171792|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171793|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171794|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171795|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14171796|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14171797|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171798|NCT04818151|Warfarin|warfarin|mesh-list
14171799|NCT04818151|Apixaban|apixaban|mesh-list
14171800|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
14171801|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14171802|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
14171803|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14171804|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
14171805|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171806|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171807|NCT04817800|Azelastine|azelastine|mesh-list
14171808|NCT04817800|Beclomethasone|beclomethasone|mesh-list
14171809|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171810|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
14171811|NCT04817800|Hormones|hormones|mesh-ancestor
14758000|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758001|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14758002|NCT05338320|Narcotics|narcotics|mesh-ancestor
14758003|NCT05338320|Analgesics|analgesics|mesh-ancestor
14758004|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
14758005|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758006|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14758007|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14758008|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
14758009|NCT05338190|Rituximab|rituximab|mesh-list
14171812|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758010|NCT05338190|Belimumab|belimumab|mesh-list
14061088|NCT02606084|Esketamine|esketamine|mesh-list
14061089|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
14061090|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14061091|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
14061092|NCT02605915|Carboplatin|carboplatin|mesh-list
14061093|NCT02605915|Docetaxel|docetaxel|mesh-list
14061094|NCT02605915|Doxorubicin|doxorubicin|mesh-list
14933855|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933856|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14933857|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933858|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933859|NCT01452711|Lansoprazole|lansoprazole|mesh-list
14933860|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
14933861|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14933862|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933863|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14933864|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061095|NCT02605915|Trastuzumab|trastuzumab|mesh-list
14061096|NCT02605915|Atezolizumab|atezolizumab|mesh-list
14061097|NCT02605915|Pertuzumab|pertuzumab|mesh-list
14061098|NCT02605915|Maytansine|maytansine|mesh-list
14061099|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14061100|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14061101|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
14758011|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758012|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758013|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
14758014|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758015|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14758016|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758017|NCT05331859|Insulin|insulin|mesh-list
14061102|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061103|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061104|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14061105|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
14061106|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061107|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061108|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14061109|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
14061110|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
14061111|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
14061112|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14061113|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14061114|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14061115|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061116|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14061117|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14061118|NCT02606032|Metronidazole|metronidazole|mesh-list
14061119|NCT02606032|Doxycycline|doxycycline|mesh-list
14061120|NCT02606032|Terbinafine|terbinafine|mesh-list
14061121|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061122|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061123|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14061124|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14061125|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
14061126|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
14061127|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758018|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14758019|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758020|NCT05330754|Caffeine|caffeine|mesh-list
14758021|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14758022|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061128|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061129|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
14061130|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
14061131|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758023|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14758024|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758025|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758026|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14758027|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14758028|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
14933865|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061132|NCT02605746|Ceritinib|ceritinib|mesh-list
14061133|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061134|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14061135|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061136|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061137|NCT02605772|Metformin|metformin|mesh-list
14061138|NCT02605772|Saxagliptin|saxagliptin|mesh-list
14061139|NCT02605772|Acarbose|acarbose|mesh-list
14061140|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14061141|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061142|NCT02605772|Incretins|incretins|mesh-ancestor
14061143|NCT02605772|Hormones|hormones|mesh-ancestor
14061144|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061145|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14061146|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
14061147|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061148|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061149|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14061150|NCT02605811|Temozolomide|temozolomide|mesh-list
14061151|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14061152|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
14061153|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061154|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061155|NCT02605460|Plerixafor|plerixafor|mesh-list
14061156|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
14061157|NCT02605460|Busulfan|busulfan|mesh-list
14061158|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14061159|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
14061160|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061161|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061162|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14758029|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061163|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
14061164|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061165|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061166|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14061167|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14061168|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14061169|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
14061170|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061171|NCT02605720|Piperaquine|piperaquine|mesh-list
14061172|NCT02605720|Artenimol|artenimol|mesh-list
14061173|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
14061174|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14061175|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14061176|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061177|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
14061178|NCT02605421|Melphalan|melphalan|mesh-list
14061179|NCT02605421|Thiotepa|thiotepa|mesh-list
14061180|NCT02605421|Carboplatin|carboplatin|mesh-list
14061181|NCT02605421|Etoposide|etoposide|mesh-list
14061182|NCT02605421|Sargramostim|sargramostim|mesh-list
14061183|NCT02605421|Lenograstim|lenograstim|mesh-list
14061184|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14061185|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
14061186|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061187|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061188|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14061189|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
14061190|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061191|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061192|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14061193|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14061194|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14061195|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14061196|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061197|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14061198|NCT02605694|Prednisone|prednisone|mesh-list
14061199|NCT02605694|Rituximab|rituximab|mesh-list
14061200|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14061201|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758030|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
14758031|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
14758032|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758033|NCT05328908|Trifluridine|trifluridine|mesh-list
14758034|NCT05328908|Nivolumab|nivolumab|mesh-list
14758035|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758036|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061202|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
14061203|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061204|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061205|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061206|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
14061207|NCT02605694|Hormones|hormones|mesh-ancestor
14061208|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061209|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14061210|NCT02605434|Levodopa|levodopa|mesh-list
14061211|NCT02605434|Carbidopa|carbidopa|mesh-list
14061212|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14061213|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14061214|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14061215|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
14061216|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061217|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061218|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061219|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14061220|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061221|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14061222|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
14061223|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
14061224|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
14061225|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14061226|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14061227|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061228|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
14061229|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14061230|NCT02605356|Dexamethasone|dexamethasone|mesh-list
14061231|NCT02605356|Bortezomib|bortezomib|mesh-list
14061232|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14061233|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061234|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
14061235|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
14061236|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061237|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061238|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14061239|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
14061240|NCT02605356|Hormones|hormones|mesh-ancestor
14061241|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061242|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14061243|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061244|NCT02605213|Vancomycin|vancomycin|mesh-list
14061245|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061246|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061247|NCT02605226|Bicalutamide|bicalutamide|mesh-list
14061248|NCT02605226|Hormones|hormones|mesh-list
14061249|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14061250|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061251|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061252|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
14758037|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14758038|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758039|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
14758040|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
14758041|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758042|NCT05326490|Metformin|metformin|mesh-list
14758043|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14061253|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
14061254|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061255|NCT02604992|Dronabinol|dronabinol|mesh-list
14061256|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
14061257|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061258|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14061259|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061260|NCT02604992|Analgesics|analgesics|mesh-ancestor
14061261|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
14061262|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061263|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14061264|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14061265|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061266|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061267|NCT02604992|Hormones|hormones|mesh-ancestor
14061268|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061269|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14061270|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
14061271|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061272|NCT02604966|Artesunate|artesunate|mesh-list
14061273|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
14061274|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14061275|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14061276|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061277|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061278|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
14061279|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
14061280|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14061281|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
14061282|NCT02605265|Capecitabine|capecitabine|mesh-list
14061283|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
14061284|NCT02605265|Irinotecan|irinotecan|mesh-list
14061285|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14061286|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
14061287|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061288|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061289|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14061290|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14061291|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061292|NCT02604914|Levodopa|levodopa|mesh-list
14061293|NCT02604914|Carbidopa|carbidopa|mesh-list
14061294|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14061295|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14061296|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14061297|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
14061298|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061299|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061300|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061301|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14061302|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061303|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14061304|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
14061305|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
14061306|NCT02604849|Gentamicins|gentamicins|mesh-list
14061307|NCT02604849|Neomycin|neomycin|mesh-list
14061308|NCT02604849|Streptomycin|streptomycin|mesh-list
14061309|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061310|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061311|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14061312|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061313|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061314|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
14061315|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14061316|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061317|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061318|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061319|NCT02604940|Analgesics|analgesics|mesh-ancestor
14061320|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
14061321|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061322|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14061323|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14061324|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14061325|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
14061326|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061327|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061328|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14061329|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061330|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
14061331|NCT02604719|Ethamsylate|ethamsylate|mesh-list
14061332|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14061333|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14061334|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061335|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
14061336|NCT02604719|Coagulants|coagulants|mesh-ancestor
14061337|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
14061338|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
14061339|NCT02604797|Sufentanil|sufentanil|mesh-list
14061340|NCT02604797|Dsuvia|dsuvia|mesh-list
14061341|NCT02604797|Nalbuphine|nalbuphine|mesh-list
14061342|NCT02604797|Ramosetron|ramosetron|mesh-list
14061343|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14061344|NCT02604797|Narcotics|narcotics|mesh-ancestor
14061345|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061346|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061347|NCT02604797|Analgesics|analgesics|mesh-ancestor
14061348|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
14061349|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061350|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14061351|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14061352|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
14061353|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
14061354|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061355|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061356|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061357|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061358|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061359|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061360|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061361|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
14061362|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
14061363|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14061364|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14061365|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
14061366|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061367|NCT02604784|Cisplatin|cisplatin|mesh-list
14061368|NCT02604784|Doxorubicin|doxorubicin|mesh-list
14061369|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14061370|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
14061371|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061372|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14061373|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14061374|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14061375|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061376|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061377|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14061378|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
14061379|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061380|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
14061381|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14061382|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061383|NCT02604615|Capecitabine|capecitabine|mesh-list
14061384|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
14061385|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14061386|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
14061387|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061388|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061389|NCT02604576|Bromopride|bromopride|mesh-list
14061390|NCT02604576|Metoclopramide|metoclopramide|mesh-list
14061391|NCT02604576|Simethicone|simethicone|mesh-list
14061392|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
14061393|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061394|NCT02604576|Emollients|emollients|mesh-ancestor
14061395|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
14061396|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
14061397|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
14061398|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061399|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061400|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14061401|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14061402|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
14061403|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061404|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14061405|NCT02604537|Ketorolac|ketorolac|mesh-list
14061406|NCT02604537|Betamethasone|betamethasone|mesh-list
14061407|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061408|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061409|NCT02604537|Analgesics|analgesics|mesh-ancestor
14061410|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
14061411|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061412|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061413|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061414|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061415|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061416|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061417|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061418|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
14061419|NCT02604537|Hormones|hormones|mesh-ancestor
14061420|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061421|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14758044|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758045|NCT05325775|SR 142801|sr 142801|mesh-list
14758046|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14061422|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
14171813|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061423|NCT02604420|Eculizumab|eculizumab|mesh-list
14061424|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14061425|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14061426|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
14061427|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061428|NCT02604459|Fentanyl|fentanyl|mesh-list
14061429|NCT02604459|Anesthetics|anesthetics|mesh-list
14061430|NCT02604459|Propofol|propofol|mesh-list
14061431|NCT02604459|Sevoflurane|sevoflurane|mesh-list
14061432|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061433|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061434|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14061435|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14061436|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
14061437|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14061438|NCT02604459|Narcotics|narcotics|mesh-ancestor
14061439|NCT02604459|Analgesics|analgesics|mesh-ancestor
14061440|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
14061441|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061442|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14061443|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14061444|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14061445|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
14061446|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14061447|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
14061448|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
14061449|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061450|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061451|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14061452|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14061453|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14061454|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061455|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
14061456|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14061457|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14061458|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061459|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
14061460|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061461|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061462|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
14061463|NCT02604134|Fluorides|fluorides|mesh-list
14061464|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
14061465|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
14061466|NCT02604134|Protective Agents|protective agents|mesh-ancestor
14061467|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061468|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14061469|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061470|NCT02604095|Melatonin|melatonin|mesh-list
14061471|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
14061472|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061473|NCT02604095|Protective Agents|protective agents|mesh-ancestor
14061474|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061475|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061476|NCT02604004|Lamivudine|lamivudine|mesh-list
14758047|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14061477|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14061478|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14061479|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061480|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061481|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
14061482|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061483|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14061484|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14061485|NCT02603848|Ibuprofen|ibuprofen|mesh-list
14061486|NCT02603848|Morphine|morphine|mesh-list
14061487|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14061488|NCT02603848|Narcotics|narcotics|mesh-ancestor
14061489|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061490|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061491|NCT02603848|Analgesics|analgesics|mesh-ancestor
14061492|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
14061493|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061494|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061495|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061496|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061497|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061498|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061499|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061500|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061501|NCT02603965|Copper|copper|mesh-list
14061502|NCT02603965|Trace Elements|trace elements|mesh-ancestor
14061503|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
14061504|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061505|NCT02603757|Vitamin D|vitamin d|mesh-list
14061506|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
14061507|NCT02603757|Vitamins|vitamins|mesh-ancestor
14061508|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
14061509|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061510|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14061511|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14061512|NCT02603822|Indomethacin|indomethacin|mesh-list
14061513|NCT02603822|Mannitol|mannitol|mesh-list
14061514|NCT02603822|Lactulose|lactulose|mesh-list
14061515|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14061516|NCT02603822|Diuretics|diuretics|mesh-ancestor
14061517|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
14061518|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061519|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061520|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061521|NCT02603822|Analgesics|analgesics|mesh-ancestor
14758048|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758049|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758050|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14758051|NCT05325489|Budesonide|budesonide|mesh-list
14758052|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061522|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
14061523|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061524|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061525|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061526|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
14061527|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
14061528|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14061529|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061530|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061531|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061532|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14061533|NCT02603861|Modafinil|modafinil|mesh-list
14061534|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14061535|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061536|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14061537|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14061538|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14061539|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758053|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14061540|NCT02603783|Capsaicin|capsaicin|mesh-list
14061541|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
14061542|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
14061543|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
14061544|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061545|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061546|NCT02603770|Lovastatin|lovastatin|mesh-list
14061547|NCT02603770|L 647318|l 647318|mesh-list
14061548|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
14061549|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14061550|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14061551|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
14061552|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061553|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14061554|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14061555|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061556|NCT02603991|Levetiracetam|levetiracetam|mesh-list
14061557|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
14061558|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
14061559|NCT02603705|Oxycodone|oxycodone|mesh-list
14061560|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14061561|NCT02603705|Narcotics|narcotics|mesh-ancestor
14061562|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061563|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061564|NCT02603705|Analgesics|analgesics|mesh-ancestor
14061565|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
14061566|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061567|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
14061568|NCT02603406|Hematinics|hematinics|mesh-ancestor
14061569|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
14061570|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14061571|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061572|NCT02603575|Caspofungin|caspofungin|mesh-list
14061573|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
14061574|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
14061575|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
14061576|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061577|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
14061578|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
14061579|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061580|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061581|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14061582|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
14061583|NCT02603575|Hormones|hormones|mesh-ancestor
14061584|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061585|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14061586|NCT02603575|Protective Agents|protective agents|mesh-ancestor
14061587|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
14061588|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061589|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061590|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061591|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061592|NCT02603445|Idelalisib|idelalisib|mesh-list
14061593|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061594|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061595|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061596|NCT02603679|Tamoxifen|tamoxifen|mesh-list
14061597|NCT02603679|Paclitaxel|paclitaxel|mesh-list
14061598|NCT02603679|Letrozole|letrozole|mesh-list
14061599|NCT02603679|Palbociclib|palbociclib|mesh-list
14061600|NCT02603679|Anastrozole|anastrozole|mesh-list
14061601|NCT02603679|Exemestane|exemestane|mesh-list
14061602|NCT02603679|Goserelin|goserelin|mesh-list
14061603|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14061604|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14061605|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061606|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
14061607|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
14061608|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
14061609|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061610|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14061611|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061612|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14061613|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
14061614|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061615|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061616|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14061617|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14061618|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14061619|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14061620|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14061621|NCT02603497|Peficitinib|peficitinib|mesh-list
14061622|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061623|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061624|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14061625|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
14061626|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061627|NCT02603315|Mitogens|mitogens|mesh-list
14061628|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
14061629|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14061630|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061631|NCT02603315|Growth Substances|growth substances|mesh-ancestor
14061632|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061633|NCT02603068|Treprostinil|treprostinil|mesh-list
14061634|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14061635|NCT02603159|Capecitabine|capecitabine|mesh-list
14061636|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14061637|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
14061638|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061639|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061640|NCT02603003|Pemetrexed|pemetrexed|mesh-list
14061641|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061642|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061643|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061644|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14061645|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14061646|NCT02603081|Ebselen|ebselen|mesh-list
14061647|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061648|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061649|NCT02603081|Analgesics|analgesics|mesh-ancestor
14061650|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
14061651|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061652|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061653|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061654|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061655|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14061656|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14061657|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
14061658|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061659|NCT02603081|Protective Agents|protective agents|mesh-ancestor
14061660|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061661|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061662|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14061663|NCT02603276|Red yeast rice|red yeast rice|mesh-list
14061664|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14061665|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14061666|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14061667|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
14061668|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061669|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061670|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14061671|NCT02602938|Aspirin|aspirin|mesh-list
14061672|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061673|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061674|NCT02602938|Analgesics|analgesics|mesh-ancestor
14061675|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
14061676|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061677|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061678|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061679|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061680|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14061681|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14061682|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061683|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14061684|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061685|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061686|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
14061687|NCT02603198|Epinephrine|epinephrine|mesh-list
14061688|NCT02603198|Nordefrin|nordefrin|mesh-list
14061689|NCT02603198|Anesthetics|anesthetics|mesh-list
14061690|NCT02603198|Mepivacaine|mepivacaine|mesh-list
14061691|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061692|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061693|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14061694|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14061695|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
14061696|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061697|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061698|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14061699|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14061700|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
14061701|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061702|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14061703|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
14061704|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
14061705|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
14061706|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14061707|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
14061708|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
14061709|NCT02603055|Vaccines|vaccines|mesh-list
14061710|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
14061711|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061712|NCT02602860|Levetiracetam|levetiracetam|mesh-list
14061713|NCT02602860|Brivaracetam|brivaracetam|mesh-list
14061714|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
14061715|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
14061716|NCT02602743|Ketamine|ketamine|mesh-list
14061717|NCT02602743|Remifentanil|remifentanil|mesh-list
14061718|NCT02602743|Propofol|propofol|mesh-list
14061719|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14061720|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061721|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061722|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14061723|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
14061724|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
14061725|NCT02602743|Analgesics|analgesics|mesh-ancestor
14061726|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
14061727|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061728|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14061729|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14061730|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14061731|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061732|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758054|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
14758055|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758056|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758057|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14758058|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
14758059|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
14758060|NCT05325489|Hormones|hormones|mesh-ancestor
14758061|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061733|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14061734|NCT02602743|Narcotics|narcotics|mesh-ancestor
14061735|NCT02602652|Vaccines|vaccines|mesh-list
14061736|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
14061737|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171814|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14171815|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
14171816|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14171817|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
14171818|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171819|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14171820|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171821|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171822|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14171823|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14171824|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14171825|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
14171826|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
14171827|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171828|NCT04817527|Edaravone|edaravone|mesh-list
14171829|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14171830|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
14171831|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171832|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14171833|NCT04817527|Protective Agents|protective agents|mesh-ancestor
14171834|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758062|NCT05322031|Aripiprazole|aripiprazole|mesh-list
14758063|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
14758064|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14061738|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
14061739|NCT02602704|Calcium|calcium|mesh-list
14061740|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14061741|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061742|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14061743|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14061744|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
14061745|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061746|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14061747|NCT02602600|Liraglutide|liraglutide|mesh-list
14061748|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14061749|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061750|NCT02602600|Incretins|incretins|mesh-ancestor
14061751|NCT02602600|Hormones|hormones|mesh-ancestor
14061752|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061753|NCT02602444|Ticagrelor|ticagrelor|mesh-list
14061754|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14061755|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14061756|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14061757|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14061758|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
14061759|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061760|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061761|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061762|NCT02602509|Rifampin|rifampin|mesh-list
14061763|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
14061764|NCT02602509|Celecoxib|celecoxib|mesh-list
14061765|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061766|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061767|NCT02602509|Analgesics|analgesics|mesh-ancestor
14061768|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
14061769|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061770|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061771|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061772|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061773|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14061774|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061775|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061776|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061777|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14061778|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
14061779|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061780|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061781|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
14061782|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14061783|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14061784|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14061785|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14061786|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14061787|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14061788|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14061789|NCT02602470|Metronidazole|metronidazole|mesh-list
14061790|NCT02602470|Azelaic acid|azelaic acid|mesh-list
14061791|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14061792|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061793|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061794|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14061795|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14061796|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14061797|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14061798|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14061799|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14061800|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14061801|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061802|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061803|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061804|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061805|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
14061806|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
14061807|NCT02602483|Ibuprofen|ibuprofen|mesh-list
14061808|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061809|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061810|NCT02602483|Analgesics|analgesics|mesh-ancestor
14061811|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
14061812|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061813|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061814|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061815|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061816|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061817|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061818|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061819|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
14061820|NCT02602483|Protective Agents|protective agents|mesh-ancestor
14061821|NCT02602483|Vitamins|vitamins|mesh-ancestor
14061822|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
14061823|NCT02602197|Acetaminophen|acetaminophen|mesh-list
14061824|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14061825|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061826|NCT02602197|Analgesics|analgesics|mesh-ancestor
14061827|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
14061828|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061829|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061830|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
14061831|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061832|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061833|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061834|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
14061835|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14061836|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061837|NCT02602002|Remifentanil|remifentanil|mesh-list
14061838|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14061839|NCT02602002|Narcotics|narcotics|mesh-ancestor
14933866|NCT01452724|Lansoprazole|lansoprazole|mesh-list
14933867|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
14933868|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14933869|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933870|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14061840|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061841|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061842|NCT02602002|Analgesics|analgesics|mesh-ancestor
14061843|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
14061844|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061845|NCT02602301|Oxytocin|oxytocin|mesh-list
14061846|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
14061847|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14061848|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061849|NCT02601989|Tadalafil|tadalafil|mesh-list
14061850|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
14061851|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14061852|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14061853|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061854|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061855|NCT02601989|Urological Agents|urological agents|mesh-ancestor
14061856|NCT02602028|Colchicine|colchicine|mesh-list
14061857|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
14061858|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061859|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14061860|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14061861|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14061862|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061863|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061864|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
14061865|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
14061866|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14061867|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061868|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061869|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
14061870|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14061871|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061872|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061873|NCT02601911|Acetaminophen|acetaminophen|mesh-list
14061874|NCT02601911|Ketorolac|ketorolac|mesh-list
14061875|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14061876|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061877|NCT02601911|Analgesics|analgesics|mesh-ancestor
14061878|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
14061879|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061880|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061881|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
14933871|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061882|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061883|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061884|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061885|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061886|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061887|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061888|NCT02601963|Minocycline|minocycline|mesh-list
14061889|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061890|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061891|NCT02601924|Anesthetics|anesthetics|mesh-list
14061892|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
14061893|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061894|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061895|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
14061896|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061897|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
14061898|NCT02601898|Progesterone|progesterone|mesh-list
14061899|NCT02601898|Progestins|progestins|mesh-ancestor
14061900|NCT02601898|Hormones|hormones|mesh-ancestor
14061901|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14061902|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061903|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
14061904|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061905|NCT02601898|Protective Agents|protective agents|mesh-ancestor
14061906|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
14061907|NCT02601898|Vitamins|vitamins|mesh-ancestor
14061908|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
14061909|NCT02601677|Fluoxetine|fluoxetine|mesh-list
14061910|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14061911|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14061912|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14061913|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061914|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061915|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
14061916|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061917|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14061918|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
14061919|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14061920|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14061921|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14061922|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061923|NCT02601703|Tacrolimus|tacrolimus|mesh-list
14061924|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14061925|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
14061926|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061927|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14061928|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061929|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061930|NCT02601651|Lidocaine|lidocaine|mesh-list
14758065|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14061931|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
14061932|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
14061933|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14061934|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061935|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
14061936|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061937|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14061938|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14061939|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14061940|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14061941|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061942|NCT02601508|Rocuronium|rocuronium|mesh-list
14061943|NCT02601508|Atracurium|atracurium|mesh-list
14758066|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14061944|NCT02601508|Cisatracurium|cisatracurium|mesh-list
14061945|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14061946|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14061947|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14061948|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061949|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061950|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14061951|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14061952|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14061953|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061954|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061955|NCT02601365|Molgramostim|molgramostim|mesh-list
14061956|NCT02601365|Sargramostim|sargramostim|mesh-list
14061957|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
14061958|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061959|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14061960|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
14061961|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14061962|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14061963|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14061964|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14061965|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061966|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
14061967|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061968|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061969|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14061970|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061971|NCT02601157|Aspirin|aspirin|mesh-list
14061972|NCT02601157|Sirolimus|sirolimus|mesh-list
14061973|NCT02601157|Clopidogrel|clopidogrel|mesh-list
14061974|NCT02601157|Ticagrelor|ticagrelor|mesh-list
14061975|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14061976|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14061977|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14061978|NCT02601157|Analgesics|analgesics|mesh-ancestor
14061979|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
14061980|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14061981|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14061982|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14061983|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14061984|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14061985|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14061986|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14061987|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14061988|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14061989|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14061990|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
14061991|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14061992|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14061993|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14061994|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
14061995|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14061996|NCT02601157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14061997|NCT02601157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14061998|NCT02601157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14061999|NCT02601157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062000|NCT02601157|Antifungal Agents|antifungal agents|mesh-ancestor
14062001|NCT02601157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062002|NCT02601157|Immunologic Factors|immunologic factors|mesh-ancestor
14062003|NCT02601040|Vaccines|vaccines|mesh-list
14062004|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
14062005|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062006|NCT02601235|Pyrilamine|pyrilamine|mesh-list
14062007|NCT02601235|Phenylephrine|phenylephrine|mesh-list
14062008|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
14062009|NCT02601235|Naphazoline|naphazoline|mesh-list
14062010|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062011|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14062012|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14062013|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
14062014|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062015|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062016|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
14062017|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
14062018|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062019|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
14062020|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14062021|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
14062022|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14062023|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
14062024|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14062025|NCT02601235|Protective Agents|protective agents|mesh-ancestor
14062026|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14062027|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14062028|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062029|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14062030|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
14062031|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
14062032|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14062033|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
14062034|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14062035|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
14062036|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14062037|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062038|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14758067|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758068|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758069|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
14171841|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14171842|NCT04817202|Antibodies|antibodies|mesh-list
14171843|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
14171844|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14171845|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
14171846|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171847|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171848|NCT04816968|Vancomycin|vancomycin|mesh-list
14171849|NCT04816968|Meropenem|meropenem|mesh-list
14171850|NCT04816968|Tazobactam|tazobactam|mesh-list
14171851|NCT04816968|Piperacillin|piperacillin|mesh-list
14171852|NCT04816968|Cefepime|cefepime|mesh-list
14171853|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14171854|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14171855|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171856|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14171857|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171858|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171859|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
14171860|NCT04816877|Narcotics|narcotics|mesh-ancestor
14171861|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171862|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171863|NCT04816877|Analgesics|analgesics|mesh-ancestor
14171864|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
14171865|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171866|NCT04816838|Osimertinib|osimertinib|mesh-list
14171867|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171868|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14171869|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171870|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171871|NCT04816682|Silymarin|silymarin|mesh-list
14171872|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
14171873|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171874|NCT04816682|Protective Agents|protective agents|mesh-ancestor
14171875|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171876|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
14171877|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14171878|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171879|NCT04816344|Anesthetics|anesthetics|mesh-list
14171880|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171881|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183191|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14183192|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
14183193|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183194|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183195|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
14183196|NCT04729556|Chitosan|chitosan|mesh-list
14183197|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14183198|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14183199|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
14183200|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183201|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14062039|NCT02600988|Vitamin D|vitamin d|mesh-list
14062040|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
14062041|NCT02600988|Vitamins|vitamins|mesh-list
14062042|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
14062043|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062044|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062045|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062046|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14062047|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14062048|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062049|NCT02600806|Azithromycin|azithromycin|mesh-list
14062050|NCT02600806|Levofloxacin|levofloxacin|mesh-list
14062051|NCT02600806|Ofloxacin|ofloxacin|mesh-list
14062052|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14062053|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062054|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14062055|NCT02600806|Renal Agents|renal agents|mesh-ancestor
14062056|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14062057|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14062058|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062059|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062060|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062061|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14062062|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14062063|NCT02600780|Allopurinol|allopurinol|mesh-list
14062064|NCT02600780|Febuxostat|febuxostat|mesh-list
14062065|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
14062066|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062067|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062068|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
14062069|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062070|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14062071|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
14062072|NCT02600780|Protective Agents|protective agents|mesh-ancestor
14062073|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062074|NCT02600741|Droperidol|droperidol|mesh-list
14062075|NCT02600741|Haloperidol|haloperidol|mesh-list
14062076|NCT02600741|Pimozide|pimozide|mesh-list
14062077|NCT02600741|Olanzapine|olanzapine|mesh-list
14062078|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
14062079|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
14062080|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
14062081|NCT02600741|Risperidone|risperidone|mesh-list
14062082|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14062083|NCT02600741|Aripiprazole|aripiprazole|mesh-list
14062084|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14062085|NCT02600741|Ziprasidone|ziprasidone|mesh-list
14062086|NCT02600741|Clozapine|clozapine|mesh-list
14062087|NCT02600741|Asenapine|asenapine|mesh-list
14062088|NCT02600741|Loxapine|loxapine|mesh-list
14062089|NCT02600741|Iloperidone|iloperidone|mesh-list
14062090|NCT02600741|Perphenazine|perphenazine|mesh-list
14062091|NCT02600741|Fluphenazine|fluphenazine|mesh-list
14062092|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
14062093|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14062094|NCT02600741|Thioridazine|thioridazine|mesh-list
14062095|NCT02600741|Thiothixene|thiothixene|mesh-list
14062096|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13913824|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913825|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13913826|NCT03484611|Cetrorelix|cetrorelix|mesh-list
13913827|NCT03484611|Menotropins|menotropins|mesh-list
13913828|NCT03484611|Progesterone|progesterone|mesh-list
13913829|NCT03484611|Progestins|progestins|mesh-ancestor
13913830|NCT03484611|Hormones|hormones|mesh-ancestor
13913831|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913832|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913833|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13913834|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13913835|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
13913836|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
13960014|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062097|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
14062098|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062099|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062100|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062101|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14062102|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14062103|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062104|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14062105|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14062106|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
14062107|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
14062108|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
14062109|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062110|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14062111|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14062112|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14062113|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062114|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
14062115|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
14062116|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14062117|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14062118|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14062119|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14062120|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14062121|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
14062122|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
14062123|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14062124|NCT02600650|Testosterone|testosterone|mesh-list
14062125|NCT02600650|Androgens|androgens|mesh-ancestor
14062126|NCT02600650|Hormones|hormones|mesh-ancestor
14062127|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14062128|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062129|NCT02600585|Vaccines|vaccines|mesh-list
14062130|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
14062131|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062132|NCT02600455|Abatacept|abatacept|mesh-list
14062133|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14062134|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062135|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062136|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062137|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
14062138|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062139|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062140|NCT02600468|Abatacept|abatacept|mesh-list
14062141|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14062142|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062143|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062144|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062145|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
14062146|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062147|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062148|NCT02600273|Nicotine|nicotine|mesh-list
14062149|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14062150|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
14062151|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062152|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062153|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14062154|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14062155|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
14758070|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
14758071|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758072|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062156|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062157|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062158|NCT02600247|Acetaminophen|acetaminophen|mesh-list
14062159|NCT02600247|Celecoxib|celecoxib|mesh-list
14062160|NCT02600247|Pregabalin|pregabalin|mesh-list
14062161|NCT02600247|Oxycodone|oxycodone|mesh-list
14062162|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14062163|NCT02600247|Tramadol|tramadol|mesh-list
14062164|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14062165|NCT02600247|Analgesics|analgesics|mesh-ancestor
14062166|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
14062167|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062168|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062169|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
14062170|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
14062171|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14062172|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062173|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062174|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062175|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14062176|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14062177|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062178|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14062179|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14062180|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14062181|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062182|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14062183|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14062184|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062185|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14062186|NCT02600247|Narcotics|narcotics|mesh-ancestor
14062187|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14062188|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14062189|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062190|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
14062191|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
14062192|NCT02600260|Enoxaparin|enoxaparin|mesh-list
14062193|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
14062194|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
14062195|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14062196|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14062197|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062198|NCT02600117|Tenofovir|tenofovir|mesh-list
14062199|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
14062200|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062201|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14062202|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14062203|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062204|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062205|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14062206|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14062207|NCT02599701|Gabapentin|gabapentin|mesh-list
14062208|NCT02599701|Analgesics|analgesics|mesh-ancestor
14062209|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
14062210|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062211|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062212|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
14062213|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14062214|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14062215|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062216|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14062217|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14062218|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14062219|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062220|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062221|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
14062222|NCT02599675|Vitamin D|vitamin d|mesh-list
14062223|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
14062224|NCT02599675|Vitamins|vitamins|mesh-ancestor
14062225|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
14062226|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062227|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062228|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062229|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
14062230|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14062231|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062232|NCT02599857|Bisoprolol|bisoprolol|mesh-list
14062233|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14062234|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
14062235|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
14062236|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062237|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062238|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14062239|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14062240|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14062241|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
14062242|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062243|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062244|NCT02599792|Ivacaftor|ivacaftor|mesh-list
14062245|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14062246|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062247|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062248|NCT02599532|Apixaban|apixaban|mesh-list
14062249|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14062250|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
14062251|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14062252|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
14062253|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062254|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062255|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
14062256|NCT02599571|Nicotine|nicotine|mesh-list
14062257|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14062258|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
14062259|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062260|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062261|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14062262|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14062263|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
14062264|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062265|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062266|NCT02599623|Anesthetics|anesthetics|mesh-list
14062267|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062268|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062269|NCT02599493|Rifampin|rifampin|mesh-list
14062270|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14062271|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
14062272|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14062273|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062274|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
14062275|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14062276|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062277|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062278|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14062279|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14062280|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14062281|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14062282|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14062283|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14062284|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14062285|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14062286|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14062287|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14062288|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062289|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062290|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062291|NCT02599311|Urological Agents|urological agents|mesh-ancestor
14171882|NCT04816461|Piperaquine|piperaquine|mesh-list
14171883|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
14171884|NCT04816461|Amodiaquine|amodiaquine|mesh-list
14171885|NCT04816461|Artenimol|artenimol|mesh-list
14171886|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
14171887|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14171888|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14171889|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14171890|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14171891|NCT04816461|Renal Agents|renal agents|mesh-ancestor
14171892|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
14171893|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14171894|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14171895|NCT04816253|Prednisolone|prednisolone|mesh-list
14171896|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
14171897|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14171898|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
14171899|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
14171900|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171901|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
14171902|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
14171903|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171904|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171905|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171906|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
14171907|NCT04816253|Hormones|hormones|mesh-ancestor
14171908|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171909|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14171910|NCT04816253|Protective Agents|protective agents|mesh-ancestor
14171911|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14171912|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171913|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14171914|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
14171915|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
14062292|NCT02599480|Mirabegron|mirabegron|mesh-list
14062293|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14062294|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14062295|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14062296|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
14062297|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062298|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062299|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062300|NCT02599480|Urological Agents|urological agents|mesh-ancestor
14062301|NCT02599337|Sorafenib|sorafenib|mesh-list
14062302|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062303|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14062304|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062305|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062306|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
14062307|NCT02599168|Propofol|propofol|mesh-list
14062308|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14062309|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062310|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062311|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14062312|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
14062313|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
14062314|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14062315|NCT02599168|Analgesics|analgesics|mesh-ancestor
14062316|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
14062317|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062318|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14062319|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14062320|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14062321|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
14062322|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062323|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062324|NCT02599077|Dienogest|dienogest|mesh-list
14062325|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
14062326|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14062327|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
14062328|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14062329|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062330|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14062331|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14062332|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14062333|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14062334|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14062335|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
14062336|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14062337|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14062338|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062339|NCT02598830|Vitamin D|vitamin d|mesh-list
14062340|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
14062341|NCT02598830|Vitamins|vitamins|mesh-ancestor
14062342|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
14062343|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062344|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062345|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062346|NCT02599090|Temozolomide|temozolomide|mesh-list
14062347|NCT02599090|Sorafenib|sorafenib|mesh-list
14062348|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14062349|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
14062350|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062351|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062352|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14062353|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062354|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
14062355|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14062356|NCT02598778|Listerine|listerine|mesh-list
14062357|NCT02598778|Fluorides|fluorides|mesh-list
14062358|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
14062359|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
14062360|NCT02598778|Protective Agents|protective agents|mesh-ancestor
14062361|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062362|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14062363|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062364|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
14062365|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
14062366|NCT02598856|Naloxone|naloxone|mesh-list
14062367|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14062368|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062369|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
14062370|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062371|NCT02598869|Triamcinolone|triamcinolone|mesh-list
14062372|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14062373|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14062374|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14062375|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14062376|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
14062377|NCT02598869|Hormones|hormones|mesh-ancestor
14062378|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14062379|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062380|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062381|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
14062382|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062383|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062384|NCT02598596|Azathioprine|azathioprine|mesh-list
14062385|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
14062386|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062387|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14062388|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062389|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062390|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
14062391|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062392|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062393|NCT02598791|Glucagon|glucagon|mesh-list
14062394|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14062395|NCT02598791|Incretins|incretins|mesh-ancestor
14062396|NCT02598791|Hormones|hormones|mesh-ancestor
14062397|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14062398|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062399|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14062400|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
14062401|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062402|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062403|NCT02598635|Vitamins|vitamins|mesh-ancestor
14062404|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
14062405|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062406|NCT02598687|Paclitaxel|paclitaxel|mesh-list
14062407|NCT02598687|Carboplatin|carboplatin|mesh-list
14062408|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14062409|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062410|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
14062411|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
14062412|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
14062413|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062414|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
14062415|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062416|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062417|NCT02598466|Abatacept|abatacept|mesh-list
14062418|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14062419|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062420|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062421|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062422|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
14062423|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062424|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062425|NCT02598427|Trastuzumab|trastuzumab|mesh-list
14062426|NCT02598427|Pertuzumab|pertuzumab|mesh-list
14062427|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14062428|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062429|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
14062430|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
14062431|NCT02598414|Protective Agents|protective agents|mesh-ancestor
14062432|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062433|NCT02598440|Alendronate|alendronate|mesh-list
14062434|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
14062435|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062436|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062437|NCT02598310|Paclitaxel|paclitaxel|mesh-list
14062438|NCT02598310|Trastuzumab|trastuzumab|mesh-list
14062439|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14062440|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062441|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14062442|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14062443|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14062444|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062445|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14062446|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
14062447|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14062448|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062449|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14062450|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14062451|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062452|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062453|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062454|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14062455|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14062456|NCT02598102|Diclofenac|diclofenac|mesh-list
14062457|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14062458|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14062459|NCT02598102|Analgesics|analgesics|mesh-ancestor
14062460|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
14062461|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062462|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062463|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14062464|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062465|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14062466|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062467|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062468|NCT02597998|BI 409306|bi 409306|mesh-list
14062469|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14062470|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062471|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062472|NCT02598063|Lamivudine|lamivudine|mesh-list
14062473|NCT02598063|Adefovir|adefovir|mesh-list
14062474|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14062475|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14062476|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14062477|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14062478|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062479|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062480|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
14062481|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062482|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14062483|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14062484|NCT02598011|Flucytosine|flucytosine|mesh-list
14062485|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
14062486|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062487|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
14062488|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062489|NCT02597868|Capecitabine|capecitabine|mesh-list
14062490|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14062491|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
14062492|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062493|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062494|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
14062495|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062496|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
14062497|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062498|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062499|NCT02597699|Lidocaine|lidocaine|mesh-list
14062500|NCT02597699|Sufentanil|sufentanil|mesh-list
14062501|NCT02597699|Remifentanil|remifentanil|mesh-list
14062502|NCT02597699|Dsuvia|dsuvia|mesh-list
14062503|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
14062504|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
14062505|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062506|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062507|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
14062508|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062509|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14062510|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14062511|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14062512|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062513|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062514|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14062515|NCT02597699|Narcotics|narcotics|mesh-ancestor
14062516|NCT02597699|Analgesics|analgesics|mesh-ancestor
14062517|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14062518|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14062519|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
14062520|NCT02597556|Albendazole|albendazole|mesh-list
14062521|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
14062522|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14062523|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062524|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
14062525|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14062526|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14062527|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14062528|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14062529|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14062530|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062531|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171916|NCT04816097|Dexamethasone|dexamethasone|mesh-list
14171917|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14171918|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14171919|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
14171920|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
14171921|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171922|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171923|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14171924|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
14171925|NCT04816097|Hormones|hormones|mesh-ancestor
14171926|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171927|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14171928|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171929|NCT04816240|Midodrine|midodrine|mesh-list
14171930|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
14171931|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
14171932|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171933|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171934|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14171935|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14171936|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14171937|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14171938|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171939|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171940|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171941|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
14171942|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14171943|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171944|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171945|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14171946|NCT04815265|Analgesics|analgesics|mesh-ancestor
14171947|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
14171948|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171949|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14171950|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14171951|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14171952|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
14171953|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14171954|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171955|NCT04815408|Paclitaxel|paclitaxel|mesh-list
14171956|NCT04815408|Carboplatin|carboplatin|mesh-list
14171957|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14171958|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14171959|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171960|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14171961|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14171962|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14171963|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171964|NCT04815395|Oxytocin|oxytocin|mesh-list
14171965|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
14171966|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14171967|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171968|NCT04815187|Montelukast|montelukast|mesh-list
14171969|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14171970|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
14062532|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
14062533|NCT02597387|Analgesics|analgesics|mesh-ancestor
14062534|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
14062535|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062536|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062537|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476050|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476051|NCT02411578|Glucagon|glucagon|mesh-list
14476052|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14476053|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476054|NCT02411578|Hormones|hormones|mesh-ancestor
14476055|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476056|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062538|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14062539|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14062540|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062541|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062542|NCT02597400|Metformin|metformin|mesh-list
14062543|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14758073|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14758074|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14758075|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
14758076|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14758077|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14758078|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14758079|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14062544|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062545|NCT02597361|Irbesartan|irbesartan|mesh-list
14062546|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14062547|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14062548|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14062549|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062550|NCT02597283|Sirolimus|sirolimus|mesh-list
14062551|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14062552|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062553|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14062554|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062555|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
14062556|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062557|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
14062558|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062559|NCT02597231|Melatonin|melatonin|mesh-list
14062560|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
14062561|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062562|NCT02597231|Protective Agents|protective agents|mesh-ancestor
14062563|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062564|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062565|NCT02597309|Canagliflozin|canagliflozin|mesh-list
14062566|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14062567|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062568|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14062569|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062570|NCT02597114|Insulin|insulin|mesh-list
14062571|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14062572|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14062573|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062574|NCT02597257|Lidocaine|lidocaine|mesh-list
14062575|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
14062576|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
14062577|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062578|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062579|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
14062580|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062581|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14062582|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14062583|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14062584|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062585|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062586|NCT02597140|Lidocaine|lidocaine|mesh-list
14062587|NCT02597140|Propofol|propofol|mesh-list
14062588|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
14476057|NCT02411578|Incretins|incretins|mesh-ancestor
14758080|NCT05320627|Edoxaban|edoxaban|mesh-list
14062589|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
14062590|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062591|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062592|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
14062593|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062594|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14062595|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14062596|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14062597|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062598|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062599|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14062600|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14062601|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
14062602|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
14062603|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14062604|NCT02597166|Ledipasvir|ledipasvir|mesh-list
14062605|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
14062606|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062607|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
14062608|NCT02597153|Analgesics|analgesics|mesh-ancestor
14062609|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
14062610|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062611|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062612|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062613|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14062614|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14062615|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062616|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062617|NCT02596984|Caspofungin|caspofungin|mesh-list
14062618|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
14062619|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062620|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062621|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062622|NCT02597322|Axitinib|axitinib|mesh-list
14062623|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062624|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14062625|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062626|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062627|NCT02597036|Paclitaxel|paclitaxel|mesh-list
14062628|NCT02597036|Ramucirumab|ramucirumab|mesh-list
14062629|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14062630|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062631|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
14062632|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
14062633|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
14062634|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062635|NCT02596880|Ribavirin|ribavirin|mesh-list
14062636|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
14062637|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
14062638|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062639|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
14062640|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062641|NCT02596828|Sirolimus|sirolimus|mesh-list
14062642|NCT02596828|Irinotecan|irinotecan|mesh-list
14062643|NCT02596828|Temozolomide|temozolomide|mesh-list
14062644|NCT02596828|Dasatinib|dasatinib|mesh-list
14062645|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14062646|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14062647|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062648|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062649|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062650|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14062651|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
14062652|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14062653|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062654|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14062655|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
14062656|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062657|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
14062658|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062659|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14062660|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
14062661|NCT02596776|Propranolol|propranolol|mesh-list
14062662|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14062663|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14062664|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
14062665|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062666|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062667|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062668|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14062669|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14062670|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14062671|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062672|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14062673|NCT02596776|Protective Agents|protective agents|mesh-ancestor
14062674|NCT02596763|Baclofen|baclofen|mesh-list
14062675|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14062676|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062677|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14062678|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062679|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14062680|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
14062681|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
14062682|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062683|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062684|NCT02596685|Nicotine|nicotine|mesh-list
14062685|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14062686|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
14062687|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062688|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062689|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14062690|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14062691|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
14062692|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062693|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062694|NCT02596555|Dabigatran|dabigatran|mesh-list
14062695|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
14062696|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14062697|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
14062698|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062699|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062700|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
14062701|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
14062702|NCT02596373|Analgesics|analgesics|mesh-ancestor
14062703|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
14062704|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062705|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062706|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062707|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14062708|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14062709|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062710|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062711|NCT02596282|Anesthetics|anesthetics|mesh-list
14062712|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062713|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062714|NCT02596334|Lamivudine|lamivudine|mesh-list
14062715|NCT02596334|Abacavir|abacavir|mesh-list
14062716|NCT02596334|Dolutegravir|dolutegravir|mesh-list
14062717|NCT02596334|Triumeq|triumeq|mesh-list
14062718|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14062719|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14062720|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062721|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062722|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
14062723|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062724|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14062725|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14062726|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14062727|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14062728|NCT02596100|Betrixaban|betrixaban|mesh-list
14062729|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14062730|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
14062731|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14062732|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
14062733|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062734|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062735|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
14062736|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14062737|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
14062738|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062739|NCT02596243|Vaccines|vaccines|mesh-list
14062740|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
14062741|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062742|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14062743|NCT02596269|Nefopam|nefopam|mesh-list
14062744|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14062745|NCT02596269|Analgesics|analgesics|mesh-ancestor
14062746|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
14062747|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062748|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062749|NCT02596256|Docetaxel|docetaxel|mesh-list
14062750|NCT02596256|Apatinib|apatinib|mesh-list
14062751|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062752|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14062753|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14062754|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14062755|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062756|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14062757|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062758|NCT02595801|Anesthetics|anesthetics|mesh-list
14062759|NCT02595801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062760|NCT02595801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062761|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
14062762|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14062763|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062764|NCT02595918|Nivolumab|nivolumab|mesh-list
14062765|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14062766|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062767|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14062768|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062769|NCT02595840|Pemetrexed|pemetrexed|mesh-list
14062770|NCT02595840|Afatinib|afatinib|mesh-list
14062771|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062772|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062773|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062774|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14062775|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14062776|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14171971|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14171972|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
14171973|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14171974|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171975|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14171976|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14171977|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171978|NCT04815200|Copper|copper|mesh-list
14171979|NCT04815200|Nickel|nickel|mesh-list
14171980|NCT04815200|Trace Elements|trace elements|mesh-ancestor
14171981|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
14171982|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171983|NCT04814875|Carboplatin|carboplatin|mesh-list
14171984|NCT04814875|Doxorubicin|doxorubicin|mesh-list
14171985|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14171986|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14171987|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14171988|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14171989|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14171990|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14171991|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14171992|NCT04814537|Bupivacaine|bupivacaine|mesh-list
14171993|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
14171994|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
14171995|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14171996|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14171997|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
14171998|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14171999|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
14172000|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
14172001|NCT04814615|Daratumumab|daratumumab|mesh-list
14172002|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172003|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14172004|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14172005|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
14172006|NCT04814303|Morphine|morphine|mesh-list
14172007|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14172008|NCT04814303|Narcotics|narcotics|mesh-ancestor
14062777|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
14062778|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14062779|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
14062780|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062781|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
14062782|NCT02595606|Protective Agents|protective agents|mesh-ancestor
14062783|NCT02595554|Paclitaxel|paclitaxel|mesh-list
14062784|NCT02595554|Cisplatin|cisplatin|mesh-list
14062785|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14062786|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062787|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
14062788|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
14062789|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
14062790|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062791|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
14062792|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
14062793|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14062794|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14062795|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062796|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062797|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062798|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062799|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
14062800|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14062801|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062802|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14062803|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14062804|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062805|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062806|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062807|NCT02595463|Lidocaine|lidocaine|mesh-list
14062808|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
14062809|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
14062810|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062811|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062812|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
14062813|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062814|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14062815|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14062816|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14062817|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062818|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062819|NCT02595476|Remifentanil|remifentanil|mesh-list
14062820|NCT02595476|Propofol|propofol|mesh-list
14062821|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14062822|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062823|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062824|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14062825|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
13913837|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
13913838|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
13913839|NCT03484507|Prednisolone|prednisolone|mesh-list
13913840|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13913841|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
13913842|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13913843|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
13913844|NCT03484507|Povidone|povidone|mesh-list
13913845|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13913846|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
13913847|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913848|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
13913849|NCT03484507|Hormones|hormones|mesh-ancestor
13913850|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913851|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913852|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13913853|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913854|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
13913855|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
13913856|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913857|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913858|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14062826|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
14062827|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14062828|NCT02595476|Narcotics|narcotics|mesh-ancestor
14062829|NCT02595476|Analgesics|analgesics|mesh-ancestor
13913859|NCT03484507|Protective Agents|protective agents|mesh-ancestor
14062830|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
14062831|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758081|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14758082|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
14758083|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14758084|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
14758085|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758086|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758087|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
14758088|NCT05319093|Ozanimod|ozanimod|mesh-list
14758089|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14758090|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758091|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758092|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
14476058|NCT02411591|Necitumumab|necitumumab|mesh-list
14476059|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758093|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758094|NCT05315271|Ketamine|ketamine|mesh-list
14758095|NCT05315271|Bupivacaine|bupivacaine|mesh-list
14758096|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
14758097|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
14758098|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758099|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758100|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
14758101|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933872|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933873|NCT01452737|Bisacodyl|bisacodyl|mesh-list
14933874|NCT01452737|Cathartics|cathartics|mesh-ancestor
14933875|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933876|NCT01452737|Laxatives|laxatives|mesh-ancestor
14933877|NCT01452750|Lansoprazole|lansoprazole|mesh-list
14062832|NCT02595541|Milrinone|milrinone|mesh-list
14062833|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
14062834|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
14062835|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14062836|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14062837|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062838|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062839|NCT02595541|Urological Agents|urological agents|mesh-ancestor
14062840|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14062841|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14062842|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14062843|NCT02595541|Protective Agents|protective agents|mesh-ancestor
14062844|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062845|NCT02595489|Vitamin D|vitamin d|mesh-list
14062846|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
14062847|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
14062848|NCT02595489|Vitamins|vitamins|mesh-list
14062849|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
14062850|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062851|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062852|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062853|NCT02595268|Pitavastatin|pitavastatin|mesh-list
14062854|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14062855|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14062856|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14062857|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
14062858|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062859|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062860|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14062861|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14062862|NCT02595190|Gabapentin|gabapentin|mesh-list
14062863|NCT02595190|Tramadol|tramadol|mesh-list
14062864|NCT02595190|Analgesics|analgesics|mesh-ancestor
14062865|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
14062866|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062867|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062868|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
14062869|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14476060|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476061|NCT02411916|Misoprostol|misoprostol|mesh-list
14476062|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14476063|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
14476064|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14476065|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476066|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14062870|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14062871|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14062872|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14062873|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14062874|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14062875|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062876|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062877|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
14062878|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14062879|NCT02595190|Narcotics|narcotics|mesh-ancestor
14062880|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
14062881|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062882|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062883|NCT02595242|Prednisone|prednisone|mesh-list
14062884|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
14062885|NCT02595242|Vincristine|vincristine|mesh-list
14062886|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062887|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
14062888|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062889|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062890|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14062891|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
14062892|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062893|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062894|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14062895|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14062896|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
14062897|NCT02595242|Hormones|hormones|mesh-ancestor
14062898|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14062899|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14062900|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14062901|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
14062902|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
14062903|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
14062904|NCT02595034|Clindamycin|clindamycin|mesh-list
14062905|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
14062906|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
14062907|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14062908|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14933878|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
14933879|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14933880|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14933881|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14933882|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933883|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933884|NCT01452763|Lansoprazole|lansoprazole|mesh-list
14062909|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062910|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14062911|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062912|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062913|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14062914|NCT02594579|Vitamin D|vitamin d|mesh-list
14062915|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
14062916|NCT02594579|Vitamins|vitamins|mesh-ancestor
14062917|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
14062918|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062919|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14062920|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062921|NCT02594761|Trastuzumab|trastuzumab|mesh-list
14062922|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14062923|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062924|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14062925|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14062926|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14062927|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
14062928|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062929|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14062930|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14062931|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062932|NCT02594735|Abatacept|abatacept|mesh-list
14062933|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14062934|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062935|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933885|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
14062936|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14062937|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
14062938|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062939|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14062940|NCT02594358|Caffeine|caffeine|mesh-list
14062941|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14062942|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062943|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14062944|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14062945|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062946|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14062947|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14062948|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
14062949|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062950|NCT02594423|Bevacizumab|bevacizumab|mesh-list
14062951|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14062952|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062953|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14062954|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14062955|NCT02594423|Growth Substances|growth substances|mesh-ancestor
14062956|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062957|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14062958|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14062959|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
14062960|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14062961|NCT02594410|Lercanidipine|lercanidipine|mesh-list
14062962|NCT02594410|Clopidogrel|clopidogrel|mesh-list
14062963|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14062964|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14062965|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14062966|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14062967|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
14062968|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14062969|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14062970|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062971|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14062972|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14062973|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14062974|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14062975|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
14062976|NCT02594462|Etonogestrel|etonogestrel|mesh-list
14062977|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14062978|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062979|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14062980|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14062981|NCT02594241|Prednisolone|prednisolone|mesh-list
14758102|NCT05315271|Analgesics|analgesics|mesh-ancestor
14062982|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14062983|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
14062984|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14062985|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
14062986|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14062987|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
14062988|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14062989|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
14062990|NCT02594241|Hormones|hormones|mesh-ancestor
14062991|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14062992|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14062993|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14062994|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14062995|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
14062996|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
14062997|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14062998|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14062999|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14063000|NCT02594241|Protective Agents|protective agents|mesh-ancestor
14063001|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14063002|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14063003|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063004|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
14063005|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14063006|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063007|NCT02593942|Remifentanil|remifentanil|mesh-list
14063008|NCT02593942|Propofol|propofol|mesh-list
14063009|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14063010|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063011|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063012|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14063013|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
14063014|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
14063015|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14063016|NCT02593942|Narcotics|narcotics|mesh-ancestor
14063017|NCT02593942|Analgesics|analgesics|mesh-ancestor
14063018|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
14063019|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172009|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172010|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172011|NCT04814303|Analgesics|analgesics|mesh-ancestor
14172012|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
14172013|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183202|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
14183203|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
14183204|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
14183205|NCT04729556|Coagulants|coagulants|mesh-ancestor
14183206|NCT04729543|Azacitidine|azacitidine|mesh-list
14183207|NCT04729543|Interleukin-2|interleukin-2|mesh-list
14183208|NCT04729543|Valproic Acid|valproic acid|mesh-list
14183209|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14183210|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
14183211|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183212|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183213|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183214|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183215|NCT04729543|Analgesics|analgesics|mesh-ancestor
14183216|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
14183217|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183218|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913860|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13913861|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913862|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
14183219|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
14183220|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
14183221|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183222|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
14183223|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14183224|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183225|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14183226|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
14183227|NCT04729868|Bupivacaine|bupivacaine|mesh-list
14183228|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
14183229|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
14183230|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
14183231|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183232|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183233|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
14183234|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183235|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14183236|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183237|NCT04729868|Analgesics|analgesics|mesh-ancestor
14183238|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14183239|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14183240|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14183241|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183242|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183243|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183244|NCT04729465|Propofol|propofol|mesh-list
14183245|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13913863|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
13913864|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
13913865|NCT03484416|Vitamin D|vitamin d|mesh-list
13913866|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
13913867|NCT03484416|Calcium|calcium|mesh-list
13913868|NCT03484416|Vitamins|vitamins|mesh-ancestor
13913869|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
13913870|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913871|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13913872|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13913873|NCT03484416|Antacids|antacids|mesh-ancestor
14183246|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913874|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183247|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063020|NCT02594072|Goserelin|goserelin|mesh-list
14063021|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063022|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063023|NCT02593968|Interferons|interferons|mesh-list
14063024|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063025|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
14063026|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063027|NCT02593747|Loratadine|loratadine|mesh-list
14063028|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
14063029|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
14063030|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14063031|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14063032|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14063033|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
14063034|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
14063035|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063036|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063037|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063038|NCT02593734|Olanzapine|olanzapine|mesh-list
14063039|NCT02593734|Risperidone|risperidone|mesh-list
14063040|NCT02593734|Fluoxetine|fluoxetine|mesh-list
14063041|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14063042|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
14063043|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063044|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063045|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063046|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14063047|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14063048|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063049|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14063050|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14063051|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
14063052|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
14063053|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
14063054|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063055|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063056|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14063057|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14063058|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063059|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14063060|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
14063061|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14063062|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14063063|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063064|NCT02593708|Paclitaxel|paclitaxel|mesh-list
14063065|NCT02593708|Trastuzumab|trastuzumab|mesh-list
14063066|NCT02593708|Pertuzumab|pertuzumab|mesh-list
14063067|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14063068|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063069|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14063070|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14063071|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14063072|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063073|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14063074|NCT02593695|Fluoxetine|fluoxetine|mesh-list
14063075|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14063076|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14063077|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063078|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063079|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063080|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
14063081|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063082|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14063083|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
14063084|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14063085|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14063086|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14063087|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063088|NCT02593721|Ibuprofen|ibuprofen|mesh-list
14063089|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14063090|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14063091|NCT02593721|Analgesics|analgesics|mesh-ancestor
14063092|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
14063093|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063094|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063095|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063096|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14063097|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14063098|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063099|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063100|NCT02593526|Bumetanide|bumetanide|mesh-list
14063101|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
14063102|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14063103|NCT02593526|Diuretics|diuretics|mesh-ancestor
14063104|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
14063105|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063106|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14063107|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063108|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063109|NCT02593643|Midazolam|midazolam|mesh-list
14063110|NCT02593643|Ketamine|ketamine|mesh-list
14063111|NCT02593643|Analgesics|analgesics|mesh-ancestor
14063112|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
14063113|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063114|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063115|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14063116|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14063117|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
14063118|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
14063119|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063120|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14063121|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14063122|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063123|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063124|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14063125|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14063126|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14063127|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14063128|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14063129|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
14063130|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
14063131|NCT02593669|Dexamethasone|dexamethasone|mesh-list
14063132|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063133|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
14063134|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
14063135|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063136|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063137|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063138|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
14063139|NCT02593669|Hormones|hormones|mesh-ancestor
14063140|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063141|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063142|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063143|NCT02593500|Budesonide|budesonide|mesh-list
14063144|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063145|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14063146|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
14063147|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063148|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063149|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14063150|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
14063151|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
14063152|NCT02593500|Hormones|hormones|mesh-ancestor
14063153|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063154|NCT02593383|Clindamycin|clindamycin|mesh-list
14063155|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
14063156|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
14063157|NCT02593383|Adapalene|adapalene|mesh-list
14063158|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14063159|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063160|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14063161|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063162|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063163|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14063164|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14063165|NCT02593383|Analgesics|analgesics|mesh-ancestor
14063166|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
14063167|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063168|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063169|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063170|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14063171|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
14063172|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14063173|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14063174|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14063175|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063176|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063177|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
14063178|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063179|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14063180|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14063181|NCT02593474|Naltrexone|naltrexone|mesh-list
14063182|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14063183|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14063184|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933886|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14063185|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
14063186|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063187|NCT02593448|Anesthetics|anesthetics|mesh-list
14063188|NCT02593448|Propofol|propofol|mesh-list
14063189|NCT02593448|Sevoflurane|sevoflurane|mesh-list
14063190|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063191|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063192|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14063193|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14063194|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
14063195|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14063196|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13913875|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913876|NCT03484299|Gemcitabine|gemcitabine|mesh-list
13913877|NCT03484299|Folfirinox|folfirinox|mesh-list
13913878|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913879|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
13913880|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063197|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14063198|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14063199|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14063200|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
14063201|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063202|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14172014|NCT04814511|Permethrin|permethrin|mesh-list
14758103|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14758104|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14758105|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
14758106|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14758107|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14758108|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758109|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913881|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913882|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
13913883|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913884|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913885|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913886|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
13913887|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913888|NCT03484260|Testosterone|testosterone|mesh-list
13913889|NCT03484260|Androgens|androgens|mesh-ancestor
13913890|NCT03484260|Hormones|hormones|mesh-ancestor
13913891|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913892|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063203|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14063204|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063205|NCT02593370|Lidocaine|lidocaine|mesh-list
14063206|NCT02593370|Epinephrine|epinephrine|mesh-list
14063207|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14063208|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
14063209|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
14063210|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063211|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063212|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
14063213|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063214|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14063215|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14063216|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14063217|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063218|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063219|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14063220|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14476067|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476068|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
14476069|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
14063221|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
14063222|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063223|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14063224|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14063225|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
14063226|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14063227|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
14063228|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
14063229|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
14063230|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14063231|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
14063232|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
14063233|NCT02593019|Adavosertib|adavosertib|mesh-list
14063234|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063235|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063236|NCT02593162|Ribavirin|ribavirin|mesh-list
14063237|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
14063238|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063239|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
14063240|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063241|NCT02592980|Warfarin|warfarin|mesh-list
14063242|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
14063243|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14063244|NCT02593201|Cefazolin|cefazolin|mesh-list
14063245|NCT02593201|Ceftazidime|ceftazidime|mesh-list
14063246|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14063247|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063248|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
14063249|NCT02592941|Deflazacort|deflazacort|mesh-list
14063250|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063251|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14063252|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
14063253|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063254|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
14063255|NCT02593227|Vaccines|vaccines|mesh-list
14063256|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
14063257|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063258|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14063259|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14063260|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14063261|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
14063262|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063263|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063264|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14063265|NCT02593110|Telmisartan|telmisartan|mesh-list
14063266|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14063267|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14063268|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14063269|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063270|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
14063271|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14063272|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063273|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758110|NCT05314660|Fluorides|fluorides|mesh-list
14063274|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14063275|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14063276|NCT02592863|Protective Agents|protective agents|mesh-ancestor
14063277|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063278|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
14063279|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14063280|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
14063281|NCT02592772|Menthol|menthol|mesh-list
14063282|NCT02592772|Nicotine|nicotine|mesh-list
14063283|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14063284|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
14063285|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063286|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063287|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14063288|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14063289|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
14063290|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063291|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063292|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
14063293|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
14063294|NCT02592915|Clonidine|clonidine|mesh-list
14063295|NCT02592915|Anesthetics|anesthetics|mesh-list
14063296|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063297|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063298|NCT02592915|Analgesics|analgesics|mesh-ancestor
14063299|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
14063300|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063301|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14063302|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
14063303|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
14063304|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14063305|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14063306|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14063307|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
14063308|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063309|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063310|NCT02592720|Tenecteplase|tenecteplase|mesh-list
14063311|NCT02592720|Tirofiban|tirofiban|mesh-list
14063312|NCT02592720|Bivalirudin|bivalirudin|mesh-list
14063313|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
14063314|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14063315|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
14063316|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063317|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063318|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
14063319|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14063320|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14063321|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14063322|NCT02592746|Capecitabine|capecitabine|mesh-list
14063323|NCT02592746|Palbociclib|palbociclib|mesh-list
14063324|NCT02592746|Leuprolide|leuprolide|mesh-list
14063325|NCT02592746|Exemestane|exemestane|mesh-list
14063326|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14063327|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
14063328|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063329|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063330|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14063331|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063332|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14063333|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
14063334|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14063335|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063336|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063337|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14063338|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14063339|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14063340|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
14063341|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063342|NCT02592694|Tenecteplase|tenecteplase|mesh-list
14063343|NCT02592694|Tirofiban|tirofiban|mesh-list
14063344|NCT02592694|Bivalirudin|bivalirudin|mesh-list
14063345|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
14063346|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14063347|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14063348|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063349|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063350|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
14063351|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14063352|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14063353|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14063354|NCT02592226|Anesthetics|anesthetics|mesh-list
14063355|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063356|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063357|NCT02592395|Folfirinox|folfirinox|mesh-list
14063358|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172015|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172016|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172017|NCT04814485|Paclitaxel|paclitaxel|mesh-list
14172018|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14172019|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14172020|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172021|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
14172022|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
14172023|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
14172024|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172025|NCT04814043|Lenvatinib|lenvatinib|mesh-list
14172026|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14172027|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172028|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14172029|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172030|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172031|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14172032|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172033|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172034|NCT04814589|Ezetimibe|ezetimibe|mesh-list
14172035|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14172036|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14172037|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
14172038|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172039|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14172040|NCT04813913|Bevacizumab|bevacizumab|mesh-list
14172041|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14172042|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172043|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14172044|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14172045|NCT04813913|Growth Substances|growth substances|mesh-ancestor
14172046|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172047|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
14172048|NCT04813952|Sevoflurane|sevoflurane|mesh-list
14172049|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14172050|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14172051|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
14172052|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
14172053|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172054|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172055|NCT04814056|Afatinib|afatinib|mesh-list
14172056|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172057|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14172058|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172059|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172060|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
14172061|NCT04814381|Ketamine|ketamine|mesh-list
14172062|NCT04814381|Analgesics|analgesics|mesh-ancestor
14172063|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
14172064|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172065|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172066|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14172067|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14172068|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
14172069|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
14172070|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172071|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14172072|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14172073|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172074|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172075|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14172076|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
14172077|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14172078|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14172079|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14063359|NCT02592278|Listerine|listerine|mesh-list
14063360|NCT02592278|Fluorides|fluorides|mesh-list
14063361|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
14063362|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
14063363|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
14063364|NCT02592278|Protective Agents|protective agents|mesh-ancestor
14063365|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063366|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14063367|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063368|NCT02592083|Tamoxifen|tamoxifen|mesh-list
14063369|NCT02592083|Goserelin|goserelin|mesh-list
14063370|NCT02592083|Palbociclib|palbociclib|mesh-list
14063371|NCT02592083|Exemestane|exemestane|mesh-list
14063372|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14063373|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14063374|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
14063375|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063376|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063377|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063378|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063379|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14063380|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14063381|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14063382|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14063383|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063384|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063385|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14063386|NCT02592122|Bromides|bromides|mesh-list
14063387|NCT02592122|Albuterol|albuterol|mesh-list
14063388|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
14063389|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14063390|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
14063391|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063392|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063393|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14063394|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
14063395|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
14063396|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14063397|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14063398|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14063399|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14063400|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
14063401|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063402|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063403|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
14063404|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14063405|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14063406|NCT02591953|Prednisolone|prednisolone|mesh-list
14063407|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
14063408|NCT02591953|Lidocaine|lidocaine|mesh-list
14063409|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14063410|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
14063411|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
14063412|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
14063413|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063414|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063415|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
14063416|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063417|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14063418|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14063419|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14063420|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063421|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063422|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063423|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
14063424|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
14063425|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063426|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
14063427|NCT02591953|Hormones|hormones|mesh-ancestor
14063428|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063429|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14063430|NCT02591953|Protective Agents|protective agents|mesh-ancestor
14063431|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063432|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063433|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
14063434|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
14063435|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
14063436|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14063437|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063438|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
14063439|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14063440|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14063441|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14063442|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063443|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063444|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063445|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14063446|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
14063447|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
14063448|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063449|NCT02591914|Bevacizumab|bevacizumab|mesh-list
14063450|NCT02591914|Ranibizumab|ranibizumab|mesh-list
14063451|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14063452|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063453|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14063454|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14063455|NCT02591914|Growth Substances|growth substances|mesh-ancestor
14063456|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063457|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
14063458|NCT02591927|Insulin|insulin|mesh-list
14063459|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14063460|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063461|NCT02591615|Paclitaxel|paclitaxel|mesh-list
14063462|NCT02591615|Carboplatin|carboplatin|mesh-list
14063463|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
14063464|NCT02591615|Pemetrexed|pemetrexed|mesh-list
14063465|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14063466|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063467|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14063468|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14063469|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14063470|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063471|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14063472|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063473|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14063474|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14063475|NCT02591888|Bupivacaine|bupivacaine|mesh-list
14063476|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
14063477|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
14063478|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063479|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913893|NCT03484221|Fluorouracil|fluorouracil|mesh-list
13913894|NCT03484221|Capecitabine|capecitabine|mesh-list
13913895|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
13913896|NCT03484221|Irinotecan|irinotecan|mesh-list
13913897|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
13913898|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913899|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913900|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913901|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913902|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
13913903|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913904|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13913905|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14063480|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
14063481|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063482|NCT02591771|Epinephrine|epinephrine|mesh-list
14063483|NCT02591771|Racepinephrine|racepinephrine|mesh-list
14063484|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
14063485|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14063486|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14063487|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
14063488|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063489|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063490|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063491|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14063492|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14063493|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
14063494|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063495|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14063496|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
14063497|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
14063498|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
14063499|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14063500|NCT02591836|Atorvastatin|atorvastatin|mesh-list
14063501|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14063502|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14063503|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
14063504|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063505|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14063506|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14063507|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063508|NCT02591849|Glucagon|glucagon|mesh-list
14063509|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14063510|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063511|NCT02591849|Hormones|hormones|mesh-ancestor
14063512|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063513|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063514|NCT02591849|Incretins|incretins|mesh-ancestor
14063515|NCT02591667|Bevacizumab|bevacizumab|mesh-list
14063516|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14063517|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063518|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14063519|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14063520|NCT02591667|Growth Substances|growth substances|mesh-ancestor
14063521|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063522|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
14063523|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
14063524|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14063525|NCT02591628|Diuretics|diuretics|mesh-ancestor
14063526|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
14063527|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063528|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14063529|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063530|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063531|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14063532|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
14063533|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063534|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
14063535|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
14063536|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
14063537|NCT02591251|Povidone|povidone|mesh-list
14063538|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14063539|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
14063540|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
14063541|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14063542|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063543|NCT02590900|Acetaminophen|acetaminophen|mesh-list
14063544|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14063545|NCT02590900|Analgesics|analgesics|mesh-ancestor
14063546|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
14063547|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063548|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063549|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
14063550|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14063551|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
14063552|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
14063553|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14063554|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
14063555|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14063556|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14063557|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
14063558|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063559|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063560|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14063561|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14063562|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14063563|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063564|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063565|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063566|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063567|NCT02590874|Analgesics|analgesics|mesh-ancestor
14063568|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
14063569|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063570|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
14063571|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14063572|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
14063573|NCT02591017|Ketamine|ketamine|mesh-list
14063574|NCT02591017|Morphine|morphine|mesh-list
14063575|NCT02591017|Chitosan|chitosan|mesh-list
14063576|NCT02591017|Analgesics|analgesics|mesh-ancestor
14063577|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
14063578|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063579|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063580|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14063581|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14063582|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
14063583|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
14063584|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063585|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14063586|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14063587|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063588|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063589|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14063590|NCT02591017|Narcotics|narcotics|mesh-ancestor
14063591|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14063592|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14063593|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
14063594|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13913906|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913907|NCT03484195|Fluorouracil|fluorouracil|mesh-list
13913908|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
13913909|NCT03484195|Irinotecan|irinotecan|mesh-list
13913910|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
13913911|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913912|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913913|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913914|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913915|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
13913916|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913917|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13913918|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13913919|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913920|NCT03484091|Hylan|hylan|mesh-list
13913921|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
13913922|NCT03484091|Protective Agents|protective agents|mesh-ancestor
13913923|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913924|NCT03483948|Azacitidine|azacitidine|mesh-list
14063595|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
14063596|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
14063597|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
14063598|NCT02591017|Coagulants|coagulants|mesh-ancestor
14063599|NCT02591095|Navitoclax|navitoclax|mesh-list
14063600|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063601|NCT02591004|Nifedipine|nifedipine|mesh-list
14063602|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14063603|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063604|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063605|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14063606|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063607|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
14063608|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
14063609|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14172080|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
14172081|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14172082|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
14172083|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14172084|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
14172085|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
14172086|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172087|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172088|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14172089|NCT04813874|Analgesics|analgesics|mesh-ancestor
14172090|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
14172091|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172092|NCT04813848|Fluorides|fluorides|mesh-list
14172093|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
14172094|NCT04813848|Protective Agents|protective agents|mesh-ancestor
14172095|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172096|NCT04813523|Cisplatin|cisplatin|mesh-list
14172097|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
14172098|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172099|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14172100|NCT04813471|Folic Acid|folic acid|mesh-list
14172101|NCT04813471|Nicorandil|nicorandil|mesh-list
14172102|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
14172103|NCT04813471|Atorvastatin|atorvastatin|mesh-list
14172104|NCT04813471|Vitamins|vitamins|mesh-ancestor
14172105|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
14172106|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172107|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14172108|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14172109|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
14758111|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
14758112|NCT05314660|Protective Agents|protective agents|mesh-ancestor
14758113|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767278|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14767279|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14767280|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
14767281|NCT00629343|Temozolomide|temozolomide|mesh-list
14767282|NCT00629343|Azacitidine|azacitidine|mesh-list
14767283|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14767284|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
14767285|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767286|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767287|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14767288|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
14767289|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767290|NCT00629382|Polymyxins|polymyxins|mesh-list
14172110|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172111|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14767291|NCT00629382|Polymyxin B|polymyxin b|mesh-list
14172112|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14172113|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172114|NCT04813471|Hematinics|hematinics|mesh-ancestor
14172115|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14172116|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14172117|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
14172118|NCT04813653|Cyclosporine|cyclosporine|mesh-list
14172119|NCT04813653|Dexamethasone|dexamethasone|mesh-list
14172120|NCT04813653|Cyclosporins|cyclosporins|mesh-list
14767292|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14767293|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172121|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172122|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
14172123|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
14172124|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063610|NCT02590653|Atorvastatin|atorvastatin|mesh-list
14063611|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14063612|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14063613|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
14063614|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063615|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14063616|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14063617|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063618|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
14063619|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063620|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
14063621|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14063622|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14063623|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063624|NCT02590536|Urological Agents|urological agents|mesh-ancestor
14063625|NCT02590705|Lidocaine|lidocaine|mesh-list
14063626|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
14063627|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
14063628|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063629|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063630|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
14063631|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063632|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14063633|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14063634|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14063635|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063636|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758114|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14758115|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14758116|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14758117|NCT05307003|Trazodone|trazodone|mesh-list
14758118|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
14758119|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14758120|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14758121|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14758122|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063646|NCT02590601|Bromocriptine|bromocriptine|mesh-list
14063647|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14063648|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14063649|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
14063650|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063651|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063652|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
14063653|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
14063654|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063655|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063656|NCT02590627|Lumefantrine|lumefantrine|mesh-list
14063657|NCT02590627|Artemether|artemether|mesh-list
14758123|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758124|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14758125|NCT05307003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14758126|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14758127|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14758128|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758129|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758130|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
14758131|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14063658|NCT02590627|Piperaquine|piperaquine|mesh-list
14063659|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14063660|NCT02590627|Artenimol|artenimol|mesh-list
14063661|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
14063662|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14063663|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14063664|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063665|NCT02590614|Vitamin D|vitamin d|mesh-list
14063666|NCT02590614|Vitamins|vitamins|mesh-ancestor
14063667|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
14063668|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063669|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14063670|NCT02590510|Methotrexate|methotrexate|mesh-list
14063671|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14063672|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
14063673|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14063674|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063675|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14063676|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
14063677|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063678|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063679|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
14063680|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063681|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14063682|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14063683|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
14063684|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14063685|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14063686|NCT02590263|Temozolomide|temozolomide|mesh-list
14063687|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14063688|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
14063689|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063690|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063691|NCT02590224|Glycine|glycine|mesh-list
14063692|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
14063693|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063694|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063695|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063696|NCT02590133|Fluorouracil|fluorouracil|mesh-list
14063697|NCT02590133|Endostar protein|endostar protein|mesh-list
14063698|NCT02590133|Endostatins|endostatins|mesh-list
14063699|NCT02590133|Nedaplatin|nedaplatin|mesh-list
14063700|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
14063701|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063702|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14063703|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063704|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14063705|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
14063706|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063707|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14063708|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14063709|NCT02590133|Growth Substances|growth substances|mesh-ancestor
14063710|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
14063711|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
14063712|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14063713|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14063714|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14063715|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14063716|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063717|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
14063718|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063719|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063720|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14063721|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063722|NCT02590055|Gemcitabine|gemcitabine|mesh-list
14063723|NCT02590055|Docetaxel|docetaxel|mesh-list
14063724|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14063725|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
14063726|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063727|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063728|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
14063729|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063730|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063731|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14063732|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
14063733|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063734|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14063735|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14063736|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14063737|NCT02590016|Insulin|insulin|mesh-list
14063738|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
14063739|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14063740|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063741|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
14063742|NCT02589782|Linezolid|linezolid|mesh-list
14063743|NCT02589782|Bedaquiline|bedaquiline|mesh-list
14063744|NCT02589782|Clofazimine|clofazimine|mesh-list
14063745|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14063746|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063747|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14063748|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14063749|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063750|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063751|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063752|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14063753|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
14063754|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063755|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
14063756|NCT02589717|Atezolizumab|atezolizumab|mesh-list
14063757|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063758|NCT02589457|Tenofovir|tenofovir|mesh-list
14063759|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
14063760|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063761|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14063762|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14063763|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063764|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063765|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14063766|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14063767|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
14063768|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14063769|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063770|NCT02589444|Vitamin D|vitamin d|mesh-list
14063771|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
14063772|NCT02589444|Vitamins|vitamins|mesh-ancestor
14063773|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
14063774|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063775|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14063776|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14063777|NCT02589678|Vaccines|vaccines|mesh-list
14063778|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
14063779|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063780|NCT02589652|Interferons|interferons|mesh-list
14063781|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
14063782|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
14063783|NCT02589652|Entecavir|entecavir|mesh-list
14063784|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14063785|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063786|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
14063787|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063788|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
14063789|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063790|NCT02589340|Buspirone|buspirone|mesh-list
14063791|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14063792|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14063793|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063794|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063795|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14063796|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14063797|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
14063798|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063799|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063800|NCT02589288|Ropivacaine|ropivacaine|mesh-list
14063801|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
14063802|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
14063803|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063804|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063805|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
14063806|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063807|NCT02589041|Ropivacaine|ropivacaine|mesh-list
14063808|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
14063809|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
14063810|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063811|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063812|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
14063813|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172125|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172126|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172127|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
14172128|NCT04813653|Hormones|hormones|mesh-ancestor
14172129|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172130|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14172131|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172132|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172133|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172134|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172135|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
14063814|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14063815|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
14063816|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063817|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14063818|NCT02589158|Darunavir|darunavir|mesh-list
14063819|NCT02589158|Cobicistat|cobicistat|mesh-list
14063820|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14063821|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14063822|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
14063823|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063824|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063825|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14063826|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14063827|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
14063828|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063829|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14063830|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14063831|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
14063832|NCT02588755|Tegafur|tegafur|mesh-list
14063833|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14063834|NCT02588755|Estrogens|estrogens|mesh-ancestor
14063835|NCT02588755|Hormones|hormones|mesh-ancestor
14063836|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063837|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758132|NCT05306340|Dexamethasone|dexamethasone|mesh-list
14758133|NCT05306340|Everolimus|everolimus|mesh-list
14758134|NCT05306340|Exemestane|exemestane|mesh-list
14758135|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14758136|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
14758137|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
14758138|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758139|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758140|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063838|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063839|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063840|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14063841|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
14063842|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063843|NCT02588781|Pemetrexed|pemetrexed|mesh-list
14063844|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063845|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063846|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063847|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14063848|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14063849|NCT02588937|Entecavir|entecavir|mesh-list
14063850|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
14063851|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063852|NCT02588534|Etanercept|etanercept|mesh-list
14063853|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14063854|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14063855|NCT02588534|Analgesics|analgesics|mesh-ancestor
14063856|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
14063857|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063858|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063859|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063860|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14063861|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063862|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14063863|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
14063864|NCT02588547|Granisetron|granisetron|mesh-list
14063865|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
14063866|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
14063867|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063868|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063869|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063870|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14063871|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
14063872|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14063873|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063874|NCT02588443|Gemcitabine|gemcitabine|mesh-list
14063875|NCT02588443|Paclitaxel|paclitaxel|mesh-list
14063876|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14063877|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758141|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
14063878|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
14758142|NCT05306340|Hormones|hormones|mesh-ancestor
14758143|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063879|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
14063880|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
14063881|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063882|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14063883|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
14063884|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
14063885|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063886|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063887|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14063888|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
14063889|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063890|NCT02588742|Melatonin|melatonin|mesh-list
14063891|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
14063892|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063893|NCT02588742|Protective Agents|protective agents|mesh-ancestor
14063894|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063895|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063896|NCT02588716|Terlipressin|terlipressin|mesh-list
14063897|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14063898|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14063899|NCT02588417|Dexamethasone|dexamethasone|mesh-list
14063900|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
14063901|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063902|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
14063903|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
14063904|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063905|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063906|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14063907|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
14063908|NCT02588417|Hormones|hormones|mesh-ancestor
14063909|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063910|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063911|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063912|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
14063913|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
14063914|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063915|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
14063916|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14063917|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063918|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063919|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
14063920|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14063921|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
14063922|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14063923|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063924|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14063925|NCT02588287|Tenofovir|tenofovir|mesh-list
14063926|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
14063927|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14063928|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14063929|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14063930|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063931|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063932|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14063933|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14063934|NCT02588235|Atorvastatin|atorvastatin|mesh-list
14063935|NCT02588235|Ezetimibe|ezetimibe|mesh-list
14063936|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14063937|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14063938|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
14063939|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063940|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14063941|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14063942|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063943|NCT02588196|Dexamethasone|dexamethasone|mesh-list
14063944|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
14063945|NCT02588196|BB 1101|bb 1101|mesh-list
14063946|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063947|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
14063948|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
14063949|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063950|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758144|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063951|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758145|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063952|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
14063953|NCT02588196|Hormones|hormones|mesh-ancestor
14063954|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14063955|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14063956|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063957|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
14063958|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063959|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063960|NCT02588131|Durvalumab|durvalumab|mesh-list
14063961|NCT02588131|Tremelimumab|tremelimumab|mesh-list
14063962|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14063963|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063964|NCT02588118|Propofol|propofol|mesh-list
14063965|NCT02588118|Cisatracurium|cisatracurium|mesh-list
14063966|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14063967|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14063968|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063969|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14063970|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
14063971|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
14063972|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14063973|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14063974|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063975|NCT02588027|Ibuprofen|ibuprofen|mesh-list
14063976|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14063977|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14063978|NCT02588027|Analgesics|analgesics|mesh-ancestor
14063979|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
14063980|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14063981|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14063982|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14063983|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14063984|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14063985|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063986|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063987|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
14758146|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758147|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
14063988|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14063989|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14063990|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758148|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14758149|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14758150|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14063991|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
14063992|NCT02587845|Coagulants|coagulants|mesh-ancestor
14063993|NCT02587871|Cytarabine|cytarabine|mesh-list
14063994|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14063995|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
14063996|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14063997|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14063998|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
14063999|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064000|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064001|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
14064002|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064003|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
14064004|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14064005|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064006|NCT02587533|Dopamine|dopamine|mesh-list
14064007|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14064008|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
14064009|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
14064010|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064011|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064012|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
14064013|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064014|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064015|NCT02587533|Protective Agents|protective agents|mesh-ancestor
14064016|NCT02587312|Nicotine|nicotine|mesh-list
14064017|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14064018|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
14064019|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064020|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064021|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14064022|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14064023|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
14064024|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064025|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064026|NCT02587416|Atorvastatin|atorvastatin|mesh-list
14064027|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14064028|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14064029|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
14064030|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064031|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14064032|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14064033|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064034|NCT02587390|Simvastatin|simvastatin|mesh-list
14064035|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14064036|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14064037|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
14064038|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064039|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14064040|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14064041|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172136|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
14172137|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172138|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
14172139|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14172140|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14172141|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
14172142|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14172143|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172144|NCT04812470|Melphalan|melphalan|mesh-list
14172145|NCT04812470|Interleukin-2|interleukin-2|mesh-list
14933887|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172146|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14172147|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
14172148|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172149|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172150|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14172151|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172152|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
14172153|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172154|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14172155|NCT04812470|Analgesics|analgesics|mesh-ancestor
14933888|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14172156|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
14933889|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064042|NCT02587325|Sirolimus|sirolimus|mesh-list
14064043|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14064044|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064045|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14064046|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064047|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
14064048|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064049|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
14064050|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064051|NCT02587273|Fentanyl|fentanyl|mesh-list
14064052|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14064053|NCT02587273|Narcotics|narcotics|mesh-ancestor
14064054|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064055|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064056|NCT02587273|Analgesics|analgesics|mesh-ancestor
14064057|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
14064058|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064059|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14064060|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14064061|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
14064062|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
14064063|NCT02587260|Clopidogrel|clopidogrel|mesh-list
14064064|NCT02587260|Ticagrelor|ticagrelor|mesh-list
14064065|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14064066|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14064067|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14064068|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14064069|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14064070|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
14064071|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064072|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064073|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064074|NCT02587247|Antibodies|antibodies|mesh-list
14064075|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
14064076|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064077|NCT02587741|Metformin|metformin|mesh-list
14064078|NCT02587741|Acarbose|acarbose|mesh-list
14064079|NCT02587741|Gliclazide|gliclazide|mesh-list
14064080|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14064081|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064082|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064083|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14064084|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064085|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064086|NCT02587052|Tacrolimus|tacrolimus|mesh-list
14758151|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758152|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14758153|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
14767294|NCT00629447|Tinzaparin|tinzaparin|mesh-list
13913925|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913926|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
14064087|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064088|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
14064089|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064090|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14064091|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064092|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064093|NCT02587130|Ketamine|ketamine|mesh-list
14064094|NCT02587130|Analgesics|analgesics|mesh-ancestor
14064095|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
14064096|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064097|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064098|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14064099|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14064100|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
14064101|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
13913927|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913928|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913929|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913930|NCT03483883|Gemcitabine|gemcitabine|mesh-list
13913931|NCT03483883|Avelumab|avelumab|mesh-list
13913932|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13913933|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
14064102|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960015|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14064103|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14064104|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14064105|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064106|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064107|NCT02587195|Teriflunomide|teriflunomide|mesh-list
14064108|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14064109|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14064110|NCT02587195|Analgesics|analgesics|mesh-ancestor
14064111|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
14064112|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064113|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064114|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064115|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14064116|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064117|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
14064118|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
14064119|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14064120|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
14064121|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14064122|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064123|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14064124|NCT02587169|Doxorubicin|doxorubicin|mesh-list
14064125|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14064126|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14064127|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064128|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14064129|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14064130|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064131|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064132|NCT02586987|Durvalumab|durvalumab|mesh-list
14064133|NCT02586987|Tremelimumab|tremelimumab|mesh-list
14064134|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14064135|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064136|NCT02586961|Betamethasone|betamethasone|mesh-list
14064137|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
14064138|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14064139|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
14064140|NCT02586961|Epinephrine|epinephrine|mesh-list
14064141|NCT02586961|Racepinephrine|racepinephrine|mesh-list
14064142|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14064143|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
14064144|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064145|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
14064146|NCT02586961|Hormones|hormones|mesh-ancestor
14064147|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064148|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064149|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14064150|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064151|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14064152|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14064153|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064154|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064155|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064156|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14064157|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14064158|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
14064159|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064160|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
14064161|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
14064162|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14064163|NCT02586753|Paclitaxel|paclitaxel|mesh-list
14064164|NCT02586753|Cisplatin|cisplatin|mesh-list
14064165|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14064166|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064167|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
14064168|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
14064169|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
14064170|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064171|NCT02586649|Bromides|bromides|mesh-list
14064172|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
14064173|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14064174|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14064175|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
14064176|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064177|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064178|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14064179|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064180|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
14064181|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
14064182|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064183|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064184|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
14064185|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
14064186|NCT02586610|Capecitabine|capecitabine|mesh-list
14064187|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14064188|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064189|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14064190|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
14064191|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064192|NCT02586636|Metformin|metformin|mesh-list
14064193|NCT02586636|Omeprazole|omeprazole|mesh-list
14064194|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064195|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064196|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14064197|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064198|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14064199|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064200|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064201|NCT02586311|Amlodipine|amlodipine|mesh-list
14064202|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14064203|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14064204|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14064205|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064206|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14064207|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064208|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14064209|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
14064210|NCT02586402|Hematinics|hematinics|mesh-ancestor
14064211|NCT02586259|Budesonide|budesonide|mesh-list
14064212|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064213|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14064214|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
14064215|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064216|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064217|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14064218|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064219|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
14064220|NCT02586259|Hormones|hormones|mesh-ancestor
14064221|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064222|NCT02586441|Bromides|bromides|mesh-list
14064223|NCT02586441|Propofol|propofol|mesh-list
14064224|NCT02586441|Rocuronium|rocuronium|mesh-list
14064225|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14064226|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064227|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064228|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14064229|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
14064230|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
14064231|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
14064232|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14064233|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14064234|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14064235|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064236|NCT02586454|Morphine|morphine|mesh-list
14064237|NCT02586454|Ropivacaine|ropivacaine|mesh-list
14064238|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14064239|NCT02586454|Narcotics|narcotics|mesh-ancestor
14064240|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064241|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064242|NCT02586454|Analgesics|analgesics|mesh-ancestor
14064243|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
14064244|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064245|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
14064246|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
14064247|NCT02586363|Entecavir|entecavir|mesh-list
14064248|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
14064249|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064250|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
14064251|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064252|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
14064253|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064254|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14064255|NCT02586194|Peficitinib|peficitinib|mesh-list
14064256|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064257|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064258|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064259|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
14064260|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064261|NCT02586038|Thalidomide|thalidomide|mesh-list
14064262|NCT02586038|Dexamethasone|dexamethasone|mesh-list
14064263|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
14064264|NCT02586038|Ixazomib|ixazomib|mesh-list
14064265|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064266|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
14064267|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064268|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14064269|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14064270|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
14064271|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064272|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064273|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14064274|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064275|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
14064276|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
14064277|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064278|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064279|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
14064280|NCT02586038|Hormones|hormones|mesh-ancestor
14064281|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064282|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14064283|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
14064284|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14064285|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064286|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14064287|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14064288|NCT02586038|Growth Substances|growth substances|mesh-ancestor
14064289|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
14064290|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
14064291|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064292|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
14064293|NCT02586181|Vitamin D|vitamin d|mesh-list
14064294|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
14064295|NCT02586181|Vitamins|vitamins|mesh-list
14064296|NCT02586181|Folic Acid|folic acid|mesh-list
14064297|NCT02586181|Calcium|calcium|mesh-list
14064298|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
14064299|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064300|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14064301|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14064302|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
14064303|NCT02586181|Hematinics|hematinics|mesh-ancestor
14064304|NCT02586129|Metformin|metformin|mesh-list
14064305|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14064306|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064307|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064308|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14064309|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14064310|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
14064311|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064312|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14064313|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14064314|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064315|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
14064316|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
14064317|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14064318|NCT02586051|Antibodies|antibodies|mesh-list
14064319|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
14064320|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14064321|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
14064322|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064323|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14064324|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064325|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
14064326|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14064327|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14064328|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14064329|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14064330|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064331|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
14064332|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064333|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064334|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14064335|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476070|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14476071|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476072|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476073|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476074|NCT02412111|Ivacaftor|ivacaftor|mesh-list
14476075|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14758154|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14064336|NCT02585973|Cisplatin|cisplatin|mesh-list
14064337|NCT02585973|Adavosertib|adavosertib|mesh-list
14064338|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064339|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064340|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064341|NCT02585947|Tenofovir|tenofovir|mesh-list
14064342|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
14064343|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064344|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14064345|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14064346|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064347|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064348|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14064349|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14064350|NCT02585882|Fluorides|fluorides|mesh-list
14064351|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
14064352|NCT02585882|Protective Agents|protective agents|mesh-ancestor
14064353|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064354|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14064355|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14064356|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
14064357|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064358|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064359|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
14064360|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14064361|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064362|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064363|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064364|NCT02585791|Glycerol|glycerol|mesh-list
14064365|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14064366|NCT02585791|Protective Agents|protective agents|mesh-ancestor
14064367|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064368|NCT02585765|Pioglitazone|pioglitazone|mesh-list
14064369|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064370|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064371|NCT02585531|Dexamethasone|dexamethasone|mesh-list
14064372|NCT02585531|Epinephrine|epinephrine|mesh-list
14064373|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064374|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
14064375|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
14758155|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14064376|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064377|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064378|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064379|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
14064380|NCT02585531|Hormones|hormones|mesh-ancestor
14064381|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064382|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14064383|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064384|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14064385|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14064386|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064387|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064388|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064389|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14064390|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14064391|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14064392|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064393|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
14064394|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
14064395|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14064396|NCT02585570|Phenylephrine|phenylephrine|mesh-list
14064397|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
14064398|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14064399|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
14064400|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
14064401|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064402|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064403|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
14064404|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14064405|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
14064406|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064407|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14064408|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14064409|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14064410|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064411|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064412|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064413|NCT02585570|Protective Agents|protective agents|mesh-ancestor
14172157|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183248|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14183249|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
14183250|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
14183251|NCT04729491|Azithromycin|azithromycin|mesh-list
14183252|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
14183253|NCT04729491|Dutasteride|dutasteride|mesh-list
14183254|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14183255|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183256|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14183257|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14183258|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183259|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183260|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
14183261|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183262|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183263|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14183264|NCT04729322|Metronidazole|metronidazole|mesh-list
14183265|NCT04729322|Vancomycin|vancomycin|mesh-list
14183266|NCT04729322|Neomycin|neomycin|mesh-list
14183267|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
14183268|NCT04729322|Nivolumab|nivolumab|mesh-list
14183269|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14183270|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183271|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14183272|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183273|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183274|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14183275|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14183276|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14183277|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14183278|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183279|NCT04729517|Azelastine|azelastine|mesh-list
14183280|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14183281|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
14183282|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183283|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183284|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14183285|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064414|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
14064415|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
14064416|NCT02585479|Pirarubicin|pirarubicin|mesh-list
14064417|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14064418|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064419|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
14064420|NCT02585479|Coagulants|coagulants|mesh-ancestor
14064421|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
14064422|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
14064423|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064424|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14064425|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14064426|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14064427|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14476076|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476077|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064428|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064429|NCT02585258|Prednisolone|prednisolone|mesh-list
14064430|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064431|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
14064432|NCT02585258|Hormones|hormones|mesh-ancestor
14064433|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064434|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064435|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14064436|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064437|NCT02585401|Aflibercept|aflibercept|mesh-list
14064438|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14064439|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14064440|NCT02585401|Growth Substances|growth substances|mesh-ancestor
14064441|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064442|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
14064443|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064444|NCT02585388|Letrozole|letrozole|mesh-list
14064445|NCT02585388|Vinorelbine|vinorelbine|mesh-list
14064446|NCT02585388|Anastrozole|anastrozole|mesh-list
14064447|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064448|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14064449|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14064450|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064451|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064452|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14064453|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
14064454|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064455|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064456|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14064457|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
14064458|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
14064459|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
14064460|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14064461|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14064462|NCT02585141|Clindamycin|clindamycin|mesh-list
14064463|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
14064464|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
14064465|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064466|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14064467|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064468|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064469|NCT02585011|Epinephrine|epinephrine|mesh-list
14064470|NCT02585011|Ropivacaine|ropivacaine|mesh-list
14064471|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
14064472|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
14064473|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064474|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476078|NCT02412228|Dexamethasone|dexamethasone|mesh-list
14476079|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
14476080|NCT02412228|Ixazomib|ixazomib|mesh-list
14476081|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14476082|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
14476083|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476084|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14476085|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14476086|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
14476087|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476088|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064475|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
14064476|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064477|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14064478|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14064479|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064480|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064481|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064482|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14064483|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14064484|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
14064485|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14064486|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064487|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
14064488|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
14064489|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14064490|NCT02584920|Rituximab|rituximab|mesh-list
14064491|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14064492|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064493|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
14064494|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064495|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14064496|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
14064497|NCT02584881|Narcotics|narcotics|mesh-ancestor
14064498|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064499|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064500|NCT02584881|Analgesics|analgesics|mesh-ancestor
14064501|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
14064502|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064503|NCT02584816|Vaccines|vaccines|mesh-list
14064504|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
14064505|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064506|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
14064507|NCT02584751|Omeprazole|omeprazole|mesh-list
14064508|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14064509|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064510|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14064511|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064512|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064513|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14064514|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
14064515|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064516|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064517|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14064518|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064519|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14064520|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
14064521|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064522|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14064523|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
14064524|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
14064525|NCT02584751|Protective Agents|protective agents|mesh-ancestor
14064526|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
14064527|NCT02584738|Prednisolone|prednisolone|mesh-list
14064528|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
14064529|NCT02584738|Bromides|bromides|mesh-list
14064530|NCT02584738|Albuterol|albuterol|mesh-list
14064531|NCT02584738|Ipratropium|ipratropium|mesh-list
14064532|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064533|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
14064534|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
14064535|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064536|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064537|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064538|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
14064539|NCT02584738|Hormones|hormones|mesh-ancestor
14064540|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064541|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14064542|NCT02584738|Protective Agents|protective agents|mesh-ancestor
14064543|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14064544|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064545|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
14064546|NCT02584738|Analgesics|analgesics|mesh-ancestor
14064547|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
14064548|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
14064549|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064550|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14064551|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14064552|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14064553|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064554|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14064555|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
14064556|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14064557|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14064558|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14064559|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064560|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14064561|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14064562|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14064563|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064564|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064565|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14064566|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
14064567|NCT02584647|Sirolimus|sirolimus|mesh-list
14064568|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14064569|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064570|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14064571|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064572|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
14064573|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064574|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
14064575|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064576|NCT02584582|Liraglutide|liraglutide|mesh-list
14064577|NCT02584582|Exenatide|exenatide|mesh-list
14064578|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14933890|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933891|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
14933892|NCT01452828|Tedizolid|tedizolid|mesh-list
14933893|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
14933894|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14933895|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933896|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14933897|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933898|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933899|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
14933900|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14933901|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933902|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
14933903|NCT01452880|Remifentanil|remifentanil|mesh-list
14933904|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14064579|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064580|NCT02584582|Incretins|incretins|mesh-ancestor
14064581|NCT02584582|Hormones|hormones|mesh-ancestor
14064582|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064583|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14064584|NCT02584543|Vaccines|vaccines|mesh-list
14064585|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
14064586|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064587|NCT02584465|Tamoxifen|tamoxifen|mesh-list
14064588|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14064589|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
14064590|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064591|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064592|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14064593|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064594|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14064595|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14064596|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14064597|NCT02584400|Imidazole|imidazole|mesh-list
14064598|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064599|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064600|NCT02584335|Lidocaine|lidocaine|mesh-list
14064601|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14064602|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
14064603|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
14064604|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064605|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064606|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
14064607|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064608|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14064609|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14064610|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14064611|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14064612|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064613|NCT02584075|Metformin|metformin|mesh-list
14064614|NCT02584075|Exenatide|exenatide|mesh-list
14064615|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064616|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064617|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14064618|NCT02584075|Incretins|incretins|mesh-ancestor
14064619|NCT02584075|Hormones|hormones|mesh-ancestor
14064620|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064621|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14064622|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
14064623|NCT02584231|Coagulants|coagulants|mesh-ancestor
14064624|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14064625|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
14064626|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064627|NCT02584036|Vaccines|vaccines|mesh-list
14064628|NCT02584036|Immunologic Factors|immunologic factors|mesh-ancestor
14064629|NCT02584036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064630|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14064631|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
14064632|NCT02584153|Coagulants|coagulants|mesh-ancestor
14064633|NCT02584010|Silicon|silicon|mesh-list
14064634|NCT02584010|Trace Elements|trace elements|mesh-ancestor
14064635|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
14064636|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172158|NCT04812860|Tramadol|tramadol|mesh-list
14172159|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14172160|NCT04812860|Narcotics|narcotics|mesh-ancestor
14172161|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172162|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172163|NCT04812860|Analgesics|analgesics|mesh-ancestor
14172164|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
14172165|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172166|NCT04812379|Aripiprazole|aripiprazole|mesh-list
14172167|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
14172168|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14172169|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14172170|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14172171|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172172|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172173|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
14172174|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
14172175|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172176|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172177|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14172178|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14172179|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
14172180|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14172181|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14172182|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14172183|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14172184|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
14172185|NCT04812535|Vilobelimab|vilobelimab|mesh-list
14172186|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14172187|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172188|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14172189|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172190|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
14172191|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172192|NCT04812509|Denosumab|denosumab|mesh-list
14172193|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14172194|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172195|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
14172196|NCT04812028|Analgesics|analgesics|mesh-ancestor
14172197|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
14172198|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172199|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172200|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
14172201|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172202|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14172203|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
14064637|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14064638|NCT02583958|Laxatives|laxatives|mesh-ancestor
14064639|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064640|NCT02583854|Hemostatics|hemostatics|mesh-list
14064641|NCT02583854|Coagulants|coagulants|mesh-ancestor
14064642|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
14064643|NCT02583828|Letrozole|letrozole|mesh-list
14064644|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064645|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
14064646|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064647|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14064648|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14064649|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
14064650|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064651|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064652|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14064653|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14064654|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14064655|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064656|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14064657|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
14064658|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064659|NCT02583893|Cytarabine|cytarabine|mesh-list
14064660|NCT02583893|Sirolimus|sirolimus|mesh-list
14064661|NCT02583893|Etoposide|etoposide|mesh-list
14064662|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
14064663|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
14064664|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14064665|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064666|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14064667|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14064668|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064669|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064670|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14064671|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
14064672|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
14064673|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064674|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064675|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
14758167|NCT05295927|Prednisone|prednisone|mesh-list
14064676|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064677|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14064678|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14758168|NCT05295927|Prednisolone|prednisolone|mesh-list
14064679|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
14064680|NCT02583893|Analgesics|analgesics|mesh-ancestor
14064681|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
14064682|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064683|NCT02583698|Carvedilol|carvedilol|mesh-list
14064684|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14064685|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14064686|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064687|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064688|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064689|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064690|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14064691|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
14064692|NCT02583698|Protective Agents|protective agents|mesh-ancestor
14064693|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14064694|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14064695|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14064696|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
14064697|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14064698|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14064699|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
14064700|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14064701|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
14064702|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064703|NCT02583672|Expectorants|expectorants|mesh-ancestor
14064704|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
14064705|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14064706|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
14064707|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064708|NCT02583672|Protective Agents|protective agents|mesh-ancestor
14064709|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064710|NCT02583672|Antidotes|antidotes|mesh-ancestor
14064711|NCT02583594|Loratadine|loratadine|mesh-list
14064712|NCT02583594|Acyclovir|acyclovir|mesh-list
14064713|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
14064714|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
14064715|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14064716|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064717|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
14064718|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
14064719|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064720|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064721|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064722|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
14064723|NCT02583594|Hormones|hormones|mesh-ancestor
14064724|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064725|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14064726|NCT02583594|Protective Agents|protective agents|mesh-ancestor
14064727|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064728|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14064729|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
14064730|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064731|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
14064732|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
14064733|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14064734|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14064735|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14064736|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
14064737|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
14064738|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064739|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064740|NCT02583633|Nifedipine|nifedipine|mesh-list
14064741|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
14064742|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14064743|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14064744|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064745|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14064746|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064747|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
14064748|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
14064749|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14064750|NCT02583568|Bevacizumab|bevacizumab|mesh-list
14064751|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14064752|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064753|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13913934|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913935|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913936|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
13913937|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913938|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13913939|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13913940|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
13913941|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913942|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13913943|NCT03483870|Morphine|morphine|mesh-list
13913944|NCT03483870|Granisetron|granisetron|mesh-list
13913945|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13913946|NCT03483870|Narcotics|narcotics|mesh-ancestor
14064754|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14064755|NCT02583568|Growth Substances|growth substances|mesh-ancestor
14064756|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064757|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
14064758|NCT02583451|Lemborexant|lemborexant|mesh-list
14064759|NCT02583451|Zopiclone|zopiclone|mesh-list
14064760|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14064761|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064762|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064763|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14064764|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14064765|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064766|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064767|NCT02583464|Tenofovir|tenofovir|mesh-list
14064768|NCT02583464|Emtricitabine|emtricitabine|mesh-list
14064769|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
14064770|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064771|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14064772|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14064773|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064774|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064775|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14064776|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14064777|NCT02583438|Saxagliptin|saxagliptin|mesh-list
14064778|NCT02583438|Incretins|incretins|mesh-ancestor
14064779|NCT02583438|Hormones|hormones|mesh-ancestor
14064780|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064781|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064782|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14064783|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
14064784|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064785|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064786|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14064787|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14064788|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
14064789|NCT02583685|Ribavirin|ribavirin|mesh-list
14064790|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14064791|NCT02583685|Simeprevir|simeprevir|mesh-list
14064792|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
14064793|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064794|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
14064795|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064796|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
14064797|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064798|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
14064799|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064800|NCT02583516|Vemurafenib|vemurafenib|mesh-list
14064801|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064802|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14064803|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064804|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064805|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14064806|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14064807|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064808|NCT02582996|Acetaminophen|acetaminophen|mesh-list
14064809|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
14064810|NCT02582996|Metoclopramide|metoclopramide|mesh-list
14064811|NCT02582996|Caffeine|caffeine|mesh-list
14064812|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14064813|NCT02582996|Analgesics|analgesics|mesh-ancestor
13913947|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064814|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
14064815|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064816|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064817|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
14064818|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14064819|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14064820|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064821|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064822|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14064823|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14064824|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
14064825|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064826|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
14064827|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
14064828|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064829|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14758169|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
14758170|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13913948|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913949|NCT03483870|Analgesics|analgesics|mesh-ancestor
13913950|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
13913951|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913952|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
13913953|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
13913954|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13913955|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13913956|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
13913957|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913958|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913959|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
13913960|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13913961|NCT03483753|Vasopressins|vasopressins|mesh-list
13913962|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
13913963|NCT03483753|Norepinephrine|norepinephrine|mesh-list
13913964|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13913965|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13913966|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
13913967|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913968|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913969|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913970|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
13913971|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
13913972|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13913973|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13913974|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
13913975|NCT03483753|Coagulants|coagulants|mesh-ancestor
13913976|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13913977|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
13913978|NCT03483649|Bevacizumab|bevacizumab|mesh-list
13913979|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13913980|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13913981|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13913982|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13913983|NCT03483649|Growth Substances|growth substances|mesh-ancestor
13913984|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913985|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
13913986|NCT03483636|Lemborexant|lemborexant|mesh-list
13913987|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13913988|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13913989|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13913990|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13913991|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13913992|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13913993|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913994|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13913995|NCT03483545|Hormones|hormones|mesh-ancestor
13913996|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13913997|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13913998|NCT03483415|Morphine|morphine|mesh-list
13913999|NCT03483415|Bupivacaine|bupivacaine|mesh-list
13914000|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
13914001|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
13914002|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914003|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064830|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14064831|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
14064832|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14064833|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
14933905|NCT01452880|Narcotics|narcotics|mesh-ancestor
14933906|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14933907|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933908|NCT01452880|Analgesics|analgesics|mesh-ancestor
14933909|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
14933910|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933911|NCT01452906|Omeprazole|omeprazole|mesh-list
14933912|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14933913|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476089|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14933914|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14933915|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064834|NCT02583217|Ketamine|ketamine|mesh-list
14064835|NCT02583217|Remifentanil|remifentanil|mesh-list
14064836|NCT02583217|Propofol|propofol|mesh-list
14064837|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14064838|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064839|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064840|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14064841|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
14476090|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476091|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
14476092|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
14064842|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
14064843|NCT02583217|Analgesics|analgesics|mesh-ancestor
14064844|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
14064845|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064846|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14064847|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14064848|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14064849|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064850|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064851|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14064852|NCT02583217|Narcotics|narcotics|mesh-ancestor
14064853|NCT02583243|Buprenorphine|buprenorphine|mesh-list
14064854|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14064855|NCT02583243|Narcotics|narcotics|mesh-ancestor
14064856|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064857|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064858|NCT02583243|Analgesics|analgesics|mesh-ancestor
14064859|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
14064860|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064861|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14064862|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
14064863|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14064864|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
14064865|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14064866|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
14064867|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064868|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064869|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
14064870|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14064871|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14064872|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064873|NCT02583282|Doxycycline|doxycycline|mesh-list
14064874|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14064875|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064876|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
14476093|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476094|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476095|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
14476096|NCT02412228|Hormones|hormones|mesh-ancestor
14476097|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476098|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476099|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
14933916|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933917|NCT01453062|Ofatumumab|ofatumumab|mesh-list
14933918|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064877|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14064878|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14064879|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
14064880|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14064881|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14064882|NCT02583022|Analgesics|analgesics|mesh-ancestor
14476100|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476101|NCT02412306|Blinatumomab|blinatumomab|mesh-list
14476102|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064883|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
14064884|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064885|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064886|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14064887|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14064888|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
14064889|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064890|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
14064891|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14064892|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14064893|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064894|NCT02582892|Vitamin D|vitamin d|mesh-list
14064895|NCT02582892|Vitamins|vitamins|mesh-ancestor
14064896|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
14064897|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064898|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14064899|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
14064900|NCT02582736|Haloperidol|haloperidol|mesh-list
14064901|NCT02582736|Pimozide|pimozide|mesh-list
14064902|NCT02582736|Olanzapine|olanzapine|mesh-list
14064903|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
14064904|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
14064905|NCT02582736|Risperidone|risperidone|mesh-list
14064906|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14064907|NCT02582736|Aripiprazole|aripiprazole|mesh-list
14064908|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14064909|NCT02582736|Ziprasidone|ziprasidone|mesh-list
14064910|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
14064911|NCT02582736|Clozapine|clozapine|mesh-list
14064912|NCT02582736|Loxapine|loxapine|mesh-list
14064913|NCT02582736|Perphenazine|perphenazine|mesh-list
14064914|NCT02582736|Fluphenazine|fluphenazine|mesh-list
14064915|NCT02582736|Flupenthixol|flupenthixol|mesh-list
14064916|NCT02582736|Thioridazine|thioridazine|mesh-list
14064917|NCT02582736|Clopenthixol|clopenthixol|mesh-list
14064918|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
14064919|NCT02582736|Fluspirilene|fluspirilene|mesh-list
14064920|NCT02582736|Thiothixene|thiothixene|mesh-list
14064921|NCT02582736|Mesoridazine|mesoridazine|mesh-list
14064922|NCT02582736|Chlormezanone|chlormezanone|mesh-list
14064923|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
14758171|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
14758172|NCT05295927|Hormones|hormones|mesh-ancestor
14758173|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14064924|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14064925|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
14064926|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064927|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064928|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064929|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14064930|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064931|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14064932|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14064933|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
14064934|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
14064935|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
14064936|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064937|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14064938|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14064939|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14064940|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14064941|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
14064942|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
14064943|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14064944|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14476103|NCT02412371|Paclitaxel|paclitaxel|mesh-list
14476104|NCT02412371|Carboplatin|carboplatin|mesh-list
14476105|NCT02412371|Veliparib|veliparib|mesh-list
14476106|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14476107|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476108|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
14476109|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
14476110|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
14476111|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064945|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14064946|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14064947|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14064948|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
14064949|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
14064950|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14758174|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758175|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14758176|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758177|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14758178|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758179|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758180|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
14758181|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14758182|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
14758183|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
14758184|NCT05293041|Coagulants|coagulants|mesh-ancestor
14758185|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14758186|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14758187|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
14758188|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758189|NCT05291325|Linaclotide|linaclotide|mesh-list
14933919|NCT01453088|Bortezomib|bortezomib|mesh-list
14064951|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064952|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14064953|NCT02582736|Analgesics|analgesics|mesh-ancestor
14064954|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
14064955|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14064956|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14064957|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14064958|NCT02582359|Cytarabine|cytarabine|mesh-list
14064959|NCT02582359|Daunorubicin|daunorubicin|mesh-list
14064960|NCT02582359|Ixazomib|ixazomib|mesh-list
14064961|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14064962|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
14064963|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064964|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14064965|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
14064966|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14064967|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14064968|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
14064969|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064970|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14064971|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14064972|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14064973|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933920|NCT01453088|Melphalan|melphalan|mesh-list
14933921|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933922|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14933923|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
14933924|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064974|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
14064975|NCT02582372|Fentanyl|fentanyl|mesh-list
14064976|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
14064977|NCT02582372|Bupivacaine|bupivacaine|mesh-list
14064978|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
14064979|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
14064980|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14064981|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14064982|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
14064983|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14064984|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14064985|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14064986|NCT02582372|Analgesics|analgesics|mesh-ancestor
14064987|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14064988|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14064989|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14064990|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
14064991|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14064992|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14064993|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14064994|NCT02582372|Narcotics|narcotics|mesh-ancestor
14064995|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14064996|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14064997|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
14064998|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
14064999|NCT02582437|Narcotics|narcotics|mesh-ancestor
14065000|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065001|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065002|NCT02582437|Analgesics|analgesics|mesh-ancestor
14065003|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
14065004|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065005|NCT02582307|Acetaminophen|acetaminophen|mesh-list
14065006|NCT02582307|Scopolamine|scopolamine|mesh-list
14065007|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
14065008|NCT02582307|Analgesics|analgesics|mesh-list
14065009|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14065010|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
14065011|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065012|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065013|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
14065014|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14065015|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
14065016|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
14065017|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065018|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
14065019|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14065020|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
14065021|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065022|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065023|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14065024|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
14065025|NCT02582476|Bumetanide|bumetanide|mesh-list
14065026|NCT02582476|Diuretics|diuretics|mesh-ancestor
14065027|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
14065028|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065029|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14065030|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14065031|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065032|NCT02582190|Colchicine|colchicine|mesh-list
14065033|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
14065034|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14065035|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
14065036|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
14065037|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
14065038|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065039|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172204|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14172205|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14172206|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172207|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14172208|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
14172209|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14172210|NCT04811573|Thalidomide|thalidomide|mesh-list
14172211|NCT04811573|Apremilast|apremilast|mesh-list
14172212|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14172213|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14172214|NCT04811573|Analgesics|analgesics|mesh-ancestor
14172215|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
14172216|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172217|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172218|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172219|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14172220|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14172221|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14172222|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172223|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172224|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172225|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
14172226|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
14172227|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14172228|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172229|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14172230|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14172231|NCT04811573|Growth Substances|growth substances|mesh-ancestor
14172232|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
14172233|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172234|NCT04811911|Methotrexate|methotrexate|mesh-list
14172235|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14172236|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
14767295|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
14065040|NCT02582177|Ketoconazole|ketoconazole|mesh-list
14065041|NCT02582177|Clotrimazole|clotrimazole|mesh-list
14065042|NCT02582177|Miconazole|miconazole|mesh-list
14065043|NCT02582177|Dexamethasone|dexamethasone|mesh-list
14065044|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
14065045|NCT02582177|Betamethasone|betamethasone|mesh-list
14065046|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
14065047|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14065048|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
14065049|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14065050|NCT02582177|BB 1101|bb 1101|mesh-list
14065051|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065052|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
14065053|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
14065054|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065055|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065056|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065057|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
14065058|NCT02582177|Hormones|hormones|mesh-ancestor
14065059|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065060|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14065061|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065062|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065063|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065064|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065065|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14065066|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
14065067|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
14065068|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065069|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14065070|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14065071|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14065072|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
14065073|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14065074|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14065075|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14065076|NCT02582203|Vancomycin|vancomycin|mesh-list
14065077|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14065078|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14065079|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065080|NCT02582047|Vaccines|vaccines|mesh-list
14065081|NCT02582047|Immunologic Factors|immunologic factors|mesh-ancestor
14065082|NCT02582047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065083|NCT02582099|Gentamicins|gentamicins|mesh-list
14065084|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14065085|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065086|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14065087|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065088|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065089|NCT02582008|Bupropion|bupropion|mesh-list
14065090|NCT02582008|Nicotine|nicotine|mesh-list
14065091|NCT02582008|Varenicline|varenicline|mesh-list
14065092|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14065093|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
14065094|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065095|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065096|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14065097|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14065098|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
14065099|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065100|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065101|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14065102|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
14065103|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14065104|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14065105|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14065106|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14065107|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
14065108|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14065109|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14065110|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065111|NCT02581969|Factor VIII|factor viii|mesh-list
14065112|NCT02581969|Coagulants|coagulants|mesh-ancestor
14065113|NCT02581982|Paclitaxel|paclitaxel|mesh-list
14065114|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
14065115|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14065116|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14065117|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065118|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
14065119|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
14065120|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
14065121|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065122|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065123|NCT02581943|Paclitaxel|paclitaxel|mesh-list
14065124|NCT02581943|Carboplatin|carboplatin|mesh-list
14065125|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
14065126|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14065127|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14065128|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065129|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
14065130|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
14065131|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
14065132|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065133|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065134|NCT02581826|Silodosin|silodosin|mesh-list
14065135|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14065136|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14065137|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14065138|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
14065139|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065140|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065141|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065142|NCT02581826|Urological Agents|urological agents|mesh-ancestor
14065143|NCT02581761|Misoprostol|misoprostol|mesh-list
14065144|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14065145|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
14065146|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14065147|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065148|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14065149|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065150|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
14065151|NCT02581696|Irsogladine|irsogladine|mesh-list
14065152|NCT02581696|Lafutidine|lafutidine|mesh-list
14065153|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065154|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14065155|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065156|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14065157|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
14065158|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
14065159|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065160|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065161|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065162|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14065163|NCT02581696|Protective Agents|protective agents|mesh-ancestor
14065164|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14065165|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
14065166|NCT02581683|Ropivacaine|ropivacaine|mesh-list
14065167|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
14065168|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
14065169|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065170|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065171|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
14065172|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933925|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14933926|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14933927|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
14933928|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065173|NCT02581683|Analgesics|analgesics|mesh-ancestor
14065174|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14065175|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
14065176|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14065177|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14065178|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065179|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14065180|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
14065181|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14065182|NCT02581748|Trastuzumab|trastuzumab|mesh-list
14065183|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065184|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933929|NCT01453101|Fludarabine|fludarabine|mesh-list
14933930|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
14933931|NCT01453101|Bortezomib|bortezomib|mesh-list
14933932|NCT01453101|Melphalan|melphalan|mesh-list
14065185|NCT02581553|Allopurinol|allopurinol|mesh-list
14065186|NCT02581553|Lesinurad|lesinurad|mesh-list
14065187|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
14065188|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065189|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065190|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
14065191|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14065192|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14065193|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
14065194|NCT02581553|Protective Agents|protective agents|mesh-ancestor
14065195|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065196|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
14065197|NCT02581553|Renal Agents|renal agents|mesh-ancestor
14065198|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
14065199|NCT02581566|Bupivacaine|bupivacaine|mesh-list
14065200|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
14065201|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
14065202|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065203|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065204|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
14065205|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065206|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14065207|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14065208|NCT02581566|Analgesics|analgesics|mesh-ancestor
14065209|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14065210|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14065211|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14065212|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
14065213|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065214|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065215|NCT02581527|Rifampin|rifampin|mesh-list
14065216|NCT02581527|Isoniazid|isoniazid|mesh-list
14065217|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
14065218|NCT02581527|Ethambutol|ethambutol|mesh-list
14065219|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14065220|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
14065221|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14065222|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065223|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
14065224|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14065225|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065226|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065227|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14065228|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14065229|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14065230|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14065231|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14933933|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933934|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14933935|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
14933936|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933937|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14933938|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
14933939|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933940|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13914004|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
13914005|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914006|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13914007|NCT03483415|Narcotics|narcotics|mesh-ancestor
13914008|NCT03483415|Analgesics|analgesics|mesh-ancestor
13914009|NCT03483389|Ethanol|ethanol|mesh-list
13914010|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13914011|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914012|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914013|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914014|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
13914015|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13914016|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13914017|NCT03483363|Bacitracin|bacitracin|mesh-list
13914018|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13914019|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933941|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
13914020|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
14065232|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14065233|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14065234|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14065235|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
14065236|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14065237|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
14065238|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14065239|NCT02581371|Protective Agents|protective agents|mesh-ancestor
14065240|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065241|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
14065242|NCT02581501|Gemcitabine|gemcitabine|mesh-list
14065243|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14065244|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14065245|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
14065246|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065247|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065248|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
14065249|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065250|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065251|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065252|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
14065253|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065254|NCT02581462|Trastuzumab|trastuzumab|mesh-list
14065255|NCT02581462|Pertuzumab|pertuzumab|mesh-list
14065256|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065257|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065258|NCT02581631|Nivolumab|nivolumab|mesh-list
14065259|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14065260|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065261|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065262|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14065263|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065264|NCT02581423|Capecitabine|capecitabine|mesh-list
14065265|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14065266|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
14065267|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065268|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065269|NCT02581124|Lapatinib|lapatinib|mesh-list
14065270|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065271|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14065272|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065273|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065274|NCT02581176|Apixaban|apixaban|mesh-list
14065275|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14065276|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
14065277|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14065278|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065279|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065280|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065281|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
14065282|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14065283|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14065284|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14065285|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065286|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065287|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14065288|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14065289|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065290|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
14065291|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065292|NCT02580968|Flunarizine|flunarizine|mesh-list
14065293|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
14065294|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14065295|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14065296|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065297|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14065298|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065299|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14065300|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
14065301|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
14065302|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065303|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
14065304|NCT02580994|Carboplatin|carboplatin|mesh-list
14065305|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
14065306|NCT02580994|Etoposide|etoposide|mesh-list
14065307|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065308|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065309|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14065310|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14065311|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14065312|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065313|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065314|NCT02581046|Dexamethasone|dexamethasone|mesh-list
14065315|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065316|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
14065317|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
14065318|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065319|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065320|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065321|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
14065322|NCT02581046|Hormones|hormones|mesh-ancestor
14065323|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758190|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14065324|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14065325|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065326|NCT02580773|Tinzaparin|tinzaparin|mesh-list
14065327|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
14758191|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
14758192|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065328|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14065329|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14065330|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065331|NCT02580604|Calcium|calcium|mesh-list
14065332|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14065333|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065334|NCT02580734|Melatonin|melatonin|mesh-list
14065335|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
14065336|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065337|NCT02580734|Protective Agents|protective agents|mesh-ancestor
14065338|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065339|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065340|NCT02580344|Ibuprofen|ibuprofen|mesh-list
14065341|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14065342|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14065343|NCT02580344|Analgesics|analgesics|mesh-ancestor
14065344|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
14065345|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065346|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065347|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065348|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14065349|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14065350|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065351|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065352|NCT02580448|Seviteronel|seviteronel|mesh-list
14065353|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065354|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14065355|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065356|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065357|NCT02580331|Metformin|metformin|mesh-list
14065358|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14065359|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172237|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14172238|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172239|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14172240|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
14172241|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172242|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172243|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
14172244|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172245|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14172246|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172247|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
14172248|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14172249|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14172250|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14172251|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
14172252|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065360|NCT02580474|Asunaprevir|asunaprevir|mesh-list
14065361|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065362|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065363|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065364|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
14065365|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14065366|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
14065367|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065368|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
14065369|NCT02580695|Protective Agents|protective agents|mesh-ancestor
14065370|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
14065371|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14065372|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14065373|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065374|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
14065375|NCT02580227|Coagulants|coagulants|mesh-ancestor
14065376|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
14065377|NCT02580006|Hematinics|hematinics|mesh-ancestor
14065378|NCT02580149|Clopidogrel|clopidogrel|mesh-list
14065379|NCT02580149|Ticagrelor|ticagrelor|mesh-list
14065380|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14065381|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14065382|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14065383|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14065384|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
14065385|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065386|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065387|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065388|NCT02579642|Ketamine|ketamine|mesh-list
14065389|NCT02579642|Analgesics|analgesics|mesh-ancestor
14065390|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
14065391|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065392|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065393|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14065394|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14065395|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
14065396|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
14065397|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065398|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14065399|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14065400|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065401|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065402|NCT02579902|Vitamin D|vitamin d|mesh-list
14065403|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
14065404|NCT02579902|Vitamins|vitamins|mesh-ancestor
14065405|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
14065406|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065407|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14065408|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14065409|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14065410|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
14065411|NCT02579590|Desogestrel|desogestrel|mesh-list
14065412|NCT02579590|Etonogestrel|etonogestrel|mesh-list
14065413|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14065414|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14065415|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14065416|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
14065417|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14065418|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065419|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14065420|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14065421|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14065422|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14065423|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065424|NCT02579590|Progestins|progestins|mesh-ancestor
14065425|NCT02579590|Hormones|hormones|mesh-ancestor
14065426|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065427|NCT02579564|Gemcitabine|gemcitabine|mesh-list
14065428|NCT02579564|Paclitaxel|paclitaxel|mesh-list
14065429|NCT02579564|Vinorelbine|vinorelbine|mesh-list
14065430|NCT02579564|Pemetrexed|pemetrexed|mesh-list
14065431|NCT02579564|Endostar protein|endostar protein|mesh-list
14065432|NCT02579564|Endostatins|endostatins|mesh-list
14065433|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14065434|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065435|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
14065436|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
14065437|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
14065438|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065439|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14065440|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
14065441|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
14065442|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065443|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065444|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065445|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
14065446|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065447|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14065448|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14065449|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14065450|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14065451|NCT02579564|Growth Substances|growth substances|mesh-ancestor
14065452|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
14065453|NCT02579707|Ivosidenib|ivosidenib|mesh-list
14065454|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065455|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065456|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065457|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14065458|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
14065459|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065460|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
14065461|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065462|NCT02579733|Azathioprine|azathioprine|mesh-list
14065463|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
14065464|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065465|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14065466|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065467|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065468|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
14065469|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065470|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14065471|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14065472|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14065473|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14065474|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
14065475|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065476|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065477|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14065478|NCT02579473|Rotigotine|rotigotine|mesh-list
14065479|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
14065480|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
14065481|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065482|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065483|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065484|NCT02579434|Midazolam|midazolam|mesh-list
14065485|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14065486|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14065487|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065488|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065489|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14065490|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14065491|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14065492|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14065493|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
14065494|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
14065495|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
14065496|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
14065497|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065498|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065499|NCT02579356|Telmisartan|telmisartan|mesh-list
14065500|NCT02579356|Atorvastatin|atorvastatin|mesh-list
14065501|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14065502|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14065503|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
14065504|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065505|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14065506|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14065507|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065508|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14065509|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14065510|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14065511|NCT02579187|Anesthetics|anesthetics|mesh-list
14065512|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065513|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065514|NCT02579161|Metronidazole|metronidazole|mesh-list
14065515|NCT02579161|Clindamycin|clindamycin|mesh-list
14065516|NCT02579161|Clindamycin palmitate|clindamycin palmitate|mesh-list
14065517|NCT02579161|Clindamycin phosphate|clindamycin phosphate|mesh-list
14065518|NCT02579161|Sulbactam|sulbactam|mesh-list
14065519|NCT02579161|Cephalosporins|cephalosporins|mesh-list
14065520|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
14065521|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065522|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14065523|NCT02579161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14065524|NCT02579161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14065525|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14065526|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065527|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065528|NCT02579161|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14065529|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14065530|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14065531|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14065532|NCT02579044|Everolimus|everolimus|mesh-list
14065533|NCT02579044|Lonafarnib|lonafarnib|mesh-list
14065534|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065535|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065536|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
14065537|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065538|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065539|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065540|NCT02578953|Dutasteride|dutasteride|mesh-list
14065541|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14065542|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14065543|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065544|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065545|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
14065546|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065547|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065548|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14065549|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14065550|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
14065551|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065552|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14065553|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14065554|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
14065555|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
14065556|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065557|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065558|NCT02578823|Antipyretics|antipyretics|mesh-list
14065559|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065560|NCT02578719|Bupivacaine|bupivacaine|mesh-list
14065561|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
14065562|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
14065563|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172253|NCT04811326|Latanoprost|latanoprost|mesh-list
14065564|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065565|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
14065566|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065567|NCT02578641|Gemcitabine|gemcitabine|mesh-list
14065568|NCT02578641|Carboplatin|carboplatin|mesh-list
14065569|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065570|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14065571|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
14065572|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065573|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
14065574|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065575|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065576|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065577|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
14065578|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065579|NCT02578602|Edetic Acid|edetic acid|mesh-list
14065580|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
14065581|NCT02578602|Antidotes|antidotes|mesh-ancestor
14065582|NCT02578602|Protective Agents|protective agents|mesh-ancestor
14065583|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065584|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
14065585|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
14065586|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065587|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14065588|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
14065589|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14172254|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14172255|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14172256|NCT04811209|Analgesics|analgesics|mesh-list
14172257|NCT04811209|Anesthetics|anesthetics|mesh-list
14172258|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172259|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172260|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
14172261|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172262|NCT04811313|Bupivacaine|bupivacaine|mesh-list
14172263|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
14476112|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14476113|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476114|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14476115|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
14476116|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14476117|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14476118|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14476119|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
14476120|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14476121|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476122|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14476123|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14476124|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14476125|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476126|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476127|NCT02412631|Varenicline|varenicline|mesh-list
14476128|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14476129|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14476130|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
14476131|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476132|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172264|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
14172265|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
14172266|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172267|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172268|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
14172269|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172270|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14172271|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14172272|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172273|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
14172274|NCT04811313|Coagulants|coagulants|mesh-ancestor
14172275|NCT04811014|Buprenorphine|buprenorphine|mesh-list
14172276|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14172277|NCT04811014|Naloxone|naloxone|mesh-list
14172278|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14172279|NCT04811014|Narcotics|narcotics|mesh-ancestor
14172280|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476133|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065590|NCT02578550|Tenofovir|tenofovir|mesh-list
14065591|NCT02578550|Emtricitabine|emtricitabine|mesh-list
14065592|NCT02578550|Darunavir|darunavir|mesh-list
14065593|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14065594|NCT02578550|Cobicistat|cobicistat|mesh-list
14065595|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14065596|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
14065597|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065598|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14065599|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14065600|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065601|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065602|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14065603|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14065604|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14065605|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14065606|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065607|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14065608|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14065609|NCT02578251|Acetaminophen|acetaminophen|mesh-list
14065610|NCT02578251|Meperidine|meperidine|mesh-list
14065611|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14065612|NCT02578251|Analgesics|analgesics|mesh-ancestor
14065613|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
14065614|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065615|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065616|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
14065617|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14065618|NCT02578251|Narcotics|narcotics|mesh-ancestor
14065619|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065620|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14065621|NCT02578277|BMS-955176|bms-955176|mesh-list
14065622|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14065623|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14065624|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
14065625|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065626|NCT02578537|Clopidogrel|clopidogrel|mesh-list
14065627|NCT02578537|Ticagrelor|ticagrelor|mesh-list
14065628|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14065629|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14065630|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14065631|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14065632|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
14065633|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065634|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065635|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065636|NCT02578472|Zolpidem|zolpidem|mesh-list
14065637|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14065638|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14065639|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065640|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065641|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14065642|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
14065643|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
14065644|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065645|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065646|NCT02578511|Ixazomib|ixazomib|mesh-list
14065647|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065648|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065649|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065650|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065651|NCT02578043|Clindamycin|clindamycin|mesh-list
14065652|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
14065653|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
14065654|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14065655|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14065656|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065657|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14065658|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065659|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065660|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
14065661|NCT02578108|Lidocaine|lidocaine|mesh-list
14065662|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
14065663|NCT02578108|Anesthetics|anesthetics|mesh-list
14476134|NCT02412644|Apremilast|apremilast|mesh-list
14476135|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14065664|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065665|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065666|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
14065667|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065668|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14065669|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14065670|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14065671|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14065672|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065673|NCT02577965|Everolimus|everolimus|mesh-list
14065674|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065675|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065676|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
14065677|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065678|NCT02578121|Dexamethasone|dexamethasone|mesh-list
14065679|NCT02578121|Pomalidomide|pomalidomide|mesh-list
14065680|NCT02578121|Ixazomib|ixazomib|mesh-list
14065681|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065682|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
14065683|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
14065684|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065685|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065686|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065687|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
14065688|NCT02578121|Hormones|hormones|mesh-ancestor
14065689|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065690|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14065691|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065692|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
14758193|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758194|NCT05282277|Raclopride|raclopride|mesh-list
14758195|NCT05282277|Estradiol|estradiol|mesh-list
14065693|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14065694|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14065695|NCT02578121|Growth Substances|growth substances|mesh-ancestor
14065696|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14065697|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065698|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065699|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065700|NCT02577848|Liraglutide|liraglutide|mesh-list
14065701|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14065702|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065703|NCT02577848|Incretins|incretins|mesh-ancestor
14065704|NCT02577848|Hormones|hormones|mesh-ancestor
14065705|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065706|NCT02577809|Indomethacin|indomethacin|mesh-list
14065707|NCT02577809|Fentanyl|fentanyl|mesh-list
14065708|NCT02577809|Morphine|morphine|mesh-list
14065709|NCT02577809|Bupivacaine|bupivacaine|mesh-list
14065710|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
14065711|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
14065712|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065713|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065714|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
14065715|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065716|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14065717|NCT02577809|Narcotics|narcotics|mesh-ancestor
14065718|NCT02577809|Analgesics|analgesics|mesh-ancestor
14065719|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14065720|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14065721|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
14065722|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14065723|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14065724|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065725|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14065726|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
14065727|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
14065728|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14065729|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14065730|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065731|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065732|NCT02577783|Dexamethasone|dexamethasone|mesh-list
14065733|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
14758196|NCT05282277|Progesterone|progesterone|mesh-list
14065734|NCT02577783|Doxorubicin|doxorubicin|mesh-list
14065735|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14758197|NCT05282277|Estrogens|estrogens|mesh-ancestor
14065736|NCT02577783|BB 1101|bb 1101|mesh-list
14065737|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065738|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
14065739|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
14065740|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065741|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065742|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065743|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
14065744|NCT02577783|Hormones|hormones|mesh-ancestor
14065745|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065746|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14065747|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065748|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065749|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065750|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065751|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14065752|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14065753|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14065754|NCT02577575|Oxytocin|oxytocin|mesh-list
14065755|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
14065756|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14065757|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065758|NCT02577614|Coagulants|coagulants|mesh-list
14065759|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14065760|NCT02577458|Everolimus|everolimus|mesh-list
14065761|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065762|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065763|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
14065764|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065765|NCT02577341|Docetaxel|docetaxel|mesh-list
14065766|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
14065767|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065768|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
14065769|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
14065770|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
14065771|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065772|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065773|NCT02577497|Fluticasone|fluticasone|mesh-list
14065774|NCT02577497|Beclomethasone|beclomethasone|mesh-list
14065775|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065776|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14065777|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
14065778|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065779|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065780|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14065781|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
14065782|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
14065783|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14065784|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
14065785|NCT02577497|Hormones|hormones|mesh-ancestor
14065786|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065787|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14065788|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
14065789|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065790|NCT02577393|Protective Agents|protective agents|mesh-ancestor
14065791|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065792|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14065793|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14065794|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065795|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14065796|NCT02577770|Caffeine|caffeine|mesh-list
14065797|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14065798|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065799|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14065800|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065801|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065802|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14065803|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14065804|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
14065805|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065806|NCT02577432|Fentanyl|fentanyl|mesh-list
14065807|NCT02577432|Bupivacaine|bupivacaine|mesh-list
14065808|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
14065809|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
14065810|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065811|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065812|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
14065813|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065814|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14065815|NCT02577432|Narcotics|narcotics|mesh-ancestor
14065816|NCT02577432|Analgesics|analgesics|mesh-ancestor
14065817|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14065818|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14065819|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
14065820|NCT02577250|Ketamine|ketamine|mesh-list
14065821|NCT02577250|Analgesics|analgesics|mesh-ancestor
14065822|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
14065823|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065824|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065825|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14065826|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14065827|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
14065828|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
14065829|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065830|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14065831|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14065832|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065833|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065834|NCT02577120|Decanoic acid|decanoic acid|mesh-list
14065835|NCT02577120|Petrolatum|petrolatum|mesh-list
14065836|NCT02577120|Emollients|emollients|mesh-ancestor
14065837|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
14065838|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
14065839|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065840|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
14065841|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14065842|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14065843|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14065844|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14065845|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065846|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
14065847|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065848|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065849|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14065850|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065851|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14065852|NCT02576964|Capecitabine|capecitabine|mesh-list
14065853|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14065854|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
14065855|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065856|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065857|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
14065858|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065859|NCT02576782|Dexamethasone|dexamethasone|mesh-list
14065860|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
14065861|NCT02576782|Bupivacaine|bupivacaine|mesh-list
14065862|NCT02576782|BB 1101|bb 1101|mesh-list
14065863|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065864|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
14065865|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
14065866|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065867|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065868|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14065869|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
14065870|NCT02576782|Hormones|hormones|mesh-ancestor
14065871|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065872|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14065873|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065874|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
14065875|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758198|NCT05282277|Hormones|hormones|mesh-ancestor
14065876|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065877|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
14065878|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
14065879|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065880|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
14065881|NCT02577094|Fludarabine|fludarabine|mesh-list
14065882|NCT02577094|Busulfan|busulfan|mesh-list
14065883|NCT02577094|Epratuzumab|epratuzumab|mesh-list
14065884|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
14065885|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065886|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065887|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065888|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
14065889|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065890|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
14065891|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14065892|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14065893|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065894|NCT02577068|Propacetamol|propacetamol|mesh-list
14065895|NCT02577068|Nefopam|nefopam|mesh-list
14065896|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14065897|NCT02577068|Analgesics|analgesics|mesh-ancestor
14065898|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
14065899|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065900|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065901|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14065902|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14065903|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14065904|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
14065905|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14065906|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065907|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14065908|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065909|NCT02576912|Dronabinol|dronabinol|mesh-list
14065910|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
14065911|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065912|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14065913|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14065914|NCT02576912|Analgesics|analgesics|mesh-ancestor
14065915|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
14065916|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065917|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14065918|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14065919|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065920|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065921|NCT02576912|Hormones|hormones|mesh-ancestor
14065922|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14065923|NCT02576808|Loratadine|loratadine|mesh-list
14065924|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
14065925|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
14065926|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13914021|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13914022|NCT03483350|Midazolam|midazolam|mesh-list
13914023|NCT03483350|Granisetron|granisetron|mesh-list
13914024|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13914025|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13914026|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914027|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914028|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13914029|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13914030|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13914031|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13914032|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
13914033|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
13914034|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
13914035|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
13914036|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914037|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914038|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
13914039|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
13914040|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914041|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914042|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13914043|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
13914044|NCT03483207|Heparin|heparin|mesh-list
14065927|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14065928|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14065929|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
14065930|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
14065931|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065932|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065933|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172281|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172282|NCT04811014|Analgesics|analgesics|mesh-ancestor
14172283|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
14172284|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172285|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14172286|NCT04811001|Osimertinib|osimertinib|mesh-list
14172287|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172288|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14172289|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172290|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172291|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
14172292|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14172293|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14172294|NCT04810819|Prednisolone|prednisolone|mesh-list
14172295|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
14172296|NCT04810819|Dyphylline|dyphylline|mesh-list
14172297|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14172298|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
14172299|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172300|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
14172301|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
14172302|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172303|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172304|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172305|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
14172306|NCT04810819|Hormones|hormones|mesh-ancestor
14172307|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172308|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14172309|NCT04810819|Protective Agents|protective agents|mesh-ancestor
14172310|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14172311|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172312|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14172313|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14172314|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
14172315|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14172316|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172317|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172318|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
14183286|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14183287|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183288|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183289|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14183290|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14183291|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14183292|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
14183293|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
14183294|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183295|NCT04729179|Cannabidiol|cannabidiol|mesh-list
14183296|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
14183297|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
14183298|NCT04729348|Lenvatinib|lenvatinib|mesh-list
14183299|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14183300|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183301|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14183302|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183303|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183304|NCT04729101|Lansoprazole|lansoprazole|mesh-list
14183305|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
14183306|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14183307|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183308|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14183309|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183310|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183311|NCT04728932|Simendan|simendan|mesh-list
14183312|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14183313|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
14183314|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14065934|NCT02576717|Ozanimod|ozanimod|mesh-list
14065935|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14065936|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065937|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14065938|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
14065939|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065940|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
14065941|NCT02576626|Albuterol|albuterol|mesh-list
14065942|NCT02576626|Ipratropium|ipratropium|mesh-list
14065943|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14065944|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
14065945|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065946|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065947|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14065948|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
14065949|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
14065950|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14065951|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14065952|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14065953|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14065954|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
14065955|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14065956|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065957|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14065958|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14933942|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14933943|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
14065959|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14065960|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
14065961|NCT02576665|Flucytosine|flucytosine|mesh-list
14065962|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
14065963|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14065964|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
14065965|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065966|NCT02576600|Remifentanil|remifentanil|mesh-list
14065967|NCT02576600|Propofol|propofol|mesh-list
14065968|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14065969|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065970|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065971|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14065972|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
14065973|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
14065974|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14065975|NCT02576600|Narcotics|narcotics|mesh-ancestor
14065976|NCT02576600|Analgesics|analgesics|mesh-ancestor
14065977|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
14065978|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065979|NCT02576457|BMS-936559|bms-936559|mesh-list
14065980|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14065981|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065982|NCT02576444|Olaparib|olaparib|mesh-list
14065983|NCT02576444|Adavosertib|adavosertib|mesh-list
14065984|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14065985|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14065986|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14065987|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14065988|NCT02576353|Fentanyl|fentanyl|mesh-list
14065989|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14065990|NCT02576353|Narcotics|narcotics|mesh-ancestor
14933944|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14065991|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14065992|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14065993|NCT02576353|Analgesics|analgesics|mesh-ancestor
14065994|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
14065995|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14065996|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14065997|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14065998|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
13914045|NCT03483207|Warfarin|warfarin|mesh-list
13914046|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
13914047|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13914048|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13914049|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914050|NCT03483181|Enoxaparin|enoxaparin|mesh-list
13914051|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
13914052|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14065999|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
14066000|NCT02576340|Octylonium|octylonium|mesh-list
14066001|NCT02576340|Bromides|bromides|mesh-list
14066002|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
14066003|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14066004|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14066005|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066006|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14066007|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066008|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14066009|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
14066010|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
14066011|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066012|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14066013|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14066014|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
14066015|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066016|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
14066017|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14066018|NCT02576314|Ledipasvir|ledipasvir|mesh-list
14066019|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
14066020|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476136|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14476137|NCT02412644|Analgesics|analgesics|mesh-ancestor
14476138|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
14476139|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476140|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476141|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476142|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14476143|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14476144|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14476145|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476146|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476147|NCT02412657|Dexamethasone|dexamethasone|mesh-list
14066021|NCT02576301|Cytarabine|cytarabine|mesh-list
14066022|NCT02576301|Combretastatin|combretastatin|mesh-list
14066023|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14066024|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
14066025|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066026|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066027|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
14066028|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066029|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066030|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
14066031|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066032|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14066033|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
14066034|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
14066035|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
14066036|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14066037|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14066038|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066039|NCT02576288|Incretins|incretins|mesh-ancestor
14066040|NCT02576288|Hormones|hormones|mesh-ancestor
14066041|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066042|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14066043|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
14066044|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066045|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066046|NCT02576275|Rituximab|rituximab|mesh-list
14066047|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14066048|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14066049|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066050|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
14066051|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066052|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14066053|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14066054|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
14066055|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066056|NCT02576223|Ropivacaine|ropivacaine|mesh-list
14066057|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
14066058|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
14066059|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066060|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066061|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
14066062|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066063|NCT02576366|Rifampin|rifampin|mesh-list
14066064|NCT02576366|Voriconazole|voriconazole|mesh-list
14066065|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14066066|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
14066067|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066068|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066069|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
14066070|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14066071|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066072|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066073|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14066074|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14066075|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14066076|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14066077|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14066078|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14066079|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
14066080|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14066081|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14066082|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14066083|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
14066084|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066085|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066086|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14066087|NCT02576327|Dexamethasone|dexamethasone|mesh-list
14066088|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
14066089|NCT02576327|Aprepitant|aprepitant|mesh-list
14066090|NCT02576327|Tropisetron|tropisetron|mesh-list
14066091|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14066092|NCT02576327|BB 1101|bb 1101|mesh-list
14066093|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066094|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
14066095|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
14066096|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066097|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066098|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14066099|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
14066100|NCT02576327|Hormones|hormones|mesh-ancestor
14066101|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066102|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14066103|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066104|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
14066105|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066106|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066107|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14066108|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066109|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14066110|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14066111|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
14066112|NCT02576015|Lidocaine|lidocaine|mesh-list
14066113|NCT02576015|Ropivacaine|ropivacaine|mesh-list
14066114|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
14066115|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
14066116|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066117|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066118|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
14066119|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066120|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14066121|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14066122|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14066123|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14066124|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066125|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
14066126|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066127|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14066128|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066129|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066130|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
14066131|NCT02576119|BMS-955176|bms-955176|mesh-list
14066132|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066133|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066134|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14066135|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14066136|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066137|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066138|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066139|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14066140|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14066141|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
14066142|NCT02575924|Imidacloprid|imidacloprid|mesh-list
14066143|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
14066144|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066145|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066146|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066147|NCT02575859|Cisplatin|cisplatin|mesh-list
14066148|NCT02575859|Mitomycins|mitomycins|mesh-list
14066149|NCT02575859|Mitomycin|mitomycin|mesh-list
14066150|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066151|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14066152|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
14066153|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066154|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14066155|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066156|NCT02575885|Nicotine|nicotine|mesh-list
14066157|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14066158|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
14066159|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066160|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066161|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14066162|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14066163|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
14066164|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066165|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066166|NCT02575768|Adenosine|adenosine|mesh-list
14066167|NCT02575768|Analgesics|analgesics|mesh-ancestor
14066168|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
14066169|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066170|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066171|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14066172|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
14066173|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14066174|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
14066175|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
14066176|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066177|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066178|NCT02575755|Azithromycin|azithromycin|mesh-list
14066179|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
14066180|NCT02575755|Piperaquine|piperaquine|mesh-list
14066181|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
14066182|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14066183|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066184|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066185|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
14066186|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14066187|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14066188|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14066189|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066190|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066191|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14066192|NCT02575755|Renal Agents|renal agents|mesh-ancestor
14066193|NCT02575729|Betamethasone|betamethasone|mesh-list
14066194|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
14066195|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066196|NCT02575729|Hormones|hormones|mesh-ancestor
14066197|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066198|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066199|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14066200|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
14066201|NCT02575677|Oxycodone|oxycodone|mesh-list
14066202|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066203|NCT02575677|Narcotics|narcotics|mesh-ancestor
14066204|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066205|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066206|NCT02575677|Analgesics|analgesics|mesh-ancestor
14066207|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
14066208|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066209|NCT02575443|Rocuronium|rocuronium|mesh-list
14066210|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14066211|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14066212|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14066213|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066214|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066215|NCT02575534|Procainamide|procainamide|mesh-list
14066216|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14066217|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14066218|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14066219|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14066220|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066221|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
14066222|NCT02575521|Propofol|propofol|mesh-list
14066223|NCT02575521|Sevoflurane|sevoflurane|mesh-list
14066224|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14066225|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066226|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066227|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14066228|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
14066229|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
14066230|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14066231|NCT02575521|Analgesics|analgesics|mesh-ancestor
14066232|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
14066233|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066234|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14066235|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14066236|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14066237|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
14066238|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066239|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066240|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14066241|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14066242|NCT02575638|Camptothecin|camptothecin|mesh-list
14066243|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14066244|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066245|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14066246|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14066247|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066248|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066249|NCT02575547|Docetaxel|docetaxel|mesh-list
14066250|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066251|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
14066252|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
14066253|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
14066254|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066255|NCT02575664|Buprenorphine|buprenorphine|mesh-list
14066256|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066257|NCT02575664|Narcotics|narcotics|mesh-ancestor
14066258|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066259|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066260|NCT02575664|Analgesics|analgesics|mesh-ancestor
14066261|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
14066262|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066263|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14066264|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14066265|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14066266|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066267|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
14066268|NCT02575508|Fluorouracil|fluorouracil|mesh-list
14066269|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
14066270|NCT02575508|Irinotecan|irinotecan|mesh-list
14066271|NCT02575508|Camptothecin|camptothecin|mesh-list
14066272|NCT02575508|Infigratinib|infigratinib|mesh-list
14066273|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
14066274|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066275|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14066276|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066277|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066278|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
14066279|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066280|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14066281|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14066282|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066283|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14066284|NCT02575248|Dienogest|dienogest|mesh-list
14066285|NCT02575248|Clomiphene|clomiphene|mesh-list
14066286|NCT02575248|Enclomiphene|enclomiphene|mesh-list
14066287|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
14066288|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14066289|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
14066290|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066291|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066292|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14066293|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
14066294|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14066295|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14066296|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14066297|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14066298|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
14066299|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14066300|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14066301|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14066302|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14066303|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14066304|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066305|NCT02575183|Varenicline|varenicline|mesh-list
14066306|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14066307|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14066308|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
14066309|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066310|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066311|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066312|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14066313|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
14066314|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14066315|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066316|NCT02575222|Nivolumab|nivolumab|mesh-list
14066317|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14066318|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066319|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14066320|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066321|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14066322|NCT02574962|Hormones|hormones|mesh-ancestor
14066323|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066324|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172319|NCT04810754|Daratumumab|daratumumab|mesh-list
14172320|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172321|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14172322|NCT04810507|Anagliptin|anagliptin|mesh-list
14172323|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14172324|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172325|NCT04810507|Incretins|incretins|mesh-ancestor
14172326|NCT04810507|Hormones|hormones|mesh-ancestor
14172327|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172328|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14172329|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
14172330|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172331|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172332|NCT04810572|Silymarin|silymarin|mesh-list
14172333|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
14172334|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172335|NCT04810572|Protective Agents|protective agents|mesh-ancestor
14066325|NCT02575092|Folic Acid|folic acid|mesh-list
14066326|NCT02575092|Enalapril|enalapril|mesh-list
14066327|NCT02575092|Enalaprilat|enalaprilat|mesh-list
14066328|NCT02575092|Maleic acid|maleic acid|mesh-list
14066329|NCT02575092|Hematinics|hematinics|mesh-ancestor
14066330|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
14066331|NCT02575092|Vitamins|vitamins|mesh-ancestor
14066332|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
14066333|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066334|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066335|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066336|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14066337|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
14066338|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14066339|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
14066340|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14066341|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14066342|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14066343|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066344|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
14066345|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14066346|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066347|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
14066348|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066349|NCT02574975|Budesonide|budesonide|mesh-list
14066350|NCT02574975|Adenosine|adenosine|mesh-list
14066351|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
14066352|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
14066353|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066354|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14066355|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
14066356|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066357|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066358|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14066359|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
14066360|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
14066361|NCT02574975|Hormones|hormones|mesh-ancestor
14066362|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066363|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14066364|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14066365|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14066366|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14066367|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066368|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066369|NCT02574975|Analgesics|analgesics|mesh-ancestor
14066370|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
14066371|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14066372|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
14066373|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14066374|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
14066375|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
14066376|NCT02574975|Miotics|miotics|mesh-ancestor
14066377|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14066378|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14066379|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14066380|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14066381|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
14066382|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
14066383|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14066384|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14066385|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066386|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066387|NCT02574741|Aripiprazole|aripiprazole|mesh-list
14066388|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
14066389|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14066390|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14066391|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14066392|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758199|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758200|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066393|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066394|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
14066395|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
14066396|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066397|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758201|NCT05282277|Progestins|progestins|mesh-ancestor
14758202|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14758203|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14758204|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066398|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14066399|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14066400|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
14066401|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14066402|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14066403|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14066404|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14066405|NCT02574663|Leucovorin|leucovorin|mesh-list
14066406|NCT02574663|Folic Acid|folic acid|mesh-list
14066407|NCT02574663|Gemcitabine|gemcitabine|mesh-list
14066408|NCT02574663|Paclitaxel|paclitaxel|mesh-list
14066409|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14066410|NCT02574663|Bevacizumab|bevacizumab|mesh-list
14066411|NCT02574663|Fluorouracil|fluorouracil|mesh-list
14066412|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
14066413|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
14066414|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14066415|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066416|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
14476148|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066417|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
14476149|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
14476150|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
14066418|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
14066419|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066420|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14066421|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14066422|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14066423|NCT02574663|Growth Substances|growth substances|mesh-ancestor
14066424|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066425|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14066426|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14066427|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
14066428|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
14066429|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066430|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066431|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066432|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
14066433|NCT02574663|Antidotes|antidotes|mesh-ancestor
14066434|NCT02574663|Protective Agents|protective agents|mesh-ancestor
14066435|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
14066436|NCT02574663|Vitamins|vitamins|mesh-ancestor
14066437|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
14066438|NCT02574663|Hematinics|hematinics|mesh-ancestor
14066439|NCT02574468|Dexamethasone|dexamethasone|mesh-list
14066440|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
14066441|NCT02574468|BB 1101|bb 1101|mesh-list
14066442|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066443|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
14066444|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
14066445|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066446|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066447|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476151|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476152|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476153|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476154|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
14476155|NCT02412657|Hormones|hormones|mesh-ancestor
14476156|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476157|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476158|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476159|NCT02412722|Paclitaxel|paclitaxel|mesh-list
14476160|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14476161|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476162|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
14476163|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
14476164|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
14758205|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14066448|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
14066449|NCT02574468|Hormones|hormones|mesh-ancestor
14066450|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066451|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14066452|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066453|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
14066454|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066455|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066456|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
14066457|NCT02574611|Neostigmine|neostigmine|mesh-list
14066458|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14066459|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066460|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066461|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
14066462|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066463|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066464|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14066465|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
14066466|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066467|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14066468|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14066469|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14066470|NCT02574754|Warfarin|warfarin|mesh-list
14066471|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
14066472|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
14066473|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14066474|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
14066475|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14066476|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066477|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14066478|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14066479|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14066480|NCT02574403|Eculizumab|eculizumab|mesh-list
14066481|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14066482|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066483|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
14066484|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066485|NCT02574377|Vaccines|vaccines|mesh-list
14066486|NCT02574377|Immunologic Factors|immunologic factors|mesh-ancestor
14066487|NCT02574377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066488|NCT02574221|Fluorides|fluorides|mesh-list
14066489|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
14066490|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
14066491|NCT02574221|Protective Agents|protective agents|mesh-ancestor
14066492|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066493|NCT02574338|Alprostadil|alprostadil|mesh-list
14066494|NCT02574338|Misoprostol|misoprostol|mesh-list
14066495|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14066496|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
14066497|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14066498|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066499|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14066500|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14066501|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
14066502|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14066503|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
14066504|NCT02574338|Urological Agents|urological agents|mesh-ancestor
14066505|NCT02574156|Insulin|insulin|mesh-list
14066506|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14066507|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066508|NCT02574130|Amikacin|amikacin|mesh-list
14066509|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066510|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066511|NCT02573935|Clarithromycin|clarithromycin|mesh-list
14066512|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066513|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066514|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14066515|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066516|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066517|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14066518|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14066519|NCT02573909|Oxycodone|oxycodone|mesh-list
14066520|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066521|NCT02573909|Narcotics|narcotics|mesh-ancestor
14066522|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066523|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066524|NCT02573909|Analgesics|analgesics|mesh-ancestor
14066525|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
14066526|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066527|NCT02573922|Oxycodone|oxycodone|mesh-list
14066528|NCT02573922|Naloxone|naloxone|mesh-list
14066529|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066530|NCT02573922|Narcotics|narcotics|mesh-ancestor
14476165|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476166|NCT02412761|Amlodipine|amlodipine|mesh-list
14476167|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14476168|NCT02412761|Lisinopril|lisinopril|mesh-list
14476169|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
14066531|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066532|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066533|NCT02573922|Analgesics|analgesics|mesh-ancestor
14758206|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14758207|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
14758208|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758209|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758210|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
14066534|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
14066535|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066536|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14066537|NCT02573896|Lenalidomide|lenalidomide|mesh-list
14066538|NCT02573896|Dinutuximab|dinutuximab|mesh-list
14066539|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
14066540|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066541|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14066542|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14066543|NCT02573896|Growth Substances|growth substances|mesh-ancestor
14066544|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14066545|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066546|NCT02573987|Lidocaine|lidocaine|mesh-list
14066547|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
14066548|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
14066549|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
14066550|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066551|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066552|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
14066553|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066554|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14066555|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14066556|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14066557|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14066558|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066559|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14066560|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
14066561|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14066562|NCT02573987|Analgesics|analgesics|mesh-ancestor
14066563|NCT02573714|Ketamine|ketamine|mesh-list
14066564|NCT02573714|Analgesics|analgesics|mesh-ancestor
14066565|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
14066566|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066567|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066568|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14066569|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14066570|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
14066571|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
14066572|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066573|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14066574|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14066575|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066576|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066577|NCT02573701|Risperidone|risperidone|mesh-list
14066578|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
14066579|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14066580|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
14066581|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066582|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066583|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066584|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14066585|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066586|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14066587|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14066588|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
14066589|NCT02573831|Oxycodone|oxycodone|mesh-list
14476170|NCT02412761|Diuretics|diuretics|mesh-list
14476171|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14066590|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066591|NCT02573831|Narcotics|narcotics|mesh-ancestor
14066592|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476172|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14066593|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066594|NCT02573831|Analgesics|analgesics|mesh-ancestor
14066595|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
14066596|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066597|NCT02573610|Levofloxacin|levofloxacin|mesh-list
14066598|NCT02573610|Ofloxacin|ofloxacin|mesh-list
14066599|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14066600|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066601|NCT02573610|Renal Agents|renal agents|mesh-ancestor
14066602|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066603|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14066604|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14066605|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066606|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066607|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066608|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14066609|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14066610|NCT02573597|Sufentanil|sufentanil|mesh-list
14066611|NCT02573597|Bupivacaine|bupivacaine|mesh-list
14066612|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
14066613|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
14066614|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066615|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066616|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
14933945|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14933946|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
14933947|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14933948|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14933949|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14933950|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933951|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933952|NCT01453283|Trabectedin|trabectedin|mesh-list
14933953|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14933954|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
14933955|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933956|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14933957|NCT01453400|Aspirin|aspirin|mesh-list
14933958|NCT01453400|Acetaminophen|acetaminophen|mesh-list
14933959|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14933960|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14933961|NCT01453400|Analgesics|analgesics|mesh-ancestor
14933962|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
14933963|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933964|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933965|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14933966|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14933967|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14066617|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066618|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066619|NCT02573597|Narcotics|narcotics|mesh-ancestor
14066620|NCT02573597|Analgesics|analgesics|mesh-ancestor
14066621|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14066622|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14066623|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
14066624|NCT02573519|Acetylcholine|acetylcholine|mesh-list
14066625|NCT02573519|Donepezil|donepezil|mesh-list
14066626|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14933968|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14933969|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933970|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14933971|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14933972|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933973|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
14933974|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14933975|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
14933976|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14933977|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
14933978|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933979|NCT01453504|Everolimus|everolimus|mesh-list
14933980|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066627|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14933981|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066628|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066629|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066630|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
14933982|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
14066631|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066632|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066633|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
14066634|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
14066635|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14066636|NCT02573727|Terlipressin|terlipressin|mesh-list
14066637|NCT02573727|Epinephrine|epinephrine|mesh-list
14066638|NCT02573727|Racepinephrine|racepinephrine|mesh-list
14066639|NCT02573727|Norepinephrine|norepinephrine|mesh-list
14066640|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
14066641|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14066642|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14066643|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
14066644|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066645|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066646|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066647|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14066648|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14066649|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
14066650|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066651|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14066652|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
14066653|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
14066654|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
14066655|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14066656|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14066657|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
14066658|NCT02573558|Propofol|propofol|mesh-list
14066659|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14066660|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066661|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066662|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14066663|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
14066664|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
14066665|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14066666|NCT02573558|Analgesics|analgesics|mesh-ancestor
14066667|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
14066668|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066669|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14066670|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14066671|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14066672|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
14066673|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066674|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172336|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172337|NCT04810585|Aflibercept|aflibercept|mesh-list
14172338|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14172339|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14172340|NCT04810585|Growth Substances|growth substances|mesh-ancestor
14172341|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172342|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
14172343|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172344|NCT04809818|Aspirin|aspirin|mesh-list
14172345|NCT04809818|Dabigatran|dabigatran|mesh-list
14172346|NCT04809818|Apixaban|apixaban|mesh-list
14172347|NCT04809818|Clopidogrel|clopidogrel|mesh-list
14172348|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14172349|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14172350|NCT04809818|Analgesics|analgesics|mesh-ancestor
14172351|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
14172352|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172353|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172354|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172355|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14172356|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14172357|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14172358|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172359|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14172360|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14172361|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172362|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
14172363|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14172364|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14172365|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14172366|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
14476173|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14066675|NCT02573363|Cytarabine|cytarabine|mesh-list
14066676|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
14066677|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14066678|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
14066679|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066680|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066681|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
14066682|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066683|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066684|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
14066685|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066686|NCT02573363|Analgesics|analgesics|mesh-ancestor
14066687|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
14066688|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066689|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14066690|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14066691|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066692|NCT02573337|Lidocaine|lidocaine|mesh-list
14066693|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
14066694|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
14066695|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066696|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066697|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
14066698|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066699|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14066700|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14066701|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14066702|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14066703|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066704|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
14066705|NCT02573064|Vancomycin|vancomycin|mesh-list
14066706|NCT02573064|Colistin|colistin|mesh-list
14066707|NCT02573064|Tigecycline|tigecycline|mesh-list
14066708|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066709|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066710|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14066711|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066712|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066713|NCT02573220|Leucovorin|leucovorin|mesh-list
14066714|NCT02573220|Fluorouracil|fluorouracil|mesh-list
14066715|NCT02573220|Irinotecan|irinotecan|mesh-list
14066716|NCT02573220|Cetuximab|cetuximab|mesh-list
14066717|NCT02573220|Camptothecin|camptothecin|mesh-list
14066718|NCT02573220|Calcium|calcium|mesh-list
14066719|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
14066720|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14066721|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066722|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
14066723|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066724|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14066725|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066726|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066727|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
14066728|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14066729|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14066730|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066731|NCT02573220|Antidotes|antidotes|mesh-ancestor
14066732|NCT02573220|Protective Agents|protective agents|mesh-ancestor
14066733|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
14066734|NCT02573220|Vitamins|vitamins|mesh-ancestor
14066735|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
14066736|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14066737|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14066738|NCT02573038|Aflibercept|aflibercept|mesh-list
14066739|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14066740|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14066741|NCT02573038|Growth Substances|growth substances|mesh-ancestor
14066742|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066743|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
14066744|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066745|NCT02573051|Isosorbide|isosorbide|mesh-list
14066746|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14066747|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14066748|NCT02573051|Misoprostol|misoprostol|mesh-list
14758211|NCT05282069|DA-8010|da-8010|mesh-list
14066749|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14066750|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
14066751|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14066752|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066753|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14066754|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14066755|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
14066756|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14066757|NCT02573051|Diuretics|diuretics|mesh-ancestor
14066758|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
14066759|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
14066760|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14066761|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066762|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14066763|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
14066764|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
14066765|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14066766|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
14066767|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066768|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
14066769|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066770|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066771|NCT02572986|Permethrin|permethrin|mesh-list
14066772|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066773|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066774|NCT02572960|Vitamin D|vitamin d|mesh-list
14066775|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
14066776|NCT02572960|Valsartan|valsartan|mesh-list
14066777|NCT02572960|Vitamins|vitamins|mesh-ancestor
14066778|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
14066779|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066780|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14066781|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14066782|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14066783|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14066784|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14066785|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066786|NCT02572947|Dolutegravir|dolutegravir|mesh-list
14066787|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14066788|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14066789|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066790|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066791|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14066792|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14066793|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
14066794|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066795|NCT02572505|Tenofovir|tenofovir|mesh-list
14066796|NCT02572505|Emtricitabine|emtricitabine|mesh-list
14066797|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14066798|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
14066799|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066800|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14066801|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14066802|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066803|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066804|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14066805|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14066806|NCT02572583|Oseltamivir|oseltamivir|mesh-list
14066807|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
14066808|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066809|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066810|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066811|NCT02572687|Durvalumab|durvalumab|mesh-list
14066812|NCT02572687|Ramucirumab|ramucirumab|mesh-list
14066813|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14066814|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066815|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
14066816|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066817|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
14066818|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066819|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14066820|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14066821|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
14066822|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066823|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066824|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14066825|NCT02572492|Dexamethasone|dexamethasone|mesh-list
14066826|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
14066827|NCT02572492|Melphalan|melphalan|mesh-list
14066828|NCT02572492|BB 1101|bb 1101|mesh-list
14066829|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066830|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
14066831|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
14066832|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066833|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066834|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14066835|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
14066836|NCT02572492|Hormones|hormones|mesh-ancestor
14066837|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066838|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14066839|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066840|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
14066841|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066842|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066843|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14066844|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
14066845|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14066846|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066847|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
14066848|NCT02572323|Tesamorelin|tesamorelin|mesh-list
14933983|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933984|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
14933985|NCT01453530|Neostigmine|neostigmine|mesh-list
14933986|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14933987|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14933988|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14933989|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
14933990|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14933991|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14933992|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14933993|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
14933994|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14933995|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14933996|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14933997|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14933998|NCT01453582|Propolis|propolis|mesh-list
14933999|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934000|NCT01453660|Cisplatin|cisplatin|mesh-list
14934001|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066849|NCT02572323|Growth Substances|growth substances|mesh-ancestor
14066850|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066851|NCT02572336|Plasminogen|plasminogen|mesh-list
14066852|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14066853|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14066854|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14066855|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066856|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
14066857|NCT02572375|Codeine|codeine|mesh-list
14066858|NCT02572375|Guaifenesin|guaifenesin|mesh-list
14066859|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14066860|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066861|NCT02572375|Narcotics|narcotics|mesh-ancestor
14066862|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066863|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066864|NCT02572375|Analgesics|analgesics|mesh-ancestor
14066865|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
14066866|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066867|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
14758212|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14758213|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14758214|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
14758215|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758216|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758217|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758218|NCT05282069|Urological Agents|urological agents|mesh-ancestor
14758219|NCT05279833|Sotalol|sotalol|mesh-list
14758220|NCT05279833|Dronedarone|dronedarone|mesh-list
14758221|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14758222|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14934002|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
14758223|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
14758224|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934003|NCT01453686|Clobetasol|clobetasol|mesh-list
14066868|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
14066869|NCT02572375|Expectorants|expectorants|mesh-ancestor
14066870|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14066871|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14066872|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
14066873|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066874|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066875|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
14066876|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14066877|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
14066878|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
14066879|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
14066880|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14066881|NCT02572089|Naloxone|naloxone|mesh-list
14066882|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14066883|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066884|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
14066885|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066886|NCT02572141|Leucovorin|leucovorin|mesh-list
14066887|NCT02572141|Fluorouracil|fluorouracil|mesh-list
14066888|NCT02572141|Capecitabine|capecitabine|mesh-list
14066889|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
14066890|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
14066891|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
14066892|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066893|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14066894|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066895|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14066896|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
14066897|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066898|NCT02572141|Antidotes|antidotes|mesh-ancestor
14066899|NCT02572141|Protective Agents|protective agents|mesh-ancestor
14066900|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
14066901|NCT02572141|Vitamins|vitamins|mesh-ancestor
14066902|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
14066903|NCT02571842|Prednisolone|prednisolone|mesh-list
14066904|NCT02571842|Rituximab|rituximab|mesh-list
14066905|NCT02571842|Enalapril|enalapril|mesh-list
14066906|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14066907|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066908|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
14066909|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066910|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14066911|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066912|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
14066913|NCT02571842|Hormones|hormones|mesh-ancestor
14066914|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066915|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14066916|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14066917|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
14066918|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066919|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066920|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14066921|NCT02571959|Amoxicillin|amoxicillin|mesh-list
14066922|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
14066923|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
14934004|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066924|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14066925|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14066926|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14066927|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066928|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14172367|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172368|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
14172369|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14172370|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
14172371|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
14172372|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14172373|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
14172374|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
14172375|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14172376|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14172377|NCT04810156|Prednisolone|prednisolone|mesh-list
14172378|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
14172379|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14172380|NCT04810156|Tacrolimus|tacrolimus|mesh-list
14172381|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14172382|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
14172383|NCT04810156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172384|NCT04810156|Immunologic Factors|immunologic factors|mesh-ancestor
14172385|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172386|NCT04810156|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14172387|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172388|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172389|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14172390|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172391|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14172392|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
14172393|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14172394|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172395|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172396|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
14172397|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
14172398|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172399|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172400|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
14172401|NCT04810156|Hormones|hormones|mesh-ancestor
14172402|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172403|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14172404|NCT04810156|Protective Agents|protective agents|mesh-ancestor
14172405|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14172406|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14172407|NCT04809974|Niacinamide|niacinamide|mesh-list
14172408|NCT04809974|Vitamins|vitamins|mesh-ancestor
14172409|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
14172410|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172411|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
14172412|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
14172413|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172414|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
14172415|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
14172416|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
14172417|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
14172418|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172419|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14172420|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
14172421|NCT04809662|Imiquimod|imiquimod|mesh-list
14172422|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14172423|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
14172424|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172425|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172426|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
14172427|NCT04809649|Itraconazole|itraconazole|mesh-list
14172428|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
14172429|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172430|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14767296|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14172431|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14172432|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183315|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14066929|NCT02571712|Timolol|timolol|mesh-list
14066930|NCT02571712|Bimatoprost|bimatoprost|mesh-list
14066931|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14066932|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14066933|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
14066934|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066935|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066936|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066937|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14066938|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14066939|NCT02571881|Oxycodone|oxycodone|mesh-list
14066940|NCT02571881|Naloxone|naloxone|mesh-list
14066941|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14066942|NCT02571881|Narcotics|narcotics|mesh-ancestor
14066943|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066944|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066945|NCT02571881|Analgesics|analgesics|mesh-ancestor
14066946|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
14066947|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066948|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14066949|NCT02571608|Metformin|metformin|mesh-list
14066950|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14066951|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066952|NCT02571283|Epinephrine|epinephrine|mesh-list
14066953|NCT02571283|Bupivacaine|bupivacaine|mesh-list
14066954|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
14066955|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
14066956|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14066957|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066958|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
14066959|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066960|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14066961|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
14066962|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14066963|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14066964|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
14066965|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14066966|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14066967|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14066968|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14066969|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
14066970|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
14066971|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
14066972|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14066973|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
14066974|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14066975|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14066976|NCT02571517|Prednisolone|prednisolone|mesh-list
14066977|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
14066978|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14066979|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
14066980|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
14066981|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066982|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
14066983|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
14066984|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14066985|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14066986|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14066987|NCT02571517|Hormones|hormones|mesh-ancestor
14066988|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14066989|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14066990|NCT02571517|Protective Agents|protective agents|mesh-ancestor
14066991|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14066992|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14066993|NCT02571556|Dexamethasone|dexamethasone|mesh-list
14066994|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14066995|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14066996|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14066997|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
14066998|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
14066999|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067000|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934005|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
14067001|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14067002|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
14067003|NCT02571556|Hormones|hormones|mesh-ancestor
14067004|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067005|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14067006|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067007|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14067008|NCT02571426|Propofol|propofol|mesh-list
14067009|NCT02571426|Sevoflurane|sevoflurane|mesh-list
14067010|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14067011|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067012|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067013|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14067014|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
14067015|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
14067016|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14067017|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14067018|NCT02571361|Acetaminophen|acetaminophen|mesh-list
14067019|NCT02571361|Ibuprofen|ibuprofen|mesh-list
14067020|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067021|NCT02571361|Analgesics|analgesics|mesh-ancestor
14067022|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
14067023|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067024|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067025|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
14067026|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067027|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067028|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067029|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14067030|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067031|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067032|NCT02571543|Ibuprofen|ibuprofen|mesh-list
14067033|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067034|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067035|NCT02571543|Analgesics|analgesics|mesh-ancestor
14067036|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
14067037|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067038|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067039|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067040|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067041|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14067042|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067043|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067044|NCT02571205|Testosterone|testosterone|mesh-list
14067045|NCT02571205|Androgens|androgens|mesh-ancestor
14067046|NCT02571205|Hormones|hormones|mesh-ancestor
14067047|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067048|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067049|NCT02571296|Progesterone|progesterone|mesh-list
14067050|NCT02571296|Progestins|progestins|mesh-ancestor
14067051|NCT02571296|Hormones|hormones|mesh-ancestor
14067052|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067053|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067054|NCT02571192|Volixibat|volixibat|mesh-list
14067055|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14067056|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
14067057|NCT02571400|Analgesics|analgesics|mesh-list
14067058|NCT02571400|Narcotics|narcotics|mesh-ancestor
14067059|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914053|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
13914054|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13914055|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
13914056|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914057|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914058|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
13914059|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13914060|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13914061|NCT03483142|Misoprostol|misoprostol|mesh-list
13914062|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13914063|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
14067060|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067061|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
14067062|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067063|NCT02571491|Ketamine|ketamine|mesh-list
14067064|NCT02571491|Morphine|morphine|mesh-list
14067065|NCT02571491|Remifentanil|remifentanil|mesh-list
14067066|NCT02571491|Analgesics|analgesics|mesh-ancestor
14067067|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
14067068|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067069|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067070|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14067071|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14067072|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
14067073|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
14067074|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067075|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14067076|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14067077|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758225|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914064|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13914065|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914066|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13914067|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914068|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
13914069|NCT03482960|Xenon|xenon|mesh-list
13914070|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14758226|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758227|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14067078|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067079|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14067080|NCT02571491|Narcotics|narcotics|mesh-ancestor
14067081|NCT02571166|Valacyclovir|valacyclovir|mesh-list
14067082|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
14067083|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067084|NCT02571179|Fentanyl|fentanyl|mesh-list
14067085|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14067086|NCT02571179|Narcotics|narcotics|mesh-ancestor
14067087|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067088|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067089|NCT02571179|Analgesics|analgesics|mesh-ancestor
14067090|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
14067091|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067092|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14067093|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14479170|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13914071|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
13914072|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
13914073|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914074|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067094|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
14067095|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
14479171|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14479172|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14479173|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
14479174|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
14479175|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
14479176|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14479177|NCT02464657|Cytarabine|cytarabine|mesh-list
14479178|NCT02464657|Dexamethasone|dexamethasone|mesh-list
14479179|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
14479180|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14479181|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14479182|NCT02464657|Prednisolone|prednisolone|mesh-list
14479183|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
14479184|NCT02464657|Nivolumab|nivolumab|mesh-list
14479185|NCT02464657|Idarubicin|idarubicin|mesh-list
14479186|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14479187|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
14479188|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479189|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
14479190|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
14479191|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479192|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479193|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479194|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
14479195|NCT02464657|Hormones|hormones|mesh-ancestor
14479295|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758228|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
14758229|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
14758230|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758231|NCT05275439|Azacitidine|azacitidine|mesh-list
14758232|NCT05275439|Venetoclax|venetoclax|mesh-list
14758233|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14758234|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
14758235|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758236|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758237|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758238|NCT05266417|Insulin|insulin|mesh-list
14758239|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14758240|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758241|NCT05265650|Nivolumab|nivolumab|mesh-list
14758242|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758243|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067096|NCT02570893|Paclitaxel|paclitaxel|mesh-list
14067097|NCT02570893|Carboplatin|carboplatin|mesh-list
14067098|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14067099|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067100|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
14067101|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
14067102|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
14067103|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067104|NCT02570971|Mannitol|mannitol|mesh-list
14067105|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14067106|NCT02570971|Diuretics|diuretics|mesh-ancestor
14067107|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
14067108|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067109|NCT02571140|Teriparatide|teriparatide|mesh-list
14067110|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
14067111|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14067112|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067113|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14067114|NCT02570841|Capsaicin|capsaicin|mesh-list
14067115|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
14067116|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
14067117|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
14067118|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067119|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067120|NCT02570789|Sunitinib|sunitinib|mesh-list
14067121|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067122|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14067123|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14067124|NCT02570789|Growth Substances|growth substances|mesh-ancestor
14067125|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067126|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
14067127|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14067128|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067129|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067130|NCT02570477|Vancomycin|vancomycin|mesh-list
14067131|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14067132|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067133|NCT02570581|Acetaminophen|acetaminophen|mesh-list
14067134|NCT02570581|Ramipril|ramipril|mesh-list
14067135|NCT02570581|Furosemide|furosemide|mesh-list
14067136|NCT02570581|Memantine|memantine|mesh-list
14067137|NCT02570581|Alprazolam|alprazolam|mesh-list
14758244|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14758245|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758246|NCT05265208|Capecitabine|capecitabine|mesh-list
14758247|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13914075|NCT03482752|Molgramostim|molgramostim|mesh-list
13914076|NCT03482752|Sargramostim|sargramostim|mesh-list
13914077|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914078|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
13914079|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914080|NCT03482544|Pregabalin|pregabalin|mesh-list
13914081|NCT03482544|Analgesics|analgesics|mesh-ancestor
13914082|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
13914083|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914084|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914085|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
13914086|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13914087|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13914088|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914089|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14758248|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
14067138|NCT02570581|Zopiclone|zopiclone|mesh-list
14067139|NCT02570581|Oxazepam|oxazepam|mesh-list
14067140|NCT02570581|Donepezil|donepezil|mesh-list
14067141|NCT02570581|Clopidogrel|clopidogrel|mesh-list
14067142|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14067143|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14067144|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14067145|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14067146|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
14067147|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067148|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067149|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067150|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067151|NCT02570581|Analgesics|analgesics|mesh-ancestor
14067152|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
14067153|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067154|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
14067155|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14067156|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067157|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
14067158|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
14067159|NCT02570581|Diuretics|diuretics|mesh-ancestor
14067160|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
14067161|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14067162|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14067163|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14067164|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14067165|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
14067166|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14067167|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14067168|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14067169|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
14067170|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14067171|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14067172|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067173|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14067174|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14067175|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14067176|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
14067177|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
14067178|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14067179|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
14067180|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067181|NCT02570230|Ketamine|ketamine|mesh-list
14067182|NCT02570230|Analgesics|analgesics|mesh-ancestor
14067183|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
14067184|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067185|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067186|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14067187|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14067188|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
14067189|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
14067190|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067191|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14067192|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14067193|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067194|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067195|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14067196|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
14067197|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067198|NCT02570243|Heparin|heparin|mesh-list
14067199|NCT02570243|Calcium heparin|calcium heparin|mesh-list
14067200|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
14067201|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14067202|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14067203|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172433|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172434|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14172435|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
14172436|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172437|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172438|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14172439|NCT04809532|Tramadol|tramadol|mesh-list
14172440|NCT04809532|Bupivacaine|bupivacaine|mesh-list
14067204|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14067205|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14067206|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067207|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14067208|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067209|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067210|NCT02569866|Cephalexin|cephalexin|mesh-list
14067211|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14067212|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067213|NCT02569879|Vaccines|vaccines|mesh-list
14067214|NCT02569879|Immunologic Factors|immunologic factors|mesh-ancestor
14067215|NCT02569879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067216|NCT02570035|Mirabegron|mirabegron|mesh-list
14067217|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14067218|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14067219|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14067220|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
14067221|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067222|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067223|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067224|NCT02570035|Urological Agents|urological agents|mesh-ancestor
14067225|NCT02569970|Fluoxetine|fluoxetine|mesh-list
14067226|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14067227|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14067228|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14067229|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067230|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067231|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
14067232|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067233|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14067234|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
14067235|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14067236|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14067237|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14067238|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067239|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
14067240|NCT02569905|Parecoxib|parecoxib|mesh-list
14067241|NCT02569905|Analgesics|analgesics|mesh-ancestor
14067242|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
14067243|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067244|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067245|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067246|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067247|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067248|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067249|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14067250|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067251|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067252|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14067253|NCT02569814|Amlodipine|amlodipine|mesh-list
14067254|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14067255|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14067256|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14067257|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14067258|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067259|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14067260|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067261|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
14067262|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14067263|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14067264|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
14067265|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14067266|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14067267|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758249|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758250|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758251|NCT05261399|Carboplatin|carboplatin|mesh-list
14758252|NCT05261399|Pemetrexed|pemetrexed|mesh-list
14067268|NCT02569489|Paclitaxel|paclitaxel|mesh-list
14067269|NCT02569489|Trastuzumab|trastuzumab|mesh-list
14067270|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14758253|NCT05261399|Osimertinib|osimertinib|mesh-list
14758254|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067271|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067272|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14067273|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14067274|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14067275|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067276|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14067277|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
14067278|NCT02569515|Hematinics|hematinics|mesh-ancestor
14067279|NCT02569463|Aldesleukin|aldesleukin|mesh-list
14067280|NCT02569463|Interleukin-2|interleukin-2|mesh-list
14067281|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067282|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067283|NCT02569463|Analgesics|analgesics|mesh-ancestor
14067284|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
14067285|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067286|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067287|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14067288|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14067289|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
14067290|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067291|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14067292|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14067293|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14067294|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
14067295|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067296|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14067297|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14067298|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067299|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
14067300|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14067301|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14067302|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067303|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14067304|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14067305|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
14067306|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067307|NCT02569554|Rabeprazole|rabeprazole|mesh-list
14067308|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14067309|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14067310|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14067311|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067312|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067313|NCT02569346|Triumeq|triumeq|mesh-list
14067314|NCT02569346|Lamivudine|lamivudine|mesh-list
14067315|NCT02569346|Abacavir|abacavir|mesh-list
14067316|NCT02569346|Dolutegravir|dolutegravir|mesh-list
14067317|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14067318|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14067319|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
14067320|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067321|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14067322|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14067323|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067324|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067325|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14067326|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14067327|NCT02569307|Minocycline|minocycline|mesh-list
14067328|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14067329|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067330|NCT02569073|Dronabinol|dronabinol|mesh-list
14067331|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
14067332|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067333|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14067334|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067335|NCT02569073|Analgesics|analgesics|mesh-ancestor
14067336|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
14067337|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067338|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14067339|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14067340|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067341|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067342|NCT02569073|Hormones|hormones|mesh-ancestor
14067343|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067344|NCT02569320|Dexamethasone|dexamethasone|mesh-list
14067345|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
14067346|NCT02569320|Pomalidomide|pomalidomide|mesh-list
14067347|NCT02569320|Ichthammol|ichthammol|mesh-list
14067348|NCT02569320|BB 1101|bb 1101|mesh-list
14067349|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14067350|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067351|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
14067352|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
14067353|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067354|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067355|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14067356|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
14067357|NCT02569320|Hormones|hormones|mesh-ancestor
14067358|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067359|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14067360|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067361|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
14067362|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067363|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067364|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
14067365|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14067366|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14067367|NCT02569320|Growth Substances|growth substances|mesh-ancestor
14067368|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
14067369|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
14067370|NCT02569125|Everolimus|everolimus|mesh-list
14067371|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067372|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14067373|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
14067374|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067375|NCT02568995|Ketorolac|ketorolac|mesh-list
14067376|NCT02568995|Epinephrine|epinephrine|mesh-list
14067377|NCT02568995|Racepinephrine|racepinephrine|mesh-list
14067378|NCT02568995|Ropivacaine|ropivacaine|mesh-list
14067379|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
14067380|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
14067381|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
14067382|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067383|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067384|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
14067385|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067386|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067387|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067388|NCT02568995|Analgesics|analgesics|mesh-ancestor
14067389|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067390|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067391|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14067392|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067393|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067394|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14067395|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14067396|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
14067397|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067398|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14067399|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14067400|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
14067401|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14067402|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
14067403|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
14067404|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
14067405|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14067406|NCT02568943|Panobinostat|panobinostat|mesh-list
14067407|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067408|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14067409|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172441|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
14067410|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067411|NCT02568839|Docetaxel|docetaxel|mesh-list
14067412|NCT02568839|Trastuzumab|trastuzumab|mesh-list
14067413|NCT02568839|Pertuzumab|pertuzumab|mesh-list
14067414|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067415|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
14067416|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
14067417|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
14067418|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067419|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14067420|NCT02568800|Cefepime|cefepime|mesh-list
14067421|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14067422|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067423|NCT02568709|Oxytocin|oxytocin|mesh-list
14067424|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
14067425|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14067426|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067427|NCT02568735|Etoricoxib|etoricoxib|mesh-list
14067428|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14067429|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067430|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067431|NCT02568735|Analgesics|analgesics|mesh-ancestor
14067432|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
14067433|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067434|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067435|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067436|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067437|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14067438|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14067439|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067440|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067441|NCT02568618|Analgesics|analgesics|mesh-list
14067442|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
14067443|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067444|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067445|NCT02568488|Metformin|metformin|mesh-list
14067446|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14067447|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067448|NCT02568241|Interferons|interferons|mesh-list
14067449|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
14067450|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
14067451|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067452|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
14067453|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067454|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
14067455|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172442|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
14172443|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172444|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172445|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
14172446|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172447|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14172448|NCT04809532|Narcotics|narcotics|mesh-ancestor
14172449|NCT04809532|Analgesics|analgesics|mesh-ancestor
14172450|NCT04809233|Tipifarnib|tipifarnib|mesh-list
14172451|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172452|NCT04809116|Pimavanserin|pimavanserin|mesh-list
14172453|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14172454|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14172455|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14172456|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14172457|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172458|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914090|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13914091|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13914092|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914093|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13914094|NCT03482492|Acetaminophen|acetaminophen|mesh-list
13914095|NCT03482492|Tramadol|tramadol|mesh-list
13914096|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914097|NCT03482492|Analgesics|analgesics|mesh-ancestor
13914098|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
14172459|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14172460|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14172461|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14172462|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
14172463|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067456|NCT02568280|Insulin|insulin|mesh-list
14067457|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14067458|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
14067459|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
14067460|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14067461|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14067462|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067463|NCT02568176|Midazolam|midazolam|mesh-list
14067464|NCT02568176|Bupropion|bupropion|mesh-list
14067465|NCT02568176|Esketamine|esketamine|mesh-list
14067466|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14067467|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14067468|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067469|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067470|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14067471|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14067472|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14067473|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14067474|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
14067475|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
14067476|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
14067477|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
14067478|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067479|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067480|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14067481|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
14067482|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14067483|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14067484|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14067485|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
14067486|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14067487|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14067488|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067489|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14067490|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14067491|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
14067492|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067493|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067494|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14067495|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
14067496|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14067497|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14067498|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14067499|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
14067500|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067501|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067502|NCT02567955|Vaccines|vaccines|mesh-list
14067503|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
14067504|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067505|NCT02567942|Propofol|propofol|mesh-list
14067506|NCT02567942|Sevoflurane|sevoflurane|mesh-list
14067507|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14067508|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067509|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067510|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14067511|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
14067512|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
14067513|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14067514|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14067515|NCT02568423|Mirikizumab|mirikizumab|mesh-list
14067516|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067517|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067518|NCT02568423|Analgesics|analgesics|mesh-ancestor
14067519|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
14067520|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067521|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067522|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067523|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067524|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14067525|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14067526|NCT02568111|Interferons|interferons|mesh-list
14067527|NCT02568111|Interferon-beta|interferon-beta|mesh-list
14067528|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
14067529|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14067530|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067531|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
14067532|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067533|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
14067534|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067535|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14067536|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14067537|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14067538|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14067539|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14067540|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067541|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067542|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14067543|NCT02567981|Vitamin A|vitamin a|mesh-list
14067544|NCT02567981|Micronutrients|micronutrients|mesh-list
14067545|NCT02567981|Trace Elements|trace elements|mesh-list
14067546|NCT02567981|Vitamins|vitamins|mesh-ancestor
14067547|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067548|NCT02568033|Paclitaxel|paclitaxel|mesh-list
14067549|NCT02568033|Docetaxel|docetaxel|mesh-list
14067550|NCT02568033|Carboplatin|carboplatin|mesh-list
14067551|NCT02568033|Pemetrexed|pemetrexed|mesh-list
14067552|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14067553|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067554|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
14067555|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
14067556|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
14067557|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067558|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067559|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14067560|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14067561|NCT02567916|Propofol|propofol|mesh-list
14067562|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14067563|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067564|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067565|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14067566|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
14067567|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
14067568|NCT02567929|Propofol|propofol|mesh-list
14067569|NCT02567929|Sevoflurane|sevoflurane|mesh-list
14067570|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14067571|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067572|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067573|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14067574|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
14067575|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
14067576|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14067577|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14067578|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14067579|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14067580|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067581|NCT02567838|Lidocaine|lidocaine|mesh-list
14067582|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
14067583|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
14067584|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067585|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067586|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
14067587|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067588|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14067589|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14067590|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14067591|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14067592|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067593|NCT02567773|Itraconazole|itraconazole|mesh-list
14067594|NCT02567773|GSK2881078|gsk2881078|mesh-list
14067595|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
14067596|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067597|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14067598|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14067599|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067600|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067601|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14067602|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14067603|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067604|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067605|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14067606|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
14067607|NCT02567773|Hormones|hormones|mesh-ancestor
14067608|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
14067609|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
14067610|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
14067611|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067612|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067613|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
14067614|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067615|NCT02567383|Docetaxel|docetaxel|mesh-list
14067616|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067617|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
14067618|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
14067619|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
14067620|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067621|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
14067622|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14067623|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14067624|NCT02567461|Aspirin|aspirin|mesh-list
14067625|NCT02567461|Edoxaban|edoxaban|mesh-list
14067626|NCT02567461|Clopidogrel|clopidogrel|mesh-list
14067627|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067628|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758255|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758256|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758257|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14758258|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14758259|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14758260|NCT05255003|Enoxaparin|enoxaparin|mesh-list
14758261|NCT05255003|Dalteparin|dalteparin|mesh-list
14758262|NCT05255003|Tinzaparin|tinzaparin|mesh-list
14758263|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14758264|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
14758265|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14067629|NCT02567461|Analgesics|analgesics|mesh-ancestor
14067630|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
14067631|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067632|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067633|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067634|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067635|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14067636|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14067637|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067638|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14067639|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14067640|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067641|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
14067642|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14067643|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14067644|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14067645|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
14067646|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067647|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14067648|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
14067649|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14067650|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
14067651|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
14067652|NCT02567396|Talazoparib|talazoparib|mesh-list
14067653|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14067654|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067655|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067656|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067657|NCT02567799|Paclitaxel|paclitaxel|mesh-list
14067658|NCT02567799|Carboplatin|carboplatin|mesh-list
14067659|NCT02567799|Genistein|genistein|mesh-list
14067660|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14067661|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067662|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
14067663|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
14067664|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
14067665|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758266|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14758267|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067666|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14934006|NCT01453686|Hormones|hormones|mesh-ancestor
14067667|NCT02567799|Protective Agents|protective agents|mesh-ancestor
14067668|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067669|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14067670|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067671|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
14067672|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14067673|NCT02567799|Estrogens|estrogens|mesh-ancestor
14067674|NCT02567799|Hormones|hormones|mesh-ancestor
14067675|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067676|NCT02567331|Capecitabine|capecitabine|mesh-list
14067677|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14067678|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
14067679|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067680|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067681|NCT02567032|Oxytocin|oxytocin|mesh-list
14067682|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
14067683|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14067684|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067685|NCT02567149|Cidofovir|cidofovir|mesh-list
14067686|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
14067687|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067688|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067689|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067690|NCT02567253|Cisplatin|cisplatin|mesh-list
14067691|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067692|NCT02567279|Denosumab|denosumab|mesh-list
14067693|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14067694|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067695|NCT02567175|Domperidone|domperidone|mesh-list
14067696|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
14067697|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
14067698|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067699|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067700|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14067701|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14067702|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
14067703|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067704|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067705|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
14067706|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
14067707|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067708|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
14067709|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067710|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067711|NCT02566967|Tofacitinib|tofacitinib|mesh-list
14067712|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14067713|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067714|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067715|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
14067716|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
14067717|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14067718|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
14067719|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067720|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067721|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14067722|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
14067723|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
14067724|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14067725|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
14067726|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067727|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067728|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14067729|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14067730|NCT02566824|Methylphenidate|methylphenidate|mesh-list
14067731|NCT02566824|Amphetamine|amphetamine|mesh-list
14067732|NCT02566824|Adderall|adderall|mesh-list
14067733|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
14067734|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14067735|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067736|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14067737|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14067738|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14067739|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067740|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
14067741|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067742|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
14067743|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
14067744|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067745|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14067746|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14067747|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
14067748|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14067749|NCT02566928|Bacitracin|bacitracin|mesh-list
14067750|NCT02566928|Mupirocin|mupirocin|mesh-list
14067751|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14067752|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067753|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
14067754|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
14067755|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14067756|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14067757|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067758|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067759|NCT02566707|Lamivudine|lamivudine|mesh-list
14067760|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14067761|NCT02566707|Dolutegravir|dolutegravir|mesh-list
14067762|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14067763|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14067764|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067765|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067766|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
14067767|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067768|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14067769|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14067770|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14067771|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14067772|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
14067773|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14067774|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14172464|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172465|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
14172466|NCT04809038|Analgesics|analgesics|mesh-ancestor
14172467|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
14172468|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172469|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172470|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
14172471|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172472|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14172473|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
14172474|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14172475|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14172476|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172477|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14172478|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
14172479|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14172480|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
14172481|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14172482|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172483|NCT04809103|Cisplatin|cisplatin|mesh-list
14172484|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172485|NCT04808882|Tinzaparin|tinzaparin|mesh-list
14172486|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14172487|NCT04808882|Dalteparin|dalteparin|mesh-list
14172488|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
14172489|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14172490|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14172491|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172492|NCT04809142|Gemcitabine|gemcitabine|mesh-list
14172493|NCT04809142|Capecitabine|capecitabine|mesh-list
14172494|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
14172495|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14172496|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
14172497|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172498|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172499|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
14172500|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172501|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172502|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172503|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
14172504|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172505|NCT04809181|Azacitidine|azacitidine|mesh-list
14172506|NCT04809181|Venetoclax|venetoclax|mesh-list
14183316|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067775|NCT02566720|Amantadine|amantadine|mesh-list
14067776|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14067777|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14067778|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
14067779|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067780|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
14067781|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067782|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067783|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067784|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067785|NCT02566720|Analgesics|analgesics|mesh-ancestor
14067786|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
14067787|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067788|NCT02566733|Remifentanil|remifentanil|mesh-list
14067789|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14067790|NCT02566733|Narcotics|narcotics|mesh-ancestor
14067791|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067792|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067793|NCT02566733|Analgesics|analgesics|mesh-ancestor
14067794|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
14067795|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067796|NCT02566356|Oxytocin|oxytocin|mesh-list
14067797|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
14067798|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14067799|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067800|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
14067801|NCT02566252|Albuterol|albuterol|mesh-list
14067802|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
14067803|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14067804|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
14067805|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067806|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067807|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14067808|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
14067809|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
14067810|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14067811|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14067812|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14067813|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14067814|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
14067815|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067816|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067817|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14067818|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
14067819|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067820|NCT02565979|Resveratrol|resveratrol|mesh-list
14067821|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
14067822|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067823|NCT02565979|Protective Agents|protective agents|mesh-ancestor
14067824|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067825|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067826|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14067827|NCT02565953|Paclitaxel|paclitaxel|mesh-list
14067828|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14067829|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067830|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14067831|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14067832|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14067833|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067834|NCT02566187|Atorvastatin|atorvastatin|mesh-list
14067835|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14067836|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14067837|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
14067838|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067839|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14067840|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14067841|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067842|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
14067843|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14067844|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067845|NCT02566096|Morphine|morphine|mesh-list
14067846|NCT02566096|Bupivacaine|bupivacaine|mesh-list
14067847|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
14067848|NCT02566096|Anesthetics|anesthetics|mesh-list
14067849|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067850|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067851|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
14067852|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067853|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14067854|NCT02566096|Narcotics|narcotics|mesh-ancestor
14067855|NCT02566096|Analgesics|analgesics|mesh-ancestor
14067856|NCT02566226|Morphine|morphine|mesh-list
14067857|NCT02566226|Bupivacaine|bupivacaine|mesh-list
14067858|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
14067859|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
14067860|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067861|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067862|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
14067863|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067864|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14067865|NCT02566226|Narcotics|narcotics|mesh-ancestor
14067866|NCT02566226|Analgesics|analgesics|mesh-ancestor
14067867|NCT02565888|Ritonavir|ritonavir|mesh-list
14067868|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14067869|NCT02565888|Cobicistat|cobicistat|mesh-list
14067870|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14067871|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14067872|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14067873|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067874|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067875|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14067876|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14067877|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
14067878|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067879|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14067880|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14067881|NCT02565719|Interferons|interferons|mesh-list
14067882|NCT02565719|Tenofovir|tenofovir|mesh-list
14067883|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
14067884|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
14067885|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14067886|NCT02565719|REP 2139|rep 2139|mesh-list
14067887|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067888|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
14067889|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067890|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14067891|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14067892|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067893|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067894|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14067895|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14067896|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
14067897|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067898|NCT02565680|Prednisone|prednisone|mesh-list
14067899|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067900|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
14067901|NCT02565680|Hormones|hormones|mesh-ancestor
14067902|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067903|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067904|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14067905|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067906|NCT02565862|Metformin|metformin|mesh-list
14067907|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14067908|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067909|NCT02565836|Thrombin|thrombin|mesh-list
14067910|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14067911|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
14067912|NCT02565836|Coagulants|coagulants|mesh-ancestor
14067913|NCT02565641|Gemcitabine|gemcitabine|mesh-list
14067914|NCT02565641|Capecitabine|capecitabine|mesh-list
14067915|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14067916|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
14067917|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067918|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14067919|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
14067920|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14067921|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067922|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14067923|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
14067924|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067925|NCT02565693|Aspirin|aspirin|mesh-list
14067926|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
14067927|NCT02565693|Dipyridamole|dipyridamole|mesh-list
14067928|NCT02565693|Apixaban|apixaban|mesh-list
14067929|NCT02565693|Clopidogrel|clopidogrel|mesh-list
14067930|NCT02565693|Calcium|calcium|mesh-list
14067931|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14067932|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067933|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14067934|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14067935|NCT02565693|Analgesics|analgesics|mesh-ancestor
14067936|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
14067937|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067938|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14067939|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14067940|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14067941|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14067942|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067943|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14067944|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14067945|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14067946|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
14067947|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14067948|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14067949|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14067950|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
14067951|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067952|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14067953|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
14067954|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14067955|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
14067956|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
14067957|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14067958|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
14067959|NCT02565602|Vitamin D|vitamin d|mesh-list
14067960|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
14067961|NCT02565602|Vitamins|vitamins|mesh-ancestor
14067962|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
14067963|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067964|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14067965|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14067966|NCT02565368|Metformin|metformin|mesh-list
14067967|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14067968|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067969|NCT02565212|Montelukast|montelukast|mesh-list
14067970|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14067971|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
14067972|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14067973|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
14067974|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14067975|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067976|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14067977|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14067978|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067979|NCT02565303|Ropivacaine|ropivacaine|mesh-list
14067980|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
14067981|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
14067982|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14067983|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067984|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
14067985|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14067986|NCT02565316|Sertraline|sertraline|mesh-list
14067987|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
14067988|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14067989|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14067990|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14067991|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14067992|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14067993|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14067994|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
14067995|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14067996|NCT02565173|Timolol|timolol|mesh-list
14067997|NCT02565173|Adenosine|adenosine|mesh-list
14067998|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14067999|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14068000|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068001|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172507|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14068002|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068003|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068004|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14068005|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14068006|NCT02565173|Analgesics|analgesics|mesh-ancestor
14068007|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
14068008|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068009|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
14068010|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14068011|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
14068012|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
14172508|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
14172509|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172510|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172511|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172512|NCT04808739|Adalimumab|adalimumab|mesh-list
14172513|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172514|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14172515|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
14172516|NCT04808856|Hormones|hormones|mesh-list
14172517|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14172518|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14172519|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
14172520|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172521|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172522|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172523|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
14172524|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
14172525|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172526|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172527|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
14172528|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14758268|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14758269|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
14758270|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13914099|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914100|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172529|NCT04808856|Protective Agents|protective agents|mesh-ancestor
14172530|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172531|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172532|NCT04808648|Itraconazole|itraconazole|mesh-list
14172533|NCT04808648|Rifampin|rifampin|mesh-list
14758271|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
14758272|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758273|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14758274|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14758275|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14758276|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14758277|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758278|NCT05250973|Dexamethasone|dexamethasone|mesh-list
14758279|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
14758280|NCT05250973|Bortezomib|bortezomib|mesh-list
14758281|NCT05250973|Daratumumab|daratumumab|mesh-list
14758282|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758283|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
14758284|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938786|NCT01484262|Liraglutide|liraglutide|mesh-list
13914101|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
13914102|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13914103|NCT03482492|Narcotics|narcotics|mesh-ancestor
13914104|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914105|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
13914106|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13914107|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914108|NCT03482440|Analgesics|analgesics|mesh-ancestor
13914109|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
13914110|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914111|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914112|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13914113|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13914114|NCT03482362|Vinorelbine|vinorelbine|mesh-list
13914115|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13914116|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172534|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
14758285|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14068013|NCT02564536|Decitabine|decitabine|mesh-list
14068014|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14068015|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
14068016|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068017|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068018|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068019|NCT02564315|Nicotine|nicotine|mesh-list
14068020|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14068021|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
14068022|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068023|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068024|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14068025|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14068026|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
14068027|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068028|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068029|NCT02564237|Vaccines|vaccines|mesh-list
14068030|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
14068031|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068032|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
14068033|NCT02564094|Hematinics|hematinics|mesh-ancestor
14068034|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
14068035|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14068036|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068037|NCT02564146|Gemcitabine|gemcitabine|mesh-list
14068038|NCT02564146|Paclitaxel|paclitaxel|mesh-list
14068039|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14068040|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14068041|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068042|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14068043|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14068044|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14068045|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068046|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14068047|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
14068048|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
14068049|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068050|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914117|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
13914118|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
13914119|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
13914120|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914121|NCT03482336|Immunoconjugates|immunoconjugates|mesh-list
13914122|NCT03482336|Immunologic Factors|immunologic factors|mesh-ancestor
13914123|NCT03482336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914124|NCT03482232|Acetaminophen|acetaminophen|mesh-list
13914125|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13914126|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13914127|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
13914128|NCT03482232|Ibuprofen|ibuprofen|mesh-list
14068051|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068052|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
14068053|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068054|NCT02564003|Oxycodone|oxycodone|mesh-list
14068055|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14068056|NCT02564003|Narcotics|narcotics|mesh-ancestor
14068057|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068058|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068059|NCT02564003|Analgesics|analgesics|mesh-ancestor
14068060|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
14068061|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068062|NCT02563951|Granisetron|granisetron|mesh-list
14068063|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
14068064|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
14068065|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068066|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068067|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14068068|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14068069|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
14068070|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068071|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068072|NCT02563925|Durvalumab|durvalumab|mesh-list
14068073|NCT02563925|Tremelimumab|tremelimumab|mesh-list
14068074|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758286|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14068075|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068076|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
14068077|NCT02563782|Tacrolimus|tacrolimus|mesh-list
14068078|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068079|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
14068080|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068081|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14068082|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068083|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068084|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14068085|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068086|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14068087|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
14068088|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068089|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068090|NCT02563795|Fentanyl|fentanyl|mesh-list
14068091|NCT02563795|Bupivacaine|bupivacaine|mesh-list
14068092|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
14068093|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
14068094|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068095|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068096|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
14068097|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068098|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14068099|NCT02563795|Narcotics|narcotics|mesh-ancestor
14068100|NCT02563795|Analgesics|analgesics|mesh-ancestor
14068101|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14068102|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14068103|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
14068104|NCT02563847|Erythritol|erythritol|mesh-list
14068105|NCT02563847|Tryptophan|tryptophan|mesh-list
14068106|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14068107|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
14068108|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14068109|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
14068110|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
14068111|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
14068112|NCT02563769|Cocaine|cocaine|mesh-list
14068113|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
14068114|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
14068115|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068116|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068117|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
14068118|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068119|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14068120|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14068121|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14068122|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068123|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068124|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
14068125|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068126|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068127|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068128|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068129|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14068130|NCT02563704|Artesunate|artesunate|mesh-list
14068131|NCT02563704|Quinine|quinine|mesh-list
14068132|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
14068133|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14068134|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14068135|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068136|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068137|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
14068138|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
14068139|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14068140|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
14068141|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14068142|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068143|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14068144|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068145|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14068146|NCT02563704|Analgesics|analgesics|mesh-ancestor
14068147|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
14068148|NCT02563821|Clonidine|clonidine|mesh-list
14068149|NCT02563821|Sufentanil|sufentanil|mesh-list
14068150|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
14068151|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
14068152|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
14068153|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068154|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068155|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
14068156|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068157|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14068158|NCT02563821|Narcotics|narcotics|mesh-ancestor
14068159|NCT02563821|Analgesics|analgesics|mesh-ancestor
14068160|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14068161|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14068162|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
14068163|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14068164|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
14068165|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
14068166|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14068167|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14068168|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14068169|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068170|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068171|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068172|NCT02563405|Doxazosin|doxazosin|mesh-list
14068173|NCT02563405|Nifedipine|nifedipine|mesh-list
14068174|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14068175|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068176|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068177|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14068178|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068179|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
14068180|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
14068181|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14068182|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14068183|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14068184|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14068185|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14068186|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068187|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068188|NCT02563340|Rituximab|rituximab|mesh-list
14068189|NCT02563340|Bortezomib|bortezomib|mesh-list
14068190|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758287|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
13914129|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
13914130|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13914131|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
13914132|NCT03482232|Expectorants|expectorants|mesh-list
13914133|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
13914134|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914135|NCT03482232|Analgesics|analgesics|mesh-ancestor
13914136|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
13914137|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914138|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914139|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13914140|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13914141|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914142|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068191|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068192|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
14068193|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068194|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14068195|NCT02563353|Teriparatide|teriparatide|mesh-list
14068196|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14068197|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068198|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14068199|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
14068200|NCT02563288|Esmolol|esmolol|mesh-list
14068201|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
14068202|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
14068203|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
14068204|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14068205|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14068206|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068207|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068208|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14068209|NCT02563288|Analgesics|analgesics|mesh-ancestor
14068210|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
14068211|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068212|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14068213|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068214|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068215|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14068216|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14068217|NCT02563327|Pyridoxine|pyridoxine|mesh-list
14068218|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
14068219|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
14068220|NCT02563327|Rifampin|rifampin|mesh-list
14068221|NCT02563327|Isoniazid|isoniazid|mesh-list
14068222|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
14068223|NCT02563327|Ethambutol|ethambutol|mesh-list
14068224|NCT02563327|Rifapentine|rifapentine|mesh-list
14068225|NCT02563327|Vitamins|vitamins|mesh-ancestor
14068226|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
14068227|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068228|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068229|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068230|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14068231|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14068232|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068233|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068234|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068235|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
14068236|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14068237|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
14068238|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
14068239|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14068240|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14068241|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14068242|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14068243|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14068244|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14068245|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14068246|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14068247|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14068248|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
14068249|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14068250|NCT02563054|Fluorouracil|fluorouracil|mesh-list
14068251|NCT02563054|Capecitabine|capecitabine|mesh-list
14068252|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068253|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
14068254|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068255|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14068256|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068257|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
14068258|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172535|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172536|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14172537|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14172538|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172539|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172540|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14172541|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
14068259|NCT02563041|Heparin|heparin|mesh-list
14068260|NCT02563041|Calcium heparin|calcium heparin|mesh-list
14068261|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
14068262|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068263|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14068264|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14068265|NCT02562950|Midazolam|midazolam|mesh-list
14068266|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14068267|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14068268|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068269|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068270|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14068271|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14068272|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14068273|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14068274|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
14068275|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
14068276|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
14068277|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
14068278|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068279|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068280|NCT02562742|Ribavirin|ribavirin|mesh-list
14068281|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
14068282|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068283|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
14068284|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068285|NCT02562690|Thrombin|thrombin|mesh-list
14068286|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
14068287|NCT02562690|Coagulants|coagulants|mesh-ancestor
14068288|NCT02562417|Dexamethasone|dexamethasone|mesh-list
14068289|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14068290|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
14068291|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
14068292|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068293|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068294|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14068295|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
14068296|NCT02562417|Hormones|hormones|mesh-ancestor
14068297|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068298|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14068299|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068300|NCT02562651|Doxycycline|doxycycline|mesh-list
14068301|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068302|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068303|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
14068304|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14068305|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14068306|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
14068307|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14068308|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068309|NCT02562664|Metformin|metformin|mesh-list
14068310|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14068311|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068312|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
14068313|NCT02562365|Carboplatin|carboplatin|mesh-list
14068314|NCT02562365|Etoposide|etoposide|mesh-list
14068315|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068316|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
14068317|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068318|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14068319|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14068320|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
14068321|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068322|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068323|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14068324|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14068325|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14068326|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14068327|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068328|NCT02562443|ON 01910|on 01910|mesh-list
14068329|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068330|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14068331|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068332|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068333|NCT02562508|Vaccines|vaccines|mesh-list
14068334|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
14068335|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068336|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
14068337|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14068338|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068339|NCT02562144|Lidocaine|lidocaine|mesh-list
14068340|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
14068341|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
14068342|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068343|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068344|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
14068345|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068346|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13914143|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
13914144|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
14068347|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14068348|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14068349|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068350|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068351|NCT02562300|Misoprostol|misoprostol|mesh-list
14068352|NCT02562300|Oxytocin|oxytocin|mesh-list
14068353|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
14476174|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14476175|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476176|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14476177|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476178|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476179|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
14476180|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
14476181|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14476182|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14476183|NCT02412761|Protective Agents|protective agents|mesh-ancestor
14476184|NCT02412878|Dexamethasone|dexamethasone|mesh-list
14476185|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476186|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
14476187|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
14476188|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476189|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476190|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476191|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
14476192|NCT02412878|Hormones|hormones|mesh-ancestor
14476193|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476194|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476195|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479196|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479197|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14479198|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479199|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14479200|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14479201|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479202|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14479203|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
14479204|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
14479205|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914145|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13914146|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
14479206|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14479207|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
14767297|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14068354|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14068355|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914147|NCT03482180|Atorvastatin|atorvastatin|mesh-list
13914148|NCT03482180|Calcium|calcium|mesh-list
13914149|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13914150|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914151|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13914152|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13914153|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
13914154|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914155|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13914156|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13914157|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914158|NCT03482167|Niacinamide|niacinamide|mesh-list
13914159|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
13914160|NCT03482167|Vitamins|vitamins|mesh-ancestor
14758288|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758289|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758290|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14758291|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14758292|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
14758293|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
14758294|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758295|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758296|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
14758297|NCT05250973|Hormones|hormones|mesh-ancestor
14934007|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934008|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934009|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
14068356|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14068357|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
14068358|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14068359|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14068360|NCT02562118|Letrozole|letrozole|mesh-list
14068361|NCT02562118|Lenvatinib|lenvatinib|mesh-list
14068362|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068363|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14068364|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14068365|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068366|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068367|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14068368|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
14068369|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068370|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068371|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14068372|NCT02562183|Kallikreins|kallikreins|mesh-list
14068373|NCT02562183|Coagulants|coagulants|mesh-ancestor
14068374|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14068375|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
14068376|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14068377|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068378|NCT02562287|Olanzapine|olanzapine|mesh-list
14068379|NCT02562287|Risperidone|risperidone|mesh-list
14068380|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14068381|NCT02562287|Clozapine|clozapine|mesh-list
14068382|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14068383|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
14068384|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068385|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068386|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068387|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14068388|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14068389|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068390|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14068391|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14068392|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
14068393|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
14068394|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
14068395|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476196|NCT02412982|Enoxaparin|enoxaparin|mesh-list
14476197|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
14476198|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
14476199|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14476200|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14476201|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476202|NCT02413034|Vancomycin|vancomycin|mesh-list
14476203|NCT02413034|Cefazolin|cefazolin|mesh-list
14476204|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14476205|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476206|NCT02413203|Celecoxib|celecoxib|mesh-list
14476207|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14068396|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14068397|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14068398|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14068399|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068400|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
14068401|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
14068402|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
14068403|NCT02562053|Fluoxetine|fluoxetine|mesh-list
14758298|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068404|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
14476208|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14934010|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14934011|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14938657|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938658|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938659|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14938660|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068405|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
14068406|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14068407|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14068408|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068409|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14068410|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14068411|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068412|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068413|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068414|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
14068415|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14068416|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
14068417|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14068418|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14068419|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14068420|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068421|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14068422|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
14068423|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14068424|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068425|NCT02561936|Rilpivirine|rilpivirine|mesh-list
14068426|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14068427|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14068428|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068429|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068430|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
14068431|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068432|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14068433|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14068434|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
14068435|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
14068436|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14068437|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14068438|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068439|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
14068440|NCT02561923|Coagulants|coagulants|mesh-ancestor
14068441|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14068442|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
14068443|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14068444|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
14068445|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068446|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
14068447|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14068448|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14068449|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14068450|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14068451|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
14068452|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068453|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14068454|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14068455|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068456|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14068457|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14068458|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14068459|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14068460|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14068461|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14068462|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
14068463|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068464|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14068465|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14068466|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068467|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
14068468|NCT02561767|Tacrolimus|tacrolimus|mesh-list
14068469|NCT02561767|Basiliximab|basiliximab|mesh-list
14068470|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068471|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
14068472|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068473|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14068474|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068475|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068476|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14068477|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068478|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14068479|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
14068480|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068481|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068482|NCT02561494|Nefopam|nefopam|mesh-list
14068483|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14068484|NCT02561494|Analgesics|analgesics|mesh-ancestor
14068485|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
14068486|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068487|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068488|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14068489|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14068490|NCT02561468|Nefopam|nefopam|mesh-list
14068491|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14068492|NCT02561468|Analgesics|analgesics|mesh-ancestor
14068493|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
14068494|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068495|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172542|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172543|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172544|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14172545|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14172546|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
14172547|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14758299|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14758300|NCT05246670|Palmidrol|palmidrol|mesh-list
14758301|NCT05246670|Analgesics|analgesics|mesh-ancestor
14758302|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
14758303|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914161|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
13914162|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914163|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
13914164|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914165|NCT03482102|Durvalumab|durvalumab|mesh-list
13914166|NCT03482102|Tremelimumab|tremelimumab|mesh-list
13914167|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13914168|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914169|NCT03482024|Tirzepatide|tirzepatide|mesh-list
13914170|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13914171|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914172|NCT03482024|Incretins|incretins|mesh-ancestor
13914173|NCT03482024|Hormones|hormones|mesh-ancestor
13914174|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914175|NCT03481998|Letrozole|letrozole|mesh-list
13914176|NCT03481998|Fulvestrant|fulvestrant|mesh-list
13914177|NCT03481998|Anastrozole|anastrozole|mesh-list
13914178|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914179|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13914180|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13914181|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914182|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914183|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13914184|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
13914185|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914186|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914187|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914188|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13914189|NCT03481972|Doxycycline|doxycycline|mesh-list
13914190|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14068496|NCT02561117|Metronidazole|metronidazole|mesh-list
14068497|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068498|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068499|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14068500|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14068501|NCT02561169|Oseltamivir|oseltamivir|mesh-list
14068502|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
14068503|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
14068504|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068505|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068506|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068507|NCT02561169|Antacids|antacids|mesh-ancestor
14068508|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14068509|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
14068510|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14068511|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068512|NCT02561013|Monensin|monensin|mesh-list
14068513|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
14068514|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068515|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14068516|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14068517|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
14068518|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
14068519|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
14068520|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068521|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068522|NCT02561013|Ionophores|ionophores|mesh-ancestor
14068523|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068524|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
14068525|NCT02560974|Capecitabine|capecitabine|mesh-list
14068526|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
14068527|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14068528|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
14068529|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068530|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068531|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
14068532|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068533|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
14068534|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068535|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068536|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14068537|NCT02560909|Vaccines|vaccines|mesh-list
14068538|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
14068539|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068540|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
14068541|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14934012|NCT01453881|Beclomethasone|beclomethasone|mesh-list
13914191|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13914192|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914193|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
13914194|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13914195|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13914196|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
13914197|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13914198|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476209|NCT02413203|Analgesics|analgesics|mesh-ancestor
14476210|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
14476211|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476212|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068542|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14068543|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068544|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
14068545|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
14068546|NCT02560766|Gabapentin|gabapentin|mesh-list
14068547|NCT02560766|Analgesics|analgesics|mesh-ancestor
14068548|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
14068549|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068550|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068551|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
14068552|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14068553|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14068554|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068555|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14068556|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14068557|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14068558|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068559|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068560|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
14068561|NCT02560688|Clopidogrel|clopidogrel|mesh-list
14068562|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14068563|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14068564|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14068565|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14068566|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
14068567|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068568|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068569|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068570|NCT02560649|Tenofovir|tenofovir|mesh-list
14068571|NCT02560649|Lamivudine|lamivudine|mesh-list
14068572|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14068573|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
14068574|NCT02560649|Entecavir|entecavir|mesh-list
14068575|NCT02560649|Adefovir|adefovir|mesh-list
14068576|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14068577|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
14068578|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068579|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14068580|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14068581|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068582|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068583|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14068584|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14068585|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
14068586|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068587|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
14068588|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14068589|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068590|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14068591|NCT02560376|Exenatide|exenatide|mesh-list
14068592|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14068593|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068594|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14068595|NCT02560376|Incretins|incretins|mesh-ancestor
14068596|NCT02560376|Hormones|hormones|mesh-ancestor
14068597|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068598|NCT02560220|Mitomycins|mitomycins|mesh-list
14068599|NCT02560220|Mitomycin|mitomycin|mesh-list
14068600|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14068601|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068602|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
14068603|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068604|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14068605|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934013|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
14934014|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14934015|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
14934016|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934017|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934018|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14934019|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
14934020|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14934021|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14934022|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14068606|NCT02560207|Cefotaxime|cefotaxime|mesh-list
14068607|NCT02560207|Cefoxitin|cefoxitin|mesh-list
14068608|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068609|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068610|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
14068611|NCT02560155|Mupirocin|mupirocin|mesh-list
14068612|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14068613|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068614|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
14068615|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068616|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14068617|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068618|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068619|NCT02559973|Buprenorphine|buprenorphine|mesh-list
14068620|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14068621|NCT02559973|Naloxone|naloxone|mesh-list
14068622|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14068623|NCT02559973|Narcotics|narcotics|mesh-ancestor
14068624|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068625|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068626|NCT02559973|Analgesics|analgesics|mesh-ancestor
14068627|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
14068628|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068629|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14068630|NCT02559921|Vaccines|vaccines|mesh-list
14068631|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
14068632|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068633|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
14068634|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14068635|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
14068636|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068637|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
14068638|NCT02559908|Protective Agents|protective agents|mesh-ancestor
14068639|NCT02559791|Reslizumab|reslizumab|mesh-list
14068640|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14068641|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
14758304|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758305|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14758306|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758307|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14758308|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14758309|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
14758310|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758311|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14758312|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14758313|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758314|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758315|NCT05246670|Hormones|hormones|mesh-ancestor
14068657|NCT02559674|Gemcitabine|gemcitabine|mesh-list
14068658|NCT02559674|Paclitaxel|paclitaxel|mesh-list
14068659|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14068660|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068661|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14068662|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14068663|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14068664|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068665|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14068666|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
14068667|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
14068668|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068669|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068670|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068671|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
14068672|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172548|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
14068673|NCT02559648|Denosumab|denosumab|mesh-list
14068674|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14068675|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068676|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
14068677|NCT02559440|Phenylephrine|phenylephrine|mesh-list
14068678|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
14068679|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14068680|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
14068681|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14068682|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14068683|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14068684|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068685|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068686|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068687|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068688|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
14068689|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
14758316|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758317|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14758318|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14068690|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068691|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
14068692|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14068693|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
14068694|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14068695|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
14068696|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14068697|NCT02559440|Protective Agents|protective agents|mesh-ancestor
14068698|NCT02559388|Montelukast|montelukast|mesh-list
14068699|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14068700|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
14068701|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14068702|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
14068703|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068704|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068705|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14068706|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14068707|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068708|NCT02559297|Sevoflurane|sevoflurane|mesh-list
14068709|NCT02559297|Desflurane|desflurane|mesh-list
14068710|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14068711|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14068712|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
14068713|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
14476213|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476214|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14476215|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14476216|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14476217|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914208|NCT03481920|Avelumab|avelumab|mesh-list
13914209|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13914210|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914211|NCT03481790|Folic Acid|folic acid|mesh-list
13914212|NCT03481790|Lactoferrin|lactoferrin|mesh-list
13914213|NCT03481790|Vitamins|vitamins|mesh-ancestor
13914214|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
14068714|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476218|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476219|NCT02413320|Paclitaxel|paclitaxel|mesh-list
14476220|NCT02413320|Docetaxel|docetaxel|mesh-list
14476221|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
14476222|NCT02413320|Carboplatin|carboplatin|mesh-list
14476223|NCT02413320|Doxorubicin|doxorubicin|mesh-list
14476224|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14476225|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068715|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068716|NCT02559232|Anticoagulants|anticoagulants|mesh-list
14068717|NCT02559154|Thalidomide|thalidomide|mesh-list
14068718|NCT02559154|Dexamethasone|dexamethasone|mesh-list
14068719|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
14068720|NCT02559154|Doxorubicin|doxorubicin|mesh-list
14068721|NCT02559154|Bortezomib|bortezomib|mesh-list
14068722|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068723|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
14068724|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068725|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14068726|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14934023|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934024|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934025|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068727|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
14068728|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068729|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068730|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14068731|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14758319|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758320|NCT05242965|Vaccines|vaccines|mesh-list
14758321|NCT05242965|Sargramostim|sargramostim|mesh-list
14758322|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
14758323|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758324|NCT05239910|Tenalisib|tenalisib|mesh-list
14758325|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
14758326|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068732|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
14068733|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
14068734|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758327|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068735|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14068736|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
14068737|NCT02559154|Hormones|hormones|mesh-ancestor
14068738|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068739|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14068740|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14068741|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14068742|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14068743|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068744|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
14068745|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068746|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068747|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14068748|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14068749|NCT02559154|Growth Substances|growth substances|mesh-ancestor
14068750|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
14068751|NCT02559167|Cannabidiol|cannabidiol|mesh-list
14068752|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
14068753|NCT02559180|Aflibercept|aflibercept|mesh-list
14068754|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14068755|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14068756|NCT02559180|Growth Substances|growth substances|mesh-ancestor
14068757|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068758|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
14068759|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068760|NCT02559141|Dobutamine|dobutamine|mesh-list
14068761|NCT02559141|Norepinephrine|norepinephrine|mesh-list
14068762|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14068763|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14934026|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14934027|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
14934028|NCT01453881|Hormones|hormones|mesh-ancestor
14934029|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934030|NCT01453920|Ranibizumab|ranibizumab|mesh-list
14068764|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068765|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172549|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13914215|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068766|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068767|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068768|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
14068769|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
14068770|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068771|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14068772|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14068773|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14068774|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14068775|NCT02559141|Protective Agents|protective agents|mesh-ancestor
14068776|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
14068777|NCT02559102|Anesthetics|anesthetics|mesh-list
14068778|NCT02559102|Sevoflurane|sevoflurane|mesh-list
14068779|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068780|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068781|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14068782|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14068783|NCT02559102|Analgesics|analgesics|mesh-ancestor
14068784|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
14068785|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068786|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14068787|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14068788|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14068789|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068790|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068791|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068792|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14068793|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14068794|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
14068795|NCT02558972|Droxidopa|droxidopa|mesh-list
14068796|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14068797|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14068798|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14068799|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
14068800|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068801|NCT02558933|Protective Agents|protective agents|mesh-ancestor
14068802|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068803|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14068804|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14068805|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068806|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14068807|NCT02558959|Capecitabine|capecitabine|mesh-list
14068808|NCT02558959|Irinotecan|irinotecan|mesh-list
14068809|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14068810|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
14068811|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068812|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068813|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14068814|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14068815|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068816|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
14068817|NCT02558868|Irinotecan|irinotecan|mesh-list
13914216|NCT03481790|Hematinics|hematinics|mesh-ancestor
13914217|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
13914218|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914219|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
13914220|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
13914221|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13914222|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914223|NCT03481517|Bupivacaine|bupivacaine|mesh-list
13914224|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
13914225|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
13914226|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068818|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914227|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914228|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
13914229|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914230|NCT03481400|Calcitonin|calcitonin|mesh-list
13914231|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
13914232|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
13914233|NCT03481400|Katacalcin|katacalcin|mesh-list
13914234|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13914235|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914236|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13914237|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
14068819|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14068820|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14068821|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068822|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068823|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
14068824|NCT02558816|Venetoclax|venetoclax|mesh-list
14068825|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14068826|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068827|NCT02558751|Vaccines|vaccines|mesh-list
14068828|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14068829|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
14068830|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068831|NCT02558595|Niacinamide|niacinamide|mesh-list
14068832|NCT02558595|Niacin|niacin|mesh-list
14068833|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
14068834|NCT02558595|Vitamins|vitamins|mesh-ancestor
14068835|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
14068836|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068837|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
14068838|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14068839|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
14068840|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068841|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14068842|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
14068843|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
14068844|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
14068845|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
14068846|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068847|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068848|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
14068849|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068850|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
14068851|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14068852|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
14068853|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14068854|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
14068855|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068856|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068857|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
14068858|NCT02558517|Prednisone|prednisone|mesh-list
14068859|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14068860|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
14068861|NCT02558517|Hormones|hormones|mesh-ancestor
14068862|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068863|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068864|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14068865|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068866|NCT02558452|Tacrolimus|tacrolimus|mesh-list
14068867|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14068868|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
14068869|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068870|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14068871|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068872|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068873|NCT02558387|Nintedanib|nintedanib|mesh-list
14068874|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068875|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14068876|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068877|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068878|NCT02558205|Liver Extracts|liver extracts|mesh-list
14068879|NCT02558205|Hematinics|hematinics|mesh-ancestor
14068880|NCT02558283|Lidocaine|lidocaine|mesh-list
14068881|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
14068882|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
14068883|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068884|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068885|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
14068886|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068887|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14068888|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14068889|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14068890|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068891|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068892|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
14068893|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14068894|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068895|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14068896|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068897|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14068898|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14068899|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14068900|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068901|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
14068902|NCT02558218|Hormones|hormones|mesh-ancestor
14068903|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14068904|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068905|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14068906|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14068907|NCT02558361|Apremilast|apremilast|mesh-list
14068908|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14068909|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14068910|NCT02558361|Analgesics|analgesics|mesh-ancestor
14068911|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
14068912|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068913|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068914|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14068915|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14068916|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14068917|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14068918|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14068919|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068920|NCT02558153|Paclitaxel|paclitaxel|mesh-list
14068921|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14068922|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14068923|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
14068924|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
14068925|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
14068926|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068927|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14068928|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14068929|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
14068930|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068931|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068932|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14934031|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14934032|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14934033|NCT01453920|Growth Substances|growth substances|mesh-ancestor
14934034|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934035|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
14934036|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934037|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
14934038|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14934039|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14934040|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
14934041|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934042|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14934043|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13914238|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
13914239|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914240|NCT03480997|Bromides|bromides|mesh-list
13914241|NCT03480997|Albuterol|albuterol|mesh-list
13914242|NCT03480997|Ipratropium|ipratropium|mesh-list
13914243|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
13914244|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13914245|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
13914246|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068933|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
14068934|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14934044|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934045|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934046|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
14934047|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14934048|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
14934049|NCT01454011|Testosterone|testosterone|mesh-list
14934050|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
14934051|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
14934052|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14934053|NCT01454011|Androgens|androgens|mesh-ancestor
14934054|NCT01454011|Hormones|hormones|mesh-ancestor
14934055|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934056|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934057|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14934058|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934059|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
14934060|NCT01454154|Glyburide|glyburide|mesh-list
14068935|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14068936|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14068937|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068938|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068939|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068940|NCT02558114|Ribavirin|ribavirin|mesh-list
14068941|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
14068942|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068943|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
14068944|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14068945|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
14068946|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
14068947|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
14068948|NCT02558023|Nicardipine|nicardipine|mesh-list
14758358|NCT05237687|Sirolimus|sirolimus|mesh-list
14758359|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14758360|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758361|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14758362|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758363|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
14758364|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758365|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
14758366|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758367|NCT05236985|Oxytocin|oxytocin|mesh-list
14758368|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
14758369|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14758370|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767298|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767299|NCT00629473|Dexamethasone|dexamethasone|mesh-list
14767300|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14767301|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767302|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
14767303|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
14767304|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767305|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068949|NCT02558023|Urapidil|urapidil|mesh-list
14068950|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14068951|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14068952|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068953|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068954|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14068955|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767306|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767307|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
14934061|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934062|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068956|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
14068957|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14068958|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
14068959|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068960|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14068961|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14068962|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14068963|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14068964|NCT02557932|Bismuth|bismuth|mesh-list
14068965|NCT02557932|Antacids|antacids|mesh-ancestor
14068966|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068967|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172550|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14172551|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14172552|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14172553|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14172554|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14172555|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14172556|NCT04808895|Aspirin|aspirin|mesh-list
14172557|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14172558|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14172559|NCT04808895|Analgesics|analgesics|mesh-ancestor
14172560|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
14172561|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172562|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172563|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172564|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14172565|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14172566|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14172567|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172568|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14172569|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14172570|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172571|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
14183317|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183318|NCT04728932|Protective Agents|protective agents|mesh-ancestor
14183319|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183320|NCT04728880|Remdesivir|remdesivir|mesh-list
14183321|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
14183322|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183323|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
14183324|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183325|NCT04728971|Caspofungin|caspofungin|mesh-list
14183326|NCT04728971|Micafungin|micafungin|mesh-list
14183327|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
14183328|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183329|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183330|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183331|NCT04728750|Pancrelipase|pancrelipase|mesh-list
14183332|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183333|NCT04728516|Amoxicillin|amoxicillin|mesh-list
14183334|NCT04728516|Pantoprazole|pantoprazole|mesh-list
14183335|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14183336|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183337|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14183338|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183339|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14183340|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183341|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183342|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14183343|NCT04728581|Mirtazapine|mirtazapine|mesh-list
14183344|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
14183345|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14068968|NCT02557984|Naltrexone|naltrexone|mesh-list
14068969|NCT02557984|Amisulpride|amisulpride|mesh-list
14068970|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14068971|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14068972|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068973|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
14068974|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068975|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14068976|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14068977|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14068978|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14068979|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14068980|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
14068981|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068982|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068983|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14068984|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
14068985|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
14068986|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14068987|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14068988|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14068989|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14068990|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14068991|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
14068992|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14068993|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14068994|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14068995|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14068996|NCT02557945|Gabapentin|gabapentin|mesh-list
14068997|NCT02557945|Analgesics|analgesics|mesh-ancestor
14068998|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
14068999|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069000|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069001|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
14069002|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14069003|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14069004|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069005|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14069006|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14069007|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14069008|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069009|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069010|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
14069011|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
14069012|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14069013|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069014|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069015|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14069016|NCT02557867|Analgesics|analgesics|mesh-ancestor
14069017|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
14069018|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069019|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14069020|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14069021|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14069022|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
14069023|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069024|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069025|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
14069026|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14758371|NCT05232032|Nociceptin|nociceptin|mesh-list
14758372|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
14758373|NCT05227391|Letrozole|letrozole|mesh-list
14758374|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14758375|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14758376|NCT05227391|Estradiol|estradiol|mesh-list
14758377|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14069027|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14069028|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14069029|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14069030|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069031|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
14069032|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758378|NCT05227391|Estrogens|estrogens|mesh-ancestor
14758379|NCT05227391|Hormones|hormones|mesh-ancestor
14069033|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069034|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14069035|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069036|NCT02557789|Lefamulin|lefamulin|mesh-list
14069037|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069038|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069039|NCT02557581|Terbutaline|terbutaline|mesh-list
14069040|NCT02557581|Clenbuterol|clenbuterol|mesh-list
14069041|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14069042|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
14069043|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069044|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069045|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14069046|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
14069047|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
14069048|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
14069049|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14069050|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14069051|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14069052|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14069053|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14069054|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069055|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069056|NCT02557958|Azithromycin|azithromycin|mesh-list
14758380|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758381|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758382|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14069057|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069058|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069059|NCT02557854|Doxorubicin|doxorubicin|mesh-list
14069060|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14069061|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14069062|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069063|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14069064|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14069065|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914247|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914248|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13914249|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
13914250|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
13914251|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13914252|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13914253|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14758383|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
14758384|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14758385|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14758386|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758387|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14767308|NCT00629473|Hormones|hormones|mesh-ancestor
14069066|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069067|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14069068|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14069069|NCT02557451|Growth Substances|growth substances|mesh-ancestor
14069070|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069071|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
14069072|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069073|NCT02557594|Tenofovir|tenofovir|mesh-list
14069074|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
14069075|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069076|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14069077|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14069078|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069079|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069080|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14069081|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14069082|NCT02557542|Polidocanol|polidocanol|mesh-list
14069083|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
13914254|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14069084|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14069085|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14069086|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
14069087|NCT02557490|Raltitrexed|raltitrexed|mesh-list
14069088|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069089|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14069090|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
14069091|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069092|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14069093|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069094|NCT02557503|Fluorouracil|fluorouracil|mesh-list
14069095|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
14069096|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
14069097|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069098|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14069099|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069100|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14069101|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
14069102|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069103|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
14069104|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
14069105|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
14069106|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069107|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069108|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
14069109|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069110|NCT02557373|Vitamins|vitamins|mesh-list
14069111|NCT02557373|Vitamin A|vitamin a|mesh-list
14758388|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14758389|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758390|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758391|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14069112|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
14069113|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
14069114|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069115|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
14069116|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069117|NCT02557373|Protective Agents|protective agents|mesh-ancestor
14069118|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14069119|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069120|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
14069121|NCT02557269|Azelastine|azelastine|mesh-list
14069122|NCT02557269|Prednisolone|prednisolone|mesh-list
14069123|NCT02557269|Xylometazoline|xylometazoline|mesh-list
14758392|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
14758393|NCT05216952|Misoprostol|misoprostol|mesh-list
14758394|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
14758395|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14758396|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
14758397|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14758398|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758399|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14758400|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758401|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
14758402|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14758403|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
13914255|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914256|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914257|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914258|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13914259|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
13914260|NCT03480958|Morphine|morphine|mesh-list
13914261|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13914262|NCT03480958|Narcotics|narcotics|mesh-ancestor
13914263|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914264|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069124|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069125|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
14069126|NCT02557269|Hormones|hormones|mesh-ancestor
14758404|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14069127|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069128|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069129|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14069130|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069131|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
14069132|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069133|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
14069134|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14069135|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14069136|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14069137|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
14069138|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14069139|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069140|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069141|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14069142|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14069143|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
14069144|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
14069145|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069146|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
14069147|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14069148|NCT02557087|Meperidine|meperidine|mesh-list
14069149|NCT02557087|Scopolamine|scopolamine|mesh-list
14069150|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14069151|NCT02557087|Narcotics|narcotics|mesh-ancestor
14069152|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069153|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069154|NCT02557087|Analgesics|analgesics|mesh-ancestor
14069155|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
14069156|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069157|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14069158|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
14069159|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
14069160|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069161|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
14069162|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14069163|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
14069164|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069165|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069166|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14069167|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
14069168|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
14069169|NCT02556931|Fludarabine|fludarabine|mesh-list
14069170|NCT02556931|Tacrolimus|tacrolimus|mesh-list
14069171|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14069172|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
14069173|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069174|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14758405|NCT05207722|Aldesleukin|aldesleukin|mesh-list
14758406|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
14758407|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
14758408|NCT05207722|Trastuzumab|trastuzumab|mesh-list
14069175|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14069176|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
14069177|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069178|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069179|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14069180|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14069181|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069182|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14069183|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14069184|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
14069185|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069186|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069187|NCT02556905|Dexamethasone|dexamethasone|mesh-list
14069188|NCT02556905|Lenalidomide|lenalidomide|mesh-list
14758409|NCT05207722|Fludarabine|fludarabine|mesh-list
14758410|NCT05207722|Interleukin-2|interleukin-2|mesh-list
14758411|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758412|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
14069189|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069190|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
14758413|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934063|NCT01454180|Leucovorin|leucovorin|mesh-list
14934064|NCT01454180|Gemcitabine|gemcitabine|mesh-list
14069191|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
14069192|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069193|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069194|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069195|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
14069196|NCT02556905|Hormones|hormones|mesh-ancestor
14069197|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069198|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14069199|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069200|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
14069201|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14069202|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14069203|NCT02556905|Growth Substances|growth substances|mesh-ancestor
14069204|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
14069205|NCT02556970|Acetaminophen|acetaminophen|mesh-list
14069206|NCT02556970|Diclofenac|diclofenac|mesh-list
14069207|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
14069208|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14069209|NCT02556970|Analgesics|analgesics|mesh-ancestor
14069210|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
14069211|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069212|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069213|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
14069214|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14069215|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069216|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14069217|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14069218|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069219|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069220|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
14069221|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
14069222|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069223|NCT02556879|Liver Extracts|liver extracts|mesh-list
14069224|NCT02556879|Antibodies|antibodies|mesh-list
14069225|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
14069226|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069227|NCT02556879|Hematinics|hematinics|mesh-ancestor
14069228|NCT02556866|Prednisone|prednisone|mesh-list
14069229|NCT02556866|Rituximab|rituximab|mesh-list
14069230|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14069231|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069232|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
14069233|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069234|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14069235|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069236|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
14069237|NCT02556866|Hormones|hormones|mesh-ancestor
14069238|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069239|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14069240|NCT02556723|Aflibercept|aflibercept|mesh-list
14069241|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14069242|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14069243|NCT02556723|Growth Substances|growth substances|mesh-ancestor
14069244|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069245|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14069246|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069247|NCT02556658|Anesthetics|anesthetics|mesh-list
14069248|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069249|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069250|NCT02556814|Dexamethasone|dexamethasone|mesh-list
14069251|NCT02556814|Caffeic acid|caffeic acid|mesh-list
14069252|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069253|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
14069254|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
14069255|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758414|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14069256|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069257|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069258|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
14069259|NCT02556814|Hormones|hormones|mesh-ancestor
14069260|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069261|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14069262|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069263|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
14069264|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934065|NCT01454180|Capecitabine|capecitabine|mesh-list
13914265|NCT03480958|Analgesics|analgesics|mesh-ancestor
13914266|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
13914267|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914268|NCT03480945|Nitroprusside|nitroprusside|mesh-list
13914269|NCT03480945|Serotonin|serotonin|mesh-list
13914270|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13914271|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
13914272|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914273|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069265|NCT02556814|Protective Agents|protective agents|mesh-ancestor
14069266|NCT02556840|Insulin|insulin|mesh-list
14069267|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14069268|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069269|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14069270|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069271|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14069272|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069273|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069274|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
14069275|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14069276|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14069277|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
14069278|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14069279|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069280|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14069281|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14069282|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14069283|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14069284|NCT02556411|Estrogens|estrogens|mesh-ancestor
14069285|NCT02556411|Hormones|hormones|mesh-ancestor
14069286|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069287|NCT02556463|Durvalumab|durvalumab|mesh-list
14069288|NCT02556463|MEDI9197|medi9197|mesh-list
14069289|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14069290|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069291|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14069292|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
14069293|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069294|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
14069295|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14069296|NCT02556437|Antibodies|antibodies|mesh-list
14069297|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
14069298|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069299|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
14069300|NCT02556424|Dexamethasone|dexamethasone|mesh-list
14069301|NCT02556424|Triamcinolone|triamcinolone|mesh-list
14069302|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069303|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
14069304|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
14069305|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069306|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069307|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069308|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
14069309|NCT02556424|Hormones|hormones|mesh-ancestor
14069310|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069311|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14069312|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172572|NCT04808791|Trifluridine|trifluridine|mesh-list
14172573|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
14172574|NCT04808791|Irinotecan|irinotecan|mesh-list
14758415|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14758416|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
14758417|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758418|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172575|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172576|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14172577|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14172578|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172579|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172580|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
14172581|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
14172582|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172583|NCT04808687|Paclitaxel|paclitaxel|mesh-list
14172584|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14172585|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172586|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
14172587|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
14172588|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
14172589|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172590|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14172591|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
14172592|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172593|NCT04808622|Protective Agents|protective agents|mesh-ancestor
14172594|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172595|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14172596|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172597|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
14172598|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172599|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
14172600|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172601|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914274|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914275|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13914276|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
13914277|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13914278|NCT03480906|Latanoprost|latanoprost|mesh-list
13914279|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13914280|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13914281|NCT03480867|Temozolomide|temozolomide|mesh-list
13914282|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13914283|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
13914284|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914285|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914286|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
13914287|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14172602|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14172603|NCT04808323|Capecitabine|capecitabine|mesh-list
14172604|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
14172605|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13914288|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914289|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914290|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914291|NCT03480789|Analgesics|analgesics|mesh-ancestor
14758419|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14758420|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758421|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758422|NCT05207722|Analgesics|analgesics|mesh-ancestor
14172606|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
14069313|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14069314|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14069315|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14069316|NCT02556268|Triumeq|triumeq|mesh-list
14069317|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
14069318|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14069319|NCT02556268|Riociguat|riociguat|mesh-list
14069320|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
14069321|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
14069322|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069323|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
14069324|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069325|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14069326|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14069327|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069328|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14069329|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14069330|NCT02556229|Aflibercept|aflibercept|mesh-list
14069331|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14069332|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14069333|NCT02556229|Growth Substances|growth substances|mesh-ancestor
14069334|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069335|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14069336|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069337|NCT02556008|Cannabidiol|cannabidiol|mesh-list
14069338|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
14069339|NCT02556060|Lamotrigine|lamotrigine|mesh-list
14069340|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
14069341|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14069342|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14069343|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069344|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14758423|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
14758424|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758425|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13914292|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
13914293|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914294|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13914295|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13914296|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13914297|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914298|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914299|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914300|NCT03480646|Prednisone|prednisone|mesh-list
13914301|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
14069345|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069346|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14069347|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13914302|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13914303|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
13914304|NCT03480646|Hormones|hormones|mesh-ancestor
13914305|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914306|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914307|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914308|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914309|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914310|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914311|NCT03480607|Dexamethasone|dexamethasone|mesh-list
13914312|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
13914313|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13914314|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
13914315|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
13914316|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914317|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914318|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914319|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
13914320|NCT03480607|Hormones|hormones|mesh-ancestor
13914321|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914322|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914323|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914324|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13914325|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914326|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914327|NCT03480607|Analgesics|analgesics|mesh-ancestor
13914328|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
13914329|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14069348|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069349|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14069350|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14069351|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
14069352|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
14069353|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069354|NCT02555943|Ritonavir|ritonavir|mesh-list
14069355|NCT02555943|Tenofovir|tenofovir|mesh-list
14069356|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
14069357|NCT02555943|Entecavir|entecavir|mesh-list
14069358|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14069359|NCT02555943|Ledipasvir|ledipasvir|mesh-list
14069360|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14069361|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14069362|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
14069363|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069364|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069365|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14069366|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14069367|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
14069368|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069369|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14069370|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14069371|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14069372|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14069373|NCT02555813|Gemcitabine|gemcitabine|mesh-list
14069374|NCT02555813|Paclitaxel|paclitaxel|mesh-list
14069375|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14069376|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14069377|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069378|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
14069379|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
14069380|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
14069381|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069382|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14069383|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
14069384|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
14069385|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069386|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069387|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14069388|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
14069389|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069390|NCT02555800|Cidofovir|cidofovir|mesh-list
14069391|NCT02555800|Bevacizumab|bevacizumab|mesh-list
14069392|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14069393|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069394|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14069395|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14069396|NCT02555800|Growth Substances|growth substances|mesh-ancestor
14069397|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069398|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14069399|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
14069400|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069401|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069402|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069403|NCT02555839|Thalidomide|thalidomide|mesh-list
14069404|NCT02555839|Dexamethasone|dexamethasone|mesh-list
14069405|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
14069406|NCT02555839|Bortezomib|bortezomib|mesh-list
14069407|NCT02555839|Pomalidomide|pomalidomide|mesh-list
14069408|NCT02555839|BB 1101|bb 1101|mesh-list
14069409|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069410|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
14069411|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
14069412|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069413|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069414|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069415|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
14069416|NCT02555839|Hormones|hormones|mesh-ancestor
14069417|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069418|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14069419|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069420|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
14069421|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069422|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069423|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
14069424|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14069425|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14069426|NCT02555839|Growth Substances|growth substances|mesh-ancestor
14069427|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
14069428|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14069429|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
14069430|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069431|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069432|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14069433|NCT02555852|Esomeprazole|esomeprazole|mesh-list
14069434|NCT02555852|Omeprazole|omeprazole|mesh-list
14069435|NCT02555852|Rabeprazole|rabeprazole|mesh-list
14069436|NCT02555852|Pantoprazole|pantoprazole|mesh-list
14069437|NCT02555852|Lansoprazole|lansoprazole|mesh-list
14069438|NCT02555852|Famotidine|famotidine|mesh-list
14069439|NCT02555852|Ranitidine|ranitidine|mesh-list
14069440|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14069441|NCT02555852|Cimetidine|cimetidine|mesh-list
14069442|NCT02555852|Nizatidine|nizatidine|mesh-list
14069443|NCT02555852|Lafutidine|lafutidine|mesh-list
14069444|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
14069445|NCT02555852|Bismuth|bismuth|mesh-list
14069446|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14069447|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
14069448|NCT02555852|Histamine|histamine|mesh-list
14069449|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
14069450|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069451|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14069452|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069453|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069454|NCT02555852|Antacids|antacids|mesh-ancestor
14069455|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
14069456|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
14069457|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069458|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069459|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
14069460|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14069461|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14069462|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069463|NCT02555696|Paclitaxel|paclitaxel|mesh-list
14758426|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14758427|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
13914330|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13914331|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13914332|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914333|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914334|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914335|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13914336|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
13914337|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914338|NCT03480516|Fluorides|fluorides|mesh-list
13914339|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
13914340|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
13914341|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
13914342|NCT03480516|Protective Agents|protective agents|mesh-ancestor
13914343|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914344|NCT03480438|Blinatumomab|blinatumomab|mesh-list
14069464|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14069465|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069466|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14758428|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069467|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14069468|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14069469|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069470|NCT02555644|Cetuximab|cetuximab|mesh-list
14069471|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069472|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14069473|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14069474|NCT02555761|Alcaftadine|alcaftadine|mesh-list
14069475|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14069476|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14069477|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
14069478|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
14069479|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069480|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069481|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069482|NCT02555748|Sunitinib|sunitinib|mesh-list
14069483|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069484|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14069485|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14069486|NCT02555748|Growth Substances|growth substances|mesh-ancestor
14069487|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069488|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
14069489|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14069490|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069491|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069492|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
14069493|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14069494|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069495|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069496|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14069497|NCT02555605|Analgesics|analgesics|mesh-ancestor
14069498|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
14758429|NCT05206110|Ketorolac|ketorolac|mesh-list
14758430|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14758431|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14069499|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069500|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14069501|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14069502|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14069503|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14069504|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069505|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069506|NCT02555488|Methylene Blue|methylene blue|mesh-list
14069507|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069508|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069509|NCT02555358|Docetaxel|docetaxel|mesh-list
14069510|NCT02555358|Capecitabine|capecitabine|mesh-list
14069511|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
14069512|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069513|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14069514|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14069515|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14069516|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069517|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14069518|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
14069519|NCT02555423|Anesthetics|anesthetics|mesh-list
14069520|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
14069521|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
14069522|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069523|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069524|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
14069525|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758432|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758433|NCT05206110|Analgesics|analgesics|mesh-ancestor
13914345|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914346|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
13914347|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
13914348|NCT03480360|Fludarabine|fludarabine|mesh-list
13914349|NCT03480360|Tacrolimus|tacrolimus|mesh-list
13914350|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13914351|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
13914352|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914353|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13914354|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13914355|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
14069526|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
14069527|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069528|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069529|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14069530|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14069531|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069532|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069533|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069534|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14069535|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14069536|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
14069537|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14069538|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
14069539|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14069540|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
14069541|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069542|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069543|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
14069544|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14069545|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14069546|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069547|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14069548|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14069549|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14758434|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
14758435|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758436|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758437|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14758438|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14758439|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14758440|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069550|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069551|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
14069552|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069553|NCT02555046|Anesthetics|anesthetics|mesh-list
14069554|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069555|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069556|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
14069557|NCT02554942|Hematinics|hematinics|mesh-ancestor
14069558|NCT02555007|Vinorelbine|vinorelbine|mesh-list
14069559|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14069560|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069561|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
14069562|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
14069563|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
14069564|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069565|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
14069566|NCT02554955|Daclizumab|daclizumab|mesh-list
14069567|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14069568|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069569|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14069570|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
14069571|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14758441|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758442|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14758443|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14758444|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
14934066|NCT01454180|Fluorouracil|fluorouracil|mesh-list
14934067|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14934068|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
14934069|NCT01454180|Folfirinox|folfirinox|mesh-list
14934070|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14934071|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
14934072|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934073|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934074|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
14069572|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069573|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069574|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069575|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14069576|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
14069577|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069578|NCT02554864|Lidocaine|lidocaine|mesh-list
14069579|NCT02554864|Ropivacaine|ropivacaine|mesh-list
14069580|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
14069581|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
14069582|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069583|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069584|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
14069585|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069586|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14069587|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14069588|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14069589|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14758445|NCT05200988|Nivolumab|nivolumab|mesh-list
14758446|NCT05200988|Ipilimumab|ipilimumab|mesh-list
14758447|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758448|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758449|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14758450|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758451|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14758452|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
14758453|NCT05191797|Atezolizumab|atezolizumab|mesh-list
14758454|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
14758455|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14758456|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
14758457|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758458|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
14758459|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758460|NCT05182840|Empagliflozin|empagliflozin|mesh-list
14758461|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14758462|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758463|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14069590|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069591|NCT02554851|Mitogens|mitogens|mesh-list
14069592|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
14069593|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069594|NCT02554812|Avelumab|avelumab|mesh-list
14069595|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14069596|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069597|NCT02554734|Levodopa|levodopa|mesh-list
14069598|NCT02554734|Carbidopa|carbidopa|mesh-list
14069599|NCT02554734|Entacapone|entacapone|mesh-list
14069600|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14069601|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14069602|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
14069603|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183346|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14758464|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069604|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069605|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069606|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14069607|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069608|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14069609|NCT02554695|Denosumab|denosumab|mesh-list
14069610|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14069611|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758465|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14758466|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14758467|NCT05177055|Methamphetamine|methamphetamine|mesh-list
14758468|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14758469|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758470|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
14758471|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
14758472|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758473|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
14758474|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758475|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758476|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
14758477|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14758478|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14758479|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14758480|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14172607|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172608|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172609|NCT04807816|Gemcitabine|gemcitabine|mesh-list
14172610|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14172611|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
14172612|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172613|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172614|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
14172615|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172616|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172617|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172618|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
14172619|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172620|NCT04807829|Nabilone|nabilone|mesh-list
14172621|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
14172622|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
14172623|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172624|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172625|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172626|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14172627|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14172628|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172629|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14172630|NCT04807569|Tamsulosin|tamsulosin|mesh-list
14172631|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14172632|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14172633|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14172634|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
14172635|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172636|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172637|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172638|NCT04807569|Urological Agents|urological agents|mesh-ancestor
14172639|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14172640|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
14172641|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14172642|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14172643|NCT04807504|Ropivacaine|ropivacaine|mesh-list
14172644|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
14069612|NCT02554318|Rifampin|rifampin|mesh-list
14069613|NCT02554318|Isoniazid|isoniazid|mesh-list
14069614|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
14069615|NCT02554318|Ethambutol|ethambutol|mesh-list
14069616|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14069617|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
14069618|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069619|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069620|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
14069621|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14069622|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069623|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069624|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14069625|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14069626|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14069627|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14069628|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14069629|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14069630|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14069631|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14069632|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
14069633|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14069634|NCT02554357|Bupivacaine|bupivacaine|mesh-list
14069635|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
14069636|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
14069637|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069638|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069639|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
14069640|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069641|NCT02554175|Propofol|propofol|mesh-list
14069642|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14069643|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069644|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069645|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14069646|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
14069647|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
14069648|NCT02554344|Curcumin|curcumin|mesh-list
14069649|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14069650|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14069651|NCT02554344|Analgesics|analgesics|mesh-ancestor
14069652|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
14069653|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069654|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069655|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069656|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14069657|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069658|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069659|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069660|NCT02554123|Vitamin E|vitamin e|mesh-list
14069661|NCT02554123|Petrolatum|petrolatum|mesh-list
14069662|NCT02554123|Vitamins|vitamins|mesh-ancestor
14069663|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
14069664|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069665|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
14069666|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069667|NCT02554123|Protective Agents|protective agents|mesh-ancestor
14069668|NCT02554123|Emollients|emollients|mesh-ancestor
14069669|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
14069670|NCT02554045|Tadalafil|tadalafil|mesh-list
14069671|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14069672|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14069673|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14069674|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069675|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069676|NCT02554045|Urological Agents|urological agents|mesh-ancestor
14069677|NCT02553824|Topiramate|topiramate|mesh-list
14069678|NCT02553824|Phentermine|phentermine|mesh-list
14069679|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
14069680|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14069681|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069682|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14069683|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
14069684|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14069685|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
14069686|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
14069687|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069688|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14069689|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069690|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069691|NCT02553551|Vitamins|vitamins|mesh-list
14069692|NCT02553551|Ascorbic Acid|ascorbic acid|mesh-list
14069693|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
14069694|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069695|NCT02553551|Antioxidants|antioxidants|mesh-ancestor
14069696|NCT02553551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069697|NCT02553551|Protective Agents|protective agents|mesh-ancestor
14069698|NCT02553642|Nivolumab|nivolumab|mesh-list
14069699|NCT02553642|Ipilimumab|ipilimumab|mesh-list
14069700|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14069701|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069702|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14069703|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069704|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
14069705|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13914356|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914357|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914358|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14069706|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069707|NCT02553603|Hormones|hormones|mesh-list
14069708|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14069709|NCT02553603|Tesamorelin|tesamorelin|mesh-list
14069710|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069711|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069712|NCT02553603|Growth Substances|growth substances|mesh-ancestor
14069713|NCT02553226|Oxytocin|oxytocin|mesh-list
14934075|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914359|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13914360|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914361|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13914362|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13914363|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
13914364|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069714|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
14069715|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14069716|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069717|NCT02553083|Amoxicillin|amoxicillin|mesh-list
14069718|NCT02553083|Doxycycline|doxycycline|mesh-list
14069719|NCT02553083|Esomeprazole|esomeprazole|mesh-list
14069720|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069721|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069722|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
14069723|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14069724|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14069725|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14069726|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069727|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14069728|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069729|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069730|NCT02553018|Methotrexate|methotrexate|mesh-list
14069731|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14069732|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
14069733|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14069734|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069735|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14069736|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
14069737|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069738|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069739|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
14069740|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069741|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14069742|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14069743|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
14069744|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14069745|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14069746|NCT02552745|Parecoxib|parecoxib|mesh-list
14934076|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934077|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934078|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
14934079|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934080|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14069747|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14069748|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14069749|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914365|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914366|NCT03480334|Nivolumab|nivolumab|mesh-list
13914367|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13914368|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914369|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13914370|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914371|NCT03480321|Cilostazol|cilostazol|mesh-list
13914372|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14069750|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069751|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14069752|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14069753|NCT02552745|Analgesics|analgesics|mesh-ancestor
14069754|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
14069755|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069756|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069757|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069758|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14069759|NCT02553044|Vitamin D|vitamin d|mesh-list
14069760|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
14069761|NCT02553044|Vitamins|vitamins|mesh-ancestor
14069762|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
14069763|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069764|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14069765|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14069766|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
14069767|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172645|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
14172646|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172647|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172648|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
14172649|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172650|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
13914373|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
14172651|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14069768|NCT02552641|Amoxicillin|amoxicillin|mesh-list
14069769|NCT02552641|Clarithromycin|clarithromycin|mesh-list
14069770|NCT02552641|Esomeprazole|esomeprazole|mesh-list
14069771|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069772|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069773|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14069774|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069775|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14069776|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069777|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069778|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14069779|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14069780|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14069781|NCT02552459|Sufentanil|sufentanil|mesh-list
14069782|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
14069783|NCT02552459|Dsuvia|dsuvia|mesh-list
14069784|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14069785|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14069786|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069787|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14069788|NCT02552459|Analgesics|analgesics|mesh-ancestor
14069789|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
14069790|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069791|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14069792|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14069793|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14069794|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
14069795|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069796|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069797|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14069798|NCT02552459|Narcotics|narcotics|mesh-ancestor
14069799|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14069800|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14069801|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
14069802|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
14069803|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
14069804|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14069805|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14069806|NCT02552342|Prednisolone|prednisolone|mesh-list
14069807|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
14069808|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14069809|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
14069810|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069811|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
14069812|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
14069813|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069814|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069815|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069816|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
14069817|NCT02552342|Hormones|hormones|mesh-ancestor
14069818|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069819|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14069820|NCT02552342|Protective Agents|protective agents|mesh-ancestor
14069821|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14172652|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
14069822|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069823|NCT02552537|Mannitol|mannitol|mesh-list
14069824|NCT02552537|Omeprazole|omeprazole|mesh-list
14069825|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14069826|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069827|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14069828|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069829|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069830|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14069831|NCT02552537|Diuretics|diuretics|mesh-ancestor
14069832|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
14069833|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069834|NCT02552589|Fluorides|fluorides|mesh-list
14069835|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
14069836|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
14069837|NCT02552589|Protective Agents|protective agents|mesh-ancestor
14069838|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069839|NCT02551861|Ribavirin|ribavirin|mesh-list
14069840|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
14069841|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
14069842|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069843|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
14069844|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069845|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
14069846|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14069847|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14069848|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14069849|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14069850|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14069851|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069852|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
14069853|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069854|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069855|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14069856|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069857|NCT02551549|Rezafungin|rezafungin|mesh-list
14069858|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
14069859|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069860|NCT02551523|Dolutegravir|dolutegravir|mesh-list
14069861|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14069862|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14069863|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14069864|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069865|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069866|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14069867|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
14069868|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069869|NCT02551536|Fexofenadine|fexofenadine|mesh-list
14069870|NCT02551536|Montelukast|montelukast|mesh-list
14069871|NCT02551536|Levocetirizine|levocetirizine|mesh-list
14069872|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14069873|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
14069874|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14069875|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
14069876|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069877|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069878|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14069879|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14069880|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069881|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14069882|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14069883|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14069884|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
14069885|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
14069886|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069887|NCT02551796|Levofloxacin|levofloxacin|mesh-list
14069888|NCT02551796|Ofloxacin|ofloxacin|mesh-list
14069889|NCT02551796|Tobramycin|tobramycin|mesh-list
14069890|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14069891|NCT02551796|Dexamethasone|dexamethasone|mesh-list
14069892|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
14069893|NCT02551796|BB 1101|bb 1101|mesh-list
14069894|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
14069895|NCT02551796|Dipivefrin|dipivefrin|mesh-list
14069896|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069897|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
14069898|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
14069899|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069900|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069901|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14069902|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
14069903|NCT02551796|Hormones|hormones|mesh-ancestor
14069904|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069905|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14069906|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069907|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
14069908|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069909|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069910|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14069911|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14069912|NCT02551796|Renal Agents|renal agents|mesh-ancestor
14069913|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14069914|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14069915|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14069916|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14069917|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14069918|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14069919|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
14069920|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
14069921|NCT02551796|Protective Agents|protective agents|mesh-ancestor
14069922|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14069923|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
14069924|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069925|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14069926|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14069927|NCT02551276|Albuterol|albuterol|mesh-list
14069928|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14069929|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
14069930|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069931|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069932|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14069933|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
14069934|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
14069935|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14069936|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14069937|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13914374|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914375|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914376|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13914377|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
13914378|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13914379|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13914380|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914381|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13914382|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
14069938|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14069939|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
14069940|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069941|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069942|NCT02551367|Letrozole|letrozole|mesh-list
14069943|NCT02551367|Clomiphene|clomiphene|mesh-list
14069944|NCT02551367|Enclomiphene|enclomiphene|mesh-list
14069945|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
14069946|NCT02551367|Hormones|hormones|mesh-list
14069947|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069948|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069949|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069950|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14069951|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14069952|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14069953|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14069954|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13914383|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13914384|NCT03480321|Protective Agents|protective agents|mesh-ancestor
13914385|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13914386|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13914387|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914388|NCT03480308|Dexamethasone|dexamethasone|mesh-list
13914389|NCT03480308|Fentanyl|fentanyl|mesh-list
13914390|NCT03480308|Bupivacaine|bupivacaine|mesh-list
13914391|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13914392|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
13914393|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
13914394|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914395|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914396|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914397|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
13914398|NCT03480308|Hormones|hormones|mesh-ancestor
13914399|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914400|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914401|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914402|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
13914403|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
13914404|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914405|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
13914406|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13914407|NCT03480308|Narcotics|narcotics|mesh-ancestor
13914408|NCT03480308|Analgesics|analgesics|mesh-ancestor
13914409|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13914410|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13914411|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
13914412|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
13914413|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13914414|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
13914415|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914416|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
14069955|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
14069956|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14069957|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
14069958|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14069959|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14069960|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14069961|NCT02551042|Factor VIII|factor viii|mesh-list
14069962|NCT02551042|Coagulants|coagulants|mesh-ancestor
14069963|NCT02551029|Capsaicin|capsaicin|mesh-list
14069964|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
14069965|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
14069966|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
14069967|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069968|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069969|NCT02550977|Gestodene|gestodene|mesh-list
14069970|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14069971|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14069972|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14069973|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
14069974|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14069975|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069976|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14069977|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14069978|NCT02550977|Progestins|progestins|mesh-ancestor
14069979|NCT02550977|Hormones|hormones|mesh-ancestor
14069980|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14069981|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
14069982|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14069983|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
14069984|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14069985|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14069986|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14069987|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
14069988|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14069989|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
14069990|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14069991|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14069992|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14069993|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
14069994|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
14069995|NCT02551107|Protective Agents|protective agents|mesh-ancestor
14069996|NCT02551133|Dexamethasone|dexamethasone|mesh-list
14069997|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14069998|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
14069999|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
14070000|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070001|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070002|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070003|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
14070004|NCT02551133|Hormones|hormones|mesh-ancestor
14183347|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14934081|NCT01454180|Antidotes|antidotes|mesh-ancestor
14934082|NCT01454180|Protective Agents|protective agents|mesh-ancestor
14934083|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
14070005|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070006|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14070007|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070008|NCT02550912|Vitamin D|vitamin d|mesh-list
14070009|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
14070010|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
14070011|NCT02550912|Vitamins|vitamins|mesh-list
14070012|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
14070013|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070014|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14070015|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14172653|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172654|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172655|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14172656|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
14172657|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14172658|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
14172659|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172660|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172661|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14172662|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
14172663|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
14172664|NCT04807413|Protective Agents|protective agents|mesh-ancestor
14172665|NCT04807673|Paclitaxel|paclitaxel|mesh-list
14172666|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
14172667|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14172668|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172669|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
14172670|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
14172671|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
14172672|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172673|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14172674|NCT04807517|Buspirone|buspirone|mesh-list
14172675|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14172676|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14172677|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172678|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172679|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14172680|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14070016|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
14070017|NCT02550782|Bupivacaine|bupivacaine|mesh-list
14070018|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
14070019|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
14070020|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070021|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070022|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
14070023|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070024|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14070025|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14070026|NCT02550782|Analgesics|analgesics|mesh-ancestor
14070027|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14070028|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14070029|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070030|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070031|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070032|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070033|NCT02550756|Capsaicin|capsaicin|mesh-list
14070034|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
14070035|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14070036|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
14070037|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070038|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070039|NCT02550665|Donepezil|donepezil|mesh-list
14070040|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14070041|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070042|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070043|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
14070044|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070045|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070046|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
14070047|NCT02550483|Beta Carotene|beta carotene|mesh-list
14070048|NCT02550483|Lycopene|lycopene|mesh-list
14070049|NCT02550483|Carotenoids|carotenoids|mesh-list
14070050|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070051|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
14070052|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070053|NCT02550483|Protective Agents|protective agents|mesh-ancestor
14070054|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070055|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14070056|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14070057|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070058|NCT02550483|Provitamins|provitamins|mesh-ancestor
14070059|NCT02550483|Vitamins|vitamins|mesh-ancestor
14070060|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
14070061|NCT02550717|Aspirin|aspirin|mesh-list
14070062|NCT02550717|Anticoagulants|anticoagulants|mesh-list
14070063|NCT02550717|Clopidogrel|clopidogrel|mesh-list
14070064|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14070065|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14070066|NCT02550717|Analgesics|analgesics|mesh-ancestor
14070067|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
14070068|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070069|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070070|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070071|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070072|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14070073|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14070074|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070075|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14070076|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14070077|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070078|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
14070079|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14070080|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14476226|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
14476227|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
14476228|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
14476229|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476230|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14476231|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
14476232|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070081|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14070082|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
14070083|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070084|NCT02550444|Clonidine|clonidine|mesh-list
14070085|NCT02550444|Analgesics|analgesics|mesh-ancestor
14070086|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
14070087|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070088|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070089|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14070090|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
14070091|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
14070092|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14070093|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14070094|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070095|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070096|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070097|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070098|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14070099|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
14070100|NCT02550314|Coagulants|coagulants|mesh-ancestor
14070101|NCT02550119|Dexamethasone|dexamethasone|mesh-list
14070102|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
14070103|NCT02550119|Aprepitant|aprepitant|mesh-list
14070104|NCT02550119|Dolasetron|dolasetron|mesh-list
14070105|NCT02550119|Ichthammol|ichthammol|mesh-list
14070106|NCT02550119|BB 1101|bb 1101|mesh-list
14070107|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070108|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
14070109|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
14070110|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070111|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070112|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070113|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
14070114|NCT02550119|Hormones|hormones|mesh-ancestor
14070115|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070116|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14070117|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070118|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
14070119|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070120|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070121|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14070122|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070123|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
14070124|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14070125|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
14070126|NCT02550093|Oxytocin|oxytocin|mesh-list
14070127|NCT02550093|Oxytocics|oxytocics|mesh-ancestor
14070128|NCT02550093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14070129|NCT02550093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070130|NCT02550067|Copper|copper|mesh-list
14070131|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14070132|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
14070133|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
14070134|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14070135|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
14070136|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14070137|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070138|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14070139|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14070140|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14070141|NCT02550067|Trace Elements|trace elements|mesh-ancestor
14070142|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
14070143|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14070144|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14070145|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14070146|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070147|NCT02550262|Fentanyl|fentanyl|mesh-list
14070148|NCT02550262|Bupivacaine|bupivacaine|mesh-list
14070149|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
14070150|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
14070151|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070152|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070153|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
14070154|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070155|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14070156|NCT02550262|Narcotics|narcotics|mesh-ancestor
14070157|NCT02550262|Analgesics|analgesics|mesh-ancestor
14070158|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14070159|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14070160|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
14070161|NCT02550418|Budesonide|budesonide|mesh-list
14070162|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070163|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14070164|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
14070165|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070166|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070167|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14070168|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
14070169|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
14070170|NCT02550418|Hormones|hormones|mesh-ancestor
14070171|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070172|NCT02550080|Dapsone|dapsone|mesh-list
14070173|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070174|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
14070175|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14070176|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14070177|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14070178|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070179|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070180|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
14070181|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14070182|NCT02550249|Nivolumab|nivolumab|mesh-list
14070183|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14070184|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070185|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14070186|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070187|NCT02550028|Levetiracetam|levetiracetam|mesh-list
14070188|NCT02550028|Phenobarbital|phenobarbital|mesh-list
14070189|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
14070190|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
14070191|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14070192|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070193|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070194|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14070195|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14070196|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070197|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070198|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
14476233|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14476234|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14070199|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
14070200|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14070201|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14070202|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14070203|NCT02550327|Gemcitabine|gemcitabine|mesh-list
14070204|NCT02550327|Paclitaxel|paclitaxel|mesh-list
14070205|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14070206|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14070207|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070208|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
14070209|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
14070210|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
14070211|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070212|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14070213|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
14476235|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
14070214|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
14070215|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070216|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070217|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14070218|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
14070219|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070220|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070221|NCT02549846|Atorvastatin|atorvastatin|mesh-list
14070222|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14070223|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14070224|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14070225|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
14070226|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070227|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14070228|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14070229|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070230|NCT02549924|Resveratrol|resveratrol|mesh-list
14070231|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
14070232|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070233|NCT02549924|Protective Agents|protective agents|mesh-ancestor
14070234|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070235|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070236|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14070237|NCT02549742|Bleomycin|bleomycin|mesh-list
14070238|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14070239|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070240|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
14070241|NCT02549963|Anticoagulants|anticoagulants|mesh-list
14070242|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14070243|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
14070244|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14070245|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
14070246|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070247|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070248|NCT02550002|Aflibercept|aflibercept|mesh-list
14070249|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14070250|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14070251|NCT02550002|Growth Substances|growth substances|mesh-ancestor
14070252|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070253|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
14070254|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070255|NCT02549898|Cilostazol|cilostazol|mesh-list
14070256|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14070257|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14070258|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
14070259|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070260|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070261|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14070262|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
14070263|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14070264|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14070265|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070266|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14070267|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
14070268|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14070269|NCT02549898|Protective Agents|protective agents|mesh-ancestor
14070270|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14070271|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14070272|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070273|NCT02549898|Hematinics|hematinics|mesh-ancestor
14070274|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14070275|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14070276|NCT02549690|Testosterone|testosterone|mesh-list
14070277|NCT02549690|Androgens|androgens|mesh-ancestor
14070278|NCT02549690|Hormones|hormones|mesh-ancestor
14070279|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070280|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070281|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
14070282|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14070283|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914417|NCT03480295|Protective Agents|protective agents|mesh-ancestor
13914418|NCT03480191|Daptomycin|daptomycin|mesh-list
13914419|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13914420|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914421|NCT03480165|Parecoxib|parecoxib|mesh-list
13914422|NCT03480165|Ropivacaine|ropivacaine|mesh-list
13914423|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
13914424|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
13914425|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914426|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070284|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070285|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14070286|NCT02549768|Analgesics|analgesics|mesh-ancestor
14070287|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
14070288|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070289|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14070290|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14070291|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070292|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070293|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070294|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070295|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
14070296|NCT02549677|Docetaxel|docetaxel|mesh-list
14070297|NCT02549677|Epirubicin|epirubicin|mesh-list
14070298|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14070299|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
14070300|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070301|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070302|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14070303|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
14070304|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070305|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070306|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14070307|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14070308|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14070309|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14070310|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14070311|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14070312|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14070313|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070314|NCT02549651|Durvalumab|durvalumab|mesh-list
14070315|NCT02549651|Tremelimumab|tremelimumab|mesh-list
14070316|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14070317|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070318|NCT02549261|Etoposide|etoposide|mesh-list
14070319|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
14070320|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070321|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14070322|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14070323|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14070324|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914427|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
14172681|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
14070325|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070326|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14070327|NCT02549326|Vitamin D|vitamin d|mesh-list
14070328|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
14070329|NCT02549326|Vitamins|vitamins|mesh-ancestor
14070330|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
14070331|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070332|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14070333|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14070334|NCT02549469|Naproxen|naproxen|mesh-list
14070335|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14070336|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14070337|NCT02549469|Analgesics|analgesics|mesh-ancestor
14070338|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
14070339|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070340|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070341|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070342|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070343|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
14070344|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14070345|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070346|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070347|NCT02549391|Cinacalcet|cinacalcet|mesh-list
14070348|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14070349|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070350|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14070351|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
14070352|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070353|NCT02549430|Letrozole|letrozole|mesh-list
14070354|NCT02549430|Fulvestrant|fulvestrant|mesh-list
14070355|NCT02549430|Palbociclib|palbociclib|mesh-list
14070356|NCT02549430|Anastrozole|anastrozole|mesh-list
14070357|NCT02549430|Exemestane|exemestane|mesh-list
14070358|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070359|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14070360|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14070361|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070362|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070363|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14758492|NCT05170685|Nivolumab|nivolumab|mesh-list
14758493|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758494|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070364|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
14070365|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070366|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070367|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14070368|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14070369|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14172682|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172683|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172684|NCT04807543|Castor Oil|castor oil|mesh-list
14172685|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14172686|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14172687|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14758495|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14070370|NCT02549105|Lidocaine|lidocaine|mesh-list
14070371|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14070372|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
14070373|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
14070374|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070375|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070376|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
14070377|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758496|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758497|NCT05170204|Durvalumab|durvalumab|mesh-list
14070378|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14070379|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14758498|NCT05170204|Pralsetinib|pralsetinib|mesh-list
14758499|NCT05170204|Entrectinib|entrectinib|mesh-list
14758500|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758501|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758502|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14758503|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758504|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758505|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
14758506|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14758507|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758508|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758509|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758510|NCT05168280|Analgesics|analgesics|mesh-ancestor
14758511|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
14070380|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14070381|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14070382|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070383|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14070384|NCT02549001|Amorolfine|amorolfine|mesh-list
14070385|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
14070386|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070387|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
14070388|NCT02548923|Propofol|propofol|mesh-list
14070389|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14070390|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070391|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070392|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14070393|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
14070394|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
14070395|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914428|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914429|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13914430|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13914431|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914432|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914433|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13914434|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914435|NCT03480165|Analgesics|analgesics|mesh-ancestor
14070396|NCT02548923|Analgesics|analgesics|mesh-ancestor
14070397|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
14070398|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070399|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14070400|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14070401|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070402|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914436|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070403|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070404|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070405|NCT02549118|Tenoxicam|tenoxicam|mesh-list
14070406|NCT02549118|Meperidine|meperidine|mesh-list
14070407|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14070408|NCT02549118|Narcotics|narcotics|mesh-ancestor
14070409|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070410|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070411|NCT02549118|Analgesics|analgesics|mesh-ancestor
14070412|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
14070413|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070414|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14070415|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14070416|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14070417|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070418|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070419|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14070420|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070421|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070422|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14070423|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14070424|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14070425|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14070426|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
14070427|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070428|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070429|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14070430|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13914437|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070431|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070432|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070433|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070434|NCT02549066|Milrinone|milrinone|mesh-list
14070435|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14070436|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14070437|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
14070438|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14070439|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14070440|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070441|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070442|NCT02549066|Protective Agents|protective agents|mesh-ancestor
14070443|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070444|NCT02548936|Simvastatin|simvastatin|mesh-list
14070445|NCT02548936|Ezetimibe|ezetimibe|mesh-list
14070446|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14070447|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14070448|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
14070449|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070450|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14070451|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14070452|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070453|NCT02548832|Magnesium Oxide|magnesium oxide|mesh-list
13914438|NCT03480100|Xylometazoline|xylometazoline|mesh-list
13914439|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
13914440|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13914441|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
13914442|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
13914443|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13914444|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070454|NCT02548832|Bezafibrate|bezafibrate|mesh-list
14070455|NCT02548832|Antacids|antacids|mesh-ancestor
14070456|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070457|NCT02548832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070458|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14070459|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
14070460|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14070461|NCT02548806|Clonidine|clonidine|mesh-list
14070462|NCT02548806|Analgesics|analgesics|mesh-ancestor
14070463|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
14070464|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070465|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070466|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14070467|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
14070468|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
14070469|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14070470|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14070471|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070472|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070473|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070474|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070475|NCT02548741|Metformin|metformin|mesh-list
14070476|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
14070477|NCT02548741|Calcium|calcium|mesh-list
14070478|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14070479|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070480|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14070481|NCT02548741|Antacids|antacids|mesh-ancestor
14070482|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070483|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070484|NCT02548780|Doxorubicin|doxorubicin|mesh-list
14070485|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14070486|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070487|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14070488|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14070489|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070490|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070491|NCT02548468|Vidarabine|vidarabine|mesh-list
14070492|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
14070493|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
14070494|NCT02548468|Fludarabine|fludarabine|mesh-list
14070495|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
14070496|NCT02548468|Tacrolimus|tacrolimus|mesh-list
14070497|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14070498|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
14070499|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070500|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070501|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14070502|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
14070503|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070504|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070505|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14070506|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14070507|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
14070508|NCT02548468|Antiviral Agents|antiviral agents|mesh-ancestor
14070509|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070510|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14070511|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070512|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14070513|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14070514|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
14070515|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14070516|NCT02548611|Clopidogrel|clopidogrel|mesh-list
14070517|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14070518|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14070519|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14070520|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14070521|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14070522|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
14070523|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070524|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070525|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070526|NCT02548533|Lidocaine|lidocaine|mesh-list
14070527|NCT02548533|Epinephrine|epinephrine|mesh-list
14070528|NCT02548533|Prilocaine|prilocaine|mesh-list
14070529|NCT02548533|Carticaine|carticaine|mesh-list
14070530|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14070531|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
14070532|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
14070533|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070534|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070535|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
14070536|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070537|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14070538|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14070539|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14070540|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14070541|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070542|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14070543|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070544|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070545|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070546|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14070547|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14070548|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
14070549|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14070550|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
14070551|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
14070552|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
14070553|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14070554|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14070555|NCT02548559|Cannabidiol|cannabidiol|mesh-list
14070556|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
14070557|NCT02548494|Insulin|insulin|mesh-list
14070558|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
14070559|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14070560|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070561|NCT02548403|Simethicone|simethicone|mesh-list
14070562|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
14070563|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070564|NCT02548403|Emollients|emollients|mesh-ancestor
14070565|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14070566|NCT02548364|Vitamin D|vitamin d|mesh-list
14070567|NCT02548364|Calcifediol|calcifediol|mesh-list
14070568|NCT02548364|Vitamins|vitamins|mesh-ancestor
14070569|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
14070570|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070571|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14070572|NCT02548117|Finasteride|finasteride|mesh-list
14070573|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14070574|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14070575|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070576|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070577|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
14070578|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070579|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070580|NCT02548117|Urological Agents|urological agents|mesh-ancestor
14070581|NCT02548195|Gemcitabine|gemcitabine|mesh-list
14070582|NCT02548195|Capecitabine|capecitabine|mesh-list
14070583|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
14070584|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14070585|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
14070586|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070587|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070588|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
14070589|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070590|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070591|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14070592|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
14070593|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070594|NCT02548286|Amlodipine|amlodipine|mesh-list
14070595|NCT02548286|Candesartan|candesartan|mesh-list
14070596|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14070597|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14070598|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14070599|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070600|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14070601|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070602|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14070603|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14070604|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14070605|NCT02548052|Betamethasone|betamethasone|mesh-list
14070606|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
14070607|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14070608|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
14070609|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14070610|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070611|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
14070612|NCT02548052|Hormones|hormones|mesh-ancestor
14070613|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070614|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070615|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14070616|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14070617|NCT02547597|Atenolol|atenolol|mesh-list
14070618|NCT02547597|Carvedilol|carvedilol|mesh-list
14070619|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14070620|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14070621|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070622|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070623|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070624|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070625|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14070626|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
14070627|NCT02547597|Protective Agents|protective agents|mesh-ancestor
14070628|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14070629|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14070630|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14070631|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
14070632|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14070633|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14070634|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14070635|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
14070636|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
14070637|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070638|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14070639|NCT02547662|Dexamethasone|dexamethasone|mesh-list
14070640|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
14070641|NCT02547662|Pomalidomide|pomalidomide|mesh-list
14070642|NCT02547662|Ixazomib|ixazomib|mesh-list
14070643|NCT02547662|Ichthammol|ichthammol|mesh-list
14070644|NCT02547662|BB 1101|bb 1101|mesh-list
14070645|NCT02547662|Glycine|glycine|mesh-list
14070646|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070647|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
14070648|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
14070649|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070650|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070651|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070652|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
14070653|NCT02547662|Hormones|hormones|mesh-ancestor
14070654|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070655|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14070656|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070657|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070658|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
14070659|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070660|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
14070661|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14070662|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14070663|NCT02547662|Growth Substances|growth substances|mesh-ancestor
14070664|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
14070665|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14070666|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
14070667|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070668|NCT02547792|Vaccines|vaccines|mesh-list
14070669|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
14070670|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070671|NCT02547870|Rilpivirine|rilpivirine|mesh-list
14070672|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14070673|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14070674|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070675|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070676|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
14070677|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070678|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14070679|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14070680|NCT02547896|Diclofenac|diclofenac|mesh-list
14070681|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14070682|NCT02547896|Codeine|codeine|mesh-list
14070683|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14070684|NCT02547896|Analgesics|analgesics|mesh-ancestor
14070685|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
14172688|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
14070686|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070687|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070688|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070689|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070690|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14070691|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070692|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070693|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14070694|NCT02547896|Narcotics|narcotics|mesh-ancestor
14070695|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070696|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
14070697|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
14070698|NCT02547844|Tenofovir|tenofovir|mesh-list
14070699|NCT02547844|Efavirenz|efavirenz|mesh-list
14070700|NCT02547844|Emtricitabine|emtricitabine|mesh-list
14070701|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
14070702|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070703|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14070704|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14070705|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070706|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070707|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14070708|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14070709|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14070710|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14070711|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14070712|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14070713|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14070714|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14070715|NCT02547519|Insulin|insulin|mesh-list
14758512|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758513|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14070716|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14070717|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172689|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172690|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172691|NCT04807543|Progestins|progestins|mesh-ancestor
14172692|NCT04807543|Hormones|hormones|mesh-ancestor
14172693|NCT04807543|Cathartics|cathartics|mesh-ancestor
14172694|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172695|NCT04807140|Paclitaxel|paclitaxel|mesh-list
14172696|NCT04807140|Carboplatin|carboplatin|mesh-list
14172697|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14172698|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172699|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14172700|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14172701|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14172702|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172703|NCT04807309|Danazol|danazol|mesh-list
14172704|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14172705|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
14172706|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172707|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172708|NCT04807166|Paclitaxel|paclitaxel|mesh-list
14172709|NCT04807166|Carboplatin|carboplatin|mesh-list
14172710|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14172711|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172712|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
14172713|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
14758514|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14758515|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14758516|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
14758517|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758518|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758519|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
14758520|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758521|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758522|NCT05158686|Paclitaxel|paclitaxel|mesh-list
14172714|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
14070718|NCT02547350|Pirarubicin|pirarubicin|mesh-list
14070719|NCT02547350|Epirubicin|epirubicin|mesh-list
14070720|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070721|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14070722|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14070723|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14070724|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758523|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14934084|NCT01454180|Vitamins|vitamins|mesh-ancestor
14070725|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070726|NCT02547402|CXA-10|cxa-10|mesh-list
14070727|NCT02547402|Simvastatin|simvastatin|mesh-list
14070728|NCT02547402|Ezetimibe|ezetimibe|mesh-list
14070729|NCT02547402|Pravastatin|pravastatin|mesh-list
14070730|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14070731|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14070732|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14070733|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
14070734|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070735|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14070736|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14070737|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070738|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070739|NCT02547480|Irinotecan|irinotecan|mesh-list
14070740|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14070741|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14070742|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070743|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070744|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070745|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14070746|NCT02547025|Amoxicillin|amoxicillin|mesh-list
14758524|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070747|NCT02547025|Clarithromycin|clarithromycin|mesh-list
14070748|NCT02547025|Levofloxacin|levofloxacin|mesh-list
14070749|NCT02547025|Ofloxacin|ofloxacin|mesh-list
14070750|NCT02547025|Tetracycline|tetracycline|mesh-list
14070751|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14070752|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14070753|NCT02547025|Rabeprazole|rabeprazole|mesh-list
14070754|NCT02547025|Bismuth|bismuth|mesh-list
14070755|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070756|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
14070757|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14070758|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070759|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070760|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14070761|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14070762|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14070763|NCT02547025|Renal Agents|renal agents|mesh-ancestor
14070764|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14070765|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14070766|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070767|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14070768|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14070769|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070770|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14070771|NCT02547025|Antacids|antacids|mesh-ancestor
14070772|NCT02547155|Anesthetics|anesthetics|mesh-list
14070773|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758525|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
14758526|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
14758527|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
14758528|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758529|NCT05157997|Antibodies|antibodies|mesh-list
14758530|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
14758531|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758532|NCT05153317|Ivacaftor|ivacaftor|mesh-list
14070774|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070775|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
14934085|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
13914445|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914446|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914447|NCT03480061|Analgesics|analgesics|mesh-ancestor
14758533|NCT05153317|Elexacaftor|elexacaftor|mesh-list
14758534|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14070776|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14070777|NCT02547103|Mupirocin|mupirocin|mesh-list
14476236|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14476237|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14758535|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14758536|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758537|NCT05151640|Nintedanib|nintedanib|mesh-list
14758538|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914448|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
13914449|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914450|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13914451|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13914452|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13914453|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914454|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914455|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914456|NCT03479996|Bupivacaine|bupivacaine|mesh-list
13914457|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
13914458|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
13914459|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914460|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914461|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
13914462|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914463|NCT03479918|Prednisone|prednisone|mesh-list
13914464|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
13914465|NCT03479918|Doxorubicin|doxorubicin|mesh-list
14476238|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14476239|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14476240|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476241|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
14476242|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14476243|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
14476244|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758539|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13914466|NCT03479918|Etoposide|etoposide|mesh-list
13914467|NCT03479918|Vincristine|vincristine|mesh-list
14070778|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14070779|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070780|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
14070781|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
14070782|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14070783|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14070784|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070785|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070786|NCT02547116|Rifampin|rifampin|mesh-list
14070787|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14070788|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
14070789|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14070790|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476245|NCT02413346|Sarecycline|sarecycline|mesh-list
14476246|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14070791|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
14070792|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14070793|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070794|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070795|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14070796|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14070797|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14070798|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14070799|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14070800|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14070801|NCT02546843|Rocuronium|rocuronium|mesh-list
14070802|NCT02546843|Atracurium|atracurium|mesh-list
14070803|NCT02546843|Cisatracurium|cisatracurium|mesh-list
14070804|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14070805|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14070806|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14070807|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070808|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070809|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14070810|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14070811|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
14070812|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070813|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070814|NCT02546791|Dasatinib|dasatinib|mesh-list
14070815|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070816|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14070817|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070818|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070819|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
14070820|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14070821|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070822|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
14070823|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
14070824|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14070825|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14070826|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14070827|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
14070828|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476247|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070829|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14070830|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14070831|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070832|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14070833|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14070834|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
14070835|NCT02546648|Coagulants|coagulants|mesh-ancestor
14070836|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
14070837|NCT02546583|Furosemide|furosemide|mesh-list
14070838|NCT02546583|Bumetanide|bumetanide|mesh-list
14070839|NCT02546583|Diuretics|diuretics|mesh-list
14070840|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14476248|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
14476249|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
14476250|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14476251|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476252|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476253|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476254|NCT02413489|Daratumumab|daratumumab|mesh-list
14934086|NCT01454440|Eptifibatide|eptifibatide|mesh-list
14070841|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
14070842|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070843|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14070844|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070845|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14070846|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14070847|NCT02546531|Gemcitabine|gemcitabine|mesh-list
14070848|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
14070849|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14476255|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914468|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13914469|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
13914470|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914471|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13914472|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13914473|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
13914474|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914475|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914476|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13914477|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13914478|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13914479|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13914480|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070850|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
14070851|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070852|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070853|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
14070854|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070855|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070856|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14070857|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
14070858|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070859|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14070860|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14070861|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
14070862|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14070863|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
14070864|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070865|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
14070866|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14070867|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070868|NCT02546141|Caseins|caseins|mesh-list
14070869|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
14070870|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
14070871|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070872|NCT02546349|Fluticasone|fluticasone|mesh-list
14070873|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
14070874|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14070875|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14070876|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070877|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14070878|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
14070879|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070880|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070881|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14070882|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
14070883|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14070884|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14070885|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
14070886|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14070887|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
14070888|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070889|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070890|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14070891|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14070892|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070893|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070894|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
14070895|NCT02546349|Hormones|hormones|mesh-ancestor
14070896|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070897|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
14070898|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14070899|NCT02546154|Hematinics|hematinics|mesh-ancestor
14070900|NCT02546232|Paclitaxel|paclitaxel|mesh-list
14070901|NCT02546232|Carboplatin|carboplatin|mesh-list
14070902|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14070903|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070904|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
14070905|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
14070906|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
14070907|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070908|NCT02546297|Budesonide|budesonide|mesh-list
14476256|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
14476257|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14476258|NCT02413593|Ledipasvir|ledipasvir|mesh-list
14476259|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
14070909|NCT02546297|Bromides|bromides|mesh-list
14070910|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
14070911|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
14183348|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183349|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183350|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14183351|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
14070912|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14070913|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070914|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14070915|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
14070916|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070917|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070918|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14070919|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
14070920|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
14070921|NCT02546297|Hormones|hormones|mesh-ancestor
14070922|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070923|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14070924|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14070925|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14070926|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
14070927|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14070928|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070929|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
14070930|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14070931|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
14070932|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
14070933|NCT02546050|Metformin|metformin|mesh-list
14070934|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14070935|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070936|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
14070937|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14070938|NCT02545751|Thymalfasin|thymalfasin|mesh-list
14070939|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14070940|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
14070941|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070942|NCT02545712|Ethanol|ethanol|mesh-list
14070943|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
14070944|NCT02545712|Sorbitol|sorbitol|mesh-list
14070945|NCT02545712|Glycerol|glycerol|mesh-list
14070946|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14070947|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14070948|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14070949|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070950|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14070951|NCT02545712|Protective Agents|protective agents|mesh-ancestor
14070952|NCT02545712|Cathartics|cathartics|mesh-ancestor
14070953|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070954|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
14070955|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
14070956|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
14070957|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070958|NCT02545777|Diclofenac|diclofenac|mesh-list
14070959|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14070960|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14070961|NCT02545777|Analgesics|analgesics|mesh-ancestor
14070962|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
14070963|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070964|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070965|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070966|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070967|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14070968|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070969|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070970|NCT02545972|Tacrolimus|tacrolimus|mesh-list
14070971|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14070972|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
14070973|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070974|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14070975|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14070976|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14070977|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
14070978|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14070979|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14070980|NCT02545959|Prednisolone|prednisolone|mesh-list
14070981|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
14070982|NCT02545959|Rituximab|rituximab|mesh-list
14070983|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14070984|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
14070985|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14070986|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14070987|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
14070988|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14070989|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14070990|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14070991|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
14070992|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
14070993|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14070994|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14070995|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
14070996|NCT02545959|Hormones|hormones|mesh-ancestor
14070997|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14070998|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14070999|NCT02545959|Protective Agents|protective agents|mesh-ancestor
14071000|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14071001|NCT02545634|Sulfalene|sulfalene|mesh-list
14071002|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071003|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14071004|NCT02545634|Renal Agents|renal agents|mesh-ancestor
14071005|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
14071006|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14071007|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14071008|NCT02545738|Liraglutide|liraglutide|mesh-list
14071009|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14071010|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758540|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914481|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13914482|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13914483|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
13914484|NCT03479918|Hormones|hormones|mesh-ancestor
13914485|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914486|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914487|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
13914488|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14071011|NCT02545738|Incretins|incretins|mesh-ancestor
14071012|NCT02545738|Hormones|hormones|mesh-ancestor
14767456|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14071013|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14172715|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172716|NCT04807335|Sufentanil|sufentanil|mesh-list
14172717|NCT04807335|Ketamine|ketamine|mesh-list
14172718|NCT04807335|Analgesics|analgesics|mesh-ancestor
14172719|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
14172720|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172721|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172722|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14172723|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14172724|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
14172725|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
14172726|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172727|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14172728|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14172729|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172730|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172731|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14172732|NCT04807335|Narcotics|narcotics|mesh-ancestor
14172733|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13914489|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
13914490|NCT03479879|Misoprostol|misoprostol|mesh-list
13914491|NCT03479879|Estradiol|estradiol|mesh-list
13914492|NCT03479879|Estrogens|estrogens|mesh-ancestor
14172734|NCT04807101|Midazolam|midazolam|mesh-list
14172735|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14172736|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14172737|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172738|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172739|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14172740|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14172741|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14172742|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14172743|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
14172744|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
14172745|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
14172746|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
14172747|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172748|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476260|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476261|NCT02413918|Iloperidone|iloperidone|mesh-list
14476262|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14476263|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14476264|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476265|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476266|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14476267|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
14476268|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
14476269|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14476270|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14476271|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476272|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476273|NCT02414204|Urological Agents|urological agents|mesh-ancestor
14476274|NCT02414854|Albuterol|albuterol|mesh-list
14476275|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14476276|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
14476277|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476278|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914493|NCT03479879|Hormones|hormones|mesh-ancestor
13914494|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914495|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914496|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13914497|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13914498|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
13914499|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14071014|NCT02545465|Riociguat|riociguat|mesh-list
14071015|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
14071016|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071017|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
14071018|NCT02545426|Calcium|calcium|mesh-list
14071019|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14071020|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071021|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14476279|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14071022|NCT02545530|Clonidine|clonidine|mesh-list
14071023|NCT02545530|Analgesics|analgesics|mesh-ancestor
14071024|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
14071025|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071026|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071027|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14476280|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
14758541|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758542|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14758543|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758544|NCT05149898|Cannabidiol|cannabidiol|mesh-list
14758545|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
14071028|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
14071029|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
14071030|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14071031|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14071032|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14071033|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
14071034|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071035|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071036|NCT02545452|Anastrozole|anastrozole|mesh-list
14071037|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
14071038|NCT02545452|Nonoxynol|nonoxynol|mesh-list
14071039|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476281|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
14476282|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14934087|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934088|NCT01454479|Lapatinib|lapatinib|mesh-list
14934089|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934090|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14934091|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934092|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071040|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071041|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14071042|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14071043|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071044|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071045|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14071046|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
14071047|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071048|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071049|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14071050|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
14071051|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14071052|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14071053|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14071054|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14071055|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14071056|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14071057|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14071058|NCT02545231|Pitavastatin|pitavastatin|mesh-list
14071059|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14071060|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14071061|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14071062|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
14071063|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071064|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071065|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14071066|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
14071067|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14071068|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071069|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
14071070|NCT02545010|Paclitaxel|paclitaxel|mesh-list
14071071|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14071072|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071073|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14071074|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14071075|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14071076|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071077|NCT02544919|SMOFlipid|smoflipid|mesh-list
14071078|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14071079|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14071080|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14071081|NCT02544906|Propofol|propofol|mesh-list
14071082|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14071083|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934093|NCT01454518|Anesthetics|anesthetics|mesh-list
14071084|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071085|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14071086|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
14071087|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
14071088|NCT02544880|Tadalafil|tadalafil|mesh-list
14071089|NCT02544880|Vaccines|vaccines|mesh-list
14071090|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
14071091|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071092|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
14071093|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14071094|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14071095|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071096|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934094|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
14934095|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934096|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934097|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
14934098|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934099|NCT01454609|Clonidine|clonidine|mesh-list
14934100|NCT01454609|Bupivacaine|bupivacaine|mesh-list
14934101|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
14071097|NCT02544880|Urological Agents|urological agents|mesh-ancestor
14071098|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
14071099|NCT02544893|Bupivacaine|bupivacaine|mesh-list
14071100|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
14071101|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
14071102|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071103|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071104|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
14934102|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
14934103|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934104|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934105|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
14934106|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934107|NCT01454609|Analgesics|analgesics|mesh-ancestor
14758546|NCT05147805|Treprostinil|treprostinil|mesh-list
14758547|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14758548|NCT05144243|Azacitidine|azacitidine|mesh-list
14758549|NCT05144243|Venetoclax|venetoclax|mesh-list
14758550|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14758551|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
14758552|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758553|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758554|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758555|NCT05141149|Gemcitabine|gemcitabine|mesh-list
14758556|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071105|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071106|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14071107|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14071108|NCT02544893|Analgesics|analgesics|mesh-ancestor
14071109|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14071110|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14071111|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14071112|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
14071113|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071114|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071115|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14071116|NCT02545153|Aprotinin|aprotinin|mesh-list
14071117|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
14071118|NCT02545153|Coagulants|coagulants|mesh-ancestor
14934108|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14934109|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
14071119|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14758557|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
14071120|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14071121|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
14071122|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071123|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071124|NCT02544815|Digoxin|digoxin|mesh-list
14071125|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14071126|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14071127|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071128|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071129|NCT02544815|Protective Agents|protective agents|mesh-ancestor
14476283|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14476284|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13914500|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914501|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
13914502|NCT03479762|Liraglutide|liraglutide|mesh-list
13914503|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13914504|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914505|NCT03479762|Incretins|incretins|mesh-ancestor
13914506|NCT03479762|Hormones|hormones|mesh-ancestor
13914507|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914508|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13914509|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
13914510|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13914511|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914512|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
14071130|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071131|NCT02544932|Warfarin|warfarin|mesh-list
14071132|NCT02544932|Dabigatran|dabigatran|mesh-list
14071133|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
14071134|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
14071135|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14071136|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
14071137|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071138|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071139|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14071140|NCT02544828|Hematinics|hematinics|mesh-ancestor
14071141|NCT02544854|Propofol|propofol|mesh-list
14071142|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14071143|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071144|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071145|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13914513|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13914514|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914515|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914518|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
14476285|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14476286|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934110|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
14934111|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14476287|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071146|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
14071147|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
14071148|NCT02545114|Tolvaptan|tolvaptan|mesh-list
14071149|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14071150|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071151|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
14071152|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071153|NCT02544776|Amlodipine|amlodipine|mesh-list
14071154|NCT02544776|Clomiphene|clomiphene|mesh-list
14071155|NCT02544776|Enclomiphene|enclomiphene|mesh-list
14071156|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
14071157|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071158|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14071159|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14071160|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14071161|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14071162|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071163|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14071164|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14934112|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14934113|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14476288|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476289|NCT02414932|Midazolam|midazolam|mesh-list
14476290|NCT02414932|Ketamine|ketamine|mesh-list
14071165|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
14934114|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14071166|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071167|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14071168|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
14071169|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14071170|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14071171|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14071172|NCT02544750|Cannabidiol|cannabidiol|mesh-list
14071173|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
14071174|NCT02544659|Pamidronate|pamidronate|mesh-list
14071175|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14071176|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071177|NCT02544698|Vaccines|vaccines|mesh-list
14071178|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
14071179|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071180|NCT02544789|Clofarabine|clofarabine|mesh-list
14071181|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071182|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
14071183|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071184|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071185|NCT02544737|Apatinib|apatinib|mesh-list
14071186|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071187|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071188|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071189|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934115|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934116|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934117|NCT01454622|Metformin|metformin|mesh-list
14934118|NCT01454622|Canagliflozin|canagliflozin|mesh-list
14934119|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934120|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934121|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14934122|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758558|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758559|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758560|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
14758561|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758562|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758563|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758564|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
14758565|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758566|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
14758567|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14758568|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14758569|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14758570|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14758571|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758572|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
14758573|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758574|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071190|NCT02544724|Interleukin-12|interleukin-12|mesh-list
14071191|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14071192|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
14071193|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071194|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14071195|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14071196|NCT02544724|Growth Substances|growth substances|mesh-ancestor
14071197|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
14071198|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071199|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14071200|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14071201|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14071202|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
14071203|NCT02544529|Laxatives|laxatives|mesh-ancestor
14071204|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758575|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14476291|NCT02414932|Analgesics|analgesics|mesh-ancestor
14476292|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
14476293|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476294|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476295|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14476296|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14476297|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
14476298|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
14476299|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476300|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14476301|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14476302|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476303|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476304|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14476305|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14476306|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14476307|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14071205|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14071206|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071207|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758576|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071208|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
14071209|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071210|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071211|NCT02544529|Miotics|miotics|mesh-ancestor
14071212|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
14071213|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071214|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14071215|NCT02544425|Dexamethasone|dexamethasone|mesh-list
14071216|NCT02544425|Etoposide|etoposide|mesh-list
14071217|NCT02544425|Melphalan|melphalan|mesh-list
14071218|NCT02544425|Busulfan|busulfan|mesh-list
14071219|NCT02544425|Asparaginase|asparaginase|mesh-list
14071220|NCT02544425|Ifosfamide|ifosfamide|mesh-list
14071221|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071222|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
14071223|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
14071224|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071225|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071226|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14071227|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
14071228|NCT02544425|Hormones|hormones|mesh-ancestor
14071229|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071230|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14071231|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071232|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14071233|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14071234|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14071235|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758577|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
14758578|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758579|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14758580|NCT05137262|Cisplatin|cisplatin|mesh-list
14758581|NCT05137262|Doxorubicin|doxorubicin|mesh-list
14758582|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14758583|NCT05137262|Methotrexate|methotrexate|mesh-list
14758584|NCT05137262|Durvalumab|durvalumab|mesh-list
14758585|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
14758586|NCT05137262|Vinblastine|vinblastine|mesh-list
14758587|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758588|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14758589|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14758590|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14071236|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934123|NCT01454635|Sertraline|sertraline|mesh-list
14934124|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
14934125|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14934126|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14934127|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14934128|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14934129|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071237|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14071238|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
14071239|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14071240|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14071241|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
14071242|NCT02544282|Acetaminophen|acetaminophen|mesh-list
14071243|NCT02544282|Sufentanil|sufentanil|mesh-list
14071244|NCT02544282|Tramadol|tramadol|mesh-list
14071245|NCT02544282|Pirinitramide|pirinitramide|mesh-list
14071246|NCT02544282|Propofol|propofol|mesh-list
14071247|NCT02544282|Sevoflurane|sevoflurane|mesh-list
14071248|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
14071249|NCT02544282|Atracurium|atracurium|mesh-list
14071250|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14071251|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476308|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14476309|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
14476310|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
14476311|NCT02414958|Empagliflozin|empagliflozin|mesh-list
14476312|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14476313|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476314|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476315|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476316|NCT02415127|Interferons|interferons|mesh-list
14934130|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934131|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
14934132|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934133|NCT01454700|Insulin|insulin|mesh-list
14934134|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14934135|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960016|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13960017|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13960018|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960019|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960020|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
13960021|NCT03158142|Atropine|atropine|mesh-list
13960022|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13960023|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13960024|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13960025|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
13960026|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960027|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960028|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13960029|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
13960030|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
13960031|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
13960032|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13960033|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13960034|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
13960035|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960036|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960037|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
13960038|NCT03158168|Astringents|astringents|mesh-ancestor
14071252|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071253|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14071254|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
14071255|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
14071256|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14071257|NCT02544282|Analgesics|analgesics|mesh-ancestor
14071258|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
14071259|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071260|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
14071261|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14071262|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14071263|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14071264|NCT02544282|Narcotics|narcotics|mesh-ancestor
14071265|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
14071266|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14071267|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14071268|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14071269|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14071270|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14071271|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14071272|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
14071273|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071274|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934136|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934137|NCT01454804|Trastuzumab|trastuzumab|mesh-list
14934138|NCT01454804|Lapatinib|lapatinib|mesh-list
14934139|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14934140|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934141|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14934142|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914546|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
13914547|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
13914548|NCT03479411|Itraconazole|itraconazole|mesh-list
13914549|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
13914550|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
13914551|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914552|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13914553|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13914554|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914555|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914556|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13914557|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
13914558|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914559|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914560|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14071275|NCT02544308|Dexamethasone|dexamethasone|mesh-list
14071276|NCT02544308|Lenalidomide|lenalidomide|mesh-list
14934143|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934144|NCT01454869|Heparin|heparin|mesh-list
14172749|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
14934145|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
14934146|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14934147|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14934148|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934149|NCT01455025|Plerixafor|plerixafor|mesh-list
14071277|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071278|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
14071279|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
14071280|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071281|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071282|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14071283|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
14071284|NCT02544308|Hormones|hormones|mesh-ancestor
14071285|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071286|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14071287|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071288|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
14071289|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14071290|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14071291|NCT02544308|Growth Substances|growth substances|mesh-ancestor
14071292|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
14071293|NCT02544191|Goserelin|goserelin|mesh-list
14071294|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14071295|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071296|NCT02544165|Caffeine|caffeine|mesh-list
14071297|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14071298|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071299|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14071300|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071301|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071302|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14071303|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14071304|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
14071305|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071306|NCT02544243|Gemcitabine|gemcitabine|mesh-list
14071307|NCT02544243|Vinorelbine|vinorelbine|mesh-list
14071308|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071309|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071310|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
14071311|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071312|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
14071313|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071314|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476317|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
14071315|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14476318|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758591|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758592|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934150|NCT01455025|Sargramostim|sargramostim|mesh-list
14934151|NCT01455025|Lenograstim|lenograstim|mesh-list
14934152|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
14934153|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934154|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14934155|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14934156|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14934157|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
13914561|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13914562|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14934158|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934159|NCT01455051|Ofatumumab|ofatumumab|mesh-list
14934160|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934161|NCT01455103|BMS-936559|bms-936559|mesh-list
14934162|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14934163|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14934164|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934165|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
14934166|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071316|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
14071317|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071318|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14071319|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14071320|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14071321|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14071322|NCT02544269|Bupivacaine|bupivacaine|mesh-list
14758593|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13914563|NCT03479320|Lidocaine|lidocaine|mesh-list
13914564|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
13914565|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
14758594|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
14758595|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14758596|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758597|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14758598|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
14071323|NCT02544269|Ropivacaine|ropivacaine|mesh-list
14071324|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
14071325|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
14071326|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758599|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
14758600|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14758601|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758602|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
13914566|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071327|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914567|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914568|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
13914569|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914570|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13914571|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13914572|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13914573|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13914574|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914575|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
13914576|NCT03479268|Pevonedistat|pevonedistat|mesh-list
13914577|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914578|NCT03479086|Topiramate|topiramate|mesh-list
13914579|NCT03479086|Naltrexone|naltrexone|mesh-list
13914580|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13914581|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14071328|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
14934167|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
14934168|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14934169|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
14934170|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071329|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071330|NCT02544061|Interleukin-12|interleukin-12|mesh-list
14071331|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14071332|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
14071333|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071334|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14071335|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14071336|NCT02544061|Growth Substances|growth substances|mesh-ancestor
13914582|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071337|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
14071338|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172750|NCT04807127|Durvalumab|durvalumab|mesh-list
14172751|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14172752|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14172753|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172754|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476319|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
14476320|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476321|NCT02415400|Aspirin|aspirin|mesh-list
13914583|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
13914584|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914585|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
13914586|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476322|NCT02415400|Vitamin K|vitamin k|mesh-list
14476323|NCT02415400|Apixaban|apixaban|mesh-list
14476324|NCT02415400|Vitamins|vitamins|mesh-ancestor
13914587|NCT03478709|Norepinephrine|norepinephrine|mesh-list
13914588|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13914589|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13914590|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914591|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914592|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914593|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914594|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
13914595|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
13914596|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476325|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
14476326|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758603|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14758604|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14758605|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758606|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14071339|NCT02543879|Azacitidine|azacitidine|mesh-list
14071340|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071341|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
14071342|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071343|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071344|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071345|NCT05226923|Meropenem|meropenem|mesh-list
14071346|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14071347|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071348|NCT05226897|Metformin|metformin|mesh-list
14071349|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
14071350|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14071351|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071352|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14071353|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071354|NCT05226871|Cetuximab|cetuximab|mesh-list
14071355|NCT05226871|Letrozole|letrozole|mesh-list
14071356|NCT05226871|Fulvestrant|fulvestrant|mesh-list
14071357|NCT05226871|Palbociclib|palbociclib|mesh-list
14071358|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071359|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071360|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14071361|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14071362|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071363|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071364|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14071365|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
14071366|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071367|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071368|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14071369|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14071370|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071371|NCT05226832|Triamcinolone|triamcinolone|mesh-list
14071372|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071373|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
14071374|NCT05226832|Hormones|hormones|mesh-ancestor
14071375|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071376|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071377|NCT05226754|Diacetylrhein|diacetylrhein|mesh-list
14071378|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071379|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
14071380|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071381|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071382|NCT05226663|Fluorides|fluorides|mesh-list
14071383|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
14071384|NCT05226663|Protective Agents|protective agents|mesh-ancestor
14071385|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071386|NCT05226429|Vaccines|vaccines|mesh-list
14071387|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
14071388|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071389|NCT05226351|Dronabinol|dronabinol|mesh-list
14071390|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
14071391|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071392|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14071393|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14071394|NCT05226351|Analgesics|analgesics|mesh-ancestor
14071395|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
14071396|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071397|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14071398|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14071399|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071400|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071401|NCT05226351|Hormones|hormones|mesh-ancestor
14172755|NCT04806945|Paclitaxel|paclitaxel|mesh-list
14071402|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071403|NCT05226299|Capsaicin|capsaicin|mesh-list
14071404|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
14071405|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
14071406|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
14071407|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071408|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071409|NCT05226013|Rasburicase|rasburicase|mesh-list
14071410|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
14071411|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14071412|NCT05225974|Liraglutide|liraglutide|mesh-list
14071413|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14071414|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071415|NCT05225974|Incretins|incretins|mesh-ancestor
14071416|NCT05225974|Hormones|hormones|mesh-ancestor
14071417|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071418|NCT05225961|Aspirin|aspirin|mesh-list
14071419|NCT05225961|Tirofiban|tirofiban|mesh-list
14071420|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14071421|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14071422|NCT05225961|Analgesics|analgesics|mesh-ancestor
14071423|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
14071424|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071425|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071426|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071427|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14071428|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14071429|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14071430|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071431|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14071432|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14071433|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071434|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
14071435|NCT05225844|Apatinib|apatinib|mesh-list
14071436|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071437|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071438|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071439|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071440|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
14071441|NCT05225831|Fludarabine|fludarabine|mesh-list
14071442|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14071443|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
14071444|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071445|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14071446|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14071447|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
14071448|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071449|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071450|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14071451|NCT05225766|Bupivacaine|bupivacaine|mesh-list
14071452|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
14071453|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
14071454|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071455|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071456|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
14071457|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071458|NCT05224492|Sulforaphane|sulforaphane|mesh-list
14071459|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14071460|NCT05224492|Protective Agents|protective agents|mesh-ancestor
14071461|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071462|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172756|NCT04806945|Carboplatin|carboplatin|mesh-list
14172757|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14172758|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172759|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14172760|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14172761|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14172762|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172763|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
14172764|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14172765|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14172766|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172767|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183352|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
14183353|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183354|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183355|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14183356|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14183357|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14183358|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14183359|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183360|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14183361|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14183362|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
14183363|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14183364|NCT04728659|Desogestrel|desogestrel|mesh-list
14183365|NCT04728659|Ganirelix|ganirelix|mesh-list
14183366|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14183367|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14183368|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14183369|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
14183370|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183371|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183372|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14183373|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14183374|NCT04728659|Progestins|progestins|mesh-ancestor
14183375|NCT04728659|Hormones|hormones|mesh-ancestor
14183376|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183377|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
14183378|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14183379|NCT04728386|Eusol|eusol|mesh-list
14183380|NCT04728386|Curcumin|curcumin|mesh-list
14183381|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14183382|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183383|NCT04728386|Analgesics|analgesics|mesh-ancestor
14183384|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
14183385|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183386|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183387|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14183388|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14183389|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183390|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183391|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183392|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
14183393|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183394|NCT04729088|Isosorbide|isosorbide|mesh-list
14183395|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14183396|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14183397|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14183398|NCT04729088|Diuretics|diuretics|mesh-ancestor
14183399|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
14183400|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071463|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
14071464|NCT05202080|Narcotics|narcotics|mesh-ancestor
14071465|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071466|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071467|NCT05202080|Analgesics|analgesics|mesh-ancestor
14071468|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
14071469|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071470|NCT05171972|Ofatumumab|ofatumumab|mesh-list
14071471|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071472|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14071473|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14071474|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14071475|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14071476|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071477|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071478|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13914597|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13914598|NCT03478605|Dexamethasone|dexamethasone|mesh-list
13914599|NCT03478605|Ondansetron|ondansetron|mesh-list
13914600|NCT03478605|Olanzapine|olanzapine|mesh-list
13914601|NCT03478605|Aprepitant|aprepitant|mesh-list
13914602|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13914603|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
13914604|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
14934171|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934172|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14934173|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
13914605|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914606|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914607|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14071479|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14071480|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071481|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
14071482|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071483|NCT05162131|Ticagrelor|ticagrelor|mesh-list
14071484|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14071485|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14071486|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14071487|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14071488|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
14071489|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071490|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071491|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071492|NCT05157412|Doxycycline|doxycycline|mesh-list
14071493|NCT05157412|Prednisolone|prednisolone|mesh-list
14071494|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14071495|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
14071496|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14071497|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
13914608|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
13914609|NCT03478605|Hormones|hormones|mesh-ancestor
13914610|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914611|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914612|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914613|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
14934174|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
14934175|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14934176|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
14934177|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934178|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914614|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
13914615|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14071498|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14071499|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
14071500|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071501|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
14071502|NCT05157412|Hormones|hormones|mesh-ancestor
14071503|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071504|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071505|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14071506|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071507|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
14071508|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
14071509|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071510|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14071511|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14071512|NCT05157412|Protective Agents|protective agents|mesh-ancestor
14071513|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14071514|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071515|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
14071516|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14071517|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14071518|NCT05155436|Amlodipine|amlodipine|mesh-list
14071519|NCT05155436|Telmisartan|telmisartan|mesh-list
14071520|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14071521|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14071522|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14071523|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071524|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14071525|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071526|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
14071527|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14071528|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14071529|NCT05151263|Aspirin|aspirin|mesh-list
14071530|NCT05151263|Salicylates|salicylates|mesh-list
14071531|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14071532|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14071533|NCT05151263|Analgesics|analgesics|mesh-ancestor
14071534|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
14071535|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071536|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071537|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071538|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14071539|NCT05151263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14071540|NCT05151263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14071541|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071542|NCT05151263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14071543|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14071544|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071545|NCT05151263|Antipyretics|antipyretics|mesh-ancestor
14071546|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
14071547|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14071548|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071549|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071550|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14071551|NCT05139212|Analgesics|analgesics|mesh-ancestor
14071552|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
14071553|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071554|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14071555|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14071556|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14071557|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
14071558|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071559|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071560|NCT05127876|Ephedrine|ephedrine|mesh-list
14071561|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
14476327|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14476328|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14476329|NCT02415400|Analgesics|analgesics|mesh-ancestor
14476330|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
14476331|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476332|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476333|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14476334|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14071562|NCT05127876|Ondansetron|ondansetron|mesh-list
14071563|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
14071564|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
14071565|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071566|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071567|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14071568|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
14071569|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
14071570|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14071571|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
14071572|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071573|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071574|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14071575|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14071576|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071577|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14071578|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14071579|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14071580|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
14071581|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14071582|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
14071583|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14071584|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14071585|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
14071586|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
14071587|NCT05124275|Pilocarpine|pilocarpine|mesh-list
14071588|NCT05124275|Miotics|miotics|mesh-ancestor
14071589|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
14071590|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071591|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071592|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13914616|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
13914617|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914618|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914619|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13914620|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13914621|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914622|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13914623|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13914624|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13914625|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13914626|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13914627|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13914628|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13914629|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
13914630|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914631|NCT03478514|Palbociclib|palbociclib|mesh-list
13914632|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914633|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13914634|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914635|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914636|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
13914637|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13914638|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071593|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14071594|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
14071595|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071596|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071597|NCT05119920|Pilocarpine|pilocarpine|mesh-list
14071598|NCT05119920|Miotics|miotics|mesh-ancestor
14071599|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
14071600|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071601|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071602|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14071603|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14071604|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
14476335|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14476336|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476337|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14476338|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14476339|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914639|NCT03478475|Vitamins|vitamins|mesh-ancestor
13914640|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
13914641|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14476340|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
14476341|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14476342|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
14071605|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071606|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914642|NCT03478436|Doxycycline|doxycycline|mesh-list
13914643|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14071607|NCT05079230|Azacitidine|azacitidine|mesh-list
14071608|NCT05079230|Venetoclax|venetoclax|mesh-list
14071609|NCT05079230|Magrolimab|magrolimab|mesh-list
14071610|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071611|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
14071612|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071613|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071614|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071615|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071616|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14071617|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
14071618|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14071619|NCT05041907|Ivermectin|ivermectin|mesh-list
14071620|NCT05041907|Remdesivir|remdesivir|mesh-list
14071621|NCT05041907|Favipiravir|favipiravir|mesh-list
14071622|NCT05041907|Antibodies|antibodies|mesh-list
14071623|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14071624|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
14071625|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071626|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14071627|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071628|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
14071629|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934179|NCT01455142|Insulin|insulin|mesh-list
14934180|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
14758607|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
14758608|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758609|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14758610|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14758611|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
14758612|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
14758613|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
14758614|NCT05130086|Islatravir|islatravir|mesh-list
14758615|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
14758616|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758617|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758618|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767457|NCT00630045|Capecitabine|capecitabine|mesh-list
14071630|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
14071631|NCT05030298|Temozolomide|temozolomide|mesh-list
14071632|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14071633|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
14071634|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071635|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071636|NCT04989699|Aflibercept|aflibercept|mesh-list
14071637|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14071638|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14071639|NCT04989699|Growth Substances|growth substances|mesh-ancestor
14071640|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071641|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
14071642|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071643|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14071644|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14071645|NCT04891484|Ondansetron|ondansetron|mesh-list
14071646|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
14071647|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
14071648|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071649|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071650|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14071651|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
14071652|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14071653|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14071654|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
14071655|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071656|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071657|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14071658|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14071659|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071660|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14071661|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14071662|NCT04861298|Quercetin|quercetin|mesh-list
14071663|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
14071664|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071665|NCT04861298|Protective Agents|protective agents|mesh-ancestor
14071666|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071667|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
14071668|NCT04859946|Busulfan|busulfan|mesh-list
14071669|NCT04859946|Thiotepa|thiotepa|mesh-list
14071670|NCT04859946|Fludarabine|fludarabine|mesh-list
14071671|NCT04859946|Tacrolimus|tacrolimus|mesh-list
14071672|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14071673|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
14071674|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071675|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14071676|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14071677|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
14071678|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071679|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071680|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14071681|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14071682|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172768|NCT04806737|Teriflunomide|teriflunomide|mesh-list
14172769|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14172770|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14172771|NCT04806737|Analgesics|analgesics|mesh-ancestor
14172772|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
14172773|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071683|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14758619|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13914644|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914645|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
13914646|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13914647|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13914648|NCT03478423|Oxycodone|oxycodone|mesh-list
13914649|NCT03478423|Hydromorphone|hydromorphone|mesh-list
13914650|NCT03478423|Codeine|codeine|mesh-list
13914651|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13914652|NCT03478423|Narcotics|narcotics|mesh-ancestor
13914653|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071684|NCT04846231|Red yeast rice|red yeast rice|mesh-list
14071685|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14071686|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14071687|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
14071688|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071689|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14071690|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14071691|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071692|NCT04844918|Tirzepatide|tirzepatide|mesh-list
14071693|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14071694|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071695|NCT04844918|Incretins|incretins|mesh-ancestor
14071696|NCT04844918|Hormones|hormones|mesh-ancestor
14071697|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071698|NCT04842708|Vaccines|vaccines|mesh-list
14071699|NCT04842708|Immunologic Factors|immunologic factors|mesh-ancestor
14071700|NCT04842708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071701|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
14071702|NCT04812366|Prednisone|prednisone|mesh-list
14071703|NCT04812366|Docetaxel|docetaxel|mesh-list
14071704|NCT04812366|Atezolizumab|atezolizumab|mesh-list
14071705|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
14071706|NCT04812366|Niraparib|niraparib|mesh-list
14071707|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071708|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
14071709|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
14071710|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
14071711|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934181|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934182|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934183|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
14934184|NCT01455233|Besifloxacin|besifloxacin|mesh-list
14934185|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14934186|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14934187|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14934188|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14934189|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934190|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14934191|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14934192|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934193|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934194|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071712|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14071713|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
14071714|NCT04812366|Hormones|hormones|mesh-ancestor
14071715|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071716|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071717|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14071718|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14071719|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071720|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
14071721|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14071722|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14071723|NCT04778397|Cytarabine|cytarabine|mesh-list
14071724|NCT04778397|Azacitidine|azacitidine|mesh-list
14071725|NCT04778397|Daunorubicin|daunorubicin|mesh-list
14071726|NCT04778397|Venetoclax|venetoclax|mesh-list
14071727|NCT04778397|Idarubicin|idarubicin|mesh-list
14071728|NCT04778397|Magrolimab|magrolimab|mesh-list
14071729|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14071730|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071731|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
14071732|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071733|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071734|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
14071735|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071736|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14071737|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
14071738|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071739|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071740|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14071741|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14071742|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14934195|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14934196|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
14934197|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14934198|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071743|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14071744|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071745|NCT04771130|Posaconazole|posaconazole|mesh-list
14071746|NCT04771130|Azacitidine|azacitidine|mesh-list
14071747|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071748|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
14071749|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071750|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071751|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071752|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
14071753|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071754|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14071755|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14071756|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14071757|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14071758|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14071759|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14071760|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
14071761|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14071762|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071763|NCT04748848|Azacitidine|azacitidine|mesh-list
14071764|NCT04748848|Venetoclax|venetoclax|mesh-list
14071765|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
14071766|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071767|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
14071768|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071769|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071770|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071771|NCT04742777|Sirolimus|sirolimus|mesh-list
14071772|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14071773|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071774|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14071775|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071776|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
14071777|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14071778|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
14071779|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071780|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
14071781|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071782|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071783|NCT04732208|Mydriatics|mydriatics|mesh-list
14071784|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
14071785|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071786|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071787|NCT04731779|Cannabidiol|cannabidiol|mesh-list
14071788|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
14071789|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
14071790|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14071791|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
14071792|NCT04721626|Tetracycline|tetracycline|mesh-list
14071793|NCT04721626|Doxycycline|doxycycline|mesh-list
14071794|NCT04721626|Povidone|povidone|mesh-list
14071795|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14071796|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914654|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914655|NCT03478423|Analgesics|analgesics|mesh-ancestor
13914656|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
13914657|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914658|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
13914659|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
13914660|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
13914661|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
13914662|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
13914663|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
13914664|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
13914665|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914666|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14071797|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
14071798|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
14071799|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
14071800|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
14071801|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14071802|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14071803|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071804|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071805|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
14071806|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13914667|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
13914668|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914669|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
14071807|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14071808|NCT04669288|Azithromycin|azithromycin|mesh-list
14071809|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14071810|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14071811|NCT04649203|Riboflavin|riboflavin|mesh-list
14071812|NCT04649203|Niacinamide|niacinamide|mesh-list
14071813|NCT04649203|Niacin|niacin|mesh-list
14071814|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
14071815|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
14071816|NCT04649203|Vitamins|vitamins|mesh-ancestor
14071817|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
14071818|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071819|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14071820|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
14071821|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14071822|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
14071823|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071824|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14071825|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
14071826|NCT04638465|Cisplatin|cisplatin|mesh-list
14071827|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071828|NCT04634162|Cangrelor|cangrelor|mesh-list
14071829|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14071830|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14071831|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14071832|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14071833|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
14071834|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071835|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071836|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071837|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
14071838|NCT04633148|Fludarabine|fludarabine|mesh-list
14071839|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14071840|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
14071841|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071842|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14071843|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14071844|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
14071845|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071846|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071847|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14071848|NCT04627753|Rituximab|rituximab|mesh-list
14071849|NCT04627753|Lenalidomide|lenalidomide|mesh-list
14071850|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071851|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071852|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
14071853|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071854|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14071855|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14071856|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14071857|NCT04627753|Growth Substances|growth substances|mesh-ancestor
14071858|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
14071859|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14071860|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14071861|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071862|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14071863|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14071864|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14071865|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071866|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
14071867|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14071868|NCT04599465|Ivacaftor|ivacaftor|mesh-list
14071869|NCT04599465|Elexacaftor|elexacaftor|mesh-list
14071870|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14071871|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14071872|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071873|NCT04589676|Naloxone|naloxone|mesh-list
14071874|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14071875|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071876|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
14071877|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071878|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
14071879|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071880|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
14071881|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14071882|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14071883|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071884|NCT04565925|Urological Agents|urological agents|mesh-ancestor
14071885|NCT04545515|Ivacaftor|ivacaftor|mesh-list
14071886|NCT04545515|Elexacaftor|elexacaftor|mesh-list
14071887|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14071888|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14071889|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071890|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
14071891|NCT04515615|Tegafur|tegafur|mesh-list
14071892|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071893|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14071894|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
14071895|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071896|NCT04489628|Vitamin D|vitamin d|mesh-list
14071897|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
14071898|NCT04489628|Vitamins|vitamins|mesh-ancestor
14071899|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
14071900|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071901|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14071902|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14071903|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14071904|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13914670|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
13914671|NCT03478306|Melatonin|melatonin|mesh-list
13914672|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
13914673|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914674|NCT03478306|Protective Agents|protective agents|mesh-ancestor
13914675|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914676|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071905|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071906|NCT04439318|Trametinib|trametinib|mesh-list
14071907|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14071908|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071909|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071910|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071911|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071912|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14071913|NCT04439318|Protective Agents|protective agents|mesh-ancestor
14071914|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071915|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14071916|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
14476343|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14476344|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
13914677|NCT03478280|Brodalumab|brodalumab|mesh-list
13914678|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
13914679|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
13914680|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
13914681|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
13914682|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13914683|NCT03478150|Protective Agents|protective agents|mesh-ancestor
13914684|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914685|NCT03478111|Methotrexate|methotrexate|mesh-list
13914686|NCT03478111|Infliximab|infliximab|mesh-list
13914687|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13914688|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
14071917|NCT04439292|Trametinib|trametinib|mesh-list
14071918|NCT04439292|Dabrafenib|dabrafenib|mesh-list
14071919|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14071920|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071921|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071922|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071923|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071924|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14071925|NCT04439292|Protective Agents|protective agents|mesh-ancestor
14071926|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071927|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14071928|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
14071929|NCT04439279|Trametinib|trametinib|mesh-list
14071930|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14071931|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071932|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071933|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071934|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071935|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14071936|NCT04439279|Protective Agents|protective agents|mesh-ancestor
14071937|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071938|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14071939|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
14071940|NCT04439266|Crizotinib|crizotinib|mesh-list
14071941|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071942|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071943|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071944|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071945|NCT04439253|Crizotinib|crizotinib|mesh-list
14071946|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071947|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071948|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071949|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071950|NCT04439227|Adavosertib|adavosertib|mesh-list
14071951|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071952|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071953|NCT04439201|Palbociclib|palbociclib|mesh-list
14071954|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071955|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071956|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071957|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071958|NCT04439136|Afatinib|afatinib|mesh-list
14071959|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071960|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14071961|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14071962|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071963|NCT04439110|Trastuzumab|trastuzumab|mesh-list
14071964|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14071965|NCT04439110|Maytansine|maytansine|mesh-list
14071966|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
14071967|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071968|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071969|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14071970|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14071971|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14071972|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14071973|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071974|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
14071975|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071976|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
14071977|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14071978|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071979|NCT04390581|Lidocaine|lidocaine|mesh-list
14071980|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
14071981|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
14476345|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
14476346|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13914689|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13914690|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914691|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13914692|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
13914693|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914694|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914695|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
13914696|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914697|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13914698|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13914699|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
13914700|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13914701|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13914702|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914703|NCT03478033|Rifampin|rifampin|mesh-list
13914704|NCT03478033|Rifabutin|rifabutin|mesh-list
13914705|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13914706|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
13914707|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13914708|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914709|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
13914710|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13914711|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914712|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914713|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13914714|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13914715|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13914716|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13914717|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13914718|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13914719|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
13914720|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
13914721|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13914722|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13914723|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914724|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13914725|NCT03477994|Clonidine|clonidine|mesh-list
13914726|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
13914727|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13914728|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914729|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914730|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914731|NCT03477994|Analgesics|analgesics|mesh-ancestor
13914732|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
13914733|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914734|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13914735|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14071982|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14071983|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14071984|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
14071985|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14071986|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14071987|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14071988|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14071989|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14071990|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14071991|NCT04379635|Paclitaxel|paclitaxel|mesh-list
14071992|NCT04379635|Carboplatin|carboplatin|mesh-list
14071993|NCT04379635|Pemetrexed|pemetrexed|mesh-list
14071994|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14071995|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14071996|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14071997|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14071998|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14071999|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072000|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072001|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14072002|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14172774|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172775|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14172776|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14172777|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14172778|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
14172779|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
14172780|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14172781|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172782|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14172783|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172784|NCT04806906|Azacitidine|azacitidine|mesh-list
14172785|NCT04806906|Cc-486|cc-486|mesh-list
14172786|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14172787|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
14172788|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172789|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172790|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172791|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14172792|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14172793|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14172794|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14172795|NCT04806438|Lidocaine|lidocaine|mesh-list
14172796|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
14172797|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
14172798|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172799|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172800|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
14172801|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172802|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14172803|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14172804|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14172805|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14172806|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172807|NCT04806230|Mirtazapine|mirtazapine|mesh-list
14172808|NCT04806230|Citalopram|citalopram|mesh-list
14172809|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14172810|NCT04806230|Sertraline|sertraline|mesh-list
14172811|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14172812|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14172813|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14172814|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172815|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172816|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
14172817|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172818|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14172819|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
14172820|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14172821|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14172822|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14172823|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
14172824|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
14172825|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14172826|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14172827|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172828|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14172829|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14934199|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14072003|NCT04366115|Dexamethasone|dexamethasone|mesh-list
14072004|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
14072005|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14072006|NCT04366115|BB 1101|bb 1101|mesh-list
14072007|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072008|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
14072009|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
14072010|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072011|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072012|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072013|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
14072014|NCT04366115|Hormones|hormones|mesh-ancestor
14072015|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072016|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14072017|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072018|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
14072019|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072020|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072021|NCT04362761|Ivacaftor|ivacaftor|mesh-list
13914736|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072022|NCT04362761|Elexacaftor|elexacaftor|mesh-list
14072023|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14072024|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14072025|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072026|NCT04335201|Defibrotide|defibrotide|mesh-list
14072027|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14072028|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14072029|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072030|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14072031|NCT04313881|Azacitidine|azacitidine|mesh-list
14072032|NCT04313881|Magrolimab|magrolimab|mesh-list
14072033|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14072034|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
14072035|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072036|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072037|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072038|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14072039|NCT04313244|Vaccines|vaccines|mesh-list
14072040|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
14072041|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072042|NCT04294225|Letrozole|letrozole|mesh-list
14072043|NCT04294225|Anastrozole|anastrozole|mesh-list
14072044|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072045|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14072046|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14072047|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072048|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072049|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14072050|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
14072051|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072052|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072053|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14072054|NCT04292470|Amitriptyline|amitriptyline|mesh-list
14072055|NCT04292470|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14072056|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14072057|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
14072058|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13914737|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914738|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914739|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914740|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13914741|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
13914742|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
13914743|NCT03477955|Silicon|silicon|mesh-list
13914744|NCT03477955|Trace Elements|trace elements|mesh-ancestor
14072059|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14072060|NCT04292470|Analgesics|analgesics|mesh-ancestor
14072061|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
14072062|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072063|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072064|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14072065|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14072066|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14072067|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072068|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072069|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072070|NCT04292470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14072071|NCT04292470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14072072|NCT04292470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072073|NCT04209790|Temozolomide|temozolomide|mesh-list
14072074|NCT04209790|Benzolamide|benzolamide|mesh-list
14072075|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14072076|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
14072077|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072078|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072079|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14072080|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072081|NCT04183790|Ivacaftor|ivacaftor|mesh-list
14072082|NCT04183790|Elexacaftor|elexacaftor|mesh-list
14072083|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14072084|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14072085|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072086|NCT04179396|Rucaparib|rucaparib|mesh-list
14072087|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14072088|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072089|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072090|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072091|NCT04177108|Paclitaxel|paclitaxel|mesh-list
14072092|NCT04177108|Atezolizumab|atezolizumab|mesh-list
14072093|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14072094|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14072095|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072096|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
14072097|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
14072098|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
14072099|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072100|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
14072101|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072102|NCT04176705|Triamcinolone|triamcinolone|mesh-list
14072103|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14072104|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14072105|NCT04176705|Lidocaine|lidocaine|mesh-list
14072106|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14072107|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
14072108|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
14072109|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072110|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072111|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
14072112|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072113|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14072114|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14072115|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14072116|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14072117|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072118|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072119|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
14072120|NCT04176705|Hormones|hormones|mesh-ancestor
14072121|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072122|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072123|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
14072124|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072125|NCT04140214|Carbocysteine|carbocysteine|mesh-list
14072126|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14072127|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072128|NCT04140214|Expectorants|expectorants|mesh-ancestor
14072129|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072130|NCT04115774|Diphosphonates|diphosphonates|mesh-list
14072131|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14072132|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072133|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14072134|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072135|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14072136|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
14072137|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14072138|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14072139|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
14072140|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072141|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14072142|NCT04034004|Naloxone|naloxone|mesh-list
14072143|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14072144|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072145|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
14072146|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072147|NCT04015622|Docetaxel|docetaxel|mesh-list
14072148|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072149|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
14072150|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
14072151|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14072152|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072153|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
14072154|NCT04015115|Narcotics|narcotics|mesh-ancestor
14072155|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072156|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072157|NCT04015115|Analgesics|analgesics|mesh-ancestor
14072158|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
14072159|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072160|NCT04012138|Insulin|insulin|mesh-list
14476347|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
14072161|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14072162|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
14072163|NCT04012138|Albuterol|albuterol|mesh-list
14072164|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14072165|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072166|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14072167|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
14072168|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072169|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14072170|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072171|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
14072172|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14072173|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14072174|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14072175|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072176|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934200|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14934201|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13914745|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
13914746|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914747|NCT03477929|Cetrorelix|cetrorelix|mesh-list
13914748|NCT03477929|Ganirelix|ganirelix|mesh-list
13914749|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
14934202|NCT01455246|Meropenem|meropenem|mesh-list
14934203|NCT01455246|Daptomycin|daptomycin|mesh-list
14934204|NCT01455246|Ceftazidime|ceftazidime|mesh-list
13914750|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914751|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914752|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13914753|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
14934205|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14934206|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934207|NCT01455337|Prednisolone|prednisolone|mesh-list
14934208|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
14934209|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14934210|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
14934211|NCT01455337|Hormones|hormones|mesh-ancestor
14934212|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934213|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934214|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14934215|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934216|NCT01455337|Protective Agents|protective agents|mesh-ancestor
14934217|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14934218|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934219|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934220|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934221|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14934222|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
14934223|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14934224|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
14072177|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072178|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072179|NCT03992456|Trifluridine|trifluridine|mesh-list
14072180|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14072181|NCT03992456|Panitumumab|panitumumab|mesh-list
14072182|NCT03992456|Antibodies|antibodies|mesh-list
14072183|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
14072184|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14072185|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
14072186|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934225|NCT01455350|Lidocaine|lidocaine|mesh-list
13914754|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13914755|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13914756|NCT03477864|Ipilimumab|ipilimumab|mesh-list
13914757|NCT03477864|Cemiplimab|cemiplimab|mesh-list
13914758|NCT03477864|Antibodies|antibodies|mesh-list
13914759|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
13914760|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13914761|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
13914762|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914763|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914764|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13914765|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960039|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960040|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960041|NCT03158129|Cisplatin|cisplatin|mesh-list
14072187|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072188|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
14934226|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
14934227|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
14934228|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934229|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934230|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
14934231|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934232|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14934233|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14934234|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14934235|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14934236|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934237|NCT01455441|Liraglutide|liraglutide|mesh-list
14934238|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934239|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934240|NCT01455441|Incretins|incretins|mesh-ancestor
14934241|NCT01455441|Hormones|hormones|mesh-ancestor
14934242|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072189|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072190|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
14072191|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072192|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
14072193|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
14072194|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072195|NCT03955861|Adalimumab|adalimumab|mesh-list
14072196|NCT03955861|Etanercept|etanercept|mesh-list
14072197|NCT03955861|Golimumab|golimumab|mesh-list
14072198|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
14072199|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072200|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14072201|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14072202|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14072203|NCT03955861|Analgesics|analgesics|mesh-ancestor
14072204|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
14072205|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072206|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072207|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072208|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072209|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
14072210|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14072211|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
14072212|NCT03912831|Fludarabine|fludarabine|mesh-list
14072213|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072214|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
14072215|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072216|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14072217|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14072218|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
14072219|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072220|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072221|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14072222|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
14072223|NCT03912298|Narcotics|narcotics|mesh-ancestor
14072224|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072225|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072226|NCT03912298|Analgesics|analgesics|mesh-ancestor
14072227|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
14072228|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072229|NCT02543697|Epinephrine|epinephrine|mesh-list
14072230|NCT02543697|Racepinephrine|racepinephrine|mesh-list
14072231|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
14476348|NCT02415400|Coagulants|coagulants|mesh-ancestor
14758620|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13914766|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
13914767|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13914768|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
13914769|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914770|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
13914771|NCT03477630|Protective Agents|protective agents|mesh-ancestor
13914772|NCT03477461|Terlipressin|terlipressin|mesh-list
13914773|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13914774|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13914775|NCT03477448|Bleomycin|bleomycin|mesh-list
13914776|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13914777|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914778|NCT03477422|Meropenem|meropenem|mesh-list
13914779|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
13914780|NCT03477422|Sulbactam|sulbactam|mesh-list
13914781|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13914782|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914783|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14072232|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14476349|NCT02415556|Insulin|insulin|mesh-list
14072233|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072234|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072235|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072236|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072237|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072238|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14072239|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14072240|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
14072241|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072242|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14072243|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072244|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
14072245|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
14072246|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14072247|NCT02543944|Clonidine|clonidine|mesh-list
14072248|NCT02543944|Naltrexone|naltrexone|mesh-list
14072249|NCT02543944|Buprenorphine|buprenorphine|mesh-list
14072250|NCT02543944|Gabapentin|gabapentin|mesh-list
14072251|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14072252|NCT02543944|Narcotics|narcotics|mesh-ancestor
14072253|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072254|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072255|NCT02543944|Analgesics|analgesics|mesh-ancestor
14072256|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
13914784|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914785|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914786|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
13914787|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13914788|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914789|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914790|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914791|NCT03477344|Analgesics|analgesics|mesh-ancestor
13914792|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
14072257|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072258|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14072259|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14072260|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
14072261|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14072262|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14072263|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14072264|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14072265|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14072266|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072267|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072268|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
14072269|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14072270|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
14072271|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
14072272|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14072273|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14072274|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072275|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072276|NCT02543710|Taxane|taxane|mesh-list
14072277|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072278|NCT02543671|Vitamin D|vitamin d|mesh-list
14072279|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
14072280|NCT02543671|Vitamins|vitamins|mesh-ancestor
14072281|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
14072282|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072283|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14072284|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14072285|NCT02543645|Atezolizumab|atezolizumab|mesh-list
14072286|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072287|NCT02543411|Lidocaine|lidocaine|mesh-list
14072288|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
14072289|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
14072290|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072291|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072292|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
14072293|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072294|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14072295|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14072296|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14072297|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14072298|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172830|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14172831|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
14172832|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14172833|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14172834|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14172835|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14172836|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14172837|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14172838|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172839|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
14072299|NCT02543606|Esomeprazole|esomeprazole|mesh-list
14072300|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14072301|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072302|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14072303|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072304|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072305|NCT02543385|Ketamine|ketamine|mesh-list
14072306|NCT02543385|Esketamine|esketamine|mesh-list
14072307|NCT02543385|Analgesics|analgesics|mesh-ancestor
14072308|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
14072309|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072310|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072311|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14072312|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14072313|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
14072314|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
14072315|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072316|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14072317|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14072318|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072319|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072320|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
14072321|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14072322|NCT02543034|Petrolatum|petrolatum|mesh-list
14072323|NCT02543034|Emollients|emollients|mesh-ancestor
14072324|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14072325|NCT02543099|Policosanol|policosanol|mesh-list
14072326|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14072327|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14072328|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
14072329|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072330|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14072331|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14072332|NCT02543086|Piperaquine|piperaquine|mesh-list
14072333|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
14072334|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14072335|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14072336|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072337|NCT02543229|Ranibizumab|ranibizumab|mesh-list
14072338|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14072339|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14072340|NCT02543229|Growth Substances|growth substances|mesh-ancestor
14072341|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072342|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14072343|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072344|NCT02543060|Fluorides|fluorides|mesh-list
14072345|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
14072346|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
14072347|NCT02543060|Protective Agents|protective agents|mesh-ancestor
14072348|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072349|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14072350|NCT02542969|Simvastatin|simvastatin|mesh-list
14072351|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14072352|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14072353|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
14072354|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072355|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14072356|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14072357|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072358|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
14072359|NCT02543073|Hormones|hormones|mesh-ancestor
14072360|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183401|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
14072361|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072362|NCT02542930|Thymalfasin|thymalfasin|mesh-list
14072363|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14072364|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
14072365|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072366|NCT02542852|Ritonavir|ritonavir|mesh-list
14072367|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14072368|NCT02542852|Dolutegravir|dolutegravir|mesh-list
14072369|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14072370|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14072371|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
14072372|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072373|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072374|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14072375|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14072376|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
14072377|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072378|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14072379|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14072380|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14072381|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14072382|NCT02542748|Norepinephrine|norepinephrine|mesh-list
14072383|NCT02542748|Ephedrine|ephedrine|mesh-list
14072384|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14072385|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072386|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072387|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072388|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072389|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072390|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
14072391|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
14072392|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072393|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14072394|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14072395|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
14072396|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14072397|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14072398|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072399|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
14072400|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072401|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072402|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
14072403|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13914793|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072404|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14072405|NCT02542592|Prednisolone|prednisolone|mesh-list
14072406|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
14072407|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14072408|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
14072409|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072410|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
14072411|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
14758621|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14758622|NCT05128071|Progesterone|progesterone|mesh-list
14758623|NCT05128071|Progestins|progestins|mesh-ancestor
14758624|NCT05128071|Hormones|hormones|mesh-ancestor
13914794|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13914795|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13914796|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13914797|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
13914798|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914799|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914800|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14767458|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
14072412|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072413|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072414|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072415|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
14072416|NCT02542592|Hormones|hormones|mesh-ancestor
14072417|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072418|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14072419|NCT02542592|Protective Agents|protective agents|mesh-ancestor
14072420|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14072421|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072422|NCT02542813|Oxytocin|oxytocin|mesh-list
14072423|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
14072424|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14072425|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072426|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14072427|NCT02542254|Albuterol|albuterol|mesh-list
14072428|NCT02542254|Ipratropium|ipratropium|mesh-list
14072429|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14072430|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
14072431|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934243|NCT01455506|Fludarabine|fludarabine|mesh-list
14934244|NCT01455506|Busulfan|busulfan|mesh-list
14934245|NCT01455506|Decitabine|decitabine|mesh-list
14934246|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934247|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14934248|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
14934249|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072432|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072433|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14072434|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072435|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
14072436|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14072437|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14072438|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14072439|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072440|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072441|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072442|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072443|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14072444|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
14934250|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934251|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
14072445|NCT02542293|Gemcitabine|gemcitabine|mesh-list
14072446|NCT02542293|Paclitaxel|paclitaxel|mesh-list
14072447|NCT02542293|Cisplatin|cisplatin|mesh-list
14072448|NCT02542293|Carboplatin|carboplatin|mesh-list
14072449|NCT02542293|Pemetrexed|pemetrexed|mesh-list
14934252|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072450|NCT02542293|Durvalumab|durvalumab|mesh-list
14934253|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
14072451|NCT02542293|Tremelimumab|tremelimumab|mesh-list
14072452|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14072453|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072454|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
14072455|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
14072456|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
14072457|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072458|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14072459|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
14072460|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
14072461|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072462|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072463|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072464|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
14072465|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072466|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14072467|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14072468|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14072469|NCT02542137|Thymalfasin|thymalfasin|mesh-list
14072470|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14072471|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
14072472|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072473|NCT02542124|Interleukin-12|interleukin-12|mesh-list
14072474|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14072475|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
14072476|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072477|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14934254|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14934255|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14934256|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934257|NCT01455532|Gemcitabine|gemcitabine|mesh-list
14934258|NCT01455532|Carboplatin|carboplatin|mesh-list
14934259|NCT01455532|Doxorubicin|doxorubicin|mesh-list
14072478|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14072479|NCT02542124|Growth Substances|growth substances|mesh-ancestor
14072480|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
14934260|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14934261|NCT01455532|Iniparib|iniparib|mesh-list
14934262|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934263|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14934264|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
14934265|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934266|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
14934267|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934268|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934269|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934270|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
14934271|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934272|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14938661|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
14072481|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072482|NCT02542111|Gemcitabine|gemcitabine|mesh-list
14072483|NCT02542111|Dexamethasone|dexamethasone|mesh-list
14072484|NCT02542111|Bortezomib|bortezomib|mesh-list
14072485|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072486|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072487|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
14072488|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
14072489|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072490|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072491|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072492|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
14072493|NCT02542111|Hormones|hormones|mesh-ancestor
14072494|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072495|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14072496|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14072497|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
14072498|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072499|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
14072500|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072501|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072502|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072503|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
14072504|NCT02542007|Sirolimus|sirolimus|mesh-list
14072505|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072506|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072507|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14072508|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072509|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
14072510|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072511|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
14072512|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072513|NCT02542098|Hydrocodone|hydrocodone|mesh-list
14072514|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14072515|NCT02542098|Narcotics|narcotics|mesh-ancestor
14072516|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072517|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072518|NCT02542098|Analgesics|analgesics|mesh-ancestor
14072519|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
14072520|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072521|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
14072522|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072523|NCT02541734|Exenatide|exenatide|mesh-list
14072524|NCT02541734|Polygeline|polygeline|mesh-list
14072525|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14072526|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072527|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14072528|NCT02541734|Incretins|incretins|mesh-ancestor
14072529|NCT02541734|Hormones|hormones|mesh-ancestor
14072530|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072531|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
14072532|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
14072533|NCT02541786|Rabeprazole|rabeprazole|mesh-list
14072534|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
14072535|NCT02541786|Lansoprazole|lansoprazole|mesh-list
14072536|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14072537|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072538|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14072539|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072540|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072541|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
14072542|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072543|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
14072544|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14172840|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14172841|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
14172842|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172843|NCT04805775|Propofol|propofol|mesh-list
14172844|NCT04805775|Desflurane|desflurane|mesh-list
14172845|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14172846|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172847|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172848|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14172849|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
14172850|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
14172851|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14172852|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13914801|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914802|NCT03477266|Mosapride|mosapride|mesh-list
13914803|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914804|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13914805|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
13914806|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914807|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914808|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914809|NCT03477175|Sorafenib|sorafenib|mesh-list
13914810|NCT03477175|Lenvatinib|lenvatinib|mesh-list
13914811|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914812|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13914813|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914814|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914815|NCT03477136|Vitamin D|vitamin d|mesh-list
13914816|NCT03477136|Vitamins|vitamins|mesh-ancestor
13914817|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
14172853|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
14172854|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172855|NCT04805957|Sulforaphane|sulforaphane|mesh-list
14172856|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13914818|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914819|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14172857|NCT04805957|Protective Agents|protective agents|mesh-ancestor
13914820|NCT03477110|Temozolomide|temozolomide|mesh-list
13914821|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14072545|NCT02541643|Elotuzumab|elotuzumab|mesh-list
14072546|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072547|NCT02541708|Folic Acid|folic acid|mesh-list
14072548|NCT02541708|Hematinics|hematinics|mesh-ancestor
14072549|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
14072550|NCT02541708|Vitamins|vitamins|mesh-ancestor
14072551|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
14072552|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072553|NCT02541526|Mirtazapine|mirtazapine|mesh-list
14072554|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
14072555|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14072556|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13914822|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
13914823|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914824|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914825|NCT03476941|Clindamycin|clindamycin|mesh-list
13914826|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
13914827|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
14072557|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
14072558|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
14072559|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072560|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072561|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072562|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14072563|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14072564|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072565|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13914828|NCT03476941|Gentamicins|gentamicins|mesh-list
13914829|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13914830|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914831|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13914832|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072566|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14072567|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14072568|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072569|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14072570|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14072571|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
14072572|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14072573|NCT02541552|Ropivacaine|ropivacaine|mesh-list
14072574|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
14072575|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
14072576|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072577|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072578|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
14072579|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072580|NCT02541500|Minocycline|minocycline|mesh-list
14072581|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072582|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072583|NCT02541396|Ketamine|ketamine|mesh-list
14072584|NCT02541396|Oxycodone|oxycodone|mesh-list
14072585|NCT02541396|Analgesics|analgesics|mesh-ancestor
14072586|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
13960042|NCT03158129|Carboplatin|carboplatin|mesh-list
14072587|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072588|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072589|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14072590|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14072591|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
14072592|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
14072593|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072594|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14072595|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14072596|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758625|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758626|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072597|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072598|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14072599|NCT02541396|Narcotics|narcotics|mesh-ancestor
14072600|NCT02541383|Thalidomide|thalidomide|mesh-list
14072601|NCT02541383|Dexamethasone|dexamethasone|mesh-list
14072602|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
14072603|NCT02541383|Bortezomib|bortezomib|mesh-list
14072604|NCT02541383|Daratumumab|daratumumab|mesh-list
14072605|NCT02541383|BB 1101|bb 1101|mesh-list
14072606|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14072607|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072608|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
14072609|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
14072610|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072611|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072612|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072613|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
14072614|NCT02541383|Hormones|hormones|mesh-ancestor
14072615|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072616|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14072617|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072618|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
14072619|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072620|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072621|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072622|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
14072623|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
14072624|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072625|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072626|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14072627|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14072628|NCT02541383|Growth Substances|growth substances|mesh-ancestor
14072629|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
14072630|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
14072631|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14072632|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
14072633|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072634|NCT02541084|Aflibercept|aflibercept|mesh-list
14072635|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14072636|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14072637|NCT02541084|Growth Substances|growth substances|mesh-ancestor
14072638|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072639|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
14072640|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072641|NCT02541071|Clonidine|clonidine|mesh-list
14072642|NCT02541071|Yohimbine|yohimbine|mesh-list
14072643|NCT02541071|Analgesics|analgesics|mesh-ancestor
14072644|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
14072645|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072646|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914833|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914834|NCT03476811|Analgesics|analgesics|mesh-list
14072647|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14072648|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
14072649|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
14072650|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14072651|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14072652|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072653|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072654|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072655|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072656|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
14072657|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14072658|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14072659|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14072660|NCT02541071|Urological Agents|urological agents|mesh-ancestor
14072661|NCT02541045|Metadoxine|metadoxine|mesh-list
14072662|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14072663|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
14072664|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14072665|NCT02541227|Protective Agents|protective agents|mesh-ancestor
14072666|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072667|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
14072668|NCT02541032|Minocycline|minocycline|mesh-list
14072669|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072670|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072671|NCT02541019|Ondansetron|ondansetron|mesh-list
14934273|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14934274|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14934275|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14938662|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
13914835|NCT03476811|Bupivacaine|bupivacaine|mesh-list
13914836|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
13914837|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
13914838|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914839|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914840|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
13914841|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914842|NCT03476772|Nalbuphine|nalbuphine|mesh-list
13914843|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13914844|NCT03476772|Narcotics|narcotics|mesh-ancestor
13914845|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914846|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914847|NCT03476772|Analgesics|analgesics|mesh-ancestor
13914848|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
13914849|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914850|NCT03476616|Valsartan|valsartan|mesh-list
13914851|NCT03476616|Eplerenone|eplerenone|mesh-list
13914852|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13914853|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13914854|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13914855|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914856|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14072672|NCT02541019|Palonosetron|palonosetron|mesh-list
14072673|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
14476350|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14072674|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
14072675|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072676|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072677|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072678|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
14072679|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
14072680|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14072681|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
14072682|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072683|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072684|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14072685|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14072686|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072687|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14072688|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14072689|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14934276|NCT01455636|Micronutrients|micronutrients|mesh-list
14934277|NCT01455636|Trace Elements|trace elements|mesh-list
14934278|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
14934279|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934280|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14072690|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
14072691|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072692|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072693|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
14072694|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14072695|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
14072696|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072697|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072698|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14072699|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072700|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
14072701|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14072702|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
14072703|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476351|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476352|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476353|NCT02415595|BMS-955176|bms-955176|mesh-list
14476354|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14476355|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14476356|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
14476357|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476358|NCT02415855|Dabigatran|dabigatran|mesh-list
14476359|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
14476360|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14476361|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14476362|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476363|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476364|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
14476365|NCT02415959|Pancrelipase|pancrelipase|mesh-list
14476366|NCT02415959|Pancreatin|pancreatin|mesh-list
14476367|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072704|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476368|NCT02416102|Losartan|losartan|mesh-list
14072705|NCT02540876|Ilorasertib|ilorasertib|mesh-list
14072706|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072707|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14072708|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072709|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072710|NCT02540824|Apatinib|apatinib|mesh-list
14072711|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072712|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14476369|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14476370|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14476371|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14476372|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14476373|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072713|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072714|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072715|NCT02540837|Bupivacaine|bupivacaine|mesh-list
14072716|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
14072717|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
14072718|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072719|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072720|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
14072721|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072722|NCT02540785|Levofloxacin|levofloxacin|mesh-list
14072723|NCT02540785|Ofloxacin|ofloxacin|mesh-list
14072724|NCT02540785|Tobramycin|tobramycin|mesh-list
14072725|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
14072726|NCT02540785|Dexamethasone|dexamethasone|mesh-list
14072727|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
14072728|NCT02540785|BB 1101|bb 1101|mesh-list
14072729|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
14072730|NCT02540785|Dipivefrin|dipivefrin|mesh-list
14072731|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072732|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
14072733|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
14072734|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072735|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072736|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072737|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
14072738|NCT02540785|Hormones|hormones|mesh-ancestor
14072739|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072740|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914857|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
13914858|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914859|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914860|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13914861|NCT03476616|Diuretics|diuretics|mesh-ancestor
13914862|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
13914863|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
13914864|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13914865|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914866|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914867|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13914868|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13914869|NCT03476564|Protective Agents|protective agents|mesh-ancestor
13914870|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072741|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072742|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
14072743|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072744|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072745|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14072746|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072747|NCT02540785|Renal Agents|renal agents|mesh-ancestor
14072748|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072749|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14072750|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14072751|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14072752|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14072753|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14072754|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
14072755|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
14072756|NCT02540785|Protective Agents|protective agents|mesh-ancestor
13914871|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
14072757|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072758|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072759|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072760|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14072761|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14072762|NCT02540720|Dexamethasone|dexamethasone|mesh-list
14072763|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
14072764|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14072765|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14072766|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072767|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
14072768|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
14072769|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072770|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072771|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072772|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
13914872|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13914873|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
13914874|NCT03476356|Clomiphene|clomiphene|mesh-list
13914875|NCT03476356|Enclomiphene|enclomiphene|mesh-list
13914876|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
13914877|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13914878|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
13914879|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914880|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914881|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13914882|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
13914883|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13914884|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13914885|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13914886|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
13914887|NCT03476174|Interleukin-2|interleukin-2|mesh-list
13914888|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14072773|NCT02540720|Hormones|hormones|mesh-ancestor
14072774|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914889|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914890|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14072775|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14758627|NCT05119855|Vaccines|vaccines|mesh-list
14758628|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
14758629|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072776|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072777|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
14072778|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
14072779|NCT02540642|Vitamins|vitamins|mesh-ancestor
14072780|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
14072781|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072782|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
14072783|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
14072784|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
14072785|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14072786|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072787|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
14072788|NCT02540707|Mirabegron|mirabegron|mesh-list
14072789|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14072790|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14072791|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
14072792|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14072793|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072794|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072795|NCT02540707|Urological Agents|urological agents|mesh-ancestor
14072796|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14072797|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14072798|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072799|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072800|NCT02540460|Delpazolid|delpazolid|mesh-list
14072801|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
14072802|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072803|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476374|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14476375|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14476376|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
14476377|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476378|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476379|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14476380|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
14476381|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
14476382|NCT02416180|Hormones|hormones|mesh-ancestor
14758630|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
14758631|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14758632|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758633|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
14758634|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758635|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072804|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14072805|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072806|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072807|NCT02540512|Acetaminophen|acetaminophen|mesh-list
14072808|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14072809|NCT02540512|Hydrocodone|hydrocodone|mesh-list
14072810|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14072811|NCT02540512|Analgesics|analgesics|mesh-ancestor
14072812|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
14072813|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072814|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072815|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
14072816|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14072817|NCT02540512|Narcotics|narcotics|mesh-ancestor
14072818|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072819|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
14072820|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072821|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14072822|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072823|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14072824|NCT02540239|Simethicone|simethicone|mesh-list
14072825|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
14072826|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072827|NCT02540239|Emollients|emollients|mesh-ancestor
14072828|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14072829|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
14072830|NCT02540395|Prednisolone|prednisolone|mesh-list
14072831|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14072832|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
14072833|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14072834|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
14072835|NCT02540395|Tacrolimus|tacrolimus|mesh-list
14072836|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14072837|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
14072838|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072839|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
14072840|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072841|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14072842|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072843|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072844|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14072845|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072846|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14072847|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
14072848|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072849|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072850|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072851|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
14072852|NCT02540395|Hormones|hormones|mesh-ancestor
14072853|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072854|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14072855|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
14072856|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
14072857|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072858|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072859|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14072860|NCT02540395|Protective Agents|protective agents|mesh-ancestor
14072861|NCT02540369|Aflibercept|aflibercept|mesh-list
14072862|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14072863|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14072864|NCT02540369|Growth Substances|growth substances|mesh-ancestor
14072865|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072866|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
14072867|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172858|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172859|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172860|NCT04805944|Dolutegravir|dolutegravir|mesh-list
14172861|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14172862|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14172863|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172864|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172865|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14172866|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479208|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14172867|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
14072868|NCT02540070|Ketorolac|ketorolac|mesh-list
14072869|NCT02540070|Epinephrine|epinephrine|mesh-list
14072870|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
14072871|NCT02540070|Morphine|morphine|mesh-list
14072872|NCT02540070|Ropivacaine|ropivacaine|mesh-list
14072873|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14072874|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072875|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072876|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14072877|NCT02540070|Analgesics|analgesics|mesh-ancestor
14072878|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
14072879|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072880|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14072881|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14072882|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14072883|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
14072884|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758636|NCT05116189|Paclitaxel|paclitaxel|mesh-list
14758637|NCT05116189|Docetaxel|docetaxel|mesh-list
14758638|NCT05116189|Bevacizumab|bevacizumab|mesh-list
14758639|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
14758640|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14758641|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072885|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072886|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14072887|NCT02540070|Narcotics|narcotics|mesh-ancestor
14072888|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
14072889|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
14072890|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14072891|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14758642|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
14758643|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
14758644|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
14758645|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072892|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
14072893|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14072894|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
14072895|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
14072896|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
14758646|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758647|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14072897|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14072898|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14072899|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072900|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14072901|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14072902|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072903|NCT02539979|Acetaminophen|acetaminophen|mesh-list
14476383|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476384|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
14072904|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14072905|NCT02539979|Analgesics|analgesics|mesh-ancestor
14476385|NCT02416193|Vitamin D|vitamin d|mesh-list
14072906|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
14183402|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14476386|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
14476387|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
14476388|NCT02416193|Vitamins|vitamins|mesh-list
14476389|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
14476390|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476391|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14476392|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14476393|NCT02416908|Cytarabine|cytarabine|mesh-list
14476394|NCT02416908|Plerixafor|plerixafor|mesh-list
14476395|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
14476396|NCT02416908|Cladribine|cladribine|mesh-list
14476397|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14476398|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
14476399|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476400|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476401|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
14476402|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476403|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14476404|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
14476405|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476406|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14072907|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072908|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072909|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
14072910|NCT02539966|Sirolimus|sirolimus|mesh-list
14072911|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14072912|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14072913|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14072914|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072915|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
14072916|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14072917|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
14072918|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476407|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14476408|NCT02416934|Dexamethasone|dexamethasone|mesh-list
13914891|NCT03476174|Analgesics|analgesics|mesh-ancestor
13914892|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
13914893|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914894|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914895|NCT03476109|Omalizumab|omalizumab|mesh-list
13914896|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13914897|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13914898|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
13914899|NCT03476083|Tenofovir|tenofovir|mesh-list
13914900|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
13914901|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914902|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13914903|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13914904|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14072919|NCT02540018|Paclitaxel|paclitaxel|mesh-list
14072920|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14072921|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072922|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14072923|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14072924|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14072925|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072926|NCT02539940|Paclitaxel|paclitaxel|mesh-list
14072927|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14072928|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072929|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
14072930|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
14072931|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
14072932|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14072933|NCT02539849|Adalimumab|adalimumab|mesh-list
14072934|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072935|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14072936|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
14072937|NCT02539706|Rocuronium|rocuronium|mesh-list
14072938|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14072939|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14072940|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14072941|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072942|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914905|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914906|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13914907|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13914908|NCT03476044|Selenium|selenium|mesh-list
13914909|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
13914910|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914911|NCT03476044|Protective Agents|protective agents|mesh-ancestor
13914912|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914913|NCT03476044|Trace Elements|trace elements|mesh-ancestor
14072943|NCT02539745|Vitamin D|vitamin d|mesh-list
14072944|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14072945|NCT02539745|Vitamins|vitamins|mesh-ancestor
14072946|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
14072947|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072948|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14072949|NCT02539641|Hormones|hormones|mesh-list
14072950|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13914914|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
13960043|NCT03158129|Docetaxel|docetaxel|mesh-list
13960044|NCT03158129|Nivolumab|nivolumab|mesh-list
13960045|NCT03158129|Pemetrexed|pemetrexed|mesh-list
13960046|NCT03158129|Ipilimumab|ipilimumab|mesh-list
13960047|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960048|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
13960049|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
13960050|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
14072951|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960051|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960052|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758648|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14758649|NCT05116189|Growth Substances|growth substances|mesh-ancestor
14072952|NCT02539628|Ropivacaine|ropivacaine|mesh-list
14072953|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
14072954|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
14072955|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14072956|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072957|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
14072958|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072959|NCT02539316|SMOFlipid|smoflipid|mesh-list
14072960|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14072961|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14072962|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14072963|NCT02539199|Misoprostol|misoprostol|mesh-list
14758650|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072964|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14072965|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
14072966|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14072967|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072968|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14072969|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072970|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
14072971|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
14072972|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14072973|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14072974|NCT02539394|Prednisolone|prednisolone|mesh-list
14072975|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
14072976|NCT02539394|Hemostatics|hemostatics|mesh-list
14072977|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14072978|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
14072979|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14072980|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
14072981|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
14072982|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14072983|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14072984|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14072985|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
14072986|NCT02539394|Hormones|hormones|mesh-ancestor
14072987|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14072988|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14072989|NCT02539394|Protective Agents|protective agents|mesh-ancestor
14072990|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14072991|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14072992|NCT02539394|Coagulants|coagulants|mesh-ancestor
14072993|NCT02538926|Prednisone|prednisone|mesh-list
14072994|NCT02538926|Cortisone|cortisone|mesh-list
14072995|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
14072996|NCT02538926|Rituximab|rituximab|mesh-list
14072997|NCT02538926|Doxorubicin|doxorubicin|mesh-list
14072998|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14072999|NCT02538926|Etoposide|etoposide|mesh-list
14073000|NCT02538926|Vincristine|vincristine|mesh-list
14073001|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
14073002|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
14073003|NCT02538926|Asparaginase|asparaginase|mesh-list
14073004|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
14073005|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14073006|NCT02538926|Antibodies|antibodies|mesh-list
14073007|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
14073008|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14073009|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14073010|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
14073011|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073012|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073013|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14073014|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
14073015|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073016|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073017|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14073018|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14073019|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14073020|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14073021|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073022|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073023|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
14073024|NCT02538926|Hormones|hormones|mesh-ancestor
14073025|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073026|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14073027|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14073028|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
14073029|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
14073030|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
14073031|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073032|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
14073033|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073034|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
14073035|NCT02538939|Antidotes|antidotes|mesh-ancestor
14073036|NCT02538939|Protective Agents|protective agents|mesh-ancestor
14073037|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073038|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
14073039|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073040|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
14073041|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14073042|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073043|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
14073044|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
14476409|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476410|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
14476411|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
14476412|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476413|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476414|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476415|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
14476416|NCT02416934|Hormones|hormones|mesh-ancestor
14476417|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476418|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476419|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476420|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14476421|NCT02417064|Citalopram|citalopram|mesh-list
14476422|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14476423|NCT02417064|Sertraline|sertraline|mesh-list
14476424|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
14476425|NCT02417064|Esketamine|esketamine|mesh-list
14476426|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14476427|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14476428|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476429|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476430|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476431|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
14476432|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476433|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14476434|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14073070|NCT02538718|Ritodrine|ritodrine|mesh-list
14073071|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
14073072|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
14073073|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073074|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073075|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
14073076|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14073077|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14073078|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14073079|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14073080|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073081|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073082|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073083|NCT02538627|Trametinib|trametinib|mesh-list
14073084|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073085|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073086|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073087|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073088|NCT02538484|Letrozole|letrozole|mesh-list
14073089|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073090|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14073091|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14073092|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073093|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073094|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14073095|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
14073096|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073097|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934281|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934282|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
14934283|NCT01455649|Cyclosporine|cyclosporine|mesh-list
14934284|NCT01455649|Everolimus|everolimus|mesh-list
14934285|NCT01455649|Tacrolimus|tacrolimus|mesh-list
14934286|NCT01455649|Cyclosporins|cyclosporins|mesh-list
14934287|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14934288|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934289|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
14934290|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934291|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934292|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934293|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
14934294|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073098|NCT02538367|Prucalopride|prucalopride|mesh-list
14073099|NCT02538367|YH12852|yh12852|mesh-list
14073100|NCT02538367|Laxatives|laxatives|mesh-ancestor
14934295|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073101|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14073102|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14073103|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14073104|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
14073105|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073106|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073107|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172868|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172869|NCT04805827|Gabapentin|gabapentin|mesh-list
14172870|NCT04805827|Analgesics|analgesics|mesh-ancestor
14172871|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
14172872|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172873|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172874|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
14172875|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14172876|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14758651|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14758652|NCT05115110|Risdiplam|risdiplam|mesh-list
14758653|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14758654|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758655|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758656|NCT05112952|Lazertinib|lazertinib|mesh-list
14172877|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172878|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14479209|NCT02464657|Protective Agents|protective agents|mesh-ancestor
14758657|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14758658|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758659|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073108|NCT02538393|Sorafenib|sorafenib|mesh-list
14073109|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073110|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073111|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073112|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073113|NCT02538224|Doxycycline|doxycycline|mesh-list
14073114|NCT02538224|Ketoprofen|ketoprofen|mesh-list
14073115|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14073116|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073117|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
14073118|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14073119|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14073120|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14073121|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073122|NCT02538224|Analgesics|analgesics|mesh-ancestor
14073123|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
14073124|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073125|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073126|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073127|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073128|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14073129|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073130|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073131|NCT02538211|Vaccines|vaccines|mesh-list
14073132|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14073133|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
14073134|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073135|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14073136|NCT02538302|Oxybutynin|oxybutynin|mesh-list
14073137|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
14073138|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
14073139|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073140|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073141|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14073142|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14073143|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
14073144|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073145|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073146|NCT02538302|Urological Agents|urological agents|mesh-ancestor
14073147|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
14073148|NCT02538302|Coagulants|coagulants|mesh-ancestor
14073149|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14073150|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
14073151|NCT02538432|Gemcitabine|gemcitabine|mesh-list
14073152|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14073153|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
14073154|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073155|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073156|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
14073157|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073158|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073159|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14073160|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
14073161|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073162|NCT02538237|Ibuprofen|ibuprofen|mesh-list
14073163|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14073164|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073165|NCT02538237|Analgesics|analgesics|mesh-ancestor
14073166|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
14073167|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073168|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073169|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073170|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073171|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14073172|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073173|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073174|NCT02538198|Lenalidomide|lenalidomide|mesh-list
14073175|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
14476435|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476436|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14476437|NCT02417064|Analgesics|analgesics|mesh-ancestor
14476438|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
14476439|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
14476440|NCT02417129|Rituximab|rituximab|mesh-list
14476441|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476442|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476443|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
14758660|NCT05111626|Nivolumab|nivolumab|mesh-list
14758661|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
14073176|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073177|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14073178|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14073179|NCT02538198|Growth Substances|growth substances|mesh-ancestor
14073180|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
14073181|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073182|NCT02538172|Valganciclovir|valganciclovir|mesh-list
14073183|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
14073184|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073185|NCT02538003|Delpazolid|delpazolid|mesh-list
14073186|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
14073187|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14073188|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073189|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14073190|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073191|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073192|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
14073193|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
14073194|NCT02538146|Vitamins|vitamins|mesh-ancestor
14073195|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
14073196|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073197|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
14073198|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
14073199|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14073200|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14073201|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758662|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14073202|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
14073203|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073204|NCT02538081|Risperidone|risperidone|mesh-list
14073205|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14073206|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
14758663|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476444|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073207|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073208|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073209|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073210|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14073211|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14073212|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073213|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14073214|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14073215|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
14073216|NCT02537860|Fentanyl|fentanyl|mesh-list
14073217|NCT02537860|Bupivacaine|bupivacaine|mesh-list
14073218|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
14073219|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
14073220|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073221|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073222|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
14934296|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934297|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934298|NCT01455831|Tinzaparin|tinzaparin|mesh-list
14934299|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14934300|NCT01455831|Dalteparin|dalteparin|mesh-list
14934301|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
14934302|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14934303|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14934304|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934305|NCT01455883|Glimepiride|glimepiride|mesh-list
14934306|NCT01455883|Exenatide|exenatide|mesh-list
14073223|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073224|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14073225|NCT02537860|Narcotics|narcotics|mesh-ancestor
14073226|NCT02537860|Analgesics|analgesics|mesh-ancestor
14073227|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14073228|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14073229|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
14073230|NCT02537847|Ertapenem|ertapenem|mesh-list
14073231|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
14073232|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
14073233|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14073234|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073235|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14073236|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073237|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073238|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14073239|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14073240|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073241|NCT02537925|Celecoxib|celecoxib|mesh-list
14073242|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14073243|NCT02537925|Nedaplatin|nedaplatin|mesh-list
14073244|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14073245|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073246|NCT02537925|Analgesics|analgesics|mesh-ancestor
14934307|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14073247|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
14073248|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073249|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073250|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073251|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073252|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14073253|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073254|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073255|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073256|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
14073257|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14073258|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073259|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14073260|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073261|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
14073262|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14073263|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073264|NCT02537509|Vitamins|vitamins|mesh-ancestor
14073265|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
14073266|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14073267|NCT02537691|Theophylline|theophylline|mesh-list
14073268|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14073269|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
14073270|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073271|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073272|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14073273|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
14073274|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14073275|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073276|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073277|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
14073278|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14073279|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14073280|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
14073281|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073282|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
14073283|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14073284|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
14073285|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14073286|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
14073287|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934308|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14073288|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073289|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
14073290|NCT02537353|Epinephrine|epinephrine|mesh-list
14073291|NCT02537353|Racepinephrine|racepinephrine|mesh-list
14073292|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
14073293|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14073294|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14073295|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073296|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073297|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073298|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073299|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14073300|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14073301|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
14073302|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073303|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14073304|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
14073305|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
14073306|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
14073307|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14073308|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
14758664|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14758665|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758666|NCT05111574|Nivolumab|nivolumab|mesh-list
14758667|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758668|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758669|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14758670|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914915|NCT03475862|Oxycodone|oxycodone|mesh-list
13914916|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13914917|NCT03475862|Narcotics|narcotics|mesh-ancestor
13914918|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914919|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914920|NCT03475862|Analgesics|analgesics|mesh-ancestor
13914921|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
13914922|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914923|NCT03475810|Midazolam|midazolam|mesh-list
14073309|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14073310|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073311|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14073312|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073313|NCT02537561|Gemcitabine|gemcitabine|mesh-list
14073314|NCT02537561|Cisplatin|cisplatin|mesh-list
14073315|NCT02537561|Talazoparib|talazoparib|mesh-list
14073316|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073317|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14073318|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
14073319|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073320|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
14073321|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073322|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073323|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14073324|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
14073325|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073326|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14073327|NCT02537600|Vemurafenib|vemurafenib|mesh-list
14073328|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073329|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073330|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073331|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073332|NCT02537379|Ribavirin|ribavirin|mesh-list
14073333|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
14073334|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914924|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13914925|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13914926|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914927|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914928|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13914929|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13914930|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13914931|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13914932|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
13914933|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
13914934|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
13914935|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
13914936|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914937|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914938|NCT03475758|Goserelin|goserelin|mesh-list
13914939|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13914940|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914941|NCT03475693|Acetaminophen|acetaminophen|mesh-list
13914942|NCT03475693|Ondansetron|ondansetron|mesh-list
13914943|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
13914944|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13914945|NCT03475693|Analgesics|analgesics|mesh-ancestor
13914946|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
13914947|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13914948|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13914949|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
13914950|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
13914951|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
13914952|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914953|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
13914954|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
13914955|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13914956|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
13914957|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13914958|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914959|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14073335|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
13914960|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14073336|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073337|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
14073338|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073339|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073340|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073341|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073342|NCT02537366|Analgesics|analgesics|mesh-ancestor
14073343|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
14073344|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073345|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14073346|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14073347|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14073348|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073349|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073350|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073351|NCT02537392|Folic Acid|folic acid|mesh-list
14073352|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
14073353|NCT02537392|Vitamins|vitamins|mesh-ancestor
14073354|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
14934309|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934310|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934311|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
14934312|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14073355|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073356|NCT02537392|Hematinics|hematinics|mesh-ancestor
14073357|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
14073358|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073359|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073360|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073361|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073362|NCT02537249|Analgesics|analgesics|mesh-ancestor
14073363|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
14073364|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073365|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14073366|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14073367|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14934313|NCT01455883|Incretins|incretins|mesh-ancestor
14934314|NCT01455883|Hormones|hormones|mesh-ancestor
14073368|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073369|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073370|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073371|NCT02537210|Mesalamine|mesalamine|mesh-list
14073372|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14073373|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073374|NCT02537210|Analgesics|analgesics|mesh-ancestor
14073375|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
14073376|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073377|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073378|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073379|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073380|NCT02537158|Sorafenib|sorafenib|mesh-list
14073381|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073382|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073383|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073384|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073385|NCT02537223|Cisplatin|cisplatin|mesh-list
14073386|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934315|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934316|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14934317|NCT01455909|Exenatide|exenatide|mesh-list
14934318|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934319|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934320|NCT01455909|Incretins|incretins|mesh-ancestor
14934321|NCT01455909|Hormones|hormones|mesh-ancestor
14934322|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476445|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073387|NCT02537197|Naltrexone|naltrexone|mesh-list
14073388|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14073389|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14073390|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073391|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
14073392|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073393|NCT02537171|Apatinib|apatinib|mesh-list
14073394|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073395|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073396|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073397|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073398|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
14073399|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14073400|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073401|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14073402|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14073403|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073404|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073405|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073406|NCT02537080|Nimodipine|nimodipine|mesh-list
14073407|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14073408|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14073409|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14073410|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073411|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14073412|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476446|NCT02417246|Metoprolol|metoprolol|mesh-list
14073413|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
14073414|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
14073415|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14073416|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
14073417|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14073418|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
14073419|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073420|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073421|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
14073422|NCT02537054|Aflibercept|aflibercept|mesh-list
14073423|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14073424|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14073425|NCT02537054|Growth Substances|growth substances|mesh-ancestor
14073426|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073427|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
14073428|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073429|NCT02536989|Omeprazole|omeprazole|mesh-list
14073430|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14073431|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476447|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14073432|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14073433|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073434|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073435|NCT02536859|Insulin|insulin|mesh-list
14073436|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14073437|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
14073438|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14073439|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073440|NCT02536937|Eliglustat|eliglustat|mesh-list
14073441|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073442|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073443|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
14073444|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14073445|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
14073446|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073447|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
14073448|NCT02536807|Protective Agents|protective agents|mesh-ancestor
14172879|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14172880|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14172881|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172882|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172883|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
14172884|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
14172885|NCT04805710|Clopidogrel|clopidogrel|mesh-list
14172886|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14172887|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14172888|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14172889|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14172890|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
14172891|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172892|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172893|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172894|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14172895|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
14172896|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14172897|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
14172898|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172899|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
14172900|NCT04805515|Nicotine|nicotine|mesh-list
14172901|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14172902|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
14172903|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172904|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172905|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14172906|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14172907|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
14172908|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172909|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172910|NCT04805580|Anesthetics|anesthetics|mesh-list
14172911|NCT04805580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172912|NCT04805580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172913|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
14172914|NCT04805229|Narcotics|narcotics|mesh-ancestor
14172915|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172916|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172917|NCT04805229|Analgesics|analgesics|mesh-ancestor
14172918|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
14172919|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172920|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14172921|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14172922|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172923|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
14172924|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
14172925|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14172926|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172927|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172928|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
14172929|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14073449|NCT02536690|Midazolam|midazolam|mesh-list
14073450|NCT02536690|Remifentanil|remifentanil|mesh-list
14073451|NCT02536690|Propofol|propofol|mesh-list
14073452|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073453|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073454|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073455|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14073456|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
14073457|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
14073458|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14073459|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14073460|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14073461|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14073462|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
14073463|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
14073464|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073465|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914961|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13914962|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13914963|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13914964|NCT03475693|Antacids|antacids|mesh-ancestor
13914965|NCT03475680|Gentamicins|gentamicins|mesh-list
13914966|NCT03475680|Ornidazole|ornidazole|mesh-list
13914967|NCT03475680|Sennosides|sennosides|mesh-list
13914968|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13914969|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13914970|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14934323|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14934324|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
14934325|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934326|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934327|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14073466|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14073467|NCT02536690|Narcotics|narcotics|mesh-ancestor
14073468|NCT02536690|Analgesics|analgesics|mesh-ancestor
14073469|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
14073470|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073471|NCT02536911|Eliglustat|eliglustat|mesh-list
14073472|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073473|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073474|NCT02536742|Fulvestrant|fulvestrant|mesh-list
14073475|NCT02536742|Palbociclib|palbociclib|mesh-list
14073476|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14073477|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073478|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14073479|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14073480|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
14073481|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073482|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073483|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073484|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073485|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073486|NCT02536755|Eliglustat|eliglustat|mesh-list
14073487|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476448|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14934328|NCT01455922|Glimepiride|glimepiride|mesh-list
14934329|NCT01455922|Exenatide|exenatide|mesh-list
14934330|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14934331|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934332|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934333|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934334|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
14934335|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14934336|NCT01455922|Incretins|incretins|mesh-ancestor
14934337|NCT01455922|Hormones|hormones|mesh-ancestor
13914971|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073488|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934338|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073489|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14073490|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073491|NCT02536495|Docetaxel|docetaxel|mesh-list
14073492|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073493|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
14073494|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
14073495|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
14073496|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073497|NCT02536417|Melatonin|melatonin|mesh-list
14073498|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
14758671|NCT05109416|Bupivacaine|bupivacaine|mesh-list
14758672|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
14758673|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
14758674|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758675|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758676|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
14758677|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758678|NCT05104866|Gemcitabine|gemcitabine|mesh-list
14758679|NCT05104866|Capecitabine|capecitabine|mesh-list
14758680|NCT05104866|Vinorelbine|vinorelbine|mesh-list
14758681|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14758682|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
14758683|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758684|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758685|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
14758686|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758687|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758688|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758689|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
14758690|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758691|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14758692|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
14758693|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
13914972|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914973|NCT03475680|Laxatives|laxatives|mesh-ancestor
13914974|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13914975|NCT03475680|Amebicides|amebicides|mesh-ancestor
13914976|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13914977|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13914978|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13914979|NCT03475628|Daratumumab|daratumumab|mesh-list
13914980|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914981|NCT03475615|Paclitaxel|paclitaxel|mesh-list
13914982|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
13914983|NCT03475615|Tegafur|tegafur|mesh-list
14073499|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758694|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14758695|NCT05097599|Trastuzumab|trastuzumab|mesh-list
14934339|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14934340|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14934341|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14934342|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934343|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
14934344|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14934345|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14934346|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14934347|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934348|NCT01456117|Pioglitazone|pioglitazone|mesh-list
13914984|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13914985|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914986|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
13914987|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
13914988|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
13914989|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914990|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13914991|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
13914992|NCT03475589|Apatinib|apatinib|mesh-list
13914993|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13914994|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14934349|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14073500|NCT02536417|Protective Agents|protective agents|mesh-ancestor
14073501|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073502|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073503|NCT02536209|Oxycodone|oxycodone|mesh-list
14073504|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14073505|NCT02536209|Narcotics|narcotics|mesh-ancestor
14073506|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073507|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073508|NCT02536209|Analgesics|analgesics|mesh-ancestor
14073509|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
14073510|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073511|NCT02536430|Ketorolac|ketorolac|mesh-list
14073512|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14073513|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14073514|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073515|NCT02536430|Analgesics|analgesics|mesh-ancestor
14073516|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
14073517|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073518|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073519|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073520|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073521|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14073522|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073523|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073524|NCT02536352|Vitamins|vitamins|mesh-list
14073525|NCT02536352|Fluorides|fluorides|mesh-list
14073526|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
14073527|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073528|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
14073529|NCT02536352|Protective Agents|protective agents|mesh-ancestor
14073530|NCT02535988|Thymalfasin|thymalfasin|mesh-list
14073531|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14073532|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
14073533|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073534|NCT02535910|Vitamin D|vitamin d|mesh-list
14073535|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
14073536|NCT02535910|Calcifediol|calcifediol|mesh-list
14073537|NCT02535910|Vitamins|vitamins|mesh-ancestor
14073538|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
14758696|NCT05097599|Talazoparib|talazoparib|mesh-list
14758697|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758698|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758699|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14758700|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758701|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758702|NCT05092958|Avelumab|avelumab|mesh-list
14758703|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14758704|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758705|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758706|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
14758707|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758708|NCT05091905|Ropivacaine|ropivacaine|mesh-list
14073539|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073540|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14073541|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14073542|NCT02535975|Metformin|metformin|mesh-list
14073543|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14758709|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
14073544|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073545|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
14073546|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073547|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073548|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073549|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073550|NCT02536014|Analgesics|analgesics|mesh-ancestor
14073551|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
14073552|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073553|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14073554|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14073555|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14073556|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073557|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073558|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073559|NCT02535767|Primaquine|primaquine|mesh-list
14073560|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
14073561|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14073562|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14073563|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073564|NCT02535936|Anesthetics|anesthetics|mesh-list
14073565|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073566|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073567|NCT02535832|Pioglitazone|pioglitazone|mesh-list
14073568|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14073569|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073570|NCT02535689|Tofacitinib|tofacitinib|mesh-list
14073571|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073572|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073573|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073574|NCT02535533|Selenium|selenium|mesh-list
14073575|NCT02535533|Axitinib|axitinib|mesh-list
14073576|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073577|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073578|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073579|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073580|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
14073581|NCT02535533|Protective Agents|protective agents|mesh-ancestor
14073582|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073583|NCT02535533|Trace Elements|trace elements|mesh-ancestor
14073584|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
14073585|NCT02535351|Sunitinib|sunitinib|mesh-list
14758710|NCT05091905|Anesthetics|anesthetics|mesh-list
14073586|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073587|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14073588|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14073589|NCT02535351|Growth Substances|growth substances|mesh-ancestor
14073590|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073591|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
14073592|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073593|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073594|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073595|NCT02535299|Metformin|metformin|mesh-list
14073596|NCT02535299|Liraglutide|liraglutide|mesh-list
14073597|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14073598|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073599|NCT02535299|Incretins|incretins|mesh-ancestor
14073600|NCT02535299|Hormones|hormones|mesh-ancestor
14073601|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073602|NCT02535273|Lidocaine|lidocaine|mesh-list
14073603|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
14073604|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
14073605|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
14073606|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073607|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073608|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
14073609|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073610|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14073611|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14073612|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14073613|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14073614|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073615|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073616|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073617|NCT02535273|Analgesics|analgesics|mesh-ancestor
14073618|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14476449|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
14073619|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14073620|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14073621|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073622|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073623|NCT02535156|Risperidone|risperidone|mesh-list
14073624|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14073625|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
14073626|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073627|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073628|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073629|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14073630|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14073631|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073632|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14073633|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14073634|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
14073638|NCT05299203|Verapamil|verapamil|mesh-list
14073639|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14073640|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14073641|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14073642|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073643|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14073644|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073645|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
14073646|NCT05299164|Gemcitabine|gemcitabine|mesh-list
14073647|NCT05299164|Rituximab|rituximab|mesh-list
14073648|NCT05299164|Vinorelbine|vinorelbine|mesh-list
14073649|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
14073650|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14073651|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073652|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
14073653|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073654|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073655|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14073656|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
14073657|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073658|NCT05299164|Antiviral Agents|antiviral agents|mesh-ancestor
14073659|NCT05299164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073660|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073661|NCT05299164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14073662|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14073663|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
14073664|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
14073665|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
14073666|NCT05299164|Analgesics|analgesics|mesh-ancestor
14073667|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
14073668|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073669|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14073670|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14073671|NCT05299125|Carboplatin|carboplatin|mesh-list
14073672|NCT05299125|Pemetrexed|pemetrexed|mesh-list
14073673|NCT05299125|Lazertinib|lazertinib|mesh-list
14073674|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073675|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073676|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073677|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14073678|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14073679|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073680|NCT05299086|Fluticasone|fluticasone|mesh-list
14073681|NCT05299086|Xhance|xhance|mesh-list
14073682|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073683|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14073684|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
14073685|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073686|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073687|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14073688|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
14073689|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073690|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14073691|NCT05299073|Denosumab|denosumab|mesh-list
14073692|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14073693|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172930|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172931|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172932|NCT04805073|Promethazine|promethazine|mesh-list
14172933|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
14172934|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
14172935|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14172936|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14172937|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
14172938|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
14172939|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172940|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172941|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172942|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14172943|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14172944|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073694|NCT05298761|Lidocaine|lidocaine|mesh-list
14073695|NCT05298761|Nalbuphine|nalbuphine|mesh-list
14073696|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14073697|NCT05298761|Narcotics|narcotics|mesh-ancestor
14073698|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073699|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073700|NCT05298761|Analgesics|analgesics|mesh-ancestor
14073701|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
14073702|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073703|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
14476450|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
14073704|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
14073705|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14073706|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14073707|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14073708|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14073709|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073727|NCT05298683|Acetaminophen|acetaminophen|mesh-list
14073728|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
14073729|NCT05298683|Promethazine|promethazine|mesh-list
14073730|NCT05298683|Dexamethasone|dexamethasone|mesh-list
14476451|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476452|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476453|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14476454|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14073731|NCT05298683|Pomalidomide|pomalidomide|mesh-list
14073732|NCT05298683|Ranitidine|ranitidine|mesh-list
14073733|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14073734|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073735|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
14758711|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073736|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
14073737|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073738|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073739|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14073740|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
14073741|NCT05298683|Hormones|hormones|mesh-ancestor
14073742|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073743|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14073744|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073745|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073746|NCT05298683|Analgesics|analgesics|mesh-ancestor
14073747|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
14073748|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
14073749|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
14073750|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14073751|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14073752|NCT05298683|Growth Substances|growth substances|mesh-ancestor
14073753|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
14073754|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14476455|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14073755|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073756|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476456|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
14476457|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476458|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476459|NCT02417831|Tamsulosin|tamsulosin|mesh-list
14476460|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14476461|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14476462|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14476463|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
14476464|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476465|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758712|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758713|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
14073757|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
14073758|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
14073759|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14073760|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
14073761|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
13914995|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13914996|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13914997|NCT03475524|Metformin|metformin|mesh-list
13914998|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13914999|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915000|NCT03475459|Melatonin|melatonin|mesh-list
13915001|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
13915002|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915003|NCT03475459|Protective Agents|protective agents|mesh-ancestor
14073762|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073763|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073764|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14073765|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
14073766|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073767|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14073768|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14073769|NCT05298592|Nivolumab|nivolumab|mesh-list
14073770|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14073771|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073772|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14073773|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073774|NCT05298462|Antibodies|antibodies|mesh-list
14073775|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
14073776|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073777|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14073778|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14073779|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14073780|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073781|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073782|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14073783|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14073784|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073785|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
13915004|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915005|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915006|NCT03475407|Dexamethasone|dexamethasone|mesh-list
13915007|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
13915008|NCT03475407|BB 1101|bb 1101|mesh-list
13915009|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073786|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073787|NCT05298423|Paclitaxel|paclitaxel|mesh-list
13915010|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
13915011|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
13915012|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915013|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915014|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13915015|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
13915016|NCT03475407|Hormones|hormones|mesh-ancestor
13915017|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915018|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14073788|NCT05298423|Etoposide|etoposide|mesh-list
14073789|NCT05298423|Carboplatin|carboplatin|mesh-list
14073790|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
14073791|NCT05298423|Pemetrexed|pemetrexed|mesh-list
14073792|NCT05298423|Durvalumab|durvalumab|mesh-list
14073793|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14073794|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073795|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
14073796|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
14073797|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
14073798|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073799|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14073800|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14073801|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14073802|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073803|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14073804|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14073805|NCT05298202|Capsaicin|capsaicin|mesh-list
14073806|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
14073807|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073808|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
14073809|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073810|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073811|NCT05298176|Carboplatin|carboplatin|mesh-list
14073812|NCT05298176|Pemetrexed|pemetrexed|mesh-list
14073813|NCT05298176|Afatinib|afatinib|mesh-list
14073814|NCT05298176|Osimertinib|osimertinib|mesh-list
14073815|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073816|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073817|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073818|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14073819|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14073820|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14073821|NCT05298163|Calcitriol|calcitriol|mesh-list
14073822|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14073823|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073824|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14073825|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14073826|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073827|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14073828|NCT05298163|Vitamins|vitamins|mesh-ancestor
14073829|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
14073830|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14073831|NCT05298085|Oxytocin|oxytocin|mesh-list
14073832|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
14073833|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14073834|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073835|NCT05298020|Gemcitabine|gemcitabine|mesh-list
14073836|NCT05298020|Paclitaxel|paclitaxel|mesh-list
14073837|NCT05298020|Endostar protein|endostar protein|mesh-list
14073838|NCT05298020|Endostatins|endostatins|mesh-list
14073839|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14073840|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073841|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
14073842|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
14073843|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
14073844|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073845|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14073846|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
14073847|NCT05298020|Antiviral Agents|antiviral agents|mesh-ancestor
14073848|NCT05298020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073849|NCT05298020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073850|NCT05298020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14073851|NCT05298020|Immunologic Factors|immunologic factors|mesh-ancestor
14073852|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073853|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14073854|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14073855|NCT05298020|Growth Substances|growth substances|mesh-ancestor
14073856|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
14073857|NCT05297994|Vaccines|vaccines|mesh-list
14073858|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
14073859|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073860|NCT05297968|Oseltamivir|oseltamivir|mesh-list
14073861|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
14073862|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073863|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073864|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073865|NCT05297929|Irbesartan|irbesartan|mesh-list
14073866|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14073867|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14073868|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14758714|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758715|NCT05086692|Interleukin-2|interleukin-2|mesh-list
14758716|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758717|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758718|NCT05086692|Analgesics|analgesics|mesh-ancestor
14758719|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
14758720|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073869|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073870|NCT05297864|Niraparib|niraparib|mesh-list
14758721|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758722|NCT05083169|Dexamethasone|dexamethasone|mesh-list
14758723|NCT05083169|Bortezomib|bortezomib|mesh-list
14758724|NCT05083169|Daratumumab|daratumumab|mesh-list
14758725|NCT05083169|Pomalidomide|pomalidomide|mesh-list
14758726|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073871|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14073872|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073873|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073874|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073875|NCT05297682|Propofol|propofol|mesh-list
14073876|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
14073877|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073878|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073879|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14073880|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14073881|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
14073882|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
14073883|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14073884|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14073885|NCT05297669|Analgesics|analgesics|mesh-ancestor
14073886|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
14073887|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073888|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073889|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14073890|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14073891|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14073892|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14073893|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073894|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073895|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14073896|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
14073897|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073898|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073899|NCT05297578|Vaccines|vaccines|mesh-list
14073900|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14073901|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
14073902|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073903|NCT05297565|Nivolumab|nivolumab|mesh-list
14073904|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758727|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
14758728|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
14073905|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073906|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14073907|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073908|NCT05297448|Rifaximin|rifaximin|mesh-list
14073909|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14934350|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934351|NCT01456208|Norepinephrine|norepinephrine|mesh-list
14934352|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
14934353|NCT01456208|Giapreza|giapreza|mesh-list
14073910|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073911|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14073912|NCT05297422|Ketamine|ketamine|mesh-list
14073913|NCT05297422|Ropivacaine|ropivacaine|mesh-list
14073914|NCT05297422|Analgesics|analgesics|mesh-ancestor
14073915|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
14073916|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14073917|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073918|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14073919|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14934354|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
14934355|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14934356|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14073920|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
14073921|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
14073922|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14073923|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14073924|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14073925|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073926|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073927|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
14073928|NCT05297292|Ranibizumab|ranibizumab|mesh-list
14476466|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934357|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073929|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14073930|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14073931|NCT05297292|Growth Substances|growth substances|mesh-ancestor
14073932|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073933|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
14073934|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172945|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172946|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
14172947|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
14172948|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
14172949|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172950|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
14172951|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
14172952|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172953|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
14758729|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758730|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758731|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758732|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
14758733|NCT05083169|Hormones|hormones|mesh-ancestor
14758734|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758735|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14758736|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758737|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
14172954|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183403|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183404|NCT04729140|Doxycycline|doxycycline|mesh-list
14183405|NCT04729140|Ivermectin|ivermectin|mesh-list
14183406|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14183407|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183408|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
14183409|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14183410|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14183411|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
14758738|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14758739|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14758740|NCT05083169|Growth Substances|growth substances|mesh-ancestor
14758741|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
14758742|NCT05074823|Ketamine|ketamine|mesh-list
14758743|NCT05074823|Analgesics|analgesics|mesh-ancestor
14758744|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
14758745|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758746|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758747|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14758748|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14758749|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
14758750|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
14183412|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14183413|NCT04728425|Antibodies|antibodies|mesh-list
14183414|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
14183415|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14183416|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
14183417|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
14183418|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183419|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14184227|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14758751|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184228|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14184229|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14073935|NCT05297123|Tretinoin|tretinoin|mesh-list
14073936|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
14073937|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073938|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
14073939|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073940|NCT05281341|Hormones|hormones|mesh-list
14073941|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14073942|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073943|NCT05276102|Emollients|emollients|mesh-list
14073944|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
14073945|NCT05273567|Guanfacine|guanfacine|mesh-list
14073946|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14073947|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14073948|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14073949|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14073950|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14073951|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14073952|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073953|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073954|NCT05265247|Esomeprazole|esomeprazole|mesh-list
14073955|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14073956|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14073957|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14073958|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073959|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073960|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
14073961|NCT05264168|Apixaban|apixaban|mesh-list
14073962|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14073963|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
14073964|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14073965|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
14073966|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073967|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073968|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
14073969|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
14073970|NCT05256797|Apixaban|apixaban|mesh-list
14073971|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14073972|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
14073973|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14073974|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
14073975|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14073976|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073977|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
14073978|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
14073979|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14073980|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14073981|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
14073982|NCT05253651|Leucovorin|leucovorin|mesh-list
14073983|NCT05253651|Bevacizumab|bevacizumab|mesh-list
14073984|NCT05253651|Trastuzumab|trastuzumab|mesh-list
14073985|NCT05253651|Cetuximab|cetuximab|mesh-list
14073986|NCT05253651|Fluorouracil|fluorouracil|mesh-list
14073987|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
14073988|NCT05253651|Tucatinib|tucatinib|mesh-list
14073989|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
14073990|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14073991|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14073992|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14073993|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14073994|NCT05253651|Growth Substances|growth substances|mesh-ancestor
14073995|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14073996|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
14073997|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
14073998|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14073999|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14074000|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13915019|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915020|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
13915021|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915022|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915023|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
14074001|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
14074002|NCT05253651|Antidotes|antidotes|mesh-ancestor
14074003|NCT05253651|Protective Agents|protective agents|mesh-ancestor
14074004|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
14074005|NCT05253651|Vitamins|vitamins|mesh-ancestor
14074006|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
14074007|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14074008|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074009|NCT05227664|Paclitaxel|paclitaxel|mesh-list
14074010|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14074011|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14074012|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074013|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
14074014|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
14074015|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
14074016|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074017|NCT05214664|Anesthetics|anesthetics|mesh-list
14074018|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074019|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074023|NCT05166577|Valganciclovir|valganciclovir|mesh-list
13915024|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13915025|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915026|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
14476467|NCT02417831|Urological Agents|urological agents|mesh-ancestor
14476468|NCT02417844|Tamsulosin|tamsulosin|mesh-list
14476469|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14476470|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14476471|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14476472|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
13915033|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
13915034|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13915035|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915036|NCT03475225|Vitamins|vitamins|mesh-ancestor
14074024|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
14172955|NCT04804696|Paclitaxel|paclitaxel|mesh-list
14074025|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074026|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758752|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14758753|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14758754|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758755|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074027|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
14074028|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074029|NCT05165771|Tofacitinib|tofacitinib|mesh-list
14074030|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14074031|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074032|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074033|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
14074034|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14074035|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14074036|NCT05150704|Prednisolone|prednisolone|mesh-list
14074037|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
14758756|NCT05071664|Golimumab|golimumab|mesh-list
14758757|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14074038|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14074039|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
14758758|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14758759|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758760|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
14758761|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758762|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
14938787|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14074040|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074041|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
14074042|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
14074043|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074044|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074045|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14074046|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
14074047|NCT05150704|Hormones|hormones|mesh-ancestor
14074048|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074049|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14074050|NCT05150704|Protective Agents|protective agents|mesh-ancestor
14758763|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915037|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
13915038|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13915039|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
13915040|NCT03475160|Citric Acid|citric acid|mesh-list
13915041|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
13915042|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
13915043|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13915044|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
13915045|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
13915046|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915047|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
13915048|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13915049|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13915050|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915051|NCT03475160|Urological Agents|urological agents|mesh-ancestor
13915052|NCT03475121|Topotecan|topotecan|mesh-list
13915053|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13915054|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14074051|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14074052|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074053|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
14074054|NCT05145309|Cathartics|cathartics|mesh-ancestor
14074055|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14074056|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14074057|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14074058|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
14074059|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074060|NCT05111002|Doxycycline|doxycycline|mesh-list
14074061|NCT05111002|Lefamulin|lefamulin|mesh-list
13915055|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915056|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915057|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915058|NCT03475017|Curcumin|curcumin|mesh-list
13915059|NCT03475017|Piperine|piperine|mesh-list
14934358|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915060|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13915061|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758764|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758765|NCT05069597|Pancrelipase|pancrelipase|mesh-list
14758766|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758767|NCT05067894|Vaccines|vaccines|mesh-list
14758768|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
14758769|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758770|NCT05067634|Cenobamate|cenobamate|mesh-list
14758771|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
14934359|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934360|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934361|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
14934362|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
14934363|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934364|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14934365|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14934366|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
14934367|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934368|NCT01456234|Oseltamivir|oseltamivir|mesh-list
14934369|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
14934370|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934371|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934372|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934373|NCT01456247|Lansoprazole|lansoprazole|mesh-list
14074062|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14074063|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934374|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
14934375|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14934376|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14934377|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14934378|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934379|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934380|NCT01456260|Lansoprazole|lansoprazole|mesh-list
14934381|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
14934382|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14934383|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14934384|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14934385|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934386|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934387|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14934388|NCT01456312|Entecavir|entecavir|mesh-list
14934389|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
14934390|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934391|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14934392|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934393|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13915062|NCT03475017|Analgesics|analgesics|mesh-ancestor
13915063|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
13915064|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915065|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915066|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915067|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13915068|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934394|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915069|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915070|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938663|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934395|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934396|NCT01456351|Rituximab|rituximab|mesh-list
14934397|NCT01456351|Fludarabine|fludarabine|mesh-list
14074064|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
14074065|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14074066|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14074067|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14074068|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
14074069|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14074070|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
14074071|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14074072|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074073|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14074074|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14074075|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074076|NCT05096884|Metoprolol|metoprolol|mesh-list
14074077|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14074078|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14074079|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
14074080|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
14074081|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074082|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074083|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14074084|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14074085|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14074086|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074087|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074088|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074089|NCT05068232|Carboplatin|carboplatin|mesh-list
14074090|NCT05068232|Etoposide|etoposide|mesh-list
14074091|NCT05068232|Durvalumab|durvalumab|mesh-list
14074092|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074093|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14074094|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14074095|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14074096|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074097|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074098|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074099|NCT05047172|Aspirin|aspirin|mesh-list
14074100|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
14074101|NCT05047172|Clopidogrel|clopidogrel|mesh-list
14074102|NCT05047172|Ticagrelor|ticagrelor|mesh-list
14074103|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14074104|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14074105|NCT05047172|Analgesics|analgesics|mesh-ancestor
14074106|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
14074107|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074108|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074109|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074110|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074111|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13915071|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13915072|NCT03474939|Midazolam|midazolam|mesh-list
13915073|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13915074|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13915075|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915076|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915077|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13915078|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14074112|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14074113|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074114|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934398|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14074115|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14934399|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14934400|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934401|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
14074116|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074117|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
14074118|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14074119|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14074120|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14074121|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
14074122|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074123|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14074124|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
14074125|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14074126|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
14074127|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
14074128|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14074129|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074130|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14074131|NCT05039073|Nivolumab|nivolumab|mesh-list
14074132|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14074133|NCT05039073|Antibodies|antibodies|mesh-list
14074134|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
14074135|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14074136|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
14074137|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
14074138|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074139|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074140|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14074141|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074142|NCT05019716|Cisplatin|cisplatin|mesh-list
14074143|NCT05019716|Etoposide|etoposide|mesh-list
14074144|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
14074145|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
14074146|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074147|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14074148|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14074149|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14074150|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915079|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13915080|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13915081|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
13915082|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
13915083|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
13915084|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
13915085|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915086|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915087|NCT03474770|Huperzine A|huperzine a|mesh-list
14074151|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074152|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
14074153|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
14074154|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14074155|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14074156|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14172956|NCT04804696|Cisplatin|cisplatin|mesh-list
14172957|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14172958|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172959|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14172960|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14172961|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14758795|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
14758796|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758797|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
14758798|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758799|NCT05056727|Valsartan|valsartan|mesh-list
14758800|NCT05056727|Lisinopril|lisinopril|mesh-list
14758801|NCT05056727|Irbesartan|irbesartan|mesh-list
14758802|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14758803|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14758804|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14758805|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758806|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14758807|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
14758808|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758809|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14758810|NCT05056727|Protective Agents|protective agents|mesh-ancestor
14758811|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758812|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
14758813|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14172962|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172963|NCT04804423|Listerine|listerine|mesh-list
14172964|NCT04804423|Fluorides|fluorides|mesh-list
14172965|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
14172966|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
14172967|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
14172968|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
14172969|NCT04804423|Protective Agents|protective agents|mesh-ancestor
14172970|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172971|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14172972|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14172973|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14172974|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14172975|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172976|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
14172977|NCT04804072|Narcotics|narcotics|mesh-ancestor
14172978|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14172979|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14172980|NCT04804072|Analgesics|analgesics|mesh-ancestor
14172981|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
14172982|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14172983|NCT04804267|Linaclotide|linaclotide|mesh-list
14172984|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14172985|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
14172986|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172987|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14172988|NCT04803539|Capecitabine|capecitabine|mesh-list
14074157|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14074158|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14074159|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074160|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
14074161|NCT04992624|Dronabinol|dronabinol|mesh-list
14074162|NCT04992624|Cannabidiol|cannabidiol|mesh-list
14074163|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
14074164|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
14074165|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074166|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14074167|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14074168|NCT04992624|Analgesics|analgesics|mesh-ancestor
14074169|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
14074170|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074171|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14074172|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14074173|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074174|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074175|NCT04992624|Hormones|hormones|mesh-ancestor
14074176|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074177|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14074178|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14074179|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074180|NCT04967443|Prazosin|prazosin|mesh-list
14074181|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14074182|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14074183|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14074184|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14074185|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074186|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074187|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074188|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074189|NCT04959981|Osimertinib|osimertinib|mesh-list
14074190|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074191|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14074192|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074193|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074194|NCT04949425|Adavosertib|adavosertib|mesh-list
14074195|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074196|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074197|NCT04946006|Oxytocin|oxytocin|mesh-list
14074198|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
14074199|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14074200|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074201|NCT04920149|Mesalamine|mesalamine|mesh-list
14074202|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14074203|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14074204|NCT04920149|Analgesics|analgesics|mesh-ancestor
14074205|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
14074206|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934402|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934403|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934404|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934405|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14934406|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
14934407|NCT01456364|Ticagrelor|ticagrelor|mesh-list
14934408|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14934409|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934410|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14934411|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14934412|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14934413|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
14934414|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934415|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934416|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934417|NCT01456468|Tretinoin|tretinoin|mesh-list
14934418|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934419|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
14934420|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
14934421|NCT01456481|Midodrine|midodrine|mesh-list
14934422|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
14934423|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
14074207|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074208|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074209|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074210|NCT04910022|Lomustine|lomustine|mesh-list
14934424|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934425|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934426|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14934427|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14934428|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14934429|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14934430|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074211|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14074212|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
14074213|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074214|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758814|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
14758815|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758816|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758817|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14758818|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
14758819|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14758820|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
14758821|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758822|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758823|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14758824|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
14758825|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
14758826|NCT05052229|Protective Agents|protective agents|mesh-ancestor
14758827|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
14758828|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14758829|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758830|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14074223|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14074224|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
14074225|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14074226|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074227|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14172989|NCT04803539|Apatinib|apatinib|mesh-list
14758831|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758832|NCT05050097|Lenalidomide|lenalidomide|mesh-list
14934431|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934432|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934433|NCT01456507|Naltrexone|naltrexone|mesh-list
14934434|NCT01456507|Oxycodone|oxycodone|mesh-list
14934435|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14074228|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074229|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074230|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14074231|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074232|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
14074233|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074234|NCT04762381|Dexamethasone|dexamethasone|mesh-list
14074235|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
14074236|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14074237|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074238|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
14074239|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
14074240|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074241|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074242|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758833|NCT05050097|Pomalidomide|pomalidomide|mesh-list
14758834|NCT05050097|Daratumumab|daratumumab|mesh-list
14758835|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
14758836|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074243|NCT04762381|Hormones|hormones|mesh-ancestor
14074244|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074245|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14074246|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074247|NCT04756804|Ethanol|ethanol|mesh-list
14074248|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
14074249|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14074250|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14074251|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934436|NCT01456507|Narcotics|narcotics|mesh-ancestor
14074252|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074253|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074254|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
14074255|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
14074256|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
14074257|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
14074258|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14074259|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14074260|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074261|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074262|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074263|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074264|NCT04697940|Decitabine|decitabine|mesh-list
14074265|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14074266|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
14074267|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074268|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074269|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074270|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14074271|NCT04697693|Citalopram|citalopram|mesh-list
14074272|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14074273|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14074274|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14074275|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074276|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074277|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
14074278|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074279|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14074280|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
14074281|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14074282|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074283|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14074284|NCT04697693|Analgesics|analgesics|mesh-ancestor
14074285|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
14074286|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
14074287|NCT04677959|Fluticasone|fluticasone|mesh-list
14074288|NCT04677959|Xhance|xhance|mesh-list
14074289|NCT04677959|Albuterol|albuterol|mesh-list
14074290|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14074291|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074292|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14074293|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
14074294|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074295|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074296|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14074297|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
14074298|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
14074299|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14074300|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14074301|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14074302|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14074303|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074304|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074305|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915088|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13915089|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915090|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915091|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
13915092|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915093|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915094|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13915095|NCT03474770|Protective Agents|protective agents|mesh-ancestor
13915096|NCT03474614|Propranolol|propranolol|mesh-list
13915097|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13915098|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13915099|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
13915100|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915101|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915102|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915103|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13915104|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13915105|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
13915106|NCT03474601|Hormones|hormones|mesh-list
14074306|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
14074307|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14074308|NCT04667078|Cangrelor|cangrelor|mesh-list
14074309|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14074310|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14074311|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14074312|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14074313|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
14074314|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915107|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915108|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915109|NCT03474510|Bupivacaine|bupivacaine|mesh-list
13915110|NCT03474510|Ropivacaine|ropivacaine|mesh-list
14074315|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074316|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074317|NCT04665739|Everolimus|everolimus|mesh-list
14074318|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14074319|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074320|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14074321|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
14074322|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074323|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074324|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14074325|NCT04665037|Posaconazole|posaconazole|mesh-list
14074326|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
14074327|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074328|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14074329|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14074330|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13915111|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
13915112|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
13915113|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915114|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915115|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
13915116|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915117|NCT03474458|Doxycycline|doxycycline|mesh-list
13915118|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13915119|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915120|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
13915121|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13915122|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13915123|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13915124|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14074331|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14074332|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14074333|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074334|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074335|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14074336|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
14074337|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074338|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074339|NCT04655157|Nivolumab|nivolumab|mesh-list
14074340|NCT04655157|Ipilimumab|ipilimumab|mesh-list
14074341|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074342|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074343|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14074344|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074345|NCT04639011|Norepinephrine|norepinephrine|mesh-list
14074346|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14074347|NCT04639011|Serotonin|serotonin|mesh-list
14074348|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14074349|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14074350|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14074351|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074352|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074353|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074354|NCT04639011|Analgesics|analgesics|mesh-ancestor
14074355|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
14074356|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074357|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
14074358|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14074359|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
14074360|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14074361|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14074362|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074363|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
14074364|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
14074365|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14074366|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14074367|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
14074368|NCT04585477|Durvalumab|durvalumab|mesh-list
14074369|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074370|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074371|NCT04578613|Rituximab|rituximab|mesh-list
14074372|NCT04578613|Chlorambucil|chlorambucil|mesh-list
14074373|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074374|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074375|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
14074376|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074377|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074378|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14074379|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
14074380|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074381|NCT04576546|Inositol|inositol|mesh-list
14074382|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
14074383|NCT04576546|Vitamins|vitamins|mesh-ancestor
14074384|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
14074385|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074386|NCT04566653|Calcium|calcium|mesh-list
14074387|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
14074388|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14074389|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074390|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
14074391|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
14074392|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074393|NCT04551677|Vaccines|vaccines|mesh-list
14074394|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
14074395|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074396|NCT04530058|Metformin|metformin|mesh-list
14074397|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14074398|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758837|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14758838|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14758839|NCT05050097|Growth Substances|growth substances|mesh-ancestor
14758840|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
14758841|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758842|NCT05049525|Itraconazole|itraconazole|mesh-list
14758843|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14758844|NCT05049525|Terbinafine|terbinafine|mesh-list
14758845|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
14758846|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758847|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14758848|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14758849|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758850|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758851|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14758852|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
14758853|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758854|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074417|NCT04512235|Dexamethasone|dexamethasone|mesh-list
14074418|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
14074419|NCT04512235|Bortezomib|bortezomib|mesh-list
14074420|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14074421|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
14074422|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915125|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915126|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14074423|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074424|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14074425|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
14074426|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074427|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074428|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13915127|NCT03474276|Azithromycin|azithromycin|mesh-list
14074429|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074430|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
14074431|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
14074432|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074433|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14074434|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
14074435|NCT04512235|Hormones|hormones|mesh-ancestor
14074436|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074437|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14074444|NCT04498832|Vaccines|vaccines|mesh-list
14074445|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
14074446|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074447|NCT04487925|Hormones|hormones|mesh-list
14074448|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14074449|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074450|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074451|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
14074452|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14074453|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074454|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14074455|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074456|NCT04447755|Lenvatinib|lenvatinib|mesh-list
14074457|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074458|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14758855|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13915128|NCT03474276|Albendazole|albendazole|mesh-list
13915129|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
13915130|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915131|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
13915132|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
13915133|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13915134|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13915135|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
13915136|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
13915137|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
13915138|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074459|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074460|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074461|NCT04430036|Gemcitabine|gemcitabine|mesh-list
14074462|NCT04430036|Cisplatin|cisplatin|mesh-list
14074463|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074464|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14074465|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
14074466|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074467|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
14074468|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074469|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074470|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14074471|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
14074472|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476473|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476474|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915139|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960053|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14758856|NCT05042128|Gemcitabine|gemcitabine|mesh-list
14758857|NCT05042128|Paclitaxel|paclitaxel|mesh-list
14758858|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14758859|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758860|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14758861|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14758862|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
13960054|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476475|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476476|NCT02417844|Urological Agents|urological agents|mesh-ancestor
14476477|NCT02417935|Pregabalin|pregabalin|mesh-list
14476478|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14476479|NCT02417935|Analgesics|analgesics|mesh-ancestor
14476480|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
14074473|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14074474|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14074475|NCT04397406|Fentanyl|fentanyl|mesh-list
14074476|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
14074477|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
14074478|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14074479|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074480|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074481|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14074482|NCT04397406|Analgesics|analgesics|mesh-ancestor
14074483|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
14074484|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074485|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14074486|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14074487|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13960055|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13960056|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13960057|NCT03158246|Vitamin D|vitamin d|mesh-list
13960058|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
13960059|NCT03158246|Calcium|calcium|mesh-list
13960060|NCT03158246|Vitamins|vitamins|mesh-ancestor
13960061|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
13960062|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960063|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13960064|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13960065|NCT03158025|Zolpidem|zolpidem|mesh-list
13960066|NCT03158025|Suvorexant|suvorexant|mesh-list
13960067|NCT03158025|Lemborexant|lemborexant|mesh-list
13960068|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13960069|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13960070|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074488|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074489|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074490|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074491|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14074492|NCT04397406|Narcotics|narcotics|mesh-ancestor
14074493|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14074494|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14074495|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
14074496|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
14074497|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
14074498|NCT04392921|Amiodarone|amiodarone|mesh-list
14074499|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14074500|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
14074501|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14074502|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14074503|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074504|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14074505|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14074506|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14074507|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074508|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14074509|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14074510|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14172990|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14172991|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
14172992|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14172993|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14172994|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14172995|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14172996|NCT04803734|Albuterol|albuterol|mesh-list
14172997|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14172998|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
14172999|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173000|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074511|NCT04342585|Progesterone|progesterone|mesh-list
14074512|NCT04342585|Progestins|progestins|mesh-ancestor
14758863|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758864|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14758865|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
14074513|NCT04342585|Hormones|hormones|mesh-ancestor
14074514|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074515|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074516|NCT04326257|Nivolumab|nivolumab|mesh-list
14074517|NCT04326257|Ipilimumab|ipilimumab|mesh-list
14074518|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074519|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074520|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14758866|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
14758867|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758868|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758869|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758870|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
14758871|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074521|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074522|NCT04303195|Metopimazine|metopimazine|mesh-list
14074523|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
14074524|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
14074525|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074526|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074527|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14074528|NCT04240626|Acetaminophen|acetaminophen|mesh-list
14074529|NCT04240626|Scopolamine|scopolamine|mesh-list
14074530|NCT04240626|Oxycodone|oxycodone|mesh-list
14074531|NCT04240626|Gabapentin|gabapentin|mesh-list
14074532|NCT04240626|Hydromorphone|hydromorphone|mesh-list
14074533|NCT04240626|Hydrocodone|hydrocodone|mesh-list
14074534|NCT04240626|Bupivacaine|bupivacaine|mesh-list
14758872|NCT05028634|Vaccines|vaccines|mesh-list
14074535|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
14074536|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14758873|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14074537|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14074538|NCT04240626|Analgesics|analgesics|mesh-ancestor
14074539|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
14074540|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074541|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074542|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
14074543|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14074544|NCT04240626|Narcotics|narcotics|mesh-ancestor
14074545|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074546|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
14074547|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14074548|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14074549|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14074550|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14074551|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14074552|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074553|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074554|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
14074555|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
14074556|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
14074557|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
14074558|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
14074559|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14074560|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
14074561|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
14074562|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14074563|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
14074564|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14074565|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
14074566|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14074567|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
14074568|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14074569|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
14074570|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14074571|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14074572|NCT04218851|Posaconazole|posaconazole|mesh-list
14074573|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
14074574|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074575|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14074576|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14074577|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14074578|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14074579|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14074580|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074581|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074582|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14074583|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
14074584|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915140|NCT03474263|Antibodies|antibodies|mesh-list
13915141|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13915142|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
13915143|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915144|NCT03474237|Hormones|hormones|mesh-list
13915145|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915146|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915147|NCT03474198|Levofloxacin|levofloxacin|mesh-list
13915148|NCT03474198|Rifampin|rifampin|mesh-list
13915149|NCT03474198|Isoniazid|isoniazid|mesh-list
13915150|NCT03474198|Linezolid|linezolid|mesh-list
13915151|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
13915152|NCT03474198|Ethambutol|ethambutol|mesh-list
13915153|NCT03474198|Rifapentine|rifapentine|mesh-list
14074585|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915154|NCT03474198|Bedaquiline|bedaquiline|mesh-list
13915155|NCT03474198|Clofazimine|clofazimine|mesh-list
14476481|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476482|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915156|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13915157|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915158|NCT03474198|Renal Agents|renal agents|mesh-ancestor
13915159|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13915160|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13915161|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13915162|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915163|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915164|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915165|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13915166|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13915167|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13915168|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
13915169|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
13915170|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13915171|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13915172|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14476483|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
14476484|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14476485|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476486|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476487|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14476488|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14476489|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14476490|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476491|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14476492|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14476493|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14476494|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476495|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
14476496|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
14476497|NCT02417961|Benralizumab|benralizumab|mesh-list
14476498|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14476499|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
14476500|NCT02418182|Acetaminophen|acetaminophen|mesh-list
14476501|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14476502|NCT02418182|Analgesics|analgesics|mesh-ancestor
14476503|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
14476504|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476505|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476506|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
14476507|NCT02418312|Famotidine|famotidine|mesh-list
14476508|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
14476509|NCT02418312|Histamine|histamine|mesh-list
14476510|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14476511|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476512|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
14476513|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
14476514|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476515|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476516|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476517|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
14074626|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
14074627|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074628|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074629|NCT04177810|Plerixafor|plerixafor|mesh-list
14074630|NCT04177810|Cemiplimab|cemiplimab|mesh-list
14074631|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14074632|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14074633|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
14074634|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074635|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074636|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074637|NCT04171700|Rucaparib|rucaparib|mesh-list
14074638|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14758874|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
14758875|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074639|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074640|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074641|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074642|NCT04126824|Triamcinolone|triamcinolone|mesh-list
14074643|NCT04126824|Bupivacaine|bupivacaine|mesh-list
14074644|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
14074645|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
14074646|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074647|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074648|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
14074649|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074650|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074651|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
14074652|NCT04126824|Hormones|hormones|mesh-ancestor
14074653|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074654|NCT04115956|Dexamethasone|dexamethasone|mesh-list
14074655|NCT04115956|Melphalan|melphalan|mesh-list
14074656|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074657|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
14074658|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
14074659|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074660|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074661|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14074662|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
14074663|NCT04115956|Hormones|hormones|mesh-ancestor
14074664|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074665|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14074666|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074667|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14074668|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
14074669|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074670|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14074671|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14074672|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
14074673|NCT04109222|Vaccines|vaccines|mesh-list
14758876|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14758877|NCT05025423|Venetoclax|venetoclax|mesh-list
13915173|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13915174|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13915175|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13915176|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13915177|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13915178|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13915179|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
13915180|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13915181|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13915182|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915183|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
13915184|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13915185|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13915186|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915187|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
13915188|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
13915189|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13915190|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915191|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915192|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13915193|NCT03473964|Hormones|hormones|mesh-ancestor
13915194|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915195|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915196|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
13915197|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915198|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915199|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
13915200|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915201|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915202|NCT03473639|Capecitabine|capecitabine|mesh-list
13915203|NCT03473639|Entinostat|entinostat|mesh-list
13915204|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13915205|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
13915206|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915207|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915208|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13915209|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915210|NCT03473626|Alicaforsen|alicaforsen|mesh-list
13915211|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13915212|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13915213|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
13915214|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915215|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
13915216|NCT03473613|Cabergoline|cabergoline|mesh-list
13915217|NCT03473613|Calcium|calcium|mesh-list
13915218|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13915219|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915220|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13915221|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13915222|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13915223|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
13915224|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
13915225|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915226|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915227|NCT03473600|Triamcinolone|triamcinolone|mesh-list
13915228|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13915229|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13915230|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14074674|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
14074675|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074676|NCT04108481|Durvalumab|durvalumab|mesh-list
14074677|NCT04108481|Methamphetamine|methamphetamine|mesh-list
14074678|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14074679|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074680|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074681|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
14074682|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074683|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14074684|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
14074685|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
14074686|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934437|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934438|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934439|NCT01456507|Analgesics|analgesics|mesh-ancestor
14934440|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
14934441|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934442|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14934443|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14074687|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
14074688|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074689|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074690|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074691|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14074692|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14074693|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14074694|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14074695|NCT04108195|Daratumumab|daratumumab|mesh-list
14758878|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758879|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14758880|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
14758881|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758882|NCT05024552|Cytarabine|cytarabine|mesh-list
14758883|NCT05024552|Daunorubicin|daunorubicin|mesh-list
14074696|NCT04108195|Pomalidomide|pomalidomide|mesh-list
14074697|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074698|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
14074699|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074700|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14074701|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14074702|NCT04108195|Growth Substances|growth substances|mesh-ancestor
14074703|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
14074704|NCT04104646|Morphine|morphine|mesh-list
14074705|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14074706|NCT04104646|Narcotics|narcotics|mesh-ancestor
14074707|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074708|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074709|NCT04104646|Analgesics|analgesics|mesh-ancestor
14074710|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
14074711|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758884|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14758885|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
14758886|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758887|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758888|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
14758889|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14758890|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758891|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
14758892|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074712|NCT04095689|Docetaxel|docetaxel|mesh-list
14074713|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
14074714|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074715|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
14074716|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
14074717|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
14934444|NCT01456546|Proguanil|proguanil|mesh-list
14934445|NCT01456546|Clopidogrel|clopidogrel|mesh-list
14183420|NCT04728321|Lenvatinib|lenvatinib|mesh-list
14934446|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934447|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14074718|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074719|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074720|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
14074721|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074722|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074723|NCT04069312|Azithromycin|azithromycin|mesh-list
14074724|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14074725|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074726|NCT04053634|Benralizumab|benralizumab|mesh-list
14074727|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14074728|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
14074729|NCT04046939|Pramipexole|pramipexole|mesh-list
14074730|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
14074731|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074732|NCT04046939|Protective Agents|protective agents|mesh-ancestor
14758893|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14758894|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14758895|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14758896|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758897|NCT05013437|Acetaminophen|acetaminophen|mesh-list
14758898|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
14758899|NCT05013437|Promethazine|promethazine|mesh-list
14758900|NCT05013437|Melphalan|melphalan|mesh-list
14758901|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
13915231|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915232|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
13915233|NCT03473600|Hormones|hormones|mesh-ancestor
13915234|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915235|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915236|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13915237|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
13915238|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074733|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476518|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14476519|NCT02418585|Citalopram|citalopram|mesh-list
14074734|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14074735|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14074736|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
14074737|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
14074738|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074739|NCT04038086|Insulin|insulin|mesh-list
14074740|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14074741|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074742|NCT04036188|Vitamin D|vitamin d|mesh-list
14074743|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
14074744|NCT04036188|Triamcinolone|triamcinolone|mesh-list
14074745|NCT04036188|Vitamins|vitamins|mesh-ancestor
14074746|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
14074747|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074748|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14074749|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14074750|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074751|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
14074752|NCT04036188|Hormones|hormones|mesh-ancestor
14074753|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074754|NCT04033263|Fluorides|fluorides|mesh-list
14074755|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
14074756|NCT04033263|Protective Agents|protective agents|mesh-ancestor
14074757|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074758|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
14074759|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14074760|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
14476520|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14476521|NCT02418585|Sertraline|sertraline|mesh-list
14476522|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
14476523|NCT02418585|Esketamine|esketamine|mesh-list
14476524|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14476525|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14476526|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476527|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476528|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476529|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
14476530|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479296|NCT02468557|Paclitaxel|paclitaxel|mesh-list
14074761|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758902|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758903|NCT05013437|Analgesics|analgesics|mesh-ancestor
14758904|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
14758905|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758906|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758907|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
14758908|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14758909|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
14758910|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758911|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758912|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14758913|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14758914|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
14758915|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14758916|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14758917|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14758918|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
14758919|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
14758920|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
14758921|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
14758922|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14758923|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14758924|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
14074783|NCT04013854|Nivolumab|nivolumab|mesh-list
14074784|NCT04013854|Ipilimumab|ipilimumab|mesh-list
14074785|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074786|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074787|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14074788|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074789|NCT03983876|Adalimumab|adalimumab|mesh-list
14074790|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074791|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074792|NCT03960125|Imipramine|imipramine|mesh-list
14074793|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14074794|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
14074795|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14074796|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14074797|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14074798|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14074799|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074800|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074801|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074802|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074803|NCT03955198|Durvalumab|durvalumab|mesh-list
14074804|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074805|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074806|NCT03940586|Letermovir|letermovir|mesh-list
14074807|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14074808|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479297|NCT02468557|Idelalisib|idelalisib|mesh-list
14758925|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
14758926|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14758927|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14758928|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
14758929|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14758930|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14758931|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14758932|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14758933|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14758934|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
14758935|NCT05009862|Aspirin|aspirin|mesh-list
14074809|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074810|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074811|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
14074812|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074813|NCT03932162|Insulin|insulin|mesh-list
14074814|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14074815|NCT03932162|Mitogens|mitogens|mesh-list
14074816|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14074817|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074818|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
14074819|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074820|NCT03930745|TOL-463|tol-463|mesh-list
14074821|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074822|NCT03912259|Emollients|emollients|mesh-list
14074823|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
14074824|NCT03905928|Nicotine|nicotine|mesh-list
14074825|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14074826|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
14074827|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074828|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074829|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14074830|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14074831|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
14074832|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074833|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074834|NCT03890367|Vaccines|vaccines|mesh-list
14074835|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
14074836|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074837|NCT03801902|Durvalumab|durvalumab|mesh-list
14074838|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
14074839|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14074840|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
14074841|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074842|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074843|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
14074844|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074845|NCT03799744|Durvalumab|durvalumab|mesh-list
14074846|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074847|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074848|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
14074849|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14074850|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074851|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
14074852|NCT03745352|Azacitidine|azacitidine|mesh-list
14074853|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14074854|NCT03745352|Pevonedistat|pevonedistat|mesh-list
14074855|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14074856|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
14074857|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074858|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758936|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
14758937|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14476531|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14476532|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14476533|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476534|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14476535|NCT02418585|Analgesics|analgesics|mesh-ancestor
14476536|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
14476537|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
14476538|NCT02418676|Insulin|insulin|mesh-list
14476539|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476540|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476541|NCT02418754|Aflibercept|aflibercept|mesh-list
14074864|NCT03724084|Cytarabine|cytarabine|mesh-list
14074865|NCT03724084|Daunorubicin|daunorubicin|mesh-list
14074866|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14074867|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
14074868|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074869|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074870|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
14074871|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14074872|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14074873|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
14934448|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14934449|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14934450|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
14074874|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074875|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14074876|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14074877|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14074878|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173001|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14173002|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14173003|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
14173004|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14173005|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14173006|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14173007|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14173008|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
14173009|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173010|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173011|NCT04803500|Simvastatin|simvastatin|mesh-list
14173012|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14173013|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14173014|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
14173015|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173016|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14173017|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14173018|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173019|NCT04803318|Everolimus|everolimus|mesh-list
14173020|NCT04803318|Lenvatinib|lenvatinib|mesh-list
14173021|NCT04803318|Trametinib|trametinib|mesh-list
14173022|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173023|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173024|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
14173025|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173026|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173027|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173028|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173029|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14934451|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934452|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934453|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934454|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
14934455|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14934456|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13915239|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915240|NCT03473431|Ketamine|ketamine|mesh-list
13915241|NCT03473431|Analgesics|analgesics|mesh-ancestor
13915242|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
13915243|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915244|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915245|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13915246|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13915247|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
13915248|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
13915249|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915250|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13915251|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13915252|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915253|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915254|NCT03473418|Ketoconazole|ketoconazole|mesh-list
14173030|NCT04803422|Amoxicillin|amoxicillin|mesh-list
14074879|NCT03715946|Nivolumab|nivolumab|mesh-list
14074880|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074881|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074882|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14074883|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074884|NCT03653832|Clonidine|clonidine|mesh-list
14074885|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
14074886|NCT03653832|Propofol|propofol|mesh-list
14074887|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14074888|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14074889|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074890|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14074891|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
14074892|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
14074893|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14074894|NCT03653832|Analgesics|analgesics|mesh-ancestor
14074895|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
14074896|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074897|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14074898|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14074899|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14074900|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
14074901|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074902|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074903|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14074904|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
14074905|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
14074906|NCT03612960|Nicotine|nicotine|mesh-list
14074907|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14074908|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
14074909|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074910|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074911|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14074912|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14074913|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
14074914|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074915|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074916|NCT03609047|Paclitaxel|paclitaxel|mesh-list
14934457|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934458|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
14934459|NCT01456585|Gemcitabine|gemcitabine|mesh-list
14934460|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14934461|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
14934462|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934463|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934464|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
14934465|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934466|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934467|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934468|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
14934469|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934470|NCT01456611|Diclofenac|diclofenac|mesh-list
14934471|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14934472|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13915255|NCT03473418|Terconazole|terconazole|mesh-list
13915256|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
13915257|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915258|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13915259|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13915260|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915261|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915262|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13915263|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
13915264|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915265|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915266|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13915267|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
13915268|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13915269|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
13915270|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915271|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915272|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14074917|NCT03609047|Docetaxel|docetaxel|mesh-list
14074918|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
14074919|NCT03609047|Doxorubicin|doxorubicin|mesh-list
14074920|NCT03609047|Epirubicin|epirubicin|mesh-list
14074921|NCT03609047|Palbociclib|palbociclib|mesh-list
14074922|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14074923|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074924|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
14074925|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
14074926|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14074927|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074928|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14074929|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
14074930|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074931|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074932|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14074933|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
14074934|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14074935|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14074936|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14074937|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14074938|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074939|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14074940|NCT03607422|Upadacitinib|upadacitinib|mesh-list
14074941|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14074942|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14074943|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758938|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14758939|NCT05009862|Analgesics|analgesics|mesh-ancestor
14758940|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
14758941|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14758942|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14758943|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14758944|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14758945|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14758946|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14758947|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14758948|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14758949|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14758950|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14758951|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
14758952|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14758953|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
14758954|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14758955|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
14758956|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
14934473|NCT01456611|Analgesics|analgesics|mesh-ancestor
14934474|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
14934475|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934476|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934477|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14934478|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934479|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14934480|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14074944|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074945|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14074946|NCT03600805|Prednisone|prednisone|mesh-list
14074947|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14074948|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
14074949|NCT03600805|Hormones|hormones|mesh-ancestor
14074950|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074951|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074952|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14074953|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074954|NCT03582176|Ketotifen|ketotifen|mesh-list
14074955|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
14074956|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
14074957|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14074958|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
14074959|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
14074960|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074961|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074962|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074963|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14074964|NCT03547427|Acetaminophen|acetaminophen|mesh-list
14074965|NCT03547427|Insulin|insulin|mesh-list
14074966|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14074967|NCT03547427|Pramlintide|pramlintide|mesh-list
14074968|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14074969|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074970|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14074971|NCT03547427|Analgesics|analgesics|mesh-ancestor
14074972|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
14074973|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074974|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
14074975|NCT03502733|Nivolumab|nivolumab|mesh-list
14074976|NCT03502733|Ipilimumab|ipilimumab|mesh-list
14074977|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14074978|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14074979|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14074980|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074981|NCT03489525|Antibodies|antibodies|mesh-list
14074982|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
14074983|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
14074984|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
14074985|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074986|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
14074987|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14074988|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14074989|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14074990|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915273|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
13915274|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13915275|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
13915276|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915277|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915278|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13915279|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
13915280|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
13915281|NCT03473314|Protective Agents|protective agents|mesh-ancestor
13915282|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13915283|NCT03473210|Erythromycin|erythromycin|mesh-list
13915284|NCT03473210|Ampicillin|ampicillin|mesh-list
13915285|NCT03473210|Dexamethasone|dexamethasone|mesh-list
13915286|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915287|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
13915288|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
13915289|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915290|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915291|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13915292|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
13915293|NCT03473210|Hormones|hormones|mesh-ancestor
13915294|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14074991|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14074992|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
14074993|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14074994|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14074995|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14074996|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14074997|NCT03434119|Insulin|insulin|mesh-list
14074998|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14074999|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
14075000|NCT03434119|Lixisenatide|lixisenatide|mesh-list
14075001|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14075002|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075003|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14075004|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
14075005|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075006|NCT03323658|Bexarotene|bexarotene|mesh-list
14075007|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075019|NCT03278626|Paclitaxel|paclitaxel|mesh-list
14075020|NCT03278626|Carboplatin|carboplatin|mesh-list
14075021|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14075022|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075023|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14075024|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14075025|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14075026|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075027|NCT03259165|Diuretics|diuretics|mesh-list
14075028|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14075029|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
14075030|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075031|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14075032|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075033|NCT03224104|Temozolomide|temozolomide|mesh-list
14075034|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075035|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
14075036|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075037|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075038|NCT03220022|Prednisone|prednisone|mesh-list
14075039|NCT03220022|Cortisone|cortisone|mesh-list
14075040|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
14075041|NCT03220022|Rituximab|rituximab|mesh-list
14075042|NCT03220022|Doxorubicin|doxorubicin|mesh-list
14075043|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14075044|NCT03220022|Etoposide|etoposide|mesh-list
14075045|NCT03220022|Vincristine|vincristine|mesh-list
14075046|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
14075047|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
14075048|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14075049|NCT03220022|Antibodies|antibodies|mesh-list
14075050|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
14075051|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14075052|NCT03220022|Lenograstim|lenograstim|mesh-list
14075053|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075054|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
14075055|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075056|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075057|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075058|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
14075059|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075060|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075061|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14075062|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14075063|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14075064|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14075065|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075066|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075067|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
14075068|NCT03220022|Hormones|hormones|mesh-ancestor
14075069|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075070|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14075071|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14075072|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14075073|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
14075074|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
14075075|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
14476542|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14476543|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14075076|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
14075077|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
14075078|NCT03211858|Insulin|insulin|mesh-list
14075079|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14075080|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
14476544|NCT02418754|Growth Substances|growth substances|mesh-ancestor
14476545|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476546|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
14476547|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476548|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
14476549|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
14075081|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
14075082|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
14075083|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14075084|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14075085|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075086|NCT03191149|Osimertinib|osimertinib|mesh-list
14075087|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075088|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14075089|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075090|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075091|NCT03113968|Ketamine|ketamine|mesh-list
14075092|NCT03113968|Analgesics|analgesics|mesh-ancestor
14075093|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
14476550|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
14075094|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173031|NCT04803422|Metronidazole|metronidazole|mesh-list
14476551|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14075095|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075096|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14075097|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14075098|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
14075099|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
14075100|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14075101|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14075102|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14075103|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075104|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075105|NCT03093480|Factor VIII|factor viii|mesh-list
14075106|NCT03093480|Coagulants|coagulants|mesh-ancestor
14075107|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
14075108|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075109|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075110|NCT03077438|Vaccines|vaccines|mesh-list
14075111|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
14075112|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915295|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13915296|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915297|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915298|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915299|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915300|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13915301|NCT03473132|Thrombin|thrombin|mesh-list
14075133|NCT03073967|Foscarnet|foscarnet|mesh-list
14075134|NCT03073967|Pritelivir|pritelivir|mesh-list
14075135|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
14075136|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075137|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14075138|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14075139|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075140|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075141|NCT03045653|Tamoxifen|tamoxifen|mesh-list
14075142|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14075143|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
14075144|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075145|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075146|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14075147|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075148|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14075149|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13915302|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
14075150|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14075151|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
14075152|NCT03007147|Leucovorin|leucovorin|mesh-list
14075153|NCT03007147|Folic Acid|folic acid|mesh-list
14075154|NCT03007147|Cytarabine|cytarabine|mesh-list
14075155|NCT03007147|Dexamethasone|dexamethasone|mesh-list
14075156|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
14075157|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
14075158|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14075159|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14075160|NCT03007147|Prednisolone|prednisolone|mesh-list
14075161|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
14075162|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
14075163|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14075164|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14075165|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14075166|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
13915303|NCT03473132|Coagulants|coagulants|mesh-ancestor
13915304|NCT03473093|Pregabalin|pregabalin|mesh-list
13915305|NCT03473093|Morphine|morphine|mesh-list
13915306|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13915307|NCT03473093|Narcotics|narcotics|mesh-ancestor
13915308|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915309|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915310|NCT03473093|Analgesics|analgesics|mesh-ancestor
13915311|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
13915312|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915313|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
13915314|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13915315|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915316|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915317|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14075167|NCT03007147|Ifosfamide|ifosfamide|mesh-list
14075168|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
14075169|NCT03007147|Doxorubicin|doxorubicin|mesh-list
14075170|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13915318|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13915319|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13915320|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13915321|NCT03472976|Imiquimod|imiquimod|mesh-list
13915322|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13915323|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
13915324|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915325|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075171|NCT03007147|Methotrexate|methotrexate|mesh-list
14075172|NCT03007147|Etoposide|etoposide|mesh-list
14075173|NCT03007147|Vincristine|vincristine|mesh-list
14075174|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
14075175|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
14075176|NCT03007147|Daunorubicin|daunorubicin|mesh-list
14075177|NCT03007147|Asparaginase|asparaginase|mesh-list
14075178|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
14075179|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
14075180|NCT03007147|Pegaspargase|pegaspargase|mesh-list
14075181|NCT03007147|Thioguanine|thioguanine|mesh-list
14075182|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
14075183|NCT03007147|Razoxane|razoxane|mesh-list
14075184|NCT03007147|Azathioprine|azathioprine|mesh-list
14075185|NCT03007147|Lenograstim|lenograstim|mesh-list
14075186|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14075187|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
14075188|NCT03007147|BB 1101|bb 1101|mesh-list
14075189|NCT03007147|Calcium|calcium|mesh-list
14075190|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
14075191|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
14075192|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075193|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
14075194|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075195|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075196|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075197|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
14075198|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075199|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075200|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14075201|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075202|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
14075203|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
14075204|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075205|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14075206|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
14075207|NCT03007147|Hormones|hormones|mesh-ancestor
14075208|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075209|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14075210|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14075211|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075212|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14075213|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13915326|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
13915327|NCT03472963|Darunavir|darunavir|mesh-list
14075214|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14075215|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14075216|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14075217|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14075218|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
14075219|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14075220|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14075221|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
14075222|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
14075223|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14075224|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14075225|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14075226|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
14075227|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075228|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14075229|NCT03007147|Antidotes|antidotes|mesh-ancestor
14075230|NCT03007147|Protective Agents|protective agents|mesh-ancestor
14075231|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
14075232|NCT03007147|Vitamins|vitamins|mesh-ancestor
14075233|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
14075234|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
14075235|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
14075236|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
14075237|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14075238|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14075239|NCT03007147|Hematinics|hematinics|mesh-ancestor
14075240|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
14075241|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14075242|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
14075243|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
14075244|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
14075245|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075246|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075247|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075248|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075249|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
14075250|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075251|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075252|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14075253|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075254|NCT03003546|Paclitaxel|paclitaxel|mesh-list
14075255|NCT03003546|Rituximab|rituximab|mesh-list
14075256|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14075257|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075258|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
14075259|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
14758991|NCT05007782|Pembrolizumab|pembrolizumab|mesh-list
14075260|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
14075261|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075262|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075263|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
14075264|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075265|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075266|NCT02991365|Insulin|insulin|mesh-list
14075267|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14075268|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075269|NCT02974621|Bevacizumab|bevacizumab|mesh-list
14075270|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14075271|NCT02974621|Olaparib|olaparib|mesh-list
14075272|NCT02974621|Cediranib|cediranib|mesh-list
14075273|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
14075274|NCT02974621|Antibodies|antibodies|mesh-list
14075275|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
13915328|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13915329|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13915330|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13915331|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
14075276|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14075277|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
14075278|NCT02974621|Maleic acid|maleic acid|mesh-list
14476552|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14476553|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
14476554|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
14476555|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476556|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476557|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476558|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14476559|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
14476560|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14476561|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14476562|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14476563|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476564|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075279|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075280|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14075281|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14075282|NCT02974621|Growth Substances|growth substances|mesh-ancestor
14075283|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075284|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
14075285|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
14075286|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075287|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14075288|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915332|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915333|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915334|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14075289|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14075290|NCT02893917|Olaparib|olaparib|mesh-list
14075291|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14075292|NCT02893917|Cediranib|cediranib|mesh-list
14075293|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075294|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075295|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075296|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14075297|NCT02890069|Everolimus|everolimus|mesh-list
14075298|NCT02890069|Panobinostat|panobinostat|mesh-list
14075299|NCT02890069|Spartalizumab|spartalizumab|mesh-list
14476565|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13915335|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13915336|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
13915337|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915338|NCT03472950|Ranolazine|ranolazine|mesh-list
13915339|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13915340|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915341|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075300|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075301|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075302|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
14075303|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075304|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14075305|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075306|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075307|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14075308|NCT02866747|Durvalumab|durvalumab|mesh-list
14075309|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075310|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075311|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
14075312|NCT02864407|Olodaterol|olodaterol|mesh-list
14075313|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14075314|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
14075315|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075316|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075317|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14075318|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
14075319|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
14075320|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14075321|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
14075322|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075323|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915342|NCT03472872|Acetaminophen|acetaminophen|mesh-list
13915343|NCT03472872|Ketorolac|ketorolac|mesh-list
13915344|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13915345|NCT03472872|Analgesics|analgesics|mesh-ancestor
14934481|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915346|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
13915347|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915348|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915349|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
13915350|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14075324|NCT02846532|Aspirin|aspirin|mesh-list
14934482|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
14934483|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14934484|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934485|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
14934486|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14934487|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934488|NCT01456650|Glyburide|glyburide|mesh-list
14934489|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13915351|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915352|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13915353|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13915354|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915355|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915356|NCT03472846|Teriparatide|teriparatide|mesh-list
13915357|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13915358|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075325|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
14075326|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14075327|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
14075328|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14075329|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
14075330|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075331|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075332|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
14075333|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14075334|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14075335|NCT02846532|Analgesics|analgesics|mesh-ancestor
14075336|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
14075337|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075338|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075339|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075340|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075341|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14075342|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14075343|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14075344|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14075345|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
14075346|NCT02743806|Vedolizumab|vedolizumab|mesh-list
14075347|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14075348|NCT02688933|Insulin|insulin|mesh-list
14075349|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14075350|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
14075351|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14075352|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173032|NCT04803422|Tazobactam|tazobactam|mesh-list
14173033|NCT04803422|Piperacillin|piperacillin|mesh-list
14173034|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
14173035|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
14173036|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14173037|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173038|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14173039|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14173040|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14173041|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173042|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934490|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934491|NCT01456689|Midazolam|midazolam|mesh-list
14934492|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14934493|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14934494|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934495|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173043|NCT04803162|Omeprazole|omeprazole|mesh-list
14173044|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14173045|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173046|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14173047|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173048|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173049|NCT04803175|Valsartan|valsartan|mesh-list
14173050|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14173051|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14934496|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14075353|NCT02550197|Vaccines|vaccines|mesh-list
14075354|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
14075355|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075356|NCT02492165|Vaccines|vaccines|mesh-list
14075357|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
14075358|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075359|NCT02476006|Atorvastatin|atorvastatin|mesh-list
14075360|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14075361|NCT02476006|Simvastatin|simvastatin|mesh-list
14075362|NCT02476006|Ezetimibe|ezetimibe|mesh-list
14075363|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14075364|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14075365|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
14075366|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075367|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14075368|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14075369|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075370|NCT02332590|Adalimumab|adalimumab|mesh-list
14075371|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075372|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075373|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
14075374|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476566|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476567|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075375|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075376|NCT02256865|Ketoconazole|ketoconazole|mesh-list
14075377|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
14075378|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14075379|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14075380|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14476568|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
14476569|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476570|NCT02419469|Cytarabine|cytarabine|mesh-list
14476571|NCT02419469|Dexamethasone|dexamethasone|mesh-list
14476572|NCT02419469|Prednisone|prednisone|mesh-list
14476573|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
14476574|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
14476575|NCT02419469|Rituximab|rituximab|mesh-list
14476576|NCT02419469|Doxorubicin|doxorubicin|mesh-list
14934497|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14934498|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14934499|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14934500|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
14934501|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
14934502|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
14934503|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
14934504|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915359|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13915360|NCT03472677|Capsaicin|capsaicin|mesh-list
13915361|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
13915362|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
13915363|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
13915364|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915365|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915366|NCT03472651|Flupenthixol|flupenthixol|mesh-list
13915367|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
13915368|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13915369|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13915370|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915371|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915372|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13915373|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13915374|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
13915375|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915376|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915377|NCT03472560|Avelumab|avelumab|mesh-list
13915378|NCT03472560|Axitinib|axitinib|mesh-list
13915379|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915380|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915381|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13915382|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915383|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915384|NCT03472508|Folic Acid|folic acid|mesh-list
14476577|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14938664|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14075381|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
14075382|NCT02256865|Testosterone|testosterone|mesh-list
14075383|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
14075384|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
14075385|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14075386|NCT02256865|Androgens|androgens|mesh-ancestor
14075387|NCT02256865|Hormones|hormones|mesh-ancestor
14075388|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075389|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075390|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14075391|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075392|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
14075393|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075394|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
14075395|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075396|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14075397|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14075398|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075399|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075400|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14075401|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
14075402|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14075403|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
14075404|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075405|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476578|NCT02419469|Methotrexate|methotrexate|mesh-list
14476579|NCT02419469|Vincristine|vincristine|mesh-list
14075408|NCT01902173|Trametinib|trametinib|mesh-list
14075409|NCT01902173|Dabrafenib|dabrafenib|mesh-list
14075410|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14075411|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075412|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14075413|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075414|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075415|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14075416|NCT01902173|Protective Agents|protective agents|mesh-ancestor
14075417|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075418|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14075419|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
14075420|NCT01900444|Vaccines|vaccines|mesh-list
14476580|NCT02419469|Daunorubicin|daunorubicin|mesh-list
14075421|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
14075422|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075423|NCT01886872|Rituximab|rituximab|mesh-list
14075424|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14075425|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14075426|NCT01886872|Antibodies|antibodies|mesh-list
14476581|NCT02419469|Asparaginase|asparaginase|mesh-list
14476582|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
14075427|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
14075428|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14075429|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
14075430|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075431|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075432|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075433|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075434|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
14075435|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075436|NCT01835145|Temozolomide|temozolomide|mesh-list
14075437|NCT01835145|Dacarbazine|dacarbazine|mesh-list
14075438|NCT01835145|Imidazole|imidazole|mesh-list
14075439|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075440|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
14075441|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075442|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075443|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075444|NCT01751126|Cyclosporine|cyclosporine|mesh-list
14075445|NCT01751126|Cyclosporins|cyclosporins|mesh-list
14075446|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075447|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075448|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075449|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
14075450|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075451|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
14075452|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075453|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
14075454|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075455|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14075456|NCT01597414|Trastuzumab|trastuzumab|mesh-list
14075457|NCT01597414|Pertuzumab|pertuzumab|mesh-list
14075458|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075459|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075460|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14075461|NCT01468896|Cetuximab|cetuximab|mesh-list
14075462|NCT01468896|Interleukin-12|interleukin-12|mesh-list
14075463|NCT01468896|Antibodies|antibodies|mesh-list
14075464|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
14075465|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14075466|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
14075467|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075468|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075469|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14075470|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14075471|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14075472|NCT01468896|Growth Substances|growth substances|mesh-ancestor
14075473|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
14075474|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
14075475|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075476|NCT01307306|Metformin|metformin|mesh-list
14075477|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14075478|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075479|NCT01299753|Propranolol|propranolol|mesh-list
14075480|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14075481|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14075482|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
14075483|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075484|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075485|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075486|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14075487|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14075488|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
14075489|NCT01251861|Bicalutamide|bicalutamide|mesh-list
14075490|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
14075491|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
14075492|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14758992|NCT05007782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14758993|NCT05007782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758994|NCT04994717|Blinatumomab|blinatumomab|mesh-list
14758995|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14758996|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14758997|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14758998|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14758999|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759000|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759001|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14759002|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14759003|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759004|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
14759005|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759006|NCT04989218|Gemcitabine|gemcitabine|mesh-list
14759007|NCT04989218|Cisplatin|cisplatin|mesh-list
14759008|NCT04989218|Durvalumab|durvalumab|mesh-list
14759009|NCT04989218|Tremelimumab|tremelimumab|mesh-list
14075493|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075494|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915385|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
13915386|NCT03472508|Enalapril|enalapril|mesh-list
13915387|NCT03472508|Enalaprilat|enalaprilat|mesh-list
13915388|NCT03472508|Hematinics|hematinics|mesh-ancestor
13915389|NCT03472508|Vitamins|vitamins|mesh-ancestor
13915390|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
13915391|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915392|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915393|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915394|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13915395|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
13915396|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14759010|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759011|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14075516|NCT01190228|Vaccines|vaccines|mesh-list
14075517|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
14075518|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075519|NCT01049035|Vaccines|vaccines|mesh-list
14075520|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14075521|NCT01049035|Immunoglobulins|immunoglobulins|mesh-list
14075522|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
14075523|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075524|NCT00859781|Ketoconazole|ketoconazole|mesh-list
14075525|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
14075526|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075527|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
14075528|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075529|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14075530|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14075531|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075532|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075533|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14075534|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
14075535|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075536|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075537|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14075538|NCT00727090|Conivaptan|conivaptan|mesh-list
14075539|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14075540|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075541|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
14075542|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075543|NCT00658814|Azacitidine|azacitidine|mesh-list
14075544|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
14075545|NCT00658814|Calicheamicins|calicheamicins|mesh-list
14075546|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14075547|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
14075548|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075549|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075550|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476583|NCT02419469|Ofatumumab|ofatumumab|mesh-list
14476584|NCT02419469|Pegaspargase|pegaspargase|mesh-list
14476585|NCT02419469|Thioguanine|thioguanine|mesh-list
14759012|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
14759013|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759014|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
14759015|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759016|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759017|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759018|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
14759019|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915405|NCT03472456|Eugenol|eugenol|mesh-list
13915406|NCT03472456|Carticaine|carticaine|mesh-list
13915407|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
13915408|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
13915409|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915410|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915411|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
13915412|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915413|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960071|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960072|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13960073|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
14075551|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476586|NCT02419469|BB 1101|bb 1101|mesh-list
14075552|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14075579|NCT00569127|Interferons|interferons|mesh-list
14075580|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
14075581|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
14075582|NCT00569127|Bevacizumab|bevacizumab|mesh-list
14075583|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14075584|NCT00569127|Octreotide|octreotide|mesh-list
14075585|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
14075586|NCT00569127|Antibodies|antibodies|mesh-list
14075587|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
14075588|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14075589|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
14075590|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075591|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14075592|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14075593|NCT00569127|Growth Substances|growth substances|mesh-ancestor
14075594|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075595|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
14075596|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
14075597|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
14075598|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075599|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14075600|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476587|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14476588|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
14476589|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075623|NCT05301608|Psilocybin|psilocybin|mesh-list
14075624|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14075625|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
14075626|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075627|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14075628|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14075629|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
14075630|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075631|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075632|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14075633|NCT05301530|Docetaxel|docetaxel|mesh-list
14075634|NCT05301530|Trastuzumab|trastuzumab|mesh-list
14075635|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075636|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
14075637|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
14075638|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
14075639|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075640|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075641|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
14075642|NCT05301517|Hematinics|hematinics|mesh-ancestor
14075643|NCT05301361|Methylphenidate|methylphenidate|mesh-list
14075644|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14075645|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075646|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14075647|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14075648|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14075649|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075650|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
14075651|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075652|NCT05301205|Gabapentin|gabapentin|mesh-list
14075653|NCT05301205|Analgesics|analgesics|mesh-ancestor
14476590|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075654|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
14075655|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075656|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075657|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
14075658|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14075659|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14075660|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14075661|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14075662|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14075663|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14075664|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075665|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075666|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
14476591|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14476592|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
14173052|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14173053|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14173054|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173055|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
14173056|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14173057|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
14173058|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173059|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
14173060|NCT04803240|Protective Agents|protective agents|mesh-ancestor
14173061|NCT04803474|Hormones|hormones|mesh-list
14173062|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173063|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173064|NCT04803370|Antibodies|antibodies|mesh-list
14173065|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
14173066|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173067|NCT04802967|Ketoprofen|ketoprofen|mesh-list
14173068|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
14173069|NCT04802967|Gabapentin|gabapentin|mesh-list
14173070|NCT04802967|Analgesics|analgesics|mesh-ancestor
14173071|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
14173072|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173073|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173074|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
14173075|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14173076|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14173077|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173078|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14173079|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14173080|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14173081|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173082|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173083|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
14173084|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173085|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173086|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173087|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173088|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14173089|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173090|NCT04802928|Isoniazid|isoniazid|mesh-list
14173091|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
14075670|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14075671|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075672|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14075673|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14075674|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075675|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
14075676|NCT05301010|Docetaxel|docetaxel|mesh-list
14075677|NCT05301010|Trastuzumab|trastuzumab|mesh-list
14075678|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075679|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14075680|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14075681|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14075682|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915414|NCT03472378|Celecoxib|celecoxib|mesh-list
13915415|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13915416|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13915417|NCT03472378|Analgesics|analgesics|mesh-ancestor
14934505|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934506|NCT01456715|Vaccines|vaccines|mesh-list
14934507|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
13915418|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
13915419|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915420|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915421|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075683|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075684|NCT05300958|Deferoxamine|deferoxamine|mesh-list
14075685|NCT05300958|Siderophores|siderophores|mesh-ancestor
13915422|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13915423|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13915424|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13915425|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075686|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14075687|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
14075688|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
14075689|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075690|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
14075691|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075692|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
14075693|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075694|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075695|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075696|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
14075697|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075698|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075699|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14075700|NCT05300854|Anesthetics|anesthetics|mesh-list
14075701|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934508|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934509|NCT01457001|Vitamin D|vitamin d|mesh-list
14934510|NCT01457001|Vitamins|vitamins|mesh-list
14934511|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
14934512|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915426|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915427|NCT03472365|Capecitabine|capecitabine|mesh-list
13915428|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
14075702|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075703|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
14075704|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14075705|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14075706|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075707|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14075708|NCT05300802|Analgesics|analgesics|mesh-ancestor
14075709|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
14075710|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075711|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14075712|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14075713|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14075714|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
14075715|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075716|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075717|NCT05300555|Warfarin|warfarin|mesh-list
14075718|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
14075719|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
14075720|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14075721|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
14075722|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14075723|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
14075724|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075725|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075726|NCT05300490|Prednisolone|prednisolone|mesh-list
14075727|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075728|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
14075729|NCT05300490|Hormones|hormones|mesh-ancestor
14075730|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075731|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075732|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14075733|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075734|NCT05300477|Acetazolamide|acetazolamide|mesh-list
14075735|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
14075736|NCT05300477|Hematinics|hematinics|mesh-ancestor
14075737|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
14075738|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14075739|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075740|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075741|NCT05300477|Diuretics|diuretics|mesh-ancestor
14075742|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
14075743|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075744|NCT05300386|Citalopram|citalopram|mesh-list
14075745|NCT05300386|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14075746|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14075747|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14075748|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075749|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075750|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
14075751|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075752|NCT05300386|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14075753|NCT05300386|Antidepressive Agents|antidepressive agents|mesh-ancestor
14075754|NCT05300386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14075755|NCT05300373|Adenosine|adenosine|mesh-list
14075756|NCT05300373|Analgesics|analgesics|mesh-ancestor
14075757|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
14075758|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075759|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075760|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14075761|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
14075762|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14075763|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
14075764|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
14075765|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075766|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075767|NCT05300360|Adenosine|adenosine|mesh-list
14075768|NCT05300360|Analgesics|analgesics|mesh-ancestor
14075769|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
14075770|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075771|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075772|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14075773|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
14075774|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14075775|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
14075776|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
14075777|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075778|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075779|NCT05300347|Adenosine|adenosine|mesh-list
14075780|NCT05300347|Analgesics|analgesics|mesh-ancestor
14075781|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
14075782|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075783|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075784|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14075785|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
14075786|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14075787|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
14075788|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
14075789|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075790|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075791|NCT05300334|Adenosine|adenosine|mesh-list
14075792|NCT05300334|Analgesics|analgesics|mesh-ancestor
14075793|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
14075794|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075795|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075796|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14075797|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
14075798|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14075799|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
14075800|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
14075801|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075802|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075803|NCT05300282|Gemcitabine|gemcitabine|mesh-list
14075804|NCT05300282|Atezolizumab|atezolizumab|mesh-list
14075805|NCT05300282|Vinorelbine|vinorelbine|mesh-list
14075806|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14075807|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14075808|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
14075809|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075810|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075811|NCT05300282|Antiviral Agents|antiviral agents|mesh-ancestor
14075812|NCT05300282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075813|NCT05300282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075814|NCT05300282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075815|NCT05300282|Immunologic Factors|immunologic factors|mesh-ancestor
14075816|NCT05300282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075817|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14075818|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
14075819|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
14075820|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
14075821|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14075822|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
14075823|NCT05300269|Capecitabine|capecitabine|mesh-list
14075824|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
14075825|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14075826|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
14075827|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075828|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075829|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
14075830|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14075831|NCT05300087|Albuterol|albuterol|mesh-list
14075832|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14075833|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
14075834|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075835|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075836|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14075837|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14075838|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
14075839|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14075840|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14075841|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14075842|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14075843|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
14075844|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075845|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075846|NCT05300048|Serabelisib|serabelisib|mesh-list
14075847|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075848|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075849|NCT05300035|Antibodies|antibodies|mesh-list
14075850|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13915429|NCT03472365|Apatinib|apatinib|mesh-list
13915430|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13915431|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
13915432|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915433|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915434|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13915435|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915436|NCT03472339|Diclofenac|diclofenac|mesh-list
13915437|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13915438|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13915439|NCT03472339|Analgesics|analgesics|mesh-ancestor
14075851|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
14075852|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075853|NCT05300009|Methotrexate|methotrexate|mesh-list
14075854|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14075855|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
14075856|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14075857|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075858|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14075859|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
14075860|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075861|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075862|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14075863|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075864|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14075865|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14075866|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
14075867|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14075868|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14075869|NCT05299944|Cannabidiol|cannabidiol|mesh-list
14075870|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
14075871|NCT05299931|Ustekinumab|ustekinumab|mesh-list
14075872|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
14075873|NCT05299593|Timolol|timolol|mesh-list
14075874|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14075875|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13915440|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
13915441|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960074|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
14075876|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
14075877|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075878|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075879|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075880|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14075881|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14075882|NCT05299580|Trametinib|trametinib|mesh-list
14075883|NCT05299580|Dabrafenib|dabrafenib|mesh-list
14075884|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075885|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13915442|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915443|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915444|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13915445|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13915446|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915447|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915448|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
13915449|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13915450|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13915451|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13915452|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915453|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915454|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
13915455|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915456|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915457|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14075886|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075887|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075888|NCT05299567|Azithromycin|azithromycin|mesh-list
14075889|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14075890|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075891|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
14075892|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075893|NCT05299476|Bevacizumab|bevacizumab|mesh-list
14075894|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476593|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476594|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476595|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14476596|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476597|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
14476598|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
14476599|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476600|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476601|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
14476602|NCT02419469|Hormones|hormones|mesh-ancestor
14476603|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476604|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476605|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14075895|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075896|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14075897|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14075898|NCT05299476|Growth Substances|growth substances|mesh-ancestor
14075899|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075900|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
14173092|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14173093|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173094|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14173095|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14173096|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
14173097|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173098|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14173099|NCT04802785|Aspirin|aspirin|mesh-list
14173100|NCT04802785|Domperidone|domperidone|mesh-list
14173101|NCT04802785|Melatonin|melatonin|mesh-list
14173102|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14173103|NCT04802785|Simethicone|simethicone|mesh-list
14173104|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14173105|NCT04802785|Citric Acid|citric acid|mesh-list
14173106|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
14173107|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
14173108|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13915458|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915459|NCT03472170|Lactoferrin|lactoferrin|mesh-list
13915460|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915461|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14173109|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
14173110|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
14173111|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173112|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
14476606|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14476607|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13915462|NCT03472144|Levofloxacin|levofloxacin|mesh-list
13915463|NCT03472144|Ofloxacin|ofloxacin|mesh-list
13915464|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13915465|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915466|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
13915467|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13915468|NCT03472144|Renal Agents|renal agents|mesh-ancestor
13915469|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13915470|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13915471|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915472|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915473|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915474|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14173113|NCT04802785|Protective Agents|protective agents|mesh-ancestor
14476608|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14476609|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476610|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14476611|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
14476612|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14476613|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13915475|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13915476|NCT03472040|Berotralstat|berotralstat|mesh-list
14173114|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075901|NCT05299398|Trazodone|trazodone|mesh-list
14075902|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14075903|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14075904|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14075905|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075906|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14075907|NCT05299398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14075908|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14075909|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14075910|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075911|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14075912|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
14075913|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14075914|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
14075915|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
13915477|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915478|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075916|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14075917|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14075918|NCT05293249|Prednisolone|prednisolone|mesh-list
14075919|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
14075920|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14075921|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
14075922|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075923|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
14075924|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
14075925|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14075926|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915479|NCT03471988|Voriconazole|voriconazole|mesh-list
13915480|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
13915481|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915482|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13915483|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13915484|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915485|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915486|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13915487|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
13915488|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075927|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14075928|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
14075929|NCT05293249|Hormones|hormones|mesh-ancestor
14075930|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075931|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14075932|NCT05293249|Protective Agents|protective agents|mesh-ancestor
14075933|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14075934|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075935|NCT05291390|Pyronaridine|pyronaridine|mesh-list
14075936|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
14075937|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14075938|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14075939|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075940|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
14075941|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14075942|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
14075943|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075944|NCT05287724|Expectorants|expectorants|mesh-ancestor
14075945|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
14075946|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14075947|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
14075948|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075949|NCT05287724|Protective Agents|protective agents|mesh-ancestor
14075950|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075951|NCT05287724|Antidotes|antidotes|mesh-ancestor
14075952|NCT05280106|Citric Acid|citric acid|mesh-list
14075953|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
14075954|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
14075955|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
14075956|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14075957|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
14075958|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
14075959|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075960|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14075961|NCT05277480|Apatinib|apatinib|mesh-list
14075962|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075963|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14075964|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075965|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075966|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
14075967|NCT05277285|Antidotes|antidotes|mesh-ancestor
14075968|NCT05277285|Protective Agents|protective agents|mesh-ancestor
14075969|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075970|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
14075971|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14075972|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
14075973|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14075974|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14075975|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
14075976|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
14075977|NCT05271721|Dexamethasone|dexamethasone|mesh-list
14075978|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
14075979|NCT05271721|BB 1101|bb 1101|mesh-list
14075980|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14075981|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
14075982|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
14075983|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759020|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759021|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
14759022|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14476614|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
14075984|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075985|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14075986|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
14075987|NCT05271721|Hormones|hormones|mesh-ancestor
14075988|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14075989|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14075990|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14075991|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
14075992|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14075993|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476615|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
14476616|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14075994|NCT05271071|Lidocaine|lidocaine|mesh-list
14075995|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
14075996|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
14075997|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759023|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14476617|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14476618|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
14476619|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476620|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14476621|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
13915489|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915490|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13915491|NCT03471819|Serotonin|serotonin|mesh-list
13915492|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13915493|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
13915494|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915495|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915496|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915497|NCT03471585|Dronabinol|dronabinol|mesh-list
13915498|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
13915499|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915500|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14476622|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
14075998|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14075999|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
14076000|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076001|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14076002|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14076003|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14076004|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14076005|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076006|NCT05269706|Cannabidiol|cannabidiol|mesh-list
14076007|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
14076008|NCT05259943|Psilocybin|psilocybin|mesh-list
14076009|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
14076010|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076011|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14076012|NCT05253287|Hormones|hormones|mesh-list
14076013|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076014|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076015|NCT05238649|Vaccines|vaccines|mesh-list
14076016|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
14076017|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076018|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
14076019|NCT05227716|Analgesics|analgesics|mesh-ancestor
14076020|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
14076021|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076022|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076023|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
14076024|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076025|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14076026|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
14076027|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14076028|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14076029|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076030|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14076031|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
14076032|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14076033|NCT05227300|Lidocaine|lidocaine|mesh-list
14076034|NCT05227300|Epinephrine|epinephrine|mesh-list
14076035|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
14076036|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
14076037|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476623|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
14476624|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
14476625|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14476626|NCT02419508|Bimatoprost|bimatoprost|mesh-list
14476627|NCT02419508|Travoprost|travoprost|mesh-list
14476628|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14476629|NCT02419508|Latanoprost|latanoprost|mesh-list
14476630|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14476631|NCT02419508|Brinzolamide|brinzolamide|mesh-list
14476632|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14476633|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14476634|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14476635|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076038|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076039|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
14076040|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076041|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14076042|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14076043|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14076044|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14759024|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14759025|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14759026|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076045|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076046|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076047|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076048|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076049|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076050|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14076051|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14076052|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
14076053|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14076054|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
14076055|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
14076056|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
14076057|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14076058|NCT05208190|Clozapine|clozapine|mesh-list
14076059|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14076060|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
14076061|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476636|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
14476637|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476638|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915501|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13915502|NCT03471585|Analgesics|analgesics|mesh-ancestor
13915503|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
13915504|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915505|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13915506|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13915507|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915508|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476639|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476640|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14076062|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076063|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076064|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14076065|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14076066|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076067|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14076068|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
14076069|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
14759027|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
14759028|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476641|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915509|NCT03471585|Hormones|hormones|mesh-ancestor
13915510|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915511|NCT03471559|Cannabidiol|cannabidiol|mesh-list
14934513|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14934514|NCT01457040|Etoposide|etoposide|mesh-list
14934515|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
14934516|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14934517|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934518|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14934519|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14934520|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934521|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934522|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
14934523|NCT01457131|Fludarabine|fludarabine|mesh-list
14934524|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934525|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
14934526|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934527|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934528|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14934529|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
14934530|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934531|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934532|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14938665|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14938666|NCT01482897|Protective Agents|protective agents|mesh-ancestor
14938667|NCT01482936|Oxycodone|oxycodone|mesh-list
14938668|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14938669|NCT01482936|Narcotics|narcotics|mesh-ancestor
14938670|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938671|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759029|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759030|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14759031|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759032|NCT04984798|Vitamin E|vitamin e|mesh-list
14759033|NCT04984798|Tocopherols|tocopherols|mesh-list
14759034|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
14759035|NCT04984798|Vitamins|vitamins|mesh-ancestor
14938672|NCT01482936|Analgesics|analgesics|mesh-ancestor
14938673|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
14938674|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938675|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
14938676|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759036|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
14759037|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476642|NCT02419547|Fentanyl|fentanyl|mesh-list
14476643|NCT02419547|Midazolam|midazolam|mesh-list
13915512|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
13915513|NCT03471507|Diclofenac|diclofenac|mesh-list
13915514|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13915515|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13915516|NCT03471507|Analgesics|analgesics|mesh-ancestor
13915517|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
14759038|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
14476644|NCT02419547|Propofol|propofol|mesh-list
14476645|NCT02419547|Sevoflurane|sevoflurane|mesh-list
14476646|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14934533|NCT01457261|Albuterol|albuterol|mesh-list
14934534|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14934535|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
14934536|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934537|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934538|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14934539|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
14934540|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
14934541|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14934542|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14934543|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14934544|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14934545|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934546|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934547|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934548|NCT01457469|Nicotine|nicotine|mesh-list
14759039|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759040|NCT04984798|Protective Agents|protective agents|mesh-ancestor
14767309|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767310|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14767311|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767312|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
14767313|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934549|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14076091|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
14076092|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076093|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076094|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14076095|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14076096|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076097|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076098|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14076099|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14076100|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076101|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
14076102|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076103|NCT05187182|Leucovorin|leucovorin|mesh-list
14076104|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
14076105|NCT05187182|Nivolumab|nivolumab|mesh-list
14076106|NCT05187182|Trastuzumab|trastuzumab|mesh-list
14076107|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
14076108|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076109|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076110|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14934550|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
14934551|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076111|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076112|NCT05187182|Antidotes|antidotes|mesh-ancestor
14076113|NCT05187182|Protective Agents|protective agents|mesh-ancestor
14076114|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476647|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476648|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476649|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14476650|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
14476651|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
14476652|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14476653|NCT02419547|Narcotics|narcotics|mesh-ancestor
14476654|NCT02419547|Analgesics|analgesics|mesh-ancestor
14476655|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
14934552|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915518|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915519|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915520|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915521|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13915522|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13915523|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915524|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915525|NCT03471455|Itraconazole|itraconazole|mesh-list
13915526|NCT03471455|Terbinafine|terbinafine|mesh-list
13915527|NCT03471455|Isotretinoin|isotretinoin|mesh-list
13915528|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
14076115|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
14076116|NCT05187182|Vitamins|vitamins|mesh-ancestor
14076117|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
14076118|NCT05179239|Paclitaxel|paclitaxel|mesh-list
14076119|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14076120|NCT05179239|Cisplatin|cisplatin|mesh-list
14076121|NCT05179239|Carboplatin|carboplatin|mesh-list
14076122|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076123|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076124|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076125|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076126|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076127|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076128|NCT05178628|Gemcitabine|gemcitabine|mesh-list
14076129|NCT05178628|Paclitaxel|paclitaxel|mesh-list
14934553|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14476656|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934554|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14934555|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
14934556|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934557|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934558|NCT01457495|Edetic Acid|edetic acid|mesh-list
14934559|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
14934560|NCT01457495|Antidotes|antidotes|mesh-ancestor
14934561|NCT01457495|Protective Agents|protective agents|mesh-ancestor
14934562|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934563|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
14934564|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
14076130|NCT05178628|Tinzaparin|tinzaparin|mesh-list
14076131|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14476657|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14076132|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076133|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076134|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076135|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076136|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076137|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14076138|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
14076139|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
14076140|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14076141|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076142|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076143|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
14076144|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076145|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
14076146|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14076147|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14076148|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14076149|NCT05178485|Bupivacaine|bupivacaine|mesh-list
14076150|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
14076151|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
14076152|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076153|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076154|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
14076155|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076156|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076157|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
14076158|NCT05178485|Hormones|hormones|mesh-ancestor
14076159|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076160|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076161|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
14076162|NCT05173324|Vaccines|vaccines|mesh-list
14076163|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
14076164|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173115|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173116|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173117|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173118|NCT04802785|Analgesics|analgesics|mesh-ancestor
14173119|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
14173120|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173121|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173122|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173123|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14173124|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14173125|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14173126|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14173127|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173128|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
14173129|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
14173130|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
14173131|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173132|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14173133|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
14173134|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173135|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
14173136|NCT04802785|Emollients|emollients|mesh-ancestor
14173137|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14173138|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
14173139|NCT04802785|Antacids|antacids|mesh-ancestor
14173140|NCT04802876|Spartalizumab|spartalizumab|mesh-list
14173141|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14173142|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173143|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476658|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14173144|NCT04802980|Gemcitabine|gemcitabine|mesh-list
14173145|NCT04802980|Paclitaxel|paclitaxel|mesh-list
14173146|NCT04802980|Carboplatin|carboplatin|mesh-list
14173147|NCT04802980|Capecitabine|capecitabine|mesh-list
14173148|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
14076165|NCT05157672|Letrozole|letrozole|mesh-list
14076166|NCT05157672|Nicotine|nicotine|mesh-list
14076167|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14076168|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
14076169|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076170|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076171|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14476659|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14476660|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14476661|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
14476662|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
14476663|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915529|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915530|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13915531|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13915532|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915533|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915534|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13915535|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
13915536|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915537|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915538|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13915539|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
13915540|NCT03471442|Bupivacaine|bupivacaine|mesh-list
13915541|NCT03471442|Ropivacaine|ropivacaine|mesh-list
13915542|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
13915543|NCT03471442|Anesthetics|anesthetics|mesh-list
13915544|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
13915545|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915546|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915547|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
13915548|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915549|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
13915550|NCT03471351|Tenalisib|tenalisib|mesh-list
13915551|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915552|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915553|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
13915554|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915555|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915556|NCT03471325|Methamphetamine|methamphetamine|mesh-list
13915557|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13915558|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915559|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
13915560|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
14076172|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14476664|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076173|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
14076174|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076175|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076176|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076177|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14076178|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14076179|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076180|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14076181|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
14076182|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759041|NCT04978493|Ustekinumab|ustekinumab|mesh-list
14759042|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
14759043|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
14759044|NCT04977453|Lenvatinib|lenvatinib|mesh-list
14759045|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759046|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759047|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14076190|NCT05147493|Dexamethasone|dexamethasone|mesh-list
14076191|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
14076192|NCT05147493|Lenalidomide|lenalidomide|mesh-list
14076193|NCT05147493|Bortezomib|bortezomib|mesh-list
14076194|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076195|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
14476665|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14076196|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076197|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076198|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14076199|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
14076200|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076201|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076202|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14076203|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076204|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
14076205|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
14076206|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076207|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14076208|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
14076209|NCT05147493|Hormones|hormones|mesh-ancestor
14076210|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076211|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14076212|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14076213|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14076214|NCT05147493|Growth Substances|growth substances|mesh-ancestor
14076215|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
14076216|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
14076217|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14076218|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076219|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14076220|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076221|NCT05122182|Proxigermanium|proxigermanium|mesh-list
14076222|NCT05122182|Candesartan|candesartan|mesh-list
14076223|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
14076224|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14076225|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14076226|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14076227|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076228|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076229|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
14076230|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
14076231|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076232|NCT05120349|Osimertinib|osimertinib|mesh-list
14076233|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076234|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14476666|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14476667|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
14476668|NCT02419612|Glimepiride|glimepiride|mesh-list
14476669|NCT02419612|Saxagliptin|saxagliptin|mesh-list
14476670|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14076235|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076236|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076237|NCT05072262|Dexamethasone|dexamethasone|mesh-list
14076238|NCT05072262|Nepafenac|nepafenac|mesh-list
14076239|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915561|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915562|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
13915563|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915564|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915565|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
13915566|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13915567|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13915568|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915569|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13915570|NCT03471260|Azacitidine|azacitidine|mesh-list
13915571|NCT03471260|Venetoclax|venetoclax|mesh-list
13915572|NCT03471260|Ivosidenib|ivosidenib|mesh-list
13915573|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13915574|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
13915575|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915576|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915577|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915578|NCT03471182|Cocaine|cocaine|mesh-list
13915579|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
13915580|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
13915581|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915582|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915583|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
13915584|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915585|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13915586|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13915587|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13915588|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915589|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915590|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
13915591|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915592|NCT03471117|Pioglitazone|pioglitazone|mesh-list
13915593|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13915594|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915595|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
13915596|NCT03471039|Growth Substances|growth substances|mesh-ancestor
13915597|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915598|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
14076240|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
14076241|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
14076242|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076243|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076244|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14076245|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
14076246|NCT05072262|Hormones|hormones|mesh-ancestor
14076247|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076248|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14076249|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076250|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14076251|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076252|NCT05072262|Analgesics|analgesics|mesh-ancestor
14076253|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
14076254|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076255|NCT05070754|Cantharidin|cantharidin|mesh-list
14076256|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076257|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076258|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
14076259|NCT05061017|Nivolumab|nivolumab|mesh-list
14076260|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076261|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
14076262|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915599|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915600|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076263|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076264|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14076265|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
14076266|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076267|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076268|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14076269|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076270|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14076271|NCT05060549|Cariprazine|cariprazine|mesh-list
14076272|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14476671|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476672|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476673|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476674|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14476675|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14476676|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
14476677|NCT02419612|Incretins|incretins|mesh-ancestor
14476678|NCT02419612|Hormones|hormones|mesh-ancestor
14476679|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476680|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14076273|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14076274|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076275|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076276|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14076277|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
14076278|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14076279|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14076280|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
14476681|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
13915601|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13915602|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
13915603|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915604|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13915605|NCT03470805|Olaparib|olaparib|mesh-list
13915606|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13915607|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915608|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915609|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960075|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960076|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960077|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13960078|NCT03157843|Heparin|heparin|mesh-list
14076281|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076282|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076283|NCT05046314|Vincristine|vincristine|mesh-list
14076284|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076285|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076286|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076287|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076288|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076289|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076290|NCT05037812|Ketorolac|ketorolac|mesh-list
14076291|NCT05037812|Clonidine|clonidine|mesh-list
14076292|NCT05037812|Epinephrine|epinephrine|mesh-list
14076293|NCT05037812|Morphine|morphine|mesh-list
14076294|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14076295|NCT05037812|Narcotics|narcotics|mesh-ancestor
14076296|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076297|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076298|NCT05037812|Analgesics|analgesics|mesh-ancestor
14076299|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
14076300|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076301|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076302|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076303|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076304|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076305|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076306|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14076307|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14076308|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
14076309|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14076310|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14076311|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
14076312|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
14076313|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14076314|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14076315|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076316|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076317|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076318|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14076319|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076320|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14076321|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
14076322|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076323|NCT05022654|Irinotecan|irinotecan|mesh-list
14076324|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14076325|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14076326|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076327|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076328|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076329|NCT05020457|Paclitaxel|paclitaxel|mesh-list
14076330|NCT05020457|Docetaxel|docetaxel|mesh-list
14076331|NCT05020457|Cisplatin|cisplatin|mesh-list
14076332|NCT05020457|Pemetrexed|pemetrexed|mesh-list
14076333|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076334|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076335|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076336|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076337|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076338|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076339|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076340|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14076341|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14076342|NCT05012943|Vaccines|vaccines|mesh-list
14076343|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
14076344|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076345|NCT05008354|Pyridoxine|pyridoxine|mesh-list
14076346|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
14076347|NCT05008354|Vitamins|vitamins|mesh-ancestor
14076348|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
14076349|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076350|NCT04988841|Nivolumab|nivolumab|mesh-list
14076351|NCT04988841|Ipilimumab|ipilimumab|mesh-list
14076352|NCT04988841|Laxatives|laxatives|mesh-list
14076353|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14076354|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076355|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076356|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14076357|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076358|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14076359|NCT04979377|Insulin|insulin|mesh-list
14076360|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14076361|NCT04979377|Hormones|hormones|mesh-list
14076362|NCT04979377|Testosterone|testosterone|mesh-list
14076363|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14076364|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14076365|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076366|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076367|NCT04979377|Androgens|androgens|mesh-ancestor
14076368|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14076369|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
14076370|NCT04974996|Prednisone|prednisone|mesh-list
14076371|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
14076372|NCT04974996|Rituximab|rituximab|mesh-list
14076373|NCT04974996|Doxorubicin|doxorubicin|mesh-list
14076374|NCT04974996|Vincristine|vincristine|mesh-list
14076375|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14076376|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076377|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
14076378|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076379|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076380|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14076381|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
14076382|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076383|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076384|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14076385|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076386|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14076387|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14076388|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14076389|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759048|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076390|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076391|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
14076392|NCT04974996|Hormones|hormones|mesh-ancestor
14476682|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476683|NCT02419755|Cytarabine|cytarabine|mesh-list
14476684|NCT02419755|Dexamethasone|dexamethasone|mesh-list
14476685|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
14476686|NCT02419755|Doxorubicin|doxorubicin|mesh-list
14476687|NCT02419755|Methotrexate|methotrexate|mesh-list
14476688|NCT02419755|Bortezomib|bortezomib|mesh-list
14076393|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076394|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14076395|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076396|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076397|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076398|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076399|NCT04974398|Gemcitabine|gemcitabine|mesh-list
14076400|NCT04974398|Cisplatin|cisplatin|mesh-list
14076401|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076402|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14076403|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
14076404|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076405|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
14076406|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14076407|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476689|NCT02419755|Asparaginase|asparaginase|mesh-list
14476690|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
14476691|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
14476692|NCT02419755|Vorinostat|vorinostat|mesh-list
14476693|NCT02419755|Pegaspargase|pegaspargase|mesh-list
14476694|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759049|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759050|NCT04973891|Metformin|metformin|mesh-list
14759051|NCT04973891|Canagliflozin|canagliflozin|mesh-list
14076408|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076409|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
14076410|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076411|NCT04972253|Infigratinib|infigratinib|mesh-list
14076412|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076413|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
14076414|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14076415|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14076416|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14076417|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14076418|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14076419|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076420|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14076421|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076422|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076423|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14759052|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14759053|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759054|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14759055|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076424|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076425|NCT04959825|Melatonin|melatonin|mesh-list
14076426|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
14076427|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076428|NCT04959825|Protective Agents|protective agents|mesh-ancestor
14076429|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076430|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076431|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
14076432|NCT04955158|Ketamine|ketamine|mesh-list
14076433|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14759056|NCT04973163|Midazolam|midazolam|mesh-list
14476695|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
14476696|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
14476697|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476698|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076434|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076435|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076436|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076437|NCT04955158|Analgesics|analgesics|mesh-ancestor
14934565|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934566|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14934567|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
14934568|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14934569|NCT01457508|Edetic Acid|edetic acid|mesh-list
14934570|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
14759057|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14759058|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14759059|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759060|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759061|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14759062|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14759063|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14759064|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14759065|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
14759066|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
14759067|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
14076438|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
14076439|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076440|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076441|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076442|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076443|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076444|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076445|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076446|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14076447|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14076448|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
14076449|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
14076450|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14076451|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14076452|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
14076453|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
14476699|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14759068|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
14759069|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934571|NCT01457508|Antidotes|antidotes|mesh-ancestor
14934572|NCT01457508|Protective Agents|protective agents|mesh-ancestor
14076454|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14076455|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076456|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076457|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076458|NCT04953156|Analgesics|analgesics|mesh-ancestor
14076459|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
14076460|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076461|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076462|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14934573|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076463|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076464|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076465|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076466|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076467|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
14173149|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14173150|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173151|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
14173152|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
14173153|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
14173154|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173155|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14173156|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
14173157|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
14173158|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173159|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173160|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173161|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
14173162|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076468|NCT04950608|Psilocybin|psilocybin|mesh-list
14076469|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
14076470|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076471|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14076472|NCT04942184|Complement Factor H|complement factor h|mesh-list
14076473|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14076474|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076475|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
14076476|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076477|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
14076478|NCT04928391|Nalbuphine|nalbuphine|mesh-list
14076479|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14076480|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076481|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076482|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076483|NCT04928391|Analgesics|analgesics|mesh-ancestor
14076484|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
14076485|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076486|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076487|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076488|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076489|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076490|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076491|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076492|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14076493|NCT04928391|Narcotics|narcotics|mesh-ancestor
14076494|NCT04928352|Bupivacaine|bupivacaine|mesh-list
14076495|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
14076496|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
14076497|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076498|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076499|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
14076500|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076501|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
14076502|NCT04928300|Ketamine|ketamine|mesh-list
14076503|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14076504|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076505|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076506|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076507|NCT04928300|Analgesics|analgesics|mesh-ancestor
14076508|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
14076509|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076510|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076511|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14759070|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076512|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076513|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076514|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076515|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076516|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14076517|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14076518|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
14076519|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
14076520|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14076521|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14076522|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14076523|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076524|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
14076525|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14076526|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14076527|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076528|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
14076529|NCT04910464|Coagulants|coagulants|mesh-ancestor
14076530|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
14076531|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14076532|NCT04910269|Antibodies|antibodies|mesh-list
14076533|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
14076534|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076535|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
14076536|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14076537|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14076538|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076539|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
14076540|NCT04905901|Coagulants|coagulants|mesh-ancestor
14076541|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
14076542|NCT04895735|Pemetrexed|pemetrexed|mesh-list
14076543|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076544|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076545|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076546|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076547|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13915610|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
13915611|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13915612|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13915613|NCT03470649|Hematinics|hematinics|mesh-ancestor
13915614|NCT03470610|Estradiol|estradiol|mesh-list
13915615|NCT03470610|Progesterone|progesterone|mesh-list
13915616|NCT03470610|Estrogens|estrogens|mesh-ancestor
13915617|NCT03470610|Hormones|hormones|mesh-ancestor
13915618|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915619|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915620|NCT03470610|Progestins|progestins|mesh-ancestor
13915621|NCT03470597|Iodine|iodine|mesh-list
13915622|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13915623|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915624|NCT03470597|Trace Elements|trace elements|mesh-ancestor
13915625|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
13915626|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915627|NCT03470532|Epinephrine|epinephrine|mesh-list
13915628|NCT03470532|Racepinephrine|racepinephrine|mesh-list
13915629|NCT03470532|Mepivacaine|mepivacaine|mesh-list
13915630|NCT03470532|Carticaine|carticaine|mesh-list
13915631|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
13915632|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13915633|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076548|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14076549|NCT04868708|Paclitaxel|paclitaxel|mesh-list
14076550|NCT04868708|Bevacizumab|bevacizumab|mesh-list
14076551|NCT04868708|Carboplatin|carboplatin|mesh-list
13915634|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
13915635|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915636|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076552|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076553|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076554|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076555|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076556|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076557|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076558|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076559|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14076560|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14759071|NCT04971785|Firsocostat|firsocostat|mesh-list
14759072|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759073|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759074|NCT04967664|Capsaicin|capsaicin|mesh-list
14759075|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
14759076|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
14759077|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
14759078|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076561|NCT04868708|Growth Substances|growth substances|mesh-ancestor
14076562|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076563|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
14076564|NCT04858009|Paclitaxel|paclitaxel|mesh-list
14076565|NCT04858009|Cisplatin|cisplatin|mesh-list
14076566|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14076567|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076568|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076569|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076570|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076571|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076572|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076573|NCT04855513|Metformin|metformin|mesh-list
14076574|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14076575|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076579|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
14076580|NCT04789408|Fludarabine|fludarabine|mesh-list
14076581|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076582|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
14076583|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076584|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076585|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14076586|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
14076587|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759079|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759080|NCT04966546|Memantine|memantine|mesh-list
14759081|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14076588|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076589|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14076590|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
14076591|NCT04778787|Digoxin|digoxin|mesh-list
14076592|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14076593|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
14076594|NCT04778787|Diuretics|diuretics|mesh-list
14076595|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14076596|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14076597|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076598|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14076599|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076600|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14076601|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14076602|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076603|NCT04778787|Protective Agents|protective agents|mesh-ancestor
14076604|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
14076605|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14076606|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
14076607|NCT04772222|Morphine|morphine|mesh-list
14076608|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14076609|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076610|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076611|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076612|NCT04772222|Analgesics|analgesics|mesh-ancestor
14076613|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
14076614|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076615|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076616|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076617|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076618|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076619|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076620|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076621|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14076622|NCT04772222|Narcotics|narcotics|mesh-ancestor
14076623|NCT04767256|Dexamethasone|dexamethasone|mesh-list
14076624|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
14076625|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076626|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
14076627|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
14076628|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076629|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076630|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14076631|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
14076632|NCT04767256|Hormones|hormones|mesh-ancestor
14076633|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076634|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14076635|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076636|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14076637|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076638|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076639|NCT04767256|Analgesics|analgesics|mesh-ancestor
14076640|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
14076641|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076642|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076643|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076644|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076645|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076646|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076647|NCT04754815|Paclitaxel|paclitaxel|mesh-list
14076648|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14076649|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
14076650|NCT04754815|Pemetrexed|pemetrexed|mesh-list
14076651|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076652|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076653|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076654|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076655|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076656|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076657|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076658|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076659|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14076660|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14076661|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
14076662|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076663|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
14076664|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076665|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076666|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14076667|NCT04740697|Tamoxifen|tamoxifen|mesh-list
14076668|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14076669|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
14076670|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076671|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076672|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14076673|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076674|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14076675|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14076676|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14173163|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
14173164|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14173165|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14173166|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173167|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
14173168|NCT04802382|Coagulants|coagulants|mesh-ancestor
14173169|NCT04802122|Propofol|propofol|mesh-list
14173170|NCT04802122|Sevoflurane|sevoflurane|mesh-list
14173171|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14173172|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173173|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173174|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14173175|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
14173176|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
14173177|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14173178|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14173179|NCT04802083|Eculizumab|eculizumab|mesh-list
14173180|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14173181|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173182|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
14173183|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173184|NCT04801953|Nimodipine|nimodipine|mesh-list
14173185|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14173186|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14173187|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14173188|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173189|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14173190|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173191|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
14173192|NCT04801888|Vaccines|vaccines|mesh-list
14173193|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
14173194|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173195|NCT04801940|Apixaban|apixaban|mesh-list
14173196|NCT04801940|Atorvastatin|atorvastatin|mesh-list
14173197|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14173198|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14173199|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
14076677|NCT04704661|Trastuzumab|trastuzumab|mesh-list
14076678|NCT04704661|Camptothecin|camptothecin|mesh-list
14076679|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
14076680|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14076681|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076682|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076683|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14076684|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14076685|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076686|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076687|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
14076688|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076689|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
14076690|NCT04696731|Fludarabine|fludarabine|mesh-list
14076691|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076692|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
14076693|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076694|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076695|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14076696|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
14076697|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076698|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076699|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14076700|NCT04683614|Norepinephrine|norepinephrine|mesh-list
14076701|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076702|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076703|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076704|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076705|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076706|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076707|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
14076708|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
14076709|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076710|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14076713|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14076714|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14076715|NCT04654351|Icatibant|icatibant|mesh-list
14076716|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14076717|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076718|NCT04654351|Analgesics|analgesics|mesh-ancestor
14076719|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
14076720|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076721|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076722|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076723|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076724|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14076725|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14076726|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076727|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14076728|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076729|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
14076730|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14076731|NCT04642352|Bupivacaine|bupivacaine|mesh-list
14076732|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
14076733|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
14934574|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
14934575|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
14934576|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934577|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14076734|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076735|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076736|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
14076737|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759082|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14759083|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
14759084|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759085|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759086|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759087|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14759088|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14759089|NCT04965597|Methotrexate|methotrexate|mesh-list
14759090|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
14934578|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
14934579|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14934580|NCT01457547|Edetic Acid|edetic acid|mesh-list
14076738|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076739|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
14076740|NCT04642352|Hormones|hormones|mesh-ancestor
14076741|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076742|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076743|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
14076744|NCT04614493|Temozolomide|temozolomide|mesh-list
14076745|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14076746|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
14934581|NCT01457547|Vaccines|vaccines|mesh-list
14934582|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
14934583|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
14934584|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934585|NCT01457547|Antidotes|antidotes|mesh-ancestor
14934586|NCT01457547|Protective Agents|protective agents|mesh-ancestor
14934587|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
14076747|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076748|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076749|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14076750|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14076751|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
14076752|NCT04597268|Midazolam|midazolam|mesh-list
14076753|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
14076754|NCT04597268|Ketamine|ketamine|mesh-list
14076755|NCT04597268|Propofol|propofol|mesh-list
14076756|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14076757|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076758|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076759|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14076760|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
14076761|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
14076762|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14076763|NCT04597268|Analgesics|analgesics|mesh-ancestor
14934588|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
14934589|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076764|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
14076765|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076766|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14076767|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14076768|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14076769|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
14076770|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14076771|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476700|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
14076772|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14076773|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14076774|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14076775|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14076776|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14076777|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14076778|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14076779|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
14076780|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
14076781|NCT04586985|Midazolam|midazolam|mesh-list
14076782|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14076783|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14076784|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076785|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076786|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14076787|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14076788|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14076789|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14076790|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
14076791|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
14076792|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
14076793|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
14076794|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759091|NCT04965597|Fludarabine|fludarabine|mesh-list
14076795|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076796|NCT04573673|Emodin|emodin|mesh-list
14076797|NCT04573673|Cathartics|cathartics|mesh-ancestor
14076798|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14076799|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14076800|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076801|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076802|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
14076803|NCT04546399|Leucovorin|leucovorin|mesh-list
14076804|NCT04546399|Folic Acid|folic acid|mesh-list
14076805|NCT04546399|Cytarabine|cytarabine|mesh-list
14076806|NCT04546399|Dexamethasone|dexamethasone|mesh-list
14076807|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
14076808|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
14076809|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14076810|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14076811|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14076812|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
14076813|NCT04546399|Methotrexate|methotrexate|mesh-list
14076814|NCT04546399|Nivolumab|nivolumab|mesh-list
14076815|NCT04546399|Etoposide|etoposide|mesh-list
14076816|NCT04546399|Vincristine|vincristine|mesh-list
14076817|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
14076818|NCT04546399|Asparaginase|asparaginase|mesh-list
14076819|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
14076820|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
14076821|NCT04546399|Pegaspargase|pegaspargase|mesh-list
14076822|NCT04546399|Thioguanine|thioguanine|mesh-list
14076823|NCT04546399|Blinatumomab|blinatumomab|mesh-list
14076824|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14076825|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
14076826|NCT04546399|Antibodies|antibodies|mesh-list
14076827|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
14076828|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14076829|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14076830|NCT04546399|BB 1101|bb 1101|mesh-list
14076831|NCT04546399|Calcium|calcium|mesh-list
14076832|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
14076833|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
14076834|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076835|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
14076836|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076837|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14076838|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14076839|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
14076840|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076841|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076842|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14076843|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14076844|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
14076845|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
14076846|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14076847|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14076848|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
14076849|NCT04546399|Hormones|hormones|mesh-ancestor
14076850|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076851|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14076852|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
14076853|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076854|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14076855|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14076856|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14076857|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
14076858|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14076859|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14076860|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
14076861|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
14076862|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14076863|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14076864|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14076865|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14076866|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14076867|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14076868|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
14076869|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14076870|NCT04546399|Antidotes|antidotes|mesh-ancestor
14076871|NCT04546399|Protective Agents|protective agents|mesh-ancestor
14076872|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
14076873|NCT04546399|Vitamins|vitamins|mesh-ancestor
14076874|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
14076875|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
14076876|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
14076877|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14076878|NCT04546399|Hematinics|hematinics|mesh-ancestor
14076879|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
14076880|NCT04542070|Rilpivirine|rilpivirine|mesh-list
14076881|NCT04542070|Cabotegravir|cabotegravir|mesh-list
14076882|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14076883|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14076884|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14076885|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076886|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
14076887|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14076888|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14076889|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14076890|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14076891|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14076892|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
14076893|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14076894|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
14076895|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076896|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759092|NCT04965597|Treosulfan|treosulfan|mesh-list
14759093|NCT04965597|Busulfan|busulfan|mesh-list
14759094|NCT04965597|Tacrolimus|tacrolimus|mesh-list
14759095|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
14759096|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14076902|NCT04522973|Ethanol|ethanol|mesh-list
14076903|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14076904|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14076905|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14076906|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076907|NCT04503252|Cefazolin|cefazolin|mesh-list
14076908|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14076909|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14076910|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
14076911|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14076912|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759097|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
14759098|NCT04965597|Antibodies|antibodies|mesh-list
14076913|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14076914|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14076915|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
14076916|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14076917|NCT04488159|Leucovorin|leucovorin|mesh-list
14076918|NCT04488159|Fluorouracil|fluorouracil|mesh-list
14076919|NCT04488159|Capecitabine|capecitabine|mesh-list
14076920|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
14076921|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
14076922|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14076923|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14076924|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076925|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14076926|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
14076927|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076928|NCT04488159|Antidotes|antidotes|mesh-ancestor
14076929|NCT04488159|Protective Agents|protective agents|mesh-ancestor
14076930|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
14076931|NCT04488159|Vitamins|vitamins|mesh-ancestor
14076932|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
14076933|NCT04445246|Iloprost|iloprost|mesh-list
14076934|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14076935|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
14076936|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14076937|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
14076938|NCT04414761|Cetrorelix|cetrorelix|mesh-list
14076939|NCT04414761|Progesterone|progesterone|mesh-list
14076940|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
14076941|NCT04414761|Ganirelix|ganirelix|mesh-list
14076942|NCT04414761|Progestins|progestins|mesh-ancestor
14076943|NCT04414761|Hormones|hormones|mesh-ancestor
14076944|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076945|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076946|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14076947|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14076948|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14076949|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
14076950|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14076951|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14076952|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14076953|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14076954|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14076955|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14076956|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
14076957|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14076958|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
14076959|NCT04414748|Cetrorelix|cetrorelix|mesh-list
14076960|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
14076961|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14076962|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
14076963|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14076964|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14076965|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
14076966|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14076967|NCT04414748|Progestins|progestins|mesh-ancestor
14076968|NCT04414748|Hormones|hormones|mesh-ancestor
14759099|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
14476701|NCT02419755|Hormones|hormones|mesh-ancestor
14476702|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476703|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476704|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476705|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14476706|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14476707|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14476708|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476709|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476710|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14476711|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
14476712|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14759100|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14076991|NCT04394182|Ritonavir|ritonavir|mesh-list
14076992|NCT04394182|Lopinavir|lopinavir|mesh-list
14076993|NCT04394182|Azithromycin|azithromycin|mesh-list
14076994|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
14076995|NCT04394182|Tazobactam|tazobactam|mesh-list
14076996|NCT04394182|Piperacillin|piperacillin|mesh-list
14076997|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14076998|NCT04394182|Heparin|heparin|mesh-list
14076999|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14077000|NCT04394182|Tinzaparin|tinzaparin|mesh-list
14077001|NCT04394182|Dalteparin|dalteparin|mesh-list
14077002|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14077003|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14077004|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
14077005|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077006|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077007|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14077008|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14077009|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
14077010|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077011|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14077012|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14077013|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
14077014|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14077015|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14759101|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14077016|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14077017|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
14077018|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14077019|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14077020|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077021|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14077022|NCT04388319|Zonisamide|zonisamide|mesh-list
14077023|NCT04388319|Bupropion|bupropion|mesh-list
14077024|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14077025|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
14077026|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14077027|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14077028|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14077029|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14077030|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077031|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
14077032|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077033|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077034|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14077035|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14077036|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077037|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
14077038|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14077039|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14077040|NCT04385277|Vitamin A|vitamin a|mesh-list
14077041|NCT04385277|Irinotecan|irinotecan|mesh-list
14077042|NCT04385277|Temozolomide|temozolomide|mesh-list
14077043|NCT04385277|Tretinoin|tretinoin|mesh-list
14077044|NCT04385277|Dinutuximab|dinutuximab|mesh-list
14077045|NCT04385277|Isotretinoin|isotretinoin|mesh-list
14077046|NCT04385277|Sargramostim|sargramostim|mesh-list
14077047|NCT04385277|Vitamins|vitamins|mesh-ancestor
14077048|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
14077049|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077050|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14077051|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14077052|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077053|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077054|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077055|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13915637|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915638|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13915639|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13915640|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
13915641|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915642|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13915643|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
13915644|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
13915645|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
13915646|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13915647|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
13915648|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
13915649|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915650|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
13915651|NCT03470480|Methamphetamine|methamphetamine|mesh-list
13915652|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13915653|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915654|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
13915655|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
13915656|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915657|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
13915658|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915659|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077056|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
14077057|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
14077058|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
14077059|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
14077060|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
14077061|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14077062|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14077063|NCT04377503|Prednisolone|prednisolone|mesh-list
14077064|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
14077065|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14077066|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
13915660|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
14077067|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14077068|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
14077069|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
14077070|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077071|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077072|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14077073|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
14077074|NCT04377503|Hormones|hormones|mesh-ancestor
14077075|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077076|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14077077|NCT04377503|Protective Agents|protective agents|mesh-ancestor
14077078|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14077079|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077080|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
14077081|NCT04360473|Ketamine|ketamine|mesh-list
14077082|NCT04360473|Anesthetics|anesthetics|mesh-list
14077083|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077084|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077085|NCT04360473|Analgesics|analgesics|mesh-ancestor
14077086|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
14077087|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077088|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14077089|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14077090|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
14077091|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14077092|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14077093|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077094|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759102|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14759103|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
14759104|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14077095|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14077096|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
14077097|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14077098|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14077099|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14077100|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
14077101|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14077102|NCT04360070|Ketamine|ketamine|mesh-list
14077103|NCT04360070|Analgesics|analgesics|mesh-ancestor
14077104|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
14077105|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077106|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077107|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14077108|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14077109|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
14077110|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
14077111|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077112|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14077113|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14077114|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759105|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759106|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759107|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
14759108|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759109|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759110|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
14759111|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759112|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14759113|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759114|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
14759115|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14759116|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14759117|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14759118|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13915661|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13915662|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13915663|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915664|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13915665|NCT03470454|Linagliptin|linagliptin|mesh-list
13915666|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14759119|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
14759120|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14759121|NCT04954742|Riociguat|riociguat|mesh-list
14759122|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
14759123|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759124|NCT04952753|Leucovorin|leucovorin|mesh-list
14759125|NCT04952753|Bevacizumab|bevacizumab|mesh-list
14759126|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
14759127|NCT04952753|Irinotecan|irinotecan|mesh-list
14759128|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
14759129|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759130|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759131|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14759132|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13915667|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915668|NCT03470454|Incretins|incretins|mesh-ancestor
14077115|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077116|NCT04358549|Favipiravir|favipiravir|mesh-list
14077117|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
14077118|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173200|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173201|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14173202|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14173203|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173204|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14173205|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
14173206|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14759133|NCT04952753|Growth Substances|growth substances|mesh-ancestor
14759134|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759135|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
14759136|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14934590|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14934591|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
14934592|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14934593|NCT01457690|Tocopherols|tocopherols|mesh-list
14934594|NCT01457690|Vitamin E|vitamin e|mesh-list
14934595|NCT01457690|Tocotrienols|tocotrienols|mesh-list
14934596|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
14934597|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
14934598|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934599|NCT01457690|Protective Agents|protective agents|mesh-ancestor
14934600|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934601|NCT01457690|Vitamins|vitamins|mesh-ancestor
14934602|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
14934603|NCT01457716|Budesonide|budesonide|mesh-list
14934604|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
13915669|NCT03470454|Hormones|hormones|mesh-ancestor
13915670|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915671|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13915672|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
13915673|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915674|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915675|NCT03470363|Sufentanil|sufentanil|mesh-list
13915676|NCT03470363|Bupivacaine|bupivacaine|mesh-list
13915677|NCT03470363|Sevoflurane|sevoflurane|mesh-list
13915678|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
13915679|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
13915680|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915681|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077119|NCT04345718|Buprenorphine|buprenorphine|mesh-list
13915682|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
14077120|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
14077121|NCT04345718|Narcotics|narcotics|mesh-ancestor
14077122|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077123|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077124|NCT04345718|Analgesics|analgesics|mesh-ancestor
14077125|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
14077126|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077127|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14077128|NCT04317105|Nivolumab|nivolumab|mesh-list
14077129|NCT04317105|Ipilimumab|ipilimumab|mesh-list
14077130|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077131|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077132|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14077133|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759137|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14759138|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759139|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759140|NCT04952753|Antidotes|antidotes|mesh-ancestor
14759141|NCT04952753|Protective Agents|protective agents|mesh-ancestor
14759142|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
14759143|NCT04952753|Vitamins|vitamins|mesh-ancestor
14759144|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
14759145|NCT04952402|Vaccines|vaccines|mesh-list
14759146|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
14759147|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759148|NCT04951362|Ivermectin|ivermectin|mesh-list
14759149|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14759150|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759151|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
14759152|NCT04949256|Leucovorin|leucovorin|mesh-list
14759153|NCT04949256|Paclitaxel|paclitaxel|mesh-list
14759154|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
14759155|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
14759156|NCT04949256|Lenvatinib|lenvatinib|mesh-list
14759157|NCT04949256|Calcium|calcium|mesh-list
14759158|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
14759159|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759160|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759161|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077156|NCT04295486|Aspirin|aspirin|mesh-list
14077157|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14077158|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14077159|NCT04295486|Analgesics|analgesics|mesh-ancestor
14077160|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
13915683|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915684|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13915685|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14077161|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077162|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077163|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14077164|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077165|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14077166|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14077167|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077168|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14077169|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14077170|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077171|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
14077172|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
14077173|NCT04267887|Prednisone|prednisone|mesh-list
14077174|NCT04267887|Cortisone|cortisone|mesh-list
14077175|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
14077176|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
13915686|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
14077177|NCT04267887|Hormones|hormones|mesh-list
14077178|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14077179|NCT04267887|Androgens|androgens|mesh-list
14077180|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
14077181|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14077182|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
14077183|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077184|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077185|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14077186|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077187|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14077188|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077189|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915687|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13915688|NCT03470363|Narcotics|narcotics|mesh-ancestor
13915689|NCT03470363|Analgesics|analgesics|mesh-ancestor
13915690|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13915691|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14077190|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
14077191|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14077192|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
14077193|NCT04267887|Protective Agents|protective agents|mesh-ancestor
14077194|NCT04267887|Vitamins|vitamins|mesh-ancestor
13915692|NCT03470350|Capecitabine|capecitabine|mesh-list
13915693|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14077195|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
14077196|NCT04267887|Estrogens|estrogens|mesh-ancestor
13915694|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
13915695|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915696|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915697|NCT03470337|Wobenzym|wobenzym|mesh-list
13915698|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13915699|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
13915700|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915701|NCT03470311|Benralizumab|benralizumab|mesh-list
13915702|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14077197|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
14077198|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
14077199|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077200|NCT04249596|Tianeptine|tianeptine|mesh-list
14077201|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14077202|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
14077203|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14077204|NCT04248335|Midazolam|midazolam|mesh-list
14077205|NCT04248335|Pantoprazole|pantoprazole|mesh-list
14077206|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14077207|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14077208|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077209|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077210|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14077211|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14077212|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14077213|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14077214|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
14077215|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
14077216|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
14077217|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
14077218|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077219|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077220|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14077221|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14077222|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14077223|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077224|NCT04236830|Fluorides|fluorides|mesh-list
14077225|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
14077226|NCT04236830|Protective Agents|protective agents|mesh-ancestor
14077227|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077228|NCT04232358|Anesthetics|anesthetics|mesh-list
14077229|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077230|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077231|NCT04221828|Paclitaxel|paclitaxel|mesh-list
14077232|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14077233|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077234|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077235|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077236|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077237|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077238|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077239|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14077240|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14077241|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077242|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
14077243|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077244|NCT04216953|Atezolizumab|atezolizumab|mesh-list
14077245|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077246|NCT04204343|Bupivacaine|bupivacaine|mesh-list
14077247|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
14077248|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
14077249|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077250|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077251|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
14077252|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077253|NCT04150042|Vitamins|vitamins|mesh-list
14077254|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
14759162|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077255|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
14077256|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
14077257|NCT04150042|Ethanol|ethanol|mesh-list
14077258|NCT04150042|Melphalan|melphalan|mesh-list
14077259|NCT04150042|Carmustine|carmustine|mesh-list
14077260|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
14077261|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077262|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077263|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
14077264|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077265|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077266|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14077267|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077268|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
14077269|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
14077270|NCT04150042|Protective Agents|protective agents|mesh-ancestor
14077271|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
14077272|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14077273|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077274|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077275|NCT04150042|Hematinics|hematinics|mesh-ancestor
14077276|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
14077277|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14077278|NCT04126538|Pirfenidone|pirfenidone|mesh-list
14077279|NCT04126538|Analgesics|analgesics|mesh-ancestor
14077280|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
14077281|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077282|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077283|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14077284|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14077285|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14077286|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077287|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077288|NCT04124601|Nivolumab|nivolumab|mesh-list
14077289|NCT04124601|Ipilimumab|ipilimumab|mesh-list
14077290|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077291|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934605|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14934606|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14934607|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
14934608|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934609|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934610|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14934611|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
14934612|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
14934613|NCT01457716|Hormones|hormones|mesh-ancestor
13915703|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
13915704|NCT03470103|Aflibercept|aflibercept|mesh-list
13915705|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13915706|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13915707|NCT03470103|Growth Substances|growth substances|mesh-ancestor
13915708|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915709|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
13915710|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915711|NCT03470077|Nalbuphine|nalbuphine|mesh-list
13915712|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915713|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915714|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13915715|NCT03470077|Narcotics|narcotics|mesh-ancestor
13915716|NCT03470077|Analgesics|analgesics|mesh-ancestor
13915717|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
13915718|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915719|NCT03470038|Mitogens|mitogens|mesh-list
13915720|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077292|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14173207|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
14077293|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077294|NCT04118010|Vitamin D|vitamin d|mesh-list
14077295|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
14077296|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
14077297|NCT04118010|Vitamins|vitamins|mesh-list
14077298|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
14077299|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077300|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14077301|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14476713|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14476714|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
14476715|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14077305|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14077306|NCT04086212|Icodextrin|icodextrin|mesh-list
14077307|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
14077308|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14077309|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077310|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14077311|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
13915721|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915722|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
13915723|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13915724|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13915725|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915726|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
13915727|NCT03469947|Coagulants|coagulants|mesh-ancestor
13915728|NCT03469895|Idelalisib|idelalisib|mesh-list
13915729|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077312|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077313|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14077314|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
14759163|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077315|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077316|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077317|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14077318|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14077319|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14077320|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
14077321|NCT04045665|Anticoagulants|anticoagulants|mesh-list
14077322|NCT04018612|Acetaminophen|acetaminophen|mesh-list
14077323|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14077324|NCT04018612|Analgesics|analgesics|mesh-ancestor
14077325|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
14077326|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077327|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077328|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
14077329|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
14077330|NCT03968393|Apixaban|apixaban|mesh-list
14077331|NCT03968393|Edoxaban|edoxaban|mesh-list
14077332|NCT03968393|Dabigatran|dabigatran|mesh-list
14077333|NCT03968393|Anticoagulants|anticoagulants|mesh-list
14476716|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14077334|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14077335|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
14077336|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14476717|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14476718|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
14476719|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14476720|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14476721|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
14476722|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915730|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476723|NCT02419755|Analgesics|analgesics|mesh-ancestor
13915731|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915732|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13915733|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13915734|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
13915735|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915736|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915737|NCT03469713|Nivolumab|nivolumab|mesh-list
13915738|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915739|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077337|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
14077338|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077339|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173208|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
14173209|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
14173210|NCT04801966|Nivolumab|nivolumab|mesh-list
14173211|NCT04801966|Atezolizumab|atezolizumab|mesh-list
14173212|NCT04801966|Olaparib|olaparib|mesh-list
14173213|NCT04801966|Palbociclib|palbociclib|mesh-list
14173214|NCT04801966|Trametinib|trametinib|mesh-list
14173215|NCT04801966|Vemurafenib|vemurafenib|mesh-list
14173216|NCT04801966|Dabrafenib|dabrafenib|mesh-list
14173217|NCT04801966|Talazoparib|talazoparib|mesh-list
14173218|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14173219|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173220|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14173221|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173222|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14173223|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173224|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173225|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14173226|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
14173227|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173228|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
14173229|NCT04801511|Vitamins|vitamins|mesh-ancestor
14173230|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
14173231|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173232|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
14173233|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173234|NCT04801511|Protective Agents|protective agents|mesh-ancestor
14173235|NCT04801303|Calcitriol|calcitriol|mesh-list
14173236|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14173237|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173238|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14173239|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14173240|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173241|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14173242|NCT04801303|Vitamins|vitamins|mesh-ancestor
14173243|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
14173244|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14173245|NCT04801589|Midazolam|midazolam|mesh-list
14173246|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
14173247|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14173248|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173249|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173250|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173251|NCT04801589|Analgesics|analgesics|mesh-ancestor
14173252|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
14173253|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173254|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14173255|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14173256|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14173257|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
14173258|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173259|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173260|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14173261|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14173262|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14173263|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14173264|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14173265|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
14173266|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
14173267|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
14173268|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
14173269|NCT04801485|Inositol|inositol|mesh-list
14173270|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
14173271|NCT04801485|Vitamins|vitamins|mesh-ancestor
14173272|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
14173273|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173274|NCT04801342|Memantine|memantine|mesh-list
14173275|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14173276|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14173277|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
14173278|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173279|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173280|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077340|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
14077341|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077342|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077343|NCT03933215|Cladribine|cladribine|mesh-list
14077344|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077345|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077346|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
14077347|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077348|NCT03906071|Docetaxel|docetaxel|mesh-list
14077349|NCT03906071|Nivolumab|nivolumab|mesh-list
14077350|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077351|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077352|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077353|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077354|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077355|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077356|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14077357|NCT03904381|Fluorouracil|fluorouracil|mesh-list
14077358|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
14077359|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077360|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14077361|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077362|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077363|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
14077364|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077365|NCT03895840|Triamcinolone|triamcinolone|mesh-list
14077366|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14077367|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14077368|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14077369|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14077370|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
14077371|NCT03895840|Hormones|hormones|mesh-ancestor
14077372|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077373|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077374|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077375|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
14077376|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077377|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077378|NCT03876873|Anesthetics|anesthetics|mesh-list
14077379|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077380|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077381|NCT03856437|Vaccines|vaccines|mesh-list
14077382|NCT03856437|Immunologic Factors|immunologic factors|mesh-ancestor
14077383|NCT03856437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077384|NCT03819660|Amifampridine|amifampridine|mesh-list
14077385|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14077386|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077387|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077388|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14077389|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14077390|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077391|NCT03810794|Donepezil|donepezil|mesh-list
14077392|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14077393|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077394|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077395|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
14077396|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077397|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077398|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
14077399|NCT03800381|Rifampin|rifampin|mesh-list
14077400|NCT03800381|Isoniazid|isoniazid|mesh-list
14077401|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
14077402|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14077403|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
14077404|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14077405|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077406|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
14077407|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14759164|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759165|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14759166|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759167|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14759168|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759169|NCT04949256|Antidotes|antidotes|mesh-ancestor
13915740|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13915741|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915742|NCT03469700|Anesthetics|anesthetics|mesh-list
13915743|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759170|NCT04949256|Protective Agents|protective agents|mesh-ancestor
14759171|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
14759172|NCT04949256|Vitamins|vitamins|mesh-ancestor
14759173|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
14759174|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759175|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759176|NCT04948333|Niacinamide|niacinamide|mesh-list
14759177|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
14759178|NCT04948333|Vitamins|vitamins|mesh-ancestor
14759179|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
14759180|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759181|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
14759182|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14759183|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
14759184|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
14759185|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915744|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915745|NCT03469583|Entecavir|entecavir|mesh-list
13915746|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
13915747|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915748|NCT03469557|Capecitabine|capecitabine|mesh-list
13915749|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
13915750|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915751|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13915752|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
13915753|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915754|NCT03469544|Hormones|hormones|mesh-list
13915755|NCT03469544|Antibodies|antibodies|mesh-list
13915756|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915757|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915758|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
13915759|NCT03469531|Cisplatin|cisplatin|mesh-list
13915760|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
13915761|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915762|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13915763|NCT03469375|Folfirinox|folfirinox|mesh-list
13915764|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915765|NCT03469323|Succinylcholine|succinylcholine|mesh-list
14077408|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915766|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
13915767|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14759186|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077409|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077410|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14077411|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14077412|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14077413|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14077414|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14077415|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14077416|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14077417|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14077418|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
13915768|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14077419|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14077420|NCT03794349|Eflornithine|eflornithine|mesh-list
14077421|NCT03794349|Irinotecan|irinotecan|mesh-list
14077422|NCT03794349|Camptothecin|camptothecin|mesh-list
14077423|NCT03794349|Temozolomide|temozolomide|mesh-list
14077424|NCT03794349|Dinutuximab|dinutuximab|mesh-list
14077425|NCT03794349|Sargramostim|sargramostim|mesh-list
14077426|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14077427|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14077428|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077429|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077430|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077431|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077432|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
14077433|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
14077434|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077435|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077436|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14077437|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14077438|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14077439|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077440|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14077441|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14077442|NCT03755973|Hormones|hormones|mesh-ancestor
14077443|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077444|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077445|NCT03747159|Belimumab|belimumab|mesh-list
14077446|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077447|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
14077448|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759187|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759188|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14759189|NCT04940390|Analgesics|analgesics|mesh-ancestor
14759190|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
14759191|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934614|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934615|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14934616|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14934617|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14077456|NCT03732495|Denosumab|denosumab|mesh-list
14077457|NCT03732495|Lenvatinib|lenvatinib|mesh-list
14077458|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077459|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14077460|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077461|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077462|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14077463|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077464|NCT03728426|Letermovir|letermovir|mesh-list
14077465|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14934618|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934619|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915769|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915770|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915771|NCT03469310|Acetaminophen|acetaminophen|mesh-list
13915772|NCT03469310|Tramadol|tramadol|mesh-list
13915773|NCT03469310|Codeine|codeine|mesh-list
13915774|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13915775|NCT03469310|Analgesics|analgesics|mesh-ancestor
13915776|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
13915777|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915778|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915779|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
14077466|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915780|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13915781|NCT03469310|Narcotics|narcotics|mesh-ancestor
13915782|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915783|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
13915784|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
13915785|NCT03469284|Methylene Blue|methylene blue|mesh-list
13915786|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915787|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915788|NCT03469271|Calcitriol|calcitriol|mesh-list
13915789|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
13915790|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13915791|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915792|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13915793|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915794|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915795|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13915796|NCT03469271|Vitamins|vitamins|mesh-ancestor
13915797|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
13915798|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13915799|NCT03469167|Epinephrine|epinephrine|mesh-list
13915800|NCT03469167|CEGP-003|cegp-003|mesh-list
13915801|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13915802|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13915803|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
13915804|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915805|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915806|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915807|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13915808|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13915809|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
13915810|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915811|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13915812|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
13915813|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
13915814|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
13915815|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13915816|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
13915817|NCT03469167|Coagulants|coagulants|mesh-ancestor
13960079|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13960080|NCT03157843|Tinzaparin|tinzaparin|mesh-list
13960081|NCT03157843|Dalteparin|dalteparin|mesh-list
13960082|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
13960083|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13960084|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13960085|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960086|NCT03157804|Plerixafor|plerixafor|mesh-list
13960087|NCT03157804|Lenograstim|lenograstim|mesh-list
13960088|NCT03157804|Sargramostim|sargramostim|mesh-list
13960089|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13960090|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
13960091|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077467|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077468|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960092|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13960093|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13915818|NCT03469128|Sertraline|sertraline|mesh-list
13915819|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
13915820|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13915821|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13915822|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13915823|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14934620|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077469|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
14077470|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077471|NCT03715166|Bumetanide|bumetanide|mesh-list
14077472|NCT03715166|Diuretics|diuretics|mesh-ancestor
14077473|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
14077474|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077475|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14077476|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14077477|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077478|NCT03680053|Cetrorelix|cetrorelix|mesh-list
14077479|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
14077480|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14077481|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
14077482|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14077483|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077484|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
14077485|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077486|NCT03680053|Progestins|progestins|mesh-ancestor
14934621|NCT01457820|Allopurinol|allopurinol|mesh-list
14077487|NCT03680053|Hormones|hormones|mesh-ancestor
14077488|NCT03666559|Azacitidine|azacitidine|mesh-list
14077489|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14077490|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
14077491|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077492|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077493|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077494|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14077495|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14077496|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
14077497|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077498|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
14077499|NCT03636152|Chloroquine|chloroquine|mesh-list
14077500|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
14077501|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14077502|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14077503|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077504|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077505|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077506|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077507|NCT03636152|Amebicides|amebicides|mesh-ancestor
14077508|NCT03617523|Vaccines|vaccines|mesh-list
14077509|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
14077510|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077511|NCT03586284|Valganciclovir|valganciclovir|mesh-list
14077512|NCT03586284|Ganciclovir|ganciclovir|mesh-list
14077513|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14077514|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
14077515|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077516|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14077517|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934622|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
13915824|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915825|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077518|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077519|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
14077520|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077521|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14077522|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077523|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077524|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
14077525|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077526|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077527|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14077528|NCT03563157|Leucovorin|leucovorin|mesh-list
14077529|NCT03563157|Paclitaxel|paclitaxel|mesh-list
14077530|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
14077531|NCT03563157|Fluorouracil|fluorouracil|mesh-list
14077532|NCT03563157|Capecitabine|capecitabine|mesh-list
14077533|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
14077534|NCT03563157|Cetuximab|cetuximab|mesh-list
14077535|NCT03563157|Avelumab|avelumab|mesh-list
14077536|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077537|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077538|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077539|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077540|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077541|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077542|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077543|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
14077544|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077545|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14759192|NCT04940052|Trametinib|trametinib|mesh-list
14759193|NCT04940052|Dabrafenib|dabrafenib|mesh-list
14759194|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077546|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077547|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
14077548|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14077549|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
14077550|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14077551|NCT03563157|Antidotes|antidotes|mesh-ancestor
14077552|NCT03563157|Protective Agents|protective agents|mesh-ancestor
14077553|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
14077554|NCT03563157|Vitamins|vitamins|mesh-ancestor
14077555|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
14077556|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077557|NCT03546192|Vaccines|vaccines|mesh-list
14077558|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
14077559|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077560|NCT03528902|Tamoxifen|tamoxifen|mesh-list
14077561|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14077562|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
14077563|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077564|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077565|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14077566|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077567|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14077568|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14077569|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14077570|NCT03517449|Paclitaxel|paclitaxel|mesh-list
14077571|NCT03517449|Doxorubicin|doxorubicin|mesh-list
14077572|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
14077573|NCT03517449|Lenvatinib|lenvatinib|mesh-list
14077574|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077575|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077576|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077577|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077578|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077579|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077580|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14077581|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759195|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14077582|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14077583|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077584|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077585|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173281|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14173282|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14173283|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14173284|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
14173285|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14173286|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173287|NCT04800978|Durvalumab|durvalumab|mesh-list
14173288|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14173289|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173290|NCT04801017|Artemisinins|artemisinins|mesh-list
14173291|NCT04801017|Artemisinin|artemisinin|mesh-list
14173292|NCT04801017|Trabedersen|trabedersen|mesh-list
14173293|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
14173294|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14173295|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14173296|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173297|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173298|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14173299|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14173300|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173301|NCT04801199|Incretins|incretins|mesh-ancestor
14173302|NCT04801199|Hormones|hormones|mesh-ancestor
14173303|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173304|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14173305|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
14173306|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173307|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183421|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183422|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14183423|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183424|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183425|NCT04728360|Ustekinumab|ustekinumab|mesh-list
14183426|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
14183427|NCT04728308|Bupivacaine|bupivacaine|mesh-list
14183428|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
14183429|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
14183430|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183431|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183432|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
14183433|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183434|NCT04728230|Carboplatin|carboplatin|mesh-list
14183435|NCT04728230|Etoposide|etoposide|mesh-list
14183436|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
14183437|NCT04728230|Durvalumab|durvalumab|mesh-list
14183438|NCT04728230|Olaparib|olaparib|mesh-list
14183439|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
14183440|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
14183441|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14183442|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
14183443|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183444|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14183445|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14183446|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14183447|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183448|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183449|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14183450|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
14183451|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183452|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13915826|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
13915827|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915828|NCT03469089|Ketamine|ketamine|mesh-list
13915829|NCT03469089|Modafinil|modafinil|mesh-list
13915830|NCT03469089|Analgesics|analgesics|mesh-ancestor
13915831|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
13915832|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915833|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915834|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13915835|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13915836|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
14077586|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14077587|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077588|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077589|NCT03490292|Paclitaxel|paclitaxel|mesh-list
14077590|NCT03490292|Carboplatin|carboplatin|mesh-list
14077591|NCT03490292|Avelumab|avelumab|mesh-list
14077592|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077593|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077594|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077595|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077596|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077597|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077598|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077599|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
14759196|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759197|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077600|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14077601|NCT03480698|Protective Agents|protective agents|mesh-ancestor
14077602|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077603|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
14077604|NCT03474744|Rituximab|rituximab|mesh-list
14077605|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077606|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077607|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
14077608|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077609|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077610|NCT03474094|Atezolizumab|atezolizumab|mesh-list
14077611|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14077612|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077613|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
14077614|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077615|NCT03470922|Nivolumab|nivolumab|mesh-list
14077616|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077617|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077618|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14077619|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077620|NCT03456063|Gemcitabine|gemcitabine|mesh-list
14077621|NCT03456063|Paclitaxel|paclitaxel|mesh-list
14077622|NCT03456063|Carboplatin|carboplatin|mesh-list
14077623|NCT03456063|Pemetrexed|pemetrexed|mesh-list
14077624|NCT03456063|Atezolizumab|atezolizumab|mesh-list
14077625|NCT03456063|Antibodies|antibodies|mesh-list
14077626|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077627|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077628|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077629|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077630|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077631|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077632|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
14077633|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077634|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14077635|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
14077636|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
14077637|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077638|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077639|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077640|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14476724|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
14476725|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14476726|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14476727|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14476728|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14476729|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476730|NCT02420015|Bupropion|bupropion|mesh-list
14476731|NCT02420015|Nicotine|nicotine|mesh-list
14077641|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14077642|NCT03438318|Atezolizumab|atezolizumab|mesh-list
14077643|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077644|NCT03387852|Fluticasone|fluticasone|mesh-list
14476732|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14476733|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
14476734|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476735|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476736|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14476737|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14476738|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14476739|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077645|NCT03387852|Xhance|xhance|mesh-list
14077646|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14077647|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14077648|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14077649|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14077650|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14077651|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
14077652|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077653|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077654|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14077655|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
14077656|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14077657|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14077658|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14759198|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
14759199|NCT04938817|Lenvatinib|lenvatinib|mesh-list
14077659|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14759200|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759201|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759202|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14077660|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14077661|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
14077662|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077663|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077664|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
14077665|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
14077666|NCT03387852|Hormones|hormones|mesh-ancestor
14077667|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077668|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
14077669|NCT03387085|Leucovorin|leucovorin|mesh-list
14077670|NCT03387085|Paclitaxel|paclitaxel|mesh-list
14077671|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
14077672|NCT03387085|Bevacizumab|bevacizumab|mesh-list
14077673|NCT03387085|Fluorouracil|fluorouracil|mesh-list
14077674|NCT03387085|Capecitabine|capecitabine|mesh-list
14077675|NCT03387085|Avelumab|avelumab|mesh-list
14077676|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077677|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077678|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077679|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077680|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077681|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077682|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077683|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
14077684|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077685|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077686|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077687|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
14077688|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14077689|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077690|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14077691|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14077692|NCT03387085|Growth Substances|growth substances|mesh-ancestor
14077693|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
14077694|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
14077695|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14077696|NCT03387085|Antidotes|antidotes|mesh-ancestor
14077697|NCT03387085|Protective Agents|protective agents|mesh-ancestor
14077698|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
14077699|NCT03387085|Vitamins|vitamins|mesh-ancestor
14077700|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
14077701|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
14077702|NCT03338972|Fludarabine|fludarabine|mesh-list
14077703|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077704|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
14077705|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077706|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077707|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077708|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
14077709|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077710|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077711|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14077712|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14077713|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14077714|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077715|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14077716|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14077717|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14077718|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077719|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
14077720|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077721|NCT03334318|Allopurinol|allopurinol|mesh-list
14077722|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
14077723|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077724|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077725|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
14077726|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14759203|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759204|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759205|NCT04923893|Dexamethasone|dexamethasone|mesh-list
14759206|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
14759207|NCT04923893|Fludarabine|fludarabine|mesh-list
14759208|NCT04923893|Lenalidomide|lenalidomide|mesh-list
14759209|NCT04923893|Bortezomib|bortezomib|mesh-list
14759210|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759211|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
14759212|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759213|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14759214|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14759215|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
14759216|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759217|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759218|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14759219|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759220|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
14759221|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
13915837|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
13915838|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915839|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13915840|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13915841|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915842|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915843|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13915844|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
13915845|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13915846|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13915847|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
13915848|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915849|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13915850|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915851|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915852|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13915853|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
13915854|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915855|NCT03468946|Caffeine|caffeine|mesh-list
13915856|NCT03468946|Citric Acid|citric acid|mesh-list
13915857|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13915858|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915859|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13915860|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915861|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915862|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13915863|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13915864|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
13915865|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915866|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
13915867|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13915868|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
13915869|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
14077727|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14077728|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
14077729|NCT03334318|Protective Agents|protective agents|mesh-ancestor
14077730|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077731|NCT03308825|Vaccines|vaccines|mesh-list
14077732|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
14077733|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077734|NCT03292250|Durvalumab|durvalumab|mesh-list
14077735|NCT03292250|Tremelimumab|tremelimumab|mesh-list
14077736|NCT03292250|Nintedanib|nintedanib|mesh-list
14077737|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077738|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077739|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14077740|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077741|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077742|NCT03239340|Osimertinib|osimertinib|mesh-list
14077743|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077744|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14077745|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077746|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077747|NCT03224507|Dexamethasone|dexamethasone|mesh-list
14077748|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
14077749|NCT03224507|Lenalidomide|lenalidomide|mesh-list
14077750|NCT03224507|Daratumumab|daratumumab|mesh-list
14077751|NCT03224507|BB 1101|bb 1101|mesh-list
14077752|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14077753|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14077754|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
14077755|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
14077756|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077757|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077758|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14077759|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
14077760|NCT03224507|Hormones|hormones|mesh-ancestor
14077761|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077762|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14077763|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077764|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
14077765|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077766|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077767|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
14077768|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14077769|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14077770|NCT03224507|Growth Substances|growth substances|mesh-ancestor
14077771|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
14077772|NCT03218085|Tenofovir|tenofovir|mesh-list
14077773|NCT03218085|Emtricitabine|emtricitabine|mesh-list
14077774|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
14077775|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077776|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14077777|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14077778|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077779|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077780|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14077781|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14077782|NCT03149211|UB-421|ub-421|mesh-list
14077783|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14077784|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
14077785|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077786|NCT03123029|Venetoclax|venetoclax|mesh-list
14077787|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077788|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
14077789|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14077790|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
14077791|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077792|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
14077793|NCT03101163|Protective Agents|protective agents|mesh-ancestor
14077794|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
14077795|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077796|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077797|NCT03038594|Hormones|hormones|mesh-list
14077798|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077799|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077800|NCT03012581|Nivolumab|nivolumab|mesh-list
14077801|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077802|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077803|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14077804|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077805|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
14077806|NCT02981628|Leucovorin|leucovorin|mesh-list
14077807|NCT02981628|Folic Acid|folic acid|mesh-list
14077808|NCT02981628|Cytarabine|cytarabine|mesh-list
14077809|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
14077810|NCT02981628|Methotrexate|methotrexate|mesh-list
14077811|NCT02981628|Vincristine|vincristine|mesh-list
14077812|NCT02981628|Asparaginase|asparaginase|mesh-list
14077813|NCT02981628|Mercaptopurine|mercaptopurine|mesh-list
14077814|NCT02981628|Pegaspargase|pegaspargase|mesh-list
14077815|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14077816|NCT02981628|Calcium|calcium|mesh-list
14077817|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
14077818|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077819|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
14077820|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077821|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077822|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077823|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
14077824|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077825|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077826|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14077827|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14077828|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14077829|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14077830|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
14077831|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14077832|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14077833|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
14077834|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
14077835|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077836|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14077837|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14077838|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
14077839|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077840|NCT02981628|Antidotes|antidotes|mesh-ancestor
14077841|NCT02981628|Protective Agents|protective agents|mesh-ancestor
14077842|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
14077843|NCT02981628|Vitamins|vitamins|mesh-ancestor
14077844|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
14077845|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077846|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
14077847|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
14077848|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
14077849|NCT02981628|Hematinics|hematinics|mesh-ancestor
14077850|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077851|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14077852|NCT02915302|Vaccines|vaccines|mesh-list
14077853|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
14077854|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077855|NCT02914405|Nivolumab|nivolumab|mesh-list
14077856|NCT02914405|Dinutuximab|dinutuximab|mesh-list
14077857|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
14077858|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
14077859|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077860|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077861|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14077862|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077863|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
14077864|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077865|NCT02908269|Vaccines|vaccines|mesh-list
14077866|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
14077867|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077868|NCT02900664|Trametinib|trametinib|mesh-list
14077869|NCT02900664|Spartalizumab|spartalizumab|mesh-list
14077870|NCT02900664|Nazartinib|nazartinib|mesh-list
14077871|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077872|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14077873|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077874|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077875|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14077876|NCT02859012|Axitinib|axitinib|mesh-list
14077877|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077878|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14077879|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077880|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077881|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
14077882|NCT02807467|Propofol|propofol|mesh-list
14077883|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14077884|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077885|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077886|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14077887|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
14077888|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
14077889|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14077890|NCT02807467|Analgesics|analgesics|mesh-ancestor
14077891|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
14077892|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077893|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14077894|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14077895|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14077896|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
14077897|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14077898|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077899|NCT02756897|Venetoclax|venetoclax|mesh-list
14077900|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077901|NCT02688790|Dalbavancin|dalbavancin|mesh-list
14077902|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14077903|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077904|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
14077905|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077906|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077907|NCT02617589|Nivolumab|nivolumab|mesh-list
14077908|NCT02617589|Temozolomide|temozolomide|mesh-list
14077909|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077910|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077911|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14077912|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077913|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077914|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
14077915|NCT02614859|Metformin|metformin|mesh-list
14077916|NCT02614859|Bicalutamide|bicalutamide|mesh-list
14077917|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14077918|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077919|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
14759222|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759223|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14759224|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
14759225|NCT04923893|Hormones|hormones|mesh-ancestor
14759226|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759227|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759228|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14077920|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
14077921|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14077922|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173308|NCT04800471|Insulin|insulin|mesh-list
14173309|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14173310|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173311|NCT04800367|Denosumab|denosumab|mesh-list
14173312|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14173313|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173314|NCT04800224|Propolis|propolis|mesh-list
14173315|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173316|NCT04800081|Valsartan|valsartan|mesh-list
14077923|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
14077924|NCT02614066|Fludarabine|fludarabine|mesh-list
14077925|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14077926|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
14077927|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077928|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14077929|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077930|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
14077931|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077932|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077933|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14077934|NCT02519348|Bevacizumab|bevacizumab|mesh-list
14077935|NCT02519348|Durvalumab|durvalumab|mesh-list
14077936|NCT02519348|Tremelimumab|tremelimumab|mesh-list
14077937|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14077938|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14077939|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14077940|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14077941|NCT02519348|Growth Substances|growth substances|mesh-ancestor
14077942|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077943|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
14077944|NCT02502747|Sargramostim|sargramostim|mesh-list
14077945|NCT02502747|Immunologic Factors|immunologic factors|mesh-ancestor
14077946|NCT02502747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077947|NCT02473276|Morphine|morphine|mesh-list
14077948|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14077949|NCT02473276|Narcotics|narcotics|mesh-ancestor
14077950|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14077951|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077952|NCT02473276|Analgesics|analgesics|mesh-ancestor
14077953|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
14077954|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14077955|NCT02457702|Glycerol|glycerol|mesh-list
14077956|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14077957|NCT02457702|Protective Agents|protective agents|mesh-ancestor
14077958|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077959|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
14077960|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14077961|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
14077962|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759229|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14759230|NCT04923893|Growth Substances|growth substances|mesh-ancestor
14759231|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
14759232|NCT04922424|Atorvastatin|atorvastatin|mesh-list
14759233|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14759234|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14759235|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
14759236|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759237|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14759238|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14759239|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759240|NCT04914741|Prednisolone|prednisolone|mesh-list
14077969|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
14077970|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759241|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
14759242|NCT04914741|Rituximab|rituximab|mesh-list
14759243|NCT04914741|Doxorubicin|doxorubicin|mesh-list
14759244|NCT04914741|Vincristine|vincristine|mesh-list
14759245|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759246|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
14759247|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759248|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14759249|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14077971|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14077972|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
14077973|NCT02309645|Coagulants|coagulants|mesh-ancestor
14077974|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
14077975|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
14077976|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14077977|NCT02286414|Vitamins|vitamins|mesh-list
14759250|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
14759251|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759252|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759253|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14759254|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759255|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14759256|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759257|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14077978|NCT02286414|Vitamin K|vitamin k|mesh-list
14077979|NCT02286414|Warfarin|warfarin|mesh-list
14077980|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
14077981|NCT02286414|Dabigatran|dabigatran|mesh-list
14077982|NCT02286414|Apixaban|apixaban|mesh-list
14077983|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
14759258|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759259|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14077984|NCT02286414|Fluindione|fluindione|mesh-list
14077985|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
14077986|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14077987|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
14077988|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14077989|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
14077990|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14077991|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
14077992|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14077993|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14077994|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14077995|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14077996|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
14077997|NCT02286414|Coagulants|coagulants|mesh-ancestor
14077998|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
14077999|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14078000|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078001|NCT02258659|Paclitaxel|paclitaxel|mesh-list
14078002|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14078003|NCT02258659|Carboplatin|carboplatin|mesh-list
14078004|NCT02258659|Fluorouracil|fluorouracil|mesh-list
14078005|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
14078006|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14078007|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078008|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
14078009|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
14078010|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
14078011|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078012|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
14078013|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14078014|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078015|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
14078016|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078017|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
14078018|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078019|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14078020|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
14078021|NCT02176967|Carboplatin|carboplatin|mesh-list
14078022|NCT02176967|Doxorubicin|doxorubicin|mesh-list
14078023|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14078024|NCT02176967|Etoposide|etoposide|mesh-list
14078025|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
14078026|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
14078027|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078028|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
14078029|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078030|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078031|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14078032|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
14078033|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078034|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078035|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14078036|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14078037|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14078038|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14078039|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078040|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14078041|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
14078042|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
14934623|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934624|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934625|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
14934626|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934627|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14934628|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
14934629|NCT01457820|Protective Agents|protective agents|mesh-ancestor
14934630|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934631|NCT01457859|Triclosan|triclosan|mesh-list
14934632|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14934633|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078043|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
14078044|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
14078045|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
14078046|NCT02143388|Cisplatin|cisplatin|mesh-list
14078047|NCT02143388|Capecitabine|capecitabine|mesh-list
14078048|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078049|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14078050|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
14078051|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078052|NCT02111850|Aldesleukin|aldesleukin|mesh-list
14078053|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
14078054|NCT02111850|Fludarabine|fludarabine|mesh-list
14078055|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078056|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
14078057|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078058|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078059|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14078060|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
14078061|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078062|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078063|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14078064|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14078065|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14078066|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
14078067|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078068|NCT02049905|Gemcitabine|gemcitabine|mesh-list
14078069|NCT02049905|Docetaxel|docetaxel|mesh-list
14078070|NCT02049905|Doxorubicin|doxorubicin|mesh-list
14078071|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14078072|NCT02049905|Ifosfamide|ifosfamide|mesh-list
14078073|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
14078074|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14078075|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
14934634|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14078076|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078077|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078078|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
14078079|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078080|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078081|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078082|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
14078083|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078084|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
14078085|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
14078086|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
14078087|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14078088|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14078089|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14078090|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14078091|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
14078092|NCT01472562|Rituximab|rituximab|mesh-list
14078093|NCT01472562|Lenalidomide|lenalidomide|mesh-list
14078094|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14078095|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078096|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
14078097|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078098|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078099|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14078100|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14078101|NCT01472562|Growth Substances|growth substances|mesh-ancestor
14078102|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
14078103|NCT01362998|Fentanyl|fentanyl|mesh-list
14078104|NCT01362998|Morphine|morphine|mesh-list
14078105|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078106|NCT01362998|Narcotics|narcotics|mesh-ancestor
14078107|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078108|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078109|NCT01362998|Analgesics|analgesics|mesh-ancestor
14078110|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
14078111|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078112|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14078113|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078114|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
14078115|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
14078116|NCT01302327|Exenatide|exenatide|mesh-list
14078117|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14078118|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078119|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14078120|NCT01302327|Incretins|incretins|mesh-ancestor
14078121|NCT01302327|Hormones|hormones|mesh-ancestor
14078122|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078123|NCT01259648|Remifentanil|remifentanil|mesh-list
14078124|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078125|NCT01259648|Narcotics|narcotics|mesh-ancestor
14078126|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078127|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078128|NCT01259648|Analgesics|analgesics|mesh-ancestor
14078129|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
14078130|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078131|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
14078132|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078133|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
14078134|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078135|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078136|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14078137|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
14078138|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078139|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078140|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14078141|NCT01065454|Riociguat|riociguat|mesh-list
14078142|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
14078143|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078144|NCT00819546|Everolimus|everolimus|mesh-list
14078145|NCT00819546|Midostaurin|midostaurin|mesh-list
14078146|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078147|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078148|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
14078149|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078150|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14078151|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078152|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078153|NCT00762554|Fentanyl|fentanyl|mesh-list
14078154|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078155|NCT00762554|Narcotics|narcotics|mesh-ancestor
14078156|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078157|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078158|NCT00762554|Analgesics|analgesics|mesh-ancestor
14078159|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
14078160|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078161|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14078162|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078163|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
14078164|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
14078165|NCT00590187|Sapacitabine|sapacitabine|mesh-list
14078166|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078167|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
14078168|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078169|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14078170|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
14078171|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078172|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
14078173|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14078174|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078175|NCT02535104|Ranpirnase|ranpirnase|mesh-list
14078176|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078177|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14078178|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078179|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078180|NCT02535130|Amikacin|amikacin|mesh-list
14078181|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14078182|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078183|NCT02534961|Cefazolin|cefazolin|mesh-list
14078184|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14078185|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078186|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
14078187|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14078188|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14078189|NCT02535039|Prednisolone|prednisolone|mesh-list
14078190|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
14078191|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14078192|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
14078193|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078194|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
14078195|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
14078196|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078197|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078198|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078199|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
14078200|NCT02535039|Hormones|hormones|mesh-ancestor
14078201|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078202|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14078203|NCT02535039|Protective Agents|protective agents|mesh-ancestor
14078204|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14078205|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078206|NCT02534870|Ritonavir|ritonavir|mesh-list
14078207|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14078208|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14078209|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
14078210|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078211|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078212|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14078213|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14078214|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
14078215|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078216|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14078217|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14173317|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14173318|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14173319|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14173320|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173321|NCT04799847|Catumaxomab|catumaxomab|mesh-list
14173322|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173323|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14173324|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
14173325|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14173326|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14078218|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
14078219|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
14078220|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078221|NCT02534753|Protective Agents|protective agents|mesh-ancestor
14078222|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078223|NCT02534753|Vitamins|vitamins|mesh-ancestor
14078224|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
14078225|NCT02534571|Epinephrine|epinephrine|mesh-list
14078226|NCT02534571|Hemostatics|hemostatics|mesh-list
14078227|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14078228|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14078229|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
14078230|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078231|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078232|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078233|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14078234|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14078235|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
14078236|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078237|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14078238|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
14078239|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
14078240|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
14078241|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14078242|NCT02534571|Coagulants|coagulants|mesh-ancestor
14759260|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759261|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
14934635|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14078243|NCT02534506|Nivolumab|nivolumab|mesh-list
14078244|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14078245|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078246|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14078247|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078248|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
14078249|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14078250|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
14078251|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078252|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
14078253|NCT02534415|Protective Agents|protective agents|mesh-ancestor
14078254|NCT02534610|Etoricoxib|etoricoxib|mesh-list
14078255|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14078256|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14078257|NCT02534610|Analgesics|analgesics|mesh-ancestor
14078258|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
14078259|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078260|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078261|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078262|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078263|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14078264|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14078265|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078266|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078267|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14078268|NCT02534363|Aripiprazole|aripiprazole|mesh-list
14078269|NCT02534363|Ziprasidone|ziprasidone|mesh-list
14078270|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
14078271|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14078272|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14078273|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14078274|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078275|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078276|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
14078277|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
14078278|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078279|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078280|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14078281|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14078282|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
14078283|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14078284|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14078285|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14078286|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14078287|NCT02534376|Simvastatin|simvastatin|mesh-list
14078288|NCT02534376|Ezetimibe|ezetimibe|mesh-list
14078289|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14078290|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14078291|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
14078292|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078293|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14078294|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14078295|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078296|NCT02534636|Interferons|interferons|mesh-list
14078297|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
14078298|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
14078299|NCT02534636|BMS-986165|bms-986165|mesh-list
14078300|NCT02534636|Famotidine|famotidine|mesh-list
14078301|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078302|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
14078303|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078304|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
14078305|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078306|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14078307|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078308|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14078309|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
14078310|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
14078311|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078312|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078313|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14078314|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14078315|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078316|NCT02534467|Montelukast|montelukast|mesh-list
14078317|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14078318|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
14078319|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14078320|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
14078321|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078322|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078323|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14078324|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14078325|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078326|NCT02534337|Leucovorin|leucovorin|mesh-list
14078327|NCT02534337|Gemcitabine|gemcitabine|mesh-list
14078328|NCT02534337|Fluorouracil|fluorouracil|mesh-list
14078329|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
14078330|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14078331|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
14078332|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078333|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078334|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
14078335|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078336|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078337|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078338|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
14078339|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078340|NCT02534337|Antidotes|antidotes|mesh-ancestor
14078341|NCT02534337|Protective Agents|protective agents|mesh-ancestor
14078342|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
14078343|NCT02534337|Vitamins|vitamins|mesh-ancestor
14078344|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
14078345|NCT02534623|Fentanyl|fentanyl|mesh-list
14078346|NCT02534623|Bupivacaine|bupivacaine|mesh-list
14078347|NCT02534623|Anesthetics|anesthetics|mesh-list
14078348|NCT02534623|Propofol|propofol|mesh-list
14078349|NCT02534623|Sevoflurane|sevoflurane|mesh-list
14078350|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
14078351|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078352|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078353|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
14078354|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759262|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759263|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759264|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
14759265|NCT04914741|Hormones|hormones|mesh-ancestor
14759266|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759267|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759268|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14759269|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14759270|NCT04903314|Cenobamate|cenobamate|mesh-list
14759271|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
14759272|NCT04899349|Metformin|metformin|mesh-list
14759273|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
14759274|NCT04899349|Fulvestrant|fulvestrant|mesh-list
14759275|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14759276|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759277|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14759278|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759279|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759280|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759281|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14759282|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14759283|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
14759284|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078355|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14078356|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078357|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
14078358|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078359|NCT02534623|Narcotics|narcotics|mesh-ancestor
14078360|NCT02534623|Analgesics|analgesics|mesh-ancestor
14078361|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14078362|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14078363|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14078364|NCT02534454|Nicotine|nicotine|mesh-list
14078365|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14078366|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
14078367|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078368|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078369|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14078370|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14078371|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
14078372|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078373|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078374|NCT02534402|Prednisone|prednisone|mesh-list
14078375|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078376|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
14078377|NCT02534402|Hormones|hormones|mesh-ancestor
14078378|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078379|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078380|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476740|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476741|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14476742|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
14476743|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14476744|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14476745|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14476746|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476747|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
14476748|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14476749|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14078381|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078382|NCT02533908|Fentanyl|fentanyl|mesh-list
14078383|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078384|NCT02533908|Narcotics|narcotics|mesh-ancestor
14078385|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078386|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078387|NCT02533908|Analgesics|analgesics|mesh-ancestor
14078388|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
14078389|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078390|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14078391|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078392|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
14078393|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
14078394|NCT02533973|Calcipotriene|calcipotriene|mesh-list
14078395|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
14078396|NCT02533791|Vaccines|vaccines|mesh-list
14078397|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
14078398|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078399|NCT02533648|Allopurinol|allopurinol|mesh-list
14078400|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
14078401|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078402|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078403|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
14078404|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078405|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14078406|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
14078407|NCT02533648|Protective Agents|protective agents|mesh-ancestor
14078408|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078409|NCT02533440|Anesthetics|anesthetics|mesh-list
14078410|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
14078411|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078412|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078413|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
14078414|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078415|NCT02533765|Olaparib|olaparib|mesh-list
14173327|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
14078416|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14078417|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078418|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078419|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078420|NCT02533557|Lidocaine|lidocaine|mesh-list
14078421|NCT02533557|Epinephrine|epinephrine|mesh-list
14078422|NCT02533557|Racepinephrine|racepinephrine|mesh-list
14078423|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
14078424|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
14078425|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
14078426|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078427|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078428|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
14078429|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078430|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14078431|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14078432|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14078433|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14078434|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078435|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14078436|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14078437|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
14078438|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078439|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14078440|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14078441|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
14078442|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14078443|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
14078444|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
14078445|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
14078446|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14078447|NCT02533544|Tenofovir|tenofovir|mesh-list
14078448|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
14078449|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078450|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14078451|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14078452|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078453|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078454|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14078455|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14078456|NCT02533492|Triclosan|triclosan|mesh-list
14078457|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14078458|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078459|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14078460|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14759285|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14759286|NCT04899193|Hormones|hormones|mesh-ancestor
14759287|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759288|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759289|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14759290|NCT04895748|Everolimus|everolimus|mesh-list
14759291|NCT04895748|Spartalizumab|spartalizumab|mesh-list
14759292|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759293|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759294|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
14759295|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759296|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14759297|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759298|NCT04895709|Nivolumab|nivolumab|mesh-list
14759299|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759300|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934636|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
14934637|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934638|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14934639|NCT01457911|Metformin|metformin|mesh-list
14934640|NCT01457911|Glimepiride|glimepiride|mesh-list
14934641|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14078461|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
14078462|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078463|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14078464|NCT02533323|Gemcitabine|gemcitabine|mesh-list
14078465|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
14078466|NCT02533323|Pegaspargase|pegaspargase|mesh-list
14078467|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14078468|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
14078469|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078470|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078471|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
14078472|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078473|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078474|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078475|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
14078476|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078477|NCT02533336|Abamectin|abamectin|mesh-list
14078478|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
14078479|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14078480|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078481|NCT02533349|Pantoprazole|pantoprazole|mesh-list
14078482|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14078483|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078484|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14078485|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078486|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078487|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
14078488|NCT02533284|Analgesics|analgesics|mesh-ancestor
14078489|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
14078490|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078491|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078492|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
14078493|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078494|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14078495|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
14078496|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14078497|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14078498|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078499|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14078500|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
14078501|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14078502|NCT02533141|Simvastatin|simvastatin|mesh-list
14078503|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14078504|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14078505|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
14078506|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078507|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14078508|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14078509|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173328|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173329|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173330|NCT04799925|Febuxostat|febuxostat|mesh-list
14173331|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
14173332|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173333|NCT04799782|Mirtazapine|mirtazapine|mesh-list
14173334|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
14173335|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14173336|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14173337|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
14173338|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
14173339|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173340|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173341|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173342|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14173343|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14173344|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173345|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14173346|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14173347|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14173348|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
14173349|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14173350|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14078513|NCT02533011|Heparin|heparin|mesh-list
14078514|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
14078515|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14078516|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14078517|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078518|NCT02533076|Capsaicin|capsaicin|mesh-list
14078519|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
14078520|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
14078521|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
14078522|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078523|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078524|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14078525|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
14078526|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078527|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078528|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078529|NCT02532660|Dexetimide|dexetimide|mesh-list
14078530|NCT02532660|Citalopram|citalopram|mesh-list
14078531|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14078532|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14078533|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14078534|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078535|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078536|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
14078537|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078538|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14934642|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934643|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14934644|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934645|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
14934646|NCT01457937|Interferons|interferons|mesh-list
14934647|NCT01457937|Ribavirin|ribavirin|mesh-list
14078539|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
14759301|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14759302|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759303|NCT04895358|Paclitaxel|paclitaxel|mesh-list
14759304|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14759305|NCT04895358|Doxorubicin|doxorubicin|mesh-list
14759306|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14759307|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
14759308|NCT04895358|Capecitabine|capecitabine|mesh-list
14759309|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759310|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759311|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759312|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759313|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14078540|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14078541|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14078542|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14078543|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
14078544|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
14078545|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078546|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14078547|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14078548|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
14078549|NCT02532790|Prednisone|prednisone|mesh-list
14078550|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078551|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
14078552|NCT02532790|Hormones|hormones|mesh-ancestor
14078553|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078554|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078555|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14078556|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078557|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
14078558|NCT02532777|Prednisone|prednisone|mesh-list
14078559|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
14078560|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
14078561|NCT02532777|Leflunomide|leflunomide|mesh-list
14078562|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14078563|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14934648|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14078564|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078565|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
14934649|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078566|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078567|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078568|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14078569|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
14078570|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078571|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078572|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14078573|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078574|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
14078575|NCT02532777|Hormones|hormones|mesh-ancestor
14078576|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078577|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14078578|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14078579|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14078580|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
14078581|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14078582|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078583|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
14078584|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
14078585|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078586|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078587|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14078588|NCT02532777|Protective Agents|protective agents|mesh-ancestor
14078589|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
14078590|NCT02532413|Entecavir|entecavir|mesh-list
14078591|NCT02532413|Poly I-C|poly i-c|mesh-list
14078592|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
14078593|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078594|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
14078595|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
14078596|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078597|NCT02532634|Dexamethasone|dexamethasone|mesh-list
14078598|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
14078599|NCT02532634|Aprepitant|aprepitant|mesh-list
14078600|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
14078601|NCT02532634|Palonosetron|palonosetron|mesh-list
14078602|NCT02532634|Ramosetron|ramosetron|mesh-list
14078603|NCT02532634|BB 1101|bb 1101|mesh-list
14078604|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078605|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
14078606|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
14078607|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078608|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078609|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078610|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
14078611|NCT02532634|Hormones|hormones|mesh-ancestor
14078612|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078613|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14078614|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078615|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
14078616|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078617|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078618|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14078619|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078620|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14078621|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14078622|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
14078623|NCT02532400|Goserelin|goserelin|mesh-list
14078624|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14078625|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078626|NCT02532491|Risperidone|risperidone|mesh-list
14078627|NCT02532491|Aripiprazole|aripiprazole|mesh-list
14078628|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14078629|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
14078630|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078631|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078632|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078633|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14078634|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14078635|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078636|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14078637|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14078638|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
14078639|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
14078640|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
14078641|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14078642|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14078643|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14078644|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14078645|NCT02532569|Vaccines|vaccines|mesh-list
14078646|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
14078647|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078648|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14078649|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14078650|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14078651|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
14078652|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078653|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14078654|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14078655|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078656|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14078657|NCT02532335|Cathartics|cathartics|mesh-ancestor
14078658|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078659|NCT02532114|Niclosamide|niclosamide|mesh-list
14078660|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
14078661|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14078662|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
14078663|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14078664|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078665|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
14078666|NCT02532270|Phenylephrine|phenylephrine|mesh-list
14078667|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
14078668|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14078669|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
14078670|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
14078671|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915870|NCT03468907|Tenofovir|tenofovir|mesh-list
13915871|NCT03468907|Telbivudine|telbivudine|mesh-list
13915872|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
13915873|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915874|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14078672|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078673|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
14078674|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14078675|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
14078676|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
14078677|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14078678|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14078679|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14078680|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
14078681|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078682|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078683|NCT02532270|Protective Agents|protective agents|mesh-ancestor
14934650|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
14934651|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934652|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
14934653|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934654|NCT01457989|Ezogabine|ezogabine|mesh-list
14934655|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
13915875|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13915876|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915877|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915878|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13915879|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13915880|NCT03468829|Gontivimab|gontivimab|mesh-list
13915881|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
13915882|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915883|NCT03468790|Fluticasone|fluticasone|mesh-list
13915884|NCT03468790|Xhance|xhance|mesh-list
13915885|NCT03468790|Budesonide|budesonide|mesh-list
13915886|NCT03468790|Albuterol|albuterol|mesh-list
13915887|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
13915888|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13915889|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13915890|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14078684|NCT02532062|Vitamin D|vitamin d|mesh-list
14078685|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
14078686|NCT02532062|Vitamins|vitamins|mesh-ancestor
14934656|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14078687|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
14078688|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078689|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14078690|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14078691|NCT02531984|Azithromycin|azithromycin|mesh-list
14078692|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14078693|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078694|NCT02532140|Cefepime|cefepime|mesh-list
14078695|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14078696|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078697|NCT02532192|Cytarabine|cytarabine|mesh-list
14078698|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
14078699|NCT02532192|Fluconazole|fluconazole|mesh-list
14078700|NCT02532192|Dexamethasone|dexamethasone|mesh-list
14078701|NCT02532192|Cisplatin|cisplatin|mesh-list
14078702|NCT02532192|Rituximab|rituximab|mesh-list
14078703|NCT02532192|Belinostat|belinostat|mesh-list
14078704|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078705|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078706|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
14078707|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
14078708|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078709|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078710|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078711|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
14078712|NCT02532192|Hormones|hormones|mesh-ancestor
14078713|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078714|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14078715|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14078716|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
14078717|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078718|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14078719|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
14078720|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078721|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
14078722|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14078723|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078724|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14078725|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14078726|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14078727|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078728|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14078729|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14078730|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
14078731|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14078732|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14078733|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
14078734|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14078735|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14078736|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14759314|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759315|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14759316|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759317|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14759318|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759319|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759320|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759321|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
14078737|NCT02532153|Ketamine|ketamine|mesh-list
14078738|NCT02532153|Analgesics|analgesics|mesh-ancestor
14078739|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
14078740|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078741|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078742|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14078743|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078744|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
14078745|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
14078746|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078747|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14078748|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14078749|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078750|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078751|NCT02532322|Acetaminophen|acetaminophen|mesh-list
14078752|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14078753|NCT02532322|Analgesics|analgesics|mesh-ancestor
14078754|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
14078755|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078756|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078757|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
14078758|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14078759|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078760|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078761|NCT02532023|Curcumin|curcumin|mesh-list
14078762|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14078763|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14078764|NCT02532023|Analgesics|analgesics|mesh-ancestor
14078765|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
14078766|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078767|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078768|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078769|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078770|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078771|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078772|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078773|NCT02531906|Oxycodone|oxycodone|mesh-list
14078774|NCT02531906|Methadone|methadone|mesh-list
14078775|NCT02531906|Gabapentin|gabapentin|mesh-list
14078776|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078777|NCT02531906|Narcotics|narcotics|mesh-ancestor
14078778|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078779|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078780|NCT02531906|Analgesics|analgesics|mesh-ancestor
14078781|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
14078782|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078783|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
14078784|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14078785|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14078786|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14078787|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14078788|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14078789|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078790|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078791|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
14078792|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
14078793|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
14078794|NCT02531854|Pemetrexed|pemetrexed|mesh-list
14078795|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078796|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078797|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078798|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14078799|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14078800|NCT02531490|Labetalol|labetalol|mesh-list
14078801|NCT02531490|Methyldopa|methyldopa|mesh-list
14078802|NCT02531490|Nifedipine|nifedipine|mesh-list
14078803|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14078804|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14078805|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078806|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14078807|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078808|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
14078809|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
14078810|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14078811|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14078812|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14078813|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
14078814|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078815|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14078816|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
14078817|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
14078818|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078819|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14078820|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14078821|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
14078822|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14078823|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14078824|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14078825|NCT02531581|Furosemide|furosemide|mesh-list
14078826|NCT02531581|Diuretics|diuretics|mesh-list
14078827|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
14078828|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078829|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14078830|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14078831|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078832|NCT02531672|Choline|choline|mesh-list
14078833|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
14078834|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14078835|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
14078836|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078837|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078838|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14078839|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
14078840|NCT02531568|Warfarin|warfarin|mesh-list
14078841|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
14078842|NCT02531451|Aspirin|aspirin|mesh-list
14078843|NCT02531451|Ibuprofen|ibuprofen|mesh-list
14078844|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14078845|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14078846|NCT02531451|Analgesics|analgesics|mesh-ancestor
14078847|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
14078848|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078849|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078850|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078851|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078852|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14078853|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078854|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078855|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14078856|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14078857|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14078858|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
14078859|NCT02531529|Fentanyl|fentanyl|mesh-list
14078860|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078861|NCT02531529|Narcotics|narcotics|mesh-ancestor
14078862|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078863|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078864|NCT02531529|Analgesics|analgesics|mesh-ancestor
14078865|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
14078866|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078867|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14078868|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078869|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
14078870|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
14078871|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
14078872|NCT02531841|Dexamethasone|dexamethasone|mesh-list
14078873|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
14078874|NCT02531841|Etoposide|etoposide|mesh-list
14078875|NCT02531841|Ifosfamide|ifosfamide|mesh-list
14078876|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
14078877|NCT02531841|Thiotepa|thiotepa|mesh-list
14078878|NCT02531841|Carmustine|carmustine|mesh-list
14078879|NCT02531841|Busulfan|busulfan|mesh-list
14078880|NCT02531841|BB 1101|bb 1101|mesh-list
14078881|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078882|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
14078883|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
14078884|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078885|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078886|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14078887|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
14078888|NCT02531841|Hormones|hormones|mesh-ancestor
14078889|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078890|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14078891|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078892|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
14078893|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078894|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078895|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14078896|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14078897|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14078898|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14078899|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
14078900|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14078901|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078902|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
14078903|NCT02531737|Docetaxel|docetaxel|mesh-list
14078904|NCT02531737|Nintedanib|nintedanib|mesh-list
14078905|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078906|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
14078907|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
14078908|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
14078909|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078910|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14078911|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078912|NCT02531412|Spironolactone|spironolactone|mesh-list
14078913|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14078914|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
14078915|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14078916|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078917|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14078918|NCT02531412|Diuretics|diuretics|mesh-ancestor
14078919|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
14078920|NCT02531477|Propofol|propofol|mesh-list
14078921|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14078922|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078923|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078924|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078925|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
14078926|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
14078927|NCT02531724|Simendan|simendan|mesh-list
14078928|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14078929|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
14078930|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14078931|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14078932|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078933|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078934|NCT02531724|Protective Agents|protective agents|mesh-ancestor
14078935|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173351|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
14173352|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14173353|NCT04799743|Resveratrol|resveratrol|mesh-list
14173354|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
14173355|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173356|NCT04799743|Protective Agents|protective agents|mesh-ancestor
14173357|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173358|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173359|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14173360|NCT04799626|Meropenem|meropenem|mesh-list
14173361|NCT04799626|Tazobactam|tazobactam|mesh-list
14173362|NCT04799626|Piperacillin|piperacillin|mesh-list
14173363|NCT04799626|Tigecycline|tigecycline|mesh-list
14173364|NCT04799626|Biapenem|biapenem|mesh-list
14173365|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14173366|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173367|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14173368|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173369|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934657|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934658|NCT01458015|Oxycodone|oxycodone|mesh-list
14934659|NCT01458015|Tapentadol|tapentadol|mesh-list
14934660|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14173370|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14173371|NCT04799262|Prednisone|prednisone|mesh-list
14173372|NCT04799262|Tofacitinib|tofacitinib|mesh-list
14173373|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173374|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
14173375|NCT04799262|Hormones|hormones|mesh-ancestor
14173376|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173377|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173378|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14173379|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173380|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173381|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173382|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173383|NCT04799639|Paclitaxel|paclitaxel|mesh-list
14173384|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14173385|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173386|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
14173387|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
14173388|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
14173389|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173390|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14173391|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173392|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173393|NCT04799002|Melphalan|melphalan|mesh-list
14173394|NCT04799002|Topotecan|topotecan|mesh-list
14173395|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14173396|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
14173397|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173398|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173399|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14173400|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173401|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
14173402|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173403|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14078936|NCT02531165|Aspirin|aspirin|mesh-list
14078937|NCT02531165|Heparin|heparin|mesh-list
14078938|NCT02531165|Fentanyl|fentanyl|mesh-list
14078939|NCT02531165|Morphine|morphine|mesh-list
14078940|NCT02531165|Ticagrelor|ticagrelor|mesh-list
14078941|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14078942|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14078943|NCT02531165|Analgesics|analgesics|mesh-ancestor
14078944|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
14078945|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14078946|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078947|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14078948|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14078949|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14078950|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14078951|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078952|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14078953|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14078954|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078955|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
14078956|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14078957|NCT02531165|Narcotics|narcotics|mesh-ancestor
14078958|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14078959|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14078960|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14078961|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
14078962|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
14078963|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
14078964|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14078965|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14078966|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14078967|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
14078968|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14078969|NCT02531191|Peficitinib|peficitinib|mesh-list
14078970|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14078971|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078972|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14078973|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
14078974|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078975|NCT02531152|Latanoprost|latanoprost|mesh-list
14078976|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14078977|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14078978|NCT02530918|Ranibizumab|ranibizumab|mesh-list
14078979|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14078980|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13915891|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13915892|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13915893|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
13915894|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915895|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915896|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13915897|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
13915898|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14078981|NCT02530918|Growth Substances|growth substances|mesh-ancestor
14078982|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078983|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
14078984|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078985|NCT02530788|Selenium|selenium|mesh-list
14078986|NCT02530788|Selenious Acid|selenious acid|mesh-list
14078987|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
14078988|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
14078989|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14078990|NCT02530788|Protective Agents|protective agents|mesh-ancestor
14078991|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14078992|NCT02530788|Trace Elements|trace elements|mesh-ancestor
14078993|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
14078994|NCT02530801|Bevacizumab|bevacizumab|mesh-list
14078995|NCT02530801|Fluorouracil|fluorouracil|mesh-list
14078996|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14078997|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14078998|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14078999|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14079000|NCT02530801|Growth Substances|growth substances|mesh-ancestor
14079001|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079002|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
14079003|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
14079004|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079005|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079006|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079007|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
14079008|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
14079009|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
14079010|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079011|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14079012|NCT02530879|Esomeprazole|esomeprazole|mesh-list
14079013|NCT02530879|Omeprazole|omeprazole|mesh-list
14079014|NCT02530879|Lansoprazole|lansoprazole|mesh-list
14079015|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
14079016|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14079017|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14079018|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14079019|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079020|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079021|NCT02530697|Miltefosine|miltefosine|mesh-list
14079022|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14079023|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
14079024|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14079025|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079026|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079027|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14079028|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14079029|NCT02530697|Protective Agents|protective agents|mesh-ancestor
14079030|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079031|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
14079032|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14079033|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
14079034|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
14079035|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079036|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079037|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14079038|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14079039|NCT02530632|Propofol|propofol|mesh-list
14079040|NCT02530632|Sevoflurane|sevoflurane|mesh-list
14079041|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
14079042|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079043|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079044|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14079045|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14079046|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
14079047|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14079048|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14079049|NCT02530411|Fulvestrant|fulvestrant|mesh-list
14079050|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14079051|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079052|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14079053|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14079054|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
14079055|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079056|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079057|NCT02530424|Trastuzumab|trastuzumab|mesh-list
14079058|NCT02530424|Pertuzumab|pertuzumab|mesh-list
14079059|NCT02530424|Fulvestrant|fulvestrant|mesh-list
14079060|NCT02530424|Palbociclib|palbociclib|mesh-list
14079061|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14079062|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079063|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14079064|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14079065|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14079066|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
14079067|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079068|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079069|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14079070|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079071|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079072|NCT02530463|Nivolumab|nivolumab|mesh-list
14079073|NCT02530463|Ipilimumab|ipilimumab|mesh-list
14079074|NCT02530463|Azacitidine|azacitidine|mesh-list
14079075|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14079076|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079077|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14079078|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079079|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079080|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
14079081|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079082|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
14079083|NCT02530502|Temozolomide|temozolomide|mesh-list
14079084|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14079085|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079086|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14079087|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
14079088|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079089|NCT02530489|Paclitaxel|paclitaxel|mesh-list
14079090|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14079091|NCT02530489|Atezolizumab|atezolizumab|mesh-list
14079092|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14079093|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14079094|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079095|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14079096|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14079097|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14079098|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079099|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
14079100|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079101|NCT02530359|Pirfenidone|pirfenidone|mesh-list
14079102|NCT02530359|Analgesics|analgesics|mesh-ancestor
14079103|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
14079104|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079105|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079106|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14079107|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14079108|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079109|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079110|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079111|NCT02530320|Palbociclib|palbociclib|mesh-list
14079112|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079113|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14079114|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079115|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079116|NCT02529982|Curcumin|curcumin|mesh-list
14079117|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14079118|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14079119|NCT02529982|Analgesics|analgesics|mesh-ancestor
14079120|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
14079121|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079122|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079123|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079124|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079125|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079126|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079127|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079128|NCT02530060|Tenofovir|tenofovir|mesh-list
14079129|NCT02530060|Emtricitabine|emtricitabine|mesh-list
14079130|NCT02530060|Rilpivirine|rilpivirine|mesh-list
14079131|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
14079132|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079133|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14079134|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14079135|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079136|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079137|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14079138|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14079139|NCT02530047|Interferons|interferons|mesh-list
14079140|NCT02530047|Interferon-beta|interferon-beta|mesh-list
14079141|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079142|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
14079143|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079144|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
14079145|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079146|NCT02529969|Curcumin|curcumin|mesh-list
14079147|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14079148|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14079149|NCT02529969|Analgesics|analgesics|mesh-ancestor
14079150|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
14079151|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934661|NCT01458015|Narcotics|narcotics|mesh-ancestor
14079152|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079153|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476750|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476751|NCT02420041|Triamcinolone|triamcinolone|mesh-list
14476752|NCT02420041|Lidocaine|lidocaine|mesh-list
14476753|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
13915899|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13915900|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
13915901|NCT03468790|Hormones|hormones|mesh-ancestor
13915902|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13915903|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13915904|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13915905|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13915906|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
13915907|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915908|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915909|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
13915910|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13915911|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
14079154|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079155|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079156|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079157|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079158|NCT02529878|Paclitaxel|paclitaxel|mesh-list
14079159|NCT02529878|Apatinib|apatinib|mesh-list
14079160|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14079161|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079162|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
14079163|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
14079164|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
14079165|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079166|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14079167|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079168|NCT02529852|Prednisone|prednisone|mesh-list
14079169|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
14079170|NCT02529852|Doxorubicin|doxorubicin|mesh-list
14079171|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14079172|NCT02529852|Vincristine|vincristine|mesh-list
14079173|NCT02529852|Lenalidomide|lenalidomide|mesh-list
14079174|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
14079175|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079176|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
14079177|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079178|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079179|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14079180|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
14079181|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079182|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079183|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14079184|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14079185|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13915912|NCT03468777|Lansoprazole|lansoprazole|mesh-list
13915913|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
13915914|NCT03468777|Ranitidine|ranitidine|mesh-list
13915915|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
13915916|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13915917|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13915918|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13915919|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915920|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915921|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13915922|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
14079186|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14079187|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079188|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079189|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
14079190|NCT02529852|Hormones|hormones|mesh-ancestor
14079191|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079192|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14079193|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14079194|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14079195|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14079196|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14079197|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14079198|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14079199|NCT02529852|Growth Substances|growth substances|mesh-ancestor
14079200|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
14079201|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14079202|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
14079203|NCT02529839|Fludarabine|fludarabine|mesh-list
14079204|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
14079205|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079206|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
14079207|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915923|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
14079208|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079209|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14079210|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
14079211|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079212|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079213|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14079214|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14079215|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
14079216|NCT02529787|Lansoprazole|lansoprazole|mesh-list
14079217|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14079218|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14079219|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14079220|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079221|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079222|NCT02529774|Leucovorin|leucovorin|mesh-list
14079223|NCT02529774|Dexamethasone|dexamethasone|mesh-list
14079224|NCT02529774|Capecitabine|capecitabine|mesh-list
14079225|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
14079226|NCT02529774|Fluorouracil|fluorouracil|mesh-list
14079227|NCT02529774|Floxuridine|floxuridine|mesh-list
14079228|NCT02529774|Heparin|heparin|mesh-list
14079229|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
14079230|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079231|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
14079232|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
14079233|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079234|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079235|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14079236|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
14079237|NCT02529774|Hormones|hormones|mesh-ancestor
14079238|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079239|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14079240|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079241|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079242|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
14079243|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079244|NCT02529774|Antidotes|antidotes|mesh-ancestor
14079245|NCT02529774|Protective Agents|protective agents|mesh-ancestor
14079246|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
14079247|NCT02529774|Vitamins|vitamins|mesh-ancestor
14079248|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
14079249|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079250|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
14079251|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
14079252|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14079253|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14079254|NCT02529514|Baclofen|baclofen|mesh-list
14079255|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13915924|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915925|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915926|NCT03468595|Listerine|listerine|mesh-list
13915927|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13915928|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915929|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
13915930|NCT03468478|Sirolimus|sirolimus|mesh-list
13915931|NCT03468478|Everolimus|everolimus|mesh-list
13915932|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915933|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079256|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079257|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13915934|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
13915935|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079258|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079259|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14079260|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
14079261|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
14079262|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079263|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079264|NCT02529579|Gemcitabine|gemcitabine|mesh-list
14079265|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079266|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
14079267|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079268|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079269|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
14079270|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079271|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079272|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079273|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
14079274|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079275|NCT02529540|Methamphetamine|methamphetamine|mesh-list
14079276|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14079277|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079278|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
14079279|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
14079280|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079281|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
14079282|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079283|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079284|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14079285|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14079286|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14079287|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14079288|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14173404|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14173405|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173406|NCT04799184|Epinephrine|epinephrine|mesh-list
14173407|NCT04799184|Racepinephrine|racepinephrine|mesh-list
14173408|NCT04799184|Bupivacaine|bupivacaine|mesh-list
14173409|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
14173410|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
14173411|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
14173412|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
14173413|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173414|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173415|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
14173416|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173417|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14173418|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14173419|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
14173420|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173421|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173422|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14173423|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14173424|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
14173425|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14173426|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
14173427|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
14173428|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
14173429|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14173430|NCT04798703|Paclitaxel|paclitaxel|mesh-list
14173431|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
14173432|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14173433|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173434|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
14173435|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
14173436|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
14173437|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173438|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14173439|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
14173440|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934662|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934663|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934664|NCT01458015|Analgesics|analgesics|mesh-ancestor
14934665|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
14173441|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
14934666|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079289|NCT02529631|Orlistat|orlistat|mesh-list
14079290|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079291|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079292|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14079293|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14079294|NCT02529670|Lidocaine|lidocaine|mesh-list
14079295|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
14079296|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
14079297|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079298|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079299|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
14079300|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079301|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14079302|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14079303|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14079304|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14079305|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079306|NCT02529683|NuvaRing|nuvaring|mesh-list
14079307|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14079308|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
14079309|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14079310|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079311|NCT02529761|Sorafenib|sorafenib|mesh-list
14079312|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079313|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14079314|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079315|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079316|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
14079317|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14079318|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079319|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14079320|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079321|NCT02529124|Caseins|caseins|mesh-list
14079322|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
14079323|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
14079324|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079325|NCT02529059|Tenofovir|tenofovir|mesh-list
14079326|NCT02529059|Emtricitabine|emtricitabine|mesh-list
14079327|NCT02529059|Rilpivirine|rilpivirine|mesh-list
14079328|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
14079329|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079330|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14079331|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14079332|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079333|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079334|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14079335|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14079336|NCT02529241|Delpazolid|delpazolid|mesh-list
14079337|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
14079338|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079339|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079340|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14079341|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079342|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079343|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
14079344|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14079345|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079346|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079347|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14079348|NCT02529202|Analgesics|analgesics|mesh-ancestor
14079349|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
14079350|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079351|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14079352|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14079353|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14079354|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
14079355|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079356|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079357|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
14079358|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14079359|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079360|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14079361|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079362|NCT02528877|Sirolimus|sirolimus|mesh-list
14079363|NCT02528877|Fludarabine|fludarabine|mesh-list
14079364|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
14079365|NCT02528877|Melphalan|melphalan|mesh-list
14079366|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
14079367|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14079368|NCT02528877|Tacrolimus|tacrolimus|mesh-list
14079369|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079370|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079371|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
14079372|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079373|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079374|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
14079375|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079376|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14079377|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079378|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079379|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079380|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14079381|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
14079382|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14079383|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
14079384|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14079385|NCT02528682|Vaccines|vaccines|mesh-list
14079386|NCT02528682|Immunologic Factors|immunologic factors|mesh-ancestor
14079387|NCT02528682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079388|NCT02528825|Remifentanil|remifentanil|mesh-list
14079389|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14079390|NCT02528825|Narcotics|narcotics|mesh-ancestor
14079391|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079392|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079393|NCT02528825|Analgesics|analgesics|mesh-ancestor
14079394|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
14079395|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079396|NCT02528760|Erythromycin|erythromycin|mesh-list
14079397|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
14079398|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14079399|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
14079400|NCT02528760|Metoclopramide|metoclopramide|mesh-list
14079401|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
14079402|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
14079403|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079404|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079405|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14079406|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14079407|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14079408|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
14079409|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079410|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079411|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079412|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079413|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14079414|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079415|NCT02528526|Inositol|inositol|mesh-list
14079416|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
14079417|NCT02528526|Vitamins|vitamins|mesh-ancestor
14079418|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
14079419|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079420|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
14079421|NCT02528461|Liver Extracts|liver extracts|mesh-list
14079422|NCT02528461|Hematinics|hematinics|mesh-ancestor
14079423|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
14079424|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079425|NCT02528513|Fentanyl|fentanyl|mesh-list
14079426|NCT02528513|Midazolam|midazolam|mesh-list
14079427|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
14079428|NCT02528513|Propofol|propofol|mesh-list
14079429|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14079430|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079431|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079432|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14079433|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
14079434|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
14079435|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14079436|NCT02528513|Analgesics|analgesics|mesh-ancestor
14079437|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
14079438|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079439|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14079440|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14079441|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14079442|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
14079443|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079444|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079445|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14079446|NCT02528513|Narcotics|narcotics|mesh-ancestor
14079447|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14934667|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14934668|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14934669|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14934670|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934671|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934672|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934673|NCT01458041|Iloprost|iloprost|mesh-list
14934674|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934675|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
14934676|NCT01458054|Ritonavir|ritonavir|mesh-list
14079448|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14079449|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14079450|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14079451|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
14079452|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
14079453|NCT02528175|Capecitabine|capecitabine|mesh-list
14079454|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14934677|NCT01458054|Omeprazole|omeprazole|mesh-list
14934678|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14079455|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
14079456|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079457|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079458|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
14079459|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14079460|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079461|NCT02528201|Celecoxib|celecoxib|mesh-list
14079462|NCT02528201|Diclofenac|diclofenac|mesh-list
14079463|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14079464|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14079465|NCT02528201|Analgesics|analgesics|mesh-ancestor
14079466|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
14079467|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079468|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079469|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079470|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079471|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14079472|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14079473|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079474|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079475|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14079476|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14079477|NCT02528383|Estradiol|estradiol|mesh-list
14079478|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14079479|NCT02528383|Estrogens|estrogens|mesh-ancestor
14079480|NCT02528383|Hormones|hormones|mesh-ancestor
14079481|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079482|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079483|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14079484|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
14079485|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14079486|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14079487|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14079488|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
14079489|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14079490|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14079491|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934679|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14934680|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
14934681|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934682|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934683|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14934684|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14934685|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
14934686|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934687|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14934688|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14934689|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14934690|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14934691|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14934692|NCT01458067|GSK2636771|gsk2636771|mesh-list
14934693|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934694|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13915936|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13915937|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13915938|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
14934695|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934696|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934697|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13915939|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13915940|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915941|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915942|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915943|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
13915944|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
14079492|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
14079493|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14079494|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14079495|NCT02528136|Oxytocin|oxytocin|mesh-list
14079496|NCT02528136|Carbetocin|carbetocin|mesh-list
14079497|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
14079498|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14079499|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079500|NCT02528123|Tobramycin|tobramycin|mesh-list
14079501|NCT02528123|Ofloxacin|ofloxacin|mesh-list
14079502|NCT02528123|Dexamethasone|dexamethasone|mesh-list
14079503|NCT02528123|Benoxinate|benoxinate|mesh-list
14079504|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
14079505|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079506|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
14079507|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
14079508|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079509|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079510|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14079511|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
14079512|NCT02528123|Hormones|hormones|mesh-ancestor
14079513|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079514|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14079515|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079516|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079517|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079518|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14079519|NCT02528123|Renal Agents|renal agents|mesh-ancestor
14079520|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14079521|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14934698|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14934699|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934700|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
14934701|NCT01458236|Beraprost|beraprost|mesh-list
14934702|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934703|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
14934704|NCT01458301|Leuprolide|leuprolide|mesh-list
14934705|NCT01458301|Relugolix|relugolix|mesh-list
14079522|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934706|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14079523|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079524|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14173442|NCT04798703|Protective Agents|protective agents|mesh-ancestor
14079525|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14079526|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
14079527|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
14079528|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079529|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
14079530|NCT02528019|Glimepiride|glimepiride|mesh-list
14079531|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14079532|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14079533|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14079534|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079535|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079536|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
14079537|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173443|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
14173444|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173445|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
14173446|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
14173447|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
14173448|NCT04798638|Osimertinib|osimertinib|mesh-list
14173449|NCT04798638|Complement Factor H|complement factor h|mesh-list
14173450|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173451|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173452|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13915945|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13915946|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13915947|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
13915948|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915949|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915950|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915951|NCT03468465|Urological Agents|urological agents|mesh-ancestor
13915952|NCT03468439|Phenol|phenol|mesh-list
13915953|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13915954|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13915955|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
13915956|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13915957|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13915958|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13915959|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13915960|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13915961|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13915962|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915963|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13915964|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915965|NCT03468348|Analgesics|analgesics|mesh-ancestor
13915966|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
14173453|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173454|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14079538|NCT02527941|Metronidazole|metronidazole|mesh-list
14079539|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079540|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079541|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14079542|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14079543|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14079544|NCT02527993|Liraglutide|liraglutide|mesh-list
14079545|NCT02527993|Acarbose|acarbose|mesh-list
14079546|NCT02527993|Verapamil|verapamil|mesh-list
14079547|NCT02527993|Pasireotide|pasireotide|mesh-list
14079548|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14079549|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079550|NCT02527993|Incretins|incretins|mesh-ancestor
14079551|NCT02527993|Hormones|hormones|mesh-ancestor
14079552|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079553|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14079554|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
14079555|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079556|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079557|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14079558|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14079559|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14079560|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14079561|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14079562|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
14079563|NCT02527733|Ranibizumab|ranibizumab|mesh-list
14079564|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14079565|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14079566|NCT02527733|Growth Substances|growth substances|mesh-ancestor
14079567|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915967|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915968|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
13915969|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13915970|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
13915971|NCT03468335|Irinotecan|irinotecan|mesh-list
13915972|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13915973|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13915974|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079568|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
13960094|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
14079569|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079570|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
14079571|NCT02527746|Epirubicin|epirubicin|mesh-list
14079572|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079573|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
14079574|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079575|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079576|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14079577|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
14079578|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079579|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079580|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14079581|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14079582|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14079583|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14079584|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079585|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
14079586|NCT02527785|Irinotecan|irinotecan|mesh-list
14079587|NCT02527785|Tegafur|tegafur|mesh-list
14079588|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079589|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14079590|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14079591|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079592|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079593|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079594|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
14079595|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
14079596|NCT02527824|Irinotecan|irinotecan|mesh-list
14079597|NCT02527824|Tegafur|tegafur|mesh-list
14079598|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079599|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14079600|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14079601|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079602|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079603|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079604|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
14079605|NCT02527811|Urinastatin|urinastatin|mesh-list
14079606|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
14079607|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14476754|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
14476755|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476756|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476757|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
14476758|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079608|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
14079609|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079610|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079611|NCT02527863|Tolvaptan|tolvaptan|mesh-list
14079612|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14079613|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079614|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
14079615|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079616|NCT02527772|Leucovorin|leucovorin|mesh-list
14476759|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14476760|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14476761|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14476762|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476763|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476764|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476765|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
14476766|NCT02420041|Hormones|hormones|mesh-ancestor
14476767|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476768|NCT02420210|Dexamethasone|dexamethasone|mesh-list
14476769|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14476770|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
14476771|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476772|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
14476773|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
14079617|NCT02527772|Gemcitabine|gemcitabine|mesh-list
14079618|NCT02527772|Fluorouracil|fluorouracil|mesh-list
14079619|NCT02527772|Doxorubicin|doxorubicin|mesh-list
14079620|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14079621|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
14079622|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079623|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
14079624|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079625|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079626|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
14079627|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079628|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079629|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079630|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
14079631|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079632|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14079633|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14079634|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14079635|NCT02527772|Antidotes|antidotes|mesh-ancestor
14079636|NCT02527772|Protective Agents|protective agents|mesh-ancestor
14079637|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
14079638|NCT02527772|Vitamins|vitamins|mesh-ancestor
14079639|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
14079640|NCT02527668|Vitamin D|vitamin d|mesh-list
14079641|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
14079642|NCT02527668|Calcifediol|calcifediol|mesh-list
14079643|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14079644|NCT02527668|Vitamins|vitamins|mesh-ancestor
14079645|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
14079646|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079647|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14079648|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14079649|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14079650|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14079651|NCT02527603|Analgesics|analgesics|mesh-ancestor
14079652|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
14759322|NCT04865289|Paclitaxel|paclitaxel|mesh-list
14759323|NCT04865289|Carboplatin|carboplatin|mesh-list
14759324|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
14759325|NCT04865289|Lenvatinib|lenvatinib|mesh-list
14759326|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759327|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759328|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759329|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759330|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759331|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759332|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759333|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759334|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759335|NCT04865237|Remdesivir|remdesivir|mesh-list
14759336|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
14759337|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759338|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
14759339|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759340|NCT04862650|Paclitaxel|paclitaxel|mesh-list
13915975|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915976|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915977|NCT03468296|Aflibercept|aflibercept|mesh-list
13915978|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13915979|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13915980|NCT03468296|Growth Substances|growth substances|mesh-ancestor
13915981|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915982|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
14079653|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079654|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079655|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14759341|NCT04862650|Carboplatin|carboplatin|mesh-list
14079656|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079657|NCT02527564|Suvorexant|suvorexant|mesh-list
14079658|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14079659|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14079660|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13915983|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915984|NCT03468231|Leucovorin|leucovorin|mesh-list
14079661|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079662|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14079663|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079664|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079665|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14079666|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079667|NCT02527577|Ropivacaine|ropivacaine|mesh-list
14079668|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
14079669|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
14079670|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079671|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079672|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
14079673|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079674|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
14079675|NCT02527213|Antidotes|antidotes|mesh-ancestor
14079676|NCT02527213|Protective Agents|protective agents|mesh-ancestor
14079677|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079678|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
14079679|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079680|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
14079681|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079682|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079683|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
14079684|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
14079685|NCT02527174|Cytarabine|cytarabine|mesh-list
14079686|NCT02527174|Idarubicin|idarubicin|mesh-list
13915985|NCT03468231|Fluorouracil|fluorouracil|mesh-list
13915986|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
14079687|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079688|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
14079689|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079690|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079691|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
14079692|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079693|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079694|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
14079695|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079696|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14079697|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14079698|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14079699|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079700|NCT02527109|Nifedipine|nifedipine|mesh-list
14476774|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13915987|NCT03468231|Sorafenib|sorafenib|mesh-list
13915988|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
13915989|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13915990|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13915991|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13915992|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13915993|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
13915994|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13915995|NCT03468231|Antidotes|antidotes|mesh-ancestor
14079701|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14079702|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14079703|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079704|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14079705|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079706|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
14079707|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
14079708|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14079709|NCT02527096|Lamivudine|lamivudine|mesh-list
14079710|NCT02527096|Dolutegravir|dolutegravir|mesh-list
14079711|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14079712|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14079713|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079714|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079715|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
14079716|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079717|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14079718|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14079719|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14079720|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14079721|NCT02527083|Ketamine|ketamine|mesh-list
14079722|NCT02527083|Remifentanil|remifentanil|mesh-list
14079723|NCT02527083|Propofol|propofol|mesh-list
14079724|NCT02527083|Sevoflurane|sevoflurane|mesh-list
14079725|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14079726|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079727|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079728|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14079729|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
14079730|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
14079731|NCT02527083|Analgesics|analgesics|mesh-ancestor
13915996|NCT03468231|Protective Agents|protective agents|mesh-ancestor
13915997|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
13915998|NCT03468231|Vitamins|vitamins|mesh-ancestor
13915999|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
13916000|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13916001|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916002|NCT03468140|Eculizumab|eculizumab|mesh-list
13916003|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
13916004|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916005|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
13916006|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916007|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
13916008|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13916009|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916010|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079732|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
14079733|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079734|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14759342|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14759343|NCT04862650|Cemiplimab|cemiplimab|mesh-list
14759344|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14079735|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14079736|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14079737|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079738|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079739|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14079740|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14079741|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14079742|NCT02527083|Narcotics|narcotics|mesh-ancestor
14079743|NCT02526888|Diltiazem|diltiazem|mesh-list
14079744|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14079745|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14079746|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14079747|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079748|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14079749|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079750|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
14079751|NCT02526914|Vasopressins|vasopressins|mesh-list
14079752|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
14079753|NCT02526914|Oxytocin|oxytocin|mesh-list
13916011|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916012|NCT03468062|Analgesics|analgesics|mesh-ancestor
13916013|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
13916014|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916015|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13916016|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13916017|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14079754|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
14079755|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14079756|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079757|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
14079758|NCT02526914|Coagulants|coagulants|mesh-ancestor
14079759|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14079760|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14079761|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
14079762|NCT02527005|Azithromycin|azithromycin|mesh-list
14079763|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
14079764|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
14079765|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14079766|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079767|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079768|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
14476775|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476776|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476777|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
14476778|NCT02420210|Hormones|hormones|mesh-ancestor
14476779|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476780|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759345|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916018|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14079769|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14079770|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14079771|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14079772|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079773|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079774|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14079775|NCT02527005|Renal Agents|renal agents|mesh-ancestor
14079776|NCT02526953|Paclitaxel|paclitaxel|mesh-list
14079777|NCT02526953|Capecitabine|capecitabine|mesh-list
14079778|NCT02526953|Mitomycins|mitomycins|mesh-list
14079779|NCT02526953|Mitomycin|mitomycin|mesh-list
14079780|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14079781|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079782|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14079783|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14079784|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14079785|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079786|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14079787|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
14079788|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14079789|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
14079790|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14079791|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14079792|NCT02526979|Mirabegron|mirabegron|mesh-list
14079793|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14079794|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14079795|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14079796|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
14079797|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079798|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079799|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079800|NCT02526979|Urological Agents|urological agents|mesh-ancestor
14079801|NCT02526875|Amlodipine|amlodipine|mesh-list
14079802|NCT02526875|Telmisartan|telmisartan|mesh-list
14079803|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14079804|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14079805|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14079806|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079807|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14079808|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079809|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
14079810|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14079811|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14079812|NCT02526810|Insulin|insulin|mesh-list
14079813|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14079814|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
14079815|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
14079816|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14079817|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079818|NCT02526758|Budesonide|budesonide|mesh-list
14079819|NCT02526758|Beclomethasone|beclomethasone|mesh-list
14079820|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
14079821|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079822|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14079823|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
14079824|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079825|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079826|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14079827|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14079828|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
14079829|NCT02526758|Hormones|hormones|mesh-ancestor
14079830|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079831|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14079832|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14079833|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14079834|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14079835|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079836|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079837|NCT02526615|Metformin|metformin|mesh-list
14079838|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
14079839|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14079840|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079841|NCT02526745|Vaccines|vaccines|mesh-list
14079842|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
14079843|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079844|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
14079845|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14079846|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079847|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
14079848|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14079849|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
14079850|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173455|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173456|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
14173457|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183453|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
14183454|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
14183455|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14183456|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14183457|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14183458|NCT04728035|Irinotecan|irinotecan|mesh-list
14183459|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14183460|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14183461|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183462|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183463|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183464|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14183465|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14184230|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14079851|NCT02526303|Nadroparin|nadroparin|mesh-list
14079852|NCT02526303|Warfarin|warfarin|mesh-list
14079853|NCT02526303|Calcium|calcium|mesh-list
14079854|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14079855|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079856|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
14079857|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14079858|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14079859|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079860|NCT02526394|Vaccines|vaccines|mesh-list
14079861|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
14079862|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079863|NCT02526004|Tobramycin|tobramycin|mesh-list
14079864|NCT02526004|Ceftazidime|ceftazidime|mesh-list
14079865|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14079866|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14079867|NCT02525991|Loxapine|loxapine|mesh-list
14079868|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14079869|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14079870|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079871|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079872|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14079873|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14079874|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
14079875|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079876|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079877|NCT02526199|Dexamethasone|dexamethasone|mesh-list
14079878|NCT02526199|Epinephrine|epinephrine|mesh-list
14079879|NCT02526199|Bupivacaine|bupivacaine|mesh-list
14079880|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079881|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
14079882|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
14079883|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079884|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079885|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14079886|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
14079887|NCT02526199|Hormones|hormones|mesh-ancestor
14079888|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079889|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14079890|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079891|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
14079892|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
14079893|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079894|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
14079895|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14079896|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14079897|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
14759346|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
13916019|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916020|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916021|NCT03468023|Calpastatin|calpastatin|mesh-list
13916022|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13916023|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
13916024|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916025|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916026|NCT03468010|Paclitaxel|paclitaxel|mesh-list
13916027|NCT03468010|Cisplatin|cisplatin|mesh-list
13916028|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13916029|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916030|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14079898|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079899|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079900|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14079901|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14173458|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14079902|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14079903|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
14079904|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
14759347|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
13916031|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759348|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759349|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916032|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
13916033|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916034|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13916035|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
13916036|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916037|NCT03467932|Insulin|insulin|mesh-list
13916038|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13916039|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13916040|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916041|NCT03467893|Antacids|antacids|mesh-list
13916042|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916043|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13916044|NCT03467750|Ketorolac|ketorolac|mesh-list
13916045|NCT03467750|Morphine|morphine|mesh-list
13916046|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13916047|NCT03467750|Narcotics|narcotics|mesh-ancestor
13916048|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916049|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916050|NCT03467750|Analgesics|analgesics|mesh-ancestor
13916051|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
13916052|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079905|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
14079906|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14079907|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14079908|NCT02526030|Aripiprazole|aripiprazole|mesh-list
14079909|NCT02526030|Ziprasidone|ziprasidone|mesh-list
14079910|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
14079911|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14079912|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14079913|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14079914|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079915|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079916|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
14079917|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
14079918|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079919|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079920|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14079921|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14079922|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
14759350|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759351|NCT04860830|BI 425809|bi 425809|mesh-list
14759352|NCT04860830|Nootropic Agents|nootropic agents|mesh-ancestor
13916053|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13916054|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916055|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916056|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916057|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13916058|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916059|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916060|NCT03467620|Cannabidiol|cannabidiol|mesh-list
13916061|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
14079923|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14079924|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14079925|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14079926|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14079927|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
14079928|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14079929|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14079930|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
13960095|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960096|NCT03157791|Simethicone|simethicone|mesh-list
13960097|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
13960098|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960099|NCT03157791|Emollients|emollients|mesh-ancestor
13960100|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960101|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
13960102|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960103|NCT03157479|Anesthetics|anesthetics|mesh-list
13960104|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
13960105|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079931|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079932|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14079933|NCT02525848|Dexamethasone|dexamethasone|mesh-list
14759353|NCT04851613|Fulvestrant|fulvestrant|mesh-list
14079934|NCT02525848|Gabapentin|gabapentin|mesh-list
14079935|NCT02525848|Aprepitant|aprepitant|mesh-list
14079936|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079937|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
14079938|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
14079939|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079940|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079941|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14079942|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
14079943|NCT02525848|Hormones|hormones|mesh-ancestor
14079944|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14079945|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14079946|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079947|NCT02525848|Analgesics|analgesics|mesh-ancestor
14079948|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
14079949|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
14079950|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14079951|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14079952|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079953|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14079954|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14079955|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14079956|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14079957|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14079958|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
14079959|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14079960|NCT02525822|Tazarotene|tazarotene|mesh-list
14079961|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
14079962|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
14079963|NCT02525484|Pirfenidone|pirfenidone|mesh-list
14079964|NCT02525484|Analgesics|analgesics|mesh-ancestor
14079965|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
14079966|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079967|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079968|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14079969|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14079970|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14079971|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079972|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079973|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14079974|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
14079975|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934707|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
14934708|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13916062|NCT03467438|Polaprezinc|polaprezinc|mesh-list
13916063|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13916064|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13916065|NCT03467334|Simethicone|simethicone|mesh-list
13916066|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
13916067|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916068|NCT03467334|Emollients|emollients|mesh-ancestor
13916069|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916070|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
13916071|NCT03467256|Fludarabine|fludarabine|mesh-list
14934709|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934710|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14934711|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934712|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
14934713|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
14934714|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934715|NCT01458431|Anesthetics|anesthetics|mesh-list
14934716|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
14934717|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
14934718|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934719|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934720|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
14934721|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934722|NCT01458470|Memantine|memantine|mesh-list
14934723|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14934724|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14934725|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
14934726|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934727|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934728|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916072|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14079976|NCT02525211|Ropivacaine|ropivacaine|mesh-list
14079977|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14079978|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
14079979|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14079980|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079981|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
14079982|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14079983|NCT02525172|Rituximab|rituximab|mesh-list
14079984|NCT02525172|Methotrexate|methotrexate|mesh-list
14079985|NCT02525172|Bortezomib|bortezomib|mesh-list
14079986|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
14079987|NCT02525172|Antibodies|antibodies|mesh-list
14079988|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
14079989|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14079990|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14079991|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14079992|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14079993|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
14079994|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14079995|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14079996|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14079997|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
14079998|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14079999|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14080000|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
14080001|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080002|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
14080003|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080004|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14080005|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14080006|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14080007|NCT02525250|Lenalidomide|lenalidomide|mesh-list
14080008|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
14080009|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080010|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14080011|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14080012|NCT02525250|Growth Substances|growth substances|mesh-ancestor
14080013|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
14080014|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080015|NCT02525237|Apatinib|apatinib|mesh-list
14080016|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080017|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14080018|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080019|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080020|NCT02525276|Hormones|hormones|mesh-list
14080021|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080022|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080023|NCT02525302|Halofuginone|halofuginone|mesh-list
14080024|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080025|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
14080026|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14080027|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14080028|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080029|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14080030|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080031|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080032|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14080033|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14080034|NCT02525302|Growth Substances|growth substances|mesh-ancestor
14080035|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080036|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
14080037|NCT02525081|Ramipril|ramipril|mesh-list
14080038|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14080039|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
14080040|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080041|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080042|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14080043|NCT02525016|Lidocaine|lidocaine|mesh-list
14080044|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
14080045|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
14080046|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080047|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080048|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
14080049|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080050|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080051|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14080052|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14080053|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080054|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080055|NCT02525003|Vitamin D|vitamin d|mesh-list
14080056|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
14080057|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
14080058|NCT02525003|Vitamins|vitamins|mesh-list
14080059|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
14080060|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080061|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14080062|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14080063|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14080064|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
14080065|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14080066|NCT02525458|Protective Agents|protective agents|mesh-ancestor
14080067|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080068|NCT02524899|Guanfacine|guanfacine|mesh-list
14080069|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14080070|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14080071|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14080072|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14080073|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14080074|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080075|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080076|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080077|NCT02524964|Tanshinone|tanshinone|mesh-list
14080078|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080079|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14080080|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080081|NCT02524964|Analgesics|analgesics|mesh-ancestor
14080082|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
14080083|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080084|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080085|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080086|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080087|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
14080088|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14080089|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080090|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14080091|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
14080092|NCT02524821|Metformin|metformin|mesh-list
14080093|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14080094|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080095|NCT02524743|Acetaminophen|acetaminophen|mesh-list
14080096|NCT02524743|Lidocaine|lidocaine|mesh-list
14080097|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
14080098|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
14080099|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080100|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080101|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
14080102|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080103|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080104|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14080105|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14080106|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080107|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080108|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080109|NCT02524743|Analgesics|analgesics|mesh-ancestor
14080110|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
14173459|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
14173460|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173461|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
14173462|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14173463|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
14173464|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173465|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
14173466|NCT04798443|Protective Agents|protective agents|mesh-ancestor
14173467|NCT04798313|Denosumab|denosumab|mesh-list
14173468|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14173469|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173470|NCT04798287|Adalimumab|adalimumab|mesh-list
14173471|NCT04798287|Etanercept|etanercept|mesh-list
14173472|NCT04798287|Golimumab|golimumab|mesh-list
14173473|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14173474|NCT04798287|Infliximab|infliximab|mesh-list
14173475|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
14173476|NCT04798287|Tofacitinib|tofacitinib|mesh-list
14173477|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173478|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173479|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
14173480|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173481|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173482|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173483|NCT04798287|Analgesics|analgesics|mesh-ancestor
14173484|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
14173485|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173486|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173487|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173488|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
14173489|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173490|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173491|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173492|NCT04798391|Dexamethasone|dexamethasone|mesh-list
14173493|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173494|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
14173495|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
14173496|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173497|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173498|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173499|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
14173500|NCT04798391|Hormones|hormones|mesh-ancestor
14173501|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080111|NCT02524652|Ropivacaine|ropivacaine|mesh-list
14080112|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
14080113|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
14080114|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080115|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080116|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
14080117|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080118|NCT02524639|Sirolimus|sirolimus|mesh-list
14080119|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14080120|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080121|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14080122|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080123|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
14080124|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14080125|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
14080126|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080127|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
14080128|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
14080129|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14080130|NCT02524444|Mefloquine|mefloquine|mesh-list
14080131|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
14080132|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14080133|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14080134|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080135|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14080136|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080137|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080138|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14080139|NCT02524444|Renal Agents|renal agents|mesh-ancestor
14080140|NCT02524405|Corticosterone|corticosterone|mesh-list
14080141|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080142|NCT02524379|Glyburide|glyburide|mesh-list
14080143|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13916073|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
13916074|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916075|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916076|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13916077|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
13916078|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080144|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080145|NCT02524301|Diprenorphine|diprenorphine|mesh-list
14080146|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14080147|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934729|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14934730|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14934731|NCT01458548|Rituximab|rituximab|mesh-list
14934732|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14934733|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934734|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
14934735|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916079|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916080|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13916081|NCT03467178|Gemcitabine|gemcitabine|mesh-list
13916082|NCT03467178|Paclitaxel|paclitaxel|mesh-list
13916083|NCT03467178|Carboplatin|carboplatin|mesh-list
13916084|NCT03467178|Doxorubicin|doxorubicin|mesh-list
13916085|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13916086|NCT03467178|Decitabine|decitabine|mesh-list
13916087|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13916088|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916089|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
14080148|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
14080149|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476781|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934736|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934737|NCT01458600|Diclofenac|diclofenac|mesh-list
13916090|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
13916091|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
14080150|NCT02524249|Caffeine|caffeine|mesh-list
14934738|NCT01458600|Propranolol|propranolol|mesh-list
14080151|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14080152|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080153|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14080154|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080155|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080156|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14080157|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14080158|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
13916092|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916093|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13916094|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
13916095|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
13916096|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916097|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916098|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916099|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
13916100|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916101|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13916102|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13916103|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14080159|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080160|NCT02524210|Omeprazole|omeprazole|mesh-list
14080161|NCT02524210|Rabeprazole|rabeprazole|mesh-list
14080162|NCT02524210|Dabigatran|dabigatran|mesh-list
14080163|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14080164|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080165|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14080166|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080167|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080168|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
14080169|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14080170|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
14080171|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
14080172|NCT02523820|Fluticasone|fluticasone|mesh-list
14080173|NCT02523820|Xhance|xhance|mesh-list
14080174|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080175|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14080176|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
14080177|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080178|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080179|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14080180|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
14080181|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
14080182|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14080183|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
14080184|NCT02523911|Simethicone|simethicone|mesh-list
14080185|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
14080186|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14080187|NCT02523911|Analgesics|analgesics|mesh-ancestor
14080188|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
13916104|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
14934739|NCT01458600|Metoprolol|metoprolol|mesh-list
14934740|NCT01458600|Methimazole|methimazole|mesh-list
14934741|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14934742|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14934743|NCT01458600|Analgesics|analgesics|mesh-ancestor
14934744|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
14934745|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934746|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934747|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14934748|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934749|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13916105|NCT03467022|Vitamins|vitamins|mesh-ancestor
14080189|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080190|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080191|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
14080192|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080193|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080194|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
14080195|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14080196|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080197|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080198|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14080199|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
14080200|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080201|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
14080202|NCT02523911|Emollients|emollients|mesh-ancestor
14080203|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
14080204|NCT02523911|Cathartics|cathartics|mesh-ancestor
14080205|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080206|NCT02523898|Metformin|metformin|mesh-list
14080207|NCT02523898|Clomiphene|clomiphene|mesh-list
14080208|NCT02523898|Enclomiphene|enclomiphene|mesh-list
14080209|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
14080210|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14080211|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080212|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14080213|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
14080214|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080215|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14080216|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
14080217|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080218|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14080219|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14080220|NCT02523768|Basiliximab|basiliximab|mesh-list
14080221|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14080222|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
14080223|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080224|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
14080225|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
14080226|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14080227|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14080228|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080229|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080230|NCT02524184|Urological Agents|urological agents|mesh-ancestor
14080231|NCT02523833|Albuterol|albuterol|mesh-list
14080232|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14080233|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
14080234|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934750|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934751|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934752|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14934753|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14934754|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934755|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934756|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14934757|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14934758|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
14934759|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
14934760|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
14934761|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14934762|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
14934763|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
14934764|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934765|NCT01458626|Mirtazapine|mirtazapine|mesh-list
14934766|NCT01458626|Paroxetine|paroxetine|mesh-list
14080235|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934767|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14080236|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14080237|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
14080238|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
14080239|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080240|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14080241|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14080242|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14080243|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
14080244|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080245|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080246|NCT02523859|Propofol|propofol|mesh-list
14080247|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14080248|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080249|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080250|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14080251|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
14080252|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
14080253|NCT02523846|Morphine|morphine|mesh-list
14080254|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14080255|NCT02523846|Narcotics|narcotics|mesh-ancestor
14080256|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080257|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080258|NCT02523846|Analgesics|analgesics|mesh-ancestor
14080259|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
14080260|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080261|NCT02523976|Cytarabine|cytarabine|mesh-list
14080262|NCT02523976|Dexamethasone|dexamethasone|mesh-list
14080263|NCT02523976|Prednisone|prednisone|mesh-list
14080264|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
14080265|NCT02523976|Methotrexate|methotrexate|mesh-list
14080266|NCT02523976|Etoposide|etoposide|mesh-list
14080267|NCT02523976|Vincristine|vincristine|mesh-list
14080268|NCT02523976|Daunorubicin|daunorubicin|mesh-list
14080269|NCT02523976|Dasatinib|dasatinib|mesh-list
14080270|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
14080271|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
14080272|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14080273|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
14080274|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080275|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080276|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14080277|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
14080278|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080279|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080280|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14080281|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080282|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
14080283|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
14080284|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080285|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080286|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
14080287|NCT02523976|Hormones|hormones|mesh-ancestor
14080288|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080289|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14080290|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14080291|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
14080292|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080293|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14080294|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
14080295|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
14080296|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080297|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14080298|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14080299|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14080300|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14080301|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14080302|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
14080303|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080304|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
14080305|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
14080306|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
14080307|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14080308|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14080309|NCT02523976|Analgesics|analgesics|mesh-ancestor
14080310|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
14080311|NCT02523755|Ropivacaine|ropivacaine|mesh-list
14080312|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
14080313|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
14934768|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14934769|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14934770|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080314|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080315|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080316|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
14080317|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080318|NCT02523547|Entecavir|entecavir|mesh-list
14080319|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
14080320|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080321|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
14080322|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14080323|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14080324|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080325|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080326|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080327|NCT02523638|Interferons|interferons|mesh-list
14080328|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
14080329|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
14080330|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080331|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
14080332|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080333|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
14080334|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080335|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
14080336|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080337|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
14080338|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
14080339|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080340|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
14080341|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
14080342|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080343|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080344|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080345|NCT02523300|Hormones|hormones|mesh-ancestor
14080346|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080347|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14080348|NCT02523300|Protective Agents|protective agents|mesh-ancestor
14080349|NCT02523131|Insulin|insulin|mesh-list
14080350|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14080351|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934771|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934772|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
13916106|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
13916107|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916108|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
13916109|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916110|NCT03467022|Protective Agents|protective agents|mesh-ancestor
13916111|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13916112|NCT03466983|Hematinics|hematinics|mesh-ancestor
13916113|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
13916114|NCT03466775|Giapreza|giapreza|mesh-list
13916115|NCT03466775|Antibodies|antibodies|mesh-list
13916116|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
13916117|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
13916118|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916119|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13916120|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14080352|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
14080353|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
14934773|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080354|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14080355|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080356|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080357|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080358|NCT02523144|Analgesics|analgesics|mesh-ancestor
14080359|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
14080360|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080361|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14080362|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14080363|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14080364|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
14080365|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080366|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080367|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14080368|NCT02523092|Hormones|hormones|mesh-ancestor
14080369|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080370|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173502|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14173503|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173504|NCT04798001|Vaccines|vaccines|mesh-list
14173505|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
14173506|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173507|NCT04797949|Aspirin|aspirin|mesh-list
14173508|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173509|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173510|NCT04797949|Analgesics|analgesics|mesh-ancestor
14173511|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
14173512|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173513|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173514|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173515|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173516|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14173517|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14173518|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173519|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14173520|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14173521|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173522|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
14173523|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
14173524|NCT04797832|Hematinics|hematinics|mesh-ancestor
14173525|NCT04797546|Morphine|morphine|mesh-list
14173526|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14759354|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759355|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759356|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14759357|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14759358|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
14759359|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759360|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759361|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
14759362|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759363|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916121|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
13916122|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916123|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916124|NCT03466749|Paclitaxel|paclitaxel|mesh-list
13916125|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13916126|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916127|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
13916128|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
13916129|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
13916130|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916131|NCT03466736|Flutemetamol|flutemetamol|mesh-list
13916132|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14080371|NCT02523053|Fluorouracil|fluorouracil|mesh-list
14080372|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
14080373|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080374|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14080375|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080376|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916133|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916134|NCT03466645|Vancomycin|vancomycin|mesh-list
13916135|NCT03466645|Cefazolin|cefazolin|mesh-list
14080377|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
14080378|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080379|NCT02522897|Ranibizumab|ranibizumab|mesh-list
14080380|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14080381|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14080382|NCT02522897|Growth Substances|growth substances|mesh-ancestor
14080383|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080384|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14080385|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080386|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
14080387|NCT02522975|Hematinics|hematinics|mesh-ancestor
14080388|NCT02522910|Docetaxel|docetaxel|mesh-list
14080389|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080390|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14080391|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14080392|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14080393|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080394|NCT02522858|Atropine|atropine|mesh-list
14080395|NCT02522858|Ephedrine|ephedrine|mesh-list
14080396|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
14080397|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14080398|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080399|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080400|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080401|NCT02522858|Analgesics|analgesics|mesh-ancestor
14080402|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
14080403|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080404|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14080405|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14080406|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14080407|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
14080408|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080409|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080410|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14080411|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080412|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14080413|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
14080414|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14080415|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
14080416|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
14759364|NCT04846868|BI 425809|bi 425809|mesh-list
14759365|NCT04846868|Nootropic Agents|nootropic agents|mesh-ancestor
14767459|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13916136|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13916137|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916138|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
13916139|NCT03466632|Propofol|propofol|mesh-list
13916140|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13916141|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916142|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916143|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13916144|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
14080417|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
14080418|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14080419|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14080420|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
14080421|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14080422|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
14080423|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13916145|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
13916146|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916147|NCT03466632|Analgesics|analgesics|mesh-ancestor
13916148|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
13916149|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080424|NCT02522754|Vaccines|vaccines|mesh-list
14080425|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
14080426|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080427|NCT02522936|Muramidase|muramidase|mesh-list
14080428|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080429|NCT02522650|Amiloride|amiloride|mesh-list
14080430|NCT02522650|Triamterene|triamterene|mesh-list
14080431|NCT02522650|Diuretics|diuretics|mesh-ancestor
14080432|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
14080433|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080434|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14080435|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14080436|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080437|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080438|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14080439|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14080440|NCT02522572|Plerixafor|plerixafor|mesh-list
14080441|NCT02522572|Bortezomib|bortezomib|mesh-list
14080442|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916150|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13916151|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13916152|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13916153|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916154|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916155|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916156|NCT03466567|Cyclosporine|cyclosporine|mesh-list
13916157|NCT03466567|Probenecid|probenecid|mesh-list
13916158|NCT03466567|Cyclosporins|cyclosporins|mesh-list
13916159|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916160|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916161|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916162|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
13916163|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476782|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14080443|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14080444|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14080445|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
14080446|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080447|NCT02522234|Lenograstim|lenograstim|mesh-list
14080448|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14080449|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
14080450|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080451|NCT02522221|Warfarin|warfarin|mesh-list
14080452|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
14080453|NCT02522169|Infliximab|infliximab|mesh-list
14080454|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
14080455|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080456|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080457|NCT02522208|Hydralazine|hydralazine|mesh-list
14080458|NCT02522208|Isosorbide|isosorbide|mesh-list
14080459|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14080460|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14080461|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14080462|NCT02522208|Diuretics|diuretics|mesh-ancestor
14080463|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
14080464|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080465|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
14080466|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14080467|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080468|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14080469|NCT02522078|Misoprostol|misoprostol|mesh-list
14080470|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14080471|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
14080472|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080473|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080474|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14080475|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080476|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
14080477|NCT02522117|Atorvastatin|atorvastatin|mesh-list
14080478|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14080479|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14080480|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
14080481|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080482|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14080483|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14080484|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080485|NCT02522130|Naproxen|naproxen|mesh-list
14080486|NCT02522130|Lidocaine|lidocaine|mesh-list
14080487|NCT02522130|Misoprostol|misoprostol|mesh-list
14080488|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
14080489|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
14080490|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080491|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080492|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
14080493|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080494|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080495|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14080496|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14080497|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080498|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080499|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14080500|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
14080501|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080502|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14080503|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080504|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
14080505|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14080506|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080507|NCT02522130|Analgesics|analgesics|mesh-ancestor
14080508|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080509|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080510|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
14080511|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14080512|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080513|NCT02522039|Timolol|timolol|mesh-list
14080514|NCT02522039|Dorzolamide|dorzolamide|mesh-list
14080515|NCT02522039|Latanoprost|latanoprost|mesh-list
14080516|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14080517|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14080518|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934774|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14934775|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
14934776|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14934777|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14934778|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14934779|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934780|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13916164|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
13916165|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916166|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
14934781|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
14934782|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
14934783|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14934784|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14934785|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916167|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934786|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13916168|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13916169|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
13916170|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
13916171|NCT03466567|Renal Agents|renal agents|mesh-ancestor
13916172|NCT03466528|Thiamine|thiamine|mesh-list
13916173|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
13916174|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
13916175|NCT03466528|Vitamins|vitamins|mesh-ancestor
14080519|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916176|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
13916177|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916178|NCT03466528|Analgesics|analgesics|mesh-ancestor
14080520|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080521|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934787|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14080522|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080523|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14080524|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14080525|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14080526|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14080527|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080528|NCT02522013|Aminophylline|aminophylline|mesh-list
14080529|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14080530|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
14080531|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080532|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080533|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14080534|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
14080535|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14080536|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14080537|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080538|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080539|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14080540|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14080541|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
14080542|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080543|NCT02522013|Protective Agents|protective agents|mesh-ancestor
14080544|NCT02521831|Bupivacaine|bupivacaine|mesh-list
14080545|NCT02521831|Anesthetics|anesthetics|mesh-list
14080546|NCT02521831|Isoflurane|isoflurane|mesh-list
14080547|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
14080548|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080549|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080550|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
14080551|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080552|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14080553|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
14080554|NCT02521714|Lenalidomide|lenalidomide|mesh-list
14080555|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
14080556|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080557|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14080558|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14080559|NCT02521714|Growth Substances|growth substances|mesh-ancestor
14080560|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
14080561|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934788|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14934789|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
14934790|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14934791|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14934792|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14934793|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14934794|NCT01458743|Cephalosporins|cephalosporins|mesh-list
14934795|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14934796|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934797|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14934798|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14934799|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14934800|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
14934801|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934802|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934803|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14934804|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14934805|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
14934806|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080562|NCT02521753|Metformin|metformin|mesh-list
14080563|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14080564|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080565|NCT02521662|Nicotine|nicotine|mesh-list
14080566|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14080567|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
14080568|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080569|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080570|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14080571|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14080572|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
14080573|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080574|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080575|NCT02521441|Lenograstim|lenograstim|mesh-list
14080576|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14080577|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
14080578|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080579|NCT02521415|Acetaminophen|acetaminophen|mesh-list
14080580|NCT02521415|Ibuprofen|ibuprofen|mesh-list
14080581|NCT02521415|Fentanyl|fentanyl|mesh-list
14080582|NCT02521415|Ketamine|ketamine|mesh-list
14080583|NCT02521415|Analgesics|analgesics|mesh-list
14080584|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
14080585|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080586|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080587|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14476783|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
14080588|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14080589|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
14934807|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
14934808|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14080590|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
14080591|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080592|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14080593|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14080594|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080595|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080596|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14080597|NCT02521415|Narcotics|narcotics|mesh-ancestor
14080598|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14080599|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080600|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
14080601|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14080602|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080603|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080604|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14080605|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080606|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14080607|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080608|NCT02521363|Taxane|taxane|mesh-list
14080609|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173527|NCT04797546|Narcotics|narcotics|mesh-ancestor
14173528|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173529|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173530|NCT04797546|Analgesics|analgesics|mesh-ancestor
14173531|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
14173532|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173533|NCT04797793|Adapalene|adapalene|mesh-list
14173534|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173535|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173536|NCT04797793|Analgesics|analgesics|mesh-ancestor
14173537|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
14173538|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173539|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173540|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173541|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173542|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
14759366|NCT04835805|Atezolizumab|atezolizumab|mesh-list
14759367|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173545|NCT04797338|Nafarelin|nafarelin|mesh-list
14173546|NCT04797338|Progesterone|progesterone|mesh-list
14173547|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14173548|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14173549|NCT04797338|Estradiol|estradiol|mesh-list
14173550|NCT04797338|Progestins|progestins|mesh-ancestor
14173551|NCT04797338|Hormones|hormones|mesh-ancestor
14759368|NCT04833855|Omalizumab|omalizumab|mesh-list
14080610|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14080611|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
14080612|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14080613|NCT02521298|Prednisolone|prednisolone|mesh-list
14759369|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14759370|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14759371|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14759372|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
14759373|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
13916179|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
13916180|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916181|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
13916182|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916183|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14759374|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759375|NCT04827576|Docetaxel|docetaxel|mesh-list
14759376|NCT04827576|Magrolimab|magrolimab|mesh-list
14759377|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759378|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759379|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759380|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759381|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759382|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759383|NCT04822337|Dexamethasone|dexamethasone|mesh-list
14759384|NCT04822337|Lenalidomide|lenalidomide|mesh-list
14759385|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759386|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
13916184|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
13916185|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13916186|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13916187|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916188|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13916189|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
13916190|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080614|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
14080615|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14080616|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
14080617|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080618|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
14080619|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
14080620|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080621|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080622|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080623|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
14080624|NCT02521298|Hormones|hormones|mesh-ancestor
14080625|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080626|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14080627|NCT02521298|Protective Agents|protective agents|mesh-ancestor
14080628|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14080629|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080630|NCT02521246|Losartan|losartan|mesh-list
14080631|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14080632|NCT02521246|Candesartan|candesartan|mesh-list
14759387|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
14080633|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
14767460|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
14080634|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
14080635|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080636|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14080637|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14080638|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14759388|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080639|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080640|NCT02521246|Diuretics|diuretics|mesh-ancestor
14080641|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
14080642|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080643|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14080644|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080645|NCT02521233|Losartan|losartan|mesh-list
14080646|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14080647|NCT02521233|Candesartan|candesartan|mesh-list
14080648|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
14080649|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
14080650|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080651|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14080652|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14080653|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14080654|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080655|NCT02521233|Diuretics|diuretics|mesh-ancestor
14080656|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
14080657|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080658|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14080659|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080660|NCT02521207|Ibuprofen|ibuprofen|mesh-list
14080661|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14080662|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080663|NCT02521207|Analgesics|analgesics|mesh-ancestor
14080664|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
14080665|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080666|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080667|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080668|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080669|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14080670|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080671|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080672|NCT02521051|Bevacizumab|bevacizumab|mesh-list
14080673|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14080674|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080675|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14080676|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14080677|NCT02521051|Growth Substances|growth substances|mesh-ancestor
14080678|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080679|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
14080680|NCT02521155|Fenbendazole|fenbendazole|mesh-list
14080681|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
14080682|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
14080683|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14080684|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080685|NCT02521064|Prednisone|prednisone|mesh-list
14080686|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080687|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
14080688|NCT02521064|Hormones|hormones|mesh-ancestor
14080689|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759389|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759390|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14759391|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
14759392|NCT04822337|Hormones|hormones|mesh-ancestor
14759393|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759394|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759395|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759396|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
14759397|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14759398|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14759399|NCT04822337|Growth Substances|growth substances|mesh-ancestor
14080690|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080691|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14080692|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080693|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
14080694|NCT02521077|Vitamins|vitamins|mesh-ancestor
14080695|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
14080696|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080697|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
14080698|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080699|NCT02521077|Protective Agents|protective agents|mesh-ancestor
14080700|NCT02521038|Ticagrelor|ticagrelor|mesh-list
14080701|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14080702|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14080703|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14080704|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14476784|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476785|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476786|NCT02420223|Propranolol|propranolol|mesh-list
14476787|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14476788|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14476789|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
14476790|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476791|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476792|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476793|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14476794|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14476795|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
14476796|NCT02420262|Insulin|insulin|mesh-list
14476797|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14476798|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
14476799|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
14476800|NCT02420262|Liraglutide|liraglutide|mesh-list
14080705|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
14080706|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080707|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080708|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080709|NCT02520934|Miglustat|miglustat|mesh-list
14080710|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080711|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080712|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14080713|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14080714|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
14080715|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080716|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14080717|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14080718|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080719|NCT02520921|Aspirin|aspirin|mesh-list
14080720|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14080721|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14476801|NCT02420262|Xultophy|xultophy|mesh-list
14476802|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14476803|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476804|NCT02420262|Incretins|incretins|mesh-ancestor
14476805|NCT02420262|Hormones|hormones|mesh-ancestor
14759400|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
14080722|NCT02520921|Analgesics|analgesics|mesh-ancestor
14080723|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
14080724|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080725|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080726|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080727|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080728|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14080729|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14080730|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080731|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14080732|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14080733|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080734|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
14080735|NCT02521012|Vitamin D|vitamin d|mesh-list
14080736|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
14080737|NCT02521012|Vitamins|vitamins|mesh-list
14080738|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
14080739|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080740|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14080741|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14080742|NCT02520635|Temozolomide|temozolomide|mesh-list
14080743|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14759401|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
13916191|NCT03466502|Vancomycin|vancomycin|mesh-list
14080744|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
14080745|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080746|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080747|NCT02520752|Midazolam|midazolam|mesh-list
14080748|NCT02520752|Caffeine|caffeine|mesh-list
14080749|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14080750|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14080751|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080752|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916192|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13916193|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080753|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14080754|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14080755|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14080756|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14476806|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13916194|NCT03466437|Methamphetamine|methamphetamine|mesh-list
13916195|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13916196|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916197|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
13916198|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
13916199|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916200|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
13916201|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916202|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916203|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916204|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13916205|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13916206|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13916207|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13916208|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
13916209|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916210|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916211|NCT03466333|Enalapril|enalapril|mesh-list
14080757|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
14080758|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
14080759|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
14080760|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
14080761|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080762|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080763|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14080764|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14080765|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080766|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14080767|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14080768|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
14080769|NCT02520570|Urinastatin|urinastatin|mesh-list
14080770|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
14080771|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14080772|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
14080773|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080774|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916212|NCT03466333|Enalaprilat|enalaprilat|mesh-list
13916213|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080775|NCT02520479|Pegaspargase|pegaspargase|mesh-list
14080776|NCT02520479|Asparaginase|asparaginase|mesh-list
14080777|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080778|NCT02520947|Desflurane|desflurane|mesh-list
14080779|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14080780|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
14080781|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
14080782|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080783|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080784|NCT02520505|Citric Acid|citric acid|mesh-list
14080785|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
14080786|NCT02520505|Clomiphene|clomiphene|mesh-list
14080787|NCT02520505|Enclomiphene|enclomiphene|mesh-list
14080788|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
14080789|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
14080790|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14080791|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
14080792|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
14080793|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080794|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14080795|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
14080796|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080797|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080798|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14080799|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
13916214|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916215|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13916216|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
13916217|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13916218|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
13916219|NCT03466320|Fludarabine|fludarabine|mesh-list
13916220|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916221|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
13916222|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916223|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916224|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13916225|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
13916226|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916227|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916228|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13916229|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
14080800|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14080801|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14080802|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14759402|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13916230|NCT03466242|Ketamine|ketamine|mesh-list
13916231|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13916232|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916233|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916234|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14759403|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13916235|NCT03466242|Analgesics|analgesics|mesh-ancestor
13916236|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
13916237|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476807|NCT02420327|Galantamine|galantamine|mesh-list
14080803|NCT02520453|Durvalumab|durvalumab|mesh-list
14080804|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14080805|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476808|NCT02420327|Nicotine|nicotine|mesh-list
14476809|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14476810|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
14476811|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476812|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476813|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14476814|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14476815|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
14476816|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476817|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476818|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14476819|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476820|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14476821|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
14479210|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14479211|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14479212|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14479213|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080806|NCT02520817|Vitamins|vitamins|mesh-list
14080807|NCT02520817|Ascorbic Acid|ascorbic acid|mesh-list
14080808|NCT02520817|Vitamin E|vitamin e|mesh-list
14080809|NCT02520817|Vitamin A|vitamin a|mesh-list
14080810|NCT02520817|Lactulose|lactulose|mesh-list
14080811|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
14080812|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080813|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
14080814|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080815|NCT02520817|Protective Agents|protective agents|mesh-ancestor
14080816|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080817|NCT02520219|Endostar protein|endostar protein|mesh-list
14080818|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14080819|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14080820|NCT02520219|Growth Substances|growth substances|mesh-ancestor
14080821|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080822|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
14080823|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080824|NCT02520245|Cemiplimab|cemiplimab|mesh-list
14479214|NCT02465489|Deferiprone|deferiprone|mesh-list
14479215|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14080825|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14080826|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080827|NCT02520180|Everolimus|everolimus|mesh-list
14080828|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080829|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14080830|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
14080831|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080832|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14080833|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
14080834|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14080835|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14080836|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
14080837|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080838|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080839|NCT02520115|Dexamethasone|dexamethasone|mesh-list
14080840|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
14080841|NCT02520115|Valproic Acid|valproic acid|mesh-list
14080842|NCT02520115|Ichthammol|ichthammol|mesh-list
14080843|NCT02520115|BB 1101|bb 1101|mesh-list
14080844|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080845|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
14080846|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
14080847|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080848|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080849|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14080850|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
14080851|NCT02520115|Hormones|hormones|mesh-ancestor
14080852|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14080853|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14080854|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080855|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
14080856|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080857|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080858|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
14080859|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
14080860|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080861|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
14080862|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14080863|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080864|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14080865|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
14080866|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
14080867|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14080868|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14080869|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14080870|NCT02520141|Ramucirumab|ramucirumab|mesh-list
14080871|NCT02520141|Antibodies|antibodies|mesh-list
14080872|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
14080873|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14080874|NCT02520141|Lexatumumab|lexatumumab|mesh-list
14080875|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
14080876|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080877|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080878|NCT02520102|Sargramostim|sargramostim|mesh-list
14080879|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
14080880|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080881|NCT02519543|Metformin|metformin|mesh-list
14080882|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14080883|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080884|NCT02519582|Niclosamide|niclosamide|mesh-list
14080885|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
14080886|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14080887|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
14080888|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14080889|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14080890|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
14080891|NCT02519699|Norepinephrine|norepinephrine|mesh-list
14080892|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14080893|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14080894|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
14080895|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080896|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080897|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080898|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
14080899|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
14080900|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080901|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14173552|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173553|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173554|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14173555|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
14173556|NCT04797338|Estrogens|estrogens|mesh-ancestor
14173557|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14173558|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14173559|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
14173560|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
14173561|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14173562|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14173563|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14173564|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173565|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934809|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14934810|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14934811|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
14934812|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14934813|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14934814|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14934815|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934816|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934817|NCT01458977|Tenofovir|tenofovir|mesh-list
14173566|NCT04797286|Urological Agents|urological agents|mesh-ancestor
14173567|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14173568|NCT04797013|Plasminogen|plasminogen|mesh-list
14173569|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14173570|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14173571|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173572|NCT04796857|Lenalidomide|lenalidomide|mesh-list
14173573|NCT04796857|Antibodies|antibodies|mesh-list
14173574|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
14173575|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173576|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14173577|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14173578|NCT04796857|Growth Substances|growth substances|mesh-ancestor
14173579|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
14173580|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934818|NCT01458977|Emtricitabine|emtricitabine|mesh-list
13916238|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13916239|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13916240|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13916241|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916242|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916243|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916244|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13916245|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13916246|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
13916247|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
14080902|NCT02519608|Aspirin|aspirin|mesh-list
14080903|NCT02519608|Clopidogrel|clopidogrel|mesh-list
14080904|NCT02519608|Ticagrelor|ticagrelor|mesh-list
14080905|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14080906|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080907|NCT02519608|Analgesics|analgesics|mesh-ancestor
14080908|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
14080909|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080910|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080911|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14080912|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14080913|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14080914|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14080915|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080916|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14080917|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14080918|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080919|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
14080920|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14080921|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14080922|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14080923|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
14080924|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080925|NCT02519660|Lidocaine|lidocaine|mesh-list
14080926|NCT02519660|Tetracaine|tetracaine|mesh-list
14080927|NCT02519660|Prilocaine|prilocaine|mesh-list
14080928|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14080929|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
14080930|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
14080931|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080932|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080933|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
14080934|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080935|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14080936|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14080937|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14080938|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080939|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080940|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14080941|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14080942|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
14080943|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14080944|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
14080945|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080946|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
14080947|NCT02519335|Razoxane|razoxane|mesh-list
14080948|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080949|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14080950|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14080951|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14080952|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080953|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080954|NCT02519335|Protective Agents|protective agents|mesh-ancestor
14080955|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080956|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
14080957|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
14080958|NCT02519322|Nivolumab|nivolumab|mesh-list
14080959|NCT02519322|Ipilimumab|ipilimumab|mesh-list
14080960|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
14080961|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
14080962|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14080963|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14080964|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14080965|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080966|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
14080967|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080968|NCT02519400|Amitriptyline|amitriptyline|mesh-list
14080969|NCT02519400|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14080970|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14080971|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
14080972|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14080973|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14080974|NCT02519400|Analgesics|analgesics|mesh-ancestor
14080975|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
14080976|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14080977|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14080978|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14938677|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14080979|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14080980|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14080981|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080982|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
14080983|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14080984|NCT02519400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14080985|NCT02519400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14080986|NCT02519400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14080987|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
14080988|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
14080989|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14080990|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14080991|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14080992|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14080993|NCT02519153|Urological Agents|urological agents|mesh-ancestor
14080994|NCT02519010|Amlodipine|amlodipine|mesh-list
14080995|NCT02519010|Valsartan|valsartan|mesh-list
14080996|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14080997|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14080998|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14080999|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14081000|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081001|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14081002|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081003|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
14081004|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14081005|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14081006|NCT02518802|Pemetrexed|pemetrexed|mesh-list
14081007|NCT02518802|Gefitinib|gefitinib|mesh-list
14081008|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081009|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081010|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081011|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14081012|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14081013|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14081014|NCT02518945|Liraglutide|liraglutide|mesh-list
14081015|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
14081016|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081017|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081018|NCT02518945|Incretins|incretins|mesh-ancestor
14081019|NCT02518945|Hormones|hormones|mesh-ancestor
14081020|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081021|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14081022|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081023|NCT02518763|Vitamin D|vitamin d|mesh-list
14081024|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
14081025|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
14081026|NCT02518763|Vitamins|vitamins|mesh-list
14934819|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14934820|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
14934821|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934822|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14934823|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14934824|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916248|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13916249|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13916250|NCT03466216|Octreotide|octreotide|mesh-list
13916251|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13916252|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13916253|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916254|NCT03466021|Liraglutide|liraglutide|mesh-list
14081027|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
14081028|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081029|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081030|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14081031|NCT02518789|Fentanyl|fentanyl|mesh-list
13916255|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13916256|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916257|NCT03466021|Incretins|incretins|mesh-ancestor
13916258|NCT03466021|Hormones|hormones|mesh-ancestor
13916259|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13916260|NCT03465969|Tacrolimus|tacrolimus|mesh-list
13916261|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916262|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
14081032|NCT02518789|Midazolam|midazolam|mesh-list
14081033|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
14081034|NCT02518789|Remifentanil|remifentanil|mesh-list
14081035|NCT02518789|Propofol|propofol|mesh-list
14081036|NCT02518789|Etomidate|etomidate|mesh-list
14081037|NCT02518789|Atracurium|atracurium|mesh-list
14081038|NCT02518789|Rocuronium|rocuronium|mesh-list
14081039|NCT02518789|Cisatracurium|cisatracurium|mesh-list
14081040|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14081041|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081042|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081043|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14081044|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
14081045|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
14081046|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14081047|NCT02518789|Analgesics|analgesics|mesh-ancestor
14081048|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
14081049|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081050|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14081051|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14081052|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14081053|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
14081054|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081055|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081056|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14081057|NCT02518789|Narcotics|narcotics|mesh-ancestor
14081058|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13916263|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916264|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14081059|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14081060|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14081061|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14081062|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
14081063|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
14081064|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14081065|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14081066|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14081067|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14081068|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14081069|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
14081070|NCT02518958|Nivolumab|nivolumab|mesh-list
14081071|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14081072|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916265|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916266|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960106|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960107|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
13960108|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
14081073|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14081074|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081075|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14081076|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081077|NCT02518503|Atorvastatin|atorvastatin|mesh-list
14081078|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13960109|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13960110|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13960111|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960112|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
13960113|NCT03157401|Coagulants|coagulants|mesh-ancestor
13960114|NCT03157310|Gefitinib|gefitinib|mesh-list
13960115|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960116|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14081079|NCT02518503|Simvastatin|simvastatin|mesh-list
14081080|NCT02518503|Pravastatin|pravastatin|mesh-list
14081081|NCT02518503|Lovastatin|lovastatin|mesh-list
14081082|NCT02518503|L 647318|l 647318|mesh-list
14081083|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
14081084|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14081085|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14081086|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
14081087|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081088|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14081089|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14081090|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081091|NCT02518594|Progesterone|progesterone|mesh-list
14081092|NCT02518594|Progestins|progestins|mesh-ancestor
14081093|NCT02518594|Hormones|hormones|mesh-ancestor
14081094|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081095|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081096|NCT02518451|Valsartan|valsartan|mesh-list
14081097|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14081098|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14081099|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14081100|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081101|NCT02518373|Omeprazole|omeprazole|mesh-list
14081102|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14081103|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081104|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14081105|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081106|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081107|NCT02518516|Atorvastatin|atorvastatin|mesh-list
14081108|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14934825|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934826|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14934827|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14938678|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938679|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938680|NCT01483053|S 20098|s 20098|mesh-list
14938681|NCT01483053|Citalopram|citalopram|mesh-list
14081109|NCT02518516|Simvastatin|simvastatin|mesh-list
14081110|NCT02518516|Pravastatin|pravastatin|mesh-list
14081111|NCT02518516|Lovastatin|lovastatin|mesh-list
14081112|NCT02518516|L 647318|l 647318|mesh-list
14081113|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
14081114|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14081115|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14081116|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
14081117|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081118|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14081119|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14081120|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081121|NCT02518438|Tramadol|tramadol|mesh-list
14081122|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14081123|NCT02518438|Narcotics|narcotics|mesh-ancestor
14081124|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081125|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081126|NCT02518438|Analgesics|analgesics|mesh-ancestor
14081127|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
14081128|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081129|NCT02518295|Sulfalene|sulfalene|mesh-list
14081130|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081131|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14081132|NCT02518295|Renal Agents|renal agents|mesh-ancestor
14081133|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
14476822|NCT02420873|Maytansine|maytansine|mesh-list
14476823|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
14476824|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14934828|NCT01459081|Zanamivir|zanamivir|mesh-list
14081134|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14081135|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14081136|NCT02518152|Alendronate|alendronate|mesh-list
14081137|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081138|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081139|NCT02518022|Insulin|insulin|mesh-list
14081140|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
14081141|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
14081142|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081143|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173581|NCT04796623|Fulvestrant|fulvestrant|mesh-list
14173582|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14173583|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173584|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14173585|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14173586|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
14173587|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173588|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173589|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
14173590|NCT04796688|Fludarabine|fludarabine|mesh-list
14173591|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173592|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
14173593|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173594|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173595|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14173596|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
14173597|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173598|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173599|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14173600|NCT04796714|Aspirin|aspirin|mesh-list
14173601|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173602|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173603|NCT04796714|Analgesics|analgesics|mesh-ancestor
14173604|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
14173605|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173606|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173607|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173608|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173609|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14173610|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14934829|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
14081144|NCT02518009|Estrogens|estrogens|mesh-list
14081145|NCT02518009|Androgens|androgens|mesh-list
14081146|NCT02518009|Hormones|hormones|mesh-ancestor
14081147|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081148|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081149|NCT02517814|Vitamin D|vitamin d|mesh-list
14081150|NCT02517814|Vitamins|vitamins|mesh-ancestor
14081151|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
14081152|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081153|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081154|NCT02517827|Paclitaxel|paclitaxel|mesh-list
14081155|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14081156|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081157|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
14081158|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
14081159|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
14081160|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081161|NCT02517788|Interferons|interferons|mesh-list
14081162|NCT02517788|Interferon-beta|interferon-beta|mesh-list
14081163|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
14081164|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081165|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
14081166|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081167|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
14081168|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081169|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14081170|NCT02517957|Loperamide|loperamide|mesh-list
14081171|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
14081172|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081173|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
14081174|NCT02517918|Sirolimus|sirolimus|mesh-list
14081175|NCT02517918|Methotrexate|methotrexate|mesh-list
14081176|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14081177|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
14081178|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14081179|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081180|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14081181|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
14081182|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081183|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081184|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
14081185|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081186|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14081187|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14081188|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
14081189|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14081190|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14081191|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14081192|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081193|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14081194|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
14081195|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081196|NCT02517736|Sorafenib|sorafenib|mesh-list
14476825|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476826|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
14081197|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081198|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14081199|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081200|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081201|NCT02517684|Prednisolone|prednisolone|mesh-list
14081202|NCT02517684|Azathioprine|azathioprine|mesh-list
14081203|NCT02517684|Infliximab|infliximab|mesh-list
14081204|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14081205|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
14081206|NCT02517684|Hormones|hormones|mesh-ancestor
14081207|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081208|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081209|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14081210|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081211|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081212|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
14081213|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14081214|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
14081215|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081216|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14476827|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
14476828|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
14476829|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476830|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476831|NCT02420951|Bupivacaine|bupivacaine|mesh-list
14476832|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
14476833|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
14476834|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476835|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476836|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
14476837|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476838|NCT02421120|Tazobactam|tazobactam|mesh-list
14476839|NCT02421120|Ceftolozane|ceftolozane|mesh-list
14081217|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14081218|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
14081219|NCT02517619|Dexamethasone|dexamethasone|mesh-list
14081220|NCT02517619|Prednisolone|prednisolone|mesh-list
14081221|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14081222|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
14081223|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14081224|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
14081225|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14934830|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081226|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14081227|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
13916267|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13916268|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
13916269|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
13916270|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14081228|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13916271|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13916272|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13916273|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916274|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916275|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13916276|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13916277|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13916278|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916279|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916280|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081229|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14081230|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
14081231|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
14081232|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081233|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081234|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081235|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
14081236|NCT02517619|Hormones|hormones|mesh-ancestor
14081237|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081238|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14081239|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081240|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14081241|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14081242|NCT02517619|Protective Agents|protective agents|mesh-ancestor
14081243|NCT02517372|Pemirolast|pemirolast|mesh-list
14081244|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
14081245|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
14081246|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081247|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081248|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081249|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
14081250|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14081251|NCT02517424|Dronabinol|dronabinol|mesh-list
14081252|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
14081253|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081254|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14081255|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14081256|NCT02517424|Analgesics|analgesics|mesh-ancestor
14081257|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
14081258|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081259|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14081260|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14081261|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081262|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081263|NCT02517424|Hormones|hormones|mesh-ancestor
14081264|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081265|NCT02517307|Heparin|heparin|mesh-list
14081266|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14081267|NCT02517307|Glycerol|glycerol|mesh-list
14081268|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
14081269|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14081270|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14081271|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081272|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14081273|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14081274|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14081275|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14081276|NCT02517307|Protective Agents|protective agents|mesh-ancestor
14081277|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081278|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14081279|NCT02517164|Calcifediol|calcifediol|mesh-list
14081280|NCT02517164|Vitamins|vitamins|mesh-ancestor
14081281|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
14081282|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081283|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081284|NCT02516826|Olmesartan|olmesartan|mesh-list
14081285|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14081286|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14081287|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14081288|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14081289|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
14081290|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081291|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14081292|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14081293|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081294|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14081295|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14081296|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14081297|NCT02517099|Azithromycin|azithromycin|mesh-list
14081298|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14081299|NCT02517099|Beclomethasone|beclomethasone|mesh-list
14081300|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14081301|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081302|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14081303|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081304|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081305|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14081306|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
14081307|NCT02517099|Hormones|hormones|mesh-ancestor
14081308|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081309|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081310|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14081311|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
14081312|NCT02516774|Adalimumab|adalimumab|mesh-list
14081313|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14081314|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14081315|NCT02516618|Fasinumab|fasinumab|mesh-list
14081316|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14081317|NCT02516618|Analgesics|analgesics|mesh-ancestor
14081318|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
14081319|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081320|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081321|NCT02516670|Vitamins|vitamins|mesh-list
14081322|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
14081323|NCT02516670|Docetaxel|docetaxel|mesh-list
14081324|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
14081325|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081326|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081327|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
14081328|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
14081329|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
14081330|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081331|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
14081332|NCT02516670|Protective Agents|protective agents|mesh-ancestor
14081333|NCT02516904|Rezafungin|rezafungin|mesh-list
14081334|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
14081335|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081336|NCT02516631|Misoprostol|misoprostol|mesh-list
14081337|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14081338|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
14081339|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14081340|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916281|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13916282|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13916283|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
13916284|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13916285|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13916286|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
13916287|NCT03465774|Doxycycline|doxycycline|mesh-list
13916288|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13916289|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916290|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
13916291|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14081341|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14934831|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934832|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934833|NCT01459133|Insulin|insulin|mesh-list
14934834|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934835|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934836|NCT01459146|Lumefantrine|lumefantrine|mesh-list
14934837|NCT01459146|Artemether|artemether|mesh-list
14081342|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081343|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
14081344|NCT02516527|Ipilimumab|ipilimumab|mesh-list
14081345|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14081346|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081347|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14081348|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081349|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
14081350|NCT02516475|Astringents|astringents|mesh-ancestor
14081351|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081352|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14081353|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
14081354|NCT02516423|Dexamethasone|dexamethasone|mesh-list
14081355|NCT02516423|Lenalidomide|lenalidomide|mesh-list
14081356|NCT02516423|Ixazomib|ixazomib|mesh-list
14081357|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14081358|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
14081359|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
14081360|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081361|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081362|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081363|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
14081364|NCT02516423|Hormones|hormones|mesh-ancestor
14934838|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
13916292|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14081365|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081366|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14081367|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081368|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
14081369|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14081370|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14081371|NCT02516423|Growth Substances|growth substances|mesh-ancestor
14934839|NCT01459146|Albendazole|albendazole|mesh-list
13916293|NCT03465592|Nivolumab|nivolumab|mesh-list
14081372|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14081373|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081374|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
14081375|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081376|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081377|NCT02516436|Buprenorphine|buprenorphine|mesh-list
13916294|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13916295|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916296|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13916297|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916298|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14759404|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759405|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759406|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14759407|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759408|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759409|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759410|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14759411|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
13916299|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14081378|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14081379|NCT02516436|Narcotics|narcotics|mesh-ancestor
14081380|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081381|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081382|NCT02516436|Analgesics|analgesics|mesh-ancestor
14081383|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
14081384|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081385|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14081386|NCT02516462|Hormones|hormones|mesh-list
14081387|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14081388|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081389|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173611|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173612|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14173613|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14173614|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173615|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
14173616|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
14173617|NCT04796428|Empagliflozin|empagliflozin|mesh-list
14173618|NCT04796428|Canagliflozin|canagliflozin|mesh-list
14173619|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14173620|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173621|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13916300|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916301|NCT03465488|Albendazole|albendazole|mesh-list
13916302|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
13916303|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14759412|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14759413|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759414|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14759415|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14759416|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14759417|NCT04816214|Carboplatin|carboplatin|mesh-list
14759418|NCT04816214|Pemetrexed|pemetrexed|mesh-list
14759419|NCT04816214|Osimertinib|osimertinib|mesh-list
14759420|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759421|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759422|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081390|NCT02516085|Metformin|metformin|mesh-list
14081391|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081392|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081393|NCT02516059|Oxycodone|oxycodone|mesh-list
14081394|NCT02516059|Naloxone|naloxone|mesh-list
14081395|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14081396|NCT02516059|Narcotics|narcotics|mesh-ancestor
14081397|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081398|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081399|NCT02516059|Analgesics|analgesics|mesh-ancestor
14081400|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
14081401|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081402|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14081403|NCT02515968|Propofol|propofol|mesh-list
14081404|NCT02515968|Desflurane|desflurane|mesh-list
14081405|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
14081406|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081407|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081408|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14081409|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14081410|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
14081411|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14081412|NCT02515955|Minocycline|minocycline|mesh-list
14081413|NCT02515955|Amphetamine|amphetamine|mesh-list
14081414|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
14081415|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14081416|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081417|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14081418|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081419|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
14081420|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
14081421|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081422|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
14081423|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081424|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081425|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
14081426|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14081427|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14081428|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14081429|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14081430|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
14081431|NCT02515929|Procyanidin|procyanidin|mesh-list
14081432|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
14081433|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081434|NCT02515929|Protective Agents|protective agents|mesh-ancestor
14081435|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081436|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14081437|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14081438|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081439|NCT02515877|Carboplatin|carboplatin|mesh-list
14081440|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081441|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
14081442|NCT02515864|Dotinurad|dotinurad|mesh-list
14081443|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14081444|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14081445|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081446|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14081447|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14081448|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081449|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081450|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081451|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14759423|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14759424|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14081452|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
14081453|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14081454|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081455|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14081456|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14081457|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14081458|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
14081459|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
14081460|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14081461|NCT02515864|Renal Agents|renal agents|mesh-ancestor
14081462|NCT02515682|Equol|equol|mesh-list
14081463|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
14081464|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14081465|NCT02515682|Estrogens|estrogens|mesh-ancestor
14081466|NCT02515682|Hormones|hormones|mesh-ancestor
14081467|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759425|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759426|NCT04807348|Metformin|metformin|mesh-list
14759427|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14759428|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081468|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081469|NCT02515695|Interferons|interferons|mesh-list
14081470|NCT02515695|Interferon-beta|interferon-beta|mesh-list
14081471|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
14081472|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081473|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
14081474|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081475|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
14081476|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081477|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14081478|NCT02515734|Leucovorin|leucovorin|mesh-list
14081479|NCT02515734|Bevacizumab|bevacizumab|mesh-list
14081480|NCT02515734|Cetuximab|cetuximab|mesh-list
14081481|NCT02515734|Fluorouracil|fluorouracil|mesh-list
14081482|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
14081483|NCT02515734|Irinotecan|irinotecan|mesh-list
14081484|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14081485|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081486|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14081487|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14081488|NCT02515734|Growth Substances|growth substances|mesh-ancestor
14081489|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081490|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
14081491|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
14081492|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081493|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14081494|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14081495|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
14081496|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14081497|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14081498|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081499|NCT02515734|Antidotes|antidotes|mesh-ancestor
14081500|NCT02515734|Protective Agents|protective agents|mesh-ancestor
14081501|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
14081502|NCT02515734|Vitamins|vitamins|mesh-ancestor
14081503|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
14081504|NCT02515604|Misoprostol|misoprostol|mesh-list
14081505|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14081506|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
14081507|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14081508|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081509|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14081510|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14759429|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
14081511|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
14081512|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14081513|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14081514|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916304|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916305|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
13916306|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13916307|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13916308|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
13916309|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
13916310|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
14081515|NCT02515526|Tolbutamide|tolbutamide|mesh-list
14081516|NCT02515526|Ethanol|ethanol|mesh-list
14081517|NCT02515526|Digoxin|digoxin|mesh-list
14081518|NCT02515526|Midazolam|midazolam|mesh-list
14081519|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
14081520|NCT02515526|Caffeine|caffeine|mesh-list
14081521|NCT02515526|Omeprazole|omeprazole|mesh-list
14081522|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14081523|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14081524|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081525|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081526|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14081527|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14081528|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14081529|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14081530|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
14081531|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
14081532|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
14081533|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
14759430|NCT04796779|Trace Elements|trace elements|mesh-ancestor
14759431|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
14759432|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759433|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
14759434|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14759435|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759436|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14759437|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759438|NCT04791514|Treprostinil|treprostinil|mesh-list
13916311|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081534|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081535|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759439|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14081536|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14081537|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081538|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13916312|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916313|NCT03465423|Propofol|propofol|mesh-list
13916314|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
13916315|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916316|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916317|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13916318|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13916319|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
13916320|NCT03465410|Tacrolimus|tacrolimus|mesh-list
13916321|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916322|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
13960117|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759440|NCT04784559|Remdesivir|remdesivir|mesh-list
14081539|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081540|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14081541|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14081542|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14081543|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14081544|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
14081545|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14081546|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081547|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14081548|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14081549|NCT02515526|Protective Agents|protective agents|mesh-ancestor
14759441|NCT04784559|Favipiravir|favipiravir|mesh-list
14759442|NCT04784559|Dexamethasone|dexamethasone|mesh-list
14759443|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759444|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
14759445|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
14081550|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
14081551|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
14081552|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14081553|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14081554|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14759446|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759447|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759448|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14759449|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
14759450|NCT04784559|Hormones|hormones|mesh-ancestor
14759451|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759452|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759453|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759454|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
14759455|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934840|NCT01459146|Praziquantel|praziquantel|mesh-list
14934841|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
14934842|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14934843|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14934844|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934845|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
14934846|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
14934847|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14934848|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14934849|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14934850|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14934851|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081555|NCT02515448|Gentamicins|gentamicins|mesh-list
14081556|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14081557|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081558|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14081559|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081560|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081561|NCT02515435|Apatinib|apatinib|mesh-list
14081562|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916323|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916324|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13916325|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916326|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916327|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13916328|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
13916329|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934852|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934853|NCT01459198|Vaccines|vaccines|mesh-list
14934854|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
14934855|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934856|NCT01459211|Dexamethasone|dexamethasone|mesh-list
14934857|NCT01459211|Lenalidomide|lenalidomide|mesh-list
14934858|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14934859|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
14934860|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
14934861|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934862|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934863|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14934864|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
14934865|NCT01459211|Hormones|hormones|mesh-ancestor
14934866|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14934867|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14934868|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934869|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
14934870|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14081563|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14081564|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081565|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081566|NCT02515565|Erythromycin|erythromycin|mesh-list
14081567|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
14934871|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14934872|NCT01459211|Growth Substances|growth substances|mesh-ancestor
14081568|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14081569|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
14081570|NCT02515565|Cephalosporins|cephalosporins|mesh-list
14081571|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14081572|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081573|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14081574|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14081575|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081576|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081577|NCT02515201|Taurolidine|taurolidine|mesh-list
14081578|NCT02515201|Heparin|heparin|mesh-list
14081579|NCT02515201|Calcium heparin|calcium heparin|mesh-list
14081580|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
14081581|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14081582|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14081583|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081584|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081585|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14081586|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081587|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14081588|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
13916330|NCT03465345|Metformin|metformin|mesh-list
13916331|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
13916332|NCT03465345|Procyanidin|procyanidin|mesh-list
13916333|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934873|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
14934874|NCT01459250|S 20098|s 20098|mesh-list
14081589|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081590|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
14081591|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14081592|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081593|NCT02515422|Ketamine|ketamine|mesh-list
14081594|NCT02515422|Bupivacaine|bupivacaine|mesh-list
14081595|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
14081596|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
14081597|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081598|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081599|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
14081600|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081601|NCT02515422|Analgesics|analgesics|mesh-ancestor
14081602|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14081603|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14081604|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
14081605|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14081606|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14081607|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081608|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081609|NCT02515188|Acetaminophen|acetaminophen|mesh-list
14081610|NCT02515188|Propacetamol|propacetamol|mesh-list
14476840|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14476841|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14476842|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476843|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14476844|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476845|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476846|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14476847|NCT02421120|Renal Agents|renal agents|mesh-ancestor
14476848|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
14081611|NCT02515188|Analgesics|analgesics|mesh-ancestor
14476849|NCT02421211|Ledipasvir|ledipasvir|mesh-list
14476850|NCT02421211|Simeprevir|simeprevir|mesh-list
14476851|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
14476852|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081612|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
14081613|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916334|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916335|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
13916336|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916337|NCT03465345|Protective Agents|protective agents|mesh-ancestor
13916338|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14081614|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081615|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14081616|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14081617|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14081618|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14476853|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
14476854|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476855|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476856|NCT02421354|Nivolumab|nivolumab|mesh-list
14476857|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759456|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
13916339|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13916340|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759457|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759458|NCT04777357|Cariprazine|cariprazine|mesh-list
14759459|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14759460|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13916341|NCT03465202|Capecitabine|capecitabine|mesh-list
13916342|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13916343|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
13916344|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916345|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916346|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13916347|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13916348|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916349|NCT03465085|Heparin|heparin|mesh-list
13916350|NCT03465085|Calcium heparin|calcium heparin|mesh-list
13916351|NCT03465085|Streptokinase|streptokinase|mesh-list
13916352|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
13916353|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14476858|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759461|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081619|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
14081620|NCT02514941|Acetaminophen|acetaminophen|mesh-list
14081621|NCT02514941|Amoxicillin|amoxicillin|mesh-list
14081622|NCT02514941|Talinolol|talinolol|mesh-list
14081623|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14081624|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081625|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14081626|NCT02514941|Analgesics|analgesics|mesh-ancestor
14081627|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
14081628|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081629|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081630|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
14081631|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14081632|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14081633|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
14081634|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081635|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081636|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14081637|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13916354|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14081638|NCT02514980|Ketamine|ketamine|mesh-list
14081639|NCT02514980|Bupivacaine|bupivacaine|mesh-list
14081640|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
14081641|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
14081642|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081643|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081644|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
13916355|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916356|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
13916357|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081645|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081646|NCT02514980|Analgesics|analgesics|mesh-ancestor
14081647|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14081648|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14081649|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
14081650|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14081651|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14081652|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081653|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081654|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
14081655|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081656|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916358|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13916359|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916360|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916361|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
14081657|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
14081658|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081659|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081660|NCT02514681|Gemcitabine|gemcitabine|mesh-list
14081661|NCT02514681|Paclitaxel|paclitaxel|mesh-list
14081662|NCT02514681|Vinorelbine|vinorelbine|mesh-list
14081663|NCT02514681|Docetaxel|docetaxel|mesh-list
14081664|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14081665|NCT02514681|Capecitabine|capecitabine|mesh-list
14081666|NCT02514681|Trastuzumab|trastuzumab|mesh-list
14081667|NCT02514681|Pertuzumab|pertuzumab|mesh-list
14081668|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14081669|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081670|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
13916362|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916363|NCT03464968|Leucovorin|leucovorin|mesh-list
13916364|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
13916365|NCT03464968|Irinotecan|irinotecan|mesh-list
13916366|NCT03464968|Fluorouracil|fluorouracil|mesh-list
13916367|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
13916368|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916369|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13916370|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13916371|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081671|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
14081672|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14081673|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081674|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14081675|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
14081676|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
14081677|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081678|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081679|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14081680|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
14081681|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081682|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14081683|NCT02514642|Clopidogrel|clopidogrel|mesh-list
14081684|NCT02514642|Ticagrelor|ticagrelor|mesh-list
14081685|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14081686|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14081687|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14081688|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14081689|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
14081690|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081691|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081692|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081693|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14081694|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081695|NCT02514629|Metformin|metformin|mesh-list
14081696|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
14081697|NCT02514629|Testosterone|testosterone|mesh-list
14081698|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
14081699|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
14081700|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14081701|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081702|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081703|NCT02514629|Androgens|androgens|mesh-ancestor
14081704|NCT02514629|Hormones|hormones|mesh-ancestor
14081705|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081706|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14081707|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081708|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
14081709|NCT02514538|Acetaminophen|acetaminophen|mesh-list
14081710|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14081711|NCT02514538|Analgesics|analgesics|mesh-ancestor
14081712|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
14081713|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081714|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081715|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
14081716|NCT02514278|Capecitabine|capecitabine|mesh-list
14081717|NCT02514278|Folfirinox|folfirinox|mesh-list
14081718|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14081719|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
13916372|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916373|NCT03464968|Antidotes|antidotes|mesh-ancestor
14081720|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081721|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916374|NCT03464968|Protective Agents|protective agents|mesh-ancestor
14081722|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
14081723|NCT02514343|Bupivacaine|bupivacaine|mesh-list
14081724|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
14081725|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
14081726|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081727|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081728|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
14081729|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081730|NCT02514343|Analgesics|analgesics|mesh-ancestor
14081731|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14081732|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
14081733|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14081734|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14081735|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081736|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14081737|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
14081738|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14173622|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183466|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183467|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14183468|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14183469|NCT04727671|Cetrorelix|cetrorelix|mesh-list
14183470|NCT04727671|Menotropins|menotropins|mesh-list
14183471|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
14183472|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14183473|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
14183474|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183475|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183476|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14183477|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14183478|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183479|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14183480|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
14183481|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
14183482|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183483|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14183484|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14183485|NCT04727684|Cetrorelix|cetrorelix|mesh-list
14183486|NCT04727684|Menotropins|menotropins|mesh-list
14183487|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
14183488|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14183489|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
14183490|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183491|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183492|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14183493|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14183494|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183495|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14183496|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
14183497|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
14183498|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183499|NCT04727515|Fentanyl|fentanyl|mesh-list
14183500|NCT04727515|Isoflurane|isoflurane|mesh-list
14183501|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14183502|NCT04727515|Narcotics|narcotics|mesh-ancestor
14183503|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183504|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183505|NCT04727515|Analgesics|analgesics|mesh-ancestor
14183506|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
14183507|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183508|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14183509|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14183510|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
14183511|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
14183512|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14183513|NCT04727775|Remdesivir|remdesivir|mesh-list
14183514|NCT04727775|Favipiravir|favipiravir|mesh-list
14183515|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
14183516|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183517|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
14183518|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183519|NCT04727853|Irinotecan|irinotecan|mesh-list
14183520|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14183521|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14183522|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183523|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479216|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
14081739|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
14081740|NCT02514330|Vitamins|vitamins|mesh-ancestor
14081741|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
14081742|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081743|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081744|NCT02514421|Gemcitabine|gemcitabine|mesh-list
14081745|NCT02514421|Paclitaxel|paclitaxel|mesh-list
14081746|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14081747|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081748|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
14081749|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
14081750|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
14081751|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081752|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14081753|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
14081754|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
14081755|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081756|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081757|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14081758|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
14081759|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916375|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916376|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
13916377|NCT03464968|Vitamins|vitamins|mesh-ancestor
13916378|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
13916379|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
13916380|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13916381|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916382|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
13916383|NCT03464942|Atezolizumab|atezolizumab|mesh-list
14081760|NCT02514200|Riboflavin|riboflavin|mesh-list
14081761|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
14081762|NCT02514200|Vitamins|vitamins|mesh-ancestor
14081763|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
14081764|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081765|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14081766|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
14081767|NCT02514018|Vaccines|vaccines|mesh-list
14081768|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
14081769|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081770|NCT02513875|Vitamin D|vitamin d|mesh-list
14081771|NCT02513875|Vitamins|vitamins|mesh-ancestor
14081772|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
14081773|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081774|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081775|NCT02513849|Tamoxifen|tamoxifen|mesh-list
13916384|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916385|NCT03464864|Treprostinil|treprostinil|mesh-list
13916386|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13916387|NCT03464734|Paclitaxel|paclitaxel|mesh-list
14759462|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081776|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14081777|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
14081778|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081779|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081780|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14081781|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916388|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
13916389|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14759463|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14081782|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14081783|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14081784|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13916390|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13916391|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916392|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
13916393|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14081785|NCT02513862|Heparin|heparin|mesh-list
14081786|NCT02513862|Protamines|protamines|mesh-list
14081787|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
14081788|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14081789|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14081790|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081791|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
14081792|NCT02513862|Coagulants|coagulants|mesh-ancestor
14081793|NCT02513927|Metoprolol|metoprolol|mesh-list
14081794|NCT02513927|Nifedipine|nifedipine|mesh-list
14081795|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14081796|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14081797|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
14081798|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
14081799|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081800|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081801|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14081802|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14081803|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14081804|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
14081805|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081806|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081807|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14081808|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14081809|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14081810|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
14081811|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
14081812|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14081813|NCT02513654|Lamotrigine|lamotrigine|mesh-list
14081814|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
14081815|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14081816|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14081817|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081818|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14081819|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081820|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14081821|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14081822|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081823|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14081824|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14081825|NCT02513888|Vitamin D|vitamin d|mesh-list
14081826|NCT02513888|Vitamins|vitamins|mesh-ancestor
14081827|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
14081828|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081829|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14081830|NCT02513693|Rocuronium|rocuronium|mesh-list
14081831|NCT02513693|Neostigmine|neostigmine|mesh-list
14476859|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14479217|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
13916394|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
13916395|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916396|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13916397|NCT03464682|Atorvastatin|atorvastatin|mesh-list
13916398|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14081832|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14081833|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14081834|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14081835|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081836|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081837|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14081838|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081839|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081840|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
14081841|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081842|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14081843|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
14081844|NCT02513433|Bupivacaine|bupivacaine|mesh-list
14081845|NCT02513433|Ropivacaine|ropivacaine|mesh-list
14081846|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
14081847|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
14081848|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
14081849|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081850|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081851|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
14081852|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081853|NCT02513381|Vitamin D|vitamin d|mesh-list
14081854|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
14081855|NCT02513381|Vitamins|vitamins|mesh-ancestor
14081856|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
14081857|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081858|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13916399|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13916400|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
13916401|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916402|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13916403|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13916404|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081859|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14081860|NCT02513394|Palbociclib|palbociclib|mesh-list
14081861|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081862|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14081863|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081864|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081865|NCT02513355|Cisplatin|cisplatin|mesh-list
14081866|NCT02513355|Endostar protein|endostar protein|mesh-list
14081867|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081868|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14081869|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14081870|NCT02513355|Growth Substances|growth substances|mesh-ancestor
14081871|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081872|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
14081873|NCT02513290|Loratadine|loratadine|mesh-list
14081874|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
14081875|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
14081876|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14081877|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14081878|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14081879|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
14081880|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
14081881|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081882|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081883|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081884|NCT02513342|Docetaxel|docetaxel|mesh-list
14081885|NCT02513342|Endostar protein|endostar protein|mesh-list
14081886|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081887|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
14081888|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
14081889|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
14081890|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081891|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14081892|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14081893|NCT02513342|Growth Substances|growth substances|mesh-ancestor
13916405|NCT03464656|Antioxidants|antioxidants|mesh-list
14081894|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081895|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
14081896|NCT02513004|Clopidogrel|clopidogrel|mesh-list
14081897|NCT02513004|Ticagrelor|ticagrelor|mesh-list
13963548|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081898|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14081899|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14081900|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14081901|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14081902|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
14081903|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081904|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081905|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081906|NCT02513147|Lopinavir|lopinavir|mesh-list
14081907|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14081908|NCT02513147|Darunavir|darunavir|mesh-list
14081909|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
14081910|NCT02513147|Dolutegravir|dolutegravir|mesh-list
14081911|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14081912|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14081913|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14081914|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081915|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081916|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14081917|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14081918|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
14081919|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081920|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14081921|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14081922|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14081923|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14081924|NCT02513069|Nicotine|nicotine|mesh-list
14081925|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
14081926|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14081927|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
14081928|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081929|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081930|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14081931|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14081932|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
14081933|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081934|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081935|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
14081936|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
14081937|NCT02512887|Anesthetics|anesthetics|mesh-list
14081938|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081939|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081940|NCT02512562|Simeprevir|simeprevir|mesh-list
14081941|NCT02512562|Odalasvir|odalasvir|mesh-list
14081942|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
14081943|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14081944|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
14081945|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081946|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081947|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
14081948|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14081949|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14081950|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14081951|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14081952|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081953|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
14081954|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14081955|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081956|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14081957|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081958|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14081959|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14081960|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14081961|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14081962|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14081963|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
14081964|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14081965|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
14081966|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081967|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14081968|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14081969|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14081970|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081971|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081972|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
14081973|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14081974|NCT02512471|Ropivacaine|ropivacaine|mesh-list
14081975|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
14081976|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
14081977|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14081978|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081979|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
14081980|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14081981|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14081982|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14081983|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081984|NCT02512523|Incretins|incretins|mesh-ancestor
14081985|NCT02512523|Hormones|hormones|mesh-ancestor
14081986|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14081987|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14081988|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
14081989|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14081990|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173623|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
14173624|NCT04796675|Fludarabine|fludarabine|mesh-list
14173625|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173626|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
14173627|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173628|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173629|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14173630|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
14173631|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173632|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173633|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14173634|NCT04796454|Gemcitabine|gemcitabine|mesh-list
14173635|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
14173636|NCT04796454|Temozolomide|temozolomide|mesh-list
14476860|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934875|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14934876|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14934877|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934878|NCT01459276|Vaccines|vaccines|mesh-list
14934879|NCT01459276|Immunologic Factors|immunologic factors|mesh-ancestor
14934880|NCT01459276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934881|NCT01459315|Dolutegravir|dolutegravir|mesh-list
14934882|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14934883|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14934884|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934885|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934886|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14934887|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14934888|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
14934889|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14934890|NCT01459367|Lansoprazole|lansoprazole|mesh-list
14934891|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
14934892|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14934893|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14934894|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14934895|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934896|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934897|NCT01459380|Bevacizumab|bevacizumab|mesh-list
13916406|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916407|NCT03464656|Protective Agents|protective agents|mesh-ancestor
13916408|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916409|NCT03464552|Celecoxib|celecoxib|mesh-list
13916410|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13916411|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916412|NCT03464552|Analgesics|analgesics|mesh-ancestor
13916413|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
13916414|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916415|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916416|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916417|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916418|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13916419|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13916420|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916421|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916422|NCT03464539|Chitosan|chitosan|mesh-list
13916423|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13916424|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13916425|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
13916426|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916427|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13916428|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
13916429|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
13916430|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
13916431|NCT03464539|Coagulants|coagulants|mesh-ancestor
13916432|NCT03464461|Ketorolac|ketorolac|mesh-list
13916433|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13916434|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13916435|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916436|NCT03464461|Analgesics|analgesics|mesh-ancestor
13916437|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
13916438|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916439|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916440|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916441|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916442|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13916443|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916444|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916445|NCT03464448|Teriflunomide|teriflunomide|mesh-list
13916446|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13916447|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916448|NCT03464448|Analgesics|analgesics|mesh-ancestor
13916449|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
13916450|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916451|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14081991|NCT02512380|Docetaxel|docetaxel|mesh-list
14081992|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
14081993|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14081994|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
14081995|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
14081996|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
14081997|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14081998|NCT02512315|Cisplatin|cisplatin|mesh-list
14081999|NCT02512315|Docetaxel|docetaxel|mesh-list
14082000|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082001|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14082002|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14082003|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14082004|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082005|NCT02512055|Atropine|atropine|mesh-list
14082006|NCT02512055|Ketamine|ketamine|mesh-list
14082007|NCT02512055|Analgesics|analgesics|mesh-ancestor
14082008|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
14082009|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082010|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082011|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14082012|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14082013|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
14082014|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
14082015|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082016|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14082017|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14082018|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082019|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082020|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14082021|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14082022|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14082023|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
14082024|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14082025|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
14082026|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
14082027|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
14082028|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14082029|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14082030|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
14082031|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
14082032|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14082033|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082034|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082035|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082036|NCT02511795|Olaparib|olaparib|mesh-list
14082037|NCT02511795|Adavosertib|adavosertib|mesh-list
14082038|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14082039|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082040|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082041|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082042|NCT02511613|Squalamine|squalamine|mesh-list
14082043|NCT02511613|Ranibizumab|ranibizumab|mesh-list
14082044|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14082045|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14082046|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14082047|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14082048|NCT02511613|Growth Substances|growth substances|mesh-ancestor
14082049|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082050|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
14082051|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082052|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082053|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082054|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14082055|NCT02511613|Protective Agents|protective agents|mesh-ancestor
14082056|NCT02511665|Metformin|metformin|mesh-list
14082057|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082058|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082059|NCT02511847|Afatinib|afatinib|mesh-list
14082060|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082061|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14082062|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082063|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082064|NCT02511639|Everolimus|everolimus|mesh-list
14082065|NCT02511639|Letrozole|letrozole|mesh-list
14082066|NCT02511639|Anastrozole|anastrozole|mesh-list
14759464|NCT04776252|Islatravir|islatravir|mesh-list
14759465|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
14759466|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759467|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759468|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759469|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14759470|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14759471|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14759472|NCT04775953|Vancomycin|vancomycin|mesh-list
14759473|NCT04775953|Cefazolin|cefazolin|mesh-list
14759474|NCT04775953|Daptomycin|daptomycin|mesh-list
14759475|NCT04775953|Dalbavancin|dalbavancin|mesh-list
14759476|NCT04775953|Oxacillin|oxacillin|mesh-list
14759477|NCT04775953|Nafcillin|nafcillin|mesh-list
14759478|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14759479|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759480|NCT04772196|Vitamin D|vitamin d|mesh-list
14759481|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
14082067|NCT02511639|Exemestane|exemestane|mesh-list
14759482|NCT04772196|Vitamins|vitamins|mesh-ancestor
14759483|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
14082068|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14082069|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082070|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082071|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
14082072|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082073|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14082074|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082075|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082076|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14082077|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
14082078|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082079|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14082080|NCT02511483|Propranolol|propranolol|mesh-list
14934898|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14934899|NCT01459380|Carboplatin|carboplatin|mesh-list
14934900|NCT01459380|Doxorubicin|doxorubicin|mesh-list
14934901|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14934902|NCT01459380|Veliparib|veliparib|mesh-list
14082081|NCT02511483|Morphine|morphine|mesh-list
14082082|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14082083|NCT02511483|Narcotics|narcotics|mesh-ancestor
14082084|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082085|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082086|NCT02511483|Analgesics|analgesics|mesh-ancestor
14082087|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
14082088|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082089|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14082090|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14082091|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082092|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934903|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
14934904|NCT01459380|Antibodies|antibodies|mesh-list
14934905|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
14934906|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14934907|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
14934908|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934909|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13916452|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916453|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916454|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916455|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
13916456|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
13916457|NCT03464435|Tobramycin|tobramycin|mesh-list
13916458|NCT03464435|Tacrolimus|tacrolimus|mesh-list
13916459|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916460|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
13916461|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934910|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14934911|NCT01459380|Growth Substances|growth substances|mesh-ancestor
14934912|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934913|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
14934914|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
14934915|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14934916|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14934917|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14934918|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934919|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934920|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14934921|NCT01459406|Levan|levan|mesh-list
14934922|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934923|NCT01459419|Antibodies|antibodies|mesh-list
14934924|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14082093|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082094|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14082095|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14082096|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
14082097|NCT02511704|Nicotine|nicotine|mesh-list
14082098|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14082099|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
14082100|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082101|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082102|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14082103|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14082104|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
14082105|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082106|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082107|NCT02511574|Progesterone|progesterone|mesh-list
14082108|NCT02511574|Progestins|progestins|mesh-ancestor
14082109|NCT02511574|Hormones|hormones|mesh-ancestor
14082110|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082111|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082112|NCT02511405|Bevacizumab|bevacizumab|mesh-list
14082113|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14082114|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082115|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14082116|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14082117|NCT02511405|Growth Substances|growth substances|mesh-ancestor
14082118|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082119|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14082120|NCT02511353|Ivermectin|ivermectin|mesh-list
14082121|NCT02511353|Piperaquine|piperaquine|mesh-list
14082122|NCT02511353|Artenimol|artenimol|mesh-list
14082123|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14082124|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082125|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
14082126|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14082127|NCT02511418|Simvastatin|simvastatin|mesh-list
14082128|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14082129|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14082130|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
14082131|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082132|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14082133|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14082134|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916462|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14082135|NCT02511366|Caseins|caseins|mesh-list
14082136|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
14082137|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
13916463|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916464|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916465|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13916466|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916467|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14082138|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082139|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
14082140|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14082141|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082142|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082143|NCT02511327|Vaccines|vaccines|mesh-list
14759484|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759485|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14759486|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14759487|NCT04771741|Acetaminophen|acetaminophen|mesh-list
14759488|NCT04771741|Ketorolac|ketorolac|mesh-list
14759489|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14759490|NCT04771741|Meloxicam|meloxicam|mesh-list
13916468|NCT03464305|Aspirin|aspirin|mesh-list
14082144|NCT02511327|Immunologic Factors|immunologic factors|mesh-ancestor
14082145|NCT02511327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082146|NCT02511223|Olaparib|olaparib|mesh-list
14082147|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14082148|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082149|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082150|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082151|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14082152|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14082153|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14082154|NCT02511210|Anesthetics|anesthetics|mesh-list
14082155|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476861|NCT02421419|Dexamethasone|dexamethasone|mesh-list
14759491|NCT04771741|Pregabalin|pregabalin|mesh-list
13916469|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13916470|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916471|NCT03464305|Analgesics|analgesics|mesh-ancestor
13916472|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
13916473|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916474|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916475|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916476|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916477|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13916478|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13916479|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916480|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13916481|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14082156|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082157|NCT02511054|Chloroquine|chloroquine|mesh-list
14082158|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
14082159|NCT02511054|Amebicides|amebicides|mesh-ancestor
14082160|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14082161|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14082162|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082163|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
14082164|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14082165|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14082166|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082167|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082168|NCT02511067|Ranibizumab|ranibizumab|mesh-list
14082169|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14082170|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14082171|NCT02511067|Growth Substances|growth substances|mesh-ancestor
14082172|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082173|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
14082174|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082175|NCT02511132|Irinotecan|irinotecan|mesh-list
14082176|NCT02511132|Temozolomide|temozolomide|mesh-list
14082177|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14082178|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14082179|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082180|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082181|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082182|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14082183|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
14082184|NCT02510976|Prucalopride|prucalopride|mesh-list
14082185|NCT02510976|Laxatives|laxatives|mesh-ancestor
14082186|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082187|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14759492|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
14759493|NCT04771741|Analgesics|analgesics|mesh-ancestor
14759494|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
14759495|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759496|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759497|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
14082188|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14082189|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
14082190|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082191|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082192|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082193|NCT02510781|Carboplatin|carboplatin|mesh-list
14082194|NCT02510781|Docetaxel|docetaxel|mesh-list
14082195|NCT02510781|Trastuzumab|trastuzumab|mesh-list
14082196|NCT02510781|Epirubicin|epirubicin|mesh-list
14082197|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082198|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
14082199|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
14082200|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
14082201|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082202|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14082203|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14082204|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14082205|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14082206|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759498|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14082207|NCT02510911|Caffeine|caffeine|mesh-list
14759499|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14759500|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759501|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14759502|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13916482|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916483|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
13916484|NCT03464292|Capsaicin|capsaicin|mesh-list
13916485|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
13916486|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916487|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
13916488|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916489|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916490|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13916491|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960118|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082208|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14082209|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082210|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14082211|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082212|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082213|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14082214|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14082215|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
14082216|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082217|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14082218|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14082219|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173637|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173638|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14173639|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
14173640|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173641|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
14173642|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173643|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173644|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173645|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
14173646|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173647|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14173648|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
14173649|NCT04796025|Bevacizumab|bevacizumab|mesh-list
14173650|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14173651|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173652|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14173653|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14173654|NCT04796025|Growth Substances|growth substances|mesh-ancestor
14173655|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173656|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
14173657|NCT04795752|Cyclosporine|cyclosporine|mesh-list
14173658|NCT04795752|Cyclosporins|cyclosporins|mesh-list
14173659|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173660|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173661|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173662|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
14173663|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173664|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
14173665|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173666|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
14173667|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173668|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14173669|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
14173670|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14173671|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173672|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14173673|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14173674|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173675|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173676|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173677|NCT04794738|Morphine|morphine|mesh-list
14173678|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14173679|NCT04794738|Narcotics|narcotics|mesh-ancestor
14173680|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173681|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082220|NCT02510950|Temozolomide|temozolomide|mesh-list
14082221|NCT02510950|Poly ICLC|poly iclc|mesh-list
14082222|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14082223|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
14082224|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759503|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14759504|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759505|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14082225|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082226|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
14082227|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
14082228|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082229|NCT02510586|Sevoflurane|sevoflurane|mesh-list
14082230|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14082231|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14082232|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
14759506|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14759507|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14082233|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
14082234|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082235|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082236|NCT02510534|Menotropins|menotropins|mesh-list
14082237|NCT02510534|Progesterone|progesterone|mesh-list
14082238|NCT02510534|Progestins|progestins|mesh-ancestor
14082239|NCT02510534|Hormones|hormones|mesh-ancestor
14082240|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082241|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082242|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14759508|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759509|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14759510|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14759511|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082243|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
14082244|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14082245|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
14082246|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14082247|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082248|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082249|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14082250|NCT02510612|Analgesics|analgesics|mesh-ancestor
14082251|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
14082252|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082253|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14082254|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14082255|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14082256|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082257|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082258|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082259|NCT02510963|Tenofovir|tenofovir|mesh-list
14082260|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
14082261|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082262|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14082263|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14082264|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082265|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082266|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14082267|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14082268|NCT02510287|Lidocaine|lidocaine|mesh-list
14082269|NCT02510287|Fentanyl|fentanyl|mesh-list
14082270|NCT02510287|Bupivacaine|bupivacaine|mesh-list
14082271|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
14082272|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
14082273|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082274|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082275|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
14759512|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
14082276|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082277|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14759513|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14082278|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14082279|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14082280|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14082281|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082282|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14082283|NCT02510287|Narcotics|narcotics|mesh-ancestor
14082284|NCT02510287|Analgesics|analgesics|mesh-ancestor
13916492|NCT03464266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13916493|NCT03464266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13916494|NCT03464266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13916495|NCT03464266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916496|NCT03464266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916497|NCT03464266|Antiviral Agents|antiviral agents|mesh-ancestor
13916498|NCT03464266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916499|NCT03464266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14082285|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14082286|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14082287|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
14082288|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
14082289|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082290|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082291|NCT02510469|Apatinib|apatinib|mesh-list
14082292|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082293|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14082294|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082295|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082296|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
14082297|NCT02510222|Analgesics|analgesics|mesh-ancestor
14082298|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
14082299|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082300|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082301|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
14082302|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082303|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14082304|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
14082305|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14082306|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14082307|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082308|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14082309|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
14082310|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14082311|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
14082312|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14082313|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
14082314|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082315|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
14082316|NCT02510235|Protective Agents|protective agents|mesh-ancestor
13916500|NCT03464266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13960119|NCT03157414|Empagliflozin|empagliflozin|mesh-list
13960120|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13960121|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960122|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960123|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960124|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
13960125|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13960126|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
13960127|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082317|NCT02510157|Dexamethasone|dexamethasone|mesh-list
14082318|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14082319|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
14082320|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
14082321|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082322|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082323|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082324|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
14082325|NCT02510157|Hormones|hormones|mesh-ancestor
14082326|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082327|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14082328|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082329|NCT02510053|Caspofungin|caspofungin|mesh-list
14082330|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
14082331|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082332|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082333|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082334|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
14082335|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14082336|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082337|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916501|NCT03464084|Melatonin|melatonin|mesh-list
13916502|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
13916503|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476862|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
14476863|NCT02421419|Lidocaine|lidocaine|mesh-list
14476864|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14476865|NCT02421419|BB 1101|bb 1101|mesh-list
13916504|NCT03464084|Protective Agents|protective agents|mesh-ancestor
14082338|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14082339|NCT02509949|Analgesics|analgesics|mesh-ancestor
14082340|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
14082341|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082342|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14082343|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14082344|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14082345|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082346|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082347|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082348|NCT02509923|Rabeprazole|rabeprazole|mesh-list
14082349|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14082350|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082351|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14082352|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082353|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082354|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
14082355|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14082356|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14082357|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14082358|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082359|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082360|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082361|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476866|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916505|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916506|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916507|NCT03464058|Rabeprazole|rabeprazole|mesh-list
13916508|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13916509|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13916510|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13916511|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960128|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
14476867|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
14476868|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
14476869|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476870|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476871|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476872|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
14476873|NCT02421419|Hormones|hormones|mesh-ancestor
14476874|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476875|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14476876|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082362|NCT02509806|Apatinib|apatinib|mesh-list
14082363|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082364|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14082365|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759514|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14759515|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
14759516|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14759517|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14759518|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
14759519|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14759520|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14759521|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14759522|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14476877|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
14476878|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
14476879|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14476880|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
14476881|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14476882|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14759523|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14759524|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759525|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
14759526|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759527|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759528|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14759529|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759530|NCT04765202|Carisoprodol|carisoprodol|mesh-list
14934925|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
13916512|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916513|NCT03464019|Etripamil|etripamil|mesh-list
13916514|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13916515|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13916516|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916517|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13916518|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916519|NCT03463967|Lycopene|lycopene|mesh-list
13960129|NCT03157193|Protective Agents|protective agents|mesh-ancestor
13916520|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14082366|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082367|NCT02509728|Choline|choline|mesh-list
14082368|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
14082369|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14082370|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
14082371|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082372|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13916521|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
13916522|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916523|NCT03463967|Protective Agents|protective agents|mesh-ancestor
13916524|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916525|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13916526|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13916527|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916528|NCT03463876|Apatinib|apatinib|mesh-list
14082373|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14082374|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
14082375|NCT02509429|Insulin|insulin|mesh-list
14082376|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14082377|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
14082378|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
14082379|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14082380|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
14082381|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082382|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082383|NCT02509273|Clonidine|clonidine|mesh-list
14082384|NCT02509273|Midazolam|midazolam|mesh-list
14082385|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14082386|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14082387|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082388|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082389|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14082390|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14082391|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14082392|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14082393|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
14759531|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14759532|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759533|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14082394|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
14082395|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
14082396|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
14082397|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082398|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082399|NCT02509273|Analgesics|analgesics|mesh-ancestor
14082400|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
14082401|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082402|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14082403|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
14082404|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
14082405|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14082406|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14082407|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14082408|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082409|NCT02509468|Sirolimus|sirolimus|mesh-list
14082410|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082411|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082412|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14082413|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082414|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
14082415|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082416|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
14082417|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082418|NCT02509559|Propranolol|propranolol|mesh-list
14082419|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14082420|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14082421|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
14759534|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082422|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082423|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082424|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082425|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14082426|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14082427|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
14082428|NCT02509312|Ketorolac|ketorolac|mesh-list
14082429|NCT02509312|Morphine|morphine|mesh-list
14082430|NCT02509312|Hydromorphone|hydromorphone|mesh-list
14082431|NCT02509312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14082432|NCT02509312|Narcotics|narcotics|mesh-ancestor
14082433|NCT02509312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082434|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082435|NCT02509312|Analgesics|analgesics|mesh-ancestor
14082436|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
14082437|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082438|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14082439|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14082440|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759535|NCT04765059|Cisplatin|cisplatin|mesh-list
14082441|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14082442|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14082443|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082444|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082445|NCT02509351|Misoprostol|misoprostol|mesh-list
14082446|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14082447|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
14082448|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14082449|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082450|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14082451|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082452|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
14082453|NCT02509286|Leucovorin|leucovorin|mesh-list
14082454|NCT02509286|Paclitaxel|paclitaxel|mesh-list
14082455|NCT02509286|Docetaxel|docetaxel|mesh-list
14082456|NCT02509286|Carboplatin|carboplatin|mesh-list
14082457|NCT02509286|Fluorouracil|fluorouracil|mesh-list
14082458|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
14082459|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14082460|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082461|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
14082462|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
14082463|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
14082464|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082465|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
14082466|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14082467|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082468|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
14082469|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082470|NCT02509286|Antidotes|antidotes|mesh-ancestor
14082471|NCT02509286|Protective Agents|protective agents|mesh-ancestor
14082472|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
14082473|NCT02509286|Vitamins|vitamins|mesh-ancestor
14082474|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
14082475|NCT02509234|Irinotecan|irinotecan|mesh-list
14082476|NCT02509234|Trabectedin|trabectedin|mesh-list
14082477|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14082478|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14082479|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082480|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082481|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082482|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14082483|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
14082484|NCT02509208|Hemostatics|hemostatics|mesh-list
14082485|NCT02509208|Coagulants|coagulants|mesh-ancestor
14476883|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14476884|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476885|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476886|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
14476887|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082486|NCT02509195|Lamivudine|lamivudine|mesh-list
14082487|NCT02509195|Abacavir|abacavir|mesh-list
14082488|NCT02509195|Dolutegravir|dolutegravir|mesh-list
13916529|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916530|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13916531|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916532|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082489|NCT02509195|Triumeq|triumeq|mesh-list
14082490|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14082491|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14082492|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082493|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082494|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
14082495|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082496|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14082497|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14082498|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14476888|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14476889|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14476890|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476891|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13916533|NCT03463733|Temozolomide|temozolomide|mesh-list
13916534|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
13916535|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13916536|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
14082499|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14173682|NCT04794738|Analgesics|analgesics|mesh-ancestor
14082500|NCT02509143|Ramosetron|ramosetron|mesh-list
14082501|NCT02509143|Antiemetics|antiemetics|mesh-list
14082502|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
14476892|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476893|NCT02421588|Doxorubicin|doxorubicin|mesh-list
14476894|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14476895|NCT02421588|Topotecan|topotecan|mesh-list
14082503|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082504|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082505|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082506|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14082507|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
14082508|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082509|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082510|NCT02508870|Azacitidine|azacitidine|mesh-list
14082511|NCT02508870|Atezolizumab|atezolizumab|mesh-list
14082512|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14082513|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
14082514|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082515|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082516|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082517|NCT02509091|Amikacin|amikacin|mesh-list
14082518|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082519|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082520|NCT02509052|Leflunomide|leflunomide|mesh-list
14476896|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14476897|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14476898|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14476899|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14476900|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14476901|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476902|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14476903|NCT02421887|Antioxidants|antioxidants|mesh-list
14476904|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476905|NCT02421887|Protective Agents|protective agents|mesh-ancestor
14476906|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916537|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916538|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916539|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
13916540|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916541|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13916542|NCT03463642|Vitamin D|vitamin d|mesh-list
13916543|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
13916544|NCT03463642|Mineral Oil|mineral oil|mesh-list
13916545|NCT03463642|Vitamins|vitamins|mesh-ancestor
13916546|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
13916547|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916548|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13916549|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13916550|NCT03463642|Emollients|emollients|mesh-ancestor
13916551|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916552|NCT03463577|Vaccines|vaccines|mesh-list
13916553|NCT03463577|Immunologic Factors|immunologic factors|mesh-ancestor
13916554|NCT03463577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916555|NCT03463564|Insulin|insulin|mesh-list
13916556|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13916557|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13916558|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916559|NCT03463525|Osimertinib|osimertinib|mesh-list
14082521|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082522|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082523|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082524|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
14082525|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082526|NCT02508857|Ketorolac|ketorolac|mesh-list
14082527|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
14082528|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14082529|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14082530|NCT02508857|Analgesics|analgesics|mesh-ancestor
14082531|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
14082532|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082533|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082534|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14082535|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14082536|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14082537|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082538|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082539|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
14082540|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082541|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14082542|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
14082543|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14082544|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14082545|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14082546|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
14082547|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14934926|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082548|NCT02508922|Vitamin D|vitamin d|mesh-list
14082549|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
14082550|NCT02508922|Vitamins|vitamins|mesh-ancestor
14082551|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
14082552|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082553|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14082554|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14082555|NCT02508805|Diclofenac|diclofenac|mesh-list
14082556|NCT02508805|Tizanidine|tizanidine|mesh-list
14082557|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14082558|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14082559|NCT02508805|Analgesics|analgesics|mesh-ancestor
14082560|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
14082561|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082562|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082563|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14082564|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14082565|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14082566|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082567|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082568|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
14082569|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14082570|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13916560|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916561|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13916562|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916563|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916564|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
13916565|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13916566|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
13916567|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082571|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
14082572|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
14082573|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14082574|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14082575|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14476907|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14934927|NCT01459445|Metformin|metformin|mesh-list
14934928|NCT01459445|Drospirenone|drospirenone|mesh-list
14934929|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14934930|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14934931|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934932|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14476908|NCT02422186|Citalopram|citalopram|mesh-list
14082576|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082577|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082578|NCT02509104|Tamsulosin|tamsulosin|mesh-list
14082579|NCT02509104|Dutasteride|dutasteride|mesh-list
14082580|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14082581|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14082582|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14082583|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082584|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082585|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082586|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082587|NCT02509104|Urological Agents|urological agents|mesh-ancestor
14082588|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14082589|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14082590|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082591|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
14082592|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082593|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
14082594|NCT02508753|Tazobactam|tazobactam|mesh-list
14082595|NCT02508753|Ceftolozane|ceftolozane|mesh-list
14082596|NCT02508753|Cephalosporins|cephalosporins|mesh-list
14082597|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082598|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082599|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14082600|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14082601|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082602|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082603|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082604|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14082605|NCT02508623|Rifaximin|rifaximin|mesh-list
14082606|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082607|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082608|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082609|NCT02508584|Antibodies|antibodies|mesh-list
14082610|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
14082611|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082612|NCT02508402|Dexamethasone|dexamethasone|mesh-list
14082613|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14082614|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
14082615|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
14082616|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082617|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082618|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082619|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
14082620|NCT02508402|Hormones|hormones|mesh-ancestor
14082621|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082622|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14082623|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082624|NCT02508311|Albuterol|albuterol|mesh-list
14082625|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14082626|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
14082627|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082628|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082629|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14082630|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
14082631|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
14082632|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14082633|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14082634|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14082635|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14082636|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
14082637|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759536|NCT04765059|Carboplatin|carboplatin|mesh-list
14082638|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082639|NCT02508350|Daptomycin|daptomycin|mesh-list
14082640|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082641|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082642|NCT02508168|Metformin|metformin|mesh-list
14082643|NCT02508168|Alogliptin|alogliptin|mesh-list
14082644|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082645|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082646|NCT02508168|Incretins|incretins|mesh-ancestor
14082647|NCT02508168|Hormones|hormones|mesh-ancestor
14082648|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082649|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14082650|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
14082651|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082652|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082653|NCT02508246|Cisplatin|cisplatin|mesh-list
14082654|NCT02508246|Docetaxel|docetaxel|mesh-list
14082655|NCT02508246|Adavosertib|adavosertib|mesh-list
14082656|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082657|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
14082658|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
14082659|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
14082660|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082661|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082662|NCT02508142|Scopolamine|scopolamine|mesh-list
14082663|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14082664|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14082665|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
14082666|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
14082667|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082668|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082669|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082670|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
14082671|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14082672|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
14082673|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082674|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082675|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14082676|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
14082677|NCT02508220|Oxytocin|oxytocin|mesh-list
14082678|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
14082679|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14082680|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916568|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
13916569|NCT03463499|Protective Agents|protective agents|mesh-ancestor
14082681|NCT02508064|Fostemsavir|fostemsavir|mesh-list
13916582|NCT03463382|Bupivacaine|bupivacaine|mesh-list
13916583|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
13916584|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
13916585|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082682|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14082683|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14082684|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
14082685|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082686|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14082687|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14082688|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082689|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
14082690|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14082691|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
14082692|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082693|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
14082694|NCT02507934|Protective Agents|protective agents|mesh-ancestor
14082695|NCT02507843|Vitamin D|vitamin d|mesh-list
14082696|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
14082697|NCT02507843|Vitamins|vitamins|mesh-ancestor
14082698|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
14082699|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082700|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14082701|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14082702|NCT02507583|Insulin|insulin|mesh-list
14082703|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082704|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082705|NCT02507648|Oseltamivir|oseltamivir|mesh-list
14082706|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
14082707|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082708|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082709|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082710|NCT02507635|Levocetirizine|levocetirizine|mesh-list
14082711|NCT02507635|Desloratadine|desloratadine|mesh-list
14082712|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14082713|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14082714|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
14082715|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
14082716|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082717|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082718|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082719|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14082720|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
14082721|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14082722|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082723|NCT02507479|Thiotepa|thiotepa|mesh-list
14082724|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14082725|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
14476909|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13916586|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916587|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
14173683|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
14082726|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082727|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082728|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14082729|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082730|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
14082731|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082732|NCT02507700|Bupivacaine|bupivacaine|mesh-list
14082733|NCT02507700|Sevoflurane|sevoflurane|mesh-list
14082734|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
14082735|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
14082736|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082737|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082738|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
14082739|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082740|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14082741|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14082742|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
14082743|NCT02507609|Rocuronium|rocuronium|mesh-list
14082744|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082745|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14082746|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14082747|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14082748|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082749|NCT02507440|Lidocaine|lidocaine|mesh-list
14082750|NCT02507440|Propofol|propofol|mesh-list
14082751|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
14082752|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
14082753|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082754|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082755|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
14082756|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082757|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14082758|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14082759|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14082760|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14082761|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082762|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14082763|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14082764|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
14082765|NCT02507362|Riboflavin|riboflavin|mesh-list
14082766|NCT02507362|Dextrans|dextrans|mesh-list
14082767|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
14082768|NCT02507362|Vitamins|vitamins|mesh-ancestor
14082769|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
14082770|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082771|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14082772|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
14082773|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
14082774|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
14082775|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
14082776|NCT02507336|Thalidomide|thalidomide|mesh-list
14082777|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082778|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
14082779|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082780|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
14082781|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082782|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082783|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14082784|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14082785|NCT02507336|Growth Substances|growth substances|mesh-ancestor
14082786|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
14759537|NCT04765059|Pemetrexed|pemetrexed|mesh-list
14759538|NCT04765059|Osimertinib|osimertinib|mesh-list
14759539|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759540|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759541|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759542|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14759543|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14082787|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082788|NCT02507323|Ticagrelor|ticagrelor|mesh-list
14082789|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14082790|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14082791|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14082792|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14082793|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14082794|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
14082795|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082796|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082797|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082798|NCT02507245|Hormones|hormones|mesh-list
14082799|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14082800|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082801|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082802|NCT02507232|Temozolomide|temozolomide|mesh-list
14082803|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14082804|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
14082805|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082806|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173684|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173685|NCT04794842|Phenol|phenol|mesh-list
14173686|NCT04794842|Tetracaine|tetracaine|mesh-list
14173687|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
14173688|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
14173689|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173690|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173691|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
14173692|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173693|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14173694|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173695|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
14173696|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14173697|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14173698|NCT04794426|Fluorides|fluorides|mesh-list
14173699|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
14173700|NCT04794426|Protective Agents|protective agents|mesh-ancestor
14173701|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173702|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
14173703|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14173704|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14082807|NCT02507284|SRX246|srx246|mesh-list
14082808|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14082809|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082810|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
14082811|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082812|NCT02506998|Histamine|histamine|mesh-list
14082813|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
14082814|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14082815|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
14082816|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
14082817|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
14082818|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082819|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082820|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082821|NCT02507167|Rifampin|rifampin|mesh-list
14082822|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14082823|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
14759544|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759545|NCT04763759|Antibodies|antibodies|mesh-list
14759546|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14759547|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
14759548|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759549|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14759550|NCT04750954|Peposertib|peposertib|mesh-list
14759551|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759552|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14759553|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759554|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759555|NCT04749628|Cannabidiol|cannabidiol|mesh-list
14759556|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
13916588|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916589|NCT03463317|Aspirin|aspirin|mesh-list
13916590|NCT03463317|Warfarin|warfarin|mesh-list
13916591|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
13916592|NCT03463317|Dabigatran|dabigatran|mesh-list
13916593|NCT03463317|Apixaban|apixaban|mesh-list
13916594|NCT03463317|Edoxaban|edoxaban|mesh-list
13916595|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
13916596|NCT03463317|Clopidogrel|clopidogrel|mesh-list
13916597|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13916598|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13916599|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13916600|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13916601|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
14082824|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082825|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082826|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
14082827|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14082828|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082829|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082830|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14082831|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14082832|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14759564|NCT04739592|Vitamin D|vitamin d|mesh-list
14759565|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
14759566|NCT04739592|Alendronate|alendronate|mesh-list
14759567|NCT04739592|Vitamins|vitamins|mesh-ancestor
14759568|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
14759569|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759570|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14759571|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14759579|NCT04736199|Androgens|androgens|mesh-list
14759580|NCT04736199|Hormones|hormones|mesh-ancestor
14759581|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759582|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759583|NCT04729387|Paclitaxel|paclitaxel|mesh-list
14759584|NCT04729387|Doxorubicin|doxorubicin|mesh-list
14759585|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14759586|NCT04729387|Olaparib|olaparib|mesh-list
14759587|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759588|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759589|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759590|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759591|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759592|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759593|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14759594|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759595|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14759596|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759597|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14759598|NCT04722146|Lenalidomide|lenalidomide|mesh-list
14934933|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14934934|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14934935|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
14082833|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14476910|NCT02422186|Sertraline|sertraline|mesh-list
14934936|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14759599|NCT04722146|Pomalidomide|pomalidomide|mesh-list
14759600|NCT04722146|Bortezomib|bortezomib|mesh-list
14759601|NCT04722146|Daratumumab|daratumumab|mesh-list
14759602|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
14759603|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759604|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14759605|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14759606|NCT04722146|Growth Substances|growth substances|mesh-ancestor
14759607|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
14082834|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14082835|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14082836|NCT02507076|Melphalan|melphalan|mesh-list
14082837|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14082838|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
14082839|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082840|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082841|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14082842|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082843|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
14082844|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082845|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
14082846|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
14082847|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
14082848|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082849|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082850|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082851|NCT02507128|Liraglutide|liraglutide|mesh-list
14082852|NCT02507128|Glucagon|glucagon|mesh-list
14082853|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14082854|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082855|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082856|NCT02507128|Incretins|incretins|mesh-ancestor
14082857|NCT02507128|Hormones|hormones|mesh-ancestor
14082858|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082859|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14082860|NCT02506803|Gemcitabine|gemcitabine|mesh-list
14082861|NCT02506803|Paclitaxel|paclitaxel|mesh-list
14082862|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14082863|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082864|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
14082865|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
14082866|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
14082867|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082868|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14082869|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
14082870|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
14082871|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082872|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082873|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082874|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
14082875|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082876|NCT02507154|Cetuximab|cetuximab|mesh-list
14082877|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14082878|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082879|NCT02506842|Leucovorin|leucovorin|mesh-list
14082880|NCT02506842|Folic Acid|folic acid|mesh-list
14082881|NCT02506842|Gemcitabine|gemcitabine|mesh-list
14082882|NCT02506842|Fluorouracil|fluorouracil|mesh-list
14759608|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759609|NCT04717414|Luspatercept|luspatercept|mesh-list
14082883|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
14082884|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
14082885|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082886|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082887|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14082888|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
13916602|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916603|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916604|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916605|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
14082889|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
14082890|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082891|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082892|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082893|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
14082894|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082895|NCT02506842|Antidotes|antidotes|mesh-ancestor
14082896|NCT02506842|Protective Agents|protective agents|mesh-ancestor
14082897|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
14082898|NCT02506842|Vitamins|vitamins|mesh-ancestor
14082899|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
14082900|NCT02506842|Hematinics|hematinics|mesh-ancestor
14082901|NCT02506699|Analgesics|analgesics|mesh-list
14082902|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
14082903|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082904|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082905|NCT02506777|Metformin|metformin|mesh-list
14082906|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
14082907|NCT02506777|Doxorubicin|doxorubicin|mesh-list
14082908|NCT02506777|Fluorouracil|fluorouracil|mesh-list
14082909|NCT02506777|Melatonin|melatonin|mesh-list
14082910|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14082911|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
14082912|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082913|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14082914|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14082915|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
14082916|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082917|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082918|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14082919|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082920|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14082921|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14082922|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14082923|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082924|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
14082925|NCT02506777|Protective Agents|protective agents|mesh-ancestor
14082926|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082927|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
13916606|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13916607|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
13916608|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14082928|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13916609|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
14082929|NCT02506647|Insulin|insulin|mesh-list
14082930|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14082931|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
14082932|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082933|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082934|NCT02506790|Toremifene|toremifene|mesh-list
14082935|NCT02506790|Metformin|metformin|mesh-list
14082936|NCT02506790|Melatonin|melatonin|mesh-list
14082937|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14082938|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082939|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
14082940|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082941|NCT02506790|Protective Agents|protective agents|mesh-ancestor
14082942|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082943|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14082944|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082945|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14082946|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14082947|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
14082948|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14082949|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14082950|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
14082951|NCT02506894|Analgesics|analgesics|mesh-ancestor
14082952|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
14082953|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082954|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082955|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
14082956|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082957|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14082958|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
14082959|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14082960|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14082961|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082962|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14082963|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
14082964|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14082965|NCT02506829|Nicotine|nicotine|mesh-list
14082966|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14082967|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
14082968|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082969|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082970|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14082971|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14082972|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
14082973|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14082974|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082975|NCT02506686|Meropenem|meropenem|mesh-list
14082976|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14082977|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14082978|NCT02506855|Ropivacaine|ropivacaine|mesh-list
14082979|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
14082980|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
14082981|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14082982|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759610|NCT04717414|Hematinics|hematinics|mesh-ancestor
14759611|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
14759612|NCT04710277|Narcotics|narcotics|mesh-ancestor
14759613|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759614|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759615|NCT04710277|Analgesics|analgesics|mesh-ancestor
14759616|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
14759617|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759618|NCT04708782|Treprostinil|treprostinil|mesh-list
14082983|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
14082984|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082985|NCT02506517|Afatinib|afatinib|mesh-list
14082986|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14082987|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14082988|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14082989|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14082990|NCT02506348|Diclofenac|diclofenac|mesh-list
14082991|NCT02506348|Nepafenac|nepafenac|mesh-list
14082992|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14082993|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14082994|NCT02506348|Analgesics|analgesics|mesh-ancestor
14082995|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
14082996|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14082997|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14082998|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14082999|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083000|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14083001|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083002|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083003|NCT02506439|Vitamin D|vitamin d|mesh-list
14083004|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
14083005|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
14083006|NCT02506439|Vitamins|vitamins|mesh-list
14083007|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
14083008|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083009|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14083010|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14083011|NCT02506231|Leucovorin|leucovorin|mesh-list
14083012|NCT02506231|Folic Acid|folic acid|mesh-list
14083013|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
14083014|NCT02506231|Antidotes|antidotes|mesh-ancestor
14083015|NCT02506231|Protective Agents|protective agents|mesh-ancestor
14083016|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083017|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
14083018|NCT02506231|Vitamins|vitamins|mesh-ancestor
14083019|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
14083020|NCT02506231|Hematinics|hematinics|mesh-ancestor
14083021|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14083022|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
14083023|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083024|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083025|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14083026|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083027|NCT02506140|Aspirin|aspirin|mesh-list
14083028|NCT02506140|Clopidogrel|clopidogrel|mesh-list
14083029|NCT02506140|Ticagrelor|ticagrelor|mesh-list
14083030|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14083031|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14083032|NCT02506140|Analgesics|analgesics|mesh-ancestor
14083033|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
14083034|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083035|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083036|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14083037|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083038|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14083039|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14083040|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083041|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13916610|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916611|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13916612|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916613|NCT03463317|Analgesics|analgesics|mesh-ancestor
13916614|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
13916615|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916616|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916617|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916618|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13916619|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13916620|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13916621|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
13916622|NCT03463265|Sirolimus|sirolimus|mesh-list
13916623|NCT03463265|Bevacizumab|bevacizumab|mesh-list
13916624|NCT03463265|Temozolomide|temozolomide|mesh-list
13916625|NCT03463265|Lomustine|lomustine|mesh-list
13960130|NCT03157388|Vancomycin|vancomycin|mesh-list
14083042|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14083043|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083044|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
14083045|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14083046|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14083047|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14083048|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
14083049|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083050|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14083051|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
14083052|NCT02506023|Coagulants|coagulants|mesh-ancestor
14083053|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14083054|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
14083055|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083056|NCT02505997|Midazolam|midazolam|mesh-list
14083057|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14083058|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14083059|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083060|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083061|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14083062|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14083063|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14083064|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083065|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
14083066|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
14083067|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
14083068|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
14083069|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083070|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083075|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
14083076|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14083077|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
14083078|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14083079|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14083080|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083081|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934937|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14934938|NCT01459445|Estrogens|estrogens|mesh-ancestor
14934939|NCT01459445|Hormones|hormones|mesh-ancestor
14083082|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
14083083|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083084|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083085|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14934940|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13916626|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13916627|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916628|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13916629|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13916630|NCT03463265|Growth Substances|growth substances|mesh-ancestor
13916631|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916632|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
13916633|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14083086|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14934941|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14934942|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
14934943|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14083087|NCT02505841|Ropivacaine|ropivacaine|mesh-list
14083088|NCT02505841|Succinylcholine|succinylcholine|mesh-list
14083089|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
14083090|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
14083091|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083092|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083093|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
14083094|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083095|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14083096|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14083097|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14083098|NCT02505776|Bimatoprost|bimatoprost|mesh-list
14083099|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14083100|NCT02505893|Sirolimus|sirolimus|mesh-list
14083101|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14083102|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083103|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14083104|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083105|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
14083106|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083107|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
14083108|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083109|NCT02505971|Propranolol|propranolol|mesh-list
14083110|NCT02505971|Nadolol|nadolol|mesh-list
14083111|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14083112|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14083113|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916634|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
13916635|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083114|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083115|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083116|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083117|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14083118|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14083119|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
14083120|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
14083121|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
14083122|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083123|NCT02505880|Anesthetics|anesthetics|mesh-list
14083124|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
14083125|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083126|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083127|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
14083128|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916636|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13916637|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916638|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13916639|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
13916640|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916641|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
14083129|NCT02505633|Lidocaine|lidocaine|mesh-list
14083130|NCT02505633|Epinephrine|epinephrine|mesh-list
14083131|NCT02505633|Racepinephrine|racepinephrine|mesh-list
14083132|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
14476911|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
14476912|NCT02422186|Esketamine|esketamine|mesh-list
14476913|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14476914|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14476915|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476916|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083133|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
14083134|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
14083135|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083136|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083137|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
14083138|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083139|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14083140|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14083141|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14083142|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083143|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476917|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476918|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
14083144|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14083145|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14083146|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
14083147|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083148|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14083149|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14083150|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
14083151|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13916642|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13916643|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
13916644|NCT03463252|Progesterone|progesterone|mesh-list
13916645|NCT03463252|Progestins|progestins|mesh-ancestor
13916646|NCT03463252|Hormones|hormones|mesh-ancestor
13916647|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13916648|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916649|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13916650|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13916651|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13916652|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
14083152|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083153|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
14083154|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
14083155|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14173705|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173706|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
14759619|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14759620|NCT04703075|Rifapentine|rifapentine|mesh-list
14759621|NCT04703075|Rifampin|rifampin|mesh-list
14759622|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14759623|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
14759624|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14759625|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173707|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
14173708|NCT04794413|Pimavanserin|pimavanserin|mesh-list
14173709|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14173710|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14173711|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14759626|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
14759627|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14759628|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759629|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916653|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13916654|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13916655|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13916656|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13916657|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13916658|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916659|NCT03463083|Fentanyl|fentanyl|mesh-list
13916660|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
13916661|NCT03463083|Bupivacaine|bupivacaine|mesh-list
13916662|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
13916663|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
13916664|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916665|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916666|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
13916667|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916668|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14173712|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14173713|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759630|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14083156|NCT02505451|Dobutamine|dobutamine|mesh-list
14083157|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14083158|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
14083159|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
14083160|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083161|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083162|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14083163|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14083164|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14083165|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
14083166|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083167|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083168|NCT02505451|Protective Agents|protective agents|mesh-ancestor
14083169|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
14083170|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14083171|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
14083172|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083173|NCT02505477|Expectorants|expectorants|mesh-ancestor
14083174|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083175|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14083176|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
14083177|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083178|NCT02505477|Protective Agents|protective agents|mesh-ancestor
14083179|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083180|NCT02505477|Antidotes|antidotes|mesh-ancestor
14083181|NCT02505516|Metformin|metformin|mesh-list
14083182|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14083183|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083184|NCT02505568|Infliximab|infliximab|mesh-list
14083185|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
14083186|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14083187|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083188|NCT02505581|Metronidazole|metronidazole|mesh-list
14083189|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
14083190|NCT02505581|Cefuroxime|cefuroxime|mesh-list
14083191|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
14083192|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083193|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14083194|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14083195|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14083196|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14083197|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14083198|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083199|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083200|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083201|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14083202|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14083203|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
14083204|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14083205|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
14083206|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083207|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
14083208|NCT02505360|Protective Agents|protective agents|mesh-ancestor
14083209|NCT02505295|Selenium|selenium|mesh-list
14083210|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
14083211|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083212|NCT02505295|Protective Agents|protective agents|mesh-ancestor
14083213|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083214|NCT02505295|Trace Elements|trace elements|mesh-ancestor
14083215|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
14083216|NCT02505282|Vitamin K|vitamin k|mesh-list
14083217|NCT02505282|Vitamins|vitamins|mesh-ancestor
14083218|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
14083219|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083220|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14083221|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14083222|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083223|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
14083224|NCT02505282|Coagulants|coagulants|mesh-ancestor
14083225|NCT02505399|Clopidogrel|clopidogrel|mesh-list
14083226|NCT02505399|Ticagrelor|ticagrelor|mesh-list
14083227|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14083228|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14083229|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14083230|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14083231|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
14083232|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083233|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083234|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083235|NCT02505386|Ertapenem|ertapenem|mesh-list
14083236|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14083237|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083238|NCT02505009|Tenofovir|tenofovir|mesh-list
14083239|NCT02505009|Entecavir|entecavir|mesh-list
14083240|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
14083241|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759631|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14759632|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14759633|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14759634|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14759635|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14083242|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14083243|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14083244|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083245|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083246|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14083247|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14083248|NCT02505048|Rucaparib|rucaparib|mesh-list
14083249|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14083250|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083251|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083252|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083253|NCT02505113|Montelukast|montelukast|mesh-list
14083254|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14083255|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083256|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14083257|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
14173714|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759636|NCT04702880|Carboplatin|carboplatin|mesh-list
14759637|NCT04702880|Nivolumab|nivolumab|mesh-list
14759638|NCT04702880|Etoposide|etoposide|mesh-list
14759639|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759640|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759641|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14759642|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934944|NCT01459445|Diuretics|diuretics|mesh-ancestor
14083258|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14083259|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083260|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14083261|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14083262|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083263|NCT02504944|Propranolol|propranolol|mesh-list
14083264|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14083265|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14083266|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14083267|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14083268|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
14083269|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083270|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083271|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083272|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14083273|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14083274|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
13960131|NCT03157388|Gentamicins|gentamicins|mesh-list
13960132|NCT03157388|Meropenem|meropenem|mesh-list
13960133|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13960134|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960135|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13960136|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960137|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960138|NCT03156855|Bismuth|bismuth|mesh-list
13960139|NCT03156855|Antacids|antacids|mesh-ancestor
13960140|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960141|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13960142|NCT03156920|Sumatriptan|sumatriptan|mesh-list
13960143|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13960144|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13960145|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13960146|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
13960147|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960148|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960149|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960150|NCT03156842|Amlodipine|amlodipine|mesh-list
13960151|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13960152|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13960153|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13960154|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13960155|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083275|NCT02504996|Acetaminophen|acetaminophen|mesh-list
14083276|NCT02504996|Morphine|morphine|mesh-list
14083277|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14083278|NCT02504996|Narcotics|narcotics|mesh-ancestor
14083279|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083280|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083281|NCT02504996|Analgesics|analgesics|mesh-ancestor
14083282|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
14083283|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083284|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14083285|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
14083286|NCT02504983|Sorafenib|sorafenib|mesh-list
14083287|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083288|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14083289|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083290|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083291|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
14083292|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14083293|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
14083294|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083295|NCT02505087|Expectorants|expectorants|mesh-ancestor
14083296|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083297|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14083298|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
14083299|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083300|NCT02505087|Protective Agents|protective agents|mesh-ancestor
14083301|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083302|NCT02505087|Antidotes|antidotes|mesh-ancestor
14083303|NCT02504801|Budesonide|budesonide|mesh-list
14083304|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14083305|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14083306|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
14083307|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083308|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083309|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14083310|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083311|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
14083312|NCT02504801|Hormones|hormones|mesh-ancestor
14083313|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14083314|NCT02504450|Haloperidol|haloperidol|mesh-list
14083315|NCT02504450|Ziprasidone|ziprasidone|mesh-list
14083316|NCT02504450|Loxapine|loxapine|mesh-list
14083317|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
14083318|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
14083319|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083320|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083321|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14083322|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14083323|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14083324|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083325|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14083326|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14476919|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083327|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
14083328|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083329|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083330|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14083331|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14083332|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
14083333|NCT02504489|Docetaxel|docetaxel|mesh-list
14083334|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083335|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14083336|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14083337|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14083338|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083339|NCT02504476|Midazolam|midazolam|mesh-list
14083340|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14083341|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14083342|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083343|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083344|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14083345|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14083346|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14083347|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083348|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
14083349|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
14083350|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
14083351|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
14083352|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083353|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083354|NCT02504463|Naltrexone|naltrexone|mesh-list
14083355|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14083356|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14083357|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083358|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
14083359|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083360|NCT02504398|Methamphetamine|methamphetamine|mesh-list
14083361|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14083362|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083363|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
14083364|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
14083365|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083366|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
14083367|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083368|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083369|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
14083370|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14083371|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14083372|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083373|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14083374|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
14083375|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14083376|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083377|NCT02504359|Cytarabine|cytarabine|mesh-list
14083378|NCT02504359|Methotrexate|methotrexate|mesh-list
14083379|NCT02504359|Etoposide|etoposide|mesh-list
14083380|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
14083381|NCT02504359|Melphalan|melphalan|mesh-list
14083382|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
14083383|NCT02504359|Carmustine|carmustine|mesh-list
14759643|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083384|NCT02504359|Ixazomib|ixazomib|mesh-list
14083385|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
14083386|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14083387|NCT02504359|Tacrolimus|tacrolimus|mesh-list
14083388|NCT02504359|Glycine|glycine|mesh-list
14083389|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14083390|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
14083391|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14083392|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083393|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14083394|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
14083395|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083396|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083397|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14083398|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083399|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14083400|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083401|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
14083402|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083403|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14083404|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083405|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14083406|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14083407|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
14083408|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083409|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14083410|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14083411|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
14083412|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14083413|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
14759644|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759645|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14759646|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083414|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
14083415|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14083416|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14083417|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14083418|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
14083419|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083420|NCT02504307|Sirolimus|sirolimus|mesh-list
14083421|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14083422|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083423|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14083424|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083425|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
14083426|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083427|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
14083428|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083429|NCT02504346|Osimertinib|osimertinib|mesh-list
14083430|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083431|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14083432|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083433|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083434|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
14083435|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083436|NCT02504333|Gemcitabine|gemcitabine|mesh-list
14759647|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
14759648|NCT04701476|Tirapazamine|tirapazamine|mesh-list
14759649|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14083437|NCT02504333|Paclitaxel|paclitaxel|mesh-list
14083438|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14083439|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083440|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083441|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
14083442|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
14083443|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14083444|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083445|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14083446|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
14083447|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
14083448|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083449|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083450|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083451|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
14083452|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083453|NCT02504177|Anticoagulants|anticoagulants|mesh-list
14083454|NCT02504164|Midazolam|midazolam|mesh-list
14083455|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14173715|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14759650|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759651|NCT04700124|Gemcitabine|gemcitabine|mesh-list
14759652|NCT04700124|Cisplatin|cisplatin|mesh-list
14759653|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
14759654|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759655|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759656|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
14759657|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083456|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14083457|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083458|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083459|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14083460|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14083461|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14083462|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083463|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
14083464|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
14083465|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
14759658|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
13916669|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14083466|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
14083467|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083468|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083469|NCT02504138|Anesthetics|anesthetics|mesh-list
14083470|NCT02504138|Propofol|propofol|mesh-list
14083471|NCT02504138|Desflurane|desflurane|mesh-list
14083472|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083473|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083474|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14083475|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083476|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
14083477|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14083478|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
14083479|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14083480|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14083481|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083482|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
14083483|NCT02504125|Coagulants|coagulants|mesh-ancestor
13916670|NCT03463083|Analgesics|analgesics|mesh-ancestor
13916671|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13916672|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13916673|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13916674|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916675|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916676|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916677|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13916678|NCT03463083|Narcotics|narcotics|mesh-ancestor
13916679|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13916680|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083484|NCT02503826|Midazolam|midazolam|mesh-list
14759659|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759660|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083485|NCT02503826|Sufentanil|sufentanil|mesh-list
14083486|NCT02503826|Dsuvia|dsuvia|mesh-list
14083487|NCT02503826|Propofol|propofol|mesh-list
14083488|NCT02503826|Cisatracurium|cisatracurium|mesh-list
14083489|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14083490|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083491|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083492|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083493|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
14083494|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
14083495|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14083496|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14083497|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14083498|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14083499|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
14083500|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
14083501|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916681|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
13916682|NCT03463070|Misoprostol|misoprostol|mesh-list
13916683|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13916684|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
13916685|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14083502|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083503|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14083504|NCT02503826|Narcotics|narcotics|mesh-ancestor
14083505|NCT02503826|Analgesics|analgesics|mesh-ancestor
14083506|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
14083507|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083508|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14083509|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14083510|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
14083511|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14083512|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083513|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14083514|NCT02503904|Metronidazole|metronidazole|mesh-list
14083515|NCT02503904|Lidocaine|lidocaine|mesh-list
14083516|NCT02503904|Epinephrine|epinephrine|mesh-list
14083517|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
14083518|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
14083519|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083520|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083521|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
14083522|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083523|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14083524|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14083525|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14083526|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083527|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083528|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083529|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14083530|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13916686|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916687|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13916688|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13916689|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
13916690|NCT03463044|Nangibotide|nangibotide|mesh-list
14083531|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916691|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14083532|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083533|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14083534|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14083535|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
14083536|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14083537|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083538|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
14083539|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
14083540|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14083541|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14083542|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14083543|NCT02503943|Metformin|metformin|mesh-list
14083544|NCT02503943|Liraglutide|liraglutide|mesh-list
14083545|NCT02503943|Mitiglinide|mitiglinide|mesh-list
14083546|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14083547|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083548|NCT02503943|Incretins|incretins|mesh-ancestor
14083549|NCT02503943|Hormones|hormones|mesh-ancestor
14083550|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173716|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14173717|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14173718|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
14173719|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173720|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173721|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14173722|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14173723|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173724|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173725|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14173726|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14173727|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173728|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
14173729|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183524|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183525|NCT04727437|Heparin|heparin|mesh-list
14183526|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14183527|NCT04727437|Tinzaparin|tinzaparin|mesh-list
14183528|NCT04727437|Dalteparin|dalteparin|mesh-list
14183529|NCT04727437|Warfarin|warfarin|mesh-list
14183530|NCT04727437|Anticoagulants|anticoagulants|mesh-list
14183531|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14183532|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14183533|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183534|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14183535|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
14183536|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183537|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14183538|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183539|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14759661|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14183540|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14083551|NCT02503761|Meropenem|meropenem|mesh-list
14083552|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14083553|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083554|NCT02503462|Ritonavir|ritonavir|mesh-list
14083555|NCT02503462|Darunavir|darunavir|mesh-list
14083556|NCT02503462|Cobicistat|cobicistat|mesh-list
14083557|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14083558|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14083559|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
14083560|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083561|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083562|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14083563|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14083564|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
14083565|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083566|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14083567|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14083568|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
14083569|NCT02503319|Oxytocin|oxytocin|mesh-list
14759662|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
14759663|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916692|NCT03463005|Propolis|propolis|mesh-list
13916693|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916694|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
14083570|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
14083571|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14083572|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083573|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14083574|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14083575|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083576|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
14083577|NCT02503319|Coagulants|coagulants|mesh-ancestor
14083578|NCT02503358|Paclitaxel|paclitaxel|mesh-list
14083579|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14083580|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083581|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083582|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14083583|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
13916695|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
13916696|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916697|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13916698|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13916699|NCT03462836|Lidocaine|lidocaine|mesh-list
13916700|NCT03462836|Ketamine|ketamine|mesh-list
14083584|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14083585|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083586|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14083587|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14083588|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14083589|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14083590|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14083591|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14083592|NCT02502968|Cytarabine|cytarabine|mesh-list
14083593|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14083594|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
14083595|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083596|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083597|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
14083598|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083599|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083600|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
14083601|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083602|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
14083603|NCT02502981|Spironolactone|spironolactone|mesh-list
14083604|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14083605|NCT02502981|Diuretics|diuretics|mesh-list
14934945|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
13916701|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
13916702|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
14083606|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14083607|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
14083608|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
14083609|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14083610|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083611|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14083612|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
14083613|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14083614|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083615|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083616|NCT02502981|Hormones|hormones|mesh-ancestor
14083617|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
14083618|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14083619|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14083620|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083621|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
14083622|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
14083623|NCT02502643|Picibanil|picibanil|mesh-list
14083624|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083625|NCT02502565|Uric Acid|uric acid|mesh-list
14083626|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
14083627|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083628|NCT02502565|Protective Agents|protective agents|mesh-ancestor
14083629|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083630|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
14083631|NCT02502825|Miotics|miotics|mesh-ancestor
14083632|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
14083633|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083634|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083635|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14083636|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14083637|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083638|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14083639|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14083640|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
14083641|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083642|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083643|NCT02502799|Methylphenidate|methylphenidate|mesh-list
14083644|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14083645|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083646|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14083647|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14083648|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083649|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083650|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
14083651|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083652|NCT02502877|Midazolam|midazolam|mesh-list
14083653|NCT02502877|Propofol|propofol|mesh-list
14083654|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14083655|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083656|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083657|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083658|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
14083659|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
14083660|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14083661|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14083662|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14083663|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14083664|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
14083665|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
14083666|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083667|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083668|NCT02502500|Celecoxib|celecoxib|mesh-list
14083669|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14083670|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14083671|NCT02502500|Analgesics|analgesics|mesh-ancestor
14083672|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
14083673|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083674|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083675|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14083676|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083677|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14083678|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14083679|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083680|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083681|NCT02502253|Resveratrol|resveratrol|mesh-list
14083682|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
14083683|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083684|NCT02502253|Protective Agents|protective agents|mesh-ancestor
14083685|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083686|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083687|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14083688|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14083689|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14759664|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14083690|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14476920|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14083691|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
14083692|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083693|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14083694|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14083695|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083696|NCT02502344|Metformin|metformin|mesh-list
14083697|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14083698|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083699|NCT02502175|Methadone|methadone|mesh-list
14083700|NCT02502175|Opium|opium|mesh-list
14083701|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14083702|NCT02502175|Narcotics|narcotics|mesh-ancestor
14083703|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083704|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083705|NCT02502175|Analgesics|analgesics|mesh-ancestor
14083706|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
14083707|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083708|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
14083709|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083710|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
14083711|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173730|NCT04794049|Lactulose|lactulose|mesh-list
14173731|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173732|NCT04794127|Pioglitazone|pioglitazone|mesh-list
14173733|NCT04794127|Trabectedin|trabectedin|mesh-list
14173734|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14173735|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173736|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14173737|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
14173738|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173739|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173740|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
14173741|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173742|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173743|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173744|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173745|NCT04793919|Tretinoin|tretinoin|mesh-list
14173746|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
14173747|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
14173748|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173749|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
14173750|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
14173751|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14173752|NCT04793711|Decanoic acid|decanoic acid|mesh-list
14083712|NCT02502032|Cisatracurium|cisatracurium|mesh-list
14083713|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14083714|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14083715|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083716|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083717|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
14083718|NCT02502708|Temozolomide|temozolomide|mesh-list
14083719|NCT02502708|Etoposide|etoposide|mesh-list
14083720|NCT02502708|Tryptophan|tryptophan|mesh-list
14083721|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083722|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
14083723|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083724|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083725|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14083726|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
14083727|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083728|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083729|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14083730|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083731|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14083732|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14083733|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083734|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14083735|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
14083736|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14083737|NCT02501941|Ketamine|ketamine|mesh-list
14083738|NCT02501941|Analgesics|analgesics|mesh-ancestor
14083739|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
14083740|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083741|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083742|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14083743|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083744|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
14083745|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
14083746|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083747|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14083748|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14083749|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083750|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083751|NCT02501954|Paclitaxel|paclitaxel|mesh-list
14083752|NCT02501954|Carboplatin|carboplatin|mesh-list
14083753|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083754|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083755|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
14083756|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14083757|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14083758|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083759|NCT02501837|Oxytocin|oxytocin|mesh-list
14083760|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
14083761|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14083762|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083763|NCT02501863|Fentanyl|fentanyl|mesh-list
14083764|NCT02501863|Ropivacaine|ropivacaine|mesh-list
14083765|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
14083766|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
14083767|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083768|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083769|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
14083770|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083771|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14083772|NCT02501863|Narcotics|narcotics|mesh-ancestor
14083773|NCT02501863|Analgesics|analgesics|mesh-ancestor
14083774|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14083775|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14083776|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
14083777|NCT02501798|Methylphenidate|methylphenidate|mesh-list
14083778|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14083779|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083780|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14083781|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14083782|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083783|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083784|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
14083785|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083786|NCT02501850|Metformin|metformin|mesh-list
14083787|NCT02501850|Liraglutide|liraglutide|mesh-list
14083788|NCT02501850|Exenatide|exenatide|mesh-list
14083789|NCT02501850|Lixisenatide|lixisenatide|mesh-list
14083790|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14083791|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083792|NCT02501850|Incretins|incretins|mesh-ancestor
14083793|NCT02501850|Hormones|hormones|mesh-ancestor
14083794|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14083795|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14083796|NCT02501564|Naproxen|naproxen|mesh-list
14083797|NCT02501564|Codeine|codeine|mesh-list
14083798|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14083799|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14083800|NCT02501564|Analgesics|analgesics|mesh-ancestor
14083801|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
14083802|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083803|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083804|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14083805|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083806|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
14083807|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14083808|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083809|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083810|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14476921|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14759665|NCT04699838|Carboplatin|carboplatin|mesh-list
14759666|NCT04699838|Etoposide|etoposide|mesh-list
14759667|NCT04699838|Durvalumab|durvalumab|mesh-list
14759668|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759669|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083811|NCT02501564|Narcotics|narcotics|mesh-ancestor
14083812|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083813|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
14083814|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083815|NCT02501616|Metformin|metformin|mesh-list
14083816|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
14083817|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14083818|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083819|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14083820|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083821|NCT02501603|Paclitaxel|paclitaxel|mesh-list
14083822|NCT02501603|Afatinib|afatinib|mesh-list
14083823|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14083824|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083825|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14083826|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14083827|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14083828|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083829|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14083830|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083831|NCT02501213|Furosemide|furosemide|mesh-list
14083832|NCT02501213|Spironolactone|spironolactone|mesh-list
14083833|NCT02501213|Diuretics|diuretics|mesh-ancestor
14083834|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
14083835|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083836|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14083837|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14083838|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083839|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14083840|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
14083841|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14083842|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14083843|NCT02501200|Ezetimibe|ezetimibe|mesh-list
14083844|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14083845|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14083846|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
14083847|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083848|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14083849|NCT02501291|Thalidomide|thalidomide|mesh-list
14083850|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083851|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
14083852|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083853|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
14083854|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14083855|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083856|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14083857|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14083858|NCT02501291|Growth Substances|growth substances|mesh-ancestor
14083859|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
14083860|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083861|NCT02501278|Cisplatin|cisplatin|mesh-list
14083862|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083863|NCT02501109|Aripiprazole|aripiprazole|mesh-list
14083864|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
14083865|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14759670|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759671|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13916703|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916704|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916705|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
13916706|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916707|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13916708|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13916709|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13916710|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13916711|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916712|NCT03462836|Analgesics|analgesics|mesh-ancestor
13916713|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14759672|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759673|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759674|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759675|NCT04688658|Nivolumab|nivolumab|mesh-list
14759676|NCT04688658|Axitinib|axitinib|mesh-list
14759677|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14083866|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14083867|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14083868|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14083869|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083870|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
14083871|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
14083872|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083873|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083874|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14083875|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14083876|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
14083877|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14083878|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14083879|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14083880|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14083881|NCT02500927|Naquotinib|naquotinib|mesh-list
14083882|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083883|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14083884|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083885|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083886|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
14083887|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14083888|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
14083889|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083890|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083891|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14083892|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
14083893|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14083894|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14083895|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14083896|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
14083897|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14083898|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083899|NCT02500940|Leucovorin|leucovorin|mesh-list
14083900|NCT02500940|Fluorouracil|fluorouracil|mesh-list
14083901|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083902|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083903|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
14083904|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083905|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14083906|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083907|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
14083908|NCT02500940|Antidotes|antidotes|mesh-ancestor
14083909|NCT02500940|Protective Agents|protective agents|mesh-ancestor
14083910|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
14083911|NCT02500940|Vitamins|vitamins|mesh-ancestor
14083912|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
14083913|NCT02500667|Rifampin|rifampin|mesh-list
14083914|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14083915|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
14083916|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14083917|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083918|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
14083919|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14083920|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083921|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083922|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14083923|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14083924|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14083925|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14083926|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14083927|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14083928|NCT02500680|Vaccines|vaccines|mesh-list
14759678|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759679|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14759680|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759681|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759682|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759683|NCT04685616|Doxorubicin|doxorubicin|mesh-list
14759684|NCT04685616|Bleomycin|bleomycin|mesh-list
14759685|NCT04685616|Dacarbazine|dacarbazine|mesh-list
14759686|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14759687|NCT04685616|Vinblastine|vinblastine|mesh-list
14759688|NCT04685616|Mitogens|mitogens|mesh-list
14759689|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14759690|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759691|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759692|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14083929|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
14083930|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083931|NCT02500446|Dolutegravir|dolutegravir|mesh-list
14083932|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14083933|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14083934|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083935|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083936|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14083937|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14083938|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
14083939|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083940|NCT02500576|Aldesleukin|aldesleukin|mesh-list
14083941|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
13916714|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13916715|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
13916716|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13916717|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13916718|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916719|NCT03462810|Cabotegravir|cabotegravir|mesh-list
13916720|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13916721|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13916722|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916723|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916724|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14083942|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
14083943|NCT02500576|Fludarabine|fludarabine|mesh-list
14083944|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
14083945|NCT02500576|Interleukin-2|interleukin-2|mesh-list
14083946|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083947|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
14083948|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759693|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916725|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13916726|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
14083949|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083950|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14083951|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
14083952|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083953|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916727|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916728|NCT03462641|Flumazenil|flumazenil|mesh-list
13916729|NCT03462641|Antidotes|antidotes|mesh-ancestor
13916730|NCT03462641|Protective Agents|protective agents|mesh-ancestor
13916731|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759694|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759695|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759696|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14759697|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
14759698|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759699|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759700|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759701|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759702|NCT04683939|Gemcitabine|gemcitabine|mesh-list
14759703|NCT04683939|Paclitaxel|paclitaxel|mesh-list
14934946|NCT01459484|Cisplatin|cisplatin|mesh-list
14934947|NCT01459484|Doxorubicin|doxorubicin|mesh-list
14083954|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14083955|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14083956|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13916732|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
14083957|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
14083958|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13916733|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
14083959|NCT02500576|Analgesics|analgesics|mesh-ancestor
14083960|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
14083961|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14083962|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14083963|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14083964|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
14083965|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14083966|NCT02500524|Permethrin|permethrin|mesh-list
14083967|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083968|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083969|NCT02500563|Caseins|caseins|mesh-list
14083970|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
14083971|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
14083972|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083973|NCT02500511|Vaccines|vaccines|mesh-list
14083974|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
14083975|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083976|NCT02500498|Abatacept|abatacept|mesh-list
14083977|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14083978|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083979|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083980|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14083981|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
14083982|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083983|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14083984|NCT02500459|Topotecan|topotecan|mesh-list
14083985|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14083986|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14083987|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083988|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083989|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14083990|NCT02500329|Acarbose|acarbose|mesh-list
14083991|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14083992|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14083993|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14083994|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14083995|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14083996|NCT02500225|Sevoflurane|sevoflurane|mesh-list
14083997|NCT02500225|Etomidate|etomidate|mesh-list
14083998|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934948|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13916734|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916735|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960156|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13960157|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960158|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
13960159|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13960160|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13960161|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
13960162|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13960163|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14083999|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14084000|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
14934949|NCT01459484|Methotrexate|methotrexate|mesh-list
14084001|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
14084002|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084003|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084004|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14084005|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14084006|NCT02500147|Metformin|metformin|mesh-list
14084007|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14084008|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084009|NCT02500212|Tacrolimus|tacrolimus|mesh-list
14084010|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14084011|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
14084012|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084013|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14084014|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084015|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173753|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
14173754|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173755|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
14173756|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14173757|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173758|NCT04793529|Vitamins|vitamins|mesh-ancestor
14173759|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
14173760|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14173761|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
14173762|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14173763|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173764|NCT04793256|Listerine|listerine|mesh-list
14173765|NCT04793256|Fluorides|fluorides|mesh-list
14476922|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476923|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14476924|NCT02422186|Analgesics|analgesics|mesh-ancestor
14476925|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
14476926|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
14476927|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14476928|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
14476929|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476930|NCT02422290|Ketamine|ketamine|mesh-list
14476931|NCT02422290|Analgesics|analgesics|mesh-ancestor
14476932|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
14476933|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476934|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476935|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14476936|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14476937|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
14476938|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
14476939|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173766|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
14476940|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14173767|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
14173768|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
14084016|NCT02500017|Melatonin|melatonin|mesh-list
14084017|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
14084018|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084019|NCT02500017|Protective Agents|protective agents|mesh-ancestor
14084020|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084021|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084022|NCT02500108|Domperidone|domperidone|mesh-list
14084023|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
14084024|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
14084025|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084026|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084027|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084028|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13916736|NCT03462446|Vitamin K|vitamin k|mesh-list
14759704|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759705|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759706|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759707|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759708|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14934950|NCT01459484|Ifosfamide|ifosfamide|mesh-list
13916737|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
13916738|NCT03462446|Vitamins|vitamins|mesh-ancestor
13916739|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
13916740|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916741|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13916742|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
13916743|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14084029|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
14084030|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916744|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
14084031|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084032|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
14084033|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
14084034|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084035|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
14084036|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084037|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084038|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
14084039|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084040|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084041|NCT02500251|Rituximab|rituximab|mesh-list
14084042|NCT02500251|Bortezomib|bortezomib|mesh-list
14084043|NCT02500251|Belimumab|belimumab|mesh-list
14084044|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084045|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084046|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
14084047|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084048|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084049|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14084050|NCT02500069|Caseins|caseins|mesh-list
14084051|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
14084052|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
14084053|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084054|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14084055|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14084056|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084057|NCT02499874|Tenofovir|tenofovir|mesh-list
14084058|NCT02499874|Lamivudine|lamivudine|mesh-list
14084059|NCT02499874|Zidovudine|zidovudine|mesh-list
14084060|NCT02499874|Emtricitabine|emtricitabine|mesh-list
14084061|NCT02499874|Efavirenz|efavirenz|mesh-list
14084062|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14084063|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
14084064|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084065|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14084066|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14084067|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084068|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084069|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14084070|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14084071|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
14084072|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14084073|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14084074|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14084075|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14084076|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14084077|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14084078|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
14084079|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
14084080|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
14084081|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084082|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084083|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
14084084|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084085|NCT02499978|Darunavir|darunavir|mesh-list
14084086|NCT02499978|Dolutegravir|dolutegravir|mesh-list
13916745|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916746|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916747|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
13916748|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13916749|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13916750|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
13916751|NCT03462446|Coagulants|coagulants|mesh-ancestor
13916752|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
13916753|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13916754|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13916755|NCT03462329|Doxycycline|doxycycline|mesh-list
14084087|NCT02499978|Cobicistat|cobicistat|mesh-list
14084088|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14084089|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14084090|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
14084091|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084092|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084093|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14084094|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14084095|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
14084096|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084097|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14084098|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14084099|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14084100|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14084101|NCT02499965|Anesthetics|anesthetics|mesh-list
14084102|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
14084103|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084104|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084105|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084106|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
14084107|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084108|NCT02499861|Decitabine|decitabine|mesh-list
14084109|NCT02499861|Genistein|genistein|mesh-list
14084110|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14084111|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
14084112|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084113|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084114|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084115|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14084116|NCT02499861|Protective Agents|protective agents|mesh-ancestor
14084117|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084118|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14084119|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
14084120|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14084121|NCT02499861|Estrogens|estrogens|mesh-ancestor
14084122|NCT02499861|Hormones|hormones|mesh-ancestor
14084123|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084124|NCT02499822|Ramipril|ramipril|mesh-list
14084125|NCT02499822|Nifedipine|nifedipine|mesh-list
14084126|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14084127|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14084128|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084129|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759709|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759710|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759711|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
14759712|NCT04683939|Antiviral Agents|antiviral agents|mesh-ancestor
14759713|NCT04683939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759714|NCT04683939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759715|NCT04683939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759716|NCT04683939|Immunologic Factors|immunologic factors|mesh-ancestor
14759717|NCT04683939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759718|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
14759719|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14759720|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
14759721|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
14759722|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759723|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084130|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14084131|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14084132|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13916756|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916757|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
13916758|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13916759|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13916760|NCT03462212|Paclitaxel|paclitaxel|mesh-list
13916761|NCT03462212|Bevacizumab|bevacizumab|mesh-list
13916762|NCT03462212|Carboplatin|carboplatin|mesh-list
13916763|NCT03462212|Rucaparib|rucaparib|mesh-list
13916764|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13916765|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916766|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
13916767|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
13916768|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759724|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759725|NCT04666961|Tamoxifen|tamoxifen|mesh-list
14759726|NCT04666961|Anastrozole|anastrozole|mesh-list
14759727|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14759728|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
14759729|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759730|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916769|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084133|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14084134|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084135|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
14084136|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
13916770|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14173769|NCT04793256|Protective Agents|protective agents|mesh-ancestor
14084137|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14084138|NCT02499757|Nicotine|nicotine|mesh-list
14084139|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14084140|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
14084141|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084142|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084143|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14084144|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14084145|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
14084146|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084147|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084148|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14084149|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14084150|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14084151|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
14084152|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084153|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084154|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084155|NCT02499614|Crizotinib|crizotinib|mesh-list
14084156|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084157|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14084158|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084159|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084160|NCT02499562|Entecavir|entecavir|mesh-list
14084161|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
14084162|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084163|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
14084164|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
14084165|NCT02499445|Sufentanil|sufentanil|mesh-list
14084166|NCT02499445|Remifentanil|remifentanil|mesh-list
14084167|NCT02499445|Propofol|propofol|mesh-list
14084168|NCT02499445|Sevoflurane|sevoflurane|mesh-list
14084169|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14084170|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084171|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084172|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14084173|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
14084174|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
14084175|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14084176|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14084177|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14084178|NCT02499445|Narcotics|narcotics|mesh-ancestor
14084179|NCT02499445|Analgesics|analgesics|mesh-ancestor
14084180|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
14084181|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084182|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14084183|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
14084184|NCT02499237|Denosumab|denosumab|mesh-list
14084185|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14084186|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759731|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759732|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084187|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
14084188|NCT02499393|Analgesics|analgesics|mesh-ancestor
14084189|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
14084190|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084191|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759733|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14084192|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
14084193|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084194|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14084195|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
14084196|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14084197|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14084198|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084199|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14084200|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
14084201|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14084202|NCT02499341|Ketamine|ketamine|mesh-list
14084203|NCT02499341|Tramadol|tramadol|mesh-list
14084204|NCT02499341|Analgesics|analgesics|mesh-ancestor
14084205|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
14084206|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084207|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084208|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14084209|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14084210|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
14084211|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
14084212|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084213|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14084214|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14084215|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084216|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084217|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14084218|NCT02499341|Narcotics|narcotics|mesh-ancestor
14084219|NCT02499354|Iron|iron|mesh-list
14084220|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14084221|NCT02499354|Trace Elements|trace elements|mesh-ancestor
14084222|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
14084223|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084224|NCT02499354|Hematinics|hematinics|mesh-ancestor
14084225|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14084226|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14084227|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
14084228|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084229|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084230|NCT02498977|Cyclosporine|cyclosporine|mesh-list
14084231|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
14084232|NCT02498977|Azathioprine|azathioprine|mesh-list
14084233|NCT02498977|Tacrolimus|tacrolimus|mesh-list
14084234|NCT02498977|Cyclosporins|cyclosporins|mesh-list
14084235|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14084236|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
14084237|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084238|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14084239|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084240|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084241|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
14084242|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084243|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
14084244|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084245|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14084246|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084247|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14084248|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
14084249|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14084250|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
14084251|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14084252|NCT02498756|Ipilimumab|ipilimumab|mesh-list
14084253|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084254|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084255|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14084256|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084257|NCT02498860|Pemetrexed|pemetrexed|mesh-list
14084258|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084259|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084260|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084261|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14084262|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14084263|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
14084264|NCT02498496|Analgesics|analgesics|mesh-ancestor
14084265|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
14084266|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084267|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084268|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
14084269|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084270|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14084271|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
14084272|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14084273|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14084274|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084275|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14084276|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
14084277|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14084278|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
14084279|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14084280|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
14084281|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084282|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084283|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14084284|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
14084285|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14084286|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
14084287|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084288|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084289|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14084290|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
14084291|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
14084292|NCT02498535|Protective Agents|protective agents|mesh-ancestor
14084293|NCT02498457|Calcium|calcium|mesh-list
14084294|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13960164|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960165|NCT03156907|Buprenorphine|buprenorphine|mesh-list
13960166|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13960167|NCT03156907|Narcotics|narcotics|mesh-ancestor
13960168|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960169|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960170|NCT03156907|Analgesics|analgesics|mesh-ancestor
13960171|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
13960172|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960173|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13960174|NCT03156790|Asparaginase|asparaginase|mesh-list
13960175|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084295|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084296|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
14084297|NCT02498509|Levocabastine|levocabastine|mesh-list
14084298|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084299|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
14084300|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14084301|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14084302|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14084303|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
14084304|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
14084305|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084306|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084307|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084308|NCT02498301|Rifaximin|rifaximin|mesh-list
14084309|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14084310|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084311|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084312|NCT02498288|Isotretinoin|isotretinoin|mesh-list
14084313|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916771|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13916772|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13916773|NCT03462212|Growth Substances|growth substances|mesh-ancestor
14173770|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173771|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14173772|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173773|NCT04793243|Vitamin D|vitamin d|mesh-list
14173774|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
14173775|NCT04793243|Vitamins|vitamins|mesh-ancestor
14173776|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
14173777|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173778|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14173779|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14173780|NCT04793399|Atezolizumab|atezolizumab|mesh-list
14173781|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14934951|NCT01459484|Mifamurtide|mifamurtide|mesh-list
13916774|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916775|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
13916776|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13916777|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916778|NCT03462173|Yimitasvir|yimitasvir|mesh-list
13916779|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
13916780|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476941|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14476942|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476943|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476944|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
14476945|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14476946|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14476947|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476948|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14476949|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476950|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173782|NCT04793152|Vancomycin|vancomycin|mesh-list
14476951|NCT02423343|Nivolumab|nivolumab|mesh-list
14759734|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14759735|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14759736|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14759737|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14759738|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759739|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759740|NCT04662710|Leucovorin|leucovorin|mesh-list
14084314|NCT02498171|Fentanyl|fentanyl|mesh-list
14084315|NCT02498171|Morphine|morphine|mesh-list
14084316|NCT02498171|Bupivacaine|bupivacaine|mesh-list
14084317|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084318|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
14084319|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084320|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084321|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
14084322|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084323|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14084324|NCT02498171|Narcotics|narcotics|mesh-ancestor
14084325|NCT02498171|Analgesics|analgesics|mesh-ancestor
14084326|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14084327|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14084328|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
14084329|NCT02498145|Nicotine|nicotine|mesh-list
14084330|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14084331|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
14084332|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084333|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084334|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14084335|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14084336|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
14084337|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084338|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084339|NCT02497911|Bupivacaine|bupivacaine|mesh-list
14084340|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084341|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
14084342|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084343|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084344|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
14084345|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084346|NCT02498015|Ribavirin|ribavirin|mesh-list
14084347|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
14084348|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084349|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
14084350|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084351|NCT02498002|Lidocaine|lidocaine|mesh-list
14084352|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084353|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
14759741|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
14759742|NCT04662710|Capecitabine|capecitabine|mesh-list
14759743|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
14934952|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
14084354|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084355|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759744|NCT04662710|Lenvatinib|lenvatinib|mesh-list
14759745|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
14084356|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
14084357|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084358|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14759746|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759747|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759748|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759749|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
14476952|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14476953|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084359|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14084360|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14084361|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14084362|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084363|NCT02497833|Tretinoin|tretinoin|mesh-list
14084364|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084365|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
14084366|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
14084367|NCT02497820|Aspirin|aspirin|mesh-list
14084368|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14084369|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084370|NCT02497820|Analgesics|analgesics|mesh-ancestor
14084371|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
14084372|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084373|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084374|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084375|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084376|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14084377|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14084378|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084379|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14084380|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14084381|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084382|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
14084383|NCT02497638|Metformin|metformin|mesh-list
14084384|NCT02497638|Biguanides|biguanides|mesh-list
14084385|NCT02497638|Atorvastatin|atorvastatin|mesh-list
14084386|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14084387|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084388|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14084389|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14084390|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
14084391|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084392|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14084393|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14084394|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084395|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
14084396|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14084397|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
14934953|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084398|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14084399|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
14084400|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084401|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084402|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
14084403|NCT02497547|Oxytocin|oxytocin|mesh-list
14084404|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
14084405|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14084406|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084407|NCT02497508|Nivolumab|nivolumab|mesh-list
14084408|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084409|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084410|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14084411|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084412|NCT02497313|Metformin|metformin|mesh-list
14084413|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
14084414|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14084415|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084416|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14084417|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084418|NCT02497378|Dexamethasone|dexamethasone|mesh-list
14084419|NCT02497378|Bortezomib|bortezomib|mesh-list
14084420|NCT02497378|Daratumumab|daratumumab|mesh-list
14084421|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084422|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
14084423|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
14084424|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084425|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084426|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084427|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
14084428|NCT02497378|Hormones|hormones|mesh-ancestor
14084429|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084430|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14084431|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084432|NCT02497326|Heparin|heparin|mesh-list
14084433|NCT02497326|Tramadol|tramadol|mesh-list
14084434|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
14084435|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14084436|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14084437|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084438|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14084439|NCT02497326|Narcotics|narcotics|mesh-ancestor
14084440|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084441|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084442|NCT02497326|Analgesics|analgesics|mesh-ancestor
14084443|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
14084444|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084445|NCT02497300|Amiloride|amiloride|mesh-list
14084446|NCT02497300|Spironolactone|spironolactone|mesh-list
14084447|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14084448|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
14084449|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084450|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084451|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14759750|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759751|NCT04662710|Antidotes|antidotes|mesh-ancestor
14759752|NCT04662710|Protective Agents|protective agents|mesh-ancestor
14759753|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759754|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
14759755|NCT04662710|Vitamins|vitamins|mesh-ancestor
14759756|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
14759757|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759758|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759759|NCT04658862|Gemcitabine|gemcitabine|mesh-list
14759760|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759761|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759762|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
14759763|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476954|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14476955|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476956|NCT02423980|Glucagon|glucagon|mesh-list
14476957|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14476958|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14476959|NCT02423980|Hormones|hormones|mesh-ancestor
14476960|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476961|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916799|NCT03461783|Charcoal|charcoal|mesh-list
13916800|NCT03461783|Antidotes|antidotes|mesh-ancestor
13916801|NCT03461783|Protective Agents|protective agents|mesh-ancestor
13916802|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916803|NCT03461718|Fentanyl|fentanyl|mesh-list
13916804|NCT03461718|Midazolam|midazolam|mesh-list
13916805|NCT03461718|Ketamine|ketamine|mesh-list
13916806|NCT03461718|Analgesics|analgesics|mesh-ancestor
13916807|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
13916808|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916809|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084452|NCT02497300|Diuretics|diuretics|mesh-ancestor
14084453|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
14084454|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14084455|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14084456|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14084457|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084458|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14084459|NCT02497118|Vinorelbine|vinorelbine|mesh-list
14084460|NCT02497118|Endostatins|endostatins|mesh-list
14084461|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084462|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14084463|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14084464|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14084465|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14084466|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084467|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14084468|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14084469|NCT02497118|Growth Substances|growth substances|mesh-ancestor
14934954|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14934955|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14934956|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14934957|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14934958|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084470|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084471|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
14084472|NCT02497222|RNS60|rns60|mesh-list
14084473|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14084474|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084475|NCT02497222|Analgesics|analgesics|mesh-ancestor
14084476|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
14084477|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084478|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084479|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084480|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084481|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14084482|NCT02497157|Leucovorin|leucovorin|mesh-list
14084483|NCT02497157|Bevacizumab|bevacizumab|mesh-list
14084484|NCT02497157|Fluorouracil|fluorouracil|mesh-list
14934959|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14934960|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
13916810|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13916811|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13916812|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
14476962|NCT02423980|Incretins|incretins|mesh-ancestor
14934961|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14934962|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934963|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14934964|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
14934965|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14934966|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14934967|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14934968|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
14934969|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14934970|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14934971|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14934972|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
14934973|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13916813|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
14084485|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
14084486|NCT02497157|Irinotecan|irinotecan|mesh-list
14084487|NCT02497157|Calcium|calcium|mesh-list
14084488|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
14084489|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084490|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084491|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14084492|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14084493|NCT02497157|Growth Substances|growth substances|mesh-ancestor
14084494|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084495|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
14084496|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14084497|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
14084498|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084499|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14084500|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759764|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
14759765|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759766|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759767|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759768|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
14759769|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934974|NCT01459601|Cabergoline|cabergoline|mesh-list
14934975|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14934976|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14934977|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
14934978|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
14934979|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934980|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14934981|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934982|NCT01459627|Ticagrelor|ticagrelor|mesh-list
14934983|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14934984|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14934985|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14934986|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14934987|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14084501|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
14084502|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14084503|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14084504|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084505|NCT02497157|Antidotes|antidotes|mesh-ancestor
14476963|NCT02424097|Listerine|listerine|mesh-list
14476964|NCT02424097|Fluorides|fluorides|mesh-list
14476965|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
14476966|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
14476967|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
14476968|NCT02424097|Protective Agents|protective agents|mesh-ancestor
14476969|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934988|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
14084506|NCT02497157|Protective Agents|protective agents|mesh-ancestor
13916814|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916815|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13916816|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13916817|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916818|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916819|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13916820|NCT03461718|Narcotics|narcotics|mesh-ancestor
13916821|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13916822|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13916823|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13916824|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13916825|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13916826|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
13916827|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
13916828|NCT03461627|Fluticasone|fluticasone|mesh-list
13916829|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13916830|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13916831|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916832|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13916833|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
13916834|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916835|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916836|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13916837|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
14476970|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14476971|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476972|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
14476973|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14476974|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
14476975|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14476976|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14476977|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14476978|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
14476979|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14476980|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14476981|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14476982|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
14476983|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14476984|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14476985|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
14476986|NCT02424357|Povidone|povidone|mesh-list
13916838|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916839|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13916840|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13916841|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13916842|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13916843|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
13916844|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916845|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916846|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
13916847|NCT03461627|Hormones|hormones|mesh-ancestor
13916848|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14476987|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14476988|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13916849|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
13916850|NCT03461575|Cyclosporine|cyclosporine|mesh-list
13916851|NCT03461575|Cyclosporins|cyclosporins|mesh-list
13916852|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916853|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916854|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916855|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
13916856|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916857|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
13916858|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916859|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916860|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13916861|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13916862|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
14084507|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
14084508|NCT02497157|Vitamins|vitamins|mesh-ancestor
14084509|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
14084510|NCT02497365|Cefazolin|cefazolin|mesh-list
14084511|NCT02497365|Tobramycin|tobramycin|mesh-list
14084512|NCT02497365|Besifloxacin|besifloxacin|mesh-list
14084513|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14084514|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084515|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14084516|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14084517|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084518|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084519|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759770|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
14759771|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14759772|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759773|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759774|NCT04657562|Tacrolimus|tacrolimus|mesh-list
14759775|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759776|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
14759777|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759778|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14759779|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916863|NCT03461328|Analgesics|analgesics|mesh-ancestor
13916864|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
13916865|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084520|NCT02497079|Formaldehyde|formaldehyde|mesh-list
14084521|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
14084522|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084523|NCT02497053|Pemetrexed|pemetrexed|mesh-list
14084524|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084525|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084526|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084527|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14084528|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14084529|NCT02496988|Temozolomide|temozolomide|mesh-list
13916866|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916867|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
13916868|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13916869|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13916870|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
13916871|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13916872|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14084530|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14084531|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
14084532|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916873|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916874|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13916875|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
13916876|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13916877|NCT03461302|Coal Tar|coal tar|mesh-list
13916878|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
13916879|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916880|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
13916881|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14084533|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084534|NCT02496962|Atorvastatin|atorvastatin|mesh-list
14084535|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14084536|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14934989|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14934990|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084537|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
13916882|NCT03461185|Growth Substances|growth substances|mesh-ancestor
13916883|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084538|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084539|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14084540|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14084541|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084542|NCT02496975|Cyclosporine|cyclosporine|mesh-list
14084543|NCT02496975|Cyclosporins|cyclosporins|mesh-list
14084544|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084545|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084546|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14084547|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
13916884|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
13916885|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916886|NCT03461081|Amlodipine|amlodipine|mesh-list
14084548|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084549|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
14084550|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084551|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
14084552|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084553|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14084554|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14084555|NCT02496754|Hormones|hormones|mesh-ancestor
14084556|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084557|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084558|NCT02496910|Amlodipine|amlodipine|mesh-list
14084559|NCT02496910|Telmisartan|telmisartan|mesh-list
14084560|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
14084561|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14084562|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14084563|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14084564|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14084565|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084566|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14084567|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084568|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
14084569|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14084570|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14084571|NCT02496910|Diuretics|diuretics|mesh-ancestor
14084572|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
13916887|NCT03461081|Telmisartan|telmisartan|mesh-list
14084573|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14084574|NCT02496741|Metformin|metformin|mesh-list
14084575|NCT02496741|Chloroquine|chloroquine|mesh-list
14084576|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14084577|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084578|NCT02496741|Amebicides|amebicides|mesh-ancestor
14084579|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14084580|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14084581|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084582|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
14084583|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173783|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14173784|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173785|NCT04793022|Anesthetics|anesthetics|mesh-list
14173786|NCT04793022|Propofol|propofol|mesh-list
14173787|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173788|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173789|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14173790|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14934991|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934992|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
14934993|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14934994|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
14934995|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14934996|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
14934997|NCT01459640|Protective Agents|protective agents|mesh-ancestor
14934998|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14934999|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14935000|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
14935001|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14935002|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14935003|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935004|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
14935005|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935006|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935007|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14935008|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935009|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
14935010|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
14935011|NCT01459809|Metformin|metformin|mesh-list
14173791|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
14173792|NCT04792723|Aspirin|aspirin|mesh-list
14935012|NCT01459809|Glimepiride|glimepiride|mesh-list
14084584|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14084585|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14084586|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759780|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759781|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
14759782|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759783|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
14759784|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759785|NCT04646837|Paclitaxel|paclitaxel|mesh-list
14084587|NCT02496715|Fluticasone|fluticasone|mesh-list
14084588|NCT02496715|Xhance|xhance|mesh-list
14084589|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14084590|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084591|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14084592|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
14084593|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084594|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084595|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14084596|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
14084597|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
14084598|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14084599|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14084600|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14084601|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14084602|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14084603|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084604|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084605|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
14084606|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14084607|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084608|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084609|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084610|NCT02496650|Analgesics|analgesics|mesh-ancestor
14084611|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
14084612|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084613|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14084614|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14084615|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14084616|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
14084617|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183541|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14759786|NCT04646837|Carboplatin|carboplatin|mesh-list
14759787|NCT04646837|Durvalumab|durvalumab|mesh-list
14759788|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759789|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759790|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759791|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759792|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759793|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759794|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759795|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
14759796|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759797|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759798|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759799|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759800|NCT04642469|Durvalumab|durvalumab|mesh-list
14759801|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759802|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759803|NCT04640623|Gemcitabine|gemcitabine|mesh-list
14759804|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759805|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
14759806|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759807|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759808|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
14759809|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759810|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759811|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759812|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
14759813|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759814|NCT04639986|Gemcitabine|gemcitabine|mesh-list
14759815|NCT04639986|Capecitabine|capecitabine|mesh-list
14759816|NCT04639986|Vinorelbine|vinorelbine|mesh-list
14084618|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084619|NCT02496494|Tacrolimus|tacrolimus|mesh-list
14084620|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14084621|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
14084622|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084623|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14084624|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759817|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759818|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
14759819|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759820|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759821|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
14759822|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759823|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759824|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759825|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
14759826|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759827|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759828|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759829|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759830|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759831|NCT04634877|Paclitaxel|paclitaxel|mesh-list
14084625|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084626|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
14084627|NCT02496377|Glycine|glycine|mesh-list
14084628|NCT02496377|Hematinics|hematinics|mesh-ancestor
14084629|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
14084630|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084631|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084632|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084633|NCT02496455|Tramadol|tramadol|mesh-list
14084634|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14084635|NCT02496455|Narcotics|narcotics|mesh-ancestor
14084636|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084637|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084638|NCT02496455|Analgesics|analgesics|mesh-ancestor
14084639|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
14084640|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084641|NCT02496299|Dexamethasone|dexamethasone|mesh-list
14084642|NCT02496299|Bupivacaine|bupivacaine|mesh-list
14084643|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759832|NCT04634877|Docetaxel|docetaxel|mesh-list
14759833|NCT04634877|Cisplatin|cisplatin|mesh-list
14759834|NCT04634877|Carboplatin|carboplatin|mesh-list
14759835|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
14759836|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759837|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759838|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759839|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759840|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759841|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084644|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
14084645|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
14084646|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084647|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084648|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084649|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
14084650|NCT02496299|Hormones|hormones|mesh-ancestor
14084651|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084652|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14084653|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084654|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084655|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
14084656|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084657|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
14084658|NCT02496286|Bevacizumab|bevacizumab|mesh-list
14084659|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084660|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084661|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14084662|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14084663|NCT02496286|Growth Substances|growth substances|mesh-ancestor
14476989|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
13916888|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
13916889|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
13916890|NCT03461081|Atorvastatin|atorvastatin|mesh-list
13916891|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13916892|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13916893|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
13916894|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916895|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13916896|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13916897|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916898|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13916899|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13916900|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13916901|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13916902|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916903|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
13916904|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14084664|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084665|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
14084666|NCT02496182|Pirfenidone|pirfenidone|mesh-list
14084667|NCT02496182|Analgesics|analgesics|mesh-ancestor
14084668|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
14084669|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084670|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084671|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14084672|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084673|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14476990|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
14476991|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14476992|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14476993|NCT02424578|Diclofenac|diclofenac|mesh-list
14084674|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084675|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084676|NCT02496078|Asunaprevir|asunaprevir|mesh-list
14084677|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
14084678|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084679|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084680|NCT02495896|Gemcitabine|gemcitabine|mesh-list
14084681|NCT02495896|Paclitaxel|paclitaxel|mesh-list
14084682|NCT02495896|Docetaxel|docetaxel|mesh-list
14084683|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14084684|NCT02495896|Cisplatin|cisplatin|mesh-list
14084685|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14084686|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084687|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
14084688|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
14084689|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
14084690|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084691|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14084692|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
14084693|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
14084694|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759842|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759843|NCT04632992|Paclitaxel|paclitaxel|mesh-list
14759844|NCT04632992|Maytansine|maytansine|mesh-list
14759845|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14759846|NCT04632992|Trastuzumab|trastuzumab|mesh-list
14759847|NCT04632992|Atezolizumab|atezolizumab|mesh-list
14759848|NCT04632992|Pertuzumab|pertuzumab|mesh-list
14759849|NCT04632992|Tucatinib|tucatinib|mesh-list
14759850|NCT04632992|Pralsetinib|pralsetinib|mesh-list
14759851|NCT04632992|Entrectinib|entrectinib|mesh-list
14759852|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759853|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759854|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14476994|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14476995|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14476996|NCT02424578|Analgesics|analgesics|mesh-ancestor
14476997|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
14476998|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14759855|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759856|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14935013|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14084695|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084696|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14084697|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
14476999|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477000|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477001|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477002|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14477003|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477004|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477005|NCT02424591|Ketamine|ketamine|mesh-list
14477006|NCT02424591|Analgesics|analgesics|mesh-ancestor
14477007|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
14477008|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477009|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759857|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084698|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084699|NCT02495922|Dexamethasone|dexamethasone|mesh-list
14084700|NCT02495922|Lenalidomide|lenalidomide|mesh-list
14084701|NCT02495922|Bortezomib|bortezomib|mesh-list
14084702|NCT02495922|Elotuzumab|elotuzumab|mesh-list
14759858|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759859|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14084703|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084704|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
14084705|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
14084706|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084707|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084708|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084709|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
14084710|NCT02495922|Hormones|hormones|mesh-ancestor
14084711|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084712|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14084713|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084714|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
14084715|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14084716|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14084717|NCT02495922|Growth Substances|growth substances|mesh-ancestor
14084718|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
14084719|NCT02495688|Anesthetics|anesthetics|mesh-list
14084720|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084721|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084722|NCT02495584|Vitamin D|vitamin d|mesh-list
14084723|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
14084724|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
14084725|NCT02495584|Vitamins|vitamins|mesh-list
14084726|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
14084727|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084728|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14084729|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14084730|NCT02495636|Atezolizumab|atezolizumab|mesh-list
14084731|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084732|NCT02495818|Lidocaine|lidocaine|mesh-list
14084733|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084734|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
14084735|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084736|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759860|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759861|NCT04629547|Suvorexant|suvorexant|mesh-list
14759862|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14759863|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14759864|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084737|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
14084738|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477010|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14084739|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14084740|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14084741|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14084742|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14084743|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084744|NCT02495662|Prednisolone|prednisolone|mesh-list
14084745|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14084746|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
14084747|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14084748|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
14084749|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14084750|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
14084751|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084752|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
14084753|NCT02495662|Hormones|hormones|mesh-ancestor
14084754|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084755|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084756|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14084757|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084758|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
14084759|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
14084760|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084761|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084762|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14084763|NCT02495662|Protective Agents|protective agents|mesh-ancestor
14084764|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14084765|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14084766|NCT02496052|Estradiol|estradiol|mesh-list
14084767|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14084768|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
14084769|NCT02496052|Estrogens|estrogens|mesh-ancestor
14084770|NCT02496052|Hormones|hormones|mesh-ancestor
14084771|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084772|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084773|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14084774|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
14084775|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14084776|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14759865|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084777|NCT02496052|Progestins|progestins|mesh-ancestor
14084778|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14084779|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
14084780|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084781|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14084782|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084783|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084784|NCT02495181|Aflibercept|aflibercept|mesh-list
14084785|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14084786|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14084787|NCT02495181|Growth Substances|growth substances|mesh-ancestor
14084788|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084789|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
14477011|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14477012|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
14477013|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
14477014|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477015|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14477016|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14084790|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084791|NCT02495324|Valsartan|valsartan|mesh-list
14084792|NCT02495324|Olmesartan|olmesartan|mesh-list
14084793|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14084794|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13916905|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13916906|NCT03461003|Losartan|losartan|mesh-list
13916907|NCT03461003|Amlodipine|amlodipine|mesh-list
14084795|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14084796|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14084797|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084798|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
14084799|NCT02495220|Bupivacaine|bupivacaine|mesh-list
14084800|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084801|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
14084802|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084803|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084804|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
14084805|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084806|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14084807|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084808|NCT02495220|Analgesics|analgesics|mesh-ancestor
14084809|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14084810|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14084811|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14084812|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
14084813|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084814|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084815|NCT02495285|Polygeline|polygeline|mesh-list
13916908|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13916909|NCT03461003|Lisinopril|lisinopril|mesh-list
14084816|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
14084817|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
14084818|NCT02495272|Oxytocin|oxytocin|mesh-list
13916910|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13916911|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13916912|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13916913|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916914|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13916915|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084819|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
14084820|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14084821|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084822|NCT02495415|Fenretinide|fenretinide|mesh-list
14084823|NCT02495415|Retinamide|retinamide|mesh-list
14084824|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477017|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477018|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477019|NCT02424630|Ropivacaine|ropivacaine|mesh-list
14477020|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
14477021|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
14477022|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477023|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477024|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
14477025|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477026|NCT02424734|Ampicillin|ampicillin|mesh-list
14477027|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14477028|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477029|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477030|NCT02424799|GSK2646264|gsk2646264|mesh-list
14477031|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14477032|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084825|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14084826|NCT02495415|Protective Agents|protective agents|mesh-ancestor
13916916|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
13916917|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13916918|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14084827|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084828|NCT02495363|Bupivacaine|bupivacaine|mesh-list
14084829|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084830|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
14759866|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14759867|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14759868|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759869|NCT04628767|Gemcitabine|gemcitabine|mesh-list
14759870|NCT04628767|Cisplatin|cisplatin|mesh-list
14759871|NCT04628767|Doxorubicin|doxorubicin|mesh-list
14759872|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13916919|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13916920|NCT03461003|Diuretics|diuretics|mesh-ancestor
13916921|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
13916922|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13916923|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13916924|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
13916925|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916926|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13916927|NCT03461003|Protective Agents|protective agents|mesh-ancestor
13916928|NCT03460964|Pilocarpine|pilocarpine|mesh-list
13916929|NCT03460964|Miotics|miotics|mesh-ancestor
13916930|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
13916931|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13916932|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916933|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13916934|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13916935|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
13916936|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13916937|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916938|NCT03460860|Tocopherols|tocopherols|mesh-list
13916939|NCT03460860|Vitamin E|vitamin e|mesh-list
13916940|NCT03460860|Tocotrienols|tocotrienols|mesh-list
14759873|NCT04628767|Methotrexate|methotrexate|mesh-list
13916941|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
13916942|NCT03460860|Lycopene|lycopene|mesh-list
13916943|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
13916944|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916945|NCT03460860|Protective Agents|protective agents|mesh-ancestor
13916946|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759874|NCT04628767|Durvalumab|durvalumab|mesh-list
14759875|NCT04628767|Vinblastine|vinblastine|mesh-list
14759876|NCT04628767|Lenograstim|lenograstim|mesh-list
14759877|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
14759878|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14759879|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
14759880|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759881|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759882|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
14759883|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759884|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
13916947|NCT03460860|Vitamins|vitamins|mesh-ancestor
13916948|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
13916949|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13916950|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13916951|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13916952|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935014|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935015|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14935016|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935017|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
14935018|NCT01459887|Prednisone|prednisone|mesh-list
14935019|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
14935020|NCT01459887|Doxorubicin|doxorubicin|mesh-list
14935021|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14935022|NCT01459887|Vincristine|vincristine|mesh-list
14759885|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14759886|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759887|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759888|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
14759889|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759890|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14759891|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14084831|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084832|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084833|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
14084834|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173793|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173794|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173795|NCT04792723|Analgesics|analgesics|mesh-ancestor
14173796|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
14173797|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173798|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173799|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173800|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14173801|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14173802|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14173803|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173804|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14759892|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14759893|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14759894|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
14759895|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13916953|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
14173805|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14173806|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759896|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
13916954|NCT03460808|Atorvastatin|atorvastatin|mesh-list
14935023|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935024|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
14759897|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14759898|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14759899|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14759900|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14759901|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759902|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759903|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759904|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759905|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759906|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
14759907|NCT04626518|Lenvatinib|lenvatinib|mesh-list
14759908|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759909|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759910|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759911|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759912|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759913|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
14759914|NCT04626479|Lenvatinib|lenvatinib|mesh-list
14759915|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14759916|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759917|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759918|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916955|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13916956|NCT03460808|Danazol|danazol|mesh-list
13916957|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13916958|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13916959|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
13916960|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916961|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13916962|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13916963|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916964|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
13916965|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13916966|NCT03460808|Expectorants|expectorants|mesh-ancestor
13916967|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
13916968|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13916969|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
13916970|NCT03460808|Protective Agents|protective agents|mesh-ancestor
13916971|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916972|NCT03460808|Antidotes|antidotes|mesh-ancestor
13916973|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13916974|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
13916975|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935025|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935026|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935027|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14935028|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
14935029|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935030|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935031|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14935032|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14935033|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14935034|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14935035|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935036|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14935037|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
14935038|NCT01459887|Hormones|hormones|mesh-ancestor
14935039|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935040|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14935041|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14935042|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
14935043|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
14935044|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
14935045|NCT01460030|Cinacalcet|cinacalcet|mesh-list
14935046|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14935047|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935048|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
13916976|NCT03460782|Ipilimumab|ipilimumab|mesh-list
13916977|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13916978|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916979|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13916980|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960176|NCT03156829|Betamethasone|betamethasone|mesh-list
13960177|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084835|NCT02494882|Dexamethasone|dexamethasone|mesh-list
14084836|NCT02494882|Dasatinib|dasatinib|mesh-list
14084837|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084838|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
14084839|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
14084840|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084841|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084842|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084843|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
14084844|NCT02494882|Hormones|hormones|mesh-ancestor
14084845|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14084846|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14084847|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084848|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14084849|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084850|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084851|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14084852|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
14084853|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084854|NCT02494830|Ketamine|ketamine|mesh-list
14084855|NCT02494830|Analgesics|analgesics|mesh-ancestor
14084856|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
14084857|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084858|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084859|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14084860|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14084861|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
14084862|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
14084863|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084864|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14084865|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14759919|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759920|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
14759921|NCT04624204|Etoposide|etoposide|mesh-list
14759922|NCT04624204|Olaparib|olaparib|mesh-list
14759923|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13916981|NCT03460743|Vaccines|vaccines|mesh-list
13916982|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
13916983|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
13916984|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916985|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
13916986|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13916987|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
13916988|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13916989|NCT03460678|Pemetrexed|pemetrexed|mesh-list
14084866|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084867|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084868|NCT02494804|Temozolomide|temozolomide|mesh-list
14084869|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14084870|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
14084871|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084872|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084873|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
14084874|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084875|NCT02495077|Acetaminophen|acetaminophen|mesh-list
14084876|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
14084877|NCT02495077|Promethazine|promethazine|mesh-list
14084878|NCT02495077|Loratadine|loratadine|mesh-list
14084879|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
14084880|NCT02495077|Prednisone|prednisone|mesh-list
14084881|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
14084882|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14084883|NCT02495077|Infliximab|infliximab|mesh-list
14084884|NCT02495077|Tacrolimus|tacrolimus|mesh-list
14084885|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
14084886|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14084887|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084888|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
14084889|NCT02495077|Hormones|hormones|mesh-ancestor
14084890|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759924|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759925|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759926|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14759927|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14759928|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759929|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759930|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14084891|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084892|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14084893|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084894|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14084895|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
14084896|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14084897|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084898|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084899|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084900|NCT02495077|Analgesics|analgesics|mesh-ancestor
14084901|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
14084902|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084903|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
14084904|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14173807|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
14759937|NCT04613518|BMS-986165|bms-986165|mesh-list
14759938|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
14759939|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14084905|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14084906|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
14084907|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14084908|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14084909|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
14084910|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
14084911|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084912|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14084913|NCT02495077|Protective Agents|protective agents|mesh-ancestor
14084914|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
14084915|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084916|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14084917|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14084918|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14084919|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
14084920|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
14084921|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14084922|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
14084923|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
14084924|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084925|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14084926|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
14084927|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14759940|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759941|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759942|NCT04606381|Lazertinib|lazertinib|mesh-list
14759943|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14759944|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084928|NCT02494895|Aspirin|aspirin|mesh-list
14084929|NCT02494895|Ticagrelor|ticagrelor|mesh-list
14084930|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14084931|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084932|NCT02494895|Analgesics|analgesics|mesh-ancestor
14084933|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
14084934|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084935|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084936|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084937|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084938|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14084939|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14084940|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084941|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14084942|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14084943|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084944|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
14759945|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759946|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
14935049|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
13916990|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13916991|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13916992|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13916993|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13916994|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13916995|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13916996|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13916997|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
13916998|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14084945|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14759947|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13916999|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917000|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13917001|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
13917002|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
13917003|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13917004|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13917005|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935050|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935051|NCT01460069|Liraglutide|liraglutide|mesh-list
14084946|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14084947|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14084948|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
14084949|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084950|NCT02494856|Naproxen|naproxen|mesh-list
14084951|NCT02494856|Esomeprazole|esomeprazole|mesh-list
14084952|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14084953|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084954|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14084955|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14084956|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084957|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14084958|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14084959|NCT02494856|Analgesics|analgesics|mesh-ancestor
14084960|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
14084961|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084962|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917006|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084963|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084964|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14084965|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
14084966|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14084967|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
14084968|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14084969|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
14084970|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14084971|NCT02494687|Domperidone|domperidone|mesh-list
14084972|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
14084973|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
14084974|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14084975|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084976|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14084977|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14084978|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
14084979|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14084980|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084981|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14084982|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
14084983|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
14084984|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14084985|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14084986|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14084987|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14084988|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084989|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14084990|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14084991|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14084992|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14084993|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
14084994|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14084995|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14084996|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14084997|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
14084998|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14084999|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085000|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085001|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085002|NCT02494466|Montelukast|montelukast|mesh-list
14085003|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14085004|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
14935052|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14935053|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935054|NCT01460069|Incretins|incretins|mesh-ancestor
14935055|NCT01460069|Hormones|hormones|mesh-ancestor
14935056|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935057|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14935058|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
14935059|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935060|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
14085005|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14085006|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
14085007|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085008|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085009|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14085010|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14085011|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085012|NCT02494349|Tamsulosin|tamsulosin|mesh-list
14085013|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
14935061|NCT01460212|Citalopram|citalopram|mesh-list
14935062|NCT01460212|Fluoxetine|fluoxetine|mesh-list
14935063|NCT01460212|Paroxetine|paroxetine|mesh-list
14935064|NCT01460212|Sertraline|sertraline|mesh-list
14935065|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
14085014|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14085015|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14085016|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14085017|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
14085018|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085019|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935066|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14935067|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14935068|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14085020|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085021|NCT02494349|Urological Agents|urological agents|mesh-ancestor
14085022|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14085023|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14085024|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
14085025|NCT02494284|Aspirin|aspirin|mesh-list
14085026|NCT02494284|Clopidogrel|clopidogrel|mesh-list
14085027|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14085028|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085029|NCT02494284|Analgesics|analgesics|mesh-ancestor
14085030|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
14085031|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085032|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085033|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085034|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085035|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14085036|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14085037|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085038|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14085039|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14085040|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085041|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
14085042|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14085043|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14085044|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14085045|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
14085046|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085047|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
14085048|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14085049|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
14085050|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
13917007|NCT03460470|Urological Agents|urological agents|mesh-ancestor
13917008|NCT03460405|Vaccines|vaccines|mesh-list
13917009|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
13917010|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917011|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13917012|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917013|NCT03460275|Osimertinib|osimertinib|mesh-list
13917014|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917015|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14085051|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085052|NCT02493933|Expectorants|expectorants|mesh-ancestor
14085053|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
14085054|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14085055|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
14085056|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085057|NCT02493933|Protective Agents|protective agents|mesh-ancestor
14085058|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085059|NCT02493933|Antidotes|antidotes|mesh-ancestor
14085060|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14085061|NCT02493933|Estrogens|estrogens|mesh-ancestor
14085062|NCT02493933|Hormones|hormones|mesh-ancestor
14085063|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085064|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14085065|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14085066|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085067|NCT02493959|Incretins|incretins|mesh-ancestor
14759948|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
14759949|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759950|NCT04586426|Daratumumab|daratumumab|mesh-list
14759951|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917016|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917017|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917018|NCT03460145|Propofol|propofol|mesh-list
13917019|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13917020|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917021|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917022|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13917023|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
13917024|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
13917025|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
13917026|NCT03460041|Bupivacaine|bupivacaine|mesh-list
13917027|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
13917028|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
13917029|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917030|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917031|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
13917032|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917033|NCT03460041|Analgesics|analgesics|mesh-ancestor
13917034|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13917035|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
13917036|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13960178|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
14085068|NCT02493959|Hormones|hormones|mesh-ancestor
14085069|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085070|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14085071|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
14085072|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759957|NCT04579224|Gemcitabine|gemcitabine|mesh-list
14759958|NCT04579224|Paclitaxel|paclitaxel|mesh-list
14085073|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085074|NCT02493894|Cefazolin|cefazolin|mesh-list
14085075|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14085076|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085077|NCT02493725|Eculizumab|eculizumab|mesh-list
14085078|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14085079|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085080|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
14085081|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085082|NCT02493738|Itraconazole|itraconazole|mesh-list
14085083|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
14085084|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085085|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14085086|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14085087|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085088|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085089|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14085090|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
14085091|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085092|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085093|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14085094|NCT02493582|Apatinib|apatinib|mesh-list
14085095|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759959|NCT04579224|Docetaxel|docetaxel|mesh-list
14759960|NCT04579224|Halichondrin B|halichondrin b|mesh-list
14759961|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14759962|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14759963|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759964|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
14759965|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
14759966|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
14759967|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935069|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917037|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917038|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917039|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13917040|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
13917041|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13917042|NCT03460002|Vaccines|vaccines|mesh-list
13917043|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
13917044|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917045|NCT03459911|Losartan|losartan|mesh-list
13917046|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13917047|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13917048|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13917049|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13917050|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917051|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
13917052|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14085096|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14085097|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085098|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085099|NCT02493504|Heparin|heparin|mesh-list
14759968|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14759969|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
14759970|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
14759971|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917053|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
13917054|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917055|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
14759972|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759973|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14759974|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
14759975|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759976|NCT04578756|Cariprazine|cariprazine|mesh-list
14759977|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14759978|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14759979|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759980|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759981|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14759982|NCT04577833|Prednisone|prednisone|mesh-list
13917056|NCT03459833|Protective Agents|protective agents|mesh-ancestor
13917057|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
13917058|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13917059|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13917060|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917061|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14085100|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
14085101|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14085102|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14085103|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085104|NCT02493465|Everolimus|everolimus|mesh-list
14085105|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085106|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085107|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
14085108|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085109|NCT02493335|Budesonide|budesonide|mesh-list
14085110|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085111|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14085112|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
14085113|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085114|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085115|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14085116|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
14085117|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
14085118|NCT02493335|Hormones|hormones|mesh-ancestor
14085119|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085120|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
14085121|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14085122|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085123|NCT02493179|Analgesics|analgesics|mesh-ancestor
14085124|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
14085125|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085126|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917062|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917063|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917064|NCT03459417|Morphine|morphine|mesh-list
13917065|NCT03459417|Sulpiride|sulpiride|mesh-list
13917066|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13917067|NCT03459417|Narcotics|narcotics|mesh-ancestor
13917068|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917069|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085127|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085128|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085129|NCT02493192|Meperidine|meperidine|mesh-list
14085130|NCT02493192|Haloperidol|haloperidol|mesh-list
14085131|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
14085132|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
14085133|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
14085134|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085135|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759983|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
14759984|NCT04577833|Niraparib|niraparib|mesh-list
14085136|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085137|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14085138|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14085139|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14759985|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14759986|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
14759987|NCT04577833|Hormones|hormones|mesh-ancestor
14759988|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14759989|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14759990|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14759991|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14759992|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14759993|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14759994|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14759995|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
14759996|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13917070|NCT03459417|Analgesics|analgesics|mesh-ancestor
14085140|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14085141|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14085142|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
14085143|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085144|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085145|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14085146|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14085147|NCT02493192|Narcotics|narcotics|mesh-ancestor
14085148|NCT02493192|Analgesics|analgesics|mesh-ancestor
14085149|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
14085150|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14173808|NCT04792645|Memantine|memantine|mesh-list
14173809|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14173810|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14173811|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
14759997|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14759998|NCT04572451|Nivolumab|nivolumab|mesh-list
14759999|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760000|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173812|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173813|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173814|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173815|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13917071|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
13917072|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917073|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13917074|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13917075|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13917076|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13917077|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
13917078|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917079|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917080|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14173816|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14173817|NCT04792749|Metformin|metformin|mesh-list
14760001|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13917081|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
14173818|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14760002|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760003|NCT04569084|Edaravone|edaravone|mesh-list
14760004|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14760005|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
14760006|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760007|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14760008|NCT04569084|Protective Agents|protective agents|mesh-ancestor
14760009|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760010|NCT04567615|Nivolumab|nivolumab|mesh-list
14085151|NCT02493283|Dapsone|dapsone|mesh-list
14085152|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085153|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
14085154|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14085155|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14085156|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14085157|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085158|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085159|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
14085160|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14085161|NCT02493231|Ketamine|ketamine|mesh-list
14085162|NCT02493231|Nefopam|nefopam|mesh-list
14085163|NCT02493231|Analgesics|analgesics|mesh-ancestor
14085164|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
14085165|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085166|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085167|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14085168|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14085169|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
14085170|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
14085171|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085172|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13917082|NCT03459404|Sufentanil|sufentanil|mesh-list
14760011|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760012|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917083|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13917084|NCT03459404|Narcotics|narcotics|mesh-ancestor
13917085|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917086|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917087|NCT03459404|Analgesics|analgesics|mesh-ancestor
13917088|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
13917089|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917090|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13917091|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13917092|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
13917093|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
14085173|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14085174|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085175|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085176|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085177|NCT02493049|Domperidone|domperidone|mesh-list
14085178|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085179|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
14085180|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
14085181|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085182|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085183|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085184|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14085185|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
14085186|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085187|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14085188|NCT02493322|Olmesartan|olmesartan|mesh-list
14085189|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14085190|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
14085191|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14085192|NCT02493322|Diuretics|diuretics|mesh-ancestor
14085193|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
14085194|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085195|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14085196|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14085197|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085198|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14085199|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14085200|NCT02492945|Lidocaine|lidocaine|mesh-list
14085201|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14085202|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
14085203|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
14085204|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085205|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085206|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
14085207|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085208|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14085209|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14085210|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14085211|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14085212|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085213|NCT02492776|Omeprazole|omeprazole|mesh-list
14085214|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14085215|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085216|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14085217|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085218|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085219|NCT02492503|Paclitaxel|paclitaxel|mesh-list
14085220|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14085221|NCT02492503|Carboplatin|carboplatin|mesh-list
14085222|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14085223|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085224|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
14085225|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
14085226|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
14085227|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085228|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14085229|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14085230|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14085231|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085232|NCT02492464|Red yeast rice|red yeast rice|mesh-list
14477033|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477034|NCT02424968|Cyclosporine|cyclosporine|mesh-list
14477035|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
14477036|NCT02424968|Cyclosporins|cyclosporins|mesh-list
14477037|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
14477038|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14477039|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477040|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477041|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085233|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14085234|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14085235|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14085236|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
14085237|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085238|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085239|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14935070|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935071|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
14935072|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085240|NCT02492412|Cyclosporine|cyclosporine|mesh-list
14085241|NCT02492412|Cyclosporins|cyclosporins|mesh-list
14085242|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085243|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085244|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085245|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
14085246|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085247|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
14085248|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085249|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14085250|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085251|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14085252|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
14085253|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14085254|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085255|NCT02492386|Everolimus|everolimus|mesh-list
14085256|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085257|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085258|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
14085259|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085260|NCT02492438|Vaccines|vaccines|mesh-list
14085261|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
14085262|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085263|NCT02492581|Nalmefene|nalmefene|mesh-list
14085264|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14085265|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917094|NCT03459248|Anesthetics|anesthetics|mesh-list
13917095|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917096|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917097|NCT03459144|Ranibizumab|ranibizumab|mesh-list
13917098|NCT03459144|Verteporfin|verteporfin|mesh-list
13917099|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13917100|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13917101|NCT03459144|Growth Substances|growth substances|mesh-ancestor
14085266|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
14085267|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085268|NCT02492373|Clobetasol|clobetasol|mesh-list
13960179|NCT03156829|Hormones|hormones|mesh-ancestor
14085269|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085270|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
14085271|NCT02492373|Hormones|hormones|mesh-ancestor
14085272|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760013|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14760014|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760015|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
14760016|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14760017|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760018|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917102|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917103|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
13917104|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917105|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13917106|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960180|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13960181|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960182|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13960183|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
13960184|NCT03156439|Huperzine A|huperzine a|mesh-list
13960185|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13960186|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960187|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960188|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
13960189|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960190|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960191|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13960192|NCT03156439|Protective Agents|protective agents|mesh-ancestor
13960193|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
13960194|NCT03156452|Prednisolone|prednisolone|mesh-list
13960195|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13960196|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960197|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13960198|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
13960199|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14085273|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085274|NCT02492490|Basiliximab|basiliximab|mesh-list
14085275|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085276|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
14085277|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085278|NCT02492308|Basiliximab|basiliximab|mesh-list
14085279|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085280|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
14085281|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085282|NCT02492360|Cisplatin|cisplatin|mesh-list
14085283|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085284|NCT02492282|Remifentanil|remifentanil|mesh-list
14085285|NCT02492282|Propofol|propofol|mesh-list
14085286|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14085287|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085288|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085289|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14085290|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
14085291|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
14085292|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14085293|NCT02492282|Narcotics|narcotics|mesh-ancestor
14085294|NCT02492282|Analgesics|analgesics|mesh-ancestor
14085295|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
14085296|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085297|NCT02492126|Citric Acid|citric acid|mesh-list
14085298|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
14085299|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
14085300|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14085301|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
14085302|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
14085303|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760019|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760020|NCT04549207|Denosumab|denosumab|mesh-list
14760021|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
14085304|NCT02492230|Warfarin|warfarin|mesh-list
14085305|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
14085306|NCT02492178|Artesunate|artesunate|mesh-list
14760022|NCT04549207|Pamidronate|pamidronate|mesh-list
14760023|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14760024|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760025|NCT04543591|Ravulizumab|ravulizumab|mesh-list
14760026|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14760027|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14760028|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
14760029|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760030|NCT04532463|Fluconazole|fluconazole|mesh-list
14760031|NCT04532463|Amphotericin B|amphotericin b|mesh-list
14760032|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14760033|NCT04532463|Flucytosine|flucytosine|mesh-list
14085307|NCT02492178|Quinine|quinine|mesh-list
14085308|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
14760034|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
14760035|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085309|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14085310|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14085311|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085312|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085313|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
14085314|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
14085315|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14085316|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
14085317|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14085318|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085319|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14085320|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917107|NCT03459105|Bupivacaine|bupivacaine|mesh-list
13917108|NCT03459105|Anesthetics|anesthetics|mesh-list
13917109|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
14085321|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085322|NCT02492178|Analgesics|analgesics|mesh-ancestor
14085323|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
13917110|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917111|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917112|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
13917113|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917114|NCT03458923|Diclofenac|diclofenac|mesh-list
13917115|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
13917116|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13917117|NCT03458923|Ranibizumab|ranibizumab|mesh-list
13917118|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
14760036|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14760037|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14760038|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760039|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760040|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13917119|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13917120|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13917121|NCT03458923|Growth Substances|growth substances|mesh-ancestor
13917122|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917123|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
13917124|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917125|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917126|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13917127|NCT03458923|Analgesics|analgesics|mesh-ancestor
13917128|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
13917129|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917130|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917131|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14085324|NCT02492217|Adalimumab|adalimumab|mesh-list
14085325|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085326|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085327|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
14085328|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14085329|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14085330|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085331|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
14085332|NCT02492087|Coagulants|coagulants|mesh-ancestor
14760041|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
14760042|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760043|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760044|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14085333|NCT02492074|Dronabinol|dronabinol|mesh-list
14085334|NCT02492074|Cannabidiol|cannabidiol|mesh-list
14085335|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
14085336|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
14085337|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085338|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14085339|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085340|NCT02492074|Analgesics|analgesics|mesh-ancestor
14085341|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
14085342|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085343|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13917132|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917133|NCT03458715|Empagliflozin|empagliflozin|mesh-list
13917134|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
13917135|NCT03458715|Linagliptin|linagliptin|mesh-list
14085344|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14085345|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085346|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085347|NCT02492074|Hormones|hormones|mesh-ancestor
14085348|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085349|NCT02491983|Letrozole|letrozole|mesh-list
14085350|NCT02491983|Fulvestrant|fulvestrant|mesh-list
14085351|NCT02491983|Palbociclib|palbociclib|mesh-list
13917136|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
13917137|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917138|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917139|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917140|NCT03458715|Incretins|incretins|mesh-ancestor
13917141|NCT03458715|Hormones|hormones|mesh-ancestor
13917142|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917143|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
13917144|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917145|NCT03458689|Analgesics|analgesics|mesh-list
13917146|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
13917147|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917148|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917149|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
13917150|NCT03458598|Narcotics|narcotics|mesh-ancestor
13917151|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917152|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917153|NCT03458598|Analgesics|analgesics|mesh-ancestor
13917154|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
13917155|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085352|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917156|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13917157|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917158|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
13917159|NCT03458481|Yimitasvir|yimitasvir|mesh-list
13917160|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
13917161|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917162|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
13917163|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13917164|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14085353|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14085354|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14085355|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085356|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085357|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14085358|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
14085359|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085360|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085361|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14085362|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14085363|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14085364|NCT02491697|Capecitabine|capecitabine|mesh-list
14085365|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14085366|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
14085367|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085368|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085369|NCT02491749|Anesthetics|anesthetics|mesh-list
14085370|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085371|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085372|NCT02491736|Ketoprofen|ketoprofen|mesh-list
14085373|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14085374|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085375|NCT02491736|Analgesics|analgesics|mesh-ancestor
14085376|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
14085377|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085378|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085379|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085380|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085381|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14085382|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085383|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085384|NCT02491970|Fluticasone|fluticasone|mesh-list
14085385|NCT02491970|Xhance|xhance|mesh-list
14477042|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
14477043|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085386|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
14085387|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14085388|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14085389|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085390|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14085391|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
14085392|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917165|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085393|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085394|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14085395|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
14085396|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
14085397|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14085398|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14085399|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14085400|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14085401|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
14085402|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085403|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085404|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
14085405|NCT02491970|Hormones|hormones|mesh-ancestor
14085406|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085407|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
14085408|NCT02491879|Ketoprofen|ketoprofen|mesh-list
14085409|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14085410|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085411|NCT02491879|Analgesics|analgesics|mesh-ancestor
14085412|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
14085413|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085414|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085415|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085416|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085417|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14085418|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085419|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085420|NCT02491723|Azithromycin|azithromycin|mesh-list
14085421|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14085422|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173819|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173820|NCT04792710|Metronidazole|metronidazole|mesh-list
14173821|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173822|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14173823|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14173824|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14173825|NCT04792840|Letrozole|letrozole|mesh-list
14173826|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173827|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14173828|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14173829|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173830|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173831|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14173832|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
14173833|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173834|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183542|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14183543|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183544|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183545|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935073|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14935074|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14935075|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14935076|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14935077|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935078|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14935079|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14935080|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935081|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14935082|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14935083|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
14935084|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14935085|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14935086|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14935087|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14935088|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935089|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
14085423|NCT02491320|Letrozole|letrozole|mesh-list
14085424|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085425|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14085426|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14085427|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085428|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085429|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14085430|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
14085431|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085432|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085433|NCT02491242|Dolutegravir|dolutegravir|mesh-list
14085434|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14085435|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14085436|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085437|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085438|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14085439|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14085440|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
13917166|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
13917167|NCT03458468|Coagulants|coagulants|mesh-ancestor
13917168|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
13917169|NCT03458455|Nivolumab|nivolumab|mesh-list
13917170|NCT03458455|Ipilimumab|ipilimumab|mesh-list
13917171|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917172|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917173|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13917174|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917175|NCT03458429|Sargramostim|sargramostim|mesh-list
13917176|NCT03458429|Lenograstim|lenograstim|mesh-list
13917177|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
13917178|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917179|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13917180|NCT03458416|Cannabidiol|cannabidiol|mesh-list
13917181|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
13917182|NCT03458260|Rituximab|rituximab|mesh-list
13917183|NCT03458260|Etoposide|etoposide|mesh-list
13917184|NCT03458260|Ifosfamide|ifosfamide|mesh-list
14085441|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085442|NCT02491268|Cilostazol|cilostazol|mesh-list
14085443|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14085444|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
14085445|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085446|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085447|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14085448|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
14085449|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14085450|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14085451|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085452|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14085453|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
14085454|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14085455|NCT02491268|Protective Agents|protective agents|mesh-ancestor
14085456|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14085457|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14085458|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085459|NCT02491606|Tafenoquine|tafenoquine|mesh-list
14085460|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
14085461|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14085462|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14085463|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085464|NCT02491515|Denosumab|denosumab|mesh-list
14085465|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14085466|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085467|NCT02491398|Rituximab|rituximab|mesh-list
14085468|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14085469|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14085470|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085471|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
14085472|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085473|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085474|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14085475|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
14085476|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085477|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
14085478|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
14085479|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085480|NCT02491528|Insulin|insulin|mesh-list
14085481|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14085482|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
14477044|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
14085483|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
14173838|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
13917185|NCT03458260|Pixantrone|pixantrone|mesh-list
13917186|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917187|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917188|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
13917189|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917190|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917191|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13917192|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13917193|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13917194|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917195|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917196|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13917197|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
13917198|NCT03458221|Tamoxifen|tamoxifen|mesh-list
13917199|NCT03458221|Itraconazole|itraconazole|mesh-list
13917200|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14085484|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14085485|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14085486|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085487|NCT02491086|Nicotine|nicotine|mesh-list
14085488|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14085489|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
14085490|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085491|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085492|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14085493|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14085494|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
14085495|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085496|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085497|NCT02490982|Teriflunomide|teriflunomide|mesh-list
14085498|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14173839|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14477045|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477046|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
14085499|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085500|NCT02490982|Analgesics|analgesics|mesh-ancestor
14085501|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
14085502|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085503|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085504|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085505|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085506|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085507|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
14085508|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14085509|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14085510|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085511|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085512|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
14085513|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085514|NCT02490904|Eplerenone|eplerenone|mesh-list
14085515|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14085516|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
14085517|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085518|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085519|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14085520|NCT02490904|Diuretics|diuretics|mesh-ancestor
14085521|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
14085522|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14085523|NCT02490657|Iloprost|iloprost|mesh-list
14085524|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14085525|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
14935090|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085526|NCT02490592|Fluorides|fluorides|mesh-list
13917201|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
13917202|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917203|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917204|NCT03458221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13917205|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917206|NCT03458221|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13917207|NCT03458221|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13917208|NCT03458221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13917209|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
13917210|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085527|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
14085528|NCT02490592|Protective Agents|protective agents|mesh-ancestor
14085529|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085530|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
14085531|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14085532|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
14085533|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14085534|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085535|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14085536|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14085537|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14085538|NCT02490865|RNS60|rns60|mesh-list
14085539|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14085540|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085541|NCT02490865|Analgesics|analgesics|mesh-ancestor
14085542|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
14085543|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085544|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085545|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085546|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085547|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14085548|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14085549|NCT02490839|Amoxicillin|amoxicillin|mesh-list
14085550|NCT02490839|Metronidazole|metronidazole|mesh-list
14085551|NCT02490839|Tetracycline|tetracycline|mesh-list
14085552|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14085553|NCT02490839|Rabeprazole|rabeprazole|mesh-list
14085554|NCT02490839|Bismuth|bismuth|mesh-list
14085555|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14085556|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085557|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
14085558|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14085559|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14477047|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085560|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14085561|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917211|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13917212|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13917213|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917214|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917215|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13917216|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13917217|NCT03458208|Metformin|metformin|mesh-list
13917218|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917219|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917220|NCT03458143|Ketamine|ketamine|mesh-list
13917221|NCT03458143|Remifentanil|remifentanil|mesh-list
13917222|NCT03458143|Analgesics|analgesics|mesh-ancestor
13917223|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
13917224|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917225|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917226|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13917227|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13917228|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
14085562|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917229|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
13917230|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917231|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13917232|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14935091|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935092|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13917233|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917234|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917235|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13917236|NCT03458143|Narcotics|narcotics|mesh-ancestor
13917237|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
13917238|NCT03458078|Midazolam|midazolam|mesh-list
13917239|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13917240|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13917241|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917242|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085563|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085564|NCT02490839|Antacids|antacids|mesh-ancestor
14085565|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14085566|NCT02490527|Simvastatin|simvastatin|mesh-list
14085567|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14085568|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14085569|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
14085570|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085571|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14085572|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14085573|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085574|NCT02490540|Sufentanil|sufentanil|mesh-list
14085575|NCT02490540|Dsuvia|dsuvia|mesh-list
14935093|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935094|NCT01460420|Lenalidomide|lenalidomide|mesh-list
14935095|NCT01460420|Bortezomib|bortezomib|mesh-list
14935096|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
14935097|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935098|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14935099|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14935100|NCT01460420|Growth Substances|growth substances|mesh-ancestor
14935101|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
14085576|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14085577|NCT02490540|Narcotics|narcotics|mesh-ancestor
14085578|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085579|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085580|NCT02490540|Analgesics|analgesics|mesh-ancestor
14085581|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
14085582|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085583|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14085584|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14085585|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
14085586|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
14085587|NCT02490436|Cetuximab|cetuximab|mesh-list
14085588|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14085589|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085590|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
14085591|NCT02490449|Lansoprazole|lansoprazole|mesh-list
14085592|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14085593|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085594|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14085595|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085596|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085597|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
14085598|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085599|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
14085600|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
14085601|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
14085602|NCT02490345|Gabapentin|gabapentin|mesh-list
14085603|NCT02490345|Analgesics|analgesics|mesh-ancestor
14085604|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
14085605|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935102|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935103|NCT01460498|Azacitidine|azacitidine|mesh-list
13917243|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13917244|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13917245|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14935104|NCT01460498|Decitabine|decitabine|mesh-list
14935105|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14935106|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
14935107|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935108|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935109|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935110|NCT01460537|Gemcitabine|gemcitabine|mesh-list
14935111|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085606|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477048|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14477049|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14477050|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477051|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14477052|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
14477053|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477054|NCT02425098|Vaccines|vaccines|mesh-list
14477055|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
14477056|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477057|NCT02425111|Vedolizumab|vedolizumab|mesh-list
14477058|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14477059|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
14935112|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13917246|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13917247|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
13917248|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
13917249|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
13917250|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
13917251|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917252|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477060|NCT02425306|Poly ICLC|poly iclc|mesh-list
13917253|NCT03458078|Analgesics|analgesics|mesh-ancestor
14477061|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
13917254|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
13917255|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917256|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13917257|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
13917258|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13917259|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917260|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13917261|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
13917262|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13917263|NCT03457753|Riluzole|riluzole|mesh-list
13917264|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
13917265|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13917266|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13917267|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917268|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917269|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917270|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13917271|NCT03457753|Protective Agents|protective agents|mesh-ancestor
13917272|NCT03457597|Pioglitazone|pioglitazone|mesh-list
13917273|NCT03457597|Tolbutamide|tolbutamide|mesh-list
13917274|NCT03457597|Metoprolol|metoprolol|mesh-list
13917275|NCT03457597|Midazolam|midazolam|mesh-list
13917276|NCT03457597|Omeprazole|omeprazole|mesh-list
13917277|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13917278|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13917279|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917280|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085607|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
14085608|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14085609|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13917281|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13917282|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13917283|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13917284|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13917285|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
13917286|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
13917287|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
13917288|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
13917289|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917290|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917291|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917292|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13917293|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917294|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13917295|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917296|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14085610|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085611|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14085612|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14085613|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14085614|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085615|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085616|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
14085617|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
13917297|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13917298|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
13917299|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
13917300|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917301|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13917302|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13917303|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13917304|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960200|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960201|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960202|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960203|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960204|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
13960205|NCT03156452|Hormones|hormones|mesh-ancestor
13960206|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085618|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14085619|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085620|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085621|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085622|NCT02490072|Analgesics|analgesics|mesh-ancestor
14085623|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
14085624|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085625|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14085626|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14085627|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14085628|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14085629|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085630|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085631|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
14085632|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
14085633|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14085634|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085635|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085636|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
14085637|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14085638|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085639|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085640|NCT02490085|Insulin|insulin|mesh-list
14085641|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14085642|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14085643|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085644|NCT02489955|Tobramycin|tobramycin|mesh-list
14085645|NCT02489955|Amikacin|amikacin|mesh-list
14085646|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14085647|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173840|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173841|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173842|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14173843|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14173844|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173845|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
14173846|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173847|NCT04792333|Firibastat|firibastat|mesh-list
14173848|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14173849|NCT04792385|Drospirenone|drospirenone|mesh-list
14173850|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
14173851|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
14173852|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14173853|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14173854|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085648|NCT02490176|Liraglutide|liraglutide|mesh-list
14085649|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14085650|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085651|NCT02490176|Incretins|incretins|mesh-ancestor
14085652|NCT02490176|Hormones|hormones|mesh-ancestor
14085653|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085654|NCT02490098|Insulin|insulin|mesh-list
14085655|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14760045|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13917305|NCT03457467|Apatinib|apatinib|mesh-list
13917306|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917307|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13917308|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917309|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917310|NCT03457389|Cabergoline|cabergoline|mesh-list
13917311|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13917312|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13917313|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
13917314|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
13917315|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917316|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917317|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917318|NCT03457337|Gefitinib|gefitinib|mesh-list
13917319|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917320|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13917321|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760046|NCT04532463|Amebicides|amebicides|mesh-ancestor
14760047|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14760048|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14760049|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14760050|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
14760051|NCT04531462|Empagliflozin|empagliflozin|mesh-list
14760052|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14760053|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760054|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14760055|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085656|NCT02490098|Glucagon|glucagon|mesh-list
14085657|NCT02490098|Hormones|hormones|mesh-list
14085658|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14760056|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
14760057|NCT04526509|Fludarabine|fludarabine|mesh-list
14760058|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13917322|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917323|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13917324|NCT03457233|Cetrorelix|cetrorelix|mesh-list
14085659|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085660|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085661|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085662|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14085663|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14085664|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085665|NCT02489695|Axitinib|axitinib|mesh-list
14760059|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
14760060|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917325|NCT03457233|Menotropins|menotropins|mesh-list
13917326|NCT03457233|Progesterone|progesterone|mesh-list
13917327|NCT03457233|Progestins|progestins|mesh-ancestor
13917328|NCT03457233|Hormones|hormones|mesh-ancestor
13917329|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917330|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917331|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13917332|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13917333|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
13917334|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
13917335|NCT03457194|Vaccines|vaccines|mesh-list
13917336|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
13917337|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917338|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
13917339|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917340|NCT03456947|Pregabalin|pregabalin|mesh-list
13917341|NCT03456947|Analgesics|analgesics|mesh-ancestor
13917342|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
13917343|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917344|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085666|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085667|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14085668|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085669|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085670|NCT02489786|Digoxin|digoxin|mesh-list
14085671|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14085672|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14085673|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085674|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085675|NCT02489786|Protective Agents|protective agents|mesh-ancestor
14085676|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085677|NCT02489760|Adalimumab|adalimumab|mesh-list
14085678|NCT02489760|Etanercept|etanercept|mesh-list
14085679|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14085680|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085681|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14085682|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085683|NCT02489760|Analgesics|analgesics|mesh-ancestor
14085684|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
14085685|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085686|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085687|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085688|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085689|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
14085690|NCT02489929|Azacitidine|azacitidine|mesh-list
14085691|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14085692|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
14085693|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085694|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085695|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085696|NCT02489864|Terlipressin|terlipressin|mesh-list
14085697|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14085698|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14085699|NCT02489240|Vitamin D|vitamin d|mesh-list
14085700|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
14085701|NCT02489240|Vitamins|vitamins|mesh-ancestor
14085702|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
14085703|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085704|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14085705|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14085706|NCT02489461|Efavirenz|efavirenz|mesh-list
14085707|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
14085708|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14085709|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14085710|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14085711|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085712|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085713|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
14085714|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085715|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14085716|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14085717|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14085718|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14085719|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14085720|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14085721|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14085722|NCT02489487|Ritonavir|ritonavir|mesh-list
14085723|NCT02489487|Darunavir|darunavir|mesh-list
14085724|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
14085725|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14085726|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14085727|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
14085728|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085729|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085730|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14085731|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14085732|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
14760061|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085733|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085734|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14085735|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14085736|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14085737|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14760062|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14760063|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
14760064|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760065|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760066|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14760067|NCT04524000|Fulvestrant|fulvestrant|mesh-list
14760068|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760069|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760070|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14760071|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14760072|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
14085738|NCT02489266|Aldesleukin|aldesleukin|mesh-list
14085739|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
14085740|NCT02489266|Fludarabine|fludarabine|mesh-list
14085741|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085742|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
14085743|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085744|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14085745|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14085746|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
14085747|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085748|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085749|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14085750|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14085751|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14935113|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
14935114|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935115|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
14935116|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935117|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935118|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935119|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
14935120|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935121|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
14935122|NCT01460563|Analgesics|analgesics|mesh-ancestor
14935123|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
14935124|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935125|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935126|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
14935127|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085752|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
14085753|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085754|NCT02489513|Ivosidenib|ivosidenib|mesh-list
14085755|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085756|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085757|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085758|NCT02489409|Gemcitabine|gemcitabine|mesh-list
14085759|NCT02489409|Vinorelbine|vinorelbine|mesh-list
14085760|NCT02489409|Endostatins|endostatins|mesh-list
14085761|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14085762|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
14085763|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085764|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085765|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
14085766|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085767|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085768|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14085769|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
14085770|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085771|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14085772|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
14085773|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
14085774|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
14085775|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14183546|NCT04727502|Analgesics|analgesics|mesh-ancestor
14085776|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14085777|NCT02489409|Growth Substances|growth substances|mesh-ancestor
14085778|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
14085779|NCT02489019|Fentanyl|fentanyl|mesh-list
14085780|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14085781|NCT02489019|Narcotics|narcotics|mesh-ancestor
14085782|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085783|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085784|NCT02489019|Analgesics|analgesics|mesh-ancestor
14085785|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
14085786|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085787|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14085788|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14085789|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
14085790|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
14085791|NCT02489006|Olaparib|olaparib|mesh-list
14085792|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14085793|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085794|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085795|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085796|NCT02488889|Ethanol|ethanol|mesh-list
14085797|NCT02488889|Varenicline|varenicline|mesh-list
14085798|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14085799|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085800|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085801|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085802|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14085803|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14085804|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
14085805|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085806|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085807|NCT02488902|Mefloquine|mefloquine|mesh-list
14085808|NCT02488902|Tafenoquine|tafenoquine|mesh-list
14085809|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
14085810|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14085811|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14085812|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085813|NCT02488993|Rifaximin|rifaximin|mesh-list
14085814|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14085815|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14085816|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085817|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
14085818|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14085819|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
14085820|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
14085821|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085822|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085823|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085824|NCT02489097|Analgesics|analgesics|mesh-ancestor
14085825|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
14085826|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085827|NCT02488694|Pemetrexed|pemetrexed|mesh-list
14085828|NCT02488694|Afatinib|afatinib|mesh-list
14085829|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085830|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085831|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085832|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14085833|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14085834|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14085835|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
14085836|NCT02488473|Ropivacaine|ropivacaine|mesh-list
14085837|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14085838|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085839|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085840|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14085841|NCT02488473|Analgesics|analgesics|mesh-ancestor
14085842|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
14085843|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085844|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14085845|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14085846|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13917345|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
13917346|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13917347|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917348|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917349|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13917350|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13917351|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13917352|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917353|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13917354|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
13917355|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917356|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917357|NCT03456752|Dexamethasone|dexamethasone|mesh-list
13917358|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917359|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
14085847|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14085848|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085849|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085850|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
14085851|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
14085852|NCT02488512|Edotreotide|edotreotide|mesh-list
14085853|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14085854|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085855|NCT02488564|Metformin|metformin|mesh-list
14085856|NCT02488564|Docetaxel|docetaxel|mesh-list
14085857|NCT02488564|Doxorubicin|doxorubicin|mesh-list
14085858|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14085859|NCT02488564|Trastuzumab|trastuzumab|mesh-list
14085860|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14085861|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085862|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085863|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
14085864|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
14085865|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
14085866|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085867|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14085868|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14085869|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14760073|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760074|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760075|NCT04523207|Relugolix|relugolix|mesh-list
14760076|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
14760077|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
14760078|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917360|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
13917361|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917362|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917363|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917364|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
13917365|NCT03456752|Hormones|hormones|mesh-ancestor
13917366|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917367|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13917368|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917369|NCT03456713|Mirikizumab|mirikizumab|mesh-list
14477062|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085870|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085871|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14085872|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
14085873|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
14085874|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085875|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085876|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14085877|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
14085878|NCT02488603|Tamoxifen|tamoxifen|mesh-list
14085879|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14085880|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
14085881|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085882|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085883|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14085884|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14085885|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14085886|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14085887|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14085888|NCT02488538|Fluoxetine|fluoxetine|mesh-list
14085889|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
14085890|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
14085891|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14085892|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14085893|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917370|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13917371|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13917372|NCT03456713|Analgesics|analgesics|mesh-ancestor
14085894|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14085895|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14085896|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14085897|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085898|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085899|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
14173855|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14760079|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760080|NCT04521803|Rifampin|rifampin|mesh-list
14760081|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14760082|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
13917373|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
13917374|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917375|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917376|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917377|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917378|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14085900|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14085901|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
14085902|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14085903|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14085904|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14085905|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14085906|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14085907|NCT02488616|Insulin|insulin|mesh-list
14085908|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14085909|NCT02488616|Hormones|hormones|mesh-list
14085910|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14085911|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085912|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085913|NCT02488642|Isosorbide|isosorbide|mesh-list
14085914|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14085915|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14085916|NCT02488642|Misoprostol|misoprostol|mesh-list
14085917|NCT02488642|Oxytocin|oxytocin|mesh-list
14085918|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
14085919|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14085920|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085921|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14085922|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
14085923|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14085924|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14085925|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14085926|NCT02488642|Diuretics|diuretics|mesh-ancestor
14085927|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
14085928|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
14085929|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14085930|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085931|NCT02488486|Remifentanil|remifentanil|mesh-list
14085932|NCT02488486|Propofol|propofol|mesh-list
14085933|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14085934|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085935|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085936|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14085937|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
14085938|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
14085939|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14085940|NCT02488486|Narcotics|narcotics|mesh-ancestor
14760083|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14085941|NCT02488486|Analgesics|analgesics|mesh-ancestor
14085942|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
14085943|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173856|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14173857|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
14173858|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173859|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14173860|NCT04792385|Diuretics|diuretics|mesh-ancestor
14173861|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
14173862|NCT04792320|Charcoal|charcoal|mesh-list
14173863|NCT04792320|Antidotes|antidotes|mesh-ancestor
14173864|NCT04792320|Protective Agents|protective agents|mesh-ancestor
14173865|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173866|NCT04792138|Phenobarbital|phenobarbital|mesh-list
14173867|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
14173868|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14173869|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173870|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173871|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14173872|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14173873|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14173874|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173875|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
14173876|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
14173877|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14173878|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14173879|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14085944|NCT02488057|Liraglutide|liraglutide|mesh-list
14085945|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14085946|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085947|NCT02488057|Incretins|incretins|mesh-ancestor
14085948|NCT02488057|Hormones|hormones|mesh-ancestor
14085949|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14085950|NCT02488291|Sufentanil|sufentanil|mesh-list
14085951|NCT02488291|Dsuvia|dsuvia|mesh-list
14085952|NCT02488291|Ropivacaine|ropivacaine|mesh-list
14085953|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
14085954|NCT02488291|Anesthetics|anesthetics|mesh-list
14085955|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085956|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085957|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
14085958|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085959|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14085960|NCT02488291|Narcotics|narcotics|mesh-ancestor
14085961|NCT02488291|Analgesics|analgesics|mesh-ancestor
14085962|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14085963|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14085964|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
14085965|NCT02488135|Hemostatics|hemostatics|mesh-list
14085966|NCT02488135|Coagulants|coagulants|mesh-ancestor
14085967|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14085968|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14085969|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14085970|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14085971|NCT02487953|Nicotine|nicotine|mesh-list
14085972|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14085973|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
14085974|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085975|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085976|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14085977|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14085978|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
14085979|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14085980|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085981|NCT02487914|Lidocaine|lidocaine|mesh-list
14085982|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
14085983|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
14085984|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14085985|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085986|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
14085987|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14085988|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14085989|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14085990|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14085991|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14085992|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14085993|NCT02487680|Chromium|chromium|mesh-list
14085994|NCT02487680|Picolinic acid|picolinic acid|mesh-list
14085995|NCT02487680|Trace Elements|trace elements|mesh-ancestor
14085996|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
14085997|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14085998|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14085999|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
14086000|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
14086001|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086002|NCT02487706|Dolutegravir|dolutegravir|mesh-list
14086003|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14086004|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14086005|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086006|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086007|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14086008|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14086009|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
14086010|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086011|NCT02487732|Ticagrelor|ticagrelor|mesh-list
14086012|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14086013|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086014|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14086015|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14086016|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14086017|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
14086018|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086019|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086020|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086021|NCT02487823|Bicalutamide|bicalutamide|mesh-list
14086022|NCT02487823|Buserelin|buserelin|mesh-list
14086023|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
14760084|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760085|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
14760086|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14086024|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
14086025|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086026|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086027|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086028|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14086029|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
14086030|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14086031|NCT02487719|Teferrol|teferrol|mesh-list
14086032|NCT02487719|Hematinics|hematinics|mesh-ancestor
14086033|NCT02487433|Tofacitinib|tofacitinib|mesh-list
14086034|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14086035|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086036|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086037|NCT02487407|Simendan|simendan|mesh-list
14086038|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14086039|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086040|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13917379|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917380|NCT03456687|Exenatide|exenatide|mesh-list
13917381|NCT03456687|Glucagon|glucagon|mesh-list
13917382|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14086041|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14086042|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086043|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086044|NCT02487407|Protective Agents|protective agents|mesh-ancestor
14086045|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086046|NCT02487381|Dronabinol|dronabinol|mesh-list
14086047|NCT02487381|Cannabidiol|cannabidiol|mesh-list
13917383|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917384|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917385|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13917386|NCT03456687|Incretins|incretins|mesh-ancestor
13917387|NCT03456687|Hormones|hormones|mesh-ancestor
14086048|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
14086049|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
14086050|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086051|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14086052|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14086053|NCT02487381|Analgesics|analgesics|mesh-ancestor
14086054|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
14086055|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086056|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14086057|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14086058|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086059|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086060|NCT02487381|Hormones|hormones|mesh-ancestor
14086061|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086062|NCT02487849|Carboplatin|carboplatin|mesh-list
14086063|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086064|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
14086065|NCT02487329|Calcium|calcium|mesh-list
14086066|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14086067|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086068|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14086069|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
14086070|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
14086071|NCT02487355|Bupivacaine|bupivacaine|mesh-list
14086072|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
14086073|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
14086074|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086075|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086076|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
13917388|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917389|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14086077|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173880|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13917390|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
13917391|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
13917392|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13917393|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917394|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917395|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13917396|NCT03456661|Analgesics|analgesics|mesh-ancestor
14086078|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14086079|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14086080|NCT02487355|Analgesics|analgesics|mesh-ancestor
14086081|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14086082|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14086083|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14086084|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
14086085|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935128|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14935129|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
14935130|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14086086|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086087|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14086088|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
14086089|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14086090|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14086091|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14086092|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
14086093|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14086094|NCT02487316|Crizotinib|crizotinib|mesh-list
14086095|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086096|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14086097|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086098|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086099|NCT02487212|Clobetasol|clobetasol|mesh-list
14086100|NCT02487212|Petrolatum|petrolatum|mesh-list
14086101|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086102|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
14086103|NCT02487212|Hormones|hormones|mesh-ancestor
14086104|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086105|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917397|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
13917398|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917399|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13917400|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13917401|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13917402|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
13917403|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086106|NCT02487212|Emollients|emollients|mesh-ancestor
14086107|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
13917404|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086108|NCT02487069|Cyclosporine|cyclosporine|mesh-list
14086109|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
14086110|NCT02487069|Methotrexate|methotrexate|mesh-list
14086111|NCT02487069|Cyclosporins|cyclosporins|mesh-list
14086112|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14086113|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14086114|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
14086115|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14086116|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086117|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14086118|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
14086119|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086120|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086121|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14086122|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086123|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14086124|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14086125|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
14086126|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14086127|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14086128|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
14086129|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086130|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14086131|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14086132|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14086133|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
14086134|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14086135|NCT02487082|Melatonin|melatonin|mesh-list
14086136|NCT02487082|Donepezil|donepezil|mesh-list
14086137|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
14086138|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086139|NCT02487082|Protective Agents|protective agents|mesh-ancestor
14086140|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086141|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086142|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14086143|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086144|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
13917405|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
13917406|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
13917407|NCT03456648|Apixaban|apixaban|mesh-list
13917408|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13917409|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
13917410|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13917411|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
13917412|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917413|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917414|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
13917415|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
13917416|NCT03456570|Progestins|progestins|mesh-ancestor
13917417|NCT03456570|Hormones|hormones|mesh-ancestor
13917418|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917419|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917420|NCT03456544|Vancomycin|vancomycin|mesh-list
13917421|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13917422|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917423|NCT03456531|Aspirin|aspirin|mesh-list
13917424|NCT03456531|Analgesics|analgesics|mesh-list
14086145|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086146|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
14086147|NCT02486822|Oxytocin|oxytocin|mesh-list
14086148|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
14086149|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14086150|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086151|NCT02486848|Minoxidil|minoxidil|mesh-list
13917425|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13917426|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13917427|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
13917428|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917429|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917430|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917431|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14086152|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14086153|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14086154|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086155|NCT02486926|Remifentanil|remifentanil|mesh-list
14086156|NCT02486926|Alfentanil|alfentanil|mesh-list
14086157|NCT02486926|Thiopental|thiopental|mesh-list
14086158|NCT02486926|Sevoflurane|sevoflurane|mesh-list
14086159|NCT02486926|Rocuronium|rocuronium|mesh-list
14086160|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086161|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14086162|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
14086163|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
14086164|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086165|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086166|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14086167|NCT02486926|Narcotics|narcotics|mesh-ancestor
14086168|NCT02486926|Analgesics|analgesics|mesh-ancestor
14086169|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
14086170|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086171|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14086172|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14086173|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14086174|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14086175|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
14086176|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14086177|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
14086178|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
14086179|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086180|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086181|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14086182|NCT02486744|Hormones|hormones|mesh-ancestor
14086183|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086184|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086185|NCT02486432|Levodopa|levodopa|mesh-list
14086186|NCT02486432|Carbidopa|carbidopa|mesh-list
14086187|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14086188|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14086189|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14086190|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
14086191|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086192|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086193|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086194|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14086195|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086196|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14086197|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
14086198|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
14086199|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
14086200|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14086201|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
14086202|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14086203|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
14086204|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086205|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086206|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
14086207|NCT02486510|Maraviroc|maraviroc|mesh-list
14086208|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14086209|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14086210|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086211|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14086212|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14086213|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
14086214|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086215|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14086216|NCT02486549|Bupivacaine|bupivacaine|mesh-list
14086217|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
14086218|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
14086219|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086220|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086221|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
14086222|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086223|NCT02486601|Paclitaxel|paclitaxel|mesh-list
14086224|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14086225|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086226|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
14086227|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
14086228|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
14086229|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086230|NCT02486640|Interferons|interferons|mesh-list
14086231|NCT02486640|Interferon-beta|interferon-beta|mesh-list
14086232|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
14086233|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086234|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
14086235|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086236|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
14086237|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086238|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14086239|NCT02486458|Listerine|listerine|mesh-list
14086240|NCT02486458|Fluorides|fluorides|mesh-list
14086241|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
14086242|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
14086243|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
14086244|NCT02486458|Protective Agents|protective agents|mesh-ancestor
14086245|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086246|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14086247|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173881|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14173882|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173883|NCT04792515|Apatinib|apatinib|mesh-list
14173884|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173885|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14173886|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173887|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173888|NCT04792034|Cocaine|cocaine|mesh-list
14173889|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
14173890|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
14173891|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173892|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173893|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
14173894|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173895|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14173896|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13917432|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13917433|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13917434|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917435|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13917436|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13917437|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917438|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
14086248|NCT02486484|Aflibercept|aflibercept|mesh-list
14086249|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14086250|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14086251|NCT02486484|Growth Substances|growth substances|mesh-ancestor
14086252|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086253|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
14086254|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086255|NCT02486367|Clopidogrel|clopidogrel|mesh-list
14086256|NCT02486367|Ticagrelor|ticagrelor|mesh-list
14086257|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086258|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14086259|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14086260|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14086261|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
14086262|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086263|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086264|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935131|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14935132|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086265|NCT02486341|Insulin|insulin|mesh-list
14086266|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14086267|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086268|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
14086269|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086270|NCT02486133|Ritonavir|ritonavir|mesh-list
14086271|NCT02486133|Darunavir|darunavir|mesh-list
14086272|NCT02486133|Tenofovir|tenofovir|mesh-list
14086273|NCT02486133|Lamivudine|lamivudine|mesh-list
14086274|NCT02486133|Emtricitabine|emtricitabine|mesh-list
14086275|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13917439|NCT03456466|Rituximab|rituximab|mesh-list
14086276|NCT02486133|Abacavir|abacavir|mesh-list
14086277|NCT02486133|Dolutegravir|dolutegravir|mesh-list
14086278|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14086279|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14086280|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
14086281|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086282|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086283|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14086284|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14086285|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
14086286|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086287|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14086288|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14086289|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14086290|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14086291|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14086292|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14086293|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
14086294|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
14935133|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14935134|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
14935135|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14935136|NCT01460602|Rituximab|rituximab|mesh-list
14935137|NCT01460602|Bortezomib|bortezomib|mesh-list
14935138|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14086295|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086296|NCT02486055|Vitamins|vitamins|mesh-ancestor
14086297|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
14935139|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935140|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
14935141|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935142|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935143|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
14086298|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
14086299|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
14086300|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086301|NCT02486276|Cilostazol|cilostazol|mesh-list
14086302|NCT02486276|Sumatriptan|sumatriptan|mesh-list
14086303|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14086304|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
14935144|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938682|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14086305|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086306|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935145|NCT01460654|Alendronate|alendronate|mesh-list
14935146|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
14086307|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14086308|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
14086309|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14086310|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14086311|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086312|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086313|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086314|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14086315|NCT02486276|Protective Agents|protective agents|mesh-ancestor
14086316|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14086317|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14086318|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086319|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14086320|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14086321|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14086322|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
14086323|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086324|NCT02485990|Olaparib|olaparib|mesh-list
14086325|NCT02485990|Tremelimumab|tremelimumab|mesh-list
14086326|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14086327|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935147|NCT01460654|Testosterone|testosterone|mesh-list
14935148|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
14086328|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086329|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086330|NCT02485821|Misoprostol|misoprostol|mesh-list
14086331|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14086332|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14086333|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14760087|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760088|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760089|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14760090|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14760091|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14086334|NCT02485821|Estradiol|estradiol|mesh-list
14086335|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14086336|NCT02485821|Estrogens|estrogens|mesh-ancestor
14086337|NCT02485821|Hormones|hormones|mesh-ancestor
14086338|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760092|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14935149|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
14086339|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086340|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14086341|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
14086342|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14086343|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14086344|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14086345|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
14086346|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14086347|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14086348|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
14086349|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14086350|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14086351|NCT02485873|Vitamin K|vitamin k|mesh-list
14086352|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
14086353|NCT02485873|Vitamins|vitamins|mesh-ancestor
14086354|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
14086355|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086356|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14086357|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
14086358|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13917440|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917441|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917442|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
13917443|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917444|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917445|NCT03456401|Sorafenib|sorafenib|mesh-list
13917446|NCT03456401|Sunitinib|sunitinib|mesh-list
13917447|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917448|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13917449|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917450|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917451|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13917452|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13917453|NCT03456401|Growth Substances|growth substances|mesh-ancestor
13917454|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917455|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
13917456|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
14086359|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
14086360|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086361|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086362|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
14086363|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14086364|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14086365|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
14086366|NCT02485873|Coagulants|coagulants|mesh-ancestor
14086367|NCT02485548|Fluorouracil|fluorouracil|mesh-list
14086368|NCT02485548|Raltitrexed|raltitrexed|mesh-list
14086369|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086370|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
14086371|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086372|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14086373|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14086374|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
14086375|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086376|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14086377|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086378|NCT02485613|Dexamethasone|dexamethasone|mesh-list
14086379|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086380|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
14086381|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
14086382|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086383|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086384|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14086385|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
14086386|NCT02485613|Hormones|hormones|mesh-ancestor
14086387|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086388|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14086389|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086390|NCT02485431|Deflazacort|deflazacort|mesh-list
14086391|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086392|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14086393|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
14086394|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086395|NCT02485444|Oxytocin|oxytocin|mesh-list
14086396|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
14086397|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14086398|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086399|NCT02485340|Isosorbide|isosorbide|mesh-list
14086400|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13917457|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086401|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14086402|NCT02485340|Sumatriptan|sumatriptan|mesh-list
14477063|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477064|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477065|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13917458|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
13917459|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
13917460|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
13917461|NCT03456102|Pravastatin|pravastatin|mesh-list
13917462|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13917463|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13917464|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
13917465|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917466|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13917467|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13917468|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960207|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960208|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14086403|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14086404|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14086405|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14086406|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
14086407|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086408|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086409|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086410|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14086411|NCT02485340|Diuretics|diuretics|mesh-ancestor
14086412|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
14760093|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14760094|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14760095|NCT04520607|Lorecivivint|lorecivivint|mesh-list
13960209|NCT03156361|Insulin|insulin|mesh-list
13960210|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13960211|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
13960212|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960213|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760096|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760097|NCT04518228|Ritonavir|ritonavir|mesh-list
14760098|NCT04518228|Lopinavir|lopinavir|mesh-list
14760099|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
13960214|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
13960215|NCT03156296|Bupivacaine|bupivacaine|mesh-list
13960216|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
14086413|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086414|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14086415|NCT02485327|Insulin|insulin|mesh-list
14086416|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14086417|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14086418|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086419|NCT02485249|Dexamethasone|dexamethasone|mesh-list
14086420|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
14086421|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14086422|NCT02485249|BB 1101|bb 1101|mesh-list
14086423|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086424|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
14086425|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
14086426|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086427|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086428|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14086429|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
14086430|NCT02485249|Hormones|hormones|mesh-ancestor
14086431|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086432|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14086433|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086434|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
14760100|NCT04518228|Darunavir|darunavir|mesh-list
14760101|NCT04518228|Tenofovir|tenofovir|mesh-list
14760102|NCT04518228|Dolutegravir|dolutegravir|mesh-list
14760103|NCT04518228|Cobicistat|cobicistat|mesh-list
14086435|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086436|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086437|NCT02485145|Diclofenac|diclofenac|mesh-list
14086438|NCT02485145|Orphenadrine|orphenadrine|mesh-list
14086439|NCT02485145|Bupivacaine|bupivacaine|mesh-list
14086440|NCT02485145|Baclofen|baclofen|mesh-list
14086441|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
14760104|NCT04518228|Cabotegravir|cabotegravir|mesh-list
14760105|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14086442|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
14086443|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086444|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086445|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
14086446|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086447|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14086448|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14086449|NCT02485145|Analgesics|analgesics|mesh-ancestor
14086450|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086451|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760106|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14760107|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
13917469|NCT03455426|Letrozole|letrozole|mesh-list
13917470|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917471|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13917472|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13917473|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917474|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917475|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13917476|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
14086452|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14086453|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086454|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086455|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14086456|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14086457|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14086458|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
14086459|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
14086460|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086461|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14086462|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14086463|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
14086464|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
14086465|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14086466|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14086467|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
14086468|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
14086469|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14086470|NCT02485041|Mirodenafil|mirodenafil|mesh-list
14086471|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14086472|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14086473|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086474|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086475|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
14086476|NCT02485262|Simeprevir|simeprevir|mesh-list
14086477|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
14086478|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086479|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
14086480|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086481|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760108|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760109|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760110|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14086482|NCT02484885|Xenon|xenon|mesh-list
14086483|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14086484|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
14086485|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
14086486|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14760111|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14086487|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086488|NCT02484963|Zolpidem|zolpidem|mesh-list
14935150|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13917477|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917478|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917479|NCT03455322|Octreotide|octreotide|mesh-list
13917480|NCT03455322|Norepinephrine|norepinephrine|mesh-list
13917481|NCT03455322|Midodrine|midodrine|mesh-list
13917482|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917483|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13917484|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917485|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13917486|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14086489|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14086490|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14086491|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086492|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086493|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14086494|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
14086495|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
14086496|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086497|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086498|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14086499|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14086500|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14086501|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
14086502|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086503|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935151|NCT01460654|Androgens|androgens|mesh-ancestor
14935152|NCT01460654|Hormones|hormones|mesh-ancestor
14935153|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935154|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086504|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086505|NCT02485067|Urological Agents|urological agents|mesh-ancestor
14086506|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
14086507|NCT02485080|Simeprevir|simeprevir|mesh-list
14086508|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
14086509|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086510|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
14086511|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086512|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086513|NCT02485184|Propranolol|propranolol|mesh-list
14086514|NCT02485184|Warfarin|warfarin|mesh-list
14086515|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14086516|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
14086517|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14086518|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
14086519|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086520|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086521|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917487|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
13917488|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086522|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14086523|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14086524|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086525|NCT02485106|Rifaximin|rifaximin|mesh-list
14086526|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
14086527|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14086528|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086529|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14086530|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14086531|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086532|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086533|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086534|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14086535|NCT02485106|Protective Agents|protective agents|mesh-ancestor
14086536|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086537|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086538|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14086539|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
14086540|NCT02485028|Mirodenafil|mirodenafil|mesh-list
14086541|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14086542|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14086543|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086544|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086545|NCT02485015|Apatinib|apatinib|mesh-list
14086546|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086547|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14086548|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760112|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
14760113|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760114|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14086549|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086550|NCT02484924|Clopidogrel|clopidogrel|mesh-list
14086551|NCT02484924|Ticagrelor|ticagrelor|mesh-list
14086552|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086553|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14086554|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14086555|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14086556|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
14086557|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086558|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086559|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086560|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14086561|NCT02484768|Hematinics|hematinics|mesh-ancestor
14086562|NCT02484833|Cetuximab|cetuximab|mesh-list
14086563|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14086564|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173897|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14173898|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14173899|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173900|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
14173901|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14760115|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14760116|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14760117|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14760118|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14935155|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14086565|NCT02484677|Docetaxel|docetaxel|mesh-list
14086566|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086567|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14086568|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14086569|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14086570|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086571|NCT02484573|Propranolol|propranolol|mesh-list
14086572|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14086573|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14086574|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
14086575|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086576|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086577|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086578|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14086579|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14086580|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086581|NCT02484755|Gefitinib|gefitinib|mesh-list
14086582|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086583|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14086584|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086585|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086586|NCT02484248|Ketotifen|ketotifen|mesh-list
14086587|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
14086588|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14086589|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14086590|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
14086591|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
14086592|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086593|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086594|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086595|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14086596|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14086597|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917489|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086598|NCT02484300|Melatonin|melatonin|mesh-list
14086599|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
14086600|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086601|NCT02484300|Protective Agents|protective agents|mesh-ancestor
14086602|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086603|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086604|NCT02484352|Oxycodone|oxycodone|mesh-list
14086605|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14086606|NCT02484352|Narcotics|narcotics|mesh-ancestor
14086607|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086608|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917490|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917491|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
13917492|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
13917493|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917494|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13917495|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13917496|NCT03455179|Methamphetamine|methamphetamine|mesh-list
13917497|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13917498|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917499|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
13917500|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
13917501|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917502|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
13917503|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917504|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917505|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
13917506|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14086609|NCT02484352|Analgesics|analgesics|mesh-ancestor
14086610|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
14086611|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086612|NCT02484170|Mannitol|mannitol|mesh-list
14086613|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14086614|NCT02484170|Diuretics|diuretics|mesh-ancestor
14086615|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
14086616|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086617|NCT02484209|Metformin|metformin|mesh-list
14086618|NCT02484209|Glimepiride|glimepiride|mesh-list
14086619|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14086620|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086621|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14086622|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14086623|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
14086624|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14086625|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086626|NCT02484261|Bortezomib|bortezomib|mesh-list
14086627|NCT02484261|Pravastatin|pravastatin|mesh-list
14086628|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086629|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14086630|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14086631|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
14086632|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086633|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14086634|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14086635|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086636|NCT02484053|Rituximab|rituximab|mesh-list
14086637|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14086638|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760119|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14760120|NCT04514497|Irinotecan|irinotecan|mesh-list
14760121|NCT04514497|Topotecan|topotecan|mesh-list
14760122|NCT04514497|Camptothecin|camptothecin|mesh-list
14760123|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14760124|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14760125|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760126|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760127|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086639|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
14086640|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086641|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14086642|NCT02483767|Goserelin|goserelin|mesh-list
14086643|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14086644|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760128|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760129|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14760130|NCT04509674|Empagliflozin|empagliflozin|mesh-list
14086645|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14086646|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14086647|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14086648|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
14086649|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086650|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14086651|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14086652|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086653|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14086654|NCT02483715|Amoxicillin|amoxicillin|mesh-list
14086655|NCT02483715|Metronidazole|metronidazole|mesh-list
14086656|NCT02483715|Tetracycline|tetracycline|mesh-list
14086657|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14086658|NCT02483715|Rabeprazole|rabeprazole|mesh-list
14086659|NCT02483715|Bismuth|bismuth|mesh-list
14086660|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14086661|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086662|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
14086663|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14086664|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14086665|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14086666|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14086667|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086668|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760131|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14760132|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760133|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14760134|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760135|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
14760136|NCT04505878|Vitamins|vitamins|mesh-ancestor
14760137|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
14760138|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760139|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
14760140|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917507|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13917508|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917509|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13917510|NCT03455140|BCT-100|bct-100|mesh-list
13917511|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086669|NCT02483715|Antacids|antacids|mesh-ancestor
14086670|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14086671|NCT02483793|Tamsulosin|tamsulosin|mesh-list
14086672|NCT02483793|Oxybutynin|oxybutynin|mesh-list
14086673|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14086674|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14086675|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14086676|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
13917512|NCT03455088|Fluoxetine|fluoxetine|mesh-list
13917513|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13917514|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13917515|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917516|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960217|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
14086677|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086678|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086679|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760141|NCT04505878|Protective Agents|protective agents|mesh-ancestor
14760142|NCT04504734|Bucillamine|bucillamine|mesh-list
14760143|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14760144|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14760145|NCT04504734|Analgesics|analgesics|mesh-ancestor
14086680|NCT02483793|Urological Agents|urological agents|mesh-ancestor
14086681|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
14086682|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
14086683|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086684|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14086685|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14086686|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
14086687|NCT02483897|Tetracaine|tetracaine|mesh-list
14086688|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14086689|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
14086690|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
14086691|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086692|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086693|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
14086694|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086695|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14086696|NCT02483845|Natalizumab|natalizumab|mesh-list
14086697|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
14086698|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086699|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14086700|NCT02483936|Olmesartan|olmesartan|mesh-list
14086701|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14760146|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
14760147|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760148|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760149|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760150|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760151|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
14086702|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
14086703|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14086704|NCT02483936|Diuretics|diuretics|mesh-ancestor
14086705|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
14086706|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086707|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14086708|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14086709|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086710|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14086711|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14086712|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14086713|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
14086714|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14086715|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14086716|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14086717|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086718|NCT02483923|Ropivacaine|ropivacaine|mesh-list
14086719|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
14086720|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
14086721|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086722|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086723|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
14086724|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086725|NCT02483884|Bombesin|bombesin|mesh-list
14086726|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086727|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086728|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086729|NCT02483689|Bupivacaine|bupivacaine|mesh-list
14086730|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
14086731|NCT02483689|Anesthetics|anesthetics|mesh-list
14086732|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086733|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086734|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
14086735|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086736|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14086737|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14086738|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14086739|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
14760152|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760153|NCT04504734|Protective Agents|protective agents|mesh-ancestor
14086740|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086741|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14086742|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14086743|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086744|NCT02483598|Buspirone|buspirone|mesh-list
14086745|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14086746|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14086747|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086748|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086749|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14086750|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14086751|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
14086752|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14086753|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086754|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14086755|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14086756|NCT02483624|Protective Agents|protective agents|mesh-ancestor
14086757|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086758|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086759|NCT02483325|Fludarabine|fludarabine|mesh-list
14086760|NCT02483325|Busulfan|busulfan|mesh-list
14086761|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
14086762|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086763|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086764|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14086765|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
14086766|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086767|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
14086768|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14086769|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14086770|NCT02483299|Metformin|metformin|mesh-list
14086771|NCT02483299|Liraglutide|liraglutide|mesh-list
14086772|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14086773|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086774|NCT02483299|Incretins|incretins|mesh-ancestor
14086775|NCT02483299|Hormones|hormones|mesh-ancestor
14086776|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086777|NCT02483182|Acyclovir|acyclovir|mesh-list
14086778|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
14086779|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086780|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
14086781|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14086782|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
14086783|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086784|NCT02483130|Expectorants|expectorants|mesh-ancestor
14760154|NCT04500236|Anesthetics|anesthetics|mesh-list
14086785|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
14086786|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14086787|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
14086788|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086789|NCT02483130|Protective Agents|protective agents|mesh-ancestor
14086790|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086791|NCT02483130|Antidotes|antidotes|mesh-ancestor
14086792|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
14086793|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
14086794|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086795|NCT02483143|Expectorants|expectorants|mesh-ancestor
14086796|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
14086797|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14086798|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
14086799|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086800|NCT02483143|Protective Agents|protective agents|mesh-ancestor
14086801|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086802|NCT02483169|Aspirin|aspirin|mesh-list
14086803|NCT02483169|Cilostazol|cilostazol|mesh-list
14086804|NCT02483169|Probucol|probucol|mesh-list
14086805|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14086806|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14086807|NCT02483169|Analgesics|analgesics|mesh-ancestor
14086808|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
14086809|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086810|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086811|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086812|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14086813|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14086814|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14086815|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086816|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086817|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14086818|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086819|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
14086820|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14086821|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
14086822|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14086823|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
14086824|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086825|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14086826|NCT02483169|Protective Agents|protective agents|mesh-ancestor
14086827|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14086828|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14086829|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14086830|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14086831|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
14086832|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14086833|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
14086834|NCT02483156|Ribavirin|ribavirin|mesh-list
14086835|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
14086836|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
14086837|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086838|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
14086839|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086840|NCT02483221|Morphine|morphine|mesh-list
14086841|NCT02483221|Hydromorphone|hydromorphone|mesh-list
14086842|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14086843|NCT02483221|Narcotics|narcotics|mesh-ancestor
14086844|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086845|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086846|NCT02483221|Analgesics|analgesics|mesh-ancestor
14086847|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
14086848|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086849|NCT02483195|Minoxidil|minoxidil|mesh-list
14086850|NCT02483195|Spironolactone|spironolactone|mesh-list
14086851|NCT02483195|Finasteride|finasteride|mesh-list
14935156|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935157|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
14935158|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14935159|NCT01460667|Acetaminophen|acetaminophen|mesh-list
14935160|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935161|NCT01460667|Analgesics|analgesics|mesh-ancestor
14935162|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
14935163|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935164|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935165|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
14935166|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
14935167|NCT01460693|Dasatinib|dasatinib|mesh-list
14935168|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935169|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14935170|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086852|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14477066|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
14477067|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477068|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477069|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14477070|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
14477071|NCT02425449|Succinylcholine|succinylcholine|mesh-list
14477072|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14477073|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14477074|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14477075|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760155|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14760156|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760157|NCT04498117|Paclitaxel|paclitaxel|mesh-list
14760158|NCT04498117|Carboplatin|carboplatin|mesh-list
14760159|NCT04498117|Oregovomab|oregovomab|mesh-list
14760160|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760161|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760162|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14760163|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14760164|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760165|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760166|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760167|NCT04495855|Dienogest|dienogest|mesh-list
14760168|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14760169|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
14760170|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14760171|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760172|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14760173|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14760174|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14760175|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14760176|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
14760177|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760178|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760179|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760180|NCT04494425|Paclitaxel|paclitaxel|mesh-list
14760181|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14935171|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935172|NCT01460706|Edotreotide|edotreotide|mesh-list
14935173|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14086853|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
14086854|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086855|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086856|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14086857|NCT02483195|Diuretics|diuretics|mesh-ancestor
14086858|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
14086859|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14086860|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14086861|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086862|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086863|NCT02483195|Urological Agents|urological agents|mesh-ancestor
14086864|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14086865|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
14760182|NCT04494425|Capecitabine|capecitabine|mesh-list
14760183|NCT04494425|Trastuzumab|trastuzumab|mesh-list
14760184|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760185|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760186|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
14760187|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
14173914|NCT04791943|Melatonin|melatonin|mesh-list
14173915|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
14173916|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935174|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935175|NCT01460797|Metformin|metformin|mesh-list
14935176|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14935177|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935178|NCT01460836|Tobramycin|tobramycin|mesh-list
14173917|NCT04791943|Protective Agents|protective agents|mesh-ancestor
14173918|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173919|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173920|NCT04791774|Caseins|caseins|mesh-list
14173921|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
14173922|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
14477076|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477077|NCT02425891|Paclitaxel|paclitaxel|mesh-list
14477078|NCT02425891|Atezolizumab|atezolizumab|mesh-list
14173923|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173924|NCT04791345|Dexamethasone|dexamethasone|mesh-list
14173925|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
14935179|NCT01460836|Aztreonam|aztreonam|mesh-list
14477079|NCT02425891|Antibodies|antibodies|mesh-list
13917517|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917518|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
13917519|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917520|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13917521|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
13917522|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13917523|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14086866|NCT02483026|Vitamin D|vitamin d|mesh-list
14086867|NCT02483026|Vitamins|vitamins|mesh-list
14086868|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
14086869|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086870|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14086871|NCT02483078|Leronlimab|leronlimab|mesh-list
14086872|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14086873|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14086874|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086875|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14086876|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14086877|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
14086878|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086879|NCT02483104|Paclitaxel|paclitaxel|mesh-list
14086880|NCT02483104|Carboplatin|carboplatin|mesh-list
14086881|NCT02483104|Veliparib|veliparib|mesh-list
14086882|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14086883|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086884|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
14086885|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
14086886|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
14086887|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086888|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14086889|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086890|NCT02482740|Tamoxifen|tamoxifen|mesh-list
14086891|NCT02482740|Letrozole|letrozole|mesh-list
14086892|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086893|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14086894|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14086895|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086896|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086897|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14086898|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
14086899|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14086900|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477080|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14477081|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13917524|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13917525|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917526|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
13917527|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13917528|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
13917529|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13917530|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917531|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13917532|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13917533|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13917534|NCT03455049|Andrographolide|andrographolide|mesh-list
13917535|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917536|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13917537|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14477082|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477083|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
13917538|NCT03455049|Analgesics|analgesics|mesh-ancestor
14086901|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14086902|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14477084|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
14477085|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
14086903|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14086904|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13917539|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
13917540|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917541|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917542|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917543|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13917544|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13917545|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917546|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
13917547|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13917548|NCT03454984|Guadecitabine|guadecitabine|mesh-list
13917549|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14086905|NCT02482766|Poractant alfa|poractant alfa|mesh-list
14086906|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14086907|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
14086908|NCT02482857|Aspirin|aspirin|mesh-list
14086909|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14086910|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14086911|NCT02482857|Analgesics|analgesics|mesh-ancestor
14086912|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
14086913|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086914|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086915|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086916|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14086917|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14086918|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14086919|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086920|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086921|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14760188|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760189|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760190|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760191|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
14760192|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760193|NCT04486833|Osimertinib|osimertinib|mesh-list
13917550|NCT03454945|Doxycycline|doxycycline|mesh-list
14086922|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086923|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
14086924|NCT02482961|Colistin|colistin|mesh-list
14086925|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14086926|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086927|NCT02482818|Pregabalin|pregabalin|mesh-list
14086928|NCT02482818|Analgesics|analgesics|mesh-ancestor
14086929|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
14086930|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14086931|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086932|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
14086933|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14086934|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14760194|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917551|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13917552|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917553|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
13917554|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13917555|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13917556|NCT03454919|Palbociclib|palbociclib|mesh-list
13917557|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917558|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13917559|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917560|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917561|NCT03454841|Ticagrelor|ticagrelor|mesh-list
13917562|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13917563|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13917564|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13917565|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13917566|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13917567|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
13917568|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917569|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917570|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917571|NCT03454789|Lidocaine|lidocaine|mesh-list
13917572|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
14086935|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086936|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14086937|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14086938|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14086939|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14086940|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14086941|NCT02482649|Methylphenidate|methylphenidate|mesh-list
14086942|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14086943|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14086944|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086945|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14086946|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14086947|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14086948|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086949|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
14086950|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935180|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935181|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935182|NCT01460888|Olaparib|olaparib|mesh-list
14935183|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14935184|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935185|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935186|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935187|NCT01460979|Sirolimus|sirolimus|mesh-list
14935188|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935189|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935190|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14935191|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935192|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
14935193|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935194|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
14935195|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935196|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
14935197|NCT01461018|Antibodies|antibodies|mesh-list
14935198|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
14935199|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14935200|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14935201|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
14935202|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935203|NCT01461031|Nefopam|nefopam|mesh-list
14086951|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14086952|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14086953|NCT02482636|Vaccines|vaccines|mesh-list
14173926|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
13917573|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
13917574|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917575|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917576|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
13917577|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917578|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13917579|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13917580|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14935204|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14086954|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14086955|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
14086956|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086957|NCT02482311|Adavosertib|adavosertib|mesh-list
14086958|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086959|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086960|NCT02482272|Lamivudine|lamivudine|mesh-list
14086961|NCT02482272|Adefovir|adefovir|mesh-list
14086962|NCT02482272|Entecavir|entecavir|mesh-list
14086963|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14086964|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14086965|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086966|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086967|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
14086968|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086969|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14086970|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14086971|NCT02482402|Iloprost|iloprost|mesh-list
14086972|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14086973|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
14086974|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
14086975|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
14086976|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14086977|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14086978|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14086979|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14086980|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
13917581|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917582|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917583|NCT03454724|Sirolimus|sirolimus|mesh-list
13917584|NCT03454724|Everolimus|everolimus|mesh-list
13917585|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917586|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13917587|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
13917588|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086981|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086982|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14086983|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14086984|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086985|NCT02482155|Ibuprofen|ibuprofen|mesh-list
14086986|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14086987|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14086988|NCT02482155|Analgesics|analgesics|mesh-ancestor
14086989|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
14086990|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917589|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13917590|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917591|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13917592|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
13917593|NCT03454646|Rivastigmine|rivastigmine|mesh-list
13917594|NCT03454646|Donepezil|donepezil|mesh-list
13917595|NCT03454646|Galantamine|galantamine|mesh-list
13917596|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
13917597|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917598|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917599|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
14086991|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14086992|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14086993|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14086994|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14086995|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14086996|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14086997|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
14086998|NCT02482090|Fludarabine|fludarabine|mesh-list
14086999|NCT02482090|Interleukin-2|interleukin-2|mesh-list
14087000|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087001|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
14087002|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087003|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087004|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14087005|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
14087006|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087007|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087008|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14087009|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14087010|NCT02482090|Analgesics|analgesics|mesh-ancestor
14087011|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
14087012|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087013|NCT02482324|Ibuprofen|ibuprofen|mesh-list
14087014|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14087015|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14087016|NCT02482324|Analgesics|analgesics|mesh-ancestor
14087017|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
14087018|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087019|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087020|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477086|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477087|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
14477088|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477089|NCT02426086|Niacinamide|niacinamide|mesh-list
14477090|NCT02426086|Imetelstat|imetelstat|mesh-list
13917600|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087021|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087022|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14087023|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087024|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087025|NCT02481960|Irinotecan|irinotecan|mesh-list
14087026|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14087027|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14087028|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087029|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087030|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087031|NCT02481791|Remifentanil|remifentanil|mesh-list
14087032|NCT02481791|Propofol|propofol|mesh-list
13917601|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935205|NCT01461031|Analgesics|analgesics|mesh-ancestor
13917602|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
14087033|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14087034|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087035|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087036|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13917603|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13917604|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
13917605|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917606|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13917607|NCT03454646|Protective Agents|protective agents|mesh-ancestor
13917608|NCT03454620|Irinotecan|irinotecan|mesh-list
13917609|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13917610|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13917611|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960218|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087037|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
14087038|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
14087039|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14087040|NCT02481791|Narcotics|narcotics|mesh-ancestor
14087041|NCT02481791|Analgesics|analgesics|mesh-ancestor
14087042|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
14087043|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087044|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14087045|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14087046|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087047|NCT02481635|Gemcitabine|gemcitabine|mesh-list
14087048|NCT02481635|Paclitaxel|paclitaxel|mesh-list
14477091|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
13917612|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917613|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917614|NCT03454529|Simvastatin|simvastatin|mesh-list
13917615|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13917616|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13917617|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
13917618|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917619|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14087049|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14087050|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477092|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477093|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477094|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14477095|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
14477096|NCT02426086|Vitamins|vitamins|mesh-ancestor
13917620|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13917621|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917622|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
13917623|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917624|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14087051|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14087052|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14087053|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14087054|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087055|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14087056|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
14087057|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
14087058|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087059|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087060|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087061|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
14087062|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087063|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
14087064|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14935206|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
13917625|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917626|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960219|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960220|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
13960221|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087065|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
14087066|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087067|NCT02481609|Expectorants|expectorants|mesh-ancestor
14087068|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
14087069|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14087070|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
14087071|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087072|NCT02481609|Protective Agents|protective agents|mesh-ancestor
14087073|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087074|NCT02481609|Antidotes|antidotes|mesh-ancestor
14087075|NCT02481453|Sirolimus|sirolimus|mesh-list
14087076|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087077|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087078|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14087079|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087080|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
14087081|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087082|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
14087083|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087084|NCT02481323|Cilostazol|cilostazol|mesh-list
14087085|NCT02481323|Isosorbide|isosorbide|mesh-list
14087086|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14087087|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14087088|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14087089|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
14087090|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087091|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477097|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
14087092|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14477098|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087093|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14087094|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14087095|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14087096|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087097|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14087098|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
14087099|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14087100|NCT02481323|Protective Agents|protective agents|mesh-ancestor
14087101|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14087102|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14087103|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760195|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760196|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760197|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760198|NCT04480918|Ketamine|ketamine|mesh-list
14760199|NCT04480918|Esketamine|esketamine|mesh-list
14760200|NCT04480918|Analgesics|analgesics|mesh-ancestor
14760201|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
14760202|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760203|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760204|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14760205|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14760206|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
14760207|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
14760208|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14760209|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14087104|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14087105|NCT02481323|Diuretics|diuretics|mesh-ancestor
14087106|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
14087107|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14173927|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14173928|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14173929|NCT04791345|Prednisolone|prednisolone|mesh-list
14173930|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
14173931|NCT04791345|Deflazacort|deflazacort|mesh-list
14087108|NCT02481479|Saxagliptin|saxagliptin|mesh-list
14087109|NCT02481479|Incretins|incretins|mesh-ancestor
14087110|NCT02481479|Hormones|hormones|mesh-ancestor
14087111|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087112|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087113|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14087114|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
14087115|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087116|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087117|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14087118|NCT02481193|Cisatracurium|cisatracurium|mesh-list
14087119|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14087120|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14087121|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087122|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087123|NCT02481180|T0001|t0001|mesh-list
14935207|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935208|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935209|NCT01461174|Memantine|memantine|mesh-list
14087124|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
14087125|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087126|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087127|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
14935210|NCT01461174|Modafinil|modafinil|mesh-list
13917627|NCT03454217|Oxycodone|oxycodone|mesh-list
13917628|NCT03454217|Tramadol|tramadol|mesh-list
13917629|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13917630|NCT03454217|Narcotics|narcotics|mesh-ancestor
14087128|NCT02480946|Methotrexate|methotrexate|mesh-list
14087129|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14087130|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
14087131|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14477099|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
13917631|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917632|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917633|NCT03454217|Analgesics|analgesics|mesh-ancestor
13917634|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
13917635|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917636|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13917637|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917638|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
13917639|NCT03453931|Hormones|hormones|mesh-ancestor
13917640|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14477100|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14477101|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935211|NCT01461174|Donepezil|donepezil|mesh-list
14935212|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13917641|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087132|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087133|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14087134|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
14087135|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087136|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087137|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
14087138|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087139|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14087140|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087141|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
14087142|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087143|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13917642|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13917643|NCT03453931|Protective Agents|protective agents|mesh-ancestor
13917644|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13917645|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917646|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
14087144|NCT02481076|Monensin|monensin|mesh-list
14087145|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
14087146|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087147|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14087148|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14087149|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
14087150|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
14087151|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
14935213|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935214|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935215|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
14935216|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935217|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935218|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
14935219|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14935220|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14935221|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
13917647|NCT03453892|Nivolumab|nivolumab|mesh-list
13917648|NCT03453892|Ipilimumab|ipilimumab|mesh-list
13917649|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917650|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917651|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13917652|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917653|NCT03453840|Lumefantrine|lumefantrine|mesh-list
13917654|NCT03453840|Artemether|artemether|mesh-list
13917655|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
13917656|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
13917657|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13917658|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13917659|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917660|NCT03453723|Lidocaine|lidocaine|mesh-list
13917661|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
13917662|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
13917663|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935222|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14935223|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14935224|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14935225|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14935226|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14935227|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14935228|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
14935229|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
14935230|NCT01461460|Tedizolid|tedizolid|mesh-list
14935231|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
14935232|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935233|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935234|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14935235|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14935236|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935237|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087152|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087153|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087154|NCT02481076|Ionophores|ionophores|mesh-ancestor
14087155|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087156|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
14087157|NCT02480894|Maraviroc|maraviroc|mesh-list
14087158|NCT02480894|Fostemsavir|fostemsavir|mesh-list
14087159|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14087160|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14087161|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917664|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917665|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
13917666|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087162|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14087163|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14087164|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
14087165|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087166|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14087167|NCT02480881|Fostemsavir|fostemsavir|mesh-list
13917667|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13917668|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13917669|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14087168|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
14087169|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14087170|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
14087171|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14087172|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087173|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14087174|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14087175|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14087176|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
14935238|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935239|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14935240|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
14935241|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14935242|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935243|NCT01461616|Insulin|insulin|mesh-list
14935244|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14935245|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
14935246|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
14935247|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14935248|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935249|NCT01461746|Docetaxel|docetaxel|mesh-list
14935250|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935251|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
14935252|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
14935253|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
14935254|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935255|NCT01461759|Cisplatin|cisplatin|mesh-list
14087177|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087178|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14087179|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14087180|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087181|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14087182|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14087183|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14087184|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14087185|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14087186|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
14087187|NCT02480647|Etonogestrel|etonogestrel|mesh-list
14087188|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14087189|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
14087190|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14087191|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760210|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14760211|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14760212|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760213|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
14760214|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14760215|NCT04479579|Apixaban|apixaban|mesh-list
14760216|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14760217|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
14760218|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14760219|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
14760220|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760221|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760222|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
14760223|NCT04477772|Antibodies|antibodies|mesh-list
14935256|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087192|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14087193|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14087194|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14087195|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
14087196|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
14087197|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087198|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14087199|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087200|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087201|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
14087202|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14087203|NCT02480543|Misoprostol|misoprostol|mesh-list
14760224|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14760225|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
14760226|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760227|NCT04468984|Navitoclax|navitoclax|mesh-list
14760228|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760229|NCT04456699|Leucovorin|leucovorin|mesh-list
14760230|NCT04456699|Bevacizumab|bevacizumab|mesh-list
14760231|NCT04456699|Fluorouracil|fluorouracil|mesh-list
14760232|NCT04456699|Capecitabine|capecitabine|mesh-list
14760233|NCT04456699|Olaparib|olaparib|mesh-list
14760234|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
14760235|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760236|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760237|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14760238|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14760239|NCT04456699|Growth Substances|growth substances|mesh-ancestor
14760240|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760241|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
14760242|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
14760243|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760244|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760245|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14760246|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
14760247|NCT04456699|Antidotes|antidotes|mesh-ancestor
14760248|NCT04456699|Protective Agents|protective agents|mesh-ancestor
14935257|NCT01461772|Carboplatin|carboplatin|mesh-list
14935258|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935259|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14935260|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
14935261|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935262|NCT01462006|Sirolimus|sirolimus|mesh-list
14935263|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935264|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935265|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14760249|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
14760250|NCT04456699|Vitamins|vitamins|mesh-ancestor
14760251|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
14935266|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935267|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
14935268|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935269|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
14935270|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935271|NCT01462058|Vitamin D|vitamin d|mesh-list
14935272|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
14935273|NCT01462058|Vitamins|vitamins|mesh-ancestor
14935274|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
14935275|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935276|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14087204|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14087205|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
14087206|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14087207|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087208|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14087209|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087210|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
14087211|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
14087212|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
14087213|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087214|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
14087215|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14087216|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087217|NCT02480751|Beraprost|beraprost|mesh-list
14087218|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14087219|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
14087220|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14087221|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14087222|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087223|NCT02480465|Incretins|incretins|mesh-ancestor
14087224|NCT02480465|Hormones|hormones|mesh-ancestor
14087225|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087226|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14087227|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
14087228|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087229|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087230|NCT02480400|Dexetimide|dexetimide|mesh-list
14087231|NCT02480400|Citalopram|citalopram|mesh-list
14087232|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14087233|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14087234|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087235|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087236|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087237|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
14087238|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087239|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14087240|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
14760252|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14760253|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760254|NCT04446962|Lenalidomide|lenalidomide|mesh-list
14760255|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
14760256|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760257|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14760258|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14760259|NCT04446962|Growth Substances|growth substances|mesh-ancestor
14760260|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14935277|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14087241|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14087242|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14087243|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14087244|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
14087245|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
14087246|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087247|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14087248|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14087249|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
14087250|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
14087251|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14087252|NCT02480387|Ledipasvir|ledipasvir|mesh-list
14087253|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
14087254|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087255|NCT02480088|Palonosetron|palonosetron|mesh-list
14087256|NCT02480088|Ramosetron|ramosetron|mesh-list
14087257|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
14087258|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
14760261|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760262|NCT04435782|Selexipag|selexipag|mesh-list
13917670|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917671|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917672|NCT03453684|Vancomycin|vancomycin|mesh-list
13917673|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13917674|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917675|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13917676|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13917677|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917678|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917679|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
13917680|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087259|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087260|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087261|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087262|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14087263|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14087264|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
14087265|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087266|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087267|NCT02480335|Bosentan|bosentan|mesh-list
14087268|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14087269|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14087270|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087271|NCT02480049|Montelukast|montelukast|mesh-list
14087272|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14087273|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
14087274|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14087275|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
14087276|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087277|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087278|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14087279|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14087280|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087281|NCT02479971|Clindamycin|clindamycin|mesh-list
14087282|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
14087283|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
14087284|NCT02479971|Gentamicins|gentamicins|mesh-list
14087285|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087286|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087287|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14087288|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087289|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760263|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14760264|NCT04434040|Atezolizumab|atezolizumab|mesh-list
14760265|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760266|NCT04431453|Remdesivir|remdesivir|mesh-list
14087290|NCT02479854|Montelukast|montelukast|mesh-list
14087291|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14087292|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
14087293|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14087294|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
14087295|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087296|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087297|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14087298|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14760267|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
14760268|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760269|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
14760270|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760271|NCT04428151|Paclitaxel|paclitaxel|mesh-list
14760272|NCT04428151|Docetaxel|docetaxel|mesh-list
14760273|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
14760274|NCT04428151|Capecitabine|capecitabine|mesh-list
14760275|NCT04428151|Cetuximab|cetuximab|mesh-list
14760276|NCT04428151|Lenvatinib|lenvatinib|mesh-list
14760277|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760278|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760279|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
14760280|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
14760281|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760282|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760283|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760284|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760285|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
14760286|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760287|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087299|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087300|NCT02479867|Cefadroxil|cefadroxil|mesh-list
14087301|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087302|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087303|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
14087304|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
14087305|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14087306|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14087307|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
14087308|NCT02479789|Lidocaine|lidocaine|mesh-list
14087309|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
14087310|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
13917681|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917682|NCT03453541|Ketorolac|ketorolac|mesh-list
13917683|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14087311|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087312|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087313|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
14087314|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087315|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14087316|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14087317|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14087318|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087319|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087320|NCT02479815|Micronutrients|micronutrients|mesh-list
14087321|NCT02479815|Trace Elements|trace elements|mesh-list
14087322|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087323|NCT02479828|Ropivacaine|ropivacaine|mesh-list
14087324|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
14087325|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
14087326|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087327|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087328|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
14087329|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173932|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14173933|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
14173934|NCT04791345|BB 1101|bb 1101|mesh-list
14173935|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173936|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
14173937|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
14173938|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173939|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173940|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173941|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
14173942|NCT04791345|Hormones|hormones|mesh-ancestor
14173943|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173944|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13917684|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13917685|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13917686|NCT03453541|Analgesics|analgesics|mesh-ancestor
13917687|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
13917688|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917689|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917690|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917691|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917692|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13917693|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917694|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917695|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13917696|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14087330|NCT02479711|Methamphetamine|methamphetamine|mesh-list
14087331|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14087332|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087333|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
14087334|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
14935278|NCT01462149|Carboplatin|carboplatin|mesh-list
14935279|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935280|NCT01462214|Everolimus|everolimus|mesh-list
14935281|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087335|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087336|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
14087337|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087338|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087339|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
14087340|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14087341|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14087342|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087343|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14087344|NCT02479620|Dexamethasone|dexamethasone|mesh-list
14087345|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
14087346|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14087347|NCT02479620|BB 1101|bb 1101|mesh-list
14087348|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087349|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
14087350|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
14087351|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087352|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087353|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087354|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
14087355|NCT02479620|Hormones|hormones|mesh-ancestor
14087356|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087357|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087358|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087359|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
14087360|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087361|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087362|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14087363|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087364|NCT02479490|Prednisone|prednisone|mesh-list
14087365|NCT02479490|Everolimus|everolimus|mesh-list
14087366|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917697|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917698|NCT03453346|Ribavirin|ribavirin|mesh-list
13917699|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
14087367|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
14087368|NCT02479490|Hormones|hormones|mesh-ancestor
14087369|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087370|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087371|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14935282|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935283|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
14935284|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935285|NCT01462422|Misoprostol|misoprostol|mesh-list
14935286|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13917700|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
13917701|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917702|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
13917703|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917704|NCT03453281|Bevacizumab|bevacizumab|mesh-list
14087372|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087373|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087374|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
14087375|NCT02479204|Atenolol|atenolol|mesh-list
14087376|NCT02479204|Diltiazem|diltiazem|mesh-list
14087377|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14087378|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14087379|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
14087380|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
14087381|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087382|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087383|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14087384|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14087385|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14760288|NCT04411836|Primaquine|primaquine|mesh-list
14760289|NCT04411836|Tafenoquine|tafenoquine|mesh-list
14760290|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
14935287|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
14935288|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14935289|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087386|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
14087387|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087388|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087389|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14087390|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087391|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14087392|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
14087393|NCT02479581|Floxacillin|floxacillin|mesh-list
14087394|NCT02479581|Dexamethasone|dexamethasone|mesh-list
14087395|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
14087396|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14087397|NCT02479581|Scopolamine|scopolamine|mesh-list
14087398|NCT02479581|Morphine|morphine|mesh-list
14087399|NCT02479581|Anesthetics|anesthetics|mesh-list
14087400|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087401|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
14087402|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
14087403|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087404|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087405|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087406|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
14087407|NCT02479581|Hormones|hormones|mesh-ancestor
14087408|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087409|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087410|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087411|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087412|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087413|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14087414|NCT02479581|Narcotics|narcotics|mesh-ancestor
14087415|NCT02479581|Analgesics|analgesics|mesh-ancestor
14087416|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
14760291|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14760292|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14760293|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760294|NCT04406857|Capecitabine|capecitabine|mesh-list
14760295|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
14760296|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760297|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
14087417|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14087418|NCT02479581|Protective Agents|protective agents|mesh-ancestor
14087419|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14087420|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
14087421|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14087422|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
14087423|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087424|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14087425|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087426|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087427|NCT02479256|Tamoxifen|tamoxifen|mesh-list
14087428|NCT02479256|Citric Acid|citric acid|mesh-list
14087429|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
14087430|NCT02479256|Clomiphene|clomiphene|mesh-list
14087431|NCT02479256|Enclomiphene|enclomiphene|mesh-list
14087432|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
14087433|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
14087434|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14087435|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
14087436|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
14087437|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087438|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14087439|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
14087440|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087441|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087442|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087443|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087444|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14087445|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14087446|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14087447|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14087448|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
14087449|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14087450|NCT02479451|Theophylline|theophylline|mesh-list
14087451|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14087452|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
14087453|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087454|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087455|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14087456|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
14087457|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14087458|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087459|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935290|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14087460|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
14935291|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917705|NCT03453281|Aflibercept|aflibercept|mesh-list
13917706|NCT03453281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917707|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760298|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087461|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14087462|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14087463|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
14087464|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087465|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
14087466|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087467|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087468|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13917708|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13917709|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13917710|NCT03453281|Growth Substances|growth substances|mesh-ancestor
13917711|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917712|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
13917713|NCT03453190|Apremilast|apremilast|mesh-list
13917714|NCT03453190|Clobetasol|clobetasol|mesh-list
13917715|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13917716|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13917717|NCT03453190|Analgesics|analgesics|mesh-ancestor
13917718|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
13917719|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917720|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477102|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14087469|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14087470|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087471|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087472|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087473|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
14087474|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
14087475|NCT02479347|Povidone|povidone|mesh-list
14087476|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14087477|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087478|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
14087479|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
14087480|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
14087481|NCT02479555|Dexamethasone|dexamethasone|mesh-list
14087482|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
14087483|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14087484|NCT02479555|BB 1101|bb 1101|mesh-list
14087485|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087486|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
14087487|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
14087488|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087489|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087490|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087491|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
14087492|NCT02479555|Hormones|hormones|mesh-ancestor
14087493|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087494|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087495|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087496|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
14087497|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087498|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087499|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
14087500|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14087501|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087502|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14087503|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087504|NCT02479178|Docetaxel|docetaxel|mesh-list
14087505|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087506|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
14087507|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
14087508|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
14087509|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087510|NCT02479230|Gemcitabine|gemcitabine|mesh-list
14087511|NCT02479230|Vaccines|vaccines|mesh-list
14087512|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
14087513|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087514|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14087515|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
14087516|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087517|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087518|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
14087519|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087520|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087521|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087522|NCT02479217|Docetaxel|docetaxel|mesh-list
14087523|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087524|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14087525|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14087526|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14087527|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087528|NCT02479529|Norepinephrine|norepinephrine|mesh-list
14087529|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14087530|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14087531|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
13917721|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917722|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917723|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14087532|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087533|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087534|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087535|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
13917724|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13917725|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917726|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917727|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
13917728|NCT03453190|Hormones|hormones|mesh-ancestor
13917729|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917730|NCT03453177|Fosfomycin|fosfomycin|mesh-list
13917731|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13917732|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917733|NCT03453164|Nivolumab|nivolumab|mesh-list
13917734|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917735|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917736|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13917737|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087536|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
14087537|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087538|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14087539|NCT02479165|Oxycodone|oxycodone|mesh-list
14087540|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14087541|NCT02479165|Narcotics|narcotics|mesh-ancestor
14935292|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
14935293|NCT01462474|Cisplatin|cisplatin|mesh-list
14935294|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935295|NCT01462487|Zanamivir|zanamivir|mesh-list
14935296|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
14935297|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935298|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935299|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935300|NCT01462500|Miltefosine|miltefosine|mesh-list
14760299|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760300|NCT04403698|Alendronate|alendronate|mesh-list
14760301|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14760302|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760303|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
14760304|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760305|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760306|NCT04380636|Paclitaxel|paclitaxel|mesh-list
14760307|NCT04380636|Etoposide|etoposide|mesh-list
14760308|NCT04380636|Carboplatin|carboplatin|mesh-list
14760309|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
14760310|NCT04380636|Pemetrexed|pemetrexed|mesh-list
14760311|NCT04380636|Durvalumab|durvalumab|mesh-list
14760312|NCT04380636|Olaparib|olaparib|mesh-list
14935301|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
14935302|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935303|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935304|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14935305|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14935306|NCT01462617|Nemiralisib|nemiralisib|mesh-list
14935307|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14935308|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935309|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938683|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14938684|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087542|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087543|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087544|NCT02479165|Analgesics|analgesics|mesh-ancestor
14087545|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
14087546|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087547|NCT02479022|Insulin|insulin|mesh-list
14087548|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14087549|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
14087550|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14087551|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087552|NCT02479074|Prednisolone|prednisolone|mesh-list
14087553|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14087554|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
14087555|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14087556|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
14087557|NCT02479074|Montelukast|montelukast|mesh-list
14087558|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14087559|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
14087560|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087561|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
14087562|NCT02479074|Hormones|hormones|mesh-ancestor
14087563|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087564|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087565|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087566|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087567|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
14087568|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
14087569|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087570|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917738|NCT03452930|Benzimidazole|benzimidazole|mesh-list
13917739|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
14087571|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14087572|NCT02479074|Protective Agents|protective agents|mesh-ancestor
14087573|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14087574|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
13917740|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13917741|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917742|NCT03452891|Simvastatin|simvastatin|mesh-list
13917743|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13917744|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13917745|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
13917746|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917747|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13917748|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13917749|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917750|NCT03452722|Plasminogen|plasminogen|mesh-list
13917751|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13917752|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13917753|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14087575|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14087576|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
14087577|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14087578|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14087579|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087580|NCT02478879|Teriparatide|teriparatide|mesh-list
14087581|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
14087582|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087583|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14087584|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14087585|NCT02478645|Ramosetron|ramosetron|mesh-list
14087586|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
14087587|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
14087588|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917754|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917755|NCT03452696|Calcium|calcium|mesh-list
13917756|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13917757|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960222|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14087589|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087590|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087591|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14087592|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
14087593|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087594|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087595|NCT02478515|Ranibizumab|ranibizumab|mesh-list
14087596|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14087597|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14087598|NCT02478515|Growth Substances|growth substances|mesh-ancestor
14087599|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087600|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
14087601|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087602|NCT02478424|Cyclosporine|cyclosporine|mesh-list
14087603|NCT02478424|Methotrexate|methotrexate|mesh-list
14087604|NCT02478424|Cannabidiol|cannabidiol|mesh-list
14087605|NCT02478424|Cyclosporins|cyclosporins|mesh-list
14935310|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14935311|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14935312|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935313|NCT01462669|Ezogabine|ezogabine|mesh-list
14935314|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
14087606|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14087607|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
14087608|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14087609|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087610|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14087611|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
14087612|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087613|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087614|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
14087615|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087616|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14087617|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087618|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
13960223|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13960224|NCT03156296|Analgesics|analgesics|mesh-ancestor
13960225|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13960226|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13960227|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13960228|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960229|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960230|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960231|NCT03156322|Fentanyl|fentanyl|mesh-list
13960232|NCT03156322|Bupivacaine|bupivacaine|mesh-list
14087619|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087620|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14087621|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
14087622|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087623|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14087624|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
14087625|NCT02478710|Vancomycin|vancomycin|mesh-list
14087626|NCT02478710|Tobramycin|tobramycin|mesh-list
14087627|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087628|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087629|NCT02478320|Ilorasertib|ilorasertib|mesh-list
14087630|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087631|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14087632|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087633|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087634|NCT02478294|Warfarin|warfarin|mesh-list
14087635|NCT02478294|Anticoagulants|anticoagulants|mesh-list
14087636|NCT02478281|Methylene Blue|methylene blue|mesh-list
14087637|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087638|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935315|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14935316|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935317|NCT01462890|Paclitaxel|paclitaxel|mesh-list
14935318|NCT01462890|Bevacizumab|bevacizumab|mesh-list
14935319|NCT01462890|Carboplatin|carboplatin|mesh-list
14935320|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14935321|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935322|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14087639|NCT02478268|Xenon|xenon|mesh-list
14087640|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14087641|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
14087642|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
14087643|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087644|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087645|NCT02478125|Docetaxel|docetaxel|mesh-list
14087646|NCT02478125|Sargramostim|sargramostim|mesh-list
14087647|NCT02478125|Lenograstim|lenograstim|mesh-list
14087648|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087649|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
14087650|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14087651|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14087652|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087653|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
14087654|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087655|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14087656|NCT02478047|Dexamethasone|dexamethasone|mesh-list
14087657|NCT02478047|Ramosetron|ramosetron|mesh-list
14087658|NCT02478047|Antiemetics|antiemetics|mesh-list
14935323|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14935324|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14935325|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935326|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14935327|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14087659|NCT02478047|Tropisetron|tropisetron|mesh-list
14087660|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087661|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
14087662|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087663|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087664|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087665|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
14087666|NCT02478047|Hormones|hormones|mesh-ancestor
14087667|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087668|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087669|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087670|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14087671|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
14087672|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087673|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087674|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14087675|NCT02478242|Nafamostat|nafamostat|mesh-list
14087676|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14087677|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14087678|NCT02478242|Analgesics|analgesics|mesh-ancestor
14087679|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
14087680|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087681|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087682|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087683|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087684|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
14087685|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
14087686|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087687|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087688|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14087689|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14087690|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14087691|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14087692|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
14087693|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
14087694|NCT02478229|Ledipasvir|ledipasvir|mesh-list
14087695|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
14087696|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173945|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173946|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
14173947|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173948|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173949|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14173950|NCT04791345|Protective Agents|protective agents|mesh-ancestor
14173951|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14173952|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
14173953|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
14173954|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14173955|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14173956|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14173957|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14173958|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14173959|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173960|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173961|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14173962|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14173963|NCT04791566|Dexamethasone|dexamethasone|mesh-list
14173964|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173965|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
14173966|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
14173967|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173968|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173969|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173970|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
14173971|NCT04791566|Hormones|hormones|mesh-ancestor
14173972|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173973|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760313|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760314|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760315|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
14760316|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
13917758|NCT03452657|Ranibizumab|ranibizumab|mesh-list
13917759|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13917760|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13917761|NCT03452657|Growth Substances|growth substances|mesh-ancestor
13917762|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917763|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
13917764|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917765|NCT03452579|Bevacizumab|bevacizumab|mesh-list
13917766|NCT03452579|Nivolumab|nivolumab|mesh-list
13917767|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917768|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917769|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14173974|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760317|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760318|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760319|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760320|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14760321|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14760322|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760323|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14760324|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14087697|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
14087698|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760325|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14760326|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
14087699|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
14087700|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087701|NCT02477956|Vitamin D|vitamin d|mesh-list
14087702|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
14087703|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
14087704|NCT02477956|Vitamins|vitamins|mesh-list
14760327|NCT04379596|Fluorouracil|fluorouracil|mesh-list
14760328|NCT04379596|Capecitabine|capecitabine|mesh-list
14760329|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
14760330|NCT04379596|Trastuzumab|trastuzumab|mesh-list
14760331|NCT04379596|Durvalumab|durvalumab|mesh-list
14760332|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760333|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760334|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
14760335|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760336|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760337|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14760338|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
14760339|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760340|NCT04377204|Lidocaine|lidocaine|mesh-list
14760341|NCT04377204|Bupivacaine|bupivacaine|mesh-list
14760342|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
14935328|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14760343|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
14087705|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
14760344|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14760345|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087706|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087707|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14087708|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14087709|NCT02477969|Metformin|metformin|mesh-list
14087710|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14087711|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087712|NCT02477995|Vaccines|vaccines|mesh-list
14087713|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
14087714|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087715|NCT02477891|Daratumumab|daratumumab|mesh-list
14087716|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087717|NCT02477852|Rifampin|rifampin|mesh-list
14087718|NCT02477852|Isoniazid|isoniazid|mesh-list
14087719|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
14087720|NCT02477852|Ethambutol|ethambutol|mesh-list
14087721|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14087722|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
14087723|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087724|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087725|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
14087726|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14087727|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087728|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087729|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14087730|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14087731|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14087732|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14087733|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14087734|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14087735|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14087736|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14087737|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
14087738|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14087739|NCT02477813|Temozolomide|temozolomide|mesh-list
14087740|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14087741|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
14087742|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087743|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087744|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14087745|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
13917770|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13917771|NCT03452579|Growth Substances|growth substances|mesh-ancestor
13917772|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917773|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
13917774|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13917775|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917776|NCT03452553|Doxorubicin|doxorubicin|mesh-list
13917777|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13917778|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917779|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13917780|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13917781|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917782|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917783|NCT03452501|Infliximab|infliximab|mesh-list
13917784|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
13917785|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917786|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13917787|NCT03452475|Lumefantrine|lumefantrine|mesh-list
14087746|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14087747|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
14087748|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14087749|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087750|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14087751|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087752|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087753|NCT02477631|Deferiprone|deferiprone|mesh-list
14087754|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14087755|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
14087756|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
14087757|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917788|NCT03452475|Artemether|artemether|mesh-list
13917789|NCT03452475|Piperaquine|piperaquine|mesh-list
14760346|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
14760347|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760348|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14760349|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14760350|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14087758|NCT02477514|Tedizolid|tedizolid|mesh-list
14087759|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
14087760|NCT02477514|Midazolam|midazolam|mesh-list
14087761|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14087762|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14087763|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14087764|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087765|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087766|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14087767|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13917790|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
13917791|NCT03452475|Mefloquine|mefloquine|mesh-list
13917792|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
13917793|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14087768|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14087769|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14760351|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14760352|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087770|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
14087771|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
14087772|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
14087773|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
14087774|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087775|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087776|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14087777|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14087778|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
14087779|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14087780|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14087781|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087782|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14087783|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14087784|NCT02477501|Norepinephrine|norepinephrine|mesh-list
14087785|NCT02477501|Ephedrine|ephedrine|mesh-list
14087786|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14087787|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14087788|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
14087789|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087790|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087791|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087792|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
14087793|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
14087794|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087795|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14087796|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14087797|NCT02477488|Allopurinol|allopurinol|mesh-list
14087798|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
14087799|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087800|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087801|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
14087802|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087803|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14087804|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
14087805|NCT02477488|Protective Agents|protective agents|mesh-ancestor
14087806|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087807|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14087808|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14087809|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087810|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087811|NCT02477397|Fluticasone|fluticasone|mesh-list
14087812|NCT02477397|Xhance|xhance|mesh-list
14087813|NCT02477397|Budesonide|budesonide|mesh-list
14087814|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
14087815|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14087816|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14087817|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14087818|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087819|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14087820|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
14087821|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173975|NCT04791475|Dexamethasone|dexamethasone|mesh-list
14935329|NCT01462890|Growth Substances|growth substances|mesh-ancestor
14935330|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935331|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
14935332|NCT01462968|Heparin|heparin|mesh-list
14935333|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
14935334|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935335|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13917794|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13917795|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917796|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13917797|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13917798|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917799|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917800|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13917801|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13917802|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917803|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
13917804|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917805|NCT03452332|Durvalumab|durvalumab|mesh-list
13917806|NCT03452332|Ipilimumab|ipilimumab|mesh-list
13917807|NCT03452332|Tremelimumab|tremelimumab|mesh-list
13917808|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
13917809|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13917810|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
13917811|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917812|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917813|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
13917814|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917815|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13917816|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917817|NCT03452306|Metformin|metformin|mesh-list
13917818|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917819|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917820|NCT03452267|Metformin|metformin|mesh-list
14087822|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087823|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14087824|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
14087825|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
14087826|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14087827|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
14087828|NCT02477397|Hormones|hormones|mesh-ancestor
14087829|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087830|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14087831|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14087832|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14087833|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
14087834|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087835|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087836|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
14087837|NCT02477267|Buprenorphine|buprenorphine|mesh-list
14087838|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14087839|NCT02477267|Naloxone|naloxone|mesh-list
14935336|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935337|NCT01463046|Cytarabine|cytarabine|mesh-list
14935338|NCT01463046|Daunorubicin|daunorubicin|mesh-list
14935339|NCT01463046|Panobinostat|panobinostat|mesh-list
14935340|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14935341|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
14935342|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935343|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935344|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
14935345|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935346|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935347|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
14935348|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935349|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14935350|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14935351|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14935352|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935353|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14935354|NCT01463072|Paclitaxel|paclitaxel|mesh-list
14935355|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14087840|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14087841|NCT02477267|Narcotics|narcotics|mesh-ancestor
14087842|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087843|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087844|NCT02477267|Analgesics|analgesics|mesh-ancestor
14087845|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
14087846|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087847|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14087848|NCT02477280|Methylphenidate|methylphenidate|mesh-list
14477103|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477104|NCT02426658|Pemetrexed|pemetrexed|mesh-list
14477105|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477106|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477107|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477108|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14087849|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14087850|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760353|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14760354|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
14760355|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760356|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
14760357|NCT04369742|Calcium|calcium|mesh-list
14760358|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14760359|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760360|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760361|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
14760362|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14760363|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14760364|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760365|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917821|NCT03452267|Pioglitazone|pioglitazone|mesh-list
13917822|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917823|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917824|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
13917825|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13917826|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917827|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
13917828|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13917829|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14087851|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14087852|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14087853|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087854|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087855|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
14087856|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087857|NCT02477306|Rabeprazole|rabeprazole|mesh-list
14087858|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14087859|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14087860|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14087861|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087862|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087863|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
14087864|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14087865|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
14087866|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14087867|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087868|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14087869|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14087870|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14087871|NCT02477254|Vaccines|vaccines|mesh-list
14935356|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14935357|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935358|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
14935359|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
14935360|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
13917830|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14935361|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935362|NCT01463150|Clopidogrel|clopidogrel|mesh-list
14935363|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14935364|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935365|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14935366|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14935367|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14477109|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14477110|NCT02426918|Vancomycin|vancomycin|mesh-list
13917831|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917832|NCT03451734|Metformin|metformin|mesh-list
13917833|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
13917834|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13917835|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917836|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13917837|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917838|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13917839|NCT03451695|Morphine|morphine|mesh-list
13917840|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13917841|NCT03451695|Narcotics|narcotics|mesh-ancestor
13917842|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917843|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917844|NCT03451695|Analgesics|analgesics|mesh-ancestor
13917845|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
13917846|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917847|NCT03451682|Procyanidin|procyanidin|mesh-list
13917848|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
13917849|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917850|NCT03451682|Protective Agents|protective agents|mesh-ancestor
13917851|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917852|NCT03451591|Cilostazol|cilostazol|mesh-list
13917853|NCT03451591|Isosorbide|isosorbide|mesh-list
13917854|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13917855|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13917856|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13917857|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
13917858|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960233|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
14935368|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
14935369|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935370|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935371|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935372|NCT01463163|Ticagrelor|ticagrelor|mesh-list
14935373|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14935374|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14087872|NCT02477254|Immunologic Factors|immunologic factors|mesh-ancestor
14087873|NCT02477254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087874|NCT02476955|Paclitaxel|paclitaxel|mesh-list
14087875|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14087876|NCT02476955|Carboplatin|carboplatin|mesh-list
14087877|NCT02476955|Anastrozole|anastrozole|mesh-list
14087878|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14087879|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14087880|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
14087881|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
14087882|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
14087883|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087884|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14087885|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14087886|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14087887|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087888|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14087889|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
14087890|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14087891|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087892|NCT02477007|Acetaminophen|acetaminophen|mesh-list
14087893|NCT02477007|Ibuprofen|ibuprofen|mesh-list
14087894|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14087895|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14087896|NCT02477007|Analgesics|analgesics|mesh-ancestor
14087897|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
14087898|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087899|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087900|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087901|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087902|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14087903|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087904|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087905|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
14087906|NCT02476799|Ketorolac|ketorolac|mesh-list
14087907|NCT02476799|Fentanyl|fentanyl|mesh-list
14087908|NCT02476799|Ropivacaine|ropivacaine|mesh-list
14087909|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
14087910|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
14087911|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087912|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087913|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
14087914|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087915|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14087916|NCT02476799|Narcotics|narcotics|mesh-ancestor
14087917|NCT02476799|Analgesics|analgesics|mesh-ancestor
14087918|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14087919|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14477111|NCT02426918|Linezolid|linezolid|mesh-list
14477112|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477113|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935375|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14935376|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14935377|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14935378|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
14935379|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935380|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935381|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935382|NCT01463215|Ambroxol|ambroxol|mesh-list
14935383|NCT01463215|Expectorants|expectorants|mesh-ancestor
14935384|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
14935385|NCT01463228|Metformin|metformin|mesh-list
14935386|NCT01463228|Canagliflozin|canagliflozin|mesh-list
14935387|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14935388|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935389|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13917859|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917860|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13917861|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
13917862|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13917863|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13917864|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917865|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13917866|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
13917867|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13917868|NCT03451591|Protective Agents|protective agents|mesh-ancestor
13917869|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13917870|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13917871|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917872|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13917873|NCT03451591|Diuretics|diuretics|mesh-ancestor
13917874|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
13917875|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13917876|NCT03451500|Levodopa|levodopa|mesh-list
13917877|NCT03451500|Carbidopa|carbidopa|mesh-list
13917878|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13917879|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14935390|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935391|NCT01463280|Lidocaine|lidocaine|mesh-list
14935392|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
14935393|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
14935394|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935395|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935396|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
14935397|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935398|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14935399|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14935400|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14935401|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14087920|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
14087921|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14087922|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14087923|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087924|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14087925|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14087926|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14087927|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087928|NCT02477098|Ropivacaine|ropivacaine|mesh-list
14087929|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
14087930|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
14087931|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087932|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917880|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13917881|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
13917882|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917883|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917884|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917885|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13917886|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917887|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13917888|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
13917889|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
13917890|NCT03451487|Acetaminophen|acetaminophen|mesh-list
13917891|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13917892|NCT03451487|Analgesics|analgesics|mesh-ancestor
13917893|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
13917894|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917895|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917896|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
13917897|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
13917898|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13917899|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
13917900|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917901|NCT03451435|Expectorants|expectorants|mesh-ancestor
14087933|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
14087934|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087935|NCT02477072|Heparin|heparin|mesh-list
14087936|NCT02477072|Calcium heparin|calcium heparin|mesh-list
14087937|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
14087938|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14087939|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14087940|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087941|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
14087942|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14087943|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
14087944|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
14087945|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087946|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087947|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14087948|NCT02476929|Analgesics|analgesics|mesh-ancestor
14087949|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
14087950|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087951|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
14087952|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14087953|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
14087954|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087955|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
14087956|NCT02476903|Protective Agents|protective agents|mesh-ancestor
14477114|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13917902|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
14087957|NCT02476864|Macitentan|macitentan|mesh-list
14087958|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14087959|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14087960|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087961|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14087962|NCT02476981|Ephedrine|ephedrine|mesh-list
14087963|NCT02476981|Midazolam|midazolam|mesh-list
14087964|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
14087965|NCT02476981|Remifentanil|remifentanil|mesh-list
14087966|NCT02476981|Propofol|propofol|mesh-list
14087967|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14087968|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14087969|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14087970|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14087971|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
14087972|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
14087973|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14087974|NCT02476981|Analgesics|analgesics|mesh-ancestor
14087975|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
14087976|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14087977|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14087978|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14087979|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14087980|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
14935402|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935403|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
14935404|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14935405|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935406|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935407|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935408|NCT01463332|Analgesics|analgesics|mesh-ancestor
14087981|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14087982|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14087983|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14087984|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14087985|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14087986|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14477115|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477116|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477117|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14087987|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
14477118|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14087988|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
14087989|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14087990|NCT02476981|Narcotics|narcotics|mesh-ancestor
14087991|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14477119|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
14087992|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
14087993|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
14087994|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14087995|NCT02476825|Fluticasone|fluticasone|mesh-list
14087996|NCT02476825|Xhance|xhance|mesh-list
14087997|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14087998|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14087999|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
14088000|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088001|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088002|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14088003|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
14088004|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
14760366|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760367|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
14760368|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14760369|NCT04346654|Dexamethasone|dexamethasone|mesh-list
14760370|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760371|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
14760372|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
14760373|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760374|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760375|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14760376|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
14760377|NCT04346654|Hormones|hormones|mesh-ancestor
14760378|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760379|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760380|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760381|NCT04346628|Favipiravir|favipiravir|mesh-list
14760382|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
14760383|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760384|NCT04340843|Decitabine|decitabine|mesh-list
14088005|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14760385|NCT04340843|Azacitidine|azacitidine|mesh-list
14088006|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
14088007|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14088008|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
14088009|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917903|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13917904|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
13917905|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917906|NCT03451435|Protective Agents|protective agents|mesh-ancestor
13917907|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917908|NCT03451435|Antidotes|antidotes|mesh-ancestor
13917909|NCT03451396|Lifitegrast|lifitegrast|mesh-list
14088010|NCT02476526|Expectorants|expectorants|mesh-ancestor
14088011|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
14088012|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14088013|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
14088014|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088015|NCT02476526|Protective Agents|protective agents|mesh-ancestor
14088016|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088017|NCT02476526|Antidotes|antidotes|mesh-ancestor
14088018|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14088019|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14088020|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
14088021|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088022|NCT02476773|Antacids|antacids|mesh-ancestor
14935409|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
14935410|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935411|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14935412|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14935413|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14935414|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
14935415|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917910|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13917911|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13917912|NCT03451331|Gemcitabine|gemcitabine|mesh-list
13917913|NCT03451331|Carboplatin|carboplatin|mesh-list
13917914|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
13917915|NCT03451331|Nivolumab|nivolumab|mesh-list
13917916|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917917|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13917918|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
13917919|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917920|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
13917921|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088023|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088024|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088025|NCT02476708|Curcumin|curcumin|mesh-list
14088026|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14088027|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14088028|NCT02476708|Analgesics|analgesics|mesh-ancestor
14088029|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
14088030|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088031|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088032|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088033|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088034|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088035|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477120|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14088036|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088037|NCT02476760|Insulin|insulin|mesh-list
14088038|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14088039|NCT02476760|Metformin|metformin|mesh-list
14088040|NCT02476760|Pioglitazone|pioglitazone|mesh-list
14935416|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935417|NCT01463371|Azithromycin|azithromycin|mesh-list
14935418|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935419|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088041|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14088042|NCT02476760|Liraglutide|liraglutide|mesh-list
14088043|NCT02476760|Exenatide|exenatide|mesh-list
14088044|NCT02476760|Glimepiride|glimepiride|mesh-list
14088045|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
14088046|NCT02476760|Vildagliptin|vildagliptin|mesh-list
14088047|NCT02476760|Saxagliptin|saxagliptin|mesh-list
14088048|NCT02476760|Acarbose|acarbose|mesh-list
14088049|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14088050|NCT02476760|Repaglinide|repaglinide|mesh-list
14088051|NCT02476760|Gliclazide|gliclazide|mesh-list
14088052|NCT02476760|Glipizide|glipizide|mesh-list
14088053|NCT02476760|Tolbutamide|tolbutamide|mesh-list
14088054|NCT02476760|Biguanides|biguanides|mesh-list
14088055|NCT02476760|Voglibose|voglibose|mesh-list
14088056|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14088057|NCT02476760|Nateglinide|nateglinide|mesh-list
14935420|NCT01463592|Iodine|iodine|mesh-list
14088058|NCT02476760|Miglitol|miglitol|mesh-list
14088059|NCT02476760|Troglitazone|troglitazone|mesh-list
14088060|NCT02476760|Meglitinide|meglitinide|mesh-list
14088061|NCT02476760|Acetohexamide|acetohexamide|mesh-list
14088062|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
14088063|NCT02476760|Buformin|buformin|mesh-list
14088064|NCT02476760|Phenformin|phenformin|mesh-list
14088065|NCT02476760|Glibornuride|glibornuride|mesh-list
14088066|NCT02476760|Tolazamide|tolazamide|mesh-list
14935421|NCT01463592|Interferons|interferons|mesh-list
14935422|NCT01463592|Ribavirin|ribavirin|mesh-list
14935423|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
14935424|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
14935425|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
14935426|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088067|NCT02476760|Carbutamide|carbutamide|mesh-list
14088068|NCT02476760|Gliquidone|gliquidone|mesh-list
14088069|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14935427|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
14935428|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088070|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14088071|NCT02476760|Incretins|incretins|mesh-list
14088072|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088073|NCT02476760|Hormones|hormones|mesh-ancestor
14088074|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088075|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
14088076|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088077|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088078|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14088079|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14088080|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088081|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
14088082|NCT02476552|Niraparib|niraparib|mesh-list
14088083|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14088084|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088085|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088086|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088087|NCT02476279|Indomethacin|indomethacin|mesh-list
14088088|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14088089|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14088090|NCT02476279|Analgesics|analgesics|mesh-ancestor
14088091|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
14088092|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088093|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088094|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088095|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088096|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
14088097|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
14088098|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14088099|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14088100|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088101|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14173976|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
14173977|NCT04791475|Bupivacaine|bupivacaine|mesh-list
14173978|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14173979|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
14173980|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
14173981|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14173982|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14173983|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14173984|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
14173985|NCT04791475|Hormones|hormones|mesh-ancestor
14173986|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14173987|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14173988|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14173989|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
14173990|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
14173991|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14173992|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
14173993|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14173994|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14173995|NCT04791475|Analgesics|analgesics|mesh-ancestor
14173996|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14173997|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14173998|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14173999|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174000|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174001|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174002|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
14174003|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14174004|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14174005|NCT04791202|Prednisolone|prednisolone|mesh-list
14174006|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
14174007|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14174008|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
14174009|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14174010|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
14174011|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
14174012|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174013|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174014|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174015|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
14174016|NCT04791202|Hormones|hormones|mesh-ancestor
14174017|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174018|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14174019|NCT04791202|Protective Agents|protective agents|mesh-ancestor
14174020|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14174021|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174022|NCT04790838|Fluticasone|fluticasone|mesh-list
14174023|NCT04790838|Xhance|xhance|mesh-list
14935429|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
14935430|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935431|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
14935432|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935433|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14935434|NCT01463592|Trace Elements|trace elements|mesh-ancestor
14935435|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
14935436|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
14935437|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14935438|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935439|NCT01463670|Lenalidomide|lenalidomide|mesh-list
14935440|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
14935441|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917922|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13917923|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13917924|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
13917925|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917926|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917927|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13917928|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
13917929|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917930|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
13917931|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13917932|NCT03451266|Ascorbic Acid|ascorbic acid|mesh-list
13917933|NCT03451266|Vitamins|vitamins|mesh-ancestor
13917934|NCT03451266|Micronutrients|micronutrients|mesh-ancestor
13917935|NCT03451266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917936|NCT03451266|Antioxidants|antioxidants|mesh-ancestor
13917937|NCT03451266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917938|NCT03451266|Protective Agents|protective agents|mesh-ancestor
13917939|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
13917940|NCT03451227|Remifentanil|remifentanil|mesh-list
13917941|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13917942|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917943|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917944|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14088102|NCT02476409|Tolvaptan|tolvaptan|mesh-list
14088103|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14088104|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088105|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
14088106|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935442|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13917945|NCT03451227|Analgesics|analgesics|mesh-ancestor
14088107|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14088108|NCT02476136|Fluoxetine|fluoxetine|mesh-list
14088109|NCT02476136|Paroxetine|paroxetine|mesh-list
14088110|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14088111|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14088112|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14088113|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14088114|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088115|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088116|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088117|NCT02476136|Analgesics|analgesics|mesh-ancestor
14088118|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
14088119|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088120|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
14088121|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14088122|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
14088123|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14088124|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
14088125|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14088126|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14088127|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14088128|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088129|NCT02476123|Nivolumab|nivolumab|mesh-list
14088130|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
14088131|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088132|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088133|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14760386|NCT04340843|Belinostat|belinostat|mesh-list
14760387|NCT04340843|Guadecitabine|guadecitabine|mesh-list
14760388|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760389|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
13917946|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
13917947|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13917948|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13917949|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13917950|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13917951|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
13917952|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960234|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
14088134|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088135|NCT02476045|Leucovorin|leucovorin|mesh-list
14088136|NCT02476045|Fluorouracil|fluorouracil|mesh-list
14088137|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
14088138|NCT02476045|Panitumumab|panitumumab|mesh-list
14088139|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
14088140|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
14088141|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088142|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088143|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088144|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088145|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
14088146|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088147|NCT02476045|Antidotes|antidotes|mesh-ancestor
14088148|NCT02476045|Protective Agents|protective agents|mesh-ancestor
14088149|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
14088150|NCT02476045|Vitamins|vitamins|mesh-ancestor
14088151|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
14088152|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088153|NCT02475876|Clindamycin|clindamycin|mesh-list
14760390|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088154|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
14088155|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
14760391|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760392|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760393|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14767314|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767315|NCT00629512|Esomeprazole|esomeprazole|mesh-list
14767316|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14767317|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767318|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14767319|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767320|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088156|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14088157|NCT02475876|Trimethoprim|trimethoprim|mesh-list
14088158|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
14760394|NCT04329039|Somatostatin|somatostatin|mesh-list
14760395|NCT04329039|Hormones|hormones|mesh-ancestor
14760396|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760397|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760398|NCT04321668|Hylan|hylan|mesh-list
14760399|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
14760400|NCT04321668|Protective Agents|protective agents|mesh-ancestor
14760401|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760402|NCT04311502|Pyridoxine|pyridoxine|mesh-list
14760403|NCT04311502|Pyridoxal|pyridoxal|mesh-list
14760404|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
14760405|NCT04311502|Rifampin|rifampin|mesh-list
14760406|NCT04311502|Rifapentine|rifapentine|mesh-list
14760407|NCT04311502|Clofazimine|clofazimine|mesh-list
14760408|NCT04311502|Isoniazid|isoniazid|mesh-list
14088159|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14088160|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088161|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14088162|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088163|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088164|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14760409|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
14760410|NCT04311502|Ethambutol|ethambutol|mesh-list
14760411|NCT04311502|Vitamins|vitamins|mesh-ancestor
14760412|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
14760413|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760414|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
14760415|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14760416|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
14760417|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14760418|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760419|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
14760420|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14760421|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760422|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760423|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14088165|NCT02475876|Renal Agents|renal agents|mesh-ancestor
14088166|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
14088167|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14088168|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14088169|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14088170|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14088171|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14088172|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14088173|NCT02475863|Warfarin|warfarin|mesh-list
14088174|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
14088175|NCT02475915|Tenofovir|tenofovir|mesh-list
14088176|NCT02475915|Emtricitabine|emtricitabine|mesh-list
14088177|NCT02475915|Efavirenz|efavirenz|mesh-list
14088178|NCT02475915|Maraviroc|maraviroc|mesh-list
14088179|NCT02475915|Darunavir|darunavir|mesh-list
14088180|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
14088181|NCT02475915|Vorinostat|vorinostat|mesh-list
14088182|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
14088183|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088184|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14088185|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14088186|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088187|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088188|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14088189|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14088190|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
14088191|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14088192|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14088193|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088194|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14088195|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14760424|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14760425|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14760426|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14760427|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14088196|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14767321|NCT00629564|Esomeprazole|esomeprazole|mesh-list
14088197|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14088198|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14088199|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14088200|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088201|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14088202|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14088203|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14088204|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14088205|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14088206|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14088207|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
14088208|NCT02475772|Cisplatin|cisplatin|mesh-list
14088209|NCT02475772|Doxorubicin|doxorubicin|mesh-list
14935443|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14935444|NCT01463670|Growth Substances|growth substances|mesh-ancestor
14935445|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
14935446|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935447|NCT01463735|Vitamin E|vitamin e|mesh-list
14935448|NCT01463735|Vitamins|vitamins|mesh-ancestor
14935449|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
14935450|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935451|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
14935452|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935453|NCT01463735|Protective Agents|protective agents|mesh-ancestor
14935454|NCT01463774|Metformin|metformin|mesh-list
14935455|NCT01463774|Canagliflozin|canagliflozin|mesh-list
14935456|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14088210|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14088211|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088212|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14088213|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14088214|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14088215|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935457|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935458|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14935459|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935460|NCT01463813|Vitamin D|vitamin d|mesh-list
14935461|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
14935462|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
14935463|NCT01463813|Vitamins|vitamins|mesh-list
13917953|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917954|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13917955|NCT03451227|Narcotics|narcotics|mesh-ancestor
13917956|NCT03451110|Fluconazole|fluconazole|mesh-list
13917957|NCT03451110|Lemborexant|lemborexant|mesh-list
13917958|NCT03451110|Famotidine|famotidine|mesh-list
13917959|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
13917960|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
13917961|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13917962|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13917963|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13917964|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935464|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
14935465|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088216|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088217|NCT02475824|Midazolam|midazolam|mesh-list
14088218|NCT02475824|Meperidine|meperidine|mesh-list
14088219|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
14088220|NCT02475824|Propofol|propofol|mesh-list
14088221|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14088222|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088223|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088224|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14088225|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
14088226|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
14088227|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14088228|NCT02475824|Analgesics|analgesics|mesh-ancestor
14088229|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
14088230|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088231|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14088232|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14088233|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14088234|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14088235|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088236|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088237|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14088238|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14760428|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14760429|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14760430|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14088239|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14088240|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14088241|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
14088242|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
14088243|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14088244|NCT02475824|Narcotics|narcotics|mesh-ancestor
14088245|NCT02475746|Itraconazole|itraconazole|mesh-list
14088246|NCT02475746|PF-06372865|pf-06372865|mesh-list
14088247|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
14088248|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088249|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14088250|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14477121|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14477122|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477123|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477124|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14477125|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14477126|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477127|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
14477128|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477129|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14477130|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088251|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088252|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917965|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917966|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13917967|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
14760431|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
14760432|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14760433|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13917968|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13917969|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13917970|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13917971|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13917972|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13917973|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13917974|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13917975|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
13917976|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
13917977|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13917978|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13917979|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13917980|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13917981|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917982|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14088253|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14088254|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
14088255|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088256|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088257|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14088258|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
14088259|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
14088260|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088261|NCT02475499|Metformin|metformin|mesh-list
14088262|NCT02475499|Pioglitazone|pioglitazone|mesh-list
14088263|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14088264|NCT02475499|Liraglutide|liraglutide|mesh-list
14760434|NCT04308304|Donepezil|donepezil|mesh-list
14088265|NCT02475499|Exenatide|exenatide|mesh-list
14088266|NCT02475499|Glimepiride|glimepiride|mesh-list
14088267|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
14088268|NCT02475499|Vildagliptin|vildagliptin|mesh-list
14767322|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14088269|NCT02475499|Saxagliptin|saxagliptin|mesh-list
14088270|NCT02475499|Acarbose|acarbose|mesh-list
14088271|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14760435|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14760436|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760437|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760438|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
14760439|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088272|NCT02475499|Repaglinide|repaglinide|mesh-list
14088273|NCT02475499|Gliclazide|gliclazide|mesh-list
14088274|NCT02475499|Glipizide|glipizide|mesh-list
14088275|NCT02475499|Tolbutamide|tolbutamide|mesh-list
14088276|NCT02475499|Biguanides|biguanides|mesh-list
14088277|NCT02475499|Voglibose|voglibose|mesh-list
14088278|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14088279|NCT02475499|Nateglinide|nateglinide|mesh-list
14088280|NCT02475499|Miglitol|miglitol|mesh-list
14088281|NCT02475499|Troglitazone|troglitazone|mesh-list
14088282|NCT02475499|Meglitinide|meglitinide|mesh-list
14088283|NCT02475499|Acetohexamide|acetohexamide|mesh-list
14088284|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
14088285|NCT02475499|Buformin|buformin|mesh-list
14088286|NCT02475499|Phenformin|phenformin|mesh-list
14088287|NCT02475499|Glibornuride|glibornuride|mesh-list
14088288|NCT02475499|Tolazamide|tolazamide|mesh-list
14088289|NCT02475499|Carbutamide|carbutamide|mesh-list
14088290|NCT02475499|Gliquidone|gliquidone|mesh-list
14088291|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14088292|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14088293|NCT02475499|Incretins|incretins|mesh-list
14088294|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088295|NCT02475499|Hormones|hormones|mesh-ancestor
14088296|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088297|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
14088298|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088299|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917983|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13917984|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13917985|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
13917986|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13917987|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13917988|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13917989|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14088300|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14088301|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14088302|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088303|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
14088304|NCT02475421|Glucagon|glucagon|mesh-list
14088305|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088306|NCT02475421|Hormones|hormones|mesh-ancestor
14088307|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088308|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088309|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
14088310|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
14477131|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477132|NCT02427802|Gentamicins|gentamicins|mesh-list
14477133|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477134|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477135|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14477136|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477137|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477138|NCT02427841|Gemcitabine|gemcitabine|mesh-list
14477139|NCT02427841|Paclitaxel|paclitaxel|mesh-list
14477140|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14088311|NCT02475681|Chlorambucil|chlorambucil|mesh-list
14088312|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088313|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760440|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760441|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
14760442|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
14760443|NCT04305054|Lenvatinib|lenvatinib|mesh-list
14760444|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760445|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13917990|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13917991|NCT03451019|Sevelamer|sevelamer|mesh-list
13917992|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
13917993|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
13917994|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13917995|NCT03450967|Durvalumab|durvalumab|mesh-list
13917996|NCT03450967|Tremelimumab|tremelimumab|mesh-list
13917997|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13917998|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960235|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960236|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960237|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
13960238|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960239|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13960240|NCT03156322|Narcotics|narcotics|mesh-ancestor
13960241|NCT03156322|Analgesics|analgesics|mesh-ancestor
13960242|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13960243|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13960244|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
13960245|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
13960246|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760446|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760447|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760448|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760449|NCT04296890|Maytansine|maytansine|mesh-list
14760450|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760451|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760452|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
14760453|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
14760454|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760455|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760456|NCT04276259|Naltrexone|naltrexone|mesh-list
14760457|NCT04276259|Buprenorphine|buprenorphine|mesh-list
14760458|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14760459|NCT04276259|Narcotics|narcotics|mesh-ancestor
14760460|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13917999|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
13918000|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13918001|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918002|NCT03450798|Anesthetics|anesthetics|mesh-list
13918003|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088314|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14088315|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
14088316|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088317|NCT02475382|Nivolumab|nivolumab|mesh-list
14088318|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088319|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088320|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14088321|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088322|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14088323|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
14088324|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088325|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
14088326|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760461|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760462|NCT04276259|Analgesics|analgesics|mesh-ancestor
14760463|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
14760464|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760465|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14760466|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14760467|NCT04272242|Pyridoxine|pyridoxine|mesh-list
14760468|NCT04272242|Pyridoxal|pyridoxal|mesh-list
14760469|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
13918004|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918005|NCT05322499|Paclitaxel|paclitaxel|mesh-list
13918006|NCT05322499|Docetaxel|docetaxel|mesh-list
13918007|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13918008|NCT05322499|Irinotecan|irinotecan|mesh-list
13918009|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13918010|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918011|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
13918012|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
13918013|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
13918014|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918015|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13918016|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13918017|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918018|NCT05322473|Adalimumab|adalimumab|mesh-list
13918019|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918020|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918021|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
13918022|NCT05322330|Fludarabine|fludarabine|mesh-list
13918023|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918024|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
14760470|NCT04272242|Isoniazid|isoniazid|mesh-list
14760471|NCT04272242|Rifapentine|rifapentine|mesh-list
14760472|NCT04272242|Dolutegravir|dolutegravir|mesh-list
14760473|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13918025|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918026|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760474|NCT04272242|Vitamins|vitamins|mesh-ancestor
14760475|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
14760476|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760477|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
14760478|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
14760479|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14760480|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918027|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13918028|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
13918029|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935466|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14935467|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13918030|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918031|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13918032|NCT05322265|Epinephrine|epinephrine|mesh-list
13918033|NCT05322265|Racepinephrine|racepinephrine|mesh-list
13918034|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
13918035|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13918036|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13918037|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
13918038|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918039|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918040|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918041|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13918042|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13918043|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
13918044|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477141|NCT02427841|Fluorouracil|fluorouracil|mesh-list
14760481|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14760482|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14760483|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
14760484|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760485|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14088327|NCT02475343|Riboflavin|riboflavin|mesh-list
14088328|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
14088329|NCT02475343|Vitamins|vitamins|mesh-ancestor
14088330|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
14088331|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760486|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14760487|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14760488|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760489|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14760490|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
14760491|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14760492|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
14760493|NCT04267926|Ubiquinone|ubiquinone|mesh-list
14760494|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
14760495|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760496|NCT04251533|Paclitaxel|paclitaxel|mesh-list
14760497|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760498|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760499|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
14088332|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14088333|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
14088334|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
13918045|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13918046|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
13918047|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
13918048|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
13918049|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13918050|NCT05322252|Misoprostol|misoprostol|mesh-list
13918051|NCT05322252|Mifepristone|mifepristone|mesh-list
13918052|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13918053|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
13918054|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13918055|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918056|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13918057|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13918058|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
13918059|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13918060|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13918061|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13918062|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13918063|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
13918064|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13918065|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13918066|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
13918067|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760500|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
14760501|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760502|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760503|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
14760504|NCT04246177|Lenvatinib|lenvatinib|mesh-list
14760505|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088335|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14088336|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
14088337|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14088338|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088339|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14088340|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14088341|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14088342|NCT02475135|Tenofovir|tenofovir|mesh-list
14088343|NCT02475135|Emtricitabine|emtricitabine|mesh-list
14088344|NCT02475135|Darunavir|darunavir|mesh-list
14088345|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13918068|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
13918069|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13918070|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13918071|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
14088346|NCT02475135|Cobicistat|cobicistat|mesh-list
14088347|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14088348|NCT02475135|Elvitegravir|elvitegravir|mesh-list
14088349|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
14088350|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088351|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14088352|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14088353|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088354|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088355|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14088356|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14088357|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14088358|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14088359|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
14088360|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14088361|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13918072|NCT05322187|Lenvatinib|lenvatinib|mesh-list
13918073|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13918074|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918075|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918076|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13918077|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918078|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918079|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
13918080|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13918081|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
13918082|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088362|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14088363|NCT02475161|Rabeprazole|rabeprazole|mesh-list
14088364|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14088365|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088366|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14088367|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088368|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088369|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
14088370|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088371|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088372|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14088373|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14088374|NCT02475317|Volixibat|volixibat|mesh-list
14088375|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13918083|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
13918084|NCT05322070|Hormones|hormones|mesh-ancestor
14088376|NCT02474953|Curcumin|curcumin|mesh-list
14088377|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14088378|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13918085|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918086|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918087|NCT05321940|Interferons|interferons|mesh-list
13918088|NCT05321940|Vaccines|vaccines|mesh-list
13918089|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
13918090|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918091|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088379|NCT02474953|Analgesics|analgesics|mesh-ancestor
14088380|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
14088381|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088382|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088383|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088384|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088385|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088386|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088387|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088388|NCT02474914|Octreotide|octreotide|mesh-list
14088389|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088390|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14088391|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088392|NCT02475057|Hormones|hormones|mesh-list
14088393|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14088394|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088395|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088396|NCT02474667|Mitogens|mitogens|mesh-list
13918092|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
13918093|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918094|NCT05321810|Warfarin|warfarin|mesh-list
13918095|NCT05321810|Apixaban|apixaban|mesh-list
14088397|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
14088398|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088399|NCT02474654|Ketorolac|ketorolac|mesh-list
14088400|NCT02474654|Epinephrine|epinephrine|mesh-list
14088401|NCT02474654|Racepinephrine|racepinephrine|mesh-list
14088402|NCT02474654|Fentanyl|fentanyl|mesh-list
14088403|NCT02474654|Bupivacaine|bupivacaine|mesh-list
14088404|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
14088405|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
14088406|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
14088407|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088408|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088409|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
14088410|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088411|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14088412|NCT02474654|Narcotics|narcotics|mesh-ancestor
14088413|NCT02474654|Analgesics|analgesics|mesh-ancestor
14088414|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14088415|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14088416|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
14088417|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14088418|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14088419|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14088420|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088421|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088422|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13918096|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
13918097|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13918098|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
13918099|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13918100|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
13918101|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088423|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14088424|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
14088425|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14088426|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
14088427|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
14088428|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
14088429|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14088430|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14088431|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14088432|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918102|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918103|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
13918104|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13918105|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918106|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13918107|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918108|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
13918109|NCT05321524|Cathartics|cathartics|mesh-ancestor
13918110|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088433|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088434|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14088435|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918111|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14088436|NCT02474706|Imipenem|imipenem|mesh-list
14088437|NCT02474706|Cefoxitin|cefoxitin|mesh-list
14088438|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14088439|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174024|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14174025|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14174026|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14174027|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14174028|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
14174029|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174030|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174031|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14174032|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
13918112|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13918113|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
13918114|NCT05321511|Hormones|hormones|mesh-ancestor
13918115|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918116|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918117|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
13918118|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13918119|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
13918120|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13918121|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13918122|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13918123|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477142|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14477143|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477144|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
14477145|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
14477146|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
14477147|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477148|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14477149|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
14477150|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
14477151|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918124|NCT05321420|Pirfenidone|pirfenidone|mesh-list
14174033|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14174034|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14174035|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14174036|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14174037|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14174038|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174039|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174040|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174041|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
14174042|NCT04790838|Hormones|hormones|mesh-ancestor
14174043|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918125|NCT05321420|Analgesics|analgesics|mesh-ancestor
13918126|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
13918127|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918128|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918129|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14174044|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
14477152|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088440|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14088441|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14088442|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14088443|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088444|NCT02474563|Prednisone|prednisone|mesh-list
14088445|NCT02474563|Bortezomib|bortezomib|mesh-list
14088446|NCT02474563|Melphalan|melphalan|mesh-list
14088447|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088448|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
14088449|NCT02474563|Hormones|hormones|mesh-ancestor
14088450|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088451|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088452|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14088453|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088454|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14088455|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
14088456|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088457|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14088458|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088459|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
14088460|NCT02474511|Anesthetics|anesthetics|mesh-list
13918130|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13918131|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918132|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918133|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918134|NCT05321329|Capecitabine|capecitabine|mesh-list
13918135|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088461|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088462|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918136|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
13918137|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088463|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
14088464|NCT02474628|Calcium|calcium|mesh-list
14088465|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14088466|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918138|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918139|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13918140|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13918141|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088467|NCT02474628|Antacids|antacids|mesh-ancestor
14088468|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088469|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088470|NCT02474433|Misoprostol|misoprostol|mesh-list
14088471|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14088472|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
14088473|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14088474|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960247|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960248|NCT03156036|Capecitabine|capecitabine|mesh-list
13960249|NCT03156036|Temozolomide|temozolomide|mesh-list
13960250|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13960251|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
14088475|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14088476|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088477|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
14088478|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14088479|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14088480|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14088481|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088482|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088483|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
14088484|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088485|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14088486|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14088487|NCT02474290|Sorafenib|sorafenib|mesh-list
14088488|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088489|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760506|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760507|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760508|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760509|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760510|NCT04243278|Aspirin|aspirin|mesh-list
14767323|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088490|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088491|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088492|NCT02474212|Enoxaparin|enoxaparin|mesh-list
14088493|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
14088494|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14088495|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14088496|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088497|NCT02474225|Bevacizumab|bevacizumab|mesh-list
14088498|NCT02474225|Ranibizumab|ranibizumab|mesh-list
14088499|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
14088500|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088501|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088502|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14088503|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14088504|NCT02474225|Growth Substances|growth substances|mesh-ancestor
14088505|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088506|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
14088507|NCT02474446|Vitamin D|vitamin d|mesh-list
14088508|NCT02474446|Vitamins|vitamins|mesh-ancestor
14088509|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
14088510|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088511|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14088512|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14088513|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
14088514|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088515|NCT02474420|Amlodipine|amlodipine|mesh-list
14088516|NCT02474420|Deferasirox|deferasirox|mesh-list
14088517|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14088518|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14088519|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14088520|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088521|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14088522|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088523|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
14477153|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14760511|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14477154|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
14477155|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477156|NCT02428192|Nivolumab|nivolumab|mesh-list
14477157|NCT02428192|Ipilimumab|ipilimumab|mesh-list
14477158|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477159|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477160|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14477161|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477162|NCT02428296|Sirolimus|sirolimus|mesh-list
14477163|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477164|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477165|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14477166|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477167|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
14088524|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14088525|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
14088526|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
14088527|NCT02474134|Interferons|interferons|mesh-list
14088528|NCT02474134|Interferon-beta|interferon-beta|mesh-list
14088529|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
14088530|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088531|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
14088532|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088533|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
14088534|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088535|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14088536|NCT02474186|Paclitaxel|paclitaxel|mesh-list
14088537|NCT02474186|Docetaxel|docetaxel|mesh-list
14088538|NCT02474186|Capecitabine|capecitabine|mesh-list
14088539|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14088540|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088541|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14088542|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14088543|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14088544|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088545|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088546|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
14088547|NCT02473900|Oseltamivir|oseltamivir|mesh-list
14088548|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
14088549|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088550|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088551|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088552|NCT02473887|Ondansetron|ondansetron|mesh-list
14088553|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
14088554|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
14760512|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14760513|NCT04243278|Analgesics|analgesics|mesh-ancestor
14088555|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088556|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088557|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088558|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
14088559|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
14088560|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14088561|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
14088562|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088563|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088564|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14088565|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14477168|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477169|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
14477170|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088566|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088567|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14088568|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14088569|NCT02473809|Liraglutide|liraglutide|mesh-list
14477171|NCT02428478|Desipramine|desipramine|mesh-list
14760514|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
14760515|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760516|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760517|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760518|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760519|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14760520|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14760521|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760522|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14760523|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14760524|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760525|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
14760526|NCT04243122|Aspirin|aspirin|mesh-list
14760527|NCT04243122|Apixaban|apixaban|mesh-list
14760528|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14760529|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14760530|NCT04243122|Analgesics|analgesics|mesh-ancestor
14760531|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
14760532|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760533|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760534|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760535|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760536|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14760537|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14760538|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760539|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14760540|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14760541|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477172|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14760542|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
14760543|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14760544|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
14760545|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14760546|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
14935468|NCT01463852|Vincristine|vincristine|mesh-list
14760547|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
14760548|NCT04241185|Gemcitabine|gemcitabine|mesh-list
14935469|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14935470|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935471|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
14935472|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
14935473|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14935474|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935475|NCT01463865|Ropivacaine|ropivacaine|mesh-list
14935476|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
14935477|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
14935478|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935479|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935480|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
14088570|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14088571|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088572|NCT02473809|Incretins|incretins|mesh-ancestor
14088573|NCT02473809|Hormones|hormones|mesh-ancestor
14088574|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088575|NCT02473562|Varenicline|varenicline|mesh-list
14760549|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
14760550|NCT04241185|Fluorouracil|fluorouracil|mesh-list
14760551|NCT04241185|Mitomycins|mitomycins|mesh-list
14760552|NCT04241185|Mitomycin|mitomycin|mesh-list
14088576|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14088577|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14088578|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
14088579|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14760553|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760554|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088580|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088581|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088582|NCT02473575|Caffeine|caffeine|mesh-list
14088583|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14088584|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088585|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14088586|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088587|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088588|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14088589|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14088590|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
14088591|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088592|NCT02473627|Pioglitazone|pioglitazone|mesh-list
14088593|NCT02473627|Tolbutamide|tolbutamide|mesh-list
14088594|NCT02473627|Midazolam|midazolam|mesh-list
14088595|NCT02473627|Omeprazole|omeprazole|mesh-list
14088596|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14088597|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14088598|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088599|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088600|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14088601|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14088602|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14760555|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
14088603|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14088604|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
14088605|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
14088606|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
14088607|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
14088608|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088609|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088610|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14088611|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14088612|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088613|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14088614|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088615|NCT02473601|Mivacurium|mivacurium|mesh-list
14760556|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088616|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14088617|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14088618|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14088619|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088620|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088621|NCT02473328|Ritonavir|ritonavir|mesh-list
14088622|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14088623|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14088624|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14088625|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
14088626|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088627|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088628|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14088629|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14088630|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
14088631|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088632|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14088633|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14088634|NCT02473302|Tocopherols|tocopherols|mesh-list
14088635|NCT02473302|Vitamin E|vitamin e|mesh-list
14935481|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477173|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
14477174|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14477175|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477176|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477177|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13918162|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
13918163|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13918164|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918165|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935482|NCT01463956|Interferons|interferons|mesh-list
14935483|NCT01463956|Ribavirin|ribavirin|mesh-list
14935484|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935485|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
14935486|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935487|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
14935488|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935489|NCT01464008|Interferons|interferons|mesh-list
14935490|NCT01464008|Ribavirin|ribavirin|mesh-list
14088636|NCT02473302|Tocotrienols|tocotrienols|mesh-list
14088637|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
13918166|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13918167|NCT05321121|Analgesics|analgesics|mesh-ancestor
14088638|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
14174045|NCT04791020|Lidocaine|lidocaine|mesh-list
14935491|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
14935492|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
14088639|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088640|NCT02473302|Protective Agents|protective agents|mesh-ancestor
14088641|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088642|NCT02473302|Vitamins|vitamins|mesh-ancestor
14088643|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
14088644|NCT02473406|Thymalfasin|thymalfasin|mesh-list
14088645|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14088646|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
14088647|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088648|NCT02473354|Remifentanil|remifentanil|mesh-list
14088649|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14088650|NCT02473354|Narcotics|narcotics|mesh-ancestor
14088651|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088652|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088653|NCT02473354|Analgesics|analgesics|mesh-ancestor
14088654|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
14088655|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088656|NCT02473263|Tazobactam|tazobactam|mesh-list
14088657|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
14088658|NCT02473263|Piperacillin|piperacillin|mesh-list
14088659|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14088660|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
14088661|NCT02473263|Norepinephrine|norepinephrine|mesh-list
14088662|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088663|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14088664|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14088665|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
14088666|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088667|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088668|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088669|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
14088670|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
14088671|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088672|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14088673|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477178|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14088674|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174046|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
14760557|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
14760558|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760559|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760560|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14760561|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
14760562|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760563|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760564|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14760565|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
14760566|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14760567|NCT04234217|Niacin|niacin|mesh-list
14760568|NCT04234217|Niacinamide|niacinamide|mesh-list
14760569|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
14760570|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14088675|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14088676|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088677|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
14088678|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14088679|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
14088680|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088681|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088682|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14088683|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
14088684|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
14088685|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14088686|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
14088687|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088688|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088689|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
14088690|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
14088691|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088692|NCT02473185|Methylphenidate|methylphenidate|mesh-list
14088693|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14088694|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088695|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14088696|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14088697|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14088698|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918168|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
13918169|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918170|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13918171|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13918172|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13918173|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
13918174|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918175|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918176|NCT05320926|Aspirin|aspirin|mesh-list
13918177|NCT05320926|Clopidogrel|clopidogrel|mesh-list
13918178|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13918179|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13918180|NCT05320926|Analgesics|analgesics|mesh-ancestor
13918181|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
13918182|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918183|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088699|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
14088700|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088701|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14760571|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
14760572|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760573|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14760574|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
14760575|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
14760576|NCT04234217|Vitamins|vitamins|mesh-ancestor
13918184|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918185|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918186|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13918187|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13918188|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918189|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13918190|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14088702|NCT02473198|Morphine|morphine|mesh-list
14760577|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
13918191|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088703|NCT02473198|Bupivacaine|bupivacaine|mesh-list
14760578|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760579|NCT04230252|Acetaminophen|acetaminophen|mesh-list
14760580|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14760581|NCT04230252|Analgesics|analgesics|mesh-ancestor
13918192|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
13918193|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13918194|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13918195|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13918196|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
13918197|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918198|NCT05320887|Nicotine|nicotine|mesh-list
13918199|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13918200|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
13918201|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918202|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918203|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13918204|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13918205|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
13918206|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088704|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
14088705|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
14088706|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088707|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088708|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
14088709|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088710|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14088711|NCT02473198|Narcotics|narcotics|mesh-ancestor
14088712|NCT02473198|Analgesics|analgesics|mesh-ancestor
14088713|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14088714|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14088715|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088716|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088717|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14088718|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088719|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088720|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
14088721|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088722|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760582|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
14088723|NCT02472873|Ethanol|ethanol|mesh-list
14760583|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088724|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14088725|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088726|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088727|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088728|NCT02473094|Metformin|metformin|mesh-list
14088729|NCT02473094|Capecitabine|capecitabine|mesh-list
14088730|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14088731|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088732|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088733|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
14088734|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088735|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088736|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14088737|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
14088738|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088739|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
14088740|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174047|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
14174048|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174049|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174050|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
14174051|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174052|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14174053|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14174054|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14174055|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174056|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174057|NCT04790812|Acetaminophen|acetaminophen|mesh-list
14174058|NCT04790812|Celecoxib|celecoxib|mesh-list
14174059|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14174060|NCT04790812|Analgesics|analgesics|mesh-ancestor
14174061|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
14174062|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174063|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174064|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
14174065|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14174066|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14174067|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174068|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14174069|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14174070|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174071|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174072|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
14174073|NCT04790734|Remifentanil|remifentanil|mesh-list
14174074|NCT04790734|Propofol|propofol|mesh-list
14174075|NCT04790734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14174076|NCT04790734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174077|NCT04790734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174078|NCT04790734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14174079|NCT04790734|Anesthetics, General|anesthetics, general|mesh-ancestor
14174080|NCT04790734|Anesthetics|anesthetics|mesh-ancestor
14174081|NCT04790734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14174082|NCT04790734|Narcotics|narcotics|mesh-ancestor
14174083|NCT04790734|Analgesics|analgesics|mesh-ancestor
14477179|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14477180|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477181|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477182|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477183|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14477184|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14477185|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477186|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477187|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14477188|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14088741|NCT02472782|Teriparatide|teriparatide|mesh-list
14088742|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14088743|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088744|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14088745|NCT02472717|Liraglutide|liraglutide|mesh-list
14088746|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14088747|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088748|NCT02472717|Incretins|incretins|mesh-ancestor
14088749|NCT02472717|Hormones|hormones|mesh-ancestor
14935493|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14935494|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935495|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
14935496|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935497|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
14935498|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935499|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
14935500|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935501|NCT01464034|Dexamethasone|dexamethasone|mesh-list
14935502|NCT01464034|Pomalidomide|pomalidomide|mesh-list
14935503|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14935504|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
14935505|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
14935506|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935507|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935508|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14935509|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
14935510|NCT01464034|Hormones|hormones|mesh-ancestor
14935511|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918207|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918208|NCT05320874|Antibodies|antibodies|mesh-list
13918209|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13918210|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
13918211|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918212|NCT05320757|Olaparib|olaparib|mesh-list
13918213|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13918214|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918215|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918216|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477189|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477190|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
14477191|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477192|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
14477193|NCT02428699|Liver Extracts|liver extracts|mesh-list
14477194|NCT02428699|Hematinics|hematinics|mesh-ancestor
14477195|NCT02428699|Vitamins|vitamins|mesh-ancestor
13918224|NCT05320692|Apatinib|apatinib|mesh-list
13918225|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
13918226|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088750|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088751|NCT02472691|Lenalidomide|lenalidomide|mesh-list
14088752|NCT02472691|Azacitidine|azacitidine|mesh-list
13918227|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13918228|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918229|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918230|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13918231|NCT05320692|Estrogens|estrogens|mesh-ancestor
13918232|NCT05320692|Hormones|hormones|mesh-ancestor
13918233|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918234|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918235|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13918236|NCT05320640|Decitabine|decitabine|mesh-list
13918237|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13918238|NCT05320640|Antibodies|antibodies|mesh-list
13918239|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
13918240|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918241|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13918242|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
13918243|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918244|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918245|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918246|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
13918247|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918248|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918249|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
13918250|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918251|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13918252|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918253|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918254|NCT05320406|Leuprolide|leuprolide|mesh-list
13918255|NCT05320406|Relugolix|relugolix|mesh-list
13918256|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13918257|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
13918258|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13918259|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918260|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13918261|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918262|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
13918263|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
13918264|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918265|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13918266|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13918267|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13918268|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918269|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918270|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13918271|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13918272|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088753|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
14088754|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088755|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14088756|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14088757|NCT02472691|Growth Substances|growth substances|mesh-ancestor
14088758|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
13918273|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
13918274|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918275|NCT05320380|Cytarabine|cytarabine|mesh-list
13918276|NCT05320380|Prednisolone|prednisolone|mesh-list
13918277|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14088759|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918278|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
13918279|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13918280|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
13918281|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
13918282|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
13918283|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13918284|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13918285|NCT05320380|Cortisone|cortisone|mesh-list
13918286|NCT05320380|Methotrexate|methotrexate|mesh-list
13918287|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
14760584|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760585|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
14760586|NCT04230031|Daratumumab|daratumumab|mesh-list
14760587|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760588|NCT04221945|Cisplatin|cisplatin|mesh-list
14760589|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
14760590|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760591|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760592|NCT04213404|Spartalizumab|spartalizumab|mesh-list
14760593|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14760594|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760595|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760596|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
14760597|NCT04210115|Leucovorin|leucovorin|mesh-list
14760598|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
13918288|NCT05320380|Fludarabine|fludarabine|mesh-list
13918289|NCT05320380|Daunorubicin|daunorubicin|mesh-list
13918290|NCT05320380|Immunoconjugates|immunoconjugates|mesh-list
13918291|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13918292|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
13918293|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13918294|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
13918295|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13918296|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918297|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13918298|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
13918299|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918300|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918301|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
13918302|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918303|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13918304|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918305|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
13918306|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935512|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14935513|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935514|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
13918307|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13918308|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
13918309|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918310|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918311|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
13918312|NCT05320380|Hormones|hormones|mesh-ancestor
13918313|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918314|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13918315|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
13918316|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
13918317|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918318|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13918319|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13918320|NCT05320380|Protective Agents|protective agents|mesh-ancestor
13918321|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13918322|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13918323|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13918324|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13918325|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14477196|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
14477197|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088760|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088761|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
14935515|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14935516|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14935517|NCT01464034|Growth Substances|growth substances|mesh-ancestor
14935518|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
14477198|NCT02428855|Dasatinib|dasatinib|mesh-list
14935519|NCT01464060|Amoxicillin|amoxicillin|mesh-list
14477199|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760599|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
14088762|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760600|NCT04210115|Calcium|calcium|mesh-list
13918330|NCT05320120|Esketamine|esketamine|mesh-list
13918331|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
13918332|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918333|NCT05320107|Ketamine|ketamine|mesh-list
13918334|NCT05320107|Analgesics|analgesics|mesh-ancestor
13918335|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
13918336|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918337|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918338|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13918339|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13918340|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
13918341|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
13918342|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918343|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13918344|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13918345|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918346|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918347|NCT05320094|Sorbitol|sorbitol|mesh-list
13918348|NCT05320094|Charcoal|charcoal|mesh-list
13918349|NCT05320094|Antidotes|antidotes|mesh-ancestor
13918350|NCT05320094|Protective Agents|protective agents|mesh-ancestor
13918351|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918352|NCT05320094|Cathartics|cathartics|mesh-ancestor
13918353|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13918354|NCT05320068|Vancomycin|vancomycin|mesh-list
13918355|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13918356|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918357|NCT05317416|Lenalidomide|lenalidomide|mesh-list
13918358|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
13918359|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918360|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13918361|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14088763|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088764|NCT02472613|Fluoxetine|fluoxetine|mesh-list
14088765|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13918362|NCT05317416|Growth Substances|growth substances|mesh-ancestor
13918363|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
14088766|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14088767|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14088768|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088769|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088770|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
13918364|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918365|NCT05316220|Mesalamine|mesalamine|mesh-list
13918366|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13918367|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13918368|NCT05316220|Analgesics|analgesics|mesh-ancestor
13918369|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
13918370|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918371|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918372|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918373|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918374|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
13918375|NCT05311813|Enoxaparin|enoxaparin|mesh-list
13918376|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
13918377|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13918378|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13918379|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088771|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088772|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13918380|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918381|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088773|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
14088774|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14088775|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13918382|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918383|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
13918384|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14088776|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13918385|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13918386|NCT05308030|Aspirin|aspirin|mesh-list
13918387|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
13918388|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13918389|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14088777|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088778|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14088779|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14088780|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088781|NCT02472600|Colistin|colistin|mesh-list
14088782|NCT02472600|Polymyxins|polymyxins|mesh-list
13918390|NCT05308030|Analgesics|analgesics|mesh-ancestor
14088783|NCT02472600|Neomycin|neomycin|mesh-list
14088784|NCT02472600|Omeprazole|omeprazole|mesh-list
14088785|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14088786|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088787|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14088788|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088789|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088790|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14088791|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088792|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14088793|NCT02472574|Plasminogen|plasminogen|mesh-list
14088794|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14088795|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14088796|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14760601|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
14760602|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760603|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14760604|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760605|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14760606|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760607|NCT04210115|Antidotes|antidotes|mesh-ancestor
14760608|NCT04210115|Protective Agents|protective agents|mesh-ancestor
14760609|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
14760610|NCT04210115|Vitamins|vitamins|mesh-ancestor
14760611|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
14760612|NCT04200417|Mitomycins|mitomycins|mesh-list
14760613|NCT04200417|Mitomycin|mitomycin|mesh-list
13918391|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
13918392|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918393|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935520|NCT01464060|Metronidazole|metronidazole|mesh-list
14935521|NCT01464060|Clarithromycin|clarithromycin|mesh-list
14935522|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935523|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935524|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14935525|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14935526|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14088797|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088798|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
14088799|NCT02472626|Cytarabine|cytarabine|mesh-list
14088800|NCT02472626|Daunorubicin|daunorubicin|mesh-list
14088801|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088802|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
14088803|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088804|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088805|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
14088806|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918394|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918395|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918396|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13918397|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13918398|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918399|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13918400|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14088807|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088808|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
14088809|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760614|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
14760615|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14935527|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918401|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918402|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
13918403|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13918404|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
13918405|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13918406|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
13918407|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
13960252|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960253|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960254|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13960255|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
13960256|NCT03156179|Calcium|calcium|mesh-list
13960257|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13960258|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960259|NCT03156153|Bumetanide|bumetanide|mesh-list
13960260|NCT03156153|Diuretics|diuretics|mesh-ancestor
14088810|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14088811|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14088812|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14088813|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088814|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
14088815|NCT02472626|Protective Agents|protective agents|mesh-ancestor
14088816|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
14088817|NCT02472626|Vitamins|vitamins|mesh-ancestor
14088818|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
14088819|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
14088820|NCT02472392|Melphalan|melphalan|mesh-list
14088821|NCT02472392|Busulfan|busulfan|mesh-list
14088822|NCT02472392|Fludarabine|fludarabine|mesh-list
14088823|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
14088824|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14088825|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088826|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
14088827|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088828|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088829|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14088830|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
14088831|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088832|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088833|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14088834|NCT02472054|Cyclosporine|cyclosporine|mesh-list
14088835|NCT02472054|Prednisolone|prednisolone|mesh-list
14088836|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14088837|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
14088838|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14088839|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
14088840|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
14088841|NCT02472054|Cyclosporins|cyclosporins|mesh-list
14088842|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14088843|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
14088844|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088845|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088846|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088847|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
14088848|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088849|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
14088850|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088851|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
14088852|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14088853|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14088854|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477200|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14088855|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
14088856|NCT02472054|Hormones|hormones|mesh-ancestor
14088857|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088858|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14088859|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088860|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
14088861|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
14088862|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088863|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088864|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14088865|NCT02472054|Protective Agents|protective agents|mesh-ancestor
14088866|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14088867|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
14088868|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14088869|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088870|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
13918408|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13918409|NCT05306704|Calcifediol|calcifediol|mesh-list
13918410|NCT05306704|Vitamins|vitamins|mesh-ancestor
13918411|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
13918412|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918413|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13918414|NCT05306548|Triamcinolone|triamcinolone|mesh-list
13918415|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13918416|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13918417|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13918418|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918419|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
13918420|NCT05306548|Hormones|hormones|mesh-ancestor
13918421|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918422|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918423|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918424|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
13918425|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918426|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088871|NCT02472080|Gemcitabine|gemcitabine|mesh-list
14088872|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
14088873|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14088874|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
14935528|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935529|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14935530|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14935531|NCT01464099|Insulin|insulin|mesh-list
14935532|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14935533|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
13918427|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
14088875|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088876|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088877|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
13918428|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918429|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
13918430|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
13918431|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
13918432|NCT05303636|Drospirenone|drospirenone|mesh-list
13918433|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13918434|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
13918435|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918436|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918437|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13918438|NCT05303636|Diuretics|diuretics|mesh-ancestor
13918439|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
13918440|NCT05303311|Dexamethasone|dexamethasone|mesh-list
13918441|NCT05303311|Meperidine|meperidine|mesh-list
13918442|NCT05303311|Bupivacaine|bupivacaine|mesh-list
13918443|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918444|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
13918445|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
13918446|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918447|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918448|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13918449|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
13918450|NCT05303311|Hormones|hormones|mesh-ancestor
13918451|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918452|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13918453|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918454|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
13918455|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
13918456|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918457|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
13918458|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13918459|NCT05303311|Narcotics|narcotics|mesh-ancestor
13918460|NCT05303311|Analgesics|analgesics|mesh-ancestor
13918461|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13918462|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
13918463|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13918464|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13918465|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918466|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
13918467|NCT05302986|Coagulants|coagulants|mesh-ancestor
14088878|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935534|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
13918468|NCT05302284|Gemcitabine|gemcitabine|mesh-list
13918469|NCT05302284|Carboplatin|carboplatin|mesh-list
14088879|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088880|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088881|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
14088882|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088883|NCT02472249|Norepinephrine|norepinephrine|mesh-list
14088884|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14088885|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14088886|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
14088887|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088888|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918470|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918471|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13918472|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
13918473|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918474|NCT05302284|Antiviral Agents|antiviral agents|mesh-ancestor
13918475|NCT05302284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918476|NCT05302284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918477|NCT05302284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918478|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
13918479|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918480|NCT05301842|Durvalumab|durvalumab|mesh-list
13918481|NCT05301842|Lenvatinib|lenvatinib|mesh-list
14088889|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088890|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
14088891|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
13918482|NCT05301842|Tremelimumab|tremelimumab|mesh-list
13918483|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918484|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918485|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13918486|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918487|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918488|NCT05294341|Norethindrone|norethindrone|mesh-list
13918489|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
13918490|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13918491|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13918492|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13918493|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
14088892|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088893|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14088894|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
14088895|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14088896|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14088897|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088898|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
14088899|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14088900|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088901|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
14088902|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
13918494|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13918495|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760616|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760617|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
14760618|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760619|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14760620|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760621|NCT04199117|Nicotine|nicotine|mesh-list
14760622|NCT04199117|Varenicline|varenicline|mesh-list
14760623|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13918496|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13918497|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13918498|NCT05289908|Folic Acid|folic acid|mesh-list
13918499|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
13918500|NCT05289908|Hydroxocobalamin|hydroxocobalamin|mesh-list
13918501|NCT05289908|Dexamethasone|dexamethasone|mesh-list
13918502|NCT05289908|Pemetrexed|pemetrexed|mesh-list
13918503|NCT05289908|Vitamins|vitamins|mesh-ancestor
14088903|NCT02472275|Hormones|hormones|mesh-list
14088904|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14088905|NCT02472275|Androgens|androgens|mesh-list
14088906|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
14088907|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088908|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088909|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
13918504|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
14174084|NCT04790734|Sensory System Agents|sensory system agents|mesh-ancestor
13960261|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
13918505|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918506|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918507|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
13918508|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
14760624|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
14760625|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918509|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918510|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088910|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088911|NCT02472275|Protective Agents|protective agents|mesh-ancestor
14088912|NCT02472275|Vitamins|vitamins|mesh-ancestor
14088913|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
14088914|NCT02472275|Estrogens|estrogens|mesh-ancestor
14088915|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14088916|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088917|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
14088918|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
14088919|NCT02472236|Digoxin|digoxin|mesh-list
14088920|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14088921|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14088922|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088923|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088924|NCT02472236|Protective Agents|protective agents|mesh-ancestor
14088925|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088926|NCT02471963|Empagliflozin|empagliflozin|mesh-list
14088927|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14088928|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918511|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
13918512|NCT05289908|Hormones|hormones|mesh-ancestor
13918513|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918514|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13918515|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918516|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918517|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918518|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13918519|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13918520|NCT05289908|Hematinics|hematinics|mesh-ancestor
13918521|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
13918522|NCT05289050|Ketamine|ketamine|mesh-list
13918523|NCT05289050|Esketamine|esketamine|mesh-list
13918524|NCT05289050|Analgesics|analgesics|mesh-ancestor
13918525|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
13918526|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918527|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918528|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13918529|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13918530|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
13918531|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
14088929|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14088930|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088931|NCT02471833|Telmisartan|telmisartan|mesh-list
14088932|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14088933|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14088934|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14088935|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088936|NCT02471820|Dexamethasone|dexamethasone|mesh-list
14088937|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
13918532|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918533|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13918534|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14088938|NCT02471820|Doxorubicin|doxorubicin|mesh-list
14088939|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14088940|NCT02471820|Lenalidomide|lenalidomide|mesh-list
14088941|NCT02471820|BB 1101|bb 1101|mesh-list
14088942|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14088943|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
14088944|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
14088945|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14088946|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088947|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14088948|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
14088949|NCT02471820|Hormones|hormones|mesh-ancestor
14088950|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918535|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477201|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918536|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918537|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
13918538|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918539|NCT05283161|Dronabinol|dronabinol|mesh-list
13918540|NCT05283161|Cannabidiol|cannabidiol|mesh-list
13918541|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
13918542|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
13918543|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918544|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918545|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13918546|NCT05283161|Analgesics|analgesics|mesh-ancestor
13918547|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
13918548|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918549|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13918550|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13918551|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918552|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918553|NCT05283161|Hormones|hormones|mesh-ancestor
13918554|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918555|NCT05278858|Triamcinolone|triamcinolone|mesh-list
13918556|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918557|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
13918558|NCT05278858|Hormones|hormones|mesh-ancestor
13918559|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088951|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14088952|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088953|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
14088954|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088955|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088956|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14088957|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14088958|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14088959|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
14088960|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14088961|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14088962|NCT02471820|Growth Substances|growth substances|mesh-ancestor
14088963|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14088964|NCT02471950|Isoflurane|isoflurane|mesh-list
14088965|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14088966|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
14088967|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
14088968|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14088969|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088970|NCT02471690|Oritavancin|oritavancin|mesh-list
14088971|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14088972|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14088973|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14088974|NCT02471677|Hormones|hormones|mesh-ancestor
14088975|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14088976|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088977|NCT02471846|Atezolizumab|atezolizumab|mesh-list
14088978|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088979|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14088980|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
14760626|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760627|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13918560|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918561|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
13918562|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
13918563|NCT05269381|Sargramostim|sargramostim|mesh-list
13918564|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918565|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
13918566|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918567|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918568|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13918569|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
13918570|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088981|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14088982|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
14760628|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14760629|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
14760630|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14760631|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760632|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
13918571|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918572|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13918573|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918574|NCT05265728|Natalizumab|natalizumab|mesh-list
13918575|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
13918576|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918577|NCT05262764|Empagliflozin|empagliflozin|mesh-list
13918578|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13918579|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918580|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13918581|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918582|NCT05260528|Cytarabine|cytarabine|mesh-list
13918583|NCT05260528|Idarubicin|idarubicin|mesh-list
13918584|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13918585|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
13918586|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918587|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918588|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
13918589|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918590|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918591|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
13918592|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918593|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14088983|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088984|NCT02471547|Mitomycins|mitomycins|mesh-list
14088985|NCT02471547|Mitomycin|mitomycin|mesh-list
14088986|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14088987|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088988|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
14088989|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088990|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14088991|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14088992|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14088993|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14088994|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14088995|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14088996|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14088997|NCT02471391|Venetoclax|venetoclax|mesh-list
14088998|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14088999|NCT02471430|Interferons|interferons|mesh-list
14089000|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
14089001|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
14089002|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14089003|NCT02471430|Panobinostat|panobinostat|mesh-list
14089004|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089005|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
14089006|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089007|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
14477202|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477203|NCT02429258|Metformin|metformin|mesh-list
14477204|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
14477205|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14477206|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477207|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14477208|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477209|NCT02429427|Celecoxib|celecoxib|mesh-list
14089008|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089009|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14089010|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089011|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089012|NCT02471209|Sevoflurane|sevoflurane|mesh-list
14089013|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
14477210|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14089014|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089015|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089016|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14089017|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14089018|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
14174085|NCT04790734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174086|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14174087|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
14174088|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14174089|NCT04790383|Protective Agents|protective agents|mesh-ancestor
14174090|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183547|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
14183548|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183549|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
14183550|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14183551|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
14183552|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14183553|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14183554|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183555|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14183556|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14183557|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13918594|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13918595|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13918596|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183558|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183559|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
14183560|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183561|NCT04727034|Propofol|propofol|mesh-list
14183562|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13918609|NCT05231603|Ivermectin|ivermectin|mesh-list
13918610|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13918611|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183563|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183564|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183565|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14183566|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
14183567|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
14183568|NCT04726982|Acetazolamide|acetazolamide|mesh-list
14183569|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
14183570|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14183571|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183572|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183573|NCT04726982|Diuretics|diuretics|mesh-ancestor
14183574|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
13918612|NCT05211635|Vitamin D|vitamin d|mesh-list
13918613|NCT05211635|Vitamins|vitamins|mesh-ancestor
13918614|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
13918615|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918616|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13918617|NCT05202145|Cyclosporine|cyclosporine|mesh-list
13918618|NCT05202145|Tacrolimus|tacrolimus|mesh-list
13918619|NCT05202145|Cyclosporins|cyclosporins|mesh-list
13918620|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918621|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
13918622|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918623|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13918624|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918625|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918626|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
13918627|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918628|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
13918629|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918630|NCT05198362|Metoprolol|metoprolol|mesh-list
13918631|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13918632|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13918633|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
13918634|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
13918635|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918636|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918637|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13918638|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13918639|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13918640|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
13918641|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918642|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918643|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
13918644|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
13918645|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918646|NCT05184335|RP5063|rp5063|mesh-list
13918647|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13918648|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13918649|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918650|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918651|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918652|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
13918653|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918654|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089019|NCT02471105|Bimatoprost|bimatoprost|mesh-list
14089020|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14089021|NCT02470832|Itraconazole|itraconazole|mesh-list
14089022|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
14089023|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089024|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14089025|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14089026|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089027|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089028|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14089029|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
14089030|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089031|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089032|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14089033|NCT02470923|Nicotine|nicotine|mesh-list
13918655|NCT05162027|Erenumab|erenumab|mesh-list
13918656|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
13918657|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918658|NCT05162027|Analgesics|analgesics|mesh-ancestor
13918659|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
13918660|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918661|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960262|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960263|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13960264|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13960265|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960266|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
13960267|NCT03156062|Salicylates|salicylates|mesh-list
13960268|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960269|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
13960270|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
13960271|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960272|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13960273|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13960274|NCT03156062|Analgesics|analgesics|mesh-ancestor
13960275|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
13960276|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960277|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960278|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960279|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14089034|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14089035|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
14089036|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089037|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089038|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14089039|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14089040|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
13918662|NCT05147415|Metoprolol|metoprolol|mesh-list
13918663|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13918664|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13918665|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
13918666|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
13918667|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918668|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918669|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13918670|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13918671|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13918672|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
13918673|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918674|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918675|NCT05142228|Erenumab|erenumab|mesh-list
13918676|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
13918677|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918678|NCT05142228|Analgesics|analgesics|mesh-ancestor
13918679|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
13918680|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918681|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918682|NCT05140499|Bupivacaine|bupivacaine|mesh-list
13918683|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
13918684|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
13918685|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918686|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918687|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
13918688|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918689|NCT05132075|Docetaxel|docetaxel|mesh-list
13918690|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918691|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
13918692|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
13918693|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
13918694|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918695|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
13918696|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13918697|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
13918698|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918699|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918700|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14089041|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089042|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089043|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
14089044|NCT02470858|Asunaprevir|asunaprevir|mesh-list
14089045|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
14089046|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089047|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
14089048|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089049|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089050|NCT02470780|Rifaximin|rifaximin|mesh-list
14089051|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14089052|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089053|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089054|NCT02470767|Anticoagulants|anticoagulants|mesh-list
13918701|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
13918702|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13918703|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
13918704|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918705|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918706|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13918707|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
13918708|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
13918709|NCT05109611|Protective Agents|protective agents|mesh-ancestor
13918710|NCT05108259|Adalimumab|adalimumab|mesh-list
13918711|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918712|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918713|NCT05102552|Huperzine A|huperzine a|mesh-list
13918714|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14089055|NCT02470611|Alendronate|alendronate|mesh-list
14089056|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14089057|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089058|NCT02470559|Aldesleukin|aldesleukin|mesh-list
14089059|NCT02470559|Interleukin-2|interleukin-2|mesh-list
14089060|NCT02470559|Sargramostim|sargramostim|mesh-list
14089061|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14089062|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918715|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918716|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918717|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
13918718|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918719|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918720|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13918721|NCT05102552|Protective Agents|protective agents|mesh-ancestor
13918722|NCT05102071|Metformin|metformin|mesh-list
13918723|NCT05102071|Empagliflozin|empagliflozin|mesh-list
13918724|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13918725|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918726|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13918727|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918728|NCT05063734|Aflibercept|aflibercept|mesh-list
13918729|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13918730|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13918731|NCT05063734|Growth Substances|growth substances|mesh-ancestor
13918732|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918733|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
13918734|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089063|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14089064|NCT02470559|Analgesics|analgesics|mesh-ancestor
14089065|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
14089066|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089067|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089068|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
14089069|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14089070|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14089071|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
14089072|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089073|NCT02470637|Insulin|insulin|mesh-list
14089074|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14089075|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
14089076|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14089077|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089078|NCT02470650|Ritonavir|ritonavir|mesh-list
14089079|NCT02470650|Darunavir|darunavir|mesh-list
14089080|NCT02470650|Tenofovir|tenofovir|mesh-list
14089081|NCT02470650|Lamivudine|lamivudine|mesh-list
14089082|NCT02470650|Emtricitabine|emtricitabine|mesh-list
14089083|NCT02470650|Abacavir|abacavir|mesh-list
14089084|NCT02470650|Cobicistat|cobicistat|mesh-list
13918735|NCT05062577|Buprenorphine|buprenorphine|mesh-list
13918736|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13918737|NCT05062577|Naloxone|naloxone|mesh-list
14089085|NCT02470650|Rilpivirine|rilpivirine|mesh-list
14089086|NCT02470650|Elvitegravir|elvitegravir|mesh-list
14089087|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14089088|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14089089|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
14089090|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089091|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089092|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14089093|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14089094|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
14089095|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089096|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14089097|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14089098|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14089099|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14089100|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14089101|NCT02470702|Oritavancin|oritavancin|mesh-list
14089102|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14089103|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089104|NCT02470676|Progesterone|progesterone|mesh-list
14089105|NCT02470676|Progestins|progestins|mesh-ancestor
14089106|NCT02470676|Hormones|hormones|mesh-ancestor
14935535|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14935536|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14935537|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918738|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13918739|NCT05062577|Narcotics|narcotics|mesh-ancestor
13918740|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918741|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918742|NCT05062577|Analgesics|analgesics|mesh-ancestor
13918743|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
13918744|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918745|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13918746|NCT05061134|Durvalumab|durvalumab|mesh-list
13918747|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918748|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918749|NCT05049226|Vaccines|vaccines|mesh-list
13918750|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
13918751|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918752|NCT05047770|Vaccines|vaccines|mesh-list
13918753|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
13918754|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918755|NCT05045703|Vitamin A|vitamin a|mesh-list
13918756|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
13918757|NCT05045703|Vitamins|vitamins|mesh-ancestor
13918758|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
13918759|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918760|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
13918761|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918762|NCT05045703|Protective Agents|protective agents|mesh-ancestor
14935538|NCT01464112|Dexamethasone|dexamethasone|mesh-list
14089107|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089108|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089109|NCT02470442|Sevoflurane|sevoflurane|mesh-list
14089110|NCT02470442|Desflurane|desflurane|mesh-list
14089111|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14089112|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14089113|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
14089114|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
14089115|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089116|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089117|NCT02470455|Atorvastatin|atorvastatin|mesh-list
14089118|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14089119|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13918763|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13918764|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918765|NCT05045378|Midazolam|midazolam|mesh-list
13918766|NCT05045378|Ketamine|ketamine|mesh-list
13918767|NCT05045378|Analgesics|analgesics|mesh-ancestor
13918768|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
13918769|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918770|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918771|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13918772|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13918773|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
13918774|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
13918775|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918776|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14089120|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
14089121|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089122|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14089123|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14089124|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089125|NCT02470546|Metformin|metformin|mesh-list
14089126|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14089127|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089128|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
14089129|NCT02470663|Calcium|calcium|mesh-list
14089130|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14089131|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089132|NCT02470663|Antacids|antacids|mesh-ancestor
14089133|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089134|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089135|NCT02470299|Ketorolac|ketorolac|mesh-list
14089136|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13918777|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13918778|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935539|NCT01464112|Bortezomib|bortezomib|mesh-list
14935540|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918779|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918780|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13918781|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13918782|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13918783|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14089137|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14089138|NCT02470299|Analgesics|analgesics|mesh-ancestor
14089139|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
14089140|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089141|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089142|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14089143|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14089144|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14089145|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089146|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089147|NCT02470117|Antacids|antacids|mesh-list
13918784|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918785|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
13918786|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
14760633|NCT04199104|Lenvatinib|lenvatinib|mesh-list
14760634|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760635|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760636|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760637|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760638|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760639|NCT04196257|Paclitaxel|paclitaxel|mesh-list
14760640|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760641|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760642|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
14935541|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
14935542|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
13918806|NCT04998279|Sargramostim|sargramostim|mesh-list
14089148|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089149|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089150|NCT02470065|Afatinib|afatinib|mesh-list
14935543|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918807|NCT04998279|Lenograstim|lenograstim|mesh-list
14089151|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089152|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13918808|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
13918809|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918810|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13960280|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13960281|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960282|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960283|NCT03156231|Acetazolamide|acetazolamide|mesh-list
13960284|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
13960285|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13960286|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960287|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960288|NCT03156231|Diuretics|diuretics|mesh-ancestor
13960289|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
13960290|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960291|NCT03155971|Paclitaxel|paclitaxel|mesh-list
13960292|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14089153|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960293|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089154|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918811|NCT04984889|Protein C|protein c|mesh-list
13918812|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
13918813|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13918814|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13918815|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918816|NCT04977830|Xenon|xenon|mesh-list
13918817|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14477211|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14477212|NCT02429427|Analgesics|analgesics|mesh-ancestor
14477213|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
14477214|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477215|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477216|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13918818|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
13918819|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
13918820|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918821|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089155|NCT02470026|Yohimbine|yohimbine|mesh-list
14089156|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
14089157|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
14089158|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089159|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089160|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14089161|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14089162|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14089163|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089164|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477217|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477218|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14477219|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14477220|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477221|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477222|NCT02429869|Everolimus|everolimus|mesh-list
14477223|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477224|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14089165|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089166|NCT02470026|Urological Agents|urological agents|mesh-ancestor
14089167|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
14089168|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14089169|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14089170|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14089171|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089172|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089173|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
14089174|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089175|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089176|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14089177|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089178|NCT02469974|Busulfan|busulfan|mesh-list
14089179|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
14089180|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089181|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
14089182|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089183|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14089184|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14089185|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089186|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14089187|NCT02469831|Rocuronium|rocuronium|mesh-list
14089188|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14089189|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14089190|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14089191|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089192|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089193|NCT02469740|Clopidogrel|clopidogrel|mesh-list
14089194|NCT02469740|Ticagrelor|ticagrelor|mesh-list
14089195|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14089196|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14089197|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14089198|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14089199|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
14089200|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089201|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477225|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
14089202|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089203|NCT02469545|Citalopram|citalopram|mesh-list
14089204|NCT02469545|Sertraline|sertraline|mesh-list
14089205|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14089206|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14089207|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089208|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089209|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089210|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
14089211|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477226|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477227|NCT02429934|Abatacept|abatacept|mesh-list
14477228|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14477229|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918826|NCT04966481|Cetuximab|cetuximab|mesh-list
13918827|NCT04966481|Palbociclib|palbociclib|mesh-list
13918828|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918829|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089212|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14089213|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
14089214|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14174091|NCT04790708|Octreotide|octreotide|mesh-list
14174092|NCT04790708|Edotreotide|edotreotide|mesh-list
14174093|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14174094|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174095|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174096|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14174097|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174098|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
14174099|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
14174100|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
13918830|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13918831|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918832|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477230|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477231|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477232|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
14477233|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477234|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13918833|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13918834|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13918835|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
13918836|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918837|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918838|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13918839|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
13918840|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
13918841|NCT04946630|Hormones|hormones|mesh-ancestor
13918842|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918843|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
13918844|NCT04929223|Bevacizumab|bevacizumab|mesh-list
13918845|NCT04929223|Cetuximab|cetuximab|mesh-list
13918846|NCT04929223|Atezolizumab|atezolizumab|mesh-list
13918847|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918848|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174101|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14174102|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
14174103|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
14174104|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174105|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174106|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174107|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14174108|NCT04790448|Irinotecan|irinotecan|mesh-list
14174109|NCT04790448|Camptothecin|camptothecin|mesh-list
14174110|NCT04790448|Cetuximab|cetuximab|mesh-list
14174111|NCT04790448|Vemurafenib|vemurafenib|mesh-list
14174112|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14174113|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14174114|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174115|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174116|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174117|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477235|NCT02430090|Fentanyl|fentanyl|mesh-list
13918849|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14477236|NCT02430090|Sufentanil|sufentanil|mesh-list
13918850|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13918851|NCT04929223|Growth Substances|growth substances|mesh-ancestor
13918852|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918853|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
14089215|NCT02469259|Oxytocin|oxytocin|mesh-list
14089216|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
14089217|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14089218|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089219|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
14089220|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14089221|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14089222|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089223|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
14089224|NCT02468999|Insulin|insulin|mesh-list
14089225|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14089226|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14089227|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089228|NCT02469012|Ribavirin|ribavirin|mesh-list
14089229|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
13918854|NCT04927312|Metronidazole|metronidazole|mesh-list
13918855|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918856|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13918857|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13918858|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13918859|NCT04915950|APD791|apd791|mesh-list
13918860|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13918861|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13918862|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
13918863|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918864|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918865|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918866|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
13918867|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918868|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918869|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
13918870|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918871|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918872|NCT04905121|Psilocybin|psilocybin|mesh-list
13918873|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
13918874|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918875|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918876|NCT04882085|Ceftazidime|ceftazidime|mesh-list
13918877|NCT04882085|Avibactam|avibactam|mesh-list
13918878|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
13918879|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14089230|NCT02469012|Ledipasvir|ledipasvir|mesh-list
14089231|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
14089232|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089233|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
13918880|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918881|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13918882|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918883|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918884|NCT04865419|Voriconazole|voriconazole|mesh-list
13918885|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
13918886|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918887|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13918888|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13918889|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918890|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918891|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13918892|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
13918893|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089234|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089235|NCT02468856|Modafinil|modafinil|mesh-list
14089236|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14089237|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089238|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14089239|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14089240|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14089241|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089242|NCT02468908|Molgramostim|molgramostim|mesh-list
14089243|NCT02468908|Sargramostim|sargramostim|mesh-list
14089244|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
14089245|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089246|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089247|NCT02468791|Rituximab|rituximab|mesh-list
14089248|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14089249|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089250|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
14089251|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089252|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14089253|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14089254|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089255|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14089256|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089257|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089258|NCT02468518|Vitamin E|vitamin e|mesh-list
14089259|NCT02468518|Vitamins|vitamins|mesh-ancestor
14089260|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
14089261|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089262|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
14089263|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089264|NCT02468518|Protective Agents|protective agents|mesh-ancestor
14089265|NCT02468531|Xenon|xenon|mesh-list
14089266|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14089267|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
13918894|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918895|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13960294|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
13960295|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
13960296|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
13960297|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960298|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
13960299|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
13960300|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13960301|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13960302|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960303|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13960304|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13960305|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960306|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960307|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960308|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13960309|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
13960310|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14089268|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
14089269|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960311|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960312|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13960313|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13960314|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13960315|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
13960316|NCT03155984|Antibodies|antibodies|mesh-list
13960317|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
13960318|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960319|NCT03155568|Bupivacaine|bupivacaine|mesh-list
13960320|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
13960321|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
13960322|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960323|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960324|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
13960325|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960326|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
13960327|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13960328|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960329|NCT03155477|Vitamins|vitamins|mesh-ancestor
13960330|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
13960331|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13960332|NCT03155646|Clonidine|clonidine|mesh-list
13960333|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
13960334|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
13960335|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13960336|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960337|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960338|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13960339|NCT03155646|Analgesics|analgesics|mesh-ancestor
13960340|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
14089270|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089271|NCT02468323|Ondansetron|ondansetron|mesh-list
13918896|NCT04821622|Talazoparib|talazoparib|mesh-list
13918897|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13918898|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918899|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918900|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918901|NCT04818632|Everolimus|everolimus|mesh-list
13918902|NCT04818632|Palbociclib|palbociclib|mesh-list
13918903|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918904|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13918905|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
13918906|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918907|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14935544|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935545|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14935546|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
14935547|NCT01464112|Hormones|hormones|mesh-ancestor
14935548|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935549|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14935550|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935551|NCT01464125|Azithromycin|azithromycin|mesh-list
14935552|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
14935553|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935554|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935555|NCT01464138|Clindamycin|clindamycin|mesh-list
14935556|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
14935557|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
14935558|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
14935559|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14935560|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918908|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918909|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918910|NCT04812548|Azacitidine|azacitidine|mesh-list
13918911|NCT04812548|Venetoclax|venetoclax|mesh-list
13918912|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13918913|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
13918914|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918915|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918916|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918917|NCT04796363|Anesthetics|anesthetics|mesh-list
13918918|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918919|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918920|NCT04774094|Ceftazidime|ceftazidime|mesh-list
13918921|NCT04774094|Avibactam|avibactam|mesh-list
13918922|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
13918923|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13918924|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918925|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14089272|NCT02468323|Palonosetron|palonosetron|mesh-list
14089273|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
14089274|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
14089275|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089276|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089277|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089278|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
14935561|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14935562|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935563|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935564|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14089279|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14089280|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14089281|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
14089282|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089283|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089284|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14089285|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14089286|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089287|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14089288|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14089289|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14089290|NCT02468297|Ibuprofen|ibuprofen|mesh-list
14089291|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13918926|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918927|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918928|NCT04768166|Miglustat|miglustat|mesh-list
13918929|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918930|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918931|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14089292|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14089293|NCT02468297|Analgesics|analgesics|mesh-ancestor
14089294|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
14089295|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089296|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089297|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14089298|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14089299|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14760643|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
14760644|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760645|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760646|NCT04188873|Varenicline|varenicline|mesh-list
14760647|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14760648|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918932|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14089300|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089301|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089302|NCT02468375|Mirabegron|mirabegron|mesh-list
14089303|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14089304|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14089305|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14089306|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089307|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089308|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089309|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089310|NCT02468375|Urological Agents|urological agents|mesh-ancestor
14089311|NCT02468232|Enalapril|enalapril|mesh-list
14089312|NCT02468232|Enalaprilat|enalaprilat|mesh-list
14089313|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14089314|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14089315|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
14089316|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089317|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089318|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14089319|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14089320|NCT02468206|Polidocanol|polidocanol|mesh-list
14089321|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14089322|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14089323|NCT02468128|Nalbuphine|nalbuphine|mesh-list
14089324|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14089325|NCT02468128|Narcotics|narcotics|mesh-ancestor
14089326|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089327|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089328|NCT02468128|Analgesics|analgesics|mesh-ancestor
14089329|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
14089330|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089331|NCT02468089|Sargramostim|sargramostim|mesh-list
14089332|NCT02468089|Immunologic Factors|immunologic factors|mesh-ancestor
14089333|NCT02468089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089334|NCT02468063|Terlipressin|terlipressin|mesh-list
13918933|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
13918934|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13918935|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13918936|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13918937|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918938|NCT04760041|Midazolam|midazolam|mesh-list
13918939|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13918940|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13918941|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13918942|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918943|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13918944|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13918945|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918946|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14089335|NCT02468063|Norepinephrine|norepinephrine|mesh-list
14089336|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14089337|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14089338|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14089339|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14760649|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760650|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14760651|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14760652|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
14760653|NCT04181827|Dexamethasone|dexamethasone|mesh-list
14760654|NCT04181827|Bortezomib|bortezomib|mesh-list
14760655|NCT04181827|Daratumumab|daratumumab|mesh-list
14760656|NCT04181827|Pomalidomide|pomalidomide|mesh-list
13918947|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
13918948|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
13918949|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
13918950|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
13918951|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918952|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918953|NCT04754035|Venetoclax|venetoclax|mesh-list
13918954|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760657|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760658|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
14760659|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
14760660|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760661|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760662|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089340|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089341|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089342|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089343|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089344|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
14089345|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
14089346|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089347|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
14089348|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14089349|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
14089350|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14089351|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
14089352|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089353|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089354|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
14089355|NCT02468167|Polidocanol|polidocanol|mesh-list
14089356|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14089357|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14089358|NCT02467907|Paclitaxel|paclitaxel|mesh-list
14089359|NCT02467907|Bevacizumab|bevacizumab|mesh-list
14089360|NCT02467907|Carboplatin|carboplatin|mesh-list
14089361|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14089362|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089363|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14089364|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14089365|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14089366|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089367|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14089368|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14089369|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14089370|NCT02467907|Growth Substances|growth substances|mesh-ancestor
14089371|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089372|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
14089373|NCT02467920|Exenatide|exenatide|mesh-list
14760663|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
13918961|NCT04746235|Decitabine|decitabine|mesh-list
14089374|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14089375|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918962|NCT04746235|Venetoclax|venetoclax|mesh-list
13918963|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13918964|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
14089376|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14089377|NCT02467920|Incretins|incretins|mesh-ancestor
14089378|NCT02467920|Hormones|hormones|mesh-ancestor
14089379|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089380|NCT02467647|Thalidomide|thalidomide|mesh-list
14089381|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14089382|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
13918965|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918966|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918967|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13918968|NCT04734080|Dronabinol|dronabinol|mesh-list
13918969|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
13918970|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918971|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13918972|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13918973|NCT04734080|Analgesics|analgesics|mesh-ancestor
13918974|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
13918975|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13918976|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13918977|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13918978|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13918979|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13918980|NCT04734080|Hormones|hormones|mesh-ancestor
13918981|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13918982|NCT04732286|Bevacizumab|bevacizumab|mesh-list
13918983|NCT04732286|Atezolizumab|atezolizumab|mesh-list
14089383|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089384|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
14089385|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14089386|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089387|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14089388|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14089389|NCT02467647|Growth Substances|growth substances|mesh-ancestor
14089390|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
14089391|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089392|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
14089393|NCT02467426|Analgesics|analgesics|mesh-ancestor
14089394|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
14760664|NCT04181827|Hormones|hormones|mesh-ancestor
14760665|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760666|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760667|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760668|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
14760669|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14760670|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14760671|NCT04181827|Growth Substances|growth substances|mesh-ancestor
14089395|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089396|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760672|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
14760673|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
14089397|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089398|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14089399|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14089400|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089401|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089402|NCT02467478|Linagliptin|linagliptin|mesh-list
14089403|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14089404|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089405|NCT02467478|Incretins|incretins|mesh-ancestor
14089406|NCT02467478|Hormones|hormones|mesh-ancestor
14089407|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14477237|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
14760674|NCT04176783|Narcotics|narcotics|mesh-ancestor
14935565|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
13918984|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13918985|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13918986|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13918987|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13918988|NCT04732286|Growth Substances|growth substances|mesh-ancestor
13918989|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13918990|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
14477238|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14477239|NCT02430090|Narcotics|narcotics|mesh-ancestor
14477240|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477241|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477242|NCT02430090|Analgesics|analgesics|mesh-ancestor
14477243|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
14477244|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089408|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14089409|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
14089410|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089411|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089412|NCT02467556|Morphine|morphine|mesh-list
14089413|NCT02467556|Memantine|memantine|mesh-list
14089414|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14089415|NCT02467556|Narcotics|narcotics|mesh-ancestor
14089416|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089417|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089418|NCT02467556|Analgesics|analgesics|mesh-ancestor
14089419|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
14089420|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089421|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14477245|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13918999|NCT04718181|Omeprazole|omeprazole|mesh-list
13919000|NCT04718181|Risdiplam|risdiplam|mesh-list
13919001|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13919002|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089422|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14089423|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
14089424|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089425|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089426|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14089427|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14089428|NCT02467595|Fentanyl|fentanyl|mesh-list
14089429|NCT02467595|Bromides|bromides|mesh-list
14089430|NCT02467595|Propofol|propofol|mesh-list
14089431|NCT02467595|Sevoflurane|sevoflurane|mesh-list
14089432|NCT02467595|Rocuronium|rocuronium|mesh-list
14089433|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14089434|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089435|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089436|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14089437|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
14089438|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
14089439|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14089440|NCT02467595|Narcotics|narcotics|mesh-ancestor
14089441|NCT02467595|Analgesics|analgesics|mesh-ancestor
14089442|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
14089443|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089444|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13919003|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13919004|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919005|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919006|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13919007|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919008|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919009|NCT04712643|Atezolizumab|atezolizumab|mesh-list
13919010|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919011|NCT04684511|Rofecoxib|rofecoxib|mesh-list
13919012|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13919013|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13919014|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919015|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919016|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14089445|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13919017|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14089446|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14089447|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
14089448|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14477246|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14089449|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14089450|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14174118|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174119|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14174120|NCT04790331|Verapamil|verapamil|mesh-list
14174121|NCT04790331|Diltiazem|diltiazem|mesh-list
14174122|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14174123|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14174124|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174125|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174126|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14174127|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174128|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
14174129|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14174130|NCT04790136|Cannabidiol|cannabidiol|mesh-list
14174131|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
14174132|NCT04790279|Amlodipine|amlodipine|mesh-list
14174133|NCT04790279|Nifedipine|nifedipine|mesh-list
14174134|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14174135|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14174136|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174137|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174138|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14174139|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174140|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
14174141|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
14174142|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13919018|NCT04684511|Analgesics|analgesics|mesh-ancestor
13919019|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
13919020|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919021|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919022|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919023|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919024|NCT04661150|Capecitabine|capecitabine|mesh-list
13919025|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
13919026|NCT04661150|Trastuzumab|trastuzumab|mesh-list
13919027|NCT04661150|Atezolizumab|atezolizumab|mesh-list
13919028|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13919029|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
13919030|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919031|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919032|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919033|NCT04650984|Doxorubicin|doxorubicin|mesh-list
13919034|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13919035|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919036|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13919037|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13919038|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919039|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919040|NCT04642404|Cannabidiol|cannabidiol|mesh-list
13919041|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
13919042|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
13919043|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13919044|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
13919045|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919046|NCT04628429|Erenumab|erenumab|mesh-list
13919047|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
13919048|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919049|NCT04628429|Analgesics|analgesics|mesh-ancestor
13919050|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
13919051|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919052|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174143|NCT04789941|Irinotecan|irinotecan|mesh-list
14477247|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
14760675|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14760676|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760677|NCT04176783|Analgesics|analgesics|mesh-ancestor
14760678|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
14760679|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760680|NCT04176172|Nicotine|nicotine|mesh-list
14760681|NCT04176172|Varenicline|varenicline|mesh-list
14760682|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14760683|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
13919053|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
13919054|NCT04622007|Pemetrexed|pemetrexed|mesh-list
14089451|NCT02467543|Ethanol|ethanol|mesh-list
14089452|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14089453|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089454|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089455|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089456|NCT02467686|Tamoxifen|tamoxifen|mesh-list
14089457|NCT02467686|Exemestane|exemestane|mesh-list
14089458|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14089459|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14089460|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
14935566|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13919055|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919056|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919057|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919058|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919059|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13919060|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13919061|NCT04614714|Niacinamide|niacinamide|mesh-list
13919062|NCT04614714|Niacin|niacin|mesh-list
13919063|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
13919064|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
13919065|NCT04614714|Vitamins|vitamins|mesh-ancestor
13919066|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
13919067|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919068|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13919069|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
13919070|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919071|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13919072|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
13919073|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
13919074|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919075|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477248|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
14477249|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
14477250|NCT02430311|Paclitaxel|paclitaxel|mesh-list
14477251|NCT02430311|Olaparib|olaparib|mesh-list
14477252|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14477253|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477254|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14477255|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
13960341|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960342|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13960343|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13960344|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13960345|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960346|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960347|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960348|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
13960349|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
14935567|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935568|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935569|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935570|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14935571|NCT01464242|Protective Agents|protective agents|mesh-ancestor
13960350|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13960351|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
13960352|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
13960353|NCT03155087|Metformin|metformin|mesh-list
13960354|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960355|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963362|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963363|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
13963364|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963365|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963366|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963367|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
13963368|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963369|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
13963370|NCT03145025|Hormones|hormones|mesh-ancestor
13963371|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963372|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963373|NCT03144947|Docetaxel|docetaxel|mesh-list
13963374|NCT03144947|Trastuzumab|trastuzumab|mesh-list
13963375|NCT03144947|Pertuzumab|pertuzumab|mesh-list
14174144|NCT04789941|Cisplatin|cisplatin|mesh-list
14477256|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919084|NCT04570631|Dexamethasone|dexamethasone|mesh-list
13919085|NCT04570631|Bortezomib|bortezomib|mesh-list
13919086|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919087|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
13919088|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
13919089|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919090|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919091|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919092|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
13919093|NCT04570631|Hormones|hormones|mesh-ancestor
13919094|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919095|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919096|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919097|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
13919098|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13919099|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
13919100|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919101|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
13919102|NCT04557527|Protective Agents|protective agents|mesh-ancestor
14089461|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089462|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089463|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14089464|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089465|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14089466|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14089467|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14089468|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14089469|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089470|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089471|NCT02467335|Fostemsavir|fostemsavir|mesh-list
14089472|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14089473|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14089474|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
14089475|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089476|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14089477|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14089478|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089479|NCT02467400|Propranolol|propranolol|mesh-list
14089480|NCT02467400|Atenolol|atenolol|mesh-list
14089481|NCT02467400|Nebivolol|nebivolol|mesh-list
14089482|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14089483|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14089484|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089485|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089486|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089487|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089488|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13919103|NCT04550260|Cisplatin|cisplatin|mesh-list
13919104|NCT04550260|Fluorouracil|fluorouracil|mesh-list
13919105|NCT04550260|Capecitabine|capecitabine|mesh-list
13919106|NCT04550260|Durvalumab|durvalumab|mesh-list
13919107|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919108|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
13919109|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919110|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13919111|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919112|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
13919113|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919114|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919115|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
13919116|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13919117|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13919118|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919119|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14089489|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14089490|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
14089491|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
14089492|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
14089493|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089494|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14089495|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14089496|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14089497|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14089498|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
14089499|NCT02467517|Ketamine|ketamine|mesh-list
14089500|NCT02467517|Analgesics|analgesics|mesh-ancestor
14089501|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
14089502|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089503|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919134|NCT04538742|Paclitaxel|paclitaxel|mesh-list
13919135|NCT04538742|Trastuzumab|trastuzumab|mesh-list
13919136|NCT04538742|Durvalumab|durvalumab|mesh-list
13919137|NCT04538742|Pertuzumab|pertuzumab|mesh-list
13919138|NCT04538742|Tucatinib|tucatinib|mesh-list
13919139|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13919140|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919141|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919142|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919143|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919144|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919145|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919146|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13919147|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919148|NCT04527107|Aflibercept|aflibercept|mesh-list
14089504|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14089505|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14089506|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
14089507|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
14089508|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089509|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14089510|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14089511|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089512|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089513|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13919149|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13919150|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13919151|NCT04527107|Growth Substances|growth substances|mesh-ancestor
13919152|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919153|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
13919154|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919155|NCT04524871|Bevacizumab|bevacizumab|mesh-list
13919156|NCT04524871|Atezolizumab|atezolizumab|mesh-list
14089514|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
14477257|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477258|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14477259|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477260|NCT02430389|Remifentanil|remifentanil|mesh-list
14477261|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14089515|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14089516|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089517|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14089518|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
14089519|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14089520|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14089521|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14089522|NCT02467673|Estradiol|estradiol|mesh-list
14089523|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14089524|NCT02467673|Progesterone|progesterone|mesh-list
14089525|NCT02467673|Estrogens|estrogens|mesh-ancestor
14089526|NCT02467673|Hormones|hormones|mesh-ancestor
14089527|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089528|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919157|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919158|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919159|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14089529|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14089530|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
14089531|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13919160|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13919161|NCT04524871|Growth Substances|growth substances|mesh-ancestor
13919162|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919163|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
13919164|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
13919165|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13919166|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
13919167|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919168|NCT04477486|Venetoclax|venetoclax|mesh-list
13919169|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919170|NCT04450173|Venetoclax|venetoclax|mesh-list
13919171|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
14089532|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14089533|NCT02467673|Progestins|progestins|mesh-ancestor
14089534|NCT02467608|Isoniazid|isoniazid|mesh-list
14089535|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
14089536|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14089537|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089538|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14089539|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14089540|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
14089541|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919172|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919173|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919185|NCT04430699|Cisplatin|cisplatin|mesh-list
13919186|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
13919187|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919188|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919189|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
14089542|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14089543|NCT02467023|Lidocaine|lidocaine|mesh-list
13919190|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13919191|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
13919192|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919193|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919194|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13919195|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
13919196|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13919197|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
13919198|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919199|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13919200|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13919201|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
13919202|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
13919203|NCT04383002|Protective Agents|protective agents|mesh-ancestor
13919204|NCT04375228|Rituximab|rituximab|mesh-list
13919205|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919206|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919207|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
13919208|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919209|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919210|NCT04370145|Meropenem|meropenem|mesh-list
13919211|NCT04370145|Tinidazole|tinidazole|mesh-list
13919212|NCT04370145|Teicoplanin|teicoplanin|mesh-list
13919213|NCT04370145|Sulperazone|sulperazone|mesh-list
14089544|NCT02467023|Fentanyl|fentanyl|mesh-list
14089545|NCT02467023|Midazolam|midazolam|mesh-list
13919214|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13919215|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089546|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
14089547|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
13919216|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
13960356|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
13919217|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919218|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13919219|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13919220|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13919221|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13919222|NCT04370145|Renal Agents|renal agents|mesh-ancestor
13919223|NCT04368429|Vaccines|vaccines|mesh-list
13919224|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
13919225|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919226|NCT04366908|Calcifediol|calcifediol|mesh-list
13919227|NCT04366908|Vitamins|vitamins|mesh-ancestor
13919228|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
13919229|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919230|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13919231|NCT04358003|Coal Tar|coal tar|mesh-list
13919232|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
13919233|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
13919234|NCT04331067|Paclitaxel|paclitaxel|mesh-list
13919235|NCT04331067|Carboplatin|carboplatin|mesh-list
13919236|NCT04331067|Nivolumab|nivolumab|mesh-list
13919237|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13919238|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919239|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919240|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919241|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919242|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919243|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919244|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13919245|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
13919246|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13919247|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13919248|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919249|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
13919250|NCT04311073|Coagulants|coagulants|mesh-ancestor
13919251|NCT04308785|Atezolizumab|atezolizumab|mesh-list
13919252|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919253|NCT04300790|Metformin|metformin|mesh-list
13919254|NCT04300790|Fulvestrant|fulvestrant|mesh-list
13919255|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13919256|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919257|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919258|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919259|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13919260|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13919261|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
13919262|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919263|NCT04298606|Vaccines|vaccines|mesh-list
13919264|NCT04298606|Mitogens|mitogens|mesh-list
13919265|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
13919266|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919267|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919268|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919271|NCT04283890|Nivolumab|nivolumab|mesh-list
13919272|NCT04283890|Ipilimumab|ipilimumab|mesh-list
13919273|NCT04283890|Melphalan|melphalan|mesh-list
13919274|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919275|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919276|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13919277|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919278|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13919279|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
13919280|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13919281|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919282|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
13919283|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919284|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
13919285|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
13919286|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13919287|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14089548|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089549|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477262|NCT02430389|Narcotics|narcotics|mesh-ancestor
13919288|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477263|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089550|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
14089551|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089552|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14089553|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14089554|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14089555|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089556|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089557|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14089558|NCT02467023|Narcotics|narcotics|mesh-ancestor
14089559|NCT02467023|Analgesics|analgesics|mesh-ancestor
14089560|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13919289|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919290|NCT04266197|Urological Agents|urological agents|mesh-ancestor
13919291|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13919292|NCT04238143|Complement Factor H|complement factor h|mesh-list
14089561|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14089562|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
14089563|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14089564|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14089565|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14089566|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14089567|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
14089568|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
14089569|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089570|NCT02467127|Vitamin D|vitamin d|mesh-list
14089571|NCT02467127|Vitamins|vitamins|mesh-ancestor
14089572|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
14089573|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089574|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13919293|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
13919294|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919295|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
14089575|NCT02466984|Metoclopramide|metoclopramide|mesh-list
14089576|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
14089577|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
14089578|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089579|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089580|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089581|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14089582|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14089583|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
14089584|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089585|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089586|NCT02466997|Tacrolimus|tacrolimus|mesh-list
14089587|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919296|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919297|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13919298|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
13919299|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919300|NCT04223856|Gemcitabine|gemcitabine|mesh-list
13919301|NCT04223856|Carboplatin|carboplatin|mesh-list
13919302|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
13919303|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919304|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13919305|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
13919306|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919307|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
14089588|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
14089589|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919308|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919309|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919310|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919311|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
13919312|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919313|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477264|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477265|NCT02430389|Analgesics|analgesics|mesh-ancestor
14477266|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
14477267|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479218|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479219|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
14479220|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14479221|NCT02465515|Incretins|incretins|mesh-ancestor
14479222|NCT02465515|Hormones|hormones|mesh-ancestor
14479223|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479224|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089590|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14089591|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089592|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479225|NCT02465528|Ceritinib|ceritinib|mesh-list
14479226|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479227|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14479228|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479229|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479230|NCT02465632|Clindamycin|clindamycin|mesh-list
14479231|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
14479232|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
14479233|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14479234|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14479235|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479236|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14089593|NCT02467010|Dexamethasone|dexamethasone|mesh-list
14089594|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
14089595|NCT02467010|Bortezomib|bortezomib|mesh-list
14089596|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14089597|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
14089598|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089599|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14089600|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14089601|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
14089602|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089603|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089604|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14089605|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14089606|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
14479237|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479238|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479239|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
14479240|NCT02465866|Promethazine|promethazine|mesh-list
14479241|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
14479242|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
14479243|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14479244|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
14479245|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
14479246|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479247|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479248|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089607|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
14089608|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479249|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14479250|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14479251|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14479252|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089609|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089610|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
14089611|NCT02467010|Hormones|hormones|mesh-ancestor
14089612|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089613|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14089614|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14089615|NCT02466828|Hematinics|hematinics|mesh-ancestor
14479253|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14479254|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14089616|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14089617|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14477268|NCT02430480|Goserelin|goserelin|mesh-list
13919351|NCT04221087|Dexamethasone|dexamethasone|mesh-list
13919352|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919353|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
13919354|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
13919355|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919356|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919357|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919358|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
13919359|NCT04221087|Hormones|hormones|mesh-ancestor
13919360|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919361|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919362|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919363|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
13919364|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
13919365|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14089618|NCT02466919|Amoxicillin|amoxicillin|mesh-list
14089619|NCT02466919|Metronidazole|metronidazole|mesh-list
14089620|NCT02466919|Clarithromycin|clarithromycin|mesh-list
14089621|NCT02466919|Levofloxacin|levofloxacin|mesh-list
14089622|NCT02466919|Ofloxacin|ofloxacin|mesh-list
14089623|NCT02466919|Pantoprazole|pantoprazole|mesh-list
14089624|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14089625|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089626|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14089627|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14089628|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14089629|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089630|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089631|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14089632|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14089633|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14089634|NCT02466919|Renal Agents|renal agents|mesh-ancestor
14089635|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14089636|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14089637|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089638|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14089639|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14089640|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089641|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14089642|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
14089643|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089644|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
14089645|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14089646|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14089647|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089648|NCT02466802|Urological Agents|urological agents|mesh-ancestor
14089649|NCT02466503|Fluticasone|fluticasone|mesh-list
14089650|NCT02466503|Xhance|xhance|mesh-list
14089651|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14089652|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14089653|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14089654|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
14089655|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089656|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089657|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14089658|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
14089659|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
14089660|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14089661|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14089662|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14089663|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14089664|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
13919366|NCT04205786|Vitamins|vitamins|mesh-ancestor
13919367|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
14089665|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089666|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089667|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
14089668|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
14089669|NCT02466581|Prednisolone|prednisolone|mesh-list
14089670|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14089671|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
14089672|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14089673|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
14089674|NCT02466581|Abatacept|abatacept|mesh-list
14089675|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
14089676|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14089677|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
14089678|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14089679|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
14089680|NCT02466581|Hormones|hormones|mesh-ancestor
14089681|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089682|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919368|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089683|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14089684|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089685|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
14089686|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
14089687|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089688|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919369|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
13919370|NCT04205786|Hematinics|hematinics|mesh-ancestor
13919371|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13919372|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919373|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919374|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13919375|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
13919376|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919377|NCT04197713|Olaparib|olaparib|mesh-list
13919378|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13919379|NCT04197713|Adavosertib|adavosertib|mesh-list
13919380|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919381|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919382|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919383|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
13919384|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13919385|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089689|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14089690|NCT02466581|Protective Agents|protective agents|mesh-ancestor
14089691|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
14089692|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13919386|NCT04187144|Renal Agents|renal agents|mesh-ancestor
13919387|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13919388|NCT04182204|Gemcitabine|gemcitabine|mesh-list
13919389|NCT04182204|Rituximab|rituximab|mesh-list
13919390|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
13919391|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919392|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919393|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
14089693|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14089694|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089695|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089696|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089697|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14089698|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14089699|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14089700|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
14089701|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14089702|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14089703|NCT02466581|Analgesics|analgesics|mesh-ancestor
14089704|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
14089705|NCT02466568|Nivolumab|nivolumab|mesh-list
14089706|NCT02466568|Vaccines|vaccines|mesh-list
13919394|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089707|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
14089708|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919395|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919396|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14089709|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14089710|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089711|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14089712|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089713|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14089714|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14089715|NCT02466490|Diuretics|diuretics|mesh-ancestor
14089716|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
14089717|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089718|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14089719|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089720|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089721|NCT02466542|Esmolol|esmolol|mesh-list
14089722|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14089723|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14089724|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13919397|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
13919398|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919399|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
13919400|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089725|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089726|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089727|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089728|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089729|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14089730|NCT02466698|Metronidazole|metronidazole|mesh-list
14089731|NCT02466698|Vancomycin|vancomycin|mesh-list
14089732|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14089733|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14089734|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089735|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
14089736|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14089737|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14089738|NCT02466698|Laxatives|laxatives|mesh-ancestor
14089739|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089740|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
14089741|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
14089742|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
14935572|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935573|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
14935574|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14935575|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
14935576|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14935577|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14935578|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935579|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14935580|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
14935581|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938685|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938686|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938687|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
14938688|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938689|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14938690|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
14938691|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14938692|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14938693|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938694|NCT01483248|Interferons|interferons|mesh-list
14938695|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14938696|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938697|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
13919401|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919402|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919403|NCT04179032|Belimumab|belimumab|mesh-list
13919404|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919405|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
13919406|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919407|NCT04169100|Prednisone|prednisone|mesh-list
13919408|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919409|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
13919410|NCT04169100|Hormones|hormones|mesh-ancestor
13919411|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919412|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919413|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919414|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089743|NCT02466464|Coagulants|coagulants|mesh-ancestor
14089744|NCT02466334|Calcitonin|calcitonin|mesh-list
14760684|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760685|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760686|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13960357|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13960358|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
13960359|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960360|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960361|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13960362|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
14089745|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
14089746|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14089747|NCT02466334|Katacalcin|katacalcin|mesh-list
14089748|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14089749|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089750|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14089751|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
14089752|NCT02466373|Clonidine|clonidine|mesh-list
14089753|NCT02466373|Analgesics|analgesics|mesh-ancestor
14089754|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
13960363|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
13960364|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13960365|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
13960366|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960367|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960368|NCT03155048|Estradiol|estradiol|mesh-list
13960369|NCT03155048|Estrogens|estrogens|mesh-list
13960370|NCT03155048|Hormones|hormones|mesh-ancestor
13960371|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089755|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960372|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960373|NCT03154827|Atezolizumab|atezolizumab|mesh-list
13960374|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960375|NCT03155035|Vitamin D|vitamin d|mesh-list
13960376|NCT03155035|Albendazole|albendazole|mesh-list
13960377|NCT03155035|Calcium|calcium|mesh-list
13960378|NCT03155035|Vitamins|vitamins|mesh-ancestor
13960379|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
13960380|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960381|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13960382|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13960383|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
13960384|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13960385|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960386|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
13960387|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13960388|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13960389|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
13960390|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
14089756|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089757|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14089758|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
14089759|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
14089760|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14089761|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14089762|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14089763|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089764|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089765|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089766|NCT02466347|Fluticasone|fluticasone|mesh-list
14089767|NCT02466347|Xhance|xhance|mesh-list
14089768|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14089769|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14089770|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14089771|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
14089772|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089773|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089774|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14760687|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14760688|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
14760689|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960391|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
14089775|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
14089776|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
14089777|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14935582|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
14935583|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14935584|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
14935585|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14935586|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
14935587|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935588|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935589|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
14089778|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14089779|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14089780|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14089781|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089782|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089783|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089784|NCT02466438|Tazobactam|tazobactam|mesh-list
14089785|NCT02466438|Piperacillin|piperacillin|mesh-list
14089786|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14089787|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14089788|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14089789|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14089790|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089791|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089792|NCT02466191|Gabapentin|gabapentin|mesh-list
14089793|NCT02466191|Memantine|memantine|mesh-list
14089794|NCT02466191|Analgesics|analgesics|mesh-ancestor
14089795|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
14089796|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089797|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089798|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
14089799|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14089800|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14089801|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089802|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14089803|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14935590|NCT01464476|Azimilide|azimilide|mesh-list
14935591|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14935592|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14089804|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14089805|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089806|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089807|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
14089808|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14089809|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14089810|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
14089811|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14089812|NCT02466204|Hormones|hormones|mesh-ancestor
14089813|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089814|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089815|NCT02466022|Fentanyl|fentanyl|mesh-list
14089816|NCT02466022|Midazolam|midazolam|mesh-list
14089817|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
14089818|NCT02466022|Bupivacaine|bupivacaine|mesh-list
14089819|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
14089820|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
14089821|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935593|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13919415|NCT04155840|Rituximab|rituximab|mesh-list
13919416|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13919417|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13919418|NCT04155840|Antibodies|antibodies|mesh-list
13919419|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
13919420|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13919421|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
13919422|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919423|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919424|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919425|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13919426|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
13919427|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919428|NCT04142125|Aspirin|aspirin|mesh-list
13919429|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
13919430|NCT04142125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13919431|NCT04142125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14089822|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089823|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
14089824|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089825|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14089826|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14089827|NCT02466022|Analgesics|analgesics|mesh-ancestor
13919432|NCT04142125|Analgesics|analgesics|mesh-ancestor
13919433|NCT04142125|Sensory System Agents|sensory system agents|mesh-ancestor
13919434|NCT04142125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919435|NCT04142125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919436|NCT04142125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919437|NCT04142125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919438|NCT04142125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13919439|NCT04142125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13919440|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919441|NCT04142125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13919442|NCT04142125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13919443|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919444|NCT04142125|Antipyretics|antipyretics|mesh-ancestor
13919445|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13919446|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
13919447|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13919448|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
13919449|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
13919450|NCT04119453|Apatinib|apatinib|mesh-list
13919451|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919452|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13919453|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919454|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919455|NCT04113317|Lenograstim|lenograstim|mesh-list
13919456|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13919457|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
13919458|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919459|NCT04092673|Trastuzumab|trastuzumab|mesh-list
13919460|NCT04092673|Fulvestrant|fulvestrant|mesh-list
13919461|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919462|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919463|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760690|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760691|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
14760692|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14760693|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14760694|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14760695|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14760696|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760697|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
14760698|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14760699|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760700|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14760701|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919464|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13919465|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13919466|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
13919467|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919468|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089828|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14089829|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14089830|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14089831|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089832|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089833|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089834|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14089835|NCT02466022|Narcotics|narcotics|mesh-ancestor
14089836|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14089837|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14089838|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
14089839|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14089840|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13919469|NCT04078152|Durvalumab|durvalumab|mesh-list
14089841|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14089842|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
13919470|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919471|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919472|NCT04060628|Docetaxel|docetaxel|mesh-list
13919473|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919474|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919475|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919476|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919477|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919478|NCT04044534|Insulin|insulin|mesh-list
13919479|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13919480|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919481|NCT04039464|Bosentan|bosentan|mesh-list
13919482|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
14089843|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
14089844|NCT02466035|Caseins|caseins|mesh-list
14089845|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
14089846|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
14089847|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089848|NCT02466074|Acetazolamide|acetazolamide|mesh-list
14089849|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
14089850|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14089851|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919483|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
13919484|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13919485|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13919486|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919487|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919488|NCT04039464|Urological Agents|urological agents|mesh-ancestor
13919489|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13919490|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13919491|NCT04037072|Mitomycins|mitomycins|mesh-list
13919492|NCT04037072|Mitomycin|mitomycin|mesh-list
13919493|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13919494|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919495|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
13919496|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919497|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13919498|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919499|NCT04033237|Nicotine|nicotine|mesh-list
13919500|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13919501|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
13919502|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919503|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919504|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13919505|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13919506|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
13919507|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13919508|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919509|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
14935594|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935595|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14935596|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935597|NCT01464489|Atropine|atropine|mesh-list
14935598|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14935599|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14935600|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14935601|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
14089852|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089853|NCT02466074|Diuretics|diuretics|mesh-ancestor
14089854|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
14089855|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089856|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
14089857|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14089858|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
14089859|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14089860|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089861|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14089862|NCT02465827|Ropivacaine|ropivacaine|mesh-list
14089863|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
14477269|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919510|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13919511|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477270|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919512|NCT04020341|Renal Agents|renal agents|mesh-ancestor
14089864|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
13919513|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13919514|NCT04019873|Lamivudine|lamivudine|mesh-list
13919515|NCT04019873|Rilpivirine|rilpivirine|mesh-list
13919516|NCT04019873|Dolutegravir|dolutegravir|mesh-list
13919517|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13919518|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13919519|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919520|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919521|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
13919522|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919523|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13919524|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13919525|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13919526|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13919527|NCT03993132|Empagliflozin|empagliflozin|mesh-list
13919528|NCT03993132|Glucagon|glucagon|mesh-list
13919529|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13919530|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13919531|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919532|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13919533|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919534|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919535|NCT03993132|Hormones|hormones|mesh-ancestor
13919536|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919537|NCT03993132|Incretins|incretins|mesh-ancestor
13919538|NCT03961256|Exenatide|exenatide|mesh-list
13919539|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13919540|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919541|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13919542|NCT03961256|Incretins|incretins|mesh-ancestor
13919543|NCT03961256|Hormones|hormones|mesh-ancestor
13919544|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14089865|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089866|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089867|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
14089868|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174145|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14174146|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14174147|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174148|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174149|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919547|NCT03819088|Zinc|zinc|mesh-list
13919548|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
13919549|NCT03819088|Trace Elements|trace elements|mesh-ancestor
13919550|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
13919551|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174150|NCT04789915|Memantine|memantine|mesh-list
14174151|NCT04789915|Amisulpride|amisulpride|mesh-list
14174152|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14174153|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13919552|NCT03819088|Astringents|astringents|mesh-ancestor
13919553|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
13919554|NCT03802604|Atezolizumab|atezolizumab|mesh-list
13919555|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
13919556|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477271|NCT02430818|Ketamine|ketamine|mesh-list
14477272|NCT02430818|Morphine|morphine|mesh-list
14477273|NCT02430818|Analgesics|analgesics|mesh-ancestor
14477274|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
14477275|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477276|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174154|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
13919557|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14174155|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174156|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174157|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174158|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14477277|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14477278|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13919558|NCT03791398|Nivolumab|nivolumab|mesh-list
13919559|NCT03791398|TIC10 compound|tic10 compound|mesh-list
14089869|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
14089870|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14089871|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
14089872|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089873|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14089874|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14089875|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
14089876|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089877|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089878|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14089879|NCT02465749|Vitamins|vitamins|mesh-list
14089880|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
14089881|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089882|NCT02465736|Cisplatin|cisplatin|mesh-list
14089883|NCT02465736|Docetaxel|docetaxel|mesh-list
14089884|NCT02465736|Vinorelbine|vinorelbine|mesh-list
14089885|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14089886|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
14089887|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
14089888|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
14089889|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089890|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14089891|NCT02465801|Lenograstim|lenograstim|mesh-list
14089892|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14089893|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
14089894|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089895|NCT02465645|Carvedilol|carvedilol|mesh-list
14089896|NCT02465645|Simvastatin|simvastatin|mesh-list
14089897|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14089898|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14089899|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
14089900|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089901|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14089902|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14089903|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14089904|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14089905|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14089906|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089907|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089908|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089909|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14089910|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
14089911|NCT02465645|Protective Agents|protective agents|mesh-ancestor
14089912|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14089913|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089914|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14089915|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
14089916|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14089917|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14089918|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
14089919|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14089920|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
14089921|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089922|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
14089923|NCT02465853|Protective Agents|protective agents|mesh-ancestor
14089924|NCT02465385|Linaclotide|linaclotide|mesh-list
13919560|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919561|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919562|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14089925|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14089926|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
14089927|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089928|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14089929|NCT02465333|Lidocaine|lidocaine|mesh-list
14935602|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919563|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919564|NCT03786081|Bevacizumab|bevacizumab|mesh-list
13919565|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
13919566|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
13919567|NCT03786081|Carboplatin|carboplatin|mesh-list
13919568|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919569|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919570|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14089930|NCT02465333|Epinephrine|epinephrine|mesh-list
14935603|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919571|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13919572|NCT03786081|Growth Substances|growth substances|mesh-ancestor
13919573|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919574|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
13919575|NCT03782207|Atezolizumab|atezolizumab|mesh-list
13919576|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919577|NCT03756311|Paclitaxel|paclitaxel|mesh-list
13919578|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13919579|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13919580|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919581|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919582|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919583|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919584|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477279|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
14089931|NCT02465333|Anesthetics, Local|anesthetics, local|mesh-list
14089932|NCT02465333|Anesthetics|anesthetics|mesh-list
14089933|NCT02465333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089934|NCT02465333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089935|NCT02465333|Sensory System Agents|sensory system agents|mesh-ancestor
14089936|NCT02465333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089937|NCT02465333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14089938|NCT02465333|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14089939|NCT02465333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14089940|NCT02465333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089941|NCT02465333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089942|NCT02465333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14477280|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
14477281|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477282|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14477283|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14477284|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089943|NCT02465333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14089944|NCT02465333|Adrenergic Agents|adrenergic agents|mesh-ancestor
14089945|NCT02465333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14089946|NCT02465333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14089947|NCT02465333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14089948|NCT02465333|Autonomic Agents|autonomic agents|mesh-ancestor
14089949|NCT02465333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14089950|NCT02465333|Respiratory System Agents|respiratory system agents|mesh-ancestor
14089951|NCT02465333|Mydriatics|mydriatics|mesh-ancestor
14089952|NCT02465333|Sympathomimetics|sympathomimetics|mesh-ancestor
14089953|NCT02465333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14089954|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
14089955|NCT02465359|Antibodies|antibodies|mesh-list
14089956|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
14089957|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14089958|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14089959|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
14089960|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089961|NCT02465320|Lidocaine|lidocaine|mesh-list
14089962|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
14089963|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
14089964|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089965|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089966|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
14089967|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089968|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14089969|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14089970|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14089971|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14089972|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14089973|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
14089974|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477285|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477286|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14477287|NCT02430818|Narcotics|narcotics|mesh-ancestor
14089975|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
14089976|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
14089977|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
14089978|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14089979|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089980|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
14089981|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14089994|NCT02465164|Oxytocin|oxytocin|mesh-list
14477288|NCT02431260|INCB054329|incb054329|mesh-list
14477289|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477290|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
14935604|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14935605|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
14935606|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
14935607|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
14935608|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14935609|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14477291|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14477292|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
14477293|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477294|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919602|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13919603|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13919604|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919605|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
13919606|NCT03721068|Fludarabine|fludarabine|mesh-list
14089995|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
14089996|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14089997|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14089998|NCT02465255|Acetaminophen|acetaminophen|mesh-list
14089999|NCT02465255|Ketorolac|ketorolac|mesh-list
14090000|NCT02465255|Tramadol|tramadol|mesh-list
13919607|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919608|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
13919609|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919610|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919611|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13919612|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
14090001|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14090002|NCT02465255|Analgesics|analgesics|mesh-ancestor
14090003|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
14090004|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477295|NCT02431533|Calcium|calcium|mesh-list
13919613|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919614|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919615|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13919616|NCT03707028|Paclitaxel|paclitaxel|mesh-list
13919617|NCT03707028|Apatinib|apatinib|mesh-list
14935610|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
14935611|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935612|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935613|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
14935614|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14935615|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
14935616|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935617|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
14935618|NCT01464528|Protective Agents|protective agents|mesh-ancestor
14935619|NCT01464593|Doxorubicin|doxorubicin|mesh-list
14935620|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14935621|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14935622|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935623|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13919618|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13919619|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919620|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919621|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919622|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919623|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919624|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13919625|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090005|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090006|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
14090007|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14090008|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090009|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090010|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14090011|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090012|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090013|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090014|NCT02465255|Narcotics|narcotics|mesh-ancestor
14090015|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090016|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14090017|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14090018|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14090019|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090020|NCT02464722|Epinephrine|epinephrine|mesh-list
14090021|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
13919626|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
13919627|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919628|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919629|NCT03634228|Cytarabine|cytarabine|mesh-list
13919630|NCT03634228|Venetoclax|venetoclax|mesh-list
14090022|NCT02464722|Remifentanil|remifentanil|mesh-list
14090023|NCT02464722|Propofol|propofol|mesh-list
14090024|NCT02464722|Rocuronium|rocuronium|mesh-list
14090025|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14090026|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935624|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14935625|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935626|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935627|NCT01464606|Dactinomycin|dactinomycin|mesh-list
14935628|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
14090027|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090028|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14090029|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
14090030|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
14090031|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935629|NCT01464606|Ifosfamide|ifosfamide|mesh-list
14935630|NCT01464606|Doxorubicin|doxorubicin|mesh-list
14935631|NCT01464606|Vincristine|vincristine|mesh-list
14935632|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935633|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
14935634|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935635|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935636|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14935637|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
14935638|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935639|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935640|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14935641|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14935642|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14935643|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14935644|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935645|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14935646|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
14090032|NCT02464722|Analgesics|analgesics|mesh-ancestor
14090033|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
14090034|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090035|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14090036|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14090037|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14090038|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
14090039|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090040|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090041|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14935647|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
14935648|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
14935649|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14090042|NCT02464722|Narcotics|narcotics|mesh-ancestor
14090043|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13919631|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13919632|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
13919633|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919634|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919635|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
13919636|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919637|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919638|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
13919639|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919640|NCT03620669|Durvalumab|durvalumab|mesh-list
13919641|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919642|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919643|NCT03604978|Nivolumab|nivolumab|mesh-list
13919644|NCT03604978|Ipilimumab|ipilimumab|mesh-list
13919645|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919646|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919647|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13919648|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477296|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14477297|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477298|NCT02431559|Doxorubicin|doxorubicin|mesh-list
14477299|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14477300|NCT02431559|Durvalumab|durvalumab|mesh-list
14090044|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14090045|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
14090046|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14090047|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14090048|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
14090049|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
14090050|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14090051|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14090052|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14090053|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14090054|NCT02464761|Verteporfin|verteporfin|mesh-list
14090055|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14090056|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090057|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
14090058|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14477301|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14477302|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919657|NCT03593213|Cariprazine|cariprazine|mesh-list
13919658|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13919659|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13919660|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13919661|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919662|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13919663|NCT03580044|Aztreonam|aztreonam|mesh-list
13919664|NCT03580044|Avibactam|avibactam|mesh-list
13919665|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13919666|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090059|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13919667|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14090060|NCT02464696|Prednisolone|prednisolone|mesh-list
13919668|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090061|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
14090062|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14090063|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
14090064|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090065|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
14090066|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
14090067|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090068|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090069|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090070|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
14090071|NCT02464696|Hormones|hormones|mesh-ancestor
14090072|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090073|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14090074|NCT02464696|Protective Agents|protective agents|mesh-ancestor
14090075|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14090076|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090077|NCT02464865|Thiamine|thiamine|mesh-list
14090078|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
14090079|NCT02464865|Vitamins|vitamins|mesh-ancestor
14090080|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
14090081|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090082|NCT02464813|Pregabalin|pregabalin|mesh-list
14090083|NCT02464813|Oxycodone|oxycodone|mesh-list
14090084|NCT02464813|Analgesics|analgesics|mesh-ancestor
14090085|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
14090086|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090087|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090088|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
14090089|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13919669|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919670|NCT03557619|Venetoclax|venetoclax|mesh-list
13919671|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
13919672|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13919673|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
13919674|NCT03557619|Estradiol|estradiol|mesh-list
13919675|NCT03557619|Estrogens|estrogens|mesh-ancestor
13919676|NCT03557619|Hormones|hormones|mesh-ancestor
13919677|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919678|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090090|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090091|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090092|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14090093|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14090094|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14090095|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090096|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090097|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090098|NCT02464813|Narcotics|narcotics|mesh-ancestor
14090099|NCT02464631|Ribavirin|ribavirin|mesh-list
14090100|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
14090101|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
14090102|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090103|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
14090104|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090105|NCT02464683|Vitamin D|vitamin d|mesh-list
14090106|NCT02464683|Vitamins|vitamins|mesh-ancestor
14090107|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
14090108|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090109|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14090110|NCT02464501|Paclitaxel|paclitaxel|mesh-list
14090111|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14090112|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090113|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
14090114|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
14090115|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
14090116|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090117|NCT02464228|Tipifarnib|tipifarnib|mesh-list
14090118|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090119|NCT02464462|Vitamin D|vitamin d|mesh-list
14090120|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
14767324|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13919679|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13919680|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
13919681|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13919682|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14090121|NCT02464462|Calcium|calcium|mesh-list
14090122|NCT02464462|Vitamins|vitamins|mesh-ancestor
14090123|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
14090124|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090125|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14090126|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14090127|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
14090128|NCT02464410|Narcotics|narcotics|mesh-ancestor
14090129|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090130|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919683|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919684|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13919685|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13919686|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13919687|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13919688|NCT03507452|BAY 2287411|bay 2287411|mesh-list
13919689|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13919690|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919691|NCT03505320|Leucovorin|leucovorin|mesh-list
13919692|NCT03505320|Folic Acid|folic acid|mesh-list
13919693|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
14090131|NCT02464410|Analgesics|analgesics|mesh-ancestor
14090132|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
14090133|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090134|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
14090135|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14090136|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090137|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
14090138|NCT02463929|Promethazine|promethazine|mesh-list
14090139|NCT02463929|Ketamine|ketamine|mesh-list
14090140|NCT02463929|Bupivacaine|bupivacaine|mesh-list
14090141|NCT02463929|Sevoflurane|sevoflurane|mesh-list
14090142|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
14090143|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
14090144|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090145|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090146|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
13919694|NCT03505320|Nivolumab|nivolumab|mesh-list
13919695|NCT03505320|Fluorouracil|fluorouracil|mesh-list
13919696|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
13919697|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
13919698|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919699|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919700|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
13919701|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919702|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13919703|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919704|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
13919705|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090147|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090148|NCT02463929|Analgesics|analgesics|mesh-ancestor
14090149|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14090150|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14090151|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
14090152|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14090153|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14090154|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090155|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090156|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14090157|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14090158|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14090159|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14090160|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
14090161|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
13919706|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14090162|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090163|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14090164|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
14090165|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
14090166|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14090167|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
14090168|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
14174159|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14090169|NCT02463825|Pimozide|pimozide|mesh-list
14090170|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14090171|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14090172|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090173|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090174|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090175|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14090176|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
14477303|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14477304|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14477305|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477306|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477307|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477308|NCT02431572|Vaccines|vaccines|mesh-list
14090177|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090178|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090179|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14090180|NCT02463994|Atezolizumab|atezolizumab|mesh-list
14090181|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090182|NCT02464020|Vancomycin|vancomycin|mesh-list
14090183|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14090184|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090185|NCT02463747|Vancomycin|vancomycin|mesh-list
14477309|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
14477310|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477311|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
13919707|NCT03505320|Antidotes|antidotes|mesh-ancestor
13919708|NCT03505320|Protective Agents|protective agents|mesh-ancestor
13919709|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
13919710|NCT03505320|Vitamins|vitamins|mesh-ancestor
13919711|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
13919712|NCT03505320|Hematinics|hematinics|mesh-ancestor
13919713|NCT03499704|Metformin|metformin|mesh-list
13919714|NCT03499704|Pioglitazone|pioglitazone|mesh-list
13919715|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
13919716|NCT03499704|Alogliptin|alogliptin|mesh-list
13919717|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13919718|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919719|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13919720|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919721|NCT03499704|Incretins|incretins|mesh-ancestor
13919722|NCT03499704|Hormones|hormones|mesh-ancestor
13919723|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919724|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13919725|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
14090186|NCT02463747|Meropenem|meropenem|mesh-list
14090187|NCT02463747|Tazobactam|tazobactam|mesh-list
14090188|NCT02463747|Piperacillin|piperacillin|mesh-list
14090189|NCT02463747|Ceftazidime|ceftazidime|mesh-list
14090190|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14090191|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14090192|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090193|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14090194|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090195|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090196|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
14090197|NCT02464124|Lactulose|lactulose|mesh-list
14090198|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090199|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14090200|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477312|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
13919726|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919727|NCT03498716|Paclitaxel|paclitaxel|mesh-list
14090201|NCT02463591|Thrombin|thrombin|mesh-list
14090202|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
14090203|NCT02463591|Coagulants|coagulants|mesh-ancestor
14090204|NCT02463552|Naproxen|naproxen|mesh-list
14090205|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14090206|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14090207|NCT02463552|Analgesics|analgesics|mesh-ancestor
14090208|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
14090209|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090210|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090211|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090212|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090213|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
14090214|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14090215|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090216|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090217|NCT02463643|Rabeprazole|rabeprazole|mesh-list
14090218|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14090219|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090220|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14090221|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090222|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090223|NCT02463682|Insulin|insulin|mesh-list
14090224|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14090225|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090226|NCT02463942|Doxycycline|doxycycline|mesh-list
14090227|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14090228|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090229|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
14090230|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14090231|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13919728|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
13919729|NCT03498716|Doxorubicin|doxorubicin|mesh-list
13919730|NCT03498716|Atezolizumab|atezolizumab|mesh-list
14090232|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14090233|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14090234|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14090235|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14090236|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
14090237|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090238|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
14090239|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14090240|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14090241|NCT02463383|Ibuprofen|ibuprofen|mesh-list
14090242|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14090243|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14090244|NCT02463383|Analgesics|analgesics|mesh-ancestor
14090245|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
14090246|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090247|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919731|NCT03498716|Epirubicin|epirubicin|mesh-list
13919732|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13919733|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919734|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919735|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919736|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919737|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919738|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919739|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
13919740|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919741|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919742|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13919743|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
13919744|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13919745|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13919746|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13919747|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13919748|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919749|NCT03443869|Valganciclovir|valganciclovir|mesh-list
14090248|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090249|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090250|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14090251|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090252|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090253|NCT02463513|Vitamins|vitamins|mesh-list
14090254|NCT02463513|Riboflavin|riboflavin|mesh-list
13919750|NCT03443869|Acyclovir|acyclovir|mesh-list
13919751|NCT03443869|Letermovir|letermovir|mesh-list
13919752|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
14090255|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
14090256|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
14090257|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090258|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14090259|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090260|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14090261|NCT02463318|Melatonin|melatonin|mesh-list
14090262|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
14090263|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090264|NCT02463318|Protective Agents|protective agents|mesh-ancestor
14090265|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090266|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090267|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14090268|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090269|NCT02463110|Sertraline|sertraline|mesh-list
14090270|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
14090271|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090272|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14090273|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14090274|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090275|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090276|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090277|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
14090278|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090279|NCT02462772|Cabotegravir|cabotegravir|mesh-list
14090280|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14090281|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14090282|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14090283|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14090284|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14090285|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14090286|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090287|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090288|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14090289|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14090290|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
14090291|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090292|NCT02462889|Aflibercept|aflibercept|mesh-list
14090293|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14090294|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14090295|NCT02462889|Growth Substances|growth substances|mesh-ancestor
14090296|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090297|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14090298|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090299|NCT02463019|Tenofovir|tenofovir|mesh-list
14090300|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
14090301|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090302|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14090303|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14090304|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090305|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090306|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14090307|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14090308|NCT02463006|Methamphetamine|methamphetamine|mesh-list
14090309|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13919753|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919754|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13919755|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919756|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919757|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090310|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090311|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
14090312|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
14090313|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919758|NCT03406247|Nivolumab|nivolumab|mesh-list
13919759|NCT03406247|Ipilimumab|ipilimumab|mesh-list
13919760|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919761|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919762|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13919763|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919764|NCT03399539|Dexamethasone|dexamethasone|mesh-list
13919765|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
13919766|NCT03399539|Venetoclax|venetoclax|mesh-list
13919767|NCT03399539|Ixazomib|ixazomib|mesh-list
13919768|NCT03399539|Ichthammol|ichthammol|mesh-list
13919769|NCT03399539|BB 1101|bb 1101|mesh-list
13919770|NCT03399539|Glycine|glycine|mesh-list
13919771|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919772|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
13919773|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
13919774|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919775|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919776|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919777|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
13919778|NCT03399539|Hormones|hormones|mesh-ancestor
14090314|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
14090315|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090316|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090317|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
14090318|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14090319|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14090320|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090321|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14090322|NCT02462941|Adenosine|adenosine|mesh-list
14090323|NCT02462941|Analgesics|analgesics|mesh-ancestor
14090324|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
14090325|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090326|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090327|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14090328|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
14090329|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14090330|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
14090331|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
14090332|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090333|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090334|NCT02462915|Lidocaine|lidocaine|mesh-list
14090335|NCT02462915|Fentanyl|fentanyl|mesh-list
14090336|NCT02462915|Propofol|propofol|mesh-list
14090337|NCT02462915|Cisatracurium|cisatracurium|mesh-list
14090338|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
14090339|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
13919779|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919780|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919781|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919782|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919783|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
13919784|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919785|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
13919786|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
13919787|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090340|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090341|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090342|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
14090343|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090344|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14090345|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14090346|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14090347|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090348|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090349|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14090350|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14090351|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
14090352|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090353|NCT02462915|Narcotics|narcotics|mesh-ancestor
14090354|NCT02462915|Analgesics|analgesics|mesh-ancestor
14090355|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14090356|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14090357|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14090358|NCT02462837|Mirabegron|mirabegron|mesh-list
14090359|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14090360|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14090361|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14090362|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
14090363|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090364|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174160|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14477313|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
13919788|NCT03396445|Paclitaxel|paclitaxel|mesh-list
13919789|NCT03396445|Carboplatin|carboplatin|mesh-list
13919790|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
14090365|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090366|NCT02462837|Urological Agents|urological agents|mesh-ancestor
14090367|NCT02462525|Dexamethasone|dexamethasone|mesh-list
14090368|NCT02462525|Pomalidomide|pomalidomide|mesh-list
14090369|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090370|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
14090371|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
14090372|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090373|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090374|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090375|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
14090376|NCT02462525|Hormones|hormones|mesh-ancestor
14090377|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090378|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14090379|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090380|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
14090381|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14090382|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14090383|NCT02462525|Growth Substances|growth substances|mesh-ancestor
14090384|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
14090385|NCT02462577|Morphine|morphine|mesh-list
14090386|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090387|NCT02462577|Narcotics|narcotics|mesh-ancestor
14090388|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090389|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090390|NCT02462577|Analgesics|analgesics|mesh-ancestor
14090391|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
14090392|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090393|NCT02462447|Choline|choline|mesh-list
14090394|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
14090395|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14090396|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
14090397|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090398|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090399|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14090400|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
14090401|NCT02462681|Ketamine|ketamine|mesh-list
14090402|NCT02462681|Analgesics|analgesics|mesh-ancestor
14090403|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
14090404|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090405|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090406|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14090407|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14090408|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
14090409|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
14090410|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090411|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14090412|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14090413|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090414|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090415|NCT02462499|Eplerenone|eplerenone|mesh-list
14090416|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13919791|NCT03396445|Pemetrexed|pemetrexed|mesh-list
13919792|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13919793|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919794|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919795|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919796|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
13919797|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090417|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
14090418|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090419|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090420|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14090421|NCT02462499|Diuretics|diuretics|mesh-ancestor
14090422|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
14090423|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14090424|NCT02462369|Glimepiride|glimepiride|mesh-list
14090425|NCT02462369|Saxagliptin|saxagliptin|mesh-list
13919798|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919799|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919800|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13919801|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14935650|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935651|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14935652|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14935653|NCT01464671|Heparin|heparin|mesh-list
14090426|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14090427|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14090428|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090429|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090430|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
14090431|NCT02462369|Incretins|incretins|mesh-ancestor
14090432|NCT02462369|Hormones|hormones|mesh-ancestor
14090433|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090434|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14090435|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
14090436|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090437|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090438|NCT02462304|Bevacizumab|bevacizumab|mesh-list
14090439|NCT02462304|Ranibizumab|ranibizumab|mesh-list
14090440|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14090441|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090442|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14090443|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14090444|NCT02462304|Growth Substances|growth substances|mesh-ancestor
14090445|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090446|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
14174161|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14174162|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174163|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14935654|NCT01464671|Bivalirudin|bivalirudin|mesh-list
14935655|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
14935656|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935657|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14935658|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935659|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
14935660|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14935661|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
14935662|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935663|NCT01464762|Bedaquiline|bedaquiline|mesh-list
14935664|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
14935665|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13919802|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
13919803|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13919804|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13919805|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13919806|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174164|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14174165|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14174166|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
14174167|NCT04789668|Atezolizumab|atezolizumab|mesh-list
14174168|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174169|NCT04790032|Cangrelor|cangrelor|mesh-list
14174170|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14174171|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14174172|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14174173|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14174174|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
14174175|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935666|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919807|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13919808|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13919809|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13919810|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13919811|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
13919812|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13919813|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919814|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13919815|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13919816|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
13919817|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13919818|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13919819|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
13919820|NCT03395197|Talazoparib|talazoparib|mesh-list
13919821|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13919822|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919823|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919824|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919825|NCT03371017|Gemcitabine|gemcitabine|mesh-list
13919826|NCT03371017|Carboplatin|carboplatin|mesh-list
13919827|NCT03371017|Capecitabine|capecitabine|mesh-list
13919828|NCT03371017|Atezolizumab|atezolizumab|mesh-list
13919829|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919830|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13919831|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
13919832|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919833|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
13919834|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090447|NCT02462317|Baclofen|baclofen|mesh-list
14090448|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14090449|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14090450|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14090451|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090452|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14090453|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935667|NCT01464801|Resveratrol|resveratrol|mesh-list
14935668|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
14935669|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935670|NCT01464801|Protective Agents|protective agents|mesh-ancestor
14935671|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935672|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090454|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14090455|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
14090456|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
14090457|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090458|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090459|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14090460|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090461|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
14090462|NCT02462109|Lorazepam|lorazepam|mesh-list
14090463|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
14090464|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
14090465|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
14090466|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090467|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090468|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090469|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14090470|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090471|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14090472|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14090473|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090474|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
14090475|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
14090476|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090477|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090478|NCT02462161|Insulin|insulin|mesh-list
14090479|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14090480|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
14090481|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
14090482|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14090483|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14090484|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090485|NCT02462174|Ketamine|ketamine|mesh-list
14090486|NCT02462174|Bupivacaine|bupivacaine|mesh-list
14090487|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
14090488|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
14090489|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090490|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090491|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
13919835|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919836|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919837|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
13919838|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960392|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960393|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960394|NCT03154814|Urinastatin|urinastatin|mesh-list
13960395|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13960396|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13960397|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
13960398|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960399|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960400|NCT03154723|Vitamin A|vitamin a|mesh-list
13960401|NCT03154723|Vitamins|vitamins|mesh-ancestor
13960402|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
14090492|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090493|NCT02462174|Analgesics|analgesics|mesh-ancestor
14090494|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14090495|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14090496|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
14090497|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14090498|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14090499|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090500|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090501|NCT02462252|Cyclosporine|cyclosporine|mesh-list
13960403|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960404|NCT03154918|Gemcitabine|gemcitabine|mesh-list
14090502|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
14935673|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935674|NCT01464944|Aspirin|aspirin|mesh-list
14935675|NCT01464944|Acetaminophen|acetaminophen|mesh-list
14935676|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14935677|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935678|NCT01464944|Analgesics|analgesics|mesh-ancestor
14935679|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
14935680|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935681|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935682|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760747|NCT04161885|Azacitidine|azacitidine|mesh-list
14760748|NCT04161885|Venetoclax|venetoclax|mesh-list
14760749|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760750|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
14760751|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760752|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935683|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935684|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935685|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14935686|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935687|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935688|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14935689|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935690|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
14935691|NCT01464983|Aspirin|aspirin|mesh-list
14935692|NCT01464983|Ibuprofen|ibuprofen|mesh-list
13960405|NCT03154918|Dexamethasone|dexamethasone|mesh-list
13960406|NCT03154918|Etoposide|etoposide|mesh-list
14090503|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14760753|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919839|NCT03298061|Prednisolone|prednisolone|mesh-list
13919840|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919841|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
13919842|NCT03298061|Hormones|hormones|mesh-ancestor
13919843|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919844|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919845|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919846|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919847|NCT03280563|Tamoxifen|tamoxifen|mesh-list
13919848|NCT03280563|Bevacizumab|bevacizumab|mesh-list
13919849|NCT03280563|Atezolizumab|atezolizumab|mesh-list
13919850|NCT03280563|Fulvestrant|fulvestrant|mesh-list
13919851|NCT03280563|Exemestane|exemestane|mesh-list
13919852|NCT03280563|Entinostat|entinostat|mesh-list
13919853|NCT03280563|Antibodies|antibodies|mesh-list
13919854|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919855|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919856|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13919857|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13919858|NCT03280563|Growth Substances|growth substances|mesh-ancestor
13919859|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919860|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
13919861|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
13919862|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13919863|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
13919864|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13919865|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919866|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13919867|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13919868|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13919869|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13919870|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13919871|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13919872|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919873|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919874|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13919875|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
13919876|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919877|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919878|NCT03248531|Adalimumab|adalimumab|mesh-list
13919879|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919880|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919881|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
13919882|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13919883|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919884|NCT03245918|Aprepitant|aprepitant|mesh-list
13919885|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
13919886|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
14090504|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14090505|NCT02462252|Cyclosporins|cyclosporins|mesh-list
14090506|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14090507|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090508|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090509|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090510|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
14090511|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090512|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
14090513|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090514|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090515|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090516|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14090517|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090518|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
14090519|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
14090520|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090521|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090522|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
14090523|NCT02462252|Hormones|hormones|mesh-ancestor
14090524|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090525|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14090526|NCT02462252|Protective Agents|protective agents|mesh-ancestor
14090527|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14090528|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090529|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
13919887|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
14090530|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
13919888|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919889|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919890|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919891|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13919892|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13919893|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919894|NCT03215511|Selitrectinib|selitrectinib|mesh-list
13919895|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919896|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919897|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
13919898|NCT03205605|Oxybutynin|oxybutynin|mesh-list
13919899|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
13919900|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
13919901|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919902|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919903|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13919904|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13919905|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
13919906|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13919907|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919908|NCT03205605|Urological Agents|urological agents|mesh-ancestor
13919909|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13919910|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919911|NCT03205605|Renal Agents|renal agents|mesh-ancestor
13919912|NCT03193866|Interferons|interferons|mesh-list
13919913|NCT03193866|Interferon-beta|interferon-beta|mesh-list
13919914|NCT03193866|Rituximab|rituximab|mesh-list
13919915|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
13919916|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
13919917|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13919918|NCT03193866|Natalizumab|natalizumab|mesh-list
13919919|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
13919920|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
13919921|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919922|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919923|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
13919924|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919925|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13919926|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
13919927|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13919928|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13919929|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919930|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13919931|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
13919932|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13919933|NCT03128619|Letrozole|letrozole|mesh-list
13919934|NCT03128619|Palbociclib|palbociclib|mesh-list
13919935|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919936|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13919937|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13919938|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13919939|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919940|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13919941|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
13919942|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760754|NCT04150887|Azacitidine|azacitidine|mesh-list
13919943|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919944|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13919945|NCT03119584|Linaclotide|linaclotide|mesh-list
13919946|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
13919947|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
13919948|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919949|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919950|NCT03118986|Olanzapine|olanzapine|mesh-list
13919951|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
13919952|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
13919953|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919954|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919955|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919956|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13919957|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13919958|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13919959|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13919960|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14760755|NCT04150887|Venetoclax|venetoclax|mesh-list
14090531|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090532|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090533|NCT02462265|Analgesics|analgesics|mesh-ancestor
14090534|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
14090535|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090536|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14090537|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13919961|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13919962|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090538|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090539|NCT02462044|Iodine|iodine|mesh-list
14090540|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
14090541|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14090542|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090543|NCT02462044|Trace Elements|trace elements|mesh-ancestor
14090544|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
14090545|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090546|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
14090547|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090548|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14090549|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090550|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090551|NCT02461706|Cannabidiol|cannabidiol|mesh-list
14090552|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
14090553|NCT02461836|Gemcitabine|gemcitabine|mesh-list
14090554|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14090555|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
14090556|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090557|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090558|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
14090559|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090560|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090561|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090562|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
14090563|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090564|NCT02461888|Dexamethasone|dexamethasone|mesh-list
14090565|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
14090566|NCT02461888|Ixazomib|ixazomib|mesh-list
14090567|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090568|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
14090569|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090570|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090571|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14090572|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
14090573|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090574|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090575|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14090576|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090577|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
14090578|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
14090579|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090580|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090581|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
14090582|NCT02461888|Hormones|hormones|mesh-ancestor
14090583|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090584|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14090585|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14090586|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090587|NCT02461875|Cabergoline|cabergoline|mesh-list
14090588|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14090589|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14090590|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
13919963|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919964|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13919965|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
13919966|NCT03047330|Leuprolide|leuprolide|mesh-list
13919967|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13919968|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
13919969|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13919970|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919971|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13919972|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919973|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
14090591|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
14090592|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13919974|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
13919975|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919976|NCT03019588|Paclitaxel|paclitaxel|mesh-list
13919977|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
13919978|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13919979|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919980|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
13919981|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
13919982|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
14090593|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090594|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090595|NCT02461719|Cyclosporine|cyclosporine|mesh-list
14090596|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14090597|NCT02461719|Cyclosporins|cyclosporins|mesh-list
14090598|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090599|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090600|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090601|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
14090602|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090603|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
14090604|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090605|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090606|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090607|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14090608|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14090609|NCT02461927|Midazolam|midazolam|mesh-list
14090610|NCT02461927|Naltrexone|naltrexone|mesh-list
14090611|NCT02461927|Ketamine|ketamine|mesh-list
14090612|NCT02461927|Analgesics|analgesics|mesh-ancestor
14090613|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
14090614|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090615|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090616|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14090617|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14090618|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
14090619|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
14935693|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14935694|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935695|NCT01464983|Analgesics|analgesics|mesh-ancestor
14935696|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
14935697|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935698|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919983|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919984|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919985|NCT02978625|Nivolumab|nivolumab|mesh-list
13919986|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14935699|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14935700|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935701|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935702|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14935703|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935704|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935705|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14935706|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090620|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090621|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14090622|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14090623|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090624|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090625|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14090626|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14090627|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14090628|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14090629|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090630|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
14090631|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
14090632|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14090633|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14090634|NCT02461914|Warfarin|warfarin|mesh-list
14477314|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477315|NCT02431637|Piperaquine|piperaquine|mesh-list
14477316|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
14935707|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
14090635|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
14090636|NCT02461667|Alendronate|alendronate|mesh-list
14477317|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13919987|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13919988|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13919989|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13919990|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13919991|NCT02951377|Dexamethasone|dexamethasone|mesh-list
13919992|NCT02951377|Lidocaine|lidocaine|mesh-list
13919993|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13919994|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
13919995|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
13919996|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13919997|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13919998|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13919999|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
13920000|NCT02951377|Hormones|hormones|mesh-ancestor
13920001|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920002|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920003|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920004|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
13920005|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
13920006|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920007|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
13920008|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13920009|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13920010|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13920011|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13920012|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920013|NCT02844907|Dexamethasone|dexamethasone|mesh-list
13920014|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920015|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
13920016|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
13920017|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920018|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920019|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920020|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
13920021|NCT02844907|Hormones|hormones|mesh-ancestor
13920022|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920023|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920024|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920025|NCT02811523|Doxorubicin|doxorubicin|mesh-list
13920026|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13920027|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920028|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13920029|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13920030|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920031|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920032|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
13920033|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13920034|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920035|NCT02717455|Panobinostat|panobinostat|mesh-list
13920036|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920037|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13920038|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920039|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920040|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
13920041|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
13920042|NCT02700451|Acetaminophen|acetaminophen|mesh-list
13920043|NCT02700451|Ketorolac|ketorolac|mesh-list
13920044|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13920045|NCT02700451|Analgesics|analgesics|mesh-ancestor
13920046|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
13920047|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920048|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920049|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
14090637|NCT02461667|Metformin|metformin|mesh-list
14090638|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14090639|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920050|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13920051|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920052|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13920053|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13920054|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920055|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920056|NCT02525692|TIC10 compound|tic10 compound|mesh-list
13920057|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920060|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
13920061|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13920062|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920063|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920064|NCT02496208|Nivolumab|nivolumab|mesh-list
13920065|NCT02496208|Ipilimumab|ipilimumab|mesh-list
13920066|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920067|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920068|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13920069|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920070|NCT02481830|Nivolumab|nivolumab|mesh-list
13920071|NCT02481830|Topotecan|topotecan|mesh-list
13920072|NCT02481830|Amrubicin|amrubicin|mesh-list
13920073|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920074|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920075|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13920076|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920077|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13920078|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13920079|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920080|NCT02366494|Docetaxel|docetaxel|mesh-list
13920081|NCT02366494|Leuprolide|leuprolide|mesh-list
14090640|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14090641|NCT02461329|Polygeline|polygeline|mesh-list
14090642|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
14090643|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
14090644|NCT02461368|Triamcinolone|triamcinolone|mesh-list
14090645|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14090646|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14090647|NCT02461368|Lidocaine|lidocaine|mesh-list
13920082|NCT02366494|Goserelin|goserelin|mesh-list
13920083|NCT02366494|Bicalutamide|bicalutamide|mesh-list
13920084|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13920085|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920086|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
13920087|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
13920088|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
13920089|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920090|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13920091|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
13920092|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14760756|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760757|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
14760758|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760759|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760760|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760761|NCT04149210|Fluorometholone|fluorometholone|mesh-list
14760762|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
14760763|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14760764|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13920093|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920094|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920095|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
14090648|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14090649|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
14090650|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
14090651|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090652|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090653|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
14090654|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090655|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14090656|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14090657|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14090658|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14477318|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14090659|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090660|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090661|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
14090662|NCT02461368|Hormones|hormones|mesh-ancestor
14090663|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090664|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090665|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
14090666|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090667|NCT02461186|Piperaquine|piperaquine|mesh-list
14090668|NCT02461186|Artenimol|artenimol|mesh-list
14090669|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
14090670|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14090671|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14090672|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090673|NCT02461004|Ezetimibe|ezetimibe|mesh-list
14090674|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14090675|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14090676|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
14090677|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090678|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14090679|NCT02461056|Ibuprofen|ibuprofen|mesh-list
14090680|NCT02461056|Hydromorphone|hydromorphone|mesh-list
14090681|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14090682|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14090683|NCT02461056|Analgesics|analgesics|mesh-ancestor
14090684|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
13920096|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
13920097|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920098|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
13920099|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13920100|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
13920101|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13920102|NCT02312245|Gemcitabine|gemcitabine|mesh-list
13920103|NCT02312245|Paclitaxel|paclitaxel|mesh-list
14090685|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090686|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090687|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090688|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090689|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14090690|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090691|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090692|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090693|NCT02461056|Narcotics|narcotics|mesh-ancestor
14090694|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090695|NCT02461121|Cyclosporine|cyclosporine|mesh-list
14090696|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
14090697|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
14090698|NCT02461121|Fludarabine|fludarabine|mesh-list
14090699|NCT02461121|Cyclosporins|cyclosporins|mesh-list
14090700|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14090701|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090702|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
14090703|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090704|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090705|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14090706|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
14090707|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090708|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090709|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14090710|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920104|NCT02312245|Bevacizumab|bevacizumab|mesh-list
13920105|NCT02312245|Doxorubicin|doxorubicin|mesh-list
13920106|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13920107|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13920108|NCT02312245|Topotecan|topotecan|mesh-list
13920109|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13920110|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
13920111|NCT02312245|Antibodies|antibodies|mesh-list
13920112|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
13920113|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13920114|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
13920115|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13920116|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920117|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
13920118|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
13920119|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
13920120|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920121|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13920122|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13920123|NCT02312245|Growth Substances|growth substances|mesh-ancestor
13920124|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920125|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
13920126|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
13920127|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920128|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
13920129|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
13920130|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920131|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920132|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920133|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13920134|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13920135|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13920136|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13920143|NCT02262923|Metoclopramide|metoclopramide|mesh-list
13920144|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
13920145|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
13920146|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920147|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920148|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920149|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13920150|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13920151|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
13920152|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920153|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920154|NCT02234323|Factor VIII|factor viii|mesh-list
13920155|NCT02234323|Coagulants|coagulants|mesh-ancestor
13920156|NCT02206984|Tamoxifen|tamoxifen|mesh-list
13920157|NCT02206984|Fulvestrant|fulvestrant|mesh-list
13920158|NCT02206984|Anastrozole|anastrozole|mesh-list
13920159|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13920160|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
13920161|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920162|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920163|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920164|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920165|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13920166|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13920167|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13920168|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13920169|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13920170|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13920171|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920172|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090711|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
14090712|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090713|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090714|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14090715|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14090716|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14090717|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
13920173|NCT02194595|Insulin|insulin|mesh-list
14090718|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13920174|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13920175|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
13920176|NCT02194595|Exenatide|exenatide|mesh-list
13920177|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
13920178|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13920179|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920180|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13920181|NCT02194595|Incretins|incretins|mesh-ancestor
13920182|NCT02194595|Hormones|hormones|mesh-ancestor
13920183|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920197|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
13920198|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13920199|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13920200|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
13920201|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920202|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920203|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
13920204|NCT02168140|Protective Agents|protective agents|mesh-ancestor
13920205|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920206|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
13920207|NCT02168140|Vitamins|vitamins|mesh-ancestor
13920208|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
13960407|NCT03154918|Ifosfamide|ifosfamide|mesh-list
13960408|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960409|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
13960410|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
13960411|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960412|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960413|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13960414|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
13960415|NCT03154918|Hormones|hormones|mesh-ancestor
13960416|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090719|NCT02461043|Paclitaxel|paclitaxel|mesh-list
14090720|NCT02461043|Cisplatin|cisplatin|mesh-list
14090721|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14090722|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090723|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
14090724|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
14090725|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
13960417|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13960418|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960419|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960420|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090726|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090727|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14090728|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090729|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090730|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
14090731|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090732|NCT02461030|Listerine|listerine|mesh-list
14090733|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
14090734|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
14090735|NCT02461030|Protective Agents|protective agents|mesh-ancestor
14090736|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090737|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14090738|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960421|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13960422|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
13960423|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
13960424|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090739|NCT02460913|Morphine|morphine|mesh-list
14477319|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960425|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960426|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
14090740|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090741|NCT02460913|Narcotics|narcotics|mesh-ancestor
14090742|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090743|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090744|NCT02460913|Analgesics|analgesics|mesh-ancestor
14090745|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
14090746|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090747|NCT02460874|Glyburide|glyburide|mesh-list
14090748|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14090749|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090750|NCT02460887|Gemcitabine|gemcitabine|mesh-list
14090751|NCT02460887|Cisplatin|cisplatin|mesh-list
14090752|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090753|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14090754|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
14090755|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090756|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
14090757|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090758|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090759|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090760|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
14090761|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090762|NCT02460497|Minoxidil|minoxidil|mesh-list
14090763|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14090764|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
14090765|NCT02460510|Mannitol|mannitol|mesh-list
14090766|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14090767|NCT02460510|Diuretics|diuretics|mesh-ancestor
14090768|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
14090769|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090770|NCT02460588|Prednisolone|prednisolone|mesh-list
14090771|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
14090772|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090773|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
14090774|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090775|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090776|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14090777|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
14090778|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090779|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920209|NCT02099188|Leucovorin|leucovorin|mesh-list
13920210|NCT02099188|Docetaxel|docetaxel|mesh-list
13920211|NCT02099188|Fluorouracil|fluorouracil|mesh-list
13920212|NCT02099188|Etoposide|etoposide|mesh-list
13920213|NCT02099188|Doxorubicin|doxorubicin|mesh-list
13920214|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13920215|NCT02099188|Ifosfamide|ifosfamide|mesh-list
13920216|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920217|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
13920218|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
14090780|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14090781|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090782|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
14090783|NCT02460588|Hormones|hormones|mesh-ancestor
14090784|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090785|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920219|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
13920220|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920221|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
13920222|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920223|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920224|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
14090786|NCT02460627|Lidocaine|lidocaine|mesh-list
14090787|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
14090788|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
14090789|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090790|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090791|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
14090792|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090793|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14090794|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14090795|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14090796|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090797|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090798|NCT02460692|Dronabinol|dronabinol|mesh-list
14090799|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
14090800|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090801|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090802|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14090803|NCT02460692|Analgesics|analgesics|mesh-ancestor
14090804|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
14090805|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090806|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14090807|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14090808|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090809|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090810|NCT02460692|Hormones|hormones|mesh-ancestor
14090811|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174176|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174177|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174178|NCT04789837|Cilostazol|cilostazol|mesh-list
14174179|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14174180|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
14174181|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174182|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174183|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14174184|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
14174185|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14174186|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14174187|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174188|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14174189|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
14174190|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14174191|NCT04789837|Protective Agents|protective agents|mesh-ancestor
14174192|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14174193|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14174194|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174214|NCT04789005|Phenylephrine|phenylephrine|mesh-list
14174215|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
14174216|NCT04789005|Norepinephrine|norepinephrine|mesh-list
14174217|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14174218|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
14174219|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
14174220|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174221|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174222|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
14174223|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14090812|NCT02460640|Morphine|morphine|mesh-list
14090813|NCT02460640|Ropivacaine|ropivacaine|mesh-list
14090814|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090815|NCT02460640|Narcotics|narcotics|mesh-ancestor
14090816|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090817|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090818|NCT02460640|Analgesics|analgesics|mesh-ancestor
14090819|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
14090820|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090821|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
14090822|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
14090823|NCT02460419|Capecitabine|capecitabine|mesh-list
14090824|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14090825|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
14090826|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090827|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090828|NCT02460276|Rituximab|rituximab|mesh-list
14090829|NCT02460276|Lenalidomide|lenalidomide|mesh-list
14090830|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920225|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920226|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14760765|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920227|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13920228|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13920229|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920230|NCT02099188|Antidotes|antidotes|mesh-ancestor
13920231|NCT02099188|Protective Agents|protective agents|mesh-ancestor
13920232|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
13920233|NCT02099188|Vitamins|vitamins|mesh-ancestor
13920234|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
13920235|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13920236|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13920237|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
13920238|NCT02099175|Leucovorin|leucovorin|mesh-list
13920239|NCT02099175|Docetaxel|docetaxel|mesh-list
13920240|NCT02099175|Fluorouracil|fluorouracil|mesh-list
13920241|NCT02099175|Etoposide|etoposide|mesh-list
13920242|NCT02099175|Doxorubicin|doxorubicin|mesh-list
13920243|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13920244|NCT02099175|Ifosfamide|ifosfamide|mesh-list
13920245|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920246|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
13920247|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
13920248|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
13920249|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920250|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
13920251|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920252|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090831|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090832|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
14090833|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090834|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14090835|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14090836|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14090837|NCT02460276|Growth Substances|growth substances|mesh-ancestor
14090838|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
14090839|NCT02460432|Paclitaxel|paclitaxel|mesh-list
14090840|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14090841|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090842|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
14090843|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
14090844|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
13920253|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
13920254|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920255|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13920256|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14090845|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090846|NCT02460289|Minoxidil|minoxidil|mesh-list
14090847|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14090848|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
14090849|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14090850|NCT02460393|Antibodies|antibodies|mesh-list
14090851|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
13920257|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14090852|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14090853|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
13920258|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090854|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760766|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
14760767|NCT04149210|Hormones|hormones|mesh-ancestor
14760768|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760769|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760770|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14760771|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
13920259|NCT02099175|Antidotes|antidotes|mesh-ancestor
13920260|NCT02099175|Protective Agents|protective agents|mesh-ancestor
13920261|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
13920262|NCT02099175|Vitamins|vitamins|mesh-ancestor
13920263|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
13920264|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13920265|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13920266|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
13920267|NCT02087826|Metformin|metformin|mesh-list
13920268|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13920269|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920270|NCT02015117|Trametinib|trametinib|mesh-list
13920271|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920272|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13920273|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920274|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920275|NCT01451736|Risperidone|risperidone|mesh-list
13920276|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13920277|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13920278|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
13920279|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920280|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920281|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920282|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13920283|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13920284|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920285|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13920286|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13920287|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
13920288|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13920289|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13920290|NCT01333046|Azacitidine|azacitidine|mesh-list
13920291|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920292|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
13920293|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920294|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920295|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920296|NCT01166633|Atorvastatin|atorvastatin|mesh-list
13920297|NCT01166633|Pitavastatin|pitavastatin|mesh-list
13920298|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13920299|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13920300|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
13920301|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920302|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13920303|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13920304|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920305|NCT01030575|Inositol|inositol|mesh-list
13920306|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
13920307|NCT01030575|Vitamins|vitamins|mesh-ancestor
13920308|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
14760772|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14760773|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14760774|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760775|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760776|NCT04141644|Ipilimumab|ipilimumab|mesh-list
14760777|NCT04141644|Osimertinib|osimertinib|mesh-list
14760778|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760779|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920309|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920310|NCT00872950|Amifampridine|amifampridine|mesh-list
13920311|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13920312|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920313|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920314|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13920315|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090855|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767325|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920316|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920317|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
13920318|NCT00740805|Doxorubicin|doxorubicin|mesh-list
13920319|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14760780|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14760781|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760782|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760783|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090856|NCT02460354|Metformin|metformin|mesh-list
14090857|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14090858|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920320|NCT00740805|Veliparib|veliparib|mesh-list
13920321|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920322|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
13920323|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920324|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13920325|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13920326|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
13920327|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920328|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920329|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13920330|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13920331|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13920332|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14090859|NCT02460367|Docetaxel|docetaxel|mesh-list
14090860|NCT02460367|Tryptophan|tryptophan|mesh-list
14090861|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090862|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
14090863|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
14090864|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
14090865|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920333|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920334|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14090866|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14090867|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
14090868|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090869|NCT02460211|Vitamin D|vitamin d|mesh-list
14090870|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
14090871|NCT02460211|Vitamins|vitamins|mesh-ancestor
14090872|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
14090873|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090874|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14090875|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14090876|NCT02460341|Ondansetron|ondansetron|mesh-list
14090877|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
14090878|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
14090879|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090880|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090881|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090882|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
14090883|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090884|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14090885|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
14090886|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090887|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090888|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14090889|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14090890|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090891|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14090892|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14090893|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
14090894|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14760784|NCT04140266|Tenofovir|tenofovir|mesh-list
13920335|NCT00493896|Enoxaparin|enoxaparin|mesh-list
13920336|NCT00493896|PENTA|penta|mesh-list
13920337|NCT00493896|Fondaparinux|fondaparinux|mesh-list
13920338|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
13920339|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13920340|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13920341|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920342|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13920343|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
13920344|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13920345|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
13920346|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920347|NCT00089791|Denosumab|denosumab|mesh-list
13920348|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14090895|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14090896|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14477320|NCT02431650|Primaquine|primaquine|mesh-list
14477321|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
13920349|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477322|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14477323|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14477324|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477325|NCT02431676|Metformin|metformin|mesh-list
14477326|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14477327|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477328|NCT02431754|Tadalafil|tadalafil|mesh-list
14477329|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
14477330|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14477331|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14477332|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477333|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477334|NCT02431754|Urological Agents|urological agents|mesh-ancestor
14477335|NCT02431806|Milnacipran|milnacipran|mesh-list
14477336|NCT02431806|Fluoxetine|fluoxetine|mesh-list
14477337|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
14477338|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14477339|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14477340|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13920350|NCT03450499|Ketamine|ketamine|mesh-list
13920351|NCT03450499|Analgesics|analgesics|mesh-ancestor
13920352|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
13920353|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920354|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920355|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13920356|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13920357|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
13920358|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
13920359|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920360|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13920361|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13920362|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920363|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920364|NCT03450434|Histamine|histamine|mesh-list
13920365|NCT03450434|Glutarimide|glutarimide|mesh-list
13920366|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
14760785|NCT04140266|Emtricitabine|emtricitabine|mesh-list
14760786|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14090897|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14090898|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090899|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
14090900|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090901|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090902|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14090903|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090904|NCT02460133|Ritonavir|ritonavir|mesh-list
14090905|NCT02460133|Ribavirin|ribavirin|mesh-list
14090906|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14090907|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14090908|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
14090909|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14090910|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090911|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14090912|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14090913|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
14090914|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14090915|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14090916|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14090917|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
14090918|NCT02460146|CXA-10|cxa-10|mesh-list
14090919|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090920|NCT02460302|Progesterone|progesterone|mesh-list
14090921|NCT02460302|Progestins|progestins|mesh-ancestor
14090922|NCT02460302|Hormones|hormones|mesh-ancestor
14090923|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090924|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090925|NCT02460068|Nivolumab|nivolumab|mesh-list
14090926|NCT02460068|Ipilimumab|ipilimumab|mesh-list
14090927|NCT02460068|Fotemustine|fotemustine|mesh-list
14090928|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14090929|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760787|NCT04140266|Dapivirine|dapivirine|mesh-list
14090930|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14090931|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090932|NCT02459977|Basiliximab|basiliximab|mesh-list
14090933|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14090934|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
14090935|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090936|NCT02459938|Glucagon|glucagon|mesh-list
14760788|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
14760789|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760790|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14760791|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14760792|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920367|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
13920368|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920369|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920370|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920371|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13920372|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920373|NCT03450317|Aspirin|aspirin|mesh-list
13920374|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13920375|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13920376|NCT03450317|Analgesics|analgesics|mesh-ancestor
14090937|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14090938|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090939|NCT02459938|Hormones|hormones|mesh-ancestor
14090940|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14090941|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090942|NCT02459938|Incretins|incretins|mesh-ancestor
14090943|NCT02460055|Dexamethasone|dexamethasone|mesh-list
14090944|NCT02460055|Fentanyl|fentanyl|mesh-list
14090945|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
14090946|NCT02460055|Ondansetron|ondansetron|mesh-list
14090947|NCT02460055|Propofol|propofol|mesh-list
14090948|NCT02460055|Sevoflurane|sevoflurane|mesh-list
14090949|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14090950|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
14090951|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
14090952|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14090953|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920377|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
13920378|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920379|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090954|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14090955|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
14090956|NCT02460055|Hormones|hormones|mesh-ancestor
14090957|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920380|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920381|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13920382|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13920383|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13920384|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920385|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13920386|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13920387|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920388|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
14090958|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14090959|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760793|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090960|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14090961|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090962|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14090963|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
14090964|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
14090965|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14090966|NCT02460055|Narcotics|narcotics|mesh-ancestor
14090967|NCT02460055|Analgesics|analgesics|mesh-ancestor
14090968|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
14090969|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14090970|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13920389|NCT03450226|Bupivacaine|bupivacaine|mesh-list
14090971|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14090972|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
14477341|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477342|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477343|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
14477344|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090973|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
14090974|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14090975|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
14090976|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14090977|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090978|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14090979|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14090980|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14477345|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14477346|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
13920390|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
14090981|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14090982|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14090983|NCT02460042|Paclitaxel|paclitaxel|mesh-list
14090984|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14090985|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14090986|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14090987|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14090988|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14090989|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14090990|NCT02459782|Anesthetics|anesthetics|mesh-list
14090991|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14090992|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14090993|NCT02460016|Ziresovir|ziresovir|mesh-list
14090994|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
14090995|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920391|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
13920392|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920393|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920394|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
13920395|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920396|NCT03450161|Fentanyl|fentanyl|mesh-list
13920397|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13920398|NCT03450161|Narcotics|narcotics|mesh-ancestor
13920399|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920400|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920401|NCT03450161|Analgesics|analgesics|mesh-ancestor
13920402|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
14090996|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
14090997|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
14090998|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
14090999|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091000|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091001|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
14091002|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14091003|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14091004|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
14091005|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091006|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091007|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
14091008|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14091009|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091010|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091011|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14091012|NCT02459509|Analgesics|analgesics|mesh-ancestor
14091013|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
14091014|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091015|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14091016|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14091017|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14091018|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091019|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091020|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091021|NCT02459613|Annexin A5|annexin a5|mesh-list
14091022|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920403|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920404|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14091023|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091024|NCT02459756|Ascorbic Acid|ascorbic acid|mesh-list
14477347|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14935708|NCT01465009|Aspirin|aspirin|mesh-list
14935709|NCT01465009|Acetaminophen|acetaminophen|mesh-list
14935710|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14935711|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935712|NCT01465009|Analgesics|analgesics|mesh-ancestor
14935713|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
14935714|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935715|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935716|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14935717|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935718|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935719|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14935720|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935721|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935722|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14935723|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935724|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
13920405|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13920406|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
13920407|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
13920408|NCT03450109|Goserelin|goserelin|mesh-list
13920409|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920410|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920411|NCT03450057|Daratumumab|daratumumab|mesh-list
13920412|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920413|NCT03450018|Gemcitabine|gemcitabine|mesh-list
14091025|NCT02459756|Citric Acid|citric acid|mesh-list
14091026|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
14091027|NCT02459756|Vitamins|vitamins|mesh-ancestor
14091028|NCT02459756|Micronutrients|micronutrients|mesh-ancestor
14091029|NCT02459756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091030|NCT02459756|Antioxidants|antioxidants|mesh-ancestor
14091031|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091032|NCT02459756|Protective Agents|protective agents|mesh-ancestor
14091033|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
14091034|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14091035|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
14091036|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
14091037|NCT02459574|Amiodarone|amiodarone|mesh-list
14091038|NCT02459574|Sotalol|sotalol|mesh-list
14091039|NCT02459574|Flecainide|flecainide|mesh-list
14091040|NCT02459574|Propafenone|propafenone|mesh-list
14091041|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14091042|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
14091043|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14091044|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091045|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14091046|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14091047|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091048|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091049|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091050|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
14091051|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14091052|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14091053|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14091054|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14091055|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14091056|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091057|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14091058|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14091059|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14091060|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
14091061|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
14091062|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091063|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14091064|NCT02459288|Clopidogrel|clopidogrel|mesh-list
14091065|NCT02459288|Ticagrelor|ticagrelor|mesh-list
13920414|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920415|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
14091066|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14091067|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14091068|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14091069|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14091070|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
13920416|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920417|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920418|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
13920419|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920420|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920421|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920422|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
13920423|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920424|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13920425|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
13920426|NCT03449940|Diclofenac|diclofenac|mesh-list
13920427|NCT03449940|Lidocaine|lidocaine|mesh-list
14091071|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091072|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091073|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091074|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
14091075|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14091076|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091077|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14091078|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091079|NCT02458963|Menotropins|menotropins|mesh-list
14091080|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14091081|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
14091082|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14091083|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091084|NCT02458742|Morphine|morphine|mesh-list
14091085|NCT02458742|Bupivacaine|bupivacaine|mesh-list
14091086|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091087|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
14091088|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091089|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091090|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
14091091|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091092|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14477348|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14477349|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14477350|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477351|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14477352|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14477353|NCT02431806|Analgesics|analgesics|mesh-ancestor
14477354|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
14477355|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477356|NCT02432040|Atorvastatin|atorvastatin|mesh-list
14477357|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14091093|NCT02458742|Narcotics|narcotics|mesh-ancestor
14091094|NCT02458742|Analgesics|analgesics|mesh-ancestor
14091095|NCT02458755|Atorvastatin|atorvastatin|mesh-list
14091096|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14091097|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14091098|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14091099|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
14091100|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477358|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14477359|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
14477360|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477361|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14477362|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14477363|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760794|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14760795|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14760796|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
14760797|NCT04123366|Olaparib|olaparib|mesh-list
14760798|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760799|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760800|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14760801|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760802|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760803|NCT04121260|Daratumumab|daratumumab|mesh-list
13920428|NCT03449940|Analgesics|analgesics|mesh-list
14477364|NCT02432274|Etoposide|etoposide|mesh-list
14477365|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
14477366|NCT02432274|Ifosfamide|ifosfamide|mesh-list
14477367|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
14477368|NCT02432274|Lenvatinib|lenvatinib|mesh-list
14477369|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14477370|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091101|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14091102|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14091103|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091104|NCT02458924|Niacin|niacin|mesh-list
14091105|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14091106|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
14091107|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091108|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14091109|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
14091110|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
14091111|NCT02458924|Vitamins|vitamins|mesh-ancestor
14091112|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
14091113|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174224|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
14174225|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
14174226|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14174227|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14174228|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14174229|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174230|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174231|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174232|NCT04789005|Protective Agents|protective agents|mesh-ancestor
14174233|NCT04788979|Melatonin|melatonin|mesh-list
14174234|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
14174235|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174236|NCT04788979|Protective Agents|protective agents|mesh-ancestor
14174237|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174238|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174239|NCT04788641|Cyclosporine|cyclosporine|mesh-list
14174240|NCT04788641|Tacrolimus|tacrolimus|mesh-list
14174241|NCT04788641|Cyclosporins|cyclosporins|mesh-list
14477371|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14477372|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14477373|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477374|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477375|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14477376|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
14477377|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13920429|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
13920430|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
13920431|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920432|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920433|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
13920434|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920435|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13920436|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13920437|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13920438|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13920439|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920440|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920441|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13920442|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13920443|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091114|NCT02459158|Arbekacin|arbekacin|mesh-list
14091115|NCT02459158|Dibekacin|dibekacin|mesh-list
14091116|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14091117|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091118|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14091119|NCT02458716|Leuprolide|leuprolide|mesh-list
14091120|NCT02458716|Bicalutamide|bicalutamide|mesh-list
14091121|NCT02458716|Androgens|androgens|mesh-list
14091122|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
14091123|NCT02458716|Hormones|hormones|mesh-ancestor
14091124|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091125|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091126|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14091127|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
13920444|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13920445|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13920446|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920447|NCT03449901|Gemcitabine|gemcitabine|mesh-list
13920448|NCT03449901|Docetaxel|docetaxel|mesh-list
13920449|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920450|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
13920451|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920452|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920453|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
14091128|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14091129|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14091130|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091131|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
14091132|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
14091133|NCT02458911|Paclitaxel|paclitaxel|mesh-list
14091134|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14091135|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091136|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14091137|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
14091138|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
14091139|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091140|NCT02458781|Metronidazole|metronidazole|mesh-list
14091141|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
14091142|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
14091143|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091144|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14091145|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14091146|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14091147|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14091148|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14091149|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091150|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091151|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091152|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14091153|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14091154|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14091155|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
14091156|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
14091157|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
14091158|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14091159|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14091160|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091161|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
14091162|NCT02458729|Coagulants|coagulants|mesh-ancestor
13920454|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920455|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920456|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920457|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
13920458|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920459|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
13920460|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
13920461|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
13920462|NCT03449836|Fluticasone|fluticasone|mesh-list
13920463|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
14091163|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14091164|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
14091165|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14091166|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14091167|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091168|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
14091169|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
14091170|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14091171|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14091172|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13920464|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920465|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13920466|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
13920467|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920468|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920469|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13920470|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
13920471|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
13920472|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13920473|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
13920474|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
13920475|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13920476|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14091173|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14091174|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091175|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091176|NCT02458547|Bupivacaine|bupivacaine|mesh-list
14091177|NCT02458547|Propofol|propofol|mesh-list
14091178|NCT02458547|Desflurane|desflurane|mesh-list
13920477|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920478|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
13920479|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920480|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13920481|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920482|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920483|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
13920484|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920485|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920486|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13920487|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
13920488|NCT03449693|Antacids|antacids|mesh-ancestor
13920489|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920490|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920491|NCT03449654|Liraglutide|liraglutide|mesh-list
13920492|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13920493|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920494|NCT03449654|Incretins|incretins|mesh-ancestor
13920495|NCT03449654|Hormones|hormones|mesh-ancestor
13920496|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091179|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091180|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
14091181|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091182|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091183|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
14091184|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091185|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14091186|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14091187|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
14091188|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14091189|NCT02458625|Iron|iron|mesh-list
14091190|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14935725|NCT01465074|Nicotine|nicotine|mesh-list
14935726|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14935727|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
14935728|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935729|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091191|NCT02458625|Trace Elements|trace elements|mesh-ancestor
14091192|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
14091193|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091194|NCT02458625|Hematinics|hematinics|mesh-ancestor
14091195|NCT02458482|Albuterol|albuterol|mesh-list
13920497|NCT03449537|Caseins|caseins|mesh-list
13920498|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
13920499|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
14091196|NCT02458482|Ipratropium|ipratropium|mesh-list
14091197|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13920500|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920501|NCT03449524|CXA-10|cxa-10|mesh-list
14091198|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
14091199|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091200|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091201|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14091202|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
14091203|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
14091204|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14091205|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14091206|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14091207|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14091208|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091209|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091210|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091211|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14091212|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
14091213|NCT02458339|Methotrexate|methotrexate|mesh-list
14935730|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14935731|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14935732|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
14935733|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935734|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935735|NCT01465113|Vitamin D|vitamin d|mesh-list
14935736|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
14935737|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
14935738|NCT01465113|Vitamins|vitamins|mesh-list
14935739|NCT01465113|Metformin|metformin|mesh-list
14935740|NCT01465113|Omeprazole|omeprazole|mesh-list
14935741|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
14935742|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935743|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14935744|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13920502|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920503|NCT03449459|Amikacin|amikacin|mesh-list
13920504|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13920505|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960427|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13960428|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14935745|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14935746|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14935747|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14935748|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14935749|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935750|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960429|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14091214|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14091215|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
14091216|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14091217|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091218|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14091219|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
14091220|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091221|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091222|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
14091223|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091224|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14477378|NCT02432287|Metformin|metformin|mesh-list
14477379|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14477380|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477381|NCT02432456|Acetaminophen|acetaminophen|mesh-list
14935751|NCT01465152|Metformin|metformin|mesh-list
14091225|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477382|NCT02432456|Ibuprofen|ibuprofen|mesh-list
14477383|NCT02432456|Ketamine|ketamine|mesh-list
14935752|NCT01465152|Repaglinide|repaglinide|mesh-list
14935753|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14091226|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
14091227|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091228|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14091229|NCT02458209|Bococizumab|bococizumab|mesh-list
14091230|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14091231|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13920506|NCT03449251|Verapamil|verapamil|mesh-list
13920507|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
13920508|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14091232|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
14091233|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091234|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14091235|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14091236|NCT02458014|Blinatumomab|blinatumomab|mesh-list
14091237|NCT02458014|Antibodies|antibodies|mesh-list
14091238|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
14091239|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14091240|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
14091241|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14091242|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
14091243|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091244|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091245|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091246|NCT02458183|Vaccines|vaccines|mesh-list
14091247|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
14091248|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091249|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
14091250|NCT02458196|Prednisone|prednisone|mesh-list
14091251|NCT02458196|Prednisolone|prednisolone|mesh-list
14091252|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091253|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
14091254|NCT02458196|Hormones|hormones|mesh-ancestor
14091255|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091256|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091257|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14091258|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091259|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14091260|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14091261|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
14091262|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14091263|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091264|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091265|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091266|NCT02458157|Furosemide|furosemide|mesh-list
14091267|NCT02458157|Diuretics|diuretics|mesh-ancestor
14091268|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
14091269|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091270|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14091271|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14091272|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091273|NCT02457975|Ranibizumab|ranibizumab|mesh-list
14091274|NCT02457975|Aflibercept|aflibercept|mesh-list
14091275|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091276|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14091277|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14091278|NCT02457975|Growth Substances|growth substances|mesh-ancestor
14091279|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091280|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
14091281|NCT02458118|Secretin|secretin|mesh-list
14091282|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14091283|NCT02458118|Hormones|hormones|mesh-ancestor
14091284|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091285|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091286|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
14091287|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14091288|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091289|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091290|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13920509|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13920510|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13920511|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920512|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13920513|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760804|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091291|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14091292|NCT02458079|Protective Agents|protective agents|mesh-ancestor
14091293|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091294|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
14091295|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14091296|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
14091297|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
14091298|NCT02457650|Fludarabine|fludarabine|mesh-list
14091299|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091300|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
14091301|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091302|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091303|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14091304|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
14091305|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091306|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091307|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14091308|NCT02457806|Phenylephrine|phenylephrine|mesh-list
14091309|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
14091310|NCT02457806|Tetracaine|tetracaine|mesh-list
14091311|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091312|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
13920514|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
13920515|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920516|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
14091313|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091314|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091315|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
14091316|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091317|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14091318|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14091319|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091320|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091321|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091322|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
14091323|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
14091324|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
14091325|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14091326|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
14091327|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14091328|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
14091329|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14091330|NCT02457806|Protective Agents|protective agents|mesh-ancestor
14091331|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14091332|NCT02457585|Infliximab|infliximab|mesh-list
14091333|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14091334|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14091335|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091336|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091337|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
14091338|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
14091339|NCT02457507|Vitamins|vitamins|mesh-ancestor
14091340|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
14091341|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091342|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
14760805|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
14760806|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760807|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760808|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760809|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760810|NCT04115644|Triamcinolone|triamcinolone|mesh-list
13920517|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14091343|NCT02457507|Hematinics|hematinics|mesh-ancestor
14091344|NCT02457286|Metformin|metformin|mesh-list
14091345|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14091346|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091347|NCT02457221|Prednisone|prednisone|mesh-list
14091348|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
13920518|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920519|NCT03449173|Sunitinib|sunitinib|mesh-list
13920520|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920521|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14760811|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14091349|NCT02457221|Tacrolimus|tacrolimus|mesh-list
14091350|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091351|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
14091352|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091353|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091354|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14091355|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
14091356|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091357|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091358|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14091359|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091360|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
14091361|NCT02457221|Hormones|hormones|mesh-ancestor
14091362|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091363|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14091364|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14091365|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091366|NCT02457351|Itraconazole|itraconazole|mesh-list
14091367|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
14091368|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091369|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14091370|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14091371|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091372|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091373|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14091374|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
14091375|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091376|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091377|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14091378|NCT02457442|Remifentanil|remifentanil|mesh-list
14091379|NCT02457442|Propofol|propofol|mesh-list
14091380|NCT02457442|Sevoflurane|sevoflurane|mesh-list
14091381|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14091382|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091383|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091384|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14091385|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
14091386|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
14091387|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14091388|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14091389|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14091390|NCT02457442|Narcotics|narcotics|mesh-ancestor
14091391|NCT02457442|Analgesics|analgesics|mesh-ancestor
14091392|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
14091393|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174242|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14174243|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
14174244|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174245|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14174246|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174247|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174248|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
14174249|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174250|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14174251|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174252|NCT04788823|Prednisone|prednisone|mesh-list
13920522|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13920523|NCT03449173|Growth Substances|growth substances|mesh-ancestor
13920524|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920525|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
13920526|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13920527|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920528|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920529|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13920530|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
13920531|NCT03449082|Coagulants|coagulants|mesh-ancestor
13920532|NCT03449056|Albuterol|albuterol|mesh-list
13920533|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14174253|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920534|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
13920535|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920536|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920537|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13920538|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
14935754|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935755|NCT01465256|Aspirin|aspirin|mesh-list
14935756|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14935757|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13920539|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
13920540|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13920541|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13920542|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13920543|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13920544|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
13920545|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920546|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920547|NCT03448835|Docetaxel|docetaxel|mesh-list
13920548|NCT03448835|Capecitabine|capecitabine|mesh-list
13920549|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
13920550|NCT03448835|Atezolizumab|atezolizumab|mesh-list
13920551|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920552|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
13920553|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
13920554|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
13920555|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920556|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920557|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
14091394|NCT02457312|Letrozole|letrozole|mesh-list
14091395|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091396|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14091397|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14091398|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091399|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091400|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13920558|NCT03448770|Lactulose|lactulose|mesh-list
13920559|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920560|NCT03448744|Entecavir|entecavir|mesh-list
13920561|NCT03448744|Thymalfasin|thymalfasin|mesh-list
13920562|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
14091401|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
14091402|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091403|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091404|NCT02457208|Rifampin|rifampin|mesh-list
14091405|NCT02457208|Isoniazid|isoniazid|mesh-list
14091406|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
14091407|NCT02457208|Ethambutol|ethambutol|mesh-list
14091408|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14091409|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
14091410|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14091411|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091412|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
14091413|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14091414|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091415|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091416|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14091417|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13920563|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920564|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13920565|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
13920566|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920567|NCT03448731|Doxycycline|doxycycline|mesh-list
13920568|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13920569|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920570|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
13920571|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13920572|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13920573|NCT03448705|Vaccines|vaccines|mesh-list
13920574|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
13920575|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920576|NCT03448640|Tropicamide|tropicamide|mesh-list
13920577|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
13920578|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
13920579|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920580|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920581|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14174254|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
14091418|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14091419|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14091420|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14091421|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14091422|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14091423|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14091424|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
14091425|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14091426|NCT02456961|Riboflavin|riboflavin|mesh-list
14091427|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
14091428|NCT02456961|Vitamins|vitamins|mesh-ancestor
13920582|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13920583|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
13920584|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920585|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920586|NCT03448588|Selenium|selenium|mesh-list
13920587|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
13920588|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920589|NCT03448588|Protective Agents|protective agents|mesh-ancestor
14091429|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
14091430|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091431|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14091432|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14091433|NCT02456974|Amoxicillin|amoxicillin|mesh-list
13920590|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920591|NCT03448588|Trace Elements|trace elements|mesh-ancestor
13920592|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
13920593|NCT03448549|Capecitabine|capecitabine|mesh-list
13920594|NCT03448549|Tegafur|tegafur|mesh-list
13920595|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
13920596|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920597|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
13920598|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920599|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920600|NCT03448159|Fluoxetine|fluoxetine|mesh-list
13920601|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13920602|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13920603|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13920604|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920605|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920606|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
13920607|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920608|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13920609|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
13920610|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13920611|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14091434|NCT02456974|Vancomycin|vancomycin|mesh-list
14091435|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
14091436|NCT02456974|Meropenem|meropenem|mesh-list
14091437|NCT02456974|Tazobactam|tazobactam|mesh-list
14091438|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
14091439|NCT02456974|Amikacin|amikacin|mesh-list
14091440|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14091441|NCT02456974|Teicoplanin|teicoplanin|mesh-list
14091442|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14091443|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091444|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13920612|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13920613|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920614|NCT03448107|Fluorides|fluorides|mesh-list
13920615|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
13920616|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
13920617|NCT03448107|Protective Agents|protective agents|mesh-ancestor
13920618|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920619|NCT03448094|Resveratrol|resveratrol|mesh-list
13920620|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
13920621|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920622|NCT03448094|Protective Agents|protective agents|mesh-ancestor
13920623|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920624|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920625|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13920626|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
13920627|NCT03447925|Salicylates|salicylates|mesh-list
13920628|NCT03447925|Petrolatum|petrolatum|mesh-list
14091445|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14091446|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174255|NCT04788823|Hormones|hormones|mesh-ancestor
13920629|NCT03447925|Emollients|emollients|mesh-ancestor
13920630|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
13920631|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13920632|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14091447|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091448|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091449|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14091450|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14091451|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13920633|NCT03447925|Analgesics|analgesics|mesh-ancestor
13920634|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
13920635|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920636|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920637|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920638|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13920639|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13920640|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920641|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920642|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920643|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
13920644|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
13920645|NCT03447873|Lamivudine|lamivudine|mesh-list
13920646|NCT03447873|Cobicistat|cobicistat|mesh-list
13920647|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13920648|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13920649|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920650|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920651|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
14091452|NCT02457130|Clopidogrel|clopidogrel|mesh-list
14091453|NCT02457130|Ticagrelor|ticagrelor|mesh-list
14091454|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14091455|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14091456|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14091457|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14091458|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
14091459|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091460|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091461|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091462|NCT02456935|Esomeprazole|esomeprazole|mesh-list
14091463|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14091464|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14091465|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14091466|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091467|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091468|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
14091469|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091470|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
14091471|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091472|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091473|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14091474|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
14091475|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091476|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091477|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14091478|NCT02457026|Triamcinolone|triamcinolone|mesh-list
14091479|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14091480|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14091481|NCT02457026|Aflibercept|aflibercept|mesh-list
14091482|NCT02457026|Verteporfin|verteporfin|mesh-list
14091483|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14091484|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091485|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
14091486|NCT02457026|Hormones|hormones|mesh-ancestor
13920652|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920653|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13920654|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13920655|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13920656|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13920657|NCT03447782|Naltrexone|naltrexone|mesh-list
14091487|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091488|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091489|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091490|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
14091491|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091492|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091493|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14091494|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14091495|NCT02457026|Growth Substances|growth substances|mesh-ancestor
14091496|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
14091497|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091498|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14091499|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14091500|NCT02456948|Minocycline|minocycline|mesh-list
14091501|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14091502|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091503|NCT02456844|Leucovorin|leucovorin|mesh-list
14091504|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
14091505|NCT02456844|Methotrexate|methotrexate|mesh-list
14091506|NCT02456844|Digoxin|digoxin|mesh-list
14091507|NCT02456844|Midazolam|midazolam|mesh-list
14091508|NCT02456844|Pravastatin|pravastatin|mesh-list
14091509|NCT02456844|Montelukast|montelukast|mesh-list
14091510|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14091511|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
14091512|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14091513|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091514|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14091515|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
14091516|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091517|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091518|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
14091519|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091520|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14091521|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091522|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
14091523|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091524|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14091525|NCT02456844|Antidotes|antidotes|mesh-ancestor
14091526|NCT02456844|Protective Agents|protective agents|mesh-ancestor
14091527|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
14091528|NCT02456844|Vitamins|vitamins|mesh-ancestor
14091529|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
14091530|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14091531|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14091532|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091533|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14091534|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14091535|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14091536|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14091537|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
14091538|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
14091539|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
14091540|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
14091541|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091542|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14091543|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
14091544|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14091545|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
14091546|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091547|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14091548|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14091549|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14091550|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14091551|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14091552|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14091553|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14091554|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14091555|NCT02456844|Analgesics|analgesics|mesh-ancestor
14091556|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
14091557|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091558|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14091559|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14091560|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091561|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14091562|NCT02456532|Zolpidem|zolpidem|mesh-list
14091563|NCT02456532|Eszopiclone|eszopiclone|mesh-list
14477384|NCT02432456|Narcotics|narcotics|mesh-list
14091564|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14091565|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14477385|NCT02432456|Methocarbamol|methocarbamol|mesh-list
14091566|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091567|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091568|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14091569|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
13920658|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13920659|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13920660|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920661|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
13920662|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920663|NCT03447691|Remifentanil|remifentanil|mesh-list
13920664|NCT03447691|Anesthetics|anesthetics|mesh-list
13920665|NCT03447691|Propofol|propofol|mesh-list
13920666|NCT03447691|Desflurane|desflurane|mesh-list
13920667|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920668|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920669|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13920670|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13920671|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
13920672|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13920673|NCT03447691|Narcotics|narcotics|mesh-ancestor
13920674|NCT03447691|Analgesics|analgesics|mesh-ancestor
13920675|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
13920676|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920677|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13920678|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
13920679|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920680|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960430|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13960431|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
13960432|NCT03154983|Docetaxel|docetaxel|mesh-list
13960433|NCT03154983|Apatinib|apatinib|mesh-list
14091570|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
14091571|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091572|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091573|NCT02456597|Lidocaine|lidocaine|mesh-list
14091574|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091575|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
14091576|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091577|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091578|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
14935758|NCT01465256|Analgesics|analgesics|mesh-ancestor
14935759|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
14935760|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935761|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935762|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960434|NCT03154983|Tegafur|tegafur|mesh-list
13960435|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960436|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
13960437|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
13960438|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
13960439|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960440|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13960441|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960442|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13960443|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
13960444|NCT03154567|Yohimbine|yohimbine|mesh-list
13960445|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
13960446|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
13960447|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960448|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960449|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13960450|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13960451|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13960452|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960453|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960454|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091579|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760812|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14760813|NCT04115644|Ketorolac|ketorolac|mesh-list
14760814|NCT04115644|Bupivacaine|bupivacaine|mesh-list
14760815|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14760816|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
14760817|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
14760818|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14760819|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760820|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
14091580|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14091581|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14091582|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14091583|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14091584|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091585|NCT02456714|Folfirinox|folfirinox|mesh-list
13920681|NCT03447470|Nivolumab|nivolumab|mesh-list
13920682|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920683|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920684|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13920685|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920686|NCT03447184|Androgens|androgens|mesh-list
13920687|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13920688|NCT03447184|Hormones|hormones|mesh-ancestor
13920689|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920690|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091586|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091587|NCT02456454|Valproic Acid|valproic acid|mesh-list
14091588|NCT02456454|Risperidone|risperidone|mesh-list
14091589|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14091590|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
14091591|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091592|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091593|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091594|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14091595|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13920691|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13920692|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920693|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920694|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13920695|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
13920696|NCT03447132|Fulvestrant|fulvestrant|mesh-list
13920697|NCT03447132|Goserelin|goserelin|mesh-list
13920698|NCT03447132|Palbociclib|palbociclib|mesh-list
13920699|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14091596|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091597|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14091598|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14091599|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
14091600|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
14091601|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091602|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
14091603|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
14091604|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14091605|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
14091606|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14091607|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
14091608|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14091609|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091610|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14091611|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14091612|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14091613|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091614|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14091615|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14091616|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14091617|NCT02456701|Vemurafenib|vemurafenib|mesh-list
14091618|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091619|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14091620|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091621|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091622|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14091623|NCT02456558|Deferiprone|deferiprone|mesh-list
14091624|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14091625|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
14091626|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
13920700|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091627|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091628|NCT02456428|Insulin|insulin|mesh-list
14091629|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14091630|NCT02456428|Metformin|metformin|mesh-list
14091631|NCT02456428|Pioglitazone|pioglitazone|mesh-list
13920701|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14091632|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14091633|NCT02456428|Liraglutide|liraglutide|mesh-list
14091634|NCT02456428|Exenatide|exenatide|mesh-list
14091635|NCT02456428|Glimepiride|glimepiride|mesh-list
14091636|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
14091637|NCT02456428|Vildagliptin|vildagliptin|mesh-list
14091638|NCT02456428|Saxagliptin|saxagliptin|mesh-list
14091639|NCT02456428|Acarbose|acarbose|mesh-list
14091640|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14091641|NCT02456428|Repaglinide|repaglinide|mesh-list
14091642|NCT02456428|Gliclazide|gliclazide|mesh-list
14091643|NCT02456428|Glipizide|glipizide|mesh-list
14091644|NCT02456428|Tolbutamide|tolbutamide|mesh-list
14091645|NCT02456428|Biguanides|biguanides|mesh-list
14091646|NCT02456428|Voglibose|voglibose|mesh-list
14091647|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14091648|NCT02456428|Nateglinide|nateglinide|mesh-list
14091649|NCT02456428|Miglitol|miglitol|mesh-list
14091650|NCT02456428|Troglitazone|troglitazone|mesh-list
14091651|NCT02456428|Meglitinide|meglitinide|mesh-list
14091652|NCT02456428|Acetohexamide|acetohexamide|mesh-list
14091653|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
14091654|NCT02456428|Buformin|buformin|mesh-list
14091655|NCT02456428|Phenformin|phenformin|mesh-list
14091656|NCT02456428|Glibornuride|glibornuride|mesh-list
14091657|NCT02456428|Tolazamide|tolazamide|mesh-list
14091658|NCT02456428|Carbutamide|carbutamide|mesh-list
14091659|NCT02456428|Gliquidone|gliquidone|mesh-list
14091660|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14091661|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14091662|NCT02456428|Incretins|incretins|mesh-list
14091663|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091664|NCT02456428|Hormones|hormones|mesh-ancestor
14091665|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091666|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
14091667|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091668|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091669|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14091670|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14091671|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091672|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
13920702|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13920703|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
13920704|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920705|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920706|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13920707|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920708|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920709|NCT03447093|Methimazole|methimazole|mesh-list
14091673|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
14091674|NCT02456350|Fludarabine|fludarabine|mesh-list
14091675|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091676|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
14091677|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091678|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091679|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14091680|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
14091681|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091682|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091683|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14091684|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
14091685|NCT02456363|Adalimumab|adalimumab|mesh-list
14091686|NCT02456363|Etanercept|etanercept|mesh-list
13920710|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
13920711|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
13920712|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
13920713|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091687|NCT02456363|Golimumab|golimumab|mesh-list
14091688|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091689|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091690|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14091691|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14091692|NCT02456363|Analgesics|analgesics|mesh-ancestor
14091693|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
14091694|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091695|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091696|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14091697|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091698|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
14091699|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14091700|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091701|NCT02456142|Morphine|morphine|mesh-list
14091702|NCT02456142|Bupivacaine|bupivacaine|mesh-list
14091703|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091704|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
14091705|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091706|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091707|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
14091708|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091709|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14091710|NCT02456142|Narcotics|narcotics|mesh-ancestor
14091711|NCT02456142|Analgesics|analgesics|mesh-ancestor
14091712|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14091713|NCT02456194|Calcium|calcium|mesh-list
14091714|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14091715|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091716|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091717|NCT02456129|Itraconazole|itraconazole|mesh-list
14091718|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
14091719|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091720|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14091721|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14091722|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091723|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091724|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14091725|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
14091726|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091727|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091728|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14091729|NCT02456207|Rituximab|rituximab|mesh-list
14091730|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14091731|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091732|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
14091733|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920714|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920715|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
13920716|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920717|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13920718|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
13920719|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920720|NCT03446937|Dexamethasone|dexamethasone|mesh-list
13920721|NCT03446937|Betamethasone|betamethasone|mesh-list
13920722|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
13920723|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13920724|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
13920725|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
13920726|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14091734|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091735|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14091736|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14091737|NCT02456116|Analgesics|analgesics|mesh-ancestor
14091738|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
14091739|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091740|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091741|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091742|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14091743|NCT02456025|Tacrolimus|tacrolimus|mesh-list
14091744|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14091745|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
14091746|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091747|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14091748|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091749|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091750|NCT02455726|Pregabalin|pregabalin|mesh-list
14091751|NCT02455726|Oxycodone|oxycodone|mesh-list
14091752|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
14091753|NCT02455726|Analgesics|analgesics|mesh-ancestor
14091754|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
14091755|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091756|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091757|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
14091758|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14091759|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14091760|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091761|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13920727|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13920728|NCT03446937|BB 1101|bb 1101|mesh-list
13920729|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920730|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
13920731|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
13920732|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920733|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920734|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920735|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
13920736|NCT03446937|Hormones|hormones|mesh-ancestor
14091762|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14091763|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14091764|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091765|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14091766|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14091767|NCT02455726|Narcotics|narcotics|mesh-ancestor
14091768|NCT02455726|Antacids|antacids|mesh-ancestor
14091769|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14091770|NCT02455908|Aldesleukin|aldesleukin|mesh-list
14091771|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091772|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14091773|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14091774|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
14091775|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091776|NCT02455869|Alendronate|alendronate|mesh-list
13920737|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920738|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920739|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920740|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13920741|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14091777|NCT02455869|Atorvastatin|atorvastatin|mesh-list
14091778|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14091779|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14091780|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
14091781|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091782|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14091783|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14091784|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091785|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14091786|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091787|NCT02455856|Itraconazole|itraconazole|mesh-list
14091788|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
14091789|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091790|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14091791|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14091792|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091793|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091794|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14091795|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
14091796|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091797|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091798|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14091799|NCT02455921|Atropine|atropine|mesh-list
14091800|NCT02455921|Neostigmine|neostigmine|mesh-list
14091801|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14091802|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14091803|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14091804|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
14091805|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091806|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091807|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14091808|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
14091809|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
14091810|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
14091811|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14091812|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14935763|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935764|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935765|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14091813|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
14091814|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091815|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935766|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935767|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13920742|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
14091816|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14091817|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091818|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14091819|NCT02455687|Budesonide|budesonide|mesh-list
14091820|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
14091821|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14091822|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14091823|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
14091824|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091825|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091826|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14091827|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14091828|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
14091829|NCT02455687|Hormones|hormones|mesh-ancestor
14091830|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091831|NCT02455687|Analgesics|analgesics|mesh-ancestor
14091832|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
14091833|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
13920743|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920744|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920745|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
13920746|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920747|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920748|NCT03446872|Leucovorin|leucovorin|mesh-list
13920749|NCT03446872|Fluorouracil|fluorouracil|mesh-list
13920750|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
13920751|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920752|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14091834|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091835|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14091836|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
14091837|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14091838|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14091839|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091840|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14091841|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
14091842|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14174256|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174257|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174258|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14174259|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174260|NCT04788914|Charcoal|charcoal|mesh-list
14174261|NCT04788914|Antidotes|antidotes|mesh-ancestor
14174262|NCT04788914|Protective Agents|protective agents|mesh-ancestor
14174263|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174264|NCT04788654|Acetaminophen|acetaminophen|mesh-list
14174265|NCT04788654|Dexamethasone|dexamethasone|mesh-list
14174266|NCT04788654|Celecoxib|celecoxib|mesh-list
14760821|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174267|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14174268|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
14174269|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
14174270|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174271|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174272|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174273|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
14174274|NCT04788654|Hormones|hormones|mesh-ancestor
14760822|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760823|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
14760824|NCT04115644|Hormones|hormones|mesh-ancestor
14174275|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174276|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14174277|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174278|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14174279|NCT04788654|Analgesics|analgesics|mesh-ancestor
14174280|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
14174281|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
14174282|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14174283|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174284|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14767326|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920753|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920754|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920755|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
13920756|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920757|NCT03446872|Antidotes|antidotes|mesh-ancestor
13920758|NCT03446872|Protective Agents|protective agents|mesh-ancestor
13920759|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
13920760|NCT03446872|Vitamins|vitamins|mesh-ancestor
13920761|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
13920762|NCT03446638|Cytarabine|cytarabine|mesh-list
14091843|NCT02455362|Morphine|morphine|mesh-list
14091844|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14091845|NCT02455362|Narcotics|narcotics|mesh-ancestor
14091846|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091847|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091848|NCT02455362|Analgesics|analgesics|mesh-ancestor
14091849|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
14091850|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091851|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
14091852|NCT02455609|Ketamine|ketamine|mesh-list
14091853|NCT02455609|Bupivacaine|bupivacaine|mesh-list
14091854|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091855|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
14091856|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091857|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091858|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
14091859|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091860|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14091861|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14091862|NCT02455609|Analgesics|analgesics|mesh-ancestor
14091863|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14091864|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14091865|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14091866|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091867|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091868|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091869|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14091870|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14091871|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
14091872|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14091873|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14091874|NCT02455401|Remifentanil|remifentanil|mesh-list
14091875|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14091876|NCT02455401|Narcotics|narcotics|mesh-ancestor
14091877|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091878|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091879|NCT02455401|Analgesics|analgesics|mesh-ancestor
14091880|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
14091881|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091882|NCT02455596|Interferons|interferons|mesh-list
14091883|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091884|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
14091885|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14091886|NCT02455440|Propofol|propofol|mesh-list
14091887|NCT02455440|Sevoflurane|sevoflurane|mesh-list
14091888|NCT02455440|Esmolol|esmolol|mesh-list
14091889|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14091890|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091891|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091892|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14091893|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
14091894|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
14091895|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14091896|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14091897|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14091898|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14091899|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14091900|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091901|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091902|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091903|NCT02455271|Eszopiclone|eszopiclone|mesh-list
14091904|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13920763|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14091905|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920764|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
13920765|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920766|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091906|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091907|NCT02455232|Lidocaine|lidocaine|mesh-list
13920767|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
13920768|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920769|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920770|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
13920771|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920772|NCT03446625|Resveratrol|resveratrol|mesh-list
13920773|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
13920774|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920775|NCT03446625|Protective Agents|protective agents|mesh-ancestor
13920776|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920777|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14091908|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091909|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
14091910|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091911|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091912|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
14091913|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091914|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13920778|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13920779|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
13920780|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
13920781|NCT03446599|Methylene Blue|methylene blue|mesh-list
13920782|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920783|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920784|NCT03446599|Hematinics|hematinics|mesh-ancestor
13920785|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
13920786|NCT03446599|Vitamins|vitamins|mesh-ancestor
13920787|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
13920788|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920789|NCT03446547|Durvalumab|durvalumab|mesh-list
13920790|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920791|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920792|NCT03446534|Amoxicillin|amoxicillin|mesh-list
13920793|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13920794|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920795|NCT03446495|Trabectedin|trabectedin|mesh-list
13920796|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14091915|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14091916|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14091917|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14091918|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091919|NCT02455245|Carboplatin|carboplatin|mesh-list
14091920|NCT02455245|Vincristine|vincristine|mesh-list
14091921|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091922|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14091923|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
14091924|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
14091925|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
14091926|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091927|NCT02454894|Lidocaine|lidocaine|mesh-list
13920797|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
14091928|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
14091929|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
14091930|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091931|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091932|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
14091933|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091934|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14091935|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14091936|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14091937|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14091938|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091939|NCT02455154|Letrozole|letrozole|mesh-list
14091940|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091941|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14091942|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14091943|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920798|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920799|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920800|NCT03446443|Metronidazole|metronidazole|mesh-list
14091944|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091945|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14091946|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
14091947|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14091948|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091949|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
13920801|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920802|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13920803|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13920804|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13920805|NCT03446001|Methylene Blue|methylene blue|mesh-list
13920806|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920807|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920808|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13920809|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13920810|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920811|NCT03445897|Miltefosine|miltefosine|mesh-list
13920812|NCT03445897|Pentamidine|pentamidine|mesh-list
14091950|NCT02455180|Vitamins|vitamins|mesh-ancestor
14091951|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
14091952|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091953|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
14091954|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091955|NCT02455180|Protective Agents|protective agents|mesh-ancestor
14091956|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
14091957|NCT02454881|Oxycodone|oxycodone|mesh-list
13920813|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
13920814|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920815|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091958|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14091959|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14091960|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091961|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14091962|NCT02454881|Analgesics|analgesics|mesh-ancestor
14091963|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
14091964|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091965|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14091966|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14091967|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14091968|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091969|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091970|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091971|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14091972|NCT02454881|Narcotics|narcotics|mesh-ancestor
14091973|NCT02455115|Chromium|chromium|mesh-list
14091974|NCT02455115|Norepinephrine|norepinephrine|mesh-list
14091975|NCT02455115|Edetic Acid|edetic acid|mesh-list
14091976|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
14091977|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14091978|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14091979|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
14091980|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14091981|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14091982|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091983|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
14091984|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
14091985|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14091986|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13920816|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14091987|NCT02455115|Trace Elements|trace elements|mesh-ancestor
14091988|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
14091989|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
13920817|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13920818|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13960455|NCT03154567|Urological Agents|urological agents|mesh-ancestor
13960456|NCT03154645|Ibuprofen|ibuprofen|mesh-list
13960457|NCT03154645|Acetazolamide|acetazolamide|mesh-list
13960458|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13960459|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13960460|NCT03154645|Analgesics|analgesics|mesh-ancestor
13960461|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
13960462|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960463|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960464|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960465|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13960466|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13960467|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960468|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960469|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
13960470|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13960471|NCT03154645|Diuretics|diuretics|mesh-ancestor
13960472|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
13960473|NCT03154385|Rituximab|rituximab|mesh-list
13960474|NCT03154385|Belimumab|belimumab|mesh-list
13960475|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13960476|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960477|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
13960478|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960479|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13960480|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960481|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
13960482|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
13960483|NCT03154528|Vitamin D|vitamin d|mesh-list
13960484|NCT03154528|Vitamins|vitamins|mesh-ancestor
13960485|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
13960486|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960487|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13960488|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
13960489|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
13960490|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960491|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
13960492|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13960493|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13960494|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13960495|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960496|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960497|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960498|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960499|NCT03154372|Metronidazole|metronidazole|mesh-list
13960500|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960501|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13960502|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13960503|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13960504|NCT03154294|Paclitaxel|paclitaxel|mesh-list
13960505|NCT03154294|Serabelisib|serabelisib|mesh-list
13960506|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13960507|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14091990|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14091991|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
14091992|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
14091993|NCT02455115|Antidotes|antidotes|mesh-ancestor
14091994|NCT02455115|Protective Agents|protective agents|mesh-ancestor
14091995|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14091996|NCT02455011|Volagidemab|volagidemab|mesh-list
14091997|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14091998|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14091999|NCT02454868|Remifentanil|remifentanil|mesh-list
14092000|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14092001|NCT02454868|Narcotics|narcotics|mesh-ancestor
14092002|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092003|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092004|NCT02454868|Analgesics|analgesics|mesh-ancestor
14092005|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
14092006|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960508|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
13960509|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
14092007|NCT02454764|Interferons|interferons|mesh-list
14092008|NCT02454764|Tenofovir|tenofovir|mesh-list
14092009|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
13920819|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
13920820|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920821|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
13920822|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
13920823|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
14092010|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
14092011|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092012|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
14092013|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092014|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14092015|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14092016|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092017|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092018|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14092019|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14092020|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
14092021|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092022|NCT02454751|Fentanyl|fentanyl|mesh-list
13920824|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920825|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920826|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
13920827|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920828|NCT03445702|Metformin|metformin|mesh-list
13920829|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13920830|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920831|NCT03445624|Infliximab|infliximab|mesh-list
13920832|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
13920833|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920834|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13920835|NCT03445611|Lidocaine|lidocaine|mesh-list
13920836|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13920837|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
13920838|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
13920839|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920840|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920841|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
13920842|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920843|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13920844|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13920845|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13920846|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13920847|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920848|NCT03445533|Ipilimumab|ipilimumab|mesh-list
13920849|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13920850|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920851|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13920852|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920853|NCT03445468|Vaccines|vaccines|mesh-list
13920854|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
13920855|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920856|NCT03445286|Fluorides|fluorides|mesh-list
13920857|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
13920858|NCT03445286|Protective Agents|protective agents|mesh-ancestor
14092023|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14092024|NCT02454751|Narcotics|narcotics|mesh-ancestor
14092025|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092026|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092027|NCT02454751|Analgesics|analgesics|mesh-ancestor
14092028|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
14092029|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092030|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14092031|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14092032|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
14092033|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
14092034|NCT02454712|Naltrexone|naltrexone|mesh-list
14092035|NCT02454712|Oxycodone|oxycodone|mesh-list
14092036|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14092037|NCT02454712|Narcotics|narcotics|mesh-ancestor
14092038|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092039|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920859|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920860|NCT03445182|Anesthetics|anesthetics|mesh-list
13920861|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092040|NCT02454712|Analgesics|analgesics|mesh-ancestor
14092041|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
14092042|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092043|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14092044|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14092045|NCT02454543|Androgens|androgens|mesh-list
14092046|NCT02454543|Hormones|hormones|mesh-ancestor
14092047|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092048|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092049|NCT02454491|Verapamil|verapamil|mesh-list
14092050|NCT02454491|Heparin|heparin|mesh-list
14092051|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
14092052|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14092053|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14092054|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920862|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920863|NCT03445104|Huperzine A|huperzine a|mesh-list
13920864|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13920865|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920866|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920867|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
13920868|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092055|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14092056|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14092057|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092058|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14092059|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092060|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
14092061|NCT02454504|Neostigmine|neostigmine|mesh-list
14092062|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14092063|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092064|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092065|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
14092066|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092067|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092068|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14092069|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
13920869|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920870|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13920871|NCT03445104|Protective Agents|protective agents|mesh-ancestor
13920872|NCT03445078|Selenium|selenium|mesh-list
13920873|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
13920874|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920875|NCT03445078|Protective Agents|protective agents|mesh-ancestor
13920876|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920877|NCT03445078|Trace Elements|trace elements|mesh-ancestor
13920878|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
13920879|NCT03444831|Buspirone|buspirone|mesh-list
14092070|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092071|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13920880|NCT03444831|Omeprazole|omeprazole|mesh-list
13920881|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13920882|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920883|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13920884|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920885|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920886|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13920887|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13920888|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920889|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920890|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13920891|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13920892|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
13920893|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920894|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
13920895|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
13920896|NCT03444649|Cytarabine|cytarabine|mesh-list
13920897|NCT03444649|Daunorubicin|daunorubicin|mesh-list
13920898|NCT03444649|Idarubicin|idarubicin|mesh-list
13920899|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13920900|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
13920901|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092072|NCT02454556|Hormones|hormones|mesh-ancestor
14092073|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092074|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920902|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920903|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
14092075|NCT02454426|Vortioxetine|vortioxetine|mesh-list
14092076|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
14092077|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14092078|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14092079|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14092080|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092081|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092082|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14092083|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14092084|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092085|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092086|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092087|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
14092088|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14092089|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14092090|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14092091|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14092092|NCT02454348|Vasopressins|vasopressins|mesh-list
14092093|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
14092094|NCT02454348|Norepinephrine|norepinephrine|mesh-list
14092095|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14092096|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14760825|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760826|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14760827|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
14760828|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760829|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760830|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14760831|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14760832|NCT04115644|Analgesics|analgesics|mesh-ancestor
14760833|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760834|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14760835|NCT04113018|Dexamethasone|dexamethasone|mesh-list
14760836|NCT04113018|Lenalidomide|lenalidomide|mesh-list
14760837|NCT04113018|Daratumumab|daratumumab|mesh-list
14760838|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760839|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
14760840|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
14760841|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760842|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760843|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14760844|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
14760845|NCT04113018|Hormones|hormones|mesh-ancestor
14760846|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760847|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760848|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092097|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
14092098|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920904|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920905|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920906|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
14760849|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
14760850|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14760851|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13920907|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920908|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13920909|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13920910|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13920911|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920912|NCT03444636|Fentanyl|fentanyl|mesh-list
13920913|NCT03444636|Bupivacaine|bupivacaine|mesh-list
13920914|NCT03444636|Ropivacaine|ropivacaine|mesh-list
13920915|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
13920916|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
13920917|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13920918|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092099|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092100|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092101|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
14092102|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
14092103|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092104|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14760852|NCT04113018|Growth Substances|growth substances|mesh-ancestor
13920919|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
13920920|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920921|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13920922|NCT03444636|Narcotics|narcotics|mesh-ancestor
13920923|NCT03444636|Analgesics|analgesics|mesh-ancestor
13920924|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13920925|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13920926|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
13920927|NCT03444519|Mannitol|mannitol|mesh-list
13920928|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13920929|NCT03444519|Diuretics|diuretics|mesh-ancestor
13920930|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
13920931|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920932|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
13920933|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13920934|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13920935|NCT03444506|Analgesics|analgesics|mesh-ancestor
13920936|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
13920937|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13920938|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920939|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13920940|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13920941|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13920942|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13920943|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13920944|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
13920945|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
13920946|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920947|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920948|NCT03444467|Glucagon|glucagon|mesh-list
13920949|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920950|NCT03444467|Hormones|hormones|mesh-ancestor
13920951|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920952|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920953|NCT03444402|Esomeprazole|esomeprazole|mesh-list
13920954|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13920955|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13920956|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13920957|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13920958|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920959|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
13920960|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
14092105|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
14092106|NCT02454348|Coagulants|coagulants|mesh-ancestor
14092107|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14092108|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
14092109|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
14092110|NCT02454322|Analgesics|analgesics|mesh-ancestor
14092111|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
14092112|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092113|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092114|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
14092115|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092116|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13920961|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920962|NCT03444246|Iodine|iodine|mesh-list
13920963|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
13920964|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13920965|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13920966|NCT03444246|Trace Elements|trace elements|mesh-ancestor
13920967|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
13920968|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960510|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092117|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
14092118|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14092119|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092120|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092121|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14092122|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
14092123|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14092124|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
14092125|NCT02454205|Levofloxacin|levofloxacin|mesh-list
14092126|NCT02454205|Ofloxacin|ofloxacin|mesh-list
13960511|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960512|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960513|NCT03154606|Calcium|calcium|mesh-list
13960514|NCT03154606|Caseins|caseins|mesh-list
14092127|NCT02454205|Isoniazid|isoniazid|mesh-list
14092128|NCT02454205|Linezolid|linezolid|mesh-list
13920969|NCT03444142|Exenatide|exenatide|mesh-list
14092129|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
14092130|NCT02454205|Bedaquiline|bedaquiline|mesh-list
14092131|NCT02454205|Kanamycin|kanamycin|mesh-list
14092132|NCT02454205|Ethionamide|ethionamide|mesh-list
14092133|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14092134|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092135|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14092136|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14092137|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092138|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092139|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092140|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14092141|NCT02454205|Renal Agents|renal agents|mesh-ancestor
14092142|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14092143|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14092144|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
14092145|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14092146|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14092147|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
14092148|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14092149|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14092150|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
14092151|NCT02454088|Triamcinolone|triamcinolone|mesh-list
14092152|NCT02454088|Calcium|calcium|mesh-list
14092153|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14092154|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092155|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14092156|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092157|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
14092158|NCT02454088|Hormones|hormones|mesh-ancestor
14092159|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174285|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14174286|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174287|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183575|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183576|NCT04726657|Insulin|insulin|mesh-list
14183577|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14183578|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
14183579|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
14183580|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
14183581|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14183582|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183583|NCT04727073|Spironolactone|spironolactone|mesh-list
14183584|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14183585|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
14183586|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183587|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477386|NCT02432456|Pantoprazole|pantoprazole|mesh-list
14760853|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
14760854|NCT04111458|Trametinib|trametinib|mesh-list
14760855|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767327|NCT00629616|Fulvestrant|fulvestrant|mesh-list
13920970|NCT03444142|Dulaglutide|dulaglutide|mesh-list
13920971|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13920972|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920973|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13920974|NCT03444142|Incretins|incretins|mesh-ancestor
13920975|NCT03444142|Hormones|hormones|mesh-ancestor
13920976|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13920977|NCT03444025|Goserelin|goserelin|mesh-list
13920978|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13920979|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920980|NCT03444012|Ticagrelor|ticagrelor|mesh-list
13920981|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13920982|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13920983|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13920984|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13920985|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
13920986|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13920987|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13920988|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920989|NCT03443999|Sirolimus|sirolimus|mesh-list
13920990|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13920991|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092160|NCT02453867|Tacrolimus|tacrolimus|mesh-list
14092161|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092162|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
14092163|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092164|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14092165|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092166|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092167|NCT02453932|Donepezil|donepezil|mesh-list
14092168|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14092169|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092170|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092171|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
14092172|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092173|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092174|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
14092175|NCT02453698|Methylphenidate|methylphenidate|mesh-list
13920992|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13920993|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13920994|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
13920995|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13920996|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
13920997|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13920998|NCT03443960|Amitriptyline|amitriptyline|mesh-list
13920999|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
13921000|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13921001|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
13921002|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13921003|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13921004|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921005|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14092176|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14092177|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092178|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14092179|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14092180|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092181|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092182|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
14092183|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092184|NCT02453659|Nicotine|nicotine|mesh-list
14760856|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760857|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760858|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760859|NCT04109729|Nivolumab|nivolumab|mesh-list
14760860|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760861|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760862|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14760863|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767328|NCT00629616|Anastrozole|anastrozole|mesh-list
14767329|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14767330|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767331|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14767332|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14767333|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
14767334|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767335|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767336|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14767337|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14092185|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14092186|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
14092187|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092188|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092189|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13921006|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921007|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13921008|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921009|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13921010|NCT03443960|Analgesics|analgesics|mesh-ancestor
13921011|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
13921012|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13921013|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14092190|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14092191|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14092192|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092193|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092194|NCT02453893|Risperidone|risperidone|mesh-list
14092195|NCT02453893|Iloperidone|iloperidone|mesh-list
14092196|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14092197|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
14092198|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092199|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092200|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092201|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14092202|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14092203|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092204|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14092205|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14092206|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
14092207|NCT02453776|Infliximab|infliximab|mesh-list
14092208|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
14092209|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092210|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092211|NCT02453607|Infliximab|infliximab|mesh-list
14092212|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
13921014|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13921015|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921016|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921017|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921018|NCT03443921|Paclitaxel|paclitaxel|mesh-list
13921019|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13921020|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921021|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
13921022|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
13921023|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
13921024|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921025|NCT03443856|Nivolumab|nivolumab|mesh-list
13921026|NCT03443856|Ipilimumab|ipilimumab|mesh-list
13921027|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921028|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921029|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13921030|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921031|NCT03443843|Fluticasone|fluticasone|mesh-list
13921032|NCT03443843|Xhance|xhance|mesh-list
13921033|NCT03443843|Loratadine|loratadine|mesh-list
13921034|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
13921035|NCT03443843|Ephedrine|ephedrine|mesh-list
13921036|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921037|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13921038|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
13921039|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921040|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921041|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13921042|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14092213|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092214|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092215|NCT02453529|Nafithromycin|nafithromycin|mesh-list
14092216|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14092217|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092218|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14092219|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092220|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092221|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
14092222|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
14092223|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
14092224|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14092225|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14092226|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092227|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
14092228|NCT02453802|Coagulants|coagulants|mesh-ancestor
14092229|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14092230|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
14092231|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14092232|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
14092233|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092234|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
14092235|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
14092236|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14760864|NCT04096170|Lidocaine|lidocaine|mesh-list
14092237|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14092238|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14092239|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14092240|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092241|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092242|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
14092243|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14092244|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092245|NCT02453516|Epinephrine|epinephrine|mesh-list
14092246|NCT02453516|Ropivacaine|ropivacaine|mesh-list
14092247|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
14092248|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
14092249|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092250|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921043|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
13921044|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13921045|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
13921046|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13921047|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13921048|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
13921049|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
13921050|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921051|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921052|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
13921053|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13921054|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13921055|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
13921056|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921057|NCT03443778|Dexamethasone|dexamethasone|mesh-list
13921058|NCT03443778|Bupivacaine|bupivacaine|mesh-list
13921059|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921060|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
14092251|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
14092252|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092253|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14092254|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13921061|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
13921062|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921063|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921064|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921065|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
13921066|NCT03443778|Hormones|hormones|mesh-ancestor
13921067|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921068|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13921069|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921070|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
13921071|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
13921072|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921073|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
13921074|NCT03443765|Vitamin D|vitamin d|mesh-list
13921075|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
13921076|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13921077|NCT03443765|Antibodies|antibodies|mesh-list
13921078|NCT03443765|Vitamins|vitamins|mesh-ancestor
13921079|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
13921080|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921081|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13921082|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
13921083|NCT03443726|Epinephrine|epinephrine|mesh-list
14092255|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
14092256|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092257|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092258|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14092259|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14092260|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
14092261|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14092262|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
14092263|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
14092264|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
14092265|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14092266|NCT02453503|Triamcinolone|triamcinolone|mesh-list
14092267|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14092268|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14092269|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14092270|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760865|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
13921084|NCT03443726|Carticaine|carticaine|mesh-list
13921085|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13921086|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14092271|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
14092272|NCT02453503|Hormones|hormones|mesh-ancestor
14092273|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092274|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092275|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092276|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
14092277|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092278|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092279|NCT02453490|Fluorouracil|fluorouracil|mesh-list
14092280|NCT02453490|Raltitrexed|raltitrexed|mesh-list
14092281|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
14092282|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092283|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14092284|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092285|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092286|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
14092287|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092288|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14092289|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092290|NCT02453464|Leucovorin|leucovorin|mesh-list
14092291|NCT02453464|Irinotecan|irinotecan|mesh-list
14092292|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14092293|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14092294|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092295|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092296|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092297|NCT02453464|Antidotes|antidotes|mesh-ancestor
14092298|NCT02453464|Protective Agents|protective agents|mesh-ancestor
14092299|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092300|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
14092301|NCT02453464|Vitamins|vitamins|mesh-ancestor
14092302|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
14092303|NCT02453425|Norepinephrine|norepinephrine|mesh-list
14092304|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14092305|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14092306|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
14092307|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092308|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092309|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092310|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
13921087|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921088|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921089|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921090|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921091|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13921092|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13921093|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
13921094|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092311|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
14092312|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092313|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14092314|NCT02453087|Rituximab|rituximab|mesh-list
14092315|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
14092316|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14092317|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092318|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
14092319|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921095|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13921096|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
13921097|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
13921098|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
13921099|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14092320|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092321|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
14092322|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14092323|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092324|NCT02453022|Omeprazole|omeprazole|mesh-list
14092325|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14092326|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092327|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14092328|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092329|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092330|NCT02452970|Gemcitabine|gemcitabine|mesh-list
14092331|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092332|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921100|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
13921101|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
13921102|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921103|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
13921104|NCT03443570|Rituximab|rituximab|mesh-list
13921105|NCT03443570|Bortezomib|bortezomib|mesh-list
13921106|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921107|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921108|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
13921109|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921110|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13921111|NCT03443518|Remifentanil|remifentanil|mesh-list
13921112|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921113|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921114|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13921115|NCT03443518|Narcotics|narcotics|mesh-ancestor
13921116|NCT03443518|Analgesics|analgesics|mesh-ancestor
13921117|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
13921118|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921119|NCT03443492|Leucovorin|leucovorin|mesh-list
13921120|NCT03443492|Gemcitabine|gemcitabine|mesh-list
13921121|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
13921122|NCT03443492|Irinotecan|irinotecan|mesh-list
13921123|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
13921124|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921125|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
13921126|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921127|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921128|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
13921129|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921130|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921131|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13921132|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
13921133|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921134|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13921135|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13921136|NCT03443492|Antidotes|antidotes|mesh-ancestor
13921137|NCT03443492|Protective Agents|protective agents|mesh-ancestor
13921138|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
13921139|NCT03443492|Vitamins|vitamins|mesh-ancestor
13921140|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
13921141|NCT03443271|Bupivacaine|bupivacaine|mesh-list
13921142|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
14092333|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
14092334|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092335|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
14092336|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092337|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092338|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092339|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
14092340|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092341|NCT02452918|Oritavancin|oritavancin|mesh-list
14092342|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14092343|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092344|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
14092345|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14092346|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14092347|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
14092348|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092349|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092350|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092351|NCT02452879|Urological Agents|urological agents|mesh-ancestor
14092352|NCT02452983|Sertraline|sertraline|mesh-list
14092353|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
14092354|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14092355|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14092356|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14092357|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13921143|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
13921144|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921145|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921146|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
13921147|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092358|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092359|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921148|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
13921149|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13921150|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
14092360|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
14092361|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092362|NCT02453009|Prednisone|prednisone|mesh-list
14092363|NCT02453009|Docetaxel|docetaxel|mesh-list
14092364|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092365|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14092366|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14092367|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092368|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092369|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092370|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
14092371|NCT02453009|Hormones|hormones|mesh-ancestor
14092372|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092373|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092374|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14092375|NCT02452775|Poly ICLC|poly iclc|mesh-list
14092376|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
14092377|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
14092378|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092379|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
14092380|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14092381|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092382|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14092383|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092384|NCT02452515|Fulacimstat|fulacimstat|mesh-list
14092385|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092386|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092387|NCT02452684|Eszopiclone|eszopiclone|mesh-list
14092388|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14092389|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092390|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092391|NCT02452437|Oxycodone|oxycodone|mesh-list
14092392|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14092393|NCT02452437|Narcotics|narcotics|mesh-ancestor
14092394|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092395|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092396|NCT02452437|Analgesics|analgesics|mesh-ancestor
14092397|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
14092398|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092399|NCT02452606|Levodopa|levodopa|mesh-list
14092400|NCT02452606|Carbidopa|carbidopa|mesh-list
14092401|NCT02452606|Entacapone|entacapone|mesh-list
14092402|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14092403|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14092404|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
14092405|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092406|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092407|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092408|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14092409|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092410|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14092411|NCT02452502|Atorvastatin|atorvastatin|mesh-list
14092412|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14092413|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14092414|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
14092415|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092416|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14092417|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14092418|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092419|NCT02452385|Vorolanib|vorolanib|mesh-list
14092420|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14092421|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092422|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092423|NCT02452450|Acetaminophen|acetaminophen|mesh-list
14092424|NCT02452450|Ibuprofen|ibuprofen|mesh-list
14092425|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14092426|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14092427|NCT02452450|Analgesics|analgesics|mesh-ancestor
14092428|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
14092429|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092430|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092431|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14760866|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
14092432|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767338|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921151|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921152|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921153|NCT03443141|Vitamin E|vitamin e|mesh-list
13921154|NCT03443141|Vitamins|vitamins|mesh-ancestor
13921155|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
13921156|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921157|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
13921158|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921159|NCT03443141|Protective Agents|protective agents|mesh-ancestor
13921160|NCT03443128|Vinorelbine|vinorelbine|mesh-list
13921161|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13921162|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921163|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
13921164|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
13921165|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
13921166|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921167|NCT03443037|Amantadine|amantadine|mesh-list
13921168|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13921169|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13921170|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
14092433|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14092434|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092435|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092436|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
14092437|NCT02452281|Ipilimumab|ipilimumab|mesh-list
14092438|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14092439|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092440|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14092441|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092442|NCT02452125|Nicotine|nicotine|mesh-list
14092443|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13921171|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921172|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
13921173|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921174|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921175|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921176|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13921177|NCT03443037|Analgesics|analgesics|mesh-ancestor
13921178|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
13921179|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921180|NCT03442972|Teduglutide|teduglutide|mesh-list
13921181|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921182|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13921183|NCT03442972|Protective Agents|protective agents|mesh-ancestor
13921184|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921185|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
13921186|NCT03442673|Gemcitabine|gemcitabine|mesh-list
13921187|NCT03442673|Vinorelbine|vinorelbine|mesh-list
13921188|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921189|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
13921190|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921191|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921192|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
13921193|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921194|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921195|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13921196|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
13921197|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921198|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13921199|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
13921200|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
13921201|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092444|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
14092445|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092446|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092447|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14092448|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14092449|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
14092450|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092451|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092452|NCT02452307|Imiquimod|imiquimod|mesh-list
14092453|NCT02452307|Molgramostim|molgramostim|mesh-list
14092454|NCT02452307|Protamines|protamines|mesh-list
14092455|NCT02452307|Sargramostim|sargramostim|mesh-list
14092456|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
14092457|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092458|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14092459|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092460|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
14092461|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
14092462|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092463|NCT02452307|Coagulants|coagulants|mesh-ancestor
14092464|NCT02452151|Infliximab|infliximab|mesh-list
14092465|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14092466|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092467|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092468|NCT02452177|Vitamin D|vitamin d|mesh-list
13921202|NCT03442621|Cortisone|cortisone|mesh-list
13921203|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960515|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13960516|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960517|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
13960518|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
13960519|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960520|NCT03154281|Everolimus|everolimus|mesh-list
13960521|NCT03154281|Niraparib|niraparib|mesh-list
13960522|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960523|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960524|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
14092469|NCT02452177|Vitamins|vitamins|mesh-ancestor
14092470|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
14092471|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092472|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14092473|NCT02452255|Propranolol|propranolol|mesh-list
14092474|NCT02452255|Metoprolol|metoprolol|mesh-list
13960525|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960526|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13960527|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960528|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092475|NCT02452255|Fenofibrate|fenofibrate|mesh-list
14092476|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14092477|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14092478|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
14092479|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092480|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092481|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760867|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092482|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14092483|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14092484|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
14092485|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
14092486|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
14092487|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092488|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14092489|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14092490|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
14092491|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14174288|NCT04789057|Atorvastatin|atorvastatin|mesh-list
14174289|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14174290|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14174291|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
14174292|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174293|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14174294|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14174295|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174296|NCT04788745|Trimetazidine|trimetazidine|mesh-list
14174297|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
14174298|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
14174299|NCT04788355|Apixaban|apixaban|mesh-list
14174300|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
14760868|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174301|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14174302|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14174303|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760869|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
14174304|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760870|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174305|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174306|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174307|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14092492|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14092493|NCT02452216|Hematinics|hematinics|mesh-ancestor
14477387|NCT02432456|Analgesics|analgesics|mesh-ancestor
14477388|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
14477389|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921204|NCT03442491|Hemostatics|hemostatics|mesh-list
13921205|NCT03442491|Coagulants|coagulants|mesh-ancestor
13921206|NCT03442309|Fluorides|fluorides|mesh-list
14477390|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477391|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14477392|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14477393|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
14477394|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
14477395|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477396|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14477397|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14477398|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477399|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921207|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
13921208|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
13921209|NCT03442309|Protective Agents|protective agents|mesh-ancestor
13921210|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921211|NCT03442283|Vitamins|vitamins|mesh-list
13921212|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
13921213|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921214|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
13921215|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13921216|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921217|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921218|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13921219|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
14760871|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14092494|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14092495|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14092496|NCT02452112|Lidocaine|lidocaine|mesh-list
14092497|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
14092498|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
14092499|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092500|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092501|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
14092502|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092503|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14092504|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14092505|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14092506|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092507|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092508|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14092509|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14092510|NCT02452099|Protective Agents|protective agents|mesh-ancestor
14092511|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092512|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14092513|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
14760872|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14760873|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14760874|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14760875|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760876|NCT04093024|Nintedanib|nintedanib|mesh-list
14760877|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760878|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14760879|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760880|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760881|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
14760882|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760883|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760884|NCT04083170|Vidarabine|vidarabine|mesh-list
14760885|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
14760886|NCT04083170|Thiotepa|thiotepa|mesh-list
14760887|NCT04083170|Fludarabine|fludarabine|mesh-list
14760888|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
14760889|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14760890|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
13921220|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13921221|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14092514|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092515|NCT02451956|Paclitaxel|paclitaxel|mesh-list
14092516|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14092517|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092518|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
14092519|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
14092520|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092521|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092522|NCT02451865|Docetaxel|docetaxel|mesh-list
14092523|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092524|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
14092525|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
14092526|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092527|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092528|NCT02451787|Vitamin D|vitamin d|mesh-list
14092529|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
14092530|NCT02451787|Vitamins|vitamins|mesh-ancestor
14092531|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
14092532|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092533|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14092534|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14092535|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
14092536|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14092537|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092538|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092539|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14092540|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14092541|NCT02451774|Protective Agents|protective agents|mesh-ancestor
14092542|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092543|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
14092544|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14092545|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
14092546|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
14092547|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14092548|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
14092549|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14092550|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092551|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14092552|NCT02451852|Osimertinib|osimertinib|mesh-list
14092553|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092554|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14092555|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092556|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092557|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
14092558|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
14092559|NCT02451748|Prednisone|prednisone|mesh-list
14092560|NCT02451748|Triamcinolone|triamcinolone|mesh-list
14092561|NCT02451748|Naproxen|naproxen|mesh-list
14092562|NCT02451748|Methotrexate|methotrexate|mesh-list
14092563|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
14092564|NCT02451748|Leflunomide|leflunomide|mesh-list
14092565|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092566|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
14092567|NCT02451748|Hormones|hormones|mesh-ancestor
14092568|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092569|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092570|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14092571|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092572|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14092573|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
14092574|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14092575|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14092576|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
14092577|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092578|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
14092579|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092580|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14092581|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092582|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
14092583|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092584|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14092585|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
14092586|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14092587|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14092588|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092589|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13921222|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921223|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
13921224|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
13921225|NCT03441841|Lidocaine|lidocaine|mesh-list
13921226|NCT03441841|Prilocaine|prilocaine|mesh-list
13921227|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13921228|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
13921229|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
13921230|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921231|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921232|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
13921233|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921234|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13921235|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13921236|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13921237|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13921238|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921239|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13921240|NCT03441815|Histamine|histamine|mesh-list
14092590|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14092591|NCT02451748|Analgesics|analgesics|mesh-ancestor
14092592|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
14092593|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092594|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
14092595|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14092596|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092597|NCT02451527|Digoxin|digoxin|mesh-list
14092598|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14092599|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14092600|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092601|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092602|NCT02451527|Protective Agents|protective agents|mesh-ancestor
14092603|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092604|NCT02451605|Analgesics|analgesics|mesh-list
14092605|NCT02451605|Ropivacaine|ropivacaine|mesh-list
14092606|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
14092607|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092608|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092609|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
14092610|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
14092611|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092612|NCT02451579|Cetirizine|cetirizine|mesh-list
14092613|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
14092614|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14092615|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14092616|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14092617|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
14092618|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092619|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092620|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092621|NCT02451475|Amitriptyline|amitriptyline|mesh-list
14092622|NCT02451475|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14092623|NCT02451475|Paroxetine|paroxetine|mesh-list
14092624|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14760891|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760892|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760893|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14760894|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
14760895|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760896|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760897|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14092625|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14092626|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14092627|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092628|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092629|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092630|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
14092631|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092632|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14092633|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
14092634|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14760898|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921241|NCT03441815|Glutarimide|glutarimide|mesh-list
14092635|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14092636|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14092637|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921242|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
13921243|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
13921244|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921245|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921246|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921247|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13921248|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921249|NCT03441529|Tazobactam|tazobactam|mesh-list
13921250|NCT03441529|Piperacillin|piperacillin|mesh-list
13921251|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13921252|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13921253|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921254|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13921255|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921256|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921257|NCT03441412|Metoprolol|metoprolol|mesh-list
13921258|NCT03441412|Epinephrine|epinephrine|mesh-list
13921259|NCT03441412|Ticagrelor|ticagrelor|mesh-list
13921260|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13921261|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13921262|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921263|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921264|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921265|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921266|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14092638|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14092639|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14092640|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14092641|NCT02451475|Analgesics|analgesics|mesh-ancestor
14092642|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
14092643|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092644|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14092645|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
14092646|NCT02451475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14092647|NCT02451475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14092648|NCT02451475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092649|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
14092650|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14092651|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092652|NCT02451423|Atezolizumab|atezolizumab|mesh-list
14092653|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092654|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14092655|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
14092656|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14092657|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14092658|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14092659|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092660|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092661|NCT02451293|Melatonin|melatonin|mesh-list
14092662|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
14092663|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092664|NCT02451293|Protective Agents|protective agents|mesh-ancestor
14092665|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921267|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13921268|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
13921269|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921270|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13921271|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
14092666|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092667|NCT02451072|Ketanserin|ketanserin|mesh-list
14092668|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
14092669|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
14092670|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092671|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14092672|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14092673|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
13921272|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
13921273|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
14092674|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921274|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13921275|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13921276|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13921277|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14092675|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092676|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14092677|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14092678|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14092679|NCT02451111|Rituximab|rituximab|mesh-list
14092680|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921278|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13921279|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
13921280|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13921281|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14092681|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092682|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
14092683|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092684|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092685|NCT02451033|Hormones|hormones|mesh-list
14092686|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092687|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092688|NCT02450994|Dexamethasone|dexamethasone|mesh-list
14092689|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092690|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
14092691|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
14092692|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092693|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092694|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092695|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
14092696|NCT02450994|Hormones|hormones|mesh-ancestor
14092697|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921282|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
13921283|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13921284|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13921285|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13921286|NCT03441373|Histamine|histamine|mesh-list
13921287|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
13921288|NCT03441373|Glutarimide|glutarimide|mesh-list
13921289|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
13921290|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
13921291|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921292|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921293|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921294|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13921295|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921296|NCT03441217|Scopolamine|scopolamine|mesh-list
13921297|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13921298|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13921299|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
14092698|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14092699|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092700|NCT02450981|Bevacizumab|bevacizumab|mesh-list
14092701|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14092702|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092703|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14092704|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14092705|NCT02450981|Growth Substances|growth substances|mesh-ancestor
14092706|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092707|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
14092708|NCT02450968|Dexamethasone|dexamethasone|mesh-list
14092709|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092710|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
14092711|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
14092712|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092713|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092714|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092715|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
14092716|NCT02450968|Hormones|hormones|mesh-ancestor
14092717|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092718|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14092719|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092720|NCT02451098|Atorvastatin|atorvastatin|mesh-list
14092721|NCT02451098|Ezetimibe|ezetimibe|mesh-list
14092722|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14092723|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13921300|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
14092724|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
13921301|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921302|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921303|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921304|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
13921305|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13921306|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
14092725|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092726|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14092727|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14092728|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092729|NCT02450786|Donepezil|donepezil|mesh-list
14092730|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14092731|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092732|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092733|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
14092734|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092735|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092736|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
14092737|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14092738|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14092739|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
14092740|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092741|NCT02450838|Antacids|antacids|mesh-ancestor
14092742|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092743|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092744|NCT02450773|Furosemide|furosemide|mesh-list
14092745|NCT02450773|Diuretics|diuretics|mesh-ancestor
14092746|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
14092747|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092748|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14092749|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092750|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092751|NCT02450877|Azacitidine|azacitidine|mesh-list
14092752|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14092753|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
14092754|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092755|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092756|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092757|NCT02450682|Warfarin|warfarin|mesh-list
14092758|NCT02450682|Apixaban|apixaban|mesh-list
14092759|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
14092760|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14092761|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
14092762|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14092763|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
14092764|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092765|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092766|NCT02450656|Docetaxel|docetaxel|mesh-list
14092767|NCT02450656|Afatinib|afatinib|mesh-list
14092768|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092769|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
14092770|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
14092771|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092772|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092773|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14092774|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092775|NCT02450513|Adalimumab|adalimumab|mesh-list
14092776|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092777|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174308|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
14174309|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14174310|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
13921307|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921308|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921309|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13921310|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
13921311|NCT03441035|Anesthetics|anesthetics|mesh-list
13921312|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174311|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
14174312|NCT04788381|Bevacizumab|bevacizumab|mesh-list
14174313|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14174314|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174315|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14174316|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14174317|NCT04788381|Growth Substances|growth substances|mesh-ancestor
14092778|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14092779|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
14092780|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14092781|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14092782|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092783|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092784|NCT02450188|Urological Agents|urological agents|mesh-ancestor
14092785|NCT02450253|Tadalafil|tadalafil|mesh-list
14092786|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14092787|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14092788|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14092789|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092790|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092791|NCT02450253|Urological Agents|urological agents|mesh-ancestor
14092792|NCT02450214|Ketamine|ketamine|mesh-list
14092793|NCT02450214|Analgesics|analgesics|mesh-ancestor
14092794|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
14092795|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092796|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092797|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14092798|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14092799|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
14092800|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
14092801|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092802|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14092803|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14092804|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14092805|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092806|NCT02450175|Everolimus|everolimus|mesh-list
14092807|NCT02450175|Letrozole|letrozole|mesh-list
14092808|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092809|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092810|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
14092811|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092812|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14092813|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14092814|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092815|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092816|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14092817|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
14092818|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092819|NCT02450279|Edetic Acid|edetic acid|mesh-list
14092820|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
14092821|NCT02450279|Antidotes|antidotes|mesh-ancestor
14092822|NCT02450279|Protective Agents|protective agents|mesh-ancestor
14092823|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092824|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
14092825|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
14092826|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092827|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14092828|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
14092829|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14092830|NCT02450149|Sorafenib|sorafenib|mesh-list
14092831|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760899|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
14760900|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
14760901|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760902|NCT04075396|Lazertinib|lazertinib|mesh-list
14760903|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13921313|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921314|NCT03440996|Listerine|listerine|mesh-list
13921315|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
13921316|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
13921317|NCT03440996|Protective Agents|protective agents|mesh-ancestor
13921318|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921319|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13921320|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921321|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
14760904|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760905|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760906|NCT04062448|Rituximab|rituximab|mesh-list
14760907|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760908|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760909|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
14760910|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092832|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14092833|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092834|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092835|NCT02450123|Sunitinib|sunitinib|mesh-list
14092836|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092837|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14092838|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14092839|NCT02450123|Growth Substances|growth substances|mesh-ancestor
14092840|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092841|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
14092842|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14092843|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092844|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092845|NCT02450084|Fentanyl|fentanyl|mesh-list
14092846|NCT02450084|Ropivacaine|ropivacaine|mesh-list
14092847|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
14092848|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
14092849|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921322|NCT03440892|Methotrexate|methotrexate|mesh-list
14760911|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760912|NCT04051320|Leuprolide|leuprolide|mesh-list
14760913|NCT04051320|Estradiol|estradiol|mesh-list
14760914|NCT04051320|Progesterone|progesterone|mesh-list
13921323|NCT03440892|Abatacept|abatacept|mesh-list
13921324|NCT03440892|Tofacitinib|tofacitinib|mesh-list
13921325|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13921326|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
13921327|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13921328|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921329|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921330|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
13921331|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921332|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921333|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
13921334|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921335|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13921336|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13921337|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
14092850|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092851|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
14092852|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092853|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14092854|NCT02450084|Narcotics|narcotics|mesh-ancestor
14092855|NCT02450084|Analgesics|analgesics|mesh-ancestor
14092856|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14092857|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14092858|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
13921338|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13921339|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13921340|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13921341|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13921342|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921343|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13921344|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14092859|NCT02450045|Bupivacaine|bupivacaine|mesh-list
14092860|NCT02450045|Ropivacaine|ropivacaine|mesh-list
14092861|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
14092862|NCT02450045|Anesthetics|anesthetics|mesh-list
14092863|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092864|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092865|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
14092866|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092867|NCT02449954|Ketorolac|ketorolac|mesh-list
14092868|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14092869|NCT02449954|Morphine|morphine|mesh-list
14092870|NCT02449954|Tramadol|tramadol|mesh-list
13921345|NCT03440892|Analgesics|analgesics|mesh-ancestor
13921346|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
13921347|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921348|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921349|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921350|NCT03440879|Goserelin|goserelin|mesh-list
14092871|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14092872|NCT02449954|Narcotics|narcotics|mesh-ancestor
14092873|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14760915|NCT04051320|Estrogens|estrogens|mesh-ancestor
14760916|NCT04051320|Hormones|hormones|mesh-ancestor
14935768|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13921351|NCT03440879|Androgens|androgens|mesh-list
13921352|NCT03440879|Hormones|hormones|mesh-ancestor
13921353|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921354|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921355|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13921356|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921357|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13921358|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921359|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960529|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13960530|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
13960531|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13960532|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13960533|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13960534|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
13960535|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13960536|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960537|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13960538|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13960539|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13960540|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13960541|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960542|NCT03153852|Glycolic acid|glycolic acid|mesh-list
13960543|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
14092874|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092875|NCT02449954|Analgesics|analgesics|mesh-ancestor
14092876|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
14092877|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092878|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14092879|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14092880|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092881|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092882|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14092883|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092884|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092885|NCT02449941|Rabeprazole|rabeprazole|mesh-list
14092886|NCT02449941|Pantoprazole|pantoprazole|mesh-list
14092887|NCT02449941|Lansoprazole|lansoprazole|mesh-list
14092888|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
14092889|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14092890|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14092891|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14092892|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092893|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092894|NCT02449811|Amlodipine|amlodipine|mesh-list
14092895|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14092896|NCT02449811|Olmesartan|olmesartan|mesh-list
14092897|NCT02449811|Perindopril|perindopril|mesh-list
14092898|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14092899|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14092900|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14092901|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092902|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14092903|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092904|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
14092905|NCT02449811|Diuretics|diuretics|mesh-ancestor
14092906|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
14092907|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14092908|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14092909|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14092910|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14092911|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
14092912|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092913|NCT02449733|Tenofovir|tenofovir|mesh-list
14092914|NCT02449733|Emtricitabine|emtricitabine|mesh-list
14092915|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14092916|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
14092917|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092918|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14092919|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13960544|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960545|NCT03153813|Capsaicin|capsaicin|mesh-list
13960546|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
14092920|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092921|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921360|NCT03440567|Rituximab|rituximab|mesh-list
13921361|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13921362|NCT03440567|Avelumab|avelumab|mesh-list
13921363|NCT03440567|Carboplatin|carboplatin|mesh-list
13921364|NCT03440567|Etoposide|etoposide|mesh-list
13921365|NCT03440567|Ifosfamide|ifosfamide|mesh-list
13921366|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
14092922|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14092923|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14092924|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
14092925|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14092926|NCT02449746|Antibodies|antibodies|mesh-list
14092927|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
14092928|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13921367|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
13921368|NCT03440567|Antibodies|antibodies|mesh-list
13921369|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
13921370|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13921371|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
13921372|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
13921373|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921374|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921375|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13921376|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13921377|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13921378|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13921379|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921380|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921381|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13921382|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
13921383|NCT03440515|Prednisone|prednisone|mesh-list
13921384|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14092929|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
14092930|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092931|NCT02449538|Everolimus|everolimus|mesh-list
14092932|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092933|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092934|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
14092935|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092936|NCT02449564|Sirolimus|sirolimus|mesh-list
14092937|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14092938|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14092939|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14092940|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092941|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
14092942|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092943|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
14092944|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092945|NCT02449720|Ropivacaine|ropivacaine|mesh-list
14092946|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
14092947|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
14092948|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092949|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092950|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
14092951|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14092952|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
14092953|NCT02449603|Exenatide|exenatide|mesh-list
14092954|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
14092955|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
13921385|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
13921386|NCT03440515|Hormones|hormones|mesh-ancestor
13921387|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092956|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14092957|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921388|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921389|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13921390|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921391|NCT03440502|Anesthetics|anesthetics|mesh-list
13921392|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921393|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921394|NCT03440359|Letrozole|letrozole|mesh-list
13921395|NCT03440359|Progesterone|progesterone|mesh-list
13921396|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921397|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13921398|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13921399|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921400|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921401|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13921402|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
14092958|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14092959|NCT02449603|Incretins|incretins|mesh-ancestor
14092960|NCT02449603|Hormones|hormones|mesh-ancestor
14092961|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14092962|NCT02450058|Paclitaxel|paclitaxel|mesh-list
14092963|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
14092964|NCT02450058|Fluorouracil|fluorouracil|mesh-list
14092965|NCT02450058|Epirubicin|epirubicin|mesh-list
14092966|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14092967|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092968|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
14092969|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
14092970|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092971|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092972|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14092973|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
14092974|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092975|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14092976|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14092977|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
14092978|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14092979|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
14092980|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14092981|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14092982|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14092983|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14092984|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14092985|NCT02449655|Paclitaxel|paclitaxel|mesh-list
14477400|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14477401|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
13921403|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921404|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921405|NCT03440359|Progestins|progestins|mesh-ancestor
13921406|NCT03440359|Hormones|hormones|mesh-ancestor
13921407|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
13921408|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
13921409|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
13921410|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13921411|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
13921412|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921413|NCT03440268|Expectorants|expectorants|mesh-ancestor
13921414|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
13921415|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13921416|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
13960547|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14092986|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14092987|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14092988|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14092989|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14092990|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14092991|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14092992|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14092993|NCT02449486|Ropivacaine|ropivacaine|mesh-list
14092994|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
14092995|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
14092996|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14092997|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14092998|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
14092999|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093000|NCT02449265|Prednisone|prednisone|mesh-list
14093001|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
14093002|NCT02449265|Doxorubicin|doxorubicin|mesh-list
14093003|NCT02449265|Vincristine|vincristine|mesh-list
14093004|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093005|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
14093006|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093007|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093008|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13921417|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921418|NCT03440268|Protective Agents|protective agents|mesh-ancestor
13921419|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921420|NCT03440268|Antidotes|antidotes|mesh-ancestor
13921421|NCT03440216|Meropenem|meropenem|mesh-list
13921422|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
13921423|NCT03440216|Temocillin|temocillin|mesh-list
13921424|NCT03440216|Penicillins|penicillins|mesh-list
13921425|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13921426|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921436|NCT03440177|Ramipril|ramipril|mesh-list
13921437|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13921438|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
13921439|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921440|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093009|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
14093010|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093011|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093012|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14093013|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14093014|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14093015|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14093016|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093017|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093018|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
14093019|NCT02449265|Hormones|hormones|mesh-ancestor
14093020|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093021|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093022|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14093023|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093024|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093025|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093026|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
14093027|NCT02449187|Metformin|metformin|mesh-list
14093028|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14093029|NCT02449187|Calcium|calcium|mesh-list
14093030|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14093031|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921441|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13921442|NCT03440034|Pioglitazone|pioglitazone|mesh-list
13921443|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13921444|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174318|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093032|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14093033|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14093034|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14093035|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14093036|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
14093037|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093038|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14093039|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14093040|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093041|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14093042|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14093043|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
14093044|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14093045|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093046|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14093047|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14093048|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093049|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093050|NCT02449369|Acetaminophen|acetaminophen|mesh-list
14093051|NCT02449369|Oxycodone|oxycodone|mesh-list
14093052|NCT02449369|Hydromorphone|hydromorphone|mesh-list
14093053|NCT02449369|Orphenadrine|orphenadrine|mesh-list
14093054|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14093055|NCT02449369|Analgesics|analgesics|mesh-ancestor
14093056|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
14093057|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921445|NCT03439943|Lixisenatide|lixisenatide|mesh-list
13921446|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13921447|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921448|NCT03439865|Ivacaftor|ivacaftor|mesh-list
13921449|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14477402|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14477403|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477404|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13921450|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13921451|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921452|NCT03439787|Epinephrine|epinephrine|mesh-list
13921453|NCT03439787|Bupivacaine|bupivacaine|mesh-list
13921454|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
13921455|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
13921456|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921457|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921458|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
13921459|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921460|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13921461|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13921462|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921463|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093058|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935769|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935770|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
14935771|NCT01465373|Progesterone|progesterone|mesh-list
14935772|NCT01465373|Progestins|progestins|mesh-ancestor
14935773|NCT01465373|Hormones|hormones|mesh-ancestor
14935774|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935775|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093059|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
14093060|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14093061|NCT02449369|Narcotics|narcotics|mesh-ancestor
14093062|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093063|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14093064|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14935776|NCT01465399|Mitogens|mitogens|mesh-list
14935777|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14935778|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935779|NCT01465438|Adalimumab|adalimumab|mesh-list
13921464|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921465|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13921466|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13921467|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
13921468|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13921469|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
13921470|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
13921471|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
14935780|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093065|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14093066|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14093067|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
14093068|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
14093069|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14093070|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14093071|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
14093072|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921472|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13921473|NCT03439709|Lanreotide|lanreotide|mesh-list
13921474|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921475|NCT03439670|Prednisone|prednisone|mesh-list
13921476|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921477|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
13921478|NCT03439670|Hormones|hormones|mesh-ancestor
13921479|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921480|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921481|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13921482|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477405|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14477406|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477407|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13921483|NCT03439501|Avelumab|avelumab|mesh-list
13921484|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921485|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921486|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
13921487|NCT03439358|Analgesics|analgesics|mesh-ancestor
13921488|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
13921489|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921490|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921491|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
13921492|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921493|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13921494|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
14093073|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093074|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
14093075|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14093076|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093077|NCT02449252|Prednisone|prednisone|mesh-list
14093078|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
14093079|NCT02449252|Doxorubicin|doxorubicin|mesh-list
14093080|NCT02449252|Vincristine|vincristine|mesh-list
14093081|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093082|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
14093083|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093084|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093085|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14093086|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
14093087|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093088|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093089|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14093090|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14093091|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14093092|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14093093|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093094|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093095|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
14093096|NCT02449252|Hormones|hormones|mesh-ancestor
14093097|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093098|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093099|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14093100|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093101|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093102|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093103|NCT02449070|Nicorandil|nicorandil|mesh-list
14093104|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14093105|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14093106|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
14093107|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
14093108|NCT02449070|Vitamins|vitamins|mesh-ancestor
14093109|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
14477408|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093110|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093111|NCT02449278|Prednisone|prednisone|mesh-list
14093112|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
14477409|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14093113|NCT02449278|Doxorubicin|doxorubicin|mesh-list
14093114|NCT02449278|Vincristine|vincristine|mesh-list
14093115|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093116|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
14093117|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093118|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093119|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14093120|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
14093121|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093122|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093123|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14093124|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14093125|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14093126|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14093127|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921495|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13921496|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13921497|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921498|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13921499|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
13921500|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13921501|NCT03439345|Fenofibrate|fenofibrate|mesh-list
13921502|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13921503|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
13921504|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921505|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13921506|NCT03439280|Dexamethasone|dexamethasone|mesh-list
13921507|NCT03439280|Pomalidomide|pomalidomide|mesh-list
13921508|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921509|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
13921510|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
13921511|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921512|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921513|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921514|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
13921515|NCT03439280|Hormones|hormones|mesh-ancestor
13921516|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921517|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13921518|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921519|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
13921520|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13921521|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13921522|NCT03439280|Growth Substances|growth substances|mesh-ancestor
13921523|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
13921524|NCT03439267|Calcium|calcium|mesh-list
13921525|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13921526|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921527|NCT03438955|Telmisartan|telmisartan|mesh-list
13921528|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13921529|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14093128|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093129|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
14093130|NCT02449278|Hormones|hormones|mesh-ancestor
14093131|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093132|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093133|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14093134|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093135|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093136|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093137|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14093138|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
14093139|NCT02449005|Coagulants|coagulants|mesh-ancestor
14093140|NCT02448797|Vinorelbine|vinorelbine|mesh-list
14093141|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14093142|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093143|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093144|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093145|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093146|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093147|NCT02448784|Donepezil|donepezil|mesh-list
14093148|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14093149|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921530|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14093150|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093151|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
14093152|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093153|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921531|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960548|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
13960549|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960550|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960551|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
13960552|NCT03153917|Melatonin|melatonin|mesh-list
13960553|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
13960554|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093154|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
14174319|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
14174320|NCT04788420|Sorafenib|sorafenib|mesh-list
14174321|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174322|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174323|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174324|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174325|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
14174326|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14174327|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174328|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13960555|NCT03153917|Protective Agents|protective agents|mesh-ancestor
13960556|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960557|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174329|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
14174330|NCT04788043|Magrolimab|magrolimab|mesh-list
14174331|NCT04788043|Antibodies|antibodies|mesh-list
14174332|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
14174333|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14174334|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
14174335|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174336|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174337|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
14174338|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14174339|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14174340|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174341|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
14174342|NCT04788121|Coagulants|coagulants|mesh-ancestor
14174343|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14174344|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14174345|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174346|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174347|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174348|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174349|NCT04787848|Bromides|bromides|mesh-list
14174350|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
14174351|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
14174352|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14174353|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174354|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
14174355|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174356|NCT04787510|Heparin|heparin|mesh-list
14174357|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14174358|NCT04787510|Tinzaparin|tinzaparin|mesh-list
14174359|NCT04787510|Dalteparin|dalteparin|mesh-list
14174360|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
14174361|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14174362|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13960558|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960559|NCT03153657|Piroxicam|piroxicam|mesh-list
13960560|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
13960561|NCT03153657|Betadex|betadex|mesh-list
13960562|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13960563|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13960564|NCT03153657|Analgesics|analgesics|mesh-ancestor
13960565|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
13960566|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960567|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960568|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960569|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13960570|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13960571|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174363|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174364|NCT04787341|Panitumumab|panitumumab|mesh-list
14174365|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921532|NCT03438942|Folic Acid|folic acid|mesh-list
13921533|NCT03438942|Hematinics|hematinics|mesh-ancestor
13921534|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
13921535|NCT03438942|Vitamins|vitamins|mesh-ancestor
13921536|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
13921537|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921538|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
13921539|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13921540|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921541|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
13921542|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14093155|NCT02448901|Edoxaban|edoxaban|mesh-list
14093156|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14093157|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
14093158|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14093159|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
14093160|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093161|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093162|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
14093163|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
14093164|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14093165|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
14093166|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093167|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
14093168|NCT02448407|Protective Agents|protective agents|mesh-ancestor
14093169|NCT02448550|Heparin|heparin|mesh-list
14093170|NCT02448550|Calcium heparin|calcium heparin|mesh-list
14093171|NCT02448550|Bivalirudin|bivalirudin|mesh-list
14093172|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
14093173|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14093174|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14093175|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093176|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
14093177|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14093178|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
14093179|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093180|NCT02448329|Paclitaxel|paclitaxel|mesh-list
14093181|NCT02448329|Adavosertib|adavosertib|mesh-list
14093182|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13921543|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14093183|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093184|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093185|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093186|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093187|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093188|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093189|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14093190|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
14093191|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14093192|NCT02448316|Prednisolone|prednisolone|mesh-list
14093193|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
14093194|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14093195|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
14477410|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14477411|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14477412|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
14477413|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477414|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477415|NCT02432716|Insulin|insulin|mesh-list
14477416|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14477417|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
14477418|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14477419|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477420|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
14477421|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14477422|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
14477423|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477424|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
14477425|NCT02432742|Protective Agents|protective agents|mesh-ancestor
14477426|NCT02433483|Cytarabine|cytarabine|mesh-list
13921544|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
13921545|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093196|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093197|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
14093198|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
14093199|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477427|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
14477428|NCT02433483|Methotrexate|methotrexate|mesh-list
14477429|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13921546|NCT03438773|Tacrolimus|tacrolimus|mesh-list
13921547|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13921548|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
13921549|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921550|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13921551|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921552|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921553|NCT03438708|Axitinib|axitinib|mesh-list
13921554|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093200|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093201|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093202|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
14093203|NCT02448316|Hormones|hormones|mesh-ancestor
14093204|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093205|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14093206|NCT02448316|Protective Agents|protective agents|mesh-ancestor
14093207|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093208|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093209|NCT02448264|Berotralstat|berotralstat|mesh-list
14093210|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093211|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093212|NCT02448290|Docetaxel|docetaxel|mesh-list
14093213|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093214|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093215|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093216|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093217|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093218|NCT02448251|Abivertinib|abivertinib|mesh-list
14093219|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14093220|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093221|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093222|NCT02448199|Meloxicam|meloxicam|mesh-list
14093223|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
14093224|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14093225|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14093226|NCT02448199|Analgesics|analgesics|mesh-ancestor
14093227|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
14093228|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093229|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093230|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093231|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14093232|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13921555|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13921556|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921557|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921558|NCT03438604|Donepezil|donepezil|mesh-list
13921559|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14093233|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093234|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093235|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
14093236|NCT02448225|Fluorides|fluorides|mesh-list
14093237|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14093238|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
14093239|NCT02448225|Protective Agents|protective agents|mesh-ancestor
14093240|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093241|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14093242|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093243|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
14093244|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
14093245|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093246|NCT02448082|Ichthammol|ichthammol|mesh-list
14093247|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
14093248|NCT02448069|Argatroban|argatroban|mesh-list
14093249|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
14093250|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14093251|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
14093252|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093253|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093254|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
14093255|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14093256|NCT02447965|Bupivacaine|bupivacaine|mesh-list
14093257|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
14093258|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
13921560|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093259|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093260|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093261|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
14093262|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093263|NCT02447939|Trametinib|trametinib|mesh-list
14093264|NCT02447939|Dabrafenib|dabrafenib|mesh-list
14093265|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093266|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14093267|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093268|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093269|NCT02447809|Aspirin|aspirin|mesh-list
14093270|NCT02447809|Clopidogrel|clopidogrel|mesh-list
14093271|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13921561|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921562|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
13921563|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921564|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921565|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
13921566|NCT03438487|Vaccines|vaccines|mesh-list
13921567|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
13921568|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921569|NCT03438344|Vaccines|vaccines|mesh-list
13921570|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
14093272|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14093273|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14093274|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14093275|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
14093276|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093277|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921571|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921572|NCT03438253|Anesthetics|anesthetics|mesh-list
13921573|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921574|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921575|NCT03438240|Fentanyl|fentanyl|mesh-list
13921576|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
13921577|NCT03438240|Bupivacaine|bupivacaine|mesh-list
13921578|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
13921579|NCT03438240|Anesthetics|anesthetics|mesh-list
13921580|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
13921581|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921582|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093278|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093279|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14093280|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14093281|NCT02447809|Analgesics|analgesics|mesh-ancestor
14093282|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
14093283|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093284|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093285|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093286|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14093287|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14093288|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14093289|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093290|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
14093291|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
14093292|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
14093293|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093294|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093295|NCT02447757|Remifentanil|remifentanil|mesh-list
14093296|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14093297|NCT02447757|Narcotics|narcotics|mesh-ancestor
14093298|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093299|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093300|NCT02447757|Analgesics|analgesics|mesh-ancestor
14093301|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
14093302|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093303|NCT02447705|Telbivudine|telbivudine|mesh-list
14093304|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
13921583|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
13921584|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921585|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13921586|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13921587|NCT03438240|Analgesics|analgesics|mesh-ancestor
14093305|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921588|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13921589|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14093306|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14093307|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093308|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093309|NCT02447835|Olanzapine|olanzapine|mesh-list
14093310|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
14093311|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
14093312|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093313|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093314|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093315|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14093316|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14093317|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093318|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14093319|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14093320|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14093321|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14093322|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093323|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093324|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
14093325|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
14093326|NCT02447796|Propofol|propofol|mesh-list
14093327|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13921590|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13921591|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921592|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921593|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921594|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13921595|NCT03438240|Narcotics|narcotics|mesh-ancestor
13921596|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13921597|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13921598|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
13921599|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
14093328|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093329|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093330|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14093331|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
14093332|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
14093333|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14093334|NCT02447796|Analgesics|analgesics|mesh-ancestor
14093335|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
14093336|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093337|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14093338|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14093339|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14093340|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
14093341|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093342|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921600|NCT03438227|Dextrans|dextrans|mesh-list
13921601|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
13921602|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
13921603|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
13921604|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
13921605|NCT03438227|Hematinics|hematinics|mesh-ancestor
13921606|NCT03438214|Vancomycin|vancomycin|mesh-list
13921607|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13921608|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921609|NCT03437980|Propofol|propofol|mesh-list
13921610|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13921611|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921612|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921613|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13921614|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
13921615|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
13921616|NCT03437902|Vitamins|vitamins|mesh-list
13921617|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
14093343|NCT02447666|Azacitidine|azacitidine|mesh-list
14093344|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14093345|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
14093346|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093347|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093348|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760917|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921618|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
13921619|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921620|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
13921621|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921622|NCT03437902|Protective Agents|protective agents|mesh-ancestor
13921623|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
13921624|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
13921625|NCT03437824|Vitamins|vitamins|mesh-ancestor
13921626|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
14093349|NCT02447679|Tegafur|tegafur|mesh-list
14093350|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14093351|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
14093352|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093353|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093354|NCT02447601|Simvastatin|simvastatin|mesh-list
14093355|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14093356|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14093357|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
14093358|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093359|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14093360|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14093361|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093362|NCT02447393|Cetirizine|cetirizine|mesh-list
14093363|NCT02447393|Levocetirizine|levocetirizine|mesh-list
14093364|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14093365|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14093366|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14093367|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
14093368|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
14093369|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093370|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093371|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093372|NCT02447406|Docetaxel|docetaxel|mesh-list
14093373|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093374|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093375|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093376|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093377|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093378|NCT02447510|Mitogens|mitogens|mesh-list
14093379|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093380|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921627|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921628|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
13921629|NCT03437824|Hematinics|hematinics|mesh-ancestor
13921630|NCT03437785|Ethanol|ethanol|mesh-list
13921631|NCT03437785|Rebamipide|rebamipide|mesh-list
13921632|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13921633|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921634|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093381|NCT02447289|Midazolam|midazolam|mesh-list
14093382|NCT02447289|Ketamine|ketamine|mesh-list
14093383|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14093384|NCT02447289|Analgesics|analgesics|mesh-ancestor
14093385|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
14093386|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093387|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093388|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14093389|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14093390|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
14093391|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
14093392|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093393|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14093394|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14093395|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093396|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093397|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14093398|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14093399|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14093400|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14093401|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14093402|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
14093403|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
14093404|NCT02447380|Docetaxel|docetaxel|mesh-list
14093405|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093406|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093407|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093408|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093409|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093410|NCT02447315|Pilocarpine|pilocarpine|mesh-list
14093411|NCT02447315|Miotics|miotics|mesh-ancestor
14093412|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
14093413|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093414|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921635|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921636|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13921637|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921638|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
13921639|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921640|NCT03437785|Protective Agents|protective agents|mesh-ancestor
13921641|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921642|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
13921643|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14093415|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14093416|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14093417|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
14093418|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093419|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093420|NCT02447224|Metronidazole|metronidazole|mesh-list
14093421|NCT02447224|Ertapenem|ertapenem|mesh-list
14093422|NCT02447224|Cefdinir|cefdinir|mesh-list
14093423|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093424|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14093425|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14093426|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14093427|NCT02447419|Gefitinib|gefitinib|mesh-list
14093428|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093429|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14093430|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093431|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093432|NCT02447211|Doxepin|doxepin|mesh-list
14093433|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14093434|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14093435|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921644|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13921645|NCT03437746|Prednisolone|prednisolone|mesh-list
13921646|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
13921647|NCT03437746|Anesthetics|anesthetics|mesh-list
13921648|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13921649|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
13921650|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921651|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
13921652|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
13921653|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921654|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921655|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921656|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
13921657|NCT03437746|Hormones|hormones|mesh-ancestor
13921658|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921659|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13921660|NCT03437746|Protective Agents|protective agents|mesh-ancestor
13921661|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13921662|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921663|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921664|NCT03437707|Acetaminophen|acetaminophen|mesh-list
13921665|NCT03437707|Ibuprofen|ibuprofen|mesh-list
13921666|NCT03437707|Morphine|morphine|mesh-list
13921667|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13921668|NCT03437707|Narcotics|narcotics|mesh-ancestor
13921669|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921670|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921671|NCT03437707|Analgesics|analgesics|mesh-ancestor
13921672|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
14093436|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093437|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13921673|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921674|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13921675|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13921676|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921677|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13921678|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13921679|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921680|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921681|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
13921682|NCT03437655|Eugenol|eugenol|mesh-list
13921683|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
13921684|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
13921685|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
13921686|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13921687|NCT03437655|Protective Agents|protective agents|mesh-ancestor
14760918|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760919|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14760920|NCT04051320|Progestins|progestins|mesh-ancestor
14760921|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14760922|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
13921688|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921689|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921690|NCT03437629|Calcium|calcium|mesh-list
13921691|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14093438|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
14093439|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14093440|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
14093441|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
14093442|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093443|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093444|NCT02447185|Triamcinolone|triamcinolone|mesh-list
14093445|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14093446|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14093447|NCT02447185|Ranibizumab|ranibizumab|mesh-list
14093448|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14093449|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14093450|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14093451|NCT02447185|Growth Substances|growth substances|mesh-ancestor
14093452|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093453|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
14093454|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093455|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093456|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
14093457|NCT02447185|Hormones|hormones|mesh-ancestor
14093458|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093459|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093460|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
14093461|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093462|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093463|NCT02446977|Riboflavin|riboflavin|mesh-list
14093464|NCT02446977|Vitamins|vitamins|mesh-ancestor
14093465|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
14093466|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093467|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
14093468|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14093469|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
14093470|NCT02447016|Tenofovir|tenofovir|mesh-list
14093471|NCT02447016|Emtricitabine|emtricitabine|mesh-list
14093472|NCT02447016|Efavirenz|efavirenz|mesh-list
14093473|NCT02447016|Rilpivirine|rilpivirine|mesh-list
14093474|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
14093475|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093476|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14093477|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14093478|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093479|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093480|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14093481|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14093482|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14093483|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14093484|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14093485|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14093486|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14093487|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14760923|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093488|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
14093489|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
14093490|NCT02447055|Melphalan|melphalan|mesh-list
14093491|NCT02447055|Fludarabine|fludarabine|mesh-list
14093492|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
14093493|NCT02447055|Tacrolimus|tacrolimus|mesh-list
14093494|NCT02447055|Lenograstim|lenograstim|mesh-list
14093495|NCT02447055|Sargramostim|sargramostim|mesh-list
14093496|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093497|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
14093498|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093499|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093500|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14093501|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
14093502|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093503|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093504|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14093505|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14093506|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
14093507|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14093508|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14093509|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093510|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14093511|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14093512|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
14093513|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14093514|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174366|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174367|NCT04787471|Riboflavin|riboflavin|mesh-list
14174368|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
14174369|NCT04787471|Vitamins|vitamins|mesh-ancestor
14174370|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
14174371|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921692|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921693|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
13921694|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
13921695|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13921696|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13921697|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
13921698|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921699|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174372|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14174373|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
14174374|NCT04787731|Lidocaine|lidocaine|mesh-list
14174375|NCT04787731|Bupivacaine|bupivacaine|mesh-list
14174376|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
14174377|NCT04787731|Anesthetics|anesthetics|mesh-list
14174378|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174379|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174380|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
14174381|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174382|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14174383|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14174384|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14174385|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174386|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174387|NCT04787289|Bevacizumab|bevacizumab|mesh-list
14174388|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14174389|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174390|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13921700|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174391|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14174392|NCT04787289|Growth Substances|growth substances|mesh-ancestor
14174393|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174394|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
14174395|NCT04787276|Rifaximin|rifaximin|mesh-list
14174396|NCT04787276|Lactulose|lactulose|mesh-list
14174397|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14174398|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174399|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174400|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14174401|NCT04786795|Pancreatin|pancreatin|mesh-list
14174402|NCT04786795|Pancrelipase|pancrelipase|mesh-list
14174403|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14174404|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174405|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
14477430|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
14093515|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14093516|NCT02447094|Plasminogen|plasminogen|mesh-list
14093517|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14093518|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14093519|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093520|NCT02446860|Nivolumab|nivolumab|mesh-list
14093521|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14093522|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093523|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14093524|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921701|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13921702|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
13921703|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921704|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921705|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921706|NCT03437460|Ibuprofen|ibuprofen|mesh-list
13921707|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921708|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13921709|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13921710|NCT03437460|Analgesics|analgesics|mesh-ancestor
13921711|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
13921712|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921713|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921714|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093525|NCT02446730|Clopidogrel|clopidogrel|mesh-list
14093526|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14093527|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14093528|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14093529|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14093530|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
14093531|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093532|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093533|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093534|NCT02446652|Paclitaxel|paclitaxel|mesh-list
14093535|NCT02446652|Carboplatin|carboplatin|mesh-list
14093536|NCT02446652|Hydralazine|hydralazine|mesh-list
14093537|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14093538|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921715|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13921716|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921717|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921718|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
13921719|NCT03437226|Simendan|simendan|mesh-list
13921720|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13921721|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
13921722|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13921723|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13921724|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921725|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921726|NCT03437226|Protective Agents|protective agents|mesh-ancestor
13921727|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921728|NCT03437213|Anesthetics|anesthetics|mesh-list
13921729|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921730|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921731|NCT03437200|Nivolumab|nivolumab|mesh-list
13921732|NCT03437200|Ipilimumab|ipilimumab|mesh-list
13921733|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921734|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921735|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13921736|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921737|NCT03437187|Analgesics|analgesics|mesh-list
13921738|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921739|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
14093539|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093540|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093541|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
14760924|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760925|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
14760926|NCT04036929|Estrogens|estrogens|mesh-list
14760927|NCT04036929|Hormones|hormones|mesh-ancestor
14760928|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760929|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760930|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14760931|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14760932|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
14760933|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13921740|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960572|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960573|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
13963376|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963377|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
13963378|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
13963379|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
13963380|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963381|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963382|NCT03144596|Tamsulosin|tamsulosin|mesh-list
13963383|NCT03144596|Alfuzosin|alfuzosin|mesh-list
13963384|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13963385|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13963386|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13963387|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
13963388|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963389|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963390|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963391|NCT03144596|Urological Agents|urological agents|mesh-ancestor
13963392|NCT03145012|Ranitidine|ranitidine|mesh-list
13963393|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
13963394|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13963395|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963396|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13963397|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
13963398|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
13963399|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963400|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963401|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963402|NCT03144778|Durvalumab|durvalumab|mesh-list
13963403|NCT03144778|Ipilimumab|ipilimumab|mesh-list
13963404|NCT03144778|Tremelimumab|tremelimumab|mesh-list
13963405|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
13963406|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13963407|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
13963408|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14093542|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093543|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14093544|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
14093545|NCT02446782|Clindamycin|clindamycin|mesh-list
14093546|NCT02446782|Cefazolin|cefazolin|mesh-list
14093547|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14093548|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093549|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14093550|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093551|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093552|NCT02446795|Sunitinib|sunitinib|mesh-list
14093553|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093554|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14093555|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14093556|NCT02446795|Growth Substances|growth substances|mesh-ancestor
14093557|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093558|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
14093559|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14093560|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093561|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093562|NCT02446834|Metformin|metformin|mesh-list
14093563|NCT02446834|Acarbose|acarbose|mesh-list
14093564|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14093565|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093566|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14093567|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093568|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093569|NCT02446574|Paclitaxel|paclitaxel|mesh-list
14093570|NCT02446574|Cisplatin|cisplatin|mesh-list
14093571|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14093572|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760934|NCT04034095|Prednisolone|prednisolone|mesh-list
14760935|NCT04034095|Docetaxel|docetaxel|mesh-list
13963409|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963410|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
13963411|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921741|NCT03437070|Doxorubicin|doxorubicin|mesh-list
14093573|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093574|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093575|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093576|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093577|NCT02446704|Temozolomide|temozolomide|mesh-list
14093578|NCT02446704|Olaparib|olaparib|mesh-list
14093579|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14093580|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
14093581|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093582|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093583|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14093584|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093585|NCT02446548|Losartan|losartan|mesh-list
14093586|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13921742|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13921743|NCT03437070|Trabectedin|trabectedin|mesh-list
13921744|NCT03437070|Olaratumab|olaratumab|mesh-list
13921745|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13921746|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921747|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13921748|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13921749|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921750|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921751|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13921752|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
13921753|NCT03437057|Aspirin|aspirin|mesh-list
13921754|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14093587|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14093588|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14093589|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14093590|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093591|NCT02446457|Rituximab|rituximab|mesh-list
14093592|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14093593|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
14093594|NCT02446457|Lenalidomide|lenalidomide|mesh-list
14093595|NCT02446457|Antibodies|antibodies|mesh-list
14093596|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
14093597|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14093598|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
14093599|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093600|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093601|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093602|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14093603|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14093604|NCT02446457|Growth Substances|growth substances|mesh-ancestor
14093605|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
14093606|NCT02446431|Sirolimus|sirolimus|mesh-list
14093607|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
14093608|NCT02446431|Bevacizumab|bevacizumab|mesh-list
14093609|NCT02446431|Valproic Acid|valproic acid|mesh-list
14093610|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093611|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
14093612|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093613|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093614|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14093615|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
14093616|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093617|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093618|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14093619|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14093620|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14093621|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14093622|NCT02446431|Growth Substances|growth substances|mesh-ancestor
14093623|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
14093624|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14093625|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093626|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14093627|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
14093628|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
14093629|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093630|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
14093631|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093632|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
13921755|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14093633|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13921756|NCT03437057|Analgesics|analgesics|mesh-ancestor
13921757|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
13921758|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921759|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921760|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921761|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13921762|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13921763|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13921764|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921765|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13921766|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13921767|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921768|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
13921769|NCT03437005|Ketoconazole|ketoconazole|mesh-list
13921770|NCT03437005|Desonide|desonide|mesh-list
13921771|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
13921772|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921773|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14093634|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093635|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14093636|NCT02446236|Rituximab|rituximab|mesh-list
14093637|NCT02446236|Lenalidomide|lenalidomide|mesh-list
14093638|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14093639|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093640|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
14093641|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093642|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093643|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14093644|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14093645|NCT02446236|Growth Substances|growth substances|mesh-ancestor
14093646|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
14093647|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14093648|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14093649|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093650|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
14093651|NCT02446353|Megestrol|megestrol|mesh-list
14093652|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093653|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093654|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
14093655|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13921774|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13921775|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921776|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921777|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13921778|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
13921779|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921780|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093656|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760936|NCT04034095|Bicalutamide|bicalutamide|mesh-list
14760937|NCT04034095|Androgens|androgens|mesh-list
14760938|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760939|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14760940|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
14760941|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093657|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14093658|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14093659|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14093660|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
14093661|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14093662|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14093663|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14093664|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
14093665|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14093666|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14093667|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093668|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
14093669|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
14093670|NCT02446301|Nalbuphine|nalbuphine|mesh-list
14093671|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14093672|NCT02446301|Narcotics|narcotics|mesh-ancestor
14093673|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093674|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760942|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093675|NCT02446301|Analgesics|analgesics|mesh-ancestor
14760943|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921781|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13921782|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921783|NCT03436992|Resveratrol|resveratrol|mesh-list
13921784|NCT03436992|Antioxidants|antioxidants|mesh-list
13921785|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921786|NCT03436992|Protective Agents|protective agents|mesh-ancestor
13921787|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921788|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921789|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13921790|NCT03436836|Lidocaine|lidocaine|mesh-list
13921791|NCT03436836|Nalbuphine|nalbuphine|mesh-list
13921792|NCT03436836|Bupivacaine|bupivacaine|mesh-list
13921793|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
13921794|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
13921795|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921796|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921797|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
13921798|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921799|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13921800|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13921801|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13921802|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13921803|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921804|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14093676|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
14093677|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093678|NCT02445976|Seviteronel|seviteronel|mesh-list
14093679|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093680|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14093681|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093682|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093683|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
13921805|NCT03436836|Narcotics|narcotics|mesh-ancestor
13921806|NCT03436836|Analgesics|analgesics|mesh-ancestor
13921807|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13921808|NCT03436719|Metronidazole|metronidazole|mesh-list
13921809|NCT03436719|Erythromycin|erythromycin|mesh-list
13921810|NCT03436719|Cefoperazone|cefoperazone|mesh-list
13921811|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13921812|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921813|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
13921814|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13921815|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13921816|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921817|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13921818|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921819|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921820|NCT03436693|Canagliflozin|canagliflozin|mesh-list
13921821|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13921822|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921823|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13921824|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477431|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14477432|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477433|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14093684|NCT02445989|NuvaRing|nuvaring|mesh-list
14093685|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14093686|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093687|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14093688|NCT02446002|Lofexidine|lofexidine|mesh-list
14093689|NCT02446002|Clonidine|clonidine|mesh-list
14093690|NCT02446002|Naltrexone|naltrexone|mesh-list
14093691|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14093692|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14093693|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093694|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
14093695|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093696|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14093697|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14093698|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14093699|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14760944|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
14760945|NCT04034095|Hormones|hormones|mesh-ancestor
14093700|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
14093701|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093702|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093703|NCT02446002|Analgesics|analgesics|mesh-ancestor
14093704|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
14093705|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
14093706|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
14093707|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14093708|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14093709|NCT02445898|Prednisolone|prednisolone|mesh-list
14093710|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
14093711|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14093712|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
14093713|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093714|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
14093715|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
14935781|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935782|NCT01465503|Heparin|heparin|mesh-list
14935783|NCT01465503|Calcium heparin|calcium heparin|mesh-list
14093716|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093717|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093718|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093719|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
14093720|NCT02445898|Hormones|hormones|mesh-ancestor
14093721|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093722|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14093723|NCT02445898|Protective Agents|protective agents|mesh-ancestor
14093724|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093725|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093726|NCT02445872|Dexamethasone|dexamethasone|mesh-list
14093727|NCT02445872|Aprepitant|aprepitant|mesh-list
14093728|NCT02445872|Palonosetron|palonosetron|mesh-list
14093729|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093730|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
14093731|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
14093732|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093733|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093734|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093735|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
14093736|NCT02445872|Hormones|hormones|mesh-ancestor
14093737|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093738|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093739|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093740|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14093741|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093742|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093743|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14093744|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14093745|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
14093746|NCT02446093|Valacyclovir|valacyclovir|mesh-list
14093747|NCT02446093|Antiviral Agents|antiviral agents|mesh-ancestor
14093748|NCT02446093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093749|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
14093750|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14093751|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14093752|NCT02445599|Dipyrone|dipyrone|mesh-list
14093753|NCT02445599|Diclofenac|diclofenac|mesh-list
14093754|NCT02445599|Atropine|atropine|mesh-list
14093755|NCT02445599|Fentanyl|fentanyl|mesh-list
14093756|NCT02445599|Midazolam|midazolam|mesh-list
14093757|NCT02445599|Tramadol|tramadol|mesh-list
14093758|NCT02445599|Nalbuphine|nalbuphine|mesh-list
14093759|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14093760|NCT02445599|Narcotics|narcotics|mesh-ancestor
14477434|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
14477435|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477436|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921832|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
13921833|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13921834|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921835|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921836|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13921837|NCT03436472|Analgesics|analgesics|mesh-ancestor
14093761|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093762|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093763|NCT02445599|Analgesics|analgesics|mesh-ancestor
14093764|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
14093765|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477437|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
14093766|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14093767|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14093768|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
14093769|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
14093770|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14093771|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14093772|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14093773|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14093774|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
14093775|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
14093776|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093777|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093778|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14093779|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14093780|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093781|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093782|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14093783|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093784|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14093785|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14093786|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
14093787|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14093788|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
14093789|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
14093790|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
14093791|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14093792|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14093793|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
14093794|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
14093795|NCT02445703|Vaccines|vaccines|mesh-list
14093796|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
14093797|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093798|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
14093799|NCT02445716|Testosterone|testosterone|mesh-list
14093800|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
14093801|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
14093802|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14093803|NCT02445716|Androgens|androgens|mesh-ancestor
14093804|NCT02445716|Hormones|hormones|mesh-ancestor
14093805|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093806|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093807|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093808|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093809|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
14093810|NCT02445547|Hormones|hormones|mesh-list
14093811|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093812|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093813|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
14093814|NCT02445508|Sevelamer|sevelamer|mesh-list
14093815|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
14093816|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
14093817|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093818|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14093819|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093820|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14093821|NCT02445352|Ezetimibe|ezetimibe|mesh-list
14093822|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14093823|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14093824|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
14093825|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093826|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14093827|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14093828|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093829|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14093830|NCT02445300|Laxatives|laxatives|mesh-ancestor
14093831|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14935784|NCT01465503|Hirudins|hirudins|mesh-list
14935785|NCT01465503|Bivalirudin|bivalirudin|mesh-list
14935786|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
14935787|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935788|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14935789|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935790|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
14093832|NCT02445339|Naltrexone|naltrexone|mesh-list
14093833|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14093834|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14935791|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14093835|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093836|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
14093837|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093838|NCT02445404|Dexamethasone|dexamethasone|mesh-list
14093839|NCT02445404|Prednisone|prednisone|mesh-list
14093840|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
14093841|NCT02445404|Ifosfamide|ifosfamide|mesh-list
14093842|NCT02445404|Carboplatin|carboplatin|mesh-list
14093843|NCT02445404|Etoposide|etoposide|mesh-list
14093844|NCT02445404|Vincristine|vincristine|mesh-list
14093845|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14093846|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
14093847|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093848|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14093849|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14093850|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
14093851|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093852|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093853|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14093854|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093855|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
14093856|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
14093857|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093858|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093859|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
14093860|NCT02445404|Hormones|hormones|mesh-ancestor
14093861|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14093862|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14093863|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093864|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14093865|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14093866|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14093867|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
14093868|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
14093869|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093870|NCT02445391|Cisplatin|cisplatin|mesh-list
14093871|NCT02445391|Carboplatin|carboplatin|mesh-list
13921838|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
13921839|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921840|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13921841|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13921842|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13921843|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921844|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921845|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921846|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
13921847|NCT03436303|Progestins|progestins|mesh-ancestor
13921848|NCT03436303|Hormones|hormones|mesh-ancestor
13921849|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921850|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921851|NCT03436225|Dexamethasone|dexamethasone|mesh-list
13921852|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
13921853|NCT03436225|Budesonide|budesonide|mesh-list
13921854|NCT03436225|Albuterol|albuterol|mesh-list
13921855|NCT03436225|BB 1101|bb 1101|mesh-list
13921856|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13921857|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
13921858|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
13921859|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921860|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921861|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13921862|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
13921863|NCT03436225|Hormones|hormones|mesh-ancestor
13921864|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13921865|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13921866|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921867|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
13921868|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921869|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921870|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14093872|NCT02445391|Capecitabine|capecitabine|mesh-list
14093873|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093874|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14093875|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
14093876|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174406|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13921871|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13921872|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
13921873|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
13921874|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13921875|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13921876|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13921877|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13921878|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
13921879|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921880|NCT03436173|Fluoxetine|fluoxetine|mesh-list
13921881|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13921882|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13921883|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13921884|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921885|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921886|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
13921887|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921888|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13921889|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
13921890|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13921891|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13921892|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13921893|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921894|NCT03436121|Midazolam|midazolam|mesh-list
13921895|NCT03436121|Ketamine|ketamine|mesh-list
13921896|NCT03436121|Analgesics|analgesics|mesh-ancestor
13921897|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
13921898|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13921899|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921900|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13921901|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13921902|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
13921903|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
13921904|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13921905|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13921906|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14093877|NCT02445066|Vitamin D|vitamin d|mesh-list
14093878|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
14093879|NCT02445066|Vitamins|vitamins|mesh-ancestor
13921907|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13921908|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921909|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13921910|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13921911|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13921912|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13921913|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13921914|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
13921915|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
13921916|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
13921917|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13921918|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921928|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13921929|NCT03435900|Metronidazole|metronidazole|mesh-list
13921930|NCT03435900|Fosfomycin|fosfomycin|mesh-list
13921931|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13921932|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921933|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
13921934|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13921935|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13921936|NCT03435744|Simvastatin|simvastatin|mesh-list
13921937|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13921938|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13921939|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
14093880|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
13921940|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093881|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921941|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14093882|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14093883|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14093884|NCT02444949|Cisplatin|cisplatin|mesh-list
14093885|NCT02444949|Endostar protein|endostar protein|mesh-list
14093886|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093887|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14093888|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14093889|NCT02444949|Growth Substances|growth substances|mesh-ancestor
14093890|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093891|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
14093892|NCT02445053|Ivacaftor|ivacaftor|mesh-list
14093893|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14093894|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14093895|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921942|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13921943|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477438|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093896|NCT02444767|Bimatoprost|bimatoprost|mesh-list
14093897|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14093898|NCT02444897|Fentanyl|fentanyl|mesh-list
14093899|NCT02444897|Nefopam|nefopam|mesh-list
14093900|NCT02444897|Ramosetron|ramosetron|mesh-list
14093901|NCT02444897|Ropivacaine|ropivacaine|mesh-list
14093902|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
14093903|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
14093904|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093905|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093906|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
14093907|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093908|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14093909|NCT02444897|Narcotics|narcotics|mesh-ancestor
14093910|NCT02444897|Analgesics|analgesics|mesh-ancestor
14093911|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14093912|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14093913|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
14093914|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
14093915|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
14093916|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093917|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14477439|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14477440|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477441|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
14477442|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477443|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14477444|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
14477445|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477446|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477447|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
14477448|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13921944|NCT03435718|Albendazole|albendazole|mesh-list
13921945|NCT03435718|Oxfendazole|oxfendazole|mesh-list
13921946|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
13921947|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13921948|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921949|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
13921950|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13921951|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13921952|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
13921953|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
13921954|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
13921955|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921956|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921957|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
13921958|NCT03435666|Capecitabine|capecitabine|mesh-list
13921959|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921960|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
13921961|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921962|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921963|NCT03435302|Temozolomide|temozolomide|mesh-list
13921964|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921965|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13921966|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
13921967|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960574|NCT03153527|Prednisone|prednisone|mesh-list
14093918|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
14093919|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093920|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093921|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14477449|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477450|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960575|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14093922|NCT02444611|Vaccines|vaccines|mesh-list
14093923|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
14935792|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
14093924|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
14093925|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093926|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14093927|NCT02444637|Rivastigmine|rivastigmine|mesh-list
14093928|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14093929|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093930|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093931|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
14093932|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093933|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093934|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14093935|NCT02444637|Protective Agents|protective agents|mesh-ancestor
14093936|NCT02444585|Denosumab|denosumab|mesh-list
14093937|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14093938|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093939|NCT02444507|Esomeprazole|esomeprazole|mesh-list
14093940|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14093941|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14093942|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14935793|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921968|NCT03435289|Gemcitabine|gemcitabine|mesh-list
13921969|NCT03435289|Paclitaxel|paclitaxel|mesh-list
13921970|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13921971|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13921972|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13921973|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
13921974|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
13921975|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
13921976|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921977|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921978|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
13921979|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
13921980|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921981|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921982|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13921983|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
14093943|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093944|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093945|NCT02444481|Polymyxins|polymyxins|mesh-list
14093946|NCT02444481|Nystatin|nystatin|mesh-list
14093947|NCT02444481|Neomycin|neomycin|mesh-list
14093948|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14093949|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14093950|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
14093951|NCT02444481|Ionophores|ionophores|mesh-ancestor
14093952|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14093953|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093954|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14093955|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14093956|NCT02444572|Enoxaparin|enoxaparin|mesh-list
14093957|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
14093958|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14093959|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14093960|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093961|NCT02444546|Sargramostim|sargramostim|mesh-list
14093962|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
14093963|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093964|NCT02444559|Clonidine|clonidine|mesh-list
14093965|NCT02444559|Ropivacaine|ropivacaine|mesh-list
14093966|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
13921984|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921985|NCT03435250|Gemcitabine|gemcitabine|mesh-list
13921986|NCT03435250|Paclitaxel|paclitaxel|mesh-list
13921987|NCT03435250|Docetaxel|docetaxel|mesh-list
13921988|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13921989|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093967|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
14093968|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093969|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093970|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
14477451|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13921990|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
13921991|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
13921992|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
14093971|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093972|NCT02444559|Analgesics|analgesics|mesh-ancestor
14093973|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14093974|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
14093975|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
14093976|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14093977|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14093978|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14093979|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
14093980|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14093981|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093982|NCT03840239|Capecitabine|capecitabine|mesh-list
14093983|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
14093984|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14093985|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
13921993|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13921994|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13921995|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
13921996|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
13921997|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13921998|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13921999|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13922000|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
13922001|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922002|NCT03435133|Ticagrelor|ticagrelor|mesh-list
13922003|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13922004|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13922005|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13922006|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13922007|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13922008|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
13922009|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922010|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922011|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922012|NCT03435107|Durvalumab|durvalumab|mesh-list
13922013|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922014|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922015|NCT03435094|Alendronate|alendronate|mesh-list
14093986|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14093987|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14093988|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
14093989|NCT03810911|Hematinics|hematinics|mesh-ancestor
14093990|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
14093991|NCT03808025|Narcotics|narcotics|mesh-ancestor
14093992|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14093993|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14093994|NCT03808025|Analgesics|analgesics|mesh-ancestor
14760946|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760947|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760948|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760949|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
14760950|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
14760951|NCT04032626|Lenalidomide|lenalidomide|mesh-list
14760952|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
14760953|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760954|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14093995|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
14093996|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14093997|NCT03757715|Dexamethasone|dexamethasone|mesh-list
14093998|NCT03757715|Bupivacaine|bupivacaine|mesh-list
14093999|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094000|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
14094001|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
14094002|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094003|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094004|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14094005|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
14094006|NCT03757715|Hormones|hormones|mesh-ancestor
14094007|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094008|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14760955|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13922016|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14760956|NCT04032626|Growth Substances|growth substances|mesh-ancestor
14760957|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
14760958|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960576|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
14174407|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
14760959|NCT04026113|Linaclotide|linaclotide|mesh-list
14477452|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
14935794|NCT01465568|Denosumab|denosumab|mesh-list
14935795|NCT01465568|Diphosphonates|diphosphonates|mesh-list
14935796|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14935797|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922017|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922018|NCT03434951|Morphine|morphine|mesh-list
13922019|NCT03434951|Bupivacaine|bupivacaine|mesh-list
13922020|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
13922021|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
13922022|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922023|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922024|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
13922025|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922026|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922027|NCT03434951|Narcotics|narcotics|mesh-ancestor
13922028|NCT03434951|Analgesics|analgesics|mesh-ancestor
13922029|NCT03434782|Listerine|listerine|mesh-list
13922030|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13922031|NCT03434782|Fluorides|fluorides|mesh-list
13922032|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
14094009|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094010|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
14094011|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
14094012|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094013|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
14094014|NCT03737604|Bupivacaine|bupivacaine|mesh-list
14094015|NCT03737604|Ropivacaine|ropivacaine|mesh-list
14094016|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
14094017|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
14094018|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094019|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094020|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
14094021|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094022|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14094023|NCT03651804|Acetaminophen|acetaminophen|mesh-list
14094024|NCT03651804|Diphosphonates|diphosphonates|mesh-list
14094025|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14094026|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14094027|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14094028|NCT03651804|Analgesics|analgesics|mesh-ancestor
14094029|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
14094030|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094031|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094032|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
14094033|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14094034|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094035|NCT03608163|Diazoxide|diazoxide|mesh-list
14094036|NCT03608163|Naloxone|naloxone|mesh-list
14094037|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14094038|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094039|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
14094040|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094041|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14094042|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
14094043|NCT03578367|Niacinamide|niacinamide|mesh-list
14094044|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
14094045|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094046|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14094047|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094048|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094049|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
14094050|NCT03578367|Vitamins|vitamins|mesh-ancestor
14094051|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
14094052|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094053|NCT03578198|Rituximab|rituximab|mesh-list
14094054|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094055|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094056|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
14094057|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094058|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094059|NCT03575793|Nivolumab|nivolumab|mesh-list
14094060|NCT03575793|Ipilimumab|ipilimumab|mesh-list
14935798|NCT01465685|Methylphenidate|methylphenidate|mesh-list
13922033|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
13922034|NCT03434782|Protective Agents|protective agents|mesh-ancestor
14094061|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922035|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922036|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13922037|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922038|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
13922039|NCT03434704|Clotrimazole|clotrimazole|mesh-list
13922040|NCT03434704|Miconazole|miconazole|mesh-list
13922041|NCT03434704|Fludarabine|fludarabine|mesh-list
13922042|NCT03434704|Thiotepa|thiotepa|mesh-list
13922043|NCT03434704|Treosulfan|treosulfan|mesh-list
13922044|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922045|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922046|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13922047|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
13922048|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922049|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13922050|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
13922051|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13922052|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922053|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13922054|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13922055|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13922056|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922057|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13922058|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
13922059|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922060|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13922061|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13922062|NCT03434691|Remifentanil|remifentanil|mesh-list
13922063|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922064|NCT03434691|Narcotics|narcotics|mesh-ancestor
13922065|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922066|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922067|NCT03434691|Analgesics|analgesics|mesh-ancestor
13922068|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
13922069|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922070|NCT03434678|Fentanyl|fentanyl|mesh-list
13922071|NCT03434678|Bupivacaine|bupivacaine|mesh-list
13922072|NCT03434678|Propofol|propofol|mesh-list
13922073|NCT03434678|Rocuronium|rocuronium|mesh-list
13922074|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
13922075|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
13922076|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922077|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922078|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
13922079|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922080|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13922081|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13922082|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
13922083|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922084|NCT03434678|Narcotics|narcotics|mesh-ancestor
13922085|NCT03434678|Analgesics|analgesics|mesh-ancestor
13922086|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13922087|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13922088|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13922089|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13922090|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13922091|NCT03434613|Ezetimibe|ezetimibe|mesh-list
13922092|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13922093|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13922094|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
13922095|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922096|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13922097|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13922098|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094062|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094063|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14094064|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094065|NCT03572283|Bethanechol|bethanechol|mesh-list
14094066|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14094067|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
14094068|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094069|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094070|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13922099|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
13922100|NCT03434340|Dexamethasone|dexamethasone|mesh-list
13922101|NCT03434340|Granisetron|granisetron|mesh-list
13922102|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922103|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
13922104|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
13922105|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922106|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922107|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13922108|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
13922109|NCT03434340|Hormones|hormones|mesh-ancestor
14760960|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14760961|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
14760962|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760963|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14760964|NCT04024436|Fulvestrant|fulvestrant|mesh-list
13922110|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922111|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13922112|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922113|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13922114|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
13922115|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094071|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14094072|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
14094073|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094074|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094075|NCT03512197|Midostaurin|midostaurin|mesh-list
14094076|NCT03512197|Staurosporine|staurosporine|mesh-list
14094077|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094078|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13922116|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922117|NCT03434275|Meloxicam|meloxicam|mesh-list
13922118|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13922119|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922120|NCT03434275|Analgesics|analgesics|mesh-ancestor
13922121|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
13922122|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922123|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922124|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922125|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13922126|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13922127|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14094079|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094080|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094081|NCT03506360|Dexamethasone|dexamethasone|mesh-list
14094082|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
14094083|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
14094084|NCT03506360|Ixazomib|ixazomib|mesh-list
14094085|NCT03506360|Ichthammol|ichthammol|mesh-list
14094086|NCT03506360|BB 1101|bb 1101|mesh-list
14094087|NCT03506360|Glycine|glycine|mesh-list
13922128|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922129|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922130|NCT03434197|Diclofenac|diclofenac|mesh-list
13922131|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13922132|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922133|NCT03434197|Analgesics|analgesics|mesh-ancestor
13922134|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
13922135|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922136|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922137|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922138|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094088|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094089|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
14094090|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
14094091|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094092|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094093|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14094094|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
14094095|NCT03506360|Hormones|hormones|mesh-ancestor
14094096|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094097|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13922139|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13922140|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960577|NCT03153527|Hormones|hormones|mesh-ancestor
14094098|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094099|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
14094100|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922141|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922142|NCT03434106|Dextrans|dextrans|mesh-list
13922143|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
13922144|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
13922145|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
13922146|NCT03434054|Losartan|losartan|mesh-list
13922147|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13922148|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13922149|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13922150|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14094101|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094102|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094103|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
14094104|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
14094105|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094106|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
14094107|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094108|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094109|NCT03471611|Sargramostim|sargramostim|mesh-list
14094110|NCT03471611|Lenograstim|lenograstim|mesh-list
14094111|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
14094112|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094113|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094114|NCT03459222|Nivolumab|nivolumab|mesh-list
14094115|NCT03459222|Ipilimumab|ipilimumab|mesh-list
14094116|NCT03459222|Linrodostat|linrodostat|mesh-list
13922151|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922152|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13922153|NCT03434041|Citalopram|citalopram|mesh-list
13922154|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13922155|NCT03434041|Sertraline|sertraline|mesh-list
13922156|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
13922157|NCT03434041|Esketamine|esketamine|mesh-list
13922158|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13922159|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13922160|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922161|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922162|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922163|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
13922164|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922165|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13922166|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14094117|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094118|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094119|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14094120|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094121|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094122|NCT03388788|CGP 12177|cgp 12177|mesh-list
14094123|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14094124|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14094125|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
14094126|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094127|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094128|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094129|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13922167|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922168|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13922169|NCT03434041|Analgesics|analgesics|mesh-ancestor
13922170|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
13922171|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
13922172|NCT03433976|Anesthetics|anesthetics|mesh-list
13922173|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922174|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922175|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13922176|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13922177|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13922178|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094130|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14094131|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
14094132|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14094133|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
14477453|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14477454|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13922179|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922180|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13922181|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922182|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922183|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
13922184|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922185|NCT03433807|Idebenone|idebenone|mesh-list
13922186|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
13922187|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922188|NCT03433807|Protective Agents|protective agents|mesh-ancestor
13922189|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922190|NCT03433586|Aspirin|aspirin|mesh-list
13922191|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13922192|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922193|NCT03433586|Analgesics|analgesics|mesh-ancestor
13922194|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
13922195|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922196|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922197|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094134|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14094135|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094136|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094137|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14094138|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174408|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174409|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
14174410|NCT04786613|Protective Agents|protective agents|mesh-ancestor
14174411|NCT04786873|Clonidine|clonidine|mesh-list
14174412|NCT04786873|Analgesics|analgesics|mesh-ancestor
14174413|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
14174414|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174415|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174416|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14174417|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
14174418|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
14174419|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14174420|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14174421|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14174422|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174423|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174424|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174425|NCT04786574|Tolvaptan|tolvaptan|mesh-list
14174426|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14174427|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174428|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
14174429|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183588|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14183589|NCT04727073|Diuretics|diuretics|mesh-ancestor
14183590|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
14183591|NCT04726631|Insulin|insulin|mesh-list
13922198|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13922199|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13922200|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13922201|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922202|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13922203|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13922204|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922205|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
13960578|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13960579|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960580|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13960581|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183592|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14183593|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
14183594|NCT04726631|Protamines|protamines|mesh-list
13960582|NCT03153267|Doxycycline|doxycycline|mesh-list
14183595|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14183596|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183597|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
14094144|NCT03365908|Ropivacaine|ropivacaine|mesh-list
14094145|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
14094146|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
14094147|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094148|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094149|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
14094150|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094151|NCT03335540|Nivolumab|nivolumab|mesh-list
14094152|NCT03335540|Ipilimumab|ipilimumab|mesh-list
14094153|NCT03335540|Linrodostat|linrodostat|mesh-list
14094154|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094155|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094156|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14094157|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094158|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094159|NCT03321643|Gemcitabine|gemcitabine|mesh-list
14094160|NCT03321643|Rituximab|rituximab|mesh-list
14094161|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14094162|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
14094163|NCT03321643|Atezolizumab|atezolizumab|mesh-list
14094164|NCT03321643|Antibodies|antibodies|mesh-list
14094165|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
14094166|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14094167|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
14094168|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094169|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094170|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094171|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094172|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
14094173|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094174|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
13922206|NCT03433534|Nivolumab|nivolumab|mesh-list
13922207|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922208|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922209|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13922210|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922211|NCT03433469|Osimertinib|osimertinib|mesh-list
13922212|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922213|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13922214|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922215|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922216|NCT03433378|Tretinoin|tretinoin|mesh-list
13922217|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094175|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094176|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094177|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094178|NCT03295240|Rituximab|rituximab|mesh-list
14094179|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14094180|NCT03295240|Venetoclax|venetoclax|mesh-list
14094181|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094182|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094183|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
14094184|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094185|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094186|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14094187|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
14094188|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094189|NCT03279471|Sertraline|sertraline|mesh-list
14094190|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
14094191|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14094192|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13922218|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
14094193|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14094194|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14094195|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094196|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094197|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
14094198|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094199|NCT03277729|Vidarabine|vidarabine|mesh-list
14094200|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
13922219|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
14094201|NCT03277729|Fludarabine|fludarabine|mesh-list
14094202|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
14094203|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094204|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
14094205|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094206|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094207|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14094208|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
14094209|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094210|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094211|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14094212|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094213|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
14094214|NCT03277729|Antiviral Agents|antiviral agents|mesh-ancestor
14094215|NCT03277729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094216|NCT03248479|Azacitidine|azacitidine|mesh-list
14094217|NCT03248479|Magrolimab|magrolimab|mesh-list
14094218|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094219|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
14094220|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094221|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094222|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094223|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094224|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
14094225|NCT03241940|Fludarabine|fludarabine|mesh-list
14094226|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
14094227|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094228|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
14094229|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094230|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094231|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14094232|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
14094233|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094234|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094235|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14094236|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094237|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
14094238|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
14094239|NCT03126630|Maytansine|maytansine|mesh-list
14094240|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094241|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094242|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14094243|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
14094244|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
14094245|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
14094246|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094247|NCT03109964|Hemostatics|hemostatics|mesh-list
14094248|NCT03109964|Surgiflo|surgiflo|mesh-list
14094249|NCT03109964|Coagulants|coagulants|mesh-ancestor
14094250|NCT03099486|Leucovorin|leucovorin|mesh-list
14094251|NCT03099486|Antidotes|antidotes|mesh-ancestor
14094252|NCT03099486|Protective Agents|protective agents|mesh-ancestor
14094253|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094254|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
14094255|NCT03099486|Vitamins|vitamins|mesh-ancestor
14094256|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
14094257|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14094258|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14094259|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14094260|NCT03017820|Iodine|iodine|mesh-list
14094261|NCT03017820|Interferons|interferons|mesh-list
14094262|NCT03017820|Interferon-beta|interferon-beta|mesh-list
14094263|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
14094264|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094265|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
14094266|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094267|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094268|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14094269|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
14094270|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094271|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094272|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14094273|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
14094274|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094275|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14094276|NCT03017820|Trace Elements|trace elements|mesh-ancestor
14094277|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
14094278|NCT02991482|Gemcitabine|gemcitabine|mesh-list
14094279|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
14094280|NCT02991482|Vinorelbine|vinorelbine|mesh-list
14094281|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094282|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
14174430|NCT04786158|Apomorphine|apomorphine|mesh-list
14094283|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094284|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094285|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
14094286|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094287|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094288|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094289|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
14094290|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094291|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094292|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14094293|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
14094294|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
14094295|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
14094296|NCT02952534|Rucaparib|rucaparib|mesh-list
14094297|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14094298|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094299|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094300|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094301|NCT02906761|Aspirin|aspirin|mesh-list
14094302|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14094303|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14094304|NCT02906761|Analgesics|analgesics|mesh-ancestor
14094305|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
14094306|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094307|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094308|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094309|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094310|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14094311|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14094312|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094313|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14094314|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14094315|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094316|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
14094317|NCT02883062|Paclitaxel|paclitaxel|mesh-list
14094318|NCT02883062|Carboplatin|carboplatin|mesh-list
14094319|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14094320|NCT02883062|Atezolizumab|atezolizumab|mesh-list
14094321|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14094322|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14094323|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094324|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14094325|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14094326|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14094327|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094328|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
14094329|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094330|NCT02725567|Ivacaftor|ivacaftor|mesh-list
14094331|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14094332|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14094333|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094334|NCT02709655|Vortioxetine|vortioxetine|mesh-list
14094335|NCT02709655|Fluoxetine|fluoxetine|mesh-list
14094336|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14094337|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14094338|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14094339|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094340|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094341|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
14094342|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094343|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14094344|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
14094345|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13922220|NCT03433352|Methimazole|methimazole|mesh-list
13922221|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
13922222|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
14094346|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14094347|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14094348|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094349|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14094350|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14094351|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094352|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14094353|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14094354|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14094355|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14094356|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14094357|NCT02648698|Levofloxacin|levofloxacin|mesh-list
14094358|NCT02648698|Tinidazole|tinidazole|mesh-list
14094359|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094360|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14094361|NCT02648698|Renal Agents|renal agents|mesh-ancestor
13922223|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
13922224|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922225|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922226|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
13922227|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922228|NCT03433326|Grazoprevir|grazoprevir|mesh-list
13922229|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
13922230|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922231|NCT03433313|Trastuzumab|trastuzumab|mesh-list
13922232|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922233|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094362|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14094363|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14094364|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094365|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094366|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094367|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14094368|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14094369|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
14094370|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14094371|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14094372|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14094373|NCT02600897|Rituximab|rituximab|mesh-list
14094374|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
14094375|NCT02600897|Lenalidomide|lenalidomide|mesh-list
14094376|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760965|NCT04024436|Futibatinib|futibatinib|mesh-list
14760966|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13922234|NCT03433235|Edoxaban|edoxaban|mesh-list
13922235|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13922236|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
13922237|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13922238|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
13922239|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922240|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922241|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
14760967|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760968|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14760969|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14760970|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
14935799|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
13922242|NCT03433222|Coal Tar|coal tar|mesh-list
13922243|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
13922244|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
13922245|NCT03433196|Atorvastatin|atorvastatin|mesh-list
13922246|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13922247|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14174431|NCT04786158|Emetics|emetics|mesh-ancestor
13922248|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
13922249|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922250|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13922251|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13922252|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922253|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
13922254|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13922255|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13922256|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922257|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
13922258|NCT03433144|Coagulants|coagulants|mesh-ancestor
13922259|NCT03433092|Carotenoids|carotenoids|mesh-list
13922260|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
13922261|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922262|NCT03433092|Protective Agents|protective agents|mesh-ancestor
13922263|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922264|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
13922265|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
13922266|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
13922267|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922268|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094377|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094378|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
14094379|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094380|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094381|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14094382|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14094383|NCT02600897|Growth Substances|growth substances|mesh-ancestor
14094384|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14094385|NCT02532257|Rituximab|rituximab|mesh-list
14094386|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13922269|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
13922270|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922271|NCT03433001|Dexamethasone|dexamethasone|mesh-list
13922272|NCT03433001|Lenalidomide|lenalidomide|mesh-list
13922273|NCT03433001|Ixazomib|ixazomib|mesh-list
13922274|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922275|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
13922276|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
13922277|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922278|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922279|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14094387|NCT02532257|Lenalidomide|lenalidomide|mesh-list
14094388|NCT02532257|Antibodies|antibodies|mesh-list
14094389|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
14094390|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14760971|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14760972|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760973|NCT04023526|Azacitidine|azacitidine|mesh-list
14760974|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14760975|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
14760976|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760977|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760978|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14760979|NCT04022980|Nivolumab|nivolumab|mesh-list
14760980|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14760981|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14760982|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14760983|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760984|NCT04005859|Lidocaine|lidocaine|mesh-list
14760985|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
14760986|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
13922280|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
13922281|NCT03433001|Hormones|hormones|mesh-ancestor
13922282|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922283|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13922284|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922285|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
14760987|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094391|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
13922286|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13922287|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14094392|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094393|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922288|NCT03433001|Growth Substances|growth substances|mesh-ancestor
14094394|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094395|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14094396|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14094397|NCT02532257|Growth Substances|growth substances|mesh-ancestor
14094398|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
14094410|NCT02340676|Interleukin-2|interleukin-2|mesh-list
14094411|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094412|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14094413|NCT02340676|Analgesics|analgesics|mesh-ancestor
14094414|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
14094415|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094416|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094417|NCT02320292|Rituximab|rituximab|mesh-list
14094418|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14094419|NCT02320292|Antibodies|antibodies|mesh-list
14094420|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
14094421|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14094422|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
14094423|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094424|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922289|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
13922290|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
13922291|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922292|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922293|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
13922294|NCT03432975|Povidone|povidone|mesh-list
13922295|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
13922296|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
13922297|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13922298|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094425|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094426|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
14094427|NCT02317783|Flutemetamol|flutemetamol|mesh-list
14094428|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
14094429|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094430|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
14094431|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094432|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14094433|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14094434|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
14094435|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094436|NCT02144584|Memantine|memantine|mesh-list
14094437|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14094438|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14094439|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
14094440|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094441|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094442|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094443|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14094444|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14760988|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14760989|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
14760990|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14760991|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14760992|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14760993|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13922299|NCT03432923|Benzocaine|benzocaine|mesh-list
13922300|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
13922301|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
13922302|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922303|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922304|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
13922305|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922306|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
13922307|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
13922308|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13922309|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14760994|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14760995|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14760996|NCT04001829|Paclitaxel|paclitaxel|mesh-list
14094455|NCT02008656|Leucovorin|leucovorin|mesh-list
14094456|NCT02008656|Fluorouracil|fluorouracil|mesh-list
14094457|NCT02008656|Capecitabine|capecitabine|mesh-list
14094458|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
14094459|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
13922310|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13922311|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13922312|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922313|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922314|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922315|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13922316|NCT03432871|Niacinamide|niacinamide|mesh-list
13922317|NCT03432871|Niacin|niacin|mesh-list
13922318|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
13922319|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
13922320|NCT03432871|Vitamins|vitamins|mesh-ancestor
13922321|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
13922322|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922323|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13922324|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
13922325|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922326|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14094460|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094461|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094462|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094463|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094464|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
14094465|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094466|NCT02008656|Antidotes|antidotes|mesh-ancestor
14094467|NCT02008656|Protective Agents|protective agents|mesh-ancestor
14094468|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
14094469|NCT02008656|Vitamins|vitamins|mesh-ancestor
14094470|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
14094471|NCT02000882|Capecitabine|capecitabine|mesh-list
14094472|NCT02000882|Trastuzumab|trastuzumab|mesh-list
14094473|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13922327|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
13922328|NCT03432793|Itraconazole|itraconazole|mesh-list
13922329|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
13922330|NCT03432793|Caffeine|caffeine|mesh-list
13922331|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13922332|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922333|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13922334|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922335|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922336|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13922337|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13922338|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
14094474|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
14094475|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477455|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14477456|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14477457|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
14477458|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477459|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477460|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935800|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14935801|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922339|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922340|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
13922341|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922342|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13922343|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13922344|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13922345|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
13922346|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922347|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13922348|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13922349|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13922350|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922351|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13922352|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13922353|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13922354|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922355|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
13922356|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13922357|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
13922358|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13922359|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13922360|NCT03432780|Docetaxel|docetaxel|mesh-list
13922361|NCT03432780|Hormones|hormones|mesh-list
13922362|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922363|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
13922364|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
13922365|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
13922366|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922367|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922368|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922369|NCT03432728|Anesthetics|anesthetics|mesh-list
13922370|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922371|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922372|NCT03432689|Cycloserine|cycloserine|mesh-list
13922373|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13922374|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922375|NCT03432689|Renal Agents|renal agents|mesh-ancestor
13922376|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13922377|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
13922378|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14094476|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094477|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094484|NCT01946477|Dexamethasone|dexamethasone|mesh-list
14094485|NCT01946477|Daratumumab|daratumumab|mesh-list
14094486|NCT01946477|Pomalidomide|pomalidomide|mesh-list
14094487|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094488|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
14094489|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
14094490|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094491|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094492|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14094493|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
14094494|NCT01946477|Hormones|hormones|mesh-ancestor
14094495|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094496|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14094497|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477461|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13922379|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
13922380|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922381|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
13922382|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922383|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922384|NCT03432663|Amiodarone|amiodarone|mesh-list
13922385|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13922386|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
13922387|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14094498|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
14094499|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14094500|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14094501|NCT01946477|Growth Substances|growth substances|mesh-ancestor
14094502|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
14094503|NCT01877837|Vidarabine|vidarabine|mesh-list
14094504|NCT01877837|Fludarabine|fludarabine|mesh-list
14094505|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
14094506|NCT01877837|Melphalan|melphalan|mesh-list
14094507|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
14094508|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094509|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13922388|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922389|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922390|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13922391|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13922392|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13922393|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922394|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13922395|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13922396|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13922397|NCT03432650|Dexamethasone|dexamethasone|mesh-list
13922398|NCT03432650|Bupivacaine|bupivacaine|mesh-list
13922399|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922400|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
13922401|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
13922402|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922403|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922404|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13922405|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
13922406|NCT03432650|Hormones|hormones|mesh-ancestor
13922407|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922408|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13922409|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922410|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
13922411|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
13922412|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922413|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
13922414|NCT03432637|Anesthetics|anesthetics|mesh-list
13922415|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922416|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922417|NCT03432598|Gemcitabine|gemcitabine|mesh-list
13922418|NCT03432598|Paclitaxel|paclitaxel|mesh-list
13922419|NCT03432598|Etoposide|etoposide|mesh-list
13922420|NCT03432598|Carboplatin|carboplatin|mesh-list
13922421|NCT03432598|Pemetrexed|pemetrexed|mesh-list
13922422|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13922423|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922424|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
13922425|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14094510|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
14094511|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094512|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13922426|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
13922427|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922428|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13922429|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
13922430|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
13922431|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922432|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094513|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
14094514|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094515|NCT01877837|Antiviral Agents|antiviral agents|mesh-ancestor
13922433|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13922434|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
13922435|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477462|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
13922436|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13922437|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13922438|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13922439|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13922440|NCT03432572|Riboflavin|riboflavin|mesh-list
13922441|NCT03432572|Thiamine|thiamine|mesh-list
14094516|NCT01877837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094517|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14094518|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
14094519|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14094520|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094521|NCT01812252|Azacitidine|azacitidine|mesh-list
14094522|NCT01812252|Decitabine|decitabine|mesh-list
14094523|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094524|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
14094525|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094526|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094527|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094528|NCT01748175|Triamcinolone|triamcinolone|mesh-list
14094529|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14094530|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14094531|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14094532|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094533|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
14094534|NCT01748175|Hormones|hormones|mesh-ancestor
14094535|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094536|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094537|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094538|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
14094539|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094540|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094541|NCT01642004|Docetaxel|docetaxel|mesh-list
14094542|NCT01642004|Nivolumab|nivolumab|mesh-list
14094543|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094544|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14094545|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14094546|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14094547|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094548|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14094549|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14094550|NCT01453179|Diclofenac|diclofenac|mesh-list
14094551|NCT01453179|Imiquimod|imiquimod|mesh-list
14094552|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14094553|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14094554|NCT01453179|Analgesics|analgesics|mesh-ancestor
14094555|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
14094556|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094557|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094558|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094559|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094560|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14094561|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094562|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477463|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477464|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13922442|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
13922443|NCT03432572|Vitamins|vitamins|mesh-ancestor
13922444|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
13922445|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922446|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13922447|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
13922448|NCT03432468|Valsartan|valsartan|mesh-list
13922449|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13922450|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13922451|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13922452|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922453|NCT03432442|Ivermectin|ivermectin|mesh-list
13922454|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13922455|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922456|NCT03432312|Nicotine|nicotine|mesh-list
13922457|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13922458|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
13922459|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922460|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094563|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094564|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
14094565|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094566|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
14094567|NCT01366092|Interleukin-2|interleukin-2|mesh-list
14094568|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094569|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14094570|NCT01366092|Analgesics|analgesics|mesh-ancestor
14094571|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
14094572|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094573|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094574|NCT01336530|Oxethazaine|oxethazaine|mesh-list
14094575|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14094576|NCT01336530|Antacids|antacids|mesh-list
14094577|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14094578|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094579|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
14094580|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094581|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094582|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14094583|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
14094584|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
14094585|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094586|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
14094587|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094588|NCT01305499|Azacitidine|azacitidine|mesh-list
14094589|NCT01305499|Entinostat|entinostat|mesh-list
14094590|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094591|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
14094592|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094593|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094594|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094595|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14094596|NCT01244815|Asenapine|asenapine|mesh-list
13922461|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13922462|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13922463|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
13922464|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922465|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922466|NCT03432273|Nicotine|nicotine|mesh-list
13922467|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13922468|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
13922469|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922470|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922471|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13922472|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13922473|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
13922474|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922475|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922476|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
13922477|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13922478|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13922479|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922480|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922481|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922482|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922483|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
13922484|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13922485|NCT03432195|Donepezil|donepezil|mesh-list
13922486|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13922487|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922488|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922489|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
13922490|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922491|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922492|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
13922493|NCT03432091|Melatonin|melatonin|mesh-list
13922494|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
13922495|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922496|NCT03432091|Protective Agents|protective agents|mesh-ancestor
13922497|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922498|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094597|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14477465|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
14094598|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14094599|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094600|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094601|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14094602|NCT01194622|Fluticasone|fluticasone|mesh-list
14094603|NCT01194622|Xhance|xhance|mesh-list
14094604|NCT01194622|Azelastine|azelastine|mesh-list
14094605|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094606|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14094607|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
13922499|NCT03431987|Ethanol|ethanol|mesh-list
13922500|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13922501|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922502|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922503|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922504|NCT03431974|Aminopterin|aminopterin|mesh-list
13922505|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13922506|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922507|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922508|NCT03431961|Triamcinolone|triamcinolone|mesh-list
13922509|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13922510|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13922511|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13922512|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922513|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
13922514|NCT03431961|Hormones|hormones|mesh-ancestor
13922515|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922516|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922517|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13922518|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
13922519|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922520|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922521|NCT03431909|Aspirin|aspirin|mesh-list
13922522|NCT03431909|Kallikreins|kallikreins|mesh-list
13922523|NCT03431909|Clopidogrel|clopidogrel|mesh-list
13922524|NCT03431909|Atorvastatin|atorvastatin|mesh-list
13922525|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14094608|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094609|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094610|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14094611|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
14094612|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14094613|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14094614|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14094615|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094616|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094617|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14094618|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14094619|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
14094620|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
14094621|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094622|NCT01190852|Fluticasone|fluticasone|mesh-list
14094623|NCT01190852|Azelastine|azelastine|mesh-list
14094624|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094625|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14094626|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
13922526|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922527|NCT03431909|Analgesics|analgesics|mesh-ancestor
13922528|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
13922529|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922530|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922531|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922532|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14760997|NCT04001829|Docetaxel|docetaxel|mesh-list
14760998|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14760999|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13922533|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13922534|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13922535|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922536|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13922537|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14094627|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094628|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094629|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14094630|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
13922538|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922539|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
13922540|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13922541|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13922542|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
13922543|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13922544|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14094631|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14094632|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13922545|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13922546|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13922547|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13922548|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
13922549|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922550|NCT03431909|Coagulants|coagulants|mesh-ancestor
13922551|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
13922552|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
13922553|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13960583|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13960584|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960585|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
13960586|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14094633|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14094634|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094635|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094636|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14094637|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14094638|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
14094639|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
14094640|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094641|NCT01142596|Asenapine|asenapine|mesh-list
14094642|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14094643|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14094644|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094645|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094646|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14094647|NCT01098110|Asenapine|asenapine|mesh-list
14094648|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14094649|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14094650|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094651|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094652|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14094653|NCT01028716|Vidarabine|vidarabine|mesh-list
14094654|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
14094655|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
14094656|NCT01028716|Fludarabine|fludarabine|mesh-list
14094657|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
14094658|NCT01028716|Tacrolimus|tacrolimus|mesh-list
14094659|NCT01028716|Lenograstim|lenograstim|mesh-list
13960587|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13960588|NCT03153436|Inositol|inositol|mesh-list
13960589|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
13960590|NCT03153436|Vitamins|vitamins|mesh-ancestor
13960591|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
13960592|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960593|NCT03152942|Aminophylline|aminophylline|mesh-list
13960594|NCT03152942|Progesterone|progesterone|mesh-list
13960595|NCT03152942|Progestins|progestins|mesh-ancestor
13960596|NCT03152942|Hormones|hormones|mesh-ancestor
13960597|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13960598|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960599|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14094660|NCT01028716|Sargramostim|sargramostim|mesh-list
14094661|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094662|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
14094663|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094664|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094665|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14094666|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
14094667|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094668|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094669|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14094670|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094671|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
14094672|NCT01028716|Antiviral Agents|antiviral agents|mesh-ancestor
14094673|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094674|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094675|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14094676|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094677|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14094678|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14094679|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
14094680|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14094681|NCT01006265|Ponesimod|ponesimod|mesh-list
14094682|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14094683|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094684|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094685|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
14094686|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094687|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
14094688|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
14094689|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094690|NCT00977483|Protective Agents|protective agents|mesh-ancestor
14094691|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094692|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
14094693|NCT00977483|Vitamins|vitamins|mesh-ancestor
14094694|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
14094695|NCT00972309|Vaccines|vaccines|mesh-list
14094696|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
14094697|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174432|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174433|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
14174434|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174435|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174436|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
14174437|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
14174438|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174439|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174440|NCT04786340|Pirenzepine|pirenzepine|mesh-list
14174441|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14174442|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14174443|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174444|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14174445|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14174446|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
14174447|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174448|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922554|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
13922555|NCT03431831|Naltrexone|naltrexone|mesh-list
13922556|NCT03431831|Bupropion|bupropion|mesh-list
13922557|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13922558|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13922559|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13922560|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922561|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
13922562|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922563|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13922564|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
13922565|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14174449|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174450|NCT04786327|Edetic Acid|edetic acid|mesh-list
14174451|NCT04786327|Mitogens|mitogens|mesh-list
14174452|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
14174453|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
14174454|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174455|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
14174456|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14174457|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
14174458|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
14174459|NCT04786327|Antidotes|antidotes|mesh-ancestor
14174460|NCT04786327|Protective Agents|protective agents|mesh-ancestor
13922566|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13922567|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13922568|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922569|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922570|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
13922571|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922572|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14094698|NCT00777348|Reproterol|reproterol|mesh-list
14094699|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14094700|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14094701|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
14094702|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094703|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094704|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094705|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14094706|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
14094707|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094708|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14094709|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
14094710|NCT00777127|Diclofenac|diclofenac|mesh-list
14094711|NCT00777127|Imiquimod|imiquimod|mesh-list
14094712|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14094713|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14094714|NCT00777127|Analgesics|analgesics|mesh-ancestor
14094715|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
13922573|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13922574|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922575|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
13922576|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13922577|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13922578|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922579|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
14094716|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094717|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094718|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094719|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094720|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14094721|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094722|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094723|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094724|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
14094725|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094726|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
14094727|NCT00761371|Imiquimod|imiquimod|mesh-list
14094728|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13922580|NCT03431805|Coagulants|coagulants|mesh-ancestor
13922581|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
13922582|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13922583|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922584|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
13922585|NCT03431714|Artesunate|artesunate|mesh-list
13922586|NCT03431714|Piperaquine|piperaquine|mesh-list
13922587|NCT03431714|Amodiaquine|amodiaquine|mesh-list
13922588|NCT03431714|Artenimol|artenimol|mesh-list
14094729|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
14094730|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094731|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922589|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
13922590|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14094732|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
14094733|NCT00591227|Insulin|insulin|mesh-list
14094734|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14094735|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
14094736|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
14094737|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14094738|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094739|NCT00534976|Montelukast|montelukast|mesh-list
14094740|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14094741|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
14094742|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14094743|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
14094744|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094745|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761000|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922591|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13922592|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094746|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14094747|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14094748|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094749|NCT00492999|Leucovorin|leucovorin|mesh-list
14094750|NCT00492999|Dexamethasone|dexamethasone|mesh-list
14094751|NCT00492999|Fluorouracil|fluorouracil|mesh-list
14094752|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
14094753|NCT00492999|Irinotecan|irinotecan|mesh-list
14094754|NCT00492999|Floxuridine|floxuridine|mesh-list
14094755|NCT00492999|Calcium|calcium|mesh-list
14094756|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
14094757|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094758|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
14094759|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
14094760|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094761|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094762|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14094763|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
14094764|NCT00492999|Hormones|hormones|mesh-ancestor
14094765|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922593|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922594|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
14094766|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14094767|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094768|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14094769|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
14094770|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094771|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094772|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094773|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
14094774|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14094775|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14094776|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094777|NCT00492999|Antidotes|antidotes|mesh-ancestor
14094778|NCT00492999|Protective Agents|protective agents|mesh-ancestor
14094779|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
14094780|NCT00492999|Vitamins|vitamins|mesh-ancestor
14094781|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
14094782|NCT00408473|Flecainide|flecainide|mesh-list
14094783|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14094784|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14094785|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14094786|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14094787|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094788|NCT00337675|Montelukast|montelukast|mesh-list
13922595|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
13922596|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13922597|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
13922598|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13922599|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
13922600|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094789|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14094790|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
14094791|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14094792|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
14094793|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094794|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094795|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14094796|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14094797|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094798|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
14094799|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
14094800|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094801|NCT00328601|Protective Agents|protective agents|mesh-ancestor
14094802|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094803|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
14094804|NCT00328601|Vitamins|vitamins|mesh-ancestor
14094805|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
14094806|NCT00317772|Topotecan|topotecan|mesh-list
13922601|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13922602|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
13922603|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
13922604|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13922605|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922606|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13922607|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13922608|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922609|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922610|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922611|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13922612|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13922613|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
13922614|NCT03431649|Beraprost|beraprost|mesh-list
13922615|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922616|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
13922617|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14094807|NCT00317772|Gefitinib|gefitinib|mesh-list
14094808|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14094809|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14094810|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094811|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094812|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094813|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14094814|NCT00294320|Imiquimod|imiquimod|mesh-list
14094815|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094816|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
14094817|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094818|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094819|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
14094820|NCT00291486|Capecitabine|capecitabine|mesh-list
14094821|NCT00291486|Antibodies|antibodies|mesh-list
14094822|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14094823|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
13922618|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13922619|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922620|NCT03431649|Urological Agents|urological agents|mesh-ancestor
13922621|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14094824|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094825|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14094826|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
14094827|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094828|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094829|NCT00284856|Fluticasone|fluticasone|mesh-list
14094830|NCT00284856|Montelukast|montelukast|mesh-list
14094831|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094832|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14094833|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
14094834|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094835|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094836|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14094837|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
14094838|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
13922622|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
13922623|NCT03431623|Hematinics|hematinics|mesh-ancestor
13922624|NCT03431597|Micronutrients|micronutrients|mesh-list
13922625|NCT03431597|Trace Elements|trace elements|mesh-list
13922626|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922627|NCT03431558|Lactoferrin|lactoferrin|mesh-list
13922628|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922629|NCT03431285|Ketamine|ketamine|mesh-list
13922630|NCT03431285|Morphine|morphine|mesh-list
13922631|NCT03431285|Analgesics|analgesics|mesh-ancestor
13922632|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
13922633|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922634|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922635|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13922636|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13922637|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
14094839|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14094840|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14094841|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
14094842|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094843|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14094844|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14094845|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094846|NCT00189319|Flecainide|flecainide|mesh-list
14094847|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14094848|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14094849|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14094850|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761001|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
14094851|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094852|NCT00189293|Imiquimod|imiquimod|mesh-list
14094853|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094854|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
13922638|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
13922639|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922640|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13922641|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13922642|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922643|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922644|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922645|NCT03431285|Narcotics|narcotics|mesh-ancestor
13922646|NCT03431272|Lifitegrast|lifitegrast|mesh-list
13922647|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13922648|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13922649|NCT03431194|Midodrine|midodrine|mesh-list
13922650|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
13922651|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
13922652|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922653|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922654|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13922655|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13922656|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13922657|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13922658|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
13922659|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922660|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922661|NCT03431168|Azithromycin|azithromycin|mesh-list
13922662|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13922663|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13922664|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922665|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13922666|NCT03431168|Renal Agents|renal agents|mesh-ancestor
13922667|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
13922668|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13922669|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13922670|NCT03431142|Aspirin|aspirin|mesh-list
13922671|NCT03431142|Clopidogrel|clopidogrel|mesh-list
14094855|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094856|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094857|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
14094858|NCT00189267|Imiquimod|imiquimod|mesh-list
14094859|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094860|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
14094861|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094862|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094863|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
14094864|NCT00189254|Imiquimod|imiquimod|mesh-list
14094865|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094866|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
14094867|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094868|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094869|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
14094870|NCT00189241|Imiquimod|imiquimod|mesh-list
14094871|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094872|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
14094873|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094874|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094875|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
14094876|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
14094877|NCT00070707|Albuterol|albuterol|mesh-list
14094878|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14094879|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
14094880|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094881|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094882|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14094883|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
14094884|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
14094885|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14094886|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14094887|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14094888|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14094889|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
14094890|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922672|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14174461|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094891|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094892|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14094893|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14094894|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14094895|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
14094896|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14094897|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
14094898|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094899|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
14094900|NCT02444169|Protective Agents|protective agents|mesh-ancestor
14094901|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14094902|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14094903|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094904|NCT02444364|Incretins|incretins|mesh-ancestor
14094905|NCT02444364|Hormones|hormones|mesh-ancestor
14094906|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094907|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14094908|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
14094909|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14094910|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922673|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922674|NCT03431142|Analgesics|analgesics|mesh-ancestor
13922675|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
13922676|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922677|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922678|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922679|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13922680|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13922681|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13922682|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922683|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13922684|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13922685|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922686|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
13922687|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14094911|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
14094912|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14094913|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14094914|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14094915|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14094916|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094917|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
14094918|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094919|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094920|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14094921|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094922|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
14094923|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094924|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
14094925|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094926|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14094927|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14094928|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
14094929|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094930|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094931|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14094932|NCT02444260|Lidocaine|lidocaine|mesh-list
14094933|NCT02444260|Midazolam|midazolam|mesh-list
14094934|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14094935|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14094936|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14094937|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094938|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14094939|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14094940|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14935802|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14935803|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14935804|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922688|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13922689|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13922690|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
13922691|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922692|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
14094941|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14094942|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
14094943|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
14094944|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
14094945|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
14094946|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094947|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094948|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
14094949|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
14094950|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14094951|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14094952|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14094953|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14094954|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14094955|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
14094956|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13922693|NCT03431077|Giapreza|giapreza|mesh-list
13922694|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
13922695|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13922696|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13922697|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
13922698|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922699|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922700|NCT03430947|Vemurafenib|vemurafenib|mesh-list
13922701|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922702|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13922703|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922704|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922705|NCT03430817|Amantadine|amantadine|mesh-list
13922706|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
13922707|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13922708|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13922709|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
13922710|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922711|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
13922712|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922713|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922714|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922715|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922716|NCT03430817|Analgesics|analgesics|mesh-ancestor
13922717|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
13922718|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922719|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
13922720|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
13922721|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922722|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922723|NCT03430661|Clopidogrel|clopidogrel|mesh-list
13922724|NCT03430661|Ticagrelor|ticagrelor|mesh-list
13922725|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14935805|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935806|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
14935807|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935808|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
14935809|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14094957|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
14094958|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094959|NCT02443727|Oxytocin|oxytocin|mesh-list
14094960|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
14094961|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14094962|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094963|NCT02443818|Sirolimus|sirolimus|mesh-list
14935810|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
14935811|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13922726|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13922727|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13922728|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13922729|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13922730|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
14094964|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14094965|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14094966|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14094967|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14094968|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
13922731|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960600|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
14094969|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14094970|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
14094971|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094972|NCT02444013|Folic Acid|folic acid|mesh-list
14094973|NCT02444013|Uric Acid|uric acid|mesh-list
14094974|NCT02444013|Hematinics|hematinics|mesh-ancestor
14094975|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
14094976|NCT02444013|Vitamins|vitamins|mesh-ancestor
14094977|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
14094978|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094979|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
14094980|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094981|NCT02444013|Protective Agents|protective agents|mesh-ancestor
14094982|NCT02443844|Tamsulosin|tamsulosin|mesh-list
14094983|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14094984|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14094985|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14094986|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
14094987|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14094988|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14094989|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094990|NCT02443844|Urological Agents|urological agents|mesh-ancestor
14094991|NCT02443922|Metformin|metformin|mesh-list
14094992|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14094993|NCT02443922|Glimepiride|glimepiride|mesh-list
14094994|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14094995|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14094996|NCT02443922|Incretins|incretins|mesh-ancestor
14094997|NCT02443922|Hormones|hormones|mesh-ancestor
14094998|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14094999|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14095000|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
14095001|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922732|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922733|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922734|NCT03430609|Hormones|hormones|mesh-list
13922735|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922736|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922737|NCT03430596|Pramipexole|pramipexole|mesh-list
13922738|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
13922739|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
13922740|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922741|NCT03430596|Protective Agents|protective agents|mesh-ancestor
13922742|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922743|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13922744|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13922745|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
13922746|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
13922747|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922748|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13922749|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13922750|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
13922751|NCT03430544|Cariprazine|cariprazine|mesh-list
13922752|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13922753|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13922754|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095002|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095003|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14095004|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095005|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
14095006|NCT02443714|Insulin|insulin|mesh-list
14095007|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14095008|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
14095009|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095010|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095011|NCT02443623|Vaccines|vaccines|mesh-list
14095012|NCT02443623|Immunologic Factors|immunologic factors|mesh-ancestor
14095013|NCT02443623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095014|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
14095015|NCT02443831|Fludarabine|fludarabine|mesh-list
14095016|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13922755|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922756|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14095017|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
14095018|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095019|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13922757|NCT03430531|Lidocaine|lidocaine|mesh-list
13922758|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
13922759|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
13922760|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922761|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922762|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
13922763|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922764|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13922765|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13922766|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13922767|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922768|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922769|NCT03430518|Durvalumab|durvalumab|mesh-list
13922770|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922771|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922772|NCT03430505|Albuterol|albuterol|mesh-list
13922773|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13922774|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
13922775|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922776|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922777|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13922778|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
13922779|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
13922780|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13922781|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13922782|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13922783|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13922784|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
13922785|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922786|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922787|NCT03430466|Fulvestrant|fulvestrant|mesh-list
13922788|NCT03430466|Tremelimumab|tremelimumab|mesh-list
13922789|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095020|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14095021|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
14095022|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922790|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922791|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13922792|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13922793|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
13922794|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922795|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922796|NCT03430362|Scopolamine|scopolamine|mesh-list
13922797|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13922798|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13922799|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
13922800|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
13922801|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922802|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922803|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13922804|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
13922805|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13922806|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
13922807|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922808|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922809|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13922810|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
13922811|NCT03430297|Dacarbazine|dacarbazine|mesh-list
13922812|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13922813|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
13922814|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922815|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960601|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960602|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13960603|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
13960604|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13960605|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13960606|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960607|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960608|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13960609|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14095023|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095024|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14095025|NCT02443545|Deferiprone|deferiprone|mesh-list
14095026|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14095027|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
14095028|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
14095029|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095030|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
14095031|NCT02443285|Cefotaxime|cefotaxime|mesh-list
14095032|NCT02443285|Cefoxitin|cefoxitin|mesh-list
14095033|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14095034|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095035|NCT02443246|Vitamin D|vitamin d|mesh-list
14095036|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
14095037|NCT02443246|Vitamins|vitamins|mesh-ancestor
14095038|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
14095039|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095040|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14095041|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14095042|NCT02443311|Betamethasone|betamethasone|mesh-list
14095043|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
14095044|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14095045|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
14095046|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
14095047|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14095048|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095049|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
14095050|NCT02443311|Hormones|hormones|mesh-ancestor
14095051|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095052|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095053|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14095054|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
14095055|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095056|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922816|NCT03430180|Naloxone|naloxone|mesh-list
13922817|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13922818|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922819|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
13922820|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922821|NCT03430024|Estrogens|estrogens|mesh-list
13922822|NCT03430024|Hormones|hormones|mesh-ancestor
13922823|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095057|NCT02443311|Analgesics|analgesics|mesh-ancestor
14095058|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
14095059|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095060|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095061|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14095062|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095063|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
14095064|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14095065|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095066|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095067|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14095068|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14095069|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14095070|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14095071|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095072|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095073|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095074|NCT02443194|Analgesics|analgesics|mesh-ancestor
14095075|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
14095076|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095077|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
14095078|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13922824|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922825|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13922826|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13922827|NCT03429998|Evolocumab|evolocumab|mesh-list
13922828|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13922829|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13922830|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13922831|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
13922832|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922833|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13922834|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
13922835|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922836|NCT03429972|Paclitaxel|paclitaxel|mesh-list
13922837|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13922838|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922839|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
13922840|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
13922841|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
13922842|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922843|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13922844|NCT03429946|Spironolactone|spironolactone|mesh-list
13922845|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13922846|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
13922847|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922848|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922849|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13922850|NCT03429946|Diuretics|diuretics|mesh-ancestor
13922851|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
13922852|NCT03429738|Ibuprofen|ibuprofen|mesh-list
13922853|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
13922854|NCT03429738|Ephedrine|ephedrine|mesh-list
13922855|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13922856|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922857|NCT03429738|Analgesics|analgesics|mesh-ancestor
13922858|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
13922859|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922860|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922861|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922862|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13922863|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13922864|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922865|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922866|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13922867|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
13922868|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14095079|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
14095080|NCT02443012|Nepafenac|nepafenac|mesh-list
14095081|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095082|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095083|NCT02443012|Analgesics|analgesics|mesh-ancestor
14095084|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
14095085|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095086|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095087|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095088|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174462|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14174463|NCT04786470|Ropivacaine|ropivacaine|mesh-list
14174464|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
14174465|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
14174466|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174467|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174468|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
14174469|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174470|NCT04785716|Niraparib|niraparib|mesh-list
14174471|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14174472|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174473|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174474|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174475|NCT04785755|Etilefrine|etilefrine|mesh-list
14174476|NCT04785755|Furosemide|furosemide|mesh-list
14174477|NCT04785755|Spironolactone|spironolactone|mesh-list
14174478|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14174479|NCT04785755|Diuretics|diuretics|mesh-list
14174480|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
14174481|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174482|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14174483|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922869|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
13922870|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
14095089|NCT02443064|Vancomycin|vancomycin|mesh-list
14095090|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14095091|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095092|NCT02443142|Acetaminophen|acetaminophen|mesh-list
14095093|NCT02443142|Ibuprofen|ibuprofen|mesh-list
14095094|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095095|NCT02443142|Analgesics|analgesics|mesh-ancestor
14095096|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
14095097|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095098|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095099|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
14095100|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095101|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095102|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095103|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14095104|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095105|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095106|NCT02442921|Colchicine|colchicine|mesh-list
14095107|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
14095108|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095109|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
13922871|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13922872|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13922873|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
13922874|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
13922875|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922876|NCT03429621|Simethicone|simethicone|mesh-list
13922877|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
13922878|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922879|NCT03429621|Emollients|emollients|mesh-ancestor
13922880|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
13922881|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
13922882|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922883|NCT03429400|Morphine|morphine|mesh-list
13922884|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922885|NCT03429400|Narcotics|narcotics|mesh-ancestor
13922886|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922887|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922888|NCT03429400|Analgesics|analgesics|mesh-ancestor
13922889|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
13922890|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922891|NCT03429309|Propofol|propofol|mesh-list
13922892|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13922893|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922894|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922895|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13922896|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
13922897|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
13922898|NCT03429179|Butorphanol|butorphanol|mesh-list
13922899|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922900|NCT03429179|Narcotics|narcotics|mesh-ancestor
13922901|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922902|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922903|NCT03429179|Analgesics|analgesics|mesh-ancestor
14095110|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
14095111|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
14095112|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095113|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095114|NCT02442791|Exenatide|exenatide|mesh-list
13922904|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
13922905|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922906|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
13922907|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
13922908|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13922909|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
13922910|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13922911|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13922912|NCT03429101|Trastuzumab|trastuzumab|mesh-list
13922913|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
13922914|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922915|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922916|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
13922917|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
13922918|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
14095115|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095116|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095117|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14095118|NCT02442791|Incretins|incretins|mesh-ancestor
13922919|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922920|NCT03429075|Citalopram|citalopram|mesh-list
13922921|NCT03429075|Psilocybin|psilocybin|mesh-list
13922922|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13922923|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13922924|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13922925|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761002|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761003|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
14095119|NCT02442791|Hormones|hormones|mesh-ancestor
14095120|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095121|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
14095122|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14095123|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14095124|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095125|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095126|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14095127|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14095128|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14095129|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761004|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761005|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
13922926|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13922927|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
13922928|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922929|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13922930|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
13922931|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13922932|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
13922933|NCT03429010|Anesthetics|anesthetics|mesh-list
14095130|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095131|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095132|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
14095133|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13922934|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922935|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922936|NCT03428906|Oxytocin|oxytocin|mesh-list
13922937|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
13922938|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13922939|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922940|NCT03428880|Morphine|morphine|mesh-list
13922941|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922942|NCT03428880|Narcotics|narcotics|mesh-ancestor
13922943|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922944|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922945|NCT03428880|Analgesics|analgesics|mesh-ancestor
13922946|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
13922947|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922948|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
13922949|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13922950|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922951|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
14095134|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
14095135|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14095136|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14095137|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095138|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14095139|NCT02442817|Linagliptin|linagliptin|mesh-list
14095140|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095141|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095142|NCT02442817|Incretins|incretins|mesh-ancestor
14095143|NCT02442817|Hormones|hormones|mesh-ancestor
14095144|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095145|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14095146|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
14095147|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922952|NCT03428685|Progestins|progestins|mesh-ancestor
13922953|NCT03428685|Hormones|hormones|mesh-ancestor
13922954|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13922955|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922956|NCT03428633|Morphine|morphine|mesh-list
14095148|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935812|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
13922957|NCT03428633|Ropivacaine|ropivacaine|mesh-list
13922958|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13922959|NCT03428633|Narcotics|narcotics|mesh-ancestor
13922960|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13922961|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922962|NCT03428633|Analgesics|analgesics|mesh-ancestor
13922963|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
13922964|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922965|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
13922966|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
13922967|NCT03428607|Olaparib|olaparib|mesh-list
13922968|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13922969|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922970|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922971|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922972|NCT03428568|Clarithromycin|clarithromycin|mesh-list
13922973|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13922974|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13922975|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13922976|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13922977|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922978|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13922979|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13922980|NCT03428529|Fluorouracil|fluorouracil|mesh-list
13922981|NCT03428529|Capecitabine|capecitabine|mesh-list
13922982|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
13922983|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13922984|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13922985|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13922986|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13922987|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
13922988|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13922989|NCT03428503|Acetaminophen|acetaminophen|mesh-list
13922990|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13922991|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13922992|NCT03428503|Analgesics|analgesics|mesh-ancestor
13922993|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
13922994|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13922995|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095149|NCT02442674|Tolvaptan|tolvaptan|mesh-list
14095150|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13922996|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
13922997|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13922998|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13922999|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13960610|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
13960611|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960612|NCT03152942|Protective Agents|protective agents|mesh-ancestor
13960613|NCT03153072|Amiodarone|amiodarone|mesh-list
13960614|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13960615|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
13960616|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13960617|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13960618|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960619|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13960620|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13960621|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13960622|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960623|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13960624|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13960625|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13960626|NCT03152981|Remifentanil|remifentanil|mesh-list
13960627|NCT03152981|Propofol|propofol|mesh-list
14095151|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095152|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
14095153|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095154|NCT02442648|Rituximab|rituximab|mesh-list
14095155|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14095156|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095157|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
14095158|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095159|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13960628|NCT03152981|Desflurane|desflurane|mesh-list
13960629|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14095160|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
14095161|NCT02442752|Lansoprazole|lansoprazole|mesh-list
14095162|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14095163|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095164|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14095165|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095166|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095167|NCT02442362|Paclitaxel|paclitaxel|mesh-list
14095168|NCT02442362|Fluorouracil|fluorouracil|mesh-list
13923000|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
13923001|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13923002|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13923003|NCT03428425|Paclitaxel|paclitaxel|mesh-list
13923004|NCT03428425|Apatinib|apatinib|mesh-list
13923005|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14095169|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
14095170|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14095171|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095172|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
14095173|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
14095174|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
14095175|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095176|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
14095177|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13923006|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923007|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
14095178|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095179|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
14095180|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095181|NCT02442739|Ketamine|ketamine|mesh-list
14095182|NCT02442739|Analgesics|analgesics|mesh-ancestor
14095183|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
14095184|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095185|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095186|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14095187|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14095188|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
13923008|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
13923009|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
13923010|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095189|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
14095190|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095191|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14095192|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14095193|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095194|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095195|NCT02442453|Turmeric extract|turmeric extract|mesh-list
14095196|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
14095197|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095198|NCT02442453|Protective Agents|protective agents|mesh-ancestor
14095199|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095200|NCT02442531|Docetaxel|docetaxel|mesh-list
14095201|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095202|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
14095203|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
14095204|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
14095205|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095206|NCT02442466|BQ 788|bq 788|mesh-list
14095207|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14095208|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14095209|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14095210|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095211|NCT02442440|Anisodamine|anisodamine|mesh-list
14095212|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14095213|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14095214|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
14095215|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923011|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923012|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923013|NCT03428373|Aspirin|aspirin|mesh-list
13923014|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
13923015|NCT03428373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14184264|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923016|NCT03428373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923017|NCT03428373|Analgesics|analgesics|mesh-ancestor
13923018|NCT03428373|Sensory System Agents|sensory system agents|mesh-ancestor
13923019|NCT03428373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923020|NCT03428373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923021|NCT03428373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923022|NCT03428373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923023|NCT03428373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13923024|NCT03428373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13923025|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923026|NCT03428373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13923027|NCT03428373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13923028|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923029|NCT03428373|Antipyretics|antipyretics|mesh-ancestor
13923030|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13923031|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
13923032|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13923033|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
13923034|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
13923035|NCT03428282|Anesthetics|anesthetics|mesh-list
14095216|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095217|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095218|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14095219|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095220|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095221|NCT02442440|Analgesics|analgesics|mesh-ancestor
14095222|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
14095223|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095224|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095225|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095226|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14095227|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095228|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
14095229|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
14095230|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
14095231|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14095232|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
14095233|NCT02442440|Protective Agents|protective agents|mesh-ancestor
14095234|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
14095235|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
14095236|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14095237|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14095238|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095239|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095240|NCT02442492|Urological Agents|urological agents|mesh-ancestor
14095241|NCT02442063|Paclitaxel|paclitaxel|mesh-list
14095242|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14095243|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14095244|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095245|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
14095246|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
14095247|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
14095248|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095249|NCT02442427|Palivizumab|palivizumab|mesh-list
14095250|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
14095251|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095252|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
14095253|NCT02442180|Prednisolone|prednisolone|mesh-list
14095254|NCT02442180|Lenograstim|lenograstim|mesh-list
14095255|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14095256|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
14095257|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095258|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095259|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
14095260|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
14095261|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095262|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095263|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
14095264|NCT02442180|Hormones|hormones|mesh-ancestor
14095265|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095266|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14095267|NCT02442180|Protective Agents|protective agents|mesh-ancestor
14095268|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095269|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923036|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095270|NCT02442128|Fentanyl|fentanyl|mesh-list
14095271|NCT02442128|Propofol|propofol|mesh-list
14095272|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14095273|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095274|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095275|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14095276|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
14095277|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
14095278|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14095279|NCT02442128|Narcotics|narcotics|mesh-ancestor
14095280|NCT02442128|Analgesics|analgesics|mesh-ancestor
14095281|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
14095282|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095283|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14095284|NCT02441933|Carboplatin|carboplatin|mesh-list
14095285|NCT02441933|Taxane|taxane|mesh-list
14095286|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095287|NCT02441907|Aflibercept|aflibercept|mesh-list
14095288|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14095289|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14095290|NCT02441907|Growth Substances|growth substances|mesh-ancestor
14095291|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095292|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
14095293|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095294|NCT02441842|Atenolol|atenolol|mesh-list
14095295|NCT02441842|Lisinopril|lisinopril|mesh-list
14095296|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14095297|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
14095298|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095299|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095300|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14095301|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14095302|NCT02441842|Protective Agents|protective agents|mesh-ancestor
14095303|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095304|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14095305|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
14095306|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
14095307|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095308|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14095309|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14095310|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14095311|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
14095312|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095313|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
14095314|NCT02441894|Promethazine|promethazine|mesh-list
14095315|NCT02441894|Dexamethasone|dexamethasone|mesh-list
14095316|NCT02441894|Prednisolone|prednisolone|mesh-list
14095317|NCT02441894|Ondansetron|ondansetron|mesh-list
14095318|NCT02441894|Metoclopramide|metoclopramide|mesh-list
14095319|NCT02441894|Granisetron|granisetron|mesh-list
14095320|NCT02441894|Ranitidine|ranitidine|mesh-list
14095321|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14095322|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095323|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
14095324|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
14095325|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095326|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095327|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095328|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
14095329|NCT02441894|Hormones|hormones|mesh-ancestor
14095330|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095331|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095332|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095333|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
14095334|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
14095335|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14095336|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
14095337|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095338|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095339|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14095340|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14095341|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095342|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14095343|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14761006|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14095344|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14095345|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14095346|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
14095347|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
13923037|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923038|NCT03428256|Anesthetics|anesthetics|mesh-list
13923039|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923040|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923041|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
13923042|NCT03428191|Remifentanil|remifentanil|mesh-list
13923043|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923044|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923045|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923046|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923047|NCT03428191|Analgesics|analgesics|mesh-ancestor
13923048|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
13923049|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923050|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13923051|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13923052|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923053|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
13923054|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923055|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923056|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13923057|NCT03428191|Narcotics|narcotics|mesh-ancestor
13923058|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
13923059|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
13923060|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095348|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
14095349|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14095350|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
14095351|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
14095352|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14095353|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14095354|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14095355|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
14095356|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14095357|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14095358|NCT02441660|Capsaicin|capsaicin|mesh-list
13923061|NCT03428139|Protective Agents|protective agents|mesh-ancestor
13923062|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923063|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
14761007|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14761008|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
13923064|NCT03428139|Vitamins|vitamins|mesh-ancestor
13923065|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
13923066|NCT03428022|Apatinib|apatinib|mesh-list
13923067|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923068|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923069|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923070|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923071|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
13923072|NCT03427944|Calcium|calcium|mesh-list
13923073|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13923074|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923075|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
13923076|NCT03427944|Coagulants|coagulants|mesh-ancestor
13923077|NCT03427801|Hematinics|hematinics|mesh-list
13923078|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14095359|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
14095360|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
14095361|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
14095362|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095363|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095364|NCT02441673|Ephedrine|ephedrine|mesh-list
14095365|NCT02441673|Meperidine|meperidine|mesh-list
14095366|NCT02441673|Tramadol|tramadol|mesh-list
14761009|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14095367|NCT02441673|Nefopam|nefopam|mesh-list
13923079|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
13923080|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13923081|NCT03427632|Protective Agents|protective agents|mesh-ancestor
13923082|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923083|NCT03427554|Tretinoin|tretinoin|mesh-list
13923084|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923085|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
13923086|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
13923087|NCT03427502|Epinephrine|epinephrine|mesh-list
13923088|NCT03427502|Bupivacaine|bupivacaine|mesh-list
13923089|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
13923090|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
14095368|NCT02441673|Metoclopramide|metoclopramide|mesh-list
14095369|NCT02441673|Ranitidine|ranitidine|mesh-list
14095370|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14095371|NCT02441673|Oxytocin|oxytocin|mesh-list
14095372|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
14095373|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14095374|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095375|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14095376|NCT02441673|Narcotics|narcotics|mesh-ancestor
14095377|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095378|NCT02441673|Analgesics|analgesics|mesh-ancestor
14095379|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
14095380|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923091|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923092|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923093|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
14095381|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
14095382|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
14095383|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095384|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14095385|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14095386|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
14095387|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095388|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095389|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14095390|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
14095391|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14095392|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
14095393|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14935813|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13923094|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095394|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14095395|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
14095396|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
14095397|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14095398|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095399|NCT02441803|Cytarabine|cytarabine|mesh-list
14095400|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
14095401|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
14095402|NCT02441803|Busulfan|busulfan|mesh-list
14095403|NCT02441803|Fludarabine|fludarabine|mesh-list
14095404|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
13923095|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13923096|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923097|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
13923098|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923099|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923100|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13923101|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13923102|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
13923103|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14095405|NCT02441803|Decitabine|decitabine|mesh-list
14095406|NCT02441803|Idarubicin|idarubicin|mesh-list
13923104|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
13923105|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
13923106|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
13923107|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13923108|NCT03427437|Epinephrine|epinephrine|mesh-list
13923109|NCT03427437|Racepinephrine|racepinephrine|mesh-list
13923110|NCT03427437|Bupivacaine|bupivacaine|mesh-list
13923111|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
13923112|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
13923113|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
14095407|NCT02441803|Clofarabine|clofarabine|mesh-list
14095408|NCT02441803|Tacrolimus|tacrolimus|mesh-list
14095409|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
14095410|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14095411|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095412|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
14095413|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095414|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095415|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14095416|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
14095417|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095418|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095419|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14095420|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14095421|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
14095422|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
14095423|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095424|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14095425|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095426|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14095427|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14095428|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
14095429|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14095430|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14095431|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14095432|NCT02441816|Aflibercept|aflibercept|mesh-list
14095433|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14095434|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14095435|NCT02441816|Growth Substances|growth substances|mesh-ancestor
14095436|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923114|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923115|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923116|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
13923117|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095437|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
14095438|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095439|NCT02441439|Iron|iron|mesh-list
14095440|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14095441|NCT02441439|Trace Elements|trace elements|mesh-ancestor
14095442|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
14095443|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095444|NCT02441439|Hematinics|hematinics|mesh-ancestor
13923118|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13923119|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923120|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
13923121|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923122|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923123|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13923124|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13923125|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
13923126|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13923127|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
13923128|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
13923129|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
14095445|NCT02441465|Vemurafenib|vemurafenib|mesh-list
14095446|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095447|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14095448|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095449|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095450|NCT02441530|Vitamin D|vitamin d|mesh-list
14095451|NCT02441530|Vitamins|vitamins|mesh-list
13923130|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13923131|NCT03427385|Ropivacaine|ropivacaine|mesh-list
13923132|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
13923133|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
13923134|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923135|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095452|NCT02441530|Vitamin E|vitamin e|mesh-list
14095453|NCT02441530|Ibuprofen|ibuprofen|mesh-list
14095454|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
14095455|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095456|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14095457|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095458|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095459|NCT02441530|Analgesics|analgesics|mesh-ancestor
14095460|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
14095461|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095462|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095463|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095464|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14095465|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184265|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13923136|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
13923137|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923138|NCT03427359|Capecitabine|capecitabine|mesh-list
13923139|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923140|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13923141|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
14095466|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095467|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
14095468|NCT02441530|Protective Agents|protective agents|mesh-ancestor
14174484|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174485|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14174486|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14174487|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174488|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14174489|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14174490|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14174491|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174492|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174493|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14174494|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
14174495|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
14174496|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174497|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14174498|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14174499|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14174500|NCT04785755|Protective Agents|protective agents|mesh-ancestor
14174501|NCT04786002|Busulfan|busulfan|mesh-list
13923142|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923143|NCT03427242|Apatinib|apatinib|mesh-list
13923144|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923145|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923146|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923147|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923148|NCT03427229|Vancomycin|vancomycin|mesh-list
13923149|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13923150|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923151|NCT03427216|Diazepam|diazepam|mesh-list
13923152|NCT03427216|Baclofen|baclofen|mesh-list
13923153|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13923154|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923155|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13923156|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923157|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13923158|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
13923159|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
13923160|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174502|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
14174503|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174504|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14174505|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
14174506|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174507|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13923161|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923162|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13923163|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
13923164|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
13923165|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
13923166|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13923167|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923168|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923169|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13923170|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13923171|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13923172|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13923173|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
13923174|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
13923175|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
13923176|NCT03427086|Biotin|biotin|mesh-list
13923177|NCT03427086|Vitamins|vitamins|mesh-ancestor
13923178|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
13923179|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923180|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
13923181|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
13923182|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923183|NCT03426982|Heparin|heparin|mesh-list
14095469|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
14095470|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14095471|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
13923184|NCT03426982|Calcium heparin|calcium heparin|mesh-list
13923185|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
13923186|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13923187|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13923188|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923189|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
13923190|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
13923191|NCT03426969|Melphalan|melphalan|mesh-list
14095472|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095473|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
14095474|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095475|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095476|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14095477|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
14095478|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095479|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095480|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14095481|NCT02441075|Ethanol|ethanol|mesh-list
14095482|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14095483|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095484|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095485|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095486|NCT02441088|Octreotide|octreotide|mesh-list
14095487|NCT02441088|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
14095488|NCT02441088|Edotreotide|edotreotide|mesh-list
14095489|NCT02441088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095490|NCT02441088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095491|NCT02441088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095492|NCT02441088|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14095493|NCT02441088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095494|NCT02441088|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14095495|NCT02441088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14095496|NCT02440880|Dexamethasone|dexamethasone|mesh-list
14095497|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
14095498|NCT02440880|BB 1101|bb 1101|mesh-list
14095499|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095500|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
14761010|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13923192|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
14095501|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
14095502|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923193|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13923194|NCT03426969|Fludarabine|fludarabine|mesh-list
13923195|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
13923196|NCT03426969|Tacrolimus|tacrolimus|mesh-list
13923197|NCT03426969|Lenograstim|lenograstim|mesh-list
13923198|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923199|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
13923200|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923201|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923202|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13923203|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
13923204|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923205|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923206|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13923207|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13923208|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
13923209|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13923210|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13923211|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923212|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13923213|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13923214|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
13923215|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13923216|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923217|NCT03426956|Canagliflozin|canagliflozin|mesh-list
13923218|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13923219|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923220|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13923221|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923222|NCT03426904|Leucovorin|leucovorin|mesh-list
13923223|NCT03426904|Fluorouracil|fluorouracil|mesh-list
13923224|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
13923225|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
13923226|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923227|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13923228|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923229|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923230|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
13923231|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923232|NCT03426904|Antidotes|antidotes|mesh-ancestor
13923233|NCT03426904|Protective Agents|protective agents|mesh-ancestor
13923234|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
13923235|NCT03426904|Vitamins|vitamins|mesh-ancestor
13923236|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
13960630|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960631|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960632|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13960633|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
13960634|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
13960635|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13960636|NCT03152981|Narcotics|narcotics|mesh-ancestor
13960637|NCT03152981|Analgesics|analgesics|mesh-ancestor
13960638|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
14095503|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095504|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095505|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
14095506|NCT02440880|Hormones|hormones|mesh-ancestor
14095507|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095508|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095509|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095510|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
14095511|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095512|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095513|NCT02440750|Dienogest|dienogest|mesh-list
14095514|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
14095515|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14095516|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
14095517|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14095518|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960639|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960640|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13960641|NCT03153163|Trastuzumab|trastuzumab|mesh-list
13960642|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14095519|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13960643|NCT03153163|Maytansine|maytansine|mesh-list
13960644|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13960645|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095520|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14095521|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14095522|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14095523|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
14095524|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095525|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095526|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095527|NCT02440958|Folfirinox|folfirinox|mesh-list
14095528|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095529|NCT02440841|Itraconazole|itraconazole|mesh-list
14095530|NCT02440841|Rifampin|rifampin|mesh-list
14095531|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
14095532|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923237|NCT03426761|Vancomycin|vancomycin|mesh-list
13923238|NCT03426761|Cefazolin|cefazolin|mesh-list
13923239|NCT03426761|Daptomycin|daptomycin|mesh-list
13923240|NCT03426761|Dalbavancin|dalbavancin|mesh-list
13923241|NCT03426761|Nafcillin|nafcillin|mesh-list
13923242|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13923243|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923244|NCT03426657|Durvalumab|durvalumab|mesh-list
13923245|NCT03426657|Tremelimumab|tremelimumab|mesh-list
13923246|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13923247|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923248|NCT03426592|Vitamin D|vitamin d|mesh-list
14095533|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14095534|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14095535|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095536|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095537|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14095538|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
14095539|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095540|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095541|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14095542|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14095543|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
14095544|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14095545|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
14095546|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14095547|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14095548|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13923249|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
13923250|NCT03426592|Vitamins|vitamins|mesh-ancestor
13923251|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
13923252|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923253|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13923254|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13923255|NCT03426553|Riboflavin|riboflavin|mesh-list
13923256|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
14095549|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14095550|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14095551|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14095552|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14095553|NCT02440581|Alendronate|alendronate|mesh-list
14095554|NCT02440581|Teriparatide|teriparatide|mesh-list
14095555|NCT02440581|Cinacalcet|cinacalcet|mesh-list
14095556|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14095557|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095558|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14095559|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14095560|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
13923257|NCT03426553|Vitamins|vitamins|mesh-ancestor
13923258|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
13923259|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923260|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13923261|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
14935814|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935815|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923262|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
13923263|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
13923264|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
13923265|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935816|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935817|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935818|NCT01465828|Clopidogrel|clopidogrel|mesh-list
14935819|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14935820|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935821|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14935822|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13923266|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923267|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923268|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923269|NCT03426527|Analgesics|analgesics|mesh-ancestor
13923270|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
13923271|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923272|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13923273|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13923274|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923275|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
13923276|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923277|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923278|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
13923279|NCT03426462|Propofol|propofol|mesh-list
13923280|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923281|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923282|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923283|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13923284|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
13923285|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
13923286|NCT03426202|Modafinil|modafinil|mesh-list
13923287|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13923288|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923289|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
13923290|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13923291|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13923292|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923293|NCT03426176|Oxytocin|oxytocin|mesh-list
13923294|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
13923295|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13923296|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923297|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
13923298|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13923299|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923300|NCT03426085|Liraglutide|liraglutide|mesh-list
13923301|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13923302|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923303|NCT03426085|Incretins|incretins|mesh-ancestor
13923304|NCT03426085|Hormones|hormones|mesh-ancestor
13923305|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13923306|NCT03426033|Warfarin|warfarin|mesh-list
13923307|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
13923308|NCT03426020|Midazolam|midazolam|mesh-list
13923309|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13923310|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923311|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923312|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923313|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13923314|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13923315|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13923316|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13923317|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
13923318|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
13923319|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
13923320|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
14095561|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095562|NCT02440828|Tobramycin|tobramycin|mesh-list
14095563|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14761011|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761012|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14761013|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761014|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761015|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14761016|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761017|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
14761018|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095564|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095565|NCT02440347|Anesthetics|anesthetics|mesh-list
14095566|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095567|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095568|NCT02440230|Anastrozole|anastrozole|mesh-list
14095569|NCT02440230|Exemestane|exemestane|mesh-list
14095570|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095571|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095572|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14095573|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14095574|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095575|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095576|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14095577|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
14095578|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095579|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095580|NCT02440399|Acetaminophen|acetaminophen|mesh-list
14095581|NCT02440399|Diclofenac|diclofenac|mesh-list
14095582|NCT02440399|Morphine|morphine|mesh-list
14095583|NCT02440399|Oxycodone|oxycodone|mesh-list
14095584|NCT02440399|Tramadol|tramadol|mesh-list
14095585|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14095586|NCT02440399|Narcotics|narcotics|mesh-ancestor
14095587|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095588|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095589|NCT02440399|Analgesics|analgesics|mesh-ancestor
14095590|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
14095591|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095592|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095593|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
14095594|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095595|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095596|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095597|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14095598|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095599|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923321|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923322|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923323|NCT03425994|Emtricitabine|emtricitabine|mesh-list
13923324|NCT03425994|Cobicistat|cobicistat|mesh-list
13923325|NCT03425994|Elvitegravir|elvitegravir|mesh-list
13923326|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
13923327|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923328|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13923329|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13923330|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923331|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923332|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13923333|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13923334|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13923335|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13923336|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13923337|NCT03425929|Oxytocin|oxytocin|mesh-list
13923338|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
13923339|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13923340|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923341|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
13923342|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
13923343|NCT03425747|Calcium|calcium|mesh-list
13923344|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13923345|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923346|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13923347|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923348|NCT03425747|Antacids|antacids|mesh-ancestor
13923349|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13923350|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
13923351|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923352|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923353|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923354|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923355|NCT03425734|Analgesics|analgesics|mesh-ancestor
14095600|NCT02440243|Vaccines|vaccines|mesh-list
14095601|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
14095602|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095603|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
14095604|NCT02440256|Narcotics|narcotics|mesh-ancestor
14095605|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095606|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095607|NCT02440256|Analgesics|analgesics|mesh-ancestor
14095608|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
14095609|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095610|NCT02440100|Midazolam|midazolam|mesh-list
14095611|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14095612|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14095613|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095614|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095615|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14095616|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14095617|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14095618|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14095619|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
14095620|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
14095621|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
14095622|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
14095623|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095624|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095625|NCT02439944|Nicotine|nicotine|mesh-list
14095626|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14095627|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
14095628|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095629|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095630|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14095631|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14095632|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14095633|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095634|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095635|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
14095636|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14095637|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095638|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095639|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095640|NCT02439905|Analgesics|analgesics|mesh-ancestor
14095641|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
14095642|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095643|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14095644|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14095645|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14095646|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
14095647|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095648|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095649|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
14095650|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14095651|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14095652|NCT02439866|Prednisolone|prednisolone|mesh-list
14095653|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
14095654|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13923356|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
13923357|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923358|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13923359|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13923360|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923361|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
13923362|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923363|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923364|NCT03425708|Febuxostat|febuxostat|mesh-list
13923365|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
13923366|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923367|NCT03425669|Methylphenidate|methylphenidate|mesh-list
13923368|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13923369|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923370|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13923371|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13923372|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13923373|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923374|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
13923375|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923376|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
14095655|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
14095656|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095657|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
14095658|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
14095659|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095660|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095661|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095662|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
14095663|NCT02439866|Hormones|hormones|mesh-ancestor
14095664|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095665|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14095666|NCT02439866|Protective Agents|protective agents|mesh-ancestor
14095667|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095668|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095669|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14095670|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
13923377|NCT03425656|Docetaxel|docetaxel|mesh-list
13923378|NCT03425656|Doxorubicin|doxorubicin|mesh-list
13923379|NCT03425656|Trastuzumab|trastuzumab|mesh-list
13923380|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923381|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
13923382|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923383|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923384|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13923385|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
13923386|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923387|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923388|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13923389|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
13923390|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
13923391|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
13923392|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13923393|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13923394|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13923395|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923396|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13923397|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
13923398|NCT03425617|Olodaterol|olodaterol|mesh-list
13923399|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13923400|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
14095671|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14095672|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
14095673|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095674|NCT02440009|Itraconazole|itraconazole|mesh-list
14095675|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
14095676|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
14095677|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095678|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14095679|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14095680|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095681|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923401|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923402|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923403|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13923404|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
13923405|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
13923406|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13923407|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
13923408|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923409|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923410|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13923411|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14095682|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14095683|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
14095684|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095685|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095686|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14095687|NCT02440009|Hormones|hormones|mesh-ancestor
14095688|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
14095689|NCT02439788|Fludarabine|fludarabine|mesh-list
14095690|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095691|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
14095692|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095693|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095694|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13923412|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13923413|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095695|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
14095696|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095697|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095698|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14095699|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
14095700|NCT02439697|Hematinics|hematinics|mesh-ancestor
13923414|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923415|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13923416|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13923417|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13923418|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
13923419|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174508|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174509|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14174517|NCT04785911|Antiemetics|antiemetics|mesh-list
14174518|NCT04785911|Histamine|histamine|mesh-list
14174519|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
14174520|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
14174521|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174522|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174523|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174524|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
14174525|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174526|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174527|NCT04785768|Morphine|morphine|mesh-list
14174528|NCT04785768|Hydromorphone|hydromorphone|mesh-list
14174529|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14174530|NCT04785768|Narcotics|narcotics|mesh-ancestor
14174531|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174532|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174533|NCT04785768|Analgesics|analgesics|mesh-ancestor
14174534|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
14174535|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174536|NCT04785547|Blinatumomab|blinatumomab|mesh-list
14174537|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174538|NCT04785183|Melatonin|melatonin|mesh-list
14174539|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
14174540|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174541|NCT04785183|Protective Agents|protective agents|mesh-ancestor
14174542|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174543|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174544|NCT04785118|Scopolamine|scopolamine|mesh-list
14174545|NCT04785118|Ondansetron|ondansetron|mesh-list
14174546|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14174547|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
14174548|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
14174549|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174550|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174551|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174552|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
14174553|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
14174554|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14174555|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
14174556|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174557|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174558|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14174559|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14174560|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174561|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14174562|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14174563|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14174564|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
14174565|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13923420|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174566|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
14174567|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14174568|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
14174569|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
14174570|NCT04785222|Bupivacaine|bupivacaine|mesh-list
14095701|NCT02439632|Levofloxacin|levofloxacin|mesh-list
14095702|NCT02439632|Ofloxacin|ofloxacin|mesh-list
14095703|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
14095704|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
14095705|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14095706|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095707|NCT02439632|Renal Agents|renal agents|mesh-ancestor
14095708|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13923421|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13923422|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13923423|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
13923424|NCT03425474|Propofol|propofol|mesh-list
13923425|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923426|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923427|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923428|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13923429|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
13923430|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
13923431|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13923432|NCT03425461|Nivolumab|nivolumab|mesh-list
13923433|NCT03425461|Ipilimumab|ipilimumab|mesh-list
13923434|NCT03425461|Antibodies|antibodies|mesh-list
13923435|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
13923436|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13923437|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
13923438|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923439|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923440|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13923441|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923442|NCT03425448|Heparin|heparin|mesh-list
13923443|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
13923444|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13923445|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13923446|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923447|NCT03425292|Bevacizumab|bevacizumab|mesh-list
13923448|NCT03425292|Nivolumab|nivolumab|mesh-list
13923449|NCT03425292|Ipilimumab|ipilimumab|mesh-list
13923450|NCT03425292|Temozolomide|temozolomide|mesh-list
13923451|NCT03425292|Lomustine|lomustine|mesh-list
13923452|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13923453|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923454|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13923455|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13923456|NCT03425292|Growth Substances|growth substances|mesh-ancestor
13923457|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095709|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14095710|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14095711|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095712|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095713|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095714|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14095715|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14095716|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14095717|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
14095718|NCT02439450|Nivolumab|nivolumab|mesh-list
14095719|NCT02439450|Pemetrexed|pemetrexed|mesh-list
14095720|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14095721|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095722|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14095723|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095724|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095725|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14095726|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13923458|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
13923459|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13923460|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923461|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13923462|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
13923463|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13923464|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923465|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923466|NCT03425162|Morphine|morphine|mesh-list
13923467|NCT03425162|Bupivacaine|bupivacaine|mesh-list
13923468|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
13923469|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
13923470|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095727|NCT02439489|Carboplatin|carboplatin|mesh-list
14095728|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923471|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923472|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
13923473|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923474|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13923475|NCT03425162|Narcotics|narcotics|mesh-ancestor
13923476|NCT03425162|Analgesics|analgesics|mesh-ancestor
13923477|NCT03425084|Morphine|morphine|mesh-list
13923478|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13923479|NCT03425084|Narcotics|narcotics|mesh-ancestor
13923480|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923481|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923482|NCT03425084|Analgesics|analgesics|mesh-ancestor
13923483|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
13923484|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960646|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13960647|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
13960648|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
13960649|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
13960650|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960651|NCT03153085|Ipilimumab|ipilimumab|mesh-list
13960652|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14935823|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14935824|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
13960653|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960654|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13960655|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960656|NCT03153137|Macitentan|macitentan|mesh-list
14095729|NCT02439190|Aspirin|aspirin|mesh-list
14095730|NCT02439190|Clopidogrel|clopidogrel|mesh-list
14095731|NCT02439190|BMS-986120|bms-986120|mesh-list
14095732|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095733|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095734|NCT02439190|Analgesics|analgesics|mesh-ancestor
14095735|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
14095736|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095737|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095738|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095739|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095740|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14095741|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14095742|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095743|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14095744|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14095745|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095746|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
14095747|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14095748|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14095749|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14095750|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
14095751|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095752|NCT02439411|Trametinib|trametinib|mesh-list
14095753|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095754|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14095755|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095756|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095757|NCT02439125|Eltoprazine|eltoprazine|mesh-list
14095758|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14095759|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
14095760|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095761|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095762|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095763|NCT02439034|Acetaminophen|acetaminophen|mesh-list
14095764|NCT02439034|Ketoprofen|ketoprofen|mesh-list
14095765|NCT02439034|Codeine|codeine|mesh-list
14095766|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095767|NCT02439034|Analgesics|analgesics|mesh-ancestor
14095768|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
14095769|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095770|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095771|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
14095772|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095773|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960657|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14095774|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095775|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14095776|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095777|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095778|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14095779|NCT02439034|Narcotics|narcotics|mesh-ancestor
14095780|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095781|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
14095782|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
14095783|NCT02438982|Rituximab|rituximab|mesh-list
14095784|NCT02438982|Tacrolimus|tacrolimus|mesh-list
14095785|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14095786|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14095787|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095788|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
14095789|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095790|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095791|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095792|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095793|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095794|NCT02438709|Etoricoxib|etoricoxib|mesh-list
14095795|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14095796|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095797|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095798|NCT02438709|Analgesics|analgesics|mesh-ancestor
14095799|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
14095800|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095801|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095802|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095803|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095804|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14095805|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095806|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095807|NCT02438761|Gedatolisib|gedatolisib|mesh-list
14095808|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14095809|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923485|NCT03424928|Thalidomide|thalidomide|mesh-list
14477466|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14477467|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14477468|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14477469|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477470|NCT02434081|Nivolumab|nivolumab|mesh-list
14477471|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477472|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935825|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923486|NCT03424928|Pomalidomide|pomalidomide|mesh-list
13923487|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
13923488|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923489|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13923490|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13923491|NCT03424928|Growth Substances|growth substances|mesh-ancestor
13923492|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
13923493|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923494|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923495|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
13923496|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13923497|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923498|NCT03424889|Xylometazoline|xylometazoline|mesh-list
14095810|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095811|NCT02438683|BI 409306|bi 409306|mesh-list
14095812|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14095813|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095814|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095815|NCT02438852|Ropivacaine|ropivacaine|mesh-list
14095816|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
14095817|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
14095818|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095819|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095820|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
14095821|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095822|NCT02438657|Lidocaine|lidocaine|mesh-list
14095823|NCT02438657|Epinephrine|epinephrine|mesh-list
14095824|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
14095825|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
13923499|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
14095826|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095827|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095828|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
14095829|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095830|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14095831|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14095832|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14095833|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14095834|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095835|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14095836|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14095837|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
14095838|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095839|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14095840|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14095841|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
14095842|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14095843|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
14095844|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
14095845|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
14095846|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14095847|NCT02438865|Epirubicin|epirubicin|mesh-list
14095848|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14095849|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095850|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14095851|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14095852|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095853|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095854|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
14095855|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14095856|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14095857|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095858|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
14095859|NCT02438566|Coagulants|coagulants|mesh-ancestor
14095860|NCT02438345|Leronlimab|leronlimab|mesh-list
14095861|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14095862|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14095863|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095864|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14095865|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14095866|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
14095867|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095868|NCT02438397|Insulin|insulin|mesh-list
14095869|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14095870|NCT02438397|Metformin|metformin|mesh-list
14095871|NCT02438397|Acarbose|acarbose|mesh-list
14095872|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095873|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095874|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14095875|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095876|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095877|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
14095878|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14095879|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
14095880|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14095881|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
14095882|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095883|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095884|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
14095885|NCT02437825|Octreotide|octreotide|mesh-list
14095886|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095887|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095888|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14095889|NCT02438072|Fexofenadine|fexofenadine|mesh-list
14095890|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
14095891|NCT02438072|Midazolam|midazolam|mesh-list
14095892|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
14095893|NCT02438072|Caffeine|caffeine|mesh-list
14095894|NCT02438072|Bupropion|bupropion|mesh-list
14095895|NCT02438072|Omeprazole|omeprazole|mesh-list
14095896|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14095897|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14935826|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935827|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095898|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14095899|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923500|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13923501|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
13923502|NCT03424876|Sunitinib|sunitinib|mesh-list
13923503|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
13923504|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923505|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13923506|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13923507|NCT03424876|Growth Substances|growth substances|mesh-ancestor
13923508|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923509|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
13923510|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923511|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923512|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923513|NCT03424759|Osimertinib|osimertinib|mesh-list
13923514|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923515|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923516|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923517|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095900|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14095901|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14095902|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14095903|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14095904|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
14095905|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
14095906|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
14095907|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
14095908|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14095909|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095910|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14095911|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14095912|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14095913|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095914|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14095915|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14095916|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14095917|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14095918|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
14095919|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14095920|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
14095921|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14095922|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14095923|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14095924|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
14095925|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14095926|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14095927|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
14095928|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
14095929|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14095930|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14095931|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14095932|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14095933|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14095934|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
14095935|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
14095936|NCT02438072|Analgesics|analgesics|mesh-ancestor
13923518|NCT03424746|Edetic Acid|edetic acid|mesh-list
13923519|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
13923520|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
13923521|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13923522|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
13923523|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
13923524|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923525|NCT03424746|Antidotes|antidotes|mesh-ancestor
13923526|NCT03424746|Protective Agents|protective agents|mesh-ancestor
13923527|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923528|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13923529|NCT03424733|Acetaminophen|acetaminophen|mesh-list
13923530|NCT03424733|Interferons|interferons|mesh-list
13923531|NCT03424733|Interferon-beta|interferon-beta|mesh-list
13923532|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
13923533|NCT03424733|Prednisone|prednisone|mesh-list
13923534|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923535|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
13923536|NCT03424733|Hormones|hormones|mesh-ancestor
13960658|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13923537|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13923538|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923539|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14095937|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
14095938|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14095939|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14095940|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14095941|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095942|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14095943|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14174571|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
14174572|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
14174573|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174574|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174575|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
14174576|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174577|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14174578|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14174579|NCT04785222|Analgesics|analgesics|mesh-ancestor
13923540|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923541|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
13923542|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923543|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923544|NCT03424733|Analgesics|analgesics|mesh-ancestor
13923545|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
13923546|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923547|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
13923548|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
13923549|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13923550|NCT03424707|Eperisone|eperisone|mesh-list
13923551|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
14174580|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14174581|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14761019|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174582|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14174583|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174584|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174585|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174586|NCT04784988|BAX 855|bax 855|mesh-list
14174587|NCT04784988|Coagulants|coagulants|mesh-ancestor
14174588|NCT04784728|Lidocaine|lidocaine|mesh-list
14174589|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
14174590|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
14174591|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174592|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174593|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
14174594|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174595|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14174596|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14174597|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14174598|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174599|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183598|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183599|NCT04726631|Coagulants|coagulants|mesh-ancestor
14183600|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
14183601|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14183602|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
14183603|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14183604|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
14183605|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183606|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183607|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
14183608|NCT04726592|Ketoprofen|ketoprofen|mesh-list
14183609|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
14183610|NCT04726592|Metoclopramide|metoclopramide|mesh-list
14183611|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
14183612|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
14183613|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183614|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183615|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183616|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14183617|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14183618|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
14761020|NCT03986424|Memantine|memantine|mesh-list
13923552|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14095944|NCT02438020|Metformin|metformin|mesh-list
14095945|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095946|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095947|NCT02437812|Metformin|metformin|mesh-list
14095948|NCT02437812|Paclitaxel|paclitaxel|mesh-list
14095949|NCT02437812|Carboplatin|carboplatin|mesh-list
14095950|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14095951|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761021|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14761022|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14761023|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
14761024|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761025|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761026|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095952|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14095953|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14095954|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14095955|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095956|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095957|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095958|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
14095959|NCT02437955|Trace Elements|trace elements|mesh-ancestor
14095960|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
14095961|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095962|NCT02437461|Triamcinolone|triamcinolone|mesh-list
14095963|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14095964|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14095965|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14761027|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14761028|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14095966|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14095967|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
14095968|NCT02437461|Hormones|hormones|mesh-ancestor
14095969|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14095970|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095971|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14095972|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
14095973|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14095974|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14095975|NCT02437721|Folic Acid|folic acid|mesh-list
14095976|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
14095977|NCT02437721|Hematinics|hematinics|mesh-ancestor
14095978|NCT02437721|Vitamins|vitamins|mesh-ancestor
14095979|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
14095980|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095981|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
14095982|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095983|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
14095984|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
14095985|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
14095986|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
14095987|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14095988|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095989|NCT02437656|Metformin|metformin|mesh-list
14095990|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14095991|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14095992|NCT02437045|Meropenem|meropenem|mesh-list
14095993|NCT02437045|Tazobactam|tazobactam|mesh-list
13923553|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13923554|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923555|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13923556|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923557|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13923558|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13923559|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923560|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
13923561|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
13923562|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
13923563|NCT03424629|Methotrexate|methotrexate|mesh-list
13923564|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13923565|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
14095994|NCT02437045|Piperacillin|piperacillin|mesh-list
14095995|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14095996|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14095997|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14095998|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14095999|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096000|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096001|NCT02436993|Paclitaxel|paclitaxel|mesh-list
14096002|NCT02436993|Bevacizumab|bevacizumab|mesh-list
14096003|NCT02436993|Carboplatin|carboplatin|mesh-list
14096004|NCT02436993|Trastuzumab|trastuzumab|mesh-list
14096005|NCT02436993|Pertuzumab|pertuzumab|mesh-list
14096006|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14096007|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096008|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14096009|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14096010|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14096011|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096012|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14096013|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14096014|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14096015|NCT02436993|Growth Substances|growth substances|mesh-ancestor
14096016|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096017|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
14096018|NCT02436980|Midazolam|midazolam|mesh-list
14761029|NCT03984448|Prednisone|prednisone|mesh-list
13923566|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13923567|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923568|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13923569|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
13923570|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923571|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923572|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
13923573|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923574|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13923575|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923576|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
13923577|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923578|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13923579|NCT03424473|Tucatinib|tucatinib|mesh-list
14096019|NCT02436980|Tramadol|tramadol|mesh-list
14096020|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14096021|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14096022|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096023|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096024|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14096025|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14096026|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096027|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14096028|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
14096029|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
14096030|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
14096031|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
14761030|NCT03984448|Cortisone|cortisone|mesh-list
13923580|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923581|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923582|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923583|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923584|NCT03424408|Aspirin|aspirin|mesh-list
14761031|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
13923585|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13923586|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923587|NCT03424408|Analgesics|analgesics|mesh-ancestor
13923588|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
13923589|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923590|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923591|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923592|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923593|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13923594|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13923595|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923596|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13923597|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14096032|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761032|NCT03984448|Rituximab|rituximab|mesh-list
14761033|NCT03984448|Doxorubicin|doxorubicin|mesh-list
14761034|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14761035|NCT03984448|Etoposide|etoposide|mesh-list
14096033|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761036|NCT03984448|Vincristine|vincristine|mesh-list
14761037|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
14761038|NCT03984448|Venetoclax|venetoclax|mesh-list
13923598|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923599|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
13923600|NCT03424356|Fentanyl|fentanyl|mesh-list
14096034|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14096035|NCT02436980|Narcotics|narcotics|mesh-ancestor
14096036|NCT02436980|Analgesics|analgesics|mesh-ancestor
14096037|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
14096038|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096039|NCT02437032|Menotropins|menotropins|mesh-list
14096040|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14096041|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
14096042|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14096043|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477473|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14477474|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477475|NCT02434328|Aflibercept|aflibercept|mesh-list
14477476|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14477477|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14477478|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14477479|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14477480|NCT02434328|Growth Substances|growth substances|mesh-ancestor
14477481|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477482|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
14477483|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477484|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14477485|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14477486|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14477487|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
14477488|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477489|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14477490|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14477491|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477492|NCT02434523|Amitriptyline|amitriptyline|mesh-list
14477493|NCT02434523|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14477494|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14477495|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
14477496|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14477497|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14477498|NCT02434523|Analgesics|analgesics|mesh-ancestor
14477499|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
14477500|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096044|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
14096045|NCT02437136|Entinostat|entinostat|mesh-list
14096046|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14096047|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096048|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14096049|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096050|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096051|NCT02436928|Vaccines|vaccines|mesh-list
14096052|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
14096053|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096054|NCT02436902|Sorafenib|sorafenib|mesh-list
14096055|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
14096056|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096057|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14096058|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096059|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096060|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14096061|NCT02436902|Estrogens|estrogens|mesh-ancestor
14096062|NCT02436902|Hormones|hormones|mesh-ancestor
14096063|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096064|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096065|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14096066|NCT02436538|Hormones|hormones|mesh-list
14096067|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096068|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096069|NCT02436798|Ondansetron|ondansetron|mesh-list
13923601|NCT03424356|Narcotics|narcotics|mesh-list
13923602|NCT03424356|Analgesics|analgesics|mesh-list
13923603|NCT03424356|Bromides|bromides|mesh-list
13923604|NCT03424356|Propofol|propofol|mesh-list
13923605|NCT03424356|Rocuronium|rocuronium|mesh-list
13923606|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923607|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096070|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
14096071|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
14096072|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096073|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096074|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096075|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
14096076|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14096077|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14096078|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
14096079|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096080|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096081|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14096082|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14096083|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096084|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096085|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13923608|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935828|NCT01465867|Selenium|selenium|mesh-list
14935829|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
14935830|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935831|NCT01465867|Protective Agents|protective agents|mesh-ancestor
14096086|NCT02436694|Dexamethasone|dexamethasone|mesh-list
14096087|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
14096088|NCT02436694|Ropivacaine|ropivacaine|mesh-list
14096089|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
14096090|NCT02436694|Anesthetics|anesthetics|mesh-list
14096091|NCT02436694|BB 1101|bb 1101|mesh-list
14096092|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096093|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
14096094|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
14096095|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096096|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096097|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096098|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
14096099|NCT02436694|Hormones|hormones|mesh-ancestor
14096100|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096101|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14096102|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096103|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14096104|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096105|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096106|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096107|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
13923609|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13923610|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
14096108|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
14096109|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14096110|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923611|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
13923612|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13923613|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
13923614|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923615|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13923616|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
13923617|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13923618|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13923619|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13923620|NCT03424291|Apatinib|apatinib|mesh-list
13923621|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923622|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923623|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923624|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923625|NCT03424226|Acetazolamide|acetazolamide|mesh-list
13923626|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
13923627|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13923628|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096111|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14096112|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14096113|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096114|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096115|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096116|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
14096117|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14096118|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14096119|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14096120|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14096121|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096122|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14096123|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096124|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096125|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14096126|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096127|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
13923629|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923630|NCT03424226|Diuretics|diuretics|mesh-ancestor
13923631|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
13923632|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923633|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
13923634|NCT03424135|Promethazine|promethazine|mesh-list
13923635|NCT03424135|Naproxen|naproxen|mesh-list
13923636|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13923637|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923638|NCT03424135|Analgesics|analgesics|mesh-ancestor
13923639|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
13923640|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923641|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923642|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923643|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923644|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
13923645|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14096128|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14096129|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
14096130|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096131|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096132|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14096133|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
14096134|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14096135|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
14096136|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096137|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096138|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14096139|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
14096140|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
14096141|NCT02436512|Protective Agents|protective agents|mesh-ancestor
14096142|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
14096143|NCT02436395|Povidone|povidone|mesh-list
14096144|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
14096145|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
14096146|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14096147|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096148|NCT02436226|Citric Acid|citric acid|mesh-list
14096149|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
14096150|NCT02436226|Clomiphene|clomiphene|mesh-list
14096151|NCT02436226|Enclomiphene|enclomiphene|mesh-list
14096152|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
14096153|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14096154|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
14096155|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14096156|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
14096157|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
14935832|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935833|NCT01465867|Trace Elements|trace elements|mesh-ancestor
14935834|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
14935835|NCT01465893|Vitamin D|vitamin d|mesh-list
14935836|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
14935837|NCT01465893|Vitamins|vitamins|mesh-list
14935838|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
14096158|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096159|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14096160|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
14096161|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096162|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096163|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14096164|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
14096165|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14096166|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14096167|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14174600|NCT04784910|Lansoprazole|lansoprazole|mesh-list
14174601|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
14174602|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14174603|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174604|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14174605|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174606|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174607|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
14174608|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14174609|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
14174610|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174611|NCT04784481|Ivermectin|ivermectin|mesh-list
14174612|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13923646|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923647|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923648|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14174613|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174614|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14174615|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14174616|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
14174617|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174618|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14174619|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174620|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14174621|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174622|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
14174623|NCT04784247|Lenvatinib|lenvatinib|mesh-list
14174624|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14174625|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174626|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174627|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174628|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174629|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
14174630|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13923649|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923650|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923651|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
13923652|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
13923653|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
13923654|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
13923655|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13923656|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13923657|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
13923658|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
13923659|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923660|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13923661|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
13923662|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
13923663|NCT03423979|Paclitaxel|paclitaxel|mesh-list
13923664|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13923665|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923666|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
13923667|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14174631|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14174632|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174633|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
14174634|NCT04784039|Coagulants|coagulants|mesh-ancestor
14174635|NCT04784104|Epinephrine|epinephrine|mesh-list
14174636|NCT04784104|Racepinephrine|racepinephrine|mesh-list
14935839|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935840|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14174637|NCT04784104|Bupivacaine|bupivacaine|mesh-list
14174638|NCT04784104|Prilocaine|prilocaine|mesh-list
13923668|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
13923669|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923670|NCT03423849|Gemcitabine|gemcitabine|mesh-list
13923671|NCT03423849|Capecitabine|capecitabine|mesh-list
13923672|NCT03423849|Vinorelbine|vinorelbine|mesh-list
14761039|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
14096168|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14096169|NCT02436083|Cefuroxime|cefuroxime|mesh-list
14096170|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
14096171|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096172|NCT02436044|Leucovorin|leucovorin|mesh-list
13923673|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096173|NCT02436044|Fluorouracil|fluorouracil|mesh-list
14096174|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
14096175|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
14761040|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14096176|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
14096177|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096178|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14096179|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096180|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096181|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
14096182|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096183|NCT02436044|Antidotes|antidotes|mesh-ancestor
14096184|NCT02436044|Protective Agents|protective agents|mesh-ancestor
14096185|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
14096186|NCT02436044|Vitamins|vitamins|mesh-ancestor
14096187|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
14096188|NCT02435927|Leucovorin|leucovorin|mesh-list
14096189|NCT02435927|Fluorouracil|fluorouracil|mesh-list
14096190|NCT02435927|Capecitabine|capecitabine|mesh-list
14096191|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
14096192|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
14096193|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096194|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14096195|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096196|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096197|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
14096198|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096199|NCT02435927|Antidotes|antidotes|mesh-ancestor
14096200|NCT02435927|Protective Agents|protective agents|mesh-ancestor
14096201|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
14096202|NCT02435927|Vitamins|vitamins|mesh-ancestor
14096203|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
14096204|NCT02435797|Nicorandil|nicorandil|mesh-list
14096205|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14096206|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14096207|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
14096208|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
14096209|NCT02435797|Vitamins|vitamins|mesh-ancestor
14096210|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
14096211|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096212|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
14096213|NCT02435771|Vitamin D|vitamin d|mesh-list
14096214|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14096215|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096216|NCT02435771|Vitamins|vitamins|mesh-ancestor
14096217|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
14096218|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14096219|NCT02435732|Heparin|heparin|mesh-list
14096220|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
14096221|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14096222|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14096223|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096224|NCT02435654|Olanzapine|olanzapine|mesh-list
14096225|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
14761041|NCT03984448|Antibodies|antibodies|mesh-list
14761042|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
14761043|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13923674|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13923675|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
13923676|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923677|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
13923678|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096226|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
14096227|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096228|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096229|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096230|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14761044|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096231|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14096232|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096233|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096234|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14096235|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14096236|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14096237|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096238|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096239|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
14096240|NCT02435563|Ritonavir|ritonavir|mesh-list
14096241|NCT02435563|Ticagrelor|ticagrelor|mesh-list
14096242|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14096243|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13923679|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923680|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923681|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
13923682|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923683|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13923684|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
13923685|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
13923686|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
13923687|NCT03423823|Ranibizumab|ranibizumab|mesh-list
13923688|NCT03423823|Aflibercept|aflibercept|mesh-list
13923689|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923690|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13923691|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13923692|NCT03423823|Growth Substances|growth substances|mesh-ancestor
13923693|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923694|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
13923695|NCT03423810|Hydralazine|hydralazine|mesh-list
13923696|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13923697|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
13923698|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13923699|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
13923700|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13923701|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
13923702|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923703|NCT03423667|Expectorants|expectorants|mesh-ancestor
13923704|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
13923705|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13923706|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
13923707|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923708|NCT03423667|Protective Agents|protective agents|mesh-ancestor
13923709|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923710|NCT03423667|Antidotes|antidotes|mesh-ancestor
13923711|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13923712|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13923713|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923714|NCT03423472|Vitamin A|vitamin a|mesh-list
13923715|NCT03423472|Vitamins|vitamins|mesh-ancestor
13923716|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
13923717|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923718|NCT03423342|Niacinamide|niacinamide|mesh-list
13923719|NCT03423342|Niacin|niacin|mesh-list
13923720|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
13923721|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
13923722|NCT03423342|Vitamins|vitamins|mesh-ancestor
13923723|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
13923724|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923725|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13923726|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
13923727|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923728|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13923729|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
13960659|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960660|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
13960661|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
13960662|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14096244|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
14096245|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096246|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096247|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13960663|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960664|NCT03152955|Sufentanil|sufentanil|mesh-list
13960665|NCT03152955|Ketamine|ketamine|mesh-list
13960666|NCT03152955|Ondansetron|ondansetron|mesh-list
13960667|NCT03152955|Analgesics|analgesics|mesh-ancestor
14096248|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14096249|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
14096250|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096251|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14096252|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14096253|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14096254|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14096255|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14096256|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14096257|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
14096258|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096259|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096260|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
14096261|NCT02435537|Morphine|morphine|mesh-list
14096262|NCT02435537|Bupivacaine|bupivacaine|mesh-list
14096263|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
14096264|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
14096265|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096266|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096267|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
14096268|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096269|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14096270|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14096271|NCT02435537|Analgesics|analgesics|mesh-ancestor
14935841|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14096272|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14096273|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14096274|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923730|NCT03423329|Ibuprofen|ibuprofen|mesh-list
13923731|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13923732|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923733|NCT03423329|Analgesics|analgesics|mesh-ancestor
13923734|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
13923735|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923736|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923737|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923738|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923739|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14477501|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477502|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14761045|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
13923740|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923741|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923742|NCT03423225|Tacrolimus|tacrolimus|mesh-list
13923743|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923744|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
13923745|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923746|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13923747|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923748|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923749|NCT03423030|Macozinone|macozinone|mesh-list
13923750|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
13923751|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14096275|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
14096276|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096277|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096278|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14096279|NCT02435537|Narcotics|narcotics|mesh-ancestor
14096280|NCT02435459|Calcium|calcium|mesh-list
14096281|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14096282|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096283|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
14096284|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13923752|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923753|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
13923754|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923755|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096285|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096286|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14761046|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761047|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761048|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14761049|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
14096287|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
14096288|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14096289|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096290|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096291|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096292|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
14096293|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
13923756|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923757|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923758|NCT03422978|Analgesics|analgesics|mesh-ancestor
13923759|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
13923760|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923761|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13923762|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13923763|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923764|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
13923765|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923766|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923767|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
13923768|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
13923769|NCT03422887|Nalbuphine|nalbuphine|mesh-list
13923770|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14096294|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14096295|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14096296|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096297|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096298|NCT02435303|Urological Agents|urological agents|mesh-ancestor
14096299|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
14096300|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14096301|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096302|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096303|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096304|NCT02435186|Paclitaxel|paclitaxel|mesh-list
14096305|NCT02435186|Cisplatin|cisplatin|mesh-list
14096306|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14096307|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761050|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096308|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14096309|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14096310|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14096311|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096312|NCT02435108|Crizotinib|crizotinib|mesh-list
14096313|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096314|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14096315|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923771|NCT03422887|Narcotics|narcotics|mesh-ancestor
13923772|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096316|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096317|NCT02434952|Piperaquine|piperaquine|mesh-list
14096318|NCT02434952|Primaquine|primaquine|mesh-list
14096319|NCT02434952|Artenimol|artenimol|mesh-list
14096320|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
14096321|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14096322|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14096323|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096324|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
14096325|NCT02434861|Digoxin|digoxin|mesh-list
14096326|NCT02434861|Rolapitant|rolapitant|mesh-list
14096327|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14096328|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14096329|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096330|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096331|NCT02434861|Protective Agents|protective agents|mesh-ancestor
14096332|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096333|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923773|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923774|NCT03422887|Analgesics|analgesics|mesh-ancestor
13923775|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
13923776|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923777|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13923778|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923779|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923780|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923781|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13923782|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923783|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923784|NCT03422874|Nelfinavir|nelfinavir|mesh-list
13923785|NCT03422874|Ixazomib|ixazomib|mesh-list
13923786|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923787|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
13923788|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923789|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923790|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13923791|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13923792|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14096334|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14096335|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14096336|NCT02434861|Analgesics|analgesics|mesh-ancestor
14096337|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
14096338|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096339|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096340|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096341|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096342|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14096343|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096344|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14096345|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14096346|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14096347|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096348|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
14096349|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096350|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096351|NCT02434822|Vaccines|vaccines|mesh-list
14096352|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
14096353|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096354|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14096355|NCT02434757|Hormones|hormones|mesh-ancestor
14096356|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096357|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174639|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14174640|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
14174641|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
14174642|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
14174643|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174644|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923793|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13923794|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
13923795|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923796|NCT03422861|Nabilone|nabilone|mesh-list
13923797|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
13923798|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
13923799|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923800|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923801|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13923802|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13923803|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13923804|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923805|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13923806|NCT03422796|Cilostazol|cilostazol|mesh-list
13923807|NCT03422796|Sumatriptan|sumatriptan|mesh-list
13923808|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13923809|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13923810|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13923811|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
13923812|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923813|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923814|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096358|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
14096359|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
14096360|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096361|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
14096362|NCT02434614|Cisplatin|cisplatin|mesh-list
14096363|NCT02434614|Docetaxel|docetaxel|mesh-list
14096364|NCT02434614|Fluorouracil|fluorouracil|mesh-list
14096365|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096366|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
14096367|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
14096368|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
14096369|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096370|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
14096371|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14096372|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096373|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
14096374|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096375|NCT02433860|Nicotine|nicotine|mesh-list
14096376|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14096377|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
14096378|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096379|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923815|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13923816|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
13923817|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923818|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13923819|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
13923820|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13923821|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13923822|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13923823|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
13923824|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13923825|NCT03422796|Protective Agents|protective agents|mesh-ancestor
13923826|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13923827|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13923828|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923829|NCT03422705|Lisinopril|lisinopril|mesh-list
13923830|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13923831|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
13923832|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923833|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923834|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13923835|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14096380|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14096381|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14096382|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
14096383|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096384|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096385|NCT02433847|Mosapride|mosapride|mesh-list
14096386|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096387|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14096388|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
13923836|NCT03422705|Protective Agents|protective agents|mesh-ancestor
14096389|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096390|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096391|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096392|NCT02433808|Neostigmine|neostigmine|mesh-list
14096393|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14096394|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096395|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096396|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
14096397|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096398|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096399|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13923837|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923838|NCT03422666|Teduglutide|teduglutide|mesh-list
13923839|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13923840|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13923841|NCT03422666|Protective Agents|protective agents|mesh-ancestor
13923842|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923843|NCT03422640|Apremilast|apremilast|mesh-list
13923844|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13923845|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14096400|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
14096401|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096402|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
14096403|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14096404|NCT02433899|Dexamethasone|dexamethasone|mesh-list
14096405|NCT02433899|Epinephrine|epinephrine|mesh-list
14096406|NCT02433899|Mepivacaine|mepivacaine|mesh-list
14096407|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096408|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
14096409|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
14096410|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096411|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096412|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096413|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
14096414|NCT02433899|Hormones|hormones|mesh-ancestor
14096415|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13923846|NCT03422640|Analgesics|analgesics|mesh-ancestor
13923847|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
13923848|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923849|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923850|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923851|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923852|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13923853|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13923854|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923855|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923856|NCT03422575|Etoricoxib|etoricoxib|mesh-list
13923857|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13923858|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13923859|NCT03422575|Analgesics|analgesics|mesh-ancestor
13923860|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
13923861|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923862|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923863|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923864|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923865|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14096416|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14096417|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096418|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14096419|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096420|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
14096421|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
14096422|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14096423|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14096424|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14096425|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096426|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096427|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13923866|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13923867|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923868|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923869|NCT03422523|Gemcitabine|gemcitabine|mesh-list
13923870|NCT03422523|Rituximab|rituximab|mesh-list
13923871|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
13923872|NCT03422523|Atezolizumab|atezolizumab|mesh-list
13923873|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13923874|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923875|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
14096428|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14096429|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14096430|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
14096431|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
14096432|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
14096433|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14096434|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
14096435|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
14096436|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096437|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
14096438|NCT02433795|Rituximab|rituximab|mesh-list
14096439|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14096440|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14096441|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096442|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
13923876|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923877|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13923878|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13923879|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
13923880|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923881|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
13923882|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923883|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923884|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13923885|NCT03422510|CXA-10|cxa-10|mesh-list
13923886|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923887|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13923888|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923889|NCT03422445|Temozolomide|temozolomide|mesh-list
13923890|NCT03422445|Apatinib|apatinib|mesh-list
13923891|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13923892|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
13923893|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923894|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923895|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13923896|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13923897|NCT03422419|Heparin|heparin|mesh-list
13923898|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
13923899|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13923900|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13923901|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923902|NCT03422406|Iodine|iodine|mesh-list
13923903|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13923904|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13923905|NCT03422406|Trace Elements|trace elements|mesh-ancestor
13923906|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
13923907|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923908|NCT03422393|Venetoclax|venetoclax|mesh-list
13923909|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923910|NCT03422315|Propofol|propofol|mesh-list
13923911|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13923912|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923913|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923914|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14096443|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096444|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096445|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14096446|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
14096447|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096448|NCT02434029|Budesonide|budesonide|mesh-list
14096449|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13923915|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
13923916|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
13923917|NCT03422289|Folic Acid|folic acid|mesh-list
13923918|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
13923919|NCT03422289|Inositol|inositol|mesh-list
13923920|NCT03422289|Hematinics|hematinics|mesh-ancestor
13923921|NCT03422289|Vitamins|vitamins|mesh-ancestor
13923922|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
13923923|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923924|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
14096450|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14096451|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
13923925|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13923926|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096452|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096453|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096454|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14096455|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
14096456|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
13923927|NCT03422055|Fucoidan|fucoidan|mesh-list
13923928|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13923929|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13923930|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
13923931|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923932|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13923933|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13923934|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477503|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14096457|NCT02434029|Hormones|hormones|mesh-ancestor
14096458|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096459|NCT02433925|Resveratrol|resveratrol|mesh-list
14096460|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
14096461|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096462|NCT02433925|Protective Agents|protective agents|mesh-ancestor
14096463|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096464|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096465|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14096466|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14096467|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14096468|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14096469|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096470|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096471|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096472|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14096473|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14096474|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
14096475|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096476|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096477|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14477504|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14477505|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477506|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477507|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477508|NCT02434523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14477509|NCT02434523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14477510|NCT02434523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477511|NCT02434770|Vaccines|vaccines|mesh-list
14477512|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
14477513|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477514|NCT02434939|Ketamine|ketamine|mesh-list
14477515|NCT02434939|Morphine|morphine|mesh-list
14477516|NCT02434939|Analgesics|analgesics|mesh-ancestor
14477517|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
14477518|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477519|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477520|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14477521|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14477522|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
13923935|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
14096478|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14096479|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
14096480|NCT02433652|Vaccines|vaccines|mesh-list
14096481|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
14096482|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096483|NCT02433626|Cisplatin|cisplatin|mesh-list
14096484|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096485|NCT02433587|Aspirin|aspirin|mesh-list
14096486|NCT02433587|Clopidogrel|clopidogrel|mesh-list
14096487|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14096488|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14096489|NCT02433587|Analgesics|analgesics|mesh-ancestor
14096490|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
14096491|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096492|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096493|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096494|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096495|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14477523|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
13923936|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14096496|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14096497|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096498|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14096499|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14096500|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096501|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
14096502|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14096503|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14096504|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14096505|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
14477524|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477525|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14477526|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14477527|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477528|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477529|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14477530|NCT02434939|Narcotics|narcotics|mesh-ancestor
14477531|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14477532|NCT02435069|Glycerol|glycerol|mesh-list
14096506|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096507|NCT02433704|Cefazolin|cefazolin|mesh-list
14096508|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477533|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14477534|NCT02435069|Protective Agents|protective agents|mesh-ancestor
14477535|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477536|NCT02435147|Denosumab|denosumab|mesh-list
14477537|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14477538|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477539|NCT02435277|Metformin|metformin|mesh-list
14477540|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14477541|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096509|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096510|NCT02433457|Omeprazole|omeprazole|mesh-list
14096511|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14096512|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096513|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14096514|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096515|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096516|NCT02433535|Simvastatin|simvastatin|mesh-list
14096517|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14096518|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14096519|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
14096520|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096521|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14096522|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14096523|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477542|NCT02435680|Gemcitabine|gemcitabine|mesh-list
14477543|NCT02435680|Carboplatin|carboplatin|mesh-list
14477544|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477545|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14477546|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
14477547|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477548|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
14477549|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096524|NCT02433522|Rituximab|rituximab|mesh-list
14096525|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477550|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477551|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477552|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
14935842|NCT01465906|Bromides|bromides|mesh-list
13923937|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13923938|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923939|NCT03421990|Anesthetics|anesthetics|mesh-list
13923940|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923941|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923942|NCT03421860|Phenylephrine|phenylephrine|mesh-list
13923943|NCT03421860|Epinephrine|epinephrine|mesh-list
13923944|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
13923945|NCT03421860|Ephedrine|ephedrine|mesh-list
13923946|NCT03421860|Norepinephrine|norepinephrine|mesh-list
13923947|NCT03421860|Ondansetron|ondansetron|mesh-list
14096526|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096527|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
14096528|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096529|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096530|NCT02433418|Diclofenac|diclofenac|mesh-list
14096531|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14096532|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14096533|NCT02433418|Analgesics|analgesics|mesh-ancestor
14477553|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477554|NCT02435836|Aripiprazole|aripiprazole|mesh-list
14477555|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
14477556|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14477557|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14477558|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13923948|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13923949|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13923950|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
13923951|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13923952|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923953|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923954|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13923955|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13923956|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
13923957|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923958|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13923959|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
13923960|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
13923961|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
13923962|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13923963|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
13923964|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13923965|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
13923966|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
13923967|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13923968|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
13923969|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13923970|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13923971|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923972|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13923973|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13923974|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13923975|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
13923976|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13923977|NCT03421860|Protective Agents|protective agents|mesh-ancestor
13923978|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13923979|NCT03421821|Ropivacaine|ropivacaine|mesh-list
13923980|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
13923981|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
13923982|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13923983|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923984|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
13923985|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13923986|NCT03421743|Molgramostim|molgramostim|mesh-list
13923987|NCT03421743|Sargramostim|sargramostim|mesh-list
13923988|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13923989|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
13923990|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13923991|NCT03421717|Chitosan|chitosan|mesh-list
13923992|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13923993|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13923994|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
13923995|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13923996|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13923997|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
13923998|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
13923999|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
14096534|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
14096535|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096536|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096537|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096538|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096539|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14096540|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924000|NCT03421717|Coagulants|coagulants|mesh-ancestor
14477559|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477560|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477561|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
14477562|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
14477563|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960668|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
13960669|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960670|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960671|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14096541|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096542|NCT02433314|Brexanolone|brexanolone|mesh-list
14096543|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
14096544|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096545|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096546|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096547|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
14096548|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
14096549|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14096550|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14096551|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14096552|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14096553|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096554|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096555|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096556|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14096557|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14096558|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14761051|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761052|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14761053|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14761054|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14761055|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14761056|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761057|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761058|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
14761059|NCT03984448|Hormones|hormones|mesh-ancestor
14761060|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096559|NCT02433730|Testosterone|testosterone|mesh-list
14096560|NCT02433730|Androgens|androgens|mesh-ancestor
14096561|NCT02433730|Hormones|hormones|mesh-ancestor
14096562|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096563|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096564|NCT02433912|Acetaminophen|acetaminophen|mesh-list
14096565|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
14096566|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14096567|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14096568|NCT02433912|Analgesics|analgesics|mesh-ancestor
14096569|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
14096570|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096571|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096572|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
14096573|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14761061|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14096574|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096575|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
14096576|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14096577|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
14096578|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
13924006|NCT03421496|Cannabidiol|cannabidiol|mesh-list
13924007|NCT03421496|Vigabatrin|vigabatrin|mesh-list
13924008|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
13924009|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924010|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924011|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
13924012|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924013|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924014|NCT03421483|Folic Acid|folic acid|mesh-list
13924015|NCT03421483|Hematinics|hematinics|mesh-ancestor
13924016|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
14761062|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14761063|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14761064|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761065|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761066|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
13924017|NCT03421483|Vitamins|vitamins|mesh-ancestor
13924018|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
13924019|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924020|NCT03421366|Posaconazole|posaconazole|mesh-list
14096579|NCT02433184|Etanercept|etanercept|mesh-list
14096580|NCT02433184|Methotrexate|methotrexate|mesh-list
14096581|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14096582|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
14096583|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14096584|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096585|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14096586|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
14096587|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096588|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096589|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
14096590|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096591|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14096592|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096593|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
14096594|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096595|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14096596|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
14096597|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14096598|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14096599|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096600|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14096601|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14096602|NCT02433184|Analgesics|analgesics|mesh-ancestor
14096603|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
13924021|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
13924022|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924023|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13924024|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13924025|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13924026|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13924027|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13924028|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924029|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924030|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13924031|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
13924032|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924033|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924034|NCT03421314|Selenium|selenium|mesh-list
13924035|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
13924036|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924037|NCT03421314|Protective Agents|protective agents|mesh-ancestor
13924038|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924039|NCT03421314|Trace Elements|trace elements|mesh-ancestor
13924040|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
13924041|NCT03421275|Fentanyl|fentanyl|mesh-list
14761067|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
13924042|NCT03421275|Esketamine|esketamine|mesh-list
13924043|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13924044|NCT03421275|Narcotics|narcotics|mesh-ancestor
14096604|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761068|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
14096605|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096606|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096607|NCT02432885|Enalapril|enalapril|mesh-list
14096608|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14096609|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
14096610|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096611|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096612|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14096613|NCT02432911|Cytarabine|cytarabine|mesh-list
14096614|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
14096615|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14096616|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
14096617|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096618|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096619|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
14096620|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096621|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096622|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
14096623|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096624|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14096625|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14096626|NCT02433041|Ketamine|ketamine|mesh-list
14096627|NCT02433041|Haloperidol|haloperidol|mesh-list
14096628|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
14096629|NCT02433041|Analgesics|analgesics|mesh-ancestor
14096630|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
14096631|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924045|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924046|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924047|NCT03421275|Analgesics|analgesics|mesh-ancestor
13924048|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
13924049|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924050|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13924051|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13924052|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
13924053|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
13924054|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
13924055|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096632|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096633|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14096634|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14096635|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
14096636|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
14096637|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096638|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14096639|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14096640|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096641|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096642|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
14096643|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
14096644|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096645|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14096646|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14096647|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096648|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14096649|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
14096650|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14096651|NCT02432846|Sunitinib|sunitinib|mesh-list
14096652|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096653|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14096654|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14096655|NCT02432846|Growth Substances|growth substances|mesh-ancestor
14096656|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924056|NCT03421119|Insulin|insulin|mesh-list
13924057|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13924058|NCT03421119|Metformin|metformin|mesh-list
13924059|NCT03421119|Liraglutide|liraglutide|mesh-list
13924060|NCT03421119|Secretagogues|secretagogues|mesh-list
13924061|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13924062|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924063|NCT03421119|Incretins|incretins|mesh-ancestor
13924064|NCT03421119|Hormones|hormones|mesh-ancestor
13924065|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924066|NCT03421002|Micafungin|micafungin|mesh-list
13924067|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
14096657|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
13924068|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14935843|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
14935844|NCT01465906|Tulobuterol|tulobuterol|mesh-list
14935845|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14935846|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
14935847|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935848|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935849|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14935850|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
13924069|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
13924070|NCT03420963|Etoposide|etoposide|mesh-list
13924071|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
13924072|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
13924073|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924074|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
13924075|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924076|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13924077|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13924078|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
14096658|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14096659|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096660|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096661|NCT02432807|Vancomycin|vancomycin|mesh-list
14096662|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14096663|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096664|NCT02432976|Insulin|insulin|mesh-list
14096665|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14096666|NCT02432976|Exenatide|exenatide|mesh-list
14096667|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
14096668|NCT02432976|Incretins|incretins|mesh-list
14096669|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14096670|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096671|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14096672|NCT02432976|Hormones|hormones|mesh-ancestor
14096673|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174645|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
14174646|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174647|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14174648|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14174649|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174650|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174651|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174652|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14174653|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14174654|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
14174655|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14174656|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
14174657|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
14174658|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
14174659|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14174660|NCT04784000|Carbamazepine|carbamazepine|mesh-list
14174661|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
14174662|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
14174663|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14174664|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174665|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174666|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14174667|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14174668|NCT04784000|Analgesics|analgesics|mesh-ancestor
14935851|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
13924079|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924080|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924081|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13924082|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13924083|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13924084|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13924085|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096674|NCT02432833|Tacrolimus|tacrolimus|mesh-list
14096675|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096676|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
14096677|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096678|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14096679|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096680|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096681|NCT02432872|Cytarabine|cytarabine|mesh-list
14096682|NCT02432872|Daunorubicin|daunorubicin|mesh-list
14096683|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14096684|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
14096685|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096686|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096687|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
14096688|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096689|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096690|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
14096691|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096692|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14096693|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14096694|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14096695|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096696|NCT02432781|Insulin|insulin|mesh-list
14096697|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14096698|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096699|NCT02432599|Choline|choline|mesh-list
14096700|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
14096701|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13924086|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
13924087|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
13924088|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
13924089|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
13924090|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
13924091|NCT03420937|Atropine|atropine|mesh-list
13924092|NCT03420937|Neostigmine|neostigmine|mesh-list
13924093|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13924094|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13924095|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13924096|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
13924097|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924098|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924099|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13924100|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
13924101|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
13924102|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
14096702|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
14096703|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096704|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096705|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14096706|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
14096707|NCT02432534|Atorvastatin|atorvastatin|mesh-list
14096708|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14096709|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14096710|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
14096711|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096712|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14096713|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14096714|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096715|NCT02432547|Aflibercept|aflibercept|mesh-list
14096716|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14096717|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14096718|NCT02432547|Growth Substances|growth substances|mesh-ancestor
14096719|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096720|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
14096721|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096722|NCT02432612|Nabiximols|nabiximols|mesh-list
14096723|NCT02432612|Analgesics|analgesics|mesh-ancestor
14096724|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
14096725|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096726|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096727|NCT02432677|Remifentanil|remifentanil|mesh-list
14096728|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14096729|NCT02432677|Narcotics|narcotics|mesh-ancestor
14096730|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096731|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096732|NCT02432677|Analgesics|analgesics|mesh-ancestor
13924103|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13924104|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13924105|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
13924106|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924107|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924108|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13924109|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096733|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
14096734|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096735|NCT02432651|Xanthohumol|xanthohumol|mesh-list
14096736|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096737|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14096738|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14096739|NCT02432651|Growth Substances|growth substances|mesh-ancestor
14096740|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096741|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
14096742|NCT02432664|Midazolam|midazolam|mesh-list
14096743|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14096744|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14096745|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924110|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13924111|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13924112|NCT03420911|Midazolam|midazolam|mesh-list
13924113|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13924114|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13924115|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924116|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924117|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13924118|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13924119|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13924120|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13924121|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
13924122|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
13924123|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
13924124|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
13924125|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924126|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924127|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13924128|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13924129|NCT03420911|Analgesics|analgesics|mesh-ancestor
13924130|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
13924131|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924132|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924133|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096746|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096747|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14096748|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14096749|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096750|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14096751|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
14096752|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
14096753|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
14096754|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
14096755|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096756|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096757|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
14096758|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14096759|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096760|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14096761|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
14096762|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14096763|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096764|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096765|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096766|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14096767|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14096768|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
14096769|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096770|NCT02432365|Paclitaxel|paclitaxel|mesh-list
14096771|NCT02432365|Cisplatin|cisplatin|mesh-list
14096772|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14096773|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096774|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
14935852|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14096775|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
14477564|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924134|NCT03420794|Analgesics|analgesics|mesh-list
14096776|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
14096777|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096778|NCT02432053|Tacrolimus|tacrolimus|mesh-list
14096779|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096780|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
14096781|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096782|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14096783|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096784|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096785|NCT02432027|Betamethasone|betamethasone|mesh-list
14096786|NCT02432027|Calcipotriene|calcipotriene|mesh-list
14096787|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096788|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
14096789|NCT02432027|Hormones|hormones|mesh-ancestor
13924135|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
13924136|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
13924137|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924138|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924139|NCT03420742|Midazolam|midazolam|mesh-list
13924140|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13924141|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13924142|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924143|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924144|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13924145|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13924146|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13924147|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13924148|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
13924149|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
14096790|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096791|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096792|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14096793|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
14096794|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
14096795|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
14096796|NCT02432261|ST 1435|st 1435|mesh-list
14096797|NCT02432261|Testosterone|testosterone|mesh-list
14096798|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
14096799|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
14096800|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14096801|NCT02432261|Androgens|androgens|mesh-ancestor
14096802|NCT02432261|Hormones|hormones|mesh-ancestor
14096803|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096804|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096805|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14096806|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096807|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
14096808|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14096809|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
14096810|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14096811|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14096812|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
14096813|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14096814|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14096815|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
14096816|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924150|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
13924151|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
13924152|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096817|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096818|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477565|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14935853|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
14935854|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935855|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935856|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
14935857|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14935858|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14935859|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
14935860|NCT01465919|Mirtazapine|mirtazapine|mesh-list
14935861|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14935862|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13924153|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924154|NCT03420703|Morphine|morphine|mesh-list
13924155|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13924156|NCT03420703|Narcotics|narcotics|mesh-ancestor
13924157|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924158|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924159|NCT03420703|Analgesics|analgesics|mesh-ancestor
13924160|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
13924161|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924162|NCT03420638|Epinephrine|epinephrine|mesh-list
13924163|NCT03420638|Bupivacaine|bupivacaine|mesh-list
13924164|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
13924165|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
13924166|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924167|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924168|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
13924169|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924170|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13924171|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13924172|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
13924173|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761069|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761070|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761071|NCT03975829|Trametinib|trametinib|mesh-list
14761072|NCT03975829|Dabrafenib|dabrafenib|mesh-list
14761073|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096819|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
14096820|NCT02431988|Fludarabine|fludarabine|mesh-list
14096821|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14096822|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
14096823|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096824|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14096825|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14096826|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
14096827|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096828|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096829|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14096830|NCT02431975|Ritonavir|ritonavir|mesh-list
14096831|NCT02431975|Lopinavir|lopinavir|mesh-list
14096832|NCT02431975|Lamivudine|lamivudine|mesh-list
14096833|NCT02431975|Zidovudine|zidovudine|mesh-list
14096834|NCT02431975|Nevirapine|nevirapine|mesh-list
14096835|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14096836|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14096837|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
14096838|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096839|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096840|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14096841|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14096842|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
14096843|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096844|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14096845|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14096846|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14096847|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14096848|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
14096849|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14096850|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14096851|NCT02431936|Prazosin|prazosin|mesh-list
14096852|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14096853|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14096854|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14096855|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14096856|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
14096857|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096858|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096859|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096860|NCT02431845|Fluoxetine|fluoxetine|mesh-list
14096861|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14096862|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14096863|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14096864|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096865|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096866|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
14761074|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924174|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096867|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096868|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14096869|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
14096870|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14096871|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14096872|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14096873|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096874|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14096875|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14096876|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096877|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14096878|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935863|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14935864|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
14935865|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
14096879|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096880|NCT02431728|Melatonin|melatonin|mesh-list
14096881|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
14096882|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096883|NCT02431728|Protective Agents|protective agents|mesh-ancestor
14096884|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096885|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096886|NCT02431663|Ketamine|ketamine|mesh-list
14096887|NCT02431663|Analgesics|analgesics|mesh-ancestor
14096888|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
14096889|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096890|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096891|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14096892|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14096893|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
14096894|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
14096895|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096896|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14096897|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14096898|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096899|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096900|NCT02431429|Miltefosine|miltefosine|mesh-list
14096901|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
14096902|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096903|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096904|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14096905|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14096906|NCT02431416|Hormones|hormones|mesh-list
14096907|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096908|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761075|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761076|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761077|NCT03974152|Nicotine|nicotine|mesh-list
14761078|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14761079|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
14761080|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761081|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761082|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14761083|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14761084|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
14761085|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761086|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761087|NCT03969901|Relebactam|relebactam|mesh-list
14761088|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14935866|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924175|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13924176|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13924177|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
13924178|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13924179|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
13924180|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
13924181|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
13924182|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13924183|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
13924184|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13924185|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
13924186|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
13924187|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096909|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
14096910|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096911|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14096912|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924188|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924189|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13924190|NCT03420586|Analgesics|analgesics|mesh-ancestor
13924191|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
13924192|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924193|NCT03420534|Iloperidone|iloperidone|mesh-list
13924194|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13924195|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13924196|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14096913|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096914|NCT02431325|Teduglutide|teduglutide|mesh-list
14096915|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096916|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14096917|NCT02431325|Protective Agents|protective agents|mesh-ancestor
14096918|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096919|NCT02431286|Dexamethasone|dexamethasone|mesh-list
14096920|NCT02431286|Aprepitant|aprepitant|mesh-list
14096921|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924197|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924198|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13924199|NCT03420469|Bupropion|bupropion|mesh-list
13924200|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13924201|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
13924202|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13924203|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13924204|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13924205|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13924206|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924207|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
13924208|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924209|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924210|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13924211|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13924212|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924213|NCT03420378|Vitamin D|vitamin d|mesh-list
13924214|NCT03420378|Vitamins|vitamins|mesh-ancestor
13924215|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
13924216|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924217|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13924218|NCT03420339|Adderall|adderall|mesh-list
13924219|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13924220|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924221|NCT03420313|Buprenorphine|buprenorphine|mesh-list
13924222|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13924223|NCT03420313|Naloxone|naloxone|mesh-list
13924224|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13924225|NCT03420313|Narcotics|narcotics|mesh-ancestor
13924226|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924227|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924228|NCT03420313|Analgesics|analgesics|mesh-ancestor
13924229|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
14096922|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
14096923|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
14096924|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096925|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096926|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096927|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
14096928|NCT02431286|Hormones|hormones|mesh-ancestor
14096929|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096930|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14096931|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096932|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14096933|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14096934|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096935|NCT02431221|Perhexiline|perhexiline|mesh-list
13924230|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924231|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13924232|NCT03420144|Hormones|hormones|mesh-list
14096936|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14761089|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924233|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924234|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924235|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
13924236|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13924237|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924238|NCT03419975|Latanoprost|latanoprost|mesh-list
13924239|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14096937|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14096938|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096939|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14096940|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096941|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
14096942|NCT02431208|Dexamethasone|dexamethasone|mesh-list
14096943|NCT02431208|Lenalidomide|lenalidomide|mesh-list
14096944|NCT02431208|Atezolizumab|atezolizumab|mesh-list
14096945|NCT02431208|Daratumumab|daratumumab|mesh-list
14096946|NCT02431208|Pomalidomide|pomalidomide|mesh-list
14096947|NCT02431208|Antibodies|antibodies|mesh-list
13924240|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13924241|NCT03419949|Pregabalin|pregabalin|mesh-list
13924242|NCT03419949|Lamotrigine|lamotrigine|mesh-list
13924243|NCT03419949|Analgesics|analgesics|mesh-ancestor
13924244|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
13924245|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924246|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924247|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
13924248|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13924249|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13924250|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924251|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13924252|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13924253|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13924254|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924255|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13924256|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13924257|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13924258|NCT03419923|Citric Acid|citric acid|mesh-list
13924259|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
14096948|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14096949|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
14096950|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096951|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14096952|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
14096953|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
14096954|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096955|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14096956|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
14096957|NCT02431208|Hormones|hormones|mesh-ancestor
14096958|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14096959|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13924260|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
13924261|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13924262|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
13924263|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
14096960|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096961|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14096962|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14096963|NCT02431208|Growth Substances|growth substances|mesh-ancestor
13924264|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924265|NCT03419910|Cyclosporine|cyclosporine|mesh-list
13924266|NCT03419910|BMS-986165|bms-986165|mesh-list
13924267|NCT03419910|Cyclosporins|cyclosporins|mesh-list
13924268|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761090|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761091|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14761092|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761093|NCT03965091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14761094|NCT03965091|Immunologic Factors|immunologic factors|mesh-ancestor
14761095|NCT03965091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924269|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924270|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924271|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
13924272|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096964|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
14096965|NCT02431143|Miltefosine|miltefosine|mesh-list
14096966|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
14096967|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096968|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14096969|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14096970|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14096971|NCT02431013|Cilostazol|cilostazol|mesh-list
14096972|NCT02431013|Simvastatin|simvastatin|mesh-list
14096973|NCT02431013|Pravastatin|pravastatin|mesh-list
14096974|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14096975|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14096976|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
14096977|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14096978|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14096979|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14096980|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14096981|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14096982|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
14096983|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14096984|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14096985|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14096986|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
14096987|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14096988|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14096989|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14096990|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
14096991|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14096992|NCT02431013|Protective Agents|protective agents|mesh-ancestor
14096993|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14096994|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14096995|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14096996|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14096997|NCT02431065|Ropivacaine|ropivacaine|mesh-list
14096998|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
14096999|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097000|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097001|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
14097002|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
14097003|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097004|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
14097005|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097006|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
14097007|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097008|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174669|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
14174670|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174671|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13924273|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
13924274|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924275|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
13924276|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13924277|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13924278|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924279|NCT03419858|Naloxone|naloxone|mesh-list
13924280|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13924281|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761096|NCT03959488|Palivizumab|palivizumab|mesh-list
14761097|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
14761098|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761099|NCT03948568|Tamoxifen|tamoxifen|mesh-list
14761100|NCT03948568|Letrozole|letrozole|mesh-list
13924282|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
13924283|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174672|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761101|NCT03948568|Anastrozole|anastrozole|mesh-list
14761102|NCT03948568|Exemestane|exemestane|mesh-list
14097009|NCT02430714|Lenvatinib|lenvatinib|mesh-list
14097010|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097011|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14097012|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097013|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097014|NCT02430896|Methylphenidate|methylphenidate|mesh-list
14097015|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14097016|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14097017|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097018|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14097019|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14097020|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097021|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097022|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
14097023|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097024|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14097025|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097026|NCT02430545|Rifampin|rifampin|mesh-list
14097027|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14097028|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
14097029|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14097030|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097031|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
14097032|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14097033|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097034|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097035|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14097036|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14097037|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14097038|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14097039|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14097040|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14097041|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
14097042|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14097043|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14097044|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14097045|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
14097046|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097047|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097048|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097049|NCT02430298|Melatonin|melatonin|mesh-list
14097050|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
14097051|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097052|NCT02430298|Protective Agents|protective agents|mesh-ancestor
14097053|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097054|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097055|NCT02430259|Isoniazid|isoniazid|mesh-list
14097056|NCT02430259|Rifapentine|rifapentine|mesh-list
14097057|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
14097058|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14097059|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097060|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14097061|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14097062|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
14097063|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924284|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13924285|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13924286|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
13924287|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924288|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13924289|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13924290|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
13924291|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
13924292|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924293|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924294|NCT03419767|Melatonin|melatonin|mesh-list
13924295|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
13924296|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924297|NCT03419767|Protective Agents|protective agents|mesh-ancestor
13924298|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924299|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097064|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14097065|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14097066|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
14097067|NCT02430181|Interferons|interferons|mesh-list
14097068|NCT02430181|Ritonavir|ritonavir|mesh-list
14097069|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
14097070|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14097071|NCT02430181|Lonafarnib|lonafarnib|mesh-list
14097072|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097073|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
14097074|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097075|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14097076|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14097077|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
14097078|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097079|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097080|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14097081|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14097082|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14097083|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13924300|NCT03419715|Bimatoprost|bimatoprost|mesh-list
13924301|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13924302|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13924303|NCT03419650|Hormones|hormones|mesh-ancestor
13924304|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924305|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924306|NCT03419624|Metformin|metformin|mesh-list
13924307|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
13924308|NCT03419624|Exenatide|exenatide|mesh-list
13924309|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13924310|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924311|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13924312|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924313|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13924314|NCT03419624|Incretins|incretins|mesh-ancestor
13924315|NCT03419624|Hormones|hormones|mesh-ancestor
13924316|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924317|NCT03419559|Durvalumab|durvalumab|mesh-list
13924318|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13924319|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924320|NCT03419494|Doxorubicin|doxorubicin|mesh-list
13924321|NCT03419494|Daunorubicin|daunorubicin|mesh-list
13924322|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13924323|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13924324|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924325|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13924326|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14097084|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
14097085|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097086|NCT02430194|Interferons|interferons|mesh-list
14097087|NCT02430194|Ritonavir|ritonavir|mesh-list
14097088|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
14097089|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
14097090|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14097091|NCT02430194|Lonafarnib|lonafarnib|mesh-list
14097092|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097093|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
14097094|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097095|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14097096|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14097097|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
14097098|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924327|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924328|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924329|NCT03419442|Docetaxel|docetaxel|mesh-list
13924330|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924331|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
13924332|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
13924333|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
13924334|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097099|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097100|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14097101|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14097102|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13924335|NCT03419429|Simvastatin|simvastatin|mesh-list
14097103|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14097104|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
14097105|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097106|NCT02430350|Edaravone|edaravone|mesh-list
14097107|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14097108|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
14097109|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097110|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14097111|NCT02430350|Protective Agents|protective agents|mesh-ancestor
14097112|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097113|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
14097114|NCT02430363|Dactolisib|dactolisib|mesh-list
14097115|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14097116|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097117|NCT02430233|Progesterone|progesterone|mesh-list
14097118|NCT02430233|Progestins|progestins|mesh-ancestor
14097119|NCT02430233|Hormones|hormones|mesh-ancestor
14097120|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924336|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13924337|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13924338|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
13924339|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924340|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13924341|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13924342|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924343|NCT03419364|Niacinamide|niacinamide|mesh-list
13924344|NCT03419364|Niacin|niacin|mesh-list
13924345|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
13924346|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
13924347|NCT03419364|Vitamins|vitamins|mesh-ancestor
13924348|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
13924349|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924350|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13924351|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
13924352|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097121|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097122|NCT02430103|Goserelin|goserelin|mesh-list
14097123|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097124|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097125|NCT02429973|Gemcitabine|gemcitabine|mesh-list
14097126|NCT02429973|Sirolimus|sirolimus|mesh-list
14097127|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14097128|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
14097129|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097130|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097131|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
14097132|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097133|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097134|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097135|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
14097136|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097137|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14097138|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14097139|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
14097140|NCT02429960|Remifentanil|remifentanil|mesh-list
14097141|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14097142|NCT02429960|Narcotics|narcotics|mesh-ancestor
13924353|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13924354|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
13924355|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
13924356|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13924357|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924358|NCT03418974|Atorvastatin|atorvastatin|mesh-list
13924359|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14097143|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097144|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097145|NCT02429960|Analgesics|analgesics|mesh-ancestor
14097146|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
13924360|NCT03418974|Pitavastatin|pitavastatin|mesh-list
13924361|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13924362|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13924363|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
14761103|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761104|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14761105|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14761106|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924364|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924365|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14097147|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097148|NCT02429921|Selenium|selenium|mesh-list
14097149|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
14097150|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097151|NCT02429921|Protective Agents|protective agents|mesh-ancestor
14097152|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097153|NCT02429921|Trace Elements|trace elements|mesh-ancestor
14097154|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
13924366|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13924367|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924368|NCT03418935|Niacinamide|niacinamide|mesh-list
13924369|NCT03418935|Niacin|niacin|mesh-list
13924370|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
13924371|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
13924372|NCT03418935|Vitamins|vitamins|mesh-ancestor
13924373|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
13924374|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924375|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13924376|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
13924377|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924378|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13924379|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
13924380|NCT03418922|Nivolumab|nivolumab|mesh-list
13924381|NCT03418922|Lenvatinib|lenvatinib|mesh-list
13924382|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13924383|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924384|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13924385|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924386|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924387|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924388|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14097155|NCT02429804|Listerine|listerine|mesh-list
14097156|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
14097157|NCT02429804|Fluorides|fluorides|mesh-list
14097158|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
14097159|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14097160|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
14097161|NCT02429804|Protective Agents|protective agents|mesh-ancestor
14097162|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097163|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14097164|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097165|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14097166|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097167|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
14097168|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
14097169|NCT02429726|Cisplatin|cisplatin|mesh-list
13924389|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13924390|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097170|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097171|NCT02429700|Paclitaxel|paclitaxel|mesh-list
14097172|NCT02429700|Etoposide|etoposide|mesh-list
14097173|NCT02429700|Carboplatin|carboplatin|mesh-list
14097174|NCT02429700|Bleomycin|bleomycin|mesh-list
14097175|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14097176|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097177|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14097178|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14097179|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14097180|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097181|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14097182|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14097183|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097184|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14097185|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
14097186|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14097187|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14097188|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097189|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183619|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097190|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097191|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097192|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
14097193|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
14097194|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097195|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
14097196|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14097197|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
14097198|NCT02429817|Edetic Acid|edetic acid|mesh-list
14097199|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
14097200|NCT02429817|Antidotes|antidotes|mesh-ancestor
14935867|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924391|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13924392|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13924393|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
13924394|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924395|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924396|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13924397|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13924398|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13924399|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13924400|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13924401|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13924402|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13924403|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13924404|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13924405|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13924406|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13924407|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
13924408|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924409|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924410|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924411|NCT03418727|Laxatives|laxatives|mesh-ancestor
13924412|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13924413|NCT03418610|Azelaic acid|azelaic acid|mesh-list
13924414|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924415|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
13924416|NCT03418597|Anesthetics|anesthetics|mesh-list
13924417|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924418|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924419|NCT03418558|Trastuzumab|trastuzumab|mesh-list
13924420|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
13924421|NCT03418558|Maytansine|maytansine|mesh-list
13924422|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13924423|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924424|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13924425|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
13924426|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
13924427|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
13924428|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924429|NCT03418532|Osimertinib|osimertinib|mesh-list
13924430|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924431|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924432|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924433|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924434|NCT03418506|Lobeline|lobeline|mesh-list
13924435|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13924436|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
13924437|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924438|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924439|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13924440|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13924441|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
13924442|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924443|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924444|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
13924445|NCT03418337|Lansoprazole|lansoprazole|mesh-list
13924446|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
13924447|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13924448|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13924449|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13924450|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097201|NCT02429817|Protective Agents|protective agents|mesh-ancestor
13924451|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924452|NCT03418246|Calcium|calcium|mesh-list
14097202|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097203|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
14097204|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
14097205|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097206|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14097207|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
14097208|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14097209|NCT02429882|Brodalumab|brodalumab|mesh-list
14097210|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
14097211|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
14097212|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14097213|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
14097214|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097215|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097216|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14097217|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
14097218|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14097219|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14097220|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14097221|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097222|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097223|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097224|NCT02429687|Paclitaxel|paclitaxel|mesh-list
14097225|NCT02429687|Etoposide|etoposide|mesh-list
14097226|NCT02429687|Carboplatin|carboplatin|mesh-list
14097227|NCT02429687|Bleomycin|bleomycin|mesh-list
14097228|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14097229|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097230|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
14097231|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
14097232|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
14097233|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097234|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14097235|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14097236|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097237|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14097238|NCT02429622|Paclitaxel|paclitaxel|mesh-list
14097239|NCT02429622|Nedaplatin|nedaplatin|mesh-list
14097240|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14097241|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097242|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
14097243|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
14097244|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14097245|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097246|NCT02429596|Lamotrigine|lamotrigine|mesh-list
14097247|NCT02429596|Carbamazepine|carbamazepine|mesh-list
14097248|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
14097249|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14097250|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097251|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097252|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14097253|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097254|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14097255|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14097256|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924453|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13924454|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960672|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13960673|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
13960674|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
13960675|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960676|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13960677|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13960678|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960679|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960680|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
13960681|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
13960682|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13960683|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
14097257|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14097258|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13924455|NCT03418090|Xenon|xenon|mesh-list
14097259|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
14097260|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14097261|NCT02429596|Analgesics|analgesics|mesh-ancestor
14097262|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
14097263|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097264|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14097265|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14097266|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
14097267|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14097268|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14097269|NCT02429570|Analgesics|analgesics|mesh-ancestor
14097270|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
14097271|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097272|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097273|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097274|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14097275|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14097276|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097277|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097278|NCT02429219|Ethanol|ethanol|mesh-list
14097279|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14097280|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097281|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097282|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097283|NCT02429193|Prednisone|prednisone|mesh-list
14097284|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
14097285|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097286|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
14097287|NCT02429193|Hormones|hormones|mesh-ancestor
14097288|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097289|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097290|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097291|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924456|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13924457|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
13924458|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
14935868|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935869|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14935870|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14935871|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935872|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13924459|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924460|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924461|NCT03418038|Vitamins|vitamins|mesh-list
13924462|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
13924463|NCT03418038|Gemcitabine|gemcitabine|mesh-list
13924464|NCT03418038|Cytarabine|cytarabine|mesh-list
13924465|NCT03418038|Dexamethasone|dexamethasone|mesh-list
13924466|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
14097292|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14097293|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097294|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097295|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
14097296|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14097297|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14097298|NCT02429375|Mocetinostat|mocetinostat|mesh-list
14097299|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14097300|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097301|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14097302|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097303|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097304|NCT02429271|Clopidogrel|clopidogrel|mesh-list
14097305|NCT02429271|Ticagrelor|ticagrelor|mesh-list
14097306|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14097307|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14097308|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14097309|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14097310|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
14097311|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935873|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13924467|NCT03418038|Cisplatin|cisplatin|mesh-list
13924468|NCT03418038|Rituximab|rituximab|mesh-list
13924469|NCT03418038|Carboplatin|carboplatin|mesh-list
13924470|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
14097312|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097313|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097314|NCT02429466|Guadecitabine|guadecitabine|mesh-list
14097315|NCT02429466|Azacitidine|azacitidine|mesh-list
14097316|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097317|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14097318|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
14097319|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097320|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097321|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14097322|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
14097323|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097324|NCT02429505|Miltefosine|miltefosine|mesh-list
14097325|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
14097326|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097327|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097328|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14097329|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14097330|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
14097331|NCT02429388|Spironolactone|spironolactone|mesh-list
14097332|NCT02429388|Diuretics|diuretics|mesh-list
14097333|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
14097334|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14097335|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
14097336|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097337|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097338|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
14097339|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097340|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097341|NCT02429232|Pioglitazone|pioglitazone|mesh-list
14097342|NCT02429232|Linagliptin|linagliptin|mesh-list
14097343|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14097344|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924471|NCT03418038|Etoposide|etoposide|mesh-list
13924472|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
13924473|NCT03418038|Ifosfamide|ifosfamide|mesh-list
13924474|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
13924475|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
13924476|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13924477|NCT03418038|Antibodies|antibodies|mesh-list
13924478|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
13924479|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13924480|NCT03418038|BB 1101|bb 1101|mesh-list
13924481|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
13924482|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097345|NCT02429232|Incretins|incretins|mesh-ancestor
14097346|NCT02429232|Hormones|hormones|mesh-ancestor
14097347|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097348|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14097349|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
14097350|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097351|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097352|NCT02429323|Sevoflurane|sevoflurane|mesh-list
14097353|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14097354|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14097355|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
14097356|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
14097357|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097358|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174673|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174674|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14174675|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14174676|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
14174677|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14174678|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174679|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13924483|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
13924484|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924485|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924486|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
13924487|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
13924488|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924489|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13924490|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
14097359|NCT02429440|Molgramostim|molgramostim|mesh-list
14097360|NCT02429440|Sargramostim|sargramostim|mesh-list
14097361|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
14097362|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097363|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097364|NCT02429453|Thrombin|thrombin|mesh-list
14097365|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
14097366|NCT02429453|Coagulants|coagulants|mesh-ancestor
14097367|NCT02429518|Miltefosine|miltefosine|mesh-list
14097368|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
14097369|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097370|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097371|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14097372|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14097373|NCT02428751|Prednisone|prednisone|mesh-list
14097374|NCT02428751|Rituximab|rituximab|mesh-list
14097375|NCT02428751|Doxorubicin|doxorubicin|mesh-list
14097376|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14097377|NCT02428751|Vincristine|vincristine|mesh-list
14097378|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14097379|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097380|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
14097381|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097382|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14097383|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14097384|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14097385|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14097386|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097387|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097388|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097389|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
14097390|NCT02428751|Hormones|hormones|mesh-ancestor
14097391|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097392|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097393|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14097394|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
14097395|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
14097396|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
14097397|NCT02428764|Gemcitabine|gemcitabine|mesh-list
14097398|NCT02428764|Carboplatin|carboplatin|mesh-list
14097399|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
14097400|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097401|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14097402|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
14097403|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097404|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
14097405|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097406|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097407|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097408|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
14097409|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097410|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14097411|NCT02428933|Bromocriptine|bromocriptine|mesh-list
14097412|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14097413|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14097414|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
14097415|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761107|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761108|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14761109|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
14761110|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761111|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761112|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14935874|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14935875|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097416|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097417|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
14097418|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
14097419|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097420|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097421|NCT02428777|Diclofenac|diclofenac|mesh-list
14097422|NCT02428777|Tramadol|tramadol|mesh-list
14097423|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14097424|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14097425|NCT02428777|Analgesics|analgesics|mesh-ancestor
14097426|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
14097427|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097428|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097429|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097430|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14097431|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14097432|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097433|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097434|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14097435|NCT02428777|Narcotics|narcotics|mesh-ancestor
14097436|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924491|NCT03418038|Hormones|hormones|mesh-ancestor
13924492|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924493|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13924494|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
13924495|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097437|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
14097438|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
14097439|NCT02429037|Cisplatin|cisplatin|mesh-list
14097440|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097441|NCT02429076|Propofol|propofol|mesh-list
14097442|NCT02429076|Sevoflurane|sevoflurane|mesh-list
14097443|NCT02429076|Methylphenidate|methylphenidate|mesh-list
14097444|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14097445|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097446|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097447|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14097448|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
14097449|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
14097450|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13924496|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924497|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14097451|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14097452|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14097453|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14097454|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14097455|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097456|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097457|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
14097458|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097459|NCT02429050|Morphine|morphine|mesh-list
14097460|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14097461|NCT02429050|Narcotics|narcotics|mesh-ancestor
14761113|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14761114|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14761115|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14761116|NCT03933904|Sirolimus|sirolimus|mesh-list
14761117|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14761118|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761119|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14761120|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761121|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
14761122|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761123|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
14097462|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097463|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097464|NCT02429050|Analgesics|analgesics|mesh-ancestor
14097465|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
13924498|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13924499|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
13924500|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
14097466|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097467|NCT02428972|Propofol|propofol|mesh-list
14097468|NCT02428972|Sevoflurane|sevoflurane|mesh-list
14097469|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14097470|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097471|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097472|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14097473|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
14097474|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
14097475|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14097476|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14097477|NCT02428946|Bromocriptine|bromocriptine|mesh-list
14097478|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14097479|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14097480|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
14097481|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097482|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097483|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
14097484|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
14097485|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097486|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097487|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14097488|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14097489|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14097490|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097491|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761124|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761125|NCT03927989|Nicotine|nicotine|mesh-list
14761126|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14761127|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
14761128|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924501|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097492|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14097493|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097494|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097495|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
14097496|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097497|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
14097498|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14097499|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14097500|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097501|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
14097502|NCT02428868|Coagulants|coagulants|mesh-ancestor
14097503|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
14097504|NCT02428686|Hematinics|hematinics|mesh-ancestor
14097505|NCT02428543|Cytarabine|cytarabine|mesh-list
14097506|NCT02428543|Ponatinib|ponatinib|mesh-list
14097507|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14097508|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
14097509|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097510|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097511|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
14097512|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097513|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097514|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
14097515|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097516|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14097517|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097518|NCT02428439|Lamotrigine|lamotrigine|mesh-list
14097519|NCT02428439|Bupropion|bupropion|mesh-list
13924502|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924503|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13924504|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13924505|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13924506|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
13924507|NCT03418038|Protective Agents|protective agents|mesh-ancestor
13960684|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
14761129|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097520|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14097521|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
14097522|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14097523|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14097524|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14097525|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097526|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097527|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
14097528|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097529|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097530|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14097531|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14097532|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761130|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14761131|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14761132|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
14761133|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935876|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14097533|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
14097534|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14097535|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14097536|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14097537|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14097538|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097539|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14097540|NCT02428270|Trametinib|trametinib|mesh-list
14097541|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097542|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14097543|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097544|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097545|NCT02428374|Clopidogrel|clopidogrel|mesh-list
14097546|NCT02428374|Ticagrelor|ticagrelor|mesh-list
14097547|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14097548|NCT02428374|Simvastatin|simvastatin|mesh-list
13924508|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13924509|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
13924510|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
13924511|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
13924512|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
13924513|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
13924514|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
13924515|NCT03417947|Vitamin D|vitamin d|mesh-list
13924516|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
13924517|NCT03417947|Vitamins|vitamins|mesh-ancestor
13924518|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
13924519|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097549|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14097550|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14097551|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14097552|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14097553|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
14097554|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097555|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097556|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097557|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14097558|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14097559|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
14097560|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14097561|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14097562|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097563|NCT02428322|Vitamin D|vitamin d|mesh-list
14097564|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
14097565|NCT02428322|Vitamins|vitamins|mesh-ancestor
14097566|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
14097567|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097568|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14097569|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14097570|NCT02428257|Ephedrine|ephedrine|mesh-list
14097571|NCT02428257|Bupivacaine|bupivacaine|mesh-list
14097572|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
14097573|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
14097574|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097575|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097576|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
13924520|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13924521|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13924522|NCT03417921|Gemcitabine|gemcitabine|mesh-list
13924523|NCT03417921|Paclitaxel|paclitaxel|mesh-list
13924524|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13924525|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924526|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
13924527|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
13924528|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
13924529|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924530|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13924531|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
13924532|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
13924533|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924534|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924535|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924536|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
13924537|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924538|NCT03417895|Apatinib|apatinib|mesh-list
13924539|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924540|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924541|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924542|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924543|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
13924544|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13924545|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924546|NCT03417700|Vitamin D|vitamin d|mesh-list
13924547|NCT03417700|Vitamins|vitamins|mesh-ancestor
13924548|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
14097577|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097578|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14097579|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
14097580|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
14097581|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14097582|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097583|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097584|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097585|NCT02428283|Remifentanil|remifentanil|mesh-list
14097586|NCT02428283|Ropivacaine|ropivacaine|mesh-list
14097587|NCT02428283|Sevoflurane|sevoflurane|mesh-list
14097588|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
14097589|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
14097590|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097591|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097592|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
14097593|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097594|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14097595|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14097596|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
14097597|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14097598|NCT02428283|Narcotics|narcotics|mesh-ancestor
14097599|NCT02428283|Analgesics|analgesics|mesh-ancestor
14097600|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14097601|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
14097602|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097603|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
13924549|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924550|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13924551|NCT03417687|Xenon|xenon|mesh-list
14097604|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097605|NCT02428205|Propranolol|propranolol|mesh-list
13924552|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13924553|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
13924554|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
13924555|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924556|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924557|NCT03417648|Vitamin E|vitamin e|mesh-list
13924558|NCT03417648|Vitamins|vitamins|mesh-ancestor
13924559|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
13924560|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924561|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
13924562|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924563|NCT03417648|Protective Agents|protective agents|mesh-ancestor
13924564|NCT03417518|Propofol|propofol|mesh-list
13924565|NCT03417518|Desflurane|desflurane|mesh-list
13924566|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13924567|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924568|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924569|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13924570|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
13924571|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
13924572|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13924573|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
13924574|NCT03417492|Citric Acid|citric acid|mesh-list
13924575|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
13924576|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
13924577|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13924578|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
13924579|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
13924580|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924581|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
13924582|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13924583|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13924584|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924585|NCT03417492|Urological Agents|urological agents|mesh-ancestor
13924586|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14097606|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14097607|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14097608|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097609|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097610|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097611|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097612|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14097613|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14097614|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
14097615|NCT02428062|Phenylephrine|phenylephrine|mesh-list
14097616|NCT02428062|Dopamine|dopamine|mesh-list
14097617|NCT02428062|Epinephrine|epinephrine|mesh-list
14097618|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
14097619|NCT02428062|Norepinephrine|norepinephrine|mesh-list
14097620|NCT02428062|Ephedrine|ephedrine|mesh-list
14097621|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14097622|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097623|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14097624|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14097625|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097626|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097627|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097628|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14097629|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14097630|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
14097631|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097632|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14761134|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761135|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
14761136|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761137|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097633|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
14097634|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
14097635|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
14097636|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14097637|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
14097638|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14761138|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
13924587|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13924588|NCT03417427|Cytarabine|cytarabine|mesh-list
13924589|NCT03417427|Decitabine|decitabine|mesh-list
14097639|NCT02428062|Protective Agents|protective agents|mesh-ancestor
14097640|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14097641|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
14097642|NCT02427932|Gentamicins|gentamicins|mesh-list
14097643|NCT02427932|Ampicillin|ampicillin|mesh-list
14097644|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14097645|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097646|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14097647|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097648|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097649|NCT02427893|Vemurafenib|vemurafenib|mesh-list
14097650|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097651|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14097652|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097653|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097654|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14097655|NCT02427880|Furosemide|furosemide|mesh-list
14097656|NCT02427880|Acetazolamide|acetazolamide|mesh-list
14097657|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14097658|NCT02427880|Diuretics|diuretics|mesh-ancestor
13924590|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13924591|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
13924592|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924593|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924594|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
13924595|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924596|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924597|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
13924598|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924599|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924600|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13924601|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13924602|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13924603|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924604|NCT03417388|Aspirin|aspirin|mesh-list
13924605|NCT03417388|Losartan|losartan|mesh-list
13924606|NCT03417388|Lisinopril|lisinopril|mesh-list
13924607|NCT03417388|Atorvastatin|atorvastatin|mesh-list
13924608|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13924609|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13924610|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13924611|NCT03417388|Analgesics|analgesics|mesh-ancestor
13924612|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
13924613|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924614|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924615|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924616|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13924617|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13924618|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13924619|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924620|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14097659|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
14097660|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097661|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14097662|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097663|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097664|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14097665|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
14097666|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14097667|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097668|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14097669|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13924621|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13924622|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924623|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
13924624|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13924625|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13924626|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
13924627|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13924628|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13924629|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13924630|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13924631|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14097670|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097671|NCT02427295|Octreotide|octreotide|mesh-list
14097672|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14097673|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097674|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097675|NCT02427334|Dienogest|dienogest|mesh-list
14097676|NCT02427334|Fluoxetine|fluoxetine|mesh-list
14097677|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14097678|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14097679|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097680|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097681|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097682|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
14097683|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097684|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14097685|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
14097686|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14097687|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14097688|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14097689|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097690|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14097691|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
14097692|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14097693|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14097694|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14097695|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14097696|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14097697|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
14097698|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924632|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13924633|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13924634|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
13924635|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13924636|NCT03417388|Protective Agents|protective agents|mesh-ancestor
13924637|NCT03417284|Melphalan|melphalan|mesh-list
13924638|NCT03417284|Lenograstim|lenograstim|mesh-list
13924639|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13924640|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
13924641|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924642|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13924643|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
13924644|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924645|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924646|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13924647|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924648|NCT03417206|Remifentanil|remifentanil|mesh-list
13924649|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13924650|NCT03417206|Narcotics|narcotics|mesh-ancestor
13924651|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924652|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924653|NCT03417206|Analgesics|analgesics|mesh-ancestor
13924654|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
13924655|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924656|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
13924657|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13924658|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924659|NCT03417037|Nivolumab|nivolumab|mesh-list
13924660|NCT03417037|Linrodostat|linrodostat|mesh-list
13924661|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13924662|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097699|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097700|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097701|NCT02427308|Miltefosine|miltefosine|mesh-list
14097702|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
14477566|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14477567|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
13924663|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13924664|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924665|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924666|NCT03416777|Tocopherols|tocopherols|mesh-list
13924667|NCT03416777|Vitamin E|vitamin e|mesh-list
13924668|NCT03416777|Tocotrienols|tocotrienols|mesh-list
13924669|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
13924670|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
13960685|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14097703|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097704|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097705|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14097706|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14097707|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
14097708|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14097709|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14097710|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097711|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
14097712|NCT02427412|Coagulants|coagulants|mesh-ancestor
14097713|NCT02427386|Estradiol|estradiol|mesh-list
14097714|NCT02427386|Estrogens|estrogens|mesh-list
14097715|NCT02427386|Hormones|hormones|mesh-ancestor
14097716|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097717|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097718|NCT02427165|Albuterol|albuterol|mesh-list
14097719|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14097720|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
14097721|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097722|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097723|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14097724|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
14097725|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
14097726|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14097727|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14097728|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14097729|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14097730|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097731|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097732|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097733|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14097734|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
14097735|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097736|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
14097737|NCT02426840|Vitamin D|vitamin d|mesh-list
14097738|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
14097739|NCT02426840|Vitamins|vitamins|mesh-list
14097740|NCT02426840|Calcium|calcium|mesh-list
14097741|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
14097742|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097743|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14097744|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14097745|NCT02426905|Trientine|trientine|mesh-list
14097746|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
14097747|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
14097748|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097749|NCT02426866|Efavirenz|efavirenz|mesh-list
14097750|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14097751|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14097752|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097753|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761139|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761140|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761141|NCT03924856|Gemcitabine|gemcitabine|mesh-list
14761142|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
14761143|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097754|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
14097755|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097756|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14097757|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14097758|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14097759|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14097760|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14097761|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14097762|NCT02426697|Fentanyl|fentanyl|mesh-list
14097763|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14097764|NCT02426697|Narcotics|narcotics|mesh-ancestor
14097765|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097766|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097767|NCT02426697|Analgesics|analgesics|mesh-ancestor
14097768|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
14097769|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097770|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14097771|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14097772|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
14097773|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
14097774|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
14097775|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
14097776|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
14097777|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14097778|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14097779|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097780|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097781|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097782|NCT02426723|Dexamethasone|dexamethasone|mesh-list
14097783|NCT02426723|Lenalidomide|lenalidomide|mesh-list
14097784|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097785|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
14097786|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
14097787|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097788|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097789|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14097790|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
14097791|NCT02426723|Hormones|hormones|mesh-ancestor
14097792|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097793|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097794|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097795|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
14097796|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14097797|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14097798|NCT02426723|Growth Substances|growth substances|mesh-ancestor
14097799|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14097800|NCT02426736|Dexamethasone|dexamethasone|mesh-list
14097801|NCT02426736|Bupivacaine|bupivacaine|mesh-list
14097802|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097803|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
14097804|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
14097805|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097806|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097807|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14097808|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
14097809|NCT02426736|Hormones|hormones|mesh-ancestor
14097810|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097811|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097812|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097813|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
14097814|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
14097815|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097816|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
14097817|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14097818|NCT02426619|Fluorides|fluorides|mesh-list
14097819|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
14097820|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
14097821|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
14097822|NCT02426619|Protective Agents|protective agents|mesh-ancestor
14097823|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097824|NCT02426502|Cyclosporine|cyclosporine|mesh-list
14097825|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
14761144|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761145|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
14761146|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097826|NCT02426502|Prednisone|prednisone|mesh-list
14097827|NCT02426502|Azathioprine|azathioprine|mesh-list
14097828|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
14097829|NCT02426502|Cyclosporins|cyclosporins|mesh-list
14097830|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097831|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
14097832|NCT02426502|Hormones|hormones|mesh-ancestor
14097833|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097834|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097835|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14097836|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097837|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097838|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097839|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097840|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
14097841|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
14761147|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
14097842|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761148|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097843|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
14097844|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14097845|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14097846|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14097847|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14097848|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
14097849|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14097850|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
14097851|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13924671|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924672|NCT03416777|Protective Agents|protective agents|mesh-ancestor
13924673|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924674|NCT03416777|Vitamins|vitamins|mesh-ancestor
13924675|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
13924676|NCT03416569|Prazosin|prazosin|mesh-list
13924677|NCT03416569|Nicotine|nicotine|mesh-list
13924678|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14097852|NCT02426281|Gemcitabine|gemcitabine|mesh-list
14097853|NCT02426281|Paclitaxel|paclitaxel|mesh-list
14097854|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14097855|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097856|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14097857|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
14097858|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14097859|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924679|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
13924680|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924681|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924682|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13924683|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13924684|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
13924685|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924686|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924687|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13924688|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13924689|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13924690|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13924691|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
13924692|NCT03416517|Irinotecan|irinotecan|mesh-list
13924693|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13924694|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13924695|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924696|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924697|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924698|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
13924699|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
13924700|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924701|NCT03416374|Dexamethasone|dexamethasone|mesh-list
13924702|NCT03416374|Lenalidomide|lenalidomide|mesh-list
13924703|NCT03416374|Bortezomib|bortezomib|mesh-list
13924704|NCT03416374|Ixazomib|ixazomib|mesh-list
13924705|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924706|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
13924707|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
13924708|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924709|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924710|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13924711|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
13924712|NCT03416374|Hormones|hormones|mesh-ancestor
13924713|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924714|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13924715|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924716|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
13924717|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13924718|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14097860|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14097861|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
14097862|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
14097863|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14097864|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097865|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097866|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
14097867|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097868|NCT02426463|Oxycodone|oxycodone|mesh-list
13924719|NCT03416374|Growth Substances|growth substances|mesh-ancestor
14097869|NCT02426463|Propofol|propofol|mesh-list
14097870|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13924720|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
13924721|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
13924722|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924723|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924724|NCT03416361|Vitamin D|vitamin d|mesh-list
13924725|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
13924726|NCT03416361|Vitamins|vitamins|mesh-ancestor
13924727|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
13924728|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097871|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097872|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097873|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14097874|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
13924729|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13924730|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13924731|NCT03416348|Ethanol|ethanol|mesh-list
13924732|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13924733|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924734|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924735|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924736|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
13924737|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13924738|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924739|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13924740|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924741|NCT03416231|Docetaxel|docetaxel|mesh-list
13924742|NCT03416231|Apatinib|apatinib|mesh-list
13924743|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924744|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
13924745|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
13924746|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
13924747|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924748|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924749|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960686|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
13960687|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13960688|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14097875|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
14097876|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14097877|NCT02426463|Narcotics|narcotics|mesh-ancestor
14097878|NCT02426463|Analgesics|analgesics|mesh-ancestor
14097879|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
14097880|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960689|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13960690|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13960691|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13960692|NCT03152955|Narcotics|narcotics|mesh-ancestor
13960693|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13960694|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
13960695|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14097881|NCT02426294|Pioglitazone|pioglitazone|mesh-list
14097882|NCT02426294|Glimepiride|glimepiride|mesh-list
14097883|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14097884|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097885|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14097886|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097887|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
14097888|NCT02426450|Leucovorin|leucovorin|mesh-list
14097889|NCT02426450|Fluorouracil|fluorouracil|mesh-list
14097890|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
14097891|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
14097892|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097893|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14097894|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097895|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14097896|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
14097897|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097898|NCT02426450|Antidotes|antidotes|mesh-ancestor
14097899|NCT02426450|Protective Agents|protective agents|mesh-ancestor
14097900|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
14097901|NCT02426450|Vitamins|vitamins|mesh-ancestor
13960696|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
13960697|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960698|NCT03152565|Avelumab|avelumab|mesh-list
14097902|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
14097903|NCT02426229|Dabigatran|dabigatran|mesh-list
14097904|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
14097905|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14097906|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
14097907|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097908|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097909|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
14097910|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
14097911|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097912|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14097913|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14097914|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097915|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
14097916|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097917|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097918|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13924750|NCT03416062|Niacinamide|niacinamide|mesh-list
13924751|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
13924752|NCT03416062|Vitamins|vitamins|mesh-ancestor
13924753|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
13924754|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924755|NCT03415906|Valsartan|valsartan|mesh-list
13924756|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
13924757|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13924758|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13924759|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924760|NCT03415828|Ethanol|ethanol|mesh-list
13924761|NCT03415828|Prednisolone|prednisolone|mesh-list
13924762|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13924763|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
13924764|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13924765|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
13924766|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13924767|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
14097919|NCT02426177|Labetalol|labetalol|mesh-list
14097920|NCT02426177|Nifedipine|nifedipine|mesh-list
14097921|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13924768|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924769|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
13924770|NCT03415828|Hormones|hormones|mesh-ancestor
13924771|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924772|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924773|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13924774|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924775|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
13924776|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
13924777|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924778|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13924779|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13924780|NCT03415828|Protective Agents|protective agents|mesh-ancestor
13924781|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13924782|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924783|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924784|NCT03415802|Paclitaxel|paclitaxel|mesh-list
13924785|NCT03415802|Tegafur|tegafur|mesh-list
13924786|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13924787|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924788|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
13924789|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
13924790|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
13924791|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924792|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13924793|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
13924794|NCT03415763|Leucovorin|leucovorin|mesh-list
13924795|NCT03415763|Capecitabine|capecitabine|mesh-list
13924796|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
14097922|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14097923|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097924|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14097925|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097926|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
14097927|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
14761149|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924797|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13924798|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
13924799|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924800|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14097928|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14097929|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14097930|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14097931|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097932|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097933|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14761150|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761151|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
14761152|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761153|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761154|NCT03917472|Aflibercept|aflibercept|mesh-list
14761155|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14761156|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14761157|NCT03917472|Growth Substances|growth substances|mesh-ancestor
14761158|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761159|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
14761160|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761161|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
13924801|NCT03415763|Antidotes|antidotes|mesh-ancestor
14097934|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
14097935|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
14097936|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097937|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14097938|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14097939|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
14097940|NCT02426164|Epinephrine|epinephrine|mesh-list
14097941|NCT02426164|Morphine|morphine|mesh-list
14097942|NCT02426164|Bupivacaine|bupivacaine|mesh-list
14097943|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
14097944|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
13924802|NCT03415763|Protective Agents|protective agents|mesh-ancestor
13924803|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924804|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
13924805|NCT03415763|Vitamins|vitamins|mesh-ancestor
13924806|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
13924807|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
13924808|NCT03415750|Everolimus|everolimus|mesh-list
13924809|NCT03415750|Tacrolimus|tacrolimus|mesh-list
13924810|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924811|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
13924812|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924813|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13924814|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924815|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924816|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924817|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14097945|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14097946|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097947|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
14097948|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14097949|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14097950|NCT02426164|Narcotics|narcotics|mesh-ancestor
14097951|NCT02426164|Analgesics|analgesics|mesh-ancestor
14935877|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14097952|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097953|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
13924818|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14097954|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
14097955|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14097956|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
14097957|NCT02426164|Hormones|hormones|mesh-ancestor
14097958|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097959|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14097960|NCT02426164|Protective Agents|protective agents|mesh-ancestor
14097961|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14097962|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14097963|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
14097964|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14097965|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097966|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14097967|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14097968|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14097969|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
14097970|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
14097971|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
14097972|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14097973|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
14097974|NCT02426099|Spironolactone|spironolactone|mesh-list
14097975|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14097976|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
14097977|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14097978|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097979|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14097980|NCT02426099|Diuretics|diuretics|mesh-ancestor
14097981|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
14097982|NCT02426060|Warfarin|warfarin|mesh-list
14097983|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
14097984|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14097985|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
14097986|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14097987|NCT02426008|Mitogens|mitogens|mesh-list
14097988|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14097989|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14097990|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
13924819|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
13924820|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13924821|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924822|NCT03415711|Mesalamine|mesalamine|mesh-list
13924823|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13924824|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13924825|NCT03415711|Analgesics|analgesics|mesh-ancestor
13924826|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
13924827|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924828|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924829|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097991|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14097992|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14097993|NCT02425813|Prednisolone|prednisolone|mesh-list
14097994|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
14097995|NCT02425813|Budesonide|budesonide|mesh-list
14097996|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14097997|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
14097998|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14097999|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
14098000|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
14098001|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098002|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098003|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098004|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
14098005|NCT02425813|Hormones|hormones|mesh-ancestor
14098006|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098007|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14098008|NCT02425813|Protective Agents|protective agents|mesh-ancestor
14098009|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14098010|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098011|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13924830|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13924831|NCT03415646|Morphine|morphine|mesh-list
14098012|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14098013|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
14174680|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174681|NCT04783935|Cladribine|cladribine|mesh-list
14174682|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924832|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13924833|NCT03415646|Narcotics|narcotics|mesh-ancestor
14174683|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14174684|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
14098014|NCT02425852|Prednisolone|prednisolone|mesh-list
14098015|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
13924834|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924835|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924836|NCT03415646|Analgesics|analgesics|mesh-ancestor
13924837|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
13924838|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924839|NCT03415594|Glucagon|glucagon|mesh-list
13924840|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13924841|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13924842|NCT03415594|Hormones|hormones|mesh-ancestor
13960699|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14098016|NCT02425852|Azathioprine|azathioprine|mesh-list
14098017|NCT02425852|Infliximab|infliximab|mesh-list
14098018|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098019|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
14098020|NCT02425852|Hormones|hormones|mesh-ancestor
14098021|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098022|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098023|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14098024|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098025|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098026|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14098027|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098028|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
14098029|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098030|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098031|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098032|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
14098033|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
14098034|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14098035|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
14098036|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14098037|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098038|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14098039|NCT02425722|Linaclotide|linaclotide|mesh-list
14098040|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14098041|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
14098042|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098043|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098044|NCT02425774|Prucalopride|prucalopride|mesh-list
14098045|NCT02425774|Laxatives|laxatives|mesh-ancestor
14098046|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098047|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14098048|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14098049|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
14098050|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098051|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098052|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098053|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
14098054|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098055|NCT02425943|Mannitol|mannitol|mesh-list
14098056|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14098057|NCT02425943|Diuretics|diuretics|mesh-ancestor
14098058|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
14098059|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098060|NCT02425709|Diclofenac|diclofenac|mesh-list
14098061|NCT02425709|Tramadol|tramadol|mesh-list
14098062|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14098063|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098064|NCT02425709|Analgesics|analgesics|mesh-ancestor
14098065|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
14098066|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935878|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
13924843|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924844|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924845|NCT03415594|Incretins|incretins|mesh-ancestor
13924846|NCT03415555|Acetaminophen|acetaminophen|mesh-list
13924847|NCT03415555|Oxycodone|oxycodone|mesh-list
13924848|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924849|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924850|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13924851|NCT03415555|Analgesics|analgesics|mesh-ancestor
13924852|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
13924853|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924854|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
13924855|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13924856|NCT03415555|Narcotics|narcotics|mesh-ancestor
13924857|NCT03415477|Denosumab|denosumab|mesh-list
13924858|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13924859|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924860|NCT03415386|Anticoagulants|anticoagulants|mesh-list
13924861|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13924862|NCT03415269|Ambroxol|ambroxol|mesh-list
13924863|NCT03415269|Expectorants|expectorants|mesh-ancestor
13924864|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
13924865|NCT03415191|Ketamine|ketamine|mesh-list
13924866|NCT03415191|Analgesics|analgesics|mesh-ancestor
13924867|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
13924868|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924869|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924870|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13924871|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13924872|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
13924873|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
13924874|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924875|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13924876|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13924877|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924878|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924879|NCT03415087|Fentanyl|fentanyl|mesh-list
13924880|NCT03415087|Bupivacaine|bupivacaine|mesh-list
13924881|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
13924882|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
13924883|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924884|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924885|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
13924886|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098067|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098068|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098069|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098070|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14098071|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098072|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098073|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14098074|NCT02425709|Narcotics|narcotics|mesh-ancestor
14098075|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098076|NCT02425566|Trimethaphan|trimethaphan|mesh-list
14098077|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
14098078|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
14098079|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
14098080|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14098081|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14098082|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14098083|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
14098084|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098085|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098086|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14098087|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14098088|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
14098089|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098090|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098091|NCT02425488|Coal Tar|coal tar|mesh-list
14098092|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
14935879|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13924887|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13924888|NCT03415087|Narcotics|narcotics|mesh-ancestor
13924889|NCT03415087|Analgesics|analgesics|mesh-ancestor
14477568|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13924890|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14098093|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
14098094|NCT02425605|Sorafenib|sorafenib|mesh-list
14098095|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098096|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14098097|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098098|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098099|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
13924891|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13924892|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
13924893|NCT03414931|Sertraline|sertraline|mesh-list
13924894|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
13924895|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13924896|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13924897|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14098100|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
14098101|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098102|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
14098103|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098104|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098105|NCT02426112|Azithromycin|azithromycin|mesh-list
14098106|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14098107|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098108|NCT02425865|Golimumab|golimumab|mesh-list
14098109|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14098110|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098111|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098112|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
14098113|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098114|NCT02425462|Dienogest|dienogest|mesh-list
14098115|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14098116|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
14098117|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14098118|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098119|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14098120|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14098121|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14098122|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14098123|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
14098124|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098125|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14098126|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098127|NCT02425501|Aflibercept|aflibercept|mesh-list
14098128|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14098129|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14098130|NCT02425501|Growth Substances|growth substances|mesh-ancestor
14098131|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098132|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
14098133|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098134|NCT02425241|Vaccines|vaccines|mesh-list
14098135|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
14098136|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098137|NCT02425137|Gemcitabine|gemcitabine|mesh-list
14098138|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098139|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
14098140|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098141|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098142|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
14098143|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098144|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924898|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13924899|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924900|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924901|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
13924902|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924903|NCT03414918|Clarithromycin|clarithromycin|mesh-list
13924904|NCT03414918|Roxithromycin|roxithromycin|mesh-list
13924905|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13924906|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13924907|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13924908|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924909|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924910|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13924911|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14098145|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13924912|NCT03414879|Lidocaine|lidocaine|mesh-list
13924913|NCT03414879|Ketamine|ketamine|mesh-list
13924914|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
14098146|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
14098147|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098148|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
14098149|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14098150|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14098151|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14098152|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14098153|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14098154|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098155|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
14098156|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098157|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098158|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14098159|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098160|NCT02425202|Ketamine|ketamine|mesh-list
14098161|NCT02425202|Analgesics|analgesics|mesh-ancestor
14098162|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
14098163|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098164|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098165|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14098166|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14098167|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
14098168|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
14098169|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098170|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14098171|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14098172|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098173|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098174|NCT02425254|Acetaminophen|acetaminophen|mesh-list
14098175|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098176|NCT02425254|Analgesics|analgesics|mesh-ancestor
14098177|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
14098178|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098179|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098180|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
14098181|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14098182|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14098183|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098184|NCT02424552|Vitamin D|vitamin d|mesh-list
14098185|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
14098186|NCT02424552|Vitamins|vitamins|mesh-ancestor
14098187|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
14098188|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098189|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14098190|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14098191|NCT02424695|Gabapentin|gabapentin|mesh-list
14098192|NCT02424695|Analgesics|analgesics|mesh-ancestor
14098193|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
14098194|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098195|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098196|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
14098197|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14098198|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14098199|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098200|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14098201|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13924915|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
13924916|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13924917|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924918|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
13924919|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924920|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13924921|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13924922|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13924923|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13924924|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924925|NCT03414879|Analgesics|analgesics|mesh-ancestor
13924926|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14098202|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14098203|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924927|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13924928|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
13924929|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13924930|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13924931|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13924932|NCT03414840|Atorvastatin|atorvastatin|mesh-list
13924933|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13924934|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13924935|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
13924936|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924937|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13924938|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13924939|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924940|NCT03414814|Osimertinib|osimertinib|mesh-list
13924941|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924942|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924943|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924944|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477569|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14477570|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14477571|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14477572|NCT02435901|Cyclosporine|cyclosporine|mesh-list
14477573|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
14098204|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098205|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
14098206|NCT02424318|Topiramate|topiramate|mesh-list
14098207|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
14098208|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14098209|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174685|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174686|NCT04783753|Itraconazole|itraconazole|mesh-list
14174687|NCT04783753|Quinidine|quinidine|mesh-list
14174688|NCT04783753|Carbamazepine|carbamazepine|mesh-list
14174689|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
14174690|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174691|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14174692|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14174693|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477574|NCT02435901|Fludarabine|fludarabine|mesh-list
14477575|NCT02435901|Melphalan|melphalan|mesh-list
14477576|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
14477577|NCT02435901|Tacrolimus|tacrolimus|mesh-list
14477578|NCT02435901|Cyclosporins|cyclosporins|mesh-list
13960700|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960701|NCT03152890|Insulin|insulin|mesh-list
13960702|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960703|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960704|NCT03152578|Capsaicin|capsaicin|mesh-list
14174694|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935880|NCT01465984|Acetaminophen|acetaminophen|mesh-list
14935881|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935882|NCT01465984|Analgesics|analgesics|mesh-ancestor
14174695|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14174696|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
14174697|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174698|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174699|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14174700|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
14174701|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
14477579|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477580|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477581|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098210|NCT02424214|Ionophores|ionophores|mesh-list
14098211|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14098212|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098213|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
14098214|NCT02424201|Misoprostol|misoprostol|mesh-list
14098215|NCT02424201|Vitamins|vitamins|mesh-ancestor
14098216|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
14098217|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098218|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14098219|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
14098220|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14098221|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14098222|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098223|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
14098224|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
13924955|NCT03414450|Dasatinib|dasatinib|mesh-list
13924956|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924957|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924958|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924959|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924960|NCT03414333|Hormones|hormones|mesh-list
13924961|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924962|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924963|NCT03414164|Procyanidin|procyanidin|mesh-list
13924964|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
14098225|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098226|NCT02424201|Protective Agents|protective agents|mesh-ancestor
14098227|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
14098228|NCT02424461|Ofloxacin|ofloxacin|mesh-list
14098229|NCT02424461|Levofloxacin|levofloxacin|mesh-list
14098230|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14098231|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098232|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14098233|NCT02424461|Renal Agents|renal agents|mesh-ancestor
14098234|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14098235|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14098236|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098237|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098238|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098239|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14098240|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14098241|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
14098242|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14098243|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14098244|NCT02424435|Prednisolone|prednisolone|mesh-list
14098245|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
14098246|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14098247|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
14098248|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098249|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
14098250|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
14098251|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174702|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14761162|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14761163|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14761164|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14761165|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761166|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761167|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
14761168|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761169|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761170|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14761171|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761172|NCT03899155|Nivolumab|nivolumab|mesh-list
14761173|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761174|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761175|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14098252|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098253|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098254|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
14098255|NCT02424435|Hormones|hormones|mesh-ancestor
14098256|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098257|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14098258|NCT02424435|Protective Agents|protective agents|mesh-ancestor
14098259|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14098260|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098261|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
14098262|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
14098263|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14098264|NCT02424136|Antibodies|antibodies|mesh-list
14098265|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
14098266|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098267|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14098268|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
14098269|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098270|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14098271|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
14098272|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14098273|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
14098274|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098275|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098276|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14098277|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
14098278|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
14098279|NCT02424136|Protective Agents|protective agents|mesh-ancestor
14098280|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
14098281|NCT02423928|Ipilimumab|ipilimumab|mesh-list
14098282|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935883|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
14935884|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935885|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935886|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
14935887|NCT01466101|Pregabalin|pregabalin|mesh-list
14935888|NCT01466101|Analgesics|analgesics|mesh-ancestor
14935889|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
14935890|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935891|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935892|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
14935893|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14935894|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14935895|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935896|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14935897|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14935898|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14935899|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14935900|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14935901|NCT01466114|Norethindrone|norethindrone|mesh-list
14935902|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
14935903|NCT01466114|Progestins|progestins|mesh-list
14935904|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14935905|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14935906|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14935907|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
14935908|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14935909|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098283|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
14098284|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935910|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13924965|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924966|NCT03414164|Protective Agents|protective agents|mesh-ancestor
13924967|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924968|NCT03414034|Prednisone|prednisone|mesh-list
13924969|NCT03414034|Onvansertib|onvansertib|mesh-list
13924970|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924971|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
13924972|NCT03414034|Hormones|hormones|mesh-ancestor
13924973|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13960705|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
14098285|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098286|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14098287|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
14098288|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098289|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098290|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14098291|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14098292|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14098293|NCT02424071|Melatonin|melatonin|mesh-list
14098294|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
14098295|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098296|NCT02424071|Protective Agents|protective agents|mesh-ancestor
14098297|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098298|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098299|NCT02423954|Sirolimus|sirolimus|mesh-list
14098300|NCT02423954|Capecitabine|capecitabine|mesh-list
14098301|NCT02423954|Nivolumab|nivolumab|mesh-list
14098302|NCT02423954|Irinotecan|irinotecan|mesh-list
14098303|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098304|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
14098305|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098306|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098307|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14098308|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14098309|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14098310|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14098311|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098312|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14098313|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098314|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14098315|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
14098316|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098317|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
14098318|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098319|NCT02423915|Vidarabine|vidarabine|mesh-list
14098320|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
13924974|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924975|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13924976|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098321|NCT02423915|Sirolimus|sirolimus|mesh-list
14098322|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
14098323|NCT02423915|Rituximab|rituximab|mesh-list
14098324|NCT02423915|Fludarabine|fludarabine|mesh-list
14098325|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
14098326|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098327|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
14098328|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098329|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098330|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14098331|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
14098332|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098333|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924977|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13924978|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13924979|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924980|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
13960706|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
14098334|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14098335|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761176|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767339|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924981|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13924982|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13924983|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13924984|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
14767340|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
14767341|NCT00629642|Oxybutynin|oxybutynin|mesh-list
14767342|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14767343|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14767344|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
14767345|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767346|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767347|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767348|NCT00629642|Urological Agents|urological agents|mesh-ancestor
13924985|NCT03413891|Coagulants|coagulants|mesh-ancestor
13924986|NCT03413800|Dexamethasone|dexamethasone|mesh-list
13924987|NCT03413800|Lenalidomide|lenalidomide|mesh-list
13924988|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13924989|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
13924990|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
13924991|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13924992|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13924993|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13924994|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
13924995|NCT03413800|Hormones|hormones|mesh-ancestor
13924996|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13924997|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13924998|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13924999|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
13925000|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13925001|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13925002|NCT03413800|Growth Substances|growth substances|mesh-ancestor
14098336|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098337|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
14098338|NCT02423915|Antiviral Agents|antiviral agents|mesh-ancestor
14098339|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098340|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14098341|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13925003|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14098342|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
14098343|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14098344|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098345|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
14098346|NCT02424045|Dexamethasone|dexamethasone|mesh-list
14098347|NCT02424045|Carboplatin|carboplatin|mesh-list
14098348|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14098349|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098350|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
14098351|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
14098352|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098353|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098354|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098355|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
14098356|NCT02424045|Hormones|hormones|mesh-ancestor
14098357|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098358|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14098359|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098360|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14098361|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
14098362|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098363|NCT02423837|Rituximab|rituximab|mesh-list
14098364|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14098365|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14098366|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098367|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
14098368|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098369|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098370|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14098371|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
14098372|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098373|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
14098374|NCT02423863|Nivolumab|nivolumab|mesh-list
14098375|NCT02423863|Durvalumab|durvalumab|mesh-list
14098376|NCT02423863|Cemiplimab|cemiplimab|mesh-list
13925004|NCT03413722|Everolimus|everolimus|mesh-list
13925005|NCT03413722|Tacrolimus|tacrolimus|mesh-list
13925006|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925007|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
13925008|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925009|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13925010|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925011|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925012|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925013|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
13925014|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925015|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925016|NCT03413436|Cisplatin|cisplatin|mesh-list
13925017|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925018|NCT03413410|Metoprolol|metoprolol|mesh-list
14761177|NCT03895203|Adalimumab|adalimumab|mesh-list
14761178|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761179|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761180|NCT03893617|Propranolol|propranolol|mesh-list
13925019|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13925020|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13925021|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
13925022|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
13925023|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098377|NCT02423863|Atezolizumab|atezolizumab|mesh-list
14098378|NCT02423863|Poly ICLC|poly iclc|mesh-list
13925024|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925025|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13925026|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13925027|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13925028|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
13925029|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925030|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925031|NCT03413371|Acetaminophen|acetaminophen|mesh-list
13925032|NCT03413371|Lidocaine|lidocaine|mesh-list
13925033|NCT03413371|Bupivacaine|bupivacaine|mesh-list
13925034|NCT03413371|Ropivacaine|ropivacaine|mesh-list
13925035|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
13925036|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
13925037|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098379|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14098380|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098381|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14098382|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098383|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
14098384|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
14098385|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098386|NCT02423811|Fursultiamin|fursultiamin|mesh-list
14098387|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
14098388|NCT02423811|Vitamins|vitamins|mesh-ancestor
14098389|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
14098390|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098391|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
14098392|NCT02423759|Gentamicins|gentamicins|mesh-list
13925038|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925039|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
13925040|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925041|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13925042|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13925043|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14098393|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14098394|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098395|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14098396|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14098397|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098398|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098399|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098400|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14098401|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14098402|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14098403|NCT02423694|Dexetimide|dexetimide|mesh-list
14761181|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13925044|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925045|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098404|NCT02423694|Citalopram|citalopram|mesh-list
13925046|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925047|NCT03413371|Analgesics|analgesics|mesh-ancestor
13925048|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
13925049|NCT03413358|Carboplatin|carboplatin|mesh-list
13925050|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925051|NCT03413319|Tilavonemab|tilavonemab|mesh-list
13925052|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
13925053|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
13925054|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13925055|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13925056|NCT03413202|Protective Agents|protective agents|mesh-ancestor
13925057|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925058|NCT03413150|Amiodarone|amiodarone|mesh-list
13925059|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13925060|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925061|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13925062|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925063|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925064|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13925065|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13925066|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13925067|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925068|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13925069|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13925070|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13960707|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
13960708|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960709|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960710|NCT03152877|Bupivacaine|bupivacaine|mesh-list
13960711|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
13960712|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
13960713|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960714|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960715|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
14098405|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14098406|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14098407|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14098408|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098409|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098410|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
14098411|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098412|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14098413|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
14098414|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14098415|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14098416|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14098417|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
14098418|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
14098419|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098420|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14098421|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14098422|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14098423|NCT02423590|Gemcitabine|gemcitabine|mesh-list
14098424|NCT02423590|Carboplatin|carboplatin|mesh-list
14098425|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098426|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098427|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
14098428|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098429|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
14098430|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098431|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098432|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098433|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
14098434|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098435|NCT02423642|Heparin|heparin|mesh-list
14098436|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
14098437|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098438|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14098439|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14098440|NCT02423603|Paclitaxel|paclitaxel|mesh-list
14761182|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13960716|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477582|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
14098441|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14098442|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098443|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14098444|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14098445|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14098446|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098447|NCT02423824|Liraglutide|liraglutide|mesh-list
14098448|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13925071|NCT03413059|Triamcinolone|triamcinolone|mesh-list
13925072|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13925073|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13925074|NCT03413059|Morphine|morphine|mesh-list
13925075|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13925076|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13925077|NCT03413059|Narcotics|narcotics|mesh-ancestor
13925078|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925079|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925080|NCT03413059|Analgesics|analgesics|mesh-ancestor
13925081|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
13925082|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925083|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13925084|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
13925085|NCT03413059|Hormones|hormones|mesh-ancestor
13925086|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13925087|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925088|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
13925089|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098449|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098450|NCT02423824|Incretins|incretins|mesh-ancestor
14098451|NCT02423824|Hormones|hormones|mesh-ancestor
14098452|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098453|NCT02423395|Orphenadrine|orphenadrine|mesh-list
14098454|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098455|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14098456|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14098457|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13925090|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925091|NCT03413020|Amoxicillin|amoxicillin|mesh-list
13925092|NCT03413020|Metronidazole|metronidazole|mesh-list
13925093|NCT03413020|Clarithromycin|clarithromycin|mesh-list
13925094|NCT03413020|Levofloxacin|levofloxacin|mesh-list
13925095|NCT03413020|Ofloxacin|ofloxacin|mesh-list
13925096|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
13925097|NCT03413020|Esomeprazole|esomeprazole|mesh-list
13925098|NCT03413020|Bismuth|bismuth|mesh-list
14098458|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14098459|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098460|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
14098461|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
14098462|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14098463|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14098464|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
14098465|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098466|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098467|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
14098468|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14098469|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098470|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
14098471|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098472|NCT02423265|Ranolazine|ranolazine|mesh-list
14098473|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14098474|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925099|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925100|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14761183|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
14761184|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761185|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925101|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925102|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14098475|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098476|NCT02423239|Gemcitabine|gemcitabine|mesh-list
14098477|NCT02423239|Paclitaxel|paclitaxel|mesh-list
14098478|NCT02423239|Sorafenib|sorafenib|mesh-list
14098479|NCT02423239|HU 211|hu 211|mesh-list
14098480|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14098481|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098482|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
14098483|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
14098484|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
14098485|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098486|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098487|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
14098488|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
14098489|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098490|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098491|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098492|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
14098493|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098494|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14098495|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14098496|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
14098497|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
14098498|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098499|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098500|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14098501|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14098502|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098503|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14098504|NCT02423239|Protective Agents|protective agents|mesh-ancestor
14098505|NCT02422784|Vitamin D|vitamin d|mesh-list
14098506|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
14098507|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
14098508|NCT02422784|Vitamins|vitamins|mesh-list
14098509|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
14098510|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098511|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14098512|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14098513|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
14098514|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14098515|NCT02422836|Protective Agents|protective agents|mesh-ancestor
14098516|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098517|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
14098518|NCT02422901|Ascorbic Acid|ascorbic acid|mesh-list
14098519|NCT02422901|Vitamins|vitamins|mesh-ancestor
14098520|NCT02422901|Micronutrients|micronutrients|mesh-ancestor
14098521|NCT02422901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098522|NCT02422901|Antioxidants|antioxidants|mesh-ancestor
14098523|NCT02422901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098524|NCT02422901|Protective Agents|protective agents|mesh-ancestor
14098525|NCT02422966|Acetaminophen|acetaminophen|mesh-list
14098526|NCT02422966|Ibuprofen|ibuprofen|mesh-list
14098527|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098528|NCT02422966|Analgesics|analgesics|mesh-ancestor
14098529|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
14098530|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761186|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925103|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13925104|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13925105|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13925106|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13925107|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925108|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13925109|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13925110|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13925111|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13925112|NCT03413020|Renal Agents|renal agents|mesh-ancestor
13925113|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13925114|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14098531|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098532|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
13925115|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925116|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13925117|NCT03413020|Antacids|antacids|mesh-ancestor
13925118|NCT03413020|Diuretics|diuretics|mesh-ancestor
13925119|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
13925120|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925121|NCT03413020|Expectorants|expectorants|mesh-ancestor
13925122|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
13925123|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
13925124|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
13925125|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925126|NCT03412994|Apatinib|apatinib|mesh-list
13925127|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925128|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13925129|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935911|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13925130|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925131|NCT03412773|Sorafenib|sorafenib|mesh-list
13925132|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925133|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13925134|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925135|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925136|NCT03412721|Analgesics|analgesics|mesh-list
13925137|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
13925138|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098533|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14098534|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098535|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098536|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14098537|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098538|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098539|NCT02422953|Micronutrients|micronutrients|mesh-list
14098540|NCT02422953|Trace Elements|trace elements|mesh-list
14098541|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098542|NCT02422888|Ticagrelor|ticagrelor|mesh-list
14098543|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14098544|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14098545|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14098546|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14098547|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14098548|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
14098549|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098550|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098551|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098552|NCT02422823|Epinephrine|epinephrine|mesh-list
14098553|NCT02422823|Carticaine|carticaine|mesh-list
14098554|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14098555|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14098556|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
14098557|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098558|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098559|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098560|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14098561|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14098562|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
14098563|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098564|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14098565|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
14098566|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
14098567|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
14098568|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14098569|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
14935912|NCT01466114|Hormones|hormones|mesh-ancestor
14098570|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
13925139|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925140|NCT03412682|Budesonide|budesonide|mesh-list
13925141|NCT03412682|Mesalamine|mesalamine|mesh-list
13925142|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13925143|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13925144|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
13925145|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925146|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925147|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13925148|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
13925149|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
13925150|NCT03412682|Hormones|hormones|mesh-ancestor
13925151|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13925152|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13925153|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098571|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098572|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
14098573|NCT02423096|Haloperidol|haloperidol|mesh-list
14098574|NCT02423096|Olanzapine|olanzapine|mesh-list
14098575|NCT02423096|Risperidone|risperidone|mesh-list
14098576|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14098577|NCT02423096|Sulpiride|sulpiride|mesh-list
14098578|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14098579|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
14098580|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098581|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098582|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098583|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14098584|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14098585|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098586|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14098587|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14098588|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
14098589|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
14098590|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
14098591|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098592|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098593|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14098594|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14098595|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14098596|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
14098597|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14098598|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14098599|NCT02423018|Pregabalin|pregabalin|mesh-list
14098600|NCT02423018|Analgesics|analgesics|mesh-ancestor
14098601|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
14098602|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098603|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098604|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
14098605|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14098606|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14098607|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098608|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14098609|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14098610|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14098611|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098612|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14098613|NCT02423083|Guanabenz|guanabenz|mesh-list
14098614|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14098615|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14098616|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14098617|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14098618|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
14098619|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098620|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098621|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098622|NCT02422563|Paclitaxel|paclitaxel|mesh-list
14098623|NCT02422563|Carboplatin|carboplatin|mesh-list
14098624|NCT02422563|Ifosfamide|ifosfamide|mesh-list
13925154|NCT03412682|Analgesics|analgesics|mesh-ancestor
13925155|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
13925156|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13925157|NCT03412591|Suvorexant|suvorexant|mesh-list
14098625|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13925158|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13925159|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13925160|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925161|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925162|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13925163|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925164|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925165|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
13925166|NCT03412552|Analgesics|analgesics|mesh-ancestor
13925167|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
13925168|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925169|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925170|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
13925171|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925172|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13925173|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
13925174|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14098626|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098627|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14098628|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14098629|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14098630|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098631|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14098632|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
14098633|NCT02422706|Metronidazole|metronidazole|mesh-list
14098634|NCT02422706|Clarithromycin|clarithromycin|mesh-list
14098635|NCT02422706|Levofloxacin|levofloxacin|mesh-list
14098636|NCT02422706|Ofloxacin|ofloxacin|mesh-list
14098637|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
14098638|NCT02422706|Doxycycline|doxycycline|mesh-list
14098639|NCT02422706|Omeprazole|omeprazole|mesh-list
14098640|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098641|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14098642|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14098643|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14098644|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14098645|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098646|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14098647|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098648|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098649|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13925175|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925176|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925177|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13925178|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
13925179|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13925180|NCT03412526|Fludarabine|fludarabine|mesh-list
13925181|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925182|NCT03412513|Mirabegron|mirabegron|mesh-list
13925183|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13925184|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13925185|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13925186|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
13925187|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925188|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925189|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925190|NCT03412513|Urological Agents|urological agents|mesh-ancestor
13925191|NCT03412500|Vancomycin|vancomycin|mesh-list
13925192|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13925193|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925194|NCT03412474|Acetaminophen|acetaminophen|mesh-list
13925195|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
13925196|NCT03412474|Bupivacaine|bupivacaine|mesh-list
13925197|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
13925198|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
13925199|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925200|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925201|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
13925202|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925203|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14098650|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14098651|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13925204|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098652|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14098653|NCT02422706|Renal Agents|renal agents|mesh-ancestor
13925205|NCT03412474|Analgesics|analgesics|mesh-ancestor
13925206|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13925207|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14761187|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14761188|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14761189|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
14761190|NCT03879135|Factor VIII|factor viii|mesh-list
14761191|NCT03879135|Coagulants|coagulants|mesh-ancestor
14761192|NCT03875664|Bupivacaine|bupivacaine|mesh-list
14761193|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
14761194|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
14761195|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14761196|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761197|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
14761198|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925208|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13925209|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
13925210|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925211|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925212|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
13925213|NCT03412409|Cytarabine|cytarabine|mesh-list
13925214|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
13925215|NCT03412409|Busulfan|busulfan|mesh-list
13925216|NCT03412409|Semustine|semustine|mesh-list
13925217|NCT03412409|Fludarabine|fludarabine|mesh-list
13925218|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13925219|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925220|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
13925221|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925222|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13925223|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13925224|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
13925225|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925226|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925227|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13925228|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13925229|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
13925230|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
13925231|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098654|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14098655|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14098656|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098657|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14098658|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
14098659|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14098660|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13925232|NCT03412305|Amoxicillin|amoxicillin|mesh-list
13925233|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13925234|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925235|NCT03412071|Metronidazole|metronidazole|mesh-list
13925236|NCT03412071|Clindamycin|clindamycin|mesh-list
13925237|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
13925238|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
13925239|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13925240|NCT03412071|Tinidazole|tinidazole|mesh-list
13925241|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925242|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13925243|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13925244|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13925245|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13925246|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925247|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925248|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13925249|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
13925250|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13925251|NCT03412006|Fulacimstat|fulacimstat|mesh-list
13925252|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925253|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925254|NCT03411967|Docetaxel|docetaxel|mesh-list
13925255|NCT03411967|Apatinib|apatinib|mesh-list
14098661|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098662|NCT02422485|Analgesics|analgesics|mesh-ancestor
14761199|NCT03874715|Insulin|insulin|mesh-list
13925256|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925257|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
13925258|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
13925259|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
13960717|NCT03152370|Leucovorin|leucovorin|mesh-list
14761200|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14098663|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
14098664|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098665|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098666|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098667|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14174703|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174704|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14174705|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14174706|NCT04783753|Analgesics|analgesics|mesh-ancestor
14174707|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
14174708|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174709|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14174710|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174711|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14174712|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13925260|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925261|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13925262|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925263|NCT03411941|Aflibercept|aflibercept|mesh-list
13925264|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13925265|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13925266|NCT03411941|Growth Substances|growth substances|mesh-ancestor
13925267|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925268|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
13925269|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925270|NCT03411850|Abatacept|abatacept|mesh-list
13925271|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13925272|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925273|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174713|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14174714|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14174715|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
14174716|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174717|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14174718|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
14174719|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14174720|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14174721|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14174722|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14174723|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
14174724|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14174725|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14174726|NCT04783636|Leuprolide|leuprolide|mesh-list
14174727|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14174728|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
14174729|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14174730|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174731|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14174732|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174733|NCT04783610|Ethanol|ethanol|mesh-list
14174734|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14174735|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174736|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174737|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925274|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925275|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
13925276|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925277|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13925278|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
13925279|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
13925280|NCT03411798|Methotrexate|methotrexate|mesh-list
13925281|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14174738|NCT04783194|Dexamethasone|dexamethasone|mesh-list
14174739|NCT04783194|Bupivacaine|bupivacaine|mesh-list
14174740|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14174741|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
14174742|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
14174743|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174744|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174745|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174746|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
13925282|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
14174747|NCT04783194|Hormones|hormones|mesh-ancestor
14938698|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960718|NCT03152370|Folic Acid|folic acid|mesh-list
13925283|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13925284|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925285|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13925286|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
13925287|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925288|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925289|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
13925290|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925291|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13925292|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925293|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
13925294|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13925295|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13925296|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
13925297|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13925298|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13925299|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925300|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13925301|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925302|NCT03411798|Analgesics|analgesics|mesh-ancestor
14098668|NCT02422589|Ceritinib|ceritinib|mesh-list
14098669|NCT02422589|Midazolam|midazolam|mesh-list
14098670|NCT02422589|Warfarin|warfarin|mesh-list
13925303|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
13925304|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925305|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098671|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14098672|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14098673|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098674|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098675|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14098676|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14098677|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14098678|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14098679|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
13925306|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13925307|NCT03411551|Anesthetics|anesthetics|mesh-list
13925308|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925309|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098680|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
14098681|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
14098682|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
14098683|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098684|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098685|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
14098686|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098687|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13960719|NCT03152370|Capecitabine|capecitabine|mesh-list
13960720|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
13960721|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
13960722|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13960723|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
13960724|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960725|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960726|NCT03152370|Antidotes|antidotes|mesh-ancestor
13960727|NCT03152370|Protective Agents|protective agents|mesh-ancestor
13960728|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960729|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
13960730|NCT03152370|Vitamins|vitamins|mesh-ancestor
13960731|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
13960732|NCT03152370|Hematinics|hematinics|mesh-ancestor
13960733|NCT03152409|Aspirin|aspirin|mesh-list
13960734|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
13960735|NCT03152409|Salicylates|salicylates|mesh-list
13960736|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13960737|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13960738|NCT03152409|Analgesics|analgesics|mesh-ancestor
13960739|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
13960740|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960741|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960742|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960743|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098688|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960744|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13960745|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14098689|NCT02422498|Cisplatin|cisplatin|mesh-list
14098690|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098691|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
13925310|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
13925311|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925312|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925313|NCT03411434|Methylphenidate|methylphenidate|mesh-list
13925314|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13925315|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925316|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13925317|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13925318|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925319|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925320|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
13925321|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925322|NCT03411369|Vitamins|vitamins|mesh-list
14098692|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14098693|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
14098694|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14098695|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
14098696|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098697|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098698|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
14098699|NCT02422654|Eliglustat|eliglustat|mesh-list
14098700|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098701|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098702|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
14098703|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14098704|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14098705|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098706|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
14098707|NCT02422056|Coagulants|coagulants|mesh-ancestor
14098708|NCT02422199|Capecitabine|capecitabine|mesh-list
14098709|NCT02422199|Lapatinib|lapatinib|mesh-list
14098710|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098711|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
14098712|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098713|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098714|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14098715|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098716|NCT02422017|Timolol|timolol|mesh-list
14098717|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14098718|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14098719|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
14098720|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098721|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098722|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098723|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14098724|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14098725|NCT02422030|Atorvastatin|atorvastatin|mesh-list
14098726|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
14098727|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14098728|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14098729|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
14098730|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098731|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14098732|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14098733|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098734|NCT02422108|Denosumab|denosumab|mesh-list
14098735|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14098736|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098737|NCT02421913|Ketamine|ketamine|mesh-list
14098738|NCT02421913|Analgesics|analgesics|mesh-ancestor
14098739|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
14098740|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098741|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098742|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14098743|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14098744|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
14098745|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
14098746|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098747|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14098748|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14098749|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925323|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
14098750|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098751|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
14098752|NCT02421926|Dasatinib|dasatinib|mesh-list
14098753|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098754|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14098755|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098756|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098757|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
14098758|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
14098759|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14098760|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14098761|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098762|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098763|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098764|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098765|NCT02421640|Cisplatin|cisplatin|mesh-list
14098766|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098767|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
14098768|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14098769|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925324|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925325|NCT03411330|Lidocaine|lidocaine|mesh-list
13925326|NCT03411330|Bupivacaine|bupivacaine|mesh-list
13925327|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
13925328|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
13925329|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925330|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925331|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
13925332|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925333|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14098770|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14098771|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098772|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098773|NCT02422277|Urological Agents|urological agents|mesh-ancestor
14098774|NCT02422121|RNS60|rns60|mesh-list
14098775|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14098776|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098777|NCT02422121|Analgesics|analgesics|mesh-ancestor
14098778|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
14098779|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098780|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098781|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098782|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098783|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14098784|NCT02421289|Efavirenz|efavirenz|mesh-list
14098785|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14098786|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14098787|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098788|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098789|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
14098790|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098791|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14098792|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14098793|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13925334|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13925335|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13925336|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925337|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925338|NCT03411252|Mirabegron|mirabegron|mesh-list
13925339|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13925340|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13925341|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13925342|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
13925343|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925344|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925345|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925346|NCT03411252|Urological Agents|urological agents|mesh-ancestor
13925347|NCT03411161|Paclitaxel|paclitaxel|mesh-list
13925348|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14098794|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14098795|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14098796|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14098797|NCT02420938|Rituximab|rituximab|mesh-list
13925349|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13925350|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925351|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
13925352|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
13925353|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
13925354|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925355|NCT03411109|Hydromorphone|hydromorphone|mesh-list
13925356|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13925357|NCT03411109|Narcotics|narcotics|mesh-ancestor
13925358|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925359|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925360|NCT03411109|Analgesics|analgesics|mesh-ancestor
14098798|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14098799|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098800|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
14098801|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098802|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098803|NCT02421042|Lenvatinib|lenvatinib|mesh-list
14098804|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098805|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14098806|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098807|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098808|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14098809|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14098810|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14098811|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
14098812|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098813|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14098814|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14098815|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098816|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
14098817|NCT02421029|Edetic Acid|edetic acid|mesh-list
14098818|NCT02421029|Calcium|calcium|mesh-list
14098819|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
14098820|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14098821|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098822|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14098823|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
14098824|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14098825|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
14098826|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
14098827|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098828|NCT02421029|Antidotes|antidotes|mesh-ancestor
14098829|NCT02421029|Protective Agents|protective agents|mesh-ancestor
14098830|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14098831|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14098832|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14098833|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14098834|NCT02420834|Laxatives|laxatives|mesh-ancestor
14098835|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174748|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174749|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14174750|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174751|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
13925361|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
13925362|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925363|NCT03411096|Ropivacaine|ropivacaine|mesh-list
13925364|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
13925365|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
13925366|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925367|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925368|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
13925369|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925370|NCT03410901|Antibodies|antibodies|mesh-list
13925371|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
14174752|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
14174753|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174754|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
14174755|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
14174756|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174757|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
14174758|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
14174759|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14174760|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
13925372|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925373|NCT03410836|Lidocaine|lidocaine|mesh-list
13925374|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
13925375|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
13925376|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925377|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925378|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
13925379|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098836|NCT02420717|Leucovorin|leucovorin|mesh-list
14098837|NCT02420717|Cytarabine|cytarabine|mesh-list
14098838|NCT02420717|Dexamethasone|dexamethasone|mesh-list
14098839|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
14098840|NCT02420717|Prednisone|prednisone|mesh-list
14098841|NCT02420717|Cortisone|cortisone|mesh-list
14098842|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
14098843|NCT02420717|Rituximab|rituximab|mesh-list
14098844|NCT02420717|Doxorubicin|doxorubicin|mesh-list
13925380|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13925381|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13925382|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13925383|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925384|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925385|NCT03410784|Paclitaxel|paclitaxel|mesh-list
13925386|NCT03410784|Carboplatin|carboplatin|mesh-list
13925387|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
14098845|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14098846|NCT02420717|Methotrexate|methotrexate|mesh-list
14098847|NCT02420717|Vincristine|vincristine|mesh-list
14098848|NCT02420717|Daunorubicin|daunorubicin|mesh-list
14098849|NCT02420717|Dasatinib|dasatinib|mesh-list
14098850|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
14098851|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14098852|NCT02420717|Antibodies|antibodies|mesh-list
14098853|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
14098854|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14098855|NCT02420717|BB 1101|bb 1101|mesh-list
14098856|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14098857|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
14098858|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098859|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098860|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14098861|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
14098862|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098863|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098864|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14098865|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098866|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
14098867|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
14098868|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098869|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098870|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
14098871|NCT02420717|Hormones|hormones|mesh-ancestor
14098872|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098873|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14098874|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
14098875|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098876|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14098877|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13925388|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13925389|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925390|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
13925391|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
13925392|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
13925393|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925394|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925395|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13925396|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925397|NCT03410654|Tacrolimus|tacrolimus|mesh-list
13925398|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925399|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
13925400|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925401|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13925402|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098878|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14098879|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14098880|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
14098881|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14098882|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098883|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
13925403|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925404|NCT03410524|Simethicone|simethicone|mesh-list
13925405|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
13925406|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925407|NCT03410524|Emollients|emollients|mesh-ancestor
13925408|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
13925409|NCT03410511|Nicotine|nicotine|mesh-list
13925410|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13925411|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
13925412|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925413|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925414|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13925415|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13925416|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
13925417|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925418|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925419|NCT03410446|Ketamine|ketamine|mesh-list
13925420|NCT03410446|Analgesics|analgesics|mesh-ancestor
13925421|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
13925422|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925423|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925424|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14098884|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14098885|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14098886|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14098887|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
14098888|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098889|NCT02420717|Antidotes|antidotes|mesh-ancestor
14098890|NCT02420717|Protective Agents|protective agents|mesh-ancestor
14098891|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
14098892|NCT02420717|Vitamins|vitamins|mesh-ancestor
14098893|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
14098894|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14098895|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
14098896|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
14098897|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
14098898|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14098899|NCT02420665|Acetic Acid|acetic acid|mesh-list
14098900|NCT02420665|Proflavine|proflavine|mesh-list
14098901|NCT02420665|Retinol acetate|retinol acetate|mesh-list
14098902|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14098903|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098904|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14098905|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
14098906|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098907|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14098908|NCT02420665|Protective Agents|protective agents|mesh-ancestor
14098909|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098910|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14098911|NCT02420782|Itraconazole|itraconazole|mesh-list
14098912|NCT02420782|Midazolam|midazolam|mesh-list
14098913|NCT02420782|Pilocarpine|pilocarpine|mesh-list
14098914|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14098915|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14098916|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14098917|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098918|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14098919|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14098920|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14098921|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14098922|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
14098923|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
14098924|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
14098925|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
14098926|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14098927|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098928|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
14098929|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098930|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14098931|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14098932|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098933|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14098934|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
14098935|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14098936|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14098937|NCT02420782|Miotics|miotics|mesh-ancestor
14098938|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
14098939|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098940|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14098941|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14098942|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
14098943|NCT02420652|Aspirin|aspirin|mesh-list
14098944|NCT02420652|Metformin|metformin|mesh-list
14098945|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14098946|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098947|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14098948|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14098949|NCT02420652|Analgesics|analgesics|mesh-ancestor
14098950|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
14098951|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14098952|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098953|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14098954|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14098955|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14098956|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098957|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14098958|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14098959|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14098960|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
14098961|NCT02420509|Leucovorin|leucovorin|mesh-list
14098962|NCT02420509|Capecitabine|capecitabine|mesh-list
14098963|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14098964|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098965|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14098966|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
14098967|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098968|NCT02420509|Antidotes|antidotes|mesh-ancestor
14098969|NCT02420509|Protective Agents|protective agents|mesh-ancestor
14098970|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
14098971|NCT02420509|Vitamins|vitamins|mesh-ancestor
14098972|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
14098973|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14098974|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14098975|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14098976|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
14098977|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14098978|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14098979|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13925425|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13925426|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
13925427|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
13925428|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925429|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13925430|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13925431|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925432|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925433|NCT03410212|Ketorolac|ketorolac|mesh-list
13925434|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13925435|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13925436|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925437|NCT03410212|Analgesics|analgesics|mesh-ancestor
13925438|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
13925439|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925440|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925441|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14098980|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098981|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
14098982|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
14098983|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098984|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14098985|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
14098986|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14098987|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
14098988|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14098989|NCT02420418|Expectorants|expectorants|mesh-ancestor
14098990|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
14098991|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14098992|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
14098993|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925442|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13925443|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13925444|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925445|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925446|NCT03410043|Osimertinib|osimertinib|mesh-list
13925447|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925448|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13925449|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925450|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925451|NCT03409874|Diclofenac|diclofenac|mesh-list
13925452|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13925453|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925454|NCT03409874|Analgesics|analgesics|mesh-ancestor
13925455|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
13925456|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925457|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925458|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13925459|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13925460|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13925461|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925462|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925463|NCT03409848|Nivolumab|nivolumab|mesh-list
13925464|NCT03409848|Ipilimumab|ipilimumab|mesh-list
13925465|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925466|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925467|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13925468|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960746|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960747|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13960748|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13960749|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960750|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
13960751|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960752|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
13960753|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
13960754|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960755|NCT03152474|Vitamin A|vitamin a|mesh-list
13960756|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
13960757|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13960758|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13960759|NCT03152474|Prednisolone|prednisolone|mesh-list
13960760|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
14098994|NCT02420418|Protective Agents|protective agents|mesh-ancestor
14098995|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14098996|NCT02420418|Antidotes|antidotes|mesh-ancestor
14098997|NCT02420171|Insulin|insulin|mesh-list
14098998|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14098999|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099000|NCT02420132|Ranibizumab|ranibizumab|mesh-list
14099001|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14099002|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14099003|NCT02420132|Growth Substances|growth substances|mesh-ancestor
14099004|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099005|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14099006|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099007|NCT02420080|Brincidofovir|brincidofovir|mesh-list
14099008|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
14099009|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099010|NCT02419742|Paclitaxel|paclitaxel|mesh-list
14099011|NCT02419742|Docetaxel|docetaxel|mesh-list
14099012|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
14099013|NCT02419742|Carboplatin|carboplatin|mesh-list
14935913|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938699|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14938700|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938701|NCT01483274|Vaccines|vaccines|mesh-list
14938702|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
14938703|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938704|NCT01483300|Cisplatin|cisplatin|mesh-list
13960761|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14099014|NCT02419742|Doxorubicin|doxorubicin|mesh-list
13960762|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
14099015|NCT02419742|Trastuzumab|trastuzumab|mesh-list
14099016|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14099017|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938705|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938706|NCT01483365|Progesterone|progesterone|mesh-list
13925469|NCT03409835|Ramosetron|ramosetron|mesh-list
13925470|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
13925471|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
13925472|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925473|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925474|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13925475|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13925476|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
13925477|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925478|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925479|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13925480|NCT03409679|Murepavadin|murepavadin|mesh-list
13925481|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099018|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
14099019|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
14099020|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
13925482|NCT03409588|Riociguat|riociguat|mesh-list
13925483|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
13925484|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925485|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13925486|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13925487|NCT03409432|Lenalidomide|lenalidomide|mesh-list
13925488|NCT03409432|Antibodies|antibodies|mesh-list
13925489|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
13925490|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13925491|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
13925492|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
13925493|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925494|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925495|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13925496|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13925497|NCT03409432|Growth Substances|growth substances|mesh-ancestor
14099021|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099022|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099023|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
14099024|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099025|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099026|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099027|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
14099028|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13925498|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
13925499|NCT03409367|Emollients|emollients|mesh-list
13925500|NCT03409367|Petrolatum|petrolatum|mesh-list
13925501|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
14477583|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477584|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14477585|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925505|NCT03409250|Ranibizumab|ranibizumab|mesh-list
13925506|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13925507|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13925508|NCT03409250|Growth Substances|growth substances|mesh-ancestor
14099029|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14099030|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14099031|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14099032|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099033|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925509|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925510|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
13925511|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925512|NCT03409237|Mannitol|mannitol|mesh-list
13925513|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13925514|NCT03409237|Diuretics|diuretics|mesh-ancestor
13925515|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
13925516|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925517|NCT03409068|Anesthetics|anesthetics|mesh-list
13925518|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925519|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925520|NCT03408847|Beclomethasone|beclomethasone|mesh-list
13925521|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13925522|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
13925523|NCT03408847|Hormones|hormones|mesh-ancestor
13925524|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13925525|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925526|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13925527|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
13925528|NCT03408756|Methotrexate|methotrexate|mesh-list
13960763|NCT03152474|Vitamins|vitamins|mesh-ancestor
14099034|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
14099035|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14099036|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
14099037|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
14099038|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099039|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099040|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14099041|NCT02420002|Analgesics|analgesics|mesh-ancestor
14099042|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
14099043|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099044|NCT02419729|Estrogens|estrogens|mesh-list
14099045|NCT02419729|Hormones|hormones|mesh-ancestor
14099046|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099047|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099048|NCT02419651|Diclofenac|diclofenac|mesh-list
14099049|NCT02419651|Tramadol|tramadol|mesh-list
13925529|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13925530|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
13925531|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13925532|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925533|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13925534|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
13925535|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099050|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14099051|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14099052|NCT02419651|Analgesics|analgesics|mesh-ancestor
14099053|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
14099054|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099055|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099056|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099057|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099058|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14099059|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099060|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099061|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14099062|NCT02419651|Narcotics|narcotics|mesh-ancestor
14099063|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099064|NCT02419820|Aspirin|aspirin|mesh-list
14099065|NCT02419820|Clopidogrel|clopidogrel|mesh-list
14099066|NCT02419820|APD791|apd791|mesh-list
14099067|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14099068|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14099069|NCT02419820|Analgesics|analgesics|mesh-ancestor
14099070|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
14099071|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099072|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099073|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099074|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099075|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14099076|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14099077|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099078|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14099079|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14099080|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099081|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
14099082|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14099083|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14099084|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14099085|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
14099086|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099087|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14099088|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14099089|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
14099090|NCT02419534|Diltiazem|diltiazem|mesh-list
14099091|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14099092|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14099093|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14099094|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099095|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14099096|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925536|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925537|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14099097|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
14099098|NCT02419560|Venetoclax|venetoclax|mesh-list
14099099|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099100|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14099101|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
14099102|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099103|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
14099104|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099105|NCT02419443|Gabapentin|gabapentin|mesh-list
13925538|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925539|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13925540|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925541|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
13925542|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099106|NCT02419443|Analgesics|analgesics|mesh-ancestor
14099107|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
14099108|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099109|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099110|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
14099111|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14099112|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14099113|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099114|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14099115|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14099116|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14099117|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099118|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099119|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
14099120|NCT02419859|Insulin|insulin|mesh-list
14099121|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14099122|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14099123|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099124|NCT02419352|Atropine|atropine|mesh-list
14761201|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
14761202|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
14761203|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
13925543|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13925544|NCT03408587|Ipilimumab|ipilimumab|mesh-list
13925545|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925546|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925547|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13925548|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925549|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13925550|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925551|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13925552|NCT03408405|Hormones|hormones|mesh-ancestor
13925553|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13925554|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925555|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
13925556|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13925557|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
13925558|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925559|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
13925560|NCT03408145|Protective Agents|protective agents|mesh-ancestor
13960764|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
13960765|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960766|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960767|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
13960768|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
13960769|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960770|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13960771|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
13960772|NCT03152474|Hormones|hormones|mesh-ancestor
13960773|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13960774|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13960775|NCT03152474|Protective Agents|protective agents|mesh-ancestor
13960776|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13960777|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960778|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
13960779|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960780|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
13960781|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960782|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13960783|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099125|NCT02419352|Neostigmine|neostigmine|mesh-list
14099126|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14099127|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14767349|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
14761204|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14761205|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14761206|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761207|NCT03870919|Palbociclib|palbociclib|mesh-list
14761208|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761209|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13925561|NCT03408093|Interferons|interferons|mesh-list
14099128|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14099129|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
14099130|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099131|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099132|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14099133|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
14099134|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
14099135|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
14099136|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14099137|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14099138|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
14099139|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099140|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099141|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14099142|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099143|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14099144|NCT02419261|Analgesics|analgesics|mesh-list
14099145|NCT02419261|Ropivacaine|ropivacaine|mesh-list
14099146|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
14099147|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
14099148|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099149|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099150|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
14099151|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099152|NCT02419118|Dexamethasone|dexamethasone|mesh-list
14099153|NCT02419118|Lenalidomide|lenalidomide|mesh-list
14099154|NCT02419118|Daratumumab|daratumumab|mesh-list
14099155|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099156|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
14099157|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
14099158|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099159|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099160|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099161|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
14099162|NCT02419118|Hormones|hormones|mesh-ancestor
13925562|NCT03408093|Interferon-beta|interferon-beta|mesh-list
13925563|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
13925564|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925565|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
13925566|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925567|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
13925568|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925569|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13925570|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
13925571|NCT03408054|Oxytocin|oxytocin|mesh-list
13925572|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
13925573|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13925574|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925575|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925576|NCT03408015|Lifitegrast|lifitegrast|mesh-list
13925577|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13925578|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13925579|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
13925580|NCT03407976|Apatinib|apatinib|mesh-list
13925581|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925582|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925583|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13925584|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925585|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925586|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
13925587|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925588|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925589|NCT03407872|Esketamine|esketamine|mesh-list
13925590|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
13925591|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14099163|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13925592|NCT03407703|Grazoprevir|grazoprevir|mesh-list
13925593|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14099164|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761210|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925594|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
14099165|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099166|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
14099167|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14099168|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14099169|NCT02419118|Growth Substances|growth substances|mesh-ancestor
14099170|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
14099171|NCT02419040|Lidocaine|lidocaine|mesh-list
14099172|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
14099173|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
14099174|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099175|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925595|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925596|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
13925597|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
13925598|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
13925599|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13925600|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925601|NCT03407521|Isosorbide|isosorbide|mesh-list
13925602|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13925603|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13925604|NCT03407521|Misoprostol|misoprostol|mesh-list
13925605|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13925606|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
13925607|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13925608|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925609|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13925610|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13925611|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
13925612|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13925613|NCT03407521|Diuretics|diuretics|mesh-ancestor
13925614|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
13925615|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925616|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13925617|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925618|NCT03407404|Midazolam|midazolam|mesh-list
13925619|NCT03407404|Ketamine|ketamine|mesh-list
13925620|NCT03407404|Morphine|morphine|mesh-list
13925621|NCT03407404|Analgesics|analgesics|mesh-ancestor
13925622|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
14099176|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
14099177|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099178|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14099179|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14099180|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14099181|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14099182|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099183|NCT02419105|Vitamin D|vitamin d|mesh-list
14099184|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
14099185|NCT02419105|Testosterone|testosterone|mesh-list
14099186|NCT02419105|Vitamins|vitamins|mesh-ancestor
14099187|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
14099188|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099189|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14099190|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14099191|NCT02419105|Androgens|androgens|mesh-ancestor
14099192|NCT02419105|Hormones|hormones|mesh-ancestor
14099193|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099194|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
14099195|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099196|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
14099197|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099198|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099199|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099200|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
13925623|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960784|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
14174761|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14099201|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099202|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099203|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14099204|NCT02419235|Ethanol|ethanol|mesh-list
14099205|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14099206|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099207|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099208|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174762|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14174763|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174764|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14174765|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761211|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761212|NCT03869866|Vaccines|vaccines|mesh-list
14761213|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
14761214|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761215|NCT03854929|Azithromycin|azithromycin|mesh-list
14761216|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
14761217|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14761218|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761219|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14761220|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14761221|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925624|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174766|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174767|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14174768|NCT04783051|Renal Agents|renal agents|mesh-ancestor
14174769|NCT04782622|Apatinib|apatinib|mesh-list
14174770|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174771|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174772|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174773|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174774|NCT04782960|Bupivacaine|bupivacaine|mesh-list
14174775|NCT04782960|Anesthetics|anesthetics|mesh-list
14174776|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
14174777|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174778|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174779|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
14174780|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174781|NCT04782804|Capecitabine|capecitabine|mesh-list
14174782|NCT04782804|Antibodies|antibodies|mesh-list
14174783|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
14174784|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174785|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14174786|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
14174787|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174788|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184266|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14767350|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
13925625|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13925626|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13925627|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
13925628|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
13925629|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925630|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13925631|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13925632|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925633|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925634|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13925635|NCT03407404|Narcotics|narcotics|mesh-ancestor
13925636|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13925637|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13925638|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13925639|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13925640|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13925641|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
13925642|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
13925643|NCT03407300|Docetaxel|docetaxel|mesh-list
13925644|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925645|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
13925646|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
13925647|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
13925648|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925649|NCT03407209|Anesthetics|anesthetics|mesh-list
13925650|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
14099209|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
14099210|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14099211|NCT02418988|Estrogens|estrogens|mesh-ancestor
14099212|NCT02418988|Hormones|hormones|mesh-ancestor
14099213|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099214|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099215|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099216|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099217|NCT02418572|Testosterone|testosterone|mesh-list
14099218|NCT02418572|Androgens|androgens|mesh-ancestor
14099219|NCT02418572|Hormones|hormones|mesh-ancestor
14099220|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099221|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099222|NCT02418702|Ketamine|ketamine|mesh-list
14099223|NCT02418702|Analgesics|analgesics|mesh-ancestor
14099224|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
14099225|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099226|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099227|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14099228|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13925651|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925652|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925653|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
13925654|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925655|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
13925656|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13925657|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925658|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13925659|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925660|NCT03407105|Ipilimumab|ipilimumab|mesh-list
13925661|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925662|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925663|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13925664|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925665|NCT03407027|Triamcinolone|triamcinolone|mesh-list
14099229|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
14099230|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
14099231|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099232|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14099233|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13925666|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14099234|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099235|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099236|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14099237|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14099238|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14099239|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
14099240|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099241|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14099242|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14099243|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099244|NCT02418624|Carboplatin|carboplatin|mesh-list
14761222|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761223|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761224|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14761225|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14761226|NCT03851614|Durvalumab|durvalumab|mesh-list
14761227|NCT03851614|Olaparib|olaparib|mesh-list
14761228|NCT03851614|Cediranib|cediranib|mesh-list
14099245|NCT02418624|Olaparib|olaparib|mesh-list
14099246|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099247|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14099248|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099249|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099250|NCT02418533|Menotropins|menotropins|mesh-list
14099251|NCT02418533|Hormones|hormones|mesh-list
14099252|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14099253|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099254|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099255|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14761229|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761230|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099256|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
14099257|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14099258|NCT02418273|Denosumab|denosumab|mesh-list
14099259|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14099260|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099261|NCT02418130|Inositol|inositol|mesh-list
14099262|NCT02418130|Thiamine|thiamine|mesh-list
14099263|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14099264|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
14099265|NCT02418130|Vitamins|vitamins|mesh-ancestor
14099266|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
14099267|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099268|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14099269|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099270|NCT02417883|Furosemide|furosemide|mesh-list
14099271|NCT02417883|Diuretics|diuretics|mesh-ancestor
14099272|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
14099273|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099274|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14099275|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14099276|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099277|NCT02417896|Spironolactone|spironolactone|mesh-list
14099278|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14099279|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
14099280|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099281|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099282|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14099283|NCT02417896|Diuretics|diuretics|mesh-ancestor
14099284|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
14099285|NCT02418065|Testosterone|testosterone|mesh-list
14099286|NCT02418065|Androgens|androgens|mesh-ancestor
14099287|NCT02418065|Hormones|hormones|mesh-ancestor
14099288|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099289|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099290|NCT02418078|Anesthetics|anesthetics|mesh-list
14099291|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925667|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13925668|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13925669|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13925670|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
13925671|NCT03407027|Hormones|hormones|mesh-ancestor
13925672|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13925673|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925674|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761231|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14761232|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925675|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
13925676|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925677|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925678|NCT03406988|Nifedipine|nifedipine|mesh-list
14099292|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099293|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
14099294|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14099295|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
14099296|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099297|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
14099298|NCT02417610|Protective Agents|protective agents|mesh-ancestor
14099299|NCT02417506|Ibuprofen|ibuprofen|mesh-list
14099300|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14099301|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14099302|NCT02417506|Analgesics|analgesics|mesh-ancestor
14099303|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
14099304|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099305|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099306|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099307|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099308|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14099309|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099310|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099311|NCT02417493|Epinephrine|epinephrine|mesh-list
14099312|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14099313|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14099314|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14099315|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099316|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099317|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099318|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14099319|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14099320|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
14099321|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099322|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14099323|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
14099324|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
14099325|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
14099326|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14099327|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
14099328|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14099329|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
14099330|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099331|NCT02417467|Nicotine|nicotine|mesh-list
14099332|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14099333|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
14099334|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099335|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099336|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14099337|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14099338|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
14099339|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099340|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099341|NCT02417389|Alendronate|alendronate|mesh-list
14099342|NCT02417389|Cinacalcet|cinacalcet|mesh-list
14099343|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14099344|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099345|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14099346|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14099347|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
14174789|NCT04782388|Alprazolam|alprazolam|mesh-list
14477586|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
14477587|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477588|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14477589|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477590|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14477591|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14477592|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
14477593|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477594|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14477595|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
13925679|NCT03406988|Iloprost|iloprost|mesh-list
13925680|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13925681|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925682|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925683|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13925684|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925685|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925686|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
13925687|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13925688|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13925689|NCT03406936|Midazolam|midazolam|mesh-list
13925690|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13925691|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13925692|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925693|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925694|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13925695|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14099348|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099349|NCT02417090|Metformin|metformin|mesh-list
14099350|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14099351|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099352|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14099353|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14099354|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14099355|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099356|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099357|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14099358|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14099359|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935914|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
14935915|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
14935916|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
13925696|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13925697|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13925698|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
13925699|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
13925700|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
13925701|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
13925702|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925703|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925704|NCT03406871|Nivolumab|nivolumab|mesh-list
13925705|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925706|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925707|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13925708|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925709|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
13925710|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13925711|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925712|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925713|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
13925714|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925715|NCT03406832|Nitroprusside|nitroprusside|mesh-list
13925716|NCT03406832|Tirofiban|tirofiban|mesh-list
13925717|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13925718|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925719|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13925720|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925721|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14935917|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935918|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935919|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935920|NCT01466231|Everolimus|everolimus|mesh-list
14935921|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935922|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925722|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13925723|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13925724|NCT03406819|Nitroprusside|nitroprusside|mesh-list
13925725|NCT03406819|Tirofiban|tirofiban|mesh-list
13925726|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13925727|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925728|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13925729|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925730|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13925731|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13925732|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13925733|NCT03406793|Iron|iron|mesh-list
13925734|NCT03406793|Zinc|zinc|mesh-list
13925735|NCT03406793|Trace Elements|trace elements|mesh-ancestor
13925736|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
13925737|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925738|NCT03406689|Nepafenac|nepafenac|mesh-list
13925739|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
13925740|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13925741|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13925742|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13925743|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925744|NCT03406689|Analgesics|analgesics|mesh-ancestor
14099360|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
14099361|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099362|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14099363|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
13925745|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
13925746|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925747|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925748|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13925749|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13925750|NCT03406676|Methylene Blue|methylene blue|mesh-list
13925751|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925752|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925753|NCT03406650|Durvalumab|durvalumab|mesh-list
13925754|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925755|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099364|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14099365|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14099366|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
14099367|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099368|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
14099369|NCT02417116|Protective Agents|protective agents|mesh-ancestor
14099370|NCT02417298|Ketamine|ketamine|mesh-list
14767351|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099371|NCT02417298|Analgesics|analgesics|mesh-ancestor
14099372|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
14099373|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099374|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099375|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14099376|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14099377|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
14099378|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
14099379|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099380|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14099381|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14099382|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099383|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099384|NCT02417103|Liraglutide|liraglutide|mesh-list
14099385|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14099386|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099387|NCT02417103|Incretins|incretins|mesh-ancestor
14761233|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761234|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13925756|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
13925757|NCT03406546|Remifentanil|remifentanil|mesh-list
13925758|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13925759|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925760|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925761|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925762|NCT03406546|Analgesics|analgesics|mesh-ancestor
13925763|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
14099388|NCT02417103|Hormones|hormones|mesh-ancestor
14099389|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099390|NCT02417207|Entecavir|entecavir|mesh-list
14099391|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
14099392|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174790|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14174791|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174792|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174793|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14174794|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14174795|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14174796|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
14174797|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
14174798|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174799|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174800|NCT04782076|Dabigatran|dabigatran|mesh-list
14174801|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
14174802|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14174803|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
14174804|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174805|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174806|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
14174807|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14174808|NCT04782089|Antibodies|antibodies|mesh-list
14174809|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
14174810|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174811|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174812|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174813|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174814|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
14174815|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14174816|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174817|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14174818|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174819|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
14174820|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174821|NCT04782258|Tolvaptan|tolvaptan|mesh-list
13925764|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174822|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14174823|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174824|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
14174825|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174826|NCT04782037|Calcium|calcium|mesh-list
14174827|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14174828|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174829|NCT04782310|Pregabalin|pregabalin|mesh-list
14174830|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14174831|NCT04782310|Analgesics|analgesics|mesh-ancestor
14174832|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
14174833|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174834|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174835|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
14174836|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14174837|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174838|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174839|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14174840|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14174841|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14174842|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174843|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13925765|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13925766|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14099393|NCT02416999|Bevacizumab|bevacizumab|mesh-list
14099394|NCT02416999|Temozolomide|temozolomide|mesh-list
14099395|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14099396|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099397|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14099398|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14099399|NCT02416999|Growth Substances|growth substances|mesh-ancestor
14099400|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099401|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
14099402|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099403|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
13925767|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13925768|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
13925769|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925770|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925771|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13925772|NCT03406546|Narcotics|narcotics|mesh-ancestor
13925773|NCT03406533|Fentanyl|fentanyl|mesh-list
13925774|NCT03406533|Midazolam|midazolam|mesh-list
13925775|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
13925776|NCT03406533|Remifentanil|remifentanil|mesh-list
13925777|NCT03406533|Propofol|propofol|mesh-list
14099404|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099405|NCT02417337|Acetaminophen|acetaminophen|mesh-list
14099406|NCT02417337|Ibuprofen|ibuprofen|mesh-list
14099407|NCT02417337|Diclofenac|diclofenac|mesh-list
14099408|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
14099409|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14099410|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14099411|NCT02417337|Analgesics|analgesics|mesh-ancestor
14099412|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
14099413|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099414|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099415|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099416|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099417|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14099418|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099419|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099420|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
14099421|NCT02416817|Thrombin|thrombin|mesh-list
14099422|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
14099423|NCT02416817|Coagulants|coagulants|mesh-ancestor
14099424|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14099425|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
14099426|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099427|NCT02416752|Remifentanil|remifentanil|mesh-list
14099428|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14099429|NCT02416752|Narcotics|narcotics|mesh-ancestor
14099430|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099431|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099432|NCT02416752|Analgesics|analgesics|mesh-ancestor
14099433|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
14099434|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099435|NCT02416765|Glucagon|glucagon|mesh-list
14099436|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099437|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099438|NCT02416765|Hormones|hormones|mesh-ancestor
14099439|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099440|NCT02416804|Buprenorphine|buprenorphine|mesh-list
14099441|NCT02416804|Tramadol|tramadol|mesh-list
14099442|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14099443|NCT02416804|Narcotics|narcotics|mesh-ancestor
14099444|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099445|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099446|NCT02416804|Analgesics|analgesics|mesh-ancestor
14099447|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
14099448|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099449|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14099450|NCT02416687|Etonogestrel|etonogestrel|mesh-list
14099451|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14099452|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
14099453|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14099454|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925778|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14099455|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14099456|NCT02416869|Dexamethasone|dexamethasone|mesh-list
13925779|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099457|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
14099458|NCT02416869|BB 1101|bb 1101|mesh-list
14099459|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099460|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
14099461|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
14099462|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099463|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925780|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925781|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14477596|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14477597|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477598|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14477599|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14477600|NCT02435992|Ozanimod|ozanimod|mesh-list
14477601|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14477602|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477603|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477604|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
14477605|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477606|NCT02436031|Desipramine|desipramine|mesh-list
14477607|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14477608|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
14477609|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14477610|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477611|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925782|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
13925783|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
13925784|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925785|NCT03406533|Analgesics|analgesics|mesh-ancestor
13925786|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
14099464|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099465|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
14099466|NCT02416869|Hormones|hormones|mesh-ancestor
14099467|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099468|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099469|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099470|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
14099471|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099472|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925787|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925788|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13925789|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13925790|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13925791|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
13925792|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925793|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925794|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13925795|NCT03406533|Narcotics|narcotics|mesh-ancestor
13925796|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13925797|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13925798|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13925799|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13925800|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
13925801|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
14099473|NCT02416739|Niacinamide|niacinamide|mesh-list
14099474|NCT02416739|Niacin|niacin|mesh-list
13925802|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
13925803|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13925804|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925805|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
13925806|NCT03406507|Ravulizumab|ravulizumab|mesh-list
13925807|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
13925808|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925809|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
13925810|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960785|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960786|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960787|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14477612|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14477613|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14477614|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14477615|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477616|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960788|NCT03152175|Propranolol|propranolol|mesh-list
13960789|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14099475|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
14099476|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
14099477|NCT02416739|Vitamins|vitamins|mesh-ancestor
14099478|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
14099479|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099480|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14099481|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
14099482|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099483|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14099484|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
14099485|NCT02416583|Oxytocin|oxytocin|mesh-list
14099486|NCT02416583|Dinoprostone|dinoprostone|mesh-list
14099487|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
14099488|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14099489|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099490|NCT02416427|Atorvastatin|atorvastatin|mesh-list
14099491|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14099492|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14099493|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
14099494|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099495|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14099496|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14099497|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099498|NCT02416388|Cytarabine|cytarabine|mesh-list
14099499|NCT02416388|Cyclosporine|cyclosporine|mesh-list
14099500|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
14099501|NCT02416388|Dexamethasone|dexamethasone|mesh-list
14099502|NCT02416388|Methotrexate|methotrexate|mesh-list
14099503|NCT02416388|Daunorubicin|daunorubicin|mesh-list
14099504|NCT02416388|Venetoclax|venetoclax|mesh-list
14099505|NCT02416388|Idarubicin|idarubicin|mesh-list
14099506|NCT02416388|Cyclosporins|cyclosporins|mesh-list
14099507|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099508|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
14099509|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
13925811|NCT03406403|Anesthetics|anesthetics|mesh-list
13925812|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925813|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925814|NCT03406299|Leucovorin|leucovorin|mesh-list
13925815|NCT03406299|Gemcitabine|gemcitabine|mesh-list
13925816|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
13925817|NCT03406299|Tegafur|tegafur|mesh-list
13925818|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925819|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13925820|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
13925821|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925822|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
13925823|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099510|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099511|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099512|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099513|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
14099514|NCT02416388|Hormones|hormones|mesh-ancestor
14099515|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099516|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099517|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099518|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14099519|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
14099520|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14099521|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14099522|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
13925824|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925825|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13925826|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
13925827|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925828|NCT03406299|Antidotes|antidotes|mesh-ancestor
13925829|NCT03406299|Protective Agents|protective agents|mesh-ancestor
13925830|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
13925831|NCT03406299|Vitamins|vitamins|mesh-ancestor
14099523|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099524|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
14099525|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925832|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
14099526|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14099527|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099528|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
13925833|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
13925834|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
14099529|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099530|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14099531|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
14099532|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099533|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
14099534|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14099535|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14099536|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14099537|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14099538|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14099539|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
14099540|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14099541|NCT02416232|Trametinib|trametinib|mesh-list
14099542|NCT02416232|Dabrafenib|dabrafenib|mesh-list
14099543|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099544|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14099545|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099546|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099547|NCT02416271|Vitamin D|vitamin d|mesh-list
14099548|NCT02416271|Alendronate|alendronate|mesh-list
14099549|NCT02416271|Teriparatide|teriparatide|mesh-list
14099550|NCT02416271|Calcium|calcium|mesh-list
14099551|NCT02416271|Vitamins|vitamins|mesh-ancestor
14099552|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
14099553|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099554|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14099555|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14099556|NCT02416531|Clobetasol|clobetasol|mesh-list
14099557|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099558|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
14099559|NCT02416531|Hormones|hormones|mesh-ancestor
14099560|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099561|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099562|NCT02416258|Betamethasone|betamethasone|mesh-list
13925835|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
13925836|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13925837|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13925838|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925839|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925840|NCT03406169|Urological Agents|urological agents|mesh-ancestor
13925841|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13925842|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13925843|NCT03406169|Protective Agents|protective agents|mesh-ancestor
13925844|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925845|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13925846|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
13925847|NCT03406091|Plerixafor|plerixafor|mesh-list
13925848|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13925849|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13925850|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
13925851|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477617|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477618|NCT02436135|Idelalisib|idelalisib|mesh-list
14477619|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925855|NCT03405974|Aspirin|aspirin|mesh-list
13925856|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13925857|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13925858|NCT03405974|Analgesics|analgesics|mesh-ancestor
13925859|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
13925860|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13925861|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925862|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099563|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
14099564|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14099565|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
14099566|NCT02416258|Calcipotriene|calcipotriene|mesh-list
14099567|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14099568|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099569|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
14099570|NCT02416258|Hormones|hormones|mesh-ancestor
14099571|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099572|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099573|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14099574|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
14099575|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
14099576|NCT02416245|Micronutrients|micronutrients|mesh-list
13925863|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099577|NCT02416245|Trace Elements|trace elements|mesh-list
14184267|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761235|NCT03839823|Gemcitabine|gemcitabine|mesh-list
14761236|NCT03839823|Paclitaxel|paclitaxel|mesh-list
14761237|NCT03839823|Vinorelbine|vinorelbine|mesh-list
14761238|NCT03839823|Docetaxel|docetaxel|mesh-list
14761239|NCT03839823|Capecitabine|capecitabine|mesh-list
14761240|NCT03839823|Letrozole|letrozole|mesh-list
14761241|NCT03839823|Anastrozole|anastrozole|mesh-list
14761242|NCT03839823|Goserelin|goserelin|mesh-list
14761243|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14935923|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
14935924|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925864|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13925865|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13925866|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925867|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13925868|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13925869|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925870|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
13925871|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
13925872|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13925873|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13925874|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925875|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
13925876|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13925877|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925878|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13925879|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
13925880|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925881|NCT03405584|Amoxicillin|amoxicillin|mesh-list
13925882|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
13925883|NCT03405584|Esomeprazole|esomeprazole|mesh-list
13925884|NCT03405584|Bismuth|bismuth|mesh-list
13925885|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925886|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13925887|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925888|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13925889|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13925890|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13925891|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925892|NCT03405584|Antacids|antacids|mesh-ancestor
13925893|NCT03405584|Diuretics|diuretics|mesh-ancestor
13925894|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
13925895|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099578|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099579|NCT02416570|Clarithromycin|clarithromycin|mesh-list
14099580|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14099581|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099582|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14099583|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099584|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099585|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14099586|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14099587|NCT02416141|Tramadol|tramadol|mesh-list
14099588|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14099589|NCT02416141|Narcotics|narcotics|mesh-ancestor
14099590|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099591|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099592|NCT02416141|Analgesics|analgesics|mesh-ancestor
14099593|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
14099594|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099595|NCT02416167|Dotinurad|dotinurad|mesh-list
14099596|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
14099597|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
14099598|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099599|NCT02416167|Renal Agents|renal agents|mesh-ancestor
14099600|NCT02416115|Morphine|morphine|mesh-list
14099601|NCT02416115|Ramosetron|ramosetron|mesh-list
14099602|NCT02416115|Naloxone|naloxone|mesh-list
14099603|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14099604|NCT02416115|Narcotics|narcotics|mesh-ancestor
14099605|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099606|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099607|NCT02416115|Analgesics|analgesics|mesh-ancestor
14099608|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
14099609|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761244|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761245|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
13925896|NCT03405584|Expectorants|expectorants|mesh-ancestor
13925897|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
13925898|NCT03405454|Durvalumab|durvalumab|mesh-list
13925899|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925900|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925901|NCT03405376|Aflibercept|aflibercept|mesh-list
13925902|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13925903|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13925904|NCT03405376|Growth Substances|growth substances|mesh-ancestor
13925905|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761246|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761247|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761248|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761249|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761250|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
14099610|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14099611|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
14099612|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
14099613|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099614|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14099615|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
14099616|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099617|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099618|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
13925906|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
13925907|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925908|NCT03405337|Factor VIII|factor viii|mesh-list
13925909|NCT03405337|Coagulants|coagulants|mesh-ancestor
13925910|NCT03405272|Cetuximab|cetuximab|mesh-list
13925911|NCT03405272|Antibodies|antibodies|mesh-list
13925912|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13925913|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
13925914|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925915|NCT03405272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925916|NCT03405272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925917|NCT03405207|Vitamin D|vitamin d|mesh-list
13925918|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
13925919|NCT03405207|Vitamins|vitamins|mesh-ancestor
13925920|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
13925921|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925922|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13925923|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13925924|NCT03405194|Efavirenz|efavirenz|mesh-list
13925925|NCT03405194|Cobicistat|cobicistat|mesh-list
13925926|NCT03405194|Elvitegravir|elvitegravir|mesh-list
13925927|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13925928|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13925929|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925930|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925931|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
13925932|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925933|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13925934|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13925935|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13925936|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13925937|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13925938|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13925939|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13925940|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13925941|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14099619|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14099620|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099621|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099622|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14099623|NCT02416063|Analgesics|analgesics|mesh-ancestor
13925942|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13925943|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
13925944|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13925945|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13925946|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925947|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13925948|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13925949|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099624|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
14761251|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
13925950|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925951|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925952|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13925953|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
13925954|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13925955|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925956|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13925957|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13925958|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13925959|NCT03405155|Nivolumab|nivolumab|mesh-list
13925960|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925961|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925962|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13925963|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925964|NCT03405142|Panitumumab|panitumumab|mesh-list
13925965|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
13925966|NCT03405142|Dextrans|dextrans|mesh-list
13925967|NCT03405142|Edetic Acid|edetic acid|mesh-list
13925968|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
13925969|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13925970|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13925971|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
13925972|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
13925973|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
13925974|NCT03405142|Antidotes|antidotes|mesh-ancestor
13925975|NCT03405142|Protective Agents|protective agents|mesh-ancestor
13925976|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925977|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
13925978|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
13925979|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925980|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13925981|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13925982|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13925983|NCT03405064|Linezolid|linezolid|mesh-list
13925984|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
13925985|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13925986|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925987|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13925988|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13925989|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13925990|NCT03404947|Ethanol|ethanol|mesh-list
13925991|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13925992|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13925993|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13925994|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13925995|NCT03404908|Acetaminophen|acetaminophen|mesh-list
13925996|NCT03404908|Dipyrone|dipyrone|mesh-list
13925997|NCT03404908|Ketoprofen|ketoprofen|mesh-list
13925998|NCT03404908|Morphine|morphine|mesh-list
13925999|NCT03404908|Ropivacaine|ropivacaine|mesh-list
13926000|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13926001|NCT03404908|Narcotics|narcotics|mesh-ancestor
13926002|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926003|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926004|NCT03404908|Analgesics|analgesics|mesh-ancestor
13926005|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
13926006|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926007|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
13926008|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
13926009|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926010|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
13926011|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13926012|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099625|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099626|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14099627|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14099628|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14099629|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
14099630|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099631|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099632|NCT02416128|Prednisolone|prednisolone|mesh-list
14099633|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14099634|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
13926013|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926014|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13926015|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926016|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926017|NCT03404804|Amoxicillin|amoxicillin|mesh-list
13926018|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926019|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960790|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13960791|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960792|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960793|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960794|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960795|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13960796|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13960797|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
13960798|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
13960799|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13960800|NCT03152097|Protective Agents|protective agents|mesh-ancestor
13960801|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960802|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960803|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
13960804|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960805|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
13960806|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960807|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963412|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13963413|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963414|NCT03144843|Apatinib|apatinib|mesh-list
13963415|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963416|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13963417|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963418|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963419|NCT03144713|Terlipressin|terlipressin|mesh-list
13963420|NCT03144713|Midodrine|midodrine|mesh-list
13963421|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
13963422|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
13963423|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963424|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963425|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14099635|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14099636|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
14099637|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14099638|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
14099639|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099640|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
14099641|NCT02416128|Hormones|hormones|mesh-ancestor
14099642|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099643|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099644|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099645|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099646|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
14099647|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
14099648|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099649|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099650|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14099651|NCT02416128|Protective Agents|protective agents|mesh-ancestor
14099652|NCT02415985|Lopinavir|lopinavir|mesh-list
14099653|NCT02415985|Rifabutin|rifabutin|mesh-list
14099654|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14099655|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14099656|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
14099657|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099658|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099659|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14099660|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14099661|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
14099662|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099663|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14099664|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14099665|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14099666|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14099667|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
14099668|NCT02415920|Oxytocin|oxytocin|mesh-list
14099669|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
14099670|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14099671|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926020|NCT03404752|Lenograstim|lenograstim|mesh-list
13926021|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13926022|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
13926023|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926024|NCT03404739|Ceftazidime|ceftazidime|mesh-list
13926025|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926026|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099672|NCT02415829|Capecitabine|capecitabine|mesh-list
14099673|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
14099674|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14099675|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
14099676|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099677|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099678|NCT02415881|Panitumumab|panitumumab|mesh-list
14099679|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14099680|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099681|NCT02415712|Fomepizole|fomepizole|mesh-list
14099682|NCT02415712|Antidotes|antidotes|mesh-ancestor
14099683|NCT02415712|Protective Agents|protective agents|mesh-ancestor
14099684|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926027|NCT03404661|Secretin|secretin|mesh-list
13926028|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13926029|NCT03404661|Hormones|hormones|mesh-ancestor
13926030|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099685|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099686|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761252|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761253|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761254|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761255|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
14761256|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761257|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14761258|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14761259|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14761260|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
14761261|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761262|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099687|NCT02415803|Clopidogrel|clopidogrel|mesh-list
14099688|NCT02415803|Ticagrelor|ticagrelor|mesh-list
14099689|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14099690|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14099691|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14761263|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
14761264|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14761265|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14761266|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14761267|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761268|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761269|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
14761270|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761271|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761272|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14761273|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099692|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14099693|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
14099694|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099695|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099696|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099697|NCT02415777|Riboflavin|riboflavin|mesh-list
14099698|NCT02415777|Thiamine|thiamine|mesh-list
14099699|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14099700|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
14099701|NCT02415777|Vitamins|vitamins|mesh-ancestor
14099702|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
14099703|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099704|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14099705|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14099706|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14099707|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099708|NCT02415569|Bisacodyl|bisacodyl|mesh-list
14761274|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
14761275|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761276|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926031|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926032|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
14761277|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
13926033|NCT03404635|Apixaban|apixaban|mesh-list
13926034|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13926035|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
13926036|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13926037|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
13926038|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926039|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926040|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
13926041|NCT03404544|Carbetocin|carbetocin|mesh-list
13926042|NCT03404544|Oxytocin|oxytocin|mesh-list
13926043|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
13926044|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13926045|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926046|NCT03404479|Celecoxib|celecoxib|mesh-list
13926047|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
13926048|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13926049|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926050|NCT03404479|Analgesics|analgesics|mesh-ancestor
14099709|NCT02415569|Cathartics|cathartics|mesh-ancestor
14099710|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099711|NCT02415569|Laxatives|laxatives|mesh-ancestor
14099712|NCT02415699|Leucovorin|leucovorin|mesh-list
14099713|NCT02415699|Fluorouracil|fluorouracil|mesh-list
14099714|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
14099715|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
14099716|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099717|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14099718|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099719|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099720|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
14099721|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099722|NCT02415699|Antidotes|antidotes|mesh-ancestor
14099723|NCT02415699|Protective Agents|protective agents|mesh-ancestor
14099724|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
14099725|NCT02415699|Vitamins|vitamins|mesh-ancestor
14099726|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
14099727|NCT02415309|Melatonin|melatonin|mesh-list
14099728|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
14099729|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099730|NCT02415309|Protective Agents|protective agents|mesh-ancestor
14099731|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099732|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174844|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14174845|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14174846|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174847|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
13926051|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
13926052|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926053|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926054|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13926055|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926056|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13926057|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13926058|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174848|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
14174849|NCT04781998|Liraglutide|liraglutide|mesh-list
14174850|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14174851|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174852|NCT04781998|Incretins|incretins|mesh-ancestor
14174853|NCT04781998|Hormones|hormones|mesh-ancestor
14174854|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174855|NCT04781803|Cyclosporine|cyclosporine|mesh-list
14174856|NCT04781803|Cyclosporins|cyclosporins|mesh-list
14174857|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174858|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174859|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14174860|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
14174861|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174862|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
14174863|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761278|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761279|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761280|NCT03833154|Durvalumab|durvalumab|mesh-list
14761281|NCT03833154|Osimertinib|osimertinib|mesh-list
14767352|NCT00629681|Pregabalin|pregabalin|mesh-list
14174864|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
14174865|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926059|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926060|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13926061|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14099733|NCT02415192|Amlodipine|amlodipine|mesh-list
14099734|NCT02415192|Valsartan|valsartan|mesh-list
14099735|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14099736|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14099737|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14099738|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099739|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14099740|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099741|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
14099742|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14099743|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14099744|NCT02415335|Dexamethasone|dexamethasone|mesh-list
14099745|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
14099746|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14099747|NCT02415335|BB 1101|bb 1101|mesh-list
14099748|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099749|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
14099750|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
14099751|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099752|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099753|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099754|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
14099755|NCT02415335|Hormones|hormones|mesh-ancestor
13926062|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926063|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
13926064|NCT03404310|Astringents|astringents|mesh-ancestor
13926065|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926066|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
13926067|NCT03404284|Vaccines|vaccines|mesh-list
13926068|NCT03404284|Immunologic Factors|immunologic factors|mesh-ancestor
13926069|NCT03404284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926070|NCT03404037|Endostatins|endostatins|mesh-list
13926071|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926072|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13926073|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13926074|NCT03404037|Growth Substances|growth substances|mesh-ancestor
13926075|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926076|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
13926077|NCT03404024|Mitogens|mitogens|mesh-list
13926078|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
13926079|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926080|NCT03404011|Glycerol|glycerol|mesh-list
13926081|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14099756|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099757|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099758|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099759|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
14099760|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099761|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099762|NCT02415413|Dexamethasone|dexamethasone|mesh-list
14099763|NCT02415413|Lenalidomide|lenalidomide|mesh-list
14099764|NCT02415413|Melphalan|melphalan|mesh-list
14099765|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099766|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
14099767|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
14099768|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099769|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099770|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14099771|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
14099772|NCT02415413|Hormones|hormones|mesh-ancestor
14099773|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099774|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099775|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099776|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
14099777|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14099778|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14099779|NCT02415413|Growth Substances|growth substances|mesh-ancestor
14099780|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
14099781|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099782|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
14174866|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14761282|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14099783|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099784|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14099785|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099786|NCT02415270|Menthol|menthol|mesh-list
14099787|NCT02415270|Nicotine|nicotine|mesh-list
13926082|NCT03404011|Protective Agents|protective agents|mesh-ancestor
13926083|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926084|NCT03403985|Calcium|calcium|mesh-list
13926085|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13926086|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926087|NCT03403972|Vancomycin|vancomycin|mesh-list
13926088|NCT03403972|Simvastatin|simvastatin|mesh-list
13926089|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14099788|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14099789|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
14099790|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099791|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099792|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14099793|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13926090|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13926091|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
13926092|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099794|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
14099795|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099796|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099797|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
14099798|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
14099799|NCT02415257|Gentamicins|gentamicins|mesh-list
14099800|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14099801|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099802|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14099803|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099804|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099805|NCT02415179|Fluticasone|fluticasone|mesh-list
14099806|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
14099807|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
14099808|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14099809|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14099810|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099811|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14099812|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
14099813|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099814|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099815|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14099816|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
14099817|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
14099818|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14099819|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14099820|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14099821|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14099822|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
14099823|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099824|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099825|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
14099826|NCT02415179|Hormones|hormones|mesh-ancestor
14099827|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099828|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
14099829|NCT02415114|Resveratrol|resveratrol|mesh-list
14099830|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
14099831|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099832|NCT02415114|Protective Agents|protective agents|mesh-ancestor
14099833|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099834|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099835|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14099836|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
14099837|NCT02414919|Etonogestrel|etonogestrel|mesh-list
14099838|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14099839|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
14099840|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14099841|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099842|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14099843|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14099844|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14099845|NCT02415023|Paclitaxel|paclitaxel|mesh-list
13926093|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13926094|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13926095|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926096|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926097|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926098|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
13926099|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
13926100|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
13926101|NCT03403842|Sufentanil|sufentanil|mesh-list
13926102|NCT03403842|Morphine|morphine|mesh-list
13926103|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13926104|NCT03403842|Narcotics|narcotics|mesh-ancestor
13926105|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926106|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099846|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14099847|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14099848|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099849|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
14099850|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
14099851|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
14099852|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099853|NCT02414880|Rocuronium|rocuronium|mesh-list
14099854|NCT02414880|Neostigmine|neostigmine|mesh-list
14099855|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14099856|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14099857|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13926107|NCT03403842|Analgesics|analgesics|mesh-ancestor
13926108|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
13926109|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926110|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13926111|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13926112|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
13926113|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
13926114|NCT03403829|Gemcitabine|gemcitabine|mesh-list
13926115|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13926116|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
13926117|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926118|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099858|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099859|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099860|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14099861|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099862|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099863|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
14099864|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099865|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14099866|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
14099867|NCT02414984|Golimumab|golimumab|mesh-list
14099868|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14099869|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099870|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099871|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
14099872|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099873|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
14099874|NCT02414945|Fludarabine|fludarabine|mesh-list
14099875|NCT02414945|Interleukin-2|interleukin-2|mesh-list
14099876|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099877|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
14761283|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761284|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13926119|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
13926120|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926121|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926122|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099878|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099879|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099880|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099881|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
14099882|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099883|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099884|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14099885|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14099886|NCT02414945|Analgesics|analgesics|mesh-ancestor
14099887|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
14099888|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099889|NCT02415062|Donepezil|donepezil|mesh-list
14099890|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14099891|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099892|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099893|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
14099894|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099895|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099896|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
14099897|NCT02415036|Melphalan|melphalan|mesh-list
14099898|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099899|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
14477620|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477621|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099900|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099901|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099902|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14099903|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099904|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
14099905|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099906|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
14099907|NCT02414802|Heparin|heparin|mesh-list
14099908|NCT02414802|Calcium heparin|calcium heparin|mesh-list
14099909|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14099910|NCT02414802|Tinzaparin|tinzaparin|mesh-list
14099911|NCT02414802|Dalteparin|dalteparin|mesh-list
14477622|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14477623|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
14477624|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14477625|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14477626|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14477627|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14477628|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477629|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099912|NCT02414802|Calcium|calcium|mesh-list
14099913|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14099914|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099915|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14099916|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
14099917|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14099918|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14099919|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099920|NCT02414750|Vemurafenib|vemurafenib|mesh-list
14099921|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099922|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14099923|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099924|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099925|NCT02414503|Oxytocin|oxytocin|mesh-list
14099926|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
14099927|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13926123|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
13926124|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926125|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13926126|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
13926127|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926128|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13926129|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13926130|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926131|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926132|NCT03403777|Avelumab|avelumab|mesh-list
13926133|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13926134|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926135|NCT03403647|Vitamin D|vitamin d|mesh-list
13926136|NCT03403647|Vitamins|vitamins|mesh-ancestor
14099928|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099929|NCT02414555|Phenylephrine|phenylephrine|mesh-list
14099930|NCT02414555|Norepinephrine|norepinephrine|mesh-list
14099931|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14099932|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14099933|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
14099934|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
14099935|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14099936|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099937|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
14099938|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
14099939|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
14099940|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14099941|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14099942|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13926137|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
13926138|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926139|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13926140|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
13926141|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13926142|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926143|NCT03403452|Apatinib|apatinib|mesh-list
13926144|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926145|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13926146|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926147|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926148|NCT03403439|Itraconazole|itraconazole|mesh-list
13926149|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
13926150|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926151|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13926152|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13926153|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926154|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926155|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13926156|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
13926157|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926158|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926159|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13926160|NCT03403140|Etanercept|etanercept|mesh-list
13926161|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13926162|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926163|NCT03403140|Analgesics|analgesics|mesh-ancestor
13926164|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
13926165|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926166|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926167|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13926168|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926169|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13926170|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926171|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
13926172|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
13926173|NCT03403101|Irinotecan|irinotecan|mesh-list
13926174|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926175|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13926176|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13926177|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926178|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926179|NCT03403049|Gemcitabine|gemcitabine|mesh-list
13926180|NCT03403049|Capecitabine|capecitabine|mesh-list
13926181|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13926182|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926183|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13926184|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
13926185|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926186|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
14099943|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
14099944|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14099945|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099946|NCT02414555|Protective Agents|protective agents|mesh-ancestor
14099947|NCT02414568|Prednisone|prednisone|mesh-list
14099948|NCT02414568|Doxorubicin|doxorubicin|mesh-list
14099949|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14099950|NCT02414568|Vinblastine|vinblastine|mesh-list
14099951|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14099952|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14099953|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14099954|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14099955|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099956|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099957|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14099958|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
14099959|NCT02414568|Hormones|hormones|mesh-ancestor
14099960|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14099961|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099962|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14099963|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14099964|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
14099965|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14099966|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
14099967|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
14099968|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
14099969|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
14099970|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
14099971|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14099972|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14099973|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926187|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926188|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926189|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14099974|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14099975|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099976|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14099977|NCT02414581|Ethanol|ethanol|mesh-list
14099978|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
14761285|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761286|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761287|NCT03824483|Venetoclax|venetoclax|mesh-list
14761288|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
14761289|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
14761290|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761291|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761292|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14761293|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926190|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
14099979|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14099980|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14099981|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14099982|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14099983|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099984|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
13926191|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926192|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13926193|NCT03403023|Cyclosporine|cyclosporine|mesh-list
13926194|NCT03403023|Cyclosporins|cyclosporins|mesh-list
13926195|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926196|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926197|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926198|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
13926199|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926200|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
13926201|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926202|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
13926203|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926204|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13926205|NCT03402984|Z 338|z 338|mesh-list
13926206|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13926207|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926208|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926209|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
13926210|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926211|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099985|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
14761294|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14099986|NCT02414529|Vitamin D|vitamin d|mesh-list
13926212|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13960808|NCT03152149|Fluticasone|fluticasone|mesh-list
14099987|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
14099988|NCT02414529|Vitamins|vitamins|mesh-list
13960809|NCT03152149|Xhance|xhance|mesh-list
13960810|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
13960811|NCT03152149|Olodaterol|olodaterol|mesh-list
13960812|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13960813|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13960814|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
13960815|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960816|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960817|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13960818|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
13960819|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960820|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13960821|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
13960822|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13960823|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
13960824|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960825|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960826|NCT03152123|Phentermine|phentermine|mesh-list
13960827|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13960828|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099989|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
14099990|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14099991|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14099992|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14099993|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
14099994|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14099995|NCT02414490|Antibodies|antibodies|mesh-list
14099996|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
14099997|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14099998|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
14099999|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100000|NCT02414685|Paclitaxel|paclitaxel|mesh-list
13960829|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
13960830|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13960831|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
13960832|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
13960833|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960834|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960835|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960836|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960837|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
13960838|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
13960839|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13960840|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13960841|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960842|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13960843|NCT03151863|Analgesics|analgesics|mesh-ancestor
14100001|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14100002|NCT02414685|Cisplatin|cisplatin|mesh-list
14100003|NCT02414685|Ifosfamide|ifosfamide|mesh-list
14100004|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
14100005|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14100006|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100007|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
14100008|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
14100009|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
14100010|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100011|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14100012|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
14100013|NCT02414724|Gemcitabine|gemcitabine|mesh-list
14100014|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14100015|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
14100016|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100017|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100018|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
14100019|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100020|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100021|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100022|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
14761295|NCT03823768|Tacrolimus|tacrolimus|mesh-list
14100023|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960844|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
14100024|NCT02414451|Propranolol|propranolol|mesh-list
14100025|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14100026|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14100027|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
14100028|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100029|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100030|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100031|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14100032|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14100033|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
14100034|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
14100035|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14100036|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14100037|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14100038|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14100039|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100040|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
14100041|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100042|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100043|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14100044|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100045|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
14100046|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14100047|NCT02414464|Calcium|calcium|mesh-list
14100048|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14100049|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100050|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14100051|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14100052|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100053|NCT02414399|Azithromycin|azithromycin|mesh-list
14100054|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14100055|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100056|NCT02414256|Anesthetics|anesthetics|mesh-list
14100057|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100058|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100059|NCT02414373|Bupivacaine|bupivacaine|mesh-list
14100060|NCT02414373|Ropivacaine|ropivacaine|mesh-list
14100061|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
14100062|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
14100063|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100064|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100065|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
14100066|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100067|NCT02414165|Flucytosine|flucytosine|mesh-list
14100068|NCT02414165|Bevacizumab|bevacizumab|mesh-list
14100069|NCT02414165|Temozolomide|temozolomide|mesh-list
14100070|NCT02414165|Lomustine|lomustine|mesh-list
14100071|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14100072|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100073|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14100074|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14100075|NCT02414165|Growth Substances|growth substances|mesh-ancestor
14100076|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100077|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
14100078|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14100079|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
14100080|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100081|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
14100082|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100083|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
13926213|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
13926214|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
13926215|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
13926216|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13926217|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926218|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
13926219|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926220|NCT03402815|Maraviroc|maraviroc|mesh-list
13926221|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13926222|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14100084|NCT02414009|Leucovorin|leucovorin|mesh-list
14100085|NCT02414009|Fluorouracil|fluorouracil|mesh-list
14100086|NCT02414009|Capecitabine|capecitabine|mesh-list
13926223|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100087|NCT02414009|Irinotecan|irinotecan|mesh-list
14100088|NCT02414009|Temozolomide|temozolomide|mesh-list
14100089|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
13926224|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14100090|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100091|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14100092|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100093|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100094|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
14100095|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100096|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14100097|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14100098|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100099|NCT02414009|Antidotes|antidotes|mesh-ancestor
14100100|NCT02414009|Protective Agents|protective agents|mesh-ancestor
14100101|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
14100102|NCT02414009|Vitamins|vitamins|mesh-ancestor
14100103|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
14100104|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14100105|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
14174867|NCT04781673|Lidocaine|lidocaine|mesh-list
14174868|NCT04781673|Ketamine|ketamine|mesh-list
14174869|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
14174870|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
13926225|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13926226|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
13926227|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926228|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13926229|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
13926230|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13926231|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926232|NCT03402698|Vitamins|vitamins|mesh-ancestor
13926233|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
13926234|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13926235|NCT03402503|Montelukast|montelukast|mesh-list
13926236|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13926237|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
13926238|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13926239|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
13926240|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926241|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926242|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13926243|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13926244|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926245|NCT03402438|Fulacimstat|fulacimstat|mesh-list
13926246|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926247|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926248|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
13926249|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
14174871|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174872|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174873|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
14174874|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174875|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14174876|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14174877|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14174878|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14174879|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174880|NCT04781673|Analgesics|analgesics|mesh-ancestor
14174881|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14174882|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14174883|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
14174884|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14174885|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14174886|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174887|NCT04781959|Lenograstim|lenograstim|mesh-list
13926250|NCT03402321|Coagulants|coagulants|mesh-ancestor
13926251|NCT03402295|Thalidomide|thalidomide|mesh-list
13926252|NCT03402295|Dexamethasone|dexamethasone|mesh-list
13926253|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
13926254|NCT03402295|Bortezomib|bortezomib|mesh-list
13926255|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926256|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
14174888|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14174889|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
14174890|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174891|NCT04781686|Docetaxel|docetaxel|mesh-list
14174892|NCT04781686|Apatinib|apatinib|mesh-list
14100106|NCT02413853|Leucovorin|leucovorin|mesh-list
13926257|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926258|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926259|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13926260|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
13926261|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926262|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926263|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13926264|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100107|NCT02413853|Bevacizumab|bevacizumab|mesh-list
14100108|NCT02413853|Fluorouracil|fluorouracil|mesh-list
14100109|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
14100110|NCT02413853|Calcium|calcium|mesh-list
14100111|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
14100112|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14100113|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100114|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14100115|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13926265|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
13926266|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
13926267|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926268|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13926269|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
13926270|NCT03402295|Hormones|hormones|mesh-ancestor
13926271|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926272|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13926273|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
13926274|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926275|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926276|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14761296|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761297|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
14761298|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926277|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13926278|NCT03402295|Growth Substances|growth substances|mesh-ancestor
13926279|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
13926280|NCT03402204|Ubenimex|ubenimex|mesh-list
14100116|NCT02413853|Growth Substances|growth substances|mesh-ancestor
14100117|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100118|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
14100119|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14100120|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
14100121|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100122|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14100123|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100124|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
14100125|NCT02413853|Antidotes|antidotes|mesh-ancestor
14100126|NCT02413853|Protective Agents|protective agents|mesh-ancestor
14100127|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
14100128|NCT02413853|Vitamins|vitamins|mesh-ancestor
14100129|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
14100130|NCT02413658|Phenytoin|phenytoin|mesh-list
14100131|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
14100132|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14100133|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14100134|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14100135|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100136|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14100137|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14100138|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
14100139|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
14100140|NCT02413281|Buprenorphine|buprenorphine|mesh-list
14100141|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14100142|NCT02413281|Narcotics|narcotics|mesh-ancestor
14100143|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100144|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100145|NCT02413281|Analgesics|analgesics|mesh-ancestor
14100146|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
14100147|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100148|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14100149|NCT02413515|Nifedipine|nifedipine|mesh-list
14100150|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14761299|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14100151|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14100152|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926281|NCT03402204|Simvastatin|simvastatin|mesh-list
13926282|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13926283|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14100153|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14100154|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100155|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
14100156|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
14100157|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100158|NCT02413554|Rivastigmine|rivastigmine|mesh-list
13926284|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
13926285|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926286|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13926287|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13926288|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926289|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13926290|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
13926291|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926292|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926293|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926294|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13926295|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926296|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
13926297|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13926298|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13926299|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
13926300|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
13926301|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
13926302|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13926303|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13926304|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926305|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926306|NCT03402191|Urological Agents|urological agents|mesh-ancestor
13926307|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
13926308|NCT03402165|Ledipasvir|ledipasvir|mesh-list
13926309|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13926310|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
13926311|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926312|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
13926313|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13926314|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13926315|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926316|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926317|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926318|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13926319|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13926320|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13926321|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926322|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926323|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100159|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14100160|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100161|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100162|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
14100163|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100164|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100165|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14100166|NCT02413554|Protective Agents|protective agents|mesh-ancestor
14100167|NCT02413541|Polymyxins|polymyxins|mesh-list
14100168|NCT02413541|Polymyxin B|polymyxin b|mesh-list
14100169|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14100170|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100171|NCT02413086|Chitosan|chitosan|mesh-list
14100172|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14100173|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14100174|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
14100175|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100176|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13926324|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13926325|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13926326|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
13926327|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14100177|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
14100178|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
13926328|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14100179|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
13926329|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
14100180|NCT02413086|Coagulants|coagulants|mesh-ancestor
14100181|NCT02413138|Hormones|hormones|mesh-list
13926330|NCT03402113|Midazolam|midazolam|mesh-list
13926331|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
13926332|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13926333|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926334|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926335|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926336|NCT03402113|Analgesics|analgesics|mesh-ancestor
13926337|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
13926338|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926339|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13926340|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13926341|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13926342|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926343|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926344|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926345|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13926346|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13926347|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13926348|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926349|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14935925|NCT01466244|Cetuximab|cetuximab|mesh-list
14935926|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935927|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13926350|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
13926351|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
14477630|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
14477631|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477632|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14477633|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14477634|NCT02436577|Ticagrelor|ticagrelor|mesh-list
14477635|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14477636|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14477637|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14477638|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14477639|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
14477640|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477641|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477642|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477643|NCT02436668|Gemcitabine|gemcitabine|mesh-list
14477644|NCT02436668|Paclitaxel|paclitaxel|mesh-list
14477645|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13926352|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
13926353|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
13926354|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14100182|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926355|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14100183|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100184|NCT02412930|Tramadol|tramadol|mesh-list
14100185|NCT02412930|Bupivacaine|bupivacaine|mesh-list
14100186|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
14100187|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
14100188|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100189|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100190|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
14100191|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100192|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14100193|NCT02412930|Narcotics|narcotics|mesh-ancestor
14100194|NCT02412930|Analgesics|analgesics|mesh-ancestor
14100195|NCT02413021|Cytarabine|cytarabine|mesh-list
14100196|NCT02413021|Deferasirox|deferasirox|mesh-list
14100197|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14100198|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
13926356|NCT03402087|Leucovorin|leucovorin|mesh-list
13926357|NCT03402087|Methotrexate|methotrexate|mesh-list
13926358|NCT03402087|BMS-986165|bms-986165|mesh-list
13926359|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13926360|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
14100199|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100200|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14935928|NCT01466257|Cetuximab|cetuximab|mesh-list
13926361|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100201|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
14100202|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100203|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100204|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
14100205|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100206|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14100207|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
14100208|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
14100209|NCT02412917|Valacyclovir|valacyclovir|mesh-list
14100210|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
14100211|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100212|NCT02412904|Menotropins|menotropins|mesh-list
14100213|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14100214|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
14100215|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100216|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100217|NCT02412813|Cobalt|cobalt|mesh-list
14100218|NCT02412813|Trace Elements|trace elements|mesh-ancestor
14100219|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
14100220|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100221|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
14100222|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100223|NCT02412566|SMOFlipid|smoflipid|mesh-list
14100224|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14100225|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14100226|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14100227|NCT02412475|Cytarabine|cytarabine|mesh-list
14100228|NCT02412475|Fludarabine|fludarabine|mesh-list
14100229|NCT02412475|Sorafenib|sorafenib|mesh-list
14100230|NCT02412475|Decitabine|decitabine|mesh-list
14100231|NCT02412475|Vorinostat|vorinostat|mesh-list
14100232|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100233|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14100234|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
14100235|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100236|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100237|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
14100238|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100239|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
14100240|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100241|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14100242|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100243|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14100244|NCT02412449|Glycine|glycine|mesh-list
14100245|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
14100246|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100247|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100248|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100249|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
14100250|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100251|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
14100252|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100253|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14100254|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14100255|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
14100256|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100257|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100258|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13926362|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926363|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13926364|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
13926365|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926366|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100259|NCT02412345|Alprostadil|alprostadil|mesh-list
14100260|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14100261|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
14100262|NCT02412345|Urological Agents|urological agents|mesh-ancestor
13926367|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
13926368|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926369|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13926370|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926371|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
13926372|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926373|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13926374|NCT03402087|Antidotes|antidotes|mesh-ancestor
14100263|NCT02412267|Carboplatin|carboplatin|mesh-list
14100264|NCT02412267|Etoposide|etoposide|mesh-list
14100265|NCT02412267|Ifosfamide|ifosfamide|mesh-list
13926375|NCT03402087|Protective Agents|protective agents|mesh-ancestor
14100266|NCT02412267|Ofatumumab|ofatumumab|mesh-list
14100267|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926376|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
13926377|NCT03402087|Vitamins|vitamins|mesh-ancestor
13926378|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
13926379|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14100268|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14100269|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14100270|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14100271|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100272|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100273|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14100274|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
14100275|NCT02412059|Prednisolone|prednisolone|mesh-list
14100276|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14100277|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
14100278|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14100279|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
14100280|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14100281|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
14100282|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100283|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
14100284|NCT02412059|Hormones|hormones|mesh-ancestor
14100285|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14100286|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100287|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14100288|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100289|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
14100290|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
14100291|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100292|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14100293|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14100294|NCT02412059|Protective Agents|protective agents|mesh-ancestor
14100295|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
14100296|NCT02412150|Remifentanil|remifentanil|mesh-list
14100297|NCT02412150|Desflurane|desflurane|mesh-list
14100298|NCT02412150|Anesthetics|anesthetics|mesh-list
14100299|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
14100300|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14100301|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100302|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100303|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926380|NCT03402048|Gemcitabine|gemcitabine|mesh-list
13926381|NCT03402048|Carboplatin|carboplatin|mesh-list
13926382|NCT03402048|Docetaxel|docetaxel|mesh-list
13926383|NCT03402048|Pemetrexed|pemetrexed|mesh-list
13926384|NCT03402048|Vinorelbine|vinorelbine|mesh-list
13926385|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926386|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13926387|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
13926388|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926389|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
14100304|NCT02412150|Analgesics|analgesics|mesh-ancestor
14100305|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
14100306|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100307|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14100308|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14100309|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14100310|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
14100311|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100312|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100313|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14100314|NCT02412150|Narcotics|narcotics|mesh-ancestor
14100315|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
13926390|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926391|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926392|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926393|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
13926394|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926395|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
13926396|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
13926397|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
13926398|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13926399|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13926400|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13926401|NCT03401957|Cetuximab|cetuximab|mesh-list
13926402|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13926403|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926404|NCT03401827|Gemcitabine|gemcitabine|mesh-list
13926405|NCT03401827|Paclitaxel|paclitaxel|mesh-list
13926406|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13926407|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100316|NCT02412189|Norepinephrine|norepinephrine|mesh-list
14100317|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14100318|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14100319|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
14100320|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926408|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
13926409|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
13926410|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
13926411|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100321|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100322|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100323|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
14100324|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
14100325|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100326|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14100327|NCT02411942|Adapalene|adapalene|mesh-list
14100328|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14100329|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14100330|NCT02411942|Analgesics|analgesics|mesh-ancestor
14100331|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
14100332|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100333|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100334|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100335|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14100336|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14100337|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
14100338|NCT02411955|Tazarotene|tazarotene|mesh-list
14100339|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
14100340|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
14100341|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
14100342|NCT02411955|Vitamins|vitamins|mesh-ancestor
14100343|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
14100344|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100345|NCT02412085|Golimumab|golimumab|mesh-list
14100346|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14100347|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100348|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100349|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
14100350|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100351|NCT02412033|Misoprostol|misoprostol|mesh-list
14100352|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14100353|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
14100354|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100355|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100356|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14100357|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14100358|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
14100359|NCT02411994|Artesunate|artesunate|mesh-list
14100360|NCT02411994|Lumefantrine|lumefantrine|mesh-list
14100361|NCT02411994|Artemether|artemether|mesh-list
14100362|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14100363|NCT02411994|Pyronaridine|pyronaridine|mesh-list
14100364|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
13926412|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13926413|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
13926414|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
13926415|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926416|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926417|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926418|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
13926419|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926420|NCT03401736|Midazolam|midazolam|mesh-list
13926421|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
13926422|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13926423|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926424|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100365|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14100366|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14100367|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100368|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100369|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
14100370|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
14100371|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14100372|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
14100373|NCT02411877|Clotrimazole|clotrimazole|mesh-list
14100374|NCT02411877|Miconazole|miconazole|mesh-list
14100375|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14100376|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100377|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
14100378|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14100379|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13926425|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926426|NCT03401736|Analgesics|analgesics|mesh-ancestor
13926427|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
13926428|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926429|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14761300|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935929|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926430|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13926431|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13926432|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926433|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926434|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100380|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100381|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100382|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14100383|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
14100384|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14100385|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100386|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14100387|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14100388|NCT02411903|Clopidogrel|clopidogrel|mesh-list
14100389|NCT02411903|Atorvastatin|atorvastatin|mesh-list
14100390|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14100391|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14100392|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14100393|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
14100394|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100395|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14100396|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14100397|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100398|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14100399|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14100400|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14100401|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14100402|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
14100403|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100404|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174893|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174894|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
14174895|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
14935930|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14100405|NCT02411786|Molgramostim|molgramostim|mesh-list
14100406|NCT02411786|Sargramostim|sargramostim|mesh-list
14100407|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
14100408|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100409|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100410|NCT02411825|Metformin|metformin|mesh-list
14100411|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14100412|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100413|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
14100414|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
14100415|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100416|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100417|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100418|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
14100419|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
14100420|NCT02411604|Tacrolimus|tacrolimus|mesh-list
14100421|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100422|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
14100423|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100424|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14100425|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100426|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100427|NCT02411149|Epinephrine|epinephrine|mesh-list
14100428|NCT02411149|Racepinephrine|racepinephrine|mesh-list
14100429|NCT02411149|Morphine|morphine|mesh-list
14100430|NCT02411149|Ropivacaine|ropivacaine|mesh-list
14100431|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
14100432|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14100433|NCT02411149|Narcotics|narcotics|mesh-ancestor
14100434|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100435|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100436|NCT02411149|Analgesics|analgesics|mesh-ancestor
14100437|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
14100438|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100439|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
14100440|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
14100441|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14100442|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14100443|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14100444|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100445|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100446|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14100447|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14100448|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
14100449|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14100450|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14100451|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
14100452|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
13926435|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13926436|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13926437|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13926438|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926439|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13926440|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
13926441|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
13926442|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
13926443|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
13926444|NCT03401619|Vitamin D|vitamin d|mesh-list
13926445|NCT03401619|Calcitonin|calcitonin|mesh-list
13926446|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
13926447|NCT03401619|Diphosphonates|diphosphonates|mesh-list
13926448|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
13926449|NCT03401619|Katacalcin|katacalcin|mesh-list
13926450|NCT03401619|Vitamins|vitamins|mesh-ancestor
13926451|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
13926452|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926453|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13926454|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13926455|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
13926456|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
13926457|NCT03401606|Remifentanil|remifentanil|mesh-list
13926458|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14100453|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14100454|NCT02411526|Risperidone|risperidone|mesh-list
14100455|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14100456|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
14100457|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100458|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174896|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
13926459|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926460|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926461|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926462|NCT03401606|Analgesics|analgesics|mesh-ancestor
13926463|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
13926464|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926465|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13926466|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13926467|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13926468|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926469|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926470|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926471|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13926472|NCT03401606|Narcotics|narcotics|mesh-ancestor
13926473|NCT03401593|Fentanyl|fentanyl|mesh-list
13926474|NCT03401593|Midazolam|midazolam|mesh-list
13926475|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13926476|NCT03401593|Narcotics|narcotics|mesh-ancestor
13926477|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926478|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926479|NCT03401593|Analgesics|analgesics|mesh-ancestor
13926480|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
13926481|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926482|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14100459|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100460|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14100461|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14100462|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100463|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14100464|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14100465|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
14100466|NCT02411630|Tenofovir|tenofovir|mesh-list
14100467|NCT02411630|Emtricitabine|emtricitabine|mesh-list
14100468|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
14100469|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100470|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14100471|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14100472|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100473|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100474|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14100475|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14100476|NCT02411318|Ethanol|ethanol|mesh-list
14100477|NCT02411318|Caffeine|caffeine|mesh-list
14100478|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14100479|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100480|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14100481|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100482|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100483|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14100484|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14100485|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
14100486|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100487|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14100488|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100489|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100490|NCT02411175|Ethanol|ethanol|mesh-list
14100491|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14100492|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100493|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100494|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100495|NCT02411331|Ethanol|ethanol|mesh-list
14100496|NCT02411331|Enoxaparin|enoxaparin|mesh-list
14100497|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
14100498|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14100499|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14100500|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100501|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14100502|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100503|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100504|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100505|NCT02411344|Pertuzumab|pertuzumab|mesh-list
14100506|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14767353|NCT00629681|Analgesics|analgesics|mesh-ancestor
14100507|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100508|NCT02410863|Trametinib|trametinib|mesh-list
14100509|NCT02410863|Dabrafenib|dabrafenib|mesh-list
14100510|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761301|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761302|NCT03812588|Citalopram|citalopram|mesh-list
14761303|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13926483|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13926484|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
13926485|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
13926486|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13926487|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13926488|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13926489|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926490|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
14761304|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14761305|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761306|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761307|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100511|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14100512|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100513|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100514|NCT02410980|Tretinoin|tretinoin|mesh-list
14100515|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100516|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
14100517|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
14100518|NCT02410759|Carbetocin|carbetocin|mesh-list
14100519|NCT02410759|Ergonovine|ergonovine|mesh-list
14100520|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
14100521|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100522|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100523|NCT02410694|Thalidomide|thalidomide|mesh-list
14100524|NCT02410694|Dexamethasone|dexamethasone|mesh-list
14100525|NCT02410694|Ixazomib|ixazomib|mesh-list
14100526|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100527|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
14100528|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
14100529|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100530|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100531|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14100532|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
14100533|NCT02410694|Hormones|hormones|mesh-ancestor
14100534|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14100535|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14100536|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100537|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100538|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
14100539|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
13926491|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
14100540|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14100541|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100542|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14100543|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14100544|NCT02410694|Growth Substances|growth substances|mesh-ancestor
13926492|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926493|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926494|NCT03401541|Vitamin D|vitamin d|mesh-list
13926495|NCT03401541|Calcifediol|calcifediol|mesh-list
13926496|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
13926497|NCT03401541|Vitamins|vitamins|mesh-ancestor
14100545|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
14100546|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14100547|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100548|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100549|NCT02410746|Ibuprofen|ibuprofen|mesh-list
14100550|NCT02410746|Morphine|morphine|mesh-list
14100551|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
14100552|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14100553|NCT02410746|Narcotics|narcotics|mesh-ancestor
14100554|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100555|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761308|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
14761309|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767354|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
14100556|NCT02410746|Analgesics|analgesics|mesh-ancestor
13926498|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
14100557|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
14100558|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935931|NCT01466452|Aspirin|aspirin|mesh-list
14935932|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14935933|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935934|NCT01466452|Analgesics|analgesics|mesh-ancestor
14935935|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
14935936|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14935937|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926499|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100559|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14100560|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14100561|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100562|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14100563|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14100564|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100565|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100566|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
14100567|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
14100568|NCT02410590|Atropine|atropine|mesh-list
14100569|NCT02410590|Rocuronium|rocuronium|mesh-list
14100570|NCT02410590|Cisatracurium|cisatracurium|mesh-list
14100571|NCT02410590|Succinylcholine|succinylcholine|mesh-list
14100572|NCT02410590|Neostigmine|neostigmine|mesh-list
14100573|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14100574|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14100575|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13926500|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13926501|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13926502|NCT03401515|Propranolol|propranolol|mesh-list
13926503|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13926504|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13926505|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926506|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926507|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100576|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100577|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100578|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14100579|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14100580|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14100581|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
14100582|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14100583|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
14100584|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
14100585|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
14100586|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14100587|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14100588|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
14100589|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100590|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100591|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14100592|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100593|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14100594|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14100595|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
14100596|NCT02410720|Cathartics|cathartics|mesh-ancestor
14100597|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14100598|NCT02410655|Oxytocin|oxytocin|mesh-list
14100599|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
14100600|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100601|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100602|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14100603|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
14100604|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100605|NCT02410460|Lidocaine|lidocaine|mesh-list
14100606|NCT02410460|Clonidine|clonidine|mesh-list
14100607|NCT02410460|Midazolam|midazolam|mesh-list
14100608|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
14100609|NCT02410460|Scopolamine|scopolamine|mesh-list
14100610|NCT02410460|Ketamine|ketamine|mesh-list
14100611|NCT02410460|Ondansetron|ondansetron|mesh-list
14100612|NCT02410460|Metoclopramide|metoclopramide|mesh-list
14100613|NCT02410460|Bupivacaine|bupivacaine|mesh-list
14100614|NCT02410460|Propofol|propofol|mesh-list
14100615|NCT02410460|Sevoflurane|sevoflurane|mesh-list
14100616|NCT02410460|Desflurane|desflurane|mesh-list
14100617|NCT02410460|Famotidine|famotidine|mesh-list
14100618|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14100619|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
14100620|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
14100621|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100622|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100623|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
14100624|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100625|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14100626|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13926508|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926509|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13926510|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13926511|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
13926512|NCT03401502|Ranolazine|ranolazine|mesh-list
13926513|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13926514|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13926515|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926516|NCT03401476|Morphine|morphine|mesh-list
14100627|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14100628|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14100629|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100630|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14100631|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14100632|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
14100633|NCT02410460|Analgesics|analgesics|mesh-ancestor
14100634|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14100635|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14100636|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14100637|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100638|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14100639|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14100640|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14100641|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14761310|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14761311|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
14761312|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14761313|NCT03809988|Letrozole|letrozole|mesh-list
14761314|NCT03809988|Fulvestrant|fulvestrant|mesh-list
14761315|NCT03809988|Palbociclib|palbociclib|mesh-list
14761316|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761317|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14100642|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
14100643|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
14100644|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14100645|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14761318|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14761319|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761320|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926517|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14100646|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
14100647|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
14100648|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14761321|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14761322|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
14761323|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761324|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761325|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761326|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13926518|NCT03401476|Narcotics|narcotics|mesh-ancestor
13926519|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926520|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926521|NCT03401476|Analgesics|analgesics|mesh-ancestor
13926522|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
13926523|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926524|NCT03401372|Doxycycline|doxycycline|mesh-list
13926525|NCT03401372|Dexamethasone|dexamethasone|mesh-list
13926526|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
13926527|NCT03401372|Bortezomib|bortezomib|mesh-list
13926528|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926529|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
14761327|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14761328|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
14761329|NCT03809884|Diuretics|diuretics|mesh-ancestor
14761330|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
14761331|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761332|NCT03809884|Expectorants|expectorants|mesh-ancestor
13926530|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100649|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
14100650|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
14100651|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14100652|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
14100653|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14100654|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14100655|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
14100656|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14100657|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14100658|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14100659|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
14100660|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14100661|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14100662|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
14100663|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14100664|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14100665|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
14100666|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14100667|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14100668|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
14100669|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
14100670|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
14100671|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
14100672|NCT02410226|Anesthetics|anesthetics|mesh-list
14100673|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100674|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100675|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
14100676|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14100677|NCT02410031|Cyproterone|cyproterone|mesh-list
14100678|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
14100679|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14100680|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14100681|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14100682|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
14100683|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100684|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100685|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14100686|NCT02410031|Estrogens|estrogens|mesh-ancestor
14100687|NCT02410031|Hormones|hormones|mesh-ancestor
14100688|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926531|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926532|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13926533|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
13926534|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926535|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926536|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13926537|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100689|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
14100690|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
14100691|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926538|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
13926539|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
13926540|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926541|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13926542|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
13926543|NCT03401372|Hormones|hormones|mesh-ancestor
13926544|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14100692|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14100693|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
14100694|NCT02410096|Miotics|miotics|mesh-ancestor
13926545|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13926546|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926547|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926548|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
14100695|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
14100696|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100697|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100698|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14100699|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14100700|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
14100701|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14100702|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14100703|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
14100704|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100705|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100706|NCT02410317|Morphine|morphine|mesh-list
14100707|NCT02410317|Ropivacaine|ropivacaine|mesh-list
14100708|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14100709|NCT02410317|Narcotics|narcotics|mesh-ancestor
14100710|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100711|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100712|NCT02410317|Analgesics|analgesics|mesh-ancestor
14100713|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
14100714|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100715|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
14100716|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
14100717|NCT02410083|Aspirin|aspirin|mesh-list
14100718|NCT02410083|Clopidogrel|clopidogrel|mesh-list
14100719|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14100720|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14100721|NCT02410083|Analgesics|analgesics|mesh-ancestor
14100722|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
14100723|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100724|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100725|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100726|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14100727|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14100728|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13926549|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13926550|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13926551|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
13926552|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13926553|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
13926554|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
14100729|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100730|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14100731|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14100732|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100733|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
14100734|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14100735|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14100736|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14100737|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
14100738|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174897|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174898|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174899|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174900|NCT04781777|Insulin|insulin|mesh-list
14174901|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14174902|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174903|NCT04781751|Insulin|insulin|mesh-list
14174904|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13926555|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174905|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174906|NCT04781270|Bevacizumab|bevacizumab|mesh-list
14174907|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14100739|NCT02410005|Calcitriol|calcitriol|mesh-list
14100740|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14100741|NCT02410005|Losartan|losartan|mesh-list
14100742|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14100743|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14100744|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14100745|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14100746|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100747|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14100748|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100749|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14100750|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14100751|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14100752|NCT02410005|Vitamins|vitamins|mesh-ancestor
14100753|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
14100754|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14100755|NCT02410135|Mirabegron|mirabegron|mesh-list
14100756|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14100757|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14100758|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14100759|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926556|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926557|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926558|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926559|NCT03401346|Analgesics|analgesics|mesh-ancestor
13926560|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
13926561|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926562|NCT03401294|Leucovorin|leucovorin|mesh-list
14100760|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100761|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100762|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100763|NCT02410135|Urological Agents|urological agents|mesh-ancestor
14100764|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
14100765|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14100766|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100767|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100768|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14100769|NCT02409810|Analgesics|analgesics|mesh-ancestor
14100770|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
14100771|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100772|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14100773|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14100774|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14100775|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
14100776|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14100777|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100778|NCT02409849|Octreotide|octreotide|mesh-list
14100779|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14100780|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14100781|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100782|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
14100783|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14100784|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14100785|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100786|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14100787|NCT02409862|Oxytocin|oxytocin|mesh-list
14100788|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
14100789|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100790|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100791|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14100792|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14100793|NCT02409498|Bupivacaine|bupivacaine|mesh-list
14100794|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
14100795|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
14100796|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477646|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477647|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
13926563|NCT03401294|Bevacizumab|bevacizumab|mesh-list
13926564|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
13926565|NCT03401294|Irinotecan|irinotecan|mesh-list
13926566|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13926567|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926568|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13926569|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14100797|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100798|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
14100799|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100800|NCT02409537|Resveratrol|resveratrol|mesh-list
14100801|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
14100802|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100803|NCT02409537|Protective Agents|protective agents|mesh-ancestor
14100804|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100805|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100806|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14100807|NCT02409407|Alprostadil|alprostadil|mesh-list
14100808|NCT02409407|Misoprostol|misoprostol|mesh-list
14100809|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14100810|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
14100811|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100812|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100813|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14100814|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14100815|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
13926570|NCT03401294|Growth Substances|growth substances|mesh-ancestor
13926571|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926572|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
13926573|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13926574|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13926575|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926576|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926577|NCT03401294|Antidotes|antidotes|mesh-ancestor
13926578|NCT03401294|Protective Agents|protective agents|mesh-ancestor
13926579|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
13926580|NCT03401294|Vitamins|vitamins|mesh-ancestor
14935938|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14935939|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935940|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14100816|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14100817|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
14100818|NCT02409407|Urological Agents|urological agents|mesh-ancestor
14100819|NCT02409563|Budesonide|budesonide|mesh-list
14100820|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100821|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14100822|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
14100823|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100824|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100825|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14100826|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
14100827|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
14100828|NCT02409563|Hormones|hormones|mesh-ancestor
14100829|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14100830|NCT02409433|Lacosamide|lacosamide|mesh-list
14100831|NCT02409433|Phenytoin|phenytoin|mesh-list
14100832|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
14100833|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14100834|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14100835|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14100836|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100837|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14100838|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14100839|NCT02409017|Insulin|insulin|mesh-list
14100840|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14100841|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100842|NCT02409004|Rifampin|rifampin|mesh-list
14100843|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14100844|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
14100845|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14100846|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100847|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
14100848|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14100849|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100850|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100851|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14100852|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14477648|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
14100853|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14100854|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14935941|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14100855|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14100856|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14100857|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
14100858|NCT02409290|Levofloxacin|levofloxacin|mesh-list
14100859|NCT02409290|Isoniazid|isoniazid|mesh-list
14100860|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
14100861|NCT02409290|Ethambutol|ethambutol|mesh-list
14100862|NCT02409290|Bedaquiline|bedaquiline|mesh-list
14100863|NCT02409290|Clofazimine|clofazimine|mesh-list
14100864|NCT02409290|Kanamycin|kanamycin|mesh-list
14100865|NCT02409290|Prothionamide|prothionamide|mesh-list
14100866|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14100867|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100868|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14100869|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14100870|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100871|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926581|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
13960845|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960846|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13960847|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13960848|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13960849|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960850|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960851|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960852|NCT03151863|Narcotics|narcotics|mesh-ancestor
13960853|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13960854|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13960855|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13960856|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960857|NCT03151772|Metformin|metformin|mesh-list
13960858|NCT03151772|Disulfiram|disulfiram|mesh-list
13960859|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960860|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100872|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100873|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14100874|NCT02409290|Renal Agents|renal agents|mesh-ancestor
14100875|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14100876|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14100877|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
14100878|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14100879|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14100880|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
14100881|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14100882|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100883|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
14100884|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14100885|NCT02409199|Docetaxel|docetaxel|mesh-list
14100886|NCT02409199|Apatinib|apatinib|mesh-list
14100887|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100888|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14100889|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14100890|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14100891|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100892|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14100893|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100894|NCT02409147|Aspirin|aspirin|mesh-list
14100895|NCT02409147|Nystatin|nystatin|mesh-list
14100896|NCT02409147|Prednisone|prednisone|mesh-list
14100897|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
14100898|NCT02409147|Basiliximab|basiliximab|mesh-list
14100899|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100900|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
14100901|NCT02409147|Hormones|hormones|mesh-ancestor
14100902|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14100903|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100904|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14100905|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100906|NCT02409147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14761333|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
14100907|NCT02409147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14761334|NCT03783442|Paclitaxel|paclitaxel|mesh-list
14761335|NCT03783442|Fluorouracil|fluorouracil|mesh-list
14761336|NCT03783442|Capecitabine|capecitabine|mesh-list
14761337|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
14761338|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14761339|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100908|NCT02409147|Analgesics|analgesics|mesh-ancestor
14761340|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14761341|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761342|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761343|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761344|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
13926582|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
13926583|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13926584|NCT03401268|Antibodies|antibodies|mesh-list
13926585|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
13926586|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926587|NCT03401177|Naproxen|naproxen|mesh-list
13926588|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13926589|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926590|NCT03401177|Analgesics|analgesics|mesh-ancestor
13926591|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
13926592|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926593|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926594|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13926595|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926596|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
13926597|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13926598|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926599|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926600|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
14100909|NCT02409147|Sensory System Agents|sensory system agents|mesh-ancestor
14100910|NCT02409147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100911|NCT02409147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14100912|NCT02409147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14100913|NCT02409147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14100914|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100915|NCT02409147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14100916|NCT02409147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14100917|NCT02409147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100918|NCT02409147|Antipyretics|antipyretics|mesh-ancestor
14100919|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14100920|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
14100921|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14100922|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14100923|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
14100924|NCT02409147|Ionophores|ionophores|mesh-ancestor
14100925|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14100926|NCT02409186|Paclitaxel|paclitaxel|mesh-list
14100927|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14100928|NCT02409186|Cisplatin|cisplatin|mesh-list
14100929|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
14100930|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14100931|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100932|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14100933|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14100934|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14100935|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100936|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14100937|NCT02408978|Naproxen|naproxen|mesh-list
14100938|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14100939|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14100940|NCT02408978|Analgesics|analgesics|mesh-ancestor
14100941|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
14100942|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100943|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100944|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100945|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14100946|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
14100947|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14100948|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14100949|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14100950|NCT02409238|Metformin|metformin|mesh-list
14100951|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14100952|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100953|NCT02408679|Vitamin D|vitamin d|mesh-list
14100954|NCT02408679|Vitamins|vitamins|mesh-ancestor
14100955|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
14100956|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938707|NCT01483365|Progestins|progestins|mesh-ancestor
14100957|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14100958|NCT02408705|Acetaminophen|acetaminophen|mesh-list
14100959|NCT02408705|Liraglutide|liraglutide|mesh-list
14100960|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14100961|NCT02408705|Analgesics|analgesics|mesh-ancestor
14100962|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
14100963|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100964|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100965|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
14100966|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14100967|NCT02408705|Incretins|incretins|mesh-ancestor
14100968|NCT02408705|Hormones|hormones|mesh-ancestor
14100969|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14100970|NCT02408744|Pirfenidone|pirfenidone|mesh-list
14100971|NCT02408744|Analgesics|analgesics|mesh-ancestor
14100972|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
14100973|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14100974|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100975|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14100976|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14100977|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100978|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14100979|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14100980|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
14100981|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14100982|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14100983|NCT02408926|Vaccines|vaccines|mesh-list
14100984|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
14100985|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100986|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
14100987|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14100988|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
14100989|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14100990|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14100991|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14100992|NCT02408562|Becaplermin|becaplermin|mesh-list
14100993|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
14100994|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14100995|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14100996|NCT02408562|Growth Substances|growth substances|mesh-ancestor
14100997|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174908|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174909|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14174910|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14174911|NCT04781270|Growth Substances|growth substances|mesh-ancestor
14174912|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174913|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
14174914|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14174915|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174916|NCT04781075|Bupivacaine|bupivacaine|mesh-list
13926601|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13926602|NCT03401073|Antibodies|antibodies|mesh-list
13926603|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
13926604|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13926605|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
13926606|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926607|NCT03401060|Denosumab|denosumab|mesh-list
13926608|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13926609|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926610|NCT03401047|Estradiol|estradiol|mesh-list
13926611|NCT03401047|Estrogens|estrogens|mesh-ancestor
14174917|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
14174918|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
14174919|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14174920|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174921|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
14174922|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174923|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
14174924|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14174925|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14174926|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
14174927|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14174928|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14174929|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926612|NCT03401047|Hormones|hormones|mesh-ancestor
13926613|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174930|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14174931|NCT04780867|Vaccines|vaccines|mesh-list
14100998|NCT02408393|Ropivacaine|ropivacaine|mesh-list
14100999|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
14101000|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
14101001|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101002|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101003|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
14101004|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101005|NCT02408354|Glycerol|glycerol|mesh-list
14101006|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13926614|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926615|NCT03400995|Ziresovir|ziresovir|mesh-list
13926616|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
13926617|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926618|NCT03400969|Glycerol|glycerol|mesh-list
13926619|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13926620|NCT03400969|Protective Agents|protective agents|mesh-ancestor
13926621|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926622|NCT03400826|Simvastatin|simvastatin|mesh-list
13926623|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13926624|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13926625|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
13926626|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926627|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13926628|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13926629|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926630|NCT03400735|Cefdinir|cefdinir|mesh-list
14761345|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761346|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761347|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
14761348|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761349|NCT03773107|Dexamethasone|dexamethasone|mesh-list
13926631|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926632|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926633|NCT03400722|Clomiphene|clomiphene|mesh-list
13926634|NCT03400722|Hormones|hormones|mesh-list
13926635|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926636|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926637|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13926638|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
14101007|NCT02408354|Protective Agents|protective agents|mesh-ancestor
14101008|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101009|NCT02408185|Colistin|colistin|mesh-list
14101010|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14101011|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101012|NCT02408302|Midazolam|midazolam|mesh-list
14101013|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14101014|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14101015|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14761350|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13926639|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13926640|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
13926641|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13926642|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13926643|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13926644|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
13926645|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13926646|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
13926647|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926648|NCT03400709|Expectorants|expectorants|mesh-ancestor
13926649|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
13926650|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13926651|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
13926652|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926653|NCT03400709|Protective Agents|protective agents|mesh-ancestor
13926654|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926655|NCT03400709|Antidotes|antidotes|mesh-ancestor
13926656|NCT03400683|Letrozole|letrozole|mesh-list
13926657|NCT03400683|Misoprostol|misoprostol|mesh-list
13926658|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926659|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14101016|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101017|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14101018|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14101019|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926660|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13926661|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101020|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13926662|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926663|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13926664|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
13926665|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926666|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926667|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13926668|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
13926669|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13926670|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13926671|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13926672|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
13926673|NCT03400592|Irinotecan|irinotecan|mesh-list
13926674|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
13926675|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13926676|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13926677|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926678|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926679|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926680|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13926681|NCT03400423|Caffeine|caffeine|mesh-list
14101021|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
14101022|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
14101023|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
14101024|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
14101025|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101026|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101027|NCT02408328|Caffeine|caffeine|mesh-list
14101028|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
14101029|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101030|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14101031|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101032|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14101033|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101034|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14101035|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14101036|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
14101037|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101038|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
14101039|NCT02408289|Procyanidin|procyanidin|mesh-list
14101040|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
14101041|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101042|NCT02408289|Protective Agents|protective agents|mesh-ancestor
14101043|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101044|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14101045|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14101046|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101047|NCT02408419|Bupivacaine|bupivacaine|mesh-list
14101048|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
14101049|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
14101050|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101051|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101052|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
14101053|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101054|NCT02408172|Metoprolol|metoprolol|mesh-list
14101055|NCT02408172|Amlodipine|amlodipine|mesh-list
14101056|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14101057|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14101058|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14101059|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101060|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14101061|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101062|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
14101063|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14101064|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
14101065|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
14101066|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101067|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14101068|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14101069|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14101070|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
14101071|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101072|NCT02408146|Celecoxib|celecoxib|mesh-list
14101073|NCT02408146|Parecoxib|parecoxib|mesh-list
14101074|NCT02408146|Fentanyl|fentanyl|mesh-list
14101075|NCT02408146|Ondansetron|ondansetron|mesh-list
14101076|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14101077|NCT02408146|Narcotics|narcotics|mesh-ancestor
14101078|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101079|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101080|NCT02408146|Analgesics|analgesics|mesh-ancestor
14101081|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
14101082|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101083|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14101084|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14101085|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
14101086|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
14101087|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101088|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14101089|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14101090|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101091|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101092|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14101093|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14101094|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101095|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
14101096|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
14101097|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101098|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
14101099|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
14101100|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14101101|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
14101102|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926682|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13926683|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926684|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13926685|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926686|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926687|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13926688|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14101103|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14101104|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14101105|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14101106|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14101107|NCT02407899|Vitamin D|vitamin d|mesh-list
14101108|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
14101109|NCT02407899|Insulin|insulin|mesh-list
14101110|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14101111|NCT02407899|Metformin|metformin|mesh-list
14101112|NCT02407899|Saxagliptin|saxagliptin|mesh-list
14101113|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14101114|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14101115|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101116|NCT02407899|Vitamins|vitamins|mesh-ancestor
14101117|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
14101118|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14101119|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14101120|NCT02407899|Incretins|incretins|mesh-ancestor
14101121|NCT02407899|Hormones|hormones|mesh-ancestor
14101122|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101123|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14101124|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101125|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101126|NCT02408042|Rituximab|rituximab|mesh-list
14101127|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
14101128|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14101129|NCT02408042|Carboplatin|carboplatin|mesh-list
14101130|NCT02408042|Etoposide|etoposide|mesh-list
14101131|NCT02408042|Ifosfamide|ifosfamide|mesh-list
14101132|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14101133|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101134|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
14101135|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101136|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477649|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
14101137|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14101138|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14101139|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14101140|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174932|NCT04780867|Immunologic Factors|immunologic factors|mesh-ancestor
14101141|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101142|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14101143|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
14101144|NCT02408003|Simendan|simendan|mesh-list
14101145|NCT02408003|Milrinone|milrinone|mesh-list
14101146|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14101147|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
14101148|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14101149|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14101150|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101151|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101152|NCT02408003|Protective Agents|protective agents|mesh-ancestor
14101153|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101154|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14101155|NCT02407821|Citalopram|citalopram|mesh-list
14101156|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14101157|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14101158|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14101159|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926689|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
13926690|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926691|NCT03400332|Nivolumab|nivolumab|mesh-list
13926692|NCT03400332|Ipilimumab|ipilimumab|mesh-list
13926693|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14101160|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101161|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
14101162|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101163|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14101164|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
14101165|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14101166|NCT02407912|Cisplatin|cisplatin|mesh-list
14101167|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101168|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14101169|NCT02407834|Eusol|eusol|mesh-list
14101170|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
14101171|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926694|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926695|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13926696|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926697|NCT03400267|Acetaminophen|acetaminophen|mesh-list
13926698|NCT03400267|Fentanyl|fentanyl|mesh-list
13926699|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13926700|NCT03400267|Narcotics|narcotics|mesh-ancestor
13926701|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926702|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926703|NCT03400267|Analgesics|analgesics|mesh-ancestor
13926704|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
13926705|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926706|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13926707|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13926708|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
13926709|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
13926710|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926711|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
13926712|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
13926713|NCT03400254|Gedatolisib|gedatolisib|mesh-list
13926714|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
13926715|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14101172|NCT02407782|Ivermectin|ivermectin|mesh-list
14101173|NCT02407782|Permethrin|permethrin|mesh-list
14101174|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14101175|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101176|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101177|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761351|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
13926716|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13926717|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926718|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926719|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926720|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926721|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14101178|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13926722|NCT03400241|Bromides|bromides|mesh-list
13926723|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
13926724|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13926725|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
13926726|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926727|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926728|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13926729|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
13926730|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
13926731|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13926732|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
13926733|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926734|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926735|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
13926736|NCT03400189|Sulthiame|sulthiame|mesh-list
13926737|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
13926738|NCT03400111|Acetaminophen|acetaminophen|mesh-list
13926739|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926740|NCT03400111|Analgesics|analgesics|mesh-ancestor
13926741|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
13926742|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926743|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926744|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
13926745|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
13926746|NCT03400020|Vitamins|vitamins|mesh-ancestor
13926747|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
13926748|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926749|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
13926750|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926751|NCT03400020|Protective Agents|protective agents|mesh-ancestor
13926752|NCT03399955|Amphotericin B|amphotericin b|mesh-list
13926753|NCT03399955|Paromomycin|paromomycin|mesh-list
13926754|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13926755|NCT03399955|Miltefosine|miltefosine|mesh-list
13926756|NCT03399955|Amebicides|amebicides|mesh-ancestor
13926757|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13926758|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13926759|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926760|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13926761|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
14101179|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
14101180|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101181|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101182|NCT02407600|Aprepitant|aprepitant|mesh-list
14101183|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
14101184|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
14101185|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
14101186|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101187|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101188|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101189|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14101190|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101191|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101192|NCT02407626|Propofol|propofol|mesh-list
14101193|NCT02407626|Sevoflurane|sevoflurane|mesh-list
14101194|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14101195|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101196|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101197|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14101198|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
13926762|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926763|NCT03399903|Mesalamine|mesalamine|mesh-list
13926764|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13926765|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926766|NCT03399903|Analgesics|analgesics|mesh-ancestor
13926767|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
13926768|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926769|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926770|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101199|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
14101200|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14101201|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14101202|NCT02407392|Acetic Acid|acetic acid|mesh-list
14101203|NCT02407392|Retinol acetate|retinol acetate|mesh-list
14101204|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14101205|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101206|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14101207|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
14101208|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101209|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14101210|NCT02407392|Protective Agents|protective agents|mesh-ancestor
14101211|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101212|NCT02407366|Carboplatin|carboplatin|mesh-list
14101213|NCT02407366|Pemetrexed|pemetrexed|mesh-list
14101214|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101215|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101216|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101217|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14101218|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14101219|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14101220|NCT02407340|Oxytocin|oxytocin|mesh-list
14101221|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
14101222|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14101223|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101224|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14101225|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101226|NCT02407509|Everolimus|everolimus|mesh-list
14101227|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101228|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101229|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
14101230|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101231|NCT02407548|Vitamin E|vitamin e|mesh-list
14101232|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
14101233|NCT02407548|Ubiquinone|ubiquinone|mesh-list
14101234|NCT02407548|Vitamins|vitamins|mesh-ancestor
14101235|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
14101236|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101237|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
14101238|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101239|NCT02407548|Protective Agents|protective agents|mesh-ancestor
14101240|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
14101241|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14101242|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101243|NCT02407210|Olmesartan|olmesartan|mesh-list
13926771|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926772|NCT03399838|Midazolam|midazolam|mesh-list
13926773|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
13926774|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13926775|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926776|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926777|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926778|NCT03399838|Analgesics|analgesics|mesh-ancestor
14101244|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14101245|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14101246|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14761352|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
13926779|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
13926780|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101247|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14101248|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14101249|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101250|NCT02407314|Aspirin|aspirin|mesh-list
14101251|NCT02407314|Ticagrelor|ticagrelor|mesh-list
14101252|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14101253|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14101254|NCT02407314|Analgesics|analgesics|mesh-ancestor
14101255|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
14101256|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101257|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101258|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101259|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101260|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14101261|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14101262|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101263|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14101264|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14101265|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101266|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
14101267|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14101268|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14101269|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14101270|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
14101271|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101272|NCT02407080|Interferons|interferons|mesh-list
14101273|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
14101274|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
14101275|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14101276|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101277|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
14101278|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101279|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
14101280|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101281|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14101282|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14101283|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101284|NCT02406950|Incretins|incretins|mesh-ancestor
14101285|NCT02406950|Hormones|hormones|mesh-ancestor
14101286|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101287|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14101288|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
14101289|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101290|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101291|NCT02406911|Ticagrelor|ticagrelor|mesh-list
14101292|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14101293|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14101294|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14101295|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14101296|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
14101297|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101298|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101299|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101300|NCT02406872|Propofol|propofol|mesh-list
14101301|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14101302|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14761353|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761354|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761355|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14761356|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
14761357|NCT03773107|Hormones|hormones|mesh-ancestor
14761358|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938708|NCT01483365|Hormones|hormones|mesh-ancestor
13926781|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13926782|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13926783|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13926784|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926785|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926786|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960861|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13926787|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13926788|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13926789|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13926790|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926791|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13926792|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
13926793|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
13926794|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
13926795|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
13926796|NCT03399708|Apremilast|apremilast|mesh-list
13926797|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13926798|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926799|NCT03399708|Analgesics|analgesics|mesh-ancestor
13926800|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
13926801|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926802|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926803|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13926804|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926805|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13926806|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13926807|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101303|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101304|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14101305|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
13926808|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926809|NCT03399669|Gefitinib|gefitinib|mesh-list
13926810|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761359|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761360|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761361|NCT03772925|Belinostat|belinostat|mesh-list
14101306|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
14101307|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
14101308|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
14101309|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14101310|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101311|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101312|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
14101313|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101314|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101315|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14101316|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
14101317|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101318|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14174933|NCT04780867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174934|NCT04780945|Olaparib|olaparib|mesh-list
14174935|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14761362|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14761363|NCT03772925|Pevonedistat|pevonedistat|mesh-list
14761364|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761365|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761366|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14761367|NCT03768960|Daratumumab|daratumumab|mesh-list
14761368|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761369|NCT03765918|Cisplatin|cisplatin|mesh-list
14761370|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
14761371|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761372|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761373|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
14761374|NCT03760718|Procaine|procaine|mesh-list
14174936|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174937|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174938|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174939|NCT04780659|Vaccines|vaccines|mesh-list
14174940|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
14174941|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174942|NCT04780750|Docetaxel|docetaxel|mesh-list
14174943|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926811|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174944|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14174945|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14174946|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761375|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
13926812|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926813|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479255|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13926814|NCT03399643|Atezolizumab|atezolizumab|mesh-list
13926815|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926816|NCT03399604|Treprostinil|treprostinil|mesh-list
13926817|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13926818|NCT03399526|Calcitriol|calcitriol|mesh-list
14761376|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
14761377|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14761378|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926819|NCT03399526|Betamethasone|betamethasone|mesh-list
14101319|NCT02406508|Sorafenib|sorafenib|mesh-list
14101320|NCT02406508|Melphalan|melphalan|mesh-list
14101321|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101322|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14101323|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101324|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101325|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14101326|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
14101327|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14101328|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101329|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
14101330|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101331|NCT02406690|Leuprolide|leuprolide|mesh-list
14101332|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14101333|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14101334|NCT02406690|Estradiol|estradiol|mesh-list
14101335|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14101336|NCT02406690|Progesterone|progesterone|mesh-list
14101337|NCT02406690|Estrogens|estrogens|mesh-ancestor
14101338|NCT02406690|Hormones|hormones|mesh-ancestor
14101339|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101340|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101341|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14101342|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
14101343|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14101344|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14101345|NCT02406690|Progestins|progestins|mesh-ancestor
14101346|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14101347|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
14101348|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14101349|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101350|NCT02406703|Mepivacaine|mepivacaine|mesh-list
14101351|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
13926820|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
13926821|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13926822|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
13926823|NCT03399526|Clobetasol|clobetasol|mesh-list
13926824|NCT03399526|Prednicarbate|prednicarbate|mesh-list
13926825|NCT03399526|Calcipotriene|calcipotriene|mesh-list
13926826|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13926827|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13926828|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
13926829|NCT03399526|Hormones|hormones|mesh-ancestor
13926830|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926831|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926832|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13926833|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
13926834|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
13926835|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13926836|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13926837|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13926838|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926839|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14101352|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
14101353|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
14101354|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101355|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101356|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
14101357|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926840|NCT03399526|Vitamins|vitamins|mesh-ancestor
13926841|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
13926842|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13926843|NCT03399487|Ceritinib|ceritinib|mesh-list
13926844|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926845|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13926846|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926847|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101358|NCT02406521|Sorafenib|sorafenib|mesh-list
13926848|NCT03399474|Lidocaine|lidocaine|mesh-list
13926849|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
13926850|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
13926851|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
13926852|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926853|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926854|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
13926855|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926856|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14101359|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14101360|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101361|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14101362|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101363|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101364|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14101365|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14101366|NCT02406222|Dexamethasone|dexamethasone|mesh-list
14101367|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
14101368|NCT02406222|Pomalidomide|pomalidomide|mesh-list
14101369|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101370|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
14101371|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101372|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101373|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14101374|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
14101375|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101376|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101377|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14101378|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101379|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
14101380|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
14101381|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101382|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101383|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
14101384|NCT02406222|Hormones|hormones|mesh-ancestor
14101385|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101386|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14101387|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14101388|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14101389|NCT02406222|Growth Substances|growth substances|mesh-ancestor
14101390|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14101391|NCT02406300|Bupivacaine|bupivacaine|mesh-list
14101392|NCT02406300|Ropivacaine|ropivacaine|mesh-list
14101393|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
14101394|NCT02406300|Sevoflurane|sevoflurane|mesh-list
14101395|NCT02406300|Desflurane|desflurane|mesh-list
14101396|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
14101397|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
14101398|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101399|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101400|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
14101401|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101402|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14101403|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14101404|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
14101405|NCT02406183|Ipilimumab|ipilimumab|mesh-list
14101406|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14101407|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101408|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14101409|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101410|NCT02406144|Dexamethasone|dexamethasone|mesh-list
14101411|NCT02406144|Lenalidomide|lenalidomide|mesh-list
14101412|NCT02406144|Ixazomib|ixazomib|mesh-list
14101413|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101414|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
14101415|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
14101416|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101417|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101418|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101419|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
13926857|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14101420|NCT02406144|Hormones|hormones|mesh-ancestor
14101421|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101422|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14101423|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926858|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13926859|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13926860|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926861|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13926862|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926863|NCT03399474|Analgesics|analgesics|mesh-ancestor
13926864|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13926865|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13926866|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13926867|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926868|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960862|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
13960863|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960864|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960865|NCT03151876|Gemcitabine|gemcitabine|mesh-list
13960866|NCT03151876|Busulfan|busulfan|mesh-list
13960867|NCT03151876|Cladribine|cladribine|mesh-list
13960868|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13960869|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
13960870|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960871|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960872|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
13960873|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960874|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960875|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960876|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
13960877|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960878|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
13960879|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13960880|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13960881|NCT03151720|Loratadine|loratadine|mesh-list
13960882|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
13960883|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960884|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13960885|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13960886|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14101424|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
14101425|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14101426|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14101427|NCT02406144|Growth Substances|growth substances|mesh-ancestor
14101428|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
14101429|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
14101430|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101431|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101432|NCT02406170|Paclitaxel|paclitaxel|mesh-list
14101433|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14101434|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101435|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14101436|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14101437|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14101438|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960887|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
13960888|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
13960889|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960890|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960891|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960892|NCT03151681|Propranolol|propranolol|mesh-list
13960893|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13960894|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13960895|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960896|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960897|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960898|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960899|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14101439|NCT02406014|Diclofenac|diclofenac|mesh-list
14101440|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14101441|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14101442|NCT02406014|Analgesics|analgesics|mesh-ancestor
14101443|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
14101444|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101445|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960900|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14761379|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
14101446|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101447|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101448|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14101449|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101450|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101451|NCT02405910|Gemcitabine|gemcitabine|mesh-list
14101452|NCT02405910|Paclitaxel|paclitaxel|mesh-list
14101453|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14101454|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101455|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14101456|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14101457|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14101458|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101459|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14101460|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
14101461|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
14101462|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101463|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477650|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477651|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14477652|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
14477653|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
14477654|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477655|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477656|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477657|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
14101464|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101465|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
14101466|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101467|NCT02406066|Oxazepam|oxazepam|mesh-list
14101468|NCT02406066|Metyrapone|metyrapone|mesh-list
14101469|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
14101470|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101471|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101472|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14101473|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101474|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101475|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14101476|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14101477|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14101478|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
14101479|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
14101480|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101481|NCT02406092|Prednisone|prednisone|mesh-list
14101482|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
14101483|NCT02406092|Rituximab|rituximab|mesh-list
14101484|NCT02406092|Doxorubicin|doxorubicin|mesh-list
14101485|NCT02406092|Fludarabine|fludarabine|mesh-list
14101486|NCT02406092|Vincristine|vincristine|mesh-list
14101487|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101488|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
14101489|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101490|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101491|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14101492|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
14101493|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101494|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101495|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14101496|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14101497|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14101498|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14101499|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14101500|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477658|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101501|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101502|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
14101503|NCT02406092|Hormones|hormones|mesh-ancestor
14101504|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101505|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14101506|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14101507|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
14101508|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
14101509|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
14101510|NCT02405988|Remifentanil|remifentanil|mesh-list
14101511|NCT02405988|Naloxone|naloxone|mesh-list
14101512|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14101513|NCT02405988|Narcotics|narcotics|mesh-ancestor
14101514|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101515|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101516|NCT02405988|Analgesics|analgesics|mesh-ancestor
14101517|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
14101518|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101519|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13926869|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
13926870|NCT03399448|Fludarabine|fludarabine|mesh-list
13926871|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13926872|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
13926873|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926874|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926875|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13926876|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
13926877|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926878|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926879|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13926880|NCT03399435|Epinephrine|epinephrine|mesh-list
13926881|NCT03399435|Racepinephrine|racepinephrine|mesh-list
13926882|NCT03399435|Bupivacaine|bupivacaine|mesh-list
13926883|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
13926884|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
13926885|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
13926886|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
13926887|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926888|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926889|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
13926890|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926891|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13926892|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14101520|NCT02406053|Antioxidants|antioxidants|mesh-list
14101521|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101522|NCT02406053|Protective Agents|protective agents|mesh-ancestor
14101523|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101524|NCT02405858|Prednisolone|prednisolone|mesh-list
14101525|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
14101526|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101527|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
14101528|NCT02405858|Hormones|hormones|mesh-ancestor
14101529|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101530|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101531|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14101532|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101533|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14101534|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101535|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101536|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
14101537|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14101538|NCT02405715|Oxytocin|oxytocin|mesh-list
14101539|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
14101540|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14101541|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101542|NCT02405598|Albuterol|albuterol|mesh-list
13926893|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926894|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101543|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14101544|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
14101545|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101546|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101547|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14101548|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
14101549|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
14101550|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13926895|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926896|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13926897|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13926898|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
13926899|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13926900|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
13926901|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
13926902|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
13926903|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13926904|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13926905|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13926906|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13926907|NCT03399318|Acetaminophen|acetaminophen|mesh-list
14101551|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14101552|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14101553|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14101554|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
14101555|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101556|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101557|NCT02405793|Meloxicam|meloxicam|mesh-list
14101558|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14101559|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14101560|NCT02405793|Analgesics|analgesics|mesh-ancestor
14101561|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
14101562|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101563|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101564|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101565|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101566|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14101567|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14101568|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101569|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101570|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
14101571|NCT02405689|Remifentanil|remifentanil|mesh-list
14101572|NCT02405689|Sevoflurane|sevoflurane|mesh-list
14101573|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14101574|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101575|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101576|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14101577|NCT02405689|Analgesics|analgesics|mesh-ancestor
14101578|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
14101579|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101580|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13926908|NCT03399318|Ibuprofen|ibuprofen|mesh-list
13926909|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926910|NCT03399318|Analgesics|analgesics|mesh-ancestor
13926911|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
14101581|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14101582|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14101583|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
14101584|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101585|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101586|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14101587|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14101588|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
14101589|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
14101590|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14101591|NCT02405689|Narcotics|narcotics|mesh-ancestor
14101592|NCT02405364|Dexamethasone|dexamethasone|mesh-list
14101593|NCT02405364|Lenalidomide|lenalidomide|mesh-list
14101594|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101595|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
13926912|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926913|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926914|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
14101596|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
13926915|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13926916|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13926917|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13926918|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13926919|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926920|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926921|NCT03399201|Anesthetics|anesthetics|mesh-list
13926922|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13926923|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926924|NCT03399110|Capecitabine|capecitabine|mesh-list
13926925|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
13926926|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13926927|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
13926928|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926929|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926930|NCT03399032|Caspofungin|caspofungin|mesh-list
14101597|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101598|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101599|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101600|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
14101601|NCT02405364|Hormones|hormones|mesh-ancestor
14101602|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101603|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13926931|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
13926932|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13926933|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13926934|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926935|NCT03399019|Midazolam|midazolam|mesh-list
13926936|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
13926937|NCT03399019|Propofol|propofol|mesh-list
13926938|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13926939|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101604|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101605|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
14101606|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14101607|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14101608|NCT02405364|Growth Substances|growth substances|mesh-ancestor
14101609|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
14101610|NCT02405156|Letrozole|letrozole|mesh-list
14101611|NCT02405156|Misoprostol|misoprostol|mesh-list
14101612|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101613|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14101614|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14101615|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101616|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101617|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14101618|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
14101619|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101620|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101621|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14101622|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
13926940|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926941|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13926942|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
13926943|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
13926944|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13926945|NCT03399019|Analgesics|analgesics|mesh-ancestor
13926946|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
13926947|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926948|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13926949|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13926950|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13926951|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
13926952|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926953|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926954|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13926955|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13926956|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14101623|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14101624|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14101625|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101626|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
14101627|NCT02405130|Epinephrine|epinephrine|mesh-list
14101628|NCT02405130|Racepinephrine|racepinephrine|mesh-list
14101629|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
13926957|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13926958|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
13926959|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
13926960|NCT03398993|Clomiphene|clomiphene|mesh-list
13926961|NCT03398993|Enclomiphene|enclomiphene|mesh-list
13926962|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
13926963|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13926964|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13926965|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
14101630|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14101631|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14101632|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
14101633|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926966|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926967|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926968|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13926969|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
13926970|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13926971|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13926972|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13926973|NCT03398941|Octreotide|octreotide|mesh-list
13926974|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13926975|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13926976|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13926977|NCT03398876|Nicotine|nicotine|mesh-list
13926978|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13926979|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
13926980|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13926981|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926982|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13926983|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13926984|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
13926985|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13926986|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13926987|NCT03398824|Metformin|metformin|mesh-list
13926988|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13926989|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926990|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13926991|NCT03398811|Etonogestrel|etonogestrel|mesh-list
13926992|NCT03398811|Desogestrel|desogestrel|mesh-list
13926993|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
13926994|NCT03398811|Progesterone|progesterone|mesh-list
13926995|NCT03398811|Progestins|progestins|mesh-ancestor
13926996|NCT03398811|Hormones|hormones|mesh-ancestor
13926997|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13926998|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13926999|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13927000|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
13927001|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13927002|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13927003|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13927004|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13927005|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13927006|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13927007|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13927008|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927009|NCT03398785|Epinephrine|epinephrine|mesh-list
13927010|NCT03398785|Racepinephrine|racepinephrine|mesh-list
13927011|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
13927012|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13927013|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927014|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927015|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927016|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927017|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927018|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13927019|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13927020|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
13927021|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927022|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14101634|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927023|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
14101635|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101636|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13927024|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
13927025|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
13927026|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13927027|NCT03398759|Butorphanol|butorphanol|mesh-list
13927028|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13927029|NCT03398759|Narcotics|narcotics|mesh-ancestor
14101637|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14101638|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
14101639|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101640|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14101641|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
14101642|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
14101643|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
14101644|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14101645|NCT02405338|Vaccines|vaccines|mesh-list
14101646|NCT02405338|Immunologic Factors|immunologic factors|mesh-ancestor
14101647|NCT02405338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927030|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927031|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927032|NCT03398759|Analgesics|analgesics|mesh-ancestor
13927033|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
13927034|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927035|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
13927036|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
14174947|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174948|NCT04780854|Metformin|metformin|mesh-list
14174949|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14174950|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183620|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183621|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14183622|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183623|NCT04726592|Analgesics|analgesics|mesh-ancestor
14183624|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
14183625|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14183626|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14183627|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14183628|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183629|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
14183630|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14183631|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14183632|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183633|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14183634|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
14183635|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
14183636|NCT04726332|Prednisone|prednisone|mesh-list
14761380|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761381|NCT03748641|Prednisone|prednisone|mesh-list
14761382|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
13927037|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13927038|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
13927039|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13927040|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927041|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13927042|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927043|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
13927044|NCT03398473|Hematinics|hematinics|mesh-ancestor
13927045|NCT03398434|Apixaban|apixaban|mesh-list
13927046|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13927047|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
13927048|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14183637|NCT04726332|Fulvestrant|fulvestrant|mesh-list
14183638|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14183639|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
14761383|NCT03748641|Niraparib|niraparib|mesh-list
13927049|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
13927050|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927051|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927052|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
13927053|NCT03398252|Doxazosin|doxazosin|mesh-list
13927054|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13927055|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13927056|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14183640|NCT04726332|Hormones|hormones|mesh-ancestor
14183641|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14935942|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927057|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14101648|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
14101649|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14101650|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101651|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14101652|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101653|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
14101654|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14101655|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14101656|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101657|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
13927058|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927059|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927060|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927061|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101658|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
14101659|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101660|NCT02404844|Tamoxifen|tamoxifen|mesh-list
14101661|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14101662|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
14101663|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101664|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101665|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13927062|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13927063|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
13927064|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101666|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101667|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14101668|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14101669|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14101670|NCT02404779|Cisatracurium|cisatracurium|mesh-list
14101671|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14101672|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14101673|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101674|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101675|NCT02405013|Ribavirin|ribavirin|mesh-list
14101676|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
14101677|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14101678|NCT02405013|Ledipasvir|ledipasvir|mesh-list
14101679|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
14101680|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101681|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
14101682|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101683|NCT02404688|Ethanol|ethanol|mesh-list
14101684|NCT02404688|Dronabinol|dronabinol|mesh-list
14101685|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14101686|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101687|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101688|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101689|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
14101690|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14101691|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13927065|NCT03398122|Apatinib|apatinib|mesh-list
13927066|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927067|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13927068|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927069|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927070|NCT03398083|Alprazolam|alprazolam|mesh-list
14101692|NCT02404688|Analgesics|analgesics|mesh-ancestor
14101693|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
14101694|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101695|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14101696|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14101697|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101698|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101699|NCT02404688|Hormones|hormones|mesh-ancestor
14101700|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101701|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
14101702|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14101703|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
14101704|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101705|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
14101706|NCT02404454|Protective Agents|protective agents|mesh-ancestor
14101707|NCT02404337|Betaine|betaine|mesh-list
14101708|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101709|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
14101710|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14101711|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
14101712|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101713|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14101714|NCT02404376|Exenatide|exenatide|mesh-list
14101715|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14101716|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101717|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14101718|NCT02404376|Incretins|incretins|mesh-ancestor
14101719|NCT02404376|Hormones|hormones|mesh-ancestor
14101720|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101721|NCT02404623|Vitamin D|vitamin d|mesh-list
14101722|NCT02404623|Vitamins|vitamins|mesh-ancestor
14101723|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
14101724|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101725|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14101726|NCT02404363|Clopidogrel|clopidogrel|mesh-list
14101727|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14101728|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14761384|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761385|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
14761386|NCT03748641|Hormones|hormones|mesh-ancestor
14761387|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761388|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761389|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761390|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761391|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14761392|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761393|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761394|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
14761395|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14761396|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13927071|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14101729|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14101730|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14101731|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
14101732|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101733|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101734|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101735|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
14101736|NCT02404519|Vitamin K|vitamin k|mesh-list
14101737|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
14101738|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14101739|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14101740|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101741|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
14101742|NCT02404519|Coagulants|coagulants|mesh-ancestor
14101743|NCT02404519|Vitamins|vitamins|mesh-ancestor
14101744|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
14101745|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101746|NCT02404259|Ritonavir|ritonavir|mesh-list
14101747|NCT02404259|Lopinavir|lopinavir|mesh-list
13927072|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927073|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927074|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13927075|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13927076|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13927077|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
13927078|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
14477659|NCT02436759|Phenylephrine|phenylephrine|mesh-list
13927079|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101748|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14101749|NCT02404259|Tenofovir|tenofovir|mesh-list
14101750|NCT02404259|Efavirenz|efavirenz|mesh-list
14101751|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14477660|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
13927080|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927081|NCT03398044|Dexamethasone|dexamethasone|mesh-list
13927082|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927083|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
14935943|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14935944|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14935945|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935946|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
14935947|NCT01466465|Vitamin D|vitamin d|mesh-list
13927084|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
13927085|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927086|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927087|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13927088|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
14101752|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14101753|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
14101754|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101755|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101756|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14101757|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14101758|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
14101759|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101760|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14101761|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14101762|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14101763|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14101764|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14101765|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14101766|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14101767|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14101768|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14101769|NCT02404142|Atracurium|atracurium|mesh-list
14101770|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14101771|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14101772|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14101773|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101774|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101775|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14101776|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14101777|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
14101778|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101779|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101780|NCT02404077|Clonidine|clonidine|mesh-list
14101781|NCT02404077|Analgesics|analgesics|mesh-ancestor
14101782|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
14101783|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101784|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101785|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14101786|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
14101787|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
14101788|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14101789|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14101790|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14101791|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
14101792|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935948|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
14935949|NCT01466465|Vitamins|vitamins|mesh-ancestor
14101793|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101794|NCT02404233|Darunavir|darunavir|mesh-list
14101795|NCT02404233|Cobicistat|cobicistat|mesh-list
14101796|NCT02404233|Rilpivirine|rilpivirine|mesh-list
14101797|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14101798|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14101799|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
14101800|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101801|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101802|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14101803|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14101804|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
14101805|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927089|NCT03398044|Hormones|hormones|mesh-ancestor
13927090|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927091|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13927092|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927093|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
13927094|NCT03398031|Antacids|antacids|mesh-ancestor
14101806|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14101807|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14101808|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14101809|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14101810|NCT02404064|Metronidazole|metronidazole|mesh-list
14101811|NCT02404064|Cefotaxime|cefotaxime|mesh-list
14101812|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14101813|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14101814|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14101815|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14101816|NCT02404038|NuvaRing|nuvaring|mesh-list
13927095|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927096|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13927097|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13927098|NCT03398018|Hormones|hormones|mesh-ancestor
13927099|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927100|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927101|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
14101817|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14101818|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14101819|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
14101820|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14101821|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101822|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14101823|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14101824|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14101825|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14101826|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14101827|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14101828|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14101829|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14101830|NCT02404051|Everolimus|everolimus|mesh-list
14101831|NCT02404051|Fulvestrant|fulvestrant|mesh-list
14101832|NCT02404051|Exemestane|exemestane|mesh-list
14101833|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101834|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14101835|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
14101836|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101837|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14101838|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14101839|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14101840|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
14101841|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101842|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14101843|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13927102|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13927103|NCT03397953|Vinorelbine|vinorelbine|mesh-list
13927104|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13927105|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927106|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
13927107|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
13927108|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
13927109|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101844|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101845|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101846|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
14101847|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14101848|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14101849|NCT02403856|Prednisolone|prednisolone|mesh-list
14101850|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
14101851|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14101852|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
14101853|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101854|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
14101855|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
14101856|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101857|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101858|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101859|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
14101860|NCT02403856|Hormones|hormones|mesh-ancestor
14101861|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101862|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14101863|NCT02403856|Protective Agents|protective agents|mesh-ancestor
14101864|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14101865|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101866|NCT02403804|Betaine|betaine|mesh-list
14101867|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101868|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
14101869|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14101870|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
14101871|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101872|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14101873|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
14101874|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14101875|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14101876|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101877|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
13927110|NCT03397914|Colistin|colistin|mesh-list
13927111|NCT03397914|Polymyxins|polymyxins|mesh-list
13927112|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13927113|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960901|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
13960902|NCT03151707|Niacinamide|niacinamide|mesh-list
13960903|NCT03151707|Niacin|niacin|mesh-list
13960904|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
13960905|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
13960906|NCT03151707|Vitamins|vitamins|mesh-ancestor
13960907|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
13960908|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960909|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13960910|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
13960911|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960912|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14101878|NCT02403596|Coagulants|coagulants|mesh-ancestor
14101879|NCT02403544|Capecitabine|capecitabine|mesh-list
14101880|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
14101881|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14101882|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
14101883|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101884|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101885|NCT02403687|Topiramate|topiramate|mesh-list
14101886|NCT02403687|Diclofenac|diclofenac|mesh-list
14101887|NCT02403687|Meloxicam|meloxicam|mesh-list
14101888|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
14101889|NCT02403687|Lidocaine|lidocaine|mesh-list
14101890|NCT02403687|Clonidine|clonidine|mesh-list
14101891|NCT02403687|Sumatriptan|sumatriptan|mesh-list
14101892|NCT02403687|Ketamine|ketamine|mesh-list
14101893|NCT02403687|Gabapentin|gabapentin|mesh-list
14101894|NCT02403687|Amitriptyline|amitriptyline|mesh-list
14101895|NCT02403687|Tizanidine|tizanidine|mesh-list
14101896|NCT02403687|Bupivacaine|bupivacaine|mesh-list
14101897|NCT02403687|Prilocaine|prilocaine|mesh-list
14101898|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
14101899|NCT02403687|Baclofen|baclofen|mesh-list
14101900|NCT02403687|Capsaicin|capsaicin|mesh-list
14101901|NCT02403687|Menthol|menthol|mesh-list
14101902|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
14101903|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
13927114|NCT03397888|Betrixaban|betrixaban|mesh-list
13927115|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13927116|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
13927117|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13927118|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
13927119|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927120|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927121|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
13927122|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
13927123|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
14935950|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
14935951|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935952|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14935953|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14935954|NCT01466478|Calcitriol|calcitriol|mesh-list
14935955|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14935956|NCT01466478|Calcipotriene|calcipotriene|mesh-list
14935957|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14935958|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13927124|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
13927125|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14101904|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14101905|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101906|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
14101907|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101908|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14101909|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14101910|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14101911|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13927126|NCT03397875|Protective Agents|protective agents|mesh-ancestor
13927127|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927128|NCT03397862|Donepezil|donepezil|mesh-list
14101912|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101913|NCT02403687|Analgesics|analgesics|mesh-ancestor
14101914|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14101915|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14101916|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
14101917|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14101918|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14101919|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101920|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
14101921|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14101922|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14101923|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14101924|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
14101925|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14101926|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14101927|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101928|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14101929|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14101930|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14101931|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14101932|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
14101933|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14101934|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14101935|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14101936|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14101937|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
14101938|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
14101939|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14101940|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14101941|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14101942|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
13927129|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13927130|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927131|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927132|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
13927133|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927134|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927135|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
13927136|NCT03397797|Rocuronium|rocuronium|mesh-list
13927137|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13960913|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
14101943|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13927138|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13927139|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13927140|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927141|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927142|NCT03397706|Valganciclovir|valganciclovir|mesh-list
13927143|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
13927144|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927145|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
13927146|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14101944|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14101945|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
14101946|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14101947|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14101948|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
14101949|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
14101950|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
14101951|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14101952|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14101953|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14101954|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14101955|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
14101956|NCT02403713|Fluticasone|fluticasone|mesh-list
14101957|NCT02403713|Xhance|xhance|mesh-list
14101958|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
14101959|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14101960|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14101961|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
14101962|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101963|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101964|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14101965|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
14101966|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
14101967|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14101968|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14101969|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14101970|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14101971|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
14101972|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14101973|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101974|NCT02403648|Glucagon|glucagon|mesh-list
14101975|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14101976|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14101977|NCT02403648|Hormones|hormones|mesh-ancestor
14101978|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14101979|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101980|NCT02403648|Incretins|incretins|mesh-ancestor
14101981|NCT02403531|Docetaxel|docetaxel|mesh-list
14101982|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14101983|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
14101984|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
14101985|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
14101986|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101987|NCT02403349|Atenolol|atenolol|mesh-list
13927147|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927148|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
13927149|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13927150|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927151|NCT03397537|Letrozole|letrozole|mesh-list
13927152|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927153|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13927154|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13927155|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927156|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927157|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13927158|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
13927159|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927160|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927161|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
13927162|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13960914|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
14101988|NCT02403349|Valsartan|valsartan|mesh-list
14101989|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14101990|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14101991|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14101992|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14101993|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14101994|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
14101995|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
14101996|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14101997|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14101998|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14101999|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14102000|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14102001|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
14102002|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14174951|NCT04781088|Paclitaxel|paclitaxel|mesh-list
14174952|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
14174953|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14174954|NCT04781088|Lenvatinib|lenvatinib|mesh-list
14174955|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14174956|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174957|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
14174958|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
14174959|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
14174960|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174961|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14174962|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174963|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174964|NCT04780581|Dexamethasone|dexamethasone|mesh-list
14174965|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
14174966|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14174967|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14174968|NCT04780581|Prednisolone|prednisolone|mesh-list
14174969|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
14174970|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14174971|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
14174972|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14174973|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
14174974|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
14174975|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174976|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174977|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14174978|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
14174979|NCT04780581|Hormones|hormones|mesh-ancestor
14174980|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14174981|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14174982|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174983|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14174984|NCT04780581|Protective Agents|protective agents|mesh-ancestor
14174985|NCT04780958|Vitamin A|vitamin a|mesh-list
14174986|NCT04780958|Vitamins|vitamins|mesh-ancestor
14174987|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
14174988|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14174989|NCT04780568|Osimertinib|osimertinib|mesh-list
14174990|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14174991|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14174992|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14174993|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14174994|NCT04780984|Bromides|bromides|mesh-list
14174995|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
14174996|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14174997|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
14174998|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14174999|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175000|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14175001|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
14175002|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
13927163|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927164|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13927165|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13927166|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13927167|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927168|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
13927169|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927170|NCT03397264|Aflibercept|aflibercept|mesh-list
13927171|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927172|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14175003|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14175004|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
13927173|NCT03397264|Growth Substances|growth substances|mesh-ancestor
13927174|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927175|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
13927176|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927177|NCT03397199|Apatinib|apatinib|mesh-list
13927178|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927179|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13927180|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927181|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927182|NCT03397186|Trabectedin|trabectedin|mesh-list
13927183|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13927184|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
13927185|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927186|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927187|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
13927188|NCT03397173|Azacitidine|azacitidine|mesh-list
13927189|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13927190|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
13927191|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927192|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927193|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927194|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
13927195|NCT03397173|Protective Agents|protective agents|mesh-ancestor
13927196|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927197|NCT03397173|Vitamins|vitamins|mesh-ancestor
13927198|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
13927199|NCT03397082|Lidocaine|lidocaine|mesh-list
13927200|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
13927201|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
13927202|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927203|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927204|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
13927205|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927206|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14102003|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
14102004|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14102005|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
14102006|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14102007|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102008|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14102009|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14102010|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14102011|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14102012|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
14102013|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14102014|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14102015|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14102016|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14102017|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102018|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
14102019|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102020|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102021|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14102022|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102023|NCT02403284|Liraglutide|liraglutide|mesh-list
14102024|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14102025|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102026|NCT02403284|Incretins|incretins|mesh-ancestor
14102027|NCT02403284|Hormones|hormones|mesh-ancestor
14102028|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102029|NCT02403128|Aflibercept|aflibercept|mesh-list
14102030|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14102031|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14102032|NCT02403128|Growth Substances|growth substances|mesh-ancestor
14102033|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102034|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
14102035|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102036|NCT02403063|Neostigmine|neostigmine|mesh-list
14102037|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14102038|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102039|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102040|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
14102041|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102042|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927207|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13927208|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13927209|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13927210|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927211|NCT03397069|Midazolam|midazolam|mesh-list
13927212|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13927213|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13927214|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927215|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927216|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13927217|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13927218|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14102043|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14102044|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
14102045|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102046|NCT02403037|Dexamethasone|dexamethasone|mesh-list
14102047|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
14102048|NCT02403037|Antiemetics|antiemetics|mesh-list
14102049|NCT02403037|Emetics|emetics|mesh-list
14102050|NCT02403037|BB 1101|bb 1101|mesh-list
14102051|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102052|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
14102053|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102054|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102055|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102056|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
14102057|NCT02403037|Hormones|hormones|mesh-ancestor
14102058|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102059|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14102060|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102061|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
14102062|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102063|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102064|NCT02402842|Docetaxel|docetaxel|mesh-list
13927219|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13927220|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
13927221|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
13927222|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
13927223|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
14102065|NCT02402842|Fluorouracil|fluorouracil|mesh-list
14102066|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102067|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
13927224|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927225|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102068|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
14102069|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
14102070|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102071|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
13927226|NCT03396926|Bevacizumab|bevacizumab|mesh-list
13927227|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13927228|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
13927229|NCT03396926|Capecitabine|capecitabine|mesh-list
13927230|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
13927231|NCT03396926|Antibodies|antibodies|mesh-list
13927232|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
13927233|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13927234|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
13927235|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927236|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927237|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13927238|NCT03396926|Growth Substances|growth substances|mesh-ancestor
14102072|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14102073|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14102074|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
14102075|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102076|NCT02402972|Leucovorin|leucovorin|mesh-list
14102077|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
14102078|NCT02402972|Floxuridine|floxuridine|mesh-list
14102079|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
14102080|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102081|NCT02402972|Antidotes|antidotes|mesh-ancestor
14102082|NCT02402972|Protective Agents|protective agents|mesh-ancestor
14102083|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761397|NCT03742895|Olaparib|olaparib|mesh-list
13927239|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102084|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
13927240|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
13927241|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
13927242|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13927243|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
13927244|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927245|NCT03396861|Aflibercept|aflibercept|mesh-list
14102085|NCT02402972|Vitamins|vitamins|mesh-ancestor
14102086|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
14102087|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14102088|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
14102089|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102090|NCT02402868|Ketamine|ketamine|mesh-list
14102091|NCT02402868|Analgesics|analgesics|mesh-ancestor
14102092|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
14102093|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102094|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102095|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14102096|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102097|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
14102098|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
14102099|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102100|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14102101|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14102102|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102103|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102104|NCT02402725|Dexamethasone|dexamethasone|mesh-list
14102105|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
14102106|NCT02402725|BB 1101|bb 1101|mesh-list
14102107|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102108|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
14102109|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
14102110|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102111|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102112|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102113|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
14102114|NCT02402725|Hormones|hormones|mesh-ancestor
14102115|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102116|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14102117|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102118|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
14102119|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102120|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102121|NCT02402712|Docetaxel|docetaxel|mesh-list
14102122|NCT02402712|Trastuzumab|trastuzumab|mesh-list
14102123|NCT02402712|Pertuzumab|pertuzumab|mesh-list
13927246|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927247|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13927248|NCT03396861|Growth Substances|growth substances|mesh-ancestor
13927249|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927250|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
13927251|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927252|NCT03396601|Ketamine|ketamine|mesh-list
14102124|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102125|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
14102126|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
14102127|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
14102128|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102129|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14102130|NCT02402621|Fentanyl|fentanyl|mesh-list
14102131|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14102132|NCT02402621|Narcotics|narcotics|mesh-ancestor
14102133|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102134|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102135|NCT02402621|Analgesics|analgesics|mesh-ancestor
13927253|NCT03396601|Analgesics|analgesics|mesh-ancestor
13927254|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
13927255|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927256|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927257|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13927258|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102136|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
14102137|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102138|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14102139|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102140|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
14102141|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
14102142|NCT02402595|Itraconazole|itraconazole|mesh-list
14102143|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
14102144|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927259|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
13927260|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
13927261|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927262|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13927263|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13927264|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927265|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927266|NCT03396588|Clonidine|clonidine|mesh-list
13927267|NCT03396588|Morphine|morphine|mesh-list
13927268|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13927269|NCT03396588|Narcotics|narcotics|mesh-ancestor
13927270|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927271|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927272|NCT03396588|Analgesics|analgesics|mesh-ancestor
13927273|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
13927274|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102145|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14102146|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14102147|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102148|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102149|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14102150|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
14102151|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102152|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102153|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14102154|NCT02402491|Aspirin|aspirin|mesh-list
14102155|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
14102156|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14102157|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14102158|NCT02402491|Analgesics|analgesics|mesh-ancestor
14102159|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
14102160|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102161|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102162|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102163|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102164|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14102165|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14102166|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102167|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14102168|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13927275|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13927276|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
13927277|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
13927278|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13927279|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13927280|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927281|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927282|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927283|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927284|NCT03396523|Losartan|losartan|mesh-list
14102169|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102170|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
14102171|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14102172|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14102173|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
14102174|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927285|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13927286|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14102175|NCT02402465|Fluticasone|fluticasone|mesh-list
14102176|NCT02402465|Xhance|xhance|mesh-list
14102177|NCT02402465|Azelastine|azelastine|mesh-list
14102178|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102179|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14102180|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
14102181|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102182|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102183|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14102184|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
14102185|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
14102186|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14102187|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14102188|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102189|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102190|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14102191|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14102192|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
14102193|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
14102194|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102195|NCT02402400|Ticagrelor|ticagrelor|mesh-list
14102196|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14102197|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14102198|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14102199|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14102200|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
14102201|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102202|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102203|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102204|NCT02402413|Androgens|androgens|mesh-list
13927287|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13927288|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13927289|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927290|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
13927291|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13927292|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927293|NCT03396484|Methyldopa|methyldopa|mesh-list
13927294|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14102205|NCT02402413|Hormones|hormones|mesh-ancestor
14102206|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102207|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102208|NCT02402283|Metronidazole|metronidazole|mesh-list
14102209|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102210|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14102211|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14102212|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14102213|NCT02402231|Omalizumab|omalizumab|mesh-list
14102214|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14102215|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14102216|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
14102217|NCT02402543|Acetaminophen|acetaminophen|mesh-list
14102218|NCT02402543|Dexamethasone|dexamethasone|mesh-list
14102219|NCT02402543|Ketamine|ketamine|mesh-list
14102220|NCT02402543|Gabapentin|gabapentin|mesh-list
14102221|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102222|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
14102223|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
14102224|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102225|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102226|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102227|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
14102228|NCT02402543|Hormones|hormones|mesh-ancestor
14102229|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102230|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14102231|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102232|NCT02402543|Analgesics|analgesics|mesh-ancestor
14102233|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
13927295|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
13927296|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
13927297|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927298|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927299|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14102234|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14102235|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102236|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
14102237|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
14102238|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102239|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14102240|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14102241|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102242|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102243|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14102244|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
14102245|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
14102246|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14102247|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14102248|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14102249|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
14102250|NCT02402348|Metformin|metformin|mesh-list
14102251|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14102252|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102253|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
14102254|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102255|NCT02402179|Tryptophan|tryptophan|mesh-list
14102256|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14102257|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
14102258|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14102259|NCT02401945|Aflibercept|aflibercept|mesh-list
14102260|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927300|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13927301|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927302|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927303|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927304|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102261|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14102262|NCT02401945|Growth Substances|growth substances|mesh-ancestor
14102263|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102264|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
14102265|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102266|NCT02401971|Thalidomide|thalidomide|mesh-list
14102267|NCT02401971|Irinotecan|irinotecan|mesh-list
14102268|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14102269|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14102270|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102271|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102272|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102273|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14102274|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
14102275|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102276|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
14102277|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14102278|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102279|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927305|NCT03396393|Artenimol|artenimol|mesh-list
13927306|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
13927307|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13927308|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13927309|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102280|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14102281|NCT02401971|Growth Substances|growth substances|mesh-ancestor
14102282|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
14102283|NCT02401880|Empagliflozin|empagliflozin|mesh-list
14102284|NCT02401880|Linagliptin|linagliptin|mesh-list
14102285|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14102286|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102287|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14102288|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102289|NCT02401880|Incretins|incretins|mesh-ancestor
14102290|NCT02401880|Hormones|hormones|mesh-ancestor
14102291|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102292|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14102293|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
14102294|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102295|NCT02401828|Dolutegravir|dolutegravir|mesh-list
14102296|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13927310|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
13927311|NCT03396380|Vitamin D|vitamin d|mesh-list
13927312|NCT03396380|Citric Acid|citric acid|mesh-list
13927313|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
14102297|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14102298|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927314|NCT03396380|Clomiphene|clomiphene|mesh-list
14175005|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102299|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102300|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14102301|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14102302|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
14102303|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102304|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14102305|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
13927315|NCT03396380|Enclomiphene|enclomiphene|mesh-list
13927316|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
13927317|NCT03396380|Calcium|calcium|mesh-list
13927318|NCT03396380|Vitamins|vitamins|mesh-ancestor
13927319|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
13927320|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927321|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13927322|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13927323|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
13927324|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14102306|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102307|NCT02401477|Amoxicillin|amoxicillin|mesh-list
14102308|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14102309|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175006|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175007|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
14175008|NCT04780412|Alprostadil|alprostadil|mesh-list
14175009|NCT04780412|Misoprostol|misoprostol|mesh-list
14175010|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14175011|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
14175012|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14175013|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175014|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14175015|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175016|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
14175017|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14175018|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
14175019|NCT04780412|Urological Agents|urological agents|mesh-ancestor
14175020|NCT04780347|Paclitaxel|paclitaxel|mesh-list
14175021|NCT04780347|Capecitabine|capecitabine|mesh-list
14175022|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14175023|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14175024|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175025|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
14175026|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
14175027|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
14175028|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175029|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14175030|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
14175031|NCT04780269|Dinoprostone|dinoprostone|mesh-list
14175032|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
14175033|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14175034|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175035|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
13927325|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
14175036|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14175037|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175038|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14175039|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175040|NCT04780217|Pembrolizumab|pembrolizumab|mesh-list
14175041|NCT04780217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14175042|NCT04780217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175043|NCT04779853|Antibodies|antibodies|mesh-list
14175044|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
14175045|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175046|NCT04779892|Infliximab|infliximab|mesh-list
14175047|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175048|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175049|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175050|NCT04780152|Fluoxetine|fluoxetine|mesh-list
14175051|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
14175052|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14175053|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14175054|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175055|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175056|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175057|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
14175058|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927326|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
14102310|NCT02401594|Enoxaparin|enoxaparin|mesh-list
14102311|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
14102312|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14102313|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
14102314|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14102315|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
14102316|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102317|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102318|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
14935959|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935960|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14935961|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14935962|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935963|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13927327|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927328|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13927329|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
13927330|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927331|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13927332|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
13927333|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13927334|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13927335|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13927336|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
13927337|NCT03396315|Alendronate|alendronate|mesh-list
13927338|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13927339|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927340|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13927341|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13927342|NCT03396276|Narcotics|narcotics|mesh-ancestor
13927343|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927344|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927345|NCT03396276|Analgesics|analgesics|mesh-ancestor
13927346|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
13927347|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927348|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13927349|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
13927350|NCT03396250|Promethazine|promethazine|mesh-list
13927351|NCT03396250|Naproxen|naproxen|mesh-list
13927352|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13927353|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13927354|NCT03396250|Analgesics|analgesics|mesh-ancestor
13927355|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
13927356|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927357|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927358|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927359|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13927360|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
13927361|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13927362|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927363|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927364|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13927365|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13927366|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927367|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
13927368|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
13927369|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
14102319|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14102320|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14102321|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
14102322|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14102323|NCT02401425|Letrozole|letrozole|mesh-list
14102324|NCT02401425|Misoprostol|misoprostol|mesh-list
14102325|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102326|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14102327|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14102328|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102329|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935964|NCT01466478|Vitamins|vitamins|mesh-ancestor
14935965|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
14935966|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14935967|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14935968|NCT01466517|Ibuprofen|ibuprofen|mesh-list
13927370|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
14102330|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14102331|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
14102332|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102333|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102334|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14102335|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
14102336|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13927371|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13927372|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13927373|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
13927374|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
13927375|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927376|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13927377|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
14102337|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14102338|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102339|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
14102340|NCT02401347|Talazoparib|talazoparib|mesh-list
14102341|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14102342|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102343|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102344|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102345|NCT02401269|Aspirin|aspirin|mesh-list
14102346|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14102347|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14102348|NCT02401269|Analgesics|analgesics|mesh-ancestor
14102349|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
14102350|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102351|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102352|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102353|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102354|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14102355|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14102356|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102357|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14102358|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14102359|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927378|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
13960915|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13960916|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102360|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
14102361|NCT02401295|Itraconazole|itraconazole|mesh-list
14102362|NCT02401295|Celecoxib|celecoxib|mesh-list
14102363|NCT02401295|Tretinoin|tretinoin|mesh-list
14102364|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14102365|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14102366|NCT02401295|Analgesics|analgesics|mesh-ancestor
14102367|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
14102368|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102369|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102370|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102371|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102372|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14102373|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14102374|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102375|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102376|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
14102377|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102378|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14102379|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14102380|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14102381|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
14102382|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102383|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14102384|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960917|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960918|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14102385|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
14102386|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
14102387|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14102388|NCT02401503|Venetoclax|venetoclax|mesh-list
14102389|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
14102390|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13960919|NCT03151668|Analgesics|analgesics|mesh-ancestor
14102391|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
14102392|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102393|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102394|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14102395|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
14102396|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14102397|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102398|NCT02401035|Pantoprazole|pantoprazole|mesh-list
14102399|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14102400|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102401|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14102402|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102403|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102404|NCT02401139|Ketamine|ketamine|mesh-list
14102405|NCT02401139|Analgesics|analgesics|mesh-ancestor
14102406|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
14102407|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102408|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102409|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14102410|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102411|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
14102412|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
14102413|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102414|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14102415|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14102416|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102417|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102418|NCT02400931|Rocuronium|rocuronium|mesh-list
14102419|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14102420|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14102421|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14102422|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927379|NCT03396107|Dexamethasone|dexamethasone|mesh-list
13927380|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927381|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
13927382|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
13927383|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927384|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102423|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102424|NCT02400879|Sufentanil|sufentanil|mesh-list
14102425|NCT02400879|Remifentanil|remifentanil|mesh-list
14102426|NCT02400879|Sevoflurane|sevoflurane|mesh-list
14102427|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14102428|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14102429|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
14102430|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
14102431|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102432|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102433|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14102434|NCT02400879|Narcotics|narcotics|mesh-ancestor
14102435|NCT02400879|Analgesics|analgesics|mesh-ancestor
14102436|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
14102437|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102438|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14102439|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102440|NCT02400645|Ketorolac|ketorolac|mesh-list
14102441|NCT02400645|Bupivacaine|bupivacaine|mesh-list
14102442|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
14102443|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
14102444|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927385|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13927386|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
13927387|NCT03396107|Hormones|hormones|mesh-ancestor
13927388|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927389|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13927390|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927391|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
13927392|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14102445|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102446|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
14102447|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102448|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14102449|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14102450|NCT02400645|Analgesics|analgesics|mesh-ancestor
14102451|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927393|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13927394|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927395|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927396|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13927397|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13927398|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13927399|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13927400|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927401|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927402|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927403|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13927404|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13927405|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
13927406|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13927407|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13927408|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
13927409|NCT03395977|Febuxostat|febuxostat|mesh-list
13927410|NCT03395977|Rasburicase|rasburicase|mesh-list
13927411|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
13927412|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102452|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102453|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14102454|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102455|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102456|NCT02400866|Olanzapine|olanzapine|mesh-list
14102457|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
14102458|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
14102459|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102460|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102461|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102462|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14102463|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14102464|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102465|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14102466|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14102467|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14102468|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14102469|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102470|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102471|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
14102472|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14102473|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14102474|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14102475|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102476|NCT02400788|Sorafenib|sorafenib|mesh-list
14102477|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102478|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14102479|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102480|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102481|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13927413|NCT03395951|Diuretics|diuretics|mesh-list
13927414|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
13927415|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927416|NCT03395912|Anesthetics|anesthetics|mesh-list
13927417|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
13927418|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927419|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927420|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
13927421|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102482|NCT02400801|Dienogest|dienogest|mesh-list
14102483|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14102484|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
14102485|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14102486|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
14102487|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14102488|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102489|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14102490|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14102491|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102492|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14102493|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14102494|NCT02400801|Estrogens|estrogens|mesh-ancestor
13927422|NCT03395899|Bevacizumab|bevacizumab|mesh-list
14102495|NCT02400801|Hormones|hormones|mesh-ancestor
14102496|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102497|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14102498|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
14102499|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
14102500|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13927423|NCT03395899|Atezolizumab|atezolizumab|mesh-list
13927424|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13927425|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927426|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927427|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13927428|NCT03395899|Growth Substances|growth substances|mesh-ancestor
13927429|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927430|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
13927431|NCT03395873|Decitabine|decitabine|mesh-list
14102501|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14102502|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14102503|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14102504|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102505|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
14102506|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102507|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927432|NCT03395873|Avelumab|avelumab|mesh-list
13927433|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13927434|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
13927435|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927436|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927437|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927438|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13927439|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
13927440|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13927441|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927442|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13927443|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
13927444|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13927445|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13927446|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13927447|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
13927448|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13927449|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927450|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13927451|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13927452|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13927453|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13927454|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927455|NCT03395730|Oxytocin|oxytocin|mesh-list
13927456|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
13927457|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13927458|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927459|NCT03395704|Hepcidins|hepcidins|mesh-list
13927460|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927461|NCT03395665|Estradiol|estradiol|mesh-list
13927462|NCT03395665|Progesterone|progesterone|mesh-list
13927463|NCT03395665|Estrogens|estrogens|mesh-ancestor
13927464|NCT03395665|Hormones|hormones|mesh-ancestor
13927465|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927466|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927467|NCT03395665|Progestins|progestins|mesh-ancestor
13927468|NCT03395587|Temozolomide|temozolomide|mesh-list
13927469|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13927470|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
13927471|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927472|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927473|NCT03395574|Terlipressin|terlipressin|mesh-list
13927474|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14102508|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14102509|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102510|NCT02400476|Budesonide|budesonide|mesh-list
14102511|NCT02400476|Loperamide|loperamide|mesh-list
14102512|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
14102513|NCT02400476|Colestipol|colestipol|mesh-list
14102514|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102515|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14102516|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
14102517|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102518|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102519|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13927475|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13927476|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13927477|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13927478|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13927479|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
13927480|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927481|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13927482|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13927483|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927484|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
13927485|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13927486|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927487|NCT03395262|Caffeine|caffeine|mesh-list
13927488|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13927489|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927490|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13927491|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927492|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927493|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13927494|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13927495|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
14102520|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
14761398|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14761399|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761400|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761401|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927496|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927497|NCT03395223|Methylene Blue|methylene blue|mesh-list
13927498|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927499|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927500|NCT03395171|Vitamin D|vitamin d|mesh-list
13927501|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
13927502|NCT03395171|Vitamins|vitamins|mesh-ancestor
13927503|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
13927504|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927505|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13927506|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13927507|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
13927508|NCT03395132|Betamethasone|betamethasone|mesh-list
13927509|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927510|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
14102521|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
14102522|NCT02400476|Hormones|hormones|mesh-ancestor
14102523|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102524|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14761402|NCT03737253|Menotropins|menotropins|mesh-list
14761403|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14102525|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14102526|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
14102527|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102528|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14102529|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
14102530|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14102531|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14102532|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102533|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
14102534|NCT02400151|Vitamin D|vitamin d|mesh-list
14761404|NCT03737253|Hormones|hormones|mesh-ancestor
14761405|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927511|NCT03395132|Hormones|hormones|mesh-ancestor
13960920|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
14102535|NCT02400151|Vitamins|vitamins|mesh-ancestor
14102536|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
13927512|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927513|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927514|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13927515|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
13927516|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13927517|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927518|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13927519|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927520|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927521|NCT03395093|Fentanyl|fentanyl|mesh-list
13927522|NCT03395093|Midazolam|midazolam|mesh-list
13927523|NCT03395093|Propofol|propofol|mesh-list
14102537|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102538|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14102539|NCT02400385|Nivolumab|nivolumab|mesh-list
14102540|NCT02400385|Sunitinib|sunitinib|mesh-list
14102541|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14102542|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102543|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14102544|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102545|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14102546|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14102547|NCT02400385|Growth Substances|growth substances|mesh-ancestor
14102548|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102549|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
14102550|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14102551|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102552|NCT02400281|Cytarabine|cytarabine|mesh-list
14102553|NCT02400281|Fludarabine|fludarabine|mesh-list
14102554|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
14102555|NCT02400281|Etoposide|etoposide|mesh-list
14102556|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
14102557|NCT02400281|Azacitidine|azacitidine|mesh-list
14102558|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
14102559|NCT02400281|Idarubicin|idarubicin|mesh-list
14102560|NCT02400281|Crenolanib|crenolanib|mesh-list
14102561|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102562|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14102563|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
14102564|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102565|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14102566|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
14102567|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102568|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
14102569|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102570|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14102571|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14102572|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14102573|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102574|NCT02400281|Analgesics|analgesics|mesh-ancestor
14102575|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
14102576|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102577|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14102578|NCT02400255|Crenolanib|crenolanib|mesh-list
14102579|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102580|NCT02400112|Vancomycin|vancomycin|mesh-list
14102581|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14102582|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102583|NCT02400021|Progesterone|progesterone|mesh-list
14102584|NCT02400021|Progestins|progestins|mesh-ancestor
14102585|NCT02400021|Hormones|hormones|mesh-ancestor
14102586|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102587|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102588|NCT02399943|Panitumumab|panitumumab|mesh-list
14102589|NCT02399943|Trametinib|trametinib|mesh-list
14102590|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14102591|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477661|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14102592|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14102593|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102594|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102595|NCT02400047|Dexamethasone|dexamethasone|mesh-list
14102596|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
14102597|NCT02400047|Ketoprofen|ketoprofen|mesh-list
14477662|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14102598|NCT02400047|BB 1101|bb 1101|mesh-list
14102599|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102600|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
14102601|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
14102602|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102603|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102604|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102605|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
14102606|NCT02400047|Hormones|hormones|mesh-ancestor
14102607|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102608|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14102609|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102610|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
14102611|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102612|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102613|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13927524|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13927525|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927526|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927527|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13927528|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
13927529|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
13927530|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13927531|NCT03395093|Narcotics|narcotics|mesh-ancestor
14102614|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14102615|NCT02400047|Analgesics|analgesics|mesh-ancestor
14102616|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
14102617|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102618|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14175059|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14175060|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14175061|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14175062|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14175063|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175064|NCT04779762|Ustekinumab|ustekinumab|mesh-list
14175065|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175066|NCT04779645|Volagidemab|volagidemab|mesh-list
14175067|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14175068|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175069|NCT04779255|Acetaminophen|acetaminophen|mesh-list
14175070|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175071|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14761406|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761407|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14761408|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
14761409|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14175072|NCT04779255|Analgesics|analgesics|mesh-ancestor
14175073|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
14175074|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175075|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
14175076|NCT04779567|Acetaminophen|acetaminophen|mesh-list
14175077|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14761410|NCT03725202|Upadacitinib|upadacitinib|mesh-list
13927532|NCT03395093|Analgesics|analgesics|mesh-ancestor
13927533|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
13927534|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927535|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13927536|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13927537|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13927538|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13927539|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
13927540|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
14175078|NCT04779567|Analgesics|analgesics|mesh-ancestor
14175079|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
14175080|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175081|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175082|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
14175083|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
14175084|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14175085|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14175086|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175087|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
14175088|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175089|NCT04779580|Anesthetics|anesthetics|mesh-list
14761411|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
13927541|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175090|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
14175091|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14761412|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14761413|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761414|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927542|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927543|NCT03395080|Paclitaxel|paclitaxel|mesh-list
13927544|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13927545|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927546|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
13927547|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
13927548|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
13927549|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927550|NCT03395028|Sargramostim|sargramostim|mesh-list
13927551|NCT03395028|Lenograstim|lenograstim|mesh-list
13927552|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
13927553|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927554|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13927555|NCT03395002|Fluticasone|fluticasone|mesh-list
14761415|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761416|NCT03725059|Paclitaxel|paclitaxel|mesh-list
14761417|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
13927556|NCT03395002|Xhance|xhance|mesh-list
13927557|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
13927558|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13927559|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927560|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13927561|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
13927562|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927563|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927564|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13927565|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
13927566|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
13927567|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13927568|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
13927569|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13927570|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
13927571|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927572|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927573|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13927574|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13927575|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927576|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927577|NCT03394989|Fluticasone|fluticasone|mesh-list
13927578|NCT03394989|Xhance|xhance|mesh-list
13927579|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13927580|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13927581|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927582|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14761418|NCT03725059|Doxorubicin|doxorubicin|mesh-list
14761419|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
14761420|NCT03725059|Epirubicin|epirubicin|mesh-list
14761421|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14761422|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761423|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14761424|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761425|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761426|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761427|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13927583|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
13927584|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927585|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927586|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13927587|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
13927588|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
13927589|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13927590|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13927591|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13927592|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927593|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927594|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927595|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927596|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
13927597|NCT03394989|Hormones|hormones|mesh-ancestor
14102619|NCT02399800|Triamcinolone|triamcinolone|mesh-list
14938788|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960921|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761428|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
14102620|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14102621|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14102622|NCT02399800|Bupivacaine|bupivacaine|mesh-list
14102623|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14102624|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
14102625|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
14102626|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102627|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102628|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
13927598|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927599|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
13927600|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13927601|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13927602|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13927603|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927604|NCT03394833|Polygeline|polygeline|mesh-list
13927605|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
13927606|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
13927607|NCT03394820|Dexamethasone|dexamethasone|mesh-list
13927608|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927609|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
13927610|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
13927611|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927612|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927613|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13927614|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
13927615|NCT03394820|Hormones|hormones|mesh-ancestor
13927616|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927617|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13927618|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927619|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
13927620|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
13927621|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
13927622|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927623|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927624|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
13927625|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102629|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102630|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102631|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
14102632|NCT02399800|Hormones|hormones|mesh-ancestor
14102633|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102634|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14102635|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
14102636|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102637|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102638|NCT02399566|Pemetrexed|pemetrexed|mesh-list
14102639|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14102640|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102641|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927626|NCT03394729|Propolis|propolis|mesh-list
13927627|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102642|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102643|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14102644|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14102645|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14102646|NCT02399592|Bevacizumab|bevacizumab|mesh-list
14102647|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14102648|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102649|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14102650|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14102651|NCT02399592|Growth Substances|growth substances|mesh-ancestor
14102652|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102653|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
14102654|NCT02399657|Dexamethasone|dexamethasone|mesh-list
14102655|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102656|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
14102657|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
14102658|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102659|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102660|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102661|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
14102662|NCT02399657|Hormones|hormones|mesh-ancestor
14477663|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13927628|NCT03394586|Golimumab|golimumab|mesh-list
13927629|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13927630|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927631|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13927632|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
13927633|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960922|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13960923|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13960924|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13960925|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
13960926|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102663|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102664|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14102665|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102666|NCT02399709|Simvastatin|simvastatin|mesh-list
14102667|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14102668|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14102669|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
14102670|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102671|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14102672|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14102673|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102674|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14102675|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14102676|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
14102677|NCT02399462|Hormones|hormones|mesh-ancestor
14102678|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102679|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102680|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102681|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102682|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
14102683|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
14102684|NCT02399449|Hematinics|hematinics|mesh-ancestor
14102685|NCT02399397|Fentanyl|fentanyl|mesh-list
14102686|NCT02399397|Midazolam|midazolam|mesh-list
14102687|NCT02399397|Anesthetics|anesthetics|mesh-list
14102688|NCT02399397|Propofol|propofol|mesh-list
14102689|NCT02399397|Rocuronium|rocuronium|mesh-list
14102690|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102691|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102692|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14102693|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102694|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
14102695|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14102696|NCT02399397|Narcotics|narcotics|mesh-ancestor
14102697|NCT02399397|Analgesics|analgesics|mesh-ancestor
14102698|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
14102699|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102700|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14102701|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14102702|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14102703|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14102704|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
14102705|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
14102706|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102707|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102708|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14102709|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14102710|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14102711|NCT02399410|Bevacizumab|bevacizumab|mesh-list
14102712|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
14102713|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14102714|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102715|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14102716|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14102717|NCT02399410|Growth Substances|growth substances|mesh-ancestor
14102718|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102719|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
14102720|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14102721|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102722|NCT02399189|Methotrexate|methotrexate|mesh-list
13960927|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102723|NCT02399189|Temozolomide|temozolomide|mesh-list
14102724|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102725|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
13960928|NCT03151525|Azathioprine|azathioprine|mesh-list
13927634|NCT03394573|Aflibercept|aflibercept|mesh-list
13927635|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927636|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13927637|NCT03394573|Growth Substances|growth substances|mesh-ancestor
13927638|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927639|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
13927640|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927641|NCT03394430|Midazolam|midazolam|mesh-list
13927642|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
13927643|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13927644|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927645|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927646|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13927647|NCT03394430|Analgesics|analgesics|mesh-ancestor
13927648|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
13927649|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927650|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13927651|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13927652|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927653|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927654|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927655|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927656|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13927657|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13927658|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13927659|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13927660|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13927661|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
13927662|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
13927663|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
13927664|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
13927665|NCT03394287|Apatinib|apatinib|mesh-list
13927666|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927667|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13927668|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927669|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927670|NCT03394222|Budesonide|budesonide|mesh-list
13927671|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927672|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13927673|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
13927674|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927675|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927676|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13927677|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
13927678|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
13927679|NCT03394222|Hormones|hormones|mesh-ancestor
13927680|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927681|NCT03394209|Oseltamivir|oseltamivir|mesh-list
13927682|NCT03394209|Favipiravir|favipiravir|mesh-list
13927683|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
13927684|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102726|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102727|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102728|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14102729|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
14102730|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14102731|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14102732|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
14102733|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102734|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14102735|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102736|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14102737|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14102738|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14102739|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14102740|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
14102741|NCT02399215|Nintedanib|nintedanib|mesh-list
14102742|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102743|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14102744|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102745|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102746|NCT02399137|Gemcitabine|gemcitabine|mesh-list
14102747|NCT02399137|Paclitaxel|paclitaxel|mesh-list
14477664|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927685|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102748|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14102749|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102750|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14102751|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14102752|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14102753|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927686|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927687|NCT03394196|Ritonavir|ritonavir|mesh-list
13927688|NCT03394196|Lopinavir|lopinavir|mesh-list
13927689|NCT03394196|Darunavir|darunavir|mesh-list
13927690|NCT03394196|Tenofovir|tenofovir|mesh-list
13927691|NCT03394196|Lamivudine|lamivudine|mesh-list
13927692|NCT03394196|Zidovudine|zidovudine|mesh-list
13927693|NCT03394196|Emtricitabine|emtricitabine|mesh-list
13927694|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
13927695|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14102754|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14102755|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
14102756|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
14102757|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102758|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102759|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14102760|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
14102761|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102762|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
14102763|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
14102764|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14102765|NCT02398994|Antibodies|antibodies|mesh-list
14477665|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927696|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13927697|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
13927698|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927699|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927700|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13927701|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13927702|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
13927703|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927704|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13927705|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13927706|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13927707|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13927708|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
13927709|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13927710|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13927711|NCT03394144|Durvalumab|durvalumab|mesh-list
13927712|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13927713|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927714|NCT03394131|Insulin|insulin|mesh-list
13927715|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13927716|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13927717|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927718|NCT03394118|Osimertinib|osimertinib|mesh-list
13927719|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927720|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13927721|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927722|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927723|NCT03394105|Docetaxel|docetaxel|mesh-list
13927724|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927725|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
13927726|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
13927727|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
13927728|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927729|NCT03394001|Ketorolac|ketorolac|mesh-list
13927730|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13927731|NCT03394001|Lidocaine|lidocaine|mesh-list
13927732|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
13927733|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
13927734|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927735|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927736|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
13927737|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927738|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13927739|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13927740|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13927741|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13960929|NCT03151525|Infliximab|infliximab|mesh-list
14102766|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
14102767|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14102768|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102769|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
14102770|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
14102771|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102772|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102773|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102774|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
14102775|NCT02398994|Hormones|hormones|mesh-ancestor
14102776|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102777|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14102778|NCT02398994|Protective Agents|protective agents|mesh-ancestor
14102779|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
14102780|NCT02398929|Bisoprolol|bisoprolol|mesh-list
14102781|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14102782|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
14102783|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
14102784|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102785|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102786|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14102787|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14102788|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14102789|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
14102790|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102791|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102792|NCT02398838|Misoprostol|misoprostol|mesh-list
14102793|NCT02398838|Mifepristone|mifepristone|mesh-list
14102794|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14102795|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
14102796|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14102797|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102798|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14102799|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102800|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
14102801|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14102802|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14102803|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14102804|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14102805|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
14102806|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14102807|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14102808|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
14102809|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102810|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
14102811|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14102812|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14102813|NCT02398656|Tenecteplase|tenecteplase|mesh-list
14102814|NCT02398656|Clopidogrel|clopidogrel|mesh-list
14102815|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14102816|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14102817|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14102818|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14102819|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
14102820|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102821|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102822|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761429|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927742|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927743|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13927744|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13927745|NCT03394001|Analgesics|analgesics|mesh-ancestor
13927746|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761430|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761431|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14761432|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
14761433|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13927747|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13927748|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13927749|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927750|NCT03393988|Fentanyl|fentanyl|mesh-list
13927751|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
13927752|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
13927753|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
13927754|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927755|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927756|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13927757|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13927758|NCT03393988|Analgesics|analgesics|mesh-ancestor
13927759|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
13927760|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927761|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13927762|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13927763|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927764|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927765|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927766|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927767|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13927768|NCT03393988|Narcotics|narcotics|mesh-ancestor
13927769|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13927770|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13927771|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
13927772|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
13927773|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
13927774|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13927775|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13927776|NCT03393949|Prednisolone|prednisolone|mesh-list
13927777|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
13927778|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13927779|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
13927780|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927781|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
13927782|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
14102823|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14102824|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14102825|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
14102826|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
14102827|NCT02398682|Protective Agents|protective agents|mesh-ancestor
14102828|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102829|NCT02398448|Allopurinol|allopurinol|mesh-list
14102830|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
14102831|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102832|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102833|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
14102834|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14102835|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14102836|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
14102837|NCT02398448|Protective Agents|protective agents|mesh-ancestor
14102838|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102839|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14102840|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102841|NCT02398630|Hormones|hormones|mesh-list
14102842|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102843|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102844|NCT02398487|Nicotine|nicotine|mesh-list
14102845|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14102846|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
14102847|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102848|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102849|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14102850|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14102851|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
14102852|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102853|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102854|NCT02398552|Sunitinib|sunitinib|mesh-list
14102855|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102856|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14102857|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14102858|NCT02398552|Growth Substances|growth substances|mesh-ancestor
14102859|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102860|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
14102861|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14102862|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102863|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102864|NCT02398357|Nadroparin|nadroparin|mesh-list
14102865|NCT02398357|Warfarin|warfarin|mesh-list
14102866|NCT02398357|Calcium|calcium|mesh-list
14102867|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938789|NCT01484262|Incretins|incretins|mesh-ancestor
13927783|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102868|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102869|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
14102870|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14102871|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14102872|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175092|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175093|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
14175094|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175095|NCT04778982|Fulvestrant|fulvestrant|mesh-list
13927784|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927785|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13927786|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
14175096|NCT04778982|Palbociclib|palbociclib|mesh-list
14175097|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14175098|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175099|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14175100|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14175101|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
14175102|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175103|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175104|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14175105|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175106|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175107|NCT04779151|Niraparib|niraparib|mesh-list
14175108|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14175109|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175110|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175111|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175112|NCT04779060|Dexamethasone|dexamethasone|mesh-list
14175113|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14175114|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
14175115|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
14175116|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175117|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175118|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175119|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
14175120|NCT04779060|Hormones|hormones|mesh-ancestor
14175121|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175122|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14175123|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183642|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183643|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14183644|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183645|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14183646|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14183647|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
14183648|NCT04726345|Fexofenadine|fexofenadine|mesh-list
14183649|NCT04726345|Terfenadine|terfenadine|mesh-list
14183650|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14183651|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14183652|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14183653|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
14183654|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
14183655|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183656|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183657|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184231|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184232|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184233|NCT04721054|Lidocaine|lidocaine|mesh-list
14184234|NCT04721054|Bupivacaine|bupivacaine|mesh-list
14184235|NCT04721054|Anesthetics|anesthetics|mesh-list
14184236|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
14184237|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184238|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938790|NCT01484262|Hormones|hormones|mesh-ancestor
13927787|NCT03393949|Hormones|hormones|mesh-ancestor
13927788|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927789|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13927790|NCT03393949|Protective Agents|protective agents|mesh-ancestor
13927791|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13927792|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927793|NCT03393858|Antibodies|antibodies|mesh-list
13927794|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
14102873|NCT02398474|Ropivacaine|ropivacaine|mesh-list
14102874|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
14102875|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
14102876|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102877|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102878|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
14102879|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102880|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
13927795|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927796|NCT03393819|Ethanol|ethanol|mesh-list
13927797|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
13927798|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13927799|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927800|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927801|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927802|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
13927803|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14102881|NCT02398539|Triamcinolone|triamcinolone|mesh-list
14102882|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14102883|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
14102884|NCT02398539|Hormones|hormones|mesh-ancestor
14102885|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14102886|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102887|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14102888|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102889|NCT02398201|Bezafibrate|bezafibrate|mesh-list
14102890|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14102891|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
14102892|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102893|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14102894|NCT02398123|Bupivacaine|bupivacaine|mesh-list
14102895|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
14102896|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
13927804|NCT03393780|Hormones|hormones|mesh-ancestor
13927805|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13927806|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927807|NCT03393767|Ranibizumab|ranibizumab|mesh-list
14102897|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102898|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102899|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
14102900|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102901|NCT02398136|Midazolam|midazolam|mesh-list
14102902|NCT02398136|Ketamine|ketamine|mesh-list
14102903|NCT02398136|Analgesics|analgesics|mesh-ancestor
14102904|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
14102905|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14102906|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102907|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14102908|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102909|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
14102910|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
14102911|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102912|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14102913|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14102914|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102915|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102916|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14102917|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14102918|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14102919|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14102920|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14102921|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
14102922|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
14102923|NCT02397928|Carboplatin|carboplatin|mesh-list
14102924|NCT02397928|Pemetrexed|pemetrexed|mesh-list
14102925|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102926|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102927|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102928|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14102929|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14102930|NCT02397720|Nivolumab|nivolumab|mesh-list
14102931|NCT02397720|Ipilimumab|ipilimumab|mesh-list
13960930|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
14102932|NCT02397720|Azacitidine|azacitidine|mesh-list
14102933|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14102934|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102935|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14102936|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102937|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14102938|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
14102939|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102940|NCT02397772|Albendazole|albendazole|mesh-list
14102941|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
14102942|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14102943|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14102944|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
14102945|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14102946|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14102947|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14102948|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14102949|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14102950|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102951|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102952|NCT02397863|Cannabidiol|cannabidiol|mesh-list
14102953|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
14102954|NCT02398058|Olaparib|olaparib|mesh-list
14102955|NCT02398058|Trabectedin|trabectedin|mesh-list
14102956|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14102957|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102958|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102959|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14102960|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14102961|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
14102962|NCT02397382|Midazolam|midazolam|mesh-list
14102963|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
14102964|NCT02397382|Caffeine|caffeine|mesh-list
14102965|NCT02397382|Omeprazole|omeprazole|mesh-list
14102966|NCT02397382|Warfarin|warfarin|mesh-list
14102967|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14102968|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14102969|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14102970|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14102971|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14102972|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14102973|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14102974|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14102975|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
14102976|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
14102977|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
14102978|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
14102979|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14102980|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14102981|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
14102982|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14102983|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14102984|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14102985|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14102986|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14102987|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13927808|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13927809|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13927810|NCT03393767|Growth Substances|growth substances|mesh-ancestor
13927811|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927812|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
13927813|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927814|NCT03393728|Propranolol|propranolol|mesh-list
13927815|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13927816|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13927817|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927818|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927819|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927820|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927821|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13927822|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13927823|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
13927824|NCT03393715|Perindopril|perindopril|mesh-list
13927825|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13927826|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
14102988|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14102989|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13927827|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927828|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927829|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13927830|NCT03393702|Gabapentin|gabapentin|mesh-list
14761434|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14761435|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14761436|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14761437|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761438|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761439|NCT03724994|Gemcitabine|gemcitabine|mesh-list
14761440|NCT03724994|Paclitaxel|paclitaxel|mesh-list
14761441|NCT03724994|Fluorouracil|fluorouracil|mesh-list
14761442|NCT03724994|Folfirinox|folfirinox|mesh-list
14761443|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14761444|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761445|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
14761446|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761447|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761448|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761449|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761450|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
13927831|NCT03393702|Analgesics|analgesics|mesh-ancestor
13927832|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
13927833|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927834|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927835|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
14761451|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
14761452|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761453|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761454|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761455|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
14761456|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761457|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
14761458|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761459|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761460|NCT03709758|Cytarabine|cytarabine|mesh-list
14761461|NCT03709758|Daunorubicin|daunorubicin|mesh-list
14761462|NCT03709758|Venetoclax|venetoclax|mesh-list
13927836|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14102990|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
14102991|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
14102992|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
14102993|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14102994|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14102995|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
14102996|NCT02397603|Bupivacaine|bupivacaine|mesh-list
14102997|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
14102998|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
14102999|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103000|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103001|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
14103002|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103003|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14103004|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14103005|NCT02397603|Analgesics|analgesics|mesh-ancestor
14103006|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14103007|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14103008|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14103009|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
14103010|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103011|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103012|NCT02397395|Simeprevir|simeprevir|mesh-list
14103013|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
14103014|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103015|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
14103016|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103017|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103018|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14103019|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103020|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103021|NCT02397512|Lactulose|lactulose|mesh-list
14103022|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103023|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
14761463|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761464|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
13927837|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13927838|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927839|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13927840|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13927841|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13927842|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935969|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14935970|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14935971|NCT01466517|Analgesics|analgesics|mesh-ancestor
13927843|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927844|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
13927845|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
13927846|NCT03393572|Nalbuphine|nalbuphine|mesh-list
13927847|NCT03393572|Bupivacaine|bupivacaine|mesh-list
13927848|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
13927849|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
13927850|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927851|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927852|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
13927853|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927854|NCT03393572|Analgesics|analgesics|mesh-ancestor
13927855|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13927856|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
13927857|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13927858|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13927859|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927860|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13927861|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
13927862|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13927863|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14103024|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14103025|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103026|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14103027|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103028|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14103029|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103030|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103031|NCT02397538|Amlodipine|amlodipine|mesh-list
14103032|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14103033|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14103034|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14103035|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103036|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103037|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14103038|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103039|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
14103040|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14103041|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14103042|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
14103043|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14103044|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14103045|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103046|NCT02397486|Vitamin E|vitamin e|mesh-list
14103047|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
14103048|NCT02397486|Vitamins|vitamins|mesh-ancestor
14103049|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
14103050|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103051|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
14103052|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103053|NCT02397486|Protective Agents|protective agents|mesh-ancestor
14103054|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14103055|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927864|NCT03393572|Narcotics|narcotics|mesh-ancestor
13927865|NCT03393507|Apatinib|apatinib|mesh-list
13927866|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927867|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13927868|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927869|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927870|NCT03393481|Enoxaparin|enoxaparin|mesh-list
13927871|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
14103056|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103057|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14477666|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14935972|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
14103058|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
14103059|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14103060|NCT02397590|Atorvastatin|atorvastatin|mesh-list
14103061|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14103062|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14761465|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761466|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761467|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
14761468|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761469|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761470|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
14761471|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761472|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14761473|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14761474|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14761475|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761476|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14761477|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
14761478|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761479|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
14761480|NCT03695510|Afatinib|afatinib|mesh-list
14761481|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761482|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761483|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14761484|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761485|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761486|NCT03673527|Tacrolimus|tacrolimus|mesh-list
14761487|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761488|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
14935973|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927872|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13927873|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13927874|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103063|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
14103064|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103065|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14103066|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14103067|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103068|NCT02397356|Ketamine|ketamine|mesh-list
14103069|NCT02397356|Analgesics|analgesics|mesh-ancestor
14103070|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
13927875|NCT03393416|Antibodies|antibodies|mesh-list
13927876|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
13927877|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927878|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
13927879|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13927880|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927881|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927882|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13927883|NCT03393403|Analgesics|analgesics|mesh-ancestor
13927884|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
13927885|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13927886|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13927887|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13927888|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13927889|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927890|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927891|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927892|NCT03393377|Valsartan|valsartan|mesh-list
13927893|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14103071|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103072|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103073|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14103074|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14103075|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
14103076|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
14103077|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103078|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13927894|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13927895|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13927896|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103079|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14103080|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103081|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103082|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14103083|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14103084|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
14103085|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103086|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103087|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14103088|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
14103089|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14103090|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14103091|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14103092|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
14103093|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103094|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103095|NCT02397330|Morphine|morphine|mesh-list
14103096|NCT02397330|Bupivacaine|bupivacaine|mesh-list
14103097|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
14103098|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
13927897|NCT03393364|Ketorolac|ketorolac|mesh-list
13927898|NCT03393364|Oxycodone|oxycodone|mesh-list
13927899|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13927900|NCT03393364|Narcotics|narcotics|mesh-ancestor
14103099|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103100|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103101|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
14103102|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103103|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14103104|NCT02397330|Narcotics|narcotics|mesh-ancestor
14103105|NCT02397330|Analgesics|analgesics|mesh-ancestor
14103106|NCT02396979|Methadone|methadone|mesh-list
14103107|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13927901|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927902|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927903|NCT03393364|Analgesics|analgesics|mesh-ancestor
13927904|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
13927905|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103108|NCT02396979|Narcotics|narcotics|mesh-ancestor
14103109|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103110|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103111|NCT02396979|Analgesics|analgesics|mesh-ancestor
14103112|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
14103113|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103114|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
14103115|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
14103116|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
14103117|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103118|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
14103119|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
14103120|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
14103121|NCT02397213|Cyclosporine|cyclosporine|mesh-list
14103122|NCT02397213|Cyclosporins|cyclosporins|mesh-list
14103123|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103124|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103125|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103126|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
14103127|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103128|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
14103129|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103130|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
14103131|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103132|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14103133|NCT02396888|Insulin|insulin|mesh-list
14103134|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13927906|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13927907|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13927908|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13927909|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103135|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103136|NCT02396563|Ropivacaine|ropivacaine|mesh-list
14103137|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
14103138|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
14103139|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103140|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103141|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
13927910|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14103142|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175124|NCT04778917|Heparin|heparin|mesh-list
14103143|NCT02396862|Factor VIII|factor viii|mesh-list
14103144|NCT02396862|Coagulants|coagulants|mesh-ancestor
14103145|NCT02396225|Voriconazole|voriconazole|mesh-list
14103146|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
14103147|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103148|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14103149|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13927911|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927912|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927913|NCT03393325|Tadalafil|tadalafil|mesh-list
13927914|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
13927915|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13927916|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14103150|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103151|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103152|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14103153|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
14103154|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14103155|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103156|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14103157|NCT02396303|Carbetocin|carbetocin|mesh-list
14103158|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
14103159|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103160|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103161|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
14103162|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
14103163|NCT02396329|Povidone|povidone|mesh-list
14103164|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14103165|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103166|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
14103167|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
14103168|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
14103169|NCT02396433|Carboplatin|carboplatin|mesh-list
14103170|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14103171|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103172|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103173|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103174|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
14103175|NCT02396030|Analgesics|analgesics|mesh-ancestor
14103176|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
14103177|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103178|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103179|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
14935974|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935975|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14935976|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14935977|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14935978|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927917|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927918|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927919|NCT03393325|Urological Agents|urological agents|mesh-ancestor
13927920|NCT03393273|Elotuzumab|elotuzumab|mesh-list
13927921|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927922|NCT03393247|Azathioprine|azathioprine|mesh-list
13927923|NCT03393247|Infliximab|infliximab|mesh-list
13927924|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
13927925|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13927926|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13927927|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
13927928|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927929|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14103180|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103181|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14103182|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
14103183|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14103184|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103185|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103186|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14103187|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
14103188|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103189|NCT02396108|Paclitaxel|paclitaxel|mesh-list
14103190|NCT02396108|Carboplatin|carboplatin|mesh-list
14183658|NCT04726280|Ropivacaine|ropivacaine|mesh-list
14935979|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103191|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103192|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103193|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
14103194|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
14103195|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
14103196|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103197|NCT02396043|Cytarabine|cytarabine|mesh-list
14103198|NCT02396043|Dexamethasone|dexamethasone|mesh-list
14103199|NCT02396043|Prednisone|prednisone|mesh-list
14103200|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
14103201|NCT02396043|Methotrexate|methotrexate|mesh-list
14103202|NCT02396043|Vincristine|vincristine|mesh-list
14103203|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
14103204|NCT02396043|Pegaspargase|pegaspargase|mesh-list
14103205|NCT02396043|Asparaginase|asparaginase|mesh-list
14103206|NCT02396043|Pirarubicin|pirarubicin|mesh-list
14103207|NCT02396043|Doxorubicin|doxorubicin|mesh-list
14103208|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103209|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
14103210|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103211|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103212|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14103213|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
14103214|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103215|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103216|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14103217|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103218|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
14103219|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
14103220|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103221|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103222|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
14103223|NCT02396043|Hormones|hormones|mesh-ancestor
13927930|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927931|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13927932|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
13927933|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927934|NCT03393117|Narcotics|narcotics|mesh-list
13927935|NCT03393117|Bupivacaine|bupivacaine|mesh-list
13927936|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
13927937|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
13927938|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927939|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927940|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
13927941|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103224|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14103225|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14103226|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103227|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14103228|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
14103229|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103230|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14103231|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
14103232|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
14103233|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14103234|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14103235|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
14103236|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927942|NCT03393117|Analgesics|analgesics|mesh-ancestor
13927943|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
13927944|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13927945|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13927946|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13927947|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927948|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13927949|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13927950|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13927951|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13927952|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
13927953|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13927954|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927955|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14103237|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103238|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
14103239|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
13927956|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14103240|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
14103241|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14103242|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14103243|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14103244|NCT02395783|Melatonin|melatonin|mesh-list
14103245|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
14103246|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103247|NCT02395783|Protective Agents|protective agents|mesh-ancestor
14103248|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103249|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103250|NCT02395705|Paclitaxel|paclitaxel|mesh-list
14103251|NCT02395705|Cisplatin|cisplatin|mesh-list
14103252|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103253|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103254|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
14103255|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
14103256|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
14103257|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103258|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
14103259|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14103260|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103261|NCT02395926|Choline|choline|mesh-list
14103262|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
14103263|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14103264|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
14103265|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103266|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103267|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14103268|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
14103269|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14103270|NCT02395952|Laxatives|laxatives|mesh-ancestor
14103271|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103272|NCT02395744|Paclitaxel|paclitaxel|mesh-list
14103273|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103274|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103275|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14103276|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14103277|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14103278|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103279|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
14103280|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103281|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103282|NCT02395458|Amoxicillin|amoxicillin|mesh-list
14103283|NCT02395458|Metronidazole|metronidazole|mesh-list
14103284|NCT02395458|Clarithromycin|clarithromycin|mesh-list
14103285|NCT02395458|Omeprazole|omeprazole|mesh-list
14103286|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14103287|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103288|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14103289|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14103290|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13927957|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
13927958|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13927959|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13927960|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
13927961|NCT03392961|Insulin|insulin|mesh-list
13927962|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13927963|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927964|NCT03392909|Gentamicins|gentamicins|mesh-list
13927965|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13927966|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13927967|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13927968|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927969|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960931|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13960932|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13960933|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
13960934|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960935|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13960936|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960937|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13960938|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
14103291|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103292|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14103293|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103294|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103295|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14103296|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14103297|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14103298|NCT02395510|Vortioxetine|vortioxetine|mesh-list
14103299|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
14103300|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14103301|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14103302|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14103303|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103304|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103305|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14103306|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14103307|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103308|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103309|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103310|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
14103311|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14103312|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14103313|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14103314|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14103315|NCT02395497|Antibodies|antibodies|mesh-list
14103316|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14103317|NCT02395497|Tacrolimus|tacrolimus|mesh-list
14103318|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
14103319|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103320|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103321|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14103322|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103323|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103324|NCT02395237|Glimepiride|glimepiride|mesh-list
14103325|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14103326|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14103327|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103328|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103329|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
14103330|NCT02394847|Propofol|propofol|mesh-list
14103331|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14103332|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103333|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103334|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14103335|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
14103336|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
14103337|NCT02395068|Irinotecan|irinotecan|mesh-list
14103338|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
14103339|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14103340|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13927970|NCT03392792|Plasminogen|plasminogen|mesh-list
13927971|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13927972|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13927973|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13927974|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927975|NCT03392740|Lisinopril|lisinopril|mesh-list
14103341|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103342|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103343|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103344|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14103345|NCT02395016|Gemcitabine|gemcitabine|mesh-list
14103346|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
14103347|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14103348|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
14103349|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103350|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103351|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
13927976|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13927977|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
13927978|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13927979|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13927980|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14103352|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103353|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103354|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103355|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
14103356|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103357|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14175125|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13927981|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13927982|NCT03392740|Protective Agents|protective agents|mesh-ancestor
13927983|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927984|NCT03392623|Niacinamide|niacinamide|mesh-list
13927985|NCT03392623|Niacin|niacin|mesh-list
13927986|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
13927987|NCT03392623|Tretinoin|tretinoin|mesh-list
13927988|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
13927989|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13927990|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
13927991|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
13927992|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13927993|NCT03392623|Protective Agents|protective agents|mesh-ancestor
13927994|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13927995|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
13927996|NCT03392623|Vitamins|vitamins|mesh-ancestor
13927997|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
13927998|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13927999|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
14175126|NCT04778917|Tinzaparin|tinzaparin|mesh-list
14175127|NCT04778917|Dalteparin|dalteparin|mesh-list
14175128|NCT04778917|Calcium heparin|calcium heparin|mesh-list
13928000|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928001|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13928002|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
13928003|NCT03392571|Gemcitabine|gemcitabine|mesh-list
13928004|NCT03392571|Paclitaxel|paclitaxel|mesh-list
13928005|NCT03392571|Cisplatin|cisplatin|mesh-list
13928006|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13928007|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928008|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
13928009|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
14175129|NCT04778917|Calcium|calcium|mesh-list
14175130|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14175131|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175132|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
14175133|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14175134|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14175135|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175136|NCT04778865|Vitamin D|vitamin d|mesh-list
14175137|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
14175138|NCT04778865|Vitamins|vitamins|mesh-list
14175139|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
14175140|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175141|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14175142|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14175143|NCT04778839|Paclitaxel|paclitaxel|mesh-list
14175144|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14175145|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14175146|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175147|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
13928010|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928011|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928012|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928013|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
13928014|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
13928015|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928016|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928017|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928018|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
13928019|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928020|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
13928021|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
13928022|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928023|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
13928024|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13928025|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928026|NCT03392311|Calcipotriene|calcipotriene|mesh-list
14175148|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
13928027|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
13928028|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14175149|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928029|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
13928030|NCT03392272|Coagulants|coagulants|mesh-ancestor
13928031|NCT03392103|Raltitrexed|raltitrexed|mesh-list
13928032|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928033|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
13928034|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928035|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928036|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13928037|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928038|NCT03392051|Clopidogrel|clopidogrel|mesh-list
13928039|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103358|NCT02394821|Metronidazole|metronidazole|mesh-list
14103359|NCT02394821|Polihexanide|polihexanide|mesh-list
14103360|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103361|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14103362|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14103363|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14103364|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
13928040|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13928041|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13928042|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13928043|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
13928044|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928045|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928046|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928047|NCT03391934|Leucovorin|leucovorin|mesh-list
13928048|NCT03391934|Fluorouracil|fluorouracil|mesh-list
13928049|NCT03391934|Irinotecan|irinotecan|mesh-list
13928050|NCT03391934|Cetuximab|cetuximab|mesh-list
13928051|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928052|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
13928053|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928054|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928055|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103365|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14103366|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14103367|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103368|NCT02394652|Metformin|metformin|mesh-list
14103369|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14103370|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14103371|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103372|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14103373|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103374|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
14103375|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103376|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14103377|NCT02394470|Protective Agents|protective agents|mesh-ancestor
14103378|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103379|NCT02394496|Fulvestrant|fulvestrant|mesh-list
14103380|NCT02394496|Lapatinib|lapatinib|mesh-list
14103381|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14103382|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14103383|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103384|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14103385|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14103386|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
14103387|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14103388|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103389|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14103390|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103391|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103392|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14103393|NCT02394483|Olorofim|olorofim|mesh-list
14103394|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
14103395|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103396|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
14103397|NCT02394418|Propofol|propofol|mesh-list
14103398|NCT02394418|Sevoflurane|sevoflurane|mesh-list
14103399|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14103400|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103401|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103402|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14103403|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
14103404|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
13928056|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14935980|NCT01466530|Misoprostol|misoprostol|mesh-list
13928057|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
13928058|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13928059|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13928060|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928061|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14103405|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14103406|NCT02394418|Analgesics|analgesics|mesh-ancestor
14103407|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
14103408|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103409|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14103410|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14103411|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14103412|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
14103413|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103414|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103415|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103416|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14103417|NCT02394145|Clopidogrel|clopidogrel|mesh-list
14103418|NCT02394145|Ticagrelor|ticagrelor|mesh-list
14103419|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103420|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14103421|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14103422|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14103423|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
14103424|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103425|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103426|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103427|NCT02394158|Metformin|metformin|mesh-list
14103428|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14103429|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103430|NCT02394197|Chloroquine|chloroquine|mesh-list
14103431|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14103432|NCT02394197|Primaquine|primaquine|mesh-list
14103433|NCT02394197|Amebicides|amebicides|mesh-ancestor
13928062|NCT03391934|Antidotes|antidotes|mesh-ancestor
13928063|NCT03391934|Protective Agents|protective agents|mesh-ancestor
13928064|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
13928065|NCT03391934|Vitamins|vitamins|mesh-ancestor
14103434|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14103435|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14103436|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103437|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
14103438|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103439|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14103440|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14103441|NCT02394197|Analgesics|analgesics|mesh-ancestor
14103442|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
14103443|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103444|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103445|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103446|NCT02394197|Filaricides|filaricides|mesh-ancestor
14103447|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
14103448|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
14103449|NCT02394119|Rituximab|rituximab|mesh-list
14103450|NCT02394119|Ofatumumab|ofatumumab|mesh-list
14103451|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14103452|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103453|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
14103454|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103455|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103456|NCT02394106|Ofatumumab|ofatumumab|mesh-list
14103457|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103458|NCT02394015|Doxorubicin|doxorubicin|mesh-list
14103459|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14761489|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761490|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13928066|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
13928067|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
13928068|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14761491|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761492|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761493|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
14103460|NCT02394015|Trabectedin|trabectedin|mesh-list
14103461|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13928069|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
14103462|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103463|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13928070|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928071|NCT03391856|Expectorants|expectorants|mesh-ancestor
13928072|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
13928073|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13928074|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
13928075|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928076|NCT03391856|Protective Agents|protective agents|mesh-ancestor
13928077|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928078|NCT03391856|Antidotes|antidotes|mesh-ancestor
13928079|NCT03391843|Cetuximab|cetuximab|mesh-list
13928080|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
13928081|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928082|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928083|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
14103464|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14103465|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103466|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103467|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14103468|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
14103469|NCT02393846|Ketoprofen|ketoprofen|mesh-list
14103470|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14103471|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14103472|NCT02393846|Analgesics|analgesics|mesh-ancestor
14103473|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
14103474|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103475|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103476|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103477|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103478|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14103479|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103480|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103481|NCT02394093|Aspirin|aspirin|mesh-list
14103482|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14103483|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14103484|NCT02394093|Analgesics|analgesics|mesh-ancestor
14103485|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
14103486|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103487|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103488|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103489|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103490|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14103491|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14103492|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103493|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103494|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13928084|NCT03391830|Atorvastatin|atorvastatin|mesh-list
13928085|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13928086|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13928087|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
13928088|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928089|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13928090|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13928091|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928092|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
13928093|NCT03391830|Protective Agents|protective agents|mesh-ancestor
13928094|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928095|NCT03391830|Vitamins|vitamins|mesh-ancestor
13928096|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
13928097|NCT03391700|Rocuronium|rocuronium|mesh-list
13928098|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13928099|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13928100|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14103495|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103496|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
14103497|NCT02393898|Paclitaxel|paclitaxel|mesh-list
14103498|NCT02393898|Bevacizumab|bevacizumab|mesh-list
14103499|NCT02393898|Carboplatin|carboplatin|mesh-list
14103500|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103501|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103502|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14103503|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
13928101|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928102|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103504|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928103|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
14103505|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103506|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928104|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13928105|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928106|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928107|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928108|NCT03391609|Analgesics|analgesics|mesh-ancestor
14103507|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14103508|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14103509|NCT02393898|Growth Substances|growth substances|mesh-ancestor
14103510|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103511|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
14103512|NCT02394028|Etrolizumab|etrolizumab|mesh-list
14103513|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103514|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
14103515|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103516|NCT02394002|Propofol|propofol|mesh-list
14103517|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14103518|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103519|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103520|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13928109|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
13928110|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928111|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13928112|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13928113|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13928114|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
13928115|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928116|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928117|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
13928118|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14103521|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
14103522|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
14103523|NCT02394054|Vasopressins|vasopressins|mesh-list
14103524|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
14103525|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
14103526|NCT02394054|Coagulants|coagulants|mesh-ancestor
14103527|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14103528|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14103529|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
14103530|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103531|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
14103532|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14103533|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14103534|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103535|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
14103536|NCT02393963|Coagulants|coagulants|mesh-ancestor
13928119|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928120|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928121|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13928122|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928123|NCT03391570|Analgesics|analgesics|mesh-ancestor
13928124|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
13928125|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928126|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928127|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103537|NCT02393664|Bupivacaine|bupivacaine|mesh-list
13928128|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13928129|NCT03391427|Lidocaine|lidocaine|mesh-list
13928130|NCT03391427|Ketamine|ketamine|mesh-list
13928131|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
13928132|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
13928133|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928134|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928135|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
13928136|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928137|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13928138|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13928139|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14103538|NCT02393664|Propofol|propofol|mesh-list
14103539|NCT02393664|Sevoflurane|sevoflurane|mesh-list
14103540|NCT02393664|Rocuronium|rocuronium|mesh-list
14103541|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
14103542|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
13928140|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928141|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928142|NCT03391427|Analgesics|analgesics|mesh-ancestor
13928143|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13928144|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14103543|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103544|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103545|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
14103546|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103547|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14103548|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14103549|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
13928145|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
13928146|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13928147|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13928148|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960939|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960940|NCT03151499|Rifampin|rifampin|mesh-list
13960941|NCT03151499|BI 409306|bi 409306|mesh-list
13960942|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14103550|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103551|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14103552|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14103553|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14103554|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14103555|NCT02393599|Cocaine|cocaine|mesh-list
14103556|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
14103557|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
14103558|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103559|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103560|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
14103561|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103562|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14103563|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14103564|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14103565|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103566|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103567|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
14103568|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103569|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
14103570|NCT02393482|Leuprolide|leuprolide|mesh-list
14103571|NCT02393482|Tibolone|tibolone|mesh-list
14103572|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
14103573|NCT02393482|Hormones|hormones|mesh-list
14103574|NCT02393482|Estradiol|estradiol|mesh-list
14103575|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14103576|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103577|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14103578|NCT02393482|Estrogens|estrogens|mesh-ancestor
14103579|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103580|NCT02393482|Antacids|antacids|mesh-ancestor
14103581|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103582|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103583|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14103584|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
14103585|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14103586|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103587|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
13960943|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
13960944|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13960945|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960946|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
13960947|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13960948|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13960949|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960950|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13960951|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13960952|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13960953|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13960954|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13960955|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13960956|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14103588|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
14103589|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14103590|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14103591|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
14103592|NCT02393482|Vitamins|vitamins|mesh-ancestor
14103593|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
14103594|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13928149|NCT03391284|Acetaminophen|acetaminophen|mesh-list
13928150|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928151|NCT03391284|Analgesics|analgesics|mesh-ancestor
13928152|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
13928153|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928154|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928155|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
13928156|NCT03391245|Vitamin D|vitamin d|mesh-list
13928157|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13928158|NCT03391245|Calcifediol|calcifediol|mesh-list
13928159|NCT03391245|Vitamins|vitamins|mesh-ancestor
13928160|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
13928161|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928162|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13928163|NCT03391219|Bevacizumab|bevacizumab|mesh-list
13928164|NCT03391219|Fasudil|fasudil|mesh-list
13928165|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928166|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928167|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13928168|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13928169|NCT03391219|Growth Substances|growth substances|mesh-ancestor
13928170|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928171|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
13928172|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13928173|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103595|NCT02393573|Metformin|metformin|mesh-list
14103596|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14103597|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103598|NCT02393625|Nivolumab|nivolumab|mesh-list
14103599|NCT02393625|Ceritinib|ceritinib|mesh-list
14103600|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14103601|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103602|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14103603|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103604|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14103605|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103606|NCT02393586|Amoxicillin|amoxicillin|mesh-list
14103607|NCT02393586|Rifampin|rifampin|mesh-list
14103608|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14103609|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
14103610|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
14103611|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14103612|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103613|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14103614|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
14103615|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
14103616|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14103617|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103618|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103619|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14103620|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14103621|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14103622|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14103623|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13928174|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928175|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13928176|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
13928177|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928178|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477667|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477668|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928182|NCT03391050|Dabrafenib|dabrafenib|mesh-list
13928183|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928184|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928185|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928186|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103624|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14103625|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14103626|NCT02393456|Oxytocin|oxytocin|mesh-list
14103627|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
14103628|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103629|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103630|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
14103631|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14103632|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14103633|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103634|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103635|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14103636|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
14477669|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
14477670|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
14477671|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928187|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
13928188|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13928189|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928190|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928191|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928192|NCT03390972|Analgesics|analgesics|mesh-ancestor
13928193|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
13928194|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928195|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14103637|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103638|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103639|NCT02393430|Rebamipide|rebamipide|mesh-list
14103640|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14103641|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103642|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
14103643|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103644|NCT02393430|Protective Agents|protective agents|mesh-ancestor
14103645|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103646|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103647|NCT02393443|Oxytocin|oxytocin|mesh-list
14103648|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
14103649|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103650|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103651|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
14103652|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14103653|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14103654|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103655|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
14477672|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
14477673|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14477674|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
14477675|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14477676|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
14477677|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14477678|NCT02436759|Protective Agents|protective agents|mesh-ancestor
14477679|NCT02436889|Mirabegron|mirabegron|mesh-list
14477680|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14477681|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14761494|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14761495|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761496|NCT03663504|Metronidazole|metronidazole|mesh-list
14761497|NCT03663504|Neomycin|neomycin|mesh-list
14761498|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761499|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14103656|NCT02393300|Coagulants|coagulants|mesh-ancestor
14103657|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
14103658|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14103659|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14103660|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
14477682|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14477683|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14103661|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
14103662|NCT02393144|Meperidine|meperidine|mesh-list
14103663|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
14103664|NCT02393144|Analgesics|analgesics|mesh-list
14103665|NCT02393144|Oxytocin|oxytocin|mesh-list
14103666|NCT02393144|Dinoprostone|dinoprostone|mesh-list
13928196|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13928197|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13928198|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
13928199|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928200|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928201|NCT03390933|Fluoxetine|fluoxetine|mesh-list
13928202|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13928203|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13928204|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928205|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928206|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928207|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
13928208|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928209|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13928210|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
13928211|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14103667|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
14103668|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103669|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103670|NCT02393144|Narcotics|narcotics|mesh-ancestor
14103671|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103672|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
14103673|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103674|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14175150|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175151|NCT04778813|Artesunate|artesunate|mesh-list
14175152|NCT04778813|Lumefantrine|lumefantrine|mesh-list
14175153|NCT04778813|Artemether|artemether|mesh-list
14175154|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14175155|NCT04778813|Artenimol|artenimol|mesh-list
14175156|NCT04778813|Pyronaridine|pyronaridine|mesh-list
14175157|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
14175158|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14175159|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14175160|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175161|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175162|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
14175163|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
14175164|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14175165|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
14175166|NCT04779047|Ritonavir|ritonavir|mesh-list
14175167|NCT04779047|Lopinavir|lopinavir|mesh-list
14175168|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
14175169|NCT04779047|Ivermectin|ivermectin|mesh-list
14175170|NCT04779047|Remdesivir|remdesivir|mesh-list
14175171|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14175172|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14175173|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
14175174|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175175|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175176|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14175177|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14175178|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
14175179|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175180|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13928212|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13928213|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13928214|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928215|NCT03390790|Lidocaine|lidocaine|mesh-list
13928216|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
13928217|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
13928218|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928219|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928220|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
13928221|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928222|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13928223|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14175181|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14175182|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
14175183|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14175184|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13928224|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13928225|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928226|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928227|NCT03390738|Nivolumab|nivolumab|mesh-list
13928228|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928229|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928230|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13928231|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928232|NCT03390712|Risperidone|risperidone|mesh-list
13928233|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13928234|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
13928235|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13928236|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
13928237|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928238|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928239|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928240|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13928241|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928242|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13928243|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13928244|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
13928245|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13928246|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13928247|NCT03390686|Paclitaxel|paclitaxel|mesh-list
13928248|NCT03390686|Bevacizumab|bevacizumab|mesh-list
13928249|NCT03390686|Carboplatin|carboplatin|mesh-list
13928250|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103675|NCT02393157|Carboplatin|carboplatin|mesh-list
14103676|NCT02393157|Etoposide|etoposide|mesh-list
14103677|NCT02393157|Ifosfamide|ifosfamide|mesh-list
14103678|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
14103679|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103680|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103681|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14103682|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14103683|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103684|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103685|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14103686|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
14103687|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14103688|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14103689|NCT02392910|Hematinics|hematinics|mesh-ancestor
14103690|NCT02392845|Docetaxel|docetaxel|mesh-list
14103691|NCT02392845|Epirubicin|epirubicin|mesh-list
14103692|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928251|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928252|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
13928253|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
13928254|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928255|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928256|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928257|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13928258|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13928259|NCT03390686|Growth Substances|growth substances|mesh-ancestor
13928260|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928261|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
13928262|NCT03390673|Bevacizumab|bevacizumab|mesh-list
13928263|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928264|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928265|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14103693|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14103694|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14103695|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14103696|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103697|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14103698|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14103699|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14103700|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103701|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
14103702|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14103703|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14103704|NCT02392780|Prednisolone|prednisolone|mesh-list
14103705|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
14103706|NCT02392780|Cannabidiol|cannabidiol|mesh-list
14103707|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13928266|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13928267|NCT03390673|Growth Substances|growth substances|mesh-ancestor
13928268|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103708|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
14103709|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14103710|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103711|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
14103712|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
14103713|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103714|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103715|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103716|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
13928269|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
13928270|NCT03390608|Trastuzumab|trastuzumab|mesh-list
13928271|NCT03390608|Estrogens|estrogens|mesh-list
13928272|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928273|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928274|NCT03390608|Hormones|hormones|mesh-ancestor
13928275|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13928276|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928277|NCT03390595|Gemcitabine|gemcitabine|mesh-list
13928278|NCT03390595|Carboplatin|carboplatin|mesh-list
13928279|NCT03390595|Avelumab|avelumab|mesh-list
13928280|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928281|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928282|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
13928283|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928284|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
13928285|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928286|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928287|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928288|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
13928289|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928290|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928291|NCT03390582|Methimazole|methimazole|mesh-list
14103717|NCT02392780|Hormones|hormones|mesh-ancestor
14103718|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14103719|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14103720|NCT02392780|Protective Agents|protective agents|mesh-ancestor
14103721|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14103722|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103723|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
14103724|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103725|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103726|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
14103727|NCT02393066|Propofol|propofol|mesh-list
14103728|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14103729|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103730|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103731|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14103732|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
14103733|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
14103734|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14103735|NCT02393066|Analgesics|analgesics|mesh-ancestor
14103736|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
14103737|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103738|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14103739|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14103740|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14103741|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14103742|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103743|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928292|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
13928293|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
13928294|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13928295|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928296|NCT03390465|Amlodipine|amlodipine|mesh-list
13928297|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14103744|NCT02392793|Irinotecan|irinotecan|mesh-list
14103745|NCT02392793|Temozolomide|temozolomide|mesh-list
13928298|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14103746|NCT02392793|Talazoparib|talazoparib|mesh-list
14103747|NCT02392793|Lenograstim|lenograstim|mesh-list
13928299|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13928300|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928301|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928302|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13928303|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928304|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
13928305|NCT03390465|Diuretics|diuretics|mesh-ancestor
13928306|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
13928307|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13928308|NCT03390387|Dexamethasone|dexamethasone|mesh-list
13928309|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
13928310|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
13928311|NCT03390387|Bortezomib|bortezomib|mesh-list
13928312|NCT03390387|Daunorubicin|daunorubicin|mesh-list
13928313|NCT03390387|Idarubicin|idarubicin|mesh-list
13928314|NCT03390387|BB 1101|bb 1101|mesh-list
13928315|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13928316|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
13928317|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
13928318|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928319|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928320|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13928321|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
13928322|NCT03390387|Hormones|hormones|mesh-ancestor
13928323|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13928324|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13928325|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928326|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
13928327|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928328|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928329|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13928330|NCT03390387|Protective Agents|protective agents|mesh-ancestor
13928331|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13928332|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13928333|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13928334|NCT03390374|Nystatin|nystatin|mesh-list
13928335|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13928336|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928337|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
13928338|NCT03390374|Ionophores|ionophores|mesh-ancestor
13928339|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928340|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928341|NCT03390062|Apatinib|apatinib|mesh-list
13928342|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928343|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928344|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928345|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928346|NCT03390036|Triamcinolone|triamcinolone|mesh-list
13928347|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13928348|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13928349|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13928350|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13928351|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
13928352|NCT03390036|Hormones|hormones|mesh-ancestor
13928353|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13928354|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928355|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928356|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
13928357|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928358|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928359|NCT03390010|Misoprostol|misoprostol|mesh-list
13928360|NCT03390010|Oxytocin|oxytocin|mesh-list
13928361|NCT03390010|Methylergonovine|methylergonovine|mesh-list
14103748|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14935981|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14935982|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
14935983|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14935984|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935985|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14103749|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14103750|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103751|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103752|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103753|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14103754|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
14103755|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14935986|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103756|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14103757|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
14103758|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14103759|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14103760|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14103761|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
14103762|NCT02392520|Cetrorelix|cetrorelix|mesh-list
14103763|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14103764|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
14103765|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103766|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103767|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
14103768|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14103769|NCT02392702|Ivacaftor|ivacaftor|mesh-list
14103770|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14103771|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103772|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103773|NCT02392468|BI 409306|bi 409306|mesh-list
14103774|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14103775|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103776|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103777|NCT02392364|Aflibercept|aflibercept|mesh-list
14103778|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14103779|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14103780|NCT02392364|Growth Substances|growth substances|mesh-ancestor
14103781|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103782|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
14103783|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103784|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14103785|NCT02392676|Olaparib|olaparib|mesh-list
14103786|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14103787|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103788|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103789|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103790|NCT02392117|Insulin|insulin|mesh-list
14103791|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14103792|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103793|NCT02392039|Loratadine|loratadine|mesh-list
14477684|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477685|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761500|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14761501|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14761502|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14761503|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761504|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761505|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
14761506|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14477686|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477687|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477688|NCT02436889|Urological Agents|urological agents|mesh-ancestor
14477689|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14477690|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14761507|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761508|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
14761509|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14761510|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14761511|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14761512|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761513|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928362|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13928363|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
13928364|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13928365|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928366|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13928367|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13928368|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
13928369|NCT03389958|Copper|copper|mesh-list
13928370|NCT03389958|Trace Elements|trace elements|mesh-ancestor
14103794|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
14103795|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
14477691|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
14103796|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14103797|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14103798|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14103799|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
14103800|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
14103801|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103802|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103803|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103804|NCT02392130|Clobetasol|clobetasol|mesh-list
14103805|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103806|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
14103807|NCT02392130|Hormones|hormones|mesh-ancestor
14103808|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14103809|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103810|NCT02392156|Factor VIII|factor viii|mesh-list
14103811|NCT02392156|Coagulants|coagulants|mesh-ancestor
14103812|NCT02392169|Methylphenidate|methylphenidate|mesh-list
14103813|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14103814|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103815|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14103816|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14103817|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103818|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103819|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
14103820|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103821|NCT02391844|Oxycodone|oxycodone|mesh-list
14103822|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14103823|NCT02391844|Narcotics|narcotics|mesh-ancestor
14103824|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103825|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103826|NCT02391844|Analgesics|analgesics|mesh-ancestor
13928371|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
13928372|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928373|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13928374|NCT03389776|Anesthetics|anesthetics|mesh-list
13928375|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928376|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928377|NCT03389763|Remifentanil|remifentanil|mesh-list
13928378|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14103827|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
14761514|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
14761515|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761516|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761517|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14103828|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103829|NCT02391883|Clopidogrel|clopidogrel|mesh-list
14103830|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14103831|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14103832|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14103833|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14103834|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
14103835|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103836|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103837|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103838|NCT02391805|Tenofovir|tenofovir|mesh-list
14103839|NCT02391805|Entecavir|entecavir|mesh-list
14103840|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
14103841|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103842|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14103843|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14103844|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761518|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767355|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767356|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767357|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
14767358|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14767359|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14767360|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767361|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14767362|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14767363|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13928379|NCT03389763|Narcotics|narcotics|mesh-ancestor
13928380|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928381|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928382|NCT03389763|Analgesics|analgesics|mesh-ancestor
13928383|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
13928384|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928385|NCT03389750|Oxymorphone|oxymorphone|mesh-list
13928386|NCT03389750|Morphine|morphine|mesh-list
13928387|NCT03389750|Oxycodone|oxycodone|mesh-list
13928388|NCT03389750|Hydromorphone|hydromorphone|mesh-list
13928389|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14103845|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103846|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14103847|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14103848|NCT02391662|Gemcitabine|gemcitabine|mesh-list
14103849|NCT02391662|Paclitaxel|paclitaxel|mesh-list
14103850|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14103851|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14103852|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103853|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
14103854|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
14103855|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
14103856|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103857|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14103858|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
13928390|NCT03389750|Narcotics|narcotics|mesh-ancestor
13928391|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928392|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928393|NCT03389750|Analgesics|analgesics|mesh-ancestor
13928394|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
13928395|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928396|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13928397|NCT03389724|Captopril|captopril|mesh-list
13928398|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13928399|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
13928400|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928401|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928402|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13960957|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
13960958|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
13960959|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960960|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960961|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960962|NCT03151460|Dopamine|dopamine|mesh-list
13960963|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
13960964|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13960965|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
13960966|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
13960967|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960968|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960969|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960970|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960971|NCT03151460|Protective Agents|protective agents|mesh-ancestor
13960972|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
14103859|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
14103860|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103861|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103862|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103863|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
14103864|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103865|NCT02391688|Fexofenadine|fexofenadine|mesh-list
14103866|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
14103867|NCT02391688|Midazolam|midazolam|mesh-list
14103868|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
14103869|NCT02391688|Caffeine|caffeine|mesh-list
14103870|NCT02391688|Bupropion|bupropion|mesh-list
14103871|NCT02391688|Omeprazole|omeprazole|mesh-list
14103872|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14103873|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14103874|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103875|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103876|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14103877|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14103878|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14103879|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14103880|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
14103881|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
14103882|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
14103883|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
13928403|NCT03389672|Anesthetics|anesthetics|mesh-list
13928404|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928405|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928406|NCT03389659|Vitamin D|vitamin d|mesh-list
13928407|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
13928408|NCT03389659|Vitamins|vitamins|mesh-ancestor
13928409|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
13928410|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928411|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13928412|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13928413|NCT03389607|Anesthetics|anesthetics|mesh-list
13928414|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928415|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928416|NCT03389490|Insulin|insulin|mesh-list
13928417|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13928418|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
13928419|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
13928420|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
13928421|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
13928422|NCT03389490|Protamines|protamines|mesh-list
13928423|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13928424|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928425|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
13928426|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928427|NCT03389490|Coagulants|coagulants|mesh-ancestor
14103884|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103885|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103886|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14103887|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14103888|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14103889|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103890|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14103891|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14103892|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14103893|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14103894|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
14103895|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14103896|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
14103897|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14103898|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14103899|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103900|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
14103901|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14103902|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14103903|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
14103904|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
14103905|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14103906|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14103907|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14103908|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14103909|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14103910|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
13928428|NCT03389451|Edetic Acid|edetic acid|mesh-list
13928429|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
13928430|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
13928431|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928432|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
14103911|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
14103912|NCT02391688|Analgesics|analgesics|mesh-ancestor
14103913|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
14103914|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103915|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14103916|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14103917|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103918|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103919|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14103920|NCT02391636|Oxytocin|oxytocin|mesh-list
14103921|NCT02391636|Carbetocin|carbetocin|mesh-list
14103922|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
14103923|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14103924|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103925|NCT02391480|Venetoclax|venetoclax|mesh-list
14103926|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928433|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13928434|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13928435|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
13928436|NCT03389412|Coagulants|coagulants|mesh-ancestor
13928437|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13928438|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
13928439|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928440|NCT03389321|Macitentan|macitentan|mesh-list
14103927|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14103928|NCT02391181|Hematinics|hematinics|mesh-ancestor
14175185|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175186|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
14175187|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
14175188|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
14175189|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14175190|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14175191|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175192|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14175193|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14175194|NCT04778358|Hormones|hormones|mesh-ancestor
14175195|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761519|NCT03652064|Dexamethasone|dexamethasone|mesh-list
14761520|NCT03652064|Lenalidomide|lenalidomide|mesh-list
14761521|NCT03652064|Bortezomib|bortezomib|mesh-list
14761522|NCT03652064|Daratumumab|daratumumab|mesh-list
13928441|NCT03389321|Riociguat|riociguat|mesh-list
14175196|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175197|NCT04778176|Levodopa|levodopa|mesh-list
14175198|NCT04778176|Carbidopa|carbidopa|mesh-list
14175199|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14175200|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14175201|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
14175202|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175203|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175204|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175205|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14175206|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175207|NCT04778072|Iron|iron|mesh-list
14175208|NCT04778072|Trace Elements|trace elements|mesh-ancestor
14175209|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
14175210|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175211|NCT04778137|Omalizumab|omalizumab|mesh-list
14175212|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14175213|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14175214|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
14175215|NCT04777968|Fluorides|fluorides|mesh-list
14175216|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
14175217|NCT04777968|Protective Agents|protective agents|mesh-ancestor
14175218|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175219|NCT04777929|Progesterone|progesterone|mesh-list
14175220|NCT04777929|Estrogens|estrogens|mesh-list
14175221|NCT04777929|Progestins|progestins|mesh-ancestor
14175222|NCT04777929|Hormones|hormones|mesh-ancestor
14175223|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175224|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175225|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14175226|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
14175227|NCT04777383|Atropine|atropine|mesh-list
14175228|NCT04777383|Phenylephrine|phenylephrine|mesh-list
14175229|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
14175230|NCT04777383|Norepinephrine|norepinephrine|mesh-list
14175231|NCT04777383|Acetylcholine|acetylcholine|mesh-list
14175232|NCT04777383|Neostigmine|neostigmine|mesh-list
14175233|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14175234|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
14175235|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
14175236|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175237|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175238|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
14175239|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14175240|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
14175241|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
14761523|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13928442|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13928443|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14175242|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13928444|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175243|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14175244|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14761524|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
13928445|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
13928446|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
13928447|NCT03389295|Cisplatin|cisplatin|mesh-list
13928448|NCT03389295|Docetaxel|docetaxel|mesh-list
13928449|NCT03389295|Fluorouracil|fluorouracil|mesh-list
13928450|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928451|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
13928452|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
13928453|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928454|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928455|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
13928456|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928457|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928458|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
13928459|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928460|NCT03389256|Apatinib|apatinib|mesh-list
13928461|NCT03389256|Gefitinib|gefitinib|mesh-list
13928462|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928463|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928464|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928465|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928466|NCT03389191|Acyclovir|acyclovir|mesh-list
14103929|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14103930|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
14103931|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
14103932|NCT02391077|Povidone|povidone|mesh-list
14103933|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103934|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14103935|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
14103936|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
14103937|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
14103938|NCT02391142|Lidocaine|lidocaine|mesh-list
14103939|NCT02391142|Ropivacaine|ropivacaine|mesh-list
14103940|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
14103941|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
14103942|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14103943|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103944|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
14103945|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14103946|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14103947|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14103948|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14103949|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14103950|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103951|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14103952|NCT02390921|Hematinics|hematinics|mesh-ancestor
14103953|NCT02390882|Tamsulosin|tamsulosin|mesh-list
14103954|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14103955|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14103956|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14103957|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
14103958|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14103959|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103960|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103961|NCT02390882|Urological Agents|urological agents|mesh-ancestor
13928467|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
13928468|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928469|NCT03389139|Anesthetics|anesthetics|mesh-list
13928470|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928471|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928472|NCT03389126|Avelumab|avelumab|mesh-list
13928473|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14103962|NCT02390700|Golimumab|golimumab|mesh-list
14103963|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14103964|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14103965|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103966|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
14103967|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103968|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
14103969|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14103970|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14103971|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103972|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
14103973|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
13928474|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103974|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103975|NCT02390674|Cyclosporine|cyclosporine|mesh-list
14103976|NCT02390674|Cyclosporins|cyclosporins|mesh-list
14103977|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14103978|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103979|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103980|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
14103981|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103982|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
14103983|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14103984|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
14103985|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103986|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14103987|NCT02390739|Aldesleukin|aldesleukin|mesh-list
14103988|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
14103989|NCT02390739|Fludarabine|fludarabine|mesh-list
14103990|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14103991|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
14103992|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14103993|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14103994|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13928475|NCT03389087|Etoposide|etoposide|mesh-list
13928476|NCT03389087|Apatinib|apatinib|mesh-list
13928477|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13928478|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103995|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
14103996|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14103997|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14103998|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14103999|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14104000|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14104001|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
14104002|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928479|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13928480|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13928481|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928482|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928483|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928484|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
14104003|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
14104004|NCT02390843|Topotecan|topotecan|mesh-list
13928485|NCT03389061|Velpatasvir|velpatasvir|mesh-list
13928486|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13928487|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
13928488|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928489|NCT03388970|Vitamin K|vitamin k|mesh-list
13928490|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
13928491|NCT03388970|Vitamins|vitamins|mesh-ancestor
13928492|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
13928493|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928494|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13928495|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13928496|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928497|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
13928498|NCT03388970|Coagulants|coagulants|mesh-ancestor
13928499|NCT03388957|Propranolol|propranolol|mesh-list
13928500|NCT03388957|Midazolam|midazolam|mesh-list
13928501|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13928502|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13928503|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928504|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928505|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13928506|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13928507|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13928508|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13928509|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
13928510|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
13928511|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
13928512|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
13928513|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928514|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928515|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13928516|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13928517|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
13928518|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14761525|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
14761526|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928519|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13928520|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
14104005|NCT02390843|Simvastatin|simvastatin|mesh-list
13928521|NCT03388892|Paclitaxel|paclitaxel|mesh-list
13928522|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13928523|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928524|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
13928525|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
13928526|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928527|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928528|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
14104006|NCT02390843|Sargramostim|sargramostim|mesh-list
14104007|NCT02390843|Lenograstim|lenograstim|mesh-list
14104008|NCT02390843|Mitogens|mitogens|mesh-list
14104009|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104010|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
14104011|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104012|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14104013|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14104014|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
14104015|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104016|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104017|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14104018|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14104019|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14104020|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
14104021|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14104022|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14104023|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104024|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14104025|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14104026|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
14104027|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14104028|NCT02390544|Melphalan|melphalan|mesh-list
14104029|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14104030|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
14104031|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104032|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104033|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14104034|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104035|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
14104036|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104037|NCT02390817|Neostigmine|neostigmine|mesh-list
14104038|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14104039|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104040|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104041|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
14104042|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104043|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104044|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14104045|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
14104046|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104047|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14104048|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14104049|NCT02390505|Ascorbic Acid|ascorbic acid|mesh-list
14104050|NCT02390505|Vitamins|vitamins|mesh-ancestor
14104051|NCT02390505|Micronutrients|micronutrients|mesh-ancestor
14104052|NCT02390505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104053|NCT02390505|Antioxidants|antioxidants|mesh-ancestor
14104054|NCT02390505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104055|NCT02390505|Protective Agents|protective agents|mesh-ancestor
14104056|NCT02390440|Bupivacaine|bupivacaine|mesh-list
14104057|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104058|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
14104059|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104060|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104061|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
14104062|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104063|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14104064|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14104065|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14104066|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
14104067|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104068|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13928529|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928530|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
13928531|NCT03388853|Doxofylline|doxofylline|mesh-list
14761527|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761528|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14761529|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
14761530|NCT03652064|Hormones|hormones|mesh-ancestor
13928532|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13928533|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
13928534|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928535|NCT03388853|Expectorants|expectorants|mesh-ancestor
13928536|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
13928537|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13928538|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
13928539|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928540|NCT03388853|Protective Agents|protective agents|mesh-ancestor
13928541|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928542|NCT03388853|Antidotes|antidotes|mesh-ancestor
13928543|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
13928544|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13928545|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
13928546|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928547|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13928548|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13928549|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928550|NCT03388827|Misoprostol|misoprostol|mesh-list
14104069|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14104070|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104071|NCT02390258|S66913|s66913|mesh-list
14761531|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761532|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761533|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761534|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
14761535|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14761536|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14761537|NCT03652064|Growth Substances|growth substances|mesh-ancestor
14761538|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
14761539|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14761540|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761541|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761542|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761543|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14761550|NCT03633058|Ketamine|ketamine|mesh-list
14104072|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14104073|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104074|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104075|NCT02390310|Lidocaine|lidocaine|mesh-list
14104076|NCT02390310|Prilocaine|prilocaine|mesh-list
14104077|NCT02390310|Anesthetics|anesthetics|mesh-list
14104078|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104079|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104080|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104081|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
14104082|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104083|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14104084|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14104085|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14104086|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928551|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14104087|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104088|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
14104089|NCT02390102|Hematinics|hematinics|mesh-ancestor
14104090|NCT02390089|Capsaicin|capsaicin|mesh-list
14104091|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
13928552|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
13928553|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13928554|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928555|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13928556|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104092|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
14104093|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
14104094|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104095|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104096|NCT02389842|Palbociclib|palbociclib|mesh-list
14104097|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104098|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14104099|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104100|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104101|NCT02389972|Dasatinib|dasatinib|mesh-list
14104102|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928557|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
13928558|NCT03388814|Bupivacaine|bupivacaine|mesh-list
13928559|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
13928560|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
13928561|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928562|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928563|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
14104103|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14104104|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104105|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104106|NCT02389751|Paclitaxel|paclitaxel|mesh-list
14104107|NCT02389751|Carboplatin|carboplatin|mesh-list
14104108|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14104109|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14104110|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104111|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
14104112|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
14104113|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
14104114|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104115|NCT02389868|Lovastatin|lovastatin|mesh-list
14104116|NCT02389868|L 647318|l 647318|mesh-list
14104117|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
14104118|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14104119|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14104120|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
14104121|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928564|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928565|NCT03388697|Insulin|insulin|mesh-list
13928566|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13928567|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928568|NCT03388671|Bupivacaine|bupivacaine|mesh-list
13928569|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
13928570|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
13928571|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928572|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928573|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
13928574|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928575|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
13928576|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13928577|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928578|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928579|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928580|NCT03388541|Analgesics|analgesics|mesh-ancestor
13928581|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
14104122|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14175245|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104123|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14104124|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104125|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
14104126|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104127|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
14104128|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104129|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14104130|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14104131|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
14104132|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104133|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104134|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14104135|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14104136|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14104137|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104138|NCT02389582|Enoxaparin|enoxaparin|mesh-list
14104139|NCT02389582|Dabigatran|dabigatran|mesh-list
14104140|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
14104141|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14104142|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14104143|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104144|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
14104145|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14104146|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
14104147|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104148|NCT02389543|Dexamethasone|dexamethasone|mesh-list
14104149|NCT02389543|Lenalidomide|lenalidomide|mesh-list
14104150|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14104151|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
14104152|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
14104153|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104154|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104155|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104156|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
14104157|NCT02389543|Hormones|hormones|mesh-ancestor
14104158|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14104159|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104160|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928582|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928583|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13928584|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13928585|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13928586|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
13928587|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928588|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928589|NCT03388463|Omeprazole|omeprazole|mesh-list
13928590|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13928591|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13928592|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13928593|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928594|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928595|NCT03388372|Temozolomide|temozolomide|mesh-list
13928596|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
13928597|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13928598|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
13928599|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928600|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928601|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928602|NCT03388346|Edetic Acid|edetic acid|mesh-list
13928603|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
13928604|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
13928605|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928606|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
13928607|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13928608|NCT03388151|Midazolam|midazolam|mesh-list
13928609|NCT03388151|Propofol|propofol|mesh-list
13928610|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13928611|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928612|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928613|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13928614|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
13928615|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
13928616|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13928617|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13928618|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13928619|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13928620|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
13928621|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
13928622|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928623|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928624|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
13928625|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13928626|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13960973|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
14104161|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
14104162|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14104163|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14104164|NCT02389543|Growth Substances|growth substances|mesh-ancestor
14104165|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
14104166|NCT02389400|Methotrexate|methotrexate|mesh-list
14104167|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14104168|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
14104169|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14104170|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104171|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14104172|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
14104173|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104174|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104175|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
14104176|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104177|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14104178|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104179|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
14104180|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14104181|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14175246|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175247|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175248|NCT04777383|Protective Agents|protective agents|mesh-ancestor
14175249|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14175250|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14175251|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14175252|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14175253|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
14175254|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14175255|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14175256|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
14175257|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14175258|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175259|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14175260|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
14175261|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14175262|NCT04777838|Amitriptyline|amitriptyline|mesh-list
14175263|NCT04777838|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14175264|NCT04777838|Citalopram|citalopram|mesh-list
13960974|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13960975|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13960976|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
14175265|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14477692|NCT02437084|Atorvastatin|atorvastatin|mesh-list
14104182|NCT02389439|Artesunate|artesunate|mesh-list
14104183|NCT02389439|Pyronaridine|pyronaridine|mesh-list
14104184|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
14104185|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14104186|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14104187|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104188|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104189|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
14104190|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
14104191|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14104192|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
14104193|NCT02389426|Bosentan|bosentan|mesh-list
14104194|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14104195|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14104196|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104197|NCT02389348|Artefenomel|artefenomel|mesh-list
14104198|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
14104199|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14104200|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14104201|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104202|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
14104203|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14104204|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
14104205|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104206|NCT02389309|Sirolimus|sirolimus|mesh-list
14104207|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
13928627|NCT03387956|Dexamethasone|dexamethasone|mesh-list
13928628|NCT03387956|Atropine|atropine|mesh-list
13928629|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14104208|NCT02389309|Dasatinib|dasatinib|mesh-list
14104209|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104210|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
14104211|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104212|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13928630|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
13928631|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
13928632|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928633|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928634|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104213|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14104214|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
14104215|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104216|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104217|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14104218|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104219|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104220|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14935987|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
14935988|NCT01466543|Udenafil|udenafil|mesh-list
14935989|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14935990|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14935991|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14935992|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935993|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14935994|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14935995|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14935996|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
14935997|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14935998|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14935999|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14936000|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936001|NCT01466686|Temozolomide|temozolomide|mesh-list
14104221|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
14104222|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14104223|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104224|NCT02389231|Interleukin-2|interleukin-2|mesh-list
14104225|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928635|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
13928636|NCT03387956|Hormones|hormones|mesh-ancestor
13928637|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13928638|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104226|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928639|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928640|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14104227|NCT02389231|Analgesics|analgesics|mesh-ancestor
14104228|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
14104229|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104230|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104231|NCT02389218|Sotalol|sotalol|mesh-list
14104232|NCT02389218|Flecainide|flecainide|mesh-list
14104233|NCT02389218|Propafenone|propafenone|mesh-list
14104234|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14104235|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14104236|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104237|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104238|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104239|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104240|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14104241|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
14104242|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
14104243|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104244|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14104245|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14104246|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104247|NCT02389179|Vitamin D|vitamin d|mesh-list
14104248|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
14104249|NCT02389179|Vitamins|vitamins|mesh-ancestor
14104250|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
13928641|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13928642|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13928643|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13928644|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
13928645|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
13928646|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
13928647|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13928648|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13928649|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
13928650|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928651|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928652|NCT03387943|Cisplatin|cisplatin|mesh-list
13928653|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928654|NCT03387904|Irinotecan|irinotecan|mesh-list
13928655|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13928656|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14104251|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104252|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14104253|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14104254|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14104255|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
14104256|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104257|NCT02388750|Palonosetron|palonosetron|mesh-list
14104258|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
14104259|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
14104260|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104261|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104262|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13928657|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928658|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928659|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928660|NCT03387826|Ticagrelor|ticagrelor|mesh-list
13928661|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13928662|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13928663|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13928664|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13928665|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14761551|NCT03633058|Analgesics|analgesics|mesh-ancestor
14761552|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
14936002|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13928666|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
13928667|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104263|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14104264|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14104265|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
14104266|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104267|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104268|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
14104269|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104270|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
14761553|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928668|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104271|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104272|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13928669|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928670|NCT03387787|Insulin|insulin|mesh-list
13928671|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13928672|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928679|NCT03387670|Simvastatin|simvastatin|mesh-list
13928680|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13928681|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13928682|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
13928683|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928684|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13928685|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13928686|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928698|NCT03387644|Pregabalin|pregabalin|mesh-list
13928699|NCT03387644|Analgesics|analgesics|mesh-ancestor
13928700|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
13928701|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928702|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928703|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
13928704|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13928705|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928706|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928707|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13928708|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13928709|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13928710|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928711|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13928712|NCT03387631|Lumefantrine|lumefantrine|mesh-list
13928713|NCT03387631|Artemether|artemether|mesh-list
13928714|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
13928715|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
13928716|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13928717|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13928718|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928719|NCT03387592|Leucovorin|leucovorin|mesh-list
13928720|NCT03387592|Fluorouracil|fluorouracil|mesh-list
13928721|NCT03387592|Capecitabine|capecitabine|mesh-list
13928722|NCT03387592|Temozolomide|temozolomide|mesh-list
13928723|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
13928724|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
13928725|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928726|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928727|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928728|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928729|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
13928730|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928731|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13928732|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
13928733|NCT03387592|Antidotes|antidotes|mesh-ancestor
13928734|NCT03387592|Protective Agents|protective agents|mesh-ancestor
13928735|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
13928736|NCT03387592|Vitamins|vitamins|mesh-ancestor
13928737|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
13928738|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
13928739|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
14104273|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14104274|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
14104275|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104276|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104277|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14104278|NCT02388581|Amoxicillin|amoxicillin|mesh-list
14104279|NCT02388581|Metronidazole|metronidazole|mesh-list
14104280|NCT02388581|Clarithromycin|clarithromycin|mesh-list
14104281|NCT02388581|Lansoprazole|lansoprazole|mesh-list
14104282|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
14104283|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104284|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104285|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14104286|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13928740|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
13928741|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928742|NCT03387566|Growth Substances|growth substances|mesh-ancestor
13928743|NCT03387501|Mitogens|mitogens|mesh-list
13928744|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928745|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928746|NCT03387475|Deferasirox|deferasirox|mesh-list
13928747|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13928748|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
13928749|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
13928750|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928751|NCT03387423|Tofacitinib|tofacitinib|mesh-list
13928752|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928753|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928754|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928755|NCT03387241|Fluticasone|fluticasone|mesh-list
13928756|NCT03387241|Xhance|xhance|mesh-list
13928757|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
13928758|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13928759|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13928760|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13928761|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13928762|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
13928763|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928764|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928765|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13928766|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
14104287|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14104288|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104289|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104290|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14104291|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14104292|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14104293|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104294|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14104295|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14104296|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14104297|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104298|NCT02388516|Vitamin D|vitamin d|mesh-list
14104299|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
14104300|NCT02388516|Vitamins|vitamins|mesh-ancestor
14104301|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
14104302|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104303|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14104304|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14104305|NCT02388477|Doxycycline|doxycycline|mesh-list
14104306|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104307|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104308|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
14104309|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14104310|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14104311|NCT02388373|Fluticasone|fluticasone|mesh-list
14104312|NCT02388373|Xhance|xhance|mesh-list
14104313|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
14104314|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14104315|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14104316|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14104317|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
14104318|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104319|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104320|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14104321|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
14104322|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
14104323|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14104324|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14104325|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14104326|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14104327|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104328|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104329|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104330|NCT02388178|Fluorides|fluorides|mesh-list
14104331|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
14104332|NCT02388178|Protective Agents|protective agents|mesh-ancestor
13928767|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
13928768|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13928769|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13928770|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13928771|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13928772|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
13928773|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928774|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928775|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
13928776|NCT03387241|Hormones|hormones|mesh-ancestor
13928777|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13928778|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
13928779|NCT03387163|Valsartan|valsartan|mesh-list
13928780|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13928781|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13928782|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13928783|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928784|NCT03387111|Leucovorin|leucovorin|mesh-list
14104333|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104334|NCT02388048|Ofatumumab|ofatumumab|mesh-list
14104335|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104336|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14104337|NCT02388061|Plasminogen|plasminogen|mesh-list
13928785|NCT03387111|Paclitaxel|paclitaxel|mesh-list
13928786|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
13928787|NCT03387111|Bevacizumab|bevacizumab|mesh-list
14104338|NCT02388061|Tenecteplase|tenecteplase|mesh-list
14104339|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14104340|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14104341|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104342|NCT02388035|Cefotaxime|cefotaxime|mesh-list
14104343|NCT02388035|Cefoxitin|cefoxitin|mesh-list
14104344|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104345|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104346|NCT02387892|Vitamin D|vitamin d|mesh-list
14104347|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
14104348|NCT02387892|Vitamins|vitamins|mesh-ancestor
14104349|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
14104350|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928788|NCT03387111|Fluorouracil|fluorouracil|mesh-list
13928789|NCT03387111|Capecitabine|capecitabine|mesh-list
13928790|NCT03387111|Cetuximab|cetuximab|mesh-list
13928791|NCT03387111|Avelumab|avelumab|mesh-list
13928792|NCT03387111|Necitumumab|necitumumab|mesh-list
13928793|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13928794|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928795|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
13928796|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
13928797|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928798|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928799|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928800|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
13928801|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928802|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13928803|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13928804|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
13928805|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14104351|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14104352|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14104353|NCT02387931|Vitamin D|vitamin d|mesh-list
14104354|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
14104355|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
14104356|NCT02387931|Vitamins|vitamins|mesh-list
14104357|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
14104358|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104359|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14104360|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14104361|NCT02387918|Dexamethasone|dexamethasone|mesh-list
14104362|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14104363|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
14104364|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
14104365|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928806|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14104366|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104367|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104368|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
13928807|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14104369|NCT02387918|Hormones|hormones|mesh-ancestor
14936003|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
14104370|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14104371|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104372|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175266|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14175267|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175268|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175269|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175270|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
14175271|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175272|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14175273|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
14175274|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14175275|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175276|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14175277|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14175278|NCT04777838|Analgesics|analgesics|mesh-ancestor
14175279|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
14175280|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14175281|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
14175282|NCT04777838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14175283|NCT04777838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14175284|NCT04777838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175285|NCT04777552|Diazepam|diazepam|mesh-list
14175286|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14175287|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
14175288|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
14175289|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
14175290|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175291|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175292|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175293|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14175294|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175295|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14175296|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14175297|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14175298|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14175299|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14175300|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14175301|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
14175302|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
14175303|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
14175304|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
14175305|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175306|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175307|NCT04777591|Bupivacaine|bupivacaine|mesh-list
14175308|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175309|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
14175310|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175311|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175312|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
13928808|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13928809|NCT03387111|Growth Substances|growth substances|mesh-ancestor
13928810|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
13928811|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
13928812|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928813|NCT03387111|Antidotes|antidotes|mesh-ancestor
13928814|NCT03387111|Protective Agents|protective agents|mesh-ancestor
13928815|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
13928816|NCT03387111|Vitamins|vitamins|mesh-ancestor
13928817|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
13928818|NCT03387098|Leucovorin|leucovorin|mesh-list
13928819|NCT03387098|Paclitaxel|paclitaxel|mesh-list
13928820|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
13928821|NCT03387098|Bevacizumab|bevacizumab|mesh-list
13928822|NCT03387098|Fluorouracil|fluorouracil|mesh-list
13928823|NCT03387098|Capecitabine|capecitabine|mesh-list
13928824|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
13928825|NCT03387098|Avelumab|avelumab|mesh-list
13928826|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13928827|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928828|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
13928829|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
13928830|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
13928831|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928832|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928833|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
14104373|NCT02387619|Amlodipine|amlodipine|mesh-list
14104374|NCT02387619|Telmisartan|telmisartan|mesh-list
14104375|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14104376|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14104377|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14104378|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13928834|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928835|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13928836|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13928837|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
13928838|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13928839|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928840|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13928841|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13928842|NCT03387098|Growth Substances|growth substances|mesh-ancestor
13928843|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
13928844|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
13928845|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928846|NCT03387098|Antidotes|antidotes|mesh-ancestor
13928847|NCT03387098|Protective Agents|protective agents|mesh-ancestor
13928848|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
13928849|NCT03387098|Vitamins|vitamins|mesh-ancestor
13928850|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
13928851|NCT03386929|Palbociclib|palbociclib|mesh-list
13928852|NCT03386929|Avelumab|avelumab|mesh-list
13928853|NCT03386929|Axitinib|axitinib|mesh-list
14104379|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104380|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104381|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13928854|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928855|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928856|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928857|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928858|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928859|NCT03386838|Carboplatin|carboplatin|mesh-list
13928860|NCT03386838|Fluorouracil|fluorouracil|mesh-list
13928861|NCT03386838|Nivolumab|nivolumab|mesh-list
13928862|NCT03386838|Cetuximab|cetuximab|mesh-list
13928863|NCT03386838|Linrodostat|linrodostat|mesh-list
13928864|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928865|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
13928866|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928867|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13928868|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928869|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
13928870|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928871|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928872|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13928873|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928874|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
13928875|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13928876|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13928877|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928878|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
13928879|NCT03386656|Coagulants|coagulants|mesh-ancestor
13928880|NCT03386643|Clobetasol|clobetasol|mesh-list
13928881|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13928882|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
13928883|NCT03386643|Hormones|hormones|mesh-ancestor
13928884|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13928885|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928886|NCT03386630|Sufentanil|sufentanil|mesh-list
13928887|NCT03386630|Morphine|morphine|mesh-list
13928888|NCT03386630|Dsuvia|dsuvia|mesh-list
13928889|NCT03386630|Bupivacaine|bupivacaine|mesh-list
13928890|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
13928891|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
13928892|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928893|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928894|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
13928895|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928896|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13928897|NCT03386630|Narcotics|narcotics|mesh-ancestor
13928898|NCT03386630|Analgesics|analgesics|mesh-ancestor
13928899|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13928900|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13928901|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
13928902|NCT03386591|Naloxone|naloxone|mesh-list
13928903|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13928904|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928905|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
13928906|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928907|NCT03386565|Lidocaine|lidocaine|mesh-list
13928908|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13928909|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
13928910|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
13928911|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928912|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104382|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104383|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
14104384|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14104385|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14104386|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
14104387|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14104388|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14104389|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104390|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14104391|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14104392|NCT02387307|Interferons|interferons|mesh-list
14104393|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104394|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
14104395|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104396|NCT02387567|Lidocaine|lidocaine|mesh-list
14104397|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104398|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
14104399|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104400|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104401|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
14104402|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104403|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14104404|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14104405|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14104406|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104407|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104408|NCT02387242|Rifampin|rifampin|mesh-list
14104409|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14104410|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
14104411|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104412|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104413|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
14104414|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14104415|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104416|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104417|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14104418|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14104419|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14104420|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14104421|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13928913|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
13928914|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928915|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13928916|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13928917|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13928918|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13928919|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928920|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
13928921|NCT03386539|Everolimus|everolimus|mesh-list
13928922|NCT03386539|Tacrolimus|tacrolimus|mesh-list
13928923|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928924|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
13928925|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928926|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13928927|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928928|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928929|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928930|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13928931|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13928932|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
13928933|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13928934|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928935|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
13928936|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13928937|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13960977|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13960978|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960979|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960980|NCT03151603|Fosfomycin|fosfomycin|mesh-list
13960981|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13960982|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13960983|NCT03151343|Empagliflozin|empagliflozin|mesh-list
13960984|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13960985|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13960986|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13960987|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960988|NCT03151369|Morphine|morphine|mesh-list
13960989|NCT03151369|Analgesics|analgesics|mesh-list
13960990|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13960991|NCT03151369|Narcotics|narcotics|mesh-ancestor
13960992|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104422|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14104423|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
14104424|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
14104425|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14104426|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14104427|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104428|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104429|NCT02387450|Urological Agents|urological agents|mesh-ancestor
14104430|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
14104431|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14104432|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
14104433|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14104434|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
14104435|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104436|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104437|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
14104438|NCT02387203|Amoxicillin|amoxicillin|mesh-list
14104439|NCT02387203|Clarithromycin|clarithromycin|mesh-list
14104440|NCT02387203|Lansoprazole|lansoprazole|mesh-list
14104441|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104442|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104443|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14104444|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104445|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104446|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14104447|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14104448|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14104449|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13960993|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13960994|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
13960995|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13960996|NCT03151213|Pregabalin|pregabalin|mesh-list
13960997|NCT03151213|Analgesics|analgesics|mesh-ancestor
13960998|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
13960999|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104450|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14104451|NCT02387086|Aspirin|aspirin|mesh-list
14104452|NCT02387086|Thalidomide|thalidomide|mesh-list
14104453|NCT02387086|Gefitinib|gefitinib|mesh-list
14104454|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13961000|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104455|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14104456|NCT02387086|Analgesics|analgesics|mesh-ancestor
14104457|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
14104458|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104459|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477693|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14477694|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14477695|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
14477696|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477697|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14477698|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14104460|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14104461|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13928938|NCT03386318|Oxycodone|oxycodone|mesh-list
13928939|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13928940|NCT03386318|Narcotics|narcotics|mesh-ancestor
13928941|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928942|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928943|NCT03386318|Analgesics|analgesics|mesh-ancestor
13928944|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
13928945|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928946|NCT03386305|Tacrolimus|tacrolimus|mesh-list
13928947|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13928948|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
13928949|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928950|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13928951|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928952|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928953|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
13928954|NCT03386279|Abrocitinib|abrocitinib|mesh-list
13928955|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13928956|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104462|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14104463|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14104464|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104465|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14104466|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14104467|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104468|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
14104469|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104470|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
14104471|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
14104472|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104473|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104474|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14104475|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14104476|NCT02387086|Growth Substances|growth substances|mesh-ancestor
14104477|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
14104478|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104479|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14104480|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
14104481|NCT02387138|Irinotecan|irinotecan|mesh-list
14104482|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104483|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14104484|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14104485|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104486|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104487|NCT02387060|Fentanyl|fentanyl|mesh-list
14104488|NCT02387060|Bupivacaine|bupivacaine|mesh-list
14104489|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104490|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
14104491|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104492|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104493|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
14104494|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104495|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14104496|NCT02387060|Narcotics|narcotics|mesh-ancestor
14104497|NCT02387060|Analgesics|analgesics|mesh-ancestor
14104498|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14104499|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14104500|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
13928957|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13928958|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13928959|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928960|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928961|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928962|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928963|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13928964|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13928965|NCT03386201|Methylene Blue|methylene blue|mesh-list
13928966|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928967|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928968|NCT03386149|Loxoprofen|loxoprofen|mesh-list
13928969|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13928970|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928971|NCT03386149|Analgesics|analgesics|mesh-ancestor
13928972|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
14104501|NCT02387021|Ropivacaine|ropivacaine|mesh-list
13928973|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104502|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104503|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
14104504|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104505|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928974|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928975|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13928976|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13928977|NCT03386071|Trametinib|trametinib|mesh-list
13928978|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13928979|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13928980|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13928981|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13928982|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
13928983|NCT03385967|Ropivacaine|ropivacaine|mesh-list
13928984|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13928985|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13928986|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104506|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
14104507|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104508|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14104509|NCT02386943|Saxagliptin|saxagliptin|mesh-list
14104510|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14104511|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104512|NCT02386943|Incretins|incretins|mesh-ancestor
14104513|NCT02386943|Hormones|hormones|mesh-ancestor
14104514|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14104515|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14104516|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
14104517|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104518|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104519|NCT02386826|Bevacizumab|bevacizumab|mesh-list
14104520|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14104521|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104522|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13928987|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13928988|NCT03385967|Analgesics|analgesics|mesh-ancestor
13928989|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
13928990|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13928991|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13928992|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13928993|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13928994|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
13928995|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13928996|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104523|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14104524|NCT02386826|Growth Substances|growth substances|mesh-ancestor
14104525|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104526|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14104527|NCT02386735|Prednisone|prednisone|mesh-list
14104528|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14104529|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
14104530|NCT02386735|Hormones|hormones|mesh-ancestor
14104531|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14104532|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104533|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104534|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104535|NCT02386358|Benzonidazole|benzonidazole|mesh-list
14104536|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104537|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
14104538|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104539|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14104540|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14104541|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14104542|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761554|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13928997|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
13928998|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
13928999|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
13929000|NCT03385863|Poractant alfa|poractant alfa|mesh-list
13929001|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
13929002|NCT03385668|Pirfenidone|pirfenidone|mesh-list
13929003|NCT03385668|Analgesics|analgesics|mesh-ancestor
14104543|NCT02386397|Gemcitabine|gemcitabine|mesh-list
14104544|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
14104545|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14104546|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
14104547|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104548|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104549|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
14104550|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104551|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104552|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104553|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
14104554|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104555|NCT02386488|Vortioxetine|vortioxetine|mesh-list
14104556|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
14104557|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14104558|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14104559|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14104560|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104561|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104562|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14104563|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14104564|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104565|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104566|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104567|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
14104568|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14104569|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14104570|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14104571|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14104572|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
14104573|NCT02386462|Propofol|propofol|mesh-list
14104574|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14104575|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104576|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104577|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14104578|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
14104579|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
14104580|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14104581|NCT02386462|Analgesics|analgesics|mesh-ancestor
14104582|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
14104583|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104584|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14104585|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14104586|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14104587|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104588|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104589|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104590|NCT02386449|Mannitol|mannitol|mesh-list
14104591|NCT02386449|Bisacodyl|bisacodyl|mesh-list
14104592|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
14104593|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
14104594|NCT02386449|Citric Acid|citric acid|mesh-list
14104595|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
14104596|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14104597|NCT02386449|Diuretics|diuretics|mesh-ancestor
14104598|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
14104599|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104600|NCT02386449|Cathartics|cathartics|mesh-ancestor
14104601|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104602|NCT02386449|Laxatives|laxatives|mesh-ancestor
14104603|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
14104604|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14104605|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
14104606|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
14104607|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104608|NCT02386449|Antacids|antacids|mesh-ancestor
14104609|NCT02386566|Natalizumab|natalizumab|mesh-list
13929004|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
14104610|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
13929005|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929006|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104611|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104612|NCT02386293|Irbesartan|irbesartan|mesh-list
14104613|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14104614|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14104615|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14104616|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104617|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
14104618|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14104619|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14104620|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104621|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
14104622|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
14104623|NCT02386475|Dexetimide|dexetimide|mesh-list
14104624|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14104625|NCT02386475|Citalopram|citalopram|mesh-list
14104626|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14104627|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14104628|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104629|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104630|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104631|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
14104632|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104633|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14104634|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
14104635|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14104636|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14104637|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14104638|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
14104639|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
14104640|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104641|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14104642|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14104643|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
14104644|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14104645|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
14104646|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
14104647|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
14104648|NCT02386150|Vaccines|vaccines|mesh-list
14104649|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
14104650|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104651|NCT02386111|Sunitinib|sunitinib|mesh-list
14104652|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104653|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14104654|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14104655|NCT02386111|Growth Substances|growth substances|mesh-ancestor
14104656|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104657|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
14104658|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13929007|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13929008|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13929009|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13929010|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929011|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929012|NCT03385551|Estradiol|estradiol|mesh-list
13929013|NCT03385551|Estrogens|estrogens|mesh-ancestor
13929014|NCT03385551|Hormones|hormones|mesh-ancestor
13929015|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929016|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929017|NCT03385538|Clopidogrel|clopidogrel|mesh-list
13929018|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13929019|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13929020|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13929021|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13929022|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
13929023|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929024|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929025|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929026|NCT03385525|Valproic Acid|valproic acid|mesh-list
13929027|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
13929028|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104659|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104660|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929029|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929030|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
13929031|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929032|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929033|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
13929034|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13929035|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929036|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13929037|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
13929038|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13929039|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13929040|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
13929041|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929042|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929043|NCT03385382|Dexamethasone|dexamethasone|mesh-list
13929044|NCT03385382|Ranibizumab|ranibizumab|mesh-list
13929045|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13929046|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
13929047|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
13929048|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929049|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929050|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929051|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
13929052|NCT03385382|Hormones|hormones|mesh-ancestor
14936004|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936005|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929053|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929054|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13929055|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929056|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14936006|NCT01466712|Beclomethasone|beclomethasone|mesh-list
13929057|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13929058|NCT03385382|Growth Substances|growth substances|mesh-ancestor
13929059|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
13929060|NCT03385356|Vitamin D|vitamin d|mesh-list
13929061|NCT03385356|Vitamins|vitamins|mesh-ancestor
13929062|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
13929063|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929064|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13929065|NCT03385304|Iodine|iodine|mesh-list
13929066|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
13929067|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13929068|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
13929069|NCT03385304|Povidone|povidone|mesh-list
13929070|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13929071|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929072|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
13929073|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
14104661|NCT02386033|Atorvastatin|atorvastatin|mesh-list
14104662|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14104663|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14104664|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
14104665|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104666|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14104667|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14104668|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175313|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175314|NCT04777045|Diltiazem|diltiazem|mesh-list
14175315|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14175316|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14175317|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175318|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175319|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14175320|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175321|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
14175322|NCT04777227|Lidocaine|lidocaine|mesh-list
14175323|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175324|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
14175325|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175326|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175327|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
13929074|NCT03385304|Trace Elements|trace elements|mesh-ancestor
13929075|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
13929076|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929077|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
13929078|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
13929079|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
13929080|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929081|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929082|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
13929083|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
13929084|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929085|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
13929086|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929087|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929088|NCT03385161|Ethanol|ethanol|mesh-list
13929089|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
13929090|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13929091|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14104669|NCT02386059|Dexamethasone|dexamethasone|mesh-list
14104670|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
14104671|NCT02386059|Ondansetron|ondansetron|mesh-list
14104672|NCT02386059|BB 1101|bb 1101|mesh-list
14104673|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14104674|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
14104675|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
14104676|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104677|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104678|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104679|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
14104680|NCT02386059|Hormones|hormones|mesh-ancestor
14104681|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14104682|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104683|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104684|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
14104685|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104686|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104687|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
14104688|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
14104689|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14104690|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
14104691|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104692|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14104693|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14104694|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104695|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14104696|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14104697|NCT02386072|Mirabegron|mirabegron|mesh-list
14104698|NCT02386072|Oxybutynin|oxybutynin|mesh-list
14104699|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14104700|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14104701|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14104702|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14104703|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104704|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104705|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104706|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104707|NCT02386072|Urological Agents|urological agents|mesh-ancestor
14104708|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14104709|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
14104710|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
14104711|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
14104712|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104713|NCT02385825|Vaccines|vaccines|mesh-list
14104714|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
14104715|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104716|NCT02385656|Modafinil|modafinil|mesh-list
14104717|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14104718|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104719|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14104720|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14104721|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14104722|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104723|NCT02385617|Octreotide|octreotide|mesh-list
14104724|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104725|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104726|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104727|NCT02385734|Mitogens|mitogens|mesh-list
13929092|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14104728|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14104729|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104730|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14104731|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
14104732|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104733|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
14104734|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104735|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
14104736|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104737|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929093|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13929094|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929095|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
13929096|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929097|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929098|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13929099|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929100|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929101|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13929102|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929103|NCT03385135|Allopurinol|allopurinol|mesh-list
13929104|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
13929105|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104738|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
14104739|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104740|NCT02385500|Fesoterodine|fesoterodine|mesh-list
14104741|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14104742|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14104743|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
14104744|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104745|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104746|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104747|NCT02385500|Urological Agents|urological agents|mesh-ancestor
14104748|NCT02385474|Fluorides|fluorides|mesh-list
14104749|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
14104750|NCT02385474|Protective Agents|protective agents|mesh-ancestor
14104751|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104752|NCT02385461|Heparin|heparin|mesh-list
14104753|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14104754|NCT02385461|Tinzaparin|tinzaparin|mesh-list
14104755|NCT02385461|Dalteparin|dalteparin|mesh-list
14104756|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
14104757|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14104758|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14104759|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104760|NCT02385448|Dienogest|dienogest|mesh-list
13929106|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929107|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
13929108|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929109|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13929110|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
13929111|NCT03385135|Protective Agents|protective agents|mesh-ancestor
13929112|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929113|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
13929114|NCT03385096|Melphalan|melphalan|mesh-list
13929115|NCT03385096|Busulfan|busulfan|mesh-list
13929116|NCT03385096|Etoposide|etoposide|mesh-list
13929117|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13929118|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
13929119|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929120|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929121|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14104761|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14104762|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14104763|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14104764|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
14104765|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14104766|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104767|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14104768|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14104769|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14104770|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14104771|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
14175328|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104772|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14104773|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104774|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104775|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14104776|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14104777|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14104778|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14104779|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14104780|NCT02385422|Propranolol|propranolol|mesh-list
14104781|NCT02385422|Carvedilol|carvedilol|mesh-list
14104782|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14104783|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14104784|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104785|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104786|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104787|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104788|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14104789|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14104790|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
14104791|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
14104792|NCT02385422|Protective Agents|protective agents|mesh-ancestor
14104793|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14104794|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104795|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14104796|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14104797|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14104798|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
14104799|NCT02385435|Bupivacaine|bupivacaine|mesh-list
14104800|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104801|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
14104802|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104803|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104804|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
14104805|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104806|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14104807|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14104808|NCT02385435|Analgesics|analgesics|mesh-ancestor
14104809|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14104810|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14104811|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14104812|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104813|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104814|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104815|NCT02385396|Folic Acid|folic acid|mesh-list
13929122|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
13929123|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929124|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929125|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13929126|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13929127|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13929128|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13929129|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929130|NCT03385057|Acetaminophen|acetaminophen|mesh-list
14104816|NCT02385396|Inositol|inositol|mesh-list
14104817|NCT02385396|Hematinics|hematinics|mesh-ancestor
14104818|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
14104819|NCT02385396|Vitamins|vitamins|mesh-ancestor
14104820|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
14104821|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104822|NCT02385266|Cycloserine|cycloserine|mesh-list
14104823|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14104824|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104825|NCT02385266|Renal Agents|renal agents|mesh-ancestor
14104826|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14104827|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
14104828|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104829|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
14104830|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104831|NCT02385305|Anesthetics|anesthetics|mesh-list
14104832|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929131|NCT03385057|Ibuprofen|ibuprofen|mesh-list
14104833|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104834|NCT02385058|Mebendazole|mebendazole|mesh-list
14104835|NCT02385058|Piperazine|piperazine|mesh-list
14104836|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
14104837|NCT02385058|DMP 777|dmp 777|mesh-list
14104838|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
14104839|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
14104840|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14104841|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104842|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
14104843|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
14104844|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
14104845|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104846|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104847|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104848|NCT02385227|Nicotine|nicotine|mesh-list
14104849|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14104850|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
14104851|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104852|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104853|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14104854|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14104855|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
14104856|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104857|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104858|NCT02385188|Acetaminophen|acetaminophen|mesh-list
14104859|NCT02385188|Imiquimod|imiquimod|mesh-list
14104860|NCT02385188|Lidocaine|lidocaine|mesh-list
14104861|NCT02385188|Petrolatum|petrolatum|mesh-list
14104862|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104863|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
14104864|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104865|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104866|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
14104867|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104868|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14104869|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14104870|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14104871|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104872|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104873|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14104874|NCT02385188|Analgesics|analgesics|mesh-ancestor
14104875|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
14104876|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14104877|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
14104878|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104879|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
14104880|NCT02385188|Emollients|emollients|mesh-ancestor
14104881|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
14104882|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14104883|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13929132|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13929133|NCT03385057|Analgesics|analgesics|mesh-ancestor
13929134|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
13929135|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929136|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929137|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
13929138|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13929139|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13929140|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929141|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13929142|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929143|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929144|NCT03384862|Folic Acid|folic acid|mesh-list
13929145|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
13929146|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
13929147|NCT03384862|Vitamins|vitamins|mesh-ancestor
13929148|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
13929149|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929150|NCT03384862|Hematinics|hematinics|mesh-ancestor
13929151|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
13961001|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
13961002|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13961003|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14104884|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14104885|NCT02385136|Temozolomide|temozolomide|mesh-list
14104886|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14104887|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
14104888|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929152|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13929153|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
13929154|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929155|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
13929156|NCT03384537|Listerine|listerine|mesh-list
13929157|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13929158|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929159|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
14104889|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104890|NCT02385071|Simeprevir|simeprevir|mesh-list
14104891|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
14104892|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104893|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
14104894|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104895|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104896|NCT02384668|Vitamin D|vitamin d|mesh-list
14104897|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
14104898|NCT02384668|Vitamins|vitamins|mesh-ancestor
14104899|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
14104900|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929160|NCT03384524|Metoprolol|metoprolol|mesh-list
13929161|NCT03384524|Bromocriptine|bromocriptine|mesh-list
13929162|NCT03384524|Tamsulosin|tamsulosin|mesh-list
13929163|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13929164|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13929165|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
13929166|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
13929167|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929168|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929169|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13929170|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13929171|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13929172|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
13929173|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929174|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929175|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13929176|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13929177|NCT03384524|Urological Agents|urological agents|mesh-ancestor
13929178|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13929179|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13929180|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
13929181|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929182|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
13929183|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
13929184|NCT03384511|Apatinib|apatinib|mesh-list
13929185|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929186|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14104901|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14104902|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14104903|NCT02384915|Prilocaine|prilocaine|mesh-list
14104904|NCT02384915|Mepivacaine|mepivacaine|mesh-list
14104905|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
14104906|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104907|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104908|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
14104909|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
14104910|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104911|NCT02384954|Rituximab|rituximab|mesh-list
14761555|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13929187|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929188|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929189|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
13929190|NCT03384277|Rituximab|rituximab|mesh-list
13929191|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104912|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761556|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14761557|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
14761558|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
14761559|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14761560|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14761561|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14104913|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104914|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
14104915|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104916|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14104917|NCT02384967|Darunavir|darunavir|mesh-list
14104918|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14104919|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14104920|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
14104921|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104922|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104923|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14104924|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14104925|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
14104926|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104927|NCT02384876|Ephedrine|ephedrine|mesh-list
14104928|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
14104929|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14104930|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14104931|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929192|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
13929193|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929194|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14104932|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
14104933|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
14104934|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104935|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13929195|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13929196|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
13929197|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929198|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929199|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13929200|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929201|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13929202|NCT03384238|Panitumumab|panitumumab|mesh-list
13929203|NCT03384238|Antibodies|antibodies|mesh-list
13929204|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
13929205|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13929206|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
13929207|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929208|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929209|NCT03384121|Rifampin|rifampin|mesh-list
13929210|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13929211|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
13929212|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13929213|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929214|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
13929215|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929216|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929217|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929218|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13929219|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13929220|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13929221|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13929222|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14104936|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104937|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104938|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104939|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14104940|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14104941|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
14104942|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
14104943|NCT02384837|Sirolimus|sirolimus|mesh-list
14104944|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14104945|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104946|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14104947|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104948|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
14104949|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14104950|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
14104951|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104952|NCT02384889|Eflornithine|eflornithine|mesh-list
14104953|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104954|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13929223|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14104955|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14104956|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13929224|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
13929225|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13929226|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
14104957|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14104958|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14104959|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104960|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104961|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
14104962|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14104963|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104964|NCT02384746|Fulvestrant|fulvestrant|mesh-list
14104965|NCT02384746|Ixazomib|ixazomib|mesh-list
14104966|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14104967|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14104968|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14104969|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14104970|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
14104971|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14104972|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104973|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
14104974|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104975|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175329|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14175330|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14175331|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14175332|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175333|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175334|NCT04777110|Esketamine|esketamine|mesh-list
14175335|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
14175336|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14175337|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14175338|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14175339|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14175340|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
14175341|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175342|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14175343|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14175344|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175345|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
14175346|NCT04776850|Dexamethasone|dexamethasone|mesh-list
14175347|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
14175348|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
14175349|NCT04776850|Busulfan|busulfan|mesh-list
14175350|NCT04776850|Rituximab|rituximab|mesh-list
14175351|NCT04776850|Fludarabine|fludarabine|mesh-list
14175352|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
14175353|NCT04776850|Bortezomib|bortezomib|mesh-list
14175354|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14175355|NCT04776850|Tacrolimus|tacrolimus|mesh-list
14175356|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
14175357|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14175358|NCT04776850|Antibodies|antibodies|mesh-list
14175359|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
14175360|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14175361|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
14175362|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14175363|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14175364|NCT04776850|BB 1101|bb 1101|mesh-list
14936007|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
13929227|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929228|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
13929229|NCT03384095|Protective Agents|protective agents|mesh-ancestor
13929230|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
13929231|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13929232|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13929233|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
13929234|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929235|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929236|NCT03383822|Insulin|insulin|mesh-list
13929237|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13929238|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13929239|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929240|NCT03383744|Vitamin A|vitamin a|mesh-list
14175365|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14175366|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
14175367|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929241|NCT03383744|Vitamins|vitamins|mesh-ancestor
13929242|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
13929243|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929244|NCT03383406|Cytarabine|cytarabine|mesh-list
13929245|NCT03383406|Methotrexate|methotrexate|mesh-list
13929246|NCT03383406|Etoposide|etoposide|mesh-list
13929247|NCT03383406|Ifosfamide|ifosfamide|mesh-list
14104976|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
14104977|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14104978|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14104979|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104980|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14104981|NCT02384343|Analgesics|analgesics|mesh-ancestor
14104982|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
14104983|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14104984|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14104985|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14104986|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13929248|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13929249|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
13929250|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13929251|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14104987|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
14104988|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14104989|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761562|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761563|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761564|NCT03613181|Paclitaxel|paclitaxel|mesh-list
14761565|NCT03613181|Capecitabine|capecitabine|mesh-list
14761566|NCT03613181|Methotrexate|methotrexate|mesh-list
13929252|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13929253|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
13929254|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929255|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929256|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
13929257|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929258|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13929259|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13929260|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
13929261|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929262|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929263|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14104990|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14104991|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
14104992|NCT02384499|Coagulants|coagulants|mesh-ancestor
14104993|NCT02384512|Rasagiline|rasagiline|mesh-list
14104994|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14104995|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14104996|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14104997|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14104998|NCT02384512|Protective Agents|protective agents|mesh-ancestor
14104999|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105000|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
14105001|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14105002|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14105003|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105004|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
14105005|NCT02384135|Coagulants|coagulants|mesh-ancestor
14105006|NCT02384122|Octreotide|octreotide|mesh-list
14105007|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929264|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13929265|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13929266|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
13929267|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929268|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13929269|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
13929270|NCT03383393|Adenosine|adenosine|mesh-list
13929271|NCT03383393|Eptifibatide|eptifibatide|mesh-list
13929272|NCT03383393|Analgesics|analgesics|mesh-ancestor
14477699|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477700|NCT02437162|Golimumab|golimumab|mesh-list
14477701|NCT02437162|Ustekinumab|ustekinumab|mesh-list
14477702|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14477703|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14477704|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477705|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761567|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13929273|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
13929274|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929275|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929276|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13929277|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
13929278|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13929279|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
13929280|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
13929281|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929282|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929283|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13929284|NCT03383367|TEMPO|tempo|mesh-list
13929285|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
13929286|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929287|NCT03383367|Protective Agents|protective agents|mesh-ancestor
14105008|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105009|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929288|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929289|NCT03383328|Prednisolone|prednisolone|mesh-list
13929290|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13929291|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
14105010|NCT02383901|Methotrexate|methotrexate|mesh-list
14105011|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14105012|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
14105013|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14761568|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761569|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14761570|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
13929292|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13929293|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
13929294|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
13929295|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13929296|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
13929297|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13929298|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
13929299|NCT03383328|Hormones|hormones|mesh-ancestor
14761571|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761572|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761573|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761574|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
14761575|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13929300|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929301|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929302|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13929303|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929304|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
13929305|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
13929306|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929307|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929308|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13929309|NCT03383328|Protective Agents|protective agents|mesh-ancestor
13929310|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13929311|NCT03383328|Analgesics|analgesics|mesh-ancestor
13929312|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
13929313|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929314|NCT03383315|Tramadol|tramadol|mesh-list
13929315|NCT03383315|Metoclopramide|metoclopramide|mesh-list
14105014|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929316|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14105015|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14105016|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
14105017|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105018|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105019|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14105020|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105021|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14105022|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105023|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
14105024|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105025|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929317|NCT03383315|Narcotics|narcotics|mesh-ancestor
13929318|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929319|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929320|NCT03383315|Analgesics|analgesics|mesh-ancestor
13929321|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
13929322|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105026|NCT02383823|Estradiol|estradiol|mesh-list
14105027|NCT02383823|Estrogens|estrogens|mesh-list
14105028|NCT02383823|Hormones|hormones|mesh-ancestor
14105029|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105030|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105031|NCT02383888|BI 425809|bi 425809|mesh-list
14105032|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
14105033|NCT02383927|Tipifarnib|tipifarnib|mesh-list
14105034|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105035|NCT02384083|Dexamethasone|dexamethasone|mesh-list
14105036|NCT02384083|Pomalidomide|pomalidomide|mesh-list
14105037|NCT02384083|Filanesib|filanesib|mesh-list
14105038|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105039|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
14105040|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
14105041|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105042|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105043|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105044|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
14105045|NCT02384083|Hormones|hormones|mesh-ancestor
14105046|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105047|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105048|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105049|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
13929323|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
13929324|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
13929325|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929326|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13929327|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13929328|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
13929329|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929330|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929331|NCT03383302|Nivolumab|nivolumab|mesh-list
13929332|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929333|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929334|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13929335|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929336|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13929337|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105050|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14477706|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
14936008|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
13929338|NCT03383237|Apatinib|apatinib|mesh-list
13929339|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929340|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13929341|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929342|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929343|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13929344|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
13929345|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
13929346|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
13929347|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13929348|NCT03383185|Progestins|progestins|mesh-list
13929349|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13929350|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105051|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14105052|NCT02384083|Growth Substances|growth substances|mesh-ancestor
14761576|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
14477707|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477708|NCT02437253|Adalimumab|adalimumab|mesh-list
14477709|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477710|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477711|NCT02437344|Naltrexone|naltrexone|mesh-list
14477712|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14477713|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14477714|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477715|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
14477716|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477717|NCT02437383|Propranolol|propranolol|mesh-list
14477718|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14477719|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14477720|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477721|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477722|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477723|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477724|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14477725|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14105053|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
14105054|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14105055|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14105056|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105057|NCT02384187|Gabapentin|gabapentin|mesh-list
14105058|NCT02384187|Analgesics|analgesics|mesh-ancestor
14105059|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
14105060|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105061|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105062|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
14105063|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14761577|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13929351|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13929352|NCT03383185|Hormones|hormones|mesh-ancestor
13929353|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929354|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13929355|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13929356|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13929357|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13929358|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13929359|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929360|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13929361|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929362|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
13929363|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929364|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929365|NCT03383068|Metformin|metformin|mesh-list
13929366|NCT03383068|Exenatide|exenatide|mesh-list
13929367|NCT03383068|Acarbose|acarbose|mesh-list
14105064|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14105065|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105066|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14105067|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14105068|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14105069|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105070|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105071|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
14105072|NCT02383680|Vaccines|vaccines|mesh-list
14105073|NCT02383680|Immunologic Factors|immunologic factors|mesh-ancestor
14105074|NCT02383680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105075|NCT02383771|Aspirin|aspirin|mesh-list
14105076|NCT02383771|Ticagrelor|ticagrelor|mesh-list
14105077|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14105078|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14105079|NCT02383771|Analgesics|analgesics|mesh-ancestor
14105080|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
14105081|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105082|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105083|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105084|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105085|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14105086|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14105087|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929368|NCT03383068|Orlistat|orlistat|mesh-list
14477726|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
13929369|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13929370|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929371|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14105088|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14105089|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14105090|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105091|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
14105092|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14105093|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14105094|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14105095|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
14105096|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105097|NCT02383563|Metformin|metformin|mesh-list
14105098|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14105099|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105100|NCT02383121|Midodrine|midodrine|mesh-list
14105101|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
13929372|NCT03383068|Incretins|incretins|mesh-ancestor
13929373|NCT03383068|Hormones|hormones|mesh-ancestor
13929374|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105102|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
14105103|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105104|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105105|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14105106|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14105107|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14105108|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14105109|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
14105110|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105111|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105112|NCT02383212|Paclitaxel|paclitaxel|mesh-list
14105113|NCT02383212|Docetaxel|docetaxel|mesh-list
14105114|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
13929375|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13929376|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929377|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105115|NCT02383212|Carboplatin|carboplatin|mesh-list
14105116|NCT02383212|Pemetrexed|pemetrexed|mesh-list
14105117|NCT02383212|Cemiplimab|cemiplimab|mesh-list
14105118|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14105119|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105120|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
14105121|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
14105122|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
14105123|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105124|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105125|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
14105126|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105127|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105128|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14105129|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
14105130|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14105131|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105132|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14105133|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14105134|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14105135|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
14761578|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761579|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14761580|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761581|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14761582|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761583|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
14761584|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761585|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14936009|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14105136|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14105137|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105138|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14105139|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105140|NCT02383030|Fulvestrant|fulvestrant|mesh-list
14105141|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105142|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105143|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14105144|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14105145|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
14105146|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105147|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105148|NCT02382757|Insulin|insulin|mesh-list
14105149|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14105150|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14105151|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105152|NCT02382653|Piroxicam|piroxicam|mesh-list
14105153|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14105154|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14105155|NCT02382653|Analgesics|analgesics|mesh-ancestor
14105156|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
14105157|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105158|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105159|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105160|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105161|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14105162|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105163|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105164|NCT02382679|Vitamins|vitamins|mesh-list
14105165|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
14105166|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105167|NCT02382666|Rolapitant|rolapitant|mesh-list
14105168|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14105169|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105170|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105171|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175368|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175369|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14175370|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
14175371|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175372|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175373|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14175374|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14175375|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
14175376|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
14175377|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175378|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175379|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
14175380|NCT04776850|Hormones|hormones|mesh-ancestor
14175381|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175382|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14175383|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
14175384|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175385|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14175386|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
14175387|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13929378|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13929379|NCT03383003|Amoxicillin|amoxicillin|mesh-list
13929380|NCT03383003|Metronidazole|metronidazole|mesh-list
13929381|NCT03383003|Clarithromycin|clarithromycin|mesh-list
14175388|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14175389|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14175390|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
14175391|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13929382|NCT03383003|Esomeprazole|esomeprazole|mesh-list
13929383|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13929384|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929385|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13929386|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13929387|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13929388|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929389|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13929390|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929391|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929392|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13929393|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14175392|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929394|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13929395|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
13929396|NCT03382938|Ropivacaine|ropivacaine|mesh-list
13929397|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13929398|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929399|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929400|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13929401|NCT03382938|Analgesics|analgesics|mesh-ancestor
13929402|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
13929403|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929404|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13929405|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13929406|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13929407|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
13929408|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929409|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929410|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
13929411|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
13929412|NCT03382886|Bevacizumab|bevacizumab|mesh-list
13929413|NCT03382886|Nivolumab|nivolumab|mesh-list
13929414|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929415|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929416|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13929417|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13929418|NCT03382886|Growth Substances|growth substances|mesh-ancestor
13929419|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929420|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
13929421|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13929422|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961004|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961005|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13961006|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13961007|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961008|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961009|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961010|NCT03151382|Tandospirone|tandospirone|mesh-list
14105172|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14105173|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
14105174|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
14105175|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105176|NCT02382549|Trametinib|trametinib|mesh-list
14105177|NCT02382549|Dabrafenib|dabrafenib|mesh-list
14105178|NCT02382549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105179|NCT02382549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14105180|NCT02382549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105181|NCT02382549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105182|NCT02382263|Gemcitabine|gemcitabine|mesh-list
14105183|NCT02382263|Paclitaxel|paclitaxel|mesh-list
14105184|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14105185|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14105186|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105187|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
14105188|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
14105189|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
14105190|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105191|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14105192|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
14105193|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
14105194|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105195|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105196|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105197|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
14105198|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105199|NCT02382445|Anesthetics|anesthetics|mesh-list
14105200|NCT02382445|Propofol|propofol|mesh-list
14105201|NCT02382445|Sevoflurane|sevoflurane|mesh-list
14105202|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105203|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105204|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14105205|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14105206|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
14105207|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14105208|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13929423|NCT03382756|Choline|choline|mesh-list
13929424|NCT03382756|Atorvastatin|atorvastatin|mesh-list
13929425|NCT03382756|Fenofibrate|fenofibrate|mesh-list
13929426|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13929427|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13929428|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
13929429|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929430|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13929431|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13929432|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929433|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
13929434|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929435|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
13929436|NCT03382743|Lidocaine|lidocaine|mesh-list
13929437|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
13929438|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
13929439|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929440|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929441|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
13929442|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929443|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13929444|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13929445|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13929446|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13929447|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929448|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
13929449|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13929450|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13929451|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929452|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
13929453|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
13929454|NCT03382717|Amorolfine|amorolfine|mesh-list
13929455|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
13929456|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929457|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
13929458|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
13929459|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929460|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14105209|NCT02382354|Remifentanil|remifentanil|mesh-list
14105210|NCT02382354|Propofol|propofol|mesh-list
14105211|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14105212|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105213|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105214|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14105215|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
14105216|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
14105217|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14105218|NCT02382354|Narcotics|narcotics|mesh-ancestor
14105219|NCT02382354|Analgesics|analgesics|mesh-ancestor
14105220|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
14105221|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105222|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
14105223|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
14105224|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105225|NCT02382328|Protective Agents|protective agents|mesh-ancestor
14105226|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105227|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
14105228|NCT02382328|Vitamins|vitamins|mesh-ancestor
14105229|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
14105230|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
14105231|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14105232|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14105233|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14105234|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
14105235|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105236|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105237|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105238|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14105239|NCT02382523|Hormones|hormones|mesh-ancestor
14105240|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105241|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929461|NCT03382587|Aflibercept|aflibercept|mesh-list
13929462|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14105242|NCT02382432|Meperidine|meperidine|mesh-list
14105243|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
14105244|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14105245|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105246|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105247|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14105248|NCT02382432|Analgesics|analgesics|mesh-ancestor
14105249|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
14105250|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105251|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14105252|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14105253|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14105254|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
14105255|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929463|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13929464|NCT03382587|Growth Substances|growth substances|mesh-ancestor
13929465|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929466|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
13929467|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929468|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13929469|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13929470|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936010|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
14105256|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105257|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14105258|NCT02382432|Narcotics|narcotics|mesh-ancestor
14105259|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14105260|NCT02382146|Dexamethasone|dexamethasone|mesh-list
14105261|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
14105262|NCT02382146|Ondansetron|ondansetron|mesh-list
14105263|NCT02382146|BB 1101|bb 1101|mesh-list
14105264|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105265|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
14105266|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
14105267|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105268|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105269|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105270|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
14105271|NCT02382146|Hormones|hormones|mesh-ancestor
14105272|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105273|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105274|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105275|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
14105276|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105277|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105278|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
14105279|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
14105280|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14105281|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
14105282|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105283|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14105284|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14936011|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936012|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936013|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14936014|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
14936015|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14936016|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14936017|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14936018|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
14936019|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936020|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936021|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
14936022|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14936023|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
14936024|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14936025|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
14936026|NCT01466712|Hormones|hormones|mesh-ancestor
14936027|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936028|NCT01466829|Hormones|hormones|mesh-list
14936029|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
14936030|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929471|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
13929472|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
14105285|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105286|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14105287|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13929473|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13929474|NCT03382431|PC-786|pc-786|mesh-list
13929475|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
13929476|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929477|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929478|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929479|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
14105288|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
14105289|NCT02381964|Vitamins|vitamins|mesh-ancestor
14105290|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
14105291|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105292|NCT02382068|Dexamethasone|dexamethasone|mesh-list
14105293|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929480|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
13929481|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13929482|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929483|NCT03382314|Vitamins|vitamins|mesh-ancestor
13929484|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
13929485|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13929486|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13929487|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13929488|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
13929489|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929490|NCT03382275|Iron|iron|mesh-list
13929491|NCT03382275|Ferric maltol|ferric maltol|mesh-list
14105294|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105295|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
14105296|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
14105297|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105298|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105299|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105300|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
14105301|NCT02382068|Hormones|hormones|mesh-ancestor
14105302|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105303|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105304|NCT02382094|Bicalutamide|bicalutamide|mesh-list
14105305|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
14105306|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
14105307|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105308|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105309|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105310|NCT02382029|Clonazepam|clonazepam|mesh-list
14105311|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
14105312|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
14105313|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
14105314|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105315|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105316|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105317|NCT02381899|Rituximab|rituximab|mesh-list
14105318|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14105319|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14105320|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105321|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
14105322|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105323|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105324|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14105325|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
14761586|NCT03593655|Tenofovir|tenofovir|mesh-list
14761587|NCT03593655|Emtricitabine|emtricitabine|mesh-list
14477727|NCT02437669|Hydromorphone|hydromorphone|mesh-list
14477728|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14477729|NCT02437669|Narcotics|narcotics|mesh-ancestor
14477730|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477731|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761588|NCT03593655|Dapivirine|dapivirine|mesh-list
14761589|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
14761590|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761591|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14105326|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105327|NCT02381600|Vitamin D|vitamin d|mesh-list
13929492|NCT03382275|Trace Elements|trace elements|mesh-ancestor
14105328|NCT02381600|Vitamins|vitamins|mesh-ancestor
14477732|NCT02437669|Analgesics|analgesics|mesh-ancestor
14477733|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
14477734|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477735|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14477736|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
14105329|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
13929493|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
14105330|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105331|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14105332|NCT02381717|Morphine|morphine|mesh-list
14105333|NCT02381717|Bupivacaine|bupivacaine|mesh-list
14105334|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
14105335|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
14105336|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105337|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105338|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
14105339|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105340|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14105341|NCT02381717|Narcotics|narcotics|mesh-ancestor
14105342|NCT02381717|Analgesics|analgesics|mesh-ancestor
14105343|NCT02381730|Aflibercept|aflibercept|mesh-list
14105344|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14105345|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14105346|NCT02381730|Growth Substances|growth substances|mesh-ancestor
14105347|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105348|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
14105349|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105350|NCT02381548|Belinostat|belinostat|mesh-list
14105351|NCT02381548|Adavosertib|adavosertib|mesh-list
14105352|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105353|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105354|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105355|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14105356|NCT02381249|Octreotide|octreotide|mesh-list
14105357|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105358|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105359|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105360|NCT02381314|Ipilimumab|ipilimumab|mesh-list
14105361|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14105362|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105363|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14105364|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105365|NCT02381275|Tenofovir|tenofovir|mesh-list
14105366|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
14105367|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105368|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14105369|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14105370|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105371|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105372|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14105373|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14105374|NCT02381184|Clomiphene|clomiphene|mesh-list
13929494|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929495|NCT03382275|Hematinics|hematinics|mesh-ancestor
13929496|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
13929497|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
13929498|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13929499|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13929500|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929501|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929502|NCT03382106|Urological Agents|urological agents|mesh-ancestor
13929503|NCT03381859|Grazoprevir|grazoprevir|mesh-list
13929504|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
13929505|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
13929506|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929507|NCT03381833|Hepcidins|hepcidins|mesh-list
13929508|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929509|NCT03381781|Cytarabine|cytarabine|mesh-list
13929510|NCT03381781|Decitabine|decitabine|mesh-list
13929511|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
14105375|NCT02381184|Enclomiphene|enclomiphene|mesh-list
14105376|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
13929512|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14105377|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14105378|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
14105379|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105380|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105381|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14105382|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
14105383|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14105384|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14105385|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14105386|NCT02381470|Amoxicillin|amoxicillin|mesh-list
14105387|NCT02381470|Rifampin|rifampin|mesh-list
14105388|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14105389|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
14105390|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
14105391|NCT02381470|Cefadroxil|cefadroxil|mesh-list
14105392|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14105393|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105394|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14105395|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
14105396|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
14105397|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14105398|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105399|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105400|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14105401|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14105402|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14105403|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14105404|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14105405|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14105406|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14105407|NCT02381158|Beclomethasone|beclomethasone|mesh-list
14105408|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105409|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
14105410|NCT02381158|Hormones|hormones|mesh-ancestor
14105411|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105412|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929513|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
13929514|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929515|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929516|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
13929517|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929518|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761592|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14761593|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761594|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761595|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14761596|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14761597|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
14761598|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761599|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761600|NCT03562871|Carboplatin|carboplatin|mesh-list
14761601|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
14761602|NCT03562871|Pemetrexed|pemetrexed|mesh-list
13929519|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
13929520|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929521|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929522|NCT03381755|Ticagrelor|ticagrelor|mesh-list
13929523|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13929524|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13929525|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13929526|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13929527|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
13929528|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105413|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14105414|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
14105415|NCT02381028|Emollients|emollients|mesh-list
14105416|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
14105417|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14105418|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
14105419|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105420|NCT02381145|Resveratrol|resveratrol|mesh-list
14105421|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
14761603|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761604|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761605|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105422|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105423|NCT02381145|Protective Agents|protective agents|mesh-ancestor
14105424|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105425|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105426|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14105427|NCT02381080|Voriconazole|voriconazole|mesh-list
14105428|NCT02381080|Erythromycin|erythromycin|mesh-list
14105429|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
14105430|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14105431|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
14105432|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
14105433|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105434|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14105435|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14105436|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105437|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105438|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14105439|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
14105440|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105441|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105442|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14105443|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14105444|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105445|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14105446|NCT02380898|Ketorolac|ketorolac|mesh-list
14105447|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14105448|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14105449|NCT02380898|Analgesics|analgesics|mesh-ancestor
14105450|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
14105451|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929529|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929530|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929531|NCT03381703|YH12852|yh12852|mesh-list
13929532|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
13929533|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13929534|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
13929535|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929536|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929537|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105452|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105453|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105454|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105455|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14105456|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105457|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175393|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
14175394|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
14175395|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175396|NCT04776512|Bupivacaine|bupivacaine|mesh-list
14175397|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175398|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
14175399|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175400|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175401|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
14175402|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175403|NCT04776525|Doxorubicin|doxorubicin|mesh-list
14175404|NCT04776525|Ifosfamide|ifosfamide|mesh-list
14175405|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14175406|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175407|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14175408|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14175409|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175410|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175411|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13929538|NCT03381664|Quinidine|quinidine|mesh-list
13929539|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
13929540|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
13929541|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
13929542|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13929543|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13929544|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961011|NCT03151382|Donepezil|donepezil|mesh-list
14105458|NCT02380573|Methylene Blue|methylene blue|mesh-list
14105459|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105460|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105461|NCT02380755|Clomiphene|clomiphene|mesh-list
14105462|NCT02380755|Enclomiphene|enclomiphene|mesh-list
14105463|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
14105464|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14105465|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
13929545|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929546|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929547|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13929548|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13929549|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
13929550|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13929551|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
13929552|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13929553|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13929554|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929555|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929556|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13929557|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13929558|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
13929559|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13929560|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13929561|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14105466|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105467|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105468|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14761606|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761607|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14761608|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14761609|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
13929562|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14105469|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
14105470|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13929563|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13929564|NCT03381599|Lenograstim|lenograstim|mesh-list
13929565|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13929566|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
13929567|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929568|NCT03381495|Sufentanil|sufentanil|mesh-list
13929569|NCT03381495|Ropivacaine|ropivacaine|mesh-list
13929570|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
13929571|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
13929572|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929573|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929574|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
13929575|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929576|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13929577|NCT03381495|Narcotics|narcotics|mesh-ancestor
13929578|NCT03381495|Analgesics|analgesics|mesh-ancestor
13929579|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13929580|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14105471|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14105472|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14105473|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
14105474|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14105475|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929581|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
13929582|NCT03381482|Anesthetics|anesthetics|mesh-list
13929583|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929584|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929585|NCT03381430|Gefitinib|gefitinib|mesh-list
13929586|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929587|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13929588|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929589|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929590|NCT03381352|Capecitabine|capecitabine|mesh-list
13929591|NCT03381352|Mitomycins|mitomycins|mesh-list
13929592|NCT03381352|Mitomycin|mitomycin|mesh-list
13929593|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13929594|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
13929595|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929596|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929597|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13929598|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
13929599|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929600|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929601|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
13929602|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13929603|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13929604|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13929605|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13929606|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929607|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
13929608|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929609|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929610|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13929611|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961012|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961013|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13961014|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105476|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
14105477|NCT02380625|Azithromycin|azithromycin|mesh-list
14105478|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14105479|NCT02380625|Sunitinib|sunitinib|mesh-list
14105480|NCT02380625|Irbesartan|irbesartan|mesh-list
14105481|NCT02380625|Atorvastatin|atorvastatin|mesh-list
14105482|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14105483|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14105484|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
14105485|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105486|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14105487|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14105488|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105489|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105490|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14105491|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14105492|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105493|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14105494|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14105495|NCT02380625|Growth Substances|growth substances|mesh-ancestor
14105496|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105497|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
14105498|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14105499|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13961015|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
13961016|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961017|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961018|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
13961019|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13961020|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961021|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961022|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961023|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13961024|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
13961025|NCT03151174|Vitamin D|vitamin d|mesh-list
13961026|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
14105500|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14105501|NCT02380521|Exenatide|exenatide|mesh-list
13961027|NCT03151174|Vitamins|vitamins|mesh-list
14105502|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14105503|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105504|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14105505|NCT02380521|Incretins|incretins|mesh-ancestor
14105506|NCT02380521|Hormones|hormones|mesh-ancestor
14105507|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105508|NCT02380586|Anesthetics|anesthetics|mesh-list
14105509|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929612|NCT03381118|Cytarabine|cytarabine|mesh-list
13929613|NCT03381118|Nivolumab|nivolumab|mesh-list
13929614|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929615|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929616|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13929617|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929618|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13929619|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
13929620|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
13929621|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929622|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13929623|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
14105510|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105511|NCT02380508|Vaccines|vaccines|mesh-list
14105512|NCT02380508|Immunologic Factors|immunologic factors|mesh-ancestor
14105513|NCT02380508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105514|NCT02380417|Ropivacaine|ropivacaine|mesh-list
13929624|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929625|NCT03381066|Cisplatin|cisplatin|mesh-list
13929626|NCT03381066|Pemetrexed|pemetrexed|mesh-list
13929627|NCT03381066|Vinorelbine|vinorelbine|mesh-list
13929628|NCT03381066|Gefitinib|gefitinib|mesh-list
13929629|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929630|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929631|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105515|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
14105516|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
14105517|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105518|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105519|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
14105520|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105521|NCT02380313|Prednisone|prednisone|mesh-list
14105522|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105523|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
14105524|NCT02380313|Hormones|hormones|mesh-ancestor
14105525|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105526|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105527|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105528|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105529|NCT02380352|Amoxicillin|amoxicillin|mesh-list
14105530|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14105531|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105532|NCT02380131|Capecitabine|capecitabine|mesh-list
14105533|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
14105534|NCT02380131|Trastuzumab|trastuzumab|mesh-list
14105535|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14105536|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
14105537|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105538|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105539|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14105540|NCT02380118|Midazolam|midazolam|mesh-list
14105541|NCT02380118|Haloperidol|haloperidol|mesh-list
14105542|NCT02380118|Olanzapine|olanzapine|mesh-list
14105543|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
14105544|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14105545|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14105546|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105547|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929632|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13929633|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929634|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13929635|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
13929636|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14105548|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14105549|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13929637|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14105550|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14105551|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14105552|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
14105553|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
14105554|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
14105555|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
14105556|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105557|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105558|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
13929638|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13929639|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
13929640|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929641|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13929642|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929643|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929644|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
13929645|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14105559|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
14105560|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105561|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105562|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14105563|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14105564|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14105565|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13929646|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
13929647|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929648|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
13929649|NCT03381040|Protective Agents|protective agents|mesh-ancestor
13929650|NCT03380975|Montelukast|montelukast|mesh-list
13929651|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13929652|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
14105566|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
14105567|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14105568|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
14105569|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14105570|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14105571|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14105572|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14105573|NCT02380001|Analgesics|analgesics|mesh-ancestor
14105574|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
14105575|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105576|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105577|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105578|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929653|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14105579|NCT02379754|Gentamicins|gentamicins|mesh-list
14105580|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14105581|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105582|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14105583|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105584|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105585|NCT02380053|Celiprolol|celiprolol|mesh-list
13929654|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
13929655|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929656|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929657|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13929658|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13929659|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929660|NCT03380949|Remifentanil|remifentanil|mesh-list
13929661|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
13929662|NCT03380949|Narcotics|narcotics|mesh-ancestor
13929663|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929664|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929665|NCT03380949|Analgesics|analgesics|mesh-ancestor
13929666|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
13929667|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929668|NCT03380936|Tacrolimus|tacrolimus|mesh-list
13929669|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
13929670|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13929671|NCT03380936|Antibodies|antibodies|mesh-list
13929672|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
13929673|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13929674|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13929675|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
13929676|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105586|NCT02380053|Bisoprolol|bisoprolol|mesh-list
14105587|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14105588|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
14105589|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
14105590|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105591|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105592|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14105593|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14105594|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14105595|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
14105596|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105597|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929677|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13929678|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929679|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929680|NCT03380871|Carboplatin|carboplatin|mesh-list
13929681|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
13929682|NCT03380871|Pemetrexed|pemetrexed|mesh-list
13929683|NCT03380871|Poly ICLC|poly iclc|mesh-list
13929684|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929685|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929686|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929687|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936031|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936032|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14936033|NCT01466855|Topotecan|topotecan|mesh-list
14936034|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14936035|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13929688|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13929689|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929690|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
13929691|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
13929692|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929693|NCT03380728|Ibogaine|ibogaine|mesh-list
13929694|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
13929695|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929696|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13929697|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13929698|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13929699|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929700|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929701|NCT03380689|Bevacizumab|bevacizumab|mesh-list
13929702|NCT03380689|Irinotecan|irinotecan|mesh-list
13929703|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929704|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929705|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13929706|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13929707|NCT03380689|Growth Substances|growth substances|mesh-ancestor
13929708|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929709|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
13929710|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14105598|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13929711|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13929712|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929713|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929714|NCT03380546|Insulin|insulin|mesh-list
13929715|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13929716|NCT03380546|Acarbose|acarbose|mesh-list
13929717|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
13929718|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13929719|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929720|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13929721|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929722|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929723|NCT03380533|Buprenorphine|buprenorphine|mesh-list
13929724|NCT03380533|Tramadol|tramadol|mesh-list
13929725|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13929726|NCT03380533|Narcotics|narcotics|mesh-ancestor
14105599|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
13929727|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929728|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929729|NCT03380533|Analgesics|analgesics|mesh-ancestor
13929730|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
13929731|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929732|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13929733|NCT03380468|Pemetrexed|pemetrexed|mesh-list
13929734|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929735|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929736|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929737|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13929738|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929739|NCT03380455|Cimetidine|cimetidine|mesh-list
13929740|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13929741|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929742|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13929743|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
13929744|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
13929745|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929746|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929747|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929748|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13929749|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13929750|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929751|NCT03380442|Ketamine|ketamine|mesh-list
13929752|NCT03380442|Psilocybin|psilocybin|mesh-list
13929753|NCT03380442|Analgesics|analgesics|mesh-ancestor
13929754|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
13929755|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929756|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929757|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13929758|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13929759|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
13929760|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
13929761|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929762|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13929763|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13929764|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929765|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929766|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
13929767|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13929768|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
13929769|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13929770|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929771|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13929772|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13929773|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929774|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929775|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929776|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13929777|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13929778|NCT03380325|Iloprost|iloprost|mesh-list
13929779|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13929780|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
13929781|NCT03380130|Nivolumab|nivolumab|mesh-list
13929782|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929783|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929784|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14105600|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
14105601|NCT02379806|Enoxaparin|enoxaparin|mesh-list
14105602|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
14105603|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14105604|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14105605|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105606|NCT02379793|Mineral Oil|mineral oil|mesh-list
14105607|NCT02379793|Emollients|emollients|mesh-ancestor
14105608|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
14105609|NCT02379767|Harmine|harmine|mesh-list
14105610|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
14105611|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105612|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14105613|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14105614|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105615|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105616|NCT02379715|Remifentanil|remifentanil|mesh-list
14105617|NCT02379715|Desflurane|desflurane|mesh-list
14105618|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14105619|NCT02379715|Narcotics|narcotics|mesh-ancestor
14105620|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105621|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105622|NCT02379715|Analgesics|analgesics|mesh-ancestor
14105623|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
14105624|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105625|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14105626|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
14105627|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
14105628|NCT02379663|Enoxaparin|enoxaparin|mesh-list
14105629|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
14105630|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14105631|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
14105632|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14105633|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
14105634|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105635|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105636|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
14105637|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14105638|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14105639|NCT02379546|Desflurane|desflurane|mesh-list
14105640|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14105641|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
14105642|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
14105643|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105644|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105645|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
14936036|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929785|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929786|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
13929787|NCT03380039|Fludarabine|fludarabine|mesh-list
13929788|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13929789|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
13929790|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929791|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929792|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13929793|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
13929794|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929795|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929796|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13929797|NCT03379987|Morphine|morphine|mesh-list
13929798|NCT03379987|Bupivacaine|bupivacaine|mesh-list
13929799|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
13929800|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
13929801|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929802|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929803|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
13929804|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929805|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13929806|NCT03379987|Narcotics|narcotics|mesh-ancestor
13929807|NCT03379987|Analgesics|analgesics|mesh-ancestor
13929808|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13929809|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
13929810|NCT03379974|Coagulants|coagulants|mesh-ancestor
13929811|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13929812|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
13929813|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929814|NCT03379909|Metformin|metformin|mesh-list
13929815|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13929816|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961028|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
13961029|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961030|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13961031|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13961032|NCT03151044|Rituximab|rituximab|mesh-list
14105646|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
14105647|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13929817|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
13929818|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929819|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929820|NCT03379428|Trastuzumab|trastuzumab|mesh-list
13929821|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13929822|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929823|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13929824|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929825|NCT03379181|Propranolol|propranolol|mesh-list
13929826|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13929827|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13929828|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
13929829|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929830|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929831|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929832|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13929833|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13929834|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
13929835|NCT03379103|Propofol|propofol|mesh-list
13929836|NCT03379103|Sevoflurane|sevoflurane|mesh-list
13929837|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13929838|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929839|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929840|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13929841|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
13929842|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
13929843|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13929844|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13929845|NCT03379012|Sunitinib|sunitinib|mesh-list
13929846|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
13929847|NCT03379012|Testosterone|testosterone|mesh-list
13929848|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
13929849|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
13929850|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14105648|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14105649|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105650|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105651|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929851|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929852|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13929853|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13929854|NCT03379012|Growth Substances|growth substances|mesh-ancestor
13929855|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929856|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
13929857|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13929858|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929859|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929860|NCT03379012|Androgens|androgens|mesh-ancestor
13929861|NCT03379012|Hormones|hormones|mesh-ancestor
13929862|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929863|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13929864|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
13929865|NCT03378960|Omeprazole|omeprazole|mesh-list
13929866|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13929867|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13929868|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13929869|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929870|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929871|NCT03378934|Aspirin|aspirin|mesh-list
14105652|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105653|NCT02379676|Clopidogrel|clopidogrel|mesh-list
14105654|NCT02379676|Ticagrelor|ticagrelor|mesh-list
14105655|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14105656|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14105657|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14105658|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13929872|NCT03378934|Clopidogrel|clopidogrel|mesh-list
13929873|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13929874|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13929875|NCT03378934|Analgesics|analgesics|mesh-ancestor
13929876|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
14105659|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
13929877|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13929878|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105660|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929879|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13929880|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13929881|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13929882|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14105661|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105662|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175412|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
14175413|NCT04776655|Leucovorin|leucovorin|mesh-list
14175414|NCT04776655|Bevacizumab|bevacizumab|mesh-list
13929883|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929884|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13929885|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13929886|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929887|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
13929888|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13929889|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13929890|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13929891|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
13929892|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13929893|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
13929894|NCT03378791|Trace Elements|trace elements|mesh-ancestor
13929895|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
13929896|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929897|NCT03378726|Micronutrients|micronutrients|mesh-list
13929898|NCT03378726|Trace Elements|trace elements|mesh-list
14175415|NCT04776655|Cetuximab|cetuximab|mesh-list
14175416|NCT04776655|Fluorouracil|fluorouracil|mesh-list
14175417|NCT04776655|Irinotecan|irinotecan|mesh-list
13929899|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929900|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
13929901|NCT03378713|Testosterone|testosterone|mesh-list
13929902|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
13929903|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
13929904|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13929905|NCT03378713|Androgens|androgens|mesh-ancestor
13929906|NCT03378713|Hormones|hormones|mesh-ancestor
13929907|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175418|NCT04776655|Calcium|calcium|mesh-list
14175419|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
14175420|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14175421|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175422|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14175423|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14175424|NCT04776655|Growth Substances|growth substances|mesh-ancestor
14175425|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175426|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
14175427|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14175428|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
14175429|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175430|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14175431|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14175432|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
14175433|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14175434|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14175435|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175436|NCT04776655|Antidotes|antidotes|mesh-ancestor
14175437|NCT04776655|Protective Agents|protective agents|mesh-ancestor
14175438|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
14175439|NCT04776655|Vitamins|vitamins|mesh-ancestor
14175440|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
14175441|NCT04776395|Dexamethasone|dexamethasone|mesh-list
14175442|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
14175443|NCT04776395|Ichthammol|ichthammol|mesh-list
14175444|NCT04776395|BB 1101|bb 1101|mesh-list
14175445|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14175446|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
13929908|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929909|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13929910|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929911|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
13929912|NCT03378674|Remifentanil|remifentanil|mesh-list
13929913|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14175447|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
14175448|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175449|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929914|NCT03378674|Narcotics|narcotics|mesh-ancestor
14175450|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175451|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
13929915|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929916|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929917|NCT03378674|Analgesics|analgesics|mesh-ancestor
13929918|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
13929919|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105663|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14105664|NCT02379377|Fluorides|fluorides|mesh-list
14105665|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14105666|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105667|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
14105668|NCT02379377|Protective Agents|protective agents|mesh-ancestor
14105669|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105670|NCT02379299|Hormones|hormones|mesh-list
14105671|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105672|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105673|NCT02379000|Triamcinolone|triamcinolone|mesh-list
14105674|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14105675|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14105676|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14105677|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105678|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
14105679|NCT02379000|Hormones|hormones|mesh-ancestor
14105680|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929920|NCT03378661|Benzonidazole|benzonidazole|mesh-list
13929921|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13929922|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
13929923|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105681|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105682|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105683|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
14105684|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105685|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105686|NCT02379026|Vitamin D|vitamin d|mesh-list
14105687|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
14105688|NCT02379026|Vitamins|vitamins|mesh-ancestor
14105689|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
14105690|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105691|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14105692|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14105693|NCT02379156|Midodrine|midodrine|mesh-list
14105694|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
14105695|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
14105696|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105697|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105698|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14105699|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14105700|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14105701|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14105702|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
14105703|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105704|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105705|NCT02378623|Apixaban|apixaban|mesh-list
14105706|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14105707|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
14105708|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14105709|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
14105710|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105711|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105712|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
14105713|NCT02378740|Ketamine|ketamine|mesh-list
14105714|NCT02378740|Analgesics|analgesics|mesh-ancestor
14105715|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
14105716|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105717|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105718|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13929924|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13929925|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13929926|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13929927|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929928|NCT03378648|Bromides|bromides|mesh-list
13929929|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
13929930|NCT03378479|Posaconazole|posaconazole|mesh-list
14105719|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14105720|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
13929931|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
14105721|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
13929932|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929933|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13929934|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13929935|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13929936|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13929937|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13929938|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929939|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929940|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13929941|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
14761610|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761611|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
14761612|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761613|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761614|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14761615|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
14761616|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761617|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929942|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13929943|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105722|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105723|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14105724|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14105725|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105726|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105727|NCT02378805|Ramipril|ramipril|mesh-list
14105728|NCT02378805|Spironolactone|spironolactone|mesh-list
13929944|NCT03378466|Heparin|heparin|mesh-list
13929945|NCT03378466|Calcium heparin|calcium heparin|mesh-list
13929946|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
13929947|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13929948|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13929949|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929950|NCT03378427|Doxycycline|doxycycline|mesh-list
13929951|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
14105729|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14105730|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14105731|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
14105732|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105733|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105734|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14105735|NCT02378805|Diuretics|diuretics|mesh-ancestor
14105736|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
14105737|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
14105738|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105739|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105740|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13929952|NCT03378427|Levofloxacin|levofloxacin|mesh-list
13929953|NCT03378427|Ofloxacin|ofloxacin|mesh-list
13929954|NCT03378427|Minocycline|minocycline|mesh-list
13929955|NCT03378427|Rifampin|rifampin|mesh-list
13929956|NCT03378427|Clindamycin|clindamycin|mesh-list
13929957|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14105741|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
14105742|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
14105743|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14105744|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14105745|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105746|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105747|NCT02378649|Urological Agents|urological agents|mesh-ancestor
14105748|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14105749|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105750|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105751|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105752|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14105753|NCT02378415|Ketamine|ketamine|mesh-list
14105754|NCT02378415|Analgesics|analgesics|mesh-ancestor
14105755|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
14105756|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105757|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761618|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14761619|NCT03539744|Dexamethasone|dexamethasone|mesh-list
13929958|NCT03378427|Tedizolid|tedizolid|mesh-list
13929959|NCT03378427|Teicoplanin|teicoplanin|mesh-list
13929960|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
13929961|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
13929962|NCT03378427|Trimethoprim|trimethoprim|mesh-list
13929963|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
13929964|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13929965|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929966|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
13929967|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13929968|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13929969|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13929970|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13929971|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13929972|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13929973|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13929974|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13929975|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13929976|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13929977|NCT03378427|Renal Agents|renal agents|mesh-ancestor
13929978|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13929979|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
13929980|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
14105758|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14105759|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14105760|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
14105761|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
14105762|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105763|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14105764|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14105765|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105766|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105767|NCT02378441|Metformin|metformin|mesh-list
14105768|NCT02378441|Atorvastatin|atorvastatin|mesh-list
14105769|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14105770|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105771|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14105772|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14105773|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
14105774|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105775|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14105776|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14105777|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105778|NCT02378532|Chloroquine|chloroquine|mesh-list
14105779|NCT02378532|Temozolomide|temozolomide|mesh-list
14105780|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14105781|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
14105782|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105783|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105784|NCT02378532|Amebicides|amebicides|mesh-ancestor
14105785|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14105786|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14105787|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105788|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
14105789|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105790|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
14105791|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14105792|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14105793|NCT02378298|Prednisolone|prednisolone|mesh-list
14105794|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
14761620|NCT03539744|Venetoclax|venetoclax|mesh-list
14761621|NCT03539744|Pomalidomide|pomalidomide|mesh-list
13929981|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13929982|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13929983|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13929984|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13929985|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13929986|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13929987|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13929988|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13929989|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13929990|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14105795|NCT02378298|Rituximab|rituximab|mesh-list
14761622|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105796|NCT02378298|Methotrexate|methotrexate|mesh-list
14761623|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
13929991|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13929992|NCT03378401|Octenidine|octenidine|mesh-list
13929993|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13929994|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14105797|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14105798|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
14105799|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14105800|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105801|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
14105802|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761624|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
14761625|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761626|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761627|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14761628|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
14761629|NCT03539744|Hormones|hormones|mesh-ancestor
14761630|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761631|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761632|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761633|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
14761634|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14761635|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14761636|NCT03539744|Growth Substances|growth substances|mesh-ancestor
14761637|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
14761638|NCT03521102|Acetaminophen|acetaminophen|mesh-list
14761639|NCT03521102|Hydromorphone|hydromorphone|mesh-list
14761640|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14761641|NCT03521102|Analgesics|analgesics|mesh-ancestor
14761642|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
14761643|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105803|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14105804|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14105805|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
14105806|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14105807|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14105808|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
14105809|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105810|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
14761644|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761645|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
14105811|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105812|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14105813|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105814|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14105815|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14105816|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
14105817|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
14105818|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105819|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105820|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
14105821|NCT02378298|Hormones|hormones|mesh-ancestor
14105822|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761646|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13929995|NCT03378323|Anesthetics|anesthetics|mesh-list
13929996|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
13929997|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13929998|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13929999|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
13930000|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930001|NCT03378310|Linrodostat|linrodostat|mesh-list
13930002|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930003|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930004|NCT03378297|Aspirin|aspirin|mesh-list
13930005|NCT03378297|Metformin|metformin|mesh-list
13930006|NCT03378297|Letrozole|letrozole|mesh-list
13930007|NCT03378297|Olaparib|olaparib|mesh-list
14761647|NCT03521102|Narcotics|narcotics|mesh-ancestor
14105823|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14105824|NCT02378298|Protective Agents|protective agents|mesh-ancestor
14105825|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14105826|NCT02378389|Docetaxel|docetaxel|mesh-list
14105827|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105828|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
14105829|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14105830|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
14105831|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105832|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
14105833|NCT02378129|Methamphetamine|methamphetamine|mesh-list
14105834|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14105835|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105836|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
14105837|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
14105838|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105839|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
14105840|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105841|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105842|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
14105843|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14105844|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14105845|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14105846|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14105847|NCT02377856|Interferons|interferons|mesh-list
14105848|NCT02377856|Ribavirin|ribavirin|mesh-list
14105849|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
14105850|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
14105851|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14105852|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105853|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
14105854|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105855|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
14105856|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105857|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
14105858|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105859|NCT02377778|Thiopental|thiopental|mesh-list
14105860|NCT02377778|Propofol|propofol|mesh-list
14105861|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14105862|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930008|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930009|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930010|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930011|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13930012|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13930013|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930014|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930015|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13930016|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
13930017|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930018|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13930019|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13930020|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13930021|NCT03378297|Analgesics|analgesics|mesh-ancestor
13930022|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
13930023|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930024|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930025|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930026|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13930027|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13930028|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13930029|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13930030|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
13930031|NCT03377907|Lidocaine|lidocaine|mesh-list
13930032|NCT03377907|Ketamine|ketamine|mesh-list
13930033|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
13930034|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
13930035|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930036|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930037|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
13930038|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930039|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13961033|NCT03151044|Epirubicin|epirubicin|mesh-list
14105863|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930040|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13930041|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13930042|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930043|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930044|NCT03377907|Analgesics|analgesics|mesh-ancestor
13930045|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13930046|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13930047|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
13930048|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13930049|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14105864|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14105865|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
14105866|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
14105867|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
14105868|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
14105869|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
14105870|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14105871|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105872|NCT02377609|Tacrolimus|tacrolimus|mesh-list
14105873|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105874|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
14105875|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105876|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14105877|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930050|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961034|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961035|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961036|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
13961037|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961038|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961039|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13961040|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13961041|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13961042|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961043|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961044|NCT03151161|Carboplatin|carboplatin|mesh-list
13961045|NCT03151161|Pemetrexed|pemetrexed|mesh-list
13961046|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961047|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961048|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961049|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13961050|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13961051|NCT03151096|Riboflavin|riboflavin|mesh-list
13961052|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
13961053|NCT03151096|Vitamins|vitamins|mesh-ancestor
13961054|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
14105878|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175452|NCT04776395|Hormones|hormones|mesh-ancestor
14175453|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175454|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14175455|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175456|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
14175457|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175458|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175459|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175460|NCT04776369|Lidocaine|lidocaine|mesh-list
14175461|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
14175462|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
14477737|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477738|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
14477739|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477740|NCT02438371|Indomethacin|indomethacin|mesh-list
14477741|NCT02438371|Nifedipine|nifedipine|mesh-list
14477742|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14477743|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14477744|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477745|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14477746|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477747|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
14477748|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
14477749|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14477750|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14477751|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14105879|NCT02377648|Everolimus|everolimus|mesh-list
14105880|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105881|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105882|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
14105883|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105884|NCT02377635|Selenious Acid|selenious acid|mesh-list
14105885|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
14105886|NCT02377635|Trace Elements|trace elements|mesh-ancestor
14105887|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
14105888|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105889|NCT02377492|Vasopressins|vasopressins|mesh-list
14105890|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
14477752|NCT02438371|Analgesics|analgesics|mesh-ancestor
14477753|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
14477754|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477755|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477756|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477757|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
14477758|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14477759|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479256|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930051|NCT03377842|Leucovorin|leucovorin|mesh-list
13930052|NCT03377842|Apatinib|apatinib|mesh-list
13930053|NCT03377842|Fluorouracil|fluorouracil|mesh-list
13930054|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
13930055|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930056|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13930057|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930058|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930059|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
13930060|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13930061|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930062|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
13930063|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930064|NCT03377842|Antidotes|antidotes|mesh-ancestor
13930065|NCT03377842|Protective Agents|protective agents|mesh-ancestor
13930066|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
14105891|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
14105892|NCT02377492|Coagulants|coagulants|mesh-ancestor
14105893|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14105894|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13930067|NCT03377842|Vitamins|vitamins|mesh-ancestor
13930068|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
13930069|NCT03377725|Decitabine|decitabine|mesh-list
13930070|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
13930071|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13930072|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
13930073|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930074|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930075|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930076|NCT03377608|Tenofovir|tenofovir|mesh-list
13930077|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13930078|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
13930079|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
13930080|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13930081|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13930082|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13930083|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930084|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930085|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13930086|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13930087|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13930088|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
13930089|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13930090|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930091|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13930092|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13930093|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13930094|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930095|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14105895|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
14105896|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761648|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930096|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13930097|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14105897|NCT02377661|Amlodipine|amlodipine|mesh-list
14105898|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14105899|NCT02377661|Olmesartan|olmesartan|mesh-list
14105900|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14105901|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14105902|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14105903|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14105904|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105905|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14105906|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105907|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
14105908|NCT02377661|Diuretics|diuretics|mesh-ancestor
14105909|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
14105910|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14105911|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14105912|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14105913|NCT02377479|Letrozole|letrozole|mesh-list
14105914|NCT02377479|Clomiphene|clomiphene|mesh-list
14105915|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105916|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14105917|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14105918|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105919|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105920|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14105921|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
14105922|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105923|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105924|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14105925|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
14105926|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14105927|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14105928|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14105929|NCT02377401|Zanamivir|zanamivir|mesh-list
14105930|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
14105931|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105932|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105933|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105934|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14105935|NCT02377388|Saxagliptin|saxagliptin|mesh-list
14105936|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14105937|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105938|NCT02377388|Incretins|incretins|mesh-ancestor
14105939|NCT02377388|Hormones|hormones|mesh-ancestor
14105940|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14105941|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14105942|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
14105943|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105944|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105945|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
14105946|NCT02377193|Tacrolimus|tacrolimus|mesh-list
13930098|NCT03377543|Aspirin|aspirin|mesh-list
13930099|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
13930100|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13930101|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13930102|NCT03377543|Analgesics|analgesics|mesh-ancestor
13930103|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
13930104|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930105|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930106|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930107|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13930108|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13961055|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930109|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105947|NCT02377193|Basiliximab|basiliximab|mesh-list
14105948|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105949|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
14105950|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105951|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14105952|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14105953|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14105954|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14105955|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105956|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14105957|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
14105958|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14105959|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105960|NCT02377180|Anesthetics|anesthetics|mesh-list
14105961|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
14105962|NCT02377180|Capsaicin|capsaicin|mesh-list
14105963|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14105964|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105965|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
14105966|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14105967|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
14105968|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
14105969|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
14105970|NCT02377076|Calcium|calcium|mesh-list
14105971|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14105972|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105973|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14105974|NCT02376972|Rifaximin|rifaximin|mesh-list
14477760|NCT02438540|Metformin|metformin|mesh-list
14477761|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14477762|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477763|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14477764|NCT02438722|Cetuximab|cetuximab|mesh-list
14477765|NCT02438722|Afatinib|afatinib|mesh-list
14477766|NCT02438722|Antibodies|antibodies|mesh-list
13930110|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13930111|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13930112|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930113|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
13930114|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
13930115|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13930116|NCT03377478|Velpatasvir|velpatasvir|mesh-list
13930117|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
13930118|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13930119|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
13930120|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
13930121|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
13930122|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930123|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930124|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930125|NCT03377400|Cisplatin|cisplatin|mesh-list
13930126|NCT03377400|Durvalumab|durvalumab|mesh-list
13930127|NCT03377400|Tremelimumab|tremelimumab|mesh-list
13930128|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930129|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13930130|NCT03377348|Triamcinolone|triamcinolone|mesh-list
13930131|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13930132|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13930133|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13930134|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930135|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
13930136|NCT03377348|Hormones|hormones|mesh-ancestor
13930137|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930138|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930139|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477767|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
14477768|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14761649|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14761650|NCT03497676|Rilpivirine|rilpivirine|mesh-list
14761651|NCT03497676|Cabotegravir|cabotegravir|mesh-list
14761652|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
14105975|NCT02376972|Metronidazole|metronidazole|mesh-list
14105976|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14105977|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14105978|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14105979|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14105980|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14105981|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
14105982|NCT02376881|Hematinics|hematinics|mesh-ancestor
14105983|NCT02376985|Everolimus|everolimus|mesh-list
14105984|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14105985|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14105986|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
14105987|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14105988|NCT02376803|Warfarin|warfarin|mesh-list
14105989|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
14105990|NCT02376478|Folic Acid|folic acid|mesh-list
14105991|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
14105992|NCT02376478|Adalimumab|adalimumab|mesh-list
14105993|NCT02376478|Etanercept|etanercept|mesh-list
14105994|NCT02376478|Methotrexate|methotrexate|mesh-list
14105995|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
14105996|NCT02376478|Infliximab|infliximab|mesh-list
14105997|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
14105998|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14105999|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
14106000|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14106001|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106002|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14106003|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
14761653|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761654|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14761655|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14761656|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930140|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
13930141|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930142|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930143|NCT03377335|Metformin|metformin|mesh-list
13930144|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
13930145|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930146|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761657|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761658|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14761659|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14761660|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13930147|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14106004|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106005|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106006|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106007|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106008|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14106009|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
13930148|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930149|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13930150|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
13930151|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
13930152|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106010|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106011|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14106012|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106013|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106014|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14106015|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106016|NCT02376478|Analgesics|analgesics|mesh-ancestor
14106017|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
14761664|NCT03484923|Spartalizumab|spartalizumab|mesh-list
14106018|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106019|NCT02376478|Hematinics|hematinics|mesh-ancestor
14106020|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
14106021|NCT02376478|Vitamins|vitamins|mesh-ancestor
14106022|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
14106023|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106024|NCT02376595|Bromides|bromides|mesh-list
14106025|NCT02376595|Rocuronium|rocuronium|mesh-list
14106026|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
14106027|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14106028|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14106029|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14106030|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106031|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106032|NCT02376452|Leucovorin|leucovorin|mesh-list
14106033|NCT02376452|Fluorouracil|fluorouracil|mesh-list
14106034|NCT02376452|Raltitrexed|raltitrexed|mesh-list
14106035|NCT02376452|Irinotecan|irinotecan|mesh-list
14106036|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
14106037|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106038|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14106039|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106040|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14106041|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
14106042|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106043|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14106044|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14106045|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106046|NCT02376452|Antidotes|antidotes|mesh-ancestor
14106047|NCT02376452|Protective Agents|protective agents|mesh-ancestor
14106048|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
14106049|NCT02376452|Vitamins|vitamins|mesh-ancestor
14106050|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
14106051|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14106052|NCT02376413|Trastuzumab|trastuzumab|mesh-list
14106053|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14106054|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106055|NCT02376309|Nandrolone|nandrolone|mesh-list
14106056|NCT02376309|Androgens|androgens|mesh-ancestor
14106057|NCT02376309|Hormones|hormones|mesh-ancestor
14106058|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106059|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106060|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
14106061|NCT02376088|Methimazole|methimazole|mesh-list
14106062|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
14106063|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
14106064|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106065|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106066|NCT02376296|Docetaxel|docetaxel|mesh-list
14106067|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106068|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
14106069|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
14106070|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
14106071|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106072|NCT02376374|Vaccines|vaccines|mesh-list
14106073|NCT02376374|Immunologic Factors|immunologic factors|mesh-ancestor
14106074|NCT02376374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106075|NCT02376192|Phenylephrine|phenylephrine|mesh-list
14106076|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
14106077|NCT02376192|Ephedrine|ephedrine|mesh-list
14106078|NCT02376192|Bupivacaine|bupivacaine|mesh-list
14106079|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106080|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
14106081|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106082|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930153|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930154|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
13930155|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
13930156|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13930157|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13930158|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
13930159|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930160|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930161|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930162|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13930163|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13930164|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106083|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
14106084|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106085|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14106086|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
14106087|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
14106088|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
14106089|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14106090|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
14106091|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
14106092|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14106093|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14106094|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14106095|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
14106096|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106097|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106098|NCT02376192|Protective Agents|protective agents|mesh-ancestor
14106099|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14106100|NCT02376049|Betamethasone|betamethasone|mesh-list
14106101|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
14106102|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14106103|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
14936037|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936038|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936039|NCT01466959|Acetic Acid|acetic acid|mesh-list
14936040|NCT01466959|Retinol acetate|retinol acetate|mesh-list
14936041|NCT01466959|Citric Acid|citric acid|mesh-list
14936042|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
14936043|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
14936044|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14936045|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
14936046|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
14936047|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936048|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14936049|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936050|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936051|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14106104|NCT02376049|Clobetasol|clobetasol|mesh-list
14106105|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
14106106|NCT02376049|Emollients|emollients|mesh-list
14106107|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14106108|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106109|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
14106110|NCT02376049|Hormones|hormones|mesh-ancestor
14106111|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106112|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106113|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14106114|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
14106115|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14106116|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106117|NCT02376049|Analgesics|analgesics|mesh-ancestor
14106118|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
14106119|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936052|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
14936053|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936054|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13930165|NCT03377218|Iodine|iodine|mesh-list
13930166|NCT03377218|Selenium|selenium|mesh-list
13930167|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
14106120|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106121|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106122|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14106123|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
14106124|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14106125|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106126|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106127|NCT02376205|Bupivacaine|bupivacaine|mesh-list
14106128|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14106129|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106130|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
14106131|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106132|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106133|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
13930168|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13930169|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13930170|NCT03377218|Trace Elements|trace elements|mesh-ancestor
13930171|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
13930172|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930173|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
13930174|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930175|NCT03377218|Protective Agents|protective agents|mesh-ancestor
13930176|NCT03377101|Fulvestrant|fulvestrant|mesh-list
14106134|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175463|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
14175464|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175465|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175466|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
14175467|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175468|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14175469|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14175470|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14175471|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175472|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175473|NCT04776369|Analgesics|analgesics|mesh-ancestor
14175474|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
14175475|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14175476|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14175477|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
14175478|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14761665|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14761666|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761667|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761668|NCT03462719|Venetoclax|venetoclax|mesh-list
14175484|NCT04776135|Edaravone|edaravone|mesh-list
14175485|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14175486|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
14175487|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175488|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14175489|NCT04776135|Protective Agents|protective agents|mesh-ancestor
14175490|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175491|NCT04776226|Citalopram|citalopram|mesh-list
14175492|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14175493|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14175494|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930177|NCT03377101|Palbociclib|palbociclib|mesh-list
13930178|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13930179|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930180|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13930181|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13930182|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
13930183|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930184|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930185|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13930186|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930187|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930188|NCT03376958|Apatinib|apatinib|mesh-list
13930189|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930190|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13930191|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930192|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930193|NCT03376932|Albuterol|albuterol|mesh-list
13930194|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
13930195|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13930196|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
13930197|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930198|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930199|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13930200|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
13930201|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
13930202|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13930203|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
13930204|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930205|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930206|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
13930207|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13930208|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13930209|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13930210|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13930211|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
13930212|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
13930213|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13930214|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477769|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
14106135|NCT02376075|Linagliptin|linagliptin|mesh-list
14106136|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106137|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106138|NCT02376075|Incretins|incretins|mesh-ancestor
14106139|NCT02376075|Hormones|hormones|mesh-ancestor
14106140|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106141|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14106142|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
14106143|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106144|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106145|NCT02375828|Glyburide|glyburide|mesh-list
14106146|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106147|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106148|NCT02376335|Rituximab|rituximab|mesh-list
14106149|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14106150|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106151|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
14106152|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106153|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106154|NCT02375880|Gemcitabine|gemcitabine|mesh-list
14106155|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106156|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14106157|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
14106158|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106159|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
14106160|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106161|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106162|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14106163|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
14106164|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106165|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
14106166|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13930215|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930216|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
13930217|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13930218|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930219|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13930220|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13930221|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
13930222|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106167|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14106168|NCT02375867|Prednisolone|prednisolone|mesh-list
14106169|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
14106170|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14106171|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
14106172|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106173|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
14106174|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
14106175|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106176|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106177|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106178|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
14106179|NCT02375867|Hormones|hormones|mesh-ancestor
14106180|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106181|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14106182|NCT02375867|Protective Agents|protective agents|mesh-ancestor
14106183|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14106184|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930223|NCT03376789|MYL-1501D|myl-1501d|mesh-list
13930224|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930225|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930226|NCT03376737|Pemetrexed|pemetrexed|mesh-list
13930227|NCT03376737|Apatinib|apatinib|mesh-list
13930228|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930229|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930230|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106185|NCT02375646|Heparin|heparin|mesh-list
14106186|NCT02375646|Enoxaparin|enoxaparin|mesh-list
14761669|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
14761670|NCT03462719|Chlorambucil|chlorambucil|mesh-list
13930231|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14106187|NCT02375646|Warfarin|warfarin|mesh-list
14106188|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
13930232|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13930233|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13930234|NCT03376698|Colchicine|colchicine|mesh-list
13930235|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
13930236|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930237|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
13930238|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761671|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930239|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
13930240|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930241|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930242|NCT03376594|Loratadine|loratadine|mesh-list
13930243|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
13930244|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
13930245|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13930246|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14106189|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14106190|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14106191|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106192|NCT02375464|Octreotide|octreotide|mesh-list
14106193|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106194|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14106195|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106196|NCT02375503|Vitamin D|vitamin d|mesh-list
14106197|NCT02375503|Calcium|calcium|mesh-list
14106198|NCT02375503|Vitamins|vitamins|mesh-ancestor
14106199|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
14106200|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106201|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14106202|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14106203|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
14106204|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14106205|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
14106206|NCT02375295|Trimethoprim|trimethoprim|mesh-list
14106207|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14106208|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106209|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14106210|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14106211|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106212|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106213|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106214|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14106215|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14106216|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14106217|NCT02375295|Renal Agents|renal agents|mesh-ancestor
14106218|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
14106219|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14106220|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14106221|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14106222|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14106223|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14106224|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
14106225|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14106226|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106227|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106228|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106229|NCT02375243|Analgesics|analgesics|mesh-ancestor
14106230|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
14761672|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761673|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14761674|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
14761675|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761676|NCT03431350|Prednisone|prednisone|mesh-list
14761677|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
14761678|NCT03431350|Niraparib|niraparib|mesh-list
14761679|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761680|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
14761681|NCT03431350|Hormones|hormones|mesh-ancestor
14761682|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761683|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761684|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761685|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761686|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13930247|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14106231|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106232|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14106233|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13930248|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
13930249|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
13930250|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930251|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930252|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930253|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
13930254|NCT03376555|Acetylcholine|acetylcholine|mesh-list
13930255|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
13930256|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13930257|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
13930258|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930259|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930260|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930261|NCT03376529|Tazobactam|tazobactam|mesh-list
13930262|NCT03376529|Piperacillin|piperacillin|mesh-list
13930263|NCT03376529|Ceftazidime|ceftazidime|mesh-list
13930264|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13930265|NCT03376529|Aztreonam|aztreonam|mesh-list
13930266|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13930267|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106234|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14106235|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14106236|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106237|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106238|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
14106239|NCT02375217|Neostigmine|neostigmine|mesh-list
14106240|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14106241|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930268|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13930269|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930270|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930271|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
13930272|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13930273|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930274|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106242|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106243|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
14106244|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106245|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106246|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14106247|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
14106248|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106249|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14106250|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14106251|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14106252|NCT02375139|Metformin|metformin|mesh-list
14106253|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106254|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106255|NCT02375191|Fentanyl|fentanyl|mesh-list
14106256|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
14106257|NCT02375191|Ropivacaine|ropivacaine|mesh-list
14106258|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13930275|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13930276|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930277|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930278|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
13930279|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930280|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
13930281|NCT03376243|Emollients|emollients|mesh-list
13930282|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106259|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106260|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106261|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106262|NCT02375191|Analgesics|analgesics|mesh-ancestor
14106263|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
14106264|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106265|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14106266|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14106267|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14106268|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
14106269|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106270|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106271|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106272|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
14106273|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14106274|NCT02375191|Narcotics|narcotics|mesh-ancestor
14106275|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14106276|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14106277|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
14106278|NCT02375178|Biguanides|biguanides|mesh-list
14106279|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
14106280|NCT02375178|Polihexanide|polihexanide|mesh-list
14106281|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14106282|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106283|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
14106284|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106285|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106286|NCT02375100|Acetaminophen|acetaminophen|mesh-list
14106287|NCT02375100|Tramadol|tramadol|mesh-list
14106288|NCT02375100|Analgesics|analgesics|mesh-list
14106289|NCT02375100|Bupivacaine|bupivacaine|mesh-list
13930283|NCT03376191|Apatinib|apatinib|mesh-list
13930284|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930285|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13930286|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930287|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930288|NCT03376178|Lidocaine|lidocaine|mesh-list
13930289|NCT03376178|Ropivacaine|ropivacaine|mesh-list
13930290|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
13930291|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
13930292|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930293|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930294|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
14106290|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106291|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
14106292|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106293|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106294|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
14106295|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106296|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13930295|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930296|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13930297|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13930298|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13930299|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930300|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930301|NCT03376139|Zonisamide|zonisamide|mesh-list
13930302|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
14106297|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
14106298|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13930303|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13930304|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930305|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930306|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13930307|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930308|NCT03376048|Ropivacaine|ropivacaine|mesh-list
13930309|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
13930310|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
13930311|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930312|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930313|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
13930314|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930315|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13930316|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
14106299|NCT02375100|Narcotics|narcotics|mesh-ancestor
14106300|NCT02375022|Endostar protein|endostar protein|mesh-list
14106301|NCT02375022|Endostatins|endostatins|mesh-list
14479257|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
13930317|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13930318|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
13930319|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
13930320|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930321|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930322|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
13930323|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13930324|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13930325|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
13930326|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930327|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106302|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14106303|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14106304|NCT02375022|Growth Substances|growth substances|mesh-ancestor
14106305|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106306|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
14106307|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930328|NCT03375788|Hormones|hormones|mesh-list
13930329|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
13930330|NCT03375788|Tesamorelin|tesamorelin|mesh-list
13930331|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930332|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930333|NCT03375788|Growth Substances|growth substances|mesh-ancestor
13930334|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
13930335|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930336|NCT03375671|Midazolam|midazolam|mesh-list
13930337|NCT03375671|Ketamine|ketamine|mesh-list
13930338|NCT03375671|Haloperidol|haloperidol|mesh-list
13930339|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
13930340|NCT03375671|Analgesics|analgesics|mesh-ancestor
13930341|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
13930342|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930343|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930344|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13930345|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13930346|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
13930347|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
13930348|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930349|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13930350|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13930351|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930352|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930353|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13930354|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13930355|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13930356|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13930357|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13930358|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
13930359|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
13930360|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
13930361|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
13930362|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930363|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13930364|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13930365|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
13930366|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13930367|NCT03375632|Dotinurad|dotinurad|mesh-list
13930368|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
13930369|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
13930370|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930371|NCT03375632|Renal Agents|renal agents|mesh-ancestor
13930372|NCT03375593|Acetaminophen|acetaminophen|mesh-list
13930373|NCT03375593|Ibuprofen|ibuprofen|mesh-list
13930374|NCT03375593|Oxycodone|oxycodone|mesh-list
13930375|NCT03375593|Hydrocodone|hydrocodone|mesh-list
13930376|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13930377|NCT03375593|Analgesics|analgesics|mesh-ancestor
13930378|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
13930379|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930380|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930381|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
13930382|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13930383|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761687|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930384|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930385|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13930386|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106308|NCT02374853|Vancomycin|vancomycin|mesh-list
14106309|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14106310|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106311|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
14106312|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14106313|NCT02374736|Antibodies|antibodies|mesh-list
14106314|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
14106315|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
14106316|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106317|NCT02374931|Estradiol|estradiol|mesh-list
14106318|NCT02374931|Estrogens|estrogens|mesh-ancestor
14106319|NCT02374931|Hormones|hormones|mesh-ancestor
14106320|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106321|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106322|NCT02374632|Octreotide|octreotide|mesh-list
14106323|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106324|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14106325|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106326|NCT02374645|Gefitinib|gefitinib|mesh-list
14106327|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106328|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14106329|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106330|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175495|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175496|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175497|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
13930387|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930388|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14767364|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930389|NCT03375593|Narcotics|narcotics|mesh-ancestor
13930390|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930391|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
13930392|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
13930393|NCT03375580|Metformin|metformin|mesh-list
13930394|NCT03375580|Simvastatin|simvastatin|mesh-list
14175498|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175499|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14175500|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
14175501|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14175502|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14175503|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
14175504|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14175505|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14175506|NCT04776096|Analgesics|analgesics|mesh-ancestor
14175507|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
14175508|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175509|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175510|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930395|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930396|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930397|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13930398|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14175511|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175512|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14175513|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13930399|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
13930400|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930401|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14175514|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14175515|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
14175516|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
14175517|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175518|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175519|NCT04775797|Tenofovir|tenofovir|mesh-list
14175520|NCT04775797|Antiviral Agents|antiviral agents|mesh-ancestor
14175521|NCT04775797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175522|NCT04775797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14175523|NCT04775797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14175524|NCT04775797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175525|NCT04775797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175526|NCT04775797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14175527|NCT04775797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14175528|NCT04775732|Infliximab|infliximab|mesh-list
14175529|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106331|NCT02374489|Ceritinib|ceritinib|mesh-list
14106332|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106333|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14106334|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106335|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106336|NCT02374320|Bupivacaine|bupivacaine|mesh-list
14106337|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106338|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
14106339|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106340|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106341|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
14106342|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106343|NCT02374567|Topiramate|topiramate|mesh-list
14106344|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
14106345|NCT02374567|Promethazine|promethazine|mesh-list
14106346|NCT02374567|Pregabalin|pregabalin|mesh-list
14106347|NCT02374567|Lamotrigine|lamotrigine|mesh-list
14106348|NCT02374567|Lacosamide|lacosamide|mesh-list
14106349|NCT02374567|Carbamazepine|carbamazepine|mesh-list
14106350|NCT02374567|Phenytoin|phenytoin|mesh-list
14106351|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
14106352|NCT02374567|Nicergoline|nicergoline|mesh-list
14106353|NCT02374567|Midazolam|midazolam|mesh-list
14106354|NCT02374567|Diazepam|diazepam|mesh-list
14106355|NCT02374567|Triazolam|triazolam|mesh-list
14106356|NCT02374567|Acamprosate|acamprosate|mesh-list
14106357|NCT02374567|Gabapentin|gabapentin|mesh-list
14106358|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14106359|NCT02374567|Amitriptyline|amitriptyline|mesh-list
14106360|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
14106361|NCT02374567|Levetiracetam|levetiracetam|mesh-list
14106362|NCT02374567|Valproic Acid|valproic acid|mesh-list
14106363|NCT02374567|Lorazepam|lorazepam|mesh-list
14106364|NCT02374567|Clonazepam|clonazepam|mesh-list
14106365|NCT02374567|Phenobarbital|phenobarbital|mesh-list
14106366|NCT02374567|Clobazam|clobazam|mesh-list
14106367|NCT02374567|Zaleplon|zaleplon|mesh-list
14106368|NCT02374567|Nitrazepam|nitrazepam|mesh-list
14106369|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
14106370|NCT02374567|Memantine|memantine|mesh-list
14106371|NCT02374567|Biperiden|biperiden|mesh-list
14106372|NCT02374567|Haloperidol|haloperidol|mesh-list
14106373|NCT02374567|Pimozide|pimozide|mesh-list
14106374|NCT02374567|Olanzapine|olanzapine|mesh-list
14106375|NCT02374567|Zolpidem|zolpidem|mesh-list
13930402|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13930403|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930404|NCT03375515|Hydromorphone|hydromorphone|mesh-list
13930405|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13930406|NCT03375515|Narcotics|narcotics|mesh-ancestor
13930407|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930408|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930409|NCT03375515|Analgesics|analgesics|mesh-ancestor
13930410|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
13930411|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930412|NCT03375502|Vaccines|vaccines|mesh-list
13930413|NCT03375502|Immunologic Factors|immunologic factors|mesh-ancestor
13930414|NCT03375502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930415|NCT03375463|Tirzepatide|tirzepatide|mesh-list
13930416|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930417|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930418|NCT03375463|Incretins|incretins|mesh-ancestor
13930419|NCT03375463|Hormones|hormones|mesh-ancestor
13930420|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930421|NCT03375424|Vedolizumab|vedolizumab|mesh-list
13930422|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930423|NCT03375398|PAZ320|paz320|mesh-list
13930424|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930425|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930426|NCT03375242|Crizotinib|crizotinib|mesh-list
13930427|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930428|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13930429|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106376|NCT02374567|Alprazolam|alprazolam|mesh-list
14106377|NCT02374567|Zopiclone|zopiclone|mesh-list
14106378|NCT02374567|S 20098|s 20098|mesh-list
14106379|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
14106380|NCT02374567|Doxepin|doxepin|mesh-list
14106381|NCT02374567|Oxazepam|oxazepam|mesh-list
14106382|NCT02374567|Temazepam|temazepam|mesh-list
14106383|NCT02374567|Brotizolam|brotizolam|mesh-list
14106384|NCT02374567|Lormetazepam|lormetazepam|mesh-list
14106385|NCT02374567|Flurazepam|flurazepam|mesh-list
14106386|NCT02374567|Mirtazapine|mirtazapine|mesh-list
14106387|NCT02374567|Trazodone|trazodone|mesh-list
14106388|NCT02374567|Buspirone|buspirone|mesh-list
14106389|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
14106390|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
14106391|NCT02374567|Bromazepam|bromazepam|mesh-list
14106392|NCT02374567|Risperidone|risperidone|mesh-list
14106393|NCT02374567|Melatonin|melatonin|mesh-list
14106394|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14106395|NCT02374567|Aripiprazole|aripiprazole|mesh-list
14106396|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14106397|NCT02374567|Ziprasidone|ziprasidone|mesh-list
14106398|NCT02374567|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14106399|NCT02374567|Clozapine|clozapine|mesh-list
14106400|NCT02374567|Amisulpride|amisulpride|mesh-list
14106401|NCT02374567|Flupenthixol|flupenthixol|mesh-list
14106402|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14106403|NCT02374567|Perphenazine|perphenazine|mesh-list
13930430|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930431|NCT03375138|Abatacept|abatacept|mesh-list
13930432|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14106404|NCT02374567|Sertindole|sertindole|mesh-list
14106405|NCT02374567|Fluphenazine|fluphenazine|mesh-list
14106406|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
14106407|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14106408|NCT02374567|Sulpiride|sulpiride|mesh-list
14106409|NCT02374567|Thioridazine|thioridazine|mesh-list
14106410|NCT02374567|Pipamperone|pipamperone|mesh-list
14106411|NCT02374567|Clopenthixol|clopenthixol|mesh-list
14106412|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
14106413|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
14106414|NCT02374567|Fluspirilene|fluspirilene|mesh-list
14106415|NCT02374567|Perazine|perazine|mesh-list
14106416|NCT02374567|Bromperidol|bromperidol|mesh-list
14106417|NCT02374567|Benperidol|benperidol|mesh-list
13930433|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930434|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930435|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930436|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
13930437|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930438|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930439|NCT03375112|Bupivacaine|bupivacaine|mesh-list
13930440|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
13930441|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
13930442|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930443|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930444|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
13930445|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930446|NCT03375034|Clonazepam|clonazepam|mesh-list
13930447|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
13930448|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
13930449|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
13930450|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930451|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930452|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930453|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
13930454|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
14106418|NCT02374567|Rivastigmine|rivastigmine|mesh-list
14106419|NCT02374567|Piracetam|piracetam|mesh-list
14106420|NCT02374567|Donepezil|donepezil|mesh-list
14106421|NCT02374567|Galantamine|galantamine|mesh-list
14106422|NCT02374567|Citalopram|citalopram|mesh-list
14106423|NCT02374567|Bupropion|bupropion|mesh-list
14106424|NCT02374567|Sertraline|sertraline|mesh-list
14106425|NCT02374567|Fluoxetine|fluoxetine|mesh-list
14106426|NCT02374567|Paroxetine|paroxetine|mesh-list
14106427|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14106428|NCT02374567|Nortriptyline|nortriptyline|mesh-list
14106429|NCT02374567|Reboxetine|reboxetine|mesh-list
14106430|NCT02374567|Imipramine|imipramine|mesh-list
14106431|NCT02374567|Clomipramine|clomipramine|mesh-list
14106432|NCT02374567|Mianserin|mianserin|mesh-list
14106433|NCT02374567|Moclobemide|moclobemide|mesh-list
14106434|NCT02374567|Opipramol|opipramol|mesh-list
14106435|NCT02374567|Trimipramine|trimipramine|mesh-list
14106436|NCT02374567|Maprotiline|maprotiline|mesh-list
14106437|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
14761688|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106438|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14106439|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14106440|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106441|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106442|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14106443|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14106444|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14106445|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14106446|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
14106447|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
13930455|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13930456|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930457|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13930458|NCT03374839|Nivolumab|nivolumab|mesh-list
13930459|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13930460|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930461|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13930462|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930463|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
13930464|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930465|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930466|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
13930467|NCT03374722|Narcotics|narcotics|mesh-ancestor
13930468|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930469|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930470|NCT03374722|Analgesics|analgesics|mesh-ancestor
13930471|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
13930472|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930473|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
13930474|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
13930475|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13930476|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13930477|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930478|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930479|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14106448|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
14106449|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
14106450|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106451|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106452|NCT02374567|Analgesics|analgesics|mesh-ancestor
14106453|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
14106454|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106455|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
14106456|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14106457|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14106458|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14106459|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14106460|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
14106461|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14106462|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14106463|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
14106464|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14106465|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14106466|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
14106467|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14106468|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14106469|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14106470|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
14106471|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14106472|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14106473|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
14106474|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
14106475|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14106476|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14106477|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
14106478|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
14106479|NCT02374567|Protective Agents|protective agents|mesh-ancestor
14106480|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
14106481|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106482|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14106483|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14106484|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14106485|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106486|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
14106487|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14106488|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14106489|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14106490|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14106491|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14106492|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14106493|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
14106494|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106495|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14106496|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14106497|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106498|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14106499|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
14106500|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
14106501|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14106502|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
14106503|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106504|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14106505|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
14106506|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14106507|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14106508|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14106509|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14106510|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14106511|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14106512|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14106513|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106514|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14106515|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14106516|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14106517|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14106518|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14106519|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14106520|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14106521|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
14106522|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14106523|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14106524|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14106525|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14106526|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14106527|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14106528|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
14106529|NCT02374242|Nivolumab|nivolumab|mesh-list
14106530|NCT02374242|Ipilimumab|ipilimumab|mesh-list
14106531|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14106532|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106533|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14106534|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106535|NCT02374047|Atorvastatin|atorvastatin|mesh-list
14106536|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14106537|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14106538|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
14761689|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
14761690|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14761691|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14761692|NCT03429543|Empagliflozin|empagliflozin|mesh-list
14761693|NCT03429543|Linagliptin|linagliptin|mesh-list
14761694|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13930480|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13930481|NCT03374670|Aflibercept|aflibercept|mesh-list
13930482|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13930483|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13930484|NCT03374670|Growth Substances|growth substances|mesh-ancestor
13930485|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930486|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
13930487|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961056|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13961057|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
13961058|NCT03151005|Metformin|metformin|mesh-list
13961059|NCT03151005|Liraglutide|liraglutide|mesh-list
13961060|NCT03151005|Exenatide|exenatide|mesh-list
13961061|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
13961062|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
13961063|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13961064|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761695|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106539|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106540|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14106541|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14106542|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106543|NCT02373943|Carotenoids|carotenoids|mesh-list
14106544|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
13930488|NCT03374540|Vitamin K|vitamin k|mesh-list
13930489|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
13930490|NCT03374540|Vitamins|vitamins|mesh-ancestor
13930491|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
13930492|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930493|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13930494|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
13930495|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13930496|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
13930497|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930498|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930499|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
13930500|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13930501|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13930502|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
13930503|NCT03374540|Coagulants|coagulants|mesh-ancestor
13930504|NCT03374514|Dexamethasone|dexamethasone|mesh-list
13930505|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106545|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106546|NCT02373943|Protective Agents|protective agents|mesh-ancestor
14106547|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106548|NCT02374008|Dexamethasone|dexamethasone|mesh-list
14106549|NCT02374008|Ketorolac|ketorolac|mesh-list
14106550|NCT02374008|Ropivacaine|ropivacaine|mesh-list
14106551|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106552|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
14106553|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
14106554|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106555|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106556|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106557|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
14106558|NCT02374008|Hormones|hormones|mesh-ancestor
14106559|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106560|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14106561|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106562|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106563|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106564|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106565|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
14106566|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106567|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
14106568|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14106569|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106570|NCT02374008|Analgesics|analgesics|mesh-ancestor
14106571|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106572|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14106573|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
14106574|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
14106575|NCT02374021|Adalimumab|adalimumab|mesh-list
14106576|NCT02374021|Etanercept|etanercept|mesh-list
14106577|NCT02374021|Methotrexate|methotrexate|mesh-list
14106578|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14106579|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
13930506|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
13930507|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
13930508|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930509|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930510|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930511|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
13930512|NCT03374514|Hormones|hormones|mesh-ancestor
13930513|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930514|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13930515|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930516|NCT03374501|PAZ320|paz320|mesh-list
13930517|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930518|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930519|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
14106580|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13930520|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930521|NCT03374345|Mitogens|mitogens|mesh-ancestor
14106581|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930522|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
13930523|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930527|NCT03374306|Atropine|atropine|mesh-list
13930528|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
13930529|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13930530|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13930531|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13930532|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
13930533|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930534|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930535|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13930536|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
13930537|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
13930538|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
13930539|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13930540|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13930541|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
13930542|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930543|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930544|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13930545|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13930546|NCT03374293|Antibodies|antibodies|mesh-list
13930547|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
13930548|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930549|NCT03374280|Cisplatin|cisplatin|mesh-list
13930550|NCT03374280|Pemetrexed|pemetrexed|mesh-list
13930551|NCT03374280|Gefitinib|gefitinib|mesh-list
13930552|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930553|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930554|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930555|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13930556|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13930557|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13930558|NCT03374254|Leucovorin|leucovorin|mesh-list
13930559|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
13930560|NCT03374254|Fluorouracil|fluorouracil|mesh-list
13930561|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
13930562|NCT03374254|Irinotecan|irinotecan|mesh-list
13930563|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930564|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13930565|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930566|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
13930567|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930568|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13930569|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930570|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
13930571|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13930572|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13930573|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930574|NCT03374254|Antidotes|antidotes|mesh-ancestor
13930575|NCT03374254|Protective Agents|protective agents|mesh-ancestor
13930576|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
13930577|NCT03374254|Vitamins|vitamins|mesh-ancestor
13930578|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
14106582|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14106583|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
14106584|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106585|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106586|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106587|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106588|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14106589|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14106590|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
14106591|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106592|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14106593|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106594|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
14106595|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14106596|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13930579|NCT03374228|Linrodostat|linrodostat|mesh-list
13930580|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930581|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106597|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106598|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14106599|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106600|NCT02374021|Analgesics|analgesics|mesh-ancestor
14106601|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
14106602|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106603|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106604|NCT02373735|Mannitol|mannitol|mesh-list
14106605|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14106606|NCT02373735|Diuretics|diuretics|mesh-ancestor
14106607|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
14106608|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106609|NCT02373449|Ketamine|ketamine|mesh-list
14106610|NCT02373449|Analgesics|analgesics|mesh-ancestor
14106611|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
14106612|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106613|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106614|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14106615|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14106616|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
14106617|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
14106618|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106619|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14106620|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14106621|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106622|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106623|NCT02373722|Petrolatum|petrolatum|mesh-list
13930582|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13930583|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13930584|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13930585|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13930586|NCT03374085|Dexamethasone|dexamethasone|mesh-list
13930587|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930588|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
13930589|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
13930590|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930591|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930592|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930593|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
13930594|NCT03374085|Hormones|hormones|mesh-ancestor
13930595|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930596|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13930597|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930598|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13930599|NCT03374007|Antibodies|antibodies|mesh-list
13930600|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
13930601|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13930602|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
13930603|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930604|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930605|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13930606|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13930607|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930608|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
13930609|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13930610|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930611|NCT03373903|Everolimus|everolimus|mesh-list
13930612|NCT03373903|Dactolisib|dactolisib|mesh-list
13930613|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106624|NCT02373722|Mineral Oil|mineral oil|mesh-list
14106625|NCT02373722|Emollients|emollients|mesh-ancestor
14106626|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106627|NCT02373514|Acetaminophen|acetaminophen|mesh-list
14106628|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14106629|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106630|NCT02373514|Analgesics|analgesics|mesh-ancestor
14106631|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
14106632|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106633|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106634|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
14106635|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14106636|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106637|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106638|NCT02373384|Allopurinol|allopurinol|mesh-list
14106639|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
13930614|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930615|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
13930616|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930617|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
13930618|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106640|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930619|NCT03373864|Anesthetics|anesthetics|mesh-list
13930620|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930621|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930622|NCT03373851|Sufentanil|sufentanil|mesh-list
13930623|NCT03373851|Dsuvia|dsuvia|mesh-list
13930624|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13930625|NCT03373851|Narcotics|narcotics|mesh-ancestor
13930626|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930627|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930628|NCT03373851|Analgesics|analgesics|mesh-ancestor
13930629|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
13930630|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930631|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13930632|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13930633|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
13930634|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
13930635|NCT03373825|Fentanyl|fentanyl|mesh-list
14106641|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
14106642|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106643|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
14106644|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106645|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14106646|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
14106647|NCT02373384|Protective Agents|protective agents|mesh-ancestor
14106648|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106649|NCT02373384|Diuretics|diuretics|mesh-ancestor
14106650|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
14106651|NCT02373384|Expectorants|expectorants|mesh-ancestor
14106652|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
14106653|NCT02373579|Methotrexate|methotrexate|mesh-list
14106654|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14106655|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
14106656|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14106657|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106658|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13930636|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13930637|NCT03373825|Narcotics|narcotics|mesh-ancestor
13930638|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930639|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930640|NCT03373825|Analgesics|analgesics|mesh-ancestor
13930641|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
13930642|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930643|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13930644|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13930645|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
13930646|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
13930647|NCT03373708|Tamoxifen|tamoxifen|mesh-list
13930648|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
13930649|NCT03373708|Docetaxel|docetaxel|mesh-list
14106659|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
14106660|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106661|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106662|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
14106663|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106664|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14106665|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14106666|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
13930650|NCT03373708|Letrozole|letrozole|mesh-list
13930651|NCT03373708|Epirubicin|epirubicin|mesh-list
13930652|NCT03373708|Goserelin|goserelin|mesh-list
13930653|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930654|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
13930655|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930656|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930657|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13930658|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
14106667|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930659|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930660|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930661|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13930662|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
13930663|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
13930664|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14106668|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14106669|NCT02373410|Bupivacaine|bupivacaine|mesh-list
14106670|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106671|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
14106672|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106673|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106674|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
14106675|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106676|NCT02373462|Olmesartan|olmesartan|mesh-list
14106677|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
14106678|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14106679|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14106680|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106681|NCT02373241|Losartan|losartan|mesh-list
14106682|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14106683|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14106684|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14106685|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14106686|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106687|NCT02373215|Nalbuphine|nalbuphine|mesh-list
14106688|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14106689|NCT02373215|Narcotics|narcotics|mesh-ancestor
14106690|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106691|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106692|NCT02373215|Analgesics|analgesics|mesh-ancestor
14106693|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
14106694|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106695|NCT02373254|Acetaminophen|acetaminophen|mesh-list
14106696|NCT02373254|Ibuprofen|ibuprofen|mesh-list
14106697|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14106698|NCT02373254|Hydrocodone|hydrocodone|mesh-list
14106699|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106700|NCT02373254|Analgesics|analgesics|mesh-ancestor
14106701|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
14106702|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106703|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106704|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
14106705|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14106706|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106707|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106708|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14106709|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106710|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106711|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14106712|NCT02373254|Narcotics|narcotics|mesh-ancestor
14106713|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106714|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
14106715|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
14106716|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14106717|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14106718|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106719|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106720|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106721|NCT02373033|Folic Acid|folic acid|mesh-list
14106722|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
14106723|NCT02373033|Hematinics|hematinics|mesh-ancestor
14106724|NCT02373033|Vitamins|vitamins|mesh-ancestor
14106725|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
13930665|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13930666|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13930667|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930668|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13930669|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
13930670|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930671|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13930672|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13930673|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13930674|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13930675|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13930676|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13930677|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13930678|NCT03373669|Vaccines|vaccines|mesh-list
13930679|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
13930680|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106726|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106727|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14106728|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
14175530|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175531|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175532|NCT04775563|Vaccines|vaccines|mesh-list
14175533|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
14175534|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175535|NCT04775303|Cyclosporine|cyclosporine|mesh-list
14175536|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14175537|NCT04775303|Cyclosporins|cyclosporins|mesh-list
14175538|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175539|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175540|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14175541|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
14175542|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175543|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
14175544|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175545|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175546|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175547|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14175548|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13930681|NCT03373656|Vaccines|vaccines|mesh-list
13930682|NCT03373656|Immunologic Factors|immunologic factors|mesh-ancestor
13930683|NCT03373656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175549|NCT04775576|Anesthetics|anesthetics|mesh-list
14175550|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175551|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175552|NCT04775381|Vitamin D|vitamin d|mesh-list
14175553|NCT04775381|Vitamins|vitamins|mesh-ancestor
14175554|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
14175555|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175556|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13930684|NCT03373409|Albuterol|albuterol|mesh-list
13930685|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13930686|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
13930687|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930688|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175557|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14175558|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
14175559|NCT04775212|Sevoflurane|sevoflurane|mesh-list
14175560|NCT04775212|Desflurane|desflurane|mesh-list
14175561|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14175562|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14175563|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
14175564|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
14175565|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175566|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175567|NCT04775238|Copper|copper|mesh-list
14175568|NCT04775238|Trace Elements|trace elements|mesh-ancestor
14175569|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
14175570|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175571|NCT04775225|Lidocaine|lidocaine|mesh-list
14175572|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175573|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
14175574|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175575|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175576|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
14175577|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175578|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14175579|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14175580|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14175581|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175582|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183659|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14183660|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
14183661|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
14183662|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183663|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930689|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13930690|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
13930691|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
13930692|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13930693|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13930694|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13930695|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13930696|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
13930697|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930698|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930699|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
13930700|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13930701|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13930702|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13930703|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13930704|NCT03373305|Lenalidomide|lenalidomide|mesh-list
13930705|NCT03373305|Piperidine|piperidine|mesh-list
13930706|NCT03373305|Antibodies|antibodies|mesh-list
13930707|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
13930708|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13930709|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
13930710|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
13930711|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930712|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930713|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13930714|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14106729|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
14106730|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
14106731|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
14106732|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106733|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106734|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106735|NCT02373280|Amoxicillin|amoxicillin|mesh-list
14106736|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
14106737|NCT02373280|Metronidazole|metronidazole|mesh-list
14106738|NCT02373280|Clarithromycin|clarithromycin|mesh-list
14106739|NCT02373280|Esomeprazole|esomeprazole|mesh-list
14106740|NCT02373280|Bismuth|bismuth|mesh-list
14106741|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14106742|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14106743|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106744|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14106745|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14106746|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106747|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106748|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106749|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14106750|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
14106751|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14106752|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106753|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14106754|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14106755|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14106756|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14106757|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14106758|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14106759|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106760|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14106761|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14106762|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14106763|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14106764|NCT02373280|Antacids|antacids|mesh-ancestor
14106765|NCT02372942|Progesterone|progesterone|mesh-list
14106766|NCT02372942|Progestins|progestins|mesh-ancestor
14106767|NCT02372942|Hormones|hormones|mesh-ancestor
14106768|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106769|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106770|NCT02373163|Amlodipine|amlodipine|mesh-list
14106771|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14106772|NCT02373163|Telmisartan|telmisartan|mesh-list
14106773|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14106774|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13930715|NCT03373305|Growth Substances|growth substances|mesh-ancestor
13930716|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
14106775|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930717|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13930718|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930719|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930720|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13930721|NCT03373266|Sevoflurane|sevoflurane|mesh-list
13930722|NCT03373266|Isoflurane|isoflurane|mesh-list
13930723|NCT03373266|Anesthetics|anesthetics|mesh-list
13930724|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13930725|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13930726|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
13930727|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930728|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930729|NCT03373227|Tacrolimus|tacrolimus|mesh-list
13930730|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930731|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
13930732|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930733|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13930734|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930735|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930736|NCT03373149|Hormones|hormones|mesh-list
13930737|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
13930738|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930739|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930740|NCT03372967|Vaccines|vaccines|mesh-list
13930741|NCT03372967|Immunologic Factors|immunologic factors|mesh-ancestor
13930742|NCT03372967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930743|NCT03372850|Esomeprazole|esomeprazole|mesh-list
13930744|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13930745|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930746|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13930747|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930748|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930749|NCT03372837|Rituximab|rituximab|mesh-list
13930750|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13930751|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930752|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
14106776|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106777|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14106778|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106779|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
14106780|NCT02373163|Diuretics|diuretics|mesh-ancestor
14106781|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
14106782|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14106783|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14106784|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14106785|NCT02372903|Palmidrol|palmidrol|mesh-list
14106786|NCT02372903|Analgesics|analgesics|mesh-ancestor
14106787|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
14106788|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106789|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106790|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14106791|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14106792|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106793|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14106794|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
14106795|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106796|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14106797|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14106798|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106799|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106800|NCT02372903|Hormones|hormones|mesh-ancestor
14106801|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106802|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
14106803|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14106804|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106805|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106806|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106807|NCT02372916|Ranibizumab|ranibizumab|mesh-list
14106808|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14106809|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14761696|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14761697|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761698|NCT03429543|Incretins|incretins|mesh-ancestor
14761699|NCT03429543|Hormones|hormones|mesh-ancestor
14761700|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930753|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930754|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930755|NCT03372785|Aspirin|aspirin|mesh-list
13930756|NCT03372785|Metoprolol|metoprolol|mesh-list
13930757|NCT03372785|Clopidogrel|clopidogrel|mesh-list
13930758|NCT03372785|Ticagrelor|ticagrelor|mesh-list
13930759|NCT03372785|Atorvastatin|atorvastatin|mesh-list
13930760|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13930761|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13930762|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13930763|NCT03372785|Analgesics|analgesics|mesh-ancestor
13930764|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
13930765|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930766|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930767|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930768|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930769|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13930770|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13930771|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930772|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13930773|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13930774|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930775|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
13930776|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13930777|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13930778|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
13930779|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13930780|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13930781|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13930782|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13930783|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13930784|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
13930785|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930786|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13930787|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13930788|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
14761701|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14761702|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
14761703|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106810|NCT02372916|Growth Substances|growth substances|mesh-ancestor
14106811|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106812|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
14106813|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106814|NCT02372526|Orlistat|orlistat|mesh-list
14106815|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106816|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106817|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13930789|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
13930790|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13930791|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13930792|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13930793|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
13961065|NCT03151005|Incretins|incretins|mesh-ancestor
13961066|NCT03151005|Hormones|hormones|mesh-ancestor
13961067|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961068|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13961069|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13961070|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13961071|NCT03151239|Niacinamide|niacinamide|mesh-list
13961072|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
13961073|NCT03151239|Vitamins|vitamins|mesh-ancestor
14106818|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14106819|NCT02372656|Metformin|metformin|mesh-list
14106820|NCT02372656|Simvastatin|simvastatin|mesh-list
14106821|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14106822|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106823|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14106824|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14761704|NCT03412565|Dexamethasone|dexamethasone|mesh-list
14761705|NCT03412565|Prednisone|prednisone|mesh-list
14106825|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
14175583|NCT04774822|Mydriatics|mydriatics|mesh-list
13930794|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
14106826|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106827|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13930795|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930796|NCT03372486|Bupivacaine|bupivacaine|mesh-list
13930797|NCT03372486|Naloxone|naloxone|mesh-list
13930798|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
13930799|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
13930800|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930801|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930802|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
13930803|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930804|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13930805|NCT03372473|Loratadine|loratadine|mesh-list
13930806|NCT03372473|Montelukast|montelukast|mesh-list
13930807|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13930808|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
13930809|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13930810|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
13930811|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930812|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930813|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13930814|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13930815|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930816|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
13930817|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
13930818|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13930819|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14106828|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14106829|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930820|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13930821|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
13930822|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
13930823|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930824|NCT03372447|Thiamine|thiamine|mesh-list
13930825|NCT03372447|Pyridoxine|pyridoxine|mesh-list
13930826|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
13930827|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
13930828|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
13930829|NCT03372447|Vitamins|vitamins|mesh-ancestor
13930830|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
13930831|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106830|NCT02372591|Buprenorphine|buprenorphine|mesh-list
14106831|NCT02372591|Hydromorphone|hydromorphone|mesh-list
14106832|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14106833|NCT02372591|Narcotics|narcotics|mesh-ancestor
14106834|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106835|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106836|NCT02372591|Analgesics|analgesics|mesh-ancestor
14106837|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
14106838|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106839|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14106840|NCT02372786|Lidocaine|lidocaine|mesh-list
14106841|NCT02372786|Tetracaine|tetracaine|mesh-list
14106842|NCT02372786|Prilocaine|prilocaine|mesh-list
14106843|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106844|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
14106845|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106846|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106847|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
14106848|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106849|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14106850|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14106851|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14106852|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14106853|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106854|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
14106855|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106856|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
14106857|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14106858|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14106859|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930832|NCT03372447|Hematinics|hematinics|mesh-ancestor
13930833|NCT03372304|Ropivacaine|ropivacaine|mesh-list
13930834|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
13930835|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
14106860|NCT02372487|Urological Agents|urological agents|mesh-ancestor
14106861|NCT02372669|Chitosan|chitosan|mesh-list
14106862|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14106863|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14106864|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
14106865|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106866|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14106867|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
14106868|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
14106869|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
14106870|NCT02372669|Coagulants|coagulants|mesh-ancestor
14106871|NCT02372760|Lidocaine|lidocaine|mesh-list
14106872|NCT02372760|Anesthetics|anesthetics|mesh-list
13930836|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930837|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930838|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
13930839|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930840|NCT03372265|Ropivacaine|ropivacaine|mesh-list
13930841|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
13930842|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
14106873|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
14106874|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14106875|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106876|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
14106877|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930843|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13930844|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930845|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
13930846|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930847|NCT03372239|Tryptophan|tryptophan|mesh-list
13930848|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13930849|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
13930850|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13930851|NCT03372200|Febuxostat|febuxostat|mesh-list
13930852|NCT03372200|Dotinurad|dotinurad|mesh-list
13930853|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
13930854|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930855|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
13930856|NCT03372200|Renal Agents|renal agents|mesh-ancestor
13930857|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
13930858|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13930859|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13930860|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13930861|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
13930862|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
13930863|NCT03372109|Calcium|calcium|mesh-list
13930864|NCT03372109|Turmeric extract|turmeric extract|mesh-list
13930865|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13930866|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930867|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
13930868|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930869|NCT03372109|Protective Agents|protective agents|mesh-ancestor
13930870|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
14106878|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14106879|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14106880|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14106881|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14106882|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106883|NCT02372461|Amoxicillin|amoxicillin|mesh-list
14106884|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14106885|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106886|NCT02372812|Dexamethasone|dexamethasone|mesh-list
14106887|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106888|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
13930871|NCT03371992|Nivolumab|nivolumab|mesh-list
13930872|NCT03371992|Atezolizumab|atezolizumab|mesh-list
13930873|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13930874|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930875|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13930876|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930877|NCT03371953|Atracurium|atracurium|mesh-list
13930878|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
13930879|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13930880|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13930881|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14106889|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
14106890|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930882|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930883|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930884|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14106891|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106892|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106893|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
14106894|NCT02372812|Hormones|hormones|mesh-ancestor
14106895|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106896|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14106897|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106898|NCT02372604|Cetirizine|cetirizine|mesh-list
13930885|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13930886|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
13930887|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930888|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930889|NCT03371862|Liraglutide|liraglutide|mesh-list
13930890|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13930891|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930892|NCT03371862|Incretins|incretins|mesh-ancestor
13930893|NCT03371862|Hormones|hormones|mesh-ancestor
13930894|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930895|NCT03371849|Montelukast|montelukast|mesh-list
13930896|NCT03371849|Levocetirizine|levocetirizine|mesh-list
13930897|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13930898|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
13930899|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13930900|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
14106899|NCT02372604|Levocetirizine|levocetirizine|mesh-list
14106900|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14106901|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14106902|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
14106903|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
13930901|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930902|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930903|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13930904|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13930905|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930906|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13930907|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13930908|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
13930909|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
13930910|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930911|NCT03371797|Amlodipine|amlodipine|mesh-list
13930912|NCT03371797|Valsartan|valsartan|mesh-list
13930913|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14106904|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106905|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106906|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106907|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14106908|NCT02372110|Caffeine|caffeine|mesh-list
14106909|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14106910|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106911|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14106912|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13930914|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13930915|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930916|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930917|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13930918|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930919|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
13930920|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13930921|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13930922|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
13930923|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930924|NCT03371589|Dexamethasone|dexamethasone|mesh-list
13930925|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930926|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
13930927|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
13930928|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930929|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930930|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930931|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
14106913|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106914|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14106915|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14106916|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
14106917|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106918|NCT02372240|Dexamethasone|dexamethasone|mesh-list
14106919|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106920|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
14106921|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
14106922|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106923|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930932|NCT03371589|Hormones|hormones|mesh-ancestor
13930933|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13930934|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14106924|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106925|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
14106926|NCT02372240|Hormones|hormones|mesh-ancestor
14106927|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106928|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14106929|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106930|NCT02372188|Caffeine|caffeine|mesh-list
14106931|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14106932|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106933|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14106934|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106935|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106936|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14106937|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14106938|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
14106939|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14106940|NCT02372292|Furosemide|furosemide|mesh-list
14106941|NCT02372292|Diuretics|diuretics|mesh-ancestor
14106942|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
14106943|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106944|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14106945|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14106946|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106947|NCT02372318|Nalmefene|nalmefene|mesh-list
14106948|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14106949|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106950|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
14106951|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14106952|NCT02372357|Posaconazole|posaconazole|mesh-list
14106953|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
14106954|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14106955|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13930935|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930936|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13930937|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13930938|NCT03371550|Docetaxel|docetaxel|mesh-list
13930939|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930940|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
13930941|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
13930942|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
13930943|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930944|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
13930945|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13930946|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13930947|NCT03371498|Prednisolone|prednisolone|mesh-list
13930948|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
13930949|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13930950|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
13930951|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13930952|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
13930953|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
13930954|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930955|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930956|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930957|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
13930958|NCT03371498|Hormones|hormones|mesh-ancestor
13930959|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106956|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13930960|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13930961|NCT03371498|Protective Agents|protective agents|mesh-ancestor
13930962|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13930963|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106957|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14106958|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14106959|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14106960|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14106961|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106962|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14106963|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
14106964|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14106965|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106966|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
14106967|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14106968|NCT02372149|Antibodies|antibodies|mesh-list
14106969|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
14106970|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14106971|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
14106972|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106973|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
14106974|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14106975|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
14106976|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106977|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14106978|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14106979|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
14106980|NCT02371993|Choline|choline|mesh-list
14106981|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
14106982|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14106983|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
14106984|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14106985|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14106986|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14106987|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
14106988|NCT02371577|Lenalidomide|lenalidomide|mesh-list
14106989|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
14106990|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14106991|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14106992|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14106993|NCT02371577|Growth Substances|growth substances|mesh-ancestor
14106994|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
13930964|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13930965|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13930966|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13930967|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930968|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13930969|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930970|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930971|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
13930972|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13930973|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
13930974|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13930975|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930976|NCT03371173|Ferric maltol|ferric maltol|mesh-list
13930977|NCT03371173|Hematinics|hematinics|mesh-ancestor
13930978|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
13930979|NCT03371095|Infliximab|infliximab|mesh-list
13930980|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13930981|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
13930982|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930983|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13930984|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13930985|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
14106995|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14106996|NCT02371603|Pioglitazone|pioglitazone|mesh-list
14106997|NCT02371603|Trimethoprim|trimethoprim|mesh-list
14106998|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14106999|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14107000|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13930986|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930987|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13930988|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14107001|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
14175584|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
14107002|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107003|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14107004|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14107005|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107006|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14107007|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107008|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14107009|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13930989|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
13930990|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13930991|NCT03371069|Methylphenidate|methylphenidate|mesh-list
13930992|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13930993|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13930994|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13930995|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13930996|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13930997|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13930998|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
13930999|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961074|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
13961075|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961076|NCT03150680|Clopidogrel|clopidogrel|mesh-list
13961077|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13961078|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13961079|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13961080|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13961081|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
13961082|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961083|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961084|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961085|NCT03150706|Avelumab|avelumab|mesh-list
13961086|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961087|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961088|NCT03150771|Aripiprazole|aripiprazole|mesh-list
13961089|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
13961090|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961091|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13961092|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961093|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961094|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961095|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
13961096|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
13961097|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961098|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961099|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13961100|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13961101|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
13961102|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13961103|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13961104|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13961105|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13961106|NCT03150576|Paclitaxel|paclitaxel|mesh-list
13961107|NCT03150576|Carboplatin|carboplatin|mesh-list
13961108|NCT03150576|Olaparib|olaparib|mesh-list
13961109|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14107010|NCT02371603|Renal Agents|renal agents|mesh-ancestor
14107011|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
14107012|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14107013|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14107014|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14107015|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14107016|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13961110|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961111|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
13961112|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
13961113|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
13961114|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961115|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14107017|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14107018|NCT02371590|Lenalidomide|lenalidomide|mesh-list
14107019|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
14107020|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
14107021|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107022|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13931000|NCT03371043|Analgesics|analgesics|mesh-list
13931001|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
13931002|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931003|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931004|NCT03370848|Aspirin|aspirin|mesh-list
13931005|NCT03370848|Psyllium|psyllium|mesh-list
13931006|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13931007|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13931008|NCT03370848|Analgesics|analgesics|mesh-ancestor
13931009|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
13931010|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931011|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931012|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931013|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931014|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13931015|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931016|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931017|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13931018|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13931019|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931020|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
13931021|NCT03370848|Cathartics|cathartics|mesh-ancestor
13931022|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931023|NCT03370835|Metoprolol|metoprolol|mesh-list
13931024|NCT03370835|Carvedilol|carvedilol|mesh-list
13931025|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13931026|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13931027|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
13931028|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
13931029|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931030|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931031|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13931032|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13931033|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13931034|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
13931035|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931036|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931037|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
13931038|NCT03370835|Protective Agents|protective agents|mesh-ancestor
13931039|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13931040|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13931041|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13931042|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
13931043|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13931044|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13931045|NCT03370783|Ethanol|ethanol|mesh-list
13931046|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13931047|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931048|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931049|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931050|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
13931051|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
13931052|NCT03370705|Captopril|captopril|mesh-list
13931053|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13931054|NCT03370705|Atorvastatin|atorvastatin|mesh-list
13931055|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13931056|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13931057|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13931058|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
13931059|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931060|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13931061|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13931062|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931063|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
13931064|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13931065|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
13931066|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13931067|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931068|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931069|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931070|NCT03370705|Analgesics|analgesics|mesh-ancestor
13931071|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
13931072|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477770|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477771|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961116|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107023|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14107024|NCT02371590|Growth Substances|growth substances|mesh-ancestor
14107025|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
14107026|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107027|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107028|NCT02371473|Acetazolamide|acetazolamide|mesh-list
14107029|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
14107030|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14107031|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107032|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107033|NCT02371473|Diuretics|diuretics|mesh-ancestor
14107034|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
14107035|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107036|NCT02371421|Allopurinol|allopurinol|mesh-list
14107037|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
14107038|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107039|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107040|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
14107041|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107042|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14107043|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
14107044|NCT02371421|Protective Agents|protective agents|mesh-ancestor
14107045|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107046|NCT02371408|Ribavirin|ribavirin|mesh-list
14107047|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
14107048|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
14107049|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107050|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
14107051|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107052|NCT02371226|Insulin|insulin|mesh-list
14107053|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14107054|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14107055|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175585|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175586|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175587|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
14175588|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175589|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
14761706|NCT03412565|Lenalidomide|lenalidomide|mesh-list
14761707|NCT03412565|Bortezomib|bortezomib|mesh-list
14761708|NCT03412565|Melphalan|melphalan|mesh-list
13931073|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13931074|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13931075|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931076|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761709|NCT03412565|Daratumumab|daratumumab|mesh-list
14761710|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761711|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
14761712|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
14761713|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761714|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761715|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14761716|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
13931077|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14107056|NCT02371304|Capecitabine|capecitabine|mesh-list
14107057|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14107058|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
14107059|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107060|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107061|NCT02371096|Rituximab|rituximab|mesh-list
14107062|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107063|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107064|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
14107065|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107066|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107067|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14107068|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
14107069|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107070|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107071|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107072|NCT02371148|Rituximab|rituximab|mesh-list
14107073|NCT02371148|Bortezomib|bortezomib|mesh-list
14107074|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14107075|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107076|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107077|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
14107078|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107079|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107080|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14107081|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
14107082|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107083|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
14107084|NCT02370862|Neostigmine|neostigmine|mesh-list
14107085|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14107086|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107087|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107088|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
14107089|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107090|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107091|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14107092|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
14107093|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761717|NCT03412565|Hormones|hormones|mesh-ancestor
14761718|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931078|NCT03370627|Antibodies|antibodies|mesh-list
13931079|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
13931080|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931081|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
13931082|NCT03370601|Azathioprine|azathioprine|mesh-list
13931083|NCT03370601|Infliximab|infliximab|mesh-list
13931084|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
13931085|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931086|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931087|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
13931088|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931089|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931090|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931091|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931092|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
13931093|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931094|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14761719|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761720|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107094|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14107095|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14107096|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14107097|NCT02370680|Aspirin|aspirin|mesh-list
14107098|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14107099|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107100|NCT02370680|Analgesics|analgesics|mesh-ancestor
14107101|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
14107102|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107103|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107104|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107105|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107106|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14107107|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931095|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931096|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
13931097|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13931098|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931099|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931100|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13931101|NCT03370588|Analgesics|analgesics|mesh-ancestor
13931102|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
13931103|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931104|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13931105|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13931106|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13931107|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
13931108|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931109|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931110|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
13931111|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13931112|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931113|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931114|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107108|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107109|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14107110|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14107111|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107112|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
14107113|NCT02370745|Insulin|insulin|mesh-list
14107114|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14107115|NCT02370745|Incretins|incretins|mesh-list
14107116|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14107117|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107118|NCT02370745|Hormones|hormones|mesh-ancestor
14107119|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107120|NCT02370758|Valganciclovir|valganciclovir|mesh-list
14107121|NCT02370758|Ganciclovir|ganciclovir|mesh-list
13931115|NCT03370562|Analgesics|analgesics|mesh-ancestor
13931116|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
13931117|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931118|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13931119|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13931120|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13931121|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107122|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14107123|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
14107124|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107125|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14107126|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107127|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107128|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
14107129|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107130|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107131|NCT02370550|Cyclosporine|cyclosporine|mesh-list
13931122|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931123|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931124|NCT03370406|Fluorouracil|fluorouracil|mesh-list
13931125|NCT03370406|Imiquimod|imiquimod|mesh-list
13931126|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
13931127|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931128|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931129|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107132|NCT02370550|Prednisone|prednisone|mesh-list
13931130|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931131|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
13931132|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931133|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13931134|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
14107133|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
14107134|NCT02370550|Calcium|calcium|mesh-list
14107135|NCT02370550|Cyclosporins|cyclosporins|mesh-list
14107136|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14107137|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107138|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107139|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
14107140|NCT02370550|Hormones|hormones|mesh-ancestor
14107141|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107142|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14107143|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107144|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107145|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931135|NCT03370380|Aflibercept|aflibercept|mesh-list
13931136|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13931137|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13931138|NCT03370380|Growth Substances|growth substances|mesh-ancestor
13931139|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107146|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107147|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
14107148|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
14107149|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107150|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14107151|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107152|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14107153|NCT02370550|Antacids|antacids|mesh-ancestor
14107154|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14107155|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
14107156|NCT02370433|Neostigmine|neostigmine|mesh-list
14107157|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14107158|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107159|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107160|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
14107161|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107162|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107163|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14107164|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
14107165|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107166|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14107167|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14107168|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14107169|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14107170|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
14107171|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107172|NCT02369978|Benzonidazole|benzonidazole|mesh-list
14107173|NCT02369978|Nifurtimox|nifurtimox|mesh-list
13931140|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
13931141|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931142|NCT03370367|Tretinoin|tretinoin|mesh-list
13931143|NCT03370367|Isotretinoin|isotretinoin|mesh-list
13931144|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931145|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
13931146|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
13931147|NCT03370328|Peppermint oil|peppermint oil|mesh-list
13931148|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
13931149|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
13931150|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931151|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931152|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931153|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
13931154|NCT03370276|Nivolumab|nivolumab|mesh-list
13931155|NCT03370276|Cetuximab|cetuximab|mesh-list
13931156|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13931157|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931158|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13931159|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931160|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
14107174|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107175|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
13931161|NCT03370159|Docetaxel|docetaxel|mesh-list
13931162|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107176|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107177|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14107178|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14107179|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14107180|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107181|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14107182|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
14107183|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14107184|NCT02369965|Ritonavir|ritonavir|mesh-list
14107185|NCT02369965|Lopinavir|lopinavir|mesh-list
14107186|NCT02369965|Tenofovir|tenofovir|mesh-list
14107187|NCT02369965|Lamivudine|lamivudine|mesh-list
14107188|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14107189|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14107190|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
14107191|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107192|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107193|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14107194|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14107195|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
14107196|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107197|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14107198|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14107199|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14107200|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14107201|NCT02369939|Fluorouracil|fluorouracil|mesh-list
14107202|NCT02369939|Mitomycins|mitomycins|mesh-list
14107203|NCT02369939|Mitomycin|mitomycin|mesh-list
14107204|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
14107205|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931163|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
13931164|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
13931165|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
13931166|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931167|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
13931168|NCT03370159|Protective Agents|protective agents|mesh-ancestor
13931169|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931170|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
13931171|NCT03370159|Vitamins|vitamins|mesh-ancestor
13931172|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
14107206|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14107207|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107208|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107209|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
14107210|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107211|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14107212|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
14107213|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14107214|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107215|NCT02369822|Ascorbic Acid|ascorbic acid|mesh-list
14107216|NCT02369822|Vitamins|vitamins|mesh-ancestor
14107217|NCT02369822|Micronutrients|micronutrients|mesh-ancestor
14107218|NCT02369822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107219|NCT02369822|Antioxidants|antioxidants|mesh-ancestor
14761721|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
14761722|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14761723|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14761724|NCT03412565|Growth Substances|growth substances|mesh-ancestor
14761725|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
14761726|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14761727|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
14761728|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931173|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
13931174|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14107220|NCT02369822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107221|NCT02369822|Protective Agents|protective agents|mesh-ancestor
14107222|NCT02369549|Curcumin|curcumin|mesh-list
14107223|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14107224|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13931175|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13931176|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13931177|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14107225|NCT02369549|Analgesics|analgesics|mesh-ancestor
14107226|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
14107227|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107228|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931178|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107229|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107230|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107231|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107232|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107233|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107234|NCT02369523|Bupivacaine|bupivacaine|mesh-list
14107235|NCT02369523|Ropivacaine|ropivacaine|mesh-list
14107236|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
14107237|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
14107238|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107239|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107240|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
14107241|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107242|NCT02369406|Lamivudine|lamivudine|mesh-list
14107243|NCT02369406|Zidovudine|zidovudine|mesh-list
14107244|NCT02369406|Nevirapine|nevirapine|mesh-list
14107245|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14107246|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14107247|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107248|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107249|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
14107250|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107251|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14107252|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14107253|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
14107254|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14107255|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14107256|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
14107257|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14107258|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
14107259|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107260|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
14107261|NCT02369380|Protective Agents|protective agents|mesh-ancestor
14175590|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
14175591|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175592|NCT04774627|Olaparib|olaparib|mesh-list
14175593|NCT04774627|Niraparib|niraparib|mesh-list
14175594|NCT04774627|Veliparib|veliparib|mesh-list
14175595|NCT04774627|Talazoparib|talazoparib|mesh-list
14175596|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14175597|NCT04774627|Rucaparib|rucaparib|mesh-list
14175598|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175599|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175600|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175601|NCT04775329|Rifaximin|rifaximin|mesh-list
14175602|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14175603|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175604|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175605|NCT04774029|Lidocaine|lidocaine|mesh-list
14175606|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175607|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
14175608|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175609|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175610|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
13931179|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
13931180|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931181|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931182|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13931183|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931184|NCT03369964|Atezolizumab|atezolizumab|mesh-list
13931185|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
13931186|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931187|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13931188|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
13931189|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
13931190|NCT03369847|Budesonide|budesonide|mesh-list
13931191|NCT03369847|Beclomethasone|beclomethasone|mesh-list
13931192|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931193|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13931194|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
13931195|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931196|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931197|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13931198|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
13931199|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
14175611|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175612|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13931200|NCT03369847|Hormones|hormones|mesh-ancestor
13931201|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931202|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
13931203|NCT03369808|Vaccines|vaccines|mesh-list
13931204|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
13931205|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931206|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13931207|NCT03369808|Antacids|antacids|mesh-ancestor
13931208|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931209|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931210|NCT03369795|Methotrexate|methotrexate|mesh-list
14107262|NCT02369133|Acetaminophen|acetaminophen|mesh-list
14107263|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107264|NCT02369133|Analgesics|analgesics|mesh-ancestor
14107265|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
14107266|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107267|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107268|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
14107269|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14107270|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14107271|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14107272|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
14107273|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107274|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14107275|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14107276|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107277|NCT02369146|UB-421|ub-421|mesh-list
14107278|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14107279|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
14107280|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107281|NCT02369081|Bisoprolol|bisoprolol|mesh-list
14107282|NCT02369081|Doxazosin|doxazosin|mesh-list
14107283|NCT02369081|Spironolactone|spironolactone|mesh-list
14107284|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14107285|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14107286|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107287|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107288|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14107289|NCT02369081|Diuretics|diuretics|mesh-ancestor
14107290|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
14107291|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14107292|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
14107293|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
14107294|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107295|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14107296|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14107297|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14107298|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107299|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107300|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107301|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14107302|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14107303|NCT02368860|Capecitabine|capecitabine|mesh-list
14107304|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
14107305|NCT02368860|Irinotecan|irinotecan|mesh-list
14107306|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14107307|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
14107308|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107309|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107310|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14107311|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14107312|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107313|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14107314|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
14107315|NCT02368730|Coagulants|coagulants|mesh-ancestor
14107316|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14107317|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
14107318|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107319|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14107320|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14107321|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
14107322|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13931211|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14107323|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
14107324|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13931212|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
13931213|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13931214|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931215|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931216|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
13931217|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931218|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931219|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
13931220|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931221|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13931222|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931223|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
13931224|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931225|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13931226|NCT03369782|Rocuronium|rocuronium|mesh-list
13931227|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13931228|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13931229|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13931230|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931231|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931232|NCT03369574|Reslizumab|reslizumab|mesh-list
13931233|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13931234|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
13931235|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
13931236|NCT03369379|Vitamins|vitamins|mesh-ancestor
13931237|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
13931238|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931239|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13931240|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13931241|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
13931242|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
13931243|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961117|NCT03150667|Clopidogrel|clopidogrel|mesh-list
13961118|NCT03150667|Ticagrelor|ticagrelor|mesh-list
13961119|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13961120|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13961121|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13961122|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13961123|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
13961124|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961125|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961126|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961127|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
13961128|NCT03150836|Durvalumab|durvalumab|mesh-list
13961129|NCT03150836|Tremelimumab|tremelimumab|mesh-list
13961130|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961131|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961132|NCT03150316|Dexamethasone|dexamethasone|mesh-list
13961133|NCT03150316|Lenalidomide|lenalidomide|mesh-list
13961134|NCT03150316|CKD-581|ckd-581|mesh-list
13961135|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13961136|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
13961137|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
13961138|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961139|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107325|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107326|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14107327|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14107328|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107329|NCT02368795|Indomethacin|indomethacin|mesh-list
14107330|NCT02368795|Isosorbide|isosorbide|mesh-list
14107331|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14107332|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14107333|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14107334|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107335|NCT02368795|Analgesics|analgesics|mesh-ancestor
14107336|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
14107337|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107338|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107339|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107340|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107341|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
13961140|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961141|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
14761729|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13961142|NCT03150316|Hormones|hormones|mesh-ancestor
14107342|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
14107343|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14107344|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14107345|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107346|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107347|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14107348|NCT02368795|Diuretics|diuretics|mesh-ancestor
14107349|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
14107350|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
14107351|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14107352|NCT02368717|Mesalamine|mesalamine|mesh-list
14107353|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14107354|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107355|NCT02368717|Analgesics|analgesics|mesh-ancestor
14107356|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
14107357|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107358|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107359|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107360|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107361|NCT02368743|Mesalamine|mesalamine|mesh-list
14107362|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14107363|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107364|NCT02368743|Analgesics|analgesics|mesh-ancestor
14107365|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
14107366|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107367|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107368|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107369|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107370|NCT02368665|Amlodipine|amlodipine|mesh-list
14107371|NCT02368665|Candesartan|candesartan|mesh-list
14107372|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
14107373|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14107374|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14107375|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14107376|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107377|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14107378|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107379|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
14107380|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14107381|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14107382|NCT02368652|Amlodipine|amlodipine|mesh-list
14107383|NCT02368652|Candesartan|candesartan|mesh-list
14107384|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
14107385|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14107386|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14107387|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14107388|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107389|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14107390|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107391|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
14107392|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14107393|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14107394|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
13931244|NCT03369262|Atosiban|atosiban|mesh-list
13931245|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
13931246|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931247|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931248|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
13931249|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13931250|NCT03369119|Montelukast|montelukast|mesh-list
13931251|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13931252|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
13931253|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13931254|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
13931255|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931256|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931257|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13931258|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13931259|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931260|NCT03369093|Amoxicillin|amoxicillin|mesh-list
13931261|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14107395|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14107396|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107397|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107398|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107399|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14107400|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13931262|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931263|NCT03369067|Insulin|insulin|mesh-list
13931264|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13931265|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931266|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107401|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107402|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
14107403|NCT02368561|Hylan|hylan|mesh-list
14107404|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14107405|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
14107406|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107407|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
14107408|NCT02368561|Protective Agents|protective agents|mesh-ancestor
14107409|NCT02368288|Entecavir|entecavir|mesh-list
14107410|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
14107411|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107412|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
14107413|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
14107414|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14107415|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
14107416|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107417|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107418|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14107419|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
14107420|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14107421|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
14107422|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107423|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107424|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14107425|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
14107426|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
14107427|NCT02368171|Protective Agents|protective agents|mesh-ancestor
14107428|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
14107429|NCT02368054|Epinephrine|epinephrine|mesh-list
14107430|NCT02368054|Racepinephrine|racepinephrine|mesh-list
14107431|NCT02368054|Bupivacaine|bupivacaine|mesh-list
14107432|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
14107433|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
14107434|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
14107435|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107436|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931267|NCT03369015|Amphetamine|amphetamine|mesh-list
13931268|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
13931269|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13931270|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107437|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
14107438|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107439|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14107440|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14107441|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107442|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107443|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107444|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14107445|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14107446|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
14107447|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14107448|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
14107449|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
14107450|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
14107451|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13931271|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
13931272|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
13931273|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931274|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
13931275|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931276|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107452|NCT02368379|Metyrapone|metyrapone|mesh-list
14107453|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
14107454|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107455|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107456|NCT02368015|Cefazolin|cefazolin|mesh-list
13931277|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107457|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14107458|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107459|NCT02368197|Paclitaxel|paclitaxel|mesh-list
14107460|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14107461|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107462|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
14107463|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
14107464|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
14107465|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107466|NCT02368249|Terlipressin|terlipressin|mesh-list
14107467|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14107468|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14107469|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
14107470|NCT02367937|Midazolam|midazolam|mesh-list
14107471|NCT02367937|Omeprazole|omeprazole|mesh-list
14107472|NCT02367937|Simvastatin|simvastatin|mesh-list
14107473|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14107474|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14107475|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107476|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107477|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14107478|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14107479|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14107480|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14107481|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
14107482|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
14107483|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
14107484|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
14107485|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107486|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107487|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13931278|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13931279|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13931280|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13931281|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13931282|NCT03369002|Seladelpar|seladelpar|mesh-list
13931283|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13931284|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
13931285|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931286|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13931287|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13931288|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931289|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
13931290|NCT03368794|Narcotics|narcotics|mesh-ancestor
13931291|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931292|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931293|NCT03368794|Analgesics|analgesics|mesh-ancestor
13931294|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
13931295|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931296|NCT03368664|Interferons|interferons|mesh-list
13931297|NCT03368664|Acyclovir|acyclovir|mesh-list
13931298|NCT03368664|Interferon-beta|interferon-beta|mesh-list
13931299|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
13931300|NCT03368664|Prednisolone|prednisolone|mesh-list
13931301|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
13931302|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
13931303|NCT03368664|Ranitidine|ranitidine|mesh-list
13931304|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
13931305|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
13931306|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931307|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
13931308|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931309|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931310|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
13931311|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
13931312|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931313|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931314|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931315|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
13931316|NCT03368664|Hormones|hormones|mesh-ancestor
14107488|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14107489|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
14477772|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13931317|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931318|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13931319|NCT03368664|Protective Agents|protective agents|mesh-ancestor
14107490|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14107491|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14107492|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107493|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14107494|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14107495|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14107496|NCT02367937|Analgesics|analgesics|mesh-ancestor
14107497|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
14107498|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107499|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14107500|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107501|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761730|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931320|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13931321|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13931322|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13931323|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
13931324|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931325|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931326|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13931327|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13931328|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
13931329|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
13931330|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931331|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931332|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13931333|NCT03368547|Edetic Acid|edetic acid|mesh-list
13931334|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13931335|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
14107502|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107503|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14107504|NCT02367924|Trabectedin|trabectedin|mesh-list
14107505|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14107506|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
14107507|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107508|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107509|NCT02367807|Tenofovir|tenofovir|mesh-list
14107510|NCT02367807|Emtricitabine|emtricitabine|mesh-list
14107511|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
14107512|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107513|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14107514|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14107515|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107516|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107517|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14107518|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14107519|NCT02367755|Lorazepam|lorazepam|mesh-list
14107520|NCT02367755|Propofol|propofol|mesh-list
14107521|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14107522|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107523|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107524|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14107525|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
14107526|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
14107527|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
14107528|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
14107529|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
14107530|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107531|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14107532|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14107533|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14107534|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14107535|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
13931336|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
13931337|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107536|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
14761731|NCT03407144|Prednisone|prednisone|mesh-list
14761732|NCT03407144|Prednisolone|prednisolone|mesh-list
14761733|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
14761734|NCT03407144|Dacarbazine|dacarbazine|mesh-list
14761735|NCT03407144|Doxorubicin|doxorubicin|mesh-list
14761736|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
14761737|NCT03407144|Etoposide|etoposide|mesh-list
14761738|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
14761739|NCT03407144|Vincristine|vincristine|mesh-list
14761740|NCT03407144|Bleomycin|bleomycin|mesh-list
14107537|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761741|NCT03407144|Vinblastine|vinblastine|mesh-list
14761742|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761743|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
13931338|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
13931339|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13931340|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13931341|NCT03368430|Melatonin|melatonin|mesh-list
13931342|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
13931343|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931344|NCT03368430|Protective Agents|protective agents|mesh-ancestor
13931345|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931346|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931347|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13931348|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13931349|NCT03368391|Lidocaine|lidocaine|mesh-list
13931350|NCT03368391|Phenylephrine|phenylephrine|mesh-list
14477773|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477774|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477775|NCT02438787|Golimumab|golimumab|mesh-list
14477776|NCT02438787|Ustekinumab|ustekinumab|mesh-list
14477777|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
14477778|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14477779|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477780|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477781|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
14477782|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761744|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761745|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931351|NCT03368391|Epinephrine|epinephrine|mesh-list
13931352|NCT03368391|Racepinephrine|racepinephrine|mesh-list
13931353|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
13931354|NCT03368391|Tetracaine|tetracaine|mesh-list
13931355|NCT03368391|Mepivacaine|mepivacaine|mesh-list
13931356|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
13931357|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
13931358|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
13931359|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107538|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107539|NCT02367664|Vaccines|vaccines|mesh-list
14107540|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
14107541|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175613|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14175614|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14175615|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175616|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175617|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
14175618|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
14175619|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175620|NCT04773951|Antibodies|antibodies|mesh-list
14175621|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14175622|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
14175623|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175624|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
14175625|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
14761746|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14761747|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
14761748|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761749|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761750|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14761751|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14761752|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14761753|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14761754|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761755|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13931360|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931361|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
13931362|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931363|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13931364|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13931365|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13931366|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13931367|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931368|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13931369|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13931370|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
14175626|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14175627|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477783|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
14107542|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
14107543|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14107544|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14107545|NCT02367560|Prednisolone|prednisolone|mesh-list
14107546|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
14107547|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14107548|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
14936055|NCT01466959|Protective Agents|protective agents|mesh-ancestor
14936056|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936057|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
14936058|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13931371|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931372|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14107549|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107550|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
14107551|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
14107552|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107553|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107554|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14107555|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
14107556|NCT02367560|Hormones|hormones|mesh-ancestor
14107557|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107558|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14107559|NCT02367560|Protective Agents|protective agents|mesh-ancestor
14107560|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14107561|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107562|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14107563|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14107564|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14107565|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
14107566|NCT02367196|Rituximab|rituximab|mesh-list
14107567|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107568|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107569|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
14107570|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107571|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107572|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14107573|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14107574|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14107575|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14107576|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107577|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107578|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107579|NCT02367404|Analgesics|analgesics|mesh-ancestor
14107580|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
14107581|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107582|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
14107583|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14107584|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
14107585|NCT02367248|Deferoxamine|deferoxamine|mesh-list
14107586|NCT02367248|Siderophores|siderophores|mesh-ancestor
14107587|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14107588|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
14107589|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
14107590|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107591|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
14107592|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14107593|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
13931373|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13931374|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
13931375|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13931376|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
13931377|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
13931378|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
13931379|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13931380|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
13931381|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13931382|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13931383|NCT03368391|Protective Agents|protective agents|mesh-ancestor
13931384|NCT03368352|Melatonin|melatonin|mesh-list
13931385|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
13931386|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931387|NCT03368352|Protective Agents|protective agents|mesh-ancestor
13931388|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931389|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477784|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14477785|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14477786|NCT02439138|Idelalisib|idelalisib|mesh-list
14107594|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14107595|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
14107596|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107597|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107598|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
14107599|NCT02367053|Glucagon|glucagon|mesh-list
14107600|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14107601|NCT02367053|Hormones|hormones|mesh-ancestor
14107602|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107603|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107604|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14107605|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
14107606|NCT02366884|Clotrimazole|clotrimazole|mesh-list
14107607|NCT02366884|Miconazole|miconazole|mesh-list
14107608|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
14107609|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107610|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14107611|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13931390|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
13931391|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931392|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
13931393|NCT03368274|Hormones|hormones|mesh-ancestor
13931394|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931395|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931396|NCT03368131|Capecitabine|capecitabine|mesh-list
14761756|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931397|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
13931398|NCT03368131|Trastuzumab|trastuzumab|mesh-list
14107612|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14107613|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107614|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107615|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14107616|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
14107617|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107618|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107619|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14107620|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14107621|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14107622|NCT02366975|Testosterone|testosterone|mesh-list
14107623|NCT02366975|Androgens|androgens|mesh-ancestor
14107624|NCT02366975|Hormones|hormones|mesh-ancestor
14107625|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107626|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107627|NCT02367118|Prednisone|prednisone|mesh-list
14107628|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107629|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
14107630|NCT02367118|Hormones|hormones|mesh-ancestor
14107631|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107632|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107633|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14107634|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107635|NCT02366949|Paclitaxel|paclitaxel|mesh-list
14107636|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14107637|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107638|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
14107639|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
14107640|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
14107641|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107642|NCT02366819|Leucovorin|leucovorin|mesh-list
14107643|NCT02366819|Fluorouracil|fluorouracil|mesh-list
14107644|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
14107645|NCT02366819|Irinotecan|irinotecan|mesh-list
14107646|NCT02366819|Calcium|calcium|mesh-list
14477787|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931399|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931400|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
13931401|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931402|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931403|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107647|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
14477788|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477789|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477790|NCT02439164|Midazolam|midazolam|mesh-list
14477791|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14477792|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14477793|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477794|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477795|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14761757|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
14761758|NCT03407144|Hormones|hormones|mesh-ancestor
14761759|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761760|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761761|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14761762|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
14761763|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761764|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761765|NCT03405090|Fentanyl|fentanyl|mesh-list
14761766|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
14761767|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14761768|NCT03405090|Narcotics|narcotics|mesh-ancestor
14761769|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14936059|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936060|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14936061|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
14936062|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936063|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936064|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936065|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936066|NCT01467115|Leucovorin|leucovorin|mesh-list
14936067|NCT01467115|Docetaxel|docetaxel|mesh-list
14936068|NCT01467115|Fluorouracil|fluorouracil|mesh-list
13931404|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
13931405|NCT03367988|Anesthetics|anesthetics|mesh-list
13931406|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931407|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931408|NCT03367988|Narcotics|narcotics|mesh-ancestor
13931409|NCT03367988|Analgesics|analgesics|mesh-ancestor
13931410|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
13931411|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931412|NCT03367728|Ropivacaine|ropivacaine|mesh-list
13931413|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
13931414|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
13931415|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107648|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14107649|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107650|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
14107651|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107652|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14107653|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107654|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107655|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
14107656|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14107657|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14107658|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107659|NCT02366819|Antidotes|antidotes|mesh-ancestor
14107660|NCT02366819|Protective Agents|protective agents|mesh-ancestor
14107661|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
14107662|NCT02366819|Vitamins|vitamins|mesh-ancestor
14107663|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
14107664|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
14107665|NCT02366546|Fludarabine|fludarabine|mesh-list
14107666|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107667|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
14107668|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107669|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107670|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14107671|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
14107672|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107673|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107674|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14107675|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
14107676|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14107677|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
14767365|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14936069|NCT01467115|Cetuximab|cetuximab|mesh-list
14107678|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107679|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
14107680|NCT02366676|Protective Agents|protective agents|mesh-ancestor
14107681|NCT02366585|Cyclosporine|cyclosporine|mesh-list
14107682|NCT02366585|Cyclosporins|cyclosporins|mesh-list
14107683|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107684|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107685|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107686|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
14107687|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107688|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
14107689|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107690|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14107691|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14107692|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14107693|NCT02366481|Vitamins|vitamins|mesh-list
14107694|NCT02366481|Vitamin K|vitamin k|mesh-list
14107695|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
14107696|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
14477796|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14477797|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14761770|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107697|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
14107698|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107699|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14107700|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14107701|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107702|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
14107703|NCT02366481|Coagulants|coagulants|mesh-ancestor
14107704|NCT02366247|Adefovir|adefovir|mesh-list
14107705|NCT02366247|Thymalfasin|thymalfasin|mesh-list
14107706|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
14107707|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107708|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14107709|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14107710|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107711|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107712|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13931416|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931417|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
13931418|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107713|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
14107714|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107715|NCT02366377|Metformin|metformin|mesh-list
14107716|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14107717|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107718|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
14107719|NCT02366299|Propofol|propofol|mesh-list
14107720|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14107721|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107722|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107723|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14107724|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
14107725|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
14107726|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107727|NCT02366299|Analgesics|analgesics|mesh-ancestor
14107728|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
14107729|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107730|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14107731|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14107732|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14107733|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107734|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931419|NCT03367676|Docetaxel|docetaxel|mesh-list
13931420|NCT03367676|Trastuzumab|trastuzumab|mesh-list
13931421|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931422|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
13931423|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
13931424|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
13931425|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931426|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13931427|NCT03367663|Prednisone|prednisone|mesh-list
14107735|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477798|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14107736|NCT02366065|Acetaminophen|acetaminophen|mesh-list
14477799|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
14477800|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
14477801|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
14107737|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107738|NCT02366065|Analgesics|analgesics|mesh-ancestor
14107739|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
14107740|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107741|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107742|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
14107743|NCT02366208|Adefovir|adefovir|mesh-list
14107744|NCT02366208|Thymalfasin|thymalfasin|mesh-list
14107745|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
14107746|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107747|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14107748|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14107749|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931428|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931429|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
13931430|NCT03367663|Hormones|hormones|mesh-ancestor
13931431|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931432|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931433|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761771|NCT03405090|Analgesics|analgesics|mesh-ancestor
14761772|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
14761773|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761774|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14761775|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13931434|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107750|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107751|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14107752|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
14107753|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107754|NCT02365909|Bupivacaine|bupivacaine|mesh-list
14107755|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
14107756|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
14107757|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107758|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107759|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
14107760|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107761|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
14107762|NCT02365857|Bupivacaine|bupivacaine|mesh-list
14107763|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
14107764|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
14107765|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107766|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107767|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
14107768|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107769|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14107770|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107771|NCT02365857|Analgesics|analgesics|mesh-ancestor
14107772|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14107773|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14107774|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14107775|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107776|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107777|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107778|NCT02365935|Paclitaxel|paclitaxel|mesh-list
14107779|NCT02365935|Cisplatin|cisplatin|mesh-list
13931435|NCT03367585|Vitamin D|vitamin d|mesh-list
13931436|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
13931437|NCT03367585|Vitamins|vitamins|mesh-ancestor
13931438|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
13931439|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931440|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13931441|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13931442|NCT03367533|Ketamine|ketamine|mesh-list
13931443|NCT03367533|Analgesics|analgesics|mesh-ancestor
13931444|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
13931445|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931446|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931447|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13931448|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13931449|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
13931450|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
13931451|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107780|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14107781|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107782|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
13931452|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13931453|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13931454|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931455|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931456|NCT03367494|Bromides|bromides|mesh-list
13931457|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
13961143|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961144|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13961145|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961146|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961147|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961148|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
13961149|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13961150|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13961151|NCT03150316|Growth Substances|growth substances|mesh-ancestor
13961152|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
13961153|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13961154|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13961155|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13961156|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963426|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13963427|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13963428|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13963429|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
13963430|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963431|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107783|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14107784|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
14107785|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107786|NCT02365675|Petrolatum|petrolatum|mesh-list
14107787|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14107788|NCT02365675|Laxatives|laxatives|mesh-ancestor
14107789|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14107790|NCT02365675|Emollients|emollients|mesh-ancestor
14107791|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
14107792|NCT02365571|Itraconazole|itraconazole|mesh-list
14107793|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
14107794|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107795|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14107796|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14107797|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963432|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13963433|NCT03144856|Apatinib|apatinib|mesh-list
14107798|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107799|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14107800|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
14107801|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107802|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107803|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14175628|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175629|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
14175630|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13963434|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963435|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13963436|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963437|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963438|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
13963439|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13963440|NCT03144882|Curcumin|curcumin|mesh-list
13963441|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13963442|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963443|NCT03144882|Analgesics|analgesics|mesh-ancestor
13963444|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
13963445|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175631|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175632|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175633|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
14175634|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
14175635|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175636|NCT04773717|Protective Agents|protective agents|mesh-ancestor
14175637|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107804|NCT02365740|Insulin|insulin|mesh-list
14107805|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14107806|NCT02365740|Hormones|hormones|mesh-list
14107807|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14107808|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107809|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107810|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
14107811|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107812|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
14107813|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107814|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931458|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
13931459|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931460|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931461|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
13931462|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931463|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931464|NCT03367195|Omeprazole|omeprazole|mesh-list
13931465|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13931466|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931467|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13931468|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107815|NCT02365727|Clonidine|clonidine|mesh-list
14107816|NCT02365727|Epinephrine|epinephrine|mesh-list
14107817|NCT02365727|Bupivacaine|bupivacaine|mesh-list
14107818|NCT02365727|Ropivacaine|ropivacaine|mesh-list
14107819|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
14107820|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
14107821|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107822|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107823|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
14107824|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107825|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14107826|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14107827|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107828|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107829|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107830|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14107831|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14107832|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
14107833|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14107834|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
14107835|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
13931469|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931470|NCT03367182|Paclitaxel|paclitaxel|mesh-list
14107836|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
14107837|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14107838|NCT02365727|Analgesics|analgesics|mesh-ancestor
14107839|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14107840|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
14107841|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13931471|NCT03367182|Bevacizumab|bevacizumab|mesh-list
13931472|NCT03367182|Doxorubicin|doxorubicin|mesh-list
13931473|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13931474|NCT03367182|Topotecan|topotecan|mesh-list
13931475|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13931476|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931477|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
13931478|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
13931479|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
13931480|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931481|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107842|NCT02365805|Paclitaxel|paclitaxel|mesh-list
14107843|NCT02365805|Docetaxel|docetaxel|mesh-list
14107844|NCT02365805|Fluorouracil|fluorouracil|mesh-list
14107845|NCT02365805|Epirubicin|epirubicin|mesh-list
14107846|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
14107847|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14107848|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107849|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
14107850|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761776|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
14107851|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
13931482|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13931483|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14107852|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107853|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
14175638|NCT04773717|Vitamins|vitamins|mesh-ancestor
14761777|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
14761778|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
14761779|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14761780|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
14107854|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14107855|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107856|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
14107857|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107858|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14107859|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14107860|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14107861|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107862|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761781|NCT03404791|Gemcitabine|gemcitabine|mesh-list
14761782|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931484|NCT03367182|Growth Substances|growth substances|mesh-ancestor
13931485|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931486|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
13931487|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13931488|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13931489|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13931490|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931491|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13931492|NCT03367143|Carboplatin|carboplatin|mesh-list
13931493|NCT03367143|Etoposide|etoposide|mesh-list
13931494|NCT03367143|Lenalidomide|lenalidomide|mesh-list
13931495|NCT03367143|Ifosfamide|ifosfamide|mesh-list
13931496|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931497|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13931498|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13931499|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13931500|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931501|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931502|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
14107863|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14107864|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
14107865|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14107866|NCT02365623|Bedaquiline|bedaquiline|mesh-list
14107867|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
14107868|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
14107869|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13931503|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931504|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13931505|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13931506|NCT03367143|Growth Substances|growth substances|mesh-ancestor
13931507|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
13931508|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14107870|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107871|NCT02365766|Gemcitabine|gemcitabine|mesh-list
14107872|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
14107873|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107874|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14107875|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
14107876|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107877|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
14107878|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107879|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107880|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107881|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
14107882|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107883|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14107884|NCT02365532|Dofetilide|dofetilide|mesh-list
14761783|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
13931509|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
13931510|NCT03367013|Lactoferrin|lactoferrin|mesh-list
13931511|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931512|NCT03366974|Clarithromycin|clarithromycin|mesh-list
13931513|NCT03366974|Midazolam|midazolam|mesh-list
13931514|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13931515|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13931516|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931517|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931518|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13931519|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13931520|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14761784|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107885|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14107886|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14107887|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14107888|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931521|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13931522|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
13931523|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
13931524|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
13931525|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
14936070|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
14936071|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
14761785|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761786|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
14761787|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761788|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761789|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931526|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931527|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931528|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13931529|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931530|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13931531|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931532|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13931533|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13931534|NCT03366883|Paclitaxel|paclitaxel|mesh-list
13931535|NCT03366883|Cisplatin|cisplatin|mesh-list
13931536|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13931537|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931538|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
14107889|NCT02365155|Vitamin D|vitamin d|mesh-list
14107890|NCT02365155|Vitamins|vitamins|mesh-list
14761790|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
14761791|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761792|NCT03390504|Docetaxel|docetaxel|mesh-list
14761793|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
14761794|NCT03390504|Mitogens|mitogens|mesh-list
14761795|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761796|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
13931539|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
13931540|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
13931541|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931542|NCT03366766|Gemcitabine|gemcitabine|mesh-list
13931543|NCT03366766|Cisplatin|cisplatin|mesh-list
14107891|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
14107892|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107893|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14107894|NCT02365272|Amikacin|amikacin|mesh-list
14107895|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14107896|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107897|NCT02365415|Sirolimus|sirolimus|mesh-list
14107898|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14107899|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107900|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14107901|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107902|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
14107903|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14107904|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
14107905|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107906|NCT02365493|Cefazolin|cefazolin|mesh-list
14107907|NCT02365493|Lactams|lactams|mesh-list
14107908|NCT02365493|beta-Lactams|beta-lactams|mesh-list
14107909|NCT02365493|Floxacillin|floxacillin|mesh-list
14107910|NCT02365493|Cloxacillin|cloxacillin|mesh-list
14107911|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14107912|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107913|NCT02365402|Entecavir|entecavir|mesh-list
14761797|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
14107914|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
14936072|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936073|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
14936074|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936075|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
14936076|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761798|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
14936077|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
14107915|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107916|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
14107917|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761799|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936078|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931544|NCT03366766|Nivolumab|nivolumab|mesh-list
13931545|NCT03366766|Pemetrexed|pemetrexed|mesh-list
13931546|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931547|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931548|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
13931549|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931550|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
14107918|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14107919|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107920|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107921|NCT02365181|Ropivacaine|ropivacaine|mesh-list
14107922|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
13931551|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931552|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931553|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931554|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
13931555|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931556|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13931557|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13931558|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13931559|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13931560|NCT03366597|Sevoflurane|sevoflurane|mesh-list
13931561|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13931562|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13931563|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
13931564|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
13931565|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931566|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931567|NCT03366584|Vitamin D|vitamin d|mesh-list
13931568|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
13931569|NCT03366584|Beta Carotene|beta carotene|mesh-list
13931570|NCT03366584|Zinc|zinc|mesh-list
13931571|NCT03366584|Dexamethasone|dexamethasone|mesh-list
13931572|NCT03366584|Carotenoids|carotenoids|mesh-list
14107923|NCT02365181|Anesthetics|anesthetics|mesh-list
14107924|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107925|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107926|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
14107927|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107928|NCT02364986|Interferons|interferons|mesh-list
14107929|NCT02364986|Interferon-beta|interferon-beta|mesh-list
14107930|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
14107931|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107932|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
14107933|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14107934|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
14107935|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107936|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14107937|NCT02364934|Propofol|propofol|mesh-list
14107938|NCT02364934|Sevoflurane|sevoflurane|mesh-list
14107939|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14107940|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107941|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107942|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14107943|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
14107944|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
14107945|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14107946|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14107947|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
14107948|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
14107949|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14107950|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14107951|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107952|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107953|NCT02364882|Urological Agents|urological agents|mesh-ancestor
13931573|NCT03366584|Picolinic acid|picolinic acid|mesh-list
13931574|NCT03366584|Vitamins|vitamins|mesh-ancestor
13931575|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
13931576|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931577|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14107954|NCT02364804|Aprepitant|aprepitant|mesh-list
14107955|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
14936079|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931578|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
13931579|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
13931580|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107956|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
13931581|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931582|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
13931583|NCT03366584|Hormones|hormones|mesh-ancestor
13931584|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931585|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13931586|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931587|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13931588|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13931589|NCT03366584|Trace Elements|trace elements|mesh-ancestor
13931590|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
13931591|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931592|NCT03366584|Protective Agents|protective agents|mesh-ancestor
13931593|NCT03366584|Provitamins|provitamins|mesh-ancestor
14761800|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761801|NCT03384654|Cytarabine|cytarabine|mesh-list
14761802|NCT03384654|Prednisone|prednisone|mesh-list
14761803|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
13931594|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13931595|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
13931596|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
14107957|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107958|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107959|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14107960|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14107961|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107962|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107963|NCT02365012|Midodrine|midodrine|mesh-list
14107964|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
14107965|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
14107966|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107967|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107968|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14107969|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14107970|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14107971|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14107972|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
14107973|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14107974|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107975|NCT02364765|Remifentanil|remifentanil|mesh-list
14107976|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14107977|NCT02364765|Narcotics|narcotics|mesh-ancestor
14107978|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14107979|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107980|NCT02364765|Analgesics|analgesics|mesh-ancestor
14107981|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
14107982|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107983|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
14107984|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14107985|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14107986|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14107987|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14107988|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
14107989|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14107990|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107991|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14107992|NCT02364479|Etanercept|etanercept|mesh-list
14107993|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14107994|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14107995|NCT02364479|Analgesics|analgesics|mesh-ancestor
14107996|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
14107997|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14107998|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14107999|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761804|NCT03384654|Doxorubicin|doxorubicin|mesh-list
14761805|NCT03384654|Methotrexate|methotrexate|mesh-list
14761806|NCT03384654|Vincristine|vincristine|mesh-list
14761807|NCT03384654|Asparaginase|asparaginase|mesh-list
14761808|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
14761809|NCT03384654|Daratumumab|daratumumab|mesh-list
14761810|NCT03384654|Pegaspargase|pegaspargase|mesh-list
14761811|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761812|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
14761813|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761814|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931597|NCT03366571|Entecavir|entecavir|mesh-list
13931598|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
13931599|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931600|NCT03366480|Paclitaxel|paclitaxel|mesh-list
13931601|NCT03366480|Carboplatin|carboplatin|mesh-list
13931602|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13931603|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931604|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
13931605|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
13931606|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
13931607|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931608|NCT03366259|Misoprostol|misoprostol|mesh-list
13931609|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13931610|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
13931611|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13931612|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931613|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13931614|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931615|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
13931616|NCT03366246|Lidocaine|lidocaine|mesh-list
13931617|NCT03366246|Prilocaine|prilocaine|mesh-list
13931618|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13931619|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
13931620|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
13931621|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931622|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931623|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
13931624|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931625|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13931626|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13931627|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13931628|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13931629|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931630|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13931631|NCT03366064|Pemetrexed|pemetrexed|mesh-list
13931632|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931633|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931634|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931635|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13931636|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13931637|NCT03366025|Progesterone|progesterone|mesh-list
13931638|NCT03366025|Progestins|progestins|mesh-ancestor
13931639|NCT03366025|Hormones|hormones|mesh-ancestor
13931640|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931641|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931642|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
13931643|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
13931644|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13931645|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931646|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931647|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
13931648|NCT03365999|Coagulants|coagulants|mesh-ancestor
13931649|NCT03365869|Sirolimus|sirolimus|mesh-list
13931650|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13931651|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931652|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13931653|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931654|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
13931655|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931656|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
13931657|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931658|NCT03365817|Fentanyl|fentanyl|mesh-list
13931659|NCT03365817|Morphine|morphine|mesh-list
13931660|NCT03365817|Oxycodone|oxycodone|mesh-list
13931661|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
13931662|NCT03365817|Tramadol|tramadol|mesh-list
13931663|NCT03365817|Methadone|methadone|mesh-list
13931664|NCT03365817|Narcotics|narcotics|mesh-ancestor
13931665|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931666|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108000|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108001|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931667|NCT03365817|Analgesics|analgesics|mesh-ancestor
13931668|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
13931669|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931670|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13961157|NCT03150459|Rifaximin|rifaximin|mesh-list
14108002|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108003|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
14108004|NCT02364752|Diuretics|diuretics|mesh-list
14108005|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14108006|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
14108007|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108008|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108009|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108010|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
14108011|NCT02364609|Afatinib|afatinib|mesh-list
14108012|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14108013|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108014|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14108015|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108016|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108017|NCT02364583|Primaquine|primaquine|mesh-list
14108018|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
14108019|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14108020|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14108021|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108022|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
14108023|NCT02364453|Growth Substances|growth substances|mesh-ancestor
14108024|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108025|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
14108026|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108027|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108028|NCT02364206|Temozolomide|temozolomide|mesh-list
14108029|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14108030|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
14108031|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108032|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108033|NCT02364258|Atorvastatin|atorvastatin|mesh-list
14108034|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13931671|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13931672|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
13931673|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
13931674|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
13931675|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
13931676|NCT03365765|Fluorouracil|fluorouracil|mesh-list
13931677|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
13931678|NCT03365765|Apatinib|apatinib|mesh-list
13931679|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
13931680|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108035|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14108036|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14108037|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
14108038|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108039|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14108040|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14108041|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108042|NCT02364362|Docetaxel|docetaxel|mesh-list
14108043|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108044|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
14108045|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
14108046|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
14108047|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175639|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
14175640|NCT04774159|Colchicine|colchicine|mesh-list
14175641|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
14175642|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175643|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
14175644|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
14175645|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
14175646|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175647|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175648|NCT04774406|Olaparib|olaparib|mesh-list
14761815|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13931681|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931682|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931683|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931684|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
13931685|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931686|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13931687|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931688|NCT03365726|Dobutamine|dobutamine|mesh-list
13931689|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13931690|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
14108048|NCT02364089|Epinephrine|epinephrine|mesh-list
14108049|NCT02364089|Racepinephrine|racepinephrine|mesh-list
14108050|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
14108051|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14108052|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14108053|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
14108054|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108055|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108056|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108057|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14108058|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14108059|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
14108060|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108061|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14108062|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
14108063|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
14108064|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
14108065|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14108066|NCT02363985|Vitamin A|vitamin a|mesh-list
14108067|NCT02363985|Vitamins|vitamins|mesh-ancestor
14108068|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
14108069|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108070|NCT02363829|Nelfinavir|nelfinavir|mesh-list
14108071|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14108072|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14108073|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
14108074|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108075|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108076|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14108077|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14108078|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
14108079|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108080|NCT02363699|Lidocaine|lidocaine|mesh-list
14108081|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
14108082|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
14108083|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108084|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108085|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
14108086|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108087|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14108088|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14108089|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14108090|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108091|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108092|NCT02363751|Bevacizumab|bevacizumab|mesh-list
14108093|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14108094|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108095|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14108096|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14108097|NCT02363751|Growth Substances|growth substances|mesh-ancestor
14108098|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108099|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
14108100|NCT02363556|Misoprostol|misoprostol|mesh-list
14108101|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14108102|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
14108103|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108104|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108105|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14108106|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108107|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
14108108|NCT02363452|Lamivudine|lamivudine|mesh-list
14108109|NCT02363452|Zidovudine|zidovudine|mesh-list
14108110|NCT02363452|Abacavir|abacavir|mesh-list
14108111|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
13931691|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
13961158|NCT03150459|Simvastatin|simvastatin|mesh-list
14175649|NCT04774406|Niraparib|niraparib|mesh-list
14108112|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14108113|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108114|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108115|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
14108116|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108117|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14108118|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14108119|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
14108120|NCT02363374|Leucovorin|leucovorin|mesh-list
14108121|NCT02363374|Folic Acid|folic acid|mesh-list
14108122|NCT02363374|Fluorouracil|fluorouracil|mesh-list
14108123|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
14108124|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
14108125|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
14108126|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108127|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108128|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108129|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108130|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
14108131|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108132|NCT02363374|Antidotes|antidotes|mesh-ancestor
14108133|NCT02363374|Protective Agents|protective agents|mesh-ancestor
14108134|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
14108135|NCT02363374|Vitamins|vitamins|mesh-ancestor
14108136|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
14108137|NCT02363374|Hematinics|hematinics|mesh-ancestor
14108138|NCT02363400|Cisplatin|cisplatin|mesh-list
14108139|NCT02363400|Epirubicin|epirubicin|mesh-list
14108140|NCT02363400|Mitomycins|mitomycins|mesh-list
14108141|NCT02363400|Mitomycin|mitomycin|mesh-list
14108142|NCT02363400|Tegafur|tegafur|mesh-list
14108143|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108144|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14108145|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14108146|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14108147|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108148|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108149|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
14108150|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14108151|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108152|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
14108153|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
14108154|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14108155|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14108156|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
14108157|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
14108158|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108159|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
14108160|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108161|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14108162|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108163|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108164|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
14108165|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13931692|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931693|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931694|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13931695|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13931696|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13931697|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
13931698|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931699|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931700|NCT03365726|Protective Agents|protective agents|mesh-ancestor
14761816|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
14761817|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108166|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108167|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14761818|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761819|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14761820|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14761821|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14761822|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14108168|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14108169|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108170|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108171|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
14108172|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108173|NCT02362906|Azithromycin|azithromycin|mesh-list
14108174|NCT02362906|Erythromycin|erythromycin|mesh-list
14108175|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
14108176|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14108177|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
14108178|NCT02362906|Cephalosporins|cephalosporins|mesh-list
14108179|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14108180|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108181|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108182|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14108183|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108184|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108185|NCT02362958|Capecitabine|capecitabine|mesh-list
14108186|NCT02362958|Vinorelbine|vinorelbine|mesh-list
14108187|NCT02362958|Lapatinib|lapatinib|mesh-list
14108188|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108189|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
14108190|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108191|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108192|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14108193|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
14108194|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
14108195|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
14108196|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14108197|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108198|NCT02363127|Progesterone|progesterone|mesh-list
14108199|NCT02363127|Progestins|progestins|mesh-ancestor
14108200|NCT02363127|Hormones|hormones|mesh-ancestor
14761823|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761824|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761825|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
14761826|NCT03384654|Hormones|hormones|mesh-ancestor
14761827|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961159|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13961160|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13961161|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
13961162|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961163|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13961164|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13961165|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961166|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961167|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108201|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108202|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108203|NCT02362945|Oxytocin|oxytocin|mesh-list
14108204|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
14108205|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108206|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108207|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
14108208|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14108209|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14108210|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
14108211|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108212|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108213|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14108214|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14108215|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14108216|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14108217|NCT02362711|Estrogens|estrogens|mesh-ancestor
14108218|NCT02362711|Hormones|hormones|mesh-ancestor
14108219|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108220|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13961168|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961169|NCT03150524|Verapamil|verapamil|mesh-list
13961170|NCT03150524|Nimodipine|nimodipine|mesh-list
13961171|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13961172|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13961173|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108221|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
14108222|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108223|NCT02362516|BI 425809|bi 425809|mesh-list
14108224|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
14108225|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
14108226|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931708|NCT03365479|Iloprost|iloprost|mesh-list
13931709|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13931710|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
13931711|NCT03365466|Aspirin|aspirin|mesh-list
13931712|NCT03365466|Heparin|heparin|mesh-list
13931713|NCT03365466|Calcium heparin|calcium heparin|mesh-list
13931714|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13931715|NCT03365466|Tinzaparin|tinzaparin|mesh-list
13931716|NCT03365466|Dalteparin|dalteparin|mesh-list
13931717|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13931718|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13931719|NCT03365466|Analgesics|analgesics|mesh-ancestor
13931720|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
13931721|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931722|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931723|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931724|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13931725|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13931726|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931727|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931728|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13931729|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13931730|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931731|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
13931732|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
13931733|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14108227|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
13931734|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
13931735|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14108228|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14108229|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14108230|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108231|NCT02362399|Urological Agents|urological agents|mesh-ancestor
14108232|NCT02362529|Minocycline|minocycline|mesh-list
14108233|NCT02362529|Celecoxib|celecoxib|mesh-list
14108234|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14108235|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108236|NCT02362529|Analgesics|analgesics|mesh-ancestor
14108237|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
14108238|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108239|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108240|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108241|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108242|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14108243|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14108244|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108245|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108246|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14108247|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108248|NCT02362581|Factor VIII|factor viii|mesh-list
14108249|NCT02362581|Coagulants|coagulants|mesh-ancestor
14108250|NCT02362308|Eplerenone|eplerenone|mesh-list
14108251|NCT02362308|Spironolactone|spironolactone|mesh-list
14108252|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14108253|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
14108254|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
14108255|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108256|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108257|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14108258|NCT02362308|Diuretics|diuretics|mesh-ancestor
14108259|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
14936080|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
14936081|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936082|NCT01467115|Antidotes|antidotes|mesh-ancestor
14936083|NCT01467115|Protective Agents|protective agents|mesh-ancestor
14936084|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
14936085|NCT01467115|Vitamins|vitamins|mesh-ancestor
14936086|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
14936087|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14936088|NCT01467115|Hematinics|hematinics|mesh-ancestor
13931736|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
13931737|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931738|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
14108260|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14108261|NCT02362308|Hormones|hormones|mesh-ancestor
14175650|NCT04774406|Veliparib|veliparib|mesh-list
14936089|NCT01467141|Insulin|insulin|mesh-list
14108262|NCT02362256|Clonidine|clonidine|mesh-list
14108263|NCT02362256|Naltrexone|naltrexone|mesh-list
14108264|NCT02362256|Lorazepam|lorazepam|mesh-list
14108265|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14108266|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14108267|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108268|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
14108269|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108270|NCT02362256|Analgesics|analgesics|mesh-ancestor
14108271|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14108272|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
14108273|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
14108274|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14108275|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14108276|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14108277|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14108278|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108279|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108280|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
14108281|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
14108282|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108283|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14108284|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108285|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14108286|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14108287|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14108288|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
14108289|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
14108290|NCT02362152|Diclofenac|diclofenac|mesh-list
14108291|NCT02362152|Fluorouracil|fluorouracil|mesh-list
14108292|NCT02362152|Imiquimod|imiquimod|mesh-list
14108293|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
14108294|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108295|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108296|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108297|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108298|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
14108299|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108300|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14108301|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108302|NCT02362152|Analgesics|analgesics|mesh-ancestor
14108303|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
14108304|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108305|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108306|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108307|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14108308|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108309|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14108310|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
14108311|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
13931739|NCT03365388|Protective Agents|protective agents|mesh-ancestor
13931740|NCT03365362|Varenicline|varenicline|mesh-list
14761828|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761829|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14761830|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
14761831|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14761832|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761833|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
14761834|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
14761835|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14761836|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14761837|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
14936090|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14936091|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
13931741|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13931742|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13931743|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
13931744|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931745|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931746|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931747|NCT03365336|Oseltamivir|oseltamivir|mesh-list
13931748|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
14108312|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
14108313|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14108314|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108315|NCT02362165|Dexamethasone|dexamethasone|mesh-list
13931749|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108316|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
14108317|NCT02362165|Doxorubicin|doxorubicin|mesh-list
14108318|NCT02362165|Bortezomib|bortezomib|mesh-list
14108319|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108320|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
14108321|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108322|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108323|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14108324|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
14108325|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108326|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108327|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14108328|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108329|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
14108330|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
14108331|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108332|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108333|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
14108334|NCT02362165|Hormones|hormones|mesh-ancestor
14108335|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108336|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14108337|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14108338|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14108339|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14108340|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108341|NCT02362022|Morphine|morphine|mesh-list
14108342|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14108343|NCT02362022|Narcotics|narcotics|mesh-ancestor
14108344|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108345|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108346|NCT02362022|Analgesics|analgesics|mesh-ancestor
14108347|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
14108348|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108349|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
14108350|NCT02361931|Hematinics|hematinics|mesh-ancestor
14108351|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
14108352|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14108353|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
14108354|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108355|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108356|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14108357|NCT02361567|Acetaminophen|acetaminophen|mesh-list
14761838|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761839|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14761840|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
14761841|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
14761842|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
14108358|NCT02361567|Oxycodone|oxycodone|mesh-list
14108359|NCT02361567|Tramadol|tramadol|mesh-list
14108360|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14108361|NCT02361567|Narcotics|narcotics|mesh-ancestor
14108362|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108363|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108364|NCT02361567|Analgesics|analgesics|mesh-ancestor
14108365|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
14108366|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108367|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108368|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
14108369|NCT02361879|Leuprolide|leuprolide|mesh-list
14761843|NCT03364868|Insulin|insulin|mesh-list
14761844|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931750|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931751|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931752|NCT03365141|Triamcinolone|triamcinolone|mesh-list
13931753|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13931754|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13931755|NCT03365141|Tacrolimus|tacrolimus|mesh-list
13931756|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13931757|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931758|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
13931759|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931760|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13931761|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761845|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931762|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108370|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
14108371|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13931763|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13931764|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
13931765|NCT03365141|Hormones|hormones|mesh-ancestor
13931766|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13931767|NCT03365115|Fentanyl|fentanyl|mesh-list
13931768|NCT03365115|Morphine|morphine|mesh-list
13931769|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13931770|NCT03365115|Narcotics|narcotics|mesh-ancestor
13931771|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931772|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931773|NCT03365115|Analgesics|analgesics|mesh-ancestor
13931774|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
13931775|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931776|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13931777|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13931778|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
13931779|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
13931780|NCT03364998|Factor VIII|factor viii|mesh-list
13931781|NCT03364998|Coagulants|coagulants|mesh-ancestor
13931782|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
13931783|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13931784|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931785|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931786|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108372|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
14108373|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108374|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108375|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14108376|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108377|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14108378|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
14108379|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14108380|NCT02361645|Ketorolac|ketorolac|mesh-list
14108381|NCT02361645|Indomethacin|indomethacin|mesh-list
14108382|NCT02361645|Nepafenac|nepafenac|mesh-list
14108383|NCT02361645|Bromfenac|bromfenac|mesh-list
14108384|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14108385|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14108386|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108387|NCT02361645|Analgesics|analgesics|mesh-ancestor
14108388|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
14108389|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108390|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108391|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108392|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108393|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14108394|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108395|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108396|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
14108397|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
14108398|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108399|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14108400|NCT02361502|Mirabegron|mirabegron|mesh-list
14108401|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14108402|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14108403|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14108404|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
14108405|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108406|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108407|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108408|NCT02361502|Urological Agents|urological agents|mesh-ancestor
14108409|NCT02361905|Leuprolide|leuprolide|mesh-list
14108410|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
14108411|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14108412|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
14761846|NCT03364686|Biotin|biotin|mesh-list
14761847|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
14761848|NCT03364686|Vitamins|vitamins|mesh-ancestor
14761849|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
14761850|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761851|NCT03361306|Elotuzumab|elotuzumab|mesh-list
14761852|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761853|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
14761854|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14761855|NCT03341962|Calcium|calcium|mesh-list
14761856|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14761857|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931787|NCT03364842|Furosemide|furosemide|mesh-list
13931788|NCT03364842|Diuretics|diuretics|mesh-ancestor
13931789|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
13931790|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931791|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13931792|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108413|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108414|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108415|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14108416|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108417|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14108418|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
14108419|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14108420|NCT02361775|Ropivacaine|ropivacaine|mesh-list
14108421|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
14108422|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
14108423|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108424|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108425|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
14108426|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108427|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
14108428|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14108429|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108430|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108431|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
14108432|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108433|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108434|NCT02361619|Clarithromycin|clarithromycin|mesh-list
14108435|NCT02361619|Diclofenac|diclofenac|mesh-list
14108436|NCT02361619|Metoprolol|metoprolol|mesh-list
14108437|NCT02361619|Midazolam|midazolam|mesh-list
14108438|NCT02361619|Caffeine|caffeine|mesh-list
14108439|NCT02361619|Esomeprazole|esomeprazole|mesh-list
14108440|NCT02361619|Dabigatran|dabigatran|mesh-list
14108441|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14108442|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14108443|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108444|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108445|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14108446|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14108447|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14108448|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14108449|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
14108450|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
14108451|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
14108452|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
14108453|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108454|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108455|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14108456|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108457|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14108458|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108459|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14108460|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108461|NCT02361619|Analgesics|analgesics|mesh-ancestor
14108462|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
14108463|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108464|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108465|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108466|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14108467|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14108468|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13931793|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931794|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
13931795|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13931796|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13931797|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13931798|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
13931799|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931800|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108469|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14108470|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14108471|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
14108472|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14175651|NCT04774406|Talazoparib|talazoparib|mesh-list
14108473|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108474|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14108475|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14108476|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14108477|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
14108478|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14108479|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
14108480|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
14108481|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14108482|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14108483|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
14108484|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
14108485|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14108486|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14108487|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14108488|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
14108489|NCT02361528|Sargramostim|sargramostim|mesh-list
14108490|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
14108491|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108492|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
14108493|NCT02361190|Testosterone|testosterone|mesh-list
13931801|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931802|NCT03364764|Sirolimus|sirolimus|mesh-list
13931803|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13931804|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931805|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13931806|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931807|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
13931808|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931809|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
13931810|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931811|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
13931812|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13931813|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931814|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931815|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
14108494|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
14108495|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
14108496|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14108497|NCT02361190|Androgens|androgens|mesh-ancestor
14108498|NCT02361190|Hormones|hormones|mesh-ancestor
14108499|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108500|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108501|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14108502|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108503|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
14108504|NCT02361112|Capecitabine|capecitabine|mesh-list
14108505|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108506|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
14108507|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108508|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108509|NCT02361177|Oxytocin|oxytocin|mesh-list
14108510|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
14108511|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108512|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108513|NCT02360956|Olmesartan|olmesartan|mesh-list
14108514|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14108515|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
14108516|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14108517|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14108518|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108519|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14108520|NCT02360800|Hemostatics|hemostatics|mesh-list
14108521|NCT02360800|Coagulants|coagulants|mesh-ancestor
14108522|NCT02360826|Simvastatin|simvastatin|mesh-list
14108523|NCT02360826|Pravastatin|pravastatin|mesh-list
14108524|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14108525|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14108526|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
14108527|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108528|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14108529|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14108530|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931816|NCT03364569|Coagulants|coagulants|mesh-ancestor
14108531|NCT02361060|Atropine|atropine|mesh-list
14108532|NCT02361060|Neostigmine|neostigmine|mesh-list
14108533|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13931817|NCT03364530|Gemcitabine|gemcitabine|mesh-list
13931818|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
13931819|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13931820|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
13931821|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931822|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931823|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
13931824|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931825|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931826|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13931827|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
13931828|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931829|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13931830|NCT03364348|Trastuzumab|trastuzumab|mesh-list
14108534|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14108535|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14108536|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
14108537|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108538|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108539|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14108540|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
14108541|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
14108542|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
14108543|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14108544|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14108545|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
14108546|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108547|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108548|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14108549|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108550|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14108551|NCT02360982|Fentanyl|fentanyl|mesh-list
14108552|NCT02360982|Propofol|propofol|mesh-list
14108553|NCT02360982|Bupivacaine|bupivacaine|mesh-list
14108554|NCT02360982|Rocuronium|rocuronium|mesh-list
14108555|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14108556|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108557|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108558|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14108559|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
14108560|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
14108561|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14108562|NCT02360982|Narcotics|narcotics|mesh-ancestor
14108563|NCT02360982|Analgesics|analgesics|mesh-ancestor
14108564|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
14108565|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108566|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14108567|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
14108568|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14108569|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14108570|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14175652|NCT04774406|Rucaparib|rucaparib|mesh-list
14175653|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14175654|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175655|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175656|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175657|NCT04773366|Cytarabine|cytarabine|mesh-list
14175658|NCT04773366|Prednisone|prednisone|mesh-list
14175659|NCT04773366|Vincristine|vincristine|mesh-list
14175660|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
14175661|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14175662|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
14175663|NCT04773366|Hormones|hormones|mesh-ancestor
14175664|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175665|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175666|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14175667|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175668|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14175669|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
14175670|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931831|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
13931832|NCT03364348|Maytansine|maytansine|mesh-list
13931833|NCT03364348|Antibodies|antibodies|mesh-list
13931834|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
13931835|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14175671|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
14108571|NCT02360709|Sirolimus|sirolimus|mesh-list
14108572|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14108573|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108574|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14108575|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108576|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
14108577|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108578|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
14108579|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108580|NCT02360644|Vitamin D|vitamin d|mesh-list
14108581|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
14108582|NCT02360644|Vitamins|vitamins|mesh-ancestor
14108583|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
14108584|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108585|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14108586|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14108587|NCT02360501|Docetaxel|docetaxel|mesh-list
14108588|NCT02360501|Capecitabine|capecitabine|mesh-list
14108589|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108590|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
14108591|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
14108592|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
14108593|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108594|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108595|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
14108596|NCT02360618|Metformin|metformin|mesh-list
14108597|NCT02360618|Simvastatin|simvastatin|mesh-list
14108598|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14108599|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108600|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14108601|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14108602|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
13931836|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
13931837|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
13931838|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
14108603|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108604|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14108605|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14108606|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108607|NCT02360423|Sirolimus|sirolimus|mesh-list
14108608|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14108609|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108610|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14108611|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108612|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
14108613|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108614|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
14108615|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108616|NCT02360592|Interferons|interferons|mesh-list
14108617|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
14108618|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
14108619|NCT02360592|Entecavir|entecavir|mesh-list
14108620|NCT02360592|Interleukin-2|interleukin-2|mesh-list
14108621|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108622|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
14108623|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108624|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
14108625|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108626|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108627|NCT02360592|Analgesics|analgesics|mesh-ancestor
14477802|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
14477803|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479258|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931839|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931840|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931841|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13931842|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
13931843|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
13931844|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
13931845|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931846|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
13931847|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13931848|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
13931849|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108628|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
13931850|NCT03364218|Expectorants|expectorants|mesh-ancestor
14108629|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108630|NCT02360384|Linaclotide|linaclotide|mesh-list
13931851|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
13931852|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13931853|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
13931854|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931855|NCT03364218|Protective Agents|protective agents|mesh-ancestor
13931856|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931857|NCT03364218|Antidotes|antidotes|mesh-ancestor
13931858|NCT03364088|Oxycodone|oxycodone|mesh-list
13931859|NCT03364088|Anesthetics|anesthetics|mesh-list
13931860|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931861|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931862|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13931863|NCT03364088|Narcotics|narcotics|mesh-ancestor
14108631|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14108632|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
14108633|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108634|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108635|NCT02360202|Clobetasol|clobetasol|mesh-list
14108636|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108637|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
14108638|NCT02360202|Hormones|hormones|mesh-ancestor
14108639|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108640|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108641|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
14108642|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108643|NCT02360254|Insulin|insulin|mesh-list
14108644|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14108645|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108646|NCT02360007|Buprenorphine|buprenorphine|mesh-list
14108647|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14108648|NCT02360007|Narcotics|narcotics|mesh-ancestor
14108649|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108650|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108651|NCT02360007|Analgesics|analgesics|mesh-ancestor
14108652|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
14108653|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108654|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14108655|NCT02359942|Citric Acid|citric acid|mesh-list
14108656|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
14108657|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
14108658|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14108659|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
14108660|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
14108661|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108662|NCT02359604|Esomeprazole|esomeprazole|mesh-list
14108663|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14108664|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108665|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14108666|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108667|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108668|NCT02359695|Hormones|hormones|mesh-list
14108669|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108670|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108671|NCT02359643|Aspirin|aspirin|mesh-list
13931864|NCT03364088|Analgesics|analgesics|mesh-ancestor
13931865|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
13931866|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931867|NCT03364075|Propranolol|propranolol|mesh-list
13931868|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13931869|NCT03364075|Serotonin|serotonin|mesh-list
13931870|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13931871|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13931872|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13931873|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931874|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931875|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931876|NCT03364075|Analgesics|analgesics|mesh-ancestor
13931877|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
13931878|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931879|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
13931880|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13931881|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
14108672|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13931882|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13931883|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13931884|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
13931885|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13931886|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13931887|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
14108673|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108674|NCT02359643|Analgesics|analgesics|mesh-ancestor
14108675|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
14108676|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931888|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13931889|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
13961174|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108677|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108678|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108679|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108680|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14108681|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14108682|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108683|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14108684|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14108685|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108686|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
14108687|NCT02359721|Clarithromycin|clarithromycin|mesh-list
14108688|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14108689|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108690|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14108691|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108692|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108693|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14108694|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14108695|NCT02359617|Insulin|insulin|mesh-list
14108696|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14108697|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108698|NCT02359292|Charcoal|charcoal|mesh-list
14108699|NCT02359292|Antidotes|antidotes|mesh-ancestor
14108700|NCT02359292|Protective Agents|protective agents|mesh-ancestor
14108701|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108702|NCT02359214|Vitamin D|vitamin d|mesh-list
14108703|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
14108704|NCT02359214|Vitamins|vitamins|mesh-ancestor
14108705|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
14108706|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108707|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14108708|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14108709|NCT02359370|Lidocaine|lidocaine|mesh-list
14108710|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
14108711|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
14108712|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
14108713|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108714|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108715|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
14108716|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108717|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14108718|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14108719|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14108720|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108721|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108722|NCT02359370|Analgesics|analgesics|mesh-ancestor
14108723|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
14108724|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14108725|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14108726|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
14108727|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14108728|NCT02359448|Melatonin|melatonin|mesh-list
14108729|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
14108730|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108731|NCT02359448|Protective Agents|protective agents|mesh-ancestor
14108732|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108733|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108734|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14108735|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108736|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
14108737|NCT02359526|Hormones|hormones|mesh-ancestor
14108738|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108739|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108740|NCT02359331|Amoxicillin|amoxicillin|mesh-list
14108741|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
14108742|NCT02359331|Metronidazole|metronidazole|mesh-list
14108743|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14108744|NCT02359331|Tetracycline|tetracycline|mesh-list
14108745|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
14108746|NCT02359331|Bismuth|bismuth|mesh-list
13931890|NCT03363984|Midazolam|midazolam|mesh-list
13931891|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13931892|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14936092|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
14936093|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
14936094|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
13931893|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931894|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931895|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13931896|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13931897|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13931898|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14108747|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14108748|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14108749|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14108750|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108751|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108752|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108753|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14108754|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14108755|NCT02359331|Antacids|antacids|mesh-ancestor
14108756|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108757|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14108758|NCT02359266|Vitamin D|vitamin d|mesh-list
14108759|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
14108760|NCT02359266|Vitamins|vitamins|mesh-ancestor
13931899|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
13931900|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
13931901|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
13931902|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
13931903|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931904|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931905|NCT03363867|Bevacizumab|bevacizumab|mesh-list
13931906|NCT03363867|Atezolizumab|atezolizumab|mesh-list
13931907|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13931908|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931909|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13931910|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13931911|NCT03363867|Growth Substances|growth substances|mesh-ancestor
13931912|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108761|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
14108762|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108763|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14108764|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14108765|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
14108766|NCT02359149|Growth Substances|growth substances|mesh-ancestor
14108767|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108768|NCT02359500|Octreotide|octreotide|mesh-list
14108769|NCT02359500|Edotreotide|edotreotide|mesh-list
13931913|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
13931914|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
13931915|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
13931916|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931917|NCT03363815|Vitamin K|vitamin k|mesh-list
13931918|NCT03363815|Metformin|metformin|mesh-list
13931919|NCT03363815|Nintedanib|nintedanib|mesh-list
13931920|NCT03363815|Digoxin|digoxin|mesh-list
13931921|NCT03363815|Midazolam|midazolam|mesh-list
13931922|NCT03363815|Omeprazole|omeprazole|mesh-list
13931923|NCT03363815|Warfarin|warfarin|mesh-list
13931924|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13931925|NCT03363815|Vitamins|vitamins|mesh-ancestor
13931926|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
14108770|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931927|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931928|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931929|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13931930|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14108771|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14108772|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108773|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14108774|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931931|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931932|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13931933|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13931934|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13931935|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13931936|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
13931937|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
13931938|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
13931939|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
13931940|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13931941|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931942|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14108775|NCT02359474|Trabectedin|trabectedin|mesh-list
14108776|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14108777|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
14108778|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108779|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108780|NCT02358824|Amlodipine|amlodipine|mesh-list
14108781|NCT02358824|Telmisartan|telmisartan|mesh-list
14108782|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14108783|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14108784|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13931943|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13931944|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
13931945|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13931946|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13931947|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931948|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
14108785|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108786|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13931949|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13931950|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13931951|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13931952|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13931953|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13931954|NCT03363815|Protective Agents|protective agents|mesh-ancestor
13931955|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13931956|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931957|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
13931958|NCT03363815|Coagulants|coagulants|mesh-ancestor
13931959|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13931960|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13931961|NCT03363659|Copper|copper|mesh-list
13931962|NCT03363659|Temozolomide|temozolomide|mesh-list
13931963|NCT03363659|Disulfiram|disulfiram|mesh-list
13931964|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13931965|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
13931966|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108787|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108788|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
14108789|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14108790|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14108791|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
14108792|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
14108793|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
14108794|NCT02358993|Methenamine|methenamine|mesh-list
14108795|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14108796|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108797|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14108798|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14108799|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108800|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108801|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108802|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14108803|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14108804|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14108805|NCT02358993|Renal Agents|renal agents|mesh-ancestor
14108806|NCT02358850|Acetaminophen|acetaminophen|mesh-list
14108807|NCT02358850|Oxycodone|oxycodone|mesh-list
14108808|NCT02358850|Hydromorphone|hydromorphone|mesh-list
14108809|NCT02358850|Hydrocodone|hydrocodone|mesh-list
14108810|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13931967|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108811|NCT02358850|Analgesics|analgesics|mesh-ancestor
14108812|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
14108813|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108814|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108815|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
14761858|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14761859|NCT03333408|Clindamycin|clindamycin|mesh-list
14761860|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
14108816|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14108817|NCT02358850|Narcotics|narcotics|mesh-ancestor
14108818|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108819|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
14108820|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
14108821|NCT02359136|Epinephrine|epinephrine|mesh-list
14108822|NCT02359136|Analgesics|analgesics|mesh-list
14108823|NCT02359136|Anesthetics|anesthetics|mesh-list
14108824|NCT02359136|Ropivacaine|ropivacaine|mesh-list
14108825|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108826|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108827|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
14108828|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
14108829|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108830|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14108831|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14108832|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
14108833|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108834|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108835|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14108836|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14108837|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
14108838|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14108839|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
14108840|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
14108841|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
14108842|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14108843|NCT02358967|Vitamin E|vitamin e|mesh-list
14108844|NCT02358967|Tocopherols|tocopherols|mesh-list
14108845|NCT02358967|Tocotrienols|tocotrienols|mesh-list
14108846|NCT02358967|Vitamins|vitamins|mesh-ancestor
14108847|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
14108848|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108849|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
14108850|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108851|NCT02358967|Protective Agents|protective agents|mesh-ancestor
14108852|NCT02359162|Gemcitabine|gemcitabine|mesh-list
14108853|NCT02359162|Prednisone|prednisone|mesh-list
14108854|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
14108855|NCT02359162|Doxorubicin|doxorubicin|mesh-list
14108856|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
14108857|NCT02359162|Etoposide|etoposide|mesh-list
14108858|NCT02359162|Vincristine|vincristine|mesh-list
13931968|NCT03363659|Trace Elements|trace elements|mesh-ancestor
13931969|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
13931970|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931971|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13931972|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
13931973|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13931974|NCT03363477|Enoxaparin|enoxaparin|mesh-list
13931975|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
13931976|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
14108859|NCT02359162|Pegaspargase|pegaspargase|mesh-list
14108860|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108861|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
14108862|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108863|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108864|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14108865|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
14108866|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108867|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108868|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14108869|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108870|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
14761861|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
14108871|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
14108872|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108873|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936095|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13931977|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14108874|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14767366|NCT00629720|Alfuzosin|alfuzosin|mesh-list
13931978|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13931979|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931980|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13931981|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13931982|NCT03363425|Lidocaine|lidocaine|mesh-list
13931983|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
13931984|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
13931985|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
13931986|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13931987|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13931988|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
13931989|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13931990|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13931991|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13931992|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13931993|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13931994|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13931995|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13931996|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108875|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14108876|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14108877|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14108878|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
14108879|NCT02359162|Hormones|hormones|mesh-ancestor
14108880|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108881|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14108882|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14108883|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
14108884|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
14108885|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
14175672|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175673|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14175674|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
14175675|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14175676|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
14175677|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
14175678|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
14175679|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14175680|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175681|NCT04773301|Ropivacaine|ropivacaine|mesh-list
14175682|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
14175683|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175684|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
14175685|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175686|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175687|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
14175688|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175689|NCT04773236|Lidocaine|lidocaine|mesh-list
14175690|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175691|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
14175692|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175693|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175694|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
14175695|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175696|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14175697|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14175698|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14175699|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14175700|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175701|NCT04774393|Decitabine|decitabine|mesh-list
14175702|NCT04774393|Venetoclax|venetoclax|mesh-list
14175703|NCT04774393|Ivosidenib|ivosidenib|mesh-list
14175704|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14175705|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
14175706|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175707|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175708|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175709|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
14175710|NCT04773392|Prednisone|prednisone|mesh-list
14175711|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
14175712|NCT04773392|Azathioprine|azathioprine|mesh-list
14175713|NCT04773392|Tacrolimus|tacrolimus|mesh-list
14175714|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
13931997|NCT03363425|Analgesics|analgesics|mesh-ancestor
13931998|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13931999|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13932000|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13932001|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
13932002|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932003|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
14108886|NCT02358707|Ibuprofen|ibuprofen|mesh-list
14108887|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14108888|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108889|NCT02358707|Analgesics|analgesics|mesh-ancestor
14108890|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
14108891|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108892|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108893|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932004|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13932005|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932006|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13932007|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13932008|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932009|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932010|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932011|NCT03363217|Trametinib|trametinib|mesh-list
13932012|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932013|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13932014|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932015|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932016|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
13932017|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932018|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
13932019|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
13932020|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
13932021|NCT03363191|Fluticasone|fluticasone|mesh-list
13932022|NCT03363191|Xhance|xhance|mesh-list
13932023|NCT03363191|Albuterol|albuterol|mesh-list
14108894|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14108895|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14108896|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108897|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108898|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
14108899|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14108900|NCT02358694|Antibodies|antibodies|mesh-list
14108901|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
14108902|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108903|NCT02358642|Lisinopril|lisinopril|mesh-list
14108904|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14108905|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14108906|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
14108907|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108908|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14108909|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14108910|NCT02358642|Protective Agents|protective agents|mesh-ancestor
14108911|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108912|NCT02358499|Posaconazole|posaconazole|mesh-list
14108913|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
14108914|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108915|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14108916|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14108917|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14108918|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14108919|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14108920|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108921|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932024|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932025|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13932026|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
13932027|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932028|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932029|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13932030|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
13932031|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
13932032|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13932033|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
13932034|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13932035|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13932036|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14108922|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14108923|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
14108924|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14108925|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108926|NCT02358356|Capecitabine|capecitabine|mesh-list
14108927|NCT02358356|Temozolomide|temozolomide|mesh-list
14108928|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14761862|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14761863|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761864|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14761865|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761866|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761867|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14761868|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
14761869|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14761870|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14108929|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
14108930|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108931|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108932|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14108933|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
14108934|NCT02358304|Calcitonin|calcitonin|mesh-list
14108935|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
14108936|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14108937|NCT02358304|Katacalcin|katacalcin|mesh-list
14108938|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14108939|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108940|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14108941|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
14108942|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
14108943|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
14108944|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
14108945|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14108946|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14108947|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
14108948|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
14108949|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108950|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108951|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108952|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14108953|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
14108954|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14108955|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
14108956|NCT02358057|Alfentanil|alfentanil|mesh-list
14108957|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14108958|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14108959|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108960|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14108961|NCT02358057|Analgesics|analgesics|mesh-ancestor
14108962|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
14108963|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14108964|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14108965|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14108966|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14108967|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14108968|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14108969|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108970|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14108971|NCT02358057|Narcotics|narcotics|mesh-ancestor
14108972|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14108973|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
14108974|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
13932037|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13932038|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
13932039|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932040|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932041|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
13932042|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13932043|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14108975|NCT02358083|Vaccines|vaccines|mesh-list
14108976|NCT02358083|Immunologic Factors|immunologic factors|mesh-ancestor
14108977|NCT02358083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108978|NCT02358161|Gemcitabine|gemcitabine|mesh-list
14108979|NCT02358161|Paclitaxel|paclitaxel|mesh-list
14108980|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14108981|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14108982|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
14108983|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
14108984|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
14108985|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14108986|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14108987|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
14108988|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
14108989|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108990|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14108991|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14108992|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
14108993|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14108994|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14108995|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14108996|NCT02358187|Poly ICLC|poly iclc|mesh-list
14108997|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
14108998|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
14108999|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109000|NCT02358200|Paclitaxel|paclitaxel|mesh-list
14109001|NCT02358200|Carboplatin|carboplatin|mesh-list
14109002|NCT02358200|Talazoparib|talazoparib|mesh-list
14109003|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14109004|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109005|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14109006|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14109007|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14109008|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109009|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14109010|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109011|NCT02358018|Edotreotide|edotreotide|mesh-list
14109012|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14109013|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109014|NCT02357797|Vortioxetine|vortioxetine|mesh-list
14109015|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
14109016|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14109017|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14109018|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14109019|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109020|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109021|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14109022|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14109023|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932044|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932045|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
13932046|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932047|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932048|NCT03362905|Lidocaine|lidocaine|mesh-list
13932049|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
13932050|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
13932051|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932052|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932053|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
13932054|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932055|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13932056|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13932057|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13932058|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932059|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932060|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
13932061|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13932062|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932063|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14109024|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109025|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109026|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
14109027|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14109028|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14109029|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14109030|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14109031|NCT02357849|Aripiprazole|aripiprazole|mesh-list
14109032|NCT02357849|Fluoxetine|fluoxetine|mesh-list
14109033|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
14109034|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14109035|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14109036|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14109037|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109038|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109039|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
14109040|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
14109041|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109042|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109043|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14109044|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14109045|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
14109046|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14109047|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14109048|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14109049|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14109050|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14109051|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14109052|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14109053|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14109054|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14109055|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14109056|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109057|NCT02357693|Aprepitant|aprepitant|mesh-list
13932064|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13932065|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932066|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932067|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932068|NCT03362814|Ritonavir|ritonavir|mesh-list
13932069|NCT03362814|Ribavirin|ribavirin|mesh-list
13932070|NCT03362814|Lactams|lactams|mesh-list
13932071|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13932072|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14109058|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
14109059|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
14109060|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109061|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109062|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109063|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14109064|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109065|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109066|NCT02357732|Nivolumab|nivolumab|mesh-list
14109067|NCT02357732|Trametinib|trametinib|mesh-list
14109068|NCT02357732|Dabrafenib|dabrafenib|mesh-list
14109069|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14109070|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109071|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14109072|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109073|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14109074|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109075|NCT02357524|Oritavancin|oritavancin|mesh-list
14109076|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14109077|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109078|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14109079|NCT02357563|Leuprolide|leuprolide|mesh-list
14109080|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
14109081|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14109082|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
14109083|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14109084|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109085|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14109086|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109087|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14109088|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
13932073|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
13932074|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932075|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109089|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14109090|NCT02357615|Nifedipine|nifedipine|mesh-list
14109091|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14109092|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14109093|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109094|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14109095|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109096|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
14109097|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
14109098|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14109099|NCT02357602|Tenofovir|tenofovir|mesh-list
14109100|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
14109101|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109102|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13932076|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13932077|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13932078|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
13932079|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932080|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13932081|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13932082|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
13932083|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13932084|NCT03362788|Vitamin K|vitamin k|mesh-list
13932085|NCT03362788|Anticoagulants|anticoagulants|mesh-list
13932086|NCT03362788|Vitamins|vitamins|mesh-ancestor
14109103|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14109104|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109105|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109106|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14109107|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14109108|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14109109|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14109110|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
14109111|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109112|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
14109113|NCT02357303|Simethicone|simethicone|mesh-list
14109114|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14109115|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
14109116|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109117|NCT02357303|Expectorants|expectorants|mesh-ancestor
14109118|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
14109119|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14109120|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
14109121|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109122|NCT02357303|Protective Agents|protective agents|mesh-ancestor
14109123|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109124|NCT02357303|Antidotes|antidotes|mesh-ancestor
14109125|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
14109126|NCT02357303|Emollients|emollients|mesh-ancestor
14109127|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
14936096|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936097|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14936098|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13932087|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
13932088|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932089|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13932090|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13932091|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932092|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
13932093|NCT03362788|Coagulants|coagulants|mesh-ancestor
13932094|NCT03362775|Propofol|propofol|mesh-list
13932095|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13932096|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932097|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932098|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13932099|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
13932100|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
13932101|NCT03362736|Ustekinumab|ustekinumab|mesh-list
13932102|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
13932103|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13932104|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932105|NCT03362684|Cetuximab|cetuximab|mesh-list
14109128|NCT02357277|Budesonide|budesonide|mesh-list
14109129|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14936099|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936100|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14936101|NCT01467258|Amantadine|amantadine|mesh-list
14109130|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14109131|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
14109132|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109133|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109134|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13932106|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932107|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932108|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13932109|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932110|NCT03362515|Furosemide|furosemide|mesh-list
13932111|NCT03362515|Diuretics|diuretics|mesh-ancestor
13932112|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
13932113|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932114|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13932115|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932116|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109135|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
14109136|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
14109137|NCT02357277|Hormones|hormones|mesh-ancestor
14109138|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109139|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
14109140|NCT02357407|Ofloxacin|ofloxacin|mesh-list
14109141|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14109142|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109143|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14109144|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14109145|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109146|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109147|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109148|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14109149|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14109150|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13932117|NCT03362411|Linrodostat|linrodostat|mesh-list
13932118|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932119|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961175|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13961176|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961177|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
13961178|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13961179|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
13961180|NCT03150420|Antidotes|antidotes|mesh-ancestor
13961181|NCT03150420|Protective Agents|protective agents|mesh-ancestor
14109151|NCT02357407|Renal Agents|renal agents|mesh-ancestor
14109152|NCT02357225|Bromides|bromides|mesh-list
14109153|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14109154|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
14109155|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13961182|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961183|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
13961184|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961185|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
13961186|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961187|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961188|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
13961189|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
13961190|NCT03150134|Cyclosporine|cyclosporine|mesh-list
13961191|NCT03150134|Cyclosporins|cyclosporins|mesh-list
13961192|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
13961193|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961194|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961195|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
13961196|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961197|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
13961198|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961199|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
13961200|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961201|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13961202|NCT03149939|Febuxostat|febuxostat|mesh-list
13961203|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
14109156|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961204|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961205|NCT03149913|Paclitaxel|paclitaxel|mesh-list
13932120|NCT03362359|Edetic Acid|edetic acid|mesh-list
13932121|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13932122|NCT03362359|Chelating Agents|chelating agents|mesh-ancestor
13932123|NCT03362359|Sequestering Agents|sequestering agents|mesh-ancestor
13932124|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932125|NCT03362359|Anticoagulants|anticoagulants|mesh-ancestor
13932126|NCT03362359|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13932127|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13932128|NCT03362281|Amoxicillin|amoxicillin|mesh-list
13932129|NCT03362281|Clarithromycin|clarithromycin|mesh-list
13932130|NCT03362281|Omeprazole|omeprazole|mesh-list
13932131|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13932132|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932133|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13932134|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13932135|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13932136|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932137|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932138|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13932139|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13932140|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13932141|NCT03362268|Omeprazole|omeprazole|mesh-list
13932142|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13932143|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13932144|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13932145|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932146|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932147|NCT03362216|Diclofenac|diclofenac|mesh-list
13932148|NCT03362216|Salicylates|salicylates|mesh-list
13932149|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
13932150|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13932151|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13932152|NCT03362216|Analgesics|analgesics|mesh-ancestor
13932153|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
13932154|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932155|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932156|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932157|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13932158|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13932159|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932160|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932161|NCT03362073|Ketamine|ketamine|mesh-list
13932162|NCT03362073|Analgesics|analgesics|mesh-ancestor
13932163|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
13932164|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932165|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932166|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13932167|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13932168|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
13932169|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
13932170|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932171|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13932172|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13932173|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932174|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932175|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
13932176|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932177|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932178|NCT03362047|Macitentan|macitentan|mesh-list
13932179|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13932180|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13932181|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109157|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109158|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
14109159|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109160|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109161|NCT02357212|Adenosine|adenosine|mesh-list
14109162|NCT02357212|Analgesics|analgesics|mesh-ancestor
14109163|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
14109164|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109165|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109166|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13932182|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14109167|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
14109168|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14109169|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
14109170|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
14109171|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109172|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175715|NCT04773392|Basiliximab|basiliximab|mesh-list
14175716|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14175717|NCT04773392|Antimetabolites|antimetabolites|mesh-list
14175718|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14175719|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
14175720|NCT04773392|Hormones|hormones|mesh-ancestor
14175721|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932183|NCT03362008|Varenicline|varenicline|mesh-list
13932184|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13932185|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13932186|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
13932187|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932188|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175722|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175723|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14175724|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175725|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14175726|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
14175727|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14175728|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175729|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175730|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14175731|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14175732|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
14175733|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14175734|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175735|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
14175736|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
14175737|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175738|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175739|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14175740|NCT04773392|Protective Agents|protective agents|mesh-ancestor
14175741|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14175742|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175743|NCT04773093|Lidocaine|lidocaine|mesh-list
13932189|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932190|NCT03361878|Metformin|metformin|mesh-list
13932191|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13932192|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932193|NCT03361800|Entinostat|entinostat|mesh-list
14175744|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175745|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
14175746|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175747|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761871|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14761872|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14761873|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761874|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
14761875|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14761876|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761877|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14761878|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14761879|NCT03326791|Aspirin|aspirin|mesh-list
14761880|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14761881|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14761882|NCT03326791|Analgesics|analgesics|mesh-ancestor
14761883|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
14175748|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
14175749|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175750|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14175751|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14175752|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14175753|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932194|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932195|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13932196|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932197|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932198|NCT03361774|Fluorides|fluorides|mesh-list
14109173|NCT02357004|Carvedilol|carvedilol|mesh-list
13932199|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
13932200|NCT03361774|Protective Agents|protective agents|mesh-ancestor
13932201|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932202|NCT03361735|Leuprolide|leuprolide|mesh-list
13932203|NCT03361735|Goserelin|goserelin|mesh-list
13932204|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13932205|NCT03361735|Hormones|hormones|mesh-list
13932206|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932207|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932208|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14477804|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477805|NCT02439281|Clonidine|clonidine|mesh-list
14477806|NCT02439281|Ropivacaine|ropivacaine|mesh-list
14477807|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
14477808|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
14477809|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477810|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477811|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
14477812|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477813|NCT02439281|Analgesics|analgesics|mesh-ancestor
14761884|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109174|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
14109175|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14109176|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14109177|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
14109178|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109179|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109180|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109181|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13932209|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
13932210|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13932211|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13932212|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932213|NCT03361709|Dexamethasone|dexamethasone|mesh-list
14109182|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
14109183|NCT02357004|Protective Agents|protective agents|mesh-ancestor
14109184|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14109185|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14109186|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14109187|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
14109188|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14109189|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14109190|NCT02357004|Diuretics|diuretics|mesh-ancestor
14109191|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
14109192|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14109193|NCT02357069|Etanercept|etanercept|mesh-list
14109194|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14109195|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14109196|NCT02357069|Analgesics|analgesics|mesh-ancestor
14109197|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
14109198|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109199|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109200|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109201|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14109202|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109203|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14109204|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
14109205|NCT02356913|Nicotine|nicotine|mesh-list
14109206|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14109207|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
14109208|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109209|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109210|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14109211|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14109212|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
14109213|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109214|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109215|NCT02356965|Ketamine|ketamine|mesh-list
14109216|NCT02356965|Analgesics|analgesics|mesh-ancestor
14109217|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
13932214|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932215|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
14109218|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477814|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13932216|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
13932217|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932218|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932219|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13932220|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
13932221|NCT03361709|Hormones|hormones|mesh-ancestor
13932222|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932223|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13932224|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932225|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
13932226|NCT03361618|Astringents|astringents|mesh-ancestor
13932227|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932228|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
13932229|NCT03361397|Lidocaine|lidocaine|mesh-list
13932230|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
13932231|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
13932232|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932233|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932234|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
13932235|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932236|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13932237|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13932238|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13932239|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932240|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932241|NCT03361319|Paclitaxel|paclitaxel|mesh-list
13932242|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13932243|NCT03361319|Nintedanib|nintedanib|mesh-list
13932244|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13932245|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932246|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
13932247|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
13932248|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
13932249|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932250|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13932251|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932252|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13932253|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13932254|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
13932255|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932256|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932257|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932258|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
13932259|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13932260|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13932261|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
13932262|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932263|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932264|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932265|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14109219|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109220|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14109221|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14109222|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
14109223|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
14109224|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109225|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14109226|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14109227|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109228|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109229|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
14109230|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14109231|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
14109232|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109233|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109234|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14109235|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
14109236|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14109237|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
14109238|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109239|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109240|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14109241|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
14109242|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
14109243|NCT02356835|Protective Agents|protective agents|mesh-ancestor
14109244|NCT02356445|Methotrexate|methotrexate|mesh-list
14109245|NCT02356445|Azathioprine|azathioprine|mesh-list
14109246|NCT02356445|Infliximab|infliximab|mesh-list
14109247|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14109248|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
14109249|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14109250|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109251|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14109252|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
14109253|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109254|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109255|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
14109256|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109257|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14109258|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14109259|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
14109260|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14109261|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14109262|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109263|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
14109264|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109265|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
14109266|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109267|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109268|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
14109269|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109270|NCT02356679|Ethanol|ethanol|mesh-list
14109271|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14109272|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109273|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109274|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109275|NCT02356146|Tacrolimus|tacrolimus|mesh-list
14109276|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14109277|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
14109278|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109279|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14109280|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109281|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109282|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14109283|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14109284|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
13932266|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13932267|NCT03361124|Oxytocin|oxytocin|mesh-list
13932268|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
13932269|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13932270|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932271|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
13932272|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
13932273|NCT03361098|Exenatide|exenatide|mesh-list
13932274|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932275|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13932276|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932277|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13932278|NCT03361098|Incretins|incretins|mesh-ancestor
13932279|NCT03361098|Hormones|hormones|mesh-ancestor
13932280|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932281|NCT03360981|Incretins|incretins|mesh-list
13932282|NCT03360981|Hormones|hormones|mesh-ancestor
13932283|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932284|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932285|NCT03360955|Anesthetics|anesthetics|mesh-list
13932286|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932287|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932288|NCT03360916|Atorvastatin|atorvastatin|mesh-list
13932289|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14109285|NCT02356419|Hematinics|hematinics|mesh-ancestor
14109286|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14109287|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13932290|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14109288|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
13932291|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
13932292|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109289|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
14109290|NCT02355938|Vancomycin|vancomycin|mesh-list
14109291|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
13932293|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13932294|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13932295|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932296|NCT03360760|Doxorubicin|doxorubicin|mesh-list
13932297|NCT03360760|Methotrexate|methotrexate|mesh-list
13932298|NCT03360760|Ifosfamide|ifosfamide|mesh-list
13932299|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
13932300|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932301|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13932302|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13932303|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13932304|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932305|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109292|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14109293|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932306|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13932307|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
13932308|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13932309|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932310|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13932311|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
13932312|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
13932313|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13932314|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13932315|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
13932316|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13932317|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14109294|NCT02355704|Atorvastatin|atorvastatin|mesh-list
14109295|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14109296|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14109297|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
14109298|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109299|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14109300|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14109301|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109302|NCT02355678|Acetaminophen|acetaminophen|mesh-list
14109303|NCT02355678|Dexamethasone|dexamethasone|mesh-list
14109304|NCT02355678|Propacetamol|propacetamol|mesh-list
14109305|NCT02355678|Tramadol|tramadol|mesh-list
14109306|NCT02355678|Anesthetics|anesthetics|mesh-list
14109307|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
14109308|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109309|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
14109310|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
14109311|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109312|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109313|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109314|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
14109315|NCT02355678|Hormones|hormones|mesh-ancestor
14109316|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109317|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14109318|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109319|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109320|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14109321|NCT02355678|Analgesics|analgesics|mesh-ancestor
14109322|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
14109323|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
14109324|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14109325|NCT02355678|Narcotics|narcotics|mesh-ancestor
14761885|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761886|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761887|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14761888|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14761889|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14761890|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761891|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14761892|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14761893|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761894|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
14761895|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14761896|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936102|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13932318|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14109326|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14109327|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14109328|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14109329|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109330|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14109331|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109332|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477815|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
14477816|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
14477817|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14477818|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14477819|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14477820|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
14936103|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14109333|NCT02355522|Lidocaine|lidocaine|mesh-list
14109334|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109335|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
14109336|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109337|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109338|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
14109339|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109340|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14109341|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14109342|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14109343|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14109344|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109345|NCT02355639|Betamethasone|betamethasone|mesh-list
14109346|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
14109347|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14109348|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
14109349|NCT02355639|Clobetasol|clobetasol|mesh-list
14109350|NCT02355639|Petrolatum|petrolatum|mesh-list
14109351|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14109352|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109353|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
14109354|NCT02355639|Hormones|hormones|mesh-ancestor
14109355|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109356|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109357|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14109358|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
14109359|NCT02355639|Emollients|emollients|mesh-ancestor
14109360|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175754|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183664|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
13932319|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
13932320|NCT03360734|Cetuximab|cetuximab|mesh-list
13932321|NCT03360734|Panitumumab|panitumumab|mesh-list
13932322|NCT03360734|Necitumumab|necitumumab|mesh-list
13932323|NCT03360734|Antibodies|antibodies|mesh-list
13932324|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
14183665|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183666|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
14183667|NCT04726553|Antimalarials|antimalarials|mesh-list
14183668|NCT04726553|Methotrexate|methotrexate|mesh-list
14183669|NCT04726553|Azathioprine|azathioprine|mesh-list
14183670|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14183671|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
14183672|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183673|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183674|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14183675|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
14183676|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183677|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477821|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477822|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477823|NCT02439320|Lasmiditan|lasmiditan|mesh-list
13932325|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932326|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932327|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961206|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13961207|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961208|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
13961209|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936104|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
14936105|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936106|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
14936107|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936108|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936109|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936110|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936111|NCT01467258|Analgesics|analgesics|mesh-ancestor
14936112|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
14936113|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936114|NCT01467297|Levofloxacin|levofloxacin|mesh-list
14936115|NCT01467297|Ofloxacin|ofloxacin|mesh-list
14936116|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14936117|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109361|NCT02355509|Acarbose|acarbose|mesh-list
14109362|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14109363|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109364|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109365|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14109366|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109367|NCT02355184|Leronlimab|leronlimab|mesh-list
14109368|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14109369|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14109370|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109371|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14109372|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14109373|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
14109374|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109375|NCT02355236|Celecoxib|celecoxib|mesh-list
14109376|NCT02355236|Naproxen|naproxen|mesh-list
14109377|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14109378|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14109379|NCT02355236|Analgesics|analgesics|mesh-ancestor
14109380|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
14109381|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109382|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109383|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109384|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14109385|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14109386|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14109387|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109388|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109389|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
14109390|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
14109391|NCT02355197|Vitamins|vitamins|mesh-ancestor
14109392|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
14109393|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109394|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
14109395|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109396|NCT02355197|Protective Agents|protective agents|mesh-ancestor
14109397|NCT02355119|Gemcitabine|gemcitabine|mesh-list
14109398|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14109399|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
14109400|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109401|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109402|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
14109403|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109404|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109405|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14109406|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
14109407|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109408|NCT02355093|Ropivacaine|ropivacaine|mesh-list
14109409|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109410|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
14109411|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109412|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109413|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
14175755|NCT04772781|Ibuprofen|ibuprofen|mesh-list
14109414|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109415|NCT02355054|Choline|choline|mesh-list
14109416|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
14109417|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13932343|NCT03360682|Tenofovir|tenofovir|mesh-list
13932344|NCT03360682|Lamivudine|lamivudine|mesh-list
13932345|NCT03360682|Emtricitabine|emtricitabine|mesh-list
13932346|NCT03360682|Abacavir|abacavir|mesh-list
13932347|NCT03360682|Dolutegravir|dolutegravir|mesh-list
13932348|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
13932349|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761897|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761898|NCT03313180|Nintedanib|nintedanib|mesh-list
14761899|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761900|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13932350|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13932351|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13932352|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932353|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932354|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13932355|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13932356|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13932357|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13932358|NCT03360279|Paclitaxel|paclitaxel|mesh-list
13932359|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13932360|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932361|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
13932362|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
13932363|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
13932364|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932365|NCT03360266|Listerine|listerine|mesh-list
13932366|NCT03360266|Fluorides|fluorides|mesh-list
13932367|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
13932368|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
14109418|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
14109419|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109420|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109421|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14109422|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
14109423|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
14109424|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14109425|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14109426|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109427|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
14109428|NCT02354885|Coagulants|coagulants|mesh-ancestor
14109429|NCT02354768|Lanreotide|lanreotide|mesh-list
14109430|NCT02354768|Loperamide|loperamide|mesh-list
13932369|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
13932370|NCT03360266|Protective Agents|protective agents|mesh-ancestor
13932371|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932372|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13932373|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932374|NCT03360123|Midazolam|midazolam|mesh-list
13932375|NCT03360123|Triazolam|triazolam|mesh-list
13932376|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14109431|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
14109432|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109433|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109434|NCT02354807|Mirabegron|mirabegron|mesh-list
14109435|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14109436|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13932377|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13932378|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932379|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109437|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14109438|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
14761901|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932380|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13932381|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13932382|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14109439|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109440|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109441|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109442|NCT02354807|Urological Agents|urological agents|mesh-ancestor
14109443|NCT02354937|Cabotegravir|cabotegravir|mesh-list
14109444|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14109445|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14109446|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109447|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109448|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14109449|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14109450|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
14109451|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109452|NCT02354950|Cabotegravir|cabotegravir|mesh-list
14109453|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14109454|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14109455|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109456|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109457|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14109458|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14109459|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
14109460|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109461|NCT02354872|Nicotine|nicotine|mesh-list
14109462|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14109463|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
14109464|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109465|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109466|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14109467|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14936118|NCT01467297|Renal Agents|renal agents|mesh-ancestor
14936119|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13932383|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13932384|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
13932385|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
13932386|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
14936120|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14936121|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14936122|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936123|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932387|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
13932388|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109468|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
14109469|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109470|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109471|NCT02354638|Nicotine|nicotine|mesh-list
14109472|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14109473|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
14109474|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109475|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109476|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14109477|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14109478|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
14109479|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109480|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109481|NCT02354612|Bevacizumab|bevacizumab|mesh-list
14109482|NCT02354612|Capecitabine|capecitabine|mesh-list
14109483|NCT02354612|Axitinib|axitinib|mesh-list
14109484|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14109485|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109486|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14109487|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14109488|NCT02354612|Growth Substances|growth substances|mesh-ancestor
14109489|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109490|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
14109491|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14109492|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
13932389|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932390|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
13932391|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
13932392|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13932393|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13932394|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932395|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
14109493|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109494|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13932396|NCT03360045|Coagulants|coagulants|mesh-ancestor
13932397|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
13932398|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13932399|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932400|NCT03359876|Warfarin|warfarin|mesh-list
13932401|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
13932402|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
14109495|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109496|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
14109497|NCT02354547|Topotecan|topotecan|mesh-list
14109498|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14109499|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
14109500|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109501|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14109502|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14109503|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
14109504|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109505|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109506|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14109507|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14109508|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14109509|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109510|NCT02354313|Lenalidomide|lenalidomide|mesh-list
14109511|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
14109512|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109513|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14109514|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14109515|NCT02354313|Growth Substances|growth substances|mesh-ancestor
14109516|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
14109517|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109518|NCT02354560|Erythromycin|erythromycin|mesh-list
14109519|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
14109520|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14109521|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
14109522|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14109523|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109524|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109525|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14109526|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109527|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109528|NCT02354261|Itraconazole|itraconazole|mesh-list
14109529|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
14109530|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109531|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14109532|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14109533|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109534|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109535|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14109536|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109537|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109538|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109539|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14109540|NCT02354170|Mifepristone|mifepristone|mesh-list
14109541|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14109542|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
14109543|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14109544|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109545|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14109546|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14109547|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13932403|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13932404|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
13932405|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13932406|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
13932407|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932408|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932409|NCT03359863|Pirfenidone|pirfenidone|mesh-list
13932410|NCT03359863|Analgesics|analgesics|mesh-ancestor
13932411|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
13932412|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109548|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
13932413|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932414|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14109549|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14109550|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14109551|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109552|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109553|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
14109554|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14109555|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14109556|NCT02353949|Flutemetamol|flutemetamol|mesh-list
14109557|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14109558|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109559|NCT02354027|Metformin|metformin|mesh-list
14109560|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14109561|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109562|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14109563|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14109564|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109565|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109566|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109567|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14109568|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14109569|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14109570|NCT02354053|Triumeq|triumeq|mesh-list
14109571|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14109572|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14109573|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
14109574|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109575|NCT02353936|Afatinib|afatinib|mesh-list
14109576|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109577|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14109578|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109579|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109580|NCT02353858|Fluorouracil|fluorouracil|mesh-list
14109581|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
14109582|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109583|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14109584|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109585|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14109586|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
14109587|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109588|NCT02353988|Bicalutamide|bicalutamide|mesh-list
14109589|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
14109590|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109591|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109592|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109593|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932415|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13932416|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932417|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13932418|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932419|NCT03359837|Insulin|insulin|mesh-list
13932420|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13932421|NCT03359837|Metformin|metformin|mesh-list
13932422|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
13932423|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
13932424|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
13932425|NCT03359837|Acarbose|acarbose|mesh-list
13932426|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
13932427|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
13932428|NCT03359837|Repaglinide|repaglinide|mesh-list
14109594|NCT02353702|Ropivacaine|ropivacaine|mesh-list
14109595|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109596|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
14109597|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109598|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109599|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
14109600|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109601|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14109602|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14109603|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109604|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
14477824|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14477825|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
13932429|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13932430|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932431|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13932432|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932433|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932434|NCT03359798|Narcotics|narcotics|mesh-list
13932435|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932436|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932437|NCT03359798|Analgesics|analgesics|mesh-ancestor
13932438|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
13932439|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932440|NCT03359746|Grazoprevir|grazoprevir|mesh-list
13932441|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
13932442|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932443|NCT03359694|Docetaxel|docetaxel|mesh-list
13932444|NCT03359694|Doxorubicin|doxorubicin|mesh-list
13932445|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13932446|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932447|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
13932448|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
13932449|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
13932450|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932451|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13932452|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13932453|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13932454|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932455|NCT03359681|Metformin|metformin|mesh-list
13932456|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13932457|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932458|NCT03359655|Scopolamine|scopolamine|mesh-list
13932459|NCT03359655|Bromides|bromides|mesh-list
13932460|NCT03359655|Misoprostol|misoprostol|mesh-list
13932461|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13932462|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13932463|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
13932464|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13932465|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932466|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13932467|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13932468|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
13932469|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
13932470|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13932471|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
13932472|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
13932473|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932474|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
13932475|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13932476|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
13932477|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932478|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932479|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13932480|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
14109605|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109606|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14109607|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109608|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109609|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109610|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109611|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109612|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14109613|NCT02353676|Bupivacaine|bupivacaine|mesh-list
14109614|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109615|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
14109616|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109617|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109618|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
14109619|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175756|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14175757|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14175758|NCT04772781|Analgesics|analgesics|mesh-ancestor
14175759|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
14175760|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175761|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932481|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
13932482|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13932483|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13932484|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932485|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
13932486|NCT03359525|Coagulants|coagulants|mesh-ancestor
13932487|NCT03359499|Trimebutine|trimebutine|mesh-list
13932488|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13932489|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
13932490|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
13932491|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932492|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932493|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13932494|NCT03359291|Macitentan|macitentan|mesh-list
13932495|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13932496|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13932497|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
13932498|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932499|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13932500|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13932501|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932502|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13932503|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13932504|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
13932505|NCT03359161|Furosemide|furosemide|mesh-list
13932506|NCT03359161|Diuretics|diuretics|mesh-ancestor
13932507|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
13932508|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932509|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13932510|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932511|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932512|NCT03359070|Miconazole|miconazole|mesh-list
13932513|NCT03359070|Clotrimazole|clotrimazole|mesh-list
13932514|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
13932515|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932516|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13932517|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13932518|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932519|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932520|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13932521|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
13932522|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932523|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932524|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13932525|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13932526|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14109620|NCT02353494|Piperaquine|piperaquine|mesh-list
14109621|NCT02353494|Artenimol|artenimol|mesh-list
14109622|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
14109623|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14109624|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14109625|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109626|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14109627|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
14109628|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109629|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
14109630|NCT02353325|Fesoterodine|fesoterodine|mesh-list
14109631|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
14109632|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109633|NCT02353325|Protective Agents|protective agents|mesh-ancestor
14109634|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109635|NCT02353325|Vitamins|vitamins|mesh-ancestor
14109636|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
14109637|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14109638|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14109639|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
14109640|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109641|NCT02353325|Urological Agents|urological agents|mesh-ancestor
14109642|NCT02353260|Docetaxel|docetaxel|mesh-list
14109643|NCT02353260|Fluorouracil|fluorouracil|mesh-list
14109644|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109645|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
14109646|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
14109647|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
14109648|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109649|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
14109650|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14109651|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14109652|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
14109653|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109654|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
14109655|NCT02353182|Remifentanil|remifentanil|mesh-list
14109656|NCT02353182|Bupivacaine|bupivacaine|mesh-list
14109657|NCT02353182|Ropivacaine|ropivacaine|mesh-list
14109658|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109659|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
13932527|NCT03359057|Folic Acid|folic acid|mesh-list
13932528|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
13932529|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
13932530|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13932531|NCT03359057|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
13932532|NCT03359057|Estradiol|estradiol|mesh-list
13932533|NCT03359057|Estrogens|estrogens|mesh-ancestor
13932534|NCT03359057|Hormones|hormones|mesh-ancestor
13932535|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109660|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109661|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109662|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
14109663|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109664|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14109665|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14109666|NCT02353182|Analgesics|analgesics|mesh-ancestor
14109667|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14109668|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13932536|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932537|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13932538|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
13932539|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13932540|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13932541|NCT03359057|Hematinics|hematinics|mesh-ancestor
13932542|NCT03359057|Vitamins|vitamins|mesh-ancestor
13932543|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
13932544|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13932545|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13932546|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13932547|NCT03359057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13932548|NCT03359018|Apatinib|apatinib|mesh-list
13932549|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932550|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13932551|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932552|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932553|NCT03359005|Vincristine|vincristine|mesh-list
13932554|NCT03359005|Temozolomide|temozolomide|mesh-list
13932555|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13932556|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932557|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
13932558|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
13932559|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
13932560|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109669|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14109670|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
14109671|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109672|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109673|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14109674|NCT02353182|Narcotics|narcotics|mesh-ancestor
14109675|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13932561|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13932562|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
13961210|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
13961211|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961212|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13961213|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109676|NCT02353507|Laxatives|laxatives|mesh-ancestor
14109677|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109678|NCT02353429|Toremifene|toremifene|mesh-list
14109679|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14109680|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109681|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14761902|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109682|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13961214|NCT03149783|Ropivacaine|ropivacaine|mesh-list
13932563|NCT03358953|Nicotine|nicotine|mesh-list
13932564|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13932565|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
13932566|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932567|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932568|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13932569|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13932570|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
13932571|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932572|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109683|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109684|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109685|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109686|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14109687|NCT02353130|Memantine|memantine|mesh-list
14109688|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14109689|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14109690|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
14109691|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109692|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109693|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109694|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14109695|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14109696|NCT02353078|Sucralfate|sucralfate|mesh-list
14109697|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14109698|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109699|NCT02353026|Artesunate|artesunate|mesh-list
14109700|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
13932573|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
13932574|NCT03358888|Narcotics|narcotics|mesh-ancestor
13932575|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932576|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932577|NCT03358888|Analgesics|analgesics|mesh-ancestor
13932578|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
13932579|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932580|NCT03358875|Docetaxel|docetaxel|mesh-list
13932581|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932582|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
13932583|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14109701|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14109702|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14109703|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109704|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109705|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
14109706|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
14109707|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14109708|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
14109709|NCT02352883|Hormones|hormones|mesh-list
14109710|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109711|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109712|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
14109713|NCT02352987|Salicylates|salicylates|mesh-list
13932584|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
13932585|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932586|NCT03358719|Poly I-C|poly i-c|mesh-list
13932587|NCT03358719|Nivolumab|nivolumab|mesh-list
13932588|NCT03358719|Decitabine|decitabine|mesh-list
14936124|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936125|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14936126|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14936127|NCT01467310|Trametinib|trametinib|mesh-list
14109714|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109715|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
14109716|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
14109717|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14109718|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14109719|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14109720|NCT02352987|Analgesics|analgesics|mesh-ancestor
14109721|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
14109722|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109723|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109724|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109725|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14936128|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109726|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14936129|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14936130|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936131|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936132|NCT01467323|Insulin|insulin|mesh-list
14936133|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14936134|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
14936135|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
13932589|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13932590|NCT03358719|Poly ICLC|poly iclc|mesh-list
13932591|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932592|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932593|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14109727|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109728|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109729|NCT02352714|Lidocaine|lidocaine|mesh-list
14109730|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109731|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
14109732|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109733|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932594|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932595|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13932596|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
13932597|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932598|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
13932599|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
13932600|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932601|NCT03358719|Laxatives|laxatives|mesh-ancestor
13932602|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13932603|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
13932604|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932605|NCT03358524|Vitamins|vitamins|mesh-list
13932606|NCT03358524|Vitamin E|vitamin e|mesh-list
13932607|NCT03358524|Tocopherols|tocopherols|mesh-list
13932608|NCT03358524|Tocotrienols|tocotrienols|mesh-list
13932609|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
13932610|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
13932611|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932612|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
13932613|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932614|NCT03358524|Protective Agents|protective agents|mesh-ancestor
13932615|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
13932616|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13932617|NCT03358277|Methylphenidate|methylphenidate|mesh-list
13932618|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932619|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
13932620|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932621|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932622|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14109734|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
14109735|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109736|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14109737|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14109738|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14109739|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14109740|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109741|NCT02352545|Montelukast|montelukast|mesh-list
14109742|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14109743|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
14109744|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13932623|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13932624|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13932625|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932626|NCT03358212|Denosumab|denosumab|mesh-list
13932627|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13932628|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932629|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
13932630|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
13932631|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13932632|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13932633|NCT03358082|Tacrolimus|tacrolimus|mesh-list
13932634|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13932635|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
13932636|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932637|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13932638|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932639|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932640|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932641|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
13932642|NCT03358017|Atorvastatin|atorvastatin|mesh-list
13932643|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14109745|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109746|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109747|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109748|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14109749|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14936136|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936137|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936138|NCT01467362|Desonide|desonide|mesh-list
14936139|NCT01467362|V0034CR|v0034cr|mesh-list
14936140|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109750|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109751|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14109752|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14936141|NCT01467362|Emollients|emollients|mesh-ancestor
14936142|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
14109753|NCT02352597|Clomiphene|clomiphene|mesh-list
14109754|NCT02352597|Enclomiphene|enclomiphene|mesh-list
14109755|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
14109756|NCT02352597|Estradiol|estradiol|mesh-list
14109757|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14936143|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
14936144|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
14936145|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936146|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936147|NCT01467401|Insulin|insulin|mesh-list
14936148|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14936149|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
13932644|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13932645|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
13932646|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932647|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14761906|NCT03301220|Daratumumab|daratumumab|mesh-list
14761907|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761908|NCT03289741|Octreotide|octreotide|mesh-list
14761909|NCT03289741|Lanreotide|lanreotide|mesh-list
14761910|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13932648|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13932649|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932650|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13932651|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932652|NCT03358004|Capecitabine|capecitabine|mesh-list
13932653|NCT03358004|Vinorelbine|vinorelbine|mesh-list
13932654|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13932655|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
13932656|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932657|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932658|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13932659|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
13932660|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
13932661|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
13932662|NCT03357939|Adalimumab|adalimumab|mesh-list
13932663|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109758|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
14761911|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761912|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761913|NCT03287947|Nintedanib|nintedanib|mesh-list
14936150|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
14936151|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13932664|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13932665|NCT03357900|Remifentanil|remifentanil|mesh-list
14109759|NCT02352597|Estrogens|estrogens|mesh-ancestor
14109760|NCT02352597|Hormones|hormones|mesh-ancestor
14109761|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109762|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109763|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14109764|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
14109765|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14109766|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14109767|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14109768|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109769|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14109770|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
14109771|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14109772|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14109773|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14109774|NCT02352519|Anesthetics|anesthetics|mesh-list
14109775|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
14109776|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109777|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109778|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
14109779|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109780|NCT02352701|Amoxicillin|amoxicillin|mesh-list
13932666|NCT03357900|Propofol|propofol|mesh-list
13932667|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13932668|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932669|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932670|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13932671|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
13932672|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
13932673|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13932674|NCT03357900|Narcotics|narcotics|mesh-ancestor
13932675|NCT03357900|Analgesics|analgesics|mesh-ancestor
13932676|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
13932677|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932678|NCT03357874|Clopidogrel|clopidogrel|mesh-list
13932679|NCT03357874|Ticagrelor|ticagrelor|mesh-list
13932680|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13932681|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13932682|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13932683|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13932684|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
13932685|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932686|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932687|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932688|NCT03357822|Interferons|interferons|mesh-list
14109781|NCT02352701|Levofloxacin|levofloxacin|mesh-list
14109782|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14109783|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109784|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14109785|NCT02352701|Renal Agents|renal agents|mesh-ancestor
14109786|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14109787|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14109788|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109789|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109790|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109791|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14109792|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14109793|NCT02352402|Ticagrelor|ticagrelor|mesh-list
14109794|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14109795|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14109796|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14109797|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14109798|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
14109799|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109800|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109801|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109802|NCT02352285|Tolvaptan|tolvaptan|mesh-list
14109803|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13932689|NCT03357822|Tenofovir|tenofovir|mesh-list
14109804|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109805|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
14109806|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109807|NCT02352168|Budesonide|budesonide|mesh-list
14109808|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109809|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14109810|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
14109811|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109812|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109813|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14109814|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
14109815|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
14109816|NCT02352168|Hormones|hormones|mesh-ancestor
14109817|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932690|NCT03357822|Entecavir|entecavir|mesh-list
13932691|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932692|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
13932693|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932694|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13932695|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13932696|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932697|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932698|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13932699|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13932700|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
13932701|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13932702|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13932703|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932704|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109818|NCT02352051|Methylphenidate|methylphenidate|mesh-list
14109819|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14109820|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14109821|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109822|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14109823|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14109824|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14109825|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109826|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
14109827|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109828|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14109829|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
14109830|NCT02351973|Amiloride|amiloride|mesh-list
14109831|NCT02351973|Diuretics|diuretics|mesh-ancestor
14109832|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
14109833|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109834|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14109835|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14109836|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14109837|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109838|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14109839|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14109840|NCT02352155|Epinephrine|epinephrine|mesh-list
14109841|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14109842|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14109843|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
14109844|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109845|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109846|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109847|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14109848|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14109849|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
14109850|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109851|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14109852|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
14109853|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
14109854|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
14109855|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14109856|NCT02351895|Copper|copper|mesh-list
14109857|NCT02351895|Trace Elements|trace elements|mesh-ancestor
14109858|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
14109859|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109860|NCT02351882|Nabilone|nabilone|mesh-list
14109861|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
14109862|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
14109863|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109864|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109865|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109866|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14109867|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14109868|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932705|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932706|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932707|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
13932708|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13932709|NCT03357757|Avelumab|avelumab|mesh-list
13932710|NCT03357757|Valproic Acid|valproic acid|mesh-list
13932711|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932712|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932713|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
13932714|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932715|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932716|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
13932717|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932718|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932719|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
14109869|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14109870|NCT02352311|Tadalafil|tadalafil|mesh-list
14109871|NCT02352311|Dutasteride|dutasteride|mesh-list
14109872|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14109873|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14109874|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14109875|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109876|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109877|NCT02352311|Urological Agents|urological agents|mesh-ancestor
14109878|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14109879|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14109880|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
14109881|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932720|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13932721|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932722|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13932723|NCT03357718|Midazolam|midazolam|mesh-list
13932724|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
13932725|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13932726|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932727|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932728|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13932729|NCT03357718|Analgesics|analgesics|mesh-ancestor
14109882|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109883|NCT02352025|Equol|equol|mesh-list
14109884|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
14109885|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14109886|NCT02352025|Estrogens|estrogens|mesh-ancestor
14109887|NCT02352025|Hormones|hormones|mesh-ancestor
14109888|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109889|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109890|NCT02351908|Tenofovir|tenofovir|mesh-list
14109891|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
14109892|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14109893|NCT02351908|Dolutegravir|dolutegravir|mesh-list
14109894|NCT02351908|Cobicistat|cobicistat|mesh-list
14109895|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14109896|NCT02351908|Elvitegravir|elvitegravir|mesh-list
14109897|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
14109898|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109899|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14109900|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14109901|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109902|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932730|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
13932731|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932732|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13932733|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13932734|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14109903|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13932735|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
13932736|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932737|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932738|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13932739|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13932740|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13932741|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13932742|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13932743|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
13932744|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
13932745|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
13932746|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
13932747|NCT03357653|Losartan|losartan|mesh-list
13932748|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13932749|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13932750|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13932751|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13932752|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932753|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
14109904|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14109905|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14109906|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14109907|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14109908|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14109909|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14109910|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14109911|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932754|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
13932755|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13932756|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13932757|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932758|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13932759|NCT03357627|Venetoclax|venetoclax|mesh-list
13932760|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932761|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
13932762|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13932763|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
13932764|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932765|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
13932766|NCT03357575|Protective Agents|protective agents|mesh-ancestor
13932767|NCT03357419|Clindamycin|clindamycin|mesh-list
13932768|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
13932769|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
13932770|NCT03357419|Cephalexin|cephalexin|mesh-list
13932771|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13932772|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109912|NCT02351869|Midazolam|midazolam|mesh-list
14109913|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
14109914|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14109915|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14109916|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109917|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109918|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14109919|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14109920|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14109921|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14109922|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
14109923|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
13932773|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13932774|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932775|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961215|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
13961216|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
13961217|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961218|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961219|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
13961220|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109924|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
14109925|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
13961221|NCT03149653|SMOFlipid|smoflipid|mesh-list
13961222|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13961223|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13961224|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13961225|NCT03149432|Gabapentin|gabapentin|mesh-list
13961226|NCT03149432|Analgesics|analgesics|mesh-ancestor
14109926|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14109927|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932776|NCT03357224|Atezolizumab|atezolizumab|mesh-list
13932777|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932778|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
13932779|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13932780|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
13932781|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13932782|NCT03357159|Antibodies|antibodies|mesh-list
13932783|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13932784|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
13932785|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932786|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13932787|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13932788|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
14109928|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14109929|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14109930|NCT02351869|Analgesics|analgesics|mesh-ancestor
14109931|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
14109932|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175762|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14175763|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175764|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14175765|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175766|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932789|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932790|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932791|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13932792|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13932793|NCT03357133|Tirofiban|tirofiban|mesh-list
13932794|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13932795|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13932796|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932797|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14936152|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936153|NCT01467414|Insulin|insulin|mesh-list
14936154|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936155|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936156|NCT01467518|Dolutegravir|dolutegravir|mesh-list
14936157|NCT01467518|Methadone|methadone|mesh-list
14936158|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14936159|NCT01467518|Narcotics|narcotics|mesh-ancestor
14936160|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932798|NCT03357055|Ketamine|ketamine|mesh-list
13932799|NCT03357055|Analgesics|analgesics|mesh-ancestor
13932800|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
13932801|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932802|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932803|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13932804|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13932805|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
13932806|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
13932807|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932808|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13932809|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13932810|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932811|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932812|NCT03356964|Hormones|hormones|mesh-list
13932813|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13932814|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932815|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932816|NCT03356912|Prednisone|prednisone|mesh-list
13932817|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932818|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
13932819|NCT03356912|Hormones|hormones|mesh-ancestor
14175767|NCT04772729|Insulin|insulin|mesh-list
14175768|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14175769|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
14175770|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14175771|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175772|NCT04772521|Nicotine|nicotine|mesh-list
14175773|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14175774|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
14175775|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175776|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175777|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14936161|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936162|NCT01467518|Analgesics|analgesics|mesh-ancestor
14109933|NCT02351765|Cisplatin|cisplatin|mesh-list
14109934|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109935|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
14109936|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
14109937|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14109938|NCT02351687|Albendazole|albendazole|mesh-list
14109939|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
14109940|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14109941|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14109942|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109943|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14109944|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109945|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109946|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14109947|NCT02351687|Renal Agents|renal agents|mesh-ancestor
14109948|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
14109949|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
14109950|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14109951|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
14109952|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
14109953|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
14761914|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761915|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14761916|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14761917|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932820|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932821|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932822|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13932823|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932824|NCT03356899|Bupivacaine|bupivacaine|mesh-list
13932825|NCT03356899|Anesthetics|anesthetics|mesh-list
14761936|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
14109954|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109955|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
14109956|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
14109957|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14109958|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14109959|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14109960|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14109961|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109962|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14109963|NCT02351622|Dexamethasone|dexamethasone|mesh-list
13932826|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
13932827|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932828|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932829|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
13932830|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932831|NCT03356873|Vitamin D|vitamin d|mesh-list
13932832|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
13932833|NCT03356873|Vitamins|vitamins|mesh-list
13932834|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
13932835|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932836|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13932837|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14109964|NCT02351622|Caffeic acid|caffeic acid|mesh-list
14109965|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109966|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
14109967|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
13932838|NCT03356834|Tenofovir|tenofovir|mesh-list
14761937|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14761938|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761939|NCT03287089|Renal Agents|renal agents|mesh-ancestor
13932839|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
13932840|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932841|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13932842|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13932843|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932844|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932845|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13932846|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13932847|NCT03356769|Aspirin|aspirin|mesh-list
13932848|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
13932849|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13932850|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13932851|NCT03356769|Analgesics|analgesics|mesh-ancestor
13932852|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
13932853|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932854|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932855|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13932856|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13932857|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13932858|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13932859|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932860|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13932861|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13932862|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932863|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
13932864|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13932865|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13932866|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932867|NCT03356730|Vitamin D|vitamin d|mesh-list
13932868|NCT03356730|Vitamins|vitamins|mesh-ancestor
14109968|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109969|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109970|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109971|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
14109972|NCT02351622|Hormones|hormones|mesh-ancestor
14109973|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109974|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14109975|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109976|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
14109977|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14109978|NCT02351622|Protective Agents|protective agents|mesh-ancestor
14109979|NCT02351804|Dexamethasone|dexamethasone|mesh-list
14109980|NCT02351804|Ropivacaine|ropivacaine|mesh-list
14109981|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14109982|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
14761940|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14761941|NCT03259867|Nivolumab|nivolumab|mesh-list
14761942|NCT03259867|Tirapazamine|tirapazamine|mesh-list
14761943|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14761944|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761945|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14761946|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932869|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
13932870|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932871|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14109983|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
14109984|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14109985|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14109986|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14109987|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
14109988|NCT02351804|Hormones|hormones|mesh-ancestor
14109989|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14109990|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14109991|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14109992|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
14109993|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
14109994|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14109995|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
14109996|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
14109997|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14109998|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14109999|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14110000|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110001|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110002|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
14110003|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110004|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110005|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14110006|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110007|NCT02351297|Caseins|caseins|mesh-list
14110008|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
14936163|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
14936164|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936165|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
14936166|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
14936167|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14936168|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13932872|NCT03356600|Apatinib|apatinib|mesh-list
13932873|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932874|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13932875|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932876|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932877|NCT03356444|Docetaxel|docetaxel|mesh-list
13932878|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
13932879|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932880|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
13932881|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
13932882|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
13932883|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932884|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13932885|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932886|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
13932887|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13932888|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932889|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13932890|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
13932891|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932892|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
13932893|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14110009|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
13932894|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13932895|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932896|NCT03356353|Urological Agents|urological agents|mesh-ancestor
13932897|NCT03356158|Cetuximab|cetuximab|mesh-list
13932898|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932899|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932900|NCT03356080|Cytarabine|cytarabine|mesh-list
13932901|NCT03356080|Decitabine|decitabine|mesh-list
13932902|NCT03356080|Tretinoin|tretinoin|mesh-list
13932903|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13932904|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
13932905|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932906|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932907|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
13932908|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13932909|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13932910|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
13932911|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932912|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932913|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
13932914|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
13932915|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13932916|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932917|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936169|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936170|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110010|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110011|NCT02351232|Liraglutide|liraglutide|mesh-list
14110012|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14110013|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110014|NCT02351232|Incretins|incretins|mesh-ancestor
14110015|NCT02351232|Hormones|hormones|mesh-ancestor
13932918|NCT03355976|Nivolumab|nivolumab|mesh-list
13932919|NCT03355976|Ipilimumab|ipilimumab|mesh-list
13932920|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13932921|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932922|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13932923|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932924|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
13932925|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13932926|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13932927|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13932928|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13932929|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932930|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
13932931|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932932|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932933|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13932934|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961227|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
13961228|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961229|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932935|NCT03355794|Everolimus|everolimus|mesh-list
13932936|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932937|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13932938|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
13932939|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932940|NCT03355768|Romidepsin|romidepsin|mesh-list
13932941|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13932942|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932943|NCT03355716|Fentanyl|fentanyl|mesh-list
13932944|NCT03355716|Ketamine|ketamine|mesh-list
13932945|NCT03355716|Morphine|morphine|mesh-list
13932946|NCT03355716|Bupivacaine|bupivacaine|mesh-list
13932947|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
13932948|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
13932949|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932950|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932951|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
14477826|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477827|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479259|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13932952|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932953|NCT03355716|Analgesics|analgesics|mesh-ancestor
13932954|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13932955|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14110016|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110017|NCT02351427|Bortezomib|bortezomib|mesh-list
14110018|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110019|NCT02351310|Betamethasone|betamethasone|mesh-list
14110020|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110021|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
14110022|NCT02351310|Hormones|hormones|mesh-ancestor
14110023|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110024|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110025|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14110026|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
14110027|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14110028|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14110029|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14110030|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110031|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110032|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110033|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110034|NCT02351440|Analgesics|analgesics|mesh-ancestor
14110035|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
14110036|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110037|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
14110038|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110039|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
14110040|NCT02351128|Lanreotide|lanreotide|mesh-list
14110041|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110042|NCT02351102|Valacyclovir|valacyclovir|mesh-list
14110043|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
14110044|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110045|NCT02350751|MEDI8852|medi8852|mesh-list
14110046|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
14110047|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110048|NCT02351024|Naproxen|naproxen|mesh-list
14110049|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14110050|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14110051|NCT02351024|Analgesics|analgesics|mesh-ancestor
14110052|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
14110053|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110054|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110055|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110056|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110057|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
14110058|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14110059|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110060|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932956|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
14477828|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477829|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
14477830|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
14477831|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477832|NCT02439879|Protective Agents|protective agents|mesh-ancestor
14477833|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932957|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13932958|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13932959|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932960|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932961|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13932962|NCT03355716|Narcotics|narcotics|mesh-ancestor
14477834|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
14477835|NCT02439879|Vitamins|vitamins|mesh-ancestor
14477836|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
14761957|NCT03255915|Tenofovir|tenofovir|mesh-list
13932963|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13932964|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
13932965|NCT03355638|Aflibercept|aflibercept|mesh-list
13932966|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13932967|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13932968|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13932969|NCT03355638|Growth Substances|growth substances|mesh-ancestor
13932970|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13932971|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
13932972|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932973|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13932974|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13932975|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13932976|NCT03355638|Analgesics|analgesics|mesh-ancestor
13932977|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
13932978|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13932979|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110061|NCT02350725|Furosemide|furosemide|mesh-list
14110062|NCT02350725|Diuretics|diuretics|mesh-ancestor
14110063|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
14110064|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110065|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14110066|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110067|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110068|NCT02350959|Atorvastatin|atorvastatin|mesh-list
14110069|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14110070|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14110071|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
14110072|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110073|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14110074|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14110075|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110076|NCT02350985|Propranolol|propranolol|mesh-list
14110077|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14110078|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14110079|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14110080|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
14110081|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110082|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110083|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110084|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14110085|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14110086|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
14110087|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14110088|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14110089|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110090|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14110091|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
14110092|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110093|NCT02350946|Oxytocin|oxytocin|mesh-list
14110094|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
14110095|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14110096|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477837|NCT02440178|Micafungin|micafungin|mesh-list
14761958|NCT03255915|Emtricitabine|emtricitabine|mesh-list
14761959|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
14110097|NCT02350712|Carboplatin|carboplatin|mesh-list
14110098|NCT02350712|Cetuximab|cetuximab|mesh-list
13932980|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13932981|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
13932982|NCT03355612|Capecitabine|capecitabine|mesh-list
13932983|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
13932984|NCT03355612|Apatinib|apatinib|mesh-list
13932985|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13932986|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
13932987|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932988|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932989|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13932990|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13932991|NCT03355560|Nivolumab|nivolumab|mesh-list
13932992|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14110099|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110100|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14110101|NCT02350439|Adenosine|adenosine|mesh-list
14110102|NCT02350439|Analgesics|analgesics|mesh-ancestor
14110103|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
14110104|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110105|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110106|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14110107|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
14110108|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14110109|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
14110110|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
14110111|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13932993|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13932994|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13932995|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13932996|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
13932997|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13932998|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13932999|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933000|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13933001|NCT03355534|Analgesics|analgesics|mesh-ancestor
13933002|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
13933003|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933004|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13933005|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13933006|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13933007|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933008|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933009|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933010|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
13933011|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13933012|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13933013|NCT03355482|Prednisolone|prednisolone|mesh-list
13933014|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
13933015|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13933016|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
14110112|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110113|NCT02350686|Capecitabine|capecitabine|mesh-list
14110114|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
13933017|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933018|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
13933019|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
13933020|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933021|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933022|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13933023|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
13933024|NCT03355482|Hormones|hormones|mesh-ancestor
13933025|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933026|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13933027|NCT03355482|Protective Agents|protective agents|mesh-ancestor
13933028|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933029|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933030|NCT03355469|Metformin|metformin|mesh-list
13933031|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933032|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933033|NCT03355352|Sufentanil|sufentanil|mesh-list
13933034|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13933035|NCT03355352|Narcotics|narcotics|mesh-ancestor
13933036|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14110115|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13933037|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933038|NCT03355352|Analgesics|analgesics|mesh-ancestor
13933039|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
13933040|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933041|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13933042|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13933043|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
13933044|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
13933045|NCT03355300|Cannabidiol|cannabidiol|mesh-list
13933046|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
13933047|NCT03355248|Acetaminophen|acetaminophen|mesh-list
13933048|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
13933049|NCT03355248|Oxycodone|oxycodone|mesh-list
13933050|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13933051|NCT03355248|Analgesics|analgesics|mesh-ancestor
13933052|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
14110116|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
14110117|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110118|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110119|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
14110120|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14110121|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14110122|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
14110123|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110124|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110125|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110126|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
14110127|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
14110128|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110129|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
14110130|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14110131|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
14110132|NCT02350673|Atezolizumab|atezolizumab|mesh-list
14110133|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110134|NCT02350361|Endostatins|endostatins|mesh-list
14110135|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14110136|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14110137|NCT02350361|Growth Substances|growth substances|mesh-ancestor
14110138|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110139|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
14110140|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110141|NCT02350335|Nicotine|nicotine|mesh-list
14110142|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14110143|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
14110144|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110145|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110146|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14110147|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14110148|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
14110149|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110150|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110151|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14110152|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14110153|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110154|NCT02350530|Bevacizumab|bevacizumab|mesh-list
14110155|NCT02350530|Fluorouracil|fluorouracil|mesh-list
14110156|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
14110157|NCT02350530|Irinotecan|irinotecan|mesh-list
14110158|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14110159|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110160|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14110161|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14110162|NCT02350530|Growth Substances|growth substances|mesh-ancestor
14110163|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110164|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
14110165|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
14110166|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110167|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14110168|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13933053|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933054|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933055|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
13933056|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13933057|NCT03355248|Narcotics|narcotics|mesh-ancestor
13933058|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933059|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13933060|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933061|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933062|NCT03355170|Domperidone|domperidone|mesh-list
13933063|NCT03355170|Lansoprazole|lansoprazole|mesh-list
13933064|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
13933065|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13933066|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13933067|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13933068|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933069|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933070|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
13933071|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
13933072|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933073|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933074|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13933075|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
13933076|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110169|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
14110170|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14110171|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14110172|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110173|NCT02350543|Aspirin|aspirin|mesh-list
14110174|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14110175|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14110176|NCT02350543|Analgesics|analgesics|mesh-ancestor
14110177|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
14110178|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110179|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110180|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110181|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110182|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14110183|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14110184|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110185|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14110186|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14110187|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110188|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
14110189|NCT02350517|Paclitaxel|paclitaxel|mesh-list
14110190|NCT02350517|Endostar protein|endostar protein|mesh-list
13933077|NCT03355118|Anesthetics|anesthetics|mesh-list
13933078|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933079|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933080|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
13933081|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13933082|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933083|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933084|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13933085|NCT03355053|Analgesics|analgesics|mesh-ancestor
13933086|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
13933087|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110191|NCT02350517|Endostatins|endostatins|mesh-list
13933088|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14110192|NCT02350517|Nedaplatin|nedaplatin|mesh-list
14110193|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14110194|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933089|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13933090|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13933091|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933092|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933093|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933094|NCT03355027|Atorvastatin|atorvastatin|mesh-list
13933095|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13933096|NCT03355027|Simvastatin|simvastatin|mesh-list
13933097|NCT03355027|Ezetimibe|ezetimibe|mesh-list
13933098|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13933099|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13933100|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
13933101|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933102|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13933103|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13933104|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933105|NCT03355014|Metformin|metformin|mesh-list
13933106|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933107|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933108|NCT03354962|Nivolumab|nivolumab|mesh-list
13933109|NCT03354962|Ipilimumab|ipilimumab|mesh-list
13933110|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933111|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933112|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13933113|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110195|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
14110196|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
14110197|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
14110198|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110199|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14110200|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14110201|NCT02350517|Growth Substances|growth substances|mesh-ancestor
14110202|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110203|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
14110204|NCT02350400|Irinotecan|irinotecan|mesh-list
14110205|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14110206|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14110207|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110208|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110209|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110210|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
14110211|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14110212|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14110213|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110214|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
14110215|NCT02350179|Coagulants|coagulants|mesh-ancestor
14110216|NCT02350231|Progesterone|progesterone|mesh-list
14110217|NCT02350231|Progestins|progestins|mesh-ancestor
14110218|NCT02350231|Hormones|hormones|mesh-ancestor
14110219|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110220|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175778|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14175779|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
14175780|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175781|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175782|NCT04772287|Gemcitabine|gemcitabine|mesh-list
14175783|NCT04772287|Paclitaxel|paclitaxel|mesh-list
14175784|NCT04772287|Vinorelbine|vinorelbine|mesh-list
14175785|NCT04772287|Docetaxel|docetaxel|mesh-list
14175786|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14175787|NCT04772287|Cisplatin|cisplatin|mesh-list
14175788|NCT04772287|Carboplatin|carboplatin|mesh-list
14175789|NCT04772287|Pemetrexed|pemetrexed|mesh-list
14175790|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14175791|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175792|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
14477838|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
13933114|NCT03354897|Torsemide|torsemide|mesh-list
13933115|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14175793|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
14175794|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
14183678|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
13933116|NCT03354897|Diuretics|diuretics|mesh-ancestor
13933117|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
14477839|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933118|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933119|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13933120|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933121|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933122|NCT03354806|Analgesics|analgesics|mesh-list
13933123|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
13933124|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933125|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933126|NCT03354624|Mitogens|mitogens|mesh-list
13933127|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
13933128|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933129|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
13933130|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13933131|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
14477840|NCT02440204|Remifentanil|remifentanil|mesh-list
14477841|NCT02440204|Sevoflurane|sevoflurane|mesh-list
14477842|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14477843|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14477844|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
14477845|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
14477846|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14477847|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761960|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14761961|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14761962|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13933132|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477848|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14477849|NCT02440204|Narcotics|narcotics|mesh-ancestor
14477850|NCT02440204|Analgesics|analgesics|mesh-ancestor
14477851|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
14477852|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477853|NCT02440308|Bombesin|bombesin|mesh-list
14477854|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761963|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933133|NCT03354572|Expectorants|expectorants|mesh-ancestor
13933134|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
13933135|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13933136|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
13933137|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933138|NCT03354572|Protective Agents|protective agents|mesh-ancestor
13933139|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933140|NCT03354572|Antidotes|antidotes|mesh-ancestor
13933141|NCT03354494|Desogestrel|desogestrel|mesh-list
13933142|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13933143|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13933144|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13933145|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933146|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13933147|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933148|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13933149|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14110221|NCT02350218|Alprostadil|alprostadil|mesh-list
14110222|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14110223|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14110224|NCT02350218|Urological Agents|urological agents|mesh-ancestor
14110225|NCT02349919|Procaterol|procaterol|mesh-list
14110226|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14110227|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
14110228|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110229|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110230|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14110231|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
14110232|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
14110233|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14110234|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14110235|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14110236|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14110237|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110238|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110239|NCT02350023|Betamethasone|betamethasone|mesh-list
14110240|NCT02350023|Latanoprost|latanoprost|mesh-list
14110241|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14110242|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14110243|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110244|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
14110245|NCT02350023|Hormones|hormones|mesh-ancestor
14110246|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110247|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110248|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14110249|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
14110250|NCT02349802|Exenatide|exenatide|mesh-list
14110251|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14110252|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110253|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14110254|NCT02349802|Incretins|incretins|mesh-ancestor
14110255|NCT02349802|Hormones|hormones|mesh-ancestor
14110256|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110257|NCT02349958|Doxorubicin|doxorubicin|mesh-list
14110258|NCT02349958|Cisplatin|cisplatin|mesh-list
14110259|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14110260|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110261|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14110262|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14110263|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110264|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933150|NCT03354494|Progestins|progestins|mesh-ancestor
13933151|NCT03354494|Hormones|hormones|mesh-ancestor
13933152|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961230|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
13961231|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13961232|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961233|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961234|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961235|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13961236|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13961237|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961238|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961239|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
13961240|NCT03149419|Paroxetine|paroxetine|mesh-list
13961241|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13961242|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13961243|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13961244|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961245|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961246|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
13961247|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961248|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13961249|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
13961250|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961251|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14110265|NCT02349763|Dexamethasone|dexamethasone|mesh-list
14110266|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
14110267|NCT02349763|BB 1101|bb 1101|mesh-list
14110268|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110269|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
14110270|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
14110271|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961252|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13961253|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961254|NCT03149588|Propofol|propofol|mesh-list
13961255|NCT03149588|Sevoflurane|sevoflurane|mesh-list
14110272|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110273|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110274|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
14110275|NCT02349763|Hormones|hormones|mesh-ancestor
14110276|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110277|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14110278|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110279|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
14110280|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110281|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110282|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14110283|NCT02349945|Hormones|hormones|mesh-ancestor
14110284|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110285|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110286|NCT02349841|Amoxicillin|amoxicillin|mesh-list
14110287|NCT02349841|Meropenem|meropenem|mesh-list
14477855|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477856|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477857|NCT02440568|Cytarabine|cytarabine|mesh-list
14477858|NCT02440568|Idarubicin|idarubicin|mesh-list
14477859|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
14477860|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14477861|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
14477862|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477863|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477864|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
14477865|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477866|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477867|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
14477868|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477869|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14477870|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14936171|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13933153|NCT03354338|Amoxicillin|amoxicillin|mesh-list
13933154|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13933155|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933156|NCT03354312|Lidocaine|lidocaine|mesh-list
13933157|NCT03354312|Epinephrine|epinephrine|mesh-list
13933158|NCT03354312|Racepinephrine|racepinephrine|mesh-list
13933159|NCT03354312|Carticaine|carticaine|mesh-list
13933160|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
13933161|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
13933162|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
13933163|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933164|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933165|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
13933166|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933167|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13933168|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13933169|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13933170|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933171|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933172|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13933173|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13933174|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933175|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933176|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13933177|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13933178|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
13933179|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13933180|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
13933181|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
13933182|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
13933183|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14110288|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
14110289|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
14110290|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14110291|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110292|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110293|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110294|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14110295|NCT02349828|Acyclovir|acyclovir|mesh-list
14110296|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
14110297|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110298|NCT02349490|Hemostatics|hemostatics|mesh-list
14110299|NCT02349490|Coagulants|coagulants|mesh-ancestor
14110300|NCT02349516|Squalamine|squalamine|mesh-list
14110301|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14110302|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14110303|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14110304|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110305|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14110306|NCT02349516|Protective Agents|protective agents|mesh-ancestor
14110307|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110308|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110309|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14110310|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14110311|NCT02349516|Growth Substances|growth substances|mesh-ancestor
14110312|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
14110313|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14110314|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14477871|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13933184|NCT03354117|Meloxicam|meloxicam|mesh-list
13933185|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
13933186|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13933187|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13933188|NCT03354117|Analgesics|analgesics|mesh-ancestor
13933189|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
13933190|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110315|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14110316|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14110317|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
14110318|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14110319|NCT02349399|Cyproterone|cyproterone|mesh-list
14110320|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
14110321|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14110322|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14110323|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14110324|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933191|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933192|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933193|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933194|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13933195|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13933196|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933197|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933198|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13933199|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933200|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13933201|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13933202|NCT03354039|Tamoxifen|tamoxifen|mesh-list
13933203|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13933204|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
13933205|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933206|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933207|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933208|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933209|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13933210|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13933211|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13933212|NCT03354013|Calcium|calcium|mesh-list
14110325|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14110326|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110327|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13933213|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13933214|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933215|NCT03353948|Metformin|metformin|mesh-list
13933216|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933217|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933218|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
13933219|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13933220|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
13933221|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933222|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
13933223|NCT03353909|Protective Agents|protective agents|mesh-ancestor
13933224|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13933225|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
13933226|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13933227|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933228|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14110328|NCT02349399|Estrogens|estrogens|mesh-ancestor
14110329|NCT02349399|Hormones|hormones|mesh-ancestor
14110330|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110331|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
14110332|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
14761964|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933229|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933230|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13933231|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933232|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933233|NCT03353857|Rifampin|rifampin|mesh-list
13933234|NCT03353857|Dienogest|dienogest|mesh-list
13933235|NCT03353857|Drospirenone|drospirenone|mesh-list
13933236|NCT03353857|Midazolam|midazolam|mesh-list
13933237|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
13933238|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13933239|NCT03353857|Norethindrone|norethindrone|mesh-list
13933240|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
13933241|NCT03353857|Desogestrel|desogestrel|mesh-list
13933242|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13933243|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14110333|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110334|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14110335|NCT02349581|Bupivacaine|bupivacaine|mesh-list
14110336|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
14110337|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
14110338|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933244|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933245|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933246|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13933247|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13933248|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13933249|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13933250|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
13933251|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
13933252|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
13933253|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
14110339|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110340|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
14110341|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110342|NCT02349607|Ibuprofen|ibuprofen|mesh-list
14110343|NCT02349607|Pregabalin|pregabalin|mesh-list
14110344|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14110345|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13933254|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933255|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933256|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14110346|NCT02349607|Analgesics|analgesics|mesh-ancestor
14110347|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
14110348|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110349|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110350|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110351|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110352|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14110353|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110354|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933257|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933258|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14761965|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14761966|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13933259|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13933260|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13933261|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13933262|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13933263|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
13933264|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13933265|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933266|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
13933267|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13933268|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933269|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13933270|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13933271|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13933272|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13933273|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13933274|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13933275|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13933276|NCT03353857|Estrogens|estrogens|mesh-ancestor
13933277|NCT03353857|Hormones|hormones|mesh-ancestor
13933278|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933279|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13933280|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
13933281|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13933282|NCT03353857|Diuretics|diuretics|mesh-ancestor
13933283|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
13933284|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13933285|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14110355|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
14761967|NCT03234972|Dexamethasone|dexamethasone|mesh-list
14761968|NCT03234972|Bortezomib|bortezomib|mesh-list
14761969|NCT03234972|Daratumumab|daratumumab|mesh-list
14110356|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14110357|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110358|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14110359|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14110360|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14110361|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14110362|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110363|NCT02349282|Vitamin D|vitamin d|mesh-list
14110364|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
14110365|NCT02349282|Calcifediol|calcifediol|mesh-list
14110366|NCT02349282|Vitamins|vitamins|mesh-ancestor
14110367|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
14110368|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110369|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14110370|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14110371|NCT02349243|Entacapone|entacapone|mesh-list
14110372|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14110373|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14110374|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14110375|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110376|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110377|NCT02349204|Zaleplon|zaleplon|mesh-list
14110378|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
14110379|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14110380|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14110381|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110382|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
14110383|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
14110384|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110385|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110386|NCT02349165|Riboflavin|riboflavin|mesh-list
14110387|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
13933286|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933287|NCT03353857|Progestins|progestins|mesh-ancestor
13933288|NCT03353831|Bevacizumab|bevacizumab|mesh-list
13933289|NCT03353831|Atezolizumab|atezolizumab|mesh-list
13933290|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933291|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933292|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13933293|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13933294|NCT03353831|Growth Substances|growth substances|mesh-ancestor
13933295|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933296|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
13933297|NCT03353480|Azithromycin|azithromycin|mesh-list
13933298|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13933299|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933300|NCT03353441|Glycine|glycine|mesh-list
13933301|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
13933302|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933303|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933304|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933305|NCT03353363|Bupivacaine|bupivacaine|mesh-list
13933306|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
13933307|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
13933308|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933309|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933310|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
13933311|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933312|NCT03353324|Bevacizumab|bevacizumab|mesh-list
13933313|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933314|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933315|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13933316|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13933317|NCT03353324|Growth Substances|growth substances|mesh-ancestor
13933318|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933319|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
13933320|NCT03353298|Allopurinol|allopurinol|mesh-list
13933321|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
13933322|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933323|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933324|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
13933325|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110388|NCT02349165|Vitamins|vitamins|mesh-ancestor
13933326|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14110389|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
13933327|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
14110390|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110391|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14110392|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
14110393|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14110394|NCT02348905|Hormones|hormones|mesh-ancestor
14110395|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110396|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110397|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14110398|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14110399|NCT02349113|Estrogens|estrogens|mesh-list
14110400|NCT02349113|Estradiol|estradiol|mesh-list
14110401|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14110402|NCT02349113|Hormones|hormones|mesh-ancestor
14110403|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110404|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110405|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14110406|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
14110407|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14110408|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14110409|NCT02348788|Chloroquine|chloroquine|mesh-list
14110410|NCT02348788|Lumefantrine|lumefantrine|mesh-list
14110411|NCT02348788|Artemether|artemether|mesh-list
14110412|NCT02348788|Primaquine|primaquine|mesh-list
14110413|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14110414|NCT02348788|Amebicides|amebicides|mesh-ancestor
14110415|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14110416|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14110417|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110418|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
14110419|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110420|NCT02348528|Dexamethasone|dexamethasone|mesh-list
14110421|NCT02348528|Lenalidomide|lenalidomide|mesh-list
13933328|NCT03353298|Protective Agents|protective agents|mesh-ancestor
14761970|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761971|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
13933329|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933330|NCT03353103|Listerine|listerine|mesh-list
13933331|NCT03353103|Fluorides|fluorides|mesh-list
13933332|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
13933333|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
13933334|NCT03353103|Protective Agents|protective agents|mesh-ancestor
13933335|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933336|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13933337|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933338|NCT03353025|Dopamine|dopamine|mesh-list
13933339|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
13933340|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13933341|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
13933342|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
13933343|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933344|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933345|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
13933346|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933347|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933348|NCT03353025|Protective Agents|protective agents|mesh-ancestor
13933349|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
13933350|NCT03353012|Etonogestrel|etonogestrel|mesh-list
13933351|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13933352|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933353|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13933354|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933355|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13933356|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13933357|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13933358|NCT03352947|Trametinib|trametinib|mesh-list
13933359|NCT03352947|Dabrafenib|dabrafenib|mesh-list
13933360|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933361|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13933362|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933363|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933364|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
14761972|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
13933365|NCT03352895|Resveratrol|resveratrol|mesh-list
13933366|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
13933367|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933368|NCT03352895|Protective Agents|protective agents|mesh-ancestor
14761973|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110422|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933369|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933370|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933371|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13933372|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13933373|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933374|NCT03352869|Metformin|metformin|mesh-list
13933375|NCT03352869|Exenatide|exenatide|mesh-list
13933376|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933377|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933378|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13933379|NCT03352869|Incretins|incretins|mesh-ancestor
13933380|NCT03352869|Hormones|hormones|mesh-ancestor
13933381|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961256|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13961257|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961258|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961259|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13961260|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
13961261|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
13961262|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13961263|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13961264|NCT03149640|Amikacin|amikacin|mesh-list
14761974|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761975|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14761976|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
14761977|NCT03234972|Hormones|hormones|mesh-ancestor
14761978|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110423|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
14110424|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
14110425|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110426|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110427|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110428|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
14110429|NCT02348528|Hormones|hormones|mesh-ancestor
14110430|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110431|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14110432|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110433|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
14110434|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14110435|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14110436|NCT02348528|Growth Substances|growth substances|mesh-ancestor
14110437|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
14110438|NCT02348463|Clindamycin|clindamycin|mesh-list
14110439|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
14110440|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
14110441|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14110442|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110443|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14110444|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110445|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110446|NCT02348255|Bevacizumab|bevacizumab|mesh-list
14110447|NCT02348255|Carmustine|carmustine|mesh-list
14110448|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14110449|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110450|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14110451|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14110452|NCT02348255|Growth Substances|growth substances|mesh-ancestor
14110453|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110454|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
14110455|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14110456|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
14110457|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110458|NCT02348268|Analgesics|analgesics|mesh-list
14110459|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
14110460|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110461|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110462|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
14110463|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
14110464|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13961265|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961266|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110465|NCT02348346|Protective Agents|protective agents|mesh-ancestor
13961267|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
14110466|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110467|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
14110468|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14110469|NCT02348333|Dotinurad|dotinurad|mesh-list
14110470|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
14110471|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
14110472|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110473|NCT02348333|Renal Agents|renal agents|mesh-ancestor
14110474|NCT02348307|Dotinurad|dotinurad|mesh-list
14110475|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
14110476|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
14110477|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110478|NCT02348307|Renal Agents|renal agents|mesh-ancestor
14110479|NCT02348424|Solithromycin|solithromycin|mesh-list
14110480|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14110481|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110482|NCT02348450|Irinotecan|irinotecan|mesh-list
13933382|NCT03352843|Primaquine|primaquine|mesh-list
13933383|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
13933384|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14110483|NCT02348450|Etoposide|etoposide|mesh-list
14110484|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110485|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14110486|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14110487|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110488|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110489|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14110490|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14110491|NCT02348372|Glycine|glycine|mesh-list
14110492|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
14110493|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110494|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110495|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175795|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175796|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13933385|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13933386|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933387|NCT03352700|Dyclonine|dyclonine|mesh-list
13933388|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
13933389|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
13933390|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933391|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175797|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
14175798|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
14175799|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175800|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175801|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14175802|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
13933392|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
13933393|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175803|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175804|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14175805|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14175806|NCT04772352|Febuxostat|febuxostat|mesh-list
14175807|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
14175808|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175809|NCT04772235|Osimertinib|osimertinib|mesh-list
13933394|NCT03352674|Insulin|insulin|mesh-list
13933395|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13933396|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
13933397|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933398|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933399|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
13933400|NCT03352479|Narcotics|narcotics|mesh-ancestor
13933401|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933402|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933403|NCT03352479|Analgesics|analgesics|mesh-ancestor
13933404|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
13933405|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933406|NCT03352362|Acetaminophen|acetaminophen|mesh-list
13933407|NCT03352362|Ibuprofen|ibuprofen|mesh-list
13933408|NCT03352362|Propacetamol|propacetamol|mesh-list
13933409|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13933410|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14175810|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933411|NCT03352362|Analgesics|analgesics|mesh-ancestor
13933412|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
13933413|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933414|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933415|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933416|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933417|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13933418|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933419|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933420|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
13933421|NCT03352349|Terlipressin|terlipressin|mesh-list
13933422|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13933423|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13933424|NCT03352128|Calcium|calcium|mesh-list
13933425|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13933426|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933427|NCT03352115|Prednisolone|prednisolone|mesh-list
13933428|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933429|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
13933430|NCT03352115|Hormones|hormones|mesh-ancestor
13933431|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933432|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933433|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933434|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933435|NCT03352076|Danazol|danazol|mesh-list
13933436|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13933437|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
13933438|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933439|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933440|NCT03351998|Atorvastatin|atorvastatin|mesh-list
13933441|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13933442|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13933443|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
13933444|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933445|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14110496|NCT02348281|Bicalutamide|bicalutamide|mesh-list
14110497|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
14110498|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
14110499|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110500|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110501|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110502|NCT02348398|Topotecan|topotecan|mesh-list
14110503|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14110504|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14110505|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110506|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110507|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110508|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
14110509|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14110510|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14110511|NCT02348190|Heparin|heparin|mesh-list
14110512|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
14110513|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14110514|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14110515|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110516|NCT02348177|Ritonavir|ritonavir|mesh-list
14110517|NCT02348177|Lopinavir|lopinavir|mesh-list
14110518|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14110519|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14110520|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
14110521|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110522|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761979|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761980|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761981|NCT03217812|Prednisone|prednisone|mesh-list
14110523|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14110524|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14110525|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
14110526|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110527|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14110528|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14110529|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
14110530|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761982|NCT03217812|Bortezomib|bortezomib|mesh-list
14761983|NCT03217812|Melphalan|melphalan|mesh-list
14110531|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
14110532|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
14110533|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110534|NCT02348125|Protective Agents|protective agents|mesh-ancestor
14110535|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110536|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
14110537|NCT02348125|Vitamins|vitamins|mesh-ancestor
14110538|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
14110539|NCT02347878|Aprepitant|aprepitant|mesh-list
13933446|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13933447|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933448|NCT03351842|Cisplatin|cisplatin|mesh-list
13933449|NCT03351842|Carboplatin|carboplatin|mesh-list
13933450|NCT03351842|Pemetrexed|pemetrexed|mesh-list
13933451|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933452|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933453|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933454|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13933455|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14110540|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
14110541|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
14110542|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110543|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110544|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110545|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14110546|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110547|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110548|NCT02347891|Belimumab|belimumab|mesh-list
14110549|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14110550|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
13933456|NCT03351751|PF-06372865|pf-06372865|mesh-list
13933457|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
13933458|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
13933459|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933460|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933461|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933462|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
13933463|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13933464|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13933465|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933466|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
13933467|NCT03351686|Coagulants|coagulants|mesh-ancestor
13933468|NCT03351647|Ustekinumab|ustekinumab|mesh-list
13933469|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
13933470|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
13933471|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13933472|NCT03351569|Antibodies|antibodies|mesh-list
13933473|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
13933474|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13933475|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
13933476|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933477|NCT03351517|Tapentadol|tapentadol|mesh-list
14110551|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110552|NCT02347865|Denosumab|denosumab|mesh-list
14110553|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14110554|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110555|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14110556|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14110557|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110558|NCT02347501|Incretins|incretins|mesh-ancestor
14110559|NCT02347501|Hormones|hormones|mesh-ancestor
14110560|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110561|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14110562|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
14110563|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110564|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110565|NCT02347839|Gefitinib|gefitinib|mesh-list
14110566|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110567|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14110568|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110569|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110570|NCT02347319|Silymarin|silymarin|mesh-list
14110571|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
13933478|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14110572|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933479|NCT03351517|Narcotics|narcotics|mesh-ancestor
13933480|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933481|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933482|NCT03351517|Analgesics|analgesics|mesh-ancestor
13933483|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
13933484|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933485|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13933486|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13933487|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933488|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933489|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933490|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933491|NCT03351361|Nivolumab|nivolumab|mesh-list
13933492|NCT03351361|Ipilimumab|ipilimumab|mesh-list
14110573|NCT02347319|Protective Agents|protective agents|mesh-ancestor
14110574|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110575|NCT02347423|Vaccines|vaccines|mesh-list
14110576|NCT02347423|Immunologic Factors|immunologic factors|mesh-ancestor
14110577|NCT02347423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110578|NCT02347358|Plasminogen|plasminogen|mesh-list
14110579|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14110580|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14110581|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14110582|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110583|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
14110584|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14110585|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110586|NCT02347111|Sotalol|sotalol|mesh-list
14110587|NCT02347111|Flecainide|flecainide|mesh-list
14110588|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14110589|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14110590|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933493|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933494|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933495|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13933496|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933497|NCT03351322|Minoxidil|minoxidil|mesh-list
13933498|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13933499|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
13933500|NCT03351296|Bevacizumab|bevacizumab|mesh-list
13933501|NCT03351296|Capecitabine|capecitabine|mesh-list
13933502|NCT03351296|Temozolomide|temozolomide|mesh-list
14110591|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110592|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110593|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110594|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14110595|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
14110596|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
14110597|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933503|NCT03351296|Streptozocin|streptozocin|mesh-list
13933504|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933505|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110598|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14110599|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14110600|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110601|NCT02347046|Dotinurad|dotinurad|mesh-list
14110602|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
14110603|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
14110604|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110605|NCT02347046|Renal Agents|renal agents|mesh-ancestor
14110606|NCT02347059|Dopamine|dopamine|mesh-list
14110607|NCT02347059|Levodopa|levodopa|mesh-list
14110608|NCT02347059|Pramipexole|pramipexole|mesh-list
14110609|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
14110610|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14110611|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14110612|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
14110613|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933506|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13933507|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13933508|NCT03351296|Growth Substances|growth substances|mesh-ancestor
13933509|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933510|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
13933511|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13933512|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
14110614|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110615|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110616|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
14110617|NCT02347059|Protective Agents|protective agents|mesh-ancestor
14110618|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14110619|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
14110620|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
14110621|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110622|NCT02347033|Sertraline|sertraline|mesh-list
14110623|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
14110624|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110625|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14110626|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14110627|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110628|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110629|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110630|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
14110631|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110632|NCT02346890|Sevelamer|sevelamer|mesh-list
14110633|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
14110634|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
14110635|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110636|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
14110637|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14110638|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933513|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933514|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13933515|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
13933516|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13961268|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961269|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
13961270|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110639|NCT02346682|Clonazepam|clonazepam|mesh-list
14110640|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14110641|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14110642|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14110643|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110644|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110645|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110646|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110647|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14110648|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
14761984|NCT03217812|Daratumumab|daratumumab|mesh-list
14761985|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14761986|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
14761987|NCT03217812|Hormones|hormones|mesh-ancestor
14761988|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14761989|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14761990|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761991|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14761992|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14761993|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
14110649|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110650|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
14110651|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
14110652|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
14110653|NCT02346539|Nicotine|nicotine|mesh-list
14110654|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14110655|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
14110656|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110657|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110658|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14110659|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14110660|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
14110661|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110662|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110663|NCT02346578|Flutamide|flutamide|mesh-list
13961271|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961272|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14110664|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
14110665|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
14110666|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110667|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110668|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14761994|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14761995|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14761996|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14761997|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
14761998|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14761999|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
14762000|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762001|NCT03201965|Dexamethasone|dexamethasone|mesh-list
14110669|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936172|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14936173|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
14175811|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14175812|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175813|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762002|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
14762003|NCT03201965|Bortezomib|bortezomib|mesh-list
14762004|NCT03201965|Daratumumab|daratumumab|mesh-list
14762005|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762006|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
14762007|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762008|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14175814|NCT04772001|Carboplatin|carboplatin|mesh-list
14175815|NCT04772001|Cisplatin|cisplatin|mesh-list
14175816|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762009|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762010|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
14762011|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762012|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762013|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762014|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762015|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
14762016|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
14762017|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762018|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175817|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
14175818|NCT04771715|Nivolumab|nivolumab|mesh-list
14175819|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14175820|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175821|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14175822|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175823|NCT04771728|Metronidazole|metronidazole|mesh-list
14762019|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
14762020|NCT03201965|Hormones|hormones|mesh-ancestor
14762021|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762022|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762023|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
14762024|NCT03195374|Narcotics|narcotics|mesh-ancestor
14762025|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762026|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762027|NCT03195374|Analgesics|analgesics|mesh-ancestor
14762028|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
14762029|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762030|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
13933517|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13933518|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13933519|NCT03351205|Estradiol|estradiol|mesh-list
13933520|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13933521|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
13933522|NCT03351205|Estrogens|estrogens|mesh-ancestor
13933523|NCT03351205|Hormones|hormones|mesh-ancestor
13933524|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933525|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933526|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13933527|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933528|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13933529|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13933530|NCT03351205|Progestins|progestins|mesh-ancestor
13933531|NCT03351062|Tamoxifen|tamoxifen|mesh-list
13933532|NCT03351062|Toremifene|toremifene|mesh-list
13933533|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13933534|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
14762031|NCT03193216|Antacids|antacids|mesh-ancestor
13933535|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933536|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933537|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933538|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933539|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13933540|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13933541|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13933542|NCT03350737|Heparin|heparin|mesh-list
13933543|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
13933544|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13933545|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13933546|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110670|NCT02346201|Methylphenidate|methylphenidate|mesh-list
14110671|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14110672|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110673|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14110674|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14110675|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110676|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110677|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
14110678|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110679|NCT02346357|Ropivacaine|ropivacaine|mesh-list
14110680|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
14110681|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
14110682|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14110683|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110684|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
14110685|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110686|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14110687|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110688|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
14110689|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
14110690|NCT02346188|Trace Elements|trace elements|mesh-ancestor
14110691|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
14110692|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110693|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
14110694|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
14110695|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14110696|NCT02346188|Protective Agents|protective agents|mesh-ancestor
14110697|NCT02346253|Leuprolide|leuprolide|mesh-list
14110698|NCT02346253|Goserelin|goserelin|mesh-list
14110699|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14110700|NCT02346253|Bicalutamide|bicalutamide|mesh-list
13933547|NCT03350659|Midodrine|midodrine|mesh-list
13933548|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
13933549|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13933550|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13933551|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933552|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933553|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933554|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933555|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933556|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
13933557|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
13933558|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933559|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14110701|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14110702|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
14110703|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14110704|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110705|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933560|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13933561|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13933562|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13933563|NCT03350633|Azathioprine|azathioprine|mesh-list
13933564|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
13933565|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933566|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13933567|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933568|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13933569|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
14110706|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110707|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
14110708|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
14175824|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762032|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762033|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762034|NCT03188068|Sirolimus|sirolimus|mesh-list
14762035|NCT03188068|Prednisolone|prednisolone|mesh-list
13933570|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933571|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933572|NCT03350399|Mitogens|mitogens|mesh-list
13933573|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
13933574|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933575|NCT03350386|Oxaprozin|oxaprozin|mesh-list
13933576|NCT03350386|Dotinurad|dotinurad|mesh-list
13933577|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
13933578|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
13933579|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933580|NCT03350386|Renal Agents|renal agents|mesh-ancestor
13933581|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13933582|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13933583|NCT03350386|Analgesics|analgesics|mesh-ancestor
13933584|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
14110709|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110710|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
14110711|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14110712|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
14110713|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14110714|NCT02346110|Dexamethasone|dexamethasone|mesh-list
14110715|NCT02346110|Epinephrine|epinephrine|mesh-list
14110716|NCT02346110|Racepinephrine|racepinephrine|mesh-list
14110717|NCT02346110|Bupivacaine|bupivacaine|mesh-list
14110718|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
14110719|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110720|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
14110721|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
14110722|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110723|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110724|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110725|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
14110726|NCT02346110|Hormones|hormones|mesh-ancestor
14110727|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110728|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14110729|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110730|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
14110731|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
14110732|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14110733|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
14110734|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14110735|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14110736|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
14110737|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110738|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110739|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14110740|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14110741|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14110742|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14110743|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
14110744|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
14110745|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14110746|NCT02346084|Maraviroc|maraviroc|mesh-list
14110747|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14110748|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14110749|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110750|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14110751|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14110752|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
14110753|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110754|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14110755|NCT02345902|Haloperidol|haloperidol|mesh-list
14110756|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
14110757|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
14110758|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
14110759|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110760|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110761|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110762|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14110763|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13933585|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110764|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14110765|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110766|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14110767|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
14110768|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110769|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110770|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14110771|NCT02345837|Clomiphene|clomiphene|mesh-list
14110772|NCT02345837|Enclomiphene|enclomiphene|mesh-list
13933586|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933587|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933588|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13933589|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933590|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933591|NCT03350373|Dotinurad|dotinurad|mesh-list
14110773|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
14110774|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14110775|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
14110776|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110777|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110778|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14110779|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
14110780|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14110781|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14110782|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14110783|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14110784|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
14110785|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14110786|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
14110787|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110788|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110789|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14110790|NCT02345993|Beclomethasone|beclomethasone|mesh-list
14110791|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
14110792|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14110793|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
14110794|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110795|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110796|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14110797|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
14110798|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14110799|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14110800|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14110801|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
14110802|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110803|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110804|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110805|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
14110806|NCT02345993|Hormones|hormones|mesh-ancestor
14110807|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110808|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
14110809|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
14110810|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14110811|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14110812|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110813|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110814|NCT02345980|Urological Agents|urological agents|mesh-ancestor
14110815|NCT02345746|Leucovorin|leucovorin|mesh-list
14110816|NCT02345746|Folic Acid|folic acid|mesh-list
14110817|NCT02345746|Fluorouracil|fluorouracil|mesh-list
14110818|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
14110819|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
14110820|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
14110821|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762036|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14762037|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933592|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
13933593|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
13933594|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933595|NCT03350373|Renal Agents|renal agents|mesh-ancestor
13933596|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
13933597|NCT03350347|Hematinics|hematinics|mesh-ancestor
13933598|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14183679|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933599|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13933600|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13933601|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933602|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933603|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933604|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933605|NCT03350334|Analgesics|analgesics|mesh-ancestor
13933606|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
13933607|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933608|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
13933609|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110822|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14110823|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110824|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14110825|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
14110826|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110827|NCT02345746|Antidotes|antidotes|mesh-ancestor
14110828|NCT02345746|Protective Agents|protective agents|mesh-ancestor
14110829|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
14110830|NCT02345746|Vitamins|vitamins|mesh-ancestor
14110831|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
14110832|NCT02345746|Hematinics|hematinics|mesh-ancestor
14110833|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14110834|NCT02345733|Amoxicillin|amoxicillin|mesh-list
14110835|NCT02345733|Metronidazole|metronidazole|mesh-list
14110836|NCT02345733|Doxycycline|doxycycline|mesh-list
14110837|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110838|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14110839|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14110840|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
14110841|NCT02345707|Cabotegravir|cabotegravir|mesh-list
14110842|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14110843|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14110844|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110845|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110846|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14110847|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14110848|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
14762038|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14762039|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762040|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
13933610|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
13933611|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
13933612|NCT03350321|Hematinics|hematinics|mesh-ancestor
13933613|NCT03350295|Nifurtimox|nifurtimox|mesh-list
13933614|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13933615|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13933616|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13933617|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933618|NCT03350191|Exenatide|exenatide|mesh-list
13933619|NCT03350191|Glucagon|glucagon|mesh-list
14762041|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762042|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
14762043|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762044|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762045|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
14110849|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14110850|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
14110851|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14110852|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
14110853|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110854|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110855|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14110856|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
14110857|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14110858|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
14110859|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110860|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110861|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14110862|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
14110863|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
14110864|NCT02345616|Protective Agents|protective agents|mesh-ancestor
14110865|NCT02345681|Furosemide|furosemide|mesh-list
14477872|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933620|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110866|NCT02345681|Diuretics|diuretics|mesh-ancestor
14110867|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
14110868|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933621|NCT03350191|Hormones|hormones|mesh-ancestor
13933622|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933623|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110869|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14110870|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14110871|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110872|NCT02345304|Digoxin|digoxin|mesh-list
14110873|NCT02345304|Midazolam|midazolam|mesh-list
14110874|NCT02345304|Omeprazole|omeprazole|mesh-list
14110875|NCT02345304|Warfarin|warfarin|mesh-list
14110876|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14110877|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14110878|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14110879|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110880|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14110881|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14110882|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110883|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14110884|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
14110885|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
14110886|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
14110887|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
14110888|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110889|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110890|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
14110891|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14110892|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110893|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14110894|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110895|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14110896|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14110897|NCT02345304|Protective Agents|protective agents|mesh-ancestor
14110898|NCT02345343|Apixaban|apixaban|mesh-list
14110899|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14110900|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
14110901|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14110902|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
14110903|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110904|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110905|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
14110906|NCT02345590|Eplerenone|eplerenone|mesh-list
14110907|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14110908|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
14110909|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110910|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110911|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14110912|NCT02345590|Diuretics|diuretics|mesh-ancestor
14110913|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
14110914|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14110915|NCT02345239|Pantoprazole|pantoprazole|mesh-list
14110916|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14110917|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14110918|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14110919|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933624|NCT03350191|Incretins|incretins|mesh-ancestor
13933625|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933626|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13933627|NCT03350126|Nivolumab|nivolumab|mesh-list
13933628|NCT03350126|Ipilimumab|ipilimumab|mesh-list
13933629|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933630|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933631|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13933632|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933633|NCT03349957|Idarubicin|idarubicin|mesh-list
13933634|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13933635|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933636|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13933637|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13933638|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933639|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933640|NCT03349866|Capecitabine|capecitabine|mesh-list
13933641|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
13933642|NCT03349866|Apatinib|apatinib|mesh-list
13933643|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13933644|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
14175825|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14110920|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110921|NCT02345148|Esketamine|esketamine|mesh-list
14110922|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
14110923|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14110924|NCT02345044|Eplerenone|eplerenone|mesh-list
14110925|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14110926|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
14110927|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110928|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110929|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14110930|NCT02345044|Diuretics|diuretics|mesh-ancestor
14110931|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
14110932|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14110933|NCT02345213|Donepezil|donepezil|mesh-list
14110934|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14110935|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14110936|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14110937|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
14110938|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14110939|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110940|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
14110941|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
14110942|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14110943|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110944|NCT02345187|Micronutrients|micronutrients|mesh-list
14110945|NCT02345187|Trace Elements|trace elements|mesh-list
14110946|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110947|NCT02344940|Tamoxifen|tamoxifen|mesh-list
14110948|NCT02344940|Toremifene|toremifene|mesh-list
14110949|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14110950|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
14110951|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110952|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110953|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933645|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933646|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933647|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13933648|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933649|NCT03349840|Insulin|insulin|mesh-list
13933650|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13933651|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
13933652|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933653|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933654|NCT03349827|Apatinib|apatinib|mesh-list
13933655|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933656|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13933657|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933658|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933659|NCT03349684|Metformin|metformin|mesh-list
13933660|NCT03349684|Acarbose|acarbose|mesh-list
14110954|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110955|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14110956|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14110957|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14110958|NCT02344888|Folic Acid|folic acid|mesh-list
14110959|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
14110960|NCT02344888|Prednisolone|prednisolone|mesh-list
14110961|NCT02344888|Citric Acid|citric acid|mesh-list
14110962|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
14110963|NCT02344888|Clomiphene|clomiphene|mesh-list
14110964|NCT02344888|Enclomiphene|enclomiphene|mesh-list
14110965|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
14110966|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
14110967|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14110968|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
14110969|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
14110970|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477873|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14110971|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14110972|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
14110973|NCT02344888|Hormones|hormones|mesh-ancestor
13933661|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933662|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110974|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14110975|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110976|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14110977|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14110978|NCT02344888|Hematinics|hematinics|mesh-ancestor
14110979|NCT02344888|Vitamins|vitamins|mesh-ancestor
14110980|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
14110981|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14110982|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
14110983|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14110984|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
13933663|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13933664|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933665|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933666|NCT03349658|Anesthetics|anesthetics|mesh-list
13933667|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933668|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933669|NCT03349619|Resveratrol|resveratrol|mesh-list
14110985|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14110986|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14110987|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14110988|NCT02344862|Dotinurad|dotinurad|mesh-list
14110989|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
13933670|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
13933671|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933672|NCT03349619|Protective Agents|protective agents|mesh-ancestor
13933673|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933674|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933675|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13933676|NCT03349606|Amphetamine|amphetamine|mesh-list
13933677|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
13933678|NCT03349606|FLB 457|flb 457|mesh-list
13933679|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13933680|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933681|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
13933682|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
13933683|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933684|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
13933685|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933686|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933687|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933688|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13933689|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13933690|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933691|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13933692|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13933693|NCT03349489|Insulin|insulin|mesh-list
13933694|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13933695|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933696|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110990|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
14110991|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110992|NCT02344862|Renal Agents|renal agents|mesh-ancestor
14110993|NCT02344875|Dotinurad|dotinurad|mesh-list
14110994|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
14110995|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
13961273|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
13961274|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961275|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961276|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13961277|NCT03149575|Carboplatin|carboplatin|mesh-list
13961278|NCT03149575|Temozolomide|temozolomide|mesh-list
13961279|NCT03149575|Lomustine|lomustine|mesh-list
13961280|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
13961281|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961282|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13961283|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
13961284|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961285|NCT03149445|Metoprolol|metoprolol|mesh-list
13961286|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13961287|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13961288|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
13961289|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
13961290|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14110996|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14110997|NCT02344875|Renal Agents|renal agents|mesh-ancestor
14110998|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
13961291|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14110999|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
13933697|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
13933698|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
13933699|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13933700|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
13933701|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933702|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933703|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13933704|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
14111000|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14111001|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14111002|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111003|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111004|NCT02344823|Urological Agents|urological agents|mesh-ancestor
14111005|NCT02344810|Leucovorin|leucovorin|mesh-list
14111006|NCT02344810|Fluorouracil|fluorouracil|mesh-list
14111007|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
14111008|NCT02344810|Calcium|calcium|mesh-list
14111009|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
14111010|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14111011|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111012|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
14111013|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111014|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111015|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111016|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111017|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
14111018|NCT02344810|Antidotes|antidotes|mesh-ancestor
14111019|NCT02344810|Protective Agents|protective agents|mesh-ancestor
14111020|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
14111021|NCT02344810|Vitamins|vitamins|mesh-ancestor
14111022|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
14175826|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14175827|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14175828|NCT04771884|Vancomycin|vancomycin|mesh-list
14175829|NCT04771884|Meropenem|meropenem|mesh-list
14175830|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
14175831|NCT04771884|Linezolid|linezolid|mesh-list
14175832|NCT04771884|Ceftazidime|ceftazidime|mesh-list
13933705|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933706|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933707|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13933708|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933709|NCT03349424|Somatostatin|somatostatin|mesh-list
13933710|NCT03349424|Hormones|hormones|mesh-ancestor
14175833|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
14175834|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14175835|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175836|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14175837|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175838|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175839|NCT04771754|Dolutegravir|dolutegravir|mesh-list
14175840|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14175841|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14175842|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175843|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175844|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13933711|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933712|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933713|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13933714|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
13933715|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933716|NCT03349346|Rituximab|rituximab|mesh-list
13933717|NCT03349346|Carboplatin|carboplatin|mesh-list
13933718|NCT03349346|Etoposide|etoposide|mesh-list
13933719|NCT03349346|Ifosfamide|ifosfamide|mesh-list
13933720|NCT03349346|Idelalisib|idelalisib|mesh-list
13933721|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13933722|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933723|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
13933724|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933725|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933726|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13933727|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14175845|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14175846|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
14175847|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175848|NCT04771559|Antibodies|antibodies|mesh-list
14175849|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
14111023|NCT02344511|Vancomycin|vancomycin|mesh-list
14111024|NCT02344511|Cefazolin|cefazolin|mesh-list
14111025|NCT02344511|Dalbavancin|dalbavancin|mesh-list
14111026|NCT02344511|Oxacillin|oxacillin|mesh-list
14111027|NCT02344511|Nafcillin|nafcillin|mesh-list
14111028|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111029|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111030|NCT02344550|Everolimus|everolimus|mesh-list
14762046|NCT03188068|Hormones|hormones|mesh-ancestor
14762047|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762048|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762049|NCT03181789|Interleukin-12|interleukin-12|mesh-list
14762050|NCT03181789|Vaccines|vaccines|mesh-list
14762051|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
14762052|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762053|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14762054|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14762055|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14762056|NCT03181789|Growth Substances|growth substances|mesh-ancestor
14762057|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
14762058|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111031|NCT02344550|Letrozole|letrozole|mesh-list
14111032|NCT02344550|Leuprolide|leuprolide|mesh-list
14111033|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111034|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111035|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
14111036|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111037|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14111038|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14111039|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111040|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111041|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14111042|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111043|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111044|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14111045|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
14111046|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111047|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111048|NCT02344784|Methylphenidate|methylphenidate|mesh-list
14111049|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14111050|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111051|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14111052|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14111053|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14111054|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111055|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
14111056|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111057|NCT02344602|Febuxostat|febuxostat|mesh-list
14111058|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
14111059|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111060|NCT02344589|Lidocaine|lidocaine|mesh-list
14111061|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
14111062|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
14111063|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933728|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13933729|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933730|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933731|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13933732|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
13933733|NCT03349216|Anesthetics|anesthetics|mesh-list
13933734|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933735|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933736|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
13933737|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13933738|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
13933739|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13933740|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111064|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111065|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
14111066|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111067|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14175850|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933741|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13933742|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
13933743|NCT03349177|Docetaxel|docetaxel|mesh-list
13933744|NCT03349177|Fluorouracil|fluorouracil|mesh-list
13933745|NCT03349177|Epirubicin|epirubicin|mesh-list
13933746|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13933747|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
13933748|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111068|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14111069|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14111070|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14111071|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111072|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
14111073|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14111074|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
14111075|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111076|NCT02344641|Exenatide|exenatide|mesh-list
14111077|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14111078|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111079|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14111080|NCT02344641|Incretins|incretins|mesh-ancestor
13933749|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933750|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13933751|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
13933752|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933753|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933754|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13933755|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
13933756|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
13933757|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
13933758|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
13933759|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13933760|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13933761|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13933762|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13933763|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933764|NCT03349112|Lidocaine|lidocaine|mesh-list
13933765|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
13933766|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
13933767|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933768|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933769|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
13933770|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933771|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13933772|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13933773|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13933774|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933775|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933776|NCT03349008|Entecavir|entecavir|mesh-list
13933777|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
13933778|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
13933779|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111081|NCT02344641|Hormones|hormones|mesh-ancestor
14111082|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14477874|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13933780|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933781|NCT03348969|Mitomycins|mitomycins|mesh-list
14111083|NCT02344732|Polymyxins|polymyxins|mesh-list
14477875|NCT02440789|Sirolimus|sirolimus|mesh-list
14477876|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14477877|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477878|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14477879|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477880|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
14477881|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14477882|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
14477883|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477884|NCT02441062|Edotreotide|edotreotide|mesh-list
14477885|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14477886|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933782|NCT03348969|Mitomycin|mitomycin|mesh-list
13933783|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14111084|NCT02344732|Neomycin|neomycin|mesh-list
14111085|NCT02344732|Polymyxin B|polymyxin b|mesh-list
14111086|NCT02344732|Dexamethasone|dexamethasone|mesh-list
14111087|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14111088|NCT02344732|Homatropine|homatropine|mesh-list
14111089|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111090|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
14111091|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
14111092|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111093|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111094|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14111095|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
14111096|NCT02344732|Hormones|hormones|mesh-ancestor
14111097|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111098|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111099|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111100|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14111101|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111102|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111103|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14111104|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111105|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111106|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
14111116|NCT02344472|Paclitaxel|paclitaxel|mesh-list
14111117|NCT02344472|Vinorelbine|vinorelbine|mesh-list
14111118|NCT02344472|Docetaxel|docetaxel|mesh-list
14111119|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13933784|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933785|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
13933786|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933787|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13933788|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111120|NCT02344472|Capecitabine|capecitabine|mesh-list
14111121|NCT02344472|Trastuzumab|trastuzumab|mesh-list
14111122|NCT02344472|Letrozole|letrozole|mesh-list
14111123|NCT02344472|Fulvestrant|fulvestrant|mesh-list
14111124|NCT02344472|Anastrozole|anastrozole|mesh-list
14111125|NCT02344472|Exemestane|exemestane|mesh-list
14111126|NCT02344472|Pertuzumab|pertuzumab|mesh-list
14111127|NCT02344472|Goserelin|goserelin|mesh-list
14111128|NCT02344472|Leuprolide|leuprolide|mesh-list
14111129|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14111130|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111131|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14111132|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14111133|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14111134|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111135|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111136|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
13933789|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
13933790|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
13933791|NCT03348917|Povidone|povidone|mesh-list
13933792|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13933793|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933794|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
13933795|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
13933796|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
13933797|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14111137|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14111138|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14111139|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14111140|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933798|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14111141|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14111142|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
13933799|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13933800|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13933801|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933802|NCT03348800|Anesthetics|anesthetics|mesh-list
13933803|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933804|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933805|NCT03348735|Lidocaine|lidocaine|mesh-list
13933806|NCT03348735|Pregabalin|pregabalin|mesh-list
13933807|NCT03348735|Capsaicin|capsaicin|mesh-list
13933808|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
13933809|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
13933810|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111143|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111144|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111145|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111146|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14111147|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14111148|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
14111149|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111150|NCT02344264|Ropivacaine|ropivacaine|mesh-list
14111151|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
14111152|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
14111153|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111154|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111155|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
14111156|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111157|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
14111158|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111159|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111160|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14111161|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14111162|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111163|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111164|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111165|NCT02344186|Liraglutide|liraglutide|mesh-list
14111166|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14111167|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111168|NCT02344186|Incretins|incretins|mesh-ancestor
14111169|NCT02344186|Hormones|hormones|mesh-ancestor
14111170|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111171|NCT02344095|Paclitaxel|paclitaxel|mesh-list
14111172|NCT02344095|Cisplatin|cisplatin|mesh-list
14111173|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14111174|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111175|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
14111176|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
13933811|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933812|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
13933813|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933814|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13933815|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13933816|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13933817|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933818|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933819|NCT03348735|Analgesics|analgesics|mesh-ancestor
13933820|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
13933821|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13933822|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13933823|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13933824|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14111177|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
14111178|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111179|NCT02343926|Metformin|metformin|mesh-list
14111180|NCT02343926|Vildagliptin|vildagliptin|mesh-list
13933825|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13933826|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
13933827|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
13933828|NCT03348696|Dexamethasone|dexamethasone|mesh-list
13933829|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
13933830|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13933831|NCT03348696|BB 1101|bb 1101|mesh-list
13933832|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933833|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
13933834|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
13933835|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933836|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933837|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13933838|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
13933839|NCT03348696|Hormones|hormones|mesh-ancestor
13933840|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933841|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933842|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933843|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
13933844|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933845|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933846|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
14111181|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14111182|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111183|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14111184|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
14111185|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111186|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111187|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
14111188|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
14111189|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14111190|NCT02344017|Prednisone|prednisone|mesh-list
14111191|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111192|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
14111193|NCT02344017|Hormones|hormones|mesh-ancestor
14111194|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111195|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111196|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111197|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111198|NCT02343861|Emollients|emollients|mesh-list
14111199|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
14111200|NCT02343718|Sirolimus|sirolimus|mesh-list
14111201|NCT02343718|Vinblastine|vinblastine|mesh-list
14111202|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111203|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111204|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14111205|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111206|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
14111207|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111208|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
14111209|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111210|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14111211|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
14111212|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
14111213|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
14111214|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111215|NCT02343692|Pancrelipase|pancrelipase|mesh-list
14111216|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14111217|NCT02343666|Plerixafor|plerixafor|mesh-list
14111218|NCT02343666|Carmustine|carmustine|mesh-list
14936174|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936175|NCT01467531|Dolutegravir|dolutegravir|mesh-list
14936176|NCT01467531|Cabotegravir|cabotegravir|mesh-list
14936177|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14936178|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14936179|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936180|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936181|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13933847|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
13933848|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
13933849|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933850|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933851|NCT03348462|Anthralin|anthralin|mesh-list
13933852|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
13933853|NCT03348423|Fentanyl|fentanyl|mesh-list
13933854|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13933855|NCT03348423|Narcotics|narcotics|mesh-ancestor
13933856|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933857|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933858|NCT03348423|Analgesics|analgesics|mesh-ancestor
13933859|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
13933860|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933861|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14111219|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14111220|NCT02343666|Lenograstim|lenograstim|mesh-list
14111221|NCT02343666|Sargramostim|sargramostim|mesh-list
14936182|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14111222|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14111223|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
14111224|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111225|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14111226|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
14111227|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111228|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111229|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14111230|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14111231|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
14111232|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111233|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111234|NCT02343679|Ceritinib|ceritinib|mesh-list
14111235|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111236|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14111237|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111238|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111239|NCT02343432|Triamcinolone|triamcinolone|mesh-list
14111240|NCT02343432|Bupivacaine|bupivacaine|mesh-list
14111241|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
14111242|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
14111243|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111244|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111245|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
14111246|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111247|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111248|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
14111249|NCT02343432|Hormones|hormones|mesh-ancestor
14111250|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111251|NCT02343484|Ethanol|ethanol|mesh-list
14111252|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14111253|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111254|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933862|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13933863|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
13933864|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
13933865|NCT03348371|Ethanol|ethanol|mesh-list
13933866|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13933867|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933868|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933869|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933870|NCT03348267|Caseins|caseins|mesh-list
13933871|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
13933872|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
13933873|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933874|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13933875|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13933876|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933877|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
13933878|NCT03348098|Paclitaxel|paclitaxel|mesh-list
13933879|NCT03348098|Apatinib|apatinib|mesh-list
13933880|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13933881|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933882|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
13933883|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
13933884|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
13933885|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933886|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13933887|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933888|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
13933889|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933890|NCT03348046|Infliximab|infliximab|mesh-list
14111255|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111256|NCT02343536|Prednisone|prednisone|mesh-list
14111257|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
14111258|NCT02343536|Rituximab|rituximab|mesh-list
14111259|NCT02343536|Vincristine|vincristine|mesh-list
14111260|NCT02343536|Azacitidine|azacitidine|mesh-list
14111261|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111262|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
14111263|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933891|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
13933892|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14111264|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111265|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14111266|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
14175851|NCT04771767|Ketamine|ketamine|mesh-list
14111267|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111268|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111269|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14111270|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14111271|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111272|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
14111273|NCT02343536|Hormones|hormones|mesh-ancestor
14111274|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933893|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13933894|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
13933895|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13933896|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
13933897|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933898|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933899|NCT03347968|Warfarin|warfarin|mesh-list
13933900|NCT03347968|Esmolol|esmolol|mesh-list
13933901|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
13933902|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13933903|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14111275|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111276|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14111277|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
14111278|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
14111279|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
14111280|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111281|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
14111282|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111283|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
14111284|NCT02343419|Miotics|miotics|mesh-ancestor
14111285|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
14111286|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111287|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111288|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14111289|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14111290|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
14111291|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14111292|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14111293|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
14111294|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111295|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111296|NCT02343614|Celecoxib|celecoxib|mesh-list
14111297|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14111298|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14111299|NCT02343614|Analgesics|analgesics|mesh-ancestor
14111300|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
14111301|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111302|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111303|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111304|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111305|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14111306|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14111307|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111308|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111309|NCT02343393|Hydralazine|hydralazine|mesh-list
14111310|NCT02343393|Isosorbide|isosorbide|mesh-list
14111311|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14111312|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14111313|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14111314|NCT02343393|Diuretics|diuretics|mesh-ancestor
14111315|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
14111316|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111317|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
14111318|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13933904|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13933905|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
13933906|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933907|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933908|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933909|NCT03347916|Gabapentin|gabapentin|mesh-list
13933910|NCT03347916|Analgesics|analgesics|mesh-ancestor
13933911|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
14111319|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175852|NCT04771767|Analgesics|analgesics|mesh-ancestor
14477887|NCT02441114|Fluticasone|fluticasone|mesh-list
13933912|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933913|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933914|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
13933915|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13933916|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13933917|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111320|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14762080|NCT03143985|Pomalidomide|pomalidomide|mesh-list
14762081|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
14762082|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111326|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
14111327|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14111328|NCT02343211|Antibodies|antibodies|mesh-list
14111329|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
14111330|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933918|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13933919|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13933920|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13933921|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933922|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933923|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
13933924|NCT03347890|Liraglutide|liraglutide|mesh-list
13933925|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13933926|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933927|NCT03347890|Incretins|incretins|mesh-ancestor
13933928|NCT03347890|Hormones|hormones|mesh-ancestor
13933929|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933930|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
13933931|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13933932|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111331|NCT02343289|Clarithromycin|clarithromycin|mesh-list
14111332|NCT02343289|Esketamine|esketamine|mesh-list
14111333|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111334|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111335|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14111336|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111337|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111338|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13961292|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13961293|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13961294|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14111339|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14111340|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
14111341|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14175853|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
14175854|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961295|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
13961296|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961297|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961298|NCT03149393|Mosapride|mosapride|mesh-list
13961299|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961300|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961301|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13961302|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
13961303|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961304|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961305|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
13961306|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961307|NCT03148990|Vaccines|vaccines|mesh-list
13961308|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
13961309|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961310|NCT03149159|Nivolumab|nivolumab|mesh-list
13961311|NCT03149159|Ipilimumab|ipilimumab|mesh-list
13961312|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961313|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961314|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14175855|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175856|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14175857|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14175858|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
13961315|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111342|NCT02342977|Lacosamide|lacosamide|mesh-list
14111343|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
14111344|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14111345|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14111346|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14111347|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111348|NCT02343250|Valsartan|valsartan|mesh-list
14111349|NCT02343250|Cilnidipine|cilnidipine|mesh-list
14111350|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14111351|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14111352|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14111353|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111354|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14111355|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14111356|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14111357|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111358|NCT02342925|Metformin|metformin|mesh-list
14111359|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14111360|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111361|NCT02342769|Abacavir|abacavir|mesh-list
14111362|NCT02342769|Dolutegravir|dolutegravir|mesh-list
14111363|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14111364|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14111365|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111366|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111367|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
14111368|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111369|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14111370|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14111371|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13933933|NCT03347786|Verapamil|verapamil|mesh-list
13933934|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13933935|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14111372|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14111373|NCT02342717|Itraconazole|itraconazole|mesh-list
14111374|NCT02342717|BI 425809|bi 425809|mesh-list
14111375|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
14111376|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111377|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14111378|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14111379|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111380|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111381|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14111382|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111383|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111384|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111385|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14111386|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
13933936|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933937|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933938|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13933939|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933940|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
13933941|NCT03347760|Octreotide|octreotide|mesh-list
13933942|NCT03347760|Edotreotide|edotreotide|mesh-list
13933943|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13933944|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933945|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13933946|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13933947|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933948|NCT03347721|Lidocaine|lidocaine|mesh-list
13933949|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
13933950|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
13933951|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13933952|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933953|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
13933954|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13933955|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14111387|NCT02342600|Trametinib|trametinib|mesh-list
14111388|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111389|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14111390|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175859|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
13933956|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13933957|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13933958|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13933959|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933960|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13933961|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
13933962|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13933963|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
13933964|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933965|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
13933966|NCT03347708|Protective Agents|protective agents|mesh-ancestor
13933967|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
13933968|NCT03347591|Hemostatics|hemostatics|mesh-list
14111391|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111392|NCT02342587|Lapatinib|lapatinib|mesh-list
14111393|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111394|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14111395|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111396|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111397|NCT02342509|Sevoflurane|sevoflurane|mesh-list
14111398|NCT02342509|Desflurane|desflurane|mesh-list
14111399|NCT02342509|Isoflurane|isoflurane|mesh-list
13933969|NCT03347591|Coagulants|coagulants|mesh-ancestor
13933970|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13933971|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
13933972|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933973|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13933974|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13933975|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
13933976|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13933977|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
13933978|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13933979|NCT03347591|Protective Agents|protective agents|mesh-ancestor
13933980|NCT03347526|Vigabatrin|vigabatrin|mesh-list
13933981|NCT03347526|Cosyntropin|cosyntropin|mesh-list
13933982|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
13933983|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13933984|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933985|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
13933986|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933987|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933988|NCT03347526|Hormones|hormones|mesh-ancestor
13933989|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13933990|NCT03347513|Glycine|glycine|mesh-list
13933991|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
13933992|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13933993|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13933994|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13933995|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
13933996|NCT03347461|Dexamethasone|dexamethasone|mesh-list
13933997|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13933998|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
13933999|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
13934000|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934001|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934002|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934003|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
13934004|NCT03347461|Hormones|hormones|mesh-ancestor
13934005|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934006|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13934007|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934008|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934009|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934010|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934011|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934012|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13934013|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13961316|NCT03149120|Nivolumab|nivolumab|mesh-list
14477888|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
14111400|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14111401|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14111402|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
14111403|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
14111404|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762083|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14111405|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111406|NCT02342574|Olorofim|olorofim|mesh-list
14111407|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
14111408|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111409|NCT02342392|Ranibizumab|ranibizumab|mesh-list
14111410|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14111411|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14111412|NCT02342392|Growth Substances|growth substances|mesh-ancestor
14111413|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111414|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
14111415|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111416|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14111417|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111418|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14111419|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111420|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111421|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
14111422|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14111423|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13934014|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13934015|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13934016|NCT03347370|Interferons|interferons|mesh-list
13934017|NCT03347370|Interferon-beta|interferon-beta|mesh-list
14111424|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
14111425|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
14111426|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111427|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111428|NCT02342275|Propranolol|propranolol|mesh-list
14111429|NCT02342275|Atenolol|atenolol|mesh-list
14111430|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14111431|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14111432|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
14111433|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111434|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111435|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111436|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14111437|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14111438|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
14111439|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
14111440|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
14111441|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111442|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14111443|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14111444|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
14111445|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111446|NCT02342145|Cyclosporine|cyclosporine|mesh-list
14111447|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
14111448|NCT02342145|Methotrexate|methotrexate|mesh-list
14936183|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
14936184|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936185|NCT01467596|Lidocaine|lidocaine|mesh-list
14936186|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
14936187|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
13934018|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
13934019|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
13934020|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111449|NCT02342145|Cyclosporins|cyclosporins|mesh-list
14111450|NCT02342145|Basiliximab|basiliximab|mesh-list
13934021|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
13934022|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934023|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
13934024|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934025|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13934026|NCT03347357|Tacrolimus|tacrolimus|mesh-list
13934027|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934028|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
13934029|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934030|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13934031|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934032|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934033|NCT03347344|Riluzole|riluzole|mesh-list
13934034|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
14111451|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13934035|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14111452|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
14936188|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
14936189|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111453|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111454|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934036|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13934037|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934038|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934039|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934040|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13934041|NCT03347344|Protective Agents|protective agents|mesh-ancestor
13934049|NCT03347240|Baclofen|baclofen|mesh-list
13934050|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13934051|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934052|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13934053|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934054|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13934055|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
13934056|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
13934057|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934058|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934059|NCT03346993|Bupivacaine|bupivacaine|mesh-list
13934060|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
13934061|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
13934062|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934063|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934064|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
13934065|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934066|NCT03346837|Itraconazole|itraconazole|mesh-list
13934067|NCT03346837|Rifampin|rifampin|mesh-list
13934068|NCT03346837|Linrodostat|linrodostat|mesh-list
13934069|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
13934070|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934071|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13934072|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13934073|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934074|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934075|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13934076|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
13934077|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934078|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111455|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111456|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
14111457|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111458|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111459|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14111460|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934079|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13934080|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13934081|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
13934082|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111461|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14111462|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111463|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
14111464|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111465|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14111466|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
14111467|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111468|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14111469|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14111470|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14111471|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
14111472|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111473|NCT02342093|Drospirenone|drospirenone|mesh-list
14111474|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14111475|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111476|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934083|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
14111477|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111478|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14111479|NCT02342093|Diuretics|diuretics|mesh-ancestor
14111480|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
14111481|NCT02342067|Pioglitazone|pioglitazone|mesh-list
14111482|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
14111483|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14111484|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111485|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14111486|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111487|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14111488|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14111489|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
14111490|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934084|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13934085|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13934086|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13934087|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13934088|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13934089|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13934090|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13934091|NCT03346772|Vaccines|vaccines|mesh-list
13934092|NCT03346772|Immunologic Factors|immunologic factors|mesh-ancestor
13934093|NCT03346772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934094|NCT03346733|Psyllium|psyllium|mesh-list
13934095|NCT03346733|Cathartics|cathartics|mesh-ancestor
13934096|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934097|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
13934098|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13934099|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
13934100|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934101|NCT03346681|Expectorants|expectorants|mesh-ancestor
13934102|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
13934103|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13934104|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
13934105|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934106|NCT03346681|Protective Agents|protective agents|mesh-ancestor
13934107|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934108|NCT03346681|Antidotes|antidotes|mesh-ancestor
13934109|NCT03346642|Decitabine|decitabine|mesh-list
13934110|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13934111|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13934112|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
13934113|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934114|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934115|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934116|NCT03346629|Misoprostol|misoprostol|mesh-list
14111491|NCT02341872|Calcium|calcium|mesh-list
14111492|NCT02341872|Fluorides|fluorides|mesh-list
14111493|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14111494|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111495|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
14111496|NCT02341872|Protective Agents|protective agents|mesh-ancestor
14111497|NCT02342002|Misoprostol|misoprostol|mesh-list
14111498|NCT02342002|Mifepristone|mifepristone|mesh-list
14111499|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14111500|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
14111501|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111502|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111503|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14111504|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762084|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13934117|NCT03346629|Mifepristone|mifepristone|mesh-list
13934118|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13934119|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
13934120|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13934121|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934122|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13934123|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934124|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
13934125|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14762085|NCT03143985|Growth Substances|growth substances|mesh-ancestor
14762086|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
14762087|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934126|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13934127|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13934128|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13934129|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
13934130|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14111505|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
14111506|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14111507|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14111508|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14111509|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14111510|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
14111511|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14111512|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14111513|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111514|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111515|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
14762088|NCT03141359|Paclitaxel|paclitaxel|mesh-list
14762089|NCT03141359|Etoposide|etoposide|mesh-list
14762090|NCT03141359|Carboplatin|carboplatin|mesh-list
14762091|NCT03141359|Durvalumab|durvalumab|mesh-list
14762092|NCT03141359|Cisplatin|cisplatin|mesh-list
14762093|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13934131|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14111516|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14111517|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13934132|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
13934133|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934134|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
13934135|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13934136|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13934137|NCT03346538|Edaravone|edaravone|mesh-list
13934138|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13934139|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
13934140|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934141|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13934142|NCT03346538|Protective Agents|protective agents|mesh-ancestor
13934143|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934144|NCT03346525|Penicillins|penicillins|mesh-list
13934145|NCT03346525|Penicillin G|penicillin g|mesh-list
13934146|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
13934147|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
13934148|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934149|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934150|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13934151|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13934152|NCT03346317|Estradiol|estradiol|mesh-list
13934153|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13934154|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
13934155|NCT03346317|Estrogens|estrogens|mesh-ancestor
14111518|NCT02341833|Sevoflurane|sevoflurane|mesh-list
14111519|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14111520|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14111521|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
14111522|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
14111523|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111524|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111525|NCT02341963|Ketamine|ketamine|mesh-list
14111526|NCT02341963|Analgesics|analgesics|mesh-ancestor
14111527|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
14111528|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477889|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14477890|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14477891|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477892|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14477893|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
14477894|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14477895|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477896|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14477897|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
14477898|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
14477899|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14477900|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
14477901|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14477902|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
14111529|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762094|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762095|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14477903|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477904|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477905|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14477906|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14477907|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14477908|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477909|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
14477910|NCT02441114|Hormones|hormones|mesh-ancestor
14477911|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934156|NCT03346317|Hormones|hormones|mesh-ancestor
13934157|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111530|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14111531|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14111532|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
14111533|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
14111534|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111535|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14111536|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14111537|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934158|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934159|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13934160|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
13934161|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13934162|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13934163|NCT03346317|Progestins|progestins|mesh-ancestor
13961317|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961318|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961319|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13961320|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961321|NCT03149250|Hemostatics|hemostatics|mesh-list
13961322|NCT03149250|Coagulants|coagulants|mesh-ancestor
13961323|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
13961324|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13961325|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
13961326|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961327|NCT03149107|Expectorants|expectorants|mesh-ancestor
13961328|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
13961329|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13961330|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
13961331|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961332|NCT03149107|Protective Agents|protective agents|mesh-ancestor
13961333|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961334|NCT03149107|Antidotes|antidotes|mesh-ancestor
13961335|NCT03148717|Misoprostol|misoprostol|mesh-list
13961336|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13961337|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
14111538|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111539|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14111540|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14111541|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14111542|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
14111543|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111544|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14111545|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14111546|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111547|NCT02341729|Ticagrelor|ticagrelor|mesh-list
14111548|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14111549|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14111550|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14111551|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14111552|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
14111553|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111554|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111555|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111556|NCT02341703|Metformin|metformin|mesh-list
14111557|NCT02341703|Pioglitazone|pioglitazone|mesh-list
14111558|NCT02341703|Letrozole|letrozole|mesh-list
14111559|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14111560|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111561|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111562|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14111563|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13961338|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111564|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111565|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111566|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14111567|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111568|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111569|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
14111570|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
14111571|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111572|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111573|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111574|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14111575|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14111576|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
14111577|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111578|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111579|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111580|NCT02341586|Iron|iron|mesh-list
14111581|NCT02341586|Trace Elements|trace elements|mesh-ancestor
14111582|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
13934164|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
13934165|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13934166|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13934167|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13934168|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13934169|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934170|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
14111583|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111584|NCT02341638|Aspirin|aspirin|mesh-list
14111585|NCT02341638|Itraconazole|itraconazole|mesh-list
14111586|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14111587|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934171|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934172|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934173|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13934174|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934175|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
13934176|NCT03346226|Propofol|propofol|mesh-list
13934177|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14111588|NCT02341638|Analgesics|analgesics|mesh-ancestor
14111589|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
14111590|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111591|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111592|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111593|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111594|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14111595|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14111596|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111597|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14111598|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14111599|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111600|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
14111601|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
14111602|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111603|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14111604|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14111605|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14111606|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111607|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111608|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14111609|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
14111610|NCT02341547|Hematinics|hematinics|mesh-ancestor
14111611|NCT02341352|Fluorides|fluorides|mesh-list
14111612|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
14111613|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
14111614|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14111615|NCT02341352|Antibodies|antibodies|mesh-list
14111616|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
14111617|NCT02341352|Protective Agents|protective agents|mesh-ancestor
14111618|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111619|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
14111620|NCT02341365|Vitamin D|vitamin d|mesh-list
14111621|NCT02341365|Vitamins|vitamins|mesh-ancestor
14111622|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
14111623|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111624|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14175860|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175861|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14175862|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14175863|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175864|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175865|NCT04771520|Piperazine|piperazine|mesh-list
14175866|NCT04771520|Mebendazole|mebendazole|mesh-list
14175867|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
13934178|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934179|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934180|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13934181|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
13934182|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
13934183|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934184|NCT03346226|Analgesics|analgesics|mesh-ancestor
13934185|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
13934186|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934187|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14175868|NCT04771520|DMP 777|dmp 777|mesh-list
14175869|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
14175870|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
14175871|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14175872|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175873|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
14175874|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
14175875|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
14175876|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175877|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934188|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13934189|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13934190|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
13934191|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934192|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934193|NCT03346200|Tamoxifen|tamoxifen|mesh-list
13934194|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13934195|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
13934196|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934197|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934198|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13934199|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934200|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13934201|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13934202|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13934203|NCT03346187|Atorvastatin|atorvastatin|mesh-list
13934204|NCT03346187|Fenofibrate|fenofibrate|mesh-list
13934205|NCT03346187|Calcium|calcium|mesh-list
14175878|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175879|NCT04771390|Selitrectinib|selitrectinib|mesh-list
14175880|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175881|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762096|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14762097|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14762098|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762099|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14762100|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14762101|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175888|NCT04771026|Dexamethasone|dexamethasone|mesh-list
14175889|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762102|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762103|NCT03133221|Idelalisib|idelalisib|mesh-list
14762104|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762105|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762106|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762107|NCT03117816|Interferons|interferons|mesh-list
14175890|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
14175891|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
14175892|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175893|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175894|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14175895|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
14175896|NCT04771026|Hormones|hormones|mesh-ancestor
14175897|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14175898|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111625|NCT02341209|Doxycycline|doxycycline|mesh-list
14111626|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111627|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111628|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
14111629|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14111630|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14111631|NCT02341300|Iron|iron|mesh-list
14111632|NCT02341300|Trace Elements|trace elements|mesh-ancestor
14111633|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
14111634|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111635|NCT02341274|Tacrolimus|tacrolimus|mesh-list
14111636|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111637|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
14111638|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111639|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14111640|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111641|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111642|NCT02341105|Amiodarone|amiodarone|mesh-list
14111643|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14111644|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
14111645|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14111646|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14111647|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111648|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14111649|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14111650|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14111651|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111652|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14111653|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14111654|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13934206|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13934207|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934208|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13934209|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13934210|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
13934211|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934212|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13934213|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13934214|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934215|NCT03346096|Thiotepa|thiotepa|mesh-list
13934216|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13934217|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
13934218|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934219|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934220|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13934221|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934222|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
13934223|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934224|NCT03346083|Betrixaban|betrixaban|mesh-list
13934225|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13934226|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
13934227|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13934228|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
13934229|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934230|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934231|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
13934232|NCT03345992|Clarithromycin|clarithromycin|mesh-list
13934233|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934234|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934235|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13934236|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934237|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934238|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13934239|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13934240|NCT03345966|Antibodies|antibodies|mesh-list
13934241|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
13934242|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934243|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13934244|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
13934245|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13961339|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934246|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934247|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934248|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
13934249|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934250|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
13934251|NCT03345836|Upadacitinib|upadacitinib|mesh-list
13934252|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
13934253|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13934254|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934255|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934256|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934257|NCT03345810|Gemcitabine|gemcitabine|mesh-list
13934258|NCT03345810|Paclitaxel|paclitaxel|mesh-list
13934259|NCT03345810|Vinorelbine|vinorelbine|mesh-list
14111655|NCT02341079|Bupivacaine|bupivacaine|mesh-list
14111656|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
14111657|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
14111658|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111659|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111660|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
14111661|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111662|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
14111663|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14111664|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14111665|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
14111666|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111667|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111668|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111669|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
14111670|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
14111671|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111672|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
14111673|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14111674|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
14111675|NCT02340936|Lenalidomide|lenalidomide|mesh-list
14111676|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
14111677|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111678|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14111679|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14111680|NCT02340936|Growth Substances|growth substances|mesh-ancestor
14111681|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
13934260|NCT03345810|Carboplatin|carboplatin|mesh-list
13934261|NCT03345810|Durvalumab|durvalumab|mesh-list
14111682|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111683|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
14111684|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
14111685|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111686|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111687|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14111688|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14111689|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14111690|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14111691|NCT02340988|Oritavancin|oritavancin|mesh-list
14111692|NCT02340988|Warfarin|warfarin|mesh-list
14111693|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
14111694|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111695|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111696|NCT02340455|Pregabalin|pregabalin|mesh-list
14111697|NCT02340455|Analgesics|analgesics|mesh-ancestor
14111698|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
14111699|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111700|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111701|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
14111702|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14111703|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14111704|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111705|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13934262|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13934263|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934264|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
13934265|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
13934266|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14111706|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13934267|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961340|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14111707|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14111708|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111709|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14111710|NCT02340481|Simethicone|simethicone|mesh-list
14111711|NCT02340481|Loperamide|loperamide|mesh-list
14111712|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
14111713|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14111714|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
14111715|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111716|NCT02340481|Emollients|emollients|mesh-ancestor
14111717|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
14111718|NCT02340611|Olaparib|olaparib|mesh-list
14111719|NCT02340611|Cediranib|cediranib|mesh-list
14111720|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14111721|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111722|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111723|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111724|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14111725|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
14111726|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13934268|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13934269|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
13934270|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
14111727|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14111728|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111729|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111730|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111731|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
13934271|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934272|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934273|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934274|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
13934275|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934276|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934277|NCT03345797|Testosterone|testosterone|mesh-list
13934278|NCT03345797|Androgens|androgens|mesh-ancestor
13934279|NCT03345797|Hormones|hormones|mesh-ancestor
14111732|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14111733|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14111734|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
14111735|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111736|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111737|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111738|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
14111739|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
14111740|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111741|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
14111742|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14111743|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
14111744|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14111745|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14111746|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14111747|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14111748|NCT02340247|Cathartics|cathartics|mesh-ancestor
14111749|NCT02340117|Gemcitabine|gemcitabine|mesh-list
14111750|NCT02340117|Paclitaxel|paclitaxel|mesh-list
13934280|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934281|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934282|NCT03345667|Ranibizumab|ranibizumab|mesh-list
13934283|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13934284|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13934285|NCT03345667|Growth Substances|growth substances|mesh-ancestor
13934286|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934287|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
13934288|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934289|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
13934290|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934291|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934292|NCT03345498|Entecavir|entecavir|mesh-list
13934293|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
13934294|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934295|NCT03345303|Bortezomib|bortezomib|mesh-list
13934296|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934297|NCT03345147|Vitamins|vitamins|mesh-list
13934298|NCT03345147|Vitamin A|vitamin a|mesh-list
14111751|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14111752|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14111753|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111754|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14111755|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14111756|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14111757|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111758|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111759|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
14111760|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
14111761|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111762|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111763|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111764|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
14111765|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111766|NCT02340182|Metronidazole|metronidazole|mesh-list
14111767|NCT02340182|Vancomycin|vancomycin|mesh-list
14111768|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
14111769|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111770|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111771|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14111772|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14111773|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14111774|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14111775|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111776|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111777|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111778|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14111779|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14111780|NCT02340169|Desoximetasone|desoximetasone|mesh-list
14111781|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111782|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
14111783|NCT02340169|Hormones|hormones|mesh-ancestor
14111784|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111785|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111786|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14111787|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
14111788|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14111789|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14111790|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14111791|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
14111792|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111793|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111794|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14111795|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14111796|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14111797|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111798|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111799|NCT02339714|Loratadine|loratadine|mesh-list
14111800|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
14111801|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14111802|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14111803|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14111804|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14111805|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
14111806|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
14111807|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111808|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934299|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
13934300|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
13934301|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934302|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
13934303|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934304|NCT03345147|Protective Agents|protective agents|mesh-ancestor
13934305|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13934306|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934307|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
13934308|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934309|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934310|NCT03345095|Temozolomide|temozolomide|mesh-list
13934311|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13934312|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
14111809|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111810|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14111811|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14111812|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934313|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934314|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934315|NCT03345004|Vitamin D|vitamin d|mesh-list
13934316|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
13934317|NCT03345004|Vitamins|vitamins|mesh-list
13934318|NCT03345004|Aluminum sulfate|aluminum sulfate|mesh-list
13934319|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
13934320|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934321|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13934322|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13934323|NCT03345004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13934324|NCT03345004|Immunologic Factors|immunologic factors|mesh-ancestor
13934325|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
13934326|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13934327|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13934328|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13934329|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13934330|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111813|NCT02339753|Carboplatin|carboplatin|mesh-list
14111814|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111815|NCT02339662|Gabapentin|gabapentin|mesh-list
14111816|NCT02339662|Amitriptyline|amitriptyline|mesh-list
14111817|NCT02339662|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14111818|NCT02339662|Analgesics|analgesics|mesh-ancestor
14111819|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
14111820|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111821|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111822|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
14111823|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14111824|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14111825|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111826|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14111827|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14111828|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14111829|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111830|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111831|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
14111832|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14111833|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
14111834|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14111835|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14111836|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14111837|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14111838|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
14111839|NCT02339662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14111840|NCT02339844|Aripiprazole|aripiprazole|mesh-list
14111841|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
14111842|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14111843|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14111844|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14111845|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14111846|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111847|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
14111848|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
14111849|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111850|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934331|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
14111851|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14111852|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14111853|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
14111854|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14111855|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14111856|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14111857|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14175899|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175900|NCT04771000|Ambrisentan|ambrisentan|mesh-list
14175901|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14183680|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14183681|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14183682|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
13934332|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14111858|NCT02339532|Carboplatin|carboplatin|mesh-list
14111859|NCT02339532|Docetaxel|docetaxel|mesh-list
13934333|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934334|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13934335|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934336|NCT03344822|Choline|choline|mesh-list
13934337|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13934338|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
13934339|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13934340|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
13934341|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934342|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934343|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13934344|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
13934345|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13934346|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
13934347|NCT03344705|Fludarabine|fludarabine|mesh-list
13934348|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934349|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
13934350|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934351|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934352|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13934353|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
13934354|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934355|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934356|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13934357|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
13934358|NCT03344679|Adenosine|adenosine|mesh-list
13934359|NCT03344679|Bupivacaine|bupivacaine|mesh-list
13934360|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
13934361|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
13934362|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934363|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934364|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
14111860|NCT02339532|Trastuzumab|trastuzumab|mesh-list
14111861|NCT02339532|Pertuzumab|pertuzumab|mesh-list
14111862|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111863|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
14111864|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
14111865|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
13934365|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934366|NCT03344679|Analgesics|analgesics|mesh-ancestor
13934367|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13934368|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
13934369|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13934370|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13934371|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934372|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13934373|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
13934374|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13934375|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
13934376|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14111866|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111867|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14111868|NCT02339350|Methotrexate|methotrexate|mesh-list
14111869|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14111870|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
14111871|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111872|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111873|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111874|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
14111875|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111876|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111877|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
14111878|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111879|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14111880|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111881|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
14111882|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111883|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14111884|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
14111885|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
14111886|NCT02339441|Methotrexate|methotrexate|mesh-list
13934377|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
14111887|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111888|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
14111889|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111890|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111891|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14111892|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
13934378|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
13934379|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934380|NCT03344627|Meropenem|meropenem|mesh-list
14111893|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934381|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934382|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934383|NCT03344614|Apatinib|apatinib|mesh-list
13934384|NCT03344614|Raltitrexed|raltitrexed|mesh-list
13934385|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934386|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13934387|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934388|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934389|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13934390|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
13934391|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13934392|NCT03344536|Fulvestrant|fulvestrant|mesh-list
14111894|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111895|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14111896|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14111897|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
14111898|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14111899|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111900|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
14111901|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
14111902|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111903|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14111904|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14111905|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14111906|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14111907|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
14111908|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14111909|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111910|NCT02339324|Interferons|interferons|mesh-list
14111911|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
14111912|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
14111913|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
14111914|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14111915|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111916|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
14111917|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111918|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
14111919|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111920|NCT02339428|Diclofenac|diclofenac|mesh-list
14111921|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14111922|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14111923|NCT02339428|Analgesics|analgesics|mesh-ancestor
14111924|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
14111925|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111926|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111927|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111928|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14111929|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14111930|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111931|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111932|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
14111933|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
14111934|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111935|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
14111936|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14111937|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14111938|NCT02339142|Prednisolone|prednisolone|mesh-list
14111939|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
14111940|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14111941|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
14111942|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14111943|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
14111944|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
14111945|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14111946|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111947|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934393|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13934394|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934395|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13934396|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13934397|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
13934398|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934399|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934400|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
13934401|NCT03344523|Hematinics|hematinics|mesh-ancestor
13961341|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961342|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
13961343|NCT03148704|Palonosetron|palonosetron|mesh-list
13961344|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
13961345|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
13961346|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961347|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961348|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14111948|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
14111949|NCT02339142|Hormones|hormones|mesh-ancestor
14111950|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111951|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14111952|NCT02339142|Protective Agents|protective agents|mesh-ancestor
14111953|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14111954|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111955|NCT02339090|Hormones|hormones|mesh-list
14111956|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111957|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111958|NCT02339116|Bevacizumab|bevacizumab|mesh-list
14111959|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
14111960|NCT02339116|Irinotecan|irinotecan|mesh-list
14111961|NCT02339116|Fluorouracil|fluorouracil|mesh-list
14111962|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14111963|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14111964|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14111965|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14111966|NCT02339116|Growth Substances|growth substances|mesh-ancestor
14111967|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961349|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13961350|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13961351|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
14111968|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
14111969|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14111970|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14111971|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111972|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111973|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
14111974|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14111975|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14111976|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
14111977|NCT02338934|Vitamin D|vitamin d|mesh-list
14762108|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
13961352|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961353|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963446|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963447|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963448|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963449|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963450|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963451|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963452|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
13963453|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963454|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963455|NCT03144453|Atropine|atropine|mesh-list
13963456|NCT03144453|Neostigmine|neostigmine|mesh-list
13963457|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13963458|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13963459|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13963460|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
13963461|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963462|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963463|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13963464|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
13963465|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
13963466|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
13963467|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13963468|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14111978|NCT02338934|Cinacalcet|cinacalcet|mesh-list
14111979|NCT02338934|Vitamins|vitamins|mesh-ancestor
14111980|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
14111981|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111982|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14111983|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14111984|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14111985|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
14111986|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111987|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
14111988|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14111989|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14111990|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14111991|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14111992|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14111993|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
14111994|NCT02338830|Progesterone|progesterone|mesh-list
14111995|NCT02338830|Progestins|progestins|mesh-ancestor
14111996|NCT02338830|Hormones|hormones|mesh-ancestor
14111997|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14111998|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14111999|NCT02338687|Calcium|calcium|mesh-list
14112000|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14112001|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112002|NCT02338674|Tenofovir|tenofovir|mesh-list
14112003|NCT02338674|Telbivudine|telbivudine|mesh-list
14112004|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
14112005|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112006|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14112007|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14112008|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112009|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112010|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14112011|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14112012|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
14112013|NCT02338518|Etoposide|etoposide|mesh-list
14112014|NCT02338518|Epirubicin|epirubicin|mesh-list
14112015|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112016|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14112017|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14112018|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14112019|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112020|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112021|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14112022|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14112023|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14112024|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112025|NCT02338544|Adapalene|adapalene|mesh-list
14112026|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14112027|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
14112028|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14112029|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14112030|NCT02338544|Analgesics|analgesics|mesh-ancestor
14112031|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
14112032|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112033|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112034|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112035|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934402|NCT03344445|Anesthetics|anesthetics|mesh-list
13934403|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934404|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934405|NCT03344393|Ketamine|ketamine|mesh-list
13934406|NCT03344393|Analgesics|analgesics|mesh-ancestor
14112036|NCT02338570|Everolimus|everolimus|mesh-list
14112037|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112038|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934407|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
13934408|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934409|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934410|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13934411|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13934412|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
13934413|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
13934414|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961354|NCT03148561|Misoprostol|misoprostol|mesh-list
14112039|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
14112040|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934415|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13934416|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13934417|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934418|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934419|NCT03344328|Bortezomib|bortezomib|mesh-list
13934420|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934421|NCT03344302|Oxytocin|oxytocin|mesh-list
13934422|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
13934423|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13934424|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934425|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13934426|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934427|NCT03344094|Interferons|interferons|mesh-list
13934428|NCT03344094|Interferon-beta|interferon-beta|mesh-list
13934429|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
13934430|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934431|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
13934432|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934433|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
13934434|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934435|NCT03344042|Fentanyl|fentanyl|mesh-list
13934436|NCT03344042|Sufentanil|sufentanil|mesh-list
13934437|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13934438|NCT03344042|Narcotics|narcotics|mesh-ancestor
13934439|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934440|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934441|NCT03344042|Analgesics|analgesics|mesh-ancestor
13934442|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
13934443|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934444|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13934445|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14112041|NCT02338622|Olaparib|olaparib|mesh-list
14112042|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14112043|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112044|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112045|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112046|NCT02338466|Tenecteplase|tenecteplase|mesh-list
14112047|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14112048|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14112049|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112050|NCT02338323|Febuxostat|febuxostat|mesh-list
14112051|NCT02338323|Benzbromarone|benzbromarone|mesh-list
14112052|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
14112053|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112054|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
14112055|NCT02338323|Renal Agents|renal agents|mesh-ancestor
14112056|NCT02338310|Letrozole|letrozole|mesh-list
14112057|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14112058|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112059|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14112060|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112061|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112062|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14112063|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
14112064|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112065|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112066|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14112067|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
14112068|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112069|NCT02338089|Oxytocin|oxytocin|mesh-list
14112070|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
14112071|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13934446|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
13934447|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
13934448|NCT03344029|Vaccines|vaccines|mesh-list
13934449|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
14112072|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112073|NCT02338232|Telmisartan|telmisartan|mesh-list
14112074|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14112075|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14762109|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
14762110|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934450|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934451|NCT03344003|Factor VIII|factor viii|mesh-list
14112076|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13934452|NCT03344003|Coagulants|coagulants|mesh-ancestor
14112077|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112078|NCT02338245|Capecitabine|capecitabine|mesh-list
14112079|NCT02338245|Lapatinib|lapatinib|mesh-list
14112080|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14112081|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
14112082|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112083|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112084|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14112085|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112086|NCT02338206|Hormones|hormones|mesh-list
14112087|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934453|NCT03343977|Docetaxel|docetaxel|mesh-list
13934454|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934455|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
13934456|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
13934457|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
13934458|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934459|NCT03343873|Midazolam|midazolam|mesh-list
13934460|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
13934461|NCT03343873|Propofol|propofol|mesh-list
13934462|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13934463|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934464|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934465|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13934466|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
13934467|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
13934468|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934469|NCT03343873|Analgesics|analgesics|mesh-ancestor
13934470|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
13934471|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934472|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13934473|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13934474|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13934475|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
13934476|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934477|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934478|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13934479|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13934480|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13934481|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13934482|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
13934483|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
13934484|NCT03343795|Progesterone|progesterone|mesh-list
13934485|NCT03343795|Progestins|progestins|mesh-ancestor
13934486|NCT03343795|Hormones|hormones|mesh-ancestor
13934487|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934488|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934489|NCT03343678|Venetoclax|venetoclax|mesh-list
13934490|NCT03343678|BI 836826|bi 836826|mesh-list
13934491|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934492|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934493|NCT03343665|Nivolumab|nivolumab|mesh-list
13934494|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934495|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934496|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13934497|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934498|NCT03343652|Nivolumab|nivolumab|mesh-list
13934499|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13934500|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14112088|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112089|NCT02338011|Gefitinib|gefitinib|mesh-list
14112090|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112091|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14112092|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112093|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112094|NCT02338115|Paclitaxel|paclitaxel|mesh-list
14112095|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13934501|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934502|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13934503|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934504|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13934505|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
14112096|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934506|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
14112097|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
14112098|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
14112099|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
14112100|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112101|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
14112102|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112103|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14112104|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13934507|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934508|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13934509|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934510|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934511|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
13934512|NCT03343548|Analgesics|analgesics|mesh-ancestor
13934513|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
13934514|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112105|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
14112106|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112107|NCT02337855|Antacids|antacids|mesh-ancestor
14112108|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112109|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112110|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
14112111|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
14112112|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14112113|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14112114|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112115|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112116|NCT02337881|Urological Agents|urological agents|mesh-ancestor
14112117|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
14112118|NCT02337972|Povidone|povidone|mesh-list
14112119|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
14112120|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
14112121|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14112122|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175902|NCT04770740|Vitamin K|vitamin k|mesh-list
14175903|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
14175904|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
14175905|NCT04770740|Vitamins|vitamins|mesh-ancestor
14175906|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
14175907|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175908|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14175909|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14175910|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934515|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934516|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
13934517|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934518|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13934519|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
13934520|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13934521|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13934522|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934523|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13934524|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
14175911|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
14175912|NCT04770740|Coagulants|coagulants|mesh-ancestor
14175913|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
14175914|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14175915|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14175916|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175917|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
14175918|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14175919|NCT04770688|Osimertinib|osimertinib|mesh-list
14175920|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175921|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14175922|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175923|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762111|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
13934525|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13934526|NCT03343509|Metronidazole|metronidazole|mesh-list
13934527|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934528|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934529|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13934530|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14175924|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14175925|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14175926|NCT04770961|Ropivacaine|ropivacaine|mesh-list
14112123|NCT02337712|Etoposide|etoposide|mesh-list
14112124|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112125|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14112126|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13934531|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
13934532|NCT03343444|Ledipasvir|ledipasvir|mesh-list
13934533|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
13934534|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934535|NCT03343431|Tenofovir|tenofovir|mesh-list
13934536|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
13934537|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934538|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13934539|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13934540|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934541|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934542|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13934543|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13934544|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13934545|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
13934546|NCT03343418|Coagulants|coagulants|mesh-ancestor
13934547|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13934548|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
13934549|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934550|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14112127|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14112128|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112129|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112130|NCT02337426|Temozolomide|temozolomide|mesh-list
14112131|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14112132|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14112133|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
14112134|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112135|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112136|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
14112137|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112138|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
14112139|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112140|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14112141|NCT02337413|Laxatives|laxatives|mesh-ancestor
14112142|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112143|NCT02337283|BI 425809|bi 425809|mesh-list
14112144|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
13934551|NCT03343366|Metronidazole|metronidazole|mesh-list
13934552|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934553|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13934554|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13934555|NCT03343002|Fentanyl|fentanyl|mesh-list
13934556|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13934557|NCT03343002|Narcotics|narcotics|mesh-ancestor
13934558|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934559|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934560|NCT03343002|Analgesics|analgesics|mesh-ancestor
14112145|NCT02337257|Vitamin D|vitamin d|mesh-list
14112146|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
14112147|NCT02337257|Vitamins|vitamins|mesh-ancestor
14112148|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
14112149|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112150|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14112151|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14112152|NCT02337231|Borage oil|borage oil|mesh-list
14112153|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112154|NCT02337322|Ritonavir|ritonavir|mesh-list
14112155|NCT02337322|Darunavir|darunavir|mesh-list
14112156|NCT02337322|Dolutegravir|dolutegravir|mesh-list
14112157|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14112158|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14112159|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
14112160|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112161|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112162|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14112163|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14112164|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
14762112|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112165|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175927|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
13934561|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
13934562|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934563|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14112166|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14112167|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13934564|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13934565|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
13934566|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
13934567|NCT03342911|Paclitaxel|paclitaxel|mesh-list
13934568|NCT03342911|Carboplatin|carboplatin|mesh-list
13934569|NCT03342911|Nivolumab|nivolumab|mesh-list
13934570|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13934571|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934572|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
13934573|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
13934574|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
13934575|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934576|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934577|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13934578|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
13934579|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13934580|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
13934581|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14112168|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14112169|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14112170|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
14112171|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14112172|NCT02337192|Curcumin|curcumin|mesh-list
14112173|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14112174|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13934582|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934583|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13961355|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13961356|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
13961357|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13961358|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961359|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13961360|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112175|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112176|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
14112177|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
14112178|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14112179|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14112180|NCT02337192|Analgesics|analgesics|mesh-ancestor
14112181|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
14112182|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112183|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112184|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112185|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112186|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112187|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112188|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112189|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
14112190|NCT02337127|Lamivudine|lamivudine|mesh-list
14112191|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14112192|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14112193|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112194|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112195|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
14112196|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112197|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14112198|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14112199|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
14112200|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14112201|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
14112202|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112203|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
14112204|NCT02337166|Protective Agents|protective agents|mesh-ancestor
13961361|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
13961362|NCT03148574|Misoprostol|misoprostol|mesh-list
13961363|NCT03148574|Oxytocin|oxytocin|mesh-list
13961364|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
14112205|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
13961365|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14112206|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175928|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
13934584|NCT03342807|Insulin|insulin|mesh-list
13934585|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13934586|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934587|NCT03342651|Vitamin D|vitamin d|mesh-list
13934588|NCT03342651|Vitamins|vitamins|mesh-ancestor
13934589|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
13934590|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934591|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13934592|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
14112207|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112208|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
14112209|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14112210|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112211|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14112212|NCT02337036|Tacrolimus|tacrolimus|mesh-list
14112213|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112214|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
14112215|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112216|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14112217|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112218|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112219|NCT02336984|Trastuzumab|trastuzumab|mesh-list
14112220|NCT02336984|Pertuzumab|pertuzumab|mesh-list
14112221|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14112222|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112223|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14112224|NCT02336906|Laxatives|laxatives|mesh-ancestor
14112225|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112226|NCT02336854|Tacrolimus|tacrolimus|mesh-list
14112227|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112228|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
14112229|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112230|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14112231|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112232|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112233|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14112234|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14112235|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112236|NCT02336659|Incretins|incretins|mesh-ancestor
14112237|NCT02336659|Hormones|hormones|mesh-ancestor
14112238|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112239|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14112240|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
14112241|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112242|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112243|NCT02336633|Resveratrol|resveratrol|mesh-list
13934593|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
13934594|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934595|NCT03342599|Protective Agents|protective agents|mesh-ancestor
13934596|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934597|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
13934598|NCT03342599|Vitamins|vitamins|mesh-ancestor
13934599|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
13934600|NCT03342443|Memantine|memantine|mesh-list
13934601|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13934602|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13934603|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
13934604|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934605|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934606|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934607|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13934608|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13934609|NCT03342352|Carboplatin|carboplatin|mesh-list
13934610|NCT03342352|Fluorouracil|fluorouracil|mesh-list
13934611|NCT03342352|Nivolumab|nivolumab|mesh-list
13934612|NCT03342352|Cetuximab|cetuximab|mesh-list
13934613|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934614|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
13934615|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934616|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13934617|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934618|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
14112244|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
14175929|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934619|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112245|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112246|NCT02336633|Protective Agents|protective agents|mesh-ancestor
14112247|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112248|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112249|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14112250|NCT02336477|Mexiletine|mexiletine|mesh-list
14112251|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14112252|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14112253|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14112254|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112255|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112256|NCT02336568|Oxytocin|oxytocin|mesh-list
14112257|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
14112258|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13934620|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934621|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13934622|NCT03342300|Doxorubicin|doxorubicin|mesh-list
13934623|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13934624|NCT03342300|Pirarubicin|pirarubicin|mesh-list
13934625|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13934626|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934627|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13934628|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13934629|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934630|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934631|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
13934632|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934633|NCT03342170|Thrombin|thrombin|mesh-list
13934634|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
13934635|NCT03342170|Coagulants|coagulants|mesh-ancestor
13934636|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
14112259|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112260|NCT02336529|Bupivacaine|bupivacaine|mesh-list
14112261|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
14112262|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
14112263|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934637|NCT03342079|Anesthetics|anesthetics|mesh-list
13934638|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
13934639|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934640|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934641|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
13934642|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934643|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13934644|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
13934645|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934646|NCT03342079|Analgesics|analgesics|mesh-ancestor
13934647|NCT03342040|Bupivacaine|bupivacaine|mesh-list
13934648|NCT03342040|Ropivacaine|ropivacaine|mesh-list
13934649|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
14112264|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112265|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
14112266|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112267|NCT02336516|Azithromycin|azithromycin|mesh-list
14112268|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14112269|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112270|NCT02336308|Ketamine|ketamine|mesh-list
14112271|NCT02336308|Analgesics|analgesics|mesh-ancestor
14112272|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
14112273|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112274|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112275|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14112276|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14112277|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
14112278|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
14112279|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112280|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14112281|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14112282|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112283|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112284|NCT02336386|Dexamethasone|dexamethasone|mesh-list
14112285|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
13934650|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
14112286|NCT02336386|Doxorubicin|doxorubicin|mesh-list
13934651|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934652|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934653|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
14112287|NCT02336386|Bortezomib|bortezomib|mesh-list
14112288|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112289|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
14112290|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112291|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112292|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14112293|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
14112294|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112295|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112296|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14112297|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112298|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
14112299|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
14112300|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112301|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112302|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
14112303|NCT02336386|Hormones|hormones|mesh-ancestor
13934654|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934655|NCT03341988|Ritonavir|ritonavir|mesh-list
14112304|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112305|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14112306|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112307|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14112308|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13934656|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13934657|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13934658|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
13934659|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934660|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934661|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13934662|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13934663|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
13934664|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934665|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13934666|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13934667|NCT03341936|Nivolumab|nivolumab|mesh-list
13934668|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934669|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112309|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14112310|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
14112311|NCT02336048|Chlorambucil|chlorambucil|mesh-list
14112312|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934670|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13934671|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934672|NCT03341845|Avelumab|avelumab|mesh-list
13934673|NCT03341845|Axitinib|axitinib|mesh-list
13934674|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934675|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934676|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13934677|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934678|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934679|NCT03341767|Clofazimine|clofazimine|mesh-list
13934680|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934681|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
13934682|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934683|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934684|NCT03341741|Tobramycin|tobramycin|mesh-list
13934685|NCT03341741|Colistin|colistin|mesh-list
13934686|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934687|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934688|NCT03341676|Dexamethasone|dexamethasone|mesh-list
13934689|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934690|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
13934691|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
13934692|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934693|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934694|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934695|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
13934696|NCT03341676|Hormones|hormones|mesh-ancestor
13934697|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934698|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13934699|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934700|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
13934701|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14112313|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934702|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934703|NCT03341494|Thalidomide|thalidomide|mesh-list
13934704|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934705|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
13934706|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934707|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
13934708|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934709|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112314|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14112315|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
14112316|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112317|NCT02336152|Anesthetics|anesthetics|mesh-list
14112318|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112319|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112320|NCT02336347|Quinidine|quinidine|mesh-list
14112321|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
14112322|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
14112323|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
14112324|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14112325|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14112326|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112327|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112328|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112329|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14112330|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14112331|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14112332|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13934710|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13934711|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13934712|NCT03341494|Growth Substances|growth substances|mesh-ancestor
13934713|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
13934714|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934715|NCT03341429|Liraglutide|liraglutide|mesh-list
13934716|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13934717|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934718|NCT03341429|Incretins|incretins|mesh-ancestor
13934719|NCT03341429|Hormones|hormones|mesh-ancestor
13934720|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934721|NCT03341390|Aspirin|aspirin|mesh-list
13934722|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13934723|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934724|NCT03341390|Analgesics|analgesics|mesh-ancestor
13934725|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
13934726|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934727|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934728|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934729|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934730|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13934731|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13934732|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934733|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13934734|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13934735|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934736|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
13934737|NCT03341260|Diclofenac|diclofenac|mesh-list
13934738|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13934739|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934740|NCT03341260|Analgesics|analgesics|mesh-ancestor
13934741|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
13934742|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934743|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934744|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934745|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934746|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13934747|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112333|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
14112334|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14112335|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14112336|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112337|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934748|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112338|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14112339|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13934749|NCT03341234|Bupivacaine|bupivacaine|mesh-list
14112340|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
14112341|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14112342|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14112343|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112344|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14112345|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14112346|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
14112347|NCT02336139|Velpatasvir|velpatasvir|mesh-list
14112348|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
14112349|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175930|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175931|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
14175932|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175933|NCT04770155|Bosentan|bosentan|mesh-list
14175934|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
14936190|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934750|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
13934751|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
13934752|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934753|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934754|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
13934755|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934756|NCT03341117|Aspirin|aspirin|mesh-list
13934757|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
13934758|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13934759|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934760|NCT03341117|Analgesics|analgesics|mesh-ancestor
13934761|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
13934762|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934763|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934764|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934765|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934766|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13934767|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13934768|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934769|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13934770|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13934771|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934772|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
13934773|NCT03341117|Antacids|antacids|mesh-ancestor
13934774|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934775|NCT03341104|Bupivacaine|bupivacaine|mesh-list
13934776|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
13934777|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
13934778|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934779|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934780|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
14936191|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
14936192|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936193|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14936194|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14936195|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14936196|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14936197|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936198|NCT01467648|Doripenem|doripenem|mesh-list
14936199|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936200|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934781|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961366|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961367|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13961368|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
13961369|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13961370|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961371|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
13961372|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
13961373|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961374|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961375|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961376|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
13961377|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961378|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961379|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175935|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936201|NCT01467687|Verapamil|verapamil|mesh-list
14112350|NCT02335736|Cetrorelix|cetrorelix|mesh-list
14112351|NCT02335736|Hormones|hormones|mesh-list
14112352|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
14112353|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112354|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112355|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14112356|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
14112357|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14112358|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
14112359|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
14112360|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14112361|NCT02335593|Hematinics|hematinics|mesh-ancestor
14112362|NCT02335593|Astringents|astringents|mesh-ancestor
14112363|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112364|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
14112365|NCT02335684|Methamphetamine|methamphetamine|mesh-list
14112366|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14112367|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112368|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
14112369|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
14112370|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112371|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
14112372|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112373|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112374|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
14112375|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14112376|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14112377|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112378|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14112379|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
14112380|NCT02335411|Capecitabine|capecitabine|mesh-list
14112381|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112382|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14112383|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14112384|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
14112385|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112386|NCT02335372|Acetic Acid|acetic acid|mesh-list
14112387|NCT02335372|Proflavine|proflavine|mesh-list
14112388|NCT02335372|Retinol acetate|retinol acetate|mesh-list
14112389|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14112390|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934782|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
13934783|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
13934784|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934785|NCT03340909|Prednisolone|prednisolone|mesh-list
13934786|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934787|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
13934788|NCT03340909|Hormones|hormones|mesh-ancestor
13934789|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934790|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934791|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13934792|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934793|NCT03340779|Dobutamine|dobutamine|mesh-list
13934794|NCT03340779|Norepinephrine|norepinephrine|mesh-list
13934795|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13934796|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13934797|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
13934798|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934799|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934800|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934801|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
13934802|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
13934803|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934804|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13934805|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13934806|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13934807|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13934808|NCT03340779|Protective Agents|protective agents|mesh-ancestor
13934809|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
13934810|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
13934811|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
13934812|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961380|NCT03148509|Risperidone|risperidone|mesh-list
14112391|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13934813|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934814|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13934815|NCT03340753|Diuretics|diuretics|mesh-ancestor
13934816|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
13934817|NCT03340753|Hormones|hormones|mesh-ancestor
13934818|NCT03340740|Cetirizine|cetirizine|mesh-list
13934819|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13934820|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13934821|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13934822|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
13934823|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
13934824|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934825|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112392|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
14112393|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112394|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14112395|NCT02335372|Protective Agents|protective agents|mesh-ancestor
14112396|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112397|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14112398|NCT02335255|Naftifine|naftifine|mesh-list
14112399|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
14112400|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112401|NCT02335151|Desflurane|desflurane|mesh-list
14112402|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14112403|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
14112404|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
14112405|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112406|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112407|NCT02335281|Mesalamine|mesalamine|mesh-list
14112408|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14112409|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14112410|NCT02335281|Analgesics|analgesics|mesh-ancestor
14112411|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
14112412|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112413|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112414|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112415|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934826|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934827|NCT03340701|Progesterone|progesterone|mesh-list
14112416|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
14112417|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14112418|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13934828|NCT03340701|Progestins|progestins|mesh-ancestor
13934829|NCT03340701|Hormones|hormones|mesh-ancestor
13934830|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934831|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934832|NCT03340662|Itraconazole|itraconazole|mesh-list
13934833|NCT03340662|Rifampin|rifampin|mesh-list
13934834|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
13934835|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
13934836|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934837|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13934838|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13934839|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934840|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934841|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13934842|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
13934843|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934844|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934845|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13934846|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14112419|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762113|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
14762114|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112420|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
14112421|NCT02335359|Coagulants|coagulants|mesh-ancestor
14112422|NCT02335398|Methadone|methadone|mesh-list
14112423|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14112424|NCT02335398|Narcotics|narcotics|mesh-ancestor
14112425|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112426|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762115|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
14762116|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14112427|NCT02335398|Analgesics|analgesics|mesh-ancestor
14762117|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14112428|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
14112429|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112430|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
14112431|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
14762118|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14762119|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112432|NCT02335190|Lidocaine|lidocaine|mesh-list
14112433|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
14112434|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
14112435|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112436|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112437|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
14112438|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112439|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14112440|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14112441|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14112442|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112443|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112444|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
14112445|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
14112446|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
14112447|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112448|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14112449|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
14112450|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14112451|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14112452|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14112453|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
14112454|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14112455|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112456|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14112457|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14112458|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14112459|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14112460|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112461|NCT02335099|Ticagrelor|ticagrelor|mesh-list
14112462|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14112463|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14112464|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14112465|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14112466|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
14112467|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112468|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112469|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112470|NCT02334904|Risperidone|risperidone|mesh-list
14112471|NCT02334904|Aripiprazole|aripiprazole|mesh-list
14112472|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14112473|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
14112474|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112475|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762120|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762121|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
14762122|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762123|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762124|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13934847|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
13934848|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13934849|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
13934850|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13934851|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13934852|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13934853|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13934854|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13934855|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13934856|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13934857|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13934858|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13934859|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934860|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13934861|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14112476|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112477|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13934862|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13934863|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13934864|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934865|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
13934866|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14112478|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14112479|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112480|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14112481|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14112482|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
14112483|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
14112484|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
14112485|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14112486|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14112487|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14112488|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14112489|NCT02334735|Vaccines|vaccines|mesh-list
14112490|NCT02334735|Poly ICLC|poly iclc|mesh-list
14112491|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
14112492|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112493|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
13934867|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
13934868|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13934869|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13934870|NCT03340597|Olorofim|olorofim|mesh-list
13934871|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
13934872|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934873|NCT03340558|Atezolizumab|atezolizumab|mesh-list
13934874|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112494|NCT02334501|Lansoprazole|lansoprazole|mesh-list
14112495|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
14112496|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14112497|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112498|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14112499|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112500|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112501|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
14112502|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13934875|NCT03340493|Tenecteplase|tenecteplase|mesh-list
13934876|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13934877|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13934878|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934879|NCT03340376|Doxorubicin|doxorubicin|mesh-list
13934880|NCT03340376|Atezolizumab|atezolizumab|mesh-list
13934881|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13934882|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934883|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13934884|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14112503|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14112504|NCT02334475|Prednisolone|prednisolone|mesh-list
14112505|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
14112506|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14112507|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
14112508|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112509|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
14112510|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
14112511|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112512|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112513|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13934885|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934886|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934887|NCT03340168|Bisphenol A|bisphenol a|mesh-list
13934888|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13934889|NCT03340168|Estrogens|estrogens|mesh-ancestor
13934890|NCT03340168|Hormones|hormones|mesh-ancestor
13934891|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934892|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934893|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13934894|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
13934895|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112514|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
14112515|NCT02334475|Hormones|hormones|mesh-ancestor
14175936|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14112516|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112517|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13934896|NCT03340168|Protective Agents|protective agents|mesh-ancestor
13934897|NCT03340129|Nivolumab|nivolumab|mesh-list
13934898|NCT03340129|Ipilimumab|ipilimumab|mesh-list
13934899|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13934900|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112518|NCT02334475|Protective Agents|protective agents|mesh-ancestor
14112519|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14112520|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934901|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13934902|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934903|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
13934904|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13934905|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13934906|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934907|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
13934908|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13934909|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112521|NCT02334605|Capsaicin|capsaicin|mesh-list
14112522|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
14112523|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
14112524|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
14112525|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934910|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
13934911|NCT03339804|Doxorubicin|doxorubicin|mesh-list
13934912|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934913|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
13934914|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934915|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934916|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13934917|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
13934918|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934919|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934920|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13934921|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13934922|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13934923|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13934924|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934925|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14112526|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112527|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
14112528|NCT02334488|Everolimus|everolimus|mesh-list
14112529|NCT02334488|Tacrolimus|tacrolimus|mesh-list
14112530|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112531|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
14112532|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112533|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14112534|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112535|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112536|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112537|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14112538|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14112539|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
14112540|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14112541|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112542|NCT02334670|Fluconazole|fluconazole|mesh-list
14112543|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
14112544|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112545|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14112546|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14112547|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112548|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112549|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14112550|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
14112551|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112552|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112553|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14112554|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13934926|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14112555|NCT02334631|Simethicone|simethicone|mesh-list
14112556|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
14112557|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112558|NCT02334631|Emollients|emollients|mesh-ancestor
14112559|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14112560|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14112561|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14112562|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
14112563|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112564|NCT02334462|Antacids|antacids|mesh-ancestor
14112565|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112566|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112567|NCT02334254|Warfarin|warfarin|mesh-list
14112568|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
14112569|NCT02334254|Clopidogrel|clopidogrel|mesh-list
14112570|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14112571|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14112572|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14112573|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14112574|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
14112575|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112576|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112577|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112578|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
14112579|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14112580|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
14112581|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14112582|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
14112583|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112584|NCT02334163|Metronidazole|metronidazole|mesh-list
14112585|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
14112586|NCT02334163|Lactulose|lactulose|mesh-list
14112587|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112588|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14112589|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14112590|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14112591|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112592|NCT02334176|Lidocaine|lidocaine|mesh-list
14112593|NCT02334176|Epinephrine|epinephrine|mesh-list
14112594|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
14112595|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
14112596|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112597|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112598|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
14112599|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112600|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14112601|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14112602|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14112603|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112604|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112605|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14112606|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14112607|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
14112608|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112609|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14112610|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14112611|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
14112612|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13934927|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13934928|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
13934929|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934930|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13934931|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13934932|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934933|NCT03339700|Gemcitabine|gemcitabine|mesh-list
13934934|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
13934935|NCT03339700|Busulfan|busulfan|mesh-list
13934936|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13934937|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
13934938|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934939|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934940|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13934941|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
14112613|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
14112614|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
14112615|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
14112616|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14112617|NCT02334150|Sufentanil|sufentanil|mesh-list
14112618|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14112619|NCT02334150|Narcotics|narcotics|mesh-ancestor
14112620|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112621|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112622|NCT02334150|Analgesics|analgesics|mesh-ancestor
14112623|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
14112624|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112625|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14112626|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14112627|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
14112628|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
14175937|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14175938|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175939|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175940|NCT04770155|Urological Agents|urological agents|mesh-ancestor
14175941|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14175942|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14175943|NCT04770389|Ezetimibe|ezetimibe|mesh-list
14175944|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
14175945|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14175946|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
14175947|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175948|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14175949|NCT04769908|Lenvatinib|lenvatinib|mesh-list
14175950|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14175951|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14175952|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14175953|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175954|NCT04769557|Acetaminophen|acetaminophen|mesh-list
14175955|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14175956|NCT04769557|Analgesics|analgesics|mesh-ancestor
14175957|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
14175958|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175959|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175960|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
14175961|NCT04769713|Ropivacaine|ropivacaine|mesh-list
14175962|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
14175963|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
14175964|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175965|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175966|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
14175967|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934942|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934943|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934944|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13934945|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13934946|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
13934947|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
14175968|NCT04769583|Metronidazole|metronidazole|mesh-list
14175969|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14175970|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14175971|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14175972|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14175973|NCT04769778|Valsartan|valsartan|mesh-list
14175974|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14175975|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14175976|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14175977|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14175978|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14175979|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13934948|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13934949|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934950|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
13934951|NCT03339635|Testosterone|testosterone|mesh-list
13934952|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
13934953|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
13934954|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13934955|NCT03339635|Androgens|androgens|mesh-ancestor
13934956|NCT03339635|Hormones|hormones|mesh-ancestor
13934957|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934958|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175980|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
14175981|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14175982|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934959|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13934960|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13934961|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
13934962|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
13934963|NCT03339596|Hematinics|hematinics|mesh-ancestor
13934964|NCT03339544|Celecoxib|celecoxib|mesh-list
13934965|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13934966|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13934967|NCT03339544|Analgesics|analgesics|mesh-ancestor
13934968|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
13934969|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934970|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934971|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934972|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13934973|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13934974|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13934975|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13934976|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13934977|NCT03339427|Vitamin D|vitamin d|mesh-list
13934978|NCT03339427|Vitamins|vitamins|mesh-ancestor
13934979|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
13934980|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934981|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13934982|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
13934983|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13934984|NCT03339362|Bupivacaine|bupivacaine|mesh-list
13934985|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
13934986|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
13934987|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13934988|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13934989|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
13934990|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13934991|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13934992|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
14112629|NCT02334046|Remifentanil|remifentanil|mesh-list
14112630|NCT02334046|Sevoflurane|sevoflurane|mesh-list
14112631|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14112632|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14112633|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
14112634|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
14112635|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112636|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112637|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14112638|NCT02334046|Narcotics|narcotics|mesh-ancestor
14112639|NCT02334046|Analgesics|analgesics|mesh-ancestor
14112640|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
14112641|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112642|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
14112643|NCT02334124|Floxacillin|floxacillin|mesh-list
14112644|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14112645|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112646|NCT02333890|Chloroquine|chloroquine|mesh-list
14112647|NCT02333890|Amebicides|amebicides|mesh-ancestor
14112648|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14112649|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14112650|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112651|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
14112652|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112653|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
14112654|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14112655|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
13934993|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
13934994|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112656|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14112657|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
14112658|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112659|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112660|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
14112661|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
14112662|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14112663|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112664|NCT02333838|Vidarabine|vidarabine|mesh-list
14112665|NCT02333838|Fludarabine|fludarabine|mesh-list
14112666|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
14112667|NCT02333838|Busulfan|busulfan|mesh-list
13934995|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
13934996|NCT03339362|Hormones|hormones|mesh-ancestor
14112668|NCT02333838|Thiotepa|thiotepa|mesh-list
14112669|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112670|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14112671|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
14112672|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112673|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112674|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
14112675|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112676|NCT02333838|Antiviral Agents|antiviral agents|mesh-ancestor
14112677|NCT02333838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112678|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
14112679|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14112680|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14112681|NCT02334007|Dalteparin|dalteparin|mesh-list
14112682|NCT02334007|Tinzaparin|tinzaparin|mesh-list
14112683|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13934997|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13934998|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13934999|NCT03339362|Protective Agents|protective agents|mesh-ancestor
13935000|NCT03339349|Enoxaparin|enoxaparin|mesh-list
13935001|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
13935002|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13935003|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13935004|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961381|NCT03148509|Aripiprazole|aripiprazole|mesh-list
13961382|NCT03148509|Bupropion|bupropion|mesh-list
13961383|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13961384|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
13961385|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961386|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112684|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
14112685|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14112686|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14112687|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112688|NCT02333799|Linezolid|linezolid|mesh-list
14112689|NCT02333799|Bedaquiline|bedaquiline|mesh-list
14112690|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14112691|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112692|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14112693|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112694|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112695|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
14112696|NCT02333682|Vitamin D|vitamin d|mesh-list
14112697|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
14112698|NCT02333682|Calcifediol|calcifediol|mesh-list
14112699|NCT02333682|Vitamins|vitamins|mesh-ancestor
14112700|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
14112701|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112702|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14112703|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14112704|NCT02333565|Everolimus|everolimus|mesh-list
14112705|NCT02333565|Octreotide|octreotide|mesh-list
14112706|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112707|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112708|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
14112709|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112710|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112711|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14112712|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
14112713|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14112714|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112715|NCT02333513|Vincristine|vincristine|mesh-list
14112716|NCT02333513|Lomustine|lomustine|mesh-list
14112717|NCT02333513|Procarbazine|procarbazine|mesh-list
14112718|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14112719|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112720|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
14112721|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
14112722|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
14112723|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112724|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14112725|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
14112726|NCT02333253|Cetrorelix|cetrorelix|mesh-list
14112727|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13961387|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112728|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
14112729|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14112730|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935005|NCT03339258|Doxazosin|doxazosin|mesh-list
14112731|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
14112732|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112733|NCT02333292|Ritonavir|ritonavir|mesh-list
14112734|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
14112735|NCT02333292|Grazoprevir|grazoprevir|mesh-list
14112736|NCT02333292|Ledipasvir|ledipasvir|mesh-list
14112737|NCT02333292|Velpatasvir|velpatasvir|mesh-list
14112738|NCT02333292|Simeprevir|simeprevir|mesh-list
14762125|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762126|NCT03100786|Dexamethasone|dexamethasone|mesh-list
14762127|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762128|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
14762129|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
14112739|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14112740|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14112741|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
14112742|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112743|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112744|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14112745|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14112746|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
14112747|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112748|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14112749|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14112750|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
14112751|NCT02333305|Vitamins|vitamins|mesh-ancestor
14112752|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
14112753|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112754|NCT02333188|Leucovorin|leucovorin|mesh-list
14112755|NCT02333188|Paclitaxel|paclitaxel|mesh-list
14112756|NCT02333188|Fluorouracil|fluorouracil|mesh-list
14112757|NCT02333188|Irinotecan|irinotecan|mesh-list
14112758|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14112759|NCT02333188|Calcium|calcium|mesh-list
14112760|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
14112761|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14112762|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112763|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
14112764|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
14112765|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
14112766|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112767|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14112768|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112769|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
14112770|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14112771|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112772|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
14112773|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14112774|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14762130|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935006|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13935007|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13935008|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13935009|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13935010|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935011|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935012|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935013|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935014|NCT03339024|Oxytocin|oxytocin|mesh-list
13935015|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
13935016|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13935017|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935018|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
13935019|NCT03338621|Rifampin|rifampin|mesh-list
14112775|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112776|NCT02333188|Antidotes|antidotes|mesh-ancestor
14112777|NCT02333188|Protective Agents|protective agents|mesh-ancestor
14112778|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
13935020|NCT03338621|Isoniazid|isoniazid|mesh-list
14112779|NCT02333188|Vitamins|vitamins|mesh-ancestor
14112780|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
14112781|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
13935021|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
13935022|NCT03338621|Ethambutol|ethambutol|mesh-list
13935023|NCT03338621|Bedaquiline|bedaquiline|mesh-list
13935024|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13935025|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935026|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13935027|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13935028|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112782|NCT02332941|Rituximab|rituximab|mesh-list
14112783|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14112784|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112785|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
14112786|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112787|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112788|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
14112789|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112790|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112791|NCT02333123|Aspirin|aspirin|mesh-list
14112792|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14112793|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14112794|NCT02333123|Analgesics|analgesics|mesh-ancestor
14112795|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
14112796|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112797|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112798|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112799|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112800|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14112801|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14112802|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112803|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13935029|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935030|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935031|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13935032|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
13935033|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
13935034|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13935035|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13935036|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13935037|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13935038|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13935039|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13935040|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13935041|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13935042|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14112804|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14112805|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935043|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
13935044|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13935045|NCT03338426|Atorvastatin|atorvastatin|mesh-list
13935046|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13935047|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14112806|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
14112807|NCT02333058|Treosulfan|treosulfan|mesh-list
14112808|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14112809|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
14112810|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112811|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112812|NCT02332954|Vortioxetine|vortioxetine|mesh-list
14112813|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
14112814|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14112815|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14112816|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14112817|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112818|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112819|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14112820|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14112821|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112822|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112823|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112824|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
14112825|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14112826|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14112827|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14112828|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14112829|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
14112830|NCT02332980|Idelalisib|idelalisib|mesh-list
14112831|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14112832|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112833|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112834|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112835|NCT02332811|Sevelamer|sevelamer|mesh-list
14112836|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
14112837|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
14112838|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112839|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14112840|NCT02332473|Molgramostim|molgramostim|mesh-list
14112841|NCT02332473|Sargramostim|sargramostim|mesh-list
14112842|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
14112843|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112844|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
14112845|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112846|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112847|NCT02332512|Apatinib|apatinib|mesh-list
14112848|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112849|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13935048|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
13935049|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935050|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13935051|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13935052|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935053|NCT03338387|Acipimox|acipimox|mesh-list
13935054|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13935055|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
13935056|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935057|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13935058|NCT03338348|Azacitidine|azacitidine|mesh-list
13935059|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13935060|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
13935061|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935062|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935063|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935064|NCT03338244|Azithromycin|azithromycin|mesh-list
13935065|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13935066|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935067|NCT03338205|Ketamine|ketamine|mesh-list
13935068|NCT03338205|Analgesics|analgesics|mesh-ancestor
13935069|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
13935070|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935071|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112850|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935072|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13935073|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13935074|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
13935075|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
13935076|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935077|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13935078|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13935079|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935080|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112851|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112852|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
14112853|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14112854|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14112855|NCT02332603|Prednisolone|prednisolone|mesh-list
14112856|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
14112857|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14112858|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
13935081|NCT03337932|Doxycycline|doxycycline|mesh-list
13935082|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13935083|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935084|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
13935085|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13935086|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13935087|NCT03337919|Nivolumab|nivolumab|mesh-list
13935088|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13935089|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935090|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13935091|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935092|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
13935093|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13935094|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935095|NCT03337828|Ethanol|ethanol|mesh-list
13935096|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13935097|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935098|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935099|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935100|NCT03337672|Midazolam|midazolam|mesh-list
13935101|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
13935102|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13935103|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935104|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935105|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935106|NCT03337672|Analgesics|analgesics|mesh-ancestor
13935107|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
13935108|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935109|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13935110|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13935111|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13935112|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935113|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935114|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935115|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13935116|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13935117|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13935118|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13935119|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13935120|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
13935121|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
13935122|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
13935123|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
13935124|NCT03337607|Celecoxib|celecoxib|mesh-list
13935125|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
13935126|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14112859|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112860|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
14112861|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
14112862|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112863|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112864|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112865|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
14477912|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
14477913|NCT02441309|Ifosfamide|ifosfamide|mesh-list
13935127|NCT03337607|Eperisone|eperisone|mesh-list
14477914|NCT02441309|Mifamurtide|mifamurtide|mesh-list
14112866|NCT02332603|Hormones|hormones|mesh-ancestor
14477915|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13935128|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
13935129|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935130|NCT03337607|Analgesics|analgesics|mesh-ancestor
13935131|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
13935132|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935133|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935134|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14477916|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
14477917|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477918|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477919|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13935135|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13935136|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13935137|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935138|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935139|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
13935140|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13935141|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112867|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112868|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14112869|NCT02332603|Protective Agents|protective agents|mesh-ancestor
14112870|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14112871|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112872|NCT02332447|Naloxone|naloxone|mesh-list
14112873|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14112874|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112875|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
14112876|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175983|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175984|NCT04769258|Vaccines|vaccines|mesh-list
14175985|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
14175986|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175987|NCT04769297|Ketamine|ketamine|mesh-list
14175988|NCT04769297|Analgesics|analgesics|mesh-ancestor
14175989|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
14175990|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14175991|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14175992|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14477920|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
14477921|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477922|NCT02441946|Anastrozole|anastrozole|mesh-list
14477923|NCT02441946|Loperamide|loperamide|mesh-list
14477924|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
14477925|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14477926|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477927|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14477928|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14477929|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477930|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477931|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14477932|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
14479260|NCT02466399|Latanoprost|latanoprost|mesh-list
14762131|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762132|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935142|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14762133|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
14112877|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
14112878|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14112879|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14112880|NCT02332629|Prednisolone|prednisolone|mesh-list
14112881|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
14112882|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14112883|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
14112884|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112885|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
13935143|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13935144|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14112886|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
14112887|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112888|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112889|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112890|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
14112891|NCT02332629|Hormones|hormones|mesh-ancestor
14112892|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112893|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14112894|NCT02332629|Protective Agents|protective agents|mesh-ancestor
14112895|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14112896|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112897|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
14112898|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14112899|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14112900|NCT02332616|Prednisolone|prednisolone|mesh-list
14112901|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
14112902|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14112903|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
14112904|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935145|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
13935146|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
13935147|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
13935148|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13935149|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935150|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935151|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935152|NCT03337581|Analgesics|analgesics|mesh-ancestor
13935153|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
13935154|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935155|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13935156|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13935157|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13935158|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935159|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14112905|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
14112906|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
14112907|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112908|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112909|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935160|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935161|NCT03337529|Ascorbic Acid|ascorbic acid|mesh-list
13935162|NCT03337529|Vitamins|vitamins|mesh-ancestor
13935163|NCT03337529|Micronutrients|micronutrients|mesh-ancestor
13935164|NCT03337529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935165|NCT03337529|Antioxidants|antioxidants|mesh-ancestor
13935166|NCT03337529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935167|NCT03337529|Protective Agents|protective agents|mesh-ancestor
13961388|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13961389|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961390|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961391|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961392|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13961393|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
13961394|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13961395|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
13961396|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13961397|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13961398|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13961399|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13961400|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13961401|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112910|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
14112911|NCT02332616|Hormones|hormones|mesh-ancestor
13935168|NCT03337503|Dronabinol|dronabinol|mesh-list
13935169|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
13935170|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935171|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13935172|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935173|NCT03337503|Analgesics|analgesics|mesh-ancestor
13935174|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
13935175|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112912|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14112913|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14112914|NCT02332616|Protective Agents|protective agents|mesh-ancestor
14112915|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14112916|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112917|NCT02332174|Rufinamide|rufinamide|mesh-list
14112918|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
14112919|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14112920|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14112921|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112922|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112923|NCT02332135|Vitamin D|vitamin d|mesh-list
14112924|NCT02332135|Vitamins|vitamins|mesh-ancestor
14112925|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
14112926|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112927|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14112928|NCT02332356|Adalimumab|adalimumab|mesh-list
14112929|NCT02332356|Azathioprine|azathioprine|mesh-list
14112930|NCT02332356|Infliximab|infliximab|mesh-list
14112931|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112932|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112933|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
14112934|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14112935|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
14112936|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112937|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14112938|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112939|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14112940|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
14112941|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112942|NCT02332057|Diclofenac|diclofenac|mesh-list
14112943|NCT02332057|Lidocaine|lidocaine|mesh-list
14112944|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
14112945|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
14112946|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14112947|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112948|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
14112949|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14112950|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14112951|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14112952|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14112953|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14112954|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112955|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14112956|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14112957|NCT02332057|Analgesics|analgesics|mesh-ancestor
14112958|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14112959|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14112960|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14112961|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112962|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
13935176|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13935177|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13935178|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935179|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935180|NCT03337503|Hormones|hormones|mesh-ancestor
13935181|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935182|NCT03337373|Cisatracurium|cisatracurium|mesh-list
13935183|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13935184|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13935185|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935186|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935187|NCT03337282|Anesthetics|anesthetics|mesh-list
13935188|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935189|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935190|NCT03337191|Morphine|morphine|mesh-list
14112963|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14112964|NCT02332031|Sorafenib|sorafenib|mesh-list
14112965|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112966|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14112967|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112968|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112969|NCT02331771|Donepezil|donepezil|mesh-list
14112970|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14112971|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112972|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112973|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
14112974|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935191|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
13935192|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13935193|NCT03337191|Narcotics|narcotics|mesh-ancestor
13935194|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935195|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935196|NCT03337191|Analgesics|analgesics|mesh-ancestor
13935197|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
13935198|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935199|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
13935200|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
13935201|NCT03337126|Metronidazole|metronidazole|mesh-list
13935202|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935203|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13935204|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13935205|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13935206|NCT03337035|Oxytocin|oxytocin|mesh-list
13935207|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
13935208|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13935209|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935210|NCT03337009|Naloxone|naloxone|mesh-list
13935211|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13935212|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935213|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
13935214|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935215|NCT03336970|Calcium|calcium|mesh-list
14112975|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112976|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
14112977|NCT02331745|Sargramostim|sargramostim|mesh-list
14112978|NCT02331745|Lenograstim|lenograstim|mesh-list
14112979|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
14112980|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14112981|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14112982|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
14112983|NCT02331823|Isoniazid|isoniazid|mesh-list
14112984|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
14112985|NCT02331823|Ethambutol|ethambutol|mesh-list
14112986|NCT02331823|Rifabutin|rifabutin|mesh-list
14112987|NCT02331823|Streptomycin|streptomycin|mesh-list
14112988|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14112989|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14112990|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14112991|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14112992|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14112993|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14112994|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14112995|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14112996|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
14112997|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14112998|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14112999|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
14113000|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14113001|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14113002|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
14113003|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14113004|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14113005|NCT02331862|Prednisolone|prednisolone|mesh-list
14113006|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
13935216|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14113007|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13961402|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
14113008|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
14113009|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113010|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
14113011|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
14113012|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113013|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113014|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14113015|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
14113016|NCT02331862|Hormones|hormones|mesh-ancestor
14113017|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113018|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14113019|NCT02331862|Protective Agents|protective agents|mesh-ancestor
14113020|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14113021|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113022|NCT02331927|Aflibercept|aflibercept|mesh-list
14113023|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14113024|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14113025|NCT02331927|Growth Substances|growth substances|mesh-ancestor
14113026|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113027|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
14113028|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113029|NCT02332005|Choline|choline|mesh-list
14113030|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
14113031|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14113032|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
14113033|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113034|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14113035|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14113036|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
14113037|NCT02331706|Interferons|interferons|mesh-list
14113038|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
14113039|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
14113040|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113041|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
14113042|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113043|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
13935217|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935218|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
13935219|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935220|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
13935221|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13935222|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935223|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
13935224|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13935225|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935226|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935227|NCT03336840|Metformin|metformin|mesh-list
13935228|NCT03336840|Promethazine|promethazine|mesh-list
13935229|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
13935230|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13935231|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935232|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
13935233|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
13935234|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13935235|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
13935236|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
13935237|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935238|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935239|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13935240|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13935241|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13935242|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935243|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
13935244|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
14113044|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113045|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
14113046|NCT02331602|Dabigatran|dabigatran|mesh-list
14113047|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14113048|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
14113049|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14113050|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
14113051|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113052|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113053|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
14113054|NCT02331576|Fentanyl|fentanyl|mesh-list
13935245|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
14113055|NCT02331576|Ropivacaine|ropivacaine|mesh-list
14113056|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
14113057|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
14113058|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113059|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113060|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
13935246|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935247|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
13935248|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
13935249|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935250|NCT03336814|Terlipressin|terlipressin|mesh-list
13935251|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13935252|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13935253|NCT03336801|Propofol|propofol|mesh-list
13935254|NCT03336801|Sevoflurane|sevoflurane|mesh-list
13935255|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14113061|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113062|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13935256|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935257|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935258|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13935259|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
13935260|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
13935261|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13935262|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13935263|NCT03336632|Cyclosporine|cyclosporine|mesh-list
13935264|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
13935265|NCT03336632|Cyclosporins|cyclosporins|mesh-list
13935266|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13935267|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
13935268|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935269|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935270|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13935271|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
13935272|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935273|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935274|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13935275|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935276|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
13935277|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935278|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
13935279|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13935280|NCT03336593|Vaccines|vaccines|mesh-list
13935281|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
13935282|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935283|NCT03336437|Estradiol|estradiol|mesh-list
13935284|NCT03336437|Estrogens|estrogens|mesh-ancestor
13935285|NCT03336437|Hormones|hormones|mesh-ancestor
13935286|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935287|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113063|NCT02331576|Narcotics|narcotics|mesh-ancestor
14113064|NCT02331576|Analgesics|analgesics|mesh-ancestor
14113065|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14113066|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14113067|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
14113068|NCT02331511|Aspirin|aspirin|mesh-list
14113069|NCT02331511|Clopidogrel|clopidogrel|mesh-list
14113070|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14113071|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113072|NCT02331511|Analgesics|analgesics|mesh-ancestor
14113073|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
14113074|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113075|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113076|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113077|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113078|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14113079|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13935288|NCT03336398|Ketamine|ketamine|mesh-list
13935289|NCT03336398|Analgesics|analgesics|mesh-ancestor
13935290|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
14113080|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113081|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14113082|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14113083|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935291|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935292|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113084|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
13935293|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13935294|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13935295|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
13935296|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
13935297|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935298|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13935299|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13935300|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113085|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14113086|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14113087|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14113088|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
14113089|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113090|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
14113091|NCT02331563|Bupivacaine|bupivacaine|mesh-list
14113092|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
14113093|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
14113094|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113095|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113096|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
14113097|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113098|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14113099|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113100|NCT02331563|Analgesics|analgesics|mesh-ancestor
14113101|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14113102|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14113103|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14113104|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
14113105|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113106|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113107|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14113108|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113109|NCT02330952|Prednisone|prednisone|mesh-list
14113110|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935301|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935302|NCT03336346|Efavirenz|efavirenz|mesh-list
13935303|NCT03336346|Dolutegravir|dolutegravir|mesh-list
13935304|NCT03336346|Etonogestrel|etonogestrel|mesh-list
13935305|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13935306|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13935307|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935308|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935309|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
13935310|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113111|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
14113112|NCT02330952|Hormones|hormones|mesh-ancestor
14113113|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113114|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113115|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14113116|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113117|NCT02330991|Temozolomide|temozolomide|mesh-list
14113118|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14113119|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
14113120|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113121|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113122|NCT02331173|Dorzolamide|dorzolamide|mesh-list
14113123|NCT02331173|Brinzolamide|brinzolamide|mesh-list
14113124|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14113125|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113126|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113127|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14113128|NCT02331030|Ropivacaine|ropivacaine|mesh-list
13935311|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13935312|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963469|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
14113129|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
14113130|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
14113131|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113132|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113133|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
14113134|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113135|NCT02331251|Gemcitabine|gemcitabine|mesh-list
14113136|NCT02331251|Paclitaxel|paclitaxel|mesh-list
14113137|NCT02331251|Vinorelbine|vinorelbine|mesh-list
14113138|NCT02331251|Docetaxel|docetaxel|mesh-list
14113139|NCT02331251|Doxorubicin|doxorubicin|mesh-list
14113140|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14113141|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
14113142|NCT02331251|Irinotecan|irinotecan|mesh-list
14113143|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14113144|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113145|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14113146|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14113147|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
13935313|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13935314|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13935315|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13935316|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13935317|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13935318|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13935319|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13935320|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13935321|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13935322|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
13935323|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13935324|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935325|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13935326|NCT03336281|Ustekinumab|ustekinumab|mesh-list
13935327|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
13935328|NCT03336242|Cannabidiol|cannabidiol|mesh-list
14113148|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113149|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14113150|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
14113151|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
14113152|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113153|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113154|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113155|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
14113156|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113157|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14113158|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14113159|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14113160|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14113161|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14175993|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14175994|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
14175995|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
14175996|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14175997|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14175998|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14175999|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183683|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935329|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
13935330|NCT03336125|Vitamin D|vitamin d|mesh-list
13935331|NCT03336125|Vitamins|vitamins|mesh-ancestor
13935332|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
13935333|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935334|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13935335|NCT03336073|Dexamethasone|dexamethasone|mesh-list
13935336|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
13935337|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13935338|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
13935339|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935340|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935341|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13935342|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
13935343|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935344|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935345|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13935346|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935347|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
13935348|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
13935349|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935350|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935351|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
13935352|NCT03336073|Hormones|hormones|mesh-ancestor
13935353|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935354|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14477933|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935355|NCT03335956|Pioglitazone|pioglitazone|mesh-list
14113162|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14113163|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14113164|NCT02330757|Clomiphene|clomiphene|mesh-list
14113165|NCT02330757|Enclomiphene|enclomiphene|mesh-list
14113166|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
14113167|NCT02330757|Estradiol|estradiol|mesh-list
14113168|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14113169|NCT02330757|Estrogens|estrogens|mesh-ancestor
14113170|NCT02330757|Hormones|hormones|mesh-ancestor
14113171|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113172|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113173|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14113174|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
14113175|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113176|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14113177|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14113178|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
14113179|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14113180|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
14113181|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14113182|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13935356|NCT03335956|Prednisone|prednisone|mesh-list
13935357|NCT03335956|Cortisone|cortisone|mesh-list
13935358|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935359|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
13935360|NCT03335956|Hormones|hormones|mesh-ancestor
13935361|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113183|NCT02330796|Bucillamine|bucillamine|mesh-list
14113184|NCT02330796|Colchicine|colchicine|mesh-list
13935362|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935363|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13935364|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935365|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14113185|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
14113186|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113187|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14113188|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
14113189|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14113190|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113191|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113192|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14113193|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113194|NCT02330796|Analgesics|analgesics|mesh-ancestor
14113195|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
14113196|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113197|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113198|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113199|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
14113200|NCT02330796|Protective Agents|protective agents|mesh-ancestor
14113201|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14113202|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113203|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935366|NCT03335904|Losartan|losartan|mesh-list
13935367|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13935368|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13935369|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13935370|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13961403|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14113204|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14113205|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14113206|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
14936202|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14936203|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14936204|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14936205|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936206|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14936207|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936208|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936209|NCT01467804|Sertraline|sertraline|mesh-list
14936210|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
14936211|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14936212|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14113207|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14113208|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
14113209|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113210|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113211|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14113212|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14113213|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113214|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
14113215|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14113216|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113217|NCT02330640|Clopidogrel|clopidogrel|mesh-list
14113218|NCT02330640|Ticagrelor|ticagrelor|mesh-list
14113219|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14113220|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14113221|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14113222|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14113223|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
14113224|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113225|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113226|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113227|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
14113228|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14113229|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
14113230|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113231|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
14113232|NCT02330822|Protective Agents|protective agents|mesh-ancestor
14113233|NCT02330783|Bevacizumab|bevacizumab|mesh-list
14113234|NCT02330783|Sorafenib|sorafenib|mesh-list
13935371|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935372|NCT03335839|Plasminogen|plasminogen|mesh-list
13935373|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13935374|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13935375|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14113235|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14113236|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113237|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14113238|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14113239|NCT02330783|Growth Substances|growth substances|mesh-ancestor
14113240|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113241|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
14113242|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14113243|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113244|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113245|NCT02330367|Abivertinib|abivertinib|mesh-list
14113246|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13935376|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961404|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13961405|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13961406|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13961407|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13961408|NCT03148522|Mirtazapine|mirtazapine|mesh-list
13961409|NCT03148522|Citalopram|citalopram|mesh-list
13961410|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13961411|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13961412|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13961413|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961414|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961415|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
13961416|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113247|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113248|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113249|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14113250|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14113251|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14113252|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113253|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113254|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113255|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113256|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
13961417|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13961418|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
13961419|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961420|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113257|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14113258|NCT02330380|Adalimumab|adalimumab|mesh-list
14113259|NCT02330380|Etanercept|etanercept|mesh-list
14113260|NCT02330380|Methotrexate|methotrexate|mesh-list
14113261|NCT02330380|Ustekinumab|ustekinumab|mesh-list
14113262|NCT02330380|Acitretin|acitretin|mesh-list
14113263|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14113264|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
14113265|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113266|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113267|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14113268|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
14113269|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113270|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113271|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
14113272|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113273|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14113274|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113275|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
14113276|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113277|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113278|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113279|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14113280|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113281|NCT02330380|Analgesics|analgesics|mesh-ancestor
14113282|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
14113283|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113284|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14113285|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
14113286|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14113287|NCT02330406|Anagliptin|anagliptin|mesh-list
14113288|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14113289|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113290|NCT02330406|Incretins|incretins|mesh-ancestor
14113291|NCT02330406|Hormones|hormones|mesh-ancestor
14113292|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113293|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14113294|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
14113295|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113296|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113297|NCT02330302|Ropivacaine|ropivacaine|mesh-list
14762134|NCT03100786|Hormones|hormones|mesh-ancestor
13935377|NCT03335826|Anesthetics|anesthetics|mesh-list
14113298|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
14113299|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
14113300|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113301|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935378|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935379|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935380|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
13935381|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
13935382|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13935383|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13935384|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935385|NCT03335579|Sufentanil|sufentanil|mesh-list
13935386|NCT03335579|Remifentanil|remifentanil|mesh-list
13935387|NCT03335579|Propofol|propofol|mesh-list
13935388|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
13935389|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935390|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935391|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13935392|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13935393|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
13935394|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13935395|NCT03335579|Narcotics|narcotics|mesh-ancestor
13935396|NCT03335579|Analgesics|analgesics|mesh-ancestor
13935397|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
14113302|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
14113303|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113304|NCT02330419|Naltrexone|naltrexone|mesh-list
14113305|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14113306|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14113307|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113308|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
14936213|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13935398|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935399|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14762135|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762136|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762137|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762138|NCT03056001|Doxorubicin|doxorubicin|mesh-list
14762139|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
14762140|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14762141|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762142|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14762143|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14762144|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762145|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762146|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762147|NCT03051516|Vaccines|vaccines|mesh-list
14762148|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
14762149|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113309|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113310|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
14113311|NCT02330120|Propofol|propofol|mesh-list
14113312|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14113313|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113314|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113315|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14113316|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
14113317|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
14113318|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113319|NCT02330120|Analgesics|analgesics|mesh-ancestor
14113320|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
14113321|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113322|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14113323|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14113324|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14113325|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
14113326|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113327|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113328|NCT02330029|Pinaverium|pinaverium|mesh-list
14113329|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14113330|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113331|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113332|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14113333|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113334|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
14113335|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
14113336|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113337|NCT02330068|Citalopram|citalopram|mesh-list
14113338|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14762150|NCT03034200|TIC10 compound|tic10 compound|mesh-list
14113339|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14113340|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113341|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113342|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113343|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
14113344|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113345|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14113346|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
14113347|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14113348|NCT02329860|Apatinib|apatinib|mesh-list
14113349|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113350|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14113351|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113352|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113353|NCT02329795|Temozolomide|temozolomide|mesh-list
14113354|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14113355|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
14113356|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113357|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113358|NCT02329561|Tramadol|tramadol|mesh-list
14113359|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14113360|NCT02329561|Narcotics|narcotics|mesh-ancestor
13935400|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
13935401|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13935402|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935403|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935404|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935405|NCT03335527|Analgesics|analgesics|mesh-ancestor
13935406|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
14113361|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113362|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113363|NCT02329561|Analgesics|analgesics|mesh-ancestor
13935407|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935408|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13935409|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13935410|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13935411|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935412|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935413|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935414|NCT03335501|Pancrelipase|pancrelipase|mesh-list
13935415|NCT03335501|Hormones|hormones|mesh-list
13935416|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935417|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935418|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935419|NCT03335436|Gabapentin|gabapentin|mesh-list
13935420|NCT03335436|Analgesics|analgesics|mesh-ancestor
13935421|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
13935422|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113364|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
13935423|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935424|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
13935425|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14762151|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935426|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13935427|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935428|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13935429|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13935430|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13935431|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935432|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935433|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
13935434|NCT03335423|Metformin|metformin|mesh-list
13935435|NCT03335423|Codeine|codeine|mesh-list
13935436|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13935437|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935438|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13935439|NCT03335423|Narcotics|narcotics|mesh-ancestor
13935440|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935441|NCT03335423|Analgesics|analgesics|mesh-ancestor
13935442|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
13935443|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935444|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
13935445|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
14113365|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113366|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14113367|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14113368|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113369|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
14113370|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14113371|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14113372|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113373|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
14113374|NCT02329756|Coagulants|coagulants|mesh-ancestor
14113375|NCT02329535|Progesterone|progesterone|mesh-list
14113376|NCT02329535|Progestins|progestins|mesh-ancestor
14113377|NCT02329535|Hormones|hormones|mesh-ancestor
14113378|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113379|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113380|NCT02329405|Rifampin|rifampin|mesh-list
14113381|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14113382|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
13935446|NCT03335293|Epinephrine|epinephrine|mesh-list
13935447|NCT03335293|Racepinephrine|racepinephrine|mesh-list
13935448|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
13935449|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14113383|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113384|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113385|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
14113386|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113387|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113388|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113389|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14113390|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14113391|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14113392|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14113393|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14113394|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14113395|NCT02329288|Triamcinolone|triamcinolone|mesh-list
14113396|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14113397|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14113398|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13935450|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13935451|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935452|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935453|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935454|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935455|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13935456|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13935457|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
13935458|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935459|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13935460|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
13935461|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
13935462|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
13935463|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13935464|NCT03335241|Doxorubicin|doxorubicin|mesh-list
13935465|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13935466|NCT03335241|Fludarabine|fludarabine|mesh-list
13935467|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13935468|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935469|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13935470|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13935471|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935472|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935473|NCT03335124|Vitamins|vitamins|mesh-list
13935474|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
13935475|NCT03335124|Thiamine|thiamine|mesh-list
14113399|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113400|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
14113401|NCT02329288|Hormones|hormones|mesh-ancestor
14113402|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935476|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
13935477|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
13935478|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935479|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935480|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
14113403|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113404|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113405|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
14113406|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113407|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113408|NCT02329054|Favipiravir|favipiravir|mesh-list
14113409|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
14113410|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176000|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176001|NCT04769076|Paclitaxel|paclitaxel|mesh-list
14176002|NCT04769076|Cisplatin|cisplatin|mesh-list
14176003|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14176004|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176005|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176006|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176007|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176008|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176009|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176010|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
14176011|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14176012|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176013|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
14176014|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183684|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14183685|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14183686|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14183687|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
13935481|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935482|NCT03335124|Protective Agents|protective agents|mesh-ancestor
13935483|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
13935484|NCT03335098|Thalidomide|thalidomide|mesh-list
13935485|NCT03335098|Dexamethasone|dexamethasone|mesh-list
13935486|NCT03335098|Bortezomib|bortezomib|mesh-list
13935487|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935488|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
13935489|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
13935490|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935491|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935492|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935493|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
13935494|NCT03335098|Hormones|hormones|mesh-ancestor
13935495|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935496|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14183688|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14183689|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183690|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14183691|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14183692|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14183693|NCT04726046|Cefotetan|cefotetan|mesh-list
13935497|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935498|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13935499|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
13935500|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
13935501|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13935502|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935503|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14183694|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935504|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14183695|NCT04725747|Midazolam|midazolam|mesh-list
14183696|NCT04725747|Ketamine|ketamine|mesh-list
13935505|NCT03335098|Growth Substances|growth substances|mesh-ancestor
13935506|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
14113411|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14113412|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113413|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113414|NCT02329080|Cytarabine|cytarabine|mesh-list
14113415|NCT02329080|Rituximab|rituximab|mesh-list
14113416|NCT02329080|Methotrexate|methotrexate|mesh-list
14113417|NCT02329080|Etoposide|etoposide|mesh-list
14113418|NCT02329080|Ifosfamide|ifosfamide|mesh-list
14113419|NCT02329080|Thiotepa|thiotepa|mesh-list
13935507|NCT03335085|Oxytocin|oxytocin|mesh-list
13935508|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
13935509|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13935510|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935511|NCT03335072|Azithromycin|azithromycin|mesh-list
13935512|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13935513|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935514|NCT03335059|Mitomycins|mitomycins|mesh-list
13935515|NCT03335059|Mitomycin|mitomycin|mesh-list
13935516|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13935517|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113420|NCT02329080|Carmustine|carmustine|mesh-list
14113421|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14113422|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113423|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
14113424|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113425|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113426|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14113427|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
14113428|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113429|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14113430|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
14113431|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113432|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
14113433|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113434|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14113435|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113436|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113437|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14113438|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14113439|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14113440|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
14113441|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113442|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14113443|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
14113444|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14113445|NCT02329171|Imiquimod|imiquimod|mesh-list
13935518|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
14113446|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14762152|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
14113447|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
14176015|NCT04768764|Bupivacaine|bupivacaine|mesh-list
13935519|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935520|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13935521|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935522|NCT03335007|Aceclofenac|aceclofenac|mesh-list
13935523|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13935524|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935525|NCT03335007|Analgesics|analgesics|mesh-ancestor
13935526|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
13935527|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935528|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935529|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935530|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935531|NCT03334981|Buprenorphine|buprenorphine|mesh-list
13935532|NCT03334981|Methadone|methadone|mesh-list
13935533|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13935534|NCT03334981|Narcotics|narcotics|mesh-ancestor
13935535|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935536|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935537|NCT03334981|Analgesics|analgesics|mesh-ancestor
13935538|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
13935539|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935540|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13935541|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
13935542|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
13935543|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13935544|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13935545|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935546|NCT03334838|Nifurtimox|nifurtimox|mesh-list
14113448|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113449|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113450|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
14113451|NCT02329132|Ranibizumab|ranibizumab|mesh-list
14113452|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14113453|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14113454|NCT02329132|Growth Substances|growth substances|mesh-ancestor
14113455|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113456|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
13935547|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13935548|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13935549|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13935550|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935551|NCT03334682|Doxycycline|doxycycline|mesh-list
13935552|NCT03334682|Spironolactone|spironolactone|mesh-list
14113457|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113458|NCT02328950|Cytarabine|cytarabine|mesh-list
14113459|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
14113460|NCT02328950|Busulfan|busulfan|mesh-list
14113461|NCT02328950|Fludarabine|fludarabine|mesh-list
14113462|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113463|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
14113464|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113465|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113466|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14113467|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
14113468|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113469|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113470|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14113471|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14113472|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
14113473|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
14113474|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113475|NCT02328729|Epinephrine|epinephrine|mesh-list
14113476|NCT02328729|Racepinephrine|racepinephrine|mesh-list
14113477|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
14113478|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14113479|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14113480|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14113481|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113482|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113483|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762153|NCT03015974|Prednisone|prednisone|mesh-list
13935553|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113484|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14762154|NCT03015974|Prednisolone|prednisolone|mesh-list
14113485|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13935554|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935555|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
13935556|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13935557|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13935558|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13935559|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
13935560|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935561|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935562|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13935563|NCT03334682|Diuretics|diuretics|mesh-ancestor
13935564|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
13935565|NCT03334591|Apatinib|apatinib|mesh-list
13935566|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113486|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
14113487|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113488|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14113489|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
14113490|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
14113491|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
14113492|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14113493|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
14113494|NCT02328963|Everolimus|everolimus|mesh-list
14113495|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113496|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113497|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
14113498|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113499|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14113500|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14113501|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
14113502|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113503|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113504|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113505|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113506|NCT02328794|Varenicline|varenicline|mesh-list
13935567|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13935568|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935569|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935570|NCT03334513|Bevacizumab|bevacizumab|mesh-list
13935571|NCT03334513|Ranibizumab|ranibizumab|mesh-list
13935572|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13935573|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935574|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13935575|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14113507|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14113508|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14113509|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
14113510|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113511|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113512|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113513|NCT02328716|Cisplatin|cisplatin|mesh-list
14113514|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113515|NCT02328651|Ribavirin|ribavirin|mesh-list
14113516|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
13935576|NCT03334513|Growth Substances|growth substances|mesh-ancestor
13935577|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935578|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
13935579|NCT03334487|Dexamethasone|dexamethasone|mesh-list
13935580|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935581|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
13935582|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
13935583|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935584|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935585|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935586|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
13935587|NCT03334487|Hormones|hormones|mesh-ancestor
13935588|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935589|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13935590|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935591|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
13935592|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935593|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13935594|NCT03334136|Calcifediol|calcifediol|mesh-list
14113517|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113518|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
14936214|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14936215|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936216|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936217|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
14936218|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936219|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
14936220|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936221|NCT01467986|Sirolimus|sirolimus|mesh-list
14936222|NCT01467986|Irinotecan|irinotecan|mesh-list
14936223|NCT01467986|Temozolomide|temozolomide|mesh-list
14936224|NCT01467986|Dasatinib|dasatinib|mesh-list
14936225|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14936226|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14936227|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936228|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936229|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936230|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14936231|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
14936232|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936233|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936234|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13935595|NCT03334136|Vitamins|vitamins|mesh-ancestor
13935596|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
13935597|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935598|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13961421|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13961422|NCT03148522|Analgesics|analgesics|mesh-ancestor
13961423|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
13961424|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
13961425|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13961426|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
13961427|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
13961428|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13961429|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961430|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961431|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14113519|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113520|NCT02328521|Nicorandil|nicorandil|mesh-list
14113521|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14113522|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14113523|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
14113524|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
14113525|NCT02328521|Vitamins|vitamins|mesh-ancestor
14113526|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
14113527|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113528|NCT02328469|Doxycycline|doxycycline|mesh-list
14113529|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
14113530|NCT02328469|Acyclovir|acyclovir|mesh-list
14113531|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113532|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113533|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
14113534|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14113535|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14113536|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
14113537|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14113538|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14936235|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
13961432|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13961433|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13961434|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
13961435|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13961436|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13961437|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13961438|NCT03148444|Cephalexin|cephalexin|mesh-list
13961439|NCT03148444|Roxithromycin|roxithromycin|mesh-list
13961440|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961441|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961442|NCT03148366|Levofloxacin|levofloxacin|mesh-list
13961443|NCT03148366|Ofloxacin|ofloxacin|mesh-list
13961444|NCT03148366|Bismuth|bismuth|mesh-list
13961445|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13961446|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961447|NCT03148366|Renal Agents|renal agents|mesh-ancestor
13961448|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113539|NCT02328495|Misoprostol|misoprostol|mesh-list
14113540|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14113541|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
14936236|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113542|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113543|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113544|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13935599|NCT03333824|Midazolam|midazolam|mesh-list
13935600|NCT03333824|Granisetron|granisetron|mesh-list
13935601|NCT03333824|Caffeine|caffeine|mesh-list
13935602|NCT03333824|Omeprazole|omeprazole|mesh-list
13935603|NCT03333824|Adavosertib|adavosertib|mesh-list
13935604|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13935605|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13935606|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935607|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935608|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13935609|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13935610|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13935611|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13935612|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
13935613|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
13935614|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
13935615|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
13935616|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935617|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935618|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13935619|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935620|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13935621|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935622|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13935623|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13935624|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13935625|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13935626|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
14113545|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14113546|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
14113547|NCT02328183|Polymyxins|polymyxins|mesh-list
14113548|NCT02328183|Polymyxin B|polymyxin b|mesh-list
14113549|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113550|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113551|NCT02328053|Voriconazole|voriconazole|mesh-list
14113552|NCT02328053|Natamycin|natamycin|mesh-list
14113553|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
14113554|NCT02328053|Clotrimazole|clotrimazole|mesh-list
14113555|NCT02328053|Miconazole|miconazole|mesh-list
14113556|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113557|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14113558|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14113559|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113560|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113561|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14113562|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
14113563|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113564|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113565|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14113566|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14113567|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113568|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14113569|NCT02328079|Acyclovir|acyclovir|mesh-list
14113570|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
14113571|NCT02328079|Prednisolone|prednisolone|mesh-list
14113572|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14113573|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
14113574|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14113575|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
13935627|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
13935628|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
13935629|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935630|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13935631|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
13935632|NCT03333668|Guanfacine|guanfacine|mesh-list
14113576|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13935633|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
13935634|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13935635|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113577|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
14176016|NCT04768764|Anesthetics|anesthetics|mesh-list
14113578|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113579|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
14113580|NCT02328079|Hormones|hormones|mesh-ancestor
14113581|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113582|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113583|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14113584|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113585|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
14113586|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
14113587|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113588|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14113589|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14113590|NCT02328079|Protective Agents|protective agents|mesh-ancestor
14113591|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113592|NCT02328209|Ranibizumab|ranibizumab|mesh-list
14113593|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14113594|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14113595|NCT02328209|Growth Substances|growth substances|mesh-ancestor
14113596|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113597|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
14113598|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113599|NCT02328118|Triamcinolone|triamcinolone|mesh-list
14113600|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14113601|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14113602|NCT02328118|Ranibizumab|ranibizumab|mesh-list
14113603|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14113604|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14113605|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14113606|NCT02328118|Growth Substances|growth substances|mesh-ancestor
14113607|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113608|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
14113609|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113610|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113611|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
14113612|NCT02328118|Hormones|hormones|mesh-ancestor
14113613|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113614|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113615|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
13935636|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13935637|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13935638|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13935639|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935640|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
13935641|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935642|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13935643|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13935644|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13935645|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13935646|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935647|NCT03333616|Nivolumab|nivolumab|mesh-list
13935648|NCT03333616|Ipilimumab|ipilimumab|mesh-list
14113616|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113617|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113618|NCT02328443|Itraconazole|itraconazole|mesh-list
14113619|NCT02328443|Rifampin|rifampin|mesh-list
14113620|NCT02328443|Midazolam|midazolam|mesh-list
14113621|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14113622|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14113623|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113624|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113625|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14113626|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14113627|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14113628|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14113629|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
14113630|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
14113631|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
14113632|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
14113633|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113634|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113635|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
14113636|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113637|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14113638|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14113639|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935649|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13935650|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935651|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13935652|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935653|NCT03333603|Esomeprazole|esomeprazole|mesh-list
13935654|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13935655|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935656|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14113640|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14113641|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
14113642|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14113643|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14113644|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14113645|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
14113646|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113647|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
14113648|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13935657|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935658|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935659|NCT03333525|Insulin|insulin|mesh-list
13935660|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13935661|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935662|NCT03333499|Trimetazidine|trimetazidine|mesh-list
13935663|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
13935664|NCT03333395|Heparin|heparin|mesh-list
13935665|NCT03333395|Albuterol|albuterol|mesh-list
13935666|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
13935667|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13935668|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13935669|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935670|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13935671|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
13935672|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935673|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935674|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13935675|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
14113649|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14113650|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14113651|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14113652|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14113653|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14113654|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14113655|NCT02328144|Metronidazole|metronidazole|mesh-list
14113656|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113657|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113658|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14113659|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14113660|NCT02327663|Emtricitabine|emtricitabine|mesh-list
14113661|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
14113662|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113663|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14113664|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113665|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113666|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113667|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14113668|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14113669|NCT02327676|Emtricitabine|emtricitabine|mesh-list
14113670|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
14113671|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113672|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14113673|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113674|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113675|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113676|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13935676|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
13935677|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13935678|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13935679|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13935680|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13935681|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935682|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935683|NCT03333369|Levodopa|levodopa|mesh-list
13935684|NCT03333369|Benserazide|benserazide|mesh-list
14113677|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14113678|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
14113679|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14113680|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14113681|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14113682|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113683|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113684|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
14113685|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113686|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113687|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14113688|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935685|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14762155|NCT03015974|Deflazacort|deflazacort|mesh-list
14762156|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
14762157|NCT03015974|Dipyridamole|dipyridamole|mesh-list
14762158|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14762159|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14762160|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14113689|NCT02327624|Clopidogrel|clopidogrel|mesh-list
14113690|NCT02327624|Ticagrelor|ticagrelor|mesh-list
14113691|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14113692|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14113693|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14113694|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14113695|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
14762161|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
14762162|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762163|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762164|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13935686|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13935687|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
13935688|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935689|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935690|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935691|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935692|NCT03333343|Gefitinib|gefitinib|mesh-list
13935693|NCT03333343|Trametinib|trametinib|mesh-list
13935694|NCT03333343|Nazartinib|nazartinib|mesh-list
13935695|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935696|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13935697|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935698|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935699|NCT03333278|Vitamins|vitamins|mesh-list
13935700|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
13935701|NCT03333278|Thiamine|thiamine|mesh-list
13935702|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
13935703|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13935704|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
14113696|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113697|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113698|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113699|NCT02327936|Fesoterodine|fesoterodine|mesh-list
14113700|NCT02327936|Oxybutynin|oxybutynin|mesh-list
14113701|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14113702|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13935705|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935706|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113703|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
14113704|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113705|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113706|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113707|NCT02327936|Urological Agents|urological agents|mesh-ancestor
14113708|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
14113709|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
14113710|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113711|NCT02327793|Labetalol|labetalol|mesh-list
14113712|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
14113713|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
14113714|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14113715|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14113716|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
14113717|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113718|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113719|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113720|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14113721|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
14113722|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
14113723|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113724|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14113725|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14113726|NCT02327754|FYX-051|fyx-051|mesh-list
14113727|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113728|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113729|NCT02327689|Emtricitabine|emtricitabine|mesh-list
14113730|NCT02327689|Adefovir|adefovir|mesh-list
14113731|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14113732|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
14113733|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113734|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14113735|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113736|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113737|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113738|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14113739|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14176017|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
14176018|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176019|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176020|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
14176021|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176025|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
14176026|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14176027|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176028|NCT04768465|Prednisone|prednisone|mesh-list
14176029|NCT04768465|Bromides|bromides|mesh-list
14176030|NCT04768465|Tacrolimus|tacrolimus|mesh-list
14176031|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14176032|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14176033|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
14176034|NCT04768465|Hormones|hormones|mesh-ancestor
14176035|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14176036|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176037|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14176038|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176039|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176040|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
14176041|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14176042|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176043|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176044|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
14176045|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14176046|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
14176047|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176048|NCT04768231|Rifampin|rifampin|mesh-list
14176049|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14176050|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
14176051|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14176052|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176053|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
14176054|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14176055|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113740|NCT02327923|Ketorolac|ketorolac|mesh-list
13935707|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
13935708|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935709|NCT03333278|Protective Agents|protective agents|mesh-ancestor
13935710|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
13935711|NCT03333083|Lamivudine|lamivudine|mesh-list
13935712|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
13935713|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13935714|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13935715|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935716|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935717|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
13935718|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935719|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13935720|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13935721|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13935722|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13935723|NCT03333018|Bromides|bromides|mesh-list
13935724|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
13935725|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14113741|NCT02327923|Lidocaine|lidocaine|mesh-list
14113742|NCT02327923|Atropine|atropine|mesh-list
14113743|NCT02327923|Ephedrine|ephedrine|mesh-list
14113744|NCT02327923|Fentanyl|fentanyl|mesh-list
14113745|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
14113746|NCT02327923|Morphine|morphine|mesh-list
14113747|NCT02327923|Tramadol|tramadol|mesh-list
14113748|NCT02327923|Ondansetron|ondansetron|mesh-list
14113749|NCT02327923|Bupivacaine|bupivacaine|mesh-list
14113750|NCT02327923|Propofol|propofol|mesh-list
14113751|NCT02327923|Neostigmine|neostigmine|mesh-list
14113752|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
14113753|NCT02327923|Esmolol|esmolol|mesh-list
14113754|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
14113755|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
13935726|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
13935727|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935728|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935729|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14113756|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113757|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113758|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
14113759|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113760|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14113761|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14113762|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14113763|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113764|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113765|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14113766|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14113767|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
14113768|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14113769|NCT02327923|Narcotics|narcotics|mesh-ancestor
14113770|NCT02327923|Analgesics|analgesics|mesh-ancestor
14113771|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14113772|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113773|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
14113774|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
14113775|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14113776|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
14113777|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
14113778|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14113779|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
14113780|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935730|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
13935731|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13935732|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13935733|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13935734|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
13935735|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935736|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113781|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14113782|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14113783|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14762165|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
14113784|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14113785|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14113786|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113787|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935737|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
13935738|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
13935739|NCT03333005|Clotrimazole|clotrimazole|mesh-list
13935740|NCT03333005|Miconazole|miconazole|mesh-list
13935741|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935742|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13935743|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13935744|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13935745|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935746|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935747|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13935748|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
13935749|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935750|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935751|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13935752|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14113788|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14113789|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113790|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14113791|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14113792|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
14113793|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
14113794|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
14113795|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14113796|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14113797|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
14113798|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14113799|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14113800|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14113801|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14113802|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14113803|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
14113804|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13935753|NCT03332953|Nicotine|nicotine|mesh-list
13935754|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13935755|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
13935756|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935757|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935758|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13935759|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13935760|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
13935761|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935762|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935763|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
13935764|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13935765|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935766|NCT03332888|Rituximab|rituximab|mesh-list
13935767|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13935768|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935769|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
14113805|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
14113806|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14113807|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14113808|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14113809|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14113810|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14113811|NCT02327715|Emtricitabine|emtricitabine|mesh-list
14113812|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
14113813|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113814|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14113815|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113816|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113817|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113818|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14113819|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14113820|NCT02327702|Emtricitabine|emtricitabine|mesh-list
14113821|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
14113822|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113823|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14113824|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113825|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113826|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113827|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13935770|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935771|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935772|NCT03332732|Metronidazole|metronidazole|mesh-list
13935773|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935774|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13935775|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13935776|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13935777|NCT03332719|Etanercept|etanercept|mesh-list
13935778|NCT03332719|Methotrexate|methotrexate|mesh-list
14113828|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14113829|NCT02327338|Ibuprofen|ibuprofen|mesh-list
14113830|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14113831|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113832|NCT02327338|Analgesics|analgesics|mesh-ancestor
14113833|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
14113834|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113835|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113836|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113837|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113838|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14113839|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113840|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113841|NCT02327299|Fesoterodine|fesoterodine|mesh-list
14113842|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14113843|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14113844|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
14113845|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113846|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113847|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113848|NCT02327299|Urological Agents|urological agents|mesh-ancestor
14113849|NCT02327416|Entecavir|entecavir|mesh-list
14113850|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14113851|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
14113852|NCT02327416|Adefovir|adefovir|mesh-list
14113853|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14113854|NCT02327416|Molgramostim|molgramostim|mesh-list
14113855|NCT02327416|Sargramostim|sargramostim|mesh-list
14113856|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
14113857|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113858|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
14113859|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14113860|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14113861|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113862|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113863|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113864|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935779|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13935780|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
13935781|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13935782|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935783|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13935784|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
13935785|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113865|NCT02327455|Dobutamine|dobutamine|mesh-list
14113866|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14113867|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
14113868|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
14113869|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113870|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113871|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14113872|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14113873|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14113874|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
14113875|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113876|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113877|NCT02327455|Protective Agents|protective agents|mesh-ancestor
14113878|NCT02327234|Ibuprofen|ibuprofen|mesh-list
14113879|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14113880|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113881|NCT02327234|Analgesics|analgesics|mesh-ancestor
14113882|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
14113883|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935786|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113884|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935787|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
13935788|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935789|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13935790|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13935791|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
13935792|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935793|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14113885|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113886|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113887|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14113888|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113889|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113890|NCT02327247|Felodipine|felodipine|mesh-list
14113891|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14113892|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14113893|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14113894|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113895|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113896|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14113897|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113898|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
14113899|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
14113900|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14113901|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113902|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113903|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113904|NCT02327156|Analgesics|analgesics|mesh-ancestor
14113905|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
14113906|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113907|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14113908|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14113909|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14113910|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
14113911|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14113912|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113913|NCT02327000|Pregabalin|pregabalin|mesh-list
14113914|NCT02327000|Analgesics|analgesics|mesh-ancestor
14113915|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
14113916|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113917|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113918|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
14113919|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14113920|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113921|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113922|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14113923|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13935794|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13935795|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935796|NCT03332719|Analgesics|analgesics|mesh-ancestor
14113924|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14113925|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113926|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14113927|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
14113928|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13935797|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
13935798|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935799|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935800|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935801|NCT03332602|Vitamins|vitamins|mesh-list
13935802|NCT03332602|Folic Acid|folic acid|mesh-list
13935803|NCT03332602|Vitamin A|vitamin a|mesh-list
14113929|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14113930|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113931|NCT02327091|Vitamins|vitamins|mesh-ancestor
14113932|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
14113933|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
14113934|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14113935|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
14113936|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14113937|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113938|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14113939|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13935804|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
14113940|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14113941|NCT02326987|Pregabalin|pregabalin|mesh-list
14113942|NCT02326987|Analgesics|analgesics|mesh-ancestor
14113943|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
14113944|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113945|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113946|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
14113947|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14113948|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14113949|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113950|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14762166|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762167|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762168|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762169|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762170|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
14762171|NCT03015974|Hormones|hormones|mesh-ancestor
14762172|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762173|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762174|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14762175|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14762176|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
14762177|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14113951|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14113952|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14113953|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113954|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14113955|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
14113956|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14113957|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113958|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14113959|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113960|NCT02327078|Nivolumab|nivolumab|mesh-list
14113961|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14113962|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14113963|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13935805|NCT03332602|Fesoterodine|fesoterodine|mesh-list
13935806|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
13935807|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
13935808|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935809|NCT03332602|Hematinics|hematinics|mesh-ancestor
13935810|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
13935811|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14113964|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113965|NCT02326779|Aspirin|aspirin|mesh-list
14113966|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14113967|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14113968|NCT02326779|Analgesics|analgesics|mesh-ancestor
14113969|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
14113970|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113971|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113972|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14113973|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14113974|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14113975|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14113976|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14113977|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14113978|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14113979|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14113980|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
14113981|NCT02326727|Fentanyl|fentanyl|mesh-list
13935812|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
13935813|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
13935814|NCT03332602|Protective Agents|protective agents|mesh-ancestor
13935815|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
13935816|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935817|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13935818|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935819|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13935820|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13935821|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
13935822|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935823|NCT03332602|Urological Agents|urological agents|mesh-ancestor
14113982|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
14113983|NCT02326727|Propofol|propofol|mesh-list
14113984|NCT02326727|Ropivacaine|ropivacaine|mesh-list
14113985|NCT02326727|Isoflurane|isoflurane|mesh-list
14113986|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14113987|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14113988|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14113989|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14113990|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
14113991|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
14113992|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
14113993|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
14113994|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14113995|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14113996|NCT02326727|Narcotics|narcotics|mesh-ancestor
14113997|NCT02326727|Analgesics|analgesics|mesh-ancestor
14113998|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14113999|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14114000|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14114001|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14114002|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14477934|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477935|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14477936|NCT02442271|Ritonavir|ritonavir|mesh-list
13935824|NCT03332589|Dabrafenib|dabrafenib|mesh-list
13935825|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935826|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13935827|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935828|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935829|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
13935830|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13935831|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
13935832|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935833|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935834|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13935835|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
13935836|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935837|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477937|NCT02442271|Ribavirin|ribavirin|mesh-list
14477938|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14114003|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14114004|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114005|NCT02326441|KX2-361|kx2-361|mesh-list
14114006|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114007|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114008|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114009|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114010|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114011|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
13935838|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13935839|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
13935840|NCT03332524|Ibuprofen|ibuprofen|mesh-list
13935841|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13935842|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13935843|NCT03332524|Analgesics|analgesics|mesh-ancestor
13935844|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
14114012|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114013|NCT02326584|Cytarabine|cytarabine|mesh-list
14114014|NCT02326584|Daunorubicin|daunorubicin|mesh-list
14114015|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14477939|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13935845|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935846|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935847|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935848|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935849|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13935850|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935851|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935852|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
13935853|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
13935854|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13935855|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
13935856|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
13935857|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935858|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13961449|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13961450|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14114016|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
14114017|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114018|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114019|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
14114020|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114021|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114022|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
14114023|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114024|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14114025|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14114026|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14114027|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114028|NCT02326623|Anesthetics|anesthetics|mesh-list
14114029|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
14114030|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114031|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114032|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
14114033|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114034|NCT02326610|Hormones|hormones|mesh-list
14114035|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114036|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114037|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13961451|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961452|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961453|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114038|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114039|NCT02326350|Aspirin|aspirin|mesh-list
14114040|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14114041|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14114042|NCT02326350|Analgesics|analgesics|mesh-ancestor
14114043|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
14114044|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114045|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114046|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114047|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114048|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14114049|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14114050|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114051|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14114052|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14114053|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114054|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
14114055|NCT02326285|Docetaxel|docetaxel|mesh-list
14114056|NCT02326285|Gefitinib|gefitinib|mesh-list
14114057|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114058|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
13961454|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13961455|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13961456|NCT03148366|Antacids|antacids|mesh-ancestor
13961457|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961458|NCT03148132|Bevacizumab|bevacizumab|mesh-list
13961459|NCT03148132|Ranibizumab|ranibizumab|mesh-list
13961460|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961461|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114059|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114060|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114061|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114062|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114063|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114064|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14114065|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14114066|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
14114067|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14114068|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114069|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14114070|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14114071|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114072|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114073|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114074|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13935859|NCT03332329|Entecavir|entecavir|mesh-list
13935860|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
13935861|NCT03332329|Molgramostim|molgramostim|mesh-list
13935862|NCT03332329|Vaccines|vaccines|mesh-list
13935863|NCT03332329|Sargramostim|sargramostim|mesh-list
13935864|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
13935865|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935866|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
13935867|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935868|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935869|NCT03332316|Dexamethasone|dexamethasone|mesh-list
13935870|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
13935871|NCT03332316|Ropivacaine|ropivacaine|mesh-list
13935872|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13935873|NCT03332316|BB 1101|bb 1101|mesh-list
13935874|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935875|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
13935876|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
13935877|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935878|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114075|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14114076|NCT02326194|Vaccines|vaccines|mesh-list
14114077|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
14114078|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114079|NCT02325986|Fluorouracil|fluorouracil|mesh-list
14114080|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114081|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
14114082|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114083|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14114084|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114085|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
14114086|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114087|NCT02326038|Methylphenidate|methylphenidate|mesh-list
14114088|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14114089|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114090|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14114091|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14114092|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14114093|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114094|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
14114095|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114096|NCT02326051|Enoxaparin|enoxaparin|mesh-list
14114097|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
14114098|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
14114099|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14114100|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14114101|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114102|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
14114103|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14114104|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
14114105|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176056|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176057|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14176058|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13935879|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935880|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
13935881|NCT03332316|Hormones|hormones|mesh-ancestor
13935882|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935883|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13935884|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935885|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
13935886|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
14114106|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14114107|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14114108|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114109|NCT05076955|Vancomycin|vancomycin|mesh-list
14114110|NCT05076955|Tobramycin|tobramycin|mesh-list
14114111|NCT05076955|Itraconazole|itraconazole|mesh-list
14114112|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14114113|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114114|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
14114115|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14114116|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14114117|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114118|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935887|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935888|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
13935889|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
13935890|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935891|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935892|NCT03332225|Interferons|interferons|mesh-list
13935893|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
13935894|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14114119|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14114120|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
14114121|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114122|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114123|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14114124|NCT05076942|Cisplatin|cisplatin|mesh-list
14114125|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114126|NCT05076799|Lactulose|lactulose|mesh-list
14114127|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114128|NCT05076773|Morphine|morphine|mesh-list
14114129|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14114130|NCT05076773|Narcotics|narcotics|mesh-ancestor
14114131|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114132|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114133|NCT05076773|Analgesics|analgesics|mesh-ancestor
14114134|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
14114135|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114136|NCT05076695|Trastuzumab|trastuzumab|mesh-list
14114137|NCT05076695|Fulvestrant|fulvestrant|mesh-list
14114138|NCT05076695|Palbociclib|palbociclib|mesh-list
14114139|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14114140|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114141|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14114142|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14114143|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14114144|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
14114145|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114146|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114147|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114148|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114149|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114150|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
14477940|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
13935895|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935896|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
13935897|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935898|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13935899|NCT03332069|Cisplatin|cisplatin|mesh-list
13935900|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935901|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
13935902|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
13935903|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13935904|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935905|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13935906|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935907|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114151|NCT05076682|Choline|choline|mesh-list
14114152|NCT05076682|Antibodies|antibodies|mesh-list
14114153|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
14114154|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114155|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
14114156|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14114157|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
13935908|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
13935909|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13935910|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13935911|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13935912|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13935913|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935914|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
13935915|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935916|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935917|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13935918|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935919|NCT03331861|Metformin|metformin|mesh-list
13935920|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13935921|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935922|NCT03331770|Latanoprost|latanoprost|mesh-list
13935923|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13935924|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13935925|NCT03331692|Anesthetics|anesthetics|mesh-list
13935926|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935927|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935928|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
13935929|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
13935930|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13935931|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13935932|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13935933|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935934|NCT03331562|Vitamins|vitamins|mesh-ancestor
13935935|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
13935936|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13935937|NCT03331523|Betamethasone|betamethasone|mesh-list
13935938|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
13935939|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13935940|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
13935941|NCT03331523|Calcipotriene|calcipotriene|mesh-list
13935942|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13935943|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13935944|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
13935945|NCT03331523|Hormones|hormones|mesh-ancestor
13935946|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13935947|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935948|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13935949|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
13935950|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
13935951|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
13935952|NCT03331484|Ticagrelor|ticagrelor|mesh-list
13935953|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13935954|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13935955|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13935956|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13935957|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
13935958|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13935959|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935960|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935961|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13935962|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
13935963|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13935964|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
13935965|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13935966|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
13935967|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
13935968|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13935969|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
13935970|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13935971|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935972|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13935973|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
13935974|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13935975|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
13935976|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13935977|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183697|NCT04725747|Analgesics|analgesics|mesh-ancestor
14114158|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114159|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14477941|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477942|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477943|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13935978|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13935979|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
13935980|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
13935981|NCT03331445|Protective Agents|protective agents|mesh-ancestor
13935982|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
13935983|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
13935984|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13935985|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13935986|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13935987|NCT03331302|Xenon|xenon|mesh-list
13935988|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13935989|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
13935990|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
13935991|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13935992|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13935993|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
13935994|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13935995|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13935996|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477944|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14477945|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
14477946|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477947|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14477948|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14477949|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
14477950|NCT02442284|Ritonavir|ritonavir|mesh-list
14477951|NCT02442284|Ribavirin|ribavirin|mesh-list
14477952|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14477953|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14477954|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
13935997|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
14114160|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14114161|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
14114162|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14114163|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114164|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14114165|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
14114166|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
14114167|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14114168|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
14114169|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14114170|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
13935998|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
13935999|NCT03331211|Dasatinib|dasatinib|mesh-list
13936000|NCT03331211|Ponatinib|ponatinib|mesh-list
13936001|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936002|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13936003|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936004|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936005|NCT03330990|Midazolam|midazolam|mesh-list
13936006|NCT03330990|Entrectinib|entrectinib|mesh-list
13936007|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13936008|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936009|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936010|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936011|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13936012|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14114171|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114172|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
14114173|NCT05076526|Protective Agents|protective agents|mesh-ancestor
14114174|NCT05076474|Orlistat|orlistat|mesh-list
14114175|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114176|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114177|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14114178|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14114179|NCT05076461|Ondansetron|ondansetron|mesh-list
14477955|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477956|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114180|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
14114181|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
13936013|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13936014|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14114182|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114183|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114184|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114185|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
14114186|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14114187|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14114188|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
14114189|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114190|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114191|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14114192|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14114193|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114194|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14114195|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14114196|NCT05076292|Glucagon|glucagon|mesh-list
14114197|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114198|NCT05076292|Hormones|hormones|mesh-ancestor
14114199|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114200|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114201|NCT05076227|Vaccines|vaccines|mesh-list
14114202|NCT05076227|Immunologic Factors|immunologic factors|mesh-ancestor
14114203|NCT05076227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114204|NCT05076175|Ozanimod|ozanimod|mesh-list
14114205|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14114206|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114207|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114208|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
14114209|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114210|NCT05076019|Atorvastatin|atorvastatin|mesh-list
14114211|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14114212|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14114213|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
14114214|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114215|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14114216|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14114217|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114218|NCT05069857|Apatinib|apatinib|mesh-list
13936015|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
13936016|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
13936017|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
13936018|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
14114219|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14114220|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114221|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114222|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114223|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114224|NCT05063136|Capecitabine|capecitabine|mesh-list
14114225|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14114226|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
14114227|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114228|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114229|NCT05034809|Melatonin|melatonin|mesh-list
14114230|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
14114231|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936019|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936020|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936021|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13936022|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936023|NCT03330886|Atezolizumab|atezolizumab|mesh-list
13936024|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936025|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14114232|NCT05034809|Protective Agents|protective agents|mesh-ancestor
14762178|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762179|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762180|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
14762181|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14762182|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14762183|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
14762184|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
14762185|NCT03013504|Docetaxel|docetaxel|mesh-list
14762186|NCT03013504|Trastuzumab|trastuzumab|mesh-list
14762187|NCT03013504|Epirubicin|epirubicin|mesh-list
14762188|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762189|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
14762190|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936026|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
13936027|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
13936028|NCT03330860|Hormones|hormones|mesh-ancestor
13936029|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936030|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936031|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936032|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936033|NCT03330808|Anesthetics|anesthetics|mesh-list
13936034|NCT03330808|Ropivacaine|ropivacaine|mesh-list
14114233|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114234|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114235|NCT04998032|Metformin|metformin|mesh-list
14114236|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14114237|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114238|NCT04993924|Cetrorelix|cetrorelix|mesh-list
14114239|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14114240|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
14114241|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14114242|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114243|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
14114244|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114245|NCT04956042|Cytarabine|cytarabine|mesh-list
14114246|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14114247|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
14114248|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477957|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14477958|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14936237|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
13936035|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936036|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936037|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936038|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
13936039|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936040|NCT03330782|Remifentanil|remifentanil|mesh-list
13936041|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13936042|NCT03330782|Narcotics|narcotics|mesh-ancestor
13936043|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936044|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936045|NCT03330782|Analgesics|analgesics|mesh-ancestor
13936046|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
13936047|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936048|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
13936049|NCT03330717|Anesthetics|anesthetics|mesh-list
13936050|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936051|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936052|NCT03330639|Capsaicin|capsaicin|mesh-list
13936053|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
13936054|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
13936055|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
13936056|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936057|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936058|NCT03330613|Anesthetics|anesthetics|mesh-list
13936059|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936060|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961462|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13961463|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13961464|NCT03148132|Growth Substances|growth substances|mesh-ancestor
13961465|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961466|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
13961467|NCT03148314|Misoprostol|misoprostol|mesh-list
13961468|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13961469|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
14477959|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
14477960|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14477961|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14477962|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14477963|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
14477964|NCT02442310|Deferiprone|deferiprone|mesh-list
14477965|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14477966|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
14477967|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
14477968|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477969|NCT02442700|Pitavastatin|pitavastatin|mesh-list
14114249|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114250|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
14114251|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114252|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114253|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
14114254|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114255|NCT04951323|Vaccines|vaccines|mesh-list
14114256|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
14114257|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114258|NCT04893785|Temozolomide|temozolomide|mesh-list
14114259|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14114260|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
14114261|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114262|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114263|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
14114264|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14114265|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114266|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14114267|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14114268|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114269|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114270|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114271|NCT04805541|Tropicamide|tropicamide|mesh-list
14114272|NCT04805541|Mydriatics|mydriatics|mesh-list
14114273|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
13936061|NCT03330223|Clopidogrel|clopidogrel|mesh-list
13936062|NCT03330223|Ticagrelor|ticagrelor|mesh-list
13936063|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13936064|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13936065|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13936066|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13936067|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
13936068|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936069|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936070|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936071|NCT03330171|Vaccines|vaccines|mesh-list
13936072|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
13936073|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936074|NCT03330132|Vaccines|vaccines|mesh-list
14114274|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114275|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114276|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14114277|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14114278|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
14114279|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114280|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114281|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
14114282|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14114283|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13936075|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
13936076|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
13936077|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936078|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
13936079|NCT03330106|Paclitaxel|paclitaxel|mesh-list
13936080|NCT03330106|Docetaxel|docetaxel|mesh-list
13936081|NCT03330106|Carboplatin|carboplatin|mesh-list
13936082|NCT03330106|Pevonedistat|pevonedistat|mesh-list
13936083|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13936084|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936085|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114284|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114285|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
14114286|NCT04803591|Coagulants|coagulants|mesh-ancestor
13936086|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
13936087|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114287|NCT04746547|Dolutegravir|dolutegravir|mesh-list
14114288|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14114289|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14114290|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114291|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114292|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14114293|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14114294|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
14114295|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114296|NCT04713709|Naloxone|naloxone|mesh-list
14114297|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14114298|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114299|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
14114300|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114301|NCT04696822|Epinephrine|epinephrine|mesh-list
14114302|NCT04696822|Racepinephrine|racepinephrine|mesh-list
14114303|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
14114304|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14114305|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14114306|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
14114307|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114308|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114309|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114310|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13936088|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936089|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936090|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13936091|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13936092|NCT03329898|Estradiol|estradiol|mesh-list
13936093|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13936094|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
13936095|NCT03329898|Estrogens|estrogens|mesh-ancestor
13936096|NCT03329898|Hormones|hormones|mesh-ancestor
14114311|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14114312|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
14114313|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114314|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14114315|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
14114316|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
14114317|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
14114318|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14176059|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14176060|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14176061|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14176062|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14176063|NCT04768075|Paclitaxel|paclitaxel|mesh-list
14176064|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14176065|NCT04768075|Carboplatin|carboplatin|mesh-list
14176066|NCT04768075|Pemetrexed|pemetrexed|mesh-list
13936097|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936098|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936099|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13936100|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
13936101|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13936102|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13936103|NCT03329898|Progestins|progestins|mesh-ancestor
13936104|NCT03329781|Curcumin|curcumin|mesh-list
14762191|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762192|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762193|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
14762194|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762195|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762196|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13936105|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14176067|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13936106|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936107|NCT03329781|Analgesics|analgesics|mesh-ancestor
13936108|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
13936109|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936110|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936111|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14176068|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936112|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13936113|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176069|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114319|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
14114320|NCT04608487|Fludarabine|fludarabine|mesh-list
14114321|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114322|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
14114323|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114324|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114325|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14114326|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
14114327|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114328|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114329|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14114330|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14114331|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114332|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114333|NCT04501861|Vasopressins|vasopressins|mesh-list
14114334|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
14114335|NCT04501861|Norepinephrine|norepinephrine|mesh-list
14114336|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13936114|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936115|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936116|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13936117|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13936118|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13936119|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
14936238|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936239|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114337|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14114338|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
14114339|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114340|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114341|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114342|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
14114343|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
14114344|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114345|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14114346|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
14114347|NCT04501861|Coagulants|coagulants|mesh-ancestor
14114348|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14114349|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
14114350|NCT04498741|Midazolam|midazolam|mesh-list
14114351|NCT04498741|Dabigatran|dabigatran|mesh-list
14114352|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14114353|NCT04498741|Tacrolimus|tacrolimus|mesh-list
14114354|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938709|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938710|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938711|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
14938712|NCT01483508|Procyanidin|procyanidin|mesh-list
14938713|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
14938714|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938715|NCT01483508|Protective Agents|protective agents|mesh-ancestor
14938716|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938717|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13936120|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936121|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13936122|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13936123|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936124|NCT03329651|Metformin|metformin|mesh-list
13936125|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13936126|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936127|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13936128|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13936129|NCT03329547|Cefixime|cefixime|mesh-list
13936130|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13936131|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13936132|NCT03329508|Pramipexole|pramipexole|mesh-list
14114355|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
14114356|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114357|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14114358|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114359|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114360|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14114361|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14114362|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938718|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14114363|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14114364|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14114365|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14114366|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14114367|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
14114368|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
14114369|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
14114370|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
14114371|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114372|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14114373|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14114374|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
14114375|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14114376|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14114377|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
14114378|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14114379|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
14114380|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
14114381|NCT04455815|Camostat|camostat|mesh-list
14114382|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
14114383|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114384|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114385|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14114386|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14114387|NCT04407988|Letrozole|letrozole|mesh-list
14114388|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114389|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14114390|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14114391|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114392|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114393|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14114394|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
14114395|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114396|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114397|NCT04342078|Vitamin D|vitamin d|mesh-list
14114398|NCT04342078|Vitamins|vitamins|mesh-ancestor
13936133|NCT03329508|Rasagiline|rasagiline|mesh-list
13936134|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
13936135|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936136|NCT03329508|Protective Agents|protective agents|mesh-ancestor
13936137|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936138|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13936139|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13936140|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
13936141|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
13936142|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936143|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14114399|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
14114400|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114401|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14114402|NCT04218266|Apixaban|apixaban|mesh-list
14114403|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14114404|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
14114405|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14114406|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
14114407|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114408|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936144|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936145|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13936146|NCT03329456|Ropivacaine|ropivacaine|mesh-list
13936147|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936148|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
13936149|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936150|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936151|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
13936152|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936153|NCT03329443|Spironolactone|spironolactone|mesh-list
13936154|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13936155|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
13936156|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936157|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936158|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13936159|NCT03329443|Diuretics|diuretics|mesh-ancestor
14114409|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
13936160|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
14114410|NCT04102241|Hemay005|hemay005|mesh-list
14114411|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
13936161|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
13936162|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
13936163|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936164|NCT03329339|Protective Agents|protective agents|mesh-ancestor
13936165|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936166|NCT03329339|Vitamins|vitamins|mesh-ancestor
13936167|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
13936168|NCT03329261|Clopidogrel|clopidogrel|mesh-list
14114412|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14114413|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14114414|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114415|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114416|NCT04083014|Bortezomib|bortezomib|mesh-list
14114417|NCT04083014|Antibodies|antibodies|mesh-list
14114418|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
14114419|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114420|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114421|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14114422|NCT04039750|Clindamycin|clindamycin|mesh-list
14114423|NCT04039750|Gentamicins|gentamicins|mesh-list
14114424|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114425|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14114426|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114427|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114428|NCT04026945|Lidocaine|lidocaine|mesh-list
14114429|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
14114430|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
14114431|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114432|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114433|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
14114434|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114435|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14114436|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14114437|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14114438|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14114439|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114440|NCT03990467|Tazobactam|tazobactam|mesh-list
14114441|NCT03990467|Piperacillin|piperacillin|mesh-list
14114442|NCT03990467|Amikacin|amikacin|mesh-list
14114443|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14114444|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114445|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14114446|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114447|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114448|NCT03980561|Varenicline|varenicline|mesh-list
14114449|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14114450|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14762197|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114451|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
14114452|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114453|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114454|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114455|NCT03978767|Acetaminophen|acetaminophen|mesh-list
14114456|NCT03978767|Ibuprofen|ibuprofen|mesh-list
14114457|NCT03978767|Ketorolac|ketorolac|mesh-list
14762198|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
14762199|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
14762200|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762201|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14762202|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14762203|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14762204|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762205|NCT02974049|Ivermectin|ivermectin|mesh-list
13936169|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13936170|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13936171|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13936172|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13936173|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
13936174|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936175|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936176|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936177|NCT03329248|Leucovorin|leucovorin|mesh-list
13936178|NCT03329248|Paclitaxel|paclitaxel|mesh-list
14114458|NCT03978767|Oxycodone|oxycodone|mesh-list
14114459|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936179|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
13936180|NCT03329248|Bevacizumab|bevacizumab|mesh-list
13936181|NCT03329248|Fluorouracil|fluorouracil|mesh-list
13936182|NCT03329248|Capecitabine|capecitabine|mesh-list
13936183|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
13936184|NCT03329248|Avelumab|avelumab|mesh-list
13936185|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13936186|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936187|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
13936188|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
13936189|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
13936190|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936191|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936192|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
13936193|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936194|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13936195|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13936196|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
13936197|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13936198|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13936199|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13936200|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13936201|NCT03329248|Growth Substances|growth substances|mesh-ancestor
13936202|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
13936203|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
13936204|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13936205|NCT03329248|Antidotes|antidotes|mesh-ancestor
14114460|NCT03978767|Analgesics|analgesics|mesh-ancestor
14114461|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
14114462|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114463|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114464|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
14114465|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14114466|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114467|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114468|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14114469|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114470|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114471|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14114472|NCT03978767|Narcotics|narcotics|mesh-ancestor
14114473|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114474|NCT03971669|Vaccines|vaccines|mesh-list
14114475|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
14114476|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114477|NCT03970993|Vaccines|vaccines|mesh-list
14114478|NCT03970993|Immunologic Factors|immunologic factors|mesh-ancestor
14114479|NCT03970993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114480|NCT03838692|Ponatinib|ponatinib|mesh-list
14477970|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14477971|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14477972|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13936206|NCT03329248|Protective Agents|protective agents|mesh-ancestor
14477973|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
14477974|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936207|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
13936208|NCT03329248|Vitamins|vitamins|mesh-ancestor
13936209|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
13936210|NCT03329183|Irinotecan|irinotecan|mesh-list
13936211|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13936212|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13936213|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936214|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936215|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936216|NCT03329118|Simvastatin|simvastatin|mesh-list
13936217|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13936218|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13936219|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
13936220|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477975|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14477976|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14762206|NCT02974049|Albendazole|albendazole|mesh-list
14762207|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
14114481|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936221|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13936222|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14176070|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
13936223|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936224|NCT03328975|Dexamethasone|dexamethasone|mesh-list
13936225|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936226|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
14114482|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114483|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114484|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114485|NCT03774186|Pancrelipase|pancrelipase|mesh-list
14114486|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114487|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
13936227|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
13936228|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936229|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936230|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114488|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14114489|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114490|NCT03739268|Sevelamer|sevelamer|mesh-list
14114491|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
14114492|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
14114493|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114494|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14114495|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114496|NCT03671525|Nimodipine|nimodipine|mesh-list
14114497|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13936231|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
13936232|NCT03328975|Hormones|hormones|mesh-ancestor
13936233|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936234|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936235|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936236|NCT03328936|Melphalan|melphalan|mesh-list
13936237|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13936238|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
13936239|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936240|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114498|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14114499|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14114500|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114501|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14114502|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114503|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
14114504|NCT03660553|Insulin|insulin|mesh-list
14114505|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14114506|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
14114507|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
14114508|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
14114509|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14114510|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114511|NCT03576443|Idelalisib|idelalisib|mesh-list
14114512|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114513|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114514|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114515|NCT03505944|Venetoclax|venetoclax|mesh-list
14114516|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114517|NCT03480776|Aspirin|aspirin|mesh-list
14114518|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14114519|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14114520|NCT03480776|Analgesics|analgesics|mesh-ancestor
14114521|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
14114522|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114523|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114524|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114525|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114526|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14114527|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14114528|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114529|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13936241|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13936242|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936243|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
13936244|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114530|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14114531|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762208|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14936240|NCT01468025|Naproxen|naproxen|mesh-list
14114532|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
14114533|NCT03466294|Azacitidine|azacitidine|mesh-list
14114534|NCT03466294|Venetoclax|venetoclax|mesh-list
14114535|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14114536|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
14114537|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114538|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114539|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936245|NCT03328884|Irinotecan|irinotecan|mesh-list
13936246|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13936247|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13936248|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936249|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114540|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
14114541|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14114542|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14114543|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114544|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
14114545|NCT03353259|Coagulants|coagulants|mesh-ancestor
14114546|NCT03247569|Edoxaban|edoxaban|mesh-list
14114547|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14114548|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
14114549|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14114550|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
14114551|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114552|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114553|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
14114554|NCT03245840|Budesonide|budesonide|mesh-list
14114555|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114556|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14114557|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
13936250|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936251|NCT03328728|Hylan|hylan|mesh-list
13936252|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
13936253|NCT03328728|Protective Agents|protective agents|mesh-ancestor
13936254|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961470|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13961471|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961472|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13961473|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114558|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114559|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114560|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14114561|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14114562|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
14114563|NCT03245840|Hormones|hormones|mesh-ancestor
14114564|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14176071|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176072|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176073|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176074|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14176075|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14176076|NCT04768439|Vitamin D|vitamin d|mesh-list
14176077|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
14176078|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14176079|NCT04768439|Calcitriol|calcitriol|mesh-list
14176080|NCT04768439|Vitamins|vitamins|mesh-list
14176081|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
14176082|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176083|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14176084|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14176085|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14176086|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176087|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176088|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14176089|NCT04767841|Metformin|metformin|mesh-list
13961474|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
13961475|NCT03148288|Vitamin D|vitamin d|mesh-list
14176090|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14176091|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176092|NCT04768023|Vitamin D|vitamin d|mesh-list
14176093|NCT04768023|Vitamins|vitamins|mesh-ancestor
14936241|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14176094|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
14176095|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961476|NCT03148288|Vitamins|vitamins|mesh-ancestor
13961477|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
14114565|NCT03174184|Amoxicillin|amoxicillin|mesh-list
14114566|NCT03174184|Rifampin|rifampin|mesh-list
14114567|NCT03174184|Meropenem|meropenem|mesh-list
13936255|NCT03328533|Phenylephrine|phenylephrine|mesh-list
13936256|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
13936257|NCT03328533|Norepinephrine|norepinephrine|mesh-list
13936258|NCT03328533|Bupivacaine|bupivacaine|mesh-list
13936259|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936260|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
13936261|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936262|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936263|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
13936264|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936265|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13936266|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
13936267|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
13936268|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
13936269|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13936270|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
13936271|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
13936272|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13936273|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13936274|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936275|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936276|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936277|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936278|NCT03328533|Protective Agents|protective agents|mesh-ancestor
13936279|NCT03328494|Paclitaxel|paclitaxel|mesh-list
13936280|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13936281|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936282|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
13936283|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114568|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
14114569|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
13936284|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
13936285|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936286|NCT03328481|Anesthetics|anesthetics|mesh-list
13936287|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936288|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936289|NCT03328364|Docetaxel|docetaxel|mesh-list
13936290|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936291|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
13936292|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
13936293|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
13936294|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936295|NCT03328312|Atropine|atropine|mesh-list
13936296|NCT03328312|Neostigmine|neostigmine|mesh-list
13936297|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13936298|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13936299|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13936300|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
13936301|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936302|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936303|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13936304|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14114570|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14114571|NCT03174184|Rifamycins|rifamycins|mesh-list
14114572|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14114573|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114574|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14114575|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
14114576|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
14114577|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14114578|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114579|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114580|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14114581|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14114582|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14114583|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14114584|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14114585|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14477977|NCT02443103|Guanabenz|guanabenz|mesh-list
14477978|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13936305|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
13936306|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
13936307|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13936308|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13936309|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
13936310|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936311|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936312|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13936313|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936314|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13936315|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
13936316|NCT03328299|Bupivacaine|bupivacaine|mesh-list
14114586|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14114587|NCT03128905|Prednisone|prednisone|mesh-list
14114588|NCT03128905|Colchicine|colchicine|mesh-list
14114589|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114590|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
14114591|NCT03128905|Hormones|hormones|mesh-ancestor
14114592|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114593|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114594|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14114595|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114596|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
14114597|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114598|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114599|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114600|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114601|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114602|NCT03121586|Pimavanserin|pimavanserin|mesh-list
14114603|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14114604|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14114605|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13936317|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936318|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
13936319|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936320|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936321|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
13936322|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936323|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936324|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936325|NCT03328299|Analgesics|analgesics|mesh-ancestor
13936326|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13936327|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14114606|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14114607|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114608|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114609|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14114610|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14114611|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14114612|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
14114613|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114614|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114615|NCT03110926|Leucovorin|leucovorin|mesh-list
14114616|NCT03110926|Paclitaxel|paclitaxel|mesh-list
14114617|NCT03110926|Carboplatin|carboplatin|mesh-list
14114618|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
14477979|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13936328|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936329|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936330|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936331|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936332|NCT03328234|Paclitaxel|paclitaxel|mesh-list
13936333|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13936334|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13936335|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936336|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
13936337|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
13936338|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
13936339|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936340|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
13936341|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936342|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13936343|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936344|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936345|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
13936346|NCT03328104|Etoposide|etoposide|mesh-list
14114619|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14114620|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114621|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114622|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114623|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114624|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114625|NCT03110926|Antidotes|antidotes|mesh-ancestor
14114626|NCT03110926|Protective Agents|protective agents|mesh-ancestor
14114627|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114628|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
14114629|NCT03110926|Vitamins|vitamins|mesh-ancestor
14114630|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
14114631|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14114632|NCT02997761|Blinatumomab|blinatumomab|mesh-list
14114633|NCT02997761|Antibodies|antibodies|mesh-list
14114634|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
14114635|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14114636|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
14114637|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14114638|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
14114639|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114640|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114641|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114642|NCT02913495|Progesterone|progesterone|mesh-list
14114643|NCT02913495|Progestins|progestins|mesh-ancestor
13936347|NCT03328104|Everolimus|everolimus|mesh-list
13936348|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936349|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
13936350|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936351|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13936352|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13936353|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
13936354|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936355|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936356|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13936357|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13936358|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13936359|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13936360|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936361|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
13936362|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13936363|NCT03327987|Vaccines|vaccines|mesh-list
13936364|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
13936365|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936366|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13936367|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14114644|NCT02913495|Hormones|hormones|mesh-ancestor
14114645|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114646|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114647|NCT02823990|Nivolumab|nivolumab|mesh-list
14114648|NCT02823990|Interleukin-2|interleukin-2|mesh-list
14114649|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114650|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14114651|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114652|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14114653|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114654|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14114655|NCT02823990|Analgesics|analgesics|mesh-ancestor
14114656|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
14114657|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114658|NCT02633098|Artesunate|artesunate|mesh-list
14114659|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
14114660|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14114661|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14114662|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114663|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114664|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
14114665|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
14114666|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14114667|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
14114668|NCT02624128|Cetuximab|cetuximab|mesh-list
14114669|NCT02624128|Valproic Acid|valproic acid|mesh-list
14114670|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114671|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14114672|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
14114673|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114674|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114675|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
13936368|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
13936369|NCT03327766|Calcifediol|calcifediol|mesh-list
13936370|NCT03327766|Vitamins|vitamins|mesh-ancestor
13936371|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
14114676|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114677|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114678|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
14114679|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14114680|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114681|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14114682|NCT02578069|Sirolimus|sirolimus|mesh-list
14114683|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14114684|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114685|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14114686|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114687|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
14114688|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114689|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
14114690|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114691|NCT02514031|Gemcitabine|gemcitabine|mesh-list
14114692|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
14114693|NCT02514031|Paclitaxel|paclitaxel|mesh-list
14114694|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14114695|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114696|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114697|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114698|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114699|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114700|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13936372|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936373|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13936374|NCT03327727|Voriconazole|voriconazole|mesh-list
13936375|NCT03327727|Amphotericin B|amphotericin b|mesh-list
13936376|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13936377|NCT03327727|Isavuconazole|isavuconazole|mesh-list
13936378|NCT03327727|VL-2397|vl-2397|mesh-list
14114701|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
14114702|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
14114703|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114704|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114705|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114706|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
14114707|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114708|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14114709|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14114710|NCT02427126|Aspirin|aspirin|mesh-list
14114711|NCT02427126|Apixaban|apixaban|mesh-list
14114712|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14114713|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14114714|NCT02427126|Analgesics|analgesics|mesh-ancestor
14114715|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
14114716|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114717|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114718|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114719|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114720|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14114721|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14114722|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114723|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14114724|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14114725|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114726|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
14114727|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14114728|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
14114729|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14114730|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
14114731|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
14114732|NCT05080569|Progesterone|progesterone|mesh-list
14477980|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14114733|NCT05080569|Progestins|progestins|mesh-ancestor
14114734|NCT05080569|Hormones|hormones|mesh-ancestor
14114735|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114736|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114737|NCT05080556|Carboplatin|carboplatin|mesh-list
14114738|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114739|NCT05080543|Terlipressin|terlipressin|mesh-list
14477981|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936379|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
13936380|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13936381|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13936382|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13936383|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936384|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936385|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13936386|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
13936387|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936388|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936389|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13936390|NCT03327727|Amebicides|amebicides|mesh-ancestor
13936391|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13936392|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13936393|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13936394|NCT03327701|Benralizumab|benralizumab|mesh-list
13936395|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13936396|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
13936397|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13936398|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13936399|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936400|NCT03327558|Mesalamine|mesalamine|mesh-list
13936401|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13936402|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936403|NCT03327558|Analgesics|analgesics|mesh-ancestor
13936404|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
13936405|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936406|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936407|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936408|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13936409|NCT03327506|Alprazolam|alprazolam|mesh-list
13936410|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936411|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936412|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936413|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13936414|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13936415|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14114740|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14114741|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14114742|NCT05080530|Vitamin D|vitamin d|mesh-list
14114743|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
14114744|NCT05080530|Vitamins|vitamins|mesh-ancestor
14114745|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
14114746|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114747|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14114748|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14114749|NCT05080478|Clopidogrel|clopidogrel|mesh-list
14114750|NCT05080478|Ticagrelor|ticagrelor|mesh-list
14114751|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14114752|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14114753|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14114754|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14114755|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
14114756|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114757|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114758|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114759|NCT05080348|Ropivacaine|ropivacaine|mesh-list
14114760|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
14114761|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
14114762|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936416|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
13936417|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
13936418|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936419|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936420|NCT03327454|Etanercept|etanercept|mesh-list
13936421|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13936422|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936423|NCT03327454|Analgesics|analgesics|mesh-ancestor
13936424|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
13936425|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936426|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114763|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114764|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
14477982|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936427|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936428|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13936429|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13936430|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936431|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
13936432|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
13936433|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936434|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936435|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936436|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936437|NCT03327389|Analgesics|analgesics|mesh-ancestor
13936438|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
13936439|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936440|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13936441|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13936442|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936443|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936444|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936445|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114765|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762209|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762210|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
14762211|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
14762212|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14762213|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14762214|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14762215|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
14762216|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
14762217|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762218|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762219|NCT02974049|Filaricides|filaricides|mesh-ancestor
14762220|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
14762221|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14762222|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762223|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14762224|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14762225|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14762226|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
14762227|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114786|NCT05080192|Fenofibrate|fenofibrate|mesh-list
14114787|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14114788|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
14114789|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114790|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14114791|NCT05080140|Ezetimibe|ezetimibe|mesh-list
14114792|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13936446|NCT03327350|Anticoagulants|anticoagulants|mesh-list
13936447|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
13936448|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13936449|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13936450|NCT03327272|Prednisolone|prednisolone|mesh-list
13936451|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
13936452|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13936453|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
13936454|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936455|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
14114793|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14114794|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
13936456|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
13936457|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936458|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936459|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13936460|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
13936461|NCT03327272|Hormones|hormones|mesh-ancestor
13936462|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936463|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13936464|NCT03327272|Protective Agents|protective agents|mesh-ancestor
13936465|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936466|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936467|NCT03327168|Adenosine|adenosine|mesh-list
13936468|NCT03327168|Analgesics|analgesics|mesh-ancestor
13936469|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
14114795|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936470|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762228|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762229|NCT02937766|Progestins|progestins|mesh-ancestor
14762230|NCT02937766|Hormones|hormones|mesh-ancestor
14762231|NCT02927938|Cytarabine|cytarabine|mesh-list
14762232|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14762233|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
14762234|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114796|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14114797|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
14114798|NCT05080049|Hematinics|hematinics|mesh-ancestor
14114799|NCT05080010|Carboplatin|carboplatin|mesh-list
14114800|NCT05080010|Etoposide|etoposide|mesh-list
14114801|NCT05080010|Vincristine|vincristine|mesh-list
14114802|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114803|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14114804|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14114805|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14114806|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114807|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114808|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114809|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114810|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114811|NCT05079880|Caffeine|caffeine|mesh-list
14114812|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
14114813|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114814|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14114815|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114816|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14114817|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114818|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14114819|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14114820|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
14114821|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114822|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14114823|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14114824|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114825|NCT05079789|Amiloride|amiloride|mesh-list
14114826|NCT05079789|Furosemide|furosemide|mesh-list
14114827|NCT05079789|Diuretics|diuretics|mesh-ancestor
14114828|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
14114829|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114830|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14114831|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14114832|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114833|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14114834|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14114835|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14762235|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762236|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
13936471|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936472|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13936473|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
13936474|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13936475|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
13936476|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
13936477|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936478|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936479|NCT03327155|Tenofovir|tenofovir|mesh-list
13936480|NCT03327155|Emtricitabine|emtricitabine|mesh-list
13936481|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
13936482|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13936483|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13936484|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13936485|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936486|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936487|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13936488|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13936489|NCT03327116|Methotrexate|methotrexate|mesh-list
13936490|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13936491|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
13936492|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13936493|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114836|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14114837|NCT05079763|Monolaurin|monolaurin|mesh-list
14114838|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
14114839|NCT05079763|Protective Agents|protective agents|mesh-ancestor
14762237|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762238|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936494|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13936495|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
13936496|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936497|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936498|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
13936499|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114840|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114841|NCT05079087|Midazolam|midazolam|mesh-list
14114842|NCT05079087|Ketamine|ketamine|mesh-list
14114843|NCT05079087|Analgesics|analgesics|mesh-ancestor
14114844|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
14114845|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114846|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936242|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936243|NCT01468025|Analgesics|analgesics|mesh-ancestor
13936500|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13936501|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936502|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
13936503|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13936504|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13936505|NCT03326960|Propofol|propofol|mesh-list
13936506|NCT03326960|Sevoflurane|sevoflurane|mesh-list
13936507|NCT03326960|Desflurane|desflurane|mesh-list
13936508|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936509|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936510|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936511|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13936512|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
14936244|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
14936245|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936246|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936513|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
13936514|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13936515|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13936516|NCT03326947|Docetaxel|docetaxel|mesh-list
13936517|NCT03326947|Fluorouracil|fluorouracil|mesh-list
13936518|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114847|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14114848|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14114849|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
14114850|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
14114851|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114852|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14114853|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14477983|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14477984|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477985|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477986|NCT02443155|Liraglutide|liraglutide|mesh-list
14477987|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14477988|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14477989|NCT02443155|Incretins|incretins|mesh-ancestor
14477990|NCT02443155|Hormones|hormones|mesh-ancestor
14762239|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
14762240|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762241|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
14762242|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14762243|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14762244|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762245|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
14762246|NCT02918201|Coagulants|coagulants|mesh-ancestor
14762247|NCT02899052|Dexamethasone|dexamethasone|mesh-list
14762248|NCT02899052|Venetoclax|venetoclax|mesh-list
14477991|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14477992|NCT02443337|Necitumumab|necitumumab|mesh-list
14477993|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762249|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14477994|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14477995|NCT02443402|Insulin|insulin|mesh-list
14762250|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
14936247|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936519|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
14762251|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
14762252|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762253|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762254|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762255|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
14762256|NCT02899052|Hormones|hormones|mesh-ancestor
13936520|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
13936521|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
13936522|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936523|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
13936524|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13936525|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936526|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
13936527|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961478|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961479|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13961480|NCT03148002|Lactulose|lactulose|mesh-list
13961481|NCT03148002|Sennosides|sennosides|mesh-list
13961482|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961483|NCT03148002|Laxatives|laxatives|mesh-ancestor
13961484|NCT03147963|Docetaxel|docetaxel|mesh-list
13961485|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961486|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
13961487|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
13961488|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
13961489|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961490|NCT03147638|Warfarin|warfarin|mesh-list
13961491|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
13961492|NCT03147859|Vedolizumab|vedolizumab|mesh-list
13961493|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961494|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
13961495|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13961496|NCT03147677|Irbesartan|irbesartan|mesh-list
13961497|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13961498|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13961499|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13961500|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961501|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13961502|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961503|NCT03147677|Vitamins|vitamins|mesh-ancestor
13961504|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
13961505|NCT03147599|Mebeverine|mebeverine|mesh-list
13961506|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
13961507|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
13961508|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
13961509|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961510|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961511|NCT03147404|Avelumab|avelumab|mesh-list
13961512|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961513|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961514|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
13961515|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
13961516|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961517|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961518|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
13961519|NCT03146962|Vitamins|vitamins|mesh-ancestor
14114854|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114855|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114856|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14114857|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14114858|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14114859|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14114860|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14114861|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
14114862|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
14114863|NCT05079022|Aflutinib|aflutinib|mesh-list
14114864|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114865|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114866|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114867|NCT05078944|Donepezil|donepezil|mesh-list
14114868|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14114869|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114870|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114871|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
13961520|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
13961521|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936248|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762257|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936528|NCT03326752|Nivolumab|nivolumab|mesh-list
14114872|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114873|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114874|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
14114875|NCT05078788|Triamcinolone|triamcinolone|mesh-list
14114876|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14114877|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
13936529|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13936530|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13936531|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936532|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936533|NCT03326674|Capecitabine|capecitabine|mesh-list
13936534|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13936535|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
13936536|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936537|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936538|NCT03326661|Clindamycin|clindamycin|mesh-list
13936539|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
13936540|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
13936541|NCT03326661|Penicillins|penicillins|mesh-list
13936542|NCT03326661|Metronidazole|metronidazole|mesh-list
13936543|NCT03326661|Penicillin V|penicillin v|mesh-list
13936544|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13936545|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13936546|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13936547|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936548|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936549|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13936550|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13936551|NCT03326609|Ropivacaine|ropivacaine|mesh-list
13936552|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936553|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
13936554|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936555|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936556|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
13936557|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936558|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
13936559|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13936560|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13936561|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936562|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
13936563|NCT03326596|Coagulants|coagulants|mesh-ancestor
13936564|NCT03326310|Azacitidine|azacitidine|mesh-list
13936565|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13936566|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
13936567|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936568|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936569|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936570|NCT03326258|Nivolumab|nivolumab|mesh-list
13936571|NCT03326258|Ipilimumab|ipilimumab|mesh-list
13936572|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
13936573|NCT03326258|Antibodies|antibodies|mesh-list
13936574|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
13936575|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
13936576|NCT03326258|Immunotoxins|immunotoxins|mesh-list
14114878|NCT05078788|Hormones|hormones|mesh-ancestor
14114879|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114880|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114881|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14114882|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
14114883|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176096|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14176097|NCT04767698|Belimumab|belimumab|mesh-list
14176098|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
14176099|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176100|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
14176101|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176102|NCT04767828|Capecitabine|capecitabine|mesh-list
14176103|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176104|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
14183698|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
14762258|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936577|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13936578|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
13936579|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114884|NCT05078372|Midazolam|midazolam|mesh-list
14114885|NCT05078372|Ropivacaine|ropivacaine|mesh-list
14114886|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
14114887|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
14114888|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114889|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114890|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
14114891|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114892|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14114893|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14114894|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13936580|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13936581|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936582|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13936583|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936584|NCT03326180|Bupivacaine|bupivacaine|mesh-list
14114895|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14114896|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14114897|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14114898|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
14114899|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
14114900|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
14762259|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762260|NCT02883400|Spironolactone|spironolactone|mesh-list
14762261|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14762262|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
13936585|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936586|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
13936587|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936588|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936589|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
13936590|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936591|NCT03326128|Bupropion|bupropion|mesh-list
13936592|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13936593|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
13936594|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13936595|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13936596|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13936597|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13936598|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936249|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
14936250|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14936251|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936252|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936253|NCT01468038|Trazodone|trazodone|mesh-list
14936254|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14936255|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14936256|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14936257|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936258|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14936259|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14936260|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14936261|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14936262|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936599|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
13936600|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936601|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936602|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13936603|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13936604|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936605|NCT03326102|Paclitaxel|paclitaxel|mesh-list
14114901|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14114902|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762263|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762264|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762265|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14762266|NCT02883400|Diuretics|diuretics|mesh-ancestor
14762267|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
14114903|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14114904|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114905|NCT05078255|Incretins|incretins|mesh-ancestor
14114906|NCT05078255|Hormones|hormones|mesh-ancestor
14114907|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114908|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114909|NCT05078177|Rituximab|rituximab|mesh-list
14114910|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14936263|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936264|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
14936265|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14936266|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
14936267|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14936268|NCT01468051|Vaccines|vaccines|mesh-list
14936269|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
14936270|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936271|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14936272|NCT01468051|Antacids|antacids|mesh-ancestor
14936273|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936274|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114911|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114912|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
14114913|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114914|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114915|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
14114916|NCT05078138|Hematinics|hematinics|mesh-ancestor
14114917|NCT05077813|Vitamin D|vitamin d|mesh-list
14114918|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
14114919|NCT05077813|Vitamins|vitamins|mesh-list
14114920|NCT05077813|Minocycline|minocycline|mesh-list
14114921|NCT05077813|Tretinoin|tretinoin|mesh-list
14114922|NCT05077813|Alitretinoin|alitretinoin|mesh-list
14114923|NCT05077813|Isotretinoin|isotretinoin|mesh-list
14114924|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
14114925|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114926|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14114927|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14936275|NCT01468155|Dabigatran|dabigatran|mesh-list
14936276|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
14936277|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14936278|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
14936279|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936280|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936281|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
14936282|NCT01468259|Droxidopa|droxidopa|mesh-list
14936283|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14936284|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14114928|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14114929|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114930|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114931|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
14114932|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
14114933|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
14114934|NCT05077592|Povidone|povidone|mesh-list
14114935|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
14114936|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
14114937|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14114938|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14114939|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
14114940|NCT05077527|Fludarabine|fludarabine|mesh-list
14114941|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14114942|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
14114943|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936285|NCT01468272|Beclomethasone|beclomethasone|mesh-list
14114944|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14114945|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14114946|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
14114947|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114948|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114949|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14936286|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
14936287|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14936288|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
14936289|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936606|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13936607|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13936608|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936609|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
14936290|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936291|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14936292|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
14936293|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14936294|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14936295|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14936296|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
14936297|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936298|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936299|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14936300|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
14936301|NCT01468272|Hormones|hormones|mesh-ancestor
14936302|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936303|NCT01468285|Betahistine|betahistine|mesh-list
14936304|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936305|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
14936306|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
14936307|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936308|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936309|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936610|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
13936611|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
13936612|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114950|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
14114951|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114952|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114953|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114954|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114955|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
14114956|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114957|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114958|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114959|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114960|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
14114961|NCT05077215|Lenvatinib|lenvatinib|mesh-list
14114962|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14114963|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114964|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14114965|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936310|NCT01468389|Capecitabine|capecitabine|mesh-list
14936311|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14936312|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
14114966|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114967|NCT05077137|Vaccines|vaccines|mesh-list
14114968|NCT05077137|Immunologic Factors|immunologic factors|mesh-ancestor
14114969|NCT05077137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114970|NCT05077111|Anesthetics|anesthetics|mesh-list
14114971|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14114972|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114973|NCT05075863|Letrozole|letrozole|mesh-list
14114974|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114975|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14114976|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14114977|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14114978|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114979|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14936313|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936613|NCT03326063|Ifetroban|ifetroban|mesh-list
14114980|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
14114981|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14114982|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114983|NCT05068141|Paclitaxel|paclitaxel|mesh-list
14114984|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14114985|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14114986|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
14114987|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
14114988|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
14114989|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14114990|NCT05068037|Antiemetics|antiemetics|mesh-list
14114991|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
14114992|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14114993|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14114994|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14114995|NCT05062356|Ketorolac|ketorolac|mesh-list
14114996|NCT05062356|Epinephrine|epinephrine|mesh-list
14114997|NCT05062356|Bupivacaine|bupivacaine|mesh-list
14114998|NCT05062356|Prilocaine|prilocaine|mesh-list
14114999|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14115000|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
14115001|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
14115002|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115003|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115004|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
14115005|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115006|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14115007|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14115008|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
14115009|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14115010|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115011|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14115012|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14115013|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
14115014|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14115015|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
13936614|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13936615|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
13936616|NCT03326050|Rifampin|rifampin|mesh-list
13936617|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
13936618|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13936619|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13936620|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13936621|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13936622|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936623|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936624|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936625|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13936626|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13936627|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13936628|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
13936629|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
13936630|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13936631|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13936632|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13936633|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13936634|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13936635|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13936636|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13936637|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
13936638|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936639|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936640|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936641|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936642|NCT03325972|Analgesics|analgesics|mesh-ancestor
13936643|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
13936644|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936645|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13936646|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13936647|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936648|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936649|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961522|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
13936650|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936651|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13936652|NCT03325959|Analgesics|analgesics|mesh-ancestor
13936653|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
13936654|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936655|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936656|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13936657|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936658|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13936659|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13936660|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13936661|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936662|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
13936663|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
13936664|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
13936665|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13936666|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
13936667|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13936668|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936669|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13936670|NCT03325803|Lidocaine|lidocaine|mesh-list
13936671|NCT03325803|Prilocaine|prilocaine|mesh-list
13936672|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13936673|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936674|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
13936675|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936676|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936677|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
14115016|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
14115017|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
14115018|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14115019|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14115020|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115021|NCT05062356|Analgesics|analgesics|mesh-ancestor
14115022|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115023|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14115024|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13936678|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936679|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13936680|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13936681|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13936682|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13936683|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936684|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13936685|NCT03325790|Ebselen|ebselen|mesh-list
14115025|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762268|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
14762269|NCT02869217|Fludarabine|fludarabine|mesh-list
14762270|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762271|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
14762272|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762273|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762274|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762275|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
14762276|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936686|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13936687|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936688|NCT03325790|Analgesics|analgesics|mesh-ancestor
13936689|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
13936690|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936691|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936692|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936693|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13936694|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13936695|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13936696|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
13936697|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762277|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762278|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14767367|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14767368|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14477996|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13936698|NCT03325790|Protective Agents|protective agents|mesh-ancestor
13936699|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13936700|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936701|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13936702|NCT03325686|Vitamin D|vitamin d|mesh-list
13936703|NCT03325686|Vitamins|vitamins|mesh-ancestor
13936704|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
13936705|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936706|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13936707|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
13936708|NCT03325647|Testosterone|testosterone|mesh-list
13936709|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
13936710|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
13936711|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13936712|NCT03325647|Androgens|androgens|mesh-ancestor
13936713|NCT03325647|Hormones|hormones|mesh-ancestor
13936714|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936715|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936716|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936717|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936718|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
13936719|NCT03325491|Acipimox|acipimox|mesh-list
14762279|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
14762280|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14762281|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762282|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762283|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14762284|NCT02856594|Analgesics|analgesics|mesh-ancestor
14762285|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
14762286|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762287|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14936314|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936315|NCT01468415|Phenol|phenol|mesh-list
14115052|NCT05053425|Cytarabine|cytarabine|mesh-list
14115053|NCT05053425|Azacitidine|azacitidine|mesh-list
14115054|NCT05053425|Venetoclax|venetoclax|mesh-list
14115055|NCT05053425|Idarubicin|idarubicin|mesh-list
14115056|NCT05053425|Cladribine|cladribine|mesh-list
14115057|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14115058|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
14115059|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115060|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115061|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
13936720|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13936721|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
13936722|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936723|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13936724|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
14936316|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14936317|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936318|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
14936319|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14936320|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14936321|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14936322|NCT01468441|Cetrorelix|cetrorelix|mesh-list
13936725|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13936726|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936727|NCT03325413|Anesthetics|anesthetics|mesh-list
13936728|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936729|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936730|NCT03325400|Fluorides|fluorides|mesh-list
13936731|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
13936732|NCT03325400|Protective Agents|protective agents|mesh-ancestor
13936733|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936734|NCT03325348|Labetalol|labetalol|mesh-list
13936735|NCT03325348|Nifedipine|nifedipine|mesh-list
13936736|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14115062|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115063|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115064|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
13936737|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13936738|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936739|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14115065|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115066|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115067|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14115068|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13936740|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936741|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
13936742|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
13936743|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13936744|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13936745|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13936746|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936747|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936748|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13936749|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
13936750|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
14115069|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14115070|NCT05044871|Paclitaxel|paclitaxel|mesh-list
14115071|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14115072|NCT05044871|Bevacizumab|bevacizumab|mesh-list
14115073|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14115074|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115075|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
14115076|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
14115077|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
14115078|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115079|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115080|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14115081|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14115082|NCT05044871|Growth Substances|growth substances|mesh-ancestor
14115083|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115084|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
14115085|NCT05021562|Niraparib|niraparib|mesh-list
13936751|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936752|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13936753|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13936754|NCT03325335|Midazolam|midazolam|mesh-list
13936755|NCT03325335|Remifentanil|remifentanil|mesh-list
14115086|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14115087|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115088|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115089|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176105|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176106|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176107|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
14176108|NCT04767633|Analgesics|analgesics|mesh-ancestor
14176109|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
14176110|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176111|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176112|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
14176113|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176114|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14176115|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
14176116|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14176117|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176118|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176119|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14176120|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
14176121|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14176122|NCT04767243|Methamphetamine|methamphetamine|mesh-list
14176123|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14176124|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176125|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
14176126|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
14176127|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176128|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
14176129|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176130|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176131|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14477997|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
14477998|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14762288|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14762289|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14762290|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
14762291|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936756|NCT03325335|Propofol|propofol|mesh-list
13936757|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936758|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936759|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936760|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13936761|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
13936762|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
14762292|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762293|NCT02847559|Bevacizumab|bevacizumab|mesh-list
14762294|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14762295|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
14115090|NCT05015686|Vaccines|vaccines|mesh-list
13936763|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13936764|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13936765|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13936766|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13936767|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
13936768|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
13936769|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936770|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936771|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13936772|NCT03325335|Narcotics|narcotics|mesh-ancestor
13936773|NCT03325335|Analgesics|analgesics|mesh-ancestor
13936774|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
13936775|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961523|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961524|NCT03146962|Protective Agents|protective agents|mesh-ancestor
14115091|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
14115092|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115093|NCT05005260|Bupivacaine|bupivacaine|mesh-list
14115094|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
14115095|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
14115096|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961525|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
13961526|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
13961527|NCT03147066|Dezocine|dezocine|mesh-list
13961528|NCT03147066|Analgesics|analgesics|mesh-ancestor
13961529|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
13961530|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115097|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115098|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
14115099|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115100|NCT04996199|Zileuton|zileuton|mesh-list
14115101|NCT04996199|Carbamazepine|carbamazepine|mesh-list
13961531|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961532|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13961533|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13961534|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13961535|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14115102|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
14115103|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
14115104|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
14115105|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14115106|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115107|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115108|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14115109|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115110|NCT04996199|Analgesics|analgesics|mesh-ancestor
14762296|NCT02847559|Antibodies|antibodies|mesh-list
14762297|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
14762298|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14762299|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
14762300|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762301|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14762302|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14762303|NCT02847559|Growth Substances|growth substances|mesh-ancestor
14762304|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762305|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
14762306|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
14762307|NCT02823574|Nivolumab|nivolumab|mesh-list
14762308|NCT02823574|Ipilimumab|ipilimumab|mesh-list
14762309|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961536|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14115111|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
14115112|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115113|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14115114|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14762310|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115115|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115116|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14115117|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14115118|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14115119|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14115120|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115121|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14115122|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14115123|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115124|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14115125|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
14115126|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115127|NCT04990284|Levodopa|levodopa|mesh-list
14115128|NCT04990284|Opicapone|opicapone|mesh-list
14115129|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14115130|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14115131|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
14115132|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14115133|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14477999|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
14478000|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
14478001|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14478002|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478003|NCT02443402|Incretins|incretins|mesh-ancestor
14478004|NCT02443402|Hormones|hormones|mesh-ancestor
14478005|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478006|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14478007|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
14478008|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936776|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
13936777|NCT03325270|Trace Elements|trace elements|mesh-ancestor
13936778|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
13936779|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936780|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
13936781|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13936782|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13936783|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936784|NCT03325166|Hematinics|hematinics|mesh-ancestor
13936785|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13936786|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13936787|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13936788|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936789|NCT03324984|Bupivacaine|bupivacaine|mesh-list
13936790|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
13936791|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936792|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
13936793|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936794|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936795|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
13936796|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936797|NCT03324867|Insulin|insulin|mesh-list
13936798|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13936799|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13936800|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478009|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478010|NCT02443883|Ramucirumab|ramucirumab|mesh-list
14478011|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478012|NCT02444143|Tacrolimus|tacrolimus|mesh-list
14478013|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115134|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115135|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14115136|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115137|NCT04988971|Corticosterone|corticosterone|mesh-list
14115138|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
14115139|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115140|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14115141|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
14115142|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
14115143|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115144|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115145|NCT04984733|Nivolumab|nivolumab|mesh-list
14478014|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
13936801|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
13936802|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
13936803|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
14115146|NCT04984733|Temozolomide|temozolomide|mesh-list
14115147|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115148|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115149|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14115150|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115151|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14115152|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
14115153|NCT04973826|Aztreonam|aztreonam|mesh-list
14115154|NCT04973826|Avibactam|avibactam|mesh-list
14115155|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14115156|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115157|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14115158|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936804|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13936805|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
13936806|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
13936807|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936808|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936809|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936810|NCT03324815|Morphine|morphine|mesh-list
13936811|NCT03324815|Methadone|methadone|mesh-list
13936812|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13936813|NCT03324815|Narcotics|narcotics|mesh-ancestor
13936814|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115159|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936815|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936816|NCT03324815|Analgesics|analgesics|mesh-ancestor
13936817|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
13936818|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936819|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
13936820|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
13936821|NCT03324776|Insulin|insulin|mesh-list
13936822|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13936823|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14115164|NCT04940637|Niraparib|niraparib|mesh-list
14115165|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14115166|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115167|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115168|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115169|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
14115170|NCT04926454|Bupivacaine|bupivacaine|mesh-list
14115171|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
14115172|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
14115173|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115174|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115175|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
14115176|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115177|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14115178|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115179|NCT04926454|Analgesics|analgesics|mesh-ancestor
13936824|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936825|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
13936826|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13936827|NCT03324685|Estradiol|estradiol|mesh-list
13936828|NCT03324685|Estrogens|estrogens|mesh-ancestor
13936829|NCT03324685|Hormones|hormones|mesh-ancestor
13936830|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936831|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936832|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13936833|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
13936834|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13936835|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13936836|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13936837|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13936838|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14115180|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14115181|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14115182|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14115183|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
14115184|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936839|NCT03324542|Ranibizumab|ranibizumab|mesh-list
13936840|NCT03324542|Aflibercept|aflibercept|mesh-list
14115185|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115186|NCT04925427|Naloxone|naloxone|mesh-list
14115187|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14115188|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115189|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
13936841|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936842|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13936843|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13936844|NCT03324542|Growth Substances|growth substances|mesh-ancestor
13936845|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936846|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
14115190|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115191|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
14115192|NCT04913025|Nivolumab|nivolumab|mesh-list
14115193|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115194|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115195|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14115196|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115197|NCT04905654|Cromakalim|cromakalim|mesh-list
14115198|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14115199|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14115200|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
14115201|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115202|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115203|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14115204|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
14115205|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
14115206|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
14115207|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14115208|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14115209|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14115210|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
14115211|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115212|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14115213|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14115214|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936323|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
14936324|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14936325|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
13936847|NCT03324503|Prednisone|prednisone|mesh-list
13936848|NCT03324503|Prednisolone|prednisolone|mesh-list
13936849|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13936850|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
13936851|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13936852|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
13936853|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13936854|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
13936855|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
13936856|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936857|NCT03324503|Hormones|hormones|mesh-ancestor
13936858|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936859|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936860|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936861|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936862|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
13936863|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
13936864|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936865|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13936866|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13936867|NCT03324503|Protective Agents|protective agents|mesh-ancestor
13936868|NCT03324490|Fentanyl|fentanyl|mesh-list
13936869|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
13936870|NCT03324490|Bupivacaine|bupivacaine|mesh-list
14762311|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14762312|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762313|NCT02807636|Gemcitabine|gemcitabine|mesh-list
14762314|NCT02807636|Carboplatin|carboplatin|mesh-list
14762315|NCT02807636|Atezolizumab|atezolizumab|mesh-list
14762316|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762317|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14762318|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
14762319|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762320|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
13936871|NCT03324490|Anesthetics|anesthetics|mesh-list
14115215|NCT04824131|Tenofovir|tenofovir|mesh-list
14115216|NCT04824131|Emtricitabine|emtricitabine|mesh-list
14115217|NCT04824131|Cabotegravir|cabotegravir|mesh-list
14115218|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
14115219|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115220|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14115221|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14115222|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115223|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115224|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14115225|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14115226|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14115227|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14115228|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14115229|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14115230|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14115231|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115232|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115233|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14115234|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14115235|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115236|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
14115237|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14115238|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
14115239|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936872|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936873|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936874|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936875|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
13936876|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936877|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13936878|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13936879|NCT03324490|Analgesics|analgesics|mesh-ancestor
13936880|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13936881|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14115240|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115241|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115242|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115243|NCT04798482|Analgesics|analgesics|mesh-ancestor
14115244|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
14115245|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115246|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14115247|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14115248|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936882|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936883|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936884|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936885|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936886|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13936887|NCT03324490|Narcotics|narcotics|mesh-ancestor
13936888|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13936889|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14936326|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14936327|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936328|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14936329|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936890|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
13936891|NCT03324425|Simvastatin|simvastatin|mesh-list
13936892|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13936893|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13936894|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
13936895|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936896|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13936897|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13936898|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936899|NCT03324334|Antibodies|antibodies|mesh-list
13936900|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
13936901|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936902|NCT03324282|Avelumab|avelumab|mesh-list
13936903|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115249|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
14115250|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936904|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936905|NCT03324243|Cytarabine|cytarabine|mesh-list
13936906|NCT03324243|Fludarabine|fludarabine|mesh-list
13936907|NCT03324243|Crenolanib|crenolanib|mesh-list
13936908|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936909|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13936910|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
13936911|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936912|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13936913|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
13936914|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936915|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
13936916|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13936917|NCT03324139|Heparin|heparin|mesh-list
13936918|NCT03324139|Calcium heparin|calcium heparin|mesh-list
13936919|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13936920|NCT03324139|Tinzaparin|tinzaparin|mesh-list
14115251|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936330|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936331|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14936332|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
14115252|NCT04797312|Sufentanil|sufentanil|mesh-list
14115253|NCT04797312|Remifentanil|remifentanil|mesh-list
14115254|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
14115255|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
14115256|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115257|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115258|NCT04797312|Narcotics|narcotics|mesh-ancestor
14115259|NCT04797312|Analgesics|analgesics|mesh-ancestor
14115260|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
14115261|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115262|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14115263|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14115264|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
14115265|NCT04771156|Ketorolac|ketorolac|mesh-list
14115266|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14936333|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
14936334|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936335|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
14936336|NCT01468480|Calcium|calcium|mesh-list
14936337|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14115267|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115268|NCT04771156|Analgesics|analgesics|mesh-ancestor
14115269|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
14115270|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115271|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115272|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115273|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14115274|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14115275|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115276|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115277|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14115278|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14115279|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
14115280|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14115281|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
14115282|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115283|NCT04735263|Atorvastatin|atorvastatin|mesh-list
14115284|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14115285|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14115286|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
14115287|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115288|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14115289|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14115290|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115291|NCT04734886|Vitamin D|vitamin d|mesh-list
14115292|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
14115293|NCT04734886|Vitamins|vitamins|mesh-list
14115294|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
14115295|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115296|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14115297|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14936338|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936921|NCT03324139|Dalteparin|dalteparin|mesh-list
13936922|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
13936923|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13936924|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13936925|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936926|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
13936927|NCT03324113|Promethazine|promethazine|mesh-list
13936928|NCT03324113|Dexamethasone|dexamethasone|mesh-list
13936929|NCT03324113|Naphazoline|naphazoline|mesh-list
13936930|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14115298|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
14115299|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14176132|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14176133|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14176134|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176135|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14176136|NCT04767295|Paclitaxel|paclitaxel|mesh-list
14176137|NCT04767295|Carboplatin|carboplatin|mesh-list
14176138|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176139|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176140|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176141|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176142|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176143|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176144|NCT04767217|Lumefantrine|lumefantrine|mesh-list
14176145|NCT04767217|Artemether|artemether|mesh-list
14176146|NCT04767217|Piperaquine|piperaquine|mesh-list
14176147|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14176148|NCT04767217|Artenimol|artenimol|mesh-list
14176149|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
14176150|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14176151|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14176152|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176153|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
14176154|NCT04767308|Fludarabine|fludarabine|mesh-list
14176155|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176156|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
14176157|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176158|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176159|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14176160|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
14176161|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176162|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176163|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14176164|NCT04767178|Acetaminophen|acetaminophen|mesh-list
14176165|NCT04767178|Ibuprofen|ibuprofen|mesh-list
14176166|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14176167|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14762321|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762322|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762323|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176168|NCT04767178|Analgesics|analgesics|mesh-ancestor
14176169|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
14176170|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176171|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176172|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14176173|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176174|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14176175|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176176|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176177|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
13936931|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936932|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
13936933|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
13936934|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936935|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936936|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13936937|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
13936938|NCT03324113|Hormones|hormones|mesh-ancestor
14176178|NCT04767542|Acetaminophen|acetaminophen|mesh-list
14176179|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176180|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14176181|NCT04767542|Analgesics|analgesics|mesh-ancestor
14176182|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
14762324|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
14762325|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762326|NCT02799134|Ascorbic Acid|ascorbic acid|mesh-list
14762327|NCT02799134|Dexamethasone|dexamethasone|mesh-list
13961537|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176183|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762328|NCT02799134|Vitamins|vitamins|mesh-ancestor
13936939|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936940|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936941|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936942|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13936943|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13936944|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14115300|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14115301|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14115302|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14115303|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115304|NCT04664959|Denosumab|denosumab|mesh-list
14115305|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14115306|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115307|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
14115308|NCT04662723|Empagliflozin|empagliflozin|mesh-list
14115309|NCT04662723|Canagliflozin|canagliflozin|mesh-list
14115310|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14115311|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
14115312|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14115313|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14115314|NCT04662723|Prednisolone|prednisolone|mesh-list
13936945|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13936946|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
13936947|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
13936948|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
13936949|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13936950|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
13936951|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
13936952|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936953|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936954|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13936955|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
13936956|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
13936957|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13936958|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13936959|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936960|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
13936961|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13936962|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
14115315|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
14115316|NCT04662723|Losartan|losartan|mesh-list
14115317|NCT04662723|Ramipril|ramipril|mesh-list
14115318|NCT04662723|Lisinopril|lisinopril|mesh-list
14115319|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14115320|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
14115321|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115322|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
14115323|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
14115324|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115325|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115326|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14115327|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
14115328|NCT04662723|Hormones|hormones|mesh-ancestor
14115329|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115330|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14115331|NCT04662723|Protective Agents|protective agents|mesh-ancestor
14115332|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14115333|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115334|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115335|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14115336|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14115337|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13936963|NCT03324061|Fulvestrant|fulvestrant|mesh-list
13936964|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13936965|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936966|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13936967|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13936968|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
13936969|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936970|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936971|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
14115338|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14115339|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14115340|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14115341|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
14115342|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115343|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14115344|NCT04654429|Ondansetron|ondansetron|mesh-list
14115345|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
14115346|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
14115347|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115348|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115349|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14115350|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
14115351|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
14115352|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14115353|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
14115354|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13936972|NCT03323866|Budesonide|budesonide|mesh-list
13936973|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13936974|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13936975|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
13936976|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13936977|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936978|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13936979|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
13936980|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
13936981|NCT03323866|Hormones|hormones|mesh-ancestor
13936982|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13936983|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
13936984|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13936985|NCT03323710|Sunitinib|sunitinib|mesh-list
13936986|NCT03323710|Propranolol|propranolol|mesh-list
13936987|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13936988|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13936989|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13936990|NCT03323710|Growth Substances|growth substances|mesh-ancestor
13936991|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13936992|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
13936993|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13936994|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13936995|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13936996|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13936997|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13936998|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
13936999|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937000|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937001|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13937002|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
13937003|NCT03323697|Citalopram|citalopram|mesh-list
13937004|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13937005|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13937006|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937007|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937008|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937009|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
13937010|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937011|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13937012|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
13937013|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13961538|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961539|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13961540|NCT03147066|Narcotics|narcotics|mesh-ancestor
13961541|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961542|NCT03147092|Losartan|losartan|mesh-list
13961543|NCT03147092|Atenolol|atenolol|mesh-list
13961544|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13961545|NCT03147092|Clonidine|clonidine|mesh-list
13961546|NCT03147092|Captopril|captopril|mesh-list
13961547|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13961548|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13961549|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13961550|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14762329|NCT02799134|Micronutrients|micronutrients|mesh-ancestor
13961551|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961552|NCT03147092|Diuretics|diuretics|mesh-ancestor
14115355|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115356|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14115357|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14115358|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115359|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14115360|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14115361|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
14115362|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14115363|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14115364|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115365|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
13937014|NCT03323684|Acetaminophen|acetaminophen|mesh-list
13937015|NCT03323684|Ketorolac|ketorolac|mesh-list
13937016|NCT03323684|Fentanyl|fentanyl|mesh-list
13937017|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13937018|NCT03323684|Narcotics|narcotics|mesh-ancestor
13937019|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937020|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937021|NCT03323684|Analgesics|analgesics|mesh-ancestor
13937022|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
13937023|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937024|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13937025|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13937026|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
13937027|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
13937028|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937029|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
13937030|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13937031|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115366|NCT04650698|Coagulants|coagulants|mesh-ancestor
14115367|NCT04593563|Psilocybin|psilocybin|mesh-list
14115368|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
14115369|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115370|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14115371|NCT04554836|Cetuximab|cetuximab|mesh-list
14115372|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115373|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115374|NCT04551911|Calcifediol|calcifediol|mesh-list
14115375|NCT04551911|Vitamins|vitamins|mesh-ancestor
14115376|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
14115377|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115378|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14115379|NCT04536272|Heparin|heparin|mesh-list
14115380|NCT04536272|Calcium heparin|calcium heparin|mesh-list
13937032|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937033|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13937034|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937035|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937036|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
13937037|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14115381|NCT04536272|Enoxaparin|enoxaparin|mesh-list
14115382|NCT04536272|Nadroparin|nadroparin|mesh-list
14115383|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
14115384|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14115385|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14115386|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115387|NCT04533880|Calcium|calcium|mesh-list
14115388|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937038|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937039|NCT03323671|Analgesics|analgesics|mesh-ancestor
13937040|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
13937041|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937042|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937043|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937044|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937045|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13937046|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937047|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937048|NCT03323619|Anesthetics|anesthetics|mesh-list
13937049|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937050|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937051|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
13937052|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13937053|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115389|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937054|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115390|NCT04529460|Antibodies|antibodies|mesh-list
14115391|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
14176184|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
13937055|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937056|NCT03323593|Analgesics|analgesics|mesh-ancestor
13937057|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
13937058|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937059|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13937060|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13937061|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13937062|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
13937063|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937064|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937065|NCT03323567|Lidocaine|lidocaine|mesh-list
13937066|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13937067|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937068|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
13937069|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937070|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937071|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
13937072|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937073|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937074|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13937075|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13937076|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937077|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937078|NCT03323541|Lenograstim|lenograstim|mesh-list
13937079|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13937080|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
13937081|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937082|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
13937083|NCT03323528|Benzocaine|benzocaine|mesh-list
13937084|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937085|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
13937086|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937087|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937088|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
13937089|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937090|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13937091|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937092|NCT03323437|Risperidone|risperidone|mesh-list
13937093|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13937094|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
13937095|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937096|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937097|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937098|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13937099|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13937100|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115392|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115393|NCT04478721|Meropenem|meropenem|mesh-list
14115394|NCT04478721|Temocillin|temocillin|mesh-list
14115395|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14115396|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115397|NCT04428203|Cannabidiol|cannabidiol|mesh-list
14115398|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
14115399|NCT04427956|Riboflavin|riboflavin|mesh-list
14115400|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
14115401|NCT04427956|Vitamins|vitamins|mesh-ancestor
14115402|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
14115403|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115404|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14115405|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
14115406|NCT04417062|Olaparib|olaparib|mesh-list
14115407|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14115408|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115409|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115410|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115411|NCT04397107|Aldesleukin|aldesleukin|mesh-list
14115412|NCT04397107|Interleukin-2|interleukin-2|mesh-list
14115413|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115414|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937101|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13937102|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13937103|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
14115415|NCT04397107|Analgesics|analgesics|mesh-ancestor
14115416|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
13937104|NCT03323385|Meloxicam|meloxicam|mesh-list
13937105|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14115417|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115418|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115419|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14115420|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14115421|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
14115422|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115423|NCT04387942|Aldesleukin|aldesleukin|mesh-list
14115424|NCT04387942|Interleukin-2|interleukin-2|mesh-list
14115425|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115426|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115427|NCT04387942|Analgesics|analgesics|mesh-ancestor
14115428|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
14115429|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115430|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937106|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937107|NCT03323385|Analgesics|analgesics|mesh-ancestor
13937108|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
13937109|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937110|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115431|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14115432|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14115433|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
14115434|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115435|NCT04386317|Terazosin|terazosin|mesh-list
14115436|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14115437|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14115438|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14115439|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
14115440|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14115441|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115442|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115443|NCT04386317|Urological Agents|urological agents|mesh-ancestor
14478015|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478016|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14478017|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115444|NCT04380142|Levodopa|levodopa|mesh-list
14115445|NCT04380142|Carbidopa|carbidopa|mesh-list
14115446|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14115447|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14478018|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937111|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937112|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937113|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13937114|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13937115|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937116|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936339|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14936340|NCT01468519|Insulin|insulin|mesh-list
14936341|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13937117|NCT03323372|Listerine|listerine|mesh-list
13937118|NCT03323372|Fluorides|fluorides|mesh-list
13937119|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
13937120|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
13937121|NCT03323372|Protective Agents|protective agents|mesh-ancestor
13937122|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937123|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13937124|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937125|NCT03323346|Disulfiram|disulfiram|mesh-list
13937126|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14936342|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936343|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936344|NCT01468545|Iloprost|iloprost|mesh-list
14936345|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14936346|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
13937127|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
13937128|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937129|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937130|NCT03323047|Acetaminophen|acetaminophen|mesh-list
14115448|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
14478019|NCT02444234|Tedizolid|tedizolid|mesh-list
14115449|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937131|NCT03323047|Dexamethasone|dexamethasone|mesh-list
14115450|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115451|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115452|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14115453|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176185|NCT04766853|Dexamethasone|dexamethasone|mesh-list
14176186|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
14176187|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14176188|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
14176189|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
14176190|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176191|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176192|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14176193|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
14176194|NCT04766853|Hormones|hormones|mesh-ancestor
14176195|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14176196|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14176197|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176198|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14176199|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
14176200|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
14176201|NCT04766853|Protective Agents|protective agents|mesh-ancestor
14176202|NCT04767035|Midazolam|midazolam|mesh-list
14176203|NCT04767035|Ketamine|ketamine|mesh-list
14176204|NCT04767035|Analgesics|analgesics|mesh-ancestor
14176205|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
14176206|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176207|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176208|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14176209|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13937132|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
13937133|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13937134|NCT03323047|BB 1101|bb 1101|mesh-list
13937135|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937136|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
13937137|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
13937138|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937139|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937140|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937141|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
14176210|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
14176211|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
14176212|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176213|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14176214|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14176215|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937142|NCT03323047|Hormones|hormones|mesh-ancestor
13937143|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937144|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13937145|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937146|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
13937147|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937148|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937149|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937150|NCT03323047|Analgesics|analgesics|mesh-ancestor
13937151|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
13937152|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
13937153|NCT03322995|Fluorouracil|fluorouracil|mesh-list
13937154|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
13937155|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937156|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176216|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176217|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14176218|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14176219|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14176220|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14176221|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14176222|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
14176223|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
14176224|NCT04766827|Paclitaxel|paclitaxel|mesh-list
14176225|NCT04766827|Docetaxel|docetaxel|mesh-list
14176226|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14176227|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13937157|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176228|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176229|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176230|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176231|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
14115454|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13937158|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937159|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
13937160|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937161|NCT03322969|Paclitaxel|paclitaxel|mesh-list
13937162|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13937163|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937164|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
13937165|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
13937166|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
14115455|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
14115456|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115457|NCT04278573|Vitamin D|vitamin d|mesh-list
14115458|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
14115459|NCT04278573|Vitamins|vitamins|mesh-ancestor
14115460|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
14115461|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115462|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14115463|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14115464|NCT04273737|Amantadine|amantadine|mesh-list
14115465|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14115466|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14115467|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
14115468|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115469|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
14115470|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936347|NCT01468571|Spironolactone|spironolactone|mesh-list
13937167|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937168|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
13937169|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
13937170|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115471|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115472|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115473|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115474|NCT04273737|Analgesics|analgesics|mesh-ancestor
14115475|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
14115476|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115477|NCT04266795|Azacitidine|azacitidine|mesh-list
14115478|NCT04266795|Venetoclax|venetoclax|mesh-list
14115479|NCT04266795|Pevonedistat|pevonedistat|mesh-list
14115480|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14115481|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
14115482|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115483|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115484|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115485|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
14115486|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115487|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115488|NCT04259944|Capecitabine|capecitabine|mesh-list
14115489|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14115490|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
14115491|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115492|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115493|NCT04217278|Cytarabine|cytarabine|mesh-list
14115494|NCT04217278|Fludarabine|fludarabine|mesh-list
14115495|NCT04217278|Busulfan|busulfan|mesh-list
14115496|NCT04217278|Thiotepa|thiotepa|mesh-list
14115497|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115498|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14115499|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
14115500|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936348|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14936349|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
14936350|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936351|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936352|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14936353|NCT01468571|Diuretics|diuretics|mesh-ancestor
14936354|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
14936355|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14936356|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14936357|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14936358|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937171|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115501|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115502|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
14115503|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115504|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
14115505|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936359|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936360|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936361|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936362|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
14936363|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14936364|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
13937172|NCT03322878|Analgesics|analgesics|mesh-ancestor
13937173|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
13937174|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937175|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937176|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
13937177|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13937178|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937179|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937180|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937181|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
13937182|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13937183|NCT03322800|Ziresovir|ziresovir|mesh-list
14115506|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
14115507|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14115508|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14115509|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14115510|NCT04205266|Hematinics|hematinics|mesh-ancestor
14115511|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14115512|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14115513|NCT04202263|Minocycline|minocycline|mesh-list
14115514|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936365|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936366|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14936367|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936368|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936369|NCT01468714|Ketoconazole|ketoconazole|mesh-list
14936370|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
14936371|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115515|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115516|NCT04192955|Salicylates|salicylates|mesh-list
14115517|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14115518|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115519|NCT04192955|Analgesics|analgesics|mesh-ancestor
14115520|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
14115521|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115522|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115523|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115524|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762330|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762331|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762332|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
14762333|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
14762334|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762335|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762336|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
14936372|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14936373|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14936374|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936375|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936376|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14478020|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
14762337|NCT02799134|Hormones|hormones|mesh-ancestor
14762338|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762339|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762340|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478021|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14478022|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478023|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14478024|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478025|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478026|NCT02444533|Bupivacaine|bupivacaine|mesh-list
14478027|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
14478028|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
14115525|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14115526|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115527|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115528|NCT04170517|Progesterone|progesterone|mesh-list
14115529|NCT04170517|Progestins|progestins|mesh-ancestor
14115530|NCT04170517|Hormones|hormones|mesh-ancestor
14115531|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115532|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936377|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
13937184|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
13937185|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937186|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
13937187|NCT03322735|Fludarabine|fludarabine|mesh-list
13937188|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115533|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
14115534|NCT04162756|Fludarabine|fludarabine|mesh-list
14115535|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115536|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
14115537|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115538|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937189|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
13937190|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937191|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937192|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13937193|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
13937194|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937195|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937196|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13937197|NCT03322631|Tirzepatide|tirzepatide|mesh-list
13937198|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13937199|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937200|NCT03322631|Incretins|incretins|mesh-ancestor
13937201|NCT03322631|Hormones|hormones|mesh-ancestor
13937202|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937203|NCT03322488|Metronidazole|metronidazole|mesh-list
13937204|NCT03322488|Doxycycline|doxycycline|mesh-list
13937205|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
13937206|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937207|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13937208|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13937209|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13937210|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
13937211|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13937212|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13937213|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937214|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937215|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937216|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13937217|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13937218|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
13937219|NCT03322358|Promethazine|promethazine|mesh-list
13937220|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13937221|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13937222|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937223|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937224|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937225|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
13937226|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
13937227|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115539|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14115540|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
14115541|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115542|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115543|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14115544|NCT04156581|Dexamethasone|dexamethasone|mesh-list
14115545|NCT04156581|Bupivacaine|bupivacaine|mesh-list
14115546|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115547|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
14115548|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
14115549|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115550|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115551|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14115552|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
13937228|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
13937229|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
14115553|NCT04156581|Hormones|hormones|mesh-ancestor
14115554|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115555|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14115556|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115557|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
14115558|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
14115559|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115560|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
14115561|NCT04153136|Valsartan|valsartan|mesh-list
14115562|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14115563|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14115564|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14115565|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14115566|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115567|NCT04149990|Valsartan|valsartan|mesh-list
14115568|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14115569|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14115570|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14115571|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115572|NCT04149964|Acetaminophen|acetaminophen|mesh-list
14115573|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14115574|NCT04149964|Oxycodone|oxycodone|mesh-list
14115575|NCT04149964|Hydrocodone|hydrocodone|mesh-list
14115576|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14115577|NCT04149964|Analgesics|analgesics|mesh-ancestor
14115578|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
14115579|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115580|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115581|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
13937230|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937231|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13937232|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
13937233|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
13937234|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937235|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937236|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13937237|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
13937238|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
13937239|NCT03322267|Cisplatin|cisplatin|mesh-list
13937240|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
14115582|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14115583|NCT04149964|Narcotics|narcotics|mesh-ancestor
14115584|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115585|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
13937241|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937242|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13937243|NCT03322150|Atropine|atropine|mesh-list
13937244|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
13937245|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13937246|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937247|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13937248|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
14115586|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
14115587|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14115588|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115589|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14115590|NCT04123379|Nivolumab|nivolumab|mesh-list
14115591|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115592|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115593|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14115594|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115595|NCT04066491|Gemcitabine|gemcitabine|mesh-list
14115596|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115597|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14115598|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
14762341|NCT02799134|Antioxidants|antioxidants|mesh-ancestor
14762342|NCT02799134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762343|NCT02799134|Protective Agents|protective agents|mesh-ancestor
14762344|NCT02792413|Denosumab|denosumab|mesh-list
14762345|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14762346|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762347|NCT02773212|Amphetamine|amphetamine|mesh-list
13937249|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937250|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115599|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937251|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13937252|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
13937253|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
13937254|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
13937255|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13937256|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13937257|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
13937258|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937259|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937260|NCT03322124|Octenidine|octenidine|mesh-list
13937261|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937262|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13937263|NCT03322098|Atropine|atropine|mesh-list
13937264|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
13937265|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13937266|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937267|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13937268|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
13937269|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937270|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115600|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
14115601|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115602|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762348|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
14762349|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14762350|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762351|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
14762352|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
13937271|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13937272|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
13937273|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
13937274|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
13937275|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14115603|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14936378|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762353|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762354|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
14115604|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
14115605|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115606|NCT04037605|Ketoconazole|ketoconazole|mesh-list
14115607|NCT04037605|Dexamethasone|dexamethasone|mesh-list
14115608|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
14115609|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
14115610|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14115611|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14115612|NCT04037605|Hormones|hormones|mesh-list
14115613|NCT04037605|Cosyntropin|cosyntropin|mesh-list
14115614|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14115615|NCT04037605|BB 1101|bb 1101|mesh-list
14115616|NCT04037605|Ganirelix|ganirelix|mesh-list
14115617|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115618|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
14115619|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
14115620|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115621|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115622|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14115623|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
14115624|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115625|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14115626|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115627|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
14115628|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762355|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937276|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13937277|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
14115629|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115630|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
14115631|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115632|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14115633|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14115634|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14115635|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
14115636|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14115637|NCT04022967|Ritonavir|ritonavir|mesh-list
14115638|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14115639|NCT04022967|Tenofovir|tenofovir|mesh-list
14115640|NCT04022967|Lamivudine|lamivudine|mesh-list
14115641|NCT04022967|Dolutegravir|dolutegravir|mesh-list
14115642|NCT04022967|Efavirenz|efavirenz|mesh-list
14115643|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14115644|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14936379|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936380|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14936381|NCT01468740|Prednisone|prednisone|mesh-list
14936382|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
14936383|NCT01468740|Dacarbazine|dacarbazine|mesh-list
13937278|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937279|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961553|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
13961554|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961555|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13961556|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13961557|NCT03147092|Analgesics|analgesics|mesh-ancestor
13961558|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
13961559|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961560|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
13961561|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
13961562|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13961563|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13961564|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13961565|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
13961566|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961567|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13961568|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13961569|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13961570|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13961571|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
13961572|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963470|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963471|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963472|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13963473|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963474|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13963475|NCT03144401|Misoprostol|misoprostol|mesh-list
13963476|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13963477|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
14115645|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
14115646|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936384|NCT01468740|Doxorubicin|doxorubicin|mesh-list
14936385|NCT01468740|Etoposide|etoposide|mesh-list
14115647|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115648|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14115649|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14115650|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
14115651|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115652|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14115653|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14115654|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14115655|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14115656|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14115657|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14115658|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14115659|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14115660|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14115661|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13937280|NCT03321981|Trastuzumab|trastuzumab|mesh-list
13937281|NCT03321981|Letrozole|letrozole|mesh-list
13937282|NCT03321981|Vinorelbine|vinorelbine|mesh-list
13937283|NCT03321981|Fulvestrant|fulvestrant|mesh-list
13937284|NCT03321981|Exemestane|exemestane|mesh-list
13937285|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13937286|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936386|NCT01468740|Vincristine|vincristine|mesh-list
14936387|NCT01468740|Bleomycin|bleomycin|mesh-list
13937287|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13937288|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13937289|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937290|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937291|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13937292|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
13937293|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937294|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937295|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13937296|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
13937297|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
13937298|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
13937299|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13937300|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13937301|NCT03321955|Ziconotide|ziconotide|mesh-list
13937302|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13937303|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937304|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937305|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937306|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937307|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13937308|NCT03321955|Protective Agents|protective agents|mesh-ancestor
13937309|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937310|NCT03321955|Analgesics|analgesics|mesh-ancestor
13937311|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
14115662|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14115663|NCT04006210|Levodopa|levodopa|mesh-list
14115664|NCT04006210|Carbidopa|carbidopa|mesh-list
14115665|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14115666|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14115667|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
14115668|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14115669|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115670|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115671|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14115672|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115673|NCT03995004|Dexamethasone|dexamethasone|mesh-list
14115674|NCT03995004|Melatonin|melatonin|mesh-list
14115675|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
14115676|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115677|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
14115678|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
14115679|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115680|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115681|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14115682|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
14115683|NCT03995004|Hormones|hormones|mesh-ancestor
13937312|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183699|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936388|NCT01468740|Vinblastine|vinblastine|mesh-list
13937313|NCT03321903|Charcoal|charcoal|mesh-list
13937314|NCT03321903|Antidotes|antidotes|mesh-ancestor
13937315|NCT03321903|Protective Agents|protective agents|mesh-ancestor
13937316|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937317|NCT03321890|Prednisone|prednisone|mesh-list
13937318|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
13937319|NCT03321890|Methotrexate|methotrexate|mesh-list
13937320|NCT03321890|Etoposide|etoposide|mesh-list
14115684|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115685|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14115686|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115687|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
14115688|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115689|NCT03995004|Protective Agents|protective agents|mesh-ancestor
14115690|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937321|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937322|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
13937323|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115691|NCT03995004|Cathartics|cathartics|mesh-ancestor
14115692|NCT03971474|Gemcitabine|gemcitabine|mesh-list
14115693|NCT03971474|Docetaxel|docetaxel|mesh-list
14115694|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
14115695|NCT03971474|Pemetrexed|pemetrexed|mesh-list
14115696|NCT03971474|Ramucirumab|ramucirumab|mesh-list
14115697|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14115698|NCT03971474|Antibodies|antibodies|mesh-list
14115699|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
14115700|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14115701|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
14115702|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115703|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13937324|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937325|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13937326|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
13937327|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937328|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937329|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13937330|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937331|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
13937332|NCT03321890|Hormones|hormones|mesh-ancestor
13937333|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937334|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13937335|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13937336|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
13937337|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13937338|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13937339|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
13937340|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
13937341|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937342|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13937343|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13937344|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13937345|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13937346|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13937347|NCT03321825|Lidocaine|lidocaine|mesh-list
13937348|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
13937349|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937350|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
13937351|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937352|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937353|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
13937354|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115704|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
14115705|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115706|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115707|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
14115708|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115709|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115710|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115711|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
14115712|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
14115713|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
14115714|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13937355|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14115715|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14115716|NCT03970655|Dexamethasone|dexamethasone|mesh-list
13937356|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13937357|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13937358|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14115717|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
14115718|NCT03970655|Epinephrine|epinephrine|mesh-list
14115719|NCT03970655|Racepinephrine|racepinephrine|mesh-list
14115720|NCT03970655|Bupivacaine|bupivacaine|mesh-list
14115721|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
14115722|NCT03970655|BB 1101|bb 1101|mesh-list
14115723|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14115724|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
14115725|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
14115726|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115727|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115728|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14115729|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
14115730|NCT03970655|Hormones|hormones|mesh-ancestor
14115731|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115732|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14115733|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115734|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
14115735|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115736|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115737|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
14115738|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
14115739|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115740|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
14115741|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14115742|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14115743|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14115744|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14115745|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14115746|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14115747|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14115748|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
14115749|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
14115750|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
13937359|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937360|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13937361|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
13937362|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
13937363|NCT03321825|Protective Agents|protective agents|mesh-ancestor
13937364|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
13937365|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13937366|NCT03321773|Amoxicillin|amoxicillin|mesh-list
13937367|NCT03321773|Metronidazole|metronidazole|mesh-list
13937368|NCT03321773|Clarithromycin|clarithromycin|mesh-list
13937369|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
13937370|NCT03321773|Pantoprazole|pantoprazole|mesh-list
13937371|NCT03321773|Bismuth|bismuth|mesh-list
13937372|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13937373|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937374|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13937375|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14115751|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14115784|NCT03968562|Doxycycline|doxycycline|mesh-list
14115785|NCT03968562|Petrolatum|petrolatum|mesh-list
14115786|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14115787|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115788|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
14767369|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14115789|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14115790|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14115791|NCT03968562|Emollients|emollients|mesh-ancestor
14115792|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
14115793|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
14115794|NCT03939026|Fludarabine|fludarabine|mesh-list
14115795|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115796|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
14115797|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115798|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937376|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13937377|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937378|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937379|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13937380|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13937381|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13937382|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937383|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13937384|NCT03321773|Antacids|antacids|mesh-ancestor
13937385|NCT03321734|Caffeine|caffeine|mesh-list
13937386|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14115799|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14115800|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
14115801|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115802|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115803|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14115804|NCT03934541|Vaccines|vaccines|mesh-list
14115805|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
14115806|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176232|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762356|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762357|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
13937387|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937388|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13937389|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937390|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937391|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13937392|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13937393|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
13937394|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937395|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
13937396|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
13937397|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937398|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937399|NCT03321318|Vitamins|vitamins|mesh-ancestor
13937400|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
13937401|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13937402|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13937403|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13937404|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
13937405|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937406|NCT03321292|Aspirin|aspirin|mesh-list
13937407|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13937408|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937409|NCT03321292|Analgesics|analgesics|mesh-ancestor
13937410|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
13937411|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937412|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937413|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937414|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937415|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13937416|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13937417|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937418|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13937419|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13937420|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937421|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
13937422|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13937423|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
13937424|NCT03321201|Coagulants|coagulants|mesh-ancestor
13937425|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
14762358|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14762359|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14767370|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
14176239|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
14176240|NCT04767074|Guaifenesin|guaifenesin|mesh-list
14176241|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14176242|NCT04767074|Expectorants|expectorants|mesh-ancestor
14176243|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
14176244|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14176245|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14176246|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
14176247|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176248|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176249|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176250|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
14176251|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14176252|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
14176253|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
14176254|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176255|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
14176256|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14115807|NCT03915613|Insulin|insulin|mesh-list
14115808|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14115809|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14115810|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115811|NCT03868150|Amiodarone|amiodarone|mesh-list
14115812|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14115813|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
14115814|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14115815|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937426|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
13937427|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937428|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14115816|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115817|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14115818|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14115819|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14115820|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115821|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14115822|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14115823|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14115824|NCT03864276|Propofol|propofol|mesh-list
14115825|NCT03864276|Desflurane|desflurane|mesh-list
14115826|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
14115827|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115828|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115829|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14115830|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14115831|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
14115832|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14115833|NCT03856788|Bupivacaine|bupivacaine|mesh-list
14115834|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
14115835|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
14115836|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14115837|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115838|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
14115839|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115840|NCT03840902|Paclitaxel|paclitaxel|mesh-list
14115841|NCT03840902|Etoposide|etoposide|mesh-list
14115842|NCT03840902|Carboplatin|carboplatin|mesh-list
14115843|NCT03840902|Pemetrexed|pemetrexed|mesh-list
14115844|NCT03840902|Durvalumab|durvalumab|mesh-list
14115845|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14115846|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115847|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
14115848|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
14115849|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
14115850|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115851|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14115852|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14115853|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937429|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13937430|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
13937431|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937432|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937433|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13937434|NCT03321110|Ubiquinone|ubiquinone|mesh-list
14115854|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14115855|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14115856|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115857|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
14115858|NCT03821610|Melphalan|melphalan|mesh-list
14115859|NCT03821610|Fludarabine|fludarabine|mesh-list
14115860|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
14115861|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115862|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
14115863|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115864|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14115865|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14115866|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
14115867|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115868|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115869|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14115870|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115871|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14936389|NCT01468740|Procarbazine|procarbazine|mesh-list
14115872|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14115873|NCT03815929|Estradiol|estradiol|mesh-list
14115874|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14115875|NCT03815929|Estrogens|estrogens|mesh-ancestor
14115876|NCT03815929|Hormones|hormones|mesh-ancestor
14115877|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115878|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115879|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14115880|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
14115881|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14115882|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14115883|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
14115884|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115885|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115886|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
14115887|NCT03811756|Vitamins|vitamins|mesh-ancestor
14115888|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
14115889|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115890|NCT03792516|Artesunate|artesunate|mesh-list
14115891|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
14115892|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14115893|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14115894|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115895|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115896|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
14115897|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
14115898|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14115899|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
14115900|NCT03768414|Gemcitabine|gemcitabine|mesh-list
14115901|NCT03768414|Paclitaxel|paclitaxel|mesh-list
14115902|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14115903|NCT03768414|Cisplatin|cisplatin|mesh-list
14115904|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14115905|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115906|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
14115907|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
14115908|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
14115909|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115910|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14115911|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
14115912|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
14115913|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14115914|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115915|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14115916|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
14115917|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115918|NCT03764137|Panitumumab|panitumumab|mesh-list
14115919|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115920|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115921|NCT03757130|Liraglutide|liraglutide|mesh-list
14115922|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14115923|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115924|NCT03757130|Incretins|incretins|mesh-ancestor
14115925|NCT03757130|Hormones|hormones|mesh-ancestor
14115926|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14115927|NCT03733418|Vitamin D|vitamin d|mesh-list
14115928|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
14115929|NCT03733418|Vitamins|vitamins|mesh-ancestor
14115930|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
14115931|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115932|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14115933|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937435|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
13937436|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
13937437|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937438|NCT03321110|Vitamins|vitamins|mesh-ancestor
13937439|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
13937440|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
13937441|NCT03320967|Coagulants|coagulants|mesh-ancestor
13937442|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13937443|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13937444|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
13937445|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937446|NCT03320928|Methotrexate|methotrexate|mesh-list
13937447|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13937448|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
14115934|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
14115935|NCT03732664|Nivolumab|nivolumab|mesh-list
14115936|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115937|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115938|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14115939|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762360|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14762361|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14762362|NCT02757872|Vitamin D|vitamin d|mesh-list
14115943|NCT03675256|Vaccines|vaccines|mesh-list
14115944|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
14115945|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937449|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13937450|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478029|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478030|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478031|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
14115974|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
14115975|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14115976|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115977|NCT03620201|Atezolizumab|atezolizumab|mesh-list
14115978|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115979|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14115980|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14115981|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14115982|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14115983|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115984|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14115985|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14115986|NCT03618225|Analgesics|analgesics|mesh-ancestor
14115987|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
14115988|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14115989|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
14115990|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14115991|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
13937451|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13937452|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
13937453|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937454|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937455|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
13937456|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937457|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13937458|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937459|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
13937460|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937461|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13937462|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
13937463|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937464|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937465|NCT03320915|Vitamins|vitamins|mesh-ancestor
13937466|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
13937467|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13937468|NCT03320707|Daratumumab|daratumumab|mesh-list
13937469|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937470|NCT03320694|Insulin|insulin|mesh-list
13937471|NCT03320694|Metformin|metformin|mesh-list
13937472|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13937473|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
13937474|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13937475|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937476|NCT03320629|Apatinib|apatinib|mesh-list
13937477|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937478|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13937479|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937480|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937481|NCT03320603|Thrombin|thrombin|mesh-list
14115992|NCT03566199|Panobinostat|panobinostat|mesh-list
14115993|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14115994|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14115995|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14115996|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14115997|NCT03561831|Propofol|propofol|mesh-list
14115998|NCT03561831|Sevoflurane|sevoflurane|mesh-list
14115999|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14116000|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116001|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116002|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14116003|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
14116004|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
14116005|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14116006|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14116007|NCT03551626|Trametinib|trametinib|mesh-list
14116008|NCT03551626|Dabrafenib|dabrafenib|mesh-list
14116009|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116010|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116011|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116012|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116013|NCT03544736|Paclitaxel|paclitaxel|mesh-list
14116014|NCT03544736|Carboplatin|carboplatin|mesh-list
14116015|NCT03544736|Nivolumab|nivolumab|mesh-list
14116016|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14116017|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478032|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478033|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
14762363|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
13937482|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
13937483|NCT03320603|Coagulants|coagulants|mesh-ancestor
13937484|NCT03320538|Rabeprazole|rabeprazole|mesh-list
13937485|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13937486|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937487|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14936390|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937488|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937489|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937490|NCT03320486|Ketoconazole|ketoconazole|mesh-list
13937491|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
13937492|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937493|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13937494|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13937495|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937496|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937497|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13937498|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
13937499|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937500|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937501|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13937502|NCT03320460|Clobetasol|clobetasol|mesh-list
13937503|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937504|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
13937505|NCT03320460|Hormones|hormones|mesh-ancestor
13937506|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116018|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
14116019|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
14116020|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
13937507|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937508|NCT03320447|Lidocaine|lidocaine|mesh-list
13937509|NCT03320447|Prilocaine|prilocaine|mesh-list
13937510|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13937511|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13937512|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
13937513|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937514|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
13937515|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937516|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937517|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
13937518|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937519|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937520|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13937521|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13937522|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937523|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937524|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13937525|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
13937526|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13961573|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13961574|NCT03147196|Bicalutamide|bicalutamide|mesh-list
13961575|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
13961576|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
14116021|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116022|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116023|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14116024|NCT03508232|Doxycycline|doxycycline|mesh-list
14116025|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14116026|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116027|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
14116028|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14116029|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14116030|NCT03501979|Capecitabine|capecitabine|mesh-list
14116031|NCT03501979|Trastuzumab|trastuzumab|mesh-list
14116032|NCT03501979|Tucatinib|tucatinib|mesh-list
13961577|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961578|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961579|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116033|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14116034|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
14116035|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116036|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116037|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116038|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116039|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116040|NCT03473574|Gemcitabine|gemcitabine|mesh-list
14116041|NCT03473574|Durvalumab|durvalumab|mesh-list
14116042|NCT03473574|Tremelimumab|tremelimumab|mesh-list
14116043|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116044|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14116045|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
14762364|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
14762365|NCT02757872|Vitamins|vitamins|mesh-list
14762366|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
14762367|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961580|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13961581|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13961582|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13961583|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13961584|NCT03146858|Enoxaparin|enoxaparin|mesh-list
13961585|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
13961586|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13961587|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13961588|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961589|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
14116046|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762368|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14762369|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14116047|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
14116048|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116049|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116050|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116051|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
14116052|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116053|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116054|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
14116055|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14116056|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14116057|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14116058|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14116059|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116060|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
14116061|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116062|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116063|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14116064|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937527|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
13937528|NCT03320187|Dinoprostone|dinoprostone|mesh-list
13937529|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
13937530|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
13937531|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13937532|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937533|NCT03320174|Tafenoquine|tafenoquine|mesh-list
13937534|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
13937535|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13937536|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13937537|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937538|NCT03320109|Vitamin D|vitamin d|mesh-list
13937539|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
13937540|NCT03320109|Vitamins|vitamins|mesh-list
13937541|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
13937542|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937543|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13937544|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937545|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
13937546|NCT03320031|Linagliptin|linagliptin|mesh-list
13937547|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13937548|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937549|NCT03320031|Incretins|incretins|mesh-ancestor
13937550|NCT03320031|Hormones|hormones|mesh-ancestor
13937551|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937552|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13937553|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
13937554|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937555|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762370|NCT02746796|Capecitabine|capecitabine|mesh-list
13937556|NCT03319901|Venetoclax|venetoclax|mesh-list
13937557|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762371|NCT02746796|Tegafur|tegafur|mesh-list
14116085|NCT03370263|Belimumab|belimumab|mesh-list
14116086|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116087|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
14116088|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116089|NCT03351439|Celecoxib|celecoxib|mesh-list
14116090|NCT03351439|Naproxen|naproxen|mesh-list
14116091|NCT03351439|Gabapentin|gabapentin|mesh-list
14116092|NCT03351439|Zopiclone|zopiclone|mesh-list
14116093|NCT03351439|Analgesics|analgesics|mesh-ancestor
14116094|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
14116095|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116096|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116097|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
14116098|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14116099|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14116100|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116101|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14116102|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14116103|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14116104|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116105|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116106|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
14116107|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14116108|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116109|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116110|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116111|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14116112|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14116113|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116114|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
14116115|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14116116|NCT03316274|Nivolumab|nivolumab|mesh-list
14116117|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116118|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116119|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14116120|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116121|NCT03252626|Alprostadil|alprostadil|mesh-list
14116122|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14116123|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
14116124|NCT03252626|Urological Agents|urological agents|mesh-ancestor
14762372|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
14762373|NCT02746796|Nivolumab|nivolumab|mesh-list
14762374|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14762375|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
14762376|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762377|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762378|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762379|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14762380|NCT02744976|Metformin|metformin|mesh-list
14762381|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13937558|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
13937559|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937560|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762382|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762383|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
14762384|NCT02743819|Ipilimumab|ipilimumab|mesh-list
14762385|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762386|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762387|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14762388|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762389|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
14762390|NCT02719392|Minocycline|minocycline|mesh-list
14762391|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14762392|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
14762393|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762394|NCT02719392|Expectorants|expectorants|mesh-ancestor
14116148|NCT03245008|Fasinumab|fasinumab|mesh-list
14116149|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937561|NCT03319823|Diuretics|diuretics|mesh-ancestor
13937562|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
13937563|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937564|NCT03319784|Triamcinolone|triamcinolone|mesh-list
13937565|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13937566|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14116150|NCT03245008|Analgesics|analgesics|mesh-ancestor
14116151|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
14116152|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937567|NCT03319784|Ketorolac|ketorolac|mesh-list
13937568|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13937569|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937570|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
13937571|NCT03319784|Hormones|hormones|mesh-ancestor
13937572|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937573|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937574|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937575|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
13937576|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937577|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937578|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13937579|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937580|NCT03319784|Analgesics|analgesics|mesh-ancestor
13937581|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
13937582|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937583|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937584|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13937588|NCT03319706|Olmesartan|olmesartan|mesh-list
13937589|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13937590|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13937591|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13937592|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13937593|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116153|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116154|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
14116155|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14116156|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
14116157|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116158|NCT03238300|Expectorants|expectorants|mesh-ancestor
14116159|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
14478034|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937594|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
13937595|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13937596|NCT03319563|Epinephrine|epinephrine|mesh-list
13937597|NCT03319563|Anesthetics|anesthetics|mesh-list
13937598|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
13937599|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937600|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937601|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13937602|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13937603|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
13937604|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937605|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937606|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14116160|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14116161|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
14116162|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116163|NCT03238300|Protective Agents|protective agents|mesh-ancestor
14116164|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116165|NCT03238300|Antidotes|antidotes|mesh-ancestor
14116166|NCT03237377|Durvalumab|durvalumab|mesh-list
14116167|NCT03237377|Tremelimumab|tremelimumab|mesh-list
14116168|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116169|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116170|NCT03236545|Estradiol|estradiol|mesh-list
14116171|NCT03236545|Estrogens|estrogens|mesh-list
14116172|NCT03236545|Hormones|hormones|mesh-ancestor
14116173|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116174|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116175|NCT03199755|Lumefantrine|lumefantrine|mesh-list
14116176|NCT03199755|Artemether|artemether|mesh-list
14116177|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14116178|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
14116179|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14116180|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14116181|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116182|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
14116183|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478035|NCT02444936|Vaccines|vaccines|mesh-list
13937607|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13937608|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
13937609|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937610|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13937611|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
13937612|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
13937613|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
13937614|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13937615|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
13937616|NCT03319550|Caseins|caseins|mesh-list
13937617|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
13937618|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
13937619|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937620|NCT03319537|Pemetrexed|pemetrexed|mesh-list
13937621|NCT03319537|Pevonedistat|pevonedistat|mesh-list
13937622|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937623|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937624|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937625|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13937626|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13937627|NCT03319498|Peppermint oil|peppermint oil|mesh-list
13937628|NCT03319498|Mineral Oil|mineral oil|mesh-list
13937629|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
13937630|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
13937631|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937632|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937633|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937634|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
13937635|NCT03319498|Emollients|emollients|mesh-ancestor
13937636|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
13937637|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13937638|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13937639|NCT03319238|Ketamine|ketamine|mesh-list
13937640|NCT03319238|Analgesics|analgesics|mesh-ancestor
14116184|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116185|NCT03181126|Venetoclax|venetoclax|mesh-list
14116186|NCT03181126|Navitoclax|navitoclax|mesh-list
14116187|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116188|NCT03174405|Avelumab|avelumab|mesh-list
14116189|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116190|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937641|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
13937642|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937643|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116191|NCT03139747|Everolimus|everolimus|mesh-list
14116192|NCT03139747|Lenvatinib|lenvatinib|mesh-list
14116193|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937644|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13937645|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13937646|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
13937647|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
13937648|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937649|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13937650|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13937651|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937652|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937653|NCT03319121|Theophylline|theophylline|mesh-list
14116194|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116195|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
14116196|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762395|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
14762396|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14116197|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116198|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116199|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116200|NCT03066648|Azacitidine|azacitidine|mesh-list
14116201|NCT03066648|Decitabine|decitabine|mesh-list
13937654|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
13937655|NCT03319121|Lansoprazole|lansoprazole|mesh-list
13937656|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14116202|NCT03066648|Spartalizumab|spartalizumab|mesh-list
14478036|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
14478037|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478038|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
14478039|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14478040|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14478041|NCT02445326|Dexamethasone|dexamethasone|mesh-list
14478042|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116203|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14116204|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
14116205|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116206|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116207|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116208|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14116209|NCT03059498|Bupivacaine|bupivacaine|mesh-list
14116210|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
14116211|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
14116212|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116213|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116214|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
14116215|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116216|NCT02943590|Atorvastatin|atorvastatin|mesh-list
14116217|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14116218|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14116219|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
14116220|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116221|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14116222|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14116223|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478043|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
14478044|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
14478045|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478046|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478047|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14116224|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
14116225|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
14116226|NCT02918292|Fludarabine|fludarabine|mesh-list
14116227|NCT02918292|Tacrolimus|tacrolimus|mesh-list
14116228|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
14116229|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14116230|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116231|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
14116232|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116233|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116234|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14116235|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
14116236|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116237|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116238|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14116239|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14116240|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116241|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14116242|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14116243|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
14116244|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14116245|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116246|NCT02902120|Grazoprevir|grazoprevir|mesh-list
14116247|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
14116248|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116249|NCT02896712|Modafinil|modafinil|mesh-list
14116250|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14116251|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116252|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14116253|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14116254|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14116255|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116256|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
14116257|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116258|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116259|NCT02654080|Vaccines|vaccines|mesh-list
14116260|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
14116261|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116262|NCT02639026|Durvalumab|durvalumab|mesh-list
14116263|NCT02639026|Tremelimumab|tremelimumab|mesh-list
14116264|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116265|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116266|NCT02618148|Estrogens|estrogens|mesh-list
14116267|NCT02618148|Hormones|hormones|mesh-ancestor
14116268|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116269|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116270|NCT02553447|Vitamin D|vitamin d|mesh-list
14116271|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
14116272|NCT02553447|Vitamins|vitamins|mesh-ancestor
14116273|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
14116274|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937657|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
13937658|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937659|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937660|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13937661|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
13937662|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13937663|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937664|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937665|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
13937666|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13937667|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13937668|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
13937669|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937670|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13937671|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937672|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13937673|NCT03319043|Budesonide|budesonide|mesh-list
13937674|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
13937675|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937676|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13937677|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
13937678|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937679|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937680|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13937681|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
13937682|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
14116275|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14116276|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14116277|NCT02486666|Enoxaparin|enoxaparin|mesh-list
14116278|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
14116279|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
14116280|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14116281|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14116282|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116283|NCT02431767|Interleukin-12|interleukin-12|mesh-list
14116284|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14116285|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
14116286|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116287|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14116288|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14116289|NCT02431767|Growth Substances|growth substances|mesh-ancestor
14116290|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
14116291|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116292|NCT02390284|Timolol|timolol|mesh-list
14116293|NCT02390284|Bimatoprost|bimatoprost|mesh-list
13937683|NCT03319043|Hormones|hormones|mesh-ancestor
13937684|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937685|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13937686|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13937687|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14936391|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
14936392|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936393|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14936394|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14936395|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
14936396|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936397|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936398|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14936399|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14936400|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14936401|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14936402|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936403|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14936404|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
14936405|NCT01468740|Hormones|hormones|mesh-ancestor
13937688|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
13937689|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937690|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937691|NCT03318887|Ribavirin|ribavirin|mesh-list
14116294|NCT02390284|Travoprost|travoprost|mesh-list
14116295|NCT02390284|Dorzolamide|dorzolamide|mesh-list
14116296|NCT02390284|Acetazolamide|acetazolamide|mesh-list
14116297|NCT02390284|Methazolamide|methazolamide|mesh-list
13937692|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
13937693|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
13937694|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937695|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
13937696|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937697|NCT03318835|Thalidomide|thalidomide|mesh-list
14116298|NCT02390284|Latanoprost|latanoprost|mesh-list
14116299|NCT02390284|Brinzolamide|brinzolamide|mesh-list
14116300|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14936406|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936407|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14936408|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14936409|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
14936410|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
13937698|NCT03318835|Prednisone|prednisone|mesh-list
13937699|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
13937700|NCT03318835|Vincristine|vincristine|mesh-list
13937701|NCT03318835|Rituximab|rituximab|mesh-list
14936411|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14936412|NCT01469143|Insulin|insulin|mesh-list
13937702|NCT03318835|Doxorubicin|doxorubicin|mesh-list
13937703|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937704|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
13937705|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937706|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
13937707|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13937708|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937709|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13937710|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13937711|NCT03318835|Growth Substances|growth substances|mesh-ancestor
13937712|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
13937713|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937714|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937715|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14116301|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14116302|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
14116303|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116304|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116305|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116306|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14116307|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14116308|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14116309|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14116310|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
13937716|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
13937717|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937718|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13937719|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937720|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
13937721|NCT03318835|Hormones|hormones|mesh-ancestor
13937722|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937723|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13937724|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13937725|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
13937726|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
13937727|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
13937728|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13937729|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13937730|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13937731|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13937732|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937733|NCT03318770|Dasatinib|dasatinib|mesh-list
13937734|NCT03318770|Blinatumomab|blinatumomab|mesh-list
13937735|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937736|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13937737|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937738|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937739|NCT03318757|Bupivacaine|bupivacaine|mesh-list
14478048|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
13937740|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937741|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
13937742|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116311|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14116312|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116313|NCT02390284|Diuretics|diuretics|mesh-ancestor
14116314|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
14116315|NCT02389517|Dexamethasone|dexamethasone|mesh-list
14116316|NCT02389517|Lenalidomide|lenalidomide|mesh-list
14116317|NCT02389517|Ixazomib|ixazomib|mesh-list
14116318|NCT02389517|Glycine|glycine|mesh-list
14116319|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14116320|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116321|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
14116322|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
14116323|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116324|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116325|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14116326|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
14116327|NCT02389517|Hormones|hormones|mesh-ancestor
14116328|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116329|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14116330|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116331|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
14116332|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14116333|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14116334|NCT02389517|Growth Substances|growth substances|mesh-ancestor
14116335|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
14116336|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116337|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
14116338|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116339|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
14116340|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116341|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
14116342|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14116343|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14116344|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116345|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
14116346|NCT05082142|Coagulants|coagulants|mesh-ancestor
14116347|NCT05081986|Cycloserine|cycloserine|mesh-list
14116348|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14116349|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116350|NCT05081986|Renal Agents|renal agents|mesh-ancestor
14116351|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14116352|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
14478049|NCT02445326|Hormones|hormones|mesh-ancestor
14478050|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478051|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14478052|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478053|NCT02445586|Docetaxel|docetaxel|mesh-list
14478054|NCT02445586|Trastuzumab|trastuzumab|mesh-list
14478055|NCT02445586|Pertuzumab|pertuzumab|mesh-list
13937743|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937744|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
13937745|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937746|NCT03318744|Aspirin|aspirin|mesh-list
13937747|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13937748|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116353|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14116354|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
14116355|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937749|NCT03318744|Analgesics|analgesics|mesh-ancestor
13937750|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
13937751|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937752|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937753|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937754|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937755|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13937756|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13937757|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937758|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13937759|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13937760|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937761|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
13937762|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
13937763|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13937764|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937765|NCT03318718|Rocuronium|rocuronium|mesh-list
13937766|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937767|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13937768|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13937769|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13937770|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961590|NCT03146793|Antidotes|antidotes|mesh-ancestor
13961591|NCT03146793|Protective Agents|protective agents|mesh-ancestor
13961592|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961593|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
13961594|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961595|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
13961596|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961597|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116356|NCT05081765|Olaparib|olaparib|mesh-list
14116357|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14116358|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116359|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116360|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116361|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
14116362|NCT05081687|Irinotecan|irinotecan|mesh-list
14116363|NCT05081687|Folfirinox|folfirinox|mesh-list
14116364|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116365|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14116366|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14116367|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116368|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116369|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
14116370|NCT05081674|Nivolumab|nivolumab|mesh-list
14116371|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14116372|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116373|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116374|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14116375|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116376|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116377|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116378|NCT05081466|Vitamin D|vitamin d|mesh-list
14116379|NCT05081466|Calcium|calcium|mesh-list
14116380|NCT05081466|Vitamins|vitamins|mesh-ancestor
14116381|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
14116382|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116383|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14116384|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13961598|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
13961599|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
13961600|NCT03147157|Tacrolimus|tacrolimus|mesh-list
13961601|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961602|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
14116385|NCT05081102|Ibuprofen|ibuprofen|mesh-list
14116386|NCT05081102|Oxycodone|oxycodone|mesh-list
14116387|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14116388|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116389|NCT05081102|Analgesics|analgesics|mesh-ancestor
14116390|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
14116391|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116392|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116393|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116394|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116395|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13937771|NCT03318536|Granisetron|granisetron|mesh-list
13937772|NCT03318536|Serotonin|serotonin|mesh-list
13937773|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
13937774|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
13937775|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937776|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937777|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937778|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13937779|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
13937780|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937781|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937782|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13937783|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
13937784|NCT03318471|Analgesics|analgesics|mesh-ancestor
13937785|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
13937786|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937787|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937788|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
13937789|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937790|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937791|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
13937792|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13937793|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937794|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937795|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937796|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
13937797|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13937798|NCT03318445|Irinotecan|irinotecan|mesh-list
13937799|NCT03318445|Rucaparib|rucaparib|mesh-list
13937800|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14116396|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116397|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116398|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14116399|NCT05081102|Narcotics|narcotics|mesh-ancestor
14116400|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116401|NCT05080985|Bupivacaine|bupivacaine|mesh-list
14116402|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937801|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13937802|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937803|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937804|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937805|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13937806|NCT03318419|Cytarabine|cytarabine|mesh-list
13937807|NCT03318419|Pegaspargase|pegaspargase|mesh-list
13937808|NCT03318419|Asparaginase|asparaginase|mesh-list
13937809|NCT03318419|Cladribine|cladribine|mesh-list
13937810|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13937811|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
14116403|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
14478056|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937812|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116404|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116405|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116406|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
14116407|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116408|NCT05080803|Bevacizumab|bevacizumab|mesh-list
14116409|NCT05080803|Ranibizumab|ranibizumab|mesh-list
14116410|NCT05080803|Aflibercept|aflibercept|mesh-list
14116411|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116412|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116413|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14116414|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14116415|NCT05080803|Growth Substances|growth substances|mesh-ancestor
14116416|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116417|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
14116418|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
14116419|NCT05062278|Vinblastine|vinblastine|mesh-list
14116420|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116421|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
14116422|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116423|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116424|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13937813|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937814|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
14116425|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14116426|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14116427|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14116428|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14116429|NCT05059873|Prednisone|prednisone|mesh-list
14116430|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116431|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
14116432|NCT05059873|Hormones|hormones|mesh-ancestor
14116433|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116434|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116435|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14116436|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116437|NCT05055830|Acetaminophen|acetaminophen|mesh-list
14116438|NCT05055830|Methadone|methadone|mesh-list
14116439|NCT05055830|Caffeine|caffeine|mesh-list
14116440|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116441|NCT05055830|Analgesics|analgesics|mesh-ancestor
14116442|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
14116443|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116444|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116445|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
14116446|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14116447|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14116448|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116449|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116450|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14116451|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14116452|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
14116453|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116454|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14116455|NCT05055830|Narcotics|narcotics|mesh-ancestor
14116456|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116457|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
14116458|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
14116459|NCT05010629|Carboplatin|carboplatin|mesh-list
14116460|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116461|NCT04997239|Vaccines|vaccines|mesh-list
14116462|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
14116463|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116464|NCT04997174|Celecoxib|celecoxib|mesh-list
14116465|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14116466|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116467|NCT04997174|Analgesics|analgesics|mesh-ancestor
14116468|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
14116469|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116470|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116471|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116472|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116473|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14116474|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14116475|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478057|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
14116476|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116477|NCT04981509|Bevacizumab|bevacizumab|mesh-list
14116478|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14116479|NCT04981509|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14116480|NCT04981509|Atezolizumab|atezolizumab|mesh-list
14116481|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
14116482|NCT04981509|Antibodies|antibodies|mesh-list
14116483|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
14116484|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14116485|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
14116486|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116487|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14116488|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14116489|NCT04981509|Growth Substances|growth substances|mesh-ancestor
14116490|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116491|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
14116492|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
14116493|NCT04981509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116494|NCT04981509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116495|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116496|NCT04976387|Acetaminophen|acetaminophen|mesh-list
14116497|NCT04976387|Ibuprofen|ibuprofen|mesh-list
14116498|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14116499|NCT04976387|Hydrocodone|hydrocodone|mesh-list
14116500|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116501|NCT04976387|Analgesics|analgesics|mesh-ancestor
14116502|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
14116503|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116504|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116505|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
14116506|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14116507|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116508|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762397|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
14762398|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937815|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937816|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937817|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
13937818|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937819|NCT03318354|Olmesartan|olmesartan|mesh-list
13937820|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
13937821|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13937822|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13937823|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13937824|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937825|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
13937826|NCT03318211|Analgesics|analgesics|mesh-ancestor
13937827|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
13937828|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937829|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937830|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
13937831|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116509|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14116510|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116511|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116512|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14116513|NCT04976387|Narcotics|narcotics|mesh-ancestor
14116514|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116515|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
14116516|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
14116517|NCT04895488|Vortioxetine|vortioxetine|mesh-list
14116518|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
14116519|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
14116520|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14116521|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14116522|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14116523|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116524|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116525|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14116526|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14116527|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14183700|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762399|NCT02719392|Protective Agents|protective agents|mesh-ancestor
14762400|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116528|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116529|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936413|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14936414|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
14936415|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
14936416|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14936417|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936418|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936419|NCT01469156|Ranibizumab|ranibizumab|mesh-list
13937832|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937833|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
13937834|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13937835|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937836|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937837|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13937838|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
13937839|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13937840|NCT03318159|Posaconazole|posaconazole|mesh-list
13937841|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
13937842|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937843|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13937844|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13937845|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13937846|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13937847|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13937848|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937849|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937850|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14116530|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
14116531|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14116532|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14116533|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14116534|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14116535|NCT04830735|Dasatinib|dasatinib|mesh-list
14116536|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116537|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116538|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116539|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116540|NCT04800692|Verapamil|verapamil|mesh-list
14116541|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14116542|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14116543|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14116544|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116545|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14116546|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116547|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
14116548|NCT04700527|Butyric Acid|butyric acid|mesh-list
14116549|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
14116550|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
14116551|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116552|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116553|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936420|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14936421|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14936422|NCT01469156|Growth Substances|growth substances|mesh-ancestor
14936423|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936424|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
14936425|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936426|NCT01469169|Iloprost|iloprost|mesh-list
14936427|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14936428|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936429|NCT01469338|Prednisone|prednisone|mesh-list
14936430|NCT01469338|Octreotide|octreotide|mesh-list
14936431|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14936432|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
14936433|NCT01469338|Hormones|hormones|mesh-ancestor
14936434|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936435|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936436|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14936437|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936438|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14116554|NCT04585724|Palbociclib|palbociclib|mesh-list
14116555|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116556|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13937851|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
13937852|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937853|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937854|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13937855|NCT03318146|Latanoprost|latanoprost|mesh-list
13937856|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13937857|NCT03318133|Anesthetics|anesthetics|mesh-list
13937858|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937859|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937860|NCT03318029|Vitamin D|vitamin d|mesh-list
13937861|NCT03318029|Vitamins|vitamins|mesh-ancestor
13937862|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
13937863|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937864|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13937865|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
14116557|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116558|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116559|NCT04571697|Methotrexate|methotrexate|mesh-list
14116560|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14116561|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
14116562|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14116563|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116564|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14116565|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
14116566|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116567|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116568|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
14116569|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116570|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14116571|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116572|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
14116573|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116574|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14116575|NCT04531982|Pimavanserin|pimavanserin|mesh-list
14116576|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14116577|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14116578|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14116579|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14116580|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116581|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116582|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13937866|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13937867|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
14116583|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14116584|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13937868|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937869|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937870|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13937871|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
13937872|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937873|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937874|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13937875|NCT03317912|Lidocaine|lidocaine|mesh-list
13937876|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937877|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
13937878|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937879|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937880|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
14116585|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
14116586|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116587|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116588|NCT04455100|Itraconazole|itraconazole|mesh-list
14116589|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
14116590|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116591|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14116592|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14116593|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116594|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116595|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14116596|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
14116597|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116598|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116599|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14116600|NCT04439578|Rifampin|rifampin|mesh-list
14116601|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14116602|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
14116603|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14116604|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116605|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
14116606|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14116607|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116608|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116609|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14116610|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13937881|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937882|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937883|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13937884|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13937885|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937886|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937887|NCT03317899|Lenograstim|lenograstim|mesh-list
13937888|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13937889|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
13937890|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937891|NCT03317847|Dexamethasone|dexamethasone|mesh-list
13937892|NCT03317847|Bromfenac|bromfenac|mesh-list
13937893|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13937894|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13937895|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
13937896|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
13937897|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937898|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937899|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13937900|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
13937901|NCT03317847|Hormones|hormones|mesh-ancestor
13937902|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937903|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13937904|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937905|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13937906|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13937907|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13937908|NCT03317847|Analgesics|analgesics|mesh-ancestor
14116611|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14116612|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14116613|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14116614|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14116615|NCT04423601|Itraconazole|itraconazole|mesh-list
14116616|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
14116617|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13937909|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
13937910|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13937911|NCT03317730|Oxycodone|oxycodone|mesh-list
13937912|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13937913|NCT03317730|Narcotics|narcotics|mesh-ancestor
13937914|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937915|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937916|NCT03317730|Analgesics|analgesics|mesh-ancestor
13937917|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
13937918|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937919|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13937920|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13937921|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937922|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116618|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14116619|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14116620|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116621|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116622|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14116623|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
14116624|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116625|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116626|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13937923|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13937924|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937925|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937926|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
13937927|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937928|NCT03317652|Nitroprusside|nitroprusside|mesh-list
13937929|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13937930|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
13937931|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14116627|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14116628|NCT04387071|Antibodies|antibodies|mesh-list
13937932|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937933|NCT03317600|Lidocaine|lidocaine|mesh-list
13937934|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
13937935|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
13937936|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937937|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937938|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
14116629|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
14116630|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14116631|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
14116632|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116633|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116634|NCT04357457|Almitrine|almitrine|mesh-list
14116635|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
13937939|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937940|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13937941|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13937942|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13937943|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937944|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937945|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
13937946|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13937947|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13937948|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13937949|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937950|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937951|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
14116636|NCT04355858|Paclitaxel|paclitaxel|mesh-list
14116637|NCT04355858|Capecitabine|capecitabine|mesh-list
14116638|NCT04355858|Everolimus|everolimus|mesh-list
14116639|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14116640|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116641|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
14116642|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
14116643|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
14116644|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116645|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14116646|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
14116647|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116648|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
14116649|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116650|NCT04315701|Cemiplimab|cemiplimab|mesh-list
14116651|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116652|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116653|NCT04249076|Clobetasol|clobetasol|mesh-list
14116654|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116655|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
14116656|NCT04249076|Hormones|hormones|mesh-ancestor
14762401|NCT02719392|Antidotes|antidotes|mesh-ancestor
14762402|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13937952|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13937953|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937954|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13937955|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13937956|NCT03317548|Progesterone|progesterone|mesh-list
13937957|NCT03317548|Progestins|progestins|mesh-ancestor
13937958|NCT03317548|Hormones|hormones|mesh-ancestor
13937959|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13937960|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116657|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116658|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116659|NCT04246801|Clobetasol|clobetasol|mesh-list
14116660|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116661|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
14116662|NCT04246801|Hormones|hormones|mesh-ancestor
14116663|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116664|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116665|NCT04173533|Azacitidine|azacitidine|mesh-list
13937961|NCT03317535|Anesthetics|anesthetics|mesh-list
13937962|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937963|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937964|NCT03317457|Doxorubicin|doxorubicin|mesh-list
13937965|NCT03317457|Durvalumab|durvalumab|mesh-list
13937966|NCT03317457|Tremelimumab|tremelimumab|mesh-list
13937967|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13937968|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937969|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13937970|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13937971|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13937972|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937973|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13937974|NCT03317327|Nivolumab|nivolumab|mesh-list
13937975|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13937976|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13937977|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13937978|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937979|NCT03317275|Fluorides|fluorides|mesh-list
13937980|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
13937981|NCT03317275|Protective Agents|protective agents|mesh-ancestor
13937982|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937983|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13937984|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
13937985|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14116666|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14116667|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
14116668|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116669|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116670|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116671|NCT04167033|Hormones|hormones|mesh-list
14116672|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116673|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116674|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14116675|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116676|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14116677|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14116678|NCT03971929|Diuretics|diuretics|mesh-ancestor
14116679|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
14116680|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116681|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13937986|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13937987|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13937988|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13937989|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13937990|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
13937991|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13937992|NCT03317210|Hematinics|hematinics|mesh-ancestor
13937993|NCT03317197|Vasopressins|vasopressins|mesh-list
14116682|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13937994|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
13937995|NCT03317197|Epinephrine|epinephrine|mesh-list
13937996|NCT03317197|Racepinephrine|racepinephrine|mesh-list
13937997|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
14116683|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13937998|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13937999|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13938000|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938001|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938002|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938003|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938004|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13938005|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13938006|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
13938007|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938008|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13938009|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
13938010|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
13938011|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
13938012|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14116684|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
14116685|NCT03971084|Caseins|caseins|mesh-list
14116686|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14116687|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
14116688|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116689|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116690|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116691|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
13938013|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
13938014|NCT03317197|Coagulants|coagulants|mesh-ancestor
13938015|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13938016|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
13938017|NCT03317158|Durvalumab|durvalumab|mesh-list
13938018|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
13938019|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938020|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938021|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13938022|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
13938023|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938024|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
13938025|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
13938026|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13938027|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938028|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
13938029|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13938030|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938031|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938032|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13938033|NCT03317067|Analgesics|analgesics|mesh-ancestor
13938034|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
13938035|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938036|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13938037|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14116692|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
14116693|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14116694|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14116695|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116696|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116697|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
14116698|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116699|NCT03916263|Metformin|metformin|mesh-list
14116700|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14116701|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116702|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
13938038|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13938039|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938040|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938041|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938042|NCT03317015|Fluticasone|fluticasone|mesh-list
13938043|NCT03317015|Triamcinolone|triamcinolone|mesh-list
13938044|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116703|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116704|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116705|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
14116706|NCT03832647|Salicylates|salicylates|mesh-list
14116707|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116708|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
14116709|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
13938045|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13938046|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
14116710|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
14116711|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14116712|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116713|NCT03832647|Analgesics|analgesics|mesh-ancestor
14116714|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
14116715|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116716|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116717|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14116718|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116719|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14116720|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116721|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116722|NCT03778671|Fentanyl|fentanyl|mesh-list
14116723|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
14116724|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
14116725|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14116726|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116727|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116728|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116729|NCT03778671|Analgesics|analgesics|mesh-ancestor
14116730|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
14116731|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116732|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14116733|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14116734|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14116735|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
14116736|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116737|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116738|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14116739|NCT03778671|Narcotics|narcotics|mesh-ancestor
14116740|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14116741|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14116742|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
14116743|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
14116744|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
14116745|NCT03698162|Bevacizumab|bevacizumab|mesh-list
14116746|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116747|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116748|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14116749|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14116750|NCT03698162|Growth Substances|growth substances|mesh-ancestor
14116751|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116752|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
14116753|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
13938047|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938048|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938049|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13938050|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
13938051|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
14116754|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14116755|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116756|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14116757|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14116758|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116759|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116760|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938052|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13938053|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
13938054|NCT03317015|Hormones|hormones|mesh-ancestor
13938055|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938056|NCT03316963|Neostigmine|neostigmine|mesh-list
13938057|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13938058|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938059|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938060|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
13938061|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938062|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938063|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13938064|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
13938065|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116761|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14116762|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14116763|NCT03644186|Paclitaxel|paclitaxel|mesh-list
14116764|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14116765|NCT03644186|Trastuzumab|trastuzumab|mesh-list
14116766|NCT03644186|Letrozole|letrozole|mesh-list
14116767|NCT03644186|Palbociclib|palbociclib|mesh-list
14116768|NCT03644186|Pertuzumab|pertuzumab|mesh-list
14116769|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14116770|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116771|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14116772|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14116773|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14116774|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116775|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116776|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13938066|NCT03316898|Memantine|memantine|mesh-list
13938067|NCT03316898|Donepezil|donepezil|mesh-list
13938068|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13938069|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938070|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938071|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
13938072|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938073|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938074|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
13938075|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14116777|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14116778|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116779|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14116780|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
14116781|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14116782|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116783|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116784|NCT03563066|Benralizumab|benralizumab|mesh-list
14116785|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14116786|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
14116787|NCT03558789|Lactoferrin|lactoferrin|mesh-list
14116788|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116789|NCT03495921|Irinotecan|irinotecan|mesh-list
14116790|NCT03495921|Camptothecin|camptothecin|mesh-list
14116791|NCT03495921|Temozolomide|temozolomide|mesh-list
14116792|NCT03495921|Immunologic Factors|immunologic factors|mesh-list
14116793|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14116794|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14116795|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116796|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116797|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116798|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14116799|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
14116800|NCT03495921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116801|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14183701|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14183702|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14183703|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
14183704|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
14183705|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183706|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14183707|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14183708|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183709|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183710|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14183711|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14183712|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14183713|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14183714|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14183715|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
14183716|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
14183717|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14183718|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14183719|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938076|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14183720|NCT04725812|Eculizumab|eculizumab|mesh-list
13938077|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
14116802|NCT03330821|Cytarabine|cytarabine|mesh-list
14116803|NCT03330821|Idarubicin|idarubicin|mesh-list
14116804|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14116805|NCT03330821|Pevonedistat|pevonedistat|mesh-list
14116806|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14116807|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
14116808|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116809|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116810|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
14116811|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116812|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116813|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
14116814|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116815|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14116816|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14116817|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14116818|NCT03317223|Amoxicillin|amoxicillin|mesh-list
14116819|NCT03317223|Clarithromycin|clarithromycin|mesh-list
14116820|NCT03317223|Lansoprazole|lansoprazole|mesh-list
14116821|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14116822|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116823|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14116824|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938078|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13938079|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13938080|NCT03316859|Naloxegol|naloxegol|mesh-list
13938081|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13938082|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938083|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
13938084|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961603|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961604|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13961605|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961606|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961607|NCT03146871|Azacitidine|azacitidine|mesh-list
13961608|NCT03146871|Decitabine|decitabine|mesh-list
13961609|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13961610|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
13961611|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961612|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961613|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961614|NCT03146650|Nivolumab|nivolumab|mesh-list
13961615|NCT03146650|Ipilimumab|ipilimumab|mesh-list
14116825|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116826|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14116827|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14116828|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14116829|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14116830|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14116831|NCT03304821|Sargramostim|sargramostim|mesh-list
14116832|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
14116833|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116834|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
14116835|NCT03154749|Carboplatin|carboplatin|mesh-list
14116836|NCT03154749|Docetaxel|docetaxel|mesh-list
13961616|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961617|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961618|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13961619|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961620|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
13961621|NCT03146533|Fludarabine|fludarabine|mesh-list
13961622|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961623|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
13961624|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961625|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116837|NCT03154749|Epirubicin|epirubicin|mesh-list
14116838|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14116839|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
14116840|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116841|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14116842|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14116843|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
13961626|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13961627|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
14176296|NCT04767113|Heparin|heparin|mesh-list
14762403|NCT02697448|Propofol|propofol|mesh-list
14762404|NCT02697448|Sevoflurane|sevoflurane|mesh-list
14762405|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14762406|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762407|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762408|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13938085|NCT03316781|Adalimumab|adalimumab|mesh-list
13938086|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938087|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13938088|NCT03316690|Metformin|metformin|mesh-list
13938089|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13938090|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116844|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116845|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116846|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13938091|NCT03316599|Gemcitabine|gemcitabine|mesh-list
13938092|NCT03316599|Paclitaxel|paclitaxel|mesh-list
13938093|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13938094|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938095|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
13938096|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
14116847|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
14116848|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
14116849|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
14116850|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14116851|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14116852|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14116853|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116854|NCT03136731|Antibodies|antibodies|mesh-list
14116855|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
14116856|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116857|NCT02983006|Nivolumab|nivolumab|mesh-list
14116858|NCT02983006|DS-8273a|ds-8273a|mesh-list
14116859|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116860|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116861|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14116862|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116863|NCT02936687|Ambrisentan|ambrisentan|mesh-list
14116864|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14116865|NCT02787590|Simvastatin|simvastatin|mesh-list
14116866|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14762409|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
14762410|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
14762411|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14762412|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14762413|NCT02685709|Octreotide|octreotide|mesh-list
14762414|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762415|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762416|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762417|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14762418|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
14762419|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
14762420|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14762421|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762422|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
14762423|NCT02684851|Coagulants|coagulants|mesh-ancestor
14762424|NCT02674529|Citalopram|citalopram|mesh-list
14762425|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14762426|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14762427|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13938097|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
13938098|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116867|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14762428|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116868|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
14116869|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116870|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14116871|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14116872|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116873|NCT02734004|Bevacizumab|bevacizumab|mesh-list
14116874|NCT02734004|Durvalumab|durvalumab|mesh-list
14116875|NCT02734004|Olaparib|olaparib|mesh-list
14116876|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938099|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13938100|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
13938101|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
13938102|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938103|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116877|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116878|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14116879|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14116880|NCT02734004|Growth Substances|growth substances|mesh-ancestor
14116881|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116882|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
14116883|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14116884|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116885|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116886|NCT02659813|Copper|copper|mesh-list
14116887|NCT02659813|Nickel|nickel|mesh-list
14116888|NCT02659813|Trace Elements|trace elements|mesh-ancestor
14116889|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
14116890|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116891|NCT02658890|Nivolumab|nivolumab|mesh-list
14116892|NCT02658890|Ipilimumab|ipilimumab|mesh-list
14116893|NCT02658890|Linrodostat|linrodostat|mesh-list
14116894|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938104|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13938105|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
13938106|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938107|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
13938108|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938109|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938110|NCT03316534|Aspirin|aspirin|mesh-list
13938111|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13938112|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13938113|NCT03316534|Analgesics|analgesics|mesh-ancestor
13938114|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
13938115|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938116|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938117|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938118|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13938119|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13938120|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13938121|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938122|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13938123|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13938124|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938125|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
13938126|NCT03316482|Leuprolide|leuprolide|mesh-list
14116895|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116896|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14116897|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116898|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116899|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
14116900|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14116901|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116902|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116903|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14116904|NCT02566863|Analgesics|analgesics|mesh-ancestor
14116905|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
14116906|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116907|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14116908|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14116909|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14116910|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
14116911|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116912|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116913|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13938127|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14116914|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116915|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14116916|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116917|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116918|NCT05084456|Docetaxel|docetaxel|mesh-list
14116919|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116920|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14116921|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
13938128|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
13938129|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13938130|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938131|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13938132|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938133|NCT03316469|Clomiphene|clomiphene|mesh-list
13938134|NCT03316469|Enclomiphene|enclomiphene|mesh-list
13938135|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
13938136|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13938137|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
14116922|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14116923|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116924|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14116925|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
14116926|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
14116927|NCT05084378|Povidone|povidone|mesh-list
14116928|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14116929|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116930|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14116931|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
14116932|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
14116933|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
14116934|NCT05084365|Sulforaphane|sulforaphane|mesh-list
14116935|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14116936|NCT05084365|Protective Agents|protective agents|mesh-ancestor
14116937|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116938|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116939|NCT05084235|Empagliflozin|empagliflozin|mesh-list
14116940|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14116941|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116942|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14116943|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116944|NCT05084196|Melatonin|melatonin|mesh-list
14116945|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
14116946|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116947|NCT05084196|Protective Agents|protective agents|mesh-ancestor
14116948|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116949|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116950|NCT05084079|Insulin|insulin|mesh-list
14116951|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14116952|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14116953|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938138|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938139|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938140|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13938141|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
13938142|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13938143|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13938144|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13938145|NCT03316352|Bupivacaine|bupivacaine|mesh-list
13938146|NCT03316352|Anesthetics|anesthetics|mesh-list
13938147|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
13938148|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938149|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938150|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
13938151|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938152|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
13938153|NCT03316339|Remifentanil|remifentanil|mesh-list
13938154|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13938155|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938156|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938157|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13938158|NCT03316339|Analgesics|analgesics|mesh-ancestor
14116954|NCT05084001|Listerine|listerine|mesh-list
14116955|NCT05084001|Fluorides|fluorides|mesh-list
14116956|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
14116957|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
14116958|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
14116959|NCT05084001|Protective Agents|protective agents|mesh-ancestor
14116960|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116961|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14116962|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14116963|NCT05083793|Pregabalin|pregabalin|mesh-list
14116964|NCT05083793|Analgesics|analgesics|mesh-ancestor
14116965|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
14116966|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14116967|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116968|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
14116969|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14116970|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14116971|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116972|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13938159|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
13938160|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938161|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13938162|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13938163|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14116973|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14116974|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14116975|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14116976|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14116977|NCT05083689|Bevacizumab|bevacizumab|mesh-list
14116978|NCT05083689|Timolol|timolol|mesh-list
14116979|NCT05083689|Dorzolamide|dorzolamide|mesh-list
14116980|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
14116981|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14116982|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14116983|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14116984|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14116985|NCT05083689|Growth Substances|growth substances|mesh-ancestor
14116986|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14116987|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
14116988|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14116989|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14116990|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
14116991|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14116992|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14116993|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14116994|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14116995|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14116996|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14116997|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14116998|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14116999|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14117000|NCT05083455|Enoxaparin|enoxaparin|mesh-list
14117001|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
14117002|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14117003|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
14117004|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14117005|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
14117006|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117007|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117008|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
14117009|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14117010|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14117011|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
14117012|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14117013|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14117014|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
14117015|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117016|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117017|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14117018|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
14117019|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
14117020|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14117021|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
14478058|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
13938164|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938165|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938166|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938167|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14117022|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176297|NCT04767113|Calcium heparin|calcium heparin|mesh-list
13938168|NCT03316339|Narcotics|narcotics|mesh-ancestor
13938169|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
13938170|NCT03316326|Irinotecan|irinotecan|mesh-list
14117023|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117024|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14117025|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14117026|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14117027|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117028|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
14117029|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14117030|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14117031|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117032|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14117033|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14117034|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
14117035|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117036|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117037|NCT05083247|Gemcitabine|gemcitabine|mesh-list
14117038|NCT05083247|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14117039|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14117040|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
14117041|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117042|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117043|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
14117044|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117045|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117046|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117047|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
14117048|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117049|NCT05083026|Antibodies|antibodies|mesh-list
14117050|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
14117051|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
14117052|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762429|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762430|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
14762431|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762432|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14762433|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
14762434|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14762435|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
14762436|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14762437|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762438|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14762439|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762440|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
14762441|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762442|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762443|NCT02632409|Nivolumab|nivolumab|mesh-list
14762444|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762445|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762446|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14762447|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762448|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
13938171|NCT03316326|Tegafur|tegafur|mesh-list
13938172|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938173|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13938174|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13938175|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938176|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938177|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13938178|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
13938179|NCT03316313|Antibodies|antibodies|mesh-list
13938180|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
14762449|NCT02619253|Vorinostat|vorinostat|mesh-list
14762450|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762451|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762452|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13938181|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
13938182|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938183|NCT03316118|Bupivacaine|bupivacaine|mesh-list
13938184|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
13938185|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
14117053|NCT05082974|Varenicline|varenicline|mesh-list
14117054|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14117055|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13938186|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938187|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938188|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
13938189|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938190|NCT03316066|Ropivacaine|ropivacaine|mesh-list
13938191|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
13938192|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
13938193|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938194|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938195|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
13938196|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117056|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
14117057|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938197|NCT03315923|Rituximab|rituximab|mesh-list
13938198|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
13938199|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
13938200|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938201|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117058|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117059|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117060|NCT05082896|Anesthetics|anesthetics|mesh-list
14117061|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117062|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117063|NCT05082753|Ivermectin|ivermectin|mesh-list
14117064|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14117065|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117066|NCT05082662|Diclofenac|diclofenac|mesh-list
14117067|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14117068|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14117069|NCT05082662|Analgesics|analgesics|mesh-ancestor
14117070|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
14117071|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117072|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938202|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
13938203|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938204|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13938205|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13938206|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13938207|NCT03315845|Anesthetics|anesthetics|mesh-list
13938208|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938209|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938210|NCT03315741|Pirfenidone|pirfenidone|mesh-list
13938211|NCT03315741|Analgesics|analgesics|mesh-ancestor
13938212|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
13938213|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938214|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938215|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13938216|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13938217|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938218|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13938219|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938220|NCT03315676|Esomeprazole|esomeprazole|mesh-list
13938221|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13938222|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938223|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13938224|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938225|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938226|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13938227|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13938228|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13938229|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13938230|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938231|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938232|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938233|NCT03315533|Analgesics|analgesics|mesh-ancestor
13938234|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
13938235|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938236|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
13938237|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13938238|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
13938239|NCT03315520|Cytarabine|cytarabine|mesh-list
14117073|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117074|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13938240|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
13938241|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13938242|NCT03315520|Etoposide|etoposide|mesh-list
13938243|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13938244|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
13938245|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938246|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13938247|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13938248|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
13938249|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938250|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938251|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13938252|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14117075|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14478059|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
14478060|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478061|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478062|NCT02445807|Clobetasol|clobetasol|mesh-list
14478063|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14478064|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
14478065|NCT02445807|Hormones|hormones|mesh-ancestor
14478066|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478067|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117076|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117077|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176298|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
14176299|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14176300|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14176301|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176302|NCT04766775|Fluorides|fluorides|mesh-list
14176303|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
14176304|NCT04766775|Protective Agents|protective agents|mesh-ancestor
14176305|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176306|NCT04766762|Flunarizine|flunarizine|mesh-list
14176307|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
14176308|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14176309|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176310|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176311|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14176312|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176313|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14176314|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
14176315|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
14176316|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176317|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
14176318|NCT04766736|Antibodies|antibodies|mesh-list
14176319|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
14176320|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176321|NCT04766307|Interleukin-2|interleukin-2|mesh-list
13938253|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13938254|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13938255|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938256|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13938257|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
13938258|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
13938259|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938260|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
13938261|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
13938262|NCT03315442|Caffeine|caffeine|mesh-list
13938263|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13938264|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938265|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13938266|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938267|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938268|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13938269|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13938270|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
13938271|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938272|NCT03315364|Paclitaxel|paclitaxel|mesh-list
13938273|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13938274|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13938275|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938276|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176322|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117078|NCT05082441|Bupivacaine|bupivacaine|mesh-list
13938277|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
13938278|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
13938279|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938280|NCT03315338|Prednisone|prednisone|mesh-list
13938281|NCT03315338|Cortisone|cortisone|mesh-list
13938282|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117079|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
14117080|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
14117081|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938283|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
13938284|NCT03315338|Hormones|hormones|mesh-ancestor
13938285|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938286|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938287|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13938288|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938289|NCT03315312|Fluorides|fluorides|mesh-list
13938290|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
13938291|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
13938292|NCT03315312|Protective Agents|protective agents|mesh-ancestor
13938293|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938294|NCT03315091|Adavosertib|adavosertib|mesh-list
13938295|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938296|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938297|NCT03315078|Busulfan|busulfan|mesh-list
13938298|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
13938299|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938300|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13938301|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
13938302|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938303|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13938304|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938305|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13961628|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961629|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961630|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13961631|NCT03146689|Ibuprofen|ibuprofen|mesh-list
13961632|NCT03146689|Capsaicin|capsaicin|mesh-list
13961633|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13961634|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13961635|NCT03146689|Analgesics|analgesics|mesh-ancestor
13961636|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
13961637|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961638|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961639|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13961640|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961641|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13961642|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961643|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961644|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
13961645|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
13961646|NCT03146481|Aceclofenac|aceclofenac|mesh-list
13961647|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14117082|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117083|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
14117084|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117085|NCT05075941|Vaccines|vaccines|mesh-list
14117086|NCT05075941|Immunologic Factors|immunologic factors|mesh-ancestor
14117087|NCT05075941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117088|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14117089|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14117090|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117091|NCT05072054|Atorvastatin|atorvastatin|mesh-list
14117092|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14117093|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14117094|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14117095|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
14117096|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117097|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14117098|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14478068|NCT02445859|Cefuroxime|cefuroxime|mesh-list
14478069|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
13961648|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13961649|NCT03146481|Analgesics|analgesics|mesh-ancestor
14117099|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117100|NCT05049902|Amoxicillin|amoxicillin|mesh-list
14117101|NCT05049902|Metronidazole|metronidazole|mesh-list
14117102|NCT05049902|Clarithromycin|clarithromycin|mesh-list
14117103|NCT05049902|Tetracycline|tetracycline|mesh-list
14117104|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
14117105|NCT05049902|Bismuth|bismuth|mesh-list
14117106|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117107|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14117108|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117109|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14117110|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14117111|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13938306|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
13938307|NCT03315052|Prednisone|prednisone|mesh-list
13938308|NCT03315052|Budesonide|budesonide|mesh-list
13938309|NCT03315052|Tacrolimus|tacrolimus|mesh-list
13938310|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938311|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
13938312|NCT03315052|Hormones|hormones|mesh-ancestor
13938313|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938314|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938315|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13938316|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938317|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13938318|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
13938319|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13938320|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938321|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938322|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13938323|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13938324|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
13938325|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13938326|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938327|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13938328|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
14117112|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117113|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14117114|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14117115|NCT05049902|Antacids|antacids|mesh-ancestor
14117116|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117117|NCT05049902|Diuretics|diuretics|mesh-ancestor
14117118|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
13938329|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938330|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13938331|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14762453|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762454|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762455|NCT02612194|Crizotinib|crizotinib|mesh-list
14762456|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762457|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14762458|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762459|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762460|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
14762461|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762462|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938332|NCT03315000|Fluticasone|fluticasone|mesh-list
13938333|NCT03315000|Xhance|xhance|mesh-list
13938334|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938335|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13938336|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
14117119|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117120|NCT05049902|Expectorants|expectorants|mesh-ancestor
14117121|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
14117122|NCT05048069|Rebamipide|rebamipide|mesh-list
14117123|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14117124|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117125|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
14117126|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117127|NCT05048069|Protective Agents|protective agents|mesh-ancestor
13938337|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938338|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762463|NCT02592317|Pioglitazone|pioglitazone|mesh-list
13938339|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14117128|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117129|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117130|NCT05036577|Dexamethasone|dexamethasone|mesh-list
13938340|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
13938341|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
13938342|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13938343|NCT03314792|Oxycodone|oxycodone|mesh-list
13938344|NCT03314792|Tapentadol|tapentadol|mesh-list
13938345|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13938346|NCT03314792|Narcotics|narcotics|mesh-ancestor
13938347|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938348|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117131|NCT05036577|Rituximab|rituximab|mesh-list
14117132|NCT05036577|Methotrexate|methotrexate|mesh-list
14117133|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117134|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
14117135|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
14117136|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117137|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117138|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117139|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
14117140|NCT05036577|Hormones|hormones|mesh-ancestor
14117141|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117142|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14117143|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117144|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117145|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
14117146|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117147|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14117148|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
14117149|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14117150|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14117151|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
14117152|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117153|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
14117154|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117155|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13938349|NCT03314792|Analgesics|analgesics|mesh-ancestor
13938350|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
13938351|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938352|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14117156|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117157|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14117158|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
14117159|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14117160|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117161|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14117162|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117163|NCT04962230|Ritonavir|ritonavir|mesh-list
14117164|NCT04962230|Carbamazepine|carbamazepine|mesh-list
14117165|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14117166|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14117167|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
14117168|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117169|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117170|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14117171|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14117172|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
14117173|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117174|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14117175|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14117176|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
14117177|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
14117178|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14117179|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117180|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117181|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14117182|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14117183|NCT04962230|Analgesics|analgesics|mesh-ancestor
14117184|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
14117185|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117186|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14117187|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14117188|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14117189|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14117190|NCT04943341|Triamcinolone|triamcinolone|mesh-list
14762464|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14117191|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13938353|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13938354|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13938355|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938356|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117192|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14117193|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14117194|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117195|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
14117196|NCT04943341|Hormones|hormones|mesh-ancestor
14117197|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117198|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117199|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117200|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
14117201|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117202|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117203|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
14117204|NCT04941040|Anesthetics|anesthetics|mesh-list
14117205|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117206|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938357|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478070|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14478071|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478072|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14478073|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
14478074|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13938358|NCT03314740|Paclitaxel|paclitaxel|mesh-list
13938359|NCT03314740|Olaparib|olaparib|mesh-list
13938360|NCT03314740|Cediranib|cediranib|mesh-list
13938361|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13938362|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938363|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
13938364|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117207|NCT04941040|Narcotics|narcotics|mesh-ancestor
14117208|NCT04941040|Analgesics|analgesics|mesh-ancestor
14117209|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
14117210|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117211|NCT04934410|Midazolam|midazolam|mesh-list
14117212|NCT04934410|Etomidate|etomidate|mesh-list
14117213|NCT04934410|Sevoflurane|sevoflurane|mesh-list
14117214|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14117215|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14117216|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117217|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117218|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13938365|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117219|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14117220|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14117221|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14117222|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
14117223|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
14117224|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
14117225|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
14117226|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117227|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117228|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14117229|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14117230|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
14117231|NCT04918927|Favipiravir|favipiravir|mesh-list
14117232|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14117233|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117234|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
14117235|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14117236|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14117237|NCT04873297|Metoclopramide|metoclopramide|mesh-list
14117238|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
14117239|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
14117240|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117241|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117242|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117243|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14117244|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14117245|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
14478075|NCT02446171|Naloxegol|naloxegol|mesh-list
13961650|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
14117246|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117247|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478076|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14117248|NCT04858711|Lidocaine|lidocaine|mesh-list
14117249|NCT04858711|Fentanyl|fentanyl|mesh-list
14117250|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
14117251|NCT04858711|Ketamine|ketamine|mesh-list
14117252|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
14117253|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
14117254|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117255|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117256|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
14117257|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117258|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14117259|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14117260|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14117261|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14117262|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938366|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938367|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13938368|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938369|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13938370|NCT03314636|Dexamethasone|dexamethasone|mesh-list
14762465|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14762466|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14762467|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
14762468|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762469|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14762470|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14762471|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762472|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14762473|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762474|NCT02586207|Cisplatin|cisplatin|mesh-list
13938371|NCT03314636|Lenalidomide|lenalidomide|mesh-list
13938372|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938373|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
13938374|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
13938375|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938376|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938377|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938378|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
13938379|NCT03314636|Hormones|hormones|mesh-ancestor
13938380|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762475|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
14762476|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938381|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13938382|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938383|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
14117263|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14117264|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14117265|NCT04858711|Analgesics|analgesics|mesh-ancestor
14117266|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14117267|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14117268|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14117269|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117270|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117271|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14117272|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14117273|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
14117274|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14117275|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14117276|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14117277|NCT04858711|Narcotics|narcotics|mesh-ancestor
14117278|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13938384|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13938385|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13938386|NCT03314636|Growth Substances|growth substances|mesh-ancestor
13938387|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
13938388|NCT03314493|Spironolactone|spironolactone|mesh-list
13938389|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13938390|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
13938391|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938392|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938393|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13938394|NCT03314493|Diuretics|diuretics|mesh-ancestor
14117279|NCT04852224|Leuprolide|leuprolide|mesh-list
14117280|NCT04852224|Goserelin|goserelin|mesh-list
14117281|NCT04852224|Androgens|androgens|mesh-list
14117282|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14117283|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
14117284|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14117285|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117286|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14117287|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117288|NCT04852224|Hormones|hormones|mesh-ancestor
14117289|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117290|NCT04826484|Bupivacaine|bupivacaine|mesh-list
14117291|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
14117292|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
14117293|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117294|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117295|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
14117296|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117297|NCT04810793|Amoxicillin|amoxicillin|mesh-list
14117298|NCT04810793|Levofloxacin|levofloxacin|mesh-list
13938395|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
13938396|NCT03314363|Trace Elements|trace elements|mesh-list
13938397|NCT03314363|Micronutrients|micronutrients|mesh-list
13938398|NCT03314363|Citric Acid|citric acid|mesh-list
13938399|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
14117299|NCT04810793|Ofloxacin|ofloxacin|mesh-list
14117300|NCT04810793|Tetracycline|tetracycline|mesh-list
14117301|NCT04810793|Furazolidone|furazolidone|mesh-list
14117302|NCT04810793|Esomeprazole|esomeprazole|mesh-list
14117303|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14117304|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117305|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14117306|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117307|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14117308|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117309|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117310|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14117311|NCT04810793|Renal Agents|renal agents|mesh-ancestor
14117312|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14117313|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14117314|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117315|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14117316|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14117317|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14117318|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14117319|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14117320|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14117321|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14117322|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14117323|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14117324|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14117325|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117326|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
14117327|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117328|NCT04728633|Carmustine|carmustine|mesh-list
14117329|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
13938400|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938401|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
13938402|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13938403|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
13938404|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
13938405|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117330|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14117331|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
14117332|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117333|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117334|NCT04725864|Progesterone|progesterone|mesh-list
14117335|NCT04725864|Progestins|progestins|mesh-ancestor
14117336|NCT04725864|Hormones|hormones|mesh-ancestor
14117337|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117338|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176323|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14176324|NCT04766307|Analgesics|analgesics|mesh-ancestor
14176325|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
14176326|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176327|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176328|NCT04766359|Paclitaxel|paclitaxel|mesh-list
14176329|NCT04766359|Cisplatin|cisplatin|mesh-list
13938406|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
14117339|NCT04684368|Carboplatin|carboplatin|mesh-list
14117340|NCT04684368|Etoposide|etoposide|mesh-list
14117341|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
14117342|NCT04684368|Ifosfamide|ifosfamide|mesh-list
14117343|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
14117344|NCT04684368|Thiotepa|thiotepa|mesh-list
14117345|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
14117346|NCT04684368|Lenograstim|lenograstim|mesh-list
14117347|NCT04684368|Mesna|mesna|mesh-list
14117348|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117349|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14117350|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14117351|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14117352|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117353|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117354|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14117355|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
14117356|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117357|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14117358|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
14117359|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117360|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14117361|NCT04684368|Protective Agents|protective agents|mesh-ancestor
14117362|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
14117363|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14117364|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117365|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117366|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117367|NCT04631393|Alfentanil|alfentanil|mesh-list
13938407|NCT03314298|Anastrozole|anastrozole|mesh-list
13938408|NCT03314298|Testosterone|testosterone|mesh-list
13938409|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
13938410|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
13938411|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13938412|NCT03314298|Androgens|androgens|mesh-ancestor
13938413|NCT03314298|Hormones|hormones|mesh-ancestor
13938414|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938415|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938416|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13938417|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938418|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
13938419|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13938420|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13938421|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938422|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938423|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13938424|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
13938425|NCT03314259|Tamsulosin|tamsulosin|mesh-list
13938426|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13938427|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13938428|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13938429|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938430|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938431|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938432|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938433|NCT03314259|Urological Agents|urological agents|mesh-ancestor
13938434|NCT03314064|Dolutegravir|dolutegravir|mesh-list
13938435|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13938436|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13938437|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938438|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938439|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13938440|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13938441|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
13938442|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938443|NCT03314025|Tamsulosin|tamsulosin|mesh-list
13938444|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13938445|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13938446|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13938447|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938448|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938449|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117368|NCT04631393|Propofol|propofol|mesh-list
13938450|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117369|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14117370|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478077|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478078|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
13938451|NCT03314025|Urological Agents|urological agents|mesh-ancestor
13938452|NCT03313960|Insulin|insulin|mesh-list
13938453|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13938454|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938455|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
13938456|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13938457|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
13938458|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938459|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
13938460|NCT03313934|Protective Agents|protective agents|mesh-ancestor
13938461|NCT03313869|Vitamin E|vitamin e|mesh-list
13938462|NCT03313869|Selenium|selenium|mesh-list
13938463|NCT03313869|Vitamins|vitamins|mesh-ancestor
13938464|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
13938465|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938466|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
13938467|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938468|NCT03313869|Protective Agents|protective agents|mesh-ancestor
13938469|NCT03313869|Trace Elements|trace elements|mesh-ancestor
13938470|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
13938471|NCT03313856|Antacids|antacids|mesh-ancestor
13938472|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938473|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938474|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13938475|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938476|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938477|NCT03313791|Caseins|caseins|mesh-list
13938478|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
13938479|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
13938480|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938481|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
13938482|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13938483|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938484|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13938485|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938486|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
13938487|NCT03313726|Hormones|hormones|mesh-ancestor
13938488|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938489|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938490|NCT03313661|Gliclazide|gliclazide|mesh-list
13938491|NCT03313661|Cabergoline|cabergoline|mesh-list
13938492|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13938493|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13938494|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
14117371|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117372|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14117373|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
14117374|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
14117375|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14117376|NCT04631393|Narcotics|narcotics|mesh-ancestor
14117377|NCT04631393|Analgesics|analgesics|mesh-ancestor
14117378|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
14117379|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117380|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
14117381|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14117382|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
14117383|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14117384|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14117385|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14117386|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117387|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117388|NCT04537923|Insulin|insulin|mesh-list
14117389|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14117390|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
14117391|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
13938495|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
13938496|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938497|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938498|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938499|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13938500|NCT03313557|Adavosertib|adavosertib|mesh-list
14117392|NCT04537923|Tirzepatide|tirzepatide|mesh-list
14117393|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936439|NCT01469351|Liraglutide|liraglutide|mesh-list
13938501|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117394|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117395|NCT04537923|Incretins|incretins|mesh-ancestor
14117396|NCT04537923|Hormones|hormones|mesh-ancestor
14117397|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117398|NCT04513314|Valproic Acid|valproic acid|mesh-list
14117399|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14117400|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
14117401|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14117402|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14117403|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14117404|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117405|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117406|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
14117407|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117408|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117409|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
14117410|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117411|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
14117412|NCT04447118|Docetaxel|docetaxel|mesh-list
14117413|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117414|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117415|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117416|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117417|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117418|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
13938502|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938503|NCT03313544|Nivolumab|nivolumab|mesh-list
14936440|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936441|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936442|NCT01469351|Incretins|incretins|mesh-ancestor
14936443|NCT01469351|Hormones|hormones|mesh-ancestor
14936444|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938504|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938505|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938506|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13938507|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938508|NCT03313531|Thrombin|thrombin|mesh-list
13938509|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
13938510|NCT03313531|Coagulants|coagulants|mesh-ancestor
13938511|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
13938512|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13938513|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938514|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936445|NCT01469416|Clopidogrel|clopidogrel|mesh-list
14936446|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14936447|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14936448|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14936449|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14936450|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14936451|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
13938515|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13938516|NCT03313479|Analgesics|analgesics|mesh-ancestor
13938517|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
13938518|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938519|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13938520|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13938521|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13938522|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938523|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938524|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961651|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936452|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936453|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936454|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936455|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14936456|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14936457|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
14936458|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13961652|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961653|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13961654|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961655|NCT03146468|Nivolumab|nivolumab|mesh-list
14117419|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14938719|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117420|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117421|NCT04409002|Niraparib|niraparib|mesh-list
14117422|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14117423|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117424|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938525|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
13938526|NCT03313414|Velpatasvir|velpatasvir|mesh-list
13938527|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
13938528|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938529|NCT03313401|Aflibercept|aflibercept|mesh-list
13938530|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13938531|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13938532|NCT03313401|Growth Substances|growth substances|mesh-ancestor
13938533|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938534|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
13938535|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938536|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13938537|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
13938538|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
13938539|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938540|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938541|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
13938542|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938543|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14117425|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117426|NCT04406415|Nafamostat|nafamostat|mesh-list
14117427|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14117428|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14117429|NCT04406415|Analgesics|analgesics|mesh-ancestor
14117430|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
14117431|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117432|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117433|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117434|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117435|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
14117436|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
14117437|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117438|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117439|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14117440|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14117441|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14117442|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117443|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
14117444|NCT04262479|Vitamin D|vitamin d|mesh-list
14117445|NCT04262479|Vitamins|vitamins|mesh-ancestor
14117446|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
14117447|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117448|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14117449|NCT04215848|Budesonide|budesonide|mesh-list
14117450|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
14117451|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117452|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14117453|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
14117454|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117455|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117456|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14117457|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
14117458|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
14117459|NCT04215848|Hormones|hormones|mesh-ancestor
14117460|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117461|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14117462|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14117463|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14117464|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117465|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117466|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117467|NCT04200534|Nicotine|nicotine|mesh-list
14117468|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14117469|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
14117470|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117471|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117472|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14117473|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14117474|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
13938544|NCT03313323|Ipilimumab|ipilimumab|mesh-list
14117475|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117476|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117477|NCT04028388|Docetaxel|docetaxel|mesh-list
14117478|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117479|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117480|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117481|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117482|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117483|NCT04003506|Bupivacaine|bupivacaine|mesh-list
14117484|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
14117485|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
14117486|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117487|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117488|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
14117489|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117490|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
14117491|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14117492|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117493|NCT03955640|Olaparib|olaparib|mesh-list
14117494|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14117495|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117496|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117497|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117498|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
14117499|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14117500|NCT03910738|Testosterone|testosterone|mesh-list
14117501|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
14117502|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
14117503|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14117504|NCT03910738|Androgens|androgens|mesh-ancestor
14117505|NCT03910738|Hormones|hormones|mesh-ancestor
14117506|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117507|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117508|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14117509|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117510|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
14117511|NCT03890744|Docetaxel|docetaxel|mesh-list
14117512|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117513|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117514|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117515|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117516|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117517|NCT03885037|Infliximab|infliximab|mesh-list
14117518|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
14117519|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117520|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117521|NCT03831503|Antibodies|antibodies|mesh-list
14117522|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
14117523|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117524|NCT03820817|Rifaximin|rifaximin|mesh-list
14117525|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14117526|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117527|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938545|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938546|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938547|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13938548|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938549|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
13938550|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938551|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938552|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
13938553|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
13938554|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117528|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
13938555|NCT03312777|Tramadol|tramadol|mesh-list
13938556|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13938557|NCT03312777|Narcotics|narcotics|mesh-ancestor
13938558|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938559|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938560|NCT03312777|Analgesics|analgesics|mesh-ancestor
13938561|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
14117529|NCT03789097|Poly ICLC|poly iclc|mesh-list
13938562|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117530|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117531|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117532|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
14117533|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
14117534|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117535|NCT03745430|Ramucirumab|ramucirumab|mesh-list
14117536|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176330|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14176331|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176332|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176333|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176334|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176335|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176336|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176337|NCT04766177|Bumetanide|bumetanide|mesh-list
14176338|NCT04766177|Diuretics|diuretics|mesh-ancestor
14176339|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
14762477|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762478|NCT02584933|Ceritinib|ceritinib|mesh-list
14762479|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762480|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14762481|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762482|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762483|NCT02571725|Olaparib|olaparib|mesh-list
14762484|NCT02571725|Tremelimumab|tremelimumab|mesh-list
14176340|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176341|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14176342|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176343|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176344|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
14176345|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
13938563|NCT03312738|Everolimus|everolimus|mesh-list
13938564|NCT03312738|Exemestane|exemestane|mesh-list
13938565|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938566|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13938567|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
13938568|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938569|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13938570|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13938571|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938572|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938573|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13938574|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
13938575|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938576|NCT03312699|Vaccines|vaccines|mesh-list
14176346|NCT04766684|Lidocaine|lidocaine|mesh-list
14176347|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
14176348|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
14176349|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176350|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176351|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
14176352|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176353|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14176354|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13938577|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
13938578|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938579|NCT03312582|Metformin|metformin|mesh-list
14176355|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14176356|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14762485|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13938580|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13938581|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938582|NCT03312530|Atezolizumab|atezolizumab|mesh-list
13938583|NCT03312530|Venetoclax|venetoclax|mesh-list
13938584|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762486|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762487|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762488|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938585|NCT03312478|Antibodies|antibodies|mesh-list
13938586|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938587|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
13938588|NCT03312426|Linrodostat|linrodostat|mesh-list
13938589|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938590|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938591|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
13938592|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13938593|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938594|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938595|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13938596|NCT03312413|Analgesics|analgesics|mesh-ancestor
13938597|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
13938598|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938599|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13938600|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13938601|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13938602|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938603|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938604|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938605|NCT03312335|Aldesleukin|aldesleukin|mesh-list
13938606|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938607|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13938608|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13938609|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
14117537|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
14117538|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14117539|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14117540|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14117541|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
14117542|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117543|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117544|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117545|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
14117546|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14117547|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
14117548|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938610|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938611|NCT03312283|Ranibizumab|ranibizumab|mesh-list
13938612|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13938613|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13938614|NCT03312283|Growth Substances|growth substances|mesh-ancestor
13938615|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938616|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
13938617|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938618|NCT03312257|Atropine|atropine|mesh-list
13938619|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13938620|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13938621|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13938622|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
13938623|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938624|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938625|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14478079|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478080|NCT02446418|Fluticasone|fluticasone|mesh-list
14478081|NCT02446418|Xhance|xhance|mesh-list
14478082|NCT02446418|Budesonide|budesonide|mesh-list
14478083|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
13938626|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
13938627|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
13938628|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
13938629|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13938630|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13938631|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
13938632|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938633|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938634|NCT03312244|Bromides|bromides|mesh-list
14117549|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117550|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14117551|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
14117552|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14117553|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
14117554|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117555|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117556|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14117557|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
14117558|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
14117559|NCT03718793|Protective Agents|protective agents|mesh-ancestor
14117560|NCT03671967|Meropenem|meropenem|mesh-list
14117561|NCT03671967|Tazobactam|tazobactam|mesh-list
14478084|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13938635|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
13938636|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
13938637|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13938638|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938639|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938640|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
13938641|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938642|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938643|NCT03312179|Incretins|incretins|mesh-list
13938644|NCT03312179|Hormones|hormones|mesh-ancestor
13938645|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938646|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938647|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
13938648|NCT03312153|Eusol|eusol|mesh-list
13938649|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
13938650|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938651|NCT03312140|Choline|choline|mesh-list
13938652|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
13938653|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13938654|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
13938655|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938656|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938657|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13938658|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
13938659|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13938660|NCT03311984|Dalteparin|dalteparin|mesh-list
13938661|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
13938662|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13938663|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13938664|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938665|NCT03311971|Methamphetamine|methamphetamine|mesh-list
13938666|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13938667|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938668|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
13938669|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
13938670|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938671|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
13938672|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938673|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938674|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938675|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13938676|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13938677|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13938678|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13938679|NCT03311958|Nivolumab|nivolumab|mesh-list
13938680|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938681|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938682|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13938683|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938684|NCT03311945|Lamivudine|lamivudine|mesh-list
13938685|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
13938686|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13938687|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13938688|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938689|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938690|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
13938691|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938692|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13938693|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13938694|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13938695|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13938696|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
13938697|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13938698|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
13938699|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938700|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
13938701|NCT03311906|Protective Agents|protective agents|mesh-ancestor
13938702|NCT03311828|Daratumumab|daratumumab|mesh-list
13938703|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938704|NCT03311789|Gemcitabine|gemcitabine|mesh-list
13938705|NCT03311789|Nivolumab|nivolumab|mesh-list
13938706|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
13938707|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938708|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13938709|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
14117562|NCT03671967|Piperacillin|piperacillin|mesh-list
14117563|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14117564|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14117565|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117566|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14117567|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117568|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117569|NCT03524326|Cetuximab|cetuximab|mesh-list
14117570|NCT03524326|Lenvatinib|lenvatinib|mesh-list
14117571|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117572|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117573|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14117574|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117575|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117576|NCT03512223|Dexamethasone|dexamethasone|mesh-list
13938710|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938711|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
13938712|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938713|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938714|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13938715|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
13938716|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938717|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961656|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961657|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961658|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13961659|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961660|NCT03146377|Capecitabine|capecitabine|mesh-list
13961661|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
13961662|NCT03146377|Irinotecan|irinotecan|mesh-list
13961663|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13961664|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
13961665|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961666|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117577|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117578|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
14117579|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
14117580|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117581|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117582|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117583|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
14117584|NCT03512223|Hormones|hormones|mesh-ancestor
14117585|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117586|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14117587|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117588|NCT03441139|Analgesics|analgesics|mesh-list
14117589|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
14117590|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117591|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117592|NCT03426254|Talazoparib|talazoparib|mesh-list
14117593|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14117594|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117595|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762489|NCT02546934|Gemcitabine|gemcitabine|mesh-list
14762490|NCT02546934|Cisplatin|cisplatin|mesh-list
14762491|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762492|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14762493|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
14762494|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762495|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
14762496|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762497|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762498|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762499|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
14762500|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762501|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14762502|NCT02536794|Durvalumab|durvalumab|mesh-list
14762503|NCT02536794|Ipilimumab|ipilimumab|mesh-list
14762504|NCT02536794|Tremelimumab|tremelimumab|mesh-list
14762505|NCT02536794|Antibodies|antibodies|mesh-list
13961667|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14762506|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
14762507|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14762508|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
13938718|NCT03311750|Panitumumab|panitumumab|mesh-list
13938719|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117596|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117597|NCT03359460|Lenalidomide|lenalidomide|mesh-list
14117598|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
14117599|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117600|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14117601|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14117602|NCT03359460|Growth Substances|growth substances|mesh-ancestor
14117603|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
13938720|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938721|NCT03311737|Anesthetics|anesthetics|mesh-list
13938722|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938723|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938724|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
13938725|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938726|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938727|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13938728|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
13938729|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117604|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117607|NCT03227263|Bevacizumab|bevacizumab|mesh-list
14117608|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117609|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117610|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14117611|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14117612|NCT03227263|Growth Substances|growth substances|mesh-ancestor
14117613|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117614|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
13938730|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13938731|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13938732|NCT03311594|Ethanol|ethanol|mesh-list
14117615|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
14117616|NCT03211416|Sorafenib|sorafenib|mesh-list
14117617|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117618|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117619|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14117620|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117621|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117622|NCT03150368|Docetaxel|docetaxel|mesh-list
14117623|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117624|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117625|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117626|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117627|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117628|NCT03147378|Docetaxel|docetaxel|mesh-list
14117629|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117630|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117631|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117632|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117633|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938733|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13938734|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938735|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938736|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117634|NCT03136640|Docetaxel|docetaxel|mesh-list
14117635|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117636|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117637|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117638|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117639|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117640|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
14117641|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14117642|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
13938737|NCT03311581|Propofol|propofol|mesh-list
13938738|NCT03311581|Sevoflurane|sevoflurane|mesh-list
13938739|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13938740|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938741|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117643|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478085|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938742|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14117644|NCT02972398|Expectorants|expectorants|mesh-ancestor
14117645|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
13938743|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
13938744|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
13938745|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13938746|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13938747|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
13938748|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938749|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938750|NCT03311516|Insulin|insulin|mesh-list
13938751|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13938752|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13938753|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938754|NCT03311464|Adalimumab|adalimumab|mesh-list
13938755|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938756|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117646|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14117647|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
14117648|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117649|NCT02972398|Protective Agents|protective agents|mesh-ancestor
14117650|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117651|NCT02972398|Antidotes|antidotes|mesh-ancestor
14117652|NCT02914470|Atezolizumab|atezolizumab|mesh-list
14117653|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117654|NCT02660710|Rituximab|rituximab|mesh-list
14117655|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117656|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938757|NCT03311425|Dexamethasone|dexamethasone|mesh-list
13938758|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
13938759|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13938760|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13938761|NCT03311425|Prednisolone|prednisolone|mesh-list
14117657|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
14117658|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117659|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117660|NCT02492711|Gemcitabine|gemcitabine|mesh-list
14117661|NCT02492711|Capecitabine|capecitabine|mesh-list
14117662|NCT02492711|Trastuzumab|trastuzumab|mesh-list
14117663|NCT02492711|Vinorelbine|vinorelbine|mesh-list
13938762|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
13938763|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13938764|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
13938765|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13938766|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
13938767|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
13938768|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938769|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938770|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938771|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
14117664|NCT02492711|Margetuximab|margetuximab|mesh-list
14117665|NCT02492711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14117666|NCT02492711|Antimetabolites|antimetabolites|mesh-ancestor
14117667|NCT02492711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117668|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117669|NCT02492711|Antiviral Agents|antiviral agents|mesh-ancestor
14117670|NCT02492711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117671|NCT02492711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117672|NCT02492711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117673|NCT02492711|Immunologic Factors|immunologic factors|mesh-ancestor
14117674|NCT02492711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117675|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117676|NCT02492711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14117677|NCT02492711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117678|NCT02492711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117679|NCT02492711|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117680|NCT02484716|Timolol|timolol|mesh-list
14117681|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14117682|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14117683|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117684|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117685|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117686|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117687|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14117688|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14762509|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762510|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938772|NCT03311425|Hormones|hormones|mesh-ancestor
14762511|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13938773|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762512|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762513|NCT02531516|Bicalutamide|bicalutamide|mesh-list
14762514|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
14762515|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
14762516|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762517|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762518|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938774|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13938775|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938776|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13938777|NCT03311425|Protective Agents|protective agents|mesh-ancestor
13938778|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13938779|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13938780|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13938781|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938782|NCT03311321|Vitamin K|vitamin k|mesh-list
13938783|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
13938784|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
13938785|NCT03311321|Vitamins|vitamins|mesh-ancestor
13938786|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
13938787|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938788|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13938789|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13938790|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938791|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
13938792|NCT03311321|Coagulants|coagulants|mesh-ancestor
13938793|NCT03311178|Dobutamine|dobutamine|mesh-list
13938794|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13938795|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
13938796|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
13938797|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938798|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938799|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13938800|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13938801|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13938802|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
13938803|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938804|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938805|NCT03311178|Protective Agents|protective agents|mesh-ancestor
13938806|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
13938807|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13938808|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938809|NCT03311022|Nefopam|nefopam|mesh-list
13938810|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13938811|NCT03311022|Analgesics|analgesics|mesh-ancestor
13938812|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
13938813|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938814|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938815|NCT03310762|Silicon|silicon|mesh-list
13938816|NCT03310762|Trace Elements|trace elements|mesh-ancestor
13938817|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
13938818|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938819|NCT03310749|Metformin|metformin|mesh-list
13938820|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13938821|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938822|NCT03310736|Hepcidins|hepcidins|mesh-list
13938823|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117700|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14117701|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14117702|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14117703|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
14117704|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117705|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14117706|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14117707|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117708|NCT05088330|Daratumumab|daratumumab|mesh-list
14117709|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938824|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13938825|NCT03310606|Lactams|lactams|mesh-list
13938826|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938827|NCT03310593|Cannabidiol|cannabidiol|mesh-list
13938828|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
14117710|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14117711|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938829|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
14117712|NCT05088174|Cyclosporine|cyclosporine|mesh-list
14117713|NCT05088174|Cyclosporins|cyclosporins|mesh-list
14117714|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938830|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13938831|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938832|NCT03310541|Fulvestrant|fulvestrant|mesh-list
13938833|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13938834|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938835|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13938836|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13938837|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
13938838|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938839|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938840|NCT03310372|Temozolomide|temozolomide|mesh-list
13938841|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13938842|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
13938843|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938844|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938845|NCT03310333|Dinoprostone|dinoprostone|mesh-list
13938846|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
13938847|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13938848|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938849|NCT03310242|Vitamin D|vitamin d|mesh-list
13938850|NCT03310242|Vitamins|vitamins|mesh-ancestor
13938851|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
13938852|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117715|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117716|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117717|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
14117718|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117719|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
14117720|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117721|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
14117722|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117723|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14117724|NCT05088083|Paclitaxel|paclitaxel|mesh-list
14117725|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14117726|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117727|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14117728|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117729|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117730|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117731|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
14117732|NCT05088057|Docetaxel|docetaxel|mesh-list
14117733|NCT05088057|Doxorubicin|doxorubicin|mesh-list
14117734|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117735|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
14117736|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117737|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117738|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14117739|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
14762519|NCT02519777|Maraviroc|maraviroc|mesh-list
14762520|NCT02519777|Dolutegravir|dolutegravir|mesh-list
14762521|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14762522|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14762523|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762524|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14762525|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14762526|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
14762527|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936459|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14117740|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117741|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117742|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14117743|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
13938853|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13938854|NCT03310125|Colchicine|colchicine|mesh-list
13938855|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
13938856|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13938857|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
13938858|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14117744|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936460|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938859|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14117745|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
14762528|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14762529|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14936461|NCT01469468|Simvastatin|simvastatin|mesh-list
14936462|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13938860|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938861|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961668|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13961669|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961670|NCT03146390|Listerine|listerine|mesh-list
13961671|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
13961672|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13961673|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961674|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
13961675|NCT03146390|Protective Agents|protective agents|mesh-ancestor
13961676|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961677|NCT03146247|Apremilast|apremilast|mesh-list
13961678|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13961679|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13961680|NCT03146247|Analgesics|analgesics|mesh-ancestor
13961681|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
13961682|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961683|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961684|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13961685|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961686|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13961687|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13961688|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961689|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961690|NCT03146000|Meloxicam|meloxicam|mesh-list
13961691|NCT03146000|Lidocaine|lidocaine|mesh-list
13961692|NCT03146000|Prilocaine|prilocaine|mesh-list
14936463|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14936464|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
14936465|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936466|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13961693|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14117746|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14117747|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14117748|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14117749|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117750|NCT05087797|Nicorandil|nicorandil|mesh-list
13961694|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
13961695|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
13961696|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961697|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961698|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
13961699|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961700|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13961701|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13961702|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13961703|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13961704|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961705|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13961706|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13961707|NCT03146000|Analgesics|analgesics|mesh-ancestor
14117751|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14117752|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14117753|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
14117754|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
14117755|NCT05087797|Vitamins|vitamins|mesh-ancestor
14117756|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
14117757|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117758|NCT05087706|Bicalutamide|bicalutamide|mesh-list
14117759|NCT05087706|Leuprolide|leuprolide|mesh-list
14117760|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
14117761|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
14117762|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117763|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936467|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13961708|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13961709|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13961710|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13961711|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13961712|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961713|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14117764|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117765|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14117766|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
14117767|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14117768|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14117769|NCT05087693|Albuterol|albuterol|mesh-list
14117770|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14117771|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
14117772|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117773|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117774|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14117775|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
14117776|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
14117777|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14117778|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14117779|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14117780|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14117781|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117782|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117783|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176357|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176358|NCT04766463|Morphine|morphine|mesh-list
14176359|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14176360|NCT04766463|Narcotics|narcotics|mesh-ancestor
14176361|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176362|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176363|NCT04766463|Analgesics|analgesics|mesh-ancestor
14176364|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
14176365|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176366|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
14176367|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14176368|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
13938862|NCT03310073|Vaccines|vaccines|mesh-list
13938863|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
13938864|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938865|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
13938866|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13938867|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13938868|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13938869|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938870|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
13938871|NCT03310060|Coagulants|coagulants|mesh-ancestor
13938872|NCT03310047|Lidocaine|lidocaine|mesh-list
13938873|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
13938874|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
13938875|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938876|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938877|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
13938878|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938879|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13938880|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13938881|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13938882|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13938883|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938884|NCT03309865|Vedolizumab|vedolizumab|mesh-list
13938885|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938886|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
13938887|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13938888|NCT03309735|Progesterone|progesterone|mesh-list
13938889|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
13938890|NCT03309735|Progestins|progestins|mesh-ancestor
13938891|NCT03309735|Hormones|hormones|mesh-ancestor
13938892|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938893|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938894|NCT03309709|Progesterone|progesterone|mesh-list
13938895|NCT03309709|Progestins|progestins|mesh-ancestor
13938896|NCT03309709|Hormones|hormones|mesh-ancestor
13938897|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938898|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938899|NCT03309644|Iodine|iodine|mesh-list
13938900|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13938901|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13938902|NCT03309644|Trace Elements|trace elements|mesh-ancestor
14176369|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176370|NCT04766450|Expectorants|expectorants|mesh-ancestor
13938903|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
14176371|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
14117784|NCT05087368|Vaccines|vaccines|mesh-list
14117785|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
14117786|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117787|NCT05087134|Choline|choline|mesh-list
14117788|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
14117789|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14117790|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
14117791|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117792|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14117793|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14117794|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
14117795|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
14117796|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14117797|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14117798|NCT05086874|Protective Agents|protective agents|mesh-ancestor
14117799|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117800|NCT05086848|Leucovorin|leucovorin|mesh-list
14117801|NCT05086848|Fluorouracil|fluorouracil|mesh-list
14117802|NCT05086848|Irinotecan|irinotecan|mesh-list
14117803|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
14117804|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117805|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14117806|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117807|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117808|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
13938904|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938905|NCT03309618|Valsartan|valsartan|mesh-list
13938906|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14117809|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117810|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14117811|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14117812|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117813|NCT05086848|Antidotes|antidotes|mesh-ancestor
14117814|NCT05086848|Protective Agents|protective agents|mesh-ancestor
14117815|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
14117816|NCT05086848|Vitamins|vitamins|mesh-ancestor
14117817|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
14117818|NCT05086822|Irinotecan|irinotecan|mesh-list
14117819|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14117820|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14117821|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117822|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117823|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117824|NCT05086627|Capecitabine|capecitabine|mesh-list
14117825|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
14117826|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14117827|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
14117828|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117829|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117830|NCT05086614|Thymalfasin|thymalfasin|mesh-list
13938907|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13938908|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13938909|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938910|NCT03309592|Ambrisentan|ambrisentan|mesh-list
13938911|NCT03309592|Tadalafil|tadalafil|mesh-list
13938912|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
13938913|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13938914|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13938915|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938916|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938917|NCT03309592|Urological Agents|urological agents|mesh-ancestor
14117831|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14117832|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
14117833|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117834|NCT05086224|Lidocaine|lidocaine|mesh-list
14117835|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
13938918|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13938919|NCT03309566|Tenofovir|tenofovir|mesh-list
13938920|NCT03309566|Emtricitabine|emtricitabine|mesh-list
13938921|NCT03309566|Efavirenz|efavirenz|mesh-list
13938922|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
14117836|NCT05086224|Anesthetics|anesthetics|mesh-list
14117837|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478086|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13938923|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117838|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117839|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
13938924|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13938925|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13938926|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938927|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938928|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13938929|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13938930|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13938931|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13938932|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14117840|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117841|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14117842|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14117843|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14117844|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14117845|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117846|NCT05086107|Rifabutin|rifabutin|mesh-list
14117847|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14117848|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117849|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14117850|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
14117851|NCT05086081|Ticagrelor|ticagrelor|mesh-list
14117852|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14117853|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14117854|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14117855|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14117856|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14117857|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
14117858|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117859|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117860|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117861|NCT05085912|Ethanol|ethanol|mesh-list
14117862|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14117863|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117864|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117865|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117866|NCT05085782|Propranolol|propranolol|mesh-list
14117867|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14117868|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14117869|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117870|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117871|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117872|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117873|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14117874|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14117875|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
14117876|NCT05085665|Ivermectin|ivermectin|mesh-list
14117877|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14117878|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117879|NCT05085652|Anesthetics|anesthetics|mesh-list
14117880|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117881|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117882|NCT05085587|Fluticasone|fluticasone|mesh-list
14117883|NCT05085587|Xhance|xhance|mesh-list
14117884|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13938933|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13938934|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13938935|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13938936|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
13938937|NCT03309527|Promethazine|promethazine|mesh-list
14117885|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14117886|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117887|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14117888|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
14117889|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117890|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117891|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14117892|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
14762530|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13938938|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13938939|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13938940|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117893|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14117894|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14117895|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14117896|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14117897|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14117898|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117899|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117900|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117901|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
14117902|NCT05085587|Hormones|hormones|mesh-ancestor
14117903|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14117904|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
14117905|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
14117906|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14117907|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14117908|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13938941|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938942|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
13938943|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
13938944|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
13938945|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938946|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
13938947|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
13938948|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13938949|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14117909|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14117910|NCT05085106|Analgesics|analgesics|mesh-ancestor
14117911|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
14117912|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117913|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117914|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14117915|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14117916|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
14117917|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117918|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117919|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
14117920|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
14117921|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14117922|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14117923|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14117924|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117925|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117926|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176372|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14176373|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
14176374|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176375|NCT04766450|Protective Agents|protective agents|mesh-ancestor
14176376|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176377|NCT04766450|Antidotes|antidotes|mesh-ancestor
14176378|NCT04766229|Gabapentin|gabapentin|mesh-list
14176379|NCT04766229|Citalopram|citalopram|mesh-list
14176380|NCT04766229|Analgesics|analgesics|mesh-ancestor
14936468|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13938950|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
13938951|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
13938952|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13938953|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13938954|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13938955|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
13938956|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
13938957|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
13938958|NCT03309436|Clomiphene|clomiphene|mesh-list
13938959|NCT03309436|Enclomiphene|enclomiphene|mesh-list
13938960|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
13938961|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13938962|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
13938963|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938964|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938965|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14176381|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
14176382|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938966|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
14117927|NCT05084573|Bupivacaine|bupivacaine|mesh-list
14117928|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
14117929|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
14117930|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117931|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117932|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
14117933|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117934|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
14117935|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14117936|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14117937|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117938|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14117939|NCT05079672|Analgesics|analgesics|mesh-ancestor
14117940|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
14117941|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117942|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14117943|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14117944|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14117945|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117946|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117947|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117948|NCT05073939|Oxytocin|oxytocin|mesh-list
14117949|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
14117950|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14117951|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117952|NCT05068206|Bevacizumab|bevacizumab|mesh-list
14117953|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14117954|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117955|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14117956|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14117957|NCT05068206|Growth Substances|growth substances|mesh-ancestor
14117958|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117959|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
14117960|NCT05063370|Simendan|simendan|mesh-list
14117961|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14117962|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
14117963|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14117964|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14117965|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14117966|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117967|NCT05063370|Protective Agents|protective agents|mesh-ancestor
14117968|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117969|NCT05063006|Methamphetamine|methamphetamine|mesh-list
14117970|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14117971|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117972|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
14117973|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
14117974|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14117975|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
14117976|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14117977|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14117978|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
14117979|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14117980|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14117981|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14117982|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14117983|NCT05028257|Vaccines|vaccines|mesh-list
14117984|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
14117985|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117986|NCT05020392|Vidarabine|vidarabine|mesh-list
14117987|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
14117988|NCT05020392|Fludarabine|fludarabine|mesh-list
14117989|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
14117990|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14117991|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
14117992|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14117993|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762531|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762532|NCT02519452|Daratumumab|daratumumab|mesh-list
14117994|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14117995|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
14117996|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762533|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762534|NCT02503774|Durvalumab|durvalumab|mesh-list
13938967|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13938968|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13938969|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13938970|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
13938971|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14117997|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14117998|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14117999|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14118000|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
14118001|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
14118002|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118003|NCT05018221|Vitamins|vitamins|mesh-list
14118004|NCT05018221|Vitamin K|vitamin k|mesh-list
14118005|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
14118006|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
14118007|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
14118008|NCT05018221|Citric Acid|citric acid|mesh-list
14118009|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
14118010|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
14118011|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118012|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
14118013|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14118014|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
14118015|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
14118016|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118017|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14118018|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14118019|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
14118020|NCT05018221|Coagulants|coagulants|mesh-ancestor
14118021|NCT05018221|Antidotes|antidotes|mesh-ancestor
14118022|NCT05018221|Protective Agents|protective agents|mesh-ancestor
14118023|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
14118024|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
14118025|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14118026|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118027|NCT05018221|Cathartics|cathartics|mesh-ancestor
14118028|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118029|NCT05016947|Dexamethasone|dexamethasone|mesh-list
14118030|NCT05016947|Venetoclax|venetoclax|mesh-list
14118031|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14118032|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118033|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
14118034|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
14118035|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118036|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118037|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118038|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
14118039|NCT05016947|Hormones|hormones|mesh-ancestor
14118040|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118041|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118042|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118043|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118044|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14118045|NCT05013242|Goserelin|goserelin|mesh-list
14118046|NCT05013242|Dienogest|dienogest|mesh-list
13938972|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938973|NCT03309215|Nickel|nickel|mesh-list
13938974|NCT03309215|Trace Elements|trace elements|mesh-ancestor
13938975|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
13938976|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938977|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13938978|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
13938979|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13938980|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13938981|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13938982|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
13938983|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13938984|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938985|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13938986|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13938987|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13938988|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118047|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118048|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762535|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118049|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14118050|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
13938989|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13938990|NCT03309163|Tramadol|tramadol|mesh-list
13938991|NCT03309163|Hydromorphone|hydromorphone|mesh-list
13938992|NCT03309163|Ropivacaine|ropivacaine|mesh-list
13938993|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
13938994|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
14118051|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14118052|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118053|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14118054|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14478087|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
14478088|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478089|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478090|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14478091|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
14478092|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
14478093|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14478094|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
14478095|NCT02446418|Hormones|hormones|mesh-ancestor
14478096|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13938995|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13938996|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13938997|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
13938998|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13938999|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14478097|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14478098|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14478099|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13939000|NCT03309163|Narcotics|narcotics|mesh-ancestor
14118055|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14118056|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14118057|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
14118058|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118059|NCT05008510|Camptothecin|camptothecin|mesh-list
14118060|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
14118061|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14118062|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118063|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14118064|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14118065|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118066|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118067|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
14118068|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118069|NCT04978298|Phenelzine|phenelzine|mesh-list
14118070|NCT04978298|Ozanimod|ozanimod|mesh-list
14118071|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14118072|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118073|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14118074|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
14118075|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118076|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
14118077|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118078|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13939001|NCT03309163|Analgesics|analgesics|mesh-ancestor
13939002|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
13939003|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13939004|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118079|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118080|NCT04976595|Testosterone|testosterone|mesh-list
14118081|NCT04976595|Androgens|androgens|mesh-ancestor
14118082|NCT04976595|Hormones|hormones|mesh-ancestor
14118083|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118084|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118085|NCT04951050|Sirolimus|sirolimus|mesh-list
14118086|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14118087|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118088|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14118089|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118090|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
14118091|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14118092|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
14118093|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939005|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
13939006|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
13939007|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
14118094|NCT04934072|Denosumab|denosumab|mesh-list
13939008|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
13939009|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13939010|NCT03309059|Protective Agents|protective agents|mesh-ancestor
13939011|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939012|NCT03308955|Tramadol|tramadol|mesh-list
13939013|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13939014|NCT03308955|Narcotics|narcotics|mesh-ancestor
13939015|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939016|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939017|NCT03308955|Analgesics|analgesics|mesh-ancestor
14118095|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14118096|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118097|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
14118098|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14118099|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118100|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118101|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118102|NCT04925648|Dasatinib|dasatinib|mesh-list
14118103|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118104|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14118105|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118106|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118107|NCT04912856|Ezogabine|ezogabine|mesh-list
14118108|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
14118109|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118110|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118111|NCT04880863|Docetaxel|docetaxel|mesh-list
14118112|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
14118113|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118114|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14118115|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14118116|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14118117|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118118|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118119|NCT04880577|Tenofovir|tenofovir|mesh-list
14118120|NCT04880577|Rituximab|rituximab|mesh-list
13939018|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
13939019|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939020|NCT03308916|Liver Extracts|liver extracts|mesh-list
13939021|NCT03308916|Hematinics|hematinics|mesh-ancestor
13939022|NCT03308890|Entecavir|entecavir|mesh-list
13939023|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
13939024|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939025|NCT03308786|Aldesleukin|aldesleukin|mesh-list
14118121|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
14118122|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118123|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118124|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
14118125|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118126|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118127|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
14118128|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118129|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14118130|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14118131|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118132|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118133|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14118134|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14176383|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176384|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
14176385|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14176386|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14176387|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176388|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14176389|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14176390|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14176391|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176392|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939026|NCT03308786|Interleukin-2|interleukin-2|mesh-list
14176393|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
14176394|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14118135|NCT04861558|Fluorouracil|fluorouracil|mesh-list
14118136|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
14118137|NCT04861558|Irinotecan|irinotecan|mesh-list
14118138|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
14118139|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118140|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14118141|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118142|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14118143|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
14118144|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118145|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14118146|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14118147|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118148|NCT04859296|Dronabinol|dronabinol|mesh-list
14118149|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
14118150|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118151|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118152|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14118153|NCT04859296|Analgesics|analgesics|mesh-ancestor
14118154|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
14118155|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118156|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14118157|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14118158|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118159|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118160|NCT04859296|Hormones|hormones|mesh-ancestor
14118161|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118162|NCT04837235|Hemay005|hemay005|mesh-list
14118163|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
14118164|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14118165|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14118166|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118167|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118168|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
14118169|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14118170|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
14118171|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118172|NCT04793646|Expectorants|expectorants|mesh-ancestor
14118173|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
14118174|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14118175|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
14118176|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118177|NCT04793646|Protective Agents|protective agents|mesh-ancestor
14118178|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118179|NCT04793646|Antidotes|antidotes|mesh-ancestor
14118180|NCT04775550|Dexamethasone|dexamethasone|mesh-list
14118181|NCT04775550|Lenalidomide|lenalidomide|mesh-list
14118182|NCT04775550|Bortezomib|bortezomib|mesh-list
14118183|NCT04775550|Daratumumab|daratumumab|mesh-list
14118184|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118185|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
14118186|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
14118187|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118188|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118189|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118190|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
14118191|NCT04775550|Hormones|hormones|mesh-ancestor
14118192|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118193|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118194|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118195|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
14118196|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14118197|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14118198|NCT04775550|Growth Substances|growth substances|mesh-ancestor
14118199|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
14118200|NCT04771962|Sevoflurane|sevoflurane|mesh-list
14118201|NCT04771962|Desflurane|desflurane|mesh-list
14118202|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14118203|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14118204|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
14118205|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
14478100|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478101|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939027|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939028|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13939029|NCT03308786|Analgesics|analgesics|mesh-ancestor
13939030|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
13939031|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939032|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939033|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13939034|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13939035|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
14118206|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118207|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118208|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
14118209|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14118210|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118211|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118212|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118213|NCT04726098|Dexamethasone|dexamethasone|mesh-list
14118214|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
14118215|NCT04726098|BB 1101|bb 1101|mesh-list
14118216|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118217|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
14118218|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
14118219|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118220|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118221|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118222|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
14118223|NCT04726098|Hormones|hormones|mesh-ancestor
14118224|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118225|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118226|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118227|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
14118228|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118229|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118230|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
14118231|NCT04699071|Lenvatinib|lenvatinib|mesh-list
14118232|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118233|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118234|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14118235|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118236|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118237|NCT04648189|Cetuximab|cetuximab|mesh-list
14118238|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118239|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118240|NCT04643249|Repaglinide|repaglinide|mesh-list
14118241|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
14118242|NCT04643249|Midazolam|midazolam|mesh-list
14118243|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
14118244|NCT04643249|Caffeine|caffeine|mesh-list
14118245|NCT04643249|Bupropion|bupropion|mesh-list
14118246|NCT04643249|Omeprazole|omeprazole|mesh-list
14118247|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14118248|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14118249|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118250|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118251|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14118252|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14118253|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118254|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14118255|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
14118256|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
14118257|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
14118258|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
14118259|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118260|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118261|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14118262|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118263|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14118264|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118265|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14118266|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14118267|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14118268|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14118269|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
14478102|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939036|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939037|NCT03308708|Norepinephrine|norepinephrine|mesh-list
14118270|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14118271|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
14118272|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14118273|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14118274|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118275|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
14118276|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14118277|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14118278|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
14118279|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
14118280|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14118281|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14118282|NCT04643249|Analgesics|analgesics|mesh-ancestor
14118283|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
14118284|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118285|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14118286|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14118287|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118288|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118289|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14118290|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118291|NCT04583618|Vaccines|vaccines|mesh-list
14118292|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14118293|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
14118294|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118295|NCT04558294|Ketanserin|ketanserin|mesh-list
14118296|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
14118297|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
14118298|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118299|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118300|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14118301|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
14118302|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118303|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118304|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14118305|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14118306|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14118307|NCT04551222|Probenecid|probenecid|mesh-list
14118308|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
14118309|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
14118310|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118311|NCT04551222|Renal Agents|renal agents|mesh-ancestor
14118312|NCT04537897|Midazolam|midazolam|mesh-list
14118313|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14118314|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14118315|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118316|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118317|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14118318|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14118319|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118320|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14118321|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
14118322|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
14118323|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
14118324|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
14118325|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118326|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118327|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
14118328|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14118329|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14118330|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118331|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
14118332|NCT04521881|Coagulants|coagulants|mesh-ancestor
14478103|NCT02446483|Rabeprazole|rabeprazole|mesh-list
13939038|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13939039|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13939040|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
13939041|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939042|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939043|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939044|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
13939045|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
13939046|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478104|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14118333|NCT04507581|Anesthetics|anesthetics|mesh-list
14118334|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118335|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118336|NCT04507438|Donepezil|donepezil|mesh-list
14118337|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14118338|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118339|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118340|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
14118341|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118342|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118343|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
14118344|NCT04505670|Donepezil|donepezil|mesh-list
14118345|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
14118346|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14118347|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118348|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118349|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
14118350|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118351|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118352|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
14118353|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14118354|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
14118355|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14118356|NCT04505670|Protective Agents|protective agents|mesh-ancestor
14176395|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14176396|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176397|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
14176398|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14176399|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
14176400|NCT04765904|Fluorides|fluorides|mesh-list
14176401|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
14176402|NCT04765904|Protective Agents|protective agents|mesh-ancestor
14176403|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939047|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13939048|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
13939049|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13939050|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939051|NCT03308643|Oxytocin|oxytocin|mesh-list
13939052|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
13939053|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13939054|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939055|NCT03308604|Cisplatin|cisplatin|mesh-list
13939056|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939057|NCT03308552|Paclitaxel|paclitaxel|mesh-list
13939058|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13939059|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13939060|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939061|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
13939062|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
13939063|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
13939064|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939065|NCT03308487|Vitamin D|vitamin d|mesh-list
13939066|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
13939067|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
13939068|NCT03308487|Vitamins|vitamins|mesh-list
13939069|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
13939070|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939071|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13939072|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13961714|NCT03146325|Metronidazole|metronidazole|mesh-list
13961715|NCT03146325|Tetracycline|tetracycline|mesh-list
13961716|NCT03146325|Omeprazole|omeprazole|mesh-list
14176404|NCT04765709|Carboplatin|carboplatin|mesh-list
14176405|NCT04765709|Pemetrexed|pemetrexed|mesh-list
14176406|NCT04765709|Durvalumab|durvalumab|mesh-list
14176407|NCT04765709|Vinorelbine|vinorelbine|mesh-list
14176408|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14176409|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176410|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176411|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176412|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14176413|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13961717|NCT03146325|Bismuth|bismuth|mesh-list
13961718|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961719|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961720|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13961721|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118357|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
14118358|NCT04474002|Cathartics|cathartics|mesh-ancestor
14118359|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118360|NCT04470622|Aprepitant|aprepitant|mesh-list
14118361|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
14118362|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
14118363|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118364|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118365|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118366|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14118367|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118368|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118369|NCT04405063|Paclitaxel|paclitaxel|mesh-list
14118370|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14118371|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118372|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
14118373|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
14118374|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
14118375|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118376|NCT04373317|Pimavanserin|pimavanserin|mesh-list
13939073|NCT03308357|Infliximab|infliximab|mesh-list
13939074|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
13939075|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13939076|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939077|NCT03308331|Nicotine|nicotine|mesh-list
13939078|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13939079|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
13939080|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939081|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939082|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13939083|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13939084|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
13939085|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939086|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939087|NCT03308253|Vancomycin|vancomycin|mesh-list
13939088|NCT03308253|Tobramycin|tobramycin|mesh-list
13939089|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13939090|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939091|NCT03308214|Imipenem|imipenem|mesh-list
13939092|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13939093|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939094|NCT03308201|Letrozole|letrozole|mesh-list
13939095|NCT03308201|Fulvestrant|fulvestrant|mesh-list
13939096|NCT03308201|Exemestane|exemestane|mesh-list
13939097|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939098|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13939099|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13939100|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939101|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939102|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13939103|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
13939104|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939105|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939106|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118377|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14118378|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
14118379|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118380|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14118381|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14118382|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118383|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118384|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14118385|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14118386|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13939107|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13939108|NCT03308149|Triamcinolone|triamcinolone|mesh-list
14118387|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14118388|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
14118389|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118390|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118391|NCT04362566|Bupivacaine|bupivacaine|mesh-list
14118392|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939109|NCT03308149|Bupivacaine|bupivacaine|mesh-list
13939110|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939111|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
14118393|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
14118394|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939112|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939113|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939114|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
13939115|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939116|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13939117|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
13939118|NCT03308149|Hormones|hormones|mesh-ancestor
13939119|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939120|NCT03308136|Lidocaine|lidocaine|mesh-list
13939121|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
13939122|NCT03308136|Anesthetics|anesthetics|mesh-list
13939123|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939124|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939125|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
13939126|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118395|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118396|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
14118397|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118398|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
14118399|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
14118400|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14118401|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118402|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118403|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118404|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118405|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118406|NCT04335084|Vitamin D|vitamin d|mesh-list
14118407|NCT04335084|Vitamins|vitamins|mesh-list
14118408|NCT04335084|Ascorbic Acid|ascorbic acid|mesh-list
14118409|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
14118410|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
14118411|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118412|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14118413|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
14118414|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14118415|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118416|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118417|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118418|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118419|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118420|NCT04335084|Antioxidants|antioxidants|mesh-ancestor
14118421|NCT04335084|Protective Agents|protective agents|mesh-ancestor
14118422|NCT04316871|Morphine|morphine|mesh-list
14118423|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14118424|NCT04316871|Narcotics|narcotics|mesh-ancestor
14118425|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118426|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118427|NCT04316871|Analgesics|analgesics|mesh-ancestor
14118428|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
14118429|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118430|NCT04295941|Trazodone|trazodone|mesh-list
14118431|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14118432|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14118433|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118434|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118435|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118436|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14118437|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14118438|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118439|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118440|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118441|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
14118442|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14118443|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
14118444|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
14118445|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
14118446|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
14118447|NCT04280692|Lumefantrine|lumefantrine|mesh-list
14118448|NCT04280692|Artemether|artemether|mesh-list
14118449|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
14118450|NCT04280692|Piperaquine|piperaquine|mesh-list
14118451|NCT04280692|Primaquine|primaquine|mesh-list
14118452|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
14118453|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14118454|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14118455|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
14118456|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13939127|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13939128|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13939129|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13939130|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939131|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939132|NCT03308084|Dexamethasone|dexamethasone|mesh-list
13939133|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
13939134|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13939135|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13939136|NCT03308084|Prednisolone|prednisolone|mesh-list
13939137|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
13939138|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13939139|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
13939140|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13939141|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
13939142|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
13939143|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939144|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939145|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13939146|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
13939147|NCT03308084|Hormones|hormones|mesh-ancestor
13939148|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939149|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13939150|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939151|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13939152|NCT03308084|Protective Agents|protective agents|mesh-ancestor
13939153|NCT03307941|Fluorouracil|fluorouracil|mesh-list
13939154|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
13939155|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
13939156|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939157|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13939158|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939159|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13939160|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
13939161|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939162|NCT03307902|Imiquimod|imiquimod|mesh-list
13939163|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13939164|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
13939165|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939166|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939167|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
13939168|NCT03307863|Topiramate|topiramate|mesh-list
13939169|NCT03307863|Carbamazepine|carbamazepine|mesh-list
13939170|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
13939171|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13939172|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939173|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
13939174|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13939175|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939176|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13939177|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13939178|NCT03307863|Analgesics|analgesics|mesh-ancestor
13939179|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
13939180|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939181|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13939182|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939183|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118457|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118458|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939184|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13939185|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13939186|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
13939187|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939188|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939189|NCT03307746|Rituximab|rituximab|mesh-list
13939190|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118459|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14118460|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118461|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118462|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14118463|NCT04280692|Renal Agents|renal agents|mesh-ancestor
14118464|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14118465|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14118466|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118467|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
13939191|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939192|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
13939193|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939194|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939195|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13939196|NCT03307720|Hormones|hormones|mesh-list
13939197|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939198|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939199|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13939200|NCT03307603|Nivolumab|nivolumab|mesh-list
13939201|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118468|NCT04122196|Pregabalin|pregabalin|mesh-list
14118469|NCT04122196|Analgesics|analgesics|mesh-ancestor
14118470|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
14118471|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118472|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118473|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
14118474|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14118475|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118476|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118477|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14118478|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14118479|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14118480|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118481|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118482|NCT04094012|Isoniazid|isoniazid|mesh-list
14118483|NCT04094012|Rifapentine|rifapentine|mesh-list
14118484|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
14118485|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14118486|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118487|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14118488|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14118489|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
14118490|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118491|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14118492|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13939202|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939203|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13939204|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939205|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
13939206|NCT03307590|Bupivacaine|bupivacaine|mesh-list
13939207|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939208|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
13939209|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939210|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939211|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
13939212|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939213|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13939214|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13939215|NCT03307590|Analgesics|analgesics|mesh-ancestor
13939216|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13939217|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13939218|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13939219|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
13939220|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118493|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
13961722|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14118494|NCT04076761|Trifluridine|trifluridine|mesh-list
14118495|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
14118496|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118497|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
14118498|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118499|NCT04062266|Azacitidine|azacitidine|mesh-list
14118500|NCT04062266|Venetoclax|venetoclax|mesh-list
14118501|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14118502|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
14118503|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118504|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118505|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118506|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
14118507|NCT04021381|Cathartics|cathartics|mesh-ancestor
14118508|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118509|NCT04004442|Avelumab|avelumab|mesh-list
14118510|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118511|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118512|NCT03970304|Vaccines|vaccines|mesh-list
14118513|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
14118514|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118515|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
14118516|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
14118517|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
14118518|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118519|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118520|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118521|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14118522|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13939221|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939222|NCT03307551|Propofol|propofol|mesh-list
13939223|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13939224|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939225|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939226|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13939227|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
13939228|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
13939229|NCT03307512|Insulin|insulin|mesh-list
14118523|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14118524|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14118525|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14118526|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
14118527|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118528|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939230|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13939231|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
13939232|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13939233|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939234|NCT03307213|Sirolimus|sirolimus|mesh-list
13939235|NCT03307213|Umirolimus|umirolimus|mesh-list
13939236|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13939237|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13939238|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
13939239|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939240|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13939241|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939242|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13939243|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939244|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
13939245|NCT03307148|Gemcitabine|gemcitabine|mesh-list
13939246|NCT03307148|Paclitaxel|paclitaxel|mesh-list
13939247|NCT03307148|Tretinoin|tretinoin|mesh-list
13939248|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13939249|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939250|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
13939251|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
13939252|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176414|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14176415|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
14176416|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176417|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13939253|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939254|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176418|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
13939255|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
13939256|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
14176419|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
13939257|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118529|NCT03944902|Niraparib|niraparib|mesh-list
14118530|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14118531|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118532|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118533|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118534|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14118535|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118536|NCT03911505|Miglustat|miglustat|mesh-list
14118537|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118538|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118539|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14118540|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14118541|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
14118542|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939258|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939259|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13939260|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
13939261|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939262|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
13939263|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
14118543|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14118544|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118545|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939264|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
13939265|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13939266|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13939267|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14118563|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
14118564|NCT03898180|Lenvatinib|lenvatinib|mesh-list
14118565|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118566|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118567|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14118568|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118569|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118570|NCT03898154|Dexamethasone|dexamethasone|mesh-list
14118571|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
14118572|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14118573|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14118574|NCT03898154|Prednisolone|prednisolone|mesh-list
14118575|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
14118576|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14118577|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
14118578|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118579|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
14118580|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
14118581|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118582|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118583|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118584|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
14118585|NCT03898154|Hormones|hormones|mesh-ancestor
14118586|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118587|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118588|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118589|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14118590|NCT03898154|Protective Agents|protective agents|mesh-ancestor
13939268|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118591|NCT03857087|Edetic Acid|edetic acid|mesh-list
14118592|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14118593|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
14118594|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
14118595|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118596|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
14118597|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14118598|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14118599|NCT03845140|Praziquantel|praziquantel|mesh-list
14118600|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
14118601|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118602|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118603|NCT03827447|Vancomycin|vancomycin|mesh-list
14118604|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14118605|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118606|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
14118607|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14118608|NCT03821857|Corticosterone|corticosterone|mesh-list
14118609|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118610|NCT03727724|Cetuximab|cetuximab|mesh-list
14118611|NCT03727724|Afatinib|afatinib|mesh-list
14118612|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118613|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118614|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14118615|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118616|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118617|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14118618|NCT03697031|Hormones|hormones|mesh-ancestor
14118619|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118620|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118621|NCT03672487|Benzonidazole|benzonidazole|mesh-list
14118622|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14118623|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
14118624|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118625|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14118626|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14118627|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118628|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118629|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
14118630|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939269|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939270|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
13939271|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939272|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939273|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13939274|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939275|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
13939276|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
13939277|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
13939278|NCT03306901|Fluorouracil|fluorouracil|mesh-list
13939279|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939280|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
13939281|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939282|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13939283|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13939284|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
13939285|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118631|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
14118632|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118633|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118634|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14118635|NCT03637764|Atezolizumab|atezolizumab|mesh-list
14118636|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118637|NCT03630835|Annexin A5|annexin a5|mesh-list
14118638|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939286|NCT03306836|Heparin|heparin|mesh-list
13939287|NCT03306836|Calcium heparin|calcium heparin|mesh-list
13939288|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
13939289|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13939290|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13939291|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939292|NCT03306745|Folic Acid|folic acid|mesh-list
13939293|NCT03306745|Hematinics|hematinics|mesh-ancestor
13939294|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
13939295|NCT03306745|Vitamins|vitamins|mesh-ancestor
13939296|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
14118639|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118640|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
13939297|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961723|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961724|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13961725|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961726|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961727|NCT03146325|Antacids|antacids|mesh-ancestor
13961728|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13961729|NCT03146052|Simethicone|simethicone|mesh-list
13961730|NCT03146052|Bisacodyl|bisacodyl|mesh-list
13961731|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961732|NCT03146052|Cathartics|cathartics|mesh-ancestor
13961733|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961734|NCT03146052|Laxatives|laxatives|mesh-ancestor
14118641|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
14118642|NCT03541850|Hormones|hormones|mesh-list
14118643|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14118644|NCT03541850|Androgens|androgens|mesh-list
14118645|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
13961735|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
13961736|NCT03146052|Emollients|emollients|mesh-ancestor
13961737|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
13961738|NCT03145649|Insulin|insulin|mesh-list
13961739|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118646|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118647|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118648|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
14118649|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118650|NCT03541850|Protective Agents|protective agents|mesh-ancestor
14118651|NCT03541850|Vitamins|vitamins|mesh-ancestor
14118652|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
14118653|NCT03541850|Estrogens|estrogens|mesh-ancestor
14118654|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118655|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118656|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
14118657|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
14118658|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
14118659|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118660|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118661|NCT03469050|Rifaximin|rifaximin|mesh-list
14118662|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14118663|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118664|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118665|NCT03415061|Insulin|insulin|mesh-list
14118666|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14118667|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118668|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118669|NCT03403621|Pentamidine|pentamidine|mesh-list
14118670|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
14118671|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118672|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14118673|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118674|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14118675|NCT03367819|Cemiplimab|cemiplimab|mesh-list
14118676|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118677|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118678|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
14118679|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14118680|NCT03327844|Metronidazole|metronidazole|mesh-list
14118681|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
14118682|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14118683|NCT03327844|Calcium|calcium|mesh-list
14118684|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14118685|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118686|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14118687|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118688|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
14118689|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14118690|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118691|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13961740|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961741|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
14118692|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14118693|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118694|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961742|NCT03145714|Anesthetics|anesthetics|mesh-list
13961743|NCT03145714|Propofol|propofol|mesh-list
14118695|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118696|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13939298|NCT03306732|Thiamine|thiamine|mesh-list
13939299|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
13939300|NCT03306732|Vitamins|vitamins|mesh-ancestor
13939301|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
13939302|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939303|NCT03306667|Dotinurad|dotinurad|mesh-list
13939304|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
13939305|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
13939306|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939307|NCT03306667|Renal Agents|renal agents|mesh-ancestor
13939308|NCT03306602|Z 350|z 350|mesh-list
13939309|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13939310|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13939311|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939312|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939313|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
13939314|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939315|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939316|NCT03306550|Aspirin|aspirin|mesh-list
13939317|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14118697|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14118698|NCT03189706|Irinotecan|irinotecan|mesh-list
14118699|NCT03189706|Temozolomide|temozolomide|mesh-list
14118700|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14118701|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14118702|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118703|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118704|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118705|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14118706|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
14118707|NCT03158883|Avelumab|avelumab|mesh-list
14118708|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118709|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176420|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176421|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
14176422|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14176423|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176424|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176425|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14176426|NCT04766047|Analgesics|analgesics|mesh-ancestor
14176427|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
14176428|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176429|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14176430|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14176431|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14176432|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
14176433|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176434|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176435|NCT04766021|Mirabegron|mirabegron|mesh-list
14176436|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14176437|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14176438|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14176439|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14176440|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939318|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13939319|NCT03306550|Analgesics|analgesics|mesh-ancestor
14176441|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176442|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176443|NCT04766021|Urological Agents|urological agents|mesh-ancestor
14176444|NCT04765267|Vitamin D|vitamin d|mesh-list
14176445|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
14176446|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
14176447|NCT04765267|Vitamins|vitamins|mesh-ancestor
14176448|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
14176449|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176450|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14176451|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14176452|NCT04765267|Astringents|astringents|mesh-ancestor
14176453|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
14176454|NCT04765514|Temozolomide|temozolomide|mesh-list
14478105|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478106|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13939320|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
13939321|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939322|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118710|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
14118711|NCT03113994|Vitamin D|vitamin d|mesh-list
14118712|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
13939323|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13939324|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939325|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13939326|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13939327|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939328|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13939329|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13939330|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939331|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
13939332|NCT03306472|Letrozole|letrozole|mesh-list
13939333|NCT03306472|Megestrol|megestrol|mesh-list
13939334|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
14118713|NCT03113994|Ubiquinone|ubiquinone|mesh-list
14118714|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
14118715|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14118716|NCT03113994|Calcium|calcium|mesh-list
14118717|NCT03113994|Vitamins|vitamins|mesh-ancestor
14118718|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
14118719|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118720|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14118721|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14118722|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14118723|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14118724|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
14118725|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118726|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14118727|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14118728|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118729|NCT03113994|Antacids|antacids|mesh-ancestor
14118730|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118731|NCT02960568|Primaquine|primaquine|mesh-list
14118732|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
13939335|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939336|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13939337|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13939338|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939339|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939340|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14118733|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14118734|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14118735|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118736|NCT02958865|PF-06700841|pf-06700841|mesh-list
14118737|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14118738|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118739|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118740|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14118741|NCT02954510|Hematinics|hematinics|mesh-ancestor
14118742|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14118743|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14118744|NCT02953665|Liraglutide|liraglutide|mesh-list
14118745|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118746|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118747|NCT02953665|Incretins|incretins|mesh-ancestor
13939341|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
13939342|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939343|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939344|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13939345|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13939346|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13939347|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
13939348|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13939349|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13939350|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13939351|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13939352|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
13939353|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13939354|NCT03306446|Adalimumab|adalimumab|mesh-list
13939355|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118748|NCT02953665|Hormones|hormones|mesh-ancestor
14118749|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118750|NCT02864004|Apomorphine|apomorphine|mesh-list
14118751|NCT02864004|Emetics|emetics|mesh-ancestor
14118752|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939356|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939357|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
13939358|NCT03306368|Narcotics|narcotics|mesh-ancestor
13939359|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939360|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939361|NCT03306368|Analgesics|analgesics|mesh-ancestor
13939362|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
13939363|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939364|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13939365|NCT03306290|Cefoxitin|cefoxitin|mesh-list
13939366|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939367|NCT03306264|Decitabine|decitabine|mesh-list
13939368|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13939369|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
13939370|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939371|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939372|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939373|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
14118753|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
14118754|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118755|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118756|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
14118757|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
14118758|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118759|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936469|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
14936470|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936471|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936472|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
14936473|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14118760|NCT02834403|Aspirin|aspirin|mesh-list
14118761|NCT02834403|Docetaxel|docetaxel|mesh-list
14118762|NCT02834403|Amlodipine|amlodipine|mesh-list
14118763|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14118764|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118765|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
14118766|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
14118767|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
14118768|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118769|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14118770|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14118771|NCT02834403|Analgesics|analgesics|mesh-ancestor
14118772|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
14118773|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118774|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118775|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118776|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118777|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14118778|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14118779|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14118780|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14118781|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118782|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
14118783|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14118784|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14118785|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118786|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14118787|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
14118788|NCT02770040|Infliximab|infliximab|mesh-list
14118789|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
14762536|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762537|NCT02496585|Prednisone|prednisone|mesh-list
14762538|NCT02496585|Nintedanib|nintedanib|mesh-list
14762539|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762540|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
14762541|NCT02496585|Hormones|hormones|mesh-ancestor
14762542|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762543|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762544|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762545|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762546|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14762547|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936474|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
14938720|NCT01483638|Axitinib|axitinib|mesh-list
14118790|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14118791|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118792|NCT02766465|Sirolimus|sirolimus|mesh-list
14118793|NCT02766465|Methotrexate|methotrexate|mesh-list
14118794|NCT02766465|Fludarabine|fludarabine|mesh-list
14118795|NCT02766465|Melphalan|melphalan|mesh-list
14118796|NCT02766465|Busulfan|busulfan|mesh-list
14118797|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
14118798|NCT02766465|Tacrolimus|tacrolimus|mesh-list
14118799|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14118800|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
14118801|NCT02766465|Lenograstim|lenograstim|mesh-list
14118802|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14118803|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
14118804|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14118805|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118806|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14118807|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
14118808|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118809|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118810|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
14118811|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118812|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14118813|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14118814|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
14118815|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118816|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14118817|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14118818|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14118819|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118820|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14118821|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
14118822|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14118823|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
14118824|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14118825|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14118826|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762548|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762549|NCT02489318|Androgens|androgens|mesh-list
14118827|NCT02748018|Insulin|insulin|mesh-list
14118828|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14118829|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118830|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
14118831|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14118832|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14118833|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
14118834|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118835|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14118836|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762550|NCT02489318|Hormones|hormones|mesh-ancestor
14762551|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939374|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13939375|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13939376|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13939377|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939378|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939379|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
13939380|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939381|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939382|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13939383|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939384|NCT03305978|Ivermectin|ivermectin|mesh-list
13939385|NCT03305978|Selamectin|selamectin|mesh-list
13939386|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13939387|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939388|NCT03305536|Vitamin D|vitamin d|mesh-list
13939389|NCT03305536|Vitamins|vitamins|mesh-list
14118837|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118838|NCT02701088|Mitomycins|mitomycins|mesh-list
14762552|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762553|NCT02484443|Dinutuximab|dinutuximab|mesh-list
14762554|NCT02484443|Sargramostim|sargramostim|mesh-list
14762555|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
14762556|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939390|NCT03305536|Vitamin K|vitamin k|mesh-list
14118839|NCT02701088|Mitomycin|mitomycin|mesh-list
14762557|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939391|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
14118840|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14118841|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118842|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
14118843|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118844|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14118845|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118846|NCT02675465|Miglustat|miglustat|mesh-list
14118847|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118848|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118849|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14118850|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14118851|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
14118852|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118853|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14118854|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13939392|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
13939393|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
13939394|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939395|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13939396|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13939397|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14118855|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118856|NCT02663908|Leuprolide|leuprolide|mesh-list
14118857|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14118858|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
14118859|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14118860|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118861|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14118862|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118863|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14118864|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14118865|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118866|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
14118867|NCT02624765|Digoxin|digoxin|mesh-list
14118868|NCT02624765|Sotalol|sotalol|mesh-list
14118869|NCT02624765|Flecainide|flecainide|mesh-list
14118870|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14118871|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13939398|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939399|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
13939400|NCT03305536|Coagulants|coagulants|mesh-ancestor
13939401|NCT03305510|Vitamin D|vitamin d|mesh-list
13939402|NCT03305510|Vitamins|vitamins|mesh-ancestor
13939403|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
13939404|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939405|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13939406|NCT03305471|Sevelamer|sevelamer|mesh-list
13939407|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
13939408|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
13939409|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939410|NCT03305445|Nivolumab|nivolumab|mesh-list
13939411|NCT03305445|Ipilimumab|ipilimumab|mesh-list
13939412|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939413|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939414|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13939415|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939416|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
13939417|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
13939418|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13939419|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13939420|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939421|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939422|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939423|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939424|NCT03305068|Celecoxib|celecoxib|mesh-list
13939425|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13939426|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13939427|NCT03305068|Analgesics|analgesics|mesh-ancestor
13939428|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
13939429|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939430|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939431|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13939432|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118872|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118873|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118874|NCT02624765|Protective Agents|protective agents|mesh-ancestor
14118875|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118876|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14118877|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14118878|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
14118879|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118880|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
14118881|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
14118882|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118883|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14118884|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14118885|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118886|NCT02554383|Amoxicillin|amoxicillin|mesh-list
14118887|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
13939433|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13939434|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13939435|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939436|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961744|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961745|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961746|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13961747|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13961748|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
13961749|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13961750|NCT03145714|Analgesics|analgesics|mesh-ancestor
13961751|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
13961752|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961753|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13961754|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13961755|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13961756|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
13961757|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961758|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961759|NCT03145610|Triclosan|triclosan|mesh-list
13961760|NCT03145610|Fluorides|fluorides|mesh-list
13961761|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
13961762|NCT03145610|Protective Agents|protective agents|mesh-ancestor
14118888|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
14118889|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14118890|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14118891|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118892|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14118893|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118894|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762558|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
14762559|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762560|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
14762561|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762562|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762563|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762564|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
14118895|NCT05090449|Losartan|losartan|mesh-list
14118896|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
14118897|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14118898|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13961763|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961764|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13961765|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961766|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13961767|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13961768|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
13961769|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961770|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13961771|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13961772|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961773|NCT03146104|Propofol|propofol|mesh-list
13961774|NCT03146104|Isoflurane|isoflurane|mesh-list
14762565|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762566|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762567|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762568|NCT02408861|Nivolumab|nivolumab|mesh-list
14936475|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961775|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14118899|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14118900|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14118901|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118902|NCT05090449|Diuretics|diuretics|mesh-ancestor
14118903|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
14118904|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118905|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14118906|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118907|NCT05090176|Povidone|povidone|mesh-list
14118908|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
14118909|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
14118910|NCT05090137|Diuretics|diuretics|mesh-list
14118911|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
14118912|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118913|NCT05090124|Adalimumab|adalimumab|mesh-list
14118914|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14118915|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14118916|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
14118917|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14118918|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
14118919|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14118920|NCT05089981|Expectorants|expectorants|mesh-ancestor
14118921|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
14118922|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14118923|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
14118924|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118925|NCT05089981|Protective Agents|protective agents|mesh-ancestor
14118926|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118927|NCT05089981|Antidotes|antidotes|mesh-ancestor
14118928|NCT05089604|Tacrolimus|tacrolimus|mesh-list
14118929|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14118930|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
14118931|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118932|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14118933|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118934|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118935|NCT05089539|Valsartan|valsartan|mesh-list
14118936|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14118937|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14118938|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14118939|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118940|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
14118941|NCT05089461|Analgesics|analgesics|mesh-ancestor
14118942|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
14118943|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118944|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118945|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118946|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14118947|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14118948|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14118949|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118950|NCT05089448|Amlodipine|amlodipine|mesh-list
14118951|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14118952|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14118953|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14118954|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118955|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14118956|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118957|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
14176455|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14176456|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
14176457|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478107|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762569|NCT02408861|Ipilimumab|ipilimumab|mesh-list
14762570|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478108|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478109|NCT02446496|Cefadroxil|cefadroxil|mesh-list
14478110|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14478111|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478112|NCT02446717|Ribavirin|ribavirin|mesh-list
14478113|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
14478114|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478115|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
14478116|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478117|NCT02446886|Hormones|hormones|mesh-list
13939437|NCT03304652|Zaleplon|zaleplon|mesh-list
13939438|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
13939439|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13939440|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939441|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939442|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
13939443|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
13939444|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939445|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939446|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
13939447|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13939448|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
14762571|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762572|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14762573|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762574|NCT02408549|Lacosamide|lacosamide|mesh-list
14762575|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
14762576|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14762577|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14936476|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
13939449|NCT03304457|Olanzapine|olanzapine|mesh-list
13939450|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
13939451|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
14118958|NCT05089383|Progesterone|progesterone|mesh-list
14118959|NCT05089383|Progestins|progestins|mesh-ancestor
14118960|NCT05089383|Hormones|hormones|mesh-ancestor
14118961|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118962|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118963|NCT05089344|Clomiphene|clomiphene|mesh-list
14118964|NCT05089344|Enclomiphene|enclomiphene|mesh-list
14118965|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
14118966|NCT05089344|Hormones|hormones|mesh-list
14118967|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14118968|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118969|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14118970|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
14118971|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14118972|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
14118973|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14118974|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14118975|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14118976|NCT05088889|Nivolumab|nivolumab|mesh-list
14118977|NCT05088889|Ipilimumab|ipilimumab|mesh-list
14118978|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14118979|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14118980|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14118981|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118982|NCT05088876|Acetaminophen|acetaminophen|mesh-list
14118983|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13939452|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
13939453|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939454|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939455|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13939456|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13939457|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13939458|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939459|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13939460|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13939461|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13939462|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939463|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939464|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939465|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
14118984|NCT05088876|Analgesics|analgesics|mesh-ancestor
14118985|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
14118986|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14118987|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118988|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
14118989|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14118990|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
14118991|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14118992|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14118993|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118994|NCT05088720|Misoprostol|misoprostol|mesh-list
14118995|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14118996|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
14118997|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14118998|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14118999|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14119000|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119001|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
14119002|NCT05088707|Misoprostol|misoprostol|mesh-list
14119003|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14119004|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
14119005|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14119006|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939466|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13939467|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13939468|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13939469|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
13939470|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13939471|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13939472|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13939473|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14119007|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14119008|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119009|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
14119010|NCT05084118|Landiolol|landiolol|mesh-list
14119011|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14119012|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14119013|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
14119014|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119015|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939474|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
13939475|NCT03304444|Bupivacaine|bupivacaine|mesh-list
13939476|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
14762578|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14762579|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762580|NCT02395666|Eflornithine|eflornithine|mesh-list
14762581|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762582|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14762583|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14762584|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14762585|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762586|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14762587|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762588|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119016|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119017|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14762589|NCT02357810|Topotecan|topotecan|mesh-list
14762590|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14119018|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
14119019|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119020|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
14119021|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119022|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119023|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14119024|NCT05077540|Misoprostol|misoprostol|mesh-list
14119025|NCT05077540|Oxytocin|oxytocin|mesh-list
14119026|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
14119027|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14762591|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14762592|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939477|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
13939478|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939479|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939480|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
13939481|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939482|NCT03304431|Lidocaine|lidocaine|mesh-list
13939483|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939484|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
14119028|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119029|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14119030|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
14119031|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14119032|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13939485|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939486|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119033|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
14119034|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14119035|NCT05064878|Fenfluramine|fenfluramine|mesh-list
14119036|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14119037|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14119038|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119039|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119040|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119041|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
14119042|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119043|NCT05057468|Cyclosporine|cyclosporine|mesh-list
14119044|NCT05057468|Rituximab|rituximab|mesh-list
14119045|NCT05057468|Cyclosporins|cyclosporins|mesh-list
14119046|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119047|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119048|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
13939487|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
13939488|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939489|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13939490|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13939491|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13939492|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939493|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939494|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13939495|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939496|NCT03304288|Rituximab|rituximab|mesh-list
13939497|NCT03304288|Tretinoin|tretinoin|mesh-list
13939498|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939499|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939500|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
13939501|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939502|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939503|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
13939504|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
13939505|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13939506|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939507|NCT03304093|Nivolumab|nivolumab|mesh-list
13939508|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939509|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939510|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13939511|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939512|NCT03304080|Trastuzumab|trastuzumab|mesh-list
13939513|NCT03304080|Pertuzumab|pertuzumab|mesh-list
13939514|NCT03304080|Palbociclib|palbociclib|mesh-list
13939515|NCT03304080|Anastrozole|anastrozole|mesh-list
13939516|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939517|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939518|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13939519|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939520|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939521|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13939522|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13939523|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14119049|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119050|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14119051|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119052|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119053|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119054|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
14119055|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119056|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
13939524|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13939525|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
13939526|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939527|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939528|NCT03303976|Vaccines|vaccines|mesh-list
13939529|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13939530|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
13939531|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939532|NCT03303924|Sulbactam|sulbactam|mesh-list
14119057|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13939533|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13939534|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939535|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13939536|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119058|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
14119059|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14119060|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939537|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939538|NCT03303677|Vancomycin|vancomycin|mesh-list
13939539|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
13939540|NCT03303677|Gentamicins|gentamicins|mesh-list
13939541|NCT03303677|Mupirocin|mupirocin|mesh-list
13939542|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13939543|NCT03303677|Trimethoprim|trimethoprim|mesh-list
13939544|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
13939545|NCT03303677|Budesonide|budesonide|mesh-list
13939546|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13939547|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13939548|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
13939549|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939550|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939551|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13939552|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
13939553|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
13939554|NCT03303677|Hormones|hormones|mesh-ancestor
13939555|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939556|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939557|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14119061|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14119062|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14119063|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119064|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119065|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119066|NCT05043077|Phenylephrine|phenylephrine|mesh-list
14119067|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
14119068|NCT05043077|Tropicamide|tropicamide|mesh-list
14119069|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14119070|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
14119071|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
14119072|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119073|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119074|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
14119075|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14119076|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
14119077|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
14119078|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14119079|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14119080|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14119081|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
14119082|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119083|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119084|NCT05043077|Protective Agents|protective agents|mesh-ancestor
14119085|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14119086|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14119087|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119088|NCT04991103|Dexamethasone|dexamethasone|mesh-list
14119089|NCT04991103|Lenalidomide|lenalidomide|mesh-list
14119090|NCT04991103|Bortezomib|bortezomib|mesh-list
14119091|NCT04991103|Daratumumab|daratumumab|mesh-list
14119092|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14119093|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
14119094|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
14119095|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119096|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119097|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119098|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
14119099|NCT04991103|Hormones|hormones|mesh-ancestor
14119100|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119101|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14119102|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119103|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
14119104|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14119105|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14119106|NCT04991103|Growth Substances|growth substances|mesh-ancestor
14119107|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
14119108|NCT04945213|Biperiden|biperiden|mesh-list
13939558|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13939559|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936477|NCT01469507|Protective Agents|protective agents|mesh-ancestor
14119109|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14119110|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14119111|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
13939560|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939561|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939562|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13939563|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13939564|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13939565|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13939566|NCT03303677|Renal Agents|renal agents|mesh-ancestor
13939567|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
13939568|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13939569|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13939570|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13939571|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13939572|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13939573|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
13939574|NCT03303651|Narcotics|narcotics|mesh-ancestor
13939575|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939576|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939577|NCT03303651|Analgesics|analgesics|mesh-ancestor
13939578|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
13939579|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939580|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
13939581|NCT03303573|Hematinics|hematinics|mesh-ancestor
13939582|NCT03303495|Leucovorin|leucovorin|mesh-list
13939583|NCT03303495|Bevacizumab|bevacizumab|mesh-list
13939584|NCT03303495|Fluorouracil|fluorouracil|mesh-list
13939585|NCT03303495|Irinotecan|irinotecan|mesh-list
13939586|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939587|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939588|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13939589|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13939590|NCT03303495|Growth Substances|growth substances|mesh-ancestor
14119112|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
14119113|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119114|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119115|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14119116|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14119117|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119118|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119119|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119120|NCT04908592|Dexamethasone|dexamethasone|mesh-list
14119121|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14119122|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
14119123|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
14119124|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119125|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119126|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119127|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
13939591|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939592|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
13939593|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
13939594|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119128|NCT04908592|Hormones|hormones|mesh-ancestor
14119129|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119130|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14119131|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119132|NCT04895930|Aflutinib|aflutinib|mesh-list
14119133|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14119134|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119135|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119136|NCT04870424|Colchicine|colchicine|mesh-list
14119137|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
14119138|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14119139|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
14119140|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
14119141|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
14119142|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119143|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939595|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13939596|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13939597|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
13939598|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14119144|NCT04850651|Fluconazole|fluconazole|mesh-list
14119145|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
14119146|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119147|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13939599|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14119148|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14119149|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119150|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119151|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14119152|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
14119153|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119154|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119155|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14119156|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14119157|NCT04828005|Naloxone|naloxone|mesh-list
13939600|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939601|NCT03303495|Antidotes|antidotes|mesh-ancestor
13939602|NCT03303495|Protective Agents|protective agents|mesh-ancestor
13939603|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
13939604|NCT03303495|Vitamins|vitamins|mesh-ancestor
13939605|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
13939606|NCT03303378|Melatonin|melatonin|mesh-list
13939607|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
13939608|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939609|NCT03303378|Protective Agents|protective agents|mesh-ancestor
14119158|NCT04828005|Nalmefene|nalmefene|mesh-list
14119159|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14119160|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119161|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
14119162|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939610|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939611|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961776|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961777|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961778|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13961779|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
13961780|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
13961781|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13961782|NCT03145623|Grazoprevir|grazoprevir|mesh-list
13961783|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
13961784|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961785|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
13961786|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961787|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961788|NCT03145896|Vitamin D|vitamin d|mesh-list
13961789|NCT03145896|Vitamins|vitamins|mesh-ancestor
13961790|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
13961791|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961792|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13961793|NCT03145675|Enoxaparin|enoxaparin|mesh-list
13961794|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
13961795|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
13961796|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13961797|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13961798|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961799|NCT03145558|Doxorubicin|doxorubicin|mesh-list
13961800|NCT03145558|Tirapazamine|tirapazamine|mesh-list
13961801|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14119163|NCT04788550|Listerine|listerine|mesh-list
14119164|NCT04788550|Fluorides|fluorides|mesh-list
14119165|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
14119166|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
14119167|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
14119168|NCT04788550|Protective Agents|protective agents|mesh-ancestor
14119169|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119170|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14119171|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176458|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176459|NCT04765527|Turmeric extract|turmeric extract|mesh-list
14176460|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
14176461|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762593|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762594|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961802|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961803|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13961804|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13961805|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176462|NCT04765527|Protective Agents|protective agents|mesh-ancestor
13961806|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961807|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
14119172|NCT04759768|Naltrexone|naltrexone|mesh-list
14119173|NCT04759768|Nalmefene|nalmefene|mesh-list
14119174|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14119175|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119176|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
14119177|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119178|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14119179|NCT04757493|Prucalopride|prucalopride|mesh-list
14119180|NCT04757493|Laxatives|laxatives|mesh-ancestor
14119181|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119182|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14119183|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14119184|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
14119185|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119186|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119187|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119188|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
14119189|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14119190|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14119191|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14119192|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119193|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119194|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119195|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119196|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119197|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14119198|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119199|NCT04731467|Paclitaxel|paclitaxel|mesh-list
14119200|NCT04731467|Nivolumab|nivolumab|mesh-list
14119201|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14119202|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119203|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
14119204|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
14119205|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
14119206|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119207|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119208|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14119209|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
14119210|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119211|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119212|NCT04723134|Leucovorin|leucovorin|mesh-list
14119213|NCT04723134|Folic Acid|folic acid|mesh-list
14119214|NCT04723134|Calcium|calcium|mesh-list
14119215|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
14119216|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14119217|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119218|NCT04723134|Antidotes|antidotes|mesh-ancestor
14119219|NCT04723134|Protective Agents|protective agents|mesh-ancestor
14119220|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
14119221|NCT04723134|Vitamins|vitamins|mesh-ancestor
14119222|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
14119223|NCT04723134|Hematinics|hematinics|mesh-ancestor
13939612|NCT03303235|Methylergonovine|methylergonovine|mesh-list
13939613|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
13939614|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13939615|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939616|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
13939617|NCT03303209|Narcotics|narcotics|mesh-ancestor
13939618|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939619|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939620|NCT03303209|Analgesics|analgesics|mesh-ancestor
13939621|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
13939622|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939623|NCT03303053|Prednisolone|prednisolone|mesh-list
13939624|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
13939625|NCT03303053|Carbimazole|carbimazole|mesh-list
13939626|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13939627|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
14119224|NCT04713319|Calcium|calcium|mesh-list
14119225|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14119226|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762595|NCT02343549|Bevacizumab|bevacizumab|mesh-list
14762596|NCT02343549|Temozolomide|temozolomide|mesh-list
14119229|NCT04691986|Niacinamide|niacinamide|mesh-list
14762597|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939628|NCT03303053|Hormones|hormones|mesh-ancestor
14119230|NCT04691986|Niacin|niacin|mesh-list
14119231|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
13939629|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939630|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939631|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13939632|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939633|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13939634|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13939635|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
13939636|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939637|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13939638|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
13939639|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
13939640|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
13939641|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13939642|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13939643|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13939644|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939645|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119232|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
14119233|NCT04691986|Vitamins|vitamins|mesh-ancestor
14119234|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
14119235|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119236|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14119237|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
14119238|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119239|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14119240|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
14119241|NCT04605081|Naltrexone|naltrexone|mesh-list
14119242|NCT04605081|Bupropion|bupropion|mesh-list
14119243|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14119244|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14119245|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119246|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
14119247|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119248|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14119249|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
14119250|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14119251|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14119252|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14119253|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119254|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119255|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
14119256|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119257|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14119258|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14119259|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119260|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
14119261|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14119262|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14119263|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119264|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
14119265|NCT04595786|Coagulants|coagulants|mesh-ancestor
14119266|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
14119267|NCT04569461|Androgens|androgens|mesh-list
14762598|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762599|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14762600|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14762601|NCT02343549|Growth Substances|growth substances|mesh-ancestor
14762602|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762603|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
14762604|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762605|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
14762606|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762607|NCT02329847|Nivolumab|nivolumab|mesh-list
14762608|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762609|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939646|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
13939647|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939648|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939649|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13939650|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939651|NCT03302845|Omeprazole|omeprazole|mesh-list
13939652|NCT03302845|Famotidine|famotidine|mesh-list
14119268|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939653|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13939654|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13939655|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13939656|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939657|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939658|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13939659|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
13939660|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
13939661|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939662|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939663|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
14119269|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119270|NCT04569461|Hormones|hormones|mesh-ancestor
14119271|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119272|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119273|NCT04565483|Benralizumab|benralizumab|mesh-list
14119274|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14119275|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
14119276|NCT04536194|Dopamine|dopamine|mesh-list
14119277|NCT04536194|Norepinephrine|norepinephrine|mesh-list
14119278|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14119279|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14119280|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
14119281|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119282|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119283|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119284|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
14119285|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
14119286|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119287|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14119288|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13939664|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939665|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939666|NCT03302728|Lenalidomide|lenalidomide|mesh-list
13939667|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13939668|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
14119289|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
14119290|NCT04536194|Protective Agents|protective agents|mesh-ancestor
14119291|NCT04449042|Anesthetics|anesthetics|mesh-list
14119292|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119293|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119294|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
14119295|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119296|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119297|NCT04341090|Apatinib|apatinib|mesh-list
14119298|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119299|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14119300|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119301|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119302|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14119303|NCT04263896|Laxatives|laxatives|mesh-ancestor
14119304|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119305|NCT04254731|Methadone|methadone|mesh-list
14119306|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14119307|NCT04254731|Narcotics|narcotics|mesh-ancestor
14119308|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119309|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119310|NCT04254731|Analgesics|analgesics|mesh-ancestor
14119311|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
14762610|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13939669|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939670|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13939671|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13939672|NCT03302728|Growth Substances|growth substances|mesh-ancestor
13939673|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
13939674|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939675|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939676|NCT03302689|Ropivacaine|ropivacaine|mesh-list
13939677|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
13939678|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13939679|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939680|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
13939681|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939682|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762611|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939683|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
13939684|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939685|NCT03302650|Norepinephrine|norepinephrine|mesh-list
13939686|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
13939687|NCT03302650|Giapreza|giapreza|mesh-list
13939688|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
13939689|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13939690|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13939691|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
13939692|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939693|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939694|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939695|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
13939696|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
13939697|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939698|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13939699|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13939700|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
13939701|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939702|NCT03302585|Vitamin D|vitamin d|mesh-list
13939703|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
13939704|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
13939705|NCT03302585|Vitamins|vitamins|mesh-list
13939706|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
13939707|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939708|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13939709|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13939710|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
13939711|NCT03302403|Fludarabine|fludarabine|mesh-list
13939712|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13939713|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
13939714|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939715|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939716|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13939717|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
13939718|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939719|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939720|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13939721|NCT03302390|Lidocaine|lidocaine|mesh-list
13939722|NCT03302390|Epinephrine|epinephrine|mesh-list
13939723|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939724|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
13939725|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939726|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939727|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
13939728|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939729|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14119312|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119313|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
14119314|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
14119315|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
14119316|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119317|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119318|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
14119319|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119320|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119321|NCT04089150|Leucovorin|leucovorin|mesh-list
14119322|NCT04089150|Gemcitabine|gemcitabine|mesh-list
14119323|NCT04089150|Paclitaxel|paclitaxel|mesh-list
14119324|NCT04089150|Fluorouracil|fluorouracil|mesh-list
14119325|NCT04089150|Capecitabine|capecitabine|mesh-list
14119326|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
14119327|NCT04089150|Irinotecan|irinotecan|mesh-list
14119328|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14119329|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119330|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
14119331|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
14119332|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
14119333|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119334|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14119335|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
13939730|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13939731|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14119336|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
13939732|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119337|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119338|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119339|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119340|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
14119341|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119342|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14119343|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14119344|NCT04089150|Antidotes|antidotes|mesh-ancestor
14119345|NCT04089150|Protective Agents|protective agents|mesh-ancestor
14119346|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
13939733|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939734|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14119347|NCT04089150|Vitamins|vitamins|mesh-ancestor
14119348|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
14119349|NCT04082780|Rifamycins|rifamycins|mesh-list
14119350|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
14119351|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14119352|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119353|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176463|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176464|NCT04765228|Doxorubicin|doxorubicin|mesh-list
14176465|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13939735|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13939736|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
13939737|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939738|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13939739|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13939740|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
13939741|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13939742|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
13939743|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
13939744|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
13939745|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13939746|NCT03302364|Risperidone|risperidone|mesh-list
13939747|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13939748|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
13939749|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939750|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939751|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939752|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13939753|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13939754|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939755|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13939756|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13939757|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
13939758|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
13939759|NCT03302351|Ketamine|ketamine|mesh-list
13939760|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13939761|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939762|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939763|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13939764|NCT03302351|Analgesics|analgesics|mesh-ancestor
13939765|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
13939766|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939767|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13939768|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13939769|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13939770|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
13939771|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939772|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176466|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14176467|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176468|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14176469|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14176470|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176471|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176472|NCT04765085|Aripiprazole|aripiprazole|mesh-list
13939773|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13939774|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13939775|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
13939776|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
13939777|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13939778|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13939779|NCT03302299|Pyridoxine|pyridoxine|mesh-list
13939780|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
13939781|NCT03302299|Isoniazid|isoniazid|mesh-list
13939782|NCT03302299|Vitamins|vitamins|mesh-ancestor
14176473|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
14176474|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14119354|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14119355|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14119356|NCT03925350|Niraparib|niraparib|mesh-list
14119357|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14119358|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119359|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119360|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119361|NCT03906526|Nivolumab|nivolumab|mesh-list
14119362|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119363|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119364|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14119365|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119366|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
14119367|NCT03829332|Lenvatinib|lenvatinib|mesh-list
14119368|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119369|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119370|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14119371|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119372|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119373|NCT03798626|Leucovorin|leucovorin|mesh-list
14119374|NCT03798626|Paclitaxel|paclitaxel|mesh-list
14119375|NCT03798626|Bevacizumab|bevacizumab|mesh-list
14119376|NCT03798626|Fluorouracil|fluorouracil|mesh-list
14119377|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
14119378|NCT03798626|Irinotecan|irinotecan|mesh-list
14119379|NCT03798626|Ramucirumab|ramucirumab|mesh-list
14119380|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
14119381|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14119382|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119383|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14119384|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14119385|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14119386|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119387|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119388|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14119389|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14119390|NCT03798626|Growth Substances|growth substances|mesh-ancestor
14119391|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119392|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
14119393|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
14762612|NCT02328105|Paclitaxel|paclitaxel|mesh-list
14762613|NCT02328105|Carboplatin|carboplatin|mesh-list
13939783|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
13939784|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939785|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
13939786|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
13939787|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13939788|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939789|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13939790|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13939791|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
13939792|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939793|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13939794|NCT03302221|Ropivacaine|ropivacaine|mesh-list
13939795|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
13939796|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939797|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939798|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939799|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
13939800|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939801|NCT03302208|Pregabalin|pregabalin|mesh-list
13939802|NCT03302208|Analgesics|analgesics|mesh-ancestor
13939803|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
13939804|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939805|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939806|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
13939807|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13939808|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119394|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14119395|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119396|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
14762614|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14762615|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13939809|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939810|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14119397|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14119398|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14119399|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119400|NCT03798626|Antidotes|antidotes|mesh-ancestor
14119401|NCT03798626|Protective Agents|protective agents|mesh-ancestor
14119402|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
14119403|NCT03798626|Vitamins|vitamins|mesh-ancestor
14119404|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
14119405|NCT03789604|Antibodies|antibodies|mesh-list
14119406|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14119407|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
14119408|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119409|NCT03522064|Carboplatin|carboplatin|mesh-list
14119410|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
14119411|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14119412|NCT03522064|Testosterone|testosterone|mesh-list
14119413|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
14119414|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
14119415|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14119416|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119417|NCT03522064|Androgens|androgens|mesh-ancestor
14119418|NCT03522064|Hormones|hormones|mesh-ancestor
14119419|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119420|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119421|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14119422|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
14119423|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
14119424|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13939811|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13939812|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13939813|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939814|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13939815|NCT03302195|Heparin|heparin|mesh-list
13939816|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
13939817|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13939818|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13939819|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939820|NCT03302182|Ritonavir|ritonavir|mesh-list
13939821|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14119425|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119426|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
14119427|NCT03408652|Denosumab|denosumab|mesh-list
14119428|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14119429|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119430|NCT03372941|Dalbavancin|dalbavancin|mesh-list
14119431|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14119432|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119433|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
14119434|NCT03292861|Sirolimus|sirolimus|mesh-list
14119435|NCT03292861|Tacrolimus|tacrolimus|mesh-list
14119436|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
14119437|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119438|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
14119439|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119440|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14119441|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119442|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119443|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14119444|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119445|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14119446|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
14119447|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14119448|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939822|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13939823|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
13939824|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939825|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939826|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13939827|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13939828|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
13939829|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939830|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13939831|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14119449|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
14119450|NCT03263117|Anesthetics|anesthetics|mesh-list
14119451|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939832|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
13939833|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13939834|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
14119452|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939835|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939836|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939837|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13939838|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
13939839|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
13939840|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13939841|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
13939842|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939843|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939844|NCT03302039|Phenylephrine|phenylephrine|mesh-list
13939845|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
13939846|NCT03302039|Bupivacaine|bupivacaine|mesh-list
13939847|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939848|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
13939849|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939850|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939851|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
13939852|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939853|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13939854|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
13939855|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
13939856|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
14119465|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14119466|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14119467|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119476|NCT03030261|Dexamethasone|dexamethasone|mesh-list
14119477|NCT03030261|Pomalidomide|pomalidomide|mesh-list
14119478|NCT03030261|Elotuzumab|elotuzumab|mesh-list
14119479|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14119480|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
14119481|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
14119482|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119483|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119484|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119485|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
14119486|NCT03030261|Hormones|hormones|mesh-ancestor
14119487|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119488|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14119489|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119490|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
14119491|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14762616|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762617|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
14762618|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
13939857|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13939858|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
13939859|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
13939860|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14119492|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14119493|NCT03030261|Growth Substances|growth substances|mesh-ancestor
14119494|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14762619|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
13939861|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13939862|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14762620|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762621|NCT02327195|Methylphenidate|methylphenidate|mesh-list
14119495|NCT02969850|Vitamin D|vitamin d|mesh-list
14119496|NCT02969850|Calcium|calcium|mesh-list
14119497|NCT02969850|Vitamins|vitamins|mesh-ancestor
14119498|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
14119499|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119500|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14119501|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14119502|NCT02947386|Nivolumab|nivolumab|mesh-list
14119503|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
14119504|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119505|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119506|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14119507|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119508|NCT02939989|Ribavirin|ribavirin|mesh-list
14119509|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
14119510|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
14119511|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119512|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
14119513|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119514|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
14119515|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14119516|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14119517|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14119518|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14119519|NCT02349867|Gemcitabine|gemcitabine|mesh-list
14119520|NCT02349867|Sorafenib|sorafenib|mesh-list
14119521|NCT02349867|Vorinostat|vorinostat|mesh-list
14119522|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14119523|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
14119524|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119525|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119526|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
14119527|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119528|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939863|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
13939864|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939865|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939866|NCT03302039|Protective Agents|protective agents|mesh-ancestor
13939867|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14119529|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119530|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
14119531|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119532|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14119533|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14119534|NCT02339766|Morphine|morphine|mesh-list
14119535|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14119536|NCT02339766|Narcotics|narcotics|mesh-ancestor
14119537|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119538|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119539|NCT02339766|Analgesics|analgesics|mesh-ancestor
14119540|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
13939868|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
13939869|NCT03301974|Coagulants|coagulants|mesh-ancestor
13939870|NCT03301766|Lidocaine|lidocaine|mesh-list
13939871|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
13939872|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
13939873|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939874|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939875|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
13939876|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13939877|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13939878|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13939879|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13939880|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939881|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939882|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
13939883|NCT03301636|Nivolumab|nivolumab|mesh-list
13939884|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119541|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119542|NCT05092386|Vaccines|vaccines|mesh-list
14119543|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
14119544|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762622|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13939885|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939886|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13939887|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961808|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961809|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963478|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13963479|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963480|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13963481|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963482|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
14119545|NCT05091775|Mesalamine|mesalamine|mesh-list
14119546|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14119547|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14119548|NCT05091775|Analgesics|analgesics|mesh-ancestor
14119549|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
14119550|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119551|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119552|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14119553|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14119554|NCT05091606|Anesthetics|anesthetics|mesh-list
14119555|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119556|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119557|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
14119558|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14119559|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
14119560|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119561|NCT05091359|Calcium|calcium|mesh-list
14119562|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14119563|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119564|NCT05091203|Vitamin D|vitamin d|mesh-list
14119565|NCT05091203|Vitamins|vitamins|mesh-ancestor
14119566|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
14119567|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119568|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14119569|NCT05091177|Acetylcholine|acetylcholine|mesh-list
14119570|NCT05091177|Antibodies|antibodies|mesh-list
14119571|NCT05091177|Neostigmine|neostigmine|mesh-list
14119572|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
14119573|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119574|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14119575|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119576|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119577|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119578|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119579|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14119580|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
14119581|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119582|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
14119583|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14119584|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
14119585|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14119586|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119587|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119588|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14119589|NCT05091151|Analgesics|analgesics|mesh-ancestor
14119590|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
14119591|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119592|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13963549|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963550|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
13963551|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963552|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14119593|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14119594|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14119595|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
14119596|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119597|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119598|NCT05091138|Buprenorphine|buprenorphine|mesh-list
14119599|NCT05091138|Bupivacaine|bupivacaine|mesh-list
14119600|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
14119601|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
14119602|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119603|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119604|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
14119605|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119606|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14119607|NCT05091138|Narcotics|narcotics|mesh-ancestor
14119608|NCT05091138|Analgesics|analgesics|mesh-ancestor
14119609|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14119610|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
14119611|NCT05091099|Alendronate|alendronate|mesh-list
14119612|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14119613|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119614|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
14119615|NCT05091086|Denosumab|denosumab|mesh-list
14119616|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14119617|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119618|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
14119619|NCT05091008|Ledipasvir|ledipasvir|mesh-list
14119620|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14119621|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
14119622|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119623|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
14119624|NCT05090761|Buprenorphine|buprenorphine|mesh-list
14119625|NCT05090761|Bupivacaine|bupivacaine|mesh-list
14119626|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14119627|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
14119628|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
14119629|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119630|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119631|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
14119632|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119633|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14119634|NCT05090761|Narcotics|narcotics|mesh-ancestor
14119635|NCT05090761|Analgesics|analgesics|mesh-ancestor
14119636|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14119637|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14119638|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
14119639|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14119640|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119641|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119642|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13939888|NCT03301454|Paclitaxel|paclitaxel|mesh-list
13939889|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13939890|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939891|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
13939892|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
13939893|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
13939894|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939895|NCT03301350|Paclitaxel|paclitaxel|mesh-list
13939896|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
13939897|NCT03301350|Carboplatin|carboplatin|mesh-list
13939898|NCT03301350|Doxorubicin|doxorubicin|mesh-list
13939899|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13939900|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13939901|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
13939902|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
13939903|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
13939904|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939905|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13939906|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
13939907|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939908|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13939909|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13939910|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
13939911|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13939912|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13939913|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13939914|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13939915|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939916|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
13939917|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13939918|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119643|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
14478118|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13939919|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
13939920|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14119644|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14478119|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14119645|NCT05090592|Atropine|atropine|mesh-list
14478120|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
13939921|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13939922|NCT03301233|Estradiol|estradiol|mesh-list
13939923|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13939924|NCT03301233|Estrogens|estrogens|mesh-ancestor
13939925|NCT03301233|Hormones|hormones|mesh-ancestor
13939926|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939927|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939928|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13939929|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
13939930|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13939931|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13939932|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
13939933|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13939934|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13939935|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939936|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939937|NCT03301233|Urological Agents|urological agents|mesh-ancestor
13939938|NCT03301207|Midazolam|midazolam|mesh-list
13939939|NCT03301207|Bupropion|bupropion|mesh-list
13939940|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
13939941|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13939942|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
13939943|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13939944|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13939945|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13939946|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939947|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13939948|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13939949|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13939950|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13939951|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
13939952|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
13939953|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
13939954|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
13939955|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13939956|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939957|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13939958|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
13939959|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13939960|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14119646|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14119647|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14119648|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14119649|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
14119650|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119651|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119652|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14119653|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
14119654|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
14119655|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
14119656|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14119657|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14119658|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119659|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119660|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119661|NCT05081583|Midazolam|midazolam|mesh-list
14119662|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14119663|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14119664|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119665|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119666|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13939961|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13939962|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
13939963|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13939964|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13939965|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939966|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13939967|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
13939968|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13939969|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13939970|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13939971|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13939972|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13939973|NCT03301207|Estrogens|estrogens|mesh-ancestor
13939974|NCT03301207|Hormones|hormones|mesh-ancestor
13939975|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939976|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13939977|NCT03301181|Itraconazole|itraconazole|mesh-list
14119667|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14119668|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14119669|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14119670|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
14119671|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
14119672|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
14119673|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
14119674|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119675|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119676|NCT05081336|Ezetimibe|ezetimibe|mesh-list
14119677|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14119678|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14119679|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
14119680|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119681|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13939978|NCT03301181|Rifampin|rifampin|mesh-list
13939979|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
13939980|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
13939981|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13939982|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13939983|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13939984|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13939985|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13939986|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13939987|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
13939988|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13939989|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13939990|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13939991|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13939992|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
13939993|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13939994|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
13939995|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13939996|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13939997|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13939998|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13939999|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13940000|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13940001|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13940002|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940003|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13940004|NCT03301025|Pregabalin|pregabalin|mesh-list
13940005|NCT03301025|Analgesics|analgesics|mesh-ancestor
13940006|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
13940007|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940008|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940009|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
13940010|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13940011|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940012|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940013|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13940014|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13940015|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14119682|NCT05077839|Trifluridine|trifluridine|mesh-list
14119683|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
14119684|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119685|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
13940016|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940017|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13940018|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13940019|NCT03300960|Ganirelix|ganirelix|mesh-list
13940020|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
13940021|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940022|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940023|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14119686|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119687|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
14119688|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13940024|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
13940025|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13940026|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13940027|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13940028|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14119689|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
14119690|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14119691|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
14119692|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119693|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119694|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
14119695|NCT05077085|Vancomycin|vancomycin|mesh-list
14119696|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14119697|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119698|NCT05069129|Vaccines|vaccines|mesh-list
14119699|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
14119700|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940029|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940030|NCT03300947|Lorazepam|lorazepam|mesh-list
13940031|NCT03300947|Psilocybin|psilocybin|mesh-list
13940032|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
13940033|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
14119701|NCT05067985|Anesthetics|anesthetics|mesh-list
14119702|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119703|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119704|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14119705|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14119706|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119707|NCT04985136|Sorafenib|sorafenib|mesh-list
14119708|NCT04985136|Apatinib|apatinib|mesh-list
14119709|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119710|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14119711|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940034|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
13940035|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940036|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940037|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13940038|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13940039|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940040|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13940041|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13940042|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13940043|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
13940044|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
14119712|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119713|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
14119714|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14119715|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
14119716|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119717|NCT04964843|Expectorants|expectorants|mesh-ancestor
14119718|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14119719|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14119720|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
14119721|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119722|NCT04964843|Protective Agents|protective agents|mesh-ancestor
14119723|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119724|NCT04964843|Antidotes|antidotes|mesh-ancestor
14119725|NCT04952350|Atorvastatin|atorvastatin|mesh-list
14119726|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14119727|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14119728|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
14119729|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119730|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14119731|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14119732|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119740|NCT04899492|Nicotine|nicotine|mesh-list
14119741|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13940045|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119742|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
14119743|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119744|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119745|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14119746|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14119747|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119748|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119749|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176475|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14176476|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14176477|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176478|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176479|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
14176480|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
14176481|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176482|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940046|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940047|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
13940048|NCT03300765|Apatinib|apatinib|mesh-list
13940049|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940050|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13940051|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940052|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940053|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
13940054|NCT03300609|Leucovorin|leucovorin|mesh-list
13940055|NCT03300609|Folic Acid|folic acid|mesh-list
13940056|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
13940057|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
13940058|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13940059|NCT03300609|Panitumumab|panitumumab|mesh-list
13940060|NCT03300609|Fluorouracil|fluorouracil|mesh-list
13940061|NCT03300609|Capecitabine|capecitabine|mesh-list
13940062|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
13940063|NCT03300609|Antibodies|antibodies|mesh-list
13940064|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
13940065|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13940066|NCT03300609|Calcium|calcium|mesh-list
13940067|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
13940068|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
14176483|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14176484|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14176485|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
14176486|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14176487|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14176488|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14176489|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14176490|NCT04765111|Rituximab|rituximab|mesh-list
14176491|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14176492|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
14176493|NCT04765111|Antibodies|antibodies|mesh-list
14176494|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
14176495|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14176496|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
14176497|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176498|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176499|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176500|NCT04764955|Vitamin D|vitamin d|mesh-list
14176501|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
14176502|NCT04764955|Vitamins|vitamins|mesh-ancestor
14176503|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
14176504|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176505|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14176506|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14176507|NCT04764825|Morphine|morphine|mesh-list
14176508|NCT04764825|Methadone|methadone|mesh-list
14176509|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14176510|NCT04764825|Narcotics|narcotics|mesh-ancestor
14176511|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176512|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176513|NCT04764825|Analgesics|analgesics|mesh-ancestor
14176514|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
14176515|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479261|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13940069|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940070|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176516|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
14176517|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
13940071|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13940072|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14119750|NCT04866017|Durvalumab|durvalumab|mesh-list
14119751|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940073|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
13940074|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940075|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940076|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940077|NCT03300609|Antidotes|antidotes|mesh-ancestor
13940078|NCT03300609|Protective Agents|protective agents|mesh-ancestor
13940079|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
13940080|NCT03300609|Vitamins|vitamins|mesh-ancestor
13940081|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
13940082|NCT03300609|Hematinics|hematinics|mesh-ancestor
13940083|NCT03300531|Betamethasone|betamethasone|mesh-list
13940084|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940085|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
13940086|NCT03300531|Hormones|hormones|mesh-ancestor
13940087|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940088|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940089|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13940090|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
13940091|NCT03300440|Vitamins|vitamins|mesh-list
13940092|NCT03300440|Biotin|biotin|mesh-list
14119752|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119753|NCT04850144|Bromides|bromides|mesh-list
14119754|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
14119755|NCT04850144|Charcoal|charcoal|mesh-list
14119756|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14119757|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
14119758|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119759|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119760|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14119761|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
14119762|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
14119763|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14119764|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119765|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119766|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119767|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
14119768|NCT04850144|Antidotes|antidotes|mesh-ancestor
14119769|NCT04850144|Protective Agents|protective agents|mesh-ancestor
14119770|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
13940093|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
14119771|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14119772|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14119773|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
14119774|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119775|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119776|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14119777|NCT04710199|Maraviroc|maraviroc|mesh-list
14119778|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14119779|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14119780|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119781|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14119782|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14119783|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
14119784|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119785|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14119786|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14119787|NCT04648696|Vancomycin|vancomycin|mesh-list
14119788|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14119789|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119790|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
14119791|NCT04639310|Ezogabine|ezogabine|mesh-list
14119792|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
14119793|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940094|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
13940095|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940096|NCT03300362|Vaccines|vaccines|mesh-list
13940097|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
13940098|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940099|NCT03300115|Abivertinib|abivertinib|mesh-list
14119794|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119795|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
13940100|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13940101|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940102|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940103|NCT03300089|Anesthetics|anesthetics|mesh-list
13940104|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940105|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940106|NCT03299998|Anesthetics|anesthetics|mesh-list
13940107|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940108|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940109|NCT03299946|Nivolumab|nivolumab|mesh-list
13940110|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940111|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940112|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14119796|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
14119797|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119798|NCT04604548|Protective Agents|protective agents|mesh-ancestor
14119799|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119800|NCT04590794|Plasminogen|plasminogen|mesh-list
14119801|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14119802|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14119803|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119804|NCT04573478|Atrasentan|atrasentan|mesh-list
14119805|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119806|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14119807|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14119808|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119809|NCT04543643|Carvedilol|carvedilol|mesh-list
14119810|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14119811|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14119812|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
14119813|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119814|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119815|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119816|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14119817|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
14119818|NCT04543643|Protective Agents|protective agents|mesh-ancestor
14119819|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14119820|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119821|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14119822|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
14119823|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14119824|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14119825|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
14119826|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14119827|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119828|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119829|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14119830|NCT04526652|Analgesics|analgesics|mesh-ancestor
14119831|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
14119832|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119833|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14119834|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14119835|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14119836|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
14119837|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119838|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119839|NCT04516993|Tenecteplase|tenecteplase|mesh-list
14119840|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14119841|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14119842|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119843|NCT04401800|Lenvatinib|lenvatinib|mesh-list
14119844|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119845|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14119846|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119847|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119848|NCT04341467|Olanzapine|olanzapine|mesh-list
14119849|NCT04341467|Amisulpride|amisulpride|mesh-list
14119850|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
14119851|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
14119852|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119853|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119854|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119855|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14119856|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14176518|NCT04765098|Tamoxifen|tamoxifen|mesh-list
14479262|NCT02466958|Milnacipran|milnacipran|mesh-list
14119857|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119858|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14119859|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14119860|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14119861|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119862|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119863|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119864|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
14119865|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14119866|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
14119867|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14119868|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
14119869|NCT04287660|Clarithromycin|clarithromycin|mesh-list
14119870|NCT04287660|Dexamethasone|dexamethasone|mesh-list
14119871|NCT04287660|Lenalidomide|lenalidomide|mesh-list
14119872|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14119873|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
14119874|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
14119875|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119876|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119877|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14119878|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
14119879|NCT04287660|Hormones|hormones|mesh-ancestor
14119880|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119881|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14119882|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119883|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
14119884|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14119885|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14119886|NCT04287660|Growth Substances|growth substances|mesh-ancestor
14119887|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
14119888|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14119889|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119890|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14119891|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119892|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119893|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14119894|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14119895|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
14119896|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
14119897|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14119898|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14119899|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
14119900|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
14119901|NCT04255277|Charcoal|charcoal|mesh-list
14119902|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14119903|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119904|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14119905|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14119906|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119907|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119908|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119909|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14119910|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14119911|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119912|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14119913|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14119914|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14119915|NCT04255277|Estrogens|estrogens|mesh-ancestor
14119916|NCT04255277|Hormones|hormones|mesh-ancestor
14119917|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14119918|NCT04255277|Antidotes|antidotes|mesh-ancestor
14119919|NCT04255277|Protective Agents|protective agents|mesh-ancestor
14119920|NCT04218539|Psilocybin|psilocybin|mesh-list
14119921|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
14119922|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119923|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14119924|NCT04149587|Brodalumab|brodalumab|mesh-list
14119925|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14119926|NCT04058158|Eculizumab|eculizumab|mesh-list
14119927|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14119928|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119929|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
14119930|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176519|NCT04765098|Etoposide|etoposide|mesh-list
14119931|NCT03966807|Nicotine|nicotine|mesh-list
14119932|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14119933|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
14119934|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119935|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119936|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14119937|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14119938|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
14119939|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14119940|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119941|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
14119942|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119943|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
14119944|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119945|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14119946|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14119947|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
14119948|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940113|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940114|NCT03299842|Fenfluramine|fenfluramine|mesh-list
13940115|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13940116|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13940117|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14119949|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119950|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14119951|NCT03924986|Gemcitabine|gemcitabine|mesh-list
14119952|NCT03924986|Cisplatin|cisplatin|mesh-list
14119953|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119954|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14119955|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
14119956|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119957|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
14119958|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119959|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14119960|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119961|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
14119962|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119963|NCT03922620|Bupivacaine|bupivacaine|mesh-list
14119964|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
14119965|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
14119966|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14119967|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119968|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
14119969|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14119970|NCT03901573|Atezolizumab|atezolizumab|mesh-list
14478121|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478122|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478123|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762623|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762624|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13940118|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940119|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940120|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
13940121|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940122|NCT03299829|Trientine|trientine|mesh-list
13940123|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
13940124|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
13940125|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940126|NCT03299725|Bismuth|bismuth|mesh-list
13940127|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940128|NCT03299725|Antacids|antacids|mesh-ancestor
13940129|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13961810|NCT03145272|Oxycodone|oxycodone|mesh-list
13961811|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13961812|NCT03145272|Narcotics|narcotics|mesh-ancestor
13961813|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762625|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14119971|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119972|NCT03853187|Durvalumab|durvalumab|mesh-list
14119973|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14478124|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479263|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
14479264|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13940130|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
13940131|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
13940132|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13940133|NCT03299712|Protective Agents|protective agents|mesh-ancestor
13940134|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940135|NCT03299660|Fluorouracil|fluorouracil|mesh-list
13940136|NCT03299660|Capecitabine|capecitabine|mesh-list
13940137|NCT03299660|Avelumab|avelumab|mesh-list
13940138|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
13940139|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940140|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940141|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940142|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940143|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
14119974|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119975|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119976|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
14119977|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119978|NCT03841110|Aldesleukin|aldesleukin|mesh-list
14119979|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
14119980|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
14119981|NCT03841110|Nivolumab|nivolumab|mesh-list
14119982|NCT03841110|Fludarabine|fludarabine|mesh-list
14119983|NCT03841110|Atezolizumab|atezolizumab|mesh-list
14119984|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14119985|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
14119986|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14119987|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14119988|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14119989|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
14119990|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14119991|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14119992|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14119993|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14119994|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14119995|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14119996|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14119997|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
14119998|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14119999|NCT03713294|Dexamethasone|dexamethasone|mesh-list
14120000|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
14120001|NCT03713294|Pomalidomide|pomalidomide|mesh-list
14120002|NCT03713294|Elotuzumab|elotuzumab|mesh-list
14120003|NCT03713294|Ichthammol|ichthammol|mesh-list
14120004|NCT03713294|BB 1101|bb 1101|mesh-list
14120005|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120006|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
14120007|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
14120008|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120009|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120010|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14120011|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
14120012|NCT03713294|Hormones|hormones|mesh-ancestor
14120013|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120014|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14120015|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120016|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
14120017|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120018|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120019|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
14120020|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14120021|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14120022|NCT03713294|Growth Substances|growth substances|mesh-ancestor
14120023|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
14120024|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
14120025|NCT03663205|Cisplatin|cisplatin|mesh-list
14120026|NCT03663205|Carboplatin|carboplatin|mesh-list
14120027|NCT03663205|Pemetrexed|pemetrexed|mesh-list
14120028|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120029|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120030|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120031|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14478125|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
14120032|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14478126|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940144|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120033|NCT03597581|Bevacizumab|bevacizumab|mesh-list
14120034|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120035|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120036|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14120037|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14120038|NCT03597581|Growth Substances|growth substances|mesh-ancestor
14120039|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120040|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
14120041|NCT03593915|Azacitidine|azacitidine|mesh-list
14120042|NCT03593915|Decitabine|decitabine|mesh-list
14120043|NCT03593915|Alvocidib|alvocidib|mesh-list
14120044|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14120045|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
14120046|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120047|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120048|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120049|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
14120050|NCT03593915|Growth Substances|growth substances|mesh-ancestor
14120051|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120052|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14120053|NCT03472586|Nivolumab|nivolumab|mesh-list
14120054|NCT03472586|Ipilimumab|ipilimumab|mesh-list
14120055|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120056|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120057|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14120058|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120059|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
14120060|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120061|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120062|NCT03423680|Aripiprazole|aripiprazole|mesh-list
14120063|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
14120064|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14120065|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14120066|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14120067|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120068|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120069|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
14120070|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
14120071|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120072|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120073|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14120074|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14120075|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
14120076|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14120077|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14120078|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14120079|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13940145|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940146|NCT03299621|Rocuronium|rocuronium|mesh-list
13940147|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13940148|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13940149|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14120080|NCT03393468|Dapivirine|dapivirine|mesh-list
14120081|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14120082|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14120083|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
14120084|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120085|NCT03371667|Methotrexate|methotrexate|mesh-list
14120086|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14120087|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
14120088|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13940150|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940151|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940152|NCT03299517|Lidocaine|lidocaine|mesh-list
13940153|NCT03299517|Amiodarone|amiodarone|mesh-list
13940154|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
13940155|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
13940156|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
13940157|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940158|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940159|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
13940160|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940161|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13940162|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14478127|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478128|NCT02447029|Lidocaine|lidocaine|mesh-list
13940163|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940164|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940165|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
13940166|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13940167|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13940168|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13940169|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940170|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13940171|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13940172|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13940173|NCT03299426|Vaccines|vaccines|mesh-list
13940174|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
14120089|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120090|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940175|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940176|NCT03299387|Gentamicins|gentamicins|mesh-list
13940177|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
13940178|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13940179|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120091|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
14120092|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120093|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120094|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
14120095|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120096|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14120097|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120098|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
14120099|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120100|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14120101|NCT03318900|Aldesleukin|aldesleukin|mesh-list
14120102|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
14120103|NCT03318900|Interleukin-2|interleukin-2|mesh-list
14120104|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14120105|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
14120106|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120107|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
14120108|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120109|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120110|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14120111|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
14120112|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120113|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120114|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14120115|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14120116|NCT03318900|Analgesics|analgesics|mesh-ancestor
14120117|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
14120118|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120119|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14120120|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14120121|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
14120122|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120123|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
14120124|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13940180|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13940181|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940182|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940183|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14120125|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120126|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
14120127|NCT03121001|Sirolimus|sirolimus|mesh-list
14120128|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
14120129|NCT03121001|Fludarabine|fludarabine|mesh-list
14120130|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
14120131|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120132|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
14120133|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120134|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120135|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14120136|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
14120137|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120138|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120139|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14120140|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14120141|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14120142|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
14120143|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14120144|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120145|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120146|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
14120147|NCT03073525|Atezolizumab|atezolizumab|mesh-list
14120148|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120149|NCT02965898|Vitamin D|vitamin d|mesh-list
14120150|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
14120151|NCT02965898|Vitamins|vitamins|mesh-list
14120152|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
14120153|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120154|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14120155|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14120156|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
14120157|NCT02952222|Propofol|propofol|mesh-list
14120158|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13940184|NCT03299387|Renal Agents|renal agents|mesh-ancestor
13940185|NCT03299296|Enoxaparin|enoxaparin|mesh-list
13940186|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
13940187|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13940188|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
13940189|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13940190|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
13940191|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940192|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940193|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
13940194|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13940195|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13940196|NCT03299257|Donepezil|donepezil|mesh-list
13940197|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13940198|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940199|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940200|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
13940201|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940202|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940203|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
13940204|NCT03299036|Doxorubicin|doxorubicin|mesh-list
13940205|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13940206|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940207|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13940208|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13940209|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940210|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940211|NCT03298958|Sirolimus|sirolimus|mesh-list
13940212|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13940213|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940214|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13940215|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940216|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
13940217|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940218|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
13940219|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940220|NCT03298906|Ticlopidine|ticlopidine|mesh-list
13940221|NCT03298906|Esketamine|esketamine|mesh-list
13940222|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
13940223|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13940224|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13940225|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13940226|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940227|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13940228|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13940229|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14120159|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120160|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940230|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14120161|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14120162|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
14120163|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
14120164|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14120165|NCT02952222|Analgesics|analgesics|mesh-ancestor
14120166|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
14120167|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120168|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14120169|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14120170|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14120171|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120172|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940231|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
13940232|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936478|NCT01469520|Lamivudine|lamivudine|mesh-list
14936479|NCT01469520|Zidovudine|zidovudine|mesh-list
14936480|NCT01469520|Nevirapine|nevirapine|mesh-list
14936481|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14936482|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14120173|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120174|NCT02922764|Carboplatin|carboplatin|mesh-list
14120175|NCT02922764|Docetaxel|docetaxel|mesh-list
13940233|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940234|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13940235|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13940236|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120176|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
14120177|NCT02922764|Nivolumab|nivolumab|mesh-list
14120178|NCT02922764|Pemetrexed|pemetrexed|mesh-list
14120179|NCT02922764|Ipilimumab|ipilimumab|mesh-list
14120180|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120181|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
14120182|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
14120183|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
14120184|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120185|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120186|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14120187|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940242|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
13940243|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13940244|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940245|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13940246|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13940247|NCT03298698|Prednisone|prednisone|mesh-list
13940248|NCT03298698|Prednisolone|prednisolone|mesh-list
13940249|NCT03298698|Rituximab|rituximab|mesh-list
13940250|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120188|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14120189|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14120190|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14120191|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14120192|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
14120193|NCT02563015|Vitamin D|vitamin d|mesh-list
14120194|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
14120195|NCT02563015|Vitamins|vitamins|mesh-ancestor
14120196|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
14120197|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120198|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14120199|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14120200|NCT02531932|Carboplatin|carboplatin|mesh-list
14478129|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
14478130|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
14478131|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478132|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478133|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
14120201|NCT02531932|Everolimus|everolimus|mesh-list
14120202|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478134|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478135|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14936483|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940251|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120203|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762626|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14762627|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762628|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
14762629|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940252|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
13940253|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940254|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13940255|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940256|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
13940257|NCT03298698|Hormones|hormones|mesh-ancestor
13940258|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940259|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13940260|NCT03298646|Diclofenac|diclofenac|mesh-list
13940261|NCT03298646|Lidocaine|lidocaine|mesh-list
13940262|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
13940263|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
13940264|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940265|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940266|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
13940267|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940268|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13940269|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13940270|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13940271|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940272|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940273|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13940274|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940275|NCT03298646|Analgesics|analgesics|mesh-ancestor
14762630|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
14762631|NCT02326311|Dasatinib|dasatinib|mesh-list
13940276|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940277|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120204|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
14120205|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120206|NCT02344290|Pitavastatin|pitavastatin|mesh-list
14120207|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14120208|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14120209|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14120210|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
14120211|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120212|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120213|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13940278|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13940279|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940280|NCT03298581|Clobetasol|clobetasol|mesh-list
13940281|NCT03298581|Halobetasol|halobetasol|mesh-list
13940282|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13940283|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940284|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
13940285|NCT03298581|Hormones|hormones|mesh-ancestor
13940286|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940287|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940288|NCT03298542|Golimumab|golimumab|mesh-list
13940289|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13940290|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940291|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940292|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
13940293|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940294|NCT03298516|Azacitidine|azacitidine|mesh-list
13940295|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940296|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
13940297|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940298|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940299|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940300|NCT03298464|Pioglitazone|pioglitazone|mesh-list
13940301|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13940302|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940303|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
13940304|NCT03298373|Nandrolone|nandrolone|mesh-list
13940305|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
14120214|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14478136|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14762632|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120215|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14120216|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120217|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120218|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120219|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120220|NCT05094804|Pembrolizumab|pembrolizumab|mesh-list
14120221|NCT05094804|Nivolumab|nivolumab|mesh-list
14120222|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120223|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940306|NCT03298373|Androgens|androgens|mesh-ancestor
13940307|NCT03298373|Hormones|hormones|mesh-ancestor
13940308|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940309|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940310|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
13940311|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13940312|NCT03298347|Caffeine|caffeine|mesh-list
13940313|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13940314|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940315|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13940316|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940317|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940318|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13940319|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13940320|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
13940321|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940322|NCT03298321|Azacitidine|azacitidine|mesh-list
13940323|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940324|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
13940325|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940326|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940327|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940328|NCT03298295|Insulin|insulin|mesh-list
13940329|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13940330|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940331|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
13940332|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
13940333|NCT03298191|Ritodrine|ritodrine|mesh-list
13940334|NCT03298191|Calcium|calcium|mesh-list
13940335|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13940336|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940337|NCT03298191|Analgesics|analgesics|mesh-ancestor
13940338|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
13940339|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940340|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
13940341|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940342|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13940343|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
13940344|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940345|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120224|NCT05094804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14120225|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120226|NCT05094596|Montelukast|montelukast|mesh-list
14120227|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14120228|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
14120229|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14120230|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
14120231|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120232|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120233|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14120234|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13940346|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
13940347|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13940348|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
13940349|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
13940350|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13940351|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13940352|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13940353|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120235|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120236|NCT05094492|Fluorides|fluorides|mesh-list
14120237|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
14120238|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
13940354|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940355|NCT03298074|Etoposide|etoposide|mesh-list
13940356|NCT03298074|Apatinib|apatinib|mesh-list
14120239|NCT05094492|Protective Agents|protective agents|mesh-ancestor
14120240|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120241|NCT05094414|Valacyclovir|valacyclovir|mesh-list
14120242|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
14120243|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120244|NCT05094375|Misoprostol|misoprostol|mesh-list
14120245|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14120246|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
14120247|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14120248|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120249|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14120250|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14120251|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
14176520|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176521|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176522|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14176523|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14176524|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176525|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176526|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14176527|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
14176528|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14176529|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176530|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14176531|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14176532|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14176533|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14176534|NCT04764916|Bupivacaine|bupivacaine|mesh-list
14176535|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
14176536|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
14176537|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176538|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176539|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
14176540|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176541|NCT04764851|Ecopipam|ecopipam|mesh-list
14176542|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14176543|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14176544|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176545|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176546|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14176547|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14176548|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
14176549|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176550|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176551|NCT04764630|Naloxone|naloxone|mesh-list
14176552|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14176553|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176554|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
14176555|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176556|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
14176557|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
14176558|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14176559|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14176560|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
14176561|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176562|NCT04764643|Expectorants|expectorants|mesh-ancestor
14176563|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
14176564|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14176565|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
14176566|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176567|NCT04764643|Protective Agents|protective agents|mesh-ancestor
14176568|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176569|NCT04764643|Antidotes|antidotes|mesh-ancestor
14176570|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
14176571|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14176572|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
14176573|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
14176574|NCT04764396|Heparin|heparin|mesh-list
14176575|NCT04764396|Calcium heparin|calcium heparin|mesh-list
14176576|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
14176577|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14176578|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14478137|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14176579|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940357|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13940358|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940359|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13940360|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13940361|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940362|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940363|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13961814|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961815|NCT03145272|Analgesics|analgesics|mesh-ancestor
13961816|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
13961817|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961818|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
13961819|NCT05255666|Irinotecan|irinotecan|mesh-list
13961820|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961821|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961822|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13961823|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13961824|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961825|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961826|NCT05255601|Nivolumab|nivolumab|mesh-list
13961827|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13961828|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961829|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13961830|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961831|NCT05255575|Ertapenem|ertapenem|mesh-list
13961832|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961833|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961834|NCT05255523|Capecitabine|capecitabine|mesh-list
13961835|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13961836|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
13961837|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961838|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961839|NCT05255484|Antibodies|antibodies|mesh-list
13961840|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
13961841|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961842|NCT05255406|Aflutinib|aflutinib|mesh-list
14478138|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14478139|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478140|NCT02447172|Gentamicins|gentamicins|mesh-list
14478141|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14478142|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478143|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14120252|NCT05093907|Capecitabine|capecitabine|mesh-list
14120253|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14120254|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
14120255|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120256|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120257|NCT05093790|Aspirin|aspirin|mesh-list
14120258|NCT05093790|Ticagrelor|ticagrelor|mesh-list
14120259|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14120260|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14120261|NCT05093790|Analgesics|analgesics|mesh-ancestor
14478144|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478145|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478146|NCT02447250|Albuterol|albuterol|mesh-list
14478147|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14478148|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
14478149|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478150|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478151|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14478152|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
13961843|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13961844|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961845|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961846|NCT05255367|Phenol|phenol|mesh-list
13961847|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13961848|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961849|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
13961850|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13961851|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13961852|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
13961853|NCT05255302|Pemetrexed|pemetrexed|mesh-list
14120262|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
13961854|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762633|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14762634|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762635|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762636|NCT02316106|Daratumumab|daratumumab|mesh-list
13940364|NCT03298009|Canagliflozin|canagliflozin|mesh-list
13940365|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13940366|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940367|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13940368|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940369|NCT03297931|Iproplatin|iproplatin|mesh-list
13940370|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940371|NCT03297879|Metformin|metformin|mesh-list
13940372|NCT03297879|Exenatide|exenatide|mesh-list
13940373|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13940374|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940375|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13940376|NCT03297879|Incretins|incretins|mesh-ancestor
13940377|NCT03297879|Hormones|hormones|mesh-ancestor
13940378|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940379|NCT03297593|Nivolumab|nivolumab|mesh-list
13940380|NCT03297593|Ipilimumab|ipilimumab|mesh-list
13940381|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940382|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940383|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13940384|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940385|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
13940386|NCT03297502|Tacrolimus|tacrolimus|mesh-list
13940387|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13940388|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940389|NCT03297502|Analgesics|analgesics|mesh-ancestor
13940390|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
14120263|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120264|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120265|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120266|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120267|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14120268|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14120269|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120270|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14120271|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14120272|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120273|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
14120274|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14120275|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14120276|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14120277|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
14120278|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120279|NCT05093478|Lidocaine|lidocaine|mesh-list
14120280|NCT05093478|Capsaicin|capsaicin|mesh-list
14120281|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
14120282|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
14120283|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120284|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120285|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
14120286|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120287|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13940391|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940392|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940393|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940394|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13940395|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
13940396|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940397|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
14120288|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14120289|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14120290|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14120291|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120292|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
14120293|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14120294|NCT05093387|Carboplatin|carboplatin|mesh-list
14120295|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
14120296|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120297|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120298|NCT05093374|Bevacizumab|bevacizumab|mesh-list
14478153|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
14120299|NCT05093374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120300|NCT05093374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120301|NCT05093374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14120302|NCT05093374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14120303|NCT05093374|Growth Substances|growth substances|mesh-ancestor
14120304|NCT05093374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120305|NCT05093374|Growth Inhibitors|growth inhibitors|mesh-ancestor
14120306|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
14762637|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14762638|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762639|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
14762640|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762641|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14762642|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
14762643|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
14762644|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762645|NCT02277444|Golimumab|golimumab|mesh-list
14762646|NCT02277444|Methotrexate|methotrexate|mesh-list
14762647|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14762648|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
14762649|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14762650|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762651|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940398|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14120307|NCT05093231|Olaparib|olaparib|mesh-list
14120308|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120309|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120310|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14120311|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120312|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120313|NCT05092984|Spironolactone|spironolactone|mesh-list
14120314|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14120315|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
14120316|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120317|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120318|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14120319|NCT05092984|Diuretics|diuretics|mesh-ancestor
14120320|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
14120321|NCT05092945|Niacin|niacin|mesh-list
14120322|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
14120323|NCT05092945|Niacinamide|niacinamide|mesh-list
14120324|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14120325|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
14120326|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120327|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14120328|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
14120329|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
14120330|NCT05092945|Vitamins|vitamins|mesh-ancestor
14120331|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
14120332|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120333|NCT05089526|Lidocaine|lidocaine|mesh-list
14120334|NCT05089526|Fentanyl|fentanyl|mesh-list
13940399|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940400|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940401|NCT03297463|Ipilimumab|ipilimumab|mesh-list
13940402|NCT03297463|Interleukin-2|interleukin-2|mesh-list
13940403|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940404|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940405|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13940406|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940407|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940408|NCT03297463|Analgesics|analgesics|mesh-ancestor
13940409|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
13940410|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120335|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
14120336|NCT05089526|Ketamine|ketamine|mesh-list
14120337|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
14120338|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
14120339|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120340|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120341|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
14120342|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120343|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14120344|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14762652|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
13940411|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940412|NCT03297359|Dalteparin|dalteparin|mesh-list
13940413|NCT03297359|Tinzaparin|tinzaparin|mesh-list
13940414|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14120345|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14120346|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14120347|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120348|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14120349|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14120350|NCT05089526|Analgesics|analgesics|mesh-ancestor
14120351|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14120352|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14120353|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14120354|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120355|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120356|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14120357|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14120358|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
14120359|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14120360|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14120361|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14120362|NCT05089526|Narcotics|narcotics|mesh-ancestor
14120363|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14120364|NCT05080218|Adalimumab|adalimumab|mesh-list
14120365|NCT05080218|Etanercept|etanercept|mesh-list
14120366|NCT05080218|Golimumab|golimumab|mesh-list
14120367|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14120368|NCT05080218|Abatacept|abatacept|mesh-list
14120369|NCT05080218|Upadacitinib|upadacitinib|mesh-list
14120370|NCT05080218|Tofacitinib|tofacitinib|mesh-list
14120371|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120372|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120373|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14120374|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14120375|NCT05080218|Analgesics|analgesics|mesh-ancestor
14120376|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
14120377|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120378|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120379|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14120380|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120381|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
14120382|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14120383|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120384|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120385|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14120386|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120387|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14120388|NCT05049616|Nifedipine|nifedipine|mesh-list
14120389|NCT05049616|Diuretics|diuretics|mesh-list
14120390|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14120391|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13940415|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
13940416|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13940417|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13940418|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940419|NCT03297073|Acetaminophen|acetaminophen|mesh-list
13940420|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940421|NCT03297073|Analgesics|analgesics|mesh-ancestor
13940422|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
13940423|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940424|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940425|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
13940426|NCT03296982|Enoxaparin|enoxaparin|mesh-list
13940427|NCT03296982|Edoxaban|edoxaban|mesh-list
13940428|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
13940429|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13940430|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13940431|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940432|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13940433|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
13940434|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14120392|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14120393|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940435|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
13940436|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176580|NCT04764227|Paclitaxel|paclitaxel|mesh-list
13940437|NCT03296930|Ritonavir|ritonavir|mesh-list
13940438|NCT03296930|Ribavirin|ribavirin|mesh-list
13940439|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
13940440|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13940441|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13940442|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
13940443|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940444|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940445|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13940446|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13940447|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
13940448|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940449|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13940450|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13940451|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
13940452|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
13940453|NCT03296670|Alprostadil|alprostadil|mesh-list
13940454|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
13940455|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13940456|NCT03296670|Urological Agents|urological agents|mesh-ancestor
13940457|NCT03296657|Fluorides|fluorides|mesh-list
13940458|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
13940459|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
13940460|NCT03296657|Protective Agents|protective agents|mesh-ancestor
13940461|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120394|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14120395|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120396|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
13940462|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
13940463|NCT03296579|Aminophylline|aminophylline|mesh-list
13940464|NCT03296579|Albuterol|albuterol|mesh-list
13940465|NCT03296579|Ipratropium|ipratropium|mesh-list
13940466|NCT03296579|Analgesics|analgesics|mesh-ancestor
13940467|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
13940468|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940469|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940470|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
13940471|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940472|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13940473|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
13940474|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13940475|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14120397|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
14120398|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14120399|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
14120400|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
14120401|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120402|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
14120403|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14120404|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120405|NCT05022810|Acetaminophen|acetaminophen|mesh-list
14120406|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14120407|NCT05022810|Analgesics|analgesics|mesh-ancestor
13940476|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120408|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
14120409|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120410|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120411|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
14120412|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
14120413|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120414|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
14120415|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
14120416|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14120417|NCT04993560|Vaccines|vaccines|mesh-list
14120418|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
14120419|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120420|NCT04947085|Ketamine|ketamine|mesh-list
14120421|NCT04947085|Analgesics|analgesics|mesh-ancestor
14120422|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
13940477|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13940478|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
13940479|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13940480|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13940481|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
13940482|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14120423|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120424|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120425|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14120426|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13940483|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
13940484|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13940485|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13940486|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13940487|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
13940488|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940489|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13940490|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
13940491|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13940492|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13940493|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940494|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14120427|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
14120428|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
14120429|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940495|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13940496|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
14120430|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14120431|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14120432|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120433|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176581|NCT04764227|Carboplatin|carboplatin|mesh-list
14176582|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176583|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176584|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176585|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176586|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176587|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176588|NCT04764344|Haloperidol|haloperidol|mesh-list
14176589|NCT04764344|Ondansetron|ondansetron|mesh-list
14176590|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
14176591|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
14176592|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
14176593|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176594|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176595|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14176596|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
14176597|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
14176598|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14176599|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
14176600|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940497|NCT03296579|Protective Agents|protective agents|mesh-ancestor
13940498|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13940499|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13940500|NCT03296488|Fentanyl|fentanyl|mesh-list
13940501|NCT03296488|Nalbuphine|nalbuphine|mesh-list
13940502|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13940503|NCT03296488|Narcotics|narcotics|mesh-ancestor
13940504|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940505|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940506|NCT03296488|Analgesics|analgesics|mesh-ancestor
13940507|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
13940508|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940509|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13940510|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13940511|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
13940512|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
13940513|NCT03296423|Vaccines|vaccines|mesh-list
13940514|NCT03296423|Immunologic Factors|immunologic factors|mesh-ancestor
13940515|NCT03296423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940516|NCT03296410|Vaccines|vaccines|mesh-list
14176601|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176602|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14176603|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14176604|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176605|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14176606|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14176607|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14176608|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
14176609|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14176610|NCT04764383|Histamine|histamine|mesh-list
14176611|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
14176612|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
14478154|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13940517|NCT03296410|Immunoglobulins|immunoglobulins|mesh-list
13940518|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
14120434|NCT04885816|Sirolimus|sirolimus|mesh-list
14120435|NCT04885816|Everolimus|everolimus|mesh-list
14120436|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120437|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120438|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
14120439|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120440|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14120441|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120442|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14120443|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
14120444|NCT04865614|Sevoflurane|sevoflurane|mesh-list
14120445|NCT04865614|Etomidate|etomidate|mesh-list
13940519|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940520|NCT03296397|Vaccines|vaccines|mesh-list
13940521|NCT03296397|Immunologic Factors|immunologic factors|mesh-ancestor
13940522|NCT03296397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961855|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961856|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961857|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961858|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13961859|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13961860|NCT05255276|Itraconazole|itraconazole|mesh-list
13961861|NCT05255276|Rifampin|rifampin|mesh-list
14120446|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14120447|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14120448|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
14120449|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
14120450|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120451|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120452|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14120453|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14120454|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
14120455|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14120456|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120457|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120458|NCT04770454|Buspirone|buspirone|mesh-list
14120459|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14120460|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14762653|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762654|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762655|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
14762656|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762657|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14120461|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762658|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961862|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
13961863|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961864|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13961865|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13961866|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961867|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961868|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13961869|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
13961870|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13961871|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961872|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13961873|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13961874|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
13961875|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13961876|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
13961877|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13961878|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13961879|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13961880|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13961881|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13961882|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13961883|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13961884|NCT05255211|Propofol|propofol|mesh-list
13961885|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13961886|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13961887|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120462|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120463|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14120464|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14120465|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
14120466|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120467|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120468|NCT04731025|Vancomycin|vancomycin|mesh-list
14120469|NCT04731025|Gentamicins|gentamicins|mesh-list
14120470|NCT04731025|Cefazolin|cefazolin|mesh-list
14120471|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14120472|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120473|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14120474|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120475|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120476|NCT04711824|Gemcitabine|gemcitabine|mesh-list
14120477|NCT04711824|Paclitaxel|paclitaxel|mesh-list
14120478|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14120479|NCT04711824|Cisplatin|cisplatin|mesh-list
14120480|NCT04711824|Carboplatin|carboplatin|mesh-list
14120481|NCT04711824|Capecitabine|capecitabine|mesh-list
14120482|NCT04711824|Durvalumab|durvalumab|mesh-list
14120483|NCT04711824|Olaparib|olaparib|mesh-list
14120484|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14120485|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120486|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
14120487|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
13940523|NCT03296358|Dexamethasone|dexamethasone|mesh-list
13940524|NCT03296358|Prednisolone|prednisolone|mesh-list
13940525|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940526|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
13940527|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
13940528|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940529|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940530|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13940531|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
13940532|NCT03296358|Hormones|hormones|mesh-ancestor
13940533|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120488|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
13940534|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14120489|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120490|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940535|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940536|NCT03296306|Cisplatin|cisplatin|mesh-list
13940537|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940538|NCT03296189|Dexamethasone|dexamethasone|mesh-list
13940539|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
13940540|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
13940541|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13940542|NCT03296189|BB 1101|bb 1101|mesh-list
13940543|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940544|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
13940545|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
13940546|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940547|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940548|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13940549|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
13940550|NCT03296189|Hormones|hormones|mesh-ancestor
13940551|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940552|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13940553|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940554|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
13940555|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
13940556|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940557|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
14120491|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
14120492|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
14120493|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120494|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120495|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120496|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
14120497|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940558|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
13940559|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940560|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120498|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14176613|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120499|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14120500|NCT04691128|Anesthetics|anesthetics|mesh-list
14120501|NCT04691128|Propofol|propofol|mesh-list
14120502|NCT04691128|Desflurane|desflurane|mesh-list
14120503|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120504|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120505|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14120506|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14120507|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
14120508|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14120509|NCT04682522|Metronidazole|metronidazole|mesh-list
14120510|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120511|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14120512|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14120513|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14120514|NCT04657809|Insulin|insulin|mesh-list
14120515|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14120516|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120517|NCT04628988|Prednisone|prednisone|mesh-list
14120518|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
14120519|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120520|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
14120521|NCT04628988|Hormones|hormones|mesh-ancestor
14120522|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120523|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120524|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14120525|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120526|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120527|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120528|NCT04601584|Antibodies|antibodies|mesh-list
14120529|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
14120530|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
14120531|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120532|NCT04585854|Caffeine|caffeine|mesh-list
14120533|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14120534|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120535|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13940561|NCT03296137|Aldesleukin|aldesleukin|mesh-list
13940562|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
13940563|NCT03296137|Nivolumab|nivolumab|mesh-list
13940564|NCT03296137|Ipilimumab|ipilimumab|mesh-list
13940565|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
13940566|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940567|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
13940568|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940569|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13940570|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13940571|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
13940572|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940573|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940574|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14120536|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120537|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120538|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14120539|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14120540|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
14120541|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940575|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940576|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13940577|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940578|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
13940579|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13940580|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13940581|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
13940582|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940583|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
13940584|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13940585|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
13940586|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14120542|NCT04582981|Raltitrexed|raltitrexed|mesh-list
14120543|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14120544|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
14120545|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940587|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940588|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13940589|NCT03295968|Ibuprofen|ibuprofen|mesh-list
13940590|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13940591|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940592|NCT03295968|Analgesics|analgesics|mesh-ancestor
13940593|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
13940594|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940595|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940596|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940597|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13940598|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13940599|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940600|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940601|NCT03295955|Amoxicillin|amoxicillin|mesh-list
13940602|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
13940603|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
13940604|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13940605|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13940606|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940607|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14120546|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120547|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14120548|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120549|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
14120550|NCT04548661|Povidone|povidone|mesh-list
14120551|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
14120552|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
14120553|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14120554|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120555|NCT04504240|Famotidine|famotidine|mesh-list
14120556|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14120557|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13940608|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940609|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940610|NCT03295903|Cannabidiol|cannabidiol|mesh-list
13940611|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
13940612|NCT03295851|Iron|iron|mesh-list
13940613|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
13940614|NCT03295851|Trace Elements|trace elements|mesh-ancestor
13940615|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
13940616|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940617|NCT03295825|Heparin|heparin|mesh-list
13940618|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
13940619|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13940620|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13940621|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940622|NCT03295786|Dopamine|dopamine|mesh-list
13940623|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13940624|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
13940625|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
13940626|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940627|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940628|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
13940629|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940630|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940631|NCT03295786|Protective Agents|protective agents|mesh-ancestor
13940632|NCT03295760|Ubiquinone|ubiquinone|mesh-list
13940633|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
14120558|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14120559|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
14120560|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
14120561|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120562|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120563|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120564|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14120565|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14120566|NCT04492306|Protective Agents|protective agents|mesh-ancestor
14120567|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120568|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14120569|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
14120570|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120571|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
14120572|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13940634|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
13940635|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120573|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
13940636|NCT03295760|Vitamins|vitamins|mesh-ancestor
13940637|NCT03295734|Losartan|losartan|mesh-list
13940638|NCT03295734|Perindopril|perindopril|mesh-list
13940639|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13940640|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13940641|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13940642|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13940643|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940644|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13940645|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
13940646|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940647|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13940648|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13940649|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940650|NCT03295487|Estrogens|estrogens|mesh-list
13940651|NCT03295487|Hormones|hormones|mesh-ancestor
13940652|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940653|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940654|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
13940655|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13940656|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940657|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
13940658|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
13940659|NCT03295383|Rituximab|rituximab|mesh-list
13940660|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940661|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
13940662|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940663|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13940664|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13940665|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
13961888|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14120574|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120575|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
14120576|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14120577|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
14120578|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120579|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
14120580|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14120581|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
14120582|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120583|NCT04459052|Expectorants|expectorants|mesh-ancestor
14120584|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
14120585|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14120586|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
14120587|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120588|NCT04459052|Protective Agents|protective agents|mesh-ancestor
14120589|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120590|NCT04459052|Antidotes|antidotes|mesh-ancestor
14120591|NCT04429802|Prucalopride|prucalopride|mesh-list
14120592|NCT04429802|Laxatives|laxatives|mesh-ancestor
14120593|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14120594|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14120595|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14120596|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
14120597|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120598|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120599|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120600|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
14120601|NCT04387760|Favipiravir|favipiravir|mesh-list
14120602|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
14120603|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14120604|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14120605|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120606|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762659|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
14762660|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120607|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120608|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14478155|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14478156|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14120609|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
14478157|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14478158|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478159|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478160|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478161|NCT02447328|Fulvestrant|fulvestrant|mesh-list
14120610|NCT04374903|Sirolimus|sirolimus|mesh-list
14120611|NCT04374903|Azithromycin|azithromycin|mesh-list
14120612|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
14120613|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14120614|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120615|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14120616|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120617|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
14120618|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120619|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
14120620|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120621|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
14120622|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14120623|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14120624|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120625|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120626|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120627|NCT04356534|Antibodies|antibodies|mesh-list
14120628|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
14120629|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120630|NCT04331756|Anesthetics|anesthetics|mesh-list
14120631|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120632|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120633|NCT04320342|Beclomethasone|beclomethasone|mesh-list
14120634|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
14120635|NCT04320342|Bromides|bromides|mesh-list
14120636|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
14120637|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14120638|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
14120639|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120640|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120641|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14120642|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
14120643|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14120644|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14120645|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14120646|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120647|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120648|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120649|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
14120650|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120651|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
14120652|NCT04320342|Hormones|hormones|mesh-ancestor
14120653|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120654|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14120655|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13940666|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940667|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940668|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13940669|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940670|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
13940671|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940672|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940673|NCT03295214|Acetaminophen|acetaminophen|mesh-list
13940674|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940675|NCT03295214|Analgesics|analgesics|mesh-ancestor
13940676|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
14120656|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14120657|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
14120658|NCT04300244|Nivolumab|nivolumab|mesh-list
14120659|NCT04300244|Ipilimumab|ipilimumab|mesh-list
14120660|NCT04300244|Sargramostim|sargramostim|mesh-list
14120661|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120662|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120663|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14120664|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120665|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
14120666|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120667|NCT04298203|Topiramate|topiramate|mesh-list
14120668|NCT04298203|Phentermine|phentermine|mesh-list
14120669|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
14120670|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14120671|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120672|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14762661|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14120673|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
14120674|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14120675|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
14120676|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
14120677|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120678|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120679|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120680|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120681|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
14120682|NCT04214418|Atezolizumab|atezolizumab|mesh-list
13940677|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940678|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940679|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
13940680|NCT03295162|Melatonin|melatonin|mesh-list
13940681|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
13940682|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940683|NCT03295162|Protective Agents|protective agents|mesh-ancestor
13940684|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940685|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940686|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13940687|NCT03295084|Capecitabine|capecitabine|mesh-list
13940688|NCT03295084|Irinotecan|irinotecan|mesh-list
13940689|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940690|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
13940691|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940692|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940693|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13940694|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13940695|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940696|NCT03294967|Vitamin E|vitamin e|mesh-list
13940697|NCT03294967|Caffeine|caffeine|mesh-list
13940698|NCT03294967|Vitamins|vitamins|mesh-ancestor
13940699|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
13940700|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940701|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13940702|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13940703|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940704|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940705|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13940706|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13940707|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
13940708|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940709|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
13940710|NCT03294967|Protective Agents|protective agents|mesh-ancestor
13940711|NCT03294798|Interferons|interferons|mesh-list
13940712|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
13940713|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
13940714|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13940715|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940716|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
13940717|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940718|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
14120683|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120684|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
14120685|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14120686|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14120687|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120688|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120689|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120690|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176614|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176615|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176616|NCT04764084|Niraparib|niraparib|mesh-list
14176617|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14176618|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176619|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176620|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176621|NCT04764214|Osimertinib|osimertinib|mesh-list
14176622|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176623|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14176624|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176625|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176626|NCT04764045|Ropivacaine|ropivacaine|mesh-list
14176627|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
14176628|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
13940719|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120691|NCT04204967|Fentanyl|fentanyl|mesh-list
14120692|NCT04204967|Remifentanil|remifentanil|mesh-list
14120693|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14120694|NCT04204967|Narcotics|narcotics|mesh-ancestor
14120695|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120696|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120697|NCT04204967|Analgesics|analgesics|mesh-ancestor
14120698|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
14120699|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120700|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14120701|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14120702|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
14120703|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
14120704|NCT04182672|Triamcinolone|triamcinolone|mesh-list
14120705|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14120706|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14120707|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14120708|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120709|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
14120710|NCT04182672|Hormones|hormones|mesh-ancestor
14120711|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120712|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120713|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120714|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
14120715|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120716|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120717|NCT04169373|Upadacitinib|upadacitinib|mesh-list
14120718|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14120719|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14120720|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120721|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120722|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120723|NCT04085445|Paclitaxel|paclitaxel|mesh-list
14120724|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14120725|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120726|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
14120727|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
14120728|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
14120729|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120730|NCT04069273|Paclitaxel|paclitaxel|mesh-list
14120731|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
14120732|NCT04069273|Ramucirumab|ramucirumab|mesh-list
14120733|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14120734|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120735|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
14120736|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
14120737|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
14120738|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120739|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120740|NCT04052568|Psilocybin|psilocybin|mesh-list
14120741|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
14120742|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120743|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14120744|NCT03854032|Nivolumab|nivolumab|mesh-list
14120745|NCT03854032|Linrodostat|linrodostat|mesh-list
14120746|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120747|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120748|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14120749|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120750|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120751|NCT03818763|Factor VIII|factor viii|mesh-list
14120752|NCT03818763|Coagulants|coagulants|mesh-ancestor
14120753|NCT03710876|Gemcitabine|gemcitabine|mesh-list
14120754|NCT03710876|Celecoxib|celecoxib|mesh-list
14120755|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14120756|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
14120757|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120758|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120759|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
14120760|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120761|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120762|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120763|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
14120764|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120765|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14120766|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940720|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
13940721|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13940722|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940723|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
13940724|NCT03294707|Coal Tar|coal tar|mesh-list
14120767|NCT03710876|Analgesics|analgesics|mesh-ancestor
14120768|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
14120769|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120770|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120771|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120772|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14120773|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14120774|NCT03688828|Amoxicillin|amoxicillin|mesh-list
14120775|NCT03688828|Clarithromycin|clarithromycin|mesh-list
14120776|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
14120777|NCT03688828|Esomeprazole|esomeprazole|mesh-list
14120778|NCT03688828|Bismuth|bismuth|mesh-list
13940725|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
13940726|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
13940727|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
13940728|NCT03294577|Docetaxel|docetaxel|mesh-list
13940729|NCT03294577|Doxorubicin|doxorubicin|mesh-list
13940730|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940731|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
13940732|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940733|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13940734|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13940735|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
13940736|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940737|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940738|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13940739|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
13940740|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
13940741|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
13940742|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13940743|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13940744|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13940745|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940746|NCT03294551|Vaccines|vaccines|mesh-list
13940747|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
13940748|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940749|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13940750|NCT03294525|Mirtazapine|mirtazapine|mesh-list
13940751|NCT03294525|Citalopram|citalopram|mesh-list
13940752|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
13940753|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13940754|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14120779|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120780|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14120781|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14120782|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14120783|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14120784|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14120785|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120786|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14120787|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14120788|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14120789|NCT03688828|Antacids|antacids|mesh-ancestor
14120790|NCT03688828|Diuretics|diuretics|mesh-ancestor
14120791|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
14120792|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120793|NCT03688828|Expectorants|expectorants|mesh-ancestor
14120794|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
14120795|NCT03643822|Dexamethasone|dexamethasone|mesh-list
14120796|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
14120797|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
14120798|NCT03643822|BB 1101|bb 1101|mesh-list
14120799|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120800|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
14120801|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
14120802|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940755|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940756|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120803|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120804|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14120805|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
14120806|NCT03643822|Hormones|hormones|mesh-ancestor
14176629|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120807|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120808|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14120809|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120810|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14120811|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120812|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120813|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14120814|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120815|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14120816|NCT03643822|Analgesics|analgesics|mesh-ancestor
14120817|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
14120818|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14120819|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14120820|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14120821|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120822|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120823|NCT03634150|Doxorubicin|doxorubicin|mesh-list
14120824|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14120825|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120826|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14478162|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14478163|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478164|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14120827|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14120828|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120829|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120830|NCT03593759|Prednisone|prednisone|mesh-list
14120831|NCT03593759|Prednisolone|prednisolone|mesh-list
14120832|NCT03593759|Methotrexate|methotrexate|mesh-list
14120833|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120834|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
14120835|NCT03593759|Hormones|hormones|mesh-ancestor
14120836|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120837|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120838|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14120839|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120840|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14120841|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
14120842|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14120843|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14120844|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
14120845|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120846|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
14120847|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120848|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14120849|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120850|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
14120851|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120852|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14120853|NCT03564821|Ivosidenib|ivosidenib|mesh-list
13940757|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940758|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
13940759|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940760|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13940761|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13940762|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940763|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13940764|NCT03294525|Analgesics|analgesics|mesh-ancestor
13940765|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
13940766|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
13940767|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13940768|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
13940769|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
13940770|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13940771|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13940772|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940773|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13940774|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13940775|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13940776|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478165|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14478166|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
13940777|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13940778|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13940779|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13940780|NCT03294486|Flucytosine|flucytosine|mesh-list
14120854|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120855|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120856|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120857|NCT03329378|Paclitaxel|paclitaxel|mesh-list
14120858|NCT03329378|Docetaxel|docetaxel|mesh-list
14120859|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14120860|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
14120861|NCT03329378|Carboplatin|carboplatin|mesh-list
14120862|NCT03329378|Doxorubicin|doxorubicin|mesh-list
14120863|NCT03329378|Trastuzumab|trastuzumab|mesh-list
14120864|NCT03329378|Pertuzumab|pertuzumab|mesh-list
14120865|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14120866|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120867|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14120868|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14120869|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
14120870|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120871|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14120872|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
14120873|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120874|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14120875|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14120876|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
14120877|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14120878|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14120879|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14120880|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14120881|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120882|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120883|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14120884|NCT03270059|Hematinics|hematinics|mesh-ancestor
14120885|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14120886|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14120887|NCT03268083|Vaccines|vaccines|mesh-list
14120888|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
14120889|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120890|NCT03170817|Regadenoson|regadenoson|mesh-list
14120891|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14120892|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14120893|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
14120894|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
14120895|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120896|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120897|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120898|NCT03148275|Trametinib|trametinib|mesh-list
14120899|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120900|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13940781|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
13940782|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940783|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
13940784|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940785|NCT03294395|Gentamicins|gentamicins|mesh-list
13940786|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
13940787|NCT03294395|Fosfomycin|fosfomycin|mesh-list
13940788|NCT03294395|Ertapenem|ertapenem|mesh-list
13940789|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13940790|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940791|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13940792|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940793|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940794|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
13940795|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13940796|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13940797|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13940798|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940799|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940800|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
13940801|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940802|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479265|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14120901|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940803|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13940804|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940805|NCT03294252|Leucovorin|leucovorin|mesh-list
13940806|NCT03294252|Folic Acid|folic acid|mesh-list
13940807|NCT03294252|Fluorouracil|fluorouracil|mesh-list
13940808|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
13940809|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
13940810|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
13940811|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940812|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13940813|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940814|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940815|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
13940816|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940817|NCT03294252|Antidotes|antidotes|mesh-ancestor
13940818|NCT03294252|Protective Agents|protective agents|mesh-ancestor
13940819|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
13940820|NCT03294252|Vitamins|vitamins|mesh-ancestor
13940821|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
13940822|NCT03294252|Hematinics|hematinics|mesh-ancestor
13940823|NCT03294174|Ropivacaine|ropivacaine|mesh-list
13940824|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
13940825|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
13940826|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940827|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940828|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
13940829|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940830|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
13940831|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13940832|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13940833|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940834|NCT03294083|Cemiplimab|cemiplimab|mesh-list
14120902|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120903|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
14120904|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14120905|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14120906|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
14120907|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14120908|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120909|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120910|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
14120911|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
14120912|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120913|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
14120914|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14120915|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
14120916|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
14120917|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14120918|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14120919|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120920|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
14120921|NCT02926651|Coagulants|coagulants|mesh-ancestor
14120922|NCT02896335|Palbociclib|palbociclib|mesh-list
14120923|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120924|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14120925|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120926|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120927|NCT02843074|Dexamethasone|dexamethasone|mesh-list
14120928|NCT02843074|Lenalidomide|lenalidomide|mesh-list
14120929|NCT02843074|Elotuzumab|elotuzumab|mesh-list
14120930|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14120931|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
14120932|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
14120933|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120934|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120935|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14120936|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
14120937|NCT02843074|Hormones|hormones|mesh-ancestor
14120938|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14120939|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14120940|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120941|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
14120942|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13940835|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940836|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940837|NCT03294070|Amlodipine|amlodipine|mesh-list
14120943|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14120944|NCT02843074|Growth Substances|growth substances|mesh-ancestor
14120945|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
14176630|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940838|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13940839|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13940840|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940841|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940842|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13940843|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940844|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
13940845|NCT03293992|Latanoprost|latanoprost|mesh-list
13940846|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13940847|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13940848|NCT03293927|Fentanyl|fentanyl|mesh-list
13940849|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
13940850|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13940851|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940852|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940853|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940854|NCT03293927|Analgesics|analgesics|mesh-ancestor
13940855|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
13940856|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176631|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
14176632|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176633|NCT04763876|Ketorolac|ketorolac|mesh-list
14176634|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14176635|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14176636|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14176637|NCT04763876|Analgesics|analgesics|mesh-ancestor
14176638|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
14176639|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176640|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176641|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14176642|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176643|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14176644|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176645|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176646|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14176647|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14176648|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176649|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
14176650|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176651|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176652|NCT04763434|Dexamethasone|dexamethasone|mesh-list
14176653|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
14176654|NCT04763434|Ropivacaine|ropivacaine|mesh-list
14176655|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14176656|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
14176657|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
14176658|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176659|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176660|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14176661|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
14176662|NCT04763434|Hormones|hormones|mesh-ancestor
14176663|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14176664|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14176665|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176666|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14176667|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176668|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14176669|NCT04763434|Analgesics|analgesics|mesh-ancestor
14176670|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
14176671|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14176672|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14176673|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14176674|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14176675|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176676|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176677|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
14176678|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
14762662|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14762663|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762664|NCT02265367|Milnacipran|milnacipran|mesh-list
14762665|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
14120946|NCT02805504|Bupivacaine|bupivacaine|mesh-list
14120947|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
14120948|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
14120949|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14120950|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120951|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
14120952|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14120953|NCT02605148|Vitamin D|vitamin d|mesh-list
13940857|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13940858|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13940859|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13940860|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
13940861|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940862|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940863|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13940864|NCT03293927|Narcotics|narcotics|mesh-ancestor
13940865|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13940866|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13940867|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
13940868|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
13940869|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
13940870|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940871|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940872|NCT03293641|Folic Acid|folic acid|mesh-list
13940873|NCT03293641|Penicillins|penicillins|mesh-list
13940874|NCT03293641|Penicillin V|penicillin v|mesh-list
13940875|NCT03293641|Proguanil|proguanil|mesh-list
13940876|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
13940877|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
13940878|NCT03293641|Hematinics|hematinics|mesh-ancestor
13940879|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
13940880|NCT03293641|Vitamins|vitamins|mesh-ancestor
13940881|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
14120954|NCT02605148|Vitamins|vitamins|mesh-ancestor
14120955|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
14120956|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120957|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14120958|NCT02505750|Capecitabine|capecitabine|mesh-list
14120959|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14120960|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
14120961|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120962|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120963|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
14120964|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14120965|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120966|NCT02395640|Capecitabine|capecitabine|mesh-list
14120967|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
14120968|NCT02395640|Epirubicin|epirubicin|mesh-list
14120969|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14120970|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
14120971|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14120972|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120973|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14120974|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14120975|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13940882|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940883|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940884|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
13940885|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940886|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940887|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13940888|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13940889|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13940890|NCT03293641|Astringents|astringents|mesh-ancestor
13940891|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
13940892|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
13940893|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13940894|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13940895|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
14120976|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14120977|NCT02381535|Cisplatin|cisplatin|mesh-list
14120978|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120979|NCT05096715|Bevacizumab|bevacizumab|mesh-list
13940896|NCT03293511|Oxytocin|oxytocin|mesh-list
13940897|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
13940898|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14120980|NCT05096715|Atezolizumab|atezolizumab|mesh-list
14120981|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13940899|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120982|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14120983|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14120984|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14120985|NCT05096715|Growth Substances|growth substances|mesh-ancestor
14120986|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14120987|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
14120988|NCT05096676|Oxytocin|oxytocin|mesh-list
14120989|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
14120990|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14120991|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940900|NCT03293472|Bupivacaine|bupivacaine|mesh-list
13940901|NCT03293472|Ropivacaine|ropivacaine|mesh-list
13940902|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
14762666|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14762667|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14762668|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13940903|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
13940904|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940905|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940906|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
13940907|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940908|NCT03293407|Iloprost|iloprost|mesh-list
13940909|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13940910|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
14121036|NCT05096520|Lidocaine|lidocaine|mesh-list
14121037|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
14121038|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
14121039|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121040|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121041|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
13940911|NCT03293368|Triamcinolone|triamcinolone|mesh-list
13961889|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
14121042|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121043|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13940912|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13940913|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13940914|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13940915|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940916|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
13940917|NCT03293368|Hormones|hormones|mesh-ancestor
13940918|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940919|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940920|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13940921|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
13940922|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940923|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121044|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14121045|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14121046|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14121047|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121048|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
14121049|NCT05096390|Axitinib|axitinib|mesh-list
14121050|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121051|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121052|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14121053|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121054|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121055|NCT05096312|Zinc|zinc|mesh-list
14121056|NCT05096312|Adapalene|adapalene|mesh-list
14121057|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14121058|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14121059|NCT05096312|Trace Elements|trace elements|mesh-ancestor
14121060|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
14121061|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121062|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14121063|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14121064|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14121065|NCT05096312|Analgesics|analgesics|mesh-ancestor
14121066|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
14121067|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940924|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
13940925|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13940926|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940927|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940928|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13940929|NCT03293277|Analgesics|analgesics|mesh-ancestor
13940930|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
13940931|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940932|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13940933|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13940934|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13940935|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
13940936|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940937|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961890|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
13961891|NCT05255159|Furosemide|furosemide|mesh-list
13961892|NCT05255159|Diuretics|diuretics|mesh-ancestor
13961893|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
13961894|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961895|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13961896|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13961897|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121068|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121069|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121070|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
14121071|NCT05096195|Vitamin D|vitamin d|mesh-list
14121072|NCT05096195|Denosumab|denosumab|mesh-list
14121073|NCT05096195|Calcium|calcium|mesh-list
14121074|NCT05096195|Vitamins|vitamins|mesh-ancestor
14121075|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
14121076|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121077|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14121078|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14121079|NCT05095714|Liver Extracts|liver extracts|mesh-list
14121080|NCT05095714|Hematinics|hematinics|mesh-ancestor
14121081|NCT05095636|Apatinib|apatinib|mesh-list
14121082|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121083|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14121084|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121085|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940938|NCT03293108|Vitamin D|vitamin d|mesh-list
13940939|NCT03293108|Denosumab|denosumab|mesh-list
13940940|NCT03293108|Calcium|calcium|mesh-list
13940941|NCT03293108|Vitamins|vitamins|mesh-ancestor
13940942|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
13940943|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940944|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13940945|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13940946|NCT03293069|Deferiprone|deferiprone|mesh-list
13940947|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13940948|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
13940949|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
13940950|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940951|NCT03293004|Vitamins|vitamins|mesh-list
13940952|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
13940953|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
14121086|NCT05095571|Niacinamide|niacinamide|mesh-list
14121087|NCT05095571|Niacin|niacin|mesh-list
14121088|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
14121089|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
14121090|NCT05095571|Vitamins|vitamins|mesh-ancestor
14121091|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
14121092|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121093|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14121094|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
14121095|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121096|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13940954|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940955|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
13940956|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940957|NCT03293004|Protective Agents|protective agents|mesh-ancestor
13940958|NCT03292965|Neostigmine|neostigmine|mesh-list
13940959|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13940960|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940961|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940962|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
13940963|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940964|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940965|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13940966|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
13940967|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940968|NCT03292926|Dexamethasone|dexamethasone|mesh-list
13940969|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
13940970|NCT03292926|Bupivacaine|bupivacaine|mesh-list
13940971|NCT03292926|BB 1101|bb 1101|mesh-list
13940972|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13940973|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
13940974|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
14121097|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
14121098|NCT05095480|Red yeast rice|red yeast rice|mesh-list
14121099|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14121100|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14121101|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14121102|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
14121103|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121104|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121105|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14121106|NCT05095467|Paclitaxel|paclitaxel|mesh-list
14121107|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14121108|NCT05095467|Tegafur|tegafur|mesh-list
14121109|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14121110|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121111|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
14478167|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940975|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13940976|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940977|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13940978|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
14121112|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
14121113|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
13940979|NCT03292926|Hormones|hormones|mesh-ancestor
13940980|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13940981|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13940982|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13940983|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
13940984|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13940985|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13940986|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
13940987|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
13940988|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13940989|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
13940990|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
14121114|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121115|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121116|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
14121117|NCT05095259|Insulin|insulin|mesh-list
13940991|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
13940992|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13940993|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121118|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14121119|NCT05095259|Epinephrine|epinephrine|mesh-list
14121120|NCT05095259|Glucagon|glucagon|mesh-list
14121121|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14121122|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121123|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14121124|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14121125|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
14121126|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121127|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121128|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14121129|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14121130|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
14121131|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121132|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14121133|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
14121134|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
14121135|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
14121136|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14121137|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14121138|NCT05095259|Hormones|hormones|mesh-ancestor
14121139|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121140|NCT05095207|Bicalutamide|bicalutamide|mesh-list
14121141|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
14121142|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
14121143|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121144|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121145|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121146|NCT05095077|Tadalafil|tadalafil|mesh-list
14121147|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
14121148|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14121149|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14121150|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121151|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121152|NCT05095077|Urological Agents|urological agents|mesh-ancestor
14121153|NCT05095025|Bupivacaine|bupivacaine|mesh-list
14121154|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
14121155|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
14121156|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121157|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121158|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
14121159|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121160|NCT05091619|Vaccines|vaccines|mesh-list
14121161|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
14121162|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121163|NCT05084027|Fludarabine|fludarabine|mesh-list
14121164|NCT05084027|Melphalan|melphalan|mesh-list
14121165|NCT05084027|Venetoclax|venetoclax|mesh-list
14121166|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121167|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121168|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121169|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
14121170|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121171|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14121172|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
14121173|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13940994|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13940995|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
13940996|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
13940997|NCT03292822|Paclitaxel|paclitaxel|mesh-list
13940998|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13940999|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941000|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
13941001|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
13941002|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
13941003|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762669|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762670|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762671|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176686|NCT04763486|Cefazolin|cefazolin|mesh-list
14176687|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14176688|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176689|NCT04763616|Cemiplimab|cemiplimab|mesh-list
14176690|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14176691|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176692|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
14176693|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14176694|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14176695|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14176696|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176697|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176698|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
14176699|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176700|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176701|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14176702|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176703|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
14176704|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14176705|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176706|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14176707|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14176708|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176709|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176710|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176711|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14176712|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14176713|NCT04763057|Calcium|calcium|mesh-list
14936484|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936485|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
14176714|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14176715|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176716|NCT04763096|Tacrolimus|tacrolimus|mesh-list
14176717|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176718|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
14176719|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176720|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14176721|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176722|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176723|NCT04762953|Leucovorin|leucovorin|mesh-list
14176724|NCT04762953|Paclitaxel|paclitaxel|mesh-list
14176725|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14176726|NCT04762953|Fluorouracil|fluorouracil|mesh-list
14176727|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176728|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176729|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176730|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176731|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176732|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176733|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
14176734|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176735|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176736|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
14176737|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176738|NCT04762953|Antidotes|antidotes|mesh-ancestor
14176739|NCT04762953|Protective Agents|protective agents|mesh-ancestor
14762672|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
13941004|NCT03292796|Bimatoprost|bimatoprost|mesh-list
13941005|NCT03292796|Latanoprost|latanoprost|mesh-list
14121174|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14121175|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14121176|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14121177|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121178|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121179|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14121180|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14121181|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121182|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
14121183|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121184|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
14121185|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121186|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121187|NCT05079074|Fulvestrant|fulvestrant|mesh-list
14121188|NCT05079074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14121189|NCT05079074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14121190|NCT05079074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121191|NCT05079074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121192|NCT05079074|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14121193|NCT05079074|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14121194|NCT05079074|Hormone Antagonists|hormone antagonists|mesh-ancestor
14121195|NCT05079074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121196|NCT05079074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121197|NCT05079074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121198|NCT05079074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121199|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
14121200|NCT05057481|Rituximab|rituximab|mesh-list
14121201|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121202|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121203|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
14121204|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121205|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121206|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14121207|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14121208|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
14121209|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14121210|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14121211|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121212|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121213|NCT05001360|Nivolumab|nivolumab|mesh-list
14121214|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14121215|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121216|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121217|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121218|NCT04986839|Acetaminophen|acetaminophen|mesh-list
14121219|NCT04986839|Ibuprofen|ibuprofen|mesh-list
14121220|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14121221|NCT04986839|Analgesics|analgesics|mesh-ancestor
14121222|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
14121223|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121224|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121225|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
14121226|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14121227|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121228|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121229|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14121230|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121231|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121232|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14121233|NCT04901299|Fulvestrant|fulvestrant|mesh-list
14121234|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121235|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121236|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14121237|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14121238|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
14121239|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121240|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121241|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
14121242|NCT04895761|Letrozole|letrozole|mesh-list
14121243|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14478168|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478169|NCT02447432|Vaccines|vaccines|mesh-list
13941006|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13941007|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13941008|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13941009|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
13941010|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
13941011|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13941012|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13941013|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941014|NCT03292744|Vitamins|vitamins|mesh-ancestor
13941015|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
13941016|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13941017|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
13941018|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
13941019|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13941020|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
13941021|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941022|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941023|NCT03292731|Progestins|progestins|mesh-ancestor
14121244|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
14121245|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121246|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121247|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14121248|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
14121249|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941024|NCT03292731|Hormones|hormones|mesh-ancestor
13941025|NCT03292575|Anticoagulants|anticoagulants|mesh-list
13941026|NCT03292315|Exenatide|exenatide|mesh-list
13941027|NCT03292315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13941028|NCT03292315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941029|NCT03292315|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13941030|NCT03292315|Incretins|incretins|mesh-ancestor
13941031|NCT03292315|Hormones|hormones|mesh-ancestor
13941032|NCT03292315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941033|NCT03292263|Nivolumab|nivolumab|mesh-list
13941034|NCT03292263|Melphalan|melphalan|mesh-list
13941035|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941036|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941037|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13941038|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941039|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13941040|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
13941041|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13941042|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121250|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121251|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14121252|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14121253|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14121254|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762673|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14762674|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14762675|NCT02265367|Analgesics|analgesics|mesh-ancestor
14762676|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
14762677|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762678|NCT02257736|Prednisone|prednisone|mesh-list
14762679|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
13941043|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
13941044|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941045|NCT03292185|Insulin|insulin|mesh-list
13941046|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13941047|NCT03292185|Liraglutide|liraglutide|mesh-list
13941048|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
13941049|NCT03292185|Xultophy|xultophy|mesh-list
13941050|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13941051|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941052|NCT03292185|Incretins|incretins|mesh-ancestor
13941053|NCT03292185|Hormones|hormones|mesh-ancestor
13941054|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941055|NCT03292172|Atezolizumab|atezolizumab|mesh-list
13941056|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941057|NCT03291899|Folfirinox|folfirinox|mesh-list
13941058|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121255|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14762680|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762681|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
13941059|NCT03291886|Exemestane|exemestane|mesh-list
14762682|NCT02257736|Hormones|hormones|mesh-ancestor
13941060|NCT03291886|Entinostat|entinostat|mesh-list
13941061|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941062|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13941063|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13941064|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941065|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941066|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13941067|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
14762683|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762684|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762685|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762686|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762687|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14762688|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762689|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762690|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
14762691|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14762692|NCT02252172|Dexamethasone|dexamethasone|mesh-list
14121256|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
14121257|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121258|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
14121259|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14121260|NCT04829383|Bevacizumab|bevacizumab|mesh-list
14121261|NCT04829383|Atezolizumab|atezolizumab|mesh-list
14121262|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121263|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121264|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14121265|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14121266|NCT04829383|Growth Substances|growth substances|mesh-ancestor
14121267|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121268|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
14121269|NCT04793100|Aflibercept|aflibercept|mesh-list
14121270|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14121271|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14121272|NCT04793100|Growth Substances|growth substances|mesh-ancestor
14121273|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121274|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
14121275|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121276|NCT04762979|Fulvestrant|fulvestrant|mesh-list
14121277|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14121278|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121279|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121280|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14121281|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14121282|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
14121283|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121284|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121285|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14121286|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121287|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121288|NCT04760028|Anesthetics|anesthetics|mesh-list
14121289|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121290|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121291|NCT04756505|Interleukin-12|interleukin-12|mesh-list
14121292|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
14121293|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14121294|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
13941068|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941069|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941070|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13941071|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13941072|NCT03291821|Cetrorelix|cetrorelix|mesh-list
13941073|NCT03291821|Menotropins|menotropins|mesh-list
13941074|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
13941075|NCT03291821|Ganirelix|ganirelix|mesh-list
13941076|NCT03291821|Hormones|hormones|mesh-ancestor
13941077|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941078|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941079|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
13941080|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13941081|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
14121295|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121296|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14121297|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14121298|NCT04756505|Growth Substances|growth substances|mesh-ancestor
14121299|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
14121300|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121301|NCT04737109|Androgens|androgens|mesh-list
14121302|NCT04737109|Hormones|hormones|mesh-ancestor
14121303|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121304|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121305|NCT04735354|Valsartan|valsartan|mesh-list
14121306|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14121307|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14121308|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14121309|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121310|NCT04675788|Ibutilide|ibutilide|mesh-list
14121311|NCT04675788|Testosterone|testosterone|mesh-list
14121312|NCT04675788|Progesterone|progesterone|mesh-list
14121313|NCT04675788|Androgens|androgens|mesh-ancestor
14121314|NCT04675788|Hormones|hormones|mesh-ancestor
14121315|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121316|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121317|NCT04675788|Progestins|progestins|mesh-ancestor
14121318|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13941082|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13941083|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13941084|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13941085|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941086|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14121319|NCT04603365|Temozolomide|temozolomide|mesh-list
14121320|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14121321|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14121322|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
14121323|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121324|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121325|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121326|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
14121327|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14121328|NCT04514302|Antibodies|antibodies|mesh-list
14121329|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
14121330|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121331|NCT04492891|Cyclosporine|cyclosporine|mesh-list
14121332|NCT04492891|Cyclosporins|cyclosporins|mesh-list
14121333|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121334|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121335|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121336|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
14121337|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121338|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
14121339|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14121340|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
14121341|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121342|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14121343|NCT04431635|Rituximab|rituximab|mesh-list
14121344|NCT04431635|Nivolumab|nivolumab|mesh-list
14121345|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478170|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13941087|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
13941088|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
13941089|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
13941090|NCT03291457|Hormones|hormones|mesh-ancestor
13941091|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941092|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961898|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
13961899|NCT05254925|Petrolatum|petrolatum|mesh-list
13961900|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13961901|NCT05254925|Protective Agents|protective agents|mesh-ancestor
13961902|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961903|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
13961904|NCT05254925|Emollients|emollients|mesh-ancestor
13961905|NCT05254899|Gemcitabine|gemcitabine|mesh-list
14121346|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121347|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
13941093|NCT03291418|Naproxen|naproxen|mesh-list
13941094|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13941095|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13941096|NCT03291418|Analgesics|analgesics|mesh-ancestor
13941097|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
13941098|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941099|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941100|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941101|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13941102|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
13941103|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13941104|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121348|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121349|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121350|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14121351|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121352|NCT04430985|Leucovorin|leucovorin|mesh-list
14121353|NCT04430985|Fluorouracil|fluorouracil|mesh-list
14121354|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
14121355|NCT04430985|Nivolumab|nivolumab|mesh-list
14121356|NCT04430985|Ipilimumab|ipilimumab|mesh-list
14121357|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
14121358|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941105|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941106|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
13941107|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941108|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941109|NCT03291314|Avelumab|avelumab|mesh-list
14121359|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121360|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121361|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121362|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
14121363|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121364|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121365|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14121366|NCT04430985|Antidotes|antidotes|mesh-ancestor
14121367|NCT04430985|Protective Agents|protective agents|mesh-ancestor
14121368|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
14121369|NCT04430985|Vitamins|vitamins|mesh-ancestor
14121370|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
14176740|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
14176741|NCT04762953|Vitamins|vitamins|mesh-ancestor
14762693|NCT02252172|Lenalidomide|lenalidomide|mesh-list
14762694|NCT02252172|Daratumumab|daratumumab|mesh-list
14762695|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14762696|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762697|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
13941110|NCT03291314|Axitinib|axitinib|mesh-list
13941111|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941112|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941113|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13941114|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941115|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941116|NCT03291249|Omeprazole|omeprazole|mesh-list
13941117|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13941118|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13941119|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13941120|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941121|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941122|NCT03291158|Minocycline|minocycline|mesh-list
13941123|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13941124|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941125|NCT03291145|Spironolactone|spironolactone|mesh-list
13941126|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
13941127|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13941128|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
13941129|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941130|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941131|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13941132|NCT03291145|Diuretics|diuretics|mesh-ancestor
14176742|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
14176743|NCT04762992|Enoxaparin|enoxaparin|mesh-list
13941133|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
14176744|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
14176745|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14176746|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14762698|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
14121371|NCT04367311|Docetaxel|docetaxel|mesh-list
14121372|NCT04367311|Pemetrexed|pemetrexed|mesh-list
14121373|NCT04367311|Atezolizumab|atezolizumab|mesh-list
14121374|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121375|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14121376|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14121377|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14121378|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121379|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121380|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14121381|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14121382|NCT04262869|Paclitaxel|paclitaxel|mesh-list
14121383|NCT04262869|Carboplatin|carboplatin|mesh-list
14121384|NCT04262869|Pemetrexed|pemetrexed|mesh-list
14121385|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14121386|NCT04262869|Durvalumab|durvalumab|mesh-list
14121387|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
14121388|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14121389|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
14121390|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14121391|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121392|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
14121393|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
14121394|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
14121395|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121396|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121397|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14121398|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14121399|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121400|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
14121401|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121402|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
14121403|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121404|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121405|NCT04189952|Rituximab|rituximab|mesh-list
14121406|NCT04189952|Carboplatin|carboplatin|mesh-list
14121407|NCT04189952|Etoposide|etoposide|mesh-list
14121408|NCT04189952|Ifosfamide|ifosfamide|mesh-list
14121409|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
14121410|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121411|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121412|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
14121413|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121414|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121415|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14121416|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14121417|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14121418|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121419|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121420|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14121421|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
14121422|NCT04182360|Carbetocin|carbetocin|mesh-list
14121423|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
14121424|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14121425|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121426|NCT04088786|Irinotecan|irinotecan|mesh-list
14121427|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14121428|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14121429|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121430|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121431|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121432|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
14121433|NCT04064814|Flunarizine|flunarizine|mesh-list
14121434|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
14121435|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121436|NCT04064814|Protective Agents|protective agents|mesh-ancestor
14121437|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121438|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
14121439|NCT04064814|Vitamins|vitamins|mesh-ancestor
14121440|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
14121441|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
14121442|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14121443|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14121444|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14121445|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14121446|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
14121447|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
14121448|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121449|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
14121450|NCT04039230|Talazoparib|talazoparib|mesh-list
14121451|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14121452|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121453|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121454|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121455|NCT03998735|Lobeline|lobeline|mesh-list
14121456|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14121457|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
14121458|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121459|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121460|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14121461|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13941134|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13941135|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
13941136|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941137|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941138|NCT03291093|Flutemetamol|flutemetamol|mesh-list
13941139|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13941140|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941141|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
13941142|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941143|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941144|NCT03290963|Ketamine|ketamine|mesh-list
13941145|NCT03290963|Analgesics|analgesics|mesh-ancestor
13941146|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
13941147|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941148|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941149|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13941150|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13941151|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
13941152|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
13941153|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941154|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14121462|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
14121463|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121464|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121465|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
14121466|NCT03981952|Vaccines|vaccines|mesh-list
14121467|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
14121468|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121469|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
14121470|NCT03968939|Promethazine|promethazine|mesh-list
14121471|NCT03968939|Melatonin|melatonin|mesh-list
14121472|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
14121473|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121474|NCT03968939|Protective Agents|protective agents|mesh-ancestor
14121475|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121476|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121477|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13941155|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13941156|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941157|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941158|NCT03290859|Propofol|propofol|mesh-list
13941159|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13941160|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941161|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941162|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13941163|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
13941164|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
13941165|NCT03290846|Secretin|secretin|mesh-list
13941166|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13941167|NCT03290846|Hormones|hormones|mesh-ancestor
13941168|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941169|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941170|NCT03290820|Aspirin|aspirin|mesh-list
13941171|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13941172|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13941173|NCT03290820|Analgesics|analgesics|mesh-ancestor
13941174|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
13941175|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941176|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762699|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121478|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14121479|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
14121480|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
14121481|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
14121482|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121483|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
14121484|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
14121485|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14121486|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14121487|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
14121488|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
14121489|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121490|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14121491|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
14121492|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
14121493|NCT03959891|Letrozole|letrozole|mesh-list
14121494|NCT03959891|Fulvestrant|fulvestrant|mesh-list
14121495|NCT03959891|Palbociclib|palbociclib|mesh-list
13941177|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941178|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13941179|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13941180|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13941181|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121496|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14121497|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121498|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14121499|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121500|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121501|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14121502|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
14121503|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941182|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13941183|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13941184|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121504|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121505|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121506|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14121507|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14121508|NCT03950609|Everolimus|everolimus|mesh-list
14121509|NCT03950609|Lenvatinib|lenvatinib|mesh-list
14121510|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121511|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121512|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
14121513|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121514|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14121515|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121516|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121517|NCT03866538|Budesonide|budesonide|mesh-list
14121518|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121519|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14121520|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
13941185|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
13941186|NCT03290703|Rabeprazole|rabeprazole|mesh-list
13941187|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13941188|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13941189|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13941190|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941191|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941192|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
13941193|NCT03290625|Ketamine|ketamine|mesh-list
13941194|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13941195|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941196|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941197|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13941198|NCT03290625|Analgesics|analgesics|mesh-ancestor
13941199|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
13941200|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941201|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13941202|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13941203|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14121521|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121522|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121523|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14121524|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
14121525|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
13941204|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
14121526|NCT03866538|Hormones|hormones|mesh-ancestor
14121527|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121528|NCT03856619|Teriflunomide|teriflunomide|mesh-list
14121529|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14121530|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14121531|NCT03856619|Analgesics|analgesics|mesh-ancestor
14121532|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
14121533|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121534|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121535|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121536|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121537|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121538|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
14121539|NCT03821272|Vaccines|vaccines|mesh-list
14121540|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
14121541|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121542|NCT03806309|Leucovorin|leucovorin|mesh-list
14121543|NCT03806309|Fluorouracil|fluorouracil|mesh-list
14121544|NCT03806309|Irinotecan|irinotecan|mesh-list
14121545|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
14121546|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121547|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121548|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121549|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121550|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
14121551|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121552|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14121553|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14121554|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121555|NCT03806309|Antidotes|antidotes|mesh-ancestor
14121556|NCT03806309|Protective Agents|protective agents|mesh-ancestor
14121557|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
14121558|NCT03806309|Vitamins|vitamins|mesh-ancestor
14121559|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
13941205|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941206|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121560|NCT03782532|Prednisone|prednisone|mesh-list
14121561|NCT03782532|Prednisolone|prednisolone|mesh-list
14121562|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121563|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
14121564|NCT03782532|Hormones|hormones|mesh-ancestor
14121565|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121566|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121567|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121568|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121569|NCT03714815|Macitentan|macitentan|mesh-list
14121570|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14121571|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14121572|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121573|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14121574|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
14121575|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14121576|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14762700|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941207|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13941208|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13941209|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
13941210|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
13941211|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13941212|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13941213|NCT03290495|Ketamine|ketamine|mesh-list
13941214|NCT03290495|Analgesics|analgesics|mesh-ancestor
13941215|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
13941216|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941217|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941218|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13941219|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13941220|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
13941221|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
13941222|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941223|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14121577|NCT03636165|Prednisolone|prednisolone|mesh-list
14121578|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
14121579|NCT03636165|Ropivacaine|ropivacaine|mesh-list
14936486|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936487|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14936488|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14936489|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
14936490|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14936491|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13941224|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13941225|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941226|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941227|NCT03290456|Prednisone|prednisone|mesh-list
13941228|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941229|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
13941230|NCT03290456|Hormones|hormones|mesh-ancestor
13941231|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941232|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941233|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13941234|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941235|NCT03290430|Nicotine|nicotine|mesh-list
13941236|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13941237|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
13941238|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941239|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121580|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14121581|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
14121582|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
14121583|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
14121584|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121585|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121586|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
14121587|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121588|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121589|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
14121590|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
14121591|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14121592|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
14121593|NCT03636165|Hormones|hormones|mesh-ancestor
14121594|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121595|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14121596|NCT03636165|Protective Agents|protective agents|mesh-ancestor
14121597|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121598|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121599|NCT03564873|Azacitidine|azacitidine|mesh-list
14121600|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
14121601|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121602|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
14121603|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121604|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121605|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121606|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14121607|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14121608|NCT03539822|Durvalumab|durvalumab|mesh-list
14121609|NCT03539822|Tremelimumab|tremelimumab|mesh-list
14121610|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14121611|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121612|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121613|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121614|NCT03528408|Nivolumab|nivolumab|mesh-list
14121615|NCT03528408|Ipilimumab|ipilimumab|mesh-list
14121616|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121617|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121618|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14121619|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121620|NCT03523312|Capecitabine|capecitabine|mesh-list
14121621|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13941240|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13941241|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13941242|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
14121622|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
14121623|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121624|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121625|NCT03521037|Rucaparib|rucaparib|mesh-list
14121626|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14121627|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478171|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
14121628|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121629|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121630|NCT03422094|Nivolumab|nivolumab|mesh-list
14121631|NCT03422094|Ipilimumab|ipilimumab|mesh-list
14121632|NCT03422094|Poly ICLC|poly iclc|mesh-list
14121633|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121634|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121635|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14121636|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121637|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
14121638|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
14121639|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121640|NCT03391869|Nivolumab|nivolumab|mesh-list
14121641|NCT03391869|Ipilimumab|ipilimumab|mesh-list
14121642|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121643|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121644|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14121645|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121646|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
14121647|NCT03384836|Propranolol|propranolol|mesh-list
14121648|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121649|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121650|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14121651|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14121652|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
14121653|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121654|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121655|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121656|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14121657|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14121658|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
14121659|NCT03311555|Docetaxel|docetaxel|mesh-list
14121660|NCT03311555|Androgens|androgens|mesh-list
13941243|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941244|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941245|NCT03290417|Vitamin D|vitamin d|mesh-list
13941246|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
13941247|NCT03290417|Vitamins|vitamins|mesh-list
13941248|NCT03290417|Curcumin|curcumin|mesh-list
14121661|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121662|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
14121663|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
14121664|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
14121665|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121666|NCT03311555|Hormones|hormones|mesh-ancestor
14121667|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121668|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121669|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
14121670|NCT03264404|Azacitidine|azacitidine|mesh-list
14121671|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121672|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121673|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121674|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
13941249|NCT03290417|Turmeric extract|turmeric extract|mesh-list
13941250|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
13941251|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941252|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13941253|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13941254|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13941255|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13941256|NCT03290417|Analgesics|analgesics|mesh-ancestor
13941257|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
13941258|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941259|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941260|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13941261|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941262|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941263|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941264|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
13941265|NCT03290417|Protective Agents|protective agents|mesh-ancestor
13941266|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
13941267|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13941268|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
13941269|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121675|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121676|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121677|NCT03246074|Paclitaxel|paclitaxel|mesh-list
14121678|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14121679|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121680|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
14121681|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
14121682|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
14121683|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121684|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
14121685|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14121686|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14121687|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14121688|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14121689|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121690|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
14121691|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121692|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121693|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14121694|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121695|NCT03148327|Durvalumab|durvalumab|mesh-list
14121696|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121697|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121698|NCT03046862|Gemcitabine|gemcitabine|mesh-list
14121699|NCT03046862|Durvalumab|durvalumab|mesh-list
14121700|NCT03046862|Tremelimumab|tremelimumab|mesh-list
14121701|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121702|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121703|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
14121704|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121705|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
14121706|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14121707|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121708|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121709|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
14121710|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121711|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121712|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14121713|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14121714|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14121715|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14121716|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
14121717|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121718|NCT02925234|Bevacizumab|bevacizumab|mesh-list
14121719|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
14121720|NCT02925234|Nivolumab|nivolumab|mesh-list
14121721|NCT02925234|Trastuzumab|trastuzumab|mesh-list
14121722|NCT02925234|Ipilimumab|ipilimumab|mesh-list
14121723|NCT02925234|Durvalumab|durvalumab|mesh-list
14121724|NCT02925234|Pertuzumab|pertuzumab|mesh-list
14121725|NCT02925234|Panitumumab|panitumumab|mesh-list
13941270|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
13941271|NCT03290365|Protective Agents|protective agents|mesh-ancestor
13941272|NCT03290196|Bupivacaine|bupivacaine|mesh-list
13941273|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
13941274|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
13941275|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941276|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941277|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
13941278|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941279|NCT03289949|Ketanserin|ketanserin|mesh-list
13941280|NCT03289949|Psilocybin|psilocybin|mesh-list
13941281|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
13941282|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121726|NCT02925234|Sunitinib|sunitinib|mesh-list
14121727|NCT02925234|Atezolizumab|atezolizumab|mesh-list
14121728|NCT02925234|Olaparib|olaparib|mesh-list
14121729|NCT02925234|Lenvatinib|lenvatinib|mesh-list
13941283|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14121730|NCT02925234|Palbociclib|palbociclib|mesh-list
14762701|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762702|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
14762703|NCT02252172|Hormones|hormones|mesh-ancestor
14762704|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762705|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762706|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762707|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
14762708|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14762709|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14762710|NCT02252172|Growth Substances|growth substances|mesh-ancestor
14762711|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
14121731|NCT02925234|Trametinib|trametinib|mesh-list
14121732|NCT02925234|Axitinib|axitinib|mesh-list
14121733|NCT02925234|Afatinib|afatinib|mesh-list
14121734|NCT02925234|Vemurafenib|vemurafenib|mesh-list
14767371|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941284|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13941285|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13941286|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13941287|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
13941288|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941289|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941290|NCT03289871|Amorolfine|amorolfine|mesh-list
13941291|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
13941292|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941293|NCT03289819|Paclitaxel|paclitaxel|mesh-list
14121735|NCT02925234|Dabrafenib|dabrafenib|mesh-list
14478172|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478173|NCT02447718|Vaccines|vaccines|mesh-list
14478174|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14478175|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
14478176|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478177|NCT02447848|Sufentanil|sufentanil|mesh-list
14478178|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14478179|NCT02447848|Narcotics|narcotics|mesh-ancestor
14478180|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767372|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121736|NCT02925234|Crizotinib|crizotinib|mesh-list
14121737|NCT02925234|Talazoparib|talazoparib|mesh-list
14121738|NCT02925234|Rucaparib|rucaparib|mesh-list
14121739|NCT02925234|Entrectinib|entrectinib|mesh-list
14121740|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121741|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121742|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14121743|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14121744|NCT02925234|Growth Substances|growth substances|mesh-ancestor
14121745|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121746|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
14121747|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14121748|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121749|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14121750|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121751|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14176747|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176748|NCT04762966|Metformin|metformin|mesh-list
14176749|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14176750|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183721|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14183722|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14183723|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
14183724|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183725|NCT04725942|Posaconazole|posaconazole|mesh-list
14183726|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
14183727|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183728|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14183729|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14183730|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14183731|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14183732|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14183733|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767373|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941294|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13941295|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
14183734|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121752|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
14121753|NCT02758431|Anastrozole|anastrozole|mesh-list
14121754|NCT02758431|Testosterone|testosterone|mesh-list
14121755|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
14121756|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
14121757|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14121758|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14121759|NCT02758431|Acyline|acyline|mesh-list
14121760|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
13941296|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
13941297|NCT03289819|Epirubicin|epirubicin|mesh-list
13941298|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13941299|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941300|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
13941301|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
13941302|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
13941303|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941304|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121761|NCT02758431|Hormones|hormones|mesh-ancestor
14121762|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121763|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121764|NCT02758431|Androgens|androgens|mesh-ancestor
14121765|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121766|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121767|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
14121768|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13941305|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
13941306|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941307|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13941308|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13941309|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
13941310|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13941311|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941312|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13941313|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13941314|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13941315|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941316|NCT03289728|Dobutamine|dobutamine|mesh-list
13941317|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13941318|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
14121769|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121770|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121771|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14121772|NCT02698293|Vitamin D|vitamin d|mesh-list
14121773|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
14121774|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
14121775|NCT02698293|Vitamins|vitamins|mesh-list
14121776|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
14121777|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121778|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14121779|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13941319|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
13941320|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941321|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941322|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13941323|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13941324|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13941325|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
13941326|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941327|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941328|NCT03289728|Protective Agents|protective agents|mesh-ancestor
13961906|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
13961907|NCT05254899|Pegaspargase|pegaspargase|mesh-list
13961908|NCT05254899|Antibodies|antibodies|mesh-list
13961909|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13961910|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
13961911|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121780|NCT02643056|Panitumumab|panitumumab|mesh-list
14121781|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121782|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961912|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13961913|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
13961914|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961915|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121783|NCT02513186|Dexamethasone|dexamethasone|mesh-list
13961916|NCT05254899|Antiviral Agents|antiviral agents|mesh-ancestor
14121784|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
14121785|NCT02513186|Lenalidomide|lenalidomide|mesh-list
14121786|NCT02513186|Bortezomib|bortezomib|mesh-list
14121787|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121788|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
14121789|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121790|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121791|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14121792|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
14121793|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121794|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121795|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14121796|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121797|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
14121798|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
14121799|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121800|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14121801|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
14121802|NCT02513186|Hormones|hormones|mesh-ancestor
14121803|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121804|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14121805|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14121806|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14121807|NCT02513186|Growth Substances|growth substances|mesh-ancestor
14121808|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14121809|NCT02471118|Adalimumab|adalimumab|mesh-list
14121810|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121811|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14121812|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
14121813|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121814|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121815|NCT02398396|Lactitol|lactitol|mesh-list
14121816|NCT02398396|Cathartics|cathartics|mesh-ancestor
14121817|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14121818|NCT02359968|Paclitaxel|paclitaxel|mesh-list
14121819|NCT02359968|Fluorouracil|fluorouracil|mesh-list
13941329|NCT03289637|Vitamin D|vitamin d|mesh-list
13941330|NCT03289637|Vitamins|vitamins|mesh-ancestor
13941331|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
13941332|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941333|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13941334|NCT03289559|Testosterone|testosterone|mesh-list
13941335|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13941336|NCT03289559|Androgens|androgens|mesh-ancestor
13941337|NCT03289559|Hormones|hormones|mesh-ancestor
13941338|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941339|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941340|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13941341|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121820|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
14121821|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14121822|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121823|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
14121824|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
14121825|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
14121826|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121827|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
14121828|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121829|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13941342|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941343|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13941344|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
13941345|NCT03289520|Clopidogrel|clopidogrel|mesh-list
13941346|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13941347|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13941348|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13941349|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13941350|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
13941351|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941352|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941353|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121830|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
14121831|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941354|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
13941355|NCT03289429|Atorvastatin|atorvastatin|mesh-list
14121832|NCT05098704|Clopidogrel|clopidogrel|mesh-list
14121833|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14121834|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14121835|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14121836|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14121837|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
14121838|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121839|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121840|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121841|NCT05098574|Drospirenone|drospirenone|mesh-list
14121842|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14121843|NCT05098574|Estradiol|estradiol|mesh-list
14121844|NCT05098574|Estrogens|estrogens|mesh-ancestor
14121845|NCT05098574|Hormones|hormones|mesh-ancestor
14121846|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14121847|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121848|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14121849|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
14121850|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14121851|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14121852|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14121853|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14121854|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14121855|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
14121856|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14121857|NCT05098574|Diuretics|diuretics|mesh-ancestor
14121858|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
14121859|NCT05098366|Furosemide|furosemide|mesh-list
14121860|NCT05098366|Diuretics|diuretics|mesh-ancestor
14121861|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
14121862|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121863|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14121864|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14121865|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121866|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13941356|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13941357|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13941358|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
13941359|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941360|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13941361|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13941362|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941363|NCT03289429|Analgesics|analgesics|mesh-ancestor
13941364|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
13941365|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941366|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121867|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14121868|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14121869|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14121870|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14121871|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121872|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121873|NCT05098327|Pioglitazone|pioglitazone|mesh-list
14121874|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14121875|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121876|NCT05098119|Paclitaxel|paclitaxel|mesh-list
14121877|NCT05098119|Carboplatin|carboplatin|mesh-list
14121878|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14121879|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121880|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14121881|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14121882|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14121883|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121884|NCT05098067|Ondansetron|ondansetron|mesh-list
13941367|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
13941368|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121885|NCT05098067|Metoclopramide|metoclopramide|mesh-list
14121886|NCT05098067|Capsaicin|capsaicin|mesh-list
14121887|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
14121888|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
14121889|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121890|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121891|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14121892|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
14121893|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
14121894|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14121895|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
14121896|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121897|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121898|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14121899|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14121900|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121901|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14121902|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14121903|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
14121904|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14121905|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14121906|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
14121907|NCT05097950|Acetaminophen|acetaminophen|mesh-list
14121908|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14121909|NCT05097950|Analgesics|analgesics|mesh-ancestor
14121910|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
14121911|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121912|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121913|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
14121914|NCT05097911|Bevacizumab|bevacizumab|mesh-list
14121915|NCT05097911|Atezolizumab|atezolizumab|mesh-list
14121916|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14121917|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121918|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14121919|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14121920|NCT05097911|Growth Substances|growth substances|mesh-ancestor
14121921|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941369|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13941370|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
13941371|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13941372|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13941373|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13941374|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
13941375|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13941376|NCT03289390|Acetaminophen|acetaminophen|mesh-list
13941377|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13941378|NCT03289390|Analgesics|analgesics|mesh-ancestor
13941379|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
13941380|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941381|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941382|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
13941391|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
13941392|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
13941393|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13941394|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13941395|NCT03289338|Prednisolone|prednisolone|mesh-list
13941396|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
13941397|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13941398|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
13941399|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14121922|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14121923|NCT05097781|Antibodies|antibodies|mesh-list
14121924|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
14121925|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
14121926|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121927|NCT05097508|Bromides|bromides|mesh-list
14121928|NCT05097508|Rocuronium|rocuronium|mesh-list
14121929|NCT05097508|Atracurium|atracurium|mesh-list
14121930|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
14121931|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14121932|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14121933|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14121934|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121935|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941400|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
14121936|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14121937|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14121938|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14121939|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121940|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121941|NCT05097365|Folic Acid|folic acid|mesh-list
14121942|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
14121943|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
14121944|NCT05097365|Vitamins|vitamins|mesh-ancestor
14121945|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
14121946|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121947|NCT05097365|Hematinics|hematinics|mesh-ancestor
14121948|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
14121949|NCT05097261|Ketamine|ketamine|mesh-list
14121950|NCT05097261|Analgesics|analgesics|mesh-ancestor
14121951|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
14121952|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121953|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941401|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
13941402|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941403|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121954|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14121955|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14121956|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
14121957|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
14121958|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121959|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14121960|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13941404|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13941405|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
13941406|NCT03289338|Hormones|hormones|mesh-ancestor
13941407|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941408|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13941409|NCT03289338|Protective Agents|protective agents|mesh-ancestor
13941410|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13941411|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941412|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13941413|NCT03289260|Imiquimod|imiquimod|mesh-list
13941414|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13941415|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
13941416|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941417|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941418|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
13941419|NCT03289182|Rituximab|rituximab|mesh-list
13941420|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941421|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941422|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
13941423|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941424|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13941425|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13941426|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13941427|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941428|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941429|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13941430|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13941431|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941432|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
13941433|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941434|NCT03289026|Aripiprazole|aripiprazole|mesh-list
13941435|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
13941436|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13941437|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13941438|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13941439|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941440|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941441|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
13941442|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
13941443|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941444|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121961|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14121962|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121963|NCT05097248|Doxorubicin|doxorubicin|mesh-list
14121964|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14121965|NCT05097248|Losartan|losartan|mesh-list
13963483|NCT03144115|Oxytocin|oxytocin|mesh-list
14121966|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14121967|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121968|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13941445|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13941446|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13941447|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
13941448|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13941449|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13941450|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13941451|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13941452|NCT03288974|Pomalidomide|pomalidomide|mesh-list
13941453|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
14121969|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14121970|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121971|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121972|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14121973|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14121974|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14121975|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14121976|NCT05097209|Gemcitabine|gemcitabine|mesh-list
14121977|NCT05097209|Cisplatin|cisplatin|mesh-list
14121978|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14121979|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14121980|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
14121981|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14121982|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
14121983|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14121984|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14121985|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14121986|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
14121987|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121988|NCT05090280|Nafamostat|nafamostat|mesh-list
14121989|NCT05090280|Naltrexone|naltrexone|mesh-list
14121990|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14121991|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14121992|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14121993|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
14121994|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14121995|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14121996|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14121997|NCT05090280|Analgesics|analgesics|mesh-ancestor
14121998|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941454|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941455|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13941456|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13941457|NCT03288974|Growth Substances|growth substances|mesh-ancestor
13941458|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
13941459|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941460|NCT03288896|Ethanol|ethanol|mesh-list
13941461|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13941462|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941463|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14121999|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122000|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
14122001|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
14122002|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122003|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122004|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14122005|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14122006|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14122007|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122008|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
14122009|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
14122010|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
14122011|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14122012|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14122013|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14122014|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14122015|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122016|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
14122017|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122018|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122019|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14122020|NCT05089851|Protective Agents|protective agents|mesh-ancestor
14936492|NCT01469559|Insulin|insulin|mesh-list
13941464|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941465|NCT03288870|Docetaxel|docetaxel|mesh-list
13941466|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941467|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
14122021|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
14122022|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14122023|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122024|NCT05087940|Diuretics|diuretics|mesh-list
14122025|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14122026|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
13941468|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
13941469|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
13941470|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941471|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
13941472|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
14122027|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122028|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14122029|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122030|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
14122031|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14122032|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
14122033|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122034|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
14122035|NCT05086939|Protective Agents|protective agents|mesh-ancestor
14122036|NCT05083325|Oseltamivir|oseltamivir|mesh-list
14122037|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
14122038|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122039|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122040|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122041|NCT05060484|Vaccines|vaccines|mesh-list
14122042|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
14122043|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122044|NCT05057572|Carvedilol|carvedilol|mesh-list
14122045|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14122046|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14122047|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
14122048|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122049|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122050|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122051|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14122052|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
14122053|NCT05057572|Protective Agents|protective agents|mesh-ancestor
14122054|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14122055|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14122056|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14122057|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
14122058|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14122059|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14122060|NCT05026801|Azithromycin|azithromycin|mesh-list
14122061|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
14122062|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122063|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122064|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
14122065|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14122066|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14122067|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122068|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122069|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176751|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
14176752|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
14176753|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176754|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
14176755|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176756|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176757|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14176758|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
13941473|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941474|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13941475|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941476|NCT03288675|Serotonin|serotonin|mesh-list
13941477|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
13941478|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13941479|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
13941480|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963484|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
14176759|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122070|NCT05019885|Ketamine|ketamine|mesh-list
14122071|NCT05019885|Analgesics|analgesics|mesh-ancestor
14122072|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
14122073|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122074|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122075|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14122076|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14122077|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
14122078|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
14122079|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122080|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14122081|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14122082|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122083|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122084|NCT04999631|Ethanol|ethanol|mesh-list
13941481|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941482|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941483|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13941484|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13941485|NCT03288636|Ritonavir|ritonavir|mesh-list
13941486|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13941487|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13941488|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
13941489|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122085|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
14122086|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14122087|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941490|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941491|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13941492|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13941493|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
13941494|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941495|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13941496|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13941497|NCT03288610|Vasopressins|vasopressins|mesh-list
13941498|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
13941499|NCT03288610|Coagulants|coagulants|mesh-ancestor
13941500|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13941501|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13941502|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
13941503|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941504|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13941505|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13941506|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941507|NCT03288532|Durvalumab|durvalumab|mesh-list
13941508|NCT03288532|Tremelimumab|tremelimumab|mesh-list
14122088|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122089|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122090|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13941509|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941510|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941511|NCT03288428|Morphine|morphine|mesh-list
13941512|NCT03288428|Nalbuphine|nalbuphine|mesh-list
13941513|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13941514|NCT03288428|Narcotics|narcotics|mesh-ancestor
13941515|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941516|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941517|NCT03288428|Analgesics|analgesics|mesh-ancestor
13941518|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
13941519|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941520|NCT03288402|Caffeine|caffeine|mesh-list
13941521|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13941522|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941523|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13941524|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941525|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941526|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13941527|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13941528|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
13941529|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941530|NCT03288350|Avelumab|avelumab|mesh-list
13941531|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14122091|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
14122092|NCT04985955|Tofacitinib|tofacitinib|mesh-list
14122093|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14122094|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122095|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122096|NCT04950660|Caffeine|caffeine|mesh-list
14122097|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14122098|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122099|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14122100|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122101|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122102|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14122103|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14122104|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
14122105|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941532|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941533|NCT03288259|Anesthetics|anesthetics|mesh-list
13941534|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
13941535|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941536|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941537|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
13941538|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941539|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
13941540|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
13941541|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941542|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
13941543|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941544|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941545|NCT03288077|Tryptophan|tryptophan|mesh-list
13941546|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13941547|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
13941548|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13941549|NCT03288051|Dobutamine|dobutamine|mesh-list
13941550|NCT03288051|Norepinephrine|norepinephrine|mesh-list
13941551|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13941552|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13941553|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
13941554|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941555|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941556|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941557|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
13941558|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
13941559|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941560|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13941561|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14122122|NCT04912791|Anesthetics|anesthetics|mesh-list
14122123|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122124|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122125|NCT04908293|Listerine|listerine|mesh-list
13941562|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13941563|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13941564|NCT03288051|Protective Agents|protective agents|mesh-ancestor
13941565|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13941566|NCT03288038|Ezetimibe|ezetimibe|mesh-list
13941567|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13941568|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13941569|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
13941570|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941571|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14122126|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
14122127|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
14122128|NCT04908293|Protective Agents|protective agents|mesh-ancestor
14122129|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122130|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14122131|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122132|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14122133|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14122134|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13941572|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13941573|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961917|NCT05254899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961918|NCT05254899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961919|NCT05254899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961920|NCT05254665|Docetaxel|docetaxel|mesh-list
13961921|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122135|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
14122136|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122137|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14122138|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14122139|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122140|NCT04858854|Sulforaphane|sulforaphane|mesh-list
14122141|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14122142|NCT04858854|Protective Agents|protective agents|mesh-ancestor
14122143|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122144|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122145|NCT04853004|Antibodies|antibodies|mesh-list
14122146|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
14122147|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122148|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14122149|NCT04839185|Hematinics|hematinics|mesh-ancestor
14122150|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14122151|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14122152|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14122153|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122154|NCT04814940|Menotropins|menotropins|mesh-list
14122155|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14122156|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
14122157|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14122158|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122159|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
14122160|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14122161|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122162|NCT04801368|Anesthetics|anesthetics|mesh-list
13961922|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
13961923|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
13961924|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
13961925|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122163|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
14122164|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122165|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122166|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
14122167|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122168|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
14122169|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
14122170|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122171|NCT04796636|Protective Agents|protective agents|mesh-ancestor
14122172|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122173|NCT04796636|Vitamins|vitamins|mesh-ancestor
14122174|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
14122175|NCT04759274|Diuretics|diuretics|mesh-list
14122176|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
14122177|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122178|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
14122179|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
13961926|NCT05254652|Pregabalin|pregabalin|mesh-list
13961927|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13961928|NCT05254652|Analgesics|analgesics|mesh-ancestor
13961929|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
13961930|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961931|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122180|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14122181|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
14122182|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14122183|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961932|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
14122184|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14762712|NCT02195479|Dexamethasone|dexamethasone|mesh-list
13941574|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
13941575|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
13941576|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941577|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941578|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13941579|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
13941580|NCT03287882|Micronutrients|micronutrients|mesh-list
13941581|NCT03287882|Trace Elements|trace elements|mesh-list
13941582|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941583|NCT03287609|Evolocumab|evolocumab|mesh-list
13941584|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13941585|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14122185|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14122186|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14122187|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122188|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122189|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13941586|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
13941587|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941588|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13941589|NCT03287505|Aripiprazole|aripiprazole|mesh-list
13941590|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
13941591|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13941592|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13941593|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14122190|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14122191|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122192|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122193|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122194|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
14122195|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14122196|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122197|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14122198|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122199|NCT04689945|Morphine|morphine|mesh-list
14122200|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13941594|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941595|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941596|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
13941597|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
13941598|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941599|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941600|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13941601|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13941602|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
13941603|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13941604|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13941605|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13941606|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13941607|NCT03287388|Rocuronium|rocuronium|mesh-list
13941608|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13941609|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13941610|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13941611|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941612|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941613|NCT03287375|Cisplatin|cisplatin|mesh-list
13941614|NCT03287375|Doxorubicin|doxorubicin|mesh-list
13941615|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
14122201|NCT04689945|Narcotics|narcotics|mesh-ancestor
14122202|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122203|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122204|NCT04689945|Analgesics|analgesics|mesh-ancestor
14122205|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
14122206|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478181|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478182|NCT02447848|Analgesics|analgesics|mesh-ancestor
14478183|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
13941616|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941617|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13941618|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13941619|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14478184|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478185|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13941620|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478186|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14478187|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
14122207|NCT04655755|Decitabine|decitabine|mesh-list
14122208|NCT04655755|Venetoclax|venetoclax|mesh-list
14122209|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14122210|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
14122211|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122212|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122213|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122214|NCT04644796|Bupivacaine|bupivacaine|mesh-list
14122215|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
14122216|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
14122217|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122218|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122219|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
14122220|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122221|NCT04616924|Clarithromycin|clarithromycin|mesh-list
14122222|NCT04616924|Rifabutin|rifabutin|mesh-list
14122223|NCT04616924|Clofazimine|clofazimine|mesh-list
14122224|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122225|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122226|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13941621|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941622|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
13941623|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13941624|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13941625|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941626|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
13941627|NCT03287336|Coagulants|coagulants|mesh-ancestor
13941628|NCT03287271|Paclitaxel|paclitaxel|mesh-list
13941629|NCT03287271|Carboplatin|carboplatin|mesh-list
13941630|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13941631|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941632|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
14122227|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122228|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122229|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14122230|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14122231|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14122232|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
14122233|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14122234|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
14122235|NCT04616274|Venetoclax|venetoclax|mesh-list
13941633|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
13941634|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
13941635|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941636|NCT03287180|Buprenorphine|buprenorphine|mesh-list
13941637|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13941638|NCT03287180|Naloxone|naloxone|mesh-list
13941639|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13941640|NCT03287180|Narcotics|narcotics|mesh-ancestor
13941641|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941642|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941643|NCT03287180|Analgesics|analgesics|mesh-ancestor
13941644|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
13941645|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941646|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13941647|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
13941648|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14122236|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122237|NCT04613622|Venetoclax|venetoclax|mesh-list
14122238|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122239|NCT04562792|Daunorubicin|daunorubicin|mesh-list
14122240|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14122241|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122242|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14122243|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14122244|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122245|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122246|NCT04546620|Prednisolone|prednisolone|mesh-list
14122247|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14122248|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
14122249|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13941649|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478188|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
13941650|NCT03287076|Exenatide|exenatide|mesh-list
14122250|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
14122251|NCT04546620|Prednisone|prednisone|mesh-list
13941651|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13941652|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941653|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13941654|NCT03287076|Incretins|incretins|mesh-ancestor
13941655|NCT03287076|Hormones|hormones|mesh-ancestor
13941656|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941657|NCT03287011|Listerine|listerine|mesh-list
13941658|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
13941659|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
13941660|NCT03287011|Protective Agents|protective agents|mesh-ancestor
13941661|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941662|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14122252|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
14122253|NCT04546620|Rituximab|rituximab|mesh-list
14122254|NCT04546620|Doxorubicin|doxorubicin|mesh-list
14122255|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14122256|NCT04546620|Vincristine|vincristine|mesh-list
14122257|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
14122258|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14122259|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
14122260|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122261|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
14122262|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122263|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122264|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14122265|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
14122266|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122267|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941663|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941664|NCT03286959|Calcium|calcium|mesh-list
13941665|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13941666|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941667|NCT03286803|Vaccines|vaccines|mesh-list
13941668|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
13941669|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941670|NCT03286764|Peppermint oil|peppermint oil|mesh-list
13941671|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
13941672|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
13941673|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941674|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941675|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13941676|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
13941677|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
13941678|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
13941679|NCT03286673|Calcium|calcium|mesh-list
14122268|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14122269|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14122270|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14122271|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14122272|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14122273|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122274|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14122275|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
14122276|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
14122277|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
14122278|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14122279|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
14122280|NCT04546620|Hormones|hormones|mesh-ancestor
14122281|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122282|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14122283|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
14122284|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
14122285|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122286|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122287|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14122288|NCT04546620|Protective Agents|protective agents|mesh-ancestor
14122289|NCT04523935|Topiramate|topiramate|mesh-list
14122290|NCT04523935|Lamotrigine|lamotrigine|mesh-list
14122291|NCT04523935|Diazepam|diazepam|mesh-list
14122292|NCT04523935|Gabapentin|gabapentin|mesh-list
14122293|NCT04523935|Amitriptyline|amitriptyline|mesh-list
14122294|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
14122295|NCT04523935|Clonazepam|clonazepam|mesh-list
13941680|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14122296|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
13941681|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478189|NCT02447991|Rizatriptan|rizatriptan|mesh-list
14122297|NCT04523935|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14122298|NCT04523935|Baclofen|baclofen|mesh-list
14122299|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
14122300|NCT04523935|Analgesics|analgesics|mesh-ancestor
14122301|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
14122302|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122303|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122304|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14122305|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14122306|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122307|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14122308|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14122309|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14122310|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122311|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122312|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
14122313|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14122314|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14122315|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14122316|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14122317|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13941682|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13941683|NCT03286673|Antacids|antacids|mesh-ancestor
13941684|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941685|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13941686|NCT03286634|Cytarabine|cytarabine|mesh-list
13941687|NCT03286634|Prednisolone|prednisolone|mesh-list
13941688|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
13941689|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
13941690|NCT03286634|Methotrexate|methotrexate|mesh-list
13941691|NCT03286634|Vincristine|vincristine|mesh-list
13941692|NCT03286634|Daunorubicin|daunorubicin|mesh-list
13941693|NCT03286634|Asparaginase|asparaginase|mesh-list
13941694|NCT03286634|Epirubicin|epirubicin|mesh-list
13941695|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
14122318|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14122319|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14122320|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14122321|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14122322|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
14122323|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
14122324|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14122325|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
14122326|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14122327|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14122328|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14122329|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
14122330|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14122331|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
14122332|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
14122333|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122334|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14122335|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14122336|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
14122337|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
14122338|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
14122339|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14122340|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14122341|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14122342|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14122343|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
14122344|NCT04515186|Miltefosine|miltefosine|mesh-list
14122345|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14122346|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
14122347|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122348|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122349|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14122350|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14122351|NCT04507841|Niraparib|niraparib|mesh-list
14122352|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13941696|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13941697|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
13941698|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941699|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122353|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122354|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122355|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122356|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
14122357|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
14122358|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14122359|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14122360|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122361|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122362|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122363|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122364|NCT04395222|Fludarabine|fludarabine|mesh-list
14122365|NCT04395222|Melphalan|melphalan|mesh-list
14122366|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
14122367|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14122368|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122369|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122370|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122371|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
14122372|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122373|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14122374|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
14122375|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14122376|NCT04389775|Glucagon|glucagon|mesh-list
14122377|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14122378|NCT04389775|Incretins|incretins|mesh-ancestor
14122379|NCT04389775|Hormones|hormones|mesh-ancestor
14122380|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122381|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122382|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122383|NCT04368455|Vaccines|vaccines|mesh-list
14122384|NCT04368455|Immunologic Factors|immunologic factors|mesh-ancestor
14122385|NCT04368455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941700|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13941701|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
13941702|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941703|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941704|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13941705|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13941706|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
13941707|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14122386|NCT04345887|Spironolactone|spironolactone|mesh-list
14122387|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13941708|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13941709|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
13941710|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
13941711|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941712|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13941713|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13941714|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
13941715|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941716|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13941717|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
13941718|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
13941719|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
13941720|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941721|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
13941722|NCT03286634|Hormones|hormones|mesh-ancestor
13941723|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941724|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14122388|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
14122389|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122390|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122391|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14122392|NCT04345887|Diuretics|diuretics|mesh-ancestor
14122393|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
14122394|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
14122395|NCT04316169|Letrozole|letrozole|mesh-list
14122396|NCT04316169|Fulvestrant|fulvestrant|mesh-list
14122397|NCT04316169|Anastrozole|anastrozole|mesh-list
14122398|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122399|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14122400|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14122401|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122402|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122403|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14122404|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
14122405|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122406|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122407|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
14122408|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14122409|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14122410|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122411|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122412|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14122413|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14122414|NCT04305145|Prednisone|prednisone|mesh-list
14122415|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
14122416|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14122417|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14122418|NCT04305145|Prednisolone|prednisolone|mesh-list
14122419|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
14122420|NCT04305145|Infliximab|infliximab|mesh-list
14122421|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14122422|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
14122423|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14122424|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
14122425|NCT04305145|Hormones|hormones|mesh-ancestor
14122426|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122427|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941725|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13941726|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13941727|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13941728|NCT03286582|Clobetasol|clobetasol|mesh-list
13941729|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941730|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
13941731|NCT03286582|Hormones|hormones|mesh-ancestor
13941732|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941733|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941734|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
13941735|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13941736|NCT03286296|Antibodies|antibodies|mesh-list
13941737|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13941738|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
13941739|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941740|NCT03286244|Paclitaxel|paclitaxel|mesh-list
13941741|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13941742|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941743|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
13941744|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
13941745|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
13941746|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122428|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14122429|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122430|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
14122431|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
14122432|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122433|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122434|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14122435|NCT04305145|Protective Agents|protective agents|mesh-ancestor
14122436|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14122437|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122438|NCT04188145|Bevacizumab|bevacizumab|mesh-list
14122439|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14122440|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122441|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14122442|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14122443|NCT04188145|Growth Substances|growth substances|mesh-ancestor
14122444|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122445|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
14176760|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936493|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13961933|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13961934|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13961935|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961936|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13961937|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13961938|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13961939|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176761|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14176762|NCT04762810|Hormones|hormones|mesh-ancestor
14176763|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122446|NCT04181606|Esmolol|esmolol|mesh-list
14122447|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14122448|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14122449|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14122450|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
14122451|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122452|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122453|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762713|NCT02195479|Prednisone|prednisone|mesh-list
14762714|NCT02195479|Melphalan|melphalan|mesh-list
14762715|NCT02195479|Bortezomib|bortezomib|mesh-list
14762716|NCT02195479|Daratumumab|daratumumab|mesh-list
14762717|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14762718|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762719|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
14762720|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
14762721|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122463|NCT04128774|Dexamethasone|dexamethasone|mesh-list
14122464|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
14122465|NCT04128774|BB 1101|bb 1101|mesh-list
14122466|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941747|NCT03286101|Ivermectin|ivermectin|mesh-list
13941748|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13941749|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941750|NCT03285906|Apatinib|apatinib|mesh-list
13941751|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122467|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
14122468|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
14122469|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122470|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122471|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122472|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
13941752|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13941753|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941754|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941755|NCT03285802|Everolimus|everolimus|mesh-list
13941756|NCT03285802|Letrozole|letrozole|mesh-list
13941757|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941758|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13941759|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
13941760|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941761|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13941762|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13941763|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941764|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941765|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13941766|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
13941767|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941768|NCT03285607|Paclitaxel|paclitaxel|mesh-list
13941769|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
13941770|NCT03285607|Doxorubicin|doxorubicin|mesh-list
13941771|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13941772|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941773|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
13941774|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
13941775|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
13941776|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941777|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13941778|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
13941779|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941780|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13941781|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13941782|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
13941783|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13941784|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13941785|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13941786|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13941787|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941788|NCT03285568|Palbociclib|palbociclib|mesh-list
14122473|NCT04128774|Hormones|hormones|mesh-ancestor
13941789|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122474|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762722|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762723|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762724|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
13941790|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13941791|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941792|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941793|NCT03285503|Aripiprazole|aripiprazole|mesh-list
13941794|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
13941795|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13941796|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13941797|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13941798|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941799|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941800|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
13941801|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
13941802|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941803|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941804|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13941805|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13941806|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
13941807|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13941808|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14122475|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14122476|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122477|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
14122478|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122479|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122480|NCT04088123|Ticagrelor|ticagrelor|mesh-list
13941809|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13941810|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13941811|NCT03285360|Fluorides|fluorides|mesh-list
13941812|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
13941813|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
13941814|NCT03285360|Protective Agents|protective agents|mesh-ancestor
13941815|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122481|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14122482|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14122483|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14122484|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14122485|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
14122486|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122487|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122488|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122489|NCT03945721|Niraparib|niraparib|mesh-list
14122490|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14122491|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122492|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122493|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122494|NCT03891706|Interleukin-2|interleukin-2|mesh-list
14122495|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122496|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14122497|NCT03891706|Analgesics|analgesics|mesh-ancestor
14122498|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
14122499|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122500|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122501|NCT03847181|Vitamin K|vitamin k|mesh-list
14122502|NCT03847181|Warfarin|warfarin|mesh-list
14122503|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
14122504|NCT03847181|Apixaban|apixaban|mesh-list
14122505|NCT03847181|Anticoagulants|anticoagulants|mesh-list
14122506|NCT03847181|Vitamins|vitamins|mesh-ancestor
14122507|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
14122508|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122509|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14122510|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
14122511|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14122512|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
14122513|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122514|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122515|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14122516|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14122517|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
14122518|NCT03847181|Coagulants|coagulants|mesh-ancestor
14122519|NCT03825796|Cytarabine|cytarabine|mesh-list
14122520|NCT03825796|Daunorubicin|daunorubicin|mesh-list
14122521|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14122522|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
14122523|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941816|NCT03285165|Propofol|propofol|mesh-list
14122524|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122525|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
14122526|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122527|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122528|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
14122529|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122530|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14122531|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14122532|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14122533|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122534|NCT03753204|Furosemide|furosemide|mesh-list
14122535|NCT03753204|Diuretics|diuretics|mesh-ancestor
14122536|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
14122537|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122538|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14122539|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14122540|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122541|NCT03679611|Neostigmine|neostigmine|mesh-list
14122542|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14122543|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122544|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941817|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13941818|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941819|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941820|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13941821|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
13941822|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
13941823|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
13941824|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13941825|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122545|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
14122546|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122547|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122548|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14122549|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
14122550|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122551|NCT03608436|Bromides|bromides|mesh-list
14122552|NCT03608436|Rocuronium|rocuronium|mesh-list
14762725|NCT02195479|Hormones|hormones|mesh-ancestor
14762726|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762727|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762728|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762729|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762730|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
14762731|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762732|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762733|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762734|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
14762735|NCT02188264|Cyclosporine|cyclosporine|mesh-list
14762736|NCT02188264|Cyclosporins|cyclosporins|mesh-list
14762737|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762738|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762739|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762740|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
14762741|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762742|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
13941826|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941827|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13941828|NCT03285087|Analgesics|analgesics|mesh-ancestor
13941829|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
13941830|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941831|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13941832|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13941833|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13941834|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
13941835|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941836|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941837|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
13941838|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13941839|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
13941840|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14936494|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941841|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
13941842|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941843|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941844|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
13941845|NCT03284749|Copper|copper|mesh-list
13941846|NCT03284749|Trace Elements|trace elements|mesh-ancestor
13941847|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
13941848|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941849|NCT03284645|Tenofovir|tenofovir|mesh-list
13941850|NCT03284645|Lamivudine|lamivudine|mesh-list
13941851|NCT03284645|Zidovudine|zidovudine|mesh-list
13941852|NCT03284645|Efavirenz|efavirenz|mesh-list
13941853|NCT03284645|Abacavir|abacavir|mesh-list
13941854|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
13941855|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941856|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13941857|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13941858|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941859|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941860|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14762743|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762744|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
14762745|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762746|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14762747|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
13941861|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13941862|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
13941863|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13941864|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13941865|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14762748|NCT02161783|Fludarabine|fludarabine|mesh-list
14762749|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762750|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
14762751|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762752|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762753|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762754|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
14762755|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762756|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762757|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762758|NCT02136134|Dexamethasone|dexamethasone|mesh-list
14762759|NCT02136134|Bortezomib|bortezomib|mesh-list
13941866|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13941867|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13941868|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13941869|NCT03284593|Azacitidine|azacitidine|mesh-list
13941870|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13941871|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
13941872|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941873|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941874|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941875|NCT03284515|Vaccines|vaccines|mesh-list
13941876|NCT03284515|Immunologic Factors|immunologic factors|mesh-ancestor
13941877|NCT03284515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762760|NCT02136134|Daratumumab|daratumumab|mesh-list
14762761|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762762|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
14762763|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
14762764|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762765|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936495|NCT01469572|Everolimus|everolimus|mesh-list
14122553|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
14122554|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14122555|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14122556|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14122557|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122558|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122559|NCT03556904|Docetaxel|docetaxel|mesh-list
14122560|NCT03556904|Hormones|hormones|mesh-list
14122561|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122562|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
14122563|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
14762766|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122564|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14762767|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
14936496|NCT01469572|Pasireotide|pasireotide|mesh-list
14936497|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936498|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122565|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122566|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122567|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122568|NCT03540758|Niacin|niacin|mesh-list
14122569|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
14122570|NCT03540758|Niacinamide|niacinamide|mesh-list
14122571|NCT03540758|Diazoxide|diazoxide|mesh-list
14122572|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14122573|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
14122574|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122575|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14122576|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
14122577|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
14122578|NCT03540758|Vitamins|vitamins|mesh-ancestor
14122579|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
14122580|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122581|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14122582|NCT03477851|Tramadol|tramadol|mesh-list
14122583|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14122584|NCT03477851|Narcotics|narcotics|mesh-ancestor
14122585|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122586|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122587|NCT03477851|Analgesics|analgesics|mesh-ancestor
14122588|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
14122589|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122590|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13941881|NCT03284463|Glyburide|glyburide|mesh-list
13941882|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13941883|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941884|NCT03284307|Midazolam|midazolam|mesh-list
13941885|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
13941886|NCT03284307|Ketamine|ketamine|mesh-list
13941887|NCT03284307|Propofol|propofol|mesh-list
13941888|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13941889|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13941890|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478190|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14478191|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
14478192|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478193|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478194|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478195|NCT02448043|Bimatoprost|bimatoprost|mesh-list
14478196|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14478197|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
14122591|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
14122592|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122593|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
14122594|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122595|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14122596|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
14122597|NCT03412188|Hormones|hormones|mesh-ancestor
14122598|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122599|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14122600|NCT03412188|Protective Agents|protective agents|mesh-ancestor
14122601|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14122602|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14122603|NCT03298945|Laxatives|laxatives|mesh-ancestor
14122604|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122605|NCT03250975|Azithromycin|azithromycin|mesh-list
14122606|NCT03250975|Budesonide|budesonide|mesh-list
14122607|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14122608|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14122609|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
14122610|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478198|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
13941891|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13941892|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
13941893|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
13941894|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13941895|NCT03284307|Analgesics|analgesics|mesh-ancestor
14122611|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122612|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14122613|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
14122614|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
13941896|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
13961940|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14122615|NCT03250975|Hormones|hormones|mesh-ancestor
14122616|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122617|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122618|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122619|NCT03218137|Adenosine|adenosine|mesh-list
14122620|NCT03218137|Verapamil|verapamil|mesh-list
13941897|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941898|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13941899|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13941900|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13941901|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
13941902|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941903|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941904|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13941905|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13941906|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13941907|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13941908|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13941909|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13941910|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14122621|NCT03218137|Analgesics|analgesics|mesh-ancestor
14122622|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
14122623|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762768|NCT02136134|Hormones|hormones|mesh-ancestor
14122624|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122625|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14122626|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
14122627|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14122628|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
14122629|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
14122630|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122631|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122632|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14122633|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14122634|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14122635|NCT03079999|Aspirin|aspirin|mesh-list
14122636|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14122637|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14122638|NCT03079999|Analgesics|analgesics|mesh-ancestor
14122639|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
14122640|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122641|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122642|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14122643|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122644|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14122645|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14122646|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122647|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14122648|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14122649|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122650|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
14122651|NCT02958709|Rifampin|rifampin|mesh-list
14122652|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14122653|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
14122654|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122655|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122656|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
14122657|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14122658|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122659|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122660|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14122661|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14122662|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14122663|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14122664|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14122665|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14122666|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
14122667|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14122668|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
14122669|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14122670|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767374|NCT00629720|Urological Agents|urological agents|mesh-ancestor
14122671|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14122672|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14122673|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14176764|NCT04762745|Thalidomide|thalidomide|mesh-list
13941911|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
13941912|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
13961941|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13961942|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13961943|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13961944|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
13961945|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
14176765|NCT04762745|Dexamethasone|dexamethasone|mesh-list
14176766|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
14176767|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14176768|NCT04762745|Pomalidomide|pomalidomide|mesh-list
14176769|NCT04762745|BB 1101|bb 1101|mesh-list
14176770|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14176771|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
13961952|NCT05254574|Diclofenac|diclofenac|mesh-list
13961953|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13961954|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13961955|NCT05254574|Analgesics|analgesics|mesh-ancestor
13961956|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
13961957|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13961958|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961959|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13961960|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176772|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
14176773|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176774|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176775|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14176776|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
14176777|NCT04762745|Hormones|hormones|mesh-ancestor
14176778|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14176779|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14176780|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176781|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
14176782|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176783|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176784|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14176785|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
14176786|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
14176787|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14176788|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14176789|NCT04762745|Growth Substances|growth substances|mesh-ancestor
14176790|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
14176791|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961961|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13961962|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961963|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961964|NCT05254405|Brexanolone|brexanolone|mesh-list
14176792|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
14176793|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14176794|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176795|NCT04762316|Pyridoxal|pyridoxal|mesh-list
14176796|NCT04762316|Pyridoxine|pyridoxine|mesh-list
14176797|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
14176798|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
14176799|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
14176800|NCT04762316|Vitamins|vitamins|mesh-ancestor
14176801|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
13961965|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
13961966|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14176802|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176803|NCT04762511|Vaccines|vaccines|mesh-list
14176804|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
14176805|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122674|NCT02947581|Albendazole|albendazole|mesh-list
14122675|NCT02947581|Praziquantel|praziquantel|mesh-list
14122676|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
14122677|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14122678|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122679|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
14122680|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14122681|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13941913|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
13941914|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13941915|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941916|NCT03284294|Vitamins|vitamins|mesh-ancestor
13941917|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
13941918|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13941919|NCT03284177|Calcium|calcium|mesh-list
13941920|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13941921|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941922|NCT03284164|Tenofovir|tenofovir|mesh-list
13941923|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
13941924|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13941925|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13941926|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13941927|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941928|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122682|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
14122683|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
14122684|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
14122685|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122686|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122687|NCT02861898|Cetuximab|cetuximab|mesh-list
14122688|NCT02861898|Mannitol|mannitol|mesh-list
14122689|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14122690|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122691|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14122692|NCT02861898|Diuretics|diuretics|mesh-ancestor
14122693|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
14122694|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122695|NCT02806687|Gemcitabine|gemcitabine|mesh-list
14122696|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14122697|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
14122698|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122699|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122700|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
14122701|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122702|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122703|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122704|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
14122705|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122706|NCT02722525|Pentetic Acid|pentetic acid|mesh-list
14122707|NCT02722525|Antidotes|antidotes|mesh-ancestor
14122708|NCT02722525|Protective Agents|protective agents|mesh-ancestor
14122709|NCT02722525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122710|NCT02722525|Chelating Agents|chelating agents|mesh-ancestor
14122711|NCT02722525|Sequestering Agents|sequestering agents|mesh-ancestor
14122712|NCT02722525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122713|NCT02722525|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14122714|NCT02632396|Rituximab|rituximab|mesh-list
14122715|NCT02632396|Ixazomib|ixazomib|mesh-list
14122716|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14122717|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122718|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
14122719|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122720|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122721|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122722|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
14122723|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941929|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13941930|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13941931|NCT03283943|Durvalumab|durvalumab|mesh-list
13941932|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13941933|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941934|NCT03283917|Dexamethasone|dexamethasone|mesh-list
13941935|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
14122724|NCT02595060|Molgramostim|molgramostim|mesh-list
14122725|NCT02595060|Sargramostim|sargramostim|mesh-list
13941936|NCT03283917|Daratumumab|daratumumab|mesh-list
14122726|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941937|NCT03283917|Ixazomib|ixazomib|mesh-list
13941938|NCT03283917|Ichthammol|ichthammol|mesh-list
13941939|NCT03283917|BB 1101|bb 1101|mesh-list
13941940|NCT03283917|Glycine|glycine|mesh-list
13941941|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13941942|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
13941943|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
13941944|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13941945|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941946|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13941947|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
13941948|NCT03283917|Hormones|hormones|mesh-ancestor
13941949|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13941950|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13941951|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13941952|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
13941953|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13941954|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941955|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
13941956|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
13941957|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13941958|NCT03283800|Copper|copper|mesh-list
13941959|NCT03283800|Trace Elements|trace elements|mesh-ancestor
13941960|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
13941961|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122727|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
14122728|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122729|NCT02525757|Paclitaxel|paclitaxel|mesh-list
14122730|NCT02525757|Carboplatin|carboplatin|mesh-list
14122731|NCT02525757|Atezolizumab|atezolizumab|mesh-list
14122732|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14122733|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122734|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
14478199|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478200|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478201|NCT02448368|Verinurad|verinurad|mesh-list
14478202|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
14478203|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14478204|NCT02448446|Ranibizumab|ranibizumab|mesh-list
14478205|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14478206|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14478207|NCT02448446|Growth Substances|growth substances|mesh-ancestor
14478208|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122735|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
14478209|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
14478210|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478211|NCT02448537|Gemcitabine|gemcitabine|mesh-list
14122736|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
14478212|NCT02448537|Doxorubicin|doxorubicin|mesh-list
14478213|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14478214|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14478215|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
14478216|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478217|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122737|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122738|NCT02404155|Clozapine|clozapine|mesh-list
14122739|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14122740|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
14122741|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122742|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13941995|NCT03283410|Propofol|propofol|mesh-list
13941996|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13941997|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122743|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122744|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14122745|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14122746|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122747|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14122748|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
14122749|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
14122750|NCT05101005|Sirolimus|sirolimus|mesh-list
14122751|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122752|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122753|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14122754|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122755|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
14122756|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122757|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
14122758|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122759|NCT05100719|Mebeverine|mebeverine|mesh-list
14122760|NCT05100719|Simethicone|simethicone|mesh-list
14122761|NCT05100719|Citric Acid|citric acid|mesh-list
14122762|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
13941998|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13941999|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13942000|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
13942001|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
13942002|NCT03283202|Prednisone|prednisone|mesh-list
13942003|NCT03283202|Prednisolone|prednisolone|mesh-list
13942004|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
13942005|NCT03283202|Rituximab|rituximab|mesh-list
13942006|NCT03283202|Vincristine|vincristine|mesh-list
13942007|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122763|NCT05100719|Alverine|alverine|mesh-list
14122764|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
14122765|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14122766|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
14122767|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
14122768|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122769|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
14122770|NCT05100719|Emollients|emollients|mesh-ancestor
14122771|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14122772|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
14122773|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
14122774|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122775|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122776|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
14122777|NCT05100563|Naltrexone|naltrexone|mesh-list
14122778|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14122779|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14122780|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122781|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
14122782|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478218|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
13942008|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
13942009|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122783|NCT05100446|Amoxicillin|amoxicillin|mesh-list
14122784|NCT05100446|Esomeprazole|esomeprazole|mesh-list
14478219|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942010|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13942011|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13942012|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
13942013|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942014|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942015|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13942016|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942017|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942018|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
13942019|NCT03283202|Hormones|hormones|mesh-ancestor
13942020|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942021|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13942022|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13942023|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
13942024|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
13942025|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
13942026|NCT03283176|Folic Acid|folic acid|mesh-list
13942027|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
13942028|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
13942029|NCT03283176|Vitamins|vitamins|mesh-ancestor
13942030|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
13942031|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942032|NCT03283176|Hematinics|hematinics|mesh-ancestor
13942033|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
13942034|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
13942035|NCT03283150|Remifentanil|remifentanil|mesh-list
13942036|NCT03283150|Propofol|propofol|mesh-list
13942037|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13942038|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942039|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942040|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13942041|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
13942042|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
14122785|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122786|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122787|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14122788|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122789|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14122790|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122791|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122792|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
14122793|NCT05100329|Analgesics|analgesics|mesh-ancestor
14122794|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
14122795|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122796|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122797|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122798|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14122799|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14122800|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122801|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122802|NCT05100303|Cytarabine|cytarabine|mesh-list
14122803|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
14762769|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762770|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762771|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122804|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14122805|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
14122806|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122807|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122808|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
14122809|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762772|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
14762773|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14762774|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14762775|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762776|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762777|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
14762778|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14762779|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762780|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762781|NCT02123758|Prednisone|prednisone|mesh-list
14762782|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
13942043|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13942044|NCT03283150|Analgesics|analgesics|mesh-ancestor
13942045|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
14762783|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762784|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
14762785|NCT02123758|Hormones|hormones|mesh-ancestor
14762786|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936499|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
13942046|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942047|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13942048|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13942049|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13942050|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
13942051|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942052|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936500|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762787|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762788|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762789|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762790|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14762791|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762792|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936501|NCT01469572|Hormones|hormones|mesh-ancestor
14936502|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936503|NCT01469598|Gemcitabine|gemcitabine|mesh-list
14936504|NCT01469598|Docetaxel|docetaxel|mesh-list
14936505|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14936506|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
14936507|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936508|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936509|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
13942053|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13942054|NCT03283150|Narcotics|narcotics|mesh-ancestor
13942055|NCT03283059|Donepezil|donepezil|mesh-list
14762793|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
14762794|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14122810|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122811|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
14122812|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122813|NCT05100303|Analgesics|analgesics|mesh-ancestor
14122814|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
14122815|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122816|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14122817|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14122818|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122819|NCT05100186|Dexamethasone|dexamethasone|mesh-list
14122820|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14122821|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
14122822|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
14762795|NCT02122562|Ketamine|ketamine|mesh-list
14762796|NCT02122562|Analgesics|analgesics|mesh-ancestor
13942056|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13942057|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942058|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942059|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
13942060|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942061|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942062|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
13942063|NCT03283046|Dexamethasone|dexamethasone|mesh-list
13942064|NCT03283046|Nivolumab|nivolumab|mesh-list
13942065|NCT03283046|Lenalidomide|lenalidomide|mesh-list
13942066|NCT03283046|Ipilimumab|ipilimumab|mesh-list
13942067|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942068|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
13942069|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
13942070|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942071|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942072|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13942073|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
13942074|NCT03283046|Hormones|hormones|mesh-ancestor
13942075|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942076|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13942077|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762797|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
14767375|NCT00629811|Mitogens|mitogens|mesh-list
13942078|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942079|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14122823|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942080|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122824|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122825|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122826|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
14122827|NCT05100186|Hormones|hormones|mesh-ancestor
14122828|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122829|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14122830|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122831|NCT05100017|Methocarbamol|methocarbamol|mesh-list
14122832|NCT05100017|Oxybutynin|oxybutynin|mesh-list
14122833|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
14122834|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
14122835|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942081|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
13942082|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13942083|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14122836|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122837|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14122838|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14122839|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
14122840|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14122841|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122842|NCT05100017|Urological Agents|urological agents|mesh-ancestor
14122843|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14122844|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14122845|NCT05099848|Leucovorin|leucovorin|mesh-list
14122846|NCT05099848|Fluorouracil|fluorouracil|mesh-list
14122847|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
14122848|NCT05099848|Apatinib|apatinib|mesh-list
14122849|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
14122850|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122851|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14122852|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122853|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122854|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
14122855|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122856|NCT05099848|Antidotes|antidotes|mesh-ancestor
14122857|NCT05099848|Protective Agents|protective agents|mesh-ancestor
14122858|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
14122859|NCT05099848|Vitamins|vitamins|mesh-ancestor
14122860|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
14122861|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14122862|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942084|NCT03283046|Growth Substances|growth substances|mesh-ancestor
13942085|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
13942086|NCT03283020|Naltrexone|naltrexone|mesh-list
13942087|NCT03283020|Remifentanil|remifentanil|mesh-list
13942088|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
13942089|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13942090|NCT03283020|Narcotics|narcotics|mesh-ancestor
13942091|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942092|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942093|NCT03283020|Analgesics|analgesics|mesh-ancestor
13942094|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
13942095|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942096|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13942097|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13942098|NCT03283007|Nintedanib|nintedanib|mesh-list
13942099|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942100|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13942101|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122863|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
14122864|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14122865|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
14122866|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122867|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
14122868|NCT05099718|Protective Agents|protective agents|mesh-ancestor
14122869|NCT05099614|Naloxone|naloxone|mesh-list
14122870|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14122871|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942102|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942103|NCT03282838|Celecoxib|celecoxib|mesh-list
13942104|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14122872|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
13942105|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13942106|NCT03282838|Analgesics|analgesics|mesh-ancestor
14122873|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122874|NCT05099601|Silymarin|silymarin|mesh-list
14122875|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
14122876|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122877|NCT05099601|Protective Agents|protective agents|mesh-ancestor
14122878|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122879|NCT05099575|Oxytocin|oxytocin|mesh-list
14122880|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
14122881|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14122882|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942107|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
13942108|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942109|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122883|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14122884|NCT05099198|Glimepiride|glimepiride|mesh-list
14122885|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14122886|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122887|NCT05099198|Incretins|incretins|mesh-ancestor
14122888|NCT05099198|Hormones|hormones|mesh-ancestor
14122889|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122890|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14122891|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
14122892|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122893|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122894|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14122895|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122896|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
14122897|NCT05099185|Trace Elements|trace elements|mesh-list
14122898|NCT05099185|Micronutrients|micronutrients|mesh-list
14122899|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122900|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
14122901|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14122902|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14122903|NCT05092165|Methylene Blue|methylene blue|mesh-list
14122904|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122905|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122906|NCT05092152|Propofol|propofol|mesh-list
14122907|NCT05092152|Esketamine|esketamine|mesh-list
14122908|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14122909|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122910|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122911|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14122912|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
14122913|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
14122914|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
14122915|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14122916|NCT05088356|Plerixafor|plerixafor|mesh-list
14122917|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
14122918|NCT05088356|Melphalan|melphalan|mesh-list
14122919|NCT05088356|Fludarabine|fludarabine|mesh-list
14122920|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
14122921|NCT05088356|Tacrolimus|tacrolimus|mesh-list
14122922|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
14122923|NCT05088356|Lenograstim|lenograstim|mesh-list
14122924|NCT05088356|Sargramostim|sargramostim|mesh-list
14122925|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14122926|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
14122927|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122928|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14122929|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14122930|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122931|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14122932|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14122933|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14122934|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
14122935|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
14122936|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122937|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13942110|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942111|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13942112|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13942113|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13942114|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942115|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942116|NCT03282825|Paclitaxel|paclitaxel|mesh-list
13942117|NCT03282825|Decitabine|decitabine|mesh-list
13942118|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14122938|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14122939|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122940|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14122941|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14176806|NCT04762498|Methotrexate|methotrexate|mesh-list
14176807|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14176808|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
14176809|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14176810|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176811|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176812|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
14176813|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176814|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176815|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
14176816|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942119|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942120|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
13942121|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
13942122|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
13942123|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942124|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13942125|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
13942126|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942133|NCT03282669|Morphine|morphine|mesh-list
13942134|NCT03282669|Hydromorphone|hydromorphone|mesh-list
13942135|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13942136|NCT03282669|Narcotics|narcotics|mesh-ancestor
13942137|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942138|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942139|NCT03282669|Analgesics|analgesics|mesh-ancestor
13942140|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
14176817|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14176818|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176819|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
14176820|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176821|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14176822|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
14176823|NCT04762784|Hormones|hormones|mesh-ancestor
14176824|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14176825|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176826|NCT04762901|Paclitaxel|paclitaxel|mesh-list
14176827|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
14176828|NCT04762901|Carboplatin|carboplatin|mesh-list
14176829|NCT04762901|Doxorubicin|doxorubicin|mesh-list
14176830|NCT04762901|Niraparib|niraparib|mesh-list
14176831|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176832|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176833|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176834|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176835|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176836|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176837|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176838|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
14176839|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176840|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14176841|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14176842|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
14176843|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14176844|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14176845|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14176846|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14176847|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176848|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14176849|NCT04761952|Azathioprine|azathioprine|mesh-list
14176850|NCT04761952|Infliximab|infliximab|mesh-list
14176851|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
14176852|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767376|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176853|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13942141|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176854|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
13942142|NCT03282643|Heparin|heparin|mesh-list
13942143|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13942144|NCT03282643|Tinzaparin|tinzaparin|mesh-list
13942145|NCT03282643|Dalteparin|dalteparin|mesh-list
13942146|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
13942147|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
13942148|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13942149|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13942150|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942151|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13942152|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
13942153|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14122942|NCT05087615|Ondansetron|ondansetron|mesh-list
14122943|NCT05087615|Metoclopramide|metoclopramide|mesh-list
14122944|NCT05087615|Granisetron|granisetron|mesh-list
14122945|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
14122946|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
14122947|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122948|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122949|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122950|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
14122951|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
14122952|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14122953|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
14122954|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942154|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
13942155|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942156|NCT03282513|Ivosidenib|ivosidenib|mesh-list
13942157|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942158|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942159|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942160|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
13942161|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942162|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
13942163|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
13942164|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961967|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961968|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961969|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
13961970|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
14122955|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122956|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14122957|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14122958|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14122959|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14122960|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14122961|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14122962|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14122963|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
14122964|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
14122965|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
13961971|NCT05254236|Vaccines|vaccines|mesh-list
13961972|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
13961973|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13961974|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14478220|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478221|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14478222|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
14478223|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478224|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14478225|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13961981|NCT05254171|Gemcitabine|gemcitabine|mesh-list
13961982|NCT05254171|Paclitaxel|paclitaxel|mesh-list
13961983|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13961984|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13961985|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
14122966|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122967|NCT05057949|Itraconazole|itraconazole|mesh-list
13961986|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
13961987|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
13961988|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13961989|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14122968|NCT05057949|Rifampin|rifampin|mesh-list
14122969|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
14122970|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14122971|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13961990|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
13961991|NCT05254171|Antiviral Agents|antiviral agents|mesh-ancestor
14122972|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14122973|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14122974|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122975|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14122976|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
14122977|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14122978|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122979|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14122980|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14122981|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
14122982|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14122983|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
14122984|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14122985|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14122986|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14122987|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14122988|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14122989|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14122990|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14122991|NCT05033041|Metoclopramide|metoclopramide|mesh-list
14122992|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
13942165|NCT03282344|Nivolumab|nivolumab|mesh-list
13942166|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942167|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942168|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13942169|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14122993|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
14122994|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14122995|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14122996|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14122997|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14762798|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762799|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762800|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14762801|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14762802|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
14122998|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14122999|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
13942170|NCT03282188|Sargramostim|sargramostim|mesh-list
13942171|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
13942172|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942173|NCT03282162|Oxytocin|oxytocin|mesh-list
13942174|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
13942175|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13942176|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942177|NCT03282136|Incretins|incretins|mesh-list
14123000|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123001|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123002|NCT05024214|Sunitinib|sunitinib|mesh-list
14123003|NCT05024214|Lenvatinib|lenvatinib|mesh-list
14123004|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123005|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14123006|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14123007|NCT05024214|Growth Substances|growth substances|mesh-ancestor
13942178|NCT03282136|Hormones|hormones|mesh-ancestor
13942179|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942180|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942181|NCT03282110|Citalopram|citalopram|mesh-list
13942182|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13942183|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13942184|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942185|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942186|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942187|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
13942188|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942189|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13942190|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
13942191|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13942192|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
13942193|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13942194|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942195|NCT03282006|Renal Agents|renal agents|mesh-ancestor
13942196|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13942197|NCT03281954|Atezolizumab|atezolizumab|mesh-list
13942198|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942199|NCT03281941|Capsaicin|capsaicin|mesh-list
13942200|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
13942201|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
13942202|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
13942203|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942204|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942205|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
13942206|NCT03281928|Diuretics|diuretics|mesh-ancestor
13942207|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
13942208|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942209|NCT03281928|Expectorants|expectorants|mesh-ancestor
13942210|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
13942211|NCT03281863|Antibodies|antibodies|mesh-list
13942212|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
13942213|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
14123008|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123009|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
14123010|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123011|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123012|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123013|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
14123014|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14123015|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123016|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13942214|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942215|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13942216|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13942217|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
13942218|NCT03281694|Nicotine|nicotine|mesh-list
13942219|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13942220|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
13942221|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942222|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942223|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13942224|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13942225|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
13942226|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942227|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123017|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123018|NCT04911660|Empagliflozin|empagliflozin|mesh-list
14123019|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14123020|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123021|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14123022|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123023|NCT04877093|Clonidine|clonidine|mesh-list
14123024|NCT04877093|Analgesics|analgesics|mesh-ancestor
14123025|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
14123026|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123027|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942228|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
13942229|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13942230|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
13942231|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942232|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942233|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
13942234|NCT03281187|Testosterone|testosterone|mesh-list
13942235|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
13942236|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
13942237|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13942238|NCT03281187|Androgens|androgens|mesh-ancestor
13942239|NCT03281187|Hormones|hormones|mesh-ancestor
14123028|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14123029|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
14123030|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
14123031|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14123032|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14123033|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14762803|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
14762804|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762805|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14762806|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14123034|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
14123035|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123036|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123037|NCT04856566|Ethanol|ethanol|mesh-list
14123038|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14123039|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123040|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123041|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123042|NCT04825704|Bupivacaine|bupivacaine|mesh-list
14123043|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
13942240|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942241|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942242|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13942243|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942244|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
13942245|NCT03280927|Efinaconazole|efinaconazole|mesh-list
13942246|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
13942247|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942248|NCT03280849|Chitosan|chitosan|mesh-list
13942249|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13942250|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13942251|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
13942252|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942253|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13942254|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
13942255|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
13942256|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
13942257|NCT03280849|Coagulants|coagulants|mesh-ancestor
13961992|NCT05254171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13961993|NCT05254171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13961994|NCT05254171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13961995|NCT05254171|Immunologic Factors|immunologic factors|mesh-ancestor
13961996|NCT05254171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963485|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13963486|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963487|NCT03144128|Vitamin D|vitamin d|mesh-list
14123044|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
14123045|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123046|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123047|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
14123048|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963488|NCT03144128|Vitamins|vitamins|mesh-ancestor
13963489|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
14123061|NCT04733040|Felzartamab|felzartamab|mesh-list
14123062|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123063|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
14123064|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123065|NCT04731974|Melatonin|melatonin|mesh-list
14123066|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
14123067|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123068|NCT04731974|Protective Agents|protective agents|mesh-ancestor
14123069|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123070|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123071|NCT04730232|Paclitaxel|paclitaxel|mesh-list
14123072|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14123073|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123074|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
14123075|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
14123076|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123077|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963490|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963491|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14123078|NCT04721353|Prazosin|prazosin|mesh-list
14123079|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14123080|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13942258|NCT03280667|Denosumab|denosumab|mesh-list
13942259|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
13942260|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942261|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942262|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13942263|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942264|NCT03280641|Warfarin|warfarin|mesh-list
13942265|NCT03280641|Dabigatran|dabigatran|mesh-list
13942266|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
13942267|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
13942268|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13942269|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
13942270|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942271|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942272|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
13942273|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942274|NCT03280407|Leucovorin|leucovorin|mesh-list
13942275|NCT03280407|Capecitabine|capecitabine|mesh-list
13942276|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
13942277|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
13942278|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13942279|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
14123081|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14123082|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14123083|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
13942280|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942281|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942282|NCT03280407|Antidotes|antidotes|mesh-ancestor
13942283|NCT03280407|Protective Agents|protective agents|mesh-ancestor
13942284|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942285|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
13942286|NCT03280407|Vitamins|vitamins|mesh-ancestor
13942287|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
13942288|NCT03280342|Topiramate|topiramate|mesh-list
13942289|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
13942290|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13942291|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942292|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
13942293|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
13942294|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13942295|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13942296|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13942297|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942298|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942299|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
13942300|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123084|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123085|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762807|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762808|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762809|NCT02098876|Everolimus|everolimus|mesh-list
14762810|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478226|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14478227|NCT02448654|Tolcapone|tolcapone|mesh-list
14478228|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14478229|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14478230|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13942301|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123086|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123087|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
14123088|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123089|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123090|NCT04658277|Clarithromycin|clarithromycin|mesh-list
13942302|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13942303|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942304|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13942305|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13942306|NCT03280316|Urological Agents|urological agents|mesh-ancestor
13942307|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14478231|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478232|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478233|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
13942308|NCT03280277|Hematinics|hematinics|mesh-ancestor
13961997|NCT05253833|Allopurinol|allopurinol|mesh-list
14123091|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14123092|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123093|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14123094|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123095|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123096|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14123097|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14123098|NCT04602117|Paclitaxel|paclitaxel|mesh-list
14123099|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14123100|NCT04602117|Trastuzumab|trastuzumab|mesh-list
14123101|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14123102|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123103|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14123104|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14123105|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123106|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123107|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123108|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14123109|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14123110|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14123111|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14123112|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123113|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478234|NCT02448771|Palbociclib|palbociclib|mesh-list
14478235|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478236|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14478237|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478238|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478239|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14478240|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14478241|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
14478242|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478243|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478244|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14478245|NCT02448810|Fluorouracil|fluorouracil|mesh-list
14478246|NCT02448810|Panitumumab|panitumumab|mesh-list
14478247|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
14478248|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478249|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14478250|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478251|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13942309|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13942310|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13942311|NCT03280251|Methylphenidate|methylphenidate|mesh-list
13942312|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13942313|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942314|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13942315|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13942316|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942317|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478252|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
14478253|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478254|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478255|NCT02448862|Fentanyl|fentanyl|mesh-list
14478256|NCT02448862|Analgesics|analgesics|mesh-list
14478257|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14478258|NCT02448862|Narcotics|narcotics|mesh-ancestor
14123114|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123115|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123116|NCT04540848|Bupivacaine|bupivacaine|mesh-list
14123117|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
14123118|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
14123119|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123120|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123121|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
14123122|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942318|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
13942319|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942320|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
13942321|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13942322|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14478259|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478260|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478261|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
14478262|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478263|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14478264|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14123123|NCT04531592|Valproic Acid|valproic acid|mesh-list
14123124|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
14123125|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123126|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123127|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
14123128|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123129|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123130|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
14123131|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14123132|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123133|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14123134|NCT04531579|Valproic Acid|valproic acid|mesh-list
14123135|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14123136|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
14123137|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123138|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123139|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
14123140|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123141|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123142|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
14123143|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14123144|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123145|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14123146|NCT04517357|Apatinib|apatinib|mesh-list
14123147|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123148|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123149|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123150|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123151|NCT04510584|Bevacizumab|bevacizumab|mesh-list
14123152|NCT04510584|Atezolizumab|atezolizumab|mesh-list
14123153|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123154|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123155|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14123156|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14123157|NCT04510584|Growth Substances|growth substances|mesh-ancestor
14123158|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123159|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
14123160|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
14123161|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14123162|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
14123163|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14123164|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
14123165|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123166|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123167|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
14123168|NCT04469764|Letrozole|letrozole|mesh-list
14123169|NCT04469764|Anastrozole|anastrozole|mesh-list
14123170|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123171|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14123172|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14123173|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123174|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123175|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14123176|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
14123177|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123178|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123179|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14123180|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
14123181|NCT04379024|Estrogens|estrogens|mesh-list
14478265|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
14478266|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
14478267|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14478268|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14478269|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
14478270|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478271|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14478272|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14478273|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
14478274|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
13942323|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942324|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
13942325|NCT03280212|Coagulants|coagulants|mesh-ancestor
13942326|NCT03280160|Ofatumumab|ofatumumab|mesh-list
13942327|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942328|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14123182|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14123183|NCT04379024|Hormones|hormones|mesh-ancestor
14123184|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123185|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123186|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14123187|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14123188|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
14123189|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14123190|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14123191|NCT04272008|Estradiol|estradiol|mesh-list
14123192|NCT04272008|Estrogens|estrogens|mesh-ancestor
14123193|NCT04272008|Hormones|hormones|mesh-ancestor
14123194|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123195|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123196|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14123197|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
14123198|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123199|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14123200|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14123201|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14123202|NCT04269213|Cytarabine|cytarabine|mesh-list
14123203|NCT04269213|Daunorubicin|daunorubicin|mesh-list
14123204|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123205|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
14123206|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123207|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123208|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
14123209|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123210|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13942329|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13942330|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942331|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
13942332|NCT03280095|Acetaminophen|acetaminophen|mesh-list
13942333|NCT03280095|Codeine|codeine|mesh-list
13942334|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13942335|NCT03280095|Analgesics|analgesics|mesh-ancestor
13942336|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
13942337|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942338|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942339|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
13942340|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13942341|NCT03280095|Narcotics|narcotics|mesh-ancestor
13942342|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942343|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
13942344|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
14123211|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
14123212|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123213|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14123214|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14123215|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13942350|NCT03280017|Ketamine|ketamine|mesh-list
13942351|NCT03280017|Analgesics|analgesics|mesh-ancestor
13942352|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
13942353|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942354|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942355|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13942356|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13942357|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
13942358|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
13942359|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942360|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13942361|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13942362|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123216|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123217|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14123218|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
14123219|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123220|NCT04176718|Dexamethasone|dexamethasone|mesh-list
14123221|NCT04176718|Daratumumab|daratumumab|mesh-list
14123222|NCT04176718|Pomalidomide|pomalidomide|mesh-list
14123223|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14123224|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
14123225|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
14123226|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123227|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123228|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14123229|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
14123230|NCT04176718|Hormones|hormones|mesh-ancestor
14123231|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123232|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14123233|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936510|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936511|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936512|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14936513|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
14936514|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936515|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
13942363|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942364|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
13942365|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13942366|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13942367|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942368|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13942369|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13942370|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942371|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942372|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936516|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936517|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
13942373|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13942374|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
13942375|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13942376|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942377|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13942378|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13942379|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13942380|NCT03279978|Midazolam|midazolam|mesh-list
13942381|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13942382|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13942383|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942384|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942385|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13942386|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13942387|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14123234|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
14123235|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14936518|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
14936519|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14936520|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936521|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936522|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14936523|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14936524|NCT01469624|Protective Agents|protective agents|mesh-ancestor
13942388|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13942389|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
13942390|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
14936525|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936526|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936527|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13942391|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
13942392|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
13942393|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942394|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942395|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
13942396|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942397|NCT03279861|Valsartan|valsartan|mesh-list
13942398|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
13942399|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13942400|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13942401|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13942402|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936528|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
14936529|NCT01469650|Vitamin D|vitamin d|mesh-list
14936530|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
14936531|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
14936532|NCT01469650|Vitamins|vitamins|mesh-list
14762811|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762812|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
13942403|NCT03279809|Aspirin|aspirin|mesh-list
13942404|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13942405|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13942406|NCT03279809|Analgesics|analgesics|mesh-ancestor
13942407|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
13942408|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942409|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942410|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942411|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13942412|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13942413|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13942414|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942415|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14762813|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762814|NCT02076009|Dexamethasone|dexamethasone|mesh-list
14762815|NCT02076009|Lenalidomide|lenalidomide|mesh-list
14762816|NCT02076009|Daratumumab|daratumumab|mesh-list
14936533|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
14936534|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936535|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14762817|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762818|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
14762819|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
14762820|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762821|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762822|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762823|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
14762824|NCT02076009|Hormones|hormones|mesh-ancestor
14762825|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936536|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13942416|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13942417|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942418|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
13942419|NCT03279796|Betamethasone|betamethasone|mesh-list
13942420|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942421|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
13942422|NCT03279796|Hormones|hormones|mesh-ancestor
13942423|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942424|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942425|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14762826|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762827|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942426|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
13942427|NCT03279757|Lidocaine|lidocaine|mesh-list
13942428|NCT03279757|Epinephrine|epinephrine|mesh-list
14123236|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14123237|NCT04176718|Growth Substances|growth substances|mesh-ancestor
14123238|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
14176855|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176856|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176857|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176858|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176859|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
14176860|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176861|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
14176862|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14176863|NCT04762030|Paclitaxel|paclitaxel|mesh-list
13942429|NCT03279757|Racepinephrine|racepinephrine|mesh-list
13942430|NCT03279757|Tetracaine|tetracaine|mesh-list
14176864|NCT04762030|Carboplatin|carboplatin|mesh-list
14176865|NCT04762030|Durvalumab|durvalumab|mesh-list
14176866|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176867|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176868|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14176869|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14176870|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14176871|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176872|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14176873|NCT04762134|Doxycycline|doxycycline|mesh-list
14176874|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14176875|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176876|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
14176877|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14176878|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14176879|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14176880|NCT04761705|Latanoprost|latanoprost|mesh-list
14176881|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14176882|NCT04762082|Tadalafil|tadalafil|mesh-list
14176883|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
14176884|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14176885|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14176886|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176887|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176888|NCT04762082|Urological Agents|urological agents|mesh-ancestor
14176889|NCT04762147|Acetaminophen|acetaminophen|mesh-list
14176890|NCT04762147|Fentanyl|fentanyl|mesh-list
14176891|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14176892|NCT04762147|Narcotics|narcotics|mesh-ancestor
14176893|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176894|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176895|NCT04762147|Analgesics|analgesics|mesh-ancestor
14176896|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
14176897|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176898|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14176899|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14176900|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
14176901|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
14176902|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14176903|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
14176904|NCT04761744|Nivolumab|nivolumab|mesh-list
14176905|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14176906|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176907|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14176908|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176909|NCT04761731|Tacrolimus|tacrolimus|mesh-list
14176910|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13942431|NCT03279757|Carticaine|carticaine|mesh-list
13942432|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
13942433|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
13942434|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
13942435|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942436|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942437|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
13942438|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942439|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13942440|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13942441|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14176911|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
14176912|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942442|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942443|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942444|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13942445|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13942446|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
13942447|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942448|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13942449|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13942450|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
13942451|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13942452|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
13942453|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
13942454|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
13942455|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13942456|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
13942457|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942458|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942459|NCT03279679|Ropivacaine|ropivacaine|mesh-list
13942460|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
13942461|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
13942462|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123239|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
14123240|NCT04163406|Trace Elements|trace elements|mesh-ancestor
14123241|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
14123242|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942463|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942464|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
13942465|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942466|NCT03279601|Capecitabine|capecitabine|mesh-list
13942467|NCT03279601|Temozolomide|temozolomide|mesh-list
13942468|NCT03279601|Dacarbazine|dacarbazine|mesh-list
13942469|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13942470|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
13942471|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123255|NCT04099355|Dronabinol|dronabinol|mesh-list
14123256|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
14123257|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123258|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14123259|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14123260|NCT04099355|Analgesics|analgesics|mesh-ancestor
14123261|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
14123262|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123263|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14123264|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14123265|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123266|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123267|NCT04099355|Hormones|hormones|mesh-ancestor
14123268|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123269|NCT03965845|Palbociclib|palbociclib|mesh-list
14123270|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123271|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123272|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942472|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942473|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13942474|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
13942475|NCT03279562|Nalmefene|nalmefene|mesh-list
13942476|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13942477|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942478|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
13942479|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123273|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123274|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
14123275|NCT03825289|Trametinib|trametinib|mesh-list
13942480|NCT03279549|Mitogens|mitogens|mesh-list
14123276|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
14123277|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14123278|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14123279|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123280|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123281|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123282|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123283|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123284|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123285|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
14123286|NCT03809533|Velpatasvir|velpatasvir|mesh-list
14123287|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
14123288|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123289|NCT03759366|Eculizumab|eculizumab|mesh-list
14123290|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14123291|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123292|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
14123293|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123294|NCT03649321|Gemcitabine|gemcitabine|mesh-list
14123295|NCT03649321|Paclitaxel|paclitaxel|mesh-list
14123296|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14123297|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14123298|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123299|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
14123300|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
14123301|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123302|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123303|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123304|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
14123305|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
14123306|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123307|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123308|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123309|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
14123310|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123319|NCT03572530|Azacitidine|azacitidine|mesh-list
14123320|NCT03572530|Decitabine|decitabine|mesh-list
14123321|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123322|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
14123323|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123324|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123325|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123330|NCT03481842|Axitinib|axitinib|mesh-list
14123331|NCT03481842|Afatinib|afatinib|mesh-list
14123332|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123333|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123334|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123335|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123336|NCT03466346|Fluoxetine|fluoxetine|mesh-list
14123337|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14123338|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14123339|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14123340|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123341|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123342|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
14123343|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123344|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14123345|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
14123346|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14123347|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14123348|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14123349|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123350|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14123351|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
14762828|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
14762829|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14762830|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14762831|NCT02076009|Growth Substances|growth substances|mesh-ancestor
14762832|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
14762833|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
14762834|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14762835|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14762836|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14762837|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14762838|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942481|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
13942482|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942483|NCT03279536|Lactoferrin|lactoferrin|mesh-list
13942484|NCT03279536|Dextrans|dextrans|mesh-list
13942485|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
13942486|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942487|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
13942488|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
13942489|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
13942490|NCT03279536|Hematinics|hematinics|mesh-ancestor
13942491|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13942492|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13942493|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942494|NCT03279341|Prucalopride|prucalopride|mesh-list
13942495|NCT03279341|Bisacodyl|bisacodyl|mesh-list
13942496|NCT03279341|Laxatives|laxatives|mesh-ancestor
13942497|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13942498|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14762839|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
14762840|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762841|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762842|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14762843|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762844|NCT02043587|Leucovorin|leucovorin|mesh-list
14762845|NCT02043587|Cytarabine|cytarabine|mesh-list
14762846|NCT02043587|Prednisone|prednisone|mesh-list
14762847|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
14762848|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14762849|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14762850|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13942499|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13942500|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
13942501|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123352|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123353|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
14123354|NCT03237819|Analgesics|analgesics|mesh-ancestor
14123355|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
14123356|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123357|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123358|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
14123359|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123360|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14123361|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
14123362|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14123363|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14123364|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762851|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
14762852|NCT02043587|Rituximab|rituximab|mesh-list
13942502|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942503|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942504|NCT03279341|Cathartics|cathartics|mesh-ancestor
13942505|NCT03279328|Petrolatum|petrolatum|mesh-list
13942506|NCT03279328|Emollients|emollients|mesh-ancestor
13942507|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
13961998|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
13961999|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962000|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962001|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
13962002|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762853|NCT02043587|Methotrexate|methotrexate|mesh-list
14762854|NCT02043587|Etoposide|etoposide|mesh-list
13962003|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13962004|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
14762855|NCT02043587|Vincristine|vincristine|mesh-list
13942508|NCT03279250|Prednisone|prednisone|mesh-list
13942509|NCT03279250|Cortisone|cortisone|mesh-list
13942510|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
13942511|NCT03279250|Hormones|hormones|mesh-list
13942512|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
13942513|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942514|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
13942515|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942516|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942517|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14123365|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14123366|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
14123367|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123368|NCT03207958|Belimumab|belimumab|mesh-list
14123369|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123370|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
13942518|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942519|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13942520|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942521|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942522|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
13942523|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13942524|NCT03279146|Tenofovir|tenofovir|mesh-list
13942525|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
13942526|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942527|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13942528|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13942529|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942530|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942531|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13942532|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14123371|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123372|NCT03205956|Levodopa|levodopa|mesh-list
14123373|NCT03205956|Carbidopa|carbidopa|mesh-list
14123374|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14123375|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14123376|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
14123377|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123378|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123379|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123380|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14123381|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123382|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
14123383|NCT03149029|Trametinib|trametinib|mesh-list
14762856|NCT02043587|Daunorubicin|daunorubicin|mesh-list
14762857|NCT02043587|Asparaginase|asparaginase|mesh-list
14762858|NCT02043587|Dasatinib|dasatinib|mesh-list
14762859|NCT02043587|Pegaspargase|pegaspargase|mesh-list
14762860|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762861|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
14762862|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762863|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762864|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762865|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
14123384|NCT03149029|Dabrafenib|dabrafenib|mesh-list
14123385|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123386|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942533|NCT03279133|Ledipasvir|ledipasvir|mesh-list
13942534|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
13942535|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942536|NCT03279120|Tenofovir|tenofovir|mesh-list
13942537|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
13942538|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
13942539|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942540|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13942541|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13942542|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942543|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942544|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13942545|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13942546|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13942547|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
13962005|NCT05253833|Protective Agents|protective agents|mesh-ancestor
14123387|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14762866|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762867|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123388|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123389|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123390|NCT03139916|Temozolomide|temozolomide|mesh-list
14123391|NCT03139916|Bavituximab|bavituximab|mesh-list
14123392|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14123393|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
14123394|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123395|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123396|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123397|NCT03019003|Durvalumab|durvalumab|mesh-list
14123398|NCT03019003|Decitabine|decitabine|mesh-list
14123399|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123400|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123401|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123402|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
14123403|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123404|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123405|NCT03003962|Gemcitabine|gemcitabine|mesh-list
14123406|NCT03003962|Paclitaxel|paclitaxel|mesh-list
14123407|NCT03003962|Cisplatin|cisplatin|mesh-list
14123408|NCT03003962|Carboplatin|carboplatin|mesh-list
14123409|NCT03003962|Pemetrexed|pemetrexed|mesh-list
13942548|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13942549|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942550|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13942551|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13942552|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13942553|NCT03278938|Bupropion|bupropion|mesh-list
13942554|NCT03278938|Citalopram|citalopram|mesh-list
13942555|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13942556|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
13942557|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14123410|NCT03003962|Durvalumab|durvalumab|mesh-list
14123411|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14123412|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123413|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
14123414|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
14123415|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123416|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123417|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123418|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
14123419|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
14123420|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123421|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123422|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762868|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762869|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762870|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762871|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
14762872|NCT02043587|Hormones|hormones|mesh-ancestor
14762873|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762874|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762875|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14762876|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
14762877|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13942558|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13942559|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13942560|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942561|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942562|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
13942563|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942564|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942565|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13942566|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13942567|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942568|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13942569|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
13942570|NCT03278860|Oxytocin|oxytocin|mesh-list
13942571|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
13942572|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13942573|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762878|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13942574|NCT03278808|Azithromycin|azithromycin|mesh-list
14123423|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
14762879|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
14762880|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14762881|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942575|NCT03278808|Chloroquine|chloroquine|mesh-list
13942576|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
13942577|NCT03278808|Atovaquone|atovaquone|mesh-list
13942578|NCT03278808|Proguanil|proguanil|mesh-list
13942579|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
13942580|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13942581|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942582|NCT03278808|Amebicides|amebicides|mesh-ancestor
13942583|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13942584|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13942585|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
13942586|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13942587|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13942588|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13942589|NCT03278808|Analgesics|analgesics|mesh-ancestor
13942590|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
13942591|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942592|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942593|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942594|NCT03278808|Filaricides|filaricides|mesh-ancestor
14762882|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14762883|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14762884|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14762885|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14762886|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14762887|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
14762888|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14762889|NCT02043587|Antidotes|antidotes|mesh-ancestor
14762890|NCT02043587|Protective Agents|protective agents|mesh-ancestor
14762891|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
14762892|NCT02043587|Vitamins|vitamins|mesh-ancestor
14762893|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
14762894|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14762895|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14762896|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123424|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123425|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14123426|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14123427|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123428|NCT02951130|Milrinone|milrinone|mesh-list
14123429|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14123430|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13942595|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
13942596|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
13942597|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942598|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942599|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
13942600|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13942601|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
13942602|NCT03278782|Romidepsin|romidepsin|mesh-list
13942603|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942604|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942605|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942606|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13942607|NCT03278652|Analgesics|analgesics|mesh-list
13942608|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
13942609|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942610|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942611|NCT03278522|Ramosetron|ramosetron|mesh-list
13942612|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
13942613|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
13942614|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942615|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942616|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13942617|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13942618|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
13942619|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942620|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123431|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
14123432|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14762897|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14936537|NCT01469702|Azithromycin|azithromycin|mesh-list
13942621|NCT03278483|Rifampin|rifampin|mesh-list
13942622|NCT03278483|Isoniazid|isoniazid|mesh-list
13942623|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14123433|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14123434|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123435|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123436|NCT02951130|Protective Agents|protective agents|mesh-ancestor
14123437|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123438|NCT02905110|Methotrexate|methotrexate|mesh-list
14123439|NCT02905110|Etoposide|etoposide|mesh-list
14123440|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14123441|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
14123442|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123443|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123444|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123445|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
14123446|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123447|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123448|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14123449|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123450|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14123451|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123452|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
14123453|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123454|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14123455|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14123456|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14123457|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14123458|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
14123459|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942624|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
13942625|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13942626|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942627|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
13942628|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13942629|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942630|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942631|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13942632|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13942633|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13942634|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13942635|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14123460|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123461|NCT02813655|Cosyntropin|cosyntropin|mesh-list
14123462|NCT02813655|Hormones|hormones|mesh-ancestor
14123463|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123464|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123465|NCT02747407|Vaccines|vaccines|mesh-list
14123466|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
14123467|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123468|NCT02718833|Dexamethasone|dexamethasone|mesh-list
14123469|NCT02718833|Bortezomib|bortezomib|mesh-list
14123470|NCT02718833|Pomalidomide|pomalidomide|mesh-list
14123471|NCT02718833|Elotuzumab|elotuzumab|mesh-list
14123472|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14123473|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
14123474|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
14123475|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123476|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942636|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13942637|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13942638|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13942639|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
13942640|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13942641|NCT03278444|Trimetazidine|trimetazidine|mesh-list
13942642|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
13942643|NCT03278431|Albendazole|albendazole|mesh-list
13942644|NCT03278431|Mebendazole|mebendazole|mesh-list
13942645|NCT03278431|Piperazine|piperazine|mesh-list
13942646|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
13942647|NCT03278431|Pyrantel|pyrantel|mesh-list
14936538|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936539|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938721|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938722|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938723|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938724|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942648|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
14123477|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14123478|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
14123479|NCT02718833|Hormones|hormones|mesh-ancestor
14123480|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123481|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14123482|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123483|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
14123484|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14123485|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14123486|NCT02718833|Growth Substances|growth substances|mesh-ancestor
14123487|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
14123488|NCT02700841|Melphalan|melphalan|mesh-list
14123489|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
14123490|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14123491|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
14123492|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123493|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942649|NCT03278431|Oxantel|oxantel|mesh-list
13942650|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
13942651|NCT03278431|DMP 777|dmp 777|mesh-list
13942652|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
13942653|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13942654|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942655|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
14123494|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14123495|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123496|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
13942656|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13942657|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13942658|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
13942659|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
13942660|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
13942661|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942662|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942663|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
13942664|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942665|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
13942666|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13942667|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13942668|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123497|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123498|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
14123499|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14123500|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
14123501|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123502|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123503|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14123504|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
14123505|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
14123506|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14123507|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
14123508|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123509|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123510|NCT02369458|Mitomycins|mitomycins|mesh-list
14123511|NCT02369458|Mitomycin|mitomycin|mesh-list
14123512|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13942669|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942670|NCT03278405|Avelumab|avelumab|mesh-list
13942671|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123513|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123514|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
14123515|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123516|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14123517|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176913|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14176914|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176915|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176916|NCT04761601|Gemcitabine|gemcitabine|mesh-list
14176917|NCT04761601|Paclitaxel|paclitaxel|mesh-list
14176918|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14176919|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176920|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
13942672|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176921|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
13942673|NCT03278379|Avelumab|avelumab|mesh-list
14123518|NCT05102448|Methotrexate|methotrexate|mesh-list
14123519|NCT05102448|Tofacitinib|tofacitinib|mesh-list
14123520|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14123521|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
14123522|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123523|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123524|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123525|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
14123526|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123527|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123528|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
14123529|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123530|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13942674|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942675|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942676|NCT03278314|Ivacaftor|ivacaftor|mesh-list
13942677|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13942678|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942679|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942680|NCT03278262|Aflibercept|aflibercept|mesh-list
13942681|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13942682|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13942683|NCT03278262|Growth Substances|growth substances|mesh-ancestor
13942684|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942685|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
13942686|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942687|NCT03278015|Gemcitabine|gemcitabine|mesh-list
13942688|NCT03278015|Paclitaxel|paclitaxel|mesh-list
13942689|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14123531|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123532|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
14123533|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123534|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14123535|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123536|NCT05102422|Propofol|propofol|mesh-list
14123537|NCT05102422|Sevoflurane|sevoflurane|mesh-list
14123538|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14123539|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123540|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123541|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14123542|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
14123543|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
14123544|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14123545|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14123546|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
14123547|NCT05102396|Oxybutynin|oxybutynin|mesh-list
14123548|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
14123549|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
14123550|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123551|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123552|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14123553|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14123554|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
14123555|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123556|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123557|NCT05102396|Urological Agents|urological agents|mesh-ancestor
14123558|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14123559|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123560|NCT05102396|Renal Agents|renal agents|mesh-ancestor
14123561|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
14123562|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14123563|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123564|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123565|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14123566|NCT05102058|Analgesics|analgesics|mesh-ancestor
14123567|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
14123568|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123569|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14123570|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14123571|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14123572|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
14123573|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123574|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942690|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13942691|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942692|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
13942693|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
13942694|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
13942695|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942696|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13942697|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
13942698|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
13942699|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942700|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942701|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13942702|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
13942703|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942704|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
13942705|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
13942706|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
13942707|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
13942708|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
13942709|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942710|NCT03277599|Tramadol|tramadol|mesh-list
13942711|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13942712|NCT03277599|Narcotics|narcotics|mesh-ancestor
13942713|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942714|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942715|NCT03277599|Analgesics|analgesics|mesh-ancestor
13942716|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
13942717|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942718|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
13942719|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14123575|NCT05102045|Memantine|memantine|mesh-list
14123576|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14123577|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14123578|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14123579|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
14123580|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123581|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123582|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123583|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14123584|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14123585|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123586|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
14123587|NCT05101954|Mitogens|mitogens|mesh-list
13942720|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13942721|NCT03277573|Analgesics|analgesics|mesh-ancestor
13942722|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
13942723|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942724|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942725|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942726|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962006|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478275|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478276|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478277|NCT02449044|Tolvaptan|tolvaptan|mesh-list
14478278|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14478279|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478280|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
13962015|NCT05253781|Aspirin|aspirin|mesh-list
13962016|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13962017|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13962018|NCT05253781|Analgesics|analgesics|mesh-ancestor
14123588|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123589|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123590|NCT05101928|Prednisone|prednisone|mesh-list
14123591|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14123592|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
14123593|NCT05101928|Hormones|hormones|mesh-ancestor
14123594|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123595|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962019|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
13962020|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962021|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123596|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14123597|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123598|NCT05101811|Vitamin D|vitamin d|mesh-list
13942727|NCT03277482|Durvalumab|durvalumab|mesh-list
13942728|NCT03277482|Tremelimumab|tremelimumab|mesh-list
13942729|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123599|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
14123600|NCT05101811|Vitamins|vitamins|mesh-list
14123601|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
14123602|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123603|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14123604|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14123605|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14123606|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14123607|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14123608|NCT05101785|Lidocaine|lidocaine|mesh-list
14123609|NCT05101785|Epinephrine|epinephrine|mesh-list
14123610|NCT05101785|Racepinephrine|racepinephrine|mesh-list
14123611|NCT05101785|Carticaine|carticaine|mesh-list
14123612|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
14123613|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
14123614|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
14123615|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123616|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123617|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
14123618|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123619|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14123620|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14123621|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14123622|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14123623|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123624|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14123625|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14123626|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
14123627|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123628|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14123629|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14123630|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
14123631|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14123632|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
14123633|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
14123634|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
14123635|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14123636|NCT05101551|Gemcitabine|gemcitabine|mesh-list
14123637|NCT05101551|Topotecan|topotecan|mesh-list
14123638|NCT05101551|Talazoparib|talazoparib|mesh-list
14123639|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123640|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
14123641|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123642|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123643|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
14123644|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123645|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123646|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123647|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
14123648|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123649|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14123650|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14123651|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14123652|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
14936540|NCT01469884|Cyclosporine|cyclosporine|mesh-list
13942730|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942731|NCT03277430|Tacrolimus|tacrolimus|mesh-list
13942732|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13942733|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
13942734|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942735|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13942736|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942737|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942738|NCT03277391|Droperidol|droperidol|mesh-list
13942739|NCT03277391|Morphine|morphine|mesh-list
13942740|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13942741|NCT03277391|Narcotics|narcotics|mesh-ancestor
13942742|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942743|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123653|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14123654|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123655|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13942744|NCT03277391|Analgesics|analgesics|mesh-ancestor
14936541|NCT01469884|Everolimus|everolimus|mesh-list
14123656|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
14123657|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14123658|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123659|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123660|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123661|NCT05101291|Bupivacaine|bupivacaine|mesh-list
14123662|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
14123663|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
14123664|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123665|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123666|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
14123667|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123668|NCT05101187|Amphotericin B|amphotericin b|mesh-list
14123669|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14123670|NCT05101187|Olorofim|olorofim|mesh-list
14123671|NCT05101187|Amebicides|amebicides|mesh-ancestor
14123672|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14123673|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14123674|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123675|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14123676|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
14123677|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14123678|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14123679|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14123680|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14123681|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123682|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
14123683|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123684|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123685|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
14123686|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14123687|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14123688|NCT05097976|Prednisolone|prednisolone|mesh-list
14123689|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
14123690|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14123691|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
14123692|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14123693|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
14123694|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
14123695|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14762898|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13942745|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
13942746|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942747|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13942748|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
13942749|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
13942750|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13942751|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13942752|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13942753|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13942754|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13942755|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13942756|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
13942757|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762899|NCT01999569|Letrozole|letrozole|mesh-list
14762900|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762901|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14762902|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14762903|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762904|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762905|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14762906|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
14762907|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762908|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762909|NCT01998971|Acetaminophen|acetaminophen|mesh-list
14762910|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
14762911|NCT01998971|Promethazine|promethazine|mesh-list
14762912|NCT01998971|Thalidomide|thalidomide|mesh-list
14762913|NCT01998971|Dexamethasone|dexamethasone|mesh-list
14762914|NCT01998971|Prednisone|prednisone|mesh-list
14762915|NCT01998971|Lenalidomide|lenalidomide|mesh-list
13942758|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123696|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123697|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762916|NCT01998971|Melphalan|melphalan|mesh-list
14762917|NCT01998971|Bortezomib|bortezomib|mesh-list
13942759|NCT03277339|Paroxetine|paroxetine|mesh-list
13942760|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13942761|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13942762|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942763|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942764|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942765|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
13942766|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123698|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
14123699|NCT05097976|Hormones|hormones|mesh-ancestor
14123700|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123701|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14123702|NCT05097976|Protective Agents|protective agents|mesh-ancestor
14123703|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14123704|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123705|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
14123706|NCT05092074|Velpatasvir|velpatasvir|mesh-list
14123707|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
14123708|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123709|NCT05091372|Lenalidomide|lenalidomide|mesh-list
14123710|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
14123711|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123712|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14123713|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14123714|NCT05091372|Growth Substances|growth substances|mesh-ancestor
14123715|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
14123716|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123717|NCT05083949|Metformin|metformin|mesh-list
14123718|NCT05083949|Empagliflozin|empagliflozin|mesh-list
14123719|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14123720|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123721|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14123722|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123723|NCT05058417|Empagliflozin|empagliflozin|mesh-list
14123724|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14123725|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123726|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14123727|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123728|NCT05037617|Oxytocin|oxytocin|mesh-list
14123729|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
14123730|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123731|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123732|NCT05036473|Levodopa|levodopa|mesh-list
14123733|NCT05036473|Carbidopa|carbidopa|mesh-list
14123734|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14123735|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14123736|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14123737|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
14123738|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123739|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123740|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123741|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13942767|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13942768|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
13942769|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13942770|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13942771|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13942772|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942773|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14123742|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123743|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14123744|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
14123745|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
14123746|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
14123747|NCT05020444|Fludarabine|fludarabine|mesh-list
14123748|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123749|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
14123750|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123751|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123752|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14936542|NCT01469884|Tacrolimus|tacrolimus|mesh-list
13942774|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
14123753|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
14176922|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123754|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123755|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123756|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14123757|NCT04971746|Pirfenidone|pirfenidone|mesh-list
14123758|NCT04971746|Nintedanib|nintedanib|mesh-list
14123759|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123760|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123761|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123762|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123763|NCT04971746|Analgesics|analgesics|mesh-ancestor
14123764|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
14123765|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123766|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123767|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14123768|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14123769|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14123770|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123771|NCT04964466|Becaplermin|becaplermin|mesh-list
14123772|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
14123773|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14123774|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14123775|NCT04964466|Growth Substances|growth substances|mesh-ancestor
14123776|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176923|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176924|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176925|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
14176926|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
14478281|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478282|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14478283|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13942775|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942776|NCT03277222|Insulin|insulin|mesh-list
13942777|NCT03277222|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13942778|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13942779|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942780|NCT03277209|Plerixafor|plerixafor|mesh-list
13942781|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13942782|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13942783|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
13942784|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942785|NCT03277079|Ezetimibe|ezetimibe|mesh-list
13942786|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
13942787|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13942788|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13942789|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
13942790|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942791|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13942792|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942793|NCT03277001|Enoxaparin|enoxaparin|mesh-list
13942794|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
13942795|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13942796|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
13942797|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13942798|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
13942799|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942800|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942801|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
13942802|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14176927|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478284|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478285|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14478286|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14478287|NCT02449902|Estradiol|estradiol|mesh-list
14478288|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14478289|NCT02449902|Estrogens|estrogens|mesh-ancestor
14478290|NCT02449902|Hormones|hormones|mesh-ancestor
14478291|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478292|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478293|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14176928|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478294|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
14478295|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13942803|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13942804|NCT03276858|Midazolam|midazolam|mesh-list
14123777|NCT04945616|Aspirin|aspirin|mesh-list
14123778|NCT04945616|Clopidogrel|clopidogrel|mesh-list
14123779|NCT04945616|Ticagrelor|ticagrelor|mesh-list
14123780|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14123781|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14123782|NCT04945616|Analgesics|analgesics|mesh-ancestor
14123783|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
14123784|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123785|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123786|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14123787|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123788|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14123789|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14123790|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123791|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14123792|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14123793|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123794|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
14123795|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14123796|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14123797|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14123798|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
14123799|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123800|NCT04940013|Misoprostol|misoprostol|mesh-list
14123801|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14123802|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
14123803|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123804|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123805|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14123806|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478296|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14478297|NCT02449915|Bupivacaine|bupivacaine|mesh-list
14478298|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
13942805|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13942806|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13942807|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14123807|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
14123808|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14123809|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14123810|NCT04923867|Estradiol|estradiol|mesh-list
14123811|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14123812|NCT04923867|Estrogens|estrogens|mesh-ancestor
14123813|NCT04923867|Hormones|hormones|mesh-ancestor
14123814|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123815|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123816|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14123817|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
14123818|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123819|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14123820|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
14123821|NCT04894864|Anesthetics|anesthetics|mesh-list
14123822|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123823|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123824|NCT04894864|Narcotics|narcotics|mesh-ancestor
14123825|NCT04894864|Analgesics|analgesics|mesh-ancestor
14123826|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
14123827|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123828|NCT04796220|Gemcitabine|gemcitabine|mesh-list
14123829|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123830|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
14123831|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123832|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123833|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
14123834|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123835|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123836|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14478299|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
13942808|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942809|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942810|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13942811|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13942812|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13942813|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13942814|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
13942815|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
14478300|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14123837|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
14123838|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123839|NCT04787991|Gemcitabine|gemcitabine|mesh-list
14123840|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
14123841|NCT04787991|Paclitaxel|paclitaxel|mesh-list
14123842|NCT04787991|Nivolumab|nivolumab|mesh-list
14123843|NCT04787991|Ipilimumab|ipilimumab|mesh-list
14123844|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14123845|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123846|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14123847|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14123848|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
14123849|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123850|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123851|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
14123852|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
14123853|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123854|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123855|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123856|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
14123857|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123858|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942816|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
13942817|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
13942818|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942819|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942820|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
13942821|NCT03276832|Imiquimod|imiquimod|mesh-list
13942822|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942823|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942824|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13942825|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
13942826|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942827|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
13942828|NCT03276689|Pregabalin|pregabalin|mesh-list
13942829|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13942830|NCT03276689|Analgesics|analgesics|mesh-ancestor
13942831|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
13942832|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123859|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14123860|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
14123861|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14123862|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14123863|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123864|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
14123865|NCT04719065|Analgesics|analgesics|mesh-ancestor
14123866|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
14123867|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123868|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123869|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123870|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14123871|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14123872|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123873|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123874|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
14123875|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123876|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123877|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
14123878|NCT04610476|Prednisolone|prednisolone|mesh-list
13942833|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942834|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
13942835|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13942836|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13942837|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942838|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13942839|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13942840|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13942841|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942842|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13942843|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13942844|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13942845|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14123879|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14123880|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
13942846|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
14123881|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14123882|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
14123883|NCT04610476|Adalimumab|adalimumab|mesh-list
14123884|NCT04610476|Etanercept|etanercept|mesh-list
14123885|NCT04610476|Apremilast|apremilast|mesh-list
14123886|NCT04610476|Golimumab|golimumab|mesh-list
14123887|NCT04610476|Methotrexate|methotrexate|mesh-list
14123888|NCT04610476|Abatacept|abatacept|mesh-list
14123889|NCT04610476|Infliximab|infliximab|mesh-list
14123890|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
14123891|NCT04610476|Ustekinumab|ustekinumab|mesh-list
14123892|NCT04610476|Ixekizumab|ixekizumab|mesh-list
14123893|NCT04610476|Tofacitinib|tofacitinib|mesh-list
14123894|NCT04610476|Leflunomide|leflunomide|mesh-list
14123895|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14123896|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
14123897|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14123898|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
14123899|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14123900|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123901|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123902|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
14123903|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123904|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123905|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
14123906|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123907|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14123908|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14123909|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
14123910|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123911|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14123912|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14123913|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
14123914|NCT04610476|Hormones|hormones|mesh-ancestor
14123915|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14123916|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14123917|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
14123918|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
14123919|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123920|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14123921|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14123922|NCT04610476|Protective Agents|protective agents|mesh-ancestor
14123923|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14123924|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14123925|NCT04610476|Analgesics|analgesics|mesh-ancestor
14123926|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
14123927|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14123928|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14123929|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14123930|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14123931|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14123932|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176929|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14176930|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
14176931|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176932|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14176933|NCT04761185|Raltitrexed|raltitrexed|mesh-list
13942847|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
13942848|NCT03276598|Losartan|losartan|mesh-list
13942849|NCT03276598|Amlodipine|amlodipine|mesh-list
13942850|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13942851|NCT03276598|Bisoprolol|bisoprolol|mesh-list
13942852|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13942853|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13942854|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14176934|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14176935|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
14176936|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176937|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176938|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14176939|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176940|NCT04761393|Xenon|xenon|mesh-list
14176941|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13942855|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176942|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
13963492|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
14123933|NCT04565574|Rifampin|rifampin|mesh-list
14123934|NCT04565574|Rabeprazole|rabeprazole|mesh-list
14123935|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14123936|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14123937|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14123938|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123939|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123940|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14123941|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
14123942|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14123943|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123944|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
14123945|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14123946|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14123947|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14123948|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14123949|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14123950|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14123951|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14936543|NCT01469884|Cyclosporins|cyclosporins|mesh-list
14936544|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14936545|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
14936546|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936547|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14936548|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936549|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936550|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
13942856|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13942857|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942858|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
13942859|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13942860|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13942861|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13942862|NCT03276598|Diuretics|diuretics|mesh-ancestor
13942863|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
13942864|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13942865|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
13942866|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
13942867|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942868|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13942869|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13942870|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13942871|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
13942872|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13942873|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13942874|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14936551|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936552|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14936553|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14936554|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936555|NCT01469975|Edetic Acid|edetic acid|mesh-list
14936556|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
14936557|NCT01469975|Antidotes|antidotes|mesh-ancestor
14936558|NCT01469975|Protective Agents|protective agents|mesh-ancestor
14936559|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936560|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
14936561|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
14936562|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936563|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14936564|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
14936565|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14936566|NCT01469988|Testosterone|testosterone|mesh-list
14936567|NCT01469988|Androgens|androgens|mesh-ancestor
14936568|NCT01469988|Hormones|hormones|mesh-ancestor
14936569|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936570|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942875|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123952|NCT04560634|Norepinephrine|norepinephrine|mesh-list
14123953|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14123954|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14123955|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14123956|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936571|NCT01470040|Aspirin|aspirin|mesh-list
14936572|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14123957|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123958|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123959|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
14123960|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
14123961|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123962|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14123963|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
14123964|NCT04483544|Olaparib|olaparib|mesh-list
14123965|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123966|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123967|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13942876|NCT03276520|Ethanol|ethanol|mesh-list
13942877|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13942878|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942879|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942880|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942881|NCT03276325|Dexamethasone|dexamethasone|mesh-list
13942882|NCT03276325|Nalbuphine|nalbuphine|mesh-list
13942883|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942884|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
13942885|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
13942886|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14123968|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14123969|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123970|NCT04474353|Temozolomide|temozolomide|mesh-list
14123971|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14123972|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
14123973|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14123974|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123975|NCT04433845|Psilocybin|psilocybin|mesh-list
14123976|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
14123977|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14123978|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14123979|NCT04364776|Durvalumab|durvalumab|mesh-list
14123980|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123981|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123982|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
14123983|NCT04357587|Capecitabine|capecitabine|mesh-list
14123984|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14123985|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14123986|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14123987|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
14123988|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176943|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
14176944|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176945|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176946|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
14176947|NCT04761133|Povidone|povidone|mesh-list
14176948|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
14176949|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
14176950|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14176951|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14176952|NCT04761198|Nivolumab|nivolumab|mesh-list
14176953|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14176954|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176955|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14176956|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176957|NCT04761029|Tramadol|tramadol|mesh-list
14176958|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14176959|NCT04761029|Narcotics|narcotics|mesh-ancestor
14176960|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14176961|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176962|NCT04761029|Analgesics|analgesics|mesh-ancestor
14176963|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
14176964|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14176965|NCT04760821|Trimetazidine|trimetazidine|mesh-list
14176966|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
14176967|NCT04760860|Prazosin|prazosin|mesh-list
14176968|NCT04760860|Terazosin|terazosin|mesh-list
14176969|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14176970|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14176971|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13942887|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942888|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14176972|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
14123989|NCT04351295|Chloroquine|chloroquine|mesh-list
14123990|NCT04351295|Favipiravir|favipiravir|mesh-list
13942889|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
13942890|NCT03276325|Hormones|hormones|mesh-ancestor
13942891|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942892|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13942893|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942894|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13942895|NCT03276325|Narcotics|narcotics|mesh-ancestor
13942896|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942897|NCT03276325|Analgesics|analgesics|mesh-ancestor
13942898|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
14123991|NCT04351295|Amebicides|amebicides|mesh-ancestor
14123992|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14123993|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14123994|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14123995|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
14123996|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14123997|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
14123998|NCT04337177|Temozolomide|temozolomide|mesh-list
14123999|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124000|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
14124001|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124002|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124003|NCT04316143|Zamicastat|zamicastat|mesh-list
13942899|NCT03276156|Apatinib|apatinib|mesh-list
13942900|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942901|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13942902|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942903|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942904|NCT03276143|Enoxaparin|enoxaparin|mesh-list
13942905|NCT03276143|Apixaban|apixaban|mesh-list
13942906|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
13942907|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13942908|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13942909|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942910|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13942911|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
13942912|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13942913|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
13942914|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942915|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
13942916|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942917|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962022|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962023|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962024|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13962025|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13962026|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962027|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13962028|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13962029|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962030|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
13962031|NCT05253768|Glycerol|glycerol|mesh-list
13962032|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13962033|NCT05253768|Protective Agents|protective agents|mesh-ancestor
13962034|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962035|NCT05253573|Nicotine|nicotine|mesh-list
13962036|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13962037|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
13962038|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962039|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124004|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124005|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124006|NCT04308330|Vorinostat|vorinostat|mesh-list
14124007|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124008|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14124009|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124010|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124011|NCT04288089|Palbociclib|palbociclib|mesh-list
13962040|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13962041|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13962042|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
13962043|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124012|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962044|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942918|NCT03275818|Paclitaxel|paclitaxel|mesh-list
13942919|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13942920|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942921|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
13942922|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
13942923|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
13942924|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942925|NCT03275701|Triumeq|triumeq|mesh-list
13942926|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13942927|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13942928|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
14124013|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14124014|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124015|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124016|NCT04271293|Edoxaban|edoxaban|mesh-list
14124017|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14124018|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
14124019|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14124020|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
14124021|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124022|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124023|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
14124024|NCT04260477|Rifampin|rifampin|mesh-list
14124025|NCT04260477|Isoniazid|isoniazid|mesh-list
14124026|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
14124027|NCT04260477|Ethambutol|ethambutol|mesh-list
14124028|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14124029|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
14124030|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124031|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124032|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
14124033|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14124034|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124035|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124036|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14124037|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14124038|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14124039|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14124040|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14124041|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14124042|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14124043|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13942929|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942930|NCT03275597|Durvalumab|durvalumab|mesh-list
13942931|NCT03275597|Tremelimumab|tremelimumab|mesh-list
13942932|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942933|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942934|NCT03275558|Sunitinib|sunitinib|mesh-list
13942935|NCT03275558|Axitinib|axitinib|mesh-list
13942936|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942937|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13942938|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13942939|NCT03275558|Growth Substances|growth substances|mesh-ancestor
13942940|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942941|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
13942942|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13942943|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13942944|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942945|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13942946|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13942947|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13942948|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
13942949|NCT03275506|Bevacizumab|bevacizumab|mesh-list
13942950|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
13942951|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13942952|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942953|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13942954|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13942955|NCT03275506|Growth Substances|growth substances|mesh-ancestor
13942956|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942957|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
13942958|NCT03275415|Budesonide|budesonide|mesh-list
13942959|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124044|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
13942960|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13942961|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
13942962|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942963|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942964|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13942965|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
13942966|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
13942967|NCT03275415|Hormones|hormones|mesh-ancestor
14124045|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14124046|NCT04246762|Vitamin K|vitamin k|mesh-list
14124047|NCT04246762|Midazolam|midazolam|mesh-list
14124048|NCT04246762|Caffeine|caffeine|mesh-list
14124049|NCT04246762|Omeprazole|omeprazole|mesh-list
14124050|NCT04246762|Warfarin|warfarin|mesh-list
14124051|NCT04246762|Vitamins|vitamins|mesh-ancestor
14124052|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
14124053|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124054|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14124055|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14124056|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124057|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14124058|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14124059|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14124060|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14124061|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
14124062|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
14124063|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
14124064|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
14124065|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124066|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124067|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
14124068|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14124069|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14124070|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14124071|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124072|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14124073|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14124074|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14124075|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14124076|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
14124077|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14124078|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14936573|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936574|NCT01470040|Analgesics|analgesics|mesh-ancestor
14936575|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
14936576|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936577|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942968|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942969|NCT03275376|Atorvastatin|atorvastatin|mesh-list
13942970|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14124079|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
14124080|NCT04246762|Coagulants|coagulants|mesh-ancestor
14124081|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14124082|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124083|NCT04141020|Sirolimus|sirolimus|mesh-list
14124084|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124085|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124086|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14124087|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124088|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
14124089|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124090|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
14124091|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124092|NCT04140721|Moxonidine|moxonidine|mesh-list
14124093|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14124094|NCT04138875|Rituximab|rituximab|mesh-list
14124095|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14124096|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14124097|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124098|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942971|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13942972|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
13942973|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13942974|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14124099|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
14124100|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124101|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124102|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124103|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
14124104|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124105|NCT04117763|Empagliflozin|empagliflozin|mesh-list
14124106|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14124107|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124108|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14124109|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124110|NCT04059562|Irinotecan|irinotecan|mesh-list
13942975|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13942976|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762918|NCT01998971|Daratumumab|daratumumab|mesh-list
14762919|NCT01998971|Pomalidomide|pomalidomide|mesh-list
14762920|NCT01998971|Montelukast|montelukast|mesh-list
14762921|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762922|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
14762923|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
13942983|NCT03275285|Dexamethasone|dexamethasone|mesh-list
13942984|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13942985|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
13942986|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
14124111|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13942987|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13942988|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942989|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14124112|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14124113|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14176973|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478301|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478302|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
14478303|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478304|NCT02450487|Piroxicam|piroxicam|mesh-list
14478305|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13942990|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
13942991|NCT03275285|Hormones|hormones|mesh-ancestor
13942992|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13942993|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13942994|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13942995|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
13942996|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13942997|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13942998|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13942999|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13943000|NCT03275207|Analgesics|analgesics|mesh-ancestor
13943001|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
13943002|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943003|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13943004|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13943005|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13943006|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
13943007|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943008|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943009|NCT03275116|Bromides|bromides|mesh-list
13943010|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
13943011|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
13943012|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13943013|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
13943014|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943015|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943016|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13943017|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
13943018|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14478306|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14478307|NCT02450487|Analgesics|analgesics|mesh-ancestor
14478308|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
14478309|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478310|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478311|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14478312|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762924|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943019|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13943020|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13943021|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
13943022|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943023|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943024|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
13943025|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14478313|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14478314|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478315|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124114|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124115|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124116|NCT04046107|Cemiplimab|cemiplimab|mesh-list
14124117|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124118|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124119|NCT04019834|Bupivacaine|bupivacaine|mesh-list
14124120|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
14124121|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
14124122|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943026|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
13943027|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
13943028|NCT03275090|SMOFlipid|smoflipid|mesh-list
13943029|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13943030|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13943031|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13943032|NCT03275012|Morphine|morphine|mesh-list
13943033|NCT03275012|Gabapentin|gabapentin|mesh-list
13943034|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13943035|NCT03275012|Narcotics|narcotics|mesh-ancestor
13943036|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124123|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124124|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
14124125|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124126|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
14124127|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
14124128|NCT03959241|Methotrexate|methotrexate|mesh-list
14124129|NCT03959241|Tacrolimus|tacrolimus|mesh-list
14124130|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124131|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
14124132|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124133|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124134|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124135|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
14124136|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124137|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124138|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14124139|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14124140|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
14124141|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14124142|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124143|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
14124144|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
14124145|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943037|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943038|NCT03275012|Analgesics|analgesics|mesh-ancestor
13943039|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
13943040|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943041|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
14124146|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14124147|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14124148|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14124149|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14124150|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14124151|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
14124152|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124153|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124154|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
14124155|NCT03882177|Pyridoxal|pyridoxal|mesh-list
14124156|NCT03882177|Pyridoxine|pyridoxine|mesh-list
14124157|NCT03882177|Pravastatin|pravastatin|mesh-list
14124158|NCT03882177|Vitamins|vitamins|mesh-ancestor
14478316|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
14478317|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13943042|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13943043|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14124159|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
14124160|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124161|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
14124162|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14124163|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14124164|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
14124165|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124166|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14124167|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14762925|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762926|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14762927|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
14762928|NCT01998971|Hormones|hormones|mesh-ancestor
14762929|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762930|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762931|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762932|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
14762933|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14762934|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14762935|NCT01998971|Growth Substances|growth substances|mesh-ancestor
14762936|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
14762937|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14762938|NCT01998971|Analgesics|analgesics|mesh-ancestor
14762939|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
14124168|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124169|NCT03863184|Rituximab|rituximab|mesh-list
14124170|NCT03863184|Lenalidomide|lenalidomide|mesh-list
14762940|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
14762941|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762942|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
14762943|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762944|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762945|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14762946|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
14124171|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
14124172|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124173|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124174|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
14124175|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124176|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124177|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14124178|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14124179|NCT03863184|Growth Substances|growth substances|mesh-ancestor
14124180|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
14124181|NCT03838744|Olaparib|olaparib|mesh-list
14124182|NCT03838744|Trabectedin|trabectedin|mesh-list
14124183|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14124184|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124185|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124186|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124187|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124188|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
14124189|NCT03736629|Azithromycin|azithromycin|mesh-list
14124190|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124191|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124192|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
14124193|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14124194|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
14124195|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14124196|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124197|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14124198|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14124199|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14124200|NCT03600701|Atezolizumab|atezolizumab|mesh-list
14124201|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14124202|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943044|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13943045|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13943046|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13943047|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943048|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943049|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
13943050|NCT03274895|Biguanides|biguanides|mesh-list
13943051|NCT03274895|Polihexanide|polihexanide|mesh-list
13943052|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
13943053|NCT03274895|Propamidine|propamidine|mesh-list
14124203|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
13943054|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13943055|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943056|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
13943057|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943058|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13943059|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13943060|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13943061|NCT03274817|Citalopram|citalopram|mesh-list
14124204|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124205|NCT03524898|Gemcitabine|gemcitabine|mesh-list
14124206|NCT03524898|Paclitaxel|paclitaxel|mesh-list
14124207|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14124208|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124209|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124210|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14124211|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14124212|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124213|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124214|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
14124215|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
14124216|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124217|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124218|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124219|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
14124220|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124221|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14124222|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
13943062|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13943063|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13943064|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13943065|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13943066|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943067|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943068|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
13943069|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124223|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
14124224|NCT03522753|Hormones|hormones|mesh-ancestor
14124225|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124226|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124227|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124228|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124229|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
14124230|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124231|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124232|NCT03435939|Losartan|losartan|mesh-list
14124233|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14124234|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14124235|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14124236|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14124237|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124238|NCT03430791|Nivolumab|nivolumab|mesh-list
14124239|NCT03430791|Ipilimumab|ipilimumab|mesh-list
14124240|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124241|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124242|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14124243|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124244|NCT03383224|Nicotine|nicotine|mesh-list
14124245|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14124246|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
14762947|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13943070|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13943071|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
13943072|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13943073|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13943074|NCT03274765|Estradiol|estradiol|mesh-list
13943075|NCT03274765|Estrogens|estrogens|mesh-ancestor
13943076|NCT03274765|Hormones|hormones|mesh-ancestor
13943077|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943078|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943079|NCT03274752|Paroxetine|paroxetine|mesh-list
13943080|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13943081|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14762948|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124247|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124248|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124249|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14124250|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14124251|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
14124252|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124253|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124254|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
14124255|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124256|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
14124257|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14124258|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14124259|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124260|NCT03229512|Urological Agents|urological agents|mesh-ancestor
14124261|NCT03180502|Temozolomide|temozolomide|mesh-list
14124262|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124263|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
14124264|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124265|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124266|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14124267|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14124268|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
14176974|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14176975|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176976|NCT04760860|Urological Agents|urological agents|mesh-ancestor
14176977|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14176978|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
14176979|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14176980|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
14176981|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176982|NCT04760704|Antibodies|antibodies|mesh-list
14176983|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
14176984|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183735|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14183736|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943082|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13943083|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943084|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943085|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
13943086|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943087|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13943088|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
13943089|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13943090|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13943091|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13943092|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943093|NCT03274700|Tamsulosin|tamsulosin|mesh-list
13943094|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13943095|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13943096|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13943097|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
13943098|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943099|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943100|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943101|NCT03274700|Urological Agents|urological agents|mesh-ancestor
13943102|NCT03274596|Vitamin E|vitamin e|mesh-list
13943103|NCT03274596|Vitamins|vitamins|mesh-ancestor
13943104|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
13943105|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943106|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
13943107|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943108|NCT03274596|Protective Agents|protective agents|mesh-ancestor
14183737|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183738|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183739|NCT04726085|Ibuprofen|ibuprofen|mesh-list
14183740|NCT04726085|Indomethacin|indomethacin|mesh-list
14183741|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14183742|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183743|NCT04726085|Analgesics|analgesics|mesh-ancestor
14183744|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
14183745|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943109|NCT03274427|Trimetazidine|trimetazidine|mesh-list
13943110|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
14124269|NCT03033914|Doxorubicin|doxorubicin|mesh-list
14124270|NCT03033914|Bleomycin|bleomycin|mesh-list
14124271|NCT03033914|Nivolumab|nivolumab|mesh-list
14124272|NCT03033914|Dacarbazine|dacarbazine|mesh-list
14124273|NCT03033914|Vinblastine|vinblastine|mesh-list
14124274|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14124275|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124276|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14124277|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14124278|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124279|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124280|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124281|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14124282|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124283|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
14124284|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14124285|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124286|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14124287|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14124288|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
14124289|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
14124290|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14124291|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14124292|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124293|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943111|NCT03274414|Cisplatin|cisplatin|mesh-list
13943112|NCT03274414|Etoposide|etoposide|mesh-list
13943113|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943114|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13943115|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13943116|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13943117|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943118|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943119|NCT03274401|Anticoagulants|anticoagulants|mesh-list
13943120|NCT03274323|Travoprost|travoprost|mesh-list
13943121|NCT03274323|Latanoprost|latanoprost|mesh-list
13943122|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13943123|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13943124|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13943125|NCT03274258|Nivolumab|nivolumab|mesh-list
13943126|NCT03274258|Ipilimumab|ipilimumab|mesh-list
13943127|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13943128|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943129|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13943130|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124294|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124295|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124296|NCT03023124|Doxorubicin|doxorubicin|mesh-list
14124297|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13962045|NCT05230810|Fulvestrant|fulvestrant|mesh-list
13962046|NCT05230810|Tucatinib|tucatinib|mesh-list
13962047|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962048|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962049|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13962050|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13962051|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
13962052|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962053|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962054|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13962055|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962056|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962057|NCT05227937|Amikacin|amikacin|mesh-list
13962058|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962059|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962060|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
13962061|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962062|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
13962063|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
13962064|NCT05178823|Fluorides|fluorides|mesh-list
14124298|NCT03023124|Dacarbazine|dacarbazine|mesh-list
14124299|NCT03023124|Trabectedin|trabectedin|mesh-list
14124300|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14124301|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962065|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
13962066|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
14124302|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13943131|NCT03274167|Gabapentin|gabapentin|mesh-list
13943132|NCT03274167|Analgesics|analgesics|mesh-ancestor
13943133|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
13943134|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943135|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124303|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14124304|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124305|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124306|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124307|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
14124308|NCT02957968|Paclitaxel|paclitaxel|mesh-list
14124309|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
14124310|NCT02957968|Carboplatin|carboplatin|mesh-list
14124311|NCT02957968|Doxorubicin|doxorubicin|mesh-list
14124312|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
14124313|NCT02957968|Decitabine|decitabine|mesh-list
14124314|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13943136|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
13943137|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13943138|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13943139|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943140|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13943141|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13943142|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13943143|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943144|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124315|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124316|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124317|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
14124318|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
14124319|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943145|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
13943146|NCT03274102|Vaccines|vaccines|mesh-list
13943147|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
13943148|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124320|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124321|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
14124322|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124323|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124324|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124325|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
14124326|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14124327|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14124328|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14124329|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14124330|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124331|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124332|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124333|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
14124334|NCT02733614|SRX246|srx246|mesh-list
14124335|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14124336|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124337|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
14124338|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124339|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
14124340|NCT02727387|Temozolomide|temozolomide|mesh-list
14124341|NCT02727387|Melphalan|melphalan|mesh-list
14124342|NCT02727387|Busulfan|busulfan|mesh-list
14124343|NCT02727387|Ifosfamide|ifosfamide|mesh-list
14124344|NCT02727387|Irinotecan|irinotecan|mesh-list
14124345|NCT02727387|Etoposide|etoposide|mesh-list
14124346|NCT02727387|Vincristine|vincristine|mesh-list
14124347|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124348|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
14124349|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124350|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124351|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124352|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
14124353|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124354|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124355|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14124356|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14124357|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14124358|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124359|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14124360|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13943149|NCT03274024|Mitomycins|mitomycins|mesh-list
13943150|NCT03274024|Mitomycin|mitomycin|mesh-list
13943151|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13943152|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943153|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
13943154|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943155|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13943156|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943157|NCT03274011|Apatinib|apatinib|mesh-list
13943158|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943159|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13943160|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943161|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943162|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13943163|NCT03273712|Octreotide|octreotide|mesh-list
13943164|NCT03273712|Edotreotide|edotreotide|mesh-list
13943165|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13943166|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13943167|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943168|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13943169|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943170|NCT03273634|Lansoprazole|lansoprazole|mesh-list
13943171|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
13943172|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13943173|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13943174|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13943175|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943176|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943177|NCT03273595|Paclitaxel|paclitaxel|mesh-list
13943178|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
13943179|NCT03273595|Trastuzumab|trastuzumab|mesh-list
13943180|NCT03273595|Epirubicin|epirubicin|mesh-list
13943181|NCT03273595|Lapatinib|lapatinib|mesh-list
13943182|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13943183|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943184|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124361|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124362|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
14124363|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
14124364|NCT02683018|Dronabinol|dronabinol|mesh-list
14124365|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
14124366|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124367|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14124368|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14762949|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14762950|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
14762951|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13943185|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
13943186|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
13943187|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943188|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943189|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
13943190|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943191|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943192|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943193|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
13943194|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13943195|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13943196|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13943197|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13943198|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13943199|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943200|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13943201|NCT03273556|Lidocaine|lidocaine|mesh-list
13943202|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
13943203|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
13943204|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943205|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943206|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
13943207|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943208|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13943209|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13943210|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14762952|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943211|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14124369|NCT02683018|Analgesics|analgesics|mesh-ancestor
14124370|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
14124371|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124372|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14124373|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14124374|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124375|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124376|NCT02683018|Hormones|hormones|mesh-ancestor
14124377|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124378|NCT02675842|Dronabinol|dronabinol|mesh-list
14478318|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14478319|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14478320|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14124379|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
14124380|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124381|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14124382|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124383|NCT02675842|Analgesics|analgesics|mesh-ancestor
14124384|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
14124385|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124386|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14124387|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14124388|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124389|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124390|NCT02675842|Hormones|hormones|mesh-ancestor
14124391|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124392|NCT02615119|Isoproterenol|isoproterenol|mesh-list
13943212|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943213|NCT03273296|Amoxicillin|amoxicillin|mesh-list
13943214|NCT03273296|Azithromycin|azithromycin|mesh-list
13943215|NCT03273296|Vancomycin|vancomycin|mesh-list
13943216|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13943217|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943218|NCT03273231|Ketamine|ketamine|mesh-list
13943219|NCT03273231|Analgesics|analgesics|mesh-ancestor
13943220|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
13943221|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943222|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943223|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13943224|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13943225|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
13943226|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
14124393|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14124394|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14124395|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
14124396|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124397|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124398|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943227|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943228|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13943229|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13943230|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943231|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943232|NCT03273192|Adalimumab|adalimumab|mesh-list
13943233|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943234|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943235|NCT03273088|Etanercept|etanercept|mesh-list
13943236|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13943237|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13943238|NCT03273088|Analgesics|analgesics|mesh-ancestor
14124399|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14124400|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
14124401|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124402|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14124403|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
14124404|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14124405|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
14124406|NCT02615119|Protective Agents|protective agents|mesh-ancestor
14124407|NCT02605486|Palbociclib|palbociclib|mesh-list
14124408|NCT02605486|Bicalutamide|bicalutamide|mesh-list
14124409|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943239|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
13943240|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943241|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124410|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14124411|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124412|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124413|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
14124414|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
14124415|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124416|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124417|NCT02598349|Capecitabine|capecitabine|mesh-list
14124418|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124419|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
14124420|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124421|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124422|NCT02574728|Sirolimus|sirolimus|mesh-list
14124423|NCT02574728|Celecoxib|celecoxib|mesh-list
14124424|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
14124425|NCT02574728|Etoposide|etoposide|mesh-list
14124426|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124427|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
14124428|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124429|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124430|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124431|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
14124432|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124433|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124434|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14124435|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14124436|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14124437|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14124438|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124439|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124440|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124441|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14124442|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
14124443|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14762953|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14762954|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14762955|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14762956|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14762957|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14762958|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
14762959|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
14762960|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14762961|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
14762962|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
14762963|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14762964|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14762965|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
14762966|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
14762967|NCT01974440|Prednisone|prednisone|mesh-list
14762968|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
14762969|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14124444|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124445|NCT02574728|Analgesics|analgesics|mesh-ancestor
14124446|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
14124447|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124448|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124449|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14124450|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14124451|NCT02555293|Rifaximin|rifaximin|mesh-list
14124452|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124453|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943242|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943243|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943244|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13943245|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943246|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
13943247|NCT03273075|Ticagrelor|ticagrelor|mesh-list
13943248|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13943249|NCT03273075|Cangrelor|cangrelor|mesh-list
13943250|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13943251|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13943252|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13943253|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13943254|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
14762970|NCT01974440|Rituximab|rituximab|mesh-list
14124454|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14124455|NCT02494921|Prednisone|prednisone|mesh-list
14124456|NCT02494921|Docetaxel|docetaxel|mesh-list
14124457|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124458|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124459|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
14124460|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
14124461|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124462|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124463|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
14124464|NCT02494921|Hormones|hormones|mesh-ancestor
14124465|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124466|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124467|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14124468|NCT05104255|Anesthetics|anesthetics|mesh-list
14124469|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124470|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124471|NCT05104229|Aspirin|aspirin|mesh-list
14124472|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14124473|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124474|NCT05104229|Analgesics|analgesics|mesh-ancestor
14124475|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
14124476|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124477|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124478|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124479|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124480|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14124481|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14124482|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124483|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14124484|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14124485|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124486|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
14124487|NCT05104138|Eplerenone|eplerenone|mesh-list
13943255|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943256|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943257|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943258|NCT03273062|Tolcapone|tolcapone|mesh-list
13943259|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13943260|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13943261|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13943262|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943263|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943264|NCT03273036|Triamcinolone|triamcinolone|mesh-list
13943265|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943266|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
13943267|NCT03273036|Hormones|hormones|mesh-ancestor
13943268|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943269|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943270|NCT03272867|Mannitol|mannitol|mesh-list
13943271|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13943272|NCT03272867|Diuretics|diuretics|mesh-ancestor
13943273|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
13943274|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943275|NCT03272802|Riluzole|riluzole|mesh-list
13943276|NCT03272802|Edaravone|edaravone|mesh-list
13943277|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
13943278|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13943279|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13943280|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943281|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124488|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14124489|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
14124490|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124491|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943282|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943283|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13943284|NCT03272802|Protective Agents|protective agents|mesh-ancestor
13943285|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13943286|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
13943287|NCT03272711|Vortioxetine|vortioxetine|mesh-list
13943288|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
14176985|NCT04760574|Testosterone|testosterone|mesh-list
14762971|NCT01974440|Doxorubicin|doxorubicin|mesh-list
13943289|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13943290|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13943291|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13943292|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943293|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943294|NCT03272711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13943295|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13943296|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13943297|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943298|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943299|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
13943300|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13943301|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13943302|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13943303|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13943304|NCT05075460|Azacitidine|azacitidine|mesh-list
13943305|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13943306|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
14124492|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14124493|NCT05104138|Diuretics|diuretics|mesh-ancestor
14124494|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
14124495|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14124496|NCT05103813|Beraprost|beraprost|mesh-list
13943307|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943308|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943309|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943310|NCT05075512|Fulvestrant|fulvestrant|mesh-list
13943311|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13943312|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124497|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14124498|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
14124499|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
14124500|NCT05103501|Fluorouracil|fluorouracil|mesh-list
14124501|NCT05103501|Cisplatin|cisplatin|mesh-list
14124502|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14124503|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124504|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124505|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
14124506|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124507|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124508|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124509|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
14124510|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124511|NCT05103410|Aripiprazole|aripiprazole|mesh-list
14124512|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
14124513|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14124514|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14124515|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14124516|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124517|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124518|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
14124519|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
14124520|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124521|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124522|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14124523|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14124524|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
14124525|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14124526|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14124527|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14124528|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14124529|NCT05103397|Prednisolone|prednisolone|mesh-list
14124530|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14124531|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
14124532|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14124533|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
14124534|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14124535|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
14124536|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124537|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
14124538|NCT05103397|Hormones|hormones|mesh-ancestor
14124539|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124540|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124541|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14124542|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124543|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
14124544|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
14124545|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124546|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14124547|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14124548|NCT05103397|Protective Agents|protective agents|mesh-ancestor
14124549|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14124550|NCT05103254|Ezetimibe|ezetimibe|mesh-list
14124551|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14124552|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14124553|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
14124554|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124555|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14124556|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124557|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14124558|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124559|NCT05103228|Menotropins|menotropins|mesh-list
14124560|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14124561|NCT05103228|Hormones|hormones|mesh-ancestor
14124562|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124563|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124564|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14124565|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
14124566|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14124567|NCT05103098|Misoprostol|misoprostol|mesh-list
14124568|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14124569|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
14124570|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14124571|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124572|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14124573|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14124574|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
14124575|NCT05103020|Bevacizumab|bevacizumab|mesh-list
14124576|NCT05103020|Cetuximab|cetuximab|mesh-list
14124577|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
14124578|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124579|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124580|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14124581|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14124582|NCT05103020|Growth Substances|growth substances|mesh-ancestor
14124583|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124584|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
14124585|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
14124586|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14124587|NCT05103007|Estrogens|estrogens|mesh-ancestor
14124588|NCT05103007|Hormones|hormones|mesh-ancestor
14124589|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124590|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124591|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14124592|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124593|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
14124594|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14124595|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14124596|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124597|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
14124598|NCT05092555|Coagulants|coagulants|mesh-ancestor
14124599|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
14124600|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14124601|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14124602|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124603|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
14124604|NCT05087199|Coagulants|coagulants|mesh-ancestor
14176986|NCT04760574|Androgens|androgens|mesh-ancestor
13943313|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13943314|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13943315|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943316|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943317|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943318|NCT05075265|Methadone|methadone|mesh-list
13943319|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13943320|NCT05075265|Narcotics|narcotics|mesh-ancestor
14176987|NCT04760574|Hormones|hormones|mesh-ancestor
14176988|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124605|NCT05060666|Ivermectin|ivermectin|mesh-list
14124606|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14124607|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124608|NCT05048134|Trametinib|trametinib|mesh-list
14124609|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124610|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14124611|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124612|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124613|NCT05021900|Tenalisib|tenalisib|mesh-list
14124614|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
14124615|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124616|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124617|NCT05019846|Bicalutamide|bicalutamide|mesh-list
14124618|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14124619|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
14124620|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943321|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943322|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943323|NCT05075265|Analgesics|analgesics|mesh-ancestor
13943324|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
13943325|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943326|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
14124621|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124622|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124623|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124624|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
14124625|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14124626|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
14124627|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14124628|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14124629|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14124630|NCT04985851|Durvalumab|durvalumab|mesh-list
14124631|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14124632|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124633|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124634|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
13943327|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
13962067|NCT05178823|Protective Agents|protective agents|mesh-ancestor
13962068|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962069|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13962070|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962071|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
13962072|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
13962073|NCT05166304|Rebamipide|rebamipide|mesh-list
13962074|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13962075|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13962076|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
13962077|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962078|NCT05166304|Protective Agents|protective agents|mesh-ancestor
13962079|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962080|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962081|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
13962082|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13962083|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962084|NCT05149638|Cosyntropin|cosyntropin|mesh-list
13962085|NCT05149638|Hormones|hormones|mesh-ancestor
13962086|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962087|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962088|NCT05143970|Trastuzumab|trastuzumab|mesh-list
13962089|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962090|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962091|NCT05096442|Paclitaxel|paclitaxel|mesh-list
13962092|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13962093|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13962094|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962095|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
13962096|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
13962097|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
13962098|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962099|NCT05093322|Gemcitabine|gemcitabine|mesh-list
13962100|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13962101|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
13962102|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762972|NCT01974440|Vincristine|vincristine|mesh-list
13943328|NCT05075499|Vaccines|vaccines|mesh-list
14124635|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124636|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
14124637|NCT04976374|Gabapentin|gabapentin|mesh-list
14124638|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14124639|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124640|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124641|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124642|NCT04976374|Analgesics|analgesics|mesh-ancestor
14124643|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
14124644|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124645|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14124646|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14124647|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14124648|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
14124649|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124650|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124651|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
14124652|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14124653|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14124654|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14124655|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14124656|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14124657|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
14124658|NCT04949412|Vitamin D|vitamin d|mesh-list
14124659|NCT04949412|Vitamins|vitamins|mesh-ancestor
14124660|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
14124661|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124662|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14124663|NCT04947020|Metformin|metformin|mesh-list
14124664|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14124665|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124666|NCT04904614|Letermovir|letermovir|mesh-list
14124667|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14124668|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124669|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124670|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124671|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
14124672|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124673|NCT04874935|Lansoprazole|lansoprazole|mesh-list
14124674|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
14124675|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14124676|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14124677|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14124678|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124679|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124680|NCT04834063|Selenium|selenium|mesh-list
14124681|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
14124682|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124683|NCT04834063|Protective Agents|protective agents|mesh-ancestor
14124684|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124685|NCT04834063|Trace Elements|trace elements|mesh-ancestor
14124686|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
14124687|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14124688|NCT04794205|Caryophyllene|caryophyllene|mesh-list
14124689|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14124690|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124691|NCT04794205|Analgesics|analgesics|mesh-ancestor
14124692|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
14124693|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124694|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124695|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14762973|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943329|NCT05075499|Immunologic Factors|immunologic factors|mesh-ancestor
13943330|NCT05075499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943331|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
13943332|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
13943333|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943334|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
13943335|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943336|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943337|NCT05074966|Cetuximab|cetuximab|mesh-list
13943338|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124696|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124697|NCT04725032|Propofol|propofol|mesh-list
13943339|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943340|NCT05074992|Ipilimumab|ipilimumab|mesh-list
13943341|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13943342|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943343|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13943344|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943345|NCT05074706|Antibodies|antibodies|mesh-list
13943346|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
13943347|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
14124698|NCT04725032|Sevoflurane|sevoflurane|mesh-list
14124699|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14124700|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124701|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124702|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14124703|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
14124704|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
14124705|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13943348|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943349|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
13943350|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13943351|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943352|NCT05074628|Renal Agents|renal agents|mesh-ancestor
13943353|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13943354|NCT05074602|Fluconazole|fluconazole|mesh-list
13943355|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
13943356|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124706|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14124707|NCT04716114|Cytarabine|cytarabine|mesh-list
14124708|NCT04716114|Fludarabine|fludarabine|mesh-list
14124709|NCT04716114|Azacitidine|azacitidine|mesh-list
14124710|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
14124711|NCT04716114|Aclarubicin|aclarubicin|mesh-list
14124712|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124713|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124714|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
14124715|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124716|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124717|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
14124718|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124719|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
14124720|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124721|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124722|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14124723|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14124724|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14124725|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14124726|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14124727|NCT04667780|Colchicine|colchicine|mesh-list
13943357|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13943358|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13943359|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943360|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943361|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13943362|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943363|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943364|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124728|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
14124729|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124730|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124731|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
14124732|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
14124733|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124734|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124735|NCT04655222|Interferons|interferons|mesh-list
14124736|NCT04655222|Interferon-beta|interferon-beta|mesh-list
14124737|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124738|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
13943365|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13943366|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13943367|NCT05074589|Leucovorin|leucovorin|mesh-list
13943368|NCT05074589|Fluorouracil|fluorouracil|mesh-list
13943369|NCT05074589|Irinotecan|irinotecan|mesh-list
13943370|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
13943371|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
13943372|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943373|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13943374|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943375|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943376|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
13943377|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943378|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13943379|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13943380|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943381|NCT05074589|Antidotes|antidotes|mesh-ancestor
13943382|NCT05074589|Protective Agents|protective agents|mesh-ancestor
13943383|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
14124739|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124740|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
14124741|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124742|NCT04620746|Penicillins|penicillins|mesh-list
14124743|NCT04620746|Penicillin G|penicillin g|mesh-list
14124744|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124745|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124746|NCT04552327|Diclofenac|diclofenac|mesh-list
14124747|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14124748|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124749|NCT04552327|Analgesics|analgesics|mesh-ancestor
14124750|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
14124751|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124752|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124753|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124754|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124755|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14124756|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124757|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124758|NCT04519905|Paclitaxel|paclitaxel|mesh-list
14124759|NCT04519905|Carboplatin|carboplatin|mesh-list
14124760|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14124761|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124762|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124763|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
14124764|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
14124765|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124766|NCT04482686|Vitamin D|vitamin d|mesh-list
14124767|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
14124768|NCT04482686|Vitamins|vitamins|mesh-list
14124769|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
14124770|NCT04482686|Zinc|zinc|mesh-list
14124771|NCT04482686|Doxycycline|doxycycline|mesh-list
14124772|NCT04482686|Ivermectin|ivermectin|mesh-list
14124773|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
14124774|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
14124775|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124776|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14124777|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14124778|NCT04482686|Trace Elements|trace elements|mesh-ancestor
14124779|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
14124780|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124781|NCT04482686|Protective Agents|protective agents|mesh-ancestor
14124782|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124783|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124784|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
14124785|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14124786|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14124787|NCT04482686|Astringents|astringents|mesh-ancestor
14124788|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
14124789|NCT04450407|Insulin|insulin|mesh-list
14124790|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14762974|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
13943384|NCT05074589|Vitamins|vitamins|mesh-ancestor
13943385|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
13943386|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14124791|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124792|NCT04423341|Cannabidiol|cannabidiol|mesh-list
14124793|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
13943387|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943388|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
13943389|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943390|NCT05073965|Vitamin D|vitamin d|mesh-list
13943391|NCT05073965|Vitamins|vitamins|mesh-ancestor
13943392|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
13943393|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943394|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13943395|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
13943396|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14124794|NCT04323462|Insulin|insulin|mesh-list
14124795|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14124796|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
14124797|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14124798|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124799|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
14124800|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
14124801|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124802|NCT04279535|Protective Agents|protective agents|mesh-ancestor
14124803|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124804|NCT04279535|Vitamins|vitamins|mesh-ancestor
14124805|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
14176989|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14176990|NCT04760327|Cisplatin|cisplatin|mesh-list
14176991|NCT04760327|Bleomycin|bleomycin|mesh-list
14176992|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14176993|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14176994|NCT04760431|Paclitaxel|paclitaxel|mesh-list
14176995|NCT04760431|Docetaxel|docetaxel|mesh-list
14176996|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14176997|NCT04760431|Trastuzumab|trastuzumab|mesh-list
14176998|NCT04760431|Pertuzumab|pertuzumab|mesh-list
14176999|NCT04760431|Taxane|taxane|mesh-list
14177000|NCT04760431|Tucatinib|tucatinib|mesh-list
14177001|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14177002|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177003|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
14177004|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
14177005|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
14177006|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177007|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478321|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943397|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943398|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943399|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13943400|NCT05065775|Analgesics|analgesics|mesh-ancestor
13943401|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
13943402|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943403|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13943404|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13943405|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13943406|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
13943407|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943408|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943409|NCT05068063|Bupivacaine|bupivacaine|mesh-list
13943410|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
13943411|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
14177008|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14177009|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177010|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
14177011|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14177012|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14177013|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177014|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
14177015|NCT04760301|Coagulants|coagulants|mesh-ancestor
14177016|NCT04759703|Pramipexole|pramipexole|mesh-list
14177017|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
14478322|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
13943412|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177018|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943413|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943414|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
14177019|NCT04759703|Protective Agents|protective agents|mesh-ancestor
14177020|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124806|NCT04166669|Itraconazole|itraconazole|mesh-list
14124807|NCT04166669|Rifampin|rifampin|mesh-list
14124808|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
13943415|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124809|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124810|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14124811|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14124812|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14762975|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762976|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14762977|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14762978|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
13943428|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
14762979|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14762980|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14762981|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14762982|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14762983|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14762984|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14124813|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124814|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14124815|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
14124816|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124817|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124818|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14124819|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14124820|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
14124821|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124822|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
14124823|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14124824|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14124825|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14124826|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14124827|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14124828|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14124829|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14124830|NCT04150770|Infliximab|infliximab|mesh-list
14124831|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
14124832|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13943429|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13943430|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
13943431|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943432|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
13943433|NCT05045586|Protective Agents|protective agents|mesh-ancestor
13943434|NCT04962022|Ritonavir|ritonavir|mesh-list
13943435|NCT04962022|Itraconazole|itraconazole|mesh-list
13943436|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13943437|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14124833|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124834|NCT04125771|Diclofenac|diclofenac|mesh-list
14124835|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14124836|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124837|NCT04125771|Analgesics|analgesics|mesh-ancestor
14124838|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
14124839|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124840|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124841|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124842|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124843|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13943438|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
14124844|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943439|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943440|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943441|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13943442|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13943443|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
13943444|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943445|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13943446|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14124845|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124846|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
14124847|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
14124848|NCT04026438|Protective Agents|protective agents|mesh-ancestor
14124849|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124850|NCT03983993|Panitumumab|panitumumab|mesh-list
14124851|NCT03983993|Niraparib|niraparib|mesh-list
14124852|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124853|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124854|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14124855|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124856|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124857|NCT03897998|Naloxone|naloxone|mesh-list
14124858|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14124859|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124860|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
14124861|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943447|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
13943448|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13943449|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13943450|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943451|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943452|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943453|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
13943454|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943455|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13943456|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943457|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943458|NCT04897841|Bupivacaine|bupivacaine|mesh-list
14124862|NCT03765359|Metformin|metformin|mesh-list
14124863|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14124864|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124865|NCT03759041|Vancomycin|vancomycin|mesh-list
14124866|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124867|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124868|NCT03711604|Tenalisib|tenalisib|mesh-list
14124869|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
14124870|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943459|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
13943460|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
13943461|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124871|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124872|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
14124873|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14124874|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124875|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124876|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124877|NCT03645603|Analgesics|analgesics|mesh-ancestor
14124878|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
14124879|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124880|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14124881|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14124882|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14124883|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
14124884|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14124885|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124886|NCT03615742|Budesonide|budesonide|mesh-list
14124887|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14124888|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14124889|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
14124890|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124891|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124892|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14124893|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
14124894|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
14124895|NCT03615742|Hormones|hormones|mesh-ancestor
14124896|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943462|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943463|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
13943464|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943465|NCT04878315|Captopril|captopril|mesh-list
13943466|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13943467|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
13943468|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943469|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943470|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13943471|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14124897|NCT03587584|Bupivacaine|bupivacaine|mesh-list
14124898|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
14124899|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
14124900|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14124901|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124902|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
14124903|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124904|NCT03581487|Durvalumab|durvalumab|mesh-list
14124905|NCT03581487|Ipilimumab|ipilimumab|mesh-list
13943472|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13943473|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14124906|NCT03581487|Tremelimumab|tremelimumab|mesh-list
14124907|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
14124908|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14124909|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
14124910|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124911|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124912|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
14124913|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124914|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14124915|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124916|NCT03542695|Alendronate|alendronate|mesh-list
14124917|NCT03542695|Copper|copper|mesh-list
14124918|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14124919|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124920|NCT03542695|Trace Elements|trace elements|mesh-ancestor
14124921|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
14124922|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
14124923|NCT03414502|Minocycline|minocycline|mesh-list
14124924|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
14124925|NCT03414502|Adalimumab|adalimumab|mesh-list
14124926|NCT03414502|Etanercept|etanercept|mesh-list
14124927|NCT03414502|Golimumab|golimumab|mesh-list
14124928|NCT03414502|Rituximab|rituximab|mesh-list
14124929|NCT03414502|Methotrexate|methotrexate|mesh-list
14124930|NCT03414502|Abatacept|abatacept|mesh-list
13943474|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
13943475|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943476|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14124931|NCT03414502|Azathioprine|azathioprine|mesh-list
14124932|NCT03414502|Infliximab|infliximab|mesh-list
14124933|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
14124934|NCT03414502|Leflunomide|leflunomide|mesh-list
14124935|NCT03414502|Tofacitinib|tofacitinib|mesh-list
14124936|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14124937|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124938|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
14124939|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124940|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14124941|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14124942|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
14124943|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14124944|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124945|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
14124946|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124947|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
13943477|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13943478|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943479|NCT04878107|Docetaxel|docetaxel|mesh-list
13943480|NCT04878107|Apatinib|apatinib|mesh-list
13943481|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943482|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14124948|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124949|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14124950|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14124951|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14124952|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943483|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
13943484|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
13943485|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943486|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13943487|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943488|NCT04877821|Paclitaxel|paclitaxel|mesh-list
13943489|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
13943490|NCT04877821|Carboplatin|carboplatin|mesh-list
13943491|NCT04877821|Epirubicin|epirubicin|mesh-list
13943492|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13943493|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943494|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
13943495|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
13943496|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
13943497|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943498|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943499|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
13943500|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943501|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943502|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943503|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
14124953|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
14124954|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14124955|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14124956|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14124957|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14124958|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14124959|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14124960|NCT03414502|Analgesics|analgesics|mesh-ancestor
14124961|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
14124962|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14124963|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14124964|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14124965|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14124966|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14124967|NCT03246828|Gliclazide|gliclazide|mesh-list
14124968|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14124969|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124970|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
14124971|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
14124972|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14124973|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14124974|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124975|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124976|NCT03199612|Urological Agents|urological agents|mesh-ancestor
14124977|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
14124978|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14124979|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14124980|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124981|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
14124982|NCT03182751|Coagulants|coagulants|mesh-ancestor
14124983|NCT03113643|Azacitidine|azacitidine|mesh-list
14124984|NCT03113643|Venetoclax|venetoclax|mesh-list
14124985|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14124986|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
14478323|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478324|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478325|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14478326|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478327|NCT02450539|Docetaxel|docetaxel|mesh-list
14478328|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478329|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
14478330|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
14478331|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
14478332|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478333|NCT02450552|Ezogabine|ezogabine|mesh-list
14478334|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
14478335|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14478336|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943504|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14478337|NCT02450578|Atovaquone|atovaquone|mesh-list
13943505|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13943506|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13943507|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13943508|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943509|NCT04824417|Itraconazole|itraconazole|mesh-list
13943510|NCT04824417|Voriconazole|voriconazole|mesh-list
13943511|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
13943512|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943513|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13943514|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13943515|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943516|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943517|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13943518|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943519|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14124987|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124988|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124989|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14124990|NCT03054519|Metformin|metformin|mesh-list
14124991|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14124992|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14124993|NCT02943733|Temozolomide|temozolomide|mesh-list
14124994|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14124995|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
14124996|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14124997|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14124998|NCT02850263|Bevacizumab|bevacizumab|mesh-list
14124999|NCT02850263|Aflibercept|aflibercept|mesh-list
14125000|NCT02850263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125001|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125002|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14125003|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14125004|NCT02850263|Growth Substances|growth substances|mesh-ancestor
14125005|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125006|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
14125007|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14125008|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125009|NCT02427451|Venetoclax|venetoclax|mesh-list
14125010|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
14125011|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125012|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125013|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14125014|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125015|NCT02398240|Rituximab|rituximab|mesh-list
14125016|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14125017|NCT02398240|Doxorubicin|doxorubicin|mesh-list
14125018|NCT02398240|Vincristine|vincristine|mesh-list
13943520|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943521|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13943522|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
13943523|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13943524|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13943525|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125019|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125020|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125021|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
14125022|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125023|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125024|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14125025|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14125026|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125027|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125028|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125029|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14125030|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
14125031|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
14125032|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
13943526|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
13943527|NCT04818866|Coagulants|coagulants|mesh-ancestor
13962103|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962104|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
14125033|NCT02330562|Bevacizumab|bevacizumab|mesh-list
14125034|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125035|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125036|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14125037|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14125038|NCT02330562|Growth Substances|growth substances|mesh-ancestor
13943528|NCT04797325|Prednisolone|prednisolone|mesh-list
13943529|NCT04797325|Infliximab|infliximab|mesh-list
13943530|NCT04797325|Vedolizumab|vedolizumab|mesh-list
14125039|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125040|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
14125041|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
14125042|NCT05106517|Denosumab|denosumab|mesh-list
14125043|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14125044|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125045|NCT05106400|Lidocaine|lidocaine|mesh-list
14125046|NCT05106400|Menthol|menthol|mesh-list
14125047|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
14125048|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
14125049|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125050|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125051|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
14125052|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125053|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14125054|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14125055|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14125056|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14125057|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125058|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
14125059|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
14125060|NCT05106179|Propranolol|propranolol|mesh-list
14125061|NCT05106179|Atenolol|atenolol|mesh-list
14125062|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14125063|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14125064|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
14125065|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125066|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125067|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125068|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14125069|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14125070|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
14125071|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
14125072|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
14125073|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125074|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14125075|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
14125076|NCT05106127|Lenvatinib|lenvatinib|mesh-list
14125077|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125078|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125079|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125080|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125081|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177021|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13943531|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14177022|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14177023|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
14177024|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
14177025|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177026|NCT04759729|Vitamin D|vitamin d|mesh-list
14177027|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
14936578|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943532|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
13943533|NCT04797325|Hormones|hormones|mesh-ancestor
13943534|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943535|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943536|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13943537|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943538|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13943539|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
13943540|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943541|NCT04780464|Prednisolone|prednisolone|mesh-list
13943542|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
13943543|NCT04780464|Doxorubicin|doxorubicin|mesh-list
13943544|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13943545|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177028|NCT04759729|Vitamins|vitamins|mesh-list
13943546|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
13943547|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943548|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125082|NCT05106023|Temozolomide|temozolomide|mesh-list
14125083|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14125084|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
14125085|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125086|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125087|NCT05105997|Dexamethasone|dexamethasone|mesh-list
14125088|NCT05105997|Bupivacaine|bupivacaine|mesh-list
14125089|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125090|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
14125091|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
14125092|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125093|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125094|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125095|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
14125096|NCT05105997|Hormones|hormones|mesh-ancestor
14125097|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125098|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14125099|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125100|NCT05105997|Anesthetics, Local|anesthetics, local|mesh-ancestor
14125101|NCT05105997|Anesthetics|anesthetics|mesh-ancestor
14125102|NCT05105997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125103|NCT05105997|Sensory System Agents|sensory system agents|mesh-ancestor
14125104|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
14125105|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14125106|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14125107|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125108|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14125109|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125110|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14125111|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125112|NCT05105412|Gemcitabine|gemcitabine|mesh-list
14125113|NCT05105412|Lenalidomide|lenalidomide|mesh-list
14125114|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14125115|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
14125116|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125117|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125118|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
14125119|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125120|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125121|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14125122|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
14125123|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125124|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14125125|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14125126|NCT05105412|Growth Substances|growth substances|mesh-ancestor
14125127|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
14125128|NCT05105347|Prednisone|prednisone|mesh-list
14125129|NCT05105347|Adalimumab|adalimumab|mesh-list
14125130|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125131|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
14125132|NCT05105347|Hormones|hormones|mesh-ancestor
13943549|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943550|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
13943551|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943552|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943553|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13943554|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13943555|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13943556|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13943557|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943558|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943559|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
13943560|NCT04780464|Hormones|hormones|mesh-ancestor
13943561|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943562|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13943563|NCT04744181|Folic Acid|folic acid|mesh-list
13943564|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
13943565|NCT04744181|Vitamins|vitamins|mesh-ancestor
13943566|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
13943567|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943568|NCT04744181|Hematinics|hematinics|mesh-ancestor
14125133|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125134|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943569|NCT04733560|Bupivacaine|bupivacaine|mesh-list
13943570|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
14125135|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14125136|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125137|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125138|NCT05105256|Prednisolone|prednisolone|mesh-list
14125139|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125140|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
14125141|NCT05105256|Hormones|hormones|mesh-ancestor
14125142|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125143|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125144|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14125145|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125146|NCT05105074|Morphine|morphine|mesh-list
14125147|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14125148|NCT05105074|Narcotics|narcotics|mesh-ancestor
14125149|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125150|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125151|NCT05105074|Analgesics|analgesics|mesh-ancestor
14125152|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
14125153|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125154|NCT05105035|Meropenem|meropenem|mesh-list
14125155|NCT05105035|Ceftazidime|ceftazidime|mesh-list
14125156|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14125157|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125158|NCT05105022|Propofol|propofol|mesh-list
14125159|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14125160|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125161|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125162|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14125163|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
14125164|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
14125165|NCT05105009|Furosemide|furosemide|mesh-list
14125166|NCT05105009|Diuretics|diuretics|mesh-ancestor
14125167|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
14125168|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125169|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14125170|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14125171|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125172|NCT05104931|Piroxicam|piroxicam|mesh-list
14125173|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14125174|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14125175|NCT05104931|Analgesics|analgesics|mesh-ancestor
14125176|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
14125177|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125178|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125179|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125180|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125181|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14125182|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125183|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125184|NCT05104788|Carboplatin|carboplatin|mesh-list
13943571|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
13943572|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943573|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943574|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
13943575|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943576|NCT04713098|Coal Tar|coal tar|mesh-list
13943577|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
13943578|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
13943579|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13943580|NCT04669561|Lifitegrast|lifitegrast|mesh-list
13943581|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13943582|NCT04647383|Lemborexant|lemborexant|mesh-list
13943583|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13943584|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943585|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943586|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13943587|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13943588|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943589|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943590|NCT04630002|Ritonavir|ritonavir|mesh-list
13943591|NCT04630002|Darunavir|darunavir|mesh-list
13943592|NCT04630002|Etravirine|etravirine|mesh-list
14762985|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13943593|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13943594|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14125185|NCT05104788|Pemetrexed|pemetrexed|mesh-list
14125186|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125187|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125188|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125189|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14125190|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14125191|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
14125192|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14125193|NCT05104762|Antibodies|antibodies|mesh-list
14125194|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
14125195|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14125196|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
14125197|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125198|NCT05104437|Vaccines|vaccines|mesh-list
13943595|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
13943596|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943597|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125199|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
14125200|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125201|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
14125202|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14125203|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125204|NCT05104333|Vaccines|vaccines|mesh-list
14125205|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
14125206|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125207|NCT05104281|Osimertinib|osimertinib|mesh-list
14125208|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125209|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125210|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125211|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125212|NCT05087732|Lidocaine|lidocaine|mesh-list
14125213|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
14125214|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
13943598|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13943599|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13943600|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
14478338|NCT02450578|Proguanil|proguanil|mesh-list
14478339|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14762986|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943601|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943602|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13943603|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13943604|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14125215|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125216|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125217|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
14125218|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125219|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14125220|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14125221|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14125222|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14125223|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125224|NCT05076786|Carboplatin|carboplatin|mesh-list
14125225|NCT05076786|Etoposide|etoposide|mesh-list
14125226|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125227|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13943605|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13943606|NCT04495452|Fentanyl|fentanyl|mesh-list
13943607|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13943608|NCT04495452|Narcotics|narcotics|mesh-ancestor
13943609|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943610|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943611|NCT04495452|Analgesics|analgesics|mesh-ancestor
13943612|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
13943613|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943614|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13943615|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13943616|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
14125228|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14125229|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125230|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125231|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943617|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
14478340|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125232|NCT05068752|Sorafenib|sorafenib|mesh-list
14125233|NCT05068752|Vemurafenib|vemurafenib|mesh-list
14125234|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125235|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125236|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125237|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177029|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
14177030|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177031|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14177032|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14177033|NCT04759742|Ropivacaine|ropivacaine|mesh-list
14177034|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
14177035|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
14177036|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177037|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177038|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
14177039|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177042|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14177043|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14177044|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177045|NCT04760262|Remifentanil|remifentanil|mesh-list
14177046|NCT04760262|Propofol|propofol|mesh-list
14177047|NCT04760262|Sevoflurane|sevoflurane|mesh-list
14177048|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14177049|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177050|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177051|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14177052|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
14177053|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
14177054|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14177055|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14177056|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14177057|NCT04760262|Narcotics|narcotics|mesh-ancestor
14177058|NCT04760262|Analgesics|analgesics|mesh-ancestor
14177059|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
14177060|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177061|NCT04758936|Clonidine|clonidine|mesh-list
14177062|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
14177063|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14177064|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177065|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177066|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14177067|NCT04758936|Analgesics|analgesics|mesh-ancestor
14177068|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
14936579|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14936580|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14936581|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14936582|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936583|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14936584|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14936585|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936586|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
14936587|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
13943618|NCT04431466|Ivermectin|ivermectin|mesh-list
13943619|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13943620|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943621|NCT04427904|Lidocaine|lidocaine|mesh-list
13943622|NCT04427904|Epinephrine|epinephrine|mesh-list
13943623|NCT04427904|Racepinephrine|racepinephrine|mesh-list
13943624|NCT04427904|Bupivacaine|bupivacaine|mesh-list
13943625|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
13943626|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
13943627|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
13943628|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943629|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943630|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
13943631|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943632|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13943633|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13943634|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13943635|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13943636|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478341|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
14936588|NCT01470053|Azelastine|azelastine|mesh-list
13943637|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14125238|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14125239|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14125240|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125241|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
14125242|NCT05012735|Provitamins|provitamins|mesh-list
14125243|NCT05012735|Vitamins|vitamins|mesh-ancestor
14125244|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
13943638|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13943639|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
13943640|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943641|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13943642|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13943643|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
14125245|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125246|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
14125247|NCT04999215|Choline|choline|mesh-list
14125248|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
14125249|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14125250|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
14125251|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125252|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125253|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14125254|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
14125255|NCT04941443|Ibuprofen|ibuprofen|mesh-list
14125256|NCT04941443|Methadone|methadone|mesh-list
14125257|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14125258|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14125259|NCT04941443|Analgesics|analgesics|mesh-ancestor
14125260|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
14125261|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125262|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125263|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125264|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125265|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13943644|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13943645|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
13943646|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
13943647|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
13943648|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13943649|NCT04416282|Terlipressin|terlipressin|mesh-list
13943650|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13943651|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13943652|NCT04377451|Metformin|metformin|mesh-list
13943653|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13943654|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943655|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
13943656|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
13943657|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
13943658|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125266|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125267|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125268|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14125269|NCT04941443|Narcotics|narcotics|mesh-ancestor
14125270|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125271|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
14125272|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
14125273|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
14125274|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14125275|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14125276|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
14125277|NCT04893148|Dulaglutide|dulaglutide|mesh-list
14125278|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14125279|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943659|NCT04239040|Nivolumab|nivolumab|mesh-list
13943660|NCT04239040|Ipilimumab|ipilimumab|mesh-list
13943661|NCT04239040|Vaccines|vaccines|mesh-list
13943662|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
13943663|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943664|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13943665|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943666|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13943667|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125283|NCT04777422|Defibrotide|defibrotide|mesh-list
14125284|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14125285|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14125286|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125287|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14125288|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
14125289|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125290|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125291|NCT04681105|Acetaminophen|acetaminophen|mesh-list
14125292|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
14125293|NCT04681105|Promethazine|promethazine|mesh-list
14125294|NCT04681105|Dexamethasone|dexamethasone|mesh-list
14125295|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
14125296|NCT04681105|Ibuprofen|ibuprofen|mesh-list
14125297|NCT04681105|Ranitidine|ranitidine|mesh-list
14125298|NCT04681105|Antibodies|antibodies|mesh-list
14125299|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
14125300|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14125301|NCT04681105|BB 1101|bb 1101|mesh-list
14125302|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
14125303|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125304|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125305|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
14125306|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
14125307|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125308|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125309|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
14125310|NCT04681105|Hormones|hormones|mesh-ancestor
14125311|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125312|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14125313|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943668|NCT04149899|Timolol|timolol|mesh-list
13943669|NCT04149899|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13943670|NCT04149899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13943671|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13943672|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13943673|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478342|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14478343|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14478344|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478345|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478346|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
14478347|NCT02450903|Ceritinib|ceritinib|mesh-list
14478348|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478349|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14478350|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478351|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478352|NCT02451137|Insulin|insulin|mesh-list
14478353|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14478354|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
14478355|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
14478356|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14762987|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943674|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943675|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943676|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943677|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13943678|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13943679|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
13943680|NCT04046263|Hematinics|hematinics|mesh-ancestor
13962105|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962106|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962107|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962108|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
13962109|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962110|NCT05084586|Epirubicin|epirubicin|mesh-list
13962111|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13962112|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13962113|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962114|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13962115|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125314|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
14125315|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478357|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762988|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
13962116|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962117|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125316|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943681|NCT03920527|Itraconazole|itraconazole|mesh-list
13943682|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
13943683|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943684|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13943685|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13943686|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943687|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943688|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13943689|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943690|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943691|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943692|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13943693|NCT03902509|Pirfenidone|pirfenidone|mesh-list
13943694|NCT03902509|Analgesics|analgesics|mesh-ancestor
13943695|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
13943696|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943697|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943698|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13943699|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13943700|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943701|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943702|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943703|NCT03873480|Epinephrine|epinephrine|mesh-list
14125317|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14125318|NCT04681105|Analgesics|analgesics|mesh-ancestor
14125319|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
13943704|NCT03873480|Bupivacaine|bupivacaine|mesh-list
13943705|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13943706|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13943707|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
14125320|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
14125321|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14125322|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125323|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14125324|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14125325|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14125326|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125327|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
14125328|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
14125329|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14125330|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
14125331|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
14125332|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125333|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14125334|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
14125335|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
14125336|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14125337|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14125338|NCT04642950|Sargramostim|sargramostim|mesh-list
14125339|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
14125340|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125341|NCT04593914|Protective Agents|protective agents|mesh-list
14125342|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125343|NCT04578015|Metronidazole|metronidazole|mesh-list
14125344|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125345|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14125346|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14125347|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14125348|NCT04573504|Clindamycin|clindamycin|mesh-list
14125349|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
13943708|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943709|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943710|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943711|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13943712|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13943713|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
13943714|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943715|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13943716|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
13943717|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
13943718|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
13943719|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13962118|NCT05074290|Taxane|taxane|mesh-list
14125350|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
14125351|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13943720|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
13943721|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
13943722|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943723|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
13943724|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
13943725|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
13943726|NCT03854370|Povidone|povidone|mesh-list
13943727|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13943728|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943729|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
13943730|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
13943731|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
13943732|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
13943733|NCT03849651|Melphalan|melphalan|mesh-list
13943734|NCT03849651|Thiotepa|thiotepa|mesh-list
13943735|NCT03849651|Fludarabine|fludarabine|mesh-list
13943736|NCT03849651|Blinatumomab|blinatumomab|mesh-list
13943737|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
13943738|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943739|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
13943740|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943741|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943742|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943743|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
13943744|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943745|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943746|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13943747|NCT03821883|Aspirin|aspirin|mesh-list
13943748|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13943749|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13943750|NCT03821883|Analgesics|analgesics|mesh-ancestor
13943751|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
13943752|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943753|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943754|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943755|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943756|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13943757|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13943758|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943759|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13943760|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13943761|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943762|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
13943763|NCT03752684|Calcium|calcium|mesh-list
13943764|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13943765|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943766|NCT03545464|Prednisone|prednisone|mesh-list
13943767|NCT03545464|Levocetirizine|levocetirizine|mesh-list
13943768|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943769|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
13943770|NCT03545464|Hormones|hormones|mesh-ancestor
13943771|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943772|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943773|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13943774|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943775|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13943776|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13943777|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
13943778|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
13943779|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943780|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943781|NCT03538938|Nicotine|nicotine|mesh-list
13943782|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13943783|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
13943784|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125352|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14125353|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125354|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14125355|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125356|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125357|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14125358|NCT04546230|Anesthetics|anesthetics|mesh-list
14125359|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943785|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943786|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14478358|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14125360|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125361|NCT04528667|Abivertinib|abivertinib|mesh-list
14125362|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125363|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125364|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125365|NCT04495257|Nivolumab|nivolumab|mesh-list
14125366|NCT04495257|Ipilimumab|ipilimumab|mesh-list
14125367|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125368|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125369|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13943787|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13943788|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
13943789|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943790|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943791|NCT03536520|Acetazolamide|acetazolamide|mesh-list
13943792|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
13943793|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13943794|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943795|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943796|NCT03536520|Diuretics|diuretics|mesh-ancestor
13943797|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
13943798|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943799|NCT03536455|Acetazolamide|acetazolamide|mesh-list
13943800|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
13943801|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14125370|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125371|NCT04468776|Zolpidem|zolpidem|mesh-list
14125372|NCT04468776|Trazodone|trazodone|mesh-list
14125373|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13943802|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943803|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943804|NCT03536455|Diuretics|diuretics|mesh-ancestor
13943805|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
13943806|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943807|NCT03536429|Acetazolamide|acetazolamide|mesh-list
13943808|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
13943809|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14125374|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14125375|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125376|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125377|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14125378|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
13943810|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943811|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943812|NCT03536429|Diuretics|diuretics|mesh-ancestor
13943813|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
13943814|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478359|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14762989|NCT01974440|Hormones|hormones|mesh-ancestor
13943815|NCT03529825|Rifaximin|rifaximin|mesh-list
13943816|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13943817|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943818|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13943819|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
13943820|NCT03475134|Nivolumab|nivolumab|mesh-list
13943821|NCT03475134|Fludarabine|fludarabine|mesh-list
13943822|NCT03475134|Interleukin-2|interleukin-2|mesh-list
13943823|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943824|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
13943825|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943826|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943827|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943828|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
13943829|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943830|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943831|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13943832|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13943833|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13943834|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13943835|NCT03475134|Analgesics|analgesics|mesh-ancestor
13943836|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
13943837|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943838|NCT03461120|Anesthetics|anesthetics|mesh-list
13943839|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
14478360|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13943840|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943841|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943842|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
13943843|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943844|NCT03384212|Cytarabine|cytarabine|mesh-list
13943845|NCT03384212|Fludarabine|fludarabine|mesh-list
13943846|NCT03384212|Busulfan|busulfan|mesh-list
14125379|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
14125380|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125381|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125382|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14125383|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14125384|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14125385|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14125386|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14125387|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14125388|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
14125389|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14125390|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
14125391|NCT04440007|Abivertinib|abivertinib|mesh-list
13943847|NCT03384212|Cladribine|cladribine|mesh-list
13943848|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943849|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13943850|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
13943851|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943852|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943853|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
13943854|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943855|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
13943856|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943857|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
13943858|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943859|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14125392|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125393|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125394|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125395|NCT04434001|Thrombin|thrombin|mesh-list
14125396|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
14125397|NCT04434001|Coagulants|coagulants|mesh-ancestor
14125398|NCT04426591|Biotin|biotin|mesh-list
14125399|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
14125400|NCT04426591|Vitamins|vitamins|mesh-ancestor
14125401|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
14125402|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177069|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177070|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14177071|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14177072|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14177073|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177074|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177075|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177076|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14177077|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
14177078|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
14177079|NCT04758871|Progesterone|progesterone|mesh-list
14177080|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
14177081|NCT04758871|Progestins|progestins|mesh-ancestor
14177082|NCT04758871|Hormones|hormones|mesh-ancestor
14177083|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177084|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177085|NCT04758858|Glucagon|glucagon|mesh-list
14177086|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943860|NCT03384225|Cytarabine|cytarabine|mesh-list
13943861|NCT03384225|Fludarabine|fludarabine|mesh-list
13943862|NCT03384225|Busulfan|busulfan|mesh-list
14177087|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177088|NCT04758858|Hormones|hormones|mesh-ancestor
14177089|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762990|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14762991|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14762992|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14762993|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
14762994|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
13943863|NCT03384225|Cladribine|cladribine|mesh-list
14177090|NCT04759079|Antiemetics|antiemetics|mesh-list
14762995|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
14125403|NCT04374240|Tretazicar|tretazicar|mesh-list
14125404|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125405|NCT04230746|Trimethoprim|trimethoprim|mesh-list
14125406|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14125407|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
14125408|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14125409|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125410|NCT04230746|Renal Agents|renal agents|mesh-ancestor
14125411|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
14125412|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14125413|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14125414|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14125415|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125416|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125417|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14125418|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14125419|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14125420|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14125421|NCT04201834|Risperidone|risperidone|mesh-list
14125422|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14125423|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
14125424|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125425|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125426|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125427|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14762996|NCT01959464|Progesterone|progesterone|mesh-list
14125428|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14125429|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125430|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14125431|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14125432|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
14125433|NCT04194775|Lenvatinib|lenvatinib|mesh-list
14762997|NCT01959464|Progestins|progestins|mesh-ancestor
13943864|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943865|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13943866|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
13943867|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943868|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943869|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
13943870|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943871|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
13943872|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13943873|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
13943874|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943875|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13943876|NCT03272698|Ketamine|ketamine|mesh-list
13943877|NCT03272698|Analgesics|analgesics|mesh-ancestor
13943878|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
13943879|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13943880|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14762998|NCT01959464|Hormones|hormones|mesh-ancestor
14762999|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763000|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943881|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13943882|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13943883|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
13943884|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
13943885|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943886|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13943887|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13943888|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763001|NCT01921166|Leuprolide|leuprolide|mesh-list
14763002|NCT01921166|Clomiphene|clomiphene|mesh-list
14763003|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14763004|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
14763005|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14763006|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763007|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763008|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936589|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13943889|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125434|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125435|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763009|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14936590|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
14936591|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14936592|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14125436|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125437|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125438|NCT04115384|Insulin|insulin|mesh-list
14125439|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14125440|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14125441|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125442|NCT04104139|Trifluridine|trifluridine|mesh-list
14125443|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
14125444|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125445|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
14125446|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125447|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14125448|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
14125449|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125450|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14125451|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
14125452|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125453|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125454|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14125455|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14125456|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14125457|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
14763010|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
14763011|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763012|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14763013|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14763014|NCT01900574|Golimumab|golimumab|mesh-list
14763015|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14763016|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14763017|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763018|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
14763019|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763020|NCT01879085|Gemcitabine|gemcitabine|mesh-list
14125469|NCT03991741|Interleukin-2|interleukin-2|mesh-list
14125470|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943890|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
13943891|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
13943892|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943893|NCT03272425|Allopurinol|allopurinol|mesh-list
13943894|NCT03272425|Lesinurad|lesinurad|mesh-list
13943895|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
13943896|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943897|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943898|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
13943899|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943900|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13943901|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
13943902|NCT03272425|Protective Agents|protective agents|mesh-ancestor
13943903|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943904|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
13943905|NCT03272425|Renal Agents|renal agents|mesh-ancestor
13943906|NCT03272477|Tamoxifen|tamoxifen|mesh-list
13943907|NCT03272477|Paclitaxel|paclitaxel|mesh-list
13943908|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13943909|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
13943910|NCT03272477|Trastuzumab|trastuzumab|mesh-list
13943911|NCT03272477|Letrozole|letrozole|mesh-list
13943912|NCT03272477|Epirubicin|epirubicin|mesh-list
13943913|NCT03272477|Anastrozole|anastrozole|mesh-list
14936593|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
14936594|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936595|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936596|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14936597|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
14936598|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14936599|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936600|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936601|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14936602|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13943914|NCT03272477|Exemestane|exemestane|mesh-list
13943915|NCT03272477|Pertuzumab|pertuzumab|mesh-list
13943916|NCT03272477|Goserelin|goserelin|mesh-list
13943917|NCT03272477|Leuprolide|leuprolide|mesh-list
14125471|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14125472|NCT03991741|Analgesics|analgesics|mesh-ancestor
14125473|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
14125474|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125475|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125476|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14125477|NCT03903692|Laxatives|laxatives|mesh-ancestor
14125478|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125479|NCT03781817|Ketamine|ketamine|mesh-list
14763021|NCT01879085|Docetaxel|docetaxel|mesh-list
14763022|NCT01879085|Vorinostat|vorinostat|mesh-list
14763023|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763024|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
14763025|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763026|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763027|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
14763028|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763029|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763030|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763031|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
14763032|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763033|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763034|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763035|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763036|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14763037|NCT01845441|Fentanyl|fentanyl|mesh-list
14763038|NCT01845441|Midazolam|midazolam|mesh-list
14763039|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
13943918|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14125480|NCT03781817|Analgesics|analgesics|mesh-ancestor
14125481|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
14125482|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125483|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125484|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14125485|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14125486|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
14125487|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
14125488|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125489|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14125490|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14125491|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125492|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125493|NCT03777982|Prednisone|prednisone|mesh-list
14125494|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
14125495|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125496|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
14125497|NCT03777982|Hormones|hormones|mesh-ancestor
14125498|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177091|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
13943919|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943920|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763040|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14763041|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763042|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763043|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14763044|NCT01845441|Analgesics|analgesics|mesh-ancestor
14763045|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
14763046|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763047|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14763048|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14763049|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14763050|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
13943921|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
13943922|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
13943923|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943924|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13943925|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
13943926|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943927|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13943928|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13943929|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
13943930|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13943931|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13943932|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14763051|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125499|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125500|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763052|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763053|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14763054|NCT01845441|Narcotics|narcotics|mesh-ancestor
13943933|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13943934|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13943935|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13943936|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
13943937|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763055|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14763056|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14763057|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
14763058|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
13943938|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13943939|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13943940|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13943941|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13943942|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13943943|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13943944|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13943945|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13943946|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
13943947|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13943948|NCT03272503|Pimozide|pimozide|mesh-list
13943949|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13943950|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13943951|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13943952|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943953|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13943954|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13943955|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
13943956|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943957|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13943958|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13943959|NCT03272412|Progesterone|progesterone|mesh-list
13943960|NCT03272412|Progestins|progestins|mesh-ancestor
13943961|NCT03272412|Hormones|hormones|mesh-ancestor
13943962|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13943963|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962119|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962120|NCT05022004|Brinzolamide|brinzolamide|mesh-list
13962121|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13962122|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962123|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962124|NCT05017610|Lomustine|lomustine|mesh-list
13962125|NCT05017610|Methimazole|methimazole|mesh-list
13962126|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13962127|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
13962128|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962129|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962130|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
13962131|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
13962132|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962133|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962134|NCT05013801|Hydroquinone|hydroquinone|mesh-list
13962135|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
13962136|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962137|NCT05013801|Protective Agents|protective agents|mesh-ancestor
14125501|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125502|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14125503|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125504|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125505|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
14125506|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14125507|NCT03769688|Metronidazole|metronidazole|mesh-list
14125508|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125509|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14125510|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14763059|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14763060|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14763061|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14763062|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
13943964|NCT03272126|Vitamin D|vitamin d|mesh-list
13943965|NCT03272126|Vitamins|vitamins|mesh-ancestor
13943966|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
13943967|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943968|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13943969|NCT03272321|Oxytocin|oxytocin|mesh-list
13943970|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
13943971|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13943972|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943973|NCT03272295|Menthol|menthol|mesh-list
13943974|NCT03272295|Sorbitol|sorbitol|mesh-list
13943975|NCT03272295|Glycerol|glycerol|mesh-list
13943976|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
13943977|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
13943978|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13943979|NCT03272295|Protective Agents|protective agents|mesh-ancestor
14125511|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14125512|NCT03751709|Blinatumomab|blinatumomab|mesh-list
14125513|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125514|NCT03748953|Ixazomib|ixazomib|mesh-list
13943980|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943981|NCT03272295|Cathartics|cathartics|mesh-ancestor
13943982|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13943983|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
13943984|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13943985|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943986|NCT03271866|Metformin|metformin|mesh-list
13943987|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13943988|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13943989|NCT03271918|Cabergoline|cabergoline|mesh-list
13943990|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13943991|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14125515|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13943992|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
13943993|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
13943994|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13943995|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125516|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
14125517|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125518|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763063|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
14763064|NCT01821833|Paclitaxel|paclitaxel|mesh-list
14763065|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763066|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763067|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763068|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763069|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
13943996|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125519|NCT03748810|Metformin|metformin|mesh-list
14125520|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
14125521|NCT03748810|Empagliflozin|empagliflozin|mesh-list
14125522|NCT03748810|Glimepiride|glimepiride|mesh-list
14125523|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14125524|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14125525|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125526|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14125527|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125528|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14125529|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14125530|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
14125531|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
14125532|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125533|NCT03691311|Denosumab|denosumab|mesh-list
14125534|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14125535|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125536|NCT03690453|Ivermectin|ivermectin|mesh-list
13943997|NCT03272009|Interferons|interferons|mesh-list
13943998|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
13943999|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
13944000|NCT03272009|Entecavir|entecavir|mesh-list
13944001|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13944002|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944003|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
14125537|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14125538|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125539|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
14763070|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944004|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944005|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
14763071|NCT01792687|Prednisone|prednisone|mesh-list
14125540|NCT03650764|Ramucirumab|ramucirumab|mesh-list
14125541|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125542|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125543|NCT03620643|Fulvestrant|fulvestrant|mesh-list
14125544|NCT03620643|Crizotinib|crizotinib|mesh-list
14125545|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14125546|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125547|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14125548|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14125549|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
14125550|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125551|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125552|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125553|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125554|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125555|NCT03572413|Bromides|bromides|mesh-list
14125556|NCT03572413|Rocuronium|rocuronium|mesh-list
14125557|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
14125558|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14125559|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14125560|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14125561|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125562|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125563|NCT03533946|Rucaparib|rucaparib|mesh-list
14125564|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14125565|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125566|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125567|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125568|NCT03500484|Liraglutide|liraglutide|mesh-list
14125569|NCT03500484|Glucagon|glucagon|mesh-list
14125570|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14125571|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14125572|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125573|NCT03500484|Incretins|incretins|mesh-ancestor
14125574|NCT03500484|Hormones|hormones|mesh-ancestor
14125575|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125576|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125577|NCT03496662|Gemcitabine|gemcitabine|mesh-list
14125578|NCT03496662|Paclitaxel|paclitaxel|mesh-list
14125579|NCT03496662|Nivolumab|nivolumab|mesh-list
14125580|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14125581|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125582|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
14125583|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
14125584|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
14125585|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125586|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14125587|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
14125588|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
14125589|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125590|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125591|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14125592|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
14125593|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125594|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125595|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14125596|NCT03416244|Nivolumab|nivolumab|mesh-list
14125597|NCT03416244|Ipilimumab|ipilimumab|mesh-list
14125598|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125599|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125600|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14125601|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125602|NCT03386578|Tenofovir|tenofovir|mesh-list
14125603|NCT03386578|Emtricitabine|emtricitabine|mesh-list
14763072|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
14763073|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14763074|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
14763075|NCT01792687|Hormones|hormones|mesh-ancestor
14763076|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763077|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763078|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763079|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763080|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14763081|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944006|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944007|NCT03271879|Empagliflozin|empagliflozin|mesh-list
13944008|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14936603|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
14125604|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14125605|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
14125606|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125607|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14125608|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14125609|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125610|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125611|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14125612|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14125613|NCT03349281|Cytarabine|cytarabine|mesh-list
14125614|NCT03349281|Dexamethasone|dexamethasone|mesh-list
14125615|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
14125616|NCT03349281|Doxorubicin|doxorubicin|mesh-list
13944009|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944010|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13944011|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944012|NCT03271983|Metronidazole|metronidazole|mesh-list
14125617|NCT03349281|Methotrexate|methotrexate|mesh-list
14125618|NCT03349281|Vincristine|vincristine|mesh-list
14125619|NCT03349281|Asparaginase|asparaginase|mesh-list
14125620|NCT03349281|Pegaspargase|pegaspargase|mesh-list
14125621|NCT03349281|Pevonedistat|pevonedistat|mesh-list
14125622|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125623|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
14125624|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
14125625|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125626|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125627|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125628|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
14125629|NCT03349281|Hormones|hormones|mesh-ancestor
14125630|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125631|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14125632|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125633|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14125634|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14125635|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125636|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125637|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125638|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14125639|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
14125640|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14125641|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13944013|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944014|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13944015|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13944016|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13944017|NCT03271905|Bromides|bromides|mesh-list
13944018|NCT03271905|Albuterol|albuterol|mesh-list
13944019|NCT03271905|Ipratropium|ipratropium|mesh-list
13944020|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
13944021|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13944022|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
13944023|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944024|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944025|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13944026|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
13944027|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
13944028|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944029|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13944030|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13944031|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14125642|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
14125643|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
14936604|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
13944032|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
13944033|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944034|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944035|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13944036|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
13944037|NCT03271749|Anesthetics|anesthetics|mesh-list
14125644|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14938725|NCT01483729|Ritonavir|ritonavir|mesh-list
14125645|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14125646|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
14125647|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125648|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14125649|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
14125650|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125651|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14125652|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14125653|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
14125654|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14125655|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
14125656|NCT03299088|Trametinib|trametinib|mesh-list
14125657|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125658|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125659|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125660|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125661|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125662|NCT03292666|Warfarin|warfarin|mesh-list
14125663|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
13944038|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944039|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944040|NCT03271450|Warfarin|warfarin|mesh-list
14125664|NCT03292666|Dabigatran|dabigatran|mesh-list
14125665|NCT03292666|Apixaban|apixaban|mesh-list
14125666|NCT03292666|Edoxaban|edoxaban|mesh-list
14125667|NCT03292666|Anticoagulants|anticoagulants|mesh-list
14125668|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14125669|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
14125670|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14125671|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
14125672|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125673|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125674|NCT03286842|Olaparib|olaparib|mesh-list
14125675|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14125676|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125677|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125678|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125679|NCT03262779|Nivolumab|nivolumab|mesh-list
14125680|NCT03262779|Ipilimumab|ipilimumab|mesh-list
14125681|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13944041|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
13944042|NCT03271450|Dabigatran|dabigatran|mesh-list
13944043|NCT03271450|Apixaban|apixaban|mesh-list
13944044|NCT03271450|Edoxaban|edoxaban|mesh-list
13944045|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
13944046|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13944047|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
13944048|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13944049|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
14125682|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125683|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14125684|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125685|NCT03236428|Daratumumab|daratumumab|mesh-list
14125686|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125687|NCT03219775|Nivolumab|nivolumab|mesh-list
14125688|NCT03219775|Ipilimumab|ipilimumab|mesh-list
14125689|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125690|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125691|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14125692|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125693|NCT03164564|Tenofovir|tenofovir|mesh-list
14125694|NCT03164564|Emtricitabine|emtricitabine|mesh-list
14125695|NCT03164564|Cabotegravir|cabotegravir|mesh-list
14125696|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
14125697|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125698|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14125699|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13944050|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944051|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944052|NCT03271502|Anesthetics|anesthetics|mesh-list
14125700|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125701|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125702|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14125703|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13944053|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944054|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125704|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14125705|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14125706|NCT03143270|Nivolumab|nivolumab|mesh-list
14125707|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125708|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125709|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14125710|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125711|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
14125712|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
14125713|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14125714|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14125715|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125716|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125717|NCT03142568|Urological Agents|urological agents|mesh-ancestor
14177092|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177093|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177094|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177095|NCT04759196|Topiramate|topiramate|mesh-list
14177096|NCT04759196|Levetiracetam|levetiracetam|mesh-list
14177097|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
14177098|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14177099|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177100|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
14183746|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183747|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14183748|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14183749|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14183750|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183751|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183752|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
14183753|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
14183754|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183755|NCT04725591|Insulin|insulin|mesh-list
14183756|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14183757|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478361|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183758|NCT04725682|Tacrolimus|tacrolimus|mesh-list
14183759|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14183760|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
14183761|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183762|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14183763|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183764|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183765|NCT04725617|Varenicline|varenicline|mesh-list
14183766|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14183767|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14183768|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
14183769|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183770|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183771|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183772|NCT04725448|Paclitaxel|paclitaxel|mesh-list
14763082|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763083|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
14763084|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14763085|NCT01776840|Rituximab|rituximab|mesh-list
14763086|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14763087|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14183773|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14183774|NCT04725448|Bevacizumab|bevacizumab|mesh-list
14183775|NCT04725448|Carboplatin|carboplatin|mesh-list
14763088|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763089|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
14763090|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763091|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14938726|NCT01483729|Lactams|lactams|mesh-list
14478362|NCT02451202|Rocuronium|rocuronium|mesh-list
14478363|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14478364|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14478365|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14478366|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478367|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478368|NCT02451488|Sargramostim|sargramostim|mesh-list
14478369|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
14183776|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14183777|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125718|NCT03100045|Artesunate|artesunate|mesh-list
14125719|NCT03100045|Artemisinins|artemisinins|mesh-list
14125720|NCT03100045|Artemisinin|artemisinin|mesh-list
14125721|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
14125722|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14125723|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14125724|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125725|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125726|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
14125727|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
14125728|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14125729|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
14125730|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
14125731|NCT02660281|Melphalan|melphalan|mesh-list
14125732|NCT02660281|Busulfan|busulfan|mesh-list
14125733|NCT02660281|Thiotepa|thiotepa|mesh-list
14125734|NCT02660281|Fludarabine|fludarabine|mesh-list
14125735|NCT02660281|Mesna|mesna|mesh-list
14125736|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14125737|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
14125738|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125739|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125740|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14125741|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
14125742|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763092|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14763093|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
14478370|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478371|NCT02451696|Everolimus|everolimus|mesh-list
14125743|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125744|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14125745|NCT02660281|Protective Agents|protective agents|mesh-ancestor
14125746|NCT02571530|Trastuzumab|trastuzumab|mesh-list
14125747|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125748|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125749|NCT02489903|Gemcitabine|gemcitabine|mesh-list
14125750|NCT02489903|Paclitaxel|paclitaxel|mesh-list
14125751|NCT02489903|Etoposide|etoposide|mesh-list
14125752|NCT02489903|Vinorelbine|vinorelbine|mesh-list
14125753|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14125754|NCT02489903|Carboplatin|carboplatin|mesh-list
14125755|NCT02489903|Irinotecan|irinotecan|mesh-list
14125756|NCT02489903|Pemetrexed|pemetrexed|mesh-list
14125757|NCT02489903|Taxane|taxane|mesh-list
14125758|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14125759|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125760|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
14125761|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
14478372|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478373|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13944068|NCT03271164|Vitamin E|vitamin e|mesh-list
14125762|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
14125763|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125764|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14125765|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
14125766|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
13944069|NCT03271164|Vitamins|vitamins|mesh-ancestor
13944070|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
13944071|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944072|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
13944073|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944074|NCT03271164|Protective Agents|protective agents|mesh-ancestor
13944075|NCT03271255|Bevacizumab|bevacizumab|mesh-list
13944076|NCT03271255|Apatinib|apatinib|mesh-list
13944077|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13944078|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944079|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13944080|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14125767|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944081|NCT03271255|Growth Substances|growth substances|mesh-ancestor
14125768|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125769|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14125770|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
14125771|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478374|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
14478375|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478376|NCT02451917|Insulin|insulin|mesh-list
14478377|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14478378|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
14478379|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
14125772|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14125773|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125774|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14125775|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13944082|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944083|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
13944084|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13944085|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944086|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944087|NCT03271073|Apatinib|apatinib|mesh-list
13944088|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944089|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13944090|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944091|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944092|NCT03270969|Tenofovir|tenofovir|mesh-list
13944093|NCT03270969|Emtricitabine|emtricitabine|mesh-list
13944094|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
13944095|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944096|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13944097|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13944098|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944099|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944100|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13944101|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13944102|NCT03270839|Meclizine|meclizine|mesh-list
13944103|NCT03270839|Scopolamine|scopolamine|mesh-list
13944104|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13944105|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
13944106|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
13944107|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944108|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944109|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125776|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14125777|NCT02438995|Cetuximab|cetuximab|mesh-list
14125778|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125779|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125780|NCT05108389|Hemostatics|hemostatics|mesh-list
14125781|NCT05108389|Coagulants|coagulants|mesh-ancestor
14125782|NCT05108350|Metformin|metformin|mesh-list
14125783|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14125784|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125785|NCT05108220|Cannabidiol|cannabidiol|mesh-list
14125786|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
14125787|NCT05108051|Oseltamivir|oseltamivir|mesh-list
14125788|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
14125789|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125790|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944110|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
13944111|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13944112|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
13944113|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944114|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944115|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13944116|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13944117|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
13944118|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
13944119|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13944120|NCT03270735|Thrombin|thrombin|mesh-list
13944121|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
13944122|NCT03270735|Coagulants|coagulants|mesh-ancestor
13962138|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962139|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13962140|NCT05012865|Avelumab|avelumab|mesh-list
13962141|NCT05012865|Axitinib|axitinib|mesh-list
13962142|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962143|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962144|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125791|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125792|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
14125793|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
14125794|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14125795|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125796|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962145|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962146|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962147|NCT04998669|Rituximab|rituximab|mesh-list
13944123|NCT03270709|Vitamin D|vitamin d|mesh-list
13944124|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
13944125|NCT03270709|Vitamins|vitamins|mesh-ancestor
13944126|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
13944127|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944128|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13944129|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13944130|NCT03270696|Propofol|propofol|mesh-list
13944131|NCT03270696|Rocuronium|rocuronium|mesh-list
13944132|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13944133|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125797|NCT05107921|Bromfenac|bromfenac|mesh-list
14125798|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14125799|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944134|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944135|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13944136|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
14125800|NCT05107921|Analgesics|analgesics|mesh-ancestor
14125801|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
14125802|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125803|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125804|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125805|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14125806|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14125807|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14125808|NCT05107375|Vaccines|vaccines|mesh-list
14125809|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
14125810|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125811|NCT05107063|Pravastatin|pravastatin|mesh-list
14125812|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14125813|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14125814|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
13944137|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
13944138|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13944139|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13944140|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13944141|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944142|NCT03270553|Metformin|metformin|mesh-list
13944143|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13944144|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944145|NCT03270462|Tacrolimus|tacrolimus|mesh-list
13944146|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13944147|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
13944148|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125815|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125816|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14125817|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14125818|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125819|NCT05106803|Amoxicillin|amoxicillin|mesh-list
14125820|NCT05106803|Vancomycin|vancomycin|mesh-list
14125821|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
14125822|NCT05106803|Clindamycin|clindamycin|mesh-list
14125823|NCT05106803|Gentamicins|gentamicins|mesh-list
14125824|NCT05106803|Tetracycline|tetracycline|mesh-list
14125825|NCT05106803|Penicillins|penicillins|mesh-list
14125826|NCT05106803|Erythromycin|erythromycin|mesh-list
14125827|NCT05106803|Ampicillin|ampicillin|mesh-list
14125828|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
14125829|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
14125830|NCT05106803|Cefepime|cefepime|mesh-list
14125831|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14125832|NCT05106803|Norfloxacin|norfloxacin|mesh-list
14125833|NCT05106803|Oxacillin|oxacillin|mesh-list
14125834|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
14125835|NCT05106803|Trimethoprim|trimethoprim|mesh-list
13944149|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13944150|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944151|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944152|NCT03269929|Midazolam|midazolam|mesh-list
13944153|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13944154|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13944155|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944156|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944157|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14125836|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
14125837|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14125838|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125839|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14125840|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125841|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125842|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944158|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13944159|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13944160|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13944161|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
13944162|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
13944163|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
13944164|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
13944165|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944166|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944167|NCT03269760|Zolpidem|zolpidem|mesh-list
13944168|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13944169|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13944170|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944171|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944172|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13944173|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
14125843|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125844|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14125845|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14125846|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14125847|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14125848|NCT05106803|Renal Agents|renal agents|mesh-ancestor
14125849|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
14125850|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14125851|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14125852|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14125853|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14125854|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14125855|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125856|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14125857|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
14125858|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14125859|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
14125860|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125861|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
14125862|NCT05106751|Protective Agents|protective agents|mesh-ancestor
14125863|NCT05106712|Vitamin D|vitamin d|mesh-list
14125864|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
14125865|NCT05106712|Letrozole|letrozole|mesh-list
14125866|NCT05106712|Clomiphene|clomiphene|mesh-list
14125867|NCT05106712|Enclomiphene|enclomiphene|mesh-list
14125868|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
14125869|NCT05106712|Vitamins|vitamins|mesh-ancestor
14125870|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
14125871|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125872|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14125873|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125874|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14125875|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125876|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14125877|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14125878|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125879|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14125880|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
14125881|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125882|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14125883|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
14125884|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14125885|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14125886|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14125887|NCT05093621|Torsemide|torsemide|mesh-list
14125888|NCT05093621|Furosemide|furosemide|mesh-list
14125889|NCT05093621|Diuretics|diuretics|mesh-ancestor
14125890|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
14125891|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125892|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14125893|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14125894|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125895|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14125896|NCT05083000|Topotecan|topotecan|mesh-list
13944174|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
13944175|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125897|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14125898|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125899|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125900|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125901|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177101|NCT04758689|Methotrexate|methotrexate|mesh-list
14177102|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14177103|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
14177104|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177105|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177106|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14177107|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
14177108|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177109|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177110|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
14177111|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177112|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14177113|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177114|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
14177115|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177116|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14177117|NCT04758728|Epinephrine|epinephrine|mesh-list
14177118|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13944176|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944177|NCT03270007|Vinorelbine|vinorelbine|mesh-list
13944178|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13944179|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944180|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
13944181|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
13944182|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
13944183|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944184|NCT03269786|Bilirubin|bilirubin|mesh-list
14936605|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936606|NCT01470092|Tibolone|tibolone|mesh-list
14936607|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
14936608|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944185|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
13944186|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177119|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14177120|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177121|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177122|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177123|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177124|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14177125|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14177126|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
14177127|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177128|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14177129|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
14177130|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
14177131|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
14177132|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14177133|NCT04758260|Antioxidants|antioxidants|mesh-list
14177134|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177135|NCT04758260|Protective Agents|protective agents|mesh-ancestor
14177136|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177137|NCT04758286|Anesthetics|anesthetics|mesh-list
14177138|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177139|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177140|NCT04757883|Antibodies|antibodies|mesh-list
14177141|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
14177142|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177143|NCT04758273|Vaccines|vaccines|mesh-list
14177144|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
14177145|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177146|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
14177147|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14177148|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177149|NCT04758000|Metformin|metformin|mesh-list
14177150|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14177151|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177152|NCT04757974|Fostemsavir|fostemsavir|mesh-list
14177153|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14936609|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183778|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
14125902|NCT05010421|Clobetasol|clobetasol|mesh-list
14125903|NCT05010421|Emollients|emollients|mesh-list
14125904|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125905|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
14125906|NCT05010421|Hormones|hormones|mesh-ancestor
14125907|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125908|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125909|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
14125910|NCT05004077|Amiodarone|amiodarone|mesh-list
14125911|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14125912|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
14125913|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14125914|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14125915|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125916|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14125917|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14125918|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14125919|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125920|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14763094|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125921|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14125922|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14125923|NCT04977024|Vaccines|vaccines|mesh-list
14125924|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
14125925|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125926|NCT04962126|Atezolizumab|atezolizumab|mesh-list
14125927|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
14125928|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14125929|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125930|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14125931|NCT04930042|Ustekinumab|ustekinumab|mesh-list
14125932|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14125933|NCT04903093|Famotidine|famotidine|mesh-list
14125934|NCT04903093|Abrocitinib|abrocitinib|mesh-list
14125935|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14125936|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125937|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14125938|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
14125939|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
14125940|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14125941|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14125942|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125943|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14125944|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125945|NCT04833413|Insulin|insulin|mesh-list
14125946|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14125947|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14125948|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125949|NCT04771689|Buprenorphine|buprenorphine|mesh-list
14125950|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14125951|NCT04771689|Naloxone|naloxone|mesh-list
14125952|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14125953|NCT04771689|Narcotics|narcotics|mesh-ancestor
13944187|NCT03269786|Protective Agents|protective agents|mesh-ancestor
13944188|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944189|NCT03270033|Dexamethasone|dexamethasone|mesh-list
13944190|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
13944191|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
13944192|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13944193|NCT03270033|BB 1101|bb 1101|mesh-list
13944194|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944195|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
13944196|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
13944197|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944198|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944199|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13944200|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
13944201|NCT03270033|Hormones|hormones|mesh-ancestor
13944202|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125954|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14125955|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125956|NCT04771689|Analgesics|analgesics|mesh-ancestor
14125957|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
14125958|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125959|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14125960|NCT04751877|Dexamethasone|dexamethasone|mesh-list
14125961|NCT04751877|Lenalidomide|lenalidomide|mesh-list
14125962|NCT04751877|Bortezomib|bortezomib|mesh-list
14125963|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14125964|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
14125965|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
14125966|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14125967|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125968|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14125969|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
14125970|NCT04751877|Hormones|hormones|mesh-ancestor
14125971|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14125972|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14125973|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125974|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
14125975|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14125976|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14125977|NCT04751877|Growth Substances|growth substances|mesh-ancestor
14125978|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
14125979|NCT04722978|Gemcitabine|gemcitabine|mesh-list
14125980|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
14125981|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14125982|NCT04722978|Carboplatin|carboplatin|mesh-list
14125983|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14125984|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14125985|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14125986|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
14125987|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944203|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13944204|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944205|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
13944206|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944207|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944208|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13944209|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944210|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944211|NCT03270033|Analgesics|analgesics|mesh-ancestor
13944212|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
13944213|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13944214|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13944215|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13944216|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
13944217|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944218|NCT03269916|Hormones|hormones|mesh-list
13944219|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13944220|NCT03269916|Estrogens|estrogens|mesh-list
13944221|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944222|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944223|NCT03269747|Prednisone|prednisone|mesh-list
13944224|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944225|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
13944226|NCT03269747|Hormones|hormones|mesh-ancestor
13944227|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944228|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944229|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13944230|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944231|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
14125988|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
14125989|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14125990|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14125991|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14125992|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
14125993|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14125994|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14125995|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14125996|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14125997|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
14125998|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14125999|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14126000|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14183779|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
14126001|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14126002|NCT04695106|Aspirin|aspirin|mesh-list
14126003|NCT04695106|Dabigatran|dabigatran|mesh-list
14126004|NCT04695106|Clopidogrel|clopidogrel|mesh-list
14126005|NCT04695106|Ticagrelor|ticagrelor|mesh-list
14126006|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14126007|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14126008|NCT04695106|Analgesics|analgesics|mesh-ancestor
14126009|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
14126010|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126011|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126012|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14936610|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936611|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14936612|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13944232|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
13944233|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944234|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
13944235|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944236|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944237|NCT03269955|Thrombin|thrombin|mesh-list
13944238|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
13944239|NCT03269955|Coagulants|coagulants|mesh-ancestor
13944240|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13944241|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13944242|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944243|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
13944244|NCT03269799|Ascorbic Acid|ascorbic acid|mesh-list
13944245|NCT03269799|Vitamins|vitamins|mesh-ancestor
13944246|NCT03269799|Micronutrients|micronutrients|mesh-ancestor
13944247|NCT03269799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944248|NCT03269799|Antioxidants|antioxidants|mesh-ancestor
13944249|NCT03269799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944250|NCT03269799|Protective Agents|protective agents|mesh-ancestor
13944251|NCT03269591|Diclofenac|diclofenac|mesh-list
13944252|NCT03269591|Progesterone|progesterone|mesh-list
13944253|NCT03269591|Progestins|progestins|mesh-ancestor
13944254|NCT03269591|Hormones|hormones|mesh-ancestor
13944255|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944256|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944257|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13944258|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944259|NCT03269591|Analgesics|analgesics|mesh-ancestor
13944260|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
13944261|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944262|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944263|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13944264|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13944265|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944266|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944267|NCT03269383|Bupivacaine|bupivacaine|mesh-list
13944268|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944269|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
13944270|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944271|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944272|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
13944273|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944274|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
13944275|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944276|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962148|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
13962149|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962150|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962151|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
13962152|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962153|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963493|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963494|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963495|NCT03143946|Vitamins|vitamins|mesh-list
13963496|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
13963497|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963498|NCT03143933|Fentanyl|fentanyl|mesh-list
13963499|NCT03143933|Propofol|propofol|mesh-list
13963500|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13963501|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126013|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13944277|NCT03269214|Phenytoin|phenytoin|mesh-list
13944278|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
13944279|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13944280|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13944281|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13944282|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944283|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13944284|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13944285|NCT03269279|Misoprostol|misoprostol|mesh-list
13944286|NCT03269279|Mifepristone|mifepristone|mesh-list
13944287|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13944288|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
13944289|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944290|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944291|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13944292|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13944293|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
13944294|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13944295|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13944296|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14126014|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14126015|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14126016|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126017|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14126018|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14126019|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126020|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
14126021|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14126022|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14126023|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13944297|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13944298|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
13944299|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13944300|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13944301|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944302|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944303|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
13944304|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13944305|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13944306|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
13944307|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13944308|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944309|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14126024|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
14126025|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126026|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
14126027|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14126028|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
14126029|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
14126030|NCT04658147|Nivolumab|nivolumab|mesh-list
14126031|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126032|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126033|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14126034|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126035|NCT04614974|Famotidine|famotidine|mesh-list
14126036|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14126037|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126038|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14126039|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
14126040|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
14126041|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126042|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936613|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944310|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944311|NCT03269318|Theophylline|theophylline|mesh-list
13944312|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13944313|NCT03269318|Montelukast|montelukast|mesh-list
13944314|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13944315|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
13944316|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944317|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944318|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13944319|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
14126043|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126044|NCT04576767|Anesthetics|anesthetics|mesh-list
14126045|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126046|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126047|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
14126048|NCT04537286|Paclitaxel|paclitaxel|mesh-list
14126049|NCT04537286|Cisplatin|cisplatin|mesh-list
14126050|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14126051|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126052|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
14126053|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
14126054|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
14126055|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126056|NCT04527887|Dexamethasone|dexamethasone|mesh-list
14126057|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14126058|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
14126059|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
14126060|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126061|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126062|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126063|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
14126064|NCT04527887|Hormones|hormones|mesh-ancestor
14126065|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126066|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14126067|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936614|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14936615|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
14936616|NCT01470092|Hormones|hormones|mesh-ancestor
14936617|NCT01470157|Ketamine|ketamine|mesh-list
14936618|NCT01470157|Analgesics|analgesics|mesh-ancestor
14936619|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
14936620|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126068|NCT04486625|Aztreonam|aztreonam|mesh-list
14126069|NCT04486625|Avibactam|avibactam|mesh-list
14126070|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13944320|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13944321|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13944322|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13944323|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
13944324|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944325|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944326|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13944327|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944328|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944329|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13944330|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13944331|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13944332|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944333|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
13944334|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13944335|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13944336|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
13944337|NCT03268733|Folic Acid|folic acid|mesh-list
13944338|NCT03268733|Hematinics|hematinics|mesh-ancestor
13944339|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
13944340|NCT03268733|Vitamins|vitamins|mesh-ancestor
13944341|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
13944342|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944343|NCT03269162|Docetaxel|docetaxel|mesh-list
13944344|NCT03269162|Pemetrexed|pemetrexed|mesh-list
13944345|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944346|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
13944347|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
13944348|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
13944349|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944350|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944351|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13944352|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13944353|NCT03268902|Niacinamide|niacinamide|mesh-list
13944354|NCT03268902|Niacin|niacin|mesh-list
14126071|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936621|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126072|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13944355|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
14126073|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126074|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126075|NCT04316364|Paclitaxel|paclitaxel|mesh-list
14126076|NCT04316364|Carboplatin|carboplatin|mesh-list
14126077|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14126078|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126079|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
14126080|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
14126081|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
14126082|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126083|NCT04235686|Amphetamine|amphetamine|mesh-list
14126084|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
14126085|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14126086|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126087|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
14126088|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
14126089|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944356|NCT03268902|Azithromycin|azithromycin|mesh-list
13944357|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
13944358|NCT03268902|Vitamins|vitamins|mesh-ancestor
13944359|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
13944360|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944361|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13944362|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944363|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
13944364|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13944365|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
13944366|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126090|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
14126091|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126092|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126093|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
14126094|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14126095|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14126096|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14126097|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13944367|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13944368|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
13944369|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13944370|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
13944371|NCT03268525|Bupivacaine|bupivacaine|mesh-list
13944372|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944373|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
13944374|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944375|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944376|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
13944377|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944378|NCT03268278|Lidocaine|lidocaine|mesh-list
13944379|NCT03268278|Epinephrine|epinephrine|mesh-list
13944380|NCT03268278|Buprenorphine|buprenorphine|mesh-list
13944381|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
13944382|NCT03268278|Anesthetics|anesthetics|mesh-list
14126098|NCT04210141|Antivenins|antivenins|mesh-list
14126099|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
14126100|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944383|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944384|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944385|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
13944386|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944387|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13944388|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13944389|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13944390|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13944391|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944392|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14126101|NCT04199767|Insulin|insulin|mesh-list
14126102|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14126103|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
14126104|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14126105|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126106|NCT04168710|Bupivacaine|bupivacaine|mesh-list
14126107|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
14126108|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
14126109|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944393|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13944394|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
14126110|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126111|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
14126112|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177154|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14177155|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
14177156|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944395|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944396|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13944397|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13944398|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
13944399|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13944400|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
13944401|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
13944402|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
13944403|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13944404|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13944405|NCT03268278|Narcotics|narcotics|mesh-ancestor
13944406|NCT03268278|Analgesics|analgesics|mesh-ancestor
13944407|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13944408|NCT03268382|Doxorubicin|doxorubicin|mesh-list
13944409|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13944410|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13944411|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944412|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13944413|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13944414|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177157|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14177158|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14177159|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177160|NCT04757779|Docetaxel|docetaxel|mesh-list
14177161|NCT04757779|Irinotecan|irinotecan|mesh-list
14177162|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177163|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
14177164|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
14177165|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
14177166|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177167|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14177168|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13944415|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944416|NCT03268226|Beclomethasone|beclomethasone|mesh-list
13944417|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
13944418|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
14177169|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177170|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
14177171|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14177172|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14177173|NCT04757740|Prednisolone|prednisolone|mesh-list
14177174|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
14177175|NCT04757740|Lidocaine|lidocaine|mesh-list
14177176|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14177177|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
14177178|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
14177179|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
14177180|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177181|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177182|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
14177183|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177184|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14177185|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14177186|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14177187|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177188|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177189|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944419|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13944420|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
13944421|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944422|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944423|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13944424|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
13944425|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13944426|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13944427|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14177190|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
14177191|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
13944428|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177192|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126113|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14126114|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14126115|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944429|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944430|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944431|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13944432|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13944433|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14126135|NCT04018872|Itraconazole|itraconazole|mesh-list
14126136|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
14126137|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126138|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14126139|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14126140|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944434|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
13944435|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944436|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
13944437|NCT03268226|Hormones|hormones|mesh-ancestor
13944438|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944439|NCT03268057|Avelumab|avelumab|mesh-list
13944440|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13944441|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944442|NCT03267771|Progesterone|progesterone|mesh-list
14126141|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126142|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14126143|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
14126144|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126145|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126146|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14126147|NCT04001777|Osimertinib|osimertinib|mesh-list
14126148|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126149|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14126150|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126151|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126152|NCT03982576|Nicotine|nicotine|mesh-list
14126153|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14126154|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
14126155|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126156|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126157|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13944443|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
13944444|NCT03267771|Progestins|progestins|mesh-ancestor
14126158|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14126159|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
14126160|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126161|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126162|NCT03969641|Vaccines|vaccines|mesh-list
14126163|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
14126164|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126165|NCT03965923|Tenofovir|tenofovir|mesh-list
14126166|NCT03965923|Emtricitabine|emtricitabine|mesh-list
14126167|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14126168|NCT03965923|Dapivirine|dapivirine|mesh-list
14126169|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
13944445|NCT03267771|Hormones|hormones|mesh-ancestor
13944446|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944447|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944448|NCT03267628|Morphine|morphine|mesh-list
13944449|NCT03267628|Anesthetics|anesthetics|mesh-list
13944450|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
13944451|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13944452|NCT03267628|Narcotics|narcotics|mesh-ancestor
13944453|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126170|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126171|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14126172|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14126173|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126174|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126175|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14126176|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14126177|NCT03942328|Vaccines|vaccines|mesh-list
14126178|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
14126179|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126180|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14126181|NCT03933813|Hematinics|hematinics|mesh-ancestor
14126182|NCT03875144|Cisplatin|cisplatin|mesh-list
14126183|NCT03875144|Doxorubicin|doxorubicin|mesh-list
14126184|NCT03875144|Pemetrexed|pemetrexed|mesh-list
14126185|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126186|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14126187|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14126188|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14126189|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126190|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126191|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14126192|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14126193|NCT03814005|Paclitaxel|paclitaxel|mesh-list
14126194|NCT03814005|Docetaxel|docetaxel|mesh-list
14126195|NCT03814005|Carboplatin|carboplatin|mesh-list
14126196|NCT03814005|Azacitidine|azacitidine|mesh-list
13944454|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944455|NCT03267628|Analgesics|analgesics|mesh-ancestor
13944456|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
13944457|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944458|NCT03268018|Calcium|calcium|mesh-list
13944459|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13944460|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944461|NCT03267654|Apatinib|apatinib|mesh-list
13944462|NCT03267654|Gefitinib|gefitinib|mesh-list
13944463|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944464|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13944465|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944466|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962154|NCT04935476|Dapsone|dapsone|mesh-list
13962155|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962156|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
13962157|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13962158|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13962159|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13962160|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962161|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962162|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
13962163|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962164|NCT04930107|Fluconazole|fluconazole|mesh-list
13962165|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
13962166|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962167|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13962168|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13962169|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962170|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962171|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13962172|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
13962173|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962174|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962175|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13962176|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14126197|NCT03814005|Pevonedistat|pevonedistat|mesh-list
14126198|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14126199|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944467|NCT03267680|Indomethacin|indomethacin|mesh-list
13944468|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
13944469|NCT03267680|Omeprazole|omeprazole|mesh-list
13944470|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13944471|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
13944472|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944473|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13944474|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13944475|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
13944476|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944477|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944478|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13944479|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13944480|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13944481|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13944482|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944483|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14126200|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14126201|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14126202|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14126203|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126204|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13944484|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944485|NCT03267680|Analgesics|analgesics|mesh-ancestor
13944486|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
13944487|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944488|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944489|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
13944490|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
13944491|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944492|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13944493|NCT03267407|Fluconazole|fluconazole|mesh-list
13944494|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
14126205|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
14126206|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126207|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14126208|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14126209|NCT03740204|Estradiol|estradiol|mesh-list
14126210|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14126211|NCT03740204|Progesterone|progesterone|mesh-list
14126212|NCT03740204|Estrogens|estrogens|mesh-ancestor
14126213|NCT03740204|Hormones|hormones|mesh-ancestor
14126214|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126215|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126216|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14126217|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
14126218|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14126219|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14126220|NCT03740204|Progestins|progestins|mesh-ancestor
14126221|NCT03726671|Choline|choline|mesh-list
14126222|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
14126223|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14126224|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
14126225|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126226|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126227|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14126228|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
14126229|NCT03701711|Lenalidomide|lenalidomide|mesh-list
14126230|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
14126231|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126232|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14126233|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14126234|NCT03701711|Growth Substances|growth substances|mesh-ancestor
13944495|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944496|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13962177|NCT04889547|Dexamethasone|dexamethasone|mesh-list
14126235|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
14126236|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126237|NCT03685773|Niacin|niacin|mesh-list
14126238|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
14126239|NCT03685773|Niacinamide|niacinamide|mesh-list
14126240|NCT03685773|Diazoxide|diazoxide|mesh-list
14126241|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14126242|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
14126243|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126244|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14126245|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
14126246|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
14126247|NCT03685773|Vitamins|vitamins|mesh-ancestor
14126248|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
14126249|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944497|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13944498|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944499|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944500|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13944501|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944502|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944503|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944504|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13944505|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13944506|NCT03267316|Gemcitabine|gemcitabine|mesh-list
13944507|NCT03267316|Paclitaxel|paclitaxel|mesh-list
14126250|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14126251|NCT03596073|Calcipotriene|calcipotriene|mesh-list
14126252|NCT03596073|Petrolatum|petrolatum|mesh-list
14126253|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
14126254|NCT03596073|Emollients|emollients|mesh-ancestor
14126255|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14126256|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14126257|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126258|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126259|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
14126260|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126261|NCT03579914|Metoprolol|metoprolol|mesh-list
14126262|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14126263|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14126264|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
14126265|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
13944508|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13944509|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126266|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126267|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126268|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13944510|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
13944511|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
13944512|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
13944513|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944514|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13944515|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
13944516|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
14126269|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14126270|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14126271|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
14126272|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126273|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126274|NCT03560258|Vaccines|vaccines|mesh-list
14126275|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
14126276|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126277|NCT03535363|Osimertinib|osimertinib|mesh-list
14126278|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126279|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14126280|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126281|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944517|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944518|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944519|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13944520|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
13944521|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944522|NCT03267329|Telmisartan|telmisartan|mesh-list
13944523|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13944524|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13944525|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13944526|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944527|NCT03267121|Apatinib|apatinib|mesh-list
13944528|NCT03267121|Tegafur|tegafur|mesh-list
13944529|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126282|NCT03384784|Galantamine|galantamine|mesh-list
14126283|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14126284|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126285|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126286|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
14126287|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944530|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13944531|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944532|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944533|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13944534|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
13944535|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
13944536|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13944537|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944538|NCT03266965|Carbidopa|carbidopa|mesh-list
13944539|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13944540|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13944541|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
13944542|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944543|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944544|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944545|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13944546|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944547|NCT03266926|Bupivacaine|bupivacaine|mesh-list
13944548|NCT03266926|Estrogens|estrogens|mesh-list
13944549|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
13944550|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944551|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
13944552|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944553|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944554|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
13944555|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944556|NCT03266926|Hormones|hormones|mesh-ancestor
13944557|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126288|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126289|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14126290|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
14126291|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126292|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
14126293|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
14126294|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126295|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126296|NCT03367572|Dexamethasone|dexamethasone|mesh-list
14126297|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
14126298|NCT03367572|Olanzapine|olanzapine|mesh-list
14126299|NCT03367572|Palonosetron|palonosetron|mesh-list
14126300|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
14126301|NCT03367572|Ichthammol|ichthammol|mesh-list
14126302|NCT03367572|BB 1101|bb 1101|mesh-list
14126303|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14126304|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
14126305|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
14126306|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126307|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126308|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126309|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
14126310|NCT03367572|Hormones|hormones|mesh-ancestor
14126311|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126312|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14126313|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126314|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14126315|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13944558|NCT03266991|Isoniazid|isoniazid|mesh-list
13944559|NCT03266991|Rifapentine|rifapentine|mesh-list
13944560|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
13944561|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13944562|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944563|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13944564|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13944565|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
13944566|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944567|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13944568|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13944569|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
13944570|NCT03266731|Aspirin|aspirin|mesh-list
13944571|NCT03266731|Clopidogrel|clopidogrel|mesh-list
13944572|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13944573|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944574|NCT03266731|Analgesics|analgesics|mesh-ancestor
13944575|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
13944576|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944577|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944578|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944579|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13944580|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13944581|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13944582|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944583|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13944584|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14126316|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126317|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14126318|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14126319|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14126320|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14126321|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126322|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763100|NCT01615029|Dexamethasone|dexamethasone|mesh-list
13944585|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944586|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
13944587|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14126323|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
14126324|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
14763101|NCT01615029|Lenalidomide|lenalidomide|mesh-list
13944588|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13944589|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13944590|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
13944591|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944592|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13944593|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13944594|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944595|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
13944596|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13944597|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13944598|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944599|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
13944600|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944601|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944602|NCT03266601|Interferons|interferons|mesh-list
13944603|NCT03266601|Ribavirin|ribavirin|mesh-list
13944604|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944605|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
13944606|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944607|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
13944608|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944609|NCT03266393|Tacrolimus|tacrolimus|mesh-list
13944610|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13944611|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
13944612|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944613|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13944614|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944615|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944616|NCT03266159|Trametinib|trametinib|mesh-list
13944617|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944618|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13944619|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944620|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944621|NCT03266250|Anesthetics|anesthetics|mesh-list
13944622|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944623|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944624|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
13944625|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13944626|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13944627|NCT03266146|Prednisolone|prednisolone|mesh-list
13944628|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
14126325|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126326|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14126327|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13944629|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13944630|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
13944631|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944632|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
13944633|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
13944634|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944635|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944636|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13944637|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
13944638|NCT03266146|Hormones|hormones|mesh-ancestor
13944639|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944640|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13944641|NCT03266146|Protective Agents|protective agents|mesh-ancestor
13944642|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13944643|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944644|NCT03266445|Buprenorphine|buprenorphine|mesh-list
13944645|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13944646|NCT03266445|Naloxone|naloxone|mesh-list
13944647|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13944648|NCT03266445|Narcotics|narcotics|mesh-ancestor
13944649|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944650|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944651|NCT03266445|Analgesics|analgesics|mesh-ancestor
13944652|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
13944653|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944654|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13944655|NCT03266081|Bupivacaine|bupivacaine|mesh-list
13944656|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944657|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
13944658|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944659|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944660|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
13944661|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944662|NCT03265886|Bupivacaine|bupivacaine|mesh-list
13944663|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944664|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
13944665|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944666|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944667|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
13944668|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944669|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13944670|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13944671|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944672|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
13962178|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
13962179|NCT04889547|BB 1101|bb 1101|mesh-list
13962180|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962181|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
13962182|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
13962183|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962184|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962185|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13962186|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
13962187|NCT04889547|Hormones|hormones|mesh-ancestor
13962188|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962189|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962190|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962191|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
13962192|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962193|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962194|NCT04875364|Eszopiclone|eszopiclone|mesh-list
13962195|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14126328|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14126329|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14126330|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
14126331|NCT03293017|Diazepam|diazepam|mesh-list
14126332|NCT03293017|Baclofen|baclofen|mesh-list
14126333|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14126334|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126335|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14126336|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126337|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14126338|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
14126339|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
14126340|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126341|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962196|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962197|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962198|NCT04873453|Cannabidiol|cannabidiol|mesh-list
13962199|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
13962200|NCT04862949|Bevacizumab|bevacizumab|mesh-list
13962201|NCT04862949|Atezolizumab|atezolizumab|mesh-list
13962202|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962203|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962204|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13962205|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13962206|NCT04862949|Growth Substances|growth substances|mesh-ancestor
13962207|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962208|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
13962209|NCT04861064|Sirolimus|sirolimus|mesh-list
13962210|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962211|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962212|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13962213|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962214|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
13962215|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962216|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
13962217|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962218|NCT04860635|Celecoxib|celecoxib|mesh-list
13962219|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13962220|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13962221|NCT04860635|Analgesics|analgesics|mesh-ancestor
13962222|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
14936622|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14126342|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14126343|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
14126344|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
14126345|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
13944673|NCT03265782|Acetaminophen|acetaminophen|mesh-list
13944674|NCT03265782|Ibuprofen|ibuprofen|mesh-list
13944675|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13944676|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944677|NCT03265782|Analgesics|analgesics|mesh-ancestor
13944678|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
13944679|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126346|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126347|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14126348|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126349|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14126350|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14126351|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14126352|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14126353|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
14126354|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
14126355|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
14126356|NCT03198559|Vorinostat|vorinostat|mesh-list
14126357|NCT03198559|Disulfiram|disulfiram|mesh-list
14126358|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126359|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14126360|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126361|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126362|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14126363|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14126364|NCT03179943|Atezolizumab|atezolizumab|mesh-list
14126365|NCT03179943|Guadecitabine|guadecitabine|mesh-list
14126366|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126367|NCT03136263|Oxytocin|oxytocin|mesh-list
14126368|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
14126369|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14126370|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126371|NCT03129113|Metformin|metformin|mesh-list
14126372|NCT03129113|Maraviroc|maraviroc|mesh-list
14126373|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14126374|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126375|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13944680|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944681|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944682|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13944683|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13944684|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944685|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944686|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
13944687|NCT03265470|Fentanyl|fentanyl|mesh-list
13944688|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
13944689|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13944690|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944691|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944692|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944693|NCT03265470|Analgesics|analgesics|mesh-ancestor
13944694|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
13944695|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944696|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13944697|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13944698|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13944699|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
13944700|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944701|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944702|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13944703|NCT03265470|Narcotics|narcotics|mesh-ancestor
13944704|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13944705|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13944706|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
13944707|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
13944708|NCT03265899|Lactitol|lactitol|mesh-list
13944709|NCT03265899|Oxytocin|oxytocin|mesh-list
13944710|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
13944711|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944712|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944713|NCT03265899|Cathartics|cathartics|mesh-ancestor
13944714|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13944715|NCT03265574|Enalapril|enalapril|mesh-list
14126376|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14126377|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126378|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14126379|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14126380|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
14126381|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126382|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13944716|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13944717|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
13944718|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944719|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944720|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14126383|NCT03102125|Regadenoson|regadenoson|mesh-list
14126384|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14126385|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14126386|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
14126387|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
14126388|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126389|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126390|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126391|NCT02982668|Metoclopramide|metoclopramide|mesh-list
14126392|NCT02982668|Mosapride|mosapride|mesh-list
14126393|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
14126394|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
14126395|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126396|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126397|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126398|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14126399|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14126400|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
14126401|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126402|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126403|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14126404|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
14126405|NCT02917096|Vidarabine|vidarabine|mesh-list
14126406|NCT02917096|Sirolimus|sirolimus|mesh-list
14126407|NCT02917096|Fludarabine|fludarabine|mesh-list
14126408|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
13944721|NCT03265795|Ether|ether|mesh-list
13944722|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13944723|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
13944724|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
13944725|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944726|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478380|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
14478381|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
14478382|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14126409|NCT02917096|Melphalan|melphalan|mesh-list
14126410|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
14126411|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14126412|NCT02917096|Tacrolimus|tacrolimus|mesh-list
14126413|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126414|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14126415|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
14126416|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126417|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763102|NCT01615029|Daratumumab|daratumumab|mesh-list
14478383|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478384|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
14478385|NCT02451930|Necitumumab|necitumumab|mesh-list
14478386|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478387|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478388|NCT02452034|Posaconazole|posaconazole|mesh-list
14478389|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
14763103|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14763104|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14763105|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
14763106|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
14763107|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763108|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126418|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
14126419|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126420|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
14763109|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478390|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126421|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126422|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14763110|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
14478391|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14763111|NCT01615029|Hormones|hormones|mesh-ancestor
14126423|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126424|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14126425|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14126426|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
14126427|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14126428|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
14126429|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14126430|NCT02917083|Cyclophosphamide|cyclophosphamide|mesh-list
14126431|NCT02917083|Fludarabine|fludarabine|mesh-list
14126432|NCT02917083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126433|NCT02917083|Immunologic Factors|immunologic factors|mesh-ancestor
14126434|NCT02917083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126435|NCT02917083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126436|NCT02917083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14126437|NCT02917083|Alkylating Agents|alkylating agents|mesh-ancestor
14126438|NCT02917083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126439|NCT02917083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126440|NCT02917083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14126441|NCT02913274|Paclitaxel|paclitaxel|mesh-list
14126442|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14126443|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126444|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
14126445|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
14126446|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
14126447|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126448|NCT02908477|Docetaxel|docetaxel|mesh-list
14126449|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126450|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
14126451|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
14126452|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
14126453|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126454|NCT02906007|Bedaquiline|bedaquiline|mesh-list
14126455|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
14126456|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14126457|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126458|NCT02775812|Cisplatin|cisplatin|mesh-list
14126459|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
14126460|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126461|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126462|NCT02757859|Pancrelipase|pancrelipase|mesh-list
14126463|NCT02757859|Pancreatin|pancreatin|mesh-list
14126464|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126465|NCT02749513|Itraconazole|itraconazole|mesh-list
14126466|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
14126467|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126468|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14126469|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14126470|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126471|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126472|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14126473|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
14126474|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126475|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126476|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14126477|NCT02684227|Paclitaxel|paclitaxel|mesh-list
14126478|NCT02684227|Carboplatin|carboplatin|mesh-list
14126479|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14126480|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14126481|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126482|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14126483|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14126484|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14126485|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177193|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
14177194|NCT04757740|Hormones|hormones|mesh-ancestor
14177195|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763112|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763113|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763114|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763115|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
14763116|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14177196|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14177197|NCT04757740|Protective Agents|protective agents|mesh-ancestor
14763117|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14478392|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14126486|NCT02682641|Rituximab|rituximab|mesh-list
14126487|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126488|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126489|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
14126490|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126491|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126492|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
14126493|NCT05110339|Ropivacaine|ropivacaine|mesh-list
14126494|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14126495|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126496|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478393|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14478394|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14478395|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14478396|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478397|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478398|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14763118|NCT01615029|Growth Substances|growth substances|mesh-ancestor
13944747|NCT03265002|Psyllium|psyllium|mesh-list
13944748|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
13944749|NCT03265002|Cathartics|cathartics|mesh-ancestor
13944750|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126497|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14126498|NCT05110339|Analgesics|analgesics|mesh-ancestor
14126499|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
14126500|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126501|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14126502|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14126503|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14126504|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
14126505|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126506|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126507|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
14126508|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
14126509|NCT05110170|Goserelin|goserelin|mesh-list
14126510|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14126511|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126512|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14126513|NCT05110144|Amitriptyline|amitriptyline|mesh-list
14126514|NCT05110144|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14126515|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14126516|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14126517|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14126518|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126519|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126520|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126521|NCT05110144|Analgesics|analgesics|mesh-ancestor
14126522|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
14126523|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126524|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
14126525|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14126526|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
14126527|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14126528|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14126529|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14126530|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
14126531|NCT05110144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14126532|NCT05110144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14126533|NCT05110144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126534|NCT05110118|Bevacizumab|bevacizumab|mesh-list
14126535|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
14126536|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126537|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126538|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14126539|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14126540|NCT05110118|Growth Substances|growth substances|mesh-ancestor
14126541|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126542|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
14763119|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
14763120|NCT01505608|Irinotecan|irinotecan|mesh-list
14763121|NCT01505608|Temozolomide|temozolomide|mesh-list
13944751|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
14126543|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14126544|NCT05109650|Antibodies|antibodies|mesh-list
14126545|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
14126546|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
14126547|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126548|NCT05109585|Antibodies|antibodies|mesh-list
14126549|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
14126550|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
14126551|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
14126552|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126553|NCT05109390|Cyclosporine|cyclosporine|mesh-list
14126554|NCT05109390|Simethicone|simethicone|mesh-list
14126555|NCT05109390|Omeprazole|omeprazole|mesh-list
14126556|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
14126557|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
14126558|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14126559|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
14126560|NCT05109390|Antacids|antacids|mesh-list
14126561|NCT05109390|Tacrolimus|tacrolimus|mesh-list
14126562|NCT05109390|Cyclosporins|cyclosporins|mesh-list
14126563|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126564|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126565|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
14126566|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14126567|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126568|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126569|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
14126570|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126571|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
14126572|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126573|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126574|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14126575|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
14126576|NCT05109390|Emollients|emollients|mesh-ancestor
14126577|NCT05109377|Tadalafil|tadalafil|mesh-list
14126578|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
14126579|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14126580|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14763122|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14763123|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14763124|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763125|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763126|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763127|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14763128|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
14763129|NCT01314118|Prednisone|prednisone|mesh-list
14763130|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
14763131|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14763132|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
14763133|NCT01314118|Hormones|hormones|mesh-ancestor
14763134|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944752|NCT03265288|Fenretinide|fenretinide|mesh-list
13944753|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944754|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13944755|NCT03265288|Protective Agents|protective agents|mesh-ancestor
13944756|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944757|NCT03265171|Plasminogen|plasminogen|mesh-list
13944758|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13944759|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13944760|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944761|NCT03265223|Ropivacaine|ropivacaine|mesh-list
13944762|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944763|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
13944764|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763135|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763136|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763137|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763138|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14763139|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763140|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763141|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
14126581|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126582|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126583|NCT05109377|Urological Agents|urological agents|mesh-ancestor
14126584|NCT05109312|Acetaminophen|acetaminophen|mesh-list
14126585|NCT05109312|Ibuprofen|ibuprofen|mesh-list
14126586|NCT05109312|Bupivacaine|bupivacaine|mesh-list
14126587|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944765|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944766|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
13944767|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944768|NCT03265197|Lidocaine|lidocaine|mesh-list
13944769|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944770|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
13944771|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944772|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944773|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
13944774|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944775|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13944776|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13944777|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13944778|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13944779|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944780|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
13944781|NCT03264638|Cyproterone|cyproterone|mesh-list
13944782|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
13944783|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
13944784|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944785|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944786|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944787|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126588|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
14126589|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944788|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13944789|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
13944790|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944791|NCT03264651|Anastrozole|anastrozole|mesh-list
13944792|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13944793|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944794|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13944795|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13944796|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944797|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944798|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13944799|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944800|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944801|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944802|NCT03264794|Gefitinib|gefitinib|mesh-list
13944803|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126590|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126591|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
14126592|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126593|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14126594|NCT05109312|Analgesics|analgesics|mesh-ancestor
14126595|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
14126596|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14126597|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14126598|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126599|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14126600|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126601|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126602|NCT05109299|Fluorides|fluorides|mesh-list
14126603|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
14126604|NCT05109299|Protective Agents|protective agents|mesh-ancestor
14763142|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14763151|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14763152|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14763153|NCT01227616|Hematinics|hematinics|mesh-ancestor
14763154|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14763155|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14763156|NCT01192698|Interferons|interferons|mesh-list
14126605|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126614|NCT05108714|Lidocaine|lidocaine|mesh-list
14126615|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
14126616|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
13944804|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13944805|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944806|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126617|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126618|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126619|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
14126620|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126621|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14126622|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14126623|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14126624|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14126625|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126626|NCT05108597|Misoprostol|misoprostol|mesh-list
14126627|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14126628|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
14126629|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944807|NCT03264781|CycloProvera|cycloprovera|mesh-list
13944808|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13944809|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13944810|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13944811|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
13944812|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944813|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944814|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13944815|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13944816|NCT03264911|Amoxicillin|amoxicillin|mesh-list
13944817|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13944818|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944819|NCT03264586|Lidocaine|lidocaine|mesh-list
13944820|NCT03264586|Prilocaine|prilocaine|mesh-list
13944821|NCT03264586|Mepivacaine|mepivacaine|mesh-list
13944822|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13944823|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944824|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
13944825|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944826|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944827|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
13944828|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944829|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13944830|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13944831|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13944832|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13944833|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944834|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14126630|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126631|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14936623|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14936624|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
14936625|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
14763157|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763158|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
14763159|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763160|NCT01188096|Poly ICLC|poly iclc|mesh-list
14763161|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
14763162|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
14763163|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936626|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14936627|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14936628|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14936629|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936630|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936631|NCT01470209|Everolimus|everolimus|mesh-list
14936632|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936633|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14936634|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
14126632|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126633|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
14126634|NCT05108545|Amphotericin B|amphotericin b|mesh-list
14126635|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14126636|NCT05108545|Amebicides|amebicides|mesh-ancestor
14126637|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13944835|NCT03264625|Vitamin D|vitamin d|mesh-list
13944836|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
13944837|NCT03264625|Vitamins|vitamins|mesh-ancestor
13944838|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
13944839|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944840|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13944841|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13944842|NCT03264547|Paclitaxel|paclitaxel|mesh-list
13944843|NCT03264547|Docetaxel|docetaxel|mesh-list
13944844|NCT03264547|Trastuzumab|trastuzumab|mesh-list
13944845|NCT03264547|Pertuzumab|pertuzumab|mesh-list
13944846|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13944847|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944848|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
13944849|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
13944850|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
13944851|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944852|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962223|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962224|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126638|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14126639|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126640|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14126641|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
14126642|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
14126643|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14126644|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14126645|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126646|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
14126647|NCT05102695|Coagulants|coagulants|mesh-ancestor
14126648|NCT05098847|Lenvatinib|lenvatinib|mesh-list
14126649|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126650|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14126651|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962225|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962226|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962227|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13962228|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13962229|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126652|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126653|NCT05097118|Ketamine|ketamine|mesh-list
14126654|NCT05097118|Bupivacaine|bupivacaine|mesh-list
14126655|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
14126656|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
14126657|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126658|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126659|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
14126660|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126661|NCT05097118|Analgesics|analgesics|mesh-ancestor
14126662|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14126663|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14126664|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
14126665|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14126666|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14126667|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126668|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126669|NCT05093920|Doxorubicin|doxorubicin|mesh-list
14126670|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14126671|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14126672|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126673|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14126674|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14126675|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126676|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126677|NCT05053737|Atezolizumab|atezolizumab|mesh-list
14126678|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177198|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14177199|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177200|NCT04757506|Naltrexone|naltrexone|mesh-list
13963502|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126679|NCT05007769|Atezolizumab|atezolizumab|mesh-list
14126680|NCT05007769|Ramucirumab|ramucirumab|mesh-list
14126681|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126682|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
14126683|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126684|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126685|NCT04772300|Sirolimus|sirolimus|mesh-list
14126686|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14126687|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126688|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14126689|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126690|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
14126691|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126692|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
14126693|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126694|NCT04707222|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14126695|NCT04707222|Metronidazole|metronidazole|mesh-list
14126696|NCT04707222|Ciprofloxacin|ciprofloxacin|mesh-list
14126697|NCT04707222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126698|NCT04707222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14126699|NCT04707222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14126700|NCT04707222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14126701|NCT04707222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14126702|NCT04707222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126703|NCT04707222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126704|NCT04707222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936635|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936636|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
14936637|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14936638|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14936639|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
14936640|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126705|NCT04707222|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14126706|NCT04707222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14126707|NCT04701060|Apatinib|apatinib|mesh-list
13944853|NCT03264430|Ketamine|ketamine|mesh-list
13944854|NCT03264430|Bupivacaine|bupivacaine|mesh-list
13944855|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
13944856|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
13944857|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944858|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944859|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
13944860|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126708|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126709|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14126710|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126711|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126712|NCT04676477|Osimertinib|osimertinib|mesh-list
14126713|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
14126714|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14126715|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126716|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14126717|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126718|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126719|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126720|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
14126721|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126722|NCT04674462|Vaccines|vaccines|mesh-list
14126723|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
14126724|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126725|NCT04626141|Abaloparatide|abaloparatide|mesh-list
14126726|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14126727|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126728|NCT04595864|Leucovorin|leucovorin|mesh-list
14126729|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
13944861|NCT03264430|Analgesics|analgesics|mesh-ancestor
13944862|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13944863|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13944864|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
13944865|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13944866|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13944867|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13944868|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126730|NCT04595864|Calcium|calcium|mesh-list
14126731|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
14126732|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14126733|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126734|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126735|NCT04595864|Antidotes|antidotes|mesh-ancestor
14126736|NCT04595864|Protective Agents|protective agents|mesh-ancestor
14126737|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
14126738|NCT04595864|Vitamins|vitamins|mesh-ancestor
13944869|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
13944870|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
13944871|NCT03264118|Coagulants|coagulants|mesh-ancestor
13944872|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
13944873|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944874|NCT03264274|Aflibercept|aflibercept|mesh-list
13944875|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13944876|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13944877|NCT03264274|Growth Substances|growth substances|mesh-ancestor
13944878|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126739|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
14126740|NCT04583462|Metformin|metformin|mesh-list
14126741|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14126742|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126743|NCT04569383|Vaccines|vaccines|mesh-list
14126744|NCT04569383|Immunologic Factors|immunologic factors|mesh-ancestor
14126745|NCT04569383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126746|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
14126747|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14126748|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14126749|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944879|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
13944880|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944881|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13944882|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13944883|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944884|NCT03264079|Itraconazole|itraconazole|mesh-list
13944885|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
13944886|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944887|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13944888|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13944889|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944890|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944891|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13944892|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944893|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944894|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944895|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13944896|NCT03263936|Cytarabine|cytarabine|mesh-list
13944897|NCT03263936|Fludarabine|fludarabine|mesh-list
13944898|NCT03263936|Decitabine|decitabine|mesh-list
13944899|NCT03263936|Vorinostat|vorinostat|mesh-list
13944900|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126750|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
14126751|NCT04555343|Coagulants|coagulants|mesh-ancestor
14126752|NCT04495088|Leucovorin|leucovorin|mesh-list
14126753|NCT04495088|Folic Acid|folic acid|mesh-list
14126754|NCT04495088|Capecitabine|capecitabine|mesh-list
14126755|NCT04495088|Fluorouracil|fluorouracil|mesh-list
14126756|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
14126757|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
14126758|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14126759|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
14126760|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126761|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126762|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126763|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
14126764|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126765|NCT04495088|Antidotes|antidotes|mesh-ancestor
14126766|NCT04495088|Protective Agents|protective agents|mesh-ancestor
14126767|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
14126768|NCT04495088|Vitamins|vitamins|mesh-ancestor
14126769|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
14126770|NCT04495088|Hematinics|hematinics|mesh-ancestor
14126771|NCT04472494|Abatacept|abatacept|mesh-list
13944901|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14126772|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14126773|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126774|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944902|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
13944903|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944904|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126775|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126776|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
14126777|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126778|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126779|NCT04464408|Favipiravir|favipiravir|mesh-list
14126780|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
14126781|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126782|NCT04456322|Cisplatin|cisplatin|mesh-list
14126783|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
14126784|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126785|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126786|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
14126787|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14126788|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
14126789|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126790|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14126791|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13944905|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
13944906|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944907|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
13944908|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13944909|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126792|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
14126793|NCT04405167|Dexamethasone|dexamethasone|mesh-list
14126794|NCT04405167|Lenalidomide|lenalidomide|mesh-list
14126795|NCT04405167|Ixazomib|ixazomib|mesh-list
14126796|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14126797|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
14126798|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
14126799|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126800|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126801|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14126802|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
14126803|NCT04405167|Hormones|hormones|mesh-ancestor
14126804|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14126805|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14126806|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126807|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
14126808|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126809|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126810|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
14126811|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14126812|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14126813|NCT04405167|Growth Substances|growth substances|mesh-ancestor
14126814|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14126815|NCT04383119|Gemcitabine|gemcitabine|mesh-list
14126816|NCT04383119|Trabectedin|trabectedin|mesh-list
14126817|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14126818|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
14126819|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126820|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126821|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
14126822|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126823|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126824|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126825|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
14126826|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126827|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14126828|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
13944910|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13944911|NCT03263741|Paclitaxel|paclitaxel|mesh-list
13944912|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14126829|NCT04339218|Carboplatin|carboplatin|mesh-list
14126830|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
14126831|NCT04339218|Pemetrexed|pemetrexed|mesh-list
14126832|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126833|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126834|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126835|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126836|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14126837|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14177201|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14177202|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13944913|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
13944914|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13944915|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944916|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
13944917|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
13944918|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
13944919|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944920|NCT03263962|Canrenone|canrenone|mesh-list
13944921|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13944922|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
13944923|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944924|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944925|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13944926|NCT03263962|Diuretics|diuretics|mesh-ancestor
13944927|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
13944928|NCT03263871|Micronutrients|micronutrients|mesh-list
13944929|NCT03263871|Trace Elements|trace elements|mesh-list
13944930|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944931|NCT03263689|Morphine|morphine|mesh-list
13944932|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13944933|NCT03263689|Narcotics|narcotics|mesh-ancestor
13944934|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13944935|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944936|NCT03263689|Analgesics|analgesics|mesh-ancestor
13944937|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
13944938|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944939|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
13944940|NCT03263767|Fludarabine|fludarabine|mesh-list
13944941|NCT03263767|Clofarabine|clofarabine|mesh-list
13944942|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
13944943|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13944944|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
13944945|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944946|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13944947|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13944948|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
13944949|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944950|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944951|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13944952|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13944953|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
13944954|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
13944955|NCT03263715|Hormones|hormones|mesh-ancestor
13944956|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944957|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126838|NCT04309877|Theophylline|theophylline|mesh-list
14126839|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14126840|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
14126841|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126842|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126843|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14126844|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
14126845|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14126846|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126847|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126848|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
14126849|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13944958|NCT03263650|Prednisone|prednisone|mesh-list
13944959|NCT03263650|Carboplatin|carboplatin|mesh-list
13944960|NCT03263650|Olaparib|olaparib|mesh-list
13944961|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13944962|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13944963|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
13944964|NCT03263650|Hormones|hormones|mesh-ancestor
13944965|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944966|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944967|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13944968|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13944969|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944970|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944971|NCT03263624|Tazarotene|tazarotene|mesh-list
13944972|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
14126850|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13944973|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
14126851|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
14126852|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126853|NCT04305548|Trabectedin|trabectedin|mesh-list
14126854|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14126855|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
14126856|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126857|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126858|NCT04281420|Niacin|niacin|mesh-list
14126859|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14126860|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
14126861|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126862|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14126863|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
14126864|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
14126865|NCT04281420|Vitamins|vitamins|mesh-ancestor
14126866|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
14126867|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126868|NCT04244552|Doxorubicin|doxorubicin|mesh-list
14126869|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14126870|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
14126871|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14126872|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126873|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14126874|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14126875|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126876|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126877|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126878|NCT04239339|Citalopram|citalopram|mesh-list
14126879|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14126880|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14126881|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14126882|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126883|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126884|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
14126885|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126886|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14126887|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
14126888|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14126889|NCT04200443|Temozolomide|temozolomide|mesh-list
14126890|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14126891|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
14126892|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126893|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126894|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
14126895|NCT04195256|Ketamine|ketamine|mesh-list
14126896|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14126897|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126898|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126899|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14126900|NCT04195256|Analgesics|analgesics|mesh-ancestor
14126901|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
14126902|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126903|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14126904|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14126905|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14126906|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14763175|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14763176|NCT01114217|Hematinics|hematinics|mesh-ancestor
14763177|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14763178|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14763179|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14763180|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14763181|NCT01114204|Hematinics|hematinics|mesh-ancestor
14763182|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14763183|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14763184|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14763185|NCT01114139|Hematinics|hematinics|mesh-ancestor
14126907|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126908|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126909|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14126910|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14126911|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
14126912|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
14126913|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14126914|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14126915|NCT04122443|Acetaminophen|acetaminophen|mesh-list
14126916|NCT04122443|Oxycodone|oxycodone|mesh-list
14126917|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936641|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936642|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14936643|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13944974|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
14126918|NCT04122443|Analgesics|analgesics|mesh-ancestor
14126919|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
14126920|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126921|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126922|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
14126923|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14126924|NCT04122443|Narcotics|narcotics|mesh-ancestor
14126925|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126926|NCT04121299|Amlodipine|amlodipine|mesh-list
14126927|NCT04121299|Carvedilol|carvedilol|mesh-list
14126928|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14126929|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14126930|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14126931|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126932|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14126933|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126934|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
14126935|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14126936|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14126937|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
14126938|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14126939|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
14126940|NCT04121299|Protective Agents|protective agents|mesh-ancestor
14126941|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14126942|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14126943|NCT04097912|Aspirin|aspirin|mesh-list
13944975|NCT03263481|Secretin|secretin|mesh-list
13944976|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13944977|NCT03263481|Hormones|hormones|mesh-ancestor
13944978|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13944979|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944980|NCT03263299|Aspirin|aspirin|mesh-list
13944981|NCT03263299|Cabergoline|cabergoline|mesh-list
13944982|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13944983|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13944984|NCT03263299|Analgesics|analgesics|mesh-ancestor
13944985|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
13944986|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13944987|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13944988|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14126944|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14126945|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14126946|NCT04097912|Analgesics|analgesics|mesh-ancestor
14126947|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
14126948|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14126949|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126950|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14126951|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126952|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14126953|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14126954|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126955|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14126956|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14126957|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126958|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
14126959|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
14126960|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14126961|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
13944989|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126962|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14126963|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126964|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14126965|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14126966|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14126967|NCT04040738|Anesthetics|anesthetics|mesh-list
14126968|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14126969|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763186|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14763187|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14126970|NCT04007224|Oxytocin|oxytocin|mesh-list
14126971|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
14126972|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13944990|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13944991|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13944992|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13944993|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13944994|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13944995|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13944996|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
13944997|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13944998|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13944999|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
13945000|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
13945001|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945002|NCT03263572|Cytarabine|cytarabine|mesh-list
13945003|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13945004|NCT03263572|Methotrexate|methotrexate|mesh-list
13945005|NCT03263572|Blinatumomab|blinatumomab|mesh-list
13945006|NCT03263572|Ponatinib|ponatinib|mesh-list
13945007|NCT03263572|Antibodies|antibodies|mesh-list
13945008|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
13945009|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13945010|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
13945011|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13945012|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
14126973|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126974|NCT04005339|Leucovorin|leucovorin|mesh-list
14126975|NCT04005339|Fluorouracil|fluorouracil|mesh-list
14126976|NCT04005339|Irinotecan|irinotecan|mesh-list
14126977|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
14126978|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14126979|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14126980|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14126981|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14126982|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
14126983|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14126984|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14126985|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14126986|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14126987|NCT04005339|Antidotes|antidotes|mesh-ancestor
13945013|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945014|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945015|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13945016|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
13945017|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945018|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945019|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
13945020|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945021|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
13945022|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945023|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13945024|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945025|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14126988|NCT04005339|Protective Agents|protective agents|mesh-ancestor
14126989|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
14126990|NCT04005339|Vitamins|vitamins|mesh-ancestor
14126991|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
14126992|NCT04003649|Nivolumab|nivolumab|mesh-list
14126993|NCT04003649|Ipilimumab|ipilimumab|mesh-list
14126994|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14126995|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945026|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13945027|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
14126996|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14126997|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945028|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14126998|NCT03981796|Paclitaxel|paclitaxel|mesh-list
14126999|NCT03981796|Carboplatin|carboplatin|mesh-list
14127000|NCT03981796|Niraparib|niraparib|mesh-list
14127001|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14127002|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127003|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127004|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127005|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14127006|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127007|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14127008|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127009|NCT03943342|Venetoclax|venetoclax|mesh-list
14127010|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127011|NCT03783351|Clopidogrel|clopidogrel|mesh-list
14127012|NCT03783351|Ticagrelor|ticagrelor|mesh-list
14127013|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14127014|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14127015|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14127016|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14127017|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
14127018|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945029|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945030|NCT03263533|Vorinostat|vorinostat|mesh-list
13945031|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945032|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13945033|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945034|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945035|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
13945036|NCT03263520|Dexamethasone|dexamethasone|mesh-list
13945037|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
13945038|NCT03263520|Nandrolone|nandrolone|mesh-list
13945039|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
13945040|NCT03263520|BB 1101|bb 1101|mesh-list
13945041|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945042|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
13945043|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
13945044|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945045|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945046|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945047|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
13945048|NCT03263520|Hormones|hormones|mesh-ancestor
13945049|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945050|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13945051|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945052|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
13945053|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945054|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945055|NCT03263520|Androgens|androgens|mesh-ancestor
13945056|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
13945057|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13945058|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
13945059|NCT03263208|Fludarabine|fludarabine|mesh-list
13945060|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945061|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
13945062|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945063|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945064|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13945065|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
13945066|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945067|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945068|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13945069|NCT03262857|Lidocaine|lidocaine|mesh-list
13945070|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
13945071|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945072|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
13945073|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945074|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127019|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127020|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127021|NCT03682224|Epinephrine|epinephrine|mesh-list
14127022|NCT03682224|Bupivacaine|bupivacaine|mesh-list
14127023|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
14127024|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
13945075|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
14127025|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945076|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127026|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127027|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
14127028|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127029|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13945077|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13945078|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13945079|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13945080|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13945081|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127030|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14127031|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
14127032|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127033|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127034|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14127035|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14127036|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
14127037|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14127038|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
14127039|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
14127040|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
14127041|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14127042|NCT03621748|Anesthetics|anesthetics|mesh-list
14127043|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127044|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127045|NCT03579693|Niacinamide|niacinamide|mesh-list
14127046|NCT03579693|Niacin|niacin|mesh-list
14127047|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
14127048|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
14127049|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
14127050|NCT03579693|Vitamins|vitamins|mesh-ancestor
14127051|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
14127052|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127053|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14127054|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
14127055|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127056|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14127057|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
14127058|NCT03557359|Nivolumab|nivolumab|mesh-list
14127059|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127060|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127061|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14127062|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945082|NCT03262857|Analgesics|analgesics|mesh-ancestor
13945083|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
13945084|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13945085|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13945086|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
13945087|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945088|NCT03262948|Paclitaxel|paclitaxel|mesh-list
14127063|NCT03540901|Acetazolamide|acetazolamide|mesh-list
14763188|NCT01059071|Eflornithine|eflornithine|mesh-list
14763189|NCT01059071|Etoposide|etoposide|mesh-list
14763190|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763191|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127064|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
14127065|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14127066|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127067|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127068|NCT03540901|Diuretics|diuretics|mesh-ancestor
14127069|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
14127070|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127071|NCT03540875|Remifentanil|remifentanil|mesh-list
14127072|NCT03540875|Propofol|propofol|mesh-list
14127073|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
14127074|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763192|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14763193|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14763194|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763195|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763196|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14763197|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14763198|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14763199|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763200|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
13945089|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13945090|NCT03262948|Carboplatin|carboplatin|mesh-list
13945091|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13945092|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945093|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
13945094|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
13945095|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
13945096|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945097|NCT03263065|Psyllium|psyllium|mesh-list
14127075|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127076|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14127077|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14127078|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
14127079|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14127080|NCT03540875|Narcotics|narcotics|mesh-ancestor
14127081|NCT03540875|Analgesics|analgesics|mesh-ancestor
14127082|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
14127083|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127084|NCT03536507|Acetazolamide|acetazolamide|mesh-list
14127085|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
14127086|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14127087|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127088|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127089|NCT03536507|Diuretics|diuretics|mesh-ancestor
14127090|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
13945098|NCT03263065|Cathartics|cathartics|mesh-ancestor
13945099|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945100|NCT03263052|Tacrolimus|tacrolimus|mesh-list
13945101|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945102|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
13945103|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945104|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13945105|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945106|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945107|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
14127091|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127092|NCT03522246|Nivolumab|nivolumab|mesh-list
14127093|NCT03522246|Rucaparib|rucaparib|mesh-list
14127094|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127095|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127096|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14127097|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127098|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14127099|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127100|NCT03517735|Remifentanil|remifentanil|mesh-list
14127101|NCT03517735|Propofol|propofol|mesh-list
14763201|NCT00934700|Xenon|xenon|mesh-list
14763202|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14763203|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
14763204|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
14763205|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763206|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763207|NCT00785291|Paclitaxel|paclitaxel|mesh-list
14763208|NCT00785291|Epothilones|epothilones|mesh-list
14763209|NCT00785291|Epothilone B|epothilone b|mesh-list
14763210|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14763211|NCT00785291|Bevacizumab|bevacizumab|mesh-list
14763212|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13945108|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945109|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945110|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
13945111|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945112|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
13945113|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13945114|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14127102|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14127103|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127104|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127105|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14127106|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
14127107|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
14127108|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14127109|NCT03517735|Narcotics|narcotics|mesh-ancestor
14127110|NCT03517735|Analgesics|analgesics|mesh-ancestor
14763213|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
14763214|NCT00785291|Antibodies|antibodies|mesh-list
13945115|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945116|NCT03262961|Urological Agents|urological agents|mesh-ancestor
13945117|NCT03262792|Andrographolide|andrographolide|mesh-list
13945118|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945119|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13945120|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13945121|NCT03262792|Analgesics|analgesics|mesh-ancestor
13945122|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
13945123|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945124|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945125|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945126|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13945127|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13945128|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127111|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
14127112|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127113|NCT03507491|Gemcitabine|gemcitabine|mesh-list
13945129|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
13945130|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13962230|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478399|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
14478400|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478401|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478402|NCT02452047|Imipenem|imipenem|mesh-list
14478403|NCT02452047|Relebactam|relebactam|mesh-list
14478404|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14478405|NCT02452047|Cilastatin|cilastatin|mesh-list
14478406|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962239|NCT04852367|Doxorubicin|doxorubicin|mesh-list
14127114|NCT03507491|Paclitaxel|paclitaxel|mesh-list
14127115|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14127116|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127117|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127118|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127119|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
14127120|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127121|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14127122|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
14127123|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
14127124|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127125|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127126|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14127127|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
14127128|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127129|NCT03400501|Insulin|insulin|mesh-list
14127130|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14127131|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
14127132|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14127133|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127134|NCT03395314|Midazolam|midazolam|mesh-list
14127135|NCT03395314|Ketamine|ketamine|mesh-list
14127136|NCT03395314|Analgesics|analgesics|mesh-ancestor
14127137|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
14127138|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127139|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127140|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14127141|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14127142|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
14127143|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
14127144|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127145|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13962240|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13962241|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962242|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13962243|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13962244|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962245|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962246|NCT04850495|Prednisone|prednisone|mesh-list
13962247|NCT04850495|Cortisone|cortisone|mesh-list
13962248|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
14127146|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14127147|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127148|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127149|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13962249|NCT04850495|Rituximab|rituximab|mesh-list
14127150|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14478407|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127151|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14127152|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14127153|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14127154|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
14127155|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
13945131|NCT03262545|Apatinib|apatinib|mesh-list
13945132|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945133|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945134|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945135|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945136|NCT03262688|Bupivacaine|bupivacaine|mesh-list
13945137|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945138|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
13945139|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945140|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945141|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
13945142|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945143|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13945144|NCT03262740|Norethindrone|norethindrone|mesh-list
13945145|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
13945146|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
13945147|NCT03262740|Estradiol|estradiol|mesh-list
13945148|NCT03262740|Branebrutinib|branebrutinib|mesh-list
13945149|NCT03262740|Estrogens|estrogens|mesh-ancestor
13945150|NCT03262740|Hormones|hormones|mesh-ancestor
13945151|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945152|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945153|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13945154|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
13945155|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945156|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13945157|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13945158|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13945159|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13945160|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14127156|NCT03347838|Nivolumab|nivolumab|mesh-list
14127157|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127158|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127159|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13945161|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
13945162|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945163|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945164|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945165|NCT03262727|BMS-986165|bms-986165|mesh-list
13945166|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14127160|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763215|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
14763216|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14763217|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
14763218|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763219|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763220|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763221|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763222|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763223|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763224|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14763225|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14763226|NCT00785291|Growth Substances|growth substances|mesh-ancestor
14763227|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763228|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
14763229|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
14763230|NCT00782288|Digitoxin|digitoxin|mesh-list
14763231|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14127178|NCT03087773|Empagliflozin|empagliflozin|mesh-list
14127179|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14127180|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945167|NCT03262727|Norethindrone|norethindrone|mesh-list
13945168|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
13945169|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
13945170|NCT03262727|Estradiol|estradiol|mesh-list
13945171|NCT03262727|Estrogens|estrogens|mesh-ancestor
13945172|NCT03262727|Hormones|hormones|mesh-ancestor
14127181|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14763232|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14127182|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127183|NCT02991807|Everolimus|everolimus|mesh-list
14127184|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127185|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14127186|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
14127187|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127188|NCT02944799|Vitamin D|vitamin d|mesh-list
14127189|NCT02944799|Alendronate|alendronate|mesh-list
14127190|NCT02944799|Calcium|calcium|mesh-list
14127191|NCT02944799|Vitamins|vitamins|mesh-ancestor
13945173|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945174|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945175|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13945176|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
13945177|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945178|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13945179|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13945180|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13945181|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13945182|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
13945183|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945184|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945185|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945186|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13945187|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
13945188|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
13945189|NCT03262142|Tazobactam|tazobactam|mesh-list
13945190|NCT03262142|Piperacillin|piperacillin|mesh-list
13945191|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13945192|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14127192|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
14127193|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127194|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14127195|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14127196|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
14127197|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14127198|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14127199|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14127200|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14127201|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127202|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
14127203|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127204|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127205|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14127206|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127207|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
14127208|NCT02722668|Sirolimus|sirolimus|mesh-list
14127209|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
14127210|NCT02722668|Fludarabine|fludarabine|mesh-list
14127211|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14127212|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14127213|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
14127214|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127215|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127216|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13945193|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945194|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13945195|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13945196|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945197|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945198|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945199|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14127217|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
14127218|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127219|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127220|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14127221|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14127222|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13945200|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13945201|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13945202|NCT03262077|Methylene Blue|methylene blue|mesh-list
13945203|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127223|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
13945204|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945205|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
13945206|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13945207|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945208|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945209|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13945210|NCT03262090|Analgesics|analgesics|mesh-ancestor
13945211|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
13945212|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945213|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13945214|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14127224|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14127225|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127226|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127227|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
14177203|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945215|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13945216|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
14936644|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13945217|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945218|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945219|NCT03262116|Insulin|insulin|mesh-list
13945220|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13945221|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
13945222|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
13945223|NCT03262116|Pancrelipase|pancrelipase|mesh-list
13945224|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13945225|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945226|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945227|NCT03262363|Curcumin|curcumin|mesh-list
13945228|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13945229|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13945230|NCT03262363|Analgesics|analgesics|mesh-ancestor
13945231|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
13945232|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945233|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945234|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945235|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945236|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945237|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945238|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945239|NCT03262376|Vitamins|vitamins|mesh-list
13945240|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
14177204|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
14177205|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763233|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763234|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763235|NCT00782288|Protective Agents|protective agents|mesh-ancestor
13945241|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945242|NCT03262103|Poly I-C|poly i-c|mesh-list
13945243|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13945244|NCT03262103|Poly ICLC|poly iclc|mesh-list
13945245|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
13945246|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
14763236|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763237|NCT00777036|Dasatinib|dasatinib|mesh-list
14763238|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763239|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763240|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763241|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763242|NCT00771654|Phentermine|phentermine|mesh-list
14763243|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14763244|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763245|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
14763246|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14763247|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
14763248|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
14763249|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763250|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
14763251|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945247|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763252|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945248|NCT03262103|Laxatives|laxatives|mesh-ancestor
13945249|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945250|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
13945251|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945252|NCT03261635|Indomethacin|indomethacin|mesh-list
13945253|NCT03261635|Ranibizumab|ranibizumab|mesh-list
13945254|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13945255|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13945256|NCT03261635|Growth Substances|growth substances|mesh-ancestor
13945257|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945258|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
13945259|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945260|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13945261|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13945262|NCT03261635|Analgesics|analgesics|mesh-ancestor
14127228|NCT02633293|Treprostinil|treprostinil|mesh-list
14127229|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14127230|NCT02599363|Paclitaxel|paclitaxel|mesh-list
14127231|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14127232|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127233|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127234|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127235|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
14127236|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127237|NCT02570672|Metformin|metformin|mesh-list
14127238|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14127239|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127240|NCT02521311|Clemastine|clemastine|mesh-list
14127241|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
14127242|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14127243|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14127244|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
14127245|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
13945263|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
13945264|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945265|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945266|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945267|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
13945268|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
13945269|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945270|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13945271|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945272|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945273|NCT03261570|Digoxin|digoxin|mesh-list
13945274|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
13945275|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13945276|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13945277|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945278|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945279|NCT03261570|Protective Agents|protective agents|mesh-ancestor
13945280|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127246|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127247|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127248|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127249|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14127250|NCT05112471|Erythritol|erythritol|mesh-list
14127251|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
14127252|NCT05111860|Bevacizumab|bevacizumab|mesh-list
14127253|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127254|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127255|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14127256|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14127257|NCT05111860|Growth Substances|growth substances|mesh-ancestor
14127258|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127259|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
14127260|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14127261|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
14127262|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945281|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13945282|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
13945283|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945284|NCT03261921|Dexamethasone|dexamethasone|mesh-list
13945285|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
14127263|NCT05111444|Paclitaxel|paclitaxel|mesh-list
14127264|NCT05111444|Capecitabine|capecitabine|mesh-list
13945286|NCT03261921|Bupivacaine|bupivacaine|mesh-list
13945287|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127265|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
14127266|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13945288|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
13945289|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
13945290|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945291|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945292|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945293|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
13945294|NCT03261921|Hormones|hormones|mesh-ancestor
13945295|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945296|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14127267|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127268|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127269|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127270|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
14127271|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127272|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14127273|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
14127274|NCT05110911|Vaccines|vaccines|mesh-list
14127275|NCT05110911|Immunologic Factors|immunologic factors|mesh-ancestor
14127276|NCT05110911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127277|NCT05110742|Vidarabine|vidarabine|mesh-list
14127278|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
14127279|NCT05110742|Fludarabine|fludarabine|mesh-list
14127280|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
14127281|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14127282|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
14127283|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127284|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127285|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14127286|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
14127287|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127288|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127289|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14127290|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14127291|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
14127292|NCT05110742|Antiviral Agents|antiviral agents|mesh-ancestor
14127293|NCT05110742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127294|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
14127295|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
14127296|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14127297|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14127298|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127299|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127300|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945297|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945298|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945299|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
13945300|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127301|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127302|NCT05110482|Oxytocin|oxytocin|mesh-list
14127303|NCT05110482|Carbetocin|carbetocin|mesh-list
14127304|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
14127305|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14127306|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127307|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
14127308|NCT05110469|Meperidine|meperidine|mesh-list
14127309|NCT05110469|Analgesics|analgesics|mesh-ancestor
14127310|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
14127311|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127312|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127313|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
14127314|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127315|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14127316|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
14127317|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13945301|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
13945302|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13945303|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13945304|NCT03261921|Analgesics|analgesics|mesh-ancestor
13945305|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13945306|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13945307|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14127318|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13945308|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
14127319|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945309|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127320|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14127321|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
13945310|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945311|NCT03261596|Mebendazole|mebendazole|mesh-list
13945312|NCT03261596|Piperazine|piperazine|mesh-list
13945313|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
13945314|NCT03261596|DMP 777|dmp 777|mesh-list
13945315|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
13945316|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
13945317|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14127322|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14127323|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14127324|NCT05110469|Narcotics|narcotics|mesh-ancestor
14127325|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14127326|NCT05110417|Bromides|bromides|mesh-list
14127327|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14127328|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
14127329|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14127330|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127331|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127332|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
14127333|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127334|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127335|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14127336|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14127337|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127338|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
14127339|NCT05103735|Remifentanil|remifentanil|mesh-list
14127340|NCT05103735|Propofol|propofol|mesh-list
14127341|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14127342|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127343|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127344|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14127345|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
14127346|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
14127347|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14127348|NCT05103735|Analgesics|analgesics|mesh-ancestor
14127349|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
14127350|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127351|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14127352|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14127353|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14127354|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
14127355|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127356|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127357|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14127358|NCT05103735|Narcotics|narcotics|mesh-ancestor
14763253|NCT00770809|Paclitaxel|paclitaxel|mesh-list
13945318|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945319|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
13945320|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
13945321|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
13945322|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945323|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945324|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945325|NCT03261791|Apatinib|apatinib|mesh-list
13945326|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945327|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945328|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945329|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945330|NCT03261284|Warfarin|warfarin|mesh-list
13945331|NCT03261284|Dabigatran|dabigatran|mesh-list
13945332|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
13945333|NCT03261284|Antithrombins|antithrombins|mesh-ancestor
13945334|NCT03261284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13945335|NCT03261284|Protease Inhibitors|protease inhibitors|mesh-ancestor
13945336|NCT03261284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945337|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763254|NCT00770809|Trastuzumab|trastuzumab|mesh-list
14763255|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14177230|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
14177231|NCT04757532|Anastrozole|anastrozole|mesh-list
14177232|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
14177233|NCT04757532|Bupropion|bupropion|mesh-list
14177234|NCT04757532|Testosterone|testosterone|mesh-list
13945338|NCT03261193|Bupivacaine|bupivacaine|mesh-list
14177235|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
14177236|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
14177237|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14763256|NCT00770809|Lapatinib|lapatinib|mesh-list
14127359|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
14127360|NCT05101356|Vaccines|vaccines|mesh-list
14127361|NCT05101356|Sargramostim|sargramostim|mesh-list
14127362|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
14127363|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763257|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14763258|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14763259|NCT00770809|Antibodies|antibodies|mesh-list
14763260|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
14763261|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14763262|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763263|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763264|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763265|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763266|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763267|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763268|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
14763269|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763270|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763271|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763272|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
14763273|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
14763274|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763275|NCT00765310|Protective Agents|protective agents|mesh-ancestor
14763276|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945339|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945340|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
13945341|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945342|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945343|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
13945344|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945345|NCT03261427|Pregabalin|pregabalin|mesh-list
13945346|NCT03261427|Analgesics|analgesics|mesh-ancestor
13945347|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
13945348|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945349|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763277|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
14763278|NCT00765310|Vitamins|vitamins|mesh-ancestor
14763279|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
14763280|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
14763281|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
14763282|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763283|NCT00764270|Protective Agents|protective agents|mesh-ancestor
14763284|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127364|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14127365|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
14127366|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127367|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
14127368|NCT05099250|Bupivacaine|bupivacaine|mesh-list
14127369|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
14127370|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
14127371|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127372|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127373|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
13945350|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
13945351|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13945352|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13945353|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945354|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13945355|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14127374|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127375|NCT05099250|Analgesics|analgesics|mesh-ancestor
14127376|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14127377|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
14127378|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14127379|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14127380|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127381|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14127382|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
14127383|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14763285|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
14763286|NCT00764270|Vitamins|vitamins|mesh-ancestor
14763287|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
14127384|NCT05094323|Bupivacaine|bupivacaine|mesh-list
13945356|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13945357|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945358|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13945359|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
13945360|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13945361|NCT03261349|Ledipasvir|ledipasvir|mesh-list
13945362|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
13945363|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945364|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
13945365|NCT03261310|Acetaminophen|acetaminophen|mesh-list
13945366|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13945367|NCT03261310|Analgesics|analgesics|mesh-ancestor
13945368|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
13945369|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945370|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945371|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
13962250|NCT04850495|Doxorubicin|doxorubicin|mesh-list
13962251|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13962252|NCT04850495|Vincristine|vincristine|mesh-list
13962253|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
13962254|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13962255|NCT04850495|Antibodies|antibodies|mesh-list
13962256|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
13962257|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13962258|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962259|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
13962260|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962261|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127385|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
14127386|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
14127387|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127388|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127389|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
14127390|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127391|NCT05092828|Morphine|morphine|mesh-list
14127392|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14127393|NCT05092828|Narcotics|narcotics|mesh-ancestor
14127394|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127395|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127396|NCT05092828|Analgesics|analgesics|mesh-ancestor
14127397|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
14127398|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127399|NCT05083052|Propolis|propolis|mesh-list
14127400|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127401|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14127402|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14127403|NCT05079802|Chitosan|chitosan|mesh-list
14127404|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127405|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
14127406|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14127407|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14127408|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
14127409|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127410|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14127411|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
14127412|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
14127413|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
14127414|NCT05079802|Coagulants|coagulants|mesh-ancestor
14127415|NCT05032794|Bisacodyl|bisacodyl|mesh-list
14127416|NCT05032794|Cathartics|cathartics|mesh-ancestor
14127417|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14127418|NCT05032794|Laxatives|laxatives|mesh-ancestor
14127419|NCT05006599|Insulin|insulin|mesh-list
14127420|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14127421|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14127422|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127423|NCT04974879|Osimertinib|osimertinib|mesh-list
14127424|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127425|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13962262|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13962263|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
13962264|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962265|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127426|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127427|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127428|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
14127429|NCT04947553|Bupropion|bupropion|mesh-list
14127430|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13945372|NCT03261102|Adalimumab|adalimumab|mesh-list
13945373|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945374|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945375|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
13945376|NCT03260829|Vitamins|vitamins|mesh-ancestor
13945377|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
13945378|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945379|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
13945380|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945381|NCT03260829|Protective Agents|protective agents|mesh-ancestor
13945382|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
13945383|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945384|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
13945385|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945386|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945387|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
13945388|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945389|NCT03260920|Oxytocin|oxytocin|mesh-list
13945390|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
13945391|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945392|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945393|NCT03261024|Nickel|nickel|mesh-list
13945394|NCT03261024|Trace Elements|trace elements|mesh-ancestor
13945395|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
13945396|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945397|NCT03260634|Voriconazole|voriconazole|mesh-list
13945398|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
13945399|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945400|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13945401|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13945402|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945403|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945404|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13945405|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
13945406|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945407|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945408|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13945409|NCT03261115|Anesthetics|anesthetics|mesh-list
13945410|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945411|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945412|NCT03260439|Tramadol|tramadol|mesh-list
13945413|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13945414|NCT03260439|Narcotics|narcotics|mesh-ancestor
13945415|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945416|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945417|NCT03260439|Analgesics|analgesics|mesh-ancestor
13945418|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
13945419|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945420|NCT03260712|Gemcitabine|gemcitabine|mesh-list
14936645|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14936646|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14936647|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936648|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936649|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936650|NCT01470339|Analgesics|analgesics|mesh-ancestor
14936651|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
14936652|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936653|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
13945421|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
13945422|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177238|NCT04757532|Danazol|danazol|mesh-list
13945423|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945424|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
13945425|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127431|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
14127432|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14127433|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14127434|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14127435|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14127436|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127437|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
14127438|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127439|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127440|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14127441|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14127442|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127443|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
14127444|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
14127445|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14127446|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14127447|NCT04910230|Niacinamide|niacinamide|mesh-list
14127448|NCT04910230|Niacin|niacin|mesh-list
14127449|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
14127450|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
14127451|NCT04910230|Vitamins|vitamins|mesh-ancestor
14127452|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
14127453|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127454|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14127455|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
14127456|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127457|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14127458|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
14127459|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
14127460|NCT04887870|Nivolumab|nivolumab|mesh-list
14127461|NCT04887870|Ipilimumab|ipilimumab|mesh-list
14127462|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127463|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127464|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14127465|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945426|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
13945427|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945428|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945429|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945430|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
13945431|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945432|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945433|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
13945434|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13945435|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
13945436|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945437|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945438|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13945439|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
13945440|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13945441|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
13945442|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945443|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945444|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13945445|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
13945446|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
13945447|NCT03260569|Protective Agents|protective agents|mesh-ancestor
13945448|NCT03260556|Pirfenidone|pirfenidone|mesh-list
13945449|NCT03260556|Analgesics|analgesics|mesh-ancestor
13945450|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
13945451|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945452|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945453|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13945454|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13945455|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945456|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945457|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945458|NCT03260283|Fentanyl|fentanyl|mesh-list
13945459|NCT03260283|Meperidine|meperidine|mesh-list
14177239|NCT04757532|Androgens|androgens|mesh-ancestor
13945460|NCT03260283|Ropivacaine|ropivacaine|mesh-list
13945461|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945462|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
13945463|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945464|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945465|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
13945466|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945467|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13945468|NCT03260283|Narcotics|narcotics|mesh-ancestor
13945469|NCT03260283|Analgesics|analgesics|mesh-ancestor
13945470|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13945471|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13945472|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
13945473|NCT03260166|Niacinamide|niacinamide|mesh-list
13945474|NCT03260166|Niacin|niacin|mesh-list
13945475|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
14127466|NCT04783857|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14127467|NCT04783857|Medroxyprogesterone|medroxyprogesterone|mesh-list
14127468|NCT04783857|Progesterone|progesterone|mesh-list
14127469|NCT04783857|Progestins|progestins|mesh-ancestor
14127470|NCT04783857|Hormones|hormones|mesh-ancestor
14127471|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127472|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127473|NCT04783857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13945476|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
13945477|NCT03260166|Vitamins|vitamins|mesh-ancestor
13945478|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
13945479|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945480|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13945481|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
13945482|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945483|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13945484|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
13945485|NCT03260010|Fosfomycin|fosfomycin|mesh-list
14478408|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
14478409|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478410|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478411|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14478412|NCT02452060|Ketamine|ketamine|mesh-list
13945486|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13945487|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945488|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
13945489|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945490|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
14127474|NCT04783857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14127475|NCT04783857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14127476|NCT04783857|Contraceptive Agents|contraceptive agents|mesh-ancestor
14127477|NCT04783857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14127478|NCT04783857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14127479|NCT04783857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14127480|NCT04783857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14127481|NCT04783857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14127482|NCT04783857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127483|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
14127484|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14127485|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127486|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
14127487|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14127488|NCT04774237|Carbachol|carbachol|mesh-list
14127489|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14127490|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14127491|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14127492|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14127493|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
14763288|NCT00621751|Carbamazepine|carbamazepine|mesh-list
14763289|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
14763290|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
14127494|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127495|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127496|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127497|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14127498|NCT04774237|Miotics|miotics|mesh-ancestor
14127499|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
14127500|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763291|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14763292|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763293|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945491|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14127501|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14127502|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
14127503|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14127504|NCT04774237|Analgesics|analgesics|mesh-ancestor
14127505|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
14127506|NCT04774237|Protective Agents|protective agents|mesh-ancestor
14127507|NCT04764942|Dexamethasone|dexamethasone|mesh-list
14127508|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
14127509|NCT04764942|Pomalidomide|pomalidomide|mesh-list
14127510|NCT04764942|Ichthammol|ichthammol|mesh-list
14127511|NCT04764942|BB 1101|bb 1101|mesh-list
14127512|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127513|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
14127514|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
14127515|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127516|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127517|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14127518|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
14127519|NCT04764942|Hormones|hormones|mesh-ancestor
14127520|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127521|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14127522|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127523|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
14127524|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127525|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127526|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
14127527|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14127528|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14127529|NCT04764942|Growth Substances|growth substances|mesh-ancestor
14127530|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
14127531|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14127532|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
14127533|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13945492|NCT03260088|Antibodies|antibodies|mesh-list
13945493|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
13945494|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
13945495|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945496|NCT03259919|Metformin|metformin|mesh-list
13945497|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13945498|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127534|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14127535|NCT04685772|Prednisolone|prednisolone|mesh-list
13945499|NCT03259958|Donepezil|donepezil|mesh-list
13945500|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13945501|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945502|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945503|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
14763294|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13945504|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945505|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945506|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
13945507|NCT03259529|Gemcitabine|gemcitabine|mesh-list
13945508|NCT03259529|Rituximab|rituximab|mesh-list
13945509|NCT03259529|Nivolumab|nivolumab|mesh-list
13945510|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13945511|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945512|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945513|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
13945514|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945515|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945516|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945517|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
13945518|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945519|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
13945520|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945521|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945522|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763295|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14763296|NCT00621751|Analgesics|analgesics|mesh-ancestor
14763297|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
14763298|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763299|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14763300|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13945523|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14127536|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
14936654|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14127537|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14127538|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
14127539|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127540|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
13945524|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13945525|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
13945526|NCT03259516|Cytarabine|cytarabine|mesh-list
14127541|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
14127542|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127543|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127544|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14127545|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
14127546|NCT04685772|Hormones|hormones|mesh-ancestor
14127547|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127548|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14127549|NCT04685772|Protective Agents|protective agents|mesh-ancestor
14127550|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13945527|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
13945528|NCT03259516|Melphalan|melphalan|mesh-list
13945529|NCT03259516|Nivolumab|nivolumab|mesh-list
13945530|NCT03259516|Fludarabine|fludarabine|mesh-list
13945531|NCT03259516|Azacitidine|azacitidine|mesh-list
14127551|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127552|NCT04674345|Sorafenib|sorafenib|mesh-list
14127553|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127554|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14127555|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127556|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127565|NCT04634578|Bevacizumab|bevacizumab|mesh-list
14127566|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127567|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127568|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14127569|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14127570|NCT04634578|Growth Substances|growth substances|mesh-ancestor
14127571|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127572|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
14127573|NCT04615936|Methylene Blue|methylene blue|mesh-list
14127574|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127575|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127576|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
14127577|NCT04550832|Bedaquiline|bedaquiline|mesh-list
14127578|NCT04550832|Delpazolid|delpazolid|mesh-list
14127579|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14127580|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127581|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14127582|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14127583|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127584|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127585|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127586|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
14127587|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14177240|NCT04757532|Hormones|hormones|mesh-ancestor
14177241|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945532|NCT03259516|Tretinoin|tretinoin|mesh-list
13945533|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
13945534|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945535|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
13945536|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945537|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945538|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13945539|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
13945540|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945541|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945542|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14177242|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945543|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945544|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13945545|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945546|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
13945547|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
13945548|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945549|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945550|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
13945551|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14127588|NCT04461028|Dexamethasone|dexamethasone|mesh-list
14127589|NCT04461028|Bupivacaine|bupivacaine|mesh-list
14127590|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127591|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
14127592|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
14127593|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127594|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127595|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14127596|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
14127597|NCT04461028|Hormones|hormones|mesh-ancestor
14127598|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127599|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14127600|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127601|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
14127602|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
14127603|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127604|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
14127605|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
14127606|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14127607|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
14127608|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127609|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945552|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13945553|NCT03259516|Urological Agents|urological agents|mesh-ancestor
13945554|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
13945555|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
13962266|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13962267|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13962268|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13962269|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13962270|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962271|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962272|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
13962273|NCT04850495|Hormones|hormones|mesh-ancestor
13962274|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962275|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962276|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13962277|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
13962278|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
13962279|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
13962280|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13962281|NCT04844905|Ivermectin|ivermectin|mesh-list
13962282|NCT04844905|Piperaquine|piperaquine|mesh-list
13962283|NCT04844905|Artenimol|artenimol|mesh-list
13962284|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13962285|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962286|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
13962287|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13962288|NCT04824274|Fentanyl|fentanyl|mesh-list
13962289|NCT04824274|Morphine|morphine|mesh-list
13962290|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13962291|NCT04824274|Narcotics|narcotics|mesh-ancestor
13962292|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962293|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962294|NCT04824274|Analgesics|analgesics|mesh-ancestor
13962295|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
13962296|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962297|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13962298|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13962299|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
13962300|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
13962301|NCT04774991|Azithromycin|azithromycin|mesh-list
13962302|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14127610|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13962303|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127611|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14127612|NCT04367909|Carboplatin|carboplatin|mesh-list
13962304|NCT04771923|Epinephrine|epinephrine|mesh-list
13962305|NCT04771923|Racepinephrine|racepinephrine|mesh-list
14127613|NCT04367909|Docetaxel|docetaxel|mesh-list
13962306|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
14127614|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
14127615|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127616|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127617|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127618|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
13945556|NCT03259672|Sevoflurane|sevoflurane|mesh-list
13945557|NCT03259672|Desflurane|desflurane|mesh-list
13945558|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13945559|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13945560|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
13945561|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
13945562|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945563|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945564|NCT03259607|Nicotine|nicotine|mesh-list
13945565|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13945566|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
13945567|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945568|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945569|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13945570|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13945571|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
13945572|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945573|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945574|NCT03259542|Itraconazole|itraconazole|mesh-list
13945575|NCT03259542|Mifepristone|mifepristone|mesh-list
13945576|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
13945577|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945578|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13945579|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13945580|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945581|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945582|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13945583|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
13945584|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945585|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127619|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127620|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127621|NCT04342039|Budesonide|budesonide|mesh-list
14127622|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127623|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14127624|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
14127625|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127626|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127627|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14127628|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14127629|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
14127630|NCT04342039|Hormones|hormones|mesh-ancestor
14127631|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127632|NCT04335058|Iron|iron|mesh-list
14127633|NCT04335058|Lactoferrin|lactoferrin|mesh-list
14763301|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945586|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13945587|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13945588|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
13945589|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945590|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13945591|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13945592|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13945593|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
13945594|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13945595|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13945596|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
13945597|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13945598|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13945599|NCT03259152|Denosumab|denosumab|mesh-list
13945600|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13945601|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945602|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
13945603|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13945604|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13945605|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
13945606|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945607|NCT03258931|Cytarabine|cytarabine|mesh-list
14127634|NCT04335058|Trace Elements|trace elements|mesh-ancestor
14127635|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
14127636|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127637|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127638|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14127639|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
14127640|NCT04329975|Coagulants|coagulants|mesh-ancestor
14127641|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14127642|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
14127643|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127644|NCT04315311|Pancrelipase|pancrelipase|mesh-list
14127645|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14127646|NCT04285255|Lidocaine|lidocaine|mesh-list
14127647|NCT04285255|Fentanyl|fentanyl|mesh-list
14127648|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
14127649|NCT04285255|Ketamine|ketamine|mesh-list
14127650|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
14127651|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
14127652|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127653|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127654|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
14127655|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945608|NCT03258931|Midostaurin|midostaurin|mesh-list
13945609|NCT03258931|Crenolanib|crenolanib|mesh-list
13945610|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945611|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
13945612|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945613|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945614|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
13945615|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945616|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945617|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
13945618|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945619|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945620|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945621|NCT03259243|Bupivacaine|bupivacaine|mesh-list
13945622|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945623|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
13945624|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127656|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14127657|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14127658|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14127659|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14127660|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127661|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13945625|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945626|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
13945627|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945628|NCT03258684|Ascorbic Acid|ascorbic acid|mesh-list
13945629|NCT03258684|Thiamine|thiamine|mesh-list
13945630|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
13945631|NCT03258684|Vitamins|vitamins|mesh-ancestor
13945632|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
13945633|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945634|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945635|NCT03258684|Antioxidants|antioxidants|mesh-ancestor
13945636|NCT03258684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945637|NCT03258684|Protective Agents|protective agents|mesh-ancestor
13945638|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
13945639|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
13945640|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945641|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
13945642|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945643|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945644|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
13945645|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127662|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14127663|NCT04285255|Analgesics|analgesics|mesh-ancestor
14127664|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14763302|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14763303|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13945646|NCT03258866|Rituximab|rituximab|mesh-list
13945647|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945648|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127665|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14127666|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14127667|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
13945649|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
14127668|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127669|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14127670|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14127671|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
14127672|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14127673|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14127674|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14127675|NCT04285255|Narcotics|narcotics|mesh-ancestor
14127676|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14127677|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
14127678|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
14127679|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14127680|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945650|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945651|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945652|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
13945653|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
13945654|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13945655|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
14127681|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127682|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
14127683|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14127684|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127685|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127686|NCT04196075|Andrographolide|andrographolide|mesh-list
14127687|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127688|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14127689|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14127690|NCT04196075|Analgesics|analgesics|mesh-ancestor
14127691|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
14127692|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127693|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127694|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127695|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14127696|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14127697|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127698|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
14127699|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14127700|NCT04169828|Leucovorin|leucovorin|mesh-list
14127701|NCT04169828|Folic Acid|folic acid|mesh-list
14127702|NCT04169828|Methotrexate|methotrexate|mesh-list
14127703|NCT04169828|Ondansetron|ondansetron|mesh-list
14127704|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
14127705|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14127706|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
14127707|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14127708|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127709|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14127710|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
14127711|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127712|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127713|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
14127714|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127715|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14127716|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14127717|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
14127718|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127719|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14127720|NCT04169828|Antidotes|antidotes|mesh-ancestor
14127721|NCT04169828|Protective Agents|protective agents|mesh-ancestor
14127722|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
14127723|NCT04169828|Vitamins|vitamins|mesh-ancestor
14127724|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
14127725|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
14127726|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
14127727|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945656|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945657|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945658|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13945659|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
13945660|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13945661|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13945662|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14127728|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14127729|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
14127730|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13945663|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
13945664|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945665|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945666|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
13945667|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13945668|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
13945669|NCT03258723|Metformin|metformin|mesh-list
13945670|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13945671|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945672|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
13945673|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13945674|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945675|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13945676|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13945677|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945678|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945679|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945680|NCT03258372|Rifampin|rifampin|mesh-list
13945681|NCT03258372|Mifepristone|mifepristone|mesh-list
13945682|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13945683|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
13945684|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13945685|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945686|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
13945687|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13945688|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945689|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945690|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13945691|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13945692|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13945693|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13945694|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13945695|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13945696|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13945697|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
13945698|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945699|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945700|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13945701|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13945702|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14127731|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
14127732|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127733|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14127734|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14127735|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127736|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14127737|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14127738|NCT04169828|Hematinics|hematinics|mesh-ancestor
14127739|NCT04165824|Edaravone|edaravone|mesh-list
14127740|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14127741|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
14127742|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127743|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14127744|NCT04165824|Protective Agents|protective agents|mesh-ancestor
14127745|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127746|NCT04161898|Prednisolone|prednisolone|mesh-list
14127747|NCT04161898|Upadacitinib|upadacitinib|mesh-list
14127748|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127749|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
14127750|NCT04161898|Hormones|hormones|mesh-ancestor
14127751|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127752|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127753|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14127754|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127755|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14127756|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14127757|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127758|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127759|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127760|NCT04158141|Cisplatin|cisplatin|mesh-list
14127761|NCT04158141|Carboplatin|carboplatin|mesh-list
14127762|NCT04158141|Pemetrexed|pemetrexed|mesh-list
14127763|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127764|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127765|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127766|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14127767|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14127768|NCT04053322|Durvalumab|durvalumab|mesh-list
14127769|NCT04053322|Olaparib|olaparib|mesh-list
14127770|NCT04053322|Fulvestrant|fulvestrant|mesh-list
14127771|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127772|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127773|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14127774|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127775|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127776|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763304|NCT00605215|Interferons|interferons|mesh-list
14763305|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
14763306|NCT00605215|Interferon-beta|interferon-beta|mesh-list
14763307|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763308|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
14763309|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763310|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14763311|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
13945703|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
13945704|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14127777|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14127778|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14127779|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
13945705|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13945706|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
13945707|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945708|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
13945709|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13945710|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14127780|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127781|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127782|NCT04030182|Vitamin D|vitamin d|mesh-list
14127783|NCT04030182|Vitamins|vitamins|mesh-ancestor
14127784|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
14127785|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127786|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14127787|NCT04000555|Vancomycin|vancomycin|mesh-list
14127788|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14127789|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945711|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
13945712|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
13945713|NCT03258385|Vitamins|vitamins|mesh-ancestor
13945714|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
13945715|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127790|NCT03988933|Rifampin|rifampin|mesh-list
14127791|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13945716|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
13945717|NCT03258385|Hematinics|hematinics|mesh-ancestor
13945718|NCT03258476|Guanfacine|guanfacine|mesh-list
13945719|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13945720|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13945721|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13945722|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13945723|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
13945724|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945725|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945726|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945727|NCT03258294|Melatonin|melatonin|mesh-list
13945728|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
13945729|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945730|NCT03258294|Protective Agents|protective agents|mesh-ancestor
14127792|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
14127793|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14127794|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127795|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
14127796|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14127797|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127798|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127799|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14763312|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945731|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962307|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
14127800|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14127801|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14127802|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14127803|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14127804|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14127805|NCT03978520|Upadacitinib|upadacitinib|mesh-list
14127806|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14127807|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14127808|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127809|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127810|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127811|NCT03875378|Estrogens|estrogens|mesh-list
14127812|NCT03875378|Hormones|hormones|mesh-ancestor
14127813|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127814|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127822|NCT03863483|Docetaxel|docetaxel|mesh-list
14127823|NCT03863483|Pemetrexed|pemetrexed|mesh-list
14763313|NCT00302744|Niacin|niacin|mesh-list
14763314|NCT00302744|Psilocybin|psilocybin|mesh-list
14763315|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14763316|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
14763317|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763318|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14763319|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
14763320|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
14763321|NCT00302744|Vitamins|vitamins|mesh-ancestor
14763322|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
14763323|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763324|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
14763325|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14763326|NCT00290511|Vidarabine|vidarabine|mesh-list
14127824|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127825|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127826|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127827|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
14127828|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127829|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127830|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13945732|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945733|NCT03258398|Avelumab|avelumab|mesh-list
13945734|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945735|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945736|NCT03258320|Docetaxel|docetaxel|mesh-list
13945737|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
13945738|NCT03258320|Satraplatin|satraplatin|mesh-list
14127831|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14127832|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14127833|NCT03854500|Tenecteplase|tenecteplase|mesh-list
14127834|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14127835|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14127836|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127837|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
14127838|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945739|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945740|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
13945741|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
13945742|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
13945743|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945744|NCT03258320|Analgesics|analgesics|mesh-ancestor
13945745|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
13945746|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945747|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127839|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763327|NCT00290511|Dexamethasone|dexamethasone|mesh-list
13945748|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14763328|NCT00290511|Rituximab|rituximab|mesh-list
14763329|NCT00290511|Fludarabine|fludarabine|mesh-list
13945749|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13945750|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945751|NCT03257930|Ethanol|ethanol|mesh-list
13945752|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13945753|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945754|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945755|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945756|NCT03257943|Ivermectin|ivermectin|mesh-list
13945757|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13945758|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945759|NCT03257683|Ranolazine|ranolazine|mesh-list
13945760|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13945761|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13945762|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945763|NCT03257670|Lidocaine|lidocaine|mesh-list
13945764|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
13945765|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
13945766|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945767|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945768|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
13945769|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945770|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13945771|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13945772|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13945773|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13945774|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945775|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
13945776|NCT03257722|Idelalisib|idelalisib|mesh-list
13945777|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13945778|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945779|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945780|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962308|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13962309|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13962310|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962311|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
13962312|NCT04771923|Coagulants|coagulants|mesh-ancestor
13962313|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13962314|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13962315|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962316|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962317|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962318|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13962319|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13962320|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
13962321|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127840|NCT03830411|Docetaxel|docetaxel|mesh-list
14127841|NCT03830411|Pemetrexed|pemetrexed|mesh-list
14127842|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127843|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127844|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127845|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
14127846|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127847|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127848|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14127849|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13962322|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13962323|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
13962324|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
14127850|NCT03802305|Anesthetics|anesthetics|mesh-list
14127851|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763330|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
14127852|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127853|NCT03661632|Nivolumab|nivolumab|mesh-list
14127854|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127855|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127856|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14127857|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177243|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14177244|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177245|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
14183780|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763331|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
14763332|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127858|NCT03512262|Abaloparatide|abaloparatide|mesh-list
14127859|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
14127860|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14127861|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127862|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14127863|NCT03456882|RNS60|rns60|mesh-list
14127864|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14127865|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936655|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
14936656|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14936657|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14936658|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14936659|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14936660|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936661|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936662|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936663|NCT01470352|Analgesics|analgesics|mesh-ancestor
14936664|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
14936665|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936666|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
14936667|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14936668|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
14936669|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
14936670|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127866|NCT03456882|Analgesics|analgesics|mesh-ancestor
14127867|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
14127868|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127869|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127870|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127871|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14127872|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14127873|NCT03374956|Liraglutide|liraglutide|mesh-list
14127874|NCT03374956|Topiramate|topiramate|mesh-list
14127875|NCT03374956|Phentermine|phentermine|mesh-list
14127876|NCT03374956|Naltrexone|naltrexone|mesh-list
14127877|NCT03374956|Bupropion|bupropion|mesh-list
14127878|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14127879|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14127880|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127881|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
14127882|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127883|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14127884|NCT03374956|Incretins|incretins|mesh-ancestor
14127885|NCT03374956|Hormones|hormones|mesh-ancestor
14127886|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14127887|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14127888|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
14127889|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14127890|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14127891|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14127892|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14127893|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127894|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
14127895|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127896|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14127897|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14127898|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127899|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
14127900|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13945781|NCT03257852|Methotrexate|methotrexate|mesh-list
13945782|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14127901|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
14127902|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14936671|NCT01470456|Rituximab|rituximab|mesh-list
14936672|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14936673|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945783|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
13945784|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13945785|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945786|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945787|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
14127903|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
14127904|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
14127905|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
13945788|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945789|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945790|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
13945791|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945792|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13945793|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945794|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
13945795|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13945796|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13945797|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
13945798|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
13945799|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945800|NCT03257514|Protective Agents|protective agents|mesh-ancestor
13945801|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945802|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
13945803|NCT03257514|Vitamins|vitamins|mesh-ancestor
13945804|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
13945805|NCT03257800|Ketamine|ketamine|mesh-list
13945806|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
13945807|NCT03257800|Sevoflurane|sevoflurane|mesh-list
13945808|NCT03257800|Analgesics|analgesics|mesh-ancestor
13945809|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
13945810|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945811|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127906|NCT03366103|Navitoclax|navitoclax|mesh-list
14127907|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127908|NCT03334253|Atropine|atropine|mesh-list
14127909|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14127910|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14127911|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14127912|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14127913|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
14127914|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127915|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127916|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14127917|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
14127918|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
14127919|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
14127920|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14127921|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14127922|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
14127923|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127924|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127925|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14127926|NCT03300479|Urapidil|urapidil|mesh-list
14127927|NCT03300479|Clevidipine|clevidipine|mesh-list
14127928|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14127929|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14127930|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127931|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14127932|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127933|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14127934|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
14127935|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14127936|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
14127937|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127938|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14127939|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14127940|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14127941|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
14127942|NCT03272464|Trametinib|trametinib|mesh-list
13945812|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13945813|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13945814|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
13945815|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
13945816|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945817|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13945818|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13945819|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945820|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945821|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13945822|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13945823|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14127943|NCT03272464|Dabrafenib|dabrafenib|mesh-list
13945824|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
13945825|NCT03257423|Metronidazole|metronidazole|mesh-list
14127944|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127945|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14127946|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945826|NCT03257423|Levofloxacin|levofloxacin|mesh-list
13945827|NCT03257423|Ofloxacin|ofloxacin|mesh-list
13945828|NCT03257423|Ertapenem|ertapenem|mesh-list
13945829|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13945830|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945831|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13945832|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13945833|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945834|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945835|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945836|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13945837|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13945838|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13945839|NCT03257423|Renal Agents|renal agents|mesh-ancestor
13945840|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13945841|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13945842|NCT03257319|Morphine|morphine|mesh-list
13945843|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13945844|NCT03257319|Narcotics|narcotics|mesh-ancestor
13945845|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14127947|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127948|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14127949|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14127950|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14127951|NCT03245151|Everolimus|everolimus|mesh-list
14127952|NCT03245151|Lenvatinib|lenvatinib|mesh-list
14127953|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127954|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14127955|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
14127956|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127957|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14127958|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14127959|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127960|NCT03070184|Metoprolol|metoprolol|mesh-list
14127961|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14127962|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14127963|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
14127964|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
14127965|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127966|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127967|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14127968|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14127969|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14127970|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
14127971|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945846|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945847|NCT03257319|Analgesics|analgesics|mesh-ancestor
13945848|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
13945849|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127972|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127973|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
14127974|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14127975|NCT02781090|Nicotine|nicotine|mesh-list
14127976|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14127977|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
14127978|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14127979|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14127980|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14127981|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13945850|NCT03257241|Cytarabine|cytarabine|mesh-list
13945851|NCT03257241|Fludarabine|fludarabine|mesh-list
13945852|NCT03257241|Daunorubicin|daunorubicin|mesh-list
13945853|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
13945854|NCT03257241|Idarubicin|idarubicin|mesh-list
14127982|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
14127983|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14127984|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127985|NCT02758847|Paclitaxel|paclitaxel|mesh-list
14127986|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14127987|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13945855|NCT03257241|Cladribine|cladribine|mesh-list
13945856|NCT03257241|Lenograstim|lenograstim|mesh-list
13945857|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945858|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945859|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
13945860|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945861|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945862|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
13945863|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945864|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
13945865|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13945866|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13945867|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13945868|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13945869|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14127988|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127989|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
14127990|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14127991|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14127992|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127993|NCT02718066|Nivolumab|nivolumab|mesh-list
14127994|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14127995|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14127996|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14127997|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14127998|NCT02390531|Bevacizumab|bevacizumab|mesh-list
14127999|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128000|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128001|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14128002|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14128003|NCT02390531|Growth Substances|growth substances|mesh-ancestor
14128004|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128005|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
14128006|NCT05116254|AZD7648|azd7648|mesh-list
14128007|NCT05116254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14128008|NCT05116254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128009|NCT05116254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128010|NCT05116228|Rituximab|rituximab|mesh-list
14128011|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128012|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128013|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
14128014|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128015|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128016|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
14128017|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14128018|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128019|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
14128020|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128021|NCT05116150|Protective Agents|protective agents|mesh-ancestor
14128022|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128023|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14128024|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
14128025|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128026|NCT05116098|Protective Agents|protective agents|mesh-ancestor
14128027|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945870|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945871|NCT03257241|Analgesics|analgesics|mesh-ancestor
13945872|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
13945873|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128028|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14128029|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14128030|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128031|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14128032|NCT05116007|Carboplatin|carboplatin|mesh-list
14128033|NCT05116007|Etoposide|etoposide|mesh-list
14128034|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128035|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14128036|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14128037|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14128038|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128039|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128040|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
14128041|NCT05115903|Adalimumab|adalimumab|mesh-list
14128042|NCT05115903|Etanercept|etanercept|mesh-list
14128043|NCT05115903|Golimumab|golimumab|mesh-list
14128044|NCT05115903|Infliximab|infliximab|mesh-list
14128045|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
14128046|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14128047|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128048|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128049|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14128050|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128051|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14128052|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128053|NCT05115903|Analgesics|analgesics|mesh-ancestor
14128054|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
14128055|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128056|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945881|NCT03257215|Vitamin D|vitamin d|mesh-list
13945882|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
13945883|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
13945884|NCT03257215|Vitamins|vitamins|mesh-list
13945885|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
14128057|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128058|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
14128059|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14128060|NCT05115578|Midazolam|midazolam|mesh-list
13945886|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945887|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13945888|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13945889|NCT03257124|Osimertinib|osimertinib|mesh-list
13945890|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945891|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945892|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945893|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945894|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
13945895|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13945896|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
13945897|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
13945898|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945899|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945900|NCT03256721|Docetaxel|docetaxel|mesh-list
13945901|NCT03256721|Pemetrexed|pemetrexed|mesh-list
13945902|NCT03256721|Apatinib|apatinib|mesh-list
13945903|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945904|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
13945905|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
13945906|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
13945907|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945908|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945909|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13945910|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13945911|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13945912|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
13945913|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13945914|NCT03256864|Everolimus|everolimus|mesh-list
13945915|NCT03256864|Tacrolimus|tacrolimus|mesh-list
13945916|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13945917|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
13945918|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945919|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13945920|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945921|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945922|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945923|NCT03256487|Morphine|morphine|mesh-list
13945924|NCT03256487|Buprenorphine|buprenorphine|mesh-list
13945925|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13945926|NCT03256487|Narcotics|narcotics|mesh-ancestor
13945927|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945928|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945929|NCT03256487|Analgesics|analgesics|mesh-ancestor
13945930|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
13945931|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945932|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13945933|NCT03256045|Dexamethasone|dexamethasone|mesh-list
13945934|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
13945935|NCT03256045|Panobinostat|panobinostat|mesh-list
13945936|NCT03256045|Ichthammol|ichthammol|mesh-list
13945937|NCT03256045|BB 1101|bb 1101|mesh-list
14128061|NCT05115578|Remifentanil|remifentanil|mesh-list
14128062|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14128063|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14128064|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128065|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128066|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14128067|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14128068|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14128069|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14128070|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
14128071|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
14128072|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
13945938|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945939|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
13945940|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
13945941|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945942|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945943|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945944|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
13945945|NCT03256045|Hormones|hormones|mesh-ancestor
13945946|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945947|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13945948|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945949|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
13945950|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945951|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945952|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13945953|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
13945954|NCT03256149|Dexamethasone|dexamethasone|mesh-list
13945955|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13945956|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
13945957|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
13945958|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13945959|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945960|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945961|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
13945962|NCT03256149|Hormones|hormones|mesh-ancestor
13945963|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128073|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
14128074|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128075|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128076|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14128077|NCT05115578|Narcotics|narcotics|mesh-ancestor
14128078|NCT05115578|Analgesics|analgesics|mesh-ancestor
14128079|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
14128080|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128081|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14128082|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
14128083|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945964|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13945965|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945966|NCT03256071|Decitabine|decitabine|mesh-list
13945967|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13945968|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
13945969|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945970|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945971|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945972|NCT03256292|Testosterone|testosterone|mesh-list
13945973|NCT03256292|Androgens|androgens|mesh-ancestor
13945974|NCT03256292|Hormones|hormones|mesh-ancestor
13945975|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945976|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962325|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
13962326|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13962327|NCT04762459|Pemetrexed|pemetrexed|mesh-list
13962328|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128084|NCT05115149|Protective Agents|protective agents|mesh-ancestor
14128085|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128086|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14128087|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128088|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
13962329|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128089|NCT05115136|Promethazine|promethazine|mesh-list
13963503|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14128090|NCT05115136|Doxepin|doxepin|mesh-list
14128091|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14128092|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14128093|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128094|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128095|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
14128096|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
14128097|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
14128098|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128099|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
14128100|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
14128101|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128102|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14128103|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
14128104|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
14128105|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128106|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945977|NCT03255811|Apatinib|apatinib|mesh-list
13945978|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13945979|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14128107|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14128108|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
14128109|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
14128110|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14128111|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
14128112|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14177246|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14177247|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
14177248|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14177249|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14177250|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14177251|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177252|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177253|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
14177254|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177255|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14177256|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14177257|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177258|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14177259|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14177260|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13945980|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13945981|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945982|NCT03255642|Clonazepam|clonazepam|mesh-list
13945983|NCT03255642|Melatonin|melatonin|mesh-list
13945984|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
13945985|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13945986|NCT03255642|Protective Agents|protective agents|mesh-ancestor
13945987|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945988|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13945989|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
13945990|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
13945991|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
13945992|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13945993|NCT03255629|Glucagon|glucagon|mesh-list
13945994|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13945995|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13945996|NCT03255629|Hormones|hormones|mesh-ancestor
13945997|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13945998|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13945999|NCT03255629|Incretins|incretins|mesh-ancestor
13946000|NCT03255226|Tolvaptan|tolvaptan|mesh-list
13946001|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
13946002|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946003|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
13946004|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946005|NCT03255278|Vaccines|vaccines|mesh-list
13946006|NCT03255278|Immunologic Factors|immunologic factors|mesh-ancestor
13946007|NCT03255278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946008|NCT03255330|Dipyrone|dipyrone|mesh-list
13946009|NCT03255330|Gabapentin|gabapentin|mesh-list
13946010|NCT03255330|Tramadol|tramadol|mesh-list
13946011|NCT03255330|Analgesics|analgesics|mesh-ancestor
13946012|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
13946013|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946014|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946015|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
13946016|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13946017|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13946018|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946019|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13946020|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13946021|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13946022|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946023|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946024|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
13946025|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13946026|NCT03255330|Narcotics|narcotics|mesh-ancestor
13946027|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13946028|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13946029|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128113|NCT05114499|Donepezil|donepezil|mesh-list
14128114|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14128115|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128116|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128117|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
14128118|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128119|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128120|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
14128121|NCT05114239|Timolol|timolol|mesh-list
14128122|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14128123|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14128124|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14128125|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14128126|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
14128127|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128128|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128129|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128130|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14128131|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14128132|NCT05114096|Betamethasone|betamethasone|mesh-list
14128133|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
14128134|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14128135|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
14128136|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14128137|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128138|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
14128139|NCT05114096|Hormones|hormones|mesh-ancestor
14128140|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128141|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128142|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14128143|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
14763333|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
13946030|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946031|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
13946032|NCT03255473|Dexamethasone|dexamethasone|mesh-list
13946033|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
13946034|NCT03255473|Prednisone|prednisone|mesh-list
13946035|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13946036|NCT03255473|BB 1101|bb 1101|mesh-list
13946037|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13946038|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
13946039|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
13946040|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946041|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946042|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946043|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
13946044|NCT03255473|Hormones|hormones|mesh-ancestor
13946045|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946046|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13946047|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946048|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
13946049|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946050|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946051|NCT03255148|Oxytocin|oxytocin|mesh-list
13946052|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
13946053|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13946054|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763334|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
13946055|NCT03254849|Empagliflozin|empagliflozin|mesh-list
13946056|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13946057|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13946058|NCT03254849|Diuretics|diuretics|mesh-ancestor
14763335|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763336|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763337|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14763338|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
14763339|NCT00290511|Hormones|hormones|mesh-ancestor
14763340|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763341|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763342|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763343|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14763344|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
14763345|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14763346|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763347|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
14763348|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763349|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763350|NCT00290511|Antiviral Agents|antiviral agents|mesh-ancestor
14763351|NCT00290511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763352|NCT00290511|Analgesics|analgesics|mesh-ancestor
14128164|NCT05113628|Methylene Blue|methylene blue|mesh-list
14128165|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128166|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128167|NCT05113615|Bromides|bromides|mesh-list
14128168|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
14128169|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14128170|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
14128171|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128172|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128173|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14128174|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
14128175|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
14128176|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14128177|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
14763353|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
14763354|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14763355|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14763356|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763357|NCT00265798|Sorafenib|sorafenib|mesh-list
14763358|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763359|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763360|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763361|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128178|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128179|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128180|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
14128181|NCT05113511|Bevacizumab|bevacizumab|mesh-list
14128182|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128183|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128184|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14128185|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14128186|NCT05113511|Growth Substances|growth substances|mesh-ancestor
14128187|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128188|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
14128189|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
14128190|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
14128191|NCT05113004|Leflunomide|leflunomide|mesh-list
14128192|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14128193|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128194|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14128195|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
14128196|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14128197|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128198|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128199|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128200|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
14128201|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14128202|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14128203|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128204|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128205|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
14128206|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128207|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14128208|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14128209|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14128210|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14128211|NCT05112692|Cetrorelix|cetrorelix|mesh-list
14128212|NCT05112692|Menotropins|menotropins|mesh-list
14128213|NCT05112692|Estradiol|estradiol|mesh-list
14128214|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14128215|NCT05112692|Progesterone|progesterone|mesh-list
14128216|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
14128217|NCT05112692|Estrogens|estrogens|mesh-ancestor
14128218|NCT05112692|Hormones|hormones|mesh-ancestor
14128219|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128220|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128221|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14128222|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
14128223|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14128224|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14128225|NCT05112692|Progestins|progestins|mesh-ancestor
14128226|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
14128227|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14128228|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128229|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14128230|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
14128231|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
13946059|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
13946060|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946061|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13946062|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946063|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946064|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13946065|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13946066|NCT03254810|Adalimumab|adalimumab|mesh-list
13946067|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13946068|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128232|NCT05105919|Aspirin|aspirin|mesh-list
14128233|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14128234|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128235|NCT05105919|Analgesics|analgesics|mesh-ancestor
14128236|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
14128237|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128238|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128239|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128240|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128241|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14128242|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14128243|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128244|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14128245|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14128246|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128247|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
14128248|NCT05105685|Hormones|hormones|mesh-list
14128249|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128250|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177261|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
14763362|NCT00255216|Policosanol|policosanol|mesh-list
14763363|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14763364|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14763365|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
14763366|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763367|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14763368|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14763369|NCT00248703|Docetaxel|docetaxel|mesh-list
14763370|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763371|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763372|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763373|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763374|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763375|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14763376|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
14763377|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
14763378|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763379|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763380|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14128251|NCT05103306|Empagliflozin|empagliflozin|mesh-list
14128252|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14128253|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128254|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14128255|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128256|NCT05102669|Antibodies|antibodies|mesh-list
14128257|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
14128258|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128259|NCT05100472|Androgens|androgens|mesh-list
14128260|NCT05100472|Hormones|hormones|mesh-ancestor
14128261|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128262|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128263|NCT05096962|Antibodies|antibodies|mesh-list
14128264|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
14128265|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128266|NCT05091242|Clonidine|clonidine|mesh-list
14128267|NCT05091242|Analgesics|analgesics|mesh-ancestor
14128268|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
14128269|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128270|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128271|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14128272|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
14128273|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
14128274|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14128275|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14128276|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14128277|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
14128278|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128279|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128280|NCT05089916|Osimertinib|osimertinib|mesh-list
14128281|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128282|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14128283|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128284|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128285|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
14128286|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14128287|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128288|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14128289|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14128290|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128291|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128292|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946069|NCT03254927|Cetuximab|cetuximab|mesh-list
13946070|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13946071|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946072|NCT03255044|Atorvastatin|atorvastatin|mesh-list
13946073|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13946074|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13946075|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13946076|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
13946077|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946078|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13946079|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13946080|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763381|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14763382|NCT00195091|Growth Substances|growth substances|mesh-ancestor
14763383|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128293|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
14128294|NCT05073822|Tacrolimus|tacrolimus|mesh-list
14128295|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128296|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
14128297|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128298|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14128299|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128300|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128301|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14128302|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763384|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
13946084|NCT03254511|Enoxaparin|enoxaparin|mesh-list
14128303|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13946085|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
14128304|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
14128305|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14128306|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128307|NCT05068336|Anesthetics|anesthetics|mesh-list
14128308|NCT05068336|Sevoflurane|sevoflurane|mesh-list
14763385|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936674|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
14936675|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936676|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14936677|NCT01470495|Sorafenib|sorafenib|mesh-list
14936678|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936679|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14936680|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936681|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936682|NCT01470690|Omeprazole|omeprazole|mesh-list
14128309|NCT05068336|Desflurane|desflurane|mesh-list
14128310|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128311|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128312|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14128313|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14128314|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
14128315|NCT05062785|Insulin|insulin|mesh-list
14128316|NCT05062785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14128317|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14128318|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128319|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
14128320|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128321|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128322|NCT05040126|Linezolid|linezolid|mesh-list
14763386|NCT00005780|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14763387|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
14763388|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763389|NCT00611143|Atorvastatin|atorvastatin|mesh-list
14763390|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14763391|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14763392|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
14763393|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763394|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14763395|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14763396|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763397|NCT00611169|Tirofiban|tirofiban|mesh-list
14763398|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14763399|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14763400|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763401|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14763402|NCT00611195|Remifentanil|remifentanil|mesh-list
14763403|NCT00611195|Propofol|propofol|mesh-list
14763404|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14763405|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763406|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763407|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14763408|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
14936683|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14128323|NCT05040126|Bedaquiline|bedaquiline|mesh-list
14128324|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14128325|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128326|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14128327|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936684|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946086|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
13946087|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13946088|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13946089|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946090|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
13946091|NCT03254589|Methotrexate|methotrexate|mesh-list
13946092|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13946093|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
13946094|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13946095|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946096|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13946097|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
13946098|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946099|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128328|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128329|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
14128330|NCT05036109|Aspirin|aspirin|mesh-list
14128331|NCT05036109|Vitamin D|vitamin d|mesh-list
14128332|NCT05036109|Vitamins|vitamins|mesh-ancestor
14128333|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
14128334|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128335|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14128336|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14128337|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128338|NCT05036109|Analgesics|analgesics|mesh-ancestor
14128339|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
14128340|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128341|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128342|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128343|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14128344|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14128345|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128346|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14128347|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14128348|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128349|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
14128350|NCT05024747|Nicotine|nicotine|mesh-list
14128351|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14128352|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
14128353|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128354|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128355|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14128356|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14128357|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
14128358|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128359|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128360|NCT05015335|Adalimumab|adalimumab|mesh-list
14128361|NCT05015335|Methotrexate|methotrexate|mesh-list
14128362|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14128363|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
14128364|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14128365|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128366|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14128367|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
14128368|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128369|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128370|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
13946100|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
13946101|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128371|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128372|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14128373|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128374|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
14128375|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128376|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14128377|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128378|NCT05003102|Fentanyl|fentanyl|mesh-list
14128379|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
14128380|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14128381|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128382|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128383|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128384|NCT05003102|Analgesics|analgesics|mesh-ancestor
14128385|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
14128386|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128387|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14128388|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14128389|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14128390|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946102|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13946103|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946104|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
13946105|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946106|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13946107|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946108|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13946109|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13946110|NCT03254589|Analgesics|analgesics|mesh-ancestor
13946111|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
13946112|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946113|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13946114|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946115|NCT03254784|BMS-986165|bms-986165|mesh-list
13946116|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
13946117|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13946118|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946119|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946120|NCT03254628|Misoprostol|misoprostol|mesh-list
13946121|NCT03254628|Oxytocin|oxytocin|mesh-list
13946122|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
13946123|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13946124|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946125|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13946126|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
13946127|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13946128|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946129|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13946130|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13946131|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946132|NCT03254186|Propranolol|propranolol|mesh-list
13946133|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13946134|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13946135|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946136|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946137|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128391|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128392|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128393|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14128394|NCT05003102|Narcotics|narcotics|mesh-ancestor
14128395|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14128396|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14128397|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
14128398|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
14128399|NCT04984811|Atezolizumab|atezolizumab|mesh-list
14128400|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128401|NCT04982796|Psilocybin|psilocybin|mesh-list
14128402|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
14128403|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946138|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946139|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13946140|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13946141|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
13946142|NCT03254173|Mirtazapine|mirtazapine|mesh-list
13946143|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
13946144|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13946145|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13946146|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
13946147|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
13946148|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946149|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946150|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946151|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14128404|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14128405|NCT04979806|Meropenem|meropenem|mesh-list
14128406|NCT04979806|Cefepime|cefepime|mesh-list
14128407|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14128408|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128409|NCT04973345|Terbutaline|terbutaline|mesh-list
14128410|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14128411|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
14128412|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128413|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128414|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14128415|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
14128416|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
14128417|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
14128418|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14128419|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14128420|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14128421|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14128422|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
14128423|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128424|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128425|NCT04964622|Ibuprofen|ibuprofen|mesh-list
14128426|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14128427|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128428|NCT04964622|Analgesics|analgesics|mesh-ancestor
14128429|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
14128430|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128431|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128432|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128433|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128434|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14128435|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128436|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128437|NCT04954339|Bevacizumab|bevacizumab|mesh-list
14128438|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128439|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128440|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14128441|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14128442|NCT04954339|Growth Substances|growth substances|mesh-ancestor
14128443|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128444|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
14177262|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14936685|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14936686|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936687|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936688|NCT01470742|Capecitabine|capecitabine|mesh-list
13946152|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14177263|NCT04757532|Diuretics|diuretics|mesh-ancestor
14177264|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
14177265|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14763409|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
14763410|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14763411|NCT00611195|Narcotics|narcotics|mesh-ancestor
14763412|NCT00611195|Analgesics|analgesics|mesh-ancestor
14763413|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
13946153|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946154|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13946155|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13946156|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13946157|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946158|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13946159|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14763414|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763415|NCT00611286|Sirolimus|sirolimus|mesh-list
13946160|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
14763416|NCT00611286|Paclitaxel|paclitaxel|mesh-list
14763417|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14763418|NCT00611286|Everolimus|everolimus|mesh-list
14763419|NCT00611286|Clopidogrel|clopidogrel|mesh-list
14936689|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14478413|NCT02452060|Analgesics|analgesics|mesh-ancestor
14763420|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
14936690|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
14936691|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936692|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936693|NCT01470755|Albuterol|albuterol|mesh-list
14936694|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14936695|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
14936696|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936697|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936698|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14936699|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
14936700|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
14936701|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14936702|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14936703|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14936704|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14936705|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
14936706|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936707|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936708|NCT01470794|Flucytosine|flucytosine|mesh-list
14936709|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
14936710|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936711|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
14936712|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936713|NCT01470807|Pancrelipase|pancrelipase|mesh-list
14936714|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14936715|NCT01470937|Acarbose|acarbose|mesh-list
13946161|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13962330|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962331|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13962332|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14936716|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14936717|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936718|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936719|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936720|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936721|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
14936722|NCT01471067|Rituximab|rituximab|mesh-list
13962333|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
13962334|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13962335|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13962336|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962337|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
13962338|NCT04754230|Coagulants|coagulants|mesh-ancestor
13962339|NCT04745949|Prednisone|prednisone|mesh-list
13962340|NCT04745949|Cortisone|cortisone|mesh-list
13962341|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
13962342|NCT04745949|Rituximab|rituximab|mesh-list
13962343|NCT04745949|Doxorubicin|doxorubicin|mesh-list
13962344|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13962345|NCT04745949|Nivolumab|nivolumab|mesh-list
13962346|NCT04745949|Daunorubicin|daunorubicin|mesh-list
13962347|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13962348|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13962349|NCT04745949|Antibodies|antibodies|mesh-list
13962350|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
13962351|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13962352|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
13962353|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962354|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
13962355|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962356|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962357|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13962358|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
13962359|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962360|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962361|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13962362|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13962363|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13962364|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13962365|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962366|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962367|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
13962368|NCT04745949|Hormones|hormones|mesh-ancestor
13962369|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962370|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962371|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13962372|NCT04718415|Paclitaxel|paclitaxel|mesh-list
13962373|NCT04718415|Carboplatin|carboplatin|mesh-list
13962374|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13962375|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962376|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
13962377|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
13962378|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
13962379|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962380|NCT04718025|Aspirin|aspirin|mesh-list
13962381|NCT04718025|Ticagrelor|ticagrelor|mesh-list
13962382|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13962383|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13962384|NCT04718025|Analgesics|analgesics|mesh-ancestor
13962385|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
13962386|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962387|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962388|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962389|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962390|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13962391|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13962392|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962393|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13962394|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13962395|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962396|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
14936723|NCT01471067|Fludarabine|fludarabine|mesh-list
13946162|NCT03254368|ZGN-1061|zgn-1061|mesh-list
13946163|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946164|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946165|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13946166|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
13946167|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13946168|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946169|NCT03253913|Sirolimus|sirolimus|mesh-list
13946170|NCT03253913|Resveratrol|resveratrol|mesh-list
13946171|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13946172|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946173|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13946174|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946175|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
13946176|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946177|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
13946178|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946179|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
13946180|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946181|NCT03253913|Protective Agents|protective agents|mesh-ancestor
13946182|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946183|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13946184|NCT03253887|Ethanol|ethanol|mesh-list
13946185|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13946186|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946187|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946188|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946189|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
13946190|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13946191|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
13946192|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946193|NCT03253328|Expectorants|expectorants|mesh-ancestor
13946194|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
14128445|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
14128446|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128447|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14128448|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128449|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128450|NCT04951804|Bupivacaine|bupivacaine|mesh-list
14128451|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
14128452|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
14128453|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128454|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128455|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
14128456|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128457|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
14128458|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14128459|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14128460|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128461|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
14128462|NCT04947514|Coagulants|coagulants|mesh-ancestor
14128463|NCT04939753|Sevoflurane|sevoflurane|mesh-list
14128464|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14128465|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13946195|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13946196|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
13946197|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946198|NCT03253328|Protective Agents|protective agents|mesh-ancestor
13946199|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946200|NCT03253328|Antidotes|antidotes|mesh-ancestor
13946201|NCT03253289|Meclizine|meclizine|mesh-list
13946202|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
13946203|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
13946204|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946205|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946206|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946207|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13946208|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
13946209|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
13946210|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946211|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946212|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13946213|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
13946214|NCT03253276|Cathartics|cathartics|mesh-ancestor
13946215|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128466|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
14128467|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
14128468|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128469|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128470|NCT04937413|Evolocumab|evolocumab|mesh-list
14128471|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14128472|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14128473|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
14128474|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128475|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13946216|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
13946217|NCT03253224|Analgesics|analgesics|mesh-ancestor
13946218|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
13946219|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946220|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946221|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
13946222|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946223|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13946224|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
13946225|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13946226|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946227|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946228|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13946229|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
13946230|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13946231|NCT03253250|Tenofovir|tenofovir|mesh-list
13946232|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13946233|NCT03253250|Entecavir|entecavir|mesh-list
13946234|NCT03253250|Adefovir|adefovir|mesh-list
13946235|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
13946236|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946237|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14936724|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
14936725|NCT01471067|Melphalan|melphalan|mesh-list
14936726|NCT01471067|Busulfan|busulfan|mesh-list
14936727|NCT01471067|Clofarabine|clofarabine|mesh-list
14936728|NCT01471067|Tacrolimus|tacrolimus|mesh-list
14936729|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
13946238|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13946239|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946240|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946241|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13946242|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14128476|NCT04871529|Gemcitabine|gemcitabine|mesh-list
14128477|NCT04871529|Carboplatin|carboplatin|mesh-list
13946243|NCT03253562|Metformin|metformin|mesh-list
13946244|NCT03253562|Vildagliptin|vildagliptin|mesh-list
13946245|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14128478|NCT04871529|Avelumab|avelumab|mesh-list
14128479|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
14128480|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
14128481|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14128482|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128483|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14128484|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
14128485|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128486|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
14128487|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128488|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128489|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128490|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
14128491|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128492|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128493|NCT04862468|Dexamethasone|dexamethasone|mesh-list
14128494|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128495|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
14128496|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
14128497|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128498|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128499|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478414|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
14936730|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13946246|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946247|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14936731|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13946248|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
14128500|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
14128501|NCT04862468|Hormones|hormones|mesh-ancestor
14936732|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128502|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128503|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14128504|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128505|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
14128506|NCT04828486|Futibatinib|futibatinib|mesh-list
14128507|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128508|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128509|NCT04819568|Terlipressin|terlipressin|mesh-list
14128510|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14128511|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14128512|NCT04818489|Colchicine|colchicine|mesh-list
14128513|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
14128514|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946249|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946250|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946251|NCT03253198|Bupivacaine|bupivacaine|mesh-list
13946252|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
13946253|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
13946254|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946255|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946256|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
13946257|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946258|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
13946259|NCT03253133|Oxycodone|oxycodone|mesh-list
13946260|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946261|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13946262|NCT03253133|Narcotics|narcotics|mesh-ancestor
13946263|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946264|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128515|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14128516|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14128517|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14128518|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128519|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128520|NCT04802408|Listerine|listerine|mesh-list
14128521|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
14128522|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14128523|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128524|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
14128525|NCT04802408|Protective Agents|protective agents|mesh-ancestor
14128526|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128527|NCT04796467|Edetic Acid|edetic acid|mesh-list
14128528|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14128529|NCT04796467|Anticoagulants|anticoagulants|mesh-ancestor
14128530|NCT04796467|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14128531|NCT04796467|Chelating Agents|chelating agents|mesh-ancestor
14128532|NCT04796467|Sequestering Agents|sequestering agents|mesh-ancestor
14128533|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128534|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14128535|NCT04765787|Acetaminophen|acetaminophen|mesh-list
14128536|NCT04765787|Orphenadrine|orphenadrine|mesh-list
14128537|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128538|NCT04765787|Analgesics|analgesics|mesh-ancestor
14128539|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
14128540|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128541|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128542|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
14128543|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14128544|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14128545|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14128546|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14128547|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
14128548|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
14128549|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14128550|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14128551|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
14128552|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128553|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128554|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
14128555|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14128556|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128557|NCT04756791|Anesthetics|anesthetics|mesh-list
14128558|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946265|NCT03253133|Analgesics|analgesics|mesh-ancestor
14128559|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946266|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
13946267|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946268|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
13946269|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13946270|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946271|NCT03253107|Trastuzumab|trastuzumab|mesh-list
13946272|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13946273|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946274|NCT03252808|Gemcitabine|gemcitabine|mesh-list
13946275|NCT03252808|Paclitaxel|paclitaxel|mesh-list
13946276|NCT03252808|Tegafur|tegafur|mesh-list
13946277|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13946278|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946279|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
13946280|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
13946281|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
13946282|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946283|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13946284|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
13946285|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
13946286|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946287|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478415|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946288|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946289|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
13946290|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946291|NCT03252938|Avelumab|avelumab|mesh-list
13946292|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13946293|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946294|NCT03252665|Nicorandil|nicorandil|mesh-list
13946295|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
13946296|NCT03252665|Alprostadil|alprostadil|mesh-list
13946297|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
13946298|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13946299|NCT03252665|Urological Agents|urological agents|mesh-ancestor
13946300|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13946301|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13946302|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
13946303|NCT03252665|Vitamins|vitamins|mesh-ancestor
13946304|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
13946305|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962397|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13962398|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13962399|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13962400|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
13962401|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962402|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
13962403|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962404|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962405|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
13962406|NCT04710628|Lenvatinib|lenvatinib|mesh-list
13962407|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962408|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962409|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13962410|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962411|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962412|NCT04708067|Atezolizumab|atezolizumab|mesh-list
13962413|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962414|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
13962415|NCT04688203|Labetalol|labetalol|mesh-list
13962416|NCT04688203|Analgesics|analgesics|mesh-ancestor
13962417|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
13962418|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962419|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962420|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
13962421|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962422|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13962423|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
13962424|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13962425|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13962426|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478416|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962427|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13962428|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
13962429|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13962430|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13962431|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13946306|NCT03252457|Dexamethasone|dexamethasone|mesh-list
13946307|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
13946308|NCT03252457|Decitabine|decitabine|mesh-list
13946309|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13946310|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
13946311|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
13946312|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946313|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128560|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
14128561|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14128562|NCT04748250|Estrogens|estrogens|mesh-ancestor
14128563|NCT04748250|Hormones|hormones|mesh-ancestor
14128564|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128565|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128566|NCT04726878|Acetaminophen|acetaminophen|mesh-list
14128567|NCT04726878|Oxycodone|oxycodone|mesh-list
13946314|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946315|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
13946316|NCT03252457|Hormones|hormones|mesh-ancestor
13946317|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946318|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13946319|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946320|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13946321|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
13946322|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946323|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946324|NCT03252496|Ephedrine|ephedrine|mesh-list
13946325|NCT03252496|Fentanyl|fentanyl|mesh-list
13946326|NCT03252496|Bupivacaine|bupivacaine|mesh-list
13946327|NCT03252496|Oxytocin|oxytocin|mesh-list
13946328|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
13946329|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
13946330|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946331|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946332|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
13946333|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946334|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13946335|NCT03252496|Narcotics|narcotics|mesh-ancestor
13946336|NCT03252496|Analgesics|analgesics|mesh-ancestor
13946337|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13946338|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14128568|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128569|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128570|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128571|NCT04726878|Analgesics|analgesics|mesh-ancestor
14128572|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
14128573|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128574|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
14128575|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14128576|NCT04726878|Narcotics|narcotics|mesh-ancestor
14128577|NCT04718727|Olanzapine|olanzapine|mesh-list
14128578|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
14128579|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
14128580|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128581|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128582|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128583|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14128584|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14128585|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128586|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14128587|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14128588|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14128589|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14128590|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946339|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
13946340|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
13946341|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14128591|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946342|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13946343|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
13946344|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
13946345|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13946346|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946347|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128592|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
14936733|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
13962432|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
14128593|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
14128594|NCT04714372|Fludarabine|fludarabine|mesh-list
14128595|NCT04714372|Daratumumab|daratumumab|mesh-list
14128596|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128597|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
14128598|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128599|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946348|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946349|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
13946350|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
14128600|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14128601|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
14128602|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128603|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128604|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14128605|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14128606|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
14128607|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14128608|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
14128609|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14128610|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128611|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14128612|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14128613|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14128614|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128615|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14128616|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14128617|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14128618|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
14128619|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128620|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14128621|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14128622|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
13946351|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946352|NCT03252418|Protective Agents|protective agents|mesh-ancestor
13946353|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946354|NCT03252418|Vitamins|vitamins|mesh-ancestor
13946355|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
13946356|NCT03252561|Anesthetics|anesthetics|mesh-list
14128623|NCT04605614|Copper|copper|mesh-list
14128624|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
14128625|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128626|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128627|NCT04605614|Trace Elements|trace elements|mesh-ancestor
14128628|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
14128629|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128630|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
14177305|NCT04757376|Denosumab|denosumab|mesh-list
14177306|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14177307|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946357|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
13946358|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946359|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946360|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
13946361|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946362|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
13946363|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
13946364|NCT03252366|Coagulants|coagulants|mesh-ancestor
13946365|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14177308|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
14177309|NCT04757337|Doxorubicin|doxorubicin|mesh-list
14177310|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177311|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
14177312|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177313|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177314|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13946366|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14177315|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
14128631|NCT04585295|Betaine|betaine|mesh-list
14128632|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128633|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
14128634|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14128635|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
14128636|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128637|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14128638|NCT04583488|Docetaxel|docetaxel|mesh-list
14128639|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128640|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
14128641|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
14128642|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
14128643|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128644|NCT04568616|Letrozole|letrozole|mesh-list
14128645|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128646|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14128647|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14128648|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128649|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128650|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14128651|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
14128652|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128653|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128654|NCT04560868|Nicotine|nicotine|mesh-list
14128655|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14128656|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
14128657|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128658|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128659|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14128660|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14128661|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
14128662|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128663|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128664|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
13946367|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
13946368|NCT03252067|Azithromycin|azithromycin|mesh-list
13946369|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13946370|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13946371|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946372|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13946373|NCT03252223|Hormones|hormones|mesh-list
13946374|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13946375|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946376|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946377|NCT03251690|Tenofovir|tenofovir|mesh-list
13946378|NCT03251690|Emtricitabine|emtricitabine|mesh-list
13946379|NCT03251690|Efavirenz|efavirenz|mesh-list
14128665|NCT04557215|Rifaximin|rifaximin|mesh-list
14128666|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14128667|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
14128668|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128669|NCT04557215|Expectorants|expectorants|mesh-ancestor
14128670|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
14128671|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14128672|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
14128673|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936734|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946380|NCT03251690|Rilpivirine|rilpivirine|mesh-list
13946381|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
13946382|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946383|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13946384|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13946385|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946386|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946387|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13946388|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13946389|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13946390|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14128674|NCT04557215|Protective Agents|protective agents|mesh-ancestor
14128675|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128676|NCT04557215|Antidotes|antidotes|mesh-ancestor
14128677|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14128678|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128679|NCT04526197|Celecoxib|celecoxib|mesh-list
13946391|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14128680|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14128681|NCT04526197|Choline|choline|mesh-list
14128682|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14128683|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128684|NCT04526197|Analgesics|analgesics|mesh-ancestor
14128685|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
14128686|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128687|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128688|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13946392|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13946393|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13946394|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13946395|NCT03251859|Ticagrelor|ticagrelor|mesh-list
13946396|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13946397|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13946398|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13946399|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13946400|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
13946401|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946402|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946403|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946404|NCT03251768|Lenograstim|lenograstim|mesh-list
13946405|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13946406|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
13946407|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946408|NCT03251872|Olaparib|olaparib|mesh-list
13946409|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13946410|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128689|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128690|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14128691|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14128692|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128693|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128694|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
14128695|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14128696|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
14128697|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128698|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14128699|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
14128700|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
14128701|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
14128702|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14128703|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14128704|NCT04526197|Growth Substances|growth substances|mesh-ancestor
14128705|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
14128706|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128707|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
14128708|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128709|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128710|NCT04511013|Nivolumab|nivolumab|mesh-list
14128711|NCT04511013|Ipilimumab|ipilimumab|mesh-list
14128712|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128713|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128714|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14128715|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128716|NCT04468230|Nicotine|nicotine|mesh-list
14128717|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13946411|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946412|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946413|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
13946414|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13946415|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946416|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946417|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
13946418|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946419|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946420|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
13946421|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
13946422|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
13946423|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13946424|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14128718|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
14128719|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128720|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946425|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946426|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
13946427|NCT03251469|Coagulants|coagulants|mesh-ancestor
13946428|NCT03251365|Gemcitabine|gemcitabine|mesh-list
13946429|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13946430|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
13946431|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946432|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946433|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
13946434|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128721|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14128722|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14128723|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
14128724|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128725|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128726|NCT04438382|Prednisone|prednisone|mesh-list
14128727|NCT04438382|Cortisone|cortisone|mesh-list
14128728|NCT04438382|Infliximab|infliximab|mesh-list
14128729|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
14128730|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14128731|NCT04438382|Antibodies|antibodies|mesh-list
14128732|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
14128733|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14128734|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
14128735|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128736|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
14128737|NCT04438382|Hormones|hormones|mesh-ancestor
14128738|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128739|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128740|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14128741|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128742|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
14128743|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14128744|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128745|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128746|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
14128747|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128748|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128749|NCT04424225|Niacin|niacin|mesh-list
14128750|NCT04424225|Psilocybin|psilocybin|mesh-list
14128751|NCT04424225|Vitamins|vitamins|mesh-ancestor
14128752|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
14128753|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128754|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
14128755|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14128756|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
14128757|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128758|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14128759|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
14128760|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
14128761|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14128762|NCT04418895|Leucovorin|leucovorin|mesh-list
14128763|NCT04418895|Fluorouracil|fluorouracil|mesh-list
14128764|NCT04418895|Capecitabine|capecitabine|mesh-list
14128765|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
14128766|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
14128767|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128768|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
14128769|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128770|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14128771|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128772|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128773|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
14128774|NCT04418895|Antidotes|antidotes|mesh-ancestor
14128775|NCT04418895|Protective Agents|protective agents|mesh-ancestor
14128776|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
14128777|NCT04418895|Vitamins|vitamins|mesh-ancestor
14128778|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
14128779|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14128780|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14128781|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128782|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
13946435|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963504|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
14128783|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128784|NCT04396535|Docetaxel|docetaxel|mesh-list
14128785|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128786|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
14128787|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
14128788|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
14128789|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128790|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14128791|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
14128792|NCT04378426|Midazolam|midazolam|mesh-list
14128793|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
14128794|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13946436|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946437|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
13946438|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946439|NCT03251300|Mirabegron|mirabegron|mesh-list
13946440|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13946441|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13946442|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13946443|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946444|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946445|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946446|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946447|NCT03251300|Urological Agents|urological agents|mesh-ancestor
13946448|NCT03251417|Irinotecan|irinotecan|mesh-list
13946449|NCT03251417|Apatinib|apatinib|mesh-list
13946450|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13946451|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13946452|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946453|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946454|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946455|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13946456|NCT03251443|Apatinib|apatinib|mesh-list
13946457|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946458|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13946459|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946460|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128795|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14128796|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128797|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128798|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14128799|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14128800|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14936735|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946461|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13946462|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
13946463|NCT03251040|Coagulants|coagulants|mesh-ancestor
13946464|NCT03250923|Acemannan|acemannan|mesh-list
13946465|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13946466|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
13946467|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946468|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946469|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
13946470|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946471|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946472|NCT03251170|Fentanyl|fentanyl|mesh-list
13946473|NCT03251170|Midazolam|midazolam|mesh-list
13946474|NCT03251170|Ketamine|ketamine|mesh-list
13946475|NCT03251170|Analgesics|analgesics|mesh-ancestor
13946476|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
13946477|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946478|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946479|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13946480|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13946481|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
13946482|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
13946483|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946484|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13946485|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13946486|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946487|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946488|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13946489|NCT03251170|Narcotics|narcotics|mesh-ancestor
13946490|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13946491|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13946492|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13946493|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14128801|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14936736|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14128802|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
14128803|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
14128804|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
14128805|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
14128806|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128807|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128808|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14128809|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128810|NCT04378426|Analgesics|analgesics|mesh-ancestor
14128811|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
14128812|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128813|NCT04376281|Norepinephrine|norepinephrine|mesh-list
14128814|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14128815|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14128816|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
14128817|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128818|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128819|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128820|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
14128821|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
14128822|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128823|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14128824|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
14478417|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14478418|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14478419|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
14478420|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
14478421|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478422|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14478423|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14478424|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936737|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
14128825|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14128826|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
14128827|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128828|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
14128829|NCT04332445|Protective Agents|protective agents|mesh-ancestor
13946494|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13946495|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
13946496|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
13946497|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
13946498|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13946499|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946500|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946501|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13946502|NCT03251222|Analgesics|analgesics|mesh-ancestor
13946503|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
13946504|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946505|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13946506|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13946507|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13946508|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946509|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946510|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946511|NCT03250910|Ribavirin|ribavirin|mesh-list
13946512|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
13946513|NCT03250910|Velpatasvir|velpatasvir|mesh-list
13946514|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
13946515|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128830|NCT04316910|Anesthetics|anesthetics|mesh-list
14128831|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
13946516|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
13946517|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962433|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962434|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13962435|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
13962436|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
13962437|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13962438|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13962439|NCT04672395|Vaccines|vaccines|mesh-list
13962440|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
13962441|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
14128832|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128833|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938727|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14128834|NCT04315272|Azithromycin|azithromycin|mesh-list
13946518|NCT03250962|Decitabine|decitabine|mesh-list
13946519|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13946520|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
13946521|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946522|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946523|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763421|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14128835|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14128836|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128837|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
14128838|NCT04314050|Tramadol|tramadol|mesh-list
14128839|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14128840|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14128841|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128842|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128843|NCT04314050|Analgesics|analgesics|mesh-ancestor
14128844|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
14128845|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128846|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14128847|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14128848|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14128849|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
14128850|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128851|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128852|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14128853|NCT04314050|Narcotics|narcotics|mesh-ancestor
14128854|NCT04299490|Analgesics|analgesics|mesh-list
14128855|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763422|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763423|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763424|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763425|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763426|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763427|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763428|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
13946532|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
13946533|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
13946534|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13946535|NCT03250520|Protective Agents|protective agents|mesh-ancestor
13946536|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946537|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
13946538|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14128856|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
14128857|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128858|NCT04299373|Ethanol|ethanol|mesh-list
14128859|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14128860|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14128861|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946539|NCT03250494|Dexamethasone|dexamethasone|mesh-list
13946540|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
13946541|NCT03250494|BB 1101|bb 1101|mesh-list
13946542|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128862|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128863|NCT04282109|Paclitaxel|paclitaxel|mesh-list
14128864|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14128865|NCT04282109|Nivolumab|nivolumab|mesh-list
14128866|NCT04282109|Cetuximab|cetuximab|mesh-list
14128867|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13946543|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
13946544|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
14128868|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128869|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
14128870|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
14128871|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
14128872|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128873|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128874|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14936738|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946545|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946546|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946547|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946548|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
13946549|NCT03250494|Hormones|hormones|mesh-ancestor
14128875|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
13963505|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
14128876|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14128877|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128878|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
14128879|NCT04205968|Leucovorin|leucovorin|mesh-list
14128880|NCT04205968|Folic Acid|folic acid|mesh-list
14128881|NCT04205968|Paclitaxel|paclitaxel|mesh-list
14128882|NCT04205968|Camptothecin|camptothecin|mesh-list
14128883|NCT04205968|Fluorouracil|fluorouracil|mesh-list
14128884|NCT04205968|Irinotecan|irinotecan|mesh-list
14128885|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14128886|NCT04205968|Ramucirumab|ramucirumab|mesh-list
14128887|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13946550|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946551|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13946552|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946553|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
13946554|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946555|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946556|NCT03250507|Bupivacaine|bupivacaine|mesh-list
13946557|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
13946558|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
13946559|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946560|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946561|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
13946562|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946563|NCT03250481|Oxycodone|oxycodone|mesh-list
14128888|NCT04205968|Antibodies|antibodies|mesh-list
14128889|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
13946564|NCT03250481|Propofol|propofol|mesh-list
13946565|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13946566|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946567|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946568|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13946569|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
13946570|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
13946571|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13946572|NCT03250481|Narcotics|narcotics|mesh-ancestor
13946573|NCT03250481|Analgesics|analgesics|mesh-ancestor
14128890|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14128891|NCT04205968|Calcium|calcium|mesh-list
14128892|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
14128893|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14128894|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128895|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
14128896|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
14128897|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
14128898|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128899|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
14128900|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128901|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14128902|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14128903|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
14128904|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14128905|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14128906|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14128907|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14128908|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128909|NCT04205968|Antidotes|antidotes|mesh-ancestor
14128910|NCT04205968|Protective Agents|protective agents|mesh-ancestor
14128911|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
14128912|NCT04205968|Vitamins|vitamins|mesh-ancestor
14128913|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
14128914|NCT04205968|Hematinics|hematinics|mesh-ancestor
14128915|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
14128916|NCT04198961|Narcotics|narcotics|mesh-ancestor
14128917|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14936739|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14936740|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936741|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14936742|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936743|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14128918|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128919|NCT04198961|Analgesics|analgesics|mesh-ancestor
14128920|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
14128921|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963506|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14128922|NCT04198623|Montelukast|montelukast|mesh-list
14128923|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13946574|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
13946575|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946576|NCT03250741|Rotigotine|rotigotine|mesh-list
13946577|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
13946578|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
13946579|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946580|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946581|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946582|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
13946583|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946584|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
13946585|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946586|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946587|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13946588|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
13946589|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946590|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946591|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13946592|NCT03250338|Cytarabine|cytarabine|mesh-list
13946593|NCT03250338|Fludarabine|fludarabine|mesh-list
13946594|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
13946595|NCT03250338|Idarubicin|idarubicin|mesh-list
13946596|NCT03250338|Crenolanib|crenolanib|mesh-list
13946597|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946598|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13946599|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
13946600|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946601|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946602|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
13946603|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946604|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
13946605|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946606|NCT03250338|Analgesics|analgesics|mesh-ancestor
13946607|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
14128924|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
14128925|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14128926|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
14128927|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14128928|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128929|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14128930|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14128931|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128932|NCT04189510|Pancrelipase|pancrelipase|mesh-list
14128933|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177316|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177317|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177318|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14177319|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14177320|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14177321|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14177322|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177323|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14177324|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14177325|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14177326|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177327|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177328|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
14177329|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177330|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177331|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14177332|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183781|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183782|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14183783|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14183784|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14183785|NCT04725448|Growth Substances|growth substances|mesh-ancestor
14183786|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183787|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
14183788|NCT04725656|Nicotine|nicotine|mesh-list
14183789|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14183790|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
13946608|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946609|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13946610|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13946611|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946612|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13946613|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13946614|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946615|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
13946616|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
13946617|NCT03249831|Pentostatin|pentostatin|mesh-list
13946618|NCT03249831|Tacrolimus|tacrolimus|mesh-list
13946619|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
13946620|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13946621|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946622|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
13946623|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946624|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946625|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13946626|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
14128934|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
14128935|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
14128936|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14128937|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128938|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128939|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
14128940|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
14128941|NCT04134845|Dantrolene|dantrolene|mesh-list
14128942|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14128943|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128944|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14128945|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128949|NCT04094558|Lactulose|lactulose|mesh-list
14128950|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14128951|NCT04071457|Lenalidomide|lenalidomide|mesh-list
14128952|NCT04071457|Daratumumab|daratumumab|mesh-list
14128953|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
14128954|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128955|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14128956|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14128957|NCT04071457|Growth Substances|growth substances|mesh-ancestor
14128958|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
14128959|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128960|NCT04050462|Nivolumab|nivolumab|mesh-list
14128961|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128962|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128963|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13946627|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946628|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128964|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128965|NCT04038346|Acetaminophen|acetaminophen|mesh-list
14128966|NCT04038346|Naproxen|naproxen|mesh-list
14128967|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14128968|NCT04038346|Analgesics|analgesics|mesh-ancestor
14128969|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
14128970|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14128971|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14128972|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
13946629|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14128973|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14128974|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14128975|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128976|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
14128977|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14128978|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14128979|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128980|NCT04034927|Olaparib|olaparib|mesh-list
14128981|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14128982|NCT04034927|Tremelimumab|tremelimumab|mesh-list
14128983|NCT04034927|Ipilimumab|ipilimumab|mesh-list
14128984|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946630|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14128985|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128986|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14128987|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14128988|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14128989|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14128990|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14128991|NCT03996265|Bupropion|bupropion|mesh-list
14128992|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13946631|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946632|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13946633|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13946634|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
14128993|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
14128994|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14128995|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14128996|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14128997|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14128998|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14128999|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
14129000|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129001|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129002|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13946635|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13946636|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129003|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14129004|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129005|NCT03943901|Prednisone|prednisone|mesh-list
14129006|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
14936744|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14129007|NCT03943901|Rituximab|rituximab|mesh-list
14129008|NCT03943901|Doxorubicin|doxorubicin|mesh-list
14129009|NCT03943901|Vincristine|vincristine|mesh-list
14129010|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129011|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
14129012|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129013|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14936745|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
14936746|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936747|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14936748|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
14936749|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14936750|NCT01471106|Dasatinib|dasatinib|mesh-list
14936751|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936752|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14936753|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936754|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936755|NCT01471132|Paclitaxel|paclitaxel|mesh-list
14936756|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
14936757|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14936758|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946637|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
13946638|NCT03250143|Cyclosporine|cyclosporine|mesh-list
13946639|NCT03250143|Azathioprine|azathioprine|mesh-list
13946640|NCT03250143|Cyclosporins|cyclosporins|mesh-list
13946641|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946642|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946643|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946644|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
14129014|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14129015|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
14129016|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129017|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129018|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14129019|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129020|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14129021|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13946645|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946646|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
13946647|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946648|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
13946649|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946650|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14129022|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14129023|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129024|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129025|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
14129026|NCT03943901|Hormones|hormones|mesh-ancestor
14129027|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129028|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129029|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14129030|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129031|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129032|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129033|NCT03932136|Sulforaphane|sulforaphane|mesh-list
14129034|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14129035|NCT03932136|Protective Agents|protective agents|mesh-ancestor
14129036|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129037|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129038|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14129039|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129040|NCT03891849|Octreotide|octreotide|mesh-list
14129041|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946651|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
13946652|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13946653|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946654|NCT03250039|Abrocitinib|abrocitinib|mesh-list
13946655|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13946656|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946657|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946658|NCT03250052|Linagliptin|linagliptin|mesh-list
13946659|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13946660|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946661|NCT03250052|Incretins|incretins|mesh-ancestor
13946662|NCT03250052|Hormones|hormones|mesh-ancestor
13946663|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129042|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129043|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129044|NCT03890133|Pregabalin|pregabalin|mesh-list
14129045|NCT03890133|Analgesics|analgesics|mesh-ancestor
14129046|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
14129047|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129048|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129049|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
14129050|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14129051|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14129052|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763429|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763430|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14763431|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13946664|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13946665|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
13946666|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946667|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946668|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
13946669|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14763432|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13946670|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946671|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13946672|NCT03249740|Sunitinib|sunitinib|mesh-list
13946673|NCT03249740|Aflibercept|aflibercept|mesh-list
13946674|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946675|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13946676|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14763433|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
14763434|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763435|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14763436|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763437|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14129053|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14129054|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14129055|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14129056|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129057|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14129058|NCT03875638|Levetiracetam|levetiracetam|mesh-list
13946677|NCT03249740|Growth Substances|growth substances|mesh-ancestor
13946678|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946679|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
13946680|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13946681|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946682|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946683|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
13946684|NCT03249506|Empagliflozin|empagliflozin|mesh-list
13946685|NCT03249506|Canagliflozin|canagliflozin|mesh-list
13946686|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
13946687|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
13946688|NCT03249506|Glucagon|glucagon|mesh-list
13946689|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13946690|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13946691|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946692|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13946693|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946694|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129059|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
14129060|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
14129061|NCT03874234|GSK3186899|gsk3186899|mesh-list
13946695|NCT03249506|Hormones|hormones|mesh-ancestor
14763438|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
14763439|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14763440|NCT00611416|Caffeine|caffeine|mesh-list
14936759|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
14936760|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936761|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
14936762|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936763|NCT01471145|Naltrexone|naltrexone|mesh-list
14936764|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14936765|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14936766|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763441|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14763442|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763443|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14763444|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763445|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763446|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14763447|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14763448|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
14763449|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763450|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
14763451|NCT00611416|Protective Agents|protective agents|mesh-ancestor
14763452|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14129062|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14129063|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129064|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129065|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14129066|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14763453|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13946696|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946697|NCT03249506|Incretins|incretins|mesh-ancestor
14129067|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129068|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129069|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129070|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129071|NCT03742414|Fluticasone|fluticasone|mesh-list
14129072|NCT03742414|Xhance|xhance|mesh-list
14129073|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129074|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13946698|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
14129075|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
14129076|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129077|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129078|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14129079|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129080|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
14129081|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14129082|NCT03727139|Rasagiline|rasagiline|mesh-list
14129083|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14129084|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129085|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129086|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14129087|NCT03727139|Protective Agents|protective agents|mesh-ancestor
14129088|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129089|NCT03723772|Insulin|insulin|mesh-list
14129090|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14129091|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14129092|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129093|NCT03713580|Venetoclax|venetoclax|mesh-list
14129094|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129095|NCT03678025|Prednisone|prednisone|mesh-list
14129096|NCT03678025|Cortisone|cortisone|mesh-list
14129097|NCT03678025|Docetaxel|docetaxel|mesh-list
14129098|NCT03678025|Leuprolide|leuprolide|mesh-list
14129099|NCT03678025|Goserelin|goserelin|mesh-list
14129100|NCT03678025|Bicalutamide|bicalutamide|mesh-list
14129101|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14129102|NCT03678025|Flutamide|flutamide|mesh-list
14129103|NCT03678025|Nilutamide|nilutamide|mesh-list
14129104|NCT03678025|Tryptophan|tryptophan|mesh-list
14129105|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129106|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129107|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129108|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129109|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129110|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129111|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
14129112|NCT03678025|Hormones|hormones|mesh-ancestor
13946699|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946700|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
13946701|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13946702|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
13946703|NCT03249402|Estradiol|estradiol|mesh-list
13946704|NCT03249402|Estrogens|estrogens|mesh-ancestor
13946705|NCT03249402|Hormones|hormones|mesh-ancestor
13946706|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946707|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946708|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13946709|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
13946710|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13946711|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13946712|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13946713|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13946714|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13946715|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13946716|NCT03249558|Morphine|morphine|mesh-list
13946717|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13946718|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13946719|NCT03249558|Narcotics|narcotics|mesh-ancestor
13946720|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14936767|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
14936768|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14936769|NCT01471158|Timolol|timolol|mesh-list
14936770|NCT01471158|Dorzolamide|dorzolamide|mesh-list
14936771|NCT01471158|Maleic acid|maleic acid|mesh-list
14936772|NCT01471158|Brinzolamide|brinzolamide|mesh-list
14936773|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14936774|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14936775|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14936776|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936777|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936778|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936779|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14936780|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14129113|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963507|NCT03143933|Narcotics|narcotics|mesh-ancestor
14129114|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129115|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129116|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14129117|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
14129118|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14129119|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
14129120|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
14129121|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
14129122|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14129123|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
14129124|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14129125|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14129126|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
14129127|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14129128|NCT03631784|Paclitaxel|paclitaxel|mesh-list
14129129|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14129130|NCT03631784|Carboplatin|carboplatin|mesh-list
14129131|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
14129132|NCT03631784|Pemetrexed|pemetrexed|mesh-list
14129133|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14129134|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129135|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129136|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936781|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936782|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14936783|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13946721|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946722|NCT03249558|Analgesics|analgesics|mesh-ancestor
13946723|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
13946724|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946725|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13946726|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13946727|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946728|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129137|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129138|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946729|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946730|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
13946731|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13946732|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
13946733|NCT03249662|Bupivacaine|bupivacaine|mesh-list
13946734|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
13946735|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
13946736|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946737|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946738|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
14129139|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129140|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129141|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14129142|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14129143|NCT03625986|Nicotine|nicotine|mesh-list
14129144|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14129145|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
14129146|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129147|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129148|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14129149|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14129150|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
14129151|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129152|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177333|NCT04756895|Vancomycin|vancomycin|mesh-list
14177334|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14177335|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177336|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
14177337|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14177338|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
14177339|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177340|NCT04756622|Expectorants|expectorants|mesh-ancestor
13946739|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946740|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13946741|NCT03249311|Milnacipran|milnacipran|mesh-list
13946742|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
13946743|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13946744|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13946745|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177341|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
14177342|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13946746|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946747|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946748|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946749|NCT03249311|Analgesics|analgesics|mesh-ancestor
13946750|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
13946751|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946752|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
13946753|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13946754|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
13946755|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13962442|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962443|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13962444|NCT04636437|Tenofovir|tenofovir|mesh-list
13962445|NCT04636437|Lamivudine|lamivudine|mesh-list
13962446|NCT04636437|Emtricitabine|emtricitabine|mesh-list
13962447|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
13962448|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
13962449|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962450|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13962451|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13962452|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129153|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
14129154|NCT03610490|Fludarabine|fludarabine|mesh-list
14129155|NCT03610490|Interleukin-2|interleukin-2|mesh-list
14129156|NCT03610490|Mitogens|mitogens|mesh-list
14129157|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129158|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
14129159|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129160|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14129161|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14129162|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
14129163|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129164|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129165|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14129166|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14129167|NCT03610490|Analgesics|analgesics|mesh-ancestor
14129168|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
14129169|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129170|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129171|NCT03567642|Etoposide|etoposide|mesh-list
14129172|NCT03567642|Osimertinib|osimertinib|mesh-list
14129173|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14129174|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129175|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14129176|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14129177|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129178|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129179|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14129180|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
14129181|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129182|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129183|NCT03526900|Atezolizumab|atezolizumab|mesh-list
14129184|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129185|NCT03504410|Cytarabine|cytarabine|mesh-list
14129186|NCT03504410|Fludarabine|fludarabine|mesh-list
14129187|NCT03504410|Etoposide|etoposide|mesh-list
14129188|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
14129189|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129190|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14129191|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
14129192|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129193|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129194|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
14129195|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946756|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13946757|NCT03249285|Perindopril|perindopril|mesh-list
13946758|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13946759|NCT03249285|Diuretics|diuretics|mesh-ancestor
13946760|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
13946761|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946762|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13946763|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946764|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946765|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13946766|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
13946767|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946768|NCT03249428|Nicotine|nicotine|mesh-list
13946769|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13946770|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
14129196|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14129197|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14129198|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14129199|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129200|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
14129201|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129202|NCT03504410|Analgesics|analgesics|mesh-ancestor
14129203|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
14129204|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129205|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14129206|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14129207|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129208|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
14129209|NCT03418961|Carvedilol|carvedilol|mesh-list
14129210|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14129211|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14129212|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129213|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129214|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129215|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129216|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14129217|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
14129218|NCT03418961|Protective Agents|protective agents|mesh-ancestor
14129219|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14129220|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14129221|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14129222|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
14129223|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14129224|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13946771|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946772|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946773|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13946774|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13946775|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
13946776|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946777|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946778|NCT03249519|Cisplatin|cisplatin|mesh-list
13946779|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946780|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13946781|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13946782|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
13946783|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
13946784|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
13946785|NCT03249259|Choline|choline|mesh-list
13946786|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
13946787|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13946788|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
14129225|NCT03416855|Insulin|insulin|mesh-list
14129226|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
14129227|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14129228|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129229|NCT03409718|Cimetidine|cimetidine|mesh-list
14129230|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14129231|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129232|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14129233|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
13946789|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129234|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
14129235|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763454|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946790|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946791|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13946792|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
13946793|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13946794|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
13946795|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
14129236|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129237|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129238|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14129239|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14129240|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478425|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946796|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946797|NCT03249181|Dolutegravir|dolutegravir|mesh-list
14129241|NCT03404778|Cimetidine|cimetidine|mesh-list
14129242|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14129243|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129244|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14129245|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
14129246|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
14129247|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129248|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129249|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129250|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14129251|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14129252|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129253|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
14129254|NCT03404180|Propofol|propofol|mesh-list
14129255|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14129256|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129257|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129258|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14129259|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
14129260|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
14129261|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14129262|NCT03404180|Analgesics|analgesics|mesh-ancestor
14129263|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
14129264|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129265|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14129266|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14129267|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14129268|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129269|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129270|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129271|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
14129272|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14129273|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129274|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129275|NCT03347617|Hematinics|hematinics|mesh-ancestor
14129276|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14129277|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14129278|NCT03342417|Nivolumab|nivolumab|mesh-list
13946798|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13946799|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13946800|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946801|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946802|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13946803|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13946804|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
13946805|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13946806|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
13946807|NCT03249012|Calcitriol|calcitriol|mesh-list
13946808|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
13946809|NCT03249012|Calcium|calcium|mesh-list
13946810|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13946811|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946812|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13946813|NCT03249012|Antacids|antacids|mesh-ancestor
13946814|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946815|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946816|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14129279|NCT03342417|Ipilimumab|ipilimumab|mesh-list
14129280|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129281|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129282|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14129283|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129284|NCT03293784|Nivolumab|nivolumab|mesh-list
14129285|NCT03293784|Ipilimumab|ipilimumab|mesh-list
14129286|NCT03293784|Infliximab|infliximab|mesh-list
14129287|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
14129288|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129289|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946817|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946818|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13946819|NCT03249012|Vitamins|vitamins|mesh-ancestor
13946820|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
13946821|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13946822|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13946823|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13946824|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946825|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946826|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129290|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14129291|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129292|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
14129293|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129294|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14129295|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129296|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
14129297|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129298|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14129299|NCT03234309|Hematinics|hematinics|mesh-ancestor
14129300|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14129301|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13946827|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946828|NCT03249168|Analgesics|analgesics|mesh-ancestor
13946829|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
13946830|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946831|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
13946832|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13946833|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
13946834|NCT03248856|Triamcinolone|triamcinolone|mesh-list
13946835|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13946836|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13946837|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13946838|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13946839|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
13946840|NCT03248856|Hormones|hormones|mesh-ancestor
13946841|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946842|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946843|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13946844|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
13946845|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946846|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129302|NCT03222609|Navitoclax|navitoclax|mesh-list
14129303|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129304|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14129305|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14129306|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129307|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
13946847|NCT03249025|Lidocaine|lidocaine|mesh-list
13946848|NCT03249025|Ketamine|ketamine|mesh-list
13946849|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
13946850|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
13946851|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946852|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946853|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
13946854|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946855|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13946856|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14129308|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129309|NCT03096041|Analgesics|analgesics|mesh-list
14129310|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
14129311|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129312|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946857|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14129313|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
14129314|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14129315|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
14129316|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129317|NCT03069300|Expectorants|expectorants|mesh-ancestor
14763455|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13946858|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13946859|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129318|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129319|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14129320|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
14129321|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129322|NCT03069300|Protective Agents|protective agents|mesh-ancestor
14129323|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129324|NCT03069300|Antidotes|antidotes|mesh-ancestor
14129325|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
14129326|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14129327|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129328|NCT03063450|Nivolumab|nivolumab|mesh-list
14129329|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129330|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129331|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14129332|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946860|NCT03249025|Analgesics|analgesics|mesh-ancestor
13946861|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13946862|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13946863|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
14129333|NCT02936388|Cisplatin|cisplatin|mesh-list
14129334|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129335|NCT02893241|Cafedrine|cafedrine|mesh-list
14129336|NCT02893241|Theodrenaline|theodrenaline|mesh-list
14129337|NCT02893241|Ephedrine|ephedrine|mesh-list
14129338|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14129339|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129340|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
14129341|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
14129342|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129343|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14129344|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129345|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129346|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129347|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14129348|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
14129349|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
14129350|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14129351|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
14129352|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129353|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14129354|NCT02839265|Protective Agents|protective agents|mesh-ancestor
14129355|NCT02807779|Dexamethasone|dexamethasone|mesh-list
14129356|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129357|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
14129358|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
13946864|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13946865|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13946866|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946867|NCT03249142|Durvalumab|durvalumab|mesh-list
13946868|NCT03249142|Tremelimumab|tremelimumab|mesh-list
13946869|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13946870|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13946871|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946872|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
14129359|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129360|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177343|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
14763456|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
13946873|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946874|NCT03248726|Bisacodyl|bisacodyl|mesh-list
13946875|NCT03248726|Cathartics|cathartics|mesh-ancestor
13946876|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946877|NCT03248726|Laxatives|laxatives|mesh-ancestor
13946878|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13946879|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13946880|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
13946881|NCT03248765|Narcotics|narcotics|mesh-ancestor
13946882|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946883|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946884|NCT03248765|Analgesics|analgesics|mesh-ancestor
13946885|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
13946886|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946887|NCT03248817|Phenylephrine|phenylephrine|mesh-list
13946888|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
13946889|NCT03248817|Bupivacaine|bupivacaine|mesh-list
13946890|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
13946891|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
13946892|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946893|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946894|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
13946895|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946896|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13946897|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
13946898|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
13946899|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
13946900|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13946901|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
14129361|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129362|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
14129363|NCT02807779|Hormones|hormones|mesh-ancestor
14129364|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129365|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129366|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129367|NCT02688309|Dexamethasone|dexamethasone|mesh-list
14129368|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129369|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
14129370|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
14129371|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129372|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129373|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129374|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
14129375|NCT02688309|Hormones|hormones|mesh-ancestor
14129376|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129377|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129378|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129379|NCT02684578|Metformin|metformin|mesh-list
14129380|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14129381|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129382|NCT02680561|Fluticasone|fluticasone|mesh-list
14129383|NCT02680561|Xhance|xhance|mesh-list
14129384|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14129385|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14129386|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129387|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14129388|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
14129389|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129390|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129391|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14129392|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129393|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
14129394|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14129395|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14129396|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14129397|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14129398|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946902|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
13946903|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13946904|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13946905|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13946906|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129399|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946907|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946908|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946909|NCT03248817|Protective Agents|protective agents|mesh-ancestor
14129400|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129401|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
14129402|NCT02680561|Hormones|hormones|mesh-ancestor
13946910|NCT03248713|Mifepristone|mifepristone|mesh-list
13946911|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13946912|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
13946913|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13946914|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946915|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14129403|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129404|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
14129405|NCT02664935|Docetaxel|docetaxel|mesh-list
14129406|NCT02664935|Durvalumab|durvalumab|mesh-list
14129407|NCT02664935|Palbociclib|palbociclib|mesh-list
14129408|NCT02664935|Osimertinib|osimertinib|mesh-list
14129409|NCT02664935|Crizotinib|crizotinib|mesh-list
14129410|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129411|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129412|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129413|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
13946916|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13946917|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13946918|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
13946919|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13946920|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13946921|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
13946922|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13946923|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
14129414|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129415|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129416|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14129417|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129418|NCT02636036|Nivolumab|nivolumab|mesh-list
14129419|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129420|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129421|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14129422|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763457|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14763458|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763459|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14763460|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
14763461|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14763462|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763463|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763464|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763465|NCT00611507|Fluorouracil|fluorouracil|mesh-list
14763466|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
14763467|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
14936784|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14177344|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177345|NCT04756622|Protective Agents|protective agents|mesh-ancestor
14177346|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177347|NCT04756622|Antidotes|antidotes|mesh-ancestor
14177348|NCT04756492|Cyclosporine|cyclosporine|mesh-list
14177349|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
14177350|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177351|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
14177352|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177353|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177354|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177355|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
14177356|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177357|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177358|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14177359|NCT04756661|Misoprostol|misoprostol|mesh-list
14177360|NCT04756661|Oxytocin|oxytocin|mesh-list
14177361|NCT04756661|Carbetocin|carbetocin|mesh-list
13963508|NCT03143933|Analgesics|analgesics|mesh-ancestor
14177362|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
14177363|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177364|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177365|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14177366|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
14177367|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14177368|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13946924|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13946925|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13946926|NCT03248544|Vitamin D|vitamin d|mesh-list
13946927|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
13946928|NCT03248544|Vitamins|vitamins|mesh-ancestor
13946929|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
13946930|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946931|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13946932|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13946933|NCT03248973|Ampicillin|ampicillin|mesh-list
13946934|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13946935|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129435|NCT02592031|Goserelin|goserelin|mesh-list
13946936|NCT03248791|Phenylephrine|phenylephrine|mesh-list
13946937|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
13946938|NCT03248791|Norepinephrine|norepinephrine|mesh-list
13946939|NCT03248791|Bupivacaine|bupivacaine|mesh-list
13946940|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
13946941|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
13946942|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946943|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946944|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
13946945|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946946|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13946947|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
13946948|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
13946949|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
13946950|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13946951|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
13946952|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
13946953|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13946954|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13946955|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13946956|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946957|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946958|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946959|NCT03248791|Protective Agents|protective agents|mesh-ancestor
13946960|NCT03248700|Vitamins|vitamins|mesh-list
13946961|NCT03248700|Vitamin A|vitamin a|mesh-list
13946962|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
13946963|NCT03248700|Retinol acetate|retinol acetate|mesh-list
13946964|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
13946965|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946966|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
13946967|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946968|NCT03248700|Protective Agents|protective agents|mesh-ancestor
13946969|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14129436|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129437|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129438|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
14129439|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14129440|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14129441|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129442|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
14129443|NCT02568124|Coagulants|coagulants|mesh-ancestor
14129444|NCT02437604|Fluticasone|fluticasone|mesh-list
14129445|NCT02437604|Xhance|xhance|mesh-list
14129446|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14129447|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14129448|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129449|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14129450|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
14129451|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129452|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129453|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14129454|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129455|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14129456|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14129457|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14129458|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14129459|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14129460|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
13946970|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13946971|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13946972|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
13946973|NCT03248648|Ketamine|ketamine|mesh-list
14129461|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946974|NCT03248648|Neostigmine|neostigmine|mesh-list
13946975|NCT03248648|Analgesics|analgesics|mesh-ancestor
13946976|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
13946977|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13946978|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13946979|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13946980|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13946981|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
13946982|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
13946983|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13946984|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13946985|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14129462|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129463|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
14129464|NCT02437604|Hormones|hormones|mesh-ancestor
14129465|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129466|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
14129467|NCT02384577|Budesonide|budesonide|mesh-list
14129468|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
14129469|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129470|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14129471|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
14129472|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129473|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129474|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14129475|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129476|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
13946986|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13946987|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13946988|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13946989|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13946990|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
13946991|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13946992|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
13946993|NCT03248401|Aspirin|aspirin|mesh-list
13946994|NCT03248401|Cilostazol|cilostazol|mesh-list
13946995|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13946996|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13946997|NCT03248401|Analgesics|analgesics|mesh-ancestor
13946998|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
13946999|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947000|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947001|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947002|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13947003|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13947004|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13947005|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947006|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13947007|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13947008|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129477|NCT02384577|Hormones|hormones|mesh-ancestor
14129478|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129479|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13947009|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
13947010|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13947011|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
13947012|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13947013|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129480|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14129481|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14129482|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129483|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129484|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129485|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
14129486|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14129487|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
14129488|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129489|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129490|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14129491|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129492|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
14129493|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14129494|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
14129495|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129496|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129497|NCT02150967|Infigratinib|infigratinib|mesh-list
14129498|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129499|NCT02092571|Progesterone|progesterone|mesh-list
14129500|NCT02092571|Progestins|progestins|mesh-ancestor
14129501|NCT02092571|Hormones|hormones|mesh-ancestor
14129502|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129503|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129504|NCT02062463|Budesonide|budesonide|mesh-list
14129505|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
14129506|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14129507|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129508|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14129509|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
14129510|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129511|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129512|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14129513|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129514|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
14129515|NCT02062463|Hormones|hormones|mesh-ancestor
14129516|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129517|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14129518|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14129519|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14129520|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129521|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129522|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129523|NCT02030457|Beclomethasone|beclomethasone|mesh-list
14129524|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129525|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
14129526|NCT02030457|Hormones|hormones|mesh-ancestor
14129527|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129528|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129529|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14763468|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947014|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947015|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13947016|NCT03248401|Protective Agents|protective agents|mesh-ancestor
14763469|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763470|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763471|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763472|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
13947017|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13947018|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13947019|NCT03248427|Paclitaxel|paclitaxel|mesh-list
13947020|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
13947021|NCT03248427|Doxorubicin|doxorubicin|mesh-list
13947022|NCT03248427|Letrozole|letrozole|mesh-list
13947023|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13947024|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947025|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
13947026|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
13947027|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763473|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129530|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129531|NCT01975298|Interferons|interferons|mesh-list
14129532|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
14129533|NCT01975298|Interferon-beta|interferon-beta|mesh-list
14129534|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129535|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
14129536|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129537|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14129538|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
14129539|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129540|NCT01889199|Flutamide|flutamide|mesh-list
14763474|NCT00611572|Flumazenil|flumazenil|mesh-list
14763475|NCT00611572|Antidotes|antidotes|mesh-ancestor
13947028|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947029|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129541|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
14129542|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
14129543|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129544|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947030|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
13947031|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947032|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13947033|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13947034|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
13947035|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13947036|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13947037|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13947038|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13947039|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947040|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13947041|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13947042|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13947043|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
13947044|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129545|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129546|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129547|NCT01729091|Lenalidomide|lenalidomide|mesh-list
14129548|NCT01729091|Melphalan|melphalan|mesh-list
14129549|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
14129550|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14129551|NCT01729091|Elotuzumab|elotuzumab|mesh-list
13947045|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13947046|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947047|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
13947048|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13947049|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947050|NCT03248297|Amoxicillin|amoxicillin|mesh-list
13947051|NCT03248297|Azithromycin|azithromycin|mesh-list
13947052|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13947053|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947054|NCT03248063|Cefazolin|cefazolin|mesh-list
13947055|NCT03248063|Cloxacillin|cloxacillin|mesh-list
13947056|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13947057|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129552|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
14129553|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129554|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14129555|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14129556|NCT01729091|Growth Substances|growth substances|mesh-ancestor
14129557|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
14129558|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129559|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14129560|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
14129561|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129562|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14129563|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13947058|NCT03247972|Evolocumab|evolocumab|mesh-list
13947059|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13947060|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14129564|NCT01624480|Modafinil|modafinil|mesh-list
14129565|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14129566|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129567|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14129568|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14129569|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14129570|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129571|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14129572|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14129573|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
14129574|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129575|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763476|NCT00611572|Protective Agents|protective agents|mesh-ancestor
14763477|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763478|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
14763479|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
14763480|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763481|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763482|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14763483|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
14763484|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478426|NCT02452190|Reslizumab|reslizumab|mesh-list
14478427|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14478428|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
14478429|NCT02452320|Acetaminophen|acetaminophen|mesh-list
14478430|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14478431|NCT02452320|Analgesics|analgesics|mesh-ancestor
14478432|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
14478433|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478434|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478435|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
14478436|NCT02452346|Tosedostat|tosedostat|mesh-list
14478437|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478438|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763485|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14763486|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
14763487|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763488|NCT00611650|Protective Agents|protective agents|mesh-ancestor
14763489|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763490|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14763491|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14763492|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763493|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14763494|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14129606|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
14129607|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129608|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
14129609|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129610|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14129611|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14129612|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
14478439|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
13947061|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
13947062|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947063|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13947064|NCT03247998|Remifentanil|remifentanil|mesh-list
13947065|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947066|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947067|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13947068|NCT03247998|Narcotics|narcotics|mesh-ancestor
13947069|NCT03247998|Analgesics|analgesics|mesh-ancestor
13947070|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
13947071|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947072|NCT03248076|Fentanyl|fentanyl|mesh-list
13947073|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13947074|NCT03248076|Narcotics|narcotics|mesh-ancestor
13947075|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947076|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947077|NCT03248076|Analgesics|analgesics|mesh-ancestor
13947078|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
13947079|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947080|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13947081|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13947082|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
13947083|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
13947084|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13947085|NCT03247920|Amoxicillin|amoxicillin|mesh-list
13947086|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
13947087|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
13947088|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14129613|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129614|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129615|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14129616|NCT01120249|Everolimus|everolimus|mesh-list
14129617|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129618|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129619|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
14129620|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129621|NCT01061515|Bevacizumab|bevacizumab|mesh-list
14129622|NCT01061515|Capecitabine|capecitabine|mesh-list
14129623|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
14129624|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129625|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129626|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14129627|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14129628|NCT01061515|Growth Substances|growth substances|mesh-ancestor
14129629|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129630|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
14129631|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14129632|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
14129633|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129634|NCT00790010|Bevacizumab|bevacizumab|mesh-list
14129635|NCT00790010|Ipilimumab|ipilimumab|mesh-list
14129636|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129637|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129638|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14478440|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947089|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947090|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13947091|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947092|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947093|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
14129639|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14129640|NCT00790010|Growth Substances|growth substances|mesh-ancestor
14129641|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129642|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
14129643|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14129644|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129645|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
14129646|NCT00712881|Docetaxel|docetaxel|mesh-list
14129647|NCT00712881|Doxorubicin|doxorubicin|mesh-list
14129648|NCT00712881|Trastuzumab|trastuzumab|mesh-list
14129649|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129650|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
14129651|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129652|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14129653|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14129654|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
14129655|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129656|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129657|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14129658|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129659|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129660|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129661|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14129662|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14129663|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14129664|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129665|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129666|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14129667|NCT00659126|Hematinics|hematinics|mesh-ancestor
14129668|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14129669|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14129670|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
14129671|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14129672|NCT05117957|Sorafenib|sorafenib|mesh-list
14129673|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129674|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14129675|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129676|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947094|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13947095|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947096|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947097|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
13947098|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947099|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947100|NCT03247712|Nivolumab|nivolumab|mesh-list
13947101|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947102|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947103|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13947104|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962453|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962454|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13962455|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13962456|NCT04630938|Lidocaine|lidocaine|mesh-list
13962457|NCT04630938|Morphine|morphine|mesh-list
13962458|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
13962459|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
13962460|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962461|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962462|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
13962463|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962464|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13962465|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13962466|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13962467|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13962468|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962469|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13962470|NCT04630938|Narcotics|narcotics|mesh-ancestor
13962471|NCT04630938|Analgesics|analgesics|mesh-ancestor
13962472|NCT04624451|Dalbavancin|dalbavancin|mesh-list
13962473|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962474|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962475|NCT04594746|Amiodarone|amiodarone|mesh-list
13962476|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13962477|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947105|NCT03247582|Edoxaban|edoxaban|mesh-list
14129677|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14129678|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14129679|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
14129680|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129681|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14129682|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129683|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177369|NCT04756323|Vaccines|vaccines|mesh-list
13947106|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13947107|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
13947108|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13947109|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
13947110|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947111|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947112|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
13947113|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
13947114|NCT03247595|Bisacodyl|bisacodyl|mesh-list
13947115|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
13947116|NCT03247595|Cathartics|cathartics|mesh-ancestor
14177370|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
14177371|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177372|NCT04756557|Fluorides|fluorides|mesh-list
14177373|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
14177374|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
14177375|NCT04756557|Protective Agents|protective agents|mesh-ancestor
14177376|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177377|NCT04756206|Dutasteride|dutasteride|mesh-list
14177378|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14177379|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14177380|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177381|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177382|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
14177383|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177384|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177385|NCT04756128|Colchicine|colchicine|mesh-list
14177386|NCT04756128|Naltrexone|naltrexone|mesh-list
14177387|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14177388|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14177389|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177390|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
14177391|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177392|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
14177393|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177394|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14177395|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14177396|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
14177397|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177398|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177399|NCT04756089|Oxytocin|oxytocin|mesh-list
14177400|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
13947117|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947118|NCT03247595|Laxatives|laxatives|mesh-ancestor
13947119|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
13947120|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
13947121|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947122|NCT03247452|Protective Agents|protective agents|mesh-ancestor
13947123|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947124|NCT03247452|Vitamins|vitamins|mesh-ancestor
14177401|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177402|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177403|NCT04755998|Vaccines|vaccines|mesh-list
14177404|NCT04755998|Immunologic Factors|immunologic factors|mesh-ancestor
14177405|NCT04755998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177406|NCT04755868|Talazoparib|talazoparib|mesh-list
14177407|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14177408|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947125|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
13947126|NCT03247283|Linrodostat|linrodostat|mesh-list
13947127|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947128|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947129|NCT03247413|Dexamethasone|dexamethasone|mesh-list
13947130|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947131|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
13947132|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
13947133|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177409|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129684|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
14129685|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129686|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129687|NCT05117398|Dalbavancin|dalbavancin|mesh-list
14129688|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14129689|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129690|NCT05117125|Heparin|heparin|mesh-list
14129691|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
14129692|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14129693|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14129694|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129695|NCT05117021|Bupivacaine|bupivacaine|mesh-list
14129696|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
14129697|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
14129698|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129699|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129700|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
14129701|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129702|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
14129703|NCT05116995|Ticagrelor|ticagrelor|mesh-list
14129704|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14129705|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14129706|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14129707|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14129708|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
14129709|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129710|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129711|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129712|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13947134|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947135|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947136|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
13947137|NCT03247413|Hormones|hormones|mesh-ancestor
13947138|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947139|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13947140|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947141|NCT03247140|Amlodipine|amlodipine|mesh-list
13947142|NCT03247140|Telmisartan|telmisartan|mesh-list
13947143|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
13947144|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13947145|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13947146|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13947147|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14129713|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
14129714|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13947148|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947149|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13947150|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947151|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947152|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13947153|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13947154|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
13947155|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13947156|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13947157|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947158|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13947159|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14129715|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
14129716|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129717|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
14129718|NCT05116891|Leucovorin|leucovorin|mesh-list
14129719|NCT05116891|Gemcitabine|gemcitabine|mesh-list
14129720|NCT05116891|Cisplatin|cisplatin|mesh-list
14129721|NCT05116891|Docetaxel|docetaxel|mesh-list
14129722|NCT05116891|Fluorouracil|fluorouracil|mesh-list
14129723|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
14129724|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129725|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14129726|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
14129727|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129728|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
13947160|NCT03247400|Atorvastatin|atorvastatin|mesh-list
13947161|NCT03247400|Simvastatin|simvastatin|mesh-list
14129729|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129730|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763495|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
14129731|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129732|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
14129733|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129734|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129735|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129736|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129737|NCT05116891|Antidotes|antidotes|mesh-ancestor
14129738|NCT05116891|Protective Agents|protective agents|mesh-ancestor
14129739|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
14129740|NCT05116891|Vitamins|vitamins|mesh-ancestor
14129741|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
14129742|NCT05116462|Gemcitabine|gemcitabine|mesh-list
14129743|NCT05116462|Paclitaxel|paclitaxel|mesh-list
14129744|NCT05116462|Docetaxel|docetaxel|mesh-list
14129745|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14129746|NCT05116462|Carboplatin|carboplatin|mesh-list
14129747|NCT05116462|Pemetrexed|pemetrexed|mesh-list
14129748|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14129749|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129750|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129751|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129752|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129753|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129754|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14129755|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
14129756|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
14129757|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129758|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129759|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14129760|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
14129761|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129762|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14129763|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14129764|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
14129765|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14129766|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
14129767|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
14129768|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14129769|NCT05116371|Estradiol|estradiol|mesh-list
14129770|NCT05116371|Estrogens|estrogens|mesh-ancestor
14129771|NCT05116371|Hormones|hormones|mesh-ancestor
14129772|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129773|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129774|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14129775|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14129776|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14129777|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14129778|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14129779|NCT05116345|Dexamethasone|dexamethasone|mesh-list
14129780|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
14129781|NCT05116345|BB 1101|bb 1101|mesh-list
14129782|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14129783|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
14129784|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
14129785|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129786|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129787|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129788|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
14129789|NCT05116345|Hormones|hormones|mesh-ancestor
14129790|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14129791|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14129792|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947162|NCT03247400|Calcium|calcium|mesh-list
13947163|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13947164|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947165|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13947166|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13947167|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
13947168|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947169|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14129793|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
14129794|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129795|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129796|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
13947170|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14129797|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14129798|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
14129799|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129800|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
14129801|NCT05116306|Protective Agents|protective agents|mesh-ancestor
14129802|NCT05116293|Acetaminophen|acetaminophen|mesh-list
14129803|NCT05116293|Digoxin|digoxin|mesh-list
14129804|NCT05116293|Midazolam|midazolam|mesh-list
14129805|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14129806|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14129807|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129808|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129809|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14129810|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14129811|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14129812|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14129813|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
14129814|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
14129815|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
14129816|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
14129817|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129818|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129819|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14129820|NCT05116293|Analgesics|analgesics|mesh-ancestor
14129821|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
14129822|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129823|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
14129824|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14129825|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14129826|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129827|NCT05116293|Protective Agents|protective agents|mesh-ancestor
14129828|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
14129829|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
14129830|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
14129831|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129832|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129833|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
14129834|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129835|NCT05104970|Cholecalciferol|cholecalciferol|mesh-list
14129836|NCT05104970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14129837|NCT05104970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129838|NCT05104970|Vitamins|vitamins|mesh-ancestor
14129839|NCT05104970|Micronutrients|micronutrients|mesh-ancestor
14129840|NCT05104970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14129841|NCT05076097|Rituximab|rituximab|mesh-list
14129842|NCT05076097|Lenalidomide|lenalidomide|mesh-list
14129843|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129844|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129845|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
14129846|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129847|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14129848|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14129849|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14129850|NCT05076097|Growth Substances|growth substances|mesh-ancestor
14129851|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
13947171|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947172|NCT03247296|Ribavirin|ribavirin|mesh-list
13947173|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
13947174|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
13947175|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947176|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
13947177|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947178|NCT03247257|Lidocaine|lidocaine|mesh-list
14129852|NCT05016895|Azithromycin|azithromycin|mesh-list
14129853|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14129854|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129855|NCT05002530|Vitamin D|vitamin d|mesh-list
14129856|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
14129857|NCT05002530|Vitamins|vitamins|mesh-list
14129858|NCT05002530|Tretinoin|tretinoin|mesh-list
14129859|NCT05002530|Isotretinoin|isotretinoin|mesh-list
14129860|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
13947179|NCT03247257|Anesthetics|anesthetics|mesh-list
14129861|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947180|NCT03247257|Propofol|propofol|mesh-list
14129862|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13947181|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
13947182|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129863|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14129864|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947183|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947184|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
13947185|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129865|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
14129866|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
14177410|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763496|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763497|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14763498|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14763499|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14763500|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14763501|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763502|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763503|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763504|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14763505|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
14763506|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14763507|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
14936785|NCT01471262|Liver Extracts|liver extracts|mesh-list
14936786|NCT01471262|Hematinics|hematinics|mesh-ancestor
14936787|NCT01471275|Metformin|metformin|mesh-list
14177426|NCT04756050|Epinephrine|epinephrine|mesh-list
14177427|NCT04756050|Racepinephrine|racepinephrine|mesh-list
14177428|NCT04756050|Bupivacaine|bupivacaine|mesh-list
14177429|NCT04756050|Prilocaine|prilocaine|mesh-list
14177430|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14177431|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
14177432|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
14177433|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
14177434|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177435|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177436|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
14177437|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177438|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14177439|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14177440|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177441|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177442|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177443|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14177444|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14177445|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
14177446|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14177447|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14177448|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
14936788|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936789|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947186|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13947187|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13947188|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13947189|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947190|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947191|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13947192|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13947193|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
13947194|NCT03247218|Memantine|memantine|mesh-list
13947195|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14936790|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14936791|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14936792|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936793|NCT01471470|Bevacizumab|bevacizumab|mesh-list
14936794|NCT01471470|Docetaxel|docetaxel|mesh-list
14936795|NCT01471470|Capecitabine|capecitabine|mesh-list
14936796|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14936797|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947196|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13947197|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
13947198|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947199|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177449|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
14177450|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14177451|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14177452|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14129867|NCT04940286|Gemcitabine|gemcitabine|mesh-list
14129868|NCT04940286|Paclitaxel|paclitaxel|mesh-list
14129869|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14129870|NCT04940286|Durvalumab|durvalumab|mesh-list
14129871|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
14129872|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14129873|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
14129874|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14129875|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129876|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129877|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129878|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129879|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129880|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14129881|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
14129882|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
14129883|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14129884|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129885|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13947200|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947201|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13947202|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13947203|NCT03246919|Oxytocin|oxytocin|mesh-list
13947204|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
13947205|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13947206|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947207|NCT03246776|Triclosan|triclosan|mesh-list
13947208|NCT03246776|Halometasone|halometasone|mesh-list
13947209|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13947210|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947211|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13947212|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13947213|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
13947214|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947215|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13947216|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947217|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
13947218|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
13947219|NCT03246776|Hormones|hormones|mesh-ancestor
13947220|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947221|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947222|NCT03246750|Cisplatin|cisplatin|mesh-list
13947223|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947224|NCT03246880|Tadalafil|tadalafil|mesh-list
13947225|NCT03246880|Tamsulosin|tamsulosin|mesh-list
13947226|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947227|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14129886|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
14129887|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129888|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129889|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
14129890|NCT04930237|Bisacodyl|bisacodyl|mesh-list
14129891|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
14129892|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
14129893|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14129894|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14129895|NCT04930237|Calcium|calcium|mesh-list
14129896|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14129897|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129898|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129899|NCT04930237|Cathartics|cathartics|mesh-ancestor
14129900|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14129901|NCT04930237|Laxatives|laxatives|mesh-ancestor
14129902|NCT04930237|Antacids|antacids|mesh-ancestor
13947228|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14129903|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14129904|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
13947229|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129905|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129906|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
14129907|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
13947230|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947231|NCT03246880|Urological Agents|urological agents|mesh-ancestor
13947232|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13947233|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13947234|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13947235|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
13947236|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947237|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947238|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13947239|NCT03246555|Perindopril|perindopril|mesh-list
13947240|NCT03246555|Indapamide|indapamide|mesh-list
13947241|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13947242|NCT03246555|Diuretics|diuretics|mesh-ancestor
13947243|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
13947244|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947245|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13947246|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947247|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947248|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13947249|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
13947250|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947251|NCT03246620|Diazepam|diazepam|mesh-list
13947252|NCT03246620|Haloperidol|haloperidol|mesh-list
13947253|NCT03246620|Olanzapine|olanzapine|mesh-list
13947254|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
14129908|NCT04836429|Trioxsalen|trioxsalen|mesh-list
14129909|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129910|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
14129911|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14763508|NCT00611689|Vatalanib|vatalanib|mesh-list
14763509|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763510|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763511|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763512|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763513|NCT00611728|Irinotecan|irinotecan|mesh-list
14763514|NCT00611728|Sunitinib|sunitinib|mesh-list
14763515|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13947255|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
13947256|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
13947257|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763516|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14763517|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763518|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763519|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129912|NCT04768504|Tofacitinib|tofacitinib|mesh-list
14129913|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14129914|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129915|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129916|NCT04753437|Amoxicillin|amoxicillin|mesh-list
14129917|NCT04753437|Clarithromycin|clarithromycin|mesh-list
14129918|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
14129919|NCT04753437|Esomeprazole|esomeprazole|mesh-list
14129920|NCT04753437|Bismuth|bismuth|mesh-list
14129921|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129922|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14129923|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947258|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947259|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947260|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13947261|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13947262|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947263|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13947264|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13947265|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13947266|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947267|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947268|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947269|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
14129924|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14129925|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177453|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13947270|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13947271|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
14129926|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14129927|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947272|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13947273|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14129928|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14129929|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14129930|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14129931|NCT04753437|Antacids|antacids|mesh-ancestor
14129932|NCT04753437|Diuretics|diuretics|mesh-ancestor
14129933|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
14129934|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129935|NCT04753437|Expectorants|expectorants|mesh-ancestor
14129936|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
14129937|NCT04690504|Melatonin|melatonin|mesh-list
14129938|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
14129939|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129940|NCT04690504|Protective Agents|protective agents|mesh-ancestor
14129941|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129942|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129943|NCT04675333|Carboplatin|carboplatin|mesh-list
14129944|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
14129945|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129946|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129947|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
14129948|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129949|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129950|NCT04671953|Metformin|metformin|mesh-list
14129951|NCT04671953|BMS-986165|bms-986165|mesh-list
14129952|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14129953|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129954|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
14129955|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14129956|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14129957|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129958|NCT04585061|Lidocaine|lidocaine|mesh-list
14129959|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
14129960|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
14129961|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14129962|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129963|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
14129964|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14129965|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14129966|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14129967|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14129968|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14129969|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129970|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14129971|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14129972|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
14129973|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14129974|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129975|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947274|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
13947275|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13947276|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13947277|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13947278|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13947279|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13947280|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
13947281|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
13947282|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
13947283|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
14129976|NCT04564157|Paclitaxel|paclitaxel|mesh-list
14129977|NCT04564157|Carboplatin|carboplatin|mesh-list
14129978|NCT04564157|Nivolumab|nivolumab|mesh-list
14478441|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478442|NCT02452463|Durvalumab|durvalumab|mesh-list
14478443|NCT02452463|Nintedanib|nintedanib|mesh-list
14478444|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
14478445|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14478446|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
14478447|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478448|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947284|NCT03246659|Polygeline|polygeline|mesh-list
13947285|NCT03246659|Gastrins|gastrins|mesh-list
13947286|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
13947287|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
13947288|NCT03246659|Hormones|hormones|mesh-ancestor
13947289|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947290|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947291|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
14129979|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14129980|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129981|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
14129982|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
14129983|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
14129984|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14129985|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14129986|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14129987|NCT04539236|Lenalidomide|lenalidomide|mesh-list
14129988|NCT04539236|Luspatercept|luspatercept|mesh-list
14129989|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
14129990|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14129991|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14129992|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14129993|NCT04539236|Growth Substances|growth substances|mesh-ancestor
14129994|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
14129995|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14129996|NCT04539236|Hematinics|hematinics|mesh-ancestor
14129997|NCT04512430|Bevacizumab|bevacizumab|mesh-list
14129998|NCT04512430|Carboplatin|carboplatin|mesh-list
14129999|NCT04512430|Pemetrexed|pemetrexed|mesh-list
14130000|NCT04512430|Atezolizumab|atezolizumab|mesh-list
14130001|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130002|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130003|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14130004|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14130005|NCT04512430|Growth Substances|growth substances|mesh-ancestor
14130006|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130007|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
14130008|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130009|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130010|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14130011|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14130012|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14130013|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
14130014|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130015|NCT04450498|Vaccines|vaccines|mesh-list
14130016|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
14130017|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130018|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14130019|NCT04425174|Anesthetics|anesthetics|mesh-list
14130020|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130021|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130022|NCT04418479|Aspirin|aspirin|mesh-list
14130023|NCT04418479|Clopidogrel|clopidogrel|mesh-list
13947292|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947293|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947294|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
13947295|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13947296|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
13947297|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947298|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947299|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13947300|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
13947301|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
13947302|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13947303|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
13947304|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947305|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947306|NCT03246386|Posaconazole|posaconazole|mesh-list
13947307|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
14130024|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13947308|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947309|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13947310|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13947311|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13947312|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13947313|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13947314|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947315|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947316|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13947317|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
13947318|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947319|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947320|NCT03246451|Metformin|metformin|mesh-list
13947321|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13947322|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947323|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13947324|NCT03246360|Cloxacillin|cloxacillin|mesh-list
13947325|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947326|NCT03246295|Insulin|insulin|mesh-list
13947327|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13947328|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947329|NCT03246009|Lenograstim|lenograstim|mesh-list
14130025|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14130026|NCT04418479|Analgesics|analgesics|mesh-ancestor
14130027|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
14130028|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130029|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130030|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130031|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14130032|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14130033|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14130034|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130035|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14130036|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14130037|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130038|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
14130039|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14130040|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14130041|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14130042|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
14130043|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130044|NCT04379713|Vaccines|vaccines|mesh-list
14130045|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14130046|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
14130047|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130048|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14130049|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
14130050|NCT04370379|Aflibercept|aflibercept|mesh-list
14130051|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14130052|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14130053|NCT04370379|Growth Substances|growth substances|mesh-ancestor
14130054|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130055|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
14130056|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130057|NCT04305899|BMS-986165|bms-986165|mesh-list
14130058|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
14130059|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14130060|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130061|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130062|NCT04250883|Iodine|iodine|mesh-list
14763520|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14763521|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14763522|NCT00611728|Growth Substances|growth substances|mesh-ancestor
14763523|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763524|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
14763525|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763526|NCT00611741|Furosemide|furosemide|mesh-list
14763527|NCT00611741|Diuretics|diuretics|mesh-ancestor
14763528|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
14763529|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763530|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14763531|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14763532|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947330|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14763533|NCT00611754|Fluorouracil|fluorouracil|mesh-list
13947331|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
13947332|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947333|NCT03246399|Lorecivivint|lorecivivint|mesh-list
13947334|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947335|NCT03246113|Temozolomide|temozolomide|mesh-list
13947336|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13947337|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
13947338|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947339|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947340|NCT03245853|Riboflavin|riboflavin|mesh-list
13947341|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
13947342|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
13947343|NCT03245853|Vitamins|vitamins|mesh-ancestor
14763534|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
14130063|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14130064|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130065|NCT04250883|Trace Elements|trace elements|mesh-ancestor
14130066|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
14130067|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130068|NCT04238624|Trametinib|trametinib|mesh-list
14130069|NCT04238624|Dabrafenib|dabrafenib|mesh-list
14130070|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130071|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14130072|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130073|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177454|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177455|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177456|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14177457|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177458|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177459|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
14177460|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177461|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
14177462|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14177463|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14177464|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
14177465|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177466|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177467|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13947344|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
14177468|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
14177469|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14177470|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
14177471|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177472|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947345|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947346|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13947347|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
13962478|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13962479|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13962480|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962481|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13962482|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13962483|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13962484|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962485|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14177473|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14763535|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
14936798|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14130074|NCT04153604|Doxycycline|doxycycline|mesh-list
14130075|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130076|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130077|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
14130078|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14130079|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14130080|NCT04129398|Letermovir|letermovir|mesh-list
14130081|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14130082|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130083|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130084|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130085|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
14130086|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947348|NCT03245970|Atenolol|atenolol|mesh-list
13947349|NCT03245970|Labetalol|labetalol|mesh-list
13947350|NCT03245970|Nifedipine|nifedipine|mesh-list
13947351|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13947352|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947353|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947354|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13947355|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947356|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947357|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
13947358|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13947359|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13947360|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13947361|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
13947362|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
14130087|NCT04126278|Dexamethasone|dexamethasone|mesh-list
14130088|NCT04126278|Cortisone|cortisone|mesh-list
14130089|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130090|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
14130091|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
14130092|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130093|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130094|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947363|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947364|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13947365|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13947366|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13947367|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
13947368|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947369|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
13947370|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13947371|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13947372|NCT03245996|Atenolol|atenolol|mesh-list
13947373|NCT03245996|Nebivolol|nebivolol|mesh-list
13947374|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13947375|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14130095|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
14130096|NCT04126278|Hormones|hormones|mesh-ancestor
14130097|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130098|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14130099|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763536|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763537|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763538|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763539|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763540|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
14763541|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130106|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
14130107|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
14130108|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130109|NCT04042935|Protective Agents|protective agents|mesh-ancestor
14130110|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130111|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
14130112|NCT04042935|Vitamins|vitamins|mesh-ancestor
14130113|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
14130114|NCT04016714|Vaccines|vaccines|mesh-list
14130115|NCT04016714|Immunoglobulins|immunoglobulins|mesh-list
14130116|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
14130117|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947376|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
14130118|NCT04014803|Aspirin|aspirin|mesh-list
14130119|NCT04014803|Clopidogrel|clopidogrel|mesh-list
14130120|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14177474|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947377|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
13947378|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947379|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947380|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13947381|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13947382|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14130121|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14130122|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14130123|NCT04014803|Analgesics|analgesics|mesh-ancestor
14130124|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
14130125|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947383|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
13947384|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947385|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947386|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947387|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14130126|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130127|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130128|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14130129|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14130130|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14130131|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130132|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14130133|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14130134|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130135|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
14130136|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14130137|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14130138|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14130139|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
14130140|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130141|NCT04006119|Cemiplimab|cemiplimab|mesh-list
14130142|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130143|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130144|NCT03971500|Aspirin|aspirin|mesh-list
14130145|NCT03971500|Ticagrelor|ticagrelor|mesh-list
14130146|NCT03971500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14130147|NCT03971500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14130148|NCT03971500|Analgesics|analgesics|mesh-ancestor
14130149|NCT03971500|Sensory System Agents|sensory system agents|mesh-ancestor
14130150|NCT03971500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130151|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130152|NCT03971500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130153|NCT03971500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14130154|NCT03971500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14130155|NCT03971500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14130156|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130157|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14130158|NCT03971500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14130159|NCT03971500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130160|NCT03971500|Antipyretics|antipyretics|mesh-ancestor
13947388|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13947389|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13947390|NCT03245658|Nabiximols|nabiximols|mesh-list
14130161|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14130162|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14130163|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14130164|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
14130165|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130166|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
14130167|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14130168|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130169|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130170|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130171|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14130172|NCT03929029|Nivolumab|nivolumab|mesh-list
14130173|NCT03929029|Ipilimumab|ipilimumab|mesh-list
14130174|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130175|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130176|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14130177|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130178|NCT03901339|Gemcitabine|gemcitabine|mesh-list
14130179|NCT03901339|Capecitabine|capecitabine|mesh-list
14130180|NCT03901339|Vinorelbine|vinorelbine|mesh-list
14130181|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14130182|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
14130183|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130184|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130185|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
14130186|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130187|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130188|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130189|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
14130190|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130191|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130192|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130193|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
14130194|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
14130195|NCT03890887|Itraconazole|itraconazole|mesh-list
14130196|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
14130197|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130198|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14130199|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14130200|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130201|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130202|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14130203|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
14130204|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130205|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130206|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14130207|NCT03838159|Paclitaxel|paclitaxel|mesh-list
14130208|NCT03838159|Carboplatin|carboplatin|mesh-list
14130209|NCT03838159|Nivolumab|nivolumab|mesh-list
14130210|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130211|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130212|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130213|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
13947391|NCT03245658|Analgesics|analgesics|mesh-ancestor
13947392|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
13947393|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947394|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947395|NCT03245671|Dexamethasone|dexamethasone|mesh-list
13947396|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
13947397|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13947398|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13947399|NCT03245671|BB 1101|bb 1101|mesh-list
13947400|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947401|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
13947402|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
13947403|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947404|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947405|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947406|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
13947407|NCT03245671|Hormones|hormones|mesh-ancestor
13947408|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947409|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13947410|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947411|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
13947412|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947413|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947414|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13947415|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
13947416|NCT03245515|Branebrutinib|branebrutinib|mesh-list
13947417|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947418|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947419|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947420|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
13947421|NCT03245528|Giapreza|giapreza|mesh-list
13947422|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13947423|NCT03245424|Ivosidenib|ivosidenib|mesh-list
13947424|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130214|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
14936799|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14130215|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936800|NCT01471470|Growth Substances|growth substances|mesh-ancestor
14936801|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177475|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
13947425|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947426|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947427|NCT03245554|Propranolol|propranolol|mesh-list
13947428|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13947429|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13947430|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
13947431|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947432|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947433|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947434|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13947435|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13947436|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947437|NCT03245541|Durvalumab|durvalumab|mesh-list
13947438|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947439|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947440|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
13947441|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947442|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947443|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13947444|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13947445|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13947446|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
13947447|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947448|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13947449|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13947450|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947451|NCT03245385|Halobetasol|halobetasol|mesh-list
13947452|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13947453|NCT03245333|Hormones|hormones|mesh-list
13947454|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947455|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947456|NCT03245307|Apatinib|apatinib|mesh-list
13947457|NCT03245307|Nifedipine|nifedipine|mesh-list
13947458|NCT03245307|Warfarin|warfarin|mesh-list
13947459|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
13947460|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947461|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947462|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947463|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947464|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13947465|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947466|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13947467|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947468|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
13947469|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
13947470|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13947471|NCT03245437|Oxytocin|oxytocin|mesh-list
13947472|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
13947473|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13947474|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947475|NCT03245450|Irinotecan|irinotecan|mesh-list
14130216|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130217|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14130218|NCT03827213|Bupivacaine|bupivacaine|mesh-list
14130219|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
14130220|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
14130221|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130222|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130223|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
14130224|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130225|NCT03797469|Niacinamide|niacinamide|mesh-list
14130226|NCT03797469|Vitamins|vitamins|mesh-ancestor
14130227|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
14130228|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130229|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
14130230|NCT03795701|Liraglutide|liraglutide|mesh-list
14130231|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14130232|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130233|NCT03795701|Incretins|incretins|mesh-ancestor
14130234|NCT03795701|Hormones|hormones|mesh-ancestor
14130235|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763542|NCT00611793|Bevacizumab|bevacizumab|mesh-list
14763543|NCT00611793|Vatalanib|vatalanib|mesh-list
14763544|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14763545|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130236|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14936802|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
14936803|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14936804|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936805|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14936806|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947476|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13947477|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13947478|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947479|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947480|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947481|NCT03245281|Diuretics|diuretics|mesh-list
13947482|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
13947483|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947484|NCT03245190|Chiauranib|chiauranib|mesh-list
13947485|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130237|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130238|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763546|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14130239|NCT03722108|Irinotecan|irinotecan|mesh-list
14130240|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14130241|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14130242|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130243|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763547|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14763548|NCT00611793|Growth Substances|growth substances|mesh-ancestor
14763549|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763550|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
14763551|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14130244|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130245|NCT03717129|Tenofovir|tenofovir|mesh-list
14130246|NCT03717129|Emtricitabine|emtricitabine|mesh-list
14130247|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14130248|NCT03717129|Cobicistat|cobicistat|mesh-list
14130249|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14130250|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14130251|NCT03717129|Elvitegravir|elvitegravir|mesh-list
14130252|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
14130253|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130254|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14130255|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14130256|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130257|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130258|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14130259|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14130260|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14130261|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14130262|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14130263|NCT03651128|Dexamethasone|dexamethasone|mesh-list
14130264|NCT03651128|Lenalidomide|lenalidomide|mesh-list
14130265|NCT03651128|Bortezomib|bortezomib|mesh-list
14130266|NCT03651128|Daratumumab|daratumumab|mesh-list
14130267|NCT03651128|Pomalidomide|pomalidomide|mesh-list
14130268|NCT03651128|Ixazomib|ixazomib|mesh-list
14130269|NCT03651128|Elotuzumab|elotuzumab|mesh-list
14130270|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130271|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
14130272|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
14130273|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130274|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130275|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14763552|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763553|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763554|NCT00611819|Interferons|interferons|mesh-list
14763555|NCT00611819|Ribavirin|ribavirin|mesh-list
14763556|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14763557|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
14763558|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763559|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
14763560|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763561|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
14763562|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763563|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
14763564|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763565|NCT00611845|Aprotinin|aprotinin|mesh-list
14130276|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
14130277|NCT03651128|Hormones|hormones|mesh-ancestor
14130278|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130279|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14130280|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130281|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
14130282|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14130283|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14130284|NCT03651128|Growth Substances|growth substances|mesh-ancestor
14130285|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
14130286|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
14130287|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130288|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130289|NCT03636295|Warfarin|warfarin|mesh-list
14130290|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
14130291|NCT03579446|Oxymorphone|oxymorphone|mesh-list
14130292|NCT03579446|Morphine|morphine|mesh-list
14130293|NCT03579446|Oxycodone|oxycodone|mesh-list
14130294|NCT03579446|Hydromorphone|hydromorphone|mesh-list
14130295|NCT03579446|Hydrocodone|hydrocodone|mesh-list
14130296|NCT03579446|Levorphanol|levorphanol|mesh-list
14130297|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14130298|NCT03579446|Narcotics|narcotics|mesh-ancestor
14130299|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130300|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130301|NCT03579446|Analgesics|analgesics|mesh-ancestor
14130302|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
14130303|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130304|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
14130305|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
14130306|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14130307|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
14130308|NCT03573700|Fludarabine|fludarabine|mesh-list
13947486|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947487|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947488|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947489|NCT03245346|Anesthetics|anesthetics|mesh-list
13947490|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947491|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947492|NCT03245021|Rituximab|rituximab|mesh-list
13947493|NCT03245021|Nivolumab|nivolumab|mesh-list
13947494|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947495|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947496|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
13947497|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947498|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13947499|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13947500|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947501|NCT03244956|Trametinib|trametinib|mesh-list
13947502|NCT03244956|Dabrafenib|dabrafenib|mesh-list
13947503|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947504|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947505|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947506|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947507|NCT03244774|Paclitaxel|paclitaxel|mesh-list
13947508|NCT03244774|Fluorouracil|fluorouracil|mesh-list
13947509|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
13947510|NCT03244774|Apatinib|apatinib|mesh-list
13947511|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13947512|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947513|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
13947514|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
13947515|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
13947516|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947517|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
13947518|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13947519|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13947520|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
13947521|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947522|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947523|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947524|NCT03244930|Plerixafor|plerixafor|mesh-list
13947525|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13947526|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14130309|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13947527|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
14130310|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
14130311|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130312|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14130313|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13947528|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947529|NCT03244943|Anesthetics|anesthetics|mesh-list
13947530|NCT03244943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947531|NCT03244943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947532|NCT03244592|Minocycline|minocycline|mesh-list
13947533|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130314|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
14130315|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947534|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947535|NCT03244488|Mecamylamine|mecamylamine|mesh-list
13947536|NCT03244488|Scopolamine|scopolamine|mesh-list
13947537|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13947538|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13947539|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
13947540|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
13947541|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947542|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947543|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14130316|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130317|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14130318|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
13947544|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
13947545|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13947546|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
13947547|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947548|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947549|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13947550|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
13947551|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14763566|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
14763567|NCT00611845|Coagulants|coagulants|mesh-ancestor
14763568|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14763569|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14763570|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
14130319|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14130320|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130321|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
14130322|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130323|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13947552|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
13947553|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
13947554|NCT03244319|Warfarin|warfarin|mesh-list
13947555|NCT03244319|Edoxaban|edoxaban|mesh-list
13947556|NCT03244319|Anticoagulants|anticoagulants|mesh-list
13947557|NCT03244319|Coagulants|coagulants|mesh-list
13947558|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13947559|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
13947560|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14130324|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14130325|NCT03525873|Methylphenidate|methylphenidate|mesh-list
14130326|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14130327|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130328|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14130329|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14130330|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14130331|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130332|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
14130333|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130334|NCT03463408|Nivolumab|nivolumab|mesh-list
14130335|NCT03463408|Ipilimumab|ipilimumab|mesh-list
13947561|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
13947562|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947563|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947564|NCT03244553|Prucalopride|prucalopride|mesh-list
13947565|NCT03244553|Laxatives|laxatives|mesh-ancestor
13947566|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947567|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
13947568|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14130336|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130337|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130338|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14130339|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130340|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
14130341|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13947569|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
13947570|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947571|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947572|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947573|NCT03244176|Avelumab|avelumab|mesh-list
13947574|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947575|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947576|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
13947577|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13947578|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13947579|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947580|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
13947581|NCT03244423|Coagulants|coagulants|mesh-ancestor
13962486|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13962487|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13962488|NCT04592237|Carboplatin|carboplatin|mesh-list
13962489|NCT04592237|Niraparib|niraparib|mesh-list
13962490|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130342|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
14130343|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130344|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
14130345|NCT03460158|Protective Agents|protective agents|mesh-ancestor
14130359|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13962491|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13962492|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962493|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962494|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
13962495|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962496|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963509|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
13963510|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963511|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13963512|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
13963513|NCT03143998|Grazoprevir|grazoprevir|mesh-list
13963514|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
13963515|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963516|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
13963517|NCT03143972|Remifentanil|remifentanil|mesh-list
13963518|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13963519|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963520|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963521|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963522|NCT03143972|Analgesics|analgesics|mesh-ancestor
14130360|NCT03169985|Ezetimibe|ezetimibe|mesh-list
14130361|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14130362|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14130363|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
14130364|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130365|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14130366|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13947582|NCT03244358|Epalrestat|epalrestat|mesh-list
14130367|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130368|NCT03140670|Rucaparib|rucaparib|mesh-list
14130369|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14130370|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130371|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130372|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130373|NCT03129360|Levetiracetam|levetiracetam|mesh-list
14130374|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
14130375|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
14763571|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763572|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947583|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947584|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947585|NCT03244462|Methotrexate|methotrexate|mesh-list
13947586|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14177476|NCT04755647|Protective Agents|protective agents|mesh-ancestor
14177477|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
14177478|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14177479|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
14177480|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177481|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
13947587|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
13947588|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13947589|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947590|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13947591|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
13947592|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947593|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947594|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
13947595|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947596|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13947597|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13947598|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
13947599|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13947600|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13947601|NCT03244540|Acetaminophen|acetaminophen|mesh-list
13947602|NCT03244540|Dipyrone|dipyrone|mesh-list
13947603|NCT03244540|Ketoprofen|ketoprofen|mesh-list
13947604|NCT03244540|Bupivacaine|bupivacaine|mesh-list
13947605|NCT03244540|Ropivacaine|ropivacaine|mesh-list
13947606|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
14177482|NCT04755634|Protective Agents|protective agents|mesh-ancestor
14177483|NCT04755764|Atenolol|atenolol|mesh-list
14177484|NCT04755764|Labetalol|labetalol|mesh-list
13947607|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
13947608|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947609|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947610|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
13947611|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947612|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13947613|NCT03244540|Analgesics|analgesics|mesh-ancestor
13947614|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
13947615|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13947616|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947617|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13947618|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13947619|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947620|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947621|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
13947622|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13947623|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947624|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14177485|NCT04755764|Nifedipine|nifedipine|mesh-list
14478449|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
14478450|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478451|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14478452|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479266|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947625|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13947626|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947627|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947628|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130376|NCT02968810|Simvastatin|simvastatin|mesh-list
14130377|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14130378|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14130379|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
14130380|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130381|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14130382|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14130383|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130384|NCT02934282|HBOC 201|hboc 201|mesh-list
14130385|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
14130386|NCT02774590|Timolol|timolol|mesh-list
14130387|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14130388|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14130389|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130390|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130391|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130392|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130393|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14130394|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14130395|NCT02624596|Midazolam|midazolam|mesh-list
14130396|NCT02624596|Ketamine|ketamine|mesh-list
14130397|NCT02624596|Analgesics|analgesics|mesh-ancestor
14130398|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
14130399|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130400|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130401|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14130402|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14130403|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
14130404|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
14130405|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130406|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14130407|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14130408|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130409|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130410|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14130411|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14130412|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14130413|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14130414|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130415|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
14130416|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
13947629|NCT03244241|Insulin|insulin|mesh-list
13947630|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13947631|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947632|NCT03243903|Insulin|insulin|mesh-list
13947633|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13947634|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13947635|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947636|NCT03243890|Vitamin D|vitamin d|mesh-list
13947637|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
13947638|NCT03243890|Vitamin K|vitamin k|mesh-list
13947639|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
13947640|NCT03243890|Vitamins|vitamins|mesh-ancestor
13947641|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
13947642|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947643|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13947644|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13947645|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13947646|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947647|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
13947648|NCT03243890|Coagulants|coagulants|mesh-ancestor
13947649|NCT03243864|Ceftazidime|ceftazidime|mesh-list
13947650|NCT03243864|Avibactam|avibactam|mesh-list
14763573|NCT00611871|Propranolol|propranolol|mesh-list
14936807|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763574|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14763575|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14763576|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
14763577|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130422|NCT02195947|Hormones|hormones|mesh-list
14130423|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130424|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130425|NCT02175173|Rufinamide|rufinamide|mesh-list
14130426|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
14130427|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14130428|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14130429|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14130430|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130431|NCT02037048|Leucovorin|leucovorin|mesh-list
14130432|NCT02037048|Paclitaxel|paclitaxel|mesh-list
14130433|NCT02037048|Carboplatin|carboplatin|mesh-list
14130434|NCT02037048|Fluorouracil|fluorouracil|mesh-list
14130435|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
14130436|NCT02037048|Calcium|calcium|mesh-list
14130437|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
14130438|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130439|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130440|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130441|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
13947651|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
13947652|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13947653|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947654|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13947655|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947656|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947657|NCT03243851|Metformin|metformin|mesh-list
13947658|NCT03243851|Temozolomide|temozolomide|mesh-list
13947659|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13947660|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947661|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13947662|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
13947663|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947664|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947665|NCT03243552|Levodopa|levodopa|mesh-list
13947666|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13947667|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13947668|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
13947669|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947670|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947671|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947672|NCT03243500|Lidocaine|lidocaine|mesh-list
13947673|NCT03243500|Bupivacaine|bupivacaine|mesh-list
13947674|NCT03243500|Atracurium|atracurium|mesh-list
13947675|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
13947676|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
13947677|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130442|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
14130443|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130444|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14130445|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130446|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
14130447|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14130448|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130449|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
14130450|NCT02037048|Antidotes|antidotes|mesh-ancestor
14130451|NCT02037048|Protective Agents|protective agents|mesh-ancestor
13947678|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947679|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
13947680|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947681|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13947682|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13947683|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14130452|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
14763578|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763579|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763580|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14763581|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14763582|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
14130453|NCT02037048|Vitamins|vitamins|mesh-ancestor
14130454|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
14130455|NCT02023905|Everolimus|everolimus|mesh-list
14130456|NCT02023905|Temozolomide|temozolomide|mesh-list
14130457|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130458|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130459|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
14130460|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130461|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14130462|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
14130463|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130464|NCT01909414|Vaccines|vaccines|mesh-list
14130465|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
14130466|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130467|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14130468|NCT01698307|Adalimumab|adalimumab|mesh-list
14130469|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130470|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14130471|NCT05118984|Azithromycin|azithromycin|mesh-list
14130472|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130473|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130474|NCT05118672|Acetaminophen|acetaminophen|mesh-list
14130475|NCT05118672|Fexofenadine|fexofenadine|mesh-list
14130476|NCT05118672|Phenylephrine|phenylephrine|mesh-list
14936808|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
14936809|NCT01471535|Interferons|interferons|mesh-list
14936810|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
14130477|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
14130478|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14130479|NCT05118672|Analgesics|analgesics|mesh-ancestor
14130480|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
14130481|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130482|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130483|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
14130484|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14130485|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
14130486|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
14130487|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
14130488|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14130489|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
14130490|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
14130491|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14130492|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14130493|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14130494|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130495|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130496|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130497|NCT05118672|Protective Agents|protective agents|mesh-ancestor
14130498|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14130499|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14130500|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13947684|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947685|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947686|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13947687|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13947688|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13947689|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
13947690|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13947691|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
13947692|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947693|NCT03243643|Apatinib|apatinib|mesh-list
13947694|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947695|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947696|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947697|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947698|NCT03243604|Hormones|hormones|mesh-list
13947699|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947700|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947701|NCT03243461|Temozolomide|temozolomide|mesh-list
13947702|NCT03243461|Valproic Acid|valproic acid|mesh-list
13947703|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13947704|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
14130501|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
14130502|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
14130503|NCT05118542|Methimazole|methimazole|mesh-list
14130504|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
14130505|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
14130506|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
14130507|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130508|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130509|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
14130510|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130511|NCT05118490|Isoniazid|isoniazid|mesh-list
14130512|NCT05118490|Rifapentine|rifapentine|mesh-list
14130513|NCT05118490|Rifampin|rifampin|mesh-list
14130514|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
14130515|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130516|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130517|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14130518|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14130519|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
14130520|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130521|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14130522|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14130523|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
14130524|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14130525|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130526|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14130527|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14130528|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14130529|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14130530|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14130531|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14130532|NCT05094154|Penicillins|penicillins|mesh-list
14130533|NCT05094154|Cephalosporins|cephalosporins|mesh-list
14130534|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130535|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130536|NCT05093205|Midazolam|midazolam|mesh-list
13947705|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947706|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947707|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
13947708|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947709|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
13947710|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947711|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947712|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
13947713|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13947714|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947715|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130537|NCT05093205|Atorvastatin|atorvastatin|mesh-list
14130538|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
14130539|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14130540|NCT05093205|Estradiol|estradiol|mesh-list
14130541|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14130542|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14130543|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
14763583|NCT00611910|Sirolimus|sirolimus|mesh-list
14763584|NCT00611910|Paclitaxel|paclitaxel|mesh-list
14763585|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763586|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763587|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763588|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763589|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763590|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763591|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14763592|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763593|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14763594|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
14763595|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130544|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130545|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13947716|NCT03243331|Gedatolisib|gedatolisib|mesh-list
14130546|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14130547|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130548|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14130549|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14130550|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763596|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
13947717|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14130551|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130552|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14130553|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14130554|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130555|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14130556|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
14763597|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763598|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14763599|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14763600|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14763601|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14763602|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130557|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
14130558|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
14130559|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
14130560|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130561|NCT05093205|Estrogens|estrogens|mesh-ancestor
14130562|NCT05093205|Hormones|hormones|mesh-ancestor
14130563|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130564|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14130565|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
14130566|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14130567|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14130568|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14130569|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13947718|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947719|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947720|NCT03243344|Surgiflo|surgiflo|mesh-list
14130570|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14130571|NCT05084534|Midodrine|midodrine|mesh-list
14130572|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
14130573|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
14130574|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130575|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130576|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14130577|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14130578|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14130579|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14130580|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130581|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130582|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130583|NCT05081219|Insulin|insulin|mesh-list
14130584|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14130585|NCT05081219|Empagliflozin|empagliflozin|mesh-list
14130586|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14130587|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130588|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14130589|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947721|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
13947722|NCT03243344|Coagulants|coagulants|mesh-ancestor
13947723|NCT03243175|Apixaban|apixaban|mesh-list
13947724|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13947725|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
13947726|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13947727|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
14130590|NCT05038475|Antibodies|antibodies|mesh-list
14130591|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
14130592|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130593|NCT05025163|Fluorides|fluorides|mesh-list
13947728|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947729|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947730|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
14130594|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
14130595|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
14130596|NCT05025163|Protective Agents|protective agents|mesh-ancestor
14130597|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130598|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14130599|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14130600|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14130601|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14130602|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130603|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947731|NCT03243019|Sirolimus|sirolimus|mesh-list
13947732|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13947733|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947734|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13947735|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947736|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
13947737|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13947738|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
13947739|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947740|NCT03243032|Ibuprofen|ibuprofen|mesh-list
13947741|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
13947742|NCT03243032|Anesthetics|anesthetics|mesh-list
13947743|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
13947744|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947745|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130604|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130605|NCT05018013|Analgesics|analgesics|mesh-ancestor
14130606|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
14130607|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130608|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
14130609|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130610|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
14177486|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14177487|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177488|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177489|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14177490|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177491|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
14177492|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
14177493|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177494|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14177495|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14177496|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
14177497|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
14177498|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177499|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14177500|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14177501|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14936811|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
14936812|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14936813|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936814|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
14936815|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936816|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
14936817|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947746|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14177502|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177503|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177504|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
14177505|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14177506|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14177507|NCT04755543|Fluorouracil|fluorouracil|mesh-list
14177508|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177509|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
14177510|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177511|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14177512|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177513|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
14177514|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177515|NCT04755322|Aspirin|aspirin|mesh-list
14177516|NCT04755322|Folic Acid|folic acid|mesh-list
14177517|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
13947747|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13947748|NCT03243032|Analgesics|analgesics|mesh-ancestor
14936818|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
13947749|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
13962497|NCT04542135|Sulindac|sulindac|mesh-list
14130611|NCT04872582|Bevacizumab|bevacizumab|mesh-list
14130612|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14130613|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130614|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130615|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13947750|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947751|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13947752|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13947753|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947754|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947755|NCT03242993|Folic Acid|folic acid|mesh-list
13947756|NCT03242993|Hematinics|hematinics|mesh-ancestor
13947757|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
13947758|NCT03242993|Vitamins|vitamins|mesh-ancestor
13947759|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
13947760|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947761|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
13947762|NCT03242967|Hematinics|hematinics|mesh-ancestor
13947763|NCT03243006|Acetaminophen|acetaminophen|mesh-list
13947764|NCT03243006|Tramadol|tramadol|mesh-list
13947765|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13947766|NCT03243006|Analgesics|analgesics|mesh-ancestor
13947767|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
13947768|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947769|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947770|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
14130616|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14130617|NCT04872582|Growth Substances|growth substances|mesh-ancestor
14130618|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130619|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
14130620|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130621|NCT04818372|Dexamethasone|dexamethasone|mesh-list
14130622|NCT04818372|Lenalidomide|lenalidomide|mesh-list
14130623|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130624|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
14130625|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
14130626|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130627|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947771|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13947772|NCT03243006|Narcotics|narcotics|mesh-ancestor
14130628|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14130629|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
14130630|NCT04818372|Hormones|hormones|mesh-ancestor
14130631|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130632|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14130633|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130634|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
14130635|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14763603|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
13947773|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947774|NCT03242915|Carboplatin|carboplatin|mesh-list
13947775|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
13947776|NCT03242915|Pemetrexed|pemetrexed|mesh-list
13947777|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947778|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947779|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947780|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947781|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13947782|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13947783|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
13947784|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13947785|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
13947786|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947787|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
13947788|NCT03242707|Protective Agents|protective agents|mesh-ancestor
13947789|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
13947790|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13947791|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947792|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962498|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13962499|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13962500|NCT04542135|Analgesics|analgesics|mesh-ancestor
13962501|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
13962502|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962503|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130636|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14130637|NCT04818372|Growth Substances|growth substances|mesh-ancestor
14130638|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
14130639|NCT04784299|Lidocaine|lidocaine|mesh-list
14130640|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
14130641|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
14130642|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130643|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130644|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
14130645|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947793|NCT03242382|Palbociclib|palbociclib|mesh-list
13947794|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947795|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947796|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947797|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947798|NCT03242460|Dexamethasone|dexamethasone|mesh-list
13947799|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
14130646|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14130647|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14130648|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14130649|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14130650|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130651|NCT04682158|Paclitaxel|paclitaxel|mesh-list
14130652|NCT04682158|Carboplatin|carboplatin|mesh-list
14130653|NCT04682158|Propranolol|propranolol|mesh-list
14130654|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130655|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130656|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130657|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
14130658|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
14130659|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130660|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14130661|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14130662|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130663|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130664|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130665|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14130666|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14130667|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
14130668|NCT04645316|Propofol|propofol|mesh-list
14130669|NCT04645316|Sevoflurane|sevoflurane|mesh-list
14130670|NCT04645316|Desflurane|desflurane|mesh-list
14130671|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14130672|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130673|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130674|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14130675|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
14130676|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
14130677|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14130678|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14130679|NCT04620382|Midodrine|midodrine|mesh-list
14130680|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
14130681|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
14130682|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130683|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130684|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14130685|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14130686|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14130687|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14130688|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130689|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130690|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130691|NCT04602533|Durvalumab|durvalumab|mesh-list
13947800|NCT03242460|Pomalidomide|pomalidomide|mesh-list
13947801|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130692|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130693|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947802|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
14130694|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
14130695|NCT04594382|Narcotics|narcotics|mesh-ancestor
14130696|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130697|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130698|NCT04594382|Analgesics|analgesics|mesh-ancestor
14130699|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
14130700|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130701|NCT04530604|Defibrotide|defibrotide|mesh-list
14130702|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13947803|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947804|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13947805|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13947806|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
13947807|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130703|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14130704|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130705|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14130706|NCT04451863|Caryophyllene|caryophyllene|mesh-list
14130707|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130708|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13947808|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947809|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13947810|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947811|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
13947812|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
13947813|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947814|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947815|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
13947816|NCT03242460|Hormones|hormones|mesh-ancestor
13947817|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947818|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13947819|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13947820|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13947821|NCT03242460|Growth Substances|growth substances|mesh-ancestor
13947822|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
13947823|NCT03242499|Lovastatin|lovastatin|mesh-list
13947824|NCT03242499|L 647318|l 647318|mesh-list
13947825|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
13947826|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13947827|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13947828|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
13947829|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947830|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13947831|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13947832|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947833|NCT03242616|Pemetrexed|pemetrexed|mesh-list
13947834|NCT03242616|Vinorelbine|vinorelbine|mesh-list
13947835|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947836|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947837|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947838|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13947839|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13947840|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13947841|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
13947842|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
13947843|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
13947844|NCT03242317|Mitomycins|mitomycins|mesh-list
13947845|NCT03242317|Mitomycin|mitomycin|mesh-list
13947846|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14130709|NCT04451863|Analgesics|analgesics|mesh-ancestor
14130710|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
14130711|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130712|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14130713|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130714|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14130715|NCT04450394|Insulin|insulin|mesh-list
14130716|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14130717|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130718|NCT04413201|Osimertinib|osimertinib|mesh-list
14130719|NCT04413201|Afatinib|afatinib|mesh-list
13947847|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947848|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
13947849|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130720|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130721|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13947850|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13947851|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947852|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
13947853|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13947854|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
13947855|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13947856|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
13947857|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947858|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947859|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
13947860|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
13947861|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947862|NCT03242239|Trastuzumab|trastuzumab|mesh-list
14130722|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130723|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130724|NCT04303325|Esketamine|esketamine|mesh-list
14130725|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
14130726|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130727|NCT04293393|Paclitaxel|paclitaxel|mesh-list
14130728|NCT04293393|Docetaxel|docetaxel|mesh-list
14130729|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
14130730|NCT04293393|Doxorubicin|doxorubicin|mesh-list
14130731|NCT04293393|Letrozole|letrozole|mesh-list
14130732|NCT04293393|Leuprolide|leuprolide|mesh-list
14130733|NCT04293393|Goserelin|goserelin|mesh-list
14130734|NCT04293393|Taxane|taxane|mesh-list
14130735|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130736|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130737|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130738|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
14130739|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
14130740|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130741|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130742|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
14130743|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130744|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14130745|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14130746|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
14130747|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14130748|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14130749|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14130750|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14130751|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130752|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14130753|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14130754|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14130755|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
14130756|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130757|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14130758|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
14130759|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14130760|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14130761|NCT04247750|Sirolimus|sirolimus|mesh-list
14130762|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130763|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130764|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14130765|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130766|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
14130767|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130768|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
14130769|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130770|NCT04230408|Paclitaxel|paclitaxel|mesh-list
14130771|NCT04230408|Carboplatin|carboplatin|mesh-list
14130772|NCT04230408|Durvalumab|durvalumab|mesh-list
14130773|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130774|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130775|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130776|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14130777|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14130778|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130779|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130780|NCT04169698|Denosumab|denosumab|mesh-list
14130781|NCT04169698|Alendronate|alendronate|mesh-list
14130782|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14130783|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130784|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
14130785|NCT04155203|Mupirocin|mupirocin|mesh-list
13947863|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947864|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947865|NCT03241875|Pregabalin|pregabalin|mesh-list
13947866|NCT03241875|Gabapentin|gabapentin|mesh-list
13947867|NCT03241875|Analgesics|analgesics|mesh-ancestor
13947868|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
13947869|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947870|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947871|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
13947872|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13947873|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947874|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947875|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13947876|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13947877|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13947878|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947879|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13947880|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13947881|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13947882|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13947883|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
13947884|NCT03241901|Lumefantrine|lumefantrine|mesh-list
13947885|NCT03241901|Artemether|artemether|mesh-list
13947886|NCT03241901|Primaquine|primaquine|mesh-list
13947887|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
13947888|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
13947889|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13947890|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13947891|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947892|NCT03241914|Megestrol|megestrol|mesh-list
14130786|NCT04155203|Calcium|calcium|mesh-list
14130787|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14130788|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130789|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14130790|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14130791|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130792|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14130793|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130794|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130795|NCT03906617|Dexamethasone|dexamethasone|mesh-list
14130796|NCT03906617|Epinephrine|epinephrine|mesh-list
14130797|NCT03906617|Bupivacaine|bupivacaine|mesh-list
14130798|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14130799|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
14130800|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
14130801|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130802|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130803|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14130804|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
14130805|NCT03906617|Hormones|hormones|mesh-ancestor
14130806|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130807|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14130808|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130809|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
14130810|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
13947893|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
13947894|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
13947895|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13947896|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
13947897|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13947898|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947899|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13947900|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13947901|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13947902|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13947903|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13947904|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947905|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
13947906|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13947907|NCT03241784|Interleukin-2|interleukin-2|mesh-list
13947908|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947909|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13947910|NCT03241784|Analgesics|analgesics|mesh-ancestor
13947911|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
14130811|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130812|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
14130813|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14130814|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14130815|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130816|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130817|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130818|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14130819|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13947912|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947913|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947914|NCT03242096|Sirolimus|sirolimus|mesh-list
13947915|NCT03242096|Paclitaxel|paclitaxel|mesh-list
13947916|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13947917|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947918|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
13947919|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
13947920|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
13947921|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947922|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13947923|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947924|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13947925|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
13947926|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130820|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14130821|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
14130822|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
14130823|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
14130824|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14130825|NCT03897673|Iron|iron|mesh-list
14130826|NCT03897673|Trace Elements|trace elements|mesh-ancestor
14130827|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
13947927|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
13947928|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947929|NCT03241888|Megestrol|megestrol|mesh-list
13947930|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
13947931|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
13947932|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13947933|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
13947934|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14130828|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130829|NCT03874494|Aripiprazole|aripiprazole|mesh-list
14130830|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
14130831|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
14130832|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130833|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14130834|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14130835|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130836|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130837|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
14130838|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
14130839|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130840|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130841|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14130842|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14130843|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
14130844|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14130845|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14130846|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14130847|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14130848|NCT03862859|Warfarin|warfarin|mesh-list
14130849|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
14130850|NCT03807817|Ethanol|ethanol|mesh-list
14130851|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14130852|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130853|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130854|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130855|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
14130856|NCT03797326|Lenvatinib|lenvatinib|mesh-list
14130857|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130858|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130859|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14130860|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130861|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130862|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
14130863|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130864|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130865|NCT03709446|Leflunomide|leflunomide|mesh-list
14130866|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130867|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130868|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130869|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
14130870|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130871|NCT03683069|Amlodipine|amlodipine|mesh-list
14130872|NCT03683069|Eplerenone|eplerenone|mesh-list
14130873|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14130874|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14130875|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14130876|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130877|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14130878|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130879|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
14130880|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14130881|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
14130882|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14130883|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14130884|NCT03683069|Diuretics|diuretics|mesh-ancestor
14130885|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
14130886|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
14130887|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14130888|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14130889|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130890|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14130891|NCT03677115|Analgesics|analgesics|mesh-ancestor
14130892|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
14130893|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130894|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14130895|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14130896|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14130897|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130898|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130899|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130900|NCT03673228|Nicotine|nicotine|mesh-list
14130901|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14130902|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
14130903|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130904|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130905|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14130906|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14130907|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
14130908|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130909|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130910|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14130911|NCT03575403|Methylphenidate|methylphenidate|mesh-list
14130912|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14130913|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130914|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14130915|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14130916|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14130917|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130918|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
14130919|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130920|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14130921|NCT03575403|Analgesics|analgesics|mesh-ancestor
14130922|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
14130923|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763604|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763605|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763606|NCT00611962|Paclitaxel|paclitaxel|mesh-list
14763607|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
14763608|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763609|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763610|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763611|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
14763612|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763613|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763614|NCT00612079|Sertindole|sertindole|mesh-list
14763615|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14763616|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13947935|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130924|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
14130925|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130926|NCT03554174|Psilocybin|psilocybin|mesh-list
14130927|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
14130928|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130929|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14130930|NCT03482297|Midodrine|midodrine|mesh-list
14130931|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
14130932|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
14130933|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130934|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130935|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14130936|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14130937|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14130938|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14130939|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
14130940|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130941|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130942|NCT03314935|Leucovorin|leucovorin|mesh-list
14130943|NCT03314935|Gemcitabine|gemcitabine|mesh-list
14130944|NCT03314935|Paclitaxel|paclitaxel|mesh-list
14130945|NCT03314935|Fluorouracil|fluorouracil|mesh-list
14130946|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
14130947|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130948|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130949|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130950|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14130951|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
14130952|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130953|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14130954|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
14130955|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
14130956|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14130957|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130958|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14130959|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
14130960|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130961|NCT03314935|Antidotes|antidotes|mesh-ancestor
14130962|NCT03314935|Protective Agents|protective agents|mesh-ancestor
14130963|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
14130964|NCT03314935|Vitamins|vitamins|mesh-ancestor
14130965|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
14130966|NCT03235505|Nicotine|nicotine|mesh-list
13947936|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13947937|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13947938|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13947939|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13947940|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13947941|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947942|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
13947943|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13947944|NCT03241472|Letrozole|letrozole|mesh-list
13947945|NCT03241472|Clomiphene|clomiphene|mesh-list
13947946|NCT03241472|Enclomiphene|enclomiphene|mesh-list
13947947|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
13947948|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947949|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947950|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13947951|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13947952|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947953|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13947954|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
13947955|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947956|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947957|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13947958|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
13947959|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13947960|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14130967|NCT03235505|Varenicline|varenicline|mesh-list
14130968|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14130969|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
14130970|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14130971|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14130972|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14130973|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14130974|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
14130975|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14130976|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130977|NCT03159897|Doxorubicin|doxorubicin|mesh-list
14130978|NCT03159897|Bleomycin|bleomycin|mesh-list
14130979|NCT03159897|Dacarbazine|dacarbazine|mesh-list
14130980|NCT03159897|Vinblastine|vinblastine|mesh-list
14130981|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14130982|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130983|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14130984|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14130985|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947961|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14130986|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14130987|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14130988|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
14130989|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14130990|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
14130991|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
14130992|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
14130993|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
14130994|NCT03025035|Olaparib|olaparib|mesh-list
14130995|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14130996|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14130997|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14130998|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14130999|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131000|NCT03003325|Aspirin|aspirin|mesh-list
14131001|NCT03003325|Interferons|interferons|mesh-list
14131002|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131003|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
14131004|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131005|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14131006|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131007|NCT03003325|Analgesics|analgesics|mesh-ancestor
14131008|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
13947962|NCT03241563|Triamcinolone|triamcinolone|mesh-list
13947963|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
13947964|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13947965|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
13947966|NCT03241563|Hormones|hormones|mesh-ancestor
13947967|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13947968|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947969|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13947970|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13947971|NCT03241745|Nivolumab|nivolumab|mesh-list
13947972|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13947973|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13947974|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13947975|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947976|NCT03241602|Lidocaine|lidocaine|mesh-list
13947977|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
13947978|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
13947979|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13947980|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13947981|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
13947982|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947983|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13947984|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13947985|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13947986|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13947987|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947988|NCT03241641|Tenofovir|tenofovir|mesh-list
13947989|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
13947990|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13947991|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14131009|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13947992|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13947993|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13947994|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13947995|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13947996|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13947997|NCT03241550|Isavuconazole|isavuconazole|mesh-list
13947998|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
13947999|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948000|NCT03241407|Triclosan|triclosan|mesh-list
13948001|NCT03241407|Fluorides|fluorides|mesh-list
13948002|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
13948003|NCT03241407|Protective Agents|protective agents|mesh-ancestor
13948004|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948005|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13948006|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948007|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13948008|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13948009|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
13948010|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948011|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13948012|NCT03241706|Glucagon|glucagon|mesh-list
13948013|NCT03241706|Somatostatin|somatostatin|mesh-list
14131010|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131011|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131012|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131013|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14131014|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14131015|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131016|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14131017|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13948014|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948015|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948016|NCT03241706|Hormones|hormones|mesh-ancestor
13948017|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948018|NCT03241381|Vitamin D|vitamin d|mesh-list
13948019|NCT03241381|Vitamins|vitamins|mesh-ancestor
13948020|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
13948021|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131018|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131019|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
14131020|NCT02955823|Dexamethasone|dexamethasone|mesh-list
13948022|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13948023|NCT03241303|Acarbose|acarbose|mesh-list
13948024|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13948025|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948026|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948027|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13948028|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948029|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
13948030|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948031|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13948032|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948033|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962504|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962505|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962506|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962507|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13962508|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962509|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962510|NCT04509973|Dexamethasone|dexamethasone|mesh-list
13962511|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962512|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
13962513|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
13962514|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962515|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962516|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131021|NCT02955823|Rituximab|rituximab|mesh-list
14131022|NCT02955823|Lenalidomide|lenalidomide|mesh-list
13962517|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
13962518|NCT04509973|Hormones|hormones|mesh-ancestor
14131023|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131024|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
14131025|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
14131026|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131027|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131028|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131029|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
14131030|NCT02955823|Hormones|hormones|mesh-ancestor
14131031|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131032|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131033|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131034|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131035|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
14131036|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131037|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14131038|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14131039|NCT02955823|Growth Substances|growth substances|mesh-ancestor
14131040|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
14131041|NCT02862132|Vedolizumab|vedolizumab|mesh-list
14131042|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131043|NCT02772081|Poractant alfa|poractant alfa|mesh-list
14131044|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14131045|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
14177518|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14177519|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14177520|NCT04755322|Analgesics|analgesics|mesh-ancestor
14177521|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
13948034|NCT03241043|Tacrolimus|tacrolimus|mesh-list
13948035|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948036|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
13948037|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948038|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13948039|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948040|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948041|NCT03241017|Durvalumab|durvalumab|mesh-list
13948042|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14177522|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177523|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177524|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14177525|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13948043|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948044|NCT03240809|Brodalumab|brodalumab|mesh-list
13948045|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13948046|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948047|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
13948048|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948049|NCT03240822|Antibodies|antibodies|mesh-list
13948050|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13948051|NCT03240822|Tacrolimus|tacrolimus|mesh-list
13948052|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
13948053|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948054|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948055|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13948056|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948057|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948058|NCT03240939|Tadalafil|tadalafil|mesh-list
13948059|NCT03240939|Dutasteride|dutasteride|mesh-list
13948060|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
13948061|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13948062|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13948063|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948064|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948065|NCT03240939|Urological Agents|urological agents|mesh-ancestor
14177526|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14177527|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13948066|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13948067|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14131046|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
14131047|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14131048|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14131049|NCT02578394|Prednisolone|prednisolone|mesh-list
14131050|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
14131051|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14131052|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14131053|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
14131054|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131055|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
14131056|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
14131057|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131058|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131059|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131060|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
14131061|NCT02578394|Hormones|hormones|mesh-ancestor
14131062|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131063|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14131064|NCT02578394|Protective Agents|protective agents|mesh-ancestor
14131065|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131066|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948068|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
13948069|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948070|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948071|NCT03240783|Dexamethasone|dexamethasone|mesh-list
13948072|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
13948073|NCT03240783|Betamethasone|betamethasone|mesh-list
13948074|NCT03240783|BB 1101|bb 1101|mesh-list
13948075|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948076|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
13948077|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
13948078|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948079|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948080|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948081|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
13948082|NCT03240783|Hormones|hormones|mesh-ancestor
13948083|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948084|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131067|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131068|NCT02341989|Carboplatin|carboplatin|mesh-list
14131069|NCT02341989|Etoposide|etoposide|mesh-list
14131070|NCT02341989|Bleomycin|bleomycin|mesh-list
14131071|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131072|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14131073|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14131074|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14131075|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948085|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948086|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
13948087|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948088|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948089|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13948090|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
13948091|NCT03240835|Docetaxel|docetaxel|mesh-list
13948092|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948093|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
13948094|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
13948095|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
13948096|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948097|NCT03240471|Calpastatin|calpastatin|mesh-list
13948098|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
13948099|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
13948100|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948101|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948102|NCT03240549|Bevacizumab|bevacizumab|mesh-list
13948103|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13948104|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948105|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13948106|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14131076|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131077|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14131078|NCT02184767|Loxapine|loxapine|mesh-list
14131079|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14131080|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14131081|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131082|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131083|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14131084|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14131085|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
14131086|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131087|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131088|NCT02122718|Allopurinol|allopurinol|mesh-list
14131089|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
14131090|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131091|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948107|NCT03240549|Growth Substances|growth substances|mesh-ancestor
13948108|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948109|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
13948110|NCT03240120|Tinzaparin|tinzaparin|mesh-list
13948111|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13948112|NCT03240120|Dalteparin|dalteparin|mesh-list
13948113|NCT03240120|Dabigatran|dabigatran|mesh-list
13948114|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
13948115|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13948116|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
13948117|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948118|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948119|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
13948120|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13948121|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13948122|NCT03240055|Etomidate|etomidate|mesh-list
13948123|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
13948124|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948125|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948126|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13948127|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13948128|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
14131092|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
14131093|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131094|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14131095|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
14131096|NCT02122718|Protective Agents|protective agents|mesh-ancestor
14131097|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131098|NCT01882816|Doxorubicin|doxorubicin|mesh-list
14131099|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14131100|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131101|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14131102|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14131103|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131104|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131105|NCT01758614|Aspirin|aspirin|mesh-list
13948129|NCT03239691|ACT-709478|act-709478|mesh-list
13948130|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13948131|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13948132|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948133|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13948134|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948135|NCT03239860|Antibodies|antibodies|mesh-list
13948136|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13948137|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
13948138|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948139|NCT03239743|Midazolam|midazolam|mesh-list
13948140|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13948141|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13948142|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948143|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131106|NCT01758614|Clopidogrel|clopidogrel|mesh-list
14131107|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14131108|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131109|NCT01758614|Analgesics|analgesics|mesh-ancestor
14131110|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
14131111|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131112|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131113|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131114|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131115|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14131116|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14131117|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131118|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14131119|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14131120|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131121|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
14131122|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14936819|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
13948144|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13948145|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13948146|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13948147|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13948148|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
13948149|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
13948150|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
13948151|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
13948152|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948153|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948154|NCT03239821|Codeine|codeine|mesh-list
13948155|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13948156|NCT03239821|Narcotics|narcotics|mesh-ancestor
13948157|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948158|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948159|NCT03239821|Analgesics|analgesics|mesh-ancestor
13948160|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
13948161|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948162|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
13948163|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
13948164|NCT03239964|Dexamethasone|dexamethasone|mesh-list
13948165|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948166|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
13948167|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
13948168|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948169|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948170|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948171|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
13948172|NCT03239964|Hormones|hormones|mesh-ancestor
13948173|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948174|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948175|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948176|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
13948177|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948178|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13948179|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948180|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948181|NCT03239600|Methotrexate|methotrexate|mesh-list
13948182|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13948183|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
13948184|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13948185|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948186|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13948187|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
13948188|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948189|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948190|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948191|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948192|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13948193|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948194|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
13948195|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13948196|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13948197|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
13948198|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14131123|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14131124|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14131125|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
14131126|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131127|NCT01593241|Carboplatin|carboplatin|mesh-list
14131128|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131129|NCT01515527|Cytarabine|cytarabine|mesh-list
14131130|NCT01515527|Decitabine|decitabine|mesh-list
14131131|NCT01515527|Cladribine|cladribine|mesh-list
14131132|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14131133|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
14131134|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948199|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948200|NCT03239327|Alprostadil|alprostadil|mesh-list
13948201|NCT03239327|Misoprostol|misoprostol|mesh-list
13948202|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13948203|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
13948204|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13948205|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948206|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13948207|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948208|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
13948209|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13948210|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
13948211|NCT03239327|Urological Agents|urological agents|mesh-ancestor
13948212|NCT03239314|Dexamethasone|dexamethasone|mesh-list
13948213|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13948214|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948215|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
13948216|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
13948217|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948218|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948219|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948220|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
13948221|NCT03239314|Hormones|hormones|mesh-ancestor
13948222|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131135|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948223|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948224|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948225|NCT03239353|Entecavir|entecavir|mesh-list
13948226|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
13948227|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962519|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962520|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962521|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962522|NCT04482621|Decitabine|decitabine|mesh-list
13962523|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13962524|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
14131136|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
14131137|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131138|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131139|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
13948228|NCT03239236|Anesthetics|anesthetics|mesh-list
13948229|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948230|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948231|NCT03239457|Mitogens|mitogens|mesh-list
13948232|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
13948233|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948234|NCT03239210|Ondansetron|ondansetron|mesh-list
13948235|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
13948236|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
13948237|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948238|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948239|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948240|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
13948241|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948242|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13948243|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
13948244|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948245|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948246|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13948247|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13948248|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948249|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13948250|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13948251|NCT03239080|Denosumab|denosumab|mesh-list
13948252|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13948253|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948254|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
13948255|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13948256|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13948257|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13948258|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14131140|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131141|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131142|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14131143|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131144|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131145|NCT01097746|Paclitaxel|paclitaxel|mesh-list
14131146|NCT01097746|Bevacizumab|bevacizumab|mesh-list
14131147|NCT01097746|Carboplatin|carboplatin|mesh-list
14131148|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14131149|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14131150|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
14131151|NCT01097746|Antibodies|antibodies|mesh-list
14131152|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
14131153|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13948259|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131154|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
14131155|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14131156|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131157|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
14131158|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
14131159|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
14131160|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131161|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13948260|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
14131162|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14131163|NCT01097746|Growth Substances|growth substances|mesh-ancestor
14131164|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131165|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
14131166|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
14131167|NCT00307242|Adefovir|adefovir|mesh-list
14131168|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14131169|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
14131170|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131171|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14131172|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14131173|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131174|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131175|NCT05120687|Cyclosporine|cyclosporine|mesh-list
14763617|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763618|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763619|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14763620|NCT00612144|Metformin|metformin|mesh-list
14763621|NCT00612144|Glimepiride|glimepiride|mesh-list
14763622|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14763623|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948261|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131176|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
14131177|NCT05120687|Adalimumab|adalimumab|mesh-list
14131178|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
14131179|NCT05120687|Methotrexate|methotrexate|mesh-list
14131180|NCT05120687|Cyclosporins|cyclosporins|mesh-list
14131181|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131182|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
14131183|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763624|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14763625|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763626|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
14763627|NCT00612157|Eszopiclone|eszopiclone|mesh-list
14763628|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14763629|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763630|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763631|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14763632|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14131184|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13948262|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948263|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13948264|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948265|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13948266|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13948267|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948268|NCT03238703|Tamoxifen|tamoxifen|mesh-list
13948269|NCT03238703|Toremifene|toremifene|mesh-list
14131185|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14131186|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
14131187|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131188|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131189|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14131190|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14131191|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
14131192|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14131193|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14131194|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
14131195|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14131196|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131197|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14131198|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13948270|NCT03238703|Letrozole|letrozole|mesh-list
13948271|NCT03238703|Anastrozole|anastrozole|mesh-list
13948272|NCT03238703|Exemestane|exemestane|mesh-list
13948273|NCT03238703|Citric Acid|citric acid|mesh-list
13948274|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
13948275|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
13948276|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13948277|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
13948278|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
13948279|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948280|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131199|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
14131200|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131201|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14131202|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14131203|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14131204|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
14131205|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14131206|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131207|NCT05120622|Tremelimumab|tremelimumab|mesh-list
14131208|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131209|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
14131210|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131211|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131212|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
14131213|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14131214|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14131215|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131216|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
14131217|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
14131218|NCT05120076|Dexamethasone|dexamethasone|mesh-list
14131219|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
14131220|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131221|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
14131222|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
14131223|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131224|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131225|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131226|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
14131227|NCT05120076|Hormones|hormones|mesh-ancestor
14131228|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131229|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131230|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131231|NCT05119712|Terbinafine|terbinafine|mesh-list
14131232|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
13948281|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13948282|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13948283|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948284|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13948285|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
13948286|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948287|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948288|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948289|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13948290|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13948291|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13948292|NCT03238365|Nivolumab|nivolumab|mesh-list
13948293|NCT03238365|Tadalafil|tadalafil|mesh-list
13948294|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13948295|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131233|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131234|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948296|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13948297|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948298|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
13948299|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13948300|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13948301|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948302|NCT03238365|Urological Agents|urological agents|mesh-ancestor
13948303|NCT03238625|Lidocaine|lidocaine|mesh-list
13948304|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
13948305|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
13948306|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948307|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948308|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
13948309|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948310|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13948311|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13948312|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13948313|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13948314|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948315|NCT03238430|Morphine|morphine|mesh-list
13948316|NCT03238430|Ropivacaine|ropivacaine|mesh-list
14131235|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948317|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13948318|NCT03238430|Narcotics|narcotics|mesh-ancestor
13948319|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131236|NCT05119452|Adalimumab|adalimumab|mesh-list
14131237|NCT05119452|Etanercept|etanercept|mesh-list
14131238|NCT05119452|Golimumab|golimumab|mesh-list
14131239|NCT05119452|Infliximab|infliximab|mesh-list
14131240|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
14131241|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
14131242|NCT05119452|Tofacitinib|tofacitinib|mesh-list
14131243|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131244|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
14131245|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131246|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14131247|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131248|NCT05119452|Analgesics|analgesics|mesh-ancestor
14131249|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
14131250|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131251|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131252|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131253|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
14131254|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14131255|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131256|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131257|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14131258|NCT05119439|Misoprostol|misoprostol|mesh-list
14131259|NCT05119439|Mifepristone|mifepristone|mesh-list
13948320|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948321|NCT03238430|Analgesics|analgesics|mesh-ancestor
13948322|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
13948323|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948324|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
13948325|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
13948326|NCT03238482|Fluticasone|fluticasone|mesh-list
13948327|NCT03238482|Xhance|xhance|mesh-list
13948328|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13948329|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13948330|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948331|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13948332|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
13948333|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948334|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948335|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13948336|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
13948337|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948338|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13948339|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13948340|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13948341|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13948342|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
13948343|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948344|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131260|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14131261|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
14131262|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14131263|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131264|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14131265|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131266|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
14131267|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14131268|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14131269|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14131270|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14131271|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
14131272|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14131273|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14131274|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
14131275|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131276|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
14936820|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14936821|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936822|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936823|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
14936824|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14936825|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14936826|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938728|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13948345|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
13948346|NCT03238482|Hormones|hormones|mesh-ancestor
13948347|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948348|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
13948349|NCT03238560|Montelukast|montelukast|mesh-list
13948350|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13948351|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
14131277|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14131278|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14131279|NCT05119257|Antibodies|antibodies|mesh-list
14131280|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14131281|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
14938729|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
14938730|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938731|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938732|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14938733|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14938734|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
14938735|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938736|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14938737|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14938738|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948352|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13948353|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
13948354|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948355|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948356|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14131282|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936827|NCT01471678|Tamsulosin|tamsulosin|mesh-list
14936828|NCT01471678|Dutasteride|dutasteride|mesh-list
14936829|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14936830|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14131283|NCT05108155|Tacrine|tacrine|mesh-list
14131284|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14131285|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131286|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131287|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14131288|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131289|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131290|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14131291|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
13948357|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13948358|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948359|NCT03238612|Clarithromycin|clarithromycin|mesh-list
13948360|NCT03238612|Oseltamivir|oseltamivir|mesh-list
13948361|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
13948362|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948363|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948364|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13948365|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948366|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948367|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13948368|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13948369|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
13948370|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13948371|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948372|NCT03238248|Azacitidine|azacitidine|mesh-list
13948373|NCT03238248|Pevonedistat|pevonedistat|mesh-list
13948374|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13948375|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
13948376|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948377|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948378|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948379|NCT03238131|Ivermectin|ivermectin|mesh-list
14131292|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131293|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
14131294|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
14131295|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131296|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131297|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131298|NCT05065918|Ethanol|ethanol|mesh-list
14131299|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14131300|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131301|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131302|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131303|NCT05061992|Lactulose|lactulose|mesh-list
14131304|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177528|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177529|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14177530|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14177531|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177532|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
14177533|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
14177534|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14177535|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14177536|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177537|NCT04755322|Hematinics|hematinics|mesh-ancestor
14177538|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
14177539|NCT04755322|Vitamins|vitamins|mesh-ancestor
14177540|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
14177541|NCT04755387|Ticagrelor|ticagrelor|mesh-list
14763633|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
14763634|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763635|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763636|NCT00612261|Triamcinolone|triamcinolone|mesh-list
14763637|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14763638|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14763639|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14763640|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14763641|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
14763642|NCT00612261|Hormones|hormones|mesh-ancestor
14763643|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763644|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131305|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
14131306|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14131307|NCT05021861|Estradiol|estradiol|mesh-list
14131308|NCT05021861|Cyproterone|cyproterone|mesh-list
14131309|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
14131310|NCT05021861|Estrogens|estrogens|mesh-ancestor
14131311|NCT05021861|Hormones|hormones|mesh-ancestor
14131312|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131313|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131314|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14131315|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
14131316|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14131317|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14131318|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14131319|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14131320|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
14131321|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
14131322|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131323|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14131324|NCT04995874|Micronutrients|micronutrients|mesh-list
14131325|NCT04995874|Trace Elements|trace elements|mesh-list
14131326|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131327|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
13948380|NCT03238131|Albendazole|albendazole|mesh-list
13948381|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13948382|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948383|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
13948384|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
13948385|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13948386|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13948387|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
13948388|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
13948389|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
14131328|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131329|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131330|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
14131331|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14131332|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131333|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131334|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131335|NCT04824144|Analgesics|analgesics|mesh-ancestor
14131336|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
14131337|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763645|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763646|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
13948390|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948391|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948392|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
14131338|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14131339|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14131340|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14131341|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
14131342|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131343|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131344|NCT04814745|Morphine|morphine|mesh-list
14131345|NCT04814745|Tramadol|tramadol|mesh-list
14131346|NCT04814745|Ropivacaine|ropivacaine|mesh-list
14131347|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14131348|NCT04814745|Narcotics|narcotics|mesh-ancestor
14131349|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131350|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131351|NCT04814745|Analgesics|analgesics|mesh-ancestor
14131352|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
14131353|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131354|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
14131355|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
14131356|NCT04752527|Sorafenib|sorafenib|mesh-list
14131357|NCT04752527|Decitabine|decitabine|mesh-list
14131358|NCT04752527|Venetoclax|venetoclax|mesh-list
14131359|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948393|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13948394|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
14131360|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14131361|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936831|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14763647|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948395|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131362|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131363|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14131364|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
14131365|NCT04738422|Glycine|glycine|mesh-list
14131366|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
14131367|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131368|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131369|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131370|NCT04716335|Harmine|harmine|mesh-list
14131371|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
14131372|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131373|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14131374|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13948396|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13948397|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13948398|NCT03238092|Estradiol|estradiol|mesh-list
13948399|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13948400|NCT03238092|Testosterone|testosterone|mesh-list
13948401|NCT03238092|Estrogens|estrogens|mesh-ancestor
13948402|NCT03238092|Hormones|hormones|mesh-ancestor
14131375|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131376|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131377|NCT04675151|Phentolamine|phentolamine|mesh-list
14131378|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14131379|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14131380|NCT04675151|Pilocarpine|pilocarpine|mesh-list
14131381|NCT04675151|Miotics|miotics|mesh-ancestor
14131382|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
14131383|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131384|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131385|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14131386|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14131387|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
14131388|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131389|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948403|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948404|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948405|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13948406|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
13948407|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13948408|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13948409|NCT03238092|Androgens|androgens|mesh-ancestor
13948410|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
13948411|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948412|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
13948413|NCT03238157|Hormones|hormones|mesh-ancestor
13948414|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948415|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948416|NCT03237936|Cyclosporine|cyclosporine|mesh-list
14131390|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14131391|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14131392|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
14131393|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14131394|NCT04663308|Volixibat|volixibat|mesh-list
14131395|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14131396|NCT04640571|Metformin|metformin|mesh-list
14131397|NCT04640571|Valacyclovir|valacyclovir|mesh-list
14131398|NCT04640571|Enalaprilat|enalaprilat|mesh-list
14131399|NCT04640571|Enalapril|enalapril|mesh-list
14131400|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14131401|NCT04640571|Pravastatin|pravastatin|mesh-list
14131402|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14131403|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131404|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14131405|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14131406|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
14131407|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131408|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14131409|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14131410|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936832|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
14936833|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936834|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131411|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
14131412|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131413|NCT04640571|Cathartics|cathartics|mesh-ancestor
14131414|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131415|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14131416|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
14131417|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14131418|NCT04572100|Paclitaxel|paclitaxel|mesh-list
14131419|NCT04572100|Carboplatin|carboplatin|mesh-list
14131420|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14131421|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131422|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
14131423|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
14131424|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
14131425|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131426|NCT04551885|Aldesleukin|aldesleukin|mesh-list
14131427|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
14131428|NCT04551885|Fludarabine|fludarabine|mesh-list
14131429|NCT04551885|Avelumab|avelumab|mesh-list
14131430|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131431|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
14131432|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131433|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131434|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14131435|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
13948417|NCT03237936|Cyclosporins|cyclosporins|mesh-list
13948418|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948419|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948420|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948421|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
13948422|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948423|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
13948424|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948425|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948426|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13948427|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13948428|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
13948429|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13948430|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
13948431|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131436|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131437|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131438|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14131439|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14131440|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14131441|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
13948432|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
13948433|NCT03238183|Protective Agents|protective agents|mesh-ancestor
13948434|NCT03238027|Durvalumab|durvalumab|mesh-list
13948435|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131442|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131443|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131444|NCT04497870|Peppermint oil|peppermint oil|mesh-list
14131445|NCT04497870|Menthol|menthol|mesh-list
14131446|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
14131447|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
14131448|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
14131449|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
14131450|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948436|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948437|NCT03237637|Propranolol|propranolol|mesh-list
13948438|NCT03237637|Atenolol|atenolol|mesh-list
13948439|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13948440|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14131451|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131452|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131453|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
14131454|NCT04487041|Vaccines|vaccines|mesh-list
14131455|NCT04487041|Immunologic Factors|immunologic factors|mesh-ancestor
14131456|NCT04487041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131457|NCT04431141|Empagliflozin|empagliflozin|mesh-list
13948441|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
13948442|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948443|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948444|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948445|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14131458|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14131459|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131460|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14131461|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131462|NCT04412395|Lactoferrin|lactoferrin|mesh-list
14131463|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131464|NCT04310748|Anesthetics|anesthetics|mesh-list
14131465|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131466|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131467|NCT04304768|Vaccines|vaccines|mesh-list
14131468|NCT04304768|Immunologic Factors|immunologic factors|mesh-ancestor
14131469|NCT04304768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131470|NCT04294498|Entecavir|entecavir|mesh-list
14131471|NCT04294498|Durvalumab|durvalumab|mesh-list
14131472|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131473|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131474|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
14131475|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131476|NCT04206488|Digoxin|digoxin|mesh-list
14131477|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14131478|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14131479|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131480|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131481|NCT04206488|Protective Agents|protective agents|mesh-ancestor
14131482|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131483|NCT04188418|Fentanyl|fentanyl|mesh-list
14131484|NCT04188418|Morphine|morphine|mesh-list
14131485|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14131486|NCT04188418|Narcotics|narcotics|mesh-ancestor
14131487|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948446|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13948447|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
13948448|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
13948449|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
13948450|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948451|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13962525|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962526|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131488|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131489|NCT04188418|Analgesics|analgesics|mesh-ancestor
14131490|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
14131491|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131492|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14131493|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14131494|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
14131495|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
14131496|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14131497|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
13962527|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962528|NCT04469959|Levodopa|levodopa|mesh-list
13962529|NCT04469959|Carbidopa|carbidopa|mesh-list
14131498|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14131499|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
14131500|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131501|NCT04177355|Antacids|antacids|mesh-ancestor
14131502|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131503|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13962530|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14177542|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14177543|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14177544|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13962531|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14131504|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14131505|NCT03912363|Insulin|insulin|mesh-list
14131506|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13948452|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
13948453|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948454|NCT03237715|Bilirubin|bilirubin|mesh-list
14131507|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131508|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14131509|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14131510|NCT03901131|Norethindrone|norethindrone|mesh-list
14131511|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
14131512|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
14131513|NCT03901131|Estradiol|estradiol|mesh-list
14131514|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14131515|NCT03901131|Estrogens|estrogens|mesh-ancestor
14131516|NCT03901131|Hormones|hormones|mesh-ancestor
14131517|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131518|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131519|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14131520|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
14131521|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14131522|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14131523|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14131524|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14131525|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14131526|NCT03814317|Treprostinil|treprostinil|mesh-list
14131527|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13948455|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
13948456|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948457|NCT03237715|Protective Agents|protective agents|mesh-ancestor
13948458|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948459|NCT03237741|Rabeprazole|rabeprazole|mesh-list
13948460|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13948461|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948462|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13948463|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948464|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948465|NCT03237533|Promethazine|promethazine|mesh-list
13948466|NCT03237533|Doxycycline|doxycycline|mesh-list
14131528|NCT03688633|Candesartan|candesartan|mesh-list
14131529|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13948467|NCT03237533|Nystatin|nystatin|mesh-list
13948468|NCT03237533|Dexamethasone|dexamethasone|mesh-list
14131530|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14131531|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14131532|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131533|NCT03613116|Vitamin D|vitamin d|mesh-list
14131534|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
14131535|NCT03613116|Vitamins|vitamins|mesh-ancestor
14131536|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
13948469|NCT03237533|Triamcinolone|triamcinolone|mesh-list
13948470|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948471|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
13948472|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
13948473|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948474|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948475|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948476|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
13948477|NCT03237533|Hormones|hormones|mesh-ancestor
13948478|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948479|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948480|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948481|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948482|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948483|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948484|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
13948485|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13948486|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13948487|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
13948488|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948489|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13948490|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
13948491|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
13948492|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948493|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14131537|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948494|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
13948495|NCT03237533|Ionophores|ionophores|mesh-ancestor
13948496|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13948497|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
13948498|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13948499|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948500|NCT03237312|Hormones|hormones|mesh-list
13948501|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948502|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948503|NCT03237611|Dexamethasone|dexamethasone|mesh-list
13948504|NCT03237611|Ondansetron|ondansetron|mesh-list
13948505|NCT03237611|Aprepitant|aprepitant|mesh-list
13948506|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
13948507|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948508|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
13948509|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
13948510|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948511|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948512|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948513|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
13948514|NCT03237611|Hormones|hormones|mesh-ancestor
13948515|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948516|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948517|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948518|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
13948519|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948520|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13948521|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
13948522|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948523|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948524|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13948525|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13948526|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948527|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13948528|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13948529|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13948530|NCT03237507|Paclitaxel|paclitaxel|mesh-list
13948531|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
13948532|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13948533|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948534|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
13948535|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
13948536|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
13948537|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948538|NCT03237416|Midazolam|midazolam|mesh-list
13948539|NCT03237416|Dabigatran|dabigatran|mesh-list
14131538|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14131539|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14131540|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14131541|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
14131542|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131543|NCT03441750|Metformin|metformin|mesh-list
14131544|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14131545|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948540|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13948541|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13948542|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948543|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948544|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13948545|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13948546|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13948547|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13948548|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
13948549|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
13948550|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
13948551|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
13948552|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948553|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131546|NCT03423264|Gabapentin|gabapentin|mesh-list
14131547|NCT03423264|Analgesics|analgesics|mesh-ancestor
14131548|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
14131549|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131550|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131551|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
14131552|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14131553|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14131554|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131555|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14131556|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14131557|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14131558|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131559|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131560|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
14131561|NCT03367715|Nivolumab|nivolumab|mesh-list
14131562|NCT03367715|Ipilimumab|ipilimumab|mesh-list
14131563|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131564|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131565|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14131566|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131567|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
14131568|NCT03225547|Mifepristone|mifepristone|mesh-list
14131569|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131570|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131571|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14131572|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
14131573|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14131574|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131575|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14131576|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14131577|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14131578|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
14131579|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14131580|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14131581|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
14131582|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131583|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
14131584|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14131585|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14131586|NCT03132454|Dexamethasone|dexamethasone|mesh-list
14131587|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
14131588|NCT03132454|Sorafenib|sorafenib|mesh-list
14131589|NCT03132454|Decitabine|decitabine|mesh-list
14131590|NCT03132454|Palbociclib|palbociclib|mesh-list
13948554|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
13948555|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13948556|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
13948557|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948558|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
13948559|NCT03237546|Anesthetics|anesthetics|mesh-list
13948560|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948561|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948562|NCT03237624|Chitosan|chitosan|mesh-list
13948563|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13948564|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13948565|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
13948566|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948567|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13948568|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
13948569|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
13948570|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
14131591|NCT03132454|Ichthammol|ichthammol|mesh-list
14131592|NCT03132454|BB 1101|bb 1101|mesh-list
14131593|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131594|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
14131595|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
14131596|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131597|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131598|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14936835|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948571|NCT03237624|Coagulants|coagulants|mesh-ancestor
14131599|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
13948572|NCT03237117|Hormones|hormones|mesh-list
14131600|NCT03132454|Hormones|hormones|mesh-ancestor
14131601|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948573|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948574|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948575|NCT03237260|Vedolizumab|vedolizumab|mesh-list
13948576|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948577|NCT03237390|Gemcitabine|gemcitabine|mesh-list
13948578|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13948579|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
13948580|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948581|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948582|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
13948583|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948584|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948585|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948586|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
13948587|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948588|NCT03236818|Bosentan|bosentan|mesh-list
13948589|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
13948590|NCT03236818|Tadalafil|tadalafil|mesh-list
13948591|NCT03236818|Macitentan|macitentan|mesh-list
13948592|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
13948593|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13948594|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13948595|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948596|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948597|NCT03236818|Urological Agents|urological agents|mesh-ancestor
13948598|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13948599|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13948600|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13948601|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
13948602|NCT03236805|Ketamine|ketamine|mesh-list
13948603|NCT03236805|Morphine|morphine|mesh-list
13948604|NCT03236805|Analgesics|analgesics|mesh-ancestor
13948605|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
13948606|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948607|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948608|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13948609|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13948610|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
13948611|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
13948612|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948613|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13948614|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13948615|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948616|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948617|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13948618|NCT03236805|Narcotics|narcotics|mesh-ancestor
13948619|NCT03236974|Fulvestrant|fulvestrant|mesh-list
13948620|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948621|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948622|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13948623|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13948624|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
13948625|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948626|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948627|NCT03236792|Dexamethasone|dexamethasone|mesh-list
13948628|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
13948629|NCT03236792|Ixazomib|ixazomib|mesh-list
13948630|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948631|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
13948632|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948633|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13948634|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13948635|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
13948636|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948637|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948638|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13948639|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948640|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
13948641|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
13948642|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948643|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948644|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
13948645|NCT03236792|Hormones|hormones|mesh-ancestor
13962532|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13948646|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948647|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948648|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
13948649|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948650|NCT03236883|Gemcitabine|gemcitabine|mesh-list
13948651|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13948652|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
13948653|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948654|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948655|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
13948656|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948657|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948658|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948659|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
13948660|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948661|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
13948662|NCT03236961|Metronidazole|metronidazole|mesh-list
14763648|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763649|NCT00612274|Sirolimus|sirolimus|mesh-list
14763650|NCT00612274|Methotrexate|methotrexate|mesh-list
14763651|NCT00612274|Tacrolimus|tacrolimus|mesh-list
13948663|NCT03236961|Levofloxacin|levofloxacin|mesh-list
13948664|NCT03236961|Ertapenem|ertapenem|mesh-list
13948665|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948666|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948667|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13948668|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13948669|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948670|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948671|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948672|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13948673|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13948674|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13948675|NCT03236961|Renal Agents|renal agents|mesh-ancestor
13948676|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13948677|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13948678|NCT03236610|Tenofovir|tenofovir|mesh-list
13948679|NCT03236610|Entecavir|entecavir|mesh-list
13948680|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
13948681|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948682|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13948683|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13948684|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948685|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948686|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13948687|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14131602|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131603|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131604|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
14131605|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948688|NCT03236649|Sorafenib|sorafenib|mesh-list
13948689|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948690|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13948691|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948692|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948693|NCT03236740|Metformin|metformin|mesh-list
13948694|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13948695|NCT03236740|Estradiol|estradiol|mesh-list
13948696|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13948697|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131606|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131607|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14131608|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14131609|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
14131610|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948698|NCT03236740|Estrogens|estrogens|mesh-ancestor
13948699|NCT03236740|Hormones|hormones|mesh-ancestor
13948700|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13948701|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13948702|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
13948703|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13962533|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
14763652|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14763653|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
14763654|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14763655|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763656|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763657|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
13948704|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13948705|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13948706|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13948707|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
13948708|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13948709|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948710|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948711|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13948712|NCT03236727|Analgesics|analgesics|mesh-ancestor
13948713|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
13948714|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763658|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763659|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763660|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
14763661|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763662|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14763663|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948715|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13948716|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13948717|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13948718|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
13948719|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948720|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948721|NCT03236987|Azithromycin|azithromycin|mesh-list
13948722|NCT03236987|Clarithromycin|clarithromycin|mesh-list
13948723|NCT03236987|Rifampin|rifampin|mesh-list
13948724|NCT03236987|Ethambutol|ethambutol|mesh-list
13948725|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948726|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948727|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13948728|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948729|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948730|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13948731|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13948732|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13948733|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
14131611|NCT03121677|Poly I-C|poly i-c|mesh-list
14131612|NCT03121677|Rituximab|rituximab|mesh-list
14131613|NCT03121677|Nivolumab|nivolumab|mesh-list
14131614|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14131615|NCT03121677|Poly ICLC|poly iclc|mesh-list
14131616|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131617|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131618|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
14131619|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131620|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131621|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14131622|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131623|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
14131624|NCT03121677|Laxatives|laxatives|mesh-ancestor
14131625|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948734|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
13948735|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13948736|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13948737|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13948738|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13948739|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13948740|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14131626|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
14131627|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131628|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
14131629|NCT03107182|Promethazine|promethazine|mesh-list
14131630|NCT03107182|Dexamethasone|dexamethasone|mesh-list
14131631|NCT03107182|Paclitaxel|paclitaxel|mesh-list
14131632|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14131633|NCT03107182|Carboplatin|carboplatin|mesh-list
14131634|NCT03107182|Nivolumab|nivolumab|mesh-list
14131635|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
14131636|NCT03107182|Famotidine|famotidine|mesh-list
14131637|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14131638|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131639|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
14131640|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
14131641|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
14131642|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131643|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131644|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
14131645|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
14131646|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131647|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948741|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13948742|NCT03236493|PF-06700841|pf-06700841|mesh-list
13948743|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13948744|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131648|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131649|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
14131650|NCT03107182|Hormones|hormones|mesh-ancestor
13948745|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948746|NCT03236584|Tenofovir|tenofovir|mesh-list
13948747|NCT03236584|Lamivudine|lamivudine|mesh-list
13948748|NCT03236584|Adefovir|adefovir|mesh-list
13948749|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
13948750|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948751|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13948752|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13948753|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948754|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948755|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13948756|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13948757|NCT03236623|Menthol|menthol|mesh-list
13948758|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
13948759|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948760|NCT03236324|Epinephrine|epinephrine|mesh-list
13948761|NCT03236324|Bupivacaine|bupivacaine|mesh-list
13948762|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
13948763|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
13948764|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131651|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131652|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131653|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131654|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14131655|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
14131656|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131657|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13948765|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948766|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
13948767|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948768|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13948769|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13948770|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
13948771|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948772|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948773|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13948774|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13948775|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
13948776|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13948777|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
13948778|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
13948779|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
13948780|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13948781|NCT03236233|PC-786|pc-786|mesh-list
13948782|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
13948783|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948784|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948785|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948786|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
13948787|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13948788|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
13948789|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948790|NCT03236220|Expectorants|expectorants|mesh-ancestor
14131658|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13948791|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
13948792|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13948793|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
13962534|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948794|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948795|NCT03236220|Protective Agents|protective agents|mesh-ancestor
13948796|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948797|NCT03236220|Antidotes|antidotes|mesh-ancestor
13962535|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962536|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962537|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13962538|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962539|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13962540|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
13962541|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
13962542|NCT04443569|Lidocaine|lidocaine|mesh-list
13962543|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
13962544|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
14131659|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14131660|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131661|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
14131662|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
14131663|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
14131664|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14131665|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
14131666|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
14131667|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131668|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14131669|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
14131670|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
14131671|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14131672|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14131673|NCT02969837|Dexamethasone|dexamethasone|mesh-list
14131674|NCT02969837|Lenalidomide|lenalidomide|mesh-list
14131675|NCT02969837|Elotuzumab|elotuzumab|mesh-list
14131676|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131677|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
14131678|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
14131679|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962545|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962546|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962547|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
13962548|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962549|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13962550|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13962551|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13962552|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13962553|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478453|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131680|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131681|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131682|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
14131683|NCT02969837|Hormones|hormones|mesh-ancestor
14131684|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131685|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131686|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131687|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
14478454|NCT02452476|Poractant alfa|poractant alfa|mesh-list
14478455|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14478456|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
14478457|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
14478458|NCT02452528|Promethazine|promethazine|mesh-list
14478459|NCT02452528|Tenofovir|tenofovir|mesh-list
14478460|NCT02452528|Entecavir|entecavir|mesh-list
14478461|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
14478462|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478463|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14478464|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14478465|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962567|NCT04357795|Cyclosporine|cyclosporine|mesh-list
13962568|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13962569|NCT04357795|Cyclosporins|cyclosporins|mesh-list
13962570|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962571|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962572|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962573|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
14131688|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14131689|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14479298|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14131690|NCT02969837|Growth Substances|growth substances|mesh-ancestor
14131691|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
14131692|NCT02870738|Triamcinolone|triamcinolone|mesh-list
14131693|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131694|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
14131695|NCT02870738|Hormones|hormones|mesh-ancestor
14131696|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131697|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131698|NCT02802852|Lenograstim|lenograstim|mesh-list
14131699|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14131700|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
14131701|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131702|NCT02789020|Rasagiline|rasagiline|mesh-list
14131703|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14131704|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131705|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131706|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14131707|NCT02789020|Protective Agents|protective agents|mesh-ancestor
14131708|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131709|NCT02524275|Docetaxel|docetaxel|mesh-list
14131710|NCT02524275|Capecitabine|capecitabine|mesh-list
14131711|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131712|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
14131713|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
14131714|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
14131715|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131716|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14131717|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
14131718|NCT02473042|Promethazine|promethazine|mesh-list
14131719|NCT02473042|Dexamethasone|dexamethasone|mesh-list
14131720|NCT02473042|Ondansetron|ondansetron|mesh-list
14131721|NCT02473042|Famotidine|famotidine|mesh-list
14131722|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131723|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
14131724|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
14131725|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948798|NCT03235947|Trimethoprim|trimethoprim|mesh-list
13948799|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
13948800|NCT03235947|Fosfomycin|fosfomycin|mesh-list
13948801|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13948802|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948803|NCT03235947|Renal Agents|renal agents|mesh-ancestor
13948804|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
13948805|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13948806|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13948807|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13948808|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948809|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948810|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13948811|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13948812|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13948813|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948814|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
13948815|NCT03236155|Narcotics|narcotics|mesh-ancestor
14131726|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131727|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131728|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
14131729|NCT02473042|Hormones|hormones|mesh-ancestor
14131730|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131731|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14131732|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131733|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
14131734|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14131735|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14131736|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
14131737|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131738|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131739|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14131740|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14131741|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131742|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14131743|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14131744|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14131745|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13948816|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131746|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
14131747|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
14131748|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14131749|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14131750|NCT02333149|Melatonin|melatonin|mesh-list
14131751|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
14131752|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131753|NCT02333149|Protective Agents|protective agents|mesh-ancestor
14131754|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131755|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131756|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
14131757|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131758|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131759|NCT02213575|Minocycline|minocycline|mesh-list
14131760|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14131761|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131762|NCT02192021|Doxorubicin|doxorubicin|mesh-list
14131763|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14131764|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14131765|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131766|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14131767|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14131768|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131769|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131770|NCT02144857|Cyclosporine|cyclosporine|mesh-list
14131771|NCT02144857|Etanercept|etanercept|mesh-list
14131772|NCT02144857|Apremilast|apremilast|mesh-list
14131773|NCT02144857|Ustekinumab|ustekinumab|mesh-list
14131774|NCT02144857|Cyclosporins|cyclosporins|mesh-list
14131775|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948817|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948818|NCT03236155|Analgesics|analgesics|mesh-ancestor
13948819|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
13948820|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948821|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
13948822|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
13948823|NCT03235973|Fludarabine|fludarabine|mesh-list
13948824|NCT03235973|Busulfan|busulfan|mesh-list
14131776|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131777|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131778|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
14131779|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948825|NCT03235973|Cladribine|cladribine|mesh-list
13948826|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948827|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948828|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131780|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
14131781|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131782|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
14131783|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131784|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14131785|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14131786|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131787|NCT02144857|Analgesics|analgesics|mesh-ancestor
14131788|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
14131789|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131790|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131791|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14131792|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14131793|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14131794|NCT02133872|Minocycline|minocycline|mesh-list
14131795|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14131796|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131797|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
14131798|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14131799|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131800|NCT01462578|Azacitidine|azacitidine|mesh-list
14131801|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14131802|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
14131803|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131804|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131805|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177545|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14177546|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
14177547|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177548|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936836|NCT01471678|Urological Agents|urological agents|mesh-ancestor
14177549|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131806|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
14131807|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14131808|NCT01219075|Estrogens|estrogens|mesh-ancestor
13948829|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
13948830|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948831|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
13948832|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13948833|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13948834|NCT03235869|Durvalumab|durvalumab|mesh-list
13948835|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13948836|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131809|NCT01219075|Hormones|hormones|mesh-ancestor
14131810|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14131811|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131812|NCT00876031|Etoposide|etoposide|mesh-list
14131813|NCT00876031|Idarubicin|idarubicin|mesh-list
14131814|NCT00876031|Trofosfamide|trofosfamide|mesh-list
14131815|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14131816|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131817|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14131818|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14131819|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131820|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131821|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14131822|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131823|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
14131824|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131825|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14131826|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
14131827|NCT05122494|Capecitabine|capecitabine|mesh-list
13948837|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
13948838|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13948839|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13948840|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13948841|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13948842|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948843|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
13948844|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131828|NCT05122494|Lapatinib|lapatinib|mesh-list
14131829|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14131830|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
14131831|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131832|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131833|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14131834|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131835|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
14131836|NCT05122481|Vitamins|vitamins|mesh-ancestor
14131837|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
14131838|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131839|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
14131840|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131841|NCT05122481|Protective Agents|protective agents|mesh-ancestor
14131842|NCT05122455|Edoxaban|edoxaban|mesh-list
14131843|NCT05122455|Clopidogrel|clopidogrel|mesh-list
14131844|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14131845|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14131846|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14131847|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14131848|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
14131849|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131850|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131851|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131852|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14131853|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
14131854|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14131855|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
14131856|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131857|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
14131858|NCT05122377|Goserelin|goserelin|mesh-list
14131859|NCT05122377|Leuprolide|leuprolide|mesh-list
14131860|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13948845|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131861|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131862|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14131863|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
13948846|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13948847|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948848|NCT03235609|Fentanyl|fentanyl|mesh-list
13948849|NCT03235609|Ketamine|ketamine|mesh-list
13948850|NCT03235609|Analgesics|analgesics|mesh-ancestor
13948851|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
13948852|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948853|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948854|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13948855|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13948856|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
13948857|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
13948858|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948859|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13948860|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13948861|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948862|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948863|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13948864|NCT03235609|Narcotics|narcotics|mesh-ancestor
13948865|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13948866|NCT03235531|Valproic Acid|valproic acid|mesh-list
13948867|NCT03235531|Lorazepam|lorazepam|mesh-list
13948868|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
13948869|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948870|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948871|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
13948872|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948873|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948874|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
13948875|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14131864|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14131865|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131866|NCT05122351|Acetaminophen|acetaminophen|mesh-list
14131867|NCT05122351|Bupivacaine|bupivacaine|mesh-list
14131868|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
14131869|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
14131870|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131871|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131872|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
14131873|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131874|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131875|NCT05122351|Analgesics|analgesics|mesh-ancestor
14131876|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
14131877|NCT05122338|Lidocaine|lidocaine|mesh-list
14131878|NCT05122338|Ropivacaine|ropivacaine|mesh-list
14131879|NCT05122338|Esketamine|esketamine|mesh-list
14131880|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
14131881|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
14131882|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131883|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131884|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
14131885|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131886|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14131887|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14131888|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14131889|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14131890|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131891|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
14131892|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14131893|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
14131894|NCT05122221|Fludarabine|fludarabine|mesh-list
14131895|NCT05122221|Interleukin-2|interleukin-2|mesh-list
14131896|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14131897|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
14131898|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131899|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131900|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14131901|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
14131902|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131903|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131904|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14131905|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131906|NCT05122221|Analgesics|analgesics|mesh-ancestor
13948876|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948877|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13948878|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
14131907|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
14131908|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131909|NCT05122117|Methylene Blue|methylene blue|mesh-list
14131910|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131911|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131912|NCT05122026|Isoniazid|isoniazid|mesh-list
14131913|NCT05122026|Rifapentine|rifapentine|mesh-list
14131914|NCT05122026|Rifampin|rifampin|mesh-list
14131915|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
14131916|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14131917|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14131918|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14131919|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14131920|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
14131921|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131922|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14131923|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14131924|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
14131925|NCT05122026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14131926|NCT05122026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131927|NCT05122026|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14131928|NCT05122026|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14131929|NCT05122026|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14131930|NCT05122026|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14131931|NCT05122026|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14131932|NCT05122026|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14131933|NCT05121883|Edaravone|edaravone|mesh-list
14131934|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14131935|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
14131936|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131937|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14131938|NCT05121883|Protective Agents|protective agents|mesh-ancestor
14131939|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131940|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14131941|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14131942|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131943|NCT05121324|Midazolam|midazolam|mesh-list
14131944|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14131945|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14131946|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131947|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131948|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14131949|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14131950|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14131951|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14131952|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
14131953|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
14131954|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
14131955|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
14131956|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131957|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131958|NCT05121233|Diclofenac|diclofenac|mesh-list
14936837|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13948879|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
14131959|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14131960|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13948880|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948881|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13948882|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13948883|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13948884|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
13948885|NCT03235700|Nicorandil|nicorandil|mesh-list
13948886|NCT03235700|Adenosine|adenosine|mesh-list
13948887|NCT03235700|Analgesics|analgesics|mesh-ancestor
13948888|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
13948889|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948890|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948891|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13948892|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
13948893|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13948894|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
13948895|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
14131961|NCT05121233|Analgesics|analgesics|mesh-ancestor
13948896|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131962|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
14131963|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131964|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131965|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14131966|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14131967|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14131968|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131969|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948897|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948898|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13948899|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
13948900|NCT03235700|Vitamins|vitamins|mesh-ancestor
13948901|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
13948902|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
14131970|NCT05120960|Osimertinib|osimertinib|mesh-list
14131971|NCT05120960|Tepotinib|tepotinib|mesh-list
14131972|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14131973|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14131974|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14131975|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131976|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13948903|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13948904|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13948905|NCT03235778|Analgesics|analgesics|mesh-ancestor
13948906|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
14131977|NCT05120934|Amitriptyline|amitriptyline|mesh-list
14131978|NCT05120934|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14131979|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14131980|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14131981|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14131982|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14131983|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14131984|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14131985|NCT05120934|Analgesics|analgesics|mesh-ancestor
14131986|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
14131987|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14131988|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
14131989|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14131990|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
14131991|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14131992|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14131993|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14131994|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
14131995|NCT05120934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14131996|NCT05120934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14131997|NCT05120934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14131998|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14131999|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
14132000|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
14132001|NCT05114720|Docetaxel|docetaxel|mesh-list
14132002|NCT05114720|Doxorubicin|doxorubicin|mesh-list
14132003|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14132004|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14132005|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132006|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
14132007|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132008|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132009|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14132010|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
14132011|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132012|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132013|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14132014|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14132015|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132016|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132017|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14132018|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14132019|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14132020|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132021|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132022|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14132023|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
14132024|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13948907|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948908|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948909|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13948910|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13948911|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14132025|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14132026|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14132027|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14132028|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
14132029|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132030|NCT05112211|Doxycycline|doxycycline|mesh-list
14132031|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14132032|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132033|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
14132034|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14132035|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14132036|NCT05111717|Desflurane|desflurane|mesh-list
14132037|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14132038|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
14132039|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
14132040|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14132041|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132042|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14132043|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
14132044|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132045|NCT05077488|Lidocaine|lidocaine|mesh-list
14132046|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
14132047|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
14132048|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14132049|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132050|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
14132051|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132052|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14132053|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14132054|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14132055|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14132056|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132057|NCT05073484|Antibodies|antibodies|mesh-list
14132058|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
14132059|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
14132060|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177550|NCT04755062|Micronutrients|micronutrients|mesh-list
14177551|NCT04755062|Trace Elements|trace elements|mesh-list
14177552|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177553|NCT04755218|Misoprostol|misoprostol|mesh-list
14177554|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14177555|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
14177556|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177557|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177558|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14177559|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177560|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
14183791|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183792|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183793|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14183794|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14183795|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
14183796|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948912|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
13948913|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13948914|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13948915|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13948916|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
13948917|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948918|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948919|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183797|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183798|NCT04725253|Niacinamide|niacinamide|mesh-list
14183799|NCT04725253|Niacin|niacin|mesh-list
14183800|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
14183801|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
14183802|NCT04725253|Vitamins|vitamins|mesh-ancestor
14183803|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
14183804|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183805|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14183806|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
13948920|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13948921|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13948922|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14132061|NCT05230303|Caffeine|caffeine|mesh-list
14132062|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14132063|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132064|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14132065|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132066|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132067|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14132068|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14132069|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
13948923|NCT03235245|Nivolumab|nivolumab|mesh-list
13948924|NCT03235245|Ipilimumab|ipilimumab|mesh-list
14132070|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132071|NCT05229991|Ritonavir|ritonavir|mesh-list
14132072|NCT05229991|Lonafarnib|lonafarnib|mesh-list
14132073|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14132074|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14132075|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
14132076|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132077|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132078|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14132079|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14132080|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
14132081|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132082|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14132083|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14132084|NCT05229913|Esketamine|esketamine|mesh-list
14132085|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
13948925|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13948926|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948927|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13948928|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948929|NCT03235037|Levodopa|levodopa|mesh-list
13948930|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13948931|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13948932|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
13948933|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948934|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948935|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948936|NCT03235141|Azithromycin|azithromycin|mesh-list
13948937|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14132086|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14132087|NCT05229796|Empagliflozin|empagliflozin|mesh-list
14132088|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13948938|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948939|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948940|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13948941|NCT03234816|Norepinephrine|norepinephrine|mesh-list
13948942|NCT03234816|Bupivacaine|bupivacaine|mesh-list
13948943|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
13948944|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
14132089|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132090|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132091|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948945|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13948946|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948947|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
13948948|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13948949|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13948950|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13948951|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
13948952|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13948953|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948954|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
13948955|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
13948956|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13948957|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
13948958|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
13948959|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948960|NCT03234842|Paclitaxel|paclitaxel|mesh-list
14132092|NCT05229627|Methylphenidate|methylphenidate|mesh-list
14132093|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14177561|NCT04754945|Dexamethasone|dexamethasone|mesh-list
13948961|NCT03234842|Carboplatin|carboplatin|mesh-list
13948962|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13948963|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13948964|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
13948965|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
13948966|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
13948967|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948968|NCT03234673|Calcipotriene|calcipotriene|mesh-list
14132094|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14132095|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132096|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14132097|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14132098|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14132099|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132100|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
14132101|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132102|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14132103|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132104|NCT05229536|Vaccines|vaccines|mesh-list
14132105|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
14132106|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132107|NCT05229510|Ribavirin|ribavirin|mesh-list
14132108|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
14132109|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132110|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
14132111|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132112|NCT05229497|Carboplatin|carboplatin|mesh-list
14132113|NCT05229497|Fluorouracil|fluorouracil|mesh-list
14132114|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132115|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
14132116|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132117|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132118|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132119|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
14132120|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132121|NCT05229276|Bone wax|bone wax|mesh-list
14132122|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
13948969|NCT03234673|Tacrolimus|tacrolimus|mesh-list
13948970|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13948971|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
13948972|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948973|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13948974|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948975|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948976|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
13948977|NCT03234517|Clindamycin|clindamycin|mesh-list
13948978|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
13948979|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
13948980|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13948981|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13948982|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13948983|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948984|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13948985|NCT03234491|Insulin|insulin|mesh-list
13948986|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13948987|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13948988|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962574|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962575|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
13962576|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962577|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
13962578|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132123|NCT05229276|Coagulants|coagulants|mesh-ancestor
14132124|NCT05229042|Ricolinostat|ricolinostat|mesh-list
14132125|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132126|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14132127|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132128|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132129|NCT05228951|Trastuzumab|trastuzumab|mesh-list
14132130|NCT05228951|Letrozole|letrozole|mesh-list
14132131|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132132|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132133|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14132134|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14132135|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13948989|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
13948990|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
14132136|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132137|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14132138|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
14132139|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14132140|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132141|NCT05228925|Vitamin D|vitamin d|mesh-list
14132142|NCT05228925|Vitamins|vitamins|mesh-ancestor
14132143|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
14132144|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132145|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14132146|NCT05228743|Paclitaxel|paclitaxel|mesh-list
14132147|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14132148|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132149|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
14132150|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132151|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132152|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132153|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
14132154|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14132155|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132156|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
14132157|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14132158|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14132159|NCT05228431|Capecitabine|capecitabine|mesh-list
14132160|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132161|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
14132162|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132163|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132164|NCT05228418|Naltrexone|naltrexone|mesh-list
14132165|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14132166|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14132167|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132168|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
14132169|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132179|NCT05228249|Cytarabine|cytarabine|mesh-list
14132180|NCT05228249|Etoposide|etoposide|mesh-list
14132181|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
14132182|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
14132183|NCT05228249|Melphalan|melphalan|mesh-list
14132184|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
13948991|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13948992|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13948993|NCT03234244|Vitamins|vitamins|mesh-ancestor
13948994|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
13948995|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13948996|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13948997|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13948998|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
13948999|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949000|NCT03234699|Midazolam|midazolam|mesh-list
13949001|NCT03234699|Cenobamate|cenobamate|mesh-list
13949002|NCT03234699|Bupropion|bupropion|mesh-list
13949003|NCT03234699|Omeprazole|omeprazole|mesh-list
13949004|NCT03234699|Warfarin|warfarin|mesh-list
13949005|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13949006|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13949007|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949008|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949009|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13949010|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13949011|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14132185|NCT05228249|Carmustine|carmustine|mesh-list
14132186|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13949012|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13949013|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
14132187|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14132188|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14132189|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132190|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14132191|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13949014|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
13949015|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
13949016|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
13949017|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949018|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949019|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
13949020|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13949021|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949022|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13949023|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949024|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13949025|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
13949026|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13949027|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13949028|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949029|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
13949030|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13949031|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14132192|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132193|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132194|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132195|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
14132196|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
13949032|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
13949033|NCT03234400|Dapivirine|dapivirine|mesh-list
13949034|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13949035|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13949036|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
13949037|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949038|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
13949039|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13949040|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13949041|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13949042|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949043|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949044|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
13949045|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132197|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132198|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132199|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
14132200|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132201|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14132202|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
14132203|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14132204|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
14132205|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
14132206|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
13949046|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949047|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13949048|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949049|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
13949050|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13949051|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949052|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949053|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13949054|NCT03234660|Analgesics|analgesics|mesh-ancestor
13949055|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
13949056|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949057|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13949058|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13949059|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13949060|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
13949061|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949062|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949063|NCT03234296|Metronidazole|metronidazole|mesh-list
13949064|NCT03234296|Levofloxacin|levofloxacin|mesh-list
13949065|NCT03234296|Ertapenem|ertapenem|mesh-list
14132207|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
13949066|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949067|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14132208|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132209|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14177562|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
14177563|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
14177564|NCT04754945|Bortezomib|bortezomib|mesh-list
14177565|NCT04754945|Ichthammol|ichthammol|mesh-list
14177566|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14177567|NCT04754945|BB 1101|bb 1101|mesh-list
14177568|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177569|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
14936838|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13949068|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14177570|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177571|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177572|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14177573|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
14177574|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177575|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177576|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14177577|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14177578|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
14177579|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
14177580|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177581|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177582|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
14177583|NCT04754945|Hormones|hormones|mesh-ancestor
14177584|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177585|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14177586|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
13949069|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13949070|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13949071|NCT03234296|Renal Agents|renal agents|mesh-ancestor
13949072|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13949073|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13949074|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949075|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949076|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949077|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13949078|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13949079|NCT03234387|Acetylcholine|acetylcholine|mesh-list
14177587|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177588|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
14177589|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14177590|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14177591|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14177592|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14177593|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177594|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
14177595|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14177596|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177597|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177598|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14177599|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177600|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177601|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
14177602|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177603|NCT04754763|Propolis|propolis|mesh-list
14177604|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177605|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14177606|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14177607|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14177608|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177609|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177610|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949080|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949081|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
13949082|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13949083|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
13949084|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949085|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949086|NCT03233828|Aldesleukin|aldesleukin|mesh-list
13949087|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949088|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14132210|NCT05222256|Simendan|simendan|mesh-list
14132211|NCT05222256|Epinephrine|epinephrine|mesh-list
13949089|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13949090|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
13949091|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949092|NCT03234062|Choline|choline|mesh-list
13949093|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
14132212|NCT05222256|Racepinephrine|racepinephrine|mesh-list
14132213|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
14132214|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14132215|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14132216|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132217|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132218|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132219|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949094|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13949095|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
13949096|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949097|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14132220|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14132221|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14132222|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
14132223|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132224|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13949098|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13949099|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
13949100|NCT03233932|Leuprolide|leuprolide|mesh-list
13949101|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13949102|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
13949103|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13949104|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949105|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13949106|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949107|NCT03233880|Azithromycin|azithromycin|mesh-list
13949108|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13949109|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949110|NCT03233815|Propofol|propofol|mesh-list
13949111|NCT03233815|Sevoflurane|sevoflurane|mesh-list
14132225|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14132226|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
14132227|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
14132228|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14132229|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14132230|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
14132231|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14132232|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14132233|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132234|NCT05222256|Protective Agents|protective agents|mesh-ancestor
14132235|NCT05220410|Psilocybin|psilocybin|mesh-list
14132236|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
14132237|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132238|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14132239|NCT05207644|Letrozole|letrozole|mesh-list
14132240|NCT05207644|Misoprostol|misoprostol|mesh-list
14132241|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132242|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14132243|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14132244|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132245|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132246|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14132247|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
14132248|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14132249|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132250|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14132251|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
14132252|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14132253|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14132254|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14132255|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
14132256|NCT05206877|Insulin|insulin|mesh-list
14132257|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14132258|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132259|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949112|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13949113|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949114|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132260|NCT05188053|Ketorolac|ketorolac|mesh-list
14132261|NCT05188053|Epinephrine|epinephrine|mesh-list
13949115|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13949116|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
13949117|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
13949118|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13949119|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13949120|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
13949121|NCT03233893|Calcium|calcium|mesh-list
13949122|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14132262|NCT05188053|Ropivacaine|ropivacaine|mesh-list
14132263|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
14132264|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
14132265|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14132266|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132267|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
14132268|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132269|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14132270|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14132271|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132272|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132273|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132274|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14132275|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14132276|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
14132277|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14132278|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
14132279|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
14132280|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
14132281|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14132282|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14132283|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14132284|NCT05188053|Analgesics|analgesics|mesh-ancestor
14132285|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132286|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132287|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14132288|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132289|NCT05183412|Methamphetamine|methamphetamine|mesh-list
14132290|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14132291|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132292|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
14132293|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
14132294|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132295|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
14132296|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132297|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132298|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132299|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14132300|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13949123|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949124|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13949125|NCT03234153|Durvalumab|durvalumab|mesh-list
13949126|NCT03234153|Tremelimumab|tremelimumab|mesh-list
13949127|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
13949128|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13949129|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949130|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949131|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13949132|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949133|NCT03233750|Vaccines|vaccines|mesh-list
13949134|NCT03233750|Immunologic Factors|immunologic factors|mesh-ancestor
14132301|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14132302|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14132303|NCT05174858|Hemostatics|hemostatics|mesh-list
14132304|NCT05174858|Coagulants|coagulants|mesh-ancestor
14132305|NCT05174039|Miglustat|miglustat|mesh-list
14132306|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132307|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949135|NCT03233750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949136|NCT03233321|Heparin|heparin|mesh-list
14132308|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14132309|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14132310|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
14132311|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132312|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14132313|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132314|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132315|NCT05168683|Rasburicase|rasburicase|mesh-list
14132316|NCT05168683|Uric Acid|uric acid|mesh-list
14132317|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
14132318|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132319|NCT05168683|Protective Agents|protective agents|mesh-ancestor
14132320|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132321|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
14132322|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132323|NCT05136326|Capecitabine|capecitabine|mesh-list
14132324|NCT05136326|Temozolomide|temozolomide|mesh-list
14132325|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132326|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
14132327|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132328|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132329|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14132330|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
14132331|NCT05121974|Azithromycin|azithromycin|mesh-list
14132332|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
14132333|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14132334|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132335|NCT05102149|Vildagliptin|vildagliptin|mesh-list
14132336|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132337|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132338|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14132339|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
14132340|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132341|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132342|NCT05060991|Antimetabolites|antimetabolites|mesh-list
14132343|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132344|NCT05057247|Docetaxel|docetaxel|mesh-list
14132345|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132346|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
14132347|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132348|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132349|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949137|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13949138|NCT03233321|Tinzaparin|tinzaparin|mesh-list
13949139|NCT03233321|Dalteparin|dalteparin|mesh-list
13949140|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
13949141|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13949142|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13949143|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949144|NCT03233412|Imiquimod|imiquimod|mesh-list
13949145|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13949146|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
13949147|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132350|NCT05036421|Empagliflozin|empagliflozin|mesh-list
14132351|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14763664|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
14763665|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14763666|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14763667|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14763668|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14763669|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763670|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14763671|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
14763672|NCT00612287|Buprenorphine|buprenorphine|mesh-list
13949148|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132352|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763673|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14132353|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13949149|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
14132354|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132355|NCT05035186|Amoxicillin|amoxicillin|mesh-list
14132356|NCT05035186|Clarithromycin|clarithromycin|mesh-list
14132357|NCT05035186|Levofloxacin|levofloxacin|mesh-list
14132358|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14132359|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132360|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14132361|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132362|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132363|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14132364|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14132365|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14132366|NCT05035186|Renal Agents|renal agents|mesh-ancestor
14132367|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14132368|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14132369|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132370|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14132371|NCT04987099|Choline|choline|mesh-list
14132372|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
14132373|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14132374|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
14132375|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132376|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14132377|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14132378|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
14132379|NCT04968015|Cytarabine|cytarabine|mesh-list
14132380|NCT04968015|Venetoclax|venetoclax|mesh-list
14132381|NCT04968015|Idarubicin|idarubicin|mesh-list
14132382|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132383|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
14132384|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132385|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949150|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13949151|NCT03233347|Nivolumab|nivolumab|mesh-list
13949152|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14132386|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
14132387|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132388|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13949153|NCT03233347|Doxorubicin|doxorubicin|mesh-list
13949154|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13949155|NCT03233347|Daunorubicin|daunorubicin|mesh-list
13949156|NCT03233347|Dacarbazine|dacarbazine|mesh-list
13949157|NCT03233347|Vinblastine|vinblastine|mesh-list
13949158|NCT03233347|Antibodies|antibodies|mesh-list
13949159|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
13949160|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13949161|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
13949162|NCT03233347|Imidazole|imidazole|mesh-list
13949163|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
13949164|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132389|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
14132390|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132391|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13949165|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949166|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13949167|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13949168|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13949169|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132392|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14132393|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14132394|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132395|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
14132396|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14763674|NCT00612287|Narcotics|narcotics|mesh-ancestor
13949170|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949171|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13949172|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13949173|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
13949174|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763675|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763676|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763677|NCT00612287|Analgesics|analgesics|mesh-ancestor
13949175|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
13949176|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132397|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949177|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
13949178|NCT03233295|Vitamin D|vitamin d|mesh-list
13949179|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
13949180|NCT03233295|Vitamins|vitamins|mesh-ancestor
13949181|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
14132398|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132399|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177611|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14177612|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14177613|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
14177614|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177615|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177616|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14177617|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14177618|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
14763678|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
14763679|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763680|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14763681|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
14763682|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14177619|NCT04754789|Aspirin|aspirin|mesh-list
14177620|NCT04754789|Ticagrelor|ticagrelor|mesh-list
14177621|NCT04754789|Atorvastatin|atorvastatin|mesh-list
14177622|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14177623|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14177624|NCT04754789|Analgesics|analgesics|mesh-ancestor
14177625|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
14177626|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177627|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177628|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14177629|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949182|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949183|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13949184|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14177630|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14177631|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14177632|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177633|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14177634|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14177635|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177636|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
14177637|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14177638|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14177639|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
14177640|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14177641|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14177642|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14177643|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14177644|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14177645|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
14177646|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177647|NCT04754399|Cannabidiol|cannabidiol|mesh-list
14177648|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
14177649|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
14177650|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14177651|NCT04753918|Trioxsalen|trioxsalen|mesh-list
14177652|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177653|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
14177654|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14177655|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
14177656|NCT04753723|Gentamicins|gentamicins|mesh-list
14177657|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14177658|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177659|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14177660|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177661|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177662|NCT04753515|Midazolam|midazolam|mesh-list
14177663|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
14177664|NCT04753515|Remifentanil|remifentanil|mesh-list
14177665|NCT04753515|Propofol|propofol|mesh-list
14177666|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14177667|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763683|NCT00612469|Listerine|listerine|mesh-list
14177668|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177669|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13949185|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14763684|NCT00612469|Vancomycin|vancomycin|mesh-list
14132400|NCT04884035|Prednisone|prednisone|mesh-list
14132401|NCT04884035|Prednisolone|prednisolone|mesh-list
14132402|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
14132403|NCT04884035|Rituximab|rituximab|mesh-list
14132404|NCT04884035|Doxorubicin|doxorubicin|mesh-list
14132405|NCT04884035|Vincristine|vincristine|mesh-list
14132406|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132407|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
14132408|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132409|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132410|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14132411|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
14132412|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132413|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132414|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14132415|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13949186|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13949187|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13949188|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
13949189|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949190|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13949191|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13949192|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949193|NCT03233152|Nivolumab|nivolumab|mesh-list
13949194|NCT03233152|Ipilimumab|ipilimumab|mesh-list
13949195|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13949196|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13949197|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949198|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13949199|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949200|NCT03233035|Ketamine|ketamine|mesh-list
13949201|NCT03233035|Analgesics|analgesics|mesh-ancestor
13949202|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
13949203|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949204|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949205|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13949206|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13949207|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
13949208|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
13949209|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949210|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13949211|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13949212|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949213|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949214|NCT03232918|Oxytocin|oxytocin|mesh-list
13949215|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
13949216|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13949217|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949218|NCT03232957|Morphine|morphine|mesh-list
13949219|NCT03232957|Bupivacaine|bupivacaine|mesh-list
13949220|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
13949221|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
13949222|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949223|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132416|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14132417|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14132418|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14132419|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132420|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132421|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
14132422|NCT04884035|Hormones|hormones|mesh-ancestor
14132423|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14132424|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14132425|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14132426|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
14132427|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132428|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132429|NCT04848688|Ivermectin|ivermectin|mesh-list
14132430|NCT04848688|Moxidectin|moxidectin|mesh-list
14132431|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13949224|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
14132432|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132433|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
14132434|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
13949225|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949226|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13949227|NCT03232957|Narcotics|narcotics|mesh-ancestor
13949228|NCT03232957|Analgesics|analgesics|mesh-ancestor
13962579|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13962580|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13962581|NCT04356638|Midazolam|midazolam|mesh-list
13962582|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
13962583|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14132435|NCT04840589|Nivolumab|nivolumab|mesh-list
14132436|NCT04840589|Ipilimumab|ipilimumab|mesh-list
14132437|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132438|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132439|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14132440|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132441|NCT04833946|Andrographolide|andrographolide|mesh-list
14132442|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132443|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14132444|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14132445|NCT04833946|Analgesics|analgesics|mesh-ancestor
14132446|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
14132447|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132448|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132449|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132450|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14132451|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14132452|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132453|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
14132454|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14132455|NCT04804540|Vedolizumab|vedolizumab|mesh-list
14132456|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14132457|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14132458|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
14132459|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14132460|NCT04795869|Antibodies|antibodies|mesh-list
14132461|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
14132462|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13962584|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962585|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962586|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13962587|NCT04356638|Analgesics|analgesics|mesh-ancestor
13962588|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
13962589|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962590|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13962591|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13962592|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13962593|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962594|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962595|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132463|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
14132464|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
14132465|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132466|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132467|NCT04772209|Heparin|heparin|mesh-list
14132468|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
14132469|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14763685|NCT00612469|Fluorides|fluorides|mesh-list
14132470|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14132471|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949229|NCT03232632|Flutemetamol|flutemetamol|mesh-list
13949230|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13949231|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949232|NCT03232710|Aripiprazole|aripiprazole|mesh-list
14763686|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
14763687|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
14478466|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478467|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14478468|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14478469|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14478470|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14478471|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478472|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478473|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
14478474|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
14478475|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
14132472|NCT04746495|Eplerenone|eplerenone|mesh-list
14132473|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14132474|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
14132475|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14132476|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132477|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14132478|NCT04746495|Diuretics|diuretics|mesh-ancestor
14132479|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
14132480|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14132481|NCT04701424|Insulin|insulin|mesh-list
14132482|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132483|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478476|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132484|NCT04680988|Gemcitabine|gemcitabine|mesh-list
14132485|NCT04680988|Paclitaxel|paclitaxel|mesh-list
14132486|NCT04680988|Pemetrexed|pemetrexed|mesh-list
14132487|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14132488|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14132489|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132490|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
14132491|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132492|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132493|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132494|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132495|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
14132496|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
14132497|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132498|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132499|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132500|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
13949233|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
13949234|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949235|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14132501|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132502|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13949236|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13949237|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949238|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949239|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
13949240|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
13949241|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949242|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949243|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13949244|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13949245|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
13949246|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13949247|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13949248|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13949249|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14132503|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14132504|NCT04582591|Cannabidiol|cannabidiol|mesh-list
14132505|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
14132506|NCT04542200|Antibodies|antibodies|mesh-list
14132507|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
14132508|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478477|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
14478478|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
14132509|NCT04538534|Nicardipine|nicardipine|mesh-list
14132510|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14132511|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14132512|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14132513|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132514|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14132515|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132516|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
14132517|NCT04529538|Vaccines|vaccines|mesh-list
14132518|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
14132519|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132520|NCT04497883|Maribavir|maribavir|mesh-list
14132521|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
14132522|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177670|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
14177671|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
14177672|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14177673|NCT04753515|Analgesics|analgesics|mesh-ancestor
14177674|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
14177675|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177676|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14177677|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14177678|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14177679|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177680|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177681|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177682|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14177683|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14177684|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14177685|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14177686|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
14177687|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
14177688|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14177689|NCT04753515|Narcotics|narcotics|mesh-ancestor
14177690|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
14177691|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14177692|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
14177693|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14177694|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
14177695|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177696|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177697|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
14177698|NCT04753619|Niclosamide|niclosamide|mesh-list
14177699|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
14177700|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14177701|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
14177702|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14177703|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177704|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
14177705|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
14177706|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14177707|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14177708|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177709|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
14177710|NCT04753151|Coagulants|coagulants|mesh-ancestor
14177711|NCT04753112|Valsartan|valsartan|mesh-list
14177712|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14177713|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14177714|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14177715|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14177716|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949250|NCT03232554|Iron|iron|mesh-list
13949251|NCT03232554|Trace Elements|trace elements|mesh-ancestor
13949252|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
13949253|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949254|NCT03232450|Aspirin|aspirin|mesh-list
13949255|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13949256|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13949257|NCT03232450|Analgesics|analgesics|mesh-ancestor
13949258|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
13949259|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949260|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949261|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13949262|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949263|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14177717|NCT04753203|Capecitabine|capecitabine|mesh-list
14177718|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13949264|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14132523|NCT04441762|Ketorolac|ketorolac|mesh-list
14132524|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14132525|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13949265|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949266|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13949267|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13949268|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949269|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
13949270|NCT03232424|Temozolomide|temozolomide|mesh-list
13949271|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13949272|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
13949273|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949274|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949275|NCT03232398|Warfarin|warfarin|mesh-list
13949276|NCT03232398|Apixaban|apixaban|mesh-list
13949277|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
13949278|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13949279|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
13949280|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13949281|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
13949282|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949283|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949284|NCT03232307|Dexamethasone|dexamethasone|mesh-list
13949285|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
13949286|NCT03232307|Rituximab|rituximab|mesh-list
13949287|NCT03232307|Lenalidomide|lenalidomide|mesh-list
13949288|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13949289|NCT03232307|Antibodies|antibodies|mesh-list
13949290|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
13949291|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14132526|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14132527|NCT04441762|Analgesics|analgesics|mesh-ancestor
14132528|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
14132529|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132530|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132531|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132532|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132533|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14132534|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132535|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132536|NCT04412694|Dexamethasone|dexamethasone|mesh-list
14132537|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
14132538|NCT04412694|BB 1101|bb 1101|mesh-list
14132539|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132540|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
14132541|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
14132542|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132543|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132544|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14132545|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
14132546|NCT04412694|Hormones|hormones|mesh-ancestor
14132547|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14132548|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14132549|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132550|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
14132551|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132552|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132553|NCT04351438|Heparin|heparin|mesh-list
14132554|NCT04351438|Citric Acid|citric acid|mesh-list
14132555|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
14132556|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
14132557|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14132558|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
14132559|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
13949292|NCT03232307|BB 1101|bb 1101|mesh-list
13949293|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
13949294|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949295|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13949296|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
14132560|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132561|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14478479|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949297|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
13949298|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132562|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14132563|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14132564|NCT04278651|Hematinics|hematinics|mesh-ancestor
13949299|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949300|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
13949301|NCT03232307|Hormones|hormones|mesh-ancestor
13949302|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949303|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13949304|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949305|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949306|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13949307|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13949308|NCT03232307|Growth Substances|growth substances|mesh-ancestor
13949309|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
13949310|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
13949311|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949312|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949313|NCT03232346|Buprenorphine|buprenorphine|mesh-list
13949314|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13949315|NCT03232346|Narcotics|narcotics|mesh-ancestor
13949316|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949317|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949318|NCT03232346|Analgesics|analgesics|mesh-ancestor
14132565|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14132566|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14132567|NCT04270643|Vitamin D|vitamin d|mesh-list
14132568|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
14132569|NCT04270643|Vitamins|vitamins|mesh-ancestor
14132570|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
14132571|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132572|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14132573|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14132574|NCT04266275|Curcumin|curcumin|mesh-list
14132575|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14132576|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14132577|NCT04266275|Analgesics|analgesics|mesh-ancestor
14132578|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
14132579|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132580|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132581|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132582|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132583|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132584|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132585|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132586|NCT04203498|Nabiximols|nabiximols|mesh-list
14132587|NCT04203498|Analgesics|analgesics|mesh-ancestor
14132588|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
14132589|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132590|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132591|NCT04200248|Aflibercept|aflibercept|mesh-list
14132592|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14132593|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14132594|NCT04200248|Growth Substances|growth substances|mesh-ancestor
14132595|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132596|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
14132597|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132598|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
14132599|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949319|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
13949320|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949321|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13949322|NCT03232216|Vitamin D|vitamin d|mesh-list
13949323|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
13949324|NCT03232216|Vitamins|vitamins|mesh-ancestor
13949325|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
13949326|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949327|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13949328|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13949329|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13949330|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13949331|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949332|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949333|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13949334|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13962596|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14132600|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
14132601|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14132602|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14132603|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132604|NCT04169191|Urological Agents|urological agents|mesh-ancestor
14132605|NCT04164732|Valsartan|valsartan|mesh-list
14132606|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14132607|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14132608|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14132609|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14132610|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132611|NCT04138615|Morphine|morphine|mesh-list
14132612|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14132613|NCT04138615|Narcotics|narcotics|mesh-ancestor
14132614|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14132615|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132616|NCT04138615|Analgesics|analgesics|mesh-ancestor
14132617|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
14132618|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132619|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14132620|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
14132621|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132622|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132623|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
14132624|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478480|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14478481|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
13949335|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132625|NCT04091750|Nivolumab|nivolumab|mesh-list
14132626|NCT04091750|Ipilimumab|ipilimumab|mesh-list
14132627|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13949336|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
13949337|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949338|NCT03231982|Amlodipine|amlodipine|mesh-list
13949339|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13949340|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14132628|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132629|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14132630|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132631|NCT04084314|Erenumab|erenumab|mesh-list
14132632|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14132633|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132634|NCT04084314|Analgesics|analgesics|mesh-ancestor
14132635|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
14132636|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132637|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132638|NCT04082728|Dipyrone|dipyrone|mesh-list
14132639|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14132640|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14132641|NCT04082728|Analgesics|analgesics|mesh-ancestor
14132642|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
14132643|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132644|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132645|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14132646|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132647|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
14132648|NCT04049786|Metoprolol|metoprolol|mesh-list
14132649|NCT04049786|Carvedilol|carvedilol|mesh-list
14132650|NCT04049786|Midazolam|midazolam|mesh-list
14132651|NCT04049786|Simvastatin|simvastatin|mesh-list
14132652|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14132653|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14132654|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14132655|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132656|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14132657|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14132658|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949341|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949342|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478482|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
13949343|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13949344|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949345|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
13949346|NCT03232034|Calcium|calcium|mesh-list
14478483|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478484|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14132659|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14132660|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
14132661|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
14132662|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
14132663|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
14132664|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132665|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132666|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13949347|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13949348|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949349|NCT03232125|Ramosetron|ramosetron|mesh-list
13949350|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
13949351|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
13949352|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949353|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132667|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14132668|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
14132669|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14132670|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14132671|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132672|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14132673|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14132674|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
14132675|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
14132676|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132677|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14132678|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14132679|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14132680|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132681|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
13949354|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949355|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13949356|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
13949357|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949358|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949359|NCT03232021|Pregabalin|pregabalin|mesh-list
13949360|NCT03232021|Analgesics|analgesics|mesh-ancestor
13949361|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
13949362|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949363|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949364|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
13949365|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13949366|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949367|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949368|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13949369|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13949370|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13949371|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949372|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949373|NCT03232112|Exenatide|exenatide|mesh-list
13949374|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13949375|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949376|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13949377|NCT03232112|Incretins|incretins|mesh-ancestor
13949378|NCT03232112|Hormones|hormones|mesh-ancestor
13949379|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949380|NCT03231722|Leucovorin|leucovorin|mesh-list
13949381|NCT03231722|Fluorouracil|fluorouracil|mesh-list
13949382|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
13949383|NCT03231722|Irinotecan|irinotecan|mesh-list
13949384|NCT03231722|Panitumumab|panitumumab|mesh-list
13949385|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
13949386|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
13949387|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949388|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13949389|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949390|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132682|NCT04049786|Protective Agents|protective agents|mesh-ancestor
14132683|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14132684|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949391|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
14132685|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13949392|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949393|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13949394|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13949395|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949396|NCT03231722|Antidotes|antidotes|mesh-ancestor
13949397|NCT03231722|Protective Agents|protective agents|mesh-ancestor
13949398|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
13949399|NCT03231722|Vitamins|vitamins|mesh-ancestor
13949400|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
13949401|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132686|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
14132687|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14132688|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14132689|NCT04045613|Atezolizumab|atezolizumab|mesh-list
14132690|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14132691|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132692|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
14132693|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132694|NCT04034238|Tofacitinib|tofacitinib|mesh-list
14132695|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14132696|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132697|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132698|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
14132699|NCT04023253|Mirabegron|mirabegron|mesh-list
14132700|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14132701|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14132702|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
14132703|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132704|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132705|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132706|NCT04023253|Urological Agents|urological agents|mesh-ancestor
14132707|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14132708|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14132709|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14132710|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132711|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
14132712|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14132713|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
14132714|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132715|NCT04005053|Expectorants|expectorants|mesh-ancestor
14132716|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
14132717|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14132718|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
14132719|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949402|NCT03231813|Emollients|emollients|mesh-list
13949403|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
13949404|NCT03231683|Ketamine|ketamine|mesh-list
13949405|NCT03231683|Remifentanil|remifentanil|mesh-list
13949406|NCT03231683|Propofol|propofol|mesh-list
13949407|NCT03231683|Esketamine|esketamine|mesh-list
13949408|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13949409|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949410|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949411|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13949412|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
13949413|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
13949414|NCT03231683|Analgesics|analgesics|mesh-ancestor
13949415|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
13949416|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949417|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13949418|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14132720|NCT04005053|Protective Agents|protective agents|mesh-ancestor
14132721|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132722|NCT04005053|Antidotes|antidotes|mesh-ancestor
14132723|NCT03970382|Aldesleukin|aldesleukin|mesh-list
14132724|NCT03970382|Nivolumab|nivolumab|mesh-list
14132725|NCT03970382|Interleukin-2|interleukin-2|mesh-list
14132726|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132727|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132728|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14132729|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132730|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13949419|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13949420|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132731|NCT03970382|Analgesics|analgesics|mesh-ancestor
13949421|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177719|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
13949422|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13949423|NCT03231683|Narcotics|narcotics|mesh-ancestor
13949424|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
13949425|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949426|NCT03231436|Bupivacaine|bupivacaine|mesh-list
13949427|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
14132732|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
14132733|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132734|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132735|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14132736|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14132737|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
14132738|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132739|NCT03952143|Insulin|insulin|mesh-list
14132740|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14132741|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
14132742|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
14132743|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132744|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132745|NCT03934372|Ponatinib|ponatinib|mesh-list
14132746|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132747|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14132748|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132749|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132750|NCT03932643|TIC10 compound|tic10 compound|mesh-list
14132751|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132752|NCT03931642|Blinatumomab|blinatumomab|mesh-list
14132753|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132754|NCT03930953|Rituximab|rituximab|mesh-list
14132755|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
14132756|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132757|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132758|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
14132759|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132760|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132761|NCT03915769|Ozanimod|ozanimod|mesh-list
14132762|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14132763|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132764|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132765|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
14132766|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132767|NCT03863288|Oxytocin|oxytocin|mesh-list
14132768|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
14132769|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14132770|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177720|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177721|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177722|NCT04753177|Paclitaxel|paclitaxel|mesh-list
14177723|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
14177724|NCT04753177|Doxorubicin|doxorubicin|mesh-list
14177725|NCT04753177|Fulvestrant|fulvestrant|mesh-list
14177726|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14177727|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14177728|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177729|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
13949428|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
14478485|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
14478486|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
14478487|NCT02452762|Vitamin D|vitamin d|mesh-list
13949429|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949430|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177730|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
14177731|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
14478488|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
14478489|NCT02452762|Vitamins|vitamins|mesh-ancestor
13949431|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
13962597|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14132771|NCT03829514|Fenofibrate|fenofibrate|mesh-list
14132772|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14132773|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
14132774|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132775|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14132776|NCT03808090|Calcium|calcium|mesh-list
14132777|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14132778|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132779|NCT03801200|Apatinib|apatinib|mesh-list
14132780|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132781|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14132782|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132783|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132784|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
14132785|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14132786|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14132787|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132788|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
14132789|NCT03801122|Coagulants|coagulants|mesh-ancestor
14132790|NCT03788291|Rituximab|rituximab|mesh-list
14132791|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
14132792|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132793|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949432|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949433|NCT03231176|Capecitabine|capecitabine|mesh-list
13949434|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13949435|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
13949436|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949437|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949438|NCT03231215|Dexamethasone|dexamethasone|mesh-list
13949439|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13949440|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
13949441|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
13949442|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949443|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949444|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949445|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
13949446|NCT03231215|Hormones|hormones|mesh-ancestor
13949447|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949448|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13949449|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962598|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13962599|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13962600|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13962601|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
13962602|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
13962603|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
13962604|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
13962605|NCT04352608|Vaccines|vaccines|mesh-list
13962606|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
13962607|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962608|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
13962609|NCT04346108|Antibodies|antibodies|mesh-list
13962610|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
13962611|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13962612|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13962613|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
13962614|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
13962615|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962616|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
13962617|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962618|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962619|NCT04305405|Benralizumab|benralizumab|mesh-list
13962620|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13962621|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
14132794|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
14132795|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132796|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14132797|NCT03785405|Valsartan|valsartan|mesh-list
14132798|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14132799|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14132800|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14132801|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132802|NCT03771157|Vaccines|vaccines|mesh-list
13962622|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13962623|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962624|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
14132803|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
14132804|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132805|NCT03752918|Niacin|niacin|mesh-list
14132806|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
14132807|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
13949450|NCT03231033|Pioglitazone|pioglitazone|mesh-list
13949451|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13949452|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949453|NCT03230786|Metformin|metformin|mesh-list
13949454|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13949455|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132808|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14132809|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
14132810|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949456|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
13949457|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
13949458|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13949459|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949460|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13949461|NCT03230851|Aspirin|aspirin|mesh-list
13949462|NCT03230851|Indobufen|indobufen|mesh-list
13949463|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13949464|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13949465|NCT03230851|Analgesics|analgesics|mesh-ancestor
13949466|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
13949467|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949468|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949469|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13949470|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949471|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13949472|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14132811|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14132812|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
14132813|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
14132814|NCT03752918|Vitamins|vitamins|mesh-ancestor
14132815|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
14132816|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132817|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
14132818|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14132819|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
14132820|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132821|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14132822|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14132823|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14132824|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132825|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14132826|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14132827|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
14132828|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132829|NCT03716180|Paclitaxel|paclitaxel|mesh-list
14132830|NCT03716180|Trastuzumab|trastuzumab|mesh-list
14132831|NCT03716180|Pertuzumab|pertuzumab|mesh-list
14132832|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14132833|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132834|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
14132835|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132836|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132837|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132838|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132839|NCT03713801|Metformin|metformin|mesh-list
14132840|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132841|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132842|NCT03704688|Trametinib|trametinib|mesh-list
14132843|NCT03704688|Ponatinib|ponatinib|mesh-list
14132844|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132845|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14132846|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132847|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132848|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
14132849|NCT03684213|Norepinephrine|norepinephrine|mesh-list
14132850|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
14132851|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
14132852|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132853|NCT03684213|Protective Agents|protective agents|mesh-ancestor
13949473|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949474|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14132854|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132855|NCT03684213|Vitamins|vitamins|mesh-ancestor
14132856|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
14478490|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
14478491|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478492|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14478493|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14478494|NCT02452866|Secnidazole|secnidazole|mesh-list
14132857|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14132858|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14132859|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
14132860|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132861|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
13949475|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13949476|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949477|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
13949478|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
13949479|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949480|NCT03230630|Melatonin|melatonin|mesh-list
13949481|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
13949482|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949483|NCT03230630|Protective Agents|protective agents|mesh-ancestor
13949484|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949485|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949486|NCT03230734|Docetaxel|docetaxel|mesh-list
13949487|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949488|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
13949489|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14132862|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
14132863|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132864|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14132865|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132866|NCT03679780|Nitroprusside|nitroprusside|mesh-list
13949490|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
13949491|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949492|NCT03230604|Z 350|z 350|mesh-list
13949493|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
13949494|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13949495|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949496|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132867|NCT03679780|BQ 788|bq 788|mesh-list
14132868|NCT03679780|Nitroarginine|nitroarginine|mesh-list
14132869|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
14132870|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14132871|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
14132872|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14132873|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132874|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14132875|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14132876|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949497|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
13949498|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949499|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949500|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
13949501|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14132877|NCT03672773|Temozolomide|temozolomide|mesh-list
14132878|NCT03672773|Talazoparib|talazoparib|mesh-list
14132879|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14132880|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
14132881|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132882|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132883|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14132884|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132885|NCT03667690|Fluconazole|fluconazole|mesh-list
13949502|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
13949503|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13949504|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949505|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13949506|NCT03230565|Ropivacaine|ropivacaine|mesh-list
13949507|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
13949508|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
13949509|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14132886|NCT03667690|Caspofungin|caspofungin|mesh-list
14132887|NCT03667690|Rezafungin|rezafungin|mesh-list
14132888|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
14478495|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14132889|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132890|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14132891|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14132892|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132893|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132894|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14132895|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
14132896|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14132897|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132898|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14132899|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14132900|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14132901|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132902|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132903|NCT03624101|Ivacaftor|ivacaftor|mesh-list
14132904|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14132905|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14132906|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132907|NCT03600350|Nivolumab|nivolumab|mesh-list
14132908|NCT03600350|Sargramostim|sargramostim|mesh-list
14132909|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132910|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132911|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14132912|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132913|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
14132914|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132915|NCT03598270|Gemcitabine|gemcitabine|mesh-list
14132916|NCT03598270|Paclitaxel|paclitaxel|mesh-list
14132917|NCT03598270|Carboplatin|carboplatin|mesh-list
14132918|NCT03598270|Doxorubicin|doxorubicin|mesh-list
14132919|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14132920|NCT03598270|Atezolizumab|atezolizumab|mesh-list
14132921|NCT03598270|Niraparib|niraparib|mesh-list
14132922|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14132923|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14132924|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132925|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
14132926|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
13949510|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949511|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
13949512|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949513|NCT03230474|Morphine|morphine|mesh-list
14132927|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
14132928|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132929|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132930|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
14132931|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
14132932|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14132933|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132934|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14132935|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
14132936|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132937|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14132938|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14132939|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14132940|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13949514|NCT03230474|Naloxone|naloxone|mesh-list
13949515|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13949516|NCT03230474|Narcotics|narcotics|mesh-ancestor
13949517|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949518|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949519|NCT03230474|Analgesics|analgesics|mesh-ancestor
13949520|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
13949521|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949522|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13949523|NCT03230227|Bupivacaine|bupivacaine|mesh-list
13949524|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
13949525|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
13949526|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949527|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949528|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
13949529|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949530|NCT03230162|Heparin|heparin|mesh-list
14132941|NCT03580525|Nicotine|nicotine|mesh-list
14132942|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14132943|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
14132944|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14132945|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132946|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14132947|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14132948|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
14132949|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132950|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132951|NCT03560297|Nitrazepam|nitrazepam|mesh-list
14132952|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
14132953|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14132954|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14132955|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132956|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14132957|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14132958|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14132959|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
14132960|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
14132961|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14132962|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763688|NCT00612469|Protective Agents|protective agents|mesh-ancestor
13949531|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13949532|NCT03230162|Tinzaparin|tinzaparin|mesh-list
13949533|NCT03230162|Dalteparin|dalteparin|mesh-list
13949534|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
13949535|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
13949536|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13949537|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13949538|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949539|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
13949540|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13949541|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13949542|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949543|NCT03230162|Urological Agents|urological agents|mesh-ancestor
13949544|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13949545|NCT03229954|Hematinics|hematinics|mesh-ancestor
13949546|NCT03230097|BI 409306|bi 409306|mesh-list
13949547|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13949548|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949549|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949550|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
13949551|NCT03229746|Vincristine|vincristine|mesh-list
13949552|NCT03229746|Azathioprine|azathioprine|mesh-list
13949553|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13949554|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949555|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
13949556|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
13949557|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
13949558|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949559|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
13949560|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13949561|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13949562|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949563|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949564|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949565|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
13949566|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13949567|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13949568|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
13949569|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949570|NCT03229668|Pregabalin|pregabalin|mesh-list
13949571|NCT03229668|Analgesics|analgesics|mesh-ancestor
13949572|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
13949573|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949574|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949575|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
13949576|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13949577|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949578|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763689|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949579|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13949580|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14763690|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13949581|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14763691|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763692|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
14763693|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
14763694|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14763695|NCT00612495|Fluorouracil|fluorouracil|mesh-list
14763696|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
14763697|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
14763698|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763699|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14132975|NCT03554707|Bevacizumab|bevacizumab|mesh-list
14132976|NCT03554707|Irinotecan|irinotecan|mesh-list
14132977|NCT03554707|Temozolomide|temozolomide|mesh-list
14132978|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14132979|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14132980|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14132981|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14132982|NCT03554707|Growth Substances|growth substances|mesh-ancestor
14132983|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14132984|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14132985|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14132986|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14132987|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14132988|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132989|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13949582|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949583|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949584|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
13949585|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14132990|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
14132991|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
14132992|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14132993|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13949586|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949587|NCT03230058|Voriconazole|voriconazole|mesh-list
13949588|NCT03230058|Natamycin|natamycin|mesh-list
13949589|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13949590|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13949591|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
13949592|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949593|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13949594|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13949595|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949596|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949597|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13949598|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
14132994|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14132995|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
14132996|NCT03505723|Coagulants|coagulants|mesh-ancestor
14132997|NCT03472092|Amitriptyline|amitriptyline|mesh-list
14132998|NCT03472092|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14132999|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14133000|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
14133001|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133002|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14133003|NCT03472092|Analgesics|analgesics|mesh-ancestor
14133004|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
14133005|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133006|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133007|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14133008|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14133009|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14133010|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133011|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
14133012|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133013|NCT03472092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13949599|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949600|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949601|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13949602|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13949603|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13949604|NCT03229694|Bosentan|bosentan|mesh-list
13949605|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
14763700|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949606|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13949607|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949608|NCT03230136|Anesthetics|anesthetics|mesh-list
13949609|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949610|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949611|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
13949612|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949613|NCT03229798|Sumatriptan|sumatriptan|mesh-list
13949614|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14133014|NCT03472092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14133015|NCT03472092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133016|NCT03436862|Nivolumab|nivolumab|mesh-list
14133017|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133018|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133019|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14133020|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133021|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
14133022|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14133023|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
14133024|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133025|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
14133026|NCT03431584|Protective Agents|protective agents|mesh-ancestor
14133027|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
14133028|NCT03410875|Vemurafenib|vemurafenib|mesh-list
14133029|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133030|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133031|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133032|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133033|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133034|NCT03401320|Letrozole|letrozole|mesh-list
14133035|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133036|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14133037|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14133038|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133039|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949615|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13949616|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13949617|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
13949618|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949619|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949620|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949621|NCT03229889|Tadalafil|tadalafil|mesh-list
13949622|NCT03229889|Tamsulosin|tamsulosin|mesh-list
13949623|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
13949624|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13949625|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13949626|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133040|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14133041|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
14133042|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133043|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133044|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
14133045|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133046|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133047|NCT03321019|Capsaicin|capsaicin|mesh-list
14133048|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
14133049|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
13949627|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949628|NCT03229889|Urological Agents|urological agents|mesh-ancestor
13949629|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13949630|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13949631|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13949632|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
13949633|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949634|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962625|NCT04237792|Propofol|propofol|mesh-list
13962626|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13962627|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962628|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133050|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
14133051|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133052|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133053|NCT03317613|Capsaicin|capsaicin|mesh-list
14133054|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
14133055|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
14133056|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
14133057|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133058|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133059|NCT03310619|Nivolumab|nivolumab|mesh-list
14133060|NCT03310619|Durvalumab|durvalumab|mesh-list
14133061|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133062|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133063|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14133064|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133065|NCT03302910|Torsemide|torsemide|mesh-list
14133066|NCT03302910|Furosemide|furosemide|mesh-list
14133067|NCT03302910|Bumetanide|bumetanide|mesh-list
14133068|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
14133069|NCT03302910|Diuretics|diuretics|mesh-list
14133070|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14133071|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
14133072|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133073|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14133074|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133075|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
14133076|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14133077|NCT03267498|Nivolumab|nivolumab|mesh-list
14133078|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133079|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133080|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13949635|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
13949636|NCT03229616|Busulfan|busulfan|mesh-list
13949637|NCT03229616|Etoposide|etoposide|mesh-list
13949638|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13949639|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
13949640|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949641|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949642|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13949643|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
13949644|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949645|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949646|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13949647|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13949648|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13949649|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13949650|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949651|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14133081|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133082|NCT03251729|Progesterone|progesterone|mesh-list
14133083|NCT03251729|Progestins|progestins|mesh-ancestor
14133084|NCT03251729|Hormones|hormones|mesh-ancestor
14133085|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133086|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133087|NCT03206073|Durvalumab|durvalumab|mesh-list
14133088|NCT03206073|Tremelimumab|tremelimumab|mesh-list
14133089|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133090|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133091|NCT03186404|Atorvastatin|atorvastatin|mesh-list
14133092|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14133093|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133094|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
14133095|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133096|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14133097|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14133098|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949652|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13949653|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13949654|NCT03229408|Analgesics|analgesics|mesh-ancestor
13949655|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
13949656|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949657|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949658|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133099|NCT03098836|Prednisone|prednisone|mesh-list
14133100|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
14133101|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133102|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
14133103|NCT03098836|Hormones|hormones|mesh-ancestor
14133104|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133105|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133106|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14133107|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133108|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14133109|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133110|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133111|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
14133112|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14133113|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
14133114|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133115|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133116|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14133117|NCT03076164|Trametinib|trametinib|mesh-list
14133118|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133119|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133120|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133121|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177732|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177733|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177734|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
14177735|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177736|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177737|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14177738|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
14177739|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14177740|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14177741|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14177742|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14177743|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177744|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14177745|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14177746|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14177747|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
14177748|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177749|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
14177750|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14177751|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
14177752|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177753|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14177754|NCT04753008|Dopamine|dopamine|mesh-list
14177755|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14177756|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
14177757|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
14177758|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177759|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177760|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
14177761|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177762|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177763|NCT04753008|Protective Agents|protective agents|mesh-ancestor
14177764|NCT04753294|Diazepam|diazepam|mesh-list
14177765|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13949659|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949660|NCT03229096|Apatinib|apatinib|mesh-list
13949661|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949662|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13949663|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949664|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949665|NCT03229174|Droxidopa|droxidopa|mesh-list
13949666|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13949667|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13949668|NCT03229148|Anesthetics|anesthetics|mesh-list
13949669|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949670|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949671|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13949672|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949673|NCT03228992|Ibuprofen|ibuprofen|mesh-list
13949674|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13949675|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13949676|NCT03228992|Analgesics|analgesics|mesh-ancestor
14133122|NCT03073070|Biotin|biotin|mesh-list
14133123|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
14133124|NCT03073070|Vitamins|vitamins|mesh-ancestor
14133125|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
14133126|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133127|NCT03063944|Azacitidine|azacitidine|mesh-list
14133128|NCT03063944|Decitabine|decitabine|mesh-list
14133129|NCT03063944|Venetoclax|venetoclax|mesh-list
13949677|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
13949678|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949679|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949680|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13949681|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949682|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14133130|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14133131|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
14133132|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133133|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133134|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133135|NCT03060577|Evolocumab|evolocumab|mesh-list
14133136|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14133137|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133138|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
14133139|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133140|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14133141|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
14133142|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
14133143|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14133144|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14133145|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133146|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133147|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133148|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133149|NCT02939742|Betamethasone|betamethasone|mesh-list
14133150|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133151|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
14133152|NCT02939742|Hormones|hormones|mesh-ancestor
14133153|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133154|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133155|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14133156|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
14133157|NCT02905214|Sirolimus|sirolimus|mesh-list
14133158|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14133159|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133160|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14133161|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133162|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
13949683|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949684|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949685|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
13949686|NCT03229278|Nivolumab|nivolumab|mesh-list
13949687|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
13949688|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13949689|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949690|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13949691|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949692|NCT03228901|Oxytocin|oxytocin|mesh-list
13949693|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
13949694|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13949695|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949696|NCT03228797|Ropivacaine|ropivacaine|mesh-list
13949697|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
13949698|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
13949699|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949700|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949701|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
13949702|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949703|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
13949704|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13949705|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
14133163|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13949706|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
13949707|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949708|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133164|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
14133165|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133166|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
14133167|NCT02816021|Azacitidine|azacitidine|mesh-list
14133168|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133169|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763701|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13949709|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13949710|NCT03228628|Analgesics|analgesics|mesh-ancestor
13949711|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
13949712|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949713|NCT03228823|Amiodarone|amiodarone|mesh-list
13949714|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
13949715|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
13949716|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13949717|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949718|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949719|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13949720|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14763702|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
14763703|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763704|NCT00612521|Adenosine|adenosine|mesh-list
14763705|NCT00612521|Analgesics|analgesics|mesh-ancestor
14763706|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
14763707|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763708|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763709|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13949721|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14133170|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14133171|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
14133172|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133173|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133174|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
14133175|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
14133176|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14133177|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14133178|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133179|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133180|NCT02812433|Urological Agents|urological agents|mesh-ancestor
14763710|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
14763711|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14763712|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
14133181|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14133182|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
13949722|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949723|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13949724|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13949725|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13949726|NCT03228732|Fluoxetine|fluoxetine|mesh-list
13949727|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
13949728|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13949729|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14133183|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133184|NCT02737046|Interferons|interferons|mesh-list
14133185|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
14133186|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
14133187|NCT02737046|Zidovudine|zidovudine|mesh-list
14133188|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14133189|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14133190|NCT02737046|Belinostat|belinostat|mesh-list
14133191|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133192|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
14133193|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133194|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
14133195|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133196|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
14133197|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133198|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14133199|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14133200|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133201|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14133202|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14133203|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14133204|NCT02723864|Veliparib|veliparib|mesh-list
14133205|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133206|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14133207|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949730|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949731|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949732|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949733|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
13949734|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949735|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13949736|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
13949737|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949738|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13949739|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13949740|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949741|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13949742|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
13949743|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
13949744|NCT03228667|Nivolumab|nivolumab|mesh-list
13949745|NCT03228667|Durvalumab|durvalumab|mesh-list
13949746|NCT03228667|Avelumab|avelumab|mesh-list
13949747|NCT03228667|Atezolizumab|atezolizumab|mesh-list
13949748|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13949749|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133208|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133209|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
14133210|NCT02676791|Povidone|povidone|mesh-list
14133211|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
14133212|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
14133213|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14133214|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133215|NCT02673996|Phenylephrine|phenylephrine|mesh-list
14133216|NCT02673996|Isoproterenol|isoproterenol|mesh-list
14133217|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
14133218|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14133219|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
14133220|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
14133221|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133222|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133223|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
14133224|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14133225|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
14133226|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
14133227|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14133228|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14133229|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14133230|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14133231|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133232|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133233|NCT02673996|Protective Agents|protective agents|mesh-ancestor
14133234|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14133235|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14133236|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14133237|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
14133238|NCT02600949|Imiquimod|imiquimod|mesh-list
14133239|NCT02600949|Vaccines|vaccines|mesh-list
14133240|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133241|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133242|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14133243|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
14133244|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133245|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
14133246|NCT02597062|Dexamethasone|dexamethasone|mesh-list
14133247|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
14133248|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133249|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
13949750|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133250|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133251|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133252|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14133253|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
13949751|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13949752|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949753|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
13949754|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949755|NCT03228771|Atorvastatin|atorvastatin|mesh-list
13949756|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13949757|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133254|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133255|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133256|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14133257|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133258|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
14133259|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
14133260|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133261|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14133262|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
14133263|NCT02597062|Hormones|hormones|mesh-ancestor
14133264|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133265|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14133266|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
14133267|NCT02498912|Fludarabine|fludarabine|mesh-list
14133268|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133269|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
14133270|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133271|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133272|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14133273|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
14133274|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133275|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133276|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14133277|NCT02130882|Benralizumab|benralizumab|mesh-list
14133278|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13949758|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
13949759|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133279|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
14133280|NCT02130453|Regadenoson|regadenoson|mesh-list
14133281|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14133282|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14133283|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
14133284|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
14133285|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133286|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133287|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949760|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13949761|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13949762|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949763|NCT03228576|Everolimus|everolimus|mesh-list
13949764|NCT03228576|Tacrolimus|tacrolimus|mesh-list
13949765|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133300|NCT02055963|Minocycline|minocycline|mesh-list
14133301|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14133302|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133303|NCT01976169|Palbociclib|palbociclib|mesh-list
14133304|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14763713|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
14763714|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763715|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763716|NCT00612547|Artesunate|artesunate|mesh-list
14763717|NCT00612547|Amodiaquine|amodiaquine|mesh-list
14763718|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
13949766|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
14763719|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14763720|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14133305|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133306|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133307|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133308|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133309|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133310|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
14133311|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
14133312|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
14133313|NCT01920932|Prednisone|prednisone|mesh-list
14133314|NCT01920932|Prednisolone|prednisolone|mesh-list
14133315|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
14133316|NCT01920932|Dacarbazine|dacarbazine|mesh-list
13949767|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949768|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13949769|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949770|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949771|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949772|NCT03228498|Choline|choline|mesh-list
13949773|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
13949774|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13949775|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
13949776|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949777|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949778|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13949779|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
13949780|NCT03228368|Atezolizumab|atezolizumab|mesh-list
13949781|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949782|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
13949783|NCT03228862|Vitamin D|vitamin d|mesh-list
13949784|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13949785|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949786|NCT03228862|Vitamins|vitamins|mesh-ancestor
13949787|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
13949788|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13949789|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
13949790|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949791|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13949792|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949793|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949794|NCT03228238|Vitamins|vitamins|mesh-list
13949795|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
13949796|NCT03228238|Vitamin E|vitamin e|mesh-list
13949797|NCT03228238|Tocopherols|tocopherols|mesh-list
13949798|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
14133317|NCT01920932|Doxorubicin|doxorubicin|mesh-list
14133318|NCT01920932|Etoposide|etoposide|mesh-list
14133319|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14133320|NCT01920932|Imidazole|imidazole|mesh-list
14133321|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133322|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
14133323|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133324|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133325|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14133326|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
14133327|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133328|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133329|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14133330|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14133331|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14133332|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14133333|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133334|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133335|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
14133336|NCT01920932|Hormones|hormones|mesh-ancestor
14133337|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133338|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14133339|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14133340|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133341|NCT01827111|Paclitaxel|paclitaxel|mesh-list
14133342|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14133343|NCT01827111|Ipilimumab|ipilimumab|mesh-list
13949799|NCT03228238|Atorvastatin|atorvastatin|mesh-list
13949800|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
14133344|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14133345|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133346|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14133347|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14133348|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14133349|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133350|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133351|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14133352|NCT01631292|Vitamin D|vitamin d|mesh-list
14133353|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
14133354|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
14133355|NCT01631292|Vitamins|vitamins|mesh-list
14133356|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
14133357|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133358|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14133359|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14936839|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936840|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
14936841|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936842|NCT01471704|Verapamil|verapamil|mesh-list
14936843|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13949801|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949802|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14936844|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14938739|NCT01483781|Canagliflozin|canagliflozin|mesh-list
14133368|NCT01437111|Vitamin D|vitamin d|mesh-list
14133369|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
14133370|NCT01437111|Alendronate|alendronate|mesh-list
14133371|NCT01437111|Vitamins|vitamins|mesh-ancestor
14133372|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
14133373|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133374|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14133375|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14133376|NCT01364597|Brivaracetam|brivaracetam|mesh-list
14133377|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
14133378|NCT01349101|Vidarabine|vidarabine|mesh-list
14133379|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
14763721|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763722|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763723|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
14763724|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
14763725|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14763726|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
14763727|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
14763728|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
14133380|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
14133381|NCT01349101|Busulfan|busulfan|mesh-list
14133382|NCT01349101|Fludarabine|fludarabine|mesh-list
14133383|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
14763729|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14763730|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763731|NCT00612612|Rituximab|rituximab|mesh-list
14763732|NCT00612612|Fludarabine|fludarabine|mesh-list
13949803|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13949804|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13949805|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
13949806|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949807|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13949808|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13949809|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949810|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
13949811|NCT03228238|Protective Agents|protective agents|mesh-ancestor
14133384|NCT01349101|Tacrolimus|tacrolimus|mesh-list
14133385|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133386|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
14763733|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
14133387|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133388|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133389|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14133390|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
14133391|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133392|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133393|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14133394|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14133395|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
14133396|NCT01349101|Antiviral Agents|antiviral agents|mesh-ancestor
14133397|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133398|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14133399|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133400|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14133401|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14133402|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
14133403|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14133404|NCT01163383|Iodine|iodine|mesh-list
14133405|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
14133406|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14133407|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14133408|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133409|NCT01163383|Trace Elements|trace elements|mesh-ancestor
14133410|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
14133411|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133412|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133413|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133414|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133415|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14133416|NCT01057121|Lenalidomide|lenalidomide|mesh-list
14133417|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
13949812|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949813|NCT03228355|Cromakalim|cromakalim|mesh-list
13949814|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13949815|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13949816|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
13949817|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949818|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949819|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13949820|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
13949821|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
14133418|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133419|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14133420|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14133421|NCT01057121|Growth Substances|growth substances|mesh-ancestor
14133422|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14133423|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133424|NCT01004263|Rizatriptan|rizatriptan|mesh-list
14133425|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14133426|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
14133427|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133428|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133429|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133430|NCT01001234|Rizatriptan|rizatriptan|mesh-list
14133431|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14133432|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
14133433|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133434|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133435|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133436|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
14133437|NCT00961792|Promethazine|promethazine|mesh-list
14133438|NCT00961792|Ethanol|ethanol|mesh-list
14133439|NCT00961792|Caffeine|caffeine|mesh-list
14133440|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14133441|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133442|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14133443|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133444|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133445|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14133446|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14133447|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
14133448|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133449|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13949822|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
13949823|NCT03228108|Amoxicillin|amoxicillin|mesh-list
13949824|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
13949825|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13949826|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
13949827|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
14133450|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133451|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133452|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14936845|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14936846|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936847|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14936848|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936849|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936850|NCT01471730|Thrombin|thrombin|mesh-list
14936851|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
13949828|NCT03228108|Fosfomycin|fosfomycin|mesh-list
13949829|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13949830|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
13949831|NCT03228108|Trimethoprim|trimethoprim|mesh-list
13949832|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
13949833|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13949834|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949835|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13949836|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13949837|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949838|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949839|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949840|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13949841|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14936852|NCT01471730|Coagulants|coagulants|mesh-ancestor
14936853|NCT01471808|Metformin|metformin|mesh-list
14936854|NCT01471808|Pioglitazone|pioglitazone|mesh-list
14936855|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14936856|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936857|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936858|NCT01471808|Incretins|incretins|mesh-ancestor
14936859|NCT01471808|Hormones|hormones|mesh-ancestor
14936860|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14936861|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14936862|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
14936863|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936864|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949842|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13949843|NCT03228108|Renal Agents|renal agents|mesh-ancestor
13949844|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
13949845|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13949846|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13949847|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13949848|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13949849|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13949850|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13949851|NCT03228030|Thiamine|thiamine|mesh-list
13949852|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
13949853|NCT03228030|Vitamins|vitamins|mesh-ancestor
13949854|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
13949855|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962629|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14133453|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13962630|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
13949856|NCT03227731|Tenofovir|tenofovir|mesh-list
13949857|NCT03227731|Emtricitabine|emtricitabine|mesh-list
13949858|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13949859|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
13949860|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949861|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13949862|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14133454|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
14133455|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
14133456|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
13949863|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949864|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949865|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13949866|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13949867|NCT03227900|Lidocaine|lidocaine|mesh-list
13949868|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
13949869|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
13949870|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949871|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949872|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
13949873|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949874|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13949875|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13949876|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13949877|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949878|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949882|NCT03228043|Apatinib|apatinib|mesh-list
13949883|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949884|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13949885|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949886|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949887|NCT03227926|Panitumumab|panitumumab|mesh-list
13949888|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13949889|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949890|NCT03227679|Bupropion|bupropion|mesh-list
14133457|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133458|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
14133459|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
14133460|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14133461|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14133462|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
14133463|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
14133464|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14133465|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
14133466|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14133467|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
14133468|NCT00950846|Busulfan|busulfan|mesh-list
14133469|NCT00950846|Fludarabine|fludarabine|mesh-list
14133470|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133471|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
14133472|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133473|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133474|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14133475|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
14133476|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133477|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133478|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14133479|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
14133480|NCT00924170|Fludarabine|fludarabine|mesh-list
14133481|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133482|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
14936865|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14133483|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949891|NCT03227679|Nicotine|nicotine|mesh-list
13949892|NCT03227679|Varenicline|varenicline|mesh-list
13949893|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13949894|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
13949895|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949896|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949897|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13949898|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14133484|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133485|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14133486|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
14133487|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133488|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133489|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14133490|NCT00894556|Sumatriptan|sumatriptan|mesh-list
14133491|NCT00894556|Rizatriptan|rizatriptan|mesh-list
14133492|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14133493|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14133494|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14133495|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
14133496|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133497|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133498|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133499|NCT00840177|Cytarabine|cytarabine|mesh-list
14133500|NCT00840177|Idarubicin|idarubicin|mesh-list
14133501|NCT00840177|Pravastatin|pravastatin|mesh-list
14133502|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14133503|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
14133504|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133505|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133506|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
14133507|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949899|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
14478496|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14478497|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478498|NCT02452931|Leuprolide|leuprolide|mesh-list
14478499|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14478500|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
14478501|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14478502|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478503|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14478504|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936866|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
14133508|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133509|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
14133510|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133511|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14133512|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14133513|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14133514|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133515|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14133516|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133517|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14133518|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14133519|NCT00820950|Betamethasone|betamethasone|mesh-list
14133520|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
14133521|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14133522|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
14763734|NCT00612612|Obatoclax|obatoclax|mesh-list
14763735|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14763736|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763737|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
14763738|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763739|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14763740|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763741|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
14133523|NCT00820950|Calcipotriene|calcipotriene|mesh-list
14133524|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14763742|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936867|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14936868|NCT01471847|Capecitabine|capecitabine|mesh-list
14936869|NCT01471847|Trastuzumab|trastuzumab|mesh-list
14936870|NCT01471847|Lapatinib|lapatinib|mesh-list
13949900|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936871|NCT01471847|Dactolisib|dactolisib|mesh-list
13962631|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
13949901|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949902|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14133525|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133526|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
14133527|NCT00820950|Hormones|hormones|mesh-ancestor
14133528|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133529|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133530|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14133531|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
14133532|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
14133533|NCT00806416|Vitamin D|vitamin d|mesh-list
14133534|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
14133535|NCT00806416|Alendronate|alendronate|mesh-list
14133536|NCT00806416|Vitamins|vitamins|mesh-ancestor
14133537|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
14133538|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133539|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14133540|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14133541|NCT00748904|Rifaximin|rifaximin|mesh-list
14133542|NCT00748904|Lactulose|lactulose|mesh-list
14133543|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14133544|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133545|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14133546|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
14133547|NCT00729651|Alendronate|alendronate|mesh-list
14133548|NCT00729651|Calcium|calcium|mesh-list
14133549|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14133550|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133551|NCT00729651|Vitamins|vitamins|mesh-ancestor
14133552|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
14936872|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14936873|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
14936874|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936875|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936876|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14936877|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14936878|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936879|NCT01471886|Ketorolac|ketorolac|mesh-list
14936880|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14936881|NCT01471886|Naproxen|naproxen|mesh-list
14936882|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13949903|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
13949904|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949905|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13949906|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13949907|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13949908|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
13949909|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13949910|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13949911|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949912|NCT03227705|Progesterone|progesterone|mesh-list
13949913|NCT03227705|Progestins|progestins|mesh-ancestor
13949914|NCT03227705|Hormones|hormones|mesh-ancestor
13949915|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949916|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133553|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14936883|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936884|NCT01471886|Analgesics|analgesics|mesh-ancestor
14936885|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
14936886|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133554|NCT00698815|Pemetrexed|pemetrexed|mesh-list
14133555|NCT00698815|Sunitinib|sunitinib|mesh-list
14133556|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133557|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133558|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133559|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14133560|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14133561|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14133562|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14133563|NCT00698815|Growth Substances|growth substances|mesh-ancestor
14133564|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133565|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14133566|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133567|NCT00698022|Risperidone|risperidone|mesh-list
14133568|NCT00698022|Mifepristone|mifepristone|mesh-list
14133569|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14133570|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
14133571|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133572|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133573|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133574|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14133575|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14133576|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133577|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133578|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14133579|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
14133580|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14763743|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763744|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763745|NCT00612625|Glucagon|glucagon|mesh-list
14763746|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14763747|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14763748|NCT00612625|Hormones|hormones|mesh-ancestor
14763749|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949917|NCT03227653|Ritonavir|ritonavir|mesh-list
14763750|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763751|NCT00612625|Incretins|incretins|mesh-ancestor
14767377|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767378|NCT00629824|Interferons|interferons|mesh-list
14767379|NCT00629824|Ribavirin|ribavirin|mesh-list
14767380|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
14767381|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13949918|NCT03227653|Lopinavir|lopinavir|mesh-list
13949919|NCT03227653|Nevirapine|nevirapine|mesh-list
13949920|NCT03227653|Efavirenz|efavirenz|mesh-list
13949921|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13949922|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13949923|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
13949924|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13949925|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949926|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13949927|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13949928|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
13949929|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949930|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13949931|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13949932|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13949933|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14133581|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
14133582|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14133583|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14133584|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14133585|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14133586|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
14133587|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14133588|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14133589|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
14133590|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133591|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
14133592|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14133593|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14133594|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
14133595|NCT00692913|Alendronate|alendronate|mesh-list
14133596|NCT00692913|Calcium|calcium|mesh-list
14133597|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14133598|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133599|NCT00692913|Vitamins|vitamins|mesh-ancestor
14133600|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
14133601|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14133602|NCT00617708|Gemcitabine|gemcitabine|mesh-list
14133603|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14133604|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14133605|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14133606|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
14133607|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133608|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949934|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13949935|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13949936|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13949937|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13949938|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13949939|NCT03227484|Empagliflozin|empagliflozin|mesh-list
13949940|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13949941|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133609|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
14133610|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133611|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133612|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133613|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
14133614|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133615|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133616|NCT00516737|Rizatriptan|rizatriptan|mesh-list
14133617|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14133618|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
14133619|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177766|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
14478505|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14478506|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478507|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478508|NCT02453282|Gemcitabine|gemcitabine|mesh-list
14478509|NCT02453282|Paclitaxel|paclitaxel|mesh-list
14478510|NCT02453282|Cisplatin|cisplatin|mesh-list
14478511|NCT02453282|Carboplatin|carboplatin|mesh-list
14763752|NCT00612638|Irinotecan|irinotecan|mesh-list
13949942|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13949943|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949944|NCT03227419|Abatacept|abatacept|mesh-list
13949945|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13949946|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949947|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949948|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13949949|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
13949950|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949951|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13949952|NCT03227562|Risperidone|risperidone|mesh-list
13949953|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13949954|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
13949955|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13949956|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478512|NCT02453282|Pemetrexed|pemetrexed|mesh-list
14478513|NCT02453282|Durvalumab|durvalumab|mesh-list
14478514|NCT02453282|Tremelimumab|tremelimumab|mesh-list
14763753|NCT00612638|Temozolomide|temozolomide|mesh-list
14478515|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14478516|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14478517|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478518|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
14478519|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
13949957|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949958|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13949959|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13949960|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13949961|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13949962|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14133620|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133621|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133622|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
14133623|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133624|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
14133625|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14133626|NCT00326898|Sorafenib|sorafenib|mesh-list
14133627|NCT00326898|Sunitinib|sunitinib|mesh-list
14133628|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763754|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
13949963|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
13949964|NCT03227432|Dexamethasone|dexamethasone|mesh-list
13949965|NCT03227432|Nivolumab|nivolumab|mesh-list
13949966|NCT03227432|Pomalidomide|pomalidomide|mesh-list
13949967|NCT03227432|Elotuzumab|elotuzumab|mesh-list
13949968|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13949969|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
13949970|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
13949971|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13949972|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949973|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949974|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
13949975|NCT03227432|Hormones|hormones|mesh-ancestor
13949976|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13949977|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14133629|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133630|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133631|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133632|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14133633|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14133634|NCT00326898|Growth Substances|growth substances|mesh-ancestor
14133635|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133636|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
14133637|NCT00156065|Haloperidol|haloperidol|mesh-list
14133638|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
14133639|NCT00156065|Asenapine|asenapine|mesh-list
14133640|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
14133641|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
14133642|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133643|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133644|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13949978|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13949979|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13949980|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13949981|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949982|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
13949983|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13949984|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13949985|NCT03227432|Growth Substances|growth substances|mesh-ancestor
13949986|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
13949987|NCT03227016|Topotecan|topotecan|mesh-list
13949988|NCT03227016|Veliparib|veliparib|mesh-list
13949989|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
13949990|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13949991|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13949992|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133645|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14478520|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
14478521|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478522|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14478523|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
14478524|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
14478525|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478526|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763755|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14936887|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13949993|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949994|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133646|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14133647|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133648|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133649|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14133650|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
14133651|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133652|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13949995|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
13949996|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13949997|NCT03226821|Tesamorelin|tesamorelin|mesh-list
13949998|NCT03226821|Growth Substances|growth substances|mesh-ancestor
13949999|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950000|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13950001|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950002|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
13950003|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
13950004|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950005|NCT03226431|Protective Agents|protective agents|mesh-ancestor
13950006|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950007|NCT03226431|Vitamins|vitamins|mesh-ancestor
13950008|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
13950009|NCT03226418|Cytarabine|cytarabine|mesh-list
13950010|NCT03226418|Azacitidine|azacitidine|mesh-list
13950011|NCT03226418|Decitabine|decitabine|mesh-list
13950012|NCT03226418|Daunorubicin|daunorubicin|mesh-list
13950013|NCT03226418|Venetoclax|venetoclax|mesh-list
14133653|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14133654|NCT00150176|Asenapine|asenapine|mesh-list
13950014|NCT03226418|Idarubicin|idarubicin|mesh-list
13950015|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13950016|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
13950017|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950018|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950019|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
13950020|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950021|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13950022|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
13950023|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950024|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133655|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14133656|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14133657|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133658|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133659|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133660|NCT00148629|Mebendazole|mebendazole|mesh-list
14133661|NCT00148629|Piperazine|piperazine|mesh-list
14133662|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
14133663|NCT00148629|DMP 777|dmp 777|mesh-list
14133664|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
14133665|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
14133666|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14133667|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133668|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
14133669|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
14133670|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
14133671|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133672|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133673|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133674|NCT00145509|Asenapine|asenapine|mesh-list
14133675|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14133676|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14133677|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133678|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133679|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133680|NCT00145496|Olanzapine|olanzapine|mesh-list
14133681|NCT00145496|Asenapine|asenapine|mesh-list
14133682|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
14133683|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
14133684|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133685|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950025|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13950026|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13950027|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13950028|NCT03226522|Bupropion|bupropion|mesh-list
14133686|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14133687|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13950029|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13950030|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
13950031|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950032|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13950033|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13950034|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14133688|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14133689|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133690|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133691|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14133692|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14763756|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14763757|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763758|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133693|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14133694|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133695|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133696|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
14133697|NCT00145470|Asenapine|asenapine|mesh-list
14133698|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14133699|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14763759|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763760|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14763761|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
14763762|NCT00612651|Temozolomide|temozolomide|mesh-list
14763763|NCT00612651|Lonafarnib|lonafarnib|mesh-list
14763764|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13950035|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133700|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133701|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133702|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133703|NCT00129402|Simvastatin|simvastatin|mesh-list
14133704|NCT00129402|Ezetimibe|ezetimibe|mesh-list
14133705|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14133706|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133707|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
13950036|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
14133708|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133709|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14133710|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14133711|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133712|NCT00101439|Ezetimibe|ezetimibe|mesh-list
14133713|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14133714|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133715|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
14133716|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133717|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14133718|NCT00096200|Paclitaxel|paclitaxel|mesh-list
14133719|NCT00096200|Carboplatin|carboplatin|mesh-list
14133720|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14133721|NCT00096200|Sorafenib|sorafenib|mesh-list
14177767|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
14133722|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13950037|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950038|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950039|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13950040|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13950041|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962632|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13962633|NCT04237792|Analgesics|analgesics|mesh-ancestor
13962634|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
13962635|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962636|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13962637|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14133723|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133724|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14133725|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14133726|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14133727|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133728|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133729|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177768|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
13962638|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13962639|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962640|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962641|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962642|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
13962643|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13962644|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13962645|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962646|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
13962647|NCT04233749|Coagulants|coagulants|mesh-ancestor
13962648|NCT04229095|Suvorexant|suvorexant|mesh-list
13962649|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13962650|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13962651|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962652|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962653|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
13962654|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962655|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177769|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177770|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177771|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177772|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14177773|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962656|NCT04210180|Varenicline|varenicline|mesh-list
13962657|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13962658|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13962659|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
13962660|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962661|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962662|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962663|NCT04175886|Tofacitinib|tofacitinib|mesh-list
13962664|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13962665|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962666|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962667|NCT04169737|Venetoclax|venetoclax|mesh-list
13962668|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
13962669|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
13962670|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962671|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962672|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
13962673|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
13962674|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
13962675|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13962676|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13962677|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962678|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962679|NCT04044001|Isoniazid|isoniazid|mesh-list
14177774|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14177775|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14177776|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14177777|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14177778|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14177779|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14133730|NCT00089245|Iodine|iodine|mesh-list
13950042|NCT03226340|Niacin|niacin|mesh-list
13950043|NCT03226340|Amlodipine|amlodipine|mesh-list
13950044|NCT03226340|Telmisartan|telmisartan|mesh-list
13950045|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
13950046|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13950047|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13950048|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14133731|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
14133732|NCT00089245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14133733|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14133734|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133735|NCT00089245|Trace Elements|trace elements|mesh-ancestor
14133736|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
14133737|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133738|NCT00089245|Immunologic Factors|immunologic factors|mesh-ancestor
14133739|NCT05065970|Felzartamab|felzartamab|mesh-list
14133740|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133741|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
14133742|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133743|NCT05037994|Prednisolone|prednisolone|mesh-list
14133744|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14133745|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
14133746|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14133747|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
14133748|NCT05037994|Gabapentin|gabapentin|mesh-list
14133749|NCT05037994|Bupivacaine|bupivacaine|mesh-list
14133750|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14133751|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
14133752|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133753|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
14133754|NCT05037994|Hormones|hormones|mesh-ancestor
14133755|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133756|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133757|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14133758|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133759|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
14133760|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
14133761|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133762|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14133763|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14133764|NCT05037994|Protective Agents|protective agents|mesh-ancestor
14133765|NCT05037994|Analgesics|analgesics|mesh-ancestor
14133766|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
14133767|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
14133768|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14133769|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14133770|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133771|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14133772|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14133773|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14133774|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133775|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133776|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
14133777|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
14133778|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
14133779|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
14133780|NCT05036434|Lenvatinib|lenvatinib|mesh-list
14133781|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133782|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950049|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950050|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13950051|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950052|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
13950053|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13950054|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14133783|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133784|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177780|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
14478527|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14478528|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
14478529|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478530|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14478531|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14478532|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478533|NCT02453321|Bupivacaine|bupivacaine|mesh-list
14133785|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133786|NCT05000294|Atezolizumab|atezolizumab|mesh-list
14133787|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133788|NCT04984616|Atorvastatin|atorvastatin|mesh-list
14133789|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14133790|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133791|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
14133792|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133793|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14133794|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14133795|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133796|NCT04972396|Metformin|metformin|mesh-list
14133797|NCT04972396|Digoxin|digoxin|mesh-list
14133798|NCT04972396|Warfarin|warfarin|mesh-list
14133799|NCT04972396|Atorvastatin|atorvastatin|mesh-list
14133800|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
14133801|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13950055|NCT03226340|Diuretics|diuretics|mesh-ancestor
13950056|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
13950057|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13950058|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13950059|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
13950060|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13950061|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
13950062|NCT03226340|Vitamins|vitamins|mesh-ancestor
13950063|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
13950064|NCT03226210|Insulin|insulin|mesh-list
13950065|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
13950066|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14133802|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14133803|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133804|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14133805|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14133806|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
14133807|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133808|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14133809|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14133810|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133811|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
14133812|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14133813|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
13950067|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950068|NCT03225937|Trastuzumab|trastuzumab|mesh-list
13950069|NCT03225937|Pertuzumab|pertuzumab|mesh-list
13950070|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
13950071|NCT03225937|Lapatinib|lapatinib|mesh-list
13950072|NCT03225937|Maytansine|maytansine|mesh-list
13950073|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950074|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950075|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950076|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950077|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950078|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13950079|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
13950080|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
13950081|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
13950082|NCT03226080|Rocuronium|rocuronium|mesh-list
13950083|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13950084|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13950085|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13950086|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950087|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950088|NCT03225963|Temozolomide|temozolomide|mesh-list
13950089|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13950090|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
13950091|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950092|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950093|NCT03225924|Prednisone|prednisone|mesh-list
13950094|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
13950095|NCT03225924|Rituximab|rituximab|mesh-list
13950096|NCT03225924|Doxorubicin|doxorubicin|mesh-list
13950097|NCT03225924|Vincristine|vincristine|mesh-list
14133814|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177781|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
13950098|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13950099|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
13950100|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950101|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950102|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13950103|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
13950104|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133815|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14133816|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14133817|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14133818|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14133819|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14133820|NCT04972396|Protective Agents|protective agents|mesh-ancestor
14133821|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14133822|NCT04972396|Estrogens|estrogens|mesh-ancestor
14133823|NCT04972396|Hormones|hormones|mesh-ancestor
14133824|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133825|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
14133826|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14133827|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14133828|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14133829|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14133830|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133831|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
14133832|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133833|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133834|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14133835|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133836|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
14133837|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14133838|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
14133839|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950105|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950106|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13950107|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950108|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13950109|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13950110|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13950111|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950112|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950113|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
13950114|NCT03225924|Hormones|hormones|mesh-ancestor
13950115|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950116|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13950117|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14133840|NCT04904952|Expectorants|expectorants|mesh-ancestor
14133841|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
14133842|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14133843|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
14133844|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133845|NCT04904952|Protective Agents|protective agents|mesh-ancestor
14133846|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133847|NCT04904952|Antidotes|antidotes|mesh-ancestor
14133848|NCT04853147|Dexamethasone|dexamethasone|mesh-list
14133849|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
14133850|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
14133851|NCT04853147|Aprepitant|aprepitant|mesh-list
14763765|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
13950118|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
13950119|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
13950120|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
13950121|NCT03226145|Scopolamine|scopolamine|mesh-list
13950122|NCT03226145|Bisacodyl|bisacodyl|mesh-list
13950123|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13950124|NCT03226145|Cathartics|cathartics|mesh-ancestor
13950125|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950126|NCT03226145|Laxatives|laxatives|mesh-ancestor
13950127|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13950128|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
13950129|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
13950130|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950131|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950132|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
13950133|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13950134|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
13950135|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133852|NCT04853147|BB 1101|bb 1101|mesh-list
14133853|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14133854|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
14133855|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
14478534|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
14133856|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950136|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950137|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13950138|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
13950139|NCT03225950|Antibodies|antibodies|mesh-list
13950140|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
13950141|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950142|NCT03225690|Morphine|morphine|mesh-list
13950143|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13950144|NCT03225690|Narcotics|narcotics|mesh-ancestor
13950145|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950146|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950147|NCT03225690|Analgesics|analgesics|mesh-ancestor
13950148|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
13950149|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950150|NCT03225755|Hormones|hormones|mesh-list
13950151|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950152|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950153|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
14133857|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133858|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14133859|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
14133860|NCT04853147|Hormones|hormones|mesh-ancestor
14133861|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14133862|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13950154|NCT03225664|Trametinib|trametinib|mesh-list
14133863|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133864|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14133865|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133866|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133867|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14133868|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14133869|NCT04810910|Molgramostim|molgramostim|mesh-list
14133870|NCT04810910|Sargramostim|sargramostim|mesh-list
14133871|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
14133872|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133873|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133874|NCT04746989|Allopurinol|allopurinol|mesh-list
14133875|NCT04746989|Probenecid|probenecid|mesh-list
14133876|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
14133877|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133878|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133879|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
14133880|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133881|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14133882|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
14133883|NCT04746989|Protective Agents|protective agents|mesh-ancestor
14133884|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133885|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
14133886|NCT04746989|Renal Agents|renal agents|mesh-ancestor
13962680|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
14133887|NCT04729049|Morphine|morphine|mesh-list
14133888|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14133889|NCT04729049|Narcotics|narcotics|mesh-ancestor
14133890|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133891|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133892|NCT04729049|Analgesics|analgesics|mesh-ancestor
14133893|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
14133894|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14133895|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
14133896|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14133897|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14133898|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
14133899|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14133900|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133901|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
14133902|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
14133903|NCT04688931|Mitomycins|mitomycins|mesh-list
14133904|NCT04688931|Mitomycin|mitomycin|mesh-list
14133905|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14133906|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133907|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
14133908|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133909|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14133910|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133911|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14133912|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14133913|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133914|NCT04663711|Anesthetics|anesthetics|mesh-list
14133915|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14133916|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133917|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
14133918|NCT04639245|Fludarabine|fludarabine|mesh-list
14133919|NCT04639245|Atezolizumab|atezolizumab|mesh-list
14133920|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14133921|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14133922|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133923|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
14133924|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133925|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133926|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14133927|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
14133928|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133929|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133930|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14133931|NCT04616534|Gemcitabine|gemcitabine|mesh-list
14133932|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14133933|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
14763766|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763767|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133934|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133935|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133936|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
14133937|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133938|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133939|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133940|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
14133941|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133942|NCT04582448|Insulin|insulin|mesh-list
14133943|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14133944|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133945|NCT04562558|Leucovorin|leucovorin|mesh-list
14133946|NCT04562558|Dactinomycin|dactinomycin|mesh-list
14133947|NCT04562558|Methotrexate|methotrexate|mesh-list
14133948|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133949|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14133950|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
14133951|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14133952|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14133953|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
14133954|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133955|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133956|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
14133957|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133958|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14133959|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133960|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
14133961|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133962|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14133963|NCT04562558|Antidotes|antidotes|mesh-ancestor
14133964|NCT04562558|Protective Agents|protective agents|mesh-ancestor
14133965|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
14133966|NCT04562558|Vitamins|vitamins|mesh-ancestor
14133967|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
14133968|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14133969|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14133970|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14133971|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14133972|NCT04547166|Bevacizumab|bevacizumab|mesh-list
14133973|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14133974|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133975|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14133976|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14133977|NCT04547166|Growth Substances|growth substances|mesh-ancestor
14133978|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133979|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
14133980|NCT04529876|Abatacept|abatacept|mesh-list
14133981|NCT04529876|Tofacitinib|tofacitinib|mesh-list
14133982|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14133983|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14133984|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133985|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133986|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
14133987|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133988|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133989|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14133990|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14133991|NCT04529863|Abatacept|abatacept|mesh-list
13950155|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950156|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950157|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950158|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950159|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950160|NCT03225781|Bleomycin|bleomycin|mesh-list
13950161|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13950162|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950163|NCT03225417|Sirolimus|sirolimus|mesh-list
13950164|NCT03225417|Ixazomib|ixazomib|mesh-list
13950165|NCT03225417|Tacrolimus|tacrolimus|mesh-list
13950166|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133992|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14133993|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950167|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
14133994|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14133995|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14133996|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
14133997|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14133998|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14133999|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14134000|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14134001|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14134002|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134003|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134004|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14134005|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134006|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134007|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
14134008|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950168|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950169|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13950170|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950171|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950172|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14936888|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14936889|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14936890|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14177782|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
14177783|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
14177784|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177785|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183807|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183808|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14183809|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14183810|NCT04725383|Amitriptyline|amitriptyline|mesh-list
14183811|NCT04725383|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14936891|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936892|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936893|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
14936894|NCT01471899|Ketorolac|ketorolac|mesh-list
14936895|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14936896|NCT01471899|Naproxen|naproxen|mesh-list
14936897|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950173|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950174|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14183812|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14936898|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936899|NCT01471899|Analgesics|analgesics|mesh-ancestor
14936900|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
14936901|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183813|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
14183814|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14763768|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763769|NCT00612755|Ribavirin|ribavirin|mesh-list
14763770|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14183815|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183816|NCT04725383|Analgesics|analgesics|mesh-ancestor
14183817|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
14183818|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183819|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183820|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14183821|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14183822|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14183823|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183824|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183825|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183826|NCT04725383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14763771|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
14763772|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763773|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
14763774|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763775|NCT00612794|Exenatide|exenatide|mesh-list
14763776|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14763777|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763778|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14763779|NCT00612794|Incretins|incretins|mesh-ancestor
14763780|NCT00612794|Hormones|hormones|mesh-ancestor
14134009|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
14134010|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14134011|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14134012|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14134013|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134014|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134015|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
14134016|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134017|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134018|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14134019|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134020|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
14134021|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134022|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134023|NCT04421092|Lidocaine|lidocaine|mesh-list
14134024|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134025|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
14134026|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134027|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134028|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
14134029|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134030|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14134031|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14134032|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14134033|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134034|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134035|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
14134036|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134037|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134038|NCT04402385|Aspirin|aspirin|mesh-list
14134039|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14134040|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14134041|NCT04402385|Analgesics|analgesics|mesh-ancestor
14134042|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
14134043|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134044|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134045|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134046|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134047|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14134048|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14134049|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134050|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14134051|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14478535|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
13962681|NCT04044001|Ethambutol|ethambutol|mesh-list
13962682|NCT04044001|Dolutegravir|dolutegravir|mesh-list
13962683|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
13962684|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962685|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962686|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962687|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962688|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13962689|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13962690|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
13962691|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13962692|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13962693|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14134052|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134053|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
14134054|NCT04393103|Atropine|atropine|mesh-list
14134055|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14134056|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14134057|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14763781|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763782|NCT00612859|Levetiracetam|levetiracetam|mesh-list
14763783|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
14134058|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14134059|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
14134060|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134061|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134062|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14134063|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
14134064|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
14134065|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
14134066|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14134067|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14134068|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
14134069|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134070|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134071|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14134072|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14134073|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14134074|NCT04347616|Aldesleukin|aldesleukin|mesh-list
14134075|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134076|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14134077|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14134078|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
14134079|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14134080|NCT04333706|Capecitabine|capecitabine|mesh-list
14134081|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14134082|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
14134083|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134084|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763784|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
14763785|NCT00612898|Lamivudine|lamivudine|mesh-list
14763786|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14763787|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14763788|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763789|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763790|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
14763791|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763792|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14763793|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14763794|NCT00612950|Glucagon|glucagon|mesh-list
14763795|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14763796|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14763797|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14763798|NCT00612950|Hormones|hormones|mesh-ancestor
14763799|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763800|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763801|NCT00612950|Incretins|incretins|mesh-ancestor
14763802|NCT00612989|Temozolomide|temozolomide|mesh-list
14763803|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14763804|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14763805|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
14763806|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936902|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936903|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134085|NCT04331002|Triamcinolone|triamcinolone|mesh-list
14134086|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14134087|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14134088|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14134089|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134090|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
14134091|NCT04331002|Hormones|hormones|mesh-ancestor
14936904|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177786|NCT04752852|Dexamethasone|dexamethasone|mesh-list
14134092|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14134093|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134094|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134095|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
14134096|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134097|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134098|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
14134099|NCT04245839|Fludarabine|fludarabine|mesh-list
14134100|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134101|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
14134102|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134103|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134104|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14134105|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
14134106|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134107|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763807|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763808|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763809|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
14763810|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
14763811|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763812|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763813|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950175|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134108|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14134109|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
14134110|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14134111|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14134112|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
14134113|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134114|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14134115|NCT04209868|Bupivacaine|bupivacaine|mesh-list
14134116|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
14763814|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763815|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
14763816|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14763817|NCT00613067|Citalopram|citalopram|mesh-list
13950176|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
13950177|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
13950178|NCT03225456|Oxytocin|oxytocin|mesh-list
13950179|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
13950180|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13950181|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950182|NCT03225352|Aspirin|aspirin|mesh-list
13950183|NCT03225352|Ibuprofen|ibuprofen|mesh-list
13950184|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950185|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950186|NCT03225352|Analgesics|analgesics|mesh-ancestor
13950187|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
13950188|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950189|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763818|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14763819|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14763820|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14763821|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763822|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763823|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
14763824|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763825|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14763826|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
14763827|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950190|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14763828|NCT00613093|Temozolomide|temozolomide|mesh-list
14763829|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14763830|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14763831|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
14134117|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134118|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
14763832|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763833|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763834|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950191|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950192|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13950193|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13950194|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950195|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13950196|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14763835|NCT00613132|Everolimus|everolimus|mesh-list
14763836|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
14134119|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134120|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134121|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
13950197|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950198|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
13950199|NCT03225326|Carticaine|carticaine|mesh-list
13950200|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
13950201|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
13950202|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950203|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950204|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
13950205|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134122|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134123|NCT04209504|Bupivacaine|bupivacaine|mesh-list
14134124|NCT04209504|Ropivacaine|ropivacaine|mesh-list
14134125|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134126|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
14134127|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134128|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134129|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
14134130|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134131|NCT04167176|Lidocaine|lidocaine|mesh-list
14134132|NCT04167176|Bupivacaine|bupivacaine|mesh-list
14134133|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134134|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
14134135|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134136|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134137|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
14134138|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134139|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14134140|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14134141|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14134142|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14763837|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
14763838|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763839|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763840|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
13950206|NCT03224923|Aspirin|aspirin|mesh-list
13950207|NCT03224923|Clopidogrel|clopidogrel|mesh-list
13950208|NCT03224923|Ticagrelor|ticagrelor|mesh-list
13950209|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950210|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950211|NCT03224923|Analgesics|analgesics|mesh-ancestor
13950212|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
13950213|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950214|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950215|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950216|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950217|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14763841|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763842|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763843|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763844|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134143|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763845|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
14763846|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14763847|NCT00613145|Capecitabine|capecitabine|mesh-list
13950218|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14763848|NCT00613145|Sorafenib|sorafenib|mesh-list
14763849|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763850|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
14763851|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763852|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763853|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14763854|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763855|NCT00613223|Etoposide|etoposide|mesh-list
14763856|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
14763857|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763858|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763859|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14763860|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13950219|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950220|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13950221|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13950222|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950223|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
13950224|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13950225|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13950226|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13950227|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
13950228|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950229|NCT03224637|Acetaminophen|acetaminophen|mesh-list
13950230|NCT03224637|Ketorolac|ketorolac|mesh-list
13950231|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13950232|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950233|NCT03224637|Analgesics|analgesics|mesh-ancestor
13950234|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
14763861|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763862|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763863|NCT00613249|Dapivirine|dapivirine|mesh-list
14763864|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14763865|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14763866|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
14763867|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763868|NCT00613288|Testosterone|testosterone|mesh-list
14763869|NCT00613288|Androgens|androgens|mesh-ancestor
14763870|NCT00613288|Hormones|hormones|mesh-ancestor
14763871|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14763872|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763873|NCT00613392|Antioxidants|antioxidants|mesh-list
14763874|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763875|NCT00613392|Protective Agents|protective agents|mesh-ancestor
14763876|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763877|NCT00613457|Cytarabine|cytarabine|mesh-list
14763878|NCT00613457|Dexamethasone|dexamethasone|mesh-list
14763879|NCT00613457|Prednisone|prednisone|mesh-list
14763880|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
14763881|NCT00613457|Ifosfamide|ifosfamide|mesh-list
14763882|NCT00613457|Doxorubicin|doxorubicin|mesh-list
14763883|NCT00613457|Methotrexate|methotrexate|mesh-list
14763884|NCT00613457|Etoposide|etoposide|mesh-list
14763885|NCT00613457|Vincristine|vincristine|mesh-list
14763886|NCT00613457|Daunorubicin|daunorubicin|mesh-list
14763887|NCT00613457|Asparaginase|asparaginase|mesh-list
14763888|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
14763889|NCT00613457|Thioguanine|thioguanine|mesh-list
14763890|NCT00613457|Vindesine|vindesine|mesh-list
14763891|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763892|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
14763893|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763894|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134180|NCT04083365|Capecitabine|capecitabine|mesh-list
14134181|NCT04083365|Durvalumab|durvalumab|mesh-list
14134182|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14134183|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
14134184|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134185|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134186|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134187|NCT04012827|Doxorubicin|doxorubicin|mesh-list
14134188|NCT04012827|Apatinib|apatinib|mesh-list
14134189|NCT04012827|Ifosfamide|ifosfamide|mesh-list
14763895|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13950235|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134190|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14134191|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134192|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14763896|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
13950236|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950237|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
13950238|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950239|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950240|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950241|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13950242|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134193|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14134194|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134195|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134196|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14134197|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14134198|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
14134199|NCT04008797|Lenvatinib|lenvatinib|mesh-list
13950243|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950244|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
13950245|NCT03224572|Vitamins|vitamins|mesh-ancestor
13950246|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
13950247|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950248|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
13950249|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950250|NCT03224572|Protective Agents|protective agents|mesh-ancestor
13962694|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13962695|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13962696|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
13962697|NCT04031729|Aspirin|aspirin|mesh-list
13962698|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13962699|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14134200|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134201|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14134202|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134203|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134204|NCT03977194|Paclitaxel|paclitaxel|mesh-list
14134205|NCT03977194|Carboplatin|carboplatin|mesh-list
14134206|NCT03977194|Atezolizumab|atezolizumab|mesh-list
14134207|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14134208|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134209|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
14134210|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
14134211|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
14134212|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134213|NCT03874091|Epinephrine|epinephrine|mesh-list
14134214|NCT03874091|Racepinephrine|racepinephrine|mesh-list
14134215|NCT03874091|Morphine|morphine|mesh-list
14134216|NCT03874091|Bupivacaine|bupivacaine|mesh-list
14134217|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
14134218|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134219|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
14134220|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134221|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134222|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
14134223|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134224|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14134225|NCT03874091|Narcotics|narcotics|mesh-ancestor
14134226|NCT03874091|Analgesics|analgesics|mesh-ancestor
14134227|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14134228|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14134229|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
14134230|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134231|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134232|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14134233|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14763897|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763898|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134234|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
14134235|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14134236|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
14134237|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
14134238|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
14134239|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14134240|NCT03773276|Norepinephrine|norepinephrine|mesh-list
14134241|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14134242|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14134243|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962700|NCT04031729|Analgesics|analgesics|mesh-ancestor
14134244|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950251|NCT03224871|Aldesleukin|aldesleukin|mesh-list
13950252|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
13950253|NCT03224871|Nivolumab|nivolumab|mesh-list
13950254|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950255|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950256|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14134245|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134246|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134247|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
14134248|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
14134249|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134250|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14134251|NCT03738696|Bupivacaine|bupivacaine|mesh-list
14134252|NCT03738696|Ropivacaine|ropivacaine|mesh-list
14134253|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134254|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
14134255|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134256|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134257|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
14134258|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134259|NCT03712787|Tilavonemab|tilavonemab|mesh-list
14134260|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
14134261|NCT03704610|Infliximab|infliximab|mesh-list
14134262|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
14134263|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14134264|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134265|NCT03679650|Decitabine|decitabine|mesh-list
14134266|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14134267|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
14134268|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134269|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134270|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134271|NCT03662815|Molgramostim|molgramostim|mesh-list
14134272|NCT03662815|Sargramostim|sargramostim|mesh-list
14134273|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
14134274|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134275|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134276|NCT03645148|Molgramostim|molgramostim|mesh-list
14134277|NCT03645148|Sargramostim|sargramostim|mesh-list
14134278|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
14134279|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134280|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134281|NCT03612921|Amantadine|amantadine|mesh-list
14134282|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14134283|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14134284|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
14134285|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14134286|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
14134287|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134288|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134289|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134290|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14134291|NCT03612921|Analgesics|analgesics|mesh-ancestor
14134292|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
14134293|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763899|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14763900|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14763901|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
14763902|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
14763903|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763904|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14763905|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
14763906|NCT00613457|Hormones|hormones|mesh-ancestor
14763907|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14134303|NCT03603808|Vaccines|vaccines|mesh-list
14134304|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
14134305|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134306|NCT03568383|Pyridoxine|pyridoxine|mesh-list
13950257|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950258|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13950259|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13950260|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
13950261|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950262|NCT03224208|Vemurafenib|vemurafenib|mesh-list
13950263|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134307|NCT03568383|Pyridoxal|pyridoxal|mesh-list
14134308|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
13950264|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950265|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950266|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950267|NCT03224338|Dolutegravir|dolutegravir|mesh-list
13950268|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13950269|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13950270|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950271|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950272|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13950273|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13950274|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
13950275|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950276|NCT03224377|Antibodies|antibodies|mesh-list
13950277|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
13950278|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
13950279|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950280|NCT03224221|Fluorouracil|fluorouracil|mesh-list
13950281|NCT03224221|Apatinib|apatinib|mesh-list
13950282|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
13950283|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950284|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13950285|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950286|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13950287|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
13950288|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950289|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950290|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950291|NCT03224039|Sufentanil|sufentanil|mesh-list
13950292|NCT03224039|Morphine|morphine|mesh-list
13950293|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13950294|NCT03224039|Narcotics|narcotics|mesh-ancestor
13950295|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950296|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950297|NCT03224039|Analgesics|analgesics|mesh-ancestor
13950298|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
13950299|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950300|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13950301|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13950302|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
13950303|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
13950304|NCT03224416|Ethanol|ethanol|mesh-list
13950305|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13950306|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950307|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950308|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950309|NCT03223779|Trifluridine|trifluridine|mesh-list
13950310|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
13950311|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950312|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
13950313|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950314|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
13950315|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13950316|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134309|NCT03568383|Isoniazid|isoniazid|mesh-list
14134310|NCT03568383|Vitamins|vitamins|mesh-ancestor
14134311|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
14134312|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134313|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
14134314|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
14134315|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14134316|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14134317|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14134318|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14763908|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14763909|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14763910|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14763911|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14763912|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14763913|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14763914|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
14763915|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13950317|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13950318|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13950319|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950320|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134319|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
14134320|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134321|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14134322|NCT03534453|Olaparib|olaparib|mesh-list
14134323|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14134324|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134325|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134326|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177787|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14177788|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
14177789|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
14177790|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177791|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177792|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177793|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
14177794|NCT04752852|Hormones|hormones|mesh-ancestor
14177795|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177796|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14177797|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177798|NCT04752813|Vitamin K|vitamin k|mesh-list
14177799|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
14177800|NCT04752813|Temozolomide|temozolomide|mesh-list
14177801|NCT04752813|Vitamins|vitamins|mesh-ancestor
14177802|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
14177803|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177804|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14177805|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
14177806|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177807|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177808|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14177809|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14177810|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
14177811|NCT04752813|Coagulants|coagulants|mesh-ancestor
14177812|NCT04752631|Tenecteplase|tenecteplase|mesh-list
14177813|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14177814|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14177815|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177816|NCT04752267|Clevudine|clevudine|mesh-list
14177817|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
14177818|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177819|NCT04752384|Buprenorphine|buprenorphine|mesh-list
14177820|NCT04752384|Tramadol|tramadol|mesh-list
14177821|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13950321|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
13950322|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950323|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
13950324|NCT03223961|Hematinics|hematinics|mesh-ancestor
13950325|NCT03223506|Acetaminophen|acetaminophen|mesh-list
13950326|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950327|NCT03223506|Analgesics|analgesics|mesh-ancestor
13950328|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
13950329|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950330|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950331|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
13950332|NCT03223896|Naloxone|naloxone|mesh-list
13950333|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13950334|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177822|NCT04752384|Narcotics|narcotics|mesh-ancestor
14177823|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177824|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177825|NCT04752384|Analgesics|analgesics|mesh-ancestor
14177826|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
14177827|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177828|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14177829|NCT04752163|Leucovorin|leucovorin|mesh-list
14177830|NCT04752163|Cytarabine|cytarabine|mesh-list
14177831|NCT04752163|Voriconazole|voriconazole|mesh-list
14177832|NCT04752163|Posaconazole|posaconazole|mesh-list
14177833|NCT04752163|Dexamethasone|dexamethasone|mesh-list
14177834|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
13950335|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
14177835|NCT04752163|Prednisone|prednisone|mesh-list
14177836|NCT04752163|Cortisone|cortisone|mesh-list
14177837|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
14177838|NCT04752163|Rituximab|rituximab|mesh-list
13950336|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950337|NCT03223519|Ascorbic Acid|ascorbic acid|mesh-list
14177839|NCT04752163|Methotrexate|methotrexate|mesh-list
14177840|NCT04752163|Vincristine|vincristine|mesh-list
14177841|NCT04752163|Azacitidine|azacitidine|mesh-list
14177842|NCT04752163|Venetoclax|venetoclax|mesh-list
13950338|NCT03223519|Ibuprofen|ibuprofen|mesh-list
13950339|NCT03223519|Vitamins|vitamins|mesh-ancestor
13950340|NCT03223519|Micronutrients|micronutrients|mesh-ancestor
13950341|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950342|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950343|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950344|NCT03223519|Analgesics|analgesics|mesh-ancestor
13950345|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
13950346|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950347|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950348|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950349|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13950350|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950351|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950352|NCT03223519|Antioxidants|antioxidants|mesh-ancestor
13950353|NCT03223519|Protective Agents|protective agents|mesh-ancestor
13950354|NCT03223402|Lamivudine|lamivudine|mesh-list
13950355|NCT03223402|Nevirapine|nevirapine|mesh-list
13950356|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13950357|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13950358|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134327|NCT03501576|Vaccines|vaccines|mesh-list
14134328|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
14134329|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134330|NCT03490903|Fentanyl|fentanyl|mesh-list
14134331|NCT03490903|Midazolam|midazolam|mesh-list
14134332|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14134333|NCT03490903|Narcotics|narcotics|mesh-ancestor
14134334|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134335|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134336|NCT03490903|Analgesics|analgesics|mesh-ancestor
14134337|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
14134338|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134339|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14134340|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14134341|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
14134342|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
14134343|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14134344|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14134345|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14134346|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14134347|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
14134348|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
14134349|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134350|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134351|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
14134352|NCT03396575|Fludarabine|fludarabine|mesh-list
14134353|NCT03396575|Vaccines|vaccines|mesh-list
14134354|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
14134355|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134356|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134357|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134358|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14134359|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
14134360|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134361|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134362|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14763916|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14763917|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
14763918|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14763919|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14763920|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14763921|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14763922|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
14763923|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14134372|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
13950359|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950360|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
13950361|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950362|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13950363|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13950364|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13950365|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14134373|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14134374|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
14134375|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950366|NCT03223220|Midazolam|midazolam|mesh-list
13950367|NCT03223220|Ketamine|ketamine|mesh-list
13950368|NCT03223220|Analgesics|analgesics|mesh-ancestor
13950369|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
13950370|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950371|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950372|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13950373|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13950374|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
13950375|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
13950376|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134376|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
14134377|NCT03200288|Protective Agents|protective agents|mesh-ancestor
14134378|NCT03164772|Durvalumab|durvalumab|mesh-list
14134379|NCT03164772|Tremelimumab|tremelimumab|mesh-list
14134380|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134381|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134382|NCT03132532|Paclitaxel|paclitaxel|mesh-list
14134383|NCT03132532|Carboplatin|carboplatin|mesh-list
14134384|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14134385|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134386|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
14134387|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
14134388|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
14134389|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134390|NCT03122496|Durvalumab|durvalumab|mesh-list
14134391|NCT03122496|Tremelimumab|tremelimumab|mesh-list
14134392|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134393|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134394|NCT03066739|Remifentanil|remifentanil|mesh-list
14134395|NCT03066739|Naloxone|naloxone|mesh-list
14134396|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14134397|NCT03066739|Narcotics|narcotics|mesh-ancestor
14134398|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134399|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134400|NCT03066739|Analgesics|analgesics|mesh-ancestor
14134401|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
14134402|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134403|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14134404|NCT03061474|Niacinamide|niacinamide|mesh-list
14134405|NCT03061474|Niacin|niacin|mesh-list
14134406|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
14134407|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
13950377|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13950378|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13950379|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950380|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950381|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13950382|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13950383|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13950384|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13950385|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950386|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
13950387|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
14134408|NCT03061474|Vitamins|vitamins|mesh-ancestor
14134409|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
14134410|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134411|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14134412|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
14134413|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134414|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14134415|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
14134416|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
14134417|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134418|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134419|NCT02963831|Durvalumab|durvalumab|mesh-list
14134420|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134421|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134422|NCT02929485|Bromocriptine|bromocriptine|mesh-list
14763924|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14763925|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
13950388|NCT03223376|Paclitaxel|paclitaxel|mesh-list
13950389|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14134423|NCT02929485|Tolcapone|tolcapone|mesh-list
14134424|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14134425|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14134426|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
14134427|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950390|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13950391|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950392|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
13950393|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
13950394|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
13950395|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950396|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13950397|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13950398|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950399|NCT03223103|Poly ICLC|poly iclc|mesh-list
13950400|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
13950401|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
13950402|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950403|NCT03223025|Hormones|hormones|mesh-list
13950404|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950405|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763926|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14763927|NCT00613470|Citalopram|citalopram|mesh-list
14763928|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14763929|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14763930|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14763931|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763932|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134428|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134429|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
14134430|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
14134431|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134432|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134433|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14134434|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134435|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
14134436|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14134437|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14134438|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14134439|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
14134440|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134441|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134442|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134443|NCT02849639|Scopolamine|scopolamine|mesh-list
14134444|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14134445|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14134446|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
14134447|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
14134448|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134449|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134450|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14134451|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
14134452|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14134453|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
14134454|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134455|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134456|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14134457|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
13950406|NCT03222960|Propolis|propolis|mesh-list
13950407|NCT03222960|Fluorides|fluorides|mesh-list
13950408|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
13950409|NCT03222960|Protective Agents|protective agents|mesh-ancestor
13950410|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950411|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950412|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
13950413|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950414|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962701|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
13962702|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962703|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962704|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962705|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962706|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13962707|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13962708|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962709|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13962710|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13950415|NCT03222544|Methylene Blue|methylene blue|mesh-list
13950416|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950417|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950418|NCT03222765|Metformin|metformin|mesh-list
13950419|NCT03222765|Linagliptin|linagliptin|mesh-list
13950420|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13950421|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950422|NCT03222765|Incretins|incretins|mesh-ancestor
13950423|NCT03222765|Hormones|hormones|mesh-ancestor
14134458|NCT02829502|Exenatide|exenatide|mesh-list
14134459|NCT02829502|Glucagon|glucagon|mesh-list
14134460|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14134461|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14134462|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134463|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14134464|NCT02829502|Incretins|incretins|mesh-ancestor
14134465|NCT02829502|Hormones|hormones|mesh-ancestor
14936905|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14936906|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936907|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936908|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
14936909|NCT01471925|Esomeprazole|esomeprazole|mesh-list
13950424|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14134466|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14134467|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14134476|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
13950425|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13950426|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
13950427|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950428|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950429|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13950430|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13950431|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950432|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950433|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
13950434|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950435|NCT03222687|Prednisone|prednisone|mesh-list
13950436|NCT03222687|Tacrolimus|tacrolimus|mesh-list
13950437|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950438|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
13950439|NCT03222687|Hormones|hormones|mesh-ancestor
13950440|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950441|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950442|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14134477|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
14134478|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14134479|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14134480|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134481|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134482|NCT02795351|Urological Agents|urological agents|mesh-ancestor
13950443|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950444|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13950445|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
13950446|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13950447|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950448|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950449|NCT03222518|Acetaminophen|acetaminophen|mesh-list
13950450|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
13950451|NCT03222518|Piroxicam|piroxicam|mesh-list
13950452|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950453|NCT03222518|Analgesics|analgesics|mesh-ancestor
13950454|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
13950455|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950456|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950457|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
14134483|NCT02735239|Leucovorin|leucovorin|mesh-list
14134484|NCT02735239|Paclitaxel|paclitaxel|mesh-list
14936910|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14936911|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14936912|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14936913|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936914|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936915|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14936916|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936917|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14134485|NCT02735239|Docetaxel|docetaxel|mesh-list
14134486|NCT02735239|Carboplatin|carboplatin|mesh-list
14134487|NCT02735239|Fluorouracil|fluorouracil|mesh-list
14134488|NCT02735239|Capecitabine|capecitabine|mesh-list
13950458|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950459|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950460|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13950461|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950462|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950463|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
13950464|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950465|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950466|NCT03222206|Analgesics|analgesics|mesh-ancestor
13950467|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
13950468|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950469|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950470|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950471|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950472|NCT03222076|Nivolumab|nivolumab|mesh-list
13950473|NCT03222076|Ipilimumab|ipilimumab|mesh-list
13950474|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950475|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950476|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13950477|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950478|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
13950479|NCT03222323|Ropivacaine|ropivacaine|mesh-list
13950480|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13950481|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950482|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950483|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950484|NCT03222323|Analgesics|analgesics|mesh-ancestor
13950485|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
13950486|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950487|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13950488|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13950489|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13950490|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
13950491|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134489|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
14134490|NCT02735239|Durvalumab|durvalumab|mesh-list
14134491|NCT02735239|Tremelimumab|tremelimumab|mesh-list
14134492|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14134493|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134494|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
14134495|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
14134496|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
14134497|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134498|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
14134499|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14134500|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134501|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
14134502|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134503|NCT02735239|Antidotes|antidotes|mesh-ancestor
14134504|NCT02735239|Protective Agents|protective agents|mesh-ancestor
14134505|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
14134506|NCT02735239|Vitamins|vitamins|mesh-ancestor
14134507|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
14134508|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134509|NCT02733133|Testosterone|testosterone|mesh-list
14134510|NCT02733133|Androgens|androgens|mesh-ancestor
14134511|NCT02733133|Hormones|hormones|mesh-ancestor
14936918|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936919|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936920|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
14936921|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
14936922|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14936923|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936924|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14134512|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14134513|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763933|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
14763934|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763935|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14936925|NCT01471990|Protective Agents|protective agents|mesh-ancestor
14177843|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13950492|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950493|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
14763936|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
14134519|NCT02697383|Dexamethasone|dexamethasone|mesh-list
14134520|NCT02697383|Ixazomib|ixazomib|mesh-list
14134521|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134522|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
14134523|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
14134524|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134525|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134526|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14134527|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
14134528|NCT02697383|Hormones|hormones|mesh-ancestor
14134529|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14134530|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14134531|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134532|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
13950494|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
13950495|NCT03222089|Leucovorin|leucovorin|mesh-list
13950496|NCT03222089|Fluorouracil|fluorouracil|mesh-list
13950497|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
13950498|NCT03222089|Irinotecan|irinotecan|mesh-list
13950499|NCT03222089|Interleukin-2|interleukin-2|mesh-list
13950500|NCT03222089|Molgramostim|molgramostim|mesh-list
13950501|NCT03222089|Sargramostim|sargramostim|mesh-list
13950502|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
13950503|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
13950504|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950505|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13950506|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950507|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13950508|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
14134533|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134534|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134535|NCT02683265|Methylphenidate|methylphenidate|mesh-list
14134536|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14134537|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134538|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14134539|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14134540|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134541|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134542|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
14134543|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14763937|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950509|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950510|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13950511|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13950512|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950513|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950514|NCT03222089|Analgesics|analgesics|mesh-ancestor
13950515|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
13950516|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950517|NCT03222089|Antidotes|antidotes|mesh-ancestor
13950518|NCT03222089|Protective Agents|protective agents|mesh-ancestor
14763938|NCT00613496|Irbesartan|irbesartan|mesh-list
14763939|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14763940|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14763941|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14763942|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763943|NCT00613561|Fludarabine|fludarabine|mesh-list
14763944|NCT00613561|Busulfan|busulfan|mesh-list
14763945|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14763946|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763947|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763948|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14763949|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
14763950|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763951|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
14763952|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14763953|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14763954|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14763955|NCT00613600|Cathartics|cathartics|mesh-ancestor
13950519|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
13950520|NCT03222089|Vitamins|vitamins|mesh-ancestor
13950521|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
13950522|NCT03222310|Itraconazole|itraconazole|mesh-list
13950523|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
13950524|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950525|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13950526|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13950527|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950528|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950529|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13950530|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
13950531|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950532|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950533|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13950534|NCT03222167|Grazoprevir|grazoprevir|mesh-list
13950535|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
13950536|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950537|NCT03221816|Folic Acid|folic acid|mesh-list
13950538|NCT03221816|Pyridoxine|pyridoxine|mesh-list
13950539|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
13950540|NCT03221816|Hematinics|hematinics|mesh-ancestor
13950541|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
13950542|NCT03221816|Vitamins|vitamins|mesh-ancestor
13950543|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
13950544|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763956|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14763957|NCT00613613|Fenofibrate|fenofibrate|mesh-list
14763958|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14763959|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
14763960|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763961|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14763962|NCT00613665|Vaccines|vaccines|mesh-list
14134571|NCT02604446|Oxycodone|oxycodone|mesh-list
14134572|NCT02604446|Tapentadol|tapentadol|mesh-list
14134573|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13950545|NCT03221855|Domperidone|domperidone|mesh-list
13950546|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
13950547|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
13950548|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950549|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950550|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950551|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13950552|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
13950553|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950554|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950555|NCT03221907|Pregabalin|pregabalin|mesh-list
13950556|NCT03221907|Analgesics|analgesics|mesh-ancestor
13950557|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
13950558|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950559|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134574|NCT02604446|Narcotics|narcotics|mesh-ancestor
14134575|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134576|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134577|NCT02604446|Analgesics|analgesics|mesh-ancestor
14134578|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
14134579|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134580|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14134581|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14134582|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134583|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134584|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
14134585|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134586|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
14134587|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134588|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
14134589|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14134590|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
14134591|NCT02529813|Fludarabine|fludarabine|mesh-list
14134592|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
14134593|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134594|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
14134595|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134596|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134597|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13950560|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
14134598|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
13950561|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13950562|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950563|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134599|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134600|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134601|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14134602|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14134603|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
14134604|NCT02488967|Paclitaxel|paclitaxel|mesh-list
14134605|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
14134606|NCT02488967|Carboplatin|carboplatin|mesh-list
14134607|NCT02488967|Doxorubicin|doxorubicin|mesh-list
14134608|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14134609|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14134610|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14134611|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134612|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
14134613|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
14134614|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
14134615|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134616|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134617|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
14134618|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134619|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134620|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14134621|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
13950564|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13950565|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13950566|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13950567|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950568|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950569|NCT03221881|Docetaxel|docetaxel|mesh-list
13950570|NCT03221881|Doxorubicin|doxorubicin|mesh-list
13950571|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13950572|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950573|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
13950574|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
13950575|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
13950576|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950577|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13950578|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13950579|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13950580|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950581|NCT03221946|Diclofenac|diclofenac|mesh-list
13950582|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950583|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950584|NCT03221946|Analgesics|analgesics|mesh-ancestor
13950585|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
13950586|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950587|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950588|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950589|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950590|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13950591|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950592|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950593|NCT03221998|Acetaminophen|acetaminophen|mesh-list
13950594|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950595|NCT03221998|Analgesics|analgesics|mesh-ancestor
13950596|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
14134622|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14134623|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14134624|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14134625|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14134626|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134627|NCT02341625|Nivolumab|nivolumab|mesh-list
14134628|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134629|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134630|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14134631|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134632|NCT02117076|Gabapentin|gabapentin|mesh-list
14134633|NCT02117076|Analgesics|analgesics|mesh-ancestor
14134634|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
14134635|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134636|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134637|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
13950597|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134638|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13950598|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950599|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
13950600|NCT03221569|Ketorolac|ketorolac|mesh-list
13950601|NCT03221569|Ketamine|ketamine|mesh-list
13950602|NCT03221569|Analgesics|analgesics|mesh-ancestor
13950603|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
13950604|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950605|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950606|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13950607|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13950608|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
13950609|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
13950610|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950611|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13950612|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14134639|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14134640|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134641|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14134642|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14134643|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14134644|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134645|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134646|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
14134647|NCT02099591|Naloxegol|naloxegol|mesh-list
14134648|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14134649|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134650|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
14134651|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134652|NCT01710176|Gemcitabine|gemcitabine|mesh-list
14134653|NCT01710176|Docetaxel|docetaxel|mesh-list
14134654|NCT01710176|Etoposide|etoposide|mesh-list
14134655|NCT01710176|Epirubicin|epirubicin|mesh-list
14134656|NCT01710176|Ifosfamide|ifosfamide|mesh-list
14134657|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
14134658|NCT01710176|Dacarbazine|dacarbazine|mesh-list
14134659|NCT01710176|Trabectedin|trabectedin|mesh-list
14134660|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14134661|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
14134662|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134663|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134664|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
14134665|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14134666|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134667|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134668|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
14134669|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134670|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
14134671|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
14134672|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
14134673|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14134674|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14134675|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14134676|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14134677|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14134678|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
14134679|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14134680|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14134681|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134682|NCT00584246|Pregabalin|pregabalin|mesh-list
14134683|NCT00584246|Analgesics|analgesics|mesh-ancestor
14134684|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
14134685|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134686|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134687|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
14134688|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14134689|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134690|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134691|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14134692|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14134693|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14134694|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134695|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14134696|NCT00584025|Levetiracetam|levetiracetam|mesh-list
14134697|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
14134698|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
14134699|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
14134700|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13950613|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950614|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950615|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950616|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950617|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950618|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950619|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14134701|NCT05124353|Protective Agents|protective agents|mesh-ancestor
14134702|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134703|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
14134704|NCT05124314|Misoprostol|misoprostol|mesh-list
14134705|NCT05124314|Mifepristone|mifepristone|mesh-list
14134706|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14134707|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
14134708|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14134709|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134710|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14134711|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14134712|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
14134713|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14134714|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14134715|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14134716|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14134717|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
14134718|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14134719|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14134720|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
14134721|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14134722|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
14134723|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14134724|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14177844|NCT04752163|Antibodies|antibodies|mesh-list
14177845|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
14177846|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14177847|NCT04752163|Lenograstim|lenograstim|mesh-list
14177848|NCT04752163|BB 1101|bb 1101|mesh-list
14177849|NCT04752163|Mesna|mesna|mesh-list
14177850|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14177851|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
14177852|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177853|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14177854|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14177855|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
14177856|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177857|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177858|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14177859|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14177860|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
14177861|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
14177862|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177863|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177864|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
14177865|NCT04752163|Hormones|hormones|mesh-ancestor
14177866|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177867|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14177868|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
14177869|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177870|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14177871|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
14177872|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177873|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14177874|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
14177875|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
14177876|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14177877|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14177878|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
14177879|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177880|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14177881|NCT04752163|Antidotes|antidotes|mesh-ancestor
13950620|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177882|NCT04752163|Protective Agents|protective agents|mesh-ancestor
14177883|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
14177884|NCT04752163|Vitamins|vitamins|mesh-ancestor
14177885|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
14177886|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13950621|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
14134725|NCT05123976|Olanzapine|olanzapine|mesh-list
14134726|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
14134727|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
14134728|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134729|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134730|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14134731|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14134732|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14134733|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134734|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950622|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13950623|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13950624|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
13950625|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950626|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950627|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950628|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
14134735|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14134736|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14134737|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134738|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134739|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134740|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
14134741|NCT05123781|Metformin|metformin|mesh-list
14134742|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14134743|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134744|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14134745|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134746|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134747|NCT05123092|Morphine|morphine|mesh-list
13950629|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
13950630|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950631|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
13950632|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13950633|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
13950634|NCT03221426|Leucovorin|leucovorin|mesh-list
13950635|NCT03221426|Docetaxel|docetaxel|mesh-list
13950636|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
13950637|NCT03221426|Fluorouracil|fluorouracil|mesh-list
13950638|NCT03221426|Capecitabine|capecitabine|mesh-list
13950639|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
13950640|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950641|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
13950642|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
13950643|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
13950644|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950645|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950646|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
13950647|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13950648|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14134748|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14134749|NCT05123092|Narcotics|narcotics|mesh-ancestor
14134750|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134751|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134752|NCT05123092|Analgesics|analgesics|mesh-ancestor
14134753|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
14134754|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134755|NCT05123053|Amifampridine|amifampridine|mesh-list
14134756|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14134757|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134758|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134759|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14134760|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134761|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134762|NCT05122884|Milrinone|milrinone|mesh-list
14134763|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14134764|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14134765|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
14134766|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14134767|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13950649|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
13950650|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950651|NCT03221426|Antidotes|antidotes|mesh-ancestor
13950652|NCT03221426|Protective Agents|protective agents|mesh-ancestor
14134768|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134769|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134770|NCT05122884|Protective Agents|protective agents|mesh-ancestor
14134771|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134772|NCT05122780|Acetylcholine|acetylcholine|mesh-list
14134773|NCT05122780|Anticoagulants|anticoagulants|mesh-list
14134774|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14134775|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14134776|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14134777|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
14134778|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950653|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
14134779|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134780|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134781|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
14134782|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14134783|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
14134784|NCT05122767|Dolutegravir|dolutegravir|mesh-list
14134785|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14134786|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14134787|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134788|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134789|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14134790|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14134791|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
14134792|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14134793|NCT05122741|Aspirin|aspirin|mesh-list
14134794|NCT05122741|Clopidogrel|clopidogrel|mesh-list
14134795|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14134796|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14134797|NCT05122741|Analgesics|analgesics|mesh-ancestor
14134798|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
14134799|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134800|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134801|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134802|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134803|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14134804|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14134805|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134806|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14134807|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14134808|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134809|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
14134810|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14134811|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14134812|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14134813|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
14134814|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134815|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
14134816|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134817|NCT05115773|Anesthetics|anesthetics|mesh-list
14134818|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134819|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763963|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
14763964|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763965|NCT00613717|Vitamin D|vitamin d|mesh-list
14763966|NCT00613717|Vitamins|vitamins|mesh-list
14763967|NCT00613717|Folic Acid|folic acid|mesh-list
14763968|NCT00613717|Vitamin A|vitamin a|mesh-list
14763969|NCT00613717|Iron|iron|mesh-list
14763970|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
14763971|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
14763972|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
14763973|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763974|NCT00613717|Trace Elements|trace elements|mesh-ancestor
14763975|NCT00613717|Hematinics|hematinics|mesh-ancestor
13950654|NCT03221426|Vitamins|vitamins|mesh-ancestor
13950655|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
13950656|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
13950657|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
13950658|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950659|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
13950660|NCT03221634|Daratumumab|daratumumab|mesh-list
13950661|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950662|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950663|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
14763976|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
13950664|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13950665|NCT03221166|Thalidomide|thalidomide|mesh-list
13950666|NCT03221166|Infliximab|infliximab|mesh-list
13950667|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
13950668|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950669|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950670|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13950671|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
13950672|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763977|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14763978|NCT00613717|Protective Agents|protective agents|mesh-ancestor
14763979|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14763980|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14763981|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14134836|NCT05089630|Vaccines|vaccines|mesh-list
14134837|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
14134838|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950673|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
13950674|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13950675|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950676|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13950677|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13950678|NCT03221166|Growth Substances|growth substances|mesh-ancestor
13950679|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
13950680|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950681|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
13950682|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13950683|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
13950684|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950685|NCT03221231|Expectorants|expectorants|mesh-ancestor
13950686|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
13950687|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13950688|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
13950689|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950690|NCT03221231|Protective Agents|protective agents|mesh-ancestor
13950691|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950692|NCT03221231|Antidotes|antidotes|mesh-ancestor
13962711|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962712|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
14134848|NCT05073718|Aspirin|aspirin|mesh-list
14134849|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14134850|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14134851|NCT05073718|Analgesics|analgesics|mesh-ancestor
14134852|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
14134853|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134854|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134855|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134856|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14134857|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14134858|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14134859|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134860|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14134861|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14936926|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963523|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
13963524|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963525|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13963526|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13963527|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13963528|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
13963529|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963530|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963531|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13963532|NCT03143972|Narcotics|narcotics|mesh-ancestor
13963533|NCT03143530|Ropivacaine|ropivacaine|mesh-list
13963534|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134862|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134863|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
14134864|NCT05069974|Linezolid|linezolid|mesh-list
14134865|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14134866|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950693|NCT03221621|Adalimumab|adalimumab|mesh-list
13950694|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950695|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950696|NCT03221023|Vancomycin|vancomycin|mesh-list
13950697|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13950698|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950699|NCT03220932|Bevacizumab|bevacizumab|mesh-list
13950700|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950701|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950702|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13950703|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13950704|NCT03220932|Growth Substances|growth substances|mesh-ancestor
13950705|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950706|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
13950707|NCT03221036|Vedolizumab|vedolizumab|mesh-list
13950708|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950709|NCT03220815|Methamphetamine|methamphetamine|mesh-list
13950710|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13950711|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950712|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
13950713|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
13950714|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950715|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
13950716|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950717|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950718|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
13950719|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13950720|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13950721|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950722|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13950723|NCT03220841|Adalimumab|adalimumab|mesh-list
13950724|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950725|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13950726|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
13950727|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13950728|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950729|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950730|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950731|NCT03220880|Analgesics|analgesics|mesh-ancestor
13950732|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
14134867|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14134868|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134869|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134870|NCT05062031|Atropine|atropine|mesh-list
14134871|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14134872|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14134873|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14134874|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14134875|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
14134876|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134877|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134878|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14134879|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
14134880|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
14134881|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
14134882|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14134883|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14134884|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
14134885|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14134886|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134887|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14134888|NCT05052099|Bevacizumab|bevacizumab|mesh-list
14134889|NCT05052099|Atezolizumab|atezolizumab|mesh-list
14134890|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14134891|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134892|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14134893|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14134894|NCT05052099|Growth Substances|growth substances|mesh-ancestor
14134895|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134896|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
14177887|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14177888|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14177889|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14177890|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
14177891|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14177892|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14177893|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14177894|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
14177895|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13950733|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950734|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13950735|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13950736|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13950737|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
13950738|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950739|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950740|NCT03220867|Risperidone|risperidone|mesh-list
13950741|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14177896|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14177897|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14177898|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14177899|NCT04752059|Trastuzumab|trastuzumab|mesh-list
14177900|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14177901|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177902|NCT04752111|Esmolol|esmolol|mesh-list
14177903|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14177904|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14177905|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14177906|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177907|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177908|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177909|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177910|NCT04751994|Sorbitol|sorbitol|mesh-list
14177911|NCT04751994|Cathartics|cathartics|mesh-ancestor
14177912|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177913|NCT04751955|Capecitabine|capecitabine|mesh-list
14177914|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14177915|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
14177916|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177917|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177918|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
14177919|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14177920|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14177921|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
14177922|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177923|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177924|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177925|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
14177926|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
14177927|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177928|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
14177929|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14177930|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
14177931|NCT04751929|Atezolizumab|atezolizumab|mesh-list
13950742|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
13950743|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950744|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950745|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950746|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13950747|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13950748|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950749|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950750|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13950751|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
13950752|NCT03220789|Methamphetamine|methamphetamine|mesh-list
13950753|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13950754|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950755|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
14177932|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177933|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14177934|NCT04751500|Metronidazole|metronidazole|mesh-list
14134897|NCT05041920|Omeprazole|omeprazole|mesh-list
14134898|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14134899|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14134900|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14134901|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14134902|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134903|NCT05001802|Ropivacaine|ropivacaine|mesh-list
14134904|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134905|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
14134906|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134907|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134908|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
14134909|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134910|NCT04975958|Atezolizumab|atezolizumab|mesh-list
14134911|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134912|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14134913|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
14134914|NCT04921189|Thiamine|thiamine|mesh-list
14134915|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
14134916|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
14134917|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134918|NCT04921189|Protective Agents|protective agents|mesh-ancestor
14134919|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134920|NCT04921189|Vitamins|vitamins|mesh-ancestor
14134921|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
14134922|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
14134923|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14134924|NCT04875871|Copper|copper|mesh-list
14134925|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14134926|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14134927|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134928|NCT04875871|Trace Elements|trace elements|mesh-ancestor
14134929|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
14134930|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134931|NCT04828538|Vitamin D|vitamin d|mesh-list
14134932|NCT04828538|Vitamins|vitamins|mesh-list
14134933|NCT04828538|Ascorbic Acid|ascorbic acid|mesh-list
14134934|NCT04828538|Folic Acid|folic acid|mesh-list
14134935|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
14134936|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
14134937|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134938|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14134939|NCT04828538|Antioxidants|antioxidants|mesh-ancestor
14134940|NCT04828538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134941|NCT04828538|Protective Agents|protective agents|mesh-ancestor
14134942|NCT04828538|Hematinics|hematinics|mesh-ancestor
14763982|NCT00613743|Morphine|morphine|mesh-list
14763983|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14763984|NCT00613743|Narcotics|narcotics|mesh-ancestor
14763985|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14763986|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14763987|NCT00613743|Analgesics|analgesics|mesh-ancestor
14763988|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
14763989|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14763990|NCT00613769|Metronidazole|metronidazole|mesh-list
14763991|NCT00613769|Trimethoprim|trimethoprim|mesh-list
14763992|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
14763993|NCT00613769|Cefuroxime|cefuroxime|mesh-list
14763994|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
14763995|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14763996|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14763997|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14763998|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14134960|NCT04827030|Ropivacaine|ropivacaine|mesh-list
14134961|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
14134962|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
14134963|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134964|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134965|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
14134966|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134967|NCT04781725|Cisplatin|cisplatin|mesh-list
14134968|NCT04781725|Vinblastine|vinblastine|mesh-list
14134969|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14134970|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14134971|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
14134972|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
14134973|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
14177935|NCT04751500|Clindamycin|clindamycin|mesh-list
14763999|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14936927|NCT01471990|Growth Substances|growth substances|mesh-ancestor
13950756|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
13950757|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950758|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
13950759|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950760|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950761|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
13950762|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13950763|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13950764|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950765|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13950766|NCT03220555|Lidocaine|lidocaine|mesh-list
14134974|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134975|NCT04737603|Buprenorphine|buprenorphine|mesh-list
14134976|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14936928|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14936929|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936930|NCT01472016|Docetaxel|docetaxel|mesh-list
14936931|NCT01472016|Cetuximab|cetuximab|mesh-list
14936932|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14936933|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936934|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
13950767|NCT03220555|Prilocaine|prilocaine|mesh-list
13950768|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
13950769|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
13950770|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950771|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950772|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
13950773|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950774|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13950775|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13950776|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13950777|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950778|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950779|NCT03220256|Lamotrigine|lamotrigine|mesh-list
13950780|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
13950781|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13950782|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950783|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950784|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13950785|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950786|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13950787|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13950788|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950789|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950790|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13950791|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
13950792|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
13950793|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950794|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950795|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950796|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
13950797|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13950798|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950799|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950800|NCT03220425|Insulin|insulin|mesh-list
13950801|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13950802|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
13950803|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
13950804|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
13950805|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
13950806|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13950807|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936935|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936936|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
13950808|NCT03220542|Amoxicillin|amoxicillin|mesh-list
13950809|NCT03220542|Clarithromycin|clarithromycin|mesh-list
13950810|NCT03220542|Sulforaphane|sulforaphane|mesh-list
13950811|NCT03220542|Esomeprazole|esomeprazole|mesh-list
13950812|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13950813|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950814|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13950815|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950816|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13950817|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936937|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936938|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14936939|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14936940|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936941|NCT01472029|Leucovorin|leucovorin|mesh-list
14936942|NCT01472029|Docetaxel|docetaxel|mesh-list
14936943|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
14936944|NCT01472029|Trastuzumab|trastuzumab|mesh-list
14134977|NCT04737603|Naloxone|naloxone|mesh-list
14134978|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14134979|NCT04737603|Narcotics|narcotics|mesh-ancestor
14134980|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14134981|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14134982|NCT04737603|Analgesics|analgesics|mesh-ancestor
14134983|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
14134984|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14134985|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14134986|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
14134987|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14134988|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14134989|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134990|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
14134991|NCT04651166|Coagulants|coagulants|mesh-ancestor
14134992|NCT04637620|Sertraline|sertraline|mesh-list
14134993|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
14134994|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14134995|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14134996|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14134997|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14134998|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14134999|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135000|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
14135001|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135002|NCT04595994|Gemcitabine|gemcitabine|mesh-list
14135003|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14135004|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
13950818|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950819|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13950820|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13950821|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13950822|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13950823|NCT03220542|Protective Agents|protective agents|mesh-ancestor
13950824|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950825|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950826|NCT03220490|Timolol|timolol|mesh-list
13950827|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13950828|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13950829|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13950830|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
13950831|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950832|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950833|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950834|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13950835|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13950836|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13950837|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13950838|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14135005|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135006|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135007|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
14135008|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135009|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135010|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135011|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
14135012|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936945|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936946|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
14936947|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
14936948|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
14936949|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936950|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14936951|NCT01472029|Antidotes|antidotes|mesh-ancestor
14936952|NCT01472029|Protective Agents|protective agents|mesh-ancestor
14135013|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
14135014|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135015|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135016|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14135017|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14135018|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135019|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135020|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135021|NCT04563559|Prednisolone|prednisolone|mesh-list
14135022|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14135023|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
14135024|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14135025|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
14135026|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14135027|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
14135028|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135029|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
14135030|NCT04563559|Hormones|hormones|mesh-ancestor
14135031|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135032|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135033|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14135034|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135035|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
14135036|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
14135037|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135038|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14135039|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14135040|NCT04563559|Protective Agents|protective agents|mesh-ancestor
14135041|NCT04359017|Lidocaine|lidocaine|mesh-list
14135042|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
14135043|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
14135044|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135045|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950839|NCT03220152|Tenofovir|tenofovir|mesh-list
13950840|NCT03220152|Emtricitabine|emtricitabine|mesh-list
13950841|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
14135046|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
14135047|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135048|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14135049|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14135050|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14135051|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135052|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135053|NCT04353310|Curcumin|curcumin|mesh-list
13950842|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950843|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14135054|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14135055|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14936953|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936954|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
14936955|NCT01472029|Vitamins|vitamins|mesh-ancestor
14936956|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
13950844|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13950845|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950846|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950847|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13950848|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13950849|NCT03220464|Interferons|interferons|mesh-list
13950850|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
13950851|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950852|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
13950853|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13950854|NCT03220126|Mirikizumab|mirikizumab|mesh-list
13950855|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13950856|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13950857|NCT03220126|Analgesics|analgesics|mesh-ancestor
13950858|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
13950859|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950860|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950861|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950862|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135056|NCT04353310|Analgesics|analgesics|mesh-ancestor
14135057|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
14183827|NCT04725383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14936957|NCT01472055|Fludarabine|fludarabine|mesh-list
13950863|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13950864|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950865|NCT03220191|Palbociclib|palbociclib|mesh-list
13950866|NCT03220191|Rabeprazole|rabeprazole|mesh-list
13950867|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950868|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950869|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950870|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950871|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13950872|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950873|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13950874|NCT03220113|Thiamine|thiamine|mesh-list
13950875|NCT03220113|Dexamethasone|dexamethasone|mesh-list
13950876|NCT03220113|Lidocaine|lidocaine|mesh-list
13950877|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950878|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
13950879|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
13950880|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950881|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950882|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950883|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
13950884|NCT03220113|Hormones|hormones|mesh-ancestor
13950885|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950886|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13950887|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950888|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
13950889|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
13950890|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950891|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
13950892|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13950893|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13950894|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13950895|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950896|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135058|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135059|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135060|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135061|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135062|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135063|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135064|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135065|NCT04345341|Bupivacaine|bupivacaine|mesh-list
14135066|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
14135067|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
14135068|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135069|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135070|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
14135071|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135072|NCT04330625|Volagidemab|volagidemab|mesh-list
14135073|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14135074|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177936|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14177937|NCT04751500|Misoprostol|misoprostol|mesh-list
14177938|NCT04751500|Mifepristone|mifepristone|mesh-list
14177939|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177940|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14177941|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14177942|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14177943|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
14177944|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14177945|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177946|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14177947|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14177948|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
14177949|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14177950|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14177951|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177952|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14177953|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14177954|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14936958|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950897|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
13950898|NCT03220113|Vitamins|vitamins|mesh-ancestor
13950899|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
14936959|NCT01472146|Doxorubicin|doxorubicin|mesh-list
14135075|NCT04234022|Pomalidomide|pomalidomide|mesh-list
14135076|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
14135077|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135078|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14135079|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14135080|NCT04234022|Growth Substances|growth substances|mesh-ancestor
13950900|NCT03219788|Remifentanil|remifentanil|mesh-list
13950901|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13950902|NCT03219788|Narcotics|narcotics|mesh-ancestor
13950903|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950904|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135081|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
14135082|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135083|NCT04165993|Docetaxel|docetaxel|mesh-list
14135084|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135085|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14135086|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14135087|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14135088|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135089|NCT04158635|Gemcitabine|gemcitabine|mesh-list
14135090|NCT04158635|Paclitaxel|paclitaxel|mesh-list
14135091|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14135092|NCT04158635|Bosentan|bosentan|mesh-list
14135093|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14135094|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135095|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
14135096|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
14135097|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
14135098|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135099|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14135100|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
14135101|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
14135102|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135103|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135104|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135105|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
14135106|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135107|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14135108|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14135109|NCT04070378|Daratumumab|daratumumab|mesh-list
14135110|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135111|NCT04064294|Levodopa|levodopa|mesh-list
14135112|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14135113|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14135114|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
14135115|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135116|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135117|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135118|NCT03991988|Montelukast|montelukast|mesh-list
14135119|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14936960|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950905|NCT03219788|Analgesics|analgesics|mesh-ancestor
13950906|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
13950907|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950908|NCT03219853|Selenium|selenium|mesh-list
13950909|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
13950910|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950911|NCT03219853|Protective Agents|protective agents|mesh-ancestor
13950912|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950913|NCT03219853|Trace Elements|trace elements|mesh-ancestor
13950914|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
13950915|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13950916|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950917|NCT03219970|Osimertinib|osimertinib|mesh-list
13950918|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950919|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950920|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950921|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950922|NCT03220009|Nivolumab|nivolumab|mesh-list
13950923|NCT03220009|Ipilimumab|ipilimumab|mesh-list
13950924|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13950925|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950926|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135120|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
14135121|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14135122|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
14135123|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135124|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135125|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14135126|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14135127|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135128|NCT03984045|Lidocaine|lidocaine|mesh-list
14135129|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
14135130|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
14135131|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
14135132|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135133|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135134|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
14135135|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135136|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13950927|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950928|NCT03219983|Bupivacaine|bupivacaine|mesh-list
13950929|NCT03219983|Ropivacaine|ropivacaine|mesh-list
13950930|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
13950931|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
13950932|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950933|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950934|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
13950935|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950936|NCT03219710|Dexamethasone|dexamethasone|mesh-list
13950937|NCT03219710|Ondansetron|ondansetron|mesh-list
13950938|NCT03219710|Olanzapine|olanzapine|mesh-list
14135137|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14135138|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14135139|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135140|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135141|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
14764000|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14764001|NCT00613769|Renal Agents|renal agents|mesh-ancestor
14764002|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
14764003|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14764004|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764005|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764006|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14764007|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14764008|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14764009|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
14764010|NCT00613782|Testosterone|testosterone|mesh-list
14764011|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
14764012|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
14764013|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14936961|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14135142|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
14135143|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14135144|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14135145|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14135146|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14135147|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14135148|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
14135149|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135150|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
14936962|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14936963|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14936964|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936965|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936966|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
14936967|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14936968|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936969|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936970|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14936971|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14936972|NCT01472263|Protective Agents|protective agents|mesh-ancestor
14936973|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936974|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
14936975|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14936976|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
14936977|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14936978|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
14135151|NCT03930602|BMS-986165|bms-986165|mesh-list
14135152|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14135153|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14135154|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135155|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135156|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14135157|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14135158|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14135159|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135160|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135161|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135162|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
14135163|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14135164|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
14135165|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14135166|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14135167|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135168|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13950939|NCT03219710|Aprepitant|aprepitant|mesh-list
13950940|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13950941|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
13950942|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
13950943|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13950944|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950945|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13950946|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
13950947|NCT03219710|Hormones|hormones|mesh-ancestor
13950948|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950949|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13950950|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950951|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
13950952|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
13950953|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13950954|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
13950955|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13950956|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950957|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13950958|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13950959|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13950960|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13950961|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13950962|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13950963|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13950964|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13950965|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14135169|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
14764014|NCT00613782|Androgens|androgens|mesh-ancestor
14764015|NCT00613782|Hormones|hormones|mesh-ancestor
14764016|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764017|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135170|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14135171|NCT03927144|Erenumab|erenumab|mesh-list
14135172|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14135173|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135174|NCT03927144|Analgesics|analgesics|mesh-ancestor
14135175|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
14135176|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135177|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135178|NCT03889795|Metformin|metformin|mesh-list
14135179|NCT03889795|Digoxin|digoxin|mesh-list
14135180|NCT03889795|Simvastatin|simvastatin|mesh-list
14135181|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14135182|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135183|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14135184|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14135185|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
14135186|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135187|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14764018|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14764019|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764020|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
14764021|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
14764022|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14764023|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
13950966|NCT03219554|Palbociclib|palbociclib|mesh-list
14135188|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14135189|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135190|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14135191|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14135192|NCT03889795|Protective Agents|protective agents|mesh-ancestor
14135193|NCT03872791|Paclitaxel|paclitaxel|mesh-list
14135194|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14135195|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135196|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
14135197|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
14135198|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
14135199|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764024|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764025|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764026|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14764027|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
13950967|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950968|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950969|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950970|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950971|NCT03219593|Apatinib|apatinib|mesh-list
14135200|NCT03843151|Itraconazole|itraconazole|mesh-list
14135201|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
14135202|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135203|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14135204|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14135205|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135206|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135207|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14135208|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
14135209|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135210|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135211|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14135212|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
14135213|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14135214|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14135215|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135216|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
14135217|NCT03822793|Coagulants|coagulants|mesh-ancestor
14135218|NCT03748134|Paclitaxel|paclitaxel|mesh-list
14135219|NCT03748134|Fluorouracil|fluorouracil|mesh-list
14135220|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14135221|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135222|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
14135223|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
14135224|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
14135225|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950972|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950973|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13950974|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14936979|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14936980|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14936981|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14135226|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
14135227|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14135228|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135229|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
14135230|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950975|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950976|NCT03219580|Fluorouracil|fluorouracil|mesh-list
13950977|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
13950978|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950979|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13950980|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13950981|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13950982|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
13950983|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135231|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
14764028|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14764029|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
14764030|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764031|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135232|NCT03710421|Fludarabine|fludarabine|mesh-list
14135233|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135234|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
14135235|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135236|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135237|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14135238|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
14135239|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135240|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135241|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14135242|NCT03703492|Estradiol|estradiol|mesh-list
14135243|NCT03703492|Estrogens|estrogens|mesh-ancestor
14135244|NCT03703492|Hormones|hormones|mesh-ancestor
14135245|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135246|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135247|NCT03664024|Carboplatin|carboplatin|mesh-list
14135248|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
14135249|NCT03664024|Pemetrexed|pemetrexed|mesh-list
14135250|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135251|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135252|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135253|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135254|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14135255|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14135256|NCT03663166|Nivolumab|nivolumab|mesh-list
14135257|NCT03663166|Ipilimumab|ipilimumab|mesh-list
14135258|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135259|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135260|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135261|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135262|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
13950984|NCT03219476|Tamoxifen|tamoxifen|mesh-list
13950985|NCT03219476|Letrozole|letrozole|mesh-list
13950986|NCT03219476|Anastrozole|anastrozole|mesh-list
13950987|NCT03219476|Exemestane|exemestane|mesh-list
13950988|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135263|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14135264|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14135265|NCT03554317|Nivolumab|nivolumab|mesh-list
14135266|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
14135267|NCT03554317|Testosterone|testosterone|mesh-list
14135268|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
14135269|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
14135270|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14135271|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135272|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135273|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135274|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135275|NCT03554317|Androgens|androgens|mesh-ancestor
14135276|NCT03554317|Hormones|hormones|mesh-ancestor
14135277|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135278|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135279|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14135280|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
14135281|NCT03434418|Osimertinib|osimertinib|mesh-list
14135282|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135283|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14135284|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135285|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135286|NCT03430063|Ipilimumab|ipilimumab|mesh-list
13950989|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13950990|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13950991|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13950992|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13950993|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13950994|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
13950995|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13950996|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13950997|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13950998|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13950999|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13951000|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13951001|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
14135287|NCT03430063|Cemiplimab|cemiplimab|mesh-list
13951002|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
13951003|NCT03219359|Vedolizumab|vedolizumab|mesh-list
13951004|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
13951005|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951006|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
13951007|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951008|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951009|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13951010|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
13951011|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951012|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951013|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13951014|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13951015|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
13951016|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
13951017|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951018|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13951019|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
13951020|NCT03219359|Hormones|hormones|mesh-ancestor
13951021|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135288|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135289|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135290|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135291|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135292|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
14135293|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135294|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135295|NCT03422731|Alovudine|alovudine|mesh-list
14135296|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
14135297|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764032|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14764033|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
13951022|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13951023|NCT03219359|Protective Agents|protective agents|mesh-ancestor
13951024|NCT03219671|Nivolumab|nivolumab|mesh-list
13951025|NCT03219671|Ipilimumab|ipilimumab|mesh-list
13951026|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951027|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951028|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13951029|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962713|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13962714|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
13962715|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962716|NCT03982030|Dalbavancin|dalbavancin|mesh-list
13962717|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962718|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962719|NCT03977363|Anticoagulants|anticoagulants|mesh-list
13962720|NCT03971110|Goserelin|goserelin|mesh-list
13962721|NCT03971110|Bicalutamide|bicalutamide|mesh-list
13962722|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962723|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962724|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
13962725|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
13962726|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962727|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962728|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
13962729|NCT03942653|Goserelin|goserelin|mesh-list
13962730|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951030|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
13951031|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
13951032|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951033|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
13951034|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951035|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951036|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13951037|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
13951038|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764034|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
14764035|NCT00613808|Protective Agents|protective agents|mesh-ancestor
14764036|NCT00613847|Trastuzumab|trastuzumab|mesh-list
14135304|NCT03306394|Trifluridine|trifluridine|mesh-list
14135305|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
14135306|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135307|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
14135308|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135309|NCT03290950|Dexamethasone|dexamethasone|mesh-list
14135310|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
14135311|NCT03290950|Lenalidomide|lenalidomide|mesh-list
14135312|NCT03290950|Daratumumab|daratumumab|mesh-list
14135313|NCT03290950|BB 1101|bb 1101|mesh-list
14135314|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135315|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
14135316|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
14135317|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135318|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135319|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14135320|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
14135321|NCT03290950|Hormones|hormones|mesh-ancestor
14135322|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135323|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14135324|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135325|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
14135326|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135327|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135328|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
14135329|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13951039|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951040|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13951041|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951042|NCT03219645|Aspirin|aspirin|mesh-list
13951043|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13951044|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951045|NCT03219645|Analgesics|analgesics|mesh-ancestor
13951046|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
13951047|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951048|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951049|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13951050|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951051|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13951052|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13951053|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951054|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13951055|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13951056|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951057|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
13951058|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
13951059|NCT03219177|Narcotics|narcotics|mesh-ancestor
13951060|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951061|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951062|NCT03219177|Analgesics|analgesics|mesh-ancestor
13951063|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
13951064|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951065|NCT03218969|Ecopipam|ecopipam|mesh-list
14135330|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14135331|NCT03290950|Growth Substances|growth substances|mesh-ancestor
14135332|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
14135333|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
14135334|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14135335|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14135336|NCT03249844|Prednisolone|prednisolone|mesh-list
14135337|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
14135338|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14135339|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
14135340|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135341|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
14135342|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
14135343|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135344|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135345|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14135346|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
14135347|NCT03249844|Hormones|hormones|mesh-ancestor
14135348|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135349|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14135350|NCT03249844|Protective Agents|protective agents|mesh-ancestor
14135351|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14135352|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135353|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
14135354|NCT03221257|Pirfenidone|pirfenidone|mesh-list
14135355|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14135356|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135357|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14135358|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
14135359|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135360|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135361|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135362|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135363|NCT03221257|Analgesics|analgesics|mesh-ancestor
14135364|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
14135365|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135366|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135367|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764037|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14764038|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14764039|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764040|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764041|NCT00613964|Diuretics|diuretics|mesh-list
14135368|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14135369|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135370|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135371|NCT03172754|Nivolumab|nivolumab|mesh-list
14135372|NCT03172754|Axitinib|axitinib|mesh-list
14135373|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135374|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135375|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135376|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135377|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14135378|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135379|NCT03044977|Octreotide|octreotide|mesh-list
14135380|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14135381|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14135382|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14177955|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14177956|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
14177957|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14936982|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
13951066|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13951067|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13951068|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951069|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951070|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13951071|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13951072|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
13951073|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951074|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14936983|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14936984|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936985|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14936986|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14936987|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14135389|NCT02755272|Gemcitabine|gemcitabine|mesh-list
14135390|NCT02755272|Carboplatin|carboplatin|mesh-list
14135391|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
14135392|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135393|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14135394|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
14135395|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135396|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
14135397|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135398|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135399|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135400|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
14135401|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135402|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135403|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
14135404|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
14135405|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14135406|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14135407|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135408|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135409|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135410|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135411|NCT02359513|Fluoxetine|fluoxetine|mesh-list
14135412|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
14135413|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14135414|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14135415|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135416|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135417|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135418|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
14135419|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936988|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14936989|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14936990|NCT01472406|Pancrelipase|pancrelipase|mesh-list
14936991|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14936992|NCT01472497|Pioglitazone|pioglitazone|mesh-list
14936993|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14936994|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14936995|NCT01472510|Ranibizumab|ranibizumab|mesh-list
14936996|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14936997|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14936998|NCT01472510|Growth Substances|growth substances|mesh-ancestor
14135420|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14135421|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14135422|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14135423|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14135424|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135425|NCT02267343|Nivolumab|nivolumab|mesh-list
14135426|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135427|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135428|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135429|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135430|NCT02261285|Nivolumab|nivolumab|mesh-list
14135431|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135432|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135433|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135434|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135435|NCT02256800|Leucovorin|leucovorin|mesh-list
14135436|NCT02256800|Bevacizumab|bevacizumab|mesh-list
14135437|NCT02256800|Irinotecan|irinotecan|mesh-list
14135438|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135439|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135440|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14135441|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14135442|NCT02256800|Growth Substances|growth substances|mesh-ancestor
14135443|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135444|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14135445|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14135446|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14135447|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135448|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135449|NCT02256800|Antidotes|antidotes|mesh-ancestor
14135450|NCT02256800|Protective Agents|protective agents|mesh-ancestor
14936999|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135451|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
14135452|NCT02256800|Vitamins|vitamins|mesh-ancestor
14135453|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
14135454|NCT02203682|Doxycycline|doxycycline|mesh-list
14478536|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478537|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478538|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
14478539|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478540|NCT02453360|Bupivacaine|bupivacaine|mesh-list
14478541|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
14478542|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
14478543|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478544|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478545|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
14478546|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951075|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
13951076|NCT03219008|Mirtazapine|mirtazapine|mesh-list
13951077|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
13951078|NCT03219008|Fluoxetine|fluoxetine|mesh-list
13951079|NCT03219008|Bupropion|bupropion|mesh-list
13951080|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
13951081|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14478547|NCT02453555|Empagliflozin|empagliflozin|mesh-list
14478548|NCT02453555|Linagliptin|linagliptin|mesh-list
14478549|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14478550|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478551|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13951082|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14135455|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135456|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135457|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
14135458|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14135459|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14135460|NCT02116335|Bosentan|bosentan|mesh-list
14135461|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14135462|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14135463|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135464|NCT01903486|Prednisone|prednisone|mesh-list
14135465|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135466|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
14135467|NCT01903486|Hormones|hormones|mesh-ancestor
14135468|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135469|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135470|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14135471|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478552|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951083|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13951084|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951085|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951086|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
13951087|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951088|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13951089|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
13951090|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13951091|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13951092|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13951093|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951094|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
13951095|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13951096|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951097|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13951098|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
13951099|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
13951100|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13951101|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13951102|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13951103|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13951104|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
13951105|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13951106|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13951107|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13951108|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14135472|NCT01811368|Cyclosporine|cyclosporine|mesh-list
14478553|NCT02453555|Incretins|incretins|mesh-ancestor
14135473|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
14135474|NCT01811368|Rituximab|rituximab|mesh-list
14135475|NCT01811368|Cyclosporins|cyclosporins|mesh-list
14135476|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
14135477|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14135478|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
14135479|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135480|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135481|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
14135482|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135483|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135484|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135485|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135486|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135487|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
14135488|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135489|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14135490|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14135491|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14135492|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14135493|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
14135494|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135495|NCT01611116|Sirolimus|sirolimus|mesh-list
14135496|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135497|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135498|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14135499|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135500|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
14135501|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135502|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
14135503|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135504|NCT01288625|Amifostine|amifostine|mesh-list
14135505|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14135506|NCT01288625|Protective Agents|protective agents|mesh-ancestor
14135507|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135508|NCT00848328|Rituximab|rituximab|mesh-list
14135509|NCT00848328|Lenalidomide|lenalidomide|mesh-list
14135510|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951109|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13951110|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13951111|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
13951112|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13951113|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13951114|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951115|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
13951116|NCT03219086|Bupivacaine|bupivacaine|mesh-list
13951117|NCT03219086|Prilocaine|prilocaine|mesh-list
13951118|NCT03219086|Anesthetics|anesthetics|mesh-list
13951119|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
14135511|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135512|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
14135513|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135514|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135515|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14135516|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14135517|NCT00848328|Growth Substances|growth substances|mesh-ancestor
14135518|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
14135519|NCT00599170|Rituximab|rituximab|mesh-list
14135520|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135521|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135522|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
14135523|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135524|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135525|NCT05128292|Selenium|selenium|mesh-list
14135526|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
14135527|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951120|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951121|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951122|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
13951123|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951124|NCT03218631|Oxandrolone|oxandrolone|mesh-list
13951125|NCT03218631|Androgens|androgens|mesh-ancestor
13951126|NCT03218631|Hormones|hormones|mesh-ancestor
13951127|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13951128|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135528|NCT05128292|Protective Agents|protective agents|mesh-ancestor
14135529|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135530|NCT05128292|Trace Elements|trace elements|mesh-ancestor
14135531|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
14135532|NCT05128175|Levodopa|levodopa|mesh-list
14135533|NCT05128175|Carbidopa|carbidopa|mesh-list
14135534|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14135535|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14135536|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14135537|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
14135538|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135539|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135540|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135541|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14135542|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135543|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14135544|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
14135545|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
14135546|NCT05128162|Psilocybin|psilocybin|mesh-list
14135547|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
14135548|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135549|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14135550|NCT05127980|Antibodies|antibodies|mesh-list
14135551|NCT05127980|Autoantibodies|autoantibodies|mesh-list
14135552|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
14135553|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135554|NCT05127746|Donepezil|donepezil|mesh-list
14135555|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14135556|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135557|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135558|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
14135559|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135560|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135561|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
14135562|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
14135563|NCT05127707|Narcotics|narcotics|mesh-ancestor
14135564|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135565|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135566|NCT05127707|Analgesics|analgesics|mesh-ancestor
14135567|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
14135568|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135569|NCT05127395|Acyclovir|acyclovir|mesh-list
14135570|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
14135571|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135572|NCT05127369|Fluoxetine|fluoxetine|mesh-list
14135573|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14135574|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14135575|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135576|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135577|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135578|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
14135579|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135580|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14135581|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
14135582|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14135583|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14135584|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14135585|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135586|NCT05126901|Ferric maltol|ferric maltol|mesh-list
14135587|NCT05126901|Hematinics|hematinics|mesh-ancestor
14135588|NCT05126836|Cilostazol|cilostazol|mesh-list
14135589|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14135590|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
14135591|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135592|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135593|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14135594|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
14135595|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14135596|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14135597|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135598|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14135599|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
14135600|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14135601|NCT05126836|Protective Agents|protective agents|mesh-ancestor
14135602|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14135603|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14135604|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135605|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
14135606|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14135607|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135608|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135609|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
14135610|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135611|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177958|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14177959|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
14177960|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14177961|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
14177962|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14177963|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14177964|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14764042|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14764043|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
14764044|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764045|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764046|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764047|NCT00614029|Sumatriptan|sumatriptan|mesh-list
14937000|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
14177972|NCT04751669|Trace Elements|trace elements|mesh-list
14177973|NCT04751669|Micronutrients|micronutrients|mesh-list
14177974|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177975|NCT04751344|Bupivacaine|bupivacaine|mesh-list
14177976|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
14177977|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
14177978|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14177979|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177980|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
14177981|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177982|NCT04751227|Modafinil|modafinil|mesh-list
14177983|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14177984|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177985|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
13951129|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
13951130|NCT03218709|Vitamins|vitamins|mesh-list
13951131|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
13951132|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951133|NCT03218657|Cyclosporine|cyclosporine|mesh-list
13951134|NCT03218657|Levamisole|levamisole|mesh-list
13951135|NCT03218657|Cyclosporins|cyclosporins|mesh-list
13951136|NCT03218657|Androgens|androgens|mesh-list
13951137|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951138|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951139|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951140|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
13951141|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951142|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
13951143|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951144|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
13951145|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951146|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13951147|NCT03218657|Hormones|hormones|mesh-ancestor
13951148|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13951149|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13951150|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
13951151|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
13951152|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13951153|NCT03218553|Dexamethasone|dexamethasone|mesh-list
13951154|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13951155|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
13951156|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
13951157|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951158|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951159|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13951160|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
13951161|NCT03218553|Hormones|hormones|mesh-ancestor
13951162|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13951163|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14177986|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13951164|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951165|NCT03218852|Prednisone|prednisone|mesh-list
13951166|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
13951167|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951168|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
13951169|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951170|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951171|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14135612|NCT05126602|Vitamin D|vitamin d|mesh-list
14135613|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
14135614|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
14135615|NCT05126602|Vitamins|vitamins|mesh-list
14135616|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
14135617|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135618|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14135619|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14135620|NCT05126342|Niraparib|niraparib|mesh-list
14135621|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14135622|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135623|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135624|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135625|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
14135626|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
14135627|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14135628|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14135629|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764048|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14135630|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135631|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135632|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135633|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
14135634|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14135635|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135636|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
14135637|NCT05126004|Azacitidine|azacitidine|mesh-list
14135638|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14135639|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14135640|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
14135641|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135642|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135643|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135644|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
14135645|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135646|NCT05126004|Expectorants|expectorants|mesh-ancestor
14135647|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
14135648|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14135649|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
14135650|NCT05126004|Protective Agents|protective agents|mesh-ancestor
14135651|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135652|NCT05126004|Antidotes|antidotes|mesh-ancestor
14135653|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
14135654|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14135655|NCT05125640|Progesterone|progesterone|mesh-list
14135656|NCT05125640|Progestins|progestins|mesh-ancestor
14764049|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14764050|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14764051|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
14764052|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951172|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
13951173|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135657|NCT05125640|Hormones|hormones|mesh-ancestor
14135658|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135659|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135660|NCT05125627|Progesterone|progesterone|mesh-list
14135661|NCT05125627|Progestins|progestins|mesh-ancestor
14135662|NCT05125627|Hormones|hormones|mesh-ancestor
14135663|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135664|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135665|NCT05125588|Meloxicam|meloxicam|mesh-list
14135666|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14135667|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951174|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951175|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13951176|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13951177|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
13951178|NCT03218852|Hormones|hormones|mesh-ancestor
13962731|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135668|NCT05125588|Analgesics|analgesics|mesh-ancestor
14135669|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
14135670|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951179|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13951180|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13951181|NCT03218800|Ertapenem|ertapenem|mesh-list
13951182|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13951183|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951184|NCT03218722|Thrombin|thrombin|mesh-list
13951185|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
13951186|NCT03218722|Coagulants|coagulants|mesh-ancestor
13951187|NCT03218514|Dalteparin|dalteparin|mesh-list
14135671|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135672|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135673|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135674|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14135675|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14135676|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951188|NCT03218514|Tinzaparin|tinzaparin|mesh-list
13951189|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13951190|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
13951191|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13951192|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14135677|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135678|NCT05125575|Metformin|metformin|mesh-list
14135679|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14135680|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135681|NCT05125549|Clopidogrel|clopidogrel|mesh-list
14135682|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14135683|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14135684|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14135685|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14135686|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
14135687|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135688|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135689|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135690|NCT05125380|Acetic Acid|acetic acid|mesh-list
14135691|NCT05125380|Retinol acetate|retinol acetate|mesh-list
14135692|NCT05125380|Lugol's solution|lugol's solution|mesh-list
14135693|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135694|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135695|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14135696|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
14135697|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135698|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14135699|NCT05125380|Protective Agents|protective agents|mesh-ancestor
14135700|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135701|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
14135702|NCT05125380|Coagulants|coagulants|mesh-ancestor
14135703|NCT05125328|Remifentanil|remifentanil|mesh-list
14135704|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14135705|NCT05125328|Narcotics|narcotics|mesh-ancestor
14135706|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135707|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135708|NCT05125328|Analgesics|analgesics|mesh-ancestor
14135709|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
14135710|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135711|NCT05125276|Aspirin|aspirin|mesh-list
14135712|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14135713|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14135714|NCT05125276|Analgesics|analgesics|mesh-ancestor
14135715|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
14135716|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135717|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135718|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135719|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135720|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14135721|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14135722|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135723|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14135724|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14135725|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135726|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
14135727|NCT05125055|Paclitaxel|paclitaxel|mesh-list
14135728|NCT05125055|Docetaxel|docetaxel|mesh-list
13951193|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135729|NCT05125055|Fluorouracil|fluorouracil|mesh-list
14135730|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14135731|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135732|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14135733|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14135734|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14135735|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135736|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
14135737|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14135738|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135739|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
14135740|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135741|NCT05125042|Amiodarone|amiodarone|mesh-list
14135742|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14135743|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
14135744|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14135745|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135746|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135747|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14135748|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14135749|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14135750|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135751|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14135752|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14135753|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14135754|NCT05124951|Carboplatin|carboplatin|mesh-list
14135755|NCT05124951|Etoposide|etoposide|mesh-list
14135756|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
14135757|NCT05124951|Ifosfamide|ifosfamide|mesh-list
14135758|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135759|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14135760|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14135761|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14135762|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135763|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135764|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14135765|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
14135766|NCT05124938|Hormones|hormones|mesh-list
14135767|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14135768|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135769|NCT05124730|Metformin|metformin|mesh-list
14135770|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14135771|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135772|NCT05124717|Metformin|metformin|mesh-list
14135773|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14135774|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135783|NCT05124431|Everolimus|everolimus|mesh-list
14135784|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135785|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937001|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937002|NCT01472640|Liraglutide|liraglutide|mesh-list
14937003|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14937004|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951194|NCT03218254|Methylphenidate|methylphenidate|mesh-list
13951195|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13951196|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951197|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13951198|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13951199|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14937005|NCT01472640|Incretins|incretins|mesh-ancestor
14937006|NCT01472640|Hormones|hormones|mesh-ancestor
13951200|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951201|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
13951202|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135786|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
14937007|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937008|NCT01472653|Cetuximab|cetuximab|mesh-list
14135787|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135788|NCT05118620|Bupivacaine|bupivacaine|mesh-list
14135789|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
14135790|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
14135791|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135792|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135793|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
14135794|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135795|NCT05115591|Anesthetics|anesthetics|mesh-list
14135796|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135797|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135798|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14135799|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14177987|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14177988|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951203|NCT03218280|Ascorbic Acid|ascorbic acid|mesh-list
13951204|NCT03218280|Vitamins|vitamins|mesh-ancestor
13951205|NCT03218280|Micronutrients|micronutrients|mesh-ancestor
13951206|NCT03218280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14177989|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14177990|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14177991|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14177992|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14177993|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14177994|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14177995|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478554|NCT02453555|Hormones|hormones|mesh-ancestor
14478555|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478556|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14478557|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
14478558|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478559|NCT02453581|Artefenomel|artefenomel|mesh-list
14478560|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
14478561|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14177996|NCT04751318|Analgesics|analgesics|mesh-ancestor
14177997|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
14177998|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14177999|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
14178000|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14178001|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
14178002|NCT04751604|Niacinamide|niacinamide|mesh-list
14178003|NCT04751604|Niacin|niacin|mesh-list
14178004|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
14178005|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
14178006|NCT04751604|Vitamins|vitamins|mesh-ancestor
14178007|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
14178008|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178009|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14178010|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
14178011|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178012|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14178013|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
14178014|NCT04751175|Dexamethasone|dexamethasone|mesh-list
14178015|NCT04751175|Ketamine|ketamine|mesh-list
14178016|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178017|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
14178018|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
14178019|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178020|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178021|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178022|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
14178023|NCT04751175|Hormones|hormones|mesh-ancestor
14178024|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178025|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14178026|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178027|NCT04751175|Analgesics|analgesics|mesh-ancestor
13951207|NCT03218280|Antioxidants|antioxidants|mesh-ancestor
13951208|NCT03218280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951209|NCT03218280|Protective Agents|protective agents|mesh-ancestor
13951210|NCT03218059|Methotrexate|methotrexate|mesh-list
13951211|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13951212|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
13951213|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178028|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
14178029|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14135800|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
14135801|NCT05109949|Empagliflozin|empagliflozin|mesh-list
14135802|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14135803|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135804|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14135805|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951214|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951215|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13951216|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
13951217|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951218|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951219|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
13951220|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951221|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13951222|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951223|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
13951224|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951225|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14135806|NCT05104918|Vortioxetine|vortioxetine|mesh-list
14135807|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14135808|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13951226|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
13951227|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13951228|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
13951229|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951230|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13951231|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951232|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
13951233|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951234|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
13951235|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13951236|NCT03217916|Protective Agents|protective agents|mesh-ancestor
13951237|NCT03218124|Remifentanil|remifentanil|mesh-list
13951238|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13951239|NCT03218124|Narcotics|narcotics|mesh-ancestor
13951240|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951241|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951242|NCT03218124|Analgesics|analgesics|mesh-ancestor
13951243|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
13951244|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951245|NCT03217838|Azacitidine|azacitidine|mesh-list
13951246|NCT03217838|Venetoclax|venetoclax|mesh-list
13951247|NCT03217838|Pyrazole|pyrazole|mesh-list
13951248|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13951249|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
13951250|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951251|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951252|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951253|NCT03217825|Losartan|losartan|mesh-list
13951254|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13951255|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13951256|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13951257|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13951258|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951259|NCT03217669|Sirolimus|sirolimus|mesh-list
13951260|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135809|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14135810|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135811|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135812|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135813|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135814|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14135815|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
14135816|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14135817|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14135818|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14135819|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135820|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14135821|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
14135822|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14135823|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13951261|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951262|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13951263|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951264|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
13951265|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951266|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
13951267|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951268|NCT03217942|Mitogens|mitogens|mesh-list
13951269|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
14135824|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14135825|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14135826|NCT05092412|Carboplatin|carboplatin|mesh-list
14135827|NCT05092412|Etoposide|etoposide|mesh-list
14135828|NCT05092412|Durvalumab|durvalumab|mesh-list
14135829|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135830|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14135831|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14135832|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14764053|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764054|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764055|NCT00614159|Ketamine|ketamine|mesh-list
14135833|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135834|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135835|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135836|NCT05089942|Insulin|insulin|mesh-list
14135837|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14135838|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14135839|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135840|NCT05087914|Naproxen|naproxen|mesh-list
14135841|NCT05087914|Levodopa|levodopa|mesh-list
14135842|NCT05087914|Carbidopa|carbidopa|mesh-list
14135843|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14135844|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14135845|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14135846|NCT05087914|Analgesics|analgesics|mesh-ancestor
14135847|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
14135848|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135849|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135850|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14135851|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14135852|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
14135853|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14135854|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135855|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135856|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14135857|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14135858|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
14135859|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135860|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14135861|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14135862|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
14135863|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
14135864|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14135865|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13951270|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962732|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962733|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
13962734|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
13962735|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
13962736|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13962737|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14135866|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14135867|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14135868|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135869|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135870|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135871|NCT05086393|Analgesics|analgesics|mesh-ancestor
14135872|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
13962738|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962739|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962740|NCT03651206|Niraparib|niraparib|mesh-list
13962741|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13962742|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135873|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135874|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
14135875|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14135876|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
14135877|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
14135878|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14135879|NCT05073172|Petrolatum|petrolatum|mesh-list
14135880|NCT05073172|Mineral Oil|mineral oil|mesh-list
14135881|NCT05073172|Emollients|emollients|mesh-ancestor
14135882|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
14135883|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14135884|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135885|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14135886|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14135887|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
14135888|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14135889|NCT05055323|Pyrvinium|pyrvinium|mesh-list
14135890|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
14135891|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14135892|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135893|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
14135894|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135895|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135896|NCT05047718|Vaccines|vaccines|mesh-list
14135897|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
14135898|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135899|NCT05044936|Cannabidiol|cannabidiol|mesh-list
14135900|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
14135901|NCT04979910|Ixekizumab|ixekizumab|mesh-list
14135902|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14764056|NCT00614159|Propofol|propofol|mesh-list
13951271|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
13951272|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764057|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13951273|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14135903|NCT04960709|Durvalumab|durvalumab|mesh-list
14135904|NCT04960709|Tremelimumab|tremelimumab|mesh-list
14135905|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135906|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135907|NCT04943627|Gemcitabine|gemcitabine|mesh-list
14135908|NCT04943627|Irinotecan|irinotecan|mesh-list
14135909|NCT04943627|Pemetrexed|pemetrexed|mesh-list
14135910|NCT04943627|Topotecan|topotecan|mesh-list
14135911|NCT04943627|Vinorelbine|vinorelbine|mesh-list
14135912|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14135913|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
14135914|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135915|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135916|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
14135917|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135918|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135919|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14135920|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
14135921|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135922|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14135923|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14135924|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14135925|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14135926|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14135927|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
14135928|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
14135929|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
14135930|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
14135931|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14135932|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14135933|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135934|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14135935|NCT04941508|Analgesics|analgesics|mesh-ancestor
14135936|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
14135937|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951274|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951275|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951276|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13951277|NCT03217409|Ezetimibe|ezetimibe|mesh-list
13951278|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14135938|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14135939|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14135940|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14135941|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
14135942|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135943|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135944|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
14135945|NCT04933331|Fluorides|fluorides|mesh-list
14135946|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
14135947|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
14135948|NCT04933331|Protective Agents|protective agents|mesh-ancestor
14135949|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135950|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14135951|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135952|NCT04932213|Tropicamide|tropicamide|mesh-list
14135953|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
14135954|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
14135955|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14135956|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14135957|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14135958|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14135959|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
14135960|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14135961|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951279|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13951280|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
13951281|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951282|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13951283|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13951284|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951285|NCT03217292|Tramadol|tramadol|mesh-list
13951286|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13951287|NCT03217292|Narcotics|narcotics|mesh-ancestor
13951288|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951289|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951290|NCT03217292|Analgesics|analgesics|mesh-ancestor
13951291|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
13951292|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951293|NCT03217448|Warfarin|warfarin|mesh-list
13951294|NCT03217448|Dabigatran|dabigatran|mesh-list
13951295|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
13951296|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
13951297|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14135962|NCT04909853|Ritonavir|ritonavir|mesh-list
14135963|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14135964|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14135965|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
14135966|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135967|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135968|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14135969|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14135970|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
14135971|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14135972|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14135973|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14135974|NCT04901988|Nivolumab|nivolumab|mesh-list
14135975|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14135976|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135977|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14135978|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135979|NCT04880876|Eluxadoline|eluxadoline|mesh-list
14135980|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14135981|NCT04874831|Avelumab|avelumab|mesh-list
14135982|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951298|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
13951299|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951300|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951301|NCT03217474|Ganciclovir|ganciclovir|mesh-list
13951302|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13951303|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
13951304|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951305|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13951306|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951307|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951308|NCT03217734|Adalimumab|adalimumab|mesh-list
13951309|NCT03217734|Methotrexate|methotrexate|mesh-list
13951310|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14135983|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951311|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
14135984|NCT04869358|Ofatumumab|ofatumumab|mesh-list
13951312|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14135985|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14135986|NCT04862260|Atorvastatin|atorvastatin|mesh-list
14135987|NCT04862260|Ezetimibe|ezetimibe|mesh-list
14135988|NCT04862260|Evolocumab|evolocumab|mesh-list
14135989|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13951313|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951314|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13951315|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
13951316|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951317|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951318|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
13951319|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951320|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14135990|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14135991|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
14135992|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14135993|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14135994|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14135995|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14135996|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14135997|NCT04846218|Progesterone|progesterone|mesh-list
14135998|NCT04846218|Progestins|progestins|mesh-ancestor
14135999|NCT04846218|Hormones|hormones|mesh-ancestor
14136000|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14136001|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136002|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
14136003|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14136004|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
14136005|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14136006|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14136007|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14136008|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136009|NCT04841499|Niacinamide|niacinamide|mesh-list
14136010|NCT04841499|Niacin|niacin|mesh-list
14136011|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
14136012|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
14136013|NCT04841499|Vitamins|vitamins|mesh-ancestor
14136014|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
14136015|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136016|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14136017|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
14136018|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136019|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14136020|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
14136021|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
14136022|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136023|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14136024|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136025|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136026|NCT04833582|Gemcitabine|gemcitabine|mesh-list
14136027|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136028|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
14136029|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136030|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136031|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
14136032|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136033|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136034|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136035|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
14136036|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136037|NCT04825678|Erenumab|erenumab|mesh-list
14136038|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14136039|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136040|NCT04825678|Analgesics|analgesics|mesh-ancestor
14136041|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
14136042|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136043|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178030|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14178031|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
14178032|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
14178033|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178034|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14178035|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13951321|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951322|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
14136044|NCT04798027|Vaccines|vaccines|mesh-list
14136045|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
14136046|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136050|NCT04773405|Lidocaine|lidocaine|mesh-list
14136051|NCT04773405|Epinephrine|epinephrine|mesh-list
14136052|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
14136053|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
14136054|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
14136055|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136056|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136057|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
14136058|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136059|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14136060|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14136061|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14136062|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14136063|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136064|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14136065|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14136066|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
14136067|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14136068|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14136069|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14136070|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
14136071|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14136072|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
14136073|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
14136074|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
14136075|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14136076|NCT04766996|Aspirin|aspirin|mesh-list
14136077|NCT04766996|Acetaminophen|acetaminophen|mesh-list
13951323|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951324|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13951325|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136078|NCT04766996|Prednisone|prednisone|mesh-list
14136079|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14136080|NCT04766996|Meloxicam|meloxicam|mesh-list
14136081|NCT04766996|Diclofenac|diclofenac|mesh-list
14136082|NCT04766996|Lidocaine|lidocaine|mesh-list
14136083|NCT04766996|Pregabalin|pregabalin|mesh-list
14136084|NCT04766996|Tramadol|tramadol|mesh-list
14136085|NCT04766996|Bupivacaine|bupivacaine|mesh-list
13951326|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
13951327|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951328|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951329|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951330|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13951331|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
14136086|NCT04766996|Propofol|propofol|mesh-list
14136087|NCT04766996|Omeprazole|omeprazole|mesh-list
14136088|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
14136089|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
14136090|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
14136091|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136092|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136093|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
14136094|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136095|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14136096|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13951332|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951333|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951334|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
13951335|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
13951336|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
13951337|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14136097|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14764058|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951338|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951339|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136098|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14136099|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136100|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136101|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
14136102|NCT04766996|Hormones|hormones|mesh-ancestor
14136103|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14136104|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14136105|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136106|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14136107|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14136108|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
14136109|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14136110|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14136111|NCT04766996|Analgesics|analgesics|mesh-ancestor
14136112|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136113|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14136114|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14136115|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14136116|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14136117|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951340|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951341|NCT03216759|Analgesics|analgesics|mesh-ancestor
13951342|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
13951343|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951344|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13951345|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13951346|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13951347|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
13951348|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951349|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951350|NCT03216733|Sirolimus|sirolimus|mesh-list
13951351|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13951352|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951353|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13951354|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951355|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
13951356|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951357|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
13951358|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764059|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764060|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14764061|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
14764062|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
14764063|NCT00614159|Analgesics|analgesics|mesh-ancestor
13951364|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
13951365|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13951366|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951367|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951368|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
13951369|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136118|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
14136119|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14136120|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
14136121|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14136122|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14136123|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14136124|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13951370|NCT03216980|Antioxidants|antioxidants|mesh-list
13951371|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951372|NCT03216980|Protective Agents|protective agents|mesh-ancestor
13951373|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951374|NCT03216876|Ursolic acid|ursolic acid|mesh-list
13951375|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951376|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13951377|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951378|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14136125|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14136126|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13951379|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951380|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951381|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13951382|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951383|NCT03216876|Analgesics|analgesics|mesh-ancestor
13951384|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
13951385|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951386|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951387|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136127|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
14136128|NCT04766996|Coagulants|coagulants|mesh-ancestor
14136129|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14136130|NCT04766996|Narcotics|narcotics|mesh-ancestor
14136131|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14136132|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14136133|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14136134|NCT04754061|Psilocybin|psilocybin|mesh-list
14136135|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
14136136|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136137|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14764064|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
14764065|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764066|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14764067|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14764068|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14764069|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764070|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136145|NCT04722601|Azacitidine|azacitidine|mesh-list
14136146|NCT04722601|Venetoclax|venetoclax|mesh-list
14136147|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
13951388|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951389|NCT03217084|Fluorides|fluorides|mesh-list
13951390|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
13951391|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
13951392|NCT03217084|Protective Agents|protective agents|mesh-ancestor
13951393|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951394|NCT03216941|Ketamine|ketamine|mesh-list
13951395|NCT03216941|Olanzapine|olanzapine|mesh-list
13951396|NCT03216941|Analgesics|analgesics|mesh-ancestor
13951397|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
13951398|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951399|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951400|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13951401|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13951402|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
13951403|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
13951404|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951405|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13951406|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13951407|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951408|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136148|NCT04722601|Cc-486|cc-486|mesh-list
14136149|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136150|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
14136151|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136152|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136153|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136154|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136155|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
14136156|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14136157|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136158|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136159|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14136160|NCT04700514|Analgesics|analgesics|mesh-ancestor
14136161|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
14136162|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136163|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14136164|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14136165|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14136166|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
14136167|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14136168|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136169|NCT04693468|Palbociclib|palbociclib|mesh-list
13951409|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
13951410|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
13951411|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13951412|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13951413|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13951414|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13951415|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13951416|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13951417|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13951418|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
14136170|NCT04693468|Axitinib|axitinib|mesh-list
14136171|NCT04693468|Crizotinib|crizotinib|mesh-list
14136172|NCT04693468|Talazoparib|talazoparib|mesh-list
14136173|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136174|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14136175|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136176|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136177|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14136178|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14136179|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14136180|NCT04654312|Diuretics|diuretics|mesh-ancestor
14136181|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
14136182|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136183|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13951419|NCT03216707|Capsaicin|capsaicin|mesh-list
13951420|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
13951421|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
13951422|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
13951423|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136184|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14136185|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136186|NCT04635644|Morphine|morphine|mesh-list
14136187|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14136188|NCT04635644|Narcotics|narcotics|mesh-ancestor
14136189|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136190|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136191|NCT04635644|Analgesics|analgesics|mesh-ancestor
14136192|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
14136193|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136194|NCT04633226|Vaccines|vaccines|mesh-list
14136195|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
14136196|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136197|NCT04623931|Temozolomide|temozolomide|mesh-list
13951424|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951425|NCT03216668|Silymarin|silymarin|mesh-list
13951426|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
13951427|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951428|NCT03216668|Protective Agents|protective agents|mesh-ancestor
13951429|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951430|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13951431|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951432|NCT03216525|Alvimopan|alvimopan|mesh-list
13951433|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13951434|NCT03216278|Metformin|metformin|mesh-list
14136198|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136199|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
14136200|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136201|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136202|NCT04617067|Gemcitabine|gemcitabine|mesh-list
14136203|NCT04617067|Paclitaxel|paclitaxel|mesh-list
14136204|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14136205|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136206|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
14136207|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
14136208|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
14136209|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951435|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
13951436|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13951437|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951438|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13951439|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951440|NCT03216356|Cycloserine|cycloserine|mesh-list
13951441|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13951442|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951443|NCT03216356|Renal Agents|renal agents|mesh-ancestor
13951444|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13951445|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
13951446|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14136210|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136211|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
14136212|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
14136213|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136214|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136215|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951447|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
13951448|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136216|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
14136217|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136218|NCT04610684|Carboplatin|carboplatin|mesh-list
14764071|NCT00614328|Naltrexone|naltrexone|mesh-list
14764072|NCT00614328|Baclofen|baclofen|mesh-list
14764073|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14764074|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14764075|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764076|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
14764077|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937009|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136219|NCT04610684|Etoposide|etoposide|mesh-list
14136220|NCT04610684|Atezolizumab|atezolizumab|mesh-list
14136221|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136222|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14136223|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14136224|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14136225|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136226|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136227|NCT04584567|Doxycycline|doxycycline|mesh-list
14136228|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14136229|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136230|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
13951449|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
13951450|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13951451|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13951452|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13951453|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13951454|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951455|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
13951456|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951457|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136231|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14136232|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14136233|NCT04578886|Guanfacine|guanfacine|mesh-list
14136234|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14136235|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14136236|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14136237|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937010|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14937011|NCT01472666|Caseins|caseins|mesh-list
13951458|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14136238|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14136239|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14136240|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951459|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136241|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136242|NCT04576325|Voriconazole|voriconazole|mesh-list
14136243|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
14136244|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136245|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14136246|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14136247|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136248|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136249|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14136250|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
14136251|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14136252|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136253|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14136254|NCT04572828|Naproxen|naproxen|mesh-list
14136255|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764078|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14937012|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
13951460|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
13951461|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13951462|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13951463|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13951464|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13951465|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951466|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
13951467|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951468|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951469|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14136256|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951470|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951471|NCT03216564|Vitamin D|vitamin d|mesh-list
13951472|NCT03216564|Calcitriol|calcitriol|mesh-list
13951473|NCT03216564|Vitamins|vitamins|mesh-ancestor
13951474|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
13951475|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136257|NCT04572828|Analgesics|analgesics|mesh-ancestor
14136258|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
14136259|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136260|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136261|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136262|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136263|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
14136264|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14136265|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136266|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136267|NCT04564625|Vitamin D|vitamin d|mesh-list
14136268|NCT04564625|Vitamins|vitamins|mesh-ancestor
14136269|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
14136270|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136271|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13951476|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13951477|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14136272|NCT04558112|Levodopa|levodopa|mesh-list
14136273|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14136274|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14136275|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
14136276|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14136277|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136278|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136279|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14136280|NCT04549311|Amoxicillin|amoxicillin|mesh-list
14136281|NCT04549311|Metronidazole|metronidazole|mesh-list
14136282|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
14136283|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
14136284|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
14136285|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14764079|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14764080|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14764081|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
14764082|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
14764083|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764084|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136286|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14136287|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136288|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
14136289|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14136290|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14136291|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14136292|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14136293|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136294|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136295|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136296|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14136297|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14136298|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14136299|NCT04493138|Azacitidine|azacitidine|mesh-list
14136300|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136301|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
14136302|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136303|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136304|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136305|NCT04473716|Paclitaxel|paclitaxel|mesh-list
14136306|NCT04473716|Cisplatin|cisplatin|mesh-list
14136307|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14136308|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136309|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14136310|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14136311|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14136312|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136313|NCT04471233|Pregabalin|pregabalin|mesh-list
14136314|NCT04471233|Analgesics|analgesics|mesh-ancestor
14136315|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
14136316|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764085|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13951478|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13951479|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14136317|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136318|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
14136319|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14136320|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14136321|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136322|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14136323|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14136324|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14136325|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136326|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14136327|NCT04435691|Azacitidine|azacitidine|mesh-list
14136328|NCT04435691|Venetoclax|venetoclax|mesh-list
14136329|NCT04435691|Magrolimab|magrolimab|mesh-list
14136330|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136331|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
14136332|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136333|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136334|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136335|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136336|NCT04422743|Tramiprosate|tramiprosate|mesh-list
14136337|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14136338|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
14136339|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
14136340|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
14136341|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
14136342|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14136343|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136344|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136345|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
14136346|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13951480|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951481|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13951482|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
13951483|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13951484|NCT03216304|Calcium|calcium|mesh-list
13951485|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13951486|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136347|NCT04413526|Estrogens|estrogens|mesh-ancestor
14136348|NCT04413526|Hormones|hormones|mesh-ancestor
14136349|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14136350|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136351|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14136352|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178036|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178037|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178038|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14178039|NCT04751188|Bezafibrate|bezafibrate|mesh-list
14178040|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14178041|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178042|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14178043|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
14178044|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178045|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14178046|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14764086|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
14764087|NCT00614471|Entecavir|entecavir|mesh-list
14764088|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
14764089|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951487|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13951488|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13951489|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13951490|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
13951491|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951492|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13951493|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13951494|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951495|NCT03216395|Epinephrine|epinephrine|mesh-list
13951496|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13951497|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13951498|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
14178047|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
14764090|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
14764091|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764092|NCT00614536|Rabeprazole|rabeprazole|mesh-list
14764093|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14136353|NCT04373733|Favipiravir|favipiravir|mesh-list
14136354|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
14136355|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136363|NCT04334070|Clofazimine|clofazimine|mesh-list
14136364|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136365|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
14136366|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13951499|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951500|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951501|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951502|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13951503|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13951504|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
13951505|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951506|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13951507|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
14136367|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136368|NCT04317807|Levetiracetam|levetiracetam|mesh-list
14136369|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
14136370|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
14136371|NCT04302324|Clarithromycin|clarithromycin|mesh-list
14136372|NCT04302324|Dexamethasone|dexamethasone|mesh-list
14136373|NCT04302324|Daratumumab|daratumumab|mesh-list
14136374|NCT04302324|Pomalidomide|pomalidomide|mesh-list
14136375|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136376|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
14136377|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
14136378|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136379|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136380|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14136381|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
14136382|NCT04302324|Hormones|hormones|mesh-ancestor
14136383|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13951508|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
13951509|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
13951510|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13951511|NCT03216447|Tacrolimus|tacrolimus|mesh-list
13951512|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951513|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
13951514|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951515|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13951516|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951517|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951518|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
13951519|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13951520|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
13951521|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951522|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951523|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13951524|NCT03216538|Protective Agents|protective agents|mesh-ancestor
13951525|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13951526|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14136384|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14764094|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14136385|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136386|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14764095|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13951527|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136387|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136388|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14136389|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136390|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136391|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14136392|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14136393|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
14136394|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14136395|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14136396|NCT04302324|Growth Substances|growth substances|mesh-ancestor
14136397|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
14136398|NCT04266912|Avelumab|avelumab|mesh-list
14136399|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14136400|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136401|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136402|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
14136403|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136404|NCT04264663|Furazolidone|furazolidone|mesh-list
14136405|NCT04264663|Tinidazole|tinidazole|mesh-list
14136406|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14136407|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136408|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14136409|NCT04264663|Renal Agents|renal agents|mesh-ancestor
14136410|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14136411|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14136412|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14136413|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14136414|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136415|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136416|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
14136417|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13951528|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951529|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
13951530|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951531|NCT03215927|Abatacept|abatacept|mesh-list
13951532|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13951533|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951534|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951535|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951536|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
13951537|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951538|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951539|NCT03215875|Torsemide|torsemide|mesh-list
13951540|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13951541|NCT03215875|Diuretics|diuretics|mesh-ancestor
13951542|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
13951543|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951544|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13951545|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13951546|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962743|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962744|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136418|NCT04256434|Nalbuphine|nalbuphine|mesh-list
14136419|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14136420|NCT04256434|Narcotics|narcotics|mesh-ancestor
14136421|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136422|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136423|NCT04256434|Analgesics|analgesics|mesh-ancestor
14136424|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
14136425|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136426|NCT04253262|Rucaparib|rucaparib|mesh-list
14136427|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14136428|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136429|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136430|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136431|NCT04227366|Methotrexate|methotrexate|mesh-list
14136432|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14136433|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
14136434|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14136435|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136436|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136437|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
14136438|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136439|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136440|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
14136441|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136442|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14136443|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136444|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
14136445|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136446|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14136447|NCT04185012|Benralizumab|benralizumab|mesh-list
14136448|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14136449|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
14136450|NCT04139655|Colchicine|colchicine|mesh-list
14136451|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
14136452|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136453|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14136454|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14136455|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14136456|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136457|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136458|NCT04122287|Levofloxacin|levofloxacin|mesh-list
14136459|NCT04122287|Ofloxacin|ofloxacin|mesh-list
14136460|NCT04122287|Tinidazole|tinidazole|mesh-list
14136461|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14136462|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136463|NCT04122287|Renal Agents|renal agents|mesh-ancestor
13951547|NCT03215797|Phenylephrine|phenylephrine|mesh-list
13951548|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
13951549|NCT03215797|Norepinephrine|norepinephrine|mesh-list
13951550|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
13951551|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13951552|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
13951553|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
13951554|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951555|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951556|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
13951557|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13951558|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
13951559|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
13951560|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13951561|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13951562|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
13951563|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951564|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951565|NCT03215797|Protective Agents|protective agents|mesh-ancestor
13951566|NCT03215693|Ensartinib|ensartinib|mesh-list
13951567|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951568|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14136464|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14136465|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14136466|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14136467|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136468|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136469|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136470|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14136471|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14136472|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
14136473|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14136474|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14136475|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14136476|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14136477|NCT04117945|Cetuximab|cetuximab|mesh-list
14136478|NCT04117945|Panitumumab|panitumumab|mesh-list
14136479|NCT04117945|Irinotecan|irinotecan|mesh-list
14136480|NCT04117945|Antibodies|antibodies|mesh-list
14937013|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
13951569|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962745|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
14136481|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
13951570|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951571|NCT03216070|Dasatinib|dasatinib|mesh-list
13951572|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951573|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13951574|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951575|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951576|NCT03215602|Pyrantel|pyrantel|mesh-list
13951577|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
13951578|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
13951579|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
13951580|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14937014|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937015|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14937016|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
14937017|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937018|NCT01472770|Gemcitabine|gemcitabine|mesh-list
14937019|NCT01472770|Capecitabine|capecitabine|mesh-list
14937020|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937021|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
14937022|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937023|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136482|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14136483|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
14136484|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136485|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136486|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14136487|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14136488|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136489|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136490|NCT04095858|Methotrexate|methotrexate|mesh-list
14136491|NCT04095858|Tacrolimus|tacrolimus|mesh-list
14136492|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14136493|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
14136494|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14136495|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136496|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136497|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
14136498|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136499|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136500|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
13951581|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951582|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
13951583|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13951584|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13951585|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951586|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951587|NCT03215719|Cisplatin|cisplatin|mesh-list
13951588|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951589|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13951590|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13951591|NCT03215966|Tadalafil|tadalafil|mesh-list
13951592|NCT03215966|Macitentan|macitentan|mesh-list
13951593|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
14136501|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136502|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14136503|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136504|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
14136505|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136506|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14136507|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14764096|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764097|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764098|NCT00614588|Anesthetics|anesthetics|mesh-list
14764099|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764100|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764101|NCT00614653|Bevacizumab|bevacizumab|mesh-list
14764102|NCT00614653|Capecitabine|capecitabine|mesh-list
14764103|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14764104|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14764105|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951594|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13951595|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13951596|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178048|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
14764106|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14764107|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14764108|NCT00614653|Growth Substances|growth substances|mesh-ancestor
14764109|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764110|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
14764111|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14764112|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
14764113|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764114|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14136525|NCT04060394|Prednisone|prednisone|mesh-list
14136526|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136527|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
14136528|NCT04060394|Hormones|hormones|mesh-ancestor
14136529|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14136530|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136531|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14136532|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136533|NCT04040621|Ceftazidime|ceftazidime|mesh-list
14136534|NCT04040621|Avibactam|avibactam|mesh-list
14136535|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14136536|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14136537|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136538|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14136539|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136540|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951597|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951598|NCT03215966|Urological Agents|urological agents|mesh-ancestor
13951599|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
13951600|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13951601|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
13951602|NCT03215498|Insulin|insulin|mesh-list
13951603|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14136541|NCT04030000|Paclitaxel|paclitaxel|mesh-list
14136542|NCT04030000|Carboplatin|carboplatin|mesh-list
14136543|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14136544|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136545|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
14136546|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
14136547|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
14136548|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136549|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14136550|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
14136551|NCT04028115|Ixazomib|ixazomib|mesh-list
14136552|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136553|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
14136554|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136555|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136556|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
14136557|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14136558|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14136559|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
14136560|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
14136561|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136562|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136563|NCT03965234|Cisplatin|cisplatin|mesh-list
14136564|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136565|NCT03952091|Dexamethasone|dexamethasone|mesh-list
14136566|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
14136567|NCT03952091|Lenalidomide|lenalidomide|mesh-list
14136568|NCT03952091|BB 1101|bb 1101|mesh-list
14136569|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136570|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
14136571|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
14136572|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136573|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136574|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13951604|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
13951605|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
13951606|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
13951607|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13951608|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951609|NCT03215446|Anesthetics|anesthetics|mesh-list
13951610|NCT03215446|Propofol|propofol|mesh-list
13951611|NCT03215446|Sevoflurane|sevoflurane|mesh-list
13951612|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136575|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
14136576|NCT03952091|Hormones|hormones|mesh-ancestor
14136577|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14136578|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14136579|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136580|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14136581|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136582|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136583|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
14136584|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14136585|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14136586|NCT03952091|Growth Substances|growth substances|mesh-ancestor
14136587|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
14136588|NCT03946527|Lanreotide|lanreotide|mesh-list
14136589|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136590|NCT03943173|Olaparib|olaparib|mesh-list
14136591|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14136592|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136593|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136594|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136595|NCT03933163|Resveratrol|resveratrol|mesh-list
14136596|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
14136597|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136598|NCT03933163|Protective Agents|protective agents|mesh-ancestor
14136599|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136600|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136601|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14136602|NCT03927443|Bimatoprost|bimatoprost|mesh-list
14136603|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14136604|NCT03913247|Metronidazole|metronidazole|mesh-list
14136605|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136606|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14764115|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951613|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951614|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13951615|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13951616|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
13951617|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13951618|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13951619|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
13951620|NCT03215264|Entinostat|entinostat|mesh-list
13951621|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
13951622|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13951623|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13951624|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951625|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951626|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136607|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14136608|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14136609|NCT03912337|Erenumab|erenumab|mesh-list
14136610|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14478562|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14478563|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478564|NCT02453672|Bevacizumab|bevacizumab|mesh-list
14478565|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478566|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951627|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951628|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951629|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13951630|NCT03215407|Betamethasone|betamethasone|mesh-list
14478567|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14478568|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14478569|NCT02453672|Growth Substances|growth substances|mesh-ancestor
14478570|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478571|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14478572|NCT02453685|Insulin|insulin|mesh-list
14478573|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14478574|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
14478575|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
14478576|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
14478577|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14478578|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
14478579|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14478580|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14136611|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136612|NCT03912337|Analgesics|analgesics|mesh-ancestor
14136613|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
14136614|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136615|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136616|NCT03895099|Desogestrel|desogestrel|mesh-list
14136617|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14136618|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13951631|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13951632|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
13951633|NCT03215407|Hormones|hormones|mesh-ancestor
13951634|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13951635|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951636|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13951637|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
13951638|NCT03215069|Empagliflozin|empagliflozin|mesh-list
13951639|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13951640|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951641|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13951642|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951643|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
14136619|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14136620|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
14136621|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14136622|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136623|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14136624|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14136625|NCT03895099|Progestins|progestins|mesh-ancestor
14136626|NCT03895099|Hormones|hormones|mesh-ancestor
14136627|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178049|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178050|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178051|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14178052|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13951644|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13951645|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
13951646|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
13951647|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951648|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951649|NCT03215017|Loperamide|loperamide|mesh-list
13951650|NCT03215017|Sorbitol|sorbitol|mesh-list
13951651|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
13951652|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13951653|NCT03215017|Cathartics|cathartics|mesh-ancestor
14178053|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
14178054|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178055|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178056|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
14178057|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14178058|NCT04751136|Protective Agents|protective agents|mesh-ancestor
13951654|NCT03214874|Torsemide|torsemide|mesh-list
13951655|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13951656|NCT03214874|Diuretics|diuretics|mesh-ancestor
13951657|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
13951658|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951659|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13951660|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13951661|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951662|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
13951663|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13951664|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951665|NCT03214731|Artesunate|artesunate|mesh-list
13951666|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
13951667|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13951668|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13951669|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951670|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178059|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178060|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
14178061|NCT04750902|Listerine|listerine|mesh-list
14478581|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764116|NCT00614666|Nikkomycin|nikkomycin|mesh-list
14764117|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
13951671|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
13951672|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
13951673|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14937024|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
14937025|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937026|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937027|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937028|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
14136628|NCT03828045|Apremilast|apremilast|mesh-list
14136629|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14136630|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14136631|NCT03828045|Analgesics|analgesics|mesh-ancestor
14136632|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
14136633|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136634|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136635|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136636|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13951674|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
13951675|NCT03214536|Ropivacaine|ropivacaine|mesh-list
13951676|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
13951677|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951678|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951679|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
13951680|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
13951681|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951682|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
13951683|NCT03214770|Calcium|calcium|mesh-list
13951684|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13951685|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951686|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13951687|NCT03214653|Propofol|propofol|mesh-list
13951688|NCT03214653|Sevoflurane|sevoflurane|mesh-list
13951689|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13951690|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951691|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951692|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13951693|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
13951694|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
13951695|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13951696|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13951697|NCT03214627|Iron|iron|mesh-list
13951698|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13951699|NCT03214627|Hematinics|hematinics|mesh-list
13951700|NCT03214627|Trace Elements|trace elements|mesh-ancestor
13951701|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
13951702|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951703|NCT03214562|Cytarabine|cytarabine|mesh-list
13951704|NCT03214562|Fludarabine|fludarabine|mesh-list
13951705|NCT03214562|Venetoclax|venetoclax|mesh-list
13951706|NCT03214562|Idarubicin|idarubicin|mesh-list
13951707|NCT03214562|Lenograstim|lenograstim|mesh-list
13951708|NCT03214562|Sargramostim|sargramostim|mesh-list
13951709|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951710|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13951711|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
13951712|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951713|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951714|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
13951715|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951716|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
13951717|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951718|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13951719|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13951720|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13951721|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13951722|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951723|NCT03214510|Fentanyl|fentanyl|mesh-list
13951724|NCT03214510|Hydromorphone|hydromorphone|mesh-list
13951725|NCT03214510|Bupivacaine|bupivacaine|mesh-list
13951726|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
13951727|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
13951728|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951729|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951730|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
13951731|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937029|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951732|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13951733|NCT03214510|Narcotics|narcotics|mesh-ancestor
13951734|NCT03214510|Analgesics|analgesics|mesh-ancestor
13951735|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13951736|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13951737|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
13962746|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13962747|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
13962748|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962749|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962750|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13962751|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
13962752|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13962753|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13962754|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13962755|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962756|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962757|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962758|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
13962759|NCT03318861|Fludarabine|fludarabine|mesh-list
14136637|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14136638|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14136639|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136640|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136641|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14136642|NCT03825874|Amikacin|amikacin|mesh-list
14136643|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136644|NCT03822351|Durvalumab|durvalumab|mesh-list
14136645|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14136646|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136647|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136648|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
14136649|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136650|NCT03805841|Bromides|bromides|mesh-list
14136651|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
14136652|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14136653|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14136654|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136655|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962760|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962761|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
13962762|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962763|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962764|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13962765|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
13962766|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962767|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962768|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13962769|NCT03119064|Irinotecan|irinotecan|mesh-list
13962770|NCT03119064|Temozolomide|temozolomide|mesh-list
13962771|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14136656|NCT03745729|Allopurinol|allopurinol|mesh-list
14136657|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
14136658|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136659|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136660|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
14136661|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136662|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14136663|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
14478582|NCT02453711|Liraglutide|liraglutide|mesh-list
13962772|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13962773|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136664|NCT03745729|Protective Agents|protective agents|mesh-ancestor
14478583|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14478584|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951738|NCT03214354|Sirolimus|sirolimus|mesh-list
14136665|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136666|NCT03744793|Pemetrexed|pemetrexed|mesh-list
14136667|NCT03744793|Avelumab|avelumab|mesh-list
14136668|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14136669|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136670|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136671|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136672|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14136673|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14136674|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136675|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
14136676|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136677|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
14136678|NCT03725384|Iron|iron|mesh-list
14136679|NCT03725384|Vitamins|vitamins|mesh-ancestor
14136680|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
14136681|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136682|NCT03725384|Trace Elements|trace elements|mesh-ancestor
14136683|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
14136684|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136685|NCT03725384|Protective Agents|protective agents|mesh-ancestor
14136686|NCT03719430|Doxorubicin|doxorubicin|mesh-list
14136687|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14136688|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136689|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14136690|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14136691|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136692|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136693|NCT03693807|Gemcitabine|gemcitabine|mesh-list
14136694|NCT03693807|Fluorouracil|fluorouracil|mesh-list
14136695|NCT03693807|Floxuridine|floxuridine|mesh-list
14136696|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
14136697|NCT03693807|Irinotecan|irinotecan|mesh-list
14136698|NCT03693807|Cetuximab|cetuximab|mesh-list
14136699|NCT03693807|Panitumumab|panitumumab|mesh-list
14136700|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136701|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
14136702|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136703|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136704|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
14136705|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136706|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136707|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136708|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
14136709|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136710|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14136711|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14136712|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136713|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
14136714|NCT03693014|Nivolumab|nivolumab|mesh-list
14136715|NCT03693014|Ipilimumab|ipilimumab|mesh-list
13951739|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
13951740|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13951741|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951742|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13951743|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951744|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
13951745|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951746|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
13951747|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951748|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951749|NCT03214393|Antibodies|antibodies|mesh-list
13951750|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
13951751|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951752|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
13951753|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13951754|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
13951755|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13951756|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
13951757|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951758|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951759|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
14136716|NCT03693014|Atezolizumab|atezolizumab|mesh-list
13951760|NCT03214003|Cisplatin|cisplatin|mesh-list
14136717|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136718|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178062|NCT04750902|Fluorides|fluorides|mesh-list
14136719|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14136720|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136721|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14136722|NCT03678350|Trioxsalen|trioxsalen|mesh-list
14136723|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136724|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
14136725|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14136726|NCT03635632|Cyclophosphamide|cyclophosphamide|mesh-list
14136727|NCT03635632|Fludarabine|fludarabine|mesh-list
14136728|NCT03635632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136729|NCT03635632|Immunologic Factors|immunologic factors|mesh-ancestor
14136730|NCT03635632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136731|NCT03635632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136732|NCT03635632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136733|NCT03635632|Alkylating Agents|alkylating agents|mesh-ancestor
14136734|NCT03635632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136735|NCT03635632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136736|NCT03635632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14136737|NCT03631043|Lenalidomide|lenalidomide|mesh-list
14136738|NCT03631043|Vaccines|vaccines|mesh-list
14136739|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
14136740|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136741|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14136742|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14136743|NCT03631043|Growth Substances|growth substances|mesh-ancestor
14136744|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
14136745|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136746|NCT03595592|Paclitaxel|paclitaxel|mesh-list
14136747|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14136748|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
14136749|NCT03595592|Carboplatin|carboplatin|mesh-list
14136750|NCT03595592|Doxorubicin|doxorubicin|mesh-list
14136751|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14136752|NCT03595592|Trastuzumab|trastuzumab|mesh-list
14136753|NCT03595592|Atezolizumab|atezolizumab|mesh-list
14136754|NCT03595592|Pertuzumab|pertuzumab|mesh-list
14136755|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14136756|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136757|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
13951761|NCT03214003|Etoposide|etoposide|mesh-list
13951762|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
14136758|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
14136759|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
14136760|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136761|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136762|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
13951763|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951764|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13951765|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13951766|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13951767|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951768|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136763|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136764|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136765|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136766|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
14136767|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14136768|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13951769|NCT03214159|Ritonavir|ritonavir|mesh-list
13951770|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13951771|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13951772|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
13951773|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951774|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951775|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13951776|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13951777|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
13951778|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951779|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13951780|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14136769|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14478585|NCT02453711|Incretins|incretins|mesh-ancestor
14764118|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951781|NCT03214302|Tenofovir|tenofovir|mesh-list
14478586|NCT02453711|Hormones|hormones|mesh-ancestor
14136770|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14764119|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951782|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
13951783|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951784|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13951785|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13951786|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951787|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136771|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136772|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136773|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
13951788|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13951789|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13951790|NCT03214055|Mannitol|mannitol|mesh-list
13951791|NCT03214055|Diuretics|diuretics|mesh-list
13951792|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13951793|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
13951794|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951795|NCT03213964|Interleukin-2|interleukin-2|mesh-list
13951796|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951797|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951798|NCT03213964|Analgesics|analgesics|mesh-ancestor
13951799|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
13951800|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951801|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951802|NCT03213977|Prednisone|prednisone|mesh-list
13951803|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
13951804|NCT03213977|Doxorubicin|doxorubicin|mesh-list
13951805|NCT03213977|Etoposide|etoposide|mesh-list
13951806|NCT03213977|Vincristine|vincristine|mesh-list
13951807|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951808|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
13951809|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951810|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136774|NCT03577431|Everolimus|everolimus|mesh-list
14136775|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136776|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
14136777|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136778|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136779|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136780|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
14136781|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136782|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136783|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14136784|NCT03568929|Idelalisib|idelalisib|mesh-list
14136785|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136786|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136787|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136788|NCT03537690|Paclitaxel|paclitaxel|mesh-list
14136789|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14136790|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14136791|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136792|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14136793|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14136794|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14136795|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136796|NCT03536728|Eflornithine|eflornithine|mesh-list
14136797|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951811|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13951812|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
13951813|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951814|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951815|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13951816|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13951817|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13951818|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13951819|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951820|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13951821|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13951822|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
13951823|NCT03213977|Hormones|hormones|mesh-ancestor
13951824|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13951825|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13951826|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
14136798|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13951827|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
13951828|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
13951829|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13951830|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13951831|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13951832|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951833|NCT03213886|Vitamin D|vitamin d|mesh-list
13951834|NCT03213886|Calcifediol|calcifediol|mesh-list
13951835|NCT03213886|Vitamins|vitamins|mesh-ancestor
13951836|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
13951837|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951838|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13951839|NCT03213769|Ubiquinone|ubiquinone|mesh-list
13951840|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
13951841|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
13951842|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951843|NCT03213769|Vitamins|vitamins|mesh-ancestor
13951844|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
13951845|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13951846|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951847|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136799|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14136800|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14136801|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136802|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14136803|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136804|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136805|NCT03510390|Metformin|metformin|mesh-list
14136806|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14136807|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136808|NCT03449108|Aldesleukin|aldesleukin|mesh-list
14136809|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
14136810|NCT03449108|Nivolumab|nivolumab|mesh-list
14136811|NCT03449108|Fludarabine|fludarabine|mesh-list
14136812|NCT03449108|Ipilimumab|ipilimumab|mesh-list
14136813|NCT03449108|Interleukin-2|interleukin-2|mesh-list
14136814|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136815|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
14136816|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136817|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136818|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136819|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
14136820|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136821|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136822|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14136823|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136824|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14136825|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14136826|NCT03449108|Analgesics|analgesics|mesh-ancestor
14136827|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
14136828|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136829|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14136830|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14136831|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
14136832|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951848|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951849|NCT03213743|Analgesics|analgesics|mesh-ancestor
13951850|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
13951851|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951852|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13951853|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13951854|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13951855|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
13951856|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951857|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951858|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
13951859|NCT03213444|Fluorouracil|fluorouracil|mesh-list
13951860|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951861|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
13951862|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951863|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13951864|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13951865|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
13951866|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951867|NCT03213639|Esomeprazole|esomeprazole|mesh-list
13951868|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14136833|NCT03442088|Apremilast|apremilast|mesh-list
14136834|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13951869|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13951870|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13951871|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951872|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951873|NCT03213548|Daminozide|daminozide|mesh-list
13951874|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
13951875|NCT03213548|Growth Substances|growth substances|mesh-ancestor
13951876|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951877|NCT03213587|Apatinib|apatinib|mesh-list
13951878|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951879|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13951880|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951881|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951882|NCT03213392|Anesthetics|anesthetics|mesh-list
13951883|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13951884|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951885|NCT03213353|Acetaminophen|acetaminophen|mesh-list
14136835|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14136836|NCT03442088|Analgesics|analgesics|mesh-ancestor
14136837|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
14136838|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136839|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136840|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14136841|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136842|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14136843|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14136844|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136845|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136846|NCT03291990|Temozolomide|temozolomide|mesh-list
14136847|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136848|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
14136849|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136850|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136851|NCT03277924|Doxorubicin|doxorubicin|mesh-list
14136852|NCT03277924|Methotrexate|methotrexate|mesh-list
13951886|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
13951887|NCT03213353|Phenylephrine|phenylephrine|mesh-list
13951888|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
13951889|NCT03213353|Guaifenesin|guaifenesin|mesh-list
13951890|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
13951891|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13951892|NCT03213353|Analgesics|analgesics|mesh-ancestor
13951893|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
13951894|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951895|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951896|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
14136853|NCT03277924|Nivolumab|nivolumab|mesh-list
14136854|NCT03277924|Sunitinib|sunitinib|mesh-list
14136855|NCT03277924|Epirubicin|epirubicin|mesh-list
14136856|NCT03277924|Ifosfamide|ifosfamide|mesh-list
14136857|NCT03277924|Dacarbazine|dacarbazine|mesh-list
14136858|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136859|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14136860|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14136861|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13951897|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13951898|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
13951899|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
13951900|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
13951901|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13951902|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
13951903|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
13951904|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13951905|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13951906|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13951907|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
13951908|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951909|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951910|NCT03213353|Protective Agents|protective agents|mesh-ancestor
13951911|NCT03213353|Expectorants|expectorants|mesh-ancestor
13951912|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
13951913|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13951914|NCT03213249|Gentamicins|gentamicins|mesh-list
13951915|NCT03213249|Cefazolin|cefazolin|mesh-list
14136862|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136863|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178063|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
14136864|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14136865|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
14136866|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14136867|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136868|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136869|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
14136870|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14136871|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14136872|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136873|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
14136874|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136875|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14136876|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136877|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14136878|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14136879|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14136880|NCT03277924|Growth Substances|growth substances|mesh-ancestor
14136881|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
14136882|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14136883|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136884|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
14136885|NCT03258853|Pancrelipase|pancrelipase|mesh-list
13951916|NCT03213249|Bacitracin|bacitracin|mesh-list
13951917|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13951918|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136886|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14136887|NCT03257267|Cemiplimab|cemiplimab|mesh-list
14136888|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136889|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136890|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
14136891|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
13951919|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14136892|NCT03247088|Busulfan|busulfan|mesh-list
14136893|NCT03247088|Fludarabine|fludarabine|mesh-list
14136894|NCT03247088|Sorafenib|sorafenib|mesh-list
14136895|NCT03247088|Tacrolimus|tacrolimus|mesh-list
14136896|NCT03247088|Lenograstim|lenograstim|mesh-list
14136897|NCT03247088|Sargramostim|sargramostim|mesh-list
14136898|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136899|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
14136900|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136901|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136902|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14136903|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
14136904|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136905|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136906|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14136907|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14136908|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14136909|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136910|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14136911|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14136912|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
14136913|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14136914|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136915|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14136916|NCT03217747|Avelumab|avelumab|mesh-list
14136917|NCT03217747|Antibodies|antibodies|mesh-list
14136918|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14136919|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
14136920|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
14136921|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136922|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136923|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136924|NCT03206151|Leucovorin|leucovorin|mesh-list
14136925|NCT03206151|Folic Acid|folic acid|mesh-list
14136926|NCT03206151|Fluorouracil|fluorouracil|mesh-list
13951920|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951921|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951922|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13951923|NCT03213158|Ixazomib|ixazomib|mesh-list
13951924|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951925|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
13951926|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963535|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
14136927|NCT03206151|Irinotecan|irinotecan|mesh-list
14136928|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
14136929|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
13951927|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951928|NCT03213145|Rifampin|rifampin|mesh-list
13951929|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13951930|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
13951931|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13951932|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951933|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
13951934|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14136930|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136931|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14136932|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136933|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14136934|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
14136935|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136936|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14136937|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14136938|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136939|NCT03206151|Antidotes|antidotes|mesh-ancestor
13951935|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951936|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951937|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13951938|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13951939|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13951940|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13951941|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13951942|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14136940|NCT03206151|Protective Agents|protective agents|mesh-ancestor
14136941|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
14136942|NCT03206151|Vitamins|vitamins|mesh-ancestor
14136943|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
14136944|NCT03206151|Hematinics|hematinics|mesh-ancestor
14136945|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
14136946|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
14136947|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14136948|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14136949|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14136950|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136951|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136952|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14136953|NCT03131726|Simvastatin|simvastatin|mesh-list
14136954|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14136955|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14136956|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
14136957|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136958|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14136959|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14136960|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14136961|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
13951943|NCT03213041|Carboplatin|carboplatin|mesh-list
13951944|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
13951945|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951946|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951947|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
13951948|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13951949|NCT03212716|Oseltamivir|oseltamivir|mesh-list
13951950|NCT03212716|Diltiazem|diltiazem|mesh-list
13951951|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
13951952|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13951953|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951954|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951955|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13951956|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13951957|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13951958|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13951959|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951960|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
13951961|NCT03212807|Lenalidomide|lenalidomide|mesh-list
13951962|NCT03212807|Durvalumab|durvalumab|mesh-list
13951963|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
14479267|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937030|NCT01472783|Veliparib|veliparib|mesh-list
14937031|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14937032|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937033|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136962|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136963|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136964|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
14136965|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14136966|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14136967|NCT03023631|Vaccines|vaccines|mesh-list
14136968|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
14136969|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136970|NCT03023462|Droperidol|droperidol|mesh-list
14136971|NCT03023462|Oxycodone|oxycodone|mesh-list
14937034|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937035|NCT01472796|Vitamin D|vitamin d|mesh-list
14937036|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
14937037|NCT01472796|Vitamins|vitamins|mesh-ancestor
14937038|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
13951964|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951965|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13951966|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13951967|NCT03212807|Growth Substances|growth substances|mesh-ancestor
13951968|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
13951969|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951970|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951971|NCT03213002|Capecitabine|capecitabine|mesh-list
13951972|NCT03213002|Temozolomide|temozolomide|mesh-list
13951973|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13951974|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
13951975|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951976|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951977|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13951978|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
13951979|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
13951980|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13951981|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951982|NCT03212742|Temozolomide|temozolomide|mesh-list
13951983|NCT03212742|Olaparib|olaparib|mesh-list
13951984|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13951985|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
13951986|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951987|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13951988|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13951989|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13951990|NCT03212820|Methamphetamine|methamphetamine|mesh-list
13951991|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13951992|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13951993|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
14136972|NCT03023462|Ondansetron|ondansetron|mesh-list
14136973|NCT03023462|Ropivacaine|ropivacaine|mesh-list
14136974|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
14136975|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
14136976|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14136977|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14136978|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
14136979|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14136980|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14136981|NCT03023462|Narcotics|narcotics|mesh-ancestor
14136982|NCT03023462|Analgesics|analgesics|mesh-ancestor
14136983|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
14136984|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
14136985|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14136986|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
14136987|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
14136988|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14136989|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
14136990|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14136991|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14136992|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14136993|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14136994|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14136995|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14136996|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14136997|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14136998|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14136999|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
14937039|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137000|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
14137001|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14137002|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
13951994|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
13951995|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13951996|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
13951997|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13951998|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13951999|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
13952000|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13952001|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13952002|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952003|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13952004|NCT03212833|Insulin|insulin|mesh-list
14137003|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137004|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137005|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14137006|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
14137007|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14137008|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
14137009|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137010|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137011|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14137012|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
14137013|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
14137014|NCT03023449|Protective Agents|protective agents|mesh-ancestor
14137015|NCT02994069|Cisplatin|cisplatin|mesh-list
14137016|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137017|NCT02987686|Infliximab|infliximab|mesh-list
13952005|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13952006|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962774|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962775|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962776|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13962777|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
13962778|NCT03117933|Paclitaxel|paclitaxel|mesh-list
13962779|NCT03117933|Olaparib|olaparib|mesh-list
13962780|NCT03117933|Cediranib|cediranib|mesh-list
13962781|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13962782|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962783|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
13962784|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
13962785|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
13962786|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962787|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13962788|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962789|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13962790|NCT03107871|Valganciclovir|valganciclovir|mesh-list
13962791|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
13962792|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962793|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
13962794|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13962795|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
13962796|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962797|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962798|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14137018|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
14137019|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137020|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14137021|NCT02963064|Antibodies|antibodies|mesh-list
14137022|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14137023|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
13962799|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
13962800|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
13962801|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13962802|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
13962803|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962804|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962805|NCT03087448|Trametinib|trametinib|mesh-list
13962806|NCT03087448|Ceritinib|ceritinib|mesh-list
13962807|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962808|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14137024|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137025|NCT02909686|Curcumin|curcumin|mesh-list
14137026|NCT02909686|Resveratrol|resveratrol|mesh-list
13962809|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137027|NCT02909686|Pycnogenols|pycnogenols|mesh-list
14137028|NCT02909686|Turmeric extract|turmeric extract|mesh-list
14137029|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14137030|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14137031|NCT02909686|Analgesics|analgesics|mesh-ancestor
14137032|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
14137033|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137034|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137035|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137036|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14137037|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137038|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137039|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137040|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
14137041|NCT02909686|Protective Agents|protective agents|mesh-ancestor
14137042|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14137043|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14137044|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
14137045|NCT02865928|Bupivacaine|bupivacaine|mesh-list
14137046|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
14137047|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
14137048|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137049|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137050|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
14137051|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137052|NCT02860091|Ropivacaine|ropivacaine|mesh-list
14137053|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
14137054|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
14137055|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137056|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137057|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
14137058|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137059|NCT02825641|Oxytocin|oxytocin|mesh-list
13952007|NCT03212677|Iron|iron|mesh-list
13952008|NCT03212677|Trace Elements|trace elements|mesh-ancestor
13952009|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
13952010|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952011|NCT03212950|Insulin|insulin|mesh-list
13952012|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13952013|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
13952014|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
13952015|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
13952016|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13952017|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952018|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
13952019|NCT03212781|Dextrans|dextrans|mesh-list
13952020|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
13952021|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
14137060|NCT02825641|Dinoprostone|dinoprostone|mesh-list
14137061|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
14137062|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14137063|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137064|NCT02824952|Osimertinib|osimertinib|mesh-list
14137065|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137066|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14137067|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137068|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178064|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
14178065|NCT04750902|Protective Agents|protective agents|mesh-ancestor
14178066|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178067|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14178068|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178069|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14178070|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14178071|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178072|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
14178073|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14178074|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178075|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13952022|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
13952023|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
13952024|NCT03212781|Trace Elements|trace elements|mesh-ancestor
14178076|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14137069|NCT02812420|Durvalumab|durvalumab|mesh-list
14137070|NCT02812420|Ipilimumab|ipilimumab|mesh-list
14137071|NCT02812420|Tremelimumab|tremelimumab|mesh-list
14137072|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
14137073|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14137074|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
14137075|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137076|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137077|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
14137078|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137079|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14137080|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137081|NCT02780609|Dexamethasone|dexamethasone|mesh-list
14137082|NCT02780609|Melphalan|melphalan|mesh-list
14137083|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
14137084|NCT02780609|Aprepitant|aprepitant|mesh-list
14137085|NCT02780609|Antiemetics|antiemetics|mesh-list
14137086|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137087|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
14137088|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137089|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137090|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137091|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
14137092|NCT02780609|Hormones|hormones|mesh-ancestor
14137093|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137094|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14137095|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137096|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14137097|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
14137098|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137099|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14137100|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137101|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
14137102|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14137103|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137104|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
14137105|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14137106|NCT02730325|Antibodies|antibodies|mesh-list
14137107|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
14137108|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137109|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
14137110|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137111|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137112|NCT02514382|Dexamethasone|dexamethasone|mesh-list
14137113|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
14137114|NCT02514382|Bortezomib|bortezomib|mesh-list
14137115|NCT02514382|Ichthammol|ichthammol|mesh-list
14137116|NCT02514382|BB 1101|bb 1101|mesh-list
14137117|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137118|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
14137119|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
14137120|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137121|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137122|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137123|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
14137124|NCT02514382|Hormones|hormones|mesh-ancestor
14137125|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137126|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14137127|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137128|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
14137129|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137130|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137131|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14137132|NCT02512692|Gemcitabine|gemcitabine|mesh-list
14137133|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137134|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14137135|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
14137136|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137137|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
14137138|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137139|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137140|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137141|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
14137142|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137143|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
14137144|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14137145|NCT02460445|Cyproterone|cyproterone|mesh-list
14137146|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14137147|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14137148|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14137149|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
14137150|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14137151|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137152|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14137153|NCT02460445|Estrogens|estrogens|mesh-ancestor
14137154|NCT02460445|Hormones|hormones|mesh-ancestor
14137155|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137156|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
14137157|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
14137158|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137159|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14137160|NCT02432404|NuvaRing|nuvaring|mesh-list
14137161|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14137162|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
13952025|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
13952026|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952027|NCT03212781|Hematinics|hematinics|mesh-ancestor
13952028|NCT03212937|Carboplatin|carboplatin|mesh-list
13952029|NCT03212937|Etoposide|etoposide|mesh-list
13952030|NCT03212937|Ifosfamide|ifosfamide|mesh-list
13952031|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952032|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13952033|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13952034|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13952035|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952036|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952037|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13952038|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
13952039|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
13952040|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13952041|NCT03212755|Antibodies|antibodies|mesh-list
13952042|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
13952043|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
13952044|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952045|NCT03212599|Disulfiram|disulfiram|mesh-list
13952046|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13952047|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
13952048|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952049|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952050|NCT03212352|Misoprostol|misoprostol|mesh-list
13952051|NCT03212352|Mifepristone|mifepristone|mesh-list
13952052|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13952053|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
13952054|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14137163|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14137164|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137165|NCT02429557|Midodrine|midodrine|mesh-list
14137166|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
14137167|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
14137168|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137169|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137170|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14137171|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14137172|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14137173|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14137174|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
14137175|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137176|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137177|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
14137178|NCT02419495|Leucovorin|leucovorin|mesh-list
14137179|NCT02419495|Folic Acid|folic acid|mesh-list
13952055|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952056|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14137180|NCT02419495|Paclitaxel|paclitaxel|mesh-list
14137181|NCT02419495|Camptothecin|camptothecin|mesh-list
14137182|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
14137183|NCT02419495|Carboplatin|carboplatin|mesh-list
14137184|NCT02419495|Doxorubicin|doxorubicin|mesh-list
14137185|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14137186|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
14137187|NCT02419495|Fluorouracil|fluorouracil|mesh-list
14137188|NCT02419495|Capecitabine|capecitabine|mesh-list
13952057|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952058|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
14137189|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
13952059|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13952060|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13952061|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13952062|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13952063|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
13952064|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13952065|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13952066|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
13952067|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952068|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
13952069|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13952070|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13952071|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
13952072|NCT03212456|Ropivacaine|ropivacaine|mesh-list
13952073|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
13952074|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
13952075|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952076|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952077|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
13952078|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952079|NCT03212456|Narcotics|narcotics|mesh-ancestor
14137190|NCT02419495|Nivolumab|nivolumab|mesh-list
14137191|NCT02419495|Irinotecan|irinotecan|mesh-list
14137192|NCT02419495|Pemetrexed|pemetrexed|mesh-list
14137193|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14137194|NCT02419495|Ipilimumab|ipilimumab|mesh-list
14137195|NCT02419495|Topotecan|topotecan|mesh-list
14137196|NCT02419495|Daunorubicin|daunorubicin|mesh-list
14137197|NCT02419495|Olaparib|olaparib|mesh-list
14137198|NCT02419495|Calcium|calcium|mesh-list
14137199|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
14137200|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14137201|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137202|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137203|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137204|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
14764120|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952080|NCT03212456|Analgesics|analgesics|mesh-ancestor
13952081|NCT03212495|Neostigmine|neostigmine|mesh-list
13952082|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952083|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952084|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952085|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952086|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13952087|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952088|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
13952089|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13952090|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
14137205|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137206|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137207|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
14137208|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137209|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952091|NCT03212469|Durvalumab|durvalumab|mesh-list
13952092|NCT03212469|Tremelimumab|tremelimumab|mesh-list
13952093|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13952094|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952095|NCT03212053|Hemostatics|hemostatics|mesh-list
14137210|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13952096|NCT03212053|Coagulants|coagulants|mesh-ancestor
14137211|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
14137212|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14137213|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14137214|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14137215|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14137216|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137217|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14137218|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14137219|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137220|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
14137221|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14137222|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14137223|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14137224|NCT02419495|Antidotes|antidotes|mesh-ancestor
14137225|NCT02419495|Protective Agents|protective agents|mesh-ancestor
14137226|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
14137227|NCT02419495|Vitamins|vitamins|mesh-ancestor
14137228|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
14137229|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14137230|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14137231|NCT02419495|Hematinics|hematinics|mesh-ancestor
14137232|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14137233|NCT02247349|Nivolumab|nivolumab|mesh-list
14137234|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137235|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137236|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14137237|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764121|NCT00614679|Tigecycline|tigecycline|mesh-list
14764122|NCT00614679|Heparin|heparin|mesh-list
14764123|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
14764124|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14764125|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14764126|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764127|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14764128|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764129|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14764130|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952097|NCT03211949|Mepivacaine|mepivacaine|mesh-list
14137238|NCT02214407|Decitabine|decitabine|mesh-list
14137239|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
14137240|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14137241|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
14137242|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137243|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137244|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137245|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
14137246|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14137247|NCT02142803|Bevacizumab|bevacizumab|mesh-list
14137248|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14137249|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
14137250|NCT02142803|Antibodies|antibodies|mesh-list
14137251|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
14137252|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14137253|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
14137254|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137255|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14137256|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14137257|NCT02142803|Growth Substances|growth substances|mesh-ancestor
14137258|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137259|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
14137260|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
14137261|NCT01899989|Carboplatin|carboplatin|mesh-list
14137262|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137263|NCT01869114|Sirolimus|sirolimus|mesh-list
14137264|NCT01869114|Azacitidine|azacitidine|mesh-list
14137265|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14137266|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
13952098|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
13952099|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
13952100|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952101|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952102|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
13952103|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952104|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
13952105|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14137267|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764131|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
14764132|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13952106|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952107|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952108|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13952109|NCT03211871|Analgesics|analgesics|mesh-ancestor
13952110|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
13952111|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952112|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13952113|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13952114|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13952115|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
13952116|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952117|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952118|NCT03211897|Midazolam|midazolam|mesh-list
13952119|NCT03211897|Haloperidol|haloperidol|mesh-list
13952120|NCT03211897|Olanzapine|olanzapine|mesh-list
13952121|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
13952122|NCT03211897|Ziprasidone|ziprasidone|mesh-list
13952123|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13952124|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14137268|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137269|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137270|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14137271|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137272|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14137273|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
14137274|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137275|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
14137276|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137277|NCT01786265|Prednisone|prednisone|mesh-list
14137278|NCT01786265|Cortisone|cortisone|mesh-list
14137279|NCT01786265|Leuprolide|leuprolide|mesh-list
14137280|NCT01786265|Goserelin|goserelin|mesh-list
14137281|NCT01786265|Flutamide|flutamide|mesh-list
14137282|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
14137283|NCT01786265|Bicalutamide|bicalutamide|mesh-list
14137284|NCT01786265|Nilutamide|nilutamide|mesh-list
14137285|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137286|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
13952125|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952126|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952127|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13952128|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13952129|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13952130|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13952131|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
13952132|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
13952133|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
14137287|NCT01786265|Hormones|hormones|mesh-ancestor
14137288|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137289|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137290|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14137291|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137292|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14137293|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
14137294|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14137295|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14137296|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137297|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137298|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
14137299|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14137300|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
14137301|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14137302|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14137303|NCT01594398|Exemestane|exemestane|mesh-list
14137304|NCT01594398|Entinostat|entinostat|mesh-list
14137305|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137306|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14137307|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137308|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137309|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14137310|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14764133|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
13952134|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
14137311|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14137312|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
14137313|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178077|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764134|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952135|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952136|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952137|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
13952138|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
13952139|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952140|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952141|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13952142|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13952143|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13952144|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952145|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
13952146|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13952147|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
13952148|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13952149|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13952150|NCT03211988|Entinostat|entinostat|mesh-list
13952151|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952152|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13952153|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952154|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137314|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137315|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14137316|NCT01573429|Bisphenol A|bisphenol a|mesh-list
14137317|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14137318|NCT01573429|Estrogens|estrogens|mesh-ancestor
14137319|NCT01573429|Hormones|hormones|mesh-ancestor
14137320|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137321|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137322|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14137323|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
14137324|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952155|NCT03211728|Pregabalin|pregabalin|mesh-list
13952156|NCT03211728|Analgesics|analgesics|mesh-ancestor
13952157|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
13952158|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952159|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952160|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
13952161|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13952162|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952163|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137325|NCT01573429|Protective Agents|protective agents|mesh-ancestor
14137326|NCT01478542|Rituximab|rituximab|mesh-list
14137327|NCT01478542|Vincristine|vincristine|mesh-list
14137328|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137329|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137330|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
13952164|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13952165|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13952166|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13952167|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952168|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13952169|NCT03211741|Bevacizumab|bevacizumab|mesh-list
14137331|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137332|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14137333|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14137334|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137335|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137336|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14137337|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137338|NCT00819221|Doxorubicin|doxorubicin|mesh-list
14137339|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14137340|NCT00819221|Olaparib|olaparib|mesh-list
14137341|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14137342|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137343|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14137344|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14137345|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137346|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137347|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14137348|NCT00807651|Insulin|insulin|mesh-list
14137349|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14137350|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14764135|NCT00614757|Expectorants|expectorants|mesh-ancestor
14137351|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137352|NCT00700791|Vitamins|vitamins|mesh-list
14137353|NCT00700791|Vitamin E|vitamin e|mesh-list
14137354|NCT00700791|Tocopherols|tocopherols|mesh-list
14137355|NCT00700791|Tocotrienols|tocotrienols|mesh-list
14137356|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
14137357|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
14764136|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
13952170|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13952171|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952172|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14764137|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13952173|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13952174|NCT03211741|Growth Substances|growth substances|mesh-ancestor
13952175|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952176|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
13952177|NCT03211572|Tamoxifen|tamoxifen|mesh-list
13952178|NCT03211572|Anastrozole|anastrozole|mesh-list
13952179|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13952180|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
13952181|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952182|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952183|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13952184|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952185|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13952186|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13952187|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13952188|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13952189|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13952190|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952191|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952192|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
13952193|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13952194|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
13952195|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764138|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
13952196|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
13952197|NCT03211650|Protective Agents|protective agents|mesh-ancestor
14137358|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137359|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
14137360|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137361|NCT00700791|Protective Agents|protective agents|mesh-ancestor
14137362|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
14137363|NCT05129748|Mannitol|mannitol|mesh-list
14137364|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14137365|NCT05129748|Diuretics|diuretics|mesh-ancestor
13952198|NCT03211455|Lidocaine|lidocaine|mesh-list
13952199|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
13952200|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
13952201|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137366|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
14137367|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137368|NCT05129748|Antidotes|antidotes|mesh-ancestor
14137369|NCT05129748|Protective Agents|protective agents|mesh-ancestor
14137370|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
14137371|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137372|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
14137373|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14137374|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137375|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
14137376|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
14137377|NCT05129722|Empagliflozin|empagliflozin|mesh-list
14137378|NCT05129722|Eplerenone|eplerenone|mesh-list
14137379|NCT05129722|Bumetanide|bumetanide|mesh-list
14137380|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14137381|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137382|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14137383|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137384|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14137385|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
14137386|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764139|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137387|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14137388|NCT05129722|Diuretics|diuretics|mesh-ancestor
14137389|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
14137390|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14137391|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14137392|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14137393|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
14137394|NCT05129670|Antacids|antacids|mesh-ancestor
14137395|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137396|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137397|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
14137398|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14137399|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137400|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14137401|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
14137402|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14137403|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137404|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952202|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952203|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
13952204|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952205|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13952206|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13952207|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13952208|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952209|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952210|NCT03211338|Progesterone|progesterone|mesh-list
14137405|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137406|NCT05129085|Dexamethasone|dexamethasone|mesh-list
14137407|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137408|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
14137409|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
14137410|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137411|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137412|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137413|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
14137414|NCT05129085|Hormones|hormones|mesh-ancestor
14137415|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137416|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14137417|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178078|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178079|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183828|NCT04725383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183829|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14183830|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14183831|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14183832|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183833|NCT04725357|Meloxicam|meloxicam|mesh-list
14183834|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14183835|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183836|NCT04725357|Analgesics|analgesics|mesh-ancestor
14183837|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
14183838|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183839|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183840|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14183841|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14183842|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14183843|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14183844|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952211|NCT03211338|Mitogens|mitogens|mesh-list
13952212|NCT03211338|Progestins|progestins|mesh-ancestor
13952213|NCT03211338|Hormones|hormones|mesh-ancestor
13952214|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952215|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952216|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
13952217|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952218|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
13952219|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13952220|NCT03211065|Antibodies|antibodies|mesh-list
13952221|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
13952222|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962810|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962811|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
13962812|NCT03084523|Hematinics|hematinics|mesh-ancestor
13952223|NCT03211052|Leuprolide|leuprolide|mesh-list
13952224|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13952225|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
13952226|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952227|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952228|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13952229|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137418|NCT05129033|Omalizumab|omalizumab|mesh-list
14137419|NCT05129033|Itraconazole|itraconazole|mesh-list
14137420|NCT05129033|Prednisone|prednisone|mesh-list
14137421|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137422|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
14137423|NCT05129033|Hormones|hormones|mesh-ancestor
14137424|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137425|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137426|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14137427|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137428|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
14137429|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137430|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14137431|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14137432|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137433|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137434|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14137435|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
14137436|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14137437|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14137438|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14137439|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
14137440|NCT05128916|Terbinafine|terbinafine|mesh-list
14137441|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
14137442|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137443|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137444|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137445|NCT05128734|Temozolomide|temozolomide|mesh-list
14137446|NCT05128734|Olaparib|olaparib|mesh-list
14137447|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14137448|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
14137449|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137450|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137451|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14137452|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137453|NCT05128721|Vaccines|vaccines|mesh-list
14137454|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
14137455|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137456|NCT05128630|Durvalumab|durvalumab|mesh-list
14137457|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137458|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137459|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14137460|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14137461|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
14137462|NCT05126511|Hormones|hormones|mesh-ancestor
14137463|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137464|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137465|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137466|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137467|NCT05097794|Indapamide|indapamide|mesh-list
14137468|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14137469|NCT05097794|Diuretics|diuretics|mesh-ancestor
14137470|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
14137471|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137472|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14137473|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14137474|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137475|NCT05073562|Folic Acid|folic acid|mesh-list
14137476|NCT05073562|Mebendazole|mebendazole|mesh-list
14137477|NCT05073562|Piperazine|piperazine|mesh-list
14137478|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
14137479|NCT05073562|DMP 777|dmp 777|mesh-list
14137480|NCT05073562|Hematinics|hematinics|mesh-ancestor
14137481|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
14137482|NCT05073562|Vitamins|vitamins|mesh-ancestor
14137483|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
13952230|NCT03211104|Curcumin|curcumin|mesh-list
13952231|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14137484|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137485|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
14137486|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
14137487|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14137488|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137489|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137490|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137491|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14137492|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137493|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137494|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764140|NCT00614757|Protective Agents|protective agents|mesh-ancestor
14764141|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764142|NCT00614757|Antidotes|antidotes|mesh-ancestor
14764143|NCT00614809|Gefitinib|gefitinib|mesh-list
14764144|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764145|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13952232|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13952233|NCT03211104|Analgesics|analgesics|mesh-ancestor
13952234|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
13952235|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952236|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952237|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952238|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952239|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952240|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952241|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952242|NCT03211143|Esomeprazole|esomeprazole|mesh-list
13952243|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13952244|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952245|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13952246|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952247|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952248|NCT03211013|Oxytocin|oxytocin|mesh-list
13952249|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
13952250|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952251|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952252|NCT03211351|Dextrans|dextrans|mesh-list
13952253|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
13952254|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
13952255|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
13952256|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13952257|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13952258|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952259|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13952260|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952261|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
13952262|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13952263|NCT03210688|Prednisone|prednisone|mesh-list
13952264|NCT03210688|Prednisolone|prednisolone|mesh-list
13952265|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952266|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
13952267|NCT03210688|Hormones|hormones|mesh-ancestor
13952268|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952269|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952270|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13952271|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952272|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13952273|NCT03210688|Vitamins|vitamins|mesh-ancestor
13952274|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
13952275|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
13952276|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13952277|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952278|NCT03210610|Colchicine|colchicine|mesh-list
13952279|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
13952280|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952281|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137516|NCT04969731|Gemcitabine|gemcitabine|mesh-list
14137517|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14137518|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
14137519|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137520|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137521|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
14137522|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137523|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137524|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137525|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
14137526|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137527|NCT04955938|Ivosidenib|ivosidenib|mesh-list
13952282|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
13952283|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
13952284|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952285|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952286|NCT03210766|Nabilone|nabilone|mesh-list
13952287|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
13952288|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
13952289|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952290|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952291|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952292|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13952293|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13952294|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952295|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13952296|NCT03210545|Betamethasone|betamethasone|mesh-list
13952297|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952298|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
13952299|NCT03210545|Hormones|hormones|mesh-ancestor
13952300|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952301|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952302|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13952303|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
13952304|NCT03210558|Testosterone|testosterone|mesh-list
13952305|NCT03210558|Androgens|androgens|mesh-ancestor
13952306|NCT03210558|Hormones|hormones|mesh-ancestor
13952307|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952308|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952309|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13952310|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
13952311|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952312|NCT03210532|Amlodipine|amlodipine|mesh-list
13952313|NCT03210532|Telmisartan|telmisartan|mesh-list
13952314|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
13952315|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13952316|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13952317|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13952318|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952319|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952320|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13952321|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952322|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
13952323|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13952324|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13952325|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
13952326|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14137528|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137529|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137530|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137531|NCT04930991|Omeprazole|omeprazole|mesh-list
14137532|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14137533|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137534|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14137535|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137536|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137537|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14137538|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137539|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764146|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764147|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764148|NCT00614835|Gemcitabine|gemcitabine|mesh-list
14764149|NCT00614835|Docetaxel|docetaxel|mesh-list
14764150|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13952327|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13952328|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952329|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13952330|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13952331|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
13952332|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
13952333|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13952334|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
13952335|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952336|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952337|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
13952338|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13952339|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13952340|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13952341|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13952342|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
13952343|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13952344|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13952345|NCT03210324|Mifepristone|mifepristone|mesh-list
13952346|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13952347|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
13952348|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952349|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952350|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13952351|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13952352|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13952353|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
13952354|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13952355|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13952356|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
13952357|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952358|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
14137540|NCT04779216|Alendronate|alendronate|mesh-list
14137541|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14137542|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137543|NCT04773184|Capsaicin|capsaicin|mesh-list
14137544|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
14137545|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
14137546|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
14137547|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137548|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178080|NCT04750603|Fluticasone|fluticasone|mesh-list
14178081|NCT04750603|Xhance|xhance|mesh-list
14178082|NCT04750603|Albuterol|albuterol|mesh-list
14178083|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178084|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14178085|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
14178086|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178087|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178088|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14178089|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
14178090|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14178091|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14178092|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
14137549|NCT04765371|Dexamethasone|dexamethasone|mesh-list
13952359|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13952360|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13952361|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
13952362|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
13952363|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13952364|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137550|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
14137551|NCT04765371|Prednisolone|prednisolone|mesh-list
14137552|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14137553|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
14137554|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14137555|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
14137556|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14137557|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
14137558|NCT04765371|BB 1101|bb 1101|mesh-list
14137559|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137560|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
14137561|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
14137562|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137563|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137564|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137565|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
14137566|NCT04765371|Hormones|hormones|mesh-ancestor
14137567|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137568|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14137569|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137570|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
14137571|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137572|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137573|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14137574|NCT04765371|Protective Agents|protective agents|mesh-ancestor
14137575|NCT04739995|Naltrexone|naltrexone|mesh-list
14137576|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14137577|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14764151|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
14764152|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764153|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952365|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952366|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
13952367|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13952368|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952369|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952370|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13952371|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
13952372|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952373|NCT03210064|Fluorouracil|fluorouracil|mesh-list
13952374|NCT03210064|Apatinib|apatinib|mesh-list
13952375|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
13952376|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952377|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13952378|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952379|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952380|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
13952381|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952382|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13952383|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952384|NCT03210025|Methyldopa|methyldopa|mesh-list
13952385|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13952386|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
13952387|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
13952388|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952389|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952390|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13952391|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13952392|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13952393|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
13952394|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952395|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952396|NCT03210038|Lidocaine|lidocaine|mesh-list
13952397|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
13952398|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
13952399|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137578|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137579|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
14764154|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
14764155|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764156|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764157|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14764158|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
14764159|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137580|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137598|NCT04437888|Ketamine|ketamine|mesh-list
14137599|NCT04437888|Analgesics|analgesics|mesh-ancestor
14137600|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
14137601|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137602|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137603|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14137604|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14137605|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
14137606|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
14137607|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137608|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14137609|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14137610|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137611|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137612|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14137613|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14137614|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14137615|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137616|NCT04405674|Paclitaxel|paclitaxel|mesh-list
14764160|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
14764161|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
14764162|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
14764163|NCT00614965|Irinotecan|irinotecan|mesh-list
14764164|NCT00614965|Pemetrexed|pemetrexed|mesh-list
14764165|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764166|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14764167|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14764168|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952400|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952401|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
13952402|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952403|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13952404|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13952405|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13952406|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952407|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952408|NCT03209908|Tenofovir|tenofovir|mesh-list
13952409|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
13952410|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952411|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13952412|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13952413|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952414|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764169|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764170|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14764171|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764172|NCT00614978|Temozolomide|temozolomide|mesh-list
14764173|NCT00614978|Lapatinib|lapatinib|mesh-list
14764174|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764175|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
14764176|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764177|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764178|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764179|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137617|NCT04405674|Bevacizumab|bevacizumab|mesh-list
14137618|NCT04405674|Carboplatin|carboplatin|mesh-list
14137619|NCT04405674|Pemetrexed|pemetrexed|mesh-list
14137620|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14137621|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137622|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137623|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137624|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
14137625|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137626|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137627|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14137628|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14137629|NCT04405674|Growth Substances|growth substances|mesh-ancestor
14137630|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137631|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
14137632|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137633|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14137634|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14137642|NCT04366518|Scopolamine|scopolamine|mesh-list
14137643|NCT04366518|Rivastigmine|rivastigmine|mesh-list
14137644|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14137645|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14137646|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137647|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137648|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
14137649|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137650|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137651|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14137652|NCT04366518|Protective Agents|protective agents|mesh-ancestor
14137653|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14137654|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
14137655|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
14137656|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137657|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14137658|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
14137659|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14137660|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14137661|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
14137662|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
14137663|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14137664|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14137665|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137666|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
14137667|NCT04360629|Coagulants|coagulants|mesh-ancestor
14137668|NCT04330664|Adagrasib|adagrasib|mesh-list
14137669|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137670|NCT04237649|Spartalizumab|spartalizumab|mesh-list
14137671|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14137672|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137673|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137674|NCT04227314|Apremilast|apremilast|mesh-list
14137675|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14137676|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14137677|NCT04227314|Analgesics|analgesics|mesh-ancestor
14137678|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
14137679|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137680|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764180|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
14137681|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137682|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14137683|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14137684|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14137685|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137686|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137687|NCT04223648|Nivolumab|nivolumab|mesh-list
14137688|NCT04223648|Ipilimumab|ipilimumab|mesh-list
14137689|NCT04223648|Durvalumab|durvalumab|mesh-list
14137690|NCT04223648|Tremelimumab|tremelimumab|mesh-list
14137691|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137692|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137693|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14137694|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137695|NCT04220775|Atezolizumab|atezolizumab|mesh-list
14137696|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137697|NCT04218708|Nicotine|nicotine|mesh-list
14137698|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14137699|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
14137700|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952415|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13952416|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13952417|NCT03209856|Vitamin D|vitamin d|mesh-list
13952418|NCT03209856|Calcitriol|calcitriol|mesh-list
13952419|NCT03209856|Vitamins|vitamins|mesh-ancestor
13952420|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
13952421|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952422|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13952423|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13952424|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13952425|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14137701|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137702|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14137703|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14137704|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
14137705|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137706|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137707|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
14137708|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
14137709|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14137710|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137711|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137712|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14137713|NCT04113720|Analgesics|analgesics|mesh-ancestor
14137714|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
14137715|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137716|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14137717|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14137718|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14137719|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
14137720|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137721|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137722|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
14137723|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
14137724|NCT04094675|Sirolimus|sirolimus|mesh-list
14137725|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14137726|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14137727|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14137728|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137729|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
14137730|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137731|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
14137732|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137743|NCT04076748|Sufentanil|sufentanil|mesh-list
14137744|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14137745|NCT04076748|Narcotics|narcotics|mesh-ancestor
14137746|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137747|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137748|NCT04076748|Analgesics|analgesics|mesh-ancestor
14137749|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
14137750|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952426|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952427|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13952428|NCT03209622|Nicotine|nicotine|mesh-list
13952429|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13952430|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
14137751|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14137752|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14137753|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
14137754|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
14137755|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
14137756|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14137757|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14137758|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14137759|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14137760|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14137761|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137762|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
14137763|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137764|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137765|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14137766|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137767|NCT04047862|Paclitaxel|paclitaxel|mesh-list
14137768|NCT04047862|Etoposide|etoposide|mesh-list
14137769|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14137770|NCT04047862|Carboplatin|carboplatin|mesh-list
14137771|NCT04047862|Fluorouracil|fluorouracil|mesh-list
14137772|NCT04047862|Capecitabine|capecitabine|mesh-list
14137773|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
14137774|NCT04047862|Pemetrexed|pemetrexed|mesh-list
14137775|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14137776|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137777|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137778|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137779|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
14137780|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137781|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
14137782|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14137783|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137784|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
14137785|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137786|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13952431|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952432|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952433|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13952434|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13952435|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
13952436|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952437|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479268|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137787|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14137788|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952438|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
13952439|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14137789|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14137790|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764181|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14764182|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14764183|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764184|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764185|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764186|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
14764187|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764188|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
14764189|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14764190|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14764191|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764192|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
14764193|NCT00615147|Coagulants|coagulants|mesh-ancestor
14764194|NCT00615160|Dacarbazine|dacarbazine|mesh-list
14764195|NCT00615160|Vatalanib|vatalanib|mesh-list
14764196|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764197|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
14764198|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764199|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952440|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13952441|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952442|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
13952443|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
13962813|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13962814|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13962815|NCT03070301|Everolimus|everolimus|mesh-list
14764200|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764201|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764202|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
14137813|NCT04038489|Aspirin|aspirin|mesh-list
14137814|NCT04038489|Tamoxifen|tamoxifen|mesh-list
14137815|NCT04038489|Paclitaxel|paclitaxel|mesh-list
14764203|NCT00615173|Azathioprine|azathioprine|mesh-list
14764204|NCT00615173|Tacrolimus|tacrolimus|mesh-list
14764205|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14764206|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
14764207|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764208|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764209|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764210|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
14764211|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478587|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478588|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
14478589|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
14478590|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478591|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478592|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14478593|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
13962816|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962817|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962818|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
13962819|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962820|NCT03064113|Ipratropium|ipratropium|mesh-list
14137816|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
14137817|NCT04038489|Doxorubicin|doxorubicin|mesh-list
14137818|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14478594|NCT02453841|Phenylephrine|phenylephrine|mesh-list
14478595|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
14478596|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14137819|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478597|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14137820|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137821|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137822|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14178093|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178094|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14178095|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14178096|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14178097|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478598|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478599|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478600|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952444|NCT03209427|Morphine|morphine|mesh-list
13952445|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13952446|NCT03209427|Narcotics|narcotics|mesh-ancestor
13952447|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952448|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952449|NCT03209427|Analgesics|analgesics|mesh-ancestor
13952450|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
14137823|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137824|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137825|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
14137826|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137827|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14137828|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14137829|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
14137830|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14137831|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14137832|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14137833|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14137834|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137835|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14137836|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14137837|NCT04038489|Analgesics|analgesics|mesh-ancestor
14137838|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
14137839|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137840|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14137841|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14137842|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13952451|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952452|NCT03209661|Menthol|menthol|mesh-list
13952453|NCT03209661|Nicotine|nicotine|mesh-list
13952454|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13952455|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
13952456|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952457|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952458|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13952459|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13952460|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
13952461|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952462|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952463|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
13952464|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
13952465|NCT03209648|Itraconazole|itraconazole|mesh-list
13952466|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
13952467|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952468|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13952469|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13952470|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952471|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137843|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14137844|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14137845|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
14137846|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14137847|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
14137848|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14137849|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14137850|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14137851|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14137852|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14137853|NCT03956368|Atorvastatin|atorvastatin|mesh-list
13952472|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13952473|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
13952474|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952475|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952476|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13952477|NCT03209401|Carboplatin|carboplatin|mesh-list
13952478|NCT03209401|Niraparib|niraparib|mesh-list
13952479|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952480|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13952481|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952482|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952483|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13952484|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
14137854|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14137855|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14137856|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
14137857|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137858|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14137859|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14137860|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137861|NCT03933007|Fexofenadine|fexofenadine|mesh-list
14137862|NCT03933007|Colchicine|colchicine|mesh-list
14137863|NCT03933007|Midazolam|midazolam|mesh-list
14137864|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14137865|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14137866|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137867|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137868|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14137869|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14137870|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14137871|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14137872|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
14137873|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
14137874|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
14137875|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
14137876|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137877|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137878|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
14137879|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14137880|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137881|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137882|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
14137883|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137884|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14137885|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14137886|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14137887|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
14137888|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
14764212|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764213|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14764214|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14764215|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764216|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
14764217|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14764218|NCT00615186|Temozolomide|temozolomide|mesh-list
14764219|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764220|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
13952485|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952486|NCT03209180|Carvedilol|carvedilol|mesh-list
13952487|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13952488|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13952489|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
13952490|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952491|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952492|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952493|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13952494|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
13952495|NCT03209180|Protective Agents|protective agents|mesh-ancestor
13952496|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13952497|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952498|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13952499|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
13952500|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13952501|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13952502|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
13952503|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952504|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
13952505|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
14764221|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764222|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952506|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
13952507|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
13952508|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
13952509|NCT03209115|Calcium|calcium|mesh-list
13952510|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13952511|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178098|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178099|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952512|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13952513|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13952514|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952515|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
13952516|NCT03209193|Sevoflurane|sevoflurane|mesh-list
13952517|NCT03209193|Desflurane|desflurane|mesh-list
13952518|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13952519|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13952520|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
13952521|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
13952522|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952523|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952524|NCT03209219|Interferons|interferons|mesh-list
13952525|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
13952526|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
13952527|NCT03209219|Cyclosporine|cyclosporine|mesh-list
13952528|NCT03209219|Cyclosporins|cyclosporins|mesh-list
13952529|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952530|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
13952531|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952532|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952533|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952534|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952535|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
13952536|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952537|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
13952538|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
13952539|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952540|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13952541|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
13952542|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952543|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13952544|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
13952545|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952546|NCT03209206|Docetaxel|docetaxel|mesh-list
13952547|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952548|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
13952549|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137900|NCT03875287|Decitabine|decitabine|mesh-list
14137901|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14137902|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
14137903|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137904|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137905|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137906|NCT03805581|Defibrotide|defibrotide|mesh-list
14137907|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14137908|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14137909|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137910|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14137911|NCT03791593|Evolocumab|evolocumab|mesh-list
14137912|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14137913|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14137914|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
14137915|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137916|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14137917|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
14137918|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137919|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137920|NCT03665506|Trifluridine|trifluridine|mesh-list
14137921|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
14137922|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137923|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
14137924|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764223|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
14764224|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
14764225|NCT00615212|Midazolam|midazolam|mesh-list
14764226|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14764227|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14764228|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764229|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764230|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14764231|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14764232|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13952550|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
13952551|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952552|NCT03209232|Infliximab|infliximab|mesh-list
13952553|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
13952554|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952555|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952556|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13952557|NCT03208972|Menotropins|menotropins|mesh-list
13952558|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952559|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952560|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13952561|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
13952562|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
13952563|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13952564|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
13952565|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952566|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952567|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13952568|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
13952569|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13952570|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
13952571|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952572|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952573|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13952574|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
13952575|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
13952576|NCT03208764|Protective Agents|protective agents|mesh-ancestor
13952577|NCT03208894|Furosemide|furosemide|mesh-list
13952578|NCT03208894|Diuretics|diuretics|mesh-ancestor
13952579|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
14764233|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14764234|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
14137937|NCT03559647|Atezolizumab|atezolizumab|mesh-list
14137938|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137939|NCT03519971|Paclitaxel|paclitaxel|mesh-list
14137940|NCT03519971|Etoposide|etoposide|mesh-list
14137941|NCT03519971|Cisplatin|cisplatin|mesh-list
14137942|NCT03519971|Carboplatin|carboplatin|mesh-list
14137943|NCT03519971|Pemetrexed|pemetrexed|mesh-list
14137944|NCT03519971|Durvalumab|durvalumab|mesh-list
14137945|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14137946|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137947|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137948|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137949|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
14137950|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137951|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14137952|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14137953|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14137954|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13952580|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952581|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13952582|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952583|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952584|NCT03208712|Atezolizumab|atezolizumab|mesh-list
14137955|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14137956|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137957|NCT03412643|Paclitaxel|paclitaxel|mesh-list
14137958|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
14137959|NCT03412643|Doxorubicin|doxorubicin|mesh-list
14137960|NCT03412643|Trastuzumab|trastuzumab|mesh-list
14137961|NCT03412643|Pertuzumab|pertuzumab|mesh-list
14137962|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14137963|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14137964|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
14137965|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
14137966|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
14137967|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14137968|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14137969|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
14137970|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137971|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14137972|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14137973|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
14137974|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14137975|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14137976|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14137977|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14478601|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137978|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764235|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
14137979|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14137980|NCT03389022|Ketamine|ketamine|mesh-list
14137981|NCT03389022|Analgesics|analgesics|mesh-ancestor
14137982|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
14137983|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14137984|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14137985|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14137986|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14137987|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
14137988|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
14137989|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14137990|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14137991|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14137992|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137993|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764236|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
14764237|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
14764238|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14137997|NCT03344159|Spironolactone|spironolactone|mesh-list
14137998|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14137999|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
14138000|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138001|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138002|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14138003|NCT03344159|Diuretics|diuretics|mesh-ancestor
14138004|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
14138005|NCT03336333|Rituximab|rituximab|mesh-list
14138006|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13952585|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952586|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13952587|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
13952588|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952589|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
13952590|NCT03208556|Fludarabine|fludarabine|mesh-list
13952591|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952592|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
14138007|NCT03336333|Venetoclax|venetoclax|mesh-list
14138008|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
14138009|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138010|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138011|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
14138012|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138013|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138014|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138015|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
14138016|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138017|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14138018|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138019|NCT03319459|Trastuzumab|trastuzumab|mesh-list
14138020|NCT03319459|Cetuximab|cetuximab|mesh-list
14138021|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138022|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138023|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
14138024|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14138025|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
14138026|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138027|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
14138028|NCT03318874|Protective Agents|protective agents|mesh-ancestor
14138029|NCT03269136|Thalidomide|thalidomide|mesh-list
14138030|NCT03269136|Dexamethasone|dexamethasone|mesh-list
14138031|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
14138032|NCT03269136|Lenalidomide|lenalidomide|mesh-list
14764239|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764240|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14764241|NCT00615212|Analgesics|analgesics|mesh-ancestor
14764242|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
13952593|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952594|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952595|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13952596|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
14764243|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767382|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138033|NCT03269136|Pomalidomide|pomalidomide|mesh-list
14138034|NCT03269136|Antibodies|antibodies|mesh-list
14138035|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
13952597|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138036|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14138037|NCT03269136|BB 1101|bb 1101|mesh-list
14138038|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
14138039|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138040|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138041|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
14138042|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
14138043|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138044|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138045|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
14138046|NCT03269136|Hormones|hormones|mesh-ancestor
14138047|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138048|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14138049|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138050|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
14138051|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138052|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138053|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14138054|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14138055|NCT03269136|Growth Substances|growth substances|mesh-ancestor
14138056|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
14138057|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138058|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
14138059|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138060|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138061|NCT03259698|Tenofovir|tenofovir|mesh-list
14138062|NCT03259698|Emtricitabine|emtricitabine|mesh-list
14138063|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14138064|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
14138065|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138066|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14138067|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14138068|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138069|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138070|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13952598|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952599|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13952600|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
13952601|NCT03208582|Diphosphonates|diphosphonates|mesh-list
13952602|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13952603|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138071|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14138072|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
13952604|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952605|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13952606|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952607|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13952608|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
13952609|NCT03208452|Analgesics|analgesics|mesh-ancestor
13952610|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
13952611|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952612|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952613|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
13952614|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952615|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13952616|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
13952617|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13952618|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952619|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952620|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13952621|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
13952622|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952623|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13952624|NCT03208465|Empagliflozin|empagliflozin|mesh-list
13952625|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13952626|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952627|NCT03208465|Incretins|incretins|mesh-ancestor
13952628|NCT03208465|Hormones|hormones|mesh-ancestor
13952629|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952630|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14138073|NCT03222531|Velpatasvir|velpatasvir|mesh-list
14138074|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
14138075|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138076|NCT03137771|Gemcitabine|gemcitabine|mesh-list
14138077|NCT03137771|Docetaxel|docetaxel|mesh-list
14138078|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
14138079|NCT03137771|Pemetrexed|pemetrexed|mesh-list
14138080|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14138081|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138082|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
14138083|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138084|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138085|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
14138086|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138087|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138088|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138089|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
14138090|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138091|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14138092|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14138093|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14138094|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138095|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14138096|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14138097|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14138098|NCT03124355|Bromides|bromides|mesh-list
14138099|NCT03124355|Galantamine|galantamine|mesh-list
14138100|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14138101|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
14138102|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14138103|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138104|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138105|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
14138106|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138107|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138108|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14138109|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
14138110|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138111|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
14138112|NCT03056339|Vidarabine|vidarabine|mesh-list
14138113|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
14138114|NCT03056339|Fludarabine|fludarabine|mesh-list
14138115|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
14138116|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138117|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
14138118|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138119|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138120|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138121|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
14138122|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138123|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138124|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14138125|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138126|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
14138127|NCT03056339|Antiviral Agents|antiviral agents|mesh-ancestor
14138128|NCT03056339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138129|NCT02937571|Dexamethasone|dexamethasone|mesh-list
14138130|NCT02937571|Lenalidomide|lenalidomide|mesh-list
14138131|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138132|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
14138133|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
14138134|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138135|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138136|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138137|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
14138138|NCT02937571|Hormones|hormones|mesh-ancestor
14138139|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138140|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14138141|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138142|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
14138143|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14138144|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14767383|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
14138145|NCT02937571|Growth Substances|growth substances|mesh-ancestor
14138146|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
14138147|NCT02648581|Ustekinumab|ustekinumab|mesh-list
14138148|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
14138149|NCT02609815|Metformin|metformin|mesh-list
14138150|NCT02609815|Glimepiride|glimepiride|mesh-list
14138151|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14138152|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138153|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14138154|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138155|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
13952631|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
13952632|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952633|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952634|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13952635|NCT03208218|Lenalidomide|lenalidomide|mesh-list
13952636|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
13952637|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952638|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13952639|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13952640|NCT03208218|Growth Substances|growth substances|mesh-ancestor
13952641|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
13952642|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952643|NCT03208413|Thalidomide|thalidomide|mesh-list
13952644|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952645|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
13952646|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952647|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
13952648|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13952649|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952650|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14138176|NCT02502786|Antibodies|antibodies|mesh-list
14138177|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
14138178|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138179|NCT02464878|Etanercept|etanercept|mesh-list
14138180|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
14138181|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14138182|NCT02464878|Basiliximab|basiliximab|mesh-list
14138183|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14138184|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
14138185|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13952651|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13952652|NCT03208413|Growth Substances|growth substances|mesh-ancestor
13952653|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
13952654|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952655|NCT03208257|Esmolol|esmolol|mesh-list
13952656|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13952657|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14138186|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14138187|NCT02464878|Analgesics|analgesics|mesh-ancestor
14138188|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
14138189|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138190|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138191|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138192|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138193|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138194|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952658|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14138195|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
14138196|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13952659|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
14138197|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14138198|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
14138199|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138200|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138201|NCT02250937|Fludarabine|fludarabine|mesh-list
14138202|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
14138203|NCT02250937|Busulfan|busulfan|mesh-list
14138204|NCT02250937|Venetoclax|venetoclax|mesh-list
14138205|NCT02250937|Cladribine|cladribine|mesh-list
14138206|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14138207|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138208|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138209|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
14138210|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952660|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952661|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952662|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952663|NCT03208270|Antithrombins|antithrombins|mesh-list
13952664|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
13952665|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13952666|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
13952667|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952668|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952669|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
13952670|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
13952671|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952672|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
13952673|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952674|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
13952675|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138211|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138212|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
14138213|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138214|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
14138215|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138216|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14138217|NCT02010606|Bevacizumab|bevacizumab|mesh-list
14138218|NCT02010606|Temozolomide|temozolomide|mesh-list
14138219|NCT02010606|Vaccines|vaccines|mesh-list
14138220|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138221|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952676|NCT03208426|Amoxicillin|amoxicillin|mesh-list
13952677|NCT03208426|Metronidazole|metronidazole|mesh-list
13952678|NCT03208426|Clarithromycin|clarithromycin|mesh-list
14138222|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14138223|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14138224|NCT02010606|Growth Substances|growth substances|mesh-ancestor
14138225|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138226|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
14138227|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138228|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
14138229|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138230|NCT02010606|Immunologic Factors|immunologic factors|mesh-ancestor
14138231|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
14138232|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
14138233|NCT02002130|Butyric Acid|butyric acid|mesh-list
13952679|NCT03208426|Tetracycline|tetracycline|mesh-list
13952680|NCT03208426|Esomeprazole|esomeprazole|mesh-list
13952681|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13952682|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952683|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13952684|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13952685|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13952686|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952687|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13952688|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952689|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952690|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13952691|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13952692|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13952693|NCT03208101|Vaccines|vaccines|mesh-list
13952694|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
13952695|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138234|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14138235|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
14138236|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138237|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
14138238|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138239|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138240|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
14138241|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
14138242|NCT01794520|Dexamethasone|dexamethasone|mesh-list
14138243|NCT01794520|Venetoclax|venetoclax|mesh-list
14138244|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138245|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
14138246|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
14138247|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138248|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138249|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138250|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
14138251|NCT01794520|Hormones|hormones|mesh-ancestor
14138252|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138253|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14138254|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138255|NCT01737502|Sirolimus|sirolimus|mesh-list
14138256|NCT01737502|Auranofin|auranofin|mesh-list
14138257|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138258|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138259|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14138260|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138261|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
14138262|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138263|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
14138264|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138265|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138266|NCT01701986|Gemcitabine|gemcitabine|mesh-list
14138267|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
14138268|NCT01701986|Rituximab|rituximab|mesh-list
14138269|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14138270|NCT01701986|Busulfan|busulfan|mesh-list
14138271|NCT01701986|Clofarabine|clofarabine|mesh-list
14138272|NCT01701986|Antibodies|antibodies|mesh-list
14138273|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
14138274|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13962821|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13962822|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
14478602|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
14138275|NCT01701986|Tacrolimus|tacrolimus|mesh-list
14138276|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
14138277|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14138278|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
14478603|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
14138279|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138280|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138281|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138282|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138283|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
14138284|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138285|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
14138286|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138287|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138288|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138289|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14764244|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764245|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14764246|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764247|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764248|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14764249|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764250|NCT00615303|Simethicone|simethicone|mesh-list
14764251|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
14764252|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952696|NCT03208361|Amoxicillin|amoxicillin|mesh-list
13952697|NCT03208361|Penicillins|penicillins|mesh-list
13952698|NCT03208361|Penicillin V|penicillin v|mesh-list
14138290|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14138291|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14138292|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
13952699|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13952700|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952701|NCT03208335|Endostatins|endostatins|mesh-list
13952702|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952703|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13952704|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13952705|NCT03208335|Growth Substances|growth substances|mesh-ancestor
13952706|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952707|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
13952708|NCT03208179|Azithromycin|azithromycin|mesh-list
13952709|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
13952710|NCT03208179|Piperaquine|piperaquine|mesh-list
14138293|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138294|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
14138295|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138296|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14138297|NCT00754949|Azithromycin|azithromycin|mesh-list
14138298|NCT00754949|Dexamethasone|dexamethasone|mesh-list
14138299|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
14138300|NCT00754949|BB 1101|bb 1101|mesh-list
14138301|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138302|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
14138303|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
14138304|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138305|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952711|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
13952712|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
13952713|NCT03208179|Artenimol|artenimol|mesh-list
13952714|NCT03208179|Artemisinins|artemisinins|mesh-list
13952715|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13952716|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952717|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
13952718|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13952719|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13952720|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13952721|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952722|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952723|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13952724|NCT03208179|Renal Agents|renal agents|mesh-ancestor
14138306|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138307|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
13952725|NCT03207698|Metformin|metformin|mesh-list
13952726|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13952727|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138308|NCT00754949|Hormones|hormones|mesh-ancestor
14138309|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764253|NCT00615303|Emollients|emollients|mesh-ancestor
14764254|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
13952728|NCT03207308|Vitamin A|vitamin a|mesh-list
13952729|NCT03207308|Vitamins|vitamins|mesh-ancestor
13952730|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
13952731|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138310|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14138311|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138312|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
14138313|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138314|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138315|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138316|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138317|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
14138318|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138319|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
14138320|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138321|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138322|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138323|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
14138324|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138325|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138326|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14178100|NCT04750473|Edetic Acid|edetic acid|mesh-list
14178101|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14178102|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
14178103|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
14178104|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764255|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
14764256|NCT00615368|Hematinics|hematinics|mesh-ancestor
13952732|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
14178105|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
14178106|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14178107|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14178108|NCT04750460|Teriparatide|teriparatide|mesh-list
14178109|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14178110|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178111|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14178112|NCT04750616|Niacinamide|niacinamide|mesh-list
14178113|NCT04750616|Niacin|niacin|mesh-list
14178114|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
14178115|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
14178116|NCT04750616|Vitamins|vitamins|mesh-ancestor
14178117|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
14178118|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178119|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14178120|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
14178121|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178122|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14178123|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
14178124|NCT04750317|Tofacitinib|tofacitinib|mesh-list
14178125|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14178126|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178127|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952733|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952734|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952735|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
13952736|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
13952737|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952738|NCT03207451|Aspirin|aspirin|mesh-list
13952739|NCT03207451|Clopidogrel|clopidogrel|mesh-list
13952740|NCT03207451|Vorapaxar|vorapaxar|mesh-list
13952741|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13952742|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13952743|NCT03207451|Analgesics|analgesics|mesh-ancestor
13952744|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
13952745|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952746|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952747|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952748|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952749|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13952750|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13952751|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952752|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14178128|NCT04750382|Gemcitabine|gemcitabine|mesh-list
14178129|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178130|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14178131|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
14178132|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764257|NCT00615381|Insulin|insulin|mesh-list
14764258|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13952753|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13952754|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952755|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
13952756|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13952757|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13952758|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13952759|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
13952760|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952761|NCT03207334|Cytarabine|cytarabine|mesh-list
13952762|NCT03207334|Midostaurin|midostaurin|mesh-list
13952763|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13952764|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
14138327|NCT05132023|Metformin|metformin|mesh-list
14138328|NCT05132023|Empagliflozin|empagliflozin|mesh-list
14138329|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14138330|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138331|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14138332|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138333|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
14138334|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
14138335|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138336|NCT05131893|Tamoxifen|tamoxifen|mesh-list
14138337|NCT05131893|Docetaxel|docetaxel|mesh-list
14138338|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
14138339|NCT05131893|Capecitabine|capecitabine|mesh-list
14138340|NCT05131893|Trastuzumab|trastuzumab|mesh-list
14138341|NCT05131893|Letrozole|letrozole|mesh-list
14138342|NCT05131893|Epirubicin|epirubicin|mesh-list
14138343|NCT05131893|Pertuzumab|pertuzumab|mesh-list
14138344|NCT05131893|Goserelin|goserelin|mesh-list
14138345|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138346|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
14138347|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
14138348|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
14138349|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138350|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138351|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
14138352|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138353|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138354|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138355|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
14138356|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14138357|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138358|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
14138359|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138360|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14138361|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14138362|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138363|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14138364|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
14138365|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138366|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14138367|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14138368|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14138369|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14138370|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14138371|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14138372|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14138373|NCT05131867|Nimodipine|nimodipine|mesh-list
14138374|NCT05131867|Milrinone|milrinone|mesh-list
14138375|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14138376|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14138377|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
14138378|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14138379|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14138380|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138381|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138382|NCT05131867|Protective Agents|protective agents|mesh-ancestor
14138383|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138384|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14138385|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14138386|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138387|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14138388|NCT05131841|Vinorelbine|vinorelbine|mesh-list
14138389|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14937040|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14937041|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14937042|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14937043|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
14937044|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14937045|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
14937046|NCT01472913|Coagulants|coagulants|mesh-ancestor
14937047|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14937048|NCT01472926|Plasminogen|plasminogen|mesh-list
14937049|NCT01472926|Tenecteplase|tenecteplase|mesh-list
14937050|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14937051|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14937052|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952765|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952766|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952767|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
13952768|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952769|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952770|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
13952771|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952772|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13952773|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952774|NCT03207165|Dobutamine|dobutamine|mesh-list
13952775|NCT03207165|Milrinone|milrinone|mesh-list
13952776|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
13952777|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13952778|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
13952779|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
14937053|NCT01472978|Metronidazole|metronidazole|mesh-list
14937054|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937055|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14937056|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14937057|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14937058|NCT01473043|Axitinib|axitinib|mesh-list
13952780|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952781|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952782|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13952783|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14937059|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937060|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14937061|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937062|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937063|NCT01473069|Ketoconazole|ketoconazole|mesh-list
14937064|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
14937065|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937066|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14138390|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138391|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
14138392|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
14138393|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
14138394|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138395|NCT05131646|Axitinib|axitinib|mesh-list
14138396|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138397|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14138398|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138399|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138400|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14138401|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
14138402|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138403|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
14138404|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
14138405|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138406|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138407|NCT05131295|Dapsone|dapsone|mesh-list
14138408|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14138409|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138410|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
14138411|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14478604|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478605|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
14478606|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14478607|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
14478608|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14138412|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13952784|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13952785|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
13952786|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952787|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952788|NCT03207165|Protective Agents|protective agents|mesh-ancestor
13952789|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13952790|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
13952791|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13952792|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952793|NCT03207542|Daratumumab|daratumumab|mesh-list
13952794|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952795|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14138413|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14138414|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138415|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138416|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
14138417|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138418|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14138419|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
14138420|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138421|NCT05131295|Antacids|antacids|mesh-ancestor
14138422|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138423|NCT05131178|Bupivacaine|bupivacaine|mesh-list
14138424|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
14138425|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
14138426|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14138427|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138428|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
14138429|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138430|NCT05130892|Tranilast|tranilast|mesh-list
14138431|NCT05130892|Colchicine|colchicine|mesh-list
14138432|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
14138433|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138434|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
14138435|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
14138436|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
14138437|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138438|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138439|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14138440|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14138441|NCT05130892|Analgesics|analgesics|mesh-ancestor
14138442|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
14764259|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13952796|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
13952797|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13952798|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952799|NCT03207477|Mydriatics|mydriatics|mesh-list
13952800|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
13952801|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952802|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952803|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
13952804|NCT03206957|Endostatins|endostatins|mesh-list
13952805|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
13952806|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952807|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13952808|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13952809|NCT03206957|Growth Substances|growth substances|mesh-ancestor
13952810|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952811|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
13952812|NCT03206944|Aspirin|aspirin|mesh-list
13952813|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13952814|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13952815|NCT03206944|Analgesics|analgesics|mesh-ancestor
13952816|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
14764260|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764261|NCT00615446|Gemcitabine|gemcitabine|mesh-list
14764262|NCT00615446|Sunitinib|sunitinib|mesh-list
14764263|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14764264|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
14764265|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764266|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764267|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
14764268|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952817|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138443|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764269|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764270|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138444|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138445|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138446|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14138447|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138448|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14138449|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14138450|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
14138451|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
14138452|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138453|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14138454|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14138455|NCT05130684|Paclitaxel|paclitaxel|mesh-list
14138456|NCT05130684|Cisplatin|cisplatin|mesh-list
14138457|NCT05130684|Nivolumab|nivolumab|mesh-list
14138458|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14138459|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138460|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
14138461|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
14138462|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
14138463|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138464|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138465|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14138466|NCT05130619|Ethanol|ethanol|mesh-list
14138467|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14138468|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138469|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14138470|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138471|NCT05130515|Niraparib|niraparib|mesh-list
14138472|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13952818|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952819|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952820|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952821|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13952822|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13952823|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764271|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
14764272|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764273|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13952824|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13952825|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14138473|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138474|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138475|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138476|NCT05130398|Vaccines|vaccines|mesh-list
14138477|NCT05130398|Immunologic Factors|immunologic factors|mesh-ancestor
14138478|NCT05130398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138479|NCT05107557|Vaccines|vaccines|mesh-list
14138480|NCT05107557|Immunologic Factors|immunologic factors|mesh-ancestor
14138481|NCT05107557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138482|NCT05065554|Rituximab|rituximab|mesh-list
14138483|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
14138484|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138485|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138486|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
14138487|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138488|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138489|NCT05045950|Memantine|memantine|mesh-list
14138490|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13952826|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952827|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
13952828|NCT03206931|Selitrectinib|selitrectinib|mesh-list
13952829|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952830|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952831|NCT03206671|Cytarabine|cytarabine|mesh-list
13952832|NCT03206671|Dexamethasone|dexamethasone|mesh-list
13952833|NCT03206671|Prednisolone|prednisolone|mesh-list
13952834|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
13952835|NCT03206671|Ifosfamide|ifosfamide|mesh-list
13952836|NCT03206671|Rituximab|rituximab|mesh-list
13952837|NCT03206671|Doxorubicin|doxorubicin|mesh-list
13952838|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13952839|NCT03206671|Methotrexate|methotrexate|mesh-list
14138491|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14138492|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
14138493|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764274|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14138494|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138495|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138496|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14138497|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14138498|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14138499|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14138500|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14138501|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
14138502|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138503|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14138504|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14138505|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138506|NCT05041101|Halichondrin B|halichondrin b|mesh-list
14138507|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
14138508|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
14138509|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
14138510|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138511|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138512|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14138513|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
14138514|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14138515|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138516|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764275|NCT00615446|Growth Substances|growth substances|mesh-ancestor
14764276|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
14764277|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14138520|NCT05028725|Lugol's solution|lugol's solution|mesh-list
14138521|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
13952840|NCT03206671|Etoposide|etoposide|mesh-list
13952841|NCT03206671|Vincristine|vincristine|mesh-list
13952842|NCT03206671|Vindesine|vindesine|mesh-list
13952843|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952844|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
13952845|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952846|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952847|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13952848|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
13952849|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952850|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138522|NCT05028725|Coagulants|coagulants|mesh-ancestor
14138523|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
14138524|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14138525|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14138526|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952851|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13952852|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13952853|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
13952854|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
13952855|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952856|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952857|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
13952858|NCT03206671|Hormones|hormones|mesh-ancestor
13952859|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952860|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14138527|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
14138528|NCT05024253|Coagulants|coagulants|mesh-ancestor
14178133|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
14178134|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178135|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178136|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14178137|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
14178138|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178139|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14178140|NCT04749940|Laxatives|laxatives|mesh-ancestor
14178141|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178142|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14178143|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
14178144|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14178145|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
14178146|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178147|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178148|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13952861|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14764278|NCT00615524|Exemestane|exemestane|mesh-list
14138529|NCT05008536|Fludarabine|fludarabine|mesh-list
14138530|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
14138531|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138532|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138533|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138534|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
14138535|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138536|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138537|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138538|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
14138539|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14138540|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
14138541|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14138542|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138543|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14138544|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138545|NCT04983901|Vancomycin|vancomycin|mesh-list
14138546|NCT04983901|Meropenem|meropenem|mesh-list
13952862|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13952863|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13952864|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13952865|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952866|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13952867|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
13952868|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952869|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13952870|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
13952871|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
13952872|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13952873|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13952874|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13952875|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
13952876|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952877|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
13952878|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
13952879|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
13952880|NCT03206723|Hydrocodone|hydrocodone|mesh-list
13952881|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13952882|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13952883|NCT03206723|Narcotics|narcotics|mesh-ancestor
13952884|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952885|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952886|NCT03206723|Analgesics|analgesics|mesh-ancestor
13952887|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
13952888|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952889|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
13952890|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
13952891|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14138547|NCT04983901|Tazobactam|tazobactam|mesh-list
14138548|NCT04983901|Linezolid|linezolid|mesh-list
14138549|NCT04983901|Piperacillin|piperacillin|mesh-list
14138550|NCT04983901|Daptomycin|daptomycin|mesh-list
14138551|NCT04983901|Imipenem|imipenem|mesh-list
14138552|NCT04983901|Cefepime|cefepime|mesh-list
14138553|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14138554|NCT04983901|Relebactam|relebactam|mesh-list
14138555|NCT04983901|Cilastatin|cilastatin|mesh-list
14138556|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138557|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138558|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14138559|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138560|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138561|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14138562|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
14138563|NCT04982848|Talazoparib|talazoparib|mesh-list
14138564|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14138565|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138566|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952892|NCT03206658|Spironolactone|spironolactone|mesh-list
13952893|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13952894|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
13952895|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13952896|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138567|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138568|NCT04968899|Dexamethasone|dexamethasone|mesh-list
14138569|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
14138570|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14138571|NCT04968899|Antibodies|antibodies|mesh-list
14138572|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
14138573|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14138574|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138575|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
14138576|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
14138577|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138578|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952897|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13952898|NCT03206658|Diuretics|diuretics|mesh-ancestor
13952899|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
13952900|NCT03206554|Ropivacaine|ropivacaine|mesh-list
13952901|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
13952902|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
13952903|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952904|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952905|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
13952906|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952907|NCT03206866|Antibodies|antibodies|mesh-list
13952908|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
13952909|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952910|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
13952911|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
13952912|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952913|NCT03206138|Imiquimod|imiquimod|mesh-list
13952914|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13952915|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
13952916|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952917|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952918|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
13952919|NCT03206177|Paclitaxel|paclitaxel|mesh-list
13952920|NCT03206177|Carboplatin|carboplatin|mesh-list
14138579|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138580|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
14138581|NCT04968899|Hormones|hormones|mesh-ancestor
14138582|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138583|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14138584|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138585|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
13952921|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13952922|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952923|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
13952924|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
13952925|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
13952926|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952927|NCT03206255|Vaccines|vaccines|mesh-list
13952928|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
13952929|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962823|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962824|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962825|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13962826|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
13962827|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13962828|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
13962829|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962830|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962831|NCT03049540|Tadalafil|tadalafil|mesh-list
14138604|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14138605|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14138606|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14138607|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14138608|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138609|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14138610|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14138611|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14138612|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
14138613|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138614|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138615|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14138616|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14138617|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
14138618|NCT04887857|Azacitidine|azacitidine|mesh-list
14138619|NCT04887857|Venetoclax|venetoclax|mesh-list
14138620|NCT04887857|Cc-486|cc-486|mesh-list
14138621|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138622|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
14138623|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952930|NCT03206411|Hormones|hormones|mesh-list
13952931|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138624|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138625|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138626|NCT04884412|Anesthetics|anesthetics|mesh-list
14138627|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14138628|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138629|NCT04868409|Rocuronium|rocuronium|mesh-list
14138630|NCT04868409|Succinylcholine|succinylcholine|mesh-list
14138631|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14138632|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14138633|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14138634|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138635|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138636|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14138637|NCT04859465|Doxorubicin|doxorubicin|mesh-list
14138638|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14138639|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14138640|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14138641|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138642|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14138643|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14138644|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764279|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764280|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14764281|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14764282|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764283|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952932|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138645|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138646|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
14138647|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138648|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138649|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
14138650|NCT04691505|Methotrexate|methotrexate|mesh-list
14138651|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13952933|NCT03206203|Carboplatin|carboplatin|mesh-list
13952934|NCT03206203|Atezolizumab|atezolizumab|mesh-list
13952935|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952936|NCT03206320|Lidocaine|lidocaine|mesh-list
13952937|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
14138652|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
14138653|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14138654|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138655|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138656|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
14178149|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14764284|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14764285|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
13952938|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
13952939|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13962832|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
14767384|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952940|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952941|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
13952942|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952943|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13952944|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13952945|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13952946|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952947|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952948|NCT03206021|Carboplatin|carboplatin|mesh-list
13952949|NCT03206021|Azacitidine|azacitidine|mesh-list
14138657|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138658|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138659|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
14138660|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138661|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14138662|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138663|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
14138664|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138665|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14138666|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
14138667|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14138668|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14138669|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764286|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764287|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764288|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
14764289|NCT00615602|Docetaxel|docetaxel|mesh-list
14764290|NCT00615602|Trastuzumab|trastuzumab|mesh-list
14764291|NCT00615602|Epirubicin|epirubicin|mesh-list
14764292|NCT00615602|Fluorouracil|fluorouracil|mesh-list
14764293|NCT00615602|Mitogens|mitogens|mesh-list
14764294|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138679|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
14138680|NCT04678401|Thiotepa|thiotepa|mesh-list
14138681|NCT04678401|Fludarabine|fludarabine|mesh-list
14138682|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13952950|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952951|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13952952|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
13952953|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952954|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952955|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
13952956|NCT03206008|Analgesics|analgesics|mesh-ancestor
14138683|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
14138684|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138685|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138686|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138687|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
14138688|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138689|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138690|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14138691|NCT04635826|Adderall|adderall|mesh-list
14138692|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14138693|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138694|NCT04590586|Thalidomide|thalidomide|mesh-list
14138695|NCT04590586|Apremilast|apremilast|mesh-list
14138696|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14138697|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14138698|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14138699|NCT04590586|Analgesics|analgesics|mesh-ancestor
14138700|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
14138701|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138702|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138703|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138704|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13952957|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
13952958|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13952959|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952960|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
13952961|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952962|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14138705|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14138706|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14764295|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
14767385|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
14138707|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138708|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138709|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138710|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
14138711|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
14138712|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138713|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138714|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14138715|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14138716|NCT04590586|Growth Substances|growth substances|mesh-ancestor
14138717|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
14138718|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138719|NCT04589754|Ifosfamide|ifosfamide|mesh-list
14138720|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138721|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138722|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14138723|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
14138724|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14138725|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14138726|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138727|NCT04543071|Gemcitabine|gemcitabine|mesh-list
14138728|NCT04543071|Paclitaxel|paclitaxel|mesh-list
14138729|NCT04543071|Cemiplimab|cemiplimab|mesh-list
14138730|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14138731|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952963|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
13952964|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13952965|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13952966|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952967|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14138732|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
14138733|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
14138734|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
14138735|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138736|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13952968|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
13952969|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13952970|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13952971|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13952972|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952973|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13952974|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
13952975|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13952976|NCT03205228|Flupenthixol|flupenthixol|mesh-list
13952977|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
13952978|NCT03205228|Omeprazole|omeprazole|mesh-list
13952979|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13952980|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13952981|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13952982|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952983|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952984|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13952985|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13952986|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13952987|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13952988|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13952989|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13952990|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
13952991|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13952992|NCT03205176|Olaparib|olaparib|mesh-list
13952993|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13952994|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13952995|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13952996|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13952997|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
13952998|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13952999|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13953000|NCT03204812|Durvalumab|durvalumab|mesh-list
13953001|NCT03204812|Ipilimumab|ipilimumab|mesh-list
13953002|NCT03204812|Tremelimumab|tremelimumab|mesh-list
13953003|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
13953004|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13953005|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
14138737|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
14138738|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
14138739|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138740|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138741|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138742|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
14138743|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138744|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138745|NCT04535141|Olanzapine|olanzapine|mesh-list
14138746|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
14138747|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
14138748|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138749|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953006|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953007|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953008|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
13953009|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953010|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14138750|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14138751|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14138752|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14138753|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14138754|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14138755|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14138756|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14138757|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138758|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953011|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953012|NCT03204929|Copper|copper|mesh-list
13953013|NCT03204929|Trace Elements|trace elements|mesh-ancestor
13953014|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
14138759|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138760|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
14138761|NCT04530630|Emtricitabine|emtricitabine|mesh-list
14138762|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
14138763|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138764|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14138765|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13953015|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953016|NCT03204786|Vasopressins|vasopressins|mesh-list
13953017|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
13953018|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
13953019|NCT03204786|Coagulants|coagulants|mesh-ancestor
14138766|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138767|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138768|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14138769|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14138770|NCT04530149|Acetaminophen|acetaminophen|mesh-list
13953020|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13953021|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13953022|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
13953023|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953024|NCT03205033|Melatonin|melatonin|mesh-list
13953025|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
13953026|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953027|NCT03205033|Protective Agents|protective agents|mesh-ancestor
13953028|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953029|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14138771|NCT04530149|Bupivacaine|bupivacaine|mesh-list
14138772|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
14138773|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
14138774|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14138775|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138776|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
14138777|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14138778|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14138779|NCT04530149|Analgesics|analgesics|mesh-ancestor
14138780|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
14138781|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14138782|NCT04529902|Abatacept|abatacept|mesh-list
14138783|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14138784|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138785|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138786|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138787|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
14138788|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138789|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953030|NCT03204734|Capecitabine|capecitabine|mesh-list
14138790|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14138791|NCT04486118|Lisinopril|lisinopril|mesh-list
14138792|NCT04486118|Benazepril|benazepril|mesh-list
14138793|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14138794|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
14138795|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138796|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138797|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14138798|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14138799|NCT04486118|Protective Agents|protective agents|mesh-ancestor
14138800|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138801|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14138802|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
14138803|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138804|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
14138805|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
14138806|NCT04370301|Melphalan|melphalan|mesh-list
14138807|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
14138808|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14138809|NCT04370301|Fludarabine|fludarabine|mesh-list
14138810|NCT04370301|Tacrolimus|tacrolimus|mesh-list
14138811|NCT04370301|Sargramostim|sargramostim|mesh-list
14138812|NCT04370301|Lenograstim|lenograstim|mesh-list
14138813|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14138814|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138815|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
13953031|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13953032|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
13953033|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953034|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953035|NCT03204760|Dexamethasone|dexamethasone|mesh-list
13953036|NCT03204760|Prednisolone|prednisolone|mesh-list
13953037|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953038|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
13953039|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
13953040|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953041|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953042|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953043|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
13953044|NCT03204760|Hormones|hormones|mesh-ancestor
13953045|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953046|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953047|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953048|NCT03204877|Melatonin|melatonin|mesh-list
13953049|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
14138816|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138817|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14138818|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14478609|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
14478610|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14764296|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764297|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953050|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953051|NCT03204877|Protective Agents|protective agents|mesh-ancestor
13953052|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953053|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953054|NCT03204799|Metformin|metformin|mesh-list
13953055|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
13953056|NCT03204799|Ezetimibe|ezetimibe|mesh-list
13953057|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953058|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953059|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13953060|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13953061|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
13953062|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953063|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13953064|NCT03204669|Trace Elements|trace elements|mesh-list
13953065|NCT03204669|Micronutrients|micronutrients|mesh-list
13953066|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478611|NCT02453841|Protective Agents|protective agents|mesh-ancestor
14479269|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479270|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
14479271|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14138819|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
14138820|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764298|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764299|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
14764300|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953067|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13953068|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13953069|NCT03204331|Norethindrone|norethindrone|mesh-list
13953070|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
13953071|NCT03204331|Estradiol|estradiol|mesh-list
13953072|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13953073|NCT03204331|Relugolix|relugolix|mesh-list
14764301|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764302|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14764303|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
14764304|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
14764305|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
14937067|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14138821|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138822|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14138823|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14138824|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138825|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14138826|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14138827|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
14138828|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14138829|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138830|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14138831|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14138832|NCT04353128|Melatonin|melatonin|mesh-list
14138833|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
14138834|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138835|NCT04353128|Protective Agents|protective agents|mesh-ancestor
14138836|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138837|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953074|NCT03204331|Estrogens|estrogens|mesh-ancestor
13953075|NCT03204331|Hormones|hormones|mesh-ancestor
13953076|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953077|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953078|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13953079|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
13953080|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13953081|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13953082|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13953083|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13953084|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14138838|NCT04340076|Ixekizumab|ixekizumab|mesh-list
14138839|NCT04340076|Brodalumab|brodalumab|mesh-list
14138840|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
14138841|NCT04325880|Tamsulosin|tamsulosin|mesh-list
14138842|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
14138843|NCT04325880|Mirabegron|mirabegron|mesh-list
14138844|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14138845|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14138846|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14138847|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
14138848|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138849|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138850|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138851|NCT04325880|Urological Agents|urological agents|mesh-ancestor
14138852|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13953085|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
13953086|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
13953087|NCT03204578|Midazolam|midazolam|mesh-list
13953088|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13953089|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13953090|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953091|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953092|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14138853|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14138854|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
14138855|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14937068|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953093|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13953094|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14138856|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14138857|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937069|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937070|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14937071|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
14937072|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937073|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937074|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14937075|NCT01473147|Exenatide|exenatide|mesh-list
14937076|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14937077|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937078|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14937079|NCT01473147|Incretins|incretins|mesh-ancestor
14937080|NCT01473147|Hormones|hormones|mesh-ancestor
14937081|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14138858|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14138859|NCT04263350|Cobicistat|cobicistat|mesh-list
14138860|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14138861|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14138862|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
14138863|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138864|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138865|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14138866|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14138867|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
14138868|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138869|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14138870|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14138871|NCT04227028|Bevacizumab|bevacizumab|mesh-list
14138872|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14138873|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
14138874|NCT04227028|Antibodies|antibodies|mesh-list
14138875|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
14138876|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14138877|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
14138878|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138879|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14138880|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14138881|NCT04227028|Growth Substances|growth substances|mesh-ancestor
14138882|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138883|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14138884|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
14138885|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
14138886|NCT04207086|Lenvatinib|lenvatinib|mesh-list
14138887|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138888|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953095|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13953096|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
13953097|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
14138889|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14138890|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138891|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138892|NCT04202458|Tenecteplase|tenecteplase|mesh-list
14138893|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14138894|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14138895|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138896|NCT04184453|Deferiprone|deferiprone|mesh-list
14138897|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14138898|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
14138899|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
14138900|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138901|NCT04101643|Evolocumab|evolocumab|mesh-list
14138902|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14138903|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14138904|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
14138905|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953098|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
13953099|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
13953100|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953101|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953102|NCT03204474|Lacosamide|lacosamide|mesh-list
13953103|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
13953104|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13953105|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13953106|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138906|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14138907|NCT03873493|Venetoclax|venetoclax|mesh-list
13953107|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953108|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
13953109|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13953110|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
13953111|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953112|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
13953113|NCT03204565|Protective Agents|protective agents|mesh-ancestor
13953114|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14138908|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138909|NCT03844048|Venetoclax|venetoclax|mesh-list
14138910|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138911|NCT03667846|Topiramate|topiramate|mesh-list
14138912|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
14138913|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14138914|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138915|NCT03580928|Venetoclax|venetoclax|mesh-list
14138916|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
14138917|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
14138918|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953115|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13953116|NCT03204318|Norethindrone|norethindrone|mesh-list
13953117|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
13953118|NCT03204318|Estradiol|estradiol|mesh-list
13953119|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13953120|NCT03204318|Relugolix|relugolix|mesh-list
13953121|NCT03204318|Estrogens|estrogens|mesh-ancestor
13953122|NCT03204318|Hormones|hormones|mesh-ancestor
13953123|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953124|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953125|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13953126|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
13953127|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13953128|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13953129|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13953130|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14138919|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138920|NCT03534323|Venetoclax|venetoclax|mesh-list
14138921|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138922|NCT03520231|Vitamin D|vitamin d|mesh-list
14138923|NCT03520231|Denosumab|denosumab|mesh-list
14138924|NCT03520231|Gemcitabine|gemcitabine|mesh-list
14138925|NCT03520231|Carboplatin|carboplatin|mesh-list
14138926|NCT03520231|Calcium|calcium|mesh-list
14138927|NCT03520231|Vitamins|vitamins|mesh-ancestor
13953131|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13953132|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
13953133|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
13953134|NCT03204097|Alendronate|alendronate|mesh-list
13953135|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13953136|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953137|NCT03203967|Morphine|morphine|mesh-list
13953138|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13953139|NCT03203967|Narcotics|narcotics|mesh-ancestor
13953140|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953141|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953142|NCT03203967|Analgesics|analgesics|mesh-ancestor
14138928|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
14138929|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138930|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138931|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14138932|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
14138933|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138934|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
14138935|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14138936|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14138937|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14138938|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
14138939|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14138940|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14138941|NCT03451578|alpha-MSH|alpha-msh|mesh-list
14138942|NCT03451578|Hormones|hormones|mesh-ancestor
14138943|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764306|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953143|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
14138944|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138945|NCT03425331|Nivolumab|nivolumab|mesh-list
14138946|NCT03425331|Ipilimumab|ipilimumab|mesh-list
14138947|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138948|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138949|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14138950|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138951|NCT03171805|Propranolol|propranolol|mesh-list
14138952|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14138953|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14138954|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
14138955|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138956|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138957|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138958|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13953144|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953145|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
13953146|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13953147|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953148|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138959|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14138960|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
14138961|NCT03107416|Bumetanide|bumetanide|mesh-list
14138962|NCT03107416|Diuretics|diuretics|mesh-ancestor
14138963|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
14138964|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138965|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14138966|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138967|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138968|NCT03094234|Propranolol|propranolol|mesh-list
14138969|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14138970|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14138971|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
14138972|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14138973|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953149|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13953150|NCT03204006|Analgesics|analgesics|mesh-ancestor
13953151|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
13953152|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953153|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13953154|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13953155|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13953156|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
13953157|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764307|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14764308|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14764309|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13953158|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953159|NCT03204032|Thalidomide|thalidomide|mesh-list
13953160|NCT03204032|Temozolomide|temozolomide|mesh-list
13953161|NCT03204032|Tegafur|tegafur|mesh-list
13953162|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13953163|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
13953164|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953165|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953166|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953167|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
13953168|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953169|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
13953170|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13953171|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953172|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13953173|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13953174|NCT03204032|Growth Substances|growth substances|mesh-ancestor
13953175|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
13953176|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13953177|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
13953178|NCT03204045|Fentanyl|fentanyl|mesh-list
13953179|NCT03204045|Oxycodone|oxycodone|mesh-list
14764310|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764311|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
14764312|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14764313|NCT00615615|Levetiracetam|levetiracetam|mesh-list
14764314|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
14764315|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
14764316|NCT00615667|Tacrolimus|tacrolimus|mesh-list
14764317|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953180|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14764318|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
14764319|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764320|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14764321|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764322|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764323|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14764324|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14764325|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764326|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764327|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764328|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
14764329|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764330|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764331|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764332|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14764333|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764334|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764335|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764336|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764337|NCT00615797|Penicillins|penicillins|mesh-list
14764338|NCT00615797|Penicillin V|penicillin v|mesh-list
13953181|NCT03204045|Narcotics|narcotics|mesh-ancestor
13953182|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953183|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953184|NCT03204045|Analgesics|analgesics|mesh-ancestor
13953185|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
14138974|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138975|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14138976|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14138977|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
14138978|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14138979|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
14138980|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14138981|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138982|NCT03034564|Droxidopa|droxidopa|mesh-list
14138983|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14138984|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14138985|NCT03034538|Zonisamide|zonisamide|mesh-list
14138986|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
13953186|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953187|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13953188|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13953189|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
13953190|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
13953191|NCT03204058|Metformin|metformin|mesh-list
13953192|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13953193|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14138987|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14138988|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138989|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14138990|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14138991|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14138992|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
14138993|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14138994|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14138995|NCT02819518|Gemcitabine|gemcitabine|mesh-list
14138996|NCT02819518|Paclitaxel|paclitaxel|mesh-list
14138997|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14478612|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
13953194|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953195|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14478613|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
14478614|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478615|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478616|NCT02454283|Vanoxerine|vanoxerine|mesh-list
14478617|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14478618|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13953196|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13953197|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
13953198|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953199|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14478619|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14138998|NCT02819518|Carboplatin|carboplatin|mesh-list
14138999|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
13953200|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13953201|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953202|NCT03204071|Metformin|metformin|mesh-list
13953203|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953204|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953205|NCT03204019|Thalidomide|thalidomide|mesh-list
13953206|NCT03204019|Temozolomide|temozolomide|mesh-list
13953207|NCT03204019|Tegafur|tegafur|mesh-list
14139000|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14139001|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139002|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
14139003|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
14139004|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
14139005|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139006|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14764339|NCT00615797|Haloperidol|haloperidol|mesh-list
14764340|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
14764341|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
14764342|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14764343|NCT00615797|Antibodies|antibodies|mesh-list
14764344|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
14764345|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14764346|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
14139007|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
14139008|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
14139009|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139010|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139011|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139012|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
14139013|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139014|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139015|NCT02549833|Poly I-C|poly i-c|mesh-list
14139016|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14139017|NCT02549833|Poly ICLC|poly iclc|mesh-list
14139018|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
14139019|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
14139020|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139021|NCT02549833|Laxatives|laxatives|mesh-ancestor
14139022|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139023|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
14139024|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139025|NCT02468180|Polidocanol|polidocanol|mesh-list
14139026|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14139027|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14139028|NCT02207465|Paclitaxel|paclitaxel|mesh-list
14139029|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14139030|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14139031|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139032|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
14139033|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
14139034|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
14139035|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178150|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178151|NCT04749914|Dabigatran|dabigatran|mesh-list
14178152|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14178153|NCT04749914|Lasmiditan|lasmiditan|mesh-list
14178154|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14178155|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14178156|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
14178157|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178158|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14178159|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14178160|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178161|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
14178162|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14178163|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
14178164|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
14178165|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14178166|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
14178167|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178168|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178169|NCT04750122|Carboplatin|carboplatin|mesh-list
14178170|NCT04750122|Docetaxel|docetaxel|mesh-list
13953208|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14178171|NCT04750122|Trastuzumab|trastuzumab|mesh-list
14178172|NCT04750122|Pertuzumab|pertuzumab|mesh-list
14178173|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764347|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139036|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
13953209|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
13953210|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953211|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953212|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953213|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
14139037|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
14139038|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
14139039|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139040|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139041|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139042|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14139043|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
14139044|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
13953214|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953215|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
13953216|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13953217|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953218|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14139045|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139046|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139047|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
14139048|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14139049|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14139050|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139051|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14139052|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14139053|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
14139054|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139055|NCT01308190|Capecitabine|capecitabine|mesh-list
13953219|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13953220|NCT03204019|Growth Substances|growth substances|mesh-ancestor
13953221|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
13953222|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13953223|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
13953224|NCT03203746|Lycopene|lycopene|mesh-list
13953225|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953226|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
14139056|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14139057|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
14139058|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139059|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953227|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953228|NCT03203746|Protective Agents|protective agents|mesh-ancestor
13953229|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953230|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13953231|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13953232|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953233|NCT03203668|Choline|choline|mesh-list
13953234|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
13953235|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13953236|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
13953237|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953238|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953239|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13953240|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
13953241|NCT03203525|Leucovorin|leucovorin|mesh-list
13953242|NCT03203525|Sirolimus|sirolimus|mesh-list
13953243|NCT03203525|Bevacizumab|bevacizumab|mesh-list
13953244|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13953245|NCT03203525|Doxorubicin|doxorubicin|mesh-list
13953246|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13953247|NCT03203525|Fluorouracil|fluorouracil|mesh-list
13953248|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
14139060|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
14139061|NCT01210768|Doxorubicin|doxorubicin|mesh-list
14139062|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14139063|NCT01210768|Epirubicin|epirubicin|mesh-list
14139064|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139065|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
14139066|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139067|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139068|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13953249|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
13953250|NCT03203525|Antibodies|antibodies|mesh-list
13953251|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
14139069|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
14139070|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139071|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139072|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14139073|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14139074|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14139075|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139076|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139077|NCT00719225|Abatacept|abatacept|mesh-list
14139078|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14139079|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139080|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139081|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139082|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
14139083|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139084|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139085|NCT00516373|Olaparib|olaparib|mesh-list
14139086|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14139087|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139088|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139089|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139090|NCT00094016|Beclomethasone|beclomethasone|mesh-list
14139091|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139092|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
14139093|NCT00094016|Hormones|hormones|mesh-ancestor
14139094|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139095|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139096|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14139097|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14139098|NCT05134350|Omeprazole|omeprazole|mesh-list
14139099|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14139100|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139101|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14139102|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139103|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139104|NCT05134337|Itraconazole|itraconazole|mesh-list
14139105|NCT05134337|Rifampin|rifampin|mesh-list
14139106|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
14139107|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139108|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14139109|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14139110|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139111|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139112|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14139113|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
14139114|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139115|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139116|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14139117|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14139118|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
14139119|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14139120|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
14139121|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14139122|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14139123|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14139124|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14139125|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14139126|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14139127|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14139128|NCT05134298|Meropenem|meropenem|mesh-list
14139129|NCT05134298|Tazobactam|tazobactam|mesh-list
14139130|NCT05134298|Piperacillin|piperacillin|mesh-list
14139131|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14139132|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14139133|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139134|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14139135|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139136|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139137|NCT05134220|Calcium|calcium|mesh-list
14139138|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14139139|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139140|NCT05134194|Gemcitabine|gemcitabine|mesh-list
14139141|NCT05134194|Capecitabine|capecitabine|mesh-list
13953252|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13953253|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
13953254|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953255|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13953256|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13953257|NCT03203525|Growth Substances|growth substances|mesh-ancestor
13953258|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953259|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
13953260|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
13953261|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13953262|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13953263|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13953264|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953265|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139142|NCT05134194|Vinorelbine|vinorelbine|mesh-list
14139143|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13953266|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
13953267|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13953268|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953269|NCT03203525|Antidotes|antidotes|mesh-ancestor
13953270|NCT03203525|Protective Agents|protective agents|mesh-ancestor
14139144|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
14139145|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139146|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139147|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
14139148|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139149|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139150|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139151|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
14139152|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139153|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14139154|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
14139155|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
14139156|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
14139157|NCT05133791|Annexin A5|annexin a5|mesh-list
14139158|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139159|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139160|NCT05133687|Bupivacaine|bupivacaine|mesh-list
14139161|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
14139162|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
14139163|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139164|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139165|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
14139166|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139167|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
14139168|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13953271|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
13953272|NCT03203525|Vitamins|vitamins|mesh-ancestor
13953273|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
14139169|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14139170|NCT05133635|Prednisolone|prednisolone|mesh-list
14139171|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
14139172|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14139173|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
14139174|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139175|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
14139176|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
14139177|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139178|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764348|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
14764349|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
14764350|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764351|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764352|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14764353|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13953274|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13953275|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953276|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
13953277|NCT03203356|Hormones|hormones|mesh-list
13953278|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953279|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953280|NCT03203304|Nivolumab|nivolumab|mesh-list
13953281|NCT03203304|Ipilimumab|ipilimumab|mesh-list
14139179|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953282|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14937082|NCT01473173|Esomeprazole|esomeprazole|mesh-list
14764354|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139180|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
14139181|NCT05133635|Hormones|hormones|mesh-ancestor
14139182|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139183|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14139184|NCT05133635|Protective Agents|protective agents|mesh-ancestor
14139185|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14139186|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139187|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
14139188|NCT05133258|Dexamethasone|dexamethasone|mesh-list
14139189|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139190|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
14139191|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
14139192|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764355|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14764356|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14764357|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
14764358|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764359|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139193|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139194|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139195|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
14139196|NCT05133258|Hormones|hormones|mesh-ancestor
14139197|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139198|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14139199|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139200|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14139201|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139202|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14139203|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139204|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139205|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139206|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14139207|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14139208|NCT05133050|Ramipril|ramipril|mesh-list
14139209|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14139210|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
14139211|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139212|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139213|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14139214|NCT05132777|Osimertinib|osimertinib|mesh-list
14139215|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139216|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139217|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139218|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139219|NCT05132712|Losartan|losartan|mesh-list
14139220|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14139221|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14139222|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14139223|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14139224|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139225|NCT05132413|Bevacizumab|bevacizumab|mesh-list
14139226|NCT05132413|Cisplatin|cisplatin|mesh-list
14139227|NCT05132413|Carboplatin|carboplatin|mesh-list
14139228|NCT05132413|Pemetrexed|pemetrexed|mesh-list
14139229|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14764360|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14764361|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14764362|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764363|NCT00615810|Efavirenz|efavirenz|mesh-list
14764364|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14764365|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14764366|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764367|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139230|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953283|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953284|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13953285|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953286|NCT03203590|Carboplatin|carboplatin|mesh-list
14139231|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14139232|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14139233|NCT05132413|Growth Substances|growth substances|mesh-ancestor
14937083|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14937084|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937085|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14937086|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937087|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937088|NCT01473251|Bevacizumab|bevacizumab|mesh-list
14937089|NCT01473251|Ranibizumab|ranibizumab|mesh-list
13953287|NCT03203590|Vinorelbine|vinorelbine|mesh-list
14139234|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139235|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
14139236|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139237|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139238|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14139239|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14139240|NCT05132270|Thalidomide|thalidomide|mesh-list
14139241|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
14139242|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139243|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
14139244|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139245|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
14139246|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14139247|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139248|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14139249|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14139250|NCT05132270|Growth Substances|growth substances|mesh-ancestor
14139251|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
14139252|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139253|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
14139254|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953288|NCT03203590|Gefitinib|gefitinib|mesh-list
13953289|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953290|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13953291|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
13953292|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
13953293|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
13953294|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139255|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139256|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14178174|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
14178175|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
14178176|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
14178177|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178178|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178179|NCT04750135|Metformin|metformin|mesh-list
14178180|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14178181|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178182|NCT04750083|Carboplatin|carboplatin|mesh-list
14937090|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953295|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13953296|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953297|NCT03203616|Trastuzumab|trastuzumab|mesh-list
13953298|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
13953299|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953300|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953301|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
13953302|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
13953303|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
13953304|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953305|NCT03203408|Hylan|hylan|mesh-list
13953306|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
13953307|NCT03203408|Protective Agents|protective agents|mesh-ancestor
13953308|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953309|NCT03203317|Insulin|insulin|mesh-list
13953310|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953311|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953312|NCT03203473|Nivolumab|nivolumab|mesh-list
14178183|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
14178184|NCT04750083|Pemetrexed|pemetrexed|mesh-list
14139257|NCT05132101|Palbociclib|palbociclib|mesh-list
14139258|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139259|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139260|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139261|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139262|NCT05129176|Metronidazole|metronidazole|mesh-list
14139263|NCT05129176|Levofloxacin|levofloxacin|mesh-list
14139264|NCT05129176|Ofloxacin|ofloxacin|mesh-list
14139265|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139266|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14139267|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14139268|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14139269|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14139270|NCT05129176|Renal Agents|renal agents|mesh-ancestor
14139271|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14139272|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139273|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139274|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139275|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139276|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14139277|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14139278|NCT05122546|Nivolumab|nivolumab|mesh-list
14139279|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139280|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139281|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14139282|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139283|NCT05121038|Leucovorin|leucovorin|mesh-list
14139284|NCT05121038|Fluorouracil|fluorouracil|mesh-list
14139285|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
14139286|NCT05121038|Irinotecan|irinotecan|mesh-list
14139287|NCT05121038|Panitumumab|panitumumab|mesh-list
14139288|NCT05121038|Folfirinox|folfirinox|mesh-list
14139289|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
14139290|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139291|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14139292|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139293|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139294|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
14139295|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139296|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14139297|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139298|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139299|NCT05121038|Antidotes|antidotes|mesh-ancestor
14139300|NCT05121038|Protective Agents|protective agents|mesh-ancestor
14139301|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
14139302|NCT05121038|Vitamins|vitamins|mesh-ancestor
14139303|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
14139304|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139305|NCT05062837|Apatinib|apatinib|mesh-list
14139306|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139307|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139308|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139309|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139310|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
14139311|NCT05033756|Olaparib|olaparib|mesh-list
14139312|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953313|NCT03203473|Ipilimumab|ipilimumab|mesh-list
14139313|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953314|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953315|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953316|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13953317|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953318|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
13953319|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
13953320|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13953321|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
13953322|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953323|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953324|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
13953325|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
13953326|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13953327|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14139314|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14139315|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139316|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139317|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
14139318|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
14139319|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
14139320|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14139321|NCT05031442|Protective Agents|protective agents|mesh-ancestor
14139322|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139323|NCT05030857|Midazolam|midazolam|mesh-list
14139324|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14139325|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14139326|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139327|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139328|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14139329|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14139330|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14139331|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14139332|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
14139333|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
14139334|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
14139335|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
14139336|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139337|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139338|NCT05027360|Nitroprusside|nitroprusside|mesh-list
14139339|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14139340|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
14139341|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14139342|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139343|NCT05027100|Irinotecan|irinotecan|mesh-list
14139344|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13953328|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13953329|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13953330|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953331|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
13953332|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953333|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953334|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13953335|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953336|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
13953337|NCT03202836|Progesterone|progesterone|mesh-list
13953338|NCT03202836|Progestins|progestins|mesh-ancestor
13953339|NCT03202836|Hormones|hormones|mesh-ancestor
13953340|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953341|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953342|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13953343|NCT03202979|Trazodone|trazodone|mesh-list
13953344|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13953345|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13953346|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953347|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953348|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13953349|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13953350|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14139345|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139346|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139347|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139348|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139349|NCT05026606|Nivolumab|nivolumab|mesh-list
14139350|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139351|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139352|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14139353|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139354|NCT05025800|Rituximab|rituximab|mesh-list
14139355|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14139356|NCT05025800|Lenalidomide|lenalidomide|mesh-list
14139357|NCT05025800|Antibodies|antibodies|mesh-list
14139358|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
14139359|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14139360|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
14139361|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953351|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13953352|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953353|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953354|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
13953355|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13953356|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
13953357|NCT03202849|Vitamin D|vitamin d|mesh-list
13953358|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
14139362|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139363|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139364|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14139365|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14139366|NCT05025800|Growth Substances|growth substances|mesh-ancestor
14139367|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14139368|NCT05010772|Decitabine|decitabine|mesh-list
14139369|NCT05010772|Venetoclax|venetoclax|mesh-list
14139370|NCT05010772|Ivosidenib|ivosidenib|mesh-list
14139371|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13953359|NCT03202849|Vitamins|vitamins|mesh-list
13953360|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
14139372|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
14139373|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139374|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139375|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139376|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
14139377|NCT04924374|Atezolizumab|atezolizumab|mesh-list
14139378|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14139379|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139380|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139381|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
14139382|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139383|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
14139384|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14139385|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139386|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139387|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14139388|NCT04912518|Analgesics|analgesics|mesh-ancestor
14139389|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
14139390|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139391|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14139392|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14139393|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14139394|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
14139395|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139396|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139397|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
13953361|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953362|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13953363|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13962833|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13962834|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13962835|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139398|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139399|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
14139400|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14139401|NCT04818320|Favipiravir|favipiravir|mesh-list
14139402|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
14139403|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139404|NCT04793906|Iron|iron|mesh-list
14139405|NCT04793906|Trace Elements|trace elements|mesh-ancestor
14139406|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
14139407|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139408|NCT04789070|Sirolimus|sirolimus|mesh-list
14139409|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14139410|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139411|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14139412|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139413|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
14139414|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139415|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
14139416|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139417|NCT04741204|Metformin|metformin|mesh-list
14139418|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14139419|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139420|NCT04738318|Dexamethasone|dexamethasone|mesh-list
14937091|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937092|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14937093|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13963536|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14937094|NCT01473251|Growth Substances|growth substances|mesh-ancestor
14139421|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
14139422|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
13953364|NCT03203031|Anesthetics|anesthetics|mesh-list
13953365|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953366|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953367|NCT03203070|Dipyrone|dipyrone|mesh-list
13953368|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14139423|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139424|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
14139425|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
14139426|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139427|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139428|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139429|NCT04738318|Hormones|hormones|mesh-ancestor
14139430|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139431|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14139432|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139433|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14139434|NCT04738318|Protective Agents|protective agents|mesh-ancestor
14139435|NCT04688788|Fexofenadine|fexofenadine|mesh-list
14139436|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
14139437|NCT04688788|Rituximab|rituximab|mesh-list
14139438|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
14139439|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139440|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139441|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
14139442|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139443|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139444|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139445|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
14139446|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
14139447|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139448|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139449|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
14139450|NCT04688788|Hormones|hormones|mesh-ancestor
14139451|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139452|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14139453|NCT04688788|Protective Agents|protective agents|mesh-ancestor
14139454|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13953369|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13953370|NCT03203070|Analgesics|analgesics|mesh-ancestor
13953371|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
13953372|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953373|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953374|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953375|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953376|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
13953377|NCT03202875|Insulin|insulin|mesh-list
13953378|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13953379|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
13953380|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
13953381|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
13953382|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953383|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953384|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
13953385|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953386|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
13953387|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953388|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953389|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14139455|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14139456|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14139457|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
14139458|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
14139459|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139460|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139461|NCT04656964|Midazolam|midazolam|mesh-list
14139462|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14139463|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14139464|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139465|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139466|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14139467|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14139468|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14139469|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14139470|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
13953390|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
14139471|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
14139472|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
14139473|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
14139474|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139475|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139476|NCT04605796|Bevacizumab|bevacizumab|mesh-list
14139477|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139478|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139479|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14139480|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14139481|NCT04605796|Growth Substances|growth substances|mesh-ancestor
14139482|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139483|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
14139484|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
14139485|NCT04599868|Analgesics|analgesics|mesh-ancestor
14139486|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
14139487|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139488|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139489|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
14139490|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139491|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13953391|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953392|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953393|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13953394|NCT03202862|Fulvestrant|fulvestrant|mesh-list
14139492|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
14139493|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14139494|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14139495|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139496|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13953395|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953396|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953397|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13953398|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13953399|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
13953400|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953401|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953402|NCT03202784|Berotralstat|berotralstat|mesh-list
13953403|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953404|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953405|NCT03202758|Durvalumab|durvalumab|mesh-list
13953406|NCT03202758|Tremelimumab|tremelimumab|mesh-list
13953407|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953408|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139497|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
14139498|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178185|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178186|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178187|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178188|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178189|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14178190|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14178191|NCT04749797|Bupivacaine|bupivacaine|mesh-list
14178192|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
14178193|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
14178194|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178195|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178196|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
14178197|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178198|NCT04749810|Eculizumab|eculizumab|mesh-list
14178199|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
13953409|NCT03202563|Metformin|metformin|mesh-list
13953410|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
14139499|NCT04515394|Cetuximab|cetuximab|mesh-list
14139500|NCT04515394|Tepotinib|tepotinib|mesh-list
14139501|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139502|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139503|NCT04513951|Leucovorin|leucovorin|mesh-list
14139504|NCT04513951|Fluorouracil|fluorouracil|mesh-list
14139505|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
14139506|NCT04513951|Irinotecan|irinotecan|mesh-list
14139507|NCT04513951|Cetuximab|cetuximab|mesh-list
14139508|NCT04513951|Avelumab|avelumab|mesh-list
14139509|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
14139510|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
14139511|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139512|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14139513|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139514|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139515|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
14139516|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139517|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14139518|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139519|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139520|NCT04513951|Antidotes|antidotes|mesh-ancestor
14139521|NCT04513951|Protective Agents|protective agents|mesh-ancestor
14139522|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
14139523|NCT04513951|Vitamins|vitamins|mesh-ancestor
14139524|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
14139525|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139526|NCT04313608|Gemcitabine|gemcitabine|mesh-list
14139527|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
14139528|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
13953411|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953412|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953413|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13953414|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953415|NCT03202615|Lactoferrin|lactoferrin|mesh-list
13953416|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953417|NCT03202459|Pregabalin|pregabalin|mesh-list
13953418|NCT03202459|Gabapentin|gabapentin|mesh-list
13953419|NCT03202459|Analgesics|analgesics|mesh-ancestor
13953420|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
13953421|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953422|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953423|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
13953424|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14139529|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14139530|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
14139531|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139532|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139533|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
14139534|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139535|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139536|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139537|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
14139538|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139539|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139540|NCT04311710|Nivolumab|nivolumab|mesh-list
13953425|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13953426|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953427|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13953428|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13953429|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14139541|NCT04311710|Ipilimumab|ipilimumab|mesh-list
14139542|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139543|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139544|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14139545|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139546|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14139547|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139548|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139549|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14139550|NCT04305327|Ustekinumab|ustekinumab|mesh-list
14139551|NCT04305327|Brodalumab|brodalumab|mesh-list
13953430|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139552|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
14139553|NCT04245865|Leucovorin|leucovorin|mesh-list
14139554|NCT04245865|Tocotrienols|tocotrienols|mesh-list
14139555|NCT04245865|Vitamin E|vitamin e|mesh-list
14139556|NCT04245865|Tocopherols|tocopherols|mesh-list
14139557|NCT04245865|Bevacizumab|bevacizumab|mesh-list
14139558|NCT04245865|Fluorouracil|fluorouracil|mesh-list
14139559|NCT04245865|Capecitabine|capecitabine|mesh-list
14139560|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
14139561|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
14139562|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139563|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139564|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14139565|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14139566|NCT04245865|Growth Substances|growth substances|mesh-ancestor
14139567|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139568|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
14139569|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
14139570|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139571|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14139572|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139573|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
14139574|NCT04245865|Antidotes|antidotes|mesh-ancestor
14139575|NCT04245865|Protective Agents|protective agents|mesh-ancestor
14139576|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
14139577|NCT04245865|Vitamins|vitamins|mesh-ancestor
14139578|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
14139579|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
14139580|NCT04244877|Rifaximin|rifaximin|mesh-list
14139581|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14139582|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139583|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139584|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
14139585|NCT04215120|Hematinics|hematinics|mesh-ancestor
14139586|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
14139587|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14139588|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14139589|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14139590|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14139591|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139592|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
14764368|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764369|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
14764370|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764371|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14764372|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14764373|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14764374|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14764375|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14764376|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14764377|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764378|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764379|NCT00615823|Atorvastatin|atorvastatin|mesh-list
14764380|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14764381|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14764382|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
14764383|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764384|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13953431|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13953432|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13953433|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13953434|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953435|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
13953436|NCT03202628|Dexamethasone|dexamethasone|mesh-list
13953437|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
13953438|NCT03202628|Pomalidomide|pomalidomide|mesh-list
13953439|NCT03202628|Ixazomib|ixazomib|mesh-list
13953440|NCT03202628|Ichthammol|ichthammol|mesh-list
13953441|NCT03202628|BB 1101|bb 1101|mesh-list
13953442|NCT03202628|Glycine|glycine|mesh-list
13953443|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953444|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
13953445|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
13953446|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953447|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139593|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139594|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139595|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13953448|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953449|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
13953450|NCT03202628|Hormones|hormones|mesh-ancestor
14139596|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764385|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14764386|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764387|NCT00615875|Naproxen|naproxen|mesh-list
14764388|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764389|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14764390|NCT00615875|Analgesics|analgesics|mesh-ancestor
14764391|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
14764392|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764393|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764394|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764395|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764396|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
14764397|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14764398|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764399|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764400|NCT00616005|Irinotecan|irinotecan|mesh-list
14764401|NCT00616005|Temozolomide|temozolomide|mesh-list
14764402|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14764403|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14764404|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764405|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764406|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764407|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764408|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
14764409|NCT00616031|Paclitaxel|paclitaxel|mesh-list
14764410|NCT00616031|Carboplatin|carboplatin|mesh-list
14764411|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
14764412|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13953451|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953452|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953453|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953454|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953455|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
13953456|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764413|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764414|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
14764415|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14764416|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14764417|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764418|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
14764419|NCT00616044|Anesthetics|anesthetics|mesh-list
14764420|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764421|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764422|NCT00616070|Difluprednate|difluprednate|mesh-list
14139597|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
14139598|NCT04012957|Hematinics|hematinics|mesh-ancestor
14139599|NCT03991884|Prednisone|prednisone|mesh-list
14139600|NCT03991884|Cortisone|cortisone|mesh-list
14139601|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
14139602|NCT03991884|Doxorubicin|doxorubicin|mesh-list
14139603|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14139604|NCT03991884|Etoposide|etoposide|mesh-list
13953457|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
13953458|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13953459|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13953460|NCT03202628|Growth Substances|growth substances|mesh-ancestor
13953461|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
13953462|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
13953463|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
13953464|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953465|NCT03202719|Vaccines|vaccines|mesh-list
13953466|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
13953467|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953468|NCT03202407|Calcium|calcium|mesh-list
13953469|NCT03202407|Sevelamer|sevelamer|mesh-list
13953470|NCT03202407|Calcium acetate|calcium acetate|mesh-list
13953471|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13953472|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139605|NCT03991884|Vincristine|vincristine|mesh-list
14139606|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
14139607|NCT03991884|Daunorubicin|daunorubicin|mesh-list
14139608|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
14139609|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
13953473|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
14764423|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
14764424|NCT00616070|Hormones|hormones|mesh-ancestor
14139610|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139611|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
14139612|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139613|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139614|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14139615|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
14139616|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139617|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139618|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14139619|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14139620|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14139621|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139622|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139623|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139624|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
13953474|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
13953475|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953476|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
13953477|NCT03202446|Chitosan|chitosan|mesh-list
13953478|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953479|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
13953480|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953481|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953482|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13953483|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
13953484|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953485|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953486|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13953487|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13953488|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14139625|NCT03991884|Hormones|hormones|mesh-ancestor
14139626|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139627|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14139628|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14139629|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
14139630|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14139631|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
14139632|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
14139633|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14139634|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139635|NCT03883581|Quinidine|quinidine|mesh-list
14139636|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
14139637|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
14139638|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
14139639|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
14139640|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14139641|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14139642|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139643|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139644|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139645|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14139646|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14139647|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14139648|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14139649|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
14139650|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14139651|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14139652|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139653|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139654|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14139655|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14139656|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
14139657|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14139658|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14139659|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14139660|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14139661|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14139662|NCT03854578|Citalopram|citalopram|mesh-list
14139663|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14139664|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14139665|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764425|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764426|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953489|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
14139666|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139667|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139668|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
14139669|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139670|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14139671|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
14139672|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14139673|NCT03844412|Lidocaine|lidocaine|mesh-list
14139674|NCT03844412|Nortriptyline|nortriptyline|mesh-list
14139675|NCT03844412|Estradiol|estradiol|mesh-list
14139676|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
14139677|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
14139678|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139679|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139680|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
14139681|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139682|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13953490|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13953491|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
13953492|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
13953493|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
13953494|NCT03202446|Coagulants|coagulants|mesh-ancestor
13953495|NCT03202186|Progesterone|progesterone|mesh-list
13953496|NCT03202186|Progestins|progestins|mesh-ancestor
13953497|NCT03202186|Hormones|hormones|mesh-ancestor
13953498|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953499|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953500|NCT03202316|Atezolizumab|atezolizumab|mesh-list
13953501|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13953502|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953503|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
14139683|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14139684|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14139685|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14139686|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139687|NCT03844412|Estrogens|estrogens|mesh-ancestor
14139688|NCT03844412|Hormones|hormones|mesh-ancestor
13953504|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953505|NCT03201861|Paclitaxel|paclitaxel|mesh-list
13953506|NCT03201861|Docetaxel|docetaxel|mesh-list
13953507|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13953508|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13953509|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953510|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
13953511|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
13953512|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
13953513|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953514|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
13953515|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14139689|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139690|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14139691|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
14139692|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14139693|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14139694|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13953516|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
13953517|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953518|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953519|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13953520|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
13953521|NCT03201913|Estrogens|estrogens|mesh-list
13953522|NCT03201913|Hormones|hormones|mesh-ancestor
13953523|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953524|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953525|NCT03201796|Levofloxacin|levofloxacin|mesh-list
13953526|NCT03201796|Ofloxacin|ofloxacin|mesh-list
13953527|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
13953528|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13953529|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953530|NCT03201796|Renal Agents|renal agents|mesh-ancestor
13953531|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13953532|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13953533|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13953534|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139695|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
14139696|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139697|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
14139698|NCT03747484|Avelumab|avelumab|mesh-list
14139699|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
14139700|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
14139701|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13953535|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953536|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953537|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13953538|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13953539|NCT03201770|Artesunate|artesunate|mesh-list
13953540|NCT03201770|Pyronaridine|pyronaridine|mesh-list
13953541|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
13953542|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13953543|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13953544|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139702|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139703|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139704|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
14139705|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139706|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
14139707|NCT03709680|Temozolomide|temozolomide|mesh-list
14139708|NCT03709680|Irinotecan|irinotecan|mesh-list
14139709|NCT03709680|Topotecan|topotecan|mesh-list
14139710|NCT03709680|Palbociclib|palbociclib|mesh-list
14139711|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139712|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
14139713|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139714|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139715|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14139716|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
14139717|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139718|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139719|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14139720|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14139721|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139722|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139723|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139724|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
14139725|NCT03660059|Peficitinib|peficitinib|mesh-list
14139726|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139727|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139728|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139729|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
14139730|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139731|NCT03512119|Ivacaftor|ivacaftor|mesh-list
14139732|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14139733|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14139734|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139735|NCT03505762|Prednisone|prednisone|mesh-list
14139736|NCT03505762|Cortisone|cortisone|mesh-list
14139737|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
14139738|NCT03505762|Rituximab|rituximab|mesh-list
14139739|NCT03505762|Doxorubicin|doxorubicin|mesh-list
14139740|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14139741|NCT03505762|Vincristine|vincristine|mesh-list
14139742|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14139743|NCT03505762|Antibodies|antibodies|mesh-list
13953545|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953546|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
13953547|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
13953548|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13953549|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
13953550|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
13953551|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
14139744|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
14139745|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14139746|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139747|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
13953552|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13953553|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963537|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139748|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139749|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139750|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14139751|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
14178200|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953554|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953555|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
13953556|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13953557|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953558|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953559|NCT03201835|Nabiximols|nabiximols|mesh-list
13953560|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953561|NCT03201835|Analgesics|analgesics|mesh-ancestor
13953562|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
13953563|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953564|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13953565|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13953566|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953567|NCT03201393|Acetaminophen|acetaminophen|mesh-list
13953568|NCT03201393|Naltrexone|naltrexone|mesh-list
14139752|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139753|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139754|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13953569|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13953570|NCT03201393|Analgesics|analgesics|mesh-ancestor
13953571|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
13953572|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953573|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953574|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
13953575|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13953576|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13962836|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962837|NCT03049540|Urological Agents|urological agents|mesh-ancestor
13962838|NCT02949700|Metformin|metformin|mesh-list
13962839|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13962840|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962841|NCT02940769|Methamphetamine|methamphetamine|mesh-list
13962842|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13962843|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962844|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
13962845|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
13962846|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962847|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
13962848|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13962849|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962850|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962851|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13962852|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13962853|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13962854|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13962855|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
13962856|NCT02938013|Velpatasvir|velpatasvir|mesh-list
13962857|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13962858|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
13962859|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962860|NCT02919683|Nivolumab|nivolumab|mesh-list
13962861|NCT02919683|Ipilimumab|ipilimumab|mesh-list
13962862|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962863|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962864|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13962865|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962866|NCT02901548|Durvalumab|durvalumab|mesh-list
13962867|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962868|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962869|NCT02890459|Denatonium|denatonium|mesh-list
13962870|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
13962871|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962872|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
13962873|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962874|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
13962875|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962876|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
13962877|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962878|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962879|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13962880|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13962881|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962882|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178201|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
14139755|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14139756|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14139757|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14139758|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139759|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139760|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
14139761|NCT03505762|Hormones|hormones|mesh-ancestor
14139762|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14139763|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14139764|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14139765|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14764427|NCT00616187|Interferons|interferons|mesh-list
14764428|NCT00616187|Interferon-beta|interferon-beta|mesh-list
13953577|NCT03201185|Ramipril|ramipril|mesh-list
13953578|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13953579|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
13953580|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953581|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953582|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13953583|NCT03201601|Inositol|inositol|mesh-list
13953584|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
13953585|NCT03201601|Vitamins|vitamins|mesh-ancestor
13953586|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
13953587|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953588|NCT03201250|Dexamethasone|dexamethasone|mesh-list
13953589|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953590|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
13953591|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
13953592|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953593|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953594|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953595|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
13953596|NCT03201250|Hormones|hormones|mesh-ancestor
13953597|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953598|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953599|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953600|NCT03201380|Choline|choline|mesh-list
13953601|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
13953602|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13953603|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
13953604|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953605|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953606|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13953607|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
13953608|NCT03201159|Pentamidine|pentamidine|mesh-list
13953609|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
13953610|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953611|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13953612|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13953613|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13953614|NCT03201146|Cisplatin|cisplatin|mesh-list
13953615|NCT03201146|Carboplatin|carboplatin|mesh-list
13953616|NCT03201146|Pemetrexed|pemetrexed|mesh-list
13953617|NCT03201146|Apatinib|apatinib|mesh-list
13953618|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953619|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953620|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953621|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13953622|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13953623|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13953624|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
13953625|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13953626|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
13953627|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13953628|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
13953629|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953630|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953631|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
13953632|NCT03200964|Anesthetics|anesthetics|mesh-list
13953633|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953634|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953635|NCT03200938|Zinc|zinc|mesh-list
13953636|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
13953637|NCT03200938|Trace Elements|trace elements|mesh-ancestor
13953638|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
14764429|NCT00616187|Atorvastatin|atorvastatin|mesh-list
13953639|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953640|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
13953641|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
13953642|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13953643|NCT03200938|Protective Agents|protective agents|mesh-ancestor
13953644|NCT03200821|Gemcitabine|gemcitabine|mesh-list
13953645|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13953646|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
13953647|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953648|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953649|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
13953650|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953651|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953652|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953653|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
13953654|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953655|NCT03200782|Empagliflozin|empagliflozin|mesh-list
14139766|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14139767|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14139768|NCT03502148|Cisplatin|cisplatin|mesh-list
14139769|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139770|NCT03450772|Pancrelipase|pancrelipase|mesh-list
14139771|NCT03450772|Pancreatin|pancreatin|mesh-list
14139772|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139773|NCT03445728|Nicorandil|nicorandil|mesh-list
14139774|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13953656|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13953657|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13953658|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953659|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953660|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139775|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14139776|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
14139777|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
14139778|NCT03445728|Vitamins|vitamins|mesh-ancestor
14139779|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
14139780|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139781|NCT03424460|Hemostatics|hemostatics|mesh-list
14139782|NCT03424460|Coagulants|coagulants|mesh-ancestor
14178202|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178203|NCT04749641|Vaccines|vaccines|mesh-list
14178204|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
14178205|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178206|NCT04749394|Apatinib|apatinib|mesh-list
14178207|NCT04749394|Antibodies|antibodies|mesh-list
14178208|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
14178209|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14178210|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
14178211|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178212|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178213|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14178214|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178215|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178216|NCT04749602|Nivolumab|nivolumab|mesh-list
14178217|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178218|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178219|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14178220|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178221|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14178222|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
14178223|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178224|NCT04748991|Amiodarone|amiodarone|mesh-list
14178225|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14178226|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
14178227|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14178228|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14178229|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764430|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953661|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953662|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
13953663|NCT03200847|Tretinoin|tretinoin|mesh-list
13953664|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953665|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953666|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
13953667|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
13953668|NCT03200808|Methylene Blue|methylene blue|mesh-list
14178230|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14764431|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
14139783|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
14139784|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139785|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139786|NCT03278691|Ketorolac|ketorolac|mesh-list
14139787|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14139788|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14764432|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764433|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14764434|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14764435|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
14764436|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139789|NCT03278691|Analgesics|analgesics|mesh-ancestor
14139790|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
14139791|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139792|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139793|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139794|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139795|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14139796|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139797|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139798|NCT03274375|Rituximab|rituximab|mesh-list
14139799|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139800|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139801|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
14139802|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139803|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139804|NCT03257761|Durvalumab|durvalumab|mesh-list
14139805|NCT03257761|Guadecitabine|guadecitabine|mesh-list
14139806|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139807|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139808|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
14139809|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139810|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139811|NCT02959619|Ensartinib|ensartinib|mesh-list
14139812|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139813|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139814|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139815|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139816|NCT02795520|OTS167|ots167|mesh-list
14139817|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139818|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139819|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139820|NCT02645149|Trametinib|trametinib|mesh-list
14139821|NCT02645149|Ceritinib|ceritinib|mesh-list
14139822|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139823|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139824|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139825|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139826|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
14139827|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139828|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139829|NCT02620579|Propranolol|propranolol|mesh-list
14139830|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14139831|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14139832|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
14139833|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139834|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139835|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139836|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14139837|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14139838|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
14139839|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14139840|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139841|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14139842|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139843|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139844|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
14139845|NCT02420314|Paclitaxel|paclitaxel|mesh-list
14139846|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14139847|NCT02420314|Carboplatin|carboplatin|mesh-list
14139848|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14139849|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139850|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
14139851|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
14139852|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
14139853|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139854|NCT02420314|Vitamins|vitamins|mesh-ancestor
14139855|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
14139856|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953669|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953670|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953671|NCT03200691|Antibodies|antibodies|mesh-list
13953672|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
13953673|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953674|NCT03200886|Triamcinolone|triamcinolone|mesh-list
13953675|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13953676|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13953677|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13953678|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953679|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
13953680|NCT03200886|Hormones|hormones|mesh-ancestor
13953681|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953682|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953683|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953684|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
13953685|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953686|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953687|NCT03200600|Dexamethasone|dexamethasone|mesh-list
13953688|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
13953689|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
13953690|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
13953691|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13953692|NCT03200600|BB 1101|bb 1101|mesh-list
13953693|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953694|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
14937095|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937096|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
14937097|NCT01473277|Triamcinolone|triamcinolone|mesh-list
14937098|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14937099|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14139857|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
14139858|NCT02420314|Protective Agents|protective agents|mesh-ancestor
14139859|NCT02370589|Vaccines|vaccines|mesh-list
14139860|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
14139861|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139862|NCT02313194|Buspirone|buspirone|mesh-list
14139863|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14764437|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14937100|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14937101|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14937102|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14937103|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
13953695|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
13953696|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953697|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953698|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953699|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
13953700|NCT03200600|Hormones|hormones|mesh-ancestor
13953701|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953702|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953703|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953704|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
13953705|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953706|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953707|NCT03200600|Analgesics|analgesics|mesh-ancestor
13953708|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
14139864|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14139865|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764438|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14764439|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764440|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
14764441|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764442|NCT00616213|Lenograstim|lenograstim|mesh-list
14764443|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14764444|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
14764445|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764446|NCT00616382|Indomethacin|indomethacin|mesh-list
14764447|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
14764448|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764449|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937104|NCT01473277|Hormones|hormones|mesh-ancestor
14139866|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139867|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14139868|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14139869|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
14139870|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139871|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139872|NCT02100956|Oxytocin|oxytocin|mesh-list
14139873|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
14139874|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14139875|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139876|NCT01752049|Timolol|timolol|mesh-list
14139877|NCT01752049|Maleic acid|maleic acid|mesh-list
14139878|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14139879|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14139880|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
14139881|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139882|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139883|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139884|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14139885|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14139886|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14139887|NCT01316523|Rituximab|rituximab|mesh-list
14139888|NCT01316523|Lenalidomide|lenalidomide|mesh-list
14139889|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14139890|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139891|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
14139892|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139893|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139894|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14139895|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14139896|NCT01316523|Growth Substances|growth substances|mesh-ancestor
14139897|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
14139898|NCT00085774|Albuterol|albuterol|mesh-list
14139899|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14139900|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
14139901|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139902|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139903|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14139904|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
14139905|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
14139906|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14139907|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14139908|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14139909|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14139910|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
14139911|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139912|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139913|NCT00071552|Fluticasone|fluticasone|mesh-list
14139914|NCT00071552|Xhance|xhance|mesh-list
14139915|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14139916|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14139917|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
14139918|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139919|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139920|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14139921|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
14139922|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
14139923|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14139924|NCT05136066|Peppermint oil|peppermint oil|mesh-list
14139925|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
14764450|NCT00616382|Analgesics|analgesics|mesh-ancestor
14764451|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
13953709|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13953710|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13953711|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953712|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13953713|NCT03200561|Prednisolone|prednisolone|mesh-list
13953714|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
13953715|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13953716|NCT03200561|Antibodies|antibodies|mesh-list
13953717|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953718|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
13953719|NCT03200561|Hormones|hormones|mesh-ancestor
14764452|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962883|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139926|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
14764453|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139927|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14139928|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139929|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14139930|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
14139931|NCT05125146|Trazodone|trazodone|mesh-list
13953720|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953721|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953722|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953723|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953724|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
13953725|NCT03200613|Heparin|heparin|mesh-list
13953726|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13953727|NCT03200613|Tinzaparin|tinzaparin|mesh-list
13953728|NCT03200613|Dalteparin|dalteparin|mesh-list
13953729|NCT03200613|Apixaban|apixaban|mesh-list
13953730|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
13953731|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13953732|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13953733|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953734|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13953735|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
14139932|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14139933|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14139934|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139935|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139936|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14139937|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14139938|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14139939|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14139940|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139941|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139942|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
14139943|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14139944|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
14139945|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14139946|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
14139947|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139948|NCT05136534|Anesthetics|anesthetics|mesh-list
14139949|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139950|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139951|NCT05136521|Trazodone|trazodone|mesh-list
14139952|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14139953|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14139954|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139955|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139956|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14139957|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14139958|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14139959|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14139960|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139961|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14139962|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
14139963|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14139964|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
14139965|NCT05136508|Propofol|propofol|mesh-list
14139966|NCT05136508|Sevoflurane|sevoflurane|mesh-list
14139967|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14139968|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14139969|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139970|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14139971|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
14139972|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
14139973|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13953736|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13953737|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
13953738|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953739|NCT03200392|Chromium|chromium|mesh-list
13953740|NCT03200392|Trace Elements|trace elements|mesh-ancestor
13953741|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
13953742|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953743|NCT03200093|Vancomycin|vancomycin|mesh-list
13953744|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13953745|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14139974|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14178231|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14178232|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14178233|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178234|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14178235|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14178236|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14178237|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
14178238|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14178239|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
14178240|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
14178241|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178242|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178243|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14178244|NCT04749043|Analgesics|analgesics|mesh-ancestor
14178245|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
14178246|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178247|NCT04749069|Remifentanil|remifentanil|mesh-list
14178248|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13953746|NCT03200197|Menthol|menthol|mesh-list
13953747|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
13953748|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
13953749|NCT03200210|Febuxostat|febuxostat|mesh-list
13953750|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
13953751|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953752|NCT03200080|Amphetamine|amphetamine|mesh-list
13953753|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
14178249|NCT04749069|Narcotics|narcotics|mesh-ancestor
14178250|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178251|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178252|NCT04749069|Analgesics|analgesics|mesh-ancestor
14178253|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
14178254|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178255|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
14178256|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14178257|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
14178258|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953754|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13953755|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953756|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
13953757|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
13953758|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953759|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
13953760|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953761|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953762|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
13953763|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13953764|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13953765|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14178259|NCT04748887|Protective Agents|protective agents|mesh-ancestor
14178260|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178261|NCT04748562|Progesterone|progesterone|mesh-list
14178262|NCT04748562|Progestins|progestins|mesh-ancestor
14178263|NCT04748562|Hormones|hormones|mesh-ancestor
14178264|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178265|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178266|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14178267|NCT04748822|Ethanol|ethanol|mesh-list
14178268|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14178269|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178270|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178271|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183845|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183846|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
14183847|NCT04725422|Pamidronate|pamidronate|mesh-list
14183848|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
14183849|NCT04725422|Adalimumab|adalimumab|mesh-list
14183850|NCT04725422|Etanercept|etanercept|mesh-list
14183851|NCT04725422|Golimumab|golimumab|mesh-list
14183852|NCT04725422|Methotrexate|methotrexate|mesh-list
14183853|NCT04725422|Infliximab|infliximab|mesh-list
14183854|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
13953766|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14183855|NCT04725422|Leflunomide|leflunomide|mesh-list
13953767|NCT03200236|Nicotine|nicotine|mesh-list
14183856|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14183857|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
14139975|NCT05135858|Methotrexate|methotrexate|mesh-list
14139976|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14139977|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
14139978|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14139979|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953768|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13953769|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
13953770|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953771|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953772|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13953773|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13953774|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
13953775|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953776|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953777|NCT03200015|Metformin|metformin|mesh-list
13953778|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953779|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953780|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
13953781|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
13953782|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953783|NCT03199989|Capecitabine|capecitabine|mesh-list
13953784|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
13953785|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14139980|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14139981|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
14139982|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139983|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139984|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
13953786|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
13953787|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953788|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953789|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
13953790|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
13953791|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953792|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
13953793|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953794|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13953795|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13953796|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
13953797|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953798|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953799|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13953800|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13953801|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13953802|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
13953803|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13953804|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953805|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953806|NCT03199794|Factor VIII|factor viii|mesh-list
13953807|NCT03199794|Coagulants|coagulants|mesh-ancestor
13953808|NCT03199976|Fluticasone|fluticasone|mesh-list
13953809|NCT03199976|Xhance|xhance|mesh-list
13953810|NCT03199976|Bromides|bromides|mesh-list
13953811|NCT03199976|Albuterol|albuterol|mesh-list
13953812|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
13953813|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953814|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13953815|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
13953816|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953817|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953818|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13953819|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
13953820|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
13953821|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13953822|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
13953823|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13953824|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
13953825|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953826|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953827|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
13953828|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
14139985|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953829|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13953830|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13953831|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13953832|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14139986|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14139987|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14139988|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
14139989|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14139990|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14139991|NCT05135845|Spartalizumab|spartalizumab|mesh-list
14139992|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14139993|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14139994|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14139995|NCT05135637|Vaccines|vaccines|mesh-list
14139996|NCT05135637|Immunologic Factors|immunologic factors|mesh-ancestor
14139997|NCT05135637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14139998|NCT05135442|Bortezomib|bortezomib|mesh-list
14139999|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953833|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962884|NCT02812667|Nivolumab|nivolumab|mesh-list
13962885|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962886|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962887|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13962888|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962889|NCT02797275|Albuterol|albuterol|mesh-list
13962890|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13962891|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
13962892|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962893|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962894|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13962895|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
13962896|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
13962897|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13962898|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13962899|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13962900|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13962901|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
13962902|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140000|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14140001|NCT05135286|Carbachol|carbachol|mesh-list
14140002|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14140003|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14140004|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14140005|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14140006|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140007|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140008|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140009|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140010|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14140011|NCT05135286|Miotics|miotics|mesh-ancestor
14140012|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
14140013|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140014|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14140015|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
14140016|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14140017|NCT05135286|Analgesics|analgesics|mesh-ancestor
14140018|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
14140019|NCT05135286|Protective Agents|protective agents|mesh-ancestor
14140020|NCT05135273|Vaccines|vaccines|mesh-list
14140021|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
14140022|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140023|NCT05135013|Drospirenone|drospirenone|mesh-list
14140024|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14140025|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13962903|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962904|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
13962905|NCT02790138|Vedolizumab|vedolizumab|mesh-list
13962906|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13962907|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13962908|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13962909|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13962910|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140026|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14140027|NCT05135013|Norethindrone|norethindrone|mesh-list
14140028|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
14479272|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14140029|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14140030|NCT05135013|Estradiol|estradiol|mesh-list
14140031|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14140032|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
14140033|NCT05135013|Estrogens|estrogens|mesh-ancestor
14140034|NCT05135013|Hormones|hormones|mesh-ancestor
14140035|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140036|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140037|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14140038|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
13953834|NCT03199664|Tacrolimus|tacrolimus|mesh-list
13953835|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13953836|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
13953837|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953838|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13953839|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953840|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953841|NCT03199690|Rifampin|rifampin|mesh-list
13953842|NCT03199690|Dolutegravir|dolutegravir|mesh-list
13953843|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13953844|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
13953845|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13953846|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13953847|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
13953848|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13953849|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953850|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953851|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13953852|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13953853|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13953854|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13953855|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13953856|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13953857|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13953858|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13953859|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13953860|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13953861|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
13953862|NCT03199950|Haloperidol|haloperidol|mesh-list
13953863|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
13953864|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
13953865|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
13953866|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953867|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953868|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953869|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13953870|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13953871|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953872|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13953873|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13953874|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
13953875|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953876|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953877|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13953878|NCT03199677|Apatinib|apatinib|mesh-list
13953879|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953880|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13953881|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953882|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953883|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13953884|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
13953885|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13953886|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
13953887|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13953888|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953889|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13953890|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953891|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953892|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
13953893|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13953894|NCT03199820|Dinoprostone|dinoprostone|mesh-list
13953895|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
13953896|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13953897|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140039|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14140040|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14140041|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14140042|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14140043|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14140044|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
14140045|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14140046|NCT05135013|Diuretics|diuretics|mesh-ancestor
14140047|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
14140048|NCT05135013|Progestins|progestins|mesh-ancestor
14140049|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14140050|NCT05134922|Gedatolisib|gedatolisib|mesh-list
14140051|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140052|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140053|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140054|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
14140055|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14140056|NCT05134792|Antibodies|antibodies|mesh-list
14140057|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
14140058|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14140059|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
14140060|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140061|NCT05134558|Xenon|xenon|mesh-list
14140062|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14140063|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
14140064|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
14140065|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140066|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140067|NCT05134519|Trastuzumab|trastuzumab|mesh-list
14140068|NCT05134519|Antibodies|antibodies|mesh-list
14140069|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14140070|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
14140071|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140072|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13953898|NCT03199339|Midazolam|midazolam|mesh-list
13953899|NCT03199339|Bupropion|bupropion|mesh-list
13953900|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13953901|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13953902|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953903|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953904|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13953905|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13953906|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13953907|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13953908|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
13953909|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
13953910|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
13953911|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
13953912|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953913|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953914|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13953915|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
13953916|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13953917|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13953918|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13953919|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
13953920|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13953921|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13953922|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13953923|NCT03199261|Exenatide|exenatide|mesh-list
13953924|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13953925|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953926|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13953927|NCT03199261|Incretins|incretins|mesh-ancestor
13953928|NCT03199261|Hormones|hormones|mesh-ancestor
13953929|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953930|NCT03199300|Trastuzumab|trastuzumab|mesh-list
13953931|NCT03199300|Bleomycin|bleomycin|mesh-list
13953932|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140073|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140074|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14140075|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14140076|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140077|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
14140078|NCT05122169|Iodine|iodine|mesh-list
14140079|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
13953933|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140080|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14140081|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
14140082|NCT05122169|Povidone|povidone|mesh-list
14140083|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14140084|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140085|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
14140086|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
13953934|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13953935|NCT03199482|Dexamethasone|dexamethasone|mesh-list
13953936|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13953937|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
13953938|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
13953939|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953940|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953941|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13953942|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
13953943|NCT03199482|Hormones|hormones|mesh-ancestor
13953944|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13953945|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13953946|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953947|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
13953948|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
13953949|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953950|NCT03199430|Protective Agents|protective agents|mesh-ancestor
13953951|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953952|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13953953|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13953954|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13953955|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13953956|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
13953957|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13953958|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13953959|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13953960|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13953961|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953962|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
13953963|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13953964|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953965|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13953966|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953967|NCT03199521|Thrombin|thrombin|mesh-list
13953968|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
13953969|NCT03199521|Coagulants|coagulants|mesh-ancestor
13953970|NCT03199170|Morphine|morphine|mesh-list
13953971|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13953972|NCT03199170|Narcotics|narcotics|mesh-ancestor
13953973|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953974|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953975|NCT03199170|Analgesics|analgesics|mesh-ancestor
13953976|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
13953977|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140087|NCT05122169|Trace Elements|trace elements|mesh-ancestor
14140088|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
14140089|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140090|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
14140091|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
14140092|NCT05121571|Sorafenib|sorafenib|mesh-list
14140093|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140094|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140095|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140096|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140097|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14140098|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140099|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140100|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140101|NCT05120141|Listerine|listerine|mesh-list
14140102|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14140103|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140104|NCT05087862|Anesthetics|anesthetics|mesh-list
14140105|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
14140106|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479273|NCT02466958|Analgesics|analgesics|mesh-ancestor
13953978|NCT03199157|Fentanyl|fentanyl|mesh-list
14140107|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953979|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13953980|NCT03199157|Narcotics|narcotics|mesh-ancestor
14140108|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
14178272|NCT04748757|Annexin A5|annexin a5|mesh-list
14140109|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140110|NCT05060523|Tolvaptan|tolvaptan|mesh-list
14140111|NCT05060523|Midodrine|midodrine|mesh-list
14140112|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14140113|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140114|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
14140115|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140116|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
14140117|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
14140118|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140119|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14140120|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14140121|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14140122|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14140123|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140124|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140125|NCT05024773|Paclitaxel|paclitaxel|mesh-list
14140126|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
13953981|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953982|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953983|NCT03199157|Analgesics|analgesics|mesh-ancestor
13953984|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
13953985|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953986|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13953987|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13953988|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
13953989|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
13953990|NCT03199105|Tetracaine|tetracaine|mesh-list
14140127|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140128|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140129|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140130|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140131|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140132|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13953991|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
13953992|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
13953993|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13953994|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13953995|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
13953996|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13953997|NCT03198637|Cisatracurium|cisatracurium|mesh-list
13953998|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13953999|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13954000|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954001|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954002|NCT03198741|Aspirin|aspirin|mesh-list
13954003|NCT03198741|Clopidogrel|clopidogrel|mesh-list
13954004|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13954005|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13954006|NCT03198741|Analgesics|analgesics|mesh-ancestor
13954007|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
13954008|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954009|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954010|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954011|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954012|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13954013|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13954014|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954015|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13954016|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13954017|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954018|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
13954019|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13954020|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13954021|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13954022|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
13954023|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954024|NCT03198819|Cefotaxime|cefotaxime|mesh-list
13954025|NCT03198819|Cefoxitin|cefoxitin|mesh-list
13954026|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13954027|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954028|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
14140133|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14140134|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
14140135|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140136|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
14140137|NCT05024773|Protective Agents|protective agents|mesh-ancestor
14140138|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
14140139|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954029|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13954030|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13954031|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13954032|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954033|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140140|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
14140141|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140142|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140143|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14140144|NCT05014334|Amoxicillin|amoxicillin|mesh-list
14140145|NCT05014334|Clarithromycin|clarithromycin|mesh-list
14140146|NCT05014334|Rabeprazole|rabeprazole|mesh-list
14140147|NCT05014334|Bismuth|bismuth|mesh-list
14140148|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14140149|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140150|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14140151|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140152|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140153|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14140154|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14140155|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14140156|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14140157|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14140158|NCT05014334|Antacids|antacids|mesh-ancestor
14140159|NCT05014087|Digoxin|digoxin|mesh-list
14140160|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13954034|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
13954035|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954036|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954037|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13954038|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954039|NCT03198676|Poly I-C|poly i-c|mesh-list
13954040|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
13954041|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954042|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
13954043|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
13954044|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954045|NCT03198585|Empagliflozin|empagliflozin|mesh-list
13954046|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13954047|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954048|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13954049|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954050|NCT03198403|Epinephrine|epinephrine|mesh-list
13954051|NCT03198403|Bupivacaine|bupivacaine|mesh-list
13954052|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
13954053|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
13954054|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954055|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954056|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
13954057|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954058|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13954059|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13954060|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
13954061|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954062|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954063|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13954064|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13954065|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
13954066|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13954067|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
13954068|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
13954069|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
13954070|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13954071|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13954072|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13954073|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954074|NCT03198949|Everolimus|everolimus|mesh-list
13954075|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478620|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478621|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
13954076|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14764454|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764455|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140161|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14140162|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140163|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140164|NCT05014087|Protective Agents|protective agents|mesh-ancestor
14140165|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140166|NCT05007522|Ketotifen|ketotifen|mesh-list
14140167|NCT05007522|Indomethacin|indomethacin|mesh-list
14140168|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14140169|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14140170|NCT05007522|Analgesics|analgesics|mesh-ancestor
14140171|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
14764456|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
14764457|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
14764458|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14764459|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14764460|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954077|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
13954078|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954079|NCT03198208|Fentanyl|fentanyl|mesh-list
13954080|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13954081|NCT03198208|Narcotics|narcotics|mesh-ancestor
13954082|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954083|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954084|NCT03198208|Analgesics|analgesics|mesh-ancestor
14140172|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140173|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954085|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
13954086|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140174|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14140175|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140176|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
14764461|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764462|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14764463|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14764464|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14764465|NCT00616382|Protective Agents|protective agents|mesh-ancestor
14764466|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
14764467|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14764468|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
14764469|NCT00616408|Octreotide|octreotide|mesh-list
14764470|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764471|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14764472|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954087|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13954088|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13954089|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
13954090|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
13954091|NCT03198338|Bupivacaine|bupivacaine|mesh-list
13954092|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
13954093|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
13954094|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764473|NCT00616460|Bivalirudin|bivalirudin|mesh-list
13954095|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954096|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
14140177|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
14764474|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
13954097|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140178|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14140179|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14140180|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140181|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140182|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
14140183|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
14140184|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14140185|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
14140186|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
14140187|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140188|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14178273|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178274|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178275|NCT04748796|Landiolol|landiolol|mesh-list
14178276|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14178277|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14178278|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
14178279|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178280|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178281|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178282|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14178283|NCT04748276|Norepinephrine|norepinephrine|mesh-list
14178284|NCT04748276|Serotonin|serotonin|mesh-list
14178285|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14178286|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14178287|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14764475|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13954098|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
13954099|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13954100|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
13954101|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954102|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954103|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13954104|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
13954105|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954106|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954107|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13962911|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962912|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962913|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13962914|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13962915|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13962916|NCT02783625|Bortezomib|bortezomib|mesh-list
13962917|NCT02783625|Romidepsin|romidepsin|mesh-list
13962918|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962919|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13962936|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
13962937|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13962938|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962939|NCT02726997|Paclitaxel|paclitaxel|mesh-list
13962940|NCT02726997|Carboplatin|carboplatin|mesh-list
13962941|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13962942|NCT02726997|Durvalumab|durvalumab|mesh-list
13962943|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
13962944|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14178288|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
14178289|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954108|NCT03198130|Cemiplimab|cemiplimab|mesh-list
13954109|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954110|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954111|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
13954112|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13954113|NCT03197961|Tenofovir|tenofovir|mesh-list
13954114|NCT03197961|Emtricitabine|emtricitabine|mesh-list
13954115|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13954116|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
13954117|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
13954118|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954119|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14140189|NCT05002192|Eucalyptol|eucalyptol|mesh-list
14140190|NCT05002192|Ambroxol|ambroxol|mesh-list
14140191|NCT05002192|Expectorants|expectorants|mesh-list
14764476|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
14764477|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764478|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954120|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13954121|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954122|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954123|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13954124|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13954125|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13954126|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13954127|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13954128|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
13954129|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14140192|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
14140193|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954130|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954131|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13954132|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13954133|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13954134|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13954135|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954136|NCT03197779|Aspirin|aspirin|mesh-list
13954137|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13954138|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13954139|NCT03197779|Analgesics|analgesics|mesh-ancestor
13954140|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
13954141|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954142|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954143|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954144|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954145|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13954146|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13954147|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954148|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13954149|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13954150|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954151|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
13954152|NCT03197818|Budesonide|budesonide|mesh-list
13954153|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
13954154|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954155|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13954156|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
13954157|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954158|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954159|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13954160|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
13954161|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
13954162|NCT03197818|Hormones|hormones|mesh-ancestor
13954163|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954164|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13954165|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13954166|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13954167|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
13954168|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954169|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954170|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
13954171|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140194|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
14140195|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
14140196|NCT05002192|Protective Agents|protective agents|mesh-ancestor
14140197|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140198|NCT04975347|Naloxone|naloxone|mesh-list
14140199|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140200|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14140201|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
14140202|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140203|NCT04975334|Naloxone|naloxone|mesh-list
14140204|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14140205|NCT04975334|Hormones|hormones|mesh-ancestor
14140206|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140207|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140208|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14140209|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
14140210|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140211|NCT04973020|Efavirenz|efavirenz|mesh-list
14140212|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14140213|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14140214|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140215|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140216|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
14140217|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140218|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14140219|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13954172|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954173|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
13954174|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954175|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140220|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14764479|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
14764480|NCT00616499|Gefitinib|gefitinib|mesh-list
13954176|NCT03197623|Alendronate|alendronate|mesh-list
13954177|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13954178|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954179|NCT03197571|Leucovorin|leucovorin|mesh-list
13954180|NCT03197571|Paclitaxel|paclitaxel|mesh-list
13954181|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
13954182|NCT03197571|Bevacizumab|bevacizumab|mesh-list
13954183|NCT03197571|Fluorouracil|fluorouracil|mesh-list
13954184|NCT03197571|Capecitabine|capecitabine|mesh-list
13954185|NCT03197571|Fulvestrant|fulvestrant|mesh-list
13954186|NCT03197571|Avelumab|avelumab|mesh-list
13954187|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13954188|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954189|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
13954190|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
13954191|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
13954192|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954193|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13954194|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
13954195|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954196|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954197|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13954198|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
13954199|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13954200|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954201|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13954202|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13954203|NCT03197571|Growth Substances|growth substances|mesh-ancestor
13954204|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
13954205|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
13954206|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13954207|NCT03197571|Antidotes|antidotes|mesh-ancestor
13954208|NCT03197571|Protective Agents|protective agents|mesh-ancestor
13954209|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
13954210|NCT03197571|Vitamins|vitamins|mesh-ancestor
13954211|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
13954212|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13954213|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13954214|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13954215|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
13954216|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764481|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954217|NCT03198013|Prednisolone|prednisolone|mesh-list
13962945|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
14140221|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14140222|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14140223|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14140224|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
14140225|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14140226|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140227|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140228|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14140229|NCT04955249|Analgesics|analgesics|mesh-ancestor
14140230|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
14140231|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140232|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14140233|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14140234|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14140235|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140236|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140237|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954218|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954219|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
13954220|NCT03198013|Hormones|hormones|mesh-ancestor
13954221|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954222|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954223|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13954224|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954225|NCT03197584|Leucovorin|leucovorin|mesh-list
13954226|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
13954227|NCT03197584|Bevacizumab|bevacizumab|mesh-list
13954228|NCT03197584|Fluorouracil|fluorouracil|mesh-list
13954229|NCT03197584|Capecitabine|capecitabine|mesh-list
13954230|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
14140251|NCT04908787|Paclitaxel|paclitaxel|mesh-list
14140252|NCT04908787|Doxorubicin|doxorubicin|mesh-list
14140253|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14140254|NCT04908787|Topotecan|topotecan|mesh-list
14764482|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764483|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954231|NCT03197584|Fulvestrant|fulvestrant|mesh-list
13954232|NCT03197584|Avelumab|avelumab|mesh-list
13954233|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954234|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954235|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13954236|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
13954237|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954238|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954239|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13954240|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
13954241|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13954242|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954243|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13954244|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13954245|NCT03197584|Growth Substances|growth substances|mesh-ancestor
13954246|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
13954247|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
13954248|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13954249|NCT03197584|Antidotes|antidotes|mesh-ancestor
13954250|NCT03197584|Protective Agents|protective agents|mesh-ancestor
13954251|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
13954252|NCT03197584|Vitamins|vitamins|mesh-ancestor
13954253|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
13954254|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13954255|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14140255|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140256|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140257|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140258|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140259|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140260|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140261|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14140262|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14140263|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14140264|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140265|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14140266|NCT04908449|Bupivacaine|bupivacaine|mesh-list
14140267|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
14140268|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
14140269|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140270|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140271|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
14140272|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140273|NCT04886453|Morphine|morphine|mesh-list
14140274|NCT04886453|Anesthetics|anesthetics|mesh-list
14140275|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954256|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13954257|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
13954258|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954259|NCT03197493|Levodopa|levodopa|mesh-list
13954260|NCT03197493|Carbidopa|carbidopa|mesh-list
13954261|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13954262|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13954263|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13954264|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
13954265|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954266|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954267|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954268|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13954269|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954270|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13954271|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
13954272|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
13954273|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
13954274|NCT03197506|Temozolomide|temozolomide|mesh-list
13954275|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954276|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954277|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13954278|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
13954279|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954280|NCT03197480|Aflibercept|aflibercept|mesh-list
13954281|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13954282|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13954283|NCT03197480|Growth Substances|growth substances|mesh-ancestor
13954284|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954285|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
13954286|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954287|NCT03197402|Caseins|caseins|mesh-list
14140276|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140277|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14140278|NCT04886453|Narcotics|narcotics|mesh-ancestor
14140279|NCT04886453|Analgesics|analgesics|mesh-ancestor
14140280|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
13954288|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
13954289|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
13954290|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954291|NCT03197298|Clopidogrel|clopidogrel|mesh-list
13954292|NCT03197298|Ticagrelor|ticagrelor|mesh-list
13954293|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13954294|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14140281|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140282|NCT04877522|Niacinamide|niacinamide|mesh-list
14140283|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
14764484|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764485|NCT00616538|Fluticasone|fluticasone|mesh-list
14764486|NCT00616538|Xhance|xhance|mesh-list
14764487|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764488|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14764489|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
14764490|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140284|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140285|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140286|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140287|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140288|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
14140289|NCT04877522|Vitamins|vitamins|mesh-ancestor
14764491|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954295|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13954296|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13954297|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
13954298|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954299|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954300|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954301|NCT03197207|Camphor|camphor|mesh-list
13954302|NCT03197207|Salicylates|salicylates|mesh-list
13954303|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
13954304|NCT03197207|Menthol|menthol|mesh-list
13954305|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13954306|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954307|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
13954308|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
13954309|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13954310|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13954311|NCT03197207|Analgesics|analgesics|mesh-ancestor
13954312|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
13954313|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954314|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954315|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954316|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954317|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13954318|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954319|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954320|NCT03197740|Donepezil|donepezil|mesh-list
13954321|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13954322|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954323|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954324|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
13954325|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954326|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954327|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
13954328|NCT03197233|Vitamin D|vitamin d|mesh-list
13954329|NCT03197233|Vitamins|vitamins|mesh-list
13954330|NCT03197233|Vitamin A|vitamin a|mesh-list
13954331|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
13954332|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
13954333|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954334|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
13954335|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954336|NCT03197233|Protective Agents|protective agents|mesh-ancestor
13954337|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13954338|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954339|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13954340|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
13954341|NCT03197077|Desogestrel|desogestrel|mesh-list
13954342|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
13954343|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
13954344|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13954345|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13954346|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954347|NCT03197077|Hormones|hormones|mesh-ancestor
13954348|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954349|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13954350|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13954351|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13954352|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14764492|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14478622|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954353|NCT03197077|Progestins|progestins|mesh-ancestor
13954354|NCT03196869|Cisplatin|cisplatin|mesh-list
13954355|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954356|NCT03196921|Amphotericin B|amphotericin b|mesh-list
13954357|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
13954358|NCT03196921|Amebicides|amebicides|mesh-ancestor
13954359|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13954360|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13954361|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954362|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13954363|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
13954364|NCT03196986|Bevacizumab|bevacizumab|mesh-list
13954365|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954366|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954367|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14478623|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478624|NCT02454296|Lidocaine|lidocaine|mesh-list
14478625|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
14478626|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
14478627|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954368|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13954369|NCT03196986|Growth Substances|growth substances|mesh-ancestor
13954370|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954371|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
13954372|NCT03196934|Cannabidiol|cannabidiol|mesh-list
13954373|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
13954374|NCT03197012|Octreotide|octreotide|mesh-list
13954375|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
13954376|NCT03197012|Edotreotide|edotreotide|mesh-list
13954377|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
13954378|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
13954379|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954380|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13954381|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13954382|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13954383|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954384|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
13954385|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13954386|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
13954387|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954388|NCT03197103|Expectorants|expectorants|mesh-ancestor
13954389|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
13954390|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13954391|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
13954392|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954393|NCT03197103|Protective Agents|protective agents|mesh-ancestor
13954394|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954395|NCT03197103|Antidotes|antidotes|mesh-ancestor
13954396|NCT03196817|Betamethasone|betamethasone|mesh-list
13954397|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
13954398|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13954399|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
13954400|NCT03196817|Lidocaine|lidocaine|mesh-list
13954401|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13954402|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
13954403|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
13954404|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954405|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954406|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
13954407|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954408|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13954409|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13954410|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13954411|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954412|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954413|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954414|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
13954415|NCT03196817|Hormones|hormones|mesh-ancestor
13954416|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954417|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13954418|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
13954419|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
13954420|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954421|NCT03196882|Iron|iron|mesh-list
14478628|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954422|NCT03196882|Trace Elements|trace elements|mesh-ancestor
14140290|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
14140291|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140292|NCT04849832|Fesoterodine|fesoterodine|mesh-list
14140293|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14140294|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14140295|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
14140296|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140297|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140298|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140299|NCT04849832|Urological Agents|urological agents|mesh-ancestor
14140300|NCT04780932|Macitentan|macitentan|mesh-list
14478629|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
14478630|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954423|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
13954424|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954425|NCT03196843|Raltitrexed|raltitrexed|mesh-list
13954426|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13954427|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
13954428|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954429|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954430|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13954431|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954432|NCT03196648|Fluorides|fluorides|mesh-list
14140301|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14140302|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14140303|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140304|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14140305|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
14140306|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14140307|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
14140308|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140309|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
14140310|NCT04769453|Protective Agents|protective agents|mesh-ancestor
14140311|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
14140312|NCT04745988|Lenvatinib|lenvatinib|mesh-list
14140313|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478631|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14478632|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14478633|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14478634|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479274|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
14764493|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
13954433|NCT03196648|Antioxidants|antioxidants|mesh-list
14140314|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140315|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140316|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140317|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140318|NCT04717154|Nivolumab|nivolumab|mesh-list
14140319|NCT04717154|Ipilimumab|ipilimumab|mesh-list
14140320|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140321|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140322|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14140323|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140324|NCT04702464|Fluconazole|fluconazole|mesh-list
14140325|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
14140326|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140327|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14140328|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14140329|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140330|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140331|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14140332|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
14140333|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140334|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140335|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14140336|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14140337|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
14140338|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
14140339|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14140340|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14140341|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140342|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954434|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
14140343|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140344|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140345|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
14140346|NCT04664972|Docetaxel|docetaxel|mesh-list
14140347|NCT04664972|Doxorubicin|doxorubicin|mesh-list
14140348|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13954435|NCT03196648|Protective Agents|protective agents|mesh-ancestor
13954436|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954437|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954438|NCT03196466|Topiramate|topiramate|mesh-list
13954439|NCT03196466|Pregabalin|pregabalin|mesh-list
13954440|NCT03196466|Lamotrigine|lamotrigine|mesh-list
13954441|NCT03196466|Zonisamide|zonisamide|mesh-list
13954442|NCT03196466|Lacosamide|lacosamide|mesh-list
13954443|NCT03196466|Carbamazepine|carbamazepine|mesh-list
13954444|NCT03196466|Phenytoin|phenytoin|mesh-list
14140349|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
14140350|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140351|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140352|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14140353|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
14140354|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140355|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140356|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14140357|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140358|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140359|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140360|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14140361|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14140362|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14140363|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140364|NCT04652544|Vitamin D|vitamin d|mesh-list
14140365|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
14140366|NCT04652544|Vitamins|vitamins|mesh-ancestor
14140367|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
14140368|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140369|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14140370|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14140371|NCT04644705|Niclosamide|niclosamide|mesh-list
14140372|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
14140373|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14140374|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
14140375|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14140376|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140377|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
14140378|NCT04637555|Valsartan|valsartan|mesh-list
14140379|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14140380|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14140381|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14140382|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140389|NCT04607122|Landiolol|landiolol|mesh-list
14140390|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14140391|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14140392|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140393|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140394|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140395|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140396|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14178290|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178291|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178292|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
14178293|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
14178294|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178295|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14178296|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14178297|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
14478635|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954445|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
13954446|NCT03196466|Rufinamide|rufinamide|mesh-list
13954447|NCT03196466|Cannabidiol|cannabidiol|mesh-list
14140397|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
14140398|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140399|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140403|NCT04576663|Phenylephrine|phenylephrine|mesh-list
14140404|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
14140405|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14140406|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
14140407|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
14140408|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140409|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140410|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
14140411|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14140412|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
14140413|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
14140414|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14140415|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14140416|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14140417|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140418|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140419|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140420|NCT04576663|Protective Agents|protective agents|mesh-ancestor
14140421|NCT04556357|Phenylephrine|phenylephrine|mesh-list
14140422|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
14140423|NCT04556357|Norepinephrine|norepinephrine|mesh-list
14140424|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14140425|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14140426|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
14140427|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
14140428|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140429|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140430|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
14140431|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
14140432|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
14140433|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14140434|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14140435|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14140436|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140437|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140438|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140439|NCT04556357|Protective Agents|protective agents|mesh-ancestor
14140440|NCT04553939|Gemcitabine|gemcitabine|mesh-list
14140441|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14140442|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
14140443|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140444|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140445|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
14140446|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140447|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140448|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140449|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
14140450|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140451|NCT04547946|Trametinib|trametinib|mesh-list
14140452|NCT04547946|Dabrafenib|dabrafenib|mesh-list
14140453|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140454|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140455|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140456|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140457|NCT04515901|Lidocaine|lidocaine|mesh-list
14140458|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
14140459|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
14140460|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140461|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140462|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
14140463|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140464|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13954448|NCT03196466|Levetiracetam|levetiracetam|mesh-list
13954449|NCT03196466|Valproic Acid|valproic acid|mesh-list
13954450|NCT03196466|Brivaracetam|brivaracetam|mesh-list
13954451|NCT03196466|Phenobarbital|phenobarbital|mesh-list
13954452|NCT03196466|Clobazam|clobazam|mesh-list
13954453|NCT03196466|Ethosuximide|ethosuximide|mesh-list
13954454|NCT03196466|Tiagabine|tiagabine|mesh-list
13954455|NCT03196466|Stiripentol|stiripentol|mesh-list
13954456|NCT03196466|Primidone|primidone|mesh-list
13954457|NCT03196466|Felbamate|felbamate|mesh-list
13954458|NCT03196466|Analgesics|analgesics|mesh-ancestor
13954459|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
13954460|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954461|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954462|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
13954463|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13954464|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954465|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954466|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13954467|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14140465|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14140466|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14140467|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14140468|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140469|NCT04501939|Venetoclax|venetoclax|mesh-list
14140470|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140471|NCT04468425|Tofacitinib|tofacitinib|mesh-list
14140472|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140473|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140474|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140475|NCT04434326|Vorolanib|vorolanib|mesh-list
14140476|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140477|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140478|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140479|NCT04426968|Interferons|interferons|mesh-list
14140480|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140481|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
14140482|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140483|NCT04400695|Paclitaxel|paclitaxel|mesh-list
14140484|NCT04400695|Vinorelbine|vinorelbine|mesh-list
14140485|NCT04400695|Docetaxel|docetaxel|mesh-list
14140486|NCT04400695|Capecitabine|capecitabine|mesh-list
14140487|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140488|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140489|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140490|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140491|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140492|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140493|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14140494|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
14140495|NCT04359329|Estradiol|estradiol|mesh-list
14140496|NCT04359329|Estrogens|estrogens|mesh-ancestor
14140497|NCT04359329|Hormones|hormones|mesh-ancestor
14140498|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140499|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140500|NCT04328506|Vorolanib|vorolanib|mesh-list
14140501|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140502|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140503|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140504|NCT04303689|Colchicine|colchicine|mesh-list
14140505|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
14140506|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140507|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140508|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140509|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140510|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140511|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140512|NCT04287855|Dexamethasone|dexamethasone|mesh-list
14140513|NCT04287855|Pomalidomide|pomalidomide|mesh-list
14140514|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14140515|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
14140516|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
14140517|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140518|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140519|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14140520|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
14140521|NCT04287855|Hormones|hormones|mesh-ancestor
14140522|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140523|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14140524|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140525|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
14140526|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14140527|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14140528|NCT04287855|Growth Substances|growth substances|mesh-ancestor
14140529|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
14140530|NCT04264897|Metformin|metformin|mesh-list
14140531|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14140532|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140533|NCT04253964|Paclitaxel|paclitaxel|mesh-list
14140534|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14140535|NCT04253964|Carboplatin|carboplatin|mesh-list
14140536|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
14140537|NCT04253964|Pemetrexed|pemetrexed|mesh-list
14140538|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140539|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954468|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13954469|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954470|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13954471|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13954472|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
13954473|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13954474|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13954475|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954476|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
13954477|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954478|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
13954479|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13954480|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14140540|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140541|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140542|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140543|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140544|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140545|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140546|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14140547|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14140548|NCT04246060|Cysteamine|cysteamine|mesh-list
14140549|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14140550|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140551|NCT04235140|Ivacaftor|ivacaftor|mesh-list
14140552|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14140553|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14140554|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140555|NCT04203875|Abatacept|abatacept|mesh-list
14140556|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14140557|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140558|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140559|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140560|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
14478636|NCT02454478|Everolimus|everolimus|mesh-list
14478637|NCT02454478|Lenvatinib|lenvatinib|mesh-list
14478638|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478639|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14478640|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
14478641|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478642|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14478643|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478644|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478645|NCT02454608|Verapamil|verapamil|mesh-list
14478646|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14478647|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14478648|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14478649|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478650|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14478651|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478652|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
14478653|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14478654|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14478655|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14478656|NCT02455050|Laxatives|laxatives|mesh-ancestor
14478657|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478658|NCT02455076|Exenatide|exenatide|mesh-list
14478659|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
14478660|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14478661|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478662|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14478663|NCT02455076|Incretins|incretins|mesh-ancestor
14478664|NCT02455076|Hormones|hormones|mesh-ancestor
14478665|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478666|NCT02455167|Ribavirin|ribavirin|mesh-list
13954481|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13954482|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13954483|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13954484|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13954485|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13954486|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13954487|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
13954488|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13954489|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13954490|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
13954491|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
13954492|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13954493|NCT03196401|Durvalumab|durvalumab|mesh-list
14140561|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140562|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140563|NCT04199026|Sirolimus|sirolimus|mesh-list
14140564|NCT04199026|Doxorubicin|doxorubicin|mesh-list
14140565|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14140566|NCT04199026|Daunorubicin|daunorubicin|mesh-list
14140567|NCT04199026|Irinotecan|irinotecan|mesh-list
14140568|NCT04199026|Vincristine|vincristine|mesh-list
14140569|NCT04199026|Everolimus|everolimus|mesh-list
14140570|NCT04199026|Temozolomide|temozolomide|mesh-list
14140571|NCT04199026|Ifosfamide|ifosfamide|mesh-list
14140572|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
14140573|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14140574|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14140575|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140576|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14140577|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14140578|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140579|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140580|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14140581|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140582|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140583|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140584|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140585|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140586|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
14140587|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140588|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14140589|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
14140590|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14140591|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140592|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
14140593|NCT04114539|Ecopipam|ecopipam|mesh-list
14140594|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14478667|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
14478668|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
14478669|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478670|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
14478671|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478672|NCT02455336|Fenofibrate|fenofibrate|mesh-list
14478673|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14478674|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
14478675|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478676|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14478677|NCT02455453|Estradiol|estradiol|mesh-list
14478678|NCT02455453|Estrogens|estrogens|mesh-ancestor
14478679|NCT02455453|Hormones|hormones|mesh-ancestor
14478680|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478681|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140595|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14140596|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140597|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140598|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14140599|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14140600|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
13954494|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140601|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140602|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140603|NCT04094298|FX006|fx006|mesh-list
14478682|NCT02455518|Acetaminophen|acetaminophen|mesh-list
14140604|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14140605|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
14140606|NCT04094298|Hormones|hormones|mesh-ancestor
14140607|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140608|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140609|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140610|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
14178298|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14178299|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954495|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962946|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13962947|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962948|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
13962949|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
13962950|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
13962951|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962952|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13962953|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
13962954|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962955|NCT02723994|Leucovorin|leucovorin|mesh-list
13962956|NCT02723994|Cytarabine|cytarabine|mesh-list
14178300|NCT04748341|Benzocaine|benzocaine|mesh-list
14178301|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
14178302|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
14178303|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178304|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178305|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
14178306|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178307|NCT04748419|Durvalumab|durvalumab|mesh-list
14178308|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178309|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178310|NCT04748042|Prednisone|prednisone|mesh-list
14178311|NCT04748042|Olaparib|olaparib|mesh-list
14178312|NCT04748042|Androgens|androgens|mesh-list
14178313|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178314|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
14178315|NCT04748042|Hormones|hormones|mesh-ancestor
14178316|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178317|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178318|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14178319|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178320|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14178321|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178322|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178323|NCT04747912|Dexamethasone|dexamethasone|mesh-list
14178324|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
14178325|NCT04747912|Methotrexate|methotrexate|mesh-list
14178326|NCT04747912|Vincristine|vincristine|mesh-list
14178327|NCT04747912|Dasatinib|dasatinib|mesh-list
14178328|NCT04747912|Ponatinib|ponatinib|mesh-list
14178329|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14178330|NCT04747912|BB 1101|bb 1101|mesh-list
14178331|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178332|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
14178333|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
14178334|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178335|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178336|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178337|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
14178338|NCT04747912|Hormones|hormones|mesh-ancestor
14178339|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178340|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14178341|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178342|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
14178343|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178344|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178345|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14178346|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
14178347|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178348|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14178349|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
14178350|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14178351|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14178352|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14178353|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
13954496|NCT03196479|Ketamine|ketamine|mesh-list
13954497|NCT03196479|Propofol|propofol|mesh-list
13954498|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13954499|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954500|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954501|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13954502|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
13954503|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
13954504|NCT03196479|Analgesics|analgesics|mesh-ancestor
13954505|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
13954506|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954507|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13954508|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13954509|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13954510|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954511|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954512|NCT03196531|Loratadine|loratadine|mesh-list
14140611|NCT04003636|Gemcitabine|gemcitabine|mesh-list
14140612|NCT04003636|Cisplatin|cisplatin|mesh-list
14140613|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
14140614|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140615|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14140616|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
14140617|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140618|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
14140619|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140620|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140621|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140622|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
14140623|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140624|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140625|NCT03976934|Tamsulosin|tamsulosin|mesh-list
14140626|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14140627|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14140628|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14140629|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140630|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140631|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140632|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140633|NCT03976934|Urological Agents|urological agents|mesh-ancestor
14140634|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
14140635|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140636|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
14140637|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140638|NCT03939897|Fulvestrant|fulvestrant|mesh-list
14140639|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14140640|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140641|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14140642|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14140643|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
14140644|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140645|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140646|NCT03909217|Dexetimide|dexetimide|mesh-list
14140647|NCT03909217|Citalopram|citalopram|mesh-list
14140648|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14140649|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14140650|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14140651|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140652|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140653|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
14140654|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140655|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14140656|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
14140657|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14140658|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14140659|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14140660|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
14140661|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
14140662|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140663|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14140664|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14140665|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
14140666|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
14140667|NCT03890289|Idelalisib|idelalisib|mesh-list
14178354|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140668|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140669|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140670|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140671|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140672|NCT03870529|Vitamins|vitamins|mesh-list
14140673|NCT03870529|Vitamin A|vitamin a|mesh-list
14140674|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
14140675|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
14140676|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
14140677|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140678|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
14140679|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140680|NCT03870529|Protective Agents|protective agents|mesh-ancestor
14140681|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14140682|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140683|NCT03770546|Betamethasone|betamethasone|mesh-list
14140684|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14140685|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
14140686|NCT03770546|Hormones|hormones|mesh-ancestor
14140687|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140688|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140689|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14140690|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
14140691|NCT03763643|Rituximab|rituximab|mesh-list
14140692|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140693|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140694|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
14140695|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140696|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140697|NCT03749187|Temozolomide|temozolomide|mesh-list
14140698|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14140699|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14140700|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
14764494|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14764495|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14764496|NCT00616551|Octreotide|octreotide|mesh-list
14140701|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140702|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140703|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140704|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14140705|NCT03712202|Nivolumab|nivolumab|mesh-list
14140706|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14140707|NCT03712202|Doxorubicin|doxorubicin|mesh-list
14140708|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14140709|NCT03712202|Daunorubicin|daunorubicin|mesh-list
14140710|NCT03712202|Bleomycin|bleomycin|mesh-list
14140711|NCT03712202|Dacarbazine|dacarbazine|mesh-list
14140712|NCT03712202|Vinblastine|vinblastine|mesh-list
14140713|NCT03712202|Antibodies|antibodies|mesh-list
14140714|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
14140715|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14140716|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
14140717|NCT03712202|Imidazole|imidazole|mesh-list
14140718|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
14140719|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140720|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140721|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14140722|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14140723|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14140724|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140725|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140726|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14140727|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764497|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14140728|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
14140729|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140730|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140731|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140732|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140733|NCT03689374|Insulin|insulin|mesh-list
14140734|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14140735|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
14140736|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
14140737|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14140738|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140739|NCT03659539|Propofol|propofol|mesh-list
14140740|NCT03659539|Desflurane|desflurane|mesh-list
14140741|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14140742|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140743|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140744|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14140745|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
14140746|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
14140747|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14140748|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
14140749|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14140750|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14140751|NCT03627858|Beclomethasone|beclomethasone|mesh-list
14140752|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
14140753|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
14140754|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14140755|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
14140756|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140757|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140758|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14140759|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
14140760|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14140761|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14140762|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14764498|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14764499|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767386|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767387|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
14767388|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767389|NCT00629837|Factor VIII|factor viii|mesh-list
14140763|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
14767390|NCT00629837|Coagulants|coagulants|mesh-ancestor
14767391|NCT00629863|Fluorouracil|fluorouracil|mesh-list
14767392|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767393|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
14767394|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767395|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14767396|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140764|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140765|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140766|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767397|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
14767398|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767399|NCT00629889|Pregabalin|pregabalin|mesh-list
14767400|NCT00629889|Levetiracetam|levetiracetam|mesh-list
14767401|NCT00629889|Analgesics|analgesics|mesh-ancestor
14767402|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
14767403|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767404|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767405|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
14767406|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14140767|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
14140768|NCT03627858|Hormones|hormones|mesh-ancestor
14140769|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140770|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14140771|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14140772|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14140773|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
14140774|NCT03620123|Docetaxel|docetaxel|mesh-list
14140775|NCT03620123|Nivolumab|nivolumab|mesh-list
14140776|NCT03620123|Ipilimumab|ipilimumab|mesh-list
14140777|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140778|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140779|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140780|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140781|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140782|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140783|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14140784|NCT03601637|Ivacaftor|ivacaftor|mesh-list
14140785|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14140786|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14140787|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140788|NCT03552692|Venetoclax|venetoclax|mesh-list
14140789|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764500|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
14764501|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
14764502|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14764503|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14764504|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764505|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764506|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14764507|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14764508|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
14764509|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14764510|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764511|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764512|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14764513|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140806|NCT03370172|Factor VIII|factor viii|mesh-list
14140807|NCT03370172|Coagulants|coagulants|mesh-ancestor
14140808|NCT03292146|Denosumab|denosumab|mesh-list
14140809|NCT03292146|Alendronate|alendronate|mesh-list
14140810|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14140811|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140812|NCT03274492|Prednisone|prednisone|mesh-list
14140813|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
14140814|NCT03274492|Rituximab|rituximab|mesh-list
14140815|NCT03274492|Doxorubicin|doxorubicin|mesh-list
14140816|NCT03274492|Vincristine|vincristine|mesh-list
14140817|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14140818|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
14140819|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140820|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
14140821|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140822|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14140823|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14140824|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
14140825|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140826|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140827|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14140828|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140829|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14140830|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14140831|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14140832|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140833|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14140834|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
14140835|NCT03274492|Hormones|hormones|mesh-ancestor
14140836|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140837|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14140838|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140839|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
14140840|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
14140841|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
14140842|NCT03270501|Golimumab|golimumab|mesh-list
14478683|NCT02455518|Ibuprofen|ibuprofen|mesh-list
14140843|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14140844|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14140845|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14140846|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
14140847|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140848|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
14140849|NCT03251651|Propofol|propofol|mesh-list
14140850|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14140851|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140852|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140853|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14140854|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
14140855|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
14140856|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14140857|NCT03251651|Analgesics|analgesics|mesh-ancestor
14764514|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14764515|NCT00616720|Interferons|interferons|mesh-list
14764516|NCT00616720|Aldesleukin|aldesleukin|mesh-list
14764517|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
14764518|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764519|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
14764520|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764521|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764522|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764523|NCT00616746|Ethanol|ethanol|mesh-list
14140858|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
14140859|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140860|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14140861|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14140862|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14140863|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14140864|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14140865|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140866|NCT03159000|Lidocaine|lidocaine|mesh-list
14140867|NCT03159000|Bupivacaine|bupivacaine|mesh-list
14140868|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
14140869|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
14140870|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140871|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140872|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
14140873|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140874|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14140875|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14140876|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14140877|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14140878|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140879|NCT03126643|Nivolumab|nivolumab|mesh-list
14140880|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140881|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140882|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14140883|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140884|NCT03126617|Elotuzumab|elotuzumab|mesh-list
14140885|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140886|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14140887|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14764524|NCT00616746|Nicotine|nicotine|mesh-list
14764525|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14764526|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
14764527|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764528|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764529|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14764530|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14764531|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
14764532|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764533|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764534|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14764535|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140888|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140889|NCT03016819|Dacarbazine|dacarbazine|mesh-list
14140890|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14140891|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
14178355|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764536|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764537|NCT00616785|Irinotecan|irinotecan|mesh-list
14764538|NCT00616785|Etoposide|etoposide|mesh-list
14140892|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140893|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178356|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14178357|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
14178358|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
14178359|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
14178360|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14178361|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178362|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14178363|NCT04747678|Ivermectin|ivermectin|mesh-list
14178364|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14178365|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178366|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
14178367|NCT04747795|Vitamins|vitamins|mesh-ancestor
14178368|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
14178369|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178370|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
14178371|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178372|NCT04747795|Protective Agents|protective agents|mesh-ancestor
14178373|NCT04747392|Teriparatide|teriparatide|mesh-list
14178374|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14178375|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178376|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14178377|NCT04747301|Dinoprostone|dinoprostone|mesh-list
14178378|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
14178379|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178380|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178381|NCT04747015|Oxytocin|oxytocin|mesh-list
14178382|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
14178383|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178384|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178385|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
14178386|NCT04746937|Norfloxacin|norfloxacin|mesh-list
14178387|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14178388|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178389|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14178390|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14178391|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14178392|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178393|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178394|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178395|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14178396|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14178397|NCT04747080|Dexamethasone|dexamethasone|mesh-list
14178398|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
14178399|NCT04747080|BB 1101|bb 1101|mesh-list
14178400|NCT04747080|Tacrolimus|tacrolimus|mesh-list
14178401|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178402|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
14178403|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
14178404|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178405|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178406|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178407|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
14178408|NCT04747080|Hormones|hormones|mesh-ancestor
14178409|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178410|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14178411|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178412|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
14178413|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178414|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178415|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14178416|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
14178417|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14178418|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
14178419|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14178420|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178421|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178422|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14178423|NCT04747171|Analgesics|analgesics|mesh-ancestor
14178424|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
14178425|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178426|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14178427|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14140894|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
14140895|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14140896|NCT02951364|Ledipasvir|ledipasvir|mesh-list
14140897|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
14140898|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140899|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
14140900|NCT02889237|Vitamin D|vitamin d|mesh-list
14140901|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
14140902|NCT02889237|Vitamins|vitamins|mesh-list
14140903|NCT02889237|Calcium|calcium|mesh-list
14140904|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
14140905|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140906|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14140907|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14140908|NCT02873962|Bevacizumab|bevacizumab|mesh-list
14140909|NCT02873962|Nivolumab|nivolumab|mesh-list
14140910|NCT02873962|Rucaparib|rucaparib|mesh-list
14140911|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14140912|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140913|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14937105|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937106|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937107|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937108|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
14937109|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937110|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937111|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14937112|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14937113|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
14937114|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764539|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764540|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14764541|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14764542|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764543|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764544|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14764545|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14764546|NCT00616850|Lidocaine|lidocaine|mesh-list
14140914|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14140915|NCT02873962|Growth Substances|growth substances|mesh-ancestor
14140916|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140917|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14140918|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14140919|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140920|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14140921|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140922|NCT02856438|Dexamethasone|dexamethasone|mesh-list
14764547|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
14764548|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
14764549|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14140923|NCT02856438|Lenalidomide|lenalidomide|mesh-list
14140924|NCT02856438|Elotuzumab|elotuzumab|mesh-list
14140925|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14140926|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
14140927|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
14140928|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140929|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140930|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14140931|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
14140932|NCT02856438|Hormones|hormones|mesh-ancestor
14140933|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14140934|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14140935|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140936|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
14478684|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14478685|NCT02455518|Oxycodone|oxycodone|mesh-list
14478686|NCT02455518|Hydrocodone|hydrocodone|mesh-list
14478687|NCT02455518|Codeine|codeine|mesh-list
14478688|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14478689|NCT02455518|Analgesics|analgesics|mesh-ancestor
14478690|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
14478691|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14140937|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14140938|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14478692|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140939|NCT02856438|Growth Substances|growth substances|mesh-ancestor
14140940|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
14140941|NCT02844816|Atezolizumab|atezolizumab|mesh-list
14140942|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14140943|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140944|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
14140945|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140946|NCT02808182|Niacin|niacin|mesh-list
14140947|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
14140948|NCT02808182|Niacinamide|niacinamide|mesh-list
14140949|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14140950|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
14140951|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140952|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14140953|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
14140954|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
14140955|NCT02808182|Vitamins|vitamins|mesh-ancestor
14140956|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
14140957|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140958|NCT02689167|Sunitinib|sunitinib|mesh-list
14140959|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140960|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14140961|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14140962|NCT02689167|Growth Substances|growth substances|mesh-ancestor
14140963|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140964|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14140965|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14140966|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140967|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140968|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14764550|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764551|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
14764552|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764553|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14767407|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14140969|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
14140970|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14140971|NCT02582697|Cisplatin|cisplatin|mesh-list
14140972|NCT02582697|Etoposide|etoposide|mesh-list
14140973|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
14140974|NCT02582697|Bleomycin|bleomycin|mesh-list
14140975|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140976|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14140977|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14140978|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14140979|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140980|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140981|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14140982|NCT02535221|Epirubicin|epirubicin|mesh-list
14140983|NCT02535221|Goserelin|goserelin|mesh-list
14140984|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14140985|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14140986|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14140987|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13954513|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
13954514|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
13954515|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13954516|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13954517|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13954518|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
13954519|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
13954520|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954521|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954522|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954523|NCT03196362|Metformin|metformin|mesh-list
13954524|NCT03196362|Pioglitazone|pioglitazone|mesh-list
13954525|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13954526|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140988|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14140989|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14140990|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14140991|NCT02529904|Vaccines|vaccines|mesh-list
14140992|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
14140993|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14140994|NCT02525796|Eplerenone|eplerenone|mesh-list
14140995|NCT02525796|Amiloride|amiloride|mesh-list
14140996|NCT02525796|Cinacalcet|cinacalcet|mesh-list
14140997|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14140998|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
14140999|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141000|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141001|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14141002|NCT02525796|Diuretics|diuretics|mesh-ancestor
14141003|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
14141004|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14141005|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14141006|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14141007|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14141008|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14141009|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141010|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141011|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14141012|NCT02217345|Hormones|hormones|mesh-list
14141013|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141014|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141015|NCT02101944|Dexamethasone|dexamethasone|mesh-list
14141016|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
14141017|NCT02101944|Ichthammol|ichthammol|mesh-list
14141018|NCT02101944|BB 1101|bb 1101|mesh-list
14141019|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141020|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
14141021|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
14141022|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141023|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141024|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141025|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
14141026|NCT02101944|Hormones|hormones|mesh-ancestor
14141027|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141028|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14141029|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141030|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14141031|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141032|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141033|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
14141034|NCT01996605|Oxytocin|oxytocin|mesh-list
14141035|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
14141036|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14141037|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141038|NCT01669915|Vitamin D|vitamin d|mesh-list
14141039|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
14141040|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
14141041|NCT01669915|Vitamins|vitamins|mesh-list
14141042|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
14141043|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141044|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14141045|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14478693|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
14478694|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14478695|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764554|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14764555|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14764556|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14478696|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14478697|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14478698|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478699|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478700|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14478701|NCT02455518|Narcotics|narcotics|mesh-ancestor
14478702|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478703|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
14478704|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
14478705|NCT02456662|Ondansetron|ondansetron|mesh-list
14478706|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
14141057|NCT01503489|Norepinephrine|norepinephrine|mesh-list
14141058|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
14141059|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
14141060|NCT01503489|Serotonin|serotonin|mesh-list
14141061|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14141062|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14141063|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14141064|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
14141065|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141066|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141067|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141068|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
14141069|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
14141070|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141071|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14141072|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14764557|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764558|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
14764559|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
14764560|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14764561|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14764562|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141073|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14141074|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
14141075|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14141076|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141077|NCT01019616|Paclitaxel|paclitaxel|mesh-list
14141078|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14141079|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141080|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
14141081|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
14141082|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
14141083|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141084|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
14141085|NCT00000587|Hematinics|hematinics|mesh-ancestor
14141086|NCT05138146|Doxorubicin|doxorubicin|mesh-list
14141087|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14141088|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14141089|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141090|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14141091|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14141092|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141093|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141094|NCT05137964|Vitamin D|vitamin d|mesh-list
14141095|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14141096|NCT05137964|Vitamins|vitamins|mesh-ancestor
14141097|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
14141098|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141099|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14141100|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
14141101|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141102|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
14141103|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14764563|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141104|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14141105|NCT05137522|Prednisolone|prednisolone|mesh-list
14141106|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
14141107|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14141108|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
14141109|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141110|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
14141111|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
14141112|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141113|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141114|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141115|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
14141116|NCT05137522|Hormones|hormones|mesh-ancestor
14141117|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141118|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14141119|NCT05137522|Protective Agents|protective agents|mesh-ancestor
14141120|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14141121|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141122|NCT05137288|Atropine|atropine|mesh-list
14141123|NCT05137288|Ondansetron|ondansetron|mesh-list
14141124|NCT05137288|Bupivacaine|bupivacaine|mesh-list
14141125|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
14141126|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
14141127|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141128|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141129|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
14141130|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141131|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
14141132|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
14764564|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14764565|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14764566|NCT00616876|Lactulose|lactulose|mesh-list
14764567|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764568|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14764569|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
14764570|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14764571|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14764572|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14764573|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764574|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764575|NCT00616915|Bupropion|bupropion|mesh-list
14764576|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14764577|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
14764578|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14764579|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14141133|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764580|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14764581|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764582|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764583|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
14764584|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764585|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764586|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14764587|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14764588|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764589|NCT00616993|Difluprednate|difluprednate|mesh-list
14764590|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
14764591|NCT00616993|Hormones|hormones|mesh-ancestor
14764592|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764593|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141134|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
14141135|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
14141136|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14141137|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
14141138|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141139|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141140|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14141141|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14141142|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141143|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14141144|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14141145|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14141146|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14141147|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14141148|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
14141149|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
14141150|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
14141151|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14141152|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14141153|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
14141154|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
14141155|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141156|NCT05137184|Fentanyl|fentanyl|mesh-list
14141157|NCT05137184|Morphine|morphine|mesh-list
14141158|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
14141159|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14141160|NCT05137184|Narcotics|narcotics|mesh-ancestor
14141161|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141162|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141163|NCT05137184|Analgesics|analgesics|mesh-ancestor
14141164|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
14141165|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141166|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14141167|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14141168|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
14141169|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
14141170|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14141171|NCT05137145|Linaclotide|linaclotide|mesh-list
14141172|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14141173|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
14141174|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141175|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141176|NCT05136976|Rituximab|rituximab|mesh-list
14141177|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141178|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141179|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
14141180|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141181|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141182|NCT05136924|Varenicline|varenicline|mesh-list
14141183|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14141184|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14141185|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
14141186|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141187|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141188|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141189|NCT05135715|Trastuzumab|trastuzumab|mesh-list
14141190|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141191|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141192|NCT05135182|Metronidazole|metronidazole|mesh-list
14141193|NCT05135182|Furazolidone|furazolidone|mesh-list
14141194|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141195|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14141196|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14141197|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14141198|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14141199|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14141200|NCT05135182|Renal Agents|renal agents|mesh-ancestor
14141201|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14141202|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14141203|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141204|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141205|NCT05135143|Antioxidants|antioxidants|mesh-list
14141206|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141207|NCT05135143|Protective Agents|protective agents|mesh-ancestor
14141208|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764594|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14764595|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14764596|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14764597|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764598|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178428|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14178429|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
14178430|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178431|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178432|NCT04747145|Temozolomide|temozolomide|mesh-list
14178433|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14178434|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
14178435|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141209|NCT05133453|Pirfenidone|pirfenidone|mesh-list
14141210|NCT05133453|Analgesics|analgesics|mesh-ancestor
14141211|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
14141212|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141213|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141214|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14141215|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141216|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141217|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141218|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141219|NCT05125978|Dipyrone|dipyrone|mesh-list
14141220|NCT05125978|Tramadol|tramadol|mesh-list
14141221|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14141222|NCT05125978|Narcotics|narcotics|mesh-ancestor
14141223|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141224|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141225|NCT05125978|Analgesics|analgesics|mesh-ancestor
14141226|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
14141227|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141228|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14141229|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141230|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141231|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141232|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
14141233|NCT05125796|Acetaminophen|acetaminophen|mesh-list
14141234|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14141235|NCT05125796|Ketoprofen|ketoprofen|mesh-list
14141236|NCT05125796|Lidocaine|lidocaine|mesh-list
14141237|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
14141238|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
14141239|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141240|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141241|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
14141242|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141243|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14141244|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14141245|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14141246|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141247|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141248|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141249|NCT05125796|Analgesics|analgesics|mesh-ancestor
14141250|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
14141251|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14141252|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141253|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141254|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14141255|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141256|NCT05125185|Insulin|insulin|mesh-list
14141257|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14141258|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141259|NCT05306028|Metformin|metformin|mesh-list
14141260|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14141261|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141262|NCT05306002|Antioxidants|antioxidants|mesh-list
14141263|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141264|NCT05306002|Protective Agents|protective agents|mesh-ancestor
14141265|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141266|NCT05305924|Fulvestrant|fulvestrant|mesh-list
14141267|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14141268|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141269|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14141270|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14141271|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
14141272|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141273|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764599|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764600|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764601|NCT00617045|Analgesics|analgesics|mesh-ancestor
14764602|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
14764603|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764604|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
14764605|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14764606|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
14141279|NCT05305898|Metformin|metformin|mesh-list
14141280|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14141281|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141282|NCT05305885|Pemetrexed|pemetrexed|mesh-list
14141283|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141284|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141285|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141286|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14141287|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14141288|NCT05305859|Azacitidine|azacitidine|mesh-list
14141289|NCT05305859|Venetoclax|venetoclax|mesh-list
14141290|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14141291|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
14141292|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141293|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141294|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141295|NCT05305794|Insulin|insulin|mesh-list
14141296|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14141297|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14141298|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141299|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14141300|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14141301|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141302|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141303|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14141304|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141305|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141306|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
14141307|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141308|NCT05305560|Ivermectin|ivermectin|mesh-list
14141309|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14141310|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141311|NCT05305495|Empagliflozin|empagliflozin|mesh-list
14141312|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14141313|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141314|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14141315|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141316|NCT05305456|Vitamins|vitamins|mesh-list
14141317|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
14141318|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
14141319|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141320|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
14141321|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141322|NCT05305456|Protective Agents|protective agents|mesh-ancestor
14141323|NCT05305404|Dexamethasone|dexamethasone|mesh-list
14141324|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
14141325|NCT05305404|BB 1101|bb 1101|mesh-list
14141326|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141327|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
14141328|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
14764607|NCT00617253|Sunitinib|sunitinib|mesh-list
14764608|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764609|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14764610|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14764611|NCT00617253|Growth Substances|growth substances|mesh-ancestor
14764612|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764613|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
14764614|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764615|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764616|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764617|NCT00617370|Paclitaxel|paclitaxel|mesh-list
14764618|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
14764619|NCT00617370|Epirubicin|epirubicin|mesh-list
14764620|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14764621|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764622|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
14764623|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
14764624|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
14764625|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764626|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14764627|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
14141329|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141330|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141331|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141332|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
14141333|NCT05305404|Hormones|hormones|mesh-ancestor
14141334|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141335|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14141336|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141337|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
14141338|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141339|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141340|NCT05305300|Vaccines|vaccines|mesh-list
14141341|NCT05305300|Somatomedin B|somatomedin b|mesh-list
14141342|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
14141343|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141344|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14141345|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14141346|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
14141347|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141348|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141349|NCT05305287|Pioglitazone|pioglitazone|mesh-list
14141350|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14141351|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141352|NCT05305183|Alendronate|alendronate|mesh-list
14141353|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14141354|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141355|NCT05305131|Gemcitabine|gemcitabine|mesh-list
14141356|NCT05305131|Bevacizumab|bevacizumab|mesh-list
14141357|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
14141358|NCT05305131|Cisplatin|cisplatin|mesh-list
14141359|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141360|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141361|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14141362|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14141363|NCT05305131|Growth Substances|growth substances|mesh-ancestor
14141364|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141365|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
14141366|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14141367|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
14141368|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141369|NCT05305131|Antiviral Agents|antiviral agents|mesh-ancestor
14141370|NCT05305131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141371|NCT05305131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141372|NCT05305131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14141373|NCT05305131|Immunologic Factors|immunologic factors|mesh-ancestor
14141374|NCT05305066|Adalimumab|adalimumab|mesh-list
14141375|NCT05305066|Etanercept|etanercept|mesh-list
14141376|NCT05305066|Golimumab|golimumab|mesh-list
14141377|NCT05305066|Upadacitinib|upadacitinib|mesh-list
14141378|NCT05305066|Tofacitinib|tofacitinib|mesh-list
14141379|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141380|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141381|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764628|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764629|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764630|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14764631|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
14764632|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14141382|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141383|NCT05305066|Analgesics|analgesics|mesh-ancestor
14141384|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
14141385|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141386|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141387|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141388|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14141389|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
14141390|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14141391|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141392|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141393|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14141394|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14764633|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14764634|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14141395|NCT05304949|Ranibizumab|ranibizumab|mesh-list
14141396|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14141397|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14141398|NCT05304949|Growth Substances|growth substances|mesh-ancestor
14141399|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141400|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
14141401|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141402|NCT05304871|Cefazolin|cefazolin|mesh-list
14141403|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14141404|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141405|NCT05304845|Aspirin|aspirin|mesh-list
14141406|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14141407|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141408|NCT05304845|Analgesics|analgesics|mesh-ancestor
14141409|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
14141410|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141411|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141412|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141413|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141414|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14141415|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14141416|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141417|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14141418|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14141419|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141420|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
14178436|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183858|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183859|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183860|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14183861|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
14183862|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183863|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183864|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
14183865|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183866|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14183867|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14183868|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
14183869|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14183870|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14183871|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14183872|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183873|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14183874|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183875|NCT04725422|Analgesics|analgesics|mesh-ancestor
14183876|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
14183877|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183878|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14183879|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14183880|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183881|NCT04725214|Temozolomide|temozolomide|mesh-list
14183882|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14183883|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
14183884|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183885|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764635|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14764636|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764637|NCT00617448|Anesthetics|anesthetics|mesh-list
14764638|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764639|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764640|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
14764641|NCT00617474|Hematinics|hematinics|mesh-ancestor
14764642|NCT00617500|Hormones|hormones|mesh-list
14764643|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764644|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764645|NCT00617513|Prucalopride|prucalopride|mesh-list
14764646|NCT00617513|Laxatives|laxatives|mesh-ancestor
14764647|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764648|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14764649|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14764650|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
14764651|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764652|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764653|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764654|NCT00617565|Insulin|insulin|mesh-list
14141421|NCT05304767|Xanomeline|xanomeline|mesh-list
14141422|NCT05304767|Trospium chloride|trospium chloride|mesh-list
14141423|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
14141424|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
14141425|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141426|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141427|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14141428|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14141429|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
14141430|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141431|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141432|NCT05304767|Urological Agents|urological agents|mesh-ancestor
14141433|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14141434|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141435|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14141436|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14141437|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
14141438|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14141439|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141440|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141441|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141442|NCT05304598|Analgesics|analgesics|mesh-ancestor
14141443|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
14141444|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141445|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14141446|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14141447|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14141448|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
14141449|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141450|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141451|NCT05304559|Ketamine|ketamine|mesh-list
14141452|NCT05304559|Esketamine|esketamine|mesh-list
14141453|NCT05304559|Analgesics|analgesics|mesh-ancestor
14141454|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
14141455|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141456|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141457|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14141458|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14141459|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
14141460|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
14141461|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141462|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14141463|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14141464|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141465|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141466|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
14764655|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14764656|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
14764657|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
14764658|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14764659|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764660|NCT00617643|Nevirapine|nevirapine|mesh-list
14764661|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14764662|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764663|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141467|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141468|NCT05304533|Itraconazole|itraconazole|mesh-list
14141469|NCT05304533|Verapamil|verapamil|mesh-list
14141470|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
14141471|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141472|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14141473|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14141474|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141475|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141476|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14141477|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
14141478|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141479|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764664|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764665|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
14141480|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14141481|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14178437|NCT04746430|Dexamethasone|dexamethasone|mesh-list
14764666|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141482|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14141483|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141484|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14141485|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
14141486|NCT05304520|Natalizumab|natalizumab|mesh-list
14141487|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
14141488|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141489|NCT05304468|Cisplatin|cisplatin|mesh-list
14141490|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141491|NCT05304455|Heparin|heparin|mesh-list
14141492|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14141493|NCT05304455|Tinzaparin|tinzaparin|mesh-list
14141494|NCT05304455|Dalteparin|dalteparin|mesh-list
14141495|NCT05304455|Dipyridamole|dipyridamole|mesh-list
14141496|NCT05304455|Apixaban|apixaban|mesh-list
14141497|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
14141498|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14141499|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14141500|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141501|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14764667|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764668|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764669|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14764670|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14764671|NCT00617656|Gemcitabine|gemcitabine|mesh-list
14764672|NCT00617656|Cisplatin|cisplatin|mesh-list
14764673|NCT00617656|Docetaxel|docetaxel|mesh-list
14764674|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764675|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14764676|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
14764677|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764678|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
14764679|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764680|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764681|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14764682|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
14764683|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764684|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
14764685|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
14764686|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
14764687|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
14764688|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14141502|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
14141503|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14141504|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
14764689|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14764690|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
14764691|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141505|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141506|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14141507|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14141508|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
14141509|NCT05304351|Vaccines|vaccines|mesh-list
14141510|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
14141511|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141512|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
14141513|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14141514|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141515|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
14141516|NCT05304273|Letrozole|letrozole|mesh-list
14141517|NCT05304273|Misoprostol|misoprostol|mesh-list
14141518|NCT05304273|Mifepristone|mifepristone|mesh-list
14141519|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141520|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14141521|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14141522|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141523|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141524|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14141525|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
14141526|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141527|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141528|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14141529|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
14141530|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14141531|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14141532|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764692|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141533|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
14141534|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14141535|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14141536|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14141537|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14141538|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
14141539|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14141540|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14141541|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
14141542|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14141543|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14141544|NCT05304169|Leuprolide|leuprolide|mesh-list
14141545|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14141546|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
14141547|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14141548|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141549|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14141550|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141551|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
14141552|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14141553|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
14141554|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141555|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141556|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14141557|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14141558|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14141559|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
14141560|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141561|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141562|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14141563|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
14141564|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
14141565|NCT05304039|Protective Agents|protective agents|mesh-ancestor
14141566|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
14141567|NCT05303987|Propofol|propofol|mesh-list
14141568|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14141569|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141570|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141571|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14141572|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
14141573|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
14141574|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141575|NCT05303987|Analgesics|analgesics|mesh-ancestor
14141576|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
14141577|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141578|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14141579|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14141580|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14141581|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
14141582|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141583|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141584|NCT05303961|Rebamipide|rebamipide|mesh-list
14141585|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14141586|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141587|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
14141588|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141589|NCT05303961|Protective Agents|protective agents|mesh-ancestor
14141590|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141591|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141592|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
14141593|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14141594|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
14141595|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14141596|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
14141597|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141598|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141599|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
14141600|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14141601|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14141602|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14141603|NCT05303688|Analgesics|analgesics|mesh-ancestor
14141604|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
14141605|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141606|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141607|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141608|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141609|NCT05303597|Lidocaine|lidocaine|mesh-list
14141610|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
14141611|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
14141612|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141613|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141614|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
14141615|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141616|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14141617|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14141618|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14141619|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141620|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141621|NCT05303532|Durvalumab|durvalumab|mesh-list
14141622|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141623|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764693|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764694|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
14764695|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14764696|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14764697|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
14764698|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141624|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
14141625|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
14141626|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141627|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14141628|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141629|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14141630|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
14141631|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141632|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
14764699|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764700|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764701|NCT00617760|Vaccines|vaccines|mesh-list
14764702|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14764703|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
14141633|NCT05303272|Abatacept|abatacept|mesh-list
14141634|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14141635|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141636|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14141637|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
14141638|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14141639|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141640|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141641|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141642|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14141643|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14141644|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
14141645|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764704|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764705|NCT00617799|Aldesleukin|aldesleukin|mesh-list
14764706|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764707|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764708|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764709|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
14764710|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764711|NCT00617877|Losartan|losartan|mesh-list
14764712|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14764713|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14764714|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14764715|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14764716|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14764717|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764718|NCT00617877|Diuretics|diuretics|mesh-ancestor
14937115|NCT01473303|Leucovorin|leucovorin|mesh-list
14141646|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141647|NCT05303259|Bevacizumab|bevacizumab|mesh-list
14141648|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141649|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141650|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14141651|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14937116|NCT01473303|Fluorouracil|fluorouracil|mesh-list
14937117|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
14764719|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
14764720|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764721|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14764722|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764723|NCT00617955|Aprotinin|aprotinin|mesh-list
14764724|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764725|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
14764726|NCT00617955|Coagulants|coagulants|mesh-ancestor
14764727|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14764728|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14764729|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
14141652|NCT05303259|Growth Substances|growth substances|mesh-ancestor
14141653|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141654|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
14141655|NCT05303220|Branebrutinib|branebrutinib|mesh-list
14141656|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14141657|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141658|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141659|NCT05303090|Lenvatinib|lenvatinib|mesh-list
14141660|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141661|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14141662|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141663|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178438|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178439|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
14178440|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
14178441|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178442|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178443|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178444|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
14178445|NCT04746430|Hormones|hormones|mesh-ancestor
14178446|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178447|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14178448|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178449|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
14178450|NCT04746365|Ivermectin|ivermectin|mesh-list
14178451|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
14178452|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14178453|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14178454|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178455|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178456|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178457|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14178458|NCT04746339|Apixaban|apixaban|mesh-list
14178459|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14178460|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
14178461|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14178462|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
14178463|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178464|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178465|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
14178466|NCT04746209|Blinatumomab|blinatumomab|mesh-list
14178467|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178468|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
14178469|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14178470|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178471|NCT04746040|Fluticasone|fluticasone|mesh-list
14178472|NCT04746040|Xhance|xhance|mesh-list
14178473|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14178474|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14178475|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178476|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14178477|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
14178478|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178479|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178480|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14178481|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
14178482|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
14178483|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14178484|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14178485|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14178486|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14178487|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
14178488|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178489|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141664|NCT05303064|Olanzapine|olanzapine|mesh-list
14141665|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
14141666|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
14141667|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141668|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141669|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141670|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14141671|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14141672|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141673|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141674|NCT05303064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14141675|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14141676|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141677|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141678|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141679|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
14141680|NCT05302999|Gabapentin|gabapentin|mesh-list
14141681|NCT05302999|Analgesics|analgesics|mesh-ancestor
14141682|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
14141683|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141684|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141685|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
14141686|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14141687|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14141688|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141689|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141690|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14141691|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14141692|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141693|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141694|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
14141695|NCT05302921|Nivolumab|nivolumab|mesh-list
14141696|NCT05302921|Ipilimumab|ipilimumab|mesh-list
14141697|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141698|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141699|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14141700|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141701|NCT05302856|Antibodies|antibodies|mesh-list
14141702|NCT05302856|Testosterone|testosterone|mesh-list
14141703|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
14141704|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141705|NCT05302856|Androgens|androgens|mesh-ancestor
14141706|NCT05302856|Hormones|hormones|mesh-ancestor
14141707|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764730|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764731|NCT00617968|Docetaxel|docetaxel|mesh-list
14764732|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141708|NCT05302817|Xenon|xenon|mesh-list
14141709|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14141710|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
14141711|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
14141712|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141713|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141714|NCT05302726|Estrogens|estrogens|mesh-list
14141715|NCT05302726|Hormones|hormones|mesh-ancestor
14141716|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141717|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141718|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
14141719|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
14141720|NCT05302713|Calcium|calcium|mesh-list
14141721|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14141722|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141723|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14141724|NCT05302713|Antacids|antacids|mesh-ancestor
14141725|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141726|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141727|NCT05302531|Amoxicillin|amoxicillin|mesh-list
14141728|NCT05302531|Levofloxacin|levofloxacin|mesh-list
14141729|NCT05302531|Ofloxacin|ofloxacin|mesh-list
14141730|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14141731|NCT05302531|Trimethoprim|trimethoprim|mesh-list
14141732|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
14141733|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14141734|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14141735|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14764733|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
14141736|NCT05302531|Renal Agents|renal agents|mesh-ancestor
14141737|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14141738|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14141739|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141740|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141741|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141742|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14141743|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14141744|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
14764734|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
14141745|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14141746|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14141747|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14141748|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14141749|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14141750|NCT05302466|Silicon|silicon|mesh-list
14141751|NCT05302466|Trace Elements|trace elements|mesh-ancestor
14141752|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
14141753|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141754|NCT05302271|Prednisone|prednisone|mesh-list
14141755|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141756|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
14141757|NCT05302271|Hormones|hormones|mesh-ancestor
14141758|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141759|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141760|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14141761|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141762|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14141763|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
14141764|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14141765|NCT05302232|Prednisolone|prednisolone|mesh-list
14141766|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
14141767|NCT05302232|Lidocaine|lidocaine|mesh-list
14141768|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14141769|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
14141770|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
14141771|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
14141772|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141773|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764735|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
14764736|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937118|NCT01473303|Irinotecan|irinotecan|mesh-list
14764737|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
14764738|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
14764739|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14764740|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14764741|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14764742|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764743|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14764744|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14764745|NCT00618059|Pilocarpine|pilocarpine|mesh-list
14764746|NCT00618059|Miotics|miotics|mesh-ancestor
14764747|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
14764748|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764749|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764750|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14764751|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14764752|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
14764753|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764754|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764755|NCT00618111|Granisetron|granisetron|mesh-list
14764756|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
14764757|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
14764758|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764759|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764760|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764761|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14764762|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
14764763|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764764|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764765|NCT00618124|Capecitabine|capecitabine|mesh-list
14764766|NCT00618124|Sunitinib|sunitinib|mesh-list
14937119|NCT01473303|Calcium|calcium|mesh-list
14141774|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
14141775|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937120|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
14141776|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14141777|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14141778|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14141779|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141780|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141781|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14141782|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
14141783|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
14141784|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141785|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
14141786|NCT05302232|Hormones|hormones|mesh-ancestor
14141787|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14141788|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14141789|NCT05302232|Protective Agents|protective agents|mesh-ancestor
14141790|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14141791|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141792|NCT05301660|Nicotine|nicotine|mesh-list
14141793|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14141794|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
14141795|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141796|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141797|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14141798|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14141799|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
14141800|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141801|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141802|NCT05301634|Bupivacaine|bupivacaine|mesh-list
14141803|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
14141804|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
14141805|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141806|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141807|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
14141808|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141809|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
14141810|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14141811|NCT05287984|Rituximab|rituximab|mesh-list
14141812|NCT05287984|Fludarabine|fludarabine|mesh-list
14141813|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
14141814|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14141815|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
14937121|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14937122|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937123|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
14937124|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937125|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937126|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937127|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937128|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
14937129|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14937130|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14937131|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937132|NCT01473303|Antidotes|antidotes|mesh-ancestor
14141816|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141817|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141818|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14141819|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
14141820|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141821|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141822|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14141823|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141824|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14141825|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141826|NCT05287308|Paclitaxel|paclitaxel|mesh-list
14141827|NCT05287308|Docetaxel|docetaxel|mesh-list
14141828|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14141829|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
14141830|NCT05287308|Doxorubicin|doxorubicin|mesh-list
14141831|NCT05287308|Epirubicin|epirubicin|mesh-list
14141832|NCT05287308|Pirarubicin|pirarubicin|mesh-list
14141833|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14141834|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141835|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
14141836|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
14141837|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
14141838|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141839|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14141840|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
14141841|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764767|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937133|NCT01473303|Protective Agents|protective agents|mesh-ancestor
14937134|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
14937135|NCT01473303|Vitamins|vitamins|mesh-ancestor
14937136|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
14937137|NCT01473316|Ketoconazole|ketoconazole|mesh-list
14937138|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
14937139|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937140|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14937141|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14937142|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937143|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937144|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14937145|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
14937146|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937147|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937148|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14938740|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14764768|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
14764769|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764770|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764771|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14764772|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14764773|NCT00618124|Growth Substances|growth substances|mesh-ancestor
14764774|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764775|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
14764776|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764777|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764778|NCT00618163|Meloxicam|meloxicam|mesh-list
14764779|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764780|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14764781|NCT00618163|Analgesics|analgesics|mesh-ancestor
14764782|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
14764783|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764784|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764785|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764786|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764787|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14764788|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14764789|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938741|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938742|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14938743|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938744|NCT01483859|Liver Extracts|liver extracts|mesh-list
14938745|NCT01483859|Hematinics|hematinics|mesh-ancestor
14938746|NCT01483911|Gontivimab|gontivimab|mesh-list
14938747|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
14938748|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937149|NCT01473472|Tenofovir|tenofovir|mesh-list
14937150|NCT01473472|Emtricitabine|emtricitabine|mesh-list
14937151|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14141842|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14141843|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14141844|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
14141845|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14141846|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14141847|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14937152|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
14937153|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937154|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14937155|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14937156|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141848|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14141849|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141852|NCT05285800|Bupivacaine|bupivacaine|mesh-list
14141853|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
14141854|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
14141855|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141856|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141857|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
14141858|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178490|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
14178491|NCT04746040|Hormones|hormones|mesh-ancestor
14178492|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178493|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
14178494|NCT04745780|Inositol|inositol|mesh-list
14178495|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
14178496|NCT04745780|Vitamins|vitamins|mesh-ancestor
14178497|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
14178498|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178499|NCT04745663|Iodine|iodine|mesh-list
14178500|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
14178501|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
14178502|NCT04745663|Povidone|povidone|mesh-list
14178503|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14178504|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178505|NCT04745663|Trace Elements|trace elements|mesh-ancestor
14937157|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937158|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14937159|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14937160|NCT01473537|Calcium|calcium|mesh-list
14937161|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14937162|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937163|NCT01473628|Rituximab|rituximab|mesh-list
14178506|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
14178507|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178508|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
14178509|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
14178510|NCT04745260|Fentanyl|fentanyl|mesh-list
14178511|NCT04745260|Midazolam|midazolam|mesh-list
14178512|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14178513|NCT04745260|Narcotics|narcotics|mesh-ancestor
14178514|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178515|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178516|NCT04745260|Analgesics|analgesics|mesh-ancestor
14178517|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
14178518|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178519|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14178520|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14178521|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
14178522|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
14178523|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14178524|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14178525|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14178526|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14178527|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
14937164|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14937165|NCT01473628|Antibodies|antibodies|mesh-list
14178528|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
14178529|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178530|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178531|NCT04745286|Ketamine|ketamine|mesh-list
14178532|NCT04745286|Esketamine|esketamine|mesh-list
14178533|NCT04745286|Analgesics|analgesics|mesh-ancestor
14937166|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
14937167|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14937168|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
14937169|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937170|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937171|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14937172|NCT01473797|Cladribine|cladribine|mesh-list
14937173|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937174|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937175|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
14937176|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141859|NCT05284656|Folic Acid|folic acid|mesh-list
14141860|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
14141861|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
14141862|NCT05284656|Hematinics|hematinics|mesh-ancestor
14141863|NCT05284656|Vitamins|vitamins|mesh-ancestor
14141864|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
14141865|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141866|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14141867|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141868|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141869|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14141870|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14141871|NCT05284656|Protective Agents|protective agents|mesh-ancestor
14141872|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
14141873|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14141874|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
14141875|NCT05284474|Mitogens|mitogens|mesh-list
14141876|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
14141877|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141878|NCT05283356|Ticagrelor|ticagrelor|mesh-list
14141879|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14141880|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14141881|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14141882|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14141883|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
14141884|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141885|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141886|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141887|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
14141888|NCT05282901|Lenvatinib|lenvatinib|mesh-list
14141889|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14141890|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141891|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14141892|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141893|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141894|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
14141895|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14141896|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14141897|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141898|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141899|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
14141900|NCT05281562|Vitamins|vitamins|mesh-ancestor
14141901|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
14141902|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141903|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
14141904|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141905|NCT05281562|Protective Agents|protective agents|mesh-ancestor
14141906|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14141907|NCT05281549|Tenecteplase|tenecteplase|mesh-list
14141908|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14141909|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14141910|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141911|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
14141912|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141913|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141914|NCT05277922|Nitroprusside|nitroprusside|mesh-list
14141915|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14141916|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
14141917|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14141918|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141919|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14141920|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
14141921|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937177|NCT01473810|Endocine|endocine|mesh-list
14141922|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141923|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
14141924|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141925|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141926|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14141927|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14141928|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141929|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
14141930|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
14141931|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
14141932|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14141933|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14141934|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141935|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141936|NCT05275725|Urological Agents|urological agents|mesh-ancestor
14141937|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
14141938|NCT05271084|Dexetimide|dexetimide|mesh-list
14141939|NCT05271084|Citalopram|citalopram|mesh-list
14141940|NCT05271084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14141941|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14141942|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14141943|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141944|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141945|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
14141946|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141947|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14141948|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
14141949|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141950|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14141951|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14141952|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
14141953|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
14141954|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141955|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14141956|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14141957|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
14141958|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14141959|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14141960|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14141961|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14141962|NCT05271084|Protective Agents|protective agents|mesh-ancestor
14141963|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
14141964|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14141965|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
14141966|NCT05268614|Cisplatin|cisplatin|mesh-list
14141967|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764790|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764791|NCT00618176|Lamivudine|lamivudine|mesh-list
14764792|NCT00618176|Zidovudine|zidovudine|mesh-list
14764793|NCT00618176|Nevirapine|nevirapine|mesh-list
14764794|NCT00618176|Stavudine|stavudine|mesh-list
14764795|NCT00618176|Didanosine|didanosine|mesh-list
14764796|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14764797|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764798|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764799|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764800|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
14764801|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764802|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764803|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764804|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
14764805|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14764806|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14764807|NCT00618202|Balsalazide|balsalazide|mesh-list
14764808|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764809|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14764810|NCT00618202|Analgesics|analgesics|mesh-ancestor
14764811|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
14764812|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764813|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938749|NCT01484015|Cefepime|cefepime|mesh-list
14141971|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
14141972|NCT05265507|Ondansetron|ondansetron|mesh-list
14141973|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
14141974|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
14141975|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14141976|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141977|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14141978|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
14141979|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
14141980|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14141981|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
14141982|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14141983|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14141984|NCT05265507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14141985|NCT05265507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14141986|NCT05265507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141987|NCT05265507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14141988|NCT05265507|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14141989|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14141990|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14141991|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14141992|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
14141993|NCT05265052|Oxycodone|oxycodone|mesh-list
14141994|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14141995|NCT05265052|Narcotics|narcotics|mesh-ancestor
14141996|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14141997|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14141998|NCT05265052|Analgesics|analgesics|mesh-ancestor
14141999|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
14142000|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142001|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14142002|NCT05263388|Hormones|hormones|mesh-ancestor
14142003|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142004|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764814|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764815|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764816|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764817|NCT00618228|Balsalazide|balsalazide|mesh-list
14764818|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764819|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14764820|NCT00618228|Analgesics|analgesics|mesh-ancestor
14764821|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
14764822|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764823|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764824|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764825|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14142017|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
14142018|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142019|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142020|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
14142021|NCT05257655|Narcotics|narcotics|mesh-ancestor
14142022|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142023|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142024|NCT05257655|Analgesics|analgesics|mesh-ancestor
14142025|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
14142026|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142027|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
14142028|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14142029|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
14142030|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
14764826|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764827|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
14764828|NCT00618241|Lamotrigine|lamotrigine|mesh-list
14764829|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14764830|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764831|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
14764832|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764833|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14764834|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14764835|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764836|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764837|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
14764838|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14142031|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764839|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14142032|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142033|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14142034|NCT05255146|Analgesics|analgesics|mesh-ancestor
14142035|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
14142036|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142039|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
14142040|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142041|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142042|NCT05245006|Antibodies|antibodies|mesh-list
14142043|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
14142044|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
14142045|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178534|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
14178535|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178536|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178537|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14178538|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14178539|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
14178540|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
14178541|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178542|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14178543|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14178544|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178545|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178546|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
14178547|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14178548|NCT04745273|Ondansetron|ondansetron|mesh-list
14178549|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
14178550|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
14178551|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764840|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14764841|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764842|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14764843|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14764844|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764845|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14764846|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14764847|NCT00618254|Granisetron|granisetron|mesh-list
14764848|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
14764849|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
14764850|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764851|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764852|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14764853|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14764854|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
14764855|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764856|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178552|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178553|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178554|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
14178555|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
14178556|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14178557|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
14178558|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178559|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178560|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14178561|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14178562|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178563|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14178564|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14178565|NCT04745442|Antithrombins|antithrombins|mesh-list
14178566|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
14178567|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14178568|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
14178569|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178570|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178571|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
14178572|NCT04745377|Antibodies|antibodies|mesh-list
14178573|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
14178574|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178575|NCT04744883|Naloxone|naloxone|mesh-list
14764857|NCT00618280|Nicotine|nicotine|mesh-list
14142046|NCT05243342|Daratumumab|daratumumab|mesh-list
14142047|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142048|NCT05243186|Methylphenidate|methylphenidate|mesh-list
14142049|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14142050|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142051|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14142052|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14142053|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14142054|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142055|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
14142056|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142057|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14142058|NCT05239468|Bezafibrate|bezafibrate|mesh-list
14142059|NCT05239468|Cathartics|cathartics|mesh-ancestor
14142060|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14142061|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14142062|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
14142063|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142064|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14142065|NCT05239169|Capecitabine|capecitabine|mesh-list
14142066|NCT05239169|Durvalumab|durvalumab|mesh-list
14142067|NCT05239169|Tremelimumab|tremelimumab|mesh-list
14142068|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14142069|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
14142070|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142071|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142072|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142073|NCT05239091|Lidocaine|lidocaine|mesh-list
14142074|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
14142075|NCT05239091|Anesthetics|anesthetics|mesh-list
14142076|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142077|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142078|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
14142079|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142080|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14142081|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14142082|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14142083|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14142084|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142085|NCT05237726|Heparin|heparin|mesh-list
14142086|NCT05237726|Enoxaparin|enoxaparin|mesh-list
14142087|NCT05237726|Calcium heparin|calcium heparin|mesh-list
14142088|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
14142089|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
14142090|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14142091|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14142092|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142093|NCT05236530|Metformin|metformin|mesh-list
14142094|NCT05236530|Repaglinide|repaglinide|mesh-list
14142095|NCT05236530|Lumefantrine|lumefantrine|mesh-list
14142096|NCT05236530|Dolutegravir|dolutegravir|mesh-list
14142097|NCT05236530|Midazolam|midazolam|mesh-list
14142098|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
14142099|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14142100|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142101|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142102|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14142103|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14142104|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142105|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14142106|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14937178|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14142107|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14142108|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14142109|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
14142110|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
14142111|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
14142112|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
14142113|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142114|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142115|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14142116|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14142117|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
14142118|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14142119|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14142120|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937179|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
14937180|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937181|NCT01473901|Temozolomide|temozolomide|mesh-list
14937182|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14937183|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
14937184|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937185|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937186|NCT01473914|Vitamins|vitamins|mesh-list
14937187|NCT01473914|Vitamin E|vitamin e|mesh-list
14937188|NCT01473914|Tocopherols|tocopherols|mesh-list
14937189|NCT01473914|Tocotrienols|tocotrienols|mesh-list
14937190|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
14937191|NCT01473914|Zinc|zinc|mesh-list
14937192|NCT01473914|Selenium|selenium|mesh-list
14937193|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
14937194|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937195|NCT01473914|Trace Elements|trace elements|mesh-ancestor
14937196|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
14937197|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937198|NCT01473914|Protective Agents|protective agents|mesh-ancestor
14937199|NCT01474174|Vaccines|vaccines|mesh-list
14937200|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
14937201|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937202|NCT01474187|Capecitabine|capecitabine|mesh-list
14937203|NCT01474187|Irinotecan|irinotecan|mesh-list
14142121|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
14142122|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14142123|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14937204|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937205|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
14764858|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14764859|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
14764860|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764861|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764862|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14764863|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14937206|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937207|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954527|NCT03196154|Insulin|insulin|mesh-list
13954528|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13954529|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954530|NCT03195634|Carvedilol|carvedilol|mesh-list
14142124|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142125|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14142126|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14142127|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14142128|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14764864|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
14764865|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954531|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13954532|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13954533|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
13954534|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954535|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954536|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954537|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13954538|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
13954539|NCT03195634|Protective Agents|protective agents|mesh-ancestor
13954540|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13954541|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954542|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13954543|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
13954544|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13954545|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13954546|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
13954547|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13954548|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13954549|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954550|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
13954551|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
13954552|NCT03195569|Paclitaxel|paclitaxel|mesh-list
13954553|NCT03195569|Bevacizumab|bevacizumab|mesh-list
13954554|NCT03195569|Carboplatin|carboplatin|mesh-list
14937208|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14937209|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14937210|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937211|NCT01474265|Varenicline|varenicline|mesh-list
14142129|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
14142130|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
14142131|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
14142132|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14142133|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14937212|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14937213|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14764866|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764867|NCT00618345|Everolimus|everolimus|mesh-list
14764868|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764869|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14764870|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
14764871|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764872|NCT00618358|Thrombin|thrombin|mesh-list
14764873|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14764874|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
14764875|NCT00618358|Coagulants|coagulants|mesh-ancestor
14764876|NCT00618384|Sorafenib|sorafenib|mesh-list
14764877|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764878|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764879|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764880|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142156|NCT05229055|Ketamine|ketamine|mesh-list
14142157|NCT05229055|Analgesics|analgesics|mesh-ancestor
14142158|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
14142159|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142160|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142161|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14142162|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14142163|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
14142164|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
14142165|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142166|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14142167|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14142168|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142169|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142170|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
14142171|NCT05217758|Mifepristone|mifepristone|mesh-list
14142172|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14142173|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
14142174|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14142175|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142176|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14937214|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
14937215|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142177|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14142178|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14142179|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
14142180|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14764881|NCT00618397|Ketamine|ketamine|mesh-list
14764882|NCT00618397|Analgesics|analgesics|mesh-ancestor
14764883|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
14937216|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142181|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14142182|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
14142183|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142184|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
14142185|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14142186|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14142187|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
14142188|NCT05217446|Cetuximab|cetuximab|mesh-list
14142189|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142190|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142191|NCT05216770|Bupivacaine|bupivacaine|mesh-list
14142192|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
14142193|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
14142194|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142195|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142196|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
14142197|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954555|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13954556|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954557|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
14142222|NCT05205499|Sirolimus|sirolimus|mesh-list
14142223|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14142224|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954558|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
13954559|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
13954560|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954561|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954562|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14142225|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14764884|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764885|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764886|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14142226|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142227|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
14142228|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14142229|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
14142230|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142231|NCT05200286|Olorofim|olorofim|mesh-list
14142232|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
14142233|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142234|NCT05192798|Paclitaxel|paclitaxel|mesh-list
14142235|NCT05192798|Bevacizumab|bevacizumab|mesh-list
14764887|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14764888|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
14764889|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
14764890|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764891|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14764892|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14764893|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764894|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764895|NCT00618423|Ketamine|ketamine|mesh-list
14764896|NCT00618423|Analgesics|analgesics|mesh-ancestor
14764897|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
14764898|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764899|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764900|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14764901|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14764902|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
14764903|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
14764904|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764905|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14764906|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14764907|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764908|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937217|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937218|NCT01474304|Acetaminophen|acetaminophen|mesh-list
14937219|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937220|NCT01474304|Analgesics|analgesics|mesh-ancestor
14937221|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
14142236|NCT05192798|Apatinib|apatinib|mesh-list
14142237|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14142238|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14142239|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142240|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14142241|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14142242|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14937222|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937223|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937224|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
14937225|NCT01474330|Pomalidomide|pomalidomide|mesh-list
14937226|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
14937227|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937228|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14937229|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14937230|NCT01474330|Growth Substances|growth substances|mesh-ancestor
14937231|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14937232|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937233|NCT01474382|Phentolamine|phentolamine|mesh-list
14937234|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14937235|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14937236|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937237|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142243|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142244|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142245|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14142246|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14142247|NCT05192798|Growth Substances|growth substances|mesh-ancestor
14142248|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142249|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
14142250|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14142251|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142252|NCT05191225|Rituximab|rituximab|mesh-list
14142253|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142254|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142255|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
14142256|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142257|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14142258|NCT05185167|Propofol|propofol|mesh-list
14142259|NCT05185167|Anesthetics|anesthetics|mesh-list
14142260|NCT05185167|Desflurane|desflurane|mesh-list
14142261|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
14142262|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14142263|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142264|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142265|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14142266|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14142267|NCT05185089|Maleic acid|maleic acid|mesh-list
14142268|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142269|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142270|NCT05182931|Trametinib|trametinib|mesh-list
14142271|NCT05182931|Dabrafenib|dabrafenib|mesh-list
14142272|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142273|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14142274|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142275|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142276|NCT05179421|Oxytocin|oxytocin|mesh-list
14142277|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
14142278|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14142279|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142280|NCT05176483|Nivolumab|nivolumab|mesh-list
14142281|NCT05176483|Ipilimumab|ipilimumab|mesh-list
14142282|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142283|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142284|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14142285|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142286|NCT05173896|Tadalafil|tadalafil|mesh-list
14142287|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
14142288|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14142289|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14142290|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142291|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142292|NCT05173896|Urological Agents|urological agents|mesh-ancestor
14142293|NCT05171075|Dalteparin|dalteparin|mesh-list
14142294|NCT05171075|Tinzaparin|tinzaparin|mesh-list
14142295|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14142296|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
14142297|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14142298|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14142299|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142300|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14142301|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
14142302|NCT05169658|Antibodies|antibodies|mesh-list
14142303|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
14142304|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14142305|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
14142306|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14142307|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
14142308|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142309|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178576|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14178577|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178578|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
14178579|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178580|NCT04745130|Cetuximab|cetuximab|mesh-list
14178581|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178582|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178583|NCT04744753|Calcium|calcium|mesh-list
14178584|NCT04744753|Ionophores|ionophores|mesh-list
14178585|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
14178586|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14178587|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178588|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14178589|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183886|NCT04725201|Heparin|heparin|mesh-list
14183887|NCT04725201|Calcium heparin|calcium heparin|mesh-list
14183888|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
14183889|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14183890|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14183891|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183892|NCT04724655|Mineral Oil|mineral oil|mesh-list
14183893|NCT04724655|Emollients|emollients|mesh-ancestor
14183894|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
14764909|NCT00618501|Leucovorin|leucovorin|mesh-list
14183895|NCT04724759|Lidocaine|lidocaine|mesh-list
14183896|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
14183897|NCT04724759|Ketamine|ketamine|mesh-list
14764910|NCT00618501|Cytarabine|cytarabine|mesh-list
13954563|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13954564|NCT03195569|Growth Substances|growth substances|mesh-ancestor
13954565|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954566|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
13954567|NCT03195946|Midazolam|midazolam|mesh-list
14142310|NCT05168930|Venetoclax|venetoclax|mesh-list
14142311|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
14142312|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142313|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14142314|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142315|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142323|NCT05133674|Tamoxifen|tamoxifen|mesh-list
14142324|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14142325|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
14142326|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142327|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142328|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14142329|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142330|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14142331|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14142332|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14142333|NCT05128617|Paclitaxel|paclitaxel|mesh-list
14142334|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
14142335|NCT05128617|Epirubicin|epirubicin|mesh-list
14142336|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14142337|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142338|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
14142339|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
14142340|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
14142341|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142342|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14142343|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
14142344|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142345|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14142346|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13954568|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13954569|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13954570|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142347|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
14142348|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14142349|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14142350|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14142351|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14142352|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142353|NCT05128344|Vigabatrin|vigabatrin|mesh-list
14142354|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
14142355|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142356|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142357|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
14142358|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142359|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142360|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
14142361|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142362|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142363|NCT05121168|Bupivacaine|bupivacaine|mesh-list
14142364|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
14142365|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
14142366|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142367|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142368|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
14764911|NCT00618501|Prednisolone|prednisolone|mesh-list
14142369|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142370|NCT05118945|Insulin|insulin|mesh-list
14764912|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
14142371|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14142372|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142373|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142374|NCT05117489|Cortisone|cortisone|mesh-list
14142375|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764913|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14764914|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14764915|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14764916|NCT00618501|Methotrexate|methotrexate|mesh-list
14142380|NCT05111821|Deferiprone|deferiprone|mesh-list
14142381|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14142382|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
14142383|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
14142384|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142385|NCT05108649|Nicotine|nicotine|mesh-list
14142386|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14142387|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
14142388|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142389|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142390|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14142391|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14142392|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
14142393|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142394|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142407|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
14142408|NCT05101629|Lenvatinib|lenvatinib|mesh-list
14142409|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142410|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142411|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14142412|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142413|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764917|NCT00618501|Etoposide|etoposide|mesh-list
14764918|NCT00618501|Vincristine|vincristine|mesh-list
14764919|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
14764920|NCT00618501|Daunorubicin|daunorubicin|mesh-list
14764921|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
14764922|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764923|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14764924|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
14764925|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14764926|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937238|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142414|NCT05100862|Rituximab|rituximab|mesh-list
14142415|NCT05100862|Lenalidomide|lenalidomide|mesh-list
14142416|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
14142417|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142418|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142419|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
14142420|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142421|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14142422|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14142423|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14142424|NCT05100862|Growth Substances|growth substances|mesh-ancestor
14142425|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
14142426|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14142427|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142428|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142429|NCT05099913|Flupenthixol|flupenthixol|mesh-list
14937239|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937240|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14142430|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14142431|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14142432|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764927|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
14937241|NCT01474460|Vitamin K|vitamin k|mesh-list
14937242|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
14937243|NCT01474460|Vitamins|vitamins|mesh-ancestor
14937244|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
14937245|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937246|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14937247|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14937248|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937249|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
14937250|NCT01474460|Coagulants|coagulants|mesh-ancestor
14937251|NCT01474473|Calpastatin|calpastatin|mesh-list
14937252|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14142433|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142434|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14142435|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14142436|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
14142437|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142438|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142439|NCT05097274|Choline|choline|mesh-list
14142440|NCT05097274|Lipotropic Agents|lipotropic agents|mesh-ancestor
14142441|NCT05097274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14142442|NCT05097274|Antimetabolites|antimetabolites|mesh-ancestor
14142443|NCT05097274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142444|NCT05097274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14142445|NCT05097274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14142446|NCT05097274|Nootropic Agents|nootropic agents|mesh-ancestor
14142447|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14142448|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14142449|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14142450|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14142451|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14142452|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142453|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
14142454|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142455|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142456|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14142457|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142458|NCT05095116|Fluticasone|fluticasone|mesh-list
14142459|NCT05095116|Xhance|xhance|mesh-list
14142460|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14142461|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14142462|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
14142463|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142464|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142465|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14142466|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
14142467|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
14142468|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14142471|NCT05084651|Itraconazole|itraconazole|mesh-list
14142472|NCT05084651|Lumefantrine|lumefantrine|mesh-list
14142473|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
14142474|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937253|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
14142475|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14142476|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14142477|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142478|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142479|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14142480|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
14142481|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142482|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142483|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14142484|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
14142485|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14142486|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14178590|NCT04744727|Acetaminophen|acetaminophen|mesh-list
14178591|NCT04744727|Meperidine|meperidine|mesh-list
14178592|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14178593|NCT04744727|Analgesics|analgesics|mesh-ancestor
14178594|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
14178595|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178596|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178597|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
14178598|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14178599|NCT04744727|Narcotics|narcotics|mesh-ancestor
14178600|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178601|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14178602|NCT04744649|Fluorouracil|fluorouracil|mesh-list
14178603|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
14178604|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178605|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14178606|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178607|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14178608|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
14937254|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937255|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142487|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
14142488|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142489|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142490|NCT05083312|Fluticasone|fluticasone|mesh-list
14142491|NCT05083312|Xhance|xhance|mesh-list
14142492|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14142493|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14142494|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
13954571|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954572|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13954573|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13954574|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13954575|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13954576|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
13954577|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
14142495|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142496|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142497|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14142498|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14142499|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14142500|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14142503|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
14142504|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142505|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142506|NCT05066308|Cannabidiol|cannabidiol|mesh-list
14142507|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
14142508|NCT05065957|Capecitabine|capecitabine|mesh-list
14142509|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14142510|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
14142511|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142512|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142513|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
14142514|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142515|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142516|NCT05049057|Erenumab|erenumab|mesh-list
14142517|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14142518|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142519|NCT05049057|Analgesics|analgesics|mesh-ancestor
14142520|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
14142521|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142522|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142523|NCT05044962|Rilpivirine|rilpivirine|mesh-list
14142524|NCT05044962|Cabotegravir|cabotegravir|mesh-list
14142525|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14142526|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
14142527|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
14142528|NCT05044962|Etonogestrel|etonogestrel|mesh-list
14142529|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14142530|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
14142531|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14142532|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142533|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14142534|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14142535|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14142536|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14142537|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14142538|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14142539|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142540|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14142541|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14142542|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142543|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937256|NCT01474499|Sorbitol|sorbitol|mesh-list
13954578|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
13954579|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
13954580|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954581|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954582|NCT03195673|Terazosin|terazosin|mesh-list
13954583|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13954584|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14142544|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
14142545|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142546|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14142547|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14142548|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14142549|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14142550|NCT05043714|Nivolumab|nivolumab|mesh-list
14142551|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142552|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142553|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14142554|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142555|NCT05036278|Factor VIII|factor viii|mesh-list
14142556|NCT05036278|Coagulants|coagulants|mesh-ancestor
14142557|NCT05029999|Doxorubicin|doxorubicin|mesh-list
14142558|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14142559|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14142560|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142561|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14142562|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14142563|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142564|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142565|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
14142566|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
14142567|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142568|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14142569|NCT05019222|Anesthetics|anesthetics|mesh-list
14142570|NCT05019222|Sevoflurane|sevoflurane|mesh-list
14142571|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142572|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142573|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14142574|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14142575|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
14142576|NCT05010148|Lidocaine|lidocaine|mesh-list
14142577|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
14142578|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
14142579|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142580|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142581|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
14142582|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142583|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14142584|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14142585|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14142586|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14142587|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937257|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14937258|NCT01474499|Glycerol|glycerol|mesh-list
14142591|NCT05004896|Midazolam|midazolam|mesh-list
14142592|NCT05004896|Ketamine|ketamine|mesh-list
14142593|NCT05004896|Analgesics|analgesics|mesh-ancestor
14142594|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
14142595|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142596|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142597|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14142598|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14142599|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
14142600|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
14142601|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142602|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14142603|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14142604|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142605|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142606|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14142607|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14142608|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14142609|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14142610|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14142611|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
14142612|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
14764928|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764929|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764930|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
14937259|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14937260|NCT01474499|Protective Agents|protective agents|mesh-ancestor
14937261|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937262|NCT01474499|Cathartics|cathartics|mesh-ancestor
14142642|NCT04989660|Phenol|phenol|mesh-list
14142643|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14142644|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142645|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
14142646|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14142647|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14178609|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178610|NCT04744675|Triamcinolone|triamcinolone|mesh-list
14178611|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14178612|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14178613|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14178614|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178615|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
14178616|NCT04744675|Hormones|hormones|mesh-ancestor
14178617|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178618|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178619|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14178620|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
14178621|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178622|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178623|NCT04744480|Anesthetics|anesthetics|mesh-list
14178624|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178625|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178626|NCT04744545|Curcumin|curcumin|mesh-list
14178627|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14178628|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14178629|NCT04744545|Analgesics|analgesics|mesh-ancestor
14178630|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
14178631|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178632|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178633|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178634|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14178635|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178636|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178637|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178638|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14178639|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178640|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
14178641|NCT04744623|Dapsone|dapsone|mesh-list
14178642|NCT04744623|Prednisolone|prednisolone|mesh-list
14178643|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14178644|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
14178645|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14178646|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
14178647|NCT04744623|Triamcinolone|triamcinolone|mesh-list
14178648|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14178649|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14178650|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14178651|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14178652|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
14178653|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14178654|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178655|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14142656|NCT04969237|Vitamin D|vitamin d|mesh-list
14142657|NCT04969237|Vitamins|vitamins|mesh-ancestor
14142658|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
14142659|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142660|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14142661|NCT04965454|Choline|choline|mesh-list
14142662|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
14142663|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14142664|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
14142665|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142666|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14142667|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14142668|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
14142671|NCT04953962|Nivolumab|nivolumab|mesh-list
14142672|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142673|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142674|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14142675|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142676|NCT04952727|Vaccines|vaccines|mesh-list
14142677|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
14142678|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142679|NCT04951986|Levofloxacin|levofloxacin|mesh-list
14142680|NCT04951986|Ofloxacin|ofloxacin|mesh-list
14142681|NCT04951986|Rifampin|rifampin|mesh-list
14142682|NCT04951986|Isoniazid|isoniazid|mesh-list
14142683|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
14142684|NCT04951986|Ethambutol|ethambutol|mesh-list
14142685|NCT04951986|Prednisone|prednisone|mesh-list
14142686|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14142687|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
14142688|NCT04951986|Hormones|hormones|mesh-ancestor
14142689|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142690|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142691|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14142692|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142693|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14142694|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142695|NCT04951986|Renal Agents|renal agents|mesh-ancestor
14142696|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14142697|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14142698|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14142699|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142700|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142701|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14142702|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14142703|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14142704|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
14764931|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14764932|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14764933|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14764934|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
14142705|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
14142706|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14142707|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14142708|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14183898|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
14142709|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14142710|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14142711|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14142712|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14142713|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14142714|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14142715|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
14142716|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14142717|NCT04943679|Interferons|interferons|mesh-list
14142718|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
14142719|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142720|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
14142721|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142722|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
14142723|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142724|NCT04939987|Acetaminophen|acetaminophen|mesh-list
14142725|NCT04939987|Ketorolac|ketorolac|mesh-list
14142726|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14142727|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14142728|NCT04939987|Ketamine|ketamine|mesh-list
14142729|NCT04939987|Oxycodone|oxycodone|mesh-list
14142730|NCT04939987|Gabapentin|gabapentin|mesh-list
14142731|NCT04939987|Tramadol|tramadol|mesh-list
14142732|NCT04939987|Hydrocodone|hydrocodone|mesh-list
14142733|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
14142734|NCT04939987|Analgesics|analgesics|mesh-ancestor
14142735|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
14142736|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142737|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142738|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14142739|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14142740|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
14142741|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
14142742|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142743|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14142744|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14142745|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142746|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142747|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14142748|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
14142749|NCT04939987|Narcotics|narcotics|mesh-ancestor
14142750|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
14142751|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14142752|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14142753|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14142754|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
14142755|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14142756|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14142757|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14142758|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14142759|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142760|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
14142761|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
14142762|NCT04939792|Vitamin D|vitamin d|mesh-list
14142763|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
14142764|NCT04939792|Vitamins|vitamins|mesh-list
14142765|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
14142766|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142767|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14142768|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14142769|NCT04938557|Insulin|insulin|mesh-list
14142770|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14142771|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142772|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478707|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
14478708|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478709|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478710|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478711|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
14478712|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14142773|NCT04933526|Dasatinib|dasatinib|mesh-list
14142774|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
14142775|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142776|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14142777|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142778|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142779|NCT04931017|Metformin|metformin|mesh-list
14142780|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142781|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142782|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
14142783|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14142784|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
14142785|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142786|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14142787|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14142788|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
14142789|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142790|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142791|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14142792|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
14142793|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14142794|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
14142795|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14142796|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
14142797|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142798|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142799|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
14142800|NCT04900038|Lamivudine|lamivudine|mesh-list
14142801|NCT04900038|Dolutegravir|dolutegravir|mesh-list
14142802|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14142803|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14142804|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142805|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142806|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
14142807|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142808|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14142809|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14142810|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14142811|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14142812|NCT04895280|Triamcinolone|triamcinolone|mesh-list
14142813|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14142814|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14142815|NCT04895280|Ketorolac|ketorolac|mesh-list
14142816|NCT04895280|Bupivacaine|bupivacaine|mesh-list
14142817|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14142818|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
14142819|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
14142820|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142821|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142822|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
14142823|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142824|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14142825|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
14142826|NCT04895280|Hormones|hormones|mesh-ancestor
14142827|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142828|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14142829|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
14142830|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142831|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142832|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14142833|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14764935|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764936|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14764937|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14478713|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14478714|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
14478715|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478716|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478717|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14478718|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14478719|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478720|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14478721|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14478722|NCT02456740|Erenumab|erenumab|mesh-list
14142834|NCT04895280|Analgesics|analgesics|mesh-ancestor
14479275|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764938|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14764939|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14764940|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
14764941|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937263|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937264|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
14937265|NCT01474642|Capecitabine|capecitabine|mesh-list
14937266|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937267|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937268|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
14937269|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937270|NCT01474902|Enoxaparin|enoxaparin|mesh-list
14142835|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14764942|NCT00618501|Antidotes|antidotes|mesh-ancestor
14764943|NCT00618501|Protective Agents|protective agents|mesh-ancestor
14764944|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
14764945|NCT00618501|Vitamins|vitamins|mesh-ancestor
14142836|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14142837|NCT04892459|Vaccines|vaccines|mesh-list
14142838|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
14142839|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142840|NCT04892446|Dexamethasone|dexamethasone|mesh-list
14142841|NCT04892446|Bortezomib|bortezomib|mesh-list
14142842|NCT04892446|Daratumumab|daratumumab|mesh-list
14142843|NCT04892446|Pomalidomide|pomalidomide|mesh-list
14142844|NCT04892446|Magrolimab|magrolimab|mesh-list
14142845|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14142846|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
14142847|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
14142848|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142849|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142850|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14142851|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
14142852|NCT04892446|Hormones|hormones|mesh-ancestor
14764946|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
14764947|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
14764948|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
14764949|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
14764950|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14764951|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
14764952|NCT00618501|Hormones|hormones|mesh-ancestor
14764953|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14764954|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14764955|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14764956|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14764957|NCT00618527|Interferons|interferons|mesh-list
14764958|NCT00618527|Interferon-beta|interferon-beta|mesh-list
14142853|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142854|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14142855|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142856|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
14142857|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14142858|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14142859|NCT04892446|Growth Substances|growth substances|mesh-ancestor
14142860|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
14142861|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14937271|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
14937272|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14937273|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14937274|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937275|NCT01474967|Metformin|metformin|mesh-list
14937276|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14937277|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937278|NCT01475019|Orlistat|orlistat|mesh-list
14937279|NCT01475019|Sibutramine|sibutramine|mesh-list
14937280|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937281|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937282|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14937283|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14937284|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
14764959|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
14937285|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14142864|NCT04881539|Cannabidiol|cannabidiol|mesh-list
14142865|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
14764960|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
14764961|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937286|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
14937287|NCT01475032|Beclomethasone|beclomethasone|mesh-list
14142866|NCT04880278|Nabilone|nabilone|mesh-list
14142867|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
14142868|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
14142869|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142870|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142871|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14142872|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14764962|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
14764963|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14764964|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14764965|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14764966|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
14764967|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14764968|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142873|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14142874|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142875|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14142876|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
14142877|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14142878|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178656|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
14178657|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14178658|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178659|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178660|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764969|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764970|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
14764971|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764972|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14764973|NCT00618579|Warfarin|warfarin|mesh-list
14178661|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178662|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
14178663|NCT04744623|Hormones|hormones|mesh-ancestor
14178664|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178665|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178666|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14178667|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
14764974|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
14764975|NCT00618631|Carfentanil|carfentanil|mesh-list
14764976|NCT00618631|Nicotine|nicotine|mesh-list
14764977|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14764978|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
14764979|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14764980|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764981|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14764982|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14764983|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
14764984|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14764985|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14764986|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14937288|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
14937289|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14178668|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
14178669|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178670|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14178671|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14178672|NCT04744623|Protective Agents|protective agents|mesh-ancestor
14178673|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14178674|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
14178675|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
14178676|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14178677|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14178678|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14178679|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
14178680|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14178681|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14178682|NCT04744571|Aspirin|aspirin|mesh-list
14178683|NCT04744571|Metoprolol|metoprolol|mesh-list
14178684|NCT04744571|Clopidogrel|clopidogrel|mesh-list
14178685|NCT04744571|Ticagrelor|ticagrelor|mesh-list
14178686|NCT04744571|Atorvastatin|atorvastatin|mesh-list
14178687|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14178688|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14764987|NCT00618631|Narcotics|narcotics|mesh-ancestor
14178689|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14178690|NCT04744571|Analgesics|analgesics|mesh-ancestor
14937290|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
14142879|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
14142880|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14142881|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
14142882|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142883|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14142884|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14142885|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
14142886|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14142887|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142888|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14142889|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14142890|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
14142891|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14764988|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14764989|NCT00618631|Analgesics|analgesics|mesh-ancestor
14764990|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
14764991|NCT00618644|Ranibizumab|ranibizumab|mesh-list
14764992|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14142897|NCT04852887|Tamoxifen|tamoxifen|mesh-list
14142898|NCT04852887|Letrozole|letrozole|mesh-list
14142899|NCT04852887|Exemestane|exemestane|mesh-list
14142900|NCT04852887|Anastrozole|anastrozole|mesh-list
14142901|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142902|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14142903|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14142904|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142905|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142906|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14142907|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
14142908|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14142909|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142910|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14142911|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14142912|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14142913|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14764993|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14764994|NCT00618644|Growth Substances|growth substances|mesh-ancestor
14764995|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142917|NCT04850846|Metformin|metformin|mesh-list
14142918|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142919|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142920|NCT04835506|Infliximab|infliximab|mesh-list
14142921|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
14764996|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
14764997|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14764998|NCT00618657|Paclitaxel|paclitaxel|mesh-list
14764999|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14765000|NCT00618657|Bevacizumab|bevacizumab|mesh-list
14765001|NCT00618657|Carboplatin|carboplatin|mesh-list
14765002|NCT00618657|Trastuzumab|trastuzumab|mesh-list
14765003|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14765004|NCT00618657|Antibodies|antibodies|mesh-list
14765005|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
14765006|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14142922|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14142923|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14142924|NCT04820686|Tenofovir|tenofovir|mesh-list
14142925|NCT04820686|Entecavir|entecavir|mesh-list
14142926|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
14142927|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14142928|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14142929|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14142930|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142931|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142932|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14142933|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14142934|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14142935|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14142936|NCT04813614|Lidocaine|lidocaine|mesh-list
14142937|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
14142938|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
14142939|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142940|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142941|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
14765007|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14765008|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142942|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142943|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14142944|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14142945|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14142946|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954585|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13954586|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
14142947|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142948|NCT04813562|Vaccines|vaccines|mesh-list
14142949|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
14142950|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142951|NCT04809285|Insulin|insulin|mesh-list
14142952|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142953|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954587|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954588|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954589|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954590|NCT03195673|Urological Agents|urological agents|mesh-ancestor
13954591|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
14142954|NCT04800393|Propofol|propofol|mesh-list
14142955|NCT04800393|Sevoflurane|sevoflurane|mesh-list
14142956|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14142957|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14142958|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142959|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14142960|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
14765009|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
14142961|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
14142962|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14142963|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14142964|NCT04796012|Irinotecan|irinotecan|mesh-list
14142965|NCT04796012|Vincristine|vincristine|mesh-list
14142966|NCT04796012|Temozolomide|temozolomide|mesh-list
14142967|NCT04796012|Atezolizumab|atezolizumab|mesh-list
14142968|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14142969|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14142970|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14142971|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142972|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14142973|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14142974|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14142975|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14142976|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14142977|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14142978|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
14142979|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
14142980|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14142981|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
14142982|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14142983|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142984|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14142985|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14142986|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14142987|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
14142988|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
14178691|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
14479276|NCT02467504|Folic Acid|folic acid|mesh-list
14765010|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
14765011|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14765012|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765013|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14937291|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14142989|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14142990|NCT04783792|Protective Agents|protective agents|mesh-ancestor
14142991|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142992|NCT04783792|Vitamins|vitamins|mesh-ancestor
14142993|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
14142994|NCT04770532|Insulin|insulin|mesh-list
14142995|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14142996|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14142997|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14142998|NCT04762680|Vaccines|vaccines|mesh-list
14142999|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
14143000|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178692|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178693|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178694|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178695|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14178696|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14178697|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14178698|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178699|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14178700|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14178701|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178702|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
14178703|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14937292|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937293|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14937294|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
14937295|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14937296|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14178704|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14178705|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
14178706|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14178707|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14178708|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14178709|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14178710|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14178711|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
14178712|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178713|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14178714|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14178715|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
14178716|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
14178717|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14178718|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14178719|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14178720|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
14178721|NCT04743934|Androgens|androgens|mesh-list
14178722|NCT04743934|Hormones|hormones|mesh-ancestor
14178723|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178724|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178725|NCT04743739|Cyclosporine|cyclosporine|mesh-list
14178726|NCT04743739|Rituximab|rituximab|mesh-list
14178727|NCT04743739|Cyclosporins|cyclosporins|mesh-list
14183899|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
14143001|NCT04757662|Tadalafil|tadalafil|mesh-list
14143002|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
14143003|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14143004|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14143005|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143006|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143007|NCT04757662|Urological Agents|urological agents|mesh-ancestor
14143008|NCT04750070|Dopamine|dopamine|mesh-list
14143009|NCT04750070|Epinephrine|epinephrine|mesh-list
14143010|NCT04750070|Racepinephrine|racepinephrine|mesh-list
14143011|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
14143012|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14143013|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14143014|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
14143015|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143016|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143017|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143018|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14143019|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14143020|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
14143021|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143022|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14143023|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
14143024|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
14143025|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
14143026|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14143027|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14143028|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
14143029|NCT04750070|Protective Agents|protective agents|mesh-ancestor
14143030|NCT04748523|Mirtazapine|mirtazapine|mesh-list
14143031|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
14143032|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14143033|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14143034|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
14143035|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
14143036|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143037|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143038|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143039|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14765014|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14765015|NCT00618657|Growth Substances|growth substances|mesh-ancestor
14765016|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143040|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14143041|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143042|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14143043|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14143044|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14143045|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14143046|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14143047|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14765017|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14765018|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
14767408|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767409|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14143048|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
14143049|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14143050|NCT04744363|Ustekinumab|ustekinumab|mesh-list
14143051|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
14767410|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14937297|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937298|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937299|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937300|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937301|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14143052|NCT04741334|Anticoagulants|anticoagulants|mesh-list
14143053|NCT04741334|Dicumarol|dicumarol|mesh-list
14767411|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14767412|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767413|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767414|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
14767415|NCT00629928|Esomeprazole|esomeprazole|mesh-list
14767416|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14143054|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14143055|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767417|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14143056|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143057|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
14143058|NCT04734028|Aspirin|aspirin|mesh-list
14143059|NCT04734028|Clopidogrel|clopidogrel|mesh-list
14143060|NCT04734028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14143061|NCT04734028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14143062|NCT04734028|Analgesics|analgesics|mesh-ancestor
14143063|NCT04734028|Sensory System Agents|sensory system agents|mesh-ancestor
14143064|NCT04734028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143065|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143066|NCT04734028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14143067|NCT04734028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143068|NCT04734028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14143069|NCT04734028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14143070|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143071|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14143072|NCT04734028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14143073|NCT04734028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143074|NCT04734028|Antipyretics|antipyretics|mesh-ancestor
14143075|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14143076|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14143077|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14143078|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
14143079|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937302|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
14937303|NCT01475032|Hormones|hormones|mesh-ancestor
14937304|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937305|NCT01475227|Zinc|zinc|mesh-list
14937306|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
14143080|NCT04732195|Pilocarpine|pilocarpine|mesh-list
14143081|NCT04732195|Miotics|miotics|mesh-ancestor
14143082|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
14143083|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143084|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143085|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14143086|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14143087|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
14143088|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143089|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143090|NCT04719221|Evolocumab|evolocumab|mesh-list
14143091|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14143092|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14143093|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
14143094|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143095|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14143096|NCT04712903|Carboplatin|carboplatin|mesh-list
14143097|NCT04712903|Etoposide|etoposide|mesh-list
14143098|NCT04712903|Durvalumab|durvalumab|mesh-list
14143099|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143100|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14143101|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14143102|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14143103|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143104|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143105|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143106|NCT04710134|Reslizumab|reslizumab|mesh-list
14143107|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14143108|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
14143109|NCT04698057|Amoxicillin|amoxicillin|mesh-list
14143110|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
14143111|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
14143112|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
14143113|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14143114|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14143115|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143116|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14143117|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14143118|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143119|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143120|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143121|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14143122|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14937307|NCT01475227|Trace Elements|trace elements|mesh-ancestor
14937308|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
14143123|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14143124|NCT04696757|Capecitabine|capecitabine|mesh-list
14143125|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14143126|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
14143127|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143128|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143129|NCT04686799|Doxycycline|doxycycline|mesh-list
14143130|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14143131|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143132|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
14143133|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14143134|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14143135|NCT04684589|Tadalafil|tadalafil|mesh-list
14143136|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
14143137|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14143138|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14765019|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14765020|NCT00618696|Antibodies|antibodies|mesh-list
14765021|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
13954592|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14143139|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143140|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143141|NCT04684589|Urological Agents|urological agents|mesh-ancestor
14143142|NCT04682834|Probenecid|probenecid|mesh-list
14143143|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
14143144|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
14143145|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143146|NCT04682834|Renal Agents|renal agents|mesh-ancestor
14143147|NCT04682743|Acetaminophen|acetaminophen|mesh-list
14143148|NCT04682743|Ondansetron|ondansetron|mesh-list
14143149|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14143150|NCT04682743|Analgesics|analgesics|mesh-ancestor
14143151|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
14143152|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143153|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143154|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
14143155|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
14143156|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
14143157|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14143158|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
14143159|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
14143160|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14143161|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
14143162|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143163|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143164|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14143165|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14143166|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143167|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14143168|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14143169|NCT04681677|Bevacizumab|bevacizumab|mesh-list
14143170|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143171|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143172|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14143173|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14143174|NCT04681677|Growth Substances|growth substances|mesh-ancestor
14143175|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143176|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
14765022|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13954593|NCT03195543|Thrombin|thrombin|mesh-list
13954594|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
13954595|NCT03195543|Coagulants|coagulants|mesh-ancestor
13954596|NCT03195530|Propofol|propofol|mesh-list
13954597|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13954598|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954599|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954600|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13954601|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
13954602|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
13954603|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
13954604|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
13954605|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13954606|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13954607|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
13954608|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954609|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14143177|NCT04676646|Spironolactone|spironolactone|mesh-list
13954610|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14143178|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14143179|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14143180|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14143181|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143182|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14143183|NCT04676646|Diuretics|diuretics|mesh-ancestor
14143184|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
14143187|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
14143188|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14143189|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143190|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143191|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14143192|NCT04656470|Analgesics|analgesics|mesh-ancestor
14143193|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
14143194|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143195|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14143196|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14143197|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14143198|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14143199|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143200|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143201|NCT04647500|Methylphenidate|methylphenidate|mesh-list
14143202|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14143203|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143204|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14143205|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14143206|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14143207|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143208|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
14143209|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765023|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
14765024|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765025|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765026|NCT00618852|Furosemide|furosemide|mesh-list
14765027|NCT00618852|Diuretics|diuretics|mesh-ancestor
14765028|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
14765029|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765030|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14143218|NCT04640402|Vaccines|vaccines|mesh-list
14143219|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
14143220|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178728|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178729|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178730|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
14178731|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178732|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14178733|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178734|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178735|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14178736|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
14178737|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178738|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
14178739|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14178740|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
14178741|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178742|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14178743|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178744|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178745|NCT04743544|Voriconazole|voriconazole|mesh-list
14765031|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765032|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765033|NCT00618969|Busulfan|busulfan|mesh-list
14765034|NCT00618969|Melphalan|melphalan|mesh-list
14765035|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
14765036|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765037|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765038|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
14765039|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765040|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14765041|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143221|NCT04636333|Vaccines|vaccines|mesh-list
14143222|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
14143223|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143226|NCT04623216|Azacitidine|azacitidine|mesh-list
14143227|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13954611|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954612|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954613|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13954614|NCT03195491|Nivolumab|nivolumab|mesh-list
13954615|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954616|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143228|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
14143229|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143230|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143231|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143232|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
14143233|NCT04621526|Ketamine|ketamine|mesh-list
14143234|NCT04621526|Propofol|propofol|mesh-list
14143235|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14143236|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143237|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143238|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14143239|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
14143240|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
14143241|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14143242|NCT04621526|Analgesics|analgesics|mesh-ancestor
14143243|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
14143244|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143245|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14143246|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14143247|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14143248|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
14143249|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143250|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143251|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14143252|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14143253|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14143254|NCT04616014|Insulin|insulin|mesh-list
14143255|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14143256|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14765042|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14765043|NCT00619021|Gemcitabine|gemcitabine|mesh-list
14765044|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14765045|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
14143257|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143258|NCT04609111|Aspirin|aspirin|mesh-list
14143259|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14143260|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14143261|NCT04609111|Analgesics|analgesics|mesh-ancestor
14143262|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
14143263|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143264|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143265|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14143266|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143267|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14143268|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14143269|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143270|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14765046|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765047|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765048|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
14765049|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765050|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954617|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13954618|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954619|NCT03195413|Lidocaine|lidocaine|mesh-list
13954620|NCT03195413|Epinephrine|epinephrine|mesh-list
13954621|NCT03195413|Racepinephrine|racepinephrine|mesh-list
13954622|NCT03195413|Bupivacaine|bupivacaine|mesh-list
13954623|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
14765051|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765052|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
14765053|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765054|NCT00619034|Diclofenac|diclofenac|mesh-list
14765055|NCT00619034|Dorzolamide|dorzolamide|mesh-list
14765056|NCT00619034|Latanoprost|latanoprost|mesh-list
14765057|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14765058|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14765059|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765060|NCT00619034|Analgesics|analgesics|mesh-ancestor
14765061|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
14765062|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765063|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765064|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14765065|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765066|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14143271|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14143272|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143273|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
14143274|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
14143275|NCT04601857|Futibatinib|futibatinib|mesh-list
14143276|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143277|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143281|NCT04597437|Zanamivir|zanamivir|mesh-list
14143282|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
14143283|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143284|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143285|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143308|NCT04566991|Deferoxamine|deferoxamine|mesh-list
14143309|NCT04566991|Siderophores|siderophores|mesh-ancestor
14143310|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14143311|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
14143312|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
14143313|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143314|NCT04560595|Caffeine|caffeine|mesh-list
14143315|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14143316|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143317|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14143318|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143319|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143320|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14143321|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14143322|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
14143323|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143324|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
14143325|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
14143326|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143327|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143328|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14143329|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765067|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143330|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143331|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
14143332|NCT04545411|Volagidemab|volagidemab|mesh-list
14143333|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14765068|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765069|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14765070|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14765071|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14765072|NCT00619203|Acetaminophen|acetaminophen|mesh-list
14765073|NCT00619203|Glycerol|glycerol|mesh-list
14765074|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765075|NCT00619203|Analgesics|analgesics|mesh-ancestor
14765076|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
14765077|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765078|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765079|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
14765080|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14765081|NCT00619203|Protective Agents|protective agents|mesh-ancestor
14765082|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
14765083|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14937309|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937310|NCT01475227|Astringents|astringents|mesh-ancestor
14937311|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
14937312|NCT01475266|Apaziquone|apaziquone|mesh-list
14937313|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143334|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143335|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14143336|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143343|NCT04530656|Vaccines|vaccines|mesh-list
14143344|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
14143345|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143346|NCT04529278|Liraglutide|liraglutide|mesh-list
14143347|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14143348|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143349|NCT04529278|Incretins|incretins|mesh-ancestor
14143350|NCT04529278|Hormones|hormones|mesh-ancestor
14143351|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14143352|NCT04518410|Gabexate|gabexate|mesh-list
14143353|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
14143354|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14765084|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765085|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14765086|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
14765087|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14765088|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765089|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765090|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765091|NCT00619268|Interferons|interferons|mesh-list
14765092|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
14765093|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
14765094|NCT00619268|Sirolimus|sirolimus|mesh-list
14143355|NCT04518410|Antibodies|antibodies|mesh-list
14143356|NCT04518410|Camostat|camostat|mesh-list
14143357|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
14143358|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143359|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
14143360|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143361|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143362|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14143363|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14143364|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
14143365|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14143366|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765095|NCT00619268|Bevacizumab|bevacizumab|mesh-list
14937314|NCT01475279|Warfarin|warfarin|mesh-list
14765096|NCT00619268|Sunitinib|sunitinib|mesh-list
14937315|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
14937316|NCT01475318|Letrozole|letrozole|mesh-list
14937317|NCT01475318|Misoprostol|misoprostol|mesh-list
14937318|NCT01475318|Mifepristone|mifepristone|mesh-list
14937319|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937320|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14178746|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
14178747|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178748|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14178749|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14178750|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178751|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178752|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14178753|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
14178754|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178755|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178756|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14178757|NCT04743622|Latanoprost|latanoprost|mesh-list
14178758|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14178759|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14178760|NCT04743180|Paclitaxel|paclitaxel|mesh-list
14178761|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14178762|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178763|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
14178764|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
14178765|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
14178766|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178767|NCT04743011|Heparin|heparin|mesh-list
14178768|NCT04743011|Calcium heparin|calcium heparin|mesh-list
14178769|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14178770|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
14178771|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14178772|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14178773|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178774|NCT04743297|Dinoprostone|dinoprostone|mesh-list
14178775|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
14178776|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14178777|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178778|NCT04743063|Losartan|losartan|mesh-list
14178779|NCT04743063|Valsartan|valsartan|mesh-list
14178780|NCT04743063|Telmisartan|telmisartan|mesh-list
14178781|NCT04743063|Candesartan|candesartan|mesh-list
14178782|NCT04743063|Olmesartan|olmesartan|mesh-list
14178783|NCT04743063|Irbesartan|irbesartan|mesh-list
14937321|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14937322|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937323|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937324|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14937325|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
14937326|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178784|NCT04743063|Eprosartan|eprosartan|mesh-list
14178785|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
14178786|NCT04743063|Giapreza|giapreza|mesh-list
14178787|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14178788|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
14178789|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14178790|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14178791|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178792|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14178793|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14178794|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14178795|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
14178796|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178797|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14178798|NCT04743193|Sevoflurane|sevoflurane|mesh-list
14178799|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
14937327|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143374|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
14143375|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143376|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
14143377|NCT04499196|Hormones|hormones|mesh-ancestor
14143378|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14143379|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143380|NCT04493216|Dolutegravir|dolutegravir|mesh-list
14143381|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14143382|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14143383|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143384|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143385|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14143386|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14143387|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
14143388|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143389|NCT04484337|Cabotegravir|cabotegravir|mesh-list
14143390|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14143391|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14143392|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14143393|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14143394|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143395|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143396|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14143397|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14143398|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
14143399|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143400|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14143401|NCT04484337|Analgesics|analgesics|mesh-ancestor
14143402|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
14143403|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143404|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143405|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143406|NCT04481919|Diuretics|diuretics|mesh-list
14143407|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
14143408|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143409|NCT04464174|Gemcitabine|gemcitabine|mesh-list
14143410|NCT04464174|Carboplatin|carboplatin|mesh-list
14143411|NCT04464174|Capecitabine|capecitabine|mesh-list
14143412|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143413|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14143414|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
14143415|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143416|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
14143417|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143418|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143419|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143420|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
14143421|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143422|NCT04460352|Leucovorin|leucovorin|mesh-list
14143423|NCT04460352|Paclitaxel|paclitaxel|mesh-list
14143424|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14143425|NCT04460352|Carboplatin|carboplatin|mesh-list
14143426|NCT04460352|Fluorouracil|fluorouracil|mesh-list
14143427|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
14143428|NCT04460352|Calcium|calcium|mesh-list
14143429|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
14143430|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14143431|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143432|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
14143433|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
14143434|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
14143435|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143436|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14143437|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143438|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
14143439|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14143440|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143441|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
14143442|NCT04460352|Antidotes|antidotes|mesh-ancestor
14143443|NCT04460352|Protective Agents|protective agents|mesh-ancestor
14143444|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
14143445|NCT04460352|Vitamins|vitamins|mesh-ancestor
14765097|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14765098|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765099|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14765100|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14765101|NCT00619268|Growth Substances|growth substances|mesh-ancestor
14143446|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
14143447|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14143448|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143449|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143450|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14143457|NCT04451187|Zopiclone|zopiclone|mesh-list
14143458|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14143459|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143460|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143461|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
14143462|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143463|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143464|NCT04446117|Prednisone|prednisone|mesh-list
14143465|NCT04446117|Atezolizumab|atezolizumab|mesh-list
14143466|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
14143467|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14143468|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
14143469|NCT04446117|Hormones|hormones|mesh-ancestor
14143470|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954624|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
13954625|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
13954626|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954627|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954628|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
13954629|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954630|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14143471|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143472|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14143473|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143474|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14143475|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143476|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143477|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
14143478|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14143479|NCT04440735|Atezolizumab|atezolizumab|mesh-list
14143480|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143481|NCT04430452|Durvalumab|durvalumab|mesh-list
14143482|NCT04430452|Ipilimumab|ipilimumab|mesh-list
14143483|NCT04430452|Tremelimumab|tremelimumab|mesh-list
14143484|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
14143485|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14143486|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
14143487|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143488|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143489|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
14143490|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954631|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13954632|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14143491|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13954633|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954634|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954635|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14143492|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143493|NCT04428008|Thymalfasin|thymalfasin|mesh-list
14143494|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14143495|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
14143496|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143497|NCT04408560|Acetaminophen|acetaminophen|mesh-list
14143498|NCT04408560|Analgesics|analgesics|mesh-list
14143499|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14143500|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
14143501|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143502|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143503|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
14937328|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14937329|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
14937330|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14937331|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14937332|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937333|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
14937334|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14937335|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14143504|NCT04398914|Paclitaxel|paclitaxel|mesh-list
14143505|NCT04398914|Trastuzumab|trastuzumab|mesh-list
14143506|NCT04398914|Pertuzumab|pertuzumab|mesh-list
14143507|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14143508|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143509|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14143510|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14143511|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14143512|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143513|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143514|NCT04398134|Entecavir|entecavir|mesh-list
14143515|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
14143516|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143517|NCT04390399|Leucovorin|leucovorin|mesh-list
14143518|NCT04390399|Gemcitabine|gemcitabine|mesh-list
14143519|NCT04390399|Paclitaxel|paclitaxel|mesh-list
14143520|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
14143521|NCT04390399|Fluorouracil|fluorouracil|mesh-list
14478723|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14478724|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478725|NCT02456740|Analgesics|analgesics|mesh-ancestor
14478726|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
14478727|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478728|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478729|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
14478730|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
14478731|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14478732|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14478733|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14478734|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478735|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14478736|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14478737|NCT02456909|Morphine|morphine|mesh-list
14478738|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14478739|NCT02456909|Narcotics|narcotics|mesh-ancestor
14478740|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478741|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478742|NCT02456909|Analgesics|analgesics|mesh-ancestor
14478743|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
14478744|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478745|NCT02457195|Granisetron|granisetron|mesh-list
14478746|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
14478747|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
14478748|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478749|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478750|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478751|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14478752|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
14478753|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478754|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937336|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14937337|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14143522|NCT04390399|Irinotecan|irinotecan|mesh-list
14143523|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14765102|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765103|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
14765104|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
14765105|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765106|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
14765107|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765108|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765109|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765110|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14765111|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14765112|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
14765113|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765114|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14765115|NCT00619333|Hormones|hormones|mesh-ancestor
14765116|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14765117|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765118|NCT00619346|Pafuramidine|pafuramidine|mesh-list
14765119|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14765120|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14765121|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14765122|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765123|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
14143524|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143525|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
14143526|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
14143527|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14143528|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143529|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143530|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
14143531|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143532|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143533|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14143534|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
14143535|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14143536|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14143537|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
14143538|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
14143539|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143540|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143541|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14143542|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14143543|NCT04390399|Antidotes|antidotes|mesh-ancestor
14143544|NCT04390399|Protective Agents|protective agents|mesh-ancestor
14143545|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
14143546|NCT04390399|Vitamins|vitamins|mesh-ancestor
14143547|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
14143548|NCT04388163|Gentian Violet|gentian violet|mesh-list
14143549|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14143550|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143551|NCT04382664|Nivolumab|nivolumab|mesh-list
14143552|NCT04382664|Ipilimumab|ipilimumab|mesh-list
14143553|NCT04382664|Sargramostim|sargramostim|mesh-list
14143554|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143555|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143556|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14143557|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143558|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
14143559|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143560|NCT04374578|Dulaglutide|dulaglutide|mesh-list
14143561|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14143562|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143563|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
14143564|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143565|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143566|NCT04354012|Gentian Violet|gentian violet|mesh-list
14143567|NCT04354012|Methylene Blue|methylene blue|mesh-list
14143568|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143569|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143570|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14143571|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143572|NCT04351555|Carboplatin|carboplatin|mesh-list
14765124|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
14765125|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765126|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143573|NCT04351555|Pemetrexed|pemetrexed|mesh-list
14143574|NCT04351555|Osimertinib|osimertinib|mesh-list
14765127|NCT00619398|Tacrolimus|tacrolimus|mesh-list
14765128|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765129|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
14765130|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765131|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14765132|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765133|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765134|NCT00619424|Pemetrexed|pemetrexed|mesh-list
14765135|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14765136|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765137|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765138|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765139|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14765140|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14765141|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14143575|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143576|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143577|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143578|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14143579|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14143580|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14143581|NCT04348032|Apatinib|apatinib|mesh-list
14143582|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143583|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14143584|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143585|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178800|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178801|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178802|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14178803|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14178804|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
14183900|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183901|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183902|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
14183903|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183904|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14183905|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14183906|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14183907|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14183908|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183909|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14183910|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14183911|NCT04724759|Analgesics|analgesics|mesh-ancestor
14183912|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14183913|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14183914|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14183915|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
14183916|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14183917|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14183918|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14183919|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
14183920|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14765142|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
14765143|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13954636|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13954637|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
13954638|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954639|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13954640|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13954641|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
13954642|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13954643|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
13954644|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
13954645|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
13954646|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13954647|NCT03195205|Antibodies|antibodies|mesh-list
13954648|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
13954649|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954650|NCT03195257|Glucagon|glucagon|mesh-list
13954651|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
13954652|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13954653|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13954654|NCT03195257|Hormones|hormones|mesh-ancestor
14143594|NCT04332744|Talazoparib|talazoparib|mesh-list
14143595|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14143596|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143597|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143598|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143603|NCT04301310|Rifampin|rifampin|mesh-list
14143604|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14143605|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
14143606|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14143607|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143608|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
14765144|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765145|NCT00619541|Fluorouracil|fluorouracil|mesh-list
14143609|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14143610|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143611|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143612|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14143613|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14143614|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14143615|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14143616|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14143617|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14765146|NCT00619541|Sorafenib|sorafenib|mesh-list
14765147|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
14765148|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765149|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14765150|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765151|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143624|NCT04288687|Niraparib|niraparib|mesh-list
14765152|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
14765153|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765154|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765155|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765156|NCT00619671|Rituximab|rituximab|mesh-list
14765157|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14765158|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765159|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
14765160|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765161|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765162|NCT00619697|Insulin|insulin|mesh-list
14765163|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14765164|NCT00619697|Metformin|metformin|mesh-list
14765165|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
14765166|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
14765167|NCT00619697|Glimepiride|glimepiride|mesh-list
14765168|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
14937338|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
14143625|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14765169|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14765170|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14765171|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937339|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14937340|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14937341|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
14937342|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14937343|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14938750|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14938751|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938752|NCT01484080|Paclitaxel|paclitaxel|mesh-list
14143626|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143627|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143628|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143629|NCT04286295|Nicotine|nicotine|mesh-list
14143630|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14143631|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
14143632|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143633|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143634|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14143635|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14143636|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
14143637|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143638|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143639|NCT04285229|Ixekizumab|ixekizumab|mesh-list
14143640|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
14143641|NCT04282629|Milrinone|milrinone|mesh-list
14143642|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14143643|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14143644|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14143645|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14143646|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14143647|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143648|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143649|NCT04282629|Protective Agents|protective agents|mesh-ancestor
14143650|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143651|NCT04280939|Anesthetics|anesthetics|mesh-list
14143652|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143653|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143654|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
14143655|NCT04277975|Narcotics|narcotics|mesh-ancestor
14143656|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143657|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143658|NCT04277975|Analgesics|analgesics|mesh-ancestor
14143659|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
14143660|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765172|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14765173|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765174|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
14765175|NCT00619710|Meropenem|meropenem|mesh-list
14765176|NCT00619710|Imipenem|imipenem|mesh-list
14143666|NCT04273165|Etravirine|etravirine|mesh-list
14143667|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14143668|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14143669|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143670|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143671|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
14143672|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143673|NCT04272801|Tamoxifen|tamoxifen|mesh-list
14143674|NCT04272801|Letrozole|letrozole|mesh-list
14143675|NCT04272801|Anastrozole|anastrozole|mesh-list
14143676|NCT04272801|Exemestane|exemestane|mesh-list
14143677|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143678|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14143679|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14143680|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143681|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143682|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14143683|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
14143684|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14143685|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143686|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14143687|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14143688|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14143689|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14765177|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14765178|NCT00619710|Cilastatin|cilastatin|mesh-list
14765179|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14765180|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765181|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
14937344|NCT01475552|Aspirin|aspirin|mesh-list
14765182|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937345|NCT01475552|Abciximab|abciximab|mesh-list
14937346|NCT01475552|Clopidogrel|clopidogrel|mesh-list
14765183|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937347|NCT01475552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14143695|NCT04259645|Bupivacaine|bupivacaine|mesh-list
14143696|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
14143697|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
14143698|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143699|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143700|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
14143701|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143702|NCT04258150|Nivolumab|nivolumab|mesh-list
14143703|NCT04258150|Ipilimumab|ipilimumab|mesh-list
14143704|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143705|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143706|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14143707|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143708|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
14143709|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143710|NCT04250493|Insulin|insulin|mesh-list
14143711|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14143712|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143713|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
14143714|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14143715|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143716|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14143717|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143718|NCT04227756|Psilocybin|psilocybin|mesh-list
14143719|NCT04227756|Mescaline|mescaline|mesh-list
14143720|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
14143721|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143722|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14143723|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14765184|NCT00619840|Methylphenidate|methylphenidate|mesh-list
14765185|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14765186|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765187|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14765188|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14765189|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765190|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765191|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
14765192|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765193|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14765194|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
14765195|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765196|NCT00619931|APD791|apd791|mesh-list
14765197|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14765198|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14143724|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
14143725|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143726|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143727|NCT04224545|Colchicine|colchicine|mesh-list
14143728|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
14143729|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143730|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
14143731|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
14143732|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
14143733|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143734|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143735|NCT04208997|Amiodarone|amiodarone|mesh-list
14143736|NCT04208997|Sotalol|sotalol|mesh-list
14143737|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14143738|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
14143739|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14178805|NCT04742504|Benralizumab|benralizumab|mesh-list
14143740|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14143741|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143742|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14143743|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14143744|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14143745|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143746|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14143747|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14143748|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14143749|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14143750|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14143751|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
14143752|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143753|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143754|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
14143755|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
14143756|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143757|NCT04206787|Afatinib|afatinib|mesh-list
14143758|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143759|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14143760|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143761|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143762|NCT04201873|Poly I-C|poly i-c|mesh-list
14143763|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
14143764|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14143765|NCT04201873|Vaccines|vaccines|mesh-list
14143766|NCT04201873|Poly ICLC|poly iclc|mesh-list
14143767|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
14143768|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143769|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143770|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143771|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
14143772|NCT04201873|Laxatives|laxatives|mesh-ancestor
14143773|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14143774|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
14143775|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143776|NCT04175600|Selexipag|selexipag|mesh-list
14143777|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14178806|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14178807|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
14178808|NCT04742699|Lemborexant|lemborexant|mesh-list
14178809|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14178810|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178811|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178812|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14178813|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14178814|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178815|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178816|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
14178817|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178818|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14178819|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14178820|NCT04742491|Emtricitabine|emtricitabine|mesh-list
14765199|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
14765200|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765201|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178821|NCT04742491|Tenofovir|tenofovir|mesh-list
14178822|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14178823|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14178824|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178825|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178826|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
14178827|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178828|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14178829|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14178830|NCT04742101|Azacitidine|azacitidine|mesh-list
14178831|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14178832|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
14178833|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178834|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178835|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178836|NCT04742348|Levodopa|levodopa|mesh-list
14178837|NCT04742348|Carbidopa|carbidopa|mesh-list
14143778|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
14143779|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
14143780|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143781|NCT04165239|Protective Agents|protective agents|mesh-ancestor
14143782|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143783|NCT04163900|Gemcitabine|gemcitabine|mesh-list
14143784|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143785|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14143786|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
14143787|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143788|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
14143789|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143790|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143791|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143792|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
14143793|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143794|NCT04153435|Calcium|calcium|mesh-list
14143795|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14143796|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143797|NCT04153188|Phenylephrine|phenylephrine|mesh-list
14143798|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
14143799|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14143800|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14143801|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
14143802|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143803|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143804|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143805|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
14143806|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
14143807|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143808|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
14143809|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14143810|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
14143811|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14143812|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
14143813|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14143814|NCT04153188|Protective Agents|protective agents|mesh-ancestor
14143815|NCT04147221|Imipenem|imipenem|mesh-list
14143816|NCT04147221|Relebactam|relebactam|mesh-list
14143817|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14143818|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143819|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14143820|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143821|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143822|NCT04140968|Progesterone|progesterone|mesh-list
14143823|NCT04140968|Progestins|progestins|mesh-ancestor
14143824|NCT04140968|Hormones|hormones|mesh-ancestor
14143825|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14143826|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143827|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
14143828|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143829|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143830|NCT04132388|Adalimumab|adalimumab|mesh-list
14765202|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765203|NCT00619944|Ritonavir|ritonavir|mesh-list
14765204|NCT00619944|Lopinavir|lopinavir|mesh-list
14765205|NCT00619944|Lumefantrine|lumefantrine|mesh-list
14765206|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14765207|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14765208|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14765209|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14765210|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765211|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765212|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14765213|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14765214|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
14765215|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143831|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14765216|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14765217|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14765218|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
14765219|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14143832|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143833|NCT04122625|Nivolumab|nivolumab|mesh-list
14765220|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14765221|NCT00619996|Docetaxel|docetaxel|mesh-list
14143834|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143835|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143836|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14143837|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143838|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
14143839|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
14143840|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14143841|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14143842|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143843|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143844|NCT04110444|Urological Agents|urological agents|mesh-ancestor
14937348|NCT01475552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937349|NCT01475552|Analgesics|analgesics|mesh-ancestor
14937350|NCT01475552|Sensory System Agents|sensory system agents|mesh-ancestor
14143845|NCT04110314|Vaccines|vaccines|mesh-list
14143846|NCT04110314|Immunologic Factors|immunologic factors|mesh-ancestor
14143847|NCT04110314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143848|NCT04108039|Cetrorelix|cetrorelix|mesh-list
14143849|NCT04108039|Progesterone|progesterone|mesh-list
14143850|NCT04108039|Ganirelix|ganirelix|mesh-list
14143851|NCT04108039|Progestins|progestins|mesh-ancestor
14143852|NCT04108039|Hormones|hormones|mesh-ancestor
14143853|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14143854|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143855|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
14143856|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14143857|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
14143858|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14143859|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
14143860|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14143861|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143862|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
14143863|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14143864|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14143865|NCT04090710|Nivolumab|nivolumab|mesh-list
14143866|NCT04090710|Ipilimumab|ipilimumab|mesh-list
14143867|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143868|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143869|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14143870|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143871|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
14143872|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14143873|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14143874|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143875|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
14143876|NCT04089865|Coagulants|coagulants|mesh-ancestor
14143877|NCT04088500|Nivolumab|nivolumab|mesh-list
14143878|NCT04088500|Ipilimumab|ipilimumab|mesh-list
14143879|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143880|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143881|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14143882|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143883|NCT04086147|Tenecteplase|tenecteplase|mesh-list
14143884|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14143885|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14143886|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143887|NCT04084860|Ketamine|ketamine|mesh-list
14143888|NCT04084860|Analgesics|analgesics|mesh-ancestor
14143889|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
14143890|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143891|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143892|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14143893|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14143894|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
14143895|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
14143896|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143897|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14143898|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14143899|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143900|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143901|NCT04079738|Ixazomib|ixazomib|mesh-list
14143902|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143903|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
14143904|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143905|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143906|NCT04072822|Prednisone|prednisone|mesh-list
14143907|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14143908|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14143909|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
14143910|NCT04072822|Hormones|hormones|mesh-ancestor
14143911|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14143912|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143913|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14143914|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143915|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143916|NCT04068194|Avelumab|avelumab|mesh-list
14143917|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14143918|NCT04068194|Peposertib|peposertib|mesh-list
14143919|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143920|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143921|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
14143922|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143923|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14143924|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143925|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143926|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
14143927|NCT04068103|Leucovorin|leucovorin|mesh-list
14143928|NCT04068103|Folic Acid|folic acid|mesh-list
14143929|NCT04068103|Fluorouracil|fluorouracil|mesh-list
14143930|NCT04068103|Capecitabine|capecitabine|mesh-list
14143931|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
14143932|NCT04068103|Calcium|calcium|mesh-list
14143933|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
14143934|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14143935|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143936|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14143937|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
14143938|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143939|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14143940|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143941|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143942|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
14143943|NCT04068103|Antidotes|antidotes|mesh-ancestor
14143944|NCT04068103|Protective Agents|protective agents|mesh-ancestor
14143945|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
14143946|NCT04068103|Vitamins|vitamins|mesh-ancestor
14143947|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
14143948|NCT04068103|Hematinics|hematinics|mesh-ancestor
14143949|NCT04064918|Timolol|timolol|mesh-list
14143950|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14143951|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14143952|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
14143953|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14143954|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143955|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143956|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14143957|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14143958|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
14143959|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14143960|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14143961|NCT04039347|Cyclosporine|cyclosporine|mesh-list
14143962|NCT04039347|Cyclosporins|cyclosporins|mesh-list
14143963|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143964|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143965|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14143966|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
14143967|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143968|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
14143969|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143970|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
14143971|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14143972|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14143973|NCT04001504|Vaccines|vaccines|mesh-list
14143974|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
14143975|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178838|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14178839|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14178840|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14178841|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
14937351|NCT01475552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937352|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178842|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178843|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178844|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178845|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14178846|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178847|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14178848|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
14178849|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
14178850|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
14178851|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14178852|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14178853|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178854|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
14178855|NCT04742205|Coagulants|coagulants|mesh-ancestor
14178856|NCT04741880|Lidocaine|lidocaine|mesh-list
14178857|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
14178858|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
14178859|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14178860|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178861|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
14178862|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178863|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14178864|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14178865|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14178866|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14178867|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178868|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
14178869|NCT04741620|Capsaicin|capsaicin|mesh-list
14178870|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
14178871|NCT04741620|Citric Acid|citric acid|mesh-list
14178872|NCT04741620|Piperine|piperine|mesh-list
14178873|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
14178874|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
14178875|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
14178876|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178877|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178878|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
14178879|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14178880|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
14178881|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
14765222|NCT00619996|Sorafenib|sorafenib|mesh-list
14937353|NCT01475552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14937354|NCT01475552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14937355|NCT01475552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14937356|NCT01475552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14765223|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765224|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
14765225|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
14765226|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
14765227|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765228|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765229|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765230|NCT00620100|Docetaxel|docetaxel|mesh-list
14765231|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765232|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
14765233|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
14937357|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937358|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14937359|NCT01475552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14937360|NCT01475552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937361|NCT01475552|Antipyretics|antipyretics|mesh-ancestor
14937362|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14937363|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14937364|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14937365|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
14937366|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937367|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
14937368|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
14143976|NCT03999710|Durvalumab|durvalumab|mesh-list
14143977|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14143978|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14143979|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
14143980|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
14143981|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14143982|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
14143983|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14143984|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14937369|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
14937370|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14937371|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14937372|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937373|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937374|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937375|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937376|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
14937377|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
14937378|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
14937379|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
14937380|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
14937381|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
14143985|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14143986|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14143987|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14143988|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14143989|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14143990|NCT03998839|Renal Agents|renal agents|mesh-ancestor
14143991|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14143992|NCT03995641|Bupivacaine|bupivacaine|mesh-list
14143993|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
14143994|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
14143995|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14143996|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14143997|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
14143998|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14143999|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144000|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
14144001|NCT03995641|Hormones|hormones|mesh-ancestor
14144002|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14144003|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14144004|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
14144005|NCT03990766|Theophylline|theophylline|mesh-list
14144006|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14144007|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
14144008|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144009|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144010|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14144011|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
14144012|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14144013|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144014|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144015|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
14144016|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14144017|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14144018|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
14144019|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144022|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
14144023|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
14144024|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478755|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
14765234|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
14765235|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765236|NCT00620165|Levetiracetam|levetiracetam|mesh-list
14765237|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
14765238|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
14765239|NCT00620178|Losartan|losartan|mesh-list
14765240|NCT00620178|Candesartan|candesartan|mesh-list
14765241|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
14765242|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14478756|NCT02457247|Antacids|antacids|mesh-ancestor
14479277|NCT02467504|Loxoprofen|loxoprofen|mesh-list
14144031|NCT03965468|Paclitaxel|paclitaxel|mesh-list
14144032|NCT03965468|Carboplatin|carboplatin|mesh-list
14144033|NCT03965468|Durvalumab|durvalumab|mesh-list
14144034|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14144035|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144036|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
14144037|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
14144038|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
14144039|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144040|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144041|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
14144042|NCT03958565|Denosumab|denosumab|mesh-list
14144043|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14144044|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14144045|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144046|NCT03954327|Tenofovir|tenofovir|mesh-list
14144047|NCT03954327|Emtricitabine|emtricitabine|mesh-list
14144048|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
14144049|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
14765243|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14765244|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14144050|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144051|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14144052|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14144053|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144054|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144055|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14144056|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14144057|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14144058|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14144059|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
14144060|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14144061|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14144062|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144063|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
14144064|NCT03954314|Coagulants|coagulants|mesh-ancestor
14144065|NCT03942120|Ustekinumab|ustekinumab|mesh-list
14144066|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
14144067|NCT03941093|Leucovorin|leucovorin|mesh-list
14144068|NCT03941093|Gemcitabine|gemcitabine|mesh-list
14144069|NCT03941093|Paclitaxel|paclitaxel|mesh-list
14144070|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14144071|NCT03941093|Irinotecan|irinotecan|mesh-list
14144072|NCT03941093|Fluorouracil|fluorouracil|mesh-list
14144073|NCT03941093|Folfirinox|folfirinox|mesh-list
14144074|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
14144075|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14144076|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144077|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
14144078|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
14144079|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
14144080|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144081|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144082|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
14144083|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
14144084|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144085|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144086|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14144087|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
14144088|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144089|NCT03941093|Antidotes|antidotes|mesh-ancestor
14144090|NCT03941093|Protective Agents|protective agents|mesh-ancestor
14144091|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
14144092|NCT03941093|Vitamins|vitamins|mesh-ancestor
14144093|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
14144094|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14144095|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14144096|NCT03938831|Fentanyl|fentanyl|mesh-list
14144097|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
14144098|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14144099|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765245|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14765246|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765247|NCT00620204|Atorvastatin|atorvastatin|mesh-list
14144100|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144101|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14144102|NCT03938831|Analgesics|analgesics|mesh-ancestor
14144103|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
14144104|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144105|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14144106|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14144107|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14144108|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
14144109|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144110|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144111|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14144112|NCT03938831|Narcotics|narcotics|mesh-ancestor
14144113|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14144114|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14144115|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
14144116|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
14144117|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
14144118|NCT03930680|Razoxane|razoxane|mesh-list
14144119|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144120|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14144121|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14144122|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14144123|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144124|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144125|NCT03930680|Protective Agents|protective agents|mesh-ancestor
14144126|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144127|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
14144128|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
14144129|NCT03919617|Volagidemab|volagidemab|mesh-list
14144130|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14144131|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765248|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14765249|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14765250|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
14765251|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765252|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14765253|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14765254|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765255|NCT00620269|Irinotecan|irinotecan|mesh-list
14765256|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14765257|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765258|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14144143|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14144144|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14144145|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144146|NCT03869944|Lamivudine|lamivudine|mesh-list
14144147|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14144148|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14144149|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144150|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144151|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
14144152|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144153|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14144154|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14144155|NCT03867357|Goserelin|goserelin|mesh-list
14144156|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14144157|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144158|NCT03864094|Phenylephrine|phenylephrine|mesh-list
14144159|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
14144160|NCT03864094|Norepinephrine|norepinephrine|mesh-list
14765259|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14144161|NCT03864094|Ephedrine|ephedrine|mesh-list
14144162|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
14144163|NCT03864094|Remifentanil|remifentanil|mesh-list
14144164|NCT03864094|Propofol|propofol|mesh-list
14144165|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14144166|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144167|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144168|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14144169|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
14144170|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
14479278|NCT02467504|Hematinics|hematinics|mesh-ancestor
14144171|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14144172|NCT03864094|Narcotics|narcotics|mesh-ancestor
14144173|NCT03864094|Analgesics|analgesics|mesh-ancestor
14144174|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
14144175|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144176|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14144177|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
14144178|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
14144179|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
14144180|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14144181|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
14144182|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
14144183|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14144184|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14144185|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14144186|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14144187|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144188|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144189|NCT03864094|Protective Agents|protective agents|mesh-ancestor
14144190|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14144191|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14144192|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14144193|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
14144194|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14144195|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144196|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
14144197|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
14144198|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144199|NCT03845166|Atezolizumab|atezolizumab|mesh-list
14144200|NCT03845166|Avelumab|avelumab|mesh-list
14144201|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144202|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144203|NCT03843970|Bupivacaine|bupivacaine|mesh-list
14144204|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
14144205|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14144206|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
14144207|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
14144208|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144209|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144210|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
14144211|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144212|NCT03841201|Nivolumab|nivolumab|mesh-list
14144213|NCT03841201|Lenvatinib|lenvatinib|mesh-list
14144214|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144215|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144216|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14144217|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144218|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14144219|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144220|NCT03841058|Abaloparatide|abaloparatide|mesh-list
14765260|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765261|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765262|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765263|NCT00620295|Gemcitabine|gemcitabine|mesh-list
14765264|NCT00620295|Bortezomib|bortezomib|mesh-list
14765265|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14765266|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
14765267|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765268|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765269|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
14765270|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765271|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765272|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765273|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
14765274|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144221|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14144222|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144223|NCT03838042|Nivolumab|nivolumab|mesh-list
14144224|NCT03838042|Entinostat|entinostat|mesh-list
14144225|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144226|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144227|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14144228|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144229|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14144230|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144231|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
14144232|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
14144233|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14144234|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
14144235|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144236|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144237|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14144238|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
14144239|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144240|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144241|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14144242|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144243|NCT03832049|Vaccines|vaccines|mesh-list
14144244|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
14144245|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144246|NCT03828201|Levofloxacin|levofloxacin|mesh-list
14144247|NCT03828201|Ofloxacin|ofloxacin|mesh-list
14144248|NCT03828201|Linezolid|linezolid|mesh-list
14144249|NCT03828201|Bedaquiline|bedaquiline|mesh-list
14144250|NCT03828201|Clofazimine|clofazimine|mesh-list
14144251|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14144252|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144253|NCT03828201|Renal Agents|renal agents|mesh-ancestor
14144254|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14765275|NCT00620347|Sunitinib|sunitinib|mesh-list
14144255|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14144256|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14144257|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144258|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144259|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144260|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14144261|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14144262|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14144263|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
14144264|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144265|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
14144266|NCT03810105|Durvalumab|durvalumab|mesh-list
14144267|NCT03810105|Olaparib|olaparib|mesh-list
14144268|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144269|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144270|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14144271|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144272|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144273|NCT03806751|Acetazolamide|acetazolamide|mesh-list
14144274|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
14144275|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14144276|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144277|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144278|NCT03806751|Diuretics|diuretics|mesh-ancestor
14144279|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
14144280|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765276|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765277|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14765278|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14765279|NCT00620347|Growth Substances|growth substances|mesh-ancestor
14144281|NCT03805399|Sirolimus|sirolimus|mesh-list
14144282|NCT03805399|Paclitaxel|paclitaxel|mesh-list
14144283|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14144284|NCT03805399|Capecitabine|capecitabine|mesh-list
14144285|NCT03805399|Everolimus|everolimus|mesh-list
14144286|NCT03805399|Apatinib|apatinib|mesh-list
14765280|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765281|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
14765282|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765283|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765284|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765285|NCT00620438|Efavirenz|efavirenz|mesh-list
14765286|NCT00620438|Nevirapine|nevirapine|mesh-list
14765287|NCT00620438|Rifampin|rifampin|mesh-list
14144287|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14765288|NCT00620438|Lumefantrine|lumefantrine|mesh-list
14144288|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14144289|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144290|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
14144291|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
14144292|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14144293|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144294|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144295|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
14144296|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937382|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
14937383|NCT01475617|Calcium|calcium|mesh-list
14144297|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
14765289|NCT00620438|Artemether|artemether|mesh-list
14765290|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14765291|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14765292|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14765293|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765294|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765295|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
14765296|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765297|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14765298|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14144298|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144299|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144300|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14144301|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14144302|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144303|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14144304|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
14144305|NCT03800979|Tofacitinib|tofacitinib|mesh-list
14144306|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14144307|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144308|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178882|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765299|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14765300|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14765301|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14765302|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14765303|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14765304|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14765305|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14937384|NCT01475617|Vitamins|vitamins|mesh-ancestor
14937385|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
14937386|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937387|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14937388|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14937389|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
14937390|NCT01475617|Hematinics|hematinics|mesh-ancestor
14937391|NCT01475656|Levetiracetam|levetiracetam|mesh-list
14937392|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
14937393|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
14937394|NCT01475708|Doxycycline|doxycycline|mesh-list
14937395|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14937396|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937397|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
14937398|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14937399|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14937400|NCT01475760|Chitosan|chitosan|mesh-list
14937401|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14937402|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14937403|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
14937404|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937405|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14937406|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
14937407|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
14937408|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
14937409|NCT01475760|Coagulants|coagulants|mesh-ancestor
14937410|NCT01475877|Bromfenac|bromfenac|mesh-list
14937411|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14937412|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937413|NCT01475877|Analgesics|analgesics|mesh-ancestor
14937414|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
13954655|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954656|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954657|NCT03195257|Incretins|incretins|mesh-ancestor
13954658|NCT03195049|Bilirubin|bilirubin|mesh-list
13954659|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
13954660|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954661|NCT03195049|Protective Agents|protective agents|mesh-ancestor
13954662|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954663|NCT03195153|Allopurinol|allopurinol|mesh-list
13954664|NCT03195153|Atorvastatin|atorvastatin|mesh-list
13954665|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13954666|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14765306|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
14765307|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14765308|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
14144309|NCT03780829|Cycloserine|cycloserine|mesh-list
14144310|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13954667|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
13954668|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954669|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13954670|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13954671|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954672|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
13954673|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954674|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13954675|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
13954676|NCT03195153|Protective Agents|protective agents|mesh-ancestor
13954677|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765309|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14765310|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14765311|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14765312|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
14765313|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14765314|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13954678|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13954679|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13954680|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954681|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13954682|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13954683|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954684|NCT03195309|Fentanyl|fentanyl|mesh-list
13954685|NCT03195309|Ropivacaine|ropivacaine|mesh-list
13954686|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
13954687|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
13954688|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954689|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954690|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
13954691|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954692|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13954693|NCT03195309|Narcotics|narcotics|mesh-ancestor
13954694|NCT03195309|Analgesics|analgesics|mesh-ancestor
13954695|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13954696|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14144311|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144312|NCT03780829|Renal Agents|renal agents|mesh-ancestor
14144313|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14144314|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
14144315|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14144316|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
14144317|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765315|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
14765316|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
14765317|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
14765318|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765319|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765320|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
14765321|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765322|NCT00620490|Ropivacaine|ropivacaine|mesh-list
14765323|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
14765324|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
14765325|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954697|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
14765326|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765327|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
14144330|NCT03770260|Ixazomib|ixazomib|mesh-list
14144331|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14144332|NCT03770260|Pevonedistat|pevonedistat|mesh-list
14144333|NCT03770260|Glycine|glycine|mesh-list
14144334|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144335|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144336|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
14144337|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
14144338|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144339|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144340|NCT03762018|Bevacizumab|bevacizumab|mesh-list
14144341|NCT03762018|Carboplatin|carboplatin|mesh-list
14144342|NCT03762018|Pemetrexed|pemetrexed|mesh-list
14144343|NCT03762018|Atezolizumab|atezolizumab|mesh-list
14144344|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144345|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144346|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14144347|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14144348|NCT03762018|Growth Substances|growth substances|mesh-ancestor
14144349|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144350|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
14144351|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144352|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144353|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14144354|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14144355|NCT03755791|Sorafenib|sorafenib|mesh-list
14144356|NCT03755791|Atezolizumab|atezolizumab|mesh-list
14144357|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144358|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14144359|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144360|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144361|NCT03750786|Leucovorin|leucovorin|mesh-list
14144362|NCT03750786|Antidotes|antidotes|mesh-ancestor
14144363|NCT03750786|Protective Agents|protective agents|mesh-ancestor
14144364|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144365|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
14144366|NCT03750786|Vitamins|vitamins|mesh-ancestor
14144367|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
14144368|NCT03748966|Calcitriol|calcitriol|mesh-list
14144369|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14144370|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14144371|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144372|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14144373|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14144374|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144375|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14144376|NCT03748966|Vitamins|vitamins|mesh-ancestor
14144377|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
14144378|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14144379|NCT03748433|Insulin|insulin|mesh-list
14144380|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14144381|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144382|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
14144383|NCT03737955|Calicheamicins|calicheamicins|mesh-list
14765328|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765329|NCT00620581|Paroxetine|paroxetine|mesh-list
14765330|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13954698|NCT03195023|Amlodipine|amlodipine|mesh-list
13954699|NCT03195023|Lisinopril|lisinopril|mesh-list
13954700|NCT03195023|Lercanidipine|lercanidipine|mesh-list
13954701|NCT03195023|Furosemide|furosemide|mesh-list
13954702|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13954703|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
13954704|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13954705|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14144384|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144385|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144386|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14144387|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
14144388|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144389|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144390|NCT03698006|Ropivacaine|ropivacaine|mesh-list
14144391|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14144392|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
14144393|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
13954706|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14144394|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144395|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144396|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
14144397|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144398|NCT03695237|Leuprolide|leuprolide|mesh-list
14144399|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14144400|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
14144401|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14144402|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144403|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14144404|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144408|NCT03657342|Cyclosporine|cyclosporine|mesh-list
14144409|NCT03657342|Cyclosporins|cyclosporins|mesh-list
14144410|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144411|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144412|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14144413|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
14144414|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144415|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
14144416|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144417|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
14144418|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144419|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14144420|NCT03656926|Cyclosporine|cyclosporine|mesh-list
14144421|NCT03656926|Cyclosporins|cyclosporins|mesh-list
14144422|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765331|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14765332|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765333|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765334|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765335|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
14765336|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765337|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14765338|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
14765339|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765340|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14765341|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14765342|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765343|NCT00620594|Dactolisib|dactolisib|mesh-list
14765344|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765345|NCT00620620|Zaleplon|zaleplon|mesh-list
14765346|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
14765347|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14765348|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765349|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765350|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
14765351|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
14765352|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765353|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765354|NCT00620646|Aspirin|aspirin|mesh-list
14765355|NCT00620646|Cilostazol|cilostazol|mesh-list
14765356|NCT00620646|Clopidogrel|clopidogrel|mesh-list
14765357|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14765358|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765359|NCT00620646|Analgesics|analgesics|mesh-ancestor
14765360|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
14765361|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765362|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765363|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14765364|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765365|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14765366|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14765367|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765368|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14765369|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14765370|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144423|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144424|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14144425|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
14144426|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765371|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
14144427|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
14144428|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144429|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
14144430|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144431|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14144432|NCT03651895|Metformin|metformin|mesh-list
14144433|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14144434|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144435|NCT03646617|Nivolumab|nivolumab|mesh-list
14144436|NCT03646617|Ipilimumab|ipilimumab|mesh-list
14144437|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144438|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144439|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14144440|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144441|NCT03643744|Celecoxib|celecoxib|mesh-list
14144442|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14144443|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14144444|NCT03643744|Analgesics|analgesics|mesh-ancestor
14144445|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
14144446|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144447|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144448|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144449|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144450|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14144451|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14144452|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144453|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144454|NCT03639389|Morphine|morphine|mesh-list
14144455|NCT03639389|Analgesics|analgesics|mesh-list
14144456|NCT03639389|Bupivacaine|bupivacaine|mesh-list
14144457|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
14144458|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
14144459|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144460|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144461|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
14144462|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144463|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14144464|NCT03639389|Narcotics|narcotics|mesh-ancestor
14144465|NCT03630705|Vaccines|vaccines|mesh-list
14144466|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
14144467|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144468|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14144469|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
14144470|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144471|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14144472|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14765372|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14765373|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14765374|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14765375|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
14765376|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765377|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14765378|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
14765379|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14765380|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
14765381|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
14144473|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144474|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
14144475|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14765382|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14765383|NCT00620646|Protective Agents|protective agents|mesh-ancestor
14765384|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14765385|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14765386|NCT00620724|Nifedipine|nifedipine|mesh-list
14765387|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14765388|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765389|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765390|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14765391|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765392|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
14765393|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
14765394|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14144476|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144477|NCT03600090|Paclitaxel|paclitaxel|mesh-list
14144478|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14144479|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144480|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
14144481|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
14144482|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
14144483|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144494|NCT03595150|Diclofenac|diclofenac|mesh-list
14144495|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14144496|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14144497|NCT03595150|Analgesics|analgesics|mesh-ancestor
14144498|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
14144499|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144500|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144501|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144502|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144503|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14144504|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144505|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144506|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14144507|NCT03594175|Reteplase|reteplase|mesh-list
14144508|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14144509|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14144510|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144511|NCT03583333|Linezolid|linezolid|mesh-list
14144512|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14144513|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144514|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14144515|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144516|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144517|NCT03582722|Orlistat|orlistat|mesh-list
14144518|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144519|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144520|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14144521|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14144522|NCT03581734|Vaccines|vaccines|mesh-list
14144523|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
14144524|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144525|NCT03576989|Mineral Oil|mineral oil|mesh-list
14144526|NCT03576989|Emollients|emollients|mesh-ancestor
14144527|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
14178883|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14178884|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178885|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14178886|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178887|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14178888|NCT04741620|Protective Agents|protective agents|mesh-ancestor
14178889|NCT04741464|Tinzaparin|tinzaparin|mesh-list
14178890|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14178891|NCT04741464|Dalteparin|dalteparin|mesh-list
14765395|NCT00620789|Dexetimide|dexetimide|mesh-list
14765396|NCT00620789|Citalopram|citalopram|mesh-list
14765397|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
14765398|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14765399|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14765400|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765401|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765402|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765403|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
14765404|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765405|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14765406|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765407|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14765408|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14765409|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
14765410|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
14144528|NCT03568318|Upadacitinib|upadacitinib|mesh-list
14144529|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14144530|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14144531|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144532|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144533|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144534|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
14144535|NCT03565445|Nivolumab|nivolumab|mesh-list
14144536|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144537|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144538|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14144539|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144540|NCT03564340|Cemiplimab|cemiplimab|mesh-list
14144541|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144542|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144543|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14144544|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14144545|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144546|NCT03493646|Azacitidine|azacitidine|mesh-list
14144547|NCT03493646|Cc-486|cc-486|mesh-list
14144548|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144549|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
14144550|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144551|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144552|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765411|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144555|NCT03473340|Pirfenidone|pirfenidone|mesh-list
14144556|NCT03473340|Analgesics|analgesics|mesh-ancestor
14144557|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
14144558|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144559|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144560|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14144561|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14144562|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144563|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144564|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144599|NCT03457896|Trastuzumab|trastuzumab|mesh-list
14144600|NCT03457896|Cetuximab|cetuximab|mesh-list
14144601|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144602|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144603|NCT03451370|Bevacizumab|bevacizumab|mesh-list
14144604|NCT03451370|Capecitabine|capecitabine|mesh-list
14937415|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937416|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937417|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14937418|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14937419|NCT01475890|Vitamin D|vitamin d|mesh-list
14937420|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
14937421|NCT01475890|Vitamins|vitamins|mesh-ancestor
14937422|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
14937423|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937424|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14937425|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14937426|NCT01476007|Vitamins|vitamins|mesh-list
14937427|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
14937428|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
14937429|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
14937430|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
14937431|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937432|NCT01476007|Hematinics|hematinics|mesh-ancestor
14937433|NCT01476124|Morphine|morphine|mesh-list
14937434|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14937435|NCT01476124|Narcotics|narcotics|mesh-ancestor
14144605|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
14144606|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144607|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144608|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14144609|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14144610|NCT03451370|Growth Substances|growth substances|mesh-ancestor
14144611|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144612|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
14144613|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144614|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
14144615|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144616|NCT03444298|Vitamin E|vitamin e|mesh-list
14144617|NCT03444298|Tocopherols|tocopherols|mesh-list
14144618|NCT03444298|Tocotrienols|tocotrienols|mesh-list
14144619|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
14144620|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
14144621|NCT03444298|Vitamins|vitamins|mesh-ancestor
14937436|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14937437|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937438|NCT01476124|Analgesics|analgesics|mesh-ancestor
14937439|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
14937440|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937441|NCT01476137|Trametinib|trametinib|mesh-list
14937442|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937443|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14937444|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937445|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937446|NCT01476176|Acetaminophen|acetaminophen|mesh-list
14937447|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937448|NCT01476176|Analgesics|analgesics|mesh-ancestor
14937449|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
14937450|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937451|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937452|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
14937453|NCT01476189|Acetaminophen|acetaminophen|mesh-list
14937454|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937455|NCT01476189|Analgesics|analgesics|mesh-ancestor
14937456|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
14937457|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937458|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937459|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
14937460|NCT01476215|Acetaminophen|acetaminophen|mesh-list
14937461|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937462|NCT01476215|Analgesics|analgesics|mesh-ancestor
14937463|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
14937464|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937465|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144622|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
14144623|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144624|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
14144625|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144626|NCT03444298|Protective Agents|protective agents|mesh-ancestor
14937466|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
14937467|NCT01476280|Palonosetron|palonosetron|mesh-list
14144627|NCT03434379|Bevacizumab|bevacizumab|mesh-list
14144628|NCT03434379|Sorafenib|sorafenib|mesh-list
14937468|NCT01476280|Ramosetron|ramosetron|mesh-list
14937469|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
14144629|NCT03434379|Atezolizumab|atezolizumab|mesh-list
14144630|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144631|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144632|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14144633|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14144634|NCT03434379|Growth Substances|growth substances|mesh-ancestor
14144635|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144636|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
14144637|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14144638|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144639|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144640|NCT03424122|Rituximab|rituximab|mesh-list
14144641|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14144642|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144643|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144644|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
14144645|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144646|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765412|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14765413|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14765414|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
14765415|NCT00620802|Clopidogrel|clopidogrel|mesh-list
14765416|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14765417|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14765418|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14765419|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14765420|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
14765421|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765422|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937470|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
14937471|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937472|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937473|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14144647|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14144648|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
14144649|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937474|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14765423|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767418|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14767419|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767420|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767421|NCT00629967|Interferons|interferons|mesh-list
14144655|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
14144656|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
14144657|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
14144658|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144659|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144660|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14144661|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14144662|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
14144663|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144664|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144665|NCT03414658|Trastuzumab|trastuzumab|mesh-list
14144666|NCT03414658|Avelumab|avelumab|mesh-list
14144667|NCT03414658|Vinorelbine|vinorelbine|mesh-list
14144668|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144669|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144670|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14144671|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
14144672|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
14937475|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14937476|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
14937477|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937478|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937479|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14937480|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14144673|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
14144674|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144675|NCT03376659|Bevacizumab|bevacizumab|mesh-list
14144676|NCT03376659|Durvalumab|durvalumab|mesh-list
14144677|NCT03376659|Capecitabine|capecitabine|mesh-list
14767422|NCT00629967|Ribavirin|ribavirin|mesh-list
14767423|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
14767424|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
14144678|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144679|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144680|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14144681|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14144682|NCT03376659|Growth Substances|growth substances|mesh-ancestor
14144683|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144684|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
14144685|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144686|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
14144687|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144688|NCT03345173|Ketamine|ketamine|mesh-list
14144689|NCT03345173|Analgesics|analgesics|mesh-ancestor
14144690|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
14144691|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144692|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144693|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14144694|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14144695|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
14144696|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
14144697|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144698|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14144699|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14144700|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144701|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144702|NCT03344419|Ketamine|ketamine|mesh-list
14144703|NCT03344419|Analgesics|analgesics|mesh-ancestor
14144704|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
14144705|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144706|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144707|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14144708|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14144709|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
14144710|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
14144711|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144712|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14144713|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14144714|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144715|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144716|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
14144717|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
14144718|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14144719|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144720|NCT03334409|Vitamins|vitamins|mesh-list
14144721|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
14765424|NCT00620867|Ibuprofen|ibuprofen|mesh-list
14765425|NCT00620867|Celecoxib|celecoxib|mesh-list
14765426|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14765427|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765428|NCT00620867|Analgesics|analgesics|mesh-ancestor
14765429|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
14765430|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765431|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765432|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14765433|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765434|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14765435|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765436|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765437|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14765438|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
14765439|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14765440|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14765441|NCT00620919|Secretin|secretin|mesh-list
14765442|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765443|NCT00620919|Hormones|hormones|mesh-ancestor
14765444|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14765445|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765446|NCT00620971|Gemcitabine|gemcitabine|mesh-list
14765447|NCT00620971|Bevacizumab|bevacizumab|mesh-list
14765448|NCT00620971|Cisplatin|cisplatin|mesh-list
14765449|NCT00620971|Docetaxel|docetaxel|mesh-list
14765450|NCT00620971|Vinorelbine|vinorelbine|mesh-list
14144722|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
14144723|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144724|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
14144725|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144726|NCT03334409|Protective Agents|protective agents|mesh-ancestor
14144727|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
14144728|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144729|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144730|NCT03326921|Vidarabine|vidarabine|mesh-list
14144731|NCT03326921|Fludarabine|fludarabine|mesh-list
14144732|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
14144733|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144734|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144735|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
14144736|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144737|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14144738|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
14144739|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144740|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
14144741|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144742|NCT03324932|Denosumab|denosumab|mesh-list
14144743|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14144744|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144745|NCT03322215|Capecitabine|capecitabine|mesh-list
14144746|NCT03322215|Fulvestrant|fulvestrant|mesh-list
14144747|NCT03322215|Palbociclib|palbociclib|mesh-list
14144748|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144749|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
14144750|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144751|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144752|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14144753|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14144754|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14144755|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
14144756|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14144757|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144758|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14144759|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144760|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14144761|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144762|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
14144763|NCT03311334|Nivolumab|nivolumab|mesh-list
14144764|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144765|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144766|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14144767|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144768|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
14144769|NCT03308448|Hematinics|hematinics|mesh-ancestor
14144770|NCT03298087|Leuprolide|leuprolide|mesh-list
14144771|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14144772|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
14144773|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14144774|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144775|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14144776|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144777|NCT03294694|Fulvestrant|fulvestrant|mesh-list
14144778|NCT03294694|Spartalizumab|spartalizumab|mesh-list
14144779|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14144780|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144781|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14144782|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14144783|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
14144784|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14144785|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144786|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14144787|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178892|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
14178893|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14178894|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14178895|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178896|NCT04741438|Nivolumab|nivolumab|mesh-list
14178897|NCT04741438|Ipilimumab|ipilimumab|mesh-list
14178898|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178899|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144788|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
14144789|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14144790|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14144791|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
14144792|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
14144793|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144794|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765451|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14765452|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765453|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14765454|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14765455|NCT00620971|Growth Substances|growth substances|mesh-ancestor
14765456|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765457|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
14765458|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14765459|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
14144795|NCT03290560|Kallikreins|kallikreins|mesh-list
14144796|NCT03290560|Coagulants|coagulants|mesh-ancestor
14144797|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14144798|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
14144799|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14144800|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144801|NCT03289910|Carboplatin|carboplatin|mesh-list
14144802|NCT03289910|Topotecan|topotecan|mesh-list
14144803|NCT03289910|Veliparib|veliparib|mesh-list
14144804|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144805|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14144806|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14937481|NCT01476358|Vitamin A|vitamin a|mesh-list
14937482|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
14937483|NCT01476358|Vitamins|vitamins|mesh-ancestor
14937484|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
14937485|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937486|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
14937487|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144807|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144808|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144809|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14144810|NCT03285763|Atezolizumab|atezolizumab|mesh-list
14144811|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144812|NCT03269994|Tazobactam|tazobactam|mesh-list
14144813|NCT03269994|Piperacillin|piperacillin|mesh-list
14937488|NCT01476358|Protective Agents|protective agents|mesh-ancestor
14937489|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14937490|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937491|NCT01476410|Doxorubicin|doxorubicin|mesh-list
14937492|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14937493|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14937494|NCT01476410|Dacarbazine|dacarbazine|mesh-list
14937495|NCT01476410|Vinblastine|vinblastine|mesh-list
14937496|NCT01476410|Antibodies|antibodies|mesh-list
14144814|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14144815|NCT03269994|Cefoxitin|cefoxitin|mesh-list
14144816|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14144817|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144818|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14144819|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937497|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
14937498|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14937499|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
14144820|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144821|NCT03258281|Evolocumab|evolocumab|mesh-list
14144822|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14144823|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14144824|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
14144825|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144826|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14144827|NCT03235986|Poractant alfa|poractant alfa|mesh-list
14144828|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14144829|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
14479279|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
14144830|NCT03199547|Azithromycin|azithromycin|mesh-list
14765460|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144831|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14144832|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479280|NCT02467504|Vitamins|vitamins|mesh-ancestor
14479281|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
14765461|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
14144833|NCT03189641|Cilostazol|cilostazol|mesh-list
14144834|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14765462|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765463|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765464|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765465|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
14765466|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
14765467|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
14765468|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
14765469|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14765470|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
14765471|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
14765472|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
14765473|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765474|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765475|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
14765476|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937500|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14937501|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
14937502|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937503|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14144835|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
14144836|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144837|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144838|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14144839|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
14144840|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14144841|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14144842|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144843|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14144844|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
14144845|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14144846|NCT03189641|Protective Agents|protective agents|mesh-ancestor
14144847|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14144848|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14144849|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478757|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478758|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478759|NCT02457325|Carticaine|carticaine|mesh-list
14478760|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
14478761|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
14478762|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478763|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478764|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
14478765|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478766|NCT02457520|Isotretinoin|isotretinoin|mesh-list
14478767|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
14478768|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14478769|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
14478770|NCT02457546|Coagulants|coagulants|mesh-ancestor
14478771|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
14478772|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14478773|NCT02457611|Ledipasvir|ledipasvir|mesh-list
14478774|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
14478775|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478776|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
14478777|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478778|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14478779|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478780|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478781|NCT02458235|Azacitidine|azacitidine|mesh-list
14478782|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14478783|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
14478784|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478785|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478786|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478787|NCT02458287|Bococizumab|bococizumab|mesh-list
14478788|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14478789|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14478790|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
14478791|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937504|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937505|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14937506|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14937507|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937508|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937509|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14937510|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14937511|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
14937512|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14937513|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14937514|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
14937515|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
14937516|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
14937517|NCT01476488|Tacrolimus|tacrolimus|mesh-list
14937518|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937519|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
14937520|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937521|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14937522|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937523|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937524|NCT01476501|Vitamin D|vitamin d|mesh-list
14765477|NCT00621036|Methotrexate|methotrexate|mesh-list
14765478|NCT00621036|Thiotepa|thiotepa|mesh-list
14765479|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
14765480|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14765481|NCT00621036|Antibodies|antibodies|mesh-list
14144872|NCT03168256|Apremilast|apremilast|mesh-list
14144873|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14144874|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14144875|NCT03168256|Analgesics|analgesics|mesh-ancestor
14144876|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
14144877|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144878|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144879|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144880|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144881|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14144882|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14144883|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144884|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144885|NCT03161223|Azacitidine|azacitidine|mesh-list
14144886|NCT03161223|Durvalumab|durvalumab|mesh-list
14144887|NCT03161223|Romidepsin|romidepsin|mesh-list
14144888|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144889|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
14144890|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144891|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144892|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478792|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14478793|NCT02458469|Trazodone|trazodone|mesh-list
14478794|NCT02458469|Buspirone|buspirone|mesh-list
14478795|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14478796|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14478797|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478798|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478799|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14478800|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14478801|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14478802|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765482|NCT00621036|Sargramostim|sargramostim|mesh-list
14765483|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14765484|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14765485|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
14765486|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14765487|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765488|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14144893|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144894|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14144895|NCT03160846|Milrinone|milrinone|mesh-list
14144896|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14144897|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14144898|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
14144899|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14144900|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14144901|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144902|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144903|NCT03160846|Protective Agents|protective agents|mesh-ancestor
14144904|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144905|NCT03138512|Nivolumab|nivolumab|mesh-list
14144906|NCT03138512|Ipilimumab|ipilimumab|mesh-list
14144907|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14144908|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144909|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14144910|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14144911|NCT03113942|Thalidomide|thalidomide|mesh-list
14144912|NCT03113942|Pomalidomide|pomalidomide|mesh-list
14144913|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
14144914|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144915|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14144916|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14144917|NCT03113942|Growth Substances|growth substances|mesh-ancestor
14144918|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
14144919|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144920|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14144921|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
14144922|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14144923|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14144924|NCT03109093|Blinatumomab|blinatumomab|mesh-list
14144925|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144926|NCT03104270|Dexamethasone|dexamethasone|mesh-list
14144927|NCT03104270|Pomalidomide|pomalidomide|mesh-list
14144928|NCT03104270|Elotuzumab|elotuzumab|mesh-list
14144929|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144930|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
14144931|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
14144932|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144933|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144934|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14144935|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
14144936|NCT03104270|Hormones|hormones|mesh-ancestor
14144937|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14144938|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14144939|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144940|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
14144941|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14144942|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14144943|NCT03104270|Growth Substances|growth substances|mesh-ancestor
14144944|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
14144945|NCT03084536|Acetaminophen|acetaminophen|mesh-list
14144946|NCT03084536|Celecoxib|celecoxib|mesh-list
14144947|NCT03084536|Fentanyl|fentanyl|mesh-list
14144948|NCT03084536|Midazolam|midazolam|mesh-list
14144949|NCT03084536|Gabapentin|gabapentin|mesh-list
14144950|NCT03084536|Bupivacaine|bupivacaine|mesh-list
14144951|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
14144952|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
14144953|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14144954|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144955|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
14144956|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144957|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14144958|NCT03084536|Narcotics|narcotics|mesh-ancestor
14144959|NCT03084536|Analgesics|analgesics|mesh-ancestor
14144960|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14144961|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14144962|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
14765489|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
14765490|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765491|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14144963|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14144964|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14144965|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14144966|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14144967|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
14144968|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
14144969|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14144970|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765492|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
14765493|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765494|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14765495|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765496|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
14144971|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14144972|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
14144973|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14144974|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144975|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14144976|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14144977|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14144978|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14144979|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
14144980|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14144981|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14144982|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
14144983|NCT03083067|Budesonide|budesonide|mesh-list
14144984|NCT03083067|Bromides|bromides|mesh-list
13954707|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954708|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14144985|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
14144986|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
14144987|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14144988|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14144989|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
14144990|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14144991|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14144992|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14144993|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
14144994|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
14144995|NCT03083067|Hormones|hormones|mesh-ancestor
14144996|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14144997|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14144998|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14144999|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14145000|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
14145001|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14145002|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145003|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
14145004|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14145005|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
14145006|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
14145007|NCT03043807|Docetaxel|docetaxel|mesh-list
14145008|NCT03043807|Leuprolide|leuprolide|mesh-list
14145009|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
14145010|NCT03043807|Bicalutamide|bicalutamide|mesh-list
14145011|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145012|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14145013|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14145014|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14145015|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145016|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14765497|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765498|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14765499|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14765500|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
14765501|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14765502|NCT00621101|Sirolimus|sirolimus|mesh-list
14145017|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
14765503|NCT00621101|Ezetimibe|ezetimibe|mesh-list
14765504|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13954709|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954710|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
13954711|NCT03195023|Diuretics|diuretics|mesh-ancestor
13954712|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
13954713|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13954714|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
13954715|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13954716|NCT03195023|Protective Agents|protective agents|mesh-ancestor
13954717|NCT03194906|Memantine|memantine|mesh-list
14145018|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14145019|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145020|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14145021|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14145022|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145023|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
14145024|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145025|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14145026|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
14145027|NCT03020875|Acetaminophen|acetaminophen|mesh-list
14145028|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14145029|NCT03020875|Analgesics|analgesics|mesh-ancestor
14145030|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
14145031|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145032|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145033|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
14145034|NCT02996305|Gaboxadol|gaboxadol|mesh-list
14145035|NCT02996305|Analgesics|analgesics|mesh-ancestor
13954718|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13954719|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13954720|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
13954721|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954722|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954723|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145036|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
14145037|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145038|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145039|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
14145040|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
14145041|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
14145042|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14145043|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145044|NCT02976753|Factor VIII|factor viii|mesh-list
14145045|NCT02976753|Coagulants|coagulants|mesh-ancestor
14145046|NCT02960022|Prednisone|prednisone|mesh-list
14145047|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
13954724|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13954725|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13954726|NCT03194815|Rituximab|rituximab|mesh-list
13954727|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
14765505|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765506|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14145048|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14145049|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
14145050|NCT02960022|Hormones|hormones|mesh-ancestor
14145051|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145052|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145053|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14145054|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145055|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14145056|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145057|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145058|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
14145059|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14145060|NCT02955082|Carboplatin|carboplatin|mesh-list
14145061|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145062|NCT02951767|Atezolizumab|atezolizumab|mesh-list
14145063|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145064|NCT02951052|Rilpivirine|rilpivirine|mesh-list
14145065|NCT02951052|Cabotegravir|cabotegravir|mesh-list
14765507|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765508|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
14765509|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765510|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
14765511|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765512|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14765513|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14765514|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
14765515|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765516|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14765517|NCT00621166|Ritonavir|ritonavir|mesh-list
14765518|NCT00621166|Lopinavir|lopinavir|mesh-list
14765519|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14937525|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
14937526|NCT01476501|Vitamins|vitamins|mesh-ancestor
14937527|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
14145066|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14145067|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14145068|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145069|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145070|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
14145071|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145072|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14937528|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937529|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14937530|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14937531|NCT01476592|Resveratrol|resveratrol|mesh-list
14937532|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
14937533|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937534|NCT01476592|Protective Agents|protective agents|mesh-ancestor
14937535|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937536|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937537|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14937538|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
14937539|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14937540|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14937541|NCT01476683|Racecadotril|racecadotril|mesh-list
14937542|NCT01476683|Thiorphan|thiorphan|mesh-list
14937543|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
14937544|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937545|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
14145073|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14145074|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14145075|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14145076|NCT02946996|Metformin|metformin|mesh-list
14145077|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14145078|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765520|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14765521|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
14765522|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765523|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765524|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14145084|NCT02912988|Letrozole|letrozole|mesh-list
14145085|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145086|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14145087|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14145088|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145089|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145090|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14145091|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
14145092|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145093|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145094|NCT02898259|Rituximab|rituximab|mesh-list
14145095|NCT02898259|Lenalidomide|lenalidomide|mesh-list
14145096|NCT02898259|Ixazomib|ixazomib|mesh-list
14937546|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937547|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937548|NCT01476774|Buprenorphine|buprenorphine|mesh-list
14937549|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14937550|NCT01476774|Narcotics|narcotics|mesh-ancestor
14145097|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145098|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145099|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
14145100|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145101|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145102|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14145103|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14145104|NCT02898259|Growth Substances|growth substances|mesh-ancestor
14145105|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
14145106|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
14145107|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145108|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178900|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14178901|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178902|NCT04741295|Heparin|heparin|mesh-list
14765525|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14765526|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
14765527|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765528|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14937551|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14937552|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937553|NCT01476774|Analgesics|analgesics|mesh-ancestor
14937554|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
14937555|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937556|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14937557|NCT01476787|Rituximab|rituximab|mesh-list
14937558|NCT01476787|Lenalidomide|lenalidomide|mesh-list
14937559|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14937560|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14937561|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937562|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
14937563|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937564|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14937565|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14937566|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14937567|NCT01476787|Growth Substances|growth substances|mesh-ancestor
14937568|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
14937569|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14937570|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
14937571|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937572|NCT01476800|Ketoconazole|ketoconazole|mesh-list
14937573|NCT01476800|Mirabegron|mirabegron|mesh-list
14937574|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
14937575|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937576|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14937577|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14937578|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937579|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937580|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14937581|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
14937582|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937583|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937584|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14937585|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14145187|NCT02878798|Topiramate|topiramate|mesh-list
14145188|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
14145189|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14145190|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145191|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14145192|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14145193|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14145194|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
14145195|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145196|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145197|NCT02854488|Ipilimumab|ipilimumab|mesh-list
14145198|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145199|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145200|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14145201|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145202|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
14145203|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14145204|NCT02841280|Diuretics|diuretics|mesh-ancestor
14145205|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
14145206|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145207|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14145208|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14145209|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145210|NCT02838745|Pemetrexed|pemetrexed|mesh-list
14145211|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145212|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145213|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145214|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14145215|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14145216|NCT02809820|Metoprolol|metoprolol|mesh-list
14145217|NCT02809820|Carvedilol|carvedilol|mesh-list
14145218|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14145219|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14145220|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14145221|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
14145222|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
14145223|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145224|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145225|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14145226|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14145227|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
14145228|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14145229|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145230|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
14145231|NCT02809820|Protective Agents|protective agents|mesh-ancestor
14145232|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14145233|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14145234|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14145235|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
14145236|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14145237|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14145238|NCT02804022|Morphine|morphine|mesh-list
14145239|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14145240|NCT02804022|Narcotics|narcotics|mesh-ancestor
14145241|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14145242|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145243|NCT02804022|Analgesics|analgesics|mesh-ancestor
14145244|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
14145245|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145246|NCT02799602|Docetaxel|docetaxel|mesh-list
14145247|NCT02799602|Androgens|androgens|mesh-list
14145248|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145249|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
14145250|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
14145251|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
14145252|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145253|NCT02799602|Hormones|hormones|mesh-ancestor
14145254|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145255|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145256|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
14145257|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145258|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145259|NCT02786498|Vitamin D|vitamin d|mesh-list
14145260|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
14145261|NCT02786498|Vitamins|vitamins|mesh-ancestor
14145262|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
14145263|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145264|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14145265|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14145266|NCT02782104|Esketamine|esketamine|mesh-list
14145267|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
14145268|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14145269|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
14145270|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
14145271|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145272|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
14145273|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765529|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14765530|NCT00621218|Tretinoin|tretinoin|mesh-list
14765531|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765532|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
14145274|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145275|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145276|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
14145277|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145278|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145279|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14145280|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145281|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14145282|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14145283|NCT02744612|Antibodies|antibodies|mesh-list
14145284|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
14145285|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14145286|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
14145287|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
14478803|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478804|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478805|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
14478806|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14478807|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
14478808|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14145288|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145289|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145290|NCT02741128|Vaccines|vaccines|mesh-list
14145291|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
14145292|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145293|NCT02729116|Ertapenem|ertapenem|mesh-list
14145294|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
14145295|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14145296|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145297|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14145298|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14145299|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145300|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145301|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145302|NCT02675959|Defibrotide|defibrotide|mesh-list
14145303|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14145304|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14145305|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145306|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14145307|NCT02675426|Upadacitinib|upadacitinib|mesh-list
14145308|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14145309|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14145310|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145311|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145312|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145313|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
14145314|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145315|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145316|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
14145317|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145318|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145319|NCT02632448|Gemcitabine|gemcitabine|mesh-list
14145320|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14145321|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
14145322|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145323|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145324|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
14145325|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145326|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145327|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145328|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
14145329|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145330|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
14145331|NCT02625480|Fludarabine|fludarabine|mesh-list
14145332|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145333|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
14145334|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145335|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145336|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145337|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
14145338|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145339|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145340|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14145341|NCT02597660|Hormones|hormones|mesh-list
14145342|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145343|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145344|NCT02592707|Dexamethasone|dexamethasone|mesh-list
14145345|NCT02592707|Ondansetron|ondansetron|mesh-list
14145346|NCT02592707|Antiemetics|antiemetics|mesh-list
14145347|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14145348|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14145349|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
14145350|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145351|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145352|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14145353|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
14145354|NCT02592707|Hormones|hormones|mesh-ancestor
14145355|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145356|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14145357|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145358|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145359|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
14145360|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14937586|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14937587|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937588|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937589|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937590|NCT01476800|Urological Agents|urological agents|mesh-ancestor
14937591|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
14937592|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14937593|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14937594|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14937595|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
14937596|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937597|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937598|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937599|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
14937600|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937601|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
14145361|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14145362|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
14145363|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14145364|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14145365|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14145366|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14145367|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14145368|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14145369|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
14145370|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
14145371|NCT02575339|Sorafenib|sorafenib|mesh-list
14145372|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145373|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14145374|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145375|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145376|NCT02537314|Benzocaine|benzocaine|mesh-list
14145377|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14145378|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
14145379|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14145380|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145381|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
14145382|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145383|NCT02535078|Durvalumab|durvalumab|mesh-list
14145384|NCT02535078|Tremelimumab|tremelimumab|mesh-list
14145385|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145386|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145387|NCT02530034|Antibodies|antibodies|mesh-list
14145388|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14145389|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
14145390|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145391|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
14145392|NCT02499003|Pixantrone|pixantrone|mesh-list
14145393|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145394|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145395|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14145396|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14145397|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145398|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145399|NCT02498444|Treprostinil|treprostinil|mesh-list
14145400|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14145401|NCT02487108|Acetaminophen|acetaminophen|mesh-list
14145402|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14145403|NCT02487108|Hydrocodone|hydrocodone|mesh-list
14145404|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14145405|NCT02487108|Analgesics|analgesics|mesh-ancestor
14145406|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
14145407|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145408|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145409|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
14145410|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14145411|NCT02487108|Narcotics|narcotics|mesh-ancestor
14145412|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14145413|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
14145414|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
14145415|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14145416|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14145417|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145418|NCT02455557|Temozolomide|temozolomide|mesh-list
14145419|NCT02455557|Sargramostim|sargramostim|mesh-list
14145420|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145421|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
14145422|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145423|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145424|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
14145425|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145426|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
14145427|NCT02455141|Carboplatin|carboplatin|mesh-list
14145428|NCT02455141|Epirubicin|epirubicin|mesh-list
14145429|NCT02455141|Taxane|taxane|mesh-list
14145430|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145431|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
14145432|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145433|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145434|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145435|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
14145436|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145437|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145438|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14145439|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14145440|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14145441|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14145442|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145443|NCT02439385|Curcumin|curcumin|mesh-list
14145444|NCT02439385|Bevacizumab|bevacizumab|mesh-list
14145445|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145446|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145447|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14145448|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14145449|NCT02439385|Growth Substances|growth substances|mesh-ancestor
14145450|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145451|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
14145452|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14145453|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14145454|NCT02439385|Analgesics|analgesics|mesh-ancestor
14145455|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
14145456|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14145457|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14937602|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937603|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14937604|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14937605|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
14937606|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937607|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937608|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14937609|NCT01477034|Vitamin D|vitamin d|mesh-list
14937610|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
14937611|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
14937612|NCT01477034|Vitamins|vitamins|mesh-list
14937613|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
14937614|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937615|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14145458|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145459|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178903|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14145460|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145461|NCT02419664|Edotreotide|edotreotide|mesh-list
14145462|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14145463|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145464|NCT02402439|Pancrelipase|pancrelipase|mesh-list
14145465|NCT02402439|Pancreatin|pancreatin|mesh-list
14145466|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14145467|NCT02393690|Iodine|iodine|mesh-list
14145468|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
14145469|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14145470|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145471|NCT02393690|Trace Elements|trace elements|mesh-ancestor
14145472|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
14145473|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145474|NCT02387996|Nivolumab|nivolumab|mesh-list
14145475|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145476|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145477|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14145478|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145479|NCT02386800|Panobinostat|panobinostat|mesh-list
14145480|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145481|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14145482|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145483|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145484|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
14145485|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145486|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145487|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14145488|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14145489|NCT02349386|Estradiol|estradiol|mesh-list
14145490|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14145491|NCT02349386|Estrogens|estrogens|mesh-ancestor
14145492|NCT02349386|Hormones|hormones|mesh-ancestor
14145493|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145494|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145495|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14145496|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
14145497|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14145498|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14145499|NCT02337985|Prednisone|prednisone|mesh-list
14145500|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
14145501|NCT02337985|Rituximab|rituximab|mesh-list
14145502|NCT02337985|Doxorubicin|doxorubicin|mesh-list
14145503|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14145504|NCT02337985|Etoposide|etoposide|mesh-list
14145505|NCT02337985|Vincristine|vincristine|mesh-list
14145506|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145507|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
14145508|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145509|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145510|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145511|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
14145512|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145513|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145514|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14145515|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145516|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14145517|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14145518|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14145519|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145520|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14145521|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
14145522|NCT02337985|Hormones|hormones|mesh-ancestor
14145523|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145524|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14145525|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14145526|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14145527|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14145528|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
14178904|NCT04741295|Tinzaparin|tinzaparin|mesh-list
14178905|NCT04741295|Dalteparin|dalteparin|mesh-list
14178906|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
14178907|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14178908|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14178909|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178910|NCT04741165|Bevacizumab|bevacizumab|mesh-list
14145529|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
14145530|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145537|NCT02308241|Ribavirin|ribavirin|mesh-list
14145538|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
14145539|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145540|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
14145541|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145542|NCT02274155|Antibodies|antibodies|mesh-list
14145543|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
14145544|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145545|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
14145546|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14145547|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14145548|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145549|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
14145550|NCT02257580|Coagulants|coagulants|mesh-ancestor
14145551|NCT02180711|Rituximab|rituximab|mesh-list
14145552|NCT02180711|Lenalidomide|lenalidomide|mesh-list
14145553|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
14145554|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145555|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145556|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
14145557|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145558|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145559|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14145560|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14145561|NCT02180711|Growth Substances|growth substances|mesh-ancestor
14145562|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
14145616|NCT02163356|Ketoconazole|ketoconazole|mesh-list
14145617|NCT02163356|Vincristine|vincristine|mesh-list
14145618|NCT02163356|Fenretinide|fenretinide|mesh-list
14145619|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14145620|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145621|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
14145622|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
14145623|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
14145624|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145625|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
14145626|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145627|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14145628|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14145629|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145630|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14145631|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
14145632|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145633|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145634|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14145635|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14145636|NCT02163356|Protective Agents|protective agents|mesh-ancestor
14145637|NCT02108652|Atezolizumab|atezolizumab|mesh-list
14145638|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145639|NCT02102477|Androgens|androgens|mesh-list
14145640|NCT02102477|Hormones|hormones|mesh-ancestor
14145641|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145642|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145643|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
14145644|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14145645|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145646|NCT02022098|Cisplatin|cisplatin|mesh-list
14145647|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145648|NCT02021006|Amoxicillin|amoxicillin|mesh-list
14145649|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
14145650|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
14145651|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14145652|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
14145653|NCT02021006|Cefixime|cefixime|mesh-list
14145654|NCT02021006|Trimethoprim|trimethoprim|mesh-list
14145655|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
14145656|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14145657|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145658|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14145659|NCT02021006|Renal Agents|renal agents|mesh-ancestor
14145660|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
14145661|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14145662|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14145663|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14145664|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145665|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145666|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14145667|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14145668|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14145669|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14145670|NCT02016924|Cobicistat|cobicistat|mesh-list
14145671|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145672|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145673|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14145674|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14145675|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
14145676|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145677|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14145678|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14145679|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
14145680|NCT02013336|Irinotecan|irinotecan|mesh-list
14145681|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145682|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
14145683|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145684|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145685|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145686|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
14145687|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145688|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145689|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14145690|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14765533|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
14765534|NCT00621283|Secretin|secretin|mesh-list
14765535|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765536|NCT00621283|Hormones|hormones|mesh-ancestor
14765537|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145691|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14145692|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145693|NCT01921140|Olaparib|olaparib|mesh-list
14145694|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14145695|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145696|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145697|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145698|NCT01904032|Vitamin D|vitamin d|mesh-list
14145699|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
14145700|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
14145701|NCT01904032|Vitamins|vitamins|mesh-list
14145702|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
14145703|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145704|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14145705|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14145706|NCT01876953|Cytarabine|cytarabine|mesh-list
14145707|NCT01876953|Dasatinib|dasatinib|mesh-list
14145708|NCT01876953|Idarubicin|idarubicin|mesh-list
14145709|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14145710|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
14145711|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145712|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145713|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
14145714|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145715|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145716|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
14145717|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145718|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14145719|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145720|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14145721|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14145722|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14145723|NCT01850355|Buspirone|buspirone|mesh-list
14145724|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14145725|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14145726|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14145727|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145728|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14145729|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14145730|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
14145731|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14145732|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145733|NCT01799629|Glycerol|glycerol|mesh-list
14145734|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14145735|NCT01799629|Protective Agents|protective agents|mesh-ancestor
14145736|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145737|NCT01772472|Trastuzumab|trastuzumab|mesh-list
14145738|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14145739|NCT01772472|Maytansine|maytansine|mesh-list
14145740|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145741|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145742|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14145743|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14145744|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14145745|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14145746|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145747|NCT01764711|Cosyntropin|cosyntropin|mesh-list
14145748|NCT01764711|Hormones|hormones|mesh-ancestor
14145749|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145750|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145751|NCT01553071|Fenretinide|fenretinide|mesh-list
14145752|NCT01553071|Safingol|safingol|mesh-list
14145753|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145754|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14145755|NCT01553071|Protective Agents|protective agents|mesh-ancestor
14145756|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145757|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145758|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145759|NCT01551472|Vitamin E|vitamin e|mesh-list
14145760|NCT01551472|Vitamins|vitamins|mesh-ancestor
14145761|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
14145762|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145763|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
14145764|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145765|NCT01551472|Protective Agents|protective agents|mesh-ancestor
14145766|NCT01506973|Gemcitabine|gemcitabine|mesh-list
14145767|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
14145768|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14145769|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14145770|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
14145771|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145772|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145773|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
14145774|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145775|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145776|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145777|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
14145778|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145779|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
14145780|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14145781|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14145782|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145783|NCT01347970|Carvedilol|carvedilol|mesh-list
14145784|NCT01347970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14145785|NCT01347970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14145786|NCT01347970|Adrenergic Agents|adrenergic agents|mesh-ancestor
14145787|NCT01347970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14145788|NCT01347970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145789|NCT01347970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145790|NCT01347970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14145791|NCT01347970|Antioxidants|antioxidants|mesh-ancestor
14145792|NCT01347970|Protective Agents|protective agents|mesh-ancestor
14145793|NCT01347970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14145794|NCT01347970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14145795|NCT01347970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14145796|NCT01347970|Vasodilator Agents|vasodilator agents|mesh-ancestor
14145797|NCT01347970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14145798|NCT01347970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14145799|NCT01294020|Tacrolimus|tacrolimus|mesh-list
14145800|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145801|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
14145802|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145803|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14145804|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145805|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145806|NCT01187810|Cytarabine|cytarabine|mesh-list
14145807|NCT01187810|Methotrexate|methotrexate|mesh-list
14145808|NCT01187810|Fenretinide|fenretinide|mesh-list
14145809|NCT01187810|Retinamide|retinamide|mesh-list
14145810|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14145811|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
14145812|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14145813|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145814|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14145815|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
14145816|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145817|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145818|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
14145819|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145820|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14145821|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145822|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
14145823|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14145824|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14937616|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938753|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14938754|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14938755|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938756|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
14145825|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
14145826|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145827|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13954728|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13954729|NCT03194815|Antibodies|antibodies|mesh-list
13954730|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
13954731|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13954732|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145828|NCT01187810|Protective Agents|protective agents|mesh-ancestor
14145829|NCT01093612|Copper|copper|mesh-list
14145830|NCT01093612|Trastuzumab|trastuzumab|mesh-list
14145831|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14145832|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145833|NCT01093612|Trace Elements|trace elements|mesh-ancestor
14145834|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
14145835|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145836|NCT00931255|Sirolimus|sirolimus|mesh-list
14145837|NCT00931255|Tacrolimus|tacrolimus|mesh-list
14145838|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145839|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
14145840|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145841|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14145842|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145843|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145844|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14145845|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145846|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14145847|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145848|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
14145849|NCT00669669|Plerixafor|plerixafor|mesh-list
14145850|NCT00669669|Temozolomide|temozolomide|mesh-list
14145851|NCT00669669|Carmustine|carmustine|mesh-list
14145852|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14145853|NCT00669669|Lenograstim|lenograstim|mesh-list
14145854|NCT00669669|Sargramostim|sargramostim|mesh-list
14145855|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14145856|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
14145857|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145858|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145859|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
14145860|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145861|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145862|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14145863|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14145864|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
14145865|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14145866|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145867|NCT00608023|Tesamorelin|tesamorelin|mesh-list
14145868|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14145869|NCT00608023|Growth Substances|growth substances|mesh-ancestor
14145870|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145871|NCT00608023|Hormones|hormones|mesh-ancestor
14145872|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478809|NCT02458638|Atezolizumab|atezolizumab|mesh-list
13954733|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954734|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
13954735|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954736|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954737|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
13954738|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
13954739|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14145877|NCT00540995|Etoposide|etoposide|mesh-list
14938757|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938758|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
14938759|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145878|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
14145879|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
14937617|NCT01477060|Metformin|metformin|mesh-list
14937618|NCT01477060|Lapatinib|lapatinib|mesh-list
14937619|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14937620|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937621|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937622|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14145880|NCT00540995|Busulfan|busulfan|mesh-list
14145881|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14145882|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14145883|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14145884|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14145885|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145886|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145887|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
14145888|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14145889|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
14145890|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145891|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14145892|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14145893|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
14145894|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
14145895|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
14145896|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
14145897|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
14145898|NCT00484471|Valproic Acid|valproic acid|mesh-list
14145899|NCT00484471|Aripiprazole|aripiprazole|mesh-list
14145900|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
14145901|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14145902|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14145903|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14145904|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14145905|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145906|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
14145907|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
14145908|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14145909|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14145910|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14145911|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14145912|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
14145913|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14145914|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14145915|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14145916|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14145917|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
14145918|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14145919|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
14145920|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
14145989|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14145990|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14145991|NCT00080756|Estradiol|estradiol|mesh-list
14145992|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14145993|NCT00080756|Testosterone|testosterone|mesh-list
14145994|NCT00080756|Deslorelin|deslorelin|mesh-list
14145995|NCT00080756|Estrogens|estrogens|mesh-ancestor
14145996|NCT00080756|Hormones|hormones|mesh-ancestor
14145997|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14145998|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14145999|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14146000|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
14146001|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14146002|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14146003|NCT00080756|Androgens|androgens|mesh-ancestor
14146004|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146005|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146006|NCT00015002|Betamethasone|betamethasone|mesh-list
14146007|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146008|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
14146009|NCT00015002|Hormones|hormones|mesh-ancestor
14146010|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146011|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146012|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14146013|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
14146014|NCT05108974|Choline|choline|mesh-list
14146015|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
14146016|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14146017|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
14146018|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146019|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146020|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14146021|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
14146022|NCT05105139|Triclosan|triclosan|mesh-list
14146023|NCT05105139|Coal Tar|coal tar|mesh-list
14146024|NCT05105139|Allantoin|allantoin|mesh-list
14146025|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14146026|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178911|NCT04741165|Lenvatinib|lenvatinib|mesh-list
14146027|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14146028|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14146029|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
14146030|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146031|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14146032|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
14146033|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146034|NCT05103215|Lidocaine|lidocaine|mesh-list
14146035|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
14146036|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
14146037|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146038|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146039|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
14146040|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146041|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14146042|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14146043|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14146044|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14146045|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178912|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14178913|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178914|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14178915|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14178916|NCT04741165|Growth Substances|growth substances|mesh-ancestor
14178917|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178918|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
14178919|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14178920|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178921|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178922|NCT04740840|Amlodipine|amlodipine|mesh-list
14178923|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14178924|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14178925|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14178926|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178927|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14178928|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178929|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
14183921|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14183922|NCT04724629|Aldesleukin|aldesleukin|mesh-list
14183923|NCT04724629|Colchicine|colchicine|mesh-list
14183924|NCT04724629|Ixekizumab|ixekizumab|mesh-list
14183925|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183926|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14183927|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14183928|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
14183929|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14183930|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
14183931|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14183932|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
14183933|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
14183934|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
14183935|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183936|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14183937|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14183938|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14183939|NCT04724486|Cetrorelix|cetrorelix|mesh-list
14183940|NCT04724486|Menotropins|menotropins|mesh-list
14183941|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
14183942|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14183943|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
14183944|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183945|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183946|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14183947|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14183948|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183949|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14183950|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
14183951|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
14183952|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183953|NCT04724473|Tretinoin|tretinoin|mesh-list
14183954|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183955|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
14183956|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
14184239|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
14146046|NCT05042700|Melatonin|melatonin|mesh-list
14146047|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
14146048|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937623|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937624|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937625|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14146049|NCT05042700|Protective Agents|protective agents|mesh-ancestor
14146050|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146051|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146052|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
14146053|NCT05033483|Trace Elements|trace elements|mesh-ancestor
14146054|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
14146055|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146056|NCT05015608|Carboplatin|carboplatin|mesh-list
14146057|NCT05015608|Pemetrexed|pemetrexed|mesh-list
14146058|NCT05015608|Osimertinib|osimertinib|mesh-list
14146059|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146060|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146061|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146062|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14146063|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14146064|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14146065|NCT05001815|Insulin|insulin|mesh-list
14146066|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14146067|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14146068|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146069|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14146070|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146071|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14146072|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146073|NCT05001555|Analgesics|analgesics|mesh-ancestor
14146074|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
14146075|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146076|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146077|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146078|NCT04975555|Siltuximab|siltuximab|mesh-list
14146079|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146080|NCT04968158|Acetaminophen|acetaminophen|mesh-list
14146081|NCT04968158|Etoricoxib|etoricoxib|mesh-list
14146082|NCT04968158|Tramadol|tramadol|mesh-list
14146083|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146084|NCT04968158|Analgesics|analgesics|mesh-ancestor
14146085|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
14146086|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146087|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146088|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
14146089|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14146090|NCT04968158|Narcotics|narcotics|mesh-ancestor
14146091|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146092|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14146093|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146094|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146095|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14146096|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14146097|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146098|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146099|NCT04905251|Misoprostol|misoprostol|mesh-list
14146100|NCT04905251|Mifepristone|mifepristone|mesh-list
14146101|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14146102|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
14146103|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14146104|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146105|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14146106|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146107|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
14146108|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14146109|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14146110|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14146111|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14146112|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
14146113|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14146114|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14146115|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
14146116|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146117|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
14146118|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14146119|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14146120|NCT04895098|Ezetimibe|ezetimibe|mesh-list
14146121|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14146122|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14146123|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14146124|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
14146125|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146126|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14146127|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146128|NCT04889066|Durvalumab|durvalumab|mesh-list
14146129|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146130|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146131|NCT04848454|Vinorelbine|vinorelbine|mesh-list
14146132|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146133|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146134|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146135|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146136|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146137|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146138|NCT04810559|Antibodies|antibodies|mesh-list
14146139|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
14146140|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146141|NCT04799236|Amphotericin B|amphotericin b|mesh-list
14146142|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14146143|NCT04799236|Miltefosine|miltefosine|mesh-list
14146144|NCT04799236|Amebicides|amebicides|mesh-ancestor
14146145|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14146146|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14146147|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146148|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14146149|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
14146150|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146151|NCT04785326|Ustekinumab|ustekinumab|mesh-list
14146152|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146153|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
14146154|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14146155|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146156|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146157|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146158|NCT04771637|Analgesics|analgesics|mesh-ancestor
14146159|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
14146160|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146161|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14146162|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14146163|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14146164|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
14146165|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146166|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146167|NCT04737343|Azathioprine|azathioprine|mesh-list
14146168|NCT04737343|Leflunomide|leflunomide|mesh-list
14146169|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
14146170|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146171|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14146172|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146173|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146174|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
14146175|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146176|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765538|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765539|NCT00621361|Etoposide|etoposide|mesh-list
14765540|NCT00621361|Cediranib|cediranib|mesh-list
14765541|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765542|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146177|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146178|NCT04696445|Morphine|morphine|mesh-list
14146179|NCT04696445|Oxycodone|oxycodone|mesh-list
14146180|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14146181|NCT04696445|Narcotics|narcotics|mesh-ancestor
14146182|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146183|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146184|NCT04696445|Analgesics|analgesics|mesh-ancestor
14146185|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
14146186|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146187|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
14146188|NCT04638881|Analgesics|analgesics|mesh-ancestor
14146189|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
14146190|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146191|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146192|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
14146193|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146194|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14146195|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
14146196|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14146197|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14146198|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146199|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14146200|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
14146201|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14146202|NCT04563338|Bevacizumab|bevacizumab|mesh-list
14146203|NCT04563338|Atezolizumab|atezolizumab|mesh-list
14146204|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146205|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146206|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14146207|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14146208|NCT04563338|Growth Substances|growth substances|mesh-ancestor
14146209|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146210|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
14146211|NCT04498273|Aspirin|aspirin|mesh-list
14146212|NCT04498273|Apixaban|apixaban|mesh-list
14146213|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14146214|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146215|NCT04498273|Analgesics|analgesics|mesh-ancestor
14146216|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
14146217|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146218|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146219|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146220|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146221|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14146222|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14146223|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146224|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14146225|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14146226|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146227|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
14146228|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14146229|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
14146230|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14146231|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
14146232|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
14146233|NCT04450953|Eplerenone|eplerenone|mesh-list
14146234|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14146235|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
14146236|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146237|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146238|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14146239|NCT04450953|Diuretics|diuretics|mesh-ancestor
14146240|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
14146241|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14178930|NCT04740593|Methamphetamine|methamphetamine|mesh-list
14178931|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14178932|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178933|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
14178934|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
14178935|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178936|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
14178937|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14178938|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178939|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
14178940|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14178941|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14178942|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14178943|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14178944|NCT04740554|Prednisone|prednisone|mesh-list
14178945|NCT04740554|Deflazacort|deflazacort|mesh-list
14178946|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14178947|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
14178948|NCT04740554|Hormones|hormones|mesh-ancestor
14178949|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146242|NCT04268498|Acetaminophen|acetaminophen|mesh-list
14146243|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
14146244|NCT04268498|Promethazine|promethazine|mesh-list
14146245|NCT04268498|Dexamethasone|dexamethasone|mesh-list
14146246|NCT04268498|Lenalidomide|lenalidomide|mesh-list
14146247|NCT04268498|Bortezomib|bortezomib|mesh-list
14146248|NCT04268498|Daratumumab|daratumumab|mesh-list
14937626|NCT01477073|Hormones|hormones|mesh-ancestor
14937627|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937628|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937629|NCT01477112|Beta Carotene|beta carotene|mesh-list
14937630|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937631|NCT01477112|Provitamins|provitamins|mesh-ancestor
14937632|NCT01477112|Vitamins|vitamins|mesh-ancestor
14937633|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
14937634|NCT01477151|Anesthetics|anesthetics|mesh-list
14937635|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14937636|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937637|NCT01477190|Morphine|morphine|mesh-list
14146249|NCT04268498|Montelukast|montelukast|mesh-list
14146250|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146251|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
14146252|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
14146253|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146254|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146255|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146256|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
14146257|NCT04268498|Hormones|hormones|mesh-ancestor
14146258|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146259|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14146260|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146261|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
14146262|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14146263|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14146264|NCT04268498|Growth Substances|growth substances|mesh-ancestor
14146265|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
14146266|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146267|NCT04268498|Analgesics|analgesics|mesh-ancestor
14146268|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
14146269|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
14146270|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14146271|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
14146272|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14146273|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
14146274|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14146275|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14146276|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146277|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14146278|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14146279|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146280|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
14146281|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
14146282|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14146283|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
14146284|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
14146285|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146286|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14146287|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
14146288|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146289|NCT04248465|Ravulizumab|ravulizumab|mesh-list
14146290|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14146291|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146292|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
14146293|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146294|NCT05245227|Misoprostol|misoprostol|mesh-list
14146295|NCT05245227|Oxytocin|oxytocin|mesh-list
14146296|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
14146297|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14146298|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146299|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14937638|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14937639|NCT01477190|Narcotics|narcotics|mesh-ancestor
14146300|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
14146301|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14146302|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146303|NCT05244954|Chloroquine|chloroquine|mesh-list
14146304|NCT05244954|Piperaquine|piperaquine|mesh-list
14146305|NCT05244954|Artenimol|artenimol|mesh-list
14146306|NCT05244954|Amebicides|amebicides|mesh-ancestor
14146307|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14146308|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14146309|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146310|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
14146311|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146312|NCT05244837|Paclitaxel|paclitaxel|mesh-list
14146313|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14146314|NCT05244837|Carboplatin|carboplatin|mesh-list
14146315|NCT05244837|Pemetrexed|pemetrexed|mesh-list
14146316|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146317|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146318|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146319|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146320|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146321|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146322|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146323|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14146324|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14146325|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
14146326|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
14146327|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14146328|NCT05244811|Progestins|progestins|mesh-list
14146329|NCT05244811|Estradiol|estradiol|mesh-list
14146330|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14146331|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146332|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14146333|NCT05244811|Hormones|hormones|mesh-ancestor
14146334|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146335|NCT05244811|Estrogens|estrogens|mesh-ancestor
14146336|NCT05244798|Paclitaxel|paclitaxel|mesh-list
14146337|NCT05244798|Cisplatin|cisplatin|mesh-list
14146338|NCT05244798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146339|NCT05244798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146340|NCT05244798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146341|NCT05244798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146342|NCT05244798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146343|NCT05244798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146344|NCT05244694|Insulin|insulin|mesh-list
14146345|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14146346|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146347|NCT05244577|Olanzapine|olanzapine|mesh-list
14146348|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
14146349|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
14146350|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146351|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146352|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146353|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14146354|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14146355|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146356|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14146357|NCT05244577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14146358|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14146359|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14146360|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146361|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146362|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
14146363|NCT05244525|Epinephrine|epinephrine|mesh-list
14146364|NCT05244525|Bupivacaine|bupivacaine|mesh-list
14146365|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
14146366|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
14146367|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146368|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146369|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
14146370|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146371|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14765543|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14765544|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14146372|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14765545|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765546|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765547|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765548|NCT00621387|Ofloxacin|ofloxacin|mesh-list
14765549|NCT00621387|Roxithromycin|roxithromycin|mesh-list
14146373|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
14146374|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478810|NCT02458638|Antibodies|antibodies|mesh-list
14767425|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14146375|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146376|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14146377|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14146378|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
14146379|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14146380|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
14146381|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
14146382|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
14146383|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14937640|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14937641|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937642|NCT01477190|Analgesics|analgesics|mesh-ancestor
14937643|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
14937644|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937645|NCT01477203|Citalopram|citalopram|mesh-list
14937646|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14937647|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14937648|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14937649|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937650|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937651|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
14937652|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765550|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14765551|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765552|NCT00621387|Renal Agents|renal agents|mesh-ancestor
14146384|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
14146385|NCT05244460|Promethazine|promethazine|mesh-list
14765553|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14765554|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14765555|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14765556|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765557|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765558|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765559|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14765560|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14937653|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14937654|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
13954740|NCT03194620|Procyanidin|procyanidin|mesh-list
14765561|NCT00621400|Dexamethasone|dexamethasone|mesh-list
14765562|NCT00621400|Lenalidomide|lenalidomide|mesh-list
13954741|NCT03194620|Theaflavin|theaflavin|mesh-list
13954742|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
13954743|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954744|NCT03194620|Protective Agents|protective agents|mesh-ancestor
13954745|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146386|NCT05244460|Droperidol|droperidol|mesh-list
14146387|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14146388|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14146389|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146390|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146391|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
14146392|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
14146393|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
14146394|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146395|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
14765563|NCT00621400|Melphalan|melphalan|mesh-list
14765564|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954746|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13954747|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13954748|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765565|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
14765566|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
14765567|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765568|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765569|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765570|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
14765571|NCT00621400|Hormones|hormones|mesh-ancestor
14765572|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14765573|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14765574|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765575|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
14765576|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14765577|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13954749|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146396|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
14146397|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146398|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14146399|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
14146400|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
14146401|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146402|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937655|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14937656|NCT01477242|Ondansetron|ondansetron|mesh-list
14937657|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
14937658|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
14937659|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937660|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937661|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937662|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
14146403|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14146404|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
14146405|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146406|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14146407|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14146408|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14146409|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14146410|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14146411|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14146412|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
14146413|NCT05244200|Insulin|insulin|mesh-list
14146414|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14146415|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146416|NCT05244109|Antibodies|antibodies|mesh-list
14146417|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
14146418|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
14146419|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146420|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
14146421|NCT05244070|Fludarabine|fludarabine|mesh-list
14146422|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146423|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
14146424|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146425|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146426|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14146427|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
14146428|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146429|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146430|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14146431|NCT05244057|Interferons|interferons|mesh-list
14146432|NCT05244057|Tenofovir|tenofovir|mesh-list
14146433|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
14146434|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
14146435|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14146436|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146437|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
14146438|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146439|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14146440|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14146441|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146442|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146443|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14146444|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14146445|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
14146446|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178950|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178951|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14178952|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937663|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
13954750|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954751|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
13954752|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954753|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13954754|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13954755|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13954756|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
13954757|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
13962957|NCT02723994|Dexamethasone|dexamethasone|mesh-list
13962958|NCT02723994|Prednisone|prednisone|mesh-list
13962959|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
14178953|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962960|NCT02723994|Doxorubicin|doxorubicin|mesh-list
13962961|NCT02723994|Methotrexate|methotrexate|mesh-list
14178954|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
14146447|NCT05243862|Atezolizumab|atezolizumab|mesh-list
14146448|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146449|NCT05243797|Lenalidomide|lenalidomide|mesh-list
14146450|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
14146451|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146452|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14146453|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14146454|NCT05243797|Growth Substances|growth substances|mesh-ancestor
14146455|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
14146456|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146457|NCT05243706|Loratadine|loratadine|mesh-list
14146458|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
14146459|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146460|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14146461|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14146462|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14146463|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
14146464|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
14146465|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146466|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146467|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146468|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14146469|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146470|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146471|NCT05243654|Metformin|metformin|mesh-list
14146472|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14146473|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146474|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
14146475|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146476|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
14146477|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146478|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146479|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14146480|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
14146481|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146482|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146483|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14146484|NCT05243446|Losartan|losartan|mesh-list
14146485|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14765578|NCT00621400|Growth Substances|growth substances|mesh-ancestor
14765579|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
14765580|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14765581|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
14765582|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765583|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14765584|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765585|NCT00621452|Aldesleukin|aldesleukin|mesh-list
14765586|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
14765587|NCT00621452|Interleukin-2|interleukin-2|mesh-list
14765588|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765589|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
14765590|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765591|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765592|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14765593|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
14765594|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765595|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765596|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14765597|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765598|NCT00621452|Analgesics|analgesics|mesh-ancestor
14765599|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
13954758|NCT03194685|FF-10101|ff-10101|mesh-list
13954759|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13954760|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954761|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954762|NCT03194724|Vitamin A|vitamin a|mesh-list
13954763|NCT03194724|Vitamins|vitamins|mesh-ancestor
13954764|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
13954765|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954766|NCT03194633|Nifedipine|nifedipine|mesh-list
13954767|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13954768|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954769|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954770|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14146486|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14146487|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14146488|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14146489|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146490|NCT05243355|Endostatins|endostatins|mesh-list
14146491|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146492|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14146493|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14146494|NCT05243355|Growth Substances|growth substances|mesh-ancestor
14146495|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146496|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
14146497|NCT05243290|Niacinamide|niacinamide|mesh-list
14146498|NCT05243290|Niacin|niacin|mesh-list
14146499|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
14146500|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
14146501|NCT05243290|Vitamins|vitamins|mesh-ancestor
14146502|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
14146503|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146504|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14146505|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
14146506|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146507|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14146508|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
14146509|NCT05239533|Nivolumab|nivolumab|mesh-list
14146510|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14146511|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146512|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146513|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14146514|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937664|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14937665|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
14937666|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937667|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146515|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
14146516|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146517|NCT05231382|Leucovorin|leucovorin|mesh-list
14146518|NCT05231382|Fluorouracil|fluorouracil|mesh-list
14146519|NCT05231382|Raltitrexed|raltitrexed|mesh-list
14146520|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
14146521|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
14146522|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146523|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14146524|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146525|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146526|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
14146527|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146528|NCT05231382|Antidotes|antidotes|mesh-ancestor
14146529|NCT05231382|Protective Agents|protective agents|mesh-ancestor
14146530|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
14146531|NCT05231382|Vitamins|vitamins|mesh-ancestor
14146532|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
14146533|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14146534|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146535|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14146536|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146537|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146538|NCT05215691|Morphine|morphine|mesh-list
14146539|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14146540|NCT05215691|Narcotics|narcotics|mesh-ancestor
14146541|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146542|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146543|NCT05215691|Analgesics|analgesics|mesh-ancestor
14146544|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
14146545|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146546|NCT05213650|Methamphetamine|methamphetamine|mesh-list
14146547|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14146548|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146549|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
14146550|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
14146551|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146552|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
14146553|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146554|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146555|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
14146556|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14146557|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14146558|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14146559|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14146560|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
14146561|NCT05203445|Olaparib|olaparib|mesh-list
14146562|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146563|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146564|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14146565|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146566|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146567|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
14146568|NCT05201612|Olaparib|olaparib|mesh-list
14146569|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146570|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146571|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14146572|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146573|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146574|NCT05200052|Colchicine|colchicine|mesh-list
14146575|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
14146576|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146577|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146578|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146579|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146580|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146581|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146582|NCT05198804|Niraparib|niraparib|mesh-list
14146583|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14146584|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146585|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146586|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146587|NCT05196945|Amoxicillin|amoxicillin|mesh-list
14146588|NCT05196945|Clarithromycin|clarithromycin|mesh-list
14146589|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
14146590|NCT05196945|Esomeprazole|esomeprazole|mesh-list
14146591|NCT05196945|Bismuth|bismuth|mesh-list
14146592|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765600|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765601|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14765602|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14765603|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
14765604|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765605|NCT00621478|Diazepam|diazepam|mesh-list
14765606|NCT00621478|Lorazepam|lorazepam|mesh-list
14765607|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
14146593|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14146594|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146595|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14146596|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146597|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14146598|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146599|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14146600|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14146601|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14146602|NCT05196945|Antacids|antacids|mesh-ancestor
14146603|NCT05196945|Diuretics|diuretics|mesh-ancestor
14146604|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
14146605|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146606|NCT05196945|Expectorants|expectorants|mesh-ancestor
14146607|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
14146608|NCT05186974|Carboplatin|carboplatin|mesh-list
14146609|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
14146610|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146611|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146612|NCT05183126|Paclitaxel|paclitaxel|mesh-list
14146613|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14146614|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146615|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146616|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146617|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146618|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146619|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146620|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
14146621|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14765608|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
14146622|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
14765609|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
14146623|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
14146624|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146625|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146626|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146627|NCT05167331|Analgesics|analgesics|mesh-ancestor
14146628|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
14146629|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146630|NCT05160597|Edetic Acid|edetic acid|mesh-list
14146631|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14146632|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
14146633|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
14146634|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146635|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
14146636|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14146637|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14146638|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
14146639|NCT05155007|Cyclosporine|cyclosporine|mesh-list
14146640|NCT05155007|Cyclosporins|cyclosporins|mesh-list
14146641|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146642|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146643|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146644|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
14146645|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146646|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
14146647|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146648|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146649|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146650|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14146651|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14146652|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
14146653|NCT05129475|Ritonavir|ritonavir|mesh-list
14146654|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14146655|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14146656|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
14146657|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146658|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146659|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14146660|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14146661|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
14146662|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146663|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14146664|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14146665|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
14146666|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146667|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146668|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
14146669|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146670|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146671|NCT05084508|Vaccines|vaccines|mesh-list
14146672|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14146673|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
14146674|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146675|NCT05083845|Anesthetics|anesthetics|mesh-list
14146676|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
14146677|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765610|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765611|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765612|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765613|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14765614|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765615|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14765616|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14765617|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765618|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
14765619|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
14765620|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765621|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765622|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14765623|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14765624|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14765625|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14765626|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
14765627|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
14765628|NCT00621491|Warfarin|warfarin|mesh-list
14146678|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146679|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
14146680|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146681|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
14146682|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146683|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178955|NCT04740190|Carboplatin|carboplatin|mesh-list
14178956|NCT04740190|Talazoparib|talazoparib|mesh-list
14178957|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178958|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14178959|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178960|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178961|NCT04740021|Carboplatin|carboplatin|mesh-list
14178962|NCT04740021|Etoposide|etoposide|mesh-list
14178963|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178964|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14178965|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14765629|NCT00621491|Anticoagulants|anticoagulants|mesh-list
14765630|NCT00621556|Secretin|secretin|mesh-list
14765631|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765632|NCT00621556|Hormones|hormones|mesh-ancestor
14178966|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14178967|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178968|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178969|NCT04740099|Naloxone|naloxone|mesh-list
14178970|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14178971|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178972|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
14178973|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14178974|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
14178975|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14178976|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178977|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178978|NCT04739774|Itraconazole|itraconazole|mesh-list
14178979|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
14178980|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14178981|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14178982|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14178983|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14178984|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14178985|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14178986|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
14178987|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14178988|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178989|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14178990|NCT04740086|Calcium|calcium|mesh-list
14178991|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14178992|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178993|NCT04739670|Gemcitabine|gemcitabine|mesh-list
14178994|NCT04739670|Bevacizumab|bevacizumab|mesh-list
14178995|NCT04739670|Carboplatin|carboplatin|mesh-list
14178996|NCT04739670|Atezolizumab|atezolizumab|mesh-list
14178997|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14765633|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14765634|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765635|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14765636|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
14765637|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765638|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14765639|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14765640|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765641|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765642|NCT00621673|Factor VIII|factor viii|mesh-list
14765643|NCT00621673|Coagulants|coagulants|mesh-ancestor
14765644|NCT00621699|Ezetimibe|ezetimibe|mesh-list
14765645|NCT00621699|Tacrolimus|tacrolimus|mesh-list
14765646|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765647|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
14765648|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765649|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14146684|NCT04954287|Vaccines|vaccines|mesh-list
14146685|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
14146686|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146687|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
14146688|NCT04938765|Analgesics|analgesics|mesh-ancestor
14146689|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
14146690|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146691|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146692|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
14146693|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146694|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14146695|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
14146696|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14146697|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14146698|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146699|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14146700|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
14146701|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14146702|NCT04935359|Gemcitabine|gemcitabine|mesh-list
14146703|NCT04935359|Paclitaxel|paclitaxel|mesh-list
14146704|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146705|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146706|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146707|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146708|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146709|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146710|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14146711|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
14146712|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
14146713|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146714|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146715|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146716|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
14146717|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146718|NCT04920344|Cisplatin|cisplatin|mesh-list
14146719|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146720|NCT04912115|Midazolam|midazolam|mesh-list
14146721|NCT04912115|Ketamine|ketamine|mesh-list
14146722|NCT04912115|Analgesics|analgesics|mesh-ancestor
14146723|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
14146724|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146725|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146726|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14146727|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14146728|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
14146729|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
14146730|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146731|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14146732|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14146733|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146734|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146735|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14146736|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14146737|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14146738|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14146739|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14146740|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
14146741|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
14146742|NCT04905693|Treprostinil|treprostinil|mesh-list
14146743|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14146744|NCT04902625|Naltrexone|naltrexone|mesh-list
14146745|NCT04902625|Bupropion|bupropion|mesh-list
14146746|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14146747|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14146748|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146749|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
14146750|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478811|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
14146751|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14146752|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
14146753|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14146754|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14146755|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14478812|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478813|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478814|NCT02458690|Dopamine|dopamine|mesh-list
14146756|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14146757|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146758|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
14146759|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146760|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14146761|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14146762|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146763|NCT04860713|Aspirin|aspirin|mesh-list
14146764|NCT04860713|Ketamine|ketamine|mesh-list
14146765|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14146766|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146767|NCT04860713|Analgesics|analgesics|mesh-ancestor
14146768|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
14146769|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146770|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146771|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146772|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146773|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14146774|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14146775|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765650|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146776|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14146777|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14146778|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146779|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
14146780|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14146781|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14146782|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
14146783|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
14146784|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14146785|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14146786|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14146787|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146788|NCT04799015|Dexamethasone|dexamethasone|mesh-list
14146789|NCT04799015|Metoclopramide|metoclopramide|mesh-list
14146790|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146791|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
14146792|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
14146793|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146794|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146795|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146796|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
14146797|NCT04799015|Hormones|hormones|mesh-ancestor
13954771|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954772|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
13954773|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
13954774|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13954775|NCT03194659|Choline|choline|mesh-list
13954776|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
13954777|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13954778|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
13954779|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954780|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13954781|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13954782|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
13954783|NCT03194594|Dexamethasone|dexamethasone|mesh-list
13954784|NCT03194594|Ketamine|ketamine|mesh-list
13954785|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954786|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
13954787|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
13962962|NCT02723994|Vincristine|vincristine|mesh-list
13954788|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954789|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937668|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14937669|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14937670|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14937671|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14937672|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14937673|NCT01477268|Sertraline|sertraline|mesh-list
13954790|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13954791|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
13954792|NCT03194594|Hormones|hormones|mesh-ancestor
13954793|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954794|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13954795|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954796|NCT03194594|Analgesics|analgesics|mesh-ancestor
13954797|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
13954798|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13954799|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13954800|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
13954801|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
13954802|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954803|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13954804|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13954805|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13954806|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954807|NCT03194555|Acetaminophen|acetaminophen|mesh-list
13954808|NCT03194555|Naltrexone|naltrexone|mesh-list
13954809|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13954810|NCT03194555|Analgesics|analgesics|mesh-ancestor
13954811|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
13954812|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954813|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954814|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
13954815|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13954816|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13954817|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
13954818|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
13954819|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954820|NCT03194139|Protective Agents|protective agents|mesh-ancestor
13954821|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954822|NCT03194204|Doxycycline|doxycycline|mesh-list
13954823|NCT03194204|Uric Acid|uric acid|mesh-list
13954824|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
13954825|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13954826|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954827|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
13954828|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13954829|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13954830|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
13954831|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954832|NCT03194204|Protective Agents|protective agents|mesh-ancestor
13954833|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954834|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
13954835|NCT03194126|Misoprostol|misoprostol|mesh-list
13954836|NCT03194126|Mifepristone|mifepristone|mesh-list
14937674|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
14146798|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146799|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14146800|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146801|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14146802|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14146803|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
14146804|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146805|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146806|NCT04796584|Antibodies|antibodies|mesh-list
14146807|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
14146808|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146809|NCT04791553|Cenobamate|cenobamate|mesh-list
14146810|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
14146811|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
14146812|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
14146813|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14146814|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146815|NCT04713657|Propranolol|propranolol|mesh-list
14146816|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14146817|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14146818|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
14146819|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14146820|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146821|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146822|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14146823|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14146824|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
14146825|NCT04701593|Triamcinolone|triamcinolone|mesh-list
14765651|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765652|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14765653|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14765654|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
14765655|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14765656|NCT00621725|Cediranib|cediranib|mesh-list
14765657|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765658|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765659|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765660|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765661|NCT00621790|Fenoldopam|fenoldopam|mesh-list
14765662|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14765663|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
14765664|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
14765665|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
14146826|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14146827|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14146828|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14146829|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146830|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
14146831|NCT04701593|Hormones|hormones|mesh-ancestor
14146832|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146833|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146834|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146835|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
14146836|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146837|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146838|NCT04611529|Ibuprofen|ibuprofen|mesh-list
14146839|NCT04611529|Diclofenac|diclofenac|mesh-list
14146840|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14146841|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14146842|NCT04611529|Analgesics|analgesics|mesh-ancestor
14146843|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
14146844|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146845|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146846|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146847|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146848|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14146849|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146850|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146851|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
14146852|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146853|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146854|NCT04552847|Octreotide|octreotide|mesh-list
14765666|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765667|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765668|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765669|NCT00621816|Nitroprusside|nitroprusside|mesh-list
14765670|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14765671|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
14765672|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14765673|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765674|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
14765675|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14765676|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765677|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14765678|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146855|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14146856|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14146857|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146858|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14146859|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
14146860|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
14146861|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14937675|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14937676|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14937677|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14937678|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765679|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14765680|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14765681|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954837|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14146862|NCT04537078|Cetrorelix|cetrorelix|mesh-list
14146863|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14146864|NCT04537078|Progesterone|progesterone|mesh-list
14146865|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
14146866|NCT04537078|Estradiol|estradiol|mesh-list
14146867|NCT04537078|Progestins|progestins|mesh-ancestor
14146868|NCT04537078|Hormones|hormones|mesh-ancestor
14146869|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146870|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146871|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14146872|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14146873|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
14146874|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14146875|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14146876|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146877|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14146878|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
14146879|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
14146880|NCT04537078|Estrogens|estrogens|mesh-ancestor
14146881|NCT04509401|Vitamins|vitamins|mesh-list
14146882|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
14146883|NCT04509401|Pyridoxal|pyridoxal|mesh-list
14146884|NCT04509401|Pyridoxine|pyridoxine|mesh-list
14146885|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
14146886|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
14146887|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146888|NCT04503551|Ranibizumab|ranibizumab|mesh-list
14146889|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14146890|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14146891|NCT04503551|Growth Substances|growth substances|mesh-ancestor
14146892|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954838|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
13954839|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13954840|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954841|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13954842|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13954843|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
13954844|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13962963|NCT02723994|Asparaginase|asparaginase|mesh-list
14146893|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
14146894|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146895|NCT04486352|Bevacizumab|bevacizumab|mesh-list
14146896|NCT04486352|Trastuzumab|trastuzumab|mesh-list
14146897|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14146898|NCT04486352|Atezolizumab|atezolizumab|mesh-list
14146899|NCT04486352|Talazoparib|talazoparib|mesh-list
14146900|NCT04486352|Maytansine|maytansine|mesh-list
14146901|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14146902|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146903|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146904|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14146905|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14146906|NCT04486352|Growth Substances|growth substances|mesh-ancestor
14146907|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146908|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
14146909|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
14146910|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14146911|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146912|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146913|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146914|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146915|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146916|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146917|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
14146918|NCT04478019|Povidone|povidone|mesh-list
14146919|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
14146920|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
14146921|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14146922|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146923|NCT04460937|Adavosertib|adavosertib|mesh-list
14146924|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146925|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146926|NCT04457596|Trastuzumab|trastuzumab|mesh-list
14146927|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14478815|NCT02458690|Norepinephrine|norepinephrine|mesh-list
14478816|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
14478817|NCT02458690|Serotonin|serotonin|mesh-list
14478818|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14478819|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
14478820|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14478821|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14478822|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478823|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478824|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478825|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478826|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
14478827|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
14478828|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478829|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14478830|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14478831|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14478832|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
14478833|NCT02458690|Protective Agents|protective agents|mesh-ancestor
14478834|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14478835|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
14478836|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14478837|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14478838|NCT02458768|Menotropins|menotropins|mesh-list
14478839|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14478840|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
14478841|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14478842|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478843|NCT02459275|Metoclopramide|metoclopramide|mesh-list
14478844|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
14146928|NCT04457596|Maytansine|maytansine|mesh-list
14478845|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
14478846|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937679|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146929|NCT04457596|Tucatinib|tucatinib|mesh-list
14146930|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146931|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146932|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14146933|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146934|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146935|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146936|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146937|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14937680|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937681|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
14937682|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937683|NCT01477294|Caffeine|caffeine|mesh-list
14937684|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14937685|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937686|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14937687|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937688|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937689|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14146938|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146939|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
14146940|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14146941|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14146942|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146943|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
14146944|NCT04448184|Coagulants|coagulants|mesh-ancestor
14146945|NCT04440176|Vaccines|vaccines|mesh-list
14146946|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
14146947|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146948|NCT04430426|Glycolic acid|glycolic acid|mesh-list
14146949|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
14146950|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146951|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
14146952|NCT04428333|Fluorouracil|fluorouracil|mesh-list
14146953|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14146954|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146955|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
14146956|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146957|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937690|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14937691|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
14937692|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937693|NCT01477385|Fluorides|fluorides|mesh-list
14937694|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
14937695|NCT01477385|Protective Agents|protective agents|mesh-ancestor
14937696|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937697|NCT01477411|Digoxin|digoxin|mesh-list
14937698|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14937699|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14146958|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146959|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
14146960|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14178998|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14178999|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14179000|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14179001|NCT04739670|Growth Substances|growth substances|mesh-ancestor
14179002|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179003|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
14179004|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14179005|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
14179006|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179007|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
14179008|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179009|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179010|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179011|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
14179012|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
14179013|NCT04739618|Ipilimumab|ipilimumab|mesh-list
14179014|NCT04739618|Sargramostim|sargramostim|mesh-list
14179015|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179016|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179017|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14179018|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146961|NCT04425252|Brequinar|brequinar|mesh-list
14146962|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146963|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146964|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146965|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146966|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
14146967|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146968|NCT04424862|Cyclosporine|cyclosporine|mesh-list
14146969|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
14146970|NCT04424862|Prednisone|prednisone|mesh-list
14146971|NCT04424862|Cyclosporins|cyclosporins|mesh-list
14146972|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14146973|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
14146974|NCT04424862|Hormones|hormones|mesh-ancestor
14146975|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14146976|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14146977|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14146978|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146979|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14146980|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146981|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14146982|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
14146983|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
14146984|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14146985|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
14146986|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14146987|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14146988|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14146989|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14765682|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
14765683|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
14765684|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
14765685|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765686|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765687|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
14765688|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14146990|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
14146991|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14146992|NCT04404140|Docetaxel|docetaxel|mesh-list
14146993|NCT04404140|Atezolizumab|atezolizumab|mesh-list
14146994|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14146995|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14146996|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14146997|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14146998|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14146999|NCT04382898|Cemiplimab|cemiplimab|mesh-list
14147000|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147001|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147002|NCT04338269|Atezolizumab|atezolizumab|mesh-list
14147003|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147014|NCT04330040|Olaparib|olaparib|mesh-list
14147015|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14147016|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147017|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147018|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147019|NCT04313166|Copper|copper|mesh-list
14147020|NCT04313166|Trace Elements|trace elements|mesh-ancestor
14147021|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
14147022|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147023|NCT04302766|Remdesivir|remdesivir|mesh-list
14147024|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
14147025|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147026|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
14147027|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147028|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
14147029|NCT04298229|Diuretics|diuretics|mesh-list
14179019|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
14147030|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14147031|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147032|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14147033|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147034|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
14147035|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
14147036|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14147037|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
14147038|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147039|NCT04278898|Expectorants|expectorants|mesh-ancestor
14147040|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
14147041|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14147042|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
14147043|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147044|NCT04278898|Protective Agents|protective agents|mesh-ancestor
14147045|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147046|NCT04278898|Antidotes|antidotes|mesh-ancestor
14147047|NCT04268849|Ascorbic Acid|ascorbic acid|mesh-list
13954845|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13954846|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13954847|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13954848|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
13954849|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13954850|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13954851|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
13954852|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954853|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
13954854|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13954855|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13954856|NCT03194061|Cisplatin|cisplatin|mesh-list
13954857|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954858|NCT03194074|Propofol|propofol|mesh-list
14147048|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14147049|NCT04268849|Vitamins|vitamins|mesh-ancestor
14147050|NCT04268849|Micronutrients|micronutrients|mesh-ancestor
14147051|NCT04268849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147052|NCT04268849|Antioxidants|antioxidants|mesh-ancestor
14147053|NCT04268849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147054|NCT04268849|Protective Agents|protective agents|mesh-ancestor
14147055|NCT04268849|Hematinics|hematinics|mesh-ancestor
14147056|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14147057|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14147058|NCT04229004|Gemcitabine|gemcitabine|mesh-list
14147059|NCT04229004|Paclitaxel|paclitaxel|mesh-list
14147060|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147061|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147062|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147063|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147064|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147065|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147066|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147067|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147068|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
14147069|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
14147070|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147071|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147072|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147073|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
14147074|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147075|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14147076|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147077|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147078|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14147079|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13954859|NCT03194074|Desflurane|desflurane|mesh-list
13954860|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13954861|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954862|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954863|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13954864|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
13954865|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
13954866|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13954867|NCT03193749|Amiodarone|amiodarone|mesh-list
13954868|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13954869|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
13954870|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13954871|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954872|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954873|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13954874|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13954875|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14147080|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147081|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
14147082|NCT04133532|Metoprolol|metoprolol|mesh-list
14147083|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14147084|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14147085|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
14147086|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
14147087|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147088|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147089|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14147090|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14147091|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14147092|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937700|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937701|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147093|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147094|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147095|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
14147096|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147097|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147098|NCT04126135|Nicotine|nicotine|mesh-list
14147099|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13954876|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954877|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13954878|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13954879|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13954880|NCT03193684|Dapagliflozin|dapagliflozin|mesh-list
13954881|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13954882|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954883|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13954884|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954885|NCT03193944|Vitamin D|vitamin d|mesh-list
13954886|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
13954887|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
13954888|NCT03193944|Vitamins|vitamins|mesh-list
13954889|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
13954890|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962964|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
14147100|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
14147101|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147102|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147103|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14147104|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14147105|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
14147106|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147107|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147108|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14147109|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
14147110|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14147111|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14147112|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14147113|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14147114|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147115|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
14147116|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147117|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147118|NCT03962855|Ifetroban|ifetroban|mesh-list
14147119|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14147120|NCT03940326|Levetiracetam|levetiracetam|mesh-list
14147121|NCT03940326|Valproic Acid|valproic acid|mesh-list
14147122|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
14147123|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
14147124|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147125|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147126|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
14147127|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147128|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147129|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
14147130|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14147131|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14147132|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14147133|NCT03918278|Gemcitabine|gemcitabine|mesh-list
14147134|NCT03918278|Paclitaxel|paclitaxel|mesh-list
14147135|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147136|NCT03918278|Carboplatin|carboplatin|mesh-list
14147137|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
14147138|NCT03918278|Pemetrexed|pemetrexed|mesh-list
14147139|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147140|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147141|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147142|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147143|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147144|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147145|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147146|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
14147147|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
14147148|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147149|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147150|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147151|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
14147152|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147153|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147154|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14147155|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14147156|NCT03892018|Paclitaxel|paclitaxel|mesh-list
14147157|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147158|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147159|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147160|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147161|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147162|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147163|NCT03885921|Atorvastatin|atorvastatin|mesh-list
14147164|NCT03885921|Simvastatin|simvastatin|mesh-list
14147165|NCT03885921|Ezetimibe|ezetimibe|mesh-list
14147166|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14147167|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147168|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
14147169|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147170|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147171|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14147172|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147173|NCT03884452|Atorvastatin|atorvastatin|mesh-list
14147174|NCT03884452|Simvastatin|simvastatin|mesh-list
14147175|NCT03884452|Ezetimibe|ezetimibe|mesh-list
14147176|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14147177|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147178|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
14147179|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147180|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147181|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14147182|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147183|NCT03882996|Atorvastatin|atorvastatin|mesh-list
14147184|NCT03882996|Ezetimibe|ezetimibe|mesh-list
14147185|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14147186|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147187|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
14147188|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147189|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147190|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14147191|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147192|NCT03882905|Ezetimibe|ezetimibe|mesh-list
14147193|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14147194|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147195|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
14147196|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147197|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147198|NCT03882892|Ezetimibe|ezetimibe|mesh-list
14147199|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14147200|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147201|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
14147202|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147203|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147204|NCT03878524|Vitamins|vitamins|mesh-list
14147205|NCT03878524|Leucovorin|leucovorin|mesh-list
14147206|NCT03878524|Vitamin A|vitamin a|mesh-list
14147207|NCT03878524|Sirolimus|sirolimus|mesh-list
14147208|NCT03878524|Celecoxib|celecoxib|mesh-list
14147209|NCT03878524|Paclitaxel|paclitaxel|mesh-list
14147210|NCT03878524|Maytansine|maytansine|mesh-list
14147211|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14147212|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147213|NCT03878524|Bevacizumab|bevacizumab|mesh-list
14147214|NCT03878524|Carboplatin|carboplatin|mesh-list
14147215|NCT03878524|Doxorubicin|doxorubicin|mesh-list
14147216|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14147217|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
14147218|NCT03878524|Fluorouracil|fluorouracil|mesh-list
14147219|NCT03878524|Capecitabine|capecitabine|mesh-list
14147220|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
14147221|NCT03878524|Nivolumab|nivolumab|mesh-list
14147222|NCT03878524|Trastuzumab|trastuzumab|mesh-list
14147223|NCT03878524|Everolimus|everolimus|mesh-list
14147224|NCT03878524|Bortezomib|bortezomib|mesh-list
14147225|NCT03878524|Sorafenib|sorafenib|mesh-list
14147226|NCT03878524|Ipilimumab|ipilimumab|mesh-list
14147227|NCT03878524|Durvalumab|durvalumab|mesh-list
14147228|NCT03878524|Sunitinib|sunitinib|mesh-list
14147229|NCT03878524|Daunorubicin|daunorubicin|mesh-list
14147230|NCT03878524|Dasatinib|dasatinib|mesh-list
14147231|NCT03878524|Olaparib|olaparib|mesh-list
14147232|NCT03878524|Venetoclax|venetoclax|mesh-list
14147233|NCT03878524|Lenvatinib|lenvatinib|mesh-list
14147234|NCT03878524|Palbociclib|palbociclib|mesh-list
14147235|NCT03878524|Vorinostat|vorinostat|mesh-list
14147236|NCT03878524|Pertuzumab|pertuzumab|mesh-list
14147237|NCT03878524|Trametinib|trametinib|mesh-list
14147238|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
14147239|NCT03878524|Tretinoin|tretinoin|mesh-list
14147240|NCT03878524|Bicalutamide|bicalutamide|mesh-list
14147241|NCT03878524|Afatinib|afatinib|mesh-list
14147242|NCT03878524|Panobinostat|panobinostat|mesh-list
14147243|NCT03878524|Vemurafenib|vemurafenib|mesh-list
14147244|NCT03878524|Dabrafenib|dabrafenib|mesh-list
14147245|NCT03878524|Ponatinib|ponatinib|mesh-list
14147246|NCT03878524|Idelalisib|idelalisib|mesh-list
14147247|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14147248|NCT03878524|Losartan|losartan|mesh-list
14765689|NCT00621998|Olanzapine|olanzapine|mesh-list
14765690|NCT00621998|Risperidone|risperidone|mesh-list
14765691|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14765692|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
14765693|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765694|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765695|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765696|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14765697|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14765698|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765699|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765700|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14765701|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
13962965|NCT02723994|Pegaspargase|pegaspargase|mesh-list
13962966|NCT02723994|Thioguanine|thioguanine|mesh-list
13962967|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
13962968|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13962969|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
13962970|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962971|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13962972|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13962973|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
13962974|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13962975|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13962976|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13962977|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13962978|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
13962979|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
13962980|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962981|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13962982|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
13962983|NCT02723994|Hormones|hormones|mesh-ancestor
14147249|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
14147250|NCT03878524|Antibodies|antibodies|mesh-list
14147251|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
14147252|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14147253|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14147254|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
14147255|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
14147256|NCT03878524|Entrectinib|entrectinib|mesh-list
14147257|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
14147258|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147259|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147260|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147261|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147262|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147263|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147264|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14147265|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14147266|NCT03878524|Growth Substances|growth substances|mesh-ancestor
14147267|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147268|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
14147269|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
14147270|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
14147271|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14147272|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14147273|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14147274|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147275|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
14147276|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147277|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147278|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14147279|NCT03878524|Antidotes|antidotes|mesh-ancestor
14147280|NCT03878524|Protective Agents|protective agents|mesh-ancestor
14147281|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
14147282|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14147283|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14147284|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147285|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
14147286|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14147287|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14147288|NCT03878524|Analgesics|analgesics|mesh-ancestor
14147289|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
14147290|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147291|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14147292|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14147293|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14765702|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
14765703|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
14765704|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765705|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765706|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14765707|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14765708|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765709|NCT00622011|Risperidone|risperidone|mesh-list
14765710|NCT00622011|Zotepine|zotepine|mesh-list
14765711|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14765712|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
14765713|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765714|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765715|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765716|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14765717|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14765718|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765719|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765720|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14765721|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
14765722|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
14765723|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14765724|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14765725|NCT00622115|Enoxaparin|enoxaparin|mesh-list
14765726|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
14765727|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14765728|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14765729|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147294|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14765730|NCT00622141|Saquinavir|saquinavir|mesh-list
14765731|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14937702|NCT01477411|Protective Agents|protective agents|mesh-ancestor
14937703|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937704|NCT01477424|Warfarin|warfarin|mesh-list
14937705|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
14147295|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14147296|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14147297|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14147298|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14147299|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14147300|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14147301|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
14147302|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14147303|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
14147304|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14147305|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
14147306|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
14147307|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14147308|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14147309|NCT03875313|Talazoparib|talazoparib|mesh-list
14147310|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14147311|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147312|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147313|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147314|NCT03867318|Atorvastatin|atorvastatin|mesh-list
14147315|NCT03867318|Ezetimibe|ezetimibe|mesh-list
14147316|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14147317|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147318|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
14147319|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147320|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147321|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14147322|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147323|NCT03867188|Bupivacaine|bupivacaine|mesh-list
14147324|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
14147325|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
14147326|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14147327|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147328|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
14147329|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147330|NCT03867110|Atorvastatin|atorvastatin|mesh-list
14147331|NCT03867110|Ezetimibe|ezetimibe|mesh-list
14147332|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14147333|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147334|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
14765732|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14765733|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
14765734|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765735|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765736|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14765737|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14765738|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
14765739|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765740|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14765741|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14765742|NCT00622206|Ritonavir|ritonavir|mesh-list
14765743|NCT00622206|Saquinavir|saquinavir|mesh-list
14765744|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14765745|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14765746|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
14765747|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765748|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765749|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14765750|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14765751|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
14765752|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765753|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14765754|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14937706|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14147335|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147336|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147337|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14147338|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147339|NCT03865082|Nivolumab|nivolumab|mesh-list
14147340|NCT03865082|Ipilimumab|ipilimumab|mesh-list
14147341|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147342|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147343|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14147344|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147345|NCT03860844|Cytarabine|cytarabine|mesh-list
14147346|NCT03860844|Dexamethasone|dexamethasone|mesh-list
14937707|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14937708|NCT01477489|Veliparib|veliparib|mesh-list
14937709|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14937710|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937711|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147347|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
14147348|NCT03860844|Doxorubicin|doxorubicin|mesh-list
14147349|NCT03860844|Methotrexate|methotrexate|mesh-list
14147350|NCT03860844|Fludarabine|fludarabine|mesh-list
14147351|NCT03860844|Etoposide|etoposide|mesh-list
14147352|NCT03860844|Vincristine|vincristine|mesh-list
14147353|NCT03860844|Daunorubicin|daunorubicin|mesh-list
14147354|NCT03860844|Asparaginase|asparaginase|mesh-list
14147355|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
14147356|NCT03860844|Idarubicin|idarubicin|mesh-list
14147357|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
14147358|NCT03860844|Pegaspargase|pegaspargase|mesh-list
14147359|NCT03860844|Montelukast|montelukast|mesh-list
14147360|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147361|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
14147362|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147363|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14147364|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14147365|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
14147366|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147367|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147368|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14147369|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14147370|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
14147371|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
14147372|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147373|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14147374|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
14147375|NCT03860844|Hormones|hormones|mesh-ancestor
14147376|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14147377|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14147378|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14147379|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14147380|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14147381|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147382|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14147383|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
14147384|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14147385|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147386|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
14147387|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
14147388|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14147389|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14147390|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147391|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
14147392|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147393|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147394|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147395|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147396|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14147397|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
14147398|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14147399|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
14147400|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14147401|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14147402|NCT03860844|Analgesics|analgesics|mesh-ancestor
14147403|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
14147404|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
14147405|NCT03840915|Gemcitabine|gemcitabine|mesh-list
14147406|NCT03840915|Paclitaxel|paclitaxel|mesh-list
14147407|NCT03840915|Docetaxel|docetaxel|mesh-list
14147408|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147409|NCT03840915|Carboplatin|carboplatin|mesh-list
14147410|NCT03840915|Pemetrexed|pemetrexed|mesh-list
14147411|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147412|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147413|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147414|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147415|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147416|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147417|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147418|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
14147419|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
14147420|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147421|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147422|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147423|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
14147424|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147425|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14147426|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14179020|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179021|NCT04739566|Trametinib|trametinib|mesh-list
14179022|NCT04739566|Dabrafenib|dabrafenib|mesh-list
14179023|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179024|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14179025|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179026|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179027|NCT04739410|Ivermectin|ivermectin|mesh-list
14179028|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14179029|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179030|NCT04739241|Insulin|insulin|mesh-list
14179031|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14179032|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14179033|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179034|NCT04739202|Bevacizumab|bevacizumab|mesh-list
14179035|NCT04739202|Atezolizumab|atezolizumab|mesh-list
14179036|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14179037|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179038|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179039|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14179040|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14179041|NCT04739202|Growth Substances|growth substances|mesh-ancestor
14179042|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179043|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
14179044|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
14179045|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
14179046|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14179047|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179048|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14179049|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179050|NCT04738955|Micafungin|micafungin|mesh-list
14179051|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
14179052|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179053|NCT04739111|Antibodies|antibodies|mesh-list
14179054|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
14179055|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14179056|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
14179057|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179058|NCT04738981|Basiliximab|basiliximab|mesh-list
14179059|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179060|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
14179061|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179062|NCT04738695|Antibodies|antibodies|mesh-list
14179063|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
14179064|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179065|NCT04738838|Oxytocin|oxytocin|mesh-list
14179066|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
14179067|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14179068|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183957|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
14183958|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14765755|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14147427|NCT03746080|Plerixafor|plerixafor|mesh-list
14147428|NCT03746080|Temozolomide|temozolomide|mesh-list
14147429|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14147430|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
14147431|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147432|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147433|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14147434|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14147435|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
14147436|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147437|NCT03715933|Carboplatin|carboplatin|mesh-list
14147438|NCT03715933|Fluorouracil|fluorouracil|mesh-list
14147439|NCT03715933|Irinotecan|irinotecan|mesh-list
14147440|NCT03715933|Pemetrexed|pemetrexed|mesh-list
14147441|NCT03715933|Temozolomide|temozolomide|mesh-list
14147442|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147443|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
14147444|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147445|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147446|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147447|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
14147448|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147449|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14147450|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14147451|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147452|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14147453|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14147454|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14147455|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
14147456|NCT03713944|Bevacizumab|bevacizumab|mesh-list
14147457|NCT03713944|Carboplatin|carboplatin|mesh-list
14147458|NCT03713944|Pemetrexed|pemetrexed|mesh-list
14147459|NCT03713944|Atezolizumab|atezolizumab|mesh-list
14147460|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147461|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147462|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14147463|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14147464|NCT03713944|Growth Substances|growth substances|mesh-ancestor
14147465|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147466|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
14147467|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147468|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147469|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14147470|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14147471|NCT03708224|Atezolizumab|atezolizumab|mesh-list
14147472|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147473|NCT03689855|Atezolizumab|atezolizumab|mesh-list
14147474|NCT03689855|Ramucirumab|ramucirumab|mesh-list
14147475|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147476|NCT03681561|Nivolumab|nivolumab|mesh-list
14147477|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147478|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147479|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14147480|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147481|NCT03678883|Gemcitabine|gemcitabine|mesh-list
14147482|NCT03678883|Paclitaxel|paclitaxel|mesh-list
14147483|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147484|NCT03678883|Carboplatin|carboplatin|mesh-list
14147485|NCT03678883|Doxorubicin|doxorubicin|mesh-list
14147486|NCT03678883|Irinotecan|irinotecan|mesh-list
14147487|NCT03678883|Lomustine|lomustine|mesh-list
14147488|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147489|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147490|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147491|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147492|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147493|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147494|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147495|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
14147496|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
14147497|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147498|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147499|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147500|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
14147501|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147502|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14147503|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14147504|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14147505|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14147506|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14147507|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
14147508|NCT03656718|Nivolumab|nivolumab|mesh-list
14147509|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147510|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147511|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14147512|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147513|NCT03639246|Paclitaxel|paclitaxel|mesh-list
14147514|NCT03639246|Doxorubicin|doxorubicin|mesh-list
14147515|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14147516|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147517|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147518|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147519|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147520|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147521|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147522|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14147523|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14147524|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14147525|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147526|NCT03556202|Mirikizumab|mirikizumab|mesh-list
14147527|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14147528|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14147529|NCT03556202|Analgesics|analgesics|mesh-ancestor
14147530|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
14147531|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147532|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147533|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14147534|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14147535|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14147536|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14147537|NCT03498378|Cetuximab|cetuximab|mesh-list
14147538|NCT03498378|Avelumab|avelumab|mesh-list
14147539|NCT03498378|Palbociclib|palbociclib|mesh-list
14147540|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147541|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147542|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14147543|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147544|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147545|NCT03466801|Prednisone|prednisone|mesh-list
14147546|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
14147547|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14147548|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14147549|NCT03466801|Hormones|hormones|mesh-ancestor
14147550|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14147551|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147552|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14147553|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147554|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
14147555|NCT03466450|Temozolomide|temozolomide|mesh-list
14147556|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14147557|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
14147558|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147559|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147560|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
14147561|NCT03449888|Calcium|calcium|mesh-list
14147562|NCT03449888|Regadenoson|regadenoson|mesh-list
14147563|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14147564|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147565|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14147566|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14147567|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14147568|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
14147569|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
14147570|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147571|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147572|NCT03415854|Gemcitabine|gemcitabine|mesh-list
14147573|NCT03415854|Paclitaxel|paclitaxel|mesh-list
14147574|NCT03415854|Cisplatin|cisplatin|mesh-list
14147575|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147576|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147577|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937712|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937713|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
13954891|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14147578|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147579|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147580|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147581|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147582|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147583|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
14147584|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
14147585|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13954892|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13954893|NCT03193957|Etanercept|etanercept|mesh-list
13954894|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13954895|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13954896|NCT03193957|Analgesics|analgesics|mesh-ancestor
13954897|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
14147586|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147587|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147588|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
14147589|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147590|NCT03409614|Cemiplimab|cemiplimab|mesh-list
14147591|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147592|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147593|NCT03408873|Aripiprazole|aripiprazole|mesh-list
14147594|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
14147595|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14147596|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14147597|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14147598|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14147599|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147600|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
14147601|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
14147602|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147603|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147604|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14147605|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14147606|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
14147607|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14147608|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14147609|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14147610|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14147611|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
14147612|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147613|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147614|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
14147615|NCT03375645|Narcotics|narcotics|mesh-ancestor
14147616|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14147617|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147618|NCT03375645|Analgesics|analgesics|mesh-ancestor
14147619|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
14147620|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147621|NCT03363763|Sirolimus|sirolimus|mesh-list
14147622|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14147623|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147624|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14147625|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147626|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
14147627|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147628|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
14147629|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147630|NCT03332667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14147631|NCT03332667|Vorinostat|vorinostat|mesh-list
14147632|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14147633|NCT03332667|Dinutuximab|dinutuximab|mesh-list
14147634|NCT03332667|Antibodies|antibodies|mesh-list
14765756|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
14765757|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765758|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14765759|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14765760|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765761|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765762|NCT00622258|Everolimus|everolimus|mesh-list
14765763|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147635|NCT03332667|Immunoglobulins|immunoglobulins|mesh-list
14147636|NCT03332667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14147637|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
14147638|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147639|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147640|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14147641|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147642|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147643|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14147644|NCT03321045|Trastuzumab|trastuzumab|mesh-list
14147645|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147646|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147647|NCT03308396|Durvalumab|durvalumab|mesh-list
14147648|NCT03308396|Guadecitabine|guadecitabine|mesh-list
14147649|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147650|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147651|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
14147652|NCT03290612|Vitamins|vitamins|mesh-ancestor
14147653|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
14147654|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147655|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
14147656|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147657|NCT03290612|Protective Agents|protective agents|mesh-ancestor
14147658|NCT03285321|Nivolumab|nivolumab|mesh-list
14147659|NCT03285321|Ipilimumab|ipilimumab|mesh-list
14147660|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147661|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147662|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14147663|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147664|NCT03284866|Vaccines|vaccines|mesh-list
14147665|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
14147666|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147667|NCT03283761|Leucovorin|leucovorin|mesh-list
14147668|NCT03283761|Paclitaxel|paclitaxel|mesh-list
14147669|NCT03283761|Fluorouracil|fluorouracil|mesh-list
14147670|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
14147671|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147672|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147673|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147674|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147675|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147676|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147677|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
14147678|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147679|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147680|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
14147681|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147682|NCT03283761|Antidotes|antidotes|mesh-ancestor
14147683|NCT03283761|Protective Agents|protective agents|mesh-ancestor
14147684|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
14147685|NCT03283761|Vitamins|vitamins|mesh-ancestor
14147686|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
14147687|NCT03251911|Ivacaftor|ivacaftor|mesh-list
14147688|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14147689|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765764|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147690|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147691|NCT03221400|Leucovorin|leucovorin|mesh-list
14147692|NCT03221400|Folic Acid|folic acid|mesh-list
14147693|NCT03221400|Fluorouracil|fluorouracil|mesh-list
14147694|NCT03221400|Niraparib|niraparib|mesh-list
14147695|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
14147696|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
14147697|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765765|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
14765766|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765767|NCT00622349|Gemcitabine|gemcitabine|mesh-list
14765768|NCT00622349|Cisplatin|cisplatin|mesh-list
14765769|NCT00622349|Docetaxel|docetaxel|mesh-list
14765770|NCT00622349|Ifosfamide|ifosfamide|mesh-list
14765771|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
14765772|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765773|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14765774|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
14765775|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765776|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
14765777|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765778|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765779|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147698|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147699|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147700|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147701|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
14147702|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147703|NCT03221400|Antidotes|antidotes|mesh-ancestor
14147704|NCT03221400|Protective Agents|protective agents|mesh-ancestor
14147705|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
14147706|NCT03221400|Vitamins|vitamins|mesh-ancestor
14147707|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
14147708|NCT03221400|Hematinics|hematinics|mesh-ancestor
14147709|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14147710|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147711|NCT03197662|Oxytocin|oxytocin|mesh-list
14147712|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
14147713|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14147714|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147715|NCT03138720|Gemcitabine|gemcitabine|mesh-list
14147716|NCT03138720|Paclitaxel|paclitaxel|mesh-list
14147717|NCT03138720|Cisplatin|cisplatin|mesh-list
14147718|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147719|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147720|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147721|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147722|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147723|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147724|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147725|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147726|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
14147727|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
14147728|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147729|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147730|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147731|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
14147732|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147733|NCT03137888|Temozolomide|temozolomide|mesh-list
14147734|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14147735|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
14147736|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147737|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147738|NCT03136809|Copper|copper|mesh-list
14147739|NCT03136809|Trace Elements|trace elements|mesh-ancestor
14147740|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
14147741|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147742|NCT03132467|Durvalumab|durvalumab|mesh-list
14147743|NCT03132467|Ipilimumab|ipilimumab|mesh-list
14147744|NCT03132467|Tremelimumab|tremelimumab|mesh-list
14147745|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
14147746|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14147747|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
14147748|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147749|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147750|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
14147751|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147752|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14147753|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147754|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
14147755|NCT03107988|Topotecan|topotecan|mesh-list
14147756|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147757|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
14147758|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147759|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14147760|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14147761|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
14147762|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147763|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147764|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14147765|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14147766|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14147767|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147768|NCT03096288|Evolocumab|evolocumab|mesh-list
14147769|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14478847|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478848|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14147770|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14147771|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
14147772|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937714|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14937715|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
14937716|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147773|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14147774|NCT03090165|Bicalutamide|bicalutamide|mesh-list
14147775|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
14147776|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
14147777|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14147778|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147779|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147780|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
14147781|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
14147782|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14147783|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
14147784|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147785|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147786|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14147787|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
14147788|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14147789|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14147790|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14147791|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
14147792|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147793|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147794|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14765780|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
14765781|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765782|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
14765783|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
14765784|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
14765785|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14765786|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
14765787|NCT00622375|Mesalamine|mesalamine|mesh-list
14765788|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14147795|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14147796|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14147797|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
14147798|NCT03041688|Decitabine|decitabine|mesh-list
14147799|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147800|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
14147801|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147802|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147803|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147804|NCT02942290|Azacitidine|azacitidine|mesh-list
14147805|NCT02942290|Venetoclax|venetoclax|mesh-list
14147806|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147807|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
14147808|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147809|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147810|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147811|NCT02919436|Tamsulosin|tamsulosin|mesh-list
14147812|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14147813|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14147814|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14147815|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14147816|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147817|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147818|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147819|NCT02919436|Urological Agents|urological agents|mesh-ancestor
14147820|NCT02879136|Methylphenidate|methylphenidate|mesh-list
14937717|NCT01477580|Antacids|antacids|mesh-ancestor
14937718|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147821|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14147822|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14147823|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147824|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14147825|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14147826|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765789|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765790|NCT00622375|Analgesics|analgesics|mesh-ancestor
14765791|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
14147827|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147828|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
14147829|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14147830|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14147831|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
14147832|NCT02877134|Ustekinumab|ustekinumab|mesh-list
14147833|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
14147834|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
14147835|NCT02875314|Thiotepa|thiotepa|mesh-list
14147836|NCT02875314|Cisplatin|cisplatin|mesh-list
14147837|NCT02875314|Carboplatin|carboplatin|mesh-list
14147838|NCT02875314|Methotrexate|methotrexate|mesh-list
14147839|NCT02875314|Etoposide|etoposide|mesh-list
14147840|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
14147841|NCT02875314|Vincristine|vincristine|mesh-list
14147842|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147843|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
14147844|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147845|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14147846|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14765792|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14147847|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
14147848|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147849|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147850|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14147851|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14147852|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
14147853|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14147854|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147855|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
14147856|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
14147857|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147858|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14147859|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14147860|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147861|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14147862|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14147863|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147864|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147865|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147866|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
14147867|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147868|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147869|NCT02741323|Maraviroc|maraviroc|mesh-list
14147870|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14147871|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14147872|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147873|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14147874|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14147875|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
14147876|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147877|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14765793|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765794|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14765795|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14765796|NCT00622414|Aflibercept|aflibercept|mesh-list
14765797|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
14765798|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13954898|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954899|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954900|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954901|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13954902|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13954903|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13954904|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
13954905|NCT03193814|Apatinib|apatinib|mesh-list
13954906|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954907|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13954908|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765799|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14147927|NCT02178436|Gemcitabine|gemcitabine|mesh-list
14147928|NCT02178436|Paclitaxel|paclitaxel|mesh-list
14147929|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14147930|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14147931|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147932|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14147933|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14147934|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
14147935|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147936|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147937|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
14147938|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
14147939|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147940|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147941|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147942|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
14147943|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147944|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14147945|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147946|NCT02086604|Lenalidomide|lenalidomide|mesh-list
14147947|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14147948|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
14147949|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147950|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14147951|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14147952|NCT02086604|Growth Substances|growth substances|mesh-ancestor
14147953|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
14147954|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147955|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179069|NCT04738773|Naltrexone|naltrexone|mesh-list
14179070|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14179071|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14179072|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179073|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
14179074|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179075|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
14179076|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
14179077|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14179078|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179079|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179080|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
14179081|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14179082|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179083|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179084|NCT04738058|Lactoferrin|lactoferrin|mesh-list
14179085|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179086|NCT04738188|Epirubicin|epirubicin|mesh-list
14179087|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14179088|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179089|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14179090|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14478849|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14478850|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14478851|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
14478852|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478853|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765800|NCT00622414|Growth Substances|growth substances|mesh-ancestor
14147956|NCT01983774|Esomeprazole|esomeprazole|mesh-list
14147957|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14147958|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14147959|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14147960|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147961|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147962|NCT01970865|Crizotinib|crizotinib|mesh-list
14147963|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147964|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14147965|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147966|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147972|NCT01554410|Gemcitabine|gemcitabine|mesh-list
14147973|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147974|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14147975|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
14147976|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14147977|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
14147978|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147979|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14147980|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147981|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
14147982|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147983|NCT01499888|Sirolimus|sirolimus|mesh-list
14147984|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
14147985|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14147986|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14147987|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14147988|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14147989|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
14147990|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14147991|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
14147992|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147993|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14147994|NCT01204684|Vaccines|vaccines|mesh-list
14147995|NCT01204684|Poly ICLC|poly iclc|mesh-list
14147996|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
14147997|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14147998|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
14147999|NCT00867191|Desloratadine|desloratadine|mesh-list
14148000|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148001|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148002|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148003|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148004|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148005|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148006|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148007|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148008|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
14148009|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
14148010|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148011|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148012|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148013|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
14148014|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148015|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148016|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148017|NCT00805584|Desloratadine|desloratadine|mesh-list
14148018|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148019|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148020|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148021|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148022|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148023|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148024|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148025|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148026|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
14148027|NCT00795522|Desloratadine|desloratadine|mesh-list
14148028|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148029|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148030|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148031|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148032|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148033|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148034|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148035|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148036|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
14148037|NCT00795158|Desloratadine|desloratadine|mesh-list
14148038|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148039|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148040|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148041|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148042|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148043|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148044|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14937719|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937720|NCT01477606|Cytarabine|cytarabine|mesh-list
14937721|NCT01477606|Daunorubicin|daunorubicin|mesh-list
14937722|NCT01477606|Midostaurin|midostaurin|mesh-list
14937723|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14148045|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148046|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
14148047|NCT00794846|Cetirizine|cetirizine|mesh-list
14148048|NCT00794846|Desloratadine|desloratadine|mesh-list
14148049|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148050|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148051|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148052|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148053|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
14148054|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148055|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148056|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148057|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148058|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148059|NCT00794768|Fexofenadine|fexofenadine|mesh-list
14148060|NCT00794768|Desloratadine|desloratadine|mesh-list
14148061|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148062|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148063|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148064|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148065|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148066|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148067|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148068|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148069|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
14148070|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148071|NCT00794599|Cetirizine|cetirizine|mesh-list
14148072|NCT00794599|Desloratadine|desloratadine|mesh-list
14148073|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148074|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148075|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148076|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148077|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
14148078|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148079|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937724|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
14148080|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148081|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148082|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148083|NCT00794495|Cetirizine|cetirizine|mesh-list
14148084|NCT00794495|Desloratadine|desloratadine|mesh-list
14148085|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148086|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148087|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148088|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148089|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
14148090|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148091|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148092|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148093|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148094|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148095|NCT00794248|Fexofenadine|fexofenadine|mesh-list
14148096|NCT00794248|Desloratadine|desloratadine|mesh-list
14148097|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148098|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
14938760|NCT01484145|Terbinafine|terbinafine|mesh-list
14148099|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148100|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148101|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148102|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148103|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148104|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148105|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
14148106|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148107|NCT00783354|Loratadine|loratadine|mesh-list
14148108|NCT00783354|Desloratadine|desloratadine|mesh-list
14148109|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148110|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148111|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148112|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148113|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148114|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148115|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148116|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148117|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
14148118|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
14148119|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148120|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148121|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
14148122|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148123|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148124|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148125|NCT00783133|Fexofenadine|fexofenadine|mesh-list
14148126|NCT00783133|Desloratadine|desloratadine|mesh-list
14148127|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148128|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148129|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148130|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148131|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148132|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148133|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148134|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148135|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
14148136|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148137|NCT00779636|Desloratadine|desloratadine|mesh-list
14148138|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148139|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148140|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148141|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148142|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148143|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14478854|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14478855|NCT02459418|Hormones|hormones|mesh-ancestor
14478856|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478857|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478858|NCT02459665|Metronidazole|metronidazole|mesh-list
14478859|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478860|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14478861|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14478862|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14478863|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14478864|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14148144|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148145|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148146|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
14148147|NCT00763529|Fluticasone|fluticasone|mesh-list
14148148|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
14148149|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14765801|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765802|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
14148150|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14148151|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
14148152|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148153|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148154|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14148155|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
14148156|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
14765803|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765804|NCT00622479|Sorafenib|sorafenib|mesh-list
14765805|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765806|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14765807|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765808|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765809|NCT00622570|Pentobarbital|pentobarbital|mesh-list
14765810|NCT00622570|Thiopental|thiopental|mesh-list
14765811|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
14765812|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14765813|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765814|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765815|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14765816|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
14765817|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
14765818|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
14765819|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
14765820|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148157|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148158|NCT00757562|Desloratadine|desloratadine|mesh-list
14148159|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14148160|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148161|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148162|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148163|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148164|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14148165|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14148166|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148167|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
14148168|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
14148169|NCT00751075|Amoxicillin|amoxicillin|mesh-list
14148170|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14148171|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148172|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148173|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148174|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148175|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
14765821|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765822|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14765823|NCT00622622|Gemcitabine|gemcitabine|mesh-list
14765824|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14765825|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
14765826|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765827|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765828|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
14765829|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765830|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765831|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765832|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
14765833|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765834|NCT00622648|Enoxaparin|enoxaparin|mesh-list
14765835|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
14765836|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14765837|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14765838|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765839|NCT00622674|Cetuximab|cetuximab|mesh-list
14765840|NCT00622674|Bortezomib|bortezomib|mesh-list
14765841|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14765842|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765843|NCT00622687|Iloprost|iloprost|mesh-list
14765844|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14148176|NCT00750750|Amoxicillin|amoxicillin|mesh-list
14148177|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14148178|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148179|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148180|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148181|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148182|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
14148183|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148184|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148185|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14148186|NCT00653835|Simvastatin|simvastatin|mesh-list
14148187|NCT00653835|Ezetimibe|ezetimibe|mesh-list
14148188|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148189|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148190|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
14148191|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148192|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148193|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148194|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148195|NCT00653796|Atorvastatin|atorvastatin|mesh-list
14148196|NCT00653796|Ezetimibe|ezetimibe|mesh-list
14148197|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148198|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148199|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
14148200|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148201|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148202|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148203|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148204|NCT00651404|Ezetimibe|ezetimibe|mesh-list
14148205|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148206|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148207|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
14148208|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148209|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148210|NCT00651391|Simvastatin|simvastatin|mesh-list
14148211|NCT00651391|Ezetimibe|ezetimibe|mesh-list
14148212|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14937725|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937726|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937727|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
14148213|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148214|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
14148215|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937728|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937729|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14937730|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
14937731|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148216|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148217|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148218|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148219|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14148220|NCT00651144|Ezetimibe|ezetimibe|mesh-list
14148221|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148222|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148223|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
14148224|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148225|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148226|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148227|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148228|NCT00651014|Ezetimibe|ezetimibe|mesh-list
14148229|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148230|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148231|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
14148232|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148233|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148234|NCT00650689|Atorvastatin|atorvastatin|mesh-list
14148235|NCT00650689|Ezetimibe|ezetimibe|mesh-list
14148236|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148237|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148238|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
14148239|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148240|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148241|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148242|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148243|NCT00650663|Simvastatin|simvastatin|mesh-list
14148244|NCT00650663|Ezetimibe|ezetimibe|mesh-list
14148245|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148246|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148247|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
14148248|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148249|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148250|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148251|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148252|NCT00589420|Docetaxel|docetaxel|mesh-list
14148253|NCT00589420|Sorafenib|sorafenib|mesh-list
14148254|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148255|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14148256|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14148257|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14148258|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148259|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148260|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148261|NCT00552097|Simvastatin|simvastatin|mesh-list
14148262|NCT00552097|Ezetimibe|ezetimibe|mesh-list
14148263|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148264|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148265|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
14148266|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148267|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148268|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148269|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148270|NCT00398294|Simvastatin|simvastatin|mesh-list
14148271|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148272|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148273|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
14148274|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148275|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148276|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148277|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148278|NCT00396175|Finasteride|finasteride|mesh-list
14148279|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148280|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148281|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14148282|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14148283|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148284|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
14148285|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148286|NCT00396175|Urological Agents|urological agents|mesh-ancestor
14148287|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
14148288|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14148289|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14148290|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
14148291|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148292|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148293|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148294|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
14148295|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
14148296|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148297|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
14148298|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14148299|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
14148300|NCT00370890|Gemcitabine|gemcitabine|mesh-list
14148301|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148302|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14148303|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
14148304|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148305|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
14148306|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148307|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148308|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14148309|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
14148310|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148311|NCT04231565|Tenofovir|tenofovir|mesh-list
14148312|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
14148313|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148314|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14148315|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14937732|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14938761|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
14148316|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148317|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148318|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14148319|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14148320|NCT04189445|Futibatinib|futibatinib|mesh-list
14148321|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148322|NCT04123444|Iloprost|iloprost|mesh-list
14148323|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14148324|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
14148325|NCT04116502|Interferons|interferons|mesh-list
14148326|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
14148327|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
14148328|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
14148329|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148330|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
14148331|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148332|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
14148333|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148334|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
14148335|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148336|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148337|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14148338|NCT04116047|Durvalumab|durvalumab|mesh-list
14148339|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148340|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14148341|NCT04095845|Tacrine|tacrine|mesh-list
14148342|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14148343|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148344|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148345|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148346|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148347|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148348|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14148349|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
14148350|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148351|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
14148352|NCT04092179|Venetoclax|venetoclax|mesh-list
14148353|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148354|NCT04046900|Metronidazole|metronidazole|mesh-list
14148355|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148356|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14148357|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14148358|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14148359|NCT04038099|Lidocaine|lidocaine|mesh-list
14148360|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
14148361|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
14148362|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148363|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148364|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
14148365|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148366|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14148367|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14148368|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14148369|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954909|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954910|NCT03193788|Folic Acid|folic acid|mesh-list
13954911|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
13954912|NCT03193788|Hydroxocobalamin|hydroxocobalamin|mesh-list
13954913|NCT03193788|Dexamethasone|dexamethasone|mesh-list
13954914|NCT03193788|Pemetrexed|pemetrexed|mesh-list
13954915|NCT03193788|Vitamins|vitamins|mesh-ancestor
13954916|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
13954917|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954918|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13954919|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
14148370|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148371|NCT03991832|Durvalumab|durvalumab|mesh-list
14148372|NCT03991832|Olaparib|olaparib|mesh-list
13954920|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
13954921|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954922|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13954923|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
13954924|NCT03193788|Hormones|hormones|mesh-ancestor
13954925|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13954926|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13954927|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148373|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14148374|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148375|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14148376|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148377|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148378|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
14148379|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14148380|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148381|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
14148382|NCT03965741|Apixaban|apixaban|mesh-list
14148383|NCT03965741|Dabigatran|dabigatran|mesh-list
14148384|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14148385|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
14148386|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14148387|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
14148388|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148389|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148390|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
14148391|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
14148392|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14148393|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
14148394|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148395|NCT03945812|Sargramostim|sargramostim|mesh-list
14148396|NCT03945812|Lenograstim|lenograstim|mesh-list
14148397|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
14148398|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148399|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14148400|NCT03920007|Trimethoprim|trimethoprim|mesh-list
14148401|NCT03920007|Polymyxins|polymyxins|mesh-list
14148402|NCT03920007|Polymyxin B|polymyxin b|mesh-list
14148403|NCT03920007|Prednisone|prednisone|mesh-list
14148404|NCT03920007|Prednisolone|prednisolone|mesh-list
14148405|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148406|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
14148407|NCT03920007|Hormones|hormones|mesh-ancestor
14148408|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148409|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148410|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14148411|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148412|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14148413|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148414|NCT03920007|Renal Agents|renal agents|mesh-ancestor
14148415|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
14148416|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14148417|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14148418|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14148419|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148420|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148421|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14148422|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14148423|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14148424|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14148425|NCT03913845|Lidocaine|lidocaine|mesh-list
14937733|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14937734|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14937735|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937736|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148426|NCT03913845|Epinephrine|epinephrine|mesh-list
14148427|NCT03913845|Racepinephrine|racepinephrine|mesh-list
14148428|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
14148429|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
14148430|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
14148431|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148432|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148433|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
14148434|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148435|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14937737|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14148436|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14148437|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14148438|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14148439|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148440|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14148441|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14148442|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
14148443|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148444|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14148445|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14148446|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
14148447|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14148448|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
14148449|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
14148450|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
14148451|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14937738|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14937739|NCT01477632|Norethindrone|norethindrone|mesh-list
14937740|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
14937741|NCT01477632|Estradiol|estradiol|mesh-list
14937742|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14937743|NCT01477632|Estrogens|estrogens|mesh-ancestor
14148452|NCT03903939|Iloprost|iloprost|mesh-list
14148453|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14148454|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
14179091|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179092|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179093|NCT04738097|Clopidogrel|clopidogrel|mesh-list
14179094|NCT04738097|Ticagrelor|ticagrelor|mesh-list
14179095|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14179096|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14179097|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14179098|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14179099|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
14179100|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179101|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179102|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179103|NCT04738045|Ritonavir|ritonavir|mesh-list
14179104|NCT04738045|Lopinavir|lopinavir|mesh-list
14179105|NCT04738045|Remdesivir|remdesivir|mesh-list
14179106|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14179107|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14179108|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179109|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179110|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179111|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14179112|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14179113|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
14179114|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179115|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14179116|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14179117|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
14179118|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14179119|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14179120|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179121|NCT04737889|Rituximab|rituximab|mesh-list
14179122|NCT04737889|Methotrexate|methotrexate|mesh-list
14179123|NCT04737889|Lenalidomide|lenalidomide|mesh-list
14179124|NCT04737889|Temozolomide|temozolomide|mesh-list
14179125|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179126|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179127|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
14179128|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179129|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179130|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14179131|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
14179132|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14179133|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14179134|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
14478865|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179135|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937744|NCT01477632|Hormones|hormones|mesh-ancestor
14148455|NCT03870438|Lamivudine|lamivudine|mesh-list
14148456|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14148457|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14148458|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148459|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148460|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
14148461|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148462|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14148463|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14148464|NCT03834363|Fentanyl|fentanyl|mesh-list
14148465|NCT03834363|Morphine|morphine|mesh-list
14148466|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14148467|NCT03834363|Narcotics|narcotics|mesh-ancestor
14148468|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148469|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148470|NCT03834363|Analgesics|analgesics|mesh-ancestor
14148471|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
14148472|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148473|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14148474|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14148475|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
14148476|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
14148477|NCT03792958|Vorolanib|vorolanib|mesh-list
14937745|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937746|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148478|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148479|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148480|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148481|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
14148482|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14148483|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14148484|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148485|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
14148486|NCT03782350|Coagulants|coagulants|mesh-ancestor
14148487|NCT03767933|Acetaminophen|acetaminophen|mesh-list
14148488|NCT03767933|Ibuprofen|ibuprofen|mesh-list
14148489|NCT03767933|Hydromorphone|hydromorphone|mesh-list
14148490|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14148491|NCT03767933|Analgesics|analgesics|mesh-ancestor
14148492|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
14148493|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148494|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148495|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
14148496|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14148497|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148498|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14148499|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14148500|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148501|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148502|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14148503|NCT03767933|Narcotics|narcotics|mesh-ancestor
14765845|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
14765846|NCT00622752|Nicotine|nicotine|mesh-list
14765847|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14765848|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
14765849|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765850|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765851|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14765852|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14765853|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
14765854|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765855|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765856|NCT00622817|Epinephrine|epinephrine|mesh-list
14765857|NCT00622817|Xylometazoline|xylometazoline|mesh-list
14937747|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14937748|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
14148504|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148505|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
14937749|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14937750|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14937751|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14937752|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14937753|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14148506|NCT03734731|Narcotics|narcotics|mesh-ancestor
14765858|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14765859|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937754|NCT01477736|Oxybutynin|oxybutynin|mesh-list
14937755|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
14937756|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14937757|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14937758|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14765860|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
14765861|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765862|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765863|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765864|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14765865|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14765866|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
14765867|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765868|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14765869|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
14765870|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
14765871|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
14765872|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14765873|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
14148507|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148508|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148509|NCT03734731|Analgesics|analgesics|mesh-ancestor
14148510|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
14148511|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148512|NCT03691714|Cetuximab|cetuximab|mesh-list
14148513|NCT03691714|Durvalumab|durvalumab|mesh-list
14148514|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14148515|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148516|NCT03636256|Docetaxel|docetaxel|mesh-list
14148517|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148518|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14148519|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14148520|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14148521|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148522|NCT03578965|Cefazolin|cefazolin|mesh-list
14148523|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14148524|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148525|NCT03559400|Gentamicins|gentamicins|mesh-list
14148526|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14148527|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148528|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14148529|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148530|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148531|NCT03558087|Gemcitabine|gemcitabine|mesh-list
14148532|NCT03558087|Nivolumab|nivolumab|mesh-list
14148533|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148534|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14148535|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
14148536|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148537|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
14148538|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148539|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148540|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14148541|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
14148542|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148543|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14148544|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14148545|NCT03519984|Cytarabine|cytarabine|mesh-list
14148546|NCT03519984|Vincristine|vincristine|mesh-list
14148547|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14148548|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
14148549|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148550|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148551|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
14148552|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148553|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14148554|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
14148555|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148556|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14148557|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
14148558|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
14148559|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
14148560|NCT03363893|Fulvestrant|fulvestrant|mesh-list
14148561|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14148562|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937759|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14148563|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14148564|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14148565|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
14148566|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148567|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148568|NCT03287778|Pyridoxine|pyridoxine|mesh-list
14148569|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
14148570|NCT03287778|Vitamins|vitamins|mesh-ancestor
14148571|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
14148572|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148573|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
14148574|NCT03277170|Montelukast|montelukast|mesh-list
14148575|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14148576|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
14148577|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14148578|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
14148579|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148580|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148581|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14148582|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14937760|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937761|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
14937762|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937763|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937764|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14937765|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937766|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
14937767|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
14937768|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14937769|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14937770|NCT01477736|Urological Agents|urological agents|mesh-ancestor
14937771|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
14937772|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14937773|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937774|NCT01477801|Vitamins|vitamins|mesh-ancestor
14937775|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
14937776|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14937777|NCT01477840|Misoprostol|misoprostol|mesh-list
14937778|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14148583|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148584|NCT03271372|Avelumab|avelumab|mesh-list
14148585|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14148586|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14148587|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148588|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
14148589|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148590|NCT03238196|Fulvestrant|fulvestrant|mesh-list
14148591|NCT03238196|Palbociclib|palbociclib|mesh-list
14148592|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14148593|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148594|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14148595|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14148596|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
14148597|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148598|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148599|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148600|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148601|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148602|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
14148603|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
14148604|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14148605|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
14148606|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148607|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14148608|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14148609|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
14148610|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148611|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148612|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14148613|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14937779|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
14937780|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14937781|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937782|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14937783|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14148614|NCT02762669|Oxytocin|oxytocin|mesh-list
14148615|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
14148616|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14148617|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148618|NCT02716948|Nivolumab|nivolumab|mesh-list
14148619|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14148620|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148621|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14148622|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148623|NCT02681237|Olaparib|olaparib|mesh-list
14148624|NCT02681237|Cediranib|cediranib|mesh-list
14148625|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14148626|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148627|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148628|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148629|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148630|NCT02431897|Estrogens|estrogens|mesh-list
14148631|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14148632|NCT02431897|Hormones|hormones|mesh-ancestor
14148633|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148634|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937784|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
14937785|NCT01477931|Bupropion|bupropion|mesh-list
14937786|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14937787|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
14937788|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14937789|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13954928|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765874|NCT00622830|Darapladib|darapladib|mesh-list
14765875|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14765876|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765877|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765878|NCT00622843|Vaccines|vaccines|mesh-list
14765879|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14765880|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
14765881|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767426|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767427|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
14767428|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767429|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
14767430|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767431|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
14767432|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767433|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
14767434|NCT00630019|Levofloxacin|levofloxacin|mesh-list
14767435|NCT00630019|Ofloxacin|ofloxacin|mesh-list
14767436|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14767437|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14767438|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14767439|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14767440|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767441|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14767442|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14767443|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767444|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767445|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767446|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14767447|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
14937790|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13954929|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954930|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13954931|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13954932|NCT03193788|Hematinics|hematinics|mesh-ancestor
13954933|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
13954934|NCT03193853|Paclitaxel|paclitaxel|mesh-list
13954935|NCT03193853|Serabelisib|serabelisib|mesh-list
13954936|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13954937|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954938|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
13954939|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
13954940|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
14765882|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
14765883|NCT00622934|Hematinics|hematinics|mesh-ancestor
14765884|NCT00623064|Gemcitabine|gemcitabine|mesh-list
14765885|NCT00623064|Lapatinib|lapatinib|mesh-list
14148660|NCT01641107|Ponatinib|ponatinib|mesh-list
14148661|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148662|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148663|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478866|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14478867|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478868|NCT02459964|Fentanyl|fentanyl|mesh-list
14478869|NCT02459964|Hydromorphone|hydromorphone|mesh-list
14478870|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14148664|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148665|NCT00843037|Sunitinib|sunitinib|mesh-list
14148666|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765886|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765887|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14765888|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
14765889|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765890|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
14765891|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148667|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14148668|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14148669|NCT00843037|Growth Substances|growth substances|mesh-ancestor
14148670|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148671|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
14148672|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148673|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148674|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148675|NCT00054964|Albuterol|albuterol|mesh-list
14148676|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14148677|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
14765892|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148678|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148679|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148680|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14148681|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
14148682|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
14148683|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14148684|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14148685|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14148686|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14148687|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14148688|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148689|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148690|NCT00045201|Irinotecan|irinotecan|mesh-list
14148691|NCT00045201|Camptothecin|camptothecin|mesh-list
14148692|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14148693|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14148694|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14148695|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148696|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148697|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148698|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148699|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14148700|NCT05073692|Liraglutide|liraglutide|mesh-list
14148701|NCT05073692|Empagliflozin|empagliflozin|mesh-list
14148702|NCT05073692|Exenatide|exenatide|mesh-list
14148703|NCT05073692|Glimepiride|glimepiride|mesh-list
14148704|NCT05073692|Linagliptin|linagliptin|mesh-list
14148705|NCT05073692|Saxagliptin|saxagliptin|mesh-list
14148706|NCT05073692|Alogliptin|alogliptin|mesh-list
14478871|NCT02459964|Narcotics|narcotics|mesh-ancestor
14478872|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478873|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478874|NCT02459964|Analgesics|analgesics|mesh-ancestor
14478875|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
14478876|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478877|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14765893|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765894|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
14765895|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765896|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148707|NCT05073692|Glipizide|glipizide|mesh-list
14148708|NCT05073692|Glucagon|glucagon|mesh-list
14478878|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14765897|NCT00623077|Etoposide|etoposide|mesh-list
14148709|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14148710|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14148711|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148712|NCT05073692|Incretins|incretins|mesh-ancestor
14148713|NCT05073692|Hormones|hormones|mesh-ancestor
14148714|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148715|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14148716|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148717|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14148718|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14148719|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14148720|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
14148721|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14148722|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
14148723|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148724|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14148725|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
14148726|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14148727|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148728|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148729|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14148730|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14148731|NCT05073640|Protective Agents|protective agents|mesh-ancestor
14148732|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148733|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
14937791|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14937792|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937793|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
14937794|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937795|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937796|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14937797|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14937798|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937799|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14937800|NCT01477983|Flecainide|flecainide|mesh-list
14937801|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14937802|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14148734|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14148735|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
14179136|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179137|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179138|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14179139|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179140|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14179141|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14179142|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14179143|NCT04737889|Growth Substances|growth substances|mesh-ancestor
14179144|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14179145|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14179146|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
14179147|NCT04737928|Latanoprost|latanoprost|mesh-list
14179148|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14179149|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14179150|NCT04737980|Dexamethasone|dexamethasone|mesh-list
14179151|NCT04737980|Bupivacaine|bupivacaine|mesh-list
14179152|NCT04737980|Ropivacaine|ropivacaine|mesh-list
14179153|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179154|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
14179155|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
14179156|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179157|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179158|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179159|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
14179160|NCT04737980|Hormones|hormones|mesh-ancestor
14179161|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179162|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14179163|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179164|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
14179165|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
14179166|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179167|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
14179168|NCT04737967|Memantine|memantine|mesh-list
14179169|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14179170|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14148736|NCT05073744|Morphine|morphine|mesh-list
14148737|NCT05073744|Nalbuphine|nalbuphine|mesh-list
14148738|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14148739|NCT05073744|Narcotics|narcotics|mesh-ancestor
14148740|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148741|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148742|NCT05073744|Analgesics|analgesics|mesh-ancestor
14148743|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
14148744|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148745|NCT05073094|Esmolol|esmolol|mesh-list
14148746|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14148747|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14148748|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14148749|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14148750|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148751|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148752|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148753|NCT05073055|Anesthetics|anesthetics|mesh-list
14148754|NCT05073055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148755|NCT05073055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148756|NCT05073029|Vitamin D|vitamin d|mesh-list
14148757|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
14148758|NCT05073029|Vitamins|vitamins|mesh-ancestor
14148759|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
14148760|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148761|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14148762|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14148763|NCT05072938|Nizatidine|nizatidine|mesh-list
14148764|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14148765|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14148766|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14148767|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
14148768|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
14148769|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148770|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148771|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148772|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
14148773|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14148774|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
14148775|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148776|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
14148777|NCT05072899|Protective Agents|protective agents|mesh-ancestor
14148778|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
14148779|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14148780|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14148781|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148782|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
14148783|NCT05072860|Coagulants|coagulants|mesh-ancestor
14148784|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
14148785|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14148786|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14148787|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148788|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
14148789|NCT05072873|Coagulants|coagulants|mesh-ancestor
14148790|NCT05072782|Methotrexate|methotrexate|mesh-list
14148791|NCT05072782|Infliximab|infliximab|mesh-list
14148792|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14148793|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
14148794|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14148795|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148796|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14148797|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
14148798|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148799|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148800|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
14148801|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148802|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14148803|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14148804|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
14148805|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14148806|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14148807|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14148808|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
14148809|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14148810|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14148811|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14148812|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14148813|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148814|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
14148815|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148816|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148817|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14148818|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148819|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
14148820|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14148821|NCT05072691|Antibodies|antibodies|mesh-list
14148822|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
14148823|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148824|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14148825|NCT05072405|Simvastatin|simvastatin|mesh-list
14148826|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14148827|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148828|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
14148829|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148830|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148831|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14148832|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148833|NCT05072249|Naloxone|naloxone|mesh-list
14148834|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14148835|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148836|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
14148837|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148838|NCT05072314|Lidocaine|lidocaine|mesh-list
14148839|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14148840|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
14148841|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148842|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148843|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
14148844|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148845|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14148846|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14148847|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14148848|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14148849|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148850|NCT05072106|Bosentan|bosentan|mesh-list
14148851|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14148852|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14148853|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148854|NCT05071794|Propofol|propofol|mesh-list
14148855|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14148856|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148857|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148858|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14148859|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
14148860|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
14148861|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
14148862|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
14148863|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765898|NCT00623077|Melphalan|melphalan|mesh-list
14765899|NCT00623077|Busulfan|busulfan|mesh-list
14765900|NCT00623077|Ifosfamide|ifosfamide|mesh-list
14765901|NCT00623077|Thiotepa|thiotepa|mesh-list
14148864|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148865|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148866|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148867|NCT05071703|Carboplatin|carboplatin|mesh-list
14148868|NCT05071703|Etoposide|etoposide|mesh-list
14148869|NCT05071703|Topotecan|topotecan|mesh-list
14148870|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148871|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14148872|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14148873|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14148874|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148875|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148876|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14148877|NCT05071781|Hormones|hormones|mesh-list
14148878|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14148879|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148880|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765902|NCT00623077|Sargramostim|sargramostim|mesh-list
14765903|NCT00623077|Mesna|mesna|mesh-list
14148881|NCT05071352|Nefopam|nefopam|mesh-list
14148882|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14148883|NCT05071352|Analgesics|analgesics|mesh-ancestor
14148884|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
14148885|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148886|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148887|NCT05071339|Ganirelix|ganirelix|mesh-list
14148888|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
14148889|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148890|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148891|NCT05071118|Pregabalin|pregabalin|mesh-list
14148892|NCT05071118|Analgesics|analgesics|mesh-ancestor
14148893|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
14148894|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148895|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148896|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
14148897|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14148898|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14148899|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148900|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14148901|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14148902|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14148903|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148904|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14148905|NCT05070520|Lumefantrine|lumefantrine|mesh-list
14148906|NCT05070520|Artemether|artemether|mesh-list
14148907|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14148908|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
14148909|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14148910|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14148911|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148912|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
14148913|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
14148914|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14148915|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148916|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765904|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14765905|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148917|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
14148918|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14148919|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148920|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148921|NCT05070468|Dexamethasone|dexamethasone|mesh-list
14148922|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14148923|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
14148924|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
14148925|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14148926|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148927|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14148928|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
14148929|NCT05070468|Hormones|hormones|mesh-ancestor
14148930|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148931|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14148932|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148933|NCT05070598|Paclitaxel|paclitaxel|mesh-list
14148934|NCT05070598|Tegafur|tegafur|mesh-list
14148935|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14148936|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148937|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
14148938|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14148939|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
14478879|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
14478880|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
14148940|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148941|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14148942|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
14148943|NCT05070260|Glenzocimab|glenzocimab|mesh-list
14148944|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
14148945|NCT05070195|Midazolam|midazolam|mesh-list
14148946|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14148947|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14148948|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14148949|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148950|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14148951|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14148952|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14148953|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14148954|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
14148955|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
14148956|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
14148957|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
14148958|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14148959|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179171|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14179172|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
14179173|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179174|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179175|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179176|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14179177|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14179178|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14179179|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14179180|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14179181|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14179182|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
14179183|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14937803|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14179184|NCT04737837|Lacosamide|lacosamide|mesh-list
14179185|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
14179186|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14179187|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14179188|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14179189|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179190|NCT04737655|Beclomethasone|beclomethasone|mesh-list
14179191|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
14179192|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
14179193|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14179194|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
14179195|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765906|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14765907|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14765908|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765909|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765910|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
14765911|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765912|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14765913|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
14179196|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179197|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14179198|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
14179199|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14179200|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14179201|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14148960|NCT05070221|Axitinib|axitinib|mesh-list
14148961|NCT05070221|Antibodies|antibodies|mesh-list
14148962|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14148963|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
14148964|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148965|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14148966|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14148967|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148968|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148969|NCT05069870|Itraconazole|itraconazole|mesh-list
14148970|NCT05069870|Rifampin|rifampin|mesh-list
14148971|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
14148972|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
14148973|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14148974|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14148975|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14148976|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14148977|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14148978|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14148979|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
14148980|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14148981|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14148982|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14148983|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14148984|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
14148985|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14148986|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
14148987|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14148988|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14148989|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14148990|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14148991|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14148992|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14148993|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14148994|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14148995|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
14148996|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14148997|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14148998|NCT05070104|Bevacizumab|bevacizumab|mesh-list
14148999|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14149000|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149001|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14149002|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14149003|NCT05070104|Growth Substances|growth substances|mesh-ancestor
14149004|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149005|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
14149006|NCT05069779|Diazepam|diazepam|mesh-list
14149007|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14149008|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
14149009|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
14149010|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
14149011|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149012|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149013|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14149014|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14149015|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149016|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14149017|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14149018|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14149019|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14149020|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149021|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14149022|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
14149023|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
14149024|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
14149025|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
14149026|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149027|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149028|NCT05069454|Vaccines|vaccines|mesh-list
14149029|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
14149030|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149031|NCT05069688|Rifampin|rifampin|mesh-list
14149032|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14149033|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
14149034|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14149035|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149036|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
14149037|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14149038|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149039|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149040|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14149041|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14149042|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14149043|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14149044|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14937804|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937805|NCT01478022|Ibuprofen|ibuprofen|mesh-list
14937806|NCT01478022|Isosorbide|isosorbide|mesh-list
14937807|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14937808|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14149045|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14149046|NCT05069298|Silybin|silybin|mesh-list
14149047|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14149048|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149049|NCT05069298|Protective Agents|protective agents|mesh-ancestor
14149050|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765914|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14765915|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14765916|NCT00623077|Protective Agents|protective agents|mesh-ancestor
14765917|NCT00623116|Testosterone|testosterone|mesh-list
14765918|NCT00623116|Estrogens|estrogens|mesh-list
14765919|NCT00623116|Androgens|androgens|mesh-ancestor
14765920|NCT00623116|Hormones|hormones|mesh-ancestor
14765921|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14765922|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765923|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
14765924|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
14149051|NCT05068960|Bupivacaine|bupivacaine|mesh-list
14149052|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
14149053|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
14149054|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149055|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149056|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
14149057|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149058|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
14149059|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14149060|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149061|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
14149062|NCT05068609|Nivolumab|nivolumab|mesh-list
14149063|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14149064|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149065|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14149066|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149067|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
14149068|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14149069|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14149070|NCT05068349|Protective Agents|protective agents|mesh-ancestor
14937809|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14937810|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14937811|NCT01478022|Analgesics|analgesics|mesh-ancestor
14937812|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
14937813|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937814|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149071|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149072|NCT05068453|Antibodies|antibodies|mesh-list
14149073|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14765925|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14765926|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
14937815|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149074|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
14149075|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149076|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14149077|NCT05067699|Calcifediol|calcifediol|mesh-list
14149078|NCT05067699|Vitamins|vitamins|mesh-ancestor
14149079|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
14149080|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149081|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14149082|NCT05067530|Paclitaxel|paclitaxel|mesh-list
14149083|NCT05067530|Carboplatin|carboplatin|mesh-list
14149084|NCT05067530|Palbociclib|palbociclib|mesh-list
14149085|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14149086|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149087|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
14149088|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
14149089|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
14149090|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149091|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14149092|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149093|NCT05067387|Dronabinol|dronabinol|mesh-list
14149094|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
14149095|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149096|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149097|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149098|NCT05067387|Analgesics|analgesics|mesh-ancestor
14149099|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
14149100|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149101|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14149102|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14149103|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149104|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149105|NCT05067387|Hormones|hormones|mesh-ancestor
14149106|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149107|NCT05067517|Nintedanib|nintedanib|mesh-list
14149108|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149109|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14149110|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149111|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149112|NCT05067153|Heparin|heparin|mesh-list
14149113|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14149114|NCT05067153|Tinzaparin|tinzaparin|mesh-list
14149115|NCT05067153|Dalteparin|dalteparin|mesh-list
14149116|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
14149117|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14149118|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14149119|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179202|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14179203|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179204|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179205|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14179206|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14179207|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14179208|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
14179209|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179210|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
14179211|NCT04737655|Hormones|hormones|mesh-ancestor
14179212|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179213|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14179214|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14179215|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14179216|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
14179217|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179218|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14765927|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14765928|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14765929|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765930|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14765931|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937816|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14937817|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14937818|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14765932|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765933|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14765934|NCT00623155|Renal Agents|renal agents|mesh-ancestor
14765935|NCT00623168|Ribavirin|ribavirin|mesh-list
14149120|NCT05067309|Letrozole|letrozole|mesh-list
14149121|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149122|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14149123|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14149124|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954941|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149125|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149126|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14149127|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
14149128|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149129|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149130|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
14149131|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149132|NCT05066802|Folfirinox|folfirinox|mesh-list
14149133|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149134|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14149135|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149136|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149137|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
14149138|NCT05066516|Linagliptin|linagliptin|mesh-list
14149139|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14149140|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149141|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14149142|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149143|NCT05066516|Incretins|incretins|mesh-ancestor
14149144|NCT05066516|Hormones|hormones|mesh-ancestor
14149145|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149146|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14149147|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
14149148|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149149|NCT05066633|Metoprolol|metoprolol|mesh-list
14149150|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14149151|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14149152|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
14149153|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
14149154|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478881|NCT02460380|Vitamin D|vitamin d|mesh-list
14478882|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
14937819|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954942|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954943|NCT03193723|Anesthetics|anesthetics|mesh-list
13954944|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954945|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954946|NCT03193710|Remifentanil|remifentanil|mesh-list
13954947|NCT03193710|Propofol|propofol|mesh-list
13954948|NCT03193710|Sevoflurane|sevoflurane|mesh-list
13954949|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14478883|NCT02460380|Vitamins|vitamins|mesh-ancestor
14765936|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
14765937|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765938|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
14765939|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14765940|NCT00623207|Atropine|atropine|mesh-list
13954950|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13954951|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954952|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14478884|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
14478885|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478886|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14478887|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14478888|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
14149155|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149156|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14149157|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14149158|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14149159|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
14149160|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149161|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149162|NCT05066607|Dexamethasone|dexamethasone|mesh-list
14149163|NCT05066607|Pomalidomide|pomalidomide|mesh-list
14149164|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149165|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
14149166|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
14149167|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149168|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149169|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14149170|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
14149171|NCT05066607|Hormones|hormones|mesh-ancestor
14149172|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149173|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14149174|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149175|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
14149176|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14149177|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14149178|NCT05066607|Growth Substances|growth substances|mesh-ancestor
14149179|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
14149180|NCT05066360|Hormones|hormones|mesh-list
14149181|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149182|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149183|NCT05066061|Analgesics|analgesics|mesh-list
14149184|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
14149185|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
14149186|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149187|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149188|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14149189|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149190|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149191|NCT05065658|Posaconazole|posaconazole|mesh-list
14149192|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
14149193|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149194|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14149195|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14149196|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14149197|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14149198|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14149199|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149200|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149201|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14149202|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
14149203|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149204|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149205|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14149206|NCT05065671|Tolcapone|tolcapone|mesh-list
14149207|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14149208|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14149209|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14149210|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149211|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149212|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149213|NCT05065671|Analgesics|analgesics|mesh-ancestor
14149214|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
14149215|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149216|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
14149217|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149218|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
14149219|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14149220|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14149221|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14149222|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149223|NCT05065905|Interferons|interferons|mesh-list
14149224|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
14149225|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149226|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
14937820|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14149227|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149228|NCT05066035|Neostigmine|neostigmine|mesh-list
14149229|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14149230|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149231|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149232|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
14149233|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149234|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149235|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14149236|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
14149237|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149238|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14149239|NCT05065164|Denosumab|denosumab|mesh-list
14149240|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14149241|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149242|NCT05065177|Vaccines|vaccines|mesh-list
14149243|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
14149244|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149245|NCT05065567|Droperidol|droperidol|mesh-list
14149246|NCT05065567|Haloperidol|haloperidol|mesh-list
14149247|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
14937821|NCT01478022|Diuretics|diuretics|mesh-ancestor
14937822|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
14937823|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
14937824|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14937825|NCT01478035|Phenytoin|phenytoin|mesh-list
14937826|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
14937827|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14937828|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14937829|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14937830|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937831|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14937832|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14149248|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
14149249|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
14149250|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149251|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149252|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14149253|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14937833|NCT01478074|Cytarabine|cytarabine|mesh-list
14937834|NCT01478074|Fludarabine|fludarabine|mesh-list
14937835|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937836|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14149254|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14149255|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149256|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149257|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14149258|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
14149259|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149260|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149261|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14149262|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14937837|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
14937838|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937839|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14149263|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14149264|NCT05065021|Paclitaxel|paclitaxel|mesh-list
14149265|NCT05065021|Bevacizumab|bevacizumab|mesh-list
14149266|NCT05065021|Niraparib|niraparib|mesh-list
14149267|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14149268|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149269|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
14149270|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
14149271|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
14149272|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149273|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14149274|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14149275|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14149276|NCT05065021|Growth Substances|growth substances|mesh-ancestor
14149277|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149278|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14149279|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14149280|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179219|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14179220|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179221|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
14179222|NCT04737278|Niacin|niacin|mesh-list
14179223|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
14179224|NCT04737278|Vitamins|vitamins|mesh-ancestor
14179225|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
14179226|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179227|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14179228|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
14179229|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179230|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14179231|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
14179232|NCT04737473|Anesthetics|anesthetics|mesh-list
14179233|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179234|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179235|NCT04736953|Sirolimus|sirolimus|mesh-list
14179236|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14179237|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179238|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14179239|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179240|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
14179241|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179242|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
14179243|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179244|NCT04737057|Fluorides|fluorides|mesh-list
14179245|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
14179246|NCT04737057|Protective Agents|protective agents|mesh-ancestor
14179247|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179248|NCT04736836|Rifaximin|rifaximin|mesh-list
14179249|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14179250|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179251|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179252|NCT04736823|Paclitaxel|paclitaxel|mesh-list
14937840|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
14937841|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937842|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
14937843|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14937844|NCT01478165|Palonosetron|palonosetron|mesh-list
14937845|NCT01478165|Anesthetics|anesthetics|mesh-list
14937846|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14937847|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937848|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
14937849|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
14937850|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937851|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937852|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14937853|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14937854|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
14937855|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937856|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937857|NCT01478230|Nicotine|nicotine|mesh-list
14179253|NCT04736823|Docetaxel|docetaxel|mesh-list
14179254|NCT04736823|Carboplatin|carboplatin|mesh-list
14179255|NCT04736823|Pemetrexed|pemetrexed|mesh-list
14179256|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14179257|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179258|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
14179259|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
14179260|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
14179261|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179262|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179263|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14179264|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14179265|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
14179266|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179267|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14179268|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179269|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179270|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14179271|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
14179272|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179273|NCT04736901|Enoxaparin|enoxaparin|mesh-list
14179274|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
14179275|NCT04736901|Apixaban|apixaban|mesh-list
14149281|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
14149282|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14149283|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
14149284|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149285|NCT05064020|Tenofovir|tenofovir|mesh-list
14149286|NCT05064020|Emtricitabine|emtricitabine|mesh-list
14149287|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14149288|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
14149289|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149290|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14149291|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14149292|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149293|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149294|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14149295|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14149296|NCT05063838|Anesthetics|anesthetics|mesh-list
14149297|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149298|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149299|NCT05063578|Lidocaine|lidocaine|mesh-list
14149300|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
14149301|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
14149302|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149303|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149304|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
14149305|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149306|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14149307|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14149308|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14149309|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14149310|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149311|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
14149312|NCT05063513|Rituximab|rituximab|mesh-list
14149313|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14149314|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149315|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
14149316|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149317|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149318|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14149319|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14149320|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
14149321|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14149322|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149323|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149324|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149325|NCT05063422|Trimethoprim|trimethoprim|mesh-list
14149326|NCT05063422|Polymyxins|polymyxins|mesh-list
14149327|NCT05063422|Polymyxin B|polymyxin b|mesh-list
14149328|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14149329|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14149330|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149331|NCT05063422|Renal Agents|renal agents|mesh-ancestor
14149332|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
14149333|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14149334|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14149335|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14149336|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149337|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149338|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14149339|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14149340|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14149341|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14149342|NCT05063422|Laxatives|laxatives|mesh-ancestor
14149343|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765941|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14765942|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14765943|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14765944|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
14765945|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765946|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765947|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14765948|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
14149352|NCT05063318|Itraconazole|itraconazole|mesh-list
14149353|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
14149354|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149355|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14149356|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14149357|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149358|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149359|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14149360|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
14149361|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149362|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149363|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14149364|NCT05063071|Tenofovir|tenofovir|mesh-list
14149365|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
14149366|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149367|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14149368|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14149369|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149370|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149371|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14149372|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14149373|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
14149374|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14149375|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14149376|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149377|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
14149378|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149379|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149380|NCT05062681|Dexamethasone|dexamethasone|mesh-list
14149381|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
14149382|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14149383|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14149384|NCT05062681|Prednisolone|prednisolone|mesh-list
14149385|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
14149386|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14149387|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
14149388|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149389|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
14149390|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
14149391|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149392|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149393|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14149394|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
14149395|NCT05062681|Hormones|hormones|mesh-ancestor
14149396|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149397|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14149398|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149399|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14149400|NCT05062681|Protective Agents|protective agents|mesh-ancestor
14149401|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
14149402|NCT05062954|Procyanidin|procyanidin|mesh-list
14149403|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
14149404|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149405|NCT05062954|Protective Agents|protective agents|mesh-ancestor
14149406|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149407|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14149408|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14765949|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
14765950|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
14765951|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14765952|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14765953|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
14765954|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765955|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765956|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
14765957|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14765958|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
14765959|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
14149409|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149410|NCT05062486|Curcumin|curcumin|mesh-list
14149411|NCT05062486|Resveratrol|resveratrol|mesh-list
14149412|NCT05062486|Quercetin|quercetin|mesh-list
14149413|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14149414|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149415|NCT05062486|Analgesics|analgesics|mesh-ancestor
14149416|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
14149417|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149418|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149419|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149420|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149421|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149422|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149423|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149424|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
14937858|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14937859|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
14937860|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937861|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937862|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14937863|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14937864|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
14937865|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937866|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937867|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
14937868|NCT01478282|Dabigatran|dabigatran|mesh-list
14937869|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14937870|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
14937871|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14937872|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
14937873|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937874|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937875|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
14937876|NCT01478308|Metformin|metformin|mesh-list
14937877|NCT01478308|Prednisone|prednisone|mesh-list
14937878|NCT01478308|Docetaxel|docetaxel|mesh-list
14937879|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14937880|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937881|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14937882|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
14937883|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
14937884|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
14937885|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937886|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14937887|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
14937888|NCT01478308|Hormones|hormones|mesh-ancestor
14937889|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14937890|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14937891|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
14149425|NCT05062486|Protective Agents|protective agents|mesh-ancestor
14149426|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14149427|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
14149428|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14149429|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14149430|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149431|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
14149432|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
14149433|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149434|NCT05062304|Fluticasone|fluticasone|mesh-list
14149435|NCT05062304|Xhance|xhance|mesh-list
14149436|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149437|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14149438|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
14149439|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149440|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149441|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14149442|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14149443|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
14937892|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14937893|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
13954953|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
14149444|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14149445|NCT05061732|Amoxicillin|amoxicillin|mesh-list
14149446|NCT05061732|Metronidazole|metronidazole|mesh-list
14149447|NCT05061732|Clarithromycin|clarithromycin|mesh-list
14149448|NCT05061732|Doxycycline|doxycycline|mesh-list
14149449|NCT05061732|Levofloxacin|levofloxacin|mesh-list
14149450|NCT05061732|Tetracycline|tetracycline|mesh-list
14149451|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
14149452|NCT05061732|Rabeprazole|rabeprazole|mesh-list
14149453|NCT05061732|Bismuth|bismuth|mesh-list
13954954|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
13954955|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13954956|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14149454|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149455|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14149456|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149457|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14149458|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14149459|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14149460|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149461|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14149462|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14149463|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
14149464|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14149465|NCT05061732|Renal Agents|renal agents|mesh-ancestor
14149466|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14149467|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14149468|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149469|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14149470|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14149471|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14149472|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14149473|NCT05061732|Antacids|antacids|mesh-ancestor
14149474|NCT05061732|Diuretics|diuretics|mesh-ancestor
14149475|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
14149476|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149477|NCT05061732|Expectorants|expectorants|mesh-ancestor
14149478|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
14765960|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149479|NCT05061901|Lisinopril|lisinopril|mesh-list
14149480|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14149481|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
14149482|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149483|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149484|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14149485|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14149486|NCT05061901|Protective Agents|protective agents|mesh-ancestor
14149487|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954957|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13954958|NCT03193710|Narcotics|narcotics|mesh-ancestor
13954959|NCT03193710|Analgesics|analgesics|mesh-ancestor
13954960|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
13954961|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13954962|NCT03193918|Paclitaxel|paclitaxel|mesh-list
13954963|NCT03193918|Ramucirumab|ramucirumab|mesh-list
13954964|NCT03193918|Crenolanib|crenolanib|mesh-list
13954965|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13954966|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954967|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
13954968|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14179276|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
14179277|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14765961|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765962|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765963|NCT00623220|Analgesics|analgesics|mesh-ancestor
13954969|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14179278|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
14179279|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14149488|NCT05061641|Progesterone|progesterone|mesh-list
14149489|NCT05061641|Progestins|progestins|mesh-ancestor
14149490|NCT05061641|Hormones|hormones|mesh-ancestor
14149491|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149492|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149493|NCT05061147|Azacitidine|azacitidine|mesh-list
14149494|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14149495|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
14149496|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149497|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149498|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149499|NCT05060822|Pirfenidone|pirfenidone|mesh-list
14149500|NCT05060822|Analgesics|analgesics|mesh-ancestor
14149501|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
14149502|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937894|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937895|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
14937896|NCT01478386|Protective Agents|protective agents|mesh-ancestor
14937897|NCT01478490|Metoprolol|metoprolol|mesh-list
13954970|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149503|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149504|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14149505|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149506|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149507|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149508|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149509|NCT05060809|Vitamin K|vitamin k|mesh-list
14149510|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
14149511|NCT05060809|Vitamins|vitamins|mesh-ancestor
14149512|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
14149513|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149514|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14149515|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14149516|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149517|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
14149518|NCT05060809|Coagulants|coagulants|mesh-ancestor
14149519|NCT05060731|Iron|iron|mesh-list
14149520|NCT05060731|Trace Elements|trace elements|mesh-ancestor
14149521|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
14149522|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149523|NCT05060588|Valsartan|valsartan|mesh-list
14149524|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14149525|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14149526|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14149527|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149528|NCT05060419|Meropenem|meropenem|mesh-list
14149529|NCT05060419|Tazobactam|tazobactam|mesh-list
14149530|NCT05060419|Piperacillin|piperacillin|mesh-list
14149531|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14149532|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14149533|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149534|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14149535|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149536|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149537|NCT05060744|Antacids|antacids|mesh-list
14149538|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
14149539|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149540|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14149541|NCT05060198|Lumefantrine|lumefantrine|mesh-list
14149542|NCT05060198|Artemether|artemether|mesh-list
14149543|NCT05060198|Piperaquine|piperaquine|mesh-list
14149544|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14149545|NCT05060198|Artenimol|artenimol|mesh-list
14149546|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
14149547|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14937898|NCT01478490|Mirabegron|mirabegron|mesh-list
13954971|NCT03194009|Metformin|metformin|mesh-list
13954972|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13954973|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13954974|NCT03193372|Azelaic acid|azelaic acid|mesh-list
13954975|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13954976|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
13954977|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
13954978|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13954979|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
13954980|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13954981|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14937899|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14149548|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14149549|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149550|NCT05059535|Acetaminophen|acetaminophen|mesh-list
14149551|NCT05059535|Analgesics|analgesics|mesh-list
14149552|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149553|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
14149554|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149555|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149556|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
14149557|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14149558|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14149559|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149560|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149561|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14149562|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14149563|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149564|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
14149565|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149566|NCT05059782|Coal Tar|coal tar|mesh-list
14149567|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
14149568|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
14149569|NCT05059418|Clonazepam|clonazepam|mesh-list
14149570|NCT05059418|Capsaicin|capsaicin|mesh-list
14149571|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
14149572|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
14149573|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
14149574|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149575|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149576|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
14149577|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
14149578|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
14149579|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149580|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149581|NCT05059028|Oxytocin|oxytocin|mesh-list
14149582|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
14149583|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14149584|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149585|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
14149586|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14149587|NCT05059145|Fluconazole|fluconazole|mesh-list
14149588|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14149589|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149590|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
14149591|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14149592|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
14149593|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14149594|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14149595|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149596|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149597|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14149598|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
14149599|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149600|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149601|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14149602|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14179280|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179281|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179282|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179283|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
14179284|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14179285|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14183959|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183960|NCT04724187|Misoprostol|misoprostol|mesh-list
14183961|NCT04724187|Oxytocin|oxytocin|mesh-list
14183962|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
14183963|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183964|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183965|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14183966|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
14183967|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14183968|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14183969|NCT04724226|Apatinib|apatinib|mesh-list
14183970|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183971|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14183972|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149603|NCT05058976|Vitamin D|vitamin d|mesh-list
14149604|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
14149605|NCT05058976|Calcium|calcium|mesh-list
14149606|NCT05058976|Vitamins|vitamins|mesh-ancestor
14149607|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
14149608|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149609|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14149610|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14149611|NCT05058677|Lidocaine|lidocaine|mesh-list
14149612|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
14149613|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
14149614|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149615|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149616|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
14149617|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149618|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14149619|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14149620|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14149621|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14149622|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149623|NCT05058612|Midodrine|midodrine|mesh-list
14149624|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
14149625|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
14149626|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149627|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149628|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14149629|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14149630|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14149631|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14149632|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14149633|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149634|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149635|NCT05058443|Denosumab|denosumab|mesh-list
14149636|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14149637|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149638|NCT05058755|Etoposide|etoposide|mesh-list
14149639|NCT05058755|Lenalidomide|lenalidomide|mesh-list
14149640|NCT05058755|Azacitidine|azacitidine|mesh-list
14149641|NCT05058755|Pegaspargase|pegaspargase|mesh-list
14149642|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14149643|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149644|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14149645|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14149646|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149647|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149648|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
14149649|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149650|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14149651|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14149652|NCT05058755|Growth Substances|growth substances|mesh-ancestor
14149653|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
14149654|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14149655|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
14149656|NCT05058209|Triamcinolone|triamcinolone|mesh-list
14149657|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14149658|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14149659|NCT05058209|Betamethasone|betamethasone|mesh-list
14149660|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
14149661|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14149662|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
14149663|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
14149664|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14149665|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14149666|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149667|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
14149668|NCT05058209|Hormones|hormones|mesh-ancestor
14149669|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149670|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149671|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14149672|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
14149673|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149674|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149675|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14149676|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14149677|NCT05058105|Meropenem|meropenem|mesh-list
14149678|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14149679|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149680|NCT05057767|Midazolam|midazolam|mesh-list
14149681|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14149682|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14149683|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149684|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149685|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14149686|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14149687|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149688|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14149689|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
14149690|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
14149691|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
14149692|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
14149693|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149694|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149695|NCT05057845|Lenvatinib|lenvatinib|mesh-list
14149696|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149697|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14149698|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149699|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149700|NCT05057663|Fluorouracil|fluorouracil|mesh-list
14149701|NCT05057663|Bleomycin|bleomycin|mesh-list
14149702|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
14149703|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149704|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14149705|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149706|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14149707|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
14149708|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149709|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14149710|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
14149711|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14149712|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14149713|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14149714|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149715|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
14149716|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149717|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149718|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14149719|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149720|NCT05057351|Glycerol|glycerol|mesh-list
14149721|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14149722|NCT05057351|Protective Agents|protective agents|mesh-ancestor
14149723|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149724|NCT05056896|Aspirin|aspirin|mesh-list
14149725|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
14149726|NCT05056896|Salicylates|salicylates|mesh-list
14149727|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14149728|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149729|NCT05056896|Analgesics|analgesics|mesh-ancestor
14149730|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
14149731|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149732|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149733|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149734|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149735|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14149736|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14149737|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149738|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14149739|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14149740|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149741|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
14149742|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149743|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
14149744|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
14149745|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179286|NCT04736927|Midazolam|midazolam|mesh-list
14179287|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14179288|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14179289|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179290|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179291|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14179292|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14149746|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
14149747|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149748|NCT05056402|Vaccines|vaccines|mesh-list
14149749|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
14149750|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149751|NCT05056142|Anesthetics|anesthetics|mesh-list
14149752|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149753|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149754|NCT05056519|Vaccines|vaccines|mesh-list
14149755|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
14149756|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149757|NCT05056337|Lenvatinib|lenvatinib|mesh-list
14149758|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149759|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14149760|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149761|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765964|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
14765965|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765966|NCT00623285|Pregabalin|pregabalin|mesh-list
13954982|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954983|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954984|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
13954985|NCT03193424|Docetaxel|docetaxel|mesh-list
13954986|NCT03193424|Apatinib|apatinib|mesh-list
13954987|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14765967|NCT00623285|Analgesics|analgesics|mesh-ancestor
14765968|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
14765969|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765970|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765971|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
14765972|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14765973|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14765974|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765975|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14765976|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14765977|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14765978|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765979|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149778|NCT05056025|Vitamins|vitamins|mesh-list
14149779|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
14149780|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149781|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14149782|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
14149783|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149784|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149785|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149786|NCT05055544|Fosfomycin|fosfomycin|mesh-list
14149787|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14149788|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149789|NCT05054868|Ketorolac|ketorolac|mesh-list
14149790|NCT05054868|Oxycodone|oxycodone|mesh-list
14149791|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14149792|NCT05054868|Narcotics|narcotics|mesh-ancestor
14149793|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149794|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149795|NCT05054868|Analgesics|analgesics|mesh-ancestor
14765980|NCT00623376|Dronabinol|dronabinol|mesh-list
14765981|NCT00623376|Nabilone|nabilone|mesh-list
14765982|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
14765983|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
13954988|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
13954989|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
14765984|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14765985|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14765986|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14765987|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14765988|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14765989|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14765990|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14765991|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
14765992|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14765993|NCT00623376|Analgesics|analgesics|mesh-ancestor
14765994|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
13954990|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
14149796|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
14149797|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179293|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14149798|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14149799|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149800|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149801|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149802|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14149803|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149804|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149805|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
14149806|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14149807|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14149808|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149809|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
14149810|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
14149811|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149812|NCT05054842|Metformin|metformin|mesh-list
14149813|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14149814|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149815|NCT05054465|Venetoclax|venetoclax|mesh-list
14149816|NCT05054465|Navitoclax|navitoclax|mesh-list
14149817|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149818|NCT05054478|Daratumumab|daratumumab|mesh-list
14149819|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149820|NCT05054426|Methotrexate|methotrexate|mesh-list
14149821|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14149822|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
14149823|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14149824|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149825|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14149826|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
14149827|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149828|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149829|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
14149830|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149831|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14149832|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14149833|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
14149834|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149835|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14149836|NCT05054751|Fulvestrant|fulvestrant|mesh-list
14149837|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14149838|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149839|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14149840|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14149841|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
14149842|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14149843|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149844|NCT05054322|Fluticasone|fluticasone|mesh-list
14149845|NCT05054322|Xhance|xhance|mesh-list
14149846|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149847|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14149848|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
14149849|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149850|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149851|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14149852|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
14149853|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
14149854|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14149855|NCT05054361|Mannitol|mannitol|mesh-list
14937900|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14937901|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
14937902|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
14149856|NCT05054361|Lactulose|lactulose|mesh-list
14149857|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14149858|NCT05054361|Diuretics|diuretics|mesh-ancestor
14765995|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14765996|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14765997|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14765998|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14765999|NCT00623376|Hormones|hormones|mesh-ancestor
14766000|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766001|NCT00623402|Interferons|interferons|mesh-list
14766002|NCT00623402|Sorafenib|sorafenib|mesh-list
14766003|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766004|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
14766005|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149859|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
14766006|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14766007|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766008|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766009|NCT00623415|Flupirtine|flupirtine|mesh-list
14766010|NCT00623415|Analgesics|analgesics|mesh-ancestor
14766011|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
14766012|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766013|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766014|NCT00623558|Docetaxel|docetaxel|mesh-list
14766015|NCT00623558|Cetuximab|cetuximab|mesh-list
14766016|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766017|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
14766018|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
14766019|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
14149860|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149861|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179294|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14179295|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
14179296|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
14179297|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
14179298|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
14179299|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179300|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179310|NCT04736524|Antibodies|antibodies|mesh-list
14179311|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
14179312|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179313|NCT04736810|Gemcitabine|gemcitabine|mesh-list
14179314|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179315|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14179316|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
14179317|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179318|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
14179319|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179320|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179321|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179322|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
14179323|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179324|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
14179325|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14179326|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14179327|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179328|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14179329|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
14179330|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179331|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14179332|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14179333|NCT04736719|Warfarin|warfarin|mesh-list
14179334|NCT04736719|Apixaban|apixaban|mesh-list
14179335|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
14179336|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14179337|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
14179338|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14179339|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179340|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179341|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179342|NCT04736433|Valsartan|valsartan|mesh-list
14179343|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14179344|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14179345|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14179346|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14179347|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179348|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179349|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766020|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149862|NCT05054114|Interferons|interferons|mesh-list
14149863|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
14149864|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149865|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
14149866|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149867|NCT05054023|Piroxicam|piroxicam|mesh-list
14149868|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14149869|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149870|NCT05054023|Analgesics|analgesics|mesh-ancestor
14149871|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
14149872|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149873|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149874|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149875|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149876|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14149877|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149878|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149879|NCT05053854|Talazoparib|talazoparib|mesh-list
14149880|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14149881|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149882|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149883|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149884|NCT05053633|Anesthetics|anesthetics|mesh-list
14149885|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14149886|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149887|NCT05053750|Paclitaxel|paclitaxel|mesh-list
14149888|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14149889|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14149890|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149891|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14149892|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14149893|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14149894|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149895|NCT05053594|Neostigmine|neostigmine|mesh-list
14149896|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14149897|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149898|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149899|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
14149900|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149901|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149902|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14149903|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
14149904|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149905|NCT05053893|Valsartan|valsartan|mesh-list
14149906|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14149907|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14149908|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14149909|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14149910|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149911|NCT05053841|Metformin|metformin|mesh-list
14149912|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14149913|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149914|NCT05053503|Lofexidine|lofexidine|mesh-list
14149915|NCT05053503|Naltrexone|naltrexone|mesh-list
14149916|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14149917|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14937903|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937904|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937905|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14937906|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14937907|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14937908|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
14149918|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149919|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
14149920|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149921|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14149922|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14149923|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14149924|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14149925|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14149926|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14149927|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149928|NCT05053009|Ibuprofen|ibuprofen|mesh-list
14149929|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14149930|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14149931|NCT05053009|Analgesics|analgesics|mesh-ancestor
14149932|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
14149933|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14149934|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149935|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14149936|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14149937|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14149938|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149939|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149940|NCT05053386|Epirubicin|epirubicin|mesh-list
14149941|NCT05053386|Idarubicin|idarubicin|mesh-list
14149942|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14149943|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149944|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14149945|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14149946|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149947|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149948|NCT05052879|Tadalafil|tadalafil|mesh-list
14149949|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
14149950|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14149951|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14149952|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14149953|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149954|NCT05052879|Urological Agents|urological agents|mesh-ancestor
14149955|NCT05052515|Ascorbic Acid|ascorbic acid|mesh-list
14149956|NCT05052515|Choline|choline|mesh-list
14149957|NCT05052515|Vitamins|vitamins|mesh-ancestor
14149958|NCT05052515|Micronutrients|micronutrients|mesh-ancestor
14149959|NCT05052515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149960|NCT05052515|Antioxidants|antioxidants|mesh-ancestor
14149961|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149962|NCT05052515|Protective Agents|protective agents|mesh-ancestor
14149963|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
14149964|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14149965|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
14149966|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14149967|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14149968|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
14149969|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14149970|NCT05052619|Cefmetazole|cefmetazole|mesh-list
14149971|NCT05052619|Sulperazone|sulperazone|mesh-list
14149972|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149973|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14149974|NCT05052619|Renal Agents|renal agents|mesh-ancestor
14937909|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937910|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954991|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13954992|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13954993|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13954994|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
13954995|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13954996|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13954997|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13954998|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13954999|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955000|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
13955001|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955002|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955003|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14149975|NCT05052931|Paclitaxel|paclitaxel|mesh-list
14149976|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
14149977|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14149978|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149979|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
14149980|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
14149981|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
14149982|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149983|NCT05052437|Capecitabine|capecitabine|mesh-list
14149984|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14149985|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
14149986|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937911|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14149987|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14149988|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
14149989|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14149990|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14149991|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
14149992|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
14149993|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14149994|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
14766021|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14766022|NCT00623688|Imidacloprid|imidacloprid|mesh-list
14766023|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
14766024|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766025|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14149995|NCT05052814|Calcium|calcium|mesh-list
14149996|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14149997|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14149998|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14149999|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150000|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
14150001|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
14150002|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
14150003|NCT05052541|Dronabinol|dronabinol|mesh-list
14150004|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
14150005|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150006|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14150007|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150008|NCT05052541|Analgesics|analgesics|mesh-ancestor
14150009|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
14150010|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150011|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14150012|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14150013|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150014|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150015|NCT05052541|Hormones|hormones|mesh-ancestor
14150016|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150017|NCT05052008|Erenumab|erenumab|mesh-list
14150018|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14150019|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150020|NCT05052008|Analgesics|analgesics|mesh-ancestor
14150021|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
14150022|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150023|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150024|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
14150025|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14150026|NCT05052359|Lectins|lectins|mesh-list
14150027|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
14150028|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
14150029|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150030|NCT05052359|Coagulants|coagulants|mesh-ancestor
14150031|NCT05051956|Palbociclib|palbociclib|mesh-list
14150032|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150033|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14150034|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150035|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179350|NCT04736420|Warfarin|warfarin|mesh-list
14179351|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
14179352|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
14179353|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14766026|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766027|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
14766028|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14766029|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14150036|NCT05051007|Lidocaine|lidocaine|mesh-list
14150037|NCT05051007|Fentanyl|fentanyl|mesh-list
14150038|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
14150039|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
14150040|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150041|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150042|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
14150043|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150044|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14150045|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14150046|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14150047|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150048|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150049|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14150050|NCT05051007|Narcotics|narcotics|mesh-ancestor
14150051|NCT05051007|Analgesics|analgesics|mesh-ancestor
14150052|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14150053|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14150054|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
14150055|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
14150056|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
14150057|NCT05051137|Infliximab|infliximab|mesh-list
14150058|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
14150059|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14150060|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14150061|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150062|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150063|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150064|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14150065|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
14150066|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150067|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14150068|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150069|NCT05051137|Analgesics|analgesics|mesh-ancestor
14150070|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
14150071|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150072|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150073|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150074|NCT05051163|Gentamicins|gentamicins|mesh-list
14150075|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
14150076|NCT05051163|Ampicillin|ampicillin|mesh-list
14150077|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14150078|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150079|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14150080|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150081|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150082|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14150083|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14150084|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14150085|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150086|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150087|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150088|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150089|NCT05050656|Analgesics|analgesics|mesh-ancestor
14150090|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
14150091|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150092|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
14150093|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14150094|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
14150095|NCT05050604|Choline|choline|mesh-list
14150096|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
14150097|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14150098|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
14150099|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150100|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150101|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14150102|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
14150103|NCT05050357|Norethindrone|norethindrone|mesh-list
14150104|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
14150105|NCT05050357|Progestins|progestins|mesh-list
14150106|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14150107|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14150108|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14150109|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
14150110|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14150111|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150112|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14150113|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14150114|NCT05050357|Hormones|hormones|mesh-ancestor
14150115|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150116|NCT05050188|Lansoprazole|lansoprazole|mesh-list
14150117|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
14150118|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14150119|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150120|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14150121|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150122|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150123|NCT05050305|Dexamethasone|dexamethasone|mesh-list
14150124|NCT05050305|Pomalidomide|pomalidomide|mesh-list
14150125|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150126|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
14150127|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
14150128|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150129|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150130|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150131|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
14150132|NCT05050305|Hormones|hormones|mesh-ancestor
14150133|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150134|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14150135|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150136|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
14150137|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14150138|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14150139|NCT05050305|Growth Substances|growth substances|mesh-ancestor
14150140|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
14150141|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
14150142|NCT05050071|Calcium|calcium|mesh-list
14150143|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14150144|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150145|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14150146|NCT05050448|Diclofenac|diclofenac|mesh-list
14150147|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14150148|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150149|NCT05050448|Analgesics|analgesics|mesh-ancestor
14150150|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
14150151|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150152|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150153|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150154|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14150155|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14150156|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150157|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150158|NCT05049603|Atorvastatin|atorvastatin|mesh-list
14150159|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14150160|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14150161|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
14150162|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150163|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14150164|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14150165|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150166|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
14150167|NCT05049863|Irinotecan|irinotecan|mesh-list
14150168|NCT05049863|Allopurinol|allopurinol|mesh-list
14150169|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14150170|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14150171|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150172|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150173|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150174|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14150175|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14150176|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
14150177|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14150178|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150179|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
14150180|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
14766030|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14766031|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150181|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14766032|NCT00623857|Vitamins|vitamins|mesh-list
14766033|NCT00623857|Zinc|zinc|mesh-list
14150182|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14937912|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14937913|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937914|NCT01478490|Urological Agents|urological agents|mesh-ancestor
14937915|NCT01478503|Mirabegron|mirabegron|mesh-list
14937916|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14937917|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14937918|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937919|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937920|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937921|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937922|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937923|NCT01478503|Urological Agents|urological agents|mesh-ancestor
14937924|NCT01478529|Mirabegron|mirabegron|mesh-list
14937925|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14937926|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14937927|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937928|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937929|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937930|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150183|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
14150184|NCT05049863|Protective Agents|protective agents|mesh-ancestor
14150185|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150186|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
14150187|NCT05049707|Analgesics|analgesics|mesh-ancestor
14150188|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
14150189|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150190|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150191|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
14150192|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150193|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14150194|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
14150195|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14150196|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150197|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150198|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14150199|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
14150200|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14179354|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
14179355|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14179356|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179357|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179358|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179359|NCT04736589|Sirolimus|sirolimus|mesh-list
14179360|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14179361|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179362|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14179363|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179364|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
14179365|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14150201|NCT05049473|Cytarabine|cytarabine|mesh-list
14937931|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937932|NCT01478529|Urological Agents|urological agents|mesh-ancestor
14937933|NCT01478568|Desipramine|desipramine|mesh-list
14937934|NCT01478568|Mirabegron|mirabegron|mesh-list
14937935|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14937936|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14937937|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14937938|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
14937939|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937940|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937941|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150202|NCT05049473|Dexamethasone|dexamethasone|mesh-list
14150203|NCT05049473|Prednisone|prednisone|mesh-list
14150204|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
14150205|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
14150206|NCT05049473|Rituximab|rituximab|mesh-list
14150207|NCT05049473|Doxorubicin|doxorubicin|mesh-list
14150208|NCT05049473|Methotrexate|methotrexate|mesh-list
14150209|NCT05049473|Etoposide|etoposide|mesh-list
14150210|NCT05049473|Vincristine|vincristine|mesh-list
14150211|NCT05049473|Vindesine|vindesine|mesh-list
14150212|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14150213|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
14150214|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150215|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14150216|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14150217|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
14150218|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150219|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150220|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14150221|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150222|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
14150223|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
14150224|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150225|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150226|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
14150227|NCT05049473|Hormones|hormones|mesh-ancestor
14150228|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150229|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14150230|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14150231|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14150232|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14150233|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14150234|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150235|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14150236|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
14150237|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14150238|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14937942|NCT01478568|Urological Agents|urological agents|mesh-ancestor
14937943|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14937944|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
14937945|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14937946|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937947|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14937948|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14937949|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14937950|NCT01478607|Capsaicin|capsaicin|mesh-list
14937951|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
14937952|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
14937953|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
14937954|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937955|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937956|NCT01478633|Galantamine|galantamine|mesh-list
14150239|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
14150240|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
14150241|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14150242|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14150243|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14150244|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
14150245|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150246|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
14150247|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
14150248|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
14150249|NCT05049681|Apatinib|apatinib|mesh-list
14150250|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150251|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14150252|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150253|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150254|NCT05048914|Acetaminophen|acetaminophen|mesh-list
14150255|NCT05048914|Dipyrone|dipyrone|mesh-list
14150256|NCT05048914|Ibuprofen|ibuprofen|mesh-list
14150257|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150258|NCT05048914|Analgesics|analgesics|mesh-ancestor
14150259|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
14150260|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150261|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150262|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
14150263|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14150264|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150265|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14150266|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14150267|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150268|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150269|NCT05048940|Vaccines|vaccines|mesh-list
14150270|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
14150271|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150272|NCT05048901|Lanreotide|lanreotide|mesh-list
14150273|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150274|NCT05048615|Itraconazole|itraconazole|mesh-list
14150275|NCT05048615|Azacitidine|azacitidine|mesh-list
14150276|NCT05048615|Venetoclax|venetoclax|mesh-list
14150277|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14150278|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
14150279|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150280|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150281|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150282|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
14937957|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14937958|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14937959|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937960|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
14937961|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14937962|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937963|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14937964|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
14937965|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937966|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
14937967|NCT01478685|Paclitaxel|paclitaxel|mesh-list
14937968|NCT01478685|Carboplatin|carboplatin|mesh-list
14937969|NCT01478685|Azacitidine|azacitidine|mesh-list
14150283|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150284|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14150285|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14150286|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14150287|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
14150288|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150289|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150290|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14150291|NCT05048511|Vitamin D|vitamin d|mesh-list
14150292|NCT05048511|Vitamins|vitamins|mesh-ancestor
14150293|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
14150294|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150295|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14150296|NCT05048589|Vaccines|vaccines|mesh-list
14150297|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
14150298|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150299|NCT05048524|Leucovorin|leucovorin|mesh-list
14150300|NCT05048524|Gemcitabine|gemcitabine|mesh-list
14150301|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
14150302|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14150303|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
14150304|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766034|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
14766035|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766036|NCT00623857|Trace Elements|trace elements|mesh-ancestor
14766037|NCT00623987|Warfarin|warfarin|mesh-list
14766038|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
14766039|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14766040|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14766041|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14766042|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150305|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150306|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
14150307|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150308|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150309|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14150310|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
14150311|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150312|NCT05048524|Antidotes|antidotes|mesh-ancestor
14150313|NCT05048524|Protective Agents|protective agents|mesh-ancestor
14150314|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
14150315|NCT05048524|Vitamins|vitamins|mesh-ancestor
14150316|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
14150317|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
14150318|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14150319|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14150320|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150321|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150322|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
14150323|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14150324|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14150325|NCT05047874|Prednisolone|prednisolone|mesh-list
14150326|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
14150327|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14150328|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
14150329|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150330|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
14150331|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
14150332|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150333|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150334|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150335|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
14150336|NCT05047874|Hormones|hormones|mesh-ancestor
14150337|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150338|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14150339|NCT05047874|Protective Agents|protective agents|mesh-ancestor
14150340|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14150341|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150342|NCT05047848|Fulvestrant|fulvestrant|mesh-list
14150343|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14150344|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150345|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14150346|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14150347|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
14150348|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150349|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150350|NCT05047991|Leucovorin|leucovorin|mesh-list
14150351|NCT05047991|Gemcitabine|gemcitabine|mesh-list
14150352|NCT05047991|Paclitaxel|paclitaxel|mesh-list
14150353|NCT05047991|Fluorouracil|fluorouracil|mesh-list
14150354|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
14150355|NCT05047991|Irinotecan|irinotecan|mesh-list
14150356|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14150357|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150358|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14150359|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14150360|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
14150361|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150362|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14150363|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
14150364|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
14150365|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150366|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150367|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14150368|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
14150369|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150370|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14150371|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14150372|NCT05047991|Antidotes|antidotes|mesh-ancestor
14150373|NCT05047991|Protective Agents|protective agents|mesh-ancestor
14150374|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
14150375|NCT05047991|Vitamins|vitamins|mesh-ancestor
14150376|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
14150377|NCT05047978|Caseins|caseins|mesh-list
14150378|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
14150379|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
14150380|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150381|NCT05047328|Inolimomab|inolimomab|mesh-list
14150382|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14150383|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
14150384|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150385|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
14150386|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14150387|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14150388|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150389|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
14150390|NCT05047133|Coagulants|coagulants|mesh-ancestor
14150391|NCT05047393|Vitamin D|vitamin d|mesh-list
14150392|NCT05047393|Vitamins|vitamins|mesh-ancestor
14150393|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
14150394|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150395|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14150396|NCT05047211|Dextrans|dextrans|mesh-list
14150397|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
14150398|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
14150399|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
14150400|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
14150401|NCT05047211|Hematinics|hematinics|mesh-ancestor
14150402|NCT05046860|Dalbavancin|dalbavancin|mesh-list
14150403|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14150404|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150405|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
14150406|NCT05047055|Rifampin|rifampin|mesh-list
14150407|NCT05047055|Isoniazid|isoniazid|mesh-list
14150408|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
14150409|NCT05047055|Ethambutol|ethambutol|mesh-list
14150410|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14150411|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150412|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14150413|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14150414|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150415|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150416|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150417|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14150418|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
14150419|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
14150420|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14150421|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14150422|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14150423|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14150424|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14150425|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14150426|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14150427|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14150428|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14150429|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
14150430|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14179366|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
14179367|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179368|NCT04736329|Telmisartan|telmisartan|mesh-list
14179369|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14179370|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14179371|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14179372|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179373|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
14179374|NCT04736381|Abatacept|abatacept|mesh-list
14179375|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14179376|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179377|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14179378|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
14179379|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14179380|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179381|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179382|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179383|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179384|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
14179385|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179386|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14179387|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179388|NCT04736108|Prednisolone|prednisolone|mesh-list
14179389|NCT04736108|Goserelin|goserelin|mesh-list
14150431|NCT05046431|Golimumab|golimumab|mesh-list
14150432|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14150433|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150434|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14150435|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
14150436|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150437|NCT05046262|Calcium|calcium|mesh-list
14150438|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14150439|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150440|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
14150441|NCT05046457|Provitamins|provitamins|mesh-ancestor
14150442|NCT05046457|Vitamins|vitamins|mesh-ancestor
14150443|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
14150444|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766043|NCT00624026|Memantine|memantine|mesh-list
14766044|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14766045|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14766046|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
14766047|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766048|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766049|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766050|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14766051|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14766052|NCT00624039|Pilocarpine|pilocarpine|mesh-list
14766053|NCT00624039|Miotics|miotics|mesh-ancestor
14766054|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
14766055|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766056|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766057|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14766058|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14766059|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
14766060|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766061|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766062|NCT00624078|Antivenins|antivenins|mesh-list
14766063|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
14766064|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766065|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14766066|NCT00624130|Dacuronium|dacuronium|mesh-list
14766067|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14766068|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766069|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14766070|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14766071|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14766072|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766073|NCT00624143|Voriconazole|voriconazole|mesh-list
14766074|NCT00624143|Amphotericin B|amphotericin b|mesh-list
14766075|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14766076|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
14766077|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766078|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14766079|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14766080|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766081|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766082|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14150488|NCT05046041|Misoprostol|misoprostol|mesh-list
14150489|NCT05046041|Mifepristone|mifepristone|mesh-list
14150490|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14150491|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
14150492|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14150493|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150494|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14150495|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150496|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
14150497|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14150498|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14150499|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14150500|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14150501|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
14150502|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14150503|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14150504|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
14150505|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150506|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
14150507|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14150508|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14150509|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
14150510|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14150511|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150512|NCT05045651|Cimetidine|cimetidine|mesh-list
14150513|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14150514|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150515|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14150516|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
14150517|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
14150518|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150519|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150520|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150521|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14150522|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14150523|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150524|NCT05045508|Varenicline|varenicline|mesh-list
14150525|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14150526|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14150527|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
14150528|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150529|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150530|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150531|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
14150532|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14150533|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150534|NCT05045248|Apraclonidine|apraclonidine|mesh-list
14150535|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14150536|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14150537|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14150538|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
14150539|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150540|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150541|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150542|NCT05045274|Aspirin|aspirin|mesh-list
14150543|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
14150544|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
14150545|NCT05045274|Giapreza|giapreza|mesh-list
14150546|NCT05045274|Clopidogrel|clopidogrel|mesh-list
14150547|NCT05045274|Ticagrelor|ticagrelor|mesh-list
14150548|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14150549|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14150550|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
14150551|NCT05045274|Diuretics|diuretics|mesh-list
14150552|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14150553|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14150554|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14150555|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
14150556|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14150557|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14150558|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150559|NCT05045274|Analgesics|analgesics|mesh-ancestor
14150560|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
14150561|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150562|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150563|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150564|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14150565|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14150566|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14150567|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150568|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14150569|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14150570|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
14150571|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14150572|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14150573|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14150574|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
14150575|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150576|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14150577|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14150578|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14150579|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14150580|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
14150581|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14150582|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
14150583|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14150584|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
14150585|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14150586|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14150587|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
14150588|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
14150589|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150590|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14150591|NCT05045274|Hormones|hormones|mesh-ancestor
14150592|NCT05045443|Curcumin|curcumin|mesh-list
14150593|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14150594|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150595|NCT05045443|Analgesics|analgesics|mesh-ancestor
14150596|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
14150597|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150598|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150599|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150600|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14150601|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150602|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150603|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150604|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14150605|NCT05045053|Lifitegrast|lifitegrast|mesh-list
14150606|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14150607|NCT05044819|Cannabidiol|cannabidiol|mesh-list
14150608|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
14150609|NCT05044728|Paclitaxel|paclitaxel|mesh-list
14150610|NCT05044728|Carboplatin|carboplatin|mesh-list
14150611|NCT05044728|Antibodies|antibodies|mesh-list
14150612|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14150613|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150614|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
14150615|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
14150616|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
14150617|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150618|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
14150619|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150620|NCT05044637|Primaquine|primaquine|mesh-list
14150621|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
14150622|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14150623|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14150624|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150625|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
14150626|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14150627|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
14150628|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150629|NCT05044429|Lidocaine|lidocaine|mesh-list
14150630|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
14150631|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
14150632|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150633|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150634|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
14150635|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150636|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14150637|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14150638|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14150639|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150640|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150641|NCT05044468|Lidocaine|lidocaine|mesh-list
14150642|NCT05044468|Bupivacaine|bupivacaine|mesh-list
14150643|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
14150644|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
14150645|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150646|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150647|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
14150648|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150649|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14150650|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14150651|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14150652|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150653|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150654|NCT05044364|Clevidipine|clevidipine|mesh-list
14150655|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14150656|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150657|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150658|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14150659|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179390|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
14179391|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179392|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
14179393|NCT04736108|Hormones|hormones|mesh-ancestor
14179394|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179395|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179396|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14179397|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179398|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14179399|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179400|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179401|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
14179402|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14179403|NCT04736225|Insulin|insulin|mesh-list
14179404|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14179405|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179406|NCT04736186|Loperamide|loperamide|mesh-list
14179407|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
14179408|NCT04736186|Bentonite|bentonite|mesh-list
14179409|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179410|NCT04736186|Antidotes|antidotes|mesh-ancestor
14179411|NCT04736186|Protective Agents|protective agents|mesh-ancestor
14179412|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179413|NCT04735978|Antibodies|antibodies|mesh-list
14179414|NCT04735978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14179415|NCT04735978|Immunologic Factors|immunologic factors|mesh-ancestor
14179416|NCT04735978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179417|NCT04735926|Calcifediol|calcifediol|mesh-list
14179418|NCT04735926|Vitamins|vitamins|mesh-ancestor
14179419|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
14179420|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179421|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14179422|NCT04735523|Warfarin|warfarin|mesh-list
14179423|NCT04735523|Dabigatran|dabigatran|mesh-list
14179424|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
14179425|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
14179426|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14179427|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179428|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179429|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179430|NCT04735445|Liver Extracts|liver extracts|mesh-list
14179431|NCT04735445|Hematinics|hematinics|mesh-ancestor
14179432|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
14179433|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
14179434|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179435|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179436|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
14179437|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
14179438|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179439|NCT04735510|Cyclosporine|cyclosporine|mesh-list
14179440|NCT04735510|Cyclosporins|cyclosporins|mesh-list
14179441|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179442|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179443|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179444|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
14179445|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179446|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
14179447|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179448|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179449|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179450|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14179451|NCT04735549|Hormones|hormones|mesh-list
14179452|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179453|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179454|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
14179455|NCT04735471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14179456|NCT04735471|Fludarabine|fludarabine|mesh-list
14179457|NCT04735471|Interleukin-2|interleukin-2|mesh-list
14179458|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179459|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
14179460|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179461|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179462|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14150660|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
14150661|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14150662|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14150663|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150664|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150665|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150666|NCT05043766|Naltrexone|naltrexone|mesh-list
14150667|NCT05043766|Oxycodone|oxycodone|mesh-list
14150668|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14150669|NCT05043766|Narcotics|narcotics|mesh-ancestor
14150670|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150671|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150672|NCT05043766|Analgesics|analgesics|mesh-ancestor
14150673|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
14150674|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150675|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14150676|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14150677|NCT05043740|Evolocumab|evolocumab|mesh-list
14150678|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14150679|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14150680|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
14150681|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937970|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14937971|NCT01478685|Cc-486|cc-486|mesh-list
14937972|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14937973|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150682|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14150683|NCT05043896|Tadalafil|tadalafil|mesh-list
14150684|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
14150685|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14150686|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14150687|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150688|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150689|NCT05043896|Urological Agents|urological agents|mesh-ancestor
14150690|NCT05043506|Palbociclib|palbociclib|mesh-list
14150691|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14150692|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150693|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14150694|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150695|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150696|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14150697|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14150698|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
14150699|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150700|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150701|NCT05043688|Paclitaxel|paclitaxel|mesh-list
14150702|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14150703|NCT05043688|Carboplatin|carboplatin|mesh-list
14150704|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14150705|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150706|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
14150707|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
14150708|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
14150709|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150710|NCT05043350|Loratadine|loratadine|mesh-list
14150711|NCT05043350|Famotidine|famotidine|mesh-list
14150712|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14150713|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150714|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14150715|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
14150716|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
14150717|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150718|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150719|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150720|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
14150721|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
14150722|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14150723|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14150724|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14150725|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14150726|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14150727|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150728|NCT05043233|Methimazole|methimazole|mesh-list
14150729|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
14937974|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
14150730|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
14150731|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150732|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150733|NCT05043129|Vaccines|vaccines|mesh-list
14150734|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
14150735|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150736|NCT05043142|Antibodies|antibodies|mesh-list
14150737|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
14150738|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150739|NCT05043116|Vitamin D|vitamin d|mesh-list
14150740|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
14150741|NCT05043116|Vitamins|vitamins|mesh-ancestor
14150742|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
14150743|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150744|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14150745|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14150746|NCT05042973|Empagliflozin|empagliflozin|mesh-list
14150747|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14150748|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150749|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14150750|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150751|NCT05042817|Sufentanil|sufentanil|mesh-list
14150752|NCT05042817|Morphine|morphine|mesh-list
14150753|NCT05042817|Prilocaine|prilocaine|mesh-list
14150754|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14150755|NCT05042817|Narcotics|narcotics|mesh-ancestor
14150756|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150757|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150758|NCT05042817|Analgesics|analgesics|mesh-ancestor
14150759|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
14150760|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150761|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14150762|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14150763|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
14150764|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
14150765|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
14150766|NCT05042674|Ergothioneine|ergothioneine|mesh-list
14150767|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
14150768|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150769|NCT05042674|Protective Agents|protective agents|mesh-ancestor
14150770|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150771|NCT05042635|Ixekizumab|ixekizumab|mesh-list
14150772|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
14150773|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
14150774|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14150775|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150776|NCT05042336|Lenvatinib|lenvatinib|mesh-list
14150777|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150778|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14150779|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150780|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150781|NCT05042271|Meropenem|meropenem|mesh-list
14150782|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14150783|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150784|NCT05042245|Silymarin|silymarin|mesh-list
14150785|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
14937975|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
14937976|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
14937977|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955004|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955005|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
13955006|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13955007|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13955008|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13955009|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955010|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955011|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
13955012|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955013|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955014|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13955015|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955016|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14937978|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14150786|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
14150787|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150788|NCT05042245|Protective Agents|protective agents|mesh-ancestor
14150789|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150790|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14150791|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14150792|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150793|NCT05041985|Diazepam|diazepam|mesh-list
14150794|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14150795|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
14150796|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
14150797|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
14150798|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150799|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150800|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150801|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14150802|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150803|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14150804|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14150805|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14150806|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14150807|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14150808|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14150809|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
14150810|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
14150811|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
14150812|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
14150813|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150814|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179463|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
14179464|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179465|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179466|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14179467|NCT04735471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14179468|NCT04735471|Analgesics|analgesics|mesh-ancestor
14179469|NCT04735471|Sensory System Agents|sensory system agents|mesh-ancestor
14179470|NCT04735471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179471|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
14179472|NCT04735042|Empagliflozin|empagliflozin|mesh-list
14179473|NCT04735042|Linagliptin|linagliptin|mesh-list
14179474|NCT04735042|Saxagliptin|saxagliptin|mesh-list
14179475|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14179476|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179477|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14179478|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179479|NCT04735042|Incretins|incretins|mesh-ancestor
14179480|NCT04735042|Hormones|hormones|mesh-ancestor
14179481|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179482|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14179483|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179484|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179485|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
14179486|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179487|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14183973|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937979|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
14937980|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938762|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938763|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14183974|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14183975|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14183976|NCT04724343|Cetrorelix|cetrorelix|mesh-list
14183977|NCT04724343|Menotropins|menotropins|mesh-list
14183978|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
14183979|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14183980|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
14183981|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14183982|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183983|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14183984|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14183985|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14183986|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14183987|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
14150815|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
14150816|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14150817|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14150818|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150819|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150820|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150821|NCT05042102|Donepezil|donepezil|mesh-list
14150822|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14150823|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150824|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150825|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
14150826|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150827|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150828|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
14150829|NCT05041647|Dronabinol|dronabinol|mesh-list
14150830|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
14150831|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150832|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14150833|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150834|NCT05041647|Analgesics|analgesics|mesh-ancestor
14150835|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
14937981|NCT01478698|Plasminogen|plasminogen|mesh-list
14937982|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14937983|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14937984|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14937985|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937986|NCT01478724|Caseins|caseins|mesh-list
14937987|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
14937988|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
14937989|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14937990|NCT01478737|Dexamethasone|dexamethasone|mesh-list
14937991|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
14937992|NCT01478737|BB 1101|bb 1101|mesh-list
14150836|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150837|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14150838|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14150839|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150840|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150841|NCT05041647|Hormones|hormones|mesh-ancestor
14150842|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150843|NCT05041582|Citalopram|citalopram|mesh-list
14150844|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14150845|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14150846|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150847|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150848|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150849|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
14150850|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150851|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14150852|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
14150853|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14150854|NCT05041790|Choline|choline|mesh-list
14150855|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
14150856|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14150857|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
14150858|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150859|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150860|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14150861|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
14150862|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
14150863|NCT05041153|Lenvatinib|lenvatinib|mesh-list
14150864|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14150865|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150866|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14150867|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150868|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150869|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14150870|NCT05041127|Cetuximab|cetuximab|mesh-list
14150871|NCT05041127|Antibodies|antibodies|mesh-list
14150872|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
14150873|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14150874|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
14150875|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937993|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150876|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150877|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
14150878|NCT05041270|Nalbuphine|nalbuphine|mesh-list
14150879|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14150880|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150881|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150882|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14150883|NCT05041270|Analgesics|analgesics|mesh-ancestor
14150884|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
14150885|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150886|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14150887|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14150888|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14150889|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
14150890|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14150891|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150892|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14150893|NCT05041270|Narcotics|narcotics|mesh-ancestor
14150894|NCT05040906|Rituximab|rituximab|mesh-list
14150895|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14150896|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150897|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
14150898|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150899|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14150900|NCT05040828|Montelukast|montelukast|mesh-list
14150901|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14150902|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
14150903|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14150904|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
14150905|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150906|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150907|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14150908|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14150909|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150910|NCT05040724|Ivermectin|ivermectin|mesh-list
14150911|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14150912|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150913|NCT05040594|Lidocaine|lidocaine|mesh-list
14150914|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
14150915|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
14150916|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150917|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150918|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
14150919|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150920|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14150921|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14150922|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14150923|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150924|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150925|NCT05040217|Mitogens|mitogens|mesh-list
14150926|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14150927|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150928|NCT05039801|Pembrolizumab|pembrolizumab|mesh-list
14150929|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14150930|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150931|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14150932|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14150933|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150934|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150935|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14150936|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14150937|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150938|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
14150939|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179488|NCT04734678|Infliximab|infliximab|mesh-list
14179489|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179490|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179491|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179492|NCT04734730|Prednisone|prednisone|mesh-list
14179493|NCT04734730|Cortisone|cortisone|mesh-list
14179494|NCT04734730|Leuprolide|leuprolide|mesh-list
14179495|NCT04734730|Goserelin|goserelin|mesh-list
14179496|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
14179497|NCT04734730|Bicalutamide|bicalutamide|mesh-list
14150940|NCT05039580|Dexamethasone|dexamethasone|mesh-list
14150941|NCT05039580|Antibodies|antibodies|mesh-list
14150942|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14150943|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
14150944|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150945|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150946|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
14150947|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
14150948|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150949|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150950|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
14150951|NCT05039580|Hormones|hormones|mesh-ancestor
14150952|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150953|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14150954|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150955|NCT05039606|Nedaplatin|nedaplatin|mesh-list
14150956|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150957|NCT05038969|Esomeprazole|esomeprazole|mesh-list
14150958|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14150959|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14150960|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14150961|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150962|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150963|NCT05038605|Metronidazole|metronidazole|mesh-list
14150964|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150965|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14150966|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14150967|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14150968|NCT05038657|Atezolizumab|atezolizumab|mesh-list
14150969|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14150970|NCT05038462|Lactoferrin|lactoferrin|mesh-list
14150971|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14150972|NCT05038072|Triamcinolone|triamcinolone|mesh-list
14150973|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14150974|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14150975|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14150976|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14150977|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
14150978|NCT05038072|Hormones|hormones|mesh-ancestor
14150979|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14150980|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150981|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14150982|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
14150983|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14150984|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14150985|NCT05038007|Bupivacaine|bupivacaine|mesh-list
14150986|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
14150987|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
14150988|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150989|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150990|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
14150991|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14150992|NCT05038410|Wobenzym|wobenzym|mesh-list
14150993|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14150994|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
14150995|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14150996|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
14150997|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14150998|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14150999|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151000|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14151001|NCT05038111|Analgesics|analgesics|mesh-ancestor
14151002|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
14151003|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151004|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14151005|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14151006|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14151007|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151008|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151009|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151010|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
14151011|NCT05038202|Bromides|bromides|mesh-list
14151012|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
14151013|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14151014|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14151015|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14151016|NCT05038228|Vitamin K|vitamin k|mesh-list
14151017|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
14151018|NCT05038228|Apixaban|apixaban|mesh-list
14151019|NCT05038228|Dabigatran|dabigatran|mesh-list
14151020|NCT05038228|Vitamins|vitamins|mesh-ancestor
14151021|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
14151022|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151023|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14151024|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
14151025|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14151026|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
14151027|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151028|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151029|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
14151030|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14151031|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14151032|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
14151033|NCT05038228|Coagulants|coagulants|mesh-ancestor
14151034|NCT05038449|Colchicine|colchicine|mesh-list
14151035|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
14151036|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14151037|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
14151038|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
14151039|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
14151040|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151041|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151042|NCT05038059|Acetic Acid|acetic acid|mesh-list
14151043|NCT05038059|Retinol acetate|retinol acetate|mesh-list
14151044|NCT05038059|Ethylene|ethylene|mesh-list
14151045|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14151046|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151047|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14151048|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
14151049|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151050|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14151051|NCT05038059|Protective Agents|protective agents|mesh-ancestor
14151052|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151053|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14151054|NCT05038059|Growth Substances|growth substances|mesh-ancestor
14151055|NCT05037695|Empagliflozin|empagliflozin|mesh-list
14151056|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14151057|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151058|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14151059|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937994|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
14937995|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
14937996|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14937997|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14937998|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14937999|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
14938000|NCT01478737|Hormones|hormones|mesh-ancestor
14938001|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938002|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14938003|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955017|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
13955018|NCT03193307|BI 409306|bi 409306|mesh-list
13955019|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13955020|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955021|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955022|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13955023|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
13955024|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13955025|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955026|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14151060|NCT05037487|Dronabinol|dronabinol|mesh-list
14151061|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
14151062|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938004|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
14151063|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14151064|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14151065|NCT05037487|Analgesics|analgesics|mesh-ancestor
14151066|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
14151067|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151068|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14151069|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14151070|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151071|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151072|NCT05037487|Hormones|hormones|mesh-ancestor
14151073|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179498|NCT04734730|Talazoparib|talazoparib|mesh-list
14179499|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179500|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
14179501|NCT04734730|Hormones|hormones|mesh-ancestor
14179502|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179503|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179504|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14179505|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179506|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14179507|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
14179508|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14179509|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13955027|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13955028|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13955029|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13955030|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13955031|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
13955032|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13955033|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14179510|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179511|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179512|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
14179513|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14179514|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
14179515|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14179516|NCT04734782|Antibodies|antibodies|mesh-list
14179517|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
14179518|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179519|NCT04734665|Bevacizumab|bevacizumab|mesh-list
14179520|NCT04734665|Niraparib|niraparib|mesh-list
14179521|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179522|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179523|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14179524|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14179525|NCT04734665|Growth Substances|growth substances|mesh-ancestor
14179526|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179527|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
14179528|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14179529|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179530|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179531|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14179532|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179533|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14179534|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179535|NCT05314673|Bevacizumab|bevacizumab|mesh-list
14179536|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179537|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179538|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14179539|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14179540|NCT05314673|Growth Substances|growth substances|mesh-ancestor
14179541|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179542|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14179543|NCT05314621|Fluticasone|fluticasone|mesh-list
14179544|NCT05314621|Xhance|xhance|mesh-list
14179545|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14179546|NCT05314621|Dextrans|dextrans|mesh-list
14179547|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14179548|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179549|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14179550|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
14183988|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
14151074|NCT05037539|Fentanyl|fentanyl|mesh-list
14151075|NCT05037539|Morphine|morphine|mesh-list
14151076|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14151077|NCT05037539|Narcotics|narcotics|mesh-ancestor
14151078|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151079|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151080|NCT05037539|Analgesics|analgesics|mesh-ancestor
14151081|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
14151082|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151083|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14151084|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14151085|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
14151086|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
14766083|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
14766084|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766085|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766086|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14766087|NCT00624143|Amebicides|amebicides|mesh-ancestor
14766088|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14151093|NCT05037253|Vitamin D|vitamin d|mesh-list
14151094|NCT05037253|Vitamins|vitamins|mesh-ancestor
14151095|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
14151096|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151097|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14151098|NCT05037240|Quercetin|quercetin|mesh-list
14151099|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
14151100|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151101|NCT05037240|Protective Agents|protective agents|mesh-ancestor
14151102|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151103|NCT05037006|Anesthetics|anesthetics|mesh-list
14151104|NCT05037006|Sevoflurane|sevoflurane|mesh-list
14151105|NCT05037006|Neostigmine|neostigmine|mesh-list
14151106|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151107|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151108|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14151109|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14151110|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
14151111|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14151112|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151113|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151114|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
14151115|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151116|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14151117|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
14151118|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151119|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
14151120|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14151121|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14151122|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151123|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
14151124|NCT05037162|Coagulants|coagulants|mesh-ancestor
14151125|NCT05036824|Tinzaparin|tinzaparin|mesh-list
14151126|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14151127|NCT05036824|Dalteparin|dalteparin|mesh-list
14938005|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938006|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938007|NCT01478997|Acetaminophen|acetaminophen|mesh-list
14938008|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14938009|NCT01478997|Analgesics|analgesics|mesh-ancestor
14938010|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
14938011|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938012|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938013|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
14938014|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14151128|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
14151129|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14151130|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14151131|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151132|NCT05036798|Lenvatinib|lenvatinib|mesh-list
14151133|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151134|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14151135|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766089|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14766090|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14766091|NCT00624182|Gemcitabine|gemcitabine|mesh-list
14766092|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766093|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
14151136|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151137|NCT05036005|Pertuzumab|pertuzumab|mesh-list
14151138|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14151139|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151140|NCT05035953|Edaravone|edaravone|mesh-list
14151141|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14151142|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
14151143|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151144|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14151145|NCT05035953|Protective Agents|protective agents|mesh-ancestor
14151146|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151147|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
14151148|NCT05036174|Promethazine|promethazine|mesh-list
14151149|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14151150|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14151151|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151152|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151153|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
14151154|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
14151155|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
14151156|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151157|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
14151158|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
14151159|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14151160|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14151161|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
14151162|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
14151163|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151164|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151165|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14151166|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
14151167|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
14151168|NCT05035888|Phenylephrine|phenylephrine|mesh-list
14151169|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
14151170|NCT05035888|Norepinephrine|norepinephrine|mesh-list
14151171|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14151172|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14151173|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
14151174|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
14151175|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151176|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151177|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
14151178|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
14151179|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
14151180|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14151181|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14151182|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14151183|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151184|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151185|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151186|NCT05035888|Protective Agents|protective agents|mesh-ancestor
14151187|NCT05035745|Talazoparib|talazoparib|mesh-list
14151188|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14151189|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151190|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151191|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151192|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14151193|NCT05035849|Acarbose|acarbose|mesh-list
14151194|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14151195|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151196|NCT05035849|Incretins|incretins|mesh-ancestor
14151197|NCT05035849|Hormones|hormones|mesh-ancestor
14151198|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151199|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14151200|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
14151201|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151202|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151203|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14151204|NCT05035381|Leucovorin|leucovorin|mesh-list
14151205|NCT05035381|Bevacizumab|bevacizumab|mesh-list
14151206|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
14151207|NCT05035381|Fluorouracil|fluorouracil|mesh-list
14151208|NCT05035381|Irinotecan|irinotecan|mesh-list
14151209|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14151210|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14151211|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151212|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14151213|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14151214|NCT05035381|Growth Substances|growth substances|mesh-ancestor
14151215|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151216|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
14151217|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
14151218|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151219|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14151220|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14151221|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
14151222|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14151223|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14151224|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151225|NCT05035381|Antidotes|antidotes|mesh-ancestor
14151226|NCT05035381|Protective Agents|protective agents|mesh-ancestor
14151227|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
14151228|NCT05035381|Vitamins|vitamins|mesh-ancestor
14151229|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
14151230|NCT05035498|Phenylephrine|phenylephrine|mesh-list
14151231|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
14151232|NCT05035498|Norepinephrine|norepinephrine|mesh-list
14151233|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14151234|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14151235|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
14151236|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
14151237|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151238|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151239|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
14151240|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
14151241|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
14151242|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14151243|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14151244|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14151245|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151246|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151247|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151248|NCT05035498|Protective Agents|protective agents|mesh-ancestor
14151249|NCT05035485|Phenylephrine|phenylephrine|mesh-list
14151250|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
14151251|NCT05035485|Norepinephrine|norepinephrine|mesh-list
14151252|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14151253|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14151254|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
13955034|NCT03193463|Topotecan|topotecan|mesh-list
13955035|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13955036|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13955037|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955038|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955039|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955040|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
13955041|NCT03193281|Dasatinib|dasatinib|mesh-list
13955042|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955043|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13955044|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955045|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955046|NCT03193606|Fluorides|fluorides|mesh-list
13955047|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
13955048|NCT03193606|Protective Agents|protective agents|mesh-ancestor
13955049|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955050|NCT03193203|Etanercept|etanercept|mesh-list
13955051|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955052|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955053|NCT03193203|Analgesics|analgesics|mesh-ancestor
13955054|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
13955055|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151255|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
14151256|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151257|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151258|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
14151259|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
14151260|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
14151261|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14151262|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14151263|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14151264|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151265|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151266|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151267|NCT05035485|Protective Agents|protective agents|mesh-ancestor
14151268|NCT05035472|Phenylephrine|phenylephrine|mesh-list
14151269|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
14151270|NCT05035472|Norepinephrine|norepinephrine|mesh-list
14151271|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14151272|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14151273|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
14151274|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
14151275|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151276|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151277|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
14151278|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
14151279|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
14151280|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14151281|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14151282|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14151283|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151284|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151285|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151286|NCT05035472|Protective Agents|protective agents|mesh-ancestor
14151287|NCT05035238|Vaccines|vaccines|mesh-list
14151288|NCT05035238|Immunologic Factors|immunologic factors|mesh-ancestor
14151289|NCT05035238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151290|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
14151291|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14151292|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
14151293|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151294|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
14151295|NCT05034965|Protective Agents|protective agents|mesh-ancestor
14179551|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179552|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179553|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14179554|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
14179555|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179556|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14179557|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14179558|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14179559|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14179560|NCT05314621|Analgesics|analgesics|mesh-ancestor
14179561|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
14179562|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179563|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14179564|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14179565|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
14179566|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
14179567|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179568|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179569|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
14179570|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
14179571|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
14179572|NCT05314569|Fentanyl|fentanyl|mesh-list
14179573|NCT05314569|Midazolam|midazolam|mesh-list
14179574|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
14179575|NCT05314569|Ketamine|ketamine|mesh-list
14179576|NCT05314569|Isoflurane|isoflurane|mesh-list
14179577|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14151296|NCT05035069|Propofol|propofol|mesh-list
14151297|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14151298|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151299|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955056|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151300|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14151301|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
14151302|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
14151303|NCT05035147|Gemcitabine|gemcitabine|mesh-list
14151304|NCT05035147|Paclitaxel|paclitaxel|mesh-list
14151305|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14151306|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14151307|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151308|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
14151309|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
14151310|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
14151311|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151312|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14151313|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
14151314|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
14151315|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151316|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766094|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151317|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14151318|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
14151319|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151320|NCT05034783|Exenatide|exenatide|mesh-list
14151321|NCT05034783|Edetic Acid|edetic acid|mesh-list
14151322|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
14151323|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
14151324|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151325|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
14151326|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14151327|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14151328|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151329|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14151330|NCT05034783|Incretins|incretins|mesh-ancestor
14151331|NCT05034783|Hormones|hormones|mesh-ancestor
14151332|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151333|NCT05034887|Trastuzumab|trastuzumab|mesh-list
14151334|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14151335|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151336|NCT05034406|Lidocaine|lidocaine|mesh-list
13955057|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955058|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955059|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955060|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955061|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
13955062|NCT03192878|Infliximab|infliximab|mesh-list
13955063|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
13955064|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955065|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955066|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
13955067|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955068|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955069|NCT03193073|Mitogens|mitogens|mesh-list
13955070|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
13955071|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151337|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
14151338|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
14151339|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
14151340|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151341|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151342|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
14151343|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151344|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14938015|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
14938016|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938017|NCT01479036|Docetaxel|docetaxel|mesh-list
14938018|NCT01479036|Epirubicin|epirubicin|mesh-list
14938019|NCT01479036|Endostatins|endostatins|mesh-list
14938020|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938021|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938022|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938023|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
14938024|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938025|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14938026|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14938027|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14938028|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938029|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14938030|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14938031|NCT01479036|Growth Substances|growth substances|mesh-ancestor
14938032|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938033|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
14151345|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14151346|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14151347|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14151348|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151349|NCT05034055|Atezolizumab|atezolizumab|mesh-list
14151350|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151351|NCT05033665|Benzocaine|benzocaine|mesh-list
14151352|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
14151353|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
14151354|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151355|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151356|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
14151357|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151358|NCT05033769|Paclitaxel|paclitaxel|mesh-list
14151359|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14151360|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14151361|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151362|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
14766095|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766096|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
14766097|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766098|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766099|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766100|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
14766101|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766102|NCT00624208|Droperidol|droperidol|mesh-list
14766103|NCT00624208|Ondansetron|ondansetron|mesh-list
14766104|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
14938034|NCT01479075|Insulin|insulin|mesh-list
14938035|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14938036|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14938037|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938038|NCT01479088|Cinacalcet|cinacalcet|mesh-list
14938039|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938040|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938041|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14938042|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
14938043|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938044|NCT01479114|Sargramostim|sargramostim|mesh-list
14938045|NCT01479114|Lenograstim|lenograstim|mesh-list
14938046|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
14938047|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938048|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14938049|NCT01479179|Trastuzumab|trastuzumab|mesh-list
14938050|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14938051|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938052|NCT01479192|Fenretinide|fenretinide|mesh-list
14938053|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938054|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14938055|NCT01479192|Protective Agents|protective agents|mesh-ancestor
14938056|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766105|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
14938057|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
14938058|NCT01479231|Lansoprazole|lansoprazole|mesh-list
14938059|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14938060|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938061|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14938062|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938063|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938064|NCT01479244|Molgramostim|molgramostim|mesh-list
14938065|NCT01479244|Sargramostim|sargramostim|mesh-list
14938066|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
14938067|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938068|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938069|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14938070|NCT01479283|Cefazolin|cefazolin|mesh-list
14938071|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14938072|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938073|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
14938074|NCT01479296|Vaccines|vaccines|mesh-list
14938075|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
14938076|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938077|NCT01479361|Atovaquone|atovaquone|mesh-list
14938078|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938079|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
14938080|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14938081|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14938082|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938083|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938084|NCT01479504|Cisplatin|cisplatin|mesh-list
14938085|NCT01479504|Docetaxel|docetaxel|mesh-list
14938086|NCT01479504|Nedaplatin|nedaplatin|mesh-list
14938087|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938088|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938089|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938090|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
14151363|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
14151364|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
14151365|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151366|NCT05034133|Cisplatin|cisplatin|mesh-list
14151367|NCT05034133|Etoposide|etoposide|mesh-list
14151368|NCT05034133|Durvalumab|durvalumab|mesh-list
14151369|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151370|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14151371|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14151372|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14151373|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151374|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151375|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14151376|NCT05033860|Vaccines|vaccines|mesh-list
14151377|NCT05033860|Immunologic Factors|immunologic factors|mesh-ancestor
14151378|NCT05033860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151379|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
14151380|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14151381|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
14151382|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14151383|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
14151384|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151385|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151386|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
14151387|NCT05033574|Hormones|hormones|mesh-list
14151388|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151389|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151390|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
14151391|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
14151392|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
14151393|NCT05033535|Olmesartan|olmesartan|mesh-list
14151394|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14151395|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14151396|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14151397|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14151398|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151399|NCT05033106|Bevacizumab|bevacizumab|mesh-list
14478889|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14151400|NCT05033106|Ranibizumab|ranibizumab|mesh-list
14151401|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14938091|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938092|NCT01479556|Pregabalin|pregabalin|mesh-list
14938093|NCT01479556|Analgesics|analgesics|mesh-ancestor
14151402|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151403|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14151404|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14151405|NCT05033106|Growth Substances|growth substances|mesh-ancestor
14151406|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151407|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
14151408|NCT05032781|Minocycline|minocycline|mesh-list
14151409|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14151410|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179578|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179579|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179580|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14179581|NCT05314569|Analgesics|analgesics|mesh-ancestor
14179582|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
14179583|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179584|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14179585|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14179586|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14179587|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
14179588|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179589|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179590|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14179591|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14179592|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
14179593|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
14179594|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14179595|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14179596|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14766106|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766107|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766108|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766109|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
14766110|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
14766111|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14766112|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
14766113|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766114|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766115|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14766116|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14766117|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179597|NCT05314569|Narcotics|narcotics|mesh-ancestor
14179598|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14766118|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766119|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14766120|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14766121|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14766122|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14766123|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
14766124|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
14766125|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
14766126|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14179599|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14179600|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14179601|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14179602|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
14179603|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
14179604|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14179605|NCT05314400|Liver Extracts|liver extracts|mesh-list
14179606|NCT05314400|Hematinics|hematinics|mesh-ancestor
14766127|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14766128|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766129|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766130|NCT00624273|Urological Agents|urological agents|mesh-ancestor
14766131|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
14766132|NCT00624312|Hematinics|hematinics|mesh-ancestor
14179607|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
14179608|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179609|NCT05314270|Copper|copper|mesh-list
14179610|NCT05314270|Trace Elements|trace elements|mesh-ancestor
14179611|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
14179612|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179613|NCT05314257|Granisetron|granisetron|mesh-list
14179614|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
14179615|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
14179616|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179617|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766133|NCT00624325|Interferons|interferons|mesh-list
14151411|NCT05032261|Norepinephrine|norepinephrine|mesh-list
14151412|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14151413|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14151414|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151415|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151416|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151417|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151418|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
14151419|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
14151420|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151421|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14151422|NCT05032287|Tamsulosin|tamsulosin|mesh-list
14151423|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14151424|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14151425|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14151426|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151427|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151428|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151429|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151430|NCT05032287|Urological Agents|urological agents|mesh-ancestor
14151431|NCT05032248|Tacrolimus|tacrolimus|mesh-list
14151432|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14151433|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
14151434|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151435|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14151436|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151437|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151438|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
14151439|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14151440|NCT05031936|Ropivacaine|ropivacaine|mesh-list
14151441|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
14151442|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
14151443|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151444|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151445|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
14151446|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151447|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14151448|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14151449|NCT05032001|Biguanides|biguanides|mesh-list
14151450|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766134|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
14766135|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
14766136|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766137|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
14766138|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766139|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
14766140|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766141|NCT00624364|Metformin|metformin|mesh-list
14766142|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
14766143|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
14766144|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14766145|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766146|NCT00624429|Budesonide|budesonide|mesh-list
14766147|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766148|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14766149|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
14766150|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766151|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766152|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14766153|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
14766154|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
14766155|NCT00624429|Hormones|hormones|mesh-ancestor
14766156|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151451|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14766157|NCT00624455|Gabapentin|gabapentin|mesh-list
14151452|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151453|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
14151454|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151455|NCT05032118|Ketamine|ketamine|mesh-list
14151456|NCT05032118|Propofol|propofol|mesh-list
14151457|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14151458|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151459|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151460|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14151461|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
14151462|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
14151463|NCT05032118|Analgesics|analgesics|mesh-ancestor
14151464|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
14151465|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151466|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14151467|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14151468|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14151469|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151470|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151471|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
14151472|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14151473|NCT05031689|Protective Agents|protective agents|mesh-ancestor
14151474|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151475|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
14151476|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
14151477|NCT05031676|Anesthetics|anesthetics|mesh-list
14151478|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151479|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151480|NCT05031676|Narcotics|narcotics|mesh-ancestor
14151481|NCT05031676|Analgesics|analgesics|mesh-ancestor
14151482|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
14151483|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151484|NCT05031481|Butoconazole|butoconazole|mesh-list
14151485|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
14151486|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151487|NCT05031520|Metoprolol|metoprolol|mesh-list
14151488|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
14151489|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14151490|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14151491|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
14151492|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
14151493|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151494|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151495|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14151496|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14151497|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14151498|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151499|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151500|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151501|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
14151502|NCT05031234|Morphine|morphine|mesh-list
14151503|NCT05031234|Anesthetics|anesthetics|mesh-list
14151504|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151505|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151506|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14151507|NCT05031234|Narcotics|narcotics|mesh-ancestor
14151508|NCT05031234|Analgesics|analgesics|mesh-ancestor
14151509|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
14151510|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151511|NCT05031143|Triamcinolone|triamcinolone|mesh-list
14151512|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14151513|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14151514|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14151515|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14151516|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
14151517|NCT05031143|Hormones|hormones|mesh-ancestor
14766158|NCT00624455|Analgesics|analgesics|mesh-ancestor
14766159|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
14766160|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766161|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766162|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
14766163|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14766164|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14766165|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151518|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151519|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151520|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14151521|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
14151522|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151523|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179618|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179619|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14179620|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
14179621|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179622|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179623|NCT05314153|Brexanolone|brexanolone|mesh-list
14179624|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
14179625|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179626|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179627|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179628|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
14179629|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
14179630|NCT05314140|Calcium|calcium|mesh-list
14179631|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14179632|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179633|NCT05314127|Fluorouracil|fluorouracil|mesh-list
14179634|NCT05314127|Imiquimod|imiquimod|mesh-list
14179635|NCT05314127|Tazarotene|tazarotene|mesh-list
14179636|NCT05314127|Petrolatum|petrolatum|mesh-list
14179637|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
14179638|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179639|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14179640|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179641|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179642|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
14179643|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179644|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14179645|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
14179646|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179647|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
14179648|NCT05314127|Emollients|emollients|mesh-ancestor
14179649|NCT05314101|Bevacizumab|bevacizumab|mesh-list
14179650|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179651|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179652|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14179653|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14179654|NCT05314101|Growth Substances|growth substances|mesh-ancestor
14179655|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179656|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
14179657|NCT05313958|Cytarabine|cytarabine|mesh-list
14179658|NCT05313958|Sorafenib|sorafenib|mesh-list
14179659|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
14179660|NCT05313958|Idarubicin|idarubicin|mesh-list
14179661|NCT05313958|Cladribine|cladribine|mesh-list
14179662|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14179663|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
14179664|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179665|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179666|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
14179667|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179668|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179669|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
14179670|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179671|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14179672|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179673|NCT05313958|Analgesics|analgesics|mesh-ancestor
14179674|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
14179675|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179676|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14179677|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14179678|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14179679|NCT05313906|Cisplatin|cisplatin|mesh-list
14179680|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179681|NCT05313828|Fluorometholone|fluorometholone|mesh-list
14179682|NCT05313828|Tobramycin|tobramycin|mesh-list
14179683|NCT05313828|Acyclovir|acyclovir|mesh-list
14179684|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
14179685|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14179686|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179687|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14179688|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
14151524|NCT05030623|Tadalafil|tadalafil|mesh-list
14151525|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
14151526|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14151527|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14151528|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151529|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151530|NCT05030623|Urological Agents|urological agents|mesh-ancestor
14151531|NCT05030545|Eplerenone|eplerenone|mesh-list
14151532|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14151533|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
14151534|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
14151535|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151536|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151537|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14151538|NCT05030545|Diuretics|diuretics|mesh-ancestor
14151539|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
14151540|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14151541|NCT05030545|Hormones|hormones|mesh-ancestor
14151542|NCT05030415|Ixekizumab|ixekizumab|mesh-list
14151543|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
14151544|NCT05030493|Bevacizumab|bevacizumab|mesh-list
14151545|NCT05030493|Panitumumab|panitumumab|mesh-list
14151546|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14151547|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151548|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14151549|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14151550|NCT05030493|Growth Substances|growth substances|mesh-ancestor
14151551|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151552|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
14151553|NCT05030116|Domperidone|domperidone|mesh-list
14151554|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
14151555|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
14151556|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151557|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151558|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14151559|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14151560|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
14151561|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151562|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151563|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
14151564|NCT05030155|Azathioprine|azathioprine|mesh-list
14151565|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14151566|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
14151567|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151568|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14151569|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14151570|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
14151571|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151572|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151573|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14151574|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
14151575|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766166|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766167|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14766168|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14766169|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766170|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766171|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
14766172|NCT00624481|Teriparatide|teriparatide|mesh-list
14766173|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14766174|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766175|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14766176|NCT00624546|Lansoprazole|lansoprazole|mesh-list
14766177|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
14766178|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14766179|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766180|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14766181|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766182|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766183|NCT00624663|Rivastigmine|rivastigmine|mesh-list
14766184|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14766185|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766186|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766187|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
14766188|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766189|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151602|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
14151603|NCT05030129|Pyridoxal|pyridoxal|mesh-list
14151604|NCT05030129|Pyridoxine|pyridoxine|mesh-list
14151605|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
14151606|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
14151607|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
14151608|NCT05030129|Vitamins|vitamins|mesh-ancestor
14151609|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
14151610|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151611|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
14151612|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14151613|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
14151614|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14151615|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14151616|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14151617|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151618|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151619|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151620|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
14151621|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
14151622|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
14151623|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
14151624|NCT05030077|Gemcitabine|gemcitabine|mesh-list
14151625|NCT05030077|Carboplatin|carboplatin|mesh-list
14151626|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151627|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14151628|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
14151629|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151630|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
14151631|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151632|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151633|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14151634|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
14151635|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151636|NCT05029453|Apatinib|apatinib|mesh-list
14151637|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151638|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14151639|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151640|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151641|NCT05029596|Heparin|heparin|mesh-list
14151642|NCT05029596|Calcium heparin|calcium heparin|mesh-list
14151643|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
14151644|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14151645|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14151646|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151647|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14151648|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955072|NCT03192943|Nivolumab|nivolumab|mesh-list
13955073|NCT03192943|Linrodostat|linrodostat|mesh-list
13955074|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955075|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955076|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13955077|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955078|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955079|NCT03193112|S 20098|s 20098|mesh-list
13955080|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13955081|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955082|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955083|NCT03192969|Abatacept|abatacept|mesh-list
13955084|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
13955085|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13955086|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955087|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955088|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955089|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
13955090|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955091|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955092|NCT03192969|Hormones|hormones|mesh-ancestor
13955093|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955094|NCT03192566|Acetaminophen|acetaminophen|mesh-list
13955095|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955096|NCT03192566|Analgesics|analgesics|mesh-ancestor
13955097|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
14151649|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14151650|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151651|NCT05029076|Liraglutide|liraglutide|mesh-list
14151652|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14151653|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151654|NCT05029076|Incretins|incretins|mesh-ancestor
14151655|NCT05029076|Hormones|hormones|mesh-ancestor
14151656|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151657|NCT05029401|Ibogaine|ibogaine|mesh-list
14151658|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
14151659|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151660|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14151661|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14151662|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14151663|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151664|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151665|NCT05029297|Capsaicin|capsaicin|mesh-list
14151666|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
14151667|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
14151668|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
14151669|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151670|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151671|NCT05029037|Ascorbic Acid|ascorbic acid|mesh-list
14151672|NCT05029037|Vitamins|vitamins|mesh-ancestor
14151673|NCT05029037|Micronutrients|micronutrients|mesh-ancestor
14151674|NCT05029037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151675|NCT05029037|Antioxidants|antioxidants|mesh-ancestor
14151676|NCT05029037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151677|NCT05029037|Protective Agents|protective agents|mesh-ancestor
14151678|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
14151679|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14151680|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
14151681|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14151682|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
14151683|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151684|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151685|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
14151686|NCT05028907|Tocopherols|tocopherols|mesh-list
14151687|NCT05028907|Vitamin E|vitamin e|mesh-list
14151688|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
14151689|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
14151690|NCT05028907|Dexamethasone|dexamethasone|mesh-list
14151691|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
14151692|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
14151693|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14151694|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
14151695|NCT05028907|BB 1101|bb 1101|mesh-list
14151696|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14151697|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
14151698|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
14151699|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151700|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151701|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14151702|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
14151703|NCT05028907|Hormones|hormones|mesh-ancestor
14151704|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151705|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14151706|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151707|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14151708|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
14151709|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
14151710|NCT05028907|Protective Agents|protective agents|mesh-ancestor
14151711|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
14151712|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151713|NCT05028907|Vitamins|vitamins|mesh-ancestor
14151714|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
14151715|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14151716|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151717|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14151718|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151719|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14151720|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14151721|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14151722|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
14151723|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
14151724|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14151725|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
14151726|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14151727|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151728|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
14151729|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14151730|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151731|NCT05028322|Imiquimod|imiquimod|mesh-list
14151732|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14151733|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
14151734|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151735|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151736|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
14151737|NCT05028348|Dexamethasone|dexamethasone|mesh-list
14151738|NCT05028348|Pomalidomide|pomalidomide|mesh-list
14151739|NCT05028348|Elotuzumab|elotuzumab|mesh-list
14151740|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14151741|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
14151742|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
14151743|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151744|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151745|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14151746|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
14151747|NCT05028348|Hormones|hormones|mesh-ancestor
14766190|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14766191|NCT00624663|Protective Agents|protective agents|mesh-ancestor
14766192|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
14766193|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
14766194|NCT00624676|Salicylates|salicylates|mesh-list
14766195|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14766196|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
14766197|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766198|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
14766199|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
14151748|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151749|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14151750|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151751|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
14151752|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14151753|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14151754|NCT05028348|Growth Substances|growth substances|mesh-ancestor
14151755|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
14179689|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179690|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
14179691|NCT05313828|Protective Agents|protective agents|mesh-ancestor
14179692|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
14179693|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179694|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
14179695|NCT05313828|Hormones|hormones|mesh-ancestor
14179696|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179697|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14179698|NCT05313750|Levofloxacin|levofloxacin|mesh-list
14179699|NCT05313750|Ofloxacin|ofloxacin|mesh-list
14179700|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
14179701|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
14179702|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14179703|NCT05313750|Renal Agents|renal agents|mesh-ancestor
14179704|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14179705|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14179706|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14179707|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179708|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766200|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14766201|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14766202|NCT00624676|Analgesics|analgesics|mesh-ancestor
14151756|NCT05028049|Sufentanil|sufentanil|mesh-list
14151757|NCT05028049|Remifentanil|remifentanil|mesh-list
14938094|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
14938095|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938096|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938097|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
14151758|NCT05028049|Dsuvia|dsuvia|mesh-list
14151759|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14151760|NCT05028049|Narcotics|narcotics|mesh-ancestor
14151761|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151762|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151763|NCT05028049|Analgesics|analgesics|mesh-ancestor
14151764|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
14938098|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14938099|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938100|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938101|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938102|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14938103|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14938104|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938105|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14938106|NCT01479634|Efavirenz|efavirenz|mesh-list
14938107|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14938108|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14938109|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938110|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938111|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
14938112|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938113|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14938114|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14938115|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14938116|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14151765|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151766|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14151767|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14151768|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
14151769|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
14151770|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
14151771|NCT05027893|Cefixime|cefixime|mesh-list
14151772|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14151773|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151774|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14151775|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14151776|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151777|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151778|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151779|NCT05028153|Azithromycin|azithromycin|mesh-list
14151780|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14151781|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151782|NCT05028140|Pioglitazone|pioglitazone|mesh-list
14151783|NCT05028140|Empagliflozin|empagliflozin|mesh-list
14151784|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14151785|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151786|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14151787|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151788|NCT05027594|Dexamethasone|dexamethasone|mesh-list
14938117|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14938118|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14938119|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
14938120|NCT01479751|Ketamine|ketamine|mesh-list
14151789|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14151790|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
14938121|NCT01479751|Rocuronium|rocuronium|mesh-list
14938122|NCT01479751|Analgesics|analgesics|mesh-ancestor
14938123|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
14938124|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938125|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938126|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14938127|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14938128|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
14938129|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
14938130|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151791|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
14151792|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151793|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151794|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14151795|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
14151796|NCT05027594|Hormones|hormones|mesh-ancestor
14151797|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151798|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14151799|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151800|NCT05027516|Azithromycin|azithromycin|mesh-list
14151801|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
14151802|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14151803|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151804|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
14151805|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14151806|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
14151807|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151808|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
14151809|NCT05027581|Protective Agents|protective agents|mesh-ancestor
14151810|NCT05027295|Riboflavin|riboflavin|mesh-list
14151811|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14151812|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14151813|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
14151814|NCT05027295|Vitamins|vitamins|mesh-ancestor
14151815|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
14151816|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151817|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14151818|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
14151819|NCT05027126|Folic Acid|folic acid|mesh-list
14151820|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
14151821|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14151822|NCT05027126|Vitamins|vitamins|mesh-ancestor
14151823|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
14151824|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151825|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14151826|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14151827|NCT05027126|Analgesics|analgesics|mesh-ancestor
14151828|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
14151829|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151830|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14151831|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14151832|NCT05027126|Hematinics|hematinics|mesh-ancestor
14151833|NCT05027386|Irinotecan|irinotecan|mesh-list
14151834|NCT05027386|Temozolomide|temozolomide|mesh-list
14151835|NCT05027386|Apatinib|apatinib|mesh-list
14151836|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14151837|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14151838|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151839|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151840|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151841|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14151842|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
14151843|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14151844|NCT05027191|Sevoflurane|sevoflurane|mesh-list
14151845|NCT05027191|Desflurane|desflurane|mesh-list
14151846|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14151847|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14151848|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
14151849|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
14151850|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151851|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151852|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14151853|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14151854|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938131|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14151855|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151856|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14151857|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14151858|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766203|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
14766204|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766205|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766206|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766207|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14766208|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14766209|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766210|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766211|NCT00624702|Maleic acid|maleic acid|mesh-list
14766212|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766213|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766214|NCT00624741|Pergolide|pergolide|mesh-list
14766215|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
14766216|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
14766217|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151859|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
14151860|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151861|NCT05026398|Fenfluramine|fenfluramine|mesh-list
14151862|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14151863|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14151864|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14151865|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151866|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151867|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
14151868|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151869|NCT05026593|Carboplatin|carboplatin|mesh-list
14151870|NCT05026593|Etoposide|etoposide|mesh-list
14151871|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151872|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14151873|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14151874|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14151875|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151876|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151877|NCT05026567|Midazolam|midazolam|mesh-list
14151878|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14151879|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14151880|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151881|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151882|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14151883|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14151884|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14151885|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14151886|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
14151887|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
14151888|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
14151889|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
14151890|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151891|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151892|NCT05026125|Remifentanil|remifentanil|mesh-list
14151893|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14151894|NCT05026125|Narcotics|narcotics|mesh-ancestor
14151895|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151896|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151897|NCT05026125|Analgesics|analgesics|mesh-ancestor
14151898|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
14151899|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151900|NCT05026229|Cytarabine|cytarabine|mesh-list
14151901|NCT05026229|Prednisone|prednisone|mesh-list
14151902|NCT05026229|Methotrexate|methotrexate|mesh-list
14151903|NCT05026229|Vincristine|vincristine|mesh-list
14151904|NCT05026229|Dasatinib|dasatinib|mesh-list
14151905|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14151906|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
14151907|NCT05026229|Hormones|hormones|mesh-ancestor
14151908|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14151909|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151910|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14151911|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151912|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14151913|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
14151914|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14151915|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14151916|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
14151917|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151918|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
14151919|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14151920|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14151921|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14151922|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
14151923|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14151924|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14151925|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
14151926|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14151927|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14151928|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
14151929|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
14151930|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
14151931|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14151932|NCT05026203|Midazolam|midazolam|mesh-list
14151933|NCT05026203|Ketamine|ketamine|mesh-list
14151934|NCT05026203|Analgesics|analgesics|mesh-ancestor
14151935|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
14151936|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151937|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151938|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14151939|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14151940|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
14478890|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478891|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14478892|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151941|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
14151942|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14151943|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14151944|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14151945|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151946|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151947|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14151948|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14151949|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14151950|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14151951|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14151952|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
14151953|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
14151954|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
14151955|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14151956|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179709|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179710|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14179711|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14183989|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14183990|NCT04724148|Fentanyl|fentanyl|mesh-list
14183991|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14183992|NCT04724148|Narcotics|narcotics|mesh-ancestor
14183993|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14183994|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14183995|NCT04724148|Analgesics|analgesics|mesh-ancestor
14183996|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
14183997|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14183998|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14183999|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14184000|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
14184001|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
14184002|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14184003|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184004|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184005|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478893|NCT02460991|Sorafenib|sorafenib|mesh-list
14478894|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478895|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14478896|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478897|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478898|NCT02461134|Ponesimod|ponesimod|mesh-list
14478899|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14478900|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478901|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184006|NCT04723836|Riboflavin|riboflavin|mesh-list
14151957|NCT05025644|Dobutamine|dobutamine|mesh-list
14151958|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14151959|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
14151960|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
14151961|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151962|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151963|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14151964|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14151965|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14151966|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
14151967|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151968|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151969|NCT05025644|Protective Agents|protective agents|mesh-ancestor
14151970|NCT05025488|Poly ICLC|poly iclc|mesh-list
14151971|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
14151972|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
14151973|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151974|NCT05025228|Acetaminophen|acetaminophen|mesh-list
14151975|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14151976|NCT05025228|Analgesics|analgesics|mesh-ancestor
14151977|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
14151978|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14151979|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14151980|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
14151981|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
14938132|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14938133|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14151982|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151983|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
14151984|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938134|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938135|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14938136|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
14938137|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14938138|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938139|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938140|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
14938141|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14938142|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14938143|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14938144|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14938145|NCT01479842|Rituximab|rituximab|mesh-list
14938146|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14938147|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14938148|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938149|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
14151985|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151986|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14151987|NCT05025033|Paclitaxel|paclitaxel|mesh-list
14151988|NCT05025033|Irinotecan|irinotecan|mesh-list
14151989|NCT05025033|Apatinib|apatinib|mesh-list
14151990|NCT05025033|Antibodies|antibodies|mesh-list
14151991|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
14938150|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938151|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14938152|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14938153|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
14938154|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938155|NCT01479881|Cyclosporine|cyclosporine|mesh-list
14938156|NCT01479881|Simeprevir|simeprevir|mesh-list
14151992|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14151993|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14151994|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
14151995|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
14151996|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
14151997|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14151998|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
14938157|NCT01479881|Tacrolimus|tacrolimus|mesh-list
14151999|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152000|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14152001|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152002|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179712|NCT05313659|Ketamine|ketamine|mesh-list
14938158|NCT01479881|Cyclosporins|cyclosporins|mesh-list
14938159|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938160|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
14938161|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938162|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14938163|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938164|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938165|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
14152003|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14152004|NCT05025098|Azacitidine|azacitidine|mesh-list
14152005|NCT05025098|Venetoclax|venetoclax|mesh-list
14152006|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14152007|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
14152008|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152009|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152010|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152011|NCT05024799|Fentanyl|fentanyl|mesh-list
14152012|NCT05024799|Butorphanol|butorphanol|mesh-list
14152013|NCT05024799|Propofol|propofol|mesh-list
14152014|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14152015|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152016|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152017|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14152018|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
14152019|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
14152020|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14152021|NCT05024799|Narcotics|narcotics|mesh-ancestor
14152022|NCT05024799|Analgesics|analgesics|mesh-ancestor
14152023|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
14152024|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152025|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14152026|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
14152027|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14152028|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14152029|NCT05024825|Acetaminophen|acetaminophen|mesh-list
14152030|NCT05024825|Ibuprofen|ibuprofen|mesh-list
14152031|NCT05024825|Gabapentin|gabapentin|mesh-list
14152032|NCT05024825|Hydrocodone|hydrocodone|mesh-list
14152033|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14152034|NCT05024825|Analgesics|analgesics|mesh-ancestor
14766218|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766219|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766220|NCT00624754|Budesonide|budesonide|mesh-list
14766221|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
14766222|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766223|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14766224|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
14766225|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766226|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766227|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14766228|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
14766229|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
14766230|NCT00624754|Hormones|hormones|mesh-ancestor
14766231|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766232|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14766233|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14766234|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14938166|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938167|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
14152035|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
14152036|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152037|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152038|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
14152039|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14152040|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152041|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14938168|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14938169|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
14938170|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
14938171|NCT01479920|Fluoxetine|fluoxetine|mesh-list
14938172|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14938173|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14152042|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14152043|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152044|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152045|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
14152046|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14152047|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14152048|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152049|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14152050|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14152051|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14152052|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152053|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
14152054|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14152055|NCT05024825|Narcotics|narcotics|mesh-ancestor
14152056|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
14152057|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
14152058|NCT05024734|Gemcitabine|gemcitabine|mesh-list
14152059|NCT05024734|Docetaxel|docetaxel|mesh-list
14152060|NCT05024734|Epirubicin|epirubicin|mesh-list
14152061|NCT05024734|Mitomycins|mitomycins|mesh-list
14152062|NCT05024734|Mitomycin|mitomycin|mesh-list
14152063|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14152064|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
14152065|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152066|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152067|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
14152068|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152069|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152070|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152071|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
14152072|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152073|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14152074|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14152075|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14152076|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14152077|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14152078|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152079|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
14152080|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14152081|NCT05024604|Progesterone|progesterone|mesh-list
14152082|NCT05024604|Progestins|progestins|mesh-ancestor
14152083|NCT05024604|Hormones|hormones|mesh-ancestor
14152084|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152085|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152086|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14152087|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
14152088|NCT05024448|Prednisone|prednisone|mesh-list
14152089|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152090|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
14152091|NCT05024448|Hormones|hormones|mesh-ancestor
14152092|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152093|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152094|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14152095|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152096|NCT05024877|Stanozolol|stanozolol|mesh-list
14152097|NCT05024877|Androgens|androgens|mesh-ancestor
14152098|NCT05024877|Hormones|hormones|mesh-ancestor
14152099|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152100|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152101|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
14152102|NCT05024526|Edaravone|edaravone|mesh-list
13955098|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955099|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955100|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
13955101|NCT03192618|Leucovorin|leucovorin|mesh-list
13955102|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
13955103|NCT03192618|Calcium|calcium|mesh-list
13955104|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
13955105|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13955106|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955107|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955108|NCT03192618|Antidotes|antidotes|mesh-ancestor
13955109|NCT03192618|Protective Agents|protective agents|mesh-ancestor
13955110|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
13955111|NCT03192618|Vitamins|vitamins|mesh-ancestor
13955112|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
13955113|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13955114|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13955115|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13955116|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
13955117|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152103|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14152104|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
14152105|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152106|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14152107|NCT05024526|Protective Agents|protective agents|mesh-ancestor
14152108|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152109|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14152110|NCT05024565|Lactams|lactams|mesh-list
14152111|NCT05024565|beta-Lactams|beta-lactams|mesh-list
14152112|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152113|NCT05024422|Pyridoxine|pyridoxine|mesh-list
14152114|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
14152115|NCT05024422|Cabergoline|cabergoline|mesh-list
14152116|NCT05024422|Vitamins|vitamins|mesh-ancestor
14152117|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
14152118|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152119|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
14152120|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14152121|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14152122|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
14152123|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
14152124|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152125|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152126|NCT05024357|Dasatinib|dasatinib|mesh-list
14152127|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152128|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14152129|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152130|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152131|NCT05024344|Dexamethasone|dexamethasone|mesh-list
14152132|NCT05024344|Ropivacaine|ropivacaine|mesh-list
14152133|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152134|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
14152135|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
14152136|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152137|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152138|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152139|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
14152140|NCT05024344|Hormones|hormones|mesh-ancestor
14152141|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152142|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14152143|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152144|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
14152145|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
14152146|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152147|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
14152148|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
14152149|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14152150|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152151|NCT05023915|Dexamethasone|dexamethasone|mesh-list
14152152|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
14152153|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152154|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
14152155|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
14152156|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152157|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152158|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152159|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
14152160|NCT05023915|Hormones|hormones|mesh-ancestor
14152161|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152162|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14152163|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152164|NCT05023941|Acetazolamide|acetazolamide|mesh-list
14152165|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
14152166|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14152167|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152168|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152169|NCT05023941|Diuretics|diuretics|mesh-ancestor
14152170|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
14152171|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152172|NCT05024266|Paclitaxel|paclitaxel|mesh-list
14152173|NCT05024266|Carboplatin|carboplatin|mesh-list
14478902|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
14478903|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152174|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14152175|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152176|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
14152177|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
14152178|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
14152179|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152180|NCT05024084|Anesthetics|anesthetics|mesh-list
14152181|NCT05024084|Sevoflurane|sevoflurane|mesh-list
14152182|NCT05024084|Desflurane|desflurane|mesh-list
14152183|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152184|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152185|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14152186|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14152187|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
14152188|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
14152189|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14152190|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152191|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14152192|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14152193|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14152194|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152195|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152196|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152197|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
14152198|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
14152199|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152200|NCT05023863|Protective Agents|protective agents|mesh-ancestor
14152201|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152202|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
14152203|NCT05023863|Vitamins|vitamins|mesh-ancestor
14152204|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
14152205|NCT05023382|Teduglutide|teduglutide|mesh-list
14152206|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152207|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14152208|NCT05023382|Protective Agents|protective agents|mesh-ancestor
14152209|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152210|NCT05023473|Morphine|morphine|mesh-list
14152211|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14152212|NCT05023473|Narcotics|narcotics|mesh-ancestor
14152213|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152214|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152215|NCT05023473|Analgesics|analgesics|mesh-ancestor
14152216|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
14152217|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152218|NCT05023408|Bleomycin|bleomycin|mesh-list
14152219|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14152220|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152221|NCT05023304|Prednisolone|prednisolone|mesh-list
14152222|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152223|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
14152224|NCT05023304|Hormones|hormones|mesh-ancestor
14152225|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152226|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152227|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14152228|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179713|NCT05313659|Analgesics|analgesics|mesh-ancestor
14179714|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
14179715|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179716|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179717|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14179718|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14179719|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
14179720|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
14179721|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179722|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14179723|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14766235|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
14766236|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766237|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766238|NCT00624767|Insulin|insulin|mesh-list
14766239|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14766240|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
14766241|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14766242|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179724|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179725|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179726|NCT05313620|Adalimumab|adalimumab|mesh-list
14179727|NCT05313620|Golimumab|golimumab|mesh-list
14179728|NCT05313620|Infliximab|infliximab|mesh-list
14179729|NCT05313620|Tofacitinib|tofacitinib|mesh-list
14179730|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179731|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179732|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
14179733|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179734|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14179735|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179736|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179737|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14179738|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179739|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
14179740|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179741|NCT05313529|Metformin|metformin|mesh-list
14179742|NCT05313529|Liraglutide|liraglutide|mesh-list
14179743|NCT05313529|Empagliflozin|empagliflozin|mesh-list
14179744|NCT05313529|Linagliptin|linagliptin|mesh-list
14179745|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14179746|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179747|NCT05313529|Incretins|incretins|mesh-ancestor
14179748|NCT05313529|Hormones|hormones|mesh-ancestor
14179749|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179750|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14179751|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179752|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14179753|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
14179754|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179755|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
14179756|NCT05313477|Vitamin D|vitamin d|mesh-list
14179757|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
14179758|NCT05313477|Calcium|calcium|mesh-list
14179759|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14179760|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179761|NCT05313477|Antacids|antacids|mesh-ancestor
14179762|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179763|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179764|NCT05313477|Vitamins|vitamins|mesh-ancestor
14179765|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
14179766|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14179767|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14179768|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14179769|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
14179770|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14179771|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179772|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179773|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14179774|NCT05313386|Analgesics|analgesics|mesh-ancestor
14179775|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
14179776|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179777|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14767448|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14152229|NCT05023759|Cannabidiol|cannabidiol|mesh-list
14152230|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
14152231|NCT05023577|Metronidazole|metronidazole|mesh-list
14152232|NCT05023577|Clarithromycin|clarithromycin|mesh-list
14152233|NCT05023577|Levofloxacin|levofloxacin|mesh-list
14152234|NCT05023577|Ofloxacin|ofloxacin|mesh-list
14152235|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
14152236|NCT05023577|Rabeprazole|rabeprazole|mesh-list
14152237|NCT05023577|Bismuth|bismuth|mesh-list
14152238|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152239|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152240|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14152241|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14152242|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14152243|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14152244|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152245|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14152246|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14152247|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14152248|NCT05023577|Renal Agents|renal agents|mesh-ancestor
14152249|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14152250|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152251|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152252|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14152253|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14152254|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152255|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14152256|NCT05023577|Antacids|antacids|mesh-ancestor
14152257|NCT05023577|Diuretics|diuretics|mesh-ancestor
14152258|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
14152259|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152260|NCT05023577|Expectorants|expectorants|mesh-ancestor
14152261|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
14152262|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14152263|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14152264|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14152265|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14152266|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152267|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152268|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152269|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14152270|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
14152271|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14152272|NCT05023122|Vitamin D|vitamin d|mesh-list
14152273|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
14152274|NCT05023122|Calcium|calcium|mesh-list
14152275|NCT05023122|Vitamins|vitamins|mesh-ancestor
14152276|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
14152277|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152278|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14152279|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14152280|NCT05022394|Nivolumab|nivolumab|mesh-list
14152281|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14152282|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152283|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14152284|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152285|NCT05022030|Cetuximab|cetuximab|mesh-list
14152286|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14152287|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152288|NCT05021887|Fluticasone|fluticasone|mesh-list
14152289|NCT05021887|Xhance|xhance|mesh-list
14152290|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152291|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14152292|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
14152293|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152294|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152295|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14152296|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
14152297|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
14478904|NCT02461160|Midazolam|midazolam|mesh-list
14152298|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14152299|NCT05022186|Cannabidiol|cannabidiol|mesh-list
14152300|NCT05022186|Tramiprosate|tramiprosate|mesh-list
14152301|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
14152302|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
14152303|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
14152304|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152305|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152306|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152307|NCT05021770|Thiotepa|thiotepa|mesh-list
14152308|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14152309|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
14152310|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152311|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152312|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14152313|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152314|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
14152315|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152316|NCT05021588|Anticoagulants|anticoagulants|mesh-list
14152317|NCT05021406|Carvedilol|carvedilol|mesh-list
14152318|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14152319|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14152320|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
14152321|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152322|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152323|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152324|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14152325|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
14152326|NCT05021406|Protective Agents|protective agents|mesh-ancestor
14152327|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14152328|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14152329|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14152330|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
14152331|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14152332|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14152333|NCT05021484|Felzartamab|felzartamab|mesh-list
14152334|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152335|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
14152336|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152337|NCT05021731|Rifampin|rifampin|mesh-list
14152338|NCT05021731|Rifapentine|rifapentine|mesh-list
14152339|NCT05021731|Isoniazid|isoniazid|mesh-list
14152340|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14152341|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
14152342|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14152343|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152344|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
14152345|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14152346|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152347|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152348|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14152349|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14152350|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14152351|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14152352|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14152353|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14152354|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14152355|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14152356|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
14152357|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14152358|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14152359|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14152360|NCT05021094|Estradiol|estradiol|mesh-list
14152361|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14152362|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
14152363|NCT05021094|Estrogens|estrogens|mesh-ancestor
14152364|NCT05021094|Hormones|hormones|mesh-ancestor
14152365|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152366|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152367|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14152368|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
14152369|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14152370|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14152371|NCT05021094|Progestins|progestins|mesh-ancestor
14152372|NCT05021263|GABA Agonists|gaba agonists|mesh-list
14152373|NCT05021263|GABA Agents|gaba agents|mesh-ancestor
14152374|NCT05021263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152375|NCT05021263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152376|NCT05021263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179778|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14179779|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14179780|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
14179781|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179782|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179783|NCT05313308|Midazolam|midazolam|mesh-list
14179784|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14179785|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14179786|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179787|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179788|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14179789|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14179790|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14179791|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14179792|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
14179793|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
14179794|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
14179795|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
14179796|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179797|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179798|NCT05313282|Apatinib|apatinib|mesh-list
14179799|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179800|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14179801|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179802|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179803|NCT05313256|Lidocaine|lidocaine|mesh-list
14179804|NCT05313256|Epinephrine|epinephrine|mesh-list
14179805|NCT05313256|Racepinephrine|racepinephrine|mesh-list
14179806|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
14179807|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
14179808|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
14179809|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179810|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179811|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
14179812|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179813|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14179814|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14179815|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14179816|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14179817|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179818|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14179819|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14179820|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14179821|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179822|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14179823|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14766243|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
14766244|NCT00624871|Ibuprofen|ibuprofen|mesh-list
14766245|NCT00624871|Vitamins|vitamins|mesh-ancestor
14766246|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
14766247|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766248|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14766249|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14766250|NCT00624871|Analgesics|analgesics|mesh-ancestor
14766251|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
14938174|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938175|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938176|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179824|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
14179825|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14179826|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14938177|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
14766252|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766253|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766254|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14152377|NCT05021276|Basiliximab|basiliximab|mesh-list
14152378|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152379|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
14152380|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152381|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
14152382|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152383|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
14152384|NCT05021315|Povidone|povidone|mesh-list
14152385|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
14152386|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
14766255|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14766256|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766257|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152387|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14152388|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152389|NCT05020964|Trastuzumab|trastuzumab|mesh-list
14152390|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14152391|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152392|NCT05020860|Paclitaxel|paclitaxel|mesh-list
14152393|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
14152394|NCT05020860|Carboplatin|carboplatin|mesh-list
14152395|NCT05020860|Doxorubicin|doxorubicin|mesh-list
14152396|NCT05020860|Trastuzumab|trastuzumab|mesh-list
14152397|NCT05020860|Pertuzumab|pertuzumab|mesh-list
14152398|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14152399|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152400|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
14152401|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
14152402|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
14152403|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152404|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766258|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
14766259|NCT00624871|Protective Agents|protective agents|mesh-ancestor
14766260|NCT00624936|Bortezomib|bortezomib|mesh-list
14766261|NCT00624936|Azacitidine|azacitidine|mesh-list
14766262|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766263|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766264|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
13955118|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13955119|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13955120|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955121|NCT03192657|Basiliximab|basiliximab|mesh-list
13955122|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
13955123|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955124|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
13955125|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955126|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955127|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955128|NCT03192644|Leucovorin|leucovorin|mesh-list
13955129|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
13955130|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
13955131|NCT03192644|Epirubicin|epirubicin|mesh-list
13955132|NCT03192644|Calcium|calcium|mesh-list
13955133|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
13955134|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955135|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13955136|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955137|NCT03192644|Antidotes|antidotes|mesh-ancestor
13955138|NCT03192644|Protective Agents|protective agents|mesh-ancestor
13955139|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
13955140|NCT03192644|Vitamins|vitamins|mesh-ancestor
13955141|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
13955142|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13955143|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13955144|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13955145|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955146|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955147|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13955148|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
13955149|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13955150|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
13955151|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14152405|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
14179827|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
14152406|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152407|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14152408|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14152409|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
14152410|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14152411|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14152412|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14152413|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152414|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152415|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14152416|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
14152417|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14152418|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152419|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152420|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14152421|NCT05020821|Analgesics|analgesics|mesh-ancestor
14152422|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
14152423|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152424|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14152425|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14152426|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14152427|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
14152428|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152429|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152430|NCT05020704|Empagliflozin|empagliflozin|mesh-list
14152431|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14152432|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152433|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14152434|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152435|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14152436|NCT05020483|Coagulants|coagulants|mesh-ancestor
14152437|NCT05020782|Belimumab|belimumab|mesh-list
14152438|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152439|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
14152440|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152441|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14152442|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14152443|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14152444|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14152445|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152446|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152447|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152448|NCT05020600|Analgesics|analgesics|mesh-ancestor
14152449|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
14152450|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152451|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
14152452|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14152453|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
14152454|NCT05020522|Phenobarbital|phenobarbital|mesh-list
14152455|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
14152456|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14152457|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152458|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152459|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14152460|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14152461|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152462|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152463|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
14152464|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
14152465|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14152466|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14152467|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14152468|NCT05020028|Cannabidiol|cannabidiol|mesh-list
14152469|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
14152470|NCT05020184|Cimetidine|cimetidine|mesh-list
14152471|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14152472|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152473|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14152474|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
14152475|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
14152476|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179828|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
14152477|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152478|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152479|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14152480|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14152481|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152482|NCT05020210|Sivelestat|sivelestat|mesh-list
14152483|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14152484|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
14152485|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152486|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152487|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
14152488|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14152489|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152490|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152491|NCT05019794|Infigratinib|infigratinib|mesh-list
14152492|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152500|NCT05019586|Amoxicillin|amoxicillin|mesh-list
14152501|NCT05019586|Clarithromycin|clarithromycin|mesh-list
14152502|NCT05019586|Levofloxacin|levofloxacin|mesh-list
14152503|NCT05019586|Ofloxacin|ofloxacin|mesh-list
14152504|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14152505|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152506|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14152507|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152508|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152509|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14152510|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14152511|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14152512|NCT05019586|Renal Agents|renal agents|mesh-ancestor
14152513|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14152514|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152515|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152516|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14152517|NCT05019690|Paclitaxel|paclitaxel|mesh-list
14152518|NCT05019690|Apatinib|apatinib|mesh-list
14152519|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14152520|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14152521|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152522|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14152523|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14152524|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14152525|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152526|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14152527|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152528|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14152529|NCT05019417|Glycerol|glycerol|mesh-list
14152530|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14152531|NCT05019417|Protective Agents|protective agents|mesh-ancestor
14152532|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766265|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766266|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152533|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152534|NCT05018923|Metronidazole|metronidazole|mesh-list
14152535|NCT05018923|Doxycycline|doxycycline|mesh-list
14152536|NCT05018923|Tetracycline|tetracycline|mesh-list
14152537|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
14152538|NCT05018923|Rabeprazole|rabeprazole|mesh-list
14152539|NCT05018923|Bismuth|bismuth|mesh-list
14152540|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152541|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152542|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14152543|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14152544|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14152545|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
14152546|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14152547|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766267|NCT00625014|Haloperidol|haloperidol|mesh-list
14184007|NCT04723836|Vitamins|vitamins|mesh-ancestor
14152548|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14152549|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152550|NCT05018923|Antacids|antacids|mesh-ancestor
14152551|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14152552|NCT05018923|Diuretics|diuretics|mesh-ancestor
14152553|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
14152554|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152555|NCT05018923|Expectorants|expectorants|mesh-ancestor
14152556|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
14152557|NCT05019326|Andrographolide|andrographolide|mesh-list
14152558|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152559|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14152560|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14152561|NCT05019326|Analgesics|analgesics|mesh-ancestor
14152562|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
14152563|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152564|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152565|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14152566|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14152567|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14152568|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152569|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
14152570|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14152571|NCT05018988|Vitamin D|vitamin d|mesh-list
14152572|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
14152573|NCT05018988|Vitamins|vitamins|mesh-list
14152574|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
14152575|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152576|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14152577|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14152578|NCT05018962|Paclitaxel|paclitaxel|mesh-list
14152579|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14152580|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152581|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
14152582|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
14152583|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
14152584|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179829|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14179830|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
14179831|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14179832|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14179833|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179834|NCT05312970|Polidocanol|polidocanol|mesh-list
14179835|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14179836|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14179837|NCT05312892|Amlodipine|amlodipine|mesh-list
14179838|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
14179839|NCT05312892|Moxonidine|moxonidine|mesh-list
14179840|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14179841|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14179842|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179843|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14179844|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179845|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
14179846|NCT05312866|Acetaminophen|acetaminophen|mesh-list
14179847|NCT05312866|Dexamethasone|dexamethasone|mesh-list
14179848|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
14179849|NCT05312866|Fentanyl|fentanyl|mesh-list
14766268|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
14766269|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
14766270|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
14766271|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766272|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766273|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179850|NCT05312866|Bupivacaine|bupivacaine|mesh-list
14179851|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179852|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
14179853|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
14766274|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14766275|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14766276|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766277|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766278|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14766279|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
14766280|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766281|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766282|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14766283|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
14766284|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
14766285|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14766286|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14766287|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766288|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766289|NCT00625079|Urological Agents|urological agents|mesh-ancestor
14766290|NCT00625092|Leucovorin|leucovorin|mesh-list
14766291|NCT00625092|Fluorouracil|fluorouracil|mesh-list
14766292|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
14152585|NCT05018637|Teriparatide|teriparatide|mesh-list
14152586|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14152587|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152588|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14152589|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
14152590|NCT05018364|Hematinics|hematinics|mesh-ancestor
14152591|NCT05018182|Leucovorin|leucovorin|mesh-list
14152592|NCT05018182|Folic Acid|folic acid|mesh-list
14152593|NCT05018182|Fluorouracil|fluorouracil|mesh-list
14152594|NCT05018182|Capecitabine|capecitabine|mesh-list
14152595|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
14152596|NCT05018182|Irinotecan|irinotecan|mesh-list
14152597|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
14152598|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
14152599|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152600|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14152601|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152602|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152603|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
14152604|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152605|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14152606|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152607|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152608|NCT05018182|Antidotes|antidotes|mesh-ancestor
14152609|NCT05018182|Protective Agents|protective agents|mesh-ancestor
14152610|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
14152611|NCT05018182|Vitamins|vitamins|mesh-ancestor
14152612|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
14152613|NCT05018182|Hematinics|hematinics|mesh-ancestor
14152614|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14152615|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152616|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14152617|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14152618|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14152619|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
14152620|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14152621|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
14152622|NCT05017454|Valproic Acid|valproic acid|mesh-list
14152623|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152624|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
14152625|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14152626|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
14152627|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152628|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152629|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
14152630|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152631|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152632|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
14152633|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14152634|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152635|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14152636|NCT05017311|Citalopram|citalopram|mesh-list
14152637|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
14766293|NCT00625092|Calcium|calcium|mesh-list
14152638|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14152639|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14766294|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
14766295|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14152640|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14152641|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152642|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152643|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
14152644|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152645|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14152646|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
14152647|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14152648|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
14152649|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
14152650|NCT05017428|Niacinamide|niacinamide|mesh-list
14152651|NCT05017428|Niacin|niacin|mesh-list
14152652|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
14152653|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
14152654|NCT05017428|Vitamins|vitamins|mesh-ancestor
14152655|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
14152656|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152657|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14152658|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
14152659|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152660|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14152661|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
14152662|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
14152663|NCT05017272|Narcotics|narcotics|mesh-ancestor
14152664|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152665|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152666|NCT05017272|Analgesics|analgesics|mesh-ancestor
14152667|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
14152668|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152669|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14152670|NCT05017103|Antibodies|antibodies|mesh-list
14152671|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
14152672|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14152673|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
14152674|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152675|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152676|NCT05017155|Mexiletine|mexiletine|mesh-list
14152677|NCT05017155|Lamotrigine|lamotrigine|mesh-list
14152678|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
14152679|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14152680|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766296|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766297|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
14766298|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766299|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766300|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766301|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766302|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
14766303|NCT00625092|Antidotes|antidotes|mesh-ancestor
14766304|NCT00625092|Protective Agents|protective agents|mesh-ancestor
14766305|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
14766306|NCT00625092|Vitamins|vitamins|mesh-ancestor
14152681|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152682|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14152683|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152684|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14152685|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14152686|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152687|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14152688|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14152689|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14152690|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14152691|NCT05017116|Entecavir|entecavir|mesh-list
14152692|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
14152693|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152694|NCT05017194|Emodepside|emodepside|mesh-list
14152695|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14152696|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152697|NCT05016869|Capecitabine|capecitabine|mesh-list
14152698|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14152699|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
14152700|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152701|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152702|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
14152703|NCT05016713|Fluorides|fluorides|mesh-list
14152704|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
14152705|NCT05016713|Protective Agents|protective agents|mesh-ancestor
14766307|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
14152706|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152707|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14152708|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152709|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
14179854|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179855|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179856|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14179857|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
14179858|NCT05312866|Hormones|hormones|mesh-ancestor
14179859|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179860|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14179861|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179862|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
14179863|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
14179864|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179865|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
14179866|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14179867|NCT05312866|Narcotics|narcotics|mesh-ancestor
14766308|NCT00625170|Haloperidol|haloperidol|mesh-list
14766309|NCT00625170|Olanzapine|olanzapine|mesh-list
14766310|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
14179868|NCT05312866|Analgesics|analgesics|mesh-ancestor
14179869|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14179870|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14179871|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
14179872|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14179873|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
14179874|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14179875|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
14179876|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14179877|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14179878|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179879|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14179880|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
14179881|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14179882|NCT05312840|Gemcitabine|gemcitabine|mesh-list
14179883|NCT05312840|Carboplatin|carboplatin|mesh-list
14179884|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179885|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14179886|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
14179887|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179888|NCT05312840|Antiviral Agents|antiviral agents|mesh-ancestor
14179889|NCT05312840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14179890|NCT05312840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179891|NCT05312840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14179892|NCT05312840|Immunologic Factors|immunologic factors|mesh-ancestor
14179893|NCT05312840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179894|NCT05296759|Gabapentin|gabapentin|mesh-list
14179895|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14179896|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
14179897|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14179898|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14179899|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14478905|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14478906|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14179900|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14179901|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179902|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
14478907|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478908|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478909|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14179903|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179904|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179905|NCT05296759|Analgesics|analgesics|mesh-ancestor
14179906|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
14179907|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179908|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
14179909|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14179910|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14179911|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179912|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14179913|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14766311|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
14179914|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14179915|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
14152710|NCT05016128|Ketamine|ketamine|mesh-list
14152711|NCT05016128|Esketamine|esketamine|mesh-list
14152712|NCT05016128|Analgesics|analgesics|mesh-ancestor
14152713|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
14152714|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152715|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152716|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14152717|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14152718|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
14152719|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
14152720|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152721|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14152722|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14152723|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152724|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152725|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
14152726|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14152727|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
14152728|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14152729|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14152730|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152731|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14152732|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152733|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152734|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152735|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152736|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14152737|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
14152738|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14152739|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152740|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14152741|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14152742|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14152743|NCT05016440|Lisinopril|lisinopril|mesh-list
14152744|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14152745|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
14152746|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152747|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152748|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14152749|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14152750|NCT05016440|Protective Agents|protective agents|mesh-ancestor
14152751|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152752|NCT05016349|Tamoxifen|tamoxifen|mesh-list
14152753|NCT05016349|Tocopherols|tocopherols|mesh-list
14152754|NCT05016349|Tretinoin|tretinoin|mesh-list
14152755|NCT05016349|Alitretinoin|alitretinoin|mesh-list
14152756|NCT05016349|Cannabidiol|cannabidiol|mesh-list
14152757|NCT05016349|Isotretinoin|isotretinoin|mesh-list
14152758|NCT05016349|Mifepristone|mifepristone|mesh-list
14152759|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14152760|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
14152761|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152762|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152763|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14152764|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152765|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14152766|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14152767|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14152768|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
14152769|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
14152770|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14152771|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14152772|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
14152773|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14152774|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14478910|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14152775|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14152776|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14152777|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
14152778|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14152779|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14152780|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
14152781|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14152782|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14152783|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
14152784|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152785|NCT05016349|Protective Agents|protective agents|mesh-ancestor
14152786|NCT05016349|Vitamins|vitamins|mesh-ancestor
14152787|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
14152788|NCT05016180|Ropivacaine|ropivacaine|mesh-list
14152789|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
14152790|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
14152791|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152792|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152793|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
14152794|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152795|NCT05016063|Fludarabine|fludarabine|mesh-list
14152796|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
14152797|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152798|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152799|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152800|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
14152801|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152802|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14152803|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14152804|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
14152805|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14152806|NCT05016076|Dexamethasone|dexamethasone|mesh-list
14152807|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152808|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
14152809|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
14152810|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152811|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152812|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152813|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
14152814|NCT05016076|Hormones|hormones|mesh-ancestor
14152815|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152816|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14152817|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152818|NCT05015907|Ropivacaine|ropivacaine|mesh-list
14152819|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
14152820|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
14152821|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152822|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152823|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
14478911|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766312|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
14152824|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152825|NCT05015595|Memantine|memantine|mesh-list
14152826|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14152827|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14152828|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
14152829|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152830|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152831|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152832|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14152833|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14152834|NCT05015621|Leucovorin|leucovorin|mesh-list
14152835|NCT05015621|Fluorouracil|fluorouracil|mesh-list
14152836|NCT05015621|Irinotecan|irinotecan|mesh-list
14152837|NCT05015621|Calcium|calcium|mesh-list
14152838|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
14152839|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14152840|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152841|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
14152842|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152843|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14478912|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14478913|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
14478914|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
14478915|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
14152844|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152845|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152846|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
14152847|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14152848|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14152849|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152850|NCT05015621|Antidotes|antidotes|mesh-ancestor
14152851|NCT05015621|Protective Agents|protective agents|mesh-ancestor
14152852|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
14152853|NCT05015621|Vitamins|vitamins|mesh-ancestor
14152854|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
14152855|NCT05015829|Dobutamine|dobutamine|mesh-list
14152856|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14152857|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
14152858|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
14152859|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152860|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152861|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14152862|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14152863|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14152864|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
14152865|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152866|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152867|NCT05015829|Protective Agents|protective agents|mesh-ancestor
14152868|NCT05015361|Propofol|propofol|mesh-list
14152869|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14152870|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152871|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152872|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14152873|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
14152874|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
14152875|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
14152876|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14152877|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14152878|NCT05015322|Prednisolone|prednisolone|mesh-list
14152879|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
14152880|NCT05015322|Bupivacaine|bupivacaine|mesh-list
14152881|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14152882|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
14152883|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
14152884|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
14152885|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152886|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152887|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
14152888|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152889|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152890|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
14152891|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
14152892|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152893|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
14152894|NCT05015322|Hormones|hormones|mesh-ancestor
14152895|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14152896|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14152897|NCT05015322|Protective Agents|protective agents|mesh-ancestor
14152898|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14152899|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152900|NCT05014711|Fentanyl|fentanyl|mesh-list
14152901|NCT05014711|Remifentanil|remifentanil|mesh-list
14152902|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14152903|NCT05014711|Narcotics|narcotics|mesh-ancestor
14152904|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152905|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152906|NCT05014711|Analgesics|analgesics|mesh-ancestor
14152907|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
14152908|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152909|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14766313|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152910|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14152911|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
14478916|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
14478917|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152912|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
14152913|NCT05014685|Amoxicillin|amoxicillin|mesh-list
14152914|NCT05014685|Metronidazole|metronidazole|mesh-list
14152915|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
14152916|NCT05014685|Rabeprazole|rabeprazole|mesh-list
14152917|NCT05014685|Bismuth|bismuth|mesh-list
14152918|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152919|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14152920|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152921|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14152922|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14152923|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14152924|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14152925|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14152926|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152927|NCT05014685|Antacids|antacids|mesh-ancestor
14152928|NCT05014685|Diuretics|diuretics|mesh-ancestor
14152929|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
14152930|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152931|NCT05014685|Expectorants|expectorants|mesh-ancestor
14152932|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
14152933|NCT05014906|Minocycline|minocycline|mesh-list
14152934|NCT05014906|Azelaic acid|azelaic acid|mesh-list
14152935|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14152936|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152937|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152938|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14152939|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
14152940|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14152941|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
14152942|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152943|NCT05014828|Lenvatinib|lenvatinib|mesh-list
14152944|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152945|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14152946|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152947|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152948|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
14152949|NCT05015387|Procyanidin|procyanidin|mesh-list
14152950|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
14152951|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152952|NCT05015387|Protective Agents|protective agents|mesh-ancestor
14152953|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152954|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14152955|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14152956|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14152957|NCT05014464|Crizotinib|crizotinib|mesh-list
14152958|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14152959|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14152960|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152961|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152962|NCT05014490|Etoricoxib|etoricoxib|mesh-list
14152963|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14152964|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14152965|NCT05014490|Analgesics|analgesics|mesh-ancestor
14152966|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
14152967|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152968|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152969|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14152970|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14152971|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14152972|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14152973|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14152974|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152975|NCT05014516|Xenon|xenon|mesh-list
14152976|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14152977|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
14152978|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
14152979|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14152980|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152981|NCT05014581|Norepinephrine|norepinephrine|mesh-list
14152982|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14152983|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14152984|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14152985|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14152986|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152987|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14152988|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
14152989|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
14152990|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14152991|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14152992|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
14152993|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14152994|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14152995|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14152996|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179916|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14179917|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14179918|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
14179919|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
14179920|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14179921|NCT05295589|Paclitaxel|paclitaxel|mesh-list
14179922|NCT05295589|Doxorubicin|doxorubicin|mesh-list
14179923|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14179924|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14179925|NCT05295589|Topotecan|topotecan|mesh-list
14179926|NCT05295589|Olaparib|olaparib|mesh-list
14179927|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14179928|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14179929|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14179930|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
14179931|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
14179932|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
14179933|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179934|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14179935|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14179936|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14179937|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179938|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14179939|NCT05292976|Albuterol|albuterol|mesh-list
14179940|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
14179941|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14179942|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
14179943|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179944|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179945|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14179946|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
14179947|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
14179948|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14179949|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14179950|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14179951|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14179952|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
14179953|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14179954|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179955|NCT05292976|Miotics|miotics|mesh-ancestor
14179956|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14179957|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14179958|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14179959|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14179960|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
14179961|NCT05291598|Ketorolac|ketorolac|mesh-list
14179962|NCT05291598|Meloxicam|meloxicam|mesh-list
14152997|NCT05014373|Favipiravir|favipiravir|mesh-list
14152998|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
14152999|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153000|NCT05014100|Lenalidomide|lenalidomide|mesh-list
14153001|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
14153002|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153003|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14153004|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14153005|NCT05014100|Growth Substances|growth substances|mesh-ancestor
14153006|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
14153007|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153008|NCT05014048|Vitamin D|vitamin d|mesh-list
14153009|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
14153010|NCT05014048|Vitamins|vitamins|mesh-ancestor
14153011|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
14153012|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153013|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14153014|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14153015|NCT05013697|Paclitaxel|paclitaxel|mesh-list
14153016|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14153017|NCT05013697|Cisplatin|cisplatin|mesh-list
14153018|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14153019|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153020|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
14153021|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
14153022|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
14153023|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153024|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
14153025|NCT05013463|Indapamide|indapamide|mesh-list
14153026|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
14153027|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14153028|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14153029|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153030|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153031|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153032|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14153033|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14153034|NCT05013463|Diuretics|diuretics|mesh-ancestor
14153035|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
14766314|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153036|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153037|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14153038|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14153039|NCT05013060|Butyric Acid|butyric acid|mesh-list
14153040|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
14153041|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
14153042|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153043|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153044|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153045|NCT05013112|Metformin|metformin|mesh-list
14153046|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14153047|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14153048|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153049|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153050|NCT05013164|Leucovorin|leucovorin|mesh-list
14153051|NCT05013164|Folic Acid|folic acid|mesh-list
14153052|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
14153053|NCT05013164|Antidotes|antidotes|mesh-ancestor
14153054|NCT05013164|Protective Agents|protective agents|mesh-ancestor
14153055|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153056|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
14153057|NCT05013164|Vitamins|vitamins|mesh-ancestor
14153058|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
14153059|NCT05013164|Hematinics|hematinics|mesh-ancestor
14153060|NCT05013034|Basiliximab|basiliximab|mesh-list
14153061|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14153062|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
14153063|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153064|NCT05013151|Castor Oil|castor oil|mesh-list
14153065|NCT05013151|Cathartics|cathartics|mesh-ancestor
14153066|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153067|NCT05013268|Paclitaxel|paclitaxel|mesh-list
14153068|NCT05013268|Docetaxel|docetaxel|mesh-list
14153069|NCT05013268|Carboplatin|carboplatin|mesh-list
14153070|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14153071|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153072|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
14153073|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
14153074|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
14153075|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153076|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
14153077|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
14153078|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14153079|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153080|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153081|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14153082|NCT05013320|Analgesics|analgesics|mesh-ancestor
14153083|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
14153084|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153085|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14153086|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14153087|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14153088|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153089|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153090|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153091|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14153092|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14153093|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14153094|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
14153095|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
14153096|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14153097|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
14153098|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14153099|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14153100|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153101|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
14153102|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153103|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153104|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14153105|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
14153106|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
14153107|NCT05012566|Protective Agents|protective agents|mesh-ancestor
14153108|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14153109|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153110|NCT05012787|Vaccines|vaccines|mesh-list
14153111|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
14153112|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
14153113|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153114|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14153115|NCT05012137|Ropivacaine|ropivacaine|mesh-list
14153116|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
14153117|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
14153118|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153119|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153120|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
14153121|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179963|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14179964|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14179965|NCT05291598|Analgesics|analgesics|mesh-ancestor
14179966|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
14179967|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179968|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179969|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14179970|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14179971|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14179972|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14179973|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14179974|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14179975|NCT05288348|Sufentanil|sufentanil|mesh-list
14179976|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14179977|NCT05288348|Narcotics|narcotics|mesh-ancestor
14179978|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14179979|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179980|NCT05288348|Analgesics|analgesics|mesh-ancestor
14179981|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
14179982|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14179983|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14179984|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14179985|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
14179986|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
14179987|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14179988|NCT05286554|Hormones|hormones|mesh-list
14179989|NCT05286554|Progesterone|progesterone|mesh-list
14184008|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
14153122|NCT05012033|Prednisolone|prednisolone|mesh-list
14153123|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153124|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
14153125|NCT05012033|Hormones|hormones|mesh-ancestor
14153126|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153127|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153128|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153129|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153130|NCT05012189|Oseltamivir|oseltamivir|mesh-list
14153131|NCT05012189|Baloxavir|baloxavir|mesh-list
14153132|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
14153133|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153134|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153135|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153136|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14153137|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14153138|NCT05011760|Amphetamine|amphetamine|mesh-list
14153139|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
14153140|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14153141|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153142|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
14153143|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
14153144|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153145|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
14153146|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153147|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153148|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153149|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14153150|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14153151|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14153152|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14153153|NCT05011487|Pemetrexed|pemetrexed|mesh-list
14153154|NCT05011487|Osimertinib|osimertinib|mesh-list
14153155|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153156|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153157|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153158|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14153159|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14153160|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14153161|NCT05011617|Anesthetics|anesthetics|mesh-list
14153162|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153163|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153164|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14153165|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14153166|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14153167|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153168|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153169|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14153170|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14153171|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14153172|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14153173|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153174|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153175|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153176|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14153177|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14153178|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
14153179|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14153180|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14153181|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
14153182|NCT05011383|Testosterone|testosterone|mesh-list
14153183|NCT05011383|Androgens|androgens|mesh-list
14153184|NCT05011383|Hormones|hormones|mesh-ancestor
14153185|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153186|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153187|NCT05010954|Lansoprazole|lansoprazole|mesh-list
14153188|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
14153189|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14153190|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153191|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14153192|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153193|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153194|NCT05010876|Icatibant|icatibant|mesh-list
14184009|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153195|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14153196|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14153197|NCT05010876|Analgesics|analgesics|mesh-ancestor
14153198|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
14153199|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153200|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153201|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153202|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14153203|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14153204|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14153205|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153206|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14153207|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14153208|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
14153209|NCT05010707|Spironolactone|spironolactone|mesh-list
14153210|NCT05010707|Hormones|hormones|mesh-list
14153211|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153212|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153213|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14153214|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
14153215|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14153216|NCT05010707|Diuretics|diuretics|mesh-ancestor
14153217|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
14153218|NCT05010668|Lenvatinib|lenvatinib|mesh-list
14153219|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153220|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14153221|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153222|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153223|NCT05010681|Lenvatinib|lenvatinib|mesh-list
14153224|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153225|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14153226|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153227|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153228|NCT05010538|Sarecycline|sarecycline|mesh-list
14153229|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14153230|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153231|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14153232|NCT05010499|Bupivacaine|bupivacaine|mesh-list
13955152|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955153|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13955154|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13955155|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955156|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
13955157|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
13955158|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13955159|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14153233|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
14153234|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
14153235|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
14153236|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153237|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955160|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153238|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
14153239|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153240|NCT05010434|Bevacizumab|bevacizumab|mesh-list
14153241|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153242|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153243|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14153244|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14153245|NCT05010434|Growth Substances|growth substances|mesh-ancestor
14153246|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153247|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
14153248|NCT05010356|Insulin|insulin|mesh-list
14153249|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14153250|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153251|NCT05010200|Poly ICLC|poly iclc|mesh-list
14153252|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
14153253|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
14153254|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153255|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
14153256|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
14153257|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153258|NCT05009901|Protective Agents|protective agents|mesh-ancestor
14153259|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153260|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
14153261|NCT05009901|Vitamins|vitamins|mesh-ancestor
14153262|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
14153263|NCT05009953|Leucovorin|leucovorin|mesh-list
14153264|NCT05009953|Fluorouracil|fluorouracil|mesh-list
14153265|NCT05009953|Irinotecan|irinotecan|mesh-list
14153266|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
14153267|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153268|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14153269|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153270|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14153271|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
14153272|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153273|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14153274|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14153275|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153276|NCT05009953|Antidotes|antidotes|mesh-ancestor
14153277|NCT05009953|Protective Agents|protective agents|mesh-ancestor
14153278|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
14153279|NCT05009953|Vitamins|vitamins|mesh-ancestor
14153280|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
14179990|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14179991|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14179992|NCT05286554|Progestins|progestins|mesh-ancestor
14179993|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
14179994|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14179995|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
14179996|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14179997|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14179998|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14179999|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180000|NCT05286190|Bupivacaine|bupivacaine|mesh-list
14180001|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
14180002|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
14180003|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180004|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180005|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
14180006|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180007|NCT05277727|Fucoidan|fucoidan|mesh-list
14180008|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14180009|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180010|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
14180011|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180012|NCT05276973|Paclitaxel|paclitaxel|mesh-list
14180013|NCT05276973|Carboplatin|carboplatin|mesh-list
14180014|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14180015|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14180016|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180017|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
14180018|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
14180019|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
14180020|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180021|NCT05275907|Amlodipine|amlodipine|mesh-list
14180022|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
14180023|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14180024|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14180025|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14180026|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180027|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14180028|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180029|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
14180030|NCT05275907|Diuretics|diuretics|mesh-ancestor
14180031|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
14180032|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14153281|NCT05009342|Calpastatin|calpastatin|mesh-list
14153282|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14153283|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
14153284|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153285|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153286|NCT05009498|Vitamin D|vitamin d|mesh-list
14153287|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
14153288|NCT05009498|Vitamins|vitamins|mesh-ancestor
14153289|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
14153290|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153291|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14153292|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14153293|NCT05009017|Bevacizumab|bevacizumab|mesh-list
14153294|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153295|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153296|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14153297|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14153298|NCT05009017|Growth Substances|growth substances|mesh-ancestor
14153299|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153300|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
14153301|NCT05009082|Paclitaxel|paclitaxel|mesh-list
14153302|NCT05009082|Bevacizumab|bevacizumab|mesh-list
14153303|NCT05009082|Carboplatin|carboplatin|mesh-list
14153304|NCT05009082|Niraparib|niraparib|mesh-list
14153305|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14153306|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153307|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
14153308|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
14153309|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
14153310|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153311|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153312|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14153313|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14153314|NCT05009082|Growth Substances|growth substances|mesh-ancestor
14153315|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153316|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
14153317|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14153318|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153319|NCT05008939|Sevoflurane|sevoflurane|mesh-list
14153320|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14153321|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14153322|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
14153323|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
14153324|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153325|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153326|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
14153327|NCT05008861|Nivolumab|nivolumab|mesh-list
14153328|NCT05008861|Durvalumab|durvalumab|mesh-list
14153329|NCT05008861|Antibodies|antibodies|mesh-list
14153330|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14153331|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
14153332|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153333|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153334|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153335|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14153336|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153337|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
14153338|NCT05008523|Narcotics|narcotics|mesh-ancestor
14153339|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153340|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153341|NCT05008523|Analgesics|analgesics|mesh-ancestor
14153342|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
14153343|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153344|NCT05008679|Oseltamivir|oseltamivir|mesh-list
14766315|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153345|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
14153346|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153347|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153348|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153349|NCT05008666|Azacitidine|azacitidine|mesh-list
14153350|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14153351|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
14153352|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153353|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153354|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153355|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
14153356|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
14153357|NCT05008458|Coagulants|coagulants|mesh-ancestor
14153358|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14153359|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14153360|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
14153361|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153362|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
14153363|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14153364|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14153365|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153366|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
14153367|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153368|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153369|NCT05008367|Dexamethasone|dexamethasone|mesh-list
14153370|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153371|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
14153372|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
14153373|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153374|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153375|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153376|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
14153377|NCT05008367|Hormones|hormones|mesh-ancestor
14153378|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153379|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153380|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153381|NCT05008029|Anesthetics|anesthetics|mesh-list
14153382|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153383|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153384|NCT05008068|Simvastatin|simvastatin|mesh-list
14153385|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14153386|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14153387|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
14153388|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153389|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14153390|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14153391|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153392|NCT05008263|Liver Extracts|liver extracts|mesh-list
14153393|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
14153394|NCT05008263|Hematinics|hematinics|mesh-ancestor
14153395|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14153396|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153397|NCT05008237|Docetaxel|docetaxel|mesh-list
14153398|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153399|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14153400|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14153401|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14153402|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153403|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
14153404|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14153405|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14153406|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14153407|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153408|NCT05008250|Metoprolol|metoprolol|mesh-list
14153409|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14153410|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14153411|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
14153412|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
14153413|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153414|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153415|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14153416|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14153417|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14153418|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153419|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153420|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153421|NCT05007678|Leflunomide|leflunomide|mesh-list
14153422|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153423|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153424|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14153425|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
14153426|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153427|NCT05007587|Leucovorin|leucovorin|mesh-list
14153428|NCT05007587|Fluorouracil|fluorouracil|mesh-list
14153429|NCT05007587|Raltitrexed|raltitrexed|mesh-list
14153430|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
14153431|NCT05007587|Lenvatinib|lenvatinib|mesh-list
14153432|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
14153433|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153434|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14153435|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153436|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14153437|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
14153438|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153439|NCT05007587|Antidotes|antidotes|mesh-ancestor
14153440|NCT05007587|Protective Agents|protective agents|mesh-ancestor
14153441|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
14153442|NCT05007587|Vitamins|vitamins|mesh-ancestor
14153443|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
14153444|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14153445|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153446|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14153447|NCT05007860|Vaccines|vaccines|mesh-list
14153448|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
14153449|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766316|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14766317|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14766318|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766319|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766320|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14180033|NCT05272384|Nivolumab|nivolumab|mesh-list
14180034|NCT05272384|Decitabine|decitabine|mesh-list
14180035|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180036|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180037|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14180038|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180039|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180040|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
14180041|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180042|NCT05271292|Chiauranib|chiauranib|mesh-list
14180043|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180044|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14180045|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180046|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180047|NCT05269537|Ephedrine|ephedrine|mesh-list
14180048|NCT05269537|Fentanyl|fentanyl|mesh-list
14180049|NCT05269537|Bupivacaine|bupivacaine|mesh-list
14180050|NCT05269537|Oxytocin|oxytocin|mesh-list
14180051|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
14180052|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
14180053|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180054|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180055|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
14180056|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180057|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13955161|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955162|NCT03192709|Urological Agents|urological agents|mesh-ancestor
13955163|NCT03192449|Albendazole|albendazole|mesh-list
13955164|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
13955165|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13955166|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955167|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
13955168|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13955169|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13955170|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
13955171|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
13955172|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
13955173|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955174|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180058|NCT05269537|Narcotics|narcotics|mesh-ancestor
14180059|NCT05269537|Analgesics|analgesics|mesh-ancestor
14180060|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14153455|NCT05007613|Atezolizumab|atezolizumab|mesh-list
14153456|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153457|NCT05006911|Bromfenac|bromfenac|mesh-list
14153458|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14153459|NCT05006911|Phenylephrine|phenylephrine|mesh-list
14153460|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
14153461|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
14153462|NCT05006911|Pilocarpine|pilocarpine|mesh-list
14153463|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14153464|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
14153465|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153466|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
14153467|NCT05006911|Protective Agents|protective agents|mesh-ancestor
14153468|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14153469|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14153470|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14153471|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14153472|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153473|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153474|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153475|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
14153476|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
14153477|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153478|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
14153479|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14153480|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
14153481|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14766321|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14766322|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766323|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766324|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766325|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
14766326|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14766327|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
14766328|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14766329|NCT00625196|Fluticasone|fluticasone|mesh-list
14153482|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
14153483|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14153484|NCT05006911|Miotics|miotics|mesh-ancestor
14153485|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14153486|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14153487|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
14153488|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14153489|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14153490|NCT05006911|Analgesics|analgesics|mesh-ancestor
14153491|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
14766330|NCT00625196|Xhance|xhance|mesh-list
14766331|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153492|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153493|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14153494|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14153495|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
14153496|NCT05006898|Pilocarpine|pilocarpine|mesh-list
14153497|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14153498|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14153499|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14153500|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14153501|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
14766332|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14766333|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
14153502|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153503|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153504|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153505|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
14153506|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
14153507|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153508|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
14153509|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14153510|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
14153511|NCT05006898|Miotics|miotics|mesh-ancestor
14153512|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14153513|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14153514|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
14153515|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
14153516|NCT05007262|Calcium|calcium|mesh-list
14153517|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14153518|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153519|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
14153520|NCT05007262|Coagulants|coagulants|mesh-ancestor
14153521|NCT05007041|Vaccines|vaccines|mesh-list
14153522|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
14153523|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153524|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
14153525|NCT05006846|Narcotics|narcotics|mesh-ancestor
14153526|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153527|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153528|NCT05006846|Analgesics|analgesics|mesh-ancestor
14153529|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
14153530|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153531|NCT05007223|Doxycycline|doxycycline|mesh-list
14153532|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14153533|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153534|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
14153535|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14153536|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14153537|NCT05007132|Trifluridine|trifluridine|mesh-list
14153538|NCT05007132|Bevacizumab|bevacizumab|mesh-list
14153539|NCT05007132|Panitumumab|panitumumab|mesh-list
14153540|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153541|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153542|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14153543|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14153544|NCT05007132|Growth Substances|growth substances|mesh-ancestor
14153545|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153546|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14153547|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
14153548|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153549|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
14153550|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153551|NCT05006469|Dexamethasone|dexamethasone|mesh-list
14153552|NCT05006469|Doxorubicin|doxorubicin|mesh-list
14153553|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14153554|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14153555|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153556|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
14153557|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
14153558|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153559|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153560|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153561|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
14153562|NCT05006469|Hormones|hormones|mesh-ancestor
14153563|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153564|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153565|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153566|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153567|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153568|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14153569|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14153570|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14153571|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14153572|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
14153573|NCT05006664|Prednisone|prednisone|mesh-list
14153574|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
14153575|NCT05006664|Doxorubicin|doxorubicin|mesh-list
14153576|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14153577|NCT05006664|Etoposide|etoposide|mesh-list
14153578|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
14153579|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14153580|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938178|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938179|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14938180|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
14938181|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14938182|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14153581|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
14153582|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153583|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14153584|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14153585|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
14153586|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153587|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153588|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14153589|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14153590|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14153591|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14153592|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153593|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153594|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
14153595|NCT05006664|Hormones|hormones|mesh-ancestor
14153596|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153597|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153598|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14153599|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153600|NCT05006677|Vitamin K|vitamin k|mesh-list
14153601|NCT05006677|Anticoagulants|anticoagulants|mesh-list
14153602|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14153603|NCT05006677|Vitamins|vitamins|mesh-ancestor
14153604|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
14153605|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153606|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14153607|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14153608|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153609|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
14153610|NCT05006677|Coagulants|coagulants|mesh-ancestor
14153611|NCT05006287|Warfarin|warfarin|mesh-list
14153612|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
14153613|NCT05006287|Dabigatran|dabigatran|mesh-list
14153614|NCT05006287|Apixaban|apixaban|mesh-list
14153615|NCT05006287|Edoxaban|edoxaban|mesh-list
14153616|NCT05006287|Anticoagulants|anticoagulants|mesh-list
14153617|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14153618|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
14153619|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14153620|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
14153621|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153622|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153623|NCT05006638|Atropine|atropine|mesh-list
14153624|NCT05006638|Ondansetron|ondansetron|mesh-list
14153625|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
14153626|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
14153627|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
14153628|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
14153629|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153630|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766334|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766335|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766336|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14766337|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
14766338|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14766339|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14766340|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14766341|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
14766342|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14766343|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14766344|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14938183|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14153631|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153632|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
14153633|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
14153634|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14153635|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
14153636|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153637|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153638|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14153639|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14153640|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153641|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14153642|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14153643|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14153644|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14153645|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14153646|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14153647|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
14153648|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
14153649|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
14153650|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14153651|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14153652|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
14153653|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14153654|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14153655|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
14153656|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
14153657|NCT05006001|Colchicine|colchicine|mesh-list
14153658|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
14153659|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14153660|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
14153661|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
14153662|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
14153663|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153664|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153665|NCT05006209|Calcium|calcium|mesh-list
14153666|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14153667|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153668|NCT05006235|Epinephrine|epinephrine|mesh-list
14153669|NCT05006235|Albuterol|albuterol|mesh-list
14153670|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14153671|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14153672|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153673|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153674|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153675|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153676|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14153677|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14153678|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
14153679|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153680|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14153681|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
14153682|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
14153683|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
14153684|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14153685|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
14153686|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14153687|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14153688|NCT05005689|Fluorides|fluorides|mesh-list
14153689|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
14153690|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153691|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
14153692|NCT05005689|Protective Agents|protective agents|mesh-ancestor
14153693|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
14153694|NCT05005494|Analgesics|analgesics|mesh-ancestor
14153695|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
14153696|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153697|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153698|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
14153699|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153700|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14153701|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
14153702|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14153703|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14153704|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153705|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14153706|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
14153707|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14153708|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
14153709|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14153710|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153711|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153712|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14153713|NCT05005715|Analgesics|analgesics|mesh-ancestor
14153714|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
14153715|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153716|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14153717|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14153718|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14153719|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153720|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153721|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153722|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
14153723|NCT05005637|Prednisone|prednisone|mesh-list
14153724|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153725|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
14153726|NCT05005637|Hormones|hormones|mesh-ancestor
14153727|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153728|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153729|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153730|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153731|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14153732|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153733|NCT05005455|Bevacizumab|bevacizumab|mesh-list
14153734|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153735|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153736|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14153737|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14153738|NCT05005455|Growth Substances|growth substances|mesh-ancestor
14153739|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153740|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
14153741|NCT05005741|Dulaglutide|dulaglutide|mesh-list
14153742|NCT05005741|Glucagon|glucagon|mesh-list
14153743|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14153744|NCT05005741|Incretins|incretins|mesh-ancestor
14153745|NCT05005741|Hormones|hormones|mesh-ancestor
14153746|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153747|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153748|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153749|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14180061|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14180062|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
14180063|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
14180064|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14180065|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14180066|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
14180067|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
14180068|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14180069|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
14180070|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180071|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180072|NCT05268744|Micronutrients|micronutrients|mesh-list
14180073|NCT05268744|Trace Elements|trace elements|mesh-list
14180074|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180075|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14180076|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
14180077|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14180078|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180079|NCT05266404|Incretins|incretins|mesh-ancestor
14180080|NCT05266404|Hormones|hormones|mesh-ancestor
14180081|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180082|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14180083|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
14180084|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180085|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180086|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14180087|NCT05263895|Ritonavir|ritonavir|mesh-list
14180088|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14153750|NCT05004909|Tretinoin|tretinoin|mesh-list
14153751|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153752|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
14153753|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
14153754|NCT05005000|Triamcinolone|triamcinolone|mesh-list
14153755|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14153756|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14153757|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14153758|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153759|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
14153760|NCT05005000|Hormones|hormones|mesh-ancestor
14153761|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153762|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153763|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14153764|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
14153765|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153766|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153767|NCT05004753|Artemisinins|artemisinins|mesh-list
14153768|NCT05004753|Artemisinin|artemisinin|mesh-list
14153769|NCT05004753|Dexamethasone|dexamethasone|mesh-list
14153770|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153771|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
14153772|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
14153773|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153774|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153775|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153776|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
14153777|NCT05004753|Hormones|hormones|mesh-ancestor
14153778|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153779|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153780|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153781|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
14766345|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
14766346|NCT00625209|Protein C|protein c|mesh-list
14766347|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766348|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
14766349|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14766350|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13955175|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
13955176|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955177|NCT03192371|Vaccines|vaccines|mesh-list
14153782|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14153783|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14153784|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153785|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
14153786|NCT05004519|Remifentanil|remifentanil|mesh-list
14153787|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14153788|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153789|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153790|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14153791|NCT05004519|Analgesics|analgesics|mesh-ancestor
14153792|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
14153793|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153794|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14153795|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14153796|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14153797|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
14153798|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153799|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153800|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14153801|NCT05004519|Narcotics|narcotics|mesh-ancestor
14153802|NCT05004545|Propofol|propofol|mesh-list
14153803|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14153804|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153805|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153806|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14153807|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
14153808|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
13955178|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
13955179|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955180|NCT03192111|Entinostat|entinostat|mesh-list
13955181|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955182|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13955183|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153809|NCT05004064|Rituximab|rituximab|mesh-list
14153810|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
14153811|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153812|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153813|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
14153814|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153815|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14153816|NCT05004207|Lactulose|lactulose|mesh-list
14153817|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153818|NCT05004142|Letrozole|letrozole|mesh-list
14153819|NCT05004142|Fulvestrant|fulvestrant|mesh-list
14153820|NCT05004142|Goserelin|goserelin|mesh-list
14153821|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153822|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14153823|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14153824|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153825|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153826|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14153827|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
14153828|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153829|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153830|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153831|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14153832|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
14153833|NCT05003765|Buprenorphine|buprenorphine|mesh-list
14153834|NCT05003765|Bupivacaine|bupivacaine|mesh-list
14153835|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14153836|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
14153837|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
14153838|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153839|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955184|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955185|NCT03192293|Metformin|metformin|mesh-list
13955186|NCT03192293|Fulvestrant|fulvestrant|mesh-list
13955187|NCT03192293|Simvastatin|simvastatin|mesh-list
13955188|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13955189|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955190|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13955191|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13955192|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
13955193|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955194|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13955195|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13955196|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955197|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13955198|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955199|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13955200|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13955201|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
13955202|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955203|NCT03192332|Plasminogen|plasminogen|mesh-list
13955204|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
13955205|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13955206|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13955207|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955208|NCT03192059|Aspirin|aspirin|mesh-list
13955209|NCT03192059|Vitamin D|vitamin d|mesh-list
13955210|NCT03192059|Curcumin|curcumin|mesh-list
13955211|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
13955212|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
13955213|NCT03192059|Lansoprazole|lansoprazole|mesh-list
13955214|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
13955215|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955216|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
13955217|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955218|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955219|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13955220|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
13955221|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955222|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955223|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13955224|NCT03192059|Vitamins|vitamins|mesh-ancestor
13955225|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
14153840|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
14153841|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153842|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14153843|NCT05003765|Narcotics|narcotics|mesh-ancestor
14153844|NCT05003765|Analgesics|analgesics|mesh-ancestor
14153845|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14153846|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14153847|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
14153848|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14153849|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14153850|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153851|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14153852|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
14153853|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14153854|NCT05003570|Fentanyl|fentanyl|mesh-list
14153855|NCT05003570|Remifentanil|remifentanil|mesh-list
14153856|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14153857|NCT05003570|Narcotics|narcotics|mesh-ancestor
14153858|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153859|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153860|NCT05003570|Analgesics|analgesics|mesh-ancestor
14153861|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
14153862|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153863|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14153864|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14153865|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
14153866|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
14153867|NCT05003713|Prednisone|prednisone|mesh-list
14153868|NCT05003713|Cortisone|cortisone|mesh-list
14153869|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153870|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
14153871|NCT05003713|Hormones|hormones|mesh-ancestor
14153872|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153873|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153874|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153875|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153876|NCT05003752|Goserelin|goserelin|mesh-list
14153877|NCT05003752|Androgens|androgens|mesh-list
14153878|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153879|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153880|NCT05003752|Hormones|hormones|mesh-ancestor
14153881|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153882|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153883|NCT05003648|Pramipexole|pramipexole|mesh-list
14153884|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
14153885|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153886|NCT05003648|Protective Agents|protective agents|mesh-ancestor
14153887|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153888|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14153889|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14153890|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
14153891|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
14153892|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14153893|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
14153894|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14153895|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14153896|NCT05003596|Prednisolone|prednisolone|mesh-list
14153897|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
14153898|NCT05003596|Narcotics|narcotics|mesh-list
14153899|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14153900|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
14153901|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153902|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
14153903|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
14153904|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153905|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153906|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153907|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
14153908|NCT05003596|Hormones|hormones|mesh-ancestor
14153909|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153910|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14153911|NCT05003596|Protective Agents|protective agents|mesh-ancestor
14153912|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153913|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153914|NCT05003596|Analgesics|analgesics|mesh-ancestor
14153915|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
14153916|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153917|NCT05003700|Lenvatinib|lenvatinib|mesh-list
14153918|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153919|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14153920|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14153921|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153922|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
14153923|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14153924|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153925|NCT05002725|Lidocaine|lidocaine|mesh-list
14153926|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
14153927|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
14153928|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153929|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153930|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
14153931|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153932|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14153933|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14153934|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14153935|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14153936|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180089|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14180090|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
14180091|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180092|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180093|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14180094|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14180095|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
14180096|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180097|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14180098|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14180099|NCT05259722|Alitretinoin|alitretinoin|mesh-list
14938184|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938185|NCT01479933|Vitamin D|vitamin d|mesh-list
14938186|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
14938187|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
14938188|NCT01479933|Vitamins|vitamins|mesh-list
14938189|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
14938190|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938191|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14938192|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938193|NCT01480050|Temozolomide|temozolomide|mesh-list
14938194|NCT01480050|Mibefradil|mibefradil|mesh-list
14938195|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14938196|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
14938197|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180100|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180101|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
14180102|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14180103|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180104|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180105|NCT05243628|Insulin|insulin|mesh-list
14180106|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14180107|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14180108|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180109|NCT05240898|Adenosine|adenosine|mesh-list
14180110|NCT05240898|Analgesics|analgesics|mesh-ancestor
14180111|NCT05240898|Sensory System Agents|sensory system agents|mesh-ancestor
14180112|NCT05240898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180113|NCT05240898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180114|NCT05240898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14180115|NCT05240898|Vasodilator Agents|vasodilator agents|mesh-ancestor
14180116|NCT05240898|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14180117|NCT05240898|Purinergic Agonists|purinergic agonists|mesh-ancestor
14180118|NCT05240898|Purinergic Agents|purinergic agents|mesh-ancestor
14180119|NCT05240898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180120|NCT05240898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180121|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
14180122|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
14180123|NCT05222555|Lenalidomide|lenalidomide|mesh-list
14180124|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
14180125|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180126|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14938198|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180127|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14153937|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14153938|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14153939|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153940|NCT05002673|Anesthetics|anesthetics|mesh-list
14153941|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14153942|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153943|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
14153944|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14153945|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14153946|NCT05002517|Prednisolone|prednisolone|mesh-list
14153947|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
14153948|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14153949|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
14153950|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153951|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
14153952|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
14153953|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153954|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153955|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153956|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
14153957|NCT05002517|Hormones|hormones|mesh-ancestor
14153958|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153959|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14153960|NCT05002517|Protective Agents|protective agents|mesh-ancestor
14153961|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153962|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153963|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
14153964|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14153965|NCT05002270|Cetuximab|cetuximab|mesh-list
14153966|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14153967|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153968|NCT05002361|Dexamethasone|dexamethasone|mesh-list
14153969|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14153970|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
14153971|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
14153972|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14153973|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14153974|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14153975|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
14153976|NCT05002361|Hormones|hormones|mesh-ancestor
14153977|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14153978|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14153979|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153980|NCT05002686|Paclitaxel|paclitaxel|mesh-list
14153981|NCT05002686|Capecitabine|capecitabine|mesh-list
14153982|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
14153983|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14153984|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14153985|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
14153986|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
14153987|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
14153988|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14153989|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14153990|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
14153991|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14153992|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14153993|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14153994|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14153995|NCT05002101|Zinc|zinc|mesh-list
14153996|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
14153997|NCT05002101|Trace Elements|trace elements|mesh-ancestor
14153998|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
14153999|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154000|NCT05002101|Astringents|astringents|mesh-ancestor
14154001|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14154002|NCT05001919|Mitogens|mitogens|mesh-list
14154003|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
14154004|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154005|NCT05001763|Prucalopride|prucalopride|mesh-list
14154006|NCT05001763|Laxatives|laxatives|mesh-ancestor
14154007|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154008|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14154009|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14154010|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
14154011|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154012|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180128|NCT05222555|Growth Substances|growth substances|mesh-ancestor
14154013|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154014|NCT05002114|Cannabidiol|cannabidiol|mesh-list
14154015|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
14154016|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14154017|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14154018|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154019|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
14154020|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
14154021|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154022|NCT05001672|Tenofovir|tenofovir|mesh-list
14154023|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
14154024|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154025|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14154026|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14154027|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154028|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154029|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14154030|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14154031|NCT05001412|Carboplatin|carboplatin|mesh-list
14154032|NCT05001412|Etoposide|etoposide|mesh-list
14154033|NCT05001412|Apatinib|apatinib|mesh-list
14154034|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154035|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14154036|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14154037|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14154038|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154039|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154040|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14154041|NCT05001776|PENTA|penta|mesh-list
14154042|NCT05001776|Fondaparinux|fondaparinux|mesh-list
14154043|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14154044|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
14154045|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14154046|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
14154047|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154048|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154049|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
14154050|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14154051|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14154052|NCT05001529|Antibodies|antibodies|mesh-list
14154053|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
14154054|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154055|NCT05001243|Bromfenac|bromfenac|mesh-list
14154056|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14154057|NCT05001243|Phenylephrine|phenylephrine|mesh-list
14154058|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
14154059|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
14154060|NCT05001243|Pilocarpine|pilocarpine|mesh-list
14154061|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14766351|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766352|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154062|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
14154063|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154064|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
14154065|NCT05001243|Protective Agents|protective agents|mesh-ancestor
14154066|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14154067|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14154068|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14154069|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14154070|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14154071|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154072|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154073|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
14154074|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
14154075|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154076|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
14154077|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14154078|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
14154079|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14154080|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
14154081|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14154082|NCT05001243|Miotics|miotics|mesh-ancestor
14154083|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14154084|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14154085|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
14154086|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14154087|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14154088|NCT05001243|Analgesics|analgesics|mesh-ancestor
14154089|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
14154090|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154091|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14154092|NCT05001061|Misoprostol|misoprostol|mesh-list
14154093|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14154094|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
14154095|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14154096|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154097|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14154098|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154099|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
14154100|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
14154101|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14154102|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154103|NCT05001152|Ozanimod|ozanimod|mesh-list
14154104|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14154105|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154106|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14154107|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
14154108|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154109|NCT05001074|Tacrolimus|tacrolimus|mesh-list
14154110|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938199|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14938200|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14938201|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938202|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938203|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938204|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
14938205|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14154111|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
14154112|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154113|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14154114|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154115|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154116|NCT05001048|Phenylephrine|phenylephrine|mesh-list
14154117|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
14154118|NCT05001048|Synephrine|synephrine|mesh-list
14154119|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14154120|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
14154121|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
14154122|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154123|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154124|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
14154125|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14154126|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
14154127|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
13955226|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13955227|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14154128|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14154129|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14154130|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14154131|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14154132|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154133|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154134|NCT05001048|Protective Agents|protective agents|mesh-ancestor
14154135|NCT05000892|Paclitaxel|paclitaxel|mesh-list
14154136|NCT05000892|Carboplatin|carboplatin|mesh-list
14154137|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13955228|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955229|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955230|NCT03192059|Analgesics|analgesics|mesh-ancestor
14154138|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955231|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
13955232|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955233|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955234|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13955235|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13955236|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13955237|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13955238|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955239|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
14154139|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938206|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14154140|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
14154141|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
14154142|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955240|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13955241|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955242|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13955243|NCT03192033|Hemostatics|hemostatics|mesh-list
13955244|NCT03192033|Coagulants|coagulants|mesh-ancestor
14154157|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
14154158|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180129|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
14180130|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180131|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
14180132|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14180133|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
14180134|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180135|NCT05221151|Pregabalin|pregabalin|mesh-list
14180136|NCT05221151|Ondansetron|ondansetron|mesh-list
14180137|NCT05221151|Melatonin|melatonin|mesh-list
14180138|NCT05221151|Analgesics|analgesics|mesh-ancestor
14180139|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
14180140|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180141|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180142|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
14180143|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14180144|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14180145|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180146|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14180147|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14180148|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14180149|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180150|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14180151|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
14180152|NCT05221151|Protective Agents|protective agents|mesh-ancestor
14180153|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
14180154|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
14180155|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180156|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
14180157|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14180158|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14180159|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
14180160|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180161|NCT05221151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14180162|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
14180163|NCT05218148|Trastuzumab|trastuzumab|mesh-list
14766353|NCT00625248|Anticoagulants|anticoagulants|mesh-list
14766354|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14766355|NCT00625274|Esomeprazole|esomeprazole|mesh-list
14766356|NCT00625274|Pantoprazole|pantoprazole|mesh-list
14766357|NCT00625274|Lansoprazole|lansoprazole|mesh-list
14766358|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
14766359|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14766360|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766361|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13955245|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
13955246|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
13955247|NCT03191981|Lenalidomide|lenalidomide|mesh-list
13955248|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766362|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766363|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766364|NCT00625339|Lamivudine|lamivudine|mesh-list
14766365|NCT00625339|Entecavir|entecavir|mesh-list
13955249|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
14766366|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14766367|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14766368|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766369|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766370|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
14766371|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766372|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14766373|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14766374|NCT00625352|Gemcitabine|gemcitabine|mesh-list
14766375|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766376|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
14938207|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766377|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766378|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154159|NCT05000086|Diphosphonates|diphosphonates|mesh-list
14154160|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
14154161|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14154162|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154163|NCT05000281|Ibuprofen|ibuprofen|mesh-list
14154164|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14154165|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14154166|NCT05000281|Analgesics|analgesics|mesh-ancestor
14154167|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
14154168|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154169|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154170|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154171|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14154172|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14154173|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154174|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154175|NCT05000047|Silicon|silicon|mesh-list
14154176|NCT05000047|Trace Elements|trace elements|mesh-ancestor
14154177|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
14154178|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154179|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14154180|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154181|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
14154182|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14154183|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154184|NCT04999878|Gemcitabine|gemcitabine|mesh-list
14154185|NCT04999878|Dexamethasone|dexamethasone|mesh-list
14154186|NCT04999878|Etoposide|etoposide|mesh-list
14154187|NCT04999878|Cisplatin|cisplatin|mesh-list
14154188|NCT04999878|Pegaspargase|pegaspargase|mesh-list
14154189|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154190|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
14154191|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
14154192|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154193|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154194|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154195|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
14154196|NCT04999878|Hormones|hormones|mesh-ancestor
14154197|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154198|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14154199|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154200|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14154201|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
14154202|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154203|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
14154204|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154205|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154206|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14154207|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
14154208|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14154209|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14154210|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14154211|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
14154212|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14154213|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
14154214|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154215|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154216|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14154217|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
14154218|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
14154219|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14154220|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
14154221|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154222|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154223|NCT04999540|Fulvestrant|fulvestrant|mesh-list
14154224|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14154225|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154226|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14154227|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14766379|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
14766380|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766381|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154228|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
14154229|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154230|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154231|NCT04999293|Clopidogrel|clopidogrel|mesh-list
14154232|NCT04999293|Ticagrelor|ticagrelor|mesh-list
14154233|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14154234|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14154235|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14154236|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14154237|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
14154238|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154239|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154240|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154241|NCT04999332|Leucovorin|leucovorin|mesh-list
14154242|NCT04999332|Docetaxel|docetaxel|mesh-list
14154243|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
14154244|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
14154245|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154246|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14154247|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14154248|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14154249|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154250|NCT04999332|Antidotes|antidotes|mesh-ancestor
14154251|NCT04999332|Protective Agents|protective agents|mesh-ancestor
14154252|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154253|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
14154254|NCT04999332|Vitamins|vitamins|mesh-ancestor
14154255|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
14154256|NCT04999449|Scopolamine|scopolamine|mesh-list
14154257|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14154258|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14154259|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
14154260|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
14154261|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154262|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154263|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154264|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
14154265|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14154266|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
14154267|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154268|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154269|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14154270|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
14154271|NCT04999176|Enoxaparin|enoxaparin|mesh-list
14154272|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
14154273|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14154274|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
14154275|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14154276|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
14154277|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154278|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154279|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
14154280|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14154281|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14154282|NCT04999137|Vitamins|vitamins|mesh-list
14154283|NCT04999137|Ascorbic Acid|ascorbic acid|mesh-list
14154284|NCT04999137|Thiamine|thiamine|mesh-list
14154285|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
14154286|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154287|NCT04999137|Antioxidants|antioxidants|mesh-ancestor
14154288|NCT04999137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154289|NCT04999137|Protective Agents|protective agents|mesh-ancestor
14154290|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
14154291|NCT04998838|Tenofovir|tenofovir|mesh-list
14154292|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
14154293|NCT04998838|Antibodies|antibodies|mesh-list
14154294|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
14154295|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14154296|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14154297|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
14154298|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154299|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14154300|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14154301|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154302|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154303|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14154304|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14154305|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
14154306|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154307|NCT04998071|Bupivacaine|bupivacaine|mesh-list
14154308|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
14154309|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
14154310|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154311|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154312|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
14154313|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154314|NCT04998344|Vaccines|vaccines|mesh-list
14154315|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
14154316|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180164|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180165|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180166|NCT05195996|Propranolol|propranolol|mesh-list
14180167|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14180168|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14180169|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14180170|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180171|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180172|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180173|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14180174|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14180175|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
14180176|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
14938208|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
14938209|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14938210|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938211|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938212|NCT01480141|Afatinib|afatinib|mesh-list
14938213|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938214|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938215|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938216|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938217|NCT01480323|Aldesleukin|aldesleukin|mesh-list
14938218|NCT01480323|Ipilimumab|ipilimumab|mesh-list
14938219|NCT01480323|Interleukin-2|interleukin-2|mesh-list
14938220|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14938221|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180177|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180178|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180179|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
14180180|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180181|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180182|NCT05162014|Empagliflozin|empagliflozin|mesh-list
14180183|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14180184|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14180185|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154317|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14154318|NCT04998253|Propofol|propofol|mesh-list
14154319|NCT04998253|Sevoflurane|sevoflurane|mesh-list
14154320|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14154321|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154322|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154323|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14154324|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
14154325|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
14154326|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14154327|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14154328|NCT04998500|Hormones|hormones|mesh-list
14154329|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154330|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154331|NCT04998214|Thrombin|thrombin|mesh-list
14154332|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
14154333|NCT04998214|Coagulants|coagulants|mesh-ancestor
14154334|NCT04997967|Ketamine|ketamine|mesh-list
14154335|NCT04997967|Propofol|propofol|mesh-list
14154336|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14154337|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154338|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154339|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14154340|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
14154341|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
14154342|NCT04997967|Analgesics|analgesics|mesh-ancestor
14154343|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
14154344|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154345|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14154346|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14154347|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14154348|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154349|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154350|NCT04997980|Amiodarone|amiodarone|mesh-list
14154351|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14154352|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
14154353|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14154354|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14154355|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154356|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14154357|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14154358|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14154359|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154360|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14154361|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14154362|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14154363|NCT04997837|Capecitabine|capecitabine|mesh-list
14154364|NCT04997837|Tegafur|tegafur|mesh-list
14154365|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
14154366|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14154367|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14154368|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
14154369|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154370|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154371|NCT04997850|Lenvatinib|lenvatinib|mesh-list
14154372|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154373|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14154374|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154375|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154376|NCT04997707|Propofol|propofol|mesh-list
14154377|NCT04997707|Sevoflurane|sevoflurane|mesh-list
14154378|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14154379|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154380|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154381|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14154382|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
14154383|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
14154384|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14154385|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14154386|NCT04997798|Trastuzumab|trastuzumab|mesh-list
14154387|NCT04997798|Letrozole|letrozole|mesh-list
14154388|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14154389|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154390|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14154391|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14154392|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154393|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154394|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14154395|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
14154396|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154397|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154398|NCT04997564|Tenofovir|tenofovir|mesh-list
14154399|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
14154400|NCT04997564|Velpatasvir|velpatasvir|mesh-list
14154401|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
14154402|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154403|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14154404|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14154405|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154406|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154407|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14154408|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14154409|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14154410|NCT04997525|Estradiol|estradiol|mesh-list
14154411|NCT04997525|Progesterone|progesterone|mesh-list
14154412|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14154413|NCT04997525|Estrogens|estrogens|mesh-ancestor
14154414|NCT04997525|Hormones|hormones|mesh-ancestor
14154415|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154416|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154417|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14154418|NCT04997525|Progestins|progestins|mesh-ancestor
14154419|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14154420|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
14154421|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
14154422|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154423|NCT04996979|Ropivacaine|ropivacaine|mesh-list
14154424|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
14154425|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
14154426|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154427|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154428|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
14154429|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154430|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
14154431|NCT04997291|Razoxane|razoxane|mesh-list
14154432|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154433|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14154434|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14154435|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14154436|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154437|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154438|NCT04997291|Protective Agents|protective agents|mesh-ancestor
14154439|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154440|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14154441|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14154442|NCT04997304|Albuterol|albuterol|mesh-list
14154443|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14154444|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
14154445|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154446|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154447|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14154448|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14154449|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14154450|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14154451|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14154452|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
14154453|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154454|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154455|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
14154456|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14154457|NCT04996550|Metoprolol|metoprolol|mesh-list
14154458|NCT04996550|Carvedilol|carvedilol|mesh-list
14154459|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14154460|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14154461|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
14154462|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
14154463|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154464|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154465|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14154466|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14154467|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14154468|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
14154469|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766382|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766383|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
14766384|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766385|NCT00625378|Sorafenib|sorafenib|mesh-list
14766386|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766387|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14766388|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766389|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766390|NCT00625430|Vidarabine|vidarabine|mesh-list
14154470|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154471|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
14154472|NCT04996550|Protective Agents|protective agents|mesh-ancestor
14154473|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14154474|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14154475|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14154476|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
14154477|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14154478|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14154479|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
14154480|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14154481|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
14154482|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154483|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154484|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14154485|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
14154486|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14154487|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
14154488|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154489|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154490|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14154491|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
14154492|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
14154493|NCT04996667|Protective Agents|protective agents|mesh-ancestor
14154494|NCT04996602|177Lu-PSMA-617|177lu-psma-617|mesh-list
14154495|NCT04996602|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
14154496|NCT04996602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14154497|NCT04996602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154498|NCT04996485|Ustekinumab|ustekinumab|mesh-list
14154499|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
14154500|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
14154501|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14154502|NCT04996290|Ropivacaine|ropivacaine|mesh-list
14154503|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
14154504|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
14154505|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154506|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154507|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
14154508|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154509|NCT04996134|Domperidone|domperidone|mesh-list
14154510|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
14154511|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
14154512|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154513|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154514|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154515|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14154516|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
14154517|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154518|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154519|NCT04996251|Bupivacaine|bupivacaine|mesh-list
14154520|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
14154521|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
14154522|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154523|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154524|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
14154525|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154526|NCT04996498|Oxytocin|oxytocin|mesh-list
14154527|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
14766391|NCT00625430|Fludarabine|fludarabine|mesh-list
14154528|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14154529|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154530|NCT04996238|Vaccines|vaccines|mesh-list
14154531|NCT04996238|Immunologic Factors|immunologic factors|mesh-ancestor
14154532|NCT04996238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180186|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938222|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14938223|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938224|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14938225|NCT01480323|Analgesics|analgesics|mesh-ancestor
14938226|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
14938227|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938228|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938229|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14938230|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14938231|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
14180187|NCT05161754|Hemostatics|hemostatics|mesh-list
14180188|NCT05161754|Coagulants|coagulants|mesh-ancestor
14180189|NCT05161195|Tamoxifen|tamoxifen|mesh-list
14180190|NCT05161195|Letrozole|letrozole|mesh-list
14180191|NCT05161195|Fulvestrant|fulvestrant|mesh-list
14180192|NCT05161195|Anastrozole|anastrozole|mesh-list
14180193|NCT05161195|Goserelin|goserelin|mesh-list
14180194|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180195|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14180196|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14180197|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180198|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180199|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14180200|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
14180201|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180202|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180203|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14180204|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14180205|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14180206|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14180207|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14180208|NCT05156710|Rituximab|rituximab|mesh-list
14180209|NCT05156710|Tacrolimus|tacrolimus|mesh-list
14180210|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
14180211|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14180212|NCT05156710|Antibodies|antibodies|mesh-list
14180213|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14180214|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
14180215|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14180216|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180217|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180218|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
14180219|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180220|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14180221|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14180222|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14180223|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180224|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180225|NCT05142696|Carboplatin|carboplatin|mesh-list
14180226|NCT05142696|Etoposide|etoposide|mesh-list
14180227|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14180228|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14180229|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180230|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14180231|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14180232|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14180233|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180234|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180235|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
14180236|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
14180237|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14180238|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
14180239|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14180240|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184010|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
14184011|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14184012|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
14184013|NCT04723940|Doxycycline|doxycycline|mesh-list
14184014|NCT04723940|Clindamycin|clindamycin|mesh-list
14184015|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
14154533|NCT04996160|Dexamethasone|dexamethasone|mesh-list
14154534|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
14154535|NCT04996160|Doxorubicin|doxorubicin|mesh-list
14154536|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14154537|NCT04996160|Bortezomib|bortezomib|mesh-list
14154538|NCT04996160|Palbociclib|palbociclib|mesh-list
14154539|NCT04996160|BB 1101|bb 1101|mesh-list
14154540|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154541|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
14154542|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
14154543|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154544|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154545|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154546|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
14154547|NCT04996160|Hormones|hormones|mesh-ancestor
14154548|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154549|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14154550|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154551|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
14154552|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154553|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154554|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14154555|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14154556|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14154557|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14154558|NCT04996017|Atezolizumab|atezolizumab|mesh-list
14154559|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154560|NCT04995653|Vancomycin|vancomycin|mesh-list
14154561|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14154562|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154563|NCT04995354|Mitogens|mitogens|mesh-list
14154564|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
14154565|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154566|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14154567|NCT04995263|Caffeine|caffeine|mesh-list
14154568|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14154569|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154570|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14154571|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154572|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154573|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14154574|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14154575|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
14154576|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154577|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154578|NCT04995497|Lidocaine|lidocaine|mesh-list
14154579|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
14154580|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
14154581|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154582|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154583|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
14154584|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154585|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14154586|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14154587|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14154588|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938232|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938233|NCT01480336|Amiodarone|amiodarone|mesh-list
14154589|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938234|NCT01480336|Ranolazine|ranolazine|mesh-list
14938235|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14154590|NCT04995133|Colistin|colistin|mesh-list
14154591|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14154592|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154593|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14154594|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14154595|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14154596|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14154597|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154598|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
14154599|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154600|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154601|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14154602|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154603|NCT04994951|Triamcinolone|triamcinolone|mesh-list
14154604|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14154605|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14154606|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14154607|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154608|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
14154609|NCT04994951|Hormones|hormones|mesh-ancestor
14154610|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154611|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154612|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14154613|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
14154614|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154615|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154616|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
14154617|NCT04995016|Axitinib|axitinib|mesh-list
14154618|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14154619|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154620|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14154621|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478918|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478919|NCT02461290|Rituximab|rituximab|mesh-list
14478920|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478921|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154622|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154623|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
14154624|NCT04994860|Zamicastat|zamicastat|mesh-list
14154625|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
14154626|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14478922|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
14154627|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14154628|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154629|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154630|NCT04994860|Urological Agents|urological agents|mesh-ancestor
14154631|NCT04994626|Rituximab|rituximab|mesh-list
14154632|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14154633|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154634|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
14154635|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154636|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14154637|NCT04994743|Cortisone|cortisone|mesh-list
14154638|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154639|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14154640|NCT04994314|Fluorides|fluorides|mesh-list
14154641|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154642|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
14154643|NCT04994314|Protective Agents|protective agents|mesh-ancestor
14154644|NCT04994262|Menthol|menthol|mesh-list
14154645|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
14154646|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
14154647|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
14154648|NCT04994574|Olodaterol|olodaterol|mesh-list
14154649|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14154650|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
14154651|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154652|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154653|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14154654|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
14154655|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
14154656|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14154657|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
14154658|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154659|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154660|NCT04994236|Leucovorin|leucovorin|mesh-list
14154661|NCT04994236|Fluorouracil|fluorouracil|mesh-list
14154662|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
14154663|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
14154664|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154665|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14154666|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154667|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14154668|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
14154669|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154670|NCT04994236|Antidotes|antidotes|mesh-ancestor
14154671|NCT04994236|Protective Agents|protective agents|mesh-ancestor
14154672|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
14154673|NCT04994236|Vitamins|vitamins|mesh-ancestor
14154674|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
14154675|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
14154676|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14154677|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
14154678|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14154679|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
14154680|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154681|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154682|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
14180241|NCT05136196|Nivolumab|nivolumab|mesh-list
14180242|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180243|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180244|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14180245|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180246|NCT05129358|Furosemide|furosemide|mesh-list
14180247|NCT05129358|Diuretics|diuretics|mesh-ancestor
14180248|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
14180249|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180250|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14180251|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14180252|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180253|NCT05115838|Islatravir|islatravir|mesh-list
14180254|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
14180255|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180256|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180257|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180258|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14180259|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14180260|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14180261|NCT05111145|Ivacaftor|ivacaftor|mesh-list
14180262|NCT05111145|Elexacaftor|elexacaftor|mesh-list
14180263|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14180264|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14180265|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180266|NCT05109728|Temozolomide|temozolomide|mesh-list
14180267|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14180268|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14180269|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14180270|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
14180271|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180272|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180273|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
14180274|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
14180275|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14180276|NCT05098028|Rifaximin|rifaximin|mesh-list
14180277|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14180278|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180279|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180280|NCT05095376|Temozolomide|temozolomide|mesh-list
14180281|NCT05095376|Lomustine|lomustine|mesh-list
14180282|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14180283|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
14180284|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180285|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180286|NCT05083975|Anesthetics|anesthetics|mesh-list
14180287|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
14180288|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180289|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180290|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
14180291|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154683|NCT04994119|Warfarin|warfarin|mesh-list
14154684|NCT04994119|Zamicastat|zamicastat|mesh-list
14154685|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
14154686|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154687|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154688|NCT04993209|Vaccines|vaccines|mesh-list
14154689|NCT04993209|Immunologic Factors|immunologic factors|mesh-ancestor
14154690|NCT04993209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154691|NCT04993365|Vaccines|vaccines|mesh-list
14154692|NCT04993365|Immunologic Factors|immunologic factors|mesh-ancestor
14154693|NCT04993365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154694|NCT04993222|Amphotericin B|amphotericin b|mesh-list
14154695|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14154696|NCT04993222|Amebicides|amebicides|mesh-ancestor
14154697|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14154698|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14154699|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154700|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14154701|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
14154702|NCT04993014|Trastuzumab|trastuzumab|mesh-list
14154703|NCT04993014|Pertuzumab|pertuzumab|mesh-list
14154704|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14154705|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154706|NCT04993040|Paclitaxel|paclitaxel|mesh-list
14154707|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14154708|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154709|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
14154710|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
14154711|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
14154712|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154713|NCT04992507|Anesthetics|anesthetics|mesh-list
14154714|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154715|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154716|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14154717|NCT04992468|Hormones|hormones|mesh-ancestor
14154718|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154719|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154720|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
14154721|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14154722|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14154723|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
14154724|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154725|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154726|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154727|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
14154728|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
14154729|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154730|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
14154731|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14154732|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
14154733|NCT04992481|Fluorides|fluorides|mesh-list
14154734|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
14154735|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
14154736|NCT04992481|Protective Agents|protective agents|mesh-ancestor
14154737|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154738|NCT04992572|Lidocaine|lidocaine|mesh-list
14154739|NCT04992572|Propofol|propofol|mesh-list
14154740|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
14154741|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
14154742|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154743|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154744|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
14154745|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154746|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14154747|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14154748|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14154749|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14180292|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
14154750|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154751|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14154752|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14154753|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
14154754|NCT04992156|Palbociclib|palbociclib|mesh-list
14154755|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938236|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
14938237|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14938238|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14154756|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14154757|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154758|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154759|NCT04992182|Vaccines|vaccines|mesh-list
14154760|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
14154761|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154762|NCT04992052|Bone wax|bone wax|mesh-list
14154763|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
14154764|NCT04992052|Coagulants|coagulants|mesh-ancestor
14154765|NCT04992143|Sorafenib|sorafenib|mesh-list
14154766|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154767|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14154768|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938239|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938240|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14938241|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14938242|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14938243|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938244|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14938245|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14938246|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14938764|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938765|NCT01484171|Idarubicin|idarubicin|mesh-list
14938766|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14938767|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938768|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14938769|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14938770|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154769|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154770|NCT04992026|Prednisone|prednisone|mesh-list
14154771|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
14154772|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154773|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
14154774|NCT04992026|Hormones|hormones|mesh-ancestor
14154775|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154776|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154777|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14154778|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154779|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14154780|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154781|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154782|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
14154783|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14180293|NCT05073237|Estrogens|estrogens|mesh-list
14180294|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14180295|NCT05073237|Hormones|hormones|mesh-ancestor
14180296|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180297|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180298|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14180299|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14180300|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
14180301|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14180302|NCT05065424|Atropine|atropine|mesh-list
14180303|NCT05065424|Fentanyl|fentanyl|mesh-list
14180304|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14180305|NCT05065424|Narcotics|narcotics|mesh-ancestor
14180306|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180307|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180308|NCT05065424|Analgesics|analgesics|mesh-ancestor
14180309|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
14180310|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180311|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14180312|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14154784|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
14154785|NCT04991597|Lidocaine|lidocaine|mesh-list
14154786|NCT04991597|Epinephrine|epinephrine|mesh-list
14154787|NCT04991597|Racepinephrine|racepinephrine|mesh-list
14154788|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
14154789|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
14154790|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
14154791|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154792|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154793|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
14154794|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154795|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14154796|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14154797|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14154798|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14154799|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154800|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14154801|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14154802|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
14154803|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154804|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14154805|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14154806|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
14154807|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14154808|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
14154809|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
14154810|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
14154811|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14154812|NCT04991584|Amoxicillin|amoxicillin|mesh-list
14154813|NCT04991584|Levofloxacin|levofloxacin|mesh-list
14154814|NCT04991584|Ofloxacin|ofloxacin|mesh-list
14154815|NCT04991584|Tetracycline|tetracycline|mesh-list
14154816|NCT04991584|Furazolidone|furazolidone|mesh-list
14154817|NCT04991584|Esomeprazole|esomeprazole|mesh-list
14154818|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14154819|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154820|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14766392|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
14766393|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766394|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766395|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
14154821|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154822|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14154823|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154824|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154825|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14154826|NCT04991584|Renal Agents|renal agents|mesh-ancestor
14154827|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14154828|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14154829|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154830|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14154831|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14154832|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14154833|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14154834|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14154835|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14154836|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14154837|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14154838|NCT04991896|Metoprolol|metoprolol|mesh-list
14154839|NCT04991896|Sotalol|sotalol|mesh-list
14154840|NCT04991896|Flecainide|flecainide|mesh-list
14154841|NCT04991896|Bisoprolol|bisoprolol|mesh-list
14154842|NCT04991896|Betaxolol|betaxolol|mesh-list
14154843|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14154844|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14766396|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154845|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
14154846|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
14154847|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154848|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154849|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14154850|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14154851|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14154852|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
14154853|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154854|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154855|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14154856|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14154857|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14154858|NCT04991181|Zamicastat|zamicastat|mesh-list
14154859|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154860|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154861|NCT04991324|Vitamin D|vitamin d|mesh-list
14154862|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
14154863|NCT04991324|Vitamins|vitamins|mesh-ancestor
14154864|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
14154865|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154866|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14154867|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14154868|NCT04991402|Dolutegravir|dolutegravir|mesh-list
14154869|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14154870|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14154871|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14154872|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154873|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154874|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14154875|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
14154876|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154877|NCT04991207|Bosentan|bosentan|mesh-list
14154878|NCT04991207|Zamicastat|zamicastat|mesh-list
14154879|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14154880|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14154881|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154882|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154883|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
14154884|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
14154885|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14154886|NCT04991064|Protective Agents|protective agents|mesh-ancestor
14154887|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154888|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
14154889|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14154890|NCT04991155|Zamicastat|zamicastat|mesh-list
14154891|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154892|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154893|NCT04991298|Fentanyl|fentanyl|mesh-list
14154894|NCT04991298|Midazolam|midazolam|mesh-list
14154895|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14154896|NCT04991298|Narcotics|narcotics|mesh-ancestor
14154897|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154898|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154899|NCT04991298|Analgesics|analgesics|mesh-ancestor
14154900|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
14154901|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154902|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14154903|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14154904|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
14154905|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
14154906|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14154907|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14154908|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14154909|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14154910|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
14154911|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
14154912|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14154913|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154914|NCT04991194|Zamicastat|zamicastat|mesh-list
14154915|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154916|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154917|NCT04991012|Triamcinolone|triamcinolone|mesh-list
14154918|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14154919|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14154920|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14154921|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154922|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
14154923|NCT04991012|Hormones|hormones|mesh-ancestor
14154924|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14154925|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154926|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766397|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766398|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
14154927|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
14154928|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154929|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154930|NCT04990830|Heparin|heparin|mesh-list
14154931|NCT04990830|Enoxaparin|enoxaparin|mesh-list
14154932|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14154933|NCT04990830|Tinzaparin|tinzaparin|mesh-list
14154934|NCT04990830|Dalteparin|dalteparin|mesh-list
14154935|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
14154936|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
14154937|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14154938|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14154939|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154940|NCT04990869|Niacinamide|niacinamide|mesh-list
14154941|NCT04990869|Niacin|niacin|mesh-list
14154942|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
14154943|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
14154944|NCT04990869|Vitamins|vitamins|mesh-ancestor
14154945|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
14154946|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154947|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14154948|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
14154949|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154950|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14154951|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
14154952|NCT04990713|Ropivacaine|ropivacaine|mesh-list
14154953|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
14154954|NCT04990713|Anesthetics|anesthetics|mesh-list
14154955|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14154956|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154957|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
14154958|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154959|NCT04990791|Aspirin|aspirin|mesh-list
14154960|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
14154961|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14154962|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14154963|NCT04990791|Analgesics|analgesics|mesh-ancestor
14154964|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
14154965|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14154966|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14154967|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14154968|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14154969|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14154970|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14154971|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154972|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14154973|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14154974|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154975|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
14154976|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14154977|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
14154978|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14154979|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
14154980|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
14766399|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766400|NCT00625430|Antiviral Agents|antiviral agents|mesh-ancestor
14766401|NCT00625430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14154981|NCT04990752|Urinastatin|urinastatin|mesh-list
14154982|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14154983|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14154984|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
14154985|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14154986|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14154987|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14154988|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14154989|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
14154990|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154991|NCT04990037|Folfirinox|folfirinox|mesh-list
14154992|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14154993|NCT04990258|Infliximab|infliximab|mesh-list
14154994|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
14154995|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14154996|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14154997|NCT04990167|Bromides|bromides|mesh-list
14154998|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
14154999|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14155000|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
14155001|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155002|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155003|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14155004|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
14155005|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
14155006|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14155007|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14155008|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155009|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155010|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
14180313|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
14180314|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
14180315|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180316|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14180317|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14180318|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
14180319|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14180320|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
14180321|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
14180322|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
14180323|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14180324|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14180325|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
14180326|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180327|NCT05059522|Pemetrexed|pemetrexed|mesh-list
14180328|NCT05059522|Avelumab|avelumab|mesh-list
14180329|NCT05059522|Axitinib|axitinib|mesh-list
14180330|NCT05059522|Talazoparib|talazoparib|mesh-list
14180331|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180332|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180333|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180334|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14180335|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14180336|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180337|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14180338|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14180339|NCT05052957|Temozolomide|temozolomide|mesh-list
14180340|NCT05052957|Carmustine|carmustine|mesh-list
14180341|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14180342|NCT05052957|Lenograstim|lenograstim|mesh-list
14180343|NCT05052957|Sargramostim|sargramostim|mesh-list
14180344|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14180345|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
14180346|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180347|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14180348|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
14180349|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180350|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180351|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180352|NCT05034952|Acetaminophen|acetaminophen|mesh-list
14180353|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14180354|NCT05034952|Analgesics|analgesics|mesh-ancestor
14180355|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
14180356|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180357|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180358|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
14180359|NCT05030441|Ivosidenib|ivosidenib|mesh-list
14180360|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180361|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180362|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180363|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
14180364|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14180365|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
14180366|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180367|NCT04987203|Nivolumab|nivolumab|mesh-list
14180368|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180369|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180370|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14180371|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180372|NCT04975256|Adagrasib|adagrasib|mesh-list
14180373|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180374|NCT04948892|Anesthetics|anesthetics|mesh-list
14180375|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180376|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180377|NCT04943783|Atorvastatin|atorvastatin|mesh-list
14180378|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14938247|NCT01480492|Telbivudine|telbivudine|mesh-list
14180379|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14180380|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
14938248|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
14155011|NCT04989413|Dronabinol|dronabinol|mesh-list
14155012|NCT04989413|Cannabidiol|cannabidiol|mesh-list
14155013|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
14155014|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
14155015|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155016|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14155017|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14155018|NCT04989413|Analgesics|analgesics|mesh-ancestor
14155019|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
14155020|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155021|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14155022|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14155023|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938249|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938250|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14938251|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938252|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938253|NCT01480531|Clevidipine|clevidipine|mesh-list
14938254|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14155024|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155025|NCT04989413|Hormones|hormones|mesh-ancestor
14155026|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155027|NCT04989335|Fludarabine|fludarabine|mesh-list
14155028|NCT04989335|Clofarabine|clofarabine|mesh-list
14155029|NCT04989335|Bisantrene|bisantrene|mesh-list
14155030|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155031|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14155032|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
14155033|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155034|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14155035|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
14155036|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14155037|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
14155038|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155039|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
14155040|NCT04989361|Protective Agents|protective agents|mesh-ancestor
14155041|NCT04989400|Misoprostol|misoprostol|mesh-list
14155042|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
14155043|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14155044|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
14155045|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14155046|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155047|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14155048|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938255|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938256|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938257|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938258|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938259|NCT01480609|Ezogabine|ezogabine|mesh-list
14938260|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
14938261|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938262|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938263|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
14938264|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14938265|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
14155049|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
14155050|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14155051|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
14155052|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14155053|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14155054|NCT04989127|Penicillins|penicillins|mesh-list
14155055|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14155056|NCT04989127|Analgesics|analgesics|mesh-list
14155057|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155058|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
14155059|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
14155060|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155061|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155062|NCT04989166|Curcumin|curcumin|mesh-list
14155063|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14155064|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14155065|NCT04989166|Analgesics|analgesics|mesh-ancestor
14155066|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
14155067|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155068|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155069|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155070|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155071|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155072|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155073|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155074|NCT04989140|Dexamethasone|dexamethasone|mesh-list
14155075|NCT04989140|Pomalidomide|pomalidomide|mesh-list
14155076|NCT04989140|Ixazomib|ixazomib|mesh-list
14155077|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155078|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
14155079|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
14155080|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155081|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155082|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155083|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
14155084|NCT04989140|Hormones|hormones|mesh-ancestor
14155085|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155086|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155087|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155088|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
14155089|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14155090|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14155091|NCT04989140|Growth Substances|growth substances|mesh-ancestor
14155092|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
14155093|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
14155094|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155095|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155096|NCT04988945|Durvalumab|durvalumab|mesh-list
14155097|NCT04988945|Tremelimumab|tremelimumab|mesh-list
14155098|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14155099|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155100|NCT04989270|Anesthetics|anesthetics|mesh-list
14155101|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938266|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938267|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14938268|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
14938269|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14938270|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14938271|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
14938272|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938273|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14938274|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14938275|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938276|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155102|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155103|NCT04989257|Clopidogrel|clopidogrel|mesh-list
14155104|NCT04989257|Ticagrelor|ticagrelor|mesh-list
14155105|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14155106|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14155107|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14155108|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14155109|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
14155110|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155111|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155112|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155113|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
14155114|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14155115|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
14155116|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155117|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155118|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14155119|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
14155120|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14155121|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
14155122|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155123|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155124|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14155125|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
14155126|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
14155127|NCT04988932|Protective Agents|protective agents|mesh-ancestor
14155128|NCT04989348|Hormones|hormones|mesh-list
14155129|NCT04989348|Progestins|progestins|mesh-list
14938277|NCT01480752|Lornoxicam|lornoxicam|mesh-list
14155130|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
14155131|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155132|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155133|NCT04988776|Bupivacaine|bupivacaine|mesh-list
14155134|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
14155135|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
14155136|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14155137|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155138|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
14155139|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155140|NCT04988789|Paclitaxel|paclitaxel|mesh-list
14155141|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14155142|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155143|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
14155144|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
14155145|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
14155146|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155147|NCT04988607|Bevacizumab|bevacizumab|mesh-list
14155148|NCT04988607|Osimertinib|osimertinib|mesh-list
14155149|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14155150|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155151|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14155152|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14155153|NCT04988607|Growth Substances|growth substances|mesh-ancestor
14155154|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155155|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
14155156|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14155157|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155158|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155159|NCT04988646|Acyclovir|acyclovir|mesh-list
14155160|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
14155161|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155162|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
14155163|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14155164|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14155165|NCT04988425|Prednisolone|prednisolone|mesh-list
14155166|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
14155167|NCT04988425|Antibodies|antibodies|mesh-list
14155168|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14155169|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14155170|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
14155171|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
14155172|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155173|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155174|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
14155175|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
14155176|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155177|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155178|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
14155179|NCT04988425|Hormones|hormones|mesh-ancestor
14155180|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155181|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14155182|NCT04988425|Protective Agents|protective agents|mesh-ancestor
14155183|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155184|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155185|NCT04988217|Interferons|interferons|mesh-list
14155186|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
14155187|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
14155188|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155189|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
14155190|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155191|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
14155192|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155193|NCT04988191|Bevacizumab|bevacizumab|mesh-list
14155194|NCT04988191|Irinotecan|irinotecan|mesh-list
14155195|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14155196|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155197|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14155198|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14155199|NCT04988191|Growth Substances|growth substances|mesh-ancestor
14155200|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155201|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
14155202|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14155203|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14155204|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184016|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
14155205|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155206|NCT04988048|Vaccines|vaccines|mesh-list
14155207|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
14155208|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155209|NCT04988256|Cyclosporine|cyclosporine|mesh-list
14155210|NCT04988256|Prednisone|prednisone|mesh-list
14155211|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
14155212|NCT04988256|Cyclosporins|cyclosporins|mesh-list
14155213|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155214|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
14155215|NCT04988256|Hormones|hormones|mesh-ancestor
14155216|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155217|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155218|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155219|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155220|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155221|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155222|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14155223|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
14155224|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
14155225|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155226|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
14155227|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155228|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14155229|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
14155230|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
14155231|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155232|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155233|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14155234|NCT04988256|Protective Agents|protective agents|mesh-ancestor
14155235|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
14155236|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14155237|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155238|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
14155239|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14155240|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14155241|NCT04988282|Prednisolone|prednisolone|mesh-list
14155242|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
14155243|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14155244|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
14155245|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155246|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
14155247|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
14155248|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155249|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155250|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155251|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
14155252|NCT04988282|Hormones|hormones|mesh-ancestor
14155253|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155254|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14155255|NCT04988282|Protective Agents|protective agents|mesh-ancestor
14155256|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155257|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180381|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180382|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14180383|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14180384|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180385|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
14180386|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180387|NCT04918186|Durvalumab|durvalumab|mesh-list
14180388|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180389|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180390|NCT04912427|Dexamethasone|dexamethasone|mesh-list
14180391|NCT04912427|Bortezomib|bortezomib|mesh-list
14180392|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766402|NCT00625456|Molgramostim|molgramostim|mesh-list
14766403|NCT00625456|Sargramostim|sargramostim|mesh-list
14766404|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
14766405|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766406|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766407|NCT00625469|Bosentan|bosentan|mesh-list
14766408|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14180393|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
14180394|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
14180395|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180396|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155258|NCT04987632|Letrozole|letrozole|mesh-list
14155259|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155260|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14155261|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14155262|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155263|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155264|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14155265|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
14155266|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155267|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155268|NCT04987463|Sirolimus|sirolimus|mesh-list
14155269|NCT04987463|Vigabatrin|vigabatrin|mesh-list
14155270|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14155271|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155272|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14155273|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155274|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
14155275|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14155276|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
14155277|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155278|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
14155279|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155280|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155281|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
14155282|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155283|NCT04987450|Prednisone|prednisone|mesh-list
14155284|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
14155285|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14155286|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14155287|NCT04987450|Prednisolone|prednisolone|mesh-list
14155288|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
14155289|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14155290|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
14155291|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155292|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
14155293|NCT04987450|Hormones|hormones|mesh-ancestor
14155294|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155295|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155296|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155297|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155298|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
14155299|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
14155300|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155301|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155302|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14155303|NCT04987450|Protective Agents|protective agents|mesh-ancestor
14155304|NCT04987567|Antioxidants|antioxidants|mesh-list
14155305|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155306|NCT04987567|Protective Agents|protective agents|mesh-ancestor
14155307|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155308|NCT04987554|Immunoferon|immunoferon|mesh-list
14155309|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14155310|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
14155311|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155312|NCT04987242|Rasburicase|rasburicase|mesh-list
14155313|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
14155314|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155315|NCT04986982|Opicapone|opicapone|mesh-list
14155316|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14155317|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155318|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155319|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14155320|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14155321|NCT04986995|Opicapone|opicapone|mesh-list
14155322|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14155323|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155324|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155325|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14155326|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14155327|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
14155328|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14155329|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14155330|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155331|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
14155332|NCT04986813|Coagulants|coagulants|mesh-ancestor
14155333|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
14155334|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14155335|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
14155336|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155337|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
14155338|NCT04986644|Protective Agents|protective agents|mesh-ancestor
14155339|NCT04986735|Empagliflozin|empagliflozin|mesh-list
14155340|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14155341|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155342|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14938278|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14938279|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14938280|NCT01480752|Analgesics|analgesics|mesh-ancestor
14938281|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
14155343|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155344|NCT04986371|Niraparib|niraparib|mesh-list
14155345|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14155346|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155347|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155348|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155349|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14155350|NCT04986254|Meropenem|meropenem|mesh-list
14155351|NCT04986254|Tazobactam|tazobactam|mesh-list
14478923|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478924|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14478925|NCT02461589|Liraglutide|liraglutide|mesh-list
14478926|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14478927|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478928|NCT02461589|Incretins|incretins|mesh-ancestor
14155352|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
14155353|NCT04986254|Piperacillin|piperacillin|mesh-list
14155354|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14155355|NCT04986254|Penicillin G|penicillin g|mesh-list
14155356|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14155357|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
14938282|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14478929|NCT02461589|Hormones|hormones|mesh-ancestor
14478930|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478931|NCT02461693|Caffeine|caffeine|mesh-list
14478932|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14478933|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478934|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14938283|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938284|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14478935|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478936|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938285|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155358|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155359|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14155360|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155361|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155362|NCT04986319|Vitamin D|vitamin d|mesh-list
14155363|NCT04986319|Vitamins|vitamins|mesh-ancestor
14155364|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
14155365|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155366|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14155367|NCT04985890|UB-421|ub-421|mesh-list
14155368|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14155369|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
14155370|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155371|NCT04986098|Paclitaxel|paclitaxel|mesh-list
14155372|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14155373|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155374|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
14155375|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
14155376|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
14155377|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180397|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180398|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
14180399|NCT04912427|Hormones|hormones|mesh-ancestor
14180400|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180401|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14180402|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180403|NCT04905407|Azacitidine|azacitidine|mesh-list
14180404|NCT04905407|Venetoclax|venetoclax|mesh-list
14180405|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180406|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
14180407|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180408|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180409|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180410|NCT04903509|Acetaminophen|acetaminophen|mesh-list
14180411|NCT04903509|Liraglutide|liraglutide|mesh-list
14180412|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14180413|NCT04903509|Analgesics|analgesics|mesh-ancestor
14180414|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
14180415|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180416|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180417|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
14180418|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14180419|NCT04903509|Incretins|incretins|mesh-ancestor
14180420|NCT04903509|Hormones|hormones|mesh-ancestor
14180421|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180422|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
14180423|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180424|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180425|NCT04859062|Lidocaine|lidocaine|mesh-list
14180426|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
14180427|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
14180428|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180429|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180430|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
14180431|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180432|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14180433|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14180434|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14180435|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14180436|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180437|NCT04844866|Gemcitabine|gemcitabine|mesh-list
14180438|NCT04844866|Rituximab|rituximab|mesh-list
14180439|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
14180440|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14180441|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14180442|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
14180443|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180444|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180445|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
14180446|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180447|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14180448|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180449|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
14180450|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180451|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
14180452|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180453|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180454|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14180455|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14180456|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
14155378|NCT04985656|Decitabine|decitabine|mesh-list
14155379|NCT04985656|Pevonedistat|pevonedistat|mesh-list
14155380|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14155381|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
14155382|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155383|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155384|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155385|NCT04985435|Adalimumab|adalimumab|mesh-list
14155386|NCT04985435|Etanercept|etanercept|mesh-list
14155387|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155388|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155389|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14155390|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14155391|NCT04985435|Analgesics|analgesics|mesh-ancestor
14155392|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
14155393|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155394|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155395|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155396|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14155397|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
14155398|NCT04985344|Propranolol|propranolol|mesh-list
14155399|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14155400|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14155401|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
14155402|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155403|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155404|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155405|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14155406|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14155407|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
14155408|NCT04985526|Octenidine|octenidine|mesh-list
14155409|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155410|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14155411|NCT04985669|Prucalopride|prucalopride|mesh-list
14155412|NCT04985669|Laxatives|laxatives|mesh-ancestor
14155413|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155414|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14155415|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14155416|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
14155417|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155418|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155419|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155420|NCT04985500|Bupivacaine|bupivacaine|mesh-list
14155421|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
14155422|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
14155423|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14155424|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155425|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
14155426|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155427|NCT04985266|Tamoxifen|tamoxifen|mesh-list
14766409|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14155428|NCT04985266|Letrozole|letrozole|mesh-list
14155429|NCT04985266|Fulvestrant|fulvestrant|mesh-list
14155430|NCT04985266|Palbociclib|palbociclib|mesh-list
14155431|NCT04985266|Anastrozole|anastrozole|mesh-list
14155432|NCT04985266|Exemestane|exemestane|mesh-list
14155433|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155434|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14155435|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14155436|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155437|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155438|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14155439|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
14155440|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766410|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766411|NCT00625495|Esomeprazole|esomeprazole|mesh-list
14766412|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14155441|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155442|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155443|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14155444|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14155445|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14155446|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14155447|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14766413|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155448|NCT04985201|Irinotecan|irinotecan|mesh-list
14155449|NCT04985201|Simvastatin|simvastatin|mesh-list
14155450|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14155451|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14766414|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14766415|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766416|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766417|NCT00625547|Levodopa|levodopa|mesh-list
14766418|NCT00625547|Cabergoline|cabergoline|mesh-list
14766419|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14766420|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14155452|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155453|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155454|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155455|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14155456|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14155457|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
14155458|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14155459|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14155460|NCT04984759|Primaquine|primaquine|mesh-list
14155461|NCT04984759|Tafenoquine|tafenoquine|mesh-list
14155462|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
14155463|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14155464|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14155465|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155466|NCT04984980|Gemcitabine|gemcitabine|mesh-list
14155467|NCT04984980|Bevacizumab|bevacizumab|mesh-list
14155468|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
14155469|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14155470|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155471|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14155472|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14766421|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
14766422|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155473|NCT04984980|Growth Substances|growth substances|mesh-ancestor
14155474|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155475|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
14155476|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14155477|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
14155478|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155479|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
14155480|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155481|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155482|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14155483|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
14155484|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14155485|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14155486|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155487|NCT04985110|Renal Agents|renal agents|mesh-ancestor
14155488|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14155489|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
14155490|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14155491|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14155492|NCT04984408|Vaccines|vaccines|mesh-list
14155493|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
14155494|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155495|NCT04984200|Mydriatics|mydriatics|mesh-list
14155496|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
14155497|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155498|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155499|NCT04984577|Edaravone|edaravone|mesh-list
14478937|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14155500|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14478938|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14478939|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
14478940|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478941|NCT02461745|Ribavirin|ribavirin|mesh-list
14478942|NCT02461745|Ritonavir|ritonavir|mesh-list
14478943|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
14478944|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478945|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
14478946|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478947|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14478948|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14478949|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
14478950|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14478951|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14155501|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
14155502|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155503|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14155504|NCT04984577|Protective Agents|protective agents|mesh-ancestor
14155505|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155506|NCT04984278|Nabiximols|nabiximols|mesh-list
14155507|NCT04984278|Analgesics|analgesics|mesh-ancestor
14155508|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
14766423|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766424|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155509|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155510|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155511|NCT04983836|Anesthetics|anesthetics|mesh-list
14155512|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14155513|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155514|NCT04984070|Metformin|metformin|mesh-list
14155515|NCT04984070|Drospirenone|drospirenone|mesh-list
14155516|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
14155517|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14155518|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
14155519|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14155520|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14155521|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14155522|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155523|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14155524|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14155525|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14155526|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14155527|NCT04984070|Estrogens|estrogens|mesh-ancestor
14155528|NCT04984070|Hormones|hormones|mesh-ancestor
14155529|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155530|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14155531|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
14155532|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14155533|NCT04984070|Diuretics|diuretics|mesh-ancestor
14155534|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
14155535|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
14155536|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14155537|NCT04983940|Testosterone|testosterone|mesh-list
14155538|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
14155539|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
14155540|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155541|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155542|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
14155543|NCT04983940|Hormones|hormones|mesh-ancestor
14155544|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155545|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155546|NCT04983940|Androgens|androgens|mesh-ancestor
14155547|NCT04983849|Metronidazole|metronidazole|mesh-list
14155548|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155549|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14155550|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14155551|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14155552|NCT04983966|Desflurane|desflurane|mesh-list
14155553|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14155554|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
14155555|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
14155556|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14155557|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155558|NCT04983550|Doxorubicin|doxorubicin|mesh-list
14155559|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14155560|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14155561|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155562|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14155563|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14478952|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14155564|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155565|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478953|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14478954|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14478955|NCT02461758|Vaccines|vaccines|mesh-list
14478956|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
14478957|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478958|NCT02462148|Dexamethasone|dexamethasone|mesh-list
14155566|NCT04983524|Propolis|propolis|mesh-list
14155567|NCT04983524|Calcium|calcium|mesh-list
14155568|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14155569|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155570|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180457|NCT04831450|Cemiplimab|cemiplimab|mesh-list
14180458|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180459|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180460|NCT04795531|Insulin|insulin|mesh-list
14180461|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14180462|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
14180463|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14180464|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180465|NCT04737187|Trifluridine|trifluridine|mesh-list
14180466|NCT04737187|Bevacizumab|bevacizumab|mesh-list
14180467|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180468|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180469|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14180470|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14180471|NCT04737187|Growth Substances|growth substances|mesh-ancestor
14180472|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180473|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
14180474|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
14180475|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180476|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
14180477|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180478|NCT04729205|Mitomycins|mitomycins|mesh-list
14180479|NCT04729205|Mitomycin|mitomycin|mesh-list
14180480|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14180481|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180482|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
14180483|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180484|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14180485|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180486|NCT04716881|Naltrexone|naltrexone|mesh-list
14180487|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14180488|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14180489|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180490|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
14180491|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180492|NCT04706013|Pyridoxal|pyridoxal|mesh-list
14180493|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
14180494|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
14180495|NCT04706013|Vitamins|vitamins|mesh-ancestor
14180496|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
14180497|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180498|NCT04697498|Anesthetics|anesthetics|mesh-list
14180499|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180500|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180501|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
14180502|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180503|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184017|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14184018|NCT04723940|Cefadroxil|cefadroxil|mesh-list
14184019|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184020|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184021|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
14478959|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
14938286|NCT01480765|Pregabalin|pregabalin|mesh-list
14938287|NCT01480765|Ketamine|ketamine|mesh-list
14938288|NCT01480765|Analgesics|analgesics|mesh-ancestor
14938289|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
14938290|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938291|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938292|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14938293|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14938294|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
14184022|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14184023|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14184024|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14184025|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184026|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14478960|NCT02462148|Epinephrine|epinephrine|mesh-list
14478961|NCT02462148|Bupivacaine|bupivacaine|mesh-list
14478962|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14938295|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
14155571|NCT04983615|Fentanyl|fentanyl|mesh-list
14155572|NCT04983615|Midazolam|midazolam|mesh-list
14155573|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14155574|NCT04983615|Narcotics|narcotics|mesh-ancestor
14155575|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14155576|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155577|NCT04983615|Analgesics|analgesics|mesh-ancestor
14155578|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
14155579|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155580|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14155581|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14155582|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
14155583|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
14155584|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14155585|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14155586|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14155587|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14155588|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
14155589|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
14155590|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155591|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155592|NCT04983095|Hormones|hormones|mesh-list
14155593|NCT04983095|Androgens|androgens|mesh-list
14155594|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
14155595|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155596|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155597|NCT04983121|Antibodies|antibodies|mesh-list
14155598|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
14155599|NCT04983121|Mitogens|mitogens|mesh-list
14155600|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
14155601|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155602|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
14155603|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155604|NCT04983160|Allopurinol|allopurinol|mesh-list
14155605|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
14155606|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155607|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155608|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
14155609|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155610|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14155611|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
14155612|NCT04983160|Protective Agents|protective agents|mesh-ancestor
14155613|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155614|NCT04982861|Cefixime|cefixime|mesh-list
14155615|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14155616|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155617|NCT04982874|Furosemide|furosemide|mesh-list
14155618|NCT04982874|Diuretics|diuretics|mesh-ancestor
14155619|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
14155620|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155621|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14155622|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14155623|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155624|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14155625|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14155626|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155627|NCT04982705|Incretins|incretins|mesh-ancestor
14155628|NCT04982705|Hormones|hormones|mesh-ancestor
14155629|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155630|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14155631|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
14155632|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155633|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155634|NCT04982809|Dexamethasone|dexamethasone|mesh-list
14155635|NCT04982809|Prednisolone|prednisolone|mesh-list
14155636|NCT04982809|Betamethasone|betamethasone|mesh-list
14155637|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155638|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
14155639|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
14155640|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155641|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155642|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155643|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
14155644|NCT04982809|Hormones|hormones|mesh-ancestor
14155645|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155646|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155647|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155648|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14155649|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
14155650|NCT04982900|Aflutinib|aflutinib|mesh-list
14155651|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14155652|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155653|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155654|NCT04982913|Oseltamivir|oseltamivir|mesh-list
14155655|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
14155656|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155657|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155658|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155659|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
14155660|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155661|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14155662|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14155663|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
14155664|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155665|NCT04982549|Paclitaxel|paclitaxel|mesh-list
14155666|NCT04982549|Carboplatin|carboplatin|mesh-list
14155667|NCT04982549|Pemetrexed|pemetrexed|mesh-list
14155668|NCT04982549|Durvalumab|durvalumab|mesh-list
14155669|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14155670|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155671|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
14155672|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
14155673|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14155674|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155675|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155676|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14155677|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14155678|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14155679|NCT04982016|Methamphetamine|methamphetamine|mesh-list
14155680|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14155681|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155682|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
14155683|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
14155684|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155685|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
14155686|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155687|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155688|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14155689|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14155690|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14155691|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14155692|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14155693|NCT04981899|Carboplatin|carboplatin|mesh-list
14155694|NCT04981899|Nivolumab|nivolumab|mesh-list
14155695|NCT04981899|Etoposide|etoposide|mesh-list
14155696|NCT04981899|Ifosfamide|ifosfamide|mesh-list
14155697|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155698|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14155699|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14155700|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155701|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14155702|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14155703|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14155704|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155705|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14938296|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938297|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14155706|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
14155707|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
14155708|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14155709|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938298|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14938299|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938300|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155710|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155711|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14155712|NCT04981951|Analgesics|analgesics|mesh-ancestor
14155713|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
14155714|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155715|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14155716|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14155717|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14155718|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
14155719|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155720|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766425|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
14938301|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
14938302|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14938303|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766426|NCT00625560|Lamivudine|lamivudine|mesh-list
14766427|NCT00625560|Entecavir|entecavir|mesh-list
14766428|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14766429|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14766430|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766431|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766432|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
14766433|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766434|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14766435|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14766436|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14766437|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766438|NCT00625677|Vaccines|vaccines|mesh-list
14766439|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
14155736|NCT04981886|Bimatoprost|bimatoprost|mesh-list
14155737|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14155738|NCT04982055|Nadroparin|nadroparin|mesh-list
14155739|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
14155740|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14155741|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14155742|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155743|NCT04981743|Vitamin D|vitamin d|mesh-list
14155744|NCT04981743|Vitamins|vitamins|mesh-ancestor
14155745|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
14155746|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155747|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14155748|NCT04981457|Misoprostol|misoprostol|mesh-list
14155749|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14155750|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
14155751|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14155752|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155753|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14155754|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155755|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
14938304|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938305|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14938306|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14938307|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14938308|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14938309|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14938310|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14938311|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14938312|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
14938313|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13955250|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955251|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955252|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13955253|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
13955254|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955255|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955256|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13955257|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955258|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13955259|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13955260|NCT03191981|Growth Substances|growth substances|mesh-ancestor
13955261|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
14155756|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
14155757|NCT04981860|Povidone|povidone|mesh-list
14766440|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155758|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
14155759|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
14155760|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14155761|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155762|NCT04981327|Apixaban|apixaban|mesh-list
14155763|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14155764|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
14155765|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14155766|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
14155767|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155768|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155769|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
14155770|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
14155771|NCT04981379|Favipiravir|favipiravir|mesh-list
14155772|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
14155773|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14155774|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14155775|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155776|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155777|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155778|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155779|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
14155780|NCT04981392|Vaccines|vaccines|mesh-list
14155781|NCT04981392|Immunologic Factors|immunologic factors|mesh-ancestor
14155782|NCT04981392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155783|NCT04981704|Itraconazole|itraconazole|mesh-list
14155784|NCT04981704|Phenytoin|phenytoin|mesh-list
14155785|NCT04981704|Paroxetine|paroxetine|mesh-list
14155786|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
14155787|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155788|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14155789|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14155790|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155791|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155792|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14155793|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
14155794|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155795|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155796|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14155797|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14155798|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14155799|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14155800|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155801|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
14155802|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14155803|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
14155804|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14155805|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14155806|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
14155807|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14155808|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14155809|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14155810|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14180504|NCT04685421|Bupivacaine|bupivacaine|mesh-list
14180505|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
14180506|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
14180507|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180508|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180509|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
14180510|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180511|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
14180512|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14180513|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
14180514|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14180515|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
14180516|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180517|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180518|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
14180519|NCT04652960|Nivolumab|nivolumab|mesh-list
14180520|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180521|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180522|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14180523|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180524|NCT04646005|Cemiplimab|cemiplimab|mesh-list
14155811|NCT04982211|Propranolol|propranolol|mesh-list
14155812|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14155813|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14155814|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
14155815|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155816|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155817|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155818|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14155819|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14155820|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
14155821|NCT04981093|Dexamethasone|dexamethasone|mesh-list
14155822|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
14155823|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155824|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
14155825|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
14155826|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155827|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155828|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155829|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
14155830|NCT04981093|Hormones|hormones|mesh-ancestor
14155831|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155832|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155833|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766441|NCT00625781|Insulin|insulin|mesh-list
14766442|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14766443|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
14766444|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14766445|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766446|NCT00625794|Nicotine|nicotine|mesh-list
14766447|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14766448|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
14766449|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938314|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938315|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14938316|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14938317|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14766450|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766451|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14766452|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14766453|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
14766454|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766455|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766456|NCT00625859|Bupropion|bupropion|mesh-list
14766457|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14766458|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
14766459|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766460|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14766461|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14766462|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766463|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766464|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
14766465|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766466|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766467|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14766468|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14766469|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766470|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
14766471|NCT00625898|Bevacizumab|bevacizumab|mesh-list
14766472|NCT00625898|Carboplatin|carboplatin|mesh-list
14766473|NCT00625898|Docetaxel|docetaxel|mesh-list
14766474|NCT00625898|Fluorouracil|fluorouracil|mesh-list
14766475|NCT00625898|Trastuzumab|trastuzumab|mesh-list
14155834|NCT04980885|Azacitidine|azacitidine|mesh-list
14766476|NCT00625898|Epirubicin|epirubicin|mesh-list
14155835|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14155836|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
14155837|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155838|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155839|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155840|NCT04980404|Decitabine|decitabine|mesh-list
14155841|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14155842|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
14155843|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155844|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155845|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155846|NCT04980170|Amoxicillin|amoxicillin|mesh-list
14155847|NCT04980170|Clindamycin|clindamycin|mesh-list
14155848|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
14155849|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
14155850|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14155851|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
14155852|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
14155853|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14155854|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155855|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14155856|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155857|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155858|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14155859|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
14155860|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14155861|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14155862|NCT04980105|Prednisolone|prednisolone|mesh-list
14155863|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
14155864|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14155865|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
14155866|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
14155867|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155868|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
14155869|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
14155870|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155871|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155872|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155873|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
14155874|NCT04980105|Hormones|hormones|mesh-ancestor
14155875|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155876|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14155877|NCT04980105|Protective Agents|protective agents|mesh-ancestor
14155878|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155879|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155880|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14155881|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
14155882|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
14155883|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
14155884|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14155885|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14155886|NCT04979663|Gemcitabine|gemcitabine|mesh-list
14155887|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
14155888|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14155889|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
14155890|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155891|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155892|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
14155893|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155894|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155895|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14155896|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
14155897|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155898|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
14155899|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14155900|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14155901|NCT04979650|Prednisolone|prednisolone|mesh-list
14155902|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
14155903|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14155904|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
14155905|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14155906|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
14155907|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
14155908|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155909|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155910|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14155911|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
14155912|NCT04979650|Hormones|hormones|mesh-ancestor
14155913|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155914|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14155915|NCT04979650|Protective Agents|protective agents|mesh-ancestor
14155916|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14155917|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155918|NCT04979611|Exenatide|exenatide|mesh-list
14155919|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14155920|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155921|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14155922|NCT04979611|Incretins|incretins|mesh-ancestor
14155923|NCT04979611|Hormones|hormones|mesh-ancestor
14155924|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14155925|NCT04979585|Paclitaxel|paclitaxel|mesh-list
14155926|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14155927|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155928|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14155929|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
14155930|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14155931|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155932|NCT04979884|Cyclosporine|cyclosporine|mesh-list
14155933|NCT04979884|Interleukin-2|interleukin-2|mesh-list
14155934|NCT04979884|Cyclosporins|cyclosporins|mesh-list
14155935|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155936|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155937|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14155938|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
14155939|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155940|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
14155941|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155942|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
14155943|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14155944|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14155945|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155946|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14155947|NCT04979884|Analgesics|analgesics|mesh-ancestor
14155948|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
14155949|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155950|NCT04979832|Metronidazole|metronidazole|mesh-list
14155951|NCT04979832|Fosfomycin|fosfomycin|mesh-list
14155952|NCT04979832|Molgramostim|molgramostim|mesh-list
14155953|NCT04979832|Sargramostim|sargramostim|mesh-list
14155954|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155955|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14155956|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14155957|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14155958|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
14155959|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155960|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14155961|NCT04979923|Lidocaine|lidocaine|mesh-list
14155962|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
14155963|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
14155964|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14155965|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155966|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
14766477|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14478963|NCT02462148|BB 1101|bb 1101|mesh-list
14155967|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14155968|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14155969|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14155970|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14155971|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14155972|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155973|NCT04979468|Lamivudine|lamivudine|mesh-list
14155974|NCT04979468|Dolutegravir|dolutegravir|mesh-list
14155975|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14155976|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14155977|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14155978|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155979|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
14155980|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14155981|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14155982|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14155983|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14155984|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14155985|NCT04979520|Brodalumab|brodalumab|mesh-list
14155986|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
14155987|NCT04979273|Epinephrine|epinephrine|mesh-list
14155988|NCT04979273|Racepinephrine|racepinephrine|mesh-list
14155989|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
14155990|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14155991|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14155992|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
14155993|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14155994|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14155995|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14155996|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14155997|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14155998|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
14155999|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156000|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14156001|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
14156002|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
14156003|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
14156004|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14156005|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
14156006|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
14156007|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
14156008|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14156009|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14156010|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
14156011|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
14156012|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156013|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156014|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156015|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14156016|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
14156017|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14180525|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180526|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180545|NCT04633239|Olaparib|olaparib|mesh-list
14156018|NCT04979091|Hormones|hormones|mesh-list
14156019|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156020|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156021|NCT04978675|Fluorides|fluorides|mesh-list
14156022|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
14156023|NCT04978675|Protective Agents|protective agents|mesh-ancestor
14156024|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156025|NCT04978688|Relugolix|relugolix|mesh-list
14156026|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
14156027|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
14156028|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156029|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156030|NCT04978649|Amlodipine|amlodipine|mesh-list
14156031|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14156032|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14156033|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156034|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156035|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14156036|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156037|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
14156038|NCT04978597|Opicapone|opicapone|mesh-list
14156039|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14156040|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156041|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156042|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14156043|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14156044|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
14156045|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14156046|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14156047|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
14156048|NCT04978584|Prednisone|prednisone|mesh-list
14156049|NCT04978584|Cortisone|cortisone|mesh-list
14156050|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
14156051|NCT04978584|Rituximab|rituximab|mesh-list
14156052|NCT04978584|Doxorubicin|doxorubicin|mesh-list
14156053|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14156054|NCT04978584|Vincristine|vincristine|mesh-list
14156055|NCT04978584|Lenalidomide|lenalidomide|mesh-list
14156056|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
14156057|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14156058|NCT04978584|Antibodies|antibodies|mesh-list
14156059|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
14156060|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14156061|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14156062|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
14156063|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156064|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156065|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14156066|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
14156067|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156068|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156069|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14156070|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14156071|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14156072|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14156073|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156074|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156075|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
14156076|NCT04978584|Hormones|hormones|mesh-ancestor
14156077|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156078|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14156079|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14156080|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
14156081|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
14156082|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
14156083|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14156084|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14156085|NCT04978584|Growth Substances|growth substances|mesh-ancestor
14156086|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
14156087|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14156088|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14156089|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14156090|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156091|NCT04977960|Canrenone|canrenone|mesh-list
14156092|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
14156093|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14156094|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
14156095|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156096|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156097|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14156098|NCT04977960|Diuretics|diuretics|mesh-ancestor
14156099|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
14156100|NCT04978155|Anesthetics|anesthetics|mesh-list
14156101|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156102|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156103|NCT04978038|Vaccines|vaccines|mesh-list
14156104|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14156105|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
14156106|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156107|NCT04977778|Fluorides|fluorides|mesh-list
14156108|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
14156109|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
14156110|NCT04977778|Protective Agents|protective agents|mesh-ancestor
14156111|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156112|NCT04977674|Naltrexone|naltrexone|mesh-list
14156113|NCT04977674|Ketamine|ketamine|mesh-list
14156114|NCT04977674|Analgesics|analgesics|mesh-ancestor
14156115|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
14156116|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156117|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156118|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14156119|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14156120|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
14156121|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
14156122|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156123|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14156124|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14156125|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156126|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156127|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14156128|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14156129|NCT04977908|Insulin|insulin|mesh-list
14156130|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14156131|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156132|NCT04977661|Vitamin E|vitamin e|mesh-list
14156133|NCT04977661|Tocopherols|tocopherols|mesh-list
14156134|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
14156135|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
14156136|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14156137|NCT04977661|Vitamins|vitamins|mesh-ancestor
14156138|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
14156139|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156140|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
14156141|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156142|NCT04977661|Protective Agents|protective agents|mesh-ancestor
14156143|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14156144|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156145|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14156146|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14156147|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
14156148|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14156149|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14156150|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14156151|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14156152|NCT04977791|Antibodies|antibodies|mesh-list
14766478|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
14156153|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14156154|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
14156155|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156156|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156157|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156158|NCT04978051|Icatibant|icatibant|mesh-list
14766479|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766480|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14766481|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14766482|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
14766483|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766484|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180546|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14156159|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14156160|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156161|NCT04978051|Analgesics|analgesics|mesh-ancestor
14156162|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
14156163|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156164|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156165|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156166|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156167|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14156168|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14156169|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156170|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14156171|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14156172|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
14156173|NCT04977427|Prednisolone|prednisolone|mesh-list
14156174|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14156175|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
14156176|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14156177|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
14156178|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14938318|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14938319|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14938320|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14156179|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
14156180|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156181|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
14156182|NCT04977427|Hormones|hormones|mesh-ancestor
14156183|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156184|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156185|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14156186|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156187|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
14156188|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
14156189|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156190|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14156191|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14156192|NCT04977427|Protective Agents|protective agents|mesh-ancestor
14156193|NCT04977336|Acetaminophen|acetaminophen|mesh-list
14156194|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156195|NCT04977336|Analgesics|analgesics|mesh-ancestor
14156196|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
14156197|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156198|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156199|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
14156200|NCT04977544|Sertraline|sertraline|mesh-list
14156201|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
14156202|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156203|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14156204|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14156205|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156206|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156207|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156208|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
14156209|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156210|NCT04977401|Glycerol|glycerol|mesh-list
14156211|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14156212|NCT04977401|Protective Agents|protective agents|mesh-ancestor
14156213|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156214|NCT04977557|Thiamine|thiamine|mesh-list
14156215|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
14156216|NCT04977557|Vitamins|vitamins|mesh-ancestor
14156217|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
14156218|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180547|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938321|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14156219|NCT04977388|Droxidopa|droxidopa|mesh-list
14156220|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14156221|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14156222|NCT04976816|Triamcinolone|triamcinolone|mesh-list
14156223|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14156224|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14156225|NCT04976816|Betamethasone|betamethasone|mesh-list
14156226|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
14156227|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14156228|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
14156229|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14156230|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14156231|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156232|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
14156233|NCT04976816|Hormones|hormones|mesh-ancestor
14156234|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156235|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156236|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14156237|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
14156238|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156239|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156240|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14156241|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
14156257|NCT04976673|Triamcinolone|triamcinolone|mesh-list
14156258|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14156259|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14156260|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14156261|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156262|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
14156263|NCT04976673|Hormones|hormones|mesh-ancestor
14156264|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156265|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156266|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14156267|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
14156268|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156269|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156270|NCT04976543|Heparin|heparin|mesh-list
14156271|NCT04976543|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14156272|NCT04976543|Tinzaparin|tinzaparin|mesh-list
14156273|NCT04976543|Dalteparin|dalteparin|mesh-list
14156274|NCT04976543|Warfarin|warfarin|mesh-list
14156275|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
14156276|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14156277|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14156278|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156279|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14156280|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14156281|NCT04976855|Buprenorphine|buprenorphine|mesh-list
14156282|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14156283|NCT04976855|Naloxone|naloxone|mesh-list
14156284|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14156285|NCT04976855|Narcotics|narcotics|mesh-ancestor
14156286|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156287|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156288|NCT04976855|Analgesics|analgesics|mesh-ancestor
14156289|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
14156290|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156291|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14156292|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
14156293|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14156294|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156295|NCT04976088|Diclofenac|diclofenac|mesh-list
14156296|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14156297|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14156298|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156299|NCT04976088|Analgesics|analgesics|mesh-ancestor
14156300|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
14156301|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156302|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156303|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156304|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156305|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14156306|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156307|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156308|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
14156309|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14156310|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14156311|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
14156312|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14156313|NCT04975932|Estrogens|estrogens|mesh-ancestor
14156314|NCT04975932|Hormones|hormones|mesh-ancestor
14156315|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156316|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156317|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14156318|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156319|NCT04975971|Dexamethasone|dexamethasone|mesh-list
14156320|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766485|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14156321|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
14156322|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
14156323|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156324|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156325|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14156326|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
14156327|NCT04975971|Hormones|hormones|mesh-ancestor
14156328|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156329|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14156330|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156331|NCT04975724|Citalopram|citalopram|mesh-list
14156332|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14156333|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14156334|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156335|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156336|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156337|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
14156338|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156339|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14156340|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
14156341|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156342|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
14156343|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14156344|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
14156345|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156346|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
14156347|NCT04975373|Protective Agents|protective agents|mesh-ancestor
14156348|NCT04975360|Caffeine|caffeine|mesh-list
14156349|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14156350|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156351|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14156352|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156353|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156354|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14156355|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14156356|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
14156357|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156358|NCT04975022|Insulin|insulin|mesh-list
14156359|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14156360|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156361|NCT04975074|Iron|iron|mesh-list
14156362|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
14156363|NCT04975074|Trace Elements|trace elements|mesh-ancestor
14156364|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
14156365|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156366|NCT04975074|Hematinics|hematinics|mesh-ancestor
14180548|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180549|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180552|NCT04614363|Edetic Acid|edetic acid|mesh-list
14180553|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14180554|NCT04614363|Anticoagulants|anticoagulants|mesh-ancestor
14180555|NCT04614363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14180556|NCT04614363|Chelating Agents|chelating agents|mesh-ancestor
14180557|NCT04614363|Sequestering Agents|sequestering agents|mesh-ancestor
14180558|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180559|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14180560|NCT04609423|Vitamin D|vitamin d|mesh-list
14180561|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
14180562|NCT04609423|Vitamins|vitamins|mesh-ancestor
14180563|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
14180564|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180565|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14180566|NCT04593459|Metformin|metformin|mesh-list
14180567|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14180568|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180569|NCT04590495|Cannabidiol|cannabidiol|mesh-list
14180570|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
14180571|NCT04588246|Memantine|memantine|mesh-list
14180572|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14180573|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14180574|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
14180575|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180576|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180577|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180578|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14180579|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14180580|NCT04587947|Valsartan|valsartan|mesh-list
14180581|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14180582|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14180583|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14180584|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180585|NCT04579640|Vitamin D|vitamin d|mesh-list
14180586|NCT04579640|Vitamins|vitamins|mesh-ancestor
14180587|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
14180588|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180589|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14180590|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
14180591|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180592|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180593|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
14180594|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14180595|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180596|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
14180597|NCT04556773|Paclitaxel|paclitaxel|mesh-list
14180598|NCT04556773|Capecitabine|capecitabine|mesh-list
14180599|NCT04556773|Trastuzumab|trastuzumab|mesh-list
14180600|NCT04556773|Durvalumab|durvalumab|mesh-list
14180601|NCT04556773|Fulvestrant|fulvestrant|mesh-list
14180602|NCT04556773|Anastrozole|anastrozole|mesh-list
14180603|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14180604|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180605|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
14180606|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
14180607|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
14180608|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180609|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180610|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
14180611|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180612|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14180613|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14180614|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14180615|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14180616|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180617|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180618|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14180619|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14180620|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156367|NCT04974827|Carboplatin|carboplatin|mesh-list
14156368|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766486|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14766487|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14766488|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14766489|NCT00625898|Growth Substances|growth substances|mesh-ancestor
14156369|NCT04974723|Teriparatide|teriparatide|mesh-list
14156370|NCT04974723|Abaloparatide|abaloparatide|mesh-list
14156371|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14156372|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156373|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14156374|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
14156375|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
14156376|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156377|NCT04974944|Paclitaxel|paclitaxel|mesh-list
14156378|NCT04974944|Bevacizumab|bevacizumab|mesh-list
14156379|NCT04974944|Carboplatin|carboplatin|mesh-list
14156380|NCT04974944|Apatinib|apatinib|mesh-list
14156381|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14156382|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156383|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
14156384|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
14156385|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
14156386|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156387|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14156388|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14156389|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14156390|NCT04974944|Growth Substances|growth substances|mesh-ancestor
14156391|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156392|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
14156393|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14156394|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156395|NCT04974580|Nicotine|nicotine|mesh-list
14156396|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14156397|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
14156398|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156399|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156400|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14156401|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14156402|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
14156403|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156404|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156405|NCT04974814|Atorvastatin|atorvastatin|mesh-list
14156406|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14156407|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14156408|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14156409|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
14156410|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156411|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14156412|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14156413|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156414|NCT04974281|Lenvatinib|lenvatinib|mesh-list
14156415|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156416|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14156417|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156418|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156419|NCT04974385|Bupivacaine|bupivacaine|mesh-list
14156420|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
14156421|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
14156422|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156423|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156424|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
14156425|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156426|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14156427|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
14156428|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156429|NCT04974060|Remifentanil|remifentanil|mesh-list
14156430|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14156431|NCT04974060|Narcotics|narcotics|mesh-ancestor
14156432|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156433|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156434|NCT04974060|Analgesics|analgesics|mesh-ancestor
14156435|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
14156436|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156437|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14156438|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
14156439|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14156440|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
14156441|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14156442|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156443|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14156444|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14156445|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156446|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
14156447|NCT04973904|Paclitaxel|paclitaxel|mesh-list
14156448|NCT04973904|Bevacizumab|bevacizumab|mesh-list
14156449|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14156450|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156451|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
14156452|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
14156453|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14156454|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156455|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14156456|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14156457|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14156458|NCT04973904|Growth Substances|growth substances|mesh-ancestor
14156459|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156460|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
14156461|NCT04973462|Oseltamivir|oseltamivir|mesh-list
14156462|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
14156463|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14156464|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156465|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156466|NCT04973722|Denosumab|denosumab|mesh-list
14156467|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14156468|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156469|NCT04973579|Anesthetics|anesthetics|mesh-list
14156470|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156471|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156472|NCT04973033|Tofacitinib|tofacitinib|mesh-list
14156473|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14156474|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156475|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156476|NCT04973319|Trastuzumab|trastuzumab|mesh-list
14156477|NCT04973319|Pertuzumab|pertuzumab|mesh-list
14156478|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14156479|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156480|NCT04972942|Daratumumab|daratumumab|mesh-list
14156481|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156482|NCT04973293|Bevacizumab|bevacizumab|mesh-list
14156483|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14156484|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156485|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14156486|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14156487|NCT04973293|Growth Substances|growth substances|mesh-ancestor
14156488|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156489|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
14156490|NCT04972656|Ambrisentan|ambrisentan|mesh-list
14156491|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14156492|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
14156493|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14156494|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
14156495|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156496|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
14156497|NCT04972383|Protective Agents|protective agents|mesh-ancestor
13955262|NCT03191903|Triamcinolone|triamcinolone|mesh-list
13955263|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13955264|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13955265|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13955266|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955267|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
13955268|NCT03191903|Hormones|hormones|mesh-ancestor
13955269|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955270|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955271|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955272|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
13955273|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955274|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156498|NCT04972617|Furosemide|furosemide|mesh-list
14156499|NCT04972617|Diuretics|diuretics|mesh-ancestor
14156500|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
14156501|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156502|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14156503|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156504|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180621|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
14180622|NCT04555603|Avelumab|avelumab|mesh-list
14180623|NCT04555603|Axitinib|axitinib|mesh-list
14180624|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180625|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180626|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14180627|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180628|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180629|NCT04542148|Insulin|insulin|mesh-list
14180630|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14180631|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
14180632|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
14180633|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14180634|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180635|NCT04514484|Nivolumab|nivolumab|mesh-list
14180636|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180637|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180638|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14180639|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180640|NCT04502433|Poractant alfa|poractant alfa|mesh-list
14180641|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14180642|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
14180643|NCT04491032|Anesthetics|anesthetics|mesh-list
14180644|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180645|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180646|NCT04482959|Carbetocin|carbetocin|mesh-list
14180647|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
14180648|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14180649|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180650|NCT04472767|Nivolumab|nivolumab|mesh-list
14180651|NCT04472767|Ipilimumab|ipilimumab|mesh-list
14180652|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180653|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180654|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14180655|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180656|NCT04458909|Gemcitabine|gemcitabine|mesh-list
14180657|NCT04458909|Cisplatin|cisplatin|mesh-list
14180658|NCT04458909|Carboplatin|carboplatin|mesh-list
14180659|NCT04458909|Nivolumab|nivolumab|mesh-list
14180660|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180661|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180662|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
14180663|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180664|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
14180665|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180666|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180667|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14180668|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
14180669|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180670|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180671|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14184027|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14184028|NCT04723940|Renal Agents|renal agents|mesh-ancestor
14184029|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
14184030|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14184031|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14184032|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184033|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
14184034|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14184035|NCT04723875|Paclitaxel|paclitaxel|mesh-list
14184036|NCT04723875|Docetaxel|docetaxel|mesh-list
14184037|NCT04723875|Carboplatin|carboplatin|mesh-list
14184038|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14184039|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184040|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
14184041|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14184042|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14184043|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184044|NCT04723862|Spironolactone|spironolactone|mesh-list
14766490|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
14156505|NCT04972292|Dipyrone|dipyrone|mesh-list
14156506|NCT04972292|Codeine|codeine|mesh-list
14156507|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14156508|NCT04972292|Narcotics|narcotics|mesh-ancestor
14156509|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156510|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156511|NCT04972292|Analgesics|analgesics|mesh-ancestor
14156512|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
14156513|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156514|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
14156515|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
14156516|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14156517|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156518|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156519|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156520|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
14156521|NCT04972123|Phenylephrine|phenylephrine|mesh-list
14156522|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
14156523|NCT04972123|Caffeine|caffeine|mesh-list
14156524|NCT04972123|Capsaicin|capsaicin|mesh-list
14156525|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14156526|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156527|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14156528|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156529|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156530|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14156531|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14156532|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
14156533|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156534|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14156535|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
14156536|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
14156537|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156538|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
14156539|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14156540|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
14156541|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
14156542|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14156543|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14156544|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14156545|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
14156546|NCT04972123|Protective Agents|protective agents|mesh-ancestor
14156547|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
14156548|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
14156549|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
14156550|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
14156551|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14156552|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
14156553|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156554|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156555|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14156556|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
14156557|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14156558|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
14156559|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156560|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156561|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14156562|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
14156563|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
14156564|NCT04972513|Protective Agents|protective agents|mesh-ancestor
14156565|NCT04972032|Estrogens|estrogens|mesh-list
14156566|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
14766491|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14766492|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14766493|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14156567|NCT04972032|Hormones|hormones|mesh-ancestor
14156568|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156569|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156570|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14766494|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
14766495|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766496|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14766497|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14156571|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
14156572|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
14156573|NCT04972032|Protective Agents|protective agents|mesh-ancestor
14766498|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14156574|NCT04972045|Curcumin|curcumin|mesh-list
14156575|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14156576|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156577|NCT04972045|Analgesics|analgesics|mesh-ancestor
14156578|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
14156579|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766499|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766500|NCT00625911|Ketamine|ketamine|mesh-list
14766501|NCT00625911|Morphine|morphine|mesh-list
14766502|NCT00625911|Analgesics|analgesics|mesh-ancestor
14156580|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156581|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156582|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156583|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156584|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156585|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156586|NCT04971759|Fentanyl|fentanyl|mesh-list
14156587|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
14156588|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
14156589|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14156590|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156591|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156592|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156593|NCT04971759|Analgesics|analgesics|mesh-ancestor
14156594|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
14156595|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156596|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14156597|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14156598|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14156599|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
14156600|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156601|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156602|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14156603|NCT04971759|Narcotics|narcotics|mesh-ancestor
14156604|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14156605|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14156606|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
14156607|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
14156608|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
14156609|NCT04971343|Antibodies|antibodies|mesh-list
14156610|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
14156611|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
14156612|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156613|NCT04971356|Aspirin|aspirin|mesh-list
14156614|NCT04971356|Ticagrelor|ticagrelor|mesh-list
14156615|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14156616|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156617|NCT04971356|Analgesics|analgesics|mesh-ancestor
14156618|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
14156619|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156620|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156621|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156622|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156623|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14156624|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14156625|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156626|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14156627|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14156628|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156629|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
14156630|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14156631|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14156632|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14156633|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
14156634|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156635|NCT04971382|Curcumin|curcumin|mesh-list
14156636|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14156637|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156638|NCT04971382|Analgesics|analgesics|mesh-ancestor
14156639|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
14156640|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156641|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156642|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156643|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156644|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766503|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
14156645|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156646|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156647|NCT04971577|Simvastatin|simvastatin|mesh-list
14156648|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14156649|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14156650|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
14156651|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156652|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14156653|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14156654|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156655|NCT04971304|Sargramostim|sargramostim|mesh-list
14156656|NCT04971304|Lenograstim|lenograstim|mesh-list
14156657|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
14156658|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156659|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14156660|NCT04971291|Bupropion|bupropion|mesh-list
14156661|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14156662|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
14156663|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156664|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14156665|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14156666|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156667|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156668|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
14156669|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156670|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156671|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14156672|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14156673|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156674|NCT04971239|Methotrexate|methotrexate|mesh-list
14156675|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14156676|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
14156677|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14156678|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156679|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14156680|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
14156681|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156682|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156683|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
14156684|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156685|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14156686|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14156687|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
14156688|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156689|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14156690|NCT04970719|Remdesivir|remdesivir|mesh-list
14156691|NCT04970719|Dexamethasone|dexamethasone|mesh-list
14156692|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14156693|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14156694|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
14156695|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
14156696|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156697|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156698|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14156699|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
14156700|NCT04970719|Hormones|hormones|mesh-ancestor
14156701|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156702|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14156703|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156704|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
14156705|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156706|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
14156707|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14156708|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14156709|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156710|NCT04970576|Warfarin|warfarin|mesh-list
14156711|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
14156712|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
14156713|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14156714|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
14156715|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14156716|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
14156717|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766504|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156718|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156719|NCT04970667|Flupenthixol|flupenthixol|mesh-list
14156720|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14156721|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14156722|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14156723|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156724|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156725|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156726|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14156727|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
14156728|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156729|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156730|NCT04970602|Methylene Blue|methylene blue|mesh-list
14156731|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156732|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156733|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14156734|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14156735|NCT04970251|Aflibercept|aflibercept|mesh-list
14156736|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14156737|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14156738|NCT04970251|Growth Substances|growth substances|mesh-ancestor
14156739|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156740|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
14156741|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156742|NCT04970069|Analgesics|analgesics|mesh-list
14156743|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
14156744|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156745|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180672|NCT04438330|Nickel|nickel|mesh-list
14180673|NCT04438330|Trace Elements|trace elements|mesh-ancestor
14180674|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
14180675|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180676|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
14180677|NCT04429893|Bupivacaine|bupivacaine|mesh-list
14180678|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
14180679|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
14180680|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180681|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180682|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
14180683|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180684|NCT04429893|Analgesics|analgesics|mesh-ancestor
14180685|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14180686|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
14180687|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14180688|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14180689|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180690|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14180691|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
14180692|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14180693|NCT04417257|Fenretinide|fenretinide|mesh-list
14180694|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180695|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14180696|NCT04417257|Protective Agents|protective agents|mesh-ancestor
14180697|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180698|NCT04410653|Afatinib|afatinib|mesh-list
14180699|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180700|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14180701|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180702|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180703|NCT04408638|Gemcitabine|gemcitabine|mesh-list
14180704|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
14180705|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
14180706|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180707|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
14180708|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180709|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180710|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
14180711|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180712|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180713|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14180714|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
14180715|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180716|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180717|NCT04403516|Dexamethasone|dexamethasone|mesh-list
14180718|NCT04403516|Prednisolone|prednisolone|mesh-list
14156746|NCT04970303|Methylphenidate|methylphenidate|mesh-list
14156747|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14156748|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156749|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14156750|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14156751|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156752|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156753|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
14156754|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156755|NCT04970108|Empagliflozin|empagliflozin|mesh-list
14156756|NCT04970108|Telmisartan|telmisartan|mesh-list
14156757|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14156758|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14156759|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14156760|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156761|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14156762|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14156763|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156764|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14156765|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14156766|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14156767|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156768|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156769|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156770|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156771|NCT04970121|Analgesics|analgesics|mesh-ancestor
14156772|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
14156773|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156774|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
14156775|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156776|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
14156777|NCT04970329|Dextrans|dextrans|mesh-list
14156778|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
14156779|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
14156780|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
14156781|NCT04970238|Simendan|simendan|mesh-list
14156782|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14156783|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
14156784|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14156785|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14156786|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156787|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156788|NCT04970238|Protective Agents|protective agents|mesh-ancestor
14156789|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156790|NCT04970342|Alprazolam|alprazolam|mesh-list
14156791|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156792|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156793|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156794|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156795|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14156796|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156797|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14156798|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14156799|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
14156800|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
14156801|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
14156802|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14156803|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
14156804|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14156805|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
14156806|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156807|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156808|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
14156809|NCT04970043|Pemetrexed|pemetrexed|mesh-list
14156810|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156811|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156812|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156813|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14156814|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14156815|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
14156816|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14156817|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156818|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156819|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156820|NCT04969705|Analgesics|analgesics|mesh-ancestor
14156821|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
14156822|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156823|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14156824|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14156825|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14156826|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14156827|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156828|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156829|NCT04969263|Vaccines|vaccines|mesh-list
14156830|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
14156831|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156832|NCT04969211|Iloperidone|iloperidone|mesh-list
14156833|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14156834|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14156835|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156836|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156837|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156838|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
14156839|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14156840|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14156841|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
14156842|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156843|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156844|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156845|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
14156846|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
14156847|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
14156848|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156849|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156850|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
14156851|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156852|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
14156853|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14156854|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
14156855|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156856|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766505|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156857|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
14156858|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156859|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156860|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
14156861|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
14156862|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14766506|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14156863|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156864|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156865|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156866|NCT04968392|Analgesics|analgesics|mesh-ancestor
14156867|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
14156868|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156869|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14156870|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14156871|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14156872|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
14156873|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156874|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156875|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
14156876|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
14156877|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14156878|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14156879|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14156880|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
14156881|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156882|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156883|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14156884|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
14156885|NCT04968132|Narcotics|narcotics|mesh-ancestor
14156886|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156887|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156888|NCT04968132|Analgesics|analgesics|mesh-ancestor
14156889|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
14156890|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156891|NCT04968002|Apatinib|apatinib|mesh-list
14156892|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156893|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14156894|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156895|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156896|NCT04967859|Gentamicins|gentamicins|mesh-list
14156897|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14156898|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14156899|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14156900|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156901|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180719|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14180720|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
14180721|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14180722|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
14180723|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14180724|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
14180725|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14180726|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
14180727|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
14180728|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180729|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180730|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180731|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
14180732|NCT04403516|Hormones|hormones|mesh-ancestor
14180733|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180734|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14180735|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180736|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14180737|NCT04403516|Protective Agents|protective agents|mesh-ancestor
14766507|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14766508|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
14766509|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
14766510|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766511|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14766512|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14766513|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766514|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180747|NCT04383639|Locust bean gum|locust bean gum|mesh-list
14180748|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
14180749|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180750|NCT04353492|Ofatumumab|ofatumumab|mesh-list
14180751|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180752|NCT04349722|Scopolamine|scopolamine|mesh-list
14180753|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14156902|NCT04968054|Propofol|propofol|mesh-list
14156903|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14156904|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156905|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156906|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14156907|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
14156908|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
14156909|NCT04967469|Calcitriol|calcitriol|mesh-list
14156910|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
14156911|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14156912|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14156913|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156914|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14156915|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156916|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156917|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14156918|NCT04967469|Vitamins|vitamins|mesh-ancestor
14156919|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
14156920|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14156921|NCT04967950|Methotrexate|methotrexate|mesh-list
13955275|NCT03191721|Triclosan|triclosan|mesh-list
13955276|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
14156922|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14156923|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14156924|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
14156925|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14156926|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156927|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14156928|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
14180754|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13955277|NCT03191721|Fluorides|fluorides|mesh-list
13955278|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
13955279|NCT03191721|Protective Agents|protective agents|mesh-ancestor
13955280|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955281|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13955282|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13955283|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13955284|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
13955285|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955286|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13955287|NCT03191539|Apremilast|apremilast|mesh-list
13955288|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955289|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955290|NCT03191539|Analgesics|analgesics|mesh-ancestor
13955291|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
13955292|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156929|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156930|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156931|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
14156932|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156933|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14156934|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14156935|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
14156936|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14156937|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14156938|NCT04967326|Carbamazepine|carbamazepine|mesh-list
14156939|NCT04967326|Phenytoin|phenytoin|mesh-list
14156940|NCT04967326|Valproic Acid|valproic acid|mesh-list
14156941|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
14156942|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156943|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156944|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
14156945|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14156946|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156947|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
14156948|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14156949|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14156950|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14156951|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14156952|NCT04967326|Analgesics|analgesics|mesh-ancestor
14156953|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
14156954|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14156955|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14156956|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14156957|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14156958|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14156959|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14156960|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14156961|NCT04967417|Paclitaxel|paclitaxel|mesh-list
13955293|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955294|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955295|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955296|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13955297|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13955298|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955299|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955300|NCT03191461|Adenosine|adenosine|mesh-list
13955301|NCT03191461|Analgesics|analgesics|mesh-ancestor
13955302|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
13955303|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955304|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955305|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13955306|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
13955307|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13955308|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
13955309|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
14156962|NCT04967417|Carboplatin|carboplatin|mesh-list
14156963|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
14156964|NCT04967417|Pemetrexed|pemetrexed|mesh-list
14156965|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14156966|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156967|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14156968|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14156969|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14156970|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156971|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14156972|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156973|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14156974|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14156975|NCT04967196|Nivolumab|nivolumab|mesh-list
14156976|NCT04967196|Ipilimumab|ipilimumab|mesh-list
14156977|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14156978|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156979|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14766515|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14766516|NCT00625911|Narcotics|narcotics|mesh-ancestor
14766517|NCT00625937|Docetaxel|docetaxel|mesh-list
14766518|NCT00625937|Tegafur|tegafur|mesh-list
14766519|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766520|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14156980|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156981|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
14156982|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14156983|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
14156984|NCT04967495|Sorafenib|sorafenib|mesh-list
14156985|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
14156986|NCT04967495|Lenvatinib|lenvatinib|mesh-list
14156987|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14156988|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14156989|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14156990|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14156991|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14156992|NCT04967495|Estrogens|estrogens|mesh-ancestor
14156993|NCT04967495|Hormones|hormones|mesh-ancestor
14156994|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14156995|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14156996|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14156997|NCT04966702|Ivermectin|ivermectin|mesh-list
14156998|NCT04966702|Albendazole|albendazole|mesh-list
14156999|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14157000|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157001|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
14157002|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
14766521|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14766522|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14766523|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766524|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766525|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
14766526|NCT00626015|Temozolomide|temozolomide|mesh-list
14766527|NCT00626015|Daclizumab|daclizumab|mesh-list
14766528|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14478964|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14478965|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
14478966|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
14478967|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766529|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
14766530|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157003|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14157004|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14157005|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
14157006|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14157007|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14157008|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157009|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157010|NCT04966676|Nivolumab|nivolumab|mesh-list
14157011|NCT04966676|Ipilimumab|ipilimumab|mesh-list
14157012|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14478968|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478969|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14478970|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
14478971|NCT02462148|Hormones|hormones|mesh-ancestor
14478972|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14478973|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14766531|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157013|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157014|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14157015|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157016|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
14157017|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
14157018|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157019|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
14157020|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157021|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157022|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14157023|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14157024|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157025|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157026|NCT04966507|Listerine|listerine|mesh-list
14157027|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14157028|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157029|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
14157030|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
14157031|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157032|NCT04966299|Erythritol|erythritol|mesh-list
14157033|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
14157034|NCT04966234|Posaconazole|posaconazole|mesh-list
14157035|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
14157036|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157037|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14157038|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14157039|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14157040|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14157041|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14157042|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157043|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157044|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14157045|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
14157046|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157047|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157048|NCT04966429|Maraviroc|maraviroc|mesh-list
14157049|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14157050|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14157051|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157052|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14157053|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14157054|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
14157055|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157056|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14157057|NCT04965818|Futibatinib|futibatinib|mesh-list
14157058|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180755|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
14180756|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
14180757|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180758|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180759|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180760|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
14180761|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14180762|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
14180763|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180764|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180765|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14180766|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
14180767|NCT04313972|Naltrexone|naltrexone|mesh-list
14180768|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14180769|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14180770|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180771|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
14180772|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180773|NCT04310020|Atezolizumab|atezolizumab|mesh-list
14180774|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14180775|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180776|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
14180777|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180778|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
14180779|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14180780|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
14180781|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14180782|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157059|NCT04965831|Aflutinib|aflutinib|mesh-list
14157060|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14157061|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157062|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157063|NCT04965545|Copper|copper|mesh-list
14157064|NCT04965545|Trace Elements|trace elements|mesh-ancestor
14157065|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
14157066|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157067|NCT04965532|Anesthetics|anesthetics|mesh-list
14157068|NCT04965532|Propofol|propofol|mesh-list
14157069|NCT04965532|Sevoflurane|sevoflurane|mesh-list
14157070|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157071|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157072|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14157073|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14157074|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
14157075|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14157076|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14157077|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
14157078|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157079|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157080|NCT04965701|Osimertinib|osimertinib|mesh-list
14157081|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157082|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14157083|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157084|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157085|NCT04965662|Tenofovir|tenofovir|mesh-list
14157086|NCT04965662|Emtricitabine|emtricitabine|mesh-list
14157087|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14157088|NCT04965662|Maraviroc|maraviroc|mesh-list
14157089|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
14157090|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157091|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14157092|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14157093|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157094|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157095|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14157096|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14157097|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14157098|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14157099|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14157100|NCT04965181|Nicotine|nicotine|mesh-list
14157101|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14157102|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
14157103|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157104|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157105|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14157106|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14157107|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
14157108|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157109|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157110|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
14157111|NCT04965116|Progestins|progestins|mesh-list
14157112|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14157113|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157114|NCT04965116|Hormones|hormones|mesh-ancestor
14157115|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157116|NCT04965298|Lansoprazole|lansoprazole|mesh-list
14157117|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
14157118|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14157119|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14157120|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14157121|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157122|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157123|NCT04965324|Anesthetics|anesthetics|mesh-list
14157124|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157125|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157126|NCT04965051|Insulin|insulin|mesh-list
14157127|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14157128|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
14157129|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14157130|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157131|NCT04964869|Epinephrine|epinephrine|mesh-list
14157132|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14157133|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14157134|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
14157135|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157136|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157137|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157138|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14157139|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14157140|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
14157141|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157142|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14157143|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
14157144|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
14157145|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
14157146|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14157147|NCT04964583|Azithromycin|azithromycin|mesh-list
14157148|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
14157149|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14157150|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157151|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
14157152|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14157153|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14157154|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157155|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157156|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14157157|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
14157158|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157159|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157160|NCT04964505|Azacitidine|azacitidine|mesh-list
14157161|NCT04964505|Venetoclax|venetoclax|mesh-list
14157162|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14157163|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
14157164|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157165|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157166|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157167|NCT04964180|Indomethacin|indomethacin|mesh-list
14157168|NCT04964180|Lidocaine|lidocaine|mesh-list
14157169|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
14157170|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
14157171|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157172|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157173|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
14157174|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157175|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14157176|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14157177|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14157178|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766532|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766533|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
14766534|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766535|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14766536|NCT00626080|Insulin|insulin|mesh-list
14766537|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14766538|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
14157179|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157180|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14157181|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14157182|NCT04964180|Analgesics|analgesics|mesh-ancestor
14157183|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14157184|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14157185|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
14157186|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
14157187|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14157188|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14157189|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157190|NCT04964427|Methylphenidate|methylphenidate|mesh-list
14157191|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14157192|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157193|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14157194|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14157195|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766539|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
14766540|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
14766541|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
14766542|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14766543|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766544|NCT00626158|Gemcitabine|gemcitabine|mesh-list
14157196|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157197|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
14157198|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157199|NCT04964414|Budesonide|budesonide|mesh-list
14157200|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
14157201|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14157202|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14157203|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
14157204|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157205|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157206|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14157207|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
14157208|NCT04964414|Hormones|hormones|mesh-ancestor
14157209|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157210|NCT04964219|Ketamine|ketamine|mesh-list
14157211|NCT04964219|Esketamine|esketamine|mesh-list
14157212|NCT04964219|Analgesics|analgesics|mesh-ancestor
14157213|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
14157214|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157215|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157216|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14157217|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14157218|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
14157219|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
14157220|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157221|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14157222|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14157223|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157224|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157225|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
14157226|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14157227|NCT04964089|Aflibercept|aflibercept|mesh-list
14157228|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14157229|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14157230|NCT04964089|Growth Substances|growth substances|mesh-ancestor
14157231|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157232|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14157233|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157234|NCT04964024|Antibodies|antibodies|mesh-list
14157235|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
14157236|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157237|NCT04963998|Copper|copper|mesh-list
14157238|NCT04963998|Trace Elements|trace elements|mesh-ancestor
14157239|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
14157240|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180783|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14180784|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
14180785|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14180786|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
14180787|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180788|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180789|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14180790|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
14180791|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
14180792|NCT04306393|Protective Agents|protective agents|mesh-ancestor
14180793|NCT04302454|Leuprolide|leuprolide|mesh-list
14180794|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14180795|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
14180796|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14180797|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180798|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14180799|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180800|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
14180801|NCT04284787|Azacitidine|azacitidine|mesh-list
14180802|NCT04284787|Venetoclax|venetoclax|mesh-list
14180803|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180804|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180805|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180806|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
14180807|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180808|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180809|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14180810|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
14180811|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14180812|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14157241|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14157242|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157243|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157244|NCT04963764|Amoxicillin|amoxicillin|mesh-list
14157245|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14157246|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157247|NCT04963712|Thymalfasin|thymalfasin|mesh-list
14157248|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14157249|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
14157250|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157251|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
14157252|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
14157253|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14157254|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157255|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157256|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
14157257|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14157258|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157259|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157260|NCT04963881|Antibodies|antibodies|mesh-list
14157261|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
14157262|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157263|NCT04963595|Vinorelbine|vinorelbine|mesh-list
14157264|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14157265|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157266|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
14157267|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
14157268|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
14157269|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157270|NCT04963257|Aripiprazole|aripiprazole|mesh-list
14157271|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
14157272|NCT04963257|Sertraline|sertraline|mesh-list
14157273|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
14157274|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14157275|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14157276|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14157277|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157278|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157279|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
14157280|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
14157281|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157282|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157283|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14157284|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14157285|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
14157286|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14157287|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14157288|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14157289|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14157290|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14157291|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14157292|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14157293|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14157294|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14157295|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14157296|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14157297|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157298|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14157299|NCT04963088|Capecitabine|capecitabine|mesh-list
14157300|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
14157301|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14157302|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
14157303|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157304|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157305|NCT04962672|Anesthetics|anesthetics|mesh-list
14157306|NCT04962672|Propofol|propofol|mesh-list
14157307|NCT04962672|Sevoflurane|sevoflurane|mesh-list
14157308|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157309|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157310|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14157311|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14157312|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
14157313|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14157314|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14157315|NCT04962893|Vaccines|vaccines|mesh-list
14157316|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
14157317|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157318|NCT04962958|Leucovorin|leucovorin|mesh-list
14157319|NCT04962958|Fluorouracil|fluorouracil|mesh-list
14157320|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
14157321|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
14157322|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157323|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14157324|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157325|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14157326|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
14157327|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157328|NCT04962958|Antidotes|antidotes|mesh-ancestor
14157329|NCT04962958|Protective Agents|protective agents|mesh-ancestor
14157330|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
14157331|NCT04962958|Vitamins|vitamins|mesh-ancestor
14157332|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
14157333|NCT04962841|Metformin|metformin|mesh-list
14157334|NCT04962841|Amlodipine|amlodipine|mesh-list
14157335|NCT04962841|Ramipril|ramipril|mesh-list
14157336|NCT04962841|Nebivolol|nebivolol|mesh-list
14157337|NCT04962841|Rivastigmine|rivastigmine|mesh-list
14157338|NCT04962841|Sertraline|sertraline|mesh-list
14157339|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14157340|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157341|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14157342|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14157343|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14157344|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157345|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14157346|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
14157347|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
14157348|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14157349|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14157350|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14938322|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14157351|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157352|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
14157353|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14157354|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
14157355|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157356|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14157357|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14157358|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14157359|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
14938323|NCT01480791|Diuretics|diuretics|mesh-ancestor
14938324|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
14938325|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938326|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14938327|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938328|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157360|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14157361|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
14157362|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14157363|NCT04962841|Protective Agents|protective agents|mesh-ancestor
14157364|NCT04962425|Trastuzumab|trastuzumab|mesh-list
14157365|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157366|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157367|NCT04962451|Ticagrelor|ticagrelor|mesh-list
14157368|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14157369|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14157370|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14157371|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14157372|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
14157373|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157374|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157375|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157376|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14157377|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14157378|NCT04962386|Hormones|hormones|mesh-list
14157379|NCT04962386|Estradiol|estradiol|mesh-list
14157380|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14157381|NCT04962386|Progesterone|progesterone|mesh-list
14157382|NCT04962386|Estrogens|estrogens|mesh-list
14157383|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157384|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157385|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14157386|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
14157387|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14157388|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14157389|NCT04962386|Progestins|progestins|mesh-ancestor
14157390|NCT04962308|Vaccines|vaccines|mesh-list
14157391|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
14157392|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157393|NCT04962438|Bevacizumab|bevacizumab|mesh-list
14157394|NCT04962438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157395|NCT04962438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157396|NCT04962438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14157397|NCT04962438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14157398|NCT04962438|Growth Substances|growth substances|mesh-ancestor
14157399|NCT04962438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157400|NCT04962438|Growth Inhibitors|growth inhibitors|mesh-ancestor
14157401|NCT04962152|Nalbuphine|nalbuphine|mesh-list
14157402|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14157403|NCT04962152|Narcotics|narcotics|mesh-ancestor
14157404|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157405|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157406|NCT04962152|Analgesics|analgesics|mesh-ancestor
14157407|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
14157408|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157409|NCT04961970|Leucovorin|leucovorin|mesh-list
14157410|NCT04961970|Gemcitabine|gemcitabine|mesh-list
14157411|NCT04961970|Fluorouracil|fluorouracil|mesh-list
14157412|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
14157413|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157414|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14157415|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
14157416|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157417|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
14157418|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157419|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157420|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14157421|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
14157422|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157423|NCT04961970|Antidotes|antidotes|mesh-ancestor
14157424|NCT04961970|Protective Agents|protective agents|mesh-ancestor
14157425|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
14157426|NCT04961970|Vitamins|vitamins|mesh-ancestor
14157427|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
14157428|NCT04961684|Amorolfine|amorolfine|mesh-list
14157429|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
14157430|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157431|NCT04961918|Durvalumab|durvalumab|mesh-list
14157432|NCT04961918|Lenvatinib|lenvatinib|mesh-list
14157433|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157434|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157435|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14157436|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157437|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157438|NCT04961931|Empagliflozin|empagliflozin|mesh-list
14157439|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14157440|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157441|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14157442|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157443|NCT04961788|Antibodies|antibodies|mesh-list
14157444|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
14157445|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180813|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14180814|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14180815|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180816|NCT04277442|Nivolumab|nivolumab|mesh-list
14180817|NCT04277442|Decitabine|decitabine|mesh-list
14180818|NCT04277442|Venetoclax|venetoclax|mesh-list
14180819|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180820|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180821|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14180822|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180823|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180824|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
14180825|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180826|NCT04275232|Plasminogen|plasminogen|mesh-list
14180827|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14180828|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14180829|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180830|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14180831|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14180832|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14180833|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180834|NCT04248712|Loratadine|loratadine|mesh-list
14180835|NCT04248712|Famotidine|famotidine|mesh-list
14180836|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14180837|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180838|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14180839|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
14180840|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
14180841|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14180842|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180843|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180844|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
14180845|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
14180846|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14180847|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14180848|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14180849|NCT04225819|Vitamin D|vitamin d|mesh-list
14180850|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
14180851|NCT04225819|Vitamins|vitamins|mesh-ancestor
14180852|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
14180853|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180854|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14180855|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14180856|NCT04214249|Cytarabine|cytarabine|mesh-list
14180857|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
14180858|NCT04214249|Daunorubicin|daunorubicin|mesh-list
14180859|NCT04214249|Idarubicin|idarubicin|mesh-list
14180860|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180861|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180862|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14180863|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
14180864|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180865|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
14180866|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180867|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14180868|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
14180869|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180870|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14180871|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14180872|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14180873|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180874|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
14180875|NCT04213794|Cisplatin|cisplatin|mesh-list
14180876|NCT04213794|Doxorubicin|doxorubicin|mesh-list
14180877|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14180878|NCT04213794|Daunorubicin|daunorubicin|mesh-list
14180879|NCT04213794|Antidotes|antidotes|mesh-list
14180880|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157446|NCT04961632|Tamoxifen|tamoxifen|mesh-list
14157447|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14157448|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
14157449|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157450|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157451|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14157452|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157453|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14157454|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14157455|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14157456|NCT04961359|Vaccines|vaccines|mesh-list
14157457|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
14157458|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157459|NCT04961268|Acetaminophen|acetaminophen|mesh-list
14157460|NCT04961268|Ibuprofen|ibuprofen|mesh-list
14157461|NCT04961268|Tramadol|tramadol|mesh-list
14157462|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14157463|NCT04961268|Analgesics|analgesics|mesh-ancestor
14157464|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
14157465|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157466|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157467|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
14157468|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14157469|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14157470|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14157471|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14157472|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157473|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157474|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14157475|NCT04961268|Narcotics|narcotics|mesh-ancestor
14157476|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157477|NCT04961554|Anesthetics|anesthetics|mesh-list
14157478|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157479|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157480|NCT04961502|Vaccines|vaccines|mesh-list
14157481|NCT04961502|Immunologic Factors|immunologic factors|mesh-ancestor
14157482|NCT04961502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157483|NCT04961307|Trastuzumab|trastuzumab|mesh-list
14157484|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157485|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157486|NCT04961528|Terlipressin|terlipressin|mesh-list
14157487|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
14157488|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14157489|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14157490|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157491|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
14157492|NCT04961528|Coagulants|coagulants|mesh-ancestor
14157493|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14157494|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14157495|NCT04961138|Lenvatinib|lenvatinib|mesh-list
14157496|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157497|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14157498|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157499|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157500|NCT04960943|Trastuzumab|trastuzumab|mesh-list
14766545|NCT00626158|Capecitabine|capecitabine|mesh-list
14766546|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766547|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
14766548|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766549|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766550|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
14766551|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766552|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766553|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766554|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
14766555|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766556|NCT00626223|Folic Acid|folic acid|mesh-list
14766557|NCT00626223|Hematinics|hematinics|mesh-ancestor
14766558|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
14766559|NCT00626223|Vitamins|vitamins|mesh-ancestor
14157501|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157502|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766560|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
14766561|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157503|NCT04960618|Gemcitabine|gemcitabine|mesh-list
14766562|NCT00626262|Esomeprazole|esomeprazole|mesh-list
14157504|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
14157505|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14157506|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
14157507|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157508|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157509|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
14157510|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157511|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157512|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14157513|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
14157514|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157515|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157516|NCT04960657|Glyburide|glyburide|mesh-list
14157517|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
14157518|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14157519|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157520|NCT04960657|Growth Substances|growth substances|mesh-ancestor
14157521|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
14157522|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157523|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157524|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14157525|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
14157526|NCT04960293|Coagulants|coagulants|mesh-ancestor
14157527|NCT04959721|Triamcinolone|triamcinolone|mesh-list
14157528|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14157529|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14157530|NCT04959721|Bupivacaine|bupivacaine|mesh-list
14157531|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14157532|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
14157533|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
14157534|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157535|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157536|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
14157537|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157538|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14157539|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
14157540|NCT04959721|Hormones|hormones|mesh-ancestor
14157541|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157542|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14157543|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
14157544|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157545|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157546|NCT04959786|Ribavirin|ribavirin|mesh-list
14157547|NCT04959786|Ivermectin|ivermectin|mesh-list
14157548|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
14157549|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
14157550|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157551|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
14157552|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157553|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14180881|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14180882|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14180883|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14180884|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180885|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180886|NCT04213794|Protective Agents|protective agents|mesh-ancestor
14180887|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180888|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
14180889|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
14180890|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14180891|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14180892|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
14180893|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
14180894|NCT04201756|Afatinib|afatinib|mesh-list
14180895|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766563|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14766564|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766565|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14180896|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14180897|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180898|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180899|NCT04199624|Ascorbic Acid|ascorbic acid|mesh-list
14180900|NCT04199624|Omeprazole|omeprazole|mesh-list
14180901|NCT04199624|Vitamins|vitamins|mesh-ancestor
14180902|NCT04199624|Micronutrients|micronutrients|mesh-ancestor
14766566|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766567|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766568|NCT00626288|Mesalamine|mesalamine|mesh-list
14766569|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14766570|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14766571|NCT00626288|Analgesics|analgesics|mesh-ancestor
14766572|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
14766573|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157554|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
14157555|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
14766574|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766575|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766576|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14766577|NCT00626483|Basiliximab|basiliximab|mesh-list
14766578|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14157556|NCT04959578|Hematinics|hematinics|mesh-ancestor
14157557|NCT04959591|Acetaminophen|acetaminophen|mesh-list
14157558|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14157559|NCT04959591|Analgesics|analgesics|mesh-ancestor
14157560|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
14157561|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157562|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157563|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
14157564|NCT04959331|Fosfomycin|fosfomycin|mesh-list
14157565|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
14157566|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
14157567|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14157568|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157569|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14157570|NCT04959331|Renal Agents|renal agents|mesh-ancestor
14157571|NCT04959253|Psilocybin|psilocybin|mesh-list
14157572|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
14157573|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157574|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14157575|NCT04959500|Temozolomide|temozolomide|mesh-list
14157576|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14157577|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
14157578|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157579|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157580|NCT04959409|Tetracaine|tetracaine|mesh-list
14157581|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
14157582|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
14157583|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157584|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157585|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
14157586|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157587|NCT04958746|Propofol|propofol|mesh-list
14157588|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14157589|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157590|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157591|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14157592|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
14157593|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
14157594|NCT04958486|Trastuzumab|trastuzumab|mesh-list
14157595|NCT04958486|Azacitidine|azacitidine|mesh-list
14157596|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157597|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157598|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14157599|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
14157600|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157601|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157602|NCT04958187|Mitogens|mitogens|mesh-list
14157603|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
14157604|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157605|NCT04958473|Axitinib|axitinib|mesh-list
14157606|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157607|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14157608|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157609|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157610|NCT04957940|SMOFlipid|smoflipid|mesh-list
14157611|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14766579|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
14157612|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14157613|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14157614|NCT04958122|Penicillins|penicillins|mesh-list
14157615|NCT04958122|Cefixime|cefixime|mesh-list
14157616|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14157617|NCT04958122|Penicillin G|penicillin g|mesh-list
14157618|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
14157619|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14157620|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157621|NCT04957927|Fluticasone|fluticasone|mesh-list
14157622|NCT04957927|Xhance|xhance|mesh-list
14157623|NCT04957927|Montelukast|montelukast|mesh-list
14157624|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14157625|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14157626|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
14157627|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157628|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157629|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14157630|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
14157631|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
14157632|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14157633|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14157634|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
14157635|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157636|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14157637|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14157638|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180903|NCT04199624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180904|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14180905|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14180906|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14180907|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180908|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180909|NCT04199624|Antioxidants|antioxidants|mesh-ancestor
14180910|NCT04199624|Protective Agents|protective agents|mesh-ancestor
14766580|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766581|NCT00626509|Sunitinib|sunitinib|mesh-list
14766582|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766583|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14766584|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14766585|NCT00626509|Growth Substances|growth substances|mesh-ancestor
14766586|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766587|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
14766588|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14766589|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766590|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180922|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
14180923|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14180924|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
14180925|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180926|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
14180927|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180928|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180929|NCT04154943|Cemiplimab|cemiplimab|mesh-list
14180930|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180931|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180932|NCT04138706|Vancomycin|vancomycin|mesh-list
14180933|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14180934|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766591|NCT00626535|Esomeprazole|esomeprazole|mesh-list
14766592|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14766593|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766594|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14766595|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766596|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766597|NCT00626600|Oxycodone|oxycodone|mesh-list
14766598|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14766599|NCT00626600|Narcotics|narcotics|mesh-ancestor
14766600|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766601|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766602|NCT00626600|Analgesics|analgesics|mesh-ancestor
14766603|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
14766604|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766605|NCT00626613|Risperidone|risperidone|mesh-list
14766606|NCT00626613|Galantamine|galantamine|mesh-list
14766607|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14157639|NCT04957615|Nivolumab|nivolumab|mesh-list
14157640|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157641|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157642|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14157643|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157644|NCT04957420|Rotigotine|rotigotine|mesh-list
14157645|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
14157646|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
14157647|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157648|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157649|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157650|NCT04957329|Latanoprost|latanoprost|mesh-list
14157651|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14157652|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14157653|NCT04957212|Carboplatin|carboplatin|mesh-list
14157654|NCT04957212|Docetaxel|docetaxel|mesh-list
14157655|NCT04957212|Trastuzumab|trastuzumab|mesh-list
14157656|NCT04957212|Pertuzumab|pertuzumab|mesh-list
14157657|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157658|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
14157659|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
14157660|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
14157661|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157662|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157663|NCT04956939|Levodopa|levodopa|mesh-list
14157664|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14157665|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14157666|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
14157667|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157668|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157669|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157670|NCT04956432|Allopurinol|allopurinol|mesh-list
14157671|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
14157672|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157673|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157674|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
14157675|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14157676|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14157677|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
14157678|NCT04956432|Protective Agents|protective agents|mesh-ancestor
14157679|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157680|NCT04956419|Fluconazole|fluconazole|mesh-list
14157681|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
14157682|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157683|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14157684|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14157685|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157686|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157687|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14157688|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
14157689|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14157690|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157691|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14157692|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14157693|NCT04956705|Vitamin D|vitamin d|mesh-list
14157694|NCT04956705|Calcium|calcium|mesh-list
14157695|NCT04956705|Vitamins|vitamins|mesh-ancestor
14157696|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
14157697|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157698|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14157699|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14157700|NCT04956484|Belimumab|belimumab|mesh-list
14157701|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14157702|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
14157703|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157704|NCT04956094|Uric Acid|uric acid|mesh-list
14157705|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
14157706|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157707|NCT04956094|Protective Agents|protective agents|mesh-ancestor
14157708|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157709|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
14766608|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
14157710|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14157711|NCT04955678|Sorbitol|sorbitol|mesh-list
14157712|NCT04955678|Calcium|calcium|mesh-list
14766609|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157713|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14157714|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157715|NCT04955678|Cathartics|cathartics|mesh-ancestor
14157716|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14157717|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14157718|NCT04955574|Metronidazole|metronidazole|mesh-list
14157719|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14157720|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157721|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
14157722|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14157723|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14157724|NCT04955834|Insulin|insulin|mesh-list
14157725|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14157726|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157727|NCT04955470|Midazolam|midazolam|mesh-list
14157728|NCT04955470|Ketamine|ketamine|mesh-list
14157729|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14157730|NCT04955470|Analgesics|analgesics|mesh-ancestor
14157731|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
14157732|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157733|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157734|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14157735|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14157736|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
14157737|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
14157738|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157739|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14157740|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14157741|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157742|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157743|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14157744|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14157745|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14157746|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14157747|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14157748|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
14157749|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
14766610|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938329|NCT01480817|Sorafenib|sorafenib|mesh-list
14184045|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14184046|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
14184047|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184048|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184049|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14184050|NCT04723862|Diuretics|diuretics|mesh-ancestor
14184051|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
14184052|NCT04723563|Heparin|heparin|mesh-list
14184053|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
14184054|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14184055|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14184056|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184057|NCT04723472|Cefuroxime|cefuroxime|mesh-list
14184058|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
14184059|NCT04723472|Bismuth|bismuth|mesh-list
14184060|NCT04723472|Antacids|antacids|mesh-ancestor
14184061|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184062|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14184063|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184064|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184065|NCT04723147|Levodopa|levodopa|mesh-list
14184066|NCT04723147|Carbidopa|carbidopa|mesh-list
14184067|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14184068|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14184069|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14184070|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
14184071|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184072|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184073|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184074|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14184075|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184076|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14184077|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
14184078|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
14184079|NCT04723342|Blinatumomab|blinatumomab|mesh-list
14184080|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184081|NCT04723459|Ivermectin|ivermectin|mesh-list
14157750|NCT04955262|Nivolumab|nivolumab|mesh-list
14157751|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157752|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157753|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14157754|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157755|NCT04955366|Abatacept|abatacept|mesh-list
14157756|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14157757|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157758|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157759|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14157760|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
14157761|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157762|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14157763|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
14157764|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
14157765|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
14157766|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157767|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157768|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14157769|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14157770|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
14157771|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
14157772|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157773|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157774|NCT04954560|Losartan|losartan|mesh-list
14157775|NCT04954560|Eprosartan|eprosartan|mesh-list
14157776|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14157777|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14157778|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14157779|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14157780|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157781|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14157782|NCT04954599|Carboplatin|carboplatin|mesh-list
14157783|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
14157784|NCT04954599|Nivolumab|nivolumab|mesh-list
14157785|NCT04954599|Ipilimumab|ipilimumab|mesh-list
14157786|NCT04954599|Atezolizumab|atezolizumab|mesh-list
14157787|NCT04954599|Durvalumab|durvalumab|mesh-list
14157788|NCT04954599|Avelumab|avelumab|mesh-list
14157789|NCT04954599|Cemiplimab|cemiplimab|mesh-list
14157790|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14157791|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157792|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157793|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157794|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14157795|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
14157796|NCT04954638|Eusol|eusol|mesh-list
13955310|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955311|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955312|NCT03191383|Vaccines|vaccines|mesh-list
13955313|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
13955314|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938330|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157797|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
14157798|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157799|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
14157800|NCT04953754|Melatonin|melatonin|mesh-list
14157801|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
14157802|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157803|NCT04953754|Protective Agents|protective agents|mesh-ancestor
14157804|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157805|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157806|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
14157807|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13955315|NCT03191370|Anesthetics|anesthetics|mesh-list
13955316|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
13955317|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13955318|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955319|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
13955320|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13962984|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13962985|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13962986|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13962987|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14157808|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157809|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14157810|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14157811|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157812|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157813|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157814|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14157815|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14157816|NCT04953741|Fluticasone|fluticasone|mesh-list
14157817|NCT04953741|Xhance|xhance|mesh-list
14157818|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14157819|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14157820|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
14157821|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157822|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157823|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14157824|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
14157825|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
14157826|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14157827|NCT04954014|Bevacizumab|bevacizumab|mesh-list
14157828|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157829|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157830|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14157831|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14157832|NCT04954014|Growth Substances|growth substances|mesh-ancestor
14157833|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157834|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
14157835|NCT04954040|Azithromycin|azithromycin|mesh-list
14157836|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
14157837|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14157838|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157839|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
14157840|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14157841|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14157842|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157843|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157844|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14180955|NCT04123470|Atezolizumab|atezolizumab|mesh-list
14180956|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180957|NCT04084769|Vaccines|vaccines|mesh-list
14180958|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
14180959|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180960|NCT04082754|Antibodies|antibodies|mesh-list
14180961|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14180962|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
14180963|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766611|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766612|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14938331|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938332|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938333|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938334|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
14938335|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
14938336|NCT01480869|Calcium|calcium|mesh-list
14938337|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938338|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938339|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14766613|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14766614|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766615|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766616|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14180970|NCT04074343|Irinotecan|irinotecan|mesh-list
14180971|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14180972|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14180973|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180974|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180975|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180976|NCT04069117|Letrozole|letrozole|mesh-list
14180977|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180978|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14180979|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14180980|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14180981|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14180982|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14180983|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
14938340|NCT01480869|Vitamins|vitamins|mesh-ancestor
14157845|NCT04953117|Paclitaxel|paclitaxel|mesh-list
14157846|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14157847|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157848|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14157849|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14157850|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14157851|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157852|NCT04953130|Vaccines|vaccines|mesh-list
14157853|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
14157854|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157855|NCT04953104|Nivolumab|nivolumab|mesh-list
14157856|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157857|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157858|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14157859|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157860|NCT04952792|Apixaban|apixaban|mesh-list
14157861|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14157862|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
14157863|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14157864|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
14157865|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157866|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157867|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
14157868|NCT04952571|Bevacizumab|bevacizumab|mesh-list
14157869|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14157870|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157871|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14157872|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14157873|NCT04952571|Growth Substances|growth substances|mesh-ancestor
14157874|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157875|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
14157876|NCT04952519|Amantadine|amantadine|mesh-list
14157877|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14157878|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14157879|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
14157880|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157881|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
14157882|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157883|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157884|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157885|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14157886|NCT04952519|Analgesics|analgesics|mesh-ancestor
14157887|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
14157888|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938341|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
14938342|NCT01480986|Irinotecan|irinotecan|mesh-list
14938343|NCT01480986|Octreotide|octreotide|mesh-list
14938344|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938345|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14938346|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14938347|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938348|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938349|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938350|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14938351|NCT01481194|Dexamethasone|dexamethasone|mesh-list
14938352|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
14938353|NCT01481194|Doxorubicin|doxorubicin|mesh-list
14938354|NCT01481194|Lenalidomide|lenalidomide|mesh-list
14938355|NCT01481194|Bortezomib|bortezomib|mesh-list
14938356|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938357|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
14938358|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938359|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14938360|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14938361|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
14938362|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938363|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938364|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14938365|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938366|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
14938367|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
14938368|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157889|NCT04952194|Levodopa|levodopa|mesh-list
14157890|NCT04952194|Carbidopa|carbidopa|mesh-list
14157891|NCT04952194|Entacapone|entacapone|mesh-list
14938369|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938370|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
14157892|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14157893|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14157894|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
14157895|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157896|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157897|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157898|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14157899|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157900|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14157901|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
14157902|NCT04952207|Grazoprevir|grazoprevir|mesh-list
14157903|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
14157904|NCT04952207|Ledipasvir|ledipasvir|mesh-list
14157905|NCT04952207|Velpatasvir|velpatasvir|mesh-list
14157906|NCT04952207|Asunaprevir|asunaprevir|mesh-list
14157907|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157908|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
14157909|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157910|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157911|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
14157912|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14157913|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
14157914|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157915|NCT04951856|Evolocumab|evolocumab|mesh-list
14157916|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14157917|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14157918|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
14157919|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157920|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14157921|NCT04952129|Selenium|selenium|mesh-list
14157922|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
14157923|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
14157924|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157925|NCT04952129|Protective Agents|protective agents|mesh-ancestor
14157926|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157927|NCT04952129|Trace Elements|trace elements|mesh-ancestor
14157928|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
14157929|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14157930|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14157931|NCT04952051|Folic Acid|folic acid|mesh-list
14157932|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
14157933|NCT04952051|Amlodipine|amlodipine|mesh-list
14157934|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14157935|NCT04952051|Enalapril|enalapril|mesh-list
14938371|NCT01481194|Hormones|hormones|mesh-ancestor
14938372|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955321|NCT03191162|Benzonidazole|benzonidazole|mesh-list
14157936|NCT04952051|Enalaprilat|enalaprilat|mesh-list
14157937|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14157938|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14157939|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14157940|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157941|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14157942|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157943|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
14157944|NCT04952051|Diuretics|diuretics|mesh-ancestor
14157945|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
14157946|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14157947|NCT04952051|Hematinics|hematinics|mesh-ancestor
14157948|NCT04952051|Vitamins|vitamins|mesh-ancestor
14157949|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
14157950|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13955322|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13955323|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
13955324|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955325|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13955326|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13955327|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13955328|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955329|NCT03191305|Warfarin|warfarin|mesh-list
13955330|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
13955331|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
13955332|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
13955333|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955334|NCT03190798|Canagliflozin|canagliflozin|mesh-list
13955335|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14157951|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
14157952|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157953|NCT04951791|SMOFlipid|smoflipid|mesh-list
14157954|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14157955|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14157956|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14157957|NCT04951713|Clarithromycin|clarithromycin|mesh-list
14157958|NCT04951713|Rifampin|rifampin|mesh-list
14157959|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14157960|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157961|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14157962|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157963|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157964|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14157965|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14157966|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14157967|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
14157968|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
14157969|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14157970|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14157971|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14157972|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14157973|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14157974|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14157975|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14180984|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14180985|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180986|NCT04061252|Brodalumab|brodalumab|mesh-list
14180987|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
14180988|NCT04041232|Glycerol|glycerol|mesh-list
14180989|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14180990|NCT04041232|Protective Agents|protective agents|mesh-ancestor
14180991|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14180992|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
14180993|NCT04040361|Ramucirumab|ramucirumab|mesh-list
14180994|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14180995|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14180996|NCT04025372|Bicalutamide|bicalutamide|mesh-list
14180997|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
14180998|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
14180999|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181000|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181001|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181002|NCT04024228|Vaccines|vaccines|mesh-list
14181003|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
14181004|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
14181005|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181006|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
14181007|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14181008|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14181009|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14181010|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14181011|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14181012|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14181013|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14181014|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
14181015|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14181016|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181017|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181018|NCT03997266|Gentamicins|gentamicins|mesh-list
14181019|NCT03997266|Ampicillin|ampicillin|mesh-list
14181020|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14181021|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181022|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14181023|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181024|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181025|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
14181026|NCT03996148|Remifentanil|remifentanil|mesh-list
14181027|NCT03996148|Propofol|propofol|mesh-list
14181028|NCT03996148|Desflurane|desflurane|mesh-list
14181029|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14181030|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14181031|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181032|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14157976|NCT04951752|Ropivacaine|ropivacaine|mesh-list
14157977|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
14157978|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
14157979|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14157980|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157981|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
14157982|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157983|NCT04951505|Cefepime|cefepime|mesh-list
14157984|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14157985|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14157986|NCT04951726|Neostigmine|neostigmine|mesh-list
14157987|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14157988|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14157989|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14157990|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
14157991|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14157992|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14157993|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14157994|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
14157995|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14157996|NCT04951349|Petrolatum|petrolatum|mesh-list
14157997|NCT04951349|Emollients|emollients|mesh-ancestor
14157998|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14157999|NCT04951167|Norepinephrine|norepinephrine|mesh-list
14158000|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14158001|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14158002|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
14158003|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158004|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158005|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938373|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14158006|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
14158007|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
14158008|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158009|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14158010|NCT04950933|Riluzole|riluzole|mesh-list
14158011|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
14158012|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14158013|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14158014|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158015|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158016|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158017|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14158018|NCT04950933|Protective Agents|protective agents|mesh-ancestor
14158019|NCT04951128|Anesthetics|anesthetics|mesh-list
14158020|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
14158021|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
14938374|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14938375|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14938376|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14938377|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938378|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14938379|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14938380|NCT01481194|Growth Substances|growth substances|mesh-ancestor
14938381|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
14938382|NCT01481233|Colchicine|colchicine|mesh-list
14938383|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
14938384|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14938385|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938386|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938387|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
14938388|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158022|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158023|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158024|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14158025|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14158026|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158027|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
14158028|NCT04951128|Coagulants|coagulants|mesh-ancestor
14158029|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
14158030|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158031|NCT04951232|Cinepazide|cinepazide|mesh-list
14158032|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
14938389|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938390|NCT01481259|Pemetrexed|pemetrexed|mesh-list
14158033|NCT04951115|Carboplatin|carboplatin|mesh-list
14158034|NCT04951115|Etoposide|etoposide|mesh-list
14158035|NCT04951115|Durvalumab|durvalumab|mesh-list
14158036|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158037|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14158038|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14158039|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14158040|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158041|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158042|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14158043|NCT04950569|Simendan|simendan|mesh-list
14158044|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14158045|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
14158046|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14158047|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14158048|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158049|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158050|NCT04950569|Protective Agents|protective agents|mesh-ancestor
14158051|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158052|NCT04950621|Propofol|propofol|mesh-list
14158053|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14158054|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158055|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158056|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14158057|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
14158058|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
14158059|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
14158060|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158061|NCT04950205|Sevoflurane|sevoflurane|mesh-list
14158062|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14158063|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14158064|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
14158065|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
14158066|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158067|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158068|NCT04950049|Dexamethasone|dexamethasone|mesh-list
14158069|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
14158070|NCT04950049|BB 1101|bb 1101|mesh-list
14158071|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158072|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
14158073|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
14158074|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158075|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158076|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14158077|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
14158078|NCT04950049|Hormones|hormones|mesh-ancestor
14158079|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158080|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14158081|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158082|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
14158083|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158084|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158085|NCT04950400|Apatinib|apatinib|mesh-list
14158086|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158087|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158088|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158089|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158090|NCT04950530|Emtricitabine|emtricitabine|mesh-list
14158091|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
14158092|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158093|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14158094|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14158095|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158096|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158097|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14158098|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14158099|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
14158100|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
14158101|NCT04950270|Coagulants|coagulants|mesh-ancestor
14158102|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14158103|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14158104|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
14158105|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158106|NCT04949867|Glucagon|glucagon|mesh-list
14158107|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14158108|NCT04949867|Hormones|hormones|mesh-ancestor
14158109|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158110|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158111|NCT04949932|Turmeric extract|turmeric extract|mesh-list
14158112|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
14158113|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158114|NCT04949932|Protective Agents|protective agents|mesh-ancestor
14158115|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158116|NCT04949464|Nicotine|nicotine|mesh-list
14158117|NCT04949464|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14158118|NCT04949464|Autonomic Agents|autonomic agents|mesh-ancestor
14158119|NCT04949464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158120|NCT04949464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158121|NCT04949464|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14158122|NCT04949464|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14158123|NCT04949464|Cholinergic Agents|cholinergic agents|mesh-ancestor
14158124|NCT04949464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158125|NCT04949464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158126|NCT04949516|Aspirin|aspirin|mesh-list
14158127|NCT04949516|Colchicine|colchicine|mesh-list
14158128|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14938391|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158129|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158130|NCT04949516|Analgesics|analgesics|mesh-ancestor
14158131|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
14158132|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158133|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158134|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158135|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158136|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14158137|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14158138|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158139|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14158140|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14158141|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158142|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
14158143|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
14158144|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
14158145|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
14158146|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
14158147|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181033|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
14181034|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
14181035|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14181036|NCT03996148|Analgesics|analgesics|mesh-ancestor
14181037|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
14181038|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181039|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14181040|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14181041|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14181042|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
14181043|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14181044|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181045|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14181046|NCT03996148|Narcotics|narcotics|mesh-ancestor
14181047|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14158148|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14158149|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14158150|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158151|NCT04949113|Nivolumab|nivolumab|mesh-list
14158152|NCT04949113|Ipilimumab|ipilimumab|mesh-list
14158153|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14158154|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158155|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14158156|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158157|NCT04949347|Glycerol|glycerol|mesh-list
14158158|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14158159|NCT04949347|Protective Agents|protective agents|mesh-ancestor
14158160|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158161|NCT04949477|Acetaminophen|acetaminophen|mesh-list
14158162|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
14158163|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14158164|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158165|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158166|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158167|NCT04949477|Analgesics|analgesics|mesh-ancestor
14158168|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
14158169|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158170|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14158171|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14158172|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14158173|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
14158174|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158175|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158176|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
14158177|NCT04948814|Vancomycin|vancomycin|mesh-list
14158178|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14158179|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158180|NCT04948749|Sirolimus|sirolimus|mesh-list
14158181|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14158182|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158183|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14158184|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158185|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
14158186|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158187|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
14158188|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158189|NCT04948788|Gemcitabine|gemcitabine|mesh-list
14158190|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
14158191|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158192|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
14158193|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158194|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158195|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
14158196|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158197|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158198|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158199|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
14158200|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158201|NCT04948697|Bevacizumab|bevacizumab|mesh-list
14158202|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14158203|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158204|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14158205|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14158206|NCT04948697|Growth Substances|growth substances|mesh-ancestor
14158207|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158208|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
14158209|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
14158210|NCT04948957|Esmolol|esmolol|mesh-list
14158211|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
14158212|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14158213|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14158214|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14158215|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
14158216|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158217|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158218|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158219|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
14158220|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14158221|NCT04948801|Velpatasvir|velpatasvir|mesh-list
14158222|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
14158223|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158224|NCT04948489|Norethindrone|norethindrone|mesh-list
14158225|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
14158226|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14158227|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14158228|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14158229|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
14158230|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14938392|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938393|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938394|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14158231|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158232|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14158233|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14158234|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
14158235|NCT04948567|Analgesics|analgesics|mesh-ancestor
14158236|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
14158237|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158238|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158239|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
14158240|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158241|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14158242|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
14158243|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14158244|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14158245|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158246|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14158247|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
14158248|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14158249|NCT04948203|Sirolimus|sirolimus|mesh-list
14158250|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14158251|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158252|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14158253|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158254|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
14158255|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158256|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
14158257|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158258|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
14766617|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
14766618|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14766619|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766620|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
14766621|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14766622|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
14158259|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
14158260|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
14158261|NCT04948125|Apatinib|apatinib|mesh-list
14158262|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158263|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158264|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158265|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158266|NCT04948385|Propofol|propofol|mesh-list
14158267|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14158268|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158269|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158270|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14158271|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
14158272|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
14158273|NCT04948372|Terlipressin|terlipressin|mesh-list
14158274|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14158275|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14158276|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14158277|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158278|NCT04948164|Naproxen|naproxen|mesh-list
14158279|NCT04948164|Sumatriptan|sumatriptan|mesh-list
14158280|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14158281|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158282|NCT04948164|Analgesics|analgesics|mesh-ancestor
14158283|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
14766623|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766624|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
14766625|NCT00626665|Tadalafil|tadalafil|mesh-list
14766626|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
14766627|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14158284|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158285|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158286|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158287|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158288|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
14158289|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14158290|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158291|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158292|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14158293|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14158294|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14158295|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
14158296|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158297|NCT04947956|Apatinib|apatinib|mesh-list
14158298|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158299|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158300|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158301|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158302|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
14158303|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
14158304|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14158305|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14158306|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158307|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158308|NCT04948151|Urological Agents|urological agents|mesh-ancestor
14158309|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
14158310|NCT04947501|Ifosfamide|ifosfamide|mesh-list
14158311|NCT04947501|Carboplatin|carboplatin|mesh-list
14158312|NCT04947501|Doxorubicin|doxorubicin|mesh-list
14158313|NCT04947501|Etoposide|etoposide|mesh-list
14158314|NCT04947501|Vincristine|vincristine|mesh-list
14158315|NCT04947501|Topotecan|topotecan|mesh-list
14158316|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158317|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
14158318|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158319|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158320|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14158321|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
14158322|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158323|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158324|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14158325|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14158326|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14158327|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14158328|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158329|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14158330|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
14158331|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
14158332|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
14158333|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14158334|NCT04947826|Antibodies|antibodies|mesh-list
14158335|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
14158336|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
14158337|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158338|NCT04947566|Ibuprofen|ibuprofen|mesh-list
14158339|NCT04947566|Naproxen|naproxen|mesh-list
14158340|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14158341|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158342|NCT04947566|Analgesics|analgesics|mesh-ancestor
14158343|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
14158344|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158345|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158346|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158347|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158348|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14158349|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158350|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158351|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
14158352|NCT04947423|Scopolamine|scopolamine|mesh-list
14158353|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14158354|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
14158355|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
14158356|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158357|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158358|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14158359|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
14158360|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14158361|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
14158362|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158363|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158364|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14181048|NCT03972280|Antibodies|antibodies|mesh-list
14181049|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14181050|NCT03972280|Sargramostim|sargramostim|mesh-list
14181051|NCT03972280|Lenograstim|lenograstim|mesh-list
14181052|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
14181053|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181054|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14181055|NCT03940131|Panitumumab|panitumumab|mesh-list
14181056|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181057|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181058|NCT03914300|Nivolumab|nivolumab|mesh-list
14181059|NCT03914300|Ipilimumab|ipilimumab|mesh-list
14181060|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181061|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181062|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14181063|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181064|NCT03912818|Gemcitabine|gemcitabine|mesh-list
14181065|NCT03912818|Carboplatin|carboplatin|mesh-list
14181066|NCT03912818|Doxorubicin|doxorubicin|mesh-list
14181067|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14181068|NCT03912818|Methotrexate|methotrexate|mesh-list
14181069|NCT03912818|Durvalumab|durvalumab|mesh-list
14181070|NCT03912818|Daunorubicin|daunorubicin|mesh-list
14181071|NCT03912818|Vinblastine|vinblastine|mesh-list
14181072|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181073|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181074|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
14766628|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14181075|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181076|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
14181077|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181078|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181079|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181080|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
14181081|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181082|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14181083|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14181084|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14181085|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14181086|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
14181087|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14181088|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
14181089|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14181090|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14181091|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14181092|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181093|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14181094|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
14181095|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
14181096|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
14181097|NCT03906539|Atorvastatin|atorvastatin|mesh-list
14181098|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14181099|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14181100|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
14181101|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181102|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14766629|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766630|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766631|NCT00626665|Urological Agents|urological agents|mesh-ancestor
14766632|NCT00626678|Prednisone|prednisone|mesh-list
14766633|NCT00626678|Azathioprine|azathioprine|mesh-list
14766634|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766635|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
14766636|NCT00626678|Hormones|hormones|mesh-ancestor
14766637|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766638|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766639|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14766640|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766641|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
14767449|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158365|NCT04947267|Epinephrine|epinephrine|mesh-list
14158366|NCT04947267|Mepivacaine|mepivacaine|mesh-list
14158367|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14158368|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14158369|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
14158370|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158371|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158372|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158373|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14158374|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14158375|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
14158376|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158377|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14158378|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
14158379|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
14158380|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
14158381|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14158382|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
14158383|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
14158384|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158385|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
14158386|NCT04947111|Antibodies|antibodies|mesh-list
14158387|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
14158388|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
14158389|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
14158390|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158391|NCT04946929|Heparin|heparin|mesh-list
14158392|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14158393|NCT04946929|Tinzaparin|tinzaparin|mesh-list
14158394|NCT04946929|Dalteparin|dalteparin|mesh-list
14158395|NCT04946929|Ticagrelor|ticagrelor|mesh-list
14158396|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
14158397|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14158398|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14158399|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158400|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14158401|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14158402|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14158403|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14158404|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
14158405|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158406|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158407|NCT04947345|Propofol|propofol|mesh-list
14158408|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14158409|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158410|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158411|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14158412|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
14158413|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
14158414|NCT04947189|Dexamethasone|dexamethasone|mesh-list
14158415|NCT04947189|Docetaxel|docetaxel|mesh-list
14158416|NCT04947189|Seviteronel|seviteronel|mesh-list
14158417|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158418|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
14158419|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
14158420|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158421|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158422|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14158423|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
14158424|NCT04947189|Hormones|hormones|mesh-ancestor
14158425|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158426|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14158427|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158428|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
14158429|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
14158430|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
14158431|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158432|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14158433|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158434|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
14158435|NCT04947254|Prednisone|prednisone|mesh-list
14158436|NCT04947254|Cortisone|cortisone|mesh-list
14766642|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158437|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
14158438|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
14158439|NCT04947254|Niraparib|niraparib|mesh-list
14158440|NCT04947254|Hormones|hormones|mesh-list
14158441|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14158442|NCT04947254|Androgens|androgens|mesh-list
14158443|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
14158444|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158445|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
14158446|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766643|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766644|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766645|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
14766646|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14766647|NCT00626717|Riboflavin|riboflavin|mesh-list
14766648|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
14766649|NCT00626717|Vitamins|vitamins|mesh-ancestor
14766650|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
14766651|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766652|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14766653|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14766654|NCT00626769|Genistein|genistein|mesh-list
14766655|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14766656|NCT00626769|Protective Agents|protective agents|mesh-ancestor
14766657|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766658|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766659|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158447|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158448|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14158449|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158450|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14158451|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158452|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158453|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
14158454|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14158455|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
14158456|NCT04947254|Protective Agents|protective agents|mesh-ancestor
14158457|NCT04947254|Vitamins|vitamins|mesh-ancestor
14158458|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
14158459|NCT04947254|Estrogens|estrogens|mesh-ancestor
14158460|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
14158461|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14158462|NCT04947241|Gemcitabine|gemcitabine|mesh-list
14158463|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14158464|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158465|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158466|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
14158467|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158468|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
14158469|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158470|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158471|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158472|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
14158473|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158474|NCT04946825|Nicotine|nicotine|mesh-list
14158475|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14158476|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
14158477|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158478|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158479|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14158480|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14158481|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
14158482|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158483|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158484|NCT04946864|Palbociclib|palbociclib|mesh-list
14158485|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158486|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158487|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158488|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158489|NCT04946734|Aspirin|aspirin|mesh-list
14158490|NCT04946734|Clopidogrel|clopidogrel|mesh-list
14158491|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14158492|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158493|NCT04946734|Analgesics|analgesics|mesh-ancestor
14158494|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
14158495|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158496|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158497|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766660|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158498|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158499|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14158500|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14158501|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158502|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14158503|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14158504|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158505|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
14158506|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14158507|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14158508|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14158509|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
14158510|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158511|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14158512|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
14158513|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14158514|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158515|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14158516|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14158517|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14158518|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158519|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
14158520|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158521|NCT04946669|Abatacept|abatacept|mesh-list
14158522|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14158523|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158524|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158525|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158526|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
14158527|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158528|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158529|NCT04946383|Dasatinib|dasatinib|mesh-list
14158530|NCT04946383|Quercetin|quercetin|mesh-list
14158531|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158532|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158533|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158534|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158535|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
14158536|NCT04946383|Protective Agents|protective agents|mesh-ancestor
14158537|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158538|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
14158539|NCT04946370|Edetic Acid|edetic acid|mesh-list
14158540|NCT04946370|Androgens|androgens|mesh-list
14158541|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14158542|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14158543|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158544|NCT04946370|Hormones|hormones|mesh-ancestor
14158545|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158546|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158547|NCT04946370|Anticoagulants|anticoagulants|mesh-ancestor
14158548|NCT04946370|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14158549|NCT04946370|Chelating Agents|chelating agents|mesh-ancestor
14158550|NCT04946370|Sequestering Agents|sequestering agents|mesh-ancestor
14158551|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158552|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14158553|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
14158554|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158555|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
14158556|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158557|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158558|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14158559|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
14158560|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158561|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158562|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14158563|NCT04946162|Tadalafil|tadalafil|mesh-list
14158564|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
14158565|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14158566|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14158567|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158568|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158569|NCT04946162|Urological Agents|urological agents|mesh-ancestor
14158570|NCT04946227|Paclitaxel|paclitaxel|mesh-list
14158571|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
14158572|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14158573|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158574|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14158575|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14158576|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14158577|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938395|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14938396|NCT01481311|Bromides|bromides|mesh-list
14938397|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
14938398|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
14938399|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
14938400|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14478974|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14478975|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
14478976|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158578|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14158579|NCT04946123|Selenium|selenium|mesh-list
14158580|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
14158581|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158582|NCT04946123|Protective Agents|protective agents|mesh-ancestor
14158583|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158584|NCT04946123|Trace Elements|trace elements|mesh-ancestor
14158585|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
14158586|NCT04945824|Dexamethasone|dexamethasone|mesh-list
14158587|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158588|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
14158589|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
14158590|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158591|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158592|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14158593|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
14158594|NCT04945824|Hormones|hormones|mesh-ancestor
14158595|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158596|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14158597|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158598|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14158599|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
14158600|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158601|NCT04945694|Fentanyl|fentanyl|mesh-list
14158602|NCT04945694|Propofol|propofol|mesh-list
14158603|NCT04945694|Sevoflurane|sevoflurane|mesh-list
14158604|NCT04945694|Atracurium|atracurium|mesh-list
14158605|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14158606|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158607|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158608|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14158609|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
14158610|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
14158611|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14158612|NCT04945694|Narcotics|narcotics|mesh-ancestor
14158613|NCT04945694|Analgesics|analgesics|mesh-ancestor
14158614|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
14158615|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158616|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14158617|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14158618|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14158619|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14158620|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14158621|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14158622|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14158623|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14158624|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
14158625|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158626|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938401|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14158627|NCT04945577|Vitamin D|vitamin d|mesh-list
14158628|NCT04945577|Vitamins|vitamins|mesh-ancestor
14158629|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
14158630|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158631|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14181103|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14181104|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181105|NCT03889912|Cemiplimab|cemiplimab|mesh-list
14181106|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181107|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158632|NCT04945226|Finasteride|finasteride|mesh-list
14158633|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14158634|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14158635|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158636|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158637|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
14158638|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158639|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158640|NCT04945226|Urological Agents|urological agents|mesh-ancestor
14158641|NCT04945434|Methamphetamine|methamphetamine|mesh-list
14158642|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14158643|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158644|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
14158645|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
14158646|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158647|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
14158648|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158649|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158650|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14158651|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14158652|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14158653|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14158654|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14158655|NCT04945122|Atorvastatin|atorvastatin|mesh-list
14158656|NCT04945122|Pitavastatin|pitavastatin|mesh-list
14158657|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14158658|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14158659|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
14158660|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158661|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14158662|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14158663|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158664|NCT04945070|Insulin|insulin|mesh-list
14158665|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14158666|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158667|NCT04945096|Cytarabine|cytarabine|mesh-list
14158668|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
14158669|NCT04945096|Cyclosporine|cyclosporine|mesh-list
14158670|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
14158671|NCT04945096|Busulfan|busulfan|mesh-list
14158672|NCT04945096|Semustine|semustine|mesh-list
14158673|NCT04945096|Decitabine|decitabine|mesh-list
14158674|NCT04945096|Cyclosporins|cyclosporins|mesh-list
14158675|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
14158676|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14158677|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158678|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
14158679|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158680|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158681|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14158682|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
14158683|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158684|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158685|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14158686|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158687|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
14158688|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
14158689|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158690|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158691|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
14158692|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
14158693|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14158694|NCT04945096|Expectorants|expectorants|mesh-ancestor
14158695|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
14158696|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14158697|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
14158698|NCT04945096|Protective Agents|protective agents|mesh-ancestor
14158699|NCT04944836|Clomiphene|clomiphene|mesh-list
14158700|NCT04944836|Enclomiphene|enclomiphene|mesh-list
14158701|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
14158702|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14158703|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
14158704|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158705|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158706|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14158707|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
14158708|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14158709|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14158710|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14158711|NCT04944966|Lumefantrine|lumefantrine|mesh-list
14158712|NCT04944966|Artemether|artemether|mesh-list
14158713|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14158714|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
14158715|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14158716|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14158717|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158718|NCT04944381|Vaccines|vaccines|mesh-list
14158719|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
14158720|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158721|NCT04944602|Omalizumab|omalizumab|mesh-list
14158722|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14158723|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14158724|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
14158725|NCT04944524|Methotrexate|methotrexate|mesh-list
14158726|NCT04944524|Tofacitinib|tofacitinib|mesh-list
14158727|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14158728|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
14158729|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14158730|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158731|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158732|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
14158733|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158734|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158735|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14158736|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158737|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14158738|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158739|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
14158740|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158741|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14158742|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158743|NCT04943952|Asparaginase|asparaginase|mesh-list
14158744|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158745|NCT04944069|Bevacizumab|bevacizumab|mesh-list
14158746|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14158747|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158748|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14158749|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14158750|NCT04944069|Growth Substances|growth substances|mesh-ancestor
14158751|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158752|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
14158753|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
14158754|NCT04944082|Ivermectin|ivermectin|mesh-list
14158755|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14158756|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478977|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158757|NCT04944095|Antibodies|antibodies|mesh-list
14158758|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
14158759|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158760|NCT04944212|Vitamin D|vitamin d|mesh-list
14158761|NCT04944212|Vitamins|vitamins|mesh-ancestor
14158762|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
14158763|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158764|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14158765|NCT04943692|Metformin|metformin|mesh-list
14158766|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14158767|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158768|NCT04944173|Durvalumab|durvalumab|mesh-list
14158769|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14158770|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158771|NCT04943588|Antibodies|antibodies|mesh-list
14158772|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
14158773|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
14158774|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158775|NCT04943653|Paclitaxel|paclitaxel|mesh-list
14158776|NCT04943653|Capecitabine|capecitabine|mesh-list
14158777|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
14478978|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
14158778|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14158779|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158780|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
14158781|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
14158782|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
14158783|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158784|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158785|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
14158786|NCT04943536|Bicalutamide|bicalutamide|mesh-list
14158787|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
14158788|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
14158789|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158790|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158791|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158792|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14158793|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14158794|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158795|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
14158796|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14158797|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158798|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14158799|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158800|NCT04943237|Analgesics|analgesics|mesh-ancestor
14158801|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
14158802|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158803|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158804|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158805|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14181108|NCT03887702|Tenofovir|tenofovir|mesh-list
14181109|NCT03887702|Entecavir|entecavir|mesh-list
14181110|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
14181111|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181112|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14181113|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14766661|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766662|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
14766663|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14181114|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181115|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181116|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14181117|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14181118|NCT03876262|Ivermectin|ivermectin|mesh-list
14181119|NCT03876262|Moxidectin|moxidectin|mesh-list
14181120|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14181121|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181122|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
14181123|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
14181127|NCT03834909|Tenofovir|tenofovir|mesh-list
14181128|NCT03834909|Emtricitabine|emtricitabine|mesh-list
14181129|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14181130|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
14181131|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181132|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14181133|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14181134|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181135|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181136|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14181137|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14766664|NCT00626769|Estrogens|estrogens|mesh-ancestor
14766665|NCT00626769|Hormones|hormones|mesh-ancestor
14766666|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766667|NCT00626834|Vigabatrin|vigabatrin|mesh-list
14766668|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
14181143|NCT03816332|Prednisone|prednisone|mesh-list
14181144|NCT03816332|Cortisone|cortisone|mesh-list
14181145|NCT03816332|Nivolumab|nivolumab|mesh-list
14181146|NCT03816332|Ipilimumab|ipilimumab|mesh-list
14181147|NCT03816332|Tacrolimus|tacrolimus|mesh-list
14181148|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14181149|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
14181150|NCT03816332|Hormones|hormones|mesh-ancestor
14181151|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181152|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181153|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14158806|NCT04943029|Paclitaxel|paclitaxel|mesh-list
14158807|NCT04943029|Carboplatin|carboplatin|mesh-list
14158808|NCT04943029|Pemetrexed|pemetrexed|mesh-list
14158809|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14158810|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158811|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
14158812|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
14158813|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
14158814|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158815|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158816|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14158817|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14158818|NCT04943198|Vemurafenib|vemurafenib|mesh-list
14158819|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158820|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158821|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158822|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158823|NCT04942899|Capecitabine|capecitabine|mesh-list
14158824|NCT04942899|Letrozole|letrozole|mesh-list
14158825|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158826|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
14158827|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158828|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158829|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14158830|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14158831|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158832|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14158833|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
14158834|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158835|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158836|NCT04943146|Aspirin|aspirin|mesh-list
14158837|NCT04943146|Prednisone|prednisone|mesh-list
14158838|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14158839|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
14158840|NCT04943146|Hormones|hormones|mesh-ancestor
14158841|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158842|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158843|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14158844|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158845|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14158846|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158847|NCT04943146|Analgesics|analgesics|mesh-ancestor
14158848|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
14158849|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158850|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158851|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14158852|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14158853|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158854|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14158855|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14158856|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158857|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
14158858|NCT04943224|Trametinib|trametinib|mesh-list
14158859|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158860|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14158861|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158862|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158863|NCT04942886|Entecavir|entecavir|mesh-list
14158864|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
14158865|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158866|NCT04942626|Capecitabine|capecitabine|mesh-list
14158867|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14158868|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158869|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
14158870|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158871|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158872|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158873|NCT04942860|Methotrexate|methotrexate|mesh-list
14158874|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14158875|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
14158876|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14478979|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
14478980|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478981|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
14158877|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158878|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14158879|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
14158880|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158881|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158882|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
14158883|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158884|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14158885|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158886|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
14158887|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158888|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14158889|NCT04942834|Amiodarone|amiodarone|mesh-list
14158890|NCT04942834|Sotalol|sotalol|mesh-list
14158891|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14158892|NCT04942834|Dronedarone|dronedarone|mesh-list
14158893|NCT04942834|Propafenone|propafenone|mesh-list
14158894|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
14158895|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14158896|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14158897|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158898|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14158899|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14158900|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14158901|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158902|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14158903|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14158904|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14158905|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14158906|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14158907|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
14158908|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158909|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158910|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
14158911|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
14158912|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158913|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14158914|NCT04942652|Itraconazole|itraconazole|mesh-list
14158915|NCT04942652|Esomeprazole|esomeprazole|mesh-list
14158916|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14158917|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14158918|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14158919|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158920|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158921|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
14158922|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158923|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14158924|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14158925|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14158926|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
14158927|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14158928|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158929|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14158930|NCT04942769|Selenium|selenium|mesh-list
14158931|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
14158932|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158933|NCT04942769|Protective Agents|protective agents|mesh-ancestor
14158934|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158935|NCT04942769|Trace Elements|trace elements|mesh-ancestor
14158936|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
14158937|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
14158938|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
14158939|NCT04942730|Busulfan|busulfan|mesh-list
14158940|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14158941|NCT04942730|Fludarabine|fludarabine|mesh-list
14158942|NCT04942730|Tacrolimus|tacrolimus|mesh-list
14158943|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14158944|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
14158945|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158946|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14158947|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14158948|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
14158949|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158950|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158951|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14158952|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14158953|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158954|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14158955|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14158956|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
14158957|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14158958|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158959|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
14158960|NCT04942340|Caffeine|caffeine|mesh-list
14158961|NCT04942340|Atipamezole|atipamezole|mesh-list
14158962|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14766669|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766670|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766671|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
14766672|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766673|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938402|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158963|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14158964|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158965|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14158966|NCT04942340|Analgesics|analgesics|mesh-ancestor
14158967|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
14158968|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14158969|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14158970|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14158971|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14158972|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
14158973|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14158974|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14158975|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14158976|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14158977|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14158978|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14158979|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14158980|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
14158981|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14158982|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14158983|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14158984|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
14158985|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14158986|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14158987|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14158988|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
14158989|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14158990|NCT04942301|Endostar protein|endostar protein|mesh-list
14158991|NCT04942301|Endostatins|endostatins|mesh-list
14158992|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14158993|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14158994|NCT04942301|Growth Substances|growth substances|mesh-ancestor
14158995|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14158996|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
14158997|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14158998|NCT04941976|Benzydamine|benzydamine|mesh-list
14158999|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14159000|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
14159001|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14159002|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14159003|NCT04942002|Prednisolone|prednisolone|mesh-list
14159004|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
14159005|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14159006|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
14159007|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14159008|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
14159009|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
14159010|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159011|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159012|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14159013|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
14159014|NCT04942002|Hormones|hormones|mesh-ancestor
14159015|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159016|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14159017|NCT04942002|Protective Agents|protective agents|mesh-ancestor
14159018|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14159019|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159020|NCT04941872|FAPI-46|fapi-46|mesh-list
14159021|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14159022|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159023|NCT04941898|Factor VIII|factor viii|mesh-list
14159024|NCT04941898|BAX 855|bax 855|mesh-list
14159025|NCT04941898|Coagulants|coagulants|mesh-ancestor
14159026|NCT04941833|Desogestrel|desogestrel|mesh-list
14159027|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14159028|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14159029|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14159030|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
14159031|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14159032|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159033|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14159034|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14159035|NCT04941833|Progestins|progestins|mesh-ancestor
14159036|NCT04941833|Hormones|hormones|mesh-ancestor
14159037|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159038|NCT04941911|Octreotide|octreotide|mesh-list
14159039|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14159040|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14159041|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159042|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
14159043|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159044|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
14159045|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159046|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14159047|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14159048|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
14159049|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159050|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159051|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14159052|NCT04941846|Nimodipine|nimodipine|mesh-list
14159053|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14159054|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14159055|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159056|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159057|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14159058|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159059|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
14159060|NCT04941625|Cystatins|cystatins|mesh-list
14159061|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14159062|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
14159063|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159064|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159065|NCT04941573|Xenon|xenon|mesh-list
14159066|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14159067|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
14159068|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
14159069|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159070|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159071|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14159072|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159073|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159074|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
14159075|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14159076|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
14159077|NCT04941131|Povidone|povidone|mesh-list
14159078|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14159079|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159080|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
14478982|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14766674|NCT00626977|Clonidine|clonidine|mesh-list
14766675|NCT00626977|Ropivacaine|ropivacaine|mesh-list
14766676|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
14766677|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
14766678|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766679|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766680|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
14766681|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766682|NCT00626977|Analgesics|analgesics|mesh-ancestor
14159081|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
14159082|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
14159083|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
14159084|NCT04941105|Evolocumab|evolocumab|mesh-list
14159085|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14159086|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14159087|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
14184082|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14184083|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14478983|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14478984|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
14478985|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14478986|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14478987|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14478988|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14478989|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
14184084|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14478990|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
14478991|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
14478992|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14478993|NCT02462382|Ropivacaine|ropivacaine|mesh-list
14478994|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
14478995|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
14478996|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14478997|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14478998|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
14478999|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479000|NCT02462473|Olanzapine|olanzapine|mesh-list
14479001|NCT02462473|Risperidone|risperidone|mesh-list
14159088|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159089|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14159090|NCT04941170|Bupivacaine|bupivacaine|mesh-list
14159091|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
14159092|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
14159093|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159094|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159095|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
14159096|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159097|NCT04941118|Anesthetics|anesthetics|mesh-list
14159098|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
14159099|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159100|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159101|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
14159102|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181154|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181155|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181156|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14181157|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181158|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181159|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
14181160|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14181161|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181162|NCT03808480|Nivolumab|nivolumab|mesh-list
14181163|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181164|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181165|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14181166|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181167|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
14181168|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14184085|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14184086|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14184087|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14184088|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184089|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184090|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184091|NCT04723238|Analgesics|analgesics|mesh-ancestor
14184092|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
14184093|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184094|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
14184095|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14184096|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
14184097|NCT04723069|Metronidazole|metronidazole|mesh-list
14184098|NCT04723069|Doxycycline|doxycycline|mesh-list
14184099|NCT04723069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184100|NCT04723069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184101|NCT04723069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14184102|NCT04723069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14184103|NCT04723069|Antimalarials|antimalarials|mesh-ancestor
14184104|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14184105|NCT04722822|Vaccines|vaccines|mesh-list
14184106|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
14184107|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184120|NCT04723030|Paclitaxel|paclitaxel|mesh-list
14184121|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14184122|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184123|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14766683|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14766684|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
14766685|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
14766686|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14184124|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14159103|NCT04940689|Lidocaine|lidocaine|mesh-list
14159104|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
14159105|NCT04940689|Remifentanil|remifentanil|mesh-list
14159106|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
14159107|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
14159108|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938403|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938404|NCT01481350|Urological Agents|urological agents|mesh-ancestor
14938405|NCT01481389|Theobromine|theobromine|mesh-list
14938406|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14938407|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
14938408|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938409|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938410|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14938411|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
14159109|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159110|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
14159111|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159112|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14159113|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14159114|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14159115|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159116|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159117|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14159118|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14159119|NCT04940689|Analgesics|analgesics|mesh-ancestor
14159120|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14159121|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14159122|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14159123|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159124|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159125|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14159126|NCT04940689|Narcotics|narcotics|mesh-ancestor
14159127|NCT04940845|Denosumab|denosumab|mesh-list
14159128|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14159129|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159130|NCT04940871|Favipiravir|favipiravir|mesh-list
14159131|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
14159132|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159133|NCT04940546|Bevacizumab|bevacizumab|mesh-list
14159134|NCT04940546|Capecitabine|capecitabine|mesh-list
14159135|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
14159136|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159137|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159138|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14159139|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14159140|NCT04940546|Growth Substances|growth substances|mesh-ancestor
14159141|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159142|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
14159143|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14159144|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
14159145|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159146|NCT04940273|Remifentanil|remifentanil|mesh-list
14159147|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14159148|NCT04940273|Narcotics|narcotics|mesh-ancestor
14159149|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159150|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159151|NCT04940273|Analgesics|analgesics|mesh-ancestor
14159152|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
14159153|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159154|NCT04940299|Nivolumab|nivolumab|mesh-list
14159155|NCT04940299|Ipilimumab|ipilimumab|mesh-list
14159156|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
14159157|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
14159158|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159159|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159160|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14159161|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159162|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
14159163|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159164|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
14159165|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14159166|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14159167|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14159168|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159169|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159170|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
14159171|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159172|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159173|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14159174|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159175|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
14159176|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14159177|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14159178|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14159179|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159180|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159181|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
14159182|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159183|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159184|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14159185|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159186|NCT04939883|Carvedilol|carvedilol|mesh-list
14159187|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14159188|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14159189|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159190|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159191|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159192|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159193|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14159194|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
14159195|NCT04939883|Protective Agents|protective agents|mesh-ancestor
14159196|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14159197|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159198|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14159199|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
14159200|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14159201|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14159202|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
14159203|NCT04939623|Probenecid|probenecid|mesh-list
14159204|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
14159205|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
14159206|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14159207|NCT04939623|Renal Agents|renal agents|mesh-ancestor
14159208|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
14159209|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159210|NCT04939662|Bevacizumab|bevacizumab|mesh-list
14159211|NCT04939662|Olaparib|olaparib|mesh-list
14159212|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159213|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159214|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14159215|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14159216|NCT04939662|Growth Substances|growth substances|mesh-ancestor
14159217|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159218|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
14159219|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14159220|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159221|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159222|NCT04939857|Trimetazidine|trimetazidine|mesh-list
14159223|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
14159224|NCT04939779|Delpazolid|delpazolid|mesh-list
14159225|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
14159226|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14159227|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159228|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14159229|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159230|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159231|NCT04939675|Lamotrigine|lamotrigine|mesh-list
14159232|NCT04939675|Zonisamide|zonisamide|mesh-list
14159233|NCT04939675|Levetiracetam|levetiracetam|mesh-list
14159234|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
14159235|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
14159236|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14159237|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159238|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159239|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14159240|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159241|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14159242|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14159243|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159244|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14159245|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14159246|NCT04939766|Insulin|insulin|mesh-list
14159247|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14159248|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159249|NCT04939649|Midazolam|midazolam|mesh-list
14159250|NCT04939649|Ketamine|ketamine|mesh-list
14159251|NCT04939649|Analgesics|analgesics|mesh-ancestor
14159252|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
14159253|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159254|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159255|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14159256|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14159257|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
14159258|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
14159259|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159260|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14159261|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14159262|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159263|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159264|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14159265|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14159266|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14159267|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14159268|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14159269|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
14159270|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
14159271|NCT04939480|Atezolizumab|atezolizumab|mesh-list
14159272|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159273|NCT04939441|Tenofovir|tenofovir|mesh-list
14159274|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
14159275|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159276|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14159277|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14159278|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159279|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159280|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14159281|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14159282|NCT04938583|Paclitaxel|paclitaxel|mesh-list
14159283|NCT04938583|Bevacizumab|bevacizumab|mesh-list
14159284|NCT04938583|Carboplatin|carboplatin|mesh-list
14159285|NCT04938583|Oregovomab|oregovomab|mesh-list
14159286|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14159287|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159288|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
14159289|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
14159290|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
14159291|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159292|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159293|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14159294|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14159295|NCT04938583|Growth Substances|growth substances|mesh-ancestor
14159296|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159297|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181169|NCT03780790|Bupivacaine|bupivacaine|mesh-list
14181170|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
14181171|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
14181172|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14181173|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181174|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
14181175|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181176|NCT03769298|Tacrolimus|tacrolimus|mesh-list
14181177|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181178|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
14181179|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181180|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14181181|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181182|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181183|NCT03761953|Oritavancin|oritavancin|mesh-list
14181184|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14181185|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181186|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14181187|NCT03751800|Dienogest|dienogest|mesh-list
14181188|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
14181189|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
14181190|NCT03751800|Estradiol|estradiol|mesh-list
14181191|NCT03751800|Estrogens|estrogens|mesh-ancestor
14181192|NCT03751800|Hormones|hormones|mesh-ancestor
14181193|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181194|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181195|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14181196|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
14181197|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14181198|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14181199|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14181200|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14181201|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14181202|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14181203|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14181204|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181205|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
14181206|NCT03709888|Pregabalin|pregabalin|mesh-list
14181207|NCT03709888|Memantine|memantine|mesh-list
14181208|NCT03709888|Analgesics|analgesics|mesh-ancestor
14181209|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
14181210|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181211|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181212|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
14181213|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14181214|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14181215|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181216|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14181217|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14181218|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14181219|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14181220|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14181221|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14181222|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14181223|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
14181224|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14181225|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14181226|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14181231|NCT03659136|Everolimus|everolimus|mesh-list
14181232|NCT03659136|Exemestane|exemestane|mesh-list
14181233|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181234|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181235|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
14181236|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181237|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14181238|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14181239|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181240|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159298|NCT04938713|Ketamine|ketamine|mesh-list
14159299|NCT04938713|Esketamine|esketamine|mesh-list
14159300|NCT04938713|Analgesics|analgesics|mesh-ancestor
14159301|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
14159302|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159303|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159304|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14159305|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14159306|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
14159307|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
14159308|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159309|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14159310|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14159311|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159312|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159313|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
14159314|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14159315|NCT04938453|Nintedanib|nintedanib|mesh-list
14159316|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159317|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14159318|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159319|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159320|NCT04938466|Hormones|hormones|mesh-list
14159321|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159322|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159323|NCT04938297|Rituximab|rituximab|mesh-list
14159324|NCT04938297|Lenalidomide|lenalidomide|mesh-list
14159325|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
14159326|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159327|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159328|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
14159329|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159330|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14159331|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14159332|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14159333|NCT04938297|Growth Substances|growth substances|mesh-ancestor
14159334|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
14159335|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14159336|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159337|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159338|NCT04938011|Progesterone|progesterone|mesh-list
14159339|NCT04938011|Progestins|progestins|mesh-ancestor
14159340|NCT04938011|Hormones|hormones|mesh-ancestor
14159341|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159342|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159343|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
14159344|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14159345|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14159346|NCT04938037|Prednisolone|prednisolone|mesh-list
14159347|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
14159348|NCT04938037|Bupivacaine|bupivacaine|mesh-list
14159349|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14159350|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
14159351|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
14159352|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
14159353|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159354|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159355|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
14159356|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159357|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14159358|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
14159359|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
14159360|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14159361|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
14159362|NCT04938037|Hormones|hormones|mesh-ancestor
14159363|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159364|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14159365|NCT04938037|Protective Agents|protective agents|mesh-ancestor
14159366|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14159367|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159368|NCT04937946|Fentanyl|fentanyl|mesh-list
14159369|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14159370|NCT04937946|Narcotics|narcotics|mesh-ancestor
14159371|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159372|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159373|NCT04937946|Analgesics|analgesics|mesh-ancestor
14159374|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
14159375|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159376|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14159377|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14159378|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
14159379|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
14159380|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
14159381|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14159382|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14159383|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14159384|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159385|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159386|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
14159387|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159388|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159389|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14159390|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159391|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
14159392|NCT04937907|Benazepril|benazepril|mesh-list
14159393|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
14159394|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14159395|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14159396|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159397|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159398|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159399|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14159400|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14159401|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
14159402|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14159403|NCT04937699|Aspirin|aspirin|mesh-list
14159404|NCT04937699|Ticagrelor|ticagrelor|mesh-list
14159405|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14159406|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14159407|NCT04937699|Analgesics|analgesics|mesh-ancestor
14159408|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
14159409|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159410|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159411|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14159412|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14159413|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14159414|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14159415|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159416|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14159417|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14159418|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159419|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
14159420|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14159421|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14159422|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14159423|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
14159424|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159425|NCT04937673|Paclitaxel|paclitaxel|mesh-list
14159426|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14159427|NCT04937673|Cisplatin|cisplatin|mesh-list
14159428|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14159429|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159430|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
14159431|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
14159432|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
14159433|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159434|NCT04937894|Tigecycline|tigecycline|mesh-list
14159435|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14159436|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159437|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14159438|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159439|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159440|NCT04937569|Ivermectin|ivermectin|mesh-list
14159441|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14159442|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159443|NCT04937634|Melphalan|melphalan|mesh-list
14159444|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14159445|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
14159446|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159447|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938412|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
14938413|NCT01481454|Vaccines|vaccines|mesh-list
14938414|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
14938415|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938416|NCT01481467|Vaccines|vaccines|mesh-list
14938417|NCT01481467|Immunologic Factors|immunologic factors|mesh-ancestor
14938418|NCT01481467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938419|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
14938420|NCT01481519|Dexamethasone|dexamethasone|mesh-list
14938421|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
14938422|NCT01481519|Povidone|povidone|mesh-list
14938423|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
14938424|NCT01481519|BB 1101|bb 1101|mesh-list
14938425|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938426|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
14159448|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14159449|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159450|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
14159451|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159452|NCT04937543|Beclomethasone|beclomethasone|mesh-list
14159453|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
14159454|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
14159455|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14159456|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
14159457|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159458|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159459|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14159460|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
14159461|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14159462|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14159463|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14159464|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159465|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159466|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159467|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14159468|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
14159469|NCT04937543|Hormones|hormones|mesh-ancestor
14159470|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159471|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14159472|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14159473|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14159474|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
14159475|NCT04937881|Tenofovir|tenofovir|mesh-list
14159476|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
14159477|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159478|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14159479|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14159480|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159481|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159482|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14159483|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14159484|NCT04937452|Rotigotine|rotigotine|mesh-list
14159485|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
14159486|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
14159487|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159488|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159489|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159490|NCT04937140|Antibodies|antibodies|mesh-list
14159491|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
14159492|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159493|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
14159494|NCT04937101|Codeine|codeine|mesh-list
14159495|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14159496|NCT04937101|Narcotics|narcotics|mesh-ancestor
14159497|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159498|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159499|NCT04937101|Analgesics|analgesics|mesh-ancestor
14159500|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
14938427|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
14938428|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938429|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159501|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159502|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
14159503|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
14159504|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
14159505|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14159506|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14159507|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
14159508|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
14159509|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159510|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159511|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14159512|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14159513|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14159514|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14159515|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
14159516|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14159517|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
14159518|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159519|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
14159520|NCT04936763|Protective Agents|protective agents|mesh-ancestor
14159521|NCT04936711|Bupivacaine|bupivacaine|mesh-list
14159522|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
14159523|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
14159524|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159525|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159526|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
14159527|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159528|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
14159529|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159530|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181241|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14181242|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
14181243|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181244|NCT03642132|Bevacizumab|bevacizumab|mesh-list
14181245|NCT03642132|Avelumab|avelumab|mesh-list
14181246|NCT03642132|Talazoparib|talazoparib|mesh-list
14181247|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181248|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181249|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14181250|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14181251|NCT03642132|Growth Substances|growth substances|mesh-ancestor
14181252|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181253|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181254|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14181255|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181256|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181257|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14181258|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14181259|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181260|NCT03622593|Aflibercept|aflibercept|mesh-list
14181261|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14181262|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14181263|NCT03622593|Growth Substances|growth substances|mesh-ancestor
14181264|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181265|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181266|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181267|NCT03622580|Aflibercept|aflibercept|mesh-list
14181268|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14181269|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14181270|NCT03622580|Growth Substances|growth substances|mesh-ancestor
14181271|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181272|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181273|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181274|NCT03616717|Modafinil|modafinil|mesh-list
14181275|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14181276|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181277|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14181278|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14181279|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14766687|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14766688|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14181280|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181281|NCT03606213|Vaccines|vaccines|mesh-list
14766689|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159531|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14159532|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14159533|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159534|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
14159535|NCT04936971|Everolimus|everolimus|mesh-list
14159536|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159537|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159538|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
14159539|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159540|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14159541|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14159542|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
14159543|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14159544|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159545|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159546|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159547|NCT04936282|Tacrolimus|tacrolimus|mesh-list
14159548|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159549|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
14159550|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159551|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14159552|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159553|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159554|NCT04936399|Nivolumab|nivolumab|mesh-list
14159555|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159556|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159557|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14159558|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159559|NCT04936295|Fulvestrant|fulvestrant|mesh-list
14159560|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14159561|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159562|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14159563|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14159564|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
14159565|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159566|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159567|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
14159568|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14159569|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
14159570|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159571|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
14159572|NCT04936204|Protective Agents|protective agents|mesh-ancestor
14159573|NCT04936126|Amantadine|amantadine|mesh-list
14159574|NCT04936126|Pramipexole|pramipexole|mesh-list
14159575|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14938430|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955336|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955337|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13955338|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955339|NCT03190681|Methylphenidate|methylphenidate|mesh-list
13955340|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13955341|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955342|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13955343|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13955344|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13955345|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955346|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
13955347|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13955348|NCT03190733|Fludarabine|fludarabine|mesh-list
13955349|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955350|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
13955351|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
13955352|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955353|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
14159576|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
14159577|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14159578|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14159579|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14159580|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766690|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766691|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159581|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159582|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
14159583|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159584|NCT04936126|Protective Agents|protective agents|mesh-ancestor
14159585|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14159586|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14159587|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
14159588|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
14159589|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159590|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
14159591|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159592|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14159593|NCT04936126|Analgesics|analgesics|mesh-ancestor
14159594|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
14159595|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159596|NCT04935814|Vasopressins|vasopressins|mesh-list
14159597|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
14159598|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
14159599|NCT04935814|Coagulants|coagulants|mesh-ancestor
14159600|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14159601|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14159602|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
14766692|NCT00626990|Temozolomide|temozolomide|mesh-list
14766693|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14159603|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159604|NCT04935931|Naltrexone|naltrexone|mesh-list
14159605|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14159606|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14159607|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159608|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
14159609|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159610|NCT04935788|Caseins|caseins|mesh-list
14159611|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
14159612|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
14159613|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159614|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14159615|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159616|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159617|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14159618|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14159619|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14159620|NCT04935515|Anticoagulants|anticoagulants|mesh-list
14159621|NCT04935515|Coagulants|coagulants|mesh-list
14159622|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
14159623|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14159624|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159625|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
14159626|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
14159627|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159628|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159629|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159630|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
14159631|NCT04935541|Remifentanil|remifentanil|mesh-list
14159632|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14159633|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159634|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159635|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14159636|NCT04935541|Analgesics|analgesics|mesh-ancestor
14159637|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
14159638|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159639|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14159640|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14159641|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14159642|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159643|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159644|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159645|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14159646|NCT04935541|Narcotics|narcotics|mesh-ancestor
14159647|NCT04935034|Vitamin D|vitamin d|mesh-list
14159648|NCT04935034|Vitamins|vitamins|mesh-ancestor
14159649|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
14159650|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159651|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14159652|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14159653|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
14159654|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14159655|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
14159656|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159657|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159658|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159659|NCT04935073|Cetrorelix|cetrorelix|mesh-list
14159660|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14159661|NCT04935073|Hormones|hormones|mesh-ancestor
14159662|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159663|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159664|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14159665|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
14159666|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14159667|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
14159668|NCT04934683|Propofol|propofol|mesh-list
14159669|NCT04934683|Etomidate|etomidate|mesh-list
14159670|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14159671|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159672|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159673|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14159674|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
14159675|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
14159676|NCT04934579|Rituximab|rituximab|mesh-list
14159677|NCT04934579|Methotrexate|methotrexate|mesh-list
14159678|NCT04934579|Lenalidomide|lenalidomide|mesh-list
14159679|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14159680|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159681|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
14159682|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159683|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14159684|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14159685|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
14159686|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14159687|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14159688|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
14159689|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159690|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
14159691|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159692|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14159693|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159694|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14159695|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14159696|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14159697|NCT04934579|Growth Substances|growth substances|mesh-ancestor
14159698|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
14159699|NCT04934852|Ephedrine|ephedrine|mesh-list
14159700|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
14159701|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14159702|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159703|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
14159704|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
14159705|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159706|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14159707|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159708|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159709|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159710|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14159711|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14159712|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
14159713|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
14159714|NCT04934618|Irinotecan|irinotecan|mesh-list
14159715|NCT04934618|Apatinib|apatinib|mesh-list
14159716|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14159717|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14159718|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159719|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159720|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159721|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14159722|NCT04934514|Gemcitabine|gemcitabine|mesh-list
14159723|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159724|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14159725|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
14159726|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159727|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
14159728|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159729|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159730|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159731|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
14159732|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181282|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
14181283|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181284|NCT03594110|Empagliflozin|empagliflozin|mesh-list
14181285|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14181286|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181287|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14181288|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766694|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
14766695|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181311|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
14181312|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14181313|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
14181314|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181315|NCT03575208|Interferons|interferons|mesh-list
14181316|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
14181317|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
14181318|NCT03575208|Antibodies|antibodies|mesh-list
14181319|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
14181320|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14181321|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14181322|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181323|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
14181324|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181325|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
14181326|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181327|NCT03547271|Vaccines|vaccines|mesh-list
14181328|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14181329|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
14181330|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181331|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14181332|NCT03534180|Venetoclax|venetoclax|mesh-list
14181333|NCT03534180|Romidepsin|romidepsin|mesh-list
14181334|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181335|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181336|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14181337|NCT03530683|Dexamethasone|dexamethasone|mesh-list
14181338|NCT03530683|Azacitidine|azacitidine|mesh-list
14181339|NCT03530683|Venetoclax|venetoclax|mesh-list
14181340|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14181341|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
14181342|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
14181343|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181344|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159733|NCT04934748|Phenylephrine|phenylephrine|mesh-list
14159734|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
14159735|NCT04934748|Norepinephrine|norepinephrine|mesh-list
14159736|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14159737|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
14159738|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
14159739|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159740|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159741|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
14159742|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14159743|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
14159744|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
14159745|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14159746|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14159747|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14159748|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159749|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159750|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159751|NCT04934748|Protective Agents|protective agents|mesh-ancestor
14159752|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14159753|NCT04934228|Clonidine|clonidine|mesh-list
14159754|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14159755|NCT04934228|Diuretics|diuretics|mesh-ancestor
14159756|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
14159757|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159758|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14159759|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159760|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159761|NCT04934228|Analgesics|analgesics|mesh-ancestor
14159762|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
14159763|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159764|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
14159765|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
14159766|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14159767|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14159768|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14159769|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159770|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159771|NCT04934475|Lenalidomide|lenalidomide|mesh-list
14159772|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
14159773|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159774|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14159775|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14159776|NCT04934475|Growth Substances|growth substances|mesh-ancestor
14159777|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
14159778|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159779|NCT04933630|Norepinephrine|norepinephrine|mesh-list
14159780|NCT04933630|Serotonin|serotonin|mesh-list
14159781|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14159782|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14159783|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14159784|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159785|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159786|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159787|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159788|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
14159789|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
14159790|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159791|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14159792|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14766696|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159793|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
14159794|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14159795|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159796|NCT04933864|Methylene Blue|methylene blue|mesh-list
14159797|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159798|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159799|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14159800|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159801|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
14159802|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
14159803|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14159804|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14159805|NCT04933292|Prednisolone|prednisolone|mesh-list
14766697|NCT00627003|Cabergoline|cabergoline|mesh-list
14159806|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
14159807|NCT04933292|Azathioprine|azathioprine|mesh-list
14159808|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14159809|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
14159810|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14159811|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159812|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14159813|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
14159814|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14159815|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159816|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159817|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159818|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14159819|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
14159820|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
14159821|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159822|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159823|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14159824|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
14159825|NCT04933292|Hormones|hormones|mesh-ancestor
14159826|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159827|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14159828|NCT04933292|Protective Agents|protective agents|mesh-ancestor
14159829|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14159830|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
14159831|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14159832|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159833|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
14159834|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14159835|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
14159836|NCT04933084|Narcotics|narcotics|mesh-ancestor
14159837|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159838|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159839|NCT04933084|Analgesics|analgesics|mesh-ancestor
14159840|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
14159841|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159842|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
14159843|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
14159844|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
14159845|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159846|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159847|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
14159848|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159849|NCT04933279|Iodine|iodine|mesh-list
14159850|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
14159851|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14159852|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159853|NCT04933279|Trace Elements|trace elements|mesh-ancestor
14159854|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
14159855|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159856|NCT04932564|Leflunomide|leflunomide|mesh-list
14159857|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159858|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159859|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14159860|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
14159861|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159862|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
14159863|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14159864|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159865|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159866|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14159867|NCT04932746|Analgesics|analgesics|mesh-ancestor
14159868|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
14159869|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159870|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14159871|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14159872|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14159873|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159874|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159875|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159876|NCT04932434|Psilocybin|psilocybin|mesh-list
14159877|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14159878|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
14159879|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159880|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14159881|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14159882|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
14159883|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159884|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159885|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14159886|NCT04932135|Hormones|hormones|mesh-list
14159887|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159888|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159889|NCT04932096|Melatonin|melatonin|mesh-list
14159890|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
14159891|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159892|NCT04932096|Protective Agents|protective agents|mesh-ancestor
14159893|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159894|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159895|NCT04932382|Misoprostol|misoprostol|mesh-list
14159896|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14159897|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
14159898|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14159899|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159900|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14159901|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14159902|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
14181345|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14181346|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
14181347|NCT03530683|Hormones|hormones|mesh-ancestor
14181348|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181349|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14181350|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181351|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181352|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
14181353|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181354|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181355|NCT03498521|Gemcitabine|gemcitabine|mesh-list
14181356|NCT03498521|Bevacizumab|bevacizumab|mesh-list
14181357|NCT03498521|Carboplatin|carboplatin|mesh-list
14181358|NCT03498521|Trastuzumab|trastuzumab|mesh-list
14181359|NCT03498521|Atezolizumab|atezolizumab|mesh-list
14181360|NCT03498521|Olaparib|olaparib|mesh-list
14181361|NCT03498521|Pertuzumab|pertuzumab|mesh-list
14181362|NCT03498521|Vemurafenib|vemurafenib|mesh-list
14938431|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
14938432|NCT01481519|Hormones|hormones|mesh-ancestor
14938433|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938434|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14181363|NCT03498521|Ivosidenib|ivosidenib|mesh-list
14181364|NCT03498521|Entrectinib|entrectinib|mesh-list
14181365|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181366|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181367|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181368|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14181369|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14181370|NCT03498521|Growth Substances|growth substances|mesh-ancestor
14181371|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181372|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181373|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181374|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
14181375|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
14181376|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181377|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159903|NCT04932187|Capecitabine|capecitabine|mesh-list
14159904|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14159905|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
14159906|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159907|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14159908|NCT04931693|Acetaminophen|acetaminophen|mesh-list
14159909|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14159910|NCT04931693|Analgesics|analgesics|mesh-ancestor
14159911|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
14159912|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159913|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159914|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
14159915|NCT04931433|Lidocaine|lidocaine|mesh-list
14159916|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
14159917|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
14159918|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159919|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159920|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
14159921|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159922|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14159923|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14159924|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14159925|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159926|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159927|NCT04931524|Mitogens|mitogens|mesh-list
14159928|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
14159929|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159930|NCT04931355|Cetrorelix|cetrorelix|mesh-list
14159931|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14159932|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159933|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14159934|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
14159935|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14159936|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
14159937|NCT04930952|Ethanol|ethanol|mesh-list
14159938|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14159939|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159940|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14159941|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159942|NCT04931225|Landiolol|landiolol|mesh-list
14159943|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14159944|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14159945|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159946|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159947|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159948|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159949|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14159950|NCT04931108|Atenolol|atenolol|mesh-list
14159951|NCT04931108|Nitrendipine|nitrendipine|mesh-list
14159952|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14159953|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14159954|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
14159955|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
14159956|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14159957|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159958|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14159959|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14159960|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14159961|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
14159962|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14159963|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159964|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14159965|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14159966|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14159967|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
14159968|NCT04931121|Viscosupplements|viscosupplements|mesh-list
14159969|NCT04931121|Protective Agents|protective agents|mesh-ancestor
14159970|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159971|NCT04930744|Metformin|metformin|mesh-list
14159972|NCT04930744|Rifampin|rifampin|mesh-list
14159973|NCT04930744|Isoniazid|isoniazid|mesh-list
14159974|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
14159975|NCT04930744|Ethambutol|ethambutol|mesh-list
14159976|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14184125|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14159977|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14159978|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14159979|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
14159980|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14159981|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14159982|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
14159983|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14159984|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14159985|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159986|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14159987|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14159988|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14159989|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14159990|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14159991|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14159992|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14159993|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14159994|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
14159995|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14159996|NCT04930627|Empagliflozin|empagliflozin|mesh-list
14159997|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14159998|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14159999|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14160000|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160001|NCT04930887|Bupivacaine|bupivacaine|mesh-list
14160002|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
14160003|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
14160004|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160005|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160006|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
14160007|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160008|NCT04930458|Listerine|listerine|mesh-list
14160009|NCT04930458|Calcium|calcium|mesh-list
14160010|NCT04930458|Fluorides|fluorides|mesh-list
14160011|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
14160012|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
14160013|NCT04930458|Caseins|caseins|mesh-list
14160014|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14160015|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160016|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
14160017|NCT04930458|Protective Agents|protective agents|mesh-ancestor
14160018|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14160019|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160020|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
14160021|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
14160022|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160023|NCT04930471|Metformin|metformin|mesh-list
14160024|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14160025|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160026|NCT04930211|Dexamethasone|dexamethasone|mesh-list
14160027|NCT04930211|Lidocaine|lidocaine|mesh-list
14160028|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160029|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
14160030|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
14160031|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160032|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160033|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160034|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
14160035|NCT04930211|Hormones|hormones|mesh-ancestor
14160036|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160037|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160038|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160039|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14160040|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
14160041|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160042|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
14160043|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14160044|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14160045|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14160046|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160047|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160048|NCT04930185|Vaccines|vaccines|mesh-list
14160049|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
14160050|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160051|NCT04930055|Vaccines|vaccines|mesh-list
14160052|NCT04930055|Immunologic Factors|immunologic factors|mesh-ancestor
14160053|NCT04930055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181378|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181379|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
14181380|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14181381|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14181382|NCT03484819|Nivolumab|nivolumab|mesh-list
14181383|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181384|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181385|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14181386|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181387|NCT03468985|Nivolumab|nivolumab|mesh-list
14181388|NCT03468985|Ipilimumab|ipilimumab|mesh-list
14181389|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181390|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181391|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14181392|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181393|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
14181394|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181395|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181396|NCT03423199|Tamoxifen|tamoxifen|mesh-list
14181397|NCT03423199|Goserelin|goserelin|mesh-list
14181398|NCT03423199|Palbociclib|palbociclib|mesh-list
14181399|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14181400|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
14181401|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181402|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181403|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14181404|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181405|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14181406|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14181407|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14181408|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14181409|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181410|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181411|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
14181412|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181413|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181414|NCT03395184|PF-06700841|pf-06700841|mesh-list
14181415|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14181416|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181417|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181418|NCT03388749|Annamycin|annamycin|mesh-list
14181419|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14181420|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181421|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
14181422|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14181423|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14181424|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181425|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14181426|NCT03384563|Analgesics|analgesics|mesh-ancestor
14181427|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
14181428|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181429|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14181430|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14181431|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14181432|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
14181433|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14181434|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160054|NCT04930133|Afatinib|afatinib|mesh-list
14160055|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160056|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14160057|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160058|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479002|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14479003|NCT02462473|Aripiprazole|aripiprazole|mesh-list
14479004|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14479005|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14479006|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
14479007|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479008|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479009|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479010|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14479011|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14160059|NCT04929652|Irinotecan|irinotecan|mesh-list
14160060|NCT04929652|Molgramostim|molgramostim|mesh-list
14160061|NCT04929652|Sargramostim|sargramostim|mesh-list
14160062|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14160063|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160064|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160065|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160066|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160067|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
14160068|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160069|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
14160070|NCT04929626|Albuterol|albuterol|mesh-list
14160071|NCT04929626|Analgesics|analgesics|mesh-ancestor
14160072|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
14160073|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160074|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160075|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
14160076|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160077|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14160078|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
14160079|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14160080|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160081|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160082|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14160083|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
14160084|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14160085|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14160086|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
14160087|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14160088|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160089|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14160090|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14160091|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14160092|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160093|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160094|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14160095|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14160096|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160097|NCT04929522|Anesthetics|anesthetics|mesh-list
14160098|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160099|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160100|NCT04929509|Listerine|listerine|mesh-list
14160101|NCT04929509|Fluorides|fluorides|mesh-list
14160102|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
14160103|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
14160104|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
14160105|NCT04929509|Protective Agents|protective agents|mesh-ancestor
14160106|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160107|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14160108|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160109|NCT04928365|Antibodies|antibodies|mesh-list
14160110|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14160111|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
14160112|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160113|NCT04928495|Ascorbic Acid|ascorbic acid|mesh-list
14160114|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
14160115|NCT04928495|Bromhexine|bromhexine|mesh-list
14160116|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14160117|NCT04928495|Vitamins|vitamins|mesh-ancestor
14160118|NCT04928495|Micronutrients|micronutrients|mesh-ancestor
14160119|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160120|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
14160121|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160122|NCT04928495|Protective Agents|protective agents|mesh-ancestor
14160123|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
14160124|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160125|NCT04928495|Expectorants|expectorants|mesh-ancestor
14160126|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160127|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14160128|NCT04928495|Antidotes|antidotes|mesh-ancestor
14160129|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
14160130|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
14160131|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14160132|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
14160133|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160134|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160135|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160136|NCT04928183|Nitroprusside|nitroprusside|mesh-list
14160137|NCT04928183|Phenylephrine|phenylephrine|mesh-list
14160138|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
14160139|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
14160140|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14160141|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
14160142|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
14160143|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160144|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160145|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
14160146|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14160147|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
14160148|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160149|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14160150|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14160151|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14160152|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160153|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160154|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160155|NCT04928183|Protective Agents|protective agents|mesh-ancestor
14160156|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
14160157|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
14160158|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14160159|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
14160160|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14160161|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
14160162|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14160163|NCT04928066|Prednisone|prednisone|mesh-list
14160164|NCT04928066|Tofacitinib|tofacitinib|mesh-list
14160165|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160166|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
14160167|NCT04928066|Hormones|hormones|mesh-ancestor
14160168|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160169|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160170|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160171|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160172|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14160173|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160174|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160175|NCT04927936|Vaccines|vaccines|mesh-list
14160176|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
14160177|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160178|NCT04927949|Cangrelor|cangrelor|mesh-list
14160179|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14160180|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14160181|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14160182|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14160183|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
14160184|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160185|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160186|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160187|NCT04928586|Pirfenidone|pirfenidone|mesh-list
14160188|NCT04928586|Analgesics|analgesics|mesh-ancestor
14160189|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
14160190|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160191|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160192|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14160193|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14160194|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160195|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160196|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160197|NCT04928651|Clonidine|clonidine|mesh-list
14160198|NCT04928651|Analgesics|analgesics|mesh-ancestor
14160199|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
14160200|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160201|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160202|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14160203|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
14160204|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
14160205|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14160206|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14160207|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14160208|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160209|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160210|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160211|NCT04928820|Edetic Acid|edetic acid|mesh-list
14160212|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14160213|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
14160214|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
14160215|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160216|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
14160217|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14160218|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14181454|NCT03377049|Acetazolamide|acetazolamide|mesh-list
14181455|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
14181456|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14181457|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181458|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181459|NCT03377049|Diuretics|diuretics|mesh-ancestor
14181460|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
14181461|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181462|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
14181463|NCT03342937|Capecitabine|capecitabine|mesh-list
14181464|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
14181465|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181466|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181467|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181468|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
14181469|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184126|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184127|NCT04722835|Albuterol|albuterol|mesh-list
14184128|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14184129|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
14184130|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184131|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184132|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14184133|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
14184134|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
14184135|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14184136|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14184137|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14184138|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14184139|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
14184140|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184141|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184142|NCT04723004|Bevacizumab|bevacizumab|mesh-list
14184143|NCT04723004|Sorafenib|sorafenib|mesh-list
14184144|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14184145|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184146|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14184147|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14184148|NCT04723004|Growth Substances|growth substances|mesh-ancestor
14184149|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184150|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
14184151|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14184152|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184153|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184154|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
14184155|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14160219|NCT04927858|Empagliflozin|empagliflozin|mesh-list
14160220|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14160221|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160222|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14160223|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160224|NCT04927585|Vaccines|vaccines|mesh-list
14160225|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
14160226|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766698|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14766699|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14766700|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
14766701|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
14766702|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160227|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
14160228|NCT04927481|Analgesics|analgesics|mesh-ancestor
14160229|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
14160230|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160231|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766703|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766704|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766705|NCT00627081|Remifentanil|remifentanil|mesh-list
14766706|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14766707|NCT00627081|Narcotics|narcotics|mesh-ancestor
14160232|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160233|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14160234|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160235|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160236|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160237|NCT04927299|Losartan|losartan|mesh-list
14160238|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14160239|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
14766708|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160240|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14160241|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14160242|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14160243|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14160244|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160245|NCT04927299|Diuretics|diuretics|mesh-ancestor
14160246|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
14766709|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766710|NCT00627081|Analgesics|analgesics|mesh-ancestor
14766711|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
14766712|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766713|NCT00627133|Levetiracetam|levetiracetam|mesh-list
14766714|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
14766715|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
14766716|NCT00627354|Prednisone|prednisone|mesh-list
14181470|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
14766717|NCT00627354|Etoposide|etoposide|mesh-list
13955354|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13955355|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955356|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13955357|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955358|NCT03190603|Celecoxib|celecoxib|mesh-list
13955359|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13955360|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13955361|NCT03190603|Analgesics|analgesics|mesh-ancestor
13955362|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
13955363|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955364|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955365|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955366|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955367|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13955368|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13955369|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955370|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955371|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
13955372|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13955373|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13955374|NCT03190642|Prednisolone|prednisolone|mesh-list
13955375|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
13955376|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13955377|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
14766718|NCT00627354|Vinorelbine|vinorelbine|mesh-list
14160247|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160248|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14160249|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160250|NCT04926844|Midazolam|midazolam|mesh-list
14160251|NCT04926844|Levetiracetam|levetiracetam|mesh-list
14160252|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14160253|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14160254|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160255|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160256|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14160257|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14160258|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14160259|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14160260|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
14160261|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
14160262|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
14160263|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
14160264|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160265|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160266|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
14160267|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
14160268|NCT04927000|Tofacitinib|tofacitinib|mesh-list
14160269|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14160270|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160271|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160272|NCT04927052|Lidocaine|lidocaine|mesh-list
14160273|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
14160274|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
14160275|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160276|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160277|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
14160278|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160279|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14160280|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14160281|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14160282|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160283|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160284|NCT04926753|Fluorouracil|fluorouracil|mesh-list
14160285|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160286|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
14160287|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160288|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14160289|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160290|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
14160291|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160292|NCT04926480|Anesthetics|anesthetics|mesh-list
14160293|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160294|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160295|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14160296|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160297|NCT04927039|Iloprost|iloprost|mesh-list
14160298|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14160299|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
14160300|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14160301|NCT04926545|Fluorouracil|fluorouracil|mesh-list
14160302|NCT04926545|Irinotecan|irinotecan|mesh-list
14160303|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
14160304|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160305|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14160306|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160307|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160308|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
14160309|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160310|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14160311|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160312|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160313|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14160314|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
14160315|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160316|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14160317|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14160318|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14160319|NCT04926532|Sorafenib|sorafenib|mesh-list
14160320|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160321|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14160322|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160323|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160324|NCT04925973|Tofacitinib|tofacitinib|mesh-list
14160325|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14160326|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160327|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160328|NCT04926155|Metformin|metformin|mesh-list
14160329|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14160330|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160331|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14160332|NCT04925531|Ampicillin|ampicillin|mesh-list
14160333|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181471|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
14181472|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
14181473|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
14181474|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181475|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181476|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
14181477|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181478|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
14181479|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181480|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181481|NCT03298984|Cytarabine|cytarabine|mesh-list
14181482|NCT03298984|Daunorubicin|daunorubicin|mesh-list
14181483|NCT03298984|Alvocidib|alvocidib|mesh-list
14181484|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181485|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
14181486|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181487|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181488|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
14181489|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181490|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181491|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
14181492|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181493|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14181494|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14181495|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14181496|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181497|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181498|NCT03298984|Growth Substances|growth substances|mesh-ancestor
14181499|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14181500|NCT03295747|Peppermint oil|peppermint oil|mesh-list
14181501|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
14181502|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
14181503|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181504|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181505|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14181506|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
14181507|NCT03295552|Carboplatin|carboplatin|mesh-list
14181508|NCT03295552|Decitabine|decitabine|mesh-list
14181509|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181510|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181511|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
14181512|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181513|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181514|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
14181515|NCT03294954|Fludarabine|fludarabine|mesh-list
14181516|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181517|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
14181518|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181519|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14181520|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14181521|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
14181522|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181523|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160334|NCT04925505|Anesthetics|anesthetics|mesh-list
14160335|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160336|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160337|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
14160338|NCT04925557|Siponimod|siponimod|mesh-list
14160339|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
14160340|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160341|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14160342|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160343|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160344|NCT04925375|Abatacept|abatacept|mesh-list
14160345|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14160346|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160347|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160348|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160349|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
14160350|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160351|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160352|NCT04925141|Dasatinib|dasatinib|mesh-list
14160353|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160354|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14160355|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160356|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160357|NCT04925063|Metformin|metformin|mesh-list
14160358|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14160359|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160360|NCT04925076|Ethanol|ethanol|mesh-list
14160361|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14160362|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160363|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160364|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160365|NCT04925167|Heparin|heparin|mesh-list
14160366|NCT04925167|Calcium heparin|calcium heparin|mesh-list
14160367|NCT04925167|Argatroban|argatroban|mesh-list
14160368|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
14160369|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14160370|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14160371|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160372|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
14160373|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14160374|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
14160375|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160376|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14160377|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14160378|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14160379|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160380|NCT04924647|Dexamethasone|dexamethasone|mesh-list
14160381|NCT04924647|Lenalidomide|lenalidomide|mesh-list
14160382|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160383|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
14160384|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
14160385|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160386|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160387|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160388|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
14160389|NCT04924647|Hormones|hormones|mesh-ancestor
14160390|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160391|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160392|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160393|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
14160394|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14160395|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14160396|NCT04924647|Growth Substances|growth substances|mesh-ancestor
14160397|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
14160398|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
14160399|NCT04924192|Irinotecan|irinotecan|mesh-list
14160400|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14160401|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160402|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160403|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160404|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160405|NCT04923659|Nimodipine|nimodipine|mesh-list
14160406|NCT04923659|Carbamazepine|carbamazepine|mesh-list
14160407|NCT04923659|Lorazepam|lorazepam|mesh-list
14160408|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
14160409|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
14160410|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160411|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14160412|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14160413|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160414|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160415|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160416|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
14160417|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
14160418|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
14160419|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160420|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160421|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14160422|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160423|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14160424|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14160425|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14160426|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
14479012|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479013|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14160427|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
14160428|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
14160429|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14160430|NCT04923659|Analgesics|analgesics|mesh-ancestor
14160431|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
14160432|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14160433|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160434|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14160435|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14160436|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14160437|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14160438|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14160439|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
14160440|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
14160441|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14160442|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160443|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160444|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14160445|NCT04923737|Analgesics|analgesics|mesh-ancestor
14160446|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
14160447|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160448|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14160449|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14160450|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14160451|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160452|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160453|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181524|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14181525|NCT03281369|Leucovorin|leucovorin|mesh-list
14181526|NCT03281369|Linagliptin|linagliptin|mesh-list
14181527|NCT03281369|Paclitaxel|paclitaxel|mesh-list
14181528|NCT03281369|Fluorouracil|fluorouracil|mesh-list
14181529|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
14181530|NCT03281369|Atezolizumab|atezolizumab|mesh-list
14181531|NCT03281369|Ramucirumab|ramucirumab|mesh-list
14181532|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14181533|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14181534|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181535|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
14181536|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
14181537|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
14181538|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181539|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
14181540|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181541|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181542|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
14181543|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181544|NCT03281369|Antidotes|antidotes|mesh-ancestor
14181545|NCT03281369|Protective Agents|protective agents|mesh-ancestor
14181546|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
14181547|NCT03281369|Vitamins|vitamins|mesh-ancestor
14181548|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
14160454|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14160455|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14160456|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14160457|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
14160458|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160459|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160460|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14160461|NCT04922944|Vaccines|vaccines|mesh-list
14160462|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
14160463|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160464|NCT04922827|Infliximab|infliximab|mesh-list
14160465|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
14160466|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160467|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160468|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
14160469|NCT04922996|Calcium|calcium|mesh-list
14160470|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14160471|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160472|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
14160473|NCT04922996|Coagulants|coagulants|mesh-ancestor
14160474|NCT04923113|Amoxicillin|amoxicillin|mesh-list
14160475|NCT04923113|Minocycline|minocycline|mesh-list
14160476|NCT04923113|Rabeprazole|rabeprazole|mesh-list
14160477|NCT04923113|Bismuth|bismuth|mesh-list
14160478|NCT04923113|Antibodies|antibodies|mesh-list
14160479|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
14160480|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160481|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14160482|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160483|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14160484|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160485|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14160486|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160487|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160488|NCT04923113|Antacids|antacids|mesh-ancestor
14479014|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14479015|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
14479016|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
14160489|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14160490|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14160491|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
14160492|NCT04922359|Lidocaine|lidocaine|mesh-list
14160493|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
14160494|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
14160495|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479017|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
14479018|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479019|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479020|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14479021|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14479022|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479023|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
14479024|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
14160496|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160497|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
14160498|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160499|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14160500|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14160501|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14160502|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160503|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160504|NCT04922567|Prednisone|prednisone|mesh-list
14160505|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
14160506|NCT04922567|Doxorubicin|doxorubicin|mesh-list
14160507|NCT04922567|Vincristine|vincristine|mesh-list
14160508|NCT04922567|Lenalidomide|lenalidomide|mesh-list
14160509|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160510|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
14160511|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160512|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160513|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14160514|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
14479025|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14160515|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160516|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160517|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14766719|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
14766720|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766721|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
14160518|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14160519|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14160520|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160521|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160522|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160523|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
14160524|NCT04922567|Hormones|hormones|mesh-ancestor
14160525|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160526|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160527|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14160528|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
14160529|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
14160530|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
14160531|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14160532|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14160533|NCT04922567|Growth Substances|growth substances|mesh-ancestor
14160534|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
14160535|NCT04922450|Paclitaxel|paclitaxel|mesh-list
14160536|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14160537|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14160538|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160539|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
14160540|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
14160541|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
14160542|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160543|NCT04922658|Vinorelbine|vinorelbine|mesh-list
14160544|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14160545|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160546|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
14160547|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
14160548|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
14160549|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160550|NCT04922723|Daratumumab|daratumumab|mesh-list
14160551|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160552|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14160553|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160554|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160555|NCT04922034|Amoxicillin|amoxicillin|mesh-list
14160556|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14160557|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160558|NCT04922008|Capecitabine|capecitabine|mesh-list
14160559|NCT04922008|Trastuzumab|trastuzumab|mesh-list
14160560|NCT04922008|Vinorelbine|vinorelbine|mesh-list
14160561|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14160562|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
14160563|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160564|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160565|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14160566|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14160567|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14160568|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14160569|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14160570|NCT04922151|Ranibizumab|ranibizumab|mesh-list
14160571|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14160572|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14160573|NCT04922151|Growth Substances|growth substances|mesh-ancestor
14160574|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160575|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
14160576|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160577|NCT04921930|Artesunate|artesunate|mesh-list
14160578|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
14160579|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14160580|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14160581|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160582|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160583|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
14160584|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
14160585|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14160586|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
14160587|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
14160588|NCT04921878|Analgesics|analgesics|mesh-ancestor
14160589|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
14160590|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160591|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160592|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160593|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14160594|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160595|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160596|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160597|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14160598|NCT04921657|Simvastatin|simvastatin|mesh-list
14160599|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14160600|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14160601|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
14160602|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160603|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14160604|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14160605|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160606|NCT04921670|Infliximab|infliximab|mesh-list
14160607|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14160608|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160609|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160610|NCT04921904|Ramucirumab|ramucirumab|mesh-list
14160611|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160612|NCT04921982|Propranolol|propranolol|mesh-list
14160613|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14160614|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14160615|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160616|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160617|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160618|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160619|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14160620|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14160621|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
14160622|NCT04921566|Torsemide|torsemide|mesh-list
14160623|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14160624|NCT04921566|Diuretics|diuretics|mesh-ancestor
14160625|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
14160626|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160627|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14160628|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160629|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181549|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14181550|NCT03281369|Incretins|incretins|mesh-ancestor
14181551|NCT03281369|Hormones|hormones|mesh-ancestor
14181552|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181553|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14181554|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
14160630|NCT04921306|Clenbuterol|clenbuterol|mesh-list
14160631|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14160632|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14160633|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160634|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160635|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160636|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160637|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14160638|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
14160639|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160640|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14160641|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160642|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
14160643|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
14160644|NCT04921111|Vaccines|vaccines|mesh-list
14160645|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
14160646|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160647|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14160648|NCT04921111|Antacids|antacids|mesh-ancestor
14160649|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160650|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160651|NCT04921371|Listerine|listerine|mesh-list
14160652|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14160653|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160654|NCT04921124|Teriparatide|teriparatide|mesh-list
14160655|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14160656|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160657|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14160658|NCT04921046|Lidocaine|lidocaine|mesh-list
14160659|NCT04921046|Midazolam|midazolam|mesh-list
14160660|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14160661|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14160662|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160663|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160664|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14160665|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14160666|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14160667|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14160668|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
14160669|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
14160670|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
14160671|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
14160672|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160673|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160674|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
14160675|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
14160676|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160677|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14160678|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14160679|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14160680|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14160681|NCT04920968|Rituximab|rituximab|mesh-list
14160682|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
14160683|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14160684|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160685|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
14160686|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160687|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160688|NCT04920838|Acetaminophen|acetaminophen|mesh-list
14160689|NCT04920838|Ciclesonide|ciclesonide|mesh-list
14160690|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
14160691|NCT04920838|Telmisartan|telmisartan|mesh-list
14160692|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14160693|NCT04920838|Analgesics|analgesics|mesh-ancestor
14160694|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
14766722|NCT00627354|Hormones|hormones|mesh-ancestor
14766723|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766724|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160695|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160696|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160697|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
14160698|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14160699|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14160700|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14160701|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160702|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
14160703|NCT04920838|Hormones|hormones|mesh-ancestor
14160704|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160705|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14160706|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14160707|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160708|NCT04920747|Taxane|taxane|mesh-list
14160709|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160710|NCT04920760|Vitamin A|vitamin a|mesh-list
14160711|NCT04920760|Vitamins|vitamins|mesh-ancestor
14160712|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
14160713|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160714|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
14160715|NCT04920669|Bupivacaine|bupivacaine|mesh-list
14160716|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
14160717|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
14160718|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160719|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160720|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
14160721|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160722|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14160723|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14160724|NCT04920669|Analgesics|analgesics|mesh-ancestor
14160725|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14160726|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14160727|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14160728|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160729|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160730|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160731|NCT04920604|Anesthetics|anesthetics|mesh-list
14160732|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160733|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160734|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
14160735|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14160736|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
14160737|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160738|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160739|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14160740|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160741|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14160742|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
14160743|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160744|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160745|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14160746|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
14160747|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
14160748|NCT04920695|Protective Agents|protective agents|mesh-ancestor
14160749|NCT04920708|Fulvestrant|fulvestrant|mesh-list
14160750|NCT04920708|Palbociclib|palbociclib|mesh-list
14160751|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160752|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160753|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14160754|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14160755|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
14160756|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160757|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160758|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14160759|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160760|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160761|NCT04920565|Polymyxins|polymyxins|mesh-list
14160762|NCT04920565|Polymyxin B|polymyxin b|mesh-list
14160763|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14160764|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160765|NCT04920682|Iodine|iodine|mesh-list
14160766|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14160767|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160768|NCT04920682|Trace Elements|trace elements|mesh-ancestor
14160769|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
14160770|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160771|NCT04921033|Prednisolone|prednisolone|mesh-list
14160772|NCT04921033|Budesonide|budesonide|mesh-list
14160773|NCT04921033|Azathioprine|azathioprine|mesh-list
14160774|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160775|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
14160776|NCT04921033|Hormones|hormones|mesh-ancestor
14160777|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160778|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160779|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160780|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160781|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
14160782|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160783|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14160784|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14160785|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160786|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
14160787|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160788|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14160789|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160790|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
14160791|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160792|NCT04920357|Vaccines|vaccines|mesh-list
14160793|NCT04920357|Immunologic Factors|immunologic factors|mesh-ancestor
14160794|NCT04920357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160795|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
14160796|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14160797|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
14160798|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160799|NCT04920448|Expectorants|expectorants|mesh-ancestor
14160800|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160801|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14160802|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
14160803|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160804|NCT04920448|Protective Agents|protective agents|mesh-ancestor
14160805|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160806|NCT04920448|Antidotes|antidotes|mesh-ancestor
14160807|NCT04920500|Cytarabine|cytarabine|mesh-list
14160808|NCT04920500|Daunorubicin|daunorubicin|mesh-list
14160809|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14160810|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
14160811|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160812|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160813|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
14160814|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160815|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160816|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
14160817|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160818|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14160819|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14160820|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160821|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160822|NCT04920032|Irinotecan|irinotecan|mesh-list
14160823|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14160824|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14160825|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160826|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160827|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160828|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
14160829|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
14160830|NCT04919460|Coagulants|coagulants|mesh-ancestor
14160831|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
14160832|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181555|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181556|NCT03278509|Metoprolol|metoprolol|mesh-list
14181557|NCT03278509|Bisoprolol|bisoprolol|mesh-list
14181558|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14181559|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14181560|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
14181561|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
14181562|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181563|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181564|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14181565|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14181566|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14181567|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
14181568|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14181569|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181570|NCT03262454|Atezolizumab|atezolizumab|mesh-list
14181571|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181572|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
14181573|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181574|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160833|NCT04919317|Dexamethasone|dexamethasone|mesh-list
14160834|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160835|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
14160836|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
14160837|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160838|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160839|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160840|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
14160841|NCT04919317|Hormones|hormones|mesh-ancestor
14160842|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160843|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160844|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160845|NCT04919252|Vedolizumab|vedolizumab|mesh-list
14160846|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160847|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
14160848|NCT04919174|Remifentanil|remifentanil|mesh-list
14160849|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14160850|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160851|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160852|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14160853|NCT04919174|Analgesics|analgesics|mesh-ancestor
14160854|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
14160855|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160856|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14160857|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14160858|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14160859|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
14160860|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160861|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160862|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14160863|NCT04919174|Narcotics|narcotics|mesh-ancestor
14160864|NCT04918914|Dapsone|dapsone|mesh-list
14160865|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160866|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
14160867|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14160868|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14160869|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14160870|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160871|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160872|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
14160873|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14160874|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
14160875|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14160876|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14160877|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160878|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
14160879|NCT04918589|Coagulants|coagulants|mesh-ancestor
14160880|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
14160881|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14160882|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14160883|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160884|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
14160885|NCT04918576|Coagulants|coagulants|mesh-ancestor
14160886|NCT04918758|Sucralfate|sucralfate|mesh-list
14160887|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14160888|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160889|NCT04918524|Aspirin|aspirin|mesh-list
14160890|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
14160891|NCT04918524|Prednisone|prednisone|mesh-list
14160892|NCT04918524|Heparin|heparin|mesh-list
14160893|NCT04918524|Enoxaparin|enoxaparin|mesh-list
14160894|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14160895|NCT04918524|Tinzaparin|tinzaparin|mesh-list
14160896|NCT04918524|Dalteparin|dalteparin|mesh-list
14160897|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160898|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
14160899|NCT04918524|Hormones|hormones|mesh-ancestor
14160900|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160901|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160902|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160903|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160904|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14160905|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14160906|NCT04918524|Analgesics|analgesics|mesh-ancestor
14160907|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
14160908|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160909|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14160910|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14160911|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14160912|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160913|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14160914|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14160915|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160916|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
14160917|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
14160918|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
14160919|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14160920|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14160921|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160922|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
14160923|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14160924|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
14160925|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14160926|NCT04918719|Expectorants|expectorants|mesh-ancestor
14160927|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160928|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14160929|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
14160930|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160931|NCT04918719|Protective Agents|protective agents|mesh-ancestor
14160932|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160933|NCT04918719|Antidotes|antidotes|mesh-ancestor
14160934|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
14160935|NCT04918563|Acetylcholine|acetylcholine|mesh-list
14160936|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
14160937|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14160938|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
14160939|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160940|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160941|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160942|NCT04918862|Granisetron|granisetron|mesh-list
14160943|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160944|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
14160945|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
14160946|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160947|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160948|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14160949|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
14160950|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14160951|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160952|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
14160953|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14160954|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14160955|NCT04918953|Prednisolone|prednisolone|mesh-list
14160956|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
14160957|NCT04918953|Budesonide|budesonide|mesh-list
14160958|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14160959|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
14160960|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160961|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
14160962|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
14160963|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14160964|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160965|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14160966|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
14160967|NCT04918953|Hormones|hormones|mesh-ancestor
14160968|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14160969|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14160970|NCT04918953|Protective Agents|protective agents|mesh-ancestor
14160971|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14160972|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160973|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14160974|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14160975|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
14160976|NCT04918433|Anesthetics|anesthetics|mesh-list
14160977|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14160978|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160979|NCT04918264|Capecitabine|capecitabine|mesh-list
14160980|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14160981|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
14160982|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160983|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14160984|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
14160985|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14160986|NCT04917718|Tacrolimus|tacrolimus|mesh-list
14160987|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14160988|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
14160989|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160990|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14160991|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14160992|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160993|NCT04917692|Empagliflozin|empagliflozin|mesh-list
14160994|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14160995|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14160996|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14160997|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14160998|NCT04917627|Vancomycin|vancomycin|mesh-list
14160999|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14161000|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161001|NCT04917900|Paclitaxel|paclitaxel|mesh-list
14161002|NCT04917900|Trastuzumab|trastuzumab|mesh-list
14161003|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14161004|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14161005|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161006|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
14161007|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
14161008|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
14161009|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161010|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161011|NCT04917757|Dexamethasone|dexamethasone|mesh-list
14161012|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161013|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
14161014|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
14161015|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161016|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161017|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161018|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
14161019|NCT04917757|Hormones|hormones|mesh-ancestor
14161020|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161021|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161022|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161023|NCT04917497|Simendan|simendan|mesh-list
14161024|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14161025|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
14161026|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14161027|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14161028|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161029|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161030|NCT04917497|Protective Agents|protective agents|mesh-ancestor
14161031|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161032|NCT04917458|Vitamin D|vitamin d|mesh-list
14161033|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
14161034|NCT04917458|Vitamins|vitamins|mesh-ancestor
14161035|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
14161036|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161037|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14161038|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14161039|NCT04917484|Octreotide|octreotide|mesh-list
14161040|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14161041|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161042|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161043|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161044|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14161045|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181580|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
14181581|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14181582|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14181583|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181584|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
14181585|NCT03216083|Coagulants|coagulants|mesh-ancestor
14181586|NCT03194932|Cytarabine|cytarabine|mesh-list
14181587|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
14181588|NCT03194932|Methotrexate|methotrexate|mesh-list
14181589|NCT03194932|Azacitidine|azacitidine|mesh-list
14181590|NCT03194932|Venetoclax|venetoclax|mesh-list
14181591|NCT03194932|Idarubicin|idarubicin|mesh-list
14181592|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14181593|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
14181594|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14181595|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181596|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181597|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
14181598|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181599|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181600|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
14181601|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181602|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14181603|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181604|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
14181605|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14181606|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14181607|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
14181608|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181609|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14181610|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14181611|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14181612|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14181613|NCT03194867|Cemiplimab|cemiplimab|mesh-list
14181614|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181615|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181616|NCT03192215|Aspirin|aspirin|mesh-list
14181617|NCT03192215|Apixaban|apixaban|mesh-list
14181618|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14181619|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14181620|NCT03192215|Analgesics|analgesics|mesh-ancestor
14181621|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
14181622|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181623|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181624|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14181625|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14181626|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14181627|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14181628|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181629|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14181630|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14181631|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181632|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
14181633|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14181634|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
14181635|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14181636|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
14181637|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
14181638|NCT03175198|Dabigatran|dabigatran|mesh-list
14181639|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
14181640|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14181641|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
14181642|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161046|NCT04917406|Dexamethasone|dexamethasone|mesh-list
14161047|NCT04917406|Lidocaine|lidocaine|mesh-list
14161048|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161049|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
14161050|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
14161051|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161052|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161053|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161054|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
14161055|NCT04917406|Hormones|hormones|mesh-ancestor
14161056|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161057|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161058|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161059|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
14161060|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
14161061|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161062|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
14161063|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14161064|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14161065|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14161066|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14161067|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161068|NCT04917055|Dexamethasone|dexamethasone|mesh-list
14161069|NCT04917055|Epinephrine|epinephrine|mesh-list
14161070|NCT04917055|Ropivacaine|ropivacaine|mesh-list
14161071|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161072|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
14161073|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
14161074|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161075|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161076|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161077|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
14161078|NCT04917055|Hormones|hormones|mesh-ancestor
14161079|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161080|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161081|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161082|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
14161083|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
14161084|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161085|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
14161086|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14161087|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14161088|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
14161089|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161090|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161091|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14161092|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14161093|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14161094|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
14161095|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
14161096|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
14161097|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14161098|NCT04917250|Gemcitabine|gemcitabine|mesh-list
14161099|NCT04917250|Dexamethasone|dexamethasone|mesh-list
14161100|NCT04917250|Etoposide|etoposide|mesh-list
14161101|NCT04917250|Pegaspargase|pegaspargase|mesh-list
14161102|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161103|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
14161104|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
14161105|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161106|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161107|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161108|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
14161109|NCT04917250|Hormones|hormones|mesh-ancestor
14161110|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161111|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161112|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161113|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14161114|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
14161115|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161116|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
14161117|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161118|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161119|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161120|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
14161121|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14161122|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14161123|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14161124|NCT04916925|Vitamin D|vitamin d|mesh-list
14161125|NCT04916925|Vitamins|vitamins|mesh-ancestor
14161126|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
14161127|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161128|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14161129|NCT04916951|Amoxicillin|amoxicillin|mesh-list
14161130|NCT04916951|Cephalexin|cephalexin|mesh-list
14161131|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14161132|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161133|NCT04916899|Rifampin|rifampin|mesh-list
14161134|NCT04916899|Isoniazid|isoniazid|mesh-list
14161135|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
14161136|NCT04916899|Ethambutol|ethambutol|mesh-list
14161137|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14161138|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
14161139|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14161140|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161141|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
14161142|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14161143|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161144|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161145|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14161146|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14161147|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14161148|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14161149|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14161150|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14161151|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14161152|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14161153|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
14161154|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14161155|NCT04916886|Vaccines|vaccines|mesh-list
14161156|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
14161157|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161158|NCT04916821|Propolis|propolis|mesh-list
14161159|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161160|NCT04916522|Colchicine|colchicine|mesh-list
14161161|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
14161162|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14161163|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
14161164|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
14161165|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
14161166|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161167|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161168|NCT04916665|Teduglutide|teduglutide|mesh-list
14161169|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161170|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14161171|NCT04916665|Protective Agents|protective agents|mesh-ancestor
14161172|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161173|NCT04916509|Fulvestrant|fulvestrant|mesh-list
14161174|NCT04916509|Palbociclib|palbociclib|mesh-list
14161175|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14161176|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161177|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161178|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14161179|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14161180|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
14161181|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161182|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161183|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14161184|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161185|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161186|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14161187|NCT04916548|Ketamine|ketamine|mesh-list
14161188|NCT04916548|Analgesics|analgesics|mesh-ancestor
14161189|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
14161190|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161191|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161192|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14161193|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14161194|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
14161195|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
14161196|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161197|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14161198|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14161199|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161200|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161201|NCT04916574|Antibodies|antibodies|mesh-list
14161202|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
14161203|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161204|NCT04916418|Ropivacaine|ropivacaine|mesh-list
14161205|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
14161206|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
14161207|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161208|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161209|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
14161210|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161211|NCT04916392|Bupivacaine|bupivacaine|mesh-list
14161212|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
14161213|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
14161214|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161215|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766725|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14766726|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766727|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14766728|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14766729|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14766730|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766731|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766732|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
14766733|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
14766734|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
14766735|NCT00627354|Analgesics|analgesics|mesh-ancestor
14766736|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
14766737|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766738|NCT00627432|Gemcitabine|gemcitabine|mesh-list
14766739|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
14161216|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
14161217|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161218|NCT04916353|Triamcinolone|triamcinolone|mesh-list
14161219|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14161220|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14766740|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766741|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
14766742|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766743|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766744|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
14766745|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14766746|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766747|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766748|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
14766749|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766750|NCT00627471|Insulin|insulin|mesh-list
14766751|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14766752|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
14766753|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14766754|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766755|NCT00627536|Mitogens|mitogens|mesh-list
14766756|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
14766757|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766758|NCT00627575|Lamotrigine|lamotrigine|mesh-list
14161221|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14161222|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161223|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
14161224|NCT04916353|Hormones|hormones|mesh-ancestor
14161225|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161226|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161227|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161228|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
14161229|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161230|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161231|NCT04916691|Ropivacaine|ropivacaine|mesh-list
14161232|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
14161233|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
14161234|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766759|NCT00627575|Phenytoin|phenytoin|mesh-list
14766760|NCT00627575|Atorvastatin|atorvastatin|mesh-list
14161235|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161236|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
14161237|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161238|NCT04916327|Antioxidants|antioxidants|mesh-list
14161239|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161240|NCT04916327|Protective Agents|protective agents|mesh-ancestor
14161241|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161242|NCT04916093|Metformin|metformin|mesh-list
14161243|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14161244|NCT04916093|Vildagliptin|vildagliptin|mesh-list
14161245|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14161246|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161247|NCT04916093|Incretins|incretins|mesh-ancestor
14161248|NCT04916093|Hormones|hormones|mesh-ancestor
14161249|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161250|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14161251|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
14161252|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161253|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161254|NCT04915846|Tamoxifen|tamoxifen|mesh-list
14161255|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14161256|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
14161257|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161258|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766761|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14766762|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14766763|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
14766764|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766765|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14766766|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14766767|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766768|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
14766769|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14766770|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766771|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14766772|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766773|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14766774|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13955378|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13955379|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
13955380|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
13955381|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955382|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955383|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955384|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
14766775|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161259|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161260|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161261|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14161262|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14161263|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14161264|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
14161265|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14161266|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161267|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
14766776|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766777|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14766778|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13955385|NCT03190642|Hormones|hormones|mesh-ancestor
13955386|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955387|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13955388|NCT03190642|Protective Agents|protective agents|mesh-ancestor
13955389|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13955390|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955391|NCT03190616|Apatinib|apatinib|mesh-list
13955392|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955393|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13955394|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955395|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955396|NCT03190668|Cefazolin|cefazolin|mesh-list
13955397|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
13955398|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14766779|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14766780|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14766781|NCT00627653|Fenofibrate|fenofibrate|mesh-list
14766782|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14766783|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
14766784|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766785|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14766786|NCT00627666|Leucovorin|leucovorin|mesh-list
14766787|NCT00627666|Methotrexate|methotrexate|mesh-list
14766788|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
14766789|NCT00627666|Fludarabine|fludarabine|mesh-list
14766790|NCT00627666|Busulfan|busulfan|mesh-list
14766791|NCT00627666|Calcium|calcium|mesh-list
14766792|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14161268|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14161269|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
14161270|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161271|NCT04916080|Expectorants|expectorants|mesh-ancestor
14161272|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
14161273|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14161274|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
14161275|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161276|NCT04916080|Protective Agents|protective agents|mesh-ancestor
14161277|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161278|NCT04916080|Antidotes|antidotes|mesh-ancestor
14161279|NCT04915963|Vitamin D|vitamin d|mesh-list
14161280|NCT04915963|Vitamins|vitamins|mesh-ancestor
14161281|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
14161282|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161283|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14161284|NCT04915807|Paclitaxel|paclitaxel|mesh-list
14161285|NCT04915807|Irinotecan|irinotecan|mesh-list
14161286|NCT04915807|Ramucirumab|ramucirumab|mesh-list
14161287|NCT04915807|Taxane|taxane|mesh-list
14161288|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14161289|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161290|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
14161291|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
14161292|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
14161293|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161294|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14161295|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14161296|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766793|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
14766794|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14766795|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766796|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14766797|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
14766798|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14766799|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14766800|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
14766801|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766802|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766803|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
14766804|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766805|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14766806|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161297|NCT04915508|Hormones|hormones|mesh-list
14161298|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161299|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161300|NCT04915612|Cytarabine|cytarabine|mesh-list
14161301|NCT04915612|Daunorubicin|daunorubicin|mesh-list
14161302|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
14161303|NCT04915612|Calicheamicins|calicheamicins|mesh-list
14161304|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14161305|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
14161306|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161307|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161308|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
14161309|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161310|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161311|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
14161312|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161313|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14161314|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14766807|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
14161315|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14161316|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161317|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181643|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181644|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
14181645|NCT03164980|Trabectedin|trabectedin|mesh-list
14181646|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14181647|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
14181648|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181649|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181650|NCT03149003|Bevacizumab|bevacizumab|mesh-list
14181651|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181652|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181653|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14181654|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14181655|NCT03149003|Growth Substances|growth substances|mesh-ancestor
14181656|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181657|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181658|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
14181659|NCT03139370|Fludarabine|fludarabine|mesh-list
14181660|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181661|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
14181662|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181663|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14181664|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14181665|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
14181666|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181667|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181668|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14181669|NCT03126799|Bevacizumab|bevacizumab|mesh-list
14181670|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14181671|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181672|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181673|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14181674|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14181675|NCT03126799|Growth Substances|growth substances|mesh-ancestor
14181676|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181677|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181678|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14181679|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181680|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181681|NCT03099174|Letrozole|letrozole|mesh-list
14181682|NCT03099174|Fulvestrant|fulvestrant|mesh-list
14181683|NCT03099174|Anastrozole|anastrozole|mesh-list
14181684|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181685|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14181686|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14181687|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181688|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181689|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14181690|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
14181691|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181692|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181693|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14181694|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14766808|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14161318|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14161319|NCT04915586|Plasminogen|plasminogen|mesh-list
14161320|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14161321|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14161322|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938435|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938436|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
14938437|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938438|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938439|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
14938440|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
14938441|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14161323|NCT04915482|Rituximab|rituximab|mesh-list
14161324|NCT04915482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161325|NCT04915482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161326|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
14161327|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161328|NCT04915482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14161329|NCT04915365|Acetazolamide|acetazolamide|mesh-list
14161330|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
14161331|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14161332|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161333|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161334|NCT04915365|Diuretics|diuretics|mesh-ancestor
14161335|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
14766809|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14161336|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161337|NCT04915287|Maleic acid|maleic acid|mesh-list
14161338|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161339|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161340|NCT04915456|Prednisolone|prednisolone|mesh-list
14161341|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161342|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
14161343|NCT04915456|Hormones|hormones|mesh-ancestor
14161344|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161345|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161346|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161347|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161348|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
14161349|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
14161350|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14161351|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161352|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161353|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
14161354|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14161355|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161356|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161357|NCT04914910|Insulin|insulin|mesh-list
14161358|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14161359|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161360|NCT04914936|Rifampin|rifampin|mesh-list
14161361|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
14161362|NCT04914936|Omeprazole|omeprazole|mesh-list
14161363|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
14161364|NCT04914936|Calcium|calcium|mesh-list
14161365|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14161366|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161367|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14161368|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766810|NCT00627666|Antidotes|antidotes|mesh-ancestor
14766811|NCT00627666|Protective Agents|protective agents|mesh-ancestor
14766812|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
14766813|NCT00627666|Vitamins|vitamins|mesh-ancestor
14766814|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
14766815|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
14766816|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14766817|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14766818|NCT00627692|Prucalopride|prucalopride|mesh-list
14766819|NCT00627692|Laxatives|laxatives|mesh-ancestor
14766820|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766821|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14766822|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14766823|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
14938442|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161369|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14161370|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161371|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161372|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14161373|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
14161374|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14161375|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161376|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
14161377|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14161378|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14161379|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14161380|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14161381|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14161382|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14161383|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14161384|NCT04914936|Antacids|antacids|mesh-ancestor
14161385|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161386|NCT04914390|Paclitaxel|paclitaxel|mesh-list
14161387|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14161388|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161389|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
14161390|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
14161391|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
14161392|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161393|NCT04914598|Cisplatin|cisplatin|mesh-list
14161394|NCT04914598|Endostar protein|endostar protein|mesh-list
14161395|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161396|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14161397|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14161398|NCT04914598|Growth Substances|growth substances|mesh-ancestor
14161399|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161400|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
14161401|NCT04913987|Cimetidine|cimetidine|mesh-list
14161402|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14161403|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161404|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14161405|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
14161406|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
14161407|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161408|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161409|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161410|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14161411|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14161412|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161413|NCT04914247|Selexipag|selexipag|mesh-list
14161414|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14161415|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
14161416|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14161417|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161418|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161419|NCT04913714|Vaccines|vaccines|mesh-list
14161420|NCT04913714|Immunologic Factors|immunologic factors|mesh-ancestor
14161421|NCT04913714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161422|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
14161423|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14161424|NCT04913831|Protective Agents|protective agents|mesh-ancestor
14161425|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161426|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
14161427|NCT04913610|Ivermectin|ivermectin|mesh-list
14161428|NCT04913610|Albendazole|albendazole|mesh-list
14161429|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14161430|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161431|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
14161432|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
14161433|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14161434|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14161435|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14161436|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14161437|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14161438|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161439|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181714|NCT03075826|Guadecitabine|guadecitabine|mesh-list
14181715|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181716|NCT03072238|Prednisone|prednisone|mesh-list
14181717|NCT03072238|Prednisolone|prednisolone|mesh-list
14181718|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14181719|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
14181720|NCT03072238|Hormones|hormones|mesh-ancestor
14181721|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181722|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181723|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14181724|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181725|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
14181726|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14181732|NCT03038672|Nivolumab|nivolumab|mesh-list
14181733|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
14181734|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
14181735|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14181736|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181737|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181738|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14181739|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181740|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
14938443|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14938444|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14938445|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
14938446|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
14181741|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181759|NCT03029702|Metformin|metformin|mesh-list
14181760|NCT03029702|Glyburide|glyburide|mesh-list
14181761|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14181762|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181763|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
14181764|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181765|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181766|NCT02993731|Gemcitabine|gemcitabine|mesh-list
14181767|NCT02993731|Paclitaxel|paclitaxel|mesh-list
14181768|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14766824|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766825|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766826|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766827|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
14766828|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14766829|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14766830|NCT00627731|Prednisolone|prednisolone|mesh-list
14766831|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
14938447|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161440|NCT04913480|Durvalumab|durvalumab|mesh-list
14161441|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161442|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161443|NCT04913922|Nivolumab|nivolumab|mesh-list
14161444|NCT04913922|Azacitidine|azacitidine|mesh-list
14161445|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161446|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161447|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14161448|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161449|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14161450|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
14161451|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161452|NCT04913389|Acetazolamide|acetazolamide|mesh-list
14161453|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
14161454|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14161455|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161456|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161457|NCT04913389|Diuretics|diuretics|mesh-ancestor
14161458|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
14161459|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161460|NCT04913402|Sufentanil|sufentanil|mesh-list
14161461|NCT04913402|Dsuvia|dsuvia|mesh-list
14161462|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14161463|NCT04913402|Narcotics|narcotics|mesh-ancestor
14161464|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161465|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161466|NCT04913402|Analgesics|analgesics|mesh-ancestor
14161467|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
14161468|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161469|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14161470|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14161471|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
14161472|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
14161473|NCT04913103|Rituximab|rituximab|mesh-list
14161474|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14161475|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161476|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161477|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
14161478|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161479|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14161480|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14161481|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
14161482|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161483|NCT04912934|Insulin|insulin|mesh-list
14161484|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14161485|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161486|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14161487|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161488|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161489|NCT04912700|Vaccines|vaccines|mesh-list
14161490|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
14161491|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161492|NCT04912765|Nivolumab|nivolumab|mesh-list
14161493|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161494|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161495|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14161496|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161497|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
14161498|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
14161499|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14161500|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14161501|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161502|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161503|NCT04912726|Urological Agents|urological agents|mesh-ancestor
14161504|NCT04912596|Albuterol|albuterol|mesh-list
14161505|NCT04912596|Procaterol|procaterol|mesh-list
14161506|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
14161507|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14161508|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
14161509|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161510|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161511|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14161512|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
14161513|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
14161514|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14161515|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14161516|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14161517|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14161518|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14161519|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161520|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161521|NCT04912596|Miotics|miotics|mesh-ancestor
14161522|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14161523|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14161524|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14161525|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14161526|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
14161527|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
14161528|NCT04912167|Valsartan|valsartan|mesh-list
14161529|NCT04912167|Enalapril|enalapril|mesh-list
14161530|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14161531|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14161532|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14161533|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14161534|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161535|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14161536|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
14161537|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161538|NCT04912271|Dexamethasone|dexamethasone|mesh-list
14161539|NCT04912271|Aprepitant|aprepitant|mesh-list
14161540|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
14161541|NCT04912271|Palonosetron|palonosetron|mesh-list
14161542|NCT04912271|Granisetron|granisetron|mesh-list
14161543|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161544|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
14161545|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
14161546|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161547|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161548|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161549|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
14161550|NCT04912271|Hormones|hormones|mesh-ancestor
14161551|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161552|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161553|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161554|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14161555|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161556|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161557|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14161558|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14161559|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
14161560|NCT04912193|Antithrombins|antithrombins|mesh-list
14161561|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
14161562|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14161563|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
14161564|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161565|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161566|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
14161567|NCT04912258|Irinotecan|irinotecan|mesh-list
14161568|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14161569|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14161570|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161571|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161572|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161573|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14161574|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
14161575|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161576|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14161577|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14161578|NCT04912128|Growth Substances|growth substances|mesh-ancestor
14161579|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161580|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
14161581|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161582|NCT04911959|Lenvatinib|lenvatinib|mesh-list
14161583|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161584|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14161585|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161586|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161587|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14161588|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14161589|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161590|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
14161591|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161592|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
14161593|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14161594|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
14161595|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161596|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161597|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14161598|NCT04912011|Diuretics|diuretics|mesh-ancestor
14161599|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
14181769|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181770|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
14181771|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
14181772|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
14181773|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181774|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181775|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
14181776|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
14181777|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181778|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181779|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181780|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
14181781|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181782|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
14181783|NCT02992743|Fludarabine|fludarabine|mesh-list
14181784|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181785|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
14181786|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181787|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14181788|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14181789|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
14181790|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181791|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181792|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14181793|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
14181794|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14181795|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181796|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181797|NCT02965703|Aspirin|aspirin|mesh-list
14181798|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14181799|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14181800|NCT02965703|Analgesics|analgesics|mesh-ancestor
14181801|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
14181802|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181803|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181804|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14181805|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14181806|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14181807|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14181808|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181809|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14181810|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14766832|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14766833|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
14766834|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14766835|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
14766836|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
14766837|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766838|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766839|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14766840|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
14766841|NCT00627731|Hormones|hormones|mesh-ancestor
14181811|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181812|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
14181816|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
14181817|NCT02936752|Entinostat|entinostat|mesh-list
14181818|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14181819|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181820|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161600|NCT04911621|Temozolomide|temozolomide|mesh-list
14161601|NCT04911621|Vaccines|vaccines|mesh-list
14161602|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14161603|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
14161604|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161605|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161606|NCT04911621|Immunologic Factors|immunologic factors|mesh-ancestor
14161607|NCT04911621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161608|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
14161609|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
14161610|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14161611|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14161612|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161613|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161614|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161615|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14161616|NCT04911127|Cannabidiol|cannabidiol|mesh-list
14161617|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
14161618|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
14161619|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14161620|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14161621|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161622|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
14161623|NCT04911413|Coagulants|coagulants|mesh-ancestor
14161624|NCT04910477|Atropine|atropine|mesh-list
14161625|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
14161626|NCT04910477|Neostigmine|neostigmine|mesh-list
14161627|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14161628|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161629|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161630|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14161631|NCT04910477|Analgesics|analgesics|mesh-ancestor
14161632|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
14161633|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161634|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14161635|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14161636|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14161637|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
14161638|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161639|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161640|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14161641|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14161642|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14161643|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
14161644|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14161645|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
14161646|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
14161647|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
14161648|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14161649|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14161650|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
14161651|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14161652|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161653|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14161654|NCT04910347|Nivolumab|nivolumab|mesh-list
14161655|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161656|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161657|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14161658|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161659|NCT04910386|Gemcitabine|gemcitabine|mesh-list
14161660|NCT04910386|Cisplatin|cisplatin|mesh-list
14161661|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161662|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14161663|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
14161664|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161665|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
14161666|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161667|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161668|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161669|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
14161670|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161671|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14161672|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161673|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
14161674|NCT04910594|Hematinics|hematinics|mesh-ancestor
14161675|NCT04910126|Doxorubicin|doxorubicin|mesh-list
14161676|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14161677|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14161678|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161679|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14161680|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14161681|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161682|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161683|NCT04910178|Empagliflozin|empagliflozin|mesh-list
14161684|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
14161685|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14161686|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14161687|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161688|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14161689|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161690|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14161691|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161692|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14161693|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14161694|NCT04910178|Protective Agents|protective agents|mesh-ancestor
14161695|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
14161696|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14161697|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
14161698|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14161699|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161700|NCT04910165|Ropivacaine|ropivacaine|mesh-list
14161701|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
14161702|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
14161703|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161704|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161705|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
14161706|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161707|NCT04909931|Vitamin D|vitamin d|mesh-list
14161708|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
14161709|NCT04909931|Vitamins|vitamins|mesh-ancestor
14161710|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
14161711|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161712|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14161713|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14161714|NCT04909918|Dexamethasone|dexamethasone|mesh-list
14161715|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
14161716|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14161717|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14161718|NCT04909918|Prednisolone|prednisolone|mesh-list
14161719|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
14161720|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14161721|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
14161722|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161723|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
14161724|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
14161725|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161726|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161727|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161728|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
14161729|NCT04909918|Hormones|hormones|mesh-ancestor
14161730|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161731|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161732|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161733|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14161734|NCT04909918|Protective Agents|protective agents|mesh-ancestor
14161735|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
14161736|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161737|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161738|NCT04909619|Anesthetics|anesthetics|mesh-list
14161739|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
14161740|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161741|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161742|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
14161743|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181821|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181822|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161744|NCT04909775|Gemcitabine|gemcitabine|mesh-list
14161745|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161746|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14161747|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
14161748|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161749|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
14161750|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161751|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161752|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161753|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
14161754|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161755|NCT04909333|Exenatide|exenatide|mesh-list
14161756|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14161757|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14161758|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161759|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14161760|NCT04909333|Incretins|incretins|mesh-ancestor
14161761|NCT04909333|Hormones|hormones|mesh-ancestor
14161762|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161763|NCT04908982|Aspirin|aspirin|mesh-list
14161764|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14161765|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14161766|NCT04908982|Analgesics|analgesics|mesh-ancestor
14161767|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
14161768|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161769|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161770|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161771|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14161772|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14161773|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14161774|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161775|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14161776|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14161777|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161778|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
14161779|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
14161780|NCT04909255|Mirabegron|mirabegron|mesh-list
14161781|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14161782|NCT04909255|Oxybutynin|oxybutynin|mesh-list
14161783|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14161784|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14161785|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
14161786|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161787|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161788|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161789|NCT04909255|Urological Agents|urological agents|mesh-ancestor
14161790|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14161791|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14161792|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14161793|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
14161794|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
14161795|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
14161796|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161797|NCT04909151|Methamphetamine|methamphetamine|mesh-list
14161798|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14161799|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161800|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
14161801|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
14161802|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161803|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
14161804|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161805|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161806|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
14161807|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14161808|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14161809|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14161810|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14161811|NCT04908865|Belimumab|belimumab|mesh-list
14161812|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14161813|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
14161814|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161815|NCT04908566|Folfirinox|folfirinox|mesh-list
14161816|NCT04908566|Antibodies|antibodies|mesh-list
14161817|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
14161818|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
14161819|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161820|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161821|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
14161822|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
14161823|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14161824|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14161825|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161826|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161827|NCT04908657|Urological Agents|urological agents|mesh-ancestor
14161828|NCT04908813|Capecitabine|capecitabine|mesh-list
14161829|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
14161830|NCT04908813|Trastuzumab|trastuzumab|mesh-list
14161831|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14161832|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
14161833|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161834|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161835|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14161836|NCT04908345|Fentanyl|fentanyl|mesh-list
14161837|NCT04908345|Methadone|methadone|mesh-list
14161838|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14161839|NCT04908345|Narcotics|narcotics|mesh-ancestor
14161840|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161841|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161842|NCT04908345|Analgesics|analgesics|mesh-ancestor
14161843|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
14161844|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161845|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14161846|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14161847|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
14161848|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
14161849|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
14161850|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
14161851|NCT04907708|Metformin|metformin|mesh-list
14161852|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14161853|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161854|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
14161855|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14161856|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14161857|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161858|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
14161859|NCT04907812|Coagulants|coagulants|mesh-ancestor
14161860|NCT04907864|Ibuprofen|ibuprofen|mesh-list
14161861|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14161862|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14161863|NCT04907864|Analgesics|analgesics|mesh-ancestor
14161864|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
14161865|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161866|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161867|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14161868|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14161869|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14161870|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161871|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161872|NCT04907721|Glucagon|glucagon|mesh-list
14161873|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14161874|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161875|NCT04907721|Hormones|hormones|mesh-ancestor
14161876|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14161877|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161878|NCT04907721|Incretins|incretins|mesh-ancestor
14161879|NCT04907682|Ribavirin|ribavirin|mesh-list
14161880|NCT04907682|Favipiravir|favipiravir|mesh-list
14161881|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
14161882|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161883|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
14161884|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161885|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14161886|NCT04907838|BQ 788|bq 788|mesh-list
14161887|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14161888|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14161889|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161890|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14161891|NCT04907474|Phenylephrine|phenylephrine|mesh-list
14161892|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
14161893|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14161894|NCT04907474|Tropicamide|tropicamide|mesh-list
14161895|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14161896|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14161897|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
14161898|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
14161899|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161900|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161901|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
14161902|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14161903|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
14161904|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
14161905|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14161906|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14161907|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14161908|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
14161909|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161910|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161911|NCT04907474|Protective Agents|protective agents|mesh-ancestor
14161912|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14161913|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14161914|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
14161915|NCT04907747|Amoxicillin|amoxicillin|mesh-list
14161916|NCT04907747|Furazolidone|furazolidone|mesh-list
14161917|NCT04907747|Esomeprazole|esomeprazole|mesh-list
14161918|NCT04907747|Bismuth|bismuth|mesh-list
14161919|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14161920|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161921|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14161922|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14161923|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14161924|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161925|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161926|NCT04907747|Antacids|antacids|mesh-ancestor
14161927|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14161928|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14161929|NCT04907747|Renal Agents|renal agents|mesh-ancestor
14766842|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766843|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14766844|NCT00627731|Protective Agents|protective agents|mesh-ancestor
14161930|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14161931|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14161932|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14161933|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14161934|NCT04907123|Diuretics|diuretics|mesh-list
14161935|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
14161936|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161937|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14161938|NCT04907084|Fenofibrate|fenofibrate|mesh-list
14161939|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14161940|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
14161941|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161942|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14161943|NCT04907110|Niacinamide|niacinamide|mesh-list
14161944|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
14161945|NCT04907110|Vitamins|vitamins|mesh-ancestor
14161946|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
14161947|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181844|NCT02888067|Bromides|bromides|mesh-list
14181845|NCT02888067|Rocuronium|rocuronium|mesh-list
14181846|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
14181847|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14181848|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14161948|NCT04907344|Paclitaxel|paclitaxel|mesh-list
14161949|NCT04907344|Carboplatin|carboplatin|mesh-list
14161950|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14161951|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14161952|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
14161953|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
14161954|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
14766845|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14161955|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161956|NCT04907019|Rifampin|rifampin|mesh-list
14161957|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14161958|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
14161959|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14161960|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14161961|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
14161962|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14161963|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14161964|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161965|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14161966|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14161967|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14161968|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14161969|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14161970|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14161971|NCT04906889|Lidocaine|lidocaine|mesh-list
14161972|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
14161973|NCT04906889|Remifentanil|remifentanil|mesh-list
14161974|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
14161975|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
14161976|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14161977|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14161978|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
14161979|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14161980|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14161981|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14161982|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14161983|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14161984|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14161985|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14161986|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14161987|NCT04906889|Analgesics|analgesics|mesh-ancestor
14161988|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14161989|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14161990|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14161991|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
14161992|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14161993|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14161994|NCT04906889|Narcotics|narcotics|mesh-ancestor
14161995|NCT04906876|Gemcitabine|gemcitabine|mesh-list
14161996|NCT04906876|Docetaxel|docetaxel|mesh-list
14161997|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14161998|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
14161999|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162000|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162001|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
14162002|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162003|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162004|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162005|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
14162006|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162007|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
14162008|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
14162009|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162010|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
14162011|NCT04906772|Ketamine|ketamine|mesh-list
14162012|NCT04906772|Propofol|propofol|mesh-list
14162013|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14162014|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162015|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162016|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14766846|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766847|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14766848|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14766849|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162017|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
14162018|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
14162019|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14162020|NCT04906772|Analgesics|analgesics|mesh-ancestor
14162021|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
14162022|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162023|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14162024|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14162025|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14162026|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
14162027|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162028|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162029|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14162030|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14162031|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14162032|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
14162033|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14162034|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14162035|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14162036|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
14162037|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162038|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162039|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162040|NCT04906915|Ketamine|ketamine|mesh-list
14162041|NCT04906915|Analgesics|analgesics|mesh-ancestor
14162042|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
14162043|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162044|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162045|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14162046|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14162047|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
14162048|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
14162049|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162050|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14162051|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14162052|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162053|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162054|NCT04906720|Colchicine|colchicine|mesh-list
14162055|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
14162056|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162057|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
14162058|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
14162059|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162060|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162061|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162062|NCT04906317|Midazolam|midazolam|mesh-list
14162063|NCT04906317|Dezocine|dezocine|mesh-list
14162064|NCT04906317|Propofol|propofol|mesh-list
14162065|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14162066|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162067|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162068|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14162069|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
14162070|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
14162071|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14162072|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14162073|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14162074|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14162075|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
14162076|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
14162077|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162078|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162079|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14162080|NCT04906317|Narcotics|narcotics|mesh-ancestor
14162081|NCT04906317|Analgesics|analgesics|mesh-ancestor
14162082|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
14162083|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162084|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14162085|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14162086|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14162087|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162088|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
14162089|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14162090|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
14162091|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
14162092|NCT04906304|Cyclosporine|cyclosporine|mesh-list
14162093|NCT04906304|Everolimus|everolimus|mesh-list
14162094|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162095|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162096|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
14162097|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162098|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14162099|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14162100|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
14162101|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162102|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162103|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162104|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162105|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
14162106|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
14162107|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162108|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14162109|NCT04906096|GDC-0084|gdc-0084|mesh-list
14162110|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162111|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162112|NCT04906083|Mitogens|mitogens|mesh-list
14162113|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162114|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162115|NCT04906161|Vitamin D|vitamin d|mesh-list
14162116|NCT04906161|Calcium|calcium|mesh-list
14162117|NCT04906161|Vitamins|vitamins|mesh-ancestor
14162118|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
14162119|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162120|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14162121|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14162122|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14162123|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14162124|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14162125|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14162126|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162127|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
14162128|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162129|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162130|NCT04905953|Neostigmine|neostigmine|mesh-list
14162131|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14162132|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162133|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162134|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
14162135|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162136|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162137|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14162138|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
14162139|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162140|NCT04905667|Trastuzumab|trastuzumab|mesh-list
14162141|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162142|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162143|NCT04905563|Acetaminophen|acetaminophen|mesh-list
14162144|NCT04905563|Ibuprofen|ibuprofen|mesh-list
14162145|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14162146|NCT04905563|Hydrocodone|hydrocodone|mesh-list
14162147|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14162148|NCT04905563|Analgesics|analgesics|mesh-ancestor
14162149|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
14162150|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162151|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162152|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
14162153|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14162154|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162155|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162156|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14162157|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181849|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14162158|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162159|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14162160|NCT04905563|Narcotics|narcotics|mesh-ancestor
14162161|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938448|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938449|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938450|NCT01481610|Diclofenac|diclofenac|mesh-list
14938451|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
14938452|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14938453|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14938454|NCT01481610|Analgesics|analgesics|mesh-ancestor
14162162|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
14162163|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
14162164|NCT04905277|Atenolol|atenolol|mesh-list
14162165|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14162166|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14162167|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
14162168|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
14162169|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162170|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162171|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14162172|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14162173|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14162174|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
14162175|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162176|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162177|NCT04905108|Riboflavin|riboflavin|mesh-list
14162178|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
14162179|NCT04905108|Vitamins|vitamins|mesh-ancestor
14162180|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
14162181|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162182|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14162183|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
14181850|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181851|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181852|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14181853|NCT02879695|Nivolumab|nivolumab|mesh-list
14181854|NCT02879695|Ipilimumab|ipilimumab|mesh-list
14181855|NCT02879695|Blinatumomab|blinatumomab|mesh-list
14181856|NCT02879695|Antibodies|antibodies|mesh-list
14181857|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
14181858|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14181859|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
14181860|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14181861|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
14181862|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181863|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181864|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14181865|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181866|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181867|NCT02864914|Empagliflozin|empagliflozin|mesh-list
14181868|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14181869|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14181870|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181871|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14181872|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181873|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
14181874|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181875|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
14181876|NCT02858921|Trametinib|trametinib|mesh-list
14181877|NCT02858921|Dabrafenib|dabrafenib|mesh-list
14181878|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181879|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181880|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14181881|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181882|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938455|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
14938456|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162184|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
14162185|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162186|NCT04905147|Mosapride|mosapride|mesh-list
14162187|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162188|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14162189|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
14162190|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162191|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162192|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162193|NCT04904536|Atorvastatin|atorvastatin|mesh-list
14162194|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14162195|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14162196|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
14162197|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162198|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14162199|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14162200|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162201|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
14162202|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14162203|NCT04904341|Protective Agents|protective agents|mesh-ancestor
14162204|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162205|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
14162206|NCT04904302|Nivolumab|nivolumab|mesh-list
14162207|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162208|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162209|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14162210|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766850|NCT00627744|Incretins|incretins|mesh-ancestor
14766851|NCT00627744|Hormones|hormones|mesh-ancestor
14162211|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
14162212|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
14162213|NCT04904185|Fludarabine|fludarabine|mesh-list
14162214|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
14162215|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162216|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
14162217|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162218|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162219|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14162220|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
14162221|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162222|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162223|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14162224|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162225|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14162226|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
14162227|NCT04904406|Lamivudine|lamivudine|mesh-list
14162228|NCT04904406|Abacavir|abacavir|mesh-list
14162229|NCT04904406|Dolutegravir|dolutegravir|mesh-list
14162230|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14162231|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14162232|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162233|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162234|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
14162235|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162236|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14162237|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14162238|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14162239|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14162240|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14162241|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14162242|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162243|NCT04903847|Tenofovir|tenofovir|mesh-list
14162244|NCT04903847|Lamivudine|lamivudine|mesh-list
14162245|NCT04903847|Dolutegravir|dolutegravir|mesh-list
14162246|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
14162247|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162248|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14162249|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14162250|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162251|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162252|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14162253|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14162254|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14162255|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14162256|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
14162257|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
14162258|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162259|NCT04903808|Protective Agents|protective agents|mesh-ancestor
14162260|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162261|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14162262|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162263|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14162264|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162265|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
14162266|NCT04903743|Bupivacaine|bupivacaine|mesh-list
14162267|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
14162268|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
14162269|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162270|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162271|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
14162272|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162273|NCT04903743|Analgesics|analgesics|mesh-ancestor
14162274|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14162275|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
14162276|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14162277|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14162278|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162279|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14162280|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
14162281|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14162282|NCT04903483|Anesthetics|anesthetics|mesh-list
14162283|NCT04903483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162284|NCT04903483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162285|NCT04903470|Bisacodyl|bisacodyl|mesh-list
14162286|NCT04903470|Cathartics|cathartics|mesh-ancestor
14162287|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162288|NCT04903470|Laxatives|laxatives|mesh-ancestor
14162289|NCT04903678|Melphalan|melphalan|mesh-list
14162290|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14162291|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
14162292|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162293|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162294|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14162295|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162296|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
14162297|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162298|NCT04903366|Timolol|timolol|mesh-list
14162299|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14162300|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14162301|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
14162302|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162303|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162304|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162305|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14162306|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14162307|NCT04903275|Fluorides|fluorides|mesh-list
14162308|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
14162309|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
14162310|NCT04903275|Protective Agents|protective agents|mesh-ancestor
14162311|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162312|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
14162313|NCT04903054|Prednisone|prednisone|mesh-list
14162314|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
14162315|NCT04903054|Tacrolimus|tacrolimus|mesh-list
14162316|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
14162317|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14162318|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162319|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
14162320|NCT04903054|Hormones|hormones|mesh-ancestor
14162321|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14162322|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162323|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14162324|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162325|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162326|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
14162327|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14162328|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162329|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162330|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14162331|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14162332|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
14162333|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162334|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162335|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
14162336|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
14162337|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162338|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162339|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14162340|NCT04903054|Protective Agents|protective agents|mesh-ancestor
14162341|NCT04902911|Antibodies|antibodies|mesh-list
14162342|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
14162343|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
14162344|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162345|NCT04902885|Carboplatin|carboplatin|mesh-list
14162346|NCT04902885|Etoposide|etoposide|mesh-list
14162347|NCT04902885|Topotecan|topotecan|mesh-list
14162348|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162349|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14162350|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14162351|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14162352|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162353|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162354|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14162355|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
14162356|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14162357|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14162358|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162359|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
14162360|NCT04902950|Coagulants|coagulants|mesh-ancestor
14181905|NCT02831764|Tenofovir|tenofovir|mesh-list
14181906|NCT02831764|Lamivudine|lamivudine|mesh-list
14181907|NCT02831764|Emtricitabine|emtricitabine|mesh-list
14181908|NCT02831764|Dolutegravir|dolutegravir|mesh-list
14181909|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
14181910|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181911|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14181912|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14181913|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181914|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181915|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14181916|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14181917|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14181918|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14181919|NCT02826161|Paclitaxel|paclitaxel|mesh-list
14181920|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14181921|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181922|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
14181923|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
14181924|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
14181925|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181926|NCT02697474|Vaccines|vaccines|mesh-list
14181927|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
14181928|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181929|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
14162361|NCT04903002|Oxytocin|oxytocin|mesh-list
14162362|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
14162363|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14162364|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162365|NCT04902859|Clonidine|clonidine|mesh-list
14162366|NCT04902859|Analgesics|analgesics|mesh-ancestor
14162367|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
14162368|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162369|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162370|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14162371|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
14162372|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
14162373|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14162374|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14162375|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14162376|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
14162377|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162378|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162379|NCT04902729|Oxytocin|oxytocin|mesh-list
14162380|NCT04902729|Carbetocin|carbetocin|mesh-list
14162381|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
14162382|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14162383|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162384|NCT04902638|Dexamethasone|dexamethasone|mesh-list
14162385|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162386|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
14162387|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
14162388|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162389|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162390|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162391|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
14162392|NCT04902638|Hormones|hormones|mesh-ancestor
14162393|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14162394|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14162395|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162396|NCT04902261|Gemcitabine|gemcitabine|mesh-list
14162397|NCT04902261|Paclitaxel|paclitaxel|mesh-list
14162398|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14162399|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162400|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
14162401|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
14162402|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162403|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162404|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14162405|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
14162406|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
14162407|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162408|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162409|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162410|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
14162411|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162412|NCT04902495|Pemetrexed|pemetrexed|mesh-list
14162413|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162414|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162415|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162416|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14162417|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14162418|NCT04902222|Morphine|morphine|mesh-list
14162419|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14162420|NCT04902222|Narcotics|narcotics|mesh-ancestor
14162421|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162422|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162423|NCT04902222|Analgesics|analgesics|mesh-ancestor
14162424|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
14162425|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162426|NCT04902378|Insulin|insulin|mesh-list
14162427|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14162428|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162429|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
14162430|NCT04902027|Analgesics|analgesics|mesh-ancestor
14162431|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
14162432|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162433|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162434|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162435|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14162436|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14162437|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162438|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162439|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
14162440|NCT04902105|Valproic Acid|valproic acid|mesh-list
14162441|NCT04902105|Ecopipam|ecopipam|mesh-list
14162442|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
14162443|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162444|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162445|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
14162446|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162447|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162448|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
14162449|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14162450|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162451|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14162452|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14162453|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14162454|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
14162455|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14162456|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14162457|NCT04902105|Analgesics|analgesics|mesh-ancestor
14162458|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
14162459|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162460|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162461|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162462|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14162463|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
14162464|NCT04902040|Nivolumab|nivolumab|mesh-list
14162465|NCT04902040|Durvalumab|durvalumab|mesh-list
14162466|NCT04902040|Avelumab|avelumab|mesh-list
14162467|NCT04902040|Atezolizumab|atezolizumab|mesh-list
14162468|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
14162469|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14162470|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
14162471|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162472|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162473|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14162474|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162475|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
14162476|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162477|NCT04901923|Itraconazole|itraconazole|mesh-list
14162478|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
14162479|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
14162480|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162481|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14162482|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14162483|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162484|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162485|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14162486|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
14162487|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14162488|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162489|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14162490|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162491|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14162492|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14162493|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162494|NCT04901494|Serotonin|serotonin|mesh-list
14162495|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14162496|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14162497|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
14162498|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162499|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162500|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162501|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14162502|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14162503|NCT04901663|Amoxicillin|amoxicillin|mesh-list
14162504|NCT04901663|Clarithromycin|clarithromycin|mesh-list
14162505|NCT04901663|Omeprazole|omeprazole|mesh-list
14162506|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162507|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162508|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14162509|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162510|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14162511|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162512|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162513|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14162514|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14162515|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14162516|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
14162517|NCT04901312|Narcotics|narcotics|mesh-ancestor
14766852|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766853|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14766854|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
14766855|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766856|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766857|NCT00627796|Lanreotide|lanreotide|mesh-list
14162518|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162519|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162520|NCT04901312|Analgesics|analgesics|mesh-ancestor
14162521|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
14162522|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162523|NCT04901117|Amoxicillin|amoxicillin|mesh-list
14162524|NCT04901117|Metronidazole|metronidazole|mesh-list
14162525|NCT04901117|Clarithromycin|clarithromycin|mesh-list
14162526|NCT04901117|Tetracycline|tetracycline|mesh-list
14162527|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
14162528|NCT04901117|Bismuth|bismuth|mesh-list
14162529|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162530|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162531|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162532|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14162533|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14162534|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14162535|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162536|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14162537|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14162538|NCT04901117|Antacids|antacids|mesh-ancestor
14162539|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162540|NCT04901117|Diuretics|diuretics|mesh-ancestor
14162541|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
14162542|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162543|NCT04901117|Expectorants|expectorants|mesh-ancestor
14162544|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
14162545|NCT04901065|Lidocaine|lidocaine|mesh-list
14162546|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
14162547|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
14162548|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162549|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162550|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
14162551|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162552|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14162553|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14162554|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14162555|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14162556|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181930|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181931|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181932|NCT02627443|Gemcitabine|gemcitabine|mesh-list
14181933|NCT02627443|Carboplatin|carboplatin|mesh-list
14181934|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181935|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181936|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
14181937|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181938|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
14181939|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181940|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181941|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162557|NCT04901208|Nicotine|nicotine|mesh-list
14162558|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14162559|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
14162560|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162561|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162562|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14162563|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14162564|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
14162565|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162566|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766858|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766859|NCT00627809|Streptokinase|streptokinase|mesh-list
14766860|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14766861|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14766862|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766863|NCT00627835|Cisplatin|cisplatin|mesh-list
14766864|NCT00627835|Sorafenib|sorafenib|mesh-list
14766865|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162575|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
14162576|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14162577|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14162578|NCT04900948|Prednisolone|prednisolone|mesh-list
14162579|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
14162580|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
14162581|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
14162582|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14162583|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
14162584|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162585|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
14162586|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
14162587|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162588|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162589|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162590|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
14162591|NCT04900948|Hormones|hormones|mesh-ancestor
14162592|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14162593|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14162594|NCT04900948|Protective Agents|protective agents|mesh-ancestor
14162595|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14162596|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162597|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14162598|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14162599|NCT04900948|Analgesics|analgesics|mesh-ancestor
14162600|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
14162601|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162602|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
14162603|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162604|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
14162605|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14162606|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162607|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162608|NCT04901104|Thymalfasin|thymalfasin|mesh-list
14162609|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14162610|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
14162611|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162612|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
14162613|NCT04900792|Temozolomide|temozolomide|mesh-list
14162614|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14162615|NCT04900792|Vitamins|vitamins|mesh-ancestor
14162616|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
14162617|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162618|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14162619|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
14162620|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162621|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162622|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
14162623|NCT04900792|Protective Agents|protective agents|mesh-ancestor
14162624|NCT04900792|Hematinics|hematinics|mesh-ancestor
14162625|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14162626|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14162627|NCT04900532|Tocotrienols|tocotrienols|mesh-list
14162628|NCT04900532|Vitamin E|vitamin e|mesh-list
14162629|NCT04900532|Tocopherols|tocopherols|mesh-list
14766866|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14162630|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
14162631|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162632|NCT04900532|Protective Agents|protective agents|mesh-ancestor
14162633|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162634|NCT04900532|Vitamins|vitamins|mesh-ancestor
14162635|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
14162636|NCT04900415|Vitamin A|vitamin a|mesh-list
14162637|NCT04900415|Vitamins|vitamins|mesh-ancestor
14162638|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
14162639|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162640|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
14162641|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14162642|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162643|NCT04900571|Renal Agents|renal agents|mesh-ancestor
14162644|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162645|NCT04900623|Paclitaxel|paclitaxel|mesh-list
14162646|NCT04900623|Cisplatin|cisplatin|mesh-list
14162647|NCT04900623|Carboplatin|carboplatin|mesh-list
14162648|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14162649|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162650|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
14162651|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
14162652|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162653|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162654|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
14162655|NCT04900766|Analgesics|analgesics|mesh-ancestor
14162656|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
14162657|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162658|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162659|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162660|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14162661|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14162662|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162663|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162664|NCT04900311|Paclitaxel|paclitaxel|mesh-list
14162665|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14162666|NCT04900311|Trastuzumab|trastuzumab|mesh-list
14162667|NCT04900311|Pertuzumab|pertuzumab|mesh-list
14162668|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14162669|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162670|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14162671|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14162672|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162673|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162674|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162675|NCT04900350|Azacitidine|azacitidine|mesh-list
14162676|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14162677|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
14162678|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162679|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162680|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162681|NCT04899921|Nivolumab|nivolumab|mesh-list
14162682|NCT04899921|Ipilimumab|ipilimumab|mesh-list
14162683|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162684|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162685|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14162686|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162687|NCT04900155|Atorvastatin|atorvastatin|mesh-list
14162688|NCT04900155|Ezetimibe|ezetimibe|mesh-list
14162689|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14162690|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14162691|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
14162692|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162693|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14162694|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14162695|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162696|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
14162697|NCT04900129|Diclofenac|diclofenac|mesh-list
14162698|NCT04900129|Salicylates|salicylates|mesh-list
14162699|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
14162700|NCT04900129|Menthol|menthol|mesh-list
14162701|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14162702|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14162703|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14162704|NCT04900129|Analgesics|analgesics|mesh-ancestor
14162705|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
14162706|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162707|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162708|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162709|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162710|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14162711|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162712|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162713|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
14162714|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14162715|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
14162716|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162717|NCT04900129|Expectorants|expectorants|mesh-ancestor
14162718|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
14162719|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14162720|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
14162721|NCT04900129|Protective Agents|protective agents|mesh-ancestor
14162722|NCT04900129|Antidotes|antidotes|mesh-ancestor
14162723|NCT04899765|Vaccines|vaccines|mesh-list
14162724|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
14162725|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
14162726|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162727|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14766867|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766868|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766869|NCT00627848|Rivastigmine|rivastigmine|mesh-list
14766870|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14766871|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766872|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766873|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
14766874|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766875|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766876|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14766877|NCT00627848|Protective Agents|protective agents|mesh-ancestor
14766878|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14766879|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
14766880|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766881|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766882|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766883|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14766884|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14766885|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766886|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766887|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14766888|NCT00627900|Sirolimus|sirolimus|mesh-list
14766889|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14766890|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162751|NCT04899570|Prednisone|prednisone|mesh-list
14162752|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
14162753|NCT04899570|Rituximab|rituximab|mesh-list
14162754|NCT04899570|Epirubicin|epirubicin|mesh-list
14162755|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
14162756|NCT04899570|Vindesine|vindesine|mesh-list
14162757|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162758|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
14162759|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162760|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162761|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14162762|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
14162763|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162764|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162765|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14162766|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14479026|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14479027|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14479028|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14479029|NCT02462486|Ranibizumab|ranibizumab|mesh-list
14479030|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14479031|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14479032|NCT02462486|Growth Substances|growth substances|mesh-ancestor
14479033|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479034|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
14479035|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479036|NCT02462720|Polidocanol|polidocanol|mesh-list
14479037|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14479038|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14479039|NCT02462928|Ranibizumab|ranibizumab|mesh-list
14162767|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162768|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
14479040|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14162769|NCT04899570|Hormones|hormones|mesh-ancestor
14162770|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14162771|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14162772|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14162773|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14162774|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14162775|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162776|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14162777|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14162778|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
14162779|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
14162780|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162781|NCT04899453|Rituximab|rituximab|mesh-list
14162782|NCT04899453|Methotrexate|methotrexate|mesh-list
14162783|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
14162784|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162785|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162786|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
14162787|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162788|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14162789|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14162790|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
14162791|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14162792|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14162793|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
14162794|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162795|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
14162796|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162797|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14162798|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162799|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14162800|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14162801|NCT04899817|Granisetron|granisetron|mesh-list
14162802|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
14162803|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
14162804|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162805|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162806|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162807|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14162808|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
14162809|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162810|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162811|NCT04899674|Bupropion|bupropion|mesh-list
14162812|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14162813|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
14162814|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14162815|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14162816|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14162817|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14162818|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162819|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
14162820|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162821|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162822|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14162823|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14162824|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162825|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14162826|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162827|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14162828|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162829|NCT04899414|Dexamethasone|dexamethasone|mesh-list
14162830|NCT04899414|Azacitidine|azacitidine|mesh-list
14162831|NCT04899414|Pegaspargase|pegaspargase|mesh-list
14162832|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162833|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
14162834|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
14162835|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162836|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162837|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162838|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
14162839|NCT04899414|Hormones|hormones|mesh-ancestor
14162840|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14181942|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
14162841|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14162842|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162843|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14162844|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
14162845|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162846|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162847|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
14162848|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
14162849|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14162850|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14162851|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162852|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14162853|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14162854|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14162855|NCT04899115|Vancomycin|vancomycin|mesh-list
14162856|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162857|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162858|NCT04898920|Dexamethasone|dexamethasone|mesh-list
14162859|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14162860|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
14162861|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
14162862|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162863|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162864|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14162865|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
14162866|NCT04898920|Hormones|hormones|mesh-ancestor
14162867|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14162868|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14162869|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162870|NCT04898946|Vaccines|vaccines|mesh-list
14162871|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
14162872|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162873|NCT04899050|Cannabidiol|cannabidiol|mesh-list
14162874|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
14162875|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
14162876|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14162877|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162878|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
14181943|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181944|NCT02619682|Lenalidomide|lenalidomide|mesh-list
14181945|NCT02619682|Ixazomib|ixazomib|mesh-list
14181946|NCT02619682|Glycine|glycine|mesh-list
14479041|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14479042|NCT02462928|Growth Substances|growth substances|mesh-ancestor
14479043|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479044|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
14479045|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181947|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
14181948|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181949|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14181950|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14181951|NCT02619682|Growth Substances|growth substances|mesh-ancestor
14181952|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181953|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181954|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181955|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
14181956|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181957|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
14181958|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14181964|NCT02586025|Docetaxel|docetaxel|mesh-list
14181965|NCT02586025|Trastuzumab|trastuzumab|mesh-list
14181966|NCT02586025|Pertuzumab|pertuzumab|mesh-list
14181967|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181968|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
14181969|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
14181970|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
14181971|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181972|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14181973|NCT02520011|Cytarabine|cytarabine|mesh-list
14181974|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
14181975|NCT02520011|Alvocidib|alvocidib|mesh-list
14162879|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
14162880|NCT04898751|Nivolumab|nivolumab|mesh-list
14162881|NCT04898751|Ipilimumab|ipilimumab|mesh-list
14162882|NCT04898751|Durvalumab|durvalumab|mesh-list
14162883|NCT04898751|Avelumab|avelumab|mesh-list
14162884|NCT04898751|Cemiplimab|cemiplimab|mesh-list
14766891|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14766892|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766893|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
14766894|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14766895|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
14766896|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766897|NCT00627913|Anesthetics|anesthetics|mesh-list
14766898|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766899|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766900|NCT00627952|Amlodipine|amlodipine|mesh-list
14766901|NCT00627952|Manidipine|manidipine|mesh-list
14766902|NCT00627952|Delapril|delapril|mesh-list
14766903|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14766904|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14766905|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766906|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766907|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14766908|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766909|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
14766910|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14766911|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
14766912|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766913|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
14162885|NCT04898751|Atezolizumab|atezolizumab|mesh-list
14162886|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14162887|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14162888|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162889|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162890|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
14162891|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14162892|NCT04898907|Mitogens|mitogens|mesh-list
14162893|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162894|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162895|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14162896|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14162897|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162898|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162899|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162900|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14162901|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
14162902|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14162903|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162904|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14162905|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14162906|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14162907|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14162908|NCT04898699|Tenofovir|tenofovir|mesh-list
14162909|NCT04898699|Emtricitabine|emtricitabine|mesh-list
14162910|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14162911|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
14162912|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162913|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14162914|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14162915|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162916|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162917|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14162918|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14162919|NCT04898725|Vitamin D|vitamin d|mesh-list
14162920|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
14162921|NCT04898725|Vitamins|vitamins|mesh-ancestor
14162922|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
14162923|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162924|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14162925|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14162926|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
14162927|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14162928|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14162929|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162930|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
14162931|NCT04898712|Coagulants|coagulants|mesh-ancestor
14162932|NCT04898387|Timolol|timolol|mesh-list
14162933|NCT04898387|Bimatoprost|bimatoprost|mesh-list
14162934|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14162935|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14162936|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
14162937|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162938|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162939|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162940|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14162941|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14162942|NCT04898374|Gemcitabine|gemcitabine|mesh-list
14162943|NCT04898374|Cisplatin|cisplatin|mesh-list
14162944|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162945|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14162946|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
14162947|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162948|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
14162949|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162950|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162951|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14162952|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
14162953|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162954|NCT04898348|Vancomycin|vancomycin|mesh-list
14162955|NCT04898348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14162956|NCT04898348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14162957|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
14162958|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162959|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14162960|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14162961|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
14162962|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162963|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
14162964|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
14162965|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162966|NCT04898023|Protective Agents|protective agents|mesh-ancestor
14162967|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162968|NCT04898023|Vitamins|vitamins|mesh-ancestor
14162969|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
14162970|NCT04898504|Floxuridine|floxuridine|mesh-list
14162971|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14162972|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
14162973|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162974|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14162975|NCT04898075|Nicotine|nicotine|mesh-list
14162976|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14162977|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
14162978|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162979|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162980|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14162981|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14162982|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
14162983|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14162984|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162985|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
14162986|NCT04898478|Narcotics|narcotics|mesh-ancestor
14162987|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14162988|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14162989|NCT04898478|Analgesics|analgesics|mesh-ancestor
14162990|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
14162991|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14162992|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
14162993|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
14162994|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14162995|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
14162996|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14162997|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14162998|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14162999|NCT04898114|Urological Agents|urological agents|mesh-ancestor
14163000|NCT04898114|Analgesics|analgesics|mesh-ancestor
14163001|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
14163002|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163003|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163004|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
14163005|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163006|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14163007|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
14163008|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14163009|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14163010|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14163011|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
14163012|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163013|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
14163014|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14163015|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14163016|NCT04898231|Prednisolone|prednisolone|mesh-list
14163017|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
14163018|NCT04898231|Infliximab|infliximab|mesh-list
14163019|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14163020|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14163021|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
14163022|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163023|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
14163024|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
14163025|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163026|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163027|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163028|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
14163029|NCT04898231|Hormones|hormones|mesh-ancestor
14163030|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163031|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14163032|NCT04898231|Protective Agents|protective agents|mesh-ancestor
14163033|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163034|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163035|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163036|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14163037|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
14163038|NCT04898270|Flupenthixol|flupenthixol|mesh-list
14163039|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
14163040|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14163041|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163042|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163043|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14163044|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14163045|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
14163046|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163047|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163048|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
14163049|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14163050|NCT04897971|Antibodies|antibodies|mesh-list
14163051|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
14163052|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163053|NCT04897958|Leuprolide|leuprolide|mesh-list
14163054|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14163055|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
14163056|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163057|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163058|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163059|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163060|NCT04897854|Folfirinox|folfirinox|mesh-list
14163061|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163062|NCT04897880|Panobinostat|panobinostat|mesh-list
14163063|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163064|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14163065|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163066|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163067|NCT04897737|Tenofovir|tenofovir|mesh-list
14163068|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
14163069|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163070|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14163071|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14163072|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163073|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163074|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14163075|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14163076|NCT04897516|Benzonidazole|benzonidazole|mesh-list
14163077|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163078|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
14163079|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163080|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14163081|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14163082|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14163083|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163084|NCT04897503|Riboflavin|riboflavin|mesh-list
14163085|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
14163086|NCT04897503|Vitamins|vitamins|mesh-ancestor
14163087|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
14163088|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163089|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14163090|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163091|NCT04897386|Pemetrexed|pemetrexed|mesh-list
14163092|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163093|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163094|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163095|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14163096|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14163097|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
14163098|NCT04897321|Fludarabine|fludarabine|mesh-list
14163099|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163100|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
14163101|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163102|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14163103|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14163104|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
14163105|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163106|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163107|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14163108|NCT04897477|Azacitidine|azacitidine|mesh-list
14163109|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14163110|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14163111|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
14163112|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163113|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163114|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163115|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14163116|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
14163117|NCT04897269|Progesterone|progesterone|mesh-list
14163118|NCT04897269|Progestins|progestins|mesh-ancestor
14163119|NCT04897269|Hormones|hormones|mesh-ancestor
14163120|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163121|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181976|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14181977|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
14181978|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14181979|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14181980|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
14181981|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14181982|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14181983|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
14181984|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181985|NCT02520011|Analgesics|analgesics|mesh-ancestor
14163122|NCT04896359|Ascorbic Acid|ascorbic acid|mesh-list
14163123|NCT04896359|Vitamins|vitamins|mesh-ancestor
14163124|NCT04896359|Micronutrients|micronutrients|mesh-ancestor
14163125|NCT04896359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163126|NCT04896359|Antioxidants|antioxidants|mesh-ancestor
14163127|NCT04896359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163128|NCT04896359|Protective Agents|protective agents|mesh-ancestor
14163129|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
14163130|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163131|NCT04896177|Sirolimus|sirolimus|mesh-list
14163132|NCT04896177|Paclitaxel|paclitaxel|mesh-list
14163133|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14163134|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163135|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
14163136|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
14163137|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
14163138|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163139|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14163140|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163141|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14163142|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
14163143|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163144|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
14163145|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163146|NCT04896125|Bimatoprost|bimatoprost|mesh-list
14163147|NCT04896125|Latanoprost|latanoprost|mesh-list
14163148|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14163149|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14163150|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14163151|NCT04896164|Curcumin|curcumin|mesh-list
14163152|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14163153|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14163154|NCT04896164|Analgesics|analgesics|mesh-ancestor
14163155|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
14163156|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163157|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163158|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163159|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14163160|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163161|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163162|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766914|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766915|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
14766916|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14163163|NCT04895917|Daratumumab|daratumumab|mesh-list
14163164|NCT04895917|Pomalidomide|pomalidomide|mesh-list
14163165|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163166|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
14163167|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163168|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14163169|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14163170|NCT04895917|Growth Substances|growth substances|mesh-ancestor
14163171|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
14163172|NCT04895657|Tazobactam|tazobactam|mesh-list
14163173|NCT04895657|Piperacillin|piperacillin|mesh-list
14163174|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14163175|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14163176|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163177|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14163178|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163179|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163180|NCT04895423|Cyclosporine|cyclosporine|mesh-list
14163181|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
14163182|NCT04895423|Methotrexate|methotrexate|mesh-list
14163183|NCT04895423|Cyclosporins|cyclosporins|mesh-list
14163184|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14163185|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
14163186|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163187|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163188|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14163189|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
14163190|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163191|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163192|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163193|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163194|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14163195|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163196|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
14163197|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14163198|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14163199|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
14163200|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163201|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14163202|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14163203|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14163204|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
14163205|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14163206|NCT04895800|Caffeine|caffeine|mesh-list
14163207|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14163208|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163209|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14163210|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163211|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163212|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14163213|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14163214|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
14163215|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163216|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
14163217|NCT04895306|Testosterone|testosterone|mesh-list
14163218|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
14163219|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
14163220|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14163221|NCT04895306|Androgens|androgens|mesh-ancestor
14163222|NCT04895306|Hormones|hormones|mesh-ancestor
14163223|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163224|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163225|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163226|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163227|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
14163228|NCT04895592|Dexamethasone|dexamethasone|mesh-list
14163229|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
14163230|NCT04895592|Ichthammol|ichthammol|mesh-list
14163231|NCT04895592|BB 1101|bb 1101|mesh-list
14163232|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163233|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
14163234|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
14163235|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163236|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163237|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163238|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
14163239|NCT04895592|Hormones|hormones|mesh-ancestor
14163240|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163241|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163242|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163243|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
14163244|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163245|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163246|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163247|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14163248|NCT04895566|Antibodies|antibodies|mesh-list
14163249|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
14163250|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14163251|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
14163252|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163253|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163254|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14163255|NCT04895059|Ezetimibe|ezetimibe|mesh-list
14163256|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14163257|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14163258|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
14163259|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163260|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14163261|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14163262|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163263|NCT04895007|Vaccines|vaccines|mesh-list
14163264|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
14163265|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163266|NCT04895137|Bevacizumab|bevacizumab|mesh-list
14163267|NCT04895137|Antibodies|antibodies|mesh-list
14163268|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14163269|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14163270|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163271|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14163272|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14163273|NCT04895137|Growth Substances|growth substances|mesh-ancestor
14163274|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163275|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
14163276|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
14163277|NCT04894994|Ipilimumab|ipilimumab|mesh-list
14163278|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14163279|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163280|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14163281|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163282|NCT04894643|Gemcitabine|gemcitabine|mesh-list
14163283|NCT04894643|Paclitaxel|paclitaxel|mesh-list
14163284|NCT04894643|Capecitabine|capecitabine|mesh-list
14163285|NCT04894643|Pancrelipase|pancrelipase|mesh-list
14163286|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14163287|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163288|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
14163289|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
14163290|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
14163291|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163292|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14163293|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
14163294|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
14163295|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163296|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163297|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163298|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
14163299|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163300|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163301|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
14163302|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14163303|NCT04894617|Amantadine|amantadine|mesh-list
14163304|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14163305|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14163306|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
14163307|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163308|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
14163309|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163310|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163311|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163312|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14163313|NCT04894617|Analgesics|analgesics|mesh-ancestor
14163314|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
14163315|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163316|NCT04894682|Vaccines|vaccines|mesh-list
14163317|NCT04894682|Immunologic Factors|immunologic factors|mesh-ancestor
14163318|NCT04894682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14181986|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
14181987|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14181988|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14181989|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14181990|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14181991|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
14181992|NCT02520011|Growth Substances|growth substances|mesh-ancestor
14181993|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14479046|NCT02463097|Insulin|insulin|mesh-list
14182007|NCT02498613|Misonidazole|misonidazole|mesh-list
14182008|NCT02498613|Olaparib|olaparib|mesh-list
14182009|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14182010|NCT02498613|Cediranib|cediranib|mesh-list
14182011|NCT02498613|Maleic acid|maleic acid|mesh-list
14182012|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163319|NCT04894253|Vaccines|vaccines|mesh-list
14163320|NCT04894253|Immunologic Factors|immunologic factors|mesh-ancestor
14163321|NCT04894253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163322|NCT04893993|Thiamine|thiamine|mesh-list
14163323|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
14163324|NCT04893993|Vitamins|vitamins|mesh-ancestor
14163325|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
14163326|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163327|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14163328|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
14163329|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14163330|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14163331|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14163332|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
14163333|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163334|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163335|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14163336|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14163337|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14163338|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163339|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163340|NCT04893980|Aldesleukin|aldesleukin|mesh-list
14163341|NCT04893980|Interleukin-2|interleukin-2|mesh-list
14163342|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163343|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14163344|NCT04893980|Analgesics|analgesics|mesh-ancestor
14163345|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
14163346|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163347|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163348|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14163349|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14163350|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
14163351|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163352|NCT04893655|Dobutamine|dobutamine|mesh-list
14163353|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14163354|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
14163355|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
14163356|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163357|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163358|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14163359|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14163360|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14163361|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
14163362|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163363|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163364|NCT04893655|Protective Agents|protective agents|mesh-ancestor
14163365|NCT04893616|Vaccines|vaccines|mesh-list
14163366|NCT04893616|Immunologic Factors|immunologic factors|mesh-ancestor
14163367|NCT04893616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163368|NCT04893733|Folic Acid|folic acid|mesh-list
14163369|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
14163370|NCT04893733|Vitamins|vitamins|mesh-ancestor
14163371|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
14163372|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163373|NCT04893733|Hematinics|hematinics|mesh-ancestor
14163374|NCT04893629|Digoxin|digoxin|mesh-list
14163375|NCT04893629|Captopril|captopril|mesh-list
14163376|NCT04893629|Furosemide|furosemide|mesh-list
14163377|NCT04893629|Diuretics|diuretics|mesh-ancestor
14163378|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
14163379|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163380|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14163381|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14163382|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163383|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14163384|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14163385|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163386|NCT04893629|Protective Agents|protective agents|mesh-ancestor
14163387|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14163388|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
14163389|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14163390|NCT04893525|Buprenorphine|buprenorphine|mesh-list
14163391|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14163392|NCT04893525|Naloxone|naloxone|mesh-list
14163393|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14163394|NCT04893525|Narcotics|narcotics|mesh-ancestor
14163395|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163396|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163397|NCT04893525|Analgesics|analgesics|mesh-ancestor
14163398|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
14163399|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163400|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14163401|NCT04893356|Dacarbazine|dacarbazine|mesh-list
14163402|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14163403|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
14163404|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163405|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163406|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
14163407|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14163408|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
14163409|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163410|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
14163411|NCT04893174|Protective Agents|protective agents|mesh-ancestor
14163412|NCT04892953|Gemcitabine|gemcitabine|mesh-list
14163413|NCT04892953|Paclitaxel|paclitaxel|mesh-list
14163414|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14163415|NCT04892953|Carboplatin|carboplatin|mesh-list
14163416|NCT04892953|Pemetrexed|pemetrexed|mesh-list
14163417|NCT04892953|Durvalumab|durvalumab|mesh-list
14163418|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
14163419|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14163420|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
14163421|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14163422|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163423|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14163424|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14163425|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14163426|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163427|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14163428|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
14163429|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
14163430|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163431|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163432|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163433|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
14163434|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163435|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14163436|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14163437|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14163438|NCT04892940|Analgesics|analgesics|mesh-list
14163439|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
14163440|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163441|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163442|NCT04893252|Durvalumab|durvalumab|mesh-list
14163443|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14163444|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163445|NCT04892732|Budesonide|budesonide|mesh-list
14163446|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
14163447|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163448|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14163449|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
14163450|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163451|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163452|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14163453|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
14163454|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
14163455|NCT04892732|Hormones|hormones|mesh-ancestor
14163456|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163457|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14163458|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14163459|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14163460|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
14163461|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163462|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163463|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
14479047|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14163464|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
14163465|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14163466|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
14163467|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163468|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163469|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14163470|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14163471|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14163472|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14163473|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14163474|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14163475|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163476|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163477|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163478|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163479|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14163480|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14163481|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163482|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163483|NCT04892511|Nitroprusside|nitroprusside|mesh-list
14163484|NCT04892511|Labetalol|labetalol|mesh-list
14163485|NCT04892511|Urapidil|urapidil|mesh-list
14163486|NCT04892511|Phenylephrine|phenylephrine|mesh-list
14163487|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14163488|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
14163489|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
14163490|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163491|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163492|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
14163493|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14163494|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
14163495|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
14163496|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14163497|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14163498|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14163499|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
14163500|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163501|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163502|NCT04892511|Protective Agents|protective agents|mesh-ancestor
14163503|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14163504|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
14163505|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14163506|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14163507|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14163508|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14163509|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14163510|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14163511|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
14163512|NCT04892693|Talazoparib|talazoparib|mesh-list
14163513|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14163514|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163515|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163516|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163517|NCT04892654|Dolutegravir|dolutegravir|mesh-list
14163518|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14163519|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14163520|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163521|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163522|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14163523|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14163524|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
14163525|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163526|NCT04892563|Morphine|morphine|mesh-list
14163527|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14163528|NCT04892563|Narcotics|narcotics|mesh-ancestor
14163529|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163530|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163531|NCT04892563|Analgesics|analgesics|mesh-ancestor
14163532|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
14163533|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182013|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182014|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182015|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182016|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14182017|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14182018|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182019|NCT02453620|Nivolumab|nivolumab|mesh-list
14182020|NCT02453620|Ipilimumab|ipilimumab|mesh-list
14182021|NCT02453620|Entinostat|entinostat|mesh-list
14163534|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
14163535|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163536|NCT04892212|Sirolimus|sirolimus|mesh-list
14163537|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14163538|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163539|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14163540|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163541|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
14163542|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163543|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
14163544|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163545|NCT04892264|Dexamethasone|dexamethasone|mesh-list
14163546|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
14163547|NCT04892264|Lenalidomide|lenalidomide|mesh-list
14163548|NCT04892264|Daratumumab|daratumumab|mesh-list
14163549|NCT04892264|Ichthammol|ichthammol|mesh-list
14163550|NCT04892264|BB 1101|bb 1101|mesh-list
14163551|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163552|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
14163553|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
14163554|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163555|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163556|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163557|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
14163558|NCT04892264|Hormones|hormones|mesh-ancestor
14163559|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163560|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163561|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163562|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
14163563|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163564|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163565|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
14163566|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14163567|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14163568|NCT04892264|Growth Substances|growth substances|mesh-ancestor
14163569|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
14163570|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163571|NCT04892069|Insulin|insulin|mesh-list
14163572|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
14163573|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14163574|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163575|NCT04892017|Trametinib|trametinib|mesh-list
14163576|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163577|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14163578|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163579|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163580|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
14163581|NCT04891861|Apixaban|apixaban|mesh-list
14163582|NCT04891861|Edoxaban|edoxaban|mesh-list
14163583|NCT04891861|Dabigatran|dabigatran|mesh-list
14163584|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14163585|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
14163586|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14163587|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
14163588|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163589|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163590|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
14163591|NCT04891744|Thalidomide|thalidomide|mesh-list
14163592|NCT04891744|Dexamethasone|dexamethasone|mesh-list
14163593|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163594|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
14163595|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
14163596|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163597|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163598|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163599|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
14163600|NCT04891744|Hormones|hormones|mesh-ancestor
14163601|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163602|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163603|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163604|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163605|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
14163606|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
14163607|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14163608|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163609|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14163610|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14163611|NCT04891744|Growth Substances|growth substances|mesh-ancestor
14163612|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
14163613|NCT04891900|Capecitabine|capecitabine|mesh-list
14163614|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
14163615|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14163616|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14163617|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
14163618|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163619|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163620|NCT04891588|Timolol|timolol|mesh-list
14163621|NCT04891588|Latanoprost|latanoprost|mesh-list
14163622|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14163623|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14163624|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14163625|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14163626|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
14163627|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163628|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163629|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163630|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14163631|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14163632|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14163633|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163634|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163635|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
14163636|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163637|NCT04891679|Misoprostol|misoprostol|mesh-list
14163638|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14163639|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
14163640|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163641|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163642|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14163643|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163644|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
14163645|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
14163646|NCT04891458|Anesthetics|anesthetics|mesh-list
14163647|NCT04891458|Propofol|propofol|mesh-list
14163648|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163649|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163650|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14163651|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14163652|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
14163653|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14163654|NCT04891458|Analgesics|analgesics|mesh-ancestor
14163655|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
14163656|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163657|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14163658|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14163659|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14163660|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
14163661|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163662|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163663|NCT04891718|Nivolumab|nivolumab|mesh-list
14163664|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14163665|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163666|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14163667|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163668|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
14163669|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14163670|NCT04891172|Antibodies|antibodies|mesh-list
14163671|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
14163672|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14163673|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
14163674|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163675|NCT04891302|Clevudine|clevudine|mesh-list
14163676|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
14163677|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163678|NCT04891211|Vitamin D|vitamin d|mesh-list
14163679|NCT04891211|Vitamins|vitamins|mesh-ancestor
14163680|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
14163681|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163682|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14163683|NCT04890626|Tenofovir|tenofovir|mesh-list
14163684|NCT04890626|Emtricitabine|emtricitabine|mesh-list
14163685|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14163686|NCT04890626|Dexamethasone|dexamethasone|mesh-list
14163687|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
14163688|NCT04890626|BB 1101|bb 1101|mesh-list
14163689|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163690|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
14163691|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
14163692|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163693|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163694|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163695|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
14163696|NCT04890626|Hormones|hormones|mesh-ancestor
14163697|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163698|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163699|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163700|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
14163701|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163702|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163703|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
14163704|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163705|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14163706|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14163707|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14163708|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14163709|NCT04890522|Gemcitabine|gemcitabine|mesh-list
14163710|NCT04890522|Fluorouracil|fluorouracil|mesh-list
14163711|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163712|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14163713|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
14163714|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163715|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
14163716|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163717|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163718|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163719|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
14163720|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163721|NCT04890561|Lemborexant|lemborexant|mesh-list
14163722|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14163723|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766917|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14163724|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163725|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14163726|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14163727|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163728|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163729|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14163730|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163731|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163732|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
14163733|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163734|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14163735|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163736|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163737|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
14163738|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182022|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14182023|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182024|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182025|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14182026|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182027|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766918|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184156|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14184157|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184158|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
14184159|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184160|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184161|NCT04722523|Carboplatin|carboplatin|mesh-list
14184162|NCT04722523|Docetaxel|docetaxel|mesh-list
14184163|NCT04722523|Cetuximab|cetuximab|mesh-list
14184164|NCT04722523|Cemiplimab|cemiplimab|mesh-list
14184165|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14766919|NCT00627965|Urological Agents|urological agents|mesh-ancestor
14163739|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14163740|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163741|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163742|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
14163743|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163744|NCT04890418|Ketamine|ketamine|mesh-list
14163745|NCT04890418|Analgesics|analgesics|mesh-ancestor
14163746|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
14163747|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766920|NCT00627991|Valsartan|valsartan|mesh-list
14766921|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14766922|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14766923|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14766924|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766925|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
14766926|NCT00628043|Hematinics|hematinics|mesh-ancestor
14766927|NCT00628056|Perhexiline|perhexiline|mesh-list
14766928|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14766929|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766930|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766931|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14766932|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766933|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
14766934|NCT00628121|Cetrorelix|cetrorelix|mesh-list
14766935|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14766936|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
14766937|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14766938|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766939|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
14766940|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14766941|NCT00628160|Terlipressin|terlipressin|mesh-list
14766942|NCT00628160|Dopamine|dopamine|mesh-list
14766943|NCT00628160|Norepinephrine|norepinephrine|mesh-list
14766944|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
14766945|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14766946|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14163748|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163749|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14163750|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14163751|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
14163752|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
14163753|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163754|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14163755|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14163756|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163757|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163758|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
14163759|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14163760|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163761|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163762|NCT04890470|Vasopressins|vasopressins|mesh-list
14163763|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
14163764|NCT04890470|Oxytocin|oxytocin|mesh-list
14163765|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
14163766|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163767|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163768|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
14163769|NCT04890470|Coagulants|coagulants|mesh-ancestor
14163770|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14163771|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14163772|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
14163773|NCT04889768|Antibodies|antibodies|mesh-list
14163774|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
14163775|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163776|NCT04889781|Dexamethasone|dexamethasone|mesh-list
14163777|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
14163778|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163779|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
14163780|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
14163781|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163782|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163783|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163784|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
14163785|NCT04889781|Hormones|hormones|mesh-ancestor
14163786|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163787|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14163788|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163789|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
14163790|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163791|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14163792|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163793|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163794|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
14163795|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163796|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163797|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14163798|NCT04889664|Ketamine|ketamine|mesh-list
14163799|NCT04889664|Analgesics|analgesics|mesh-ancestor
14163800|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
14163801|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163802|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163803|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14163804|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14163805|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
14163806|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
14163807|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163808|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14163809|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14163810|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163811|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163812|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
14163813|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163814|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163815|NCT04889196|Fluorides|fluorides|mesh-list
14163816|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
14163817|NCT04889196|Protective Agents|protective agents|mesh-ancestor
14163818|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163819|NCT04888663|Paclitaxel|paclitaxel|mesh-list
14163820|NCT04888663|Trastuzumab|trastuzumab|mesh-list
14163821|NCT04888663|Ramucirumab|ramucirumab|mesh-list
14163822|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14163823|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163824|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
14163825|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
14163826|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
14163827|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163828|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14163829|NCT04888728|Nebivolol|nebivolol|mesh-list
14163830|NCT04888728|Paroxetine|paroxetine|mesh-list
14163831|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14163832|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14163833|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14163834|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163835|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163836|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
14163837|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163838|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14163839|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
14163840|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14163841|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14163842|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14163843|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163844|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14163845|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
14163846|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14163847|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14163848|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14163849|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
14163850|NCT04888741|Cyclosporine|cyclosporine|mesh-list
14163851|NCT04888741|Sirolimus|sirolimus|mesh-list
14163852|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
14163853|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
14163854|NCT04888741|Cyclosporins|cyclosporins|mesh-list
14163855|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
14163856|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14163857|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
14163858|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163859|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14163860|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14163861|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
14163862|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163863|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163864|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14163865|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163866|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
14163867|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163868|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
14163869|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14163870|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14163871|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14163872|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
14163873|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14163874|NCT04888715|Pirfenidone|pirfenidone|mesh-list
14163875|NCT04888715|Nintedanib|nintedanib|mesh-list
14163876|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163877|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14163878|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163879|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163880|NCT04888715|Analgesics|analgesics|mesh-ancestor
14163881|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
14163882|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163883|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163884|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14163885|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14163886|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163887|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182033|NCT02345265|Olaparib|olaparib|mesh-list
14182034|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14182035|NCT02345265|Cediranib|cediranib|mesh-list
14182036|NCT02345265|Maleic acid|maleic acid|mesh-list
14182037|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182038|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182039|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182040|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182041|NCT02315534|Temozolomide|temozolomide|mesh-list
14182042|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14182043|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
14182044|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182045|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182046|NCT02311920|Nivolumab|nivolumab|mesh-list
14182047|NCT02311920|Ipilimumab|ipilimumab|mesh-list
14182048|NCT02311920|Temozolomide|temozolomide|mesh-list
14182049|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182050|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182051|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14182052|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182053|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14182054|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
14182055|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
14182056|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182057|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182058|NCT02310321|Cytarabine|cytarabine|mesh-list
14182059|NCT02310321|Idarubicin|idarubicin|mesh-list
14182060|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14182061|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
14182062|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182063|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182064|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
14182065|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182066|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14182067|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
14163888|NCT04888403|Paclitaxel|paclitaxel|mesh-list
14163889|NCT04888403|Nedaplatin|nedaplatin|mesh-list
14163890|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14163891|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163892|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
14163893|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
14163894|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
14163895|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163896|NCT04887818|Lidocaine|lidocaine|mesh-list
14163897|NCT04887818|Diltiazem|diltiazem|mesh-list
14163898|NCT04887818|Nifedipine|nifedipine|mesh-list
14163899|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
14163900|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
14163901|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163902|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163903|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
14163904|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163905|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14163906|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14163907|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14163908|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14163909|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163910|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14163911|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14163912|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
14163913|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
14163914|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163915|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14163916|NCT04887961|Trabectedin|trabectedin|mesh-list
14163917|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14163918|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
14163919|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163920|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163921|NCT04887649|Morphine|morphine|mesh-list
14163922|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14163923|NCT04887649|Narcotics|narcotics|mesh-ancestor
14163924|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163925|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163926|NCT04887649|Analgesics|analgesics|mesh-ancestor
14163927|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
14163928|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163929|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
14163930|NCT04887805|Lenvatinib|lenvatinib|mesh-list
14163931|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14163932|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14163933|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14163934|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938457|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938458|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938459|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14938460|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14938461|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163935|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163936|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
14163937|NCT04887844|Lidocaine|lidocaine|mesh-list
14163938|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
14163939|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
14163940|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14163941|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163942|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
14163943|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163944|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14163945|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14163946|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14163947|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14163948|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163949|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14163950|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
14163951|NCT04887844|Hormones|hormones|mesh-ancestor
14163952|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14163953|NCT04887467|Apomorphine|apomorphine|mesh-list
14163954|NCT04887467|Emetics|emetics|mesh-ancestor
14163955|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163956|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
14938462|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938463|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14938464|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
14938465|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938466|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
14938467|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
14938468|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
14938469|NCT01481714|Citric Acid|citric acid|mesh-list
14938470|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
14938471|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14938472|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
14938473|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
14938474|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163957|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14163958|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163959|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
14163960|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
14163961|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14163962|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163963|NCT04887493|Alprostadil|alprostadil|mesh-list
14163964|NCT04887493|Misoprostol|misoprostol|mesh-list
14163965|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14163966|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
14163967|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14163968|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163969|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14163970|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14163971|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
14163972|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14163973|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
14163974|NCT04887493|Urological Agents|urological agents|mesh-ancestor
14163975|NCT04887389|Listerine|listerine|mesh-list
14163976|NCT04887389|Fluorides|fluorides|mesh-list
14163977|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
14163978|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
14163979|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
14163980|NCT04887389|Protective Agents|protective agents|mesh-ancestor
14163981|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163982|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14163983|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14163984|NCT04887311|Tempol|tempol|mesh-list
14163985|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
14163986|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14163987|NCT04887311|Protective Agents|protective agents|mesh-ancestor
14163988|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14163989|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14163990|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14163991|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14163992|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14163993|NCT04886986|Edetic Acid|edetic acid|mesh-list
14163994|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14163995|NCT04886986|Anticoagulants|anticoagulants|mesh-ancestor
14163996|NCT04886986|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14163997|NCT04886986|Chelating Agents|chelating agents|mesh-ancestor
14163998|NCT04886986|Sequestering Agents|sequestering agents|mesh-ancestor
14163999|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164000|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14164001|NCT04886869|Caffeine|caffeine|mesh-list
14164002|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14164003|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164004|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14164005|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164006|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164007|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14164008|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14938475|NCT01481714|Cathartics|cathartics|mesh-ancestor
14164009|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
14164010|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164011|NCT04886752|Vitamins|vitamins|mesh-list
14164012|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
14164013|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
14164014|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
14164015|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164016|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
14184166|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938476|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938477|NCT01481714|Antacids|antacids|mesh-ancestor
14164017|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164018|NCT04886752|Protective Agents|protective agents|mesh-ancestor
14164019|NCT04886323|Ketoconazole|ketoconazole|mesh-list
14164020|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
14164021|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164022|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14164023|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14164024|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164025|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164026|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14164027|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
14164028|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164029|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164030|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14164031|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
14164032|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14164033|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164034|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
14164035|NCT04886297|Resveratrol|resveratrol|mesh-list
14164036|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
14164037|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164038|NCT04886297|Protective Agents|protective agents|mesh-ancestor
14164039|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164040|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164041|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14164042|NCT04886362|Ivermectin|ivermectin|mesh-list
14164043|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14164044|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164045|NCT04886193|Leucovorin|leucovorin|mesh-list
14164046|NCT04886193|Docetaxel|docetaxel|mesh-list
14164047|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
14164048|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164049|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14164050|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164051|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164052|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164053|NCT04886193|Antidotes|antidotes|mesh-ancestor
14164054|NCT04886193|Protective Agents|protective agents|mesh-ancestor
14164055|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164056|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
14164057|NCT04886193|Vitamins|vitamins|mesh-ancestor
14164058|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
14164059|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14164060|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14164061|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14164062|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14164063|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164064|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14164065|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164066|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164067|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14164068|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182068|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182069|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14182070|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14182071|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14182072|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182073|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
14182074|NCT02298959|Aflibercept|aflibercept|mesh-list
14182075|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
14182076|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182077|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182078|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182079|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182080|NCT02298959|Growth Substances|growth substances|mesh-ancestor
14182081|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182082|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182083|NCT02279719|Sorafenib|sorafenib|mesh-list
14182084|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182085|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182086|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182087|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164069|NCT04885907|Vaccines|vaccines|mesh-list
14164070|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
14164071|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164072|NCT04885764|Vaccines|vaccines|mesh-list
14164073|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
14164074|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164075|NCT04885777|Lidocaine|lidocaine|mesh-list
14164076|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
14164077|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
14164078|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164079|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164080|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
14164081|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164082|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14164083|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14164084|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14164085|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14164086|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164087|NCT04885660|Lisinopril|lisinopril|mesh-list
14164088|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14164089|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
14164090|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164091|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164092|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14164093|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14164094|NCT04885660|Protective Agents|protective agents|mesh-ancestor
14164095|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164096|NCT04885686|Formaldehyde|formaldehyde|mesh-list
14164097|NCT04885686|Thymol|thymol|mesh-list
14164098|NCT04885686|Dexamethasone|dexamethasone|mesh-list
14164099|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
14164100|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14164101|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
14164102|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
14164103|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164104|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164105|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164106|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
14164107|NCT04885686|Hormones|hormones|mesh-ancestor
14164108|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164109|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14164110|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164111|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
14164112|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164113|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14164114|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
14164115|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
14164116|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
14164117|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164118|NCT04885751|Rebamipide|rebamipide|mesh-list
14164119|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14164120|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164121|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
14164122|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164123|NCT04885751|Protective Agents|protective agents|mesh-ancestor
14164124|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164125|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164126|NCT04885803|Vitamin D|vitamin d|mesh-list
14164127|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
14164128|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
14164129|NCT04885803|Vitamins|vitamins|mesh-list
14164130|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
14164131|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164132|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14164133|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14164134|NCT04885270|Cisplatin|cisplatin|mesh-list
14164135|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164136|NCT04885426|Metformin|metformin|mesh-list
14164137|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164138|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164139|NCT04885413|Niraparib|niraparib|mesh-list
14164140|NCT04885413|Antibodies|antibodies|mesh-list
14164141|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
14164142|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164143|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14164144|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164145|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164146|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164147|NCT04885153|Fenofibrate|fenofibrate|mesh-list
14164148|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14164149|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
14164150|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164151|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14164152|NCT04884997|Temozolomide|temozolomide|mesh-list
14164153|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14164154|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
14164155|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164156|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164157|NCT04884906|Paclitaxel|paclitaxel|mesh-list
14164158|NCT04884906|Cisplatin|cisplatin|mesh-list
14164159|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14164160|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164161|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
14164162|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164163|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164164|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164165|NCT04885075|Midazolam|midazolam|mesh-list
14164166|NCT04885075|Diazepam|diazepam|mesh-list
14164167|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14164168|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14164169|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164170|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164171|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14164172|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14164173|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14164174|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14164175|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
14164176|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
14164177|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
14164178|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
14164179|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164180|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164181|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
14164182|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
14164183|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
14164184|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164185|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164186|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14164187|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14164188|NCT04884919|Chitosan|chitosan|mesh-list
14164189|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14164190|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14164191|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
14164192|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164193|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14164194|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
14164195|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
14164196|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
14164197|NCT04884919|Coagulants|coagulants|mesh-ancestor
14164198|NCT04885049|Racecadotril|racecadotril|mesh-list
14164199|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
14164200|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164201|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
14164202|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164203|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164204|NCT04884802|Phenylephrine|phenylephrine|mesh-list
14164205|NCT04884802|Norepinephrine|norepinephrine|mesh-list
14164206|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14164207|NCT04884802|Propofol|propofol|mesh-list
14164208|NCT04884802|Etomidate|etomidate|mesh-list
14164209|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14164210|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164211|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164212|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14164213|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
14164214|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
14164215|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14164216|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
14164217|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
14164218|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164219|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
14164220|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
14164221|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
14164222|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14164223|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14164224|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14164225|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
14164226|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164227|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164228|NCT04884802|Protective Agents|protective agents|mesh-ancestor
14164229|NCT04884750|Vaccines|vaccines|mesh-list
14164230|NCT04884750|Immunologic Factors|immunologic factors|mesh-ancestor
14164231|NCT04884750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164232|NCT04884503|Clonazepam|clonazepam|mesh-list
14164233|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
14164234|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
14164235|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
14164236|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164237|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164238|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164239|NCT04884516|Vitamin A|vitamin a|mesh-list
14164240|NCT04884516|Vitamins|vitamins|mesh-ancestor
14164241|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
14164242|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164243|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14164244|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14164245|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164246|NCT04884490|Renal Agents|renal agents|mesh-ancestor
14164247|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14164248|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
14164249|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14164250|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14164251|NCT04884399|Ranibizumab|ranibizumab|mesh-list
14164252|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14164253|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14164254|NCT04884399|Growth Substances|growth substances|mesh-ancestor
14164255|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164256|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
14164257|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164258|NCT04884139|Tenofovir|tenofovir|mesh-list
14164259|NCT04884139|Lamivudine|lamivudine|mesh-list
14164260|NCT04884139|Emtricitabine|emtricitabine|mesh-list
14164261|NCT04884139|Dolutegravir|dolutegravir|mesh-list
14164262|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
14164263|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164264|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14164265|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14164266|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164267|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164268|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14164269|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14164270|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14164271|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14164272|NCT04884282|Docetaxel|docetaxel|mesh-list
14164273|NCT04884282|Nivolumab|nivolumab|mesh-list
14164274|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164275|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
14164276|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164277|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164278|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164279|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14164280|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14182093|NCT02235857|Dextrans|dextrans|mesh-list
14182094|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
14182095|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
14182096|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
14182097|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
14182098|NCT02230189|Miotics|miotics|mesh-ancestor
14182099|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
14182100|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182101|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182102|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14182103|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14182104|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
14182105|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14182106|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14182107|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
14182108|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184167|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164281|NCT04883996|Pilocarpine|pilocarpine|mesh-list
14164282|NCT04883996|Miotics|miotics|mesh-ancestor
14164283|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
14164284|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164285|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164286|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14164287|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14164288|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
14164289|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164290|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164291|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
14164292|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14164293|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
14164294|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14164295|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164296|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
14164297|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
14164298|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14164299|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
14164300|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164301|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
14164302|NCT04884464|Protective Agents|protective agents|mesh-ancestor
14164303|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14164304|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14164305|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14164306|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
14164307|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164308|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14164309|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14164310|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164311|NCT04883736|Tretinoin|tretinoin|mesh-list
14164312|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164313|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
14164314|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14164315|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
14164316|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14164317|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
14164318|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164319|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
14164320|NCT04883892|Protective Agents|protective agents|mesh-ancestor
14164321|NCT04883528|Valsartan|valsartan|mesh-list
14164322|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14164323|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14164324|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14164325|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14164326|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164327|NCT04883632|Lidocaine|lidocaine|mesh-list
14164328|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
14164329|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
14164330|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164331|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164332|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
14164333|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164334|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14164335|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14164336|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14164337|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14164338|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164339|NCT04883255|Dronabinol|dronabinol|mesh-list
14164340|NCT04883255|Cannabidiol|cannabidiol|mesh-list
14164341|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
14164342|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
14164343|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164344|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14164345|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14164346|NCT04883255|Analgesics|analgesics|mesh-ancestor
14164347|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
14164348|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164349|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14164350|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14164351|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164352|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164353|NCT04883255|Hormones|hormones|mesh-ancestor
14164354|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164355|NCT04883164|Antibodies|antibodies|mesh-list
14164356|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
14164357|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164358|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14164359|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
14164360|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14164361|NCT04883034|Analgesics|analgesics|mesh-list
14164362|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
14164363|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164364|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164365|NCT04882839|Psilocybin|psilocybin|mesh-list
14164366|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
14164367|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164368|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14164369|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
14164370|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
14164371|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14164372|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14164373|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164374|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164375|NCT04882826|Urological Agents|urological agents|mesh-ancestor
14164376|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14164377|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
14164378|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164379|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164380|NCT04882813|Incretins|incretins|mesh-ancestor
14164381|NCT04882813|Hormones|hormones|mesh-ancestor
14164382|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164383|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14164384|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
14164385|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164386|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164387|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14164388|NCT04883125|Pioglitazone|pioglitazone|mesh-list
14164389|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164390|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164391|NCT04882774|Treprostinil|treprostinil|mesh-list
14164392|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14164393|NCT04882540|Brivaracetam|brivaracetam|mesh-list
14164394|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
14164395|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
14164396|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14164397|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164398|NCT04882683|Prednisone|prednisone|mesh-list
14164399|NCT04882683|Adalimumab|adalimumab|mesh-list
14164400|NCT04882683|Azathioprine|azathioprine|mesh-list
14164401|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14164402|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
14164403|NCT04882683|Hormones|hormones|mesh-ancestor
14164404|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164405|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164406|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14164407|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164408|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164409|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
14164410|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164411|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14164412|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164413|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
14164414|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
14164415|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14164416|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164417|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164418|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182109|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164419|NCT04882163|Gemcitabine|gemcitabine|mesh-list
14164420|NCT04882163|Dexamethasone|dexamethasone|mesh-list
14164421|NCT04882163|Rituximab|rituximab|mesh-list
14164422|NCT04882163|Lenalidomide|lenalidomide|mesh-list
14164423|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14164424|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164425|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14164426|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
14164427|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
14164428|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164429|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164430|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164431|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
14164432|NCT04882163|Hormones|hormones|mesh-ancestor
14164433|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164434|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14164435|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14164436|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
14164437|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164438|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14164439|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
14164440|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164441|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
14164442|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164443|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164444|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164445|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14164446|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14164447|NCT04882163|Growth Substances|growth substances|mesh-ancestor
14164448|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
14164449|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14164450|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
14164451|NCT04881942|Menthol|menthol|mesh-list
14164452|NCT04881942|Nicotine|nicotine|mesh-list
14164453|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14164454|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
14164455|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164456|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164457|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14164458|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14164459|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
14164460|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766947|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164461|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164462|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
14164463|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14164464|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
14164465|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14164466|NCT04881929|Docetaxel|docetaxel|mesh-list
14164467|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164468|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14164469|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164470|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164471|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164472|NCT04881747|Lasmiditan|lasmiditan|mesh-list
14164473|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14164474|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
14164475|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164476|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164477|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164478|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
14164479|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14164480|NCT04881682|Antibodies|antibodies|mesh-list
14164481|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
14164482|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164483|NCT04881474|Ibuprofen|ibuprofen|mesh-list
14164484|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14164485|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14164486|NCT04881474|Analgesics|analgesics|mesh-ancestor
14164487|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
14164488|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164489|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164490|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14164491|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164492|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14164493|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164494|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164495|NCT04881851|Folic Acid|folic acid|mesh-list
14164496|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
14164497|NCT04881851|Inositol|inositol|mesh-list
14164498|NCT04881851|Hematinics|hematinics|mesh-ancestor
14164499|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
14164500|NCT04881851|Vitamins|vitamins|mesh-ancestor
14164501|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
14164502|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164503|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
14164504|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164505|NCT04881851|Protective Agents|protective agents|mesh-ancestor
14164506|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
14164507|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14164508|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164509|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164510|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164511|NCT04881110|Liraglutide|liraglutide|mesh-list
14164512|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164513|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164514|NCT04881110|Incretins|incretins|mesh-ancestor
14164515|NCT04881110|Hormones|hormones|mesh-ancestor
14164516|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164517|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
14164518|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14164519|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164520|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164521|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164522|NCT04880746|Cladribine|cladribine|mesh-list
14164523|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164524|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164525|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
14164526|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164527|NCT04880811|Afatinib|afatinib|mesh-list
14164528|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164529|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14164530|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164531|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164532|NCT04880785|Lamivudine|lamivudine|mesh-list
14164533|NCT04880785|Dolutegravir|dolutegravir|mesh-list
14164534|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14164535|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14164536|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164537|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164538|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
14164539|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164540|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14164541|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14164542|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14164543|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14164544|NCT04880655|Bacitracin|bacitracin|mesh-list
14164545|NCT04880655|Petrolatum|petrolatum|mesh-list
14164546|NCT04880655|Emollients|emollients|mesh-ancestor
14164547|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
14164548|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14164549|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164550|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14164551|NCT04880499|Folic Acid|folic acid|mesh-list
14164552|NCT04880499|Riboflavin|riboflavin|mesh-list
14164553|NCT04880499|Vitamins|vitamins|mesh-ancestor
14164554|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
14164555|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164556|NCT04880499|Hematinics|hematinics|mesh-ancestor
14164557|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
14164558|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14164559|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
14164560|NCT04880395|Lamivudine|lamivudine|mesh-list
14164561|NCT04880395|Emtricitabine|emtricitabine|mesh-list
14164562|NCT04880395|Dolutegravir|dolutegravir|mesh-list
14164563|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14164564|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14164565|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164566|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164567|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
14164568|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164569|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14164570|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14164571|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14164572|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14182126|NCT02192398|Guanfacine|guanfacine|mesh-list
14182127|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14182128|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14182129|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14182130|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14182131|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182132|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182133|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182134|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182135|NCT02179086|Temozolomide|temozolomide|mesh-list
14182136|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14182137|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
14182138|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182139|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182140|NCT02178956|Paclitaxel|paclitaxel|mesh-list
14182141|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14182142|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182143|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
14182144|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
14182145|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
14182146|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182147|NCT02167945|Ritonavir|ritonavir|mesh-list
14182148|NCT02167945|Ribavirin|ribavirin|mesh-list
14182149|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14182150|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14182151|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
14182152|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182153|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182154|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14182155|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14766948|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766949|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766950|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
14766951|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
14182156|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
14182157|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182158|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14182159|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14182160|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
14182161|NCT02160015|Rituximab|rituximab|mesh-list
14182162|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14182163|NCT02160015|Lenalidomide|lenalidomide|mesh-list
14182164|NCT02160015|Antibodies|antibodies|mesh-list
14182165|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
14182166|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14182167|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
14182168|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182169|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182170|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182171|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182172|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182173|NCT02160015|Growth Substances|growth substances|mesh-ancestor
14182174|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182175|NCT02159755|Palbociclib|palbociclib|mesh-list
14182176|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182177|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182178|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182179|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182180|NCT02152995|Iodine|iodine|mesh-list
14182181|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
14182182|NCT02152995|Trametinib|trametinib|mesh-list
14182183|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14182184|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182185|NCT02152995|Trace Elements|trace elements|mesh-ancestor
14766952|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766953|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14182186|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
14182187|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164573|NCT04879992|Amoxicillin|amoxicillin|mesh-list
14164574|NCT04879992|Metronidazole|metronidazole|mesh-list
14164575|NCT04879992|Tetracycline|tetracycline|mesh-list
14164576|NCT04879992|Rifabutin|rifabutin|mesh-list
14164577|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
14164578|NCT04879992|Esomeprazole|esomeprazole|mesh-list
14164579|NCT04879992|Bismuth|bismuth|mesh-list
14164580|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164581|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14164582|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164583|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14164584|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14164585|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14164586|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164587|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14164588|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164589|NCT04879992|Antacids|antacids|mesh-ancestor
14164590|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14164591|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14164592|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
14164593|NCT04879992|Diuretics|diuretics|mesh-ancestor
14164594|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
14164595|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164596|NCT04879992|Expectorants|expectorants|mesh-ancestor
14164597|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
14164598|NCT04879966|Infliximab|infliximab|mesh-list
14164599|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
14164600|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164601|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164602|NCT04879446|Mitogens|mitogens|mesh-list
14164603|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164604|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164605|NCT04879511|Metformin|metformin|mesh-list
14164606|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164607|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164608|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
14164609|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14164610|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14164611|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164612|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
14164613|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164614|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766954|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14766955|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14766956|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
14766957|NCT00628160|Protective Agents|protective agents|mesh-ancestor
14766958|NCT00628225|Bupropion|bupropion|mesh-list
14938478|NCT01481831|Palonosetron|palonosetron|mesh-list
14938479|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
14938480|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
14938481|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938482|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938483|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938484|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14766959|NCT00628225|Nicotine|nicotine|mesh-list
14766960|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14766961|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
14766962|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164624|NCT04879420|Teriparatide|teriparatide|mesh-list
14164625|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
14164626|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14164627|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164628|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14164629|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14164630|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14164631|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164632|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14164633|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14164634|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14164635|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164636|NCT04879550|Antithrombins|antithrombins|mesh-list
14164637|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
14164638|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14766963|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766964|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14164639|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
14164640|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164641|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164642|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
14164643|NCT04879407|Warfarin|warfarin|mesh-list
14164644|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
14164645|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
14164646|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14164647|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
14164648|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14164649|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
14164650|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164651|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164652|NCT04879004|Ropivacaine|ropivacaine|mesh-list
14164653|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
14164654|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
14164655|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164656|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164657|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
14164658|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164659|NCT04879134|Apomorphine|apomorphine|mesh-list
14164660|NCT04879134|Emetics|emetics|mesh-ancestor
14164661|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164662|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
14164663|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164664|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164665|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
14164666|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
14164667|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164668|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164669|NCT04878926|Midazolam|midazolam|mesh-list
14164670|NCT04878926|Propofol|propofol|mesh-list
14164671|NCT04878926|Anesthetics|anesthetics|mesh-list
14164672|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
14164673|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14164674|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164675|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164676|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14164677|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
14164678|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14164679|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14164680|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14164681|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14164682|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
14164683|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
14164684|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164685|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164686|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
14164687|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164688|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
14164689|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
14164690|NCT04879030|Levofloxacin|levofloxacin|mesh-list
14164691|NCT04879030|Meropenem|meropenem|mesh-list
14164692|NCT04879030|Tazobactam|tazobactam|mesh-list
14164693|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
14164694|NCT04879030|Piperacillin|piperacillin|mesh-list
14164695|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
14164696|NCT04879030|Imipenem|imipenem|mesh-list
14164697|NCT04879030|Ceftazidime|ceftazidime|mesh-list
14164698|NCT04879030|Ertapenem|ertapenem|mesh-list
14164699|NCT04879030|Lactams|lactams|mesh-list
14164700|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14164701|NCT04879030|Cefotaxime|cefotaxime|mesh-list
14164702|NCT04879030|Cefixime|cefixime|mesh-list
14164703|NCT04879030|beta-Lactams|beta-lactams|mesh-list
14164704|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
14164705|NCT04879030|Ticarcillin|ticarcillin|mesh-list
14164706|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14164707|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164708|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14164709|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14164710|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164711|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164712|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164713|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14164714|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14164715|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14164716|NCT04879030|Renal Agents|renal agents|mesh-ancestor
14164717|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14164718|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14164719|NCT04878835|Ranibizumab|ranibizumab|mesh-list
14164720|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14164721|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14164722|NCT04878835|Growth Substances|growth substances|mesh-ancestor
14164723|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164724|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
14164725|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164726|NCT04878770|Cyclosporine|cyclosporine|mesh-list
14164727|NCT04878770|Cyclosporins|cyclosporins|mesh-list
14164728|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164729|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164730|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164731|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
14164732|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164733|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
14164734|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164735|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
14164736|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164737|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14164738|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
14164739|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14164740|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164741|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164742|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14164743|NCT04878510|Analgesics|analgesics|mesh-ancestor
14164744|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
14164745|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164746|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14164747|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14164748|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14164749|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
14164750|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164751|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164752|NCT04878718|Vancomycin|vancomycin|mesh-list
14164753|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14164754|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164755|NCT04878497|Warfarin|warfarin|mesh-list
14164756|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
14164757|NCT04878497|Dabigatran|dabigatran|mesh-list
14164758|NCT04878497|Apixaban|apixaban|mesh-list
14164759|NCT04878497|Edoxaban|edoxaban|mesh-list
14164760|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
14164761|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14164762|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
14164763|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14164764|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
14164765|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164766|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164767|NCT04878198|Melatonin|melatonin|mesh-list
14164768|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
14164769|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164770|NCT04878198|Protective Agents|protective agents|mesh-ancestor
14164771|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164772|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182188|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182189|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182190|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182191|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182192|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
14182193|NCT02048813|Rituximab|rituximab|mesh-list
14182194|NCT02048813|Fludarabine|fludarabine|mesh-list
14182195|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
14182196|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14182197|NCT02048813|Antibodies|antibodies|mesh-list
14182198|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
14182199|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14182200|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14182201|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
14182202|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182203|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182204|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14182205|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
14182206|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182207|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182208|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14164773|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14164774|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14164775|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164776|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
14164777|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
14164778|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164779|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
14164780|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14164781|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164782|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164783|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14164784|NCT04877639|Analgesics|analgesics|mesh-ancestor
14164785|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
14164786|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164787|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14164788|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14164789|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14164790|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
14164791|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164792|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164793|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
14164794|NCT04877613|Fludarabine|fludarabine|mesh-list
14164795|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164796|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
14164797|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164798|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164799|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14164800|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
14164801|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164802|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164803|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14164804|NCT04878016|Carboplatin|carboplatin|mesh-list
14164805|NCT04878016|Etoposide|etoposide|mesh-list
14164806|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164807|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14164808|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14164809|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14164810|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164811|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164812|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
14164813|NCT04877834|Lansoprazole|lansoprazole|mesh-list
14164814|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14164815|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164816|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14164817|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164818|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164819|NCT05257993|Gemcitabine|gemcitabine|mesh-list
14164820|NCT05257993|Paclitaxel|paclitaxel|mesh-list
14164821|NCT05257993|Folfirinox|folfirinox|mesh-list
14164822|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14164823|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164824|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14164825|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164826|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164827|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164828|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14164829|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
14164830|NCT05257993|Antiviral Agents|antiviral agents|mesh-ancestor
14164831|NCT05257993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14164832|NCT05257993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164833|NCT05257993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164834|NCT05257993|Immunologic Factors|immunologic factors|mesh-ancestor
14164835|NCT05257993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164836|NCT05257902|Choline|choline|mesh-list
14164837|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
14164838|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14164839|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
14164840|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164841|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164842|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14164843|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
14164844|NCT05257824|Aspirin|aspirin|mesh-list
14164845|NCT05257824|Clopidogrel|clopidogrel|mesh-list
14164846|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14164847|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14164848|NCT05257824|Analgesics|analgesics|mesh-ancestor
14164849|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
14164850|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164851|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164852|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14164853|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164854|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14164855|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14164856|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164857|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14164858|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14164859|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164860|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
14164861|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14164862|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14164863|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14164864|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
14164865|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766965|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14766966|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
14766967|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14766968|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766969|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14164871|NCT05257460|Insulin|insulin|mesh-list
14164872|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14164873|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
14164874|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14164875|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164876|NCT05257408|Paclitaxel|paclitaxel|mesh-list
14164877|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14164878|NCT05257408|Doxorubicin|doxorubicin|mesh-list
14164879|NCT05257408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14164880|NCT05257408|Topotecan|topotecan|mesh-list
14164881|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14164882|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164883|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
14164884|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164885|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164886|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164887|NCT05257408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14164888|NCT05257408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14164889|NCT05257408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14164890|NCT05257408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164891|NCT05257408|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14164892|NCT05257395|Letrozole|letrozole|mesh-list
14766970|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
14766971|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766972|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14164893|NCT05257395|Anastrozole|anastrozole|mesh-list
14164894|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164895|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14164896|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14164897|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164898|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164899|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14164900|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
14164901|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164902|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164903|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14164904|NCT05257291|Melatonin|melatonin|mesh-list
14164905|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
14164906|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164907|NCT05257291|Protective Agents|protective agents|mesh-ancestor
14164908|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164909|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164910|NCT05257083|Dexamethasone|dexamethasone|mesh-list
14164911|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
14164912|NCT05257083|Fludarabine|fludarabine|mesh-list
14164913|NCT05257083|Lenalidomide|lenalidomide|mesh-list
14164914|NCT05257083|Bortezomib|bortezomib|mesh-list
14164915|NCT05257083|Daratumumab|daratumumab|mesh-list
14164916|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164917|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
14766973|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14164918|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164919|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164920|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14164921|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
14164922|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164923|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164924|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14164925|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14164926|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
14164927|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
14164928|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164929|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14164930|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
14164931|NCT05257083|Hormones|hormones|mesh-ancestor
14164932|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14164933|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14164934|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14164935|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14164936|NCT05257083|Growth Substances|growth substances|mesh-ancestor
14164937|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
14164938|NCT05257018|Doxorubicin|doxorubicin|mesh-list
14164939|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14164940|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164941|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14164942|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14164943|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164944|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164945|NCT05256953|Anesthetics|anesthetics|mesh-list
14164946|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14164947|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164948|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
14164949|NCT05256901|Neostigmine|neostigmine|mesh-list
14164950|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14164951|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164952|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164953|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
14164954|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14164955|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164956|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14164957|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
14164958|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14164959|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14164960|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14164961|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14164962|NCT05256758|Fenofibrate|fenofibrate|mesh-list
14164963|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14164964|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
14164965|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164966|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14164967|NCT05256745|Paclitaxel|paclitaxel|mesh-list
14164968|NCT05256745|Docetaxel|docetaxel|mesh-list
14164969|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
14164970|NCT05256745|Carboplatin|carboplatin|mesh-list
14164971|NCT05256745|Doxorubicin|doxorubicin|mesh-list
14164972|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14164973|NCT05256745|Trastuzumab|trastuzumab|mesh-list
14164974|NCT05256745|Pertuzumab|pertuzumab|mesh-list
14164975|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14164976|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164977|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
14164978|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
14164979|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
14164980|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164981|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164982|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
14164983|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14164984|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14164985|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14164986|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
14164987|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14164988|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14164989|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14164990|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14164991|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14164992|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14164993|NCT05256719|Abatacept|abatacept|mesh-list
14164994|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14164995|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14164996|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14164997|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14164998|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
14164999|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165000|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165001|NCT05256693|Vancomycin|vancomycin|mesh-list
14165002|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14165003|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165004|NCT05256472|Axitinib|axitinib|mesh-list
14165005|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165006|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14165007|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165008|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182209|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14182210|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
14182211|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14182212|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14182213|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
14182214|NCT02030028|Hormones|hormones|mesh-ancestor
14182215|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182216|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182217|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182218|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182219|NCT02024607|Leucovorin|leucovorin|mesh-list
14182220|NCT02024607|Bevacizumab|bevacizumab|mesh-list
14182221|NCT02024607|Fluorouracil|fluorouracil|mesh-list
14182222|NCT02024607|Capecitabine|capecitabine|mesh-list
14182223|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
14182224|NCT02024607|Irinotecan|irinotecan|mesh-list
14182225|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182226|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182227|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182228|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182229|NCT02024607|Growth Substances|growth substances|mesh-ancestor
14182230|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182231|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182232|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
14182233|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182234|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14182235|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14182236|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
14182237|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14182238|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14182239|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182240|NCT02024607|Antidotes|antidotes|mesh-ancestor
14182241|NCT02024607|Protective Agents|protective agents|mesh-ancestor
14182242|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
14182243|NCT02024607|Vitamins|vitamins|mesh-ancestor
14182244|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
14165009|NCT05256342|Etoricoxib|etoricoxib|mesh-list
14165010|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14165011|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14165012|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14165013|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165014|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165015|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165016|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165017|NCT05256342|Analgesics|analgesics|mesh-ancestor
14165018|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
14165019|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165020|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
14165021|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14165022|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
14165023|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14165024|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165025|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165026|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165027|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14165028|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14165029|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165030|NCT05256264|Ketamine|ketamine|mesh-list
14165031|NCT05256264|Analgesics|analgesics|mesh-ancestor
14165032|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
14165033|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165034|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165035|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14165036|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14165037|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
14165038|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
14165039|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165040|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14165041|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14165042|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165043|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165044|NCT05256173|Melatonin|melatonin|mesh-list
14165045|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
14165046|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165047|NCT05256173|Protective Agents|protective agents|mesh-ancestor
14165048|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165049|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165050|NCT05256147|Ibuprofen|ibuprofen|mesh-list
14165051|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14165052|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165053|NCT05256147|Analgesics|analgesics|mesh-ancestor
14165054|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
14165055|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165056|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165057|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165058|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165059|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14165060|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165061|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14766974|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14766975|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
14766976|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14766977|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14766978|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14766979|NCT00628238|Rituximab|rituximab|mesh-list
14766980|NCT00628238|Lenalidomide|lenalidomide|mesh-list
14766981|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14766982|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165071|NCT05256069|Propranolol|propranolol|mesh-list
14165072|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14165073|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14165074|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
14165075|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165076|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165077|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165078|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14165079|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14165080|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
14165081|NCT05255991|Treprostinil|treprostinil|mesh-list
14165082|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14165083|NCT05255913|Fluorides|fluorides|mesh-list
14165084|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
14165085|NCT05255913|Protective Agents|protective agents|mesh-ancestor
14165086|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165087|NCT05255848|Heparin|heparin|mesh-list
14165088|NCT05255848|Calcium heparin|calcium heparin|mesh-list
14165089|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
14165090|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14165091|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14165092|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165093|NCT05255770|Benzocaine|benzocaine|mesh-list
14165094|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
14165095|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
14165096|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165097|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165098|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
14165099|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14766983|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
14766984|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766985|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14766986|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14766987|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14766988|NCT00628238|Growth Substances|growth substances|mesh-ancestor
14766989|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
14766990|NCT00628290|Cannabidiol|cannabidiol|mesh-list
14766991|NCT00628290|Amisulpride|amisulpride|mesh-list
14766992|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
14766993|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14766994|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14766995|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14766996|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14766997|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14766998|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14766999|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
14767000|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767001|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767002|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14165100|NCT05238831|Paclitaxel|paclitaxel|mesh-list
14165101|NCT05238831|Vinorelbine|vinorelbine|mesh-list
14165102|NCT05238831|Maytansine|maytansine|mesh-list
14165103|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14165104|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14165105|NCT05238831|Bevacizumab|bevacizumab|mesh-list
14165106|NCT05238831|Carboplatin|carboplatin|mesh-list
14165107|NCT05238831|Capecitabine|capecitabine|mesh-list
14165108|NCT05238831|Trastuzumab|trastuzumab|mesh-list
14165109|NCT05238831|Irinotecan|irinotecan|mesh-list
14165110|NCT05238831|Atezolizumab|atezolizumab|mesh-list
14165111|NCT05238831|Letrozole|letrozole|mesh-list
14165112|NCT05238831|Olaparib|olaparib|mesh-list
14165113|NCT05238831|Fulvestrant|fulvestrant|mesh-list
14165114|NCT05238831|Palbociclib|palbociclib|mesh-list
14165115|NCT05238831|Anastrozole|anastrozole|mesh-list
14165116|NCT05238831|Pertuzumab|pertuzumab|mesh-list
14165117|NCT05238831|Niraparib|niraparib|mesh-list
14165118|NCT05238831|Vemurafenib|vemurafenib|mesh-list
14165119|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14165120|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
14165121|NCT05238831|Antibodies|antibodies|mesh-list
14165122|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
14165123|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14165124|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14165125|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
14165126|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
14165127|NCT05238831|Entrectinib|entrectinib|mesh-list
14165128|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
14767003|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
14767004|NCT00628316|Caffeine|caffeine|mesh-list
14165129|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165130|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165131|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165132|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
14165133|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165134|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165135|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14165136|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14165137|NCT05238831|Growth Substances|growth substances|mesh-ancestor
14184168|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165138|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165139|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
14165140|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
14165141|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14165142|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
14165143|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14165144|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14165145|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165146|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14165147|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14165148|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14165149|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
14165150|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165151|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14165152|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165153|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14165154|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14165155|NCT05231941|Lidocaine|lidocaine|mesh-list
14165156|NCT05231941|Ropivacaine|ropivacaine|mesh-list
14165157|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14165158|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
14165159|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165160|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165161|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
14165162|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165163|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14165164|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14165165|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14165166|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165167|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165168|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
14165169|NCT05231590|Paraproteins|paraproteins|mesh-list
14165170|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
14165171|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165172|NCT05222984|Decitabine|decitabine|mesh-list
14165173|NCT05222984|Venetoclax|venetoclax|mesh-list
14165174|NCT05222984|Navitoclax|navitoclax|mesh-list
14165175|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14165176|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
14165177|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165178|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165179|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165180|NCT05216575|Almitrine|almitrine|mesh-list
14165181|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14165182|NCT05214417|Ketamine|ketamine|mesh-list
14165183|NCT05214417|Analgesics|analgesics|mesh-ancestor
14165184|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
14165185|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165186|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165187|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14165188|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14165189|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
14165190|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
14165191|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165192|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14165193|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14165194|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165195|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165196|NCT05205252|Dexamethasone|dexamethasone|mesh-list
14165197|NCT05205252|Dexamethasone acetate|dexamethasone acetate|mesh-list
14165198|NCT05205252|Lenalidomide|lenalidomide|mesh-list
14165199|NCT05205252|Daratumumab|daratumumab|mesh-list
14165200|NCT05205252|Pomalidomide|pomalidomide|mesh-list
14165201|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
14165202|NCT05205252|BB 1101|bb 1101|mesh-list
14165203|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14165204|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165205|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
14165206|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
14165207|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165208|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165209|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165210|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
14165211|NCT05205252|Hormones|hormones|mesh-ancestor
14165212|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165213|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165214|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165215|NCT05205252|Protease Inhibitors|protease inhibitors|mesh-ancestor
14165216|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165217|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165218|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
14165219|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14165220|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14165221|NCT05205252|Growth Substances|growth substances|mesh-ancestor
14165222|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
14165223|NCT05197842|Prednisone|prednisone|mesh-list
14165224|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
14165225|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
14165226|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165227|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
14165228|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165229|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165230|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14165231|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
14165232|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165233|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165234|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14165235|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165236|NCT05197842|Hormones|hormones|mesh-ancestor
14165237|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165238|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165239|NCT05189730|Paclitaxel|paclitaxel|mesh-list
14165240|NCT05189730|Carboplatin|carboplatin|mesh-list
14165241|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165242|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165243|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165244|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
14165245|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165246|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165247|NCT05168709|Vaccines|vaccines|mesh-list
14165248|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
14165249|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165250|NCT05163106|Letrozole|letrozole|mesh-list
14165251|NCT05163106|Goserelin|goserelin|mesh-list
14165252|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165253|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14165254|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14165255|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165256|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165257|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14165258|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
14165259|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165260|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165261|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165262|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14165263|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14165264|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14165265|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
14165266|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165267|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14165268|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14165269|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165270|NCT05048264|Dexamethasone|dexamethasone|mesh-list
14165271|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
14165272|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14165273|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14165274|NCT05048264|Prednisolone|prednisolone|mesh-list
14165275|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
14165276|NCT05048264|Triamcinolone|triamcinolone|mesh-list
14165277|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14165278|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14165279|NCT05048264|Betamethasone|betamethasone|mesh-list
14165280|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14165281|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
14165282|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14165283|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165284|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
14165285|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
14165286|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165287|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165288|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165289|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
14165290|NCT05048264|Hormones|hormones|mesh-ancestor
14165291|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165292|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165293|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165294|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14165295|NCT05048264|Protective Agents|protective agents|mesh-ancestor
14165296|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165297|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
14165298|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165299|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165300|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14165301|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
14165302|NCT05028608|Carbamazepine|carbamazepine|mesh-list
14165303|NCT05028608|Midazolam|midazolam|mesh-list
14165304|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14165305|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14165306|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165307|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165308|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14165309|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14165310|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14165311|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14165312|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
14165313|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
14165314|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
14165315|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
14165316|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165317|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165318|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
14165319|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
14165320|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165321|NCT05028608|Analgesics|analgesics|mesh-ancestor
14165322|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
14165323|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165324|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14165325|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165326|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14165327|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14165328|NCT05020899|Nicotine|nicotine|mesh-list
14165329|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14165330|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
14165331|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165332|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165333|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14165334|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14165335|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
14165336|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165337|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165338|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14165339|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14165340|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14165341|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165342|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165343|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14165344|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165345|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165346|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
14165347|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165348|NCT04873596|Midazolam|midazolam|mesh-list
14165349|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
14165350|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14165351|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165352|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165353|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165354|NCT04873596|Analgesics|analgesics|mesh-ancestor
14165355|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
14165356|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165357|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14165358|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14165359|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14165360|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
14165361|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165362|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165363|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14165364|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14165365|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14165366|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14165367|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14165368|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
14165369|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
14165370|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
14165371|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
14165372|NCT04854434|Trifluridine|trifluridine|mesh-list
14165373|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
14165374|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165375|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165376|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
14165377|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165378|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
14165379|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165380|NCT04795336|Melatonin|melatonin|mesh-list
14165381|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
14165382|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165383|NCT04795336|Protective Agents|protective agents|mesh-ancestor
14165384|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165385|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165386|NCT04685876|Bupivacaine|bupivacaine|mesh-list
14165387|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
14165388|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
14165389|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165390|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165391|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
14165392|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165393|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14165394|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14165395|NCT04676399|Diuretics|diuretics|mesh-ancestor
14165396|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
14165397|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165398|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14165399|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165400|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165401|NCT04659603|Maytansine|maytansine|mesh-list
14165402|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165403|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165404|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165405|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
14165406|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165407|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165408|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
14165409|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14165410|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165411|NCT04576962|Vaccines|vaccines|mesh-list
14165412|NCT04576962|Immunologic Factors|immunologic factors|mesh-ancestor
14165413|NCT04576962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165414|NCT04569045|Lidocaine|lidocaine|mesh-list
14165415|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
14165416|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
14165417|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165418|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165419|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
14165420|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165421|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14165422|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14165423|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14165424|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165425|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165426|NCT04550195|Famotidine|famotidine|mesh-list
14165427|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14165428|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165429|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14165430|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
14165431|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
14165432|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165433|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165434|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165435|NCT04537962|Listerine|listerine|mesh-list
14165436|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
14165437|NCT04537962|Fluorides|fluorides|mesh-list
14165438|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
14165439|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
14165440|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
14165441|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
14165442|NCT04537962|Protective Agents|protective agents|mesh-ancestor
14165443|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165444|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14165445|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165446|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
14165447|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14767005|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14767006|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767007|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14767008|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767009|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767010|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14767011|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14767012|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
14767013|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767014|NCT00628342|Esomeprazole|esomeprazole|mesh-list
14767015|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14767016|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767017|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14165448|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
14165449|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165450|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14165451|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165452|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
14165453|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165454|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
14165455|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14165456|NCT04535882|Protective Agents|protective agents|mesh-ancestor
14165457|NCT04525391|Durvalumab|durvalumab|mesh-list
14165458|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165459|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165460|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
14165461|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14165462|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
14165463|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165464|NCT04481048|Expectorants|expectorants|mesh-ancestor
14165465|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
14165466|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14165467|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
14165468|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165469|NCT04481048|Protective Agents|protective agents|mesh-ancestor
14165470|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165471|NCT04481048|Antidotes|antidotes|mesh-ancestor
14165472|NCT04469530|Sirolimus|sirolimus|mesh-list
14165473|NCT04469530|Celecoxib|celecoxib|mesh-list
14165474|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
14165475|NCT04469530|Etoposide|etoposide|mesh-list
14165476|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165477|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
14165478|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165479|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165480|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14165481|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
14165482|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165483|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165484|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14165485|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165486|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14165487|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14165488|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165489|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14165490|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165491|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14165492|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
14165493|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14165494|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165495|NCT04469530|Analgesics|analgesics|mesh-ancestor
14165496|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
14165497|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165498|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165499|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14165500|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14165501|NCT04425291|Vaccines|vaccines|mesh-list
14165502|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
14165503|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165504|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
14165505|NCT04423055|Etonogestrel|etonogestrel|mesh-list
14165506|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14165507|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165508|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14165509|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14165510|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
14165511|NCT04389073|Bevacizumab|bevacizumab|mesh-list
14165512|NCT04389073|Capecitabine|capecitabine|mesh-list
14165513|NCT04389073|Vinorelbine|vinorelbine|mesh-list
14165514|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165515|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
14165516|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165517|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165518|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14165519|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
14165520|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165521|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165522|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14165523|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165524|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14165525|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14165526|NCT04389073|Growth Substances|growth substances|mesh-ancestor
14165527|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
14165528|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14165529|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
14165530|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165531|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165532|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
14165533|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165534|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
14165535|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165536|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165537|NCT04371445|Dexamethasone|dexamethasone|mesh-list
14165538|NCT04371445|Prednisolone|prednisolone|mesh-list
14165539|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14165540|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
14165541|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14165542|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
14165543|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14165544|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
14165545|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767018|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767019|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767020|NCT00628459|Micronutrients|micronutrients|mesh-list
14165546|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
14165547|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
14165548|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165549|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165550|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165551|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
14165552|NCT04371445|Hormones|hormones|mesh-ancestor
14165553|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165554|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165555|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165556|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14165557|NCT04371445|Protective Agents|protective agents|mesh-ancestor
14165558|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
14165559|NCT04357782|Vitamins|vitamins|mesh-ancestor
14165560|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
14165561|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165562|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
14165563|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165564|NCT04357782|Protective Agents|protective agents|mesh-ancestor
14165565|NCT04337073|Propofol|propofol|mesh-list
14165566|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14165567|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165568|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165569|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14165570|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
14165571|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
14165572|NCT04330248|Carbamazepine|carbamazepine|mesh-list
14165573|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
14165574|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
14165575|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14165576|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165577|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165578|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14165579|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165580|NCT04330248|Analgesics|analgesics|mesh-ancestor
14165581|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
14165582|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165583|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14165584|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165585|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165586|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14165587|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14165588|NCT04316806|Rifaximin|rifaximin|mesh-list
14165589|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14165590|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165591|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165592|NCT04311606|Aflibercept|aflibercept|mesh-list
14165593|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14165594|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14165595|NCT04311606|Growth Substances|growth substances|mesh-ancestor
14165596|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165597|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
14165598|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479048|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479049|NCT02463331|Chloroquine|chloroquine|mesh-list
14479050|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14479051|NCT02463331|Prednisone|prednisone|mesh-list
14165599|NCT04309916|Esomeprazole|esomeprazole|mesh-list
14165600|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14165601|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165602|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14165603|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165604|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165605|NCT04284397|Aspirin|aspirin|mesh-list
14165606|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14165607|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165608|NCT04284397|Analgesics|analgesics|mesh-ancestor
14165609|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
14165610|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165611|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165612|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165613|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165614|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14165615|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14165616|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165617|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14165618|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14165619|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165620|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
14165621|NCT04275999|Ivermectin|ivermectin|mesh-list
14165622|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14165623|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165624|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14165625|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
14165626|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165627|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165628|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165629|NCT04245215|Ustekinumab|ustekinumab|mesh-list
14165630|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
14165631|NCT04189107|Dexamethasone|dexamethasone|mesh-list
14165632|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
14165633|NCT04189107|BB 1101|bb 1101|mesh-list
14165634|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165635|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
14165636|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
14165637|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165638|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165639|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165640|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
14165641|NCT04189107|Hormones|hormones|mesh-ancestor
14165642|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165643|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165644|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165645|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
14165646|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165647|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165651|NCT04112095|Norgestrel|norgestrel|mesh-list
14165652|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14165653|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14479052|NCT02463331|Azathioprine|azathioprine|mesh-list
14479053|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479054|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
14479055|NCT02463331|Hormones|hormones|mesh-ancestor
14479056|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479057|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479058|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14479059|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479060|NCT02463331|Amebicides|amebicides|mesh-ancestor
14165654|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14165655|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
14165656|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14165657|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165658|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14165659|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14165660|NCT04050553|Tirzepatide|tirzepatide|mesh-list
14165661|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14165662|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165663|NCT04050553|Incretins|incretins|mesh-ancestor
14165664|NCT04050553|Hormones|hormones|mesh-ancestor
14165665|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165666|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
14165667|NCT04049331|Testosterone|testosterone|mesh-list
14165668|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
14165669|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
14165670|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14165671|NCT04049331|Androgens|androgens|mesh-ancestor
14165672|NCT04049331|Hormones|hormones|mesh-ancestor
14165673|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165674|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165675|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165676|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165677|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
14165678|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
14165679|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165680|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165681|NCT03955471|Niraparib|niraparib|mesh-list
14165682|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14165683|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165684|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165685|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165686|NCT03946891|Furosemide|furosemide|mesh-list
14165687|NCT03946891|Diuretics|diuretics|mesh-ancestor
14165688|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
14165689|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165690|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14165691|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14165692|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165693|NCT03934684|Dexamethasone|dexamethasone|mesh-list
14165694|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
14165695|NCT03934684|Lenalidomide|lenalidomide|mesh-list
14165696|NCT03934684|BB 1101|bb 1101|mesh-list
14165697|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165698|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
14165699|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
14165700|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165701|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165702|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165703|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
14165704|NCT03934684|Hormones|hormones|mesh-ancestor
14165705|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165706|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165707|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165708|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
14165709|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165710|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165711|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
14165712|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14165713|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14165714|NCT03934684|Growth Substances|growth substances|mesh-ancestor
14165715|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
14165716|NCT03911453|Rucaparib|rucaparib|mesh-list
14165717|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14165718|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165719|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165720|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165721|NCT03871049|Dexamethasone|dexamethasone|mesh-list
14165722|NCT03871049|Bupivacaine|bupivacaine|mesh-list
14165723|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165724|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
14165725|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
14479061|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14479062|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14165726|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165727|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165728|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165729|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
14165730|NCT03871049|Hormones|hormones|mesh-ancestor
14165731|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165732|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165733|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165734|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
14165735|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
14165736|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14165737|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
14165738|NCT03849625|Aspirin|aspirin|mesh-list
14165739|NCT03849625|Acetaminophen|acetaminophen|mesh-list
14165740|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14165741|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14165742|NCT03849625|Analgesics|analgesics|mesh-ancestor
14165743|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
14165744|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165745|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165746|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165747|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165748|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14165749|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14938485|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14938486|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
14938487|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938488|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938489|NCT01481844|Amoxicillin|amoxicillin|mesh-list
14165750|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165751|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14165752|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14165753|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165754|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
14165755|NCT03769844|Molgramostim|molgramostim|mesh-list
14165756|NCT03769844|Sargramostim|sargramostim|mesh-list
14165757|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
14165758|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165759|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165760|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
14165761|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14165762|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165763|NCT03755804|Prednisone|prednisone|mesh-list
14165764|NCT03755804|Prednisolone|prednisolone|mesh-list
14165765|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
14165766|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14165767|NCT03755804|Dacarbazine|dacarbazine|mesh-list
14165768|NCT03755804|Doxorubicin|doxorubicin|mesh-list
14165769|NCT03755804|Etoposide|etoposide|mesh-list
14165770|NCT03755804|Vincristine|vincristine|mesh-list
14165771|NCT03755804|Bleomycin|bleomycin|mesh-list
14165772|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14165773|NCT03755804|Vinblastine|vinblastine|mesh-list
14165774|NCT03755804|Imidazole|imidazole|mesh-list
14165775|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165776|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
14165777|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165778|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165779|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14165780|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
14165781|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165782|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165783|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14165784|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14165785|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14165786|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14165787|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165788|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165789|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
14165790|NCT03755804|Hormones|hormones|mesh-ancestor
14165791|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165792|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165793|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165794|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165795|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
14165796|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
14767021|NCT00628459|Trace Elements|trace elements|mesh-list
14165797|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165798|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
14165799|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165800|NCT03742986|Paclitaxel|paclitaxel|mesh-list
14165801|NCT03742986|Docetaxel|docetaxel|mesh-list
14767022|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767023|NCT00628550|Vasopressins|vasopressins|mesh-list
14767024|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
14767025|NCT00628550|Epinephrine|epinephrine|mesh-list
14767026|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14767027|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14165802|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14165803|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
14165804|NCT03742986|Doxorubicin|doxorubicin|mesh-list
14165805|NCT03742986|Nivolumab|nivolumab|mesh-list
14165806|NCT03742986|Trastuzumab|trastuzumab|mesh-list
14165807|NCT03742986|Pertuzumab|pertuzumab|mesh-list
14165808|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165809|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165810|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165811|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
14165812|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165813|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165814|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165815|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
14165816|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165817|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165818|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14165819|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
14165820|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14165821|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14165822|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14165823|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14767028|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
14767029|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165824|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165825|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165826|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14165827|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
14165828|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165829|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165830|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
14165831|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165832|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165833|NCT03612973|Insulin|insulin|mesh-list
14165834|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14165835|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165836|NCT03589014|Propranolol|propranolol|mesh-list
14165837|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14165838|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14165839|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
14165840|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14165841|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767450|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14165842|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165843|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14165844|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14165845|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
14165846|NCT03583255|Dexamethasone|dexamethasone|mesh-list
14165847|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
14165848|NCT03583255|Ichthammol|ichthammol|mesh-list
14165849|NCT03583255|BB 1101|bb 1101|mesh-list
14165850|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14165851|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
14165852|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
14165853|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14165854|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165855|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14165856|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
14165857|NCT03583255|Hormones|hormones|mesh-ancestor
14165858|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165859|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165860|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165861|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
14165862|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165863|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165864|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
14165865|NCT03557918|Tremelimumab|tremelimumab|mesh-list
14165866|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165867|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
14165868|NCT03456843|Docetaxel|docetaxel|mesh-list
14165869|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
14165870|NCT03456843|Hormones|hormones|mesh-list
14165871|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14165872|NCT03456843|Androgens|androgens|mesh-list
14165873|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
14165874|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165875|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165876|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938490|NCT01481844|Metronidazole|metronidazole|mesh-list
14938491|NCT01481844|Clarithromycin|clarithromycin|mesh-list
14938492|NCT01481844|Tetracycline|tetracycline|mesh-list
14938493|NCT01481844|Tinidazole|tinidazole|mesh-list
14938494|NCT01481844|Lansoprazole|lansoprazole|mesh-list
14938495|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
14938496|NCT01481844|Bismuth|bismuth|mesh-list
14938497|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14938498|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14938499|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938500|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14938501|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14938502|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14938503|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938504|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938505|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14165877|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165878|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165879|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14165880|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165881|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
14165882|NCT03456843|Protective Agents|protective agents|mesh-ancestor
14165883|NCT03456843|Vitamins|vitamins|mesh-ancestor
14165884|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
14165885|NCT03456843|Estrogens|estrogens|mesh-ancestor
14165886|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14165887|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
14165888|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
14165889|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
14165890|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165891|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
14165892|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165893|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165894|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14165895|NCT03428126|Durvalumab|durvalumab|mesh-list
14165896|NCT03428126|Trametinib|trametinib|mesh-list
14165897|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165898|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165899|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938506|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14165900|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165901|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938507|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14165902|NCT03352934|Avelumab|avelumab|mesh-list
14165903|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165904|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165905|NCT03341689|Psilocybin|psilocybin|mesh-list
14165906|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
14165907|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165908|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14165909|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
14165910|NCT03340766|Blinatumomab|blinatumomab|mesh-list
14165911|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165912|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165913|NCT03300817|Poly ICLC|poly iclc|mesh-list
14767030|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767031|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767032|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14767033|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14767034|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
14767035|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767036|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14767037|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
14165914|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
14165915|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
14165916|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182307|NCT01955499|Lenalidomide|lenalidomide|mesh-list
14182308|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
14182309|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182310|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182311|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182312|NCT01955499|Growth Substances|growth substances|mesh-ancestor
14182313|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182314|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182315|NCT01929811|Metformin|metformin|mesh-list
14182316|NCT01929811|Docetaxel|docetaxel|mesh-list
14182317|NCT01929811|Epirubicin|epirubicin|mesh-list
14182318|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14182319|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182320|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182321|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
14182322|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
14182323|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
14182324|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182325|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14182326|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14182327|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14182328|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182329|NCT01925131|Prednisone|prednisone|mesh-list
14182330|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
14182331|NCT01925131|Vincristine|vincristine|mesh-list
14182332|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14182333|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14182334|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
14182335|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182336|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182337|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14182338|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
14182339|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182340|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182341|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14182342|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14182343|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
14182344|NCT01925131|Hormones|hormones|mesh-ancestor
14182345|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182346|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14182347|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14182348|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
14182349|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
14182350|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
14182351|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182352|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14182353|NCT01886859|Lenalidomide|lenalidomide|mesh-list
14165917|NCT03257033|Gemcitabine|gemcitabine|mesh-list
14165918|NCT03257033|Paclitaxel|paclitaxel|mesh-list
14165919|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14165920|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165921|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
14165922|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
14165923|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
14165924|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165925|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14165926|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
14165927|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
14165928|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165929|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165930|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165931|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
14165932|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165933|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
14165934|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165935|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165936|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
14165937|NCT03192397|Sirolimus|sirolimus|mesh-list
14165938|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
14165939|NCT03192397|Melphalan|melphalan|mesh-list
14165940|NCT03192397|Fludarabine|fludarabine|mesh-list
14165941|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
14165942|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14165943|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
14165944|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165945|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14165946|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14165947|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
14165948|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165949|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165950|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14165951|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14165952|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
14165953|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14165954|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14165955|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
14165956|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14165957|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165958|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165959|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
14165960|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
14165961|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14165962|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
14165963|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165964|NCT03154580|Expectorants|expectorants|mesh-ancestor
14165965|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
14165966|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14165967|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
14165968|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165969|NCT03154580|Protective Agents|protective agents|mesh-ancestor
14165970|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14165971|NCT03154580|Antidotes|antidotes|mesh-ancestor
14938508|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938509|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14938510|NCT01481844|Antacids|antacids|mesh-ancestor
14938511|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
14938512|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14165972|NCT03123978|Niclosamide|niclosamide|mesh-list
14165973|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
14165974|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14165975|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
14165976|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14165977|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14165978|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
14165979|NCT03043599|Nivolumab|nivolumab|mesh-list
14165980|NCT03043599|Ipilimumab|ipilimumab|mesh-list
14165981|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165982|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767038|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
14165983|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14165984|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938513|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
14165985|NCT02877550|Venetoclax|venetoclax|mesh-list
14165986|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
14165987|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165988|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14165989|NCT02720185|Dasatinib|dasatinib|mesh-list
14165990|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14165991|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14165992|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165993|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165994|NCT02706847|Upadacitinib|upadacitinib|mesh-list
14165995|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14165996|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14165997|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14165998|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14165999|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166000|NCT02657434|Carboplatin|carboplatin|mesh-list
14166001|NCT02657434|Pemetrexed|pemetrexed|mesh-list
14166002|NCT02657434|Atezolizumab|atezolizumab|mesh-list
14166003|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166004|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166005|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166006|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14166007|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14166008|NCT02564900|Camptothecin|camptothecin|mesh-list
14166009|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
14166010|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14166011|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166012|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14166013|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14166014|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166015|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166016|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
14166017|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166018|NCT02496780|Insulin|insulin|mesh-list
14166019|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14166020|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
14166021|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
14166022|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14166023|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166024|NCT02393859|Dexamethasone|dexamethasone|mesh-list
14166025|NCT02393859|Methotrexate|methotrexate|mesh-list
14166026|NCT02393859|Daunorubicin|daunorubicin|mesh-list
14166027|NCT02393859|Asparaginase|asparaginase|mesh-list
14166028|NCT02393859|Ifosfamide|ifosfamide|mesh-list
14166029|NCT02393859|Blinatumomab|blinatumomab|mesh-list
14166030|NCT02393859|Pegaspargase|pegaspargase|mesh-list
14166031|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166032|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
14166033|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
14166034|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166035|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166036|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166037|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
14166038|NCT02393859|Hormones|hormones|mesh-ancestor
14166039|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166040|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166041|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166042|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14166043|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
14166044|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14166045|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14166046|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
14166047|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166048|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
14166049|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166050|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14166051|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166052|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
14767039|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
14166053|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166054|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14166055|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14166056|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14166057|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14767040|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14166058|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14166059|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
14166060|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14166061|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166062|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14166063|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166064|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166065|NCT02178358|Sorafenib|sorafenib|mesh-list
14166066|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166067|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14166068|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166069|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166070|NCT02157610|Nicotine|nicotine|mesh-list
14166071|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14166072|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
14166073|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166074|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166075|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14166076|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14166077|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
14166078|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166079|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166080|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
14166081|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14166082|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14166083|NCT01838174|Prednisolone|prednisolone|mesh-list
14166084|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
14166085|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14166086|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
14938514|NCT01481870|Sorafenib|sorafenib|mesh-list
14938515|NCT01481870|Sunitinib|sunitinib|mesh-list
14938516|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938517|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14938518|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938519|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938520|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14938521|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14938522|NCT01481870|Growth Substances|growth substances|mesh-ancestor
14938523|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938524|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
14938525|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14938526|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14938527|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
14938528|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938529|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166087|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166088|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
14166089|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
14166090|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166091|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166092|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166093|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
14166094|NCT01838174|Hormones|hormones|mesh-ancestor
14166095|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166096|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14166097|NCT01838174|Protective Agents|protective agents|mesh-ancestor
14166098|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166099|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166100|NCT01532310|Belimumab|belimumab|mesh-list
14166101|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166102|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
14166103|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166104|NCT01495637|Sargramostim|sargramostim|mesh-list
14166105|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
14166106|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166107|NCT01243190|Ofatumumab|ofatumumab|mesh-list
14166108|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166109|NCT00903110|Mecasermin|mecasermin|mesh-list
14166110|NCT00903110|Growth Substances|growth substances|mesh-ancestor
14166111|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166112|NCT00806390|Metoprolol|metoprolol|mesh-list
14166113|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14166114|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14166115|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
14166116|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
14166117|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166118|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166119|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14166120|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14166121|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14166122|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
14166123|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166124|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166125|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
14166126|NCT00566618|Dasatinib|dasatinib|mesh-list
14166127|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166128|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14166129|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166130|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166131|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14166132|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166133|NCT00442559|Montelukast|montelukast|mesh-list
14166134|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14166135|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
14166136|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14166137|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166138|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166139|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166140|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14166141|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14166142|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166143|NCT00117338|Montelukast|montelukast|mesh-list
14166144|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14166145|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
14166146|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14166147|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166148|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166149|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166150|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14166151|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14166152|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166153|NCT04877626|Artesunate|artesunate|mesh-list
14166154|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
14166155|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14166156|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14166157|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166158|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166159|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
14166160|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
14166161|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14166162|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
14166163|NCT04877509|Vitamin D|vitamin d|mesh-list
14166164|NCT04877509|Vitamin A|vitamin a|mesh-list
14166165|NCT04877509|Selenium|selenium|mesh-list
14166166|NCT04877509|Copper|copper|mesh-list
14166167|NCT04877509|Vitamins|vitamins|mesh-ancestor
14166168|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
14166169|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166170|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
14166171|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166172|NCT04877509|Protective Agents|protective agents|mesh-ancestor
14166173|NCT04877509|Trace Elements|trace elements|mesh-ancestor
14166174|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14166175|NCT04877275|Dexamethasone|dexamethasone|mesh-list
14166176|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
14166177|NCT04877275|Doxorubicin|doxorubicin|mesh-list
14166178|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14166179|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166180|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
14166181|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166182|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166183|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14166184|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
14166185|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166186|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166187|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14166188|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166189|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
14166190|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
14166191|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166192|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166193|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
14166194|NCT04877275|Hormones|hormones|mesh-ancestor
14166195|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166196|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166197|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14166198|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14166199|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14166200|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166201|NCT04877210|Insulin|insulin|mesh-list
14166202|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14166203|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14166204|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166205|NCT04877106|Metformin|metformin|mesh-list
14166206|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14166207|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14166208|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166209|NCT04877106|Incretins|incretins|mesh-ancestor
14166210|NCT04877106|Hormones|hormones|mesh-ancestor
14166211|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166212|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14166213|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
14166214|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166215|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166216|NCT04876716|Voriconazole|voriconazole|mesh-list
14166217|NCT04876716|Posaconazole|posaconazole|mesh-list
14166218|NCT04876716|Isavuconazole|isavuconazole|mesh-list
14166219|NCT04876716|Anidulafungin|anidulafungin|mesh-list
14166220|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
14938530|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14938531|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14938532|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14938771|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938772|NCT01484184|Levodopa|levodopa|mesh-list
14938773|NCT01484184|Buspirone|buspirone|mesh-list
14938774|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14938775|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14938776|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
14938777|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938778|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166221|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166222|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14166223|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14166224|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166225|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166226|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14166227|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166228|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166229|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166230|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14166231|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14166232|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14166233|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14182354|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
14182355|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182356|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182357|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182358|NCT01886859|Growth Substances|growth substances|mesh-ancestor
14182359|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182360|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182361|NCT01856478|Methotrexate|methotrexate|mesh-list
14182362|NCT01856478|Afatinib|afatinib|mesh-list
14182363|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14182364|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
14182365|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14479063|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479064|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
14182366|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182367|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14479065|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166234|NCT04876638|Minocycline|minocycline|mesh-list
14166235|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14166236|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166237|NCT04876859|Anesthetics|anesthetics|mesh-list
14166238|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166239|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166240|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
14166241|NCT04876807|Omeprazole|omeprazole|mesh-list
14166242|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14166243|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166244|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14166245|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166246|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166247|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166248|NCT04876430|Meropenem|meropenem|mesh-list
14166249|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14166250|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166251|NCT04876313|Paclitaxel|paclitaxel|mesh-list
14166252|NCT04876313|Nivolumab|nivolumab|mesh-list
14166253|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14166254|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166255|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
14166256|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
14166257|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
14166258|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166259|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14166260|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14166261|NCT04876755|TEMPO|tempo|mesh-list
14166262|NCT04876755|TEMPOL-H|tempol-h|mesh-list
14166263|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
14166264|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166265|NCT04876755|Protective Agents|protective agents|mesh-ancestor
14166266|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166267|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14166268|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
14166269|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
14166270|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
14166271|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166272|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14166273|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
14166274|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
14166275|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166276|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166277|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166278|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14166279|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
14166280|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14166281|NCT04876521|Olanzapine|olanzapine|mesh-list
14166282|NCT04876521|Amisulpride|amisulpride|mesh-list
14166283|NCT04876521|Fluoxetine|fluoxetine|mesh-list
14166284|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
14166285|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
14166286|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166287|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166288|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166289|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14166290|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14166291|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166292|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14166293|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14166294|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14166295|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14166296|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166297|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166298|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
14166299|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14166300|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
14166301|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14166302|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14166303|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166304|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14166305|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
14166306|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
14166307|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14166308|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14166309|NCT04876534|Prednisolone|prednisolone|mesh-list
14166310|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
14166311|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14166312|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14166313|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
14166314|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166315|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
14166316|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
14166317|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166318|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166319|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166320|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
14166321|NCT04876534|Hormones|hormones|mesh-ancestor
14166322|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166323|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14166324|NCT04876534|Protective Agents|protective agents|mesh-ancestor
14166325|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166326|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166327|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
14166328|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166329|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
14166330|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166331|NCT04876261|Protective Agents|protective agents|mesh-ancestor
14166332|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166333|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14166334|NCT04875819|Vaccines|vaccines|mesh-list
14166335|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14166336|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
14166337|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166352|NCT04876079|Insulin|insulin|mesh-list
14166353|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14166354|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166355|NCT04876027|Dulaglutide|dulaglutide|mesh-list
14166356|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14166357|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166358|NCT04875767|Coal Tar|coal tar|mesh-list
14166359|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
14166360|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14166361|NCT04875728|Cefazolin|cefazolin|mesh-list
14166362|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14166363|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166364|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14166365|NCT04875702|Allopurinol|allopurinol|mesh-list
14166366|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
14166367|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166368|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166369|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
14166370|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166371|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14166372|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
14166373|NCT04875702|Protective Agents|protective agents|mesh-ancestor
14166374|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166375|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
14166376|NCT04875585|Lenvatinib|lenvatinib|mesh-list
14166377|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14166378|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166379|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14166380|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166381|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479066|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14479067|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479068|NCT02463331|Analgesics|analgesics|mesh-ancestor
14166382|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14166383|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
14166384|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166385|NCT04875611|Nivolumab|nivolumab|mesh-list
14166386|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14166387|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166388|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14166389|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166390|NCT04875026|Fluorouracil|fluorouracil|mesh-list
14166391|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
14166392|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166393|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14166394|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166395|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166396|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
14166397|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166398|NCT04874844|Antibodies|antibodies|mesh-list
14166399|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14767041|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
14767042|NCT00628550|Coagulants|coagulants|mesh-ancestor
14767043|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14767044|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
14767045|NCT00628576|Heparin|heparin|mesh-list
14166400|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
14166401|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182368|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
14182369|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182370|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182371|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14182372|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182373|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14182374|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14182375|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
14182376|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182377|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14182378|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182379|NCT01829568|Rituximab|rituximab|mesh-list
14182380|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14182381|NCT01829568|Lenalidomide|lenalidomide|mesh-list
14182382|NCT01829568|Antibodies|antibodies|mesh-list
14182383|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
14182384|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14182385|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
14182386|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182387|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182388|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182389|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182390|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182391|NCT01829568|Growth Substances|growth substances|mesh-ancestor
14182392|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182393|NCT01803555|Budesonide|budesonide|mesh-list
14182394|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
14182395|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14182396|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14182397|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14182398|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
14182399|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182400|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182401|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14182402|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
14182403|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
14182404|NCT01803555|Hormones|hormones|mesh-ancestor
14182405|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182406|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14182407|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14182408|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14182409|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182410|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182411|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182412|NCT01791816|Phenylephrine|phenylephrine|mesh-list
14182413|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
14182414|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14767046|NCT00628576|Calcium heparin|calcium heparin|mesh-list
14182415|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14767047|NCT00628576|Tinzaparin|tinzaparin|mesh-list
14767048|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14166402|NCT04875039|Dexamethasone|dexamethasone|mesh-list
14166403|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
14166404|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
14166405|NCT04875039|BB 1101|bb 1101|mesh-list
14166406|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166407|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
14166408|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
14166409|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166410|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166411|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166412|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
14166413|NCT04875039|Hormones|hormones|mesh-ancestor
14166414|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166415|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166416|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166417|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
14166418|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166419|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166420|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14166421|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166422|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166423|NCT04875039|Analgesics|analgesics|mesh-ancestor
14166424|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
14166425|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14166426|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14166427|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14166428|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
14166429|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166430|NCT04874688|Provitamins|provitamins|mesh-list
14166431|NCT04874688|Beta Carotene|beta carotene|mesh-list
14166432|NCT04874688|Vitamins|vitamins|mesh-ancestor
14166433|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
14166434|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166435|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
14166436|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14166437|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14166438|NCT04874610|Prednisolone|prednisolone|mesh-list
14166439|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
14166440|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14166441|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
14166442|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166443|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
14166444|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
14166445|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166446|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166447|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166448|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
14166449|NCT04874610|Hormones|hormones|mesh-ancestor
14166450|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166451|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14166452|NCT04874610|Protective Agents|protective agents|mesh-ancestor
14166453|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166454|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166455|NCT04874675|Acetaminophen|acetaminophen|mesh-list
14166456|NCT04874675|Ibuprofen|ibuprofen|mesh-list
14166457|NCT04874675|Diclofenac|diclofenac|mesh-list
14166458|NCT04874675|Codeine|codeine|mesh-list
14166459|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166460|NCT04874675|Analgesics|analgesics|mesh-ancestor
14166461|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
14166462|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166463|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166464|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
14166465|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14166466|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166467|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166468|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14166469|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166470|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166471|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14166472|NCT04874675|Narcotics|narcotics|mesh-ancestor
14166473|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166474|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
14166475|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
14166476|NCT04874506|TEMPO|tempo|mesh-list
14166477|NCT04874506|TEMPOL-H|tempol-h|mesh-list
14166478|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
14182416|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
14166479|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166480|NCT04874506|Protective Agents|protective agents|mesh-ancestor
14166481|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166482|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14166483|NCT04874246|Vasopressins|vasopressins|mesh-list
14166484|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
14166485|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
14166486|NCT04874246|Coagulants|coagulants|mesh-ancestor
14166487|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14166488|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14166489|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
14166490|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166491|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
14166492|NCT04874428|Apixaban|apixaban|mesh-list
14166493|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14166494|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
14166495|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14166496|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
14166497|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166498|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166499|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
14166500|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
14166501|NCT04873895|Axitinib|axitinib|mesh-list
14166502|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
14166503|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14166504|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14166505|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166506|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166507|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166508|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166509|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166510|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14166511|NCT04873531|Neostigmine|neostigmine|mesh-list
14166512|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14166513|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166514|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166515|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
14166516|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166517|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166518|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14166519|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
14166520|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166521|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
14166522|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
14166523|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166524|NCT04873440|Manganese|manganese|mesh-list
14166525|NCT04873440|Trace Elements|trace elements|mesh-ancestor
14166526|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
14166527|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166528|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
14166529|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14166530|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166531|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14166532|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14166533|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166534|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166535|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166536|NCT04873557|Copper|copper|mesh-list
14166537|NCT04873557|Trace Elements|trace elements|mesh-ancestor
14166538|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
14166539|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166540|NCT04873479|Ketamine|ketamine|mesh-list
14166541|NCT04873479|Esketamine|esketamine|mesh-list
14166542|NCT04873479|Analgesics|analgesics|mesh-ancestor
14166543|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
14166544|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166545|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166546|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14166547|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14166548|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
14166549|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
14166550|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166551|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14166552|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14166553|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166554|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166555|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
14166556|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14166557|NCT04873349|Oleuropein|oleuropein|mesh-list
14166558|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166559|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14166560|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
14166561|NCT04873284|Dexamethasone|dexamethasone|mesh-list
14166562|NCT04873284|Aprepitant|aprepitant|mesh-list
14166563|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
14166564|NCT04873284|Granisetron|granisetron|mesh-list
14166565|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166566|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
14166567|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
14166568|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166569|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166570|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166571|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
14166572|NCT04873284|Hormones|hormones|mesh-ancestor
14166573|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166574|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166575|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166576|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14166577|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166578|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166579|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14166580|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
14166581|NCT04873102|Danazol|danazol|mesh-list
14166582|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14166583|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166584|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166585|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166586|NCT04873011|Quinine|quinine|mesh-list
14166587|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
14166588|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14166589|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14166590|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166591|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14166592|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166593|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14166594|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166595|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166596|NCT04873011|Analgesics|analgesics|mesh-ancestor
14166597|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
14166598|NCT04872985|Paclitaxel|paclitaxel|mesh-list
14166599|NCT04872985|Docetaxel|docetaxel|mesh-list
14166600|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
14166601|NCT04872985|Doxorubicin|doxorubicin|mesh-list
14166602|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14166603|NCT04872985|Epirubicin|epirubicin|mesh-list
14166604|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14166605|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166606|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14166607|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14166608|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
14166609|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166610|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166611|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
14166612|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166613|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166614|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14166615|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
14166616|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14166617|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14166618|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14166619|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14166620|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166621|NCT04873063|Beclomethasone|beclomethasone|mesh-list
14166622|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166623|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
14166624|NCT04873063|Hormones|hormones|mesh-ancestor
14166625|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166626|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166627|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14166628|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
14166629|NCT04872907|Fluorides|fluorides|mesh-list
14166630|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
14166631|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
14166632|NCT04872907|Protective Agents|protective agents|mesh-ancestor
14166633|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182417|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
14182418|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182419|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182420|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
14182421|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14182422|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
14182423|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
14182424|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14182425|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14182426|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14182427|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182428|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182429|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182430|NCT01791816|Protective Agents|protective agents|mesh-ancestor
14182431|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182432|NCT01786434|Fentanyl|fentanyl|mesh-list
14182433|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14182434|NCT01786434|Narcotics|narcotics|mesh-ancestor
14182435|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182436|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182437|NCT01786434|Analgesics|analgesics|mesh-ancestor
14182438|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
14182439|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182440|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14182441|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14182442|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
14182443|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
14182444|NCT01784159|Aspirin|aspirin|mesh-list
14182445|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14182446|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14182447|NCT01784159|Analgesics|analgesics|mesh-ancestor
14182448|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
14182449|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182450|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182451|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14182452|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182453|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14182454|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14182455|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182456|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14182457|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14182458|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182459|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
14182460|NCT01776307|Capecitabine|capecitabine|mesh-list
14182461|NCT01776307|Cetuximab|cetuximab|mesh-list
14182462|NCT01776307|Panitumumab|panitumumab|mesh-list
14182463|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14182464|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
14182465|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182466|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182467|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182468|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14182469|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14182470|NCT01771107|Doxorubicin|doxorubicin|mesh-list
14182471|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14182472|NCT01771107|Dacarbazine|dacarbazine|mesh-list
14182473|NCT01771107|Vinblastine|vinblastine|mesh-list
14182474|NCT01771107|Antibodies|antibodies|mesh-list
14182475|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
14182476|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14182477|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
14182478|NCT01771107|Imidazole|imidazole|mesh-list
14182479|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
14182480|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182481|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182482|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14182483|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14182484|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14182485|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182486|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182487|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14182488|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
14182489|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14182490|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14166634|NCT04872608|Letrozole|letrozole|mesh-list
14166635|NCT04872608|Palbociclib|palbociclib|mesh-list
14166636|NCT04872608|Onapristone|onapristone|mesh-list
14166637|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166638|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14166639|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14166640|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166641|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166642|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14166643|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166644|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166645|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166646|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14166647|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14166648|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
14166649|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14166650|NCT04872881|Fentanyl|fentanyl|mesh-list
14166651|NCT04872881|Propofol|propofol|mesh-list
14166652|NCT04872881|Rocuronium|rocuronium|mesh-list
14166653|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14166654|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166655|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166656|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14166657|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
14166658|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
14166659|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14166660|NCT04872881|Narcotics|narcotics|mesh-ancestor
14166661|NCT04872881|Analgesics|analgesics|mesh-ancestor
14166662|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
14166663|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166664|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14166665|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14166666|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14166667|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14166668|NCT04872634|Cetuximab|cetuximab|mesh-list
14166669|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14166670|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166671|NCT04872270|Caffeine|caffeine|mesh-list
14166672|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14166673|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166674|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14166675|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166676|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166677|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14166678|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14166679|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
14166680|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166681|NCT04872218|Abatacept|abatacept|mesh-list
14166682|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14166683|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166684|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166685|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166686|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
14166687|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166688|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166689|NCT04872400|Vancomycin|vancomycin|mesh-list
14166690|NCT04872400|Tobramycin|tobramycin|mesh-list
14166691|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14166692|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166693|NCT04872192|Anesthetics|anesthetics|mesh-list
14166694|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166695|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166696|NCT04872231|Voriconazole|voriconazole|mesh-list
14166697|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
14166698|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166699|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14166700|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14166701|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166702|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166703|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14166704|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166705|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166706|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166707|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14166708|NCT04872283|Aspirin|aspirin|mesh-list
14166709|NCT04872283|Acetaminophen|acetaminophen|mesh-list
14166710|NCT04872283|Ketorolac|ketorolac|mesh-list
14166711|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14166712|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14166713|NCT04872283|Oxycodone|oxycodone|mesh-list
14166714|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14166715|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166716|NCT04872283|Analgesics|analgesics|mesh-ancestor
14166717|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
14166718|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166719|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166720|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166721|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166722|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14166723|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14166724|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166725|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14166726|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14166727|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166728|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
14166729|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14166730|NCT04872283|Narcotics|narcotics|mesh-ancestor
14166731|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166732|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
14166733|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14166734|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
14166735|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14166736|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166737|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14166738|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14166739|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14166740|NCT04872322|Ropivacaine|ropivacaine|mesh-list
14166741|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14166742|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
14166743|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
14166744|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166745|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166746|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
14166747|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166748|NCT04871958|Insulin|insulin|mesh-list
14166749|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14166750|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166751|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14166752|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
14938533|NCT01482052|Vaccines|vaccines|mesh-list
14938534|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
14938535|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955399|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166753|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166754|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166755|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14166756|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
14166757|NCT04871724|Fluconazole|fluconazole|mesh-list
14166758|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
14166759|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938536|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13955400|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13955401|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13955402|NCT03190447|Laxatives|laxatives|mesh-ancestor
13955403|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13955404|NCT03190304|Enalapril|enalapril|mesh-list
13955405|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13955406|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
13955407|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
13955408|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955409|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13955410|NCT03189953|Exenatide|exenatide|mesh-list
13955411|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13955412|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955413|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13955414|NCT03189953|Incretins|incretins|mesh-ancestor
13955415|NCT03189953|Hormones|hormones|mesh-ancestor
13955416|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13955417|NCT03190239|Pemetrexed|pemetrexed|mesh-list
14166760|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14166761|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14166762|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166763|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166764|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14166765|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166766|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767049|NCT00628576|Dalteparin|dalteparin|mesh-list
14767050|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
14767051|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14166767|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166768|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14166769|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14166770|NCT04871802|Taxifolin|taxifolin|mesh-list
14166771|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14166772|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166773|NCT04871802|Analgesics|analgesics|mesh-ancestor
14166774|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
14166775|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166776|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166777|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166778|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166779|NCT04871633|Azithromycin|azithromycin|mesh-list
14166780|NCT04871633|Remdesivir|remdesivir|mesh-list
14166781|NCT04871633|Dexamethasone|dexamethasone|mesh-list
14166782|NCT04871633|Prednisolone|prednisolone|mesh-list
14166783|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14166784|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166785|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
14166786|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
14166787|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166788|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166789|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166790|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
14166791|NCT04871633|Hormones|hormones|mesh-ancestor
14166792|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166793|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166794|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166795|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166796|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14166797|NCT04871633|Protective Agents|protective agents|mesh-ancestor
14166798|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14166799|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166800|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
14166801|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
14166802|NCT04871750|Caseins|caseins|mesh-list
14166803|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
14166804|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
14166805|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166806|NCT04871932|Vaccines|vaccines|mesh-list
14166807|NCT04871932|Immunologic Factors|immunologic factors|mesh-ancestor
14166808|NCT04871932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166809|NCT04871321|Gemcitabine|gemcitabine|mesh-list
14166810|NCT04871321|Paclitaxel|paclitaxel|mesh-list
14166811|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14166812|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166813|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
14166814|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
14166815|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
14166816|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166817|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14166818|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
14166819|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
14166820|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166821|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767052|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13955418|NCT03190239|Apatinib|apatinib|mesh-list
13955419|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955420|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955421|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955422|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13955423|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13955424|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13955425|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14166822|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166823|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
14166824|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166825|NCT04871191|Rituximab|rituximab|mesh-list
14166826|NCT04871191|Abatacept|abatacept|mesh-list
14166827|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14166828|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166829|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
14166830|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166831|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166832|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14166833|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166834|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14166835|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
14166836|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14166837|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166838|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166839|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166840|NCT04871308|Analgesics|analgesics|mesh-ancestor
14166841|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
14166842|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166843|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14166844|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14166845|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14166846|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
14166847|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166848|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166849|NCT04871204|Octreotide|octreotide|mesh-list
14166850|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166851|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166852|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166853|NCT04871269|Dronabinol|dronabinol|mesh-list
14166854|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
14166855|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166856|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14166857|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166858|NCT04871269|Analgesics|analgesics|mesh-ancestor
14166859|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
14166860|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166861|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14166862|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14166863|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166864|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166865|NCT04871269|Hormones|hormones|mesh-ancestor
14166866|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166867|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14166868|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14166869|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14166870|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14166871|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166872|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166873|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166874|NCT04870957|Analgesics|analgesics|mesh-ancestor
14166875|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
14166876|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166877|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
14166878|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14166879|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
14166880|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14166881|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14166882|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14166883|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166884|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166885|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14166886|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14166887|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166888|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
14166889|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182491|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14182492|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14182493|NCT01695941|Rituximab|rituximab|mesh-list
14182494|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14166890|NCT04870372|Selegiline|selegiline|mesh-list
14166891|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
14166892|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14166893|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14166894|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14166895|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14166896|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166897|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166898|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14166899|NCT04870372|Protective Agents|protective agents|mesh-ancestor
14166900|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166901|NCT04870671|Tenofovir|tenofovir|mesh-list
14166902|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
14166903|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14166904|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14166905|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14166906|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166907|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166908|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14166909|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14166910|NCT04870866|Niacinamide|niacinamide|mesh-list
14166911|NCT04870866|Niacin|niacin|mesh-list
14166912|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
14166913|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
14166914|NCT04870866|Vitamins|vitamins|mesh-ancestor
14166915|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
14166916|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166917|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14166918|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
14166919|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166920|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14166921|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
14166922|NCT04870489|Isotretinoin|isotretinoin|mesh-list
14166923|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
14166924|NCT04870541|Nefopam|nefopam|mesh-list
14166925|NCT04870541|Ondansetron|ondansetron|mesh-list
14166926|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
14166927|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
14166928|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166929|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166930|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14166931|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
14166932|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
14166933|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14166934|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
14166935|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14166936|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166937|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14166938|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14166939|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14166940|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14166941|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14166942|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166943|NCT04870541|Analgesics|analgesics|mesh-ancestor
14166944|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
14166945|NCT04870502|Clomiphene|clomiphene|mesh-list
14166946|NCT04870502|Enclomiphene|enclomiphene|mesh-list
14166947|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
14166948|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14166949|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
14166950|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14166951|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166952|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14166953|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
14166954|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14166955|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14767053|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767054|NCT00628667|Esomeprazole|esomeprazole|mesh-list
14767055|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14166956|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14166957|NCT04870359|Prednisolone|prednisolone|mesh-list
14166958|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14166959|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166960|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
14166961|NCT04870359|Hormones|hormones|mesh-ancestor
14166962|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182495|NCT01695941|Bortezomib|bortezomib|mesh-list
14166963|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166964|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14166965|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166966|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
14166967|NCT04870203|Adalimumab|adalimumab|mesh-list
14166968|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166969|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166970|NCT04870190|Osimertinib|osimertinib|mesh-list
14166971|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166972|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14166973|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166974|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166975|NCT04870021|Vaccines|vaccines|mesh-list
14166976|NCT04870021|Immunologic Factors|immunologic factors|mesh-ancestor
14166977|NCT04870021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166978|NCT04870060|Curcumin|curcumin|mesh-list
14166979|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14166980|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14166981|NCT04870060|Analgesics|analgesics|mesh-ancestor
14166982|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
14166983|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14166984|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166985|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14166986|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14166987|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14166988|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14166989|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14166990|NCT04870073|Mannitol|mannitol|mesh-list
14166991|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14166992|NCT04870073|Diuretics|diuretics|mesh-ancestor
14166993|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
14166994|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166995|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14166996|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
14166997|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14166998|NCT04869592|Vaccines|vaccines|mesh-list
14166999|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
14167000|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167001|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
14167002|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167003|NCT04869501|Atezolizumab|atezolizumab|mesh-list
14167004|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167005|NCT04869579|Selenium|selenium|mesh-list
14167006|NCT04869579|Selenious Acid|selenious acid|mesh-list
14167007|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
14167008|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167009|NCT04869579|Protective Agents|protective agents|mesh-ancestor
14167010|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767056|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767057|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14767058|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767059|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767060|NCT00628680|Heparin|heparin|mesh-list
14767061|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
14767062|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14167011|NCT04869579|Trace Elements|trace elements|mesh-ancestor
14167012|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
14167013|NCT04869709|Betamethasone|betamethasone|mesh-list
14167014|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
14167015|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14167016|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
14167017|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14167018|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167019|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
14167020|NCT04869709|Hormones|hormones|mesh-ancestor
14167021|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167022|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167023|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14167024|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
14167025|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
14167026|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14767063|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14167027|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
14167028|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167029|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
14167030|NCT04869306|Protective Agents|protective agents|mesh-ancestor
14767451|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14167031|NCT04869176|Caffeine|caffeine|mesh-list
14167032|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
14167033|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167034|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14167035|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167036|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14167037|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167038|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14167039|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14167040|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
14167041|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167042|NCT04869046|Acetaminophen|acetaminophen|mesh-list
14167043|NCT04869046|Ibuprofen|ibuprofen|mesh-list
14167044|NCT04869046|Analgesics|analgesics|mesh-list
14167045|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
14167046|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14167047|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
14167048|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167049|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167050|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
14167051|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14167052|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167053|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14167054|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14167055|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167056|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167057|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167058|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
14167059|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938537|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14938538|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14938539|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
14938540|NCT01482117|Cilostazol|cilostazol|mesh-list
14938541|NCT01482117|Clopidogrel|clopidogrel|mesh-list
14938542|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14938543|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14938544|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14938545|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14938546|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
14938547|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938548|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938549|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938550|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14938551|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
14938552|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938553|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14938554|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
14938555|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14938556|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14167060|NCT04868903|Vitamin D|vitamin d|mesh-list
14167061|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
14167062|NCT04868903|Vitamins|vitamins|mesh-ancestor
14167063|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
14167064|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167065|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14167066|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14167067|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
14167068|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14167069|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167070|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14167071|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
14167072|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14167073|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167074|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167075|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167076|NCT04868760|Ipilimumab|ipilimumab|mesh-list
14167077|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167078|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167079|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14167080|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167081|NCT04868747|Lidocaine|lidocaine|mesh-list
14167082|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167083|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
14938557|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
14182496|NCT01695941|Antibodies|antibodies|mesh-list
14167084|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167085|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167086|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
14167087|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167088|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14167089|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14167090|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14167091|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14167092|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182497|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
14182498|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14182499|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
14182500|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182501|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182502|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182503|NCT01681264|Guanfacine|guanfacine|mesh-list
14182504|NCT01681264|Morphine|morphine|mesh-list
14182505|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14182506|NCT01681264|Narcotics|narcotics|mesh-ancestor
14182507|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182508|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182509|NCT01681264|Analgesics|analgesics|mesh-ancestor
14182510|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
14182511|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182512|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14182513|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14182514|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14182515|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14182516|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182517|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182518|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182519|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
14182520|NCT01678586|Gabapentin|gabapentin|mesh-list
14182521|NCT01678586|Analgesics|analgesics|mesh-ancestor
14182522|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
14182523|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182524|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182525|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
14182526|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14182527|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14182528|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182529|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14182530|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14182531|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14182532|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182533|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182534|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
14182535|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14182536|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14182537|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
14182538|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
14182539|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
14182540|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
14182541|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14182542|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14182543|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
14182544|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
14182545|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14182546|NCT01630213|Vitamin D|vitamin d|mesh-list
14182547|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
14182548|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
14182549|NCT01630213|Vitamins|vitamins|mesh-list
14182550|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
14182551|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182552|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14182553|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14182554|NCT01623167|Cyclosporine|cyclosporine|mesh-list
14182555|NCT01623167|Cyclosporins|cyclosporins|mesh-list
14182556|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14182557|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767064|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182558|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182559|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14182560|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
14182561|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767065|NCT00628706|Dronabinol|dronabinol|mesh-list
14767066|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
14767067|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767068|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767069|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14767070|NCT00628706|Analgesics|analgesics|mesh-ancestor
14767071|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
14767072|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13955426|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955427|NCT03189836|Rituximab|rituximab|mesh-list
14167093|NCT04868552|Naloxone|naloxone|mesh-list
14167094|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14167095|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167096|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
14167097|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167098|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
14167099|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14167100|NCT04868513|Fluorides|fluorides|mesh-list
14167101|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
14167102|NCT04868513|Protective Agents|protective agents|mesh-ancestor
14167103|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167104|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14167105|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167106|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
14167107|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
14167108|NCT04868838|Daratumumab|daratumumab|mesh-list
14167109|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167110|NCT04868773|Trifluridine|trifluridine|mesh-list
14167111|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
14167112|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167113|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
14167114|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167115|NCT04868175|Timolol|timolol|mesh-list
14167116|NCT04868175|Travoprost|travoprost|mesh-list
14167117|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14167118|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14167119|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
14167120|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167121|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767073|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13955428|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13955429|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13955430|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
13955431|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13955432|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13955433|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
13955434|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13955435|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
13955436|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
13955437|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
13955438|NCT03189901|Simendan|simendan|mesh-list
13955439|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13955440|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
13955441|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13955442|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13955443|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13955444|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13955445|NCT03189901|Protective Agents|protective agents|mesh-ancestor
13955446|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13962988|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13962989|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13962990|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13962991|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
13962992|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13962993|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13962994|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
13962995|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
13962996|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13962997|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13962998|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
13962999|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963000|NCT02723994|Antidotes|antidotes|mesh-ancestor
13963001|NCT02723994|Protective Agents|protective agents|mesh-ancestor
14167122|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167123|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14167124|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14167125|NCT04868227|Vitamin D|vitamin d|mesh-list
14167126|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
14167127|NCT04868227|Vitamins|vitamins|mesh-ancestor
14167128|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
14167129|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167130|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14167131|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14167132|NCT04868461|Caseins|caseins|mesh-list
14167133|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
14167134|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
14167135|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167136|NCT04868019|Fenofibrate|fenofibrate|mesh-list
14167137|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14167138|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
14167139|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167140|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14167141|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
14167142|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
14167143|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14167144|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167145|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14167146|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14167147|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167148|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167149|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167150|NCT04868253|Oxazepam|oxazepam|mesh-list
14167151|NCT04868253|Metyrapone|metyrapone|mesh-list
14167152|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
14167153|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167154|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167155|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14167156|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167157|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167158|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14167159|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14167160|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14167161|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
14167162|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
14167163|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167164|NCT04867993|Amikacin|amikacin|mesh-list
14167165|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14167166|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167167|NCT04868058|Ropivacaine|ropivacaine|mesh-list
14167168|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167169|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
14167170|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167171|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167172|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
14167173|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167174|NCT04868565|Caffeine|caffeine|mesh-list
14167175|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
14167176|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167177|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14167178|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167179|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14167180|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167181|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14167182|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14167183|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
14167184|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167185|NCT04868045|Hormones|hormones|mesh-list
14767074|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14767075|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767076|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767077|NCT00628706|Hormones|hormones|mesh-ancestor
14167186|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
14182562|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
14167187|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167188|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167189|NCT04867720|Everolimus|everolimus|mesh-list
14167190|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167191|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14167192|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
14167193|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167194|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
14167195|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167196|NCT04867343|Fentanyl|fentanyl|mesh-list
14167197|NCT04867343|Remifentanil|remifentanil|mesh-list
14167198|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14167199|NCT04867343|Narcotics|narcotics|mesh-ancestor
14167200|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167201|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167202|NCT04867343|Analgesics|analgesics|mesh-ancestor
14167203|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
14167204|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167205|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14167206|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14167207|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
14167208|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
14167209|NCT04867226|Colchicine|colchicine|mesh-list
14167210|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
14167211|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14167212|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
14167213|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
14167214|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
14167215|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167216|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167217|NCT04867252|Inositol|inositol|mesh-list
14167218|NCT04867252|Metformin|metformin|mesh-list
14167219|NCT04867252|Pioglitazone|pioglitazone|mesh-list
14167220|NCT04867252|Resveratrol|resveratrol|mesh-list
14167221|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14167222|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167223|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
14167224|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167225|NCT04867252|Protective Agents|protective agents|mesh-ancestor
14167226|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167227|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14167228|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
14167229|NCT04867252|Vitamins|vitamins|mesh-ancestor
14167230|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
14182563|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182564|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
14182565|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182566|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14182567|NCT01528046|Metformin|metformin|mesh-list
14182568|NCT01528046|Irinotecan|irinotecan|mesh-list
14182569|NCT01528046|Camptothecin|camptothecin|mesh-list
14182570|NCT01528046|Vincristine|vincristine|mesh-list
14182571|NCT01528046|Temozolomide|temozolomide|mesh-list
14182572|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14182573|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182574|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14182575|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14182576|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182577|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182578|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182579|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14182580|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14182581|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14182582|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14182583|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14182584|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
14182585|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14182586|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182587|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182588|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182589|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182590|NCT01441349|Simvastatin|simvastatin|mesh-list
14182591|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14182592|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14182593|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
14182594|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182595|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14167231|NCT04866498|Analgesics|analgesics|mesh-list
14167232|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
14167233|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167234|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167241|NCT04866654|Nivolumab|nivolumab|mesh-list
14167242|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167243|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167244|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14167245|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167246|NCT04866355|Ibuprofen|ibuprofen|mesh-list
14167247|NCT04866355|Scopolamine|scopolamine|mesh-list
14167248|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14167249|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14167250|NCT04866355|Analgesics|analgesics|mesh-ancestor
14167251|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
14167252|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167253|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167254|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167255|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14167256|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14167257|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167258|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167259|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14167260|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
14167261|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
14167262|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14167263|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
14167264|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14167265|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
14167266|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167267|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14167268|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
14167269|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167270|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167271|NCT04866108|Capecitabine|capecitabine|mesh-list
14167272|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14167273|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
14167274|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167275|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167276|NCT04866056|Azacitidine|azacitidine|mesh-list
14167277|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14167278|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
14167279|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167280|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167281|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167282|NCT04865900|Antibodies|antibodies|mesh-list
14167283|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
14167284|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167285|NCT04865848|Anesthetics|anesthetics|mesh-list
14167286|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167287|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167288|NCT04865705|Paclitaxel|paclitaxel|mesh-list
14167289|NCT04865705|Cisplatin|cisplatin|mesh-list
14167290|NCT04865705|Carboplatin|carboplatin|mesh-list
14167291|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14167292|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167293|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
14167294|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
14167295|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
14167296|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167297|NCT04865991|Propofol|propofol|mesh-list
14167298|NCT04865991|Sevoflurane|sevoflurane|mesh-list
14167299|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14167300|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167301|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167302|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14767078|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167303|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
14167304|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
14167305|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14167306|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14167307|NCT04865510|Heparin|heparin|mesh-list
14167308|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
14167309|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167310|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14167311|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14167312|NCT04865211|Bupivacaine|bupivacaine|mesh-list
14167313|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167314|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
14167315|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167316|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167317|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
14167318|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167319|NCT04865445|Midazolam|midazolam|mesh-list
14167320|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14167321|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14767079|NCT00628719|Amphotericin B|amphotericin b|mesh-list
14167322|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167323|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167324|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14167325|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14167326|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14167327|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14167328|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
14167329|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
14167330|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
14167331|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
14167332|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167333|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167334|NCT04865250|Paclitaxel|paclitaxel|mesh-list
14167335|NCT04865250|Carboplatin|carboplatin|mesh-list
14167336|NCT04865250|Atezolizumab|atezolizumab|mesh-list
14167337|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14167338|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167339|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
14167340|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
14167341|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
14167342|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167343|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
14167344|NCT04865562|Testosterone|testosterone|mesh-list
14167345|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
14167346|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
14167347|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14167348|NCT04865562|Androgens|androgens|mesh-ancestor
14167349|NCT04865562|Hormones|hormones|mesh-ancestor
14167350|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167351|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167352|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14167353|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167354|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
14167355|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
14167356|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14167357|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14167358|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167359|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
14167360|NCT04865380|Coagulants|coagulants|mesh-ancestor
14167361|NCT04865185|Ethanol|ethanol|mesh-list
14167362|NCT04865185|Lidocaine|lidocaine|mesh-list
14167363|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14767080|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14767081|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14767082|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
14767083|NCT00628719|Amebicides|amebicides|mesh-ancestor
14767084|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14167364|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167365|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167366|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167367|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167368|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
14167369|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
14167370|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167371|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14167372|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14167373|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14767085|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14167374|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14167375|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167376|NCT04865159|Tipifarnib|tipifarnib|mesh-list
14167377|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167378|NCT04864977|Insulin|insulin|mesh-list
14167379|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14167380|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167381|NCT04864782|Paclitaxel|paclitaxel|mesh-list
14167382|NCT04864782|Carboplatin|carboplatin|mesh-list
14167383|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14167384|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167385|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
14167386|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
14167387|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
14167388|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182596|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14182597|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182598|NCT01156545|Afatinib|afatinib|mesh-list
14182599|NCT01156545|Simvastatin|simvastatin|mesh-list
14182600|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14182601|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14182602|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
14182603|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182604|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14182605|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14182606|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182607|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182608|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14182609|NCT01140516|Trimethoprim|trimethoprim|mesh-list
14182610|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14182611|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182612|NCT01140516|Renal Agents|renal agents|mesh-ancestor
14182613|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
14182614|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14182615|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14182616|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14182617|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182618|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182619|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14182620|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14182621|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14182622|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
14182623|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182624|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182625|NCT00544830|Leuprolide|leuprolide|mesh-list
14182626|NCT00544830|Goserelin|goserelin|mesh-list
14182627|NCT00544830|Bicalutamide|bicalutamide|mesh-list
14182628|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14182629|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
14182630|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14182631|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182632|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14182633|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182634|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
14182635|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
14182636|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182637|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
14182638|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
14182639|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182640|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
14182641|NCT00371059|Memantine|memantine|mesh-list
14182642|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14182643|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14182644|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
14182645|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182646|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938558|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14938559|NCT01482117|Protective Agents|protective agents|mesh-ancestor
14182647|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182648|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14182649|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14182650|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14182651|NCT00215813|Poly I-C|poly i-c|mesh-list
14182652|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
14182653|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167389|NCT04864717|Doxycycline|doxycycline|mesh-list
14167390|NCT04864717|Isotretinoin|isotretinoin|mesh-list
14167391|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14167392|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167393|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
14167394|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14167395|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14167396|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
14167397|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14167398|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14167399|NCT04865029|Estradiol|estradiol|mesh-list
14167400|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14167401|NCT04865029|Progesterone|progesterone|mesh-list
14167402|NCT04865029|Estrogens|estrogens|mesh-ancestor
14167403|NCT04865029|Hormones|hormones|mesh-ancestor
14167404|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167405|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167406|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14167407|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
14167408|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14167409|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14167410|NCT04865029|Progestins|progestins|mesh-ancestor
14167411|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14167412|NCT04864379|Molgramostim|molgramostim|mesh-list
14167413|NCT04864379|Sargramostim|sargramostim|mesh-list
14167414|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
14167415|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167416|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167417|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167418|NCT04864431|Vitamin D|vitamin d|mesh-list
14167419|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
14167420|NCT04864431|Vitamins|vitamins|mesh-ancestor
14167421|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
14167422|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167423|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14167424|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14167425|NCT04864210|Bupivacaine|bupivacaine|mesh-list
14167426|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167427|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
14167428|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167429|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167430|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
14167431|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167432|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
14167433|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14167434|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
14167435|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167436|NCT04864314|Protective Agents|protective agents|mesh-ancestor
14167437|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167438|NCT04864366|Tenofovir|tenofovir|mesh-list
14167439|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
14167440|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167441|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14167442|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14167443|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167444|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167445|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14167446|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14167447|NCT04864444|Piperaquine|piperaquine|mesh-list
14167448|NCT04864444|Primaquine|primaquine|mesh-list
14167449|NCT04864444|Artenimol|artenimol|mesh-list
14167450|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
14167451|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14167452|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14167453|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767086|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767087|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14767088|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
14767089|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14767090|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767091|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
14767092|NCT00628732|Topotecan|topotecan|mesh-list
14767093|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767094|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
14938560|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14167454|NCT04864067|Leucovorin|leucovorin|mesh-list
14167455|NCT04864067|Capecitabine|capecitabine|mesh-list
14167456|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
14767095|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767096|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767097|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14767098|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
14767099|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167457|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14167458|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
14167459|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167460|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167461|NCT04864067|Antidotes|antidotes|mesh-ancestor
14167462|NCT04864067|Protective Agents|protective agents|mesh-ancestor
14167463|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167464|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
14167465|NCT04864067|Vitamins|vitamins|mesh-ancestor
14167466|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
14767100|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767101|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14767102|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14767103|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14167467|NCT04864509|Melatonin|melatonin|mesh-list
14167468|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
14167469|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167470|NCT04864509|Protective Agents|protective agents|mesh-ancestor
14167471|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167472|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167473|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
14167474|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14167475|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
14167476|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167477|NCT04864496|Expectorants|expectorants|mesh-ancestor
14167478|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
14167479|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14167480|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
14167481|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167482|NCT04864496|Protective Agents|protective agents|mesh-ancestor
14167483|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167484|NCT04864496|Antidotes|antidotes|mesh-ancestor
14167485|NCT04863742|Prednisolone|prednisolone|mesh-list
14167486|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14167487|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
14167488|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14167489|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
14167490|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14167491|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
14167492|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167493|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
14167494|NCT04863742|Hormones|hormones|mesh-ancestor
14167495|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167496|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167497|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14167498|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167499|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
14167500|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
14167501|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167502|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14167503|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14167504|NCT04863742|Protective Agents|protective agents|mesh-ancestor
14167505|NCT04863807|Anesthetics|anesthetics|mesh-list
14167506|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167507|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167508|NCT04863638|Vaccines|vaccines|mesh-list
14167509|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
14167510|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167511|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
14167512|NCT04863430|Apatinib|apatinib|mesh-list
14167513|NCT04863430|Tegafur|tegafur|mesh-list
14167514|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167515|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14167516|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167517|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167518|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14167519|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
14167520|NCT04863183|Triamcinolone|triamcinolone|mesh-list
14167521|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14167522|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14167523|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14167524|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167525|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
14167526|NCT04863183|Hormones|hormones|mesh-ancestor
14167527|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167528|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167529|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14167530|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
14167531|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167532|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167533|NCT04863274|Atorvastatin|atorvastatin|mesh-list
14167534|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14167535|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14167536|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
14167537|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167538|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14167539|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14167540|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167541|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14167542|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14167543|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
14167544|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167545|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167546|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14182654|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
14182655|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
14182656|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182657|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
14182658|NCT04734418|Remifentanil|remifentanil|mesh-list
14182659|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14182660|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182661|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182662|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14182663|NCT04734418|Analgesics|analgesics|mesh-ancestor
14182664|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
14182665|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182666|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14182667|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14182668|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14182669|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182670|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182671|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182672|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14182673|NCT04734418|Narcotics|narcotics|mesh-ancestor
14184169|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184170|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14184171|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
14184172|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14184173|NCT04722354|Growth Substances|growth substances|mesh-ancestor
14184174|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184240|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184241|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14184242|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14184243|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14184244|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14184245|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184246|NCT04721119|Anesthetics|anesthetics|mesh-list
14184247|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184248|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184249|NCT04721301|Maraviroc|maraviroc|mesh-list
14184250|NCT04721301|Nivolumab|nivolumab|mesh-list
14184251|NCT04721301|Ipilimumab|ipilimumab|mesh-list
14184252|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14184253|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184254|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14184255|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184256|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14184257|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14184258|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14184259|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14184260|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
14184261|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184262|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14184263|NCT04720807|Letrozole|letrozole|mesh-list
14167547|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
14167548|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167549|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14167550|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167551|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167552|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
14167553|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167554|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167555|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14167556|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
14167557|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167558|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167559|NCT04862767|Aldesleukin|aldesleukin|mesh-list
14167560|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167561|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14167562|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14167563|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
14167564|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167565|NCT04862845|Pregabalin|pregabalin|mesh-list
14167566|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14167567|NCT04862845|Analgesics|analgesics|mesh-ancestor
14167568|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
14167569|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167570|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167571|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
14167572|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14767104|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767105|NCT00628810|Leucovorin|leucovorin|mesh-list
14767106|NCT00628810|Bevacizumab|bevacizumab|mesh-list
14767107|NCT00628810|Fluorouracil|fluorouracil|mesh-list
14767108|NCT00628810|Irinotecan|irinotecan|mesh-list
14767109|NCT00628810|Calcium|calcium|mesh-list
14767110|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
14767111|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14767112|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767113|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14767114|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14767115|NCT00628810|Growth Substances|growth substances|mesh-ancestor
14167573|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14167574|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167575|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14167576|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14167577|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14167578|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167579|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14167580|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14167581|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14167582|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167583|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
14167584|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
14167585|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
14167586|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167587|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14167588|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167589|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167590|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
14167591|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167592|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167593|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14167594|NCT04862377|Budesonide|budesonide|mesh-list
14167595|NCT04862377|Poractant alfa|poractant alfa|mesh-list
14167596|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167597|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14167598|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
14167599|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167600|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167601|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14167602|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
14167603|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
14167604|NCT04862377|Hormones|hormones|mesh-ancestor
14167605|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767116|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767117|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
14167606|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14167607|NCT04862234|Dulaglutide|dulaglutide|mesh-list
14167608|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14167609|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167610|NCT04861948|Bevacizumab|bevacizumab|mesh-list
14167611|NCT04861948|Carboplatin|carboplatin|mesh-list
14167612|NCT04861948|Pemetrexed|pemetrexed|mesh-list
14167613|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167614|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167615|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14167616|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14167617|NCT04861948|Growth Substances|growth substances|mesh-ancestor
14167618|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167619|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
14167620|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167621|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167622|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14167623|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14167624|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14167625|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
14167626|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167627|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167628|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167629|NCT04861922|Heparin|heparin|mesh-list
14167630|NCT04861922|Calcium heparin|calcium heparin|mesh-list
14167631|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
14167632|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14167633|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14167634|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167635|NCT04861142|Denosumab|denosumab|mesh-list
14167636|NCT04861142|Alendronate|alendronate|mesh-list
14167637|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14167638|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167639|NCT04861051|Ketamine|ketamine|mesh-list
14167640|NCT04861051|Analgesics|analgesics|mesh-ancestor
14167641|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
14167642|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167643|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167644|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14167645|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14167646|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
14167647|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
14167648|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167649|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14167650|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14167651|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167652|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182674|NCT04734405|Fluconazole|fluconazole|mesh-list
14182675|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
14182676|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182677|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14182678|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14182679|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182680|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182681|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14182682|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
14182683|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182684|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182685|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14182686|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14182687|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14182688|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182689|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182690|NCT04734353|Ticagrelor|ticagrelor|mesh-list
14182691|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14182692|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14182693|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14182694|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14182695|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14182696|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
14938561|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14938562|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167653|NCT04860739|Vaccines|vaccines|mesh-list
14167654|NCT04860739|Immunologic Factors|immunologic factors|mesh-ancestor
14167655|NCT04860739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167656|NCT04861103|Enoxaparin|enoxaparin|mesh-list
14167657|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
14167658|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14167659|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14167660|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167661|NCT04860674|Carboplatin|carboplatin|mesh-list
14767118|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14767119|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
14167662|NCT04860674|Etoposide|etoposide|mesh-list
14167663|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14167664|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167665|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14167666|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14167667|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14167668|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167669|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167670|NCT04860856|Ropivacaine|ropivacaine|mesh-list
14167671|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167672|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
14167673|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167674|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167675|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
14167676|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167677|NCT04860505|Doxycycline|doxycycline|mesh-list
14167678|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14167679|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167680|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
14167681|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14167682|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14167683|NCT04861207|Cladribine|cladribine|mesh-list
14167684|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167685|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14167686|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
14167687|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167688|NCT04860531|Betamethasone|betamethasone|mesh-list
14167689|NCT04860531|Lidocaine|lidocaine|mesh-list
14167690|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167691|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
14167692|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167693|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167694|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
14167695|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767120|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167696|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14167697|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14167698|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14167699|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14167700|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167701|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167702|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
14167703|NCT04860531|Hormones|hormones|mesh-ancestor
14167704|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167705|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14167706|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
14167707|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
14167708|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
14167709|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14167710|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14167711|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167712|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167713|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167714|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14167715|NCT04860141|Gabapentin|gabapentin|mesh-list
14167716|NCT04860141|Analgesics|analgesics|mesh-ancestor
14167717|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
14167718|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167719|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167720|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
14167721|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14767121|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14167722|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14167723|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167724|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14167725|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14167726|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14167727|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167728|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167729|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
14167730|NCT04860167|Diclofenac|diclofenac|mesh-list
14167731|NCT04860167|Lidocaine|lidocaine|mesh-list
14167732|NCT04860167|Propofol|propofol|mesh-list
14167733|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14167734|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167735|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167736|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14167737|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
14167738|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
14167739|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14167740|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14167741|NCT04860167|Analgesics|analgesics|mesh-ancestor
14167742|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
14167743|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167744|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14167745|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14167746|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14167747|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167748|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167749|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167750|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14167751|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14167752|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14167753|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14167754|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
14167755|NCT04860076|Nivolumab|nivolumab|mesh-list
14167756|NCT04860076|Ipilimumab|ipilimumab|mesh-list
14167757|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167758|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167759|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14167760|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167761|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
14167762|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14167763|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
14167764|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
14167765|NCT04860011|Metolazone|metolazone|mesh-list
14167766|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14167767|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167768|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14167769|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167770|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14167771|NCT04860011|Diuretics|diuretics|mesh-ancestor
14167772|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
14167773|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14167774|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14167775|NCT04859738|Lidocaine|lidocaine|mesh-list
14167776|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
14167777|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
14167778|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167779|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167780|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
14167781|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167782|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14167783|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14167784|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14167785|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14167786|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167787|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
14167788|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167789|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167790|NCT04860219|Lactoferrin|lactoferrin|mesh-list
14167791|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167792|NCT04859660|Tamsulosin|tamsulosin|mesh-list
14167793|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14167794|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14167795|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14167796|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
14167797|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167798|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167799|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167800|NCT04859660|Urological Agents|urological agents|mesh-ancestor
14167801|NCT04859621|Vitamin D|vitamin d|mesh-list
14167802|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
14167803|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
14167804|NCT04859621|Vitamins|vitamins|mesh-list
14167805|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14167806|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
14167807|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167808|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14167809|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14167810|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167811|NCT04859556|Dipivefrin|dipivefrin|mesh-list
14167812|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14167813|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
14167814|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167815|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167816|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167817|NCT04859569|Denosumab|denosumab|mesh-list
14167818|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14167819|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167820|NCT04859530|Lugol's solution|lugol's solution|mesh-list
14167821|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
14167822|NCT04859530|Coagulants|coagulants|mesh-ancestor
14167823|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
14167824|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14167825|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167826|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167827|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14167828|NCT04859283|Analgesics|analgesics|mesh-ancestor
14167829|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
14167830|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167831|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14167832|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14167833|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14167834|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
14167835|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167836|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167837|NCT04859452|Metformin|metformin|mesh-list
14167838|NCT04859452|Glyburide|glyburide|mesh-list
14167839|NCT04859452|Valsartan|valsartan|mesh-list
14167840|NCT04859452|Simvastatin|simvastatin|mesh-list
14167841|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14167842|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167843|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14167844|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14167845|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
14167846|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167847|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14167848|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14167849|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167850|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14167851|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14167852|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14167853|NCT04859361|Imiquimod|imiquimod|mesh-list
14167854|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14167855|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
14167856|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167857|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167858|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
14167859|NCT04859322|Glucagon|glucagon|mesh-list
14167860|NCT04859322|Somatostatin|somatostatin|mesh-list
14167861|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167862|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14167863|NCT04859322|Hormones|hormones|mesh-ancestor
14167864|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167865|NCT04859244|Remdesivir|remdesivir|mesh-list
14167866|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
14167867|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167868|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
14167869|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167870|NCT04858997|Palbociclib|palbociclib|mesh-list
14167871|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167872|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14167873|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167874|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182697|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182698|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182699|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182700|NCT04734119|Anesthetics|anesthetics|mesh-list
14182701|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182702|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182703|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14182704|NCT04733781|Lidocaine|lidocaine|mesh-list
14182705|NCT04733781|Epinephrine|epinephrine|mesh-list
14182706|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
14182707|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
14182708|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182709|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182710|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
14182711|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182712|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14182713|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14182714|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14182715|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14182716|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182717|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14182718|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14182719|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182720|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182721|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14182722|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14182723|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
14182724|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14182725|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
14182726|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
14182727|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
14182728|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14182729|NCT04733625|Vitamin D|vitamin d|mesh-list
14182730|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
14182731|NCT04733625|Vitamins|vitamins|mesh-ancestor
14182732|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
14182733|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182734|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14182735|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14182736|NCT04733326|Ketorolac|ketorolac|mesh-list
14182737|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14182738|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14182739|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14182740|NCT04733326|Analgesics|analgesics|mesh-ancestor
14182741|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
14182742|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182743|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182744|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14182745|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182746|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14182747|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14182748|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182749|NCT04733963|Bevacizumab|bevacizumab|mesh-list
14182750|NCT04733963|Capecitabine|capecitabine|mesh-list
14182751|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182752|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182753|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182754|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182755|NCT04733963|Growth Substances|growth substances|mesh-ancestor
14182756|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182757|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182758|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14182759|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
14182760|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182761|NCT04733521|Cisplatin|cisplatin|mesh-list
14182762|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182763|NCT04733508|Exenatide|exenatide|mesh-list
14182764|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14182765|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182766|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14182767|NCT04733508|Incretins|incretins|mesh-ancestor
14182768|NCT04733508|Hormones|hormones|mesh-ancestor
14184175|NCT04722471|Progesterone|progesterone|mesh-list
14184176|NCT04722471|Progestins|progestins|mesh-ancestor
14167875|NCT04858841|Levetiracetam|levetiracetam|mesh-list
14167876|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
14167877|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
14167878|NCT04858529|Carboplatin|carboplatin|mesh-list
14167879|NCT04858529|Docetaxel|docetaxel|mesh-list
14167880|NCT04858529|Trastuzumab|trastuzumab|mesh-list
14167881|NCT04858529|Pertuzumab|pertuzumab|mesh-list
14167882|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167883|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
14167884|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
14167885|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
14167886|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167887|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167888|NCT04858516|Trastuzumab|trastuzumab|mesh-list
14167889|NCT04858516|Palbociclib|palbociclib|mesh-list
14167890|NCT04858516|Exemestane|exemestane|mesh-list
14167891|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14167892|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167893|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14167894|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167895|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167896|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14167897|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14167898|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14167899|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
14167900|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14167901|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167902|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
14167903|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
14167904|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14167905|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14167906|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167907|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167908|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167909|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14167910|NCT04858087|Lumefantrine|lumefantrine|mesh-list
14167911|NCT04858087|Artemether|artemether|mesh-list
14767122|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767123|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
14767124|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14767125|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14767126|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14167912|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14167913|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
14167914|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14167915|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14167916|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167917|NCT04858048|Anesthetics|anesthetics|mesh-list
14167918|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167919|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167920|NCT04857983|Memantine|memantine|mesh-list
14167921|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14167922|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14167923|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
14167924|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167925|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167926|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167927|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14167928|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14167929|NCT04857801|Teduglutide|teduglutide|mesh-list
14167930|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14167931|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14167932|NCT04857801|Protective Agents|protective agents|mesh-ancestor
14167933|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167934|NCT04857840|Firibastat|firibastat|mesh-list
14167935|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14167936|NCT04857320|Insulin|insulin|mesh-list
14167937|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14167938|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14167939|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167940|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14167941|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767127|NCT00628810|Antidotes|antidotes|mesh-ancestor
14167942|NCT04857450|Ketamine|ketamine|mesh-list
14167943|NCT04857450|Etomidate|etomidate|mesh-list
14167944|NCT04857450|Analgesics|analgesics|mesh-ancestor
14167945|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
14167946|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14167947|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167948|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14167949|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14167950|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
14167951|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
14167952|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14167953|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14167954|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14167955|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14167956|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167957|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14167958|NCT04857177|Ranibizumab|ranibizumab|mesh-list
14167959|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14167960|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14167961|NCT04857177|Growth Substances|growth substances|mesh-ancestor
14167962|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167963|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
14167964|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167965|NCT04857203|Vitamin D|vitamin d|mesh-list
14167966|NCT04857203|Vitamins|vitamins|mesh-ancestor
14167967|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
14167968|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167969|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14167970|NCT04856761|Capecitabine|capecitabine|mesh-list
14167971|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14167972|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
14167973|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167974|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167975|NCT04856852|Iodine|iodine|mesh-list
14167976|NCT04856852|Temozolomide|temozolomide|mesh-list
14167977|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14167978|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
14167979|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167980|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167981|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14167982|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167983|NCT04856852|Trace Elements|trace elements|mesh-ancestor
14167984|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
14167985|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14167986|NCT04856878|Vancomycin|vancomycin|mesh-list
14167987|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14167988|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14167989|NCT04856787|Fluorouracil|fluorouracil|mesh-list
14167990|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
14167991|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14167992|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14167993|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14167994|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14167995|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
14167996|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182769|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182770|NCT04733235|Progesterone|progesterone|mesh-list
14182771|NCT04733235|Hormones|hormones|mesh-ancestor
14182772|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14182773|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182774|NCT04733235|Progestins|progestins|mesh-ancestor
14182775|NCT04733131|Abatacept|abatacept|mesh-list
14182776|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14182777|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182778|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182779|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14182780|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
14182781|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182782|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14182783|NCT04733066|Teduglutide|teduglutide|mesh-list
14182784|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14182785|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14182786|NCT04733066|Protective Agents|protective agents|mesh-ancestor
14182787|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182788|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
14182789|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14182790|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
14182791|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
14182792|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
14167997|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
14167998|NCT04856969|Olmesartan|olmesartan|mesh-list
14167999|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14168000|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168001|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14168002|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168003|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14168004|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14168005|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14168006|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
14168007|NCT04856644|Rifapentine|rifapentine|mesh-list
14168008|NCT04856644|Rifampin|rifampin|mesh-list
14168009|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14168010|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168011|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14168012|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14168013|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168014|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168015|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168016|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14168017|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
14168018|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
14168019|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14168020|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14168021|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14168022|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14168023|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14168024|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14168025|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14168026|NCT04856371|Letrozole|letrozole|mesh-list
14168027|NCT04856371|Fulvestrant|fulvestrant|mesh-list
14168028|NCT04856371|Palbociclib|palbociclib|mesh-list
14168029|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168030|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14168031|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14168032|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168033|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168034|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14168035|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
14168036|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168037|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168038|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168039|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14168040|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14168041|NCT04856137|Paclitaxel|paclitaxel|mesh-list
14168042|NCT04856137|Rituximab|rituximab|mesh-list
14168043|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14168044|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168045|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14168046|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14168047|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14168048|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168049|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168050|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
14168051|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168052|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168053|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
14168054|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168055|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168056|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
14168057|NCT04856098|Bromides|bromides|mesh-list
14168058|NCT04856098|Maleic acid|maleic acid|mesh-list
14168059|NCT04856098|Charcoal|charcoal|mesh-list
14168060|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
14168061|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168062|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168063|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14168064|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14168065|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14168066|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
14168067|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168068|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168069|NCT04856098|Antidotes|antidotes|mesh-ancestor
14168070|NCT04856098|Protective Agents|protective agents|mesh-ancestor
14168071|NCT04856111|Pirfenidone|pirfenidone|mesh-list
14168072|NCT04856111|Nintedanib|nintedanib|mesh-list
14168073|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168074|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14168075|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168076|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168077|NCT04856111|Analgesics|analgesics|mesh-ancestor
14168078|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
14168079|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168080|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168081|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14168082|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168083|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168084|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168085|NCT04855968|Analgesics|analgesics|mesh-list
14168086|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
14168087|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168088|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168089|NCT04856124|Ketamine|ketamine|mesh-list
14168090|NCT04856124|Esketamine|esketamine|mesh-list
14168091|NCT04856124|Analgesics|analgesics|mesh-ancestor
14168092|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
14168093|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168094|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168095|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14168096|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14168097|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
14168098|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
14168099|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168100|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14168101|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14168102|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168103|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168104|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
14168105|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168112|NCT04855279|Listerine|listerine|mesh-list
14168113|NCT04855279|Fluorides|fluorides|mesh-list
14168114|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
14168115|NCT04855279|Glycerol|glycerol|mesh-list
14168116|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
14168117|NCT04855279|Protective Agents|protective agents|mesh-ancestor
14168118|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168119|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14168120|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168121|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14168122|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14168123|NCT04855266|Hematinics|hematinics|mesh-ancestor
14168124|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14168125|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14168126|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168127|NCT04855695|Venetoclax|venetoclax|mesh-list
14168128|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
14168129|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
14168130|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168131|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168132|NCT04855110|Warfarin|warfarin|mesh-list
14168133|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
14168134|NCT04854837|Remdesivir|remdesivir|mesh-list
14168135|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
14168136|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168137|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
14168138|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168139|NCT04854889|Decitabine|decitabine|mesh-list
14168140|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14168141|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
14168142|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168143|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168144|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168145|NCT04854759|Amantadine|amantadine|mesh-list
14168146|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14168147|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14168148|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
14168149|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168150|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
14168151|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168152|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168153|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168154|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168155|NCT04854759|Analgesics|analgesics|mesh-ancestor
14168156|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
14168157|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168158|NCT04855136|Dexamethasone|dexamethasone|mesh-list
14168159|NCT04855136|Bortezomib|bortezomib|mesh-list
14168160|NCT04855136|Pomalidomide|pomalidomide|mesh-list
14168161|NCT04855136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168162|NCT04855136|Antiemetics|antiemetics|mesh-ancestor
14168163|NCT04855136|Autonomic Agents|autonomic agents|mesh-ancestor
14168164|NCT04855136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168165|NCT04855136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168166|NCT04855136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14168167|NCT04855136|Glucocorticoids|glucocorticoids|mesh-ancestor
14168168|NCT04855136|Hormones|hormones|mesh-ancestor
14168169|NCT04855136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168170|NCT04855136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168171|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168172|NCT04855136|Immunologic Factors|immunologic factors|mesh-ancestor
14168173|NCT04855136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14168174|NCT04855136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14168175|NCT04855136|Growth Substances|growth substances|mesh-ancestor
14168176|NCT04855136|Growth Inhibitors|growth inhibitors|mesh-ancestor
14168177|NCT04854668|Bevacizumab|bevacizumab|mesh-list
14168178|NCT04854668|Capecitabine|capecitabine|mesh-list
14168179|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
14168180|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168181|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168182|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14767128|NCT00628810|Protective Agents|protective agents|mesh-ancestor
14767129|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
14767130|NCT00628810|Vitamins|vitamins|mesh-ancestor
14767131|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
14767132|NCT00628914|Dexetimide|dexetimide|mesh-list
14767133|NCT00628914|Eszopiclone|eszopiclone|mesh-list
14767134|NCT00628914|Citalopram|citalopram|mesh-list
14767135|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14767136|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14767137|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14767138|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767139|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767140|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
14767141|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767142|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14767143|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
14767144|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767145|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14767146|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14168183|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14168184|NCT04854668|Growth Substances|growth substances|mesh-ancestor
14168185|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168186|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
14168187|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14168188|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
14168189|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182793|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
14182794|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182795|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
14182796|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14182797|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14182798|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14182799|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168190|NCT04854460|Ivermectin|ivermectin|mesh-list
14168191|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14168192|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168193|NCT04854551|Naltrexone|naltrexone|mesh-list
14168194|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14168195|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14168196|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168197|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
14168198|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168199|NCT04854577|Anesthetics|anesthetics|mesh-list
14168200|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168201|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168202|NCT04854538|Budesonide|budesonide|mesh-list
14168203|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168204|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14168205|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
14168206|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168207|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168208|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14168209|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
14168210|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
14168211|NCT04854538|Hormones|hormones|mesh-ancestor
14168212|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168213|NCT04854395|Bupivacaine|bupivacaine|mesh-list
14168214|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
14168215|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
14168216|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168217|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168218|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
14168219|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168220|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14168221|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14168222|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168223|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14168224|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
14168225|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
14168226|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168227|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168228|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14168229|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14168230|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14168231|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
14168232|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168233|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14767147|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
14767148|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
14767149|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767150|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14767151|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14767152|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
14767153|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14767154|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767155|NCT00628953|Esomeprazole|esomeprazole|mesh-list
14767156|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14767157|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767158|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14767159|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168234|NCT04854044|TIC10 compound|tic10 compound|mesh-list
14168235|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168236|NCT04854252|Fentanyl|fentanyl|mesh-list
14168237|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14168238|NCT04854252|Narcotics|narcotics|mesh-ancestor
14168239|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168240|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168241|NCT04854252|Analgesics|analgesics|mesh-ancestor
14168242|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
14168243|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168244|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14168245|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14168246|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
14168247|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
14168248|NCT04853758|Valsartan|valsartan|mesh-list
14767452|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14168249|NCT04853758|Enalapril|enalapril|mesh-list
14168250|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14168251|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14168252|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14168253|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14168254|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14168255|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14168256|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168257|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
14168258|NCT04853797|Calcium|calcium|mesh-list
14168259|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14168260|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168261|NCT04853875|Amoxicillin|amoxicillin|mesh-list
14168262|NCT04853875|Metronidazole|metronidazole|mesh-list
14168263|NCT04853875|Clarithromycin|clarithromycin|mesh-list
14168264|NCT04853875|Tetracycline|tetracycline|mesh-list
14168265|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14168266|NCT04853875|Bismuth|bismuth|mesh-list
14168267|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14168268|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168269|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14168270|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14168271|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14168272|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168273|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168274|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14168275|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14168276|NCT04853875|Antacids|antacids|mesh-ancestor
14168277|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14168278|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14168279|NCT04853615|Empagliflozin|empagliflozin|mesh-list
14168280|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14168281|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168282|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14168283|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168284|NCT04853446|Dexamethasone|dexamethasone|mesh-list
14168285|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
14168286|NCT04853446|BB 1101|bb 1101|mesh-list
14168287|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168288|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
14168289|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
14168290|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168291|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168292|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14168293|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
14168294|NCT04853446|Hormones|hormones|mesh-ancestor
14168295|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168296|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168297|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168298|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
14168299|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168300|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168301|NCT04853719|Aspirin|aspirin|mesh-list
14168302|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
14168303|NCT04853719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14168304|NCT04853719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168305|NCT04853719|Analgesics|analgesics|mesh-ancestor
14168306|NCT04853719|Sensory System Agents|sensory system agents|mesh-ancestor
14168307|NCT04853719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168308|NCT04853719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168309|NCT04853719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168310|NCT04853719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168311|NCT04853719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14168312|NCT04853719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14168313|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168314|NCT04853719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14168315|NCT04853719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14168316|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168317|NCT04853719|Antipyretics|antipyretics|mesh-ancestor
14168318|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14168319|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
14168320|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14168321|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
14168322|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
14168323|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
14168324|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14168325|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
14168326|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168327|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
14168328|NCT04853589|Protective Agents|protective agents|mesh-ancestor
14168329|NCT04853628|Ethanol|ethanol|mesh-list
14168330|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14168331|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168332|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168333|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168334|NCT04853524|Tenofovir|tenofovir|mesh-list
14168335|NCT04853524|Emtricitabine|emtricitabine|mesh-list
14168336|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
14168337|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168338|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14168339|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14168340|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168341|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168342|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14168343|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14168344|NCT04853901|Remdesivir|remdesivir|mesh-list
14168345|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168346|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168347|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
14168348|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
14168349|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14168350|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14168351|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168352|NCT04853199|Quercetin|quercetin|mesh-list
14168353|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
14168354|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168355|NCT04853199|Protective Agents|protective agents|mesh-ancestor
14168356|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168357|NCT04853069|Estradiol|estradiol|mesh-list
14168358|NCT04853069|Estrogens|estrogens|mesh-ancestor
14168359|NCT04853069|Hormones|hormones|mesh-ancestor
14168360|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168361|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168362|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
14168363|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14168364|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168365|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
14168366|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14168367|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168368|NCT04852510|Metformin|metformin|mesh-list
14168369|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14168370|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182800|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
14182801|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14182802|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
14182803|NCT04732390|Bupivacaine|bupivacaine|mesh-list
14182804|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
14182805|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
14182806|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182807|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182808|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
14182809|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182810|NCT04732390|Analgesics|analgesics|mesh-ancestor
14182811|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14182812|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
14182813|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14182814|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14182815|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182816|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14182817|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
14182818|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14182819|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
14182820|NCT04732377|Bupivacaine|bupivacaine|mesh-list
14182821|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
14182822|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
14182823|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182824|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182825|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
14182826|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182827|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14182828|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14182829|NCT04732377|Analgesics|analgesics|mesh-ancestor
14182830|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14168371|NCT04852315|Caffeine|caffeine|mesh-list
14168372|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14168373|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168374|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14168375|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168376|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168377|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14168378|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14168379|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
14168380|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168381|NCT04852484|Ketamine|ketamine|mesh-list
14168382|NCT04852484|Morphine|morphine|mesh-list
14168383|NCT04852484|Anesthetics|anesthetics|mesh-list
14168384|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
14168385|NCT04852484|Analgesics|analgesics|mesh-ancestor
14168386|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
14168387|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168388|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168389|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14168390|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14168391|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
14168392|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168393|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14168394|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14168395|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168396|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168397|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14168398|NCT04852484|Narcotics|narcotics|mesh-ancestor
14168399|NCT04852068|Vaccines|vaccines|mesh-list
14168400|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
14168401|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168402|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14168403|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14168404|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14168405|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
14168406|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168407|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168408|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14168409|NCT04851821|Quercetin|quercetin|mesh-list
14168410|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
14168411|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168412|NCT04851821|Protective Agents|protective agents|mesh-ancestor
14168413|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168414|NCT04851977|Vaccines|vaccines|mesh-list
14168415|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
14168416|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168417|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
14168418|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14168419|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
14168420|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168421|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
14168422|NCT04851548|Protective Agents|protective agents|mesh-ancestor
14168423|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14168424|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168425|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168426|NCT04852081|Tamoxifen|tamoxifen|mesh-list
14168427|NCT04852081|Letrozole|letrozole|mesh-list
14168428|NCT04852081|Fulvestrant|fulvestrant|mesh-list
14168429|NCT04852081|Palbociclib|palbociclib|mesh-list
14168430|NCT04852081|Anastrozole|anastrozole|mesh-list
14168431|NCT04852081|Exemestane|exemestane|mesh-list
14168432|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168433|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14168434|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14168435|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168436|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168437|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14168438|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14168439|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168440|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168441|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168442|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14168443|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14479069|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
14184177|NCT04722471|Hormones|hormones|mesh-ancestor
14168444|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14168445|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14168446|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14168447|NCT04851457|Tirofiban|tirofiban|mesh-list
14168448|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14168449|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14168450|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168451|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14168452|NCT04851392|Dronabinol|dronabinol|mesh-list
14168453|NCT04851392|Cannabidiol|cannabidiol|mesh-list
14168454|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
14168455|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
14168456|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168457|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168458|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168459|NCT04851392|Analgesics|analgesics|mesh-ancestor
14168460|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
14168461|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168462|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14168463|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14168464|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168465|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168466|NCT04851392|Hormones|hormones|mesh-ancestor
14168467|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168468|NCT04851015|Trimethoprim|trimethoprim|mesh-list
14168469|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14168470|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
14168471|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14168472|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168473|NCT04851015|Renal Agents|renal agents|mesh-ancestor
14168474|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
14168475|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14168476|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14168477|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14168478|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168479|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168480|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14168481|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14168482|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14168483|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14168484|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14168485|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14168486|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168487|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
14168488|NCT04851002|Mitogens|mitogens|mesh-list
14168489|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
14168490|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168491|NCT04850911|Ketamine|ketamine|mesh-list
14168492|NCT04850911|Analgesics|analgesics|mesh-ancestor
14168493|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
14168494|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168495|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168496|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14168497|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14168498|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
14168499|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
14168500|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168501|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14168502|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14168503|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168504|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168505|NCT04851132|Durvalumab|durvalumab|mesh-list
14168506|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168507|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168508|NCT04850885|Dexamethasone|dexamethasone|mesh-list
14168509|NCT04850885|Lidocaine|lidocaine|mesh-list
14168510|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168511|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
14168512|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
14168513|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168514|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168515|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14168516|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
14168517|NCT04850885|Hormones|hormones|mesh-ancestor
14168518|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168519|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168520|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168521|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
14168522|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
14168523|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168524|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
14168525|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14168526|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14168527|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14168528|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14168529|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168530|NCT04850950|Tenofovir|tenofovir|mesh-list
14168531|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
14168532|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168533|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14168534|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14168535|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168536|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168537|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14168538|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14168539|NCT04850937|Esketamine|esketamine|mesh-list
14168540|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
14168541|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168542|NCT04850638|Furosemide|furosemide|mesh-list
14168543|NCT04850638|Diuretics|diuretics|mesh-ancestor
14168544|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
14168545|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168546|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14168547|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14168548|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168549|NCT04850755|Nivolumab|nivolumab|mesh-list
14168550|NCT04850755|Ipilimumab|ipilimumab|mesh-list
14168551|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168552|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168553|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14168554|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168555|NCT04850378|Dalteparin|dalteparin|mesh-list
14168556|NCT04850378|Tinzaparin|tinzaparin|mesh-list
14168557|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14168558|NCT04850378|Apixaban|apixaban|mesh-list
14168559|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14168560|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
14168561|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14168562|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
14168563|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168564|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168565|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
14168566|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14168567|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14168568|NCT04850560|Decitabine|decitabine|mesh-list
14168569|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14168570|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
14168571|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168572|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168573|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168574|NCT04850404|Ropivacaine|ropivacaine|mesh-list
14168575|NCT04850404|Rocuronium|rocuronium|mesh-list
14168576|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
14168577|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
14168578|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168579|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168580|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
14168581|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168582|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14168583|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14168584|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14168585|NCT04850417|Aspirin|aspirin|mesh-list
14168586|NCT04850417|Clopidogrel|clopidogrel|mesh-list
14168587|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14168588|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14168589|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168590|NCT04850417|Analgesics|analgesics|mesh-ancestor
14168591|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
14168592|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168593|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168594|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168595|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168596|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14168597|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14168598|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168599|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14168600|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14168601|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168602|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
14168603|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14168604|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14168605|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14168606|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
14168607|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168608|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14168609|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182831|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14182832|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14182833|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
14182834|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182835|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182836|NCT04732455|Lidocaine|lidocaine|mesh-list
14182837|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14182838|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
14182839|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
14182840|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182841|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182842|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
14182843|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182844|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14182845|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14182846|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14182847|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14182848|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182849|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14182850|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14182851|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14182852|NCT04732455|Analgesics|analgesics|mesh-ancestor
14182853|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
14182854|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14182855|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
14182856|NCT04732364|Bupivacaine|bupivacaine|mesh-list
14182857|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
14182858|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
14182859|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182860|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182861|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
14182862|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182863|NCT04732598|Paclitaxel|paclitaxel|mesh-list
14182864|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14182865|NCT04732598|Bevacizumab|bevacizumab|mesh-list
14182866|NCT04732598|Atezolizumab|atezolizumab|mesh-list
14182867|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14182868|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14182869|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
14182870|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14182871|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
14182872|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182873|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14182874|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14182875|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14182876|NCT04732598|Growth Substances|growth substances|mesh-ancestor
14182877|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182878|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
14182879|NCT04732507|Lidocaine|lidocaine|mesh-list
14182880|NCT04732507|Bupivacaine|bupivacaine|mesh-list
14182881|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
14182882|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
14182883|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14182884|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182885|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
14168610|NCT04850235|Paclitaxel|paclitaxel|mesh-list
14168611|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14168612|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168613|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
14168614|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
14168615|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
14168616|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168617|NCT04850261|Nafarelin|nafarelin|mesh-list
14168618|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14168619|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
14168620|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14168621|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168622|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
14168623|NCT04850040|Apatinib|apatinib|mesh-list
14168624|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168625|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14168626|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168627|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168628|NCT04850001|Aspirin|aspirin|mesh-list
14168629|NCT04850001|Clopidogrel|clopidogrel|mesh-list
14168630|NCT04850001|Atorvastatin|atorvastatin|mesh-list
14168631|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14168632|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168633|NCT04850001|Analgesics|analgesics|mesh-ancestor
14168634|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
14168635|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168636|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168637|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168638|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168639|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14168640|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14168641|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168642|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14168643|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14168644|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168645|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
14168646|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14168647|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14168648|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
14168649|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14168650|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14168651|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14168652|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14168653|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14168654|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
14168655|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168656|NCT04849845|Insulin|insulin|mesh-list
14168657|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14168658|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14168659|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168660|NCT04849858|Bupivacaine|bupivacaine|mesh-list
14168661|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
14168662|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
14168663|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168664|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168665|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
14168666|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938563|NCT01482156|Everolimus|everolimus|mesh-list
14938564|NCT01482156|Dactolisib|dactolisib|mesh-list
14938565|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938566|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938567|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
14938568|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938569|NCT01482299|Everolimus|everolimus|mesh-list
14938570|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938571|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938572|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
14938573|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938574|NCT01482338|Drospirenone|drospirenone|mesh-list
14938575|NCT01482338|Desogestrel|desogestrel|mesh-list
14938576|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14938577|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
14938578|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938579|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938580|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14938581|NCT01482338|Diuretics|diuretics|mesh-ancestor
14168667|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
14168668|NCT04849533|Prednisone|prednisone|mesh-list
14168669|NCT04849533|Everolimus|everolimus|mesh-list
14168670|NCT04849533|Abatacept|abatacept|mesh-list
14168671|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
14168672|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14168673|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168674|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
14168675|NCT04849533|Hormones|hormones|mesh-ancestor
14168676|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168677|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168678|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168679|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168680|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14168681|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
14168682|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14168683|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14168684|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
14168685|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14168686|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168687|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168688|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168689|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14168690|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168691|NCT04849377|Cisplatin|cisplatin|mesh-list
14168692|NCT04849377|Carboplatin|carboplatin|mesh-list
14168693|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168694|NCT04849455|Morphine|morphine|mesh-list
14168695|NCT04849455|Ropivacaine|ropivacaine|mesh-list
14168696|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
14168697|NCT04849455|Anesthetics|anesthetics|mesh-list
14168698|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14168699|NCT04849455|Narcotics|narcotics|mesh-ancestor
14168700|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168701|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168702|NCT04849455|Analgesics|analgesics|mesh-ancestor
14168703|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
14168704|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168705|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
14168706|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168707|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
14168708|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14168709|NCT04849013|Ketanserin|ketanserin|mesh-list
14168710|NCT04849013|Mescaline|mescaline|mesh-list
14168711|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14168712|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14168713|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14168714|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
14168715|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168716|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168717|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168718|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
14168719|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168720|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14168721|NCT04849026|Clozapine|clozapine|mesh-list
14168722|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14168723|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
14168724|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168725|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168726|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168727|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14168728|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14168729|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168730|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168731|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
14168732|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
14168733|NCT04849299|Cyclosporine|cyclosporine|mesh-list
14168734|NCT04849299|Cyclosporins|cyclosporins|mesh-list
14168735|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168736|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168737|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14168738|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
14938582|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
14168739|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168740|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
14168741|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168742|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
14168743|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168744|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14168745|NCT04848974|Cytarabine|cytarabine|mesh-list
14168746|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14168747|NCT04848974|Cladribine|cladribine|mesh-list
14168748|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14168749|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
14168750|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168751|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168752|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
14168753|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168754|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14168755|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
14168756|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168757|NCT04848857|Colchicine|colchicine|mesh-list
14168758|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
14168759|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168760|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
14168761|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
14168762|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
14168763|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168764|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168765|NCT04848792|Sulforaphane|sulforaphane|mesh-list
14168766|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14168767|NCT04848792|Protective Agents|protective agents|mesh-ancestor
14168768|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168769|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168770|NCT04848467|Vaccines|vaccines|mesh-list
14168771|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
14168772|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168773|NCT04848259|Dexamethasone|dexamethasone|mesh-list
14168774|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
14168775|NCT04848259|BB 1101|bb 1101|mesh-list
14168776|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168777|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
14168778|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
14168779|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168780|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168781|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14168782|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
14168783|NCT04848259|Hormones|hormones|mesh-ancestor
14168784|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168785|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168786|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168787|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
14168788|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168789|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168790|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
14168791|NCT04848519|Propranolol|propranolol|mesh-list
14168792|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168793|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168794|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14168795|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14168796|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
14168797|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168798|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168799|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168800|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14168801|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14168802|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
14182886|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182887|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14182888|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14182889|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14182890|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14182891|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182892|NCT04732247|Oxytocin|oxytocin|mesh-list
14182893|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
14182894|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14182895|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184178|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184179|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184180|NCT04721873|Topiramate|topiramate|mesh-list
14184181|NCT04721873|Phentermine|phentermine|mesh-list
14168803|NCT04848246|Bupropion|bupropion|mesh-list
14168804|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14168805|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
14168806|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168807|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14168808|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14168809|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14168810|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168811|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
14168812|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168813|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168814|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14168815|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14168816|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168817|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
14168818|NCT04848181|Finasteride|finasteride|mesh-list
14168819|NCT04848181|Cyproterone|cyproterone|mesh-list
14168820|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14168821|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14168822|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168823|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168824|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
14168825|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168826|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168827|NCT04848181|Urological Agents|urological agents|mesh-ancestor
14168828|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
14168829|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168830|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14168831|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
14168832|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14168833|NCT04848116|Nivolumab|nivolumab|mesh-list
14168834|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14168835|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168836|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14168837|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168838|NCT04847791|Lactoferrin|lactoferrin|mesh-list
14168839|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168840|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
14168841|NCT04848064|Fludarabine|fludarabine|mesh-list
14168842|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
14168843|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
14168844|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
14168845|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14168846|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
14168847|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168848|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168849|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14168850|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
14168851|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168852|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168853|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14168854|NCT04847921|Dalbavancin|dalbavancin|mesh-list
14168855|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14168856|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168857|NCT04847895|Ranibizumab|ranibizumab|mesh-list
14168858|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14168859|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14168860|NCT04847895|Growth Substances|growth substances|mesh-ancestor
14168861|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168862|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
14168863|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168864|NCT04847947|Vitamin D|vitamin d|mesh-list
14168865|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
14168866|NCT04847947|Vitamins|vitamins|mesh-ancestor
14168867|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
14168868|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168869|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14168870|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14168871|NCT04847752|Aspirin|aspirin|mesh-list
14168872|NCT04847752|Warfarin|warfarin|mesh-list
14168873|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
14168874|NCT04847752|Dabigatran|dabigatran|mesh-list
14168875|NCT04847752|Anticoagulants|anticoagulants|mesh-list
14168876|NCT04847752|Clopidogrel|clopidogrel|mesh-list
14168877|NCT04847752|Atorvastatin|atorvastatin|mesh-list
14168878|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14168879|NCT04847752|Evolocumab|evolocumab|mesh-list
14168880|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14168881|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14168882|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168883|NCT04847752|Analgesics|analgesics|mesh-ancestor
14168884|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
14168885|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168886|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168887|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168888|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168889|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14168890|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14168891|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168892|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14168893|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14168894|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168895|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
14168896|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14168897|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14168898|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
14168899|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14168900|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14168901|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14168902|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14168903|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
14168904|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168905|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14168906|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
14168907|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14168908|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
14168909|NCT04847622|Remdesivir|remdesivir|mesh-list
14168910|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
14767453|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14168911|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168912|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
14168913|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168914|NCT04847661|Mefloquine|mefloquine|mesh-list
14168915|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
14168916|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14168917|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14168918|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14168919|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
14168920|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14168921|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14168922|NCT04847687|Prednisolone|prednisolone|mesh-list
14168923|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
14168924|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14168925|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
14168926|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168927|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
14168928|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
14168929|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168930|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168931|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14168932|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
14168933|NCT04847687|Hormones|hormones|mesh-ancestor
14168934|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14168935|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14168936|NCT04847687|Protective Agents|protective agents|mesh-ancestor
14168937|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14168938|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14168939|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14168940|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
14168941|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14168942|NCT04847024|Parecoxib|parecoxib|mesh-list
14168943|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14168944|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14168945|NCT04847024|Analgesics|analgesics|mesh-ancestor
14168946|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
14168947|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168948|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168949|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14168950|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14168951|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14168952|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14168953|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14168954|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168955|NCT04847245|Pregabalin|pregabalin|mesh-list
14168956|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14168957|NCT04847245|Esketamine|esketamine|mesh-list
14168958|NCT04847245|Analgesics|analgesics|mesh-ancestor
14168959|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
14168960|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168961|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168962|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
14168963|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14168964|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14168965|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168966|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14168967|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14168968|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14168969|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168970|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168971|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14168972|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14168973|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14168974|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
14168975|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
14168976|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
14168977|NCT04846673|Pregabalin|pregabalin|mesh-list
14168978|NCT04846673|Analgesics|analgesics|mesh-ancestor
14168979|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
14168980|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14168981|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14168982|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
14168983|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14168984|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14168985|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14168986|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14168987|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14168988|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14168989|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14168990|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14168991|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
14168992|NCT04846673|Protective Agents|protective agents|mesh-ancestor
14168993|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
14168994|NCT04846673|Vitamins|vitamins|mesh-ancestor
14168995|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
14168996|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
14168997|NCT04846621|Calcium|calcium|mesh-list
14168998|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14168999|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169000|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169001|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169002|NCT04846829|Citalopram|citalopram|mesh-list
14169003|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14169004|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14169005|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169006|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169007|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14169008|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
14169009|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169010|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14169011|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
14169012|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14169013|NCT04846855|Anesthetics|anesthetics|mesh-list
14169014|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
14169015|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14169016|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169017|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
14169018|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169019|NCT04846634|Gemcitabine|gemcitabine|mesh-list
14169020|NCT04846634|Paclitaxel|paclitaxel|mesh-list
14169021|NCT04846634|Docetaxel|docetaxel|mesh-list
14169022|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14169023|NCT04846634|Cisplatin|cisplatin|mesh-list
14169024|NCT04846634|Carboplatin|carboplatin|mesh-list
14169025|NCT04846634|Pemetrexed|pemetrexed|mesh-list
14169026|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169027|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169028|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169029|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14169030|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14169031|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169032|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14169033|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
14169034|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
14169035|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169036|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169037|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14169038|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
14169039|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169040|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14169041|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14169042|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14169043|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
14169044|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
14169045|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169046|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
14169047|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169048|NCT04846452|Paclitaxel|paclitaxel|mesh-list
14169049|NCT04846452|Carboplatin|carboplatin|mesh-list
14169050|NCT04846452|Pemetrexed|pemetrexed|mesh-list
14169051|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14169052|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169053|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
14169054|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
14169055|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
14169056|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169057|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169058|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14169059|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14169060|NCT04846478|Talazoparib|talazoparib|mesh-list
14169061|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14169062|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169063|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169064|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169065|NCT04846335|Doxycycline|doxycycline|mesh-list
14169066|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14169067|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169068|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
14169069|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14169070|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14182896|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14182897|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14182898|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14182899|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14182900|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14182901|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14182902|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14182903|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14182904|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
14169071|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
14169072|NCT04845880|Paraproteins|paraproteins|mesh-list
14169073|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
14169074|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169075|NCT04845737|Vitamin D|vitamin d|mesh-list
14169076|NCT04845737|Vitamins|vitamins|mesh-ancestor
14169077|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
14169078|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169079|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14169080|NCT04845607|Amiodarone|amiodarone|mesh-list
14169081|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14169082|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
14169083|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14169084|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169085|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169086|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14169087|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14169088|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14169089|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169090|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14169091|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14169092|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14169093|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
14169094|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14169095|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14169096|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169097|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
14169098|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14169099|NCT04845646|Itraconazole|itraconazole|mesh-list
14169100|NCT04845646|Phenytoin|phenytoin|mesh-list
14169101|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
14169102|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14169103|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14169104|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14169105|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14169106|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169107|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14169108|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14169109|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14169110|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169111|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14169112|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
14169113|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14169114|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14169115|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14169116|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14169117|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14169118|NCT04845399|Factor VIII|factor viii|mesh-list
14169119|NCT04845399|Coagulants|coagulants|mesh-ancestor
14169120|NCT04845217|Peppermint oil|peppermint oil|mesh-list
14169121|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
14169122|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
14169123|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14169124|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14169125|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14169126|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
14169127|NCT04845139|Nivolumab|nivolumab|mesh-list
14169128|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14169129|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14169130|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14169131|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169132|NCT04844996|Ezetimibe|ezetimibe|mesh-list
14169133|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14169134|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14169135|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
14169136|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14169137|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14169138|NCT04845061|Nebivolol|nebivolol|mesh-list
14169139|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14169140|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
14169141|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14169142|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14169143|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14169144|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
14184268|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479299|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938791|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184269|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14938792|NCT01484327|Carvedilol|carvedilol|mesh-list
14938793|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14938794|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14938795|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
14184270|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
14184271|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184272|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184273|NCT04720768|Palbociclib|palbociclib|mesh-list
14184274|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184275|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14184276|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184277|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184278|NCT04720833|Vitamin D|vitamin d|mesh-list
14184279|NCT04720833|Calcium|calcium|mesh-list
14184280|NCT04720833|Vitamins|vitamins|mesh-ancestor
14184281|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
14184282|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184283|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14184284|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14184285|NCT04720859|Canagliflozin|canagliflozin|mesh-list
14184286|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14184287|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184288|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14184289|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184290|NCT04720326|Tacrolimus|tacrolimus|mesh-list
14184291|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184292|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
14184293|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184294|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14184295|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184296|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184297|NCT04720573|Neostigmine|neostigmine|mesh-list
14184298|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14184299|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184300|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184301|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
14184302|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184303|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184304|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14184305|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
14184306|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184307|NCT04720287|Bupivacaine|bupivacaine|mesh-list
14184308|NCT04720287|Neostigmine|neostigmine|mesh-list
14184309|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
14184310|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
14938796|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938797|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938798|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938799|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14938800|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
14184311|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184312|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184313|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
14184314|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184315|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14184316|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184317|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479300|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
14479301|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
14479302|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
14479303|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479304|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479305|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
14479306|NCT02468648|Velpatasvir|velpatasvir|mesh-list
14479307|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
14479308|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479309|NCT02468700|Dexamethasone|dexamethasone|mesh-list
14479310|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479311|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
14184318|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
14184319|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184320|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14184321|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
14236520|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14236521|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236522|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236523|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
14236524|NCT00115297|Montelukast|montelukast|mesh-list
14236525|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14236526|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
14236527|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14236528|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
14236529|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14236530|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236531|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14236532|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14236533|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236534|NCT00115336|Ibuprofen|ibuprofen|mesh-list
14236535|NCT00115336|Ketorolac|ketorolac|mesh-list
14236536|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14236537|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14236538|NCT00115336|Analgesics|analgesics|mesh-ancestor
14236539|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
14236540|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236541|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236542|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236543|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236544|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14236545|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236546|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236547|NCT00115349|Deferiprone|deferiprone|mesh-list
14236548|NCT00115349|Deferoxamine|deferoxamine|mesh-list
14236549|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14236550|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
14236551|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
14236552|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236553|NCT00115349|Siderophores|siderophores|mesh-ancestor
14236554|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
14236555|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236556|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236557|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236558|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236559|NCT00115765|Bevacizumab|bevacizumab|mesh-list
14236560|NCT00115765|Panitumumab|panitumumab|mesh-list
14236561|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
14236562|NCT00115765|Irinotecan|irinotecan|mesh-list
14236563|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236564|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236565|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14236566|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14236567|NCT00115765|Growth Substances|growth substances|mesh-ancestor
14236568|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236569|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236570|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14236571|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14236572|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236573|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236574|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
14236575|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14236576|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
14236577|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14236578|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
14236579|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236580|NCT00115804|Fluoxetine|fluoxetine|mesh-list
14184332|NCT04720248|Dipyrone|dipyrone|mesh-list
14184333|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14184334|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14184335|NCT04720248|Analgesics|analgesics|mesh-ancestor
14184336|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
14184337|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184338|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184339|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14184340|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184341|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
14184342|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
14184343|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184344|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14184345|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14184346|NCT04720183|Analgesics|analgesics|mesh-ancestor
14184347|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
14767461|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767462|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184348|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184349|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184350|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14184351|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184352|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14184353|NCT04720131|Capecitabine|capecitabine|mesh-list
14184354|NCT04720131|Apatinib|apatinib|mesh-list
14184355|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14184356|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
14184357|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184358|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184359|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14184360|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184361|NCT04720105|Halobetasol|halobetasol|mesh-list
14184362|NCT04720105|Tazarotene|tazarotene|mesh-list
14184363|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
14184364|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
14184365|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14184366|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
14184367|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14184368|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
14184369|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14184370|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
14184371|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184372|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184373|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
14184374|NCT04719819|Anesthetics|anesthetics|mesh-list
14184375|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184376|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184377|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
14184378|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14184379|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184380|NCT04719507|Meperidine|meperidine|mesh-list
14184381|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14184382|NCT04719507|Narcotics|narcotics|mesh-ancestor
14184383|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184384|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184385|NCT04719507|Analgesics|analgesics|mesh-ancestor
14184386|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
14184387|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184388|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14184389|NCT04719715|Antibodies|antibodies|mesh-list
14184390|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
14184391|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184392|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14184393|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184394|NCT04719585|Analgesics|analgesics|mesh-ancestor
14184395|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
14184396|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184397|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14184398|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14184399|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14184400|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184401|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184402|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
14184403|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767463|NCT00630084|Interferons|interferons|mesh-list
14767464|NCT00630084|Ribavirin|ribavirin|mesh-list
14767465|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
14767466|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
14767467|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14767468|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767469|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
14767470|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938801|NCT01484327|Protective Agents|protective agents|mesh-ancestor
14184404|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
14184405|NCT04719481|Pravastatin|pravastatin|mesh-list
14184406|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14184407|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14184408|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
14184409|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184410|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14184411|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14184412|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184413|NCT04719104|Bilirubin|bilirubin|mesh-list
14184414|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
14184415|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184416|NCT04719104|Protective Agents|protective agents|mesh-ancestor
14184417|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184418|NCT04719273|Anastrozole|anastrozole|mesh-list
14184419|NCT04719273|Onapristone|onapristone|mesh-list
14184420|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14184421|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184422|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14938802|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14938803|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14938804|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14938805|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
14938806|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14938807|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14938808|NCT01484457|Pancrelipase|pancrelipase|mesh-list
14938809|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938810|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14938811|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
14184423|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14184424|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184425|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184426|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14184427|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
14184428|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184429|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184430|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14184431|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
14184432|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14184433|NCT04718792|Psilocybin|psilocybin|mesh-list
14184434|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
14184435|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184436|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14184437|NCT04718805|Darunavir|darunavir|mesh-list
14184438|NCT04718805|Cobicistat|cobicistat|mesh-list
14184439|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14184440|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14184441|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
14767471|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
14184442|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184443|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184444|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14184445|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14184446|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
14184447|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184448|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14184449|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14938812|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767472|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184450|NCT04718740|Vitamin K|vitamin k|mesh-list
14184451|NCT04718740|Repaglinide|repaglinide|mesh-list
14184452|NCT04718740|Midazolam|midazolam|mesh-list
14479312|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
14479313|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479314|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479315|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479316|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
14479317|NCT02468700|Hormones|hormones|mesh-ancestor
14479318|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479319|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14479320|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479321|NCT02468830|Mirabegron|mirabegron|mesh-list
14479322|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14479323|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14479324|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14479325|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
14479326|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479327|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479328|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479329|NCT02468830|Urological Agents|urological agents|mesh-ancestor
14479330|NCT02469077|Morphine|morphine|mesh-list
14479331|NCT02469077|Naloxone|naloxone|mesh-list
14479332|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14479333|NCT02469077|Narcotics|narcotics|mesh-ancestor
14479334|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479335|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479336|NCT02469077|Analgesics|analgesics|mesh-ancestor
14479337|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
14479338|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479339|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14479340|NCT02469090|Apomorphine|apomorphine|mesh-list
14479341|NCT02469090|Emetics|emetics|mesh-ancestor
14479342|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479343|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
14479344|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479345|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479346|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
14479347|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
14479348|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479349|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479350|NCT02469116|Carboplatin|carboplatin|mesh-list
14479351|NCT02469116|Docetaxel|docetaxel|mesh-list
14479352|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479353|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
14479354|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14479355|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14479356|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479357|NCT02469246|Lamivudine|lamivudine|mesh-list
14479358|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14479359|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14479360|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767473|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
14767474|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767475|NCT00630097|Modafinil|modafinil|mesh-list
14184453|NCT04718740|Caffeine|caffeine|mesh-list
14184454|NCT04718740|Bupropion|bupropion|mesh-list
14184455|NCT04718740|Omeprazole|omeprazole|mesh-list
14184456|NCT04718740|Warfarin|warfarin|mesh-list
14184457|NCT04718740|Vitamins|vitamins|mesh-ancestor
14184458|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
14184459|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184460|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14184461|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14184462|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184463|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14184464|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14184465|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14184466|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14184467|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
14184468|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
14184469|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
14184470|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
14184471|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184472|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184473|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
14184474|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14184475|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14184476|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14184477|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184478|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14184479|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14184480|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14184481|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14184482|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
14184483|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14184484|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
14184485|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14184486|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14184487|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14184488|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
14184489|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14184490|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14184491|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14184492|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14184493|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
14184494|NCT04718740|Coagulants|coagulants|mesh-ancestor
14184495|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14184496|NCT04718701|Paclitaxel|paclitaxel|mesh-list
14184497|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14184498|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184499|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
14184500|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
14184501|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
14184502|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184503|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
14184504|NCT04718402|Analgesics|analgesics|mesh-ancestor
14184505|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
14184506|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184507|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184508|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184509|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14184510|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14184511|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184512|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767476|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14767477|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807149|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
14184526|NCT04718311|Tacrolimus|tacrolimus|mesh-list
14184527|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184528|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
14184529|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184530|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14184531|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184532|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184533|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
14479361|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479362|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
14479363|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479364|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14479365|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479366|NCT02469298|Oseltamivir|oseltamivir|mesh-list
14479367|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
14479368|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479369|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479370|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479371|NCT02469597|Furosemide|furosemide|mesh-list
14479372|NCT02469597|Diuretics|diuretics|mesh-ancestor
14938813|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14938814|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14938815|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
14938816|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14938817|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938818|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14938819|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14938820|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14938821|NCT01484691|Budesonide|budesonide|mesh-list
14938822|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938823|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14938824|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
14938825|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938826|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938827|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14938828|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
14938829|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
14938830|NCT01484691|Hormones|hormones|mesh-ancestor
14938831|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14938832|NCT01484717|Nicotine|nicotine|mesh-list
14938833|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14938834|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
14938835|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938836|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938837|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14938838|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14938839|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
14938840|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938841|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938842|NCT01484756|Micronutrients|micronutrients|mesh-list
14938843|NCT01484756|Trace Elements|trace elements|mesh-list
14938844|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938845|NCT01484964|Peficitinib|peficitinib|mesh-list
14938846|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938847|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938848|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184534|NCT04718376|Analgesics|analgesics|mesh-ancestor
14184535|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
14184536|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184537|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184538|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184539|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14184540|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14184541|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184542|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184543|NCT04718584|Antibodies|antibodies|mesh-list
14184544|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14184545|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
14184546|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184547|NCT04718649|Celecoxib|celecoxib|mesh-list
14184548|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14184549|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14184550|NCT04718649|Analgesics|analgesics|mesh-ancestor
14184551|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
14184552|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184553|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184554|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14184555|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184556|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14184557|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14184558|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184559|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236581|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14184560|NCT04718714|Midazolam|midazolam|mesh-list
14479373|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
14479374|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479375|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14479376|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479377|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479378|NCT02469610|Bupivacaine|bupivacaine|mesh-list
14479379|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
14479380|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
14479381|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938849|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
14767478|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14767479|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14767480|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14767481|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767482|NCT00630110|Docetaxel|docetaxel|mesh-list
14767483|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767484|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938850|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938851|NCT01484990|Levodopa|levodopa|mesh-list
14938852|NCT01484990|Carbidopa|carbidopa|mesh-list
14938853|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14938854|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14479382|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479383|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
14479384|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479385|NCT02469701|Nivolumab|nivolumab|mesh-list
14479386|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14479387|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479388|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14479389|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479390|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
14479391|NCT02469961|Propofol|propofol|mesh-list
14479392|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14479393|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479394|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479395|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14479396|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
14479397|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
14479398|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479399|NCT02469961|Analgesics|analgesics|mesh-ancestor
14479400|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
14479401|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479402|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14479403|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14479404|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14479405|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14479406|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479407|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479411|NCT02470234|Methylphenidate|methylphenidate|mesh-list
14479412|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14479413|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479414|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14479415|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14479416|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479417|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479418|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
14479419|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479420|NCT02470390|Fentanyl|fentanyl|mesh-list
14479421|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14767485|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938855|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14938856|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
14938857|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184561|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
14184562|NCT04718714|Propofol|propofol|mesh-list
14184563|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14184564|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184565|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184566|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14184567|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
14184568|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
14184569|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14184570|NCT04718714|Analgesics|analgesics|mesh-ancestor
14184571|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
14184572|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184573|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14184574|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14184575|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14184576|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
14184577|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184578|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184579|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14184580|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14184581|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14184582|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14184583|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
14184584|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
14184585|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
14184586|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14184587|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14184588|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184589|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184590|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14184591|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14184592|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14184593|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14184594|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184595|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767486|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14767487|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767488|NCT00630149|Pemetrexed|pemetrexed|mesh-list
14767489|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767490|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184596|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
14184597|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14184598|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
14184599|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14184600|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14184601|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184602|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14184603|NCT04718038|Cetuximab|cetuximab|mesh-list
14184604|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14184605|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184606|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
14184607|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
14184608|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14184609|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14184610|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184611|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184612|NCT04718233|Urological Agents|urological agents|mesh-ancestor
14184613|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14184614|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14184615|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184616|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184617|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
14184618|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184619|NCT04718259|Midazolam|midazolam|mesh-list
14184620|NCT04718259|Bupivacaine|bupivacaine|mesh-list
14184621|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
14184622|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
14184623|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184624|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184625|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
14184626|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184627|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14184628|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14184629|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14184630|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14184631|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14184632|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14184633|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
14184634|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
14767491|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767492|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15026616|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
14184635|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
14184636|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184637|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184638|NCT04717973|Vitamin D|vitamin d|mesh-list
14184639|NCT04717973|Vitamins|vitamins|mesh-list
14184640|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
14184641|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
14184642|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
14184643|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184644|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14184645|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
14184646|NCT04717973|Hematinics|hematinics|mesh-ancestor
14184647|NCT04717908|Linezolid|linezolid|mesh-list
14184648|NCT04717908|Cycloserine|cycloserine|mesh-list
14184649|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
14184650|NCT04717908|Bedaquiline|bedaquiline|mesh-list
14184651|NCT04717908|Clofazimine|clofazimine|mesh-list
14184652|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184653|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184654|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14184655|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184656|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184657|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14184658|NCT04717908|Renal Agents|renal agents|mesh-ancestor
14184659|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14184660|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
14184661|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
14184662|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14184663|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
14184664|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
14184665|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14184666|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184667|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14184668|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184669|NCT04718220|Antibodies|antibodies|mesh-list
14184670|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
14184671|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184672|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14184673|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14184674|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184675|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
14184676|NCT04717531|Docetaxel|docetaxel|mesh-list
14184677|NCT04717531|Trastuzumab|trastuzumab|mesh-list
14184678|NCT04717531|Epirubicin|epirubicin|mesh-list
14184679|NCT04717531|Pertuzumab|pertuzumab|mesh-list
14184680|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184681|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
14184682|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184683|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184684|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14184685|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
14184686|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184687|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184688|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14184689|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
14184690|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
14184691|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
14184692|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14184693|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14184694|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14184695|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14184696|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184697|NCT04717609|Ropivacaine|ropivacaine|mesh-list
14184698|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
14184699|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
14184700|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184701|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184702|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
14184703|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184704|NCT04717102|Desflurane|desflurane|mesh-list
14184705|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14184706|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
14184707|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
14184708|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184709|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184710|NCT04717089|Anesthetics|anesthetics|mesh-list
14184711|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184712|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184713|NCT04716894|Itraconazole|itraconazole|mesh-list
14184714|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
14184715|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184716|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14184717|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14184718|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184719|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184720|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14184721|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
14184722|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184723|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184724|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14184725|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14184726|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14184727|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184728|NCT04717193|Epinephrine|epinephrine|mesh-list
14184729|NCT04717193|Racepinephrine|racepinephrine|mesh-list
14184730|NCT04717193|Bupivacaine|bupivacaine|mesh-list
14184731|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
14184732|NCT04717193|Anesthetics|anesthetics|mesh-list
14184733|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
14184734|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184735|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184736|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
14184737|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938858|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938859|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938860|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14938861|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938862|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14938863|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
14938864|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
14938865|NCT01485003|Natalizumab|natalizumab|mesh-list
14184738|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14184739|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14184740|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
14184741|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184742|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184743|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14184744|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14184745|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
14184746|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14184747|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
14184748|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
14184749|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
14184750|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14184751|NCT04716569|Ivermectin|ivermectin|mesh-list
14184752|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14184753|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184754|NCT04716868|Levan|levan|mesh-list
14184755|NCT04716868|Psyllium|psyllium|mesh-list
14184756|NCT04716868|Cathartics|cathartics|mesh-ancestor
14184757|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14184758|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184759|NCT04716751|Paclitaxel|paclitaxel|mesh-list
14184760|NCT04716751|Carboplatin|carboplatin|mesh-list
14184761|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14184762|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184763|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
14184764|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
14184765|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
14184766|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184767|NCT04716686|Niraparib|niraparib|mesh-list
14184768|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14184769|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184770|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184771|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184772|NCT04716296|Ketamine|ketamine|mesh-list
14184773|NCT04716296|Analgesics|analgesics|mesh-ancestor
14184774|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
14184775|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938866|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
14184776|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184777|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14184778|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14184779|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
14184780|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
14184781|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184782|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14184783|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14184784|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184785|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236582|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14236583|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14236584|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236585|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236586|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
14236587|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236588|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14236589|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236590|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236591|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14236592|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14236593|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236594|NCT00116207|Niacinamide|niacinamide|mesh-list
14236595|NCT00116207|Allopurinol|allopurinol|mesh-list
14236596|NCT00116207|Antioxidants|antioxidants|mesh-list
14236597|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
14479422|NCT02470390|Narcotics|narcotics|mesh-ancestor
14479423|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479424|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479425|NCT02470390|Analgesics|analgesics|mesh-ancestor
14479426|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
14479427|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479428|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14479429|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14479430|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
14479431|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
14479432|NCT02470403|Licogliflozin|licogliflozin|mesh-list
14479433|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14479434|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479435|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14479436|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479437|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14479438|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
14479439|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14479440|NCT02470585|Paclitaxel|paclitaxel|mesh-list
14479441|NCT02470585|Carboplatin|carboplatin|mesh-list
14479442|NCT02470585|Veliparib|veliparib|mesh-list
14479443|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14479444|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479445|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14479446|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
14479447|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14479448|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479449|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14479450|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479451|NCT02470741|Letrozole|letrozole|mesh-list
14479452|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479453|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14479454|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14479455|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479456|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479457|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14479458|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
14479459|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479460|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479461|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14479462|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
14479463|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479464|NCT02471183|Selexipag|selexipag|mesh-list
14479465|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14479466|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
14479467|NCT02471404|Glimepiride|glimepiride|mesh-list
14479468|NCT02471404|Saxagliptin|saxagliptin|mesh-list
14479469|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14479470|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184786|NCT04716413|Dsuvia|dsuvia|mesh-list
14184787|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14184788|NCT04716413|Narcotics|narcotics|mesh-ancestor
14184789|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184790|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184791|NCT04716413|Analgesics|analgesics|mesh-ancestor
14184792|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
14184793|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184794|NCT04716426|Tetracycline|tetracycline|mesh-list
14184795|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184796|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184797|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14184798|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184799|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184800|NCT04716179|Hormones|hormones|mesh-list
14184801|NCT04716179|Testosterone|testosterone|mesh-list
14184802|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184803|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184804|NCT04716179|Androgens|androgens|mesh-ancestor
14184805|NCT04715763|Telmisartan|telmisartan|mesh-list
14184806|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14184807|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14184808|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14184809|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184810|NCT04715737|Vasopressins|vasopressins|mesh-list
14184811|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
14479471|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14479472|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479473|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14479474|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14479475|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
14938867|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938868|NCT01485068|Paclitaxel|paclitaxel|mesh-list
14479476|NCT02471404|Incretins|incretins|mesh-ancestor
14479477|NCT02471404|Hormones|hormones|mesh-ancestor
14479478|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479479|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14479480|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
14479481|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938869|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14938870|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479482|NCT02471521|Rocuronium|rocuronium|mesh-list
14479483|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14479484|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14479485|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14479486|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479487|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527138|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527139|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527140|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527141|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
14527142|NCT04066647|Hormones|hormones|mesh-ancestor
14527143|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527144|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14527145|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527146|NCT04066426|Acetaminophen|acetaminophen|mesh-list
14527147|NCT04066426|Dexamethasone|dexamethasone|mesh-list
14527148|NCT04066426|Naproxen|naproxen|mesh-list
14527149|NCT04066426|Codeine|codeine|mesh-list
14527150|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14527151|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
14527152|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
14527153|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527154|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527155|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527156|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
14527157|NCT04066426|Hormones|hormones|mesh-ancestor
14527158|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527159|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14527160|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527161|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14527162|NCT04066426|Analgesics|analgesics|mesh-ancestor
14527163|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
14527164|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
14529953|NCT03465735|Edoxaban|edoxaban|mesh-list
14184812|NCT04715737|Oxytocin|oxytocin|mesh-list
14184813|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
14184814|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14184815|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184816|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
14184817|NCT04715737|Coagulants|coagulants|mesh-ancestor
14184818|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14184819|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14184820|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
14184821|NCT04715633|Apatinib|apatinib|mesh-list
14184822|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14184823|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184824|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14184825|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184826|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184827|NCT04715620|Niraparib|niraparib|mesh-list
14184828|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14184829|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184830|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184831|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184832|NCT04715568|Losartan|losartan|mesh-list
14184833|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
14184834|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
14184835|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14184836|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14184837|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14184838|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184839|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14184840|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
14184841|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184842|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
14184843|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184844|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184845|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14184846|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
14184847|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184848|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184849|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14184850|NCT04715269|Alprazolam|alprazolam|mesh-list
14184851|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14184852|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184853|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184854|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14184855|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14184856|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14184857|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
14184858|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
14184859|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184860|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184861|NCT04715152|Dexamethasone|dexamethasone|mesh-list
14184862|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
14184863|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
14184864|NCT04715152|BB 1101|bb 1101|mesh-list
14184865|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14184866|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
14184867|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
14184868|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184869|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184870|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14184871|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
14184872|NCT04715152|Hormones|hormones|mesh-ancestor
14184873|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184874|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14184875|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184876|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
14184877|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184878|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184879|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
14184880|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
14184881|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184882|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
14184883|NCT04715360|Favipiravir|favipiravir|mesh-list
14184884|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
14184885|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938871|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938872|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938873|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
14938874|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938875|NCT01485081|Paclitaxel|paclitaxel|mesh-list
14938876|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14938877|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938878|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
14938879|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
14938880|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
14184886|NCT04715295|Azithromycin|azithromycin|mesh-list
14184887|NCT04715295|Doxycycline|doxycycline|mesh-list
14184888|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
14184889|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
14184890|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184891|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184892|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
14184893|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14184894|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14184895|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184896|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184897|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184898|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14184899|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
14184900|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14184901|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
14184902|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
14184903|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14184904|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14184905|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184906|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
14184907|NCT04715165|Bupivacaine|bupivacaine|mesh-list
14184908|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
14184909|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
14184910|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14184911|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184912|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
14184913|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184914|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14184915|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14184916|NCT04715165|Analgesics|analgesics|mesh-ancestor
14184917|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14184918|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14184919|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14184920|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
14184921|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14184922|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184923|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
14184924|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
14184925|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14184926|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14184927|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184928|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184929|NCT04715113|Urological Agents|urological agents|mesh-ancestor
14184930|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
14184931|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184932|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
14184933|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184934|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184935|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14184936|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
14938881|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184937|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184938|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184939|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14236598|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236599|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236600|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
14236601|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236602|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14236603|NCT00116207|Protective Agents|protective agents|mesh-ancestor
14184940|NCT04714554|Erythromycin|erythromycin|mesh-list
14184941|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
14184942|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14184943|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
14184944|NCT04714554|Relugolix|relugolix|mesh-list
14184945|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14184946|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184947|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14184948|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14184949|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184950|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184951|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
14184952|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
14184953|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184954|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184955|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
14184956|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14184957|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
14767493|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14767494|NCT00630175|Zolpidem|zolpidem|mesh-list
14767495|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14767496|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14767497|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767498|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184958|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184959|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184960|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14184961|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
14184962|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184963|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184964|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14184965|NCT04714242|Ranibizumab|ranibizumab|mesh-list
14184966|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14184967|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14184968|NCT04714242|Growth Substances|growth substances|mesh-ancestor
14184969|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184970|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14184971|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14184972|NCT04714229|Vaccines|vaccines|mesh-list
14184973|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
14184974|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184975|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
14184976|NCT04714515|Ivermectin|ivermectin|mesh-list
14184977|NCT04714515|Montelukast|montelukast|mesh-list
14184978|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
14184979|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14184980|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14184981|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14184982|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14184983|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14184984|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14184985|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14184986|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
14184987|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14184988|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
14184989|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14184990|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184991|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14184992|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14184993|NCT04714541|Ketamine|ketamine|mesh-list
14184994|NCT04714541|Analgesics|analgesics|mesh-ancestor
14184995|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
14184996|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14184997|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14184998|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14184999|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185000|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
14185001|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
14767499|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14767500|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
14767501|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
14767502|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767503|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767504|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
14767505|NCT00630214|Vitamin D|vitamin d|mesh-list
14767506|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
14185002|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185003|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14185004|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14185005|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185006|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185007|NCT04713969|Pantoprazole|pantoprazole|mesh-list
14185008|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14185009|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185010|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14185011|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185012|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185013|NCT04714073|Itraconazole|itraconazole|mesh-list
14185014|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
14185015|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185016|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14185017|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185018|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185019|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185020|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14185021|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
14185022|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479488|NCT02471651|Dexamethasone|dexamethasone|mesh-list
14479489|NCT02471651|Ranibizumab|ranibizumab|mesh-list
14479490|NCT02471651|Aflibercept|aflibercept|mesh-list
14479491|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479492|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14479493|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14479494|NCT02471651|Growth Substances|growth substances|mesh-ancestor
14479495|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479496|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
14479497|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479498|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
14479499|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
14479500|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479501|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479502|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
14479503|NCT02471651|Hormones|hormones|mesh-ancestor
14479504|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479505|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14479506|NCT02472145|Decitabine|decitabine|mesh-list
14479507|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14479508|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
14479509|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479510|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479511|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479512|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
14479513|NCT02472223|Povidone|povidone|mesh-list
14479514|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
14479515|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
14479516|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
14479517|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14767507|NCT00630214|Vitamins|vitamins|mesh-list
14767508|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
14767509|NCT00630214|Calcium|calcium|mesh-list
14767510|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
14767511|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767512|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14767513|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14767514|NCT00630214|Antacids|antacids|mesh-ancestor
14767515|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767516|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767517|NCT00630357|Levetiracetam|levetiracetam|mesh-list
14185023|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185024|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14185025|NCT04714112|Dexamethasone|dexamethasone|mesh-list
14185026|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
14185027|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14185028|NCT04714112|BB 1101|bb 1101|mesh-list
14185029|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185030|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
14185031|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
14185032|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185033|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185034|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185035|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
14185036|NCT04714112|Hormones|hormones|mesh-ancestor
14185037|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185038|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14185039|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185040|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
14185041|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185042|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185043|NCT04714099|Cyclosporine|cyclosporine|mesh-list
14185044|NCT04714099|Cyclosporins|cyclosporins|mesh-list
14185045|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185046|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185047|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185048|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
14185049|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185050|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
14185051|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185052|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
14185053|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185054|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14185055|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
14479518|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479519|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14479520|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14479521|NCT02472314|Bupivacaine|bupivacaine|mesh-list
14479522|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14479523|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
14479524|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479525|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479526|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
14479527|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479528|NCT02472353|Metformin|metformin|mesh-list
14479529|NCT02472353|Doxorubicin|doxorubicin|mesh-list
14479530|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14479531|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479532|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14479533|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479534|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14767518|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
14767519|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
14479535|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14479536|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479537|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479538|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14479539|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479540|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
14479541|NCT02472366|Hormones|hormones|mesh-ancestor
14479542|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479543|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479544|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
14479545|NCT02472522|Ropivacaine|ropivacaine|mesh-list
14479546|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
14479547|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14479548|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479549|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479550|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479551|NCT02472522|Analgesics|analgesics|mesh-ancestor
14479552|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
14479553|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479554|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14767520|NCT00630370|ATI 7505|ati 7505|mesh-list
14767521|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14185056|NCT04713956|Busulfan|busulfan|mesh-list
14185057|NCT04713956|Fludarabine|fludarabine|mesh-list
14185058|NCT04713956|Decitabine|decitabine|mesh-list
14185059|NCT04713956|Sargramostim|sargramostim|mesh-list
14185060|NCT04713956|Lenograstim|lenograstim|mesh-list
14185061|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185062|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
14185063|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185064|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185065|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14185066|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
14185067|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185068|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185069|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14185070|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14185071|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
14185072|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185073|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14185074|NCT04714177|Edaravone|edaravone|mesh-list
14185075|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14185076|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
14185077|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185078|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14185079|NCT04714177|Protective Agents|protective agents|mesh-ancestor
14185080|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185081|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14185082|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14185083|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14185084|NCT04713904|Estradiol|estradiol|mesh-list
14185085|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14185086|NCT04713904|Estrogens|estrogens|mesh-ancestor
14185087|NCT04713904|Hormones|hormones|mesh-ancestor
14185088|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185089|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185090|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14185091|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
14185092|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14185093|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14185094|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14185095|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14185096|NCT04713891|Atezolizumab|atezolizumab|mesh-list
14185097|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14185098|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185099|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
14185100|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185101|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14767522|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14767523|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
14185102|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185103|NCT04713787|Albendazole|albendazole|mesh-list
14185104|NCT04713787|Oxfendazole|oxfendazole|mesh-list
14185105|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
14185106|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14185107|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185108|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
14185109|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14185110|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14185111|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
14185112|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
14185113|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
14185114|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185115|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185116|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
14185117|NCT04713644|Propofol|propofol|mesh-list
14185118|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14185119|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185120|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185121|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185122|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
14185123|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
14185124|NCT04713488|Vaccines|vaccines|mesh-list
14185125|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
14767524|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185126|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185127|NCT04713735|Lactoferrin|lactoferrin|mesh-list
14185128|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185129|NCT04713761|Carboplatin|carboplatin|mesh-list
14185130|NCT04713761|Pemetrexed|pemetrexed|mesh-list
14185131|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185132|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185133|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185134|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14185135|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14185136|NCT04713631|Artesunate|artesunate|mesh-list
14185137|NCT04713631|Curcumin|curcumin|mesh-list
14185138|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14185139|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14185140|NCT04713631|Analgesics|analgesics|mesh-ancestor
14185141|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
14185142|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185143|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185144|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185145|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185146|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185147|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185148|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185149|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
14185150|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14185151|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14185152|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185153|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
14185154|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
14185155|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14185156|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
14185157|NCT04713254|Metoprolol|metoprolol|mesh-list
14185158|NCT04713254|Midazolam|midazolam|mesh-list
14185159|NCT04713254|Bupropion|bupropion|mesh-list
14185160|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14185161|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14185162|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185163|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185164|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14185165|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14185166|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185167|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185168|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
14185169|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
14185170|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
14185171|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
14185172|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185173|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185174|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14185175|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
14185176|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14185177|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14185178|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185179|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
14185180|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14185181|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185182|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185183|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14185184|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14185185|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
14185186|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
14185187|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185188|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14185189|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14185190|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14185191|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
14185192|NCT04713176|Remdesivir|remdesivir|mesh-list
14185193|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
14185194|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185195|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
14185196|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185197|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
14185198|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
14185199|NCT04713371|Ipilimumab|ipilimumab|mesh-list
14185200|NCT04713371|Sargramostim|sargramostim|mesh-list
14185201|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185202|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
14185203|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185204|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479555|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14185205|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14185206|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
14185207|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185208|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185209|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14185210|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14185211|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14185212|NCT04713410|Prednisolone|prednisolone|mesh-list
14185213|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185214|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
14185215|NCT04713410|Hormones|hormones|mesh-ancestor
14185216|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185217|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185218|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14185219|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185220|NCT04713189|Fentanyl|fentanyl|mesh-list
14185221|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14185222|NCT04713189|Narcotics|narcotics|mesh-ancestor
14185223|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185224|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185225|NCT04713189|Analgesics|analgesics|mesh-ancestor
14185226|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
14185227|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185228|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14185229|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185230|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
14185231|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
14185232|NCT04713163|Vaccines|vaccines|mesh-list
14185233|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
14185234|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185235|NCT04713332|Vitamin E|vitamin e|mesh-list
14185236|NCT04713332|Tocopherols|tocopherols|mesh-list
14185237|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
14185238|NCT04713332|Vitamins|vitamins|mesh-ancestor
14185239|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
14185240|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185241|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
14185242|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185243|NCT04713332|Protective Agents|protective agents|mesh-ancestor
14185244|NCT04712929|Fluconazole|fluconazole|mesh-list
14185245|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
14185246|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185247|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14185248|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185249|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185250|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185251|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14185252|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
14185253|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185254|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185255|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14185256|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14185257|NCT04712734|Iloperidone|iloperidone|mesh-list
14185258|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14185259|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14185260|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185261|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185262|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185263|NCT04712539|Oseltamivir|oseltamivir|mesh-list
14185264|NCT04712539|Baloxavir|baloxavir|mesh-list
14185265|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
14185266|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185267|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185268|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185269|NCT04712799|Xylometazoline|xylometazoline|mesh-list
14185270|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
14185271|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14185272|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14185273|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
14185274|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14185275|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
14185276|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185277|NCT04712435|Expectorants|expectorants|mesh-ancestor
14185278|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
14185279|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14185280|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
14185281|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185282|NCT04712435|Protective Agents|protective agents|mesh-ancestor
14185283|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185284|NCT04712435|Antidotes|antidotes|mesh-ancestor
14236604|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236605|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
14236606|NCT00116207|Vitamins|vitamins|mesh-ancestor
14236607|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
14236608|NCT00116272|Etanercept|etanercept|mesh-list
14236609|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14236610|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14236611|NCT00116272|Analgesics|analgesics|mesh-ancestor
14236612|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
14236613|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236614|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236615|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236616|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236617|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236618|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236619|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
14236620|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14236621|NCT00116649|Imiquimod|imiquimod|mesh-list
14236622|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14236623|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
14236624|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236625|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236626|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
14236627|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14236628|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14236629|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14236630|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14236631|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236632|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236633|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
14236634|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236635|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14236636|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14236637|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
14236638|NCT00116831|Glipizide|glipizide|mesh-list
14236639|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14236640|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236641|NCT00116844|Valacyclovir|valacyclovir|mesh-list
14236642|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
14236643|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236644|NCT00116857|Sertraline|sertraline|mesh-list
14236645|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236646|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236647|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14236648|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14236649|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14236650|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236651|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236652|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
14236653|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236654|NCT00117156|Rituximab|rituximab|mesh-list
14236655|NCT00117156|Fludarabine|fludarabine|mesh-list
14236656|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236657|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236658|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
14236659|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236660|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236661|NCT00117507|Deferasirox|deferasirox|mesh-list
14236662|NCT00117507|Chelating Agents|chelating agents|mesh-list
14236663|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14236664|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
14236665|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236666|NCT00117572|Docetaxel|docetaxel|mesh-list
14236667|NCT00117572|Fluorouracil|fluorouracil|mesh-list
14236668|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
14236669|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236670|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
14479556|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
14479557|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529954|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
14236671|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236672|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
14185285|NCT04712357|Ascorbic Acid|ascorbic acid|mesh-list
14185286|NCT04712357|Tenofovir|tenofovir|mesh-list
14185287|NCT04712357|Emtricitabine|emtricitabine|mesh-list
14185288|NCT04712357|Vitamins|vitamins|mesh-ancestor
14185289|NCT04712357|Micronutrients|micronutrients|mesh-ancestor
14185290|NCT04712357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185291|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
14185292|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185293|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14185294|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14185295|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185296|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185297|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14185298|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14185299|NCT04712357|Antioxidants|antioxidants|mesh-ancestor
14185300|NCT04712357|Protective Agents|protective agents|mesh-ancestor
14185301|NCT04712396|Itraconazole|itraconazole|mesh-list
14185302|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
14185303|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185304|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14185305|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185306|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185307|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185308|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14185309|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
14185310|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185311|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185312|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14185313|NCT04712266|Insulin|insulin|mesh-list
14185314|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14185315|NCT04712266|Glucagon|glucagon|mesh-list
14185316|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14185317|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185318|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185319|NCT04712266|Hormones|hormones|mesh-ancestor
14185320|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185321|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
14185322|NCT04712279|Ivermectin|ivermectin|mesh-list
14185323|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
14185324|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14185325|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14185326|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185327|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479558|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479559|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
14479560|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
14479561|NCT02472652|Aripiprazole|aripiprazole|mesh-list
14479562|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
14479563|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14479564|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14479565|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14479566|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479567|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479568|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
14479569|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
14479570|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479571|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479572|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14479573|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14479574|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
14479575|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14479576|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14479577|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14479578|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14479579|NCT02472756|Rituximab|rituximab|mesh-list
14479580|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14479581|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479582|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
14479583|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479584|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479585|NCT02472847|Dronabinol|dronabinol|mesh-list
14479586|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
14479587|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479588|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185328|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185329|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185330|NCT04711889|Urinastatin|urinastatin|mesh-list
14185331|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14767525|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767526|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767527|NCT00630383|Histamine|histamine|mesh-list
14767528|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
14767529|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
14767530|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767531|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767532|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807150|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14807151|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185332|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14185333|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
14185334|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185335|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185336|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
14185337|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14185338|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14185339|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807152|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807153|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14807154|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14807155|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807156|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807157|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14807158|NCT00820053|Epirubicin|epirubicin|mesh-list
14807159|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
14185340|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185341|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185342|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14185343|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14185344|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185345|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185346|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185347|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
14185348|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14185349|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
14185350|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14185351|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185352|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185353|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14185354|NCT04712058|Tenofovir|tenofovir|mesh-list
14185355|NCT04712058|Emtricitabine|emtricitabine|mesh-list
14185356|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14185357|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
14185358|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185359|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14185360|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14185361|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185362|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185363|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14185364|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14185365|NCT04711668|Lidocaine|lidocaine|mesh-list
14185366|NCT04711668|Ketamine|ketamine|mesh-list
14185367|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
14185368|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
14185369|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185370|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185371|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
14185372|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185373|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14185374|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14185375|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14185376|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185377|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185378|NCT04711668|Analgesics|analgesics|mesh-ancestor
14185379|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14185380|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185381|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
14807160|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14185382|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14185383|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14185384|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185385|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
14185386|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14185387|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
14185388|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185389|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
14185390|NCT04711642|Protective Agents|protective agents|mesh-ancestor
14185391|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14185392|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
14185393|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14185394|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14185395|NCT04711291|Tacrolimus|tacrolimus|mesh-list
14185396|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185397|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
14185398|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185399|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14185400|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185401|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185402|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
14185403|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14185404|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
14185405|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185406|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
14185407|NCT04711304|Protective Agents|protective agents|mesh-ancestor
14185408|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14185409|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
14185410|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185411|NCT04711265|Vaccines|vaccines|mesh-list
14185412|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
14185413|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185414|NCT04711434|Antibodies|antibodies|mesh-list
14185415|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
14185416|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185417|NCT04711213|Dexamethasone|dexamethasone|mesh-list
14185418|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
14185419|NCT04711213|BB 1101|bb 1101|mesh-list
14185420|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185421|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
14185422|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
14185423|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185424|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185425|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185426|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
14185427|NCT04711213|Hormones|hormones|mesh-ancestor
14185428|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185429|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14185430|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185431|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
14185432|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185433|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938882|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14938883|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14938884|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
14185434|NCT04711161|Paclitaxel|paclitaxel|mesh-list
14529955|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14529956|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14529957|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529958|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14529959|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
14529960|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14529961|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
14529962|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529963|NCT03457818|Denosumab|denosumab|mesh-list
14185435|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14185436|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185437|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
14185438|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
14185439|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
14185440|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185441|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14185442|NCT04711122|Cephalosporins|cephalosporins|mesh-list
14185443|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185444|NCT04711096|Bupivacaine|bupivacaine|mesh-list
14185445|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
14185446|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
14185447|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185448|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185449|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
14185450|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185451|NCT04710927|Fluorides|fluorides|mesh-list
14185452|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
14185453|NCT04710927|Protective Agents|protective agents|mesh-ancestor
14185454|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185455|NCT04711109|Denosumab|denosumab|mesh-list
14185456|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14185457|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185458|NCT04710914|Midazolam|midazolam|mesh-list
14185459|NCT04710914|Isoflurane|isoflurane|mesh-list
14185460|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14185461|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14185462|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185463|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185464|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14185465|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14185466|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185467|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185468|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
14185469|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
14185470|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
14185471|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
14185472|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185473|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185474|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14185475|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14185476|NCT04711044|Menthol|menthol|mesh-list
14185477|NCT04711044|Histamine|histamine|mesh-list
14185478|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
14185479|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
14185480|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
14185481|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
14185482|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185483|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185484|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185485|NCT04710719|Triamcinolone|triamcinolone|mesh-list
14185486|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14185487|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14185488|NCT04710719|Fluorouracil|fluorouracil|mesh-list
14185489|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14185490|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
14185491|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185492|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14185493|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185494|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185495|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
14185496|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185497|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185498|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
14185499|NCT04710719|Hormones|hormones|mesh-ancestor
14185500|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185501|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236673|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236674|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
14236675|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236676|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236677|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
14236678|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236679|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
14185502|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
14185503|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
14185504|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185505|NCT04710329|Protective Agents|protective agents|mesh-ancestor
14185506|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185507|NCT04710329|Vitamins|vitamins|mesh-ancestor
14185508|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
14185509|NCT04710498|Atezolizumab|atezolizumab|mesh-list
14185510|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185511|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14185512|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
14185513|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
14185514|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14185515|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14185516|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185517|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
14185518|NCT04710017|Coagulants|coagulants|mesh-ancestor
14185519|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14185520|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14185521|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14185522|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
14185523|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14185524|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185525|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14185526|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14185527|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14185528|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14185529|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185530|NCT04710160|Calcium|calcium|mesh-list
14185531|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14185532|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185533|NCT04709770|Simethicone|simethicone|mesh-list
14185534|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185535|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
14185536|NCT04709770|Emollients|emollients|mesh-ancestor
14185537|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
14185538|NCT04709731|Ponatinib|ponatinib|mesh-list
14185539|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185540|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14185541|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185542|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185543|NCT04709471|Nicotine|nicotine|mesh-list
14185544|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14185545|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
14185546|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185547|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185548|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14185549|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14185550|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
14185551|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185552|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185553|NCT04709744|Vitamin D|vitamin d|mesh-list
14185554|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
14185555|NCT04709744|Vitamins|vitamins|mesh-list
14185556|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
14185557|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185558|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14185559|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14185560|NCT04709380|Sorafenib|sorafenib|mesh-list
14185561|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185562|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14185563|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185564|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185565|NCT04709185|Dexamethasone|dexamethasone|mesh-list
14185566|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185567|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
14185568|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
14185569|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185570|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185571|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185572|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
14185573|NCT04709185|Hormones|hormones|mesh-ancestor
14236680|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236681|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14185574|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185575|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14185576|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185577|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
14185578|NCT04709172|Cefditoren|cefditoren|mesh-list
14185579|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14185580|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185581|NCT04709315|Choline|choline|mesh-list
14185582|NCT04709315|Rocuronium|rocuronium|mesh-list
14185583|NCT04709315|Succinylcholine|succinylcholine|mesh-list
14185584|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14185585|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14185586|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14185587|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185588|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185589|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
14185590|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14185591|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
14185592|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185593|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185594|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14185595|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
14185596|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14185597|NCT04709094|Bupropion|bupropion|mesh-list
14185598|NCT04709094|Warfarin|warfarin|mesh-list
14185599|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14185600|NCT04709094|Norethindrone|norethindrone|mesh-list
14185601|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
14185602|NCT04709094|Norinyl|norinyl|mesh-list
14185603|NCT04709094|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14185604|NCT04709094|Estradiol|estradiol|mesh-list
14185605|NCT04709094|Estrogens|estrogens|mesh-ancestor
14185606|NCT04709094|Hormones|hormones|mesh-ancestor
14185607|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185608|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185609|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14185610|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
14185611|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14185612|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14185613|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
14185614|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14185615|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
14185616|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185617|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14185618|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14185619|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185620|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185621|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
14479589|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479590|NCT02472847|Analgesics|analgesics|mesh-ancestor
14479591|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
14479592|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479593|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14479594|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14479595|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479596|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479597|NCT02472847|Hormones|hormones|mesh-ancestor
14479598|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479599|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
14479600|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14479601|NCT02472886|Ledipasvir|ledipasvir|mesh-list
14479602|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
14479603|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479604|NCT02472977|Nivolumab|nivolumab|mesh-list
14479605|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14479606|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479607|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14479608|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479609|NCT02473250|Fluoxetine|fluoxetine|mesh-list
14479610|NCT02473250|Citalopram|citalopram|mesh-list
14479611|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14479612|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14479613|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185622|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185623|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14185624|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185625|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185626|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14185627|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14185628|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14185629|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14185630|NCT04709094|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14479614|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479615|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479616|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
14479617|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479618|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14479619|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
14479620|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14479621|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14479622|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14479623|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479624|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
14479625|NCT02473367|Antacids|antacids|mesh-list
14479626|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14479627|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479628|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
14479629|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479630|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14479631|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14479632|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479633|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479634|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479635|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
14479636|NCT02473640|Esomeprazole|esomeprazole|mesh-list
14479637|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14479638|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479639|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14479640|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479641|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479642|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14479643|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479644|NCT02473783|Sertraline|sertraline|mesh-list
14479645|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
14479646|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14479647|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14479648|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14479649|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479650|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479651|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479652|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
14479653|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479654|NCT02473913|Silymarin|silymarin|mesh-list
14479655|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
14479656|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479657|NCT02473913|Protective Agents|protective agents|mesh-ancestor
14479658|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479659|NCT02474199|Acetaminophen|acetaminophen|mesh-list
14479660|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
14479661|NCT02474199|Promethazine|promethazine|mesh-list
14479662|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479663|NCT02474199|Analgesics|analgesics|mesh-ancestor
14479664|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
14479665|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479666|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479667|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
14479668|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14479669|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14479670|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479671|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
14479672|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
14479673|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
14479674|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
14479675|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479676|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14479677|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
14185631|NCT04709211|Bupivacaine|bupivacaine|mesh-list
14185632|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14185633|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
14185634|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185635|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185636|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
14185637|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185638|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14185639|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14185640|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
14185641|NCT04709081|Itraconazole|itraconazole|mesh-list
14185642|NCT04709081|Digoxin|digoxin|mesh-list
14185643|NCT04709081|Midazolam|midazolam|mesh-list
14185644|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14185645|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14185646|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185647|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185648|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14185649|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14185650|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185651|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185652|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
14185653|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
14185654|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
14185655|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
14185656|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185657|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185658|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
14185659|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185660|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14185661|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185662|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185663|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14185664|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14185665|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185666|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14185667|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14185668|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14185669|NCT04709081|Protective Agents|protective agents|mesh-ancestor
14185670|NCT04709276|Carboplatin|carboplatin|mesh-list
14185671|NCT04709276|Nivolumab|nivolumab|mesh-list
14185672|NCT04709276|Ipilimumab|ipilimumab|mesh-list
14185673|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185674|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14185675|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14185676|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185677|NCT04709029|Dexamethasone|dexamethasone|mesh-list
14185678|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
14185679|NCT04709029|BB 1101|bb 1101|mesh-list
14185680|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185681|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
14185682|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
14185683|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185684|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185685|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185686|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
14185687|NCT04709029|Hormones|hormones|mesh-ancestor
14185688|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185689|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14185690|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185691|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
14185692|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185693|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185694|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14185695|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14185696|NCT04708821|Dexamethasone|dexamethasone|mesh-list
14185697|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14185698|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185699|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
14185700|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
14185701|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185702|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185703|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14185704|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
14185705|NCT04708821|Hormones|hormones|mesh-ancestor
14185706|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14185707|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14185708|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185709|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14185710|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14185711|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14185712|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14185713|NCT04708821|Analgesics|analgesics|mesh-ancestor
14185714|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
14185715|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185716|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14185717|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14185718|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
14185719|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
14185720|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185721|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185722|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
14185723|NCT04708964|Analgesics|analgesics|mesh-ancestor
14185724|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
14185725|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185726|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185727|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14185728|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14185729|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14185730|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185731|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14185732|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185733|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236682|NCT00117598|Sirolimus|sirolimus|mesh-list
14236683|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14236684|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236685|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14236686|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236687|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
14236688|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236689|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
14236690|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236691|NCT00117637|Interferons|interferons|mesh-list
14236692|NCT00117637|Sorafenib|sorafenib|mesh-list
14236693|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236694|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
14236695|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236696|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236697|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236698|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236699|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14236700|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14236701|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14236702|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14236703|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236704|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236705|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
14236706|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236707|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14236708|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14236709|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
14236710|NCT00117715|Caffeine|caffeine|mesh-list
14236711|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14236712|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236713|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14236714|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236715|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236716|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14236717|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14185734|NCT04708496|Efavirenz|efavirenz|mesh-list
14185735|NCT04708496|Lumefantrine|lumefantrine|mesh-list
14185736|NCT04708496|Dolutegravir|dolutegravir|mesh-list
14185737|NCT04708496|Artemether|artemether|mesh-list
14185738|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14185739|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14185740|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14185741|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185742|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185743|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
14185744|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185745|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14185746|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14185747|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14185748|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14185749|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14185750|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14185751|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
14185752|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14185753|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14185754|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14185755|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14185756|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14185757|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14185758|NCT04708249|Inositol|inositol|mesh-list
14185759|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
14185760|NCT04708249|Vitamins|vitamins|mesh-ancestor
14185761|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
14185762|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185763|NCT04708353|Ascorbic Acid|ascorbic acid|mesh-list
14185764|NCT04708353|Pregabalin|pregabalin|mesh-list
14185765|NCT04708353|Vitamins|vitamins|mesh-ancestor
14185766|NCT04708353|Micronutrients|micronutrients|mesh-ancestor
14185767|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185768|NCT04708353|Analgesics|analgesics|mesh-ancestor
14185769|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
14185770|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185771|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
14185772|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14185773|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185774|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185775|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14185776|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14185777|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14185778|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185779|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14185780|NCT04708353|Antioxidants|antioxidants|mesh-ancestor
14185781|NCT04708353|Protective Agents|protective agents|mesh-ancestor
14185782|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
14185783|NCT04707950|Oxytocin|oxytocin|mesh-list
14185784|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
14185785|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14185786|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185787|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14185788|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14185789|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185790|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
14185791|NCT04707950|Coagulants|coagulants|mesh-ancestor
14185792|NCT04708106|Menthol|menthol|mesh-list
14185793|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
14185794|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14185795|NCT04708171|Anesthetics|anesthetics|mesh-list
14185796|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185797|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185798|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
14185799|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14185800|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
14185801|NCT04707742|Povidone|povidone|mesh-list
14185802|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
14185803|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
14185804|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14185805|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185806|NCT04707560|Heparin|heparin|mesh-list
14185807|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
14185808|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14185809|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14185810|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185811|NCT04707547|Nivolumab|nivolumab|mesh-list
14185812|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14185813|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185814|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14185815|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185816|NCT04707508|Metformin|metformin|mesh-list
14185817|NCT04707508|Valsartan|valsartan|mesh-list
14185818|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14185819|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185820|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14185821|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14185822|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14185823|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185824|NCT04707703|Isavuconazole|isavuconazole|mesh-list
14185825|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
14185826|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185827|NCT04707209|Sirolimus|sirolimus|mesh-list
14185828|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14185829|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185830|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14185831|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185832|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
14185833|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185834|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
14185835|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185836|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14185837|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185838|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
14185839|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14185840|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185841|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14185842|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479678|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
14479679|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479680|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479681|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14479682|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
14479683|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
14479684|NCT02474355|Osimertinib|osimertinib|mesh-list
14479685|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479686|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14479687|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479688|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479689|NCT02474407|Diazepam|diazepam|mesh-list
14479690|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14479691|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
14479692|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
14479693|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
14479694|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479695|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479696|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479697|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14479698|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479699|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14479700|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14479701|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14479702|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14479703|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14479704|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14479705|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
14479706|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
14479707|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
14479708|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
14479709|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479710|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479711|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
14479712|NCT02475070|Vildagliptin|vildagliptin|mesh-list
14479713|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14479714|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479715|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14479716|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479717|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14479718|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14479719|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185843|NCT04707118|Paclitaxel|paclitaxel|mesh-list
14185844|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14185845|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14185846|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185847|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
14185848|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
14185849|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
14185850|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185851|NCT04707027|Aflibercept|aflibercept|mesh-list
14185852|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14185853|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14185854|NCT04707027|Growth Substances|growth substances|mesh-ancestor
14185855|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185856|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
14185857|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185858|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
14185859|NCT04706936|Fludarabine|fludarabine|mesh-list
14185860|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185861|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
14185862|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185863|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185864|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14185865|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
14185866|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185867|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185868|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14185869|NCT04706806|Acetic Acid|acetic acid|mesh-list
14185870|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14185871|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185872|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
14185873|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14185874|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185875|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14185876|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185877|NCT04706910|Furosemide|furosemide|mesh-list
14185878|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14938885|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185879|NCT04706910|Diuretics|diuretics|mesh-ancestor
14185880|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
14185881|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185882|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14185883|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185884|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185885|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
14185886|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185887|NCT04706949|Carboplatin|carboplatin|mesh-list
14185888|NCT04706949|Pemetrexed|pemetrexed|mesh-list
14185889|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185890|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185891|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185892|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14185893|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14185894|NCT04706897|Lidocaine|lidocaine|mesh-list
14185895|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
14185896|NCT04706897|Ketamine|ketamine|mesh-list
14185897|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
14185898|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
14185899|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185900|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185901|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
14185902|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185903|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14185904|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14185905|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14185906|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185907|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185908|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14185909|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14185910|NCT04706897|Analgesics|analgesics|mesh-ancestor
14479720|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
14479721|NCT02475265|Estradiol|estradiol|mesh-list
14479722|NCT02475265|Estrogens|estrogens|mesh-ancestor
14185911|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14185912|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14185913|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14185914|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
14185915|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185916|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14185917|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185918|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
14185919|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14185920|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14236718|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
14236719|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236720|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
14236721|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
14236722|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14236723|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14236724|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
14236725|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236726|NCT00117962|Carboplatin|carboplatin|mesh-list
14236727|NCT00117962|Pemetrexed|pemetrexed|mesh-list
14236728|NCT00117962|Cetuximab|cetuximab|mesh-list
14236729|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236730|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236731|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236732|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14236733|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14236734|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236735|NCT00118040|Genistein|genistein|mesh-list
14236736|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14236737|NCT00118040|Protective Agents|protective agents|mesh-ancestor
14236738|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236739|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236740|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236741|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236742|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236743|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
14236744|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14236745|NCT00118040|Estrogens|estrogens|mesh-ancestor
14236746|NCT00118040|Hormones|hormones|mesh-ancestor
14236747|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14236748|NCT00118131|Docetaxel|docetaxel|mesh-list
14236749|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236750|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
14236751|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236752|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
14236753|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236754|NCT00118144|Bortezomib|bortezomib|mesh-list
14236755|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236756|NCT00118157|Tamoxifen|tamoxifen|mesh-list
14236757|NCT00118157|Lapatinib|lapatinib|mesh-list
14236758|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236759|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14236760|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
14236761|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14236762|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236763|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14236764|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236765|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14236766|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14236767|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14236768|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236769|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236770|NCT00118209|Prednisone|prednisone|mesh-list
14236771|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
14236772|NCT00118209|Rituximab|rituximab|mesh-list
14236773|NCT00118209|Doxorubicin|doxorubicin|mesh-list
14236774|NCT00118209|Etoposide|etoposide|mesh-list
14236775|NCT00118209|Vincristine|vincristine|mesh-list
14236776|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236777|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
14236778|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767533|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14236779|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236780|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14767534|NCT00630435|Estrogens|estrogens|mesh-ancestor
14185921|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
14185922|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14185923|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
14185924|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185925|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
14185926|NCT04706455|Protective Agents|protective agents|mesh-ancestor
14185927|NCT04706429|Trientine|trientine|mesh-list
14185928|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
14185929|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
14185930|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185931|NCT04706247|Anesthetics|anesthetics|mesh-list
14185932|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185933|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185934|NCT04706130|Artesunate|artesunate|mesh-list
14185935|NCT04706130|Primaquine|primaquine|mesh-list
14185936|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
14185937|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14185938|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14185939|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14185940|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14185941|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
14185942|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
14185943|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14185944|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
14185945|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
14185946|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
14185947|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14185948|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14185949|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14185950|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185951|NCT04706546|Urological Agents|urological agents|mesh-ancestor
14185952|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
14185953|NCT04706377|Vitamins|vitamins|mesh-ancestor
14185954|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
14185955|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185956|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
14767535|NCT00630435|Hormones|hormones|mesh-ancestor
14767536|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767537|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767538|NCT00630474|Xylometazoline|xylometazoline|mesh-list
14767539|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
14767540|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14767541|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
14767542|NCT00630500|Memantine|memantine|mesh-list
14185957|NCT04706091|Suvorexant|suvorexant|mesh-list
14185958|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14185959|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14185960|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185961|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185962|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14185963|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185964|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185965|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
14185966|NCT04705948|Ketamine|ketamine|mesh-list
14185967|NCT04705948|Analgesics|analgesics|mesh-ancestor
14185968|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
14185969|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14185970|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185971|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14185972|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14185973|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
14185974|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
14185975|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14185976|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14185977|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14185978|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14185979|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185980|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14185981|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
14185982|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14185983|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14185984|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14185985|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
14185986|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14236781|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
14185987|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14185988|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14185989|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14185990|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
14185991|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14185992|NCT04705987|Colchicine|colchicine|mesh-list
14185993|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
14185994|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14185995|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
14185996|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
14185997|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
14185998|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14185999|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186000|NCT04705909|Pitavastatin|pitavastatin|mesh-list
14186001|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14186002|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14186003|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14186004|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
14186005|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186006|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186007|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14186008|NCT04706026|Anesthetics|anesthetics|mesh-list
14186009|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186010|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186011|NCT04705727|Budesonide|budesonide|mesh-list
14186012|NCT04705727|Terbutaline|terbutaline|mesh-list
14186013|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
14186014|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14186015|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14186016|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14186017|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
14186018|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186019|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186020|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14479723|NCT02475265|Hormones|hormones|mesh-ancestor
14479724|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479725|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479726|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14479727|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
14479728|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14479729|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14479730|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14479731|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14479732|NCT02475369|Pancrelipase|pancrelipase|mesh-list
14479733|NCT02475369|Pancreatin|pancreatin|mesh-list
14479734|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479735|NCT02475564|Resveratrol|resveratrol|mesh-list
14479736|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
14479737|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479738|NCT02475564|Protective Agents|protective agents|mesh-ancestor
14479739|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479740|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479741|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14479742|NCT02475629|Ibalizumab|ibalizumab|mesh-list
14479743|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14479744|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479745|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
14479746|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479747|NCT02475733|Metronidazole|metronidazole|mesh-list
14479748|NCT02475733|Meropenem|meropenem|mesh-list
14479749|NCT02475733|Ceftazidime|ceftazidime|mesh-list
14479750|NCT02475733|Avibactam|avibactam|mesh-list
14479751|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14479752|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479753|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14479754|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14479755|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14479756|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14479757|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479758|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479759|NCT02475837|Vorapaxar|vorapaxar|mesh-list
14479760|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14479761|NCT02476175|Mirabegron|mirabegron|mesh-list
14479762|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14479763|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14186021|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
14186022|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
14186023|NCT04705727|Hormones|hormones|mesh-ancestor
14186024|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14186025|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14186026|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14186027|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14186028|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186029|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186030|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186031|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
14186032|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
14186033|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14186034|NCT04705584|Cyclosporine|cyclosporine|mesh-list
14186035|NCT04705584|Prednisolone|prednisolone|mesh-list
14186036|NCT04705584|Cyclosporins|cyclosporins|mesh-list
14186037|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186038|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186039|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14186040|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
14186041|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186042|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
14186043|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186044|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
14186045|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14186046|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14186047|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14186048|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
14186049|NCT04705584|Hormones|hormones|mesh-ancestor
14186050|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14186051|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14186052|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186053|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14186054|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186055|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186056|NCT04705337|Simendan|simendan|mesh-list
14186057|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14186058|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186059|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14186060|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14186061|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186062|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186063|NCT04705337|Protective Agents|protective agents|mesh-ancestor
14186064|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186065|NCT04705480|Pregabalin|pregabalin|mesh-list
14186066|NCT04705480|Gabapentin|gabapentin|mesh-list
14186067|NCT04705480|Analgesics|analgesics|mesh-ancestor
14186068|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
14186069|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186070|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186071|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
14186072|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14186073|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186074|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186075|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14186076|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14186077|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186078|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186079|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186080|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14186081|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14186082|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186083|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
14186084|NCT04705402|Mannitol|mannitol|mesh-list
14186085|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14186086|NCT04705402|Diuretics|diuretics|mesh-ancestor
14186087|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
14186088|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186089|NCT04705519|Paclitaxel|paclitaxel|mesh-list
14186090|NCT04705519|Bevacizumab|bevacizumab|mesh-list
14186091|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14186092|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186093|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
14186094|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
14186095|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
14186096|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186097|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186098|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14186099|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14186100|NCT04705519|Growth Substances|growth substances|mesh-ancestor
14186101|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186102|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
14186103|NCT04705428|Fluorides|fluorides|mesh-list
14186104|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
14186105|NCT04705428|Protective Agents|protective agents|mesh-ancestor
14186106|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186107|NCT04705415|Niclosamide|niclosamide|mesh-list
14186108|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
14186109|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14186110|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
14186111|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14186112|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186113|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
14186114|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
14186115|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186116|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14186117|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186118|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186119|NCT04704921|Ranibizumab|ranibizumab|mesh-list
14186120|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14186121|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14186122|NCT04704921|Growth Substances|growth substances|mesh-ancestor
14186123|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186124|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
14186125|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186126|NCT04704947|Alendronate|alendronate|mesh-list
14186127|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14186128|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
14186129|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14186130|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186131|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14186132|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186133|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186134|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236782|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236783|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236784|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14236785|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236786|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14186135|NCT04704622|Midazolam|midazolam|mesh-list
14186136|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
14186137|NCT04704622|Ketamine|ketamine|mesh-list
14186138|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14186139|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186140|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186141|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186142|NCT04704622|Analgesics|analgesics|mesh-ancestor
14186143|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
14186144|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186145|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14186146|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14186147|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14186148|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186149|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186150|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186151|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14186152|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14186153|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
14186154|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
14186155|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14186156|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14186157|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14186158|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14186159|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186160|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186161|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
14186162|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
14186163|NCT04704596|Anesthetics|anesthetics|mesh-list
14186164|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186165|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186166|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
14186167|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186168|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14186169|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14186170|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186171|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186172|NCT04704440|Urological Agents|urological agents|mesh-ancestor
14186173|NCT04704713|Afamelanotide|afamelanotide|mesh-list
14186174|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
14186175|NCT04704297|Acetaminophen|acetaminophen|mesh-list
14186176|NCT04704297|Ibuprofen|ibuprofen|mesh-list
14186177|NCT04704297|Ketorolac|ketorolac|mesh-list
14186178|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14186179|NCT04704297|Amitriptyline|amitriptyline|mesh-list
14186180|NCT04704297|Bupivacaine|bupivacaine|mesh-list
14186181|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
14186182|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
14186183|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
14186184|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186185|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186186|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
14186187|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186188|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186189|NCT04704297|Analgesics|analgesics|mesh-ancestor
14186190|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
14186191|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14186192|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14186193|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14186194|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14186195|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186196|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186197|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14186198|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
14186199|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186200|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14186201|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14186202|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186203|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14186204|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14186205|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186206|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186207|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186208|NCT04704453|Amitriptyline|amitriptyline|mesh-list
14479764|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14938886|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14938887|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938888|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14938889|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938890|NCT01485185|Gabapentin|gabapentin|mesh-list
14938891|NCT01485185|Donepezil|donepezil|mesh-list
14938892|NCT01485185|Analgesics|analgesics|mesh-ancestor
14938893|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
14938894|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938895|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938896|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
14938897|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14938898|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14938899|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938900|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14938901|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14938902|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14938903|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14938904|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938905|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
14938906|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14186209|NCT04704453|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14186210|NCT04704453|Capsaicin|capsaicin|mesh-list
14186211|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
14186212|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
14186213|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
14186214|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186215|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186216|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14186217|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
14186218|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186219|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186220|NCT04704453|Analgesics|analgesics|mesh-ancestor
14186221|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14186222|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14186223|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186224|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186225|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186226|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186227|NCT04704453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14186228|NCT04704453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186229|NCT04704453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186230|NCT04704245|Petrolatum|petrolatum|mesh-list
14186231|NCT04704245|Mitogens|mitogens|mesh-list
14186232|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
14186233|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186234|NCT04704245|Emollients|emollients|mesh-ancestor
14186235|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
14186236|NCT04704141|Hormones|hormones|mesh-list
14186237|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14186238|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186239|NCT04703868|Rabeprazole|rabeprazole|mesh-list
14186240|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14186241|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186242|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14186243|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186244|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186245|NCT04703803|Lidocaine|lidocaine|mesh-list
14186246|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
14186247|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
14186248|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186249|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938907|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186250|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
14186251|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186252|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14186253|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14186254|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14186255|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186256|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186257|NCT04704063|Vitamin E|vitamin e|mesh-list
14186258|NCT04704063|Tocopherols|tocopherols|mesh-list
14186259|NCT04704063|Tocotrienols|tocotrienols|mesh-list
14186260|NCT04704063|Tocovid|tocovid|mesh-list
14186261|NCT04704063|Vitamins|vitamins|mesh-ancestor
14186262|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
14186263|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186264|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
14186265|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186266|NCT04704063|Protective Agents|protective agents|mesh-ancestor
14186267|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
14186268|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186269|NCT04703465|Tenofovir|tenofovir|mesh-list
14186270|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
14186271|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186272|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14186273|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14186274|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186275|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186276|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14186277|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14186278|NCT04703608|Ivermectin|ivermectin|mesh-list
14186279|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14186280|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186281|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
14186282|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
14186283|NCT04703673|Ephedrine|ephedrine|mesh-list
14186284|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
14186285|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14186286|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
14186287|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14186288|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186289|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
14186290|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186291|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186292|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186293|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186294|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14186295|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14186296|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
14186297|NCT04703426|Sargramostim|sargramostim|mesh-list
14186298|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186299|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186300|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
14479765|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
14479766|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479767|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479768|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479769|NCT02476175|Urological Agents|urological agents|mesh-ancestor
14479770|NCT02476422|Ibuprofen|ibuprofen|mesh-list
14479771|NCT02476422|Diclofenac|diclofenac|mesh-list
14479772|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14186301|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186302|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
14186303|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186304|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186305|NCT04703257|Dipyrone|dipyrone|mesh-list
14186306|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14186307|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186308|NCT04703257|Analgesics|analgesics|mesh-ancestor
14186309|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
14186310|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186311|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186312|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14186313|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14186314|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
14186315|NCT04702906|Trimetazidine|trimetazidine|mesh-list
14186316|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186317|NCT04703127|Lidocaine|lidocaine|mesh-list
14186318|NCT04703127|Tadalafil|tadalafil|mesh-list
14186319|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
14186320|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
14186321|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186322|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186323|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
14186324|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186325|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14186326|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14186327|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14186328|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186329|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186330|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186331|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14186332|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14186333|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186334|NCT04703127|Urological Agents|urological agents|mesh-ancestor
14186335|NCT04702971|Flunarizine|flunarizine|mesh-list
14186336|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
14186337|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14186338|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186339|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186340|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14186341|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186342|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14186343|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
14186344|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
14186345|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186346|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186347|NCT04703088|Ondansetron|ondansetron|mesh-list
14186348|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
14186349|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
14186350|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186351|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186352|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186353|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
14186354|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
14186355|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14186356|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
14186357|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186358|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186359|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14186360|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186361|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186362|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186363|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14186364|NCT04702698|Peposertib|peposertib|mesh-list
14186365|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14186366|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186367|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186368|NCT04702685|Ropivacaine|ropivacaine|mesh-list
14186369|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
14186370|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
14186371|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186372|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186373|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
14186374|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767543|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14186375|NCT04702490|Empagliflozin|empagliflozin|mesh-list
14186376|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14186377|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186378|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14186379|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186380|NCT04702048|Aflibercept|aflibercept|mesh-list
14186381|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14186382|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14186383|NCT04702048|Growth Substances|growth substances|mesh-ancestor
14186384|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186385|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
14186386|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186387|NCT04702061|Anesthetics|anesthetics|mesh-list
14186388|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186389|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186390|NCT04702334|Lidocaine|lidocaine|mesh-list
14186391|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
14186392|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
14938908|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
14938909|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
14938910|NCT01485198|Acetaminophen|acetaminophen|mesh-list
14938911|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186393|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
14186394|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186395|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186396|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
14186397|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186398|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14186399|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14186400|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14186401|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186402|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186403|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14186404|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
14186405|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
14186406|NCT04702334|Protective Agents|protective agents|mesh-ancestor
14938912|NCT01485198|Analgesics|analgesics|mesh-ancestor
14186407|NCT04702360|Ivacaftor|ivacaftor|mesh-list
14186408|NCT04702360|Elexacaftor|elexacaftor|mesh-list
14186409|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14186410|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186411|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186412|NCT04702204|Denosumab|denosumab|mesh-list
14186413|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14186414|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186415|NCT04702009|Antibodies|antibodies|mesh-list
14186416|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14186417|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
14186418|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186419|NCT04701606|Artesunate|artesunate|mesh-list
14186420|NCT04701606|Pyronaridine|pyronaridine|mesh-list
14186421|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
14186422|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14186423|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14186424|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186425|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186426|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
14186427|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
14186428|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14186429|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
14186430|NCT04701710|Ivermectin|ivermectin|mesh-list
14186431|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14186432|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186433|NCT04701528|Tacrolimus|tacrolimus|mesh-list
14186434|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14186435|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
14186436|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186437|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14186438|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186439|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186440|NCT04701463|Calcium|calcium|mesh-list
14938913|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
14938914|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186441|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14186442|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938915|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186443|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14186444|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14186445|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186446|NCT04701307|Niraparib|niraparib|mesh-list
14186447|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
14186448|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
14186449|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
14186450|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186451|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14186452|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186453|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186454|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186455|NCT04701333|Cabergoline|cabergoline|mesh-list
14186456|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14186457|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14186458|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
14186459|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
14186460|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186461|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186462|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186463|NCT04701242|Ezetimibe|ezetimibe|mesh-list
14186464|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14186465|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14186466|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
14186467|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186468|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14186469|NCT04701320|Methamphetamine|methamphetamine|mesh-list
14186470|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14186471|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186472|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
14186473|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
14186474|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186475|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
14186476|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186477|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186478|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186479|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14186480|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14186481|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186482|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14186483|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
14186484|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14479773|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479774|NCT02476422|Analgesics|analgesics|mesh-ancestor
14479775|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
14479776|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479777|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479778|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479779|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14186485|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
14186486|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186487|NCT04701034|Prednisolone|prednisolone|mesh-list
14186488|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
14186489|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14186490|NCT04701034|Antibodies|antibodies|mesh-list
14186491|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
14186492|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14186493|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14186494|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
14186495|NCT04701034|Hormones|hormones|mesh-ancestor
14186496|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14186497|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186498|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14186499|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186500|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
14186501|NCT04701008|Ketamine|ketamine|mesh-list
14186502|NCT04701008|Analgesics|analgesics|mesh-ancestor
14186503|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
14186504|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186505|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186506|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14186507|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14186508|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
14186509|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
14186510|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186511|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14186512|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14186513|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186514|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186515|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
14186516|NCT04700826|Apixaban|apixaban|mesh-list
14186517|NCT04700826|Edoxaban|edoxaban|mesh-list
14186518|NCT04700826|Dabigatran|dabigatran|mesh-list
14186519|NCT04700826|Anticoagulants|anticoagulants|mesh-list
14186520|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14186521|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
14186522|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14186523|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
14186524|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186525|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186526|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
14186527|NCT04700670|Coagulants|coagulants|mesh-ancestor
14186528|NCT04700592|Ketamine|ketamine|mesh-list
14186529|NCT04700592|Gabapentin|gabapentin|mesh-list
14186530|NCT04700592|Analgesics|analgesics|mesh-ancestor
14186531|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
14186532|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186533|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186534|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14186535|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14186536|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
14186537|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
14186538|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186539|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14186540|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14186541|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186542|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186543|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
14186544|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14186545|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186546|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186547|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
14186548|NCT04700943|Anesthetics|anesthetics|mesh-list
14186549|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186550|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186551|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
14186552|NCT04700696|Narcotics|narcotics|mesh-ancestor
14186553|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186554|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186555|NCT04700696|Analgesics|analgesics|mesh-ancestor
14186556|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
14186557|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236787|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14236788|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14236789|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236790|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938916|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
14938917|NCT01485211|Riboflavin|riboflavin|mesh-list
14938918|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
14938919|NCT01485211|Vitamins|vitamins|mesh-ancestor
14938920|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
14938921|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938922|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14938923|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
14938924|NCT01485224|Thalidomide|thalidomide|mesh-list
14938925|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14186558|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
14186559|NCT04700709|Sirolimus|sirolimus|mesh-list
14186560|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14186561|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186562|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14186563|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
14186564|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14186565|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186566|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186567|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186568|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
14186569|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14186570|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
14186571|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186572|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
14186573|NCT04700761|Anesthetics|anesthetics|mesh-list
14186574|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186575|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186576|NCT04700761|Narcotics|narcotics|mesh-ancestor
14186577|NCT04700761|Analgesics|analgesics|mesh-ancestor
14186578|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
14186579|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186580|NCT04700839|Metformin|metformin|mesh-list
14186581|NCT04700839|Canagliflozin|canagliflozin|mesh-list
14186582|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14186583|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14186584|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186585|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186586|NCT04700475|Citric Acid|citric acid|mesh-list
14186587|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
14186588|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
14186589|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14186590|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
14186591|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
14186592|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186593|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14186594|NCT04700436|Ezetimibe|ezetimibe|mesh-list
14186595|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14186596|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14186597|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
14186598|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186599|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14186600|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14186601|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186602|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
14186603|NCT04700228|Bupivacaine|bupivacaine|mesh-list
14186604|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
14186605|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
14186606|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186607|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186608|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
14186609|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186610|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14186611|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186612|NCT04700228|Analgesics|analgesics|mesh-ancestor
14186613|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14186614|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14186615|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14186616|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186617|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186618|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186619|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
14938926|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
14186620|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186621|NCT04700046|Mexiletine|mexiletine|mesh-list
14938927|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938928|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
14186622|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14186623|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14186624|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14186625|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186626|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186627|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14186628|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14186629|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186630|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
14186631|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
14186632|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186633|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186634|NCT04699903|Antibodies|antibodies|mesh-list
14186635|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
14186636|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
14186637|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186638|NCT04699734|Lidocaine|lidocaine|mesh-list
14186639|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
14186640|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
14186641|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186642|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186643|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
14186644|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186645|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14186646|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14186647|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14186648|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186649|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186650|NCT04699721|Paclitaxel|paclitaxel|mesh-list
14186651|NCT04699721|Carboplatin|carboplatin|mesh-list
14186652|NCT04699721|Nivolumab|nivolumab|mesh-list
14186653|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14186654|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186655|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
14186656|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
14186657|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
14186658|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186659|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186660|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14186661|NCT04699591|Domperidone|domperidone|mesh-list
14186662|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
14186663|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
14186664|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186665|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186666|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186667|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14186668|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
14186669|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186670|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186671|NCT04699214|Endostar protein|endostar protein|mesh-list
14186672|NCT04699214|Endostatins|endostatins|mesh-list
14186673|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14186674|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14186675|NCT04699214|Growth Substances|growth substances|mesh-ancestor
14186676|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186677|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
14186678|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186679|NCT04698850|Ranibizumab|ranibizumab|mesh-list
14186680|NCT04698850|Aflibercept|aflibercept|mesh-list
14186681|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14186682|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14186683|NCT04698850|Growth Substances|growth substances|mesh-ancestor
14186684|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186685|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
14186686|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186687|NCT04698941|Paclitaxel|paclitaxel|mesh-list
14186688|NCT04698941|Simvastatin|simvastatin|mesh-list
14186689|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14186690|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186691|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
14186692|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
14186693|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
14479780|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14186694|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186695|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14186696|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14186697|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
14186698|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14186699|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14186700|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186701|NCT04699058|Antibodies|antibodies|mesh-list
14186702|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
14186703|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479781|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479782|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479783|NCT02476617|Ritonavir|ritonavir|mesh-list
14479784|NCT02476617|Ribavirin|ribavirin|mesh-list
14479785|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14479786|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14479787|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
14479788|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479789|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479790|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14479791|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479792|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
14479793|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479794|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14479795|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14479796|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
14479797|NCT02477215|Dexamethasone|dexamethasone|mesh-list
14479798|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14479799|NCT02477215|Ixazomib|ixazomib|mesh-list
14479800|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479801|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
14479802|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
14479803|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479804|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479805|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14479806|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
14479807|NCT02477215|Hormones|hormones|mesh-ancestor
14479808|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14479809|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14479810|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479811|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14479812|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
14479813|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479814|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
14479815|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479816|NCT02477332|Omalizumab|omalizumab|mesh-list
14479817|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14479818|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14479819|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
14479820|NCT02477423|Gentamicins|gentamicins|mesh-list
14479821|NCT02477423|Ampicillin|ampicillin|mesh-list
14479822|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14479823|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479824|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14479825|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479826|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479827|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14479828|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14479829|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479830|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
14479831|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479832|NCT02477839|Lacosamide|lacosamide|mesh-list
14479833|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
14479834|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14479835|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14479836|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14479837|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479838|NCT02478164|Ponatinib|ponatinib|mesh-list
14479839|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479840|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14479841|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479842|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479843|NCT02478372|Bupivacaine|bupivacaine|mesh-list
14479844|NCT02478372|Ropivacaine|ropivacaine|mesh-list
14186704|NCT04699110|Adenosine|adenosine|mesh-list
14186705|NCT04699110|Epinephrine|epinephrine|mesh-list
14186706|NCT04699110|Racepinephrine|racepinephrine|mesh-list
14186707|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
14186708|NCT04699110|Analgesics|analgesics|mesh-ancestor
14186709|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
14186710|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186711|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186712|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14186713|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
14479845|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
14479846|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
14479847|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
14479848|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479849|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479850|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
14767544|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14767545|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
14767546|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767547|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479851|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479852|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
14479853|NCT02478398|Loratadine|loratadine|mesh-list
14479854|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14479855|NCT02478398|Epinephrine|epinephrine|mesh-list
14479856|NCT02478398|Albuterol|albuterol|mesh-list
14479857|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14479858|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14479859|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
14479860|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479861|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479862|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479863|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14479864|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14479865|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
14479866|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479867|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14479868|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
14479869|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
14479870|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
14479871|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14479872|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
14479873|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14479874|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14479875|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479876|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
14479877|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14479878|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
14479879|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14479880|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14479881|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
14479882|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
14479883|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14479884|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479885|NCT02478398|Analgesics|analgesics|mesh-ancestor
14479886|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
14479887|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479888|NCT02478463|Cabotegravir|cabotegravir|mesh-list
14479889|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14479890|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14479891|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479892|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479893|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14479894|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479895|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
14479896|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479897|NCT02478489|Naltrexone|naltrexone|mesh-list
14479898|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14479899|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14479900|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479901|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
14479902|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767548|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479903|NCT02478580|Modafinil|modafinil|mesh-list
14479904|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14186714|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14479905|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186715|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
14186716|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
14186717|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186718|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186719|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14186720|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14186721|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186722|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14186723|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14186724|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
14186725|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14186726|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14186727|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
14186728|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
14186729|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14186730|NCT04699097|Azithromycin|azithromycin|mesh-list
14186731|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14186732|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186733|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14186734|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14186735|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14186736|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
14186737|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186738|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14186739|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14186740|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186741|NCT04698746|Anesthetics|anesthetics|mesh-list
14186742|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
14186743|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186744|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186745|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
14186746|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186747|NCT04698772|Ketamine|ketamine|mesh-list
14186748|NCT04698772|Morphine|morphine|mesh-list
14767549|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14767550|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14767551|NCT00630513|Ampicillin|ampicillin|mesh-list
14767552|NCT00630513|Ertapenem|ertapenem|mesh-list
14767553|NCT00630513|Sulbactam|sulbactam|mesh-list
14767554|NCT00630513|Sultamicillin|sultamicillin|mesh-list
14767555|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14767556|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767557|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14938929|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14938930|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938931|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14938932|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14938933|NCT01485224|Growth Substances|growth substances|mesh-ancestor
14938934|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
14938935|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14938936|NCT01485315|Mannitol|mannitol|mesh-list
14767558|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186749|NCT04698772|Analgesics|analgesics|mesh-ancestor
14186750|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
14186751|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186752|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186753|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14186754|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14186755|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
14186756|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
14186757|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186758|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14186759|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14186760|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186761|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186762|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14186763|NCT04698772|Narcotics|narcotics|mesh-ancestor
14186764|NCT04698512|Sirolimus|sirolimus|mesh-list
14186765|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14186766|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186767|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14186768|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186769|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
14186770|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14186771|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
14767559|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186772|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236791|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
14236792|NCT00118209|Hormones|hormones|mesh-ancestor
14236793|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14236794|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14236795|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14236796|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
14236797|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236798|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
14236799|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
14236800|NCT00118274|Vaccines|vaccines|mesh-list
14236801|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
14236802|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
14236803|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236804|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236805|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767560|NCT00630630|Levetiracetam|levetiracetam|mesh-list
14767561|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
14767562|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
14236806|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14236807|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
14236808|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236809|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236810|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14236811|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14236812|NCT00118287|Etanercept|etanercept|mesh-list
14236813|NCT00118287|Azacitidine|azacitidine|mesh-list
14236814|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236815|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
14236816|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767563|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
14767564|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
14767565|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236817|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236818|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236819|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14236820|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14236821|NCT00118287|Analgesics|analgesics|mesh-ancestor
14236822|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
14236823|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236824|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938937|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14938938|NCT01485315|Diuretics|diuretics|mesh-ancestor
14938939|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
14938940|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938941|NCT01485367|Adapalene|adapalene|mesh-list
14236825|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236826|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236827|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236828|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236829|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
14236830|NCT00118352|Cyclosporine|cyclosporine|mesh-list
14236831|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
14236832|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14236833|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
14236834|NCT00118352|Fludarabine|fludarabine|mesh-list
14236835|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
14236836|NCT00118352|Antibodies|antibodies|mesh-list
14236837|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
14236838|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14236839|NCT00118352|Cyclosporins|cyclosporins|mesh-list
14236840|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
14767566|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767567|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
14767568|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14938942|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14938943|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14938944|NCT01485367|Analgesics|analgesics|mesh-ancestor
14938945|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
14938946|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938947|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236841|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938948|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236842|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236843|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14767569|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767570|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14767571|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14767572|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186773|NCT04698226|Temazepam|temazepam|mesh-list
14186774|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14186775|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186776|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186777|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14186778|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186779|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186780|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
14186781|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
14186782|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186783|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186784|NCT04698213|Avelumab|avelumab|mesh-list
14186785|NCT04698213|Axitinib|axitinib|mesh-list
14186786|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186787|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186788|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14186789|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186790|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186791|NCT04698317|Mitogens|mitogens|mesh-list
14186792|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
14186793|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186794|NCT04697992|Vitamins|vitamins|mesh-list
14186795|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
14186796|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
14186797|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
14186798|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186799|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14186800|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14186801|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186802|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
14186803|NCT04697992|Coagulants|coagulants|mesh-ancestor
14186804|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
14186805|NCT04697992|Protective Agents|protective agents|mesh-ancestor
14186806|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
14186807|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
14186808|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14186809|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14186810|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186811|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186812|NCT04697862|Urological Agents|urological agents|mesh-ancestor
14186813|NCT04697602|Colchicine|colchicine|mesh-list
14186814|NCT04697602|Febuxostat|febuxostat|mesh-list
14186815|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
14186816|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14186817|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
14186818|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
14186819|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
14186820|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186821|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186822|NCT04697641|Amoxicillin|amoxicillin|mesh-list
14186823|NCT04697641|Clarithromycin|clarithromycin|mesh-list
14186824|NCT04697641|Pantoprazole|pantoprazole|mesh-list
14186825|NCT04697641|Z 338|z 338|mesh-list
14186826|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14186827|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186828|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14186829|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186830|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186831|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14186832|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14186833|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14186834|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186835|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14186836|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14186837|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
14186838|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186839|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186840|NCT04697732|Anesthetics|anesthetics|mesh-list
14186841|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186842|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186853|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
14186854|NCT04697537|Ropivacaine|ropivacaine|mesh-list
14186855|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
14186856|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186857|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186858|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14186859|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186860|NCT04697537|Analgesics|analgesics|mesh-ancestor
14186861|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
14186862|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186863|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14186864|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14186865|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14186866|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186867|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186868|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186869|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
14186870|NCT04697485|Eplerenone|eplerenone|mesh-list
14186871|NCT04697485|Bumetanide|bumetanide|mesh-list
14186872|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14186873|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
14186874|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14186875|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186876|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14186877|NCT04697485|Diuretics|diuretics|mesh-ancestor
14186878|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
14186879|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14186880|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14186881|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14186882|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186883|NCT04697745|Dexamethasone|dexamethasone|mesh-list
14186884|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
14186885|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14186886|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
14186887|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
14186888|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14186889|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186890|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186891|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
14186892|NCT04697745|Hormones|hormones|mesh-ancestor
14186893|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14186894|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14186895|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186896|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14186897|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186898|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14186899|NCT04697745|Analgesics|analgesics|mesh-ancestor
14186900|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
14186901|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14479906|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14479907|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14479908|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14479909|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479910|NCT02479412|Albuterol|albuterol|mesh-list
14479911|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14479912|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
14479913|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479914|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479915|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14479916|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
14479917|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
14479918|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14479919|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14479920|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14186902|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14186903|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14186904|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
14186905|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186906|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186907|NCT04697511|Midazolam|midazolam|mesh-list
14186908|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14186909|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14186910|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186911|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186912|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14186913|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14186914|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14186915|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14186916|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
14186917|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
14186918|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
14186919|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
14186920|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14186921|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186922|NCT04697355|Beta Carotene|beta carotene|mesh-list
14186923|NCT04697355|Naringenin|naringenin|mesh-list
14186924|NCT04697355|Carotenoids|carotenoids|mesh-list
14186925|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
14186926|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186927|NCT04697355|Protective Agents|protective agents|mesh-ancestor
14186928|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186929|NCT04697355|Provitamins|provitamins|mesh-ancestor
14186930|NCT04697355|Vitamins|vitamins|mesh-ancestor
14186931|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
14186932|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14186933|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186934|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14186935|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
14186936|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14186937|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14186938|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186939|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
14186940|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186941|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
14186942|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
14186943|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
14186944|NCT04696939|Carboplatin|carboplatin|mesh-list
14186945|NCT04696939|Etoposide|etoposide|mesh-list
14186946|NCT04696939|Atezolizumab|atezolizumab|mesh-list
14186947|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186948|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14186949|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14186950|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14186951|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186952|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186953|NCT04697186|Amoxicillin|amoxicillin|mesh-list
14186954|NCT04697186|Clarithromycin|clarithromycin|mesh-list
14186955|NCT04697186|Rabeprazole|rabeprazole|mesh-list
14186956|NCT04697186|Bismuth|bismuth|mesh-list
14186957|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14186958|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186959|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14186960|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186961|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186962|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14186963|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14186964|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14186965|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186966|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14186967|NCT04697186|Antacids|antacids|mesh-ancestor
14186968|NCT04696848|Durvalumab|durvalumab|mesh-list
14186969|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14186970|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14186971|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
14186972|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14186973|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
14186974|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186975|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
14186976|NCT04696666|Protective Agents|protective agents|mesh-ancestor
14186977|NCT04696783|Esomeprazole|esomeprazole|mesh-list
14186978|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14186979|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14186980|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14186981|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14186982|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186983|NCT04696523|Xenon|xenon|mesh-list
14186984|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14186985|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
14186986|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
14186987|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14186988|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14186989|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
14767573|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767574|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
14767575|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767576|NCT00630695|Lanreotide|lanreotide|mesh-list
14767577|NCT00630695|Somatostatin|somatostatin|mesh-list
14767578|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767579|NCT00630695|Hormones|hormones|mesh-ancestor
14767580|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767581|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767582|NCT00630708|Losartan|losartan|mesh-list
14186990|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14186991|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14186992|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14186993|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
14186994|NCT04696224|Coagulants|coagulants|mesh-ancestor
14236844|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
14236845|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236846|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236847|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236848|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
14236849|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236850|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
14236851|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236852|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14236853|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14236854|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14236855|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
14236856|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14236857|NCT00118365|Eflornithine|eflornithine|mesh-list
14236858|NCT00118365|Sulindac|sulindac|mesh-list
14236859|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236860|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14236861|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14236862|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14236863|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236864|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14236865|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236866|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236867|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14236868|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14236869|NCT00118365|Analgesics|analgesics|mesh-ancestor
14236870|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
14236871|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236872|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236873|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236874|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236875|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14236876|NCT00118378|Modafinil|modafinil|mesh-list
14236877|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14236878|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236879|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14236880|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14236881|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14236882|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236883|NCT00118404|Fluoxetine|fluoxetine|mesh-list
14186995|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
14186996|NCT04696536|Listerine|listerine|mesh-list
14186997|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14186998|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14186999|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
14187000|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14187001|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187002|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14187003|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187004|NCT04696042|Lanreotide|lanreotide|mesh-list
14187005|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767583|NCT00630708|Benazepril|benazepril|mesh-list
14767584|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14767585|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14767586|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14767587|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14767588|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767589|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14767590|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
14187015|NCT04695925|Carboplatin|carboplatin|mesh-list
14187016|NCT04695925|Pemetrexed|pemetrexed|mesh-list
14187017|NCT04695925|Osimertinib|osimertinib|mesh-list
14187018|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187019|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187020|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187021|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14187022|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14187023|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14187024|NCT04696120|Apixaban|apixaban|mesh-list
14187025|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14187026|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
14187027|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14187028|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
14187029|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187030|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187031|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
14187032|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
14187033|NCT04695613|Analgesics|analgesics|mesh-ancestor
14187034|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
14187035|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187036|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187037|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
14187038|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187039|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14187040|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
14187041|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14187042|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187043|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187044|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14187045|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
14187046|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14187047|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
14187048|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14187049|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14187050|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14187051|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187052|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187053|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
14187054|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187055|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187056|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14187057|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187058|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14187059|NCT04695483|Hormones|hormones|mesh-ancestor
14187060|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187061|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187062|NCT04695509|Propofol|propofol|mesh-list
14187063|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14187064|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187065|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187066|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14479921|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14187067|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
14187068|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
14187069|NCT04695769|Ribavirin|ribavirin|mesh-list
14187070|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
14187071|NCT04695769|Velpatasvir|velpatasvir|mesh-list
14187072|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14187073|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
14187074|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187075|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
14187076|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187077|NCT04695704|Montelukast|montelukast|mesh-list
14187078|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14187079|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14187080|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
14187081|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
14187082|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187083|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187084|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14187085|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14187086|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187087|NCT04695197|Artesunate|artesunate|mesh-list
14187088|NCT04695197|Lumefantrine|lumefantrine|mesh-list
14187089|NCT04695197|Artemether|artemether|mesh-list
14187090|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14187091|NCT04695197|Pyronaridine|pyronaridine|mesh-list
14187092|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
14187093|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14187094|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14187095|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187096|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187097|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
14187098|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
14187099|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14187100|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
14187101|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
14187102|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187103|NCT04694612|Remdesivir|remdesivir|mesh-list
14187104|NCT04694612|Favipiravir|favipiravir|mesh-list
14187105|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
14187106|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187107|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
14187108|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187109|NCT04694586|Rifampin|rifampin|mesh-list
14187110|NCT04694586|Isoniazid|isoniazid|mesh-list
14187111|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
14187112|NCT04694586|Ethambutol|ethambutol|mesh-list
14479922|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
14479923|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479924|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479925|NCT02479880|Tenofovir|tenofovir|mesh-list
14479926|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
14479927|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479928|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14479929|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14479930|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479931|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479932|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14479933|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14479934|NCT02480010|Pertuzumab|pertuzumab|mesh-list
14479935|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14479936|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14479937|NCT02480114|Acetaminophen|acetaminophen|mesh-list
14479938|NCT02480114|Ibuprofen|ibuprofen|mesh-list
14479939|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14479940|NCT02480114|Fentanyl|fentanyl|mesh-list
14479941|NCT02480114|Oxycodone|oxycodone|mesh-list
14479942|NCT02480114|Hydrocodone|hydrocodone|mesh-list
14479943|NCT02480114|Gabapentin|gabapentin|mesh-list
14479944|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14479945|NCT02480114|Narcotics|narcotics|mesh-ancestor
14187113|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14187114|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
14187115|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14479946|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479947|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479948|NCT02480114|Analgesics|analgesics|mesh-ancestor
14479949|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
14479950|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187116|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187117|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
14187118|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14187119|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187120|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187121|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14187122|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14187123|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14187124|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14187125|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14187126|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14187127|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14187128|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14187129|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
14187130|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14187131|NCT04694846|Bupropion|bupropion|mesh-list
14187132|NCT04694846|Nicotine|nicotine|mesh-list
14187133|NCT04694846|Varenicline|varenicline|mesh-list
14187134|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14187135|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
14187136|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187137|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187138|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14187139|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14187140|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
14187141|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187142|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187143|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14187144|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
14187145|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14187146|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14187147|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14187148|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187149|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
14187150|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14187151|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14187152|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187153|NCT04694677|Misoprostol|misoprostol|mesh-list
14187154|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
14187155|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14187156|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14187157|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187158|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
14187159|NCT04694677|Coagulants|coagulants|mesh-ancestor
14187160|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14187161|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
14187162|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14187163|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187164|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14187165|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14187166|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
14236884|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14236885|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14236886|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14236887|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236888|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236889|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
14938949|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236890|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236891|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14236892|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236893|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236894|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14236895|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14236896|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236897|NCT00118417|Clonazepam|clonazepam|mesh-list
14236898|NCT00118417|Sertraline|sertraline|mesh-list
14236899|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236900|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236901|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14236902|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14479951|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14187167|NCT04694183|Paclitaxel|paclitaxel|mesh-list
14187168|NCT04694183|Antibodies|antibodies|mesh-list
14187169|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
14187170|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14187171|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187172|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14187173|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14187174|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14187175|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187176|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
14187177|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187178|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
14187179|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187180|NCT04694092|Landiolol|landiolol|mesh-list
14187181|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14187182|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14187183|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
14187184|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187185|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187186|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187187|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14187188|NCT04694300|Acetaminophen|acetaminophen|mesh-list
14187189|NCT04694300|Naproxen|naproxen|mesh-list
14187190|NCT04694300|Tramadol|tramadol|mesh-list
14187191|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14187192|NCT04694300|Analgesics|analgesics|mesh-ancestor
14187193|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
14187194|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187195|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187196|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
14187197|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14187198|NCT04694300|Narcotics|narcotics|mesh-ancestor
14187199|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187200|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14187201|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187202|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187203|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
14187204|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14187205|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187206|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187207|NCT04694105|Dexamethasone|dexamethasone|mesh-list
14187208|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
14187209|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187210|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
14187211|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
14187212|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187213|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187214|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14187215|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
14187216|NCT04694105|Hormones|hormones|mesh-ancestor
14187217|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187218|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14187219|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187220|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14187221|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187222|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14187223|NCT04694105|Analgesics|analgesics|mesh-ancestor
14187224|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
14187225|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14187226|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14187227|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14187228|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
14187229|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187230|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187231|NCT04693910|Hormones|hormones|mesh-list
14187232|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187233|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187234|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
14187235|NCT04693897|Mirabegron|mirabegron|mesh-list
14187236|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14187237|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14187238|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
14187239|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187240|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187241|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187242|NCT04693897|Urological Agents|urological agents|mesh-ancestor
14187243|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14187244|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14187245|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14187246|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
14187247|NCT04693962|Mitogens|mitogens|mesh-list
14187248|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
14187249|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187250|NCT04693169|Choline|choline|mesh-list
14187251|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
14187252|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14187253|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
14187254|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187255|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14187256|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14187257|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
14187258|NCT04693156|Bupivacaine|bupivacaine|mesh-list
14187259|NCT04693156|Prilocaine|prilocaine|mesh-list
14187260|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
14187261|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
14187262|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187263|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187264|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
14187265|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187266|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
14187267|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14187268|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14187269|NCT04693312|Prednisolone|prednisolone|mesh-list
14187270|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
14187271|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14187272|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
14187273|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187274|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
14187275|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
14187276|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187277|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187278|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14187279|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
14187280|NCT04693312|Hormones|hormones|mesh-ancestor
14187281|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187282|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14187283|NCT04693312|Protective Agents|protective agents|mesh-ancestor
14187284|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14187285|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187286|NCT04693026|Remdesivir|remdesivir|mesh-list
14187287|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
14187288|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187289|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
14187290|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187294|NCT04692623|Insulin|insulin|mesh-list
14187295|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14187296|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
14187297|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
14187298|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14187299|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187300|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14187301|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187302|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14187303|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14187304|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187305|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187306|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236903|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14236904|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236905|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236906|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
14236907|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236908|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
14236909|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
14236910|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
14236911|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
14236912|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236913|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
14187307|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
14187308|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14187309|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
14187310|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187311|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
14187312|NCT04692558|Protective Agents|protective agents|mesh-ancestor
14187313|NCT04692844|Propranolol|propranolol|mesh-list
14187314|NCT04692844|Primidone|primidone|mesh-list
14187315|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14187316|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14187317|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
14187318|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187319|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187320|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187321|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14187322|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14187323|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
14187324|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
14187325|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
14187326|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
14187327|NCT04692896|Lidocaine|lidocaine|mesh-list
14187328|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
14187329|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
14187330|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187331|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187332|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
14187333|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187334|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14187335|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14187336|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14187337|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187338|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187339|NCT04692740|Chlorambucil|chlorambucil|mesh-list
14187340|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14187341|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
14187342|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187343|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187344|NCT04692285|Zolpidem|zolpidem|mesh-list
14187345|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14187346|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14187347|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187348|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187349|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14187350|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
14187351|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
14187352|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187353|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187354|NCT04692376|Cyclosporine|cyclosporine|mesh-list
14187355|NCT04692376|Cyclosporins|cyclosporins|mesh-list
14187356|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
14187357|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187358|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187359|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187360|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
14187361|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187362|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
14187363|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187364|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14187365|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187366|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14187367|NCT04692376|Hormones|hormones|mesh-ancestor
14187368|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187369|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
14187370|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14187371|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187372|NCT04692051|Gemcitabine|gemcitabine|mesh-list
14187373|NCT04692051|Paclitaxel|paclitaxel|mesh-list
14187374|NCT04692051|Cisplatin|cisplatin|mesh-list
14187375|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14187376|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187377|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
14187378|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
14187379|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
14187380|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187381|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14187382|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
14187383|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
14187384|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187385|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187386|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187387|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
14187388|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187389|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14187390|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187391|NCT04691687|Furosemide|furosemide|mesh-list
14479952|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14479953|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
14479954|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
14479955|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14479956|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
14479957|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14479958|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14479959|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479960|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14479961|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14938950|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
14938951|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14938952|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
14938953|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938954|NCT01485445|Fluticasone|fluticasone|mesh-list
14938955|NCT01485445|Xhance|xhance|mesh-list
14938956|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14938957|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14938958|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
14938959|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938960|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938961|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14938962|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
14938963|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
14187392|NCT04691687|Diuretics|diuretics|mesh-ancestor
14479962|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479963|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
14479964|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14479965|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14479966|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14479967|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14479968|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14479969|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14479970|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
14479971|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
14479972|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
14479973|NCT02480153|Adalimumab|adalimumab|mesh-list
14767591|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767592|NCT00630851|Donepezil|donepezil|mesh-list
14767593|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14767594|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767595|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767596|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
14767597|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767598|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767599|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
14767600|NCT00630890|Capecitabine|capecitabine|mesh-list
14767601|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14767602|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
14767603|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14938964|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14187393|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
14187394|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187395|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14187396|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187397|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187398|NCT04691726|Dipyrone|dipyrone|mesh-list
14187399|NCT04691726|Lidocaine|lidocaine|mesh-list
14187400|NCT04691726|Morphine|morphine|mesh-list
14187401|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
14187402|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
14187403|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187404|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187405|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
14479974|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187406|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187407|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14187408|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14187409|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14187410|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187411|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187412|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14187413|NCT04691726|Narcotics|narcotics|mesh-ancestor
14187414|NCT04691726|Analgesics|analgesics|mesh-ancestor
14187415|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14187416|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14187417|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187418|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187419|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
14187420|NCT04691817|Atezolizumab|atezolizumab|mesh-list
14479975|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14479976|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14479977|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
14479978|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14479979|NCT02480621|Bupivacaine|bupivacaine|mesh-list
14479980|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
14479981|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
14479982|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14479983|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14479984|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
14479985|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14479986|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
14479987|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14479988|NCT02480712|Velpatasvir|velpatasvir|mesh-list
14479989|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
14479990|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527165|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14527166|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527167|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
14527168|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14527169|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527170|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527171|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14527172|NCT04066426|Narcotics|narcotics|mesh-ancestor
14527173|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527174|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
14527175|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
14527176|NCT04060654|Buprenorphine|buprenorphine|mesh-list
14527177|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14527178|NCT04060654|Narcotics|narcotics|mesh-ancestor
14527179|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527180|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527181|NCT04060654|Analgesics|analgesics|mesh-ancestor
14527182|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
14527183|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527184|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14527185|NCT04058353|Ivacaftor|ivacaftor|mesh-list
14527186|NCT04058353|Elexacaftor|elexacaftor|mesh-list
14527187|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14527188|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14527189|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527190|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
14527191|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14527192|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527193|NCT04051684|Ropivacaine|ropivacaine|mesh-list
14527194|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527195|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
14527196|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527197|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527198|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
14527199|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527200|NCT04045964|Nicotine|nicotine|mesh-list
14527201|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14527202|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
14527203|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527204|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527205|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14527206|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14767604|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527207|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
14187421|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187422|NCT04691934|Anesthetics|anesthetics|mesh-list
14187423|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187424|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187425|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
14187426|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14187427|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14187428|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187429|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
14187430|NCT04691362|Coagulants|coagulants|mesh-ancestor
14187431|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14187432|NCT04690920|Remdesivir|remdesivir|mesh-list
14187433|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187434|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187435|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
14187436|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
14187437|NCT04691076|Fentanyl|fentanyl|mesh-list
14187438|NCT04691076|Propofol|propofol|mesh-list
14187439|NCT04691076|Esketamine|esketamine|mesh-list
14938965|NCT01485562|Misoprostol|misoprostol|mesh-list
14938966|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14938967|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
14938968|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14187440|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14187441|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187442|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187443|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14187444|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
14187445|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
14187446|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14187447|NCT04691076|Narcotics|narcotics|mesh-ancestor
14187448|NCT04691076|Analgesics|analgesics|mesh-ancestor
14187449|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
14187450|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187451|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14187452|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
14187453|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14187454|NCT04691063|Carboplatin|carboplatin|mesh-list
14187455|NCT04691063|Etoposide|etoposide|mesh-list
14187456|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
14187457|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187458|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14187459|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14187460|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14187461|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187462|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187463|NCT04690608|Triamcinolone|triamcinolone|mesh-list
14187464|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14187465|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14187466|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14187467|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187468|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
14187469|NCT04690608|Hormones|hormones|mesh-ancestor
14187470|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187471|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187472|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187473|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
14187474|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187475|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187476|NCT04690647|Dexamethasone|dexamethasone|mesh-list
14187477|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
14187478|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187479|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
14187480|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
14187481|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187482|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187483|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14187484|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
14187485|NCT04690647|Hormones|hormones|mesh-ancestor
14187486|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187487|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14187488|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187489|NCT04690647|Analgesics|analgesics|mesh-ancestor
14187490|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
14236914|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236915|NCT00118716|Fluticasone|fluticasone|mesh-list
14236916|NCT00118716|Xhance|xhance|mesh-list
14187491|NCT04690751|Cenobamate|cenobamate|mesh-list
14187492|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
14187493|NCT04690556|Ranibizumab|ranibizumab|mesh-list
14187494|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14187495|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14187496|NCT04690556|Growth Substances|growth substances|mesh-ancestor
14187497|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187498|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
14187499|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187500|NCT04690270|Sumatriptan|sumatriptan|mesh-list
14187501|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14187502|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14187503|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14187504|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
14187505|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187506|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187507|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187508|NCT04689958|Vitamin D|vitamin d|mesh-list
14187509|NCT04689958|Vitamins|vitamins|mesh-ancestor
14187510|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
14187511|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187512|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14187513|NCT04689971|Vitamins|vitamins|mesh-list
14187514|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
14187515|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
14187516|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187517|NCT04690309|Insulin|insulin|mesh-list
14187518|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14187519|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14187520|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187521|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
14187522|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187523|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14187524|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
14187525|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
14187526|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187527|NCT04689412|Resveratrol|resveratrol|mesh-list
14187528|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
14187529|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187530|NCT04689412|Protective Agents|protective agents|mesh-ancestor
14187531|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187532|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187533|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14187534|NCT04689191|Vaccines|vaccines|mesh-list
14767605|NCT00630903|Methoxsalen|methoxsalen|mesh-list
14938969|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938970|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14938971|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14938972|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
14938973|NCT01485653|Mepivacaine|mepivacaine|mesh-list
14938974|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
14938975|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
14938976|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187535|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
14187536|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187537|NCT04689100|Leucovorin|leucovorin|mesh-list
14187538|NCT04689100|Fluorouracil|fluorouracil|mesh-list
14187539|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
14187540|NCT04689100|Irinotecan|irinotecan|mesh-list
14187541|NCT04689100|Calcium|calcium|mesh-list
14187542|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
14187543|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14187544|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187545|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
14187546|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767606|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14767607|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14767608|NCT00630929|Ibuprofen|ibuprofen|mesh-list
14767609|NCT00630929|Celecoxib|celecoxib|mesh-list
14767610|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14767611|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14767612|NCT00630929|Analgesics|analgesics|mesh-ancestor
14767613|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
14767614|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767615|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767616|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767617|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187547|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14187548|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187549|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187550|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
14187551|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14187552|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14187553|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187554|NCT04689100|Antidotes|antidotes|mesh-ancestor
14187555|NCT04689100|Protective Agents|protective agents|mesh-ancestor
14187556|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
14187557|NCT04689100|Vitamins|vitamins|mesh-ancestor
14187558|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
14187559|NCT04689165|Vaccines|vaccines|mesh-list
14187560|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
14187561|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187562|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
14187563|NCT04688983|Blinatumomab|blinatumomab|mesh-list
14187564|NCT04688983|Ponatinib|ponatinib|mesh-list
14187565|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187566|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14187567|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187568|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187569|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
14187570|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
14187571|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
14187572|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14187573|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14187574|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
14187575|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
14187576|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187577|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187578|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187579|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14187580|NCT04688723|Dabigatran|dabigatran|mesh-list
14187581|NCT04688723|Clopidogrel|clopidogrel|mesh-list
14187582|NCT04688723|Ticagrelor|ticagrelor|mesh-list
14187583|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14187584|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14187585|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14187586|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14187587|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
14187588|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187589|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187590|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187591|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
14187592|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14187593|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
14187594|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187595|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
14236917|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14236918|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236919|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14236920|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
14236921|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236922|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236923|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14236924|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
14236925|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
14236926|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14236927|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14236928|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14236929|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14236930|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
14236931|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236932|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236933|NCT00118742|Cyclosporine|cyclosporine|mesh-list
14236934|NCT00118742|Sirolimus|sirolimus|mesh-list
14236935|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
14236936|NCT00118742|Tacrolimus|tacrolimus|mesh-list
14236937|NCT00118742|Cyclosporins|cyclosporins|mesh-list
14236938|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14479991|NCT02480764|Valsartan|valsartan|mesh-list
14236939|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
14236940|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236941|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14236942|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14479992|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14187596|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14187597|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
14187598|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14187599|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14187600|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767618|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14187601|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14187602|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14187603|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187604|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187605|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187606|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14479993|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14479994|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14479995|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14479996|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14479997|NCT02480998|Vaccines|vaccines|mesh-list
14479998|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
14479999|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480000|NCT02481219|Erythromycin|erythromycin|mesh-list
14480001|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
14480002|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14480003|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
14480004|NCT02481219|Metoclopramide|metoclopramide|mesh-list
14480005|NCT02481219|Bisacodyl|bisacodyl|mesh-list
14480006|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14480007|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
14480008|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
14480009|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480010|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480011|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14480012|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14480013|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14480014|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
14480015|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480016|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480017|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14480018|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480019|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14480020|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480021|NCT02481219|Cathartics|cathartics|mesh-ancestor
14480022|NCT02481219|Laxatives|laxatives|mesh-ancestor
14480023|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
14480024|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
14480025|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480026|NCT02481297|Rituximab|rituximab|mesh-list
14480027|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480028|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480029|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
14480030|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480031|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14480032|NCT02481375|Iron|iron|mesh-list
14480033|NCT02481375|Trace Elements|trace elements|mesh-list
14480034|NCT02481375|Micronutrients|micronutrients|mesh-list
14480035|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480036|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
14480037|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
14480038|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
14480039|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480040|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480041|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
14480042|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480043|NCT02481934|Lenalidomide|lenalidomide|mesh-list
14480044|NCT02481934|Bortezomib|bortezomib|mesh-list
14480045|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
14480046|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480047|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14480048|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14480049|NCT02481934|Growth Substances|growth substances|mesh-ancestor
14480050|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
14480051|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480052|NCT02481947|Laxatives|laxatives|mesh-list
14187607|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
14187608|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14187609|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187610|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14187611|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14187612|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14187613|NCT04688346|Epinephrine|epinephrine|mesh-list
14187614|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14187615|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14187616|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
14187617|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187618|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187619|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187620|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14187621|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14187622|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
14187623|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187624|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14187625|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
14187626|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
14187627|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
14187628|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14187629|NCT04688021|Cytarabine|cytarabine|mesh-list
14187630|NCT04688021|Cyclosporine|cyclosporine|mesh-list
14187631|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
14187632|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
14187633|NCT04688021|Busulfan|busulfan|mesh-list
14187634|NCT04688021|Cyclosporins|cyclosporins|mesh-list
14187635|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14187636|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
14187637|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187638|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
14187639|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187640|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187641|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14187642|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
14187643|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187644|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187645|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14187646|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14187647|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
14187648|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
14187649|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187650|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187651|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
14187652|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
14187653|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14187654|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14187655|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14187656|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
14187657|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14187658|NCT04688151|Rituximab|rituximab|mesh-list
14187659|NCT04688151|Durvalumab|durvalumab|mesh-list
14187660|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
14187661|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14187662|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187663|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
14187664|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187665|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187666|NCT04687878|Insulin|insulin|mesh-list
14187667|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14187668|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14187669|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767619|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767620|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767621|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14767622|NCT00630942|Minocycline|minocycline|mesh-list
14767623|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14480053|NCT02481947|Lubiprostone|lubiprostone|mesh-list
14480054|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14480055|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14480056|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480057|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14480058|NCT02482129|Dexamethasone|dexamethasone|mesh-list
14480059|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14480060|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14480061|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480062|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
14480063|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
14938977|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938978|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
14938979|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14938980|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
14938981|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
14480064|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480065|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480066|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14480067|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
14480068|NCT02482129|Hormones|hormones|mesh-ancestor
14480069|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480070|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14480071|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480072|NCT02482298|Ticagrelor|ticagrelor|mesh-list
14480073|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14480074|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14480075|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14480076|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14480077|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
14480078|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480079|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480080|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480081|NCT02482428|Imiquimod|imiquimod|mesh-list
14480082|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14480083|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
14480084|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480085|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480086|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
14480087|NCT02482675|Caseins|caseins|mesh-list
14480088|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
14480089|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
14480090|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480091|NCT02483000|Biotin|biotin|mesh-list
14480092|NCT02483000|Cytarabine|cytarabine|mesh-list
14480093|NCT02483000|Etoposide|etoposide|mesh-list
14480094|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
14480095|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
14480096|NCT02483000|Melphalan|melphalan|mesh-list
14480097|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
14480098|NCT02483000|Carmustine|carmustine|mesh-list
14480099|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14480100|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14480101|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14480102|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480103|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14480104|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14480105|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480106|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480107|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14480108|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
14480109|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
14480110|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480111|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14480112|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
14767624|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767625|NCT00630968|Levetiracetam|levetiracetam|mesh-list
14767626|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
14767627|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
14767628|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14767629|NCT00630981|Citalopram|citalopram|mesh-list
14767630|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14767631|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14938982|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187683|NCT04687566|Memantine|memantine|mesh-list
14187684|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
14187685|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14187686|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14187687|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
14187688|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187689|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187690|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187691|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14187692|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14187693|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
14187694|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
14187695|NCT04687631|Bevacizumab|bevacizumab|mesh-list
14187696|NCT04687631|Cetuximab|cetuximab|mesh-list
14187697|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14187698|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187699|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14187700|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14187701|NCT04687631|Growth Substances|growth substances|mesh-ancestor
14187702|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187703|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
14187704|NCT04687761|Cytarabine|cytarabine|mesh-list
14187705|NCT04687761|Azacitidine|azacitidine|mesh-list
14187706|NCT04687761|Venetoclax|venetoclax|mesh-list
14187707|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14187708|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
14187709|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187710|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187711|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
14187712|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187713|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187714|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
14187715|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187716|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187717|NCT04687514|Dulaglutide|dulaglutide|mesh-list
14187718|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14187719|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187720|NCT04687332|Tryptophan|tryptophan|mesh-list
14187721|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14187722|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
14187723|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14187724|NCT04687449|Curcumin|curcumin|mesh-list
14187725|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14187726|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14187727|NCT04687449|Analgesics|analgesics|mesh-ancestor
14187728|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
14187729|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187730|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187731|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187732|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187733|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187734|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187735|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187736|NCT04687111|Valsartan|valsartan|mesh-list
14187737|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14187738|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14187739|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14187740|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14187741|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187742|NCT04686890|Acetaminophen|acetaminophen|mesh-list
14187743|NCT04686890|Tramadol|tramadol|mesh-list
14187744|NCT04686890|Analgesics|analgesics|mesh-list
14187745|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14187746|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
14187747|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187748|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187749|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
14187750|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14187751|NCT04686890|Narcotics|narcotics|mesh-ancestor
14187752|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187753|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
14187754|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187755|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
14187756|NCT04687163|Fluorouracil|fluorouracil|mesh-list
14187757|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187758|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
14187759|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187760|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14187761|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187762|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
14187763|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187764|NCT04686929|Abatacept|abatacept|mesh-list
14187765|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14187766|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187767|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187768|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14187769|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
14187770|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187771|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187772|NCT04687098|Idarubicin|idarubicin|mesh-list
14187773|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14187774|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187775|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14187776|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14187777|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187778|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236943|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236944|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
14236945|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236946|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
14236947|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236948|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14236949|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236950|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14236951|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
14236952|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14236953|NCT00118755|Bevacizumab|bevacizumab|mesh-list
14236954|NCT00118755|Capecitabine|capecitabine|mesh-list
14236955|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
14236956|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236957|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236958|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14236959|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14236960|NCT00118755|Growth Substances|growth substances|mesh-ancestor
14236961|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236962|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236963|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236964|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
14236965|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236966|NCT00118898|Ritonavir|ritonavir|mesh-list
14236967|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14236968|NCT00118898|Tenofovir|tenofovir|mesh-list
14236969|NCT00118898|Lamivudine|lamivudine|mesh-list
14236970|NCT00118898|Emtricitabine|emtricitabine|mesh-list
14236971|NCT00118898|Abacavir|abacavir|mesh-list
14236972|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14236973|NCT00118898|Efavirenz|efavirenz|mesh-list
14236974|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
14236975|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14236976|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14236977|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
14236978|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236979|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236980|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14236981|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14236982|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
14236983|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236984|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14236985|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14236986|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14236987|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14236988|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14236989|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14236990|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14236991|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14767632|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187779|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
14187780|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
14187781|NCT04686448|Fentanyl|fentanyl|mesh-list
14187782|NCT04686448|Ketamine|ketamine|mesh-list
14187783|NCT04686448|Propofol|propofol|mesh-list
14187784|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14187785|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187786|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187787|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14187788|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
14187789|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
14187790|NCT04686448|Analgesics|analgesics|mesh-ancestor
14187791|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
14187792|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187793|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14187794|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14187795|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14187796|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187797|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187798|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14187799|NCT04686448|Narcotics|narcotics|mesh-ancestor
14187800|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14187801|NCT04686825|DA-8010|da-8010|mesh-list
14187802|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14187803|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14187804|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
14187805|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187806|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187807|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187808|NCT04686643|Niacin|niacin|mesh-list
14187809|NCT04686643|Amlodipine|amlodipine|mesh-list
14187810|NCT04686643|Valsartan|valsartan|mesh-list
14187811|NCT04686643|Indapamide|indapamide|mesh-list
14187812|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14187813|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14187814|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14187815|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187816|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14187817|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187818|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
14187819|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14187820|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14187821|NCT04686643|Diuretics|diuretics|mesh-ancestor
14187822|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
14187823|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14187824|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14187825|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
14187826|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14187827|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
14187828|NCT04686643|Vitamins|vitamins|mesh-ancestor
14187829|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
14187830|NCT04685980|Morphine|morphine|mesh-list
14187831|NCT04685980|Anesthetics|anesthetics|mesh-list
14187832|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
14187833|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187834|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187835|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14187836|NCT04685980|Narcotics|narcotics|mesh-ancestor
14187837|NCT04685980|Analgesics|analgesics|mesh-ancestor
14187838|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
14187839|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187840|NCT04686058|Midazolam|midazolam|mesh-list
14187841|NCT04686058|Meperidine|meperidine|mesh-list
14187842|NCT04686058|Propofol|propofol|mesh-list
14187843|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14187844|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187845|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187846|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14187847|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
14187848|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
14187849|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14187850|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14187851|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14187852|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14187853|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
14187854|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
14187855|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187856|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187857|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14187858|NCT04686058|Narcotics|narcotics|mesh-ancestor
14187859|NCT04686058|Analgesics|analgesics|mesh-ancestor
14187860|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
14187861|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187862|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
14187863|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14767633|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767634|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767635|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
13963553|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13963554|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13963555|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13963556|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963557|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13963558|NCT03143465|Calcitonin|calcitonin|mesh-list
13963559|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
13963560|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
13963561|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14187864|NCT04685512|Tenofovir|tenofovir|mesh-list
14187865|NCT04685512|Emtricitabine|emtricitabine|mesh-list
14187866|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
14187867|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187868|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13963562|NCT03143465|Katacalcin|katacalcin|mesh-list
14187869|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14187870|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187871|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187872|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14187873|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14187874|NCT04685642|Aspirin|aspirin|mesh-list
14187875|NCT04685642|Atorvastatin|atorvastatin|mesh-list
14187876|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14187877|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14187878|NCT04685642|Analgesics|analgesics|mesh-ancestor
14187879|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
14187880|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187881|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187882|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187883|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14187884|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14187885|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14187886|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480113|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480114|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14480115|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
14480116|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14480117|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
14767636|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963563|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
14187887|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14187888|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14187889|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187890|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
14187891|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14187892|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14187893|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
14187894|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14187895|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14187896|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
14187897|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14187898|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187899|NCT04685694|Misoprostol|misoprostol|mesh-list
14187900|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14187901|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
14187902|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14187903|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187904|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14187905|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14187906|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
14187907|NCT04685538|Tetracaine|tetracaine|mesh-list
14938983|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
14938984|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14938985|NCT01485692|Promethazine|promethazine|mesh-list
14938986|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
14938987|NCT01485692|Midazolam|midazolam|mesh-list
14187908|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
14187909|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
14187910|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
14187911|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187912|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187913|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
14187914|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14187915|NCT04685148|Estradiol|estradiol|mesh-list
14187916|NCT04685148|Estrogens|estrogens|mesh-ancestor
14187917|NCT04685148|Hormones|hormones|mesh-ancestor
14187918|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187919|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187920|NCT04685031|Clobetasol|clobetasol|mesh-list
14187921|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
14187922|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
14187923|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14187924|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
14187925|NCT04685031|Hormones|hormones|mesh-ancestor
14187926|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14187927|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187928|NCT04685005|Caffeine|caffeine|mesh-list
14187929|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14187930|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187931|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14187932|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187933|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187934|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14187935|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14187936|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
14187937|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236992|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14236993|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
14236994|NCT00119015|Fluticasone|fluticasone|mesh-list
14236995|NCT00119015|Xhance|xhance|mesh-list
14236996|NCT00119015|Montelukast|montelukast|mesh-list
14236997|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236998|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14236999|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
14237000|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237001|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237002|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14237003|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
14237004|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237005|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14237006|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14237007|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
14237008|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237009|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14237010|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14938988|NCT01485692|Haloperidol|haloperidol|mesh-list
14187938|NCT04684667|Propranolol|propranolol|mesh-list
14187939|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14187940|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14187941|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
14187942|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187943|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187944|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187945|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14187946|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14187947|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
14187948|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14187949|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14187950|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187951|NCT04684199|Melatonin|melatonin|mesh-list
14187952|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
14187953|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187954|NCT04684199|Protective Agents|protective agents|mesh-ancestor
14187955|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187956|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14187957|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
14187958|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14187959|NCT04684498|Oseltamivir|oseltamivir|mesh-list
14187960|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
14187961|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14187962|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187963|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187964|NCT04683965|Bevacizumab|bevacizumab|mesh-list
14187965|NCT04683965|Pemetrexed|pemetrexed|mesh-list
14187966|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14187967|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187968|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14187969|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14187970|NCT04683965|Growth Substances|growth substances|mesh-ancestor
14187971|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187972|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
14187973|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187974|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187975|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14187976|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14187977|NCT04684017|Carboplatin|carboplatin|mesh-list
14187978|NCT04684017|Etoposide|etoposide|mesh-list
14187979|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187980|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14187981|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14187982|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14187983|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14187984|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187985|NCT04683458|Paclitaxel|paclitaxel|mesh-list
14187986|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14187987|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14187988|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14187989|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
14187990|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
14187991|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
14187992|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187993|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
14187994|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
14187995|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14187996|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14187997|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14187998|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
14187999|NCT04683445|Trastuzumab|trastuzumab|mesh-list
14188000|NCT04683445|Pertuzumab|pertuzumab|mesh-list
14188001|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188002|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188015|NCT04683406|Oseltamivir|oseltamivir|mesh-list
14188016|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
14188017|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188018|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188019|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188020|NCT04683341|Tenofovir|tenofovir|mesh-list
14188021|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
14188022|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188023|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14188024|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14188025|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188026|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188027|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14188028|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14188029|NCT04683315|Gemcitabine|gemcitabine|mesh-list
14188030|NCT04683315|Paclitaxel|paclitaxel|mesh-list
14188031|NCT04683315|Fluorouracil|fluorouracil|mesh-list
14188032|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188033|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188034|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14188035|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14188036|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14188037|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188038|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188039|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
14188040|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
14188041|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188042|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188043|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188044|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
14188045|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188046|NCT04683198|Carboplatin|carboplatin|mesh-list
14188047|NCT04683198|Etoposide|etoposide|mesh-list
14188048|NCT04683198|Apatinib|apatinib|mesh-list
14188049|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188050|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188051|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14188052|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14188053|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188054|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480118|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
14188055|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14188056|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14188057|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14188058|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14188059|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14188060|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14188061|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
14188062|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188063|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188064|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188065|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
14188066|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14188067|NCT04683146|Propranolol|propranolol|mesh-list
14188068|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14188069|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188070|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
14188071|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
14188072|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14188073|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14188074|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
14188075|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188076|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188077|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188078|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14188079|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14188080|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
14188081|NCT04683237|Liraglutide|liraglutide|mesh-list
14188082|NCT04683237|Megestrol|megestrol|mesh-list
14188083|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
14188084|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14188085|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188086|NCT04683237|Incretins|incretins|mesh-ancestor
14188087|NCT04683237|Hormones|hormones|mesh-ancestor
14188088|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14188089|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14188090|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14188091|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14188092|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
14188093|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14188094|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14188095|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14188096|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14188097|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188098|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
14188099|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14188100|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
14188101|NCT04683679|Olaparib|olaparib|mesh-list
14188102|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188103|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188104|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14188105|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188106|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237011|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237012|NCT00119106|Tenofovir|tenofovir|mesh-list
14237013|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
14237014|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237015|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14237016|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14237017|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237018|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237019|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14237020|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14237021|NCT00119158|Fluticasone|fluticasone|mesh-list
14237022|NCT00119158|Xhance|xhance|mesh-list
14237023|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
14237024|NCT00119158|Tacrolimus|tacrolimus|mesh-list
14237025|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237026|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14237027|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
14237028|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237029|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237030|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14237031|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
14237032|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237033|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14237034|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14237035|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14237036|NCT00119158|Analgesics|analgesics|mesh-ancestor
14237037|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
14237038|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237039|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237040|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
14237041|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14237042|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237043|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237044|NCT00119262|Tamoxifen|tamoxifen|mesh-list
14237045|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
14237046|NCT00119262|Bevacizumab|bevacizumab|mesh-list
14237047|NCT00119262|Doxorubicin|doxorubicin|mesh-list
14237048|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14237049|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14237050|NCT00119262|Antibodies|antibodies|mesh-list
14237051|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
14237052|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14237053|NCT00119262|Lenograstim|lenograstim|mesh-list
14237054|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14237055|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237056|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237057|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14938989|NCT01485692|Olanzapine|olanzapine|mesh-list
14188107|NCT04682782|Esketamine|esketamine|mesh-list
14188108|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
14188109|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14188110|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14188111|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14188112|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14188113|NCT04682691|Erythromycin|erythromycin|mesh-list
14188114|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
14188115|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14188116|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
14188117|NCT04682691|Metoclopramide|metoclopramide|mesh-list
14188118|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
14188119|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
14188120|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188121|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188122|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14188123|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14188124|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14188125|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
14188126|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188127|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188128|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14188129|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188130|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14188131|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188132|NCT04682795|Insulin|insulin|mesh-list
14188133|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14188134|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188135|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14188136|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14188137|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188138|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
14188139|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
14188140|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188141|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188142|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
14188143|NCT04682587|Avelumab|avelumab|mesh-list
14188144|NCT04682587|Axitinib|axitinib|mesh-list
14188145|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188146|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188147|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14480119|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
14480120|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
14480121|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
14480122|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
14480123|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
14480124|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
14480125|NCT02483000|Vitamins|vitamins|mesh-ancestor
14480126|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
14480127|NCT02483585|Erenumab|erenumab|mesh-list
14480128|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14480129|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480130|NCT02483585|Analgesics|analgesics|mesh-ancestor
14480131|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
14480132|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480133|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480134|NCT02483611|Lidocaine|lidocaine|mesh-list
14480135|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
14480136|NCT02483611|Cisatracurium|cisatracurium|mesh-list
14480137|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
14480138|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
14480139|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480140|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480141|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
14480142|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480143|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14480144|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14480145|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14480146|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14480147|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480148|NCT02483611|Analgesics|analgesics|mesh-ancestor
14480149|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
14480150|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14480151|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14480152|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
14188148|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188149|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188150|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
14188151|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14188152|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14188153|NCT04681937|Prednisolone|prednisolone|mesh-list
14188154|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
14188155|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14188156|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
14188157|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
14188158|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14188159|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
14188160|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
14938990|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
14938991|NCT01485692|Ziprasidone|ziprasidone|mesh-list
14938992|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14480153|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14188161|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188162|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188163|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14188164|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
14188165|NCT04681937|Hormones|hormones|mesh-ancestor
14188166|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14188167|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14188168|NCT04681937|Protective Agents|protective agents|mesh-ancestor
14188169|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14188170|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188171|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14188172|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
14188173|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
14188174|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14188175|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188176|NCT04682249|Apatinib|apatinib|mesh-list
14188177|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188178|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14188179|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188180|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188181|NCT04682184|Propranolol|propranolol|mesh-list
14188182|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
14188183|NCT04682184|Ephedrine|ephedrine|mesh-list
14188184|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14188185|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14188186|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
14188187|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188188|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188189|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188190|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14188191|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14188192|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
14188193|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14188194|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
14188195|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188196|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14188197|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
14188198|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
14188199|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14188200|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14188201|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
14188202|NCT04682210|Bevacizumab|bevacizumab|mesh-list
14188203|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188204|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188205|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14188206|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14188207|NCT04682210|Growth Substances|growth substances|mesh-ancestor
14188208|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188209|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
14188210|NCT04682132|Antibodies|antibodies|mesh-list
14188211|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
14188212|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188213|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
14188214|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14188215|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188216|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188217|NCT04681911|Gemcitabine|gemcitabine|mesh-list
14188218|NCT04681911|Paclitaxel|paclitaxel|mesh-list
14188219|NCT04681911|Vinorelbine|vinorelbine|mesh-list
14188220|NCT04681911|Carboplatin|carboplatin|mesh-list
14188221|NCT04681911|Capecitabine|capecitabine|mesh-list
14188222|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188223|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188224|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14188225|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
14188226|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
14188227|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188228|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188229|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
14188230|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
14188231|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188232|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188233|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188234|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
14188235|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188236|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
14188237|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14188238|NCT04682041|Antibodies|antibodies|mesh-list
14188239|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
14188240|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188241|NCT04681469|Niraparib|niraparib|mesh-list
14188242|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14188243|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188244|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188245|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188246|NCT04681833|Vaccines|vaccines|mesh-list
14188247|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
14188248|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188249|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
14188250|NCT04680884|Clotrimazole|clotrimazole|mesh-list
14188251|NCT04680884|Miconazole|miconazole|mesh-list
14188252|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188253|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14188254|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14188255|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14188256|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188257|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188258|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14188259|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
14188260|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14188261|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188262|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14188263|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14188264|NCT04680962|Rituximab|rituximab|mesh-list
14188265|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480154|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14480155|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14480156|NCT02483975|Albuterol|albuterol|mesh-list
14480157|NCT02483975|Montelukast|montelukast|mesh-list
14480158|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14480159|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
14480160|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14480161|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
14480162|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480163|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480164|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14480165|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14480166|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480167|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14480168|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
14480169|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480170|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
14480171|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14480172|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14480173|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14480174|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14480175|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14480176|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480177|NCT02484222|Fentanyl|fentanyl|mesh-list
14480178|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14480179|NCT02484222|Narcotics|narcotics|mesh-ancestor
14480180|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480181|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188266|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188267|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
14188268|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188269|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14188270|NCT04681027|Oxymorphone|oxymorphone|mesh-list
14188271|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14188272|NCT04681027|Narcotics|narcotics|mesh-ancestor
14188273|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188274|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188275|NCT04681027|Analgesics|analgesics|mesh-ancestor
14188276|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
14188277|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188278|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14188279|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14188280|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188281|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188282|NCT04681053|Ivermectin|ivermectin|mesh-list
14188283|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14188284|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188285|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14188286|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188287|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188288|NCT04680923|Bupivacaine|bupivacaine|mesh-list
14188289|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
14188290|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
14188291|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188292|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188293|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
14188294|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188295|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14188296|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14188297|NCT04680819|Propolis|propolis|mesh-list
14188298|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237058|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
14237059|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237060|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237061|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14237062|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
14237063|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14237064|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237065|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237066|NCT00119262|Growth Substances|growth substances|mesh-ancestor
14237067|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237068|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14237069|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14237070|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14237071|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237072|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14237073|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14237074|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
14237075|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237076|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14237077|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14237078|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14237079|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14237080|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14237081|NCT00119379|Tenofovir|tenofovir|mesh-list
14237082|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
14237083|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237084|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14237085|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14237086|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237087|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237088|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14237089|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14237090|NCT00119392|Cyclosporine|cyclosporine|mesh-list
14237091|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
14237092|NCT00119392|Rituximab|rituximab|mesh-list
14237093|NCT00119392|Fludarabine|fludarabine|mesh-list
14237094|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
14237095|NCT00119392|Cyclosporins|cyclosporins|mesh-list
14237096|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14237097|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237098|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188299|NCT04680650|Anesthetics|anesthetics|mesh-list
14188300|NCT04680650|Propofol|propofol|mesh-list
14188301|NCT04680650|Sevoflurane|sevoflurane|mesh-list
14188302|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188303|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188304|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14188305|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14188306|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
14188307|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14188308|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14188309|NCT04680442|Trastuzumab|trastuzumab|mesh-list
14188310|NCT04680442|Pertuzumab|pertuzumab|mesh-list
14188311|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14188312|NCT04680442|Maytansine|maytansine|mesh-list
14188313|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188314|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188315|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188316|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14188317|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14188318|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14188319|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188320|NCT04680221|Bupivacaine|bupivacaine|mesh-list
14188321|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
14188322|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
14188323|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188324|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188325|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
14188326|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188327|NCT04680091|Efavirenz|efavirenz|mesh-list
14188328|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14188329|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14188330|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188331|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188332|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
14188333|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188334|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14938993|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14938994|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14938995|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14938996|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14938997|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14188335|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14188336|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14188337|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14188338|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14188339|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14188340|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
14188341|NCT04680143|Hematinics|hematinics|mesh-ancestor
14188342|NCT04680208|Anesthetics|anesthetics|mesh-list
14938998|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14237099|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
14237100|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237101|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237102|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237103|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
14237104|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237105|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237106|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237107|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
14237108|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237109|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237110|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14237111|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14237112|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14237113|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
14237114|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14237115|NCT00119678|Prednisone|prednisone|mesh-list
14237116|NCT00119678|Abatacept|abatacept|mesh-list
14237117|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237118|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
14237119|NCT00119678|Hormones|hormones|mesh-ancestor
14237120|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237121|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237122|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14938999|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14939000|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
14939001|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
14939002|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
14939003|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
14939004|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939005|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188343|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188344|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188345|NCT04679948|Midazolam|midazolam|mesh-list
14188346|NCT04679948|Caffeine|caffeine|mesh-list
14188347|NCT04679948|Omeprazole|omeprazole|mesh-list
14188348|NCT04679948|Warfarin|warfarin|mesh-list
14188349|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14188350|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14188351|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188352|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188353|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14188354|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14188355|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14188356|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14188357|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
14188358|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
14188359|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
14188360|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
14188361|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188362|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188363|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
14188364|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14188365|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14188366|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14188367|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188368|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14188369|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14188370|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14188371|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14188372|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
14188373|NCT04680286|Methadone|methadone|mesh-list
14188374|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14188375|NCT04680286|Narcotics|narcotics|mesh-ancestor
14188376|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188377|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188378|NCT04680286|Analgesics|analgesics|mesh-ancestor
14188379|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
14188380|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188381|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
14188382|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
14188383|NCT04679831|Praziquantel|praziquantel|mesh-list
14188384|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
14188385|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14188386|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188387|NCT04679740|Sirolimus|sirolimus|mesh-list
14188388|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14188389|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188390|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14188391|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188392|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
14188393|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188394|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
14188395|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188396|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
14188397|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14188398|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188399|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
14188400|NCT04679389|Acetazolamide|acetazolamide|mesh-list
14188401|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
14188402|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14188403|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188404|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188405|NCT04679389|Diuretics|diuretics|mesh-ancestor
14188406|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
14188407|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188408|NCT04680195|Thalidomide|thalidomide|mesh-list
14480182|NCT02484222|Analgesics|analgesics|mesh-ancestor
14188409|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188410|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
14188411|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188412|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
14188413|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14188414|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188415|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14188416|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14188417|NCT04680195|Growth Substances|growth substances|mesh-ancestor
14188418|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
14188419|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188420|NCT04679597|Capecitabine|capecitabine|mesh-list
14188421|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
14188422|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188423|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
14188424|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188425|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188426|NCT04679506|Cytarabine|cytarabine|mesh-list
14188427|NCT04679506|Etoposide|etoposide|mesh-list
14188428|NCT04679506|Cladribine|cladribine|mesh-list
14188429|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188430|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188431|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14188432|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14188433|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188434|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188435|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188436|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
14188437|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
14188438|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188439|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188440|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
14188441|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188442|NCT04679480|Cemiplimab|cemiplimab|mesh-list
14188443|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188444|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188445|NCT04679376|Atorvastatin|atorvastatin|mesh-list
14188446|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14188447|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14188448|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
14188449|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188450|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14188451|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14188452|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188453|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14188454|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
14188455|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188456|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14188457|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14188458|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188459|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188460|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188461|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14188462|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963564|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13963565|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13963566|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963567|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963568|NCT03143465|Urological Agents|urological agents|mesh-ancestor
13963569|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13963570|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963571|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13963572|NCT03143491|Paclitaxel|paclitaxel|mesh-list
13963573|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188463|NCT04679142|Baclofen|baclofen|mesh-list
14188464|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14188465|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188466|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14188467|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188468|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14188469|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
14188470|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
14188471|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188472|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188473|NCT04679064|Gemcitabine|gemcitabine|mesh-list
14188474|NCT04679064|Paclitaxel|paclitaxel|mesh-list
14188475|NCT04679064|Bevacizumab|bevacizumab|mesh-list
14188476|NCT04679064|Doxorubicin|doxorubicin|mesh-list
14188477|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14188478|NCT04679064|Topotecan|topotecan|mesh-list
14188479|NCT04679064|Niraparib|niraparib|mesh-list
14188480|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188481|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188482|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
14188483|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
14188484|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
14188485|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188486|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188487|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14188488|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14188489|NCT04679064|Growth Substances|growth substances|mesh-ancestor
14188490|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188491|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
14188492|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188493|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
14188494|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
14188495|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188496|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188497|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188498|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
14188499|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14188500|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14188501|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14188502|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14188503|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14237123|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237124|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14237125|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237126|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237127|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
14237128|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237129|NCT00120250|Eszopiclone|eszopiclone|mesh-list
14237130|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14237131|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14237132|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237133|NCT00120289|Niacin|niacin|mesh-list
14237134|NCT00120289|Simvastatin|simvastatin|mesh-list
14237135|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14237136|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14237137|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
14237138|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237139|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14237140|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14237141|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237142|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
14237143|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
14237144|NCT00120289|Vitamins|vitamins|mesh-ancestor
14237145|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
14237146|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242832|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242833|NCT00191139|Gemcitabine|gemcitabine|mesh-list
14242834|NCT00191139|Cisplatin|cisplatin|mesh-list
14242835|NCT00191139|Docetaxel|docetaxel|mesh-list
14242836|NCT00191139|Etoposide|etoposide|mesh-list
14242837|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
14242838|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242839|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242840|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
14242841|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242842|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
14242843|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242844|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188504|NCT04679103|Eculizumab|eculizumab|mesh-list
14188505|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14188506|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188507|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
14188508|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188509|NCT04678830|Leronlimab|leronlimab|mesh-list
14188510|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14188511|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14188512|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188513|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14188514|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14188515|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
14188516|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188517|NCT04678791|Cisplatin|cisplatin|mesh-list
14188518|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
14188519|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188520|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188521|NCT04678739|Remdesivir|remdesivir|mesh-list
14188522|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
14188523|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188524|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
14188525|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188526|NCT04678492|Amoxicillin|amoxicillin|mesh-list
14188527|NCT04678492|Tetracycline|tetracycline|mesh-list
14188528|NCT04678492|Furazolidone|furazolidone|mesh-list
14188529|NCT04678492|Esomeprazole|esomeprazole|mesh-list
14188530|NCT04678492|Bismuth|bismuth|mesh-list
14188531|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14188532|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188533|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14188534|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14188535|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14188536|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188537|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188538|NCT04678492|Antacids|antacids|mesh-ancestor
14188539|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14188540|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14188541|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14188542|NCT04678492|Renal Agents|renal agents|mesh-ancestor
14188543|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14188544|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14188545|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14188546|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14188547|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
14188548|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14188549|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188550|NCT04678154|Vancomycin|vancomycin|mesh-list
14188551|NCT04678154|Tobramycin|tobramycin|mesh-list
14188552|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14188553|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188554|NCT04678076|Ketoprofen|ketoprofen|mesh-list
14188555|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
14480183|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
14480184|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480185|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14480186|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14480187|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
14480188|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
14480189|NCT02484651|Rocuronium|rocuronium|mesh-list
14480190|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14480191|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14480192|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14480193|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480194|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188556|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14188557|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14188558|NCT04678076|Analgesics|analgesics|mesh-ancestor
14188559|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
14188560|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188561|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188562|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14188563|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14188564|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14188565|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188566|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188569|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
14188570|NCT04678050|Ketamine|ketamine|mesh-list
14188571|NCT04678050|Propofol|propofol|mesh-list
14188572|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14188573|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188574|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188575|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14188576|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
14188577|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
14188578|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14188579|NCT04678050|Analgesics|analgesics|mesh-ancestor
14188580|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
14188581|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188582|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14188583|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14188584|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14188585|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
14188586|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188587|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188588|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14188589|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14188590|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14188591|NCT04678661|Insulin|insulin|mesh-list
14188592|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14188593|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188594|NCT04677985|Analgesics|analgesics|mesh-list
14188595|NCT04677985|Menthol|menthol|mesh-list
14188596|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
14188597|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188598|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188599|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
14188600|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
14188601|NCT04677868|Methotrexate|methotrexate|mesh-list
14188602|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14188603|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
14188604|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14188605|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188606|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188607|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
14188608|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188609|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188610|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
14188611|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188612|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14188613|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188614|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
14188615|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14188616|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14188617|NCT04678362|Avelumab|avelumab|mesh-list
14188618|NCT04678362|Talazoparib|talazoparib|mesh-list
14188619|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188620|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188621|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14188622|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188623|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188624|NCT04677855|Prednisone|prednisone|mesh-list
14188625|NCT04677855|Dutasteride|dutasteride|mesh-list
14188626|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14188627|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
14188628|NCT04677855|Hormones|hormones|mesh-ancestor
14188629|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14188630|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480195|NCT02484690|Ranibizumab|ranibizumab|mesh-list
14480196|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14767637|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14188631|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14188632|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188633|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14188634|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14188635|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188636|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188637|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
14188638|NCT04677335|Lovastatin|lovastatin|mesh-list
14188639|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14188640|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14188641|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
14188642|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188643|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14188644|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14188645|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188646|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
14188647|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188648|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188649|NCT04676958|Vitamin K|vitamin k|mesh-list
14188650|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
14188651|NCT04676958|Vitamins|vitamins|mesh-ancestor
14188652|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
14188653|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188654|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14188655|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14188656|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188657|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
14188658|NCT04676958|Coagulants|coagulants|mesh-ancestor
14188659|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14188660|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14188661|NCT04677114|Buprenorphine|buprenorphine|mesh-list
14188662|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14188663|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188664|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
14188665|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14188666|NCT04677114|Narcotics|narcotics|mesh-ancestor
14188667|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188668|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188669|NCT04677114|Analgesics|analgesics|mesh-ancestor
14188670|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
14188671|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188672|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14188673|NCT04677049|Niacin|niacin|mesh-list
14188674|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
14188675|NCT04677049|Vitamins|vitamins|mesh-ancestor
14188676|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
14188677|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188678|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
14188679|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14188680|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
14188681|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188682|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14188683|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14237147|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
14237148|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14480197|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14939006|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
14237149|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14188684|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
14188685|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14188686|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14188687|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
14188688|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188689|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14188690|NCT04676997|Paclitaxel|paclitaxel|mesh-list
14188691|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
14188692|NCT04676997|Epirubicin|epirubicin|mesh-list
14188693|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188694|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188695|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
14188696|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
14188697|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
14188698|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188699|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188700|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
14188701|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188702|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14188703|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14188704|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
14188705|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14188706|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14188707|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14188708|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14188709|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188710|NCT04676763|Histamine|histamine|mesh-list
14188711|NCT04676763|Substance P|substance p|mesh-list
14188712|NCT04676763|Neurokinin A|neurokinin a|mesh-list
14188713|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
14188714|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
14188715|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188716|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188717|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188718|NCT04676789|Pegaspargase|pegaspargase|mesh-list
14188719|NCT04676789|Antibodies|antibodies|mesh-list
14188720|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14188721|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
14188722|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188723|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188724|NCT04676659|Tenecteplase|tenecteplase|mesh-list
14188725|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14188726|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14188727|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188728|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
14188729|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188730|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188731|NCT04676204|Teriflunomide|teriflunomide|mesh-list
14188732|NCT04676204|Cladribine|cladribine|mesh-list
14188733|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14188734|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14188735|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188736|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188737|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
14188738|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188739|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14188740|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188741|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
14188742|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14188743|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14188744|NCT04676204|Analgesics|analgesics|mesh-ancestor
14188745|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
14188746|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188747|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14188748|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14188749|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
14188750|NCT04676776|Mifepristone|mifepristone|mesh-list
14188751|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14188752|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
14188753|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14188754|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188755|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14188756|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14188757|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14237150|NCT00120523|Analgesics|analgesics|mesh-ancestor
14188758|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14188759|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
14188760|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14188761|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14188762|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
14188763|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14188764|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
14188765|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14188766|NCT04676139|Fluoxetine|fluoxetine|mesh-list
14188767|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14188768|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14188769|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14188770|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188771|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188772|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
14188773|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188774|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14188775|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
14188776|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14188777|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14188778|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14188779|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188780|NCT04676061|Norethindrone|norethindrone|mesh-list
14188781|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
14188782|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14188783|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14188784|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14188785|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
14188786|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14188787|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188788|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14188789|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14188790|NCT04676035|Vitamin K|vitamin k|mesh-list
14188791|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
14188792|NCT04676035|Midazolam|midazolam|mesh-list
14188793|NCT04676035|Omeprazole|omeprazole|mesh-list
14188794|NCT04676035|Warfarin|warfarin|mesh-list
14188795|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14188796|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14188797|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188798|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188799|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14188800|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14188801|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14188802|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14188803|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
14188804|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
14188805|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
14188806|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
14188807|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188808|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188809|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
14188810|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14188811|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14188812|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14188813|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188814|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14188815|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14188816|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
14188817|NCT04676035|Coagulants|coagulants|mesh-ancestor
14188818|NCT04676035|Vitamins|vitamins|mesh-ancestor
14188819|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
14188820|NCT04675944|Treprostinil|treprostinil|mesh-list
14188821|NCT04675944|Zamicastat|zamicastat|mesh-list
14188822|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14188823|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188824|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188825|NCT04675697|Etoposide|etoposide|mesh-list
14188826|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188827|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188828|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14188829|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14188830|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480198|NCT02484690|Growth Substances|growth substances|mesh-ancestor
14480199|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188831|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188832|NCT04676126|Dorzolamide|dorzolamide|mesh-list
14188833|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14188834|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14188835|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188836|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188837|NCT04675619|Pirfenidone|pirfenidone|mesh-list
14188838|NCT04675619|Analgesics|analgesics|mesh-ancestor
14188839|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
14188840|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188841|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188842|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14188843|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14188844|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14188845|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14188846|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188847|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
14188848|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
14188849|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
14188850|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
14188851|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188852|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188853|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14188854|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14188855|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188856|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188857|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
14188858|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188859|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
14188860|NCT04675710|Trametinib|trametinib|mesh-list
14188861|NCT04675710|Dabrafenib|dabrafenib|mesh-list
14188862|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188863|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188864|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14188865|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188866|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188867|NCT04675528|Paclitaxel|paclitaxel|mesh-list
14188868|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188869|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188870|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
14188871|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
14188872|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
14188873|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767638|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
14767639|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767640|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14767641|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14767642|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188874|NCT04675983|Fluorouracil|fluorouracil|mesh-list
14188875|NCT04675983|Capecitabine|capecitabine|mesh-list
14188876|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
14188877|NCT04675983|Ramucirumab|ramucirumab|mesh-list
14188878|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188879|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
14188880|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188881|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188882|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188883|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
14188884|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188885|NCT04675177|Polidocanol|polidocanol|mesh-list
14188886|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14188887|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14188888|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
14188889|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14188890|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
14188891|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188892|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
14188893|NCT04675385|Protective Agents|protective agents|mesh-ancestor
14188894|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
14480200|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
14480201|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480202|NCT02484859|Metoprolol|metoprolol|mesh-list
14480203|NCT02484859|Remifentanil|remifentanil|mesh-list
14480204|NCT02484859|Tramadol|tramadol|mesh-list
14480205|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14767643|NCT00631033|Metformin|metformin|mesh-list
14767644|NCT00631033|Diazoxide|diazoxide|mesh-list
14188895|NCT04675086|Remdesivir|remdesivir|mesh-list
14188896|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
14188897|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14188898|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188899|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
14188900|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188901|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188902|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14188903|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14188904|NCT04675372|Midazolam|midazolam|mesh-list
14188905|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
14480206|NCT02484859|Narcotics|narcotics|mesh-ancestor
14480207|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480208|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480209|NCT02484859|Analgesics|analgesics|mesh-ancestor
14480210|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
14480211|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480212|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14480213|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14480214|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
14480215|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
14480216|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14480217|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14480218|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14480219|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
14480220|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480221|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480222|NCT02484911|Dexamethasone|dexamethasone|mesh-list
14480223|NCT02484911|Olanzapine|olanzapine|mesh-list
14480224|NCT02484911|Aprepitant|aprepitant|mesh-list
14480225|NCT02484911|Palonosetron|palonosetron|mesh-list
14480226|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480227|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
14480228|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
14480229|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480230|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480231|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14480232|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
14480233|NCT02484911|Hormones|hormones|mesh-ancestor
14480234|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480235|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14480236|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480237|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14480238|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14480239|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480240|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14480241|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14480242|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14480243|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14480244|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480245|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480246|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
14480247|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14480248|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14480249|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14480250|NCT02485158|Dronabinol|dronabinol|mesh-list
14480251|NCT02485158|Amphetamine|amphetamine|mesh-list
14480252|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
14480253|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14767645|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14767646|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963574|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963575|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
13963576|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
13963577|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
13963578|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963579|NCT03143244|Ketorolac|ketorolac|mesh-list
13963580|NCT03143244|Midazolam|midazolam|mesh-list
13963581|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
13963582|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13963583|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963584|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188906|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14480254|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188907|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188908|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188909|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14188910|NCT04675372|Analgesics|analgesics|mesh-ancestor
14188911|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
14188912|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188913|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14188914|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14188915|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14188916|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
14188917|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14188918|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188919|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14188920|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14188921|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14188922|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14188923|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14188924|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
14188925|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
14188926|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
14188927|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
14188928|NCT04674956|Gemcitabine|gemcitabine|mesh-list
14188929|NCT04674956|Paclitaxel|paclitaxel|mesh-list
14767647|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14767648|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
14767649|NCT00631085|Tocopherols|tocopherols|mesh-list
14767650|NCT00631085|Vitamin E|vitamin e|mesh-list
14188930|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14188931|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188932|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
14767651|NCT00631085|Tocotrienols|tocotrienols|mesh-list
14188933|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
14188934|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
14188935|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188936|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14188937|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
14188938|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
14188939|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188940|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188941|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14188942|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
14188943|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188944|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14237151|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
14237152|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237153|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237154|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237155|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237156|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237157|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237158|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
14237159|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14237160|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237161|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237162|NCT00120874|Memantine|memantine|mesh-list
14237163|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14237164|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14237165|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
14237166|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14237167|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237168|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237169|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14237170|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14237171|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
14237172|NCT00121134|Bevacizumab|bevacizumab|mesh-list
14237173|NCT00121134|Capecitabine|capecitabine|mesh-list
14237174|NCT00121134|Methotrexate|methotrexate|mesh-list
14237175|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237176|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
14237177|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237178|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237179|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14237180|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
14767652|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
14767653|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
14767654|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
14188945|NCT04674423|Tenofovir|tenofovir|mesh-list
14188946|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
14188947|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188948|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14188949|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14188950|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14188951|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188952|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14188953|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14188954|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
14188955|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14188956|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188957|NCT04674176|Rifaximin|rifaximin|mesh-list
14188958|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14188959|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188960|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14188961|NCT04674254|Bevacizumab|bevacizumab|mesh-list
14188962|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188963|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188964|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14188965|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14188966|NCT04674254|Growth Substances|growth substances|mesh-ancestor
14188967|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188968|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
14188969|NCT04674527|Temozolomide|temozolomide|mesh-list
14188970|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14188971|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
14188972|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14188973|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188974|NCT04673877|Vancomycin|vancomycin|mesh-list
14188975|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14188976|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14188977|NCT04673955|Cetuximab|cetuximab|mesh-list
14188978|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14188979|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14188980|NCT04673799|Denosumab|denosumab|mesh-list
14188981|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14188982|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188983|NCT04673812|Fentanyl|fentanyl|mesh-list
14188984|NCT04673812|Bupivacaine|bupivacaine|mesh-list
14188985|NCT04673812|Naloxone|naloxone|mesh-list
14188986|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
14188987|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
14188988|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14188989|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14188990|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
14188991|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14188992|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14188993|NCT04673812|Narcotics|narcotics|mesh-ancestor
14188994|NCT04673812|Analgesics|analgesics|mesh-ancestor
14188995|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14188996|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14188997|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
14188998|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14188999|NCT04674137|Histamine|histamine|mesh-list
14189000|NCT04674137|Glutarimide|glutarimide|mesh-list
14189001|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
14189002|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
14189003|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189004|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189005|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189006|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14189007|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189008|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
14189009|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
14189010|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
14189011|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189012|NCT04673461|Xylometazoline|xylometazoline|mesh-list
14189013|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
14189014|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14189015|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
14189016|NCT04673500|Lidocaine|lidocaine|mesh-list
14189017|NCT04673500|Propofol|propofol|mesh-list
14189018|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
14189019|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
14189020|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189021|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480255|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
14189022|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
14189023|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189024|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14189025|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14189026|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14189027|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14189028|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189029|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14189030|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14189031|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
14189032|NCT04673578|Celecoxib|celecoxib|mesh-list
14189033|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14189034|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189035|NCT04673578|Analgesics|analgesics|mesh-ancestor
14189036|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
14189037|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189038|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189039|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189040|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189041|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14189042|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14189043|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189044|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189045|NCT04673396|Norcantharidin|norcantharidin|mesh-list
14189046|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189047|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189048|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189049|NCT04672928|Paclitaxel|paclitaxel|mesh-list
14189050|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14189051|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189052|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
14189053|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
14189054|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
14189055|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189056|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
14189057|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14189058|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14189059|NCT04673162|Prednisolone|prednisolone|mesh-list
14189060|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
14189061|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14189062|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
14189063|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189064|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
14189065|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
14189066|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189067|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189068|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14189069|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
14189070|NCT04673162|Hormones|hormones|mesh-ancestor
14189071|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14189072|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14189073|NCT04673162|Protective Agents|protective agents|mesh-ancestor
14767655|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767656|NCT00631085|Protective Agents|protective agents|mesh-ancestor
14767657|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189074|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14189075|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189076|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
14189077|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14189078|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14189079|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14189080|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14189081|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189082|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
14189083|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189084|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189085|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14189086|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189087|NCT04673214|Acetaminophen|acetaminophen|mesh-list
14189088|NCT04673214|Azithromycin|azithromycin|mesh-list
14189089|NCT04673214|Ivermectin|ivermectin|mesh-list
14767658|NCT00631085|Vitamins|vitamins|mesh-ancestor
14189090|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189091|NCT04673214|Analgesics|analgesics|mesh-ancestor
14767659|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
14939007|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
14939008|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939009|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939010|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14189092|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
14189093|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189094|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189095|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
14189096|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189097|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189098|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14237181|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237182|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237183|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14237184|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237185|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237186|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237187|NCT00121134|Growth Substances|growth substances|mesh-ancestor
14237188|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237189|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14767660|NCT00631124|Drospirenone|drospirenone|mesh-list
14767661|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14767662|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14767663|NCT00631124|Estradiol|estradiol|mesh-list
14237190|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
14237191|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14237192|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
14237193|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14237194|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237195|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237196|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14767664|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14767665|NCT00631124|Estrogens|estrogens|mesh-ancestor
14767666|NCT00631124|Hormones|hormones|mesh-ancestor
14767667|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237197|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14237198|NCT00121186|Methotrexate|methotrexate|mesh-list
14237199|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
14237200|NCT00121186|Fludarabine|fludarabine|mesh-list
14237201|NCT00121186|Melphalan|melphalan|mesh-list
14237202|NCT00121186|Tacrolimus|tacrolimus|mesh-list
14237203|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14237204|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
14237205|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14237206|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237207|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237208|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
14237209|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237210|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237211|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237212|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237213|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14237214|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237215|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
14237216|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237217|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14237218|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14237219|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14480256|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
14480257|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480258|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
14480259|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480260|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480261|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14480262|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14480263|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14480264|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14480265|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14480266|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
14480267|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14480268|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14480269|NCT02485158|Analgesics|analgesics|mesh-ancestor
14767668|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189099|NCT04672759|Durvalumab|durvalumab|mesh-list
14189100|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14189101|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14189102|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189103|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
14189104|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480270|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
14480271|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14480272|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14480273|NCT02485158|Hormones|hormones|mesh-ancestor
14480274|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480275|NCT02485353|Cytarabine|cytarabine|mesh-list
14480276|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14480277|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
14480278|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480279|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480280|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
14480281|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480282|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14480283|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
14480284|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480285|NCT02485834|Docetaxel|docetaxel|mesh-list
14480286|NCT02485834|Capecitabine|capecitabine|mesh-list
14480287|NCT02485834|Irinotecan|irinotecan|mesh-list
14480288|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480289|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
14189105|NCT04672499|Cortisone|cortisone|mesh-list
14480290|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
14480291|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
14480292|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480293|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14480294|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
14480295|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14480296|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14480297|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480298|NCT02486016|Fentanyl|fentanyl|mesh-list
14480299|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14480300|NCT02486016|Narcotics|narcotics|mesh-ancestor
14480301|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480302|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480303|NCT02486016|Analgesics|analgesics|mesh-ancestor
14480304|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
14480305|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480306|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14480307|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14480308|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
14480309|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
14480310|NCT02486211|Amantadine|amantadine|mesh-list
14480311|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14480312|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14480313|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
14480314|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480315|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
14480316|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480317|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480318|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480319|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14480320|NCT02486211|Analgesics|analgesics|mesh-ancestor
14480321|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
14480322|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480323|NCT02486302|Etanercept|etanercept|mesh-list
14480324|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14480325|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14480326|NCT02486302|Analgesics|analgesics|mesh-ancestor
14480327|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
14480328|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480329|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480330|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189106|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189107|NCT04672525|Rifampin|rifampin|mesh-list
14189108|NCT04672525|Rifabutin|rifabutin|mesh-list
14189109|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14189110|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
14189111|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189112|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189113|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
14189114|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14189115|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189116|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189117|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14189118|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14189119|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14189120|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14189121|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14189122|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14189123|NCT04672707|Bromhexine|bromhexine|mesh-list
14189124|NCT04672707|Expectorants|expectorants|mesh-ancestor
14189125|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
14189126|NCT04672213|Tranexamic Acid|tranexamic acid|mesh-list
14189127|NCT04672213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14189128|NCT04672213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14189129|NCT04672213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189130|NCT04672213|Hemostatics|hemostatics|mesh-ancestor
14189131|NCT04672213|Coagulants|coagulants|mesh-ancestor
14189132|NCT04672005|Leucovorin|leucovorin|mesh-list
14189133|NCT04672005|Gemcitabine|gemcitabine|mesh-list
14189134|NCT04672005|Paclitaxel|paclitaxel|mesh-list
14189135|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14189136|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
14189137|NCT04672005|Irinotecan|irinotecan|mesh-list
14189138|NCT04672005|Folfirinox|folfirinox|mesh-list
14189139|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14189140|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189141|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14189142|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14189143|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14189144|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189145|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14189146|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
14189147|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
14189148|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189149|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189150|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189151|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
14189152|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189153|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14189154|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14189155|NCT04672005|Antidotes|antidotes|mesh-ancestor
14189156|NCT04672005|Protective Agents|protective agents|mesh-ancestor
14189157|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
14189158|NCT04672005|Vitamins|vitamins|mesh-ancestor
14189159|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
14189160|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
14189161|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14189162|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
14189163|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189164|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
14189165|NCT04671914|Protective Agents|protective agents|mesh-ancestor
14189166|NCT04671836|Lorazepam|lorazepam|mesh-list
14189167|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
14189168|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
14189169|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
14189170|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189171|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189172|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14189173|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14189174|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189175|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14189176|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14189177|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14189178|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
14189179|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
14189180|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189181|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189182|NCT04671589|Meropenem|meropenem|mesh-list
14189183|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189184|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189185|NCT04671563|Tenofovir|tenofovir|mesh-list
14189186|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
14189187|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189188|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14189189|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14189190|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189191|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189192|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14189193|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14189194|NCT04671446|Autoantibodies|autoantibodies|mesh-list
14189195|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
14189196|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189197|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14189198|NCT04671160|Dalteparin|dalteparin|mesh-list
14189199|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
14189200|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14189201|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14189202|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189203|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
14189204|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
14189205|NCT04671420|Rituximab|rituximab|mesh-list
14189206|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14189207|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189208|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
14189209|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189210|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189211|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
14189212|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14189213|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
14189214|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189215|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
14189216|NCT04671108|Protective Agents|protective agents|mesh-ancestor
14189217|NCT04670978|Bevacizumab|bevacizumab|mesh-list
14189218|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14189219|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189220|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14189221|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14189222|NCT04670978|Growth Substances|growth substances|mesh-ancestor
14189223|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189224|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14189225|NCT04671056|Pioglitazone|pioglitazone|mesh-list
14189226|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14189227|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189228|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
14189229|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189230|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
14189231|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14189232|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
14189233|NCT04670601|Analgesics|analgesics|mesh-ancestor
14189234|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
14189235|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189236|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189237|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14189238|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189239|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189240|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189241|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14189242|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189243|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189244|NCT04670913|Apatinib|apatinib|mesh-list
14189245|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189246|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14189247|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189248|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189249|NCT04671069|Clopidogrel|clopidogrel|mesh-list
14189250|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14189251|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14189252|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14189253|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14189254|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
14189255|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480331|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189256|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480332|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14189257|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237220|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
14237221|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14237222|NCT00121199|Prednisone|prednisone|mesh-list
14237223|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
14237224|NCT00121199|Bevacizumab|bevacizumab|mesh-list
14237225|NCT00121199|Rituximab|rituximab|mesh-list
14237226|NCT00121199|Doxorubicin|doxorubicin|mesh-list
14237227|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14237228|NCT00121199|Vincristine|vincristine|mesh-list
14237229|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14237230|NCT00121199|Antibodies|antibodies|mesh-list
14237231|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
14237232|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14237233|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237234|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
14237235|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237236|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237237|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14237238|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
14237239|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237240|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237241|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14237242|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237243|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237244|NCT00121199|Growth Substances|growth substances|mesh-ancestor
14237245|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237246|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14237247|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14237248|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14237249|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237250|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237251|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
14237252|NCT00121199|Hormones|hormones|mesh-ancestor
14237253|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237254|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14237255|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14237256|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14237257|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14237258|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14237259|NCT00121225|Vorinostat|vorinostat|mesh-list
14237260|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237261|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14237262|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237263|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237264|NCT00121251|Gemcitabine|gemcitabine|mesh-list
14237265|NCT00121251|Capecitabine|capecitabine|mesh-list
14237266|NCT00121251|Sorafenib|sorafenib|mesh-list
14237267|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237268|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
14237269|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237270|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237271|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
14237272|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237273|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237274|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237275|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
14237276|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237277|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237278|NCT00121641|Metformin|metformin|mesh-list
14237279|NCT00121641|Saxagliptin|saxagliptin|mesh-list
14237280|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14237281|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237282|NCT00121641|Incretins|incretins|mesh-ancestor
14237283|NCT00121641|Hormones|hormones|mesh-ancestor
14237284|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237285|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14237286|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
14237287|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237288|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237289|NCT00121667|Metformin|metformin|mesh-list
14237290|NCT00121667|Pioglitazone|pioglitazone|mesh-list
14237291|NCT00121667|Saxagliptin|saxagliptin|mesh-list
14237292|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14237293|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237294|NCT00121667|Incretins|incretins|mesh-ancestor
14237295|NCT00121667|Hormones|hormones|mesh-ancestor
14189258|NCT04670796|Trastuzumab|trastuzumab|mesh-list
14189259|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14189260|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189261|NCT04670809|Clevidipine|clevidipine|mesh-list
14189262|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14189263|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14189264|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189265|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14189266|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189267|NCT04670666|Metformin|metformin|mesh-list
14189268|NCT04670666|Empagliflozin|empagliflozin|mesh-list
14189269|NCT04670666|Linagliptin|linagliptin|mesh-list
14189270|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14189271|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189272|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14189273|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189274|NCT04670666|Incretins|incretins|mesh-ancestor
14189275|NCT04670666|Hormones|hormones|mesh-ancestor
14189276|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14189277|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14189278|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
14189279|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189280|NCT04670471|Remifentanil|remifentanil|mesh-list
14189281|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14189282|NCT04670471|Narcotics|narcotics|mesh-ancestor
14189283|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189284|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189285|NCT04670471|Analgesics|analgesics|mesh-ancestor
14189286|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
14189287|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189288|NCT04670432|Troxerutin|troxerutin|mesh-list
14189289|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
14189290|NCT04670497|Epinephrine|epinephrine|mesh-list
14189291|NCT04670497|Racepinephrine|racepinephrine|mesh-list
14189292|NCT04670497|Bupivacaine|bupivacaine|mesh-list
14189293|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
14189294|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
14189295|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
14189296|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189297|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189298|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
14189299|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189300|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14189301|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14189302|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
14189303|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189304|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189305|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14189306|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14189307|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
14189308|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14189309|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
14189310|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
14189311|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
14189312|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14189313|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14189314|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189315|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189316|NCT04670224|Anesthetics|anesthetics|mesh-list
14189317|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189318|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189319|NCT04669821|Propofol|propofol|mesh-list
14189320|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14189321|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189322|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189323|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14189324|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
14189325|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
14189326|NCT04670081|Niacinamide|niacinamide|mesh-list
14767669|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14767670|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
14767671|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14189327|NCT04670081|Niacin|niacin|mesh-list
14189328|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
14189329|NCT04670081|Psilocybin|psilocybin|mesh-list
14189330|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
14189331|NCT04670081|Vitamins|vitamins|mesh-ancestor
14189332|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
14189333|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189334|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14189335|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
14189336|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189337|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14189338|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
14189339|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
14189340|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14189341|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
14189342|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189343|NCT04669717|Amoxicillin|amoxicillin|mesh-list
14189344|NCT04669717|Azithromycin|azithromycin|mesh-list
14189345|NCT04669717|Metronidazole|metronidazole|mesh-list
14189346|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189347|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189348|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14189349|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14189350|NCT04669782|Teriparatide|teriparatide|mesh-list
14189351|NCT04669782|Vitamin K|vitamin k|mesh-list
14189352|NCT04669782|Vitamins|vitamins|mesh-ancestor
14189353|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
14189354|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189355|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14189356|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14189357|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189358|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
14189359|NCT04669782|Coagulants|coagulants|mesh-ancestor
14189360|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14189361|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14189362|NCT04669990|Remdesivir|remdesivir|mesh-list
14189363|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
14189364|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189365|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
14189366|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189367|NCT04669392|Ethanol|ethanol|mesh-list
14189368|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14189369|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189370|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189371|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189372|NCT04669457|Midazolam|midazolam|mesh-list
14189373|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
14189374|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14189375|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189376|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189377|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189378|NCT04669457|Analgesics|analgesics|mesh-ancestor
14189379|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
14189380|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189381|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14189382|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14189383|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14189384|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
14189385|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189386|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189387|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14189388|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14189389|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14189390|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14189391|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14480333|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14480334|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
14480335|NCT02486328|Midazolam|midazolam|mesh-list
14480336|NCT02486328|Meperidine|meperidine|mesh-list
14480337|NCT02486328|Remifentanil|remifentanil|mesh-list
14480338|NCT02486328|Propofol|propofol|mesh-list
14480339|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14480340|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480341|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480342|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14480343|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
14480344|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
14189392|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
14189393|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
14189394|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
14480345|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14480346|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14189395|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
14189396|NCT04669158|Idebenone|idebenone|mesh-list
14189397|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
14189398|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189399|NCT04669158|Protective Agents|protective agents|mesh-ancestor
14189400|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189401|NCT04669171|Rituximab|rituximab|mesh-list
14189402|NCT04669171|Lenalidomide|lenalidomide|mesh-list
14189403|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14189404|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189405|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
14189406|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189407|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189408|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14189409|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14189410|NCT04669171|Growth Substances|growth substances|mesh-ancestor
14189411|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
14189412|NCT04669145|Ropivacaine|ropivacaine|mesh-list
14189413|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
14189414|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
14189415|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189416|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480347|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14480348|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14480349|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
14480350|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
14480351|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480352|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480353|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14480354|NCT02486328|Narcotics|narcotics|mesh-ancestor
14480355|NCT02486328|Analgesics|analgesics|mesh-ancestor
14480356|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
14480357|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480358|NCT02486406|Ritonavir|ritonavir|mesh-list
14480359|NCT02486406|Ribavirin|ribavirin|mesh-list
14480360|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14480361|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14480362|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
14480363|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480364|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480365|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14480366|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14480367|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
14480368|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480369|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14480370|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14480371|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
14480372|NCT02486627|Levofloxacin|levofloxacin|mesh-list
14480373|NCT02486627|Ofloxacin|ofloxacin|mesh-list
14480374|NCT02486627|Meropenem|meropenem|mesh-list
14480375|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14480376|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480377|NCT02486627|Renal Agents|renal agents|mesh-ancestor
14480378|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14480379|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14480380|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14480381|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480382|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480383|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480384|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14480385|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14480386|NCT02486653|Tamsulosin|tamsulosin|mesh-list
14480387|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14480388|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14480389|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14480390|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
14480391|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480392|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480393|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480394|NCT02486653|Urological Agents|urological agents|mesh-ancestor
14480395|NCT02486757|Estradiol|estradiol|mesh-list
14480396|NCT02486757|Progesterone|progesterone|mesh-list
14480397|NCT02486757|Estrogens|estrogens|mesh-ancestor
14480398|NCT02486757|Hormones|hormones|mesh-ancestor
14189417|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
14189418|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527208|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189419|NCT04668976|Gemcitabine|gemcitabine|mesh-list
14189420|NCT04668976|Fluorouracil|fluorouracil|mesh-list
14189421|NCT04668976|Floxuridine|floxuridine|mesh-list
14189422|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
14189423|NCT04668976|Irinotecan|irinotecan|mesh-list
14189424|NCT04668976|Cetuximab|cetuximab|mesh-list
14189425|NCT04668976|Panitumumab|panitumumab|mesh-list
14189426|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14189427|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
14189428|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189429|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189430|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
14189431|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189432|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189433|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189434|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
14189435|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189436|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14189437|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14189438|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14189439|NCT04669366|Sunitinib|sunitinib|mesh-list
14189440|NCT04669366|Axitinib|axitinib|mesh-list
14189441|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189442|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14189443|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14189444|NCT04669366|Growth Substances|growth substances|mesh-ancestor
14189445|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189446|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
14189447|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14189448|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189449|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189450|NCT04669197|Gemcitabine|gemcitabine|mesh-list
14189451|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
14189452|NCT04669197|Paclitaxel|paclitaxel|mesh-list
14189453|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14189454|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14189455|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189456|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
14189457|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
14189458|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
14189459|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189460|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14189461|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
14189462|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
14189463|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189464|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189465|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189466|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
14189467|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189468|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
14189469|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14189470|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14189471|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189472|NCT04668859|Midodrine|midodrine|mesh-list
14189473|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
14189474|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
14189475|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189476|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189477|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14189478|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14189479|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14189480|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14189481|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
14189482|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189483|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237296|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237297|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14237298|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
14237299|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237300|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237301|NCT00121719|Lenvatinib|lenvatinib|mesh-list
14237302|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237303|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14189484|NCT04668456|Lidocaine|lidocaine|mesh-list
14189485|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
14189486|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
14189487|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
14189488|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189489|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189490|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
14189491|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189492|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14189493|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14189494|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14189495|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14189496|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189497|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14189498|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189499|NCT04668456|Analgesics|analgesics|mesh-ancestor
14189500|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14189501|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14189502|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14189503|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
14189504|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189505|NCT04668417|Vaccines|vaccines|mesh-list
14189506|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
14189507|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189508|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
14189509|NCT04668690|Analgesics|analgesics|mesh-ancestor
14189510|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
14189511|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189512|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189513|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189514|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14189515|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14189516|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189517|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189518|NCT04668469|Acetaminophen|acetaminophen|mesh-list
14189519|NCT04668469|Vitamins|vitamins|mesh-list
14189520|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
14189521|NCT04668469|Zinc|zinc|mesh-list
14189522|NCT04668469|Azithromycin|azithromycin|mesh-list
14189523|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
14189524|NCT04668469|Ivermectin|ivermectin|mesh-list
14189525|NCT04668469|Lactoferrin|lactoferrin|mesh-list
14189526|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
14189527|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
14189528|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189529|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189530|NCT04668469|Analgesics|analgesics|mesh-ancestor
14189531|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
14189532|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767672|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14767673|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14189533|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
14189534|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189535|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189536|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
14189537|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14189538|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14767674|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14767675|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14767676|NCT00631124|Diuretics|diuretics|mesh-ancestor
14767677|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
14767678|NCT00631150|Levetiracetam|levetiracetam|mesh-list
14189539|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189540|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189541|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189542|NCT04668469|Trace Elements|trace elements|mesh-ancestor
14189543|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
14189544|NCT04668469|Protective Agents|protective agents|mesh-ancestor
14189545|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14189546|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14189547|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
14189548|NCT04668469|Coagulants|coagulants|mesh-ancestor
14189549|NCT04668352|Dactolisib|dactolisib|mesh-list
14189550|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189551|NCT04668300|Durvalumab|durvalumab|mesh-list
14189552|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
14189553|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14189554|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
14189555|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14189556|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189557|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
14189558|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189559|NCT04668274|Resveratrol|resveratrol|mesh-list
14189560|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
14189561|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189562|NCT04668274|Protective Agents|protective agents|mesh-ancestor
14189563|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189564|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189565|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14189566|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14189567|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
14189568|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14189569|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14189570|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
14189571|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189572|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
14189573|NCT04668131|Protective Agents|protective agents|mesh-ancestor
14189574|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14189575|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14189576|NCT04667663|Dexamethasone|dexamethasone|mesh-list
14189577|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
14189578|NCT04667663|Daratumumab|daratumumab|mesh-list
14189579|NCT04667663|Pomalidomide|pomalidomide|mesh-list
14189580|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189581|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
14189582|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189583|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189584|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14189585|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
14189586|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189587|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189588|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14189589|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189590|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
14189591|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
14189592|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189593|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14189594|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
14189595|NCT04667663|Hormones|hormones|mesh-ancestor
14189596|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14189597|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14189598|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14189599|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14189600|NCT04667663|Growth Substances|growth substances|mesh-ancestor
14189601|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14189602|NCT04667910|Ranibizumab|ranibizumab|mesh-list
14189603|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14189604|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14189605|NCT04667910|Growth Substances|growth substances|mesh-ancestor
14189606|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189607|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
14189608|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939011|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14189609|NCT04667897|Ranibizumab|ranibizumab|mesh-list
14189610|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14189611|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14189612|NCT04667897|Growth Substances|growth substances|mesh-ancestor
14189613|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189614|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
14189615|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189616|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
14189617|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14189618|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
14189619|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189620|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
14189621|NCT04667819|Protective Agents|protective agents|mesh-ancestor
14189622|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14189623|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14189624|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14189625|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14189626|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189627|NCT04667351|Fluorouracil|fluorouracil|mesh-list
14189628|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
14189629|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189630|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14189631|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189632|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189633|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
14189634|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189635|NCT04667507|Dexamethasone|dexamethasone|mesh-list
14189636|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189637|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
14189638|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
14189639|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189640|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189641|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14189642|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
14189643|NCT04667507|Hormones|hormones|mesh-ancestor
14189644|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14189645|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14189646|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189647|NCT04667299|Amoxicillin|amoxicillin|mesh-list
14189648|NCT04667299|Metronidazole|metronidazole|mesh-list
14189649|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
14189650|NCT04667299|Rabeprazole|rabeprazole|mesh-list
14189651|NCT04667299|Bismuth|bismuth|mesh-list
14189652|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189653|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189654|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189655|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14189656|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14189657|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14189658|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14189659|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14480399|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480400|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480401|NCT02486757|Progestins|progestins|mesh-ancestor
14480402|NCT02486796|Ubiquinone|ubiquinone|mesh-list
14480403|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
14480404|NCT02486796|Melatonin|melatonin|mesh-list
14480405|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
14480406|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480407|NCT02486796|Protective Agents|protective agents|mesh-ancestor
14480408|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480409|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480410|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
14480411|NCT02486796|Vitamins|vitamins|mesh-ancestor
14480412|NCT02486952|Prednisone|prednisone|mesh-list
14480413|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
14480414|NCT02486952|Rituximab|rituximab|mesh-list
14480415|NCT02486952|Vincristine|vincristine|mesh-list
14480416|NCT02486952|Doxorubicin|doxorubicin|mesh-list
14480417|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14480418|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14480419|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
14480420|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767679|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
14189660|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189661|NCT04667299|Antacids|antacids|mesh-ancestor
14480421|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14480422|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14767680|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
14189662|NCT04667299|Diuretics|diuretics|mesh-ancestor
14189663|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
14189664|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189665|NCT04667299|Expectorants|expectorants|mesh-ancestor
14189666|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
14189667|NCT04667143|Metformin|metformin|mesh-list
14189668|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14189669|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189670|NCT04666948|Vancomycin|vancomycin|mesh-list
14189671|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189672|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189673|NCT04666987|Liraglutide|liraglutide|mesh-list
14189674|NCT04666987|Xultophy|xultophy|mesh-list
14189675|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14189676|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189677|NCT04666987|Incretins|incretins|mesh-ancestor
14189678|NCT04666987|Hormones|hormones|mesh-ancestor
14189679|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14189680|NCT04666805|Tamoxifen|tamoxifen|mesh-list
14189681|NCT04666805|Toremifene|toremifene|mesh-list
14189682|NCT04666805|Letrozole|letrozole|mesh-list
14189683|NCT04666805|Anastrozole|anastrozole|mesh-list
14189684|NCT04666805|Exemestane|exemestane|mesh-list
14189685|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189686|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14189687|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14189688|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189689|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189690|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14189691|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
14189692|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14189693|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189694|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14189695|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14189696|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14189697|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14189698|NCT04667117|Ofatumumab|ofatumumab|mesh-list
14189699|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237304|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237305|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237306|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
14237307|NCT00121810|Sirolimus|sirolimus|mesh-list
14237308|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14237309|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14237310|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237311|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14237312|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
14237313|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14237314|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237315|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237316|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237317|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
14237318|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237319|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
14767681|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
14767682|NCT00631202|Hematinics|hematinics|mesh-ancestor
14767683|NCT00631228|Everolimus|everolimus|mesh-list
14767684|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767685|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767686|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
14767687|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767688|NCT00631501|Doxycycline|doxycycline|mesh-list
14767689|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14237320|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767690|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189700|NCT04666675|Upadacitinib|upadacitinib|mesh-list
14189701|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14189702|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14189703|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189704|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189705|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189706|NCT04666701|Ketorolac|ketorolac|mesh-list
14189707|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14189708|NCT04666701|Scopolamine|scopolamine|mesh-list
14189709|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14189710|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14189711|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189712|NCT04666701|Analgesics|analgesics|mesh-ancestor
14189713|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
14189714|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189715|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767691|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
14939012|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14189716|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189717|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189718|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14189719|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189720|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189721|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14189722|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
14189723|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
14189724|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14189725|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
14189726|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14189727|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
14189728|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189729|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14189730|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
14189731|NCT04666623|Esketamine|esketamine|mesh-list
14189732|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
14189733|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14189734|NCT04666714|Pregabalin|pregabalin|mesh-list
14189735|NCT04666714|Analgesics|analgesics|mesh-ancestor
14189736|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
14189737|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189738|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189739|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
14189740|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14189741|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14189742|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189743|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14189744|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14189745|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14189746|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189747|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14189748|NCT04666324|Simethicone|simethicone|mesh-list
14189749|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
14189750|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189751|NCT04666324|Emollients|emollients|mesh-ancestor
14189752|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
14189753|NCT04666649|Venetoclax|venetoclax|mesh-list
14189754|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189755|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14189756|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
14939013|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14189757|NCT04666051|Coagulants|coagulants|mesh-ancestor
14189758|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
14189759|NCT04666168|Fludarabine|fludarabine|mesh-list
14189760|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189761|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
14189762|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189763|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767692|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14939014|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
14189764|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14767693|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14767694|NCT00631514|Acetaminophen|acetaminophen|mesh-list
14767695|NCT00631514|Ibuprofen|ibuprofen|mesh-list
14767696|NCT00631514|Piroxicam|piroxicam|mesh-list
14767697|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14767698|NCT00631514|Analgesics|analgesics|mesh-ancestor
14767699|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
14189765|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
14189766|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189767|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189768|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14189769|NCT04665895|Fluticasone|fluticasone|mesh-list
14189770|NCT04665895|Xhance|xhance|mesh-list
14189771|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14189772|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14189773|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
14189774|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189775|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189776|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14189777|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
14189778|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
14189779|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14189780|NCT04665986|Docetaxel|docetaxel|mesh-list
14189781|NCT04665986|Vinorelbine|vinorelbine|mesh-list
14189782|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189783|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
14189784|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
14189785|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
14189786|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189787|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14189788|NCT04665830|Evolocumab|evolocumab|mesh-list
14189789|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14189790|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14189791|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
14189792|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189793|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14189794|NCT04665791|Vaccines|vaccines|mesh-list
14189795|NCT04665791|Immunologic Factors|immunologic factors|mesh-ancestor
14189796|NCT04665791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189797|NCT04665531|Ropivacaine|ropivacaine|mesh-list
14189798|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
14189799|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
14189800|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189801|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189802|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
14189803|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189804|NCT04665765|Rituximab|rituximab|mesh-list
14189805|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14189806|NCT04665765|Carboplatin|carboplatin|mesh-list
14189807|NCT04665765|Etoposide|etoposide|mesh-list
14189808|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
14189809|NCT04665765|Ifosfamide|ifosfamide|mesh-list
14189810|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
14189811|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
14189812|NCT04665765|Antibodies|antibodies|mesh-list
14189813|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
14189814|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14189815|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
14189816|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
14189817|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189818|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189819|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189820|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14189821|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14189822|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14189823|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189824|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189825|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14189826|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
14189827|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
14189828|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
14189829|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
14189830|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
14189831|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
14189832|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14189833|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
14189834|NCT04665453|Melatonin|melatonin|mesh-list
14189835|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14189836|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189837|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189838|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14189839|NCT04665453|Analgesics|analgesics|mesh-ancestor
14189840|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
14189841|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14189842|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14189843|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14189844|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14189845|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
14189846|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189847|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189848|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
14189849|NCT04665453|Protective Agents|protective agents|mesh-ancestor
14189850|NCT04665362|Apatinib|apatinib|mesh-list
14189851|NCT04665362|Antibodies|antibodies|mesh-list
14189852|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
14189853|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189854|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189855|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14189856|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189857|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189858|NCT04665648|Nicorandil|nicorandil|mesh-list
14189859|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14189860|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14189861|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
14189862|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
14189863|NCT04665648|Vitamins|vitamins|mesh-ancestor
14189864|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
14189865|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189866|NCT04665232|Progesterone|progesterone|mesh-list
14189867|NCT04665232|Progestins|progestins|mesh-ancestor
14189868|NCT04665232|Hormones|hormones|mesh-ancestor
14189869|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14189870|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189871|NCT04665141|Omalizumab|omalizumab|mesh-list
14189872|NCT04665141|Benralizumab|benralizumab|mesh-list
14189873|NCT04665141|Reslizumab|reslizumab|mesh-list
14189874|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14189875|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14189876|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
14189877|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
14189878|NCT04665063|Fludarabine|fludarabine|mesh-list
14189879|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189880|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
14189881|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189882|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189883|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14189884|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
14189885|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189886|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189887|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14189888|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
14189889|NCT04665076|Fludarabine|fludarabine|mesh-list
14189890|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189891|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
14189892|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189893|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14189894|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14189895|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
14189896|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189897|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480423|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
14939015|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14939016|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
14939017|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14939018|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14939019|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
14939020|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
14939021|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14939022|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
14939023|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
14189898|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14939024|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14939025|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14939026|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
14939027|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
14939028|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14939029|NCT01485718|Cathartics|cathartics|mesh-ancestor
14767700|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767701|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767702|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
14767703|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14767704|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767705|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767706|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14939030|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939031|NCT01485731|Nelfinavir|nelfinavir|mesh-list
14939032|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14939033|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14939034|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
14939035|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939036|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939037|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14939038|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14939039|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
14939040|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939041|NCT01485744|Leucovorin|leucovorin|mesh-list
14939042|NCT01485744|Fluorouracil|fluorouracil|mesh-list
14939043|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
14939044|NCT01485744|Irinotecan|irinotecan|mesh-list
14939045|NCT01485744|Folfirinox|folfirinox|mesh-list
14939046|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
14939047|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939048|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14939049|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480424|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480425|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480426|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14480427|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480428|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480429|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
14480430|NCT02486952|Hormones|hormones|mesh-ancestor
14480431|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480432|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14480433|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14480434|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
14480435|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
14480436|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
14480437|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14480438|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14480439|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14480440|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480441|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
14480442|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14480443|NCT02487030|Ledipasvir|ledipasvir|mesh-list
14767707|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767708|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767709|NCT00631527|Sunitinib|sunitinib|mesh-list
14767710|NCT00631527|Leuprolide|leuprolide|mesh-list
14767711|NCT00631527|Goserelin|goserelin|mesh-list
14767712|NCT00631527|Bicalutamide|bicalutamide|mesh-list
14767713|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767714|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14767715|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14189899|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14189900|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
14189901|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189902|NCT04665284|Empagliflozin|empagliflozin|mesh-list
14189903|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14189904|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189905|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14189906|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767716|NCT00631527|Growth Substances|growth substances|mesh-ancestor
14767717|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939050|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939051|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
14189917|NCT04665310|Tacrolimus|tacrolimus|mesh-list
14189918|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14189919|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
14189920|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189921|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14189922|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189923|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939052|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939053|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14939054|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14939055|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939056|NCT01485744|Antidotes|antidotes|mesh-ancestor
14939057|NCT01485744|Protective Agents|protective agents|mesh-ancestor
14939058|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
14939059|NCT01485744|Vitamins|vitamins|mesh-ancestor
14939060|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
14939061|NCT01485809|Gefitinib|gefitinib|mesh-list
14939062|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939063|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14939064|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939065|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939066|NCT01485822|Travoprost|travoprost|mesh-list
14939067|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14939068|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14189924|NCT04664894|Ribavirin|ribavirin|mesh-list
14189925|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
14189926|NCT04664894|Velpatasvir|velpatasvir|mesh-list
14189927|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
14189928|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189929|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
14189930|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189931|NCT04664803|Cefdinir|cefdinir|mesh-list
14189932|NCT04664803|Cefetamet|cefetamet|mesh-list
14189933|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14189934|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189935|NCT04664725|Repaglinide|repaglinide|mesh-list
14189936|NCT04664725|Bupropion|bupropion|mesh-list
14189937|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14189938|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
14189939|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14189940|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14189941|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14189942|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14189943|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189944|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
14189945|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14189946|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189947|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14189948|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14189949|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14189950|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14237321|NCT00121836|Bevacizumab|bevacizumab|mesh-list
14237322|NCT00121836|Capecitabine|capecitabine|mesh-list
14237323|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237324|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237325|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237326|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237327|NCT00121836|Growth Substances|growth substances|mesh-ancestor
14237328|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237329|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237330|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237331|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
14237332|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237333|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
14237334|NCT00121992|Docetaxel|docetaxel|mesh-list
14237335|NCT00121992|Doxorubicin|doxorubicin|mesh-list
14237336|NCT00121992|Fluorouracil|fluorouracil|mesh-list
14237337|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237338|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
14237339|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237340|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237341|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14237342|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
14237343|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237344|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939069|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14939070|NCT01485835|Dexamethasone|dexamethasone|mesh-list
14189951|NCT04664829|Capecitabine|capecitabine|mesh-list
14189952|NCT04664829|Bexarotene|bexarotene|mesh-list
14189953|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14189954|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
14189955|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189956|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189957|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
14189958|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
14189959|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
14189960|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14189961|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189962|NCT04664595|Propofol|propofol|mesh-list
14189963|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14189964|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189965|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189966|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14189967|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
14189968|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
14189969|NCT04664530|Esketamine|esketamine|mesh-list
14189970|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
14480444|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
14480445|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480446|NCT02487199|Ritonavir|ritonavir|mesh-list
14480447|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14480448|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14480449|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
14480450|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480451|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480452|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14480453|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14480454|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
14480455|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480456|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14480457|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14480458|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
14480459|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14480460|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480461|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480462|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14480463|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14480464|NCT02487225|Protective Agents|protective agents|mesh-ancestor
14480465|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480466|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
14480467|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14480468|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
14480469|NCT02487303|Acetaminophen|acetaminophen|mesh-list
14480470|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14480471|NCT02487303|Analgesics|analgesics|mesh-ancestor
14480472|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
14480473|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480474|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480475|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
14480476|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
14480477|NCT02487446|Bromides|bromides|mesh-list
14480478|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
14480479|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480480|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14480481|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14480482|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14480483|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
14480484|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480485|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480486|NCT02487485|Sirolimus|sirolimus|mesh-list
14480487|NCT02487485|Ketamine|ketamine|mesh-list
14480488|NCT02487485|Analgesics|analgesics|mesh-ancestor
14480489|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
14480490|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480491|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480492|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14480493|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14480494|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
14480495|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
14189971|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14189972|NCT04664361|Niacinamide|niacinamide|mesh-list
14189973|NCT04664361|Niacin|niacin|mesh-list
14189974|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
14480496|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189975|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
14189976|NCT04664361|Vitamins|vitamins|mesh-ancestor
14189977|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
14189978|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189979|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14189980|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
14189981|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14189982|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14189983|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
14189984|NCT04664517|Anesthetics|anesthetics|mesh-list
14189985|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14189986|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189987|NCT04664010|Vitamins|vitamins|mesh-list
14189988|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
14189989|NCT04664010|Interferons|interferons|mesh-list
14189990|NCT04664010|Ribavirin|ribavirin|mesh-list
14189991|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
14189992|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14189993|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
14189994|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14189995|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14189996|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
14189997|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14189998|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
14189999|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190000|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
14190001|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
14190002|NCT04664010|Protective Agents|protective agents|mesh-ancestor
14190003|NCT04664127|Valacyclovir|valacyclovir|mesh-list
14190004|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
14190005|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190006|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14190007|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14190008|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14190009|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14190010|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190011|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190012|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190013|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14190014|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
14190015|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14190016|NCT04663763|Capecitabine|capecitabine|mesh-list
14190017|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
14190018|NCT04663763|Antibodies|antibodies|mesh-list
14190019|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
14190020|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190021|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14190022|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
14190023|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190024|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190025|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
14190026|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14190027|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190028|NCT04664023|Vaccines|vaccines|mesh-list
14190029|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
14190030|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190031|NCT04663386|Budesonide|budesonide|mesh-list
14767718|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
14767719|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14767720|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767721|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767722|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14190032|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
14190033|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190034|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14190035|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
14190036|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190037|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190038|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14190039|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
14190040|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
14190041|NCT04663386|Hormones|hormones|mesh-ancestor
14190042|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190043|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14190044|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14190045|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14190046|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190047|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190048|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190049|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
14190050|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
14190051|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14190052|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
14190053|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14190054|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190055|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14190056|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14190057|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14190058|NCT04663295|Insulin|insulin|mesh-list
14190059|NCT04663295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190060|NCT04663295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190061|NCT04663269|Dexamethasone|dexamethasone|mesh-list
14190062|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190063|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
14190064|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
14190065|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190066|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190067|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14190068|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
14190069|NCT04663269|Hormones|hormones|mesh-ancestor
14190070|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190071|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190072|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237345|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14237346|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14237347|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14237348|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14237349|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14237350|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14237351|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14237352|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237353|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
14237354|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237355|NCT00122278|Dexamethasone|dexamethasone|mesh-list
14237356|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237357|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
14237358|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
14237359|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237360|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237361|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14237362|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
14237363|NCT00122278|Hormones|hormones|mesh-ancestor
14237364|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237365|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14237366|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237367|NCT00122317|Eculizumab|eculizumab|mesh-list
14237368|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14237369|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237370|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
14237371|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237372|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14237373|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14237374|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237375|NCT00122382|Methotrexate|methotrexate|mesh-list
14237376|NCT00122382|Abatacept|abatacept|mesh-list
14237377|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14237378|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
14237379|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14237380|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237381|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237382|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
14237383|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237384|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237385|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237386|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237387|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14237388|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237389|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
14237390|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767723|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
14190073|NCT04662788|Antibodies|antibodies|mesh-list
14190074|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14190075|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
14190076|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190077|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14190078|NCT04662736|Tedizolid|tedizolid|mesh-list
14190079|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190080|NCT04662840|Anesthetics|anesthetics|mesh-list
14190081|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
14190082|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190083|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190084|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
14190085|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190086|NCT04662866|Metformin|metformin|mesh-list
14190087|NCT04662866|Pioglitazone|pioglitazone|mesh-list
14190088|NCT04662866|Empagliflozin|empagliflozin|mesh-list
14190089|NCT04662866|Linagliptin|linagliptin|mesh-list
14190090|NCT04662866|Biguanides|biguanides|mesh-list
14190091|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
14190092|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190093|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190094|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14190095|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190096|NCT04662866|Incretins|incretins|mesh-ancestor
14190097|NCT04662866|Hormones|hormones|mesh-ancestor
14190098|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190099|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14190100|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190101|NCT04662476|Vitamin D|vitamin d|mesh-list
14190102|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
14190103|NCT04662476|Vitamins|vitamins|mesh-ancestor
14190104|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
14190105|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190106|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14190107|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14190108|NCT04662567|Acetaminophen|acetaminophen|mesh-list
14190109|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190110|NCT04662567|Analgesics|analgesics|mesh-ancestor
14190111|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
14190112|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190113|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190114|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
14190115|NCT04662658|Xenon|xenon|mesh-list
14190116|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14190117|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
14190118|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
14190119|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190120|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190121|NCT04662385|Listerine|listerine|mesh-list
14190122|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
14190123|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
14190124|NCT04662385|Protective Agents|protective agents|mesh-ancestor
14190125|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190126|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14190127|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190128|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
14190129|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14190130|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190131|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190132|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190133|NCT04662177|Analgesics|analgesics|mesh-ancestor
14190134|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
14190135|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190136|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14190137|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14190138|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14190139|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190140|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190141|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190142|NCT04662125|Acetaminophen|acetaminophen|mesh-list
14190143|NCT04662125|Prednisolone|prednisolone|mesh-list
14190144|NCT04662125|Pregabalin|pregabalin|mesh-list
14190145|NCT04662125|Caffeine|caffeine|mesh-list
14190146|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190147|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
14190148|NCT04662125|Hormones|hormones|mesh-ancestor
14190149|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190150|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190151|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190152|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190153|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190154|NCT04662125|Analgesics|analgesics|mesh-ancestor
14190155|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
14190156|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
14190157|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14190158|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14190159|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190160|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14190161|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14190162|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14190163|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190164|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14190165|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190166|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
14190167|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14190168|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14190169|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190170|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14190171|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14190172|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
14190173|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190174|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
14190175|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190176|NCT04662242|Selenium|selenium|mesh-list
14190177|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
14190178|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190179|NCT04662242|Protective Agents|protective agents|mesh-ancestor
14190180|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190181|NCT04662242|Trace Elements|trace elements|mesh-ancestor
14190182|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
14190183|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
14480497|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14480498|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14480499|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480500|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480501|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14480502|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480503|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14480504|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767724|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14939071|NCT01485835|Bortezomib|bortezomib|mesh-list
14939072|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939073|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
14939074|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
14939075|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939076|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939077|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939078|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
14939079|NCT01485835|Hormones|hormones|mesh-ancestor
14939080|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14939081|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14939082|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190184|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767725|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14767726|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
14767727|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
14767728|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767729|NCT00631579|Rasburicase|rasburicase|mesh-list
14767730|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
14767731|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939083|NCT01485848|Paclitaxel|paclitaxel|mesh-list
14939084|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14190185|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
14190186|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
14190187|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14190188|NCT04661709|Aspirin|aspirin|mesh-list
14190189|NCT04661709|Metoprolol|metoprolol|mesh-list
14190190|NCT04661709|Isosorbide|isosorbide|mesh-list
14939085|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939086|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
14190191|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14190192|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14190193|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
14480505|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
14480506|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14480507|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
14480508|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
14480509|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14480510|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14480511|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14480512|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
14480513|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480514|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480515|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480516|NCT02487563|Decitabine|decitabine|mesh-list
14480517|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14480518|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
14480519|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480520|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480521|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480522|NCT02488070|Edetic Acid|edetic acid|mesh-list
14480523|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
14480524|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
14480525|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480526|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
14480527|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14480528|NCT02488330|Bevacizumab|bevacizumab|mesh-list
14480529|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14480530|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480531|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480532|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14480533|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14480534|NCT02488330|Growth Substances|growth substances|mesh-ancestor
14480535|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480536|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
14480537|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14480538|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480539|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480540|NCT02488980|Mefloquine|mefloquine|mesh-list
14480541|NCT02488980|Tafenoquine|tafenoquine|mesh-list
14480542|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
14480543|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14480544|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14480545|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480546|NCT02489227|Adalimumab|adalimumab|mesh-list
14480547|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480548|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527209|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527210|NCT04054193|Dexamethasone|dexamethasone|mesh-list
14527211|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
14527212|NCT04054193|Aprepitant|aprepitant|mesh-list
14527213|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
14527214|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14527215|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
14527216|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
14527217|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527218|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527219|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527220|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
14527221|NCT04054193|Hormones|hormones|mesh-ancestor
14527222|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527223|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14527224|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527225|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14527226|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527227|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527228|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14939087|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
14190194|NCT04661709|Trimetazidine|trimetazidine|mesh-list
14190195|NCT04661709|Clopidogrel|clopidogrel|mesh-list
14190196|NCT04661709|Atorvastatin|atorvastatin|mesh-list
14190197|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190198|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14190199|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190200|NCT04661709|Analgesics|analgesics|mesh-ancestor
14190201|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
14190202|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190203|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190204|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190205|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14190206|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14190207|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190208|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14190209|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14190210|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190211|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
14190212|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14190213|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14190214|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
14190215|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14190216|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14190217|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14190218|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14190219|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14190220|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
14190221|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190222|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14190223|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14190224|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
14190225|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
14190226|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14190227|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14767732|NCT00631592|Dolutegravir|dolutegravir|mesh-list
14767733|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14767734|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14767735|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767736|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767737|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14767738|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14767739|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
14767740|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190228|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14190229|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190230|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14190231|NCT04661709|Diuretics|diuretics|mesh-ancestor
14190232|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
14190233|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
14190234|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14190235|NCT04661696|Paclitaxel|paclitaxel|mesh-list
14190236|NCT04661696|Carboplatin|carboplatin|mesh-list
14190237|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14190238|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190239|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
14190240|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
14190241|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
14190242|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190243|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
14190244|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14190245|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190246|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190247|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190248|NCT04661475|Analgesics|analgesics|mesh-ancestor
14190249|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
14190250|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190251|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14190252|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14190253|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14190254|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190255|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190256|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190257|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
14190258|NCT04661852|Topotecan|topotecan|mesh-list
14190259|NCT04661852|Mitogens|mitogens|mesh-list
14480549|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
14767741|NCT00631618|Sunitinib|sunitinib|mesh-list
14190260|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190261|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
14190262|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190263|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190264|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14190265|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
14190266|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190267|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190268|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14190269|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14190270|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14190271|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190272|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
14190273|NCT04661345|Coagulase|coagulase|mesh-list
14190274|NCT04661345|Coagulants|coagulants|mesh-ancestor
14190275|NCT04661397|Tenofovir|tenofovir|mesh-list
14190276|NCT04661397|Emtricitabine|emtricitabine|mesh-list
14190277|NCT04661397|Darunavir|darunavir|mesh-list
14190278|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14190279|NCT04661397|Cobicistat|cobicistat|mesh-list
14190280|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14190281|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
14190282|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190283|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14190284|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14190285|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190286|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190287|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14190288|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14190289|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14190290|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14190291|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14190292|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14190293|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14190294|NCT04660773|Pregabalin|pregabalin|mesh-list
14190295|NCT04660773|Analgesics|analgesics|mesh-ancestor
14190296|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
14190297|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190298|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939088|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
14190299|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
14190300|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14190301|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14190302|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190303|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14190304|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14190305|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14190306|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190307|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14190308|NCT04660916|Isotretinoin|isotretinoin|mesh-list
14190309|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237391|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14237392|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14237393|NCT00122447|Aspirin|aspirin|mesh-list
14237394|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
14237395|NCT00122447|Olmesartan|olmesartan|mesh-list
14237396|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14237397|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14237398|NCT00122447|Analgesics|analgesics|mesh-ancestor
14237399|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
15034840|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14237400|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237401|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237402|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237403|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237404|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14237405|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14237406|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237407|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14237408|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14237409|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480550|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480551|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480552|NCT02489500|Bortezomib|bortezomib|mesh-list
14767742|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767743|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14767744|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14767745|NCT00631618|Growth Substances|growth substances|mesh-ancestor
14767746|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767747|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
14767748|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14767749|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767750|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767751|NCT00631631|Mifamurtide|mifamurtide|mesh-list
14767752|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14767753|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
14767754|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767755|NCT00631722|Haloperidol|haloperidol|mesh-list
14939089|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939090|NCT01485926|Carboplatin|carboplatin|mesh-list
14939091|NCT01485926|Docetaxel|docetaxel|mesh-list
14939092|NCT01485926|Trastuzumab|trastuzumab|mesh-list
14939093|NCT01485926|Lapatinib|lapatinib|mesh-list
14939094|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939095|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
14939096|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
14939097|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
14939098|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939099|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14190310|NCT04660786|Vitamin D|vitamin d|mesh-list
14190311|NCT04660786|Triamcinolone|triamcinolone|mesh-list
14190312|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14190313|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14190314|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14190315|NCT04660786|Vitamins|vitamins|mesh-ancestor
14190316|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
14190317|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190318|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14190319|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190320|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
14190321|NCT04660786|Hormones|hormones|mesh-ancestor
14190322|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190323|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190324|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
14190325|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190326|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190327|NCT04660643|Tirzepatide|tirzepatide|mesh-list
14190328|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190329|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190330|NCT04660643|Incretins|incretins|mesh-ancestor
14190331|NCT04660643|Hormones|hormones|mesh-ancestor
14190332|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190333|NCT04660461|Lansoprazole|lansoprazole|mesh-list
14190334|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
14190335|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14190336|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14190337|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14190338|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190339|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190340|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
14190341|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190342|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190343|NCT04660565|Prednisone|prednisone|mesh-list
14190344|NCT04660565|Belimumab|belimumab|mesh-list
14190345|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190346|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
14190347|NCT04660565|Hormones|hormones|mesh-ancestor
14190348|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190349|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190350|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190351|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190352|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190353|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
14190354|NCT04660110|Piperaquine|piperaquine|mesh-list
14190355|NCT04660110|Artenimol|artenimol|mesh-list
14190356|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
14939100|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14190357|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14767756|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
14939101|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190358|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14190359|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190360|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14190361|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14190362|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190363|NCT04659915|Metformin|metformin|mesh-list
14190364|NCT04659915|Prednisone|prednisone|mesh-list
14190365|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190366|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190367|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190368|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
14190369|NCT04659915|Hormones|hormones|mesh-ancestor
14190370|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190371|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190372|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190373|NCT04660123|Bismuth|bismuth|mesh-list
14190374|NCT04660123|Antacids|antacids|mesh-ancestor
14190375|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190376|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14190377|NCT04659785|Apatinib|apatinib|mesh-list
14190378|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190379|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14190380|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190381|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190387|NCT04659525|Ezetimibe|ezetimibe|mesh-list
14190388|NCT04659525|Evolocumab|evolocumab|mesh-list
14190389|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14190390|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14190391|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
14190392|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190393|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14190394|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
14190395|NCT04659551|Nivolumab|nivolumab|mesh-list
14190396|NCT04659551|Epirubicin|epirubicin|mesh-list
14190397|NCT04659551|Exemestane|exemestane|mesh-list
14190398|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14190399|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190400|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
14190401|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190402|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190403|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14190404|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
14190405|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190406|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190407|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14190408|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14190409|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14190410|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14190411|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14190412|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14190413|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190414|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14190415|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14190416|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14190417|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
14190418|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190419|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
14190420|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14190421|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
14190422|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14190423|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14190424|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190425|NCT04659616|Cytarabine|cytarabine|mesh-list
14190426|NCT04659616|Daunorubicin|daunorubicin|mesh-list
14190427|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14190428|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
14190429|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190430|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190431|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
14190432|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190433|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190434|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
14190435|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190436|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14190437|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14190438|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14190439|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190440|NCT04659499|Paclitaxel|paclitaxel|mesh-list
14190441|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14190442|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190443|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14190444|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14190445|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14190446|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190447|NCT04659642|Fentanyl|fentanyl|mesh-list
14190448|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
14190449|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14190450|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190451|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190452|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190453|NCT04659642|Analgesics|analgesics|mesh-ancestor
14480553|NCT02489500|Melphalan|melphalan|mesh-list
14480554|NCT02489500|Sargramostim|sargramostim|mesh-list
14480555|NCT02489500|Lenograstim|lenograstim|mesh-list
14480556|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480557|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14480558|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
14480559|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480560|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14480561|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14480562|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
14480563|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480564|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14480565|NCT02489630|Ketamine|ketamine|mesh-list
14480566|NCT02489630|Analgesics|analgesics|mesh-list
14480567|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
14480568|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480569|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480570|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14480571|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14480572|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
14480573|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
14480574|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480575|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14480576|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14480577|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480578|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480579|NCT02489734|Sevoflurane|sevoflurane|mesh-list
14480580|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14480581|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14480582|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
14480583|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
14480584|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939102|NCT01485939|Lidocaine|lidocaine|mesh-list
14939103|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
14939104|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
14939105|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939106|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939107|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
14939108|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939109|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14939110|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14939111|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14939112|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939113|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939114|NCT01485978|Ramipril|ramipril|mesh-list
15034841|NCT01997658|Protective Agents|protective agents|mesh-ancestor
14480585|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480586|NCT02489968|Empagliflozin|empagliflozin|mesh-list
14480587|NCT02489968|Linagliptin|linagliptin|mesh-list
14480588|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14480589|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480590|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14480591|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190454|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
14190455|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190456|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14190457|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14190458|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14190459|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190460|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190461|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190462|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14190463|NCT04659642|Narcotics|narcotics|mesh-ancestor
14190464|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14190465|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14190466|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
14190467|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
14190468|NCT04659278|Peppermint oil|peppermint oil|mesh-list
14190469|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
14190470|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
14190471|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190472|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190473|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14190474|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
14190475|NCT04659109|Glenzocimab|glenzocimab|mesh-list
14190476|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
14190477|NCT04659070|Telmisartan|telmisartan|mesh-list
14190478|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14190479|NCT04659070|Ezetimibe|ezetimibe|mesh-list
14190480|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14190481|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14190482|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
14190483|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190484|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14190485|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14190486|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190487|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14190488|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14190489|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14190490|NCT04658927|Dexamethasone|dexamethasone|mesh-list
14190491|NCT04658927|Prednisone|prednisone|mesh-list
14190492|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190493|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
14190494|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
14190495|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190496|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190497|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767757|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
14767758|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
14767759|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767760|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767761|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767762|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14767763|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14767764|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767765|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767766|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14190498|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
14190499|NCT04658927|Hormones|hormones|mesh-ancestor
14237410|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
14237411|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14237412|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14237413|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14237414|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
14237415|NCT00122447|Protective Agents|protective agents|mesh-ancestor
14237416|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
14237417|NCT00122447|Vitamins|vitamins|mesh-ancestor
14237418|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
14237419|NCT00122460|Cisplatin|cisplatin|mesh-list
14237420|NCT00122460|Carboplatin|carboplatin|mesh-list
14237421|NCT00122460|Fluorouracil|fluorouracil|mesh-list
14237422|NCT00122460|Cetuximab|cetuximab|mesh-list
14237423|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237424|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
14237425|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237426|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237427|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237428|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
14237429|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237430|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14190500|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190501|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190502|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237431|NCT00122681|Vaccines|vaccines|mesh-list
14237432|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
14237433|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237434|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
14237435|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237436|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
14237437|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237438|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237439|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14237440|NCT00123110|Metformin|metformin|mesh-list
14237441|NCT00123110|Leuprolide|leuprolide|mesh-list
14237442|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14237443|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237444|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14237445|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
14237446|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14237447|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14237448|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237449|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
14237450|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14237451|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14237452|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237453|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
14237454|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237455|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
14237456|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237457|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
14237458|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14237459|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14237460|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237461|NCT00123162|Urological Agents|urological agents|mesh-ancestor
14237462|NCT00123474|Dasatinib|dasatinib|mesh-list
14237463|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237464|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237465|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237466|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237467|NCT00123487|Dasatinib|dasatinib|mesh-list
14237468|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237469|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237470|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237471|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237472|NCT00123604|Metoprolol|metoprolol|mesh-list
14237473|NCT00123604|Carvedilol|carvedilol|mesh-list
14237474|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14237475|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14237476|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
14237477|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
14237478|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237479|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237480|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14237481|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14237482|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14237483|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
14237484|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14237485|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237486|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
14237487|NCT00123604|Protective Agents|protective agents|mesh-ancestor
14237488|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14237489|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14237490|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14237491|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
14237492|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14237493|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14237494|NCT00123630|Omalizumab|omalizumab|mesh-list
14939115|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14939116|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
14939117|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939118|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939119|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14939120|NCT01486004|Simeprevir|simeprevir|mesh-list
14939121|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
14939122|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939123|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
14939124|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939125|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939126|NCT01486017|Peficitinib|peficitinib|mesh-list
14939127|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190503|NCT04659057|Lidocaine|lidocaine|mesh-list
14190504|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
14190505|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
14190506|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
14190507|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190508|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190509|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
14190510|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190511|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14190512|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14190513|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14190514|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14190515|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190516|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14190517|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190518|NCT04659057|Analgesics|analgesics|mesh-ancestor
14190519|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14190520|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14190521|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14190522|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190523|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190524|NCT04658836|Triamcinolone|triamcinolone|mesh-list
14190525|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14190526|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14190527|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14190528|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190529|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
14190530|NCT04658836|Hormones|hormones|mesh-ancestor
14190531|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190532|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190533|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190534|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
14190535|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190536|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190537|NCT04658680|Vaccines|vaccines|mesh-list
14190538|NCT04658680|Immunologic Factors|immunologic factors|mesh-ancestor
14190539|NCT04658680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190540|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
14190541|NCT04658732|Gabapentin|gabapentin|mesh-list
14190542|NCT04658732|Alprazolam|alprazolam|mesh-list
14190543|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14190544|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190545|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190546|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190547|NCT04658732|Analgesics|analgesics|mesh-ancestor
14190548|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
14190549|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190550|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14190551|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14190552|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14190553|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190554|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190555|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190556|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
14190557|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14190558|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14190559|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14190560|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14190561|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14190562|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
14190563|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
14190564|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
14190565|NCT04658420|Ketamine|ketamine|mesh-list
14190566|NCT04658420|Analgesics|analgesics|mesh-ancestor
14190567|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
14190568|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190569|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480592|NCT02489968|Incretins|incretins|mesh-ancestor
14939128|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190570|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14190571|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14190572|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
14190573|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
14190574|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190575|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14190576|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14190577|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190578|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190579|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14190580|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
14190581|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190582|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
14190583|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14190584|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
14190585|NCT04658355|Povidone|povidone|mesh-list
14190586|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14190587|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190588|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
14190589|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
14190590|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
14190591|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
14190592|NCT04658160|Imidacloprid|imidacloprid|mesh-list
14190593|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
14190594|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190595|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190596|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190597|NCT04658134|Glycine|glycine|mesh-list
14190598|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
14190599|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190600|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190601|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190602|NCT04657939|Pioglitazone|pioglitazone|mesh-list
14190603|NCT04657939|Liraglutide|liraglutide|mesh-list
14190604|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190605|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190606|NCT04657939|Incretins|incretins|mesh-ancestor
14190607|NCT04657939|Hormones|hormones|mesh-ancestor
14190608|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190609|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
14190610|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14190611|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190612|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
14190613|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14190614|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14190615|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190616|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190617|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
14190618|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190619|NCT04657497|Camostat|camostat|mesh-list
14190620|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
14190621|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190622|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190623|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14190624|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14190625|NCT04657692|Anesthetics|anesthetics|mesh-list
14190626|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190627|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190628|NCT04657484|Prednisolone|prednisolone|mesh-list
14190629|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14190630|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
14190631|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14190632|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
14190633|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14190634|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
14190635|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190636|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
14190637|NCT04657484|Hormones|hormones|mesh-ancestor
14190638|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190639|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190640|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190641|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190642|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
14190643|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
14190644|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190645|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14190646|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14190647|NCT04657484|Protective Agents|protective agents|mesh-ancestor
14190648|NCT04657107|Ketamine|ketamine|mesh-list
14190649|NCT04657107|Esketamine|esketamine|mesh-list
14190650|NCT04657107|Analgesics|analgesics|mesh-ancestor
14190651|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
14190652|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190653|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190654|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14190655|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14190656|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
14190657|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
14190658|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190659|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14190660|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14190661|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190662|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190663|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
14190664|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14190665|NCT04657172|Pilocarpine|pilocarpine|mesh-list
14190666|NCT04657172|Miotics|miotics|mesh-ancestor
14190667|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
14190668|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190669|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190670|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14190671|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14190672|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
14190673|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190674|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237495|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14237496|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14237497|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14237498|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
14237499|NCT00123643|Glyburide|glyburide|mesh-list
14237500|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14237501|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237502|NCT00123955|Spironolactone|spironolactone|mesh-list
14237503|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14237504|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
14237505|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237506|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237507|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14237508|NCT00123955|Diuretics|diuretics|mesh-ancestor
14237509|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
14237510|NCT00124020|Vancomycin|vancomycin|mesh-list
14237511|NCT00124020|Telavancin|telavancin|mesh-list
14237512|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14237513|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237514|NCT00124072|Folic Acid|folic acid|mesh-list
14237515|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
14237516|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
14237517|NCT00124072|Simvastatin|simvastatin|mesh-list
14237518|NCT00124072|Vitamins|vitamins|mesh-ancestor
14237519|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
14237520|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237521|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14237522|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14237523|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
14237524|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237525|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14237526|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14237527|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237528|NCT00124072|Hematinics|hematinics|mesh-ancestor
14237529|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
14237530|NCT00124176|Albuterol|albuterol|mesh-list
14237531|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14237532|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
14237533|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237534|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237535|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14237536|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
14237537|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
14237538|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14190675|NCT04656665|Aspirin|aspirin|mesh-list
14190676|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14190677|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190678|NCT04656665|Analgesics|analgesics|mesh-ancestor
14190679|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
14190680|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190681|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190682|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190683|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190684|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14190685|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14190686|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190687|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14190688|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14480593|NCT02489968|Hormones|hormones|mesh-ancestor
14480594|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480595|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14480596|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
14480597|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480598|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
14480599|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14939129|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939130|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
14939131|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939132|NCT01486082|Amoxicillin|amoxicillin|mesh-list
14480600|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
14480601|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480602|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480603|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14480604|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
14480605|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
14480606|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14939133|NCT01486082|Clarithromycin|clarithromycin|mesh-list
14939134|NCT01486082|Omeprazole|omeprazole|mesh-list
14939135|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14939136|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939137|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14939138|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939139|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14939140|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939141|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939142|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14939143|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14939144|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14939145|NCT01486251|Axitinib|axitinib|mesh-list
14939146|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939147|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14939148|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939149|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939150|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
14939151|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
14939152|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14939153|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939154|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939155|NCT01486433|Aspirin|aspirin|mesh-list
14939156|NCT01486433|Simvastatin|simvastatin|mesh-list
14939157|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14939158|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939159|NCT01486433|Analgesics|analgesics|mesh-ancestor
14480607|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
14480608|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480609|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480610|NCT02490293|Cephalosporins|cephalosporins|mesh-list
14480611|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14480612|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480613|NCT02490475|Docetaxel|docetaxel|mesh-list
14480614|NCT02490475|Pertuzumab|pertuzumab|mesh-list
14480615|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480616|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
14480617|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
14480618|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
14480619|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939160|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
14939161|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190689|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190690|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
14190691|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
14190692|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14190693|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14190694|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190695|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
14190696|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14190697|NCT04656041|Paclitaxel|paclitaxel|mesh-list
14190698|NCT04656041|Carboplatin|carboplatin|mesh-list
14190699|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14190700|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190701|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14190702|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14480620|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480621|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
14480622|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14480623|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14480624|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480625|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
14480626|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14480627|NCT02490670|Cephalexin|cephalexin|mesh-list
14480628|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14480629|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480630|NCT02490878|Bevacizumab|bevacizumab|mesh-list
14480631|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480632|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480633|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14480634|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14480635|NCT02490878|Growth Substances|growth substances|mesh-ancestor
14480636|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480637|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
14480638|NCT02491437|Progesterone|progesterone|mesh-list
14480639|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
14480640|NCT02491437|Progestins|progestins|mesh-ancestor
14480641|NCT02491437|Hormones|hormones|mesh-ancestor
14480642|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480643|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480644|NCT02491463|Vaccines|vaccines|mesh-list
14480645|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
14480646|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480647|NCT02491684|Interferons|interferons|mesh-list
14480648|NCT02491684|Interferon-beta|interferon-beta|mesh-list
14480649|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
14480650|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480651|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
14480652|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480653|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
14480654|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480655|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14480656|NCT02491788|Suvorexant|suvorexant|mesh-list
14480657|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14480658|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14480659|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480660|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480661|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14480662|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480663|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480664|NCT02491892|Pertuzumab|pertuzumab|mesh-list
14480665|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480666|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480667|NCT02491944|Osimertinib|osimertinib|mesh-list
14480668|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480669|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14480670|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480671|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480672|NCT02492451|Progesterone|progesterone|mesh-list
14480673|NCT02492451|Progestins|progestins|mesh-ancestor
14480674|NCT02492451|Hormones|hormones|mesh-ancestor
14480675|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480676|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480677|NCT02492750|Dexamethasone|dexamethasone|mesh-list
14480678|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
14480679|NCT02492750|Lenalidomide|lenalidomide|mesh-list
14480680|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14767767|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
14190703|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14190704|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190705|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14190706|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190707|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190708|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
14190709|NCT04656262|Doxorubicin|doxorubicin|mesh-list
14190710|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190711|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
14190712|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190713|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190714|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14190715|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
14190716|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190717|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190718|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14190719|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14190720|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14190721|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14190722|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190723|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14190724|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
14190725|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14190726|NCT04656184|Antibodies|antibodies|mesh-list
14190727|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
14190728|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14190729|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
14190730|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190731|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190732|NCT04656249|Lenvatinib|lenvatinib|mesh-list
14190733|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190734|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14190735|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190736|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190737|NCT04655482|Aflibercept|aflibercept|mesh-list
14190738|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14190739|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14190740|NCT04655482|Growth Substances|growth substances|mesh-ancestor
14190741|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190742|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
14190743|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190744|NCT04655807|Adalimumab|adalimumab|mesh-list
14190745|NCT04655807|Ustekinumab|ustekinumab|mesh-list
14190746|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190747|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190748|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
14190749|NCT04655664|Vitamin D|vitamin d|mesh-list
14190750|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
14190751|NCT04655664|Vitamins|vitamins|mesh-list
14480681|NCT02492750|Ichthammol|ichthammol|mesh-list
14480682|NCT02492750|BB 1101|bb 1101|mesh-list
14480683|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480684|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
14480685|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
14480686|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480687|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480688|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14480689|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
14480690|NCT02492750|Hormones|hormones|mesh-ancestor
14190752|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
14480691|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480692|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14480693|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480694|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
14480695|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14480696|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14480697|NCT02492750|Growth Substances|growth substances|mesh-ancestor
14480698|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
14480699|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
14480700|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480701|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480702|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14480703|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14480704|NCT02492763|Metformin|metformin|mesh-list
14480705|NCT02492763|Liraglutide|liraglutide|mesh-list
14480706|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190753|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190754|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14190755|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14190756|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
14190757|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14190758|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14190759|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14190760|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14190761|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
14190762|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190763|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190764|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14190765|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
14190766|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
14190767|NCT04655508|Hormones|hormones|mesh-ancestor
14190768|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190769|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
14190770|NCT04655729|Infliximab|infliximab|mesh-list
14190771|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
14190772|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14190773|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190774|NCT04655170|Albuterol|albuterol|mesh-list
14190775|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
14190776|NCT04655170|Ipratropium|ipratropium|mesh-list
14190777|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14190778|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14190779|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
14190780|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190781|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190782|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14190783|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
14190784|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14190785|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14190786|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14190787|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
14190788|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190789|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190790|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
14190791|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14190792|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
14190793|NCT04655183|Niraparib|niraparib|mesh-list
14190794|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14939162|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939163|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939164|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939165|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14939166|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14939167|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939168|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14939169|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14190795|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190796|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190797|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190798|NCT04655040|Caffeine|caffeine|mesh-list
14190799|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14190800|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190801|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14190802|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190803|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190804|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14190805|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14190806|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
14190807|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767768|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767769|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767770|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14767771|NCT00631813|Prucalopride|prucalopride|mesh-list
14767772|NCT00631813|Laxatives|laxatives|mesh-ancestor
14767773|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767774|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14767775|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14767776|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
14767777|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767778|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767779|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767780|NCT00631943|Pregabalin|pregabalin|mesh-list
14767781|NCT00631943|Analgesics|analgesics|mesh-ancestor
14767782|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
14190823|NCT04654962|Anesthetics|anesthetics|mesh-list
14190824|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190825|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237539|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14237540|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14237541|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14237542|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
14237543|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14237544|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237545|NCT00124449|Abatacept|abatacept|mesh-list
14237546|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14237547|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237548|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237549|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237550|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
14237551|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237552|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237553|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14237554|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
14237555|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14237556|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
14237557|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14237558|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237559|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14237560|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14237561|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237562|NCT00124579|Thalidomide|thalidomide|mesh-list
14237563|NCT00124579|Dexamethasone|dexamethasone|mesh-list
14237564|NCT00124579|Bortezomib|bortezomib|mesh-list
14237565|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237566|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
14237567|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
14237568|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237569|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237570|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939170|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190826|NCT04654416|Colchicine|colchicine|mesh-list
14190827|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
14190828|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190829|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
14190830|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
14190831|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
14190832|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190833|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190834|NCT04654676|Vildagliptin|vildagliptin|mesh-list
14190835|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190836|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190837|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14190838|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
14190839|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190840|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190841|NCT04654819|Anesthetics|anesthetics|mesh-list
14190842|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190843|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190844|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14190845|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
14190846|NCT04654741|Ganirelix|ganirelix|mesh-list
14190847|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14190848|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14190849|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14190850|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
14190851|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14190852|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190853|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14190854|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14190855|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14190856|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190857|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190858|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
14190859|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190860|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
14190861|NCT04654195|Doxorubicin|doxorubicin|mesh-list
14190862|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190863|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
14190864|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190865|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190866|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14190867|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
14190868|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190869|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190870|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14190871|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14190872|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14190873|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14190874|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190875|NCT04654208|Palbociclib|palbociclib|mesh-list
14190876|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190877|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14190878|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237571|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
14190879|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190880|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
14190881|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14190882|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14190883|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190884|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
14190885|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
14190886|NCT04654026|Aspirin|aspirin|mesh-list
14190887|NCT04654026|Clopidogrel|clopidogrel|mesh-list
14190888|NCT04654026|Ticagrelor|ticagrelor|mesh-list
14190889|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14190890|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190891|NCT04654026|Analgesics|analgesics|mesh-ancestor
14190892|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
14190893|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190894|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190895|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190896|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190897|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14190898|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14190899|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190900|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14190901|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14190902|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190903|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
14190904|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14190905|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14190906|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14190907|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
14190908|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14190909|NCT04653831|Pirfenidone|pirfenidone|mesh-list
14190910|NCT04653831|Analgesics|analgesics|mesh-ancestor
14190911|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
14190912|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190913|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190914|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14190915|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190916|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480707|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480708|NCT02492763|Incretins|incretins|mesh-ancestor
14480709|NCT02492763|Hormones|hormones|mesh-ancestor
14939171|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
14480710|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480711|NCT02492802|Posaconazole|posaconazole|mesh-list
14480712|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
14480713|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480714|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14480715|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14480716|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14480717|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14480718|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14480719|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480720|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480721|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14480722|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
14480723|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480724|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480725|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
14480726|NCT02492841|Calcium|calcium|mesh-list
14480727|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14480728|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480729|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14480730|NCT02492984|Factor VIII|factor viii|mesh-list
14480731|NCT02492984|Coagulants|coagulants|mesh-ancestor
14480732|NCT02492997|Glycerol|glycerol|mesh-list
14480733|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14480734|NCT02492997|Protective Agents|protective agents|mesh-ancestor
14480735|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480736|NCT02493257|Ethanol|ethanol|mesh-list
14480737|NCT02493257|Capsaicin|capsaicin|mesh-list
14480738|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14480739|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480740|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939172|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14190917|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190918|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190919|NCT04653506|Acetaminophen|acetaminophen|mesh-list
14190920|NCT04653506|Ibuprofen|ibuprofen|mesh-list
14190921|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14190922|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14190923|NCT04653506|Analgesics|analgesics|mesh-ancestor
14190924|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
14190925|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190926|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190927|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190928|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190929|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14190930|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14190931|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190932|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
14190933|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
14190934|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14190935|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14190936|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190937|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
14190938|NCT04653623|Coagulants|coagulants|mesh-ancestor
14190939|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
14190940|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14190941|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14190942|NCT04653792|Pregabalin|pregabalin|mesh-list
14190943|NCT04653792|Analgesics|analgesics|mesh-ancestor
14190944|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
14190945|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190946|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190947|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
14190948|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14190949|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14190950|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190951|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14190952|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14190953|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14190954|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190955|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14190956|NCT04653779|Metformin|metformin|mesh-list
14190957|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14190958|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190959|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
14190960|NCT04653493|Fludarabine|fludarabine|mesh-list
14190961|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14190962|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
14190963|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190964|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14190965|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14190966|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
14190967|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14190968|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190969|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14190970|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
14190971|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14190972|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14190973|NCT04653415|Prednisolone|prednisolone|mesh-list
14190974|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
14190975|NCT04653415|Gabapentin|gabapentin|mesh-list
14190976|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14190977|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
14190978|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14190979|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
14190980|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
14190981|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14190982|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14190983|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14190984|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
14190985|NCT04653415|Hormones|hormones|mesh-ancestor
14190986|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14190987|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14190988|NCT04653415|Protective Agents|protective agents|mesh-ancestor
14190989|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14190990|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14190991|NCT04653415|Analgesics|analgesics|mesh-ancestor
14190992|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
14190993|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
14190994|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14190995|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14190996|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14190997|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14190998|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14190999|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14191000|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191001|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191002|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
14191003|NCT04653246|Dexamethasone|dexamethasone|mesh-list
14191004|NCT04653246|Lenalidomide|lenalidomide|mesh-list
14191005|NCT04653246|Bortezomib|bortezomib|mesh-list
14191006|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191007|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
14191008|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
14191009|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191010|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191011|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191012|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
14191013|NCT04653246|Hormones|hormones|mesh-ancestor
14191014|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191015|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14191016|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191017|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
14191018|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14191019|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14191020|NCT04653246|Growth Substances|growth substances|mesh-ancestor
14191021|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
14191022|NCT04653337|Norepinephrine|norepinephrine|mesh-list
14191023|NCT04653337|Serotonin|serotonin|mesh-list
14191024|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
14191025|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14191026|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14191027|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191028|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191029|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191030|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191031|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
14191032|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
14191033|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191034|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14191035|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14191036|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
14191037|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14191038|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14237572|NCT00124579|Hormones|hormones|mesh-ancestor
14237573|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237574|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14237575|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237576|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237577|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
14237578|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
14237579|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14191039|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
14191040|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
14191041|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14191042|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14191043|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191044|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191045|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191046|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191047|NCT04652739|Prednisolone|prednisolone|mesh-list
14191048|NCT04652739|Lycopene|lycopene|mesh-list
14191049|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191050|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
14191051|NCT04652739|Hormones|hormones|mesh-ancestor
14191052|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191053|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191054|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14191055|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191056|NCT04652739|Protective Agents|protective agents|mesh-ancestor
14191057|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
14191058|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480741|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480742|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
14480743|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14480744|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
14480745|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480746|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
14480747|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480748|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480749|NCT02493452|Plecanatide|plecanatide|mesh-list
14480750|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14480751|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
14480752|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480753|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14480754|NCT02493517|Lanreotide|lanreotide|mesh-list
14480755|NCT02493517|Somatostatin|somatostatin|mesh-list
14480756|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480757|NCT02493517|Hormones|hormones|mesh-ancestor
14480758|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480759|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480760|NCT02493712|Mesalamine|mesalamine|mesh-list
14480761|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14480762|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14480763|NCT02493712|Analgesics|analgesics|mesh-ancestor
14480764|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
14480765|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480766|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480767|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480768|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14480769|NCT02493764|Tazobactam|tazobactam|mesh-list
14480770|NCT02493764|Linezolid|linezolid|mesh-list
14480771|NCT02493764|Piperacillin|piperacillin|mesh-list
14480772|NCT02493764|Imipenem|imipenem|mesh-list
14480773|NCT02493764|Relebactam|relebactam|mesh-list
14480774|NCT02493764|Cilastatin|cilastatin|mesh-list
14480775|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14480776|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480777|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14480778|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480779|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480780|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14480781|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
14480782|NCT02493777|Methylphenidate|methylphenidate|mesh-list
14480783|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14480784|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480785|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14480786|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14480787|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14480788|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480789|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
14480790|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480791|NCT02493855|Ritonavir|ritonavir|mesh-list
14480792|NCT02493855|Ribavirin|ribavirin|mesh-list
14480793|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14480794|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14191059|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14480795|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14191060|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14191061|NCT04652661|Midazolam|midazolam|mesh-list
14191062|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
14191063|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14191064|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191065|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191066|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14191067|NCT04652661|Analgesics|analgesics|mesh-ancestor
14191068|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
14191069|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191070|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14191071|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14191072|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14191073|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191074|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191075|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191076|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14191077|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14191078|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14191079|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14191080|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14191081|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
14191082|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
14191083|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
14191084|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
14191085|NCT04652765|Bicalutamide|bicalutamide|mesh-list
14191086|NCT04652765|Camostat|camostat|mesh-list
14191087|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
14191088|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
14191089|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191090|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191091|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191092|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
14191093|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191094|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191095|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14191096|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14767783|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767784|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767785|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
14767786|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14767787|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14767788|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767789|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191097|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
14191098|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14191099|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191100|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191101|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14191102|NCT04652427|Analgesics|analgesics|mesh-ancestor
14191103|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
14191104|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191105|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14191106|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14191107|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14191108|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191109|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191110|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191111|NCT04652440|Antibodies|antibodies|mesh-list
14191112|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14191113|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
14191114|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191115|NCT04652284|Amoxicillin|amoxicillin|mesh-list
14191116|NCT04652284|Clarithromycin|clarithromycin|mesh-list
14191117|NCT04652284|Rifabutin|rifabutin|mesh-list
14191118|NCT04652284|Tinidazole|tinidazole|mesh-list
14191119|NCT04652284|Esomeprazole|esomeprazole|mesh-list
14191120|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14191121|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191122|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14191123|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191124|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14191125|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191126|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191127|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14191128|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14191129|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14191130|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14191131|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
14191132|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
14191133|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14480796|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480797|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480798|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14480799|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14480800|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
14480801|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480802|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14480803|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14480804|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
14480805|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14480806|NCT02493868|Citalopram|citalopram|mesh-list
14480807|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14480808|NCT02493868|Sertraline|sertraline|mesh-list
14480809|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
14480810|NCT02493868|Esketamine|esketamine|mesh-list
14480811|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14480812|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14480813|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14480814|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480815|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480816|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
14480817|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480818|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14480819|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14480820|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480821|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14480822|NCT02493868|Analgesics|analgesics|mesh-ancestor
14480823|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
14480824|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
14480825|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
14480826|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14480827|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14480828|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14480829|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14480830|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480831|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
14480832|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480833|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480834|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14480835|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480836|NCT02494102|Modafinil|modafinil|mesh-list
14480837|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14480838|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480839|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14480840|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14480841|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14480842|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480843|NCT02494180|Fentanyl|fentanyl|mesh-list
14480844|NCT02494180|Midazolam|midazolam|mesh-list
14480845|NCT02494180|Diazepam|diazepam|mesh-list
14480846|NCT02494180|Meperidine|meperidine|mesh-list
14480847|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14480848|NCT02494180|Narcotics|narcotics|mesh-ancestor
14480849|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480850|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480851|NCT02494180|Analgesics|analgesics|mesh-ancestor
14480852|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
14480853|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480854|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14480855|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14939173|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14191134|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14191135|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14191136|NCT04652323|Calcium|calcium|mesh-list
14191137|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191138|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191139|NCT04651959|Favipiravir|favipiravir|mesh-list
14191140|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
14191141|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191142|NCT04652011|Analgesics|analgesics|mesh-list
14191143|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
14191144|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191145|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191146|NCT04652193|Anesthetics|anesthetics|mesh-list
14191147|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191148|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191149|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
14191150|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14191151|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191152|NCT04652115|Defibrotide|defibrotide|mesh-list
14191153|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14191154|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14191155|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191156|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14191157|NCT04652076|Paclitaxel|paclitaxel|mesh-list
14191158|NCT04652076|Carboplatin|carboplatin|mesh-list
14191159|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
14191160|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14191161|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191162|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
14191163|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
14191164|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
14191165|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191166|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14191167|NCT04651842|Insulin|insulin|mesh-list
14191168|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14191169|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191170|NCT04652089|Simvastatin|simvastatin|mesh-list
14191171|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14191172|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14191173|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
14191174|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191175|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14191176|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14191177|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191178|NCT04651595|Morphine|morphine|mesh-list
14191179|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14191180|NCT04651595|Narcotics|narcotics|mesh-ancestor
14191181|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191182|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191183|NCT04651595|Analgesics|analgesics|mesh-ancestor
14191184|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
14191185|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191186|NCT04651556|Acetaminophen|acetaminophen|mesh-list
14191187|NCT04651556|Ketorolac|ketorolac|mesh-list
14191188|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
14191189|NCT04651556|Bupivacaine|bupivacaine|mesh-list
14191190|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
14191191|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
14191192|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191193|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191194|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
14191195|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191196|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14191197|NCT04651556|Analgesics|analgesics|mesh-ancestor
14191198|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
14191199|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14191200|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191201|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191202|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14191203|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191204|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191205|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14191206|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
14191207|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14191208|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191209|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191210|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
14191211|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14191212|NCT04651049|Propranolol|propranolol|mesh-list
14191213|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14191214|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14191215|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191216|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191217|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191218|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191219|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14191220|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14191221|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14191222|NCT04651205|Thiamine|thiamine|mesh-list
14191223|NCT04651205|Vitamins|vitamins|mesh-ancestor
14191224|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
14191225|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191226|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
14237580|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237581|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237582|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237583|NCT00124579|Growth Substances|growth substances|mesh-ancestor
14237584|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237585|NCT00124618|Cetuximab|cetuximab|mesh-list
14237586|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237587|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237588|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14237589|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237590|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237591|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237592|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237593|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
14237594|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14237595|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14237596|NCT00124709|Analgesics|analgesics|mesh-ancestor
14237597|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
14237598|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237599|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237600|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237601|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237602|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237603|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237604|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
14237605|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14237606|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237607|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939174|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
14939175|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14939176|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14939177|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
14939178|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
14939179|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14939180|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939181|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939182|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
14237608|NCT00124735|Rocuronium|rocuronium|mesh-list
14237609|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14237610|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14237611|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14237612|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237613|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237614|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
14237615|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237616|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237617|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237618|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237619|NCT00124943|Paclitaxel|paclitaxel|mesh-list
14237620|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14237621|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14237622|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237623|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
14237624|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
14237625|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
14237626|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939183|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14237627|NCT00124982|Abatacept|abatacept|mesh-list
14237628|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
14191227|NCT04650893|Dexamethasone|dexamethasone|mesh-list
14191228|NCT04650893|Ketorolac|ketorolac|mesh-list
14191229|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191230|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
14191231|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
14191232|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191233|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191234|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191235|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
14191236|NCT04650893|Hormones|hormones|mesh-ancestor
14191237|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191238|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14191239|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191240|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14191241|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14191242|NCT04650893|Analgesics|analgesics|mesh-ancestor
14191243|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
14191244|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191245|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14191246|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191247|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191248|NCT04650841|Naloxone|naloxone|mesh-list
14191249|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14191250|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191251|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
14191252|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191253|NCT04650880|Vitamin D|vitamin d|mesh-list
14191254|NCT04650880|Vitamins|vitamins|mesh-ancestor
14191255|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
14191256|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191257|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14191258|NCT04650828|Tenofovir|tenofovir|mesh-list
14191259|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
14191260|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191261|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14191262|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14191263|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191264|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191265|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14191266|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14191267|NCT04650555|Genistein|genistein|mesh-list
14191268|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14191269|NCT04650555|Protective Agents|protective agents|mesh-ancestor
14191270|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191271|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191272|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14191273|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191274|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191275|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
14191276|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14191277|NCT04650555|Estrogens|estrogens|mesh-ancestor
14191278|NCT04650555|Hormones|hormones|mesh-ancestor
14191279|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191280|NCT04650542|Paroxetine|paroxetine|mesh-list
14191281|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14191282|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14191283|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191284|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191285|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191286|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
14191287|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191288|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14191289|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
14191290|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14191291|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14191292|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14191293|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191294|NCT04650269|Emtricitabine|emtricitabine|mesh-list
14191295|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
14191296|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191297|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14191298|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14191299|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480856|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
14191300|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191301|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14191302|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14191303|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14191304|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14191305|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191306|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
14191307|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
14191308|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191309|NCT04649892|Naltrexone|naltrexone|mesh-list
14191310|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14191311|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14191312|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191313|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
14191314|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191315|NCT04649723|Rifampin|rifampin|mesh-list
14191316|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14191317|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
14191318|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14191319|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191320|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
14191321|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14191322|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191323|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191324|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14191325|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14191326|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14191327|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14191328|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14191329|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14191330|NCT04649645|Nicotine|nicotine|mesh-list
14191331|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14191332|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
14191333|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191334|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191335|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14191336|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14191337|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
14191338|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191339|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191340|NCT04649229|Aprepitant|aprepitant|mesh-list
14191341|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14191342|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
14191343|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
14191344|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191345|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191346|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191347|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14191348|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191349|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191350|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14191351|NCT04649697|Clobetasol|clobetasol|mesh-list
14191352|NCT04649697|Rebamipide|rebamipide|mesh-list
14191353|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480857|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
14480858|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14480859|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14480860|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14480861|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14480862|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
14480863|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
14480864|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480865|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480866|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
14480867|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
14480868|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
14480869|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14480870|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14191354|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
14191355|NCT04649697|Hormones|hormones|mesh-ancestor
14191356|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191357|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191358|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14191359|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191360|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
14191361|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191362|NCT04649697|Protective Agents|protective agents|mesh-ancestor
14191363|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191364|NCT04649502|Metformin|metformin|mesh-list
14191365|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14191366|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191367|NCT04649398|Nimodipine|nimodipine|mesh-list
14191368|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14191369|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14191370|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191371|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191372|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191373|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191374|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
14191375|NCT04648891|Lidocaine|lidocaine|mesh-list
14191376|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
14191377|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
14191378|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191379|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191380|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
14191381|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191382|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14191383|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14191384|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14191385|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191386|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191387|NCT04648969|Hormones|hormones|mesh-list
14191388|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191389|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237629|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14237630|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237631|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237632|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237633|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
14237634|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237635|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
14237636|NCT00125034|Cetuximab|cetuximab|mesh-list
14237637|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237638|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237639|NCT00125138|Metylperon|metylperon|mesh-list
14237640|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14237641|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14237642|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14237643|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237644|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14237645|NCT00125164|Mecasermin|mecasermin|mesh-list
14237646|NCT00125164|Growth Substances|growth substances|mesh-ancestor
14237647|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237648|NCT00125190|Mecasermin|mecasermin|mesh-list
14237649|NCT00125190|Growth Substances|growth substances|mesh-ancestor
14237650|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237651|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14237652|NCT00125359|Bexarotene|bexarotene|mesh-list
14237653|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237654|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237655|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237656|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237657|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14237658|NCT00125372|Bexarotene|bexarotene|mesh-list
14237659|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237660|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237661|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237662|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237663|NCT00125515|Naltrexone|naltrexone|mesh-list
14237664|NCT00125515|Memantine|memantine|mesh-list
14237665|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14480871|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14191390|NCT04648813|Bromides|bromides|mesh-list
14191391|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
14191392|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14191393|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
14191394|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191395|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191396|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14191397|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
14191398|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
14191399|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14191400|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
14191401|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191402|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191403|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
14191404|NCT04648358|Dexamethasone|dexamethasone|mesh-list
14191405|NCT04648358|Bupivacaine|bupivacaine|mesh-list
14191406|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191407|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
14191408|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
14191409|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191410|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191411|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191412|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
14191413|NCT04648358|Hormones|hormones|mesh-ancestor
14191414|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237666|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14767790|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14767791|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14767792|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767793|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767794|NCT00631995|Vaccines|vaccines|mesh-list
14767795|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
14767796|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767797|NCT00632073|Maleic acid|maleic acid|mesh-list
14767798|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767799|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767800|NCT00632086|Aspirin|aspirin|mesh-list
14767801|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14767802|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14767803|NCT00632086|Analgesics|analgesics|mesh-ancestor
14767804|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
14767805|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767806|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767807|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767808|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767809|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14767810|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14767811|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767812|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14767813|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14767814|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237667|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237668|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
14237669|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237670|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14237671|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14237672|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
14237673|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14237674|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237675|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14237676|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14237677|NCT00125528|Cycloserine|cycloserine|mesh-list
14237678|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14237679|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237680|NCT00125528|Renal Agents|renal agents|mesh-ancestor
14237681|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14237682|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
14237683|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14237684|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
14237685|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237686|NCT00125593|Simvastatin|simvastatin|mesh-list
14237687|NCT00125593|Ezetimibe|ezetimibe|mesh-list
14237688|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14237689|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14191415|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14191416|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191417|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
14191418|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
14191419|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191420|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
14191421|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
14191422|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14191423|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14191424|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
14191425|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
14191426|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191427|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191428|NCT04648917|Caffeic acid|caffeic acid|mesh-list
14191429|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
14191430|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191431|NCT04648917|Protective Agents|protective agents|mesh-ancestor
14191432|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191433|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14191434|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
14191435|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14191436|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
14191437|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191438|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14191439|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
14191440|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191441|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191442|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14191443|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14191444|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191445|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191446|NCT04648332|Bupivacaine|bupivacaine|mesh-list
14191447|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
14191448|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
14191449|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191450|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191451|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
14191452|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191453|NCT04648020|Clonidine|clonidine|mesh-list
14191454|NCT04648020|Analgesics|analgesics|mesh-ancestor
14191455|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
14191456|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191457|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191458|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14191459|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
14191460|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
14191461|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14191462|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14191463|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14191464|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191465|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191466|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191467|NCT04648280|Fostemsavir|fostemsavir|mesh-list
14191468|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14191469|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14191470|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
14191471|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191472|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14191473|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14191474|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191475|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
14191476|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14191477|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
14191478|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191479|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191480|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14191481|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
14191482|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191483|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191484|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14191485|NCT04647669|Interferons|interferons|mesh-list
14191486|NCT04647669|Interferon-beta|interferon-beta|mesh-list
14191487|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
14191488|NCT04647669|Remdesivir|remdesivir|mesh-list
14191489|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
14191490|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191491|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
14939184|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939185|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939186|NCT01486485|Nafamostat|nafamostat|mesh-list
14939187|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14939188|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939189|NCT01486485|Analgesics|analgesics|mesh-ancestor
14939190|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
14939191|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939192|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939193|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939194|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939195|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
14939196|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
14939197|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939198|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939199|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14939200|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14939201|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14939202|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939203|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
14939204|NCT01486511|Liver Extracts|liver extracts|mesh-list
14939205|NCT01486511|Hematinics|hematinics|mesh-ancestor
14191492|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191493|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
14191494|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191495|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14191496|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
14191497|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191498|NCT04647877|Phenytoin|phenytoin|mesh-list
14191499|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
14191500|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14191501|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14191502|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191503|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191504|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14191505|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14191506|NCT04647838|Tepotinib|tepotinib|mesh-list
14191507|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191508|NCT04647773|Pregabalin|pregabalin|mesh-list
14191509|NCT04647773|Analgesics|analgesics|mesh-ancestor
14191510|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
14191511|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191512|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191513|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
14191514|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14191515|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191516|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191517|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191518|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14191519|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14191520|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191521|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14191522|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14191523|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14191524|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14191525|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14191526|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14191527|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14191528|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14191529|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191530|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191531|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191532|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191533|NCT04647695|Interferons|interferons|mesh-list
14191534|NCT04647695|Interferon-beta|interferon-beta|mesh-list
14191535|NCT04647695|Remdesivir|remdesivir|mesh-list
14191536|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
14191537|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191538|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
14191539|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191540|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
14939206|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14191541|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191542|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
14191543|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191544|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14191545|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
14191546|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191547|NCT04647344|Paclitaxel|paclitaxel|mesh-list
14191548|NCT04647344|Carboplatin|carboplatin|mesh-list
14191549|NCT04647344|Pemetrexed|pemetrexed|mesh-list
14191550|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14191551|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191552|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
14191553|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
14191554|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
14191555|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191556|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191557|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14191558|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14191559|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
14191560|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
14191561|NCT04646876|Analgesics|analgesics|mesh-ancestor
14191562|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
14191563|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191564|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191565|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
14191566|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191567|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14191568|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
14191569|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14191570|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191571|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191572|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191573|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
14191574|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14191575|NCT04647110|Crizotinib|crizotinib|mesh-list
14191576|NCT04647110|Ceritinib|ceritinib|mesh-list
14191577|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191578|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14191579|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191580|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191581|NCT04646824|Pemetrexed|pemetrexed|mesh-list
14191582|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191583|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191584|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191585|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14191586|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14191587|NCT04646707|Lidocaine|lidocaine|mesh-list
14191588|NCT04646707|Bupivacaine|bupivacaine|mesh-list
14191589|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
14191590|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
14191591|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191592|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191593|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
14191594|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191595|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14191596|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14191597|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14191598|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191599|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237690|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
14237691|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237692|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14237693|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14237694|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237695|NCT00125853|Atenolol|atenolol|mesh-list
14237696|NCT00125853|Nebivolol|nebivolol|mesh-list
14237697|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14237698|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14237699|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
14191600|NCT04646759|Capecitabine|capecitabine|mesh-list
14191601|NCT04646759|Fulvestrant|fulvestrant|mesh-list
14191602|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14191603|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
14191604|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191605|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191606|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14191607|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14191608|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14191609|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
14191610|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191611|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191612|NCT04646694|Ketamine|ketamine|mesh-list
14191613|NCT04646694|Analgesics|analgesics|mesh-ancestor
14191614|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
14191615|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191616|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191617|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14191618|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14191619|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
14191620|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
14191621|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191622|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14191623|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14191624|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191625|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191626|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
14191627|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14191628|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191629|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191630|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14191631|NCT04646317|Analgesics|analgesics|mesh-ancestor
14191632|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
14480872|NCT02494336|Ropivacaine|ropivacaine|mesh-list
14480873|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
14480874|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
14480875|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14480876|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480877|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
14480878|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480879|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
14480880|NCT02494583|Capecitabine|capecitabine|mesh-list
14480881|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480882|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480883|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14480884|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
14480885|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480886|NCT02494596|Capecitabine|capecitabine|mesh-list
14480887|NCT02494596|Pertuzumab|pertuzumab|mesh-list
14480888|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14480889|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
14480890|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480891|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480892|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480893|NCT02494713|Ketoconazole|ketoconazole|mesh-list
14480894|NCT02494713|Docetaxel|docetaxel|mesh-list
14480895|NCT02494713|Doxorubicin|doxorubicin|mesh-list
14480896|NCT02494713|Estramustine|estramustine|mesh-list
14480897|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480898|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
14480899|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
14480900|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
14480901|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480902|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14480903|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14480904|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14480905|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480906|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
14480907|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480908|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14480909|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14767815|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
14480910|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14480911|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
14191633|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191634|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14191635|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14191636|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14191637|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
14191638|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191639|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191640|NCT04646161|Misoprostol|misoprostol|mesh-list
14191641|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14191642|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
14191643|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14191644|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191645|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14191646|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191647|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
14191648|NCT04646135|Lorazepam|lorazepam|mesh-list
14191649|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
14191650|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
14191651|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
14191652|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191653|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191654|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191655|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14191656|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191657|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14191658|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14191659|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14191660|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
14191661|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
14191662|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191663|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191664|NCT04645914|Nicotine|nicotine|mesh-list
14191665|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14191666|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
14191667|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191668|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191669|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14191670|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14191671|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
14191672|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191673|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767816|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
14767817|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14767818|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14767819|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767820|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14767821|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767822|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14767823|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
14767824|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767825|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14767826|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767827|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767828|NCT00632268|Leucovorin|leucovorin|mesh-list
14767829|NCT00632268|Everolimus|everolimus|mesh-list
14767830|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767831|NCT00632268|Antidotes|antidotes|mesh-ancestor
14767832|NCT00632268|Protective Agents|protective agents|mesh-ancestor
14767833|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767834|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
14767835|NCT00632268|Vitamins|vitamins|mesh-ancestor
14767836|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
14767837|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767838|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
14767839|NCT00632333|Fluorouracil|fluorouracil|mesh-list
14191699|NCT04646109|Azithromycin|azithromycin|mesh-list
14191700|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
14191701|NCT04646109|Ivermectin|ivermectin|mesh-list
14191702|NCT04646109|Favipiravir|favipiravir|mesh-list
14191703|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14191704|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191705|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
14191706|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14191707|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14191708|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191709|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191710|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191711|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
14191712|NCT04645940|Rabeprazole|rabeprazole|mesh-list
14191713|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14191714|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191715|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14191716|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191717|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191718|NCT04646187|Adalimumab|adalimumab|mesh-list
14191719|NCT04646187|Infliximab|infliximab|mesh-list
14191720|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191721|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191722|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
14191723|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191724|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
14191725|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14191726|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191727|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14191728|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
14191729|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14191730|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191731|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191732|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191733|NCT04645745|Folic Acid|folic acid|mesh-list
14191734|NCT04645745|Inositol|inositol|mesh-list
14191735|NCT04645745|Hematinics|hematinics|mesh-ancestor
14191736|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
14191737|NCT04645745|Vitamins|vitamins|mesh-ancestor
14191738|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
14191739|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191740|NCT04645004|Aspirin|aspirin|mesh-list
14191741|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14191742|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14191743|NCT04645004|Analgesics|analgesics|mesh-ancestor
14191744|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
14191745|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191746|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191747|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191748|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191749|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14191750|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14191751|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191752|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14191753|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14191754|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191755|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
14191756|NCT04645303|Triamcinolone|triamcinolone|mesh-list
14191757|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14191758|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14191759|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
14191760|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14191761|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191762|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
14191763|NCT04645303|Hormones|hormones|mesh-ancestor
14191764|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191765|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191766|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14191767|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
14191768|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191769|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191770|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14191771|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
14191772|NCT04645303|Protective Agents|protective agents|mesh-ancestor
14191773|NCT04644627|Gentamicins|gentamicins|mesh-list
14191774|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14191775|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527229|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
14191776|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14191777|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191778|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237700|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
14237701|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237702|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237703|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14237704|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14237705|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14237706|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
14237707|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14237708|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237709|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
14237710|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14237711|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14237712|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14237713|NCT00125931|Pentazocine|pentazocine|mesh-list
14237714|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14237715|NCT00125931|Narcotics|narcotics|mesh-ancestor
14237716|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14237717|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237718|NCT00125931|Analgesics|analgesics|mesh-ancestor
14237719|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
14237720|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237721|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14237722|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14237723|NCT00125957|Bupropion|bupropion|mesh-list
14237724|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14237725|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
14237726|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14237727|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14237728|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14237729|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14237730|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237731|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
14237732|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14237733|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237734|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14237735|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14237736|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237737|NCT00126191|Leucovorin|leucovorin|mesh-list
14237738|NCT00126191|Cytarabine|cytarabine|mesh-list
14237739|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
14237740|NCT00126191|Ifosfamide|ifosfamide|mesh-list
14237741|NCT00126191|Rituximab|rituximab|mesh-list
14237742|NCT00126191|Doxorubicin|doxorubicin|mesh-list
14237743|NCT00126191|Methotrexate|methotrexate|mesh-list
14237744|NCT00126191|Etoposide|etoposide|mesh-list
14237745|NCT00126191|Vincristine|vincristine|mesh-list
14237746|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237747|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
14237748|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237749|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237750|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14237751|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
14237752|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237753|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237754|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14237755|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237756|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14237757|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14237758|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14237759|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237760|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14237761|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
14237762|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14237763|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237764|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
14237765|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237766|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14237767|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14237768|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14237769|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
14237770|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237771|NCT00126191|Antidotes|antidotes|mesh-ancestor
14237772|NCT00126191|Protective Agents|protective agents|mesh-ancestor
14191779|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
14191780|NCT04644484|Vaccines|vaccines|mesh-list
14191781|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
14191782|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
14191783|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191784|NCT04644354|Nifedipine|nifedipine|mesh-list
14191785|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14191786|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191787|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191788|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191789|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191790|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
14191791|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
14191792|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14191793|NCT04644250|Paclitaxel|paclitaxel|mesh-list
14191794|NCT04644250|Carboplatin|carboplatin|mesh-list
14191795|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14191796|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191797|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
14191798|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
14191799|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
14191800|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191801|NCT04644094|Dexamethasone|dexamethasone|mesh-list
14191802|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191803|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
14191804|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
14191805|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191806|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191807|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14191808|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
14191809|NCT04644094|Hormones|hormones|mesh-ancestor
14191810|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191811|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14191812|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191813|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14191814|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14191815|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191816|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
14191817|NCT04644185|Paraproteins|paraproteins|mesh-list
14191818|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
14191819|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191820|NCT04644406|Trastuzumab|trastuzumab|mesh-list
14191821|NCT04644406|Pertuzumab|pertuzumab|mesh-list
14191822|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480912|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480913|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480914|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14480915|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14480916|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
14480917|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14480918|NCT02495038|Rocuronium|rocuronium|mesh-list
14480919|NCT02495038|Atracurium|atracurium|mesh-list
14480920|NCT02495038|Cisatracurium|cisatracurium|mesh-list
14480921|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14480922|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14480923|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14480924|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480925|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480926|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14480927|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14191823|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191824|NCT04643821|Calcitriol|calcitriol|mesh-list
14191825|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
14191826|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14191827|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
14191828|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191829|NCT04643821|Expectorants|expectorants|mesh-ancestor
14191830|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
14191831|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14191832|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
14191833|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191834|NCT04643821|Protective Agents|protective agents|mesh-ancestor
14191835|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191836|NCT04643821|Antidotes|antidotes|mesh-ancestor
14191837|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14191838|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14191839|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14191840|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14191841|NCT04643821|Vitamins|vitamins|mesh-ancestor
14191842|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
14191843|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14191844|NCT04644016|Cyclosporine|cyclosporine|mesh-list
14191845|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
14191846|NCT04644016|Fludarabine|fludarabine|mesh-list
14191847|NCT04644016|Busulfan|busulfan|mesh-list
14191848|NCT04644016|Clofarabine|clofarabine|mesh-list
14191849|NCT04644016|Cyclosporins|cyclosporins|mesh-list
14191850|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191851|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14191852|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
14191853|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191854|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14191855|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
14191856|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191857|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191858|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
14191859|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480928|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
14191860|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
14191861|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191862|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14191863|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14237773|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
14237774|NCT00126191|Vitamins|vitamins|mesh-ancestor
14237775|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
14237776|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
14237777|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
14237778|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
14237779|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14237780|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237781|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237782|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237783|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14237784|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14237785|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237786|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237787|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191864|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14191865|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
14191866|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14191867|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
14191868|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14191869|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14191870|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14191871|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191872|NCT04643691|Losartan|losartan|mesh-list
14191873|NCT04643691|Spironolactone|spironolactone|mesh-list
14191874|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14191875|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14191876|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14191877|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14191878|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191879|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14191880|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
14191881|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191882|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191883|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14191884|NCT04643691|Diuretics|diuretics|mesh-ancestor
14191885|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
14191886|NCT04643483|Adalimumab|adalimumab|mesh-list
14191887|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
14191888|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191889|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14191890|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14191891|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
14191892|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191893|NCT04643327|Levetiracetam|levetiracetam|mesh-list
14191894|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
14191895|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
14191896|NCT04643132|Ketamine|ketamine|mesh-list
14191897|NCT04643132|Esketamine|esketamine|mesh-list
14191898|NCT04643132|Analgesics|analgesics|mesh-ancestor
14191899|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
14191900|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191901|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191902|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14191903|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14191904|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
14191905|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
14191906|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191907|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14191908|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14191909|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191910|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191911|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
14191912|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14191913|NCT04643301|Liraglutide|liraglutide|mesh-list
14191914|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14191915|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191916|NCT04643301|Incretins|incretins|mesh-ancestor
14191917|NCT04643301|Hormones|hormones|mesh-ancestor
14191918|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191919|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14191920|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191921|NCT04643093|Ezetimibe|ezetimibe|mesh-list
14191922|NCT04643093|Pitavastatin|pitavastatin|mesh-list
14191923|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14191924|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14191925|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
14191926|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191927|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14191928|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14191929|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191930|NCT04643106|Hemostatics|hemostatics|mesh-list
14191931|NCT04643106|Coagulants|coagulants|mesh-ancestor
14191932|NCT04642846|Fluorides|fluorides|mesh-list
14191933|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
14191934|NCT04642846|Protective Agents|protective agents|mesh-ancestor
14191935|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237788|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14237789|NCT00126490|Aldesleukin|aldesleukin|mesh-list
14237790|NCT00126490|Bevacizumab|bevacizumab|mesh-list
14527230|NCT04053270|Afamelanotide|afamelanotide|mesh-list
14191936|NCT04642664|Apatinib|apatinib|mesh-list
14191937|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191938|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14191939|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191940|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480929|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480930|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480931|NCT02495103|Metformin|metformin|mesh-list
14480932|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14480933|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480934|NCT02495168|Budesonide|budesonide|mesh-list
14480935|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
14480936|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14480937|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14480938|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14480939|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
14480940|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480941|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480942|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14480943|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
14480944|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
14480945|NCT02495168|Hormones|hormones|mesh-ancestor
14480946|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14480947|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14480948|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14480949|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14480950|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
14480951|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480952|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480953|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14480954|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480955|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14480956|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480957|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480958|NCT02495389|Mirabegron|mirabegron|mesh-list
14480959|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14480960|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14480961|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14480962|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
14480963|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14480964|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480965|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480966|NCT02495389|Urological Agents|urological agents|mesh-ancestor
14480967|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
14480968|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14480969|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14480970|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
14480971|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
14480972|NCT02495779|Tenofovir|tenofovir|mesh-list
14480973|NCT02495779|Emtricitabine|emtricitabine|mesh-list
14480974|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
14480975|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14480976|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14480977|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14480978|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480979|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480980|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14480981|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14480982|NCT02495831|Diclofenac|diclofenac|mesh-list
14527231|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
14767840|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767841|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
14191941|NCT04642807|Calpastatin|calpastatin|mesh-list
14191942|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14191943|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
14191944|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191945|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191946|NCT04642547|Lenvatinib|lenvatinib|mesh-list
14807161|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939207|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
14939208|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
14939209|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14939210|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
14939211|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
14939212|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14191947|NCT04642547|Gefitinib|gefitinib|mesh-list
14191948|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14191949|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14191950|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191951|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191952|NCT04642261|Empagliflozin|empagliflozin|mesh-list
14191953|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14191954|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191955|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14191956|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191957|NCT04642391|Cosyntropin|cosyntropin|mesh-list
14191958|NCT04642391|Hormones|hormones|mesh-ancestor
14191959|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14191960|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191961|NCT04642131|Caffeine|caffeine|mesh-list
14191962|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14191963|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191964|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14191965|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14191966|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14191967|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14191968|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14191969|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
14191970|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191971|NCT04642001|Listerine|listerine|mesh-list
14191972|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
14191973|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
14191974|NCT04642001|Protective Agents|protective agents|mesh-ancestor
14191975|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191976|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14191977|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14191978|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
14191979|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
14191980|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14191981|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480983|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14480984|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14480985|NCT02495831|Analgesics|analgesics|mesh-ancestor
14480986|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
14480987|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14480988|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191982|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191983|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
14191984|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
14191985|NCT04641104|Thiamine|thiamine|mesh-list
14191986|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
14191987|NCT04641104|Vitamins|vitamins|mesh-ancestor
14191988|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
14191989|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14191990|NCT04641338|Dipyrone|dipyrone|mesh-list
14191991|NCT04641338|Codeine|codeine|mesh-list
14191992|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14191993|NCT04641338|Narcotics|narcotics|mesh-ancestor
14191994|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14191995|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480989|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14191996|NCT04641338|Analgesics|analgesics|mesh-ancestor
14191997|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
14191998|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14191999|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
14192000|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
14192001|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14192002|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14192003|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192004|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14192005|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
14192006|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
14192007|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192008|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14192009|NCT04641026|Protective Agents|protective agents|mesh-ancestor
14192010|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192011|NCT04641234|Aflibercept|aflibercept|mesh-list
14192012|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14192013|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14192014|NCT04641234|Growth Substances|growth substances|mesh-ancestor
14192015|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192016|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
14192017|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192018|NCT04641351|Triamcinolone|triamcinolone|mesh-list
14192019|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14192020|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14192021|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14192022|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192023|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
14192024|NCT04641351|Hormones|hormones|mesh-ancestor
14192025|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192026|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192027|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192028|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
14192029|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192030|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192031|NCT04641247|Niraparib|niraparib|mesh-list
14192032|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14192033|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192034|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192035|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192036|NCT04640870|Afatinib|afatinib|mesh-list
14192037|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192038|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14192039|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192040|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192041|NCT04640896|Lidocaine|lidocaine|mesh-list
14192042|NCT04640896|Bupivacaine|bupivacaine|mesh-list
14192043|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192044|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
14192045|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192046|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192047|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
14192048|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192049|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14767842|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767843|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14767844|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767845|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
14767846|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807162|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14807163|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14192050|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14192051|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14480990|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807164|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807165|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807166|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14807167|NCT00820092|Hormones|hormones|mesh-ancestor
14807168|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14807169|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807170|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14807171|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14192052|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192053|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237791|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14237792|NCT00126490|Interleukin-2|interleukin-2|mesh-list
14237793|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
14237794|NCT00126490|Antibodies|antibodies|mesh-list
14237795|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
14237796|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14237797|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
14237798|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237799|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237800|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237801|NCT00126490|Growth Substances|growth substances|mesh-ancestor
14237802|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237803|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237804|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
14237805|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14237806|NCT00126490|Analgesics|analgesics|mesh-ancestor
14237807|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
14237808|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237809|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14237810|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14237811|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
14237812|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237813|NCT00126503|Bevacizumab|bevacizumab|mesh-list
14237814|NCT00126503|Sorafenib|sorafenib|mesh-list
14237815|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237816|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767847|NCT00632385|Eletriptan|eletriptan|mesh-list
14767848|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14767849|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
14767850|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767851|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767852|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767853|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
14767854|NCT00632476|Vitamins|vitamins|mesh-ancestor
14767855|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
14767856|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767857|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
14767858|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939213|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
14237817|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237818|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237819|NCT00126503|Growth Substances|growth substances|mesh-ancestor
14237820|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237821|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237822|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237823|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237824|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237825|NCT00126555|Gefitinib|gefitinib|mesh-list
14237826|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237827|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237828|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237829|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237830|NCT00126568|Sorafenib|sorafenib|mesh-list
14237831|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237832|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237833|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237834|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237835|NCT00126581|Paclitaxel|paclitaxel|mesh-list
14237836|NCT00126581|Carboplatin|carboplatin|mesh-list
14237837|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14237838|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14237839|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14237840|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237841|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
14237842|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
14237843|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
14237844|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237845|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237846|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237847|NCT00126594|Interferons|interferons|mesh-list
14237848|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
14939214|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
14237849|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
14767859|NCT00632476|Protective Agents|protective agents|mesh-ancestor
14192054|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
14192055|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192056|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
14192057|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192058|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14192059|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
14192060|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192061|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14192062|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14192063|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
14192064|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192065|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192066|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14192067|NCT04640181|Enoxaparin|enoxaparin|mesh-list
14192068|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
14192069|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14192070|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
14192071|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14192072|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
14192073|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192074|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192075|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
14192076|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14192077|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14192078|NCT04640129|Interferons|interferons|mesh-list
14192079|NCT04640129|Tenofovir|tenofovir|mesh-list
14192080|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
14192081|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192082|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
14192083|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192084|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14192085|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14192086|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192087|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192088|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14192089|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14192090|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
14192091|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192092|NCT04640324|Vitamin D|vitamin d|mesh-list
14192093|NCT04640324|Vitamins|vitamins|mesh-list
14192094|NCT04640324|Vitamin E|vitamin e|mesh-list
14192095|NCT04640324|Silybin|silybin|mesh-list
14192096|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
14192097|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192098|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14192099|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
14192100|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192101|NCT04640324|Protective Agents|protective agents|mesh-ancestor
14192102|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14192103|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192104|NCT04640285|Menthol|menthol|mesh-list
14480991|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14480992|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14480993|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14480994|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
14480995|NCT02495857|Viscosupplements|viscosupplements|mesh-list
14480996|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14480997|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
14480998|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14480999|NCT02495857|Protective Agents|protective agents|mesh-ancestor
14481000|NCT02495883|Ethanol|ethanol|mesh-list
14481001|NCT02495883|Propranolol|propranolol|mesh-list
14481002|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14481003|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14481004|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481005|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481006|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481007|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481008|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14481009|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14481010|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
14481011|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14527232|NCT04049552|Sirolimus|sirolimus|mesh-list
14767860|NCT00632554|Prednisolone|prednisolone|mesh-list
14192105|NCT04640285|Nicotine|nicotine|mesh-list
14192106|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14192107|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
14192108|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192109|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192110|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14192111|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14192112|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
14192113|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192114|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192115|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
14192116|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
14192117|NCT04639817|Levofloxacin|levofloxacin|mesh-list
14192118|NCT04639817|Ofloxacin|ofloxacin|mesh-list
14192119|NCT04639817|Trimethoprim|trimethoprim|mesh-list
14192120|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14192121|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
14192122|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14192123|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192124|NCT04639817|Renal Agents|renal agents|mesh-ancestor
14192125|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14192126|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14192127|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14192128|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192129|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192130|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192131|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14192132|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14192133|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
14192134|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14192135|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14192136|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14192137|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14192138|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14192139|NCT04639804|Celecoxib|celecoxib|mesh-list
14192140|NCT04639804|Naproxen|naproxen|mesh-list
14192141|NCT04639804|Aceclofenac|aceclofenac|mesh-list
14192142|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14192143|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14192144|NCT04639804|Analgesics|analgesics|mesh-ancestor
14192145|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
14192146|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192147|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192148|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192149|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14192150|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14192151|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14192152|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192153|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192154|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
14192155|NCT04639362|Venetoclax|venetoclax|mesh-list
14192156|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
14192157|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192158|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192159|NCT04639232|Probenecid|probenecid|mesh-list
14192160|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
14192161|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
14192162|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14192163|NCT04639232|Renal Agents|renal agents|mesh-ancestor
14192164|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14192165|NCT04639284|Antibodies|antibodies|mesh-list
14192166|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
14192167|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192168|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14192169|NCT04639284|Growth Substances|growth substances|mesh-ancestor
14192170|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
14192171|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192172|NCT04639271|Trastuzumab|trastuzumab|mesh-list
14192173|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14192174|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192175|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192176|NCT04639180|Apatinib|apatinib|mesh-list
14192177|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192178|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14192179|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939215|NCT01486602|Paclitaxel|paclitaxel|mesh-list
14237850|NCT00126594|Sorafenib|sorafenib|mesh-list
14237851|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237852|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
14237853|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192180|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192181|NCT04638816|Lidocaine|lidocaine|mesh-list
14192182|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
14192183|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192184|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
14192185|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192186|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192187|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
14192188|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192189|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14192190|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14192191|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14192192|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192193|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192194|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14192195|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
14192196|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
14192197|NCT04638816|Protective Agents|protective agents|mesh-ancestor
14192198|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14192199|NCT04639193|Acetazolamide|acetazolamide|mesh-list
14192200|NCT04639193|Eszopiclone|eszopiclone|mesh-list
14192201|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14192202|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14192203|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14192204|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192205|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192206|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192207|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192208|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14192209|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
14192210|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14192211|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
14192212|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14192213|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192214|NCT04639193|Diuretics|diuretics|mesh-ancestor
14192215|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
14192216|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14192217|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192218|NCT04638686|Lamivudine|lamivudine|mesh-list
14192219|NCT04638686|Dolutegravir|dolutegravir|mesh-list
14192220|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14192221|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14192222|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192223|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192224|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
14192225|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192226|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14192227|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14192228|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14192229|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14192230|NCT04638790|Dexamethasone|dexamethasone|mesh-list
14192231|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
14192232|NCT04638790|Dacarbazine|dacarbazine|mesh-list
14192233|NCT04638790|Doxorubicin|doxorubicin|mesh-list
14192234|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14192235|NCT04638790|Etoposide|etoposide|mesh-list
14192236|NCT04638790|Vincristine|vincristine|mesh-list
14192237|NCT04638790|Bleomycin|bleomycin|mesh-list
14192238|NCT04638790|Vinblastine|vinblastine|mesh-list
14192239|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192240|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
14192241|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192242|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14192243|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14192244|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
14192245|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192246|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192247|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14192248|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192249|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
14192250|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
14192251|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192252|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192253|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
14192254|NCT04638790|Hormones|hormones|mesh-ancestor
14192255|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192256|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14192257|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14192258|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14192259|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14192260|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192261|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14192262|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
14192263|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
14192264|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
14192265|NCT04639115|Ozanimod|ozanimod|mesh-list
14192266|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14192267|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192268|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192269|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
14192270|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192271|NCT04638582|Paclitaxel|paclitaxel|mesh-list
14192272|NCT04638582|Carboplatin|carboplatin|mesh-list
14192273|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
14192274|NCT04638582|Pemetrexed|pemetrexed|mesh-list
14192275|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14192276|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192277|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14192278|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14192279|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14192280|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192281|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192282|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192283|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14192284|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14192285|NCT04638751|Pembrolizumab|pembrolizumab|mesh-list
14192286|NCT04638751|Nivolumab|nivolumab|mesh-list
14192287|NCT04638751|Ipilimumab|ipilimumab|mesh-list
14192288|NCT04638751|Durvalumab|durvalumab|mesh-list
14192289|NCT04638751|Avelumab|avelumab|mesh-list
14192290|NCT04638751|Cemiplimab|cemiplimab|mesh-list
14192291|NCT04638751|Atezolizumab|atezolizumab|mesh-list
14192292|NCT04638751|Antineoplastic Agents|antineoplastic agents|mesh-list
14192293|NCT04638751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192294|NCT04638751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14192295|NCT04638751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237854|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14237855|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237856|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237857|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
14237858|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237859|NCT00127036|Bevacizumab|bevacizumab|mesh-list
14237860|NCT00127036|Capecitabine|capecitabine|mesh-list
14237861|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
14237862|NCT00127036|Irinotecan|irinotecan|mesh-list
14237863|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237864|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237865|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14237866|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14237867|NCT00127036|Growth Substances|growth substances|mesh-ancestor
14237868|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237869|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237870|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237871|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
14237872|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237873|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14237874|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14237875|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237876|NCT00127101|Vorinostat|vorinostat|mesh-list
14237877|NCT00127101|Bexarotene|bexarotene|mesh-list
14237878|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237879|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14237880|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237881|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237882|NCT00127166|Fluticasone|fluticasone|mesh-list
14237883|NCT00127166|Xhance|xhance|mesh-list
14237884|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14237885|NCT00127166|Montelukast|montelukast|mesh-list
14237886|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237887|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14192296|NCT04638517|Danazol|danazol|mesh-list
14192297|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14192298|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
14192299|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192300|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192301|NCT04638400|Simvastatin|simvastatin|mesh-list
14192302|NCT04638400|Ezetimibe|ezetimibe|mesh-list
14192303|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14192304|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14192305|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
14192306|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192307|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14192308|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14192309|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192310|NCT04638439|Entecavir|entecavir|mesh-list
14192311|NCT04638439|Nivolumab|nivolumab|mesh-list
14192312|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192313|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192314|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14192315|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192316|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
14192317|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14237888|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
14481012|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481013|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481014|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14481015|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14237889|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237890|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237891|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14237892|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
14237893|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
14237894|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14237895|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14237896|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14237897|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14237898|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
14237899|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14237900|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237901|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14237902|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
14237903|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237904|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14237905|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14237906|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14237907|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14237908|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237909|NCT00127192|Incretins|incretins|mesh-ancestor
14237910|NCT00127192|Hormones|hormones|mesh-ancestor
14237911|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14237912|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14237913|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
14237914|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237915|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237916|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
14237917|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
14237918|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
14237919|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14237920|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237921|NCT00127218|Niacin|niacin|mesh-list
14237922|NCT00127218|Atorvastatin|atorvastatin|mesh-list
14237923|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14237924|NCT00127218|Simvastatin|simvastatin|mesh-list
14237925|NCT00127218|Pravastatin|pravastatin|mesh-list
14237926|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14237927|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14237928|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
14237929|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237930|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14237931|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14237932|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237933|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14481016|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14192318|NCT04638036|Cetuximab|cetuximab|mesh-list
14192319|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192320|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192321|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
14192322|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14192323|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14192324|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14192325|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192326|NCT04637152|Valsartan|valsartan|mesh-list
14192327|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14192328|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14192329|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14192330|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14192331|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192332|NCT04636918|Cyclosporine|cyclosporine|mesh-list
14192333|NCT04636918|Cyclosporins|cyclosporins|mesh-list
14192334|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192335|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192336|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14767861|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14767862|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
14192337|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
14192338|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192339|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
14192340|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192341|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
14192342|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14192343|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14192344|NCT04637204|Axitinib|axitinib|mesh-list
14192345|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192346|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14192347|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192348|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192349|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
14192350|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14192351|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14192352|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14192353|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481017|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481018|NCT02496000|Insulin|insulin|mesh-list
14481019|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481020|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481021|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
14481022|NCT02496221|Incretins|incretins|mesh-ancestor
14481023|NCT02496221|Hormones|hormones|mesh-ancestor
14481024|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481025|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481026|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14481027|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14481028|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
14767863|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14767864|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
14767865|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14767866|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
14767867|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14767868|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
14767869|NCT00632554|Hormones|hormones|mesh-ancestor
14767870|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14767871|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767872|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14767873|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767874|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
14767875|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
14767876|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767877|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767878|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14767879|NCT00632554|Protective Agents|protective agents|mesh-ancestor
14767880|NCT00632580|Ropivacaine|ropivacaine|mesh-list
14767881|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
14767882|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
14767883|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767884|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767885|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
14767886|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192354|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14192355|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14192356|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192357|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192358|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192359|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14192360|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14481029|NCT02497040|Bupivacaine|bupivacaine|mesh-list
14481030|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
14481031|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481032|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
14481033|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481034|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481035|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
14481036|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481037|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14481038|NCT02497287|Citalopram|citalopram|mesh-list
14481039|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14481040|NCT02497287|Sertraline|sertraline|mesh-list
14481041|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
14481042|NCT02497287|Esketamine|esketamine|mesh-list
14481043|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14481044|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14481045|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481046|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481047|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481048|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
14481049|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481050|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14481051|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14481052|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481053|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14481054|NCT02497287|Analgesics|analgesics|mesh-ancestor
14481055|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
14481056|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
14481057|NCT02497391|Evacetrapib|evacetrapib|mesh-list
14481058|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14481059|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14481060|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
14481061|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481062|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14481063|NCT02497404|Fludarabine|fludarabine|mesh-list
14481064|NCT02497404|Azacitidine|azacitidine|mesh-list
14481065|NCT02497404|Melphalan|melphalan|mesh-list
14481066|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
14481067|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481068|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14481069|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
14481070|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481071|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481072|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
14481073|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481074|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481075|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14481076|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
14481077|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14481078|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481079|NCT02497469|Adalimumab|adalimumab|mesh-list
14481080|NCT02497469|Vedolizumab|vedolizumab|mesh-list
14481081|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481082|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481083|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481084|NCT02497781|Ceftazidime|ceftazidime|mesh-list
14481085|NCT02497781|Cefepime|cefepime|mesh-list
14481086|NCT02497781|Avibactam|avibactam|mesh-list
14481087|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14481088|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14481089|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481090|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14481091|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481092|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481093|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
14481094|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481095|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
14481096|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192361|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192362|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
14192363|NCT04636957|Hormones|hormones|mesh-ancestor
14192364|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192365|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192366|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
14192367|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14192368|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
14192369|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192370|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14192371|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14192372|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14192373|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192374|NCT04637360|Calcitriol|calcitriol|mesh-list
14192375|NCT04637360|Cinacalcet|cinacalcet|mesh-list
14192376|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14192377|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192378|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14192379|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192380|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192381|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14192382|NCT04637360|Vitamins|vitamins|mesh-ancestor
14192383|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
14192384|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14192385|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14192386|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
14192387|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192388|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
14192389|NCT04636632|Aprepitant|aprepitant|mesh-list
14192390|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
14192391|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
14192392|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192393|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192394|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192395|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14192396|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192397|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192398|NCT04636671|Dexamethasone|dexamethasone|mesh-list
14192399|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
14192400|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14192401|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14192402|NCT04636671|Prednisolone|prednisolone|mesh-list
14192403|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
14192404|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14192405|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
14192406|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192407|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
14192408|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
14192409|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192410|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192411|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192412|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
14192413|NCT04636671|Hormones|hormones|mesh-ancestor
14192414|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192415|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14192416|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192417|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14192418|NCT04636671|Protective Agents|protective agents|mesh-ancestor
14237934|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
14237935|NCT00127218|Vitamins|vitamins|mesh-ancestor
14237936|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
14237937|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237938|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
14237939|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14237940|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14237941|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242845|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242846|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
14242847|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242848|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242849|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242850|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242851|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14242852|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14192419|NCT04636125|Doxycycline|doxycycline|mesh-list
14192420|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14192421|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192422|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
14192423|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14192424|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14939216|NCT01486602|Carboplatin|carboplatin|mesh-list
14192425|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14192426|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14192427|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14192428|NCT04636255|Calcium|calcium|mesh-list
14192429|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14192430|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192431|NCT04635774|Insulin|insulin|mesh-list
14192432|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14192433|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192434|NCT04635852|Fentanyl|fentanyl|mesh-list
14192435|NCT04635852|Morphine|morphine|mesh-list
14192436|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14192437|NCT04635852|Narcotics|narcotics|mesh-ancestor
14192438|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192439|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192440|NCT04635852|Analgesics|analgesics|mesh-ancestor
14192441|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
14192442|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192443|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14192444|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14192445|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
14192446|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
14192447|NCT04635839|Heparin|heparin|mesh-list
14192448|NCT04635839|Calcium heparin|calcium heparin|mesh-list
14192449|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
14192450|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14192451|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14192452|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192453|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
14192454|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192455|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
14192456|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192457|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192458|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
14192459|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192460|NCT04635280|Pancrelipase|pancrelipase|mesh-list
14192461|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192462|NCT04635176|Dexamethasone|dexamethasone|mesh-list
14192463|NCT04635176|Epinephrine|epinephrine|mesh-list
14192464|NCT04635176|Bupivacaine|bupivacaine|mesh-list
14192465|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192466|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
14192467|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
14192468|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192469|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192470|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192471|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
14192472|NCT04635176|Hormones|hormones|mesh-ancestor
14192473|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192474|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14192475|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192476|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192477|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
14192478|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192479|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
14192480|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14192481|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14192482|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
14192483|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192484|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192485|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14192486|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14192487|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14192488|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
14192489|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
14192490|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
14192491|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14192492|NCT04635566|Mebeverine|mebeverine|mesh-list
14192493|NCT04635566|Alverine|alverine|mesh-list
14192494|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
14192495|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
14192496|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
14192497|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192498|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192499|NCT04635293|Simendan|simendan|mesh-list
14192500|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14192501|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
14192502|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14192503|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14192504|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192505|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192506|NCT04635293|Protective Agents|protective agents|mesh-ancestor
14192507|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192508|NCT04635007|Misoprostol|misoprostol|mesh-list
14192509|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
14192510|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14192511|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14192512|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192513|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
14192514|NCT04635007|Coagulants|coagulants|mesh-ancestor
14192515|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14192516|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
14192517|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14192518|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192519|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14192520|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192521|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
14192522|NCT04635553|Praziquantel|praziquantel|mesh-list
14192523|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
14192524|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14192525|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192526|NCT04635189|Dexamethasone|dexamethasone|mesh-list
14192527|NCT04635189|Lenalidomide|lenalidomide|mesh-list
14192528|NCT04635189|Daratumumab|daratumumab|mesh-list
14192529|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192530|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
14192531|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
14192532|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192533|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192534|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192535|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
14192536|NCT04635189|Hormones|hormones|mesh-ancestor
14481097|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527233|NCT04049552|Petrolatum|petrolatum|mesh-list
14527234|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14527235|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527236|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14527237|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527238|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
14527239|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14527240|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
14527241|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527242|NCT04049552|Emollients|emollients|mesh-ancestor
14527243|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
14527244|NCT04050865|Dexamethasone|dexamethasone|mesh-list
14527245|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14527246|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
14527247|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
14527248|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527249|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527250|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527251|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
14527252|NCT04050865|Hormones|hormones|mesh-ancestor
14527253|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527254|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14527255|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527256|NCT04050371|Tenofovir|tenofovir|mesh-list
14527257|NCT04050371|Emtricitabine|emtricitabine|mesh-list
14527258|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
14527259|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527260|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14527261|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14527262|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192537|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527263|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192538|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14192539|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192540|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
14192541|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14192542|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14192543|NCT04635189|Growth Substances|growth substances|mesh-ancestor
14192544|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
14237942|NCT00127712|Amiodarone|amiodarone|mesh-list
14237943|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14237944|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
14237945|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14237946|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14237947|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237948|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14237949|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14237950|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14237951|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237952|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14237953|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14237954|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14237955|NCT00127803|Vaccines|vaccines|mesh-list
14237956|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
14237957|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237958|NCT00127842|Etanercept|etanercept|mesh-list
14237959|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14237960|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14237961|NCT00127842|Analgesics|analgesics|mesh-ancestor
14237962|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
14237963|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237964|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237965|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237966|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14237967|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14237968|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14237969|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
14237970|NCT00127855|Vaccines|vaccines|mesh-list
14237971|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14237972|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
14237973|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14237974|NCT00127933|Capecitabine|capecitabine|mesh-list
14237975|NCT00127933|Docetaxel|docetaxel|mesh-list
14237976|NCT00127933|Trastuzumab|trastuzumab|mesh-list
14237977|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14237978|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
14237979|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237980|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237981|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
14237982|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
14237983|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
14237984|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14237985|NCT00128102|Vorinostat|vorinostat|mesh-list
14237986|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14237987|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14237988|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14237989|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237990|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
14237991|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14237992|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14237993|NCT00128180|Prednisolone|prednisolone|mesh-list
14481098|NCT02498236|Oxytocin|oxytocin|mesh-list
14481099|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
14481100|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14481101|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481102|NCT02498418|Rifaximin|rifaximin|mesh-list
14481103|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14481104|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481105|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481106|NCT02498483|Acetaminophen|acetaminophen|mesh-list
14481107|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481108|NCT02498483|Analgesics|analgesics|mesh-ancestor
14481109|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
14481110|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14237994|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
14481111|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481112|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
14192545|NCT04634838|Copper|copper|mesh-list
14192546|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14192547|NCT04634838|Trace Elements|trace elements|mesh-ancestor
14192548|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
14192549|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192550|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192551|NCT04634981|Anesthetics|anesthetics|mesh-list
14192552|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192553|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192554|NCT04634656|Lidocaine|lidocaine|mesh-list
14192555|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192556|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
14192557|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192558|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192559|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
14192560|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192561|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14192562|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14192563|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14192564|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192565|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192566|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
14192567|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14481113|NCT02498522|Metformin|metformin|mesh-list
14481114|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481115|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481116|NCT02498652|Allopurinol|allopurinol|mesh-list
14481117|NCT02498652|Verinurad|verinurad|mesh-list
14481118|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
14481119|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481120|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192568|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192569|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14192570|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192571|NCT04634721|Bupivacaine|bupivacaine|mesh-list
14192572|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192573|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
14192574|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192575|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192576|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
14192577|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192578|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
14192579|NCT04634669|Bupropion|bupropion|mesh-list
14192580|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14192581|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
14192582|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14192583|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14192584|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14192585|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192586|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192587|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
14192588|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192589|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192590|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14192591|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14192592|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192593|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
14192594|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
14192595|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14192596|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14192597|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
14192598|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192599|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192600|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14192601|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14192602|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14192603|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14192604|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14192605|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
14192606|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481121|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
14481122|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481123|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14481124|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
14192607|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192608|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192609|NCT04634058|Antibodies|antibodies|mesh-list
14192610|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
14192611|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
14192612|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192613|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
14192614|NCT04633902|Olaparib|olaparib|mesh-list
14192615|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192616|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192617|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14192618|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192619|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192620|NCT04633850|Dexamethasone|dexamethasone|mesh-list
14192621|NCT04633850|Bupivacaine|bupivacaine|mesh-list
14192622|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192623|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
14192624|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
14192625|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192626|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192627|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192628|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
14192629|NCT04633850|Hormones|hormones|mesh-ancestor
14192630|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192631|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14192632|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192633|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192634|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
14192635|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192636|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
14192637|NCT04633746|Endostatins|endostatins|mesh-list
14192638|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192639|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14192640|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14192641|NCT04633746|Growth Substances|growth substances|mesh-ancestor
14192642|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192643|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
14192644|NCT04633733|Tacrolimus|tacrolimus|mesh-list
14192645|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192646|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
14192647|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192648|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14192649|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192650|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192651|NCT04633577|Lidocaine|lidocaine|mesh-list
13963585|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963586|NCT03143244|Analgesics|analgesics|mesh-ancestor
13963587|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
13963588|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963589|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13963590|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13963591|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13963592|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
13963593|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192652|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
14192653|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
14192654|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192655|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192656|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
14192657|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192658|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14192659|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14192660|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14192661|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192662|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192663|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14192664|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14192665|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14192666|NCT04633044|Betaine|betaine|mesh-list
14192667|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192668|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
14192669|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14192670|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
14192671|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192672|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14192673|NCT04633122|Sunitinib|sunitinib|mesh-list
14192674|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192675|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14192676|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14192677|NCT04633122|Growth Substances|growth substances|mesh-ancestor
14192678|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192679|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
14192680|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14192681|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192682|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192683|NCT04632693|Ascorbic Acid|ascorbic acid|mesh-list
14192684|NCT04632693|Vitamins|vitamins|mesh-ancestor
14192685|NCT04632693|Micronutrients|micronutrients|mesh-ancestor
14192686|NCT04632693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192687|NCT04632693|Antioxidants|antioxidants|mesh-ancestor
14192688|NCT04632693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192689|NCT04632693|Protective Agents|protective agents|mesh-ancestor
14192690|NCT04632589|Losartan|losartan|mesh-list
14192691|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14192692|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14192693|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14192694|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14192695|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192696|NCT04632758|Crizotinib|crizotinib|mesh-list
14192697|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192698|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14192699|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192700|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14237995|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14237996|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
14237997|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14237998|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
14237999|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
14238000|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238001|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238002|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238003|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
14238004|NCT00128180|Hormones|hormones|mesh-ancestor
14238005|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238006|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14238007|NCT00128180|Protective Agents|protective agents|mesh-ancestor
14238008|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238009|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238010|NCT00128206|Rifampin|rifampin|mesh-list
14238011|NCT00128206|Isoniazid|isoniazid|mesh-list
14238012|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14238013|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
14238014|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14238015|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238016|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
14238017|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238018|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238019|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238020|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14238021|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14238022|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14238023|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14238024|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14238025|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14238026|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14238027|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14238028|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
14238029|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14238030|NCT00128401|Cycloserine|cycloserine|mesh-list
14192701|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
14192702|NCT04632316|Fludarabine|fludarabine|mesh-list
14192703|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192704|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
14192705|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192706|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14192707|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14192708|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
14192709|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192710|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192711|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14192712|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
14481125|NCT02498652|Protective Agents|protective agents|mesh-ancestor
14481126|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481127|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
14481128|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14481129|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14481130|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14481131|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481132|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481133|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
14481134|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481135|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481136|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14481137|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481138|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
14481139|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14481140|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
14481141|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481142|NCT02499029|Expectorants|expectorants|mesh-ancestor
14481143|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
14481144|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14481145|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
14481146|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481147|NCT02499029|Protective Agents|protective agents|mesh-ancestor
14481148|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481149|NCT02499029|Antidotes|antidotes|mesh-ancestor
14481150|NCT02499081|Ixazomib|ixazomib|mesh-list
14481151|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481152|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
14481153|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481154|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481155|NCT02499120|Cetuximab|cetuximab|mesh-list
14481156|NCT02499120|Palbociclib|palbociclib|mesh-list
14481157|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481158|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481159|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14481160|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481161|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481162|NCT02499146|Letrozole|letrozole|mesh-list
14481163|NCT02499146|Palbociclib|palbociclib|mesh-list
14481164|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481165|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14481166|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14481167|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481168|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481169|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14481170|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
14481171|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481172|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481173|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14481174|NCT02499159|Bupivacaine|bupivacaine|mesh-list
14481175|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481176|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
14481177|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481178|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481179|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
14481180|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481181|NCT02499497|Androgens|androgens|mesh-list
14481182|NCT02499497|Hormones|hormones|mesh-ancestor
14481183|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481184|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481185|NCT02499575|Bupivacaine|bupivacaine|mesh-list
14192713|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14192714|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
14192715|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192716|NCT04632433|Cemiplimab|cemiplimab|mesh-list
14192717|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192718|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192719|NCT04632238|Metronidazole|metronidazole|mesh-list
14192720|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192721|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14192722|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14192723|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14192724|NCT04632121|Nicorandil|nicorandil|mesh-list
14192725|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14192726|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14192727|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
14192728|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
14767887|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
14767888|NCT00632606|Metoclopramide|metoclopramide|mesh-list
14767889|NCT00632606|Analgesics|analgesics|mesh-ancestor
14767890|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
14767891|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767892|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192729|NCT04632121|Vitamins|vitamins|mesh-ancestor
14481186|NCT02499575|Ropivacaine|ropivacaine|mesh-list
14481187|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481188|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
14481189|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481190|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481191|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
14481192|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481193|NCT02499770|Carboplatin|carboplatin|mesh-list
14481194|NCT02499770|Etoposide|etoposide|mesh-list
14481195|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481196|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14481197|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14481198|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14481199|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481200|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481201|NCT02499783|Adalimumab|adalimumab|mesh-list
14481202|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481203|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481204|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
14481205|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481206|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481207|NCT02500602|Doxazosin|doxazosin|mesh-list
14481208|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14481209|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14481210|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14481211|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14481212|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481213|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481214|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481215|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481216|NCT02500628|Metformin|metformin|mesh-list
14481217|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481218|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481219|NCT02500641|Naproxen|naproxen|mesh-list
14481220|NCT02500641|Colchicine|colchicine|mesh-list
14481221|NCT02500641|Allopurinol|allopurinol|mesh-list
14481222|NCT02500641|Febuxostat|febuxostat|mesh-list
14481223|NCT02500641|Omeprazole|omeprazole|mesh-list
14481224|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14481225|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481226|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14481227|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481228|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481229|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14481230|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481231|NCT02500641|Analgesics|analgesics|mesh-ancestor
14481232|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
14481233|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481234|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481235|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481236|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481237|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
14192730|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
14481238|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14767893|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
14192731|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192732|NCT04631874|Varenicline|varenicline|mesh-list
14192733|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14192734|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14192735|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
14192736|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192737|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192738|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192739|NCT04631822|Dexamethasone|dexamethasone|mesh-list
14192740|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192741|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
14192742|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
14192743|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192744|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192745|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192746|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
14192747|NCT04631822|Hormones|hormones|mesh-ancestor
14192748|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192749|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14192750|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192751|NCT04631627|Aspirin|aspirin|mesh-list
14192752|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14192753|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14192754|NCT04631627|Analgesics|analgesics|mesh-ancestor
14192755|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
14192756|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192757|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192758|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192759|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14192760|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14192761|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14192762|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192763|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14192764|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14192765|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192766|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
14192767|NCT04631315|Prednisolone|prednisolone|mesh-list
14192768|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14192769|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
14192770|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14192771|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
14192772|NCT04631315|Phenylephrine|phenylephrine|mesh-list
14192773|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
14192774|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14192775|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14192776|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
14192777|NCT04631315|Difluprednate|difluprednate|mesh-list
14192778|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14192779|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14192780|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
14192781|NCT04631315|Hormones|hormones|mesh-ancestor
14192782|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192783|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192784|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14192785|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192786|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
14192787|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
14192788|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192789|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14192790|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14192791|NCT04631315|Protective Agents|protective agents|mesh-ancestor
14192792|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14192793|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
14192794|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
14192795|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14192796|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
14192797|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
14192798|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14192799|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14192800|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14192801|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
14192802|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192803|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192804|NCT04631341|Melatonin|melatonin|mesh-list
14192805|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
14192806|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192807|NCT04631341|Protective Agents|protective agents|mesh-ancestor
14192808|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192809|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192810|NCT04631484|Riboflavin|riboflavin|mesh-list
14192811|NCT04631484|Niacinamide|niacinamide|mesh-list
14192812|NCT04631484|Niacin|niacin|mesh-list
14192813|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
14192814|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
14192815|NCT04631484|Vitamins|vitamins|mesh-ancestor
14192816|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
14192817|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192818|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14192819|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14192820|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14192821|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
14192822|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192823|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14192824|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
14192825|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14192826|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14192827|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14192828|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
14192829|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14192830|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
14192831|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192832|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
14192833|NCT04631263|Protective Agents|protective agents|mesh-ancestor
14767894|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767895|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14767896|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
14192837|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14192838|NCT04630821|Eusol|eusol|mesh-list
14192839|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
14192840|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192841|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
14192842|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14192843|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14192844|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192845|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
14192846|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192847|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192848|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14192849|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14192850|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192851|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
14192852|NCT04630522|Vitamin D|vitamin d|mesh-list
14192853|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
14192854|NCT04630522|Calcium|calcium|mesh-list
14192855|NCT04630522|Vitamins|vitamins|mesh-ancestor
14192856|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
14192857|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192858|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14192859|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14192860|NCT04630444|Riluzole|riluzole|mesh-list
14192861|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
14192862|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14192863|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14192864|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192865|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192866|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192867|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14192868|NCT04630444|Protective Agents|protective agents|mesh-ancestor
14238031|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14238032|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767897|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14238033|NCT00128401|Renal Agents|renal agents|mesh-ancestor
14238034|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14192869|NCT04630548|Copper|copper|mesh-list
14192870|NCT04630548|Trace Elements|trace elements|mesh-ancestor
14192871|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
14192872|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192873|NCT04630288|Clopidogrel|clopidogrel|mesh-list
14192874|NCT04630288|Ticagrelor|ticagrelor|mesh-list
14192875|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14192876|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14192877|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14192878|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14192879|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
14192880|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192881|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192882|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192883|NCT04630171|Anesthetics|anesthetics|mesh-list
14192884|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192885|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192886|NCT04629885|Oxytocin|oxytocin|mesh-list
14192887|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
14192888|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14192889|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192890|NCT04629976|Tenofovir|tenofovir|mesh-list
14192891|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
14192892|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192893|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14192894|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14192895|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192896|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192897|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14192898|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14192899|NCT04630210|Atezolizumab|atezolizumab|mesh-list
14192900|NCT04630210|Letrozole|letrozole|mesh-list
14192901|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192902|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14192903|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14192904|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14192905|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192906|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14192907|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
14192908|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14192909|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192910|NCT04629495|Sirolimus|sirolimus|mesh-list
14192911|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14192912|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192913|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14192914|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192915|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
14192916|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192917|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
14192918|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192919|NCT04629846|Docetaxel|docetaxel|mesh-list
14192920|NCT04629846|Trastuzumab|trastuzumab|mesh-list
14192921|NCT04629846|Pertuzumab|pertuzumab|mesh-list
14192922|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192923|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14192924|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14192925|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14192926|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192927|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14192928|NCT04629573|Anesthetics|anesthetics|mesh-list
14192929|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192930|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192931|NCT04629612|Anesthetics|anesthetics|mesh-list
14192932|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192933|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192934|NCT04629144|Belimumab|belimumab|mesh-list
14192935|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192936|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
14192937|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192938|NCT04629209|TIC10 compound|tic10 compound|mesh-list
14192939|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192940|NCT04629196|Ustekinumab|ustekinumab|mesh-list
14192941|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
14192942|NCT04628884|Heparin|heparin|mesh-list
14192943|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
14192944|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14192945|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14192946|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192947|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14192948|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192949|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192950|NCT04629118|Sirolimus|sirolimus|mesh-list
14192951|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14192952|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14192953|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14192954|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14192955|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
14192956|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14192957|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
14192958|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192959|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
14192960|NCT04628559|Ketamine|ketamine|mesh-list
14192961|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14192962|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14192963|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192964|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14192965|NCT04628559|Analgesics|analgesics|mesh-ancestor
14192966|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
14192967|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192968|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14192969|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14192970|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14192971|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
14192972|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238035|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
14238036|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14238037|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
14238038|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238039|NCT00128661|Vaccines|vaccines|mesh-list
14238040|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
14238041|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238042|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14238043|NCT00128830|Etravirine|etravirine|mesh-list
14238044|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
14238045|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14238046|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
14238047|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238048|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238049|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238050|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
14238051|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238052|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14238053|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14238054|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14238055|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14238056|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14238057|NCT00128921|Bortezomib|bortezomib|mesh-list
14238058|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238059|NCT00129116|Vaccines|vaccines|mesh-list
14238060|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
14238061|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238062|NCT00129129|Vaccines|vaccines|mesh-list
14238063|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
14238064|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238065|NCT00129220|Haloperidol|haloperidol|mesh-list
14238066|NCT00129220|Olanzapine|olanzapine|mesh-list
14192973|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192974|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14192975|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14192976|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
14192977|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
14192978|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14192979|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14192980|NCT04628676|Epinephrine|epinephrine|mesh-list
14192981|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
14192982|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
14192983|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14192984|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14192985|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
14192986|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14192987|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14192988|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14192989|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14192990|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14192991|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
14192992|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14192993|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14192994|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
14192995|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
14192996|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
14192997|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14192998|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14192999|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14193000|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
14193001|NCT04628676|Coagulants|coagulants|mesh-ancestor
14193002|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
14193003|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193004|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14193005|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193006|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14193007|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193008|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193009|NCT04628325|Furosemide|furosemide|mesh-list
14193010|NCT04628325|Diuretics|diuretics|mesh-ancestor
14193011|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
14193012|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193013|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14193014|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14193015|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238067|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
14238068|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
14238069|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
14238070|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238071|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238072|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238073|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14238074|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14238075|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238076|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238077|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14238078|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238079|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238080|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238081|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238082|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
14238083|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14238084|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
14238085|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14238086|NCT00129246|Naltrexone|naltrexone|mesh-list
14238087|NCT00129246|Bupropion|bupropion|mesh-list
14238088|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14238089|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14238090|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238091|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
14238092|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238093|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14238094|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
14767898|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14767899|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238095|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193016|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
14193017|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14193018|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14193019|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
14193020|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193021|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193022|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193023|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
14193024|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
14193025|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193026|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
14193027|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14193028|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
14193029|NCT04628624|Antioxidants|antioxidants|mesh-list
14193030|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193031|NCT04628624|Protective Agents|protective agents|mesh-ancestor
14193032|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193033|NCT04628000|Vitamin D|vitamin d|mesh-list
14193034|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
14193035|NCT04628000|Vitamins|vitamins|mesh-list
14193036|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
14193037|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193038|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14193039|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14193040|NCT04628026|Venetoclax|venetoclax|mesh-list
14193041|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193042|NCT04627870|Paclitaxel|paclitaxel|mesh-list
14193043|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14193044|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193045|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
14193046|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
14193047|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
14193048|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193049|NCT04628143|Nafamostat|nafamostat|mesh-list
14193050|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14193051|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193052|NCT04628143|Analgesics|analgesics|mesh-ancestor
14193053|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
14193054|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193055|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193056|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193057|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193058|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
14193059|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
14193060|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193061|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193062|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14193063|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14193064|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14193065|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193066|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
14193067|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
14193068|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
14193069|NCT04627779|Analgesics|analgesics|mesh-ancestor
14193070|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
14193071|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193072|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193073|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14193074|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193075|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193076|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193077|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14193078|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193079|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193080|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14193081|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14193082|NCT04627467|Chloroquine|chloroquine|mesh-list
14193083|NCT04627467|Amebicides|amebicides|mesh-ancestor
14939217|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14193084|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14193085|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14193086|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193087|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
14193088|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193089|NCT04627623|Antibodies|antibodies|mesh-list
14193090|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
14193091|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
14193092|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193093|NCT04627363|Bevacizumab|bevacizumab|mesh-list
14193094|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193095|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193096|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14193097|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14193098|NCT04627363|Growth Substances|growth substances|mesh-ancestor
14193099|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193100|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
14193101|NCT04627298|Vaccines|vaccines|mesh-list
14193102|NCT04627298|Immunologic Factors|immunologic factors|mesh-ancestor
14193103|NCT04627298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193104|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
14193105|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
14193106|NCT04627181|Hematinics|hematinics|mesh-ancestor
14193107|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
14193108|NCT04627181|Vitamins|vitamins|mesh-ancestor
14193109|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
14193110|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193111|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
14193112|NCT04627012|Lenvatinib|lenvatinib|mesh-list
14193113|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193114|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193115|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193116|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14193117|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193118|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
14193119|NCT04626739|Fludarabine|fludarabine|mesh-list
14193120|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193121|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
14193122|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193123|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193124|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14193125|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
14193126|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193127|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193128|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14193129|NCT04627129|Itraconazole|itraconazole|mesh-list
14193130|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
14193131|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193132|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14767900|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14767901|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
14767902|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13963594|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963595|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13963596|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13963597|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13963598|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13963599|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13963600|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
14193133|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14193134|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193135|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193136|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14193137|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
14193138|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193139|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193140|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14193141|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14767903|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
14767904|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
14767905|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767906|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14767907|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14767908|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
14767909|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963601|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
13963602|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
13963603|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
13963604|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13963605|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963606|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767910|NCT00632645|Olanzapine|olanzapine|mesh-list
14193142|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14193143|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193144|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
14193145|NCT04626765|Fludarabine|fludarabine|mesh-list
14193146|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193147|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
14193148|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193149|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193150|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14193151|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
14193152|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193153|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193154|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14193155|NCT04626973|Ezetimibe|ezetimibe|mesh-list
14193156|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14193157|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14193158|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14193159|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
14193160|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193161|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14193162|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238096|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14238097|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238098|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238099|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238100|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
14238101|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238102|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14238103|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14238104|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939218|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939219|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
14939220|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238105|NCT00129259|Iron|iron|mesh-list
14238106|NCT00129259|Trace Elements|trace elements|mesh-ancestor
14238107|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
14238108|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238109|NCT00129272|Bupropion|bupropion|mesh-list
14238110|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14238111|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
14238112|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238113|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14238114|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238115|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238116|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238117|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
14238118|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238119|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238120|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14238121|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14238122|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238123|NCT00129285|Modafinil|modafinil|mesh-list
14238124|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14238125|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238126|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14238127|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14767911|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
14767912|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
14767913|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
14939221|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
14767914|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
14767915|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767916|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767917|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767918|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14767919|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14767920|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14767921|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14767922|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14767923|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14767924|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939222|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193163|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
14193164|NCT04626752|Fludarabine|fludarabine|mesh-list
14193165|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193166|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
14193167|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193168|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193169|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14193170|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
14193171|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193172|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193173|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14193174|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
14193175|NCT04626726|Fludarabine|fludarabine|mesh-list
14193176|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193177|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
14193178|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193179|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193180|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14193181|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
14193182|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193183|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193184|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14193185|NCT04626414|Ferric maltol|ferric maltol|mesh-list
14193186|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
14193187|NCT04626414|Hematinics|hematinics|mesh-ancestor
14193188|NCT04626089|Metformin|metformin|mesh-list
14193189|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193190|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193191|NCT04626193|Amoxicillin|amoxicillin|mesh-list
14193192|NCT04626193|Doxycycline|doxycycline|mesh-list
14193193|NCT04626193|Levofloxacin|levofloxacin|mesh-list
14193194|NCT04626193|Ofloxacin|ofloxacin|mesh-list
14193195|NCT04626193|Esomeprazole|esomeprazole|mesh-list
14193196|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14481239|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
14481240|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
14481241|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
14481242|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481243|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
14481244|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14481245|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
14481246|NCT02500641|Protective Agents|protective agents|mesh-ancestor
14481247|NCT02500706|Insulin|insulin|mesh-list
14481248|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14481249|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
14481250|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
14481251|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14481252|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481253|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481254|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14481255|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14481256|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14481257|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481258|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481259|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481260|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481261|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481262|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
14481263|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14481264|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481265|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
14481266|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
14481267|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14481268|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
14481269|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14481270|NCT02500836|Cocaine|cocaine|mesh-list
14481271|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14193197|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193198|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14481272|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481273|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
14481274|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193199|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193200|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14193201|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193202|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193203|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
14193204|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14193205|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14193206|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14193207|NCT04626193|Renal Agents|renal agents|mesh-ancestor
14193208|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14193209|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14193210|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481275|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481276|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
14481277|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481278|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14481279|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14481280|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14481281|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481282|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481283|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
14481284|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481285|NCT02500979|Insulin|insulin|mesh-list
14481286|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14481287|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
14481288|NCT02500979|Pramlintide|pramlintide|mesh-list
14481289|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14481290|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481291|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481292|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
14481293|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14481294|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14481295|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481296|NCT02501135|Bupivacaine|bupivacaine|mesh-list
14481297|NCT02501135|Ropivacaine|ropivacaine|mesh-list
14481298|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481299|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
14481300|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481301|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481302|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
14481303|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481304|NCT02501161|Insulin|insulin|mesh-list
14481305|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14481306|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
14481307|NCT02501161|Liraglutide|liraglutide|mesh-list
14481308|NCT02501161|Xultophy|xultophy|mesh-list
14481309|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481310|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481311|NCT02501161|Incretins|incretins|mesh-ancestor
14481312|NCT02501161|Hormones|hormones|mesh-ancestor
14481313|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481314|NCT02501265|Nicotine|nicotine|mesh-list
14481315|NCT02501265|Varenicline|varenicline|mesh-list
14481316|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14481317|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
14481318|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481319|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481320|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14481321|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14481322|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
14481323|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481324|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481325|NCT02501473|Rituximab|rituximab|mesh-list
14481326|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
14481327|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481328|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481329|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
14481330|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481331|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481332|NCT02501629|Reslizumab|reslizumab|mesh-list
14481333|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14481334|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
14481335|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
14481336|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14193211|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14193212|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14193213|NCT04626258|Fluconazole|fluconazole|mesh-list
14193214|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
14193215|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193216|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14193217|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14939223|NCT01486706|Gabapentin|gabapentin|mesh-list
14939224|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
14193218|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193219|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193220|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14193221|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
14193222|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193223|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193224|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14193225|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14193226|NCT04626063|Acetaminophen|acetaminophen|mesh-list
14193227|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14193228|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14193229|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193230|NCT04626063|Analgesics|analgesics|mesh-ancestor
14193231|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
14193232|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193233|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193234|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
14193235|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193236|NCT04625985|Metformin|metformin|mesh-list
14193237|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939225|NCT01486706|Analgesics|analgesics|mesh-ancestor
14939226|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
14939227|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939228|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939229|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
14939230|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14193238|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193239|NCT04625907|Dactinomycin|dactinomycin|mesh-list
14193240|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
14193241|NCT04625907|Temozolomide|temozolomide|mesh-list
14193242|NCT04625907|Ifosfamide|ifosfamide|mesh-list
14193243|NCT04625907|Doxorubicin|doxorubicin|mesh-list
14193244|NCT04625907|Irinotecan|irinotecan|mesh-list
14193245|NCT04625907|Vincristine|vincristine|mesh-list
14193246|NCT04625907|Vinorelbine|vinorelbine|mesh-list
14193247|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193248|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
14193249|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193250|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193251|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14193252|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
14193253|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193254|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193255|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14193256|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14193257|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14193258|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14193259|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193260|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14193261|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14193262|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14193263|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14193264|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14193265|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14193266|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193267|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14193268|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14193269|NCT04625699|Durvalumab|durvalumab|mesh-list
14193270|NCT04625699|Tremelimumab|tremelimumab|mesh-list
14193271|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193272|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193273|NCT04625608|Acetaminophen|acetaminophen|mesh-list
14193274|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193275|NCT04625608|Analgesics|analgesics|mesh-ancestor
14193276|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
14527264|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14939231|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193277|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193278|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193279|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
14193280|NCT04625595|Methyldopa|methyldopa|mesh-list
14193281|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14193282|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
14193283|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
14193284|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193285|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193286|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14193287|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14193288|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14193289|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
14193290|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193291|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193292|NCT04625283|Ketamine|ketamine|mesh-list
14193293|NCT04625283|Analgesics|analgesics|mesh-ancestor
14193294|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
14193295|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193296|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193297|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14193298|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14193299|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
14193300|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
14193301|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193302|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14193303|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14193304|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193305|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193306|NCT04625257|Antibodies|antibodies|mesh-list
14193307|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
14193308|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193309|NCT04625543|Paclitaxel|paclitaxel|mesh-list
14193310|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14193311|NCT04625543|Cisplatin|cisplatin|mesh-list
14193312|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14193313|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193314|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14193315|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14193316|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14193317|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193318|NCT04625426|Protective Agents|protective agents|mesh-list
14193319|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193320|NCT04625179|Melatonin|melatonin|mesh-list
14193321|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
14193322|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
14193323|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193324|NCT04625179|Protective Agents|protective agents|mesh-ancestor
14193325|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193326|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193327|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14193328|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
14193329|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
14193330|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14193331|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
14193332|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
14193333|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193334|NCT04624958|Rituximab|rituximab|mesh-list
14193335|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
14193336|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193337|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193338|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
14193339|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193340|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193341|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14193342|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193343|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193344|NCT04624984|Gemcitabine|gemcitabine|mesh-list
14193345|NCT04624984|Doxorubicin|doxorubicin|mesh-list
14193346|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14193347|NCT04624984|Vinorelbine|vinorelbine|mesh-list
14193348|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14193349|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14193350|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
14767925|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193351|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193352|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193353|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
14193354|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193355|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193356|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193357|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
14193358|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193359|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14193360|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14193361|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14193362|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14193363|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
14193364|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
14193365|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
14193366|NCT04624906|Rituximab|rituximab|mesh-list
14193367|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14481337|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14481338|NCT02501902|Paclitaxel|paclitaxel|mesh-list
14481339|NCT02501902|Palbociclib|palbociclib|mesh-list
14481340|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14481341|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481342|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
14481343|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
14481344|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
14481345|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481346|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14481347|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481348|NCT02501928|Fesoterodine|fesoterodine|mesh-list
14481349|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14481350|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14481351|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
14481352|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481353|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481354|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481355|NCT02501928|Urological Agents|urological agents|mesh-ancestor
14481356|NCT02502149|Factor VIII|factor viii|mesh-list
14481357|NCT02502149|Coagulants|coagulants|mesh-ancestor
14481358|NCT02502487|Ropivacaine|ropivacaine|mesh-list
14481359|NCT02502487|Tetracaine|tetracaine|mesh-list
14481360|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481361|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
14481362|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481363|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481364|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
14481365|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481366|NCT02502734|Fluticasone|fluticasone|mesh-list
14481367|NCT02502734|Xhance|xhance|mesh-list
14481368|NCT02502734|Albuterol|albuterol|mesh-list
14481369|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481370|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14481371|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
14481372|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481373|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481374|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14481375|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
14481376|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
14481377|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14481378|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
14481379|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14481380|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14481381|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14481382|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14481383|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481384|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481385|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481386|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
14481387|NCT02502864|Docetaxel|docetaxel|mesh-list
14481388|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481389|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
14481390|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481391|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481392|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14481393|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
14481394|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193368|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
14193369|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193370|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193371|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
14193372|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193373|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193374|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14193375|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
14193376|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193377|NCT04625114|Gabexate|gabexate|mesh-list
14193378|NCT04625114|Camostat|camostat|mesh-list
14193379|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
14193380|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193381|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193382|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14193383|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14193384|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
14193385|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
14193386|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193387|NCT04624750|Mexiletine|mexiletine|mesh-list
14193388|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14193389|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14193390|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14193391|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14193392|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238128|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14238129|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238130|NCT00129311|Selegiline|selegiline|mesh-list
14238131|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
14238132|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238133|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14238134|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14238135|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14238136|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238137|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238138|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14238139|NCT00129311|Protective Agents|protective agents|mesh-ancestor
14238140|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238141|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
14238142|NCT00129376|Docetaxel|docetaxel|mesh-list
14238143|NCT00129376|Doxorubicin|doxorubicin|mesh-list
14238144|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238145|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
14238146|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238147|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238148|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238149|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
14238150|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238151|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238152|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238153|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238154|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238155|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238156|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14238157|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14238158|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14238159|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238160|NCT00129389|Paclitaxel|paclitaxel|mesh-list
14238161|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
14238162|NCT00129389|Doxorubicin|doxorubicin|mesh-list
14238163|NCT00129389|Fluorouracil|fluorouracil|mesh-list
14238164|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14238165|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238166|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238167|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238168|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238169|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238170|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238171|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
14238172|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238173|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238174|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238175|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
14238176|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238177|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14193393|NCT04624828|Androgens|androgens|mesh-list
14193394|NCT04624828|Hormones|hormones|mesh-ancestor
14193395|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193396|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193397|NCT04624295|Aspirin|aspirin|mesh-list
14193398|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14193399|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193400|NCT04624295|Analgesics|analgesics|mesh-ancestor
14193401|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
14193402|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193403|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193404|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193405|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193406|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14193407|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14193408|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193409|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14193410|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14193411|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193412|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
14193413|NCT04624399|Atezolizumab|atezolizumab|mesh-list
14193414|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193415|NCT04624178|Nivolumab|nivolumab|mesh-list
14193416|NCT04624178|Rucaparib|rucaparib|mesh-list
14193417|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193418|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193419|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14193420|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193421|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14193422|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193423|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
14193424|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
14193425|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14193426|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14193427|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193428|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193429|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193430|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193431|NCT04624360|Dexamethasone|dexamethasone|mesh-list
14193432|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193433|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
14193434|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
14193435|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193436|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193437|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193438|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
14193439|NCT04624360|Hormones|hormones|mesh-ancestor
14193440|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193441|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14193442|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193443|NCT04623879|Ivacaftor|ivacaftor|mesh-list
14193444|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14193445|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14193446|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193447|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
14193448|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193449|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193450|NCT04624217|Gemcitabine|gemcitabine|mesh-list
14193451|NCT04624217|Paclitaxel|paclitaxel|mesh-list
14193452|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14193453|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193454|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14193455|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14193456|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14193457|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193458|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14193459|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
14193460|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
14193461|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193462|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481395|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481396|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14481397|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
14481398|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
14481399|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
14193463|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193464|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
14193465|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193466|NCT04623866|Valsartan|valsartan|mesh-list
14193467|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14193468|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14193469|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14193470|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193471|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
14193472|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
14193473|NCT04623619|Vitamins|vitamins|mesh-ancestor
14193474|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
14193475|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193476|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
14193477|NCT04623840|Tadalafil|tadalafil|mesh-list
14193478|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
14193479|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14193480|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14193481|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193482|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193483|NCT04623840|Urological Agents|urological agents|mesh-ancestor
14193484|NCT04623086|Insulin|insulin|mesh-list
14193485|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14193486|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
14193487|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193488|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193489|NCT04623385|Tretinoin|tretinoin|mesh-list
14193490|NCT04623385|Isotretinoin|isotretinoin|mesh-list
14193491|NCT04623385|Testosterone|testosterone|mesh-list
14193492|NCT04623385|Androgens|androgens|mesh-ancestor
14193493|NCT04623385|Hormones|hormones|mesh-ancestor
14193494|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193495|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193496|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193497|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
14193498|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
14193499|NCT04623021|Nafamostat|nafamostat|mesh-list
14193500|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14193501|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193502|NCT04623021|Analgesics|analgesics|mesh-ancestor
14193503|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
14193504|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193505|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193506|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193507|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193508|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
14193509|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
14193510|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193511|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193512|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14193513|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14193514|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14193515|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193516|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
14193517|NCT04622618|Gabapentin|gabapentin|mesh-list
14193518|NCT04622618|Analgesics|analgesics|mesh-ancestor
14193519|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
14193520|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193521|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193522|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
14193523|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14193524|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193525|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193526|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193527|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14193528|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14193529|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193530|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193531|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
14193532|NCT04622865|Quercetin|quercetin|mesh-list
14193533|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
14193534|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193535|NCT04622865|Protective Agents|protective agents|mesh-ancestor
14193536|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193537|NCT04622995|Diazepam|diazepam|mesh-list
14193538|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14193539|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
14193540|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
14193541|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
14193542|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193543|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193544|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193545|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14193546|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193547|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14193548|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14193549|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14193550|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193551|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193552|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14193553|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
14193554|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
14193555|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
14193556|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
14193557|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193558|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238178|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14238179|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14238180|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238181|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
14238182|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14238183|NCT00129467|Methylphenidate|methylphenidate|mesh-list
14238184|NCT00129467|Serotonin|serotonin|mesh-list
14238185|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14238186|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14238187|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238188|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14238189|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238190|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238191|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238192|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
14238193|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238194|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14238195|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
14238196|NCT00129545|Warfarin|warfarin|mesh-list
14238197|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
14238198|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
14238199|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14238200|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238201|NCT00129727|Paclitaxel|paclitaxel|mesh-list
14238202|NCT00129727|Bevacizumab|bevacizumab|mesh-list
14238203|NCT00129727|Carboplatin|carboplatin|mesh-list
14238204|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14238205|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238206|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238207|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238208|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238209|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238210|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14238211|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14238212|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14238213|NCT00129727|Growth Substances|growth substances|mesh-ancestor
14238214|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238215|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
14238216|NCT00129766|Palivizumab|palivizumab|mesh-list
14238217|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
14238218|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767926|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767927|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
14238219|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
14238220|NCT00129935|Docetaxel|docetaxel|mesh-list
14238221|NCT00129935|Capecitabine|capecitabine|mesh-list
14238222|NCT00129935|Epirubicin|epirubicin|mesh-list
14238223|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238224|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
14238225|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238226|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238227|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14767928|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14767929|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
14238228|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
14238229|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767930|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14767931|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
14767932|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
14767933|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14767934|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767935|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939232|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939233|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193559|NCT04622709|Furosemide|furosemide|mesh-list
14193560|NCT04622709|Diuretics|diuretics|mesh-list
14193561|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14193562|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
14193563|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193564|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14193565|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939234|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14939235|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14939236|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939237|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939238|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
14939239|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14193566|NCT04622956|Methotrexate|methotrexate|mesh-list
14193567|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14193568|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
14193569|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14193570|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193571|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14193572|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
14193573|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193574|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193575|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
14193576|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193577|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14193578|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193579|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
14193580|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193581|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14193582|NCT04622891|Azithromycin|azithromycin|mesh-list
14193583|NCT04622891|Clarithromycin|clarithromycin|mesh-list
14193584|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14193585|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193586|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14193587|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193588|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193589|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14193590|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14193591|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
14193592|NCT04622566|Lenvatinib|lenvatinib|mesh-list
14193593|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193594|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193595|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14193596|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193597|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193598|NCT04622813|Acetaminophen|acetaminophen|mesh-list
14193599|NCT04622813|Ketoprofen|ketoprofen|mesh-list
14193600|NCT04622813|Nefopam|nefopam|mesh-list
14193601|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193602|NCT04622813|Analgesics|analgesics|mesh-ancestor
14193603|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
14193604|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193605|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193606|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
14193607|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14193608|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193609|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193610|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14193611|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193612|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193613|NCT04622579|Rituximab|rituximab|mesh-list
14193614|NCT04622579|Lenalidomide|lenalidomide|mesh-list
14193615|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14767936|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14767937|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14193616|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193617|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
14193618|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193619|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193620|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14193621|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14193622|NCT04622579|Growth Substances|growth substances|mesh-ancestor
14193623|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
14193624|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
14193625|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14193626|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14193627|NCT04622917|Prednisolone|prednisolone|mesh-list
14193628|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
14193629|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14193630|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
14193631|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193632|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
14193633|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
14193634|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193635|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193636|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193637|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
14193638|NCT04622917|Hormones|hormones|mesh-ancestor
14193639|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193640|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14193641|NCT04622917|Protective Agents|protective agents|mesh-ancestor
14193642|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14193643|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193644|NCT04622982|Vitamin D|vitamin d|mesh-list
14193645|NCT04622982|Vitamins|vitamins|mesh-ancestor
14193646|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
14193647|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193648|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14193649|NCT04622488|Diclofenac|diclofenac|mesh-list
14193650|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14193651|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193652|NCT04622488|Analgesics|analgesics|mesh-ancestor
14193653|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
14193654|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193655|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193656|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193657|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193658|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14193659|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193660|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193661|NCT04622202|Pregabalin|pregabalin|mesh-list
14193662|NCT04622202|Analgesics|analgesics|mesh-ancestor
14193663|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
14193664|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193665|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193666|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
14193667|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14193668|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14193669|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193670|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14193671|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14193672|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193673|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193674|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193675|NCT04622358|Rabeprazole|rabeprazole|mesh-list
14193676|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14193677|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193678|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14193679|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193680|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193681|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
14193682|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14193683|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14193684|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193685|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
14193686|NCT04622397|Coagulants|coagulants|mesh-ancestor
14193687|NCT04622111|Metformin|metformin|mesh-list
14193688|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193689|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193690|NCT04621929|Topiramate|topiramate|mesh-list
14193691|NCT04621929|Phentermine|phentermine|mesh-list
14193692|NCT04621929|Allopurinol|allopurinol|mesh-list
14193693|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193694|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
14193695|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193696|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193697|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
14193698|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193699|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
14193700|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193701|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14193702|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
14193703|NCT04621929|Protective Agents|protective agents|mesh-ancestor
14193704|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14193705|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
14193706|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14193707|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
14193708|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
14193709|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481400|NCT02503085|Ibuprofen|ibuprofen|mesh-list
14481401|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14481402|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481403|NCT02503085|Analgesics|analgesics|mesh-ancestor
14481404|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
14481405|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481406|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481407|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481408|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481409|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14481410|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481411|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481412|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
14481413|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481414|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481415|NCT02503540|Aflibercept|aflibercept|mesh-list
14481416|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14481417|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14481418|NCT02503540|Growth Substances|growth substances|mesh-ancestor
14481419|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481420|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
14481421|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481422|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
14481423|NCT02503735|Ledipasvir|ledipasvir|mesh-list
14481424|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
14481425|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481426|NCT02503865|Orlistat|orlistat|mesh-list
14481427|NCT02503865|Diltiazem|diltiazem|mesh-list
14481428|NCT02503865|Atorvastatin|atorvastatin|mesh-list
14481429|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14481430|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14481431|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
14481432|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481433|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14481434|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14481435|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481436|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14481437|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14481438|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481439|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14481440|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481441|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
14481442|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14481443|NCT02503982|Valganciclovir|valganciclovir|mesh-list
14481444|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
14481445|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481446|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
14481447|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14481448|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
14481449|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14481450|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
14193710|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
14193711|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193712|NCT04622020|Anesthetics|anesthetics|mesh-list
14193713|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193714|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193715|NCT04622033|Brodalumab|brodalumab|mesh-list
14193716|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
14193717|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14193718|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
14193719|NCT04621799|Coagulants|coagulants|mesh-ancestor
14193720|NCT04621370|Capecitabine|capecitabine|mesh-list
14193721|NCT04621370|Durvalumab|durvalumab|mesh-list
14193722|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14193723|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
14193724|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193725|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193726|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193727|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
14193728|NCT04621461|Astringents|astringents|mesh-ancestor
14193729|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193730|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14193731|NCT04621487|Amoxicillin|amoxicillin|mesh-list
14193732|NCT04621487|Metronidazole|metronidazole|mesh-list
14193733|NCT04621487|Clarithromycin|clarithromycin|mesh-list
14193734|NCT04621487|Pantoprazole|pantoprazole|mesh-list
14193735|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14193736|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193737|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14193738|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14193739|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14193740|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193741|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193742|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14193743|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14193744|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14193745|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193746|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14193747|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
14193748|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14193749|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14193750|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14193751|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193752|NCT04621617|Midodrine|midodrine|mesh-list
14193753|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
14193754|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
14193755|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193756|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193757|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14193758|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14193759|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14193760|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14193761|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
14193762|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193763|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193764|NCT04621669|Metformin|metformin|mesh-list
14193765|NCT04621669|Digoxin|digoxin|mesh-list
14193766|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14193767|NCT04621669|Calcium|calcium|mesh-list
14193768|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193769|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193770|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14193771|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14193772|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14193773|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
14193774|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193775|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14193776|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14193777|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193778|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14193779|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14193780|NCT04621669|Protective Agents|protective agents|mesh-ancestor
14193781|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
14193782|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14193783|NCT04621318|Denosumab|denosumab|mesh-list
14193784|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14193785|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193786|NCT04621227|Midazolam|midazolam|mesh-list
14193787|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14193788|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14193789|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14193790|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193791|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193792|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14939240|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14939241|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
14939242|NCT01486706|Urological Agents|urological agents|mesh-ancestor
14193793|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193794|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193795|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14193796|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
14193797|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
14193798|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
14193799|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
14193800|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193801|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193802|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14193803|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14193804|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
14939243|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14939244|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
14939245|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939246|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
14939247|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
14939248|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14939249|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939250|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939251|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
14939252|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
14939253|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14939254|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939255|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939256|NCT01486888|Insulin|insulin|mesh-list
14193805|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14193806|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14193807|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193808|NCT04621513|Montelukast|montelukast|mesh-list
14193809|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14193810|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
14193811|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14193812|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
14193813|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193814|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193815|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14193816|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14193817|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193818|NCT04621149|Lactoferrin|lactoferrin|mesh-list
14193819|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
14193820|NCT04621149|Famotidine|famotidine|mesh-list
14193821|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14193822|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193823|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14193824|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
14193825|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
14193826|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193827|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193828|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193829|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193830|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
14193831|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
14193832|NCT04620954|Nivolumab|nivolumab|mesh-list
14939257|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14193833|NCT04620954|Oregovomab|oregovomab|mesh-list
14939258|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193834|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193835|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193836|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14193837|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193838|NCT04621253|Dipyrone|dipyrone|mesh-list
14193839|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14193840|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193841|NCT04621253|Analgesics|analgesics|mesh-ancestor
14481451|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481452|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481453|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
14481454|NCT02504268|Methotrexate|methotrexate|mesh-list
14481455|NCT02504268|Abatacept|abatacept|mesh-list
14481456|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14481457|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
14481458|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14481459|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481460|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14481461|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
14481462|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481463|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481464|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
14481465|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481466|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14481467|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481468|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
14481469|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481470|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14481471|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14481472|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
14481473|NCT02504294|Hematinics|hematinics|mesh-ancestor
14481474|NCT02504320|Febuxostat|febuxostat|mesh-list
14481475|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
14481476|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481477|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
14193842|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
14481478|NCT02504541|Testosterone|testosterone|mesh-list
14767938|NCT00632697|Protective Agents|protective agents|mesh-ancestor
14767939|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767940|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
14767941|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14767942|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
14939259|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939260|NCT01486901|Insulin|insulin|mesh-list
14939261|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14939262|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
14939263|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
14939264|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
14939265|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939266|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939267|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
14939268|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939269|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939270|NCT01486940|Insulin|insulin|mesh-list
14193843|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193844|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193845|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14193846|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193847|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
14193848|NCT04621058|Vitamin D|vitamin d|mesh-list
14193849|NCT04621058|Vitamins|vitamins|mesh-list
14193850|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
14193851|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193852|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14193853|NCT04621110|Fentanyl|fentanyl|mesh-list
14481479|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
14481480|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
14767943|NCT00632723|Gefitinib|gefitinib|mesh-list
14767944|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767945|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14767946|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767947|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767948|NCT00632762|Amantadine|amantadine|mesh-list
14767949|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14767950|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14767951|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
14939271|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14193854|NCT04621110|Midazolam|midazolam|mesh-list
14193855|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
14193856|NCT04621110|Ketamine|ketamine|mesh-list
14193857|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14193858|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193859|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193860|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14193861|NCT04621110|Analgesics|analgesics|mesh-ancestor
14481481|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14481482|NCT02504541|Androgens|androgens|mesh-ancestor
14481483|NCT02504541|Hormones|hormones|mesh-ancestor
14481484|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481485|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481486|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14481487|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481488|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
14481489|NCT02504554|Vancomycin|vancomycin|mesh-list
14481490|NCT02504554|Omeprazole|omeprazole|mesh-list
14481491|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14481492|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481493|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14481494|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481495|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14481496|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481497|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481498|NCT02504671|Folic Acid|folic acid|mesh-list
14481499|NCT02504671|Hematinics|hematinics|mesh-ancestor
14481500|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
14481501|NCT02504671|Vitamins|vitamins|mesh-ancestor
14481502|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
14481503|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481504|NCT02504723|Carvedilol|carvedilol|mesh-list
14481505|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14481506|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14481507|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481508|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193862|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
14193863|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193864|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14193865|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14193866|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14193867|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
14193868|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193869|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193870|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14193871|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14193872|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
14193873|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
14193874|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14193875|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14193876|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14193877|NCT04621110|Narcotics|narcotics|mesh-ancestor
14193878|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14193879|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14193880|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193881|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193882|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
14193883|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
14193884|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14193885|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14238230|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238231|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238232|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238233|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238234|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238235|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14238236|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
14238237|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14238238|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14481509|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481510|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481511|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14238239|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14238240|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481512|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
14238241|NCT00129961|Cyclosporine|cyclosporine|mesh-list
14238242|NCT00129961|Sirolimus|sirolimus|mesh-list
14193886|NCT04620967|Insulin|insulin|mesh-list
14193887|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14193888|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
14193889|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
14193890|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14193891|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193892|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193893|NCT04620785|Methylene Blue|methylene blue|mesh-list
14481513|NCT02504723|Protective Agents|protective agents|mesh-ancestor
14481514|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14481515|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481516|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14481517|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
14939272|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
14939273|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
14939274|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
14939275|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
14939276|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
14939277|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193894|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193895|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193896|NCT04620720|Gabapentin|gabapentin|mesh-list
14193897|NCT04620720|Analgesics|analgesics|mesh-ancestor
14193898|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
14193899|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14193900|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193901|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
14193902|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14193903|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14193904|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193905|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14193906|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14193907|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14193908|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193909|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193910|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
14193911|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
14193912|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14193913|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193914|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14193915|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193916|NCT04620603|Nivolumab|nivolumab|mesh-list
14939278|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193917|NCT04620603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481518|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14481519|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14481520|NCT02504775|Acetaminophen|acetaminophen|mesh-list
14481521|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481522|NCT02504775|Analgesics|analgesics|mesh-ancestor
14767952|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767953|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
14767954|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767955|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767956|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767957|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14767958|NCT00632762|Analgesics|analgesics|mesh-ancestor
14767959|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
14767960|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14767961|NCT00632840|Atorvastatin|atorvastatin|mesh-list
14767962|NCT00632840|Fenofibrate|fenofibrate|mesh-list
14767963|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14767964|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14767965|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
14767966|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767967|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14767968|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14767969|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767970|NCT00632853|Carboplatin|carboplatin|mesh-list
14767971|NCT00632853|Etoposide|etoposide|mesh-list
14767972|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14767973|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14767974|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14939279|NCT01486953|Sevoflurane|sevoflurane|mesh-list
14481523|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
14939280|NCT01486953|Desflurane|desflurane|mesh-list
14767975|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14767976|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767977|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767978|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
14767979|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
14767980|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14767981|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14767982|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14767983|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767984|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939281|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14939282|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14939283|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
14939284|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
14939285|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939286|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939287|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14939288|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14939289|NCT01486979|Estradiol|estradiol|mesh-list
14939290|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14939291|NCT01486979|Estrogens|estrogens|mesh-ancestor
14939292|NCT01486979|Hormones|hormones|mesh-ancestor
14939293|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14939294|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939295|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14939296|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
14939297|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14939298|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14939299|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
14939300|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14939301|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939302|NCT01487096|Teriflunomide|teriflunomide|mesh-list
14939303|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14939304|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939305|NCT01487096|Analgesics|analgesics|mesh-ancestor
14939306|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
14939307|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939308|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939309|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939310|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939311|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939312|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
14193918|NCT04620603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193919|NCT04620603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14193920|NCT04620603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193921|NCT04620616|Menthol|menthol|mesh-list
14193922|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
14193923|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
14193924|NCT04620473|Oxaliplatin|oxaliplatin|mesh-list
14193925|NCT04620473|Capecitabine|capecitabine|mesh-list
14193926|NCT04620473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193927|NCT04620473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14193928|NCT04620473|Antimetabolites|antimetabolites|mesh-ancestor
14193929|NCT04620473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193930|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
14193931|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14193932|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
14238243|NCT00129961|Tacrolimus|tacrolimus|mesh-list
14238244|NCT00129961|Cyclosporins|cyclosporins|mesh-list
14238245|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238246|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
14238247|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238248|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14238249|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238250|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238251|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
14238252|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238253|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14238254|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238255|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14238256|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14238257|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238258|NCT00130039|Cilostazol|cilostazol|mesh-list
14238259|NCT00130039|Clopidogrel|clopidogrel|mesh-list
14238260|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14481524|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481525|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481526|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
14481527|NCT02504827|Ceftazidime|ceftazidime|mesh-list
14481528|NCT02504827|Avibactam|avibactam|mesh-list
14481529|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14481530|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14481531|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481532|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14481533|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481534|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481535|NCT02504892|Everolimus|everolimus|mesh-list
14481536|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481537|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481538|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
14481539|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481540|NCT02504931|Sertraline|sertraline|mesh-list
14481541|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
14481542|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14481543|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14481544|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14481545|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481546|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481547|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481548|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
14481549|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481550|NCT02505269|Doxorubicin|doxorubicin|mesh-list
14481551|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14481552|NCT02505269|Dacarbazine|dacarbazine|mesh-list
14481553|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14481554|NCT02505269|Imidazole|imidazole|mesh-list
14481555|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14481556|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481557|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14481558|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14481559|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481560|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481561|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14481562|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
14481563|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481564|NCT02505334|Liraglutide|liraglutide|mesh-list
14481565|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481566|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481567|NCT02505334|Incretins|incretins|mesh-ancestor
14481568|NCT02505334|Hormones|hormones|mesh-ancestor
14481569|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481570|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
14481571|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481572|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
14481573|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481574|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481575|NCT02505945|Omeprazole|omeprazole|mesh-list
14481576|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14193933|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193934|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14193935|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14193936|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
14193937|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193938|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193939|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14193940|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14193941|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193942|NCT04620018|Amoxicillin|amoxicillin|mesh-list
14193943|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14193944|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193945|NCT04620031|Propofol|propofol|mesh-list
14193946|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14193947|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193948|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481577|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481578|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14481579|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481580|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193949|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14481581|NCT02506114|Ipilimumab|ipilimumab|mesh-list
14481582|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481583|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481584|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14481585|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481586|NCT02506257|Biguanides|biguanides|mesh-list
14481587|NCT02506257|Polihexanide|polihexanide|mesh-list
14481588|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481589|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481590|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
14481591|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481592|NCT02506634|Esomeprazole|esomeprazole|mesh-list
14481593|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14481594|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481595|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14481596|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481597|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527265|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14527266|NCT04048681|Cocaine|cocaine|mesh-list
14527267|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527268|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
14527269|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527270|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527271|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
14527272|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527273|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14193950|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
14193951|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
14193952|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14193953|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14193954|NCT04620200|Nivolumab|nivolumab|mesh-list
14193955|NCT04620200|Ipilimumab|ipilimumab|mesh-list
14193956|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
14193957|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14193958|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193959|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14193960|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193961|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193962|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14193963|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14193964|NCT04620343|Anesthetics|anesthetics|mesh-list
14193965|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14193966|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193967|NCT04620291|UB-421|ub-421|mesh-list
14193968|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14193969|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
14193970|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193971|NCT04620304|UB-421|ub-421|mesh-list
14193972|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14193973|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
14193974|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14193975|NCT04620213|Phentolamine|phentolamine|mesh-list
14193976|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14193977|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14193978|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14193979|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14193980|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
14193981|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193982|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193983|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14193984|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14193985|NCT04619758|Emollients|emollients|mesh-list
14193986|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
14193987|NCT04619914|Letrozole|letrozole|mesh-list
14193988|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14193989|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14193990|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14193991|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14193992|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14193993|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14193994|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
14527274|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14193995|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14193996|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527275|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14481598|NCT02506660|Dexamethasone|dexamethasone|mesh-list
14481599|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
14481600|NCT02506660|Bupivacaine|bupivacaine|mesh-list
14481601|NCT02506660|BB 1101|bb 1101|mesh-list
14481602|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481603|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
14481604|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
14481605|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481606|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481607|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481608|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
14481609|NCT02506660|Hormones|hormones|mesh-ancestor
14481610|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481611|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14481612|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481613|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
14481614|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481615|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481616|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481617|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
14481618|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481619|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
14481620|NCT02506673|Midazolam|midazolam|mesh-list
14481621|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14481622|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14481623|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481624|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481625|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14481626|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14481627|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14481628|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14481629|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
14481630|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
14481631|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
14481632|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
14481633|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14193997|NCT04619875|Lactulose|lactulose|mesh-list
14193998|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14193999|NCT04619862|Gabapentin|gabapentin|mesh-list
14194000|NCT04619862|Analgesics|analgesics|mesh-ancestor
14194001|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
14194002|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194003|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194004|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
14194005|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14194006|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14194007|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194008|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14194009|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14194010|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14194011|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194012|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194013|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
14194014|NCT04619290|Methylene Blue|methylene blue|mesh-list
14194015|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194016|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194017|NCT04619303|Dexamethasone|dexamethasone|mesh-list
14194018|NCT04619303|Bevacizumab|bevacizumab|mesh-list
14194019|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14194020|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194021|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14194022|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14194023|NCT04619303|Growth Substances|growth substances|mesh-ancestor
14481634|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481635|NCT02506816|Olaparib|olaparib|mesh-list
14481636|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14481637|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481638|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767985|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14767986|NCT00633035|Esomeprazole|esomeprazole|mesh-list
14767987|NCT00633035|Famotidine|famotidine|mesh-list
14767988|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14767989|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14767990|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14767991|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14767992|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14767993|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14767994|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
14767995|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
14767996|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14767997|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14767998|NCT00633269|Olaparib|olaparib|mesh-list
14767999|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14768000|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768001|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768002|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768003|NCT00633282|Pioglitazone|pioglitazone|mesh-list
14768004|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14768005|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14768006|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768007|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14768008|NCT00633347|Cetrorelix|cetrorelix|mesh-list
14768009|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14768010|NCT00633347|Hormones|hormones|mesh-ancestor
14768011|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768012|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768013|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14768014|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
14768015|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14768016|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768017|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
14768018|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14768019|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
14768020|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14768021|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768022|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194024|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194025|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
14194026|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768023|NCT00633373|Cyclosporine|cyclosporine|mesh-list
14768024|NCT00633373|Cyclosporins|cyclosporins|mesh-list
14768025|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768026|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768027|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768028|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
14768029|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768030|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
14768031|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768032|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
14768033|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194027|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
14194028|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
14194029|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194030|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194031|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
14194032|NCT04619303|Hormones|hormones|mesh-ancestor
14481639|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481640|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
14481641|NCT02506868|Hematinics|hematinics|mesh-ancestor
14481642|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
14481643|NCT02506881|Hematinics|hematinics|mesh-ancestor
14481644|NCT02507011|Carvedilol|carvedilol|mesh-list
14481645|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14481646|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14481647|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481648|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481649|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481650|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481651|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14481652|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
14768034|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14768035|NCT00633386|Celecoxib|celecoxib|mesh-list
14481653|NCT02507011|Protective Agents|protective agents|mesh-ancestor
14481654|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14481655|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481656|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14481657|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
14481658|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14481659|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14481660|NCT02507219|Ibuprofen|ibuprofen|mesh-list
14481661|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14481662|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481663|NCT02507219|Analgesics|analgesics|mesh-ancestor
14481664|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
14481665|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481666|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481667|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481668|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481669|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14481670|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481671|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481672|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14481673|NCT02507375|Pertuzumab|pertuzumab|mesh-list
14481674|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481675|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14481676|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481677|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481678|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481679|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
14481680|NCT02508077|Leucovorin|leucovorin|mesh-list
14481681|NCT02508077|Folic Acid|folic acid|mesh-list
14481682|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14481683|NCT02508077|Panitumumab|panitumumab|mesh-list
14481684|NCT02508077|Fluorouracil|fluorouracil|mesh-list
14481685|NCT02508077|Irinotecan|irinotecan|mesh-list
14481686|NCT02508077|Camptothecin|camptothecin|mesh-list
14481687|NCT02508077|Antibodies|antibodies|mesh-list
14481688|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
14481689|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14481690|NCT02508077|Calcium|calcium|mesh-list
14481691|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
14481692|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
14481693|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481694|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481695|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14481696|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14481697|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
14481698|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481699|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14481700|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194033|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194034|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14194035|NCT04619537|Docetaxel|docetaxel|mesh-list
14194036|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194037|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14194038|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
14194039|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
14194040|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194041|NCT04619563|Docetaxel|docetaxel|mesh-list
14194042|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481701|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14481702|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14481703|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481704|NCT02508077|Antidotes|antidotes|mesh-ancestor
14194043|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14194044|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14194045|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14194046|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194047|NCT04619316|Trametinib|trametinib|mesh-list
14481705|NCT02508077|Protective Agents|protective agents|mesh-ancestor
14481706|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
14481707|NCT02508077|Vitamins|vitamins|mesh-ancestor
14481708|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
14481709|NCT02508077|Hematinics|hematinics|mesh-ancestor
14481710|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14481711|NCT02508103|Oxytocin|oxytocin|mesh-list
14481712|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
14481713|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14481714|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481715|NCT02508207|Ivacaftor|ivacaftor|mesh-list
14768036|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14768037|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14768038|NCT00633386|Analgesics|analgesics|mesh-ancestor
14768039|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
14768040|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768041|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481716|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14481717|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481718|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481719|NCT02508259|Suramin|suramin|mesh-list
14481720|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
14768042|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768043|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14768044|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14768045|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14768046|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768047|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768048|NCT00633412|Esomeprazole|esomeprazole|mesh-list
14768049|NCT00633412|Ranitidine|ranitidine|mesh-list
14768050|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14768051|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14768052|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768053|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14768054|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768055|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481721|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
14481722|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14481723|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481724|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481725|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14481726|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14481727|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
14481728|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
14481729|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481730|NCT02508389|Protective Agents|protective agents|mesh-ancestor
14481731|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481732|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
14481733|NCT02508428|Diuretics|diuretics|mesh-ancestor
14481734|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
14481735|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481736|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14481737|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481738|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481739|NCT02508636|Leuprolide|leuprolide|mesh-list
14481740|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14481741|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
14481742|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14481743|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481744|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14481745|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481746|NCT02508701|Vaccines|vaccines|mesh-list
14481747|NCT02508701|Immunologic Factors|immunologic factors|mesh-ancestor
14481748|NCT02508701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481749|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14481750|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14481751|NCT02508935|Narcotics|narcotics|mesh-ancestor
14481752|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481753|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481754|NCT02508935|Analgesics|analgesics|mesh-ancestor
14481755|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
14481756|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194048|NCT04619316|Dabrafenib|dabrafenib|mesh-list
14194049|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194050|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14194051|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194052|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194053|NCT04619251|Itraconazole|itraconazole|mesh-list
14194054|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
14194055|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194056|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14194057|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14194058|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481757|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14481758|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481759|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481760|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481761|NCT02509026|Etanercept|etanercept|mesh-list
14481762|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14481763|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481764|NCT02509026|Analgesics|analgesics|mesh-ancestor
14481765|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
14481766|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481767|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481768|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481769|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481770|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481771|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481772|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
14768056|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14768057|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
14768058|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
14768059|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768060|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768061|NCT00633425|Glimepiride|glimepiride|mesh-list
14768062|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14768063|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14481773|NCT02509065|Pancrelipase|pancrelipase|mesh-list
14768064|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768065|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768066|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
14768067|NCT00633438|Celecoxib|celecoxib|mesh-list
14768068|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14768069|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14768070|NCT00633438|Analgesics|analgesics|mesh-ancestor
14768071|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
14768072|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768073|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768074|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768075|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14768076|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14768077|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14768078|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768079|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768080|NCT00633490|Apatinib|apatinib|mesh-list
14939313|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
14939314|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14939315|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939316|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14939317|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14939318|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939319|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939320|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026617|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026618|NCT01944436|Rivastigmine|rivastigmine|mesh-list
15026619|NCT01944436|Donepezil|donepezil|mesh-list
15026620|NCT01944436|Galantamine|galantamine|mesh-list
15026621|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
15026622|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026623|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026624|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
15026625|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026626|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026627|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
15026628|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15026629|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
15026630|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026631|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15026632|NCT01944436|Protective Agents|protective agents|mesh-ancestor
15026633|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
15026634|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14481774|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768081|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481775|NCT02509078|Cisatracurium|cisatracurium|mesh-list
14481776|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14481777|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14481778|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481779|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481780|NCT02509481|Ivermectin|ivermectin|mesh-list
14481781|NCT02509481|Albendazole|albendazole|mesh-list
14481782|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14481783|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481784|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
14481785|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
14481786|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14481787|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14481788|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
14481789|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
14481790|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
14194059|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194060|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14194061|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
14194062|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194063|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194064|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14481791|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481792|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481793|NCT02509624|Selonsertib|selonsertib|mesh-list
14481794|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14481795|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481796|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481797|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14481798|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
14481799|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14481800|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14481801|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14481802|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
14481803|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14481804|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481805|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14481806|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14481807|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14481808|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768082|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14194065|NCT04619381|Clopidogrel|clopidogrel|mesh-list
14194066|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14194067|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14194068|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14194069|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14194070|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
14194071|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194072|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194073|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238261|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14238262|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14238263|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14238264|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
14238265|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238266|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238267|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238268|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14238269|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
14238270|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238271|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14481809|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481810|NCT02510001|Crizotinib|crizotinib|mesh-list
14481811|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481812|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14481813|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481814|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481815|NCT02510014|Buprenorphine|buprenorphine|mesh-list
14481816|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14481817|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14481818|NCT02510014|Narcotics|narcotics|mesh-ancestor
14481819|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481820|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481821|NCT02510014|Analgesics|analgesics|mesh-ancestor
14481822|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
14481823|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481824|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14481825|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
14481826|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14481827|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14481828|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481829|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
14481830|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
14481831|NCT02510794|Ranibizumab|ranibizumab|mesh-list
14481832|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14481833|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14481834|NCT02510794|Growth Substances|growth substances|mesh-ancestor
14481835|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481836|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
14481837|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481838|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
14481839|NCT02511184|Crizotinib|crizotinib|mesh-list
14481840|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14481841|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481842|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14481843|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481844|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194074|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
14194075|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14194076|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194077|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194078|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14194079|NCT04618965|Analgesics|analgesics|mesh-ancestor
14194080|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
14194081|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194082|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14194083|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14194084|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14194085|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
14194086|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194087|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194088|NCT04619095|Psyllium|psyllium|mesh-list
14194089|NCT04619095|Cathartics|cathartics|mesh-ancestor
14194090|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481845|NCT02511236|Nicotine|nicotine|mesh-list
14481846|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14481847|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
14481848|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481849|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481850|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14481851|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14481852|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
14481853|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481854|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481855|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14481856|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14481857|NCT02511431|Ritonavir|ritonavir|mesh-list
14481858|NCT02511431|Lonafarnib|lonafarnib|mesh-list
14481859|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14768083|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768084|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768085|NCT00633542|Interferons|interferons|mesh-list
14768086|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
14768087|NCT00633542|Thalidomide|thalidomide|mesh-list
14768088|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768089|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
14768090|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768091|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
14768092|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768093|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768094|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
14768095|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14768096|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14768097|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14768098|NCT00633542|Growth Substances|growth substances|mesh-ancestor
14768099|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
14768100|NCT00633568|Cisplatin|cisplatin|mesh-list
14768101|NCT00633568|Docetaxel|docetaxel|mesh-list
14768102|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768103|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
14768104|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
14768105|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
14194100|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
14194101|NCT04618913|Apixaban|apixaban|mesh-list
14194102|NCT04618913|Edoxaban|edoxaban|mesh-list
14194103|NCT04618913|Dabigatran|dabigatran|mesh-list
14194104|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14194105|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
14194106|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14194107|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
14194108|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194109|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194110|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
14194111|NCT04618952|Calcium|calcium|mesh-list
14194112|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14481860|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14481861|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
14481862|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481863|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481864|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14481865|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14481866|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
14481867|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481868|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14481869|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14481870|NCT02511535|Vaccines|vaccines|mesh-list
14481871|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
14481872|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481873|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
14481874|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14481875|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481876|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14481877|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14481878|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481879|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481880|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481881|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14481882|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14481883|NCT02511587|Vaccines|vaccines|mesh-list
14481884|NCT02511587|Immunologic Factors|immunologic factors|mesh-ancestor
14481885|NCT02511587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481886|NCT02512042|Brinzolamide|brinzolamide|mesh-list
14481887|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14481888|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14481889|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481890|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
14481891|NCT02512302|Bromides|bromides|mesh-list
14481892|NCT02512302|Charcoal|charcoal|mesh-list
14481893|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
14481894|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14481895|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14481896|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14481897|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
14481898|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481899|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481900|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768106|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194113|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194114|NCT04619433|Carboplatin|carboplatin|mesh-list
14194115|NCT04619433|Pemetrexed|pemetrexed|mesh-list
14194116|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194117|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194118|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194119|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14194120|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14194121|NCT04619160|Propofol|propofol|mesh-list
14194122|NCT04619160|Sevoflurane|sevoflurane|mesh-list
14194123|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14194124|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194125|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194126|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14768107|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
14768108|NCT00633581|Vitamins|vitamins|mesh-ancestor
14768109|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
14768110|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768111|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
14194127|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
14194128|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
14768112|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768113|NCT00633581|Protective Agents|protective agents|mesh-ancestor
14194129|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14194130|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14194131|NCT04619069|Hormones|hormones|mesh-list
14194132|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194133|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194134|NCT04618497|Ketorolac|ketorolac|mesh-list
14194135|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
14194136|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14194137|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14194138|NCT04618497|Analgesics|analgesics|mesh-ancestor
14194139|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
14194140|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194141|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939321|NCT01487226|Paclitaxel|paclitaxel|mesh-list
14939322|NCT01487226|Cisplatin|cisplatin|mesh-list
14194142|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481901|NCT02512302|Antidotes|antidotes|mesh-ancestor
14481902|NCT02512302|Protective Agents|protective agents|mesh-ancestor
14481903|NCT02512575|Prednisolone|prednisolone|mesh-list
14481904|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14481905|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
14481906|NCT02512575|Hormones|hormones|mesh-ancestor
14481907|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481908|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481909|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14481910|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481911|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
14481912|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14481913|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
14481914|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481915|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14481916|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14768114|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14768115|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14768116|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
14768117|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
14768118|NCT00633672|Esomeprazole|esomeprazole|mesh-list
14768119|NCT00633672|Ranitidine|ranitidine|mesh-list
14768120|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14768121|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14768122|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768123|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14768124|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768125|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194143|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194144|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14194145|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194146|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194147|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14194148|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
14194149|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
14194150|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481917|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
14481918|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481919|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14481920|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14481921|NCT02512783|Lidocaine|lidocaine|mesh-list
14481922|NCT02512783|Propofol|propofol|mesh-list
14481923|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481924|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
14481925|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481926|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481927|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
14481928|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481929|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14194151|NCT04618367|Lenvatinib|lenvatinib|mesh-list
14194152|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194153|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14194154|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194155|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481930|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14481931|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14481932|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14481933|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481934|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14481935|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14481936|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
14481937|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
14481938|NCT02512809|Isoflurane|isoflurane|mesh-list
14481939|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14481940|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481941|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481942|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14481943|NCT02512809|Analgesics|analgesics|mesh-ancestor
14481944|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
14481945|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481946|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14481947|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14194156|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14194157|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14194158|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14481948|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14194159|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
14194160|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14194161|NCT04618536|Protective Agents|protective agents|mesh-ancestor
14194162|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194163|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14194164|NCT04618601|Spironolactone|spironolactone|mesh-list
14194165|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14194166|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
14194167|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194168|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194169|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14194170|NCT04618601|Diuretics|diuretics|mesh-ancestor
14194171|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
14194172|NCT04618107|Anesthetics|anesthetics|mesh-list
14194173|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194174|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194175|NCT04618146|Morphine|morphine|mesh-list
14194176|NCT04618146|Bupivacaine|bupivacaine|mesh-list
14194177|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
14194178|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
14194179|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194180|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194181|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
14194182|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194183|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14194184|NCT04618146|Narcotics|narcotics|mesh-ancestor
14194185|NCT04618146|Analgesics|analgesics|mesh-ancestor
14194186|NCT04618289|Vitamin D|vitamin d|mesh-list
14194187|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
14481949|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481950|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481951|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481952|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14481953|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
14481954|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
14481955|NCT02512861|Bupivacaine|bupivacaine|mesh-list
14481956|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
14481957|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
14481958|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14481959|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481960|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
14481961|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481962|NCT02513095|Dantrolene|dantrolene|mesh-list
14481963|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14481964|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481965|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14481966|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481967|NCT02513160|Beclomethasone|beclomethasone|mesh-list
14481968|NCT02513160|Albuterol|albuterol|mesh-list
14481969|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14481970|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
14194188|NCT04618289|Vitamins|vitamins|mesh-ancestor
14194189|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
14194190|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194191|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14194192|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14194193|NCT04618328|Tretinoin|tretinoin|mesh-list
14194194|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194195|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
14194196|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
14194197|NCT04617782|Donepezil|donepezil|mesh-list
14194198|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14194199|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194200|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194201|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
14194202|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481971|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14481972|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481973|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14481974|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
14481975|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
14481976|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14481977|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14481978|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14481979|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14481980|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
14481981|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14481982|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481983|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768126|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14768127|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
14768128|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
14768129|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768130|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768131|NCT00633685|Fluoxetine|fluoxetine|mesh-list
14768132|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14768133|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14768134|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14768135|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768136|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768137|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
14768138|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768139|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14768140|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
14194203|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194204|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
14194205|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
14194206|NCT04617938|Narcotics|narcotics|mesh-ancestor
14194207|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194208|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194209|NCT04617938|Analgesics|analgesics|mesh-ancestor
14194210|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
14194211|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194212|NCT04617613|Amoxicillin|amoxicillin|mesh-list
14194213|NCT04617613|Metronidazole|metronidazole|mesh-list
14194214|NCT04617613|Clarithromycin|clarithromycin|mesh-list
14768141|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768142|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14768143|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14768144|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768145|NCT00633698|Niacin|niacin|mesh-list
14768146|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
14768147|NCT00633698|Niacinamide|niacinamide|mesh-list
14768148|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14768149|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
14768150|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768151|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14768152|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
14768153|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
14768154|NCT00633698|Vitamins|vitamins|mesh-ancestor
14768155|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
14768156|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768157|NCT00633763|Fallypride|fallypride|mesh-list
14768158|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14768159|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14768160|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
14768161|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768162|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768163|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194215|NCT04617613|Omeprazole|omeprazole|mesh-list
14194216|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14194217|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194218|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14194219|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14194220|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14194221|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194222|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14194223|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194224|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194225|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14194226|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14194227|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14194228|NCT04617626|Azithromycin|azithromycin|mesh-list
14194229|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14194230|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194231|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
14194232|NCT04617652|Analgesics|analgesics|mesh-ancestor
14194233|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
14194234|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194235|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194236|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
14194237|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194238|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14194239|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
14194240|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14194241|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14194242|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194243|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14194244|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
14194245|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14194246|NCT04617795|Insulin|insulin|mesh-list
14194247|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14194248|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194249|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
14194250|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14194251|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14194252|NCT04617561|Prednisolone|prednisolone|mesh-list
14194253|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
14194254|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14194255|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14481984|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
14481985|NCT02513160|Hormones|hormones|mesh-ancestor
14481986|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14481987|NCT02513212|Fluorides|fluorides|mesh-list
14481988|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
14481989|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
14481990|NCT02513212|Protective Agents|protective agents|mesh-ancestor
14481991|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14481992|NCT02513446|Itraconazole|itraconazole|mesh-list
14481993|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
14481994|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14481995|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14481996|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14194256|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
14194257|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
14194258|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194259|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
14194260|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
14194261|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194262|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194263|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194264|NCT04617561|Hormones|hormones|mesh-ancestor
14194265|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194266|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14194267|NCT04617561|Protective Agents|protective agents|mesh-ancestor
14194268|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14194269|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194270|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14481997|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194271|NCT04617483|Vaccines|vaccines|mesh-list
14194272|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
14481998|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14481999|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14482000|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
14482001|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482002|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482003|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14482004|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14482005|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
14482006|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482007|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
14482008|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14482009|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482010|NCT02513498|Ixazomib|ixazomib|mesh-list
14482011|NCT02513498|Glycine|glycine|mesh-list
14482012|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482013|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482014|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
14482015|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482016|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
14482017|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482018|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482019|NCT02513550|Ixekizumab|ixekizumab|mesh-list
14482020|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482021|NCT02513719|Everolimus|everolimus|mesh-list
14482022|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768164|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
14768165|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14768166|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
14768167|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768168|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768169|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14768170|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
14768171|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14768172|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14768173|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14768174|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
14768175|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768176|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768177|NCT00633802|Risperidone|risperidone|mesh-list
14939323|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14939324|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194273|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194274|NCT04617249|Anesthetics|anesthetics|mesh-list
14194275|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194276|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238272|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14238273|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14238274|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14238275|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
14238276|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14238277|NCT00130039|Protective Agents|protective agents|mesh-ancestor
14238278|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14238279|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14238280|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238281|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
14939325|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
14939326|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
14482023|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939327|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
15034842|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238282|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
14768178|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15034843|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034844|NCT01997762|Resveratrol|resveratrol|mesh-list
15034845|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
14482024|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
14482025|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482026|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14482027|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14482028|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482029|NCT02513771|Incretins|incretins|mesh-ancestor
14482030|NCT02513771|Hormones|hormones|mesh-ancestor
14482031|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482032|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14482033|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
14482034|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482035|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482036|NCT02513823|Vitamin D|vitamin d|mesh-list
14482037|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
14482038|NCT02513823|Vitamins|vitamins|mesh-ancestor
14482039|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
14482040|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482041|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14482042|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14482043|NCT02513940|Ibutilide|ibutilide|mesh-list
14482044|NCT02513940|Testosterone|testosterone|mesh-list
14482045|NCT02513940|Progesterone|progesterone|mesh-list
14482046|NCT02513940|Androgens|androgens|mesh-ancestor
14482047|NCT02513940|Hormones|hormones|mesh-ancestor
14482048|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482049|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482050|NCT02513940|Progestins|progestins|mesh-ancestor
14482051|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14482052|NCT02514044|Adderall|adderall|mesh-list
14482053|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
14482054|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14482055|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482056|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14482057|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14482058|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939328|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939329|NCT01487278|Misoprostol|misoprostol|mesh-list
14194277|NCT04617171|Benralizumab|benralizumab|mesh-list
14194278|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14194279|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
14194280|NCT04616872|Methotrexate|methotrexate|mesh-list
14194281|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14194282|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
14194283|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14194284|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482059|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482060|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
14482061|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482062|NCT02514122|Ketamine|ketamine|mesh-list
14482063|NCT02514122|Analgesics|analgesics|mesh-ancestor
14482064|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
14482065|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482066|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482067|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14482068|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14482069|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
14482070|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
14482071|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482072|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14482073|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14482074|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482075|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482076|NCT02514174|Afatinib|afatinib|mesh-list
14939330|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14194285|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14194286|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
14194287|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194288|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194289|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
14194290|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194291|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14194292|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194293|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
14482077|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482078|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14482079|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482080|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482081|NCT02514473|Ivacaftor|ivacaftor|mesh-list
14482082|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14482083|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482084|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482085|NCT02514551|Paclitaxel|paclitaxel|mesh-list
14482086|NCT02514551|Ramucirumab|ramucirumab|mesh-list
14482087|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14482088|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482089|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
14482090|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
14482091|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
14482092|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482093|NCT02514772|Rituximab|rituximab|mesh-list
14482094|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14482095|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482096|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
14482097|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482098|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482099|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
14482100|NCT02515045|Prednisolone|prednisolone|mesh-list
14482101|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14482102|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
14482103|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14482104|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
14482105|NCT02515045|Nepafenac|nepafenac|mesh-list
14482106|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14482107|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
14194294|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194295|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14194296|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14194297|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
14194298|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14194299|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
14194300|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14194301|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194302|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14194303|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14194304|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194305|NCT04616807|Mexiletine|mexiletine|mesh-list
14194306|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14194307|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14194308|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14194309|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14194310|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194311|NCT04617015|Bromides|bromides|mesh-list
14482108|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482109|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
14482110|NCT02515045|Hormones|hormones|mesh-ancestor
14482111|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482112|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482113|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14194312|NCT04617015|Ipratropium|ipratropium|mesh-list
14194313|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
14194314|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14194315|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
14194316|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194317|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194318|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14194319|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
14194320|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14194321|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14194322|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194323|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194324|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
14482114|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482115|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
14482116|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
14482117|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482118|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482119|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14482120|NCT02515045|Protective Agents|protective agents|mesh-ancestor
14482121|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14482122|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482123|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14482124|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14482125|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482126|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482127|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14194325|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194326|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
14194327|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194328|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482128|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482129|NCT02515045|Analgesics|analgesics|mesh-ancestor
14482130|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
14482131|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527276|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14527277|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527278|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
14527279|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527280|NCT04041453|Ivermectin|ivermectin|mesh-list
14527281|NCT04041453|Albendazole|albendazole|mesh-list
14527282|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14527283|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527284|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
14527285|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
14527286|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14527287|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14527288|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
14527289|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
14527290|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
14527291|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527292|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527293|NCT04041219|Tacrolimus|tacrolimus|mesh-list
14527294|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14527295|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
14527296|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527297|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14527298|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527299|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527300|NCT04039867|Gemcitabine|gemcitabine|mesh-list
14527301|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
14527302|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14527303|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
14527304|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527305|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527306|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
14527307|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527308|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527309|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14527310|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
14194329|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14194330|NCT04616859|Ethanol|ethanol|mesh-list
14194331|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14194332|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194333|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194334|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194335|NCT04616586|Siltuximab|siltuximab|mesh-list
14194336|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194337|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
14194338|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14194339|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
14194340|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194341|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194342|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14482132|NCT02515279|Ribavirin|ribavirin|mesh-list
14482133|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14482134|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
14482135|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482136|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
14482137|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482138|NCT02515305|Clindamycin|clindamycin|mesh-list
14768179|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
14768180|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768181|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482139|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
14482140|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
14482141|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14482142|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14482143|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482144|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14482145|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482146|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482147|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482148|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
14482149|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14482150|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482151|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482152|NCT02515890|Midazolam|midazolam|mesh-list
14482153|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
14482154|NCT02515890|Ketamine|ketamine|mesh-list
14482155|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14482156|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482157|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482158|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482159|NCT02515890|Analgesics|analgesics|mesh-ancestor
14482160|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
14482161|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482162|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14482163|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14482164|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14482165|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
14482166|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482167|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482168|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14482169|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14482170|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
14482171|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
14482172|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14482173|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14482174|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482175|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14482176|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14482177|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14482178|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
14482179|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
14482180|NCT02516098|Scopolamine|scopolamine|mesh-list
14482181|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14482182|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482183|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
14482184|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
14768182|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963607|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13963608|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963609|NCT03143036|Thalidomide|thalidomide|mesh-list
13963610|NCT03143036|Dexamethasone|dexamethasone|mesh-list
13963611|NCT03143036|Daratumumab|daratumumab|mesh-list
13963612|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963613|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
13963614|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
13963615|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963616|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963617|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963618|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
14768183|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14768184|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768185|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768186|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768187|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13963619|NCT03143036|Hormones|hormones|mesh-ancestor
14768188|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
14482185|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482186|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482187|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482188|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
14482189|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14482190|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
14482191|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482192|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482193|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14482194|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
14482195|NCT02516150|Ethanol|ethanol|mesh-list
14194343|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
14194344|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14194345|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14194346|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14194347|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
14194348|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194349|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194350|NCT04616352|Cefuroxime|cefuroxime|mesh-list
14194351|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
14194352|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14194353|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194354|NCT04616313|Xenon|xenon|mesh-list
14194355|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14482196|NCT02516150|Glucagon|glucagon|mesh-list
14482197|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14482198|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482199|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482200|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482201|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482202|NCT02516150|Hormones|hormones|mesh-ancestor
14482203|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482204|NCT02516202|Estradiol|estradiol|mesh-list
14482205|NCT02516202|Estrogens|estrogens|mesh-ancestor
14482206|NCT02516202|Hormones|hormones|mesh-ancestor
14482207|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482208|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194356|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
14194357|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
14194358|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194359|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194360|NCT04616391|Insulin|insulin|mesh-list
14194361|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14194362|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194363|NCT04615910|Exenatide|exenatide|mesh-list
14194364|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14194365|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194366|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14194367|NCT04615910|Incretins|incretins|mesh-ancestor
14194368|NCT04615910|Hormones|hormones|mesh-ancestor
14194369|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194370|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
14194371|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
14194372|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14194373|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14194374|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14194375|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482209|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14482210|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14194376|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
14194377|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14194378|NCT04615767|Inositol|inositol|mesh-list
14194379|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
14194380|NCT04615767|Vitamins|vitamins|mesh-ancestor
14482211|NCT02516332|Citalopram|citalopram|mesh-list
14194381|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
14939331|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
14939332|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14939333|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939334|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14939335|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939336|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
14194382|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194383|NCT04615702|Acetaminophen|acetaminophen|mesh-list
14194384|NCT04615702|Metronidazole|metronidazole|mesh-list
14194385|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
14194386|NCT04615702|Imipenem|imipenem|mesh-list
14194387|NCT04615702|Diclofenac|diclofenac|mesh-list
14194388|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14194389|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
14194390|NCT04615702|Secretin|secretin|mesh-list
14194391|NCT04615702|Bilirubin|bilirubin|mesh-list
14194392|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194393|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14194394|NCT04615702|Analgesics|analgesics|mesh-ancestor
14194395|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
14194396|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194397|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
14194398|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482212|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14482213|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14482214|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482215|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482216|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482217|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
14482218|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482219|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14482220|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
14482221|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14482222|NCT02516410|Ivacaftor|ivacaftor|mesh-list
14194399|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14194400|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14194401|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14194402|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194403|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194404|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14194405|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194406|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194407|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14194408|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14194409|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194410|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14194411|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14194412|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14194413|NCT04615702|Narcotics|narcotics|mesh-ancestor
14194414|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194415|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194416|NCT04615702|Hormones|hormones|mesh-ancestor
14482223|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14482224|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482225|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482226|NCT02516592|Fluticasone|fluticasone|mesh-list
14482227|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14482228|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482229|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14194417|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194418|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
14194419|NCT04615702|Protective Agents|protective agents|mesh-ancestor
14194420|NCT04615611|Albuterol|albuterol|mesh-list
14194421|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14194422|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
14482230|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
14482231|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768189|NCT00633958|Alovudine|alovudine|mesh-list
14768190|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
14768191|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768192|NCT00634062|Lamotrigine|lamotrigine|mesh-list
14768193|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
14768194|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14768195|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807172|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14194423|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194424|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194425|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14194426|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
14194427|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
14194428|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14194429|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14194430|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14194431|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14482232|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482233|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14482234|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
14482235|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482236|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14482237|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14482238|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14482239|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14482240|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
14768196|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768197|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14768198|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768199|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14768200|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768201|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768202|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768203|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14768204|NCT00634140|Ezetimibe|ezetimibe|mesh-list
14482241|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482242|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482243|NCT02517021|Dexamethasone|dexamethasone|mesh-list
14482244|NCT02517021|Palonosetron|palonosetron|mesh-list
14482245|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482246|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
14482247|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
14482248|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482249|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482250|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482251|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
14482252|NCT02517021|Hormones|hormones|mesh-ancestor
14482253|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482254|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14482255|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482256|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14482257|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14482258|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
14768205|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14768206|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14768207|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
14768208|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768209|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14482259|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482260|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482261|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
14482262|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14482263|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
14482264|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14482265|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482266|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14482267|NCT02517515|Ritonavir|ritonavir|mesh-list
14482268|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14482269|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14482270|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
14482271|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482272|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482273|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14482274|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14482275|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
14482276|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768210|NCT00634192|Tobramycin|tobramycin|mesh-list
14482277|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14482278|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14482279|NCT02517528|Ritonavir|ritonavir|mesh-list
14482280|NCT02517528|Ribavirin|ribavirin|mesh-list
14482281|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14482282|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14482283|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
14482284|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482285|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482286|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14482287|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14482288|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
14482289|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482290|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14482291|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14482292|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
14482293|NCT02517580|Vitamin K|vitamin k|mesh-list
14482294|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
14482295|NCT02517580|Vitamins|vitamins|mesh-ancestor
14482296|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
14482297|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482298|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14482299|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14482300|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482301|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
14482302|NCT02517580|Coagulants|coagulants|mesh-ancestor
14482303|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14482304|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14482305|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14482306|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482307|NCT02517905|Bupivacaine|bupivacaine|mesh-list
14482308|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
14482309|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
14482310|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194432|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
14194433|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194434|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194435|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14194436|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194437|NCT04615481|Metronidazole|metronidazole|mesh-list
14194438|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194439|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14482311|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482312|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
14482313|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482314|NCT02517996|Lidocaine|lidocaine|mesh-list
14482315|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
14768211|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14768212|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194440|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14194441|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14194442|NCT04615403|Travoprost|travoprost|mesh-list
14194443|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14194444|NCT04615351|Metformin|metformin|mesh-list
14194445|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14194446|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482316|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
14482317|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482318|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482319|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
14482320|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482321|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14768213|NCT00634205|Doxorubicin|doxorubicin|mesh-list
14768214|NCT00634205|Valproic Acid|valproic acid|mesh-list
14768215|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14768216|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768217|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14482322|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14482323|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14482324|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482325|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482326|NCT02518113|Dexamethasone|dexamethasone|mesh-list
14482327|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194447|NCT04615013|Leucovorin|leucovorin|mesh-list
14194448|NCT04615013|Paclitaxel|paclitaxel|mesh-list
14194449|NCT04615013|Docetaxel|docetaxel|mesh-list
14194450|NCT04615013|Carboplatin|carboplatin|mesh-list
14194451|NCT04615013|Fluorouracil|fluorouracil|mesh-list
14194452|NCT04615013|Capecitabine|capecitabine|mesh-list
14194453|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
14194454|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14194455|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14194456|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194457|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14194458|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14194459|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14194460|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482328|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
14482329|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
14482330|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482331|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482332|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482333|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
14482334|NCT02518113|Hormones|hormones|mesh-ancestor
14482335|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482336|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14482337|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482338|NCT02518191|Goserelin|goserelin|mesh-list
14482339|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14482340|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482341|NCT02518464|Ticagrelor|ticagrelor|mesh-list
14482342|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14482343|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14482344|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14482345|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14482346|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
14482347|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482348|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482349|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482350|NCT02518971|Tamsulosin|tamsulosin|mesh-list
14482351|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14482352|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14482353|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14482354|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
14482355|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482356|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482357|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482358|NCT02518971|Urological Agents|urological agents|mesh-ancestor
14482359|NCT02519023|Acetaminophen|acetaminophen|mesh-list
14482360|NCT02519023|Ibuprofen|ibuprofen|mesh-list
14482361|NCT02519023|Epinephrine|epinephrine|mesh-list
14482362|NCT02519023|Oxycodone|oxycodone|mesh-list
14482363|NCT02519023|Bupivacaine|bupivacaine|mesh-list
14482364|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
14482365|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
14482366|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482367|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482368|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
14482369|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482370|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482371|NCT02519023|Analgesics|analgesics|mesh-ancestor
14482372|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
14939337|NCT01487304|Hormones|hormones|mesh-list
14194461|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
14194462|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14194463|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194464|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
14194465|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194466|NCT04615013|Antidotes|antidotes|mesh-ancestor
14194467|NCT04615013|Protective Agents|protective agents|mesh-ancestor
14194468|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
14194469|NCT04615013|Vitamins|vitamins|mesh-ancestor
14194470|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
14194471|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
14482373|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14482374|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482375|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482376|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14482377|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482378|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482379|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14482380|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14482381|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14482382|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482383|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14482384|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14482385|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
14482386|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14482387|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
14482388|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
14482389|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
14194472|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14194473|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
14194474|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194475|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
14194476|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194477|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14238283|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14238284|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14238285|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238286|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14238287|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
14238288|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
14238289|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14238290|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
14238291|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238292|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14238293|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14238294|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14238295|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14238296|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238297|NCT00130247|Rifampin|rifampin|mesh-list
14768218|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14768219|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768220|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768221|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
14768222|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
14768223|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768224|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768225|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
14768226|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768227|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768228|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768229|NCT00634231|Valacyclovir|valacyclovir|mesh-list
14194478|NCT04614727|Calcium|calcium|mesh-list
14194479|NCT04614727|Fluorides|fluorides|mesh-list
14194480|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14194481|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194482|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
14194483|NCT04614727|Protective Agents|protective agents|mesh-ancestor
14194484|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
14194485|NCT04614636|Fludarabine|fludarabine|mesh-list
14194486|NCT04614636|Daratumumab|daratumumab|mesh-list
14194487|NCT04614636|Elotuzumab|elotuzumab|mesh-list
14194488|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194489|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
14194490|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194491|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194492|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14194493|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
14194494|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194495|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194496|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14194497|NCT04614610|Lidocaine|lidocaine|mesh-list
14194498|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
14768230|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
14194499|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
14194500|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194501|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194502|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
14194503|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194504|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14194505|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14194506|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14194507|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14194508|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194509|NCT04614584|Mirtazapine|mirtazapine|mesh-list
14194510|NCT04614584|Methamphetamine|methamphetamine|mesh-list
14194511|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14194512|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14194513|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14194514|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
14194515|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
14194516|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194517|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194518|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194519|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14194520|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14194521|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238298|NCT00130247|Isoniazid|isoniazid|mesh-list
14238299|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
14238300|NCT00130247|Ethambutol|ethambutol|mesh-list
14238301|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14238302|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
14238303|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14238304|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238305|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
14238306|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238307|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238308|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238309|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14238310|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14238311|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14238312|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14482390|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14482391|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14482392|NCT02519023|Narcotics|narcotics|mesh-ancestor
14482393|NCT02519231|Naproxen|naproxen|mesh-list
14482394|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14482395|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482396|NCT02519231|Analgesics|analgesics|mesh-ancestor
14482397|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
14482398|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482399|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482400|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768231|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768232|NCT00634309|Candesartan|candesartan|mesh-list
14768233|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14768234|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14768235|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14768236|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768237|NCT00634348|Aripiprazole|aripiprazole|mesh-list
14768238|NCT00634348|Ziprasidone|ziprasidone|mesh-list
14768239|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
14768240|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768241|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14768242|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768243|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768244|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768245|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
14194522|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14194523|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14194524|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14768246|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
14768247|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768248|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768249|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14768250|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14768251|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
14768252|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14768253|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14768254|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14768255|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14939338|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194525|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
14194526|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14194527|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14194528|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
14194529|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14194530|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14194531|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
14194532|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
14194533|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194534|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
14194535|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14194536|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14194537|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14194538|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14194539|NCT04614311|Triamcinolone|triamcinolone|mesh-list
14194540|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14194541|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14194542|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14194543|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194544|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
14194545|NCT04614311|Hormones|hormones|mesh-ancestor
14194546|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194547|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194548|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194549|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
14194550|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194551|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194552|NCT04614298|Brodalumab|brodalumab|mesh-list
14194553|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
14194554|NCT04614259|Bupivacaine|bupivacaine|mesh-list
14482401|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482402|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
14194555|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
14194556|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
14194557|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194558|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194559|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
14194560|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194561|NCT04614194|Letrozole|letrozole|mesh-list
14194562|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194563|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14194564|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14194565|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194566|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194567|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14482403|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14482404|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482405|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482406|NCT02519387|Buprenorphine|buprenorphine|mesh-list
14482407|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14482408|NCT02519387|Narcotics|narcotics|mesh-ancestor
14482409|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482410|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482411|NCT02519387|Analgesics|analgesics|mesh-ancestor
14482412|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
14482413|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482414|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14482415|NCT02519595|Ketamine|ketamine|mesh-list
14482416|NCT02519595|Analgesics|analgesics|mesh-ancestor
14482417|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
14482418|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482419|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482420|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14482421|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14482422|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
14482423|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
14482424|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482425|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14482426|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14482427|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482428|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482429|NCT02519842|Dexamethasone|dexamethasone|mesh-list
14482430|NCT02519842|Ondansetron|ondansetron|mesh-list
14482431|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
14482432|NCT02519842|Aprepitant|aprepitant|mesh-list
14482433|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
14482434|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482435|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
14482436|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
14482437|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482438|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482439|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482440|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
14194568|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
14194569|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194570|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194571|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
14194572|NCT04613960|Analgesics|analgesics|mesh-ancestor
14194573|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
14194574|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194575|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194576|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
14194577|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194578|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14482441|NCT02519842|Hormones|hormones|mesh-ancestor
14482442|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482443|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14482444|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482445|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
14482446|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482447|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14482448|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
14482449|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482450|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768256|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14194579|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
14482451|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14194580|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14194581|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14194582|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194583|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14482452|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14482453|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482454|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14482455|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14482456|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14482457|NCT02520388|Methylphenidate|methylphenidate|mesh-list
14482458|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14482459|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482460|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14482461|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14482462|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482463|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482464|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
14482465|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482466|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
14482467|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14482468|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482469|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14482470|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482471|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
14482472|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14482473|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482474|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
14482475|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482476|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
14482477|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482478|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482479|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14482480|NCT02522299|Nemiralisib|nemiralisib|mesh-list
14482481|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14939339|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939340|NCT01487317|Rivastigmine|rivastigmine|mesh-list
14939341|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14939342|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939343|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939344|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
14939345|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482482|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482483|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482484|NCT02522325|Cocaine|cocaine|mesh-list
14482485|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
14482486|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
14482487|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
14482488|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482489|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482490|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
14482491|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482492|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14482493|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14482494|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14482495|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482496|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194584|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
14194585|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14194586|NCT04613609|Nicotine|nicotine|mesh-list
14194587|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14194588|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
14194589|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194590|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194591|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14194592|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14194593|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
14194594|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194595|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194596|NCT04613700|Secretin|secretin|mesh-list
14194597|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194598|NCT04613700|Hormones|hormones|mesh-ancestor
14194599|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194600|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194601|NCT04613869|Hydromorphone|hydromorphone|mesh-list
14194602|NCT04613869|Esketamine|esketamine|mesh-list
14194603|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14194604|NCT04613869|Narcotics|narcotics|mesh-ancestor
14194605|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194606|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194607|NCT04613869|Analgesics|analgesics|mesh-ancestor
14194608|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
14194609|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482497|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
14482498|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482499|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14482500|NCT02522377|Midazolam|midazolam|mesh-list
14482501|NCT02522377|Ketamine|ketamine|mesh-list
14482502|NCT02522377|Analgesics|analgesics|mesh-ancestor
14482503|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
14482504|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482505|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482506|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14482507|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14482508|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
14482509|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
14482510|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482511|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14482512|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14482513|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482514|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482515|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482516|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14482517|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14482518|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14482519|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14194610|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
14194611|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14194612|NCT04613726|Ondansetron|ondansetron|mesh-list
14194613|NCT04613726|Granisetron|granisetron|mesh-list
14194614|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
14194615|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
14194616|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482520|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
14482521|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
14482522|NCT02522767|Mesalamine|mesalamine|mesh-list
14482523|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14482524|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482525|NCT02522767|Analgesics|analgesics|mesh-ancestor
14482526|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
14482527|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482528|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482529|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482530|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482531|NCT02522780|Mesalamine|mesalamine|mesh-list
14482532|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14482533|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482534|NCT02522780|Analgesics|analgesics|mesh-ancestor
14482535|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
14482536|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768257|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14768258|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14807173|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14807174|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807175|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807176|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
14807177|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807178|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14807179|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14807180|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14482537|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482538|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482539|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482540|NCT02523235|Ropivacaine|ropivacaine|mesh-list
14482541|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
14482542|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
14482543|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482544|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482545|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
14482546|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482547|NCT02523586|Anesthetics|anesthetics|mesh-list
14482548|NCT02523586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482549|NCT02523586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482550|NCT02523599|Bupivacaine|bupivacaine|mesh-list
14482551|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
14482552|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
14482553|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482554|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482555|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
14482556|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482557|NCT02524054|Furosemide|furosemide|mesh-list
14482558|NCT02524054|Diuretics|diuretics|mesh-ancestor
14482559|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
14482560|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482561|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14482562|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482563|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482564|NCT02524106|Bococizumab|bococizumab|mesh-list
14482565|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14194617|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194618|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194619|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
14194620|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
14194621|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14194622|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
14194623|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194624|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194625|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14194626|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14194627|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194628|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14194629|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14482566|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14768259|NCT00634400|Candesartan|candesartan|mesh-list
14194630|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
14194631|NCT04613557|Fludarabine|fludarabine|mesh-list
14768260|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14194632|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
14194633|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194634|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
14482567|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
14482568|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482569|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14482570|NCT02524145|Isoproterenol|isoproterenol|mesh-list
14482571|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
14194635|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194636|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194637|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14194638|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
14194639|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194640|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194641|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14482572|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
14482573|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14482574|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482575|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482576|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482577|NCT02524145|Analgesics|analgesics|mesh-ancestor
14482578|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
14482579|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482580|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14482581|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14482582|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14482583|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
14482584|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482585|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482586|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482587|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14482588|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14482589|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
14482590|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14482591|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14482592|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
14482593|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14482594|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
14482595|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14482596|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
14482597|NCT02524145|Protective Agents|protective agents|mesh-ancestor
14482598|NCT02524561|Estradiol|estradiol|mesh-list
14482599|NCT02524561|Progesterone|progesterone|mesh-list
14482600|NCT02524561|Estrogens|estrogens|mesh-ancestor
14482601|NCT02524561|Hormones|hormones|mesh-ancestor
14482602|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482603|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482604|NCT02524561|Progestins|progestins|mesh-ancestor
14527311|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527312|NCT04039412|Levofloxacin|levofloxacin|mesh-list
14527313|NCT04039412|Ofloxacin|ofloxacin|mesh-list
14527314|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14527315|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527316|NCT04039412|Renal Agents|renal agents|mesh-ancestor
14194642|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14194643|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
14194644|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14194645|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194646|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194647|NCT04613102|Cannabidiol|cannabidiol|mesh-list
14194648|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
14194649|NCT04613219|Tofacitinib|tofacitinib|mesh-list
14194650|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14194651|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194652|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194653|NCT04613167|Evolocumab|evolocumab|mesh-list
14194654|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14482605|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
14482606|NCT02524665|Salicylates|salicylates|mesh-list
14482607|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14482608|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482609|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
14482610|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
14482611|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482612|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14482613|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482614|NCT02524665|Analgesics|analgesics|mesh-ancestor
14482615|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
14482616|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482617|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482618|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482619|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482620|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14482621|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482622|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482623|NCT02524769|Estrogens|estrogens|mesh-list
14768261|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14768262|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14768263|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768264|NCT00634413|Budesonide|budesonide|mesh-list
14768265|NCT00634413|Theophylline|theophylline|mesh-list
14768266|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768267|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14768268|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
14768269|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768270|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768271|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14768272|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
14768273|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
14768274|NCT00634413|Hormones|hormones|mesh-ancestor
14768275|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768276|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14768277|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768278|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768279|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
14768280|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14768281|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14768282|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
14768283|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768284|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14768285|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14768286|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14768287|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14768288|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768289|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
14768290|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768291|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768292|NCT00634491|Acetazolamide|acetazolamide|mesh-list
14768293|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
14939346|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194655|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14194656|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
14194657|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194658|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14194659|NCT04613271|Azithromycin|azithromycin|mesh-list
14194660|NCT04613271|Favipiravir|favipiravir|mesh-list
14482624|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14482625|NCT02524769|Hormones|hormones|mesh-ancestor
14482626|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482627|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482628|NCT02524847|Methoxsalen|methoxsalen|mesh-list
14482629|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14482630|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482631|NCT02525133|Bupivacaine|bupivacaine|mesh-list
14482632|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
14482633|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
14482634|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194661|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14194662|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194663|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
14194664|NCT04613206|Vaccines|vaccines|mesh-list
14194665|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
14194666|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194667|NCT04613284|Durvalumab|durvalumab|mesh-list
14194668|NCT04613284|Endostar protein|endostar protein|mesh-list
14482635|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482636|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
14768294|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14768295|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768296|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768297|NCT00634491|Diuretics|diuretics|mesh-ancestor
14768298|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
14768299|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768300|NCT00634556|Levodopa|levodopa|mesh-list
14768301|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14768302|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14768303|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14768304|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
14768305|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768306|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768307|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768308|NCT00634595|Paclitaxel|paclitaxel|mesh-list
14768309|NCT00634595|Cisplatin|cisplatin|mesh-list
14768310|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14768311|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194669|NCT04613284|Endostatins|endostatins|mesh-list
14768312|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
14939347|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14939348|NCT01487317|Protective Agents|protective agents|mesh-ancestor
14939349|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
14768313|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
14768314|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
14768315|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768316|NCT00634634|Sorafenib|sorafenib|mesh-list
14768317|NCT00634634|Letrozole|letrozole|mesh-list
14768318|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768319|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14768320|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768321|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768322|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14768323|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14768324|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14768325|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768326|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768327|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939350|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939351|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939352|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
14939353|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939354|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939355|NCT01487395|Donepezil|donepezil|mesh-list
14939356|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14939357|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939358|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939359|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
14939360|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939361|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939362|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
14939363|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
14194670|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14939364|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14482637|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482638|NCT02525471|RNS60|rns60|mesh-list
14482639|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14482640|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482641|NCT02525471|Analgesics|analgesics|mesh-ancestor
14482642|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
14482643|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482644|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482645|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482646|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482647|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14482648|NCT02525523|Alicaforsen|alicaforsen|mesh-list
14482649|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482650|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14482651|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
14482652|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482653|NCT02525536|Trebananib|trebananib|mesh-list
14482654|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14194671|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194672|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14194673|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14194674|NCT04613284|Growth Substances|growth substances|mesh-ancestor
14194675|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194676|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
14194677|NCT04613024|Topiramate|topiramate|mesh-list
14194678|NCT04613024|Gabapentin|gabapentin|mesh-list
14482655|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14482656|NCT02525536|Growth Substances|growth substances|mesh-ancestor
14482657|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482658|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
14939365|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939366|NCT01487421|Insulin|insulin|mesh-list
14939367|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14194679|NCT04613024|Analgesics|analgesics|mesh-ancestor
14194680|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
14194681|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194682|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194683|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
14194684|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14194685|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14194686|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194687|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14194688|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14194689|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14194690|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194691|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194692|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
14194693|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14194694|NCT04612998|Atropine|atropine|mesh-list
14194695|NCT04612998|Ephedrine|ephedrine|mesh-list
14194696|NCT04612998|Metoclopramide|metoclopramide|mesh-list
14194697|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14194698|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14194699|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14194700|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
14194701|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194702|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194703|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14194704|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
14482659|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482660|NCT02525549|Adapalene|adapalene|mesh-list
14482661|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14482662|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482663|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14482664|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482665|NCT02525549|Analgesics|analgesics|mesh-ancestor
14482666|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
14768328|NCT00634686|Vitamin D|vitamin d|mesh-list
14768329|NCT00634686|Calcium|calcium|mesh-list
14768330|NCT00634686|Vitamins|vitamins|mesh-ancestor
14768331|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
14939368|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
14939369|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
14939370|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939371|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939372|NCT01487512|Hydromorphone|hydromorphone|mesh-list
14939373|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14939374|NCT01487512|Narcotics|narcotics|mesh-ancestor
14482667|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482668|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482669|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482670|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14482671|NCT02525653|Gemcitabine|gemcitabine|mesh-list
14482672|NCT02525653|Paclitaxel|paclitaxel|mesh-list
14482673|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14482674|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14482675|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482676|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
14482677|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
14482678|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
14482679|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482680|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14482681|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
14482682|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
14482683|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482684|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482685|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14482686|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
14482687|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482688|NCT02525718|Dexamethasone|dexamethasone|mesh-list
14482689|NCT02525718|Epinephrine|epinephrine|mesh-list
14482690|NCT02525718|Bupivacaine|bupivacaine|mesh-list
14482691|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482692|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
14482693|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
14482694|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482695|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482696|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14482697|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
14482698|NCT02525718|Hormones|hormones|mesh-ancestor
14482699|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482700|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14482701|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482702|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
14482703|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
14482704|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482705|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
14482706|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14482707|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14194705|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
14194706|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
14194707|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14194708|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14482708|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
14482709|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482710|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482711|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14482712|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14482713|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14482714|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
14482715|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
14482716|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
14482717|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14482718|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
14482719|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14482720|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482721|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
14768332|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194709|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
14194710|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194711|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194712|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
14194713|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194714|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14194715|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14194716|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
14194717|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14194718|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
14194719|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14194720|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
14194721|NCT04612920|Acetaminophen|acetaminophen|mesh-list
14194722|NCT04612920|Ibuprofen|ibuprofen|mesh-list
14194723|NCT04612920|Oxycodone|oxycodone|mesh-list
14194724|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14482722|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14482723|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482724|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482725|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14482726|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14482727|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14482728|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482729|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14482730|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
14482731|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482732|NCT02526212|Buprenorphine|buprenorphine|mesh-list
14482733|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14482734|NCT02526212|Narcotics|narcotics|mesh-ancestor
14482735|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482736|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482737|NCT02526212|Analgesics|analgesics|mesh-ancestor
14482738|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
14482739|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482740|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14482741|NCT02526550|Vaccines|vaccines|mesh-list
14482742|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
14482743|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482744|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
14482745|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14482746|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14482747|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482748|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
14482749|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482750|NCT02527265|Insulin|insulin|mesh-list
14482751|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14482752|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482753|NCT02527421|Betamethasone|betamethasone|mesh-list
14482754|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482755|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
14482756|NCT02527421|Hormones|hormones|mesh-ancestor
14482757|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482758|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482759|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14482760|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
14482761|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
14482762|NCT02527512|Povidone|povidone|mesh-list
14482763|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
14482764|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
14482765|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14482766|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482767|NCT02528188|Tanezumab|tanezumab|mesh-list
14482768|NCT02528188|Analgesics|analgesics|mesh-ancestor
14482769|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
14482770|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482771|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482772|NCT02528214|Prednisone|prednisone|mesh-list
14482773|NCT02528214|Prednisolone|prednisolone|mesh-list
14482774|NCT02528214|Albuterol|albuterol|mesh-list
14194725|NCT04612920|Analgesics|analgesics|mesh-ancestor
14194726|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
14194727|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194728|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194729|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
14194730|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14194731|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194732|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194733|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14194734|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194735|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194736|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14194737|NCT04612920|Narcotics|narcotics|mesh-ancestor
14194738|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238313|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14238314|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14238315|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14238316|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14238317|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
14238318|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14238319|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
14238320|NCT00130286|Hormones|hormones|mesh-list
14482775|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14482776|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
14482777|NCT02528214|Hormones|hormones|mesh-ancestor
14482778|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482779|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482780|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14482781|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482782|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
14482783|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482784|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14482785|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14482786|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
14482787|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
14482788|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14482789|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14482790|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14482791|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14482792|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
14482793|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482794|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482795|NCT02528253|Tramadol|tramadol|mesh-list
14482796|NCT02528253|Tanezumab|tanezumab|mesh-list
14482797|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14482798|NCT02528253|Narcotics|narcotics|mesh-ancestor
14482799|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482800|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482801|NCT02528253|Analgesics|analgesics|mesh-ancestor
14482802|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
14482803|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482804|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
14482805|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14482806|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482807|NCT02528409|Vortioxetine|vortioxetine|mesh-list
14482808|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
14482809|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14482810|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14482811|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14482812|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482813|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482814|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14482815|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14482816|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14482817|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482818|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768333|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14768334|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14768335|NCT00634712|Candesartan|candesartan|mesh-list
14768336|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14768337|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14768338|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14768339|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768340|NCT00634725|Gemcitabine|gemcitabine|mesh-list
14768341|NCT00634725|Capecitabine|capecitabine|mesh-list
14768342|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14768343|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14768344|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
14768345|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768346|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768347|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
14768348|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482819|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
14482820|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14482821|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14482822|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14482823|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14482824|NCT02529072|Nivolumab|nivolumab|mesh-list
14482825|NCT02529072|Vaccines|vaccines|mesh-list
14482826|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
14482827|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482828|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14482829|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482830|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14482831|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482832|NCT02529995|Osimertinib|osimertinib|mesh-list
14482833|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482834|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14482835|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482836|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482837|NCT02530125|Pidilizumab|pidilizumab|mesh-list
14482838|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14482839|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482840|NCT02530151|Clonidine|clonidine|mesh-list
14482841|NCT02530151|Morphine|morphine|mesh-list
14482842|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14482843|NCT02530151|Narcotics|narcotics|mesh-ancestor
14482844|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482845|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482846|NCT02530151|Analgesics|analgesics|mesh-ancestor
14482847|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
14482848|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482849|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14482850|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
14482851|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
14482852|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14482853|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14482854|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14482855|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
14482856|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482857|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482858|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
14482859|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
14482860|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482861|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
14482862|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482863|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482864|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
14482865|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482866|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14482867|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14482868|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
14768349|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768350|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768351|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
14768352|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768353|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14768354|NCT00634790|Alprazolam|alprazolam|mesh-list
14768355|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14768356|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768357|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768358|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14768359|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768360|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768361|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
14768362|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
14768363|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768364|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768365|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
14768366|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14768367|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768368|NCT00634894|Letrozole|letrozole|mesh-list
14768369|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768370|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14768371|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14482869|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194739|NCT04613180|Montelukast|montelukast|mesh-list
14482870|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482871|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482872|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
14482873|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482874|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14482875|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14482876|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
14482877|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482878|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482879|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482880|NCT02530476|Sorafenib|sorafenib|mesh-list
14482881|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482882|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14482883|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482884|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482885|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
14482886|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14482887|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14482888|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482889|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
14482890|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482891|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
14482892|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14482893|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14482894|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482895|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
14482896|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482897|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
14482898|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14482899|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14482900|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482901|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
14482902|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
14482903|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14482904|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14482905|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482906|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14482907|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482908|NCT02531113|Ozanimod|ozanimod|mesh-list
14482909|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14482910|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482911|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14482912|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
14482913|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482914|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
14482915|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14482916|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14482917|NCT02531321|Estradiol|estradiol|mesh-list
14482918|NCT02531321|Estrogens|estrogens|mesh-ancestor
14482919|NCT02531321|Hormones|hormones|mesh-ancestor
14527317|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14527318|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14527319|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14527320|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527321|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527322|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768372|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194740|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14194741|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
14194742|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14194743|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
14194744|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194745|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194746|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14482920|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482921|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482922|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14482923|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
14482924|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14482925|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14482926|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14194747|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14194748|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194749|NCT04612894|Apatinib|apatinib|mesh-list
14194750|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194751|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14194752|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194753|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194754|NCT04612634|Vaccines|vaccines|mesh-list
14194755|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
14194756|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194757|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
14194758|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14194759|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
14194760|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14194761|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194762|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194763|NCT04612556|Vaccines|vaccines|mesh-list
14194764|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
14194765|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194766|NCT04612582|Thalidomide|thalidomide|mesh-list
14194767|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
14194768|NCT04612582|Bortezomib|bortezomib|mesh-list
14194769|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194770|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
14194771|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194772|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194773|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14482927|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14482928|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14482929|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14482930|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14482931|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
14482932|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482933|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
14482934|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14482935|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482936|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14482937|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14482938|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482939|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482940|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482941|NCT02531633|Prednisone|prednisone|mesh-list
14482942|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14482943|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194774|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
14194775|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194776|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194777|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14194778|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
14194779|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14194780|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194781|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14194782|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14194783|NCT04612582|Growth Substances|growth substances|mesh-ancestor
14194784|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
14194785|NCT04612530|Nivolumab|nivolumab|mesh-list
14194786|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14194787|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194788|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14194789|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194790|NCT04612504|Atezolizumab|atezolizumab|mesh-list
14194791|NCT04612504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194792|NCT04612179|Sirolimus|sirolimus|mesh-list
14194793|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14194794|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482944|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
14194795|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14194796|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194797|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
14194798|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194799|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
14194800|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194801|NCT04612257|Insulin|insulin|mesh-list
14194802|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14194803|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194804|NCT04611958|Bupivacaine|bupivacaine|mesh-list
14194805|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
14194806|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
14482945|NCT02531633|Hormones|hormones|mesh-ancestor
14482946|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14482947|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482948|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14482949|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14482950|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
14482951|NCT02531698|Vaccines|vaccines|mesh-list
14482952|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
14482953|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482954|NCT02531971|Fentanyl|fentanyl|mesh-list
14482955|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14482956|NCT02531971|Narcotics|narcotics|mesh-ancestor
14482957|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482958|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482959|NCT02531971|Analgesics|analgesics|mesh-ancestor
14482960|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
14482961|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482962|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482963|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14194807|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194808|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194809|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
14194810|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194811|NCT04611971|Belimumab|belimumab|mesh-list
14194812|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194813|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
14194814|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194815|NCT04611724|Folfirinox|folfirinox|mesh-list
14194816|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194817|NCT04611438|Cannabidiol|cannabidiol|mesh-list
14482964|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
14482965|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
14482966|NCT02532010|Cytarabine|cytarabine|mesh-list
14482967|NCT02532010|Decitabine|decitabine|mesh-list
14194818|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
14194819|NCT04611711|Decitabine|decitabine|mesh-list
14194820|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14194821|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
14194822|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194823|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194824|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482968|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14482969|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
14482970|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482971|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807181|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14482972|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
14482973|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482974|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14482975|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
14482976|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482977|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482978|NCT02532283|Oseltamivir|oseltamivir|mesh-list
14482979|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
14482980|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14482981|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14482982|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482983|NCT02532374|Nicotine|nicotine|mesh-list
14482984|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14482985|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
14482986|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14482987|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194825|NCT04611685|Parecoxib|parecoxib|mesh-list
14482988|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14482989|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14482990|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
14482991|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14482992|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14482993|NCT02532647|Midazolam|midazolam|mesh-list
14482994|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14482995|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14482996|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14482997|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14482998|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14482999|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14483000|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14483001|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14483002|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
14483003|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
14483004|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
14483005|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
14483006|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483007|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483008|NCT02532855|Metformin|metformin|mesh-list
14483009|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14483010|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
14483011|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14483012|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483013|NCT02532855|Incretins|incretins|mesh-ancestor
14483014|NCT02532855|Hormones|hormones|mesh-ancestor
14483015|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483016|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14483017|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14483018|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483019|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483020|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14194826|NCT04611685|Loxoprofen|loxoprofen|mesh-list
14194827|NCT04611685|Tramadol|tramadol|mesh-list
14194828|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14194829|NCT04611685|Narcotics|narcotics|mesh-ancestor
14194830|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194831|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194832|NCT04611685|Analgesics|analgesics|mesh-ancestor
14194833|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
14194834|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194835|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14194836|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14194837|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194838|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194839|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14194840|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14194841|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194842|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194843|NCT04611373|Levamisole|levamisole|mesh-list
14194844|NCT04611373|Acetazolamide|acetazolamide|mesh-list
14194845|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
14194846|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14194847|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194848|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194849|NCT04611373|Diuretics|diuretics|mesh-ancestor
14194850|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
14194851|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194852|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14194853|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
14194854|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
14194855|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
14194856|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14194857|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194858|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194859|NCT04611464|Misoprostol|misoprostol|mesh-list
14194860|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14194861|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
14194862|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14194863|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194864|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14194865|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483021|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
14194866|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
14483022|NCT02532998|Eplerenone|eplerenone|mesh-list
14807182|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
14483023|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14483024|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
14483025|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483026|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483027|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14483028|NCT02532998|Diuretics|diuretics|mesh-ancestor
14483029|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
14483030|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14483031|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14527323|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14527324|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14527325|NCT04036110|Vitamins|vitamins|mesh-list
14527326|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
14527327|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
14527328|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527329|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
14527330|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527331|NCT04036110|Protective Agents|protective agents|mesh-ancestor
14527332|NCT04024501|Verinurad|verinurad|mesh-list
14527333|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
14527334|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527335|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
14527336|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14527337|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
14527338|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527339|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527340|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
14527341|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527342|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
14527343|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14527344|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
14527345|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527346|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527347|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
14527348|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527349|NCT04031885|Paclitaxel|paclitaxel|mesh-list
14527350|NCT04031885|Docetaxel|docetaxel|mesh-list
14527351|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14527352|NCT04031885|Capecitabine|capecitabine|mesh-list
14527353|NCT04031885|Fulvestrant|fulvestrant|mesh-list
14527354|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14527355|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527356|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14527357|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
14527358|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
14527359|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527360|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14527361|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
14527362|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14527363|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14768373|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768374|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14768375|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768376|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768377|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768378|NCT00634959|Maraviroc|maraviroc|mesh-list
14768379|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14768380|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14768381|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768382|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14768383|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14768384|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
14768385|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768386|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14768387|NCT00634985|Eletriptan|eletriptan|mesh-list
14483032|NCT02533375|Adalimumab|adalimumab|mesh-list
14483033|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483034|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483035|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
14483036|NCT02533401|Rituximab|rituximab|mesh-list
14483037|NCT02533401|Fludarabine|fludarabine|mesh-list
14483038|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483039|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
14483040|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483041|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483042|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14483043|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
14483044|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483045|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483046|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14483047|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14483048|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14483049|NCT02533427|Norgestimate|norgestimate|mesh-list
14194867|NCT04611776|Gemcitabine|gemcitabine|mesh-list
14194868|NCT04611776|Paclitaxel|paclitaxel|mesh-list
14194869|NCT04611776|Carboplatin|carboplatin|mesh-list
14194870|NCT04611776|Pemetrexed|pemetrexed|mesh-list
14194871|NCT04611776|Atezolizumab|atezolizumab|mesh-list
14194872|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14194873|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194874|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
14194875|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
14194876|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
14194877|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194878|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14194879|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
14194880|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
14194881|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194882|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194883|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194884|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
14194885|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194886|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14194887|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238321|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238322|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238323|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14238324|NCT00130442|Dacarbazine|dacarbazine|mesh-list
14238325|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238326|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
14238327|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238328|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238329|NCT00130520|Bevacizumab|bevacizumab|mesh-list
14238330|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14238331|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14483050|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14483051|NCT02533427|Estradiol|estradiol|mesh-list
14483052|NCT02533427|Estrogens|estrogens|mesh-ancestor
14483053|NCT02533427|Hormones|hormones|mesh-ancestor
14483054|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483055|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483056|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14483057|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
14483058|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14483059|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14483060|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14483061|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14483062|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14483063|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14483064|NCT02533453|Exenatide|exenatide|mesh-list
14483065|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14483066|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483067|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14483068|NCT02533453|Incretins|incretins|mesh-ancestor
14483069|NCT02533453|Hormones|hormones|mesh-ancestor
14483070|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483071|NCT02533466|Listerine|listerine|mesh-list
14483072|NCT02533466|Fluorides|fluorides|mesh-list
14483073|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
14483074|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
14483075|NCT02533466|Protective Agents|protective agents|mesh-ancestor
14483076|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483077|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14483078|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483079|NCT02533505|Budesonide|budesonide|mesh-list
14483080|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
14483081|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483082|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14483083|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
14483084|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483085|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483086|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14483087|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
14483088|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
14483089|NCT02533505|Hormones|hormones|mesh-ancestor
14483090|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483091|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14483092|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14483093|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14483094|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
14483095|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483096|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483097|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14483098|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14483099|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14483100|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483101|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
14483102|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483103|NCT02533674|Gemcitabine|gemcitabine|mesh-list
14483104|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14483105|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
14483106|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483107|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483108|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
14483109|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483110|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483111|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483112|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
14483113|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194888|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
14194889|NCT04611126|Nivolumab|nivolumab|mesh-list
14194890|NCT04611126|Fludarabine|fludarabine|mesh-list
14194891|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
14194892|NCT04611126|Ipilimumab|ipilimumab|mesh-list
14194893|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483114|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14483115|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
14483116|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483117|NCT02534129|Petrolatum|petrolatum|mesh-list
14483118|NCT02534129|Emollients|emollients|mesh-ancestor
14483119|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483120|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
14483121|NCT02534883|Misoprostol|misoprostol|mesh-list
14483122|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14483123|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
14483124|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14483125|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194894|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
14194895|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194896|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14194897|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14194898|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
14194899|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194900|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194901|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14194902|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14194903|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14194904|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14194905|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
14194906|NCT04611152|Aflibercept|aflibercept|mesh-list
14194907|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14194908|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14194909|NCT04611152|Growth Substances|growth substances|mesh-ancestor
14194910|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194911|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
14194912|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194913|NCT04611165|Nivolumab|nivolumab|mesh-list
14483126|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14483127|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483128|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
14483129|NCT02534935|Vaccines|vaccines|mesh-list
14483130|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
14483131|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483132|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14483133|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14483134|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14483135|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483136|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483137|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483138|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483139|NCT02535000|Analgesics|analgesics|mesh-ancestor
14483140|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
14483141|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483142|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
14483143|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14483144|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
14483145|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
14483146|NCT02535416|Promethazine|promethazine|mesh-list
14483147|NCT02535416|Cetirizine|cetirizine|mesh-list
14483148|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14483149|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14483150|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483151|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483152|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
14483153|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
14483154|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
14483155|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483156|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
14483157|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
14483158|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483159|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14194914|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14194915|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194916|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14194917|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483160|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
14483161|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
14483162|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483163|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483164|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14483165|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
14483166|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483167|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14483168|NCT02535611|Memantine|memantine|mesh-list
14483169|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14194918|NCT04610879|Carbamazepine|carbamazepine|mesh-list
14194919|NCT04610879|Levetiracetam|levetiracetam|mesh-list
14194920|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
14194921|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
14194922|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
14194923|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14194924|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14194925|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194926|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14194927|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14194928|NCT04610879|Analgesics|analgesics|mesh-ancestor
14194929|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
14194930|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14194931|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14194932|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14194933|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194934|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14483170|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14483171|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
14483172|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483173|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483174|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483175|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14483176|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14483177|NCT02535715|Insulin|insulin|mesh-list
14483178|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14194935|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14194936|NCT04610580|Choline|choline|mesh-list
14194937|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
14194938|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14194939|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
14194940|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194941|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483179|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14483180|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483181|NCT02535806|Cytarabine|cytarabine|mesh-list
14483182|NCT02535806|Dexamethasone|dexamethasone|mesh-list
14483183|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
14483184|NCT02535806|Methotrexate|methotrexate|mesh-list
14483185|NCT02535806|Vincristine|vincristine|mesh-list
14483186|NCT02535806|Bortezomib|bortezomib|mesh-list
14483187|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
14483188|NCT02535806|Pegaspargase|pegaspargase|mesh-list
14483189|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483190|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
14483191|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
14483192|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483193|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483194|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483195|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
14483196|NCT02535806|Hormones|hormones|mesh-ancestor
14194942|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14194943|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
14194944|NCT04611243|Vaccines|vaccines|mesh-list
14194945|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
14194946|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194947|NCT04610567|Methotrexate|methotrexate|mesh-list
14194948|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14194949|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
14194950|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14194951|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194952|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14194953|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
14194954|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194955|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194956|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
14194957|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14194958|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14194959|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14194960|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
14194961|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483197|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483198|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14483199|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483200|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14483201|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
14483202|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14939375|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939376|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939377|NCT01487512|Analgesics|analgesics|mesh-ancestor
14939378|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
14939379|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939380|NCT01487564|Hydromorphone|hydromorphone|mesh-list
14939381|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14939382|NCT01487564|Narcotics|narcotics|mesh-ancestor
14939383|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939384|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939385|NCT01487564|Analgesics|analgesics|mesh-ancestor
14194962|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14483203|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14483204|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
14483205|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483206|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483207|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768388|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14768389|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
14768390|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768391|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768392|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768393|NCT00634998|Ascorbic Acid|ascorbic acid|mesh-list
14768394|NCT00634998|Vitamins|vitamins|mesh-ancestor
14939386|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
14939387|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939388|NCT01487629|Bevacizumab|bevacizumab|mesh-list
14939389|NCT01487629|Ranibizumab|ranibizumab|mesh-list
14939390|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14939391|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939392|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14939393|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14939394|NCT01487629|Growth Substances|growth substances|mesh-ancestor
14939395|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939396|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
14939397|NCT01487785|Gemcitabine|gemcitabine|mesh-list
14939398|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14939399|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
14939400|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939401|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939402|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
14939403|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939404|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939405|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939406|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
14939407|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939408|NCT01487798|Insulin|insulin|mesh-list
14939409|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14939410|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
14939411|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
14939412|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14939413|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939414|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939415|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
14939416|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
14939417|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14939418|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939419|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939420|NCT01487993|Metformin|metformin|mesh-list
14939421|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939422|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939423|NCT01488045|Fentanyl|fentanyl|mesh-list
14768395|NCT00634998|Micronutrients|micronutrients|mesh-ancestor
14194963|NCT04610541|Remdesivir|remdesivir|mesh-list
14768396|NCT00634998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768397|NCT00634998|Antioxidants|antioxidants|mesh-ancestor
14194964|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
14194965|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194966|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
14194967|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14194968|NCT04610320|Daratumumab|daratumumab|mesh-list
14194969|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194970|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
14194971|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14194972|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14194973|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14194974|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
14194975|NCT04610164|Coagulants|coagulants|mesh-ancestor
14483208|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14483209|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483210|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
14483211|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483212|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14483213|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
14483214|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483215|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14483216|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
14483217|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
14483218|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
14483219|NCT02535806|Analgesics|analgesics|mesh-ancestor
14483220|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
14483221|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14483222|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14483223|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
14483224|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14483225|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14483226|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483227|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
14483228|NCT02535949|Coagulants|coagulants|mesh-ancestor
14483229|NCT02536040|Fluorides|fluorides|mesh-list
14483230|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
14483231|NCT02536040|Protective Agents|protective agents|mesh-ancestor
14483232|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483233|NCT02536105|Methylphenidate|methylphenidate|mesh-list
14483234|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14483235|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483236|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14483237|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14483238|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483239|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483240|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
14483241|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483242|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14483243|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14483244|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483245|NCT02536248|Incretins|incretins|mesh-ancestor
14483246|NCT02536248|Hormones|hormones|mesh-ancestor
14483247|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483248|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14483249|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
14483250|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483251|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483252|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
14483253|NCT02536313|Velpatasvir|velpatasvir|mesh-list
14483254|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
14483255|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483256|NCT02536664|Rituximab|rituximab|mesh-list
14483257|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14194976|NCT04610307|Anesthetics|anesthetics|mesh-list
14194977|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483258|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483259|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
14483260|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483261|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483262|NCT02536833|Lorecivivint|lorecivivint|mesh-list
14483263|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483264|NCT02536846|Olanzapine|olanzapine|mesh-list
14483265|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
14483266|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
14483267|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768398|NCT00634998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768399|NCT00634998|Protective Agents|protective agents|mesh-ancestor
14768400|NCT00635037|Bupivacaine|bupivacaine|mesh-list
14768401|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
14768402|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
14768403|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768404|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768405|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
14768406|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768407|NCT00635076|Alprazolam|alprazolam|mesh-list
14768408|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14194978|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768409|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768410|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768411|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14768412|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768413|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768414|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
14768415|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
14768416|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768417|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768418|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14768419|NCT00635258|Ganirelix|ganirelix|mesh-list
14768420|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768421|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768422|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
14768423|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14768424|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
14768425|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14768426|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14768427|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768428|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768429|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768430|NCT00635284|Sirolimus|sirolimus|mesh-list
14768431|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14768432|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768433|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14768434|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768435|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
14768436|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768437|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
14768438|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768439|NCT00635310|Liver Extracts|liver extracts|mesh-list
14768440|NCT00635310|Hematinics|hematinics|mesh-ancestor
14768441|NCT00635323|Capecitabine|capecitabine|mesh-list
14768442|NCT00635323|Irinotecan|irinotecan|mesh-list
14768443|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14768444|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
14768445|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768446|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194979|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
14194980|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14194981|NCT04610502|Antibodies|antibodies|mesh-list
14194982|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
14194983|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194984|NCT04610398|Dexamethasone|dexamethasone|mesh-list
14194985|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
14194986|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14194987|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
14194988|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
14194989|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483268|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768447|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14768448|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14483269|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483270|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14483271|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14483272|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483273|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14483274|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14483275|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14483276|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483277|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483278|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483279|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
14483280|NCT02536976|Mirabegron|mirabegron|mesh-list
14483281|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14483282|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14483283|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14483284|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
14483285|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483286|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483287|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483288|NCT02536976|Urological Agents|urological agents|mesh-ancestor
14483289|NCT02537015|Bimatoprost|bimatoprost|mesh-list
14483290|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14483291|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
14483292|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
14483293|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14483294|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483295|NCT02537873|Cocaine|cocaine|mesh-list
14483296|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
14483297|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
14483298|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483299|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483300|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
14483301|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483302|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14483303|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14483304|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14768449|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768450|NCT00635401|Varenicline|varenicline|mesh-list
14194990|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14194991|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14194992|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
14194993|NCT04610398|Hormones|hormones|mesh-ancestor
14194994|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14194995|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14194996|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14194997|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
14194998|NCT04610125|Fludarabine|fludarabine|mesh-list
14194999|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14195000|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
14195001|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195002|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195003|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14195004|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
14195005|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195006|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195007|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14195008|NCT04609865|Lidocaine|lidocaine|mesh-list
14195009|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
14195010|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
14195011|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195012|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195013|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
14195014|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195015|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14195016|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14195017|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14195018|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483305|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483306|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483307|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
14483308|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483309|NCT02537951|Lidocaine|lidocaine|mesh-list
14483310|NCT02537951|Prilocaine|prilocaine|mesh-list
14483311|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14483312|NCT02537951|Capsaicin|capsaicin|mesh-list
14483313|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
14483314|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
14195019|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483315|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483316|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483317|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
14483318|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483319|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14483320|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14483321|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14483322|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483323|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483324|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
14483325|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483326|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14483327|NCT02538016|Tolvaptan|tolvaptan|mesh-list
14483328|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14483329|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483330|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
14483331|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483332|NCT02538042|Nicotine|nicotine|mesh-list
14483333|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14483334|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
14483335|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483336|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483337|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14768451|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14768452|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14768453|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
14768454|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768455|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768456|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768457|NCT00635414|Esomeprazole|esomeprazole|mesh-list
14768458|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14768459|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768460|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14768461|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768462|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768463|NCT00635531|Alprazolam|alprazolam|mesh-list
14768464|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14768465|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768466|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768467|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14768468|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768469|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768470|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
14768471|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
14768472|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807183|NCT00820326|Dolasetron|dolasetron|mesh-list
14195020|NCT04609748|Nimesulide|nimesulide|mesh-list
14195021|NCT04609748|Cannabidiol|cannabidiol|mesh-list
14195022|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
14195023|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14195024|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195025|NCT04609748|Analgesics|analgesics|mesh-ancestor
14195026|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
14195027|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195028|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195029|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195030|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195031|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14195032|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195033|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195034|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14195035|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195036|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14195037|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
14195038|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14195039|NCT04609761|Antibodies|antibodies|mesh-list
14195040|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
14195041|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14195042|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
14195043|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195044|NCT04609540|Trastuzumab|trastuzumab|mesh-list
14195045|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14195046|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483338|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14483339|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
14483340|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483341|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483342|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
14483343|NCT02538107|Hematinics|hematinics|mesh-ancestor
14483344|NCT02538354|Riboflavin|riboflavin|mesh-list
14483345|NCT02538354|Vitamins|vitamins|mesh-ancestor
14483346|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
14483347|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483348|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
14483349|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14483350|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483351|NCT02538614|Idelalisib|idelalisib|mesh-list
14483352|NCT02538614|BI 836826|bi 836826|mesh-list
14483353|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483354|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483355|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483356|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14483357|NCT02538679|Epinephrine|epinephrine|mesh-list
14483358|NCT02538679|Racepinephrine|racepinephrine|mesh-list
14483359|NCT02538679|Bupivacaine|bupivacaine|mesh-list
14483360|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
14483361|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
14483362|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
14483363|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483364|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483365|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
14483366|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483367|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14483368|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14483369|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
14483370|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483371|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483372|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14483373|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14483374|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
14483375|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14483376|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
14483377|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
14483378|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
14483379|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14483380|NCT02538965|Lenalidomide|lenalidomide|mesh-list
14483381|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
14483382|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483383|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14483384|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14768473|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195047|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14195048|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
14195049|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14195050|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14195051|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195052|NCT04609254|Acetaminophen|acetaminophen|mesh-list
14195053|NCT04609254|Ibuprofen|ibuprofen|mesh-list
14195054|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14195055|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14195056|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195057|NCT04609254|Analgesics|analgesics|mesh-ancestor
14195058|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
14195059|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483385|NCT02538965|Growth Substances|growth substances|mesh-ancestor
14195060|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483386|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
14483387|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483388|NCT02539108|Vaccines|vaccines|mesh-list
14195061|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195062|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195063|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14195064|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195065|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195066|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
14195067|NCT04609293|Apatinib|apatinib|mesh-list
14195068|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195069|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14195070|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195071|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195072|NCT04609189|Vitamin D|vitamin d|mesh-list
14195073|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
14483389|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
14483390|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483391|NCT02539342|Calcium|calcium|mesh-list
14483392|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14483393|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483394|NCT02539368|Infliximab|infliximab|mesh-list
14483395|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483396|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483397|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483398|NCT02539459|Everolimus|everolimus|mesh-list
14195074|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
14195075|NCT04609189|Calcium|calcium|mesh-list
14195076|NCT04609189|Vitamins|vitamins|mesh-ancestor
14195077|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
14195078|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195079|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14195080|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14195081|NCT04609189|Antacids|antacids|mesh-ancestor
14195082|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195083|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238332|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238333|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14238334|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14238335|NCT00130520|Growth Substances|growth substances|mesh-ancestor
14238336|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238337|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
14238338|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14238339|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238340|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238341|NCT00130533|Capecitabine|capecitabine|mesh-list
14238342|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14238343|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
14238344|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238345|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238346|NCT00130637|Daclizumab|daclizumab|mesh-list
14238347|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238348|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
14238349|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238350|NCT00130689|Cetuximab|cetuximab|mesh-list
14238351|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14483399|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483400|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483401|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
14483402|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238352|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238353|NCT00130728|Bevacizumab|bevacizumab|mesh-list
14238354|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14238355|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14238356|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238357|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14483403|NCT02539511|Ketamine|ketamine|mesh-list
14483404|NCT02539511|Analgesics|analgesics|mesh-ancestor
14483405|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
14483406|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483407|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483408|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14483409|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14483410|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
14483411|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
14483412|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483413|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14238358|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14195084|NCT04609176|Apatinib|apatinib|mesh-list
14195085|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195086|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14195087|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195088|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195089|NCT04609397|Hemay005|hemay005|mesh-list
14483414|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14483415|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483416|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483417|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14483418|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
14483419|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483420|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
14483421|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14483422|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14483423|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483424|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
14483425|NCT02540226|Coagulants|coagulants|mesh-ancestor
14483426|NCT02540265|Meloxicam|meloxicam|mesh-list
14483427|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14483428|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14483429|NCT02540265|Analgesics|analgesics|mesh-ancestor
14483430|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
14483431|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483432|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483433|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483434|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483435|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14483436|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14483437|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483438|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483439|NCT02540356|Antibodies|antibodies|mesh-list
14483440|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
14483441|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
14483442|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483443|NCT02540668|Warfarin|warfarin|mesh-list
14483444|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
14483445|NCT02540954|Aflibercept|aflibercept|mesh-list
14483446|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14483447|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14483448|NCT02540954|Growth Substances|growth substances|mesh-ancestor
14483449|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483450|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
14483451|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483452|NCT02541409|Interferons|interferons|mesh-list
14483453|NCT02541409|Ribavirin|ribavirin|mesh-list
14483454|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
14483455|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
14483456|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14483457|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
14483458|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483459|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
14483460|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483461|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
14483462|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483463|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
14483464|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483465|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
14483466|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14483467|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
14483468|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483469|NCT02541422|Expectorants|expectorants|mesh-ancestor
14483470|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
14483471|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14195090|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195091|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14195092|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14195093|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195094|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195095|NCT04609098|Piperaquine|piperaquine|mesh-list
14195096|NCT04609098|Artenimol|artenimol|mesh-list
14195097|NCT04609098|Tafenoquine|tafenoquine|mesh-list
14195098|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
14195099|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14195100|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14483472|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
14483473|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483474|NCT02541422|Protective Agents|protective agents|mesh-ancestor
14483475|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483476|NCT02541422|Antidotes|antidotes|mesh-ancestor
14483477|NCT02541565|Prednisone|prednisone|mesh-list
14483478|NCT02541565|Cortisone|cortisone|mesh-list
14483479|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
14483480|NCT02541565|Rituximab|rituximab|mesh-list
14483481|NCT02541565|Doxorubicin|doxorubicin|mesh-list
14483482|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14483483|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
14483484|NCT02541565|Vincristine|vincristine|mesh-list
14483485|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14483486|NCT02541565|Antibodies|antibodies|mesh-list
14483487|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
14483488|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14483489|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483490|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
14483491|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483492|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14768474|NCT00635557|Carboplatin|carboplatin|mesh-list
14768475|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768476|NCT00635713|Fulvestrant|fulvestrant|mesh-list
14768477|NCT00635713|Anastrozole|anastrozole|mesh-list
14768478|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768479|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768480|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14768481|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14768482|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768483|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768484|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768485|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14768486|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14768487|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768488|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768489|NCT00635726|Gemcitabine|gemcitabine|mesh-list
14768490|NCT00635726|Cisplatin|cisplatin|mesh-list
14768491|NCT00635726|Doxorubicin|doxorubicin|mesh-list
14768492|NCT00635726|Methotrexate|methotrexate|mesh-list
14768493|NCT00635726|Vinblastine|vinblastine|mesh-list
14768494|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768495|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14768496|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
14483493|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14483494|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
14483495|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483496|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483497|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14483498|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14483499|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14483500|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14483501|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483502|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483503|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
14483504|NCT02541565|Hormones|hormones|mesh-ancestor
14483505|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768497|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768498|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
14768499|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768500|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768501|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768502|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
14768503|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768504|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14768505|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14768506|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14768507|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14768508|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
14768509|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14768510|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
14768511|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14768512|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14768513|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14768514|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14483506|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768515|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
14483507|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14195101|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195102|NCT04608734|Midazolam|midazolam|mesh-list
14195103|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14195104|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14195105|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195106|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195107|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14195108|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14195109|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14195110|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14195111|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
14195112|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
14195113|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
14195114|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
14195115|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195116|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195117|NCT04609033|Ketamine|ketamine|mesh-list
14195118|NCT04609033|Morphine|morphine|mesh-list
14195119|NCT04609033|Bupivacaine|bupivacaine|mesh-list
14195120|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
14195121|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
14195122|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195123|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195124|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
14195125|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195126|NCT04609033|Analgesics|analgesics|mesh-ancestor
14195127|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14483508|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
14483509|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
14483510|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
14527364|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14527365|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
14527366|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527367|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527368|NCT04029584|Rifampin|rifampin|mesh-list
14527369|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14527370|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
14527371|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14527372|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527373|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
14527374|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14527375|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527376|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527377|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14527378|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14527379|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14527380|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14527381|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14527382|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14527383|NCT04028960|Insulin|insulin|mesh-list
14527384|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14527385|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14527386|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527387|NCT04023695|Lidocaine|lidocaine|mesh-list
14527388|NCT04023695|Epinephrine|epinephrine|mesh-list
14527389|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527390|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
14527391|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527392|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527393|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
14527394|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195128|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14195129|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
14195130|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14195131|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14195132|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195133|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195134|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14195135|NCT04609033|Narcotics|narcotics|mesh-ancestor
14195136|NCT04608981|Prednisolone|prednisolone|mesh-list
14195137|NCT04608981|Diclofenac|diclofenac|mesh-list
14195138|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195139|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
14195140|NCT04608981|Hormones|hormones|mesh-ancestor
14195141|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483511|NCT02541604|Atezolizumab|atezolizumab|mesh-list
14483512|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483513|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14483514|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14483515|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14483516|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483517|NCT02541864|Amoxicillin|amoxicillin|mesh-list
14483518|NCT02541864|Metronidazole|metronidazole|mesh-list
14483519|NCT02541864|Clarithromycin|clarithromycin|mesh-list
14483520|NCT02541864|Tetracycline|tetracycline|mesh-list
14483521|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14483522|NCT02541864|Pantoprazole|pantoprazole|mesh-list
14483523|NCT02541864|Bismuth|bismuth|mesh-list
14483524|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14483525|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483526|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14483527|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14483528|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14195142|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195143|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14195144|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195145|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195146|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14195147|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939424|NCT01488045|Midazolam|midazolam|mesh-list
14939425|NCT01488045|Propofol|propofol|mesh-list
14483529|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483530|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483531|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14483532|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14483533|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14483534|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483535|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14483536|NCT02541864|Antacids|antacids|mesh-ancestor
14483537|NCT02541903|Afatinib|afatinib|mesh-list
14939426|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14195148|NCT04608981|Analgesics|analgesics|mesh-ancestor
14195149|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
14195150|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483538|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483539|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14483540|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483541|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483542|NCT02542150|Ethanol|ethanol|mesh-list
14768516|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
14768517|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
14768518|NCT00635791|Sorafenib|sorafenib|mesh-list
14768519|NCT00635791|Vorinostat|vorinostat|mesh-list
14768520|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768521|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14768522|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768523|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768524|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14768525|NCT00635856|Gefitinib|gefitinib|mesh-list
14768526|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768527|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14768528|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768529|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768530|NCT00635921|Ziprasidone|ziprasidone|mesh-list
14768531|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14768532|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
14768533|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768534|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768535|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768536|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14768537|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768538|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768539|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768540|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14195151|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14195152|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195153|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195154|NCT04608669|Acetaminophen|acetaminophen|mesh-list
14195155|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14768541|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
14195156|NCT04608669|Analgesics|analgesics|mesh-ancestor
14195157|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
14195158|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195159|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195160|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
14195161|NCT04608448|Sirolimus|sirolimus|mesh-list
14483543|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14483544|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483545|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483546|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483547|NCT02542410|Cabergoline|cabergoline|mesh-list
14483548|NCT02542410|Norethindrone|norethindrone|mesh-list
14483549|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
14483550|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14483551|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14483552|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14483553|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
14483554|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14483555|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483556|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14483557|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14483558|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14483559|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14483560|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
14483561|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
14483562|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483563|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483564|NCT02542462|Vaccines|vaccines|mesh-list
14768542|NCT00635960|Hormones|hormones|mesh-list
14768543|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768544|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768545|NCT00635973|Gefitinib|gefitinib|mesh-list
14768546|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768547|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14768548|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768549|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768550|NCT00635986|Fentanyl|fentanyl|mesh-list
14768551|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14768552|NCT00635986|Narcotics|narcotics|mesh-ancestor
14768553|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768554|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768555|NCT00635986|Analgesics|analgesics|mesh-ancestor
14768556|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
14768557|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768558|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14768559|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14768560|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
14768561|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
14768562|NCT00636038|Beta Carotene|beta carotene|mesh-list
14768563|NCT00636038|Carotenoids|carotenoids|mesh-list
14768564|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
14195162|NCT04608448|Petrolatum|petrolatum|mesh-list
14768565|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768566|NCT00636038|Protective Agents|protective agents|mesh-ancestor
14768567|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768568|NCT00636038|Provitamins|provitamins|mesh-ancestor
14768569|NCT00636038|Vitamins|vitamins|mesh-ancestor
14768570|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
14768571|NCT00636064|Parecoxib|parecoxib|mesh-list
14768572|NCT00636064|Valdecoxib|valdecoxib|mesh-list
14768573|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14768574|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14768575|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768576|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768577|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14768578|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14768579|NCT00636064|Analgesics|analgesics|mesh-ancestor
14768580|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
14768581|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768582|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768583|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768584|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195163|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14195164|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195165|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14195166|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483565|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
14483566|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483567|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
14483568|NCT02542605|Erenumab|erenumab|mesh-list
14483569|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14483570|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483571|NCT02542605|Analgesics|analgesics|mesh-ancestor
14483572|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
14483573|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483574|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483575|NCT02542605|Growth Substances|growth substances|mesh-ancestor
14483576|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
14483577|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483578|NCT02542631|Insulin|insulin|mesh-list
14483579|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14483580|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14483581|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939427|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939428|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939429|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14939430|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
14939431|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
14939432|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14939433|NCT01488045|Narcotics|narcotics|mesh-ancestor
14939434|NCT01488045|Analgesics|analgesics|mesh-ancestor
14939435|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
14939436|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939437|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14483582|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
14483583|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14483584|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483585|NCT02542943|Fluorides|fluorides|mesh-list
14483586|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
14483587|NCT02542943|Protective Agents|protective agents|mesh-ancestor
14483588|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483589|NCT02543346|Cetirizine|cetirizine|mesh-list
14483590|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14483591|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14483592|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14939438|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14939439|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14195167|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
14483593|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
14483594|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
14483595|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483596|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483597|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483598|NCT02543658|Neostigmine|neostigmine|mesh-list
14483599|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14483600|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483601|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483602|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
14483603|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483604|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483605|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14483606|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
14483607|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483608|NCT02543801|Ketorolac|ketorolac|mesh-list
14483609|NCT02543801|Clonidine|clonidine|mesh-list
14483610|NCT02543801|Epinephrine|epinephrine|mesh-list
14483611|NCT02543801|Bupivacaine|bupivacaine|mesh-list
14483612|NCT02543801|Ropivacaine|ropivacaine|mesh-list
14483613|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
14483614|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
14483615|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483616|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483617|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
14483618|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483619|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14939440|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14195168|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14195169|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
14195170|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195171|NCT04608448|Emollients|emollients|mesh-ancestor
14195172|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195173|NCT04608474|Evolocumab|evolocumab|mesh-list
14483620|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14483621|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14483622|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483623|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483624|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14483625|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14483626|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
14483627|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14483628|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
14483629|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
14483630|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
14483631|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14483632|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14483633|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14483634|NCT02543801|Analgesics|analgesics|mesh-ancestor
14483635|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195174|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14483636|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483637|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14483638|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483639|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14483640|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
14768585|NCT00636116|Antivenins|antivenins|mesh-list
14768586|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
14768587|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768588|NCT00636142|Infliximab|infliximab|mesh-list
14768589|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14768590|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768591|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14768592|NCT00636246|Sertraline|sertraline|mesh-list
14768593|NCT00636246|Reboxetine|reboxetine|mesh-list
14768594|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
14768595|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768596|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14768597|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14768598|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939441|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
14939442|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
14939443|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939444|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939445|NCT01488136|Diazoxide|diazoxide|mesh-list
14939446|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14939447|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
14939448|NCT01488201|Brodalumab|brodalumab|mesh-list
14939449|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
14939450|NCT01488227|Vitamin D|vitamin d|mesh-list
14939451|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
14939452|NCT01488227|Vitamins|vitamins|mesh-list
14939453|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
14939454|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939455|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14939456|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14939457|NCT01488253|Sirolimus|sirolimus|mesh-list
14939458|NCT01488253|Tacrolimus|tacrolimus|mesh-list
14939459|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939460|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
14939461|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939462|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14939463|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939464|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939465|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14939466|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939467|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14939468|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939469|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
14939470|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14939471|NCT01488266|Milnacipran|milnacipran|mesh-list
14939472|NCT01488266|Aripiprazole|aripiprazole|mesh-list
14939473|NCT01488266|Mirtazapine|mirtazapine|mesh-list
14939474|NCT01488266|Citalopram|citalopram|mesh-list
14195175|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14195176|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14195177|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
14195178|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195179|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14195180|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195181|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14195182|NCT04608539|Hematinics|hematinics|mesh-ancestor
14483641|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14195183|NCT04608253|Choline|choline|mesh-list
14195184|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
14195185|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14195186|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
14195187|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195188|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195189|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14195190|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
14195191|NCT04608500|Minocycline|minocycline|mesh-list
14195192|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14195193|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483642|NCT02543918|Ixekizumab|ixekizumab|mesh-list
14483643|NCT02543918|Vaccines|vaccines|mesh-list
14483644|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14483645|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
14483646|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483647|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483648|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
14483649|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14483650|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
14483651|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939475|NCT01488266|Bupropion|bupropion|mesh-list
14939476|NCT01488266|Fluoxetine|fluoxetine|mesh-list
14939477|NCT01488266|Paroxetine|paroxetine|mesh-list
14939478|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14939479|NCT01488266|Sertraline|sertraline|mesh-list
14939480|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
14939481|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14939482|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14939483|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939484|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939485|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939486|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
14939487|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483652|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483653|NCT02544152|Lubiprostone|lubiprostone|mesh-list
14939488|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14939489|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14939490|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939491|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14939492|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
14939493|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14939494|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14195194|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14195195|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14195196|NCT04607772|Gemcitabine|gemcitabine|mesh-list
14483654|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14483655|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483656|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483657|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
14483658|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
14483659|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483660|NCT02544217|Protective Agents|protective agents|mesh-ancestor
14483661|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483662|NCT02544321|Bromocriptine|bromocriptine|mesh-list
14483663|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14483664|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14483665|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
14483666|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483667|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483668|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
14483669|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
14483670|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483671|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483672|NCT02544451|Ivacaftor|ivacaftor|mesh-list
14939495|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195197|NCT04607772|Rituximab|rituximab|mesh-list
14195198|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
14195199|NCT04607772|Lenalidomide|lenalidomide|mesh-list
14195200|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14483673|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14483674|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14483675|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483676|NCT02544607|Ketamine|ketamine|mesh-list
14483677|NCT02544607|Analgesics|analgesics|mesh-ancestor
14483678|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
14483679|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483680|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483681|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14483682|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14483683|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
14483684|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
14483685|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483686|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14768599|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768600|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768601|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
14768602|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768603|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14768604|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
14768605|NCT00636259|Bicalutamide|bicalutamide|mesh-list
14768606|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
14768607|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768608|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768609|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768610|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768611|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14768612|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
14768613|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768614|NCT00636298|Bevacizumab|bevacizumab|mesh-list
14768615|NCT00636298|Cetuximab|cetuximab|mesh-list
14768616|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14768617|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768618|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14768619|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14768620|NCT00636298|Growth Substances|growth substances|mesh-ancestor
14768621|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768622|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
14768623|NCT00636311|Gemcitabine|gemcitabine|mesh-list
14768624|NCT00636311|Bortezomib|bortezomib|mesh-list
14768625|NCT00636311|Vinorelbine|vinorelbine|mesh-list
14768626|NCT00636311|Ifosfamide|ifosfamide|mesh-list
14768627|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14768628|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
14768629|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768630|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768631|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
14483687|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14483688|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483689|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483690|NCT02544763|Cannabidiol|cannabidiol|mesh-list
14483691|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
14483692|NCT02544984|Azithromycin|azithromycin|mesh-list
14483693|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14483694|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483695|NCT02545075|Ipilimumab|ipilimumab|mesh-list
14483696|NCT02545075|Dacarbazine|dacarbazine|mesh-list
14483697|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14483698|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483699|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14483700|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483701|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14483702|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
14483703|NCT02545504|Leucovorin|leucovorin|mesh-list
14483704|NCT02545504|Fluorouracil|fluorouracil|mesh-list
14483705|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
14483706|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
14483707|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483708|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14483709|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483710|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483711|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
14483712|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483713|NCT02545504|Antidotes|antidotes|mesh-ancestor
14483714|NCT02545504|Protective Agents|protective agents|mesh-ancestor
14483715|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
14483716|NCT02545504|Vitamins|vitamins|mesh-ancestor
14483717|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
14483718|NCT02545907|Thalidomide|thalidomide|mesh-list
14483719|NCT02545907|Dexamethasone|dexamethasone|mesh-list
14483720|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483721|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
14483722|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
13963620|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963621|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13963622|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963623|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963624|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
13963625|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
13963626|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13963627|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963628|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13963629|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13963630|NCT03143036|Growth Substances|growth substances|mesh-ancestor
13963631|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
13963632|NCT03143023|Fluorides|fluorides|mesh-list
13963633|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
13963634|NCT03143023|Protective Agents|protective agents|mesh-ancestor
14195201|NCT04607772|Venetoclax|venetoclax|mesh-list
14195202|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14195203|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195204|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
14195205|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195206|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195207|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14195208|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
14195209|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195210|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
14195211|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195212|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195213|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14195214|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14195215|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14195216|NCT04607772|Growth Substances|growth substances|mesh-ancestor
14195217|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
14195218|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14195219|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
14195220|NCT04608006|Fentanyl|fentanyl|mesh-list
14195221|NCT04608006|Bupivacaine|bupivacaine|mesh-list
14195222|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
13963635|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483723|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483724|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483725|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483726|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
14483727|NCT02545907|Hormones|hormones|mesh-ancestor
14483728|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483729|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14483730|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483731|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483732|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
14483733|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
14483734|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14483735|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483736|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14483737|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14483738|NCT02545907|Growth Substances|growth substances|mesh-ancestor
14483739|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
14483740|NCT02545933|Aspirin|aspirin|mesh-list
14483741|NCT02545933|Ticagrelor|ticagrelor|mesh-list
14483742|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14483743|NCT02545933|Vorapaxar|vorapaxar|mesh-list
14483744|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14483745|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14768632|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768633|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768634|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768635|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
14768636|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768637|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14768638|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14768639|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14768640|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14768641|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14768642|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
14807184|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
14807185|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
14807186|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807187|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807188|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14807189|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14807190|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
14807191|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807192|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807193|NCT00820352|Bosentan|bosentan|mesh-list
14807194|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14807195|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14807196|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807197|NCT00820404|BLI-489|bli-489|mesh-list
14807198|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14807199|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807200|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807201|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14807202|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807203|NCT00820417|Cetuximab|cetuximab|mesh-list
14807204|NCT00820417|Gefitinib|gefitinib|mesh-list
14807205|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14807206|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807207|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14807208|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807209|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939496|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14939497|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14939498|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939499|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
14939500|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14939501|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14939502|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14939503|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14939504|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14939505|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14939506|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14939507|NCT01488266|Analgesics|analgesics|mesh-ancestor
14939508|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
14939509|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14939510|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
14483746|NCT02545933|Analgesics|analgesics|mesh-ancestor
14483747|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
14483748|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483749|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483750|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483751|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483752|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14483753|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14483754|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483755|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14483756|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14483757|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483758|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
14483759|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14483760|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14483761|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14483762|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
14483763|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483764|NCT02546193|Misoprostol|misoprostol|mesh-list
14483765|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14483766|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
14483767|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14483768|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483769|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14483770|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483771|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
14483772|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14195223|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
14195224|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195225|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195226|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
14195227|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195228|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14195229|NCT04608006|Narcotics|narcotics|mesh-ancestor
14483773|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14483774|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14483775|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
14483776|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483777|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14483778|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14483779|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483780|NCT02546570|Oxytocin|oxytocin|mesh-list
14483781|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
14768643|NCT00636415|Morphine|morphine|mesh-list
14768644|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14768645|NCT00636415|Narcotics|narcotics|mesh-ancestor
14768646|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768647|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768648|NCT00636415|Analgesics|analgesics|mesh-ancestor
14768649|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
14768650|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768651|NCT00636428|Midazolam|midazolam|mesh-list
14768652|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14768653|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14768654|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768655|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768656|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14195230|NCT04608006|Analgesics|analgesics|mesh-ancestor
14195231|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14195232|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14195233|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
14195234|NCT04607733|Mirikizumab|mirikizumab|mesh-list
14483782|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14768657|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13963636|NCT03142789|Cerivastatin|cerivastatin|mesh-list
13963637|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13963638|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13963639|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13963640|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
13963641|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963642|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963643|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13963644|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
13963645|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13963646|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483783|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483784|NCT02546765|Acetaminophen|acetaminophen|mesh-list
14483785|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
14483786|NCT02546765|Propofol|propofol|mesh-list
14483787|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14483788|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14483789|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483790|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14483791|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
14483792|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
14483793|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195235|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14195236|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195237|NCT04607733|Analgesics|analgesics|mesh-ancestor
14483794|NCT02546765|Analgesics|analgesics|mesh-ancestor
14483795|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
14483796|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483797|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14483798|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14483799|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14483800|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
14483801|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483802|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483803|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
14483804|NCT02547012|Amoxicillin|amoxicillin|mesh-list
14483805|NCT02547012|Levofloxacin|levofloxacin|mesh-list
14483806|NCT02547012|Ofloxacin|ofloxacin|mesh-list
14483807|NCT02547012|Tetracycline|tetracycline|mesh-list
14483808|NCT02547012|Esomeprazole|esomeprazole|mesh-list
14483809|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14483810|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483811|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14483812|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483813|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14483814|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483815|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483816|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14483817|NCT02547012|Renal Agents|renal agents|mesh-ancestor
14195238|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
14195239|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195240|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195241|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195242|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195243|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14195244|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195245|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
14195246|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14195247|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14195248|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483818|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14483819|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14483820|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483821|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14483822|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14483823|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14483824|NCT02547038|Amoxicillin|amoxicillin|mesh-list
14483825|NCT02547038|Metronidazole|metronidazole|mesh-list
14483826|NCT02547038|Clarithromycin|clarithromycin|mesh-list
14483827|NCT02547038|Tetracycline|tetracycline|mesh-list
14483828|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14483829|NCT02547038|Pantoprazole|pantoprazole|mesh-list
14483830|NCT02547038|Bismuth|bismuth|mesh-list
14483831|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14483832|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14483833|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14483834|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14483835|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14483836|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483837|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768658|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14195249|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
14195250|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14483838|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14483839|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14483840|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14768659|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14768660|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
14483841|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483842|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14483843|NCT02547038|Antacids|antacids|mesh-ancestor
14483844|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14483845|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14483846|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14483847|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
14483848|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483849|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
14483850|NCT02547454|Hematinics|hematinics|mesh-ancestor
14483851|NCT02547623|Dexamethasone|dexamethasone|mesh-list
14483852|NCT02547623|Prednisolone|prednisolone|mesh-list
14195251|NCT04607629|Omalizumab|omalizumab|mesh-list
14195252|NCT04607629|Budesonide|budesonide|mesh-list
14195253|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
14195254|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14195255|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14195256|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195257|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14195258|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
14195259|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195260|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195261|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14195262|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
14195263|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
14195264|NCT04607629|Hormones|hormones|mesh-ancestor
14195265|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195266|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14195267|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14195268|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14195269|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
14195270|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195271|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195272|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14768661|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
14768662|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
14768663|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
14768664|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768665|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195273|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
14195274|NCT04607603|Cannabidiol|cannabidiol|mesh-list
14195275|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
14195276|NCT04607447|Dexamethasone|dexamethasone|mesh-list
14195277|NCT04607447|Atorvastatin|atorvastatin|mesh-list
14195278|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195279|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
14195280|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
14195281|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195282|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195283|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195284|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
14768666|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14939511|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
14939512|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14939513|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14939514|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14939515|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14939516|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
14195285|NCT04607447|Hormones|hormones|mesh-ancestor
14195286|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195287|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14195288|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195289|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14195290|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14195291|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
14195292|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195293|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14483853|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768667|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768668|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
14768669|NCT00636493|Hormones|hormones|mesh-ancestor
14768670|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768671|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483854|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
14768672|NCT00636519|Antitoxins|antitoxins|mesh-list
14483855|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
14768673|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
14768674|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
14483856|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483857|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483858|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768675|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768676|NCT00636545|Oblimersen|oblimersen|mesh-list
14195294|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14195295|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195296|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
14195297|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14195298|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195299|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195300|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195301|NCT04607525|Analgesics|analgesics|mesh-ancestor
14195302|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
14195303|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195304|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14483859|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
14483860|NCT02547623|Hormones|hormones|mesh-ancestor
14483861|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483862|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14483863|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483864|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14483865|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
14483866|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483867|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14483868|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483869|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
14483870|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14483871|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14483872|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
14483873|NCT02547935|Saxagliptin|saxagliptin|mesh-list
14483874|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14483875|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483876|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14483877|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483878|NCT02547935|Incretins|incretins|mesh-ancestor
14483879|NCT02547935|Hormones|hormones|mesh-ancestor
14483880|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195305|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14483881|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14483882|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
14483883|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483884|NCT02547974|Vaccines|vaccines|mesh-list
14483885|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
14483886|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483887|NCT02547987|Carboplatin|carboplatin|mesh-list
14483888|NCT02547987|Docetaxel|docetaxel|mesh-list
14483889|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483890|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
14483891|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
14483892|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
14483893|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483894|NCT02548078|Vaccines|vaccines|mesh-list
14483895|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
14483896|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483897|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14483898|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14483899|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
14483900|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14483901|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483902|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14483903|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14483904|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14483905|NCT02548650|Aspirin|aspirin|mesh-list
14483906|NCT02548650|Clopidogrel|clopidogrel|mesh-list
14483907|NCT02548650|Vorapaxar|vorapaxar|mesh-list
14483908|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14768677|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768678|NCT00636584|Nitroprusside|nitroprusside|mesh-list
14768679|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14768680|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
14768681|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14768682|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768683|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
14768684|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14768685|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768686|NCT00636766|Metformin|metformin|mesh-list
14768687|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
14768688|NCT00636766|Rimonabant|rimonabant|mesh-list
14768689|NCT00636766|Atorvastatin|atorvastatin|mesh-list
14768690|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14768691|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939517|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14939518|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939519|NCT01488305|Micronutrients|micronutrients|mesh-list
14939520|NCT01488305|Trace Elements|trace elements|mesh-list
14939521|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939522|NCT01488344|Nintedanib|nintedanib|mesh-list
14939523|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939524|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14939525|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939526|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939527|NCT01488396|Cyclosporine|cyclosporine|mesh-list
14939528|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14939529|NCT01488396|Cyclosporins|cyclosporins|mesh-list
14939530|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939531|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939532|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939533|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
14939534|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939535|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
14939536|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939537|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
14939538|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939539|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14939540|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14939541|NCT01488526|Tenofovir|tenofovir|mesh-list
14939542|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
14195306|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14195307|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
14195308|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939543|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939544|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14939545|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14939546|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939547|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939548|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14939549|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14939550|NCT01488552|Metformin|metformin|mesh-list
14939551|NCT01488552|Gemcitabine|gemcitabine|mesh-list
14939552|NCT01488552|Paclitaxel|paclitaxel|mesh-list
14939553|NCT01488552|Folfirinox|folfirinox|mesh-list
14939554|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14939555|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939556|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
14195309|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195310|NCT04607642|Manganese|manganese|mesh-list
14195311|NCT04607642|Trace Elements|trace elements|mesh-ancestor
14195312|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
14195313|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238359|NCT00130728|Growth Substances|growth substances|mesh-ancestor
14238360|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238361|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
14238362|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14238363|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238364|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238365|NCT00130780|Bevacizumab|bevacizumab|mesh-list
14238366|NCT00130780|Docetaxel|docetaxel|mesh-list
14238367|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14238368|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238369|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14238370|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14238371|NCT00130780|Growth Substances|growth substances|mesh-ancestor
14238372|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238373|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
14238374|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238375|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238376|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
14483909|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14483910|NCT02548650|Analgesics|analgesics|mesh-ancestor
14483911|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
14483912|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483913|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483914|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483915|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14483916|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14483917|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14483918|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483919|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14483920|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14483921|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483922|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
14483923|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14483924|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14483925|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14483926|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
14483927|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483928|NCT02548728|Oxytocin|oxytocin|mesh-list
14483929|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
14483930|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14483931|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483932|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
14483933|NCT02548910|Citric Acid|citric acid|mesh-list
14483934|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
14483935|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14483936|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
14483937|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
14483938|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483939|NCT02548962|Dexamethasone|dexamethasone|mesh-list
14483940|NCT02548962|Pomalidomide|pomalidomide|mesh-list
14483941|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483942|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
14483943|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
14483944|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483945|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768692|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14768693|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14768694|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
14768695|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768696|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14768697|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14768698|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768699|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14768700|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14768701|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14768702|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768703|NCT00636766|Hormones|hormones|mesh-ancestor
14768704|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768705|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14768706|NCT00636831|Cefazolin|cefazolin|mesh-list
14768707|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768708|NCT00636870|Fexofenadine|fexofenadine|mesh-list
14768709|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14768710|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14768711|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14768712|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
14768713|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
14768714|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768715|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195314|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
14195315|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14195316|NCT04606914|Maytansine|maytansine|mesh-list
14195317|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14195318|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195319|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14195320|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14195321|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14195322|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195323|NCT04606836|Bupivacaine|bupivacaine|mesh-list
14768716|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195324|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
14483946|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768717|NCT00636883|Gemcitabine|gemcitabine|mesh-list
14483947|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
14483948|NCT02548962|Hormones|hormones|mesh-ancestor
14483949|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483950|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14483951|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483952|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
14483953|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14483954|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14483955|NCT02548962|Growth Substances|growth substances|mesh-ancestor
14483956|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
14483957|NCT02549196|Donepezil|donepezil|mesh-list
14483958|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
14483959|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14483960|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14483961|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483962|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
14483963|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483964|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483965|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
14483966|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14483967|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14483968|NCT02549196|Urological Agents|urological agents|mesh-ancestor
14483969|NCT02549573|Apomorphine|apomorphine|mesh-list
14483970|NCT02549573|Emetics|emetics|mesh-ancestor
14483971|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483972|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
14483973|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483974|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483975|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
14483976|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
14768718|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
14768719|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14768720|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
14768721|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768722|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768723|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
14768724|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768725|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768726|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768727|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
14768728|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768729|NCT00636896|Olanzapine|olanzapine|mesh-list
14768730|NCT00636896|Modafinil|modafinil|mesh-list
14768731|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
14768732|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
14768733|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768734|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195325|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
14195326|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195327|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195328|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
14768735|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768736|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14768737|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14768738|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768739|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14768740|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14768741|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14768742|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14768743|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768744|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768745|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
14768746|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14768747|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14768748|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14768749|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14768750|NCT00636909|Cyclosporine|cyclosporine|mesh-list
14768751|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
14768752|NCT00636909|Methotrexate|methotrexate|mesh-list
14768753|NCT00636909|Fludarabine|fludarabine|mesh-list
14768754|NCT00636909|Cyclosporins|cyclosporins|mesh-list
14768755|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14195329|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768756|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
14768757|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483977|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14483978|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483979|NCT02550106|Omalizumab|omalizumab|mesh-list
14483980|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14483981|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14483982|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
14527395|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14527396|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14527397|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14527398|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14527399|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527400|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14527401|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14527402|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
14527403|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768758|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14768759|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14768760|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
14768761|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768762|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768763|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14768764|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14768765|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
14768766|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14768767|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14768768|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
14768769|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
14768770|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768771|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14195344|NCT04606563|Losartan|losartan|mesh-list
14195345|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14768772|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14195346|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14195347|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14195348|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14195349|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195350|NCT04606537|Itraconazole|itraconazole|mesh-list
14195351|NCT04606537|Rifampin|rifampin|mesh-list
14195352|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
14195353|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195354|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14195355|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14195356|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195357|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195358|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14195359|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
14195360|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195361|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195362|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14527404|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14527405|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14527406|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
14768773|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
14768774|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768775|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14768776|NCT00636922|Everolimus|everolimus|mesh-list
14195363|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14195364|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
14195365|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14195366|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
14195367|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14195368|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14195369|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14195370|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14195371|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14483983|NCT02550743|Capecitabine|capecitabine|mesh-list
14483984|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14483985|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
14483986|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14483987|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14483988|NCT02550795|Dexamethasone|dexamethasone|mesh-list
14483989|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
14483990|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14483991|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
14483992|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
14483993|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14483994|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14483995|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14483996|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
14483997|NCT02550795|Hormones|hormones|mesh-ancestor
14483998|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14483999|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14484000|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484001|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14484002|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14484003|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14484004|NCT02550795|Analgesics|analgesics|mesh-ancestor
14484005|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
14484006|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14484007|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14484008|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14484009|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
14484010|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484011|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484012|NCT02551055|Paclitaxel|paclitaxel|mesh-list
14484013|NCT02551055|Docetaxel|docetaxel|mesh-list
14484014|NCT02551055|Serabelisib|serabelisib|mesh-list
14484015|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14484016|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484017|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484018|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484019|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
14939557|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
14939558|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
14939559|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939560|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14939561|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
14939562|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
14939563|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939564|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939565|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939566|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
14939567|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939568|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484020|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484021|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484022|NCT02551094|Colchicine|colchicine|mesh-list
14484023|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
14484024|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484025|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484026|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484027|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
14484028|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484029|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484030|NCT02551159|Carboplatin|carboplatin|mesh-list
14484031|NCT02551159|Fluorouracil|fluorouracil|mesh-list
14484032|NCT02551159|Cetuximab|cetuximab|mesh-list
14484033|NCT02551159|Durvalumab|durvalumab|mesh-list
14484034|NCT02551159|Tremelimumab|tremelimumab|mesh-list
14195372|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14195373|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14195374|NCT04606212|Losartan|losartan|mesh-list
14195375|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14195376|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14484035|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14195377|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14195378|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14242853|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14242854|NCT00191152|Gemcitabine|gemcitabine|mesh-list
14242855|NCT00191152|Capecitabine|capecitabine|mesh-list
14242856|NCT00191152|Docetaxel|docetaxel|mesh-list
14242857|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242858|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
14242859|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242860|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242861|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
14242862|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242863|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242864|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242865|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
14242866|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242867|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242868|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242869|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242870|NCT00191191|Pemetrexed|pemetrexed|mesh-list
14242871|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242872|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242873|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242874|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14242875|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14242876|NCT00191269|Gemcitabine|gemcitabine|mesh-list
14242877|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242878|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
14242879|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242880|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242881|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
14242882|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242883|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242884|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242885|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
14242886|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242887|NCT00191282|Insulin|insulin|mesh-list
14242888|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14242889|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
14242890|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
14242891|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
14242892|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
14242893|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
14242894|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14242895|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242896|NCT00191308|Pemetrexed|pemetrexed|mesh-list
14242897|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242898|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242899|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242900|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14242901|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14242902|NCT00191334|Gemcitabine|gemcitabine|mesh-list
14242903|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242904|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242905|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
14242906|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242907|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
14242908|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242909|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242910|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242911|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
14242912|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242913|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14242914|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14484036|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484037|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
14484038|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484039|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14484040|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484041|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
14484042|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484043|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14484044|NCT02551432|Paclitaxel|paclitaxel|mesh-list
14484045|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
14484046|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14484047|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484048|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484049|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484050|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
14484051|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484052|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14484053|NCT02551692|Nicotine|nicotine|mesh-list
14484054|NCT02551692|Varenicline|varenicline|mesh-list
14484055|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14484056|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
14484057|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484058|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484059|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14768777|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768778|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768779|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
14484060|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14484061|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
14484062|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484063|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484064|NCT02551731|Cannabidiol|cannabidiol|mesh-list
14484065|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
14484066|NCT02551744|Pantoprazole|pantoprazole|mesh-list
14484067|NCT02551744|Famotidine|famotidine|mesh-list
14484068|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14484069|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
14484070|NCT02551744|Histamine|histamine|mesh-list
14484071|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14484072|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484073|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484074|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484075|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
14484076|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
14484077|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484078|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484079|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
14484080|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
14484081|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484082|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484083|NCT02551874|Metformin|metformin|mesh-list
14484084|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
14484085|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
14484086|NCT02551874|Saxagliptin|saxagliptin|mesh-list
14484087|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484088|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484089|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14484090|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484091|NCT02551874|Incretins|incretins|mesh-ancestor
14484092|NCT02551874|Hormones|hormones|mesh-ancestor
14484093|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14484094|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14484095|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484096|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484097|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
14484098|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14484099|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484100|NCT02552147|Nicotine|nicotine|mesh-list
14484101|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14484102|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
14484103|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484104|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484105|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14484106|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14768780|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484107|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
14484108|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484109|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484110|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
14484111|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484112|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
14484113|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484114|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484115|NCT02552225|Amitriptyline|amitriptyline|mesh-list
14484116|NCT02552225|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14484117|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14484118|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
14484119|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14484120|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14484121|NCT02552225|Analgesics|analgesics|mesh-ancestor
14484122|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
14484123|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484124|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484125|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14484126|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14484127|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14484128|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484129|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
14195379|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195380|NCT04606225|Losartan|losartan|mesh-list
14195381|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14195382|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14195383|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14195384|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14195385|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195386|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14195387|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14195388|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195389|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14484130|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484131|NCT02552225|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14484132|NCT02552225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14484133|NCT02552225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14484134|NCT02552303|Modafinil|modafinil|mesh-list
14484135|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14768781|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14768782|NCT00636935|Clindamycin|clindamycin|mesh-list
14768783|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
14768784|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
14768785|NCT00636935|Dapsone|dapsone|mesh-list
14768786|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14768787|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14768788|NCT00636935|Primaquine|primaquine|mesh-list
14768789|NCT00636935|Trimethoprim|trimethoprim|mesh-list
14768790|NCT00636935|Atovaquone|atovaquone|mesh-list
14768791|NCT00636935|Pentamidine|pentamidine|mesh-list
14768792|NCT00636935|Prednisone|prednisone|mesh-list
14484136|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484137|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14484138|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14484139|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14484140|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484141|NCT02552355|Metformin|metformin|mesh-list
14484142|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484143|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484144|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
14484145|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14484146|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484147|NCT02553629|Rocuronium|rocuronium|mesh-list
14484148|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14484149|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14484150|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14484151|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484152|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484153|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14768793|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768794|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
14768795|NCT00636935|Hormones|hormones|mesh-ancestor
14484154|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14484155|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14484156|NCT02553772|Laxatives|laxatives|mesh-ancestor
14484157|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484158|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
14484159|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14484160|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14484161|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14484162|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
14484163|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484164|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484165|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484166|NCT02553928|Memantine|memantine|mesh-list
14484167|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14484168|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14484169|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
14484170|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484171|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484172|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484173|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14484174|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14484175|NCT02554279|Menotropins|menotropins|mesh-list
14484176|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14484177|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
14484178|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14484179|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484180|NCT02554721|Aspirin|aspirin|mesh-list
14484181|NCT02554721|Cilostazol|cilostazol|mesh-list
14484182|NCT02554721|Clopidogrel|clopidogrel|mesh-list
14484183|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14484184|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14484185|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14484186|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14484187|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
14484188|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484189|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484190|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939569|NCT01488565|Azacitidine|azacitidine|mesh-list
14939570|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14768796|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768797|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768798|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768799|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768800|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768801|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
14768802|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14768803|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768804|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768805|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
14768806|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14768807|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14195390|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195391|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195392|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
14195393|NCT04606017|Antacids|antacids|mesh-ancestor
14195394|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195395|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195396|NCT04605770|Pemetrexed|pemetrexed|mesh-list
14195397|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195398|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195399|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195400|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14195401|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14195402|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14195403|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14195404|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
14195405|NCT04605952|Antibodies|antibodies|mesh-list
14195406|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
14195407|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
14195408|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768808|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14768809|NCT00636935|Renal Agents|renal agents|mesh-ancestor
14939571|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
14195409|NCT04605562|Palbociclib|palbociclib|mesh-list
14195410|NCT04605562|Antibodies|antibodies|mesh-list
14195411|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
14195412|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
14195413|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195414|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195415|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14195416|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484191|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14484192|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14484193|NCT02554721|Analgesics|analgesics|mesh-ancestor
14484194|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
14484195|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484196|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484197|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484198|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14484199|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14484200|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14484201|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484202|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
14484203|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14484204|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
14484205|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14484206|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
14484207|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
14484208|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14484209|NCT02554721|Protective Agents|protective agents|mesh-ancestor
14484210|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14484211|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14484212|NCT02554786|Fluticasone|fluticasone|mesh-list
14484213|NCT02554786|Xhance|xhance|mesh-list
14484214|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
14484215|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14484216|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484217|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14484218|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
14484219|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484220|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484221|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14484222|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
14484223|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484224|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14484225|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14484226|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14484227|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14484228|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
14484229|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484230|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484231|NCT02554890|Valsartan|valsartan|mesh-list
14484232|NCT02554890|Enalapril|enalapril|mesh-list
14484233|NCT02554890|Enalaprilat|enalaprilat|mesh-list
14484234|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14484235|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14484236|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14484237|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14484238|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484239|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14484240|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484241|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484242|NCT02554903|Macitentan|macitentan|mesh-list
14484243|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14484244|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14484245|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484246|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14484247|NCT02554981|Cyclosporine|cyclosporine|mesh-list
14939572|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195417|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195418|NCT04605419|Calcium|calcium|mesh-list
14195419|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14195420|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195421|NCT04605588|Ribavirin|ribavirin|mesh-list
14195422|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
14195423|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
14484248|NCT02554981|Cyclosporins|cyclosporins|mesh-list
14195424|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
14484249|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484250|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484251|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484252|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
14484253|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484254|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
14484255|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484256|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484257|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484258|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14484259|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14484260|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484261|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484262|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
14484263|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484264|NCT02555228|Simethicone|simethicone|mesh-list
14484265|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
14484266|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484267|NCT02555228|Emollients|emollients|mesh-ancestor
14484268|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484269|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
14484270|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14484271|NCT02555683|Growth Substances|growth substances|mesh-ancestor
14484272|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484273|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
14484274|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14484275|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
14484276|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14484277|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484278|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484279|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484280|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
14484281|NCT02556203|Aspirin|aspirin|mesh-list
14484282|NCT02556203|Vitamin K|vitamin k|mesh-list
14484283|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
14484284|NCT02556203|Clopidogrel|clopidogrel|mesh-list
14484285|NCT02556203|Vitamins|vitamins|mesh-ancestor
14484286|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
14484287|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484288|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14484289|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14484290|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14484291|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14484292|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
14484293|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484294|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768810|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14768811|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14768812|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14768813|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14768814|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
14768815|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
14768816|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14768817|NCT00636974|Anesthetics|anesthetics|mesh-list
14768818|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14768819|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484295|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14484296|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
14484297|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14484298|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484299|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484300|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
14484301|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14484302|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14484303|NCT02556203|Analgesics|analgesics|mesh-ancestor
14484304|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
14484305|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484306|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484307|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484308|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14484309|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14484310|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14484311|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
14484312|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14484313|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
14484314|NCT02556203|Coagulants|coagulants|mesh-ancestor
14484315|NCT02556307|Ribavirin|ribavirin|mesh-list
14484316|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14484317|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
14484318|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484319|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
14484320|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484321|NCT02556333|Tenofovir|tenofovir|mesh-list
14484322|NCT02556333|Emtricitabine|emtricitabine|mesh-list
14484323|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
14484324|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484325|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14484326|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14484327|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484328|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484329|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14484330|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14484331|NCT02556632|Curcumin|curcumin|mesh-list
14484332|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14484333|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14484334|NCT02556632|Analgesics|analgesics|mesh-ancestor
14484335|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
14484336|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484337|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484338|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484339|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484340|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484341|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484342|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484343|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
14484344|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14484345|NCT02556775|Antibodies|antibodies|mesh-list
14484346|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
14484347|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14768820|NCT00637026|Gefitinib|gefitinib|mesh-list
14768821|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195425|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484348|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
14484349|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484350|NCT02556788|Trifarotene|trifarotene|mesh-list
14484351|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195426|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
14195427|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195428|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
14195429|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14195430|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14195431|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195432|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195433|NCT04605575|Vinorelbine|vinorelbine|mesh-list
14195434|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14195435|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195436|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
14195437|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484352|NCT02556918|Insulin|insulin|mesh-list
14484353|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14484354|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
14484355|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14195438|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
14195439|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195440|NCT04605393|Dronabinol|dronabinol|mesh-list
14195441|NCT04605393|Cannabidiol|cannabidiol|mesh-list
14195442|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
14195443|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
14195444|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195445|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14484356|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
14484357|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
14484358|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484359|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195446|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195447|NCT04605393|Analgesics|analgesics|mesh-ancestor
14195448|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
14195449|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484360|NCT02556918|Incretins|incretins|mesh-ancestor
14484361|NCT02556918|Hormones|hormones|mesh-ancestor
14484362|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14484363|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14484364|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
14195450|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14195451|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14195452|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195453|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195454|NCT04605393|Hormones|hormones|mesh-ancestor
14768822|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14768823|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768824|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768825|NCT00637065|Bosentan|bosentan|mesh-list
14768826|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14768827|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14768828|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768829|NCT00637078|Amlodipine|amlodipine|mesh-list
14768830|NCT00637078|Spironolactone|spironolactone|mesh-list
14768831|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14195455|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195456|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14195457|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14195458|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238377|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238378|NCT00130793|Vaccines|vaccines|mesh-list
14238379|NCT00130793|Immunoglobulins|immunoglobulins|mesh-list
14238380|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
14238381|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238382|NCT00130832|Vaccines|vaccines|mesh-list
14238383|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
14238384|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238385|NCT00130923|Risperidone|risperidone|mesh-list
14238386|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14238387|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
14238388|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238389|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238390|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238391|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14238392|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14238393|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238394|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238395|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14238396|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
14238397|NCT00131248|Metoclopramide|metoclopramide|mesh-list
14238398|NCT00131248|Ranitidine|ranitidine|mesh-list
14238399|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14238400|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
14238401|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
14238402|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238403|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238404|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238405|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14238406|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14238407|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
14238408|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238409|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238410|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14238411|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14238412|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
14238413|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
14238414|NCT00131352|Hylan|hylan|mesh-list
14238415|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
14238416|NCT00131352|Protective Agents|protective agents|mesh-ancestor
14238417|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238418|NCT00131378|Hormones|hormones|mesh-list
14238419|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238420|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238421|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14238422|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14238423|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238424|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238425|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238426|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238427|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238428|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14484365|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484366|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484367|NCT02557035|Dexamethasone|dexamethasone|mesh-list
14484368|NCT02557035|Palonosetron|palonosetron|mesh-list
14484369|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768832|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14768833|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14768834|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768835|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14768836|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768837|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
14768838|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14768839|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768840|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768841|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14195459|NCT04605731|Durvalumab|durvalumab|mesh-list
14195460|NCT04605731|Ipilimumab|ipilimumab|mesh-list
14195461|NCT04605731|Tremelimumab|tremelimumab|mesh-list
14195462|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
14195463|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14195464|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
14768842|NCT00637078|Diuretics|diuretics|mesh-ancestor
14768843|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
14768844|NCT00637091|Irinotecan|irinotecan|mesh-list
14768845|NCT00637091|Cetuximab|cetuximab|mesh-list
14768846|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14939573|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939574|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939575|NCT01488656|Vitamin D|vitamin d|mesh-list
14939576|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14939577|NCT01488656|Antioxidants|antioxidants|mesh-list
14939578|NCT01488656|Vitamins|vitamins|mesh-ancestor
14939579|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
14939580|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939581|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14939582|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939583|NCT01488656|Protective Agents|protective agents|mesh-ancestor
14939584|NCT01488734|Vitamin D|vitamin d|mesh-list
14939585|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
14939586|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
14939587|NCT01488734|Vitamins|vitamins|mesh-list
14939588|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
14939589|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939590|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14195465|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14195466|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195467|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
14484370|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
14484371|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
14484372|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484373|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484374|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484375|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
14484376|NCT02557035|Hormones|hormones|mesh-ancestor
14484377|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14484378|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14484379|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484380|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14484381|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14484382|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
14484383|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484384|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484385|NCT02557100|Adalimumab|adalimumab|mesh-list
14484386|NCT02557100|Methotrexate|methotrexate|mesh-list
14484387|NCT02557100|Abatacept|abatacept|mesh-list
14484388|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14484389|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
14484390|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14484391|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484392|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14484393|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
14484394|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484395|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484396|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484397|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484398|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14484399|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484400|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
14484401|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195468|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195469|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14195470|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195471|NCT04604938|Losartan|losartan|mesh-list
14195472|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14195473|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14484402|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14484403|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484404|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14484405|NCT02557646|Ribavirin|ribavirin|mesh-list
14484406|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14484407|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
14484408|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484409|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
14484410|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484411|NCT02558231|Selexipag|selexipag|mesh-list
14484412|NCT02558231|Tadalafil|tadalafil|mesh-list
14484413|NCT02558231|Macitentan|macitentan|mesh-list
14484414|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
14484415|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14484416|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14484417|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484418|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484419|NCT02558231|Urological Agents|urological agents|mesh-ancestor
14484420|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14484421|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14484422|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14484423|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14484424|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
14484425|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484426|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484427|NCT02558374|Timolol|timolol|mesh-list
14768847|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14195474|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14195475|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14195476|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195477|NCT04604756|Losartan|losartan|mesh-list
14195478|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14195479|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14195480|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14195481|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14195482|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195483|NCT04604886|Dobutamine|dobutamine|mesh-list
14195484|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14195485|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
14195486|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
14195487|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195488|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484428|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14484429|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14484430|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14484431|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14484432|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
14484433|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484434|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484435|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484436|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14484437|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14527407|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14527408|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
14527409|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
14527410|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
14527411|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14527412|NCT04018664|Nalbuphine|nalbuphine|mesh-list
14527413|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14527414|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14527415|NCT04018664|Narcotics|narcotics|mesh-ancestor
14527416|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527417|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527418|NCT04018664|Analgesics|analgesics|mesh-ancestor
14527419|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
14527420|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527421|NCT04027803|Eculizumab|eculizumab|mesh-list
14527422|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14527423|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14527424|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
14527425|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527426|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
14527427|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14527428|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527429|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
14527430|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
14527431|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14527432|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
14527433|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527434|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527435|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14527436|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
14527437|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
14527438|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14527439|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527440|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527441|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527442|NCT04009577|Lemborexant|lemborexant|mesh-list
14527443|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14527444|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527445|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527446|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14527447|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14527448|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527449|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527450|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
14527451|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
14527452|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527453|NCT03995680|Mebendazole|mebendazole|mesh-list
14527454|NCT03995680|Piperazine|piperazine|mesh-list
14527455|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
14527456|NCT03995680|DMP 777|dmp 777|mesh-list
14527457|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
14527458|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
14527459|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14527460|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527461|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
14527462|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
14527463|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
14527464|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527465|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527466|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527467|NCT04005404|Ropivacaine|ropivacaine|mesh-list
14527468|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527469|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
14527470|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527471|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484438|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14484439|NCT02558400|Latanoprost|latanoprost|mesh-list
14484440|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14484441|NCT02558829|Insulin|insulin|mesh-list
14484442|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14484443|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484444|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484445|NCT02558894|Durvalumab|durvalumab|mesh-list
14484446|NCT02558894|Tremelimumab|tremelimumab|mesh-list
14484447|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14484448|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14939591|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14939592|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14484449|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484450|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
14484451|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484452|NCT02559206|Linaclotide|linaclotide|mesh-list
14484453|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14484454|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
14484455|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484456|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484457|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
14484458|NCT02559310|Linezolid|linezolid|mesh-list
14484459|NCT02559310|Lefamulin|lefamulin|mesh-list
14484460|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14484461|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484462|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14484463|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14484464|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484465|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484466|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484467|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14484468|NCT02559414|Aspirin|aspirin|mesh-list
14484469|NCT02559414|Clopidogrel|clopidogrel|mesh-list
14484470|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14484471|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14484472|NCT02559414|Analgesics|analgesics|mesh-ancestor
14484473|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
14484474|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484475|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484476|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484477|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484478|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14484479|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14484480|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484481|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14484482|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14484483|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484484|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
14484485|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14484486|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14768848|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768849|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768850|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768851|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14768852|NCT00637104|Chromium|chromium|mesh-list
14768853|NCT00637104|Trace Elements|trace elements|mesh-ancestor
14768854|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
14768855|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768856|NCT00637117|Interferons|interferons|mesh-list
14768857|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
14768858|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768859|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
14768860|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768861|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
14768862|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768863|NCT00637143|Cyclosporine|cyclosporine|mesh-list
14768864|NCT00637143|Tacrolimus|tacrolimus|mesh-list
14768865|NCT00637143|Cyclosporins|cyclosporins|mesh-list
14768866|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14768867|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
14768868|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768869|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14768870|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768871|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484487|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14484488|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
14484489|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484490|NCT02559505|Vaccines|vaccines|mesh-list
14484491|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
14484492|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484493|NCT02559570|Linaclotide|linaclotide|mesh-list
14484494|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14484495|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
14484496|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484497|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484498|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14768872|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
14768873|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14768874|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14768875|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14768876|NCT00637182|Anastrozole|anastrozole|mesh-list
14768877|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768878|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768879|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14768880|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14768881|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768882|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768883|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14768884|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
14768885|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14768886|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768887|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
14768888|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
14768889|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14768890|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14768891|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14768892|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768893|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14768894|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14768895|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
14768896|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14768897|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14768898|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
14768899|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768900|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768901|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768902|NCT00637325|Trastuzumab|trastuzumab|mesh-list
14768903|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14768904|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768905|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
14768906|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14768907|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768908|NCT00637403|Megestrol|megestrol|mesh-list
14768909|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
14768910|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14768911|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14768912|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14768913|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
14768914|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14768915|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768916|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14768917|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14768918|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14768919|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768920|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
14768921|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14768922|NCT00637442|Galantamine|galantamine|mesh-list
14768923|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14768924|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768925|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768926|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
14768927|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768928|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768929|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14768930|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
14484499|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
14484500|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484501|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
14484502|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14484503|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484504|NCT02559713|Vedolizumab|vedolizumab|mesh-list
14484505|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484506|NCT02559817|Linaclotide|linaclotide|mesh-list
14484507|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14484508|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
14484509|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484510|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484511|NCT02560012|Sirolimus|sirolimus|mesh-list
14484512|NCT02560012|Everolimus|everolimus|mesh-list
14484513|NCT02560012|Sorafenib|sorafenib|mesh-list
14484514|NCT02560012|Sunitinib|sunitinib|mesh-list
14484515|NCT02560012|Axitinib|axitinib|mesh-list
14484516|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484517|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484518|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
14484519|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484520|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14484521|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484522|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484523|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14484524|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14484525|NCT02560012|Growth Substances|growth substances|mesh-ancestor
14484526|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
14484527|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14484528|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484529|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14484530|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
14484531|NCT02560025|Cytarabine|cytarabine|mesh-list
14484532|NCT02560025|Daunorubicin|daunorubicin|mesh-list
14484533|NCT02560025|Idarubicin|idarubicin|mesh-list
14484534|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14484535|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
14484536|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484537|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484538|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
14484539|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484540|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484541|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
14484542|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484543|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14484544|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14484545|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14484546|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484547|NCT02560038|Gemcitabine|gemcitabine|mesh-list
14484548|NCT02560038|Paclitaxel|paclitaxel|mesh-list
14768931|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768932|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
14768933|NCT00637455|Fexofenadine|fexofenadine|mesh-list
14768934|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14768935|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14768936|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14768937|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
14768938|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
14768939|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768940|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768941|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768942|NCT00637468|Aspirin|aspirin|mesh-list
14768943|NCT00637468|Heparin|heparin|mesh-list
14768944|NCT00637468|Acetazolamide|acetazolamide|mesh-list
14768945|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14768946|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
14768947|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14768948|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14768949|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768950|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14768951|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14768952|NCT00637468|Analgesics|analgesics|mesh-ancestor
14768953|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
14768954|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768955|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768956|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14768957|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484549|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14484550|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484551|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484552|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484553|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14484554|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484555|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14484556|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
14484557|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
14484558|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484559|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484560|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484561|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
14484562|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484563|NCT02560051|Ketoconazole|ketoconazole|mesh-list
14484564|NCT02560051|Docetaxel|docetaxel|mesh-list
14484565|NCT02560051|Doxorubicin|doxorubicin|mesh-list
14484566|NCT02560051|Estramustine|estramustine|mesh-list
14484567|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195489|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14195490|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14195491|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14195492|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14195493|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195494|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195495|NCT04604886|Protective Agents|protective agents|mesh-ancestor
14195496|NCT04604678|Metformin|metformin|mesh-list
14195497|NCT04604678|Naltrexone|naltrexone|mesh-list
14195498|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14195499|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195500|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14195501|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14195502|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
14195503|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195504|NCT04604795|Itraconazole|itraconazole|mesh-list
14195505|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
14195506|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195507|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14195508|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14195509|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195510|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195511|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14195512|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
14195513|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195514|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195515|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14195516|NCT04604704|Niacinamide|niacinamide|mesh-list
14195517|NCT04604704|Naltrexone|naltrexone|mesh-list
14195518|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14195519|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14484568|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484569|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484570|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
14484571|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484572|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14484573|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14484574|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14484575|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484576|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
14484577|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484578|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14484579|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14484580|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14484581|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
14484582|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14484583|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484584|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14195520|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484585|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14768958|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14768959|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14768960|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768961|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
14768962|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
14768963|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14484586|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
14484587|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14484588|NCT02560389|Levodopa|levodopa|mesh-list
14484589|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14484590|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14484591|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
14484592|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484593|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484594|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195521|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
14484595|NCT02560558|Abatacept|abatacept|mesh-list
14484596|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14484597|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484598|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484599|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484600|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
14484601|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484602|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484603|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14484604|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14484605|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484606|NCT02560779|Sorafenib|sorafenib|mesh-list
14484607|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484608|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14484609|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484610|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484611|NCT02561078|Insulin|insulin|mesh-list
14484612|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14484613|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484614|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484615|NCT02561130|Metformin|metformin|mesh-list
14484616|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
14484617|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
14484618|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484619|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484620|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14768964|NCT00637468|Diuretics|diuretics|mesh-ancestor
14768965|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
14768966|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14768967|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
14768968|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768969|NCT00637481|Atorvastatin|atorvastatin|mesh-list
14768970|NCT00637481|Calcium|calcium|mesh-list
14768971|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14768972|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768973|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14768974|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14768975|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
14768976|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768977|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14768978|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14768979|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768980|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
14195522|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195523|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
14195524|NCT04604704|Vitamins|vitamins|mesh-ancestor
14195525|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
14195526|NCT04604509|Bupropion|bupropion|mesh-list
14195527|NCT04604509|Nicotine|nicotine|mesh-list
14195528|NCT04604509|Varenicline|varenicline|mesh-list
14195529|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14195530|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
14195531|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195532|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195533|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14195534|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14195535|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
14195536|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195537|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195538|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14195539|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
14195540|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14195541|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14195542|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14195543|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14195544|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
14195545|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14195546|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14195547|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484621|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484622|NCT02561273|Prednisone|prednisone|mesh-list
14484623|NCT02561273|Cortisone|cortisone|mesh-list
14484624|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
14484625|NCT02561273|Doxorubicin|doxorubicin|mesh-list
14484626|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14484627|NCT02561273|Etoposide|etoposide|mesh-list
14484628|NCT02561273|Vincristine|vincristine|mesh-list
14484629|NCT02561273|Lenalidomide|lenalidomide|mesh-list
14484630|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
14484631|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
14484632|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484633|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
14484634|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484635|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484636|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14484637|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
14484638|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484639|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484640|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14484641|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14484642|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14484643|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14484644|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195548|NCT04604366|Alprostadil|alprostadil|mesh-list
14195549|NCT04604366|Misoprostol|misoprostol|mesh-list
14195550|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14195551|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
14195552|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14195553|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484645|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484646|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
14939593|NCT01488773|Montelukast|montelukast|mesh-list
14939594|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14939595|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
14484647|NCT02561273|Hormones|hormones|mesh-ancestor
14484648|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14484649|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14484650|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14484651|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484652|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484653|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
14484654|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14484655|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14484656|NCT02561273|Growth Substances|growth substances|mesh-ancestor
14484657|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
14484658|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
14484659|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484660|NCT02561481|Sulforaphane|sulforaphane|mesh-list
14484661|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14484662|NCT02561481|Protective Agents|protective agents|mesh-ancestor
14195554|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14195555|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195556|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
14195557|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14195558|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
14195559|NCT04604366|Urological Agents|urological agents|mesh-ancestor
14195560|NCT04604327|Bemiparin|bemiparin|mesh-list
14195561|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
14195562|NCT04604223|Pioglitazone|pioglitazone|mesh-list
14195563|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14195564|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195565|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
14195566|NCT04604028|Lenalidomide|lenalidomide|mesh-list
14484663|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484664|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484665|NCT02561702|Mexiletine|mexiletine|mesh-list
14484666|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14484667|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14484668|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14484669|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14484670|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195567|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939596|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939597|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939598|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14939599|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14939600|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14939601|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14939602|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14939603|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
14939604|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939605|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195568|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
14939606|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14939607|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14939608|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14939609|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14195569|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195570|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195571|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14195572|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
14195573|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195574|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939610|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15026635|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026636|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484671|NCT02561806|Ustekinumab|ustekinumab|mesh-list
14484672|NCT02561806|Ixekizumab|ixekizumab|mesh-list
14484673|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484674|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
14484675|NCT02561832|Carboplatin|carboplatin|mesh-list
14484676|NCT02561832|Olaparib|olaparib|mesh-list
14484677|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484678|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
14484679|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484680|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484681|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14484682|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
14484683|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484684|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484685|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14484686|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14484687|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484688|NCT02561897|Warfarin|warfarin|mesh-list
14484689|NCT02561897|Edoxaban|edoxaban|mesh-list
14484690|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
14484691|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14484692|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
14484693|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14484694|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484695|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484696|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484697|NCT02562066|Amifampridine|amifampridine|mesh-list
14484698|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14484699|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484700|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484701|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14484702|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14484703|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484704|NCT02562521|Nicotine|nicotine|mesh-list
14484705|NCT02562521|Varenicline|varenicline|mesh-list
14484706|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14484707|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
14484708|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484709|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195575|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14195576|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14484710|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14195577|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14195578|NCT04604028|Growth Substances|growth substances|mesh-ancestor
14195579|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
14195580|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14195581|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14195582|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484711|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14484712|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
14484713|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484714|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484715|NCT02562755|Sorafenib|sorafenib|mesh-list
14484716|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484717|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14484718|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484719|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484720|NCT02562898|Gemcitabine|gemcitabine|mesh-list
14484721|NCT02562898|Paclitaxel|paclitaxel|mesh-list
14484722|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14484723|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484724|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484725|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484726|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14484727|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484728|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14484729|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
14484730|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
14484731|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484732|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484733|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484734|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
14484735|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484736|NCT02562924|Prednisone|prednisone|mesh-list
14484737|NCT02562924|Budesonide|budesonide|mesh-list
14484738|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484739|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
14484740|NCT02562924|Hormones|hormones|mesh-ancestor
14484741|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14484742|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484743|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14484744|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14768981|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14768982|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14768983|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14768984|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14768985|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768986|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
14768987|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14768988|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14768989|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14768990|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14768991|NCT00637559|Esomeprazole|esomeprazole|mesh-list
14768992|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14768993|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14768994|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14768995|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14768996|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14768997|NCT00637585|Fexofenadine|fexofenadine|mesh-list
14195583|NCT04603729|Dexamethasone|dexamethasone|mesh-list
14195584|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
14195585|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14195586|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14195587|NCT04603729|Prednisolone|prednisolone|mesh-list
14195588|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
14195589|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14195590|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
14195591|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195592|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
14195593|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
14195594|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195595|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195596|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195597|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
14195598|NCT04603729|Hormones|hormones|mesh-ancestor
14195599|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195600|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14195601|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195602|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14195603|NCT04603729|Protective Agents|protective agents|mesh-ancestor
14195604|NCT04603976|Erenumab|erenumab|mesh-list
14195605|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14195606|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195607|NCT04603976|Analgesics|analgesics|mesh-ancestor
14484745|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14484746|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
14484747|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484748|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14484749|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
14484750|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
14484751|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14484752|NCT02563067|Growth Substances|growth substances|mesh-ancestor
14768998|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14768999|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14769000|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14769001|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
14769002|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
14769003|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769004|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769005|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769006|NCT00637611|Fexofenadine|fexofenadine|mesh-list
14769007|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14769008|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14769009|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14769010|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
14769011|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
14769012|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769013|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769014|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769015|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
14769016|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14769017|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
14769018|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769019|NCT00637624|Expectorants|expectorants|mesh-ancestor
14769020|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
14769021|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14769022|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
14769023|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484753|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484754|NCT02563093|Vaccines|vaccines|mesh-list
14484755|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
14484756|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484757|NCT02563496|Chloroquine|chloroquine|mesh-list
14484758|NCT02563496|Tafenoquine|tafenoquine|mesh-list
14484759|NCT02563496|Amebicides|amebicides|mesh-ancestor
14484760|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14484761|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14939611|NCT01488838|Cisplatin|cisplatin|mesh-list
14939612|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939613|NCT01488955|Fosfomycin|fosfomycin|mesh-list
14939614|NCT01488955|Ibuprofen|ibuprofen|mesh-list
14939615|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14939616|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939617|NCT01488955|Analgesics|analgesics|mesh-ancestor
14939618|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
14939619|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939620|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939621|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939622|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939623|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14939624|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939625|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484762|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484763|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
14484764|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484765|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
14484766|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14484767|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484768|NCT02563561|Apaziquone|apaziquone|mesh-list
14484769|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484770|NCT02563834|Insulin|insulin|mesh-list
14939626|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14484771|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484772|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484773|NCT02563860|Lovastatin|lovastatin|mesh-list
14484774|NCT02563860|L 647318|l 647318|mesh-list
14484775|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
14484776|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14484777|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14484778|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
14484779|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484780|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14484781|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14484782|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484783|NCT02564029|Lorazepam|lorazepam|mesh-list
14484784|NCT02564029|PF-06372865|pf-06372865|mesh-list
14484785|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
14195608|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
14195609|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195610|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195611|NCT04603833|Docetaxel|docetaxel|mesh-list
14484786|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
14484787|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
14484788|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484789|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484790|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484791|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14484792|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14484793|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14484794|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14484795|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14484796|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
14769024|NCT00637624|Protective Agents|protective agents|mesh-ancestor
14769025|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769026|NCT00637624|Antidotes|antidotes|mesh-ancestor
14769027|NCT00637637|Ritonavir|ritonavir|mesh-list
14195612|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195613|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
14195614|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
14195615|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
14195616|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195617|NCT04603872|Dasatinib|dasatinib|mesh-list
14195618|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195619|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14195620|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195621|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484797|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
14484798|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769028|NCT00637637|Indinavir|indinavir|mesh-list
14769029|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14769030|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14769031|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
14769032|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769033|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769034|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13963647|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963648|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13963649|NCT03143010|Analgesics|analgesics|mesh-ancestor
14769035|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14769036|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
14769037|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769038|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14769039|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963650|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
13963651|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963652|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13963653|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13963654|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13963655|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
13963656|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484799|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484800|NCT02564198|Ramucirumab|ramucirumab|mesh-list
14484801|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484802|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14484803|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
14484804|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484805|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484806|NCT02564211|Incretins|incretins|mesh-ancestor
14484807|NCT02564211|Hormones|hormones|mesh-ancestor
14484808|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14484809|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14484810|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484811|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484812|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484813|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14484814|NCT02564471|Doxycycline|doxycycline|mesh-list
14484815|NCT02564471|Chloroquine|chloroquine|mesh-list
14484816|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14484817|NCT02564471|Atovaquone|atovaquone|mesh-list
14484818|NCT02564471|Proguanil|proguanil|mesh-list
14484819|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14484820|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484821|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
14484822|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14484823|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14484824|NCT02564471|Amebicides|amebicides|mesh-ancestor
14484825|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484826|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14484827|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14484828|NCT02564471|Analgesics|analgesics|mesh-ancestor
14484829|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
14484830|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484831|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484832|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484833|NCT02564471|Filaricides|filaricides|mesh-ancestor
14484834|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
14484835|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
14484836|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484837|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484838|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
14484839|NCT02564497|Abatacept|abatacept|mesh-list
14484840|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14484841|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484842|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484843|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484844|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
14484845|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484846|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484847|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
14484848|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14195622|NCT04603924|Niclosamide|niclosamide|mesh-list
14195623|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
14195624|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14195625|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
14195626|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14195627|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195628|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
14195629|NCT04603937|Aflibercept|aflibercept|mesh-list
14195630|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14195631|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14195632|NCT04603937|Growth Substances|growth substances|mesh-ancestor
14195633|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195634|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
14195635|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195636|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
14195637|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14484849|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
14484850|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14484851|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484852|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484853|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484854|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
14769040|NCT00637663|Lamivudine|lamivudine|mesh-list
14769041|NCT00637663|Entecavir|entecavir|mesh-list
14195638|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
14484855|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
14484856|NCT02564926|Glimepiride|glimepiride|mesh-list
14769042|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14484857|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14484858|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484859|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14484860|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484861|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14484862|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484863|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
14484864|NCT02564952|Cannabidiol|cannabidiol|mesh-list
14484865|NCT02564952|Clobazam|clobazam|mesh-list
14484866|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
14484867|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14484868|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14484869|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14484870|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484871|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14484872|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14484873|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
14484874|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
14484875|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484876|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484877|NCT02565108|Cannabidiol|cannabidiol|mesh-list
14484878|NCT02565108|Clobazam|clobazam|mesh-list
14484879|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
14484880|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14484881|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14484882|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14484883|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484884|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14484885|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14484886|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
14484887|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
14484888|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484889|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484890|NCT02565147|Heparin|heparin|mesh-list
14484891|NCT02565147|Bivalirudin|bivalirudin|mesh-list
14484892|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
14484893|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14484894|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14484895|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484896|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
14484897|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14484898|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14484899|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484900|NCT02565186|Lasmiditan|lasmiditan|mesh-list
14484901|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14484902|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
14769043|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14769044|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769045|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484903|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484904|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484905|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484906|NCT02565381|Nicotine|nicotine|mesh-list
14195639|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14195640|NCT04603794|Povidone|povidone|mesh-list
14195641|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14195642|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195643|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
14484907|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14484908|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
14484909|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484910|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484911|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14484912|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14484913|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
14484914|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484915|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484916|NCT02565511|CNP520|cnp520|mesh-list
14769046|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
14195644|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195645|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
14195646|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
14195647|NCT04603664|Cystatins|cystatins|mesh-list
14195648|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14195649|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
14195650|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484917|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14484918|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484919|NCT02565628|PF-06669571|pf-06669571|mesh-list
14484920|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
14484921|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
14484922|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195651|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195652|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
14195653|NCT04603508|Empagliflozin|empagliflozin|mesh-list
14195654|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14195655|NCT04603508|Calcium|calcium|mesh-list
14195656|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14195657|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195658|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14195659|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14195660|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14195661|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
14195662|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195663|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14195664|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14195665|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195666|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14195667|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14195668|NCT04603573|Listerine|listerine|mesh-list
14195669|NCT04603573|Fluorides|fluorides|mesh-list
14195670|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
14195671|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
14195672|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
14195673|NCT04603573|Protective Agents|protective agents|mesh-ancestor
14484923|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484924|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484925|NCT02565810|Adalimumab|adalimumab|mesh-list
14484926|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14484927|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484928|NCT02565901|Sirolimus|sirolimus|mesh-list
14484929|NCT02565901|Carboplatin|carboplatin|mesh-list
14484930|NCT02565901|Docetaxel|docetaxel|mesh-list
14484931|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484932|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14484933|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14484934|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14484935|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484936|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14484937|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14484938|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14484939|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
14484940|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484941|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
14484942|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484943|NCT02565914|Ivacaftor|ivacaftor|mesh-list
14484944|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14484945|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14484946|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484947|NCT02566005|Misoprostol|misoprostol|mesh-list
14484948|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14484949|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
14484950|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14484951|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484952|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14484953|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484954|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
14484955|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
14484956|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
14484957|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14484958|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
14484959|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14484960|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484961|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14484962|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
14484963|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
14484964|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14484965|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
14484966|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484967|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484968|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14195674|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195675|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14195676|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195677|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
14195678|NCT04603456|Antacids|antacids|mesh-ancestor
14195679|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14484969|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14527472|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
14527473|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527474|NCT03993288|Iron|iron|mesh-list
14527475|NCT03993288|Trace Elements|trace elements|mesh-ancestor
14527476|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
14527477|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527478|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
14527479|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14527480|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527481|NCT03978832|Risperidone|risperidone|mesh-list
14527482|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14527483|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
14527484|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527485|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527486|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527487|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14527488|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14527489|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527490|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14527491|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14527492|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
14527493|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14527494|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
14527495|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
14527496|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
14527497|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14527498|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527499|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14527500|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14527501|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14195680|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195681|NCT04603131|Vaccines|vaccines|mesh-list
14195682|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
14195683|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238429|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
14238430|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238431|NCT00131469|Teriparatide|teriparatide|mesh-list
14238432|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14238433|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238434|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14238435|NCT00131664|Metformin|metformin|mesh-list
14238436|NCT00131664|Glimepiride|glimepiride|mesh-list
14238437|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
14238438|NCT00131664|Maleic acid|maleic acid|mesh-list
14238439|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14238440|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238441|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527502|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14527503|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14527504|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14527505|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14527506|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529964|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14529965|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529966|NCT03455556|Atezolizumab|atezolizumab|mesh-list
14529967|NCT03455556|Maytansine|maytansine|mesh-list
14529968|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14529969|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14484970|NCT02566369|Trifarotene|trifarotene|mesh-list
14769047|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769048|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14769049|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14769050|NCT00637715|Alfuzosin|alfuzosin|mesh-list
14769051|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14769052|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14769053|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14769054|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14484971|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484972|NCT02566889|Infliximab|infliximab|mesh-list
14484973|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
14484974|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484975|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484976|NCT02566902|Albuterol|albuterol|mesh-list
14484977|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14484978|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
14484979|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769055|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769056|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195684|NCT04603066|Ondansetron|ondansetron|mesh-list
14195685|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
14195686|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
14195687|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195688|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769057|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769058|NCT00637715|Urological Agents|urological agents|mesh-ancestor
14769059|NCT00637767|Melphalan|melphalan|mesh-list
14769060|NCT00637767|Antibodies|antibodies|mesh-list
14769061|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14769062|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
14769063|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769064|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14769065|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
14769066|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769067|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769068|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14769069|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769070|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
14769071|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14769072|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14769073|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
14769074|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769075|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769076|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769077|NCT00637819|Leflunomide|leflunomide|mesh-list
14769078|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769079|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769080|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769081|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
14769082|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769083|NCT00637845|Esomeprazole|esomeprazole|mesh-list
14769084|NCT00637845|Lansoprazole|lansoprazole|mesh-list
14769085|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
14769086|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14769087|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14769088|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14769089|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769090|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939627|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195689|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14484980|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769091|NCT00637858|Lycopene|lycopene|mesh-list
14769092|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769093|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
14769094|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769095|NCT00637858|Protective Agents|protective agents|mesh-ancestor
14939628|NCT01489059|Ipilimumab|ipilimumab|mesh-list
14195690|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
14195691|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195692|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14195693|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
14195694|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195695|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195696|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14195697|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14195698|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195699|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14195700|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14195701|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
14195702|NCT04602754|Empagliflozin|empagliflozin|mesh-list
14484981|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14484982|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
14484983|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
14484984|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14484985|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14484986|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14484987|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14484988|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
14484989|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14484990|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939629|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14939630|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939631|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14939632|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939633|NCT01489072|Remifentanil|remifentanil|mesh-list
14939634|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14939635|NCT01489072|Narcotics|narcotics|mesh-ancestor
14939636|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939637|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939638|NCT01489072|Analgesics|analgesics|mesh-ancestor
13963657|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963658|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13963659|NCT03142776|Clarithromycin|clarithromycin|mesh-list
13963660|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963661|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13963662|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963663|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963664|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13963665|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963666|NCT03142880|Ropivacaine|ropivacaine|mesh-list
13963667|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
13963668|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
13963669|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963670|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195703|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14195704|NCT04602754|Calcium|calcium|mesh-list
14195705|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14195706|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195707|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14195708|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14195709|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14484991|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
14484992|NCT02566993|Doxorubicin|doxorubicin|mesh-list
14484993|NCT02566993|Vincristine|vincristine|mesh-list
14484994|NCT02566993|Topotecan|topotecan|mesh-list
14484995|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14484996|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
14484997|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14484998|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14484999|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14485000|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
14485001|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485002|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485003|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14485004|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14485005|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14485006|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14485007|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485008|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14485009|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14485010|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14485011|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14485012|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14485013|NCT02567552|Progesterone|progesterone|mesh-list
14485014|NCT02567552|Progestins|progestins|mesh-ancestor
14485015|NCT02567552|Hormones|hormones|mesh-ancestor
14485016|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485017|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485018|NCT02567656|Tenalisib|tenalisib|mesh-list
14485019|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
14485020|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485021|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485022|NCT02567708|Nemiralisib|nemiralisib|mesh-list
14485023|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485024|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485025|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485026|NCT02567968|Caffeine|caffeine|mesh-list
14485027|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
14195710|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
14195711|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195712|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14195713|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14195714|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195715|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14485028|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485029|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14527507|NCT04004481|Morphine|morphine|mesh-list
14769096|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769097|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14769098|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14769099|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769100|NCT00637871|Tamoxifen|tamoxifen|mesh-list
14769101|NCT00637871|Bicalutamide|bicalutamide|mesh-list
14769102|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14769103|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
14769104|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14769105|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769106|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14769107|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769108|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14769109|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14769110|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14769111|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
14769112|NCT00637884|Fexofenadine|fexofenadine|mesh-list
14769113|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14769114|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14769115|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14769116|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
14769117|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
14769118|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195716|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14195717|NCT04602767|Phenylephrine|phenylephrine|mesh-list
14195718|NCT04602767|Vasopressins|vasopressins|mesh-list
14195719|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
14195720|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
14195721|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14195722|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
14769119|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769120|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769121|NCT00637897|Paclitaxel|paclitaxel|mesh-list
14769122|NCT00637897|Docetaxel|docetaxel|mesh-list
14195723|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
14527508|NCT04004481|Tramadol|tramadol|mesh-list
14527509|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14527510|NCT04004481|Narcotics|narcotics|mesh-ancestor
14527511|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527512|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527513|NCT04004481|Analgesics|analgesics|mesh-ancestor
14527514|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
14527515|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527516|NCT03997851|Acetaminophen|acetaminophen|mesh-list
14527517|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14527518|NCT03997851|Analgesics|analgesics|mesh-ancestor
14527519|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
14527520|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527521|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527522|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
14527523|NCT03996694|Oxycodone|oxycodone|mesh-list
14527524|NCT03996694|Buprenorphine|buprenorphine|mesh-list
14527525|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14527526|NCT03996694|Narcotics|narcotics|mesh-ancestor
14527527|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485030|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485031|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14485032|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485033|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14485034|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14485035|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
14485036|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485037|NCT02568046|Leucovorin|leucovorin|mesh-list
14485038|NCT02568046|Fluorouracil|fluorouracil|mesh-list
14485039|NCT02568046|Irinotecan|irinotecan|mesh-list
14485040|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
14485041|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485042|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14485043|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485044|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14485045|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
14485046|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485047|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14485048|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14485049|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485050|NCT02568046|Antidotes|antidotes|mesh-ancestor
14485051|NCT02568046|Protective Agents|protective agents|mesh-ancestor
14485052|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
14485053|NCT02568046|Vitamins|vitamins|mesh-ancestor
14485054|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
14769123|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14769124|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14769125|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769126|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
14769127|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
14769128|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
14769129|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769130|NCT00637910|Docetaxel|docetaxel|mesh-list
14769131|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14769132|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769133|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14769134|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14939639|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
14939640|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939641|NCT01489124|Imipenem|imipenem|mesh-list
14939642|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14939643|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939644|NCT01489137|Remifentanil|remifentanil|mesh-list
14939645|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14939646|NCT01489137|Narcotics|narcotics|mesh-ancestor
14939647|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939648|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939649|NCT01489137|Analgesics|analgesics|mesh-ancestor
14939650|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
14939651|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939652|NCT01489176|Regadenoson|regadenoson|mesh-list
14939653|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14939654|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14939655|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
14939656|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
14939657|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939658|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939659|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939660|NCT01489202|Cobalt|cobalt|mesh-list
14939661|NCT01489202|Chromium|chromium|mesh-list
14939662|NCT01489202|Everolimus|everolimus|mesh-list
14195724|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195725|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195726|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
14195727|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14195728|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
14195729|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
14195730|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14195731|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14195732|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14195733|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
14195734|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485055|NCT02568397|Dabigatran|dabigatran|mesh-list
14939663|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195735|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195736|NCT04602767|Protective Agents|protective agents|mesh-ancestor
14195737|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
14195738|NCT04602767|Coagulants|coagulants|mesh-ancestor
14195739|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14485056|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
14485057|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14485058|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485059|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485060|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485061|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
14485062|NCT02568644|Ketoprofen|ketoprofen|mesh-list
14485063|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14485064|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14485065|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14485066|NCT02568644|Analgesics|analgesics|mesh-ancestor
14485067|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
14485068|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485069|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485070|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14485071|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14485072|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485073|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485074|NCT02568683|Vincristine|vincristine|mesh-list
14485075|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14485076|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485077|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
14485078|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
14485079|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
14485080|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485081|NCT02568852|Anesthetics|anesthetics|mesh-list
14485082|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485083|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485084|NCT02569437|Fluticasone|fluticasone|mesh-list
14485085|NCT02569437|Doxycycline|doxycycline|mesh-list
14485086|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
14485087|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14485088|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14485089|NCT02569437|Prednisolone|prednisolone|mesh-list
14485090|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
14485091|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14485092|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
14485093|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485094|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
14485095|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
14485096|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769135|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14769136|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769137|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14769138|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769139|NCT00637949|Rofecoxib|rofecoxib|mesh-list
14769140|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
14769141|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14769142|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14195740|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
14195741|NCT04602273|Azacitidine|azacitidine|mesh-list
14485097|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485098|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14485099|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
14485100|NCT02569437|Hormones|hormones|mesh-ancestor
14485101|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485102|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14485103|NCT02569437|Protective Agents|protective agents|mesh-ancestor
14485104|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485105|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485106|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14485107|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485108|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
14485109|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14485110|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14195742|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14195743|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
14769143|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195744|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195745|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485111|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14485112|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14485113|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485114|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14485115|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14485116|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
14485117|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14485118|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485119|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14485120|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485121|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485122|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
14485123|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14485124|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14485125|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485126|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
14485127|NCT02569658|Coagulants|coagulants|mesh-ancestor
14485128|NCT02569710|Simeprevir|simeprevir|mesh-list
14485129|NCT02569710|Odalasvir|odalasvir|mesh-list
14485130|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
14485131|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485132|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485133|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485134|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485135|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
14485136|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485137|NCT02569801|Fulvestrant|fulvestrant|mesh-list
14485138|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485139|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485140|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14485141|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14485142|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
14485143|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485144|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485145|NCT02569996|Rituximab|rituximab|mesh-list
14485146|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485147|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485148|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
14485149|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485150|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14485151|NCT02570022|Bupivacaine|bupivacaine|mesh-list
14485152|NCT02570022|Ropivacaine|ropivacaine|mesh-list
14485153|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
14485154|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
14485155|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485156|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485157|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
14485158|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485159|NCT02570074|Fosfomycin|fosfomycin|mesh-list
14485160|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14485161|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485162|NCT02570139|Protective Agents|protective agents|mesh-list
14485163|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485164|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14485165|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14485166|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485167|NCT02570711|Gemcitabine|gemcitabine|mesh-list
14485168|NCT02570711|Paclitaxel|paclitaxel|mesh-list
14485169|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
14485170|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14485171|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485172|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14485173|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14485174|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
14485175|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485176|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14485177|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
14485178|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
14485179|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485180|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485181|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14485182|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
14485183|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485184|NCT02571049|Sumatriptan|sumatriptan|mesh-list
14485185|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14195746|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195747|NCT04602247|Fesoterodine|fesoterodine|mesh-list
14769144|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769145|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769146|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769147|NCT00637949|Analgesics|analgesics|mesh-ancestor
14769148|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
14769149|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769150|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769151|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769152|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939664|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939665|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
14939666|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939667|NCT01489202|Trace Elements|trace elements|mesh-ancestor
14939668|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
14939669|NCT01489228|Benzonidazole|benzonidazole|mesh-list
14939670|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939671|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
14939672|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939673|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14939674|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14939675|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14939676|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939677|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14939678|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
14939679|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14939680|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939681|NCT01489319|Analgesics|analgesics|mesh-ancestor
14939682|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
14939683|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939684|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939685|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939686|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939687|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14939688|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939689|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939690|NCT01489371|Doxorubicin|doxorubicin|mesh-list
14939691|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14939692|NCT01489371|Interleukin-12|interleukin-12|mesh-list
14195748|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14195749|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14195750|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
14195751|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195752|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195753|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195754|NCT04602247|Urological Agents|urological agents|mesh-ancestor
14195755|NCT04602026|Coal Tar|coal tar|mesh-list
14195756|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
14195757|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195758|NCT04602143|Testosterone|testosterone|mesh-list
14195759|NCT04602143|Androgens|androgens|mesh-ancestor
14939693|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14939694|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195760|NCT04602143|Hormones|hormones|mesh-ancestor
14939695|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14242915|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14485186|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14485187|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14485188|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
14485189|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485190|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485191|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485192|NCT02571153|Ketamine|ketamine|mesh-list
14485193|NCT02571153|Analgesics|analgesics|mesh-ancestor
14485194|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
14485195|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485196|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485197|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14485198|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14485199|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
14485200|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
14485201|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485202|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14485203|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14485204|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485205|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485206|NCT02571439|Ropivacaine|ropivacaine|mesh-list
14485207|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
14485208|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
14485209|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485210|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485211|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
14485212|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485213|NCT02571634|Fentanyl|fentanyl|mesh-list
14485214|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14485215|NCT02571634|Narcotics|narcotics|mesh-ancestor
14485216|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485217|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485218|NCT02571634|Analgesics|analgesics|mesh-ancestor
14485219|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
14485220|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485221|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14485222|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14485223|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
14485224|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
14485225|NCT02571777|Fluticasone|fluticasone|mesh-list
14485226|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14485227|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485228|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14485229|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
14485230|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485231|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485232|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14485233|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485234|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14485235|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14485236|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14485237|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14485238|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14485239|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
14485240|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485241|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485242|NCT02571972|Timolol|timolol|mesh-list
14485243|NCT02571972|Dorzolamide|dorzolamide|mesh-list
14485244|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14529970|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
14529971|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529972|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14529973|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14529974|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14529975|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14529976|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529977|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
14529978|NCT03447639|Povidone|povidone|mesh-list
14529979|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
14529980|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
14529981|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14529982|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485245|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14485246|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
14485247|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485248|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485249|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485250|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14485251|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14485252|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14485253|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485254|NCT02572167|Nivolumab|nivolumab|mesh-list
14485255|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14485256|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485257|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195761|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195762|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195763|NCT04601961|Propofol|propofol|mesh-list
14195764|NCT04601961|Sevoflurane|sevoflurane|mesh-list
14485258|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14485259|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485260|NCT02572609|Ambroxol|ambroxol|mesh-list
14485261|NCT02572609|Expectorants|expectorants|mesh-ancestor
14485262|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485263|NCT02572752|Nintedanib|nintedanib|mesh-list
14485264|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485265|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485266|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769153|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
14769154|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14769155|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
14769156|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769157|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14769158|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769159|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
14769160|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769161|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
14769162|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14769163|NCT00637962|Protective Agents|protective agents|mesh-ancestor
14769164|NCT00637975|Pregabalin|pregabalin|mesh-list
14769165|NCT00637975|Oxycodone|oxycodone|mesh-list
14769166|NCT00637975|Analgesics|analgesics|mesh-ancestor
14769167|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
14769168|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769169|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769170|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
14769171|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14769172|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14769173|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769174|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14769175|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14769176|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14769177|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14769178|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14769179|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14769180|NCT00637975|Narcotics|narcotics|mesh-ancestor
14769181|NCT00637988|Aspirin|aspirin|mesh-list
14769182|NCT00637988|Rofecoxib|rofecoxib|mesh-list
14769183|NCT00637988|Esomeprazole|esomeprazole|mesh-list
14769184|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769185|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195765|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14195766|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195767|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195768|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14195769|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
14195770|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
14195771|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14195772|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14195773|NCT04602065|Antibodies|antibodies|mesh-list
14195774|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14769186|NCT00637988|Analgesics|analgesics|mesh-ancestor
14769187|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
14769188|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769189|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195775|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
14769190|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485267|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485268|NCT02573012|Prednisone|prednisone|mesh-list
14485269|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485270|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
14485271|NCT02573012|Hormones|hormones|mesh-ancestor
14485272|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485273|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485274|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485275|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485276|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
14485277|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14485278|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
14485279|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485280|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485281|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14485282|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485283|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
14485284|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14485285|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14485286|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485287|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485288|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14485289|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
14485290|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485291|NCT02573311|Tamsulosin|tamsulosin|mesh-list
14485292|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14485293|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14485294|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14485295|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
14485296|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485297|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485298|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485299|NCT02573311|Urological Agents|urological agents|mesh-ancestor
14485300|NCT02573493|Paclitaxel|paclitaxel|mesh-list
14485301|NCT02573493|Cisplatin|cisplatin|mesh-list
14485302|NCT02573493|Cetuximab|cetuximab|mesh-list
14485303|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14485304|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485305|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
14485306|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
14485307|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
14485308|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485309|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485310|NCT02573857|Artefenomel|artefenomel|mesh-list
14485311|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
14485312|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14485313|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14485314|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485315|NCT02573870|Fluticasone|fluticasone|mesh-list
14485316|NCT02573870|Xhance|xhance|mesh-list
14485317|NCT02573870|Albuterol|albuterol|mesh-list
14485318|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485319|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14485320|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
14485321|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485322|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485323|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14485324|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485325|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
14485326|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14485327|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
14485328|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14485329|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14485330|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14485331|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14485332|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
14485333|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485334|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485335|NCT02573883|Clobetasol|clobetasol|mesh-list
14939696|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14939697|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939698|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485336|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485337|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
14195776|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195777|NCT04602013|Paclitaxel|paclitaxel|mesh-list
14195778|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14195779|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14195780|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195781|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14195782|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14195783|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14195784|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195785|NCT04601688|Dexamethasone|dexamethasone|mesh-list
14195786|NCT04601688|Bevacizumab|bevacizumab|mesh-list
14195787|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14195788|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195789|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14195790|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14195791|NCT04601688|Growth Substances|growth substances|mesh-ancestor
14195792|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195793|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
14195794|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195795|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
14195796|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
14195797|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195798|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195799|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
14195800|NCT04601688|Hormones|hormones|mesh-ancestor
14195801|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485338|NCT02573883|Hormones|hormones|mesh-ancestor
14485339|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485340|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485341|NCT02574078|Gemcitabine|gemcitabine|mesh-list
14485342|NCT02574078|Paclitaxel|paclitaxel|mesh-list
14485343|NCT02574078|Docetaxel|docetaxel|mesh-list
14485344|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14485345|NCT02574078|Bevacizumab|bevacizumab|mesh-list
14195802|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485346|NCT02574078|Carboplatin|carboplatin|mesh-list
14485347|NCT02574078|Nivolumab|nivolumab|mesh-list
14485348|NCT02574078|Pemetrexed|pemetrexed|mesh-list
14485349|NCT02574078|Crizotinib|crizotinib|mesh-list
14485350|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14485351|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485352|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14485353|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14485354|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14485355|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485356|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485357|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14485358|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14485359|NCT02574078|Growth Substances|growth substances|mesh-ancestor
14939699|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14939700|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
14939701|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939702|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14939703|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14939704|NCT01489371|Growth Substances|growth substances|mesh-ancestor
14485360|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485361|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
14939705|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
14195803|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
14195804|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14195805|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14529983|NCT03426137|Ketorolac|ketorolac|mesh-list
14529984|NCT03426137|Oxycodone|oxycodone|mesh-list
14529985|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14529986|NCT03426137|Narcotics|narcotics|mesh-ancestor
14529987|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529988|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529989|NCT03426137|Analgesics|analgesics|mesh-ancestor
14529990|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
14529991|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529992|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14529993|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529994|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529995|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14529996|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14529997|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485362|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14485363|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
14485364|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
14485365|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485366|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485367|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14485368|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
14485369|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14485370|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14485371|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14485372|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485373|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14485374|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485375|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485376|NCT02574520|Bupivacaine|bupivacaine|mesh-list
14485377|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14485378|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
14485379|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
14485380|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485381|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485382|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
14485383|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485384|NCT02574598|Docetaxel|docetaxel|mesh-list
14485385|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
14485386|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485387|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
14485388|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
14485389|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
14485390|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195806|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195807|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14195808|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14195809|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
14195810|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14195811|NCT04601701|Dexamethasone|dexamethasone|mesh-list
14769191|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769192|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14769193|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14769194|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769195|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14769196|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769197|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769198|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
14769199|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14769200|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14769201|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14769202|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14769203|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
14769204|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14769205|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14769206|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14769207|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14769208|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769209|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
14769210|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769211|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769212|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14769213|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769214|NCT00638079|Megestrol|megestrol|mesh-list
14769215|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
14769216|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14769217|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14769218|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14195812|NCT04601701|Bevacizumab|bevacizumab|mesh-list
14195813|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14195814|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195815|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14195816|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14195817|NCT04601701|Growth Substances|growth substances|mesh-ancestor
14195818|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195819|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
14195820|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195821|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
14195822|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
14485391|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485392|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14485393|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
14485394|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485395|NCT02574832|Lidocaine|lidocaine|mesh-list
14485396|NCT02574832|Fentanyl|fentanyl|mesh-list
14485397|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
14485398|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
14485399|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485400|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485401|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
14485402|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485403|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14485404|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14485405|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14485406|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14485407|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485408|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14485409|NCT02574832|Narcotics|narcotics|mesh-ancestor
14485410|NCT02574832|Analgesics|analgesics|mesh-ancestor
14485411|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14485412|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14485413|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
14485414|NCT02574845|Metformin|metformin|mesh-list
14485415|NCT02574845|Furosemide|furosemide|mesh-list
14485416|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14485417|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14485418|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485419|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14485420|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14485421|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
14485422|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485423|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14485424|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14485425|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485426|NCT02574845|Diuretics|diuretics|mesh-ancestor
14485427|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
14485428|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14485429|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14485430|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
14485431|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485432|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769219|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
14769220|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14769221|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195823|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195824|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14485433|NCT02575833|Erenumab|erenumab|mesh-list
14485434|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14485435|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485436|NCT02575833|Analgesics|analgesics|mesh-ancestor
14485437|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
14485438|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485439|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527528|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527529|NCT03996694|Analgesics|analgesics|mesh-ancestor
14527530|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
14527531|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527532|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14527533|NCT03988907|Midazolam|midazolam|mesh-list
14527534|NCT03988907|Risdiplam|risdiplam|mesh-list
14527535|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14527536|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14527537|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527538|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527539|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14527540|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14195825|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
14195826|NCT04601701|Hormones|hormones|mesh-ancestor
14195827|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195828|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14195829|NCT04601675|Dexamethasone|dexamethasone|mesh-list
14527541|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14527542|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14527543|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
13963671|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
14485440|NCT02576067|Methotrexate|methotrexate|mesh-list
14485441|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14485442|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
14485443|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14485444|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485445|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14485446|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
14485447|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485448|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485449|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
14485450|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485451|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14195830|NCT04601675|Ranibizumab|ranibizumab|mesh-list
14195831|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195832|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
14195833|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
14485452|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14485453|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
14485454|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769222|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14769223|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14769224|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14769225|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769226|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
14769227|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13963672|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963673|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
14485455|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14485456|NCT02576145|Daclizumab|daclizumab|mesh-list
14485457|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14485458|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
14485459|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485460|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
14485461|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14485462|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14485463|NCT02576249|Prednisolone|prednisolone|mesh-list
14485464|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
14485465|NCT02576249|Ropivacaine|ropivacaine|mesh-list
14485466|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14485467|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
14485468|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
14485469|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
14485470|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485471|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485472|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
14485473|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485474|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769228|NCT00638118|Fexofenadine|fexofenadine|mesh-list
14769229|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14769230|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14769231|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14769232|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
14769233|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
14769234|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963674|NCT03142646|Fludarabine|fludarabine|mesh-list
13963675|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963676|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
13963677|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963678|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963679|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14195834|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195835|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195836|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14195837|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
14195838|NCT04601675|Hormones|hormones|mesh-ancestor
14195839|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195840|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14195841|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195842|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14195843|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14195844|NCT04601675|Growth Substances|growth substances|mesh-ancestor
14485475|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
14485476|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
14485477|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14485478|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
14485479|NCT02576249|Hormones|hormones|mesh-ancestor
14485480|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485481|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14485482|NCT02576249|Protective Agents|protective agents|mesh-ancestor
14485483|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485484|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485485|NCT02576509|Nivolumab|nivolumab|mesh-list
14485486|NCT02576509|Sorafenib|sorafenib|mesh-list
14485487|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485488|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769235|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769236|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769237|NCT00638131|Bosentan|bosentan|mesh-list
14769238|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14769239|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14769240|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769241|NCT00638209|Insulin|insulin|mesh-list
14769242|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14769243|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14769244|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807210|NCT00820469|Rituximab|rituximab|mesh-list
14807211|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14807212|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807213|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
14807214|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807215|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807216|NCT00820482|Menotropins|menotropins|mesh-list
14807217|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14807218|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
14807219|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14807220|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807221|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
14807222|NCT00820547|Bevacizumab|bevacizumab|mesh-list
14807223|NCT00820547|Docetaxel|docetaxel|mesh-list
14807224|NCT00820547|Fluorouracil|fluorouracil|mesh-list
14807225|NCT00820547|Epirubicin|epirubicin|mesh-list
14807226|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807227|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
14807228|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807229|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807230|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14807231|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
14807232|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195845|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
14195846|NCT04601402|Avelumab|avelumab|mesh-list
14195847|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485489|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14485490|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807233|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807234|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14807235|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13963680|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
13963681|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963682|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963683|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13963684|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
13963685|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13963686|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963687|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
14195848|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195849|NCT04601324|Fluticasone|fluticasone|mesh-list
14195850|NCT04601324|Xhance|xhance|mesh-list
14195851|NCT04601324|Azelastine|azelastine|mesh-list
14195852|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195853|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14195854|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
14195855|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195856|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195857|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14195858|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485491|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485492|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485493|NCT02576639|CNP520|cnp520|mesh-list
14485494|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485495|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485496|NCT02576652|Tetracycline|tetracycline|mesh-list
14485497|NCT02576652|Demeclocycline|demeclocycline|mesh-list
14485498|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14485499|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485500|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14485501|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485502|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485503|NCT02576678|Apremilast|apremilast|mesh-list
14485504|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14485505|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14485506|NCT02576678|Analgesics|analgesics|mesh-ancestor
14485507|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
14485508|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485509|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485510|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485511|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14485512|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14485513|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14485514|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485515|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485516|NCT02576938|Triamcinolone|triamcinolone|mesh-list
14485517|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485518|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
14485519|NCT02576938|Hormones|hormones|mesh-ancestor
14485520|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485521|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485522|NCT02576977|Dexamethasone|dexamethasone|mesh-list
14485523|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
14485524|NCT02576977|Pomalidomide|pomalidomide|mesh-list
14485525|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485526|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
14485527|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
14485528|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485529|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485530|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14485531|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
14485532|NCT02576977|Hormones|hormones|mesh-ancestor
14485533|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485534|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485535|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485536|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485537|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
14485538|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14485539|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14485540|NCT02576977|Growth Substances|growth substances|mesh-ancestor
14769245|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
14769246|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14769247|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14769248|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769249|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
14769250|NCT00638300|Calcium|calcium|mesh-list
14769251|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14939706|NCT01489410|Ethanol|ethanol|mesh-list
14939707|NCT01489410|Doxorubicin|doxorubicin|mesh-list
14769252|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769253|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14769254|NCT00638326|Clopidogrel|clopidogrel|mesh-list
14769255|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14939708|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14939709|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
14485541|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
14485542|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
14485543|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485544|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485545|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14485546|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
14485547|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14485548|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485549|NCT02577003|Incretins|incretins|mesh-ancestor
14485550|NCT02577003|Hormones|hormones|mesh-ancestor
14485551|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485552|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14485553|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485554|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485555|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485556|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14485557|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14485558|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
14485559|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14485560|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485561|NCT02577016|Incretins|incretins|mesh-ancestor
14485562|NCT02577016|Hormones|hormones|mesh-ancestor
14485563|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485564|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14485565|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
14195859|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195860|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14195861|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14485566|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485567|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485568|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14485569|NCT02577029|Interferons|interferons|mesh-list
14485570|NCT02577029|Tenofovir|tenofovir|mesh-list
14485571|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
14485572|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
14485573|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14485574|NCT02577029|Entecavir|entecavir|mesh-list
14485575|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
14485576|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14485577|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485578|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
14195862|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195863|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195864|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14195865|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14195866|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
14195867|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
14195868|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195869|NCT04600999|Favipiravir|favipiravir|mesh-list
14195870|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
14195871|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195872|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
14195873|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14195874|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14195875|NCT04601142|Prednisolone|prednisolone|mesh-list
14195876|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
14195877|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14195878|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
14485579|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485580|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14485581|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14485582|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485583|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485584|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14485585|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14485586|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
14485587|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485588|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
14485589|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485590|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
14485591|NCT02577042|Atorvastatin|atorvastatin|mesh-list
14485592|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14195879|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195880|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
14485593|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14195881|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
14195882|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485594|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
14485595|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485596|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14485597|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14485598|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485599|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14485600|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14485601|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
14485602|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485603|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14485604|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14485605|NCT02577107|Ranibizumab|ranibizumab|mesh-list
14485606|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14485607|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14485608|NCT02577107|Growth Substances|growth substances|mesh-ancestor
14485609|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485610|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
14485611|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485612|NCT02577315|Metformin|metformin|mesh-list
14485613|NCT02577315|Empagliflozin|empagliflozin|mesh-list
14485614|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14485615|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485616|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14485617|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769256|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14769257|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14769258|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14195883|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195884|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14769259|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
14769260|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769261|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769262|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769263|NCT00638391|Anastrozole|anastrozole|mesh-list
14769264|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14769265|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769266|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14769267|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14769268|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769269|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769270|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14769271|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
14769272|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14769273|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769274|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14769275|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14769276|NCT00638482|Diuretics|diuretics|mesh-ancestor
14769277|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
14769278|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769279|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14769280|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14769281|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769282|NCT00638534|Telithromycin|telithromycin|mesh-list
14769283|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14769284|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769285|NCT00638560|Vitamins|vitamins|mesh-list
14769286|NCT00638560|Ascorbic Acid|ascorbic acid|mesh-list
14769287|NCT00638560|Vitamin E|vitamin e|mesh-list
14769288|NCT00638560|Antioxidants|antioxidants|mesh-list
14769289|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
14769290|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769291|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769292|NCT00638560|Protective Agents|protective agents|mesh-ancestor
14769293|NCT00638612|Valacyclovir|valacyclovir|mesh-list
14769294|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
14769295|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769296|NCT00638638|Abciximab|abciximab|mesh-list
14769297|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
14769298|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14769299|NCT00638677|Sorbitol|sorbitol|mesh-list
14769300|NCT00638677|Cathartics|cathartics|mesh-ancestor
14769301|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14769302|NCT00638729|Clonidine|clonidine|mesh-list
14195885|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
14769303|NCT00638729|Midazolam|midazolam|mesh-list
14195886|NCT04601142|Hormones|hormones|mesh-ancestor
14195887|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14195888|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14195889|NCT04601142|Protective Agents|protective agents|mesh-ancestor
14195890|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14195891|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14195892|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
14195893|NCT04601259|Salicylates|salicylates|mesh-list
14195894|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195895|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
14195896|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
14485618|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
14485619|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14485620|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
14485621|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
14485622|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14485623|NCT02577601|Estradiol|estradiol|mesh-list
14485624|NCT02577601|Estrogens|estrogens|mesh-ancestor
14485625|NCT02577601|Hormones|hormones|mesh-ancestor
14485626|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485627|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485628|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14485629|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
14485630|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14485631|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14485632|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14485633|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14485634|NCT02577718|Ethanol|ethanol|mesh-list
14485635|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
14485636|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14485637|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485638|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485639|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769304|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14769305|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14769306|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14769307|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769308|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14769309|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14769310|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14769311|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14769312|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
14769313|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
14769314|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
14769315|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
14769316|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769317|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769318|NCT00638729|Analgesics|analgesics|mesh-ancestor
14769319|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
14769320|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769321|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14769322|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
14769323|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
14769324|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14769325|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14769326|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14769327|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14769328|NCT00638742|Latanoprost|latanoprost|mesh-list
14769329|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14769330|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14769331|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
14769332|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14769333|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14769334|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769335|NCT00638807|Celecoxib|celecoxib|mesh-list
14769336|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769337|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769338|NCT00638807|Analgesics|analgesics|mesh-ancestor
14769339|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
14769340|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769341|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769342|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769343|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14485640|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
14485641|NCT02577991|Triamcinolone|triamcinolone|mesh-list
14485642|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485643|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485644|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
14485645|NCT02577991|Hormones|hormones|mesh-ancestor
14485646|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485647|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
14485648|NCT02578186|Promethazine|promethazine|mesh-list
14485649|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14485650|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14485651|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939710|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14939711|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939712|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14939713|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14939714|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939715|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939716|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14939717|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195897|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
14195898|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14195899|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14195900|NCT04601259|Analgesics|analgesics|mesh-ancestor
14195901|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
14195902|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195903|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195904|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14195905|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195906|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14195907|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195908|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195909|NCT04601389|Omalizumab|omalizumab|mesh-list
14195910|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14195911|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14195912|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14195913|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
14195914|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
14195915|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195916|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
14195917|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14195918|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
14195919|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527544|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
14527545|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
14527546|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
14527547|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527548|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527549|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14527550|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527551|NCT03988088|Lasmiditan|lasmiditan|mesh-list
14527552|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14527553|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
14527554|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527555|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527556|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527557|NCT03980522|Rilonacept|rilonacept|mesh-list
14527558|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14527559|NCT03999684|Tretinoin|tretinoin|mesh-list
14527560|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527561|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
14527562|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
14527563|NCT03993392|Buprenorphine|buprenorphine|mesh-list
14527564|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14527565|NCT03993392|Narcotics|narcotics|mesh-ancestor
14527566|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527567|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527568|NCT03993392|Analgesics|analgesics|mesh-ancestor
14527569|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
14527570|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527571|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14527572|NCT03989427|Listerine|listerine|mesh-list
14527573|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
14527574|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
14527575|NCT03989427|Protective Agents|protective agents|mesh-ancestor
14939718|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485652|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485653|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
14485654|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
14485655|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
14485656|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485657|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
14485658|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
14485659|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14485660|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14485661|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
14485662|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
14485663|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485664|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485665|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14485666|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
14485667|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
14485668|NCT02578316|Lenvatinib|lenvatinib|mesh-list
14485669|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485670|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485671|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485672|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485673|NCT02578706|Aspirin|aspirin|mesh-list
14485674|NCT02578706|Clopidogrel|clopidogrel|mesh-list
14485675|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14195920|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195921|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14195922|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
14195923|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14195924|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
14485676|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14485677|NCT02578706|Analgesics|analgesics|mesh-ancestor
14485678|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
14485679|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485680|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485681|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485682|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195925|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195926|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195927|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14195928|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
14195929|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
14195930|NCT04601077|Protective Agents|protective agents|mesh-ancestor
14238442|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238443|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14238444|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238445|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
14238446|NCT00131677|Tenofovir|tenofovir|mesh-list
14238447|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
14238448|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238449|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14238450|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238451|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238452|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238453|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14238454|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14238455|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
14238456|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14485683|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14485684|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14485685|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485686|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14485687|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14485688|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485689|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
14485690|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14485691|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14485692|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14485693|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
14485694|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485695|NCT02578862|Propofol|propofol|mesh-list
14485696|NCT02578862|Sevoflurane|sevoflurane|mesh-list
14485697|NCT02578862|Isoflurane|isoflurane|mesh-list
14485698|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14485699|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485700|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485701|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14485702|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
14485703|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
14485704|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14485705|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14485706|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
14485707|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14485708|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14485709|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485710|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
14485711|NCT02578901|Coagulants|coagulants|mesh-ancestor
14485712|NCT02579057|Furosemide|furosemide|mesh-list
14485713|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14485714|NCT02579057|Diuretics|diuretics|mesh-ancestor
14485715|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
14485716|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485717|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14485718|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14485719|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485720|NCT02579343|Dexetimide|dexetimide|mesh-list
14485721|NCT02579343|Citalopram|citalopram|mesh-list
14485722|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14485723|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14195931|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14195932|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14195933|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195934|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14195935|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195936|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195937|NCT04601116|Atorvastatin|atorvastatin|mesh-list
14195938|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14485724|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14485725|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485726|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485727|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
14485728|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485729|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14485730|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
14485731|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14485732|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14485733|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14485734|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
14485735|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
14485736|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485737|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14485738|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14485739|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
14485740|NCT02579382|Vesatolimod|vesatolimod|mesh-list
14485741|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
14485742|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485743|NCT02579421|Progesterone|progesterone|mesh-list
14485744|NCT02579421|Progestins|progestins|mesh-ancestor
14485745|NCT02579421|Hormones|hormones|mesh-ancestor
14485746|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485747|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485748|NCT02579603|Pirfenidone|pirfenidone|mesh-list
14485749|NCT02579603|Nintedanib|nintedanib|mesh-list
14485750|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485751|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485752|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485753|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485754|NCT02579603|Analgesics|analgesics|mesh-ancestor
14485755|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
14485756|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485757|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485758|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14485759|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14485760|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485761|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14485762|NCT02579616|Lenvatinib|lenvatinib|mesh-list
14769344|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14769345|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14485763|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485764|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485765|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485766|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485767|NCT02579629|Ropivacaine|ropivacaine|mesh-list
14485768|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
14485769|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
14485770|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485771|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485772|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
14485773|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485774|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
14485775|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14485776|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
14769346|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769347|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769348|NCT00638833|Memantine|memantine|mesh-list
14769349|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14769350|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14769351|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
14769352|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769353|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769354|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769355|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14769356|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14769357|NCT00638859|Telithromycin|telithromycin|mesh-list
14769358|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14769359|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769360|NCT00638976|Eptifibatide|eptifibatide|mesh-list
14769361|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14769362|NCT00639015|Phenylephrine|phenylephrine|mesh-list
14769363|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
14769364|NCT00639015|Norepinephrine|norepinephrine|mesh-list
14769365|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14769366|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
14769367|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
14769368|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769369|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769370|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
14769371|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14769372|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
14769373|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
14769374|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14769375|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14769376|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14769377|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
14485777|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769378|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769379|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769380|NCT00639015|Protective Agents|protective agents|mesh-ancestor
14769381|NCT00639119|Ropinirole|ropinirole|mesh-list
14769382|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14769383|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14769384|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
14769385|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
14769386|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769387|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485778|NCT02579772|Expectorants|expectorants|mesh-ancestor
14485779|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485780|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14485781|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
14485782|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485783|NCT02579772|Protective Agents|protective agents|mesh-ancestor
14485784|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485785|NCT02579772|Antidotes|antidotes|mesh-ancestor
14485786|NCT02579811|Axitinib|axitinib|mesh-list
14485787|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485788|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14485789|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485790|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485791|NCT02579863|Dexamethasone|dexamethasone|mesh-list
14485792|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
14485793|NCT02579863|Lenalidomide|lenalidomide|mesh-list
14485794|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485795|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
14485796|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
14485797|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485798|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195939|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14195940|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
14195941|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195942|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14195943|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14195944|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195945|NCT04600648|Insulin|insulin|mesh-list
14195946|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14195947|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195948|NCT04600167|Isoniazid|isoniazid|mesh-list
14195949|NCT04600167|Rifapentine|rifapentine|mesh-list
14485799|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14485800|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
14485801|NCT02579863|Hormones|hormones|mesh-ancestor
14485802|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485803|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485804|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485805|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14485806|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
14485807|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14485808|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14485809|NCT02579863|Growth Substances|growth substances|mesh-ancestor
14485810|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
14485811|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
14485812|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485813|NCT02579928|Midazolam|midazolam|mesh-list
14485814|NCT02579928|Ketamine|ketamine|mesh-list
14485815|NCT02579928|Analgesics|analgesics|mesh-ancestor
14485816|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
14485817|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485818|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485819|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14485820|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14485821|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
14485822|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
14485823|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485824|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14485825|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14485826|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485827|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485828|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14485829|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14485830|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14485831|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14195950|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
14195951|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14195952|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195953|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14195954|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14195955|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
14195956|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195957|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14195958|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14195959|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
14485832|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14485833|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
14485834|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
14485835|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
14485836|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485837|NCT02580591|Empagliflozin|empagliflozin|mesh-list
14485838|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14485839|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485840|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14485841|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485842|NCT02580877|Insulin|insulin|mesh-list
14485843|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14485844|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
14485845|NCT02580877|Methamphetamine|methamphetamine|mesh-list
14195960|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14769388|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195961|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
14195962|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195963|NCT04600427|Anesthetics|anesthetics|mesh-list
14195964|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195965|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195966|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14195967|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14195968|NCT04600271|Norepinephrine|norepinephrine|mesh-list
14195969|NCT04600271|Analgesics|analgesics|mesh-list
14195970|NCT04600271|Diuretics|diuretics|mesh-list
14195971|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
14195972|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14195973|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195974|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
14195975|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14485846|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14485847|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485848|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14485849|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
14485850|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
14485851|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485852|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
14485853|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485854|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485855|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
14485856|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14485857|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14485858|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14485859|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14485860|NCT02581111|Naloxone|naloxone|mesh-list
14485861|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14485862|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485863|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
14485864|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485865|NCT02581163|Ritonavir|ritonavir|mesh-list
14939719|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939720|NCT01489488|Riociguat|riociguat|mesh-list
14939721|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
14939722|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939723|NCT01489566|Fluorouracil|fluorouracil|mesh-list
14939724|NCT01489566|Mitomycins|mitomycins|mesh-list
14939725|NCT01489566|Mitomycin|mitomycin|mesh-list
13963688|NCT03142763|Choline|choline|mesh-list
14485866|NCT02581163|Ribavirin|ribavirin|mesh-list
14485867|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14769389|NCT00639249|SA 4503|sa 4503|mesh-list
14769390|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
14769391|NCT00639262|Temozolomide|temozolomide|mesh-list
14769392|NCT00639262|Sorafenib|sorafenib|mesh-list
14769393|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14769394|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
14769395|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769396|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769397|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14769398|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769399|NCT00639327|Irinotecan|irinotecan|mesh-list
14769400|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14939726|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
13963689|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
13963690|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13963691|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
13963692|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963693|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963694|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13963695|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
13963696|NCT03142620|Vitamin D|vitamin d|mesh-list
13963697|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
13963698|NCT03142620|Amoxicillin|amoxicillin|mesh-list
13963699|NCT03142620|Clarithromycin|clarithromycin|mesh-list
13963700|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
13963701|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13963702|NCT03142620|Esomeprazole|esomeprazole|mesh-list
13963703|NCT03142620|Vitamins|vitamins|mesh-ancestor
13963704|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
13963705|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963706|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13963707|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14485868|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14485869|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485870|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485871|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485872|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14485873|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14485874|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
14485875|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485876|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14769401|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14769402|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963708|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13963709|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963710|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14769403|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769404|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769405|NCT00639366|Trastuzumab|trastuzumab|mesh-list
14769406|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14769407|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769408|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
14769409|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14769410|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769411|NCT00639483|Celecoxib|celecoxib|mesh-list
14769412|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769413|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769414|NCT00639483|Analgesics|analgesics|mesh-ancestor
14769415|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
14769416|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769417|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769418|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769419|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939727|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939728|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14939729|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939730|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939731|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
14939732|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939733|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14939734|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
14939735|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14939736|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939737|NCT01489592|Turmeric extract|turmeric extract|mesh-list
14939738|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
14939739|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939740|NCT01489592|Protective Agents|protective agents|mesh-ancestor
14939741|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939742|NCT01489631|Sufentanil|sufentanil|mesh-list
14939743|NCT01489631|Gabapentin|gabapentin|mesh-list
14939744|NCT01489631|Bupivacaine|bupivacaine|mesh-list
14939745|NCT01489631|Ropivacaine|ropivacaine|mesh-list
14939746|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
14939747|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
14939748|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939749|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939750|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
14939751|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939752|NCT01489631|Analgesics|analgesics|mesh-ancestor
14939753|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
14939754|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14939755|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14939756|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14485877|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14485878|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
14485879|NCT02581189|Ritonavir|ritonavir|mesh-list
14485880|NCT02581189|Ribavirin|ribavirin|mesh-list
14485881|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14485882|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14485883|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485884|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485885|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485886|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14485887|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14485888|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
14485889|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485890|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14485891|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14485892|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
14485893|NCT02581202|Ritonavir|ritonavir|mesh-list
14485894|NCT02581202|Lopinavir|lopinavir|mesh-list
14485895|NCT02581202|Lamivudine|lamivudine|mesh-list
14485896|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14485897|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14485898|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
14769420|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14769421|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769422|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769423|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769424|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
14769425|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14769426|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
14769427|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769428|NCT00639496|Expectorants|expectorants|mesh-ancestor
14769429|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
14769430|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14769431|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
14769432|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769433|NCT00639496|Protective Agents|protective agents|mesh-ancestor
14769434|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769435|NCT00639496|Antidotes|antidotes|mesh-ancestor
14769436|NCT00639522|Paclitaxel|paclitaxel|mesh-list
14769437|NCT00639522|Capecitabine|capecitabine|mesh-list
14769438|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14769439|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769440|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
14769441|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
14769442|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
14769443|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769444|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14769445|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
14769446|NCT00639574|Nefopam|nefopam|mesh-list
14769447|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769448|NCT00639574|Analgesics|analgesics|mesh-ancestor
14485899|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485900|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769449|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
14769450|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769451|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769452|NCT00639587|Cetirizine|cetirizine|mesh-list
14769453|NCT00639587|Ketotifen|ketotifen|mesh-list
14769454|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14769455|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14769456|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13963711|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963712|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14769457|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
14769458|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
14769459|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769460|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769461|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769462|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
14769463|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14769464|NCT00639691|Omalizumab|omalizumab|mesh-list
14769465|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14939757|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14939758|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14939759|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939760|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939761|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
13963713|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14195976|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14195977|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14195978|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195979|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195980|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
14195981|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
14195982|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14195983|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14485901|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14769466|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14769467|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
14485902|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14485903|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
14485904|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485905|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14485906|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14485907|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14485908|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14485909|NCT02581345|Adalimumab|adalimumab|mesh-list
14485910|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485911|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14485912|NCT02581839|Dexamethasone|dexamethasone|mesh-list
14485913|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
14485914|NCT02581839|Ondansetron|ondansetron|mesh-list
14485915|NCT02581839|BB 1101|bb 1101|mesh-list
14485916|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14485917|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
14485918|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
14485919|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485920|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485921|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14485922|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
14485923|NCT02581839|Hormones|hormones|mesh-ancestor
14485924|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14485925|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14485926|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485927|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485928|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485929|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485930|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
14485931|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14485932|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14485933|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
14485934|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14485935|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14195984|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14195985|NCT04600089|Ketamine|ketamine|mesh-list
14195986|NCT04600089|Analgesics|analgesics|mesh-ancestor
14485936|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14485937|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14485938|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14485939|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14485940|NCT02581891|Aflibercept|aflibercept|mesh-list
14485941|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14485942|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14485943|NCT02581891|Growth Substances|growth substances|mesh-ancestor
14485944|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485945|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
14485946|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485947|NCT02581995|Aflibercept|aflibercept|mesh-list
14485948|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14485949|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14485950|NCT02581995|Growth Substances|growth substances|mesh-ancestor
14485951|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485952|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
14485953|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14485954|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
14485955|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
14485956|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14485957|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14485958|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485959|NCT02582515|Cycloserine|cycloserine|mesh-list
14485960|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14485961|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14195987|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
14195988|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14485962|NCT02582515|Renal Agents|renal agents|mesh-ancestor
14485963|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14485964|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
14485965|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14485966|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
14485967|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485968|NCT02582632|Ritonavir|ritonavir|mesh-list
14195989|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14195990|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14195991|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14195992|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
14195993|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
14195994|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14195995|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14195996|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14195997|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14195998|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14195999|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
14196000|NCT04600414|Narcotics|narcotics|mesh-ancestor
14196001|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196002|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196003|NCT04600414|Analgesics|analgesics|mesh-ancestor
14196004|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
14196005|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196006|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
14196007|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196008|NCT04600115|Adenosine|adenosine|mesh-list
14196009|NCT04600115|Regadenoson|regadenoson|mesh-list
14196010|NCT04600115|Analgesics|analgesics|mesh-ancestor
14196011|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
14196012|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196013|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196014|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14196015|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
14196016|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14196017|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
14196018|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
14196019|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196020|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196021|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14196022|NCT04600492|Riociguat|riociguat|mesh-list
14485969|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14485970|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14485971|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485972|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485973|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485974|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14485975|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14485976|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
14485977|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196023|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
14196024|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196025|NCT04600037|Pregabalin|pregabalin|mesh-list
14196026|NCT04600037|Analgesics|analgesics|mesh-ancestor
14196027|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
14196028|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196029|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14485978|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14485979|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14485980|NCT02582671|Ritonavir|ritonavir|mesh-list
14485981|NCT02582671|Ribavirin|ribavirin|mesh-list
14485982|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14485983|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14485984|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
14485985|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485986|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14485987|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14485988|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14485989|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
14485990|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14485991|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14485992|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14485993|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
14485994|NCT02582684|Lamivudine|lamivudine|mesh-list
14196030|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
14485995|NCT02582684|Dolutegravir|dolutegravir|mesh-list
14485996|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14485997|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14485998|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14485999|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486000|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
14486001|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486002|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14486003|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14486004|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14486005|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14486006|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
14486007|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14486008|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486009|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14486010|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486011|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
14486012|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14486013|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486014|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14486015|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486016|NCT02582866|Lacosamide|lacosamide|mesh-list
14486017|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
14486018|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14486019|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14486020|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486021|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486022|NCT02582970|Bevacizumab|bevacizumab|mesh-list
14486023|NCT02582970|Fluorouracil|fluorouracil|mesh-list
14486024|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
14486025|NCT02582970|Irinotecan|irinotecan|mesh-list
14486026|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14486027|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486028|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14486029|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14486030|NCT02582970|Growth Substances|growth substances|mesh-ancestor
14486031|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486032|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
14486033|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
14486034|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486035|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486036|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486037|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
14486038|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14486039|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14486040|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486041|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
14486042|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14486043|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14486044|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486045|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14486046|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14486047|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
14486048|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486049|NCT02583399|Ibuprofen|ibuprofen|mesh-list
14486050|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14486051|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14486052|NCT02583399|Analgesics|analgesics|mesh-ancestor
14486053|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
14486054|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486055|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486056|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14486057|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14486058|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14486059|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196031|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14196032|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14196033|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196034|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14196035|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14196036|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14196037|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486060|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486061|NCT02583477|Gemcitabine|gemcitabine|mesh-list
14486062|NCT02583477|Paclitaxel|paclitaxel|mesh-list
14486063|NCT02583477|Durvalumab|durvalumab|mesh-list
14486064|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14486065|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14486066|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486067|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
14486068|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
14486069|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
14486070|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486071|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486072|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
14486073|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
14486074|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486075|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486076|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486077|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
14486078|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486079|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14527576|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527577|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14527578|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527579|NCT03981822|Cantharidin|cantharidin|mesh-list
14527580|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527581|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527582|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
14527583|NCT03992482|Antibodies|antibodies|mesh-list
14527584|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
14527585|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14527586|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14527587|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
14527588|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527589|NCT03993119|Anticoagulants|anticoagulants|mesh-list
14769468|NCT00639743|Tenecteplase|tenecteplase|mesh-list
14769469|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14769470|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14769471|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769472|NCT00639756|Allopurinol|allopurinol|mesh-list
14769473|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
14769474|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196038|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14196039|NCT04599894|Pregabalin|pregabalin|mesh-list
14196040|NCT04599894|Analgesics|analgesics|mesh-ancestor
14196041|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
14196042|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196043|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196044|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
14196045|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14196046|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14196047|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769475|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769476|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
14527590|NCT03988803|Memantine|memantine|mesh-list
14527591|NCT03988803|BI 425809|bi 425809|mesh-list
14769477|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769478|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14769479|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
14769480|NCT00639756|Protective Agents|protective agents|mesh-ancestor
14769481|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769482|NCT00639873|Doxycycline|doxycycline|mesh-list
14769483|NCT00639873|Artesunate|artesunate|mesh-list
14769484|NCT00639873|Quinine|quinine|mesh-list
14769485|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14769486|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769487|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
14769488|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14769489|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14769490|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769491|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
14769492|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
14769493|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14769494|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
14769495|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14769496|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769497|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14769498|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769499|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769500|NCT00639873|Analgesics|analgesics|mesh-ancestor
14769501|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
14769502|NCT00639925|Gemcitabine|gemcitabine|mesh-list
14769503|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14769504|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
14769505|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196048|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14196049|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14527592|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14527593|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14769506|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486080|NCT02584257|Albuterol|albuterol|mesh-list
14486081|NCT02584257|Procaterol|procaterol|mesh-list
14486082|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
14486083|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14486084|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
14486085|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486086|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486087|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14486088|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
14486089|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
14196050|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14196051|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196052|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14196053|NCT04599478|Naltrexone|naltrexone|mesh-list
14196054|NCT04599478|Bupropion|bupropion|mesh-list
14486090|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14486091|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14486092|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14486093|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14486094|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
14486095|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486096|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486097|NCT02584257|Miotics|miotics|mesh-ancestor
14486098|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14486099|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14486100|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14486101|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14486102|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
14486103|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
14486104|NCT02584452|Dexamethasone|dexamethasone|mesh-list
14486105|NCT02584452|Fentanyl|fentanyl|mesh-list
14486106|NCT02584452|Bupivacaine|bupivacaine|mesh-list
14486107|NCT02584452|Ropivacaine|ropivacaine|mesh-list
14486108|NCT02584452|Mepivacaine|mepivacaine|mesh-list
14486109|NCT02584452|Propofol|propofol|mesh-list
14486110|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769507|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
14769508|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769509|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769510|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769511|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
14769512|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769513|NCT00639938|Nevirapine|nevirapine|mesh-list
14769514|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
14769515|NCT00639938|Antibodies|antibodies|mesh-list
14769516|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
14769517|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14769518|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14769519|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
14769520|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769521|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14769522|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14769523|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769524|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769525|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
14769526|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769527|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14769528|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14769529|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14769530|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14769531|NCT00640003|Baclofen|baclofen|mesh-list
14769532|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14769533|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769534|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14769535|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769536|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14769537|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
14769538|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
14769539|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769540|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196055|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14196056|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14196057|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196058|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
14196059|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486111|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
14486112|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
14486113|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196060|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14196061|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
14486114|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486115|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14486116|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
14486117|NCT02584452|Hormones|hormones|mesh-ancestor
14486118|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14486119|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14486120|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486121|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
14486122|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
14486123|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486124|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
14486125|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14486126|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14486127|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
14486128|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14486129|NCT02584452|Narcotics|narcotics|mesh-ancestor
14486130|NCT02584452|Analgesics|analgesics|mesh-ancestor
14486131|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14486132|NCT02584504|Atorvastatin|atorvastatin|mesh-list
14486133|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14486134|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14486135|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
14486136|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486137|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14486138|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14486139|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486140|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
14486141|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
14486142|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486143|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
14486144|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14486145|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
14486146|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14486147|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196062|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14196063|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14196064|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14196065|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14196066|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196067|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
14196068|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196069|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14486148|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486149|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486150|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
14486151|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
14486152|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14486153|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14486154|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14486155|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486156|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486157|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
14486158|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486159|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486160|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14486161|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486162|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
14486163|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14486164|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14486165|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486166|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
14486167|NCT02584725|Coagulants|coagulants|mesh-ancestor
14486168|NCT02584855|Ixekizumab|ixekizumab|mesh-list
14486169|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
14486170|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14486171|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
14486172|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
14486173|NCT02584959|Complement C1s|complement c1s|mesh-list
14486174|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14486175|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14486176|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
14486177|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486178|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14486179|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486180|NCT02585713|Dalteparin|dalteparin|mesh-list
14486181|NCT02585713|Tinzaparin|tinzaparin|mesh-list
14486182|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14486183|NCT02585713|Apixaban|apixaban|mesh-list
14486184|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14486185|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
14486186|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14486187|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
14486188|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486189|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486190|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
14486191|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14486192|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14486193|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14486194|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486195|NCT02585843|Spironolactone|spironolactone|mesh-list
14486196|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14486197|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
14486198|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14486199|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486200|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14486201|NCT02585843|Diuretics|diuretics|mesh-ancestor
14486202|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
14486203|NCT02585895|Evolocumab|evolocumab|mesh-list
14486204|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14486205|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14486206|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
14486207|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486208|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14486209|NCT02585960|Factor VIII|factor viii|mesh-list
14769541|NCT00640029|Meloxicam|meloxicam|mesh-list
14769542|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769543|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769544|NCT00640029|Analgesics|analgesics|mesh-ancestor
14769545|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
14769546|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769547|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769548|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769549|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769550|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14769551|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769552|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769553|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769554|NCT00640081|Leucovorin|leucovorin|mesh-list
14769555|NCT00640081|Fluorouracil|fluorouracil|mesh-list
14769556|NCT00640081|Capecitabine|capecitabine|mesh-list
14769557|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
14769558|NCT00640081|Cetuximab|cetuximab|mesh-list
14769559|NCT00640081|Calcium|calcium|mesh-list
14769560|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
14769561|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14769562|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769563|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
14769564|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196070|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14196071|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196072|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
14196073|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196074|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196075|NCT04599621|Uric Acid|uric acid|mesh-list
14196076|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
14196077|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196078|NCT04599621|Protective Agents|protective agents|mesh-ancestor
14196079|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196080|NCT04599699|Androgens|androgens|mesh-list
14196081|NCT04599699|Hormones|hormones|mesh-ancestor
14196082|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196083|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196084|NCT04599075|Insulin|insulin|mesh-list
14196085|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14196086|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14196087|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196088|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
14196089|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14196090|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14196091|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196092|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
14196093|NCT04599205|Coagulants|coagulants|mesh-ancestor
14196094|NCT04599140|Nivolumab|nivolumab|mesh-list
14196095|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196096|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196097|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14196098|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196099|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
14486210|NCT02585960|BAX 855|bax 855|mesh-list
14486211|NCT02585960|Coagulants|coagulants|mesh-ancestor
14486212|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
14486213|NCT02585999|Ortho Evra|ortho evra|mesh-list
14486214|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14486215|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486216|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14486217|NCT02586155|Atorvastatin|atorvastatin|mesh-list
14486218|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14486219|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14486220|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14486221|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
14486222|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486223|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14486224|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14486225|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486226|NCT02586727|Aflibercept|aflibercept|mesh-list
14486227|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14486228|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14486229|NCT02586727|Growth Substances|growth substances|mesh-ancestor
14486230|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486231|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
14486232|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486233|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14486234|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
14486235|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486236|NCT02587065|Interferons|interferons|mesh-list
14486237|NCT02587065|Interferon-beta|interferon-beta|mesh-list
14486238|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
14486239|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486240|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
14486241|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486242|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
14486243|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486244|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14486245|NCT02587117|Prednisolone|prednisolone|mesh-list
14486246|NCT02587117|Lycopene|lycopene|mesh-list
14486247|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14486248|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
14486249|NCT02587117|Hormones|hormones|mesh-ancestor
14486250|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14486251|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486252|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14486253|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486254|NCT02587117|Protective Agents|protective agents|mesh-ancestor
14486255|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
14486256|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486257|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14486258|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14486259|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
14486260|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
14486261|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
14486262|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486263|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486264|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
14486265|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486266|NCT02587351|Metoprolol|metoprolol|mesh-list
14486267|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14196100|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
14196101|NCT04598880|Cathartics|cathartics|mesh-ancestor
14196102|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238457|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
14238458|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14238459|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238460|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14238461|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14486268|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14486269|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
14486270|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
14486271|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486272|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486273|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14486274|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14486275|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14486276|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
14486277|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486278|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486279|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
14527594|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
14527595|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939762|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14527596|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527597|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527598|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14527599|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14527600|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
14527601|NCT03987191|Insulin|insulin|mesh-list
14527602|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
14527603|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14527604|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14527605|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527606|NCT03988842|Heparin|heparin|mesh-list
14527607|NCT03988842|Calcium heparin|calcium heparin|mesh-list
14527608|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14527609|NCT03988842|Plasminogen|plasminogen|mesh-list
14527610|NCT03988842|Apixaban|apixaban|mesh-list
14527611|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
14527612|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14527613|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14527614|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527615|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14527616|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
14527617|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14238462|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14238463|NCT00131911|Sorafenib|sorafenib|mesh-list
14238464|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238465|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14238466|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238467|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238468|NCT00131937|Sorafenib|sorafenib|mesh-list
14238469|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238470|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14238471|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238472|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238473|NCT00132002|Vorinostat|vorinostat|mesh-list
14238474|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238475|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14238476|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238477|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238478|NCT00132028|Vorinostat|vorinostat|mesh-list
14238479|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238480|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14238481|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238482|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238483|NCT00132301|Prednisone|prednisone|mesh-list
14238484|NCT00132301|Docetaxel|docetaxel|mesh-list
14238485|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527618|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
14527619|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527620|NCT03981861|Metformin|metformin|mesh-list
14527621|NCT03981861|Spironolactone|spironolactone|mesh-list
14527622|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14486280|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14486281|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486290|NCT05249556|Ganaxolone|ganaxolone|mesh-list
14486291|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
14486292|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486293|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486294|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486295|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
14486296|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
14486297|NCT05249478|Fentanyl|fentanyl|mesh-list
14486298|NCT05249478|Bupivacaine|bupivacaine|mesh-list
14486299|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
14486300|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
14486301|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486302|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486303|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
14486304|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486305|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14486306|NCT05249478|Narcotics|narcotics|mesh-ancestor
14486307|NCT05249478|Analgesics|analgesics|mesh-ancestor
14486308|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14486309|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14486310|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
14486311|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
14486312|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486313|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
14486314|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486315|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486316|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14486317|NCT05249309|Ketamine|ketamine|mesh-list
14486318|NCT05249309|Analgesics|analgesics|mesh-ancestor
14486319|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
14486320|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486321|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486322|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14486323|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14486324|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
14486325|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
14486326|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486327|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14486328|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14486329|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486330|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486331|NCT05249231|Fluorides|fluorides|mesh-list
14486332|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
14486333|NCT05249231|Protective Agents|protective agents|mesh-ancestor
14486334|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486335|NCT05249153|Sufentanil|sufentanil|mesh-list
14486336|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
14486337|NCT05249153|Dsuvia|dsuvia|mesh-list
14486338|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14486339|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486340|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486341|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769565|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14769566|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769567|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769568|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
14769569|NCT00640081|Antidotes|antidotes|mesh-ancestor
14769570|NCT00640081|Protective Agents|protective agents|mesh-ancestor
14769571|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
14769572|NCT00640081|Vitamins|vitamins|mesh-ancestor
14769573|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
14769574|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14769575|NCT00640094|Melatonin|melatonin|mesh-list
14769576|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
14769577|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769578|NCT00640094|Protective Agents|protective agents|mesh-ancestor
14486342|NCT05249153|Analgesics|analgesics|mesh-ancestor
14486343|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
14486344|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486345|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14486346|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14486347|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14486348|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
14486349|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486350|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486351|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14486352|NCT05249153|Narcotics|narcotics|mesh-ancestor
14486353|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14486354|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14486355|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
14486356|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
14486357|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14486358|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14486359|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486360|NCT05249101|Capecitabine|capecitabine|mesh-list
14486361|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486362|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
14486363|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486364|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486365|NCT05249023|Butyric Acid|butyric acid|mesh-list
14486366|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
14486367|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
14486368|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486369|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486370|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486371|NCT05248945|Carbamazepine|carbamazepine|mesh-list
14486372|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
14486373|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
14486374|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14486375|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486376|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486377|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14486378|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14486379|NCT05248945|Analgesics|analgesics|mesh-ancestor
14486380|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
14486381|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486382|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14486383|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486384|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486385|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14486386|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14486387|NCT05248932|Norepinephrine|norepinephrine|mesh-list
14486388|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14486389|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14769579|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196103|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
14196104|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
14196105|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14196106|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196107|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196108|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
14196109|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14196110|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196111|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196112|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14196113|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196114|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196115|NCT04598542|Triamcinolone|triamcinolone|mesh-list
14196116|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14196117|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14196118|NCT04598542|Lorecivivint|lorecivivint|mesh-list
14196119|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14196120|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196121|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
14196122|NCT04598542|Hormones|hormones|mesh-ancestor
14196123|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196124|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196125|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196126|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
14486390|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
14486391|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486392|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486393|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486394|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
14486395|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
14486396|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486397|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14527623|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527624|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14527625|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
14527626|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527627|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14527628|NCT03981861|Diuretics|diuretics|mesh-ancestor
14527629|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
14527630|NCT03987074|Firsocostat|firsocostat|mesh-list
14527631|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527632|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527633|NCT03979820|Phenelzine|phenelzine|mesh-list
14527634|NCT03979820|Tyramine|tyramine|mesh-list
14527635|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
14527636|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14527637|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14527638|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527639|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527640|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
14527641|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
14527642|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527643|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527644|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14527645|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14527646|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14769580|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196127|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196128|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196129|NCT04598594|Nicotine|nicotine|mesh-list
14196130|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14196131|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
13963714|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963715|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13963716|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13963717|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13963718|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13968003|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968004|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13968005|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13968006|NCT03113695|Growth Substances|growth substances|mesh-ancestor
13968007|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
13968008|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968009|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196132|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196133|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196134|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14486417|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14486418|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14486419|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486420|NCT05248334|Ranibizumab|ranibizumab|mesh-list
14486421|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14486422|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14486423|NCT05248334|Growth Substances|growth substances|mesh-ancestor
14486424|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486425|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
14486426|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486427|NCT05248152|Acetaminophen|acetaminophen|mesh-list
14486428|NCT05248152|Ibuprofen|ibuprofen|mesh-list
14769581|NCT00640159|Selegiline|selegiline|mesh-list
14769582|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
14769583|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14769584|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14769585|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14769586|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14769587|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769588|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769589|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14769590|NCT00640159|Protective Agents|protective agents|mesh-ancestor
14769591|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769592|NCT00640198|Memantine|memantine|mesh-list
14769593|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14769594|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14769595|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
14486429|NCT05248152|Pregabalin|pregabalin|mesh-list
14769596|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769597|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769598|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769599|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14769600|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14769601|NCT00640237|Calcifediol|calcifediol|mesh-list
14769602|NCT00640237|Vitamins|vitamins|mesh-ancestor
14769603|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
14769604|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769605|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14769606|NCT00640263|Ritonavir|ritonavir|mesh-list
14769607|NCT00640263|Lopinavir|lopinavir|mesh-list
14769608|NCT00640263|Lamivudine|lamivudine|mesh-list
14769609|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14769610|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14769611|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
14769612|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769613|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769614|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14769615|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14769616|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
14769617|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769618|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13963719|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
14486430|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14486431|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14486432|NCT05248152|Analgesics|analgesics|mesh-ancestor
14486433|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
14486434|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486435|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486436|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14486437|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14486438|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13963720|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13963721|NCT03142607|Metronidazole|metronidazole|mesh-list
13963722|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13963723|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963724|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
13963725|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
13963726|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13963727|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13963728|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13963729|NCT03142516|Leucovorin|leucovorin|mesh-list
13963730|NCT03142516|Folic Acid|folic acid|mesh-list
13963731|NCT03142516|Fluorouracil|fluorouracil|mesh-list
14486439|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486440|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769619|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14769620|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14939763|NCT01489631|Narcotics|narcotics|mesh-ancestor
14939764|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14939765|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14196135|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14196136|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
14196137|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196138|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196139|NCT04598191|Iloprost|iloprost|mesh-list
14196140|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14196141|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
14196142|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
14196143|NCT04598074|Narcotics|narcotics|mesh-ancestor
14196144|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238486|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238487|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238488|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238489|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238490|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238491|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
14238492|NCT00132301|Hormones|hormones|mesh-ancestor
14238493|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238494|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238495|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238496|NCT00132314|Risperidone|risperidone|mesh-list
14238497|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
14238498|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14238499|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
14238500|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238501|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238502|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238503|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14238504|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238505|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238506|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14238507|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
14238508|NCT00132496|Rabeprazole|rabeprazole|mesh-list
14238509|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14238510|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238511|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14238512|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238513|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238514|NCT00132678|Risperidone|risperidone|mesh-list
14238515|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14238516|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
14238517|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238518|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238519|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238520|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14238521|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14238522|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238523|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238524|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14238525|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
14238526|NCT00132691|Cyclosporine|cyclosporine|mesh-list
14238527|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
14238528|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14238529|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
14238530|NCT00132691|Chlorambucil|chlorambucil|mesh-list
14238531|NCT00132691|Methotrexate|methotrexate|mesh-list
14238532|NCT00132691|Azathioprine|azathioprine|mesh-list
14238533|NCT00132691|Infliximab|infliximab|mesh-list
14238534|NCT00132691|Tacrolimus|tacrolimus|mesh-list
14238535|NCT00132691|Cyclosporins|cyclosporins|mesh-list
14238536|NCT00132691|Daclizumab|daclizumab|mesh-list
14238537|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14238538|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
14238539|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
14238540|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238541|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238542|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238543|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238544|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238545|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238546|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14486441|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
14486442|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14486443|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486444|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14486445|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14486446|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14486447|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486448|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14486449|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
14486450|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14486451|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486452|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486453|NCT05247905|Capecitabine|capecitabine|mesh-list
14486454|NCT05247905|Temozolomide|temozolomide|mesh-list
14486455|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14939766|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
13963732|NCT03142516|Irinotecan|irinotecan|mesh-list
14196145|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486456|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486457|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
14486458|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486459|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486460|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14486461|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
14486462|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14486463|NCT05247788|Ethanol|ethanol|mesh-list
14486464|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14486465|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486466|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486467|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486468|NCT05247697|Mirtazapine|mirtazapine|mesh-list
14486469|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
14486470|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14486471|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14486472|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
14486473|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
14486474|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486475|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486476|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486477|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14196146|NCT04598074|Analgesics|analgesics|mesh-ancestor
14196147|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
14196148|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196149|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
14486478|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14486479|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486480|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14486481|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14486482|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14486483|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
14486484|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14486485|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14486486|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
14486487|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14486488|NCT05247684|Paclitaxel|paclitaxel|mesh-list
14486489|NCT05247684|Carboplatin|carboplatin|mesh-list
14486490|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14486491|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486492|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
14486493|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
14486494|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
14486495|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486496|NCT05247619|Paclitaxel|paclitaxel|mesh-list
14486497|NCT05247619|Bevacizumab|bevacizumab|mesh-list
14486498|NCT05247619|Carboplatin|carboplatin|mesh-list
14486499|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14486500|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486501|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
14769621|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14769622|NCT00640276|Pitavastatin|pitavastatin|mesh-list
14769623|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14196150|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14196151|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196152|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486502|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
14486503|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
14486504|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486505|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14486506|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14486507|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14486508|NCT05247619|Growth Substances|growth substances|mesh-ancestor
14486509|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486510|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
14486511|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
14486512|NCT05247554|Prednisone|prednisone|mesh-list
14486513|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14486514|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
14486515|NCT05247554|Hormones|hormones|mesh-ancestor
14486516|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14486517|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486518|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14486519|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486520|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
14486521|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14486522|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14486523|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486524|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486525|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486526|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14486527|NCT05243563|Clobetasol|clobetasol|mesh-list
14486528|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14486529|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
14486530|NCT05243563|Hormones|hormones|mesh-ancestor
14486531|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14486532|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486533|NCT05231694|Mitogens|mitogens|mesh-list
14486534|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
14486535|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486536|NCT05227131|Capecitabine|capecitabine|mesh-list
14486537|NCT05227131|Tucatinib|tucatinib|mesh-list
14486538|NCT05227131|Margetuximab|margetuximab|mesh-list
14486539|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486540|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
14486541|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486542|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769624|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14769625|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14769626|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
14769627|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769628|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769629|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14769630|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14769631|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14769632|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14769633|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769634|NCT00640432|Celecoxib|celecoxib|mesh-list
14769635|NCT00640432|Diclofenac|diclofenac|mesh-list
14769636|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769637|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769638|NCT00640432|Analgesics|analgesics|mesh-ancestor
14769639|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
14769640|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769641|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769642|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769643|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769644|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14769645|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769646|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769647|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769648|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
14769649|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
14769650|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14939767|NCT01489644|Metformin|metformin|mesh-list
14939768|NCT01489644|Repaglinide|repaglinide|mesh-list
14939769|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14486543|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14486544|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939770|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486545|NCT05220813|Lidocaine|lidocaine|mesh-list
14486546|NCT05220813|Bupivacaine|bupivacaine|mesh-list
14486547|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
14486548|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
14769651|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14769652|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769653|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769654|NCT00640458|Urological Agents|urological agents|mesh-ancestor
14769655|NCT00640471|Cetuximab|cetuximab|mesh-list
14769656|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14769657|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769658|NCT00640549|Atorvastatin|atorvastatin|mesh-list
14769659|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14769660|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14769661|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
14769662|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769663|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14769664|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14769665|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769666|NCT00640575|Triamcinolone|triamcinolone|mesh-list
14769667|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14769668|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14769669|NCT00640575|Lidocaine|lidocaine|mesh-list
14769670|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14769671|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
14769672|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
14769673|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14769674|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769675|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
14769676|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769677|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14769678|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14769679|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14769680|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14769681|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769682|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769683|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
14769684|NCT00640575|Hormones|hormones|mesh-ancestor
14769685|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14769686|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769687|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
14769688|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196153|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14196154|NCT04598061|Analgesics|analgesics|mesh-ancestor
14196155|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
14196156|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196157|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14196158|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14196159|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14196160|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
14196161|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196162|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196163|NCT04597762|Cyclosporine|cyclosporine|mesh-list
14196164|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
14196165|NCT04597762|Cyclosporins|cyclosporins|mesh-list
14196166|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196167|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196168|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196169|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
14196170|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196171|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
14196172|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196173|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14196174|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196175|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14196176|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196177|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
14196178|NCT04597619|Analgesics|analgesics|mesh-ancestor
14486549|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486550|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486551|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
14486552|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486553|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14486554|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14486555|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14486556|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486557|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486558|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
14486559|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
14486560|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486561|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
14486562|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14486563|NCT05215236|Narcotics|narcotics|mesh-ancestor
14486564|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486565|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486566|NCT05215236|Analgesics|analgesics|mesh-ancestor
14486567|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
14196179|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
14196180|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196181|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196182|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
14196183|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14196184|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196185|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
14196186|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
14196187|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14196188|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14196189|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196190|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196191|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196192|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196193|NCT04597424|Doxycycline|doxycycline|mesh-list
14196194|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14196195|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196196|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
14196197|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14196198|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14196199|NCT04597203|Hydroquinone|hydroquinone|mesh-list
14196200|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
14196201|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486568|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486569|NCT05184348|Acitretin|acitretin|mesh-list
14486570|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
14486571|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
14486572|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
14486573|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14486574|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486575|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
14486576|NCT05159193|Carboplatin|carboplatin|mesh-list
14486577|NCT05159193|Docetaxel|docetaxel|mesh-list
14486578|NCT05159193|Doxorubicin|doxorubicin|mesh-list
14486579|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14486580|NCT05159193|Trastuzumab|trastuzumab|mesh-list
14486581|NCT05159193|Pertuzumab|pertuzumab|mesh-list
14486582|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486583|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
14486584|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486585|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14486586|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14486587|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
14486588|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486589|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486590|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14486591|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14486592|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14196202|NCT04597203|Protective Agents|protective agents|mesh-ancestor
14196203|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196204|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14196205|NCT04597190|Norepinephrine|norepinephrine|mesh-list
14196206|NCT04597190|Serotonin|serotonin|mesh-list
14196207|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14196208|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14196209|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14196210|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14196211|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486593|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14486594|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14196212|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196213|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486595|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14769689|NCT00640588|Adefovir|adefovir|mesh-list
14769690|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14769691|NCT00640588|Telbivudine|telbivudine|mesh-list
14769692|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
14769693|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769694|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14769695|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14769696|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769697|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769698|NCT00640627|Celecoxib|celecoxib|mesh-list
14769699|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769700|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769701|NCT00640627|Analgesics|analgesics|mesh-ancestor
14196214|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
14196215|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
14196216|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196217|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14196218|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14769702|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
14769703|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769704|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769705|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769706|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769707|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14196219|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
14196220|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14196221|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238547|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
14238548|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14238549|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14238550|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
14238551|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14238552|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238553|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14238554|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238555|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14238556|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
14238557|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238558|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14238559|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14238560|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
14238561|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14238562|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238563|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238564|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
14238565|NCT00132691|Hormones|hormones|mesh-ancestor
14238566|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238567|NCT00132730|MK 0873|mk 0873|mesh-list
14238568|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14238569|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14238570|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238571|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238572|NCT00132769|MK 0873|mk 0873|mesh-list
14238573|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14238574|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14238575|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238576|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238577|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
14238578|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14238579|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238580|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
14238581|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14238582|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14238583|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
14238584|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
14238585|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238586|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238587|NCT00133575|Vaccines|vaccines|mesh-list
14238588|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
14238589|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238590|NCT00133705|Mifepristone|mifepristone|mesh-list
14238591|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14238592|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
14486596|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14486597|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486598|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14486599|NCT05156437|Amoxicillin|amoxicillin|mesh-list
14486600|NCT05156437|Vancomycin|vancomycin|mesh-list
14486601|NCT05156437|Levofloxacin|levofloxacin|mesh-list
14486602|NCT05156437|Rifampin|rifampin|mesh-list
14196222|NCT04596826|Dronabinol|dronabinol|mesh-list
14486603|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
14486604|NCT05156437|Linezolid|linezolid|mesh-list
14486605|NCT05156437|Daptomycin|daptomycin|mesh-list
14486606|NCT05156437|Cephalexin|cephalexin|mesh-list
14486607|NCT05156437|Ampicillin|ampicillin|mesh-list
14486608|NCT05156437|Cefepime|cefepime|mesh-list
14486609|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14486610|NCT05156437|Oxacillin|oxacillin|mesh-list
14486611|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
14486612|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14486613|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486614|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14486615|NCT05156437|Renal Agents|renal agents|mesh-ancestor
14486616|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14486617|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14486618|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486619|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486620|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486621|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14486622|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14486623|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14486624|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
14486625|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
14486626|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14486627|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14486628|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14486629|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14486630|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14486631|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14486632|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14486633|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14486634|NCT05148546|Nivolumab|nivolumab|mesh-list
14486635|NCT05148546|Ipilimumab|ipilimumab|mesh-list
14486636|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14486637|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486638|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14486639|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527647|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
14527648|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527649|NCT03972137|Nicotine|nicotine|mesh-list
14527650|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14527651|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
14527652|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527653|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527654|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14527655|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14527656|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527657|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769708|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769709|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769710|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769711|NCT00640640|Bevacizumab|bevacizumab|mesh-list
14769712|NCT00640640|Ranibizumab|ranibizumab|mesh-list
14196223|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
14196224|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196225|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14196226|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14196227|NCT04596826|Analgesics|analgesics|mesh-ancestor
14196228|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
14196229|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196230|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14196231|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14486640|NCT05146154|Imipenem|imipenem|mesh-list
14486641|NCT05146154|Relebactam|relebactam|mesh-list
14486642|NCT05146154|Cilastatin|cilastatin|mesh-list
14486643|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14486644|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486645|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14486646|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486647|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486648|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14196232|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486649|NCT05143424|Morphine|morphine|mesh-list
14486650|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14486651|NCT05143424|Narcotics|narcotics|mesh-ancestor
14486652|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486653|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486654|NCT05143424|Analgesics|analgesics|mesh-ancestor
14486655|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
14486656|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486657|NCT05132166|Sirolimus|sirolimus|mesh-list
14486658|NCT05132166|Everolimus|everolimus|mesh-list
14486659|NCT05132166|Vedolizumab|vedolizumab|mesh-list
14486660|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14486661|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486662|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486663|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
14486664|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486665|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14486666|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486667|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14486668|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
14486669|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14486670|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
14486671|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
14486672|NCT05115630|Melphalan|melphalan|mesh-list
14486673|NCT05115630|Fludarabine|fludarabine|mesh-list
14486674|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
14486675|NCT05115630|Tacrolimus|tacrolimus|mesh-list
14486676|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486677|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
14486678|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486679|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14486680|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14486681|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
14196233|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196234|NCT04596826|Hormones|hormones|mesh-ancestor
14196235|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196236|NCT04596839|Remdesivir|remdesivir|mesh-list
14196237|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
14196238|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196239|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
14196240|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196241|NCT04597099|Flutamide|flutamide|mesh-list
14196242|NCT04597099|Estradiol|estradiol|mesh-list
14196243|NCT04597099|Progesterone|progesterone|mesh-list
14196244|NCT04597099|Estrogens|estrogens|mesh-ancestor
14196245|NCT04597099|Hormones|hormones|mesh-ancestor
14196246|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196247|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196248|NCT04597099|Progestins|progestins|mesh-ancestor
14196249|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
14196250|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
14196251|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14196252|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196253|NCT04596488|Efavirenz|efavirenz|mesh-list
14196254|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14196255|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14769713|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14769714|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769715|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14486682|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486683|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486684|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14486685|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486686|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
14486687|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14486688|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486689|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14486690|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14486691|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
14486692|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14486693|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486694|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14486695|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
14486696|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14486697|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486698|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14486706|NCT05082155|Bupivacaine|bupivacaine|mesh-list
14486707|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
14486708|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
14486709|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486710|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486711|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
14486712|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486713|NCT05078606|Anesthetics|anesthetics|mesh-list
14486714|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486715|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486716|NCT05055050|Imiquimod|imiquimod|mesh-list
14486717|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14486718|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
14486719|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486720|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486721|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
14486722|NCT05035836|Tamoxifen|tamoxifen|mesh-list
14486723|NCT05035836|Letrozole|letrozole|mesh-list
14486724|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486725|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14486726|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14486727|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486728|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486729|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14486730|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
14486731|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14486732|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486733|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14486734|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14486735|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14486736|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14486737|NCT05028829|Atorvastatin|atorvastatin|mesh-list
14486738|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14486739|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14486740|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
14486741|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486742|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14486743|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14486744|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486745|NCT04990128|Triamcinolone|triamcinolone|mesh-list
14486746|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14486747|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
14486748|NCT04990128|Hormones|hormones|mesh-ancestor
14486749|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14486750|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486751|NCT04969224|Ivacaftor|ivacaftor|mesh-list
14486752|NCT04969224|Elexacaftor|elexacaftor|mesh-list
14486753|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14486754|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486755|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486756|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14486757|NCT04964544|Calcium|calcium|mesh-list
14196256|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196257|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196258|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
14196259|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196260|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14196261|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14196262|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14196263|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14196264|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14196265|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14196266|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
14486758|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14486759|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486760|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14486761|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14486762|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
14486763|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486764|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14486765|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14486766|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486767|NCT04932915|Niclosamide|niclosamide|mesh-list
14486768|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
14196267|NCT04595942|Midodrine|midodrine|mesh-list
14196268|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
14196269|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
14196270|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196271|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196272|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14196273|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14196274|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14196275|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14196276|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
14196277|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196278|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196279|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196280|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
14196281|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14196282|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
14486769|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14486770|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
14486771|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14486772|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486773|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
14486774|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
14486775|NCT04892277|Fludarabine|fludarabine|mesh-list
14486776|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486777|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
14486778|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486779|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14486780|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14486781|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
14486782|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486783|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486784|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14486785|NCT04874038|Lidocaine|lidocaine|mesh-list
14486786|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
14486787|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
14486788|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486789|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486790|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
14486791|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486792|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14486793|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14486794|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14486795|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486796|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486797|NCT04867785|Dulaglutide|dulaglutide|mesh-list
14486798|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14486799|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486800|NCT04845490|Mitomycins|mitomycins|mesh-list
14486801|NCT04845490|Mitomycin|mitomycin|mesh-list
14196283|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196284|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14196285|NCT04595929|Leucovorin|leucovorin|mesh-list
14196286|NCT04595929|Docetaxel|docetaxel|mesh-list
14196287|NCT04595929|Fluorouracil|fluorouracil|mesh-list
14196288|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
14196289|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486802|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14486803|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486804|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
14486805|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486806|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14486807|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486808|NCT04830397|Timolol|timolol|mesh-list
14486809|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14486810|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14486811|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
14486812|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486813|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486814|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486815|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14486816|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14486817|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
14486818|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14486819|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14486820|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486821|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486822|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14486823|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14486824|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486825|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
14486826|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486827|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14486828|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14486829|NCT04819360|Urological Agents|urological agents|mesh-ancestor
14486830|NCT04808466|Paclitaxel|paclitaxel|mesh-list
14486831|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14486832|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486833|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
14486834|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
14486835|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
14486836|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486837|NCT04787354|Capecitabine|capecitabine|mesh-list
14486838|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
14486839|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486840|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
14486841|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486842|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486843|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
14486844|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14486845|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486846|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14486847|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486848|NCT04730206|Camostat|camostat|mesh-list
14486849|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
14486850|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486851|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486852|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14196290|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14196291|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14196292|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14196293|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196294|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
14196295|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14196296|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486853|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14486854|NCT04670679|Cetuximab|cetuximab|mesh-list
14486855|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14486856|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527658|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196297|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
14196298|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196299|NCT04595929|Antidotes|antidotes|mesh-ancestor
14486857|NCT04647916|Camptothecin|camptothecin|mesh-list
14486858|NCT04647916|Irinotecan|irinotecan|mesh-list
14486859|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
14486860|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
14486861|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486862|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14486863|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486864|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14486865|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14486866|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486867|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486868|NCT04631510|Gabapentin|gabapentin|mesh-list
14486869|NCT04631510|Analgesics|analgesics|mesh-ancestor
14486870|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
14486871|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486872|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486873|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
14486874|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14486875|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14486876|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486877|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14486878|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14769716|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14769717|NCT00640640|Growth Substances|growth substances|mesh-ancestor
14769718|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769719|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
14769720|NCT00640679|Clopidogrel|clopidogrel|mesh-list
14769721|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14769722|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14769723|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14196300|NCT04595929|Protective Agents|protective agents|mesh-ancestor
14196301|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
14196302|NCT04595929|Vitamins|vitamins|mesh-ancestor
14196303|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
14196304|NCT04595812|Misoprostol|misoprostol|mesh-list
14196305|NCT04595812|Hemostatics|hemostatics|mesh-list
14196306|NCT04595812|Oxytocin|oxytocin|mesh-list
14196307|NCT04595812|Carbetocin|carbetocin|mesh-list
14196308|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
14196309|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14196310|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769724|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14939771|NCT01489683|Lidocaine|lidocaine|mesh-list
14939772|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
14939773|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
14939774|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939775|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939776|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
14939777|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939778|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14939779|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14939780|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14939781|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939782|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939783|NCT01489696|Tamsulosin|tamsulosin|mesh-list
14939784|NCT01489696|Mirabegron|mirabegron|mesh-list
14939785|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14939786|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14939787|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14939788|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
14939789|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939790|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939791|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196311|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14196312|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
14196313|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14196314|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14196315|NCT04595812|Coagulants|coagulants|mesh-ancestor
14196316|NCT04595981|Cisplatin|cisplatin|mesh-list
14196317|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196318|NCT04595877|Dipyrone|dipyrone|mesh-list
14486879|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14939792|NCT01489696|Urological Agents|urological agents|mesh-ancestor
14769725|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
14196319|NCT04595877|Endorphins|endorphins|mesh-list
14196320|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
14486880|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486881|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486882|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
14486883|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
14486884|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
14486885|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486886|NCT04603898|Protective Agents|protective agents|mesh-ancestor
14486887|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486888|NCT04603898|Vitamins|vitamins|mesh-ancestor
14486889|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
14486890|NCT04590664|Verteporfin|verteporfin|mesh-list
14486891|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14486892|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
14769726|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769727|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769728|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769729|NCT00640705|Diclofenac|diclofenac|mesh-list
14769730|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769731|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769732|NCT00640705|Analgesics|analgesics|mesh-ancestor
14769733|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
14769734|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769735|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769736|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769737|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769738|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769739|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769740|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769741|NCT00640744|Atorvastatin|atorvastatin|mesh-list
14769742|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14769743|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14769744|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
14769745|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769746|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14769747|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14769748|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769749|NCT00640796|Aldesleukin|aldesleukin|mesh-list
14769750|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
14769751|NCT00640796|Fludarabine|fludarabine|mesh-list
14769752|NCT00640796|Interleukin-2|interleukin-2|mesh-list
14769753|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769754|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
14769755|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769756|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769757|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14769758|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
14769759|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769760|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769761|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14769762|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769763|NCT00640796|Analgesics|analgesics|mesh-ancestor
14769764|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
14769765|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769766|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14769767|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14769768|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
14769769|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769770|NCT00640809|Ibuprofen|ibuprofen|mesh-list
14769771|NCT00640809|Celecoxib|celecoxib|mesh-list
14769772|NCT00640809|Omeprazole|omeprazole|mesh-list
14769773|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769774|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769775|NCT00640809|Analgesics|analgesics|mesh-ancestor
14769776|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
14769777|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769778|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769779|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769780|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769781|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769782|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769783|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769784|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14769785|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14769786|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14486893|NCT04582266|Remdesivir|remdesivir|mesh-list
14486894|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
14486895|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486896|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
14486897|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486898|NCT04571619|Buprenorphine|buprenorphine|mesh-list
14486899|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14486900|NCT04571619|Narcotics|narcotics|mesh-ancestor
14486901|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486902|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486903|NCT04571619|Analgesics|analgesics|mesh-ancestor
14486904|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
14486905|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486906|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14486907|NCT04563923|Avdoralimab|avdoralimab|mesh-list
14486908|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14486909|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
14486910|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486911|NCT04555577|Temozolomide|temozolomide|mesh-list
14486912|NCT04555577|Peposertib|peposertib|mesh-list
14486913|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14486914|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
14486915|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486916|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486917|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14486918|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14486919|NCT04542434|Niclosamide|niclosamide|mesh-list
14486920|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
14486921|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14486922|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
14486923|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14486924|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486925|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
14486926|NCT04526795|Cytarabine|cytarabine|mesh-list
14486927|NCT04526795|Fludarabine|fludarabine|mesh-list
14486928|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14486929|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14486930|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
14486931|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486932|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14486933|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
14486934|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486935|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
14486936|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486937|NCT04516057|Nabilone|nabilone|mesh-list
14486938|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
14486939|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
14486940|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486941|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486942|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14486943|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14486944|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14486945|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486946|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14486947|NCT04477850|Luspatercept|luspatercept|mesh-list
14486948|NCT04477850|Hematinics|hematinics|mesh-ancestor
14486949|NCT04477733|Butorphanol|butorphanol|mesh-list
14486950|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14486951|NCT04477733|Narcotics|narcotics|mesh-ancestor
14486952|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486953|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486954|NCT04477733|Analgesics|analgesics|mesh-ancestor
14486955|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
14486956|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486957|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
14486958|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
14486959|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14486960|NCT04436731|Phentolamine|phentolamine|mesh-list
14486961|NCT04436731|Phenylephrine|phenylephrine|mesh-list
14486962|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
14486963|NCT04436731|Norepinephrine|norepinephrine|mesh-list
14486964|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
14486965|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14486966|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14486967|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14486968|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14486969|NCT04436731|Analgesics|analgesics|mesh-ancestor
14486970|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
14486971|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14486972|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14486973|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14486974|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14486975|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
14486976|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14486977|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14486978|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14486979|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
14486980|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
14486981|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
14486982|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14486983|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
14486984|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
14486985|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14486986|NCT04436731|Protective Agents|protective agents|mesh-ancestor
14486987|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14486988|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14486989|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14486990|NCT04436458|Niclosamide|niclosamide|mesh-list
14486991|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
14486992|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14486993|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
14486994|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14486995|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14486996|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
14486997|NCT04428385|Artemisinins|artemisinins|mesh-list
14486998|NCT04428385|Artemisinin|artemisinin|mesh-list
14486999|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
14487000|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14487001|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14487002|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487003|NCT04404088|Rituximab|rituximab|mesh-list
14487004|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14769787|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14769788|NCT00640861|Vaccines|vaccines|mesh-list
14769789|NCT00640861|Sargramostim|sargramostim|mesh-list
14769790|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
14769791|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
14769792|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769793|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14769794|NCT00640887|Ritonavir|ritonavir|mesh-list
14769795|NCT00640887|Lopinavir|lopinavir|mesh-list
14769796|NCT00640887|Nevirapine|nevirapine|mesh-list
14769797|NCT00640887|Efavirenz|efavirenz|mesh-list
14769798|NCT00640887|Rifabutin|rifabutin|mesh-list
14769799|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14769800|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14769801|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
14769802|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769803|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769804|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14769805|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14196321|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14196322|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14196323|NCT04595877|Analgesics|analgesics|mesh-ancestor
14769806|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
14769807|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769808|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14769809|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14769810|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14769811|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14769812|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14769813|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14487005|NCT04404088|Lenalidomide|lenalidomide|mesh-list
14769814|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14196324|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
14196325|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196326|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196327|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196328|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196329|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
14196330|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196331|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196332|NCT04595617|Antibodies|antibodies|mesh-list
14196333|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
14487006|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
14487007|NCT04404088|Antibodies|antibodies|mesh-list
14487008|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
14487009|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14487010|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
14487011|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487012|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487013|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487014|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14487015|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14487016|NCT04404088|Growth Substances|growth substances|mesh-ancestor
14487017|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
14487018|NCT04339101|Sirolimus|sirolimus|mesh-list
14487019|NCT04339101|Fludarabine|fludarabine|mesh-list
14487020|NCT04339101|Melphalan|melphalan|mesh-list
14487021|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
14487022|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14487023|NCT04339101|Tacrolimus|tacrolimus|mesh-list
14196334|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196335|NCT04595318|Varenicline|varenicline|mesh-list
14196336|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14196337|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14196338|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
14196339|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196340|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196341|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196342|NCT04595591|Remifentanil|remifentanil|mesh-list
14196343|NCT04595591|Rocuronium|rocuronium|mesh-list
14487024|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487025|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487026|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487027|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
14487028|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487029|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14487030|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487031|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14487032|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487033|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14487034|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
14487035|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14487036|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
14487037|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14487038|NCT04336098|Gemcitabine|gemcitabine|mesh-list
14487039|NCT04336098|Paclitaxel|paclitaxel|mesh-list
14487040|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
14487041|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14487042|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487043|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487044|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487045|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
14196344|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14196345|NCT04595591|Narcotics|narcotics|mesh-ancestor
14196346|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196347|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196348|NCT04595591|Analgesics|analgesics|mesh-ancestor
14196349|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
14196350|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196351|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14196352|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14196353|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14487046|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487047|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487048|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487049|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
14487050|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
14487051|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487052|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487053|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487054|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
14487055|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487056|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487057|NCT04329728|Dexamethasone|dexamethasone|mesh-list
14487058|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14487059|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487060|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
14196354|NCT04595409|Ustekinumab|ustekinumab|mesh-list
14487061|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
14487062|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487063|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487064|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14487065|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
14487066|NCT04329728|Hormones|hormones|mesh-ancestor
14487067|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487068|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14487069|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487070|NCT04321954|Lenvatinib|lenvatinib|mesh-list
14487071|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487072|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14487073|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487074|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487075|NCT04283656|Tenofovir|tenofovir|mesh-list
14487076|NCT04283656|Lamivudine|lamivudine|mesh-list
14487077|NCT04283656|Spironolactone|spironolactone|mesh-list
14487078|NCT04283656|Estradiol|estradiol|mesh-list
14487079|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
14487080|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487081|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14487082|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14487083|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487084|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487085|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14487086|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14487087|NCT04283656|Estrogens|estrogens|mesh-ancestor
14487088|NCT04283656|Hormones|hormones|mesh-ancestor
14487089|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487090|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196355|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
14238593|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14238594|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238595|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14487091|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14487092|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
14487093|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14487094|NCT04283656|Diuretics|diuretics|mesh-ancestor
14487095|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
14487096|NCT04250805|Lidocaine|lidocaine|mesh-list
14487097|NCT04250805|Ropivacaine|ropivacaine|mesh-list
14487098|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
14487099|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
14487100|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14487101|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487102|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
14487103|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487104|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14487105|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14487106|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14487107|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14487108|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487109|NCT04242173|Cemiplimab|cemiplimab|mesh-list
14487110|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487111|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487112|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
14487113|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14487114|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14487115|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
14487116|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
14487117|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14487118|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487119|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
14487120|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487121|NCT04218773|Phenylephrine|phenylephrine|mesh-list
14769815|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14769816|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14238596|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14238597|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14238598|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
14238599|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14238600|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14238601|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
14238602|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238603|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
14238604|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14487122|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
14487123|NCT04218773|Norepinephrine|norepinephrine|mesh-list
14487124|NCT04218773|Synephrine|synephrine|mesh-list
14487125|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14487126|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
14487127|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
14487128|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487129|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487130|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
14487131|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14487132|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
14487133|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
14487134|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14487135|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14487136|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14487137|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
14487138|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487139|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487140|NCT04218773|Protective Agents|protective agents|mesh-ancestor
14487141|NCT04203160|Gemcitabine|gemcitabine|mesh-list
14487142|NCT04203160|Cisplatin|cisplatin|mesh-list
14487143|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487144|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487145|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
14487146|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487147|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
14487148|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487149|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487150|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487151|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
14487152|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487153|NCT04201262|Ravulizumab|ravulizumab|mesh-list
14487154|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14487155|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487156|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
14487157|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487158|NCT04186286|Propranolol|propranolol|mesh-list
14487159|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14769817|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14769818|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14487160|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14487161|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
14487162|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487163|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487164|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487165|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14487166|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14487167|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14487168|NCT04178460|Niraparib|niraparib|mesh-list
14487169|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14487170|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487171|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487172|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487173|NCT04092894|Suvorexant|suvorexant|mesh-list
14487174|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14487175|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14487176|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14487177|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487178|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14769819|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
14769820|NCT00640939|Diclofenac|diclofenac|mesh-list
14769821|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14769822|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14769823|NCT00640939|Analgesics|analgesics|mesh-ancestor
14769824|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
14769825|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769826|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769827|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769828|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769829|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14769830|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769831|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769832|NCT00640952|Acamprosate|acamprosate|mesh-list
14487179|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487180|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487181|NCT04055012|Metformin|metformin|mesh-list
14487182|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14487183|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487184|NCT04044560|Blinatumomab|blinatumomab|mesh-list
14487185|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487186|NCT03990896|Talazoparib|talazoparib|mesh-list
14487187|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14487188|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487189|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487190|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487191|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
14487192|NCT03959566|Bedaquiline|bedaquiline|mesh-list
14487193|NCT03959566|Midazolam|midazolam|mesh-list
14487194|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14487195|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14487196|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14487197|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487198|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14487199|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14487200|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14487201|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14487202|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
14487203|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
14487204|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
14487205|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
14487206|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487207|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487208|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14487209|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487210|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14487211|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14487212|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487213|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487214|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
14487215|NCT03952130|Insulin|insulin|mesh-list
14487216|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14487217|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
14487218|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
14487219|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14487220|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487221|NCT03922477|Atezolizumab|atezolizumab|mesh-list
14487222|NCT03922477|Magrolimab|magrolimab|mesh-list
14487223|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487224|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14527659|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
14527660|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
14527661|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527662|NCT03984838|Dolutegravir|dolutegravir|mesh-list
14527663|NCT03984838|Rilpivirine|rilpivirine|mesh-list
14527664|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14527665|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14527666|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527667|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527668|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14527669|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14527670|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
14527671|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527672|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14527673|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14527674|NCT03983941|Ropivacaine|ropivacaine|mesh-list
14527675|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527676|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
14527677|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527678|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527679|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
14527680|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527681|NCT03976752|Tenofovir|tenofovir|mesh-list
14527682|NCT03976752|Emtricitabine|emtricitabine|mesh-list
14527683|NCT03976752|Cobicistat|cobicistat|mesh-list
14527684|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14527685|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14527686|NCT03976752|Elvitegravir|elvitegravir|mesh-list
14527687|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
14527688|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769833|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14196356|NCT04594759|Isotretinoin|isotretinoin|mesh-list
14196357|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
14487225|NCT03915405|Avelumab|avelumab|mesh-list
14487226|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487227|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487228|NCT03907176|Acetaminophen|acetaminophen|mesh-list
14487229|NCT03907176|Ibuprofen|ibuprofen|mesh-list
14487230|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14487231|NCT03907176|Analgesics|analgesics|mesh-ancestor
14487232|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
14487233|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487234|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487235|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
14487236|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14487237|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487238|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487239|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14487240|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487241|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487242|NCT03807440|Empagliflozin|empagliflozin|mesh-list
14487243|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14487244|NCT03807440|Linagliptin|linagliptin|mesh-list
14487245|NCT03807440|Metformin|metformin|mesh-list
14487246|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14487247|NCT03807440|Glucagon|glucagon|mesh-list
14487248|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14487249|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487250|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14487251|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487252|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14487253|NCT03807440|Hormones|hormones|mesh-ancestor
14487254|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487255|NCT03807440|Incretins|incretins|mesh-ancestor
14487256|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
14487257|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487258|NCT03801369|Durvalumab|durvalumab|mesh-list
14487259|NCT03801369|Olaparib|olaparib|mesh-list
14487260|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14487261|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
14487262|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14487263|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
14487264|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487265|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487266|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
14487267|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487268|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487269|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487270|NCT03787680|Olaparib|olaparib|mesh-list
14487271|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14487272|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487273|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487274|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487275|NCT03777436|Apremilast|apremilast|mesh-list
14487276|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14487277|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14487278|NCT03777436|Analgesics|analgesics|mesh-ancestor
14487279|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
14769834|NCT00640991|Insulin|insulin|mesh-list
14196358|NCT04594915|Edoxaban|edoxaban|mesh-list
14196359|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14196360|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
14196361|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14196362|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196363|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196364|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196365|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
14196366|NCT04594772|Gemcitabine|gemcitabine|mesh-list
14196367|NCT04594772|Paclitaxel|paclitaxel|mesh-list
14196368|NCT04594772|Fluorouracil|fluorouracil|mesh-list
14196369|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
14196370|NCT04594772|Irinotecan|irinotecan|mesh-list
14196371|NCT04594772|Folfirinox|folfirinox|mesh-list
14196372|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14196373|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196374|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14196375|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14196376|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487280|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487281|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487282|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487283|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487284|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14487285|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14487286|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487287|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487288|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
14487289|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487290|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487291|NCT03759288|Adalimumab|adalimumab|mesh-list
14487292|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487293|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487294|NCT03753919|Durvalumab|durvalumab|mesh-list
14487295|NCT03753919|Tremelimumab|tremelimumab|mesh-list
14487296|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487297|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487298|NCT03675672|Misoprostol|misoprostol|mesh-list
14487299|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14487300|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
14487301|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14487302|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487303|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14487304|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14487305|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
14487306|NCT03664830|Plerixafor|plerixafor|mesh-list
14487307|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14487308|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14769835|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
14769836|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
14769837|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14769838|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769839|NCT00641004|Esomeprazole|esomeprazole|mesh-list
14769840|NCT00641004|Rebamipide|rebamipide|mesh-list
14769841|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14769842|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14769843|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14769844|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769845|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769846|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
14769847|NCT00641004|Protective Agents|protective agents|mesh-ancestor
14769848|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769849|NCT00641030|Melphalan|melphalan|mesh-list
14769850|NCT00641030|Clofarabine|clofarabine|mesh-list
14769851|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14769852|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
14769853|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769854|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769855|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14769856|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769857|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
14769858|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769859|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14769860|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
14769861|NCT00641082|Adefovir|adefovir|mesh-list
14769862|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14769863|NCT00641082|Clevudine|clevudine|mesh-list
14769864|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
14769865|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769866|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14769867|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14769868|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769869|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769870|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
14769871|NCT00641095|Rituximab|rituximab|mesh-list
14769872|NCT00641095|Fludarabine|fludarabine|mesh-list
14769873|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769874|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
14769875|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769876|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14769877|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14769878|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
14769879|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487309|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
14487310|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196377|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196378|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14196379|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
14196380|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
14196381|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196382|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196383|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196384|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
14196385|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196386|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14196387|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14196388|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
14196389|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14196390|NCT04594018|Minoxidil|minoxidil|mesh-list
14196391|NCT04594018|Finasteride|finasteride|mesh-list
14196392|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14196393|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14196394|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769880|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769881|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14769882|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14769883|NCT00641160|Vinorelbine|vinorelbine|mesh-list
14769884|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14769885|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769886|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
14769887|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
14769888|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
14769889|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769890|NCT00641173|Paroxetine|paroxetine|mesh-list
14769891|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14769892|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14769893|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14769894|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769895|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769896|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
14769897|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769898|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14769899|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
14769900|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14769901|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14769902|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14769903|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769904|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
14769905|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14769906|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14769907|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
14769908|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
14769909|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14238605|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14238606|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
14238607|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238608|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238609|NCT00133978|Selenium|selenium|mesh-list
14238610|NCT00133978|Antioxidants|antioxidants|mesh-list
14238611|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238612|NCT00133978|Protective Agents|protective agents|mesh-ancestor
14238613|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238614|NCT00133978|Trace Elements|trace elements|mesh-ancestor
14238615|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
14238616|NCT00133991|Leucovorin|leucovorin|mesh-list
14238617|NCT00133991|Cytarabine|cytarabine|mesh-list
14238618|NCT00133991|Prednisone|prednisone|mesh-list
14238619|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
14238620|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
14238621|NCT00133991|Rituximab|rituximab|mesh-list
14238622|NCT00133991|Methotrexate|methotrexate|mesh-list
14238623|NCT00133991|Vincristine|vincristine|mesh-list
14238624|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238625|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
14238626|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238627|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238628|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238629|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
14238630|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238631|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487311|NCT03639948|Carboplatin|carboplatin|mesh-list
14196395|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196396|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
14196397|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196398|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196399|NCT04594018|Urological Agents|urological agents|mesh-ancestor
14196400|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14196401|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
14196402|NCT04594005|Paclitaxel|paclitaxel|mesh-list
14196403|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14196404|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196405|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14196406|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14196407|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487312|NCT03639948|Docetaxel|docetaxel|mesh-list
14487313|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
14487314|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487315|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487316|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
14487317|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487318|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487319|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487320|NCT03619707|Progesterone|progesterone|mesh-list
14487321|NCT03619707|Progestins|progestins|mesh-ancestor
14487322|NCT03619707|Hormones|hormones|mesh-ancestor
14487323|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487324|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487325|NCT03586999|Nivolumab|nivolumab|mesh-list
14487326|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487327|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487328|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14487329|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487330|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
14487331|NCT03539900|Naltrexone|naltrexone|mesh-list
14487332|NCT03539900|Bupropion|bupropion|mesh-list
14487333|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14487334|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14487335|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487336|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
14487337|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487338|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14487339|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
14487340|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14487341|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14487342|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14487343|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14487344|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487345|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
14487346|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487347|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14487348|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14487349|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487350|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14487351|NCT03500380|Capecitabine|capecitabine|mesh-list
14487352|NCT03500380|Lapatinib|lapatinib|mesh-list
14487353|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487354|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
14487355|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487356|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487357|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14487358|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487359|NCT03494569|Fludarabine|fludarabine|mesh-list
14487360|NCT03494569|Melphalan|melphalan|mesh-list
14487361|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
14487362|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14487363|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487364|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487365|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487366|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
14487367|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487368|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14487369|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
14487370|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14487371|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
14487372|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487373|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487374|NCT03401853|Rituximab|rituximab|mesh-list
14487375|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14487376|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
14487377|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
14487378|NCT03401853|Antibodies|antibodies|mesh-list
14487379|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
14487380|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14487381|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
14487382|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487383|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487384|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487385|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
14487386|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487387|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487388|NCT03389620|Dexamethasone|dexamethasone|mesh-list
14487389|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487390|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
14487391|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
14487392|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487393|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487394|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14487395|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
14487396|NCT03389620|Hormones|hormones|mesh-ancestor
14487397|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487398|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14487399|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487400|NCT03386721|Gemcitabine|gemcitabine|mesh-list
14487401|NCT03386721|Atezolizumab|atezolizumab|mesh-list
14487402|NCT03386721|Vinorelbine|vinorelbine|mesh-list
14487403|NCT03386721|Antibodies|antibodies|mesh-list
14487404|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
14487405|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487406|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487407|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
14487408|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487409|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487410|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
14487411|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769910|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769911|NCT00641212|Budesonide|budesonide|mesh-list
14769912|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769913|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14769914|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
14769915|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769916|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769917|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14769918|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
14769919|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
14769920|NCT00641212|Hormones|hormones|mesh-ancestor
14769921|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14769922|NCT00641264|Omeprazole|omeprazole|mesh-list
14769923|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14769924|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14769925|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14769926|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769927|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769928|NCT00641329|Clonidine|clonidine|mesh-list
14769929|NCT00641329|Analgesics|analgesics|mesh-ancestor
14769930|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
14769931|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769932|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769933|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14769934|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
14939793|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14939794|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14939795|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14939796|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
14939797|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14487412|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487413|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487414|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487415|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487416|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
14769935|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
14487417|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487418|NCT03345849|Upadacitinib|upadacitinib|mesh-list
14487419|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14487420|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14487421|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487422|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487423|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487424|NCT03342001|Calcitonin|calcitonin|mesh-list
14487425|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
14487426|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14487427|NCT03342001|Katacalcin|katacalcin|mesh-list
14487428|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14487429|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487430|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14487431|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
14487432|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
14487433|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487434|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487435|NCT03317119|Trifluridine|trifluridine|mesh-list
14939798|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14939799|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
14487436|NCT03317119|Trametinib|trametinib|mesh-list
14487437|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487438|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14487439|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487440|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487441|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
14487442|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
14487443|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487444|NCT03297710|Trifluridine|trifluridine|mesh-list
14487445|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
14487446|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487447|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
14487448|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487449|NCT03256916|Nelfinavir|nelfinavir|mesh-list
14487450|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14487451|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14487452|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
14487453|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14769936|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14769937|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14769938|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14769939|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
14769940|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14769941|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769942|NCT00641407|Insulin|insulin|mesh-list
14769943|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14769944|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
14769945|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14769946|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769947|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
14769948|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14769949|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14769950|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14769951|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14769952|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14769953|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
14769954|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14769955|NCT00641446|Budesonide|budesonide|mesh-list
14769956|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769957|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14769958|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
14769959|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769960|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769961|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14769962|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
14769963|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
14769964|NCT00641446|Hormones|hormones|mesh-ancestor
14769965|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14769966|NCT00641472|Budesonide|budesonide|mesh-list
14769967|NCT00641472|Montelukast|montelukast|mesh-list
14769968|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14769969|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14769970|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
14487454|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487455|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14939800|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487456|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14487457|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
14487458|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487461|NCT03241771|Naloxone|naloxone|mesh-list
14487462|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14487463|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487464|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
14487465|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487466|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
14487467|NCT03233854|Fludarabine|fludarabine|mesh-list
14487468|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
14487469|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487470|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
14487471|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487472|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487473|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14487474|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
14487475|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487476|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196408|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196409|NCT04594343|Disulfiram|disulfiram|mesh-list
14196410|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14196411|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14196412|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196413|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196414|NCT04593706|Dexamethasone|dexamethasone|mesh-list
14196415|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
14196416|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14196417|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14196418|NCT04593706|Prednisolone|prednisolone|mesh-list
14196419|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
14196420|NCT04593706|Triamcinolone|triamcinolone|mesh-list
14196421|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14196422|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14196423|NCT04593706|Betamethasone|betamethasone|mesh-list
14196424|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
14196425|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14196426|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
14196427|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
14196428|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
14196429|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14196430|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
14196431|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14196432|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14196433|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14196434|NCT04593706|BB 1101|bb 1101|mesh-list
14196435|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196436|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
14196437|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
14196438|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196439|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196440|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14196441|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
14196442|NCT04593706|Hormones|hormones|mesh-ancestor
14196443|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196444|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14196445|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196446|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14196447|NCT04593706|Protective Agents|protective agents|mesh-ancestor
14196448|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487477|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14196449|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
14196450|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196451|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196452|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14196453|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
14196454|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196455|NCT04593836|Peppermint oil|peppermint oil|mesh-list
14196456|NCT04593836|Menthol|menthol|mesh-list
14196457|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
14196458|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
14196459|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
14196460|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
14196461|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487478|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487479|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
14487480|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
14487481|NCT03220776|Gabapentin|gabapentin|mesh-list
14487482|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14487483|NCT03220776|Analgesics|analgesics|mesh-ancestor
14487484|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
14487485|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487486|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487487|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
14487488|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14487489|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14487490|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14487491|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14487492|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14487493|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14487494|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487495|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487496|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
14487497|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
14487498|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487499|NCT03220776|Expectorants|expectorants|mesh-ancestor
14487500|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
14487501|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14487502|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
14487503|NCT03220776|Protective Agents|protective agents|mesh-ancestor
14487504|NCT03220776|Antidotes|antidotes|mesh-ancestor
14769971|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14769972|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769973|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14769974|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
14769975|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
14769976|NCT00641472|Hormones|hormones|mesh-ancestor
14196462|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196463|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14196464|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
14196465|NCT04593654|Dalteparin|dalteparin|mesh-list
14196466|NCT04593654|Tinzaparin|tinzaparin|mesh-list
14196467|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14769977|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14769978|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14769979|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
14769980|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14769981|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14769982|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769983|NCT00641537|Cladribine|cladribine|mesh-list
14769984|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14769985|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14769986|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
14769987|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14769988|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
14769989|NCT00641589|Hematinics|hematinics|mesh-ancestor
14769990|NCT00641602|Esomeprazole|esomeprazole|mesh-list
14769991|NCT00641602|Lansoprazole|lansoprazole|mesh-list
14769992|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
14769993|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14769994|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14769995|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14769996|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807236|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14196468|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
14196469|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14196470|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14196471|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196472|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14196473|NCT04593238|Calcium|calcium|mesh-list
14196474|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14196475|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196476|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196477|NCT04593524|Vitamin D|vitamin d|mesh-list
14196478|NCT04593524|Vitamins|vitamins|mesh-ancestor
14196479|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
14196480|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196481|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14196482|NCT04593329|Dipyrone|dipyrone|mesh-list
14196483|NCT04593329|Tramadol|tramadol|mesh-list
14196484|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14487505|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14487506|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
14487507|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14487508|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
14487509|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14487510|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487511|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14487512|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14487513|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487514|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
14487515|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
14487516|NCT03128359|Melphalan|melphalan|mesh-list
14487517|NCT03128359|Busulfan|busulfan|mesh-list
14487518|NCT03128359|Fludarabine|fludarabine|mesh-list
14487519|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
14487520|NCT03128359|Tacrolimus|tacrolimus|mesh-list
14487521|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196485|NCT04593329|Narcotics|narcotics|mesh-ancestor
14196486|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196487|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196488|NCT04593329|Analgesics|analgesics|mesh-ancestor
14196489|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
14196490|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487522|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
14487523|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487524|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487525|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14487526|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
14487527|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487528|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487529|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14487530|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487531|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
14487532|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14487533|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487534|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14487535|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14487536|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
14487537|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14487538|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487539|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
14487540|NCT03113487|Vaccines|vaccines|mesh-list
14487541|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
14487542|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487543|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487544|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487545|NCT03094884|Paclitaxel|paclitaxel|mesh-list
14487546|NCT03094884|Carboplatin|carboplatin|mesh-list
14487547|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487548|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487549|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487550|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
14487551|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487552|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487553|NCT03091192|Sunitinib|sunitinib|mesh-list
14487554|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487555|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14487556|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14487557|NCT03091192|Growth Substances|growth substances|mesh-ancestor
14487558|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487559|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
14487560|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14487561|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196491|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14196492|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14196493|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196494|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196495|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
14196496|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
14196497|NCT04593446|Cathartics|cathartics|mesh-ancestor
14196498|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14196499|NCT04593160|Acetaminophen|acetaminophen|mesh-list
14196500|NCT04593160|Diclofenac|diclofenac|mesh-list
14196501|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14196502|NCT04593160|Analgesics|analgesics|mesh-ancestor
14196503|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
14196504|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487562|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487563|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
14487564|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14487565|NCT03047005|Naltrexone|naltrexone|mesh-list
14487566|NCT03047005|Bupropion|bupropion|mesh-list
14487567|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14487568|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14487569|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487570|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
14487571|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487572|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14487573|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
14487574|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14487575|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14487576|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14487577|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14487578|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487579|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
14487580|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487581|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14487582|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14487583|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487584|NCT03009240|Decitabine|decitabine|mesh-list
14487585|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14487586|NCT03009240|Pevonedistat|pevonedistat|mesh-list
14487587|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487588|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
14487589|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487590|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487591|NCT03002103|Gemcitabine|gemcitabine|mesh-list
14487592|NCT03002103|Paclitaxel|paclitaxel|mesh-list
14487593|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487594|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487595|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487596|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
14487597|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487598|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487599|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487600|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
14487601|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
14487602|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487603|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487604|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487605|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
14487606|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487607|NCT02996825|Gemcitabine|gemcitabine|mesh-list
14487608|NCT02996825|Maytansine|maytansine|mesh-list
14487609|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487610|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
14487611|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487612|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487613|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
14487614|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487615|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487616|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487617|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
14769997|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14769998|NCT00641654|Interferons|interferons|mesh-list
14769999|NCT00641654|Ribavirin|ribavirin|mesh-list
14770000|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
14770001|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
14770002|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14770003|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770004|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
14770005|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770006|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
14770007|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770008|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
14770009|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770010|NCT00641680|Fluticasone|fluticasone|mesh-list
14770011|NCT00641680|Xhance|xhance|mesh-list
14770012|NCT00641680|Budesonide|budesonide|mesh-list
14770013|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487618|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770014|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14487619|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487620|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487621|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14487622|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487623|NCT02944617|Micronutrients|micronutrients|mesh-list
14487624|NCT02944617|Trace Elements|trace elements|mesh-list
14487625|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527689|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14527690|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14527691|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527692|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527693|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14527694|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14527695|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14527696|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14527697|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14527698|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14770015|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
14770016|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770017|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770018|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14770019|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
14770020|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14770021|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14770022|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
14770023|NCT00641680|Hormones|hormones|mesh-ancestor
14770024|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770025|NCT00641693|Budesonide|budesonide|mesh-list
14770026|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770027|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14770028|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
14770029|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770030|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770031|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14770032|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
14770033|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
14770034|NCT00641693|Hormones|hormones|mesh-ancestor
14770035|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770036|NCT00641758|Pycnogenols|pycnogenols|mesh-list
14770037|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14770038|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
14770039|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770040|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
14770041|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770042|NCT00641758|Protective Agents|protective agents|mesh-ancestor
14770043|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14770044|NCT00641810|Caffeine|caffeine|mesh-list
14770045|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14770046|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527699|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14487650|NCT02865135|Vaccines|vaccines|mesh-list
14487651|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
14487652|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487653|NCT02859558|Tenofovir|tenofovir|mesh-list
14487654|NCT02859558|Emtricitabine|emtricitabine|mesh-list
14487655|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14487656|NCT02859558|Cobicistat|cobicistat|mesh-list
14770047|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14770048|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770049|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770050|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14770051|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14770052|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
14770053|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487657|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14487658|NCT02859558|Elvitegravir|elvitegravir|mesh-list
14807237|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14807238|NCT00820547|Growth Substances|growth substances|mesh-ancestor
14807239|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
14807240|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807241|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
14807242|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
14196505|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196506|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
14807243|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
14807244|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14807245|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14807246|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14196507|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14807247|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14807248|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807249|NCT00820690|Paclitaxel|paclitaxel|mesh-list
14807250|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
14807251|NCT00820690|Doxorubicin|doxorubicin|mesh-list
14807252|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14807253|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807254|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807255|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14807256|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14807257|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807258|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807259|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
14939801|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939802|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807260|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939803|NCT01489709|Urological Agents|urological agents|mesh-ancestor
14939804|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14939805|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14939806|NCT01489852|Estradiol|estradiol|mesh-list
14939807|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14939808|NCT01489852|Estrogens|estrogens|mesh-ancestor
14939809|NCT01489852|Hormones|hormones|mesh-ancestor
14939810|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14939811|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939812|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14939813|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
14939814|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14939815|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14939816|NCT01489865|Fluorouracil|fluorouracil|mesh-list
14196508|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196509|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196510|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14196511|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196512|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196513|NCT04593108|Letrozole|letrozole|mesh-list
14196514|NCT04593108|Misoprostol|misoprostol|mesh-list
14196515|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196516|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14196517|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14196518|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487659|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14487660|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
14487661|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487662|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14487663|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14487664|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487665|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487666|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14487667|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14487668|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14487669|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14487670|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
14487671|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487672|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487673|NCT02632045|Fulvestrant|fulvestrant|mesh-list
14487674|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14487675|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487676|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14487677|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14487678|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
14487679|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487680|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487681|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
14487682|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14487683|NCT02572791|Mupirocin|mupirocin|mesh-list
14487684|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14487685|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487686|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
14487687|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
14487688|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14487689|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14487690|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487691|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487692|NCT02486718|Gemcitabine|gemcitabine|mesh-list
14487693|NCT02486718|Docetaxel|docetaxel|mesh-list
14487694|NCT02486718|Pemetrexed|pemetrexed|mesh-list
14487695|NCT02486718|Atezolizumab|atezolizumab|mesh-list
14487696|NCT02486718|Vinorelbine|vinorelbine|mesh-list
14487697|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487698|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487699|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
14487700|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487701|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
14487702|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196519|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196520|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14196521|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
14196522|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196523|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196524|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14196525|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
14196526|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14196527|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14196528|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14196529|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
14196530|NCT04592952|Calcitonin|calcitonin|mesh-list
14196531|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
14196532|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14196533|NCT04592952|Erenumab|erenumab|mesh-list
14196534|NCT04592952|Katacalcin|katacalcin|mesh-list
14196535|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14196536|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196537|NCT04592952|Analgesics|analgesics|mesh-ancestor
14196538|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
14196539|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196540|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196541|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14487703|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487704|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487705|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
14487706|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487707|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487708|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
14487709|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487710|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14196542|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14196543|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
14196544|NCT04593030|Warfarin|warfarin|mesh-list
14196545|NCT04593030|Apixaban|apixaban|mesh-list
14196546|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
14196547|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14196548|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
14196549|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14196550|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196551|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487711|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14487712|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487713|NCT02481310|Cytarabine|cytarabine|mesh-list
14487714|NCT02481310|Prednisone|prednisone|mesh-list
14487715|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
14487716|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14196552|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238632|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238633|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14238634|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238635|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
14238636|NCT00133991|Hormones|hormones|mesh-ancestor
14238637|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238638|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238639|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14238640|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
14238641|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14238642|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14238643|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
14238644|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
14238645|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238646|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14238647|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238648|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
14238649|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238650|NCT00133991|Antidotes|antidotes|mesh-ancestor
14238651|NCT00133991|Protective Agents|protective agents|mesh-ancestor
14238652|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
14238653|NCT00133991|Vitamins|vitamins|mesh-ancestor
14238654|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
14238655|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14238656|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238657|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238658|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238659|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
14238660|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
14238661|NCT00134004|Fludarabine|fludarabine|mesh-list
14238662|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
14238663|NCT00134004|Tacrolimus|tacrolimus|mesh-list
14238664|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238665|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
14238666|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238667|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238668|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238669|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
14238670|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238671|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238672|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238673|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14238674|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
14238675|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14238676|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238677|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14238678|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14238679|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
14238680|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14238681|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238682|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
14238683|NCT00134017|Busulfan|busulfan|mesh-list
14238684|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196553|NCT04592822|Dabigatran|dabigatran|mesh-list
14196554|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
14196555|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14196556|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196557|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196558|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196559|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
14487717|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14487718|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14487719|NCT02481310|Cortisone|cortisone|mesh-list
14487720|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
14487721|NCT02481310|Rituximab|rituximab|mesh-list
14487722|NCT02481310|Doxorubicin|doxorubicin|mesh-list
14487723|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14487724|NCT02481310|Methotrexate|methotrexate|mesh-list
14487725|NCT02481310|Etoposide|etoposide|mesh-list
14487726|NCT02481310|Vincristine|vincristine|mesh-list
14487727|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
14487728|NCT02481310|Ixazomib|ixazomib|mesh-list
14487729|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
14487730|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14487731|NCT02481310|Antibodies|antibodies|mesh-list
14487732|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
14487733|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14487734|NCT02481310|Glycine|glycine|mesh-list
14487735|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487736|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
14487737|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487738|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487739|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14487740|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
14487741|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487742|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487743|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14487744|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14196560|NCT04592744|Vasopressins|vasopressins|mesh-list
14487745|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14487746|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14487747|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487748|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487749|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
14487750|NCT02481310|Hormones|hormones|mesh-ancestor
14487751|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487752|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14487753|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14487754|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
14487755|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14487756|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487757|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
14487758|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
14487759|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14487760|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14487761|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487762|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
14487763|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487764|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487765|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14487766|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487767|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
13963733|NCT03142516|Panitumumab|panitumumab|mesh-list
13963734|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
13963735|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
13963736|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963737|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13963738|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963739|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963740|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
13963741|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963742|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13963743|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13963744|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963745|NCT03142516|Antidotes|antidotes|mesh-ancestor
13963746|NCT03142516|Protective Agents|protective agents|mesh-ancestor
13963747|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
13963748|NCT03142516|Vitamins|vitamins|mesh-ancestor
13963749|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
13963750|NCT03142516|Hematinics|hematinics|mesh-ancestor
13968010|NCT03113396|Baclofen|baclofen|mesh-list
14487768|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
14487769|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
14487770|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487771|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
14487772|NCT02443324|Ramucirumab|ramucirumab|mesh-list
14487773|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487774|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487775|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
14487776|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487777|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487778|NCT02331134|Lenograstim|lenograstim|mesh-list
14487779|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14487780|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
14487781|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487782|NCT02205762|Cytarabine|cytarabine|mesh-list
14487783|NCT02205762|Prednisone|prednisone|mesh-list
14487784|NCT02205762|Indomethacin|indomethacin|mesh-list
14487785|NCT02205762|Methotrexate|methotrexate|mesh-list
14487786|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
14196561|NCT04592744|Epinephrine|epinephrine|mesh-list
14196562|NCT04592744|Norepinephrine|norepinephrine|mesh-list
14196563|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
14196564|NCT04592744|Giapreza|giapreza|mesh-list
14196565|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
14196566|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14196567|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14196568|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
14196569|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196570|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196571|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487787|NCT02205762|Vinblastine|vinblastine|mesh-list
14487788|NCT02205762|Cladribine|cladribine|mesh-list
14487789|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
14487790|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14487791|NCT02205762|Antibodies|antibodies|mesh-list
14487792|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
14487793|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14487794|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14487795|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
14487796|NCT02205762|Hormones|hormones|mesh-ancestor
14487797|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487798|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487799|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14487800|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487801|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14487802|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
14487803|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14487804|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487805|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
14487806|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487807|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14487808|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487809|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14487810|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487811|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
14487812|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487813|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14487814|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
14487815|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487816|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14487817|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14487818|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14487819|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14487820|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14487821|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14487822|NCT02205762|Analgesics|analgesics|mesh-ancestor
14487823|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
14487824|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487825|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
14487826|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
14487827|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14487828|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
14196572|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14196573|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14487829|NCT02159495|Fludarabine|fludarabine|mesh-list
14487830|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
14487831|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487832|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
14487833|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487834|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770054|NCT00641914|Budesonide|budesonide|mesh-list
14770055|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770056|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14770057|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
14770058|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770059|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770060|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14770061|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
14770062|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
14770063|NCT00641914|Hormones|hormones|mesh-ancestor
14770064|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770065|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
14770066|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14770067|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
14770068|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770069|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770070|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770071|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
14770072|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770073|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770074|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770075|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14770076|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14770077|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770078|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770079|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14770080|NCT00641979|Budesonide|budesonide|mesh-list
14770081|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770082|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14770083|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
14770084|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196574|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
14196575|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196576|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14196577|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
14196578|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
14196579|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
14196580|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14196581|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
14196582|NCT04592744|Coagulants|coagulants|mesh-ancestor
14487835|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14487836|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
14487837|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487838|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487839|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14487840|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487841|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
14487842|NCT02157051|Vaccines|vaccines|mesh-list
14487843|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
14487844|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487845|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
14487846|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14487847|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
14487848|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487849|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
14487850|NCT02136901|Protective Agents|protective agents|mesh-ancestor
14487851|NCT02134301|Oritavancin|oritavancin|mesh-list
14487852|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14487853|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487854|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
14487855|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14487856|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
14487857|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487858|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
14770085|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770086|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14770087|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
14770088|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
14770089|NCT00641979|Hormones|hormones|mesh-ancestor
14770090|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770091|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
14770092|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14770093|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14770094|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770095|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770096|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14770097|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770098|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770099|NCT00642096|Metoprolol|metoprolol|mesh-list
14770100|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14770101|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14770102|NCT00642096|Diuretics|diuretics|mesh-ancestor
14770103|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
14770104|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770105|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14770106|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770107|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770108|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14770109|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
14770110|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
14770111|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770112|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14770113|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14770114|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14770115|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
14770116|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770117|NCT00642122|Budesonide|budesonide|mesh-list
14770118|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770119|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14770120|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
14770121|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770122|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770123|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14770124|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
14770125|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
14770126|NCT00642122|Hormones|hormones|mesh-ancestor
14770127|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770128|NCT00642135|Phenylephrine|phenylephrine|mesh-list
14770129|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
14770130|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14770131|NCT00642135|Tropicamide|tropicamide|mesh-list
14770132|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14770133|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
14770134|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
14196583|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14196584|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
14196585|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14196586|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196587|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196588|NCT04592666|Carboplatin|carboplatin|mesh-list
14487859|NCT02108496|Protective Agents|protective agents|mesh-ancestor
14487860|NCT02069730|Androgens|androgens|mesh-list
14807261|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196589|NCT04592666|Pemetrexed|pemetrexed|mesh-list
14487861|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
14487862|NCT02069730|Hormones|hormones|mesh-ancestor
14487863|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487864|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487865|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
14487866|NCT02057133|Tamoxifen|tamoxifen|mesh-list
14487867|NCT02057133|Trastuzumab|trastuzumab|mesh-list
14487868|NCT02057133|Pertuzumab|pertuzumab|mesh-list
14487869|NCT02057133|Everolimus|everolimus|mesh-list
14487870|NCT02057133|Letrozole|letrozole|mesh-list
14487871|NCT02057133|Fulvestrant|fulvestrant|mesh-list
14487872|NCT02057133|Anastrozole|anastrozole|mesh-list
14487873|NCT02057133|Exemestane|exemestane|mesh-list
14487874|NCT02057133|Loperamide|loperamide|mesh-list
14487875|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14487876|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487877|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487878|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
14487879|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487880|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14487881|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14487882|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487883|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487884|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14487885|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
14487886|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14487887|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14487888|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14487889|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14487890|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14487891|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14487892|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
14487893|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14487894|NCT02056236|Midazolam|midazolam|mesh-list
14196590|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196591|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196592|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487895|NCT02056236|Levetiracetam|levetiracetam|mesh-list
14487896|NCT02056236|Valproic Acid|valproic acid|mesh-list
14487897|NCT02056236|Lorazepam|lorazepam|mesh-list
14487898|NCT02056236|Thiopental|thiopental|mesh-list
14487899|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
14487900|NCT02056236|Propofol|propofol|mesh-list
14487901|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14487902|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14487903|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487904|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14487905|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
14487906|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
14487907|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14487908|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14487909|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14487910|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14487911|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
14487912|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
14487913|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487914|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487915|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
14487916|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487917|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
14487918|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
14487919|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
14487920|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487921|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14487922|NCT02007044|Rituximab|rituximab|mesh-list
14487923|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14487924|NCT02007044|Antibodies|antibodies|mesh-list
14487925|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
14487926|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14487927|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
14487928|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487929|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939817|NCT01489865|Veliparib|veliparib|mesh-list
14196593|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14196594|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14196595|NCT04593056|Warfarin|warfarin|mesh-list
14196596|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
14196597|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
14487930|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14487931|NCT01962246|Capecitabine|capecitabine|mesh-list
14487932|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
14487933|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14487934|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
14487935|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487936|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487937|NCT01810705|Asparaginase|asparaginase|mesh-list
14487938|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487939|NCT01568918|Tamsulosin|tamsulosin|mesh-list
14487940|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14487941|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14487942|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14487943|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
14487944|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487945|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487946|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487947|NCT01568918|Urological Agents|urological agents|mesh-ancestor
14487948|NCT01517243|Sirolimus|sirolimus|mesh-list
14487949|NCT01517243|Sunitinib|sunitinib|mesh-list
14487950|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14487951|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14487952|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14487953|NCT01517243|Growth Substances|growth substances|mesh-ancestor
14487954|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487955|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
14487956|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14487957|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14487958|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487959|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14487960|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487961|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14487962|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
14487963|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14487964|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
14487965|NCT01269190|Proflavine|proflavine|mesh-list
14487966|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14487967|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14487968|NCT00667121|Tamoxifen|tamoxifen|mesh-list
14487969|NCT00667121|Gabapentin|gabapentin|mesh-list
14770135|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770136|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770137|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
14770138|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14770139|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
14770140|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
14770141|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14770142|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14770143|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14770144|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
14770145|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770146|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770147|NCT00642135|Protective Agents|protective agents|mesh-ancestor
14770148|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14770149|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14770150|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14770151|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
14770152|NCT00642161|Budesonide|budesonide|mesh-list
14770153|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770154|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14770155|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
14770156|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770157|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770158|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14770159|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
14196598|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14196599|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
14196600|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14196601|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196602|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196603|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196604|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
14196605|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14770160|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
14487970|NCT00667121|Dexetimide|dexetimide|mesh-list
14487971|NCT00667121|Citalopram|citalopram|mesh-list
14487972|NCT00667121|Sertraline|sertraline|mesh-list
14487973|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14487974|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14487975|NCT00667121|Analgesics|analgesics|mesh-ancestor
14487976|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
14487977|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14487978|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14487979|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
14487980|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14487981|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14487982|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14487983|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14487984|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14487985|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14487986|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14487987|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
14487988|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14487989|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14487990|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14487991|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
14487992|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14487993|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
14487994|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14487995|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14487996|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
14487997|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
14487998|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14487999|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14770161|NCT00642161|Hormones|hormones|mesh-ancestor
14770162|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770163|NCT00642187|Budesonide|budesonide|mesh-list
14770164|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770165|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14770166|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
14770167|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770168|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770169|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14770170|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
14770171|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
14770172|NCT00642187|Hormones|hormones|mesh-ancestor
14770173|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770174|NCT00642226|Triamcinolone|triamcinolone|mesh-list
14770175|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770176|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
14770177|NCT00642226|Hormones|hormones|mesh-ancestor
14770178|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770179|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770180|NCT00642252|Fluorides|fluorides|mesh-list
14196606|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196607|NCT04593043|Warfarin|warfarin|mesh-list
14196608|NCT04593043|Dabigatran|dabigatran|mesh-list
14196609|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
14196610|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
14196611|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14196612|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196613|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196614|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488000|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
14488001|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14488002|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
14488003|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14488004|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14488005|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488006|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14488007|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14488008|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14488009|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14488010|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
14488011|NCT00641381|Carmustine|carmustine|mesh-list
14488012|NCT00641381|Etoposide|etoposide|mesh-list
14488013|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488014|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
14488015|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488016|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488017|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488018|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
14488019|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488020|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488021|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14488022|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488023|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488024|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488025|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488026|NCT00544414|Leucovorin|leucovorin|mesh-list
14488027|NCT00544414|Gemcitabine|gemcitabine|mesh-list
14488028|NCT00544414|Docetaxel|docetaxel|mesh-list
14488029|NCT00544414|Fluorouracil|fluorouracil|mesh-list
14488030|NCT00544414|Calcium|calcium|mesh-list
14488031|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
14488032|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488033|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14488034|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
14488035|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488036|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
14488037|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488038|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196615|NCT04592211|Paclitaxel|paclitaxel|mesh-list
14196616|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
14196617|NCT04592211|Olaparib|olaparib|mesh-list
14196618|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14196619|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196620|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
14196621|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
14196622|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
14196623|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196624|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196625|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14939818|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
14939819|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939820|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14939821|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939822|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196626|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196627|NCT04592159|Nabiximols|nabiximols|mesh-list
14196628|NCT04592159|Analgesics|analgesics|mesh-ancestor
14488039|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488040|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
14488041|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488042|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
14488043|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
14488044|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
14488045|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14488046|NCT00544414|Antidotes|antidotes|mesh-ancestor
14488047|NCT00544414|Protective Agents|protective agents|mesh-ancestor
14488048|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
14488049|NCT00544414|Vitamins|vitamins|mesh-ancestor
14488050|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
14939823|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
14488051|NCT00534469|Cytarabine|cytarabine|mesh-list
14488052|NCT00534469|Aldesleukin|aldesleukin|mesh-list
14488053|NCT00534469|Etoposide|etoposide|mesh-list
14488054|NCT00534469|Idarubicin|idarubicin|mesh-list
14488055|NCT00534469|Busulfan|busulfan|mesh-list
14488056|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488057|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488058|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488059|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488060|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488061|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488062|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14488063|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
14488064|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
14488065|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196629|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
14488066|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488067|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
14488068|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488069|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
14488070|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488071|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14196630|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196631|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196632|NCT04592419|Aflibercept|aflibercept|mesh-list
14196633|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14196634|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14196635|NCT04592419|Growth Substances|growth substances|mesh-ancestor
14196636|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196637|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
14196638|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196639|NCT04592380|Clevidipine|clevidipine|mesh-list
14196640|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14196641|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14196642|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14196643|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14196644|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14196645|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14196646|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196647|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14196648|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196649|NCT04592198|Palonosetron|palonosetron|mesh-list
14196650|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
14196651|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
14196652|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196653|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196654|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14196655|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14196656|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14488072|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14488073|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14488074|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14488075|NCT00534430|Cyclosporine|cyclosporine|mesh-list
14488076|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
14488077|NCT00534430|Etoposide|etoposide|mesh-list
14488078|NCT00534430|Busulfan|busulfan|mesh-list
14488079|NCT00534430|Cyclosporins|cyclosporins|mesh-list
14488080|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488081|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488082|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488083|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488084|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488085|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488086|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488087|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
14488088|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488089|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
14488090|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488091|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
14488092|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488093|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14488094|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14488095|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14488096|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
14488097|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14488098|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
14488099|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488100|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14488101|NCT00003927|Paclitaxel|paclitaxel|mesh-list
14488102|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
14488103|NCT00003927|Doxorubicin|doxorubicin|mesh-list
14488104|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14488105|NCT00003927|Amifostine|amifostine|mesh-list
14488106|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488107|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488108|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
14488109|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
14488110|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
14488111|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488112|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488113|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
14488114|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488115|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488116|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488117|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
14488118|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14488119|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14488120|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488121|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488122|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488123|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14488124|NCT00003927|Protective Agents|protective agents|mesh-ancestor
14488125|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14488126|NCT02588261|Gefitinib|gefitinib|mesh-list
14488127|NCT02588261|Naquotinib|naquotinib|mesh-list
14488128|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939824|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939825|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14939826|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939827|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
14939828|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14939829|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14939830|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14488129|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14488130|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488131|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488132|NCT02588339|Sirolimus|sirolimus|mesh-list
14488133|NCT02588339|Panobinostat|panobinostat|mesh-list
14488134|NCT02588339|Tacrolimus|tacrolimus|mesh-list
14488135|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488136|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
14488137|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488138|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14488139|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488140|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488141|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14488142|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488143|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14488144|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488145|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
14488146|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14488147|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14488148|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
14488149|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488150|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
14488151|NCT02588612|Fludarabine|fludarabine|mesh-list
14488152|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488153|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
14488154|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488155|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488156|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488157|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
14488158|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488159|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488160|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14939831|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14488161|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
14488162|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14488163|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
14488164|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488165|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
14488166|NCT02588872|Protective Agents|protective agents|mesh-ancestor
14488167|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
14488168|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14488169|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14488170|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770181|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
14770182|NCT00642252|Protective Agents|protective agents|mesh-ancestor
14770183|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196657|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
14196658|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196659|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196660|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
14196661|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14770184|NCT00642291|Emtricitabine|emtricitabine|mesh-list
14196662|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14196663|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14196664|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196665|NCT04592081|Dexamethasone|dexamethasone|mesh-list
14196666|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
14196667|NCT04592081|BB 1101|bb 1101|mesh-list
14196668|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196669|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
14196670|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
14196671|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196672|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196673|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14196674|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
14196675|NCT04592081|Hormones|hormones|mesh-ancestor
14770185|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
14770186|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770187|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14770188|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14770189|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770190|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770191|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14770192|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14770193|NCT00642330|Ibuprofen|ibuprofen|mesh-list
14770194|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14770195|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14770196|NCT00642330|Analgesics|analgesics|mesh-ancestor
14770197|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
14770198|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770199|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770200|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770201|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770202|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14770203|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770204|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770205|NCT00642395|Bortezomib|bortezomib|mesh-list
14770206|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770207|NCT00642408|Micronutrients|micronutrients|mesh-list
14770208|NCT00642408|Trace Elements|trace elements|mesh-list
14770209|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770210|NCT00642421|Octreotide|octreotide|mesh-list
14770211|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14770212|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14770213|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770214|NCT00642434|Metoprolol|metoprolol|mesh-list
14770215|NCT00642434|Carvedilol|carvedilol|mesh-list
14770216|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14196676|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196677|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14488171|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
14488172|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
14488173|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14488174|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
14488175|NCT02589626|Empagliflozin|empagliflozin|mesh-list
14488176|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14488177|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770217|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14770218|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
14196678|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196679|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196680|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196681|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196682|NCT04591795|Diclofenac|diclofenac|mesh-list
14196683|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14196684|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14488178|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14488179|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488180|NCT02589639|Empagliflozin|empagliflozin|mesh-list
14488181|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14488182|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488183|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14488184|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488185|NCT02589665|Mirikizumab|mirikizumab|mesh-list
14488186|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14196685|NCT04591795|Analgesics|analgesics|mesh-ancestor
14196686|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
14196687|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196688|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196689|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196690|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196691|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14196692|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196693|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196694|NCT04591743|Nicotine|nicotine|mesh-list
14196695|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14196696|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
14196697|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196698|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196699|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14196700|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14196701|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
14196702|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196703|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196704|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
14196705|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14196706|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196707|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14196708|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196709|NCT04592016|Diclofenac|diclofenac|mesh-list
14196710|NCT04592016|Coal Tar|coal tar|mesh-list
14488187|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14488188|NCT02589665|Analgesics|analgesics|mesh-ancestor
14488189|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
14488190|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488191|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488192|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488193|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488194|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14488195|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14488196|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14488197|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14488198|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488199|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
14196711|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14196712|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14196713|NCT04592016|Analgesics|analgesics|mesh-ancestor
14196714|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
14488200|NCT02589977|Regadenoson|regadenoson|mesh-list
14488201|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14488202|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14488203|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
14488204|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
14488205|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488206|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488207|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488208|NCT02590003|Paclitaxel|paclitaxel|mesh-list
14488209|NCT02590003|Carboplatin|carboplatin|mesh-list
14488210|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488211|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488212|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
14196715|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196716|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196717|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196718|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196719|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14196720|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196721|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196722|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
14196723|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
14196724|NCT04592029|Bevacizumab|bevacizumab|mesh-list
14196725|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196726|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196727|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14196728|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14196729|NCT04592029|Growth Substances|growth substances|mesh-ancestor
14196730|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196731|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
14488213|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
14488214|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
14488215|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488216|NCT02590432|Linaclotide|linaclotide|mesh-list
14488217|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14488218|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
14488219|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488220|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14488221|NCT02590588|Idelalisib|idelalisib|mesh-list
14196732|NCT04591847|Vitamin D|vitamin d|mesh-list
14196733|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
14196734|NCT04591847|Vitamins|vitamins|mesh-ancestor
14196735|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
14196736|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196737|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14488222|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488223|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488224|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488225|NCT02591238|Melatonin|melatonin|mesh-list
14488226|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
14488227|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488228|NCT02591238|Protective Agents|protective agents|mesh-ancestor
14488229|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488230|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488231|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
14488232|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14196738|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14196739|NCT04591535|Levodopa|levodopa|mesh-list
14196740|NCT04591535|Carbidopa|carbidopa|mesh-list
14196741|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14196742|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14196743|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14196744|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
14196745|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196746|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196747|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196748|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14196749|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196750|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14196751|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
14196752|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
14196753|NCT04591444|Fluorides|fluorides|mesh-list
14196754|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
14196755|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
14488233|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488234|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14488235|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488236|NCT02592434|Tofacitinib|tofacitinib|mesh-list
14488237|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14488238|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488239|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488240|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14488241|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
14488242|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488243|NCT02592629|Triamcinolone|triamcinolone|mesh-list
14488244|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14488245|NCT02592629|Lidocaine|lidocaine|mesh-list
14488246|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
14488247|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
14488248|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
14488249|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488250|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488251|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
14488252|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488253|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14488254|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14488255|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14488256|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14488257|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488258|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488259|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
14488260|NCT02592629|Hormones|hormones|mesh-ancestor
14488261|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14488262|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196756|NCT04591444|Protective Agents|protective agents|mesh-ancestor
14196757|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196758|NCT04591457|Insulin|insulin|mesh-list
14196759|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14196760|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
14196761|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14196762|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196763|NCT04591327|Anesthetics|anesthetics|mesh-list
14488263|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
14527700|NCT03976466|Calcium|calcium|mesh-list
14527701|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14527702|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527703|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527704|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
14527705|NCT03979066|Atezolizumab|atezolizumab|mesh-list
14527706|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527707|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
14527708|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14527709|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527710|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14527711|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
14527712|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527713|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
14527714|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527715|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
14527716|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14527717|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
14527718|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527719|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
14527720|NCT03967444|Protective Agents|protective agents|mesh-ancestor
14527721|NCT03966365|Timolol|timolol|mesh-list
14527722|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14527723|NCT03966365|Dorzolamide|dorzolamide|mesh-list
14527724|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14770219|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
14770220|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770221|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770222|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14770223|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14770224|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14770225|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14770226|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770227|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196764|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196765|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196766|NCT04591275|Denosumab|denosumab|mesh-list
14527725|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14488264|NCT02592798|Abatacept|abatacept|mesh-list
14939832|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939833|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
14939834|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939835|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939836|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14196767|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14196768|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488265|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14488266|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488267|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488268|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488269|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
14488270|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488271|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238685|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
14238686|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238687|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238688|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238689|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
14238690|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488272|NCT02592876|Rituximab|rituximab|mesh-list
14488273|NCT02592876|Carboplatin|carboplatin|mesh-list
14488274|NCT02592876|Etoposide|etoposide|mesh-list
14488275|NCT02592876|Ifosfamide|ifosfamide|mesh-list
14488276|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488277|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488278|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
14488279|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488280|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488281|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488282|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488283|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488284|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488285|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488286|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488287|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
14488288|NCT02593097|Metformin|metformin|mesh-list
14488289|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14488290|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488291|NCT02593305|Methamphetamine|methamphetamine|mesh-list
14488292|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14488293|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488294|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
14488295|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
14488296|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488297|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
14488298|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488299|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488300|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
14488301|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14488302|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14488303|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238691|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238692|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238693|NCT00134043|Vorinostat|vorinostat|mesh-list
14238694|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238695|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14238696|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238697|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238698|NCT00134056|Prednisone|prednisone|mesh-list
14238699|NCT00134056|Docetaxel|docetaxel|mesh-list
14238700|NCT00134056|Atrasentan|atrasentan|mesh-list
14238701|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238702|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238703|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238704|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238705|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238706|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238707|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
14238708|NCT00134056|Hormones|hormones|mesh-ancestor
14238709|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14488304|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14488305|NCT02593396|Bupropion|bupropion|mesh-list
14488306|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14488307|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
14488308|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14488309|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14488310|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14488311|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14488312|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488313|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
14488314|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488315|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488316|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14488317|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14488318|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488319|NCT02593539|Nemiralisib|nemiralisib|mesh-list
14488320|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14488321|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488322|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488323|NCT02593773|Interferons|interferons|mesh-list
14488324|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
14488325|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488326|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
14488327|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488328|NCT02593903|Trimethoprim|trimethoprim|mesh-list
14488329|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14488330|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
14488331|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14488332|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196769|NCT04591600|Ivermectin|ivermectin|mesh-list
14196770|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14196771|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196772|NCT04591405|Vaccines|vaccines|mesh-list
14196773|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
14196774|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196775|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
14196776|NCT04591210|Giapreza|giapreza|mesh-list
14196777|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14196778|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
14196779|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14196780|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14196781|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196782|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14196783|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14196784|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196785|NCT04590742|Melatonin|melatonin|mesh-list
14196786|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
14196787|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196788|NCT04590742|Protective Agents|protective agents|mesh-ancestor
14196789|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196790|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488333|NCT02593903|Renal Agents|renal agents|mesh-ancestor
14488334|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
14488335|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14488336|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14488337|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14488338|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488339|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488340|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14488341|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14488342|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14488343|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14488344|NCT02594111|Colchicine|colchicine|mesh-list
14488345|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
14488346|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488347|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14488348|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14488349|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14488350|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488351|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488352|NCT02594163|Rituximab|rituximab|mesh-list
14488353|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14488354|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14196791|NCT04590638|Epinephrine|epinephrine|mesh-list
14527726|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
14488355|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488356|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196792|NCT04590638|Racepinephrine|racepinephrine|mesh-list
14196793|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
14196794|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14196795|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14196796|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
14196797|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196798|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196799|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196800|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14196801|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14196802|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
14196803|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196804|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14196805|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
14196806|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
14196807|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
14196808|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14196809|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14196810|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14196811|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14196812|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
14196813|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488357|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
14488358|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770228|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
14770229|NCT00642434|Protective Agents|protective agents|mesh-ancestor
14770230|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14770231|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770232|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14770233|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
14770234|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14770235|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14770236|NCT00642499|Dronabinol|dronabinol|mesh-list
14770237|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
14770238|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770239|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770240|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14770241|NCT00642499|Analgesics|analgesics|mesh-ancestor
14770242|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
14770243|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770244|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14770245|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14770246|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770247|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770248|NCT00642499|Hormones|hormones|mesh-ancestor
14770249|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770250|NCT00642512|Dronabinol|dronabinol|mesh-list
14770251|NCT00642512|Ondansetron|ondansetron|mesh-list
14770252|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
14770253|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
14770254|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770255|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770256|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939837|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488359|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488360|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488361|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
14488362|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488363|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14770257|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
14770258|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
14770259|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14770260|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
14939838|NCT01489917|Heparin|heparin|mesh-list
14488364|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14488365|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
14488366|NCT02595398|Triamcinolone|triamcinolone|mesh-list
14488367|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14488368|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14488369|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14488370|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488371|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
14488372|NCT02595398|Hormones|hormones|mesh-ancestor
14488373|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14488374|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488375|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488376|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
14488377|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488378|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196814|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14196815|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14196816|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196817|NCT04590820|Rituximab|rituximab|mesh-list
14196818|NCT04590820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196819|NCT04590820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196820|NCT04590820|Immunologic Factors|immunologic factors|mesh-ancestor
14196821|NCT04590820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196822|NCT04590820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196823|NCT04590612|Levodopa|levodopa|mesh-list
14488379|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14488380|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488381|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14488382|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488383|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488384|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14488385|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14488386|NCT02595684|Tadalafil|tadalafil|mesh-list
14488387|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
14488388|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14488389|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14488390|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488391|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488392|NCT02595684|Urological Agents|urological agents|mesh-ancestor
14488393|NCT02595723|Megestrol|megestrol|mesh-list
14488394|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
14488395|NCT02595723|Phenytoin|phenytoin|mesh-list
14488396|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14488397|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14488398|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14488399|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
14488400|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14488401|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488402|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14488403|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14488404|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14196824|NCT04590612|Carbidopa|carbidopa|mesh-list
14196825|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14196826|NCT04590612|Citalopram|citalopram|mesh-list
14196827|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14488405|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488406|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
14488407|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14488408|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
14488409|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14488410|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14488411|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14488412|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488413|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14488414|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14488415|NCT02595749|Oxytocin|oxytocin|mesh-list
14488416|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
14488417|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14196828|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14488418|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488419|NCT02596022|Ketamine|ketamine|mesh-list
14488420|NCT02596022|Analgesics|analgesics|mesh-ancestor
14488421|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
14488422|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488423|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488424|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14488425|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14488426|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
14488427|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
14488428|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488429|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14488430|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14488431|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488432|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488433|NCT02596035|Nivolumab|nivolumab|mesh-list
14488434|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488435|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488436|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14488437|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488438|NCT02596451|Diclofenac|diclofenac|mesh-list
14488439|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14488440|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14488441|NCT02596451|Analgesics|analgesics|mesh-ancestor
14196829|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14196830|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
14488442|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
14488443|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770261|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770262|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770263|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14770264|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770265|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770266|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770267|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14770268|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
14770269|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939839|NCT01489917|Hemostatics|hemostatics|mesh-list
14939840|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
14939841|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14939842|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14939843|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939844|NCT01489917|Coagulants|coagulants|mesh-ancestor
14939845|NCT01489943|Pioglitazone|pioglitazone|mesh-list
14939846|NCT01489943|Midazolam|midazolam|mesh-list
14939847|NCT01489943|Omeprazole|omeprazole|mesh-list
14939848|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14939849|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14939850|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14939851|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196831|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196832|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196833|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196834|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14196835|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488444|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488445|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488446|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770270|NCT00642512|Analgesics|analgesics|mesh-ancestor
14770271|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
14770272|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14939852|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939853|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14488447|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14488448|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488449|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488450|NCT02596620|Amoxicillin|amoxicillin|mesh-list
14488451|NCT02596620|Metronidazole|metronidazole|mesh-list
14488452|NCT02596620|Levofloxacin|levofloxacin|mesh-list
14488453|NCT02596620|Esomeprazole|esomeprazole|mesh-list
14488454|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770273|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14939854|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14939855|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14488455|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488456|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14488457|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14770274|NCT00642512|Hormones|hormones|mesh-ancestor
14770275|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770276|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
14770277|NCT00642551|Vitamin K|vitamin k|mesh-list
14770278|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
14770279|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14770280|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14770281|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770282|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
14196836|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14196837|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14196838|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14196839|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
14196840|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14196841|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
14196842|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14196843|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14770283|NCT00642551|Coagulants|coagulants|mesh-ancestor
14770284|NCT00642551|Vitamins|vitamins|mesh-ancestor
14770285|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
14770286|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770287|NCT00642577|Leucovorin|leucovorin|mesh-list
14770288|NCT00642577|Bevacizumab|bevacizumab|mesh-list
14770289|NCT00642577|Fluorouracil|fluorouracil|mesh-list
14770290|NCT00642577|Irinotecan|irinotecan|mesh-list
14770291|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14770292|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770293|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14770294|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14770295|NCT00642577|Growth Substances|growth substances|mesh-ancestor
14770296|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770297|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
14770298|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
14770299|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770300|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14770301|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14770302|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
14770303|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14770304|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14770305|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770306|NCT00642577|Antidotes|antidotes|mesh-ancestor
14770307|NCT00642577|Protective Agents|protective agents|mesh-ancestor
14770308|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
14770309|NCT00642577|Vitamins|vitamins|mesh-ancestor
14770310|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
14770311|NCT00642655|Rituximab|rituximab|mesh-list
14770312|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196844|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
14196845|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
14196846|NCT04590625|Carboplatin|carboplatin|mesh-list
14196847|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14196848|NCT04590625|Apatinib|apatinib|mesh-list
14196849|NCT04590625|Cisplatin|cisplatin|mesh-list
14196850|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196851|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196852|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14196853|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488458|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14488459|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14488460|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14488461|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488462|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488463|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14488464|NCT02596620|Renal Agents|renal agents|mesh-ancestor
14488465|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488466|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488467|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488468|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14488469|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14488470|NCT02596711|Nicotine|nicotine|mesh-list
14488471|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
14770313|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770314|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
14488472|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14488473|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
14488474|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488475|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488476|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14488477|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14488478|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
14488479|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488480|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770315|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770316|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770317|NCT00642681|Insulin|insulin|mesh-list
14770318|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14770319|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770320|NCT00642733|Gemcitabine|gemcitabine|mesh-list
14939856|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14939857|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
14939858|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
14939859|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
14939860|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
14939861|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939862|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939863|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14939864|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14939865|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
14939866|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14939867|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14939868|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939869|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939870|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14939871|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939872|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14939873|NCT01489982|Zopiclone|zopiclone|mesh-list
14939874|NCT01489982|Doxepin|doxepin|mesh-list
14939875|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14939876|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939877|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939878|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14939879|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14939880|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
14939881|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14939882|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
14939883|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
14939884|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939885|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939886|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
14939887|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
14939888|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939889|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939890|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939891|NCT01490047|Etanercept|etanercept|mesh-list
14939892|NCT01490047|Doxorubicin|doxorubicin|mesh-list
14939893|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14939894|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14939895|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939896|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14939897|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14939898|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939899|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770321|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14770322|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14770323|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
14770324|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770325|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770326|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
14770327|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770328|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770329|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14770330|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
14770331|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770332|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14770333|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14770334|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14488481|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
14488482|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
14488483|NCT02596867|Propranolol|propranolol|mesh-list
14488484|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14488485|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14488486|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
14488487|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488488|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488489|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488490|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14488491|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14488492|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
14488493|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
14488494|NCT02596945|Hematinics|hematinics|mesh-ancestor
14488495|NCT02596958|Bevacizumab|bevacizumab|mesh-list
14488496|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488497|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488498|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14488499|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14488500|NCT02596958|Growth Substances|growth substances|mesh-ancestor
14488501|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488502|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
14488503|NCT02596971|Prednisone|prednisone|mesh-list
14488504|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
14488505|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14488506|NCT02596971|Rituximab|rituximab|mesh-list
14488507|NCT02596971|Doxorubicin|doxorubicin|mesh-list
14488508|NCT02596971|Vincristine|vincristine|mesh-list
14488509|NCT02596971|Atezolizumab|atezolizumab|mesh-list
14488510|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
14488511|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488512|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
14488513|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488514|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488515|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488516|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
14488517|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488518|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488519|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14488520|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488521|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14488522|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488523|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488524|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488525|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488526|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
14488527|NCT02596971|Hormones|hormones|mesh-ancestor
14488528|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14488529|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14488530|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488531|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
14488532|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
14488533|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
14488534|NCT02597049|Metformin|metformin|mesh-list
14488535|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
14488536|NCT02597049|Empagliflozin|empagliflozin|mesh-list
14488537|NCT02597049|Canagliflozin|canagliflozin|mesh-list
14488538|NCT02597049|Dulaglutide|dulaglutide|mesh-list
14488539|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14488540|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14488541|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488542|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488543|NCT02597101|Metformin|metformin|mesh-list
14488544|NCT02597101|Saxagliptin|saxagliptin|mesh-list
14488545|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14488546|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488547|NCT02597101|Incretins|incretins|mesh-ancestor
14488548|NCT02597101|Hormones|hormones|mesh-ancestor
14488549|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14488550|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14488551|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
14488552|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488553|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488554|NCT02597478|Fentanyl|fentanyl|mesh-list
14488555|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14488556|NCT02597478|Narcotics|narcotics|mesh-ancestor
14488557|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488558|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488559|NCT02597478|Analgesics|analgesics|mesh-ancestor
14488560|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
14488561|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488562|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14488563|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14488564|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
14488565|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
14488566|NCT02597543|Regadenoson|regadenoson|mesh-list
14488567|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14488568|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14488569|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
14488570|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
14488571|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488572|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488573|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488574|NCT02597855|Aflibercept|aflibercept|mesh-list
14488575|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14488576|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14488577|NCT02597855|Growth Substances|growth substances|mesh-ancestor
14488578|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488579|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
14488580|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488581|NCT02597907|Aprepitant|aprepitant|mesh-list
14488582|NCT02597907|Palonosetron|palonosetron|mesh-list
14488583|NCT02597907|Ramosetron|ramosetron|mesh-list
14488584|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
13963751|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488585|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
14488586|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488587|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488588|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14488589|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14488590|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488591|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488592|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14488593|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14488594|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
14488595|NCT02597933|Nintedanib|nintedanib|mesh-list
14488596|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488597|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14488598|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488599|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488600|NCT02597946|Paclitaxel|paclitaxel|mesh-list
14488601|NCT02597946|Afatinib|afatinib|mesh-list
14488602|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14488603|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488604|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
14488605|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
14488606|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
14488607|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488608|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14488609|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488610|NCT02598193|Pirfenidone|pirfenidone|mesh-list
14488611|NCT02598193|Nintedanib|nintedanib|mesh-list
14488612|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488613|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14488614|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488615|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488616|NCT02598193|Analgesics|analgesics|mesh-ancestor
13963752|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
13963753|NCT03142165|Promethazine|promethazine|mesh-list
13963754|NCT03142165|Famotidine|famotidine|mesh-list
13963755|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13963756|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14196854|NCT04590183|Prednisolone|prednisolone|mesh-list
14196855|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14196856|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
14196857|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14196858|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
14196859|NCT04590183|Tacrolimus|tacrolimus|mesh-list
14196860|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14196861|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
14196862|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14196863|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
14488617|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
14488618|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488619|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488620|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14488621|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14488622|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488623|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488624|NCT02598583|Ravulizumab|ravulizumab|mesh-list
14488625|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14488626|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488627|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
14488628|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488629|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
14488630|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14488631|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488632|NCT02599402|Nivolumab|nivolumab|mesh-list
14488633|NCT02599402|Ipilimumab|ipilimumab|mesh-list
14488634|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488635|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488636|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14488637|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488638|NCT02599649|Nivolumab|nivolumab|mesh-list
14488639|NCT02599649|Azacitidine|azacitidine|mesh-list
14488640|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196864|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196865|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14196866|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770335|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770336|NCT00642798|Incretins|incretins|mesh-ancestor
14770337|NCT00642798|Hormones|hormones|mesh-ancestor
14770338|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770339|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14770340|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
14770341|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770342|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770343|NCT00642824|Bevacizumab|bevacizumab|mesh-list
14770344|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14196867|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488641|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488642|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14196868|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196869|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
14196870|NCT04590183|Hormones|hormones|mesh-ancestor
14488643|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488644|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14488645|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
14488646|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488647|NCT02600325|Grazoprevir|grazoprevir|mesh-list
14488648|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
14488649|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488650|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
14488651|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14488652|NCT02600351|Ledipasvir|ledipasvir|mesh-list
14488653|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
14488654|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770345|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196871|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196872|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14196873|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196874|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
14196875|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
14196876|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196877|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14488655|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
14488656|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14488657|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488658|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14488659|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14488660|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488661|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488662|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488663|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14488664|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14488665|NCT02600611|Vancomycin|vancomycin|mesh-list
14488666|NCT02600611|Iclaprim|iclaprim|mesh-list
14488667|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770346|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14770347|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14770348|NCT00642824|Growth Substances|growth substances|mesh-ancestor
14770349|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770350|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
14196878|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14196879|NCT04590183|Protective Agents|protective agents|mesh-ancestor
14196880|NCT04590508|Xanthohumol|xanthohumol|mesh-list
14770351|NCT00642837|Acetaminophen|acetaminophen|mesh-list
14770352|NCT00642837|Tramadol|tramadol|mesh-list
14770353|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14770354|NCT00642837|Analgesics|analgesics|mesh-ancestor
14770355|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
14770356|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770357|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770358|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
14770359|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14770360|NCT00642837|Narcotics|narcotics|mesh-ancestor
14770361|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770362|NCT00642863|Vitamin D|vitamin d|mesh-list
14770363|NCT00642863|Vitamins|vitamins|mesh-list
14770364|NCT00642863|Vitamin A|vitamin a|mesh-list
14770365|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
14770366|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
14770367|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770368|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
14770369|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770370|NCT00642863|Protective Agents|protective agents|mesh-ancestor
14770371|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14770372|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770373|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14770374|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
14770375|NCT00642915|Glimepiride|glimepiride|mesh-list
14770376|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14770377|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770378|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14770379|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963757|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963758|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963759|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
14196881|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196882|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14196883|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14196884|NCT04590508|Growth Substances|growth substances|mesh-ancestor
14196885|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196886|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
14196887|NCT04590482|Letrozole|letrozole|mesh-list
14196888|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196889|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14488668|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488669|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14488670|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488671|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488672|NCT02600715|Morphine|morphine|mesh-list
14488673|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14488674|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14488675|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14488676|NCT02600715|Narcotics|narcotics|mesh-ancestor
14488677|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488678|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196890|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14196891|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196892|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196893|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14196894|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
14196895|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14196896|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488679|NCT02600715|Analgesics|analgesics|mesh-ancestor
14488680|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
14488681|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488682|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14488683|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14488684|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14488685|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488686|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
14488687|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488688|NCT02600767|Lumefantrine|lumefantrine|mesh-list
14488689|NCT02600767|Artemether|artemether|mesh-list
14488690|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14488691|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
14488692|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14488693|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14488694|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488695|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14488696|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14488697|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14488698|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
14488699|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488700|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
14488701|NCT02600871|Povidone|povidone|mesh-list
14488702|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
14488703|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
14488704|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14488705|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488706|NCT02601027|Acetaminophen|acetaminophen|mesh-list
14488707|NCT02601027|Oxycodone|oxycodone|mesh-list
14488708|NCT02601027|Hydromorphone|hydromorphone|mesh-list
14488709|NCT02601027|Ondansetron|ondansetron|mesh-list
14488710|NCT02601027|Bupivacaine|bupivacaine|mesh-list
14488711|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
14488712|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
14488713|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488714|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488715|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
14488716|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488717|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14488718|NCT02601027|Narcotics|narcotics|mesh-ancestor
14488719|NCT02601027|Analgesics|analgesics|mesh-ancestor
14488720|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
14488721|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
14488722|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14488723|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
14488724|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
14488725|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14488726|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
14488727|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488728|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488729|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14488730|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14488731|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14488732|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14488733|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14488734|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
14488735|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
14196897|NCT04590196|Curcumin|curcumin|mesh-list
14488736|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14488737|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
14488738|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488739|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
14488740|NCT02601170|Protective Agents|protective agents|mesh-ancestor
14488741|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
14488742|NCT02601313|Fludarabine|fludarabine|mesh-list
14488743|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14488744|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
14196898|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14196899|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14196900|NCT04590196|Analgesics|analgesics|mesh-ancestor
14196901|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
14196902|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196903|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196904|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14196905|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14196906|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196907|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196908|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196909|NCT04589819|Teriparatide|teriparatide|mesh-list
14196910|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14196911|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196912|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14196913|NCT04589728|Venetoclax|venetoclax|mesh-list
14196914|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196915|NCT04589429|Morphine|morphine|mesh-list
14196916|NCT04589429|Nalbuphine|nalbuphine|mesh-list
14196917|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14196918|NCT04589429|Narcotics|narcotics|mesh-ancestor
14196919|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196920|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196921|NCT04589429|Analgesics|analgesics|mesh-ancestor
14196922|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
14488745|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488746|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488747|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14488748|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
14488749|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488750|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488751|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14488752|NCT02601573|Ribavirin|ribavirin|mesh-list
14488753|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
14488754|NCT02601573|Grazoprevir|grazoprevir|mesh-list
14488755|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
14488756|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488757|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
14488758|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488759|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14488760|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
14488761|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527727|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527728|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527729|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527730|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14527731|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14527732|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14527733|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14527734|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14196923|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939900|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14939901|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14939902|NCT01490047|Analgesics|analgesics|mesh-ancestor
14939903|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
14939904|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939905|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196924|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
14196925|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14196926|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14196927|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14196928|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14196929|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196930|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
14196931|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488762|NCT02601833|Fluorides|fluorides|mesh-list
14488763|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
14488764|NCT02601833|Protective Agents|protective agents|mesh-ancestor
14488765|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488766|NCT02601976|Ribavirin|ribavirin|mesh-list
14939906|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939907|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14939908|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939909|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14939910|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
14939911|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
14939912|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939913|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488767|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14488768|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
14488769|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488770|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
14488771|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488772|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
14488773|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488774|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488775|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
14488776|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488777|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14488778|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14488779|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14488780|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14770380|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
14770381|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
14770382|NCT00642967|Hematinics|hematinics|mesh-ancestor
14770383|NCT00642980|Clindamycin|clindamycin|mesh-list
14770384|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
14770385|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
14770386|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770387|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770388|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14770389|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196932|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196933|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14196934|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196935|NCT04589390|Selexipag|selexipag|mesh-list
14196936|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14196937|NCT04589546|Niacinamide|niacinamide|mesh-list
14196938|NCT04589546|Niacin|niacin|mesh-list
14196939|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
14196940|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
14196941|NCT04589546|Vitamins|vitamins|mesh-ancestor
14196942|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
14770390|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770391|NCT00643071|Tacrolimus|tacrolimus|mesh-list
14770392|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14770393|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
14770394|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770395|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14770396|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770397|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770398|NCT00643136|Pregabalin|pregabalin|mesh-list
14770399|NCT00643136|Analgesics|analgesics|mesh-ancestor
14770400|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
14770401|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770402|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770403|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
14770404|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14770405|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770406|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770407|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14770408|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14770409|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14939914|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
14196943|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196944|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14196945|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
14488781|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
14196946|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196947|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14196948|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
14196949|NCT04589494|Morphine|morphine|mesh-list
14196950|NCT04589494|Tramadol|tramadol|mesh-list
14196951|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14196952|NCT04589494|Narcotics|narcotics|mesh-ancestor
14196953|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196954|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488782|NCT02603120|Tenofovir|tenofovir|mesh-list
14488783|NCT02603120|Emtricitabine|emtricitabine|mesh-list
14488784|NCT02603120|Lamivudine|lamivudine|mesh-list
14488785|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14488786|NCT02603120|Triumeq|triumeq|mesh-list
14488787|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
14488788|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488789|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14488790|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14488791|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488792|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488793|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14488794|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14488795|NCT02603393|Fluticasone|fluticasone|mesh-list
14488796|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
14488797|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14488798|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488799|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14196955|NCT04589494|Analgesics|analgesics|mesh-ancestor
14196956|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
14196957|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196958|NCT04589325|Ixekizumab|ixekizumab|mesh-list
14196959|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
14196960|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
14196961|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14196962|NCT04589299|Antibodies|antibodies|mesh-list
14196963|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
14196964|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238710|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238711|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238712|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14238713|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14238714|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
14238715|NCT00134082|Rituximab|rituximab|mesh-list
14238716|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238717|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
14238718|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238719|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238720|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238721|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
14238722|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238723|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238724|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238725|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14770410|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770411|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770412|NCT00643149|Amoxicillin|amoxicillin|mesh-list
14770413|NCT00643149|Azithromycin|azithromycin|mesh-list
14770414|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770415|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770416|NCT00643227|Azithromycin|azithromycin|mesh-list
14770417|NCT00643227|Clarithromycin|clarithromycin|mesh-list
14770418|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770419|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770420|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14770421|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770422|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770423|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14770424|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14770425|NCT00643240|Antibodies|antibodies|mesh-list
14770426|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14770427|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
14770428|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770429|NCT00643292|Amoxicillin|amoxicillin|mesh-list
14770430|NCT00643292|Azithromycin|azithromycin|mesh-list
14238726|NCT00134563|Teriflunomide|teriflunomide|mesh-list
14488800|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
14770431|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
14488801|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488802|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488803|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14488804|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
14488805|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14488806|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14488807|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
14488808|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14488809|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
14488810|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488811|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488812|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14488813|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14488814|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14488815|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
14488816|NCT02603419|Avelumab|avelumab|mesh-list
14488817|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14488818|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14488819|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488820|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
14488821|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488822|NCT02603809|Lisinopril|lisinopril|mesh-list
14488823|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14488824|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
14488825|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488826|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488827|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14488828|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14488829|NCT02603809|Protective Agents|protective agents|mesh-ancestor
14488830|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488831|NCT02603926|Pregnanolone|pregnanolone|mesh-list
14488832|NCT02603926|Brexanolone|brexanolone|mesh-list
14488833|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
14488834|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488835|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488836|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
14488837|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488838|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488839|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
14488840|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
14488841|NCT02603952|Oseltamivir|oseltamivir|mesh-list
14488842|NCT02603952|MEDI8852|medi8852|mesh-list
14939915|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14939916|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939917|NCT01490203|Edetic Acid|edetic acid|mesh-list
14939918|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
14939919|NCT01490203|Antidotes|antidotes|mesh-ancestor
14939920|NCT01490203|Protective Agents|protective agents|mesh-ancestor
14939921|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939922|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
14196965|NCT04589143|S 20098|s 20098|mesh-list
14196966|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14196967|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14196968|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196969|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
14196970|NCT04589130|Naltrexone|naltrexone|mesh-list
14196971|NCT04589130|Bupropion|bupropion|mesh-list
14196972|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14196973|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14488843|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
14939923|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
14939924|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488844|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488845|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488846|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488847|NCT02604173|Budesonide|budesonide|mesh-list
14488848|NCT02604173|Acetazolamide|acetazolamide|mesh-list
14488849|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488850|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14488851|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
14488852|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488853|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488854|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14488855|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
14488856|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
14488857|NCT02604173|Hormones|hormones|mesh-ancestor
14488858|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14488859|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
14488860|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14488861|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488862|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488863|NCT02604173|Diuretics|diuretics|mesh-ancestor
14488864|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
14488865|NCT02604199|Tenofovir|tenofovir|mesh-list
14488866|NCT02604199|Entecavir|entecavir|mesh-list
14488867|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
14488868|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14488869|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
14488870|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488871|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14488872|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14488873|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488874|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488875|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14488876|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14488877|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
14488878|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488879|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488880|NCT02604212|Tenofovir|tenofovir|mesh-list
14488881|NCT02604212|Entecavir|entecavir|mesh-list
14488882|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
14488883|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14488884|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
14488885|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488886|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14488887|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14488888|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488889|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488890|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14488891|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14488892|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
14488893|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488894|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196974|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14196975|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
14196976|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14196977|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14196978|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
14196979|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14196980|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14196981|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14196982|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14196983|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196984|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
14196985|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14196986|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14196987|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14196988|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14196989|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14196990|NCT04589234|Gemcitabine|gemcitabine|mesh-list
14196991|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14488895|NCT02604342|Docetaxel|docetaxel|mesh-list
14488896|NCT02604342|Pemetrexed|pemetrexed|mesh-list
14488897|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14488898|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
14488899|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
14488900|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
14488901|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196992|NCT04589234|Folfirinox|folfirinox|mesh-list
14196993|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14196994|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
14196995|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14196996|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14196997|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
14196998|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14196999|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197000|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14197001|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
14197002|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488902|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488903|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14488904|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14488905|NCT02604550|Naproxen|naproxen|mesh-list
14488906|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14488907|NCT02604550|Ropivacaine|ropivacaine|mesh-list
14488908|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
14488909|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
14488910|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488911|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488912|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
14488913|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488914|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14488915|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14488916|NCT02604550|Analgesics|analgesics|mesh-ancestor
14488917|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488918|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488919|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
14488920|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14488921|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488922|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488923|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14488924|NCT02604550|Narcotics|narcotics|mesh-ancestor
14488925|NCT02604589|Hydromorphone|hydromorphone|mesh-list
14488926|NCT02604589|Bupivacaine|bupivacaine|mesh-list
14488927|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
14488928|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
14488929|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488930|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488931|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
14488932|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488933|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14488934|NCT02604589|Narcotics|narcotics|mesh-ancestor
14488935|NCT02604589|Analgesics|analgesics|mesh-ancestor
14488936|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
14488937|NCT02604810|Antibodies|antibodies|mesh-list
14488938|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
14488939|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14488940|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14488941|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
14488942|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
14488943|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488944|NCT02605122|Amoxicillin|amoxicillin|mesh-list
14770432|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
14197003|NCT04588935|Bisoprolol|bisoprolol|mesh-list
14197004|NCT04588935|Perindopril|perindopril|mesh-list
14197005|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14197006|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
14197007|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
14197008|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488945|NCT02605122|Azithromycin|azithromycin|mesh-list
14770433|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14488946|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
14770434|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770435|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770436|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14770437|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197009|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197010|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14488947|NCT02605122|Erythromycin|erythromycin|mesh-list
14488948|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
14488949|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14488950|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
14488951|NCT02605122|Ampicillin|ampicillin|mesh-list
14488952|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
14488953|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
14488954|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14488955|NCT02605122|Solithromycin|solithromycin|mesh-list
14488956|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
14488957|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14488958|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14488959|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14488960|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14488961|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770438|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770439|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
14770440|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14770441|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
14770442|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
14770443|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770444|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770445|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14770446|NCT00643357|Analgesics|analgesics|mesh-ancestor
14770447|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
14770448|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770449|NCT00643409|Azithromycin|azithromycin|mesh-list
14770450|NCT00643409|Levofloxacin|levofloxacin|mesh-list
14770451|NCT00643409|Ofloxacin|ofloxacin|mesh-list
14770452|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770453|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770454|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14770455|NCT00643409|Renal Agents|renal agents|mesh-ancestor
14770456|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14770457|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14770458|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770459|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770460|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770461|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14770462|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14939925|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14939926|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
14939927|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14197011|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14770463|NCT00643500|Levetiracetam|levetiracetam|mesh-list
14770464|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
14770465|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
14770466|NCT00643539|Azithromycin|azithromycin|mesh-list
14770467|NCT00643539|Amoxicillin|amoxicillin|mesh-list
14770468|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770469|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807262|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14807263|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
14807264|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14807265|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14807266|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14939928|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14939929|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14939930|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963760|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
13963761|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
14197012|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14197013|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
14197014|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197015|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197016|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14197017|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
14197018|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197019|NCT04588987|Apatinib|apatinib|mesh-list
14197020|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197021|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14197022|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197023|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488962|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488963|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14488964|NCT02605174|Lasmiditan|lasmiditan|mesh-list
14488965|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14770470|NCT00643643|Maraviroc|maraviroc|mesh-list
14770471|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14770472|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14770473|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770474|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14770475|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14770476|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
14770477|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770478|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14770479|NCT00643734|Azithromycin|azithromycin|mesh-list
14770480|NCT00643734|Levofloxacin|levofloxacin|mesh-list
14770481|NCT00643734|Ofloxacin|ofloxacin|mesh-list
14770482|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197031|NCT04588532|Doxepin|doxepin|mesh-list
14197032|NCT04588532|Histamine|histamine|mesh-list
14197033|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
14770483|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939931|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14939932|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14197034|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
14197035|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197036|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197037|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197038|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14197039|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14197040|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197041|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14197042|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
14197043|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14197044|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
14197045|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
14197046|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197047|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
14197048|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
14197049|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14197050|NCT04588792|Furosemide|furosemide|mesh-list
14488966|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
14488967|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488968|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488969|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488970|NCT02605187|Acetaminophen|acetaminophen|mesh-list
14488971|NCT02605187|Ibuprofen|ibuprofen|mesh-list
14488972|NCT02605187|Morphine|morphine|mesh-list
14488973|NCT02605187|Gabapentin|gabapentin|mesh-list
14488974|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14488975|NCT02605187|Narcotics|narcotics|mesh-ancestor
14488976|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14488977|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14488978|NCT02605187|Analgesics|analgesics|mesh-ancestor
14488979|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
14488980|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14488981|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14488982|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
14770484|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14197051|NCT04588792|Diuretics|diuretics|mesh-ancestor
14197052|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
14939933|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939934|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939935|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
14488983|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14488984|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14488985|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14488986|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14488987|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14488988|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14488989|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
14488990|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14488991|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14488992|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14488993|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14488994|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14488995|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14488996|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
14488997|NCT02605304|Ribavirin|ribavirin|mesh-list
14488998|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
14488999|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14489000|NCT02605304|Ledipasvir|ledipasvir|mesh-list
14489001|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
14489002|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489003|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
14489004|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489005|NCT02605395|Rabeprazole|rabeprazole|mesh-list
14489006|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14489007|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489008|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14489009|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489010|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489011|NCT02605642|Infliximab|infliximab|mesh-list
14489012|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
14489013|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489014|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489015|NCT02605837|Budesonide|budesonide|mesh-list
14489016|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14489017|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14489018|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
14489019|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489020|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489021|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14489022|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
14489023|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
14489024|NCT02605837|Hormones|hormones|mesh-ancestor
14489025|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489026|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14489027|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
14489028|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489029|NCT02606253|Metolazone|metolazone|mesh-list
14489030|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
14489031|NCT02606253|Tolvaptan|tolvaptan|mesh-list
14489032|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14489033|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489034|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
14489035|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489036|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14489037|NCT02606253|Diuretics|diuretics|mesh-ancestor
14489038|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14770485|NCT00643734|Renal Agents|renal agents|mesh-ancestor
14197053|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197054|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14197055|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197056|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197057|NCT04588441|Adenosine|adenosine|mesh-list
14197058|NCT04588441|Analgesics|analgesics|mesh-ancestor
14197059|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
14197060|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197061|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197062|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14197063|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
14197064|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14197065|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
14197066|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
14197067|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197068|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197069|NCT04588688|Mifepristone|mifepristone|mesh-list
14489039|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489040|NCT02606877|Pirfenidone|pirfenidone|mesh-list
14489041|NCT02606877|Nintedanib|nintedanib|mesh-list
14197070|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14197071|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
14197072|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14197073|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197074|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14197075|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14197076|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14489042|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489043|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14489044|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489045|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489046|NCT02606877|Analgesics|analgesics|mesh-ancestor
14489047|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
14489048|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489049|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489050|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14489051|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14489052|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14489053|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489054|NCT02607254|Pregabalin|pregabalin|mesh-list
14489055|NCT02607254|Analgesics|analgesics|mesh-ancestor
14489056|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
14489057|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489058|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489059|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
14489060|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14489061|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489062|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489063|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14489064|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14489065|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14489066|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489067|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14489068|NCT02607306|Insulin|insulin|mesh-list
14489069|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14489070|NCT02607306|Liraglutide|liraglutide|mesh-list
14489071|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
14489072|NCT02607306|Xultophy|xultophy|mesh-list
14489073|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14489074|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489075|NCT02607306|Incretins|incretins|mesh-ancestor
14489076|NCT02607306|Hormones|hormones|mesh-ancestor
14489077|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489078|NCT02607618|Vancomycin|vancomycin|mesh-list
14489079|NCT02607618|Iclaprim|iclaprim|mesh-list
14197077|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
14489080|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489081|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489082|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14489083|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489084|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489085|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
14489086|NCT02607735|Velpatasvir|velpatasvir|mesh-list
14489087|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
14489088|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489089|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
14489090|NCT02607800|Velpatasvir|velpatasvir|mesh-list
14489091|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
14489092|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489093|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14197078|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14197079|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14197080|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
14197081|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14197082|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
14197083|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14197084|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14197085|NCT04588389|Lidocaine|lidocaine|mesh-list
14197086|NCT04588389|Ropivacaine|ropivacaine|mesh-list
14770486|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14770487|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14770488|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770489|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197087|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
14489094|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14489095|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489096|NCT02607865|Incretins|incretins|mesh-ancestor
14489097|NCT02607865|Hormones|hormones|mesh-ancestor
14489098|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489099|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14489100|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
14489101|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489102|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489103|NCT02608099|Apixaban|apixaban|mesh-list
14489104|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14489105|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
14489106|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14489107|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
14489108|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489109|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489110|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
14489111|NCT02608177|Linagliptin|linagliptin|mesh-list
14489112|NCT02608177|Glipizide|glipizide|mesh-list
14489113|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14489114|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489115|NCT02608177|Incretins|incretins|mesh-ancestor
14489116|NCT02608177|Hormones|hormones|mesh-ancestor
14489117|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489118|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14489119|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
14489120|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489121|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489122|NCT02608229|Gemcitabine|gemcitabine|mesh-list
14489123|NCT02608229|Paclitaxel|paclitaxel|mesh-list
14489124|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14489125|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14489126|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489127|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
14197088|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
14197089|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197090|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197091|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
14197092|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197093|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14197094|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14197095|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14197096|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197097|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197098|NCT04588233|Melatonin|melatonin|mesh-list
14197099|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
14197100|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197101|NCT04588233|Protective Agents|protective agents|mesh-ancestor
14489128|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
14489129|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
14489130|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489131|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14489132|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
14489133|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
14770490|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197102|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197103|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197104|NCT04588220|Plasminogen|plasminogen|mesh-list
14489134|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489135|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489136|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14489137|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
14489138|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489139|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
14489140|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14489141|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
14489142|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489143|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
14489144|NCT02608489|Protective Agents|protective agents|mesh-ancestor
14489145|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
14489146|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14197105|NCT04588220|Melatonin|melatonin|mesh-list
14197106|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
14197107|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197108|NCT04588220|Protective Agents|protective agents|mesh-ancestor
14197109|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197110|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197111|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14197112|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14489147|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489148|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
14489149|NCT02609399|Oseltamivir|oseltamivir|mesh-list
14489150|NCT02609399|Peramivir|peramivir|mesh-list
14489151|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
14489152|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489153|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489154|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489155|NCT02609607|Bisacodyl|bisacodyl|mesh-list
14489156|NCT02609607|Cathartics|cathartics|mesh-ancestor
14489157|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489158|NCT02609607|Laxatives|laxatives|mesh-ancestor
14489159|NCT02609659|Ritonavir|ritonavir|mesh-list
14489160|NCT02609659|Ribavirin|ribavirin|mesh-list
14489161|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14489162|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14489163|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
14489164|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489165|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489166|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14489167|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14489168|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
14489169|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489170|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14489171|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14489172|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
14770491|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14770492|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14770493|NCT00643799|Celecoxib|celecoxib|mesh-list
14770494|NCT00643799|Naproxen|naproxen|mesh-list
14197113|NCT04588194|Dexamethasone|dexamethasone|mesh-list
14197114|NCT04588194|Rituximab|rituximab|mesh-list
14489173|NCT02609984|Atezolizumab|atezolizumab|mesh-list
14489174|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489175|NCT02610140|Vinorelbine|vinorelbine|mesh-list
14770495|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14489176|NCT02610140|Maytansine|maytansine|mesh-list
14489177|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14489178|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770496|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197115|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14197116|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
14197117|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
14197118|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197119|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197120|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197121|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
14197122|NCT04588194|Hormones|hormones|mesh-ancestor
14489179|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14489180|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14489181|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14770497|NCT00643799|Analgesics|analgesics|mesh-ancestor
14770498|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
14770499|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770500|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770501|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770502|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770503|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14770504|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14770505|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770506|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770507|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
14770508|NCT00643825|Temozolomide|temozolomide|mesh-list
14770509|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14770510|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
14770511|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770512|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770513|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
14770514|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770515|NCT00644020|Fluorouracil|fluorouracil|mesh-list
14770516|NCT00644020|Mitomycins|mitomycins|mesh-list
14770517|NCT00644020|Mitomycin|mitomycin|mesh-list
14770518|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
14770519|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770520|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14770521|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770522|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14770523|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
14197123|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14197124|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14197125|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197126|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14197127|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
14770524|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770525|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14770526|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
14770527|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14770528|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770529|NCT00644033|Frovatriptan|frovatriptan|mesh-list
14770530|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14770531|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
14770532|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770533|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770534|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770535|NCT00644085|Aspirin|aspirin|mesh-list
14770536|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14770537|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14770538|NCT00644085|Analgesics|analgesics|mesh-ancestor
14770539|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
14770540|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770541|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770542|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770543|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197128|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489182|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489183|NCT02610231|Istradefylline|istradefylline|mesh-list
14489184|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14489185|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14489186|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14489187|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
14489188|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489189|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489190|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489191|NCT02610777|Azacitidine|azacitidine|mesh-list
14489192|NCT02610777|Pevonedistat|pevonedistat|mesh-list
14489193|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14489194|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
14489195|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489196|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489197|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489198|NCT02610816|Fluticasone|fluticasone|mesh-list
14489199|NCT02610816|Xhance|xhance|mesh-list
14489200|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14489201|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14489202|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
14489203|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489204|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489205|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14489206|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
14489207|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
14489208|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14489209|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14489210|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
14489211|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14489212|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489213|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489214|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
14489215|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489216|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489217|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14489218|NCT02611154|Testosterone|testosterone|mesh-list
14489219|NCT02611154|Androgens|androgens|mesh-ancestor
14489220|NCT02611154|Hormones|hormones|mesh-ancestor
14489221|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14939936|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14939937|NCT01490229|Ezetimibe|ezetimibe|mesh-list
14939938|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14939939|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14939940|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
14939941|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939942|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14939943|NCT01490255|Amlodipine|amlodipine|mesh-list
14939944|NCT01490255|Ranolazine|ranolazine|mesh-list
14197129|NCT04588090|Cisplatin|cisplatin|mesh-list
14197130|NCT04588090|Paclitaxel|paclitaxel|mesh-list
14197131|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197132|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14197133|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
14197134|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
14197135|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
14197136|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197137|NCT04588285|Ambroxol|ambroxol|mesh-list
14197138|NCT04588285|Expectorants|expectorants|mesh-ancestor
14197139|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
14197140|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
14197141|NCT04587973|Ropivacaine|ropivacaine|mesh-list
14197142|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14197143|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489222|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489223|NCT02611752|Buprenorphine|buprenorphine|mesh-list
14489224|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14489225|NCT02611752|Narcotics|narcotics|mesh-ancestor
14489226|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489227|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489228|NCT02611752|Analgesics|analgesics|mesh-ancestor
14489229|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
14489230|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489231|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14489232|NCT02611765|Penicillins|penicillins|mesh-list
14489233|NCT02611765|Penicillin G|penicillin g|mesh-list
14489234|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14489235|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
14489236|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489237|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489238|NCT02611778|Ranibizumab|ranibizumab|mesh-list
14197144|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197145|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197146|NCT04587973|Analgesics|analgesics|mesh-ancestor
14489239|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14770544|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14770545|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14770546|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770547|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14770548|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14770549|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770550|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
14770551|NCT00644111|Hydromorphone|hydromorphone|mesh-list
14770552|NCT00644111|Bupivacaine|bupivacaine|mesh-list
14770553|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
14770554|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
14770555|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770556|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770557|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
14770558|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770559|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14770560|NCT00644111|Narcotics|narcotics|mesh-ancestor
14770561|NCT00644111|Analgesics|analgesics|mesh-ancestor
14770562|NCT00644124|Aflibercept|aflibercept|mesh-list
14770563|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14770564|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14770565|NCT00644124|Growth Substances|growth substances|mesh-ancestor
14770566|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770567|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
14770568|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770569|NCT00644137|Pregabalin|pregabalin|mesh-list
14770570|NCT00644137|Analgesics|analgesics|mesh-ancestor
14197147|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
14197148|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197149|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14197150|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14197151|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14197152|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
14197153|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197154|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197155|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
14197156|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
14197157|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
14242916|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242917|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242918|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
14242919|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242920|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242921|NCT00191451|Gemcitabine|gemcitabine|mesh-list
14242922|NCT00191451|Carboplatin|carboplatin|mesh-list
14242923|NCT00191451|Trastuzumab|trastuzumab|mesh-list
14242924|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242925|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242926|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
14242927|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242928|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
14242929|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242930|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242931|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242932|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
14242933|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242934|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14242935|NCT00191477|Gemcitabine|gemcitabine|mesh-list
14242936|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242937|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
14242938|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242939|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242940|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
14242941|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242942|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242943|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242944|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
14242945|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242946|NCT00191646|Gemcitabine|gemcitabine|mesh-list
14242947|NCT00191646|Paclitaxel|paclitaxel|mesh-list
14242948|NCT00191646|Carboplatin|carboplatin|mesh-list
14242949|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14242950|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242951|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242952|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
14197158|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
14197159|NCT04587843|Naltrexone|naltrexone|mesh-list
14197160|NCT04587843|Bupropion|bupropion|mesh-list
14197161|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14197162|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14197163|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197164|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
14197165|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197166|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14197167|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
14197168|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14197169|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14197170|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14489240|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14489241|NCT02611778|Growth Substances|growth substances|mesh-ancestor
14489242|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489243|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
14489244|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489245|NCT02611817|Vedolizumab|vedolizumab|mesh-list
14489246|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489247|NCT02611830|Vedolizumab|vedolizumab|mesh-list
14489248|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489249|NCT02611882|Edetic Acid|edetic acid|mesh-list
14489250|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
14489251|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
14489252|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
14489253|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489254|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
14489255|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14770571|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
14770572|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770573|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770574|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
14770575|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14770576|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770577|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770578|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14770579|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14770580|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770581|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770582|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770583|NCT00644176|Azithromycin|azithromycin|mesh-list
14770584|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770585|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770586|NCT00644215|Mitomycins|mitomycins|mesh-list
14770587|NCT00644215|Mitomycin|mitomycin|mesh-list
14770588|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14770589|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770590|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
14770591|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770592|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14770593|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770594|NCT00644293|Azithromycin|azithromycin|mesh-list
14770595|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770596|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770597|NCT00644306|Thalidomide|thalidomide|mesh-list
14770598|NCT00644306|Prednisone|prednisone|mesh-list
14770599|NCT00644306|Melphalan|melphalan|mesh-list
14770600|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770601|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
14770602|NCT00644306|Hormones|hormones|mesh-ancestor
14770603|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770604|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770605|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14770606|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770607|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14770608|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
14770609|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770610|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14770611|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14770612|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
14770613|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
14489256|NCT02612064|Fluorides|fluorides|mesh-list
14770614|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489257|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
14489258|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
14489259|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
14489260|NCT02612064|Protective Agents|protective agents|mesh-ancestor
14489261|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489262|NCT02612077|Bevacizumab|bevacizumab|mesh-list
14489263|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489264|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489265|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14489266|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14197171|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197172|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197173|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
14197174|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197175|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14197176|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14197177|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197178|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14489267|NCT02612077|Growth Substances|growth substances|mesh-ancestor
14489268|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489269|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
14527735|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14527736|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527737|NCT03965351|Probenecid|probenecid|mesh-list
14527738|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
14527739|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
14527740|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527741|NCT03965351|Renal Agents|renal agents|mesh-ancestor
14527742|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
14527743|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14527744|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
14527745|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527746|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527747|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14527748|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
14527749|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
14527750|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14527751|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527752|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527753|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527754|NCT03965052|Travoprost|travoprost|mesh-list
14527755|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14527756|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14527757|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14527758|NCT03965039|Fluorides|fluorides|mesh-list
14527759|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
14527760|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
14527761|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
14527762|NCT03965039|Protective Agents|protective agents|mesh-ancestor
14527763|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527764|NCT03963401|PF-06700841|pf-06700841|mesh-list
14527765|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14527766|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527767|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527768|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
14527769|NCT03962634|Tetracaine|tetracaine|mesh-list
14527770|NCT03962634|Carticaine|carticaine|mesh-list
14527771|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527772|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
14197179|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
14197180|NCT04588311|Hematinics|hematinics|mesh-ancestor
14197181|NCT04587778|Ketamine|ketamine|mesh-list
14197182|NCT04587778|Esketamine|esketamine|mesh-list
14197183|NCT04587778|Analgesics|analgesics|mesh-ancestor
14197184|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
14197185|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197186|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197187|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14527773|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527774|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527775|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
14527776|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489270|NCT02612779|Dexamethasone|dexamethasone|mesh-list
14489271|NCT02612779|Nivolumab|nivolumab|mesh-list
14489272|NCT02612779|Pomalidomide|pomalidomide|mesh-list
14489273|NCT02612779|Elotuzumab|elotuzumab|mesh-list
14489274|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14489275|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
14489276|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
14489277|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489278|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489279|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489280|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
14489281|NCT02612779|Hormones|hormones|mesh-ancestor
14489282|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489283|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14489284|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489285|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489286|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14489287|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489288|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
14489289|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14489290|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14489291|NCT02612779|Growth Substances|growth substances|mesh-ancestor
14489292|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
14489293|NCT02613117|Fluorides|fluorides|mesh-list
14489294|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
14489295|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
14489296|NCT02613117|Protective Agents|protective agents|mesh-ancestor
14489297|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489298|NCT02613169|Isoniazid|isoniazid|mesh-list
14489299|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
14489300|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489301|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489302|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14489303|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14489304|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
14489305|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489306|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14489307|NCT02613208|Paclitaxel|paclitaxel|mesh-list
14489308|NCT02613208|Bevacizumab|bevacizumab|mesh-list
14489309|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14489310|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489311|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
14489312|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
14489313|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
14489314|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770615|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770616|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14939945|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14939946|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14939947|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14939948|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939949|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14939950|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939951|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
14939952|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14939953|NCT01490268|Sufentanil|sufentanil|mesh-list
14489315|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489316|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14770617|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14770618|NCT00644306|Growth Substances|growth substances|mesh-ancestor
14770619|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
14770620|NCT00644319|Ibuprofen|ibuprofen|mesh-list
14770621|NCT00644319|Morphine|morphine|mesh-list
14770622|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14770623|NCT00644319|Narcotics|narcotics|mesh-ancestor
14770624|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770625|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770626|NCT00644319|Analgesics|analgesics|mesh-ancestor
14770627|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
14770628|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770629|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14770630|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14770631|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14770632|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770633|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14489317|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14489318|NCT02613208|Growth Substances|growth substances|mesh-ancestor
14489319|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489320|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
14489321|NCT02613221|Panitumumab|panitumumab|mesh-list
14489322|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489323|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197188|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14197189|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
14197190|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
14197191|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197192|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14197193|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14197194|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197195|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197196|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
14489324|NCT02613403|Ribavirin|ribavirin|mesh-list
14489325|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
14489326|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
14489327|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489328|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
14489329|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489330|NCT02613507|Docetaxel|docetaxel|mesh-list
14770634|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489331|NCT02613507|Nivolumab|nivolumab|mesh-list
14489332|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489333|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
14489334|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
14489335|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
14489336|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489337|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489338|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14489339|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
14489340|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
14489341|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489342|NCT02613572|Protective Agents|protective agents|mesh-ancestor
14489343|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489344|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
14489345|NCT02613572|Vitamins|vitamins|mesh-ancestor
14489346|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
14489347|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
14489348|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14489349|NCT02613871|Ledipasvir|ledipasvir|mesh-list
14489350|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
14489351|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489352|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
14489353|NCT02613897|Saxagliptin|saxagliptin|mesh-list
14489354|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14489355|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489356|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14489357|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489358|NCT02613897|Incretins|incretins|mesh-ancestor
14489359|NCT02613897|Hormones|hormones|mesh-ancestor
14489360|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489361|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14489362|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
14489363|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489364|NCT02613910|Acetaminophen|acetaminophen|mesh-list
14489365|NCT02613910|Cetirizine|cetirizine|mesh-list
14489366|NCT02613910|Prednisone|prednisone|mesh-list
14489367|NCT02613910|Prednisolone|prednisolone|mesh-list
14489368|NCT02613910|Ofatumumab|ofatumumab|mesh-list
14489369|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
14489370|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14489371|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14489372|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
14489373|NCT02613910|Hormones|hormones|mesh-ancestor
14489374|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770635|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770636|NCT00644371|Rituximab|rituximab|mesh-list
14770637|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14770638|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770639|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
14770640|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770641|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489375|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770642|NCT00644384|Acitretin|acitretin|mesh-list
14770643|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
14770644|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
14770645|NCT00644449|Azithromycin|azithromycin|mesh-list
14770646|NCT00644449|Levofloxacin|levofloxacin|mesh-list
14770647|NCT00644449|Ofloxacin|ofloxacin|mesh-list
14770648|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770649|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770650|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14770651|NCT00644449|Renal Agents|renal agents|mesh-ancestor
14770652|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14770653|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14770654|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770655|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770656|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770657|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14770658|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14770659|NCT00644475|Candesartan|candesartan|mesh-list
14770660|NCT00644475|Imidapril|imidapril|mesh-list
14770661|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14770662|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14770663|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14770664|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770665|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14770666|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
14770667|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770668|NCT00644540|Vaccines|vaccines|mesh-list
14770669|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
14770670|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197197|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14197198|NCT04587505|Morphine|morphine|mesh-list
14197199|NCT04587505|Tramadol|tramadol|mesh-list
14770671|NCT00644553|Amoxicillin|amoxicillin|mesh-list
14770672|NCT00644553|Clarithromycin|clarithromycin|mesh-list
14770673|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
14770674|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14770675|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770676|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770677|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14770678|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770679|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770680|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14770681|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14197200|NCT04587505|Anesthetics|anesthetics|mesh-list
14197201|NCT04587505|Ropivacaine|ropivacaine|mesh-list
14197202|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197203|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197204|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14197205|NCT04587505|Narcotics|narcotics|mesh-ancestor
14197206|NCT04587505|Analgesics|analgesics|mesh-ancestor
14197207|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
14197208|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197209|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
14238727|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14238728|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14238729|NCT00134563|Analgesics|analgesics|mesh-ancestor
14238730|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
14238731|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238732|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238733|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238734|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238735|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238736|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
14238737|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14238738|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
14238739|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238740|NCT00134901|Memantine|memantine|mesh-list
14238741|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14238742|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14238743|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
14238744|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238745|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238746|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238747|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14489376|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14489377|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489378|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14489379|NCT02613910|Analgesics|analgesics|mesh-ancestor
14489380|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
14489381|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489382|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
14489383|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14489384|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14489385|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
14489386|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489387|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489388|NCT02614560|Fludarabine|fludarabine|mesh-list
14489389|NCT02614560|Melphalan|melphalan|mesh-list
14489390|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489391|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489392|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14489393|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
14489394|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489395|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14489396|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
14489397|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14489398|NCT02614703|Acetic Acid|acetic acid|mesh-list
14489399|NCT02614703|Retinol acetate|retinol acetate|mesh-list
14489400|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489401|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489402|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14489403|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
14489404|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489405|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14489406|NCT02614703|Protective Agents|protective agents|mesh-ancestor
14489407|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489408|NCT02614794|Capecitabine|capecitabine|mesh-list
14489409|NCT02614794|Trastuzumab|trastuzumab|mesh-list
14489410|NCT02614794|Tucatinib|tucatinib|mesh-list
14489411|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14489412|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
14489413|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489414|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489415|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489416|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14489417|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489418|NCT02615470|Vaccines|vaccines|mesh-list
14489419|NCT02615470|Immunologic Factors|immunologic factors|mesh-ancestor
14197210|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
14197211|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14197212|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
14197213|NCT04587141|Hematinics|hematinics|mesh-ancestor
14197214|NCT04587115|Oxycodone|oxycodone|mesh-list
14197215|NCT04587115|Risperidone|risperidone|mesh-list
14197216|NCT04587115|Ziprasidone|ziprasidone|mesh-list
14197217|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14197218|NCT04587115|Narcotics|narcotics|mesh-ancestor
14939954|NCT01490268|Dsuvia|dsuvia|mesh-list
14939955|NCT01490268|Hydromorphone|hydromorphone|mesh-list
14197219|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197220|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197221|NCT04587115|Analgesics|analgesics|mesh-ancestor
14197222|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
14197223|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197224|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14489420|NCT02615470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489421|NCT02615535|Alprostadil|alprostadil|mesh-list
14489422|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14489423|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
14489424|NCT02615535|Urological Agents|urological agents|mesh-ancestor
14939956|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14197225|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
14197226|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197227|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197228|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14197229|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14197230|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14197231|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14197232|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
14197233|NCT04586543|Docetaxel|docetaxel|mesh-list
14197234|NCT04586543|Selegiline|selegiline|mesh-list
14197235|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489425|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14489426|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14489427|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14489428|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
14489429|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489430|NCT02616250|Ivermectin|ivermectin|mesh-list
14489431|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14489432|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14489433|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489434|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14489435|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14489436|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14489437|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14489438|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14489439|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489440|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939957|NCT01490268|Narcotics|narcotics|mesh-ancestor
14939958|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14939959|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939960|NCT01490268|Analgesics|analgesics|mesh-ancestor
14939961|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
14939962|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939963|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14939964|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14939965|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
14939966|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
14939967|NCT01490333|Vitamin D|vitamin d|mesh-list
14197236|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14489441|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489442|NCT02616523|Lidocaine|lidocaine|mesh-list
14489443|NCT02616523|Fentanyl|fentanyl|mesh-list
14489444|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
14197237|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14197238|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14197239|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197240|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
14197241|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14197242|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14197243|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14489445|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
14489446|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
14489447|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489448|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489449|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
14489450|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197244|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14197245|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197246|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14197247|NCT04586543|Protective Agents|protective agents|mesh-ancestor
14197248|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197249|NCT04586504|Midazolam|midazolam|mesh-list
14197250|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14197251|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14197252|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197253|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197254|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14197255|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14197256|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14197257|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14197258|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
14489451|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14489452|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14489453|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14489454|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489455|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489456|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14939968|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
14939969|NCT01490333|Vitamins|vitamins|mesh-ancestor
14489457|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14489458|NCT02616523|Analgesics|analgesics|mesh-ancestor
14489459|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14489460|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14489461|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14489462|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14489463|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489464|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14489465|NCT02616523|Narcotics|narcotics|mesh-ancestor
14489466|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14489467|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14197259|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
14197260|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
14197261|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
14197262|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197263|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197264|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14197265|NCT04586790|Epinephrine|epinephrine|mesh-list
14197266|NCT04586790|Racepinephrine|racepinephrine|mesh-list
14197267|NCT04586790|Midodrine|midodrine|mesh-list
14197268|NCT04586790|Norepinephrine|norepinephrine|mesh-list
14197269|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
14197270|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14489468|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
14489469|NCT02616601|Fluorouracil|fluorouracil|mesh-list
14489470|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
14489471|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489472|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14489473|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489474|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14489475|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
14489476|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489477|NCT02616614|Clindamycin|clindamycin|mesh-list
14489478|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
14489479|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
14489480|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14489481|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197271|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14197272|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
14197273|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197274|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197275|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197276|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14197277|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14197278|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
14197279|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197280|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14489482|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489483|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14489484|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489485|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489486|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
14489487|NCT02616783|Lamivudine|lamivudine|mesh-list
14489488|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14489489|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14489490|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489491|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489492|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
14489493|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489494|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14489495|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14489496|NCT02617628|Naltrexone|naltrexone|mesh-list
14489497|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14489498|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14489499|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770682|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14770683|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
14770684|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
14770685|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14770686|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14770687|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770688|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770689|NCT00644605|Urological Agents|urological agents|mesh-ancestor
14939970|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
14197281|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14489500|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
14489501|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489502|NCT02617667|Cyclosporine|cyclosporine|mesh-list
14489503|NCT02617667|Cyclosporins|cyclosporins|mesh-list
14489504|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489505|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489506|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14489507|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
14489508|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489509|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
14489510|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489511|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
14489512|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489513|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14489514|NCT02617784|Oseltamivir|oseltamivir|mesh-list
14489515|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
14489516|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489517|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489518|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489519|NCT02617888|Bismuth|bismuth|mesh-list
14489520|NCT02617888|Antacids|antacids|mesh-ancestor
14489521|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489522|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489523|NCT02618187|Vancomycin|vancomycin|mesh-list
14489524|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489525|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489526|NCT02618343|Ondansetron|ondansetron|mesh-list
14489527|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
14489528|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
14489529|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489530|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489531|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489532|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
14489533|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
14489534|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14489535|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
14489536|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489537|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489538|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14489539|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14489540|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489541|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14489542|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14489543|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
14489544|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14489545|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14489546|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489547|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
14489548|NCT02618382|Coagulants|coagulants|mesh-ancestor
14489549|NCT02618772|Midazolam|midazolam|mesh-list
14489550|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14489551|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14489552|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489553|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489554|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14489555|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14489556|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14489557|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14489558|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
14489559|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
14489560|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
14489561|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
14489562|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489563|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489564|NCT02619409|Bupivacaine|bupivacaine|mesh-list
14489565|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
14489566|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
14489567|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489568|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770690|NCT00644618|Gemcitabine|gemcitabine|mesh-list
14770691|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14770692|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
14770693|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770694|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489569|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
14489570|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489571|NCT02619617|Pasireotide|pasireotide|mesh-list
14770695|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
14489572|NCT02619617|Hormones|hormones|mesh-ancestor
14489573|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489574|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489575|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
14489576|NCT02619799|Midazolam|midazolam|mesh-list
14489577|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14489578|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14489579|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489580|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489581|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14489582|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14489583|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14489584|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14489585|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
14489586|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
14489587|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
14489588|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
14489589|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489590|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489591|NCT02619799|Analgesics|analgesics|mesh-ancestor
14197282|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
14197283|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
14197284|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14197285|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14197286|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
14197287|NCT04586790|Coagulants|coagulants|mesh-ancestor
14489592|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
14489593|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489594|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14489595|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
14489596|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14489597|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489598|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14489599|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
14489600|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14489601|NCT02620020|Fasinumab|fasinumab|mesh-list
14489602|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14489603|NCT02620020|Analgesics|analgesics|mesh-ancestor
14489604|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
14489605|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489606|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489607|NCT02620384|Metolazone|metolazone|mesh-list
14489608|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14489609|NCT02620384|Diuretics|diuretics|mesh-ancestor
14489610|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
14489611|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489612|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14489613|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489614|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489615|NCT02620683|Lidocaine|lidocaine|mesh-list
14489616|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
14489617|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
14489618|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489619|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489620|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
14489621|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489622|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14489623|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14489624|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14489625|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489626|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489627|NCT02620774|Tazobactam|tazobactam|mesh-list
14489628|NCT02620774|Ceftolozane|ceftolozane|mesh-list
14489629|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14489630|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489631|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197288|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14197289|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
14197290|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14197291|NCT04586465|Gemcitabine|gemcitabine|mesh-list
14197292|NCT04586465|Carboplatin|carboplatin|mesh-list
14197293|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
14197294|NCT04586465|Pemetrexed|pemetrexed|mesh-list
14197295|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197296|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14489632|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14197297|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
14197298|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197299|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
14197300|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197301|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489633|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489634|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489635|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14489636|NCT02620774|Renal Agents|renal agents|mesh-ancestor
14489637|NCT02620787|Tedizolid|tedizolid|mesh-list
14489638|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489639|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489640|NCT02620878|Pancrelipase|pancrelipase|mesh-list
14489641|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489642|NCT02620904|Mifepristone|mifepristone|mesh-list
14489643|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14489644|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
14489645|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14489646|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489647|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14489648|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14489649|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14489650|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
14489651|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14489652|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14489653|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
14489654|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489655|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
14489656|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14489657|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14489658|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
14489659|NCT02621060|Antacids|antacids|mesh-ancestor
14489660|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489661|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489662|NCT02621619|Acetaminophen|acetaminophen|mesh-list
14489663|NCT02621619|Hydromorphone|hydromorphone|mesh-list
14489664|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14489665|NCT02621619|Analgesics|analgesics|mesh-ancestor
14489666|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
14489667|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489668|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489669|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
14770696|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770697|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770698|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14770699|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
14770700|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770701|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
14770702|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
14770703|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14770704|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14770705|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770706|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770707|NCT00644631|Urological Agents|urological agents|mesh-ancestor
14770708|NCT00644670|Atorvastatin|atorvastatin|mesh-list
14770709|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14770710|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14770711|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
14770712|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770713|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14197302|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14197303|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
14197304|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197305|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14197306|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14197307|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14197308|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14197309|NCT04586335|Olaparib|olaparib|mesh-list
14489670|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14489671|NCT02621619|Narcotics|narcotics|mesh-ancestor
14489672|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489673|NCT02621931|Calcitonin|calcitonin|mesh-list
14807267|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14197310|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14197311|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197312|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197313|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197314|NCT04586088|Apatinib|apatinib|mesh-list
14197315|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197316|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14197317|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197318|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197319|NCT04586166|Imidacloprid|imidacloprid|mesh-list
14197320|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
14939971|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939972|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14939973|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14197321|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197322|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197323|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197324|NCT04586348|Iodine|iodine|mesh-list
14197325|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
14197326|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14197327|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197328|NCT04586348|Trace Elements|trace elements|mesh-ancestor
14197329|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
14197330|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197331|NCT04586062|Plasminogen|plasminogen|mesh-list
14489674|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14489675|NCT02621931|Katacalcin|katacalcin|mesh-list
14489676|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14489677|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489678|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14489679|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
14489680|NCT02622074|Paclitaxel|paclitaxel|mesh-list
14489681|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14489682|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
14489683|NCT02622074|Carboplatin|carboplatin|mesh-list
14489684|NCT02622074|Doxorubicin|doxorubicin|mesh-list
14197332|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14197333|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14197334|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197335|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
14197336|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14197337|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
14197338|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197339|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
14197340|NCT04586361|Protective Agents|protective agents|mesh-ancestor
14197341|NCT04585997|Omalizumab|omalizumab|mesh-list
14197342|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14197343|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14197344|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
14197345|NCT04585737|Tenofovir|tenofovir|mesh-list
14197346|NCT04585737|Lamivudine|lamivudine|mesh-list
14939974|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14939975|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
14197347|NCT04585737|Emtricitabine|emtricitabine|mesh-list
14197348|NCT04585737|Dolutegravir|dolutegravir|mesh-list
14489685|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
14489686|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14489687|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489688|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
14489689|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
14489690|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
14489691|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489692|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14489693|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
14489694|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489695|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489696|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14489697|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
14489698|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14489699|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14489700|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14197349|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14197350|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
14197351|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197352|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14489701|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14489702|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489703|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489704|NCT02622113|Canagliflozin|canagliflozin|mesh-list
14489705|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14489706|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489707|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14770714|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14770715|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770716|NCT00644696|Cefixime|cefixime|mesh-list
14770717|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
14770718|NCT00644696|Irinotecan|irinotecan|mesh-list
14770719|NCT00644696|Bortezomib|bortezomib|mesh-list
14770720|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14770721|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14770722|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770723|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770724|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770725|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770726|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770727|NCT00644709|Atorvastatin|atorvastatin|mesh-list
14770728|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14770729|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14770730|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
14770731|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770732|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14807268|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939976|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14939977|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14939978|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14939979|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14939980|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
14939981|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14939982|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14939983|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14939984|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14939985|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
14939986|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939987|NCT01490437|Dexamethasone|dexamethasone|mesh-list
14939988|NCT01490437|Pemetrexed|pemetrexed|mesh-list
14939989|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14939990|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14939991|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14939992|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
14939993|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
14939994|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14939995|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14939996|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
14939997|NCT01490437|Hormones|hormones|mesh-ancestor
14939998|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14939999|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14940000|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489708|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489709|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14489710|NCT02622321|Coagulants|coagulants|mesh-ancestor
14527777|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14527778|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14527779|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14527780|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527781|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527782|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
14527783|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
14527784|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
14527785|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14527786|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
14527787|NCT03962738|Lasmiditan|lasmiditan|mesh-list
14527788|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14527789|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
14527790|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527791|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527792|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527793|NCT03946124|Fesoterodine|fesoterodine|mesh-list
14527794|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14489711|NCT02622724|Interferons|interferons|mesh-list
14489712|NCT02622724|Interferon-beta|interferon-beta|mesh-list
14489713|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
14489714|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489715|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
14489716|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489717|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
14489718|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489719|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14489720|NCT02623803|Lidocaine|lidocaine|mesh-list
14489721|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
14489722|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
14489723|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489724|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489725|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
14489726|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489727|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14489728|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14489729|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14489730|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489731|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489732|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
14489733|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14489734|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14489735|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14489736|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489737|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
14489738|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489739|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489740|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14489741|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489742|NCT02624050|Propofol|propofol|mesh-list
14489743|NCT02624050|Methohexital|methohexital|mesh-list
14489744|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14489745|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489746|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489747|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14489748|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
14489749|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
14489750|NCT02624180|Colchicine|colchicine|mesh-list
14489751|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
14489752|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489753|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
14489754|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
14489755|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
14489756|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489757|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489758|NCT02624492|Rituximab|rituximab|mesh-list
14489759|NCT02624492|BI 836826|bi 836826|mesh-list
14489760|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489761|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489762|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
14489763|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489764|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489765|NCT02624700|Pemetrexed|pemetrexed|mesh-list
14489766|NCT02624700|Sorafenib|sorafenib|mesh-list
14489767|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489768|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489769|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489770|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14489771|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14489772|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14489773|NCT02624843|Ethanol|ethanol|mesh-list
14489774|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
14489775|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14489776|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489777|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489778|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489779|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
13963762|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963763|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
13963764|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
13963765|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963766|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13963767|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
14489780|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
14489781|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
14489782|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489783|NCT02624986|Rituximab|rituximab|mesh-list
14489784|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
14489785|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489786|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489787|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
14489788|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489789|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14489790|NCT02625181|Promethazine|promethazine|mesh-list
14489791|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
14489792|NCT02625181|Meclizine|meclizine|mesh-list
14489793|NCT02625181|Dexamethasone|dexamethasone|mesh-list
14489794|NCT02625181|Fentanyl|fentanyl|mesh-list
14489795|NCT02625181|Sufentanil|sufentanil|mesh-list
14489796|NCT02625181|Scopolamine|scopolamine|mesh-list
14770733|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14770734|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770735|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
14770736|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
14770737|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
14770738|NCT00644735|Esomeprazole|esomeprazole|mesh-list
14770739|NCT00644735|Lansoprazole|lansoprazole|mesh-list
14940001|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197353|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14197354|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197355|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197356|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14197357|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14197358|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14197359|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14197360|NCT04585867|Bupivacaine|bupivacaine|mesh-list
14197361|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
14197362|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
14197363|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197364|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197365|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
14197366|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197367|NCT04585841|Cannabidiol|cannabidiol|mesh-list
14197368|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
14197369|NCT04585932|Leuprolide|leuprolide|mesh-list
14197370|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14197371|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
14197372|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14197373|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197374|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14197375|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197376|NCT04585776|Insulin|insulin|mesh-list
14197377|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14770740|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
14770741|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14770742|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14770743|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14770744|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940002|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14940003|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15026637|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026638|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
15026639|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026640|NCT01944683|Midazolam|midazolam|mesh-list
13963768|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
13963769|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963770|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963771|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13963772|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
13963773|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
13963774|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13963775|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14197378|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197379|NCT04585711|Etanercept|etanercept|mesh-list
14197380|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14197381|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197382|NCT04585711|Analgesics|analgesics|mesh-ancestor
14197383|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
14197384|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197385|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770745|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197386|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14489797|NCT02625181|Oxymorphone|oxymorphone|mesh-list
14489798|NCT02625181|Meperidine|meperidine|mesh-list
14489799|NCT02625181|Droperidol|droperidol|mesh-list
14489800|NCT02625181|Ketamine|ketamine|mesh-list
14489801|NCT02625181|Morphine|morphine|mesh-list
14489802|NCT02625181|Remifentanil|remifentanil|mesh-list
14489803|NCT02625181|Oxycodone|oxycodone|mesh-list
14489804|NCT02625181|Methadone|methadone|mesh-list
14197387|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197388|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197389|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940004|NCT01490476|Everolimus|everolimus|mesh-list
14940005|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940006|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940007|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
14940008|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940009|NCT01490502|Vitamin D|vitamin d|mesh-list
14940010|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
14940011|NCT01490502|Vitamins|vitamins|mesh-ancestor
14489805|NCT02625181|Hydromorphone|hydromorphone|mesh-list
14489806|NCT02625181|Hydrocodone|hydrocodone|mesh-list
14489807|NCT02625181|Alfentanil|alfentanil|mesh-list
14197390|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
14489808|NCT02625181|Haloperidol|haloperidol|mesh-list
14489809|NCT02625181|Ondansetron|ondansetron|mesh-list
14489810|NCT02625181|Aprepitant|aprepitant|mesh-list
14489811|NCT02625181|Palonosetron|palonosetron|mesh-list
14489812|NCT02625181|Metoclopramide|metoclopramide|mesh-list
14940012|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
14940013|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940014|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14940015|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14940016|NCT01490567|Donepezil|donepezil|mesh-list
14940017|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14940018|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940019|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940020|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
14940021|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940022|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940023|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
14940024|NCT01490658|Metformin|metformin|mesh-list
14940025|NCT01490658|Repaglinide|repaglinide|mesh-list
14940026|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940027|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940028|NCT01490671|Tenofovir|tenofovir|mesh-list
14940029|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
14940030|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940031|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14940032|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14940033|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940034|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940035|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14940036|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14940037|NCT01490749|Carboplatin|carboplatin|mesh-list
14940038|NCT01490749|Capecitabine|capecitabine|mesh-list
14940039|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
14940040|NCT01490749|Everolimus|everolimus|mesh-list
14940041|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940042|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14940043|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
14940044|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940045|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940046|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
14197391|NCT04585893|Rituximab|rituximab|mesh-list
14197392|NCT04585893|Etoposide|etoposide|mesh-list
14197393|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14197394|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197395|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
14197396|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197397|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197398|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14197399|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14197400|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14197401|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197402|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197403|NCT04585490|Paclitaxel|paclitaxel|mesh-list
14197404|NCT04585490|Cisplatin|cisplatin|mesh-list
14197405|NCT04585490|Carboplatin|carboplatin|mesh-list
14197406|NCT04585490|Pemetrexed|pemetrexed|mesh-list
14197407|NCT04585490|Durvalumab|durvalumab|mesh-list
14940047|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940048|NCT01490762|Insulin|insulin|mesh-list
14940049|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14940050|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940051|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940052|NCT01490905|Ibuprofen|ibuprofen|mesh-list
14197408|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14489813|NCT02625181|Granisetron|granisetron|mesh-list
14489814|NCT02625181|Ramosetron|ramosetron|mesh-list
14489815|NCT02625181|Tropisetron|tropisetron|mesh-list
14489816|NCT02625181|Dolasetron|dolasetron|mesh-list
14489817|NCT02625181|Anesthetics|anesthetics|mesh-list
14489818|NCT02625181|Propofol|propofol|mesh-list
14489819|NCT02625181|Sevoflurane|sevoflurane|mesh-list
14489820|NCT02625181|Desflurane|desflurane|mesh-list
14489821|NCT02625181|Isoflurane|isoflurane|mesh-list
14489822|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14489823|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14489824|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
14489825|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
14489826|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489827|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489828|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489829|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
14489830|NCT02625181|Hormones|hormones|mesh-ancestor
14527795|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14527796|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527797|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527798|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940053|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14197409|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14197410|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197411|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14197412|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
14197413|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14527799|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197414|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197415|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527800|NCT03946124|Urological Agents|urological agents|mesh-ancestor
14197416|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14197417|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14197418|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14197419|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
14197420|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527801|NCT03961308|Vedolizumab|vedolizumab|mesh-list
14527802|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527803|NCT03961295|Vedolizumab|vedolizumab|mesh-list
14527804|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527805|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14527806|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14527807|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14527808|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14527809|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527810|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527811|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527812|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527813|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14527814|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527815|NCT03954444|Phenylephrine|phenylephrine|mesh-list
14527816|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
14527817|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14527818|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14527819|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14527820|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527821|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527822|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527823|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
14527824|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
14527825|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527826|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
14527827|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14527828|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
14527829|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14527830|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
14527831|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14197421|NCT04585334|Diclofenac|diclofenac|mesh-list
14197422|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14489831|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14489832|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14489833|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489834|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14489835|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14489836|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14489837|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
14489838|NCT02625181|Analgesics|analgesics|mesh-ancestor
14489839|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
14489840|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14489841|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14489842|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14489843|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14489844|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489845|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14489846|NCT02625181|Narcotics|narcotics|mesh-ancestor
14489847|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14489848|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14489849|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14489850|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
14489851|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14489852|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14489853|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
14489854|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14489855|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14489856|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14489857|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14489858|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
14489859|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
14489860|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14489861|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14489862|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
14489863|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14489864|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14489865|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14489866|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
14489867|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14489868|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
14489869|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14489870|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
14197423|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197424|NCT04585334|Analgesics|analgesics|mesh-ancestor
14197425|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
14197426|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197427|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197428|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14197429|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197430|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14197431|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197432|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197433|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14197434|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
14197435|NCT04585542|Laxatives|laxatives|mesh-ancestor
14197436|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197437|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
14197438|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
14197439|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197440|NCT04585412|Palonosetron|palonosetron|mesh-list
14197441|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
14197442|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
14197443|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489871|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14489872|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
14489873|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
14489874|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14489875|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14489876|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
14489877|NCT02625207|Maraviroc|maraviroc|mesh-list
14489878|NCT02625207|Darunavir|darunavir|mesh-list
14489879|NCT02625207|Cobicistat|cobicistat|mesh-list
14489880|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14489881|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14489882|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489883|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14489884|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14489885|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
14489886|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489887|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14489888|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14489889|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14489890|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
14489891|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489892|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14489893|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14489894|NCT02625259|Lansoprazole|lansoprazole|mesh-list
14489895|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
14489896|NCT02625259|Serabelisib|serabelisib|mesh-list
14489897|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14489898|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14489899|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14489900|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489901|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489902|NCT02625298|Pemetrexed|pemetrexed|mesh-list
14770746|NCT00644748|Gabapentin|gabapentin|mesh-list
14770747|NCT00644748|Analgesics|analgesics|mesh-ancestor
14770748|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
14770749|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770750|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770751|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
14770752|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14770753|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770754|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770755|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770756|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14770757|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14770758|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770759|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770760|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
14770761|NCT00644761|Adefovir|adefovir|mesh-list
14770762|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14770763|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
14770764|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770765|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14770766|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14770767|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770768|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770769|NCT00644774|Azithromycin|azithromycin|mesh-list
14770770|NCT00644774|Cefdinir|cefdinir|mesh-list
14770771|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770772|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770773|NCT00644800|Ziprasidone|ziprasidone|mesh-list
14770774|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14770775|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
14770776|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770777|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770778|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770779|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14770780|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770781|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770782|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770783|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14770784|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
14770785|NCT00644891|Amoxicillin|amoxicillin|mesh-list
14770786|NCT00644891|Cefdinir|cefdinir|mesh-list
14770787|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770788|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770789|NCT00644904|Vitamin D|vitamin d|mesh-list
14770790|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
14770791|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
14770792|NCT00644904|Vitamins|vitamins|mesh-list
14770793|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
14770794|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770795|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14770796|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14770797|NCT00644943|Amoxicillin|amoxicillin|mesh-list
14770798|NCT00644943|Cefdinir|cefdinir|mesh-list
14770799|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489903|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770800|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770801|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
14770802|NCT00644956|Tadalafil|tadalafil|mesh-list
14489904|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489905|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489906|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14489907|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14489908|NCT02625610|Leucovorin|leucovorin|mesh-list
14489909|NCT02625610|Fluorouracil|fluorouracil|mesh-list
14489910|NCT02625610|Capecitabine|capecitabine|mesh-list
14489911|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
14489912|NCT02625610|Avelumab|avelumab|mesh-list
14489913|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
14489914|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
14489915|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489916|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14489917|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489918|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14489919|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
14489920|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489921|NCT02625610|Antidotes|antidotes|mesh-ancestor
14489922|NCT02625610|Protective Agents|protective agents|mesh-ancestor
14197444|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197445|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197446|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14197447|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14197448|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
14197449|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197450|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197451|NCT04585438|Diclofenac|diclofenac|mesh-list
14197452|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14197453|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197454|NCT04585438|Analgesics|analgesics|mesh-ancestor
14197455|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
14197456|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197457|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197458|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14197459|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197460|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14197461|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197462|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197463|NCT04585321|Diclofenac|diclofenac|mesh-list
14197464|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14197465|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14197466|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197467|NCT04585321|Analgesics|analgesics|mesh-ancestor
14489923|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
14489924|NCT02625610|Vitamins|vitamins|mesh-ancestor
14489925|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
14489926|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489927|NCT02625623|Paclitaxel|paclitaxel|mesh-list
14489928|NCT02625623|Irinotecan|irinotecan|mesh-list
14489929|NCT02625623|Avelumab|avelumab|mesh-list
14489930|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14489931|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770803|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
14770804|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14197468|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
14489932|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
14489933|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
14489934|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
14489935|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489936|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14489937|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14489938|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489939|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489940|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
14489941|NCT02625909|Velpatasvir|velpatasvir|mesh-list
14489942|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
14489943|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489944|NCT02625974|Nifurtimox|nifurtimox|mesh-list
14489945|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14489946|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14489947|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14489948|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197469|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14489949|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
14489950|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14489951|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489952|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489953|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
14489954|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770805|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14770806|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770807|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770808|NCT00644956|Urological Agents|urological agents|mesh-ancestor
14770809|NCT00644982|Sertraline|sertraline|mesh-list
14770810|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14770811|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
14770812|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770813|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14770814|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14770815|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770816|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770817|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770818|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
14770819|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770820|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14770821|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14770822|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
14770823|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
14489955|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
14489956|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
14489957|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14770824|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14770825|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14770826|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770827|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770828|NCT00645034|Urological Agents|urological agents|mesh-ancestor
14770829|NCT00645060|Antibodies|antibodies|mesh-list
14770830|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14770831|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
14770832|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770833|NCT00645073|Levofloxacin|levofloxacin|mesh-list
14770834|NCT00645073|Ofloxacin|ofloxacin|mesh-list
14770835|NCT00645073|Cefdinir|cefdinir|mesh-list
14770836|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14770837|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770838|NCT00645073|Renal Agents|renal agents|mesh-ancestor
14770839|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770840|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14770841|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14770842|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770843|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770844|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14770845|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14770846|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14770847|NCT00645086|Clarithromycin|clarithromycin|mesh-list
14770848|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770849|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770850|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14770851|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770852|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770853|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14770854|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14770855|NCT00645112|Azithromycin|azithromycin|mesh-list
14770856|NCT00645112|Cefdinir|cefdinir|mesh-list
14770857|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770858|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770859|NCT00645125|Amoxicillin|amoxicillin|mesh-list
14770860|NCT00645125|Cefdinir|cefdinir|mesh-list
14770861|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14770862|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770863|NCT00645138|Anesthetics|anesthetics|mesh-list
14770864|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770865|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963776|NCT03142321|Vedolizumab|vedolizumab|mesh-list
13963777|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963778|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13963779|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14489958|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14489959|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489960|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14489961|NCT02626182|Urological Agents|urological agents|mesh-ancestor
14489962|NCT02626611|Omalizumab|omalizumab|mesh-list
14489963|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14489964|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14489965|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
14489966|NCT02627144|Interferons|interferons|mesh-list
14489967|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
14489968|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
14489969|NCT02627144|Bevacizumab|bevacizumab|mesh-list
14489970|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14489971|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489972|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14489973|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14489974|NCT02627144|Growth Substances|growth substances|mesh-ancestor
14489975|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489976|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
14489977|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
14489978|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489979|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
14770866|NCT00645151|Atorvastatin|atorvastatin|mesh-list
14770867|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14770868|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14770869|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
14770870|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770871|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14770872|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14940054|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14940055|NCT01490905|Analgesics|analgesics|mesh-ancestor
14940056|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
14940057|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940058|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940059|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940060|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940061|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14940062|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940063|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940064|NCT01490944|Iron|iron|mesh-list
14940065|NCT01490944|Folic Acid|folic acid|mesh-list
14940066|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
14940067|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
14940068|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
14940069|NCT01490944|Trace Elements|trace elements|mesh-ancestor
14940070|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
14940071|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940072|NCT01490944|Hematinics|hematinics|mesh-ancestor
14940073|NCT01490944|Vitamins|vitamins|mesh-ancestor
14940074|NCT01490996|Curcumin|curcumin|mesh-list
14940075|NCT01490996|Capecitabine|capecitabine|mesh-list
14940076|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14940077|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
14197470|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14489980|NCT02627677|Ponatinib|ponatinib|mesh-list
14489981|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14489982|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14197471|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14197472|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197473|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14197474|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197475|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238748|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14242953|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242954|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242955|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242956|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
14242957|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
14242958|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242959|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242960|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14489983|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14489984|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940078|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940079|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940080|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14489985|NCT02628106|Alprostadil|alprostadil|mesh-list
14940081|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14489986|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14489987|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14489988|NCT02628106|Urological Agents|urological agents|mesh-ancestor
14489989|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14489990|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14489991|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14489992|NCT02628600|Amikacin|amikacin|mesh-list
14489993|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489994|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489995|NCT02628769|Solithromycin|solithromycin|mesh-list
14489996|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14489997|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14489998|NCT02629094|Eplerenone|eplerenone|mesh-list
14489999|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14490000|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
14490001|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490002|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490003|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14490004|NCT02629094|Diuretics|diuretics|mesh-ancestor
14490005|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
14490006|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490007|NCT02629354|Ibuprofen|ibuprofen|mesh-list
14490008|NCT02629354|Caffeine|caffeine|mesh-list
14490009|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490010|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490011|NCT02629354|Analgesics|analgesics|mesh-ancestor
14490012|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
14490013|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490014|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490015|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490016|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490017|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14490018|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490019|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490020|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14490021|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14490022|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14490023|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14490024|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
14490025|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490026|NCT02629822|Tenofovir|tenofovir|mesh-list
14490027|NCT02629822|Lamivudine|lamivudine|mesh-list
14490028|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
14490029|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490030|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14490031|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14490032|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490033|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490034|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14490035|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14490036|NCT02629861|Calcitonin|calcitonin|mesh-list
14490037|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14490038|NCT02629861|Katacalcin|katacalcin|mesh-list
14490039|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14490040|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490041|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14490042|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
14490043|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
14490044|NCT02629965|Olodaterol|olodaterol|mesh-list
14490045|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14490046|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
14490047|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490048|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490049|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14490050|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
14490051|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
14490052|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14490053|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
14490054|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490055|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490056|NCT02629991|Oxytocin|oxytocin|mesh-list
14770873|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490057|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
14490058|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14490059|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490060|NCT02630017|Methylphenidate|methylphenidate|mesh-list
14490061|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14490062|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490063|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14490064|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14490065|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14490066|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490067|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
14490068|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490069|NCT02630030|Ixazomib|ixazomib|mesh-list
14490070|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490071|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
14490072|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490073|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490074|NCT02630186|Atezolizumab|atezolizumab|mesh-list
14490075|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490076|NCT02630316|Treprostinil|treprostinil|mesh-list
14490077|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490087|NCT02630563|Cyclosporine|cyclosporine|mesh-list
14490088|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
14490089|NCT02630563|Cyclosporins|cyclosporins|mesh-list
14490090|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490091|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490092|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490093|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
14490094|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490095|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
14490096|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490097|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490098|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490099|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14770874|NCT00645190|Galantamine|galantamine|mesh-list
14770875|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14770876|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770877|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770878|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
14770879|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770880|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770881|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14770882|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
14770883|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770884|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
14770885|NCT00645203|Cefdinir|cefdinir|mesh-list
14770886|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197476|NCT04585230|Mineral Oil|mineral oil|mesh-list
14197477|NCT04585230|Emollients|emollients|mesh-ancestor
14197478|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
14197479|NCT04585152|Rituximab|rituximab|mesh-list
14197480|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14197481|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197482|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
14197483|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197484|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197485|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14197486|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14197487|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14197488|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14197489|NCT04585022|Cimetidine|cimetidine|mesh-list
14197490|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14197491|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197492|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14197493|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
14197494|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
14197495|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197496|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197497|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490100|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14490101|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490102|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14490103|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
14490104|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14490105|NCT02630693|Tamoxifen|tamoxifen|mesh-list
14490106|NCT02630693|Fulvestrant|fulvestrant|mesh-list
14490107|NCT02630693|Palbociclib|palbociclib|mesh-list
14490108|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14490109|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14490110|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
14770887|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770888|NCT00645229|Ziprasidone|ziprasidone|mesh-list
14770889|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14770890|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
14770891|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770892|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770893|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770894|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14770895|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770896|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770897|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770898|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14770899|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
14770900|NCT00645242|Fluconazole|fluconazole|mesh-list
14770901|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
14770902|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14770903|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14770904|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14770905|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770906|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770907|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14770908|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
14770909|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14770910|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770911|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14770912|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14770913|NCT00645255|Sibutramine|sibutramine|mesh-list
14770914|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
14770915|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770916|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
14770917|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14770918|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
14770919|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
14770920|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14940082|NCT01490996|Analgesics|analgesics|mesh-ancestor
14940083|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
14197498|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14197499|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14197500|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770921|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14770922|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770923|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197501|NCT04584515|Itraconazole|itraconazole|mesh-list
14197502|NCT04584515|Rifampin|rifampin|mesh-list
14197503|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
14197504|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197505|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14197506|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14197507|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940084|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940085|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940086|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940087|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197508|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770924|NCT00645268|Urological Agents|urological agents|mesh-ancestor
14770925|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14770926|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14770927|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14770928|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
14490111|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940088|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940089|NCT01491009|Midazolam|midazolam|mesh-list
14490112|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490113|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14490114|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490115|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14490116|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14490117|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14490118|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14490119|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14490120|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490121|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490122|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14490123|NCT02630706|Metformin|metformin|mesh-list
14490124|NCT02630706|Glimepiride|glimepiride|mesh-list
14490125|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
14490126|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490127|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490128|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14490129|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490130|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
14490131|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14490132|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197509|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14197510|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
14197511|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14197512|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197513|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14197514|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14197515|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
14197516|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197517|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
14197518|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14197519|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14197520|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14490133|NCT02630719|Timolol|timolol|mesh-list
14490134|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14490135|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
14490136|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14770929|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770930|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770931|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770932|NCT00645281|Urological Agents|urological agents|mesh-ancestor
14807269|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14807270|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807271|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
14807272|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
14197521|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14807273|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14807274|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807275|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807276|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
14807277|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807278|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807279|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807280|NCT00820885|Teduglutide|teduglutide|mesh-list
14807281|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14807282|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14940090|NCT01491009|Remifentanil|remifentanil|mesh-list
14940091|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13963780|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13963781|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963782|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963783|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
13963784|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963785|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13963786|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13963787|NCT03142139|Vaccines|vaccines|mesh-list
13963788|NCT03142139|Immunologic Factors|immunologic factors|mesh-ancestor
13963789|NCT03142139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963790|NCT03142360|Beraprost|beraprost|mesh-list
13963791|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13963792|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
13963793|NCT03142542|Udenafil|udenafil|mesh-list
14490137|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14490138|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14490139|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490140|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490141|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490142|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490143|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14490144|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490145|NCT02630966|Vedolizumab|vedolizumab|mesh-list
14490146|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490147|NCT02630992|Amoxicillin|amoxicillin|mesh-list
14490148|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
14490149|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
14490150|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14490151|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14490152|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490153|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14490154|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490155|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490156|NCT02631057|Warfarin|warfarin|mesh-list
14490157|NCT02631057|Dabigatran|dabigatran|mesh-list
14490158|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
14490159|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
14490160|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14490161|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
14490162|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490163|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490164|NCT02631525|Propofol|propofol|mesh-list
14490165|NCT02631525|Desflurane|desflurane|mesh-list
14490166|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14490167|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490168|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490169|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14490170|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
14490171|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
14490172|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14490173|NCT02631538|Rituximab|rituximab|mesh-list
14490174|NCT02631538|Belimumab|belimumab|mesh-list
14490175|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14490176|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490177|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
14490178|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197522|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14197523|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14197524|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14197525|NCT04584580|Heparin|heparin|mesh-list
14197526|NCT04584580|Enoxaparin|enoxaparin|mesh-list
14197527|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14197528|NCT04584580|Tinzaparin|tinzaparin|mesh-list
14197529|NCT04584580|Dalteparin|dalteparin|mesh-list
14197530|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
14490179|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490180|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490181|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
14490182|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14197531|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14197532|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14197533|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197534|NCT04584749|Lidocaine|lidocaine|mesh-list
14490183|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490184|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490185|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14490186|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490187|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490188|NCT02631551|Analgesics|analgesics|mesh-ancestor
14490189|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
14490190|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490191|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490192|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490193|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14490194|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14770933|NCT00645294|Adefovir|adefovir|mesh-list
14770934|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14770935|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
14490195|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
14770936|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197535|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
14490196|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
14490197|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490198|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490199|NCT02631590|Gemcitabine|gemcitabine|mesh-list
14490200|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490201|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14490202|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
14490203|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490204|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
14490205|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490206|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490207|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490208|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
14490209|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490210|NCT02631746|Nivolumab|nivolumab|mesh-list
14490211|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14490212|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490213|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14490214|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490215|NCT02631772|Ribavirin|ribavirin|mesh-list
14490216|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
14490217|NCT02631772|Ledipasvir|ledipasvir|mesh-list
14490218|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
14490219|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490220|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
14490221|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490222|NCT02631876|Paclitaxel|paclitaxel|mesh-list
14490223|NCT02631876|Maytansine|maytansine|mesh-list
14940092|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14940093|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940094|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940095|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14940096|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14940097|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940098|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14940099|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
14940100|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
14940101|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
14940102|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
14940103|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940104|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940105|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14490224|NCT02631876|Doxorubicin|doxorubicin|mesh-list
14490225|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14490226|NCT02631876|Topotecan|topotecan|mesh-list
14490227|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14770937|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14770938|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14770939|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14770940|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770941|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14770942|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14770943|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770944|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770945|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770946|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770947|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14770948|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14770949|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
14770950|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770951|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770952|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14770953|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14770954|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
14770955|NCT00645320|Ziprasidone|ziprasidone|mesh-list
14770956|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14770957|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
14770958|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14770959|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770960|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770961|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13963794|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14490228|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940106|NCT01491009|Narcotics|narcotics|mesh-ancestor
14940107|NCT01491009|Analgesics|analgesics|mesh-ancestor
14490229|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
14490230|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
14490231|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
14490232|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490233|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14490234|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14490235|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14490236|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490237|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14490238|NCT02631954|Voriconazole|voriconazole|mesh-list
14490239|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
14490240|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490241|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14490242|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14490243|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490244|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490245|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14490246|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
14490247|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490248|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490249|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14490250|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14490251|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14490252|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490253|NCT02632747|Empagliflozin|empagliflozin|mesh-list
14490254|NCT02632747|Ramipril|ramipril|mesh-list
14490255|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14490256|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490257|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490258|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490259|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14490260|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
14490261|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490262|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490263|NCT02632812|Naproxen|naproxen|mesh-list
14490264|NCT02632812|Rebamipide|rebamipide|mesh-list
14490265|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490266|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490267|NCT02632812|Analgesics|analgesics|mesh-ancestor
14490268|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
14490269|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490270|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490271|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490272|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490273|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
14490274|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14490275|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527832|NCT03954444|Protective Agents|protective agents|mesh-ancestor
14940108|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
14940109|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940110|NCT01491048|Tacrine|tacrine|mesh-list
14940111|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14940112|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940113|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940114|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
14940115|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940116|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940117|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14940118|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
14940119|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940120|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
13963795|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13963796|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963797|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963798|NCT03141827|Insulin|insulin|mesh-list
13963799|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13963800|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963801|NCT03141970|Prednisone|prednisone|mesh-list
13963802|NCT03141970|Prednisolone|prednisolone|mesh-list
13963803|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963804|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
13963805|NCT03141970|Hormones|hormones|mesh-ancestor
14940121|NCT01491061|Ranolazine|ranolazine|mesh-list
13968011|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14940122|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14940123|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940124|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940125|NCT01491100|Interferons|interferons|mesh-list
14940126|NCT01491100|Interferon-beta|interferon-beta|mesh-list
14940127|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
14940128|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940129|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
14940130|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940131|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
14940132|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770962|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770963|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770964|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770965|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14770966|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
14770967|NCT00645372|Risperidone|risperidone|mesh-list
14770968|NCT00645372|Ziprasidone|ziprasidone|mesh-list
14490276|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490277|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14490278|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490279|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
14490280|NCT02632812|Protective Agents|protective agents|mesh-ancestor
14527833|NCT03953820|Diazepam|diazepam|mesh-list
14527834|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14527835|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
14770969|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14770970|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
14770971|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807283|NCT00820885|Protective Agents|protective agents|mesh-ancestor
14527836|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
14527837|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
14527838|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527839|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527840|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527841|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14527842|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527843|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14527844|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14527845|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14527846|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14527847|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14527848|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14527849|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
14527850|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
14527851|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
14527852|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
14527853|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527854|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527855|NCT03961100|Entrectinib|entrectinib|mesh-list
14527856|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14527857|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527858|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527859|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14527860|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
14527861|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527862|NCT03960658|Ketamine|ketamine|mesh-list
14527863|NCT03960658|Analgesics|analgesics|mesh-ancestor
14527864|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
14527865|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527866|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527867|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14527868|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14527869|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
14527870|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
14527871|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527872|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14527873|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14527874|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527875|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527876|NCT03959332|Baloxavir|baloxavir|mesh-list
14527877|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
14527878|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527879|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490281|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14490282|NCT02633046|Hormones|hormones|mesh-ancestor
14490283|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490284|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490285|NCT02633371|Oxybutynin|oxybutynin|mesh-list
14490286|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
14490287|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
14490288|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490289|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490290|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14490291|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14490292|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
14490293|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197536|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
14197537|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197538|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197539|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
14197540|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197541|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14490294|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490295|NCT02633371|Urological Agents|urological agents|mesh-ancestor
14490296|NCT02633488|Metformin|metformin|mesh-list
14490297|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14197542|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14197543|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14197544|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197545|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490298|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490299|NCT02633800|Carboplatin|carboplatin|mesh-list
14490300|NCT02633800|Cetuximab|cetuximab|mesh-list
14490301|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490302|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14490303|NCT02633956|Atorvastatin|atorvastatin|mesh-list
14490304|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14490305|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14490306|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
14490307|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490308|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14490309|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14490310|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490311|NCT02634073|Lamivudine|lamivudine|mesh-list
14490312|NCT02634073|Sorbitol|sorbitol|mesh-list
14490313|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14490314|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14490315|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490316|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490317|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
14490318|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490319|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14490320|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14490321|NCT02634073|Cathartics|cathartics|mesh-ancestor
14490322|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490323|NCT02634320|Aripiprazole|aripiprazole|mesh-list
14490324|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
14490325|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
14490326|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14490327|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14490328|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14490329|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490330|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490331|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
14490332|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
14490333|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197546|NCT04584710|Dactolisib|dactolisib|mesh-list
14197547|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197548|NCT04584671|Xenon|xenon|mesh-list
14197549|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14197550|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
14197551|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
14197552|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197553|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197554|NCT04584736|Ezetimibe|ezetimibe|mesh-list
14197555|NCT04584736|Pitavastatin|pitavastatin|mesh-list
14197556|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14197557|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14490334|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490335|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14490336|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14490337|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
14490338|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14490339|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14490340|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14490341|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14490342|NCT02634333|Aflibercept|aflibercept|mesh-list
14490343|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
14490344|NCT02634333|Mitogens|mitogens|mesh-list
14490345|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14490346|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14490347|NCT02634333|Growth Substances|growth substances|mesh-ancestor
14490348|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490349|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
14490350|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490351|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
14490352|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490353|NCT02634346|Olanzapine|olanzapine|mesh-list
14490354|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
14490355|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
14490356|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490357|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490358|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490359|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14490360|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14490361|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490362|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14490363|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14490364|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14490365|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14490366|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490367|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490368|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
14490369|NCT02634580|Ezetimibe|ezetimibe|mesh-list
14490370|NCT02634580|Evolocumab|evolocumab|mesh-list
14197558|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
14197559|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197560|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14197561|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14197562|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197563|NCT04584125|Riboflavin|riboflavin|mesh-list
14197564|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
14770972|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770973|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197565|NCT04584125|Dextrans|dextrans|mesh-list
14490371|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14490372|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14490373|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14490374|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
14490375|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490376|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14490377|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
14490378|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490379|NCT02634684|Amphetamine|amphetamine|mesh-list
14490380|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
14490381|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14490382|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490383|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
14490384|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
14490385|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197566|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14197567|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14490386|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
14490387|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490388|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490389|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490390|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14490391|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14490392|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14490393|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14490394|NCT02634788|Buprenorphine|buprenorphine|mesh-list
14490395|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14490396|NCT02634788|Narcotics|narcotics|mesh-ancestor
14490397|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490398|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490399|NCT02634788|Analgesics|analgesics|mesh-ancestor
14490400|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
14490401|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490402|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14490403|NCT02634801|Methotrexate|methotrexate|mesh-list
14490404|NCT02634801|Ixekizumab|ixekizumab|mesh-list
14490405|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14490406|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
14490407|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14490408|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490409|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14490410|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
14490411|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490412|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490413|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490414|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490415|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14490416|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490417|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
14490418|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14770974|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14770975|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14770976|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770977|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770978|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14770979|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
14770980|NCT00645398|Pregabalin|pregabalin|mesh-list
14770981|NCT00645398|Analgesics|analgesics|mesh-ancestor
14770982|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
14770983|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14770984|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14770985|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
14770986|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14770987|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770988|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770989|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14770990|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14770991|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14940133|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14940134|NCT01491139|Olaparib|olaparib|mesh-list
14197568|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
14197569|NCT04584125|Vitamins|vitamins|mesh-ancestor
14197570|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
14197571|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197572|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14197573|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
14197574|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
14197575|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
14197576|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
14197577|NCT04584307|Pomalidomide|pomalidomide|mesh-list
14197578|NCT04584307|Elotuzumab|elotuzumab|mesh-list
14197579|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
14197580|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197581|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14197582|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14197583|NCT04584307|Growth Substances|growth substances|mesh-ancestor
14197584|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
14197585|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197586|NCT04584034|Albuterol|albuterol|mesh-list
14197587|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
14197588|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
14197589|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197590|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197591|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14490419|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14490420|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14490421|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14490422|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490423|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14490424|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14490425|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14770992|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14770993|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14770994|NCT00645424|Atorvastatin|atorvastatin|mesh-list
14770995|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14770996|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14197592|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
14197593|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
14197594|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14197595|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14197596|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14197597|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14197598|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
14197599|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197600|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197601|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14490426|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490427|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
14490428|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490429|NCT02635204|Clobetasol|clobetasol|mesh-list
14490430|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490431|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
14490432|NCT02635204|Hormones|hormones|mesh-ancestor
14490433|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490434|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490435|NCT02635386|Metformin|metformin|mesh-list
14490436|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
14490437|NCT02635386|Exenatide|exenatide|mesh-list
14490438|NCT02635386|Topiramate|topiramate|mesh-list
14490439|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14490440|NCT02635386|Phentermine|phentermine|mesh-list
14490441|NCT02635386|Glucagon|glucagon|mesh-list
14490442|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14490443|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14770997|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
14770998|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14770999|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14771000|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14771001|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771002|NCT00645437|Levofloxacin|levofloxacin|mesh-list
14771003|NCT00645437|Ofloxacin|ofloxacin|mesh-list
14771004|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14771005|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771006|NCT00645437|Renal Agents|renal agents|mesh-ancestor
14771007|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14771008|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14771009|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14771010|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771011|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771012|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771013|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14771014|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14771015|NCT00645502|Risperidone|risperidone|mesh-list
14771016|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14771017|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
14771018|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771019|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771020|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771021|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14771022|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771023|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771024|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771025|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14197602|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238749|NCT00135226|Aspirin|aspirin|mesh-list
14771026|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
14771027|NCT00645515|Risperidone|risperidone|mesh-list
14771028|NCT00645515|Ziprasidone|ziprasidone|mesh-list
14771029|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14771030|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
14771031|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771032|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771033|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771034|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14771035|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771036|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940135|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940136|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14940137|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940138|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940139|NCT01491191|Palmidrol|palmidrol|mesh-list
14940140|NCT01491191|Analgesics|analgesics|mesh-ancestor
14940141|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
14940142|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940143|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963806|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238750|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14238751|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14238752|NCT00135226|Analgesics|analgesics|mesh-ancestor
14238753|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
14940144|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14940145|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14940146|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940147|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940148|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
14940149|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940150|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14940151|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14940152|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940153|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940154|NCT01491191|Hormones|hormones|mesh-ancestor
14940155|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940156|NCT01491204|Paclitaxel|paclitaxel|mesh-list
14940157|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14940158|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940159|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
14940160|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
14940161|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
14940162|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940163|NCT01491217|Paclitaxel|paclitaxel|mesh-list
14940164|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14940165|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940166|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
14940167|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
14940168|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
14940169|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940170|NCT01491256|Atorvastatin|atorvastatin|mesh-list
14238754|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238755|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238756|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238757|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238758|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14242961|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
14490444|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490445|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490446|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14490447|NCT02635386|Incretins|incretins|mesh-ancestor
14490448|NCT02635386|Hormones|hormones|mesh-ancestor
14490449|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490450|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
14771037|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771038|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14771039|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
14771040|NCT00645554|Galantamine|galantamine|mesh-list
14771041|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14771042|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771043|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771044|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
14771045|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771046|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771047|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14771048|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
14771049|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771050|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
14771051|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
14771052|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14771053|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771054|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771055|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771056|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771057|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14771058|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14771059|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771060|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771061|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771062|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
14771063|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14771064|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
14771065|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14771066|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14771067|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771068|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14771069|NCT00645606|Rituximab|rituximab|mesh-list
14771070|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14771071|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771072|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
14771073|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771074|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771075|NCT00645632|Doxorubicin|doxorubicin|mesh-list
14771076|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14771077|NCT00645632|Methotrexate|methotrexate|mesh-list
14771078|NCT00645632|Ifosfamide|ifosfamide|mesh-list
14771079|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771080|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14940171|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14940172|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14940173|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
14940174|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940175|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14940176|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14940177|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940178|NCT01491295|Tenofovir|tenofovir|mesh-list
14940179|NCT01491295|Lamivudine|lamivudine|mesh-list
14940180|NCT01491295|Adefovir|adefovir|mesh-list
14940181|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
14940182|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940183|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14940184|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14940185|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197603|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197604|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197605|NCT04583813|Empagliflozin|empagliflozin|mesh-list
14197606|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14197607|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197608|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14771081|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14490451|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490452|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14490453|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
14490454|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
14490455|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
14490456|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490457|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490458|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490459|NCT02635542|Cisatracurium|cisatracurium|mesh-list
14490460|NCT02635542|Succinylcholine|succinylcholine|mesh-list
14490461|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14490462|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14490463|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490464|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490465|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14490466|NCT02635724|Peramivir|peramivir|mesh-list
14490467|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
14490468|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197609|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197610|NCT04583410|Nicotine|nicotine|mesh-list
14197611|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14197612|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
14197613|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197614|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197615|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14197616|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14197617|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
14490469|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963807|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963808|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13963809|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963810|NCT03142035|Dienogest|dienogest|mesh-list
13963811|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13963812|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
13963813|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13963814|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963815|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13963816|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13963817|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14490470|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490471|NCT02635828|Promethazine|promethazine|mesh-list
14490472|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
14490473|NCT02635828|Dexamethasone|dexamethasone|mesh-list
14490474|NCT02635828|Palonosetron|palonosetron|mesh-list
14490475|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490476|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
14771082|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14771083|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771084|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771085|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14771086|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
14771087|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14771088|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771089|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14771090|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
14771091|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
14771092|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14771093|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14771094|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
14771095|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771096|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14771097|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14771098|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
14771099|NCT00645658|Testosterone|testosterone|mesh-list
14771100|NCT00645658|Androgens|androgens|mesh-ancestor
14771101|NCT00645658|Hormones|hormones|mesh-ancestor
14771102|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771103|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771104|NCT00645723|Colistin|colistin|mesh-list
14771105|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14771106|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771107|NCT00645801|Lubiprostone|lubiprostone|mesh-list
14771108|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14771109|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771110|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771111|NCT00645814|Adalimumab|adalimumab|mesh-list
14771112|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771113|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771114|NCT00645866|Docetaxel|docetaxel|mesh-list
14771115|NCT00645866|Capecitabine|capecitabine|mesh-list
14771116|NCT00645866|Epirubicin|epirubicin|mesh-list
14771117|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771118|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
14771119|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
14771120|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
14771121|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771122|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14771123|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
14771124|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14771125|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14771126|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14771127|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771128|NCT00645879|Citric Acid|citric acid|mesh-list
14771129|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
14771130|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
14771131|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14771132|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
14771133|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
14771134|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771135|NCT00645892|Adalimumab|adalimumab|mesh-list
14771136|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771137|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490477|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
14490478|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490479|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490480|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490481|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
14490482|NCT02635828|Hormones|hormones|mesh-ancestor
14490483|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490484|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14490485|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490486|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14771138|NCT00645905|Adalimumab|adalimumab|mesh-list
14490487|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14490488|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
14490489|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490490|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490491|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
14490492|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490493|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14490494|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
14490495|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
14490496|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14490497|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14490498|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14490499|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490500|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
14771139|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771140|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771141|NCT00645918|Clopidogrel|clopidogrel|mesh-list
14771142|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14771143|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14771144|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14771145|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14771146|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
14771147|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771148|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771149|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771150|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14771151|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771152|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771153|NCT00646009|Fluticasone|fluticasone|mesh-list
14771154|NCT00646009|Budesonide|budesonide|mesh-list
14771155|NCT00646009|Albuterol|albuterol|mesh-list
14940186|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771156|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
14771157|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14771158|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14771159|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771160|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14771161|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
14771162|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771163|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771164|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14771165|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14771166|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14771167|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14771168|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
14771169|NCT00646009|Hormones|hormones|mesh-ancestor
14771170|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771171|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14771172|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14771173|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14771174|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771175|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771176|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771177|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
14771178|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14771179|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
14771180|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
14771181|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14771182|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940187|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14197618|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197619|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197620|NCT04583267|Tenofovir|tenofovir|mesh-list
14197621|NCT04583267|Emtricitabine|emtricitabine|mesh-list
14197622|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
14197623|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197624|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14197625|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14197626|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197627|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197628|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14197629|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14197630|NCT04583111|Domperidone|domperidone|mesh-list
14490501|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
14490502|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
14490503|NCT02635984|Olanzapine|olanzapine|mesh-list
14490504|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
14490505|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
14490506|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490507|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490508|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490509|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14771183|NCT00646035|Vitamins|vitamins|mesh-ancestor
14771184|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
14771185|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14771186|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14771187|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
14771188|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
14771189|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771190|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771191|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14771192|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14771193|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
14771194|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771195|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771196|NCT00646087|Ketamine|ketamine|mesh-list
14771197|NCT00646087|Analgesics|analgesics|mesh-ancestor
14771198|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
14771199|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771200|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771201|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14771202|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14771203|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
14197631|NCT04583111|Sulpiride|sulpiride|mesh-list
14197632|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
14197633|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
14197634|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197635|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197636|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197637|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14197638|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
14771204|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
14771205|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771206|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14771207|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14771208|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771209|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771210|NCT00646126|Artesunate|artesunate|mesh-list
14771211|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
14771212|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
14771213|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
14771214|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14771215|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14771216|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771217|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197639|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197640|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197641|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14197642|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14197643|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197644|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14197645|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14197646|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
14238759|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14238760|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238761|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14238762|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14238763|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238764|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
14238765|NCT00135330|Exenatide|exenatide|mesh-list
14238766|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
14238767|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490510|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14490511|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490512|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14490513|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14490514|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14771218|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
14771219|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
14490515|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14490516|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490517|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490518|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
14490519|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
14490520|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490521|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490522|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
14490523|NCT02636725|Axitinib|axitinib|mesh-list
14490524|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14490525|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490526|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14490527|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490528|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490529|NCT02637037|Metformin|metformin|mesh-list
14490530|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
14490531|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490532|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490533|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14490534|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490535|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
14490536|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14490537|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14490538|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
14490539|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
14490540|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490541|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490542|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14771220|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14771221|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
14771222|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14771223|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771224|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771225|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14771226|NCT00646126|Renal Agents|renal agents|mesh-ancestor
14771227|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
14771228|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771229|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771230|NCT00646152|Poly ICLC|poly iclc|mesh-list
14771231|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
14771232|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
14771233|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771234|NCT00646178|Adalimumab|adalimumab|mesh-list
14771235|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771236|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771237|NCT00646191|Adalimumab|adalimumab|mesh-list
14771238|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771239|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771240|NCT00646204|Memantine|memantine|mesh-list
14771241|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14771242|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14771243|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
14771244|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771245|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771246|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771247|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14771248|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14771249|NCT00646230|Fenretinide|fenretinide|mesh-list
14771250|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771251|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14771252|NCT00646230|Protective Agents|protective agents|mesh-ancestor
14771253|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771254|NCT00646321|Budesonide|budesonide|mesh-list
14771255|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
14771256|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14771257|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771258|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14771259|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
14771260|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771261|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771262|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14771263|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
14771264|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
14771265|NCT00646321|Hormones|hormones|mesh-ancestor
14807284|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490543|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490544|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14490545|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14490546|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14490547|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490548|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490549|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490550|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490551|NCT02637323|Triamcinolone|triamcinolone|mesh-list
14490552|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14490553|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14490554|NCT02637323|FX006|fx006|mesh-list
14490555|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14490556|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490557|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
14490558|NCT02637323|Hormones|hormones|mesh-ancestor
14490559|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490560|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490561|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490562|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
14490563|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490564|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490565|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
14490566|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
14490567|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490568|NCT02637895|Vortioxetine|vortioxetine|mesh-list
14490569|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
14490570|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940188|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14197647|NCT04582968|Capecitabine|capecitabine|mesh-list
14940189|NCT01491321|Loxoprofen|loxoprofen|mesh-list
14940190|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14940191|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14940192|NCT01491321|Analgesics|analgesics|mesh-ancestor
14940193|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
14197648|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14197649|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
14197650|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197651|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197652|NCT04583046|Iloprost|iloprost|mesh-list
14197653|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14197654|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
14197655|NCT04583137|Lidocaine|lidocaine|mesh-list
14197656|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
14197657|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
14197658|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197659|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197660|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
14197661|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197662|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14197663|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14197664|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14197665|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197666|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197667|NCT04583020|Temozolomide|temozolomide|mesh-list
14197668|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14197669|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
14197670|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197671|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197672|NCT04582942|Lactulose|lactulose|mesh-list
14197673|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197674|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14197675|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14197676|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197677|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197678|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14197679|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197680|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197681|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
14197682|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197683|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14490571|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14490572|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14197684|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197685|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197686|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197687|NCT04582604|Decitabine|decitabine|mesh-list
14197688|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14197689|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
14197690|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490573|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490574|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490575|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14490576|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14490577|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14490578|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490579|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490580|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
14490581|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14490582|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14490583|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14490584|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14490585|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14490586|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
14490587|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
14490588|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490589|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490590|NCT02638012|Hemostatics|hemostatics|mesh-list
14490591|NCT02638012|Coagulants|coagulants|mesh-ancestor
14490592|NCT02638168|Methylphenidate|methylphenidate|mesh-list
14490593|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14490594|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490595|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14490596|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14490597|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14490598|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490599|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
14490600|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490601|NCT02638259|GP2015|gp2015|mesh-list
14490602|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490603|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
14490604|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14771266|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771267|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14771268|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14771269|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14771270|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771271|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771272|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771273|NCT00646386|Adalimumab|adalimumab|mesh-list
14771274|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771275|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771276|NCT00646425|Basiliximab|basiliximab|mesh-list
14771277|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940194|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940195|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940196|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940197|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490605|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
14490606|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490607|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14490608|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14490609|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14490610|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771278|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
14771279|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771280|NCT00646503|Telbivudine|telbivudine|mesh-list
14771281|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
14771282|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771283|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14771284|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771285|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771286|NCT00646516|Budesonide|budesonide|mesh-list
14771287|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
14807285|NCT00820911|Cyclosporine|cyclosporine|mesh-list
14490611|NCT02638948|Methotrexate|methotrexate|mesh-list
14490612|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14490613|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
14490614|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14940198|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14940199|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14940200|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940201|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
14940202|NCT01491503|Cetirizine|cetirizine|mesh-list
14940203|NCT01491503|Montelukast|montelukast|mesh-list
14940204|NCT01491503|Levocetirizine|levocetirizine|mesh-list
14940205|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14940206|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
14940207|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14940208|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
14940209|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940210|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940211|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14940212|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14940213|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940214|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14940215|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14940216|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
14940217|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
14940218|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940219|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14940220|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14940221|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14940222|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14940223|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
14940224|NCT01491815|Abatacept|abatacept|mesh-list
14940225|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14940226|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940227|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940228|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940229|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
14940230|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940231|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940232|NCT01491867|Travoprost|travoprost|mesh-list
14940233|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14940234|NCT01492062|Pancrelipase|pancrelipase|mesh-list
14940235|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14940236|NCT01492114|Resveratrol|resveratrol|mesh-list
14940237|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
14940238|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940239|NCT01492114|Protective Agents|protective agents|mesh-ancestor
14940240|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940241|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940242|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14940243|NCT01492153|Insulin|insulin|mesh-list
14940244|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14940245|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
14940246|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
14940247|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
14940248|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490615|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490616|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14490617|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
14530138|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14530139|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530140|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530141|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14530142|NCT03305055|Narcotics|narcotics|mesh-ancestor
14530143|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14530144|NCT03302247|Gemcitabine|gemcitabine|mesh-list
14530145|NCT03302247|Nivolumab|nivolumab|mesh-list
14530146|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14530147|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
14530148|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530149|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530150|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
14530151|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530152|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530153|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14197691|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490618|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490619|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490620|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490621|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490622|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14490623|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490624|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
14490625|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490626|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14490627|NCT02639182|Axitinib|axitinib|mesh-list
14490628|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490629|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14490630|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490631|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490632|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
14490633|NCT02639247|Velpatasvir|velpatasvir|mesh-list
14490634|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
14490635|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490636|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
14490637|NCT02639338|Velpatasvir|velpatasvir|mesh-list
14490638|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
14490639|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490640|NCT02639429|Misoprostol|misoprostol|mesh-list
14490641|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14490642|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
14490643|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14490644|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490645|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14490646|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490647|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
14490648|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14490649|NCT02639637|Valsartan|valsartan|mesh-list
14490650|NCT02639637|Enalaprilat|enalaprilat|mesh-list
14490651|NCT02639637|Enalapril|enalapril|mesh-list
14490652|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490653|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490654|NCT02639637|Incretins|incretins|mesh-ancestor
14490655|NCT02639637|Hormones|hormones|mesh-ancestor
14490656|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771288|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14771289|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771290|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14771291|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
14771292|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197692|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197693|NCT04582786|Morphine|morphine|mesh-list
14197694|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14197695|NCT04582786|Narcotics|narcotics|mesh-ancestor
14197696|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197697|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197698|NCT04582786|Analgesics|analgesics|mesh-ancestor
14197699|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
14197700|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197701|NCT04582084|Etanercept|etanercept|mesh-list
14197702|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14197703|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197704|NCT04582084|Analgesics|analgesics|mesh-ancestor
14197705|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
14490657|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14490658|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
14490659|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490660|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490661|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490662|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14490663|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14490664|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14490665|NCT02640053|Paclitaxel|paclitaxel|mesh-list
14490666|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14490667|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14490668|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490669|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
14490670|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
14490671|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14490672|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490673|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
14490674|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
14490675|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490676|NCT02640404|Vaccines|vaccines|mesh-list
14490677|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
14490678|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490679|NCT02640755|Paclitaxel|paclitaxel|mesh-list
14490680|NCT02640755|Fulvestrant|fulvestrant|mesh-list
14490681|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14490682|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490683|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
14490684|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
14490685|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
14490686|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490687|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14490688|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14490689|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14490690|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14490691|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490692|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940249|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940250|NCT01492166|Insulin|insulin|mesh-list
14940251|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14940252|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940253|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940254|NCT01492179|Lidocaine|lidocaine|mesh-list
14940255|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
14940256|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
14940257|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940258|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940259|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
14940260|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940261|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14940262|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14940263|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14940264|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940265|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940266|NCT01492205|Insulin|insulin|mesh-list
14940267|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14940268|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940269|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940270|NCT01492218|Insulin|insulin|mesh-list
14940271|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14940272|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14197706|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197707|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197708|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14197709|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197710|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14197711|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14197712|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
14197713|NCT04582305|Bleomycin|bleomycin|mesh-list
14197714|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14197715|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197716|NCT04582136|Sirolimus|sirolimus|mesh-list
14197717|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197718|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197719|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14197720|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197721|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
14490693|NCT02641080|Aspirin|aspirin|mesh-list
14197722|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530154|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
14530155|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530156|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530157|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14530158|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
14530159|NCT03277183|Hematinics|hematinics|mesh-ancestor
14530160|NCT03248141|Factor VIII|factor viii|mesh-list
14530161|NCT03248141|Coagulants|coagulants|mesh-ancestor
14530162|NCT03251326|Propranolol|propranolol|mesh-list
14530163|NCT03251326|Nabilone|nabilone|mesh-list
14530164|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14530165|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14530166|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490694|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490695|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490696|NCT02641080|Analgesics|analgesics|mesh-ancestor
14490697|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
14490698|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490699|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490700|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14197723|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
14197724|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197725|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14197726|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14197727|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197728|NCT04582032|Analgesics|analgesics|mesh-ancestor
14197729|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
14197730|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197731|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197732|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14197733|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197734|NCT04582097|Ramipril|ramipril|mesh-list
14197735|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14197736|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
14197737|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197738|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197739|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14197740|NCT04581876|Paclitaxel|paclitaxel|mesh-list
14197741|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14197742|NCT04581876|Raltitrexed|raltitrexed|mesh-list
14197743|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14197744|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197745|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
14197746|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
14197747|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
14197748|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197749|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14197750|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
14197751|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14197752|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197753|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
14197754|NCT04581967|Doxorubicin|doxorubicin|mesh-list
14197755|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14197756|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
14490701|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490702|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14490703|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14490704|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490705|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14490706|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14490707|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490708|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
14490709|NCT02641353|Thalidomide|thalidomide|mesh-list
14490710|NCT02641353|Apremilast|apremilast|mesh-list
14490711|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490712|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490713|NCT02641353|Analgesics|analgesics|mesh-ancestor
14490714|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
14490715|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490716|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490717|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490718|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490719|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13963818|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13963819|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
13963820|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963821|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13963822|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963823|NCT03141658|Ketamine|ketamine|mesh-list
13963824|NCT03141658|Analgesics|analgesics|mesh-ancestor
13963825|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
13963826|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963827|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963828|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13963829|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14197757|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490720|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14490721|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771293|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771294|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14771295|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
14771296|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
14771297|NCT00646516|Hormones|hormones|mesh-ancestor
14771298|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771299|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14771300|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14771301|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14771302|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771303|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771304|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197758|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14197759|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14197760|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
14197761|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197762|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197763|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14197764|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14197765|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14197766|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14197767|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197768|NCT04581447|Metformin|metformin|mesh-list
14197769|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14197770|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197771|NCT04581603|Topiramate|topiramate|mesh-list
14197772|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
14197773|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14197774|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197775|NCT04581213|Anesthetics|anesthetics|mesh-list
14197776|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197777|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197778|NCT04581408|Ivacaftor|ivacaftor|mesh-list
14197779|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14197780|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197781|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238768|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238769|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14238770|NCT00135330|Incretins|incretins|mesh-ancestor
14238771|NCT00135330|Hormones|hormones|mesh-ancestor
14238772|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238773|NCT00135356|Ritonavir|ritonavir|mesh-list
14238774|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14238775|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14238776|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14238777|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
14238778|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14238779|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238780|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238781|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14238782|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14490722|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490723|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490724|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
14490725|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
14490726|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14490727|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490728|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14490729|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14490730|NCT02641353|Growth Substances|growth substances|mesh-ancestor
14490731|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
14490732|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490733|NCT02641379|Ribavirin|ribavirin|mesh-list
14490734|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14490735|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
14490736|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490737|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
14490738|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490739|NCT02641522|Siltuximab|siltuximab|mesh-list
14490740|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771305|NCT00646529|Budesonide|budesonide|mesh-list
14238783|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
14490741|NCT02641561|Indomethacin|indomethacin|mesh-list
14490742|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490743|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490744|NCT02641561|Analgesics|analgesics|mesh-ancestor
14490745|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
14490746|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490747|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490748|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490749|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490750|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
14490751|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
14490752|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14771306|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
14771307|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14771308|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771309|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14771310|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
14771311|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771312|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771313|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14771314|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
14771315|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
14771316|NCT00646529|Hormones|hormones|mesh-ancestor
14771317|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771318|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14771319|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14771320|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14771321|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14197782|NCT04581265|Paclitaxel|paclitaxel|mesh-list
14197783|NCT04581265|Ifosfamide|ifosfamide|mesh-list
14771322|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940273|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026641|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15026642|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15026643|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026644|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026645|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15026646|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026647|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026648|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15026649|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
15026650|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
15026651|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
15026652|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
15026653|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026654|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026655|NCT01944735|Mannitol|mannitol|mesh-list
15026656|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15026657|NCT01944735|Diuretics|diuretics|mesh-ancestor
15026658|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
15026659|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026660|NCT01944800|Ticagrelor|ticagrelor|mesh-list
15026661|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15026662|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15026663|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15026664|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15026665|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15026666|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
15026667|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026668|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026669|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026670|NCT01944852|Icodextrin|icodextrin|mesh-list
15026671|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
15026672|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15026673|NCT01945021|Crizotinib|crizotinib|mesh-list
15026674|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026675|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15026676|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026677|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026678|NCT01945047|Midazolam|midazolam|mesh-list
14197784|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14197785|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15026679|NCT01945047|Ketamine|ketamine|mesh-list
15026680|NCT01945047|Analgesics|analgesics|mesh-ancestor
14197786|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197787|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
14197788|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
14197789|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
14197790|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197791|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14197792|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
14197793|NCT04580797|PF-06700841|pf-06700841|mesh-list
14197794|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14197795|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197796|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197797|NCT04580355|Amoxicillin|amoxicillin|mesh-list
14197798|NCT04580355|Metronidazole|metronidazole|mesh-list
14197799|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197800|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197801|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14197802|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14197803|NCT04580342|Propranolol|propranolol|mesh-list
14197804|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14197805|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14197806|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
14197807|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197808|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197809|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197810|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14197811|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14197812|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
14197813|NCT04580472|Clindamycin|clindamycin|mesh-list
14197814|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
14197815|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
14197816|NCT04580472|Cephalexin|cephalexin|mesh-list
14771323|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771324|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14771325|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14771326|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771327|NCT00646594|Fluticasone|fluticasone|mesh-list
14771328|NCT00646594|Budesonide|budesonide|mesh-list
14771329|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
14771330|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14771331|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14771332|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14771333|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771334|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14771335|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
14940274|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13963830|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
13963831|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
13963832|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963833|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13963834|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13963835|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963836|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963837|NCT03141645|Ondansetron|ondansetron|mesh-list
13963838|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
14771336|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771337|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963839|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
13963840|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963841|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963842|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963843|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
13963844|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
13963845|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13963846|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
13963847|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963848|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963849|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13963850|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13963851|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963852|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13963853|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13963854|NCT03141918|Curcumin|curcumin|mesh-list
13963855|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13963856|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490753|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14490754|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490755|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527880|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529998|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529999|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
14530000|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14530001|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14530002|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530003|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
14530004|NCT03425799|Coagulants|coagulants|mesh-ancestor
14530005|NCT03382925|Triamcinolone|triamcinolone|mesh-list
14530006|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14530007|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14530008|NCT03382925|Lidocaine|lidocaine|mesh-list
14530009|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14530010|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
14530011|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
14530012|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771338|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14771339|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
14771340|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
14771341|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14771342|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
14771343|NCT00646594|Hormones|hormones|mesh-ancestor
14771344|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771345|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14771346|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14197817|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197818|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197819|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14197820|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197821|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197822|NCT04580394|Oxybutynin|oxybutynin|mesh-list
14197823|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14197824|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14197825|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14197826|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771347|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14771348|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771349|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771350|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197827|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197828|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
14197829|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197830|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197831|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
14197832|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
14771351|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
14771352|NCT00646607|Leucovorin|leucovorin|mesh-list
14771353|NCT00646607|Fluorouracil|fluorouracil|mesh-list
14771354|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
14771355|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
14771356|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
14771357|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771358|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14771359|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771360|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14771361|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
14771362|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771363|NCT00646607|Antidotes|antidotes|mesh-ancestor
14940275|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940276|NCT01492504|Asunaprevir|asunaprevir|mesh-list
14940277|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
14940278|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940279|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940280|NCT01492543|Tegafur|tegafur|mesh-list
14940281|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14940282|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
14940283|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940284|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940285|NCT01492556|Etoposide|etoposide|mesh-list
14940286|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14490756|NCT02641691|Leucovorin|leucovorin|mesh-list
14490757|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14490758|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
14490759|NCT02641691|Fluorouracil|fluorouracil|mesh-list
14490760|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
14490761|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
14490762|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
14490763|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490764|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14490765|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14490766|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14490767|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
14771364|NCT00646607|Protective Agents|protective agents|mesh-ancestor
14771365|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
14771366|NCT00646607|Vitamins|vitamins|mesh-ancestor
14771367|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
14771368|NCT00646620|Fluticasone|fluticasone|mesh-list
14771369|NCT00646620|Budesonide|budesonide|mesh-list
14771370|NCT00646620|Albuterol|albuterol|mesh-list
14771371|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
14771372|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14771373|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14771374|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14771375|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771376|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14771377|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
14771378|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771379|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771380|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14771381|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
14771382|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
14771383|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14771384|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
14771385|NCT00646620|Hormones|hormones|mesh-ancestor
14771386|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771387|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14771388|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14771389|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14771390|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771391|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771392|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771393|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
14771394|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14771395|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
14771396|NCT00646659|Carboplatin|carboplatin|mesh-list
14771397|NCT00646659|Docetaxel|docetaxel|mesh-list
14771398|NCT00646659|Fluorouracil|fluorouracil|mesh-list
14771399|NCT00646659|Cetuximab|cetuximab|mesh-list
14197833|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197834|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14771400|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771401|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
14771402|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
14771403|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
14771404|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771405|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
14771406|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14771407|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14771408|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
14771409|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771410|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14771411|NCT00646711|Valproic Acid|valproic acid|mesh-list
14771412|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
14940287|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197835|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14197836|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
14197837|NCT04580394|Urological Agents|urological agents|mesh-ancestor
14197838|NCT04580199|Ethanol|ethanol|mesh-list
14490768|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771413|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771414|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771415|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
14771416|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771417|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490769|NCT02641691|Antidotes|antidotes|mesh-ancestor
14490770|NCT02641691|Protective Agents|protective agents|mesh-ancestor
14490771|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
14490772|NCT02641691|Vitamins|vitamins|mesh-ancestor
14490773|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
14490774|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
14490775|NCT02642159|Niacin|niacin|mesh-list
14490776|NCT02642159|Niacinamide|niacinamide|mesh-list
14490777|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14490778|NCT02642159|Ezetimibe|ezetimibe|mesh-list
14490779|NCT02642159|Fenofibrate|fenofibrate|mesh-list
14490780|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14490781|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14490782|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
14490783|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490784|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14490785|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
14490786|NCT02642159|Vitamins|vitamins|mesh-ancestor
14490787|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
14490788|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490789|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
14490790|NCT02642653|Lovastatin|lovastatin|mesh-list
14490791|NCT02642653|L 647318|l 647318|mesh-list
14490792|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
14490793|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14490794|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14490795|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
14490796|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490797|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14490798|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14490799|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490800|NCT02643251|Clonidine|clonidine|mesh-list
14490801|NCT02643251|Analgesics|analgesics|mesh-ancestor
14490802|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
14490803|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490804|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490805|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490806|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
14490807|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
14490808|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14490809|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14490810|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14490811|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490812|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490813|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490814|NCT02643355|Clonidine|clonidine|mesh-list
14490815|NCT02643355|Olanzapine|olanzapine|mesh-list
14940288|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14940289|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14940290|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940291|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940292|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
14940293|NCT01492608|Analgesics|analgesics|mesh-ancestor
14490816|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
14490817|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
14490818|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490819|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490820|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490821|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14490822|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14490823|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490824|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771418|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
14771419|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771420|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771421|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771422|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
14771423|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14771424|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771425|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14771426|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
14771427|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14490825|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14490826|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14771428|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771429|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490827|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807286|NCT00820911|Everolimus|everolimus|mesh-list
14490828|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490829|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490830|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
14490831|NCT02643355|Analgesics|analgesics|mesh-ancestor
14490832|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
14490833|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14490834|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
14490835|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14490836|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14490837|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14490838|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490839|NCT02643394|Acetaminophen|acetaminophen|mesh-list
14490840|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490841|NCT02643394|Analgesics|analgesics|mesh-ancestor
14490842|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
14490843|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490844|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490845|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
14490846|NCT02643615|Propofol|propofol|mesh-list
14490847|NCT02643615|Desflurane|desflurane|mesh-list
14490848|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14490849|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490850|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490851|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14490852|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
14490853|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
14490854|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14490855|NCT02643862|Omalizumab|omalizumab|mesh-list
14490856|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14490857|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14490858|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
14490859|NCT02643979|Ketamine|ketamine|mesh-list
14490860|NCT02643979|Propofol|propofol|mesh-list
14490861|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14490862|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490863|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490864|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14490865|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
14490866|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
14490867|NCT02643979|Analgesics|analgesics|mesh-ancestor
14490868|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
14490869|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490870|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14490871|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14490872|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14490873|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490874|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490875|NCT02645617|Imidacloprid|imidacloprid|mesh-list
14490876|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
14490877|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490878|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490879|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490880|NCT02646124|Naproxen|naproxen|mesh-list
14490881|NCT02646124|Diazepam|diazepam|mesh-list
14490882|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490883|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14490884|NCT02646124|Analgesics|analgesics|mesh-ancestor
14490885|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
14490886|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14490887|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490888|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490889|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490890|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
14490891|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14490892|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490893|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490894|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14490895|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
14490896|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
14490897|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
14490898|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490899|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14490900|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490901|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14490902|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14490903|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14197839|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14197840|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197841|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197842|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490904|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14490905|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14490906|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14490907|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
14490908|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
14490909|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
14490910|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
14490911|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490912|NCT02646332|Amoxicillin|amoxicillin|mesh-list
14490913|NCT02646332|Metronidazole|metronidazole|mesh-list
14490914|NCT02646332|Clarithromycin|clarithromycin|mesh-list
14490915|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
14197843|NCT04580498|Paclitaxel|paclitaxel|mesh-list
14197844|NCT04580498|Carboplatin|carboplatin|mesh-list
14197845|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14490916|NCT02646332|Lansoprazole|lansoprazole|mesh-list
14490917|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14490918|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490919|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14490920|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14490921|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14490922|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490923|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490924|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14490925|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14490926|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14490927|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490928|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14490929|NCT02646449|Mirtazapine|mirtazapine|mesh-list
14490930|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
14490931|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14490932|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14490933|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
14490934|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
14490935|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14490936|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490937|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490938|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14490939|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14490940|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490941|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14490942|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14490943|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14490944|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
14490945|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14490946|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14490947|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
14490948|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14490949|NCT02647203|Fluorides|fluorides|mesh-list
14490950|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
14490951|NCT02647203|Protective Agents|protective agents|mesh-ancestor
14490952|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490953|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14490954|NCT02647320|Firuglipel|firuglipel|mesh-list
14490955|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490956|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490957|NCT02647320|Incretins|incretins|mesh-ancestor
14197846|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197847|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
14490958|NCT02647320|Hormones|hormones|mesh-ancestor
14490959|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490960|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14490961|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
14490962|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490963|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490964|NCT02647788|Acetaminophen|acetaminophen|mesh-list
14490965|NCT02647788|Ibuprofen|ibuprofen|mesh-list
14490966|NCT02647788|Codeine|codeine|mesh-list
14490967|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14197848|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
14490968|NCT02647788|Analgesics|analgesics|mesh-ancestor
14490969|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
14527881|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
14490970|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771430|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771431|NCT00646750|Rituximab|rituximab|mesh-list
14771432|NCT00646750|Melphalan|melphalan|mesh-list
14771433|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14771434|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771435|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
14771436|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771437|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771438|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14771439|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
14771440|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771441|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14771442|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14771443|NCT00646802|Progesterone|progesterone|mesh-list
14771444|NCT00646802|Progestins|progestins|mesh-ancestor
14771445|NCT00646802|Hormones|hormones|mesh-ancestor
14771446|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771447|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771448|NCT00646815|Hormones|hormones|mesh-list
14771449|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771450|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771451|NCT00646841|Doxazosin|doxazosin|mesh-list
14771452|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771453|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14771454|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14771455|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14771456|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771457|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771458|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771459|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771460|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
14771461|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
14771462|NCT00646854|Doxorubicin|doxorubicin|mesh-list
14771463|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14771464|NCT00646854|Vincristine|vincristine|mesh-list
14771465|NCT00646854|Lenograstim|lenograstim|mesh-list
14771466|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14771467|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
14771468|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771469|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771470|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14771471|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
14771472|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963857|NCT03141918|Analgesics|analgesics|mesh-ancestor
13963858|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
13963859|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963860|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963861|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13963862|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963863|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963864|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771473|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771474|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14771475|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14771476|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14771477|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14771478|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14771479|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14771480|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771481|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14771482|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
14771483|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
14771484|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
14771485|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14771486|NCT00646880|Propiverine|propiverine|mesh-list
14490971|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490972|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
14490973|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14490974|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14490975|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14490976|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14490977|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14490978|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14490979|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14490980|NCT02647788|Narcotics|narcotics|mesh-ancestor
14490981|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14490982|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
14490983|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
14490984|NCT02647866|KHK4083|khk4083|mesh-list
14490985|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
14490986|NCT02647944|Liraglutide|liraglutide|mesh-list
14490987|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14490988|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14490989|NCT02647944|Incretins|incretins|mesh-ancestor
14490990|NCT02647944|Hormones|hormones|mesh-ancestor
14490991|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14490992|NCT02648204|Dulaglutide|dulaglutide|mesh-list
14490993|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14197849|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
14197850|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197851|NCT04580277|Tofacitinib|tofacitinib|mesh-list
14197852|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14197853|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197854|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197855|NCT04580147|Aflibercept|aflibercept|mesh-list
14197856|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14197857|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14197858|NCT04580147|Growth Substances|growth substances|mesh-ancestor
14197859|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197860|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
14197861|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197862|NCT04579614|Vaccines|vaccines|mesh-list
14197863|NCT04579614|Immunologic Factors|immunologic factors|mesh-ancestor
14197864|NCT04579614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197865|NCT04579731|Lactitol|lactitol|mesh-list
14197866|NCT04579731|Cathartics|cathartics|mesh-ancestor
14771487|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14771488|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14771489|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
14771490|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771491|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771492|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771493|NCT00646880|Urological Agents|urological agents|mesh-ancestor
14771494|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
14771495|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
14771496|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771497|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
14771498|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14771499|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771500|NCT00646932|Vitamins|vitamins|mesh-ancestor
14771501|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
14771502|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14771503|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
14771504|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14771505|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
14771506|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
14771507|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771508|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771509|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14771510|NCT00646945|Analgesics|analgesics|mesh-ancestor
14771511|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
14771512|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771513|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14771514|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
14771515|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807287|NCT00820911|Cyclosporins|cyclosporins|mesh-list
14807288|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807289|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807290|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807291|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
14807292|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940294|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
14197867|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14490994|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807293|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
14197868|NCT04579302|Bupivacaine|bupivacaine|mesh-list
14197869|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
14807294|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14490995|NCT02648217|Insulin|insulin|mesh-list
14490996|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14490997|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
14490998|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
14490999|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14491000|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
14491001|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14491002|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491003|NCT02649192|Vitamin D|vitamin d|mesh-list
14491004|NCT02649192|Vitamin A|vitamin a|mesh-list
14491005|NCT02649192|Vitamins|vitamins|mesh-ancestor
14491006|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
14491007|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491008|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14491009|NCT02649231|Ketamine|ketamine|mesh-list
14491010|NCT02649231|Analgesics|analgesics|mesh-ancestor
14491011|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
14491012|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491013|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491014|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14491015|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14491016|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
14491017|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
14491018|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491019|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14491020|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14491021|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491022|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491023|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
14491024|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14491025|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491026|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
14940295|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940296|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940297|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
14940298|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940299|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14940300|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
14940301|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14940302|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197870|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
14197871|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197872|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197873|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
14197874|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197875|NCT04578938|Ketamine|ketamine|mesh-list
14197876|NCT04578938|Analgesics|analgesics|mesh-ancestor
14197877|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
14491027|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14491028|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14527882|NCT03958656|Fludarabine|fludarabine|mesh-list
14527883|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14527884|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
14527885|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527886|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527887|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14527888|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
14527889|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527890|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527891|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14527892|NCT03951805|Insulin|insulin|mesh-list
14527893|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14527894|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
14527895|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14527896|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527897|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14527898|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
14527899|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527900|NCT03949621|Vedolizumab|vedolizumab|mesh-list
14527901|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527902|NCT03949244|Latanoprost|latanoprost|mesh-list
14527903|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14527904|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14527905|NCT03948581|Vedolizumab|vedolizumab|mesh-list
14527906|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491029|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491030|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
14491031|NCT02650856|Coagulants|coagulants|mesh-ancestor
14491032|NCT02650921|Lidocaine|lidocaine|mesh-list
14491033|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491034|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
14491035|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491036|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491037|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
14491038|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491039|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14491040|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14491041|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14491042|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14491043|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491044|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
14491045|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491046|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527907|NCT03948386|Bupivacaine|bupivacaine|mesh-list
14527908|NCT03948386|Mepivacaine|mepivacaine|mesh-list
14527909|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527910|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
14527911|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527912|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527913|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
14527914|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527915|NCT03943095|Fluorides|fluorides|mesh-list
14527916|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
14527917|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
14527918|NCT03943095|Protective Agents|protective agents|mesh-ancestor
14527919|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527920|NCT03942042|Ixekizumab|ixekizumab|mesh-list
14527921|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14527922|NCT03923530|Eplerenone|eplerenone|mesh-list
14527923|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14527924|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
14527925|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527926|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527927|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14527928|NCT03923530|Diuretics|diuretics|mesh-ancestor
14527929|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
14527930|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14527931|NCT03914417|Imiquimod|imiquimod|mesh-list
14527932|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14527933|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
14527934|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527935|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527936|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
14527937|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
14527938|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14527939|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
14527940|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527941|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527942|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14527943|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
14940303|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940304|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14940305|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
14940306|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14940307|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14940308|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14197878|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197879|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197880|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14197881|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14197882|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
14197883|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
14197884|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14197885|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14197886|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14197887|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197888|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491047|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
14491048|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
14491049|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
14491050|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14491051|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14491052|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491053|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491054|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491055|NCT02651155|Lubiprostone|lubiprostone|mesh-list
14491056|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14491057|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14491058|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491059|NCT02651220|Adapalene|adapalene|mesh-list
14491060|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14491061|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14491062|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
14491063|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14491064|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14491065|NCT02651220|Analgesics|analgesics|mesh-ancestor
14491066|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
14491067|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197889|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14197890|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14197891|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14491068|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491069|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14491070|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14491071|NCT02651259|Vitamins|vitamins|mesh-list
14491072|NCT02651259|Pyridoxine|pyridoxine|mesh-list
14491073|NCT02651259|Pyridoxal|pyridoxal|mesh-list
14491074|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
14491075|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
14491076|NCT02651259|Isoniazid|isoniazid|mesh-list
14491077|NCT02651259|Rifapentine|rifapentine|mesh-list
14491078|NCT02651259|Rifamycins|rifamycins|mesh-list
14491079|NCT02651259|Hydrazine|hydrazine|mesh-list
14491080|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
14491081|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491082|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
14491083|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14491084|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491085|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14491086|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14491087|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
14491088|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491089|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14491090|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14491091|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
14491092|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491093|NCT02651272|Macitentan|macitentan|mesh-list
14491094|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14491095|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14491096|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491097|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14491098|NCT02651415|Perindopril|perindopril|mesh-list
14491099|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14491100|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
14491101|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491102|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491103|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14491104|NCT02651428|Taurolidine|taurolidine|mesh-list
14491105|NCT02651428|Heparin|heparin|mesh-list
14491106|NCT02651428|Calcium heparin|calcium heparin|mesh-list
14491107|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
14491108|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491109|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14771516|NCT00647023|Metformin|metformin|mesh-list
14771517|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14771518|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197892|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197893|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197894|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14197895|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14197896|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771519|NCT00647049|Cytarabine|cytarabine|mesh-list
14491110|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14491111|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491112|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14491113|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491114|NCT02651584|Buprenorphine|buprenorphine|mesh-list
14491115|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491116|NCT02651584|Narcotics|narcotics|mesh-ancestor
14491117|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491118|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491119|NCT02651584|Analgesics|analgesics|mesh-ancestor
14491120|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
14491121|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491122|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14491123|NCT02651688|Enclomiphene|enclomiphene|mesh-list
14491124|NCT02651688|Clomiphene|clomiphene|mesh-list
14491125|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
14491126|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14491127|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
14491128|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491129|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491130|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14491131|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
14491132|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14491133|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14491134|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14491135|NCT02651987|Lanreotide|lanreotide|mesh-list
14491136|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491137|NCT02652156|Bupivacaine|bupivacaine|mesh-list
14491138|NCT02652156|Ropivacaine|ropivacaine|mesh-list
14491139|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491140|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
14491141|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491142|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491143|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
14491144|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197897|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
14197898|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238784|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238785|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14238786|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14238787|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238788|NCT00135512|Bupropion|bupropion|mesh-list
14238789|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14238790|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
14238791|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238792|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14238793|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238794|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238795|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491145|NCT02652260|Tenofovir|tenofovir|mesh-list
14491146|NCT02652260|Lamivudine|lamivudine|mesh-list
14491147|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14491148|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
14491149|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491150|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14491151|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14491152|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491153|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491154|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14491155|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14491156|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
14491157|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14491158|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14491159|NCT02652390|Prednisolone|prednisolone|mesh-list
14491160|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
14491161|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14491162|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
14491163|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14491164|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
14491165|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
14527944|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
14527945|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14527946|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527947|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491166|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491167|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491168|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491169|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
14491170|NCT02652390|Hormones|hormones|mesh-ancestor
14491171|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491172|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14491173|NCT02652390|Protective Agents|protective agents|mesh-ancestor
14491174|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14491175|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491176|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14491177|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
14491178|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491179|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14491180|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14491181|NCT02653144|Dexamethasone|dexamethasone|mesh-list
14491182|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
14491183|NCT02653144|Ropivacaine|ropivacaine|mesh-list
14491184|NCT02653144|Anesthetics|anesthetics|mesh-list
14491185|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14491186|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
14491187|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
14491188|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771520|NCT00647049|Rituximab|rituximab|mesh-list
14771521|NCT00647049|Methotrexate|methotrexate|mesh-list
14771522|NCT00647049|Thiotepa|thiotepa|mesh-list
14771523|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14771524|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771525|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
14771526|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771527|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771528|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14771529|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
14771530|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14771531|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14771532|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
14771533|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771534|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
14771535|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771536|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14771537|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14771538|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14771539|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
14940309|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14940310|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940311|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940312|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940313|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940314|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
14940315|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940316|NCT01492712|Propofol|propofol|mesh-list
14940317|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14940318|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940319|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940320|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14940321|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
14940322|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
14940323|NCT01492725|Plasminogen|plasminogen|mesh-list
14940324|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14940325|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14940326|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14197899|NCT04579133|Durvalumab|durvalumab|mesh-list
14197900|NCT04579133|Olaparib|olaparib|mesh-list
14197901|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14197902|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197903|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14197904|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197905|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197906|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
14197907|NCT04578847|Dasatinib|dasatinib|mesh-list
14197908|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197909|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14197910|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197911|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197912|NCT04578470|Vitamin D|vitamin d|mesh-list
14197913|NCT04578470|Vitamins|vitamins|mesh-ancestor
14197914|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
14197915|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197916|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14197917|NCT04578496|Afamelanotide|afamelanotide|mesh-list
14197918|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
14197919|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
14197920|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
14197921|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14197922|NCT04578691|Protective Agents|protective agents|mesh-ancestor
14238796|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
14238797|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238798|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238799|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14238800|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14238801|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238802|NCT00135694|Prednisone|prednisone|mesh-list
14238803|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14238804|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238805|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
14238806|NCT00135694|Hormones|hormones|mesh-ancestor
14238807|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238808|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238809|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238810|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238811|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238812|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238813|NCT00135707|Vitamins|vitamins|mesh-list
14238814|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
14238815|NCT00135707|Vitamin E|vitamin e|mesh-list
14238816|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
14238817|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
14238818|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238819|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
14238820|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238821|NCT00135707|Protective Agents|protective agents|mesh-ancestor
14238822|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14238823|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
14238824|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238825|NCT00136084|Cytarabine|cytarabine|mesh-list
14238826|NCT00136084|Dexamethasone|dexamethasone|mesh-list
14238827|NCT00136084|Prednisone|prednisone|mesh-list
14238828|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
14238829|NCT00136084|Methotrexate|methotrexate|mesh-list
14238830|NCT00136084|Etoposide|etoposide|mesh-list
14238831|NCT00136084|Vincristine|vincristine|mesh-list
14238832|NCT00136084|Daunorubicin|daunorubicin|mesh-list
14238833|NCT00136084|Asparaginase|asparaginase|mesh-list
14238834|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
14238835|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
14238836|NCT00136084|Cladribine|cladribine|mesh-list
14238837|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
14238838|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238839|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
14238840|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238841|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238842|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238843|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
14238844|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238845|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238846|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238847|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238848|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
14238849|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
14238850|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238851|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238852|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
14238853|NCT00136084|Hormones|hormones|mesh-ancestor
14238854|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238855|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238856|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14238857|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
14238858|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14238859|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14197923|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197924|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14197925|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14197926|NCT04578236|Tretinoin|tretinoin|mesh-list
14197927|NCT04578236|Captopril|captopril|mesh-list
14197928|NCT04578236|Isotretinoin|isotretinoin|mesh-list
14197929|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491189|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491190|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491191|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
14491192|NCT02653144|Hormones|hormones|mesh-ancestor
14491193|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491194|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14491195|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491196|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14491197|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491198|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14491199|NCT02653144|Analgesics|analgesics|mesh-ancestor
14491200|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
14491201|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14491202|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14491203|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14491204|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491205|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491206|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491207|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491208|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14491209|NCT02653183|Laxatives|laxatives|mesh-ancestor
14491210|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491211|NCT02653300|Insulin|insulin|mesh-list
14491212|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14491213|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491214|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14491215|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14491216|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
14491217|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
14491218|NCT02653560|Citric Acid|citric acid|mesh-list
14491219|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
14491220|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
14491221|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14491222|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
14491223|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
14491224|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491225|NCT02653560|Diuretics|diuretics|mesh-ancestor
14491226|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
14491227|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491228|NCT02653560|Expectorants|expectorants|mesh-ancestor
14491229|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
14491230|NCT02653560|Cathartics|cathartics|mesh-ancestor
14491231|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491232|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
14491233|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14491234|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491235|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14491236|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14491237|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
14491238|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491239|NCT02653872|Itraconazole|itraconazole|mesh-list
14491240|NCT02653872|Verapamil|verapamil|mesh-list
14491241|NCT02653872|Diltiazem|diltiazem|mesh-list
14491242|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
14491243|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491244|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14491245|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14491246|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491247|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491248|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14491249|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
14491250|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491251|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491252|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14491253|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771540|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197930|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
14771541|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14197931|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14491254|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14491255|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14491256|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14491257|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
14491258|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14491259|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14491260|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14491261|NCT02654054|Norethindrone|norethindrone|mesh-list
14491262|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
14491263|NCT02654054|Estradiol|estradiol|mesh-list
14491264|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14491265|NCT02654054|Estrogens|estrogens|mesh-ancestor
14491266|NCT02654054|Hormones|hormones|mesh-ancestor
14491267|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491268|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491269|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14491270|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
14491271|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14940327|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940328|NCT01492881|Doxorubicin|doxorubicin|mesh-list
14940329|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14940330|NCT01492881|Bortezomib|bortezomib|mesh-list
14940331|NCT01492881|Vorinostat|vorinostat|mesh-list
14197932|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14197933|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
14197934|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197935|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197936|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14197937|NCT04578158|Quercetin|quercetin|mesh-list
14197938|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
14197939|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197940|NCT04578158|Protective Agents|protective agents|mesh-ancestor
14197941|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197942|NCT04577846|Cephalexin|cephalexin|mesh-list
14197943|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197944|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197945|NCT04577885|Rifampin|rifampin|mesh-list
14197946|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14197947|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
14197948|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14197949|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197950|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
14197951|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14197952|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197953|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197954|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14197955|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14197956|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14197957|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14491272|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14491273|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14491274|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14491275|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14491276|NCT02654145|Omalizumab|omalizumab|mesh-list
14491277|NCT02654145|Albuterol|albuterol|mesh-list
14491278|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14491279|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
14491280|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491281|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491282|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14491283|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
14491284|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
14491285|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14491286|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14491287|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14491288|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14491289|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491290|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491291|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491292|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14491293|NCT02654483|Serlopitant|serlopitant|mesh-list
14491294|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14940332|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14491295|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491296|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491297|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491298|NCT02654860|Acetaminophen|acetaminophen|mesh-list
14491299|NCT02654860|Bupivacaine|bupivacaine|mesh-list
14491300|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
14197958|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14197959|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14197960|NCT04577716|Listerine|listerine|mesh-list
14197961|NCT04577716|Fluorides|fluorides|mesh-list
14197962|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
14197963|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
14491301|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
14491302|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491303|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491304|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
14491305|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771542|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
14771543|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14771544|NCT00647101|Latanoprost|latanoprost|mesh-list
14771545|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14771546|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14771547|NCT00647127|Fentanyl|fentanyl|mesh-list
14771548|NCT00647127|Buprenorphine|buprenorphine|mesh-list
13963865|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963866|NCT03141632|Dulaglutide|dulaglutide|mesh-list
13963867|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14197964|NCT04577716|Protective Agents|protective agents|mesh-ancestor
14197965|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197966|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14197967|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197968|NCT04577443|Adenosine|adenosine|mesh-list
14197969|NCT04577443|Analgesics|analgesics|mesh-ancestor
14197970|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
13963868|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963869|NCT03141593|Vitamin D|vitamin d|mesh-list
13963870|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
13963871|NCT03141593|Vitamins|vitamins|mesh-list
13963872|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
13963873|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963874|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13963875|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13963876|NCT03141398|Pancrelipase|pancrelipase|mesh-list
13963877|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963878|NCT03141268|Lactulose|lactulose|mesh-list
13963879|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963880|NCT03141476|Cefuroxime|cefuroxime|mesh-list
14197971|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14197972|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197973|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14197974|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
14197975|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14197976|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
14197977|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
14197978|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14197979|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14197980|NCT04577378|Itraconazole|itraconazole|mesh-list
14197981|NCT04577378|Tretinoin|tretinoin|mesh-list
14197982|NCT04577378|Isotretinoin|isotretinoin|mesh-list
14197983|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
14197984|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197985|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14197986|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14197987|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14197988|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963881|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
13963882|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13963883|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14197989|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14197990|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
14197991|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14197992|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14197993|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14197994|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14197995|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
14197996|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
14491306|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14491307|NCT02654860|Analgesics|analgesics|mesh-ancestor
14491308|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
14491309|NCT02655224|Relugolix|relugolix|mesh-list
14491310|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
14491311|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
14491312|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491313|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491314|NCT02655237|Leuprolide|leuprolide|mesh-list
14491315|NCT02655237|Relugolix|relugolix|mesh-list
14491316|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14491317|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
14491318|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14491319|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491320|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14491321|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491322|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
14491323|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
14491324|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491325|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
14491326|NCT02655354|Promethazine|promethazine|mesh-list
14491327|NCT02655354|Prazosin|prazosin|mesh-list
14491328|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14491329|NCT02655354|Mirtazapine|mirtazapine|mesh-list
14491330|NCT02655354|Trazodone|trazodone|mesh-list
14491331|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
14491332|NCT02655354|Sertraline|sertraline|mesh-list
14491333|NCT02655354|Fluoxetine|fluoxetine|mesh-list
14197997|NCT04577417|Methylphenidate|methylphenidate|mesh-list
14197998|NCT04577417|Amphetamine|amphetamine|mesh-list
14197999|NCT04577417|Adderall|adderall|mesh-list
14198000|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
14198001|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14491334|NCT02655354|Paroxetine|paroxetine|mesh-list
14491335|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14491336|NCT02655354|Citalopram|citalopram|mesh-list
14491337|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14491338|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14491339|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14491340|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491341|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491342|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491343|NCT02655354|Analgesics|analgesics|mesh-ancestor
14491344|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
14491345|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491346|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
14491347|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14491348|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
14491349|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14491350|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
14491351|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14491352|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14491353|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14491354|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491355|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
14491356|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14491357|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14198002|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14198003|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198004|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14198005|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14198006|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198007|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198008|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
14491358|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491359|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491360|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
14491361|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
14491362|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14198009|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491363|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14491364|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
14940333|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491365|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
14491366|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14491367|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
14491368|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
14491369|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14491370|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14491371|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14491372|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14771549|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14771550|NCT00647127|Narcotics|narcotics|mesh-ancestor
14771551|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771552|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771553|NCT00647127|Analgesics|analgesics|mesh-ancestor
14771554|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
14771555|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771556|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14771557|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14771558|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
14198010|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
14198011|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
14198012|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198013|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
14198014|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14491373|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14771559|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
14771560|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14771561|NCT00647140|Levodopa|levodopa|mesh-list
14771562|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
14771563|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771564|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771565|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771566|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14771567|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14771568|NCT00647166|Azathioprine|azathioprine|mesh-list
14771569|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
14771570|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771571|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14771572|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771573|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14771574|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
14771575|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771576|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771577|NCT00647192|Eplerenone|eplerenone|mesh-list
14771578|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14771579|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
14771580|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771581|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771582|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14771583|NCT00647192|Diuretics|diuretics|mesh-ancestor
14771584|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
14771585|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771586|NCT00647218|Paclitaxel|paclitaxel|mesh-list
14771587|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14771588|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963884|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
13963885|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
13963886|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13963887|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963888|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
13963889|NCT03141203|Romidepsin|romidepsin|mesh-list
13963890|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13963891|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963892|NCT03141125|Ethanol|ethanol|mesh-list
13963893|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14198015|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
14198016|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14491374|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491375|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14491376|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14491377|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14491378|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14491379|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14491380|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14491381|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14491382|NCT02655419|Metronidazole|metronidazole|mesh-list
14491383|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491384|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14491385|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14491386|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14491387|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
14491388|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
14491389|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14491390|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14491391|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491392|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
14491393|NCT02655653|Coagulants|coagulants|mesh-ancestor
14491394|NCT02655679|Ether|ether|mesh-list
14491395|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14491396|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
14491397|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
14491398|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491399|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491400|NCT02656069|Glucagon|glucagon|mesh-list
14491401|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14491402|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491403|NCT02656069|Hormones|hormones|mesh-ancestor
14491404|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491405|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491406|NCT02656069|Incretins|incretins|mesh-ancestor
14491407|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
14491408|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14491409|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14491410|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491411|NCT02656173|Tamsulosin|tamsulosin|mesh-list
14491412|NCT02656173|Mirabegron|mirabegron|mesh-list
14491413|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14491414|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14491415|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14491416|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491417|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491418|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491419|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491420|NCT02656173|Urological Agents|urological agents|mesh-ancestor
14491421|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14491422|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14491423|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14491424|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14491425|NCT02656329|Lugol's solution|lugol's solution|mesh-list
14491426|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491427|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491428|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491429|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14491430|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
14491431|NCT02656329|Coagulants|coagulants|mesh-ancestor
14491432|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
14491433|NCT02657031|Promethazine|promethazine|mesh-list
14491434|NCT02657031|Ketamine|ketamine|mesh-list
14491435|NCT02657031|Ondansetron|ondansetron|mesh-list
14491436|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
14491437|NCT02657031|Analgesics|analgesics|mesh-ancestor
14491438|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
14491439|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491440|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491441|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14491442|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14491443|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
14491444|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
14491445|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491446|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14198017|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
14198018|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198019|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198020|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14198021|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
14198022|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198023|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198024|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14198025|NCT04577027|Travoprost|travoprost|mesh-list
14491447|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14491448|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491449|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491450|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
14491451|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
14491452|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491453|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
14491454|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
14491455|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14491456|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
14491457|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14491458|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14491459|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14491460|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14491461|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14491462|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14491463|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491464|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14491465|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
14491466|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
14491467|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14491468|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14491469|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
14491470|NCT02657252|Polidocanol|polidocanol|mesh-list
14491471|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14491472|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14491473|NCT02657369|Lenvatinib|lenvatinib|mesh-list
14491474|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491475|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14491476|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491477|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491478|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
14491479|NCT02657889|Niraparib|niraparib|mesh-list
14491480|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491481|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491482|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14491483|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491484|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491485|NCT02657928|Letrozole|letrozole|mesh-list
14491486|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491487|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14491488|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14491489|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491490|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491491|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14491492|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
14491493|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491494|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491495|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
14491496|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491497|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491498|NCT02658084|Trastuzumab|trastuzumab|mesh-list
14491499|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14491500|NCT02658084|Vinorelbine|vinorelbine|mesh-list
14491501|NCT02658084|Maytansine|maytansine|mesh-list
14491502|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491503|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491504|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14491505|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
14491506|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
14491507|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
14491508|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491509|NCT02658149|Ketorolac|ketorolac|mesh-list
14491510|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14491511|NCT02658149|Epinephrine|epinephrine|mesh-list
14491512|NCT02658149|Morphine|morphine|mesh-list
14491513|NCT02658149|Ropivacaine|ropivacaine|mesh-list
14491514|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491515|NCT02658149|Narcotics|narcotics|mesh-ancestor
14491516|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491517|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491518|NCT02658149|Analgesics|analgesics|mesh-ancestor
14491519|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
14491520|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491521|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491522|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
14491523|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14491524|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14491525|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491526|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491527|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491528|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14491529|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14491530|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
14491531|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14491532|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
14491533|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
14491534|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
14491535|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14491536|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14491537|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14491538|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14491539|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14491540|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14491541|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491542|NCT02658240|Epinephrine|epinephrine|mesh-list
14771589|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
14771590|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
14771591|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
14771592|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771593|NCT00647244|Tenofovir|tenofovir|mesh-list
14771594|NCT00647244|Abacavir|abacavir|mesh-list
14771595|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
14771596|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771597|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14198026|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14198027|NCT04577040|Tadalafil|tadalafil|mesh-list
14198028|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
14198029|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14198030|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14198031|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198032|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198033|NCT04577040|Urological Agents|urological agents|mesh-ancestor
14238860|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
14238861|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
14238862|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238863|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14238864|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238865|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14238866|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14238867|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14238868|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
14238869|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238870|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238871|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238872|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238873|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14238874|NCT00136084|Analgesics|analgesics|mesh-ancestor
14238875|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
14238876|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14238877|NCT00136318|Ribavirin|ribavirin|mesh-list
14238878|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14238879|NCT00136318|Citalopram|citalopram|mesh-list
14238880|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
14238881|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238882|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
14238883|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238884|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14238885|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238886|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14238887|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238888|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
14238889|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771598|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14771599|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491543|NCT02658240|Ropivacaine|ropivacaine|mesh-list
14491544|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491545|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
14491546|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491547|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491548|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
14491549|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771600|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242962|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491550|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14491551|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14491552|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491553|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491554|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198034|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
14198035|NCT04576975|Ketamine|ketamine|mesh-list
14198036|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14198037|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198038|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491555|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14771601|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14771602|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14771603|NCT00647257|Losartan|losartan|mesh-list
14771604|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771605|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771606|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14771607|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14771608|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771609|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
14771610|NCT00647465|Vaccines|vaccines|mesh-list
14771611|NCT00647465|Immunologic Factors|immunologic factors|mesh-ancestor
14771612|NCT00647465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771613|NCT00647491|Adalimumab|adalimumab|mesh-list
14771614|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771615|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771616|NCT00647530|Fluorouracil|fluorouracil|mesh-list
14771617|NCT00647530|Capecitabine|capecitabine|mesh-list
14771618|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
14771619|NCT00647530|Panitumumab|panitumumab|mesh-list
14771620|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
14771621|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771622|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14771623|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771624|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198039|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198040|NCT04576975|Analgesics|analgesics|mesh-ancestor
14198041|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
14198042|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771625|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
14771626|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771627|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14771628|NCT00647543|Atorvastatin|atorvastatin|mesh-list
14771629|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14771630|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14771631|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
14771632|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771633|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14771634|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14771635|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771636|NCT00647608|Propranolol|propranolol|mesh-list
14771637|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14771638|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14771639|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771640|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771641|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771642|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771643|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771644|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771645|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
14771646|NCT00647621|Phenytoin|phenytoin|mesh-list
14771647|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
14771648|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14771649|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14771650|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771651|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771652|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14198043|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14198044|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14491556|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14491557|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
14491558|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14491559|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
14491560|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
14491561|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
14491562|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14491563|NCT02658461|Trastuzumab|trastuzumab|mesh-list
14491564|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491565|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491566|NCT02658487|Cytarabine|cytarabine|mesh-list
14491567|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14491568|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
14491569|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491570|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491571|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
14491572|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491573|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14491574|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
14491575|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198045|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14198046|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14198047|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198048|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198049|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14198050|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14198051|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
14198052|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
14198053|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14198054|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14198055|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
14198056|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14198057|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198058|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198059|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198060|NCT04577430|Analgesics|analgesics|mesh-ancestor
14198061|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
14491576|NCT02658734|Trastuzumab|trastuzumab|mesh-list
14491577|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14491578|NCT02658734|Maytansine|maytansine|mesh-list
14771653|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14771654|NCT00647634|Alprazolam|alprazolam|mesh-list
14771655|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14771656|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771657|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771658|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14771659|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771660|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771661|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
14771662|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
14771663|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771664|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771665|NCT00647647|Terbinafine|terbinafine|mesh-list
14771666|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
14771667|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771668|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771669|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771670|NCT00647660|Nadolol|nadolol|mesh-list
14771671|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
14771672|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14771673|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14771674|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771675|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771676|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771677|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771678|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771679|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771680|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
14771681|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
14771682|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771683|NCT00647660|Diuretics|diuretics|mesh-ancestor
14771684|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
14771685|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14771686|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771687|NCT00647673|Verapamil|verapamil|mesh-list
14771688|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771689|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14198062|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491579|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14771690|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198063|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14198064|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14198065|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14198066|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491580|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491581|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14491582|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14491583|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14491584|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14491585|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491586|NCT02659020|Gemcitabine|gemcitabine|mesh-list
14491587|NCT02659020|Docetaxel|docetaxel|mesh-list
14491588|NCT02659020|Olaratumab|olaratumab|mesh-list
14491589|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14491590|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
14491591|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491592|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491593|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
14491594|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491595|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491596|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14491597|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
14491598|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491599|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
14491600|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
14198067|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491601|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
14491602|NCT02659501|Acetaminophen|acetaminophen|mesh-list
14491603|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14491604|NCT02659501|Epinephrine|epinephrine|mesh-list
14491605|NCT02659501|Diazepam|diazepam|mesh-list
14491606|NCT02659501|Morphine|morphine|mesh-list
14491607|NCT02659501|Hydrocodone|hydrocodone|mesh-list
14491608|NCT02659501|Bupivacaine|bupivacaine|mesh-list
14491609|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491610|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
14491611|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491612|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491613|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
14491614|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491615|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491616|NCT02659501|Narcotics|narcotics|mesh-ancestor
14491617|NCT02659501|Analgesics|analgesics|mesh-ancestor
14491618|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14491619|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
14491620|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14491621|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14771691|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771692|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14771693|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771694|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
14771695|NCT00647686|Fentanyl|fentanyl|mesh-list
14771696|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14771697|NCT00647686|Narcotics|narcotics|mesh-ancestor
14771698|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771699|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771700|NCT00647686|Analgesics|analgesics|mesh-ancestor
14940334|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14940335|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14198068|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491622|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
14491623|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491624|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491625|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14491626|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14491627|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
14491628|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14491629|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
14491630|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
14771701|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
14771702|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807295|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
14940336|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491631|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
14491632|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14491633|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
14491634|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14491635|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
14491636|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
14491637|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491638|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14491639|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14491640|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14491641|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14491642|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14491643|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14491644|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14491645|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
14491646|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
14491647|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
14491648|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14491649|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771703|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14771704|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14940337|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940338|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14940339|NCT01492894|Cyclosporine|cyclosporine|mesh-list
14491650|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14491651|NCT02659540|Nivolumab|nivolumab|mesh-list
14491652|NCT02659540|Ipilimumab|ipilimumab|mesh-list
14491653|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491654|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940340|NCT01492894|Sirolimus|sirolimus|mesh-list
14940341|NCT01492894|Tacrolimus|tacrolimus|mesh-list
14940342|NCT01492894|Cyclosporins|cyclosporins|mesh-list
13963894|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491655|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14491656|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527948|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527949|NCT03936387|Ropivacaine|ropivacaine|mesh-list
14527950|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527951|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
14527952|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527953|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527954|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
14527955|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527956|NCT03935399|Oxytocin|oxytocin|mesh-list
14527957|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
14527958|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14527959|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527960|NCT03928327|Itraconazole|itraconazole|mesh-list
14771705|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
14771706|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
14771707|NCT00647712|Valproic Acid|valproic acid|mesh-list
14771708|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
14771709|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771710|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771711|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
14771712|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771713|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771714|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
14771715|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771716|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771717|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940343|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940344|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
14940345|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940346|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14940347|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963895|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963896|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963897|NCT03140982|Propofol|propofol|mesh-list
13963898|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13963899|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963900|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940348|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940349|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
14940350|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940351|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
14940352|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940353|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14771718|NCT00647738|Baclofen|baclofen|mesh-list
14771719|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14771720|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491657|NCT02659787|Buprenorphine|buprenorphine|mesh-list
14491658|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491659|NCT02659787|Narcotics|narcotics|mesh-ancestor
14491660|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491661|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491662|NCT02659787|Analgesics|analgesics|mesh-ancestor
14491663|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
14491664|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491665|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14491666|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
14491667|NCT02659943|Fludarabine|fludarabine|mesh-list
14491668|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14491669|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
14491670|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491671|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14491672|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14491673|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
14491674|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491675|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491676|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14491677|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
14491678|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14491679|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14491680|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
14491681|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14491682|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14491683|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491684|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14491685|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491686|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491687|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14491688|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491689|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
14491690|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
14491691|NCT02660229|Morphine|morphine|mesh-list
14198084|NCT04577404|Edaravone|edaravone|mesh-list
14198085|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14198086|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
14198087|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198088|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14198089|NCT04577404|Protective Agents|protective agents|mesh-ancestor
14198090|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491692|NCT02660229|Oxycodone|oxycodone|mesh-list
14491693|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491694|NCT02660229|Narcotics|narcotics|mesh-ancestor
14491695|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491696|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491697|NCT02660229|Analgesics|analgesics|mesh-ancestor
14491698|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
14491699|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491700|NCT02660242|Glucagon|glucagon|mesh-list
14771721|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14771722|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771723|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14771724|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
14771725|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
14771726|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771727|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771728|NCT00647751|Lamotrigine|lamotrigine|mesh-list
14771729|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
14771730|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14771731|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771732|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771733|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14771734|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940354|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14940355|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940356|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
14940357|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
14491701|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14491702|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940358|NCT01492920|Vitamins|vitamins|mesh-ancestor
14198091|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
14198092|NCT04576364|Analgesics|analgesics|mesh-ancestor
14198093|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
14491703|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491704|NCT02660242|Hormones|hormones|mesh-ancestor
14491705|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491706|NCT02660242|Incretins|incretins|mesh-ancestor
14491707|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
14491708|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14491709|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14940359|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
14940360|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940361|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
14940362|NCT01492959|Insulin|insulin|mesh-list
14940363|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14940364|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940365|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940366|NCT01492972|Leuprolide|leuprolide|mesh-list
14940367|NCT01492972|Goserelin|goserelin|mesh-list
14198094|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198095|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198096|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
14198097|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940368|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14940369|NCT01492972|Buserelin|buserelin|mesh-list
14940370|NCT01492972|Androgens|androgens|mesh-list
14940371|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14940372|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
14198098|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14198099|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
14198100|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14198101|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198102|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198103|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14198104|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
14198105|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14198106|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
14198107|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14198108|NCT04576143|Paclitaxel|paclitaxel|mesh-list
14198109|NCT04576143|Docetaxel|docetaxel|mesh-list
14198110|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
14491710|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
14491711|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14491712|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14527961|NCT03928327|Rifampin|rifampin|mesh-list
14527962|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
14527963|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527964|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14527965|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14527966|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527967|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527968|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14527969|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
14527970|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14527971|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527972|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14527973|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14527974|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
14527975|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14527976|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
14527977|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14527978|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14527979|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14527980|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14527981|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14527982|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14527983|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14527984|NCT03933774|Tretinoin|tretinoin|mesh-list
14527985|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527986|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
14527987|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
14527988|NCT03933618|Anastrozole|anastrozole|mesh-list
14527989|NCT03933618|Clomiphene|clomiphene|mesh-list
14527990|NCT03933618|Enclomiphene|enclomiphene|mesh-list
14527991|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
14198111|NCT04576143|Epirubicin|epirubicin|mesh-list
14198112|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14198113|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198114|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
14198115|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
14198116|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
14491713|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491714|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
14491715|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491716|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491717|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14491718|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491719|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
14491720|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
14491721|NCT02660580|Adalimumab|adalimumab|mesh-list
14491722|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14491723|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14491724|NCT02660918|Bupivacaine|bupivacaine|mesh-list
14491725|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491726|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
14491727|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491728|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491729|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
14491730|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491731|NCT02660983|Donepezil|donepezil|mesh-list
14198117|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198118|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198119|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
14198120|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198121|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198122|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14198123|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
14198124|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14198125|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14198126|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14198127|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14198128|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771735|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14771736|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771737|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771738|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771739|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14198129|NCT04576390|Ondansetron|ondansetron|mesh-list
14771740|NCT00647777|Olanzapine|olanzapine|mesh-list
14771741|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
14771742|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
14771743|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771744|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940373|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14491732|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14491733|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491734|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940374|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198130|NCT04576390|Palonosetron|palonosetron|mesh-list
14198131|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
14198132|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
14198133|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198134|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198135|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14198136|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
14198137|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
14198138|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14940375|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14940376|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940377|NCT01492972|Hormones|hormones|mesh-ancestor
14940378|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940379|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
14940380|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14940381|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
14940382|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14940383|NCT01492985|Vaccines|vaccines|mesh-list
14198139|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
14198140|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491735|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
14771745|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14771746|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14940384|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
14940385|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940386|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
14940387|NCT01493050|Calcium|calcium|mesh-list
14940388|NCT01493050|Sevelamer|sevelamer|mesh-list
14940389|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14940390|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198141|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198142|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14198143|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14198144|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198145|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14198146|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14198147|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14198148|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
14198149|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14198150|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198151|NCT04575844|Liraglutide|liraglutide|mesh-list
14198152|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14198153|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198154|NCT04575844|Incretins|incretins|mesh-ancestor
14198155|NCT04575844|Hormones|hormones|mesh-ancestor
14198156|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14198157|NCT04575688|Bupivacaine|bupivacaine|mesh-list
14198158|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491736|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491737|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491738|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
14940391|NCT01493050|Antacids|antacids|mesh-ancestor
14940392|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940393|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14940394|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
14198159|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
14198160|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198161|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198162|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
14198163|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940395|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
14940396|NCT01493102|Vasopressins|vasopressins|mesh-list
14940397|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
14198164|NCT04575779|Cyclosporine|cyclosporine|mesh-list
14198165|NCT04575779|Cyclosporins|cyclosporins|mesh-list
14198166|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198167|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198168|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198169|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
14198170|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198171|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
14198172|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198173|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
14198174|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198175|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14198176|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
14198177|NCT04575675|Valsartan|valsartan|mesh-list
14198178|NCT04575675|Carvedilol|carvedilol|mesh-list
14198179|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14198180|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14198181|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14198182|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
14198183|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14198184|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14198185|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14491739|NCT02661061|Midazolam|midazolam|mesh-list
14491740|NCT02661061|Ketamine|ketamine|mesh-list
14491741|NCT02661061|Analgesics|analgesics|mesh-ancestor
14491742|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
14491743|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491744|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491745|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14491746|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14491747|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
14491748|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
14491749|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940398|NCT01493102|Norepinephrine|norepinephrine|mesh-list
14940399|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14940400|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14491750|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14491751|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14491752|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491753|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491754|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14491755|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14491756|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14491757|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14491758|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14491759|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
14491760|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
14491761|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
14491762|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
14491763|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491764|NCT02661178|Emodepside|emodepside|mesh-list
14491765|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14491766|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491767|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14491768|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14491769|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491770|NCT02661490|Vaccines|vaccines|mesh-list
14491771|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
14491772|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491773|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
14491774|NCT02661594|Amisulpride|amisulpride|mesh-list
14491775|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14491776|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198186|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198187|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14198188|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14491777|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14491778|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14491779|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491780|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491781|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491782|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491783|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14491784|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14491785|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491786|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14491787|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14491788|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
14491789|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491790|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14491791|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
14491792|NCT02661815|Paclitaxel|paclitaxel|mesh-list
14491793|NCT02661815|Bevacizumab|bevacizumab|mesh-list
14491794|NCT02661815|Ricolinostat|ricolinostat|mesh-list
14491795|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14491796|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491797|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14491798|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14491799|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14198189|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198190|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14198191|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
14198192|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198193|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
14198194|NCT04575675|Protective Agents|protective agents|mesh-ancestor
14198195|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14198196|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14491800|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491801|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491802|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14491803|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14491804|NCT02661815|Growth Substances|growth substances|mesh-ancestor
14491805|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491806|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14491807|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14491808|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491809|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
14491810|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771747|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14491811|NCT02662036|Bupivacaine|bupivacaine|mesh-list
14198197|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14198198|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
14198199|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14198200|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14491812|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491813|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
14491814|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491815|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491816|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
14771748|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771749|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771750|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14771751|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14771752|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771753|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771754|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771755|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
14771756|NCT00647816|Propranolol|propranolol|mesh-list
14771757|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14771758|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14771759|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
14771760|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771761|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771762|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771763|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771764|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771765|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
14771766|NCT00647829|Valdecoxib|valdecoxib|mesh-list
14771767|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14771768|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14771769|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771770|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771771|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14771772|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14771773|NCT00647829|Analgesics|analgesics|mesh-ancestor
14771774|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
14771775|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771776|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771777|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771778|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771779|NCT00647842|Fentanyl|fentanyl|mesh-list
14771780|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14771781|NCT00647842|Narcotics|narcotics|mesh-ancestor
14771782|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807296|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940401|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
14198201|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
14198202|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491817|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491818|NCT02662556|Sufentanil|sufentanil|mesh-list
14491819|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491820|NCT02662556|Narcotics|narcotics|mesh-ancestor
14491821|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491822|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491823|NCT02662556|Analgesics|analgesics|mesh-ancestor
14491824|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
14491825|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491826|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14491827|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14491828|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
14491829|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
14491830|NCT02662569|Atorvastatin|atorvastatin|mesh-list
14491831|NCT02662569|Evolocumab|evolocumab|mesh-list
14491832|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14491833|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14491834|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
14491835|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491836|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14491837|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14491838|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491839|NCT02662764|Sufentanil|sufentanil|mesh-list
14491840|NCT02662764|Dsuvia|dsuvia|mesh-list
14491841|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491842|NCT02662764|Narcotics|narcotics|mesh-ancestor
14491843|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491844|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491845|NCT02662764|Analgesics|analgesics|mesh-ancestor
14491846|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
14491847|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771783|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771784|NCT00647842|Analgesics|analgesics|mesh-ancestor
14771785|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
14771786|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771787|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14771788|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14771789|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
14771790|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
14771791|NCT00647868|Testosterone|testosterone|mesh-list
14771792|NCT00647868|Androgens|androgens|mesh-ancestor
14771793|NCT00647868|Hormones|hormones|mesh-ancestor
14940402|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940403|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940404|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940405|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
14940406|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
14940407|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940408|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14940409|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
14940410|NCT01493102|Coagulants|coagulants|mesh-ancestor
14940411|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14940412|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
14940413|NCT01493115|Insulin|insulin|mesh-list
14940414|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14940415|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
14940416|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940417|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940418|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
14940419|NCT01493154|Vaccines|vaccines|mesh-list
14940420|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
14940421|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940422|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940423|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940424|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14940425|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
14940426|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940427|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940428|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14940429|NCT01493310|Paclitaxel|paclitaxel|mesh-list
14940430|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14940431|NCT01493310|Mifepristone|mifepristone|mesh-list
14940432|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14940433|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940434|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
14940435|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
14940436|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
14940437|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940438|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14940439|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
14940440|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14940441|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940442|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14940443|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14940444|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14940445|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
14940446|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14940447|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14940448|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
14940449|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940450|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
14940451|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14198203|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14198204|NCT04575675|Diuretics|diuretics|mesh-ancestor
14807297|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14940452|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14491848|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14491849|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14491850|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
14491851|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
14491852|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14491853|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14491854|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14491855|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14491856|NCT02663674|Fluconazole|fluconazole|mesh-list
14491857|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
14491858|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491859|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14491860|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14491861|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491862|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491863|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14491864|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
14491865|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14491866|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491867|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14491868|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14491869|NCT02663687|Complement C1s|complement c1s|mesh-list
14491870|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14491871|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14491872|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
14491873|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491874|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14491875|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14491876|NCT02663895|Treprostinil|treprostinil|mesh-list
14491877|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14491878|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
14491879|NCT02664220|Povidone|povidone|mesh-list
14491880|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
14491881|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
14491882|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14491883|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491884|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
14491885|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14491886|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14491887|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491888|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
14491889|NCT02664909|Coagulants|coagulants|mesh-ancestor
14491890|NCT02664922|Ketamine|ketamine|mesh-list
14491891|NCT02664922|Remifentanil|remifentanil|mesh-list
14491892|NCT02664922|Propofol|propofol|mesh-list
14491893|NCT02664922|Sevoflurane|sevoflurane|mesh-list
14491894|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14491895|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491896|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491897|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14491898|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
14491899|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
14491900|NCT02664922|Analgesics|analgesics|mesh-ancestor
14491901|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
14491902|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771794|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771795|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771796|NCT00647881|Paroxetine|paroxetine|mesh-list
14771797|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14771798|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14771799|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771800|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771801|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771802|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
14771803|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771804|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14491903|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14491904|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14491905|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14491906|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491907|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771805|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
14491908|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14491909|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14491910|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14491911|NCT02664922|Narcotics|narcotics|mesh-ancestor
14491912|NCT02664961|Bevacizumab|bevacizumab|mesh-list
14491913|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14491914|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491915|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14491916|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14491917|NCT02664961|Growth Substances|growth substances|mesh-ancestor
14491918|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491919|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
14491920|NCT02665260|Cantharidin|cantharidin|mesh-list
14491921|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491922|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491923|NCT02665273|Bupivacaine|bupivacaine|mesh-list
14491924|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
14491925|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
14491926|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14491927|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491928|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
14491929|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491930|NCT02665286|Naproxen|naproxen|mesh-list
14491931|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14491932|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14491933|NCT02665286|Orphenadrine|orphenadrine|mesh-list
14491934|NCT02665286|Methocarbamol|methocarbamol|mesh-list
14491935|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14491936|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14491937|NCT02665286|Analgesics|analgesics|mesh-ancestor
14491938|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
14491939|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491940|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491941|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14491942|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
14491943|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14491944|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491945|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491946|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
14491947|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14491948|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14491949|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14491950|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14491951|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14491952|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
14491953|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
14491954|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14491955|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
14491956|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14491957|NCT02665689|Ranibizumab|ranibizumab|mesh-list
14491958|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14491959|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14491960|NCT02665689|Growth Substances|growth substances|mesh-ancestor
14491961|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491962|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
14491963|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14491964|NCT02665728|Laxatives|laxatives|mesh-list
14491965|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14491966|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
14491967|NCT02666352|Ruzasvir|ruzasvir|mesh-list
14491968|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
14491969|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14491970|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14491971|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14491972|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
14491973|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491974|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14491975|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491976|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14491977|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14491978|NCT02666742|Aspirin|aspirin|mesh-list
14491979|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
14491980|NCT02666742|Edoxaban|edoxaban|mesh-list
14771806|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771807|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14491981|NCT02666742|Dabigatran|dabigatran|mesh-list
14491982|NCT02666742|Anticoagulants|anticoagulants|mesh-list
14491983|NCT02666742|Coagulants|coagulants|mesh-list
14491984|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14491985|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14491986|NCT02666742|Analgesics|analgesics|mesh-ancestor
14491987|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
14491988|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14491989|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198205|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
14198206|NCT04575675|Hormones|hormones|mesh-ancestor
14198207|NCT04575922|Nivolumab|nivolumab|mesh-list
14198208|NCT04575922|Ipilimumab|ipilimumab|mesh-list
14198209|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14198210|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198211|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14198212|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198213|NCT04575558|Azithromycin|azithromycin|mesh-list
14198214|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
14198215|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14198216|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198217|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
14198218|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14198219|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14198220|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491990|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14491991|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14491992|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14491993|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14491994|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14491995|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14491996|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14491997|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14491998|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
14491999|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14492000|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
14492001|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14492002|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
14492003|NCT02666846|Ibuprofen|ibuprofen|mesh-list
14492004|NCT02666846|Diclofenac|diclofenac|mesh-list
14492005|NCT02666846|Salicylates|salicylates|mesh-list
14492006|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
14492007|NCT02666846|Menthol|menthol|mesh-list
14492008|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14492009|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198221|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492010|NCT02666846|Analgesics|analgesics|mesh-ancestor
14492011|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
14492012|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492013|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492014|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198222|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198223|NCT04575519|Aspirin|aspirin|mesh-list
14198224|NCT04575519|Ibuprofen|ibuprofen|mesh-list
14198225|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14198226|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198227|NCT04575519|Analgesics|analgesics|mesh-ancestor
14198228|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
14198229|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198230|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940453|NCT01493336|Capecitabine|capecitabine|mesh-list
14940454|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14940455|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
14940456|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940457|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198231|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198232|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198233|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14492015|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940458|NCT01493388|Insulin|insulin|mesh-list
14940459|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492016|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14492017|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492018|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492019|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
14492020|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
14492021|NCT02666950|Cytarabine|cytarabine|mesh-list
14492022|NCT02666950|Adavosertib|adavosertib|mesh-list
14940460|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940461|NCT01493440|Atosiban|atosiban|mesh-list
14940462|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
14940463|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940464|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198234|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198235|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198236|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14198237|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14198238|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14198239|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
14198240|NCT04575194|Liraglutide|liraglutide|mesh-list
14198241|NCT04575194|Naltrexone|naltrexone|mesh-list
14198242|NCT04575194|Bupropion|bupropion|mesh-list
14198243|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14198244|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14198245|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198246|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
14198247|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198248|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14198249|NCT04575194|Incretins|incretins|mesh-ancestor
14198250|NCT04575194|Hormones|hormones|mesh-ancestor
14198251|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14198252|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14198253|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
14198254|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14198255|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14198256|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14198257|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198258|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198259|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
14198260|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198261|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14198262|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14198263|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198264|NCT04575233|Ropivacaine|ropivacaine|mesh-list
14198265|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
14198266|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
14198267|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198268|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492023|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14492024|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
14492025|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492026|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492027|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
14492028|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492029|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940465|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
14940466|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14940467|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
14940468|NCT01493453|Fludarabine|fludarabine|mesh-list
14940469|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940470|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
14940471|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940472|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940473|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14940474|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
13963901|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13963902|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
13963903|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
13963904|NCT03140956|Levodopa|levodopa|mesh-list
13963905|NCT03140956|Carbidopa|carbidopa|mesh-list
13963906|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13963907|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13963908|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
13963909|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13963910|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492030|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
14492031|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492032|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771808|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14771809|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771810|NCT00647894|Alprazolam|alprazolam|mesh-list
14771811|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14771812|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771813|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771814|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14771815|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14198269|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
14198270|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198271|NCT04575415|Bevacizumab|bevacizumab|mesh-list
14198272|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14198273|NCT04575415|Gefitinib|gefitinib|mesh-list
14771816|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771817|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
14771818|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
14771819|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771820|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771821|NCT00647907|Voriconazole|voriconazole|mesh-list
14771822|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
14771823|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771824|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14198274|NCT04575415|Osimertinib|osimertinib|mesh-list
14198275|NCT04575415|Afatinib|afatinib|mesh-list
14771825|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14771826|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771827|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771828|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14771829|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
14771830|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771831|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771832|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14771833|NCT00647920|Adalimumab|adalimumab|mesh-list
14771834|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771835|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198276|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14198277|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198278|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14198279|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14198280|NCT04575415|Growth Substances|growth substances|mesh-ancestor
14771836|NCT00647946|Tenofovir|tenofovir|mesh-list
14771837|NCT00647946|Abacavir|abacavir|mesh-list
14771838|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
14771839|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771840|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14771841|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14771842|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771843|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771844|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14771845|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14771846|NCT00647959|Doxycycline|doxycycline|mesh-list
14771847|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14771848|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771849|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
14771850|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14771851|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14771852|NCT00647972|Olanzapine|olanzapine|mesh-list
14771853|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
14771854|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
14771855|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771856|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771857|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14198281|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198282|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
14198283|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14198284|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492033|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14492034|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14492035|NCT02667704|Nintedanib|nintedanib|mesh-list
14492036|NCT02667704|Bosentan|bosentan|mesh-list
14492037|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492038|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14492039|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492040|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492041|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14492042|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14492043|NCT02668393|Docetaxel|docetaxel|mesh-list
14492044|NCT02668393|Nintedanib|nintedanib|mesh-list
14492045|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492046|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
14492047|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
14492048|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
14492049|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492050|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14492051|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492052|NCT02668432|Amiodarone|amiodarone|mesh-list
14492053|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14492054|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
14492055|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14492056|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492057|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492058|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14492059|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14492060|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14492061|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492062|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14492063|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14492064|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14492065|NCT02668640|Adalimumab|adalimumab|mesh-list
14492066|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771858|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14771859|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771860|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771861|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771862|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14771863|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14771864|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771865|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771866|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771867|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
14771868|NCT00647985|Fexofenadine|fexofenadine|mesh-list
14771869|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14771870|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14771871|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14771872|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
14771873|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
14771874|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771875|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771876|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771877|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14771878|NCT00648011|Quinapril|quinapril|mesh-list
14771879|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771880|NCT00648011|Diuretics|diuretics|mesh-ancestor
14771881|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
14771882|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771883|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14198285|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198286|NCT04575389|Uric Acid|uric acid|mesh-list
14198287|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
14198288|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198289|NCT04575389|Protective Agents|protective agents|mesh-ancestor
14198290|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198291|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
14198292|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14198293|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198294|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14198295|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14198296|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198297|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198298|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198299|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14198300|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14198301|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
14198302|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14492067|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492068|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14492069|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492070|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492071|NCT02669043|Ketamine|ketamine|mesh-list
14492072|NCT02669043|Analgesics|analgesics|mesh-ancestor
14492073|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
14492074|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492075|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492076|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14492077|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14492078|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
14492079|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
14492080|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492081|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14492082|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14492083|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492084|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492085|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14492086|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492087|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492088|NCT02669407|Lidocaine|lidocaine|mesh-list
14492089|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
14492090|NCT02669407|Anesthetics|anesthetics|mesh-list
14492091|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492092|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492093|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
14492094|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492095|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14492096|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14492097|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14492098|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492099|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527992|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527993|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14527994|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527995|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14527996|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14527997|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527998|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14527999|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
14528000|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528001|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528002|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14528003|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
14528004|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14528005|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14528006|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14528007|NCT03927105|Nivolumab|nivolumab|mesh-list
14528008|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14528009|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528010|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14528011|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528012|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
14528013|NCT03923933|Bumetanide|bumetanide|mesh-list
14528014|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14528015|NCT03923933|Diuretics|diuretics|mesh-ancestor
14528016|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
14528017|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528018|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14528019|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528020|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528021|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14528022|NCT03909295|Valsartan|valsartan|mesh-list
14528023|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14528024|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14528025|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14528026|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14528027|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528028|NCT03930264|Azathioprine|azathioprine|mesh-list
14492100|NCT02669615|Melphalan|melphalan|mesh-list
14492101|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14492102|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
14492103|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492104|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492105|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14492106|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14492107|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
14492108|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492109|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14492110|NCT02669914|Durvalumab|durvalumab|mesh-list
14492111|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492112|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198303|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198304|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198305|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238890|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14238891|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
14238892|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238893|NCT00136695|Anastrozole|anastrozole|mesh-list
14238894|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238895|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238896|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14238897|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14492113|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
14492114|NCT02670343|Testosterone|testosterone|mesh-list
14492115|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
14492116|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
14492117|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14492118|NCT02670343|Androgens|androgens|mesh-ancestor
14492119|NCT02670343|Hormones|hormones|mesh-ancestor
14492120|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492121|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492122|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14492123|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492124|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
14238898|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238899|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238900|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14238901|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
14238902|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238903|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238904|NCT00136760|Bupropion|bupropion|mesh-list
14238905|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14492125|NCT02670538|Cariprazine|cariprazine|mesh-list
14492126|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14492127|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14492128|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492129|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492130|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14492131|NCT02670551|Cariprazine|cariprazine|mesh-list
14492132|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14492133|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14492134|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492135|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492136|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14492137|NCT02670915|Insulin|insulin|mesh-list
14492138|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14492139|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
14238906|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
14238907|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14238908|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14238909|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14238910|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492140|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
14492141|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14492142|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492143|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492144|NCT02671266|Oxytocin|oxytocin|mesh-list
14492145|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
14492146|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14492147|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492148|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
14528029|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
14198306|NCT04574960|Gemcitabine|gemcitabine|mesh-list
14198307|NCT04574960|Carboplatin|carboplatin|mesh-list
14198308|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198309|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14198310|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
14198311|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198312|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
14198313|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198314|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198315|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198316|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
14492149|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14492150|NCT02671500|Velpatasvir|velpatasvir|mesh-list
14492151|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
14492152|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940475|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940476|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940477|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14940478|NCT01493479|Rituximab|rituximab|mesh-list
14940479|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14940480|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940481|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
14940482|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940483|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940484|NCT01493570|BI 409306|bi 409306|mesh-list
14940485|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14940486|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492153|NCT02672111|Buprenorphine|buprenorphine|mesh-list
14492154|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492155|NCT02672111|Narcotics|narcotics|mesh-ancestor
14492156|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492157|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492158|NCT02672111|Analgesics|analgesics|mesh-ancestor
14492159|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
14492160|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492161|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14492162|NCT02673138|Canagliflozin|canagliflozin|mesh-list
14492163|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14492164|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492165|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492166|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492167|NCT02673372|Ketamine|ketamine|mesh-list
14492168|NCT02673372|Morphine|morphine|mesh-list
14492169|NCT02673372|Analgesics|analgesics|mesh-ancestor
14492170|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
14492171|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492172|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492173|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14492174|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14492175|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
14492176|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
14492177|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492178|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14492179|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14492180|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492181|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198317|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198318|NCT04574947|Lidocaine|lidocaine|mesh-list
14198319|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
14198320|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
14198321|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198322|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198323|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
14198324|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198325|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14940487|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492182|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492183|NCT02673372|Narcotics|narcotics|mesh-ancestor
14492184|NCT02674399|Hylan|hylan|mesh-list
14492185|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
14492186|NCT02674399|Protective Agents|protective agents|mesh-ancestor
14940488|NCT01493622|Minocycline|minocycline|mesh-list
14492187|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492188|NCT02674412|Buspirone|buspirone|mesh-list
14492189|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14492190|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14198326|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14198327|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14198328|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492191|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492192|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492193|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14492194|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14492195|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
14492196|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492197|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492198|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14771884|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771885|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771886|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14771887|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
14771888|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771889|NCT00648024|Anagrelide|anagrelide|mesh-list
14771890|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14771891|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14771892|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771893|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14771894|NCT00648050|Verapamil|verapamil|mesh-list
14771895|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771896|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14771897|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771898|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771899|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14771900|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771901|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
14771902|NCT00648063|Letrozole|letrozole|mesh-list
14771903|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771904|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14771905|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14771906|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771907|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771908|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14771909|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
14771910|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771911|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771912|NCT00648076|Valproic Acid|valproic acid|mesh-list
14771913|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
14771914|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771915|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940489|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14940490|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940491|NCT01493635|Analgesics|analgesics|mesh-list
14940492|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
14198329|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198336|NCT04574778|Acetaminophen|acetaminophen|mesh-list
14198337|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198338|NCT04574778|Analgesics|analgesics|mesh-ancestor
14198339|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
14198340|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198341|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198342|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
14198343|NCT04574791|Tizanidine|tizanidine|mesh-list
14198344|NCT04574791|Analgesics|analgesics|mesh-ancestor
14771916|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
14771917|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771918|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771919|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
14771920|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14771921|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14771922|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771923|NCT00648128|Clarithromycin|clarithromycin|mesh-list
14492199|NCT02674854|Latanoprost|latanoprost|mesh-list
14492200|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14492201|NCT02675907|Meloxicam|meloxicam|mesh-list
14492202|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14492203|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14492204|NCT02675907|Analgesics|analgesics|mesh-ancestor
14492205|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
14492206|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492207|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492208|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492209|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492210|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14492211|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14492212|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492213|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492214|NCT02676375|Bupropion|bupropion|mesh-list
14492215|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14492216|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
14492217|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14198345|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
14198346|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198347|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198348|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
14198349|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14198350|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14198351|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
14198352|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
14198353|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14198354|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14198355|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14198356|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
14198357|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198358|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198359|NCT04575064|Remdesivir|remdesivir|mesh-list
14198360|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
14198361|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198362|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
14492218|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14492219|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14492220|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492221|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492222|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
14492223|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492224|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492225|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14492226|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14492227|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492228|NCT02676466|Losartan|losartan|mesh-list
14492229|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14492230|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14492231|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14492232|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14492233|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492234|NCT02676895|Vaccines|vaccines|mesh-list
14492235|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
14771924|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14771925|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771926|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14771927|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771928|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771929|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14771930|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14771931|NCT00648141|Celecoxib|celecoxib|mesh-list
14771932|NCT00648141|Diclofenac|diclofenac|mesh-list
14771933|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14771934|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14771935|NCT00648141|Analgesics|analgesics|mesh-ancestor
14771936|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
14771937|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771938|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771939|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198363|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940493|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940494|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940495|NCT01493648|Vitamin D|vitamin d|mesh-list
14940496|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
14940497|NCT01493648|Vitamins|vitamins|mesh-ancestor
14198364|NCT04574479|Morphine|morphine|mesh-list
14198365|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14198366|NCT04574479|Narcotics|narcotics|mesh-ancestor
14198367|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940498|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
14940499|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940500|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14940501|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14940502|NCT01493674|Folic Acid|folic acid|mesh-list
14940503|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
14198368|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198369|NCT04574479|Analgesics|analgesics|mesh-ancestor
14198370|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
14198371|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198372|NCT04574141|Melatonin|melatonin|mesh-list
14198373|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
14198374|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198375|NCT04574141|Protective Agents|protective agents|mesh-ancestor
14198376|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198377|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198378|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
14198379|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14198380|NCT04573855|Antibodies|antibodies|mesh-list
14198381|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
14198382|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198383|NCT04573803|Phenytoin|phenytoin|mesh-list
14198384|NCT04573803|Levetiracetam|levetiracetam|mesh-list
14198385|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
14198386|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
14198387|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14198388|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14198389|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198390|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198391|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14198392|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14198393|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14198394|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14198395|NCT04573426|Acetaminophen|acetaminophen|mesh-list
14198396|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198397|NCT04573426|Analgesics|analgesics|mesh-ancestor
14198398|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
14198399|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198400|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492236|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492237|NCT02677116|Doxorubicin|doxorubicin|mesh-list
14492238|NCT02677116|Irinotecan|irinotecan|mesh-list
14492239|NCT02677116|Vincristine|vincristine|mesh-list
14492240|NCT02677116|Ifosfamide|ifosfamide|mesh-list
14492241|NCT02677116|Olaratumab|olaratumab|mesh-list
14492242|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14492243|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492244|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14492245|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14492246|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492247|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492248|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14492249|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14492250|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
14492251|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14492252|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14492253|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14492254|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
14492255|NCT02677324|Venetoclax|venetoclax|mesh-list
14492256|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492257|NCT02677493|Vaccines|vaccines|mesh-list
14492258|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
14198401|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
14771940|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771941|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14771942|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14771943|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963911|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492259|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492260|NCT02677623|Mannitol|mannitol|mesh-list
14492261|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14492262|NCT02677623|Diuretics|diuretics|mesh-ancestor
14492263|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
14492264|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492265|NCT02677701|Azithromycin|azithromycin|mesh-list
14492266|NCT02677701|Tobramycin|tobramycin|mesh-list
14492267|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14492268|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492269|NCT02677844|Loperamide|loperamide|mesh-list
14492270|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
14492271|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14492272|NCT02678286|Meloxicam|meloxicam|mesh-list
14771944|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771945|NCT00648154|Letrozole|letrozole|mesh-list
14771946|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14771947|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14771948|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14771949|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771950|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771951|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14771952|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
13963912|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13963913|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963914|NCT03140943|Thalidomide|thalidomide|mesh-list
13963915|NCT03140943|Dexamethasone|dexamethasone|mesh-list
13963916|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771953|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14771954|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771955|NCT00648180|Doxycycline|doxycycline|mesh-list
14771956|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14771957|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14771958|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
14771959|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14771960|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13963917|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
13963918|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
13963919|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963920|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771961|NCT00648193|Paroxetine|paroxetine|mesh-list
14771962|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14771963|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14492273|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13963921|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13963922|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
13963923|NCT03140943|Hormones|hormones|mesh-ancestor
13963924|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13963925|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13963926|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963927|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963928|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
13963929|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
13963930|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13963931|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963932|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14492274|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14492275|NCT02678286|Analgesics|analgesics|mesh-ancestor
14492276|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
14492277|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492278|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492279|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492280|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492281|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14492282|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14492283|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492284|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492285|NCT02678416|Acetaminophen|acetaminophen|mesh-list
14492286|NCT02678416|Morphine|morphine|mesh-list
14492287|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492288|NCT02678416|Narcotics|narcotics|mesh-ancestor
14492289|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492290|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492291|NCT02678416|Analgesics|analgesics|mesh-ancestor
14492292|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
14492293|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492294|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14771964|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14771965|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771966|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14771967|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
14771968|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771969|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14771970|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
14771971|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14771972|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14771973|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14771974|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771975|NCT00648219|Olmesartan|olmesartan|mesh-list
14771976|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14771977|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14771978|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14771979|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14771980|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771981|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14771982|NCT00648258|Naproxen|naproxen|mesh-list
14771983|NCT00648258|Valdecoxib|valdecoxib|mesh-list
14771984|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14771985|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14771986|NCT00648258|Analgesics|analgesics|mesh-ancestor
14771987|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
14771988|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14771989|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14771990|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14771991|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14771992|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
14771993|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14771994|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14771995|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14771996|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14771997|NCT00648271|Metoprolol|metoprolol|mesh-list
14771998|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14771999|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772000|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
14772001|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
14772002|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772003|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772004|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14772005|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14772006|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14492295|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
14492296|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
14492297|NCT02679274|Testosterone|testosterone|mesh-list
14492298|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
14492299|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
14492300|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14492301|NCT02679274|Androgens|androgens|mesh-ancestor
14492302|NCT02679274|Hormones|hormones|mesh-ancestor
14492303|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492304|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492305|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14492306|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492307|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
14492308|NCT02679469|Nalmefene|nalmefene|mesh-list
14492309|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14492310|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492311|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
14492312|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492313|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
14492314|NCT02679573|Linezolid|linezolid|mesh-list
14492315|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14492316|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492317|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14492318|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14492319|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492320|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492321|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492322|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14492323|NCT02679755|Letrozole|letrozole|mesh-list
14492324|NCT02679755|Palbociclib|palbociclib|mesh-list
14492325|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492326|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14492327|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14492328|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492329|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492330|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14492331|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14492332|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492333|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492334|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14492335|NCT02679911|Amorolfine|amorolfine|mesh-list
14492336|NCT02679911|Ciclopirox|ciclopirox|mesh-list
14492337|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
14492338|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492339|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14492340|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14492341|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
14492342|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528030|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528031|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14528032|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528033|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14528034|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
14528035|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772007|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772008|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772009|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528036|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528037|NCT03929367|Oxytocin|oxytocin|mesh-list
14528038|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
14528039|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14528040|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528041|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14528042|NCT03928522|Vancomycin|vancomycin|mesh-list
14528043|NCT03928522|Tobramycin|tobramycin|mesh-list
14528044|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528045|NCT03910439|Avelumab|avelumab|mesh-list
14772010|NCT00648297|Nadolol|nadolol|mesh-list
14772011|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
14772012|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14772013|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14528046|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14528047|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528048|NCT03927950|Citalopram|citalopram|mesh-list
14528049|NCT03927950|Bupropion|bupropion|mesh-list
14528050|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14528051|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14528052|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528053|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528054|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528055|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
14528056|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528057|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14528058|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
14528059|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772014|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772015|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772016|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772017|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772018|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14772019|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14198426|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
14198427|NCT04573686|Hematinics|hematinics|mesh-ancestor
14198428|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
14198429|NCT04573153|Sorbitol|sorbitol|mesh-list
14198430|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
14198431|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14198432|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14198433|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198434|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198435|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198436|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492343|NCT02680054|Insulin|insulin|mesh-list
14492344|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
14492345|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492346|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198437|NCT04573153|Cathartics|cathartics|mesh-ancestor
14198438|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238911|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238912|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
14238913|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14238914|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238915|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14238916|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14238917|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238918|NCT00136916|Insulin|insulin|mesh-list
14238919|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14238920|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14238921|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492347|NCT02680301|Triamcinolone|triamcinolone|mesh-list
14492348|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14492349|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14492350|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14492351|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492352|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
14492353|NCT02680301|Hormones|hormones|mesh-ancestor
14492354|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492355|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492356|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14492357|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
14492358|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492359|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492360|NCT02680314|Methotrexate|methotrexate|mesh-list
14492361|NCT02680314|Misoprostol|misoprostol|mesh-list
14238922|NCT00136955|Irinotecan|irinotecan|mesh-list
14238923|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14238924|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14238925|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238926|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238927|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238928|NCT00137046|Insulin|insulin|mesh-list
14238929|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14492362|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14492363|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
14492364|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14492365|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492366|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14492367|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
14492368|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492369|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492370|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
14492371|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492372|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14492373|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14492374|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
14492375|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492376|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14492377|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14492378|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14492379|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
14492380|NCT02680457|Insulin|insulin|mesh-list
14492381|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14492382|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
14772020|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
14940504|NCT01493674|Hematinics|hematinics|mesh-ancestor
14940505|NCT01493674|Vitamins|vitamins|mesh-ancestor
14940506|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
14940507|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940508|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
14492383|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772021|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
14772022|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772023|NCT00648297|Diuretics|diuretics|mesh-ancestor
14772024|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772025|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14772026|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772027|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14940509|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14492384|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492385|NCT02680756|Ferric maltol|ferric maltol|mesh-list
14492386|NCT02680756|Hematinics|hematinics|mesh-ancestor
14492387|NCT02680847|Naltrexone|naltrexone|mesh-list
14492388|NCT02680847|Oxycodone|oxycodone|mesh-list
14492389|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492390|NCT02680847|Narcotics|narcotics|mesh-ancestor
14492391|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492392|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492393|NCT02680847|Analgesics|analgesics|mesh-ancestor
14492394|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
14492395|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492396|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14492397|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14492398|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
14492399|NCT02681094|Saxagliptin|saxagliptin|mesh-list
14492400|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14492401|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492402|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492403|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492404|NCT02681094|Incretins|incretins|mesh-ancestor
14492405|NCT02681094|Hormones|hormones|mesh-ancestor
14492406|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492407|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14492408|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
14492409|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492410|NCT02681510|Nicotine|nicotine|mesh-list
14492411|NCT02681510|Varenicline|varenicline|mesh-list
14492412|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14492413|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
14492414|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492415|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492416|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14492417|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14492418|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
14492419|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492420|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492421|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14492422|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492423|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
14492424|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14492425|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14492426|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492427|NCT02682381|Teduglutide|teduglutide|mesh-list
14492428|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14492429|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14492430|NCT02682381|Protective Agents|protective agents|mesh-ancestor
14492431|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492432|NCT02682498|Bupivacaine|bupivacaine|mesh-list
14492433|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
14492434|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
14492435|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492436|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492437|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
14492438|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492439|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
14492440|NCT02682563|Gliclazide|gliclazide|mesh-list
14492441|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14492442|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492443|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492444|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492445|NCT02682602|Tacrine|tacrine|mesh-list
14492446|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14492447|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492448|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492449|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
14492450|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492451|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492452|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14492453|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
14772028|NCT00648310|Estrogens|estrogens|mesh-list
14772029|NCT00648310|Hormones|hormones|mesh-ancestor
14940510|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
14940511|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14940512|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772030|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772031|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772032|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14772033|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14772034|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772035|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198439|NCT04573192|Lomustine|lomustine|mesh-list
14492454|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492455|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
14492456|NCT02682784|Oxytocin|oxytocin|mesh-list
14492457|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
14492458|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14492459|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492460|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
14492461|NCT02683109|Olodaterol|olodaterol|mesh-list
14492462|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14492463|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
14492464|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492465|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492466|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14492467|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
14492468|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
14492469|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14492470|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772036|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772037|NCT00648310|Urological Agents|urological agents|mesh-ancestor
14772038|NCT00648323|Doxazosin|doxazosin|mesh-list
14772039|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772040|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14772041|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14198440|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14198441|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
14198442|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198443|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198444|NCT04573049|Simendan|simendan|mesh-list
14772042|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14772043|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
14940513|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14492471|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492472|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492473|NCT02683161|Varenicline|varenicline|mesh-list
14492474|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14492475|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14492476|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
14492477|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492478|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492479|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492480|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14492481|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492482|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492483|NCT02683187|Incretins|incretins|mesh-ancestor
14492484|NCT02683187|Hormones|hormones|mesh-ancestor
14492485|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492486|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14492487|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
14492488|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492489|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492490|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14492491|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492492|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492493|NCT02683525|Incretins|incretins|mesh-ancestor
14492494|NCT02683525|Hormones|hormones|mesh-ancestor
14492495|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940514|NCT01493843|Paclitaxel|paclitaxel|mesh-list
14198445|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14198446|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14198447|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14198448|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14198449|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198450|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198451|NCT04573049|Protective Agents|protective agents|mesh-ancestor
14492496|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14198452|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198453|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
14198454|NCT04572698|Growth Substances|growth substances|mesh-ancestor
14198455|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198456|NCT04572867|Diuretics|diuretics|mesh-list
14198457|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
14198458|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198459|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14198460|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14198461|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14198462|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198463|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198464|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14198465|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14198466|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14198467|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
14198468|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198469|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198470|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14198471|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14198472|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
14198473|NCT04572724|Valsartan|valsartan|mesh-list
14198474|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14198475|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14198476|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14198477|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198478|NCT04572997|Apremilast|apremilast|mesh-list
14198479|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14198480|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198481|NCT04572997|Analgesics|analgesics|mesh-ancestor
14198482|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
14198483|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198484|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198485|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198486|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198487|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14198488|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14198489|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198490|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198491|NCT04572620|Rituximab|rituximab|mesh-list
14198492|NCT04572620|Abatacept|abatacept|mesh-list
14238930|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14238931|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238932|NCT00137111|Cytarabine|cytarabine|mesh-list
14238933|NCT00137111|Dexamethasone|dexamethasone|mesh-list
14238934|NCT00137111|Prednisone|prednisone|mesh-list
14238935|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
14238936|NCT00137111|Doxorubicin|doxorubicin|mesh-list
14238937|NCT00137111|Methotrexate|methotrexate|mesh-list
14238938|NCT00137111|Etoposide|etoposide|mesh-list
14492497|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
14492498|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492499|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492500|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
14492501|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14492502|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
14492503|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492504|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492505|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14492506|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
14492507|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
14492508|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14492509|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
14492510|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492511|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492512|NCT02683707|Lidocaine|lidocaine|mesh-list
14492513|NCT02683707|Fentanyl|fentanyl|mesh-list
14492514|NCT02683707|Midazolam|midazolam|mesh-list
14492515|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
14492516|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
14492517|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492518|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492519|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
14940515|NCT01493843|Bevacizumab|bevacizumab|mesh-list
14492520|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492521|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14492522|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14492523|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14492524|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492525|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492526|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492527|NCT02683707|Narcotics|narcotics|mesh-ancestor
14492528|NCT02683707|Analgesics|analgesics|mesh-ancestor
14492529|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14492530|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14492531|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
14492532|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14492533|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14492534|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14492535|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14492536|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
14492537|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
14492538|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492539|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
14492540|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14492541|NCT02683746|Incretins|incretins|mesh-ancestor
14492542|NCT02683746|Hormones|hormones|mesh-ancestor
14492543|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492544|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492545|NCT02683941|Lanreotide|lanreotide|mesh-list
14492546|NCT02683941|Somatostatin|somatostatin|mesh-list
14492547|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492548|NCT02683941|Hormones|hormones|mesh-ancestor
14492549|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492550|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492551|NCT02684136|Suvorexant|suvorexant|mesh-list
14492552|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14492553|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14492554|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492555|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492556|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14492557|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492558|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492559|NCT02684344|Tamsulosin|tamsulosin|mesh-list
14492560|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14492561|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14492562|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14492563|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
14492564|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492565|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492566|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492567|NCT02684344|Urological Agents|urological agents|mesh-ancestor
14492568|NCT02684357|Ustekinumab|ustekinumab|mesh-list
14492569|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14492570|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
14492571|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
14492572|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492573|NCT02684370|Ustekinumab|ustekinumab|mesh-list
14492574|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14492575|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
14492576|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
14492577|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492578|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
14492579|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492580|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492581|NCT02684942|Fentanyl|fentanyl|mesh-list
14198493|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14198494|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198495|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
14198496|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198497|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198498|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14198499|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198500|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198501|NCT04572542|Paclitaxel|paclitaxel|mesh-list
14198502|NCT04572542|Apatinib|apatinib|mesh-list
14492582|NCT02684942|Meperidine|meperidine|mesh-list
14492583|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492584|NCT02684942|Narcotics|narcotics|mesh-ancestor
14198503|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14198504|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198505|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14198506|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14198507|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14198508|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198509|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14198510|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198511|NCT04572763|Venetoclax|venetoclax|mesh-list
14198512|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198513|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14198514|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14198515|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14198516|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198517|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198518|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14198519|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198520|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198521|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
14198522|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198523|NCT04572217|Topiramate|topiramate|mesh-list
14198524|NCT04572217|Phentermine|phentermine|mesh-list
14198525|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
14198526|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14198527|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238939|NCT00137111|Vincristine|vincristine|mesh-list
14238940|NCT00137111|Daunorubicin|daunorubicin|mesh-list
14238941|NCT00137111|Asparaginase|asparaginase|mesh-list
14238942|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
14238943|NCT00137111|Pegaspargase|pegaspargase|mesh-list
14238944|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14238945|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
14238946|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238947|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14238948|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14238949|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
14238950|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238951|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238952|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14238953|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238954|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
14238955|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
14238956|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14238957|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14238958|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
14238959|NCT00137111|Hormones|hormones|mesh-ancestor
14238960|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14238961|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14238962|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14238963|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14238964|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14238965|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238966|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14238967|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
14238968|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14238969|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14238970|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
14238971|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
14238972|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14238973|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14238974|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14238975|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
14238976|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14238977|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238978|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238979|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238980|NCT00137423|Sunitinib|sunitinib|mesh-list
14238981|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238982|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14238983|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14238984|NCT00137423|Growth Substances|growth substances|mesh-ancestor
14238985|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14238986|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14198528|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14198529|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
14198530|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14198531|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
14198532|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
14198533|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492585|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492586|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492587|NCT02684942|Analgesics|analgesics|mesh-ancestor
14492588|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
14492589|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492590|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14492591|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14492592|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
14492593|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
14492594|NCT02685033|Dalbavancin|dalbavancin|mesh-list
14492595|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14492596|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492597|NCT02685072|Progesterone|progesterone|mesh-list
14492598|NCT02685072|Progestins|progestins|mesh-ancestor
14492599|NCT02685072|Hormones|hormones|mesh-ancestor
14492600|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772044|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772045|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772046|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772047|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
14772048|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
14772049|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772050|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14772051|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772052|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14772053|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
14772054|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772055|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14772056|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772057|NCT00648349|Rabeprazole|rabeprazole|mesh-list
14772058|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14772059|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772060|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14772061|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772062|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772063|NCT00648362|Glimepiride|glimepiride|mesh-list
14772064|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14772065|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772066|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772067|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14772068|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
14772069|NCT00648388|Cilostazol|cilostazol|mesh-list
14772070|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14772071|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
14772072|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772073|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772074|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14772075|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
14772076|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14772077|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14772078|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772079|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14198534|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
14198535|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198536|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198537|NCT04572373|SMOFlipid|smoflipid|mesh-list
14772080|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
14772081|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14772082|NCT00648388|Protective Agents|protective agents|mesh-ancestor
14772083|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14772084|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14772085|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772086|NCT00648401|Verapamil|verapamil|mesh-list
14772087|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14772088|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14772089|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198538|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14492601|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492602|NCT02685267|Prednisone|prednisone|mesh-list
14492603|NCT02685267|Docetaxel|docetaxel|mesh-list
14492604|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492605|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
14492606|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
14492607|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
14492608|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492609|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492610|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
14492611|NCT02685267|Hormones|hormones|mesh-ancestor
14492612|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492613|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492614|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14492615|NCT02685436|Domperidone|domperidone|mesh-list
14492616|NCT02685436|Omeprazole|omeprazole|mesh-list
14492617|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14492618|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14492619|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14492620|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492621|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492622|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
14492623|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
14492624|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492625|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492626|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14492627|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
14492628|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492629|NCT02685826|Dexamethasone|dexamethasone|mesh-list
14492630|NCT02685826|Lenalidomide|lenalidomide|mesh-list
14492631|NCT02685826|Durvalumab|durvalumab|mesh-list
14198539|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14198540|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14198541|NCT04571879|Lidocaine|lidocaine|mesh-list
14198542|NCT04571879|Midazolam|midazolam|mesh-list
14198543|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
14198544|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
14198545|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198546|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492632|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492633|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
14492634|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
14492635|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492636|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492637|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14492638|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
14492639|NCT02685826|Hormones|hormones|mesh-ancestor
14492640|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492641|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14492642|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492643|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
14492644|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14492645|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14492646|NCT02685826|Growth Substances|growth substances|mesh-ancestor
14492647|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14492648|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492649|NCT02686164|Lenvatinib|lenvatinib|mesh-list
14492650|NCT02686164|Midazolam|midazolam|mesh-list
14492651|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14492652|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14492653|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492654|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492655|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14492656|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14492657|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14492658|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14492659|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
14492660|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
14492661|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
14492662|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
14492663|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492664|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492665|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492666|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14198547|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
14492667|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492668|NCT02687451|Oxymorphone|oxymorphone|mesh-list
14492669|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492670|NCT02687451|Narcotics|narcotics|mesh-ancestor
14492671|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492672|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492673|NCT02687451|Analgesics|analgesics|mesh-ancestor
14492674|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
14492675|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492676|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14492677|NCT02687815|Vitamin D|vitamin d|mesh-list
14492678|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
14492679|NCT02687815|Vitamins|vitamins|mesh-ancestor
14492680|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
14492681|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492682|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14492683|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14492684|NCT02688387|Ambrisentan|ambrisentan|mesh-list
14492685|NCT02688387|Tadalafil|tadalafil|mesh-list
14492686|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
14492687|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14198548|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198549|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14198550|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14198551|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14198552|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198553|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198554|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14198555|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14198556|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14198557|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14198558|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14198559|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14198560|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
14198561|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
14492688|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14492689|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492690|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492691|NCT02688387|Urological Agents|urological agents|mesh-ancestor
14492692|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14492693|NCT02688556|Cyclosporine|cyclosporine|mesh-list
14492694|NCT02688556|Cyclosporins|cyclosporins|mesh-list
14492695|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492696|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492697|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14492698|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
14492699|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492700|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
14492701|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492702|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
14492703|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492704|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14492705|NCT02688764|Calcium|calcium|mesh-list
14492706|NCT02688764|Calcium acetate|calcium acetate|mesh-list
14492707|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14492708|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772090|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772091|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14772092|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963933|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13963934|NCT03140943|Growth Substances|growth substances|mesh-ancestor
13963935|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
13968012|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968013|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13968014|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968015|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13968016|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
13968017|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
13968018|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198562|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
14198563|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198564|NCT04571437|Capecitabine|capecitabine|mesh-list
14198565|NCT04571437|Letrozole|letrozole|mesh-list
14198566|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14198567|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
14198568|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198569|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492709|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
14492710|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
14492711|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492712|NCT02688829|Sirolimus|sirolimus|mesh-list
14492713|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14492714|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492715|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14492716|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492717|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
14492718|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14492719|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
14492720|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492721|NCT02688842|Sirolimus|sirolimus|mesh-list
14492722|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14492723|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492724|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14492725|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492726|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
14492727|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14492728|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
14492729|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528060|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14528061|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
14528062|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14528063|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14528064|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528065|NCT03927781|Pregabalin|pregabalin|mesh-list
14528066|NCT03927781|Analgesics|analgesics|mesh-ancestor
14528067|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
14528068|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528069|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528070|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
14528071|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14528072|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528073|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528074|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14528075|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14528076|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14528077|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528078|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14528079|NCT03905811|Terazosin|terazosin|mesh-list
14528080|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14528081|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14528082|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14528083|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
14528084|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528085|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528086|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198570|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14528087|NCT03905811|Urological Agents|urological agents|mesh-ancestor
14528088|NCT03895307|Anesthetics|anesthetics|mesh-list
14528089|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
14528090|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528091|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528092|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
14528093|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528094|NCT03905642|Amikacin|amikacin|mesh-list
14528095|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14528096|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528097|NCT03892889|Aripiprazole|aripiprazole|mesh-list
14528098|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
14528099|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14528100|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14528101|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14528102|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528103|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528104|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
14198571|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14198572|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198573|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14198574|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
14198575|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14198576|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198577|NCT04571489|Gemcitabine|gemcitabine|mesh-list
14198578|NCT04571489|Tegafur|tegafur|mesh-list
14492730|NCT02689063|Acetaminophen|acetaminophen|mesh-list
14492731|NCT02689063|Ibuprofen|ibuprofen|mesh-list
14492732|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14492733|NCT02689063|Analgesics|analgesics|mesh-ancestor
14492734|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
14492735|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492736|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492737|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
14492738|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14492739|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492740|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492741|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14492742|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492743|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492744|NCT02689206|Glycine|glycine|mesh-list
14492745|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
14492746|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492747|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492748|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492749|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14492750|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492751|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492752|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
14492753|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
14492754|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
14198579|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14198580|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
14198581|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198582|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198583|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
14198584|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198585|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198586|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198587|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
14198588|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198589|NCT04571996|Acetaminophen|acetaminophen|mesh-list
14198590|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198591|NCT04571996|Analgesics|analgesics|mesh-ancestor
14198592|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
14198593|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198594|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198595|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
14198596|NCT04571580|Reteplase|reteplase|mesh-list
14198597|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14198598|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14492755|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
14492756|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14492757|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492758|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14492759|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14492760|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14492761|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14492762|NCT02690558|Gemcitabine|gemcitabine|mesh-list
14198599|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14198600|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198601|NCT04571606|Bupivacaine|bupivacaine|mesh-list
14198602|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
14198603|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
14198604|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198605|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198606|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
14198607|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198608|NCT04571164|Rotigotine|rotigotine|mesh-list
14198609|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
14198610|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
14492763|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
14492764|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492765|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14492766|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
14492767|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492768|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
14492769|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492770|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198611|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492771|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198612|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492772|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
14492773|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492774|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492775|NCT02690714|Plasminogen|plasminogen|mesh-list
14492776|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14492777|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14492778|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492779|NCT02690727|Tenalisib|tenalisib|mesh-list
14492780|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
14492781|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492782|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492783|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
14492784|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14492785|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492786|NCT02690974|Valsartan|valsartan|mesh-list
14492787|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14492788|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14492789|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14492790|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14492791|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492792|NCT02691416|Propofol|propofol|mesh-list
14492793|NCT02691416|Sevoflurane|sevoflurane|mesh-list
14492794|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14492795|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492796|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492797|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14492798|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
14492799|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
14492800|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14492801|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14492802|NCT02691468|Silicon|silicon|mesh-list
14492803|NCT02691468|Trace Elements|trace elements|mesh-ancestor
14492804|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
14492805|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492806|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14492807|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14492808|NCT02691494|Norethindrone|norethindrone|mesh-list
14492809|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
14492810|NCT02691494|Estradiol|estradiol|mesh-list
14492811|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14492812|NCT02691494|Estrogens|estrogens|mesh-ancestor
14492813|NCT02691494|Hormones|hormones|mesh-ancestor
14492814|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492815|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492816|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14492817|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
14492818|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14492819|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14492820|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14198613|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198614|NCT04571151|Halobetasol|halobetasol|mesh-list
14198615|NCT04571151|Calcipotriene|calcipotriene|mesh-list
14198616|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
14198617|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14238987|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14238988|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14238989|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14238990|NCT00137436|Prednisone|prednisone|mesh-list
14238991|NCT00137436|Docetaxel|docetaxel|mesh-list
14238992|NCT00137436|Sunitinib|sunitinib|mesh-list
14238993|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14238994|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14238995|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14238996|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
14238997|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492821|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14492822|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14492823|NCT02691507|Decanoic acid|decanoic acid|mesh-list
14492824|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
14940516|NCT01493843|Carboplatin|carboplatin|mesh-list
14940517|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14940518|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940519|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
14940520|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
14940521|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
14940522|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940523|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14940524|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14940525|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14940526|NCT01493843|Growth Substances|growth substances|mesh-ancestor
14940527|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940528|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
15026681|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
15026682|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026683|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026684|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15026685|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15026686|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
15026687|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
15026688|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026689|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15026690|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15026691|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026692|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026693|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15026694|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15026695|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15026696|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026697|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026698|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
15026699|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
15026700|NCT01945099|Insulin|insulin|mesh-list
15026701|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15026702|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026703|NCT01945268|Vaccines|vaccines|mesh-list
15026704|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
15026705|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034846|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034847|NCT01997762|Protective Agents|protective agents|mesh-ancestor
15034848|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034849|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034850|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15034851|NCT01997775|Metformin|metformin|mesh-list
15034852|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15034853|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034854|NCT01997788|Morphine|morphine|mesh-list
15034855|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15034856|NCT01997788|Narcotics|narcotics|mesh-ancestor
15034857|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034858|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034859|NCT01997788|Analgesics|analgesics|mesh-ancestor
15034860|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
15034861|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034862|NCT01997801|Ketamine|ketamine|mesh-list
15034863|NCT01997801|Analgesics|analgesics|mesh-ancestor
15034864|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
15034865|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034866|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034867|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14492825|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492826|NCT02691572|Acetaminophen|acetaminophen|mesh-list
14492827|NCT02691572|Ketorolac|ketorolac|mesh-list
14492828|NCT02691572|Fentanyl|fentanyl|mesh-list
14492829|NCT02691572|Bupivacaine|bupivacaine|mesh-list
14492830|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
14492831|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
14492832|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492833|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492834|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
14492835|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772093|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
14772094|NCT00648414|Fentanyl|fentanyl|mesh-list
14772095|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14772096|NCT00648414|Narcotics|narcotics|mesh-ancestor
14772097|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772098|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198618|NCT04571229|Mifamurtide|mifamurtide|mesh-list
14198619|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14198620|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
14198621|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198622|NCT04570956|Tamoxifen|tamoxifen|mesh-list
14198623|NCT04570956|Afimoxifene|afimoxifene|mesh-list
14198624|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14198625|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
14198626|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772099|NCT00648414|Analgesics|analgesics|mesh-ancestor
14772100|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
14772101|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772102|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14772103|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14772104|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
14772105|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
14772106|NCT00648427|Paroxetine|paroxetine|mesh-list
14772107|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14772108|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772109|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940529|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14772110|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772111|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772112|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
14772113|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772114|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14772115|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
14772116|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772117|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14772118|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14772119|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772120|NCT00648440|Midodrine|midodrine|mesh-list
14772121|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
14772122|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
14772123|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772124|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772125|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14772126|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14772127|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14772128|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14772129|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772130|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772131|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772132|NCT00648453|Clopidogrel|clopidogrel|mesh-list
14940530|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14198627|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198628|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14198629|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198630|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14198631|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14198632|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14198633|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
14238998|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14238999|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
14239000|NCT00137436|Hormones|hormones|mesh-ancestor
14239001|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239002|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239003|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239004|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14239005|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14239006|NCT00137436|Growth Substances|growth substances|mesh-ancestor
14239007|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
14239008|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14239009|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239010|NCT00137449|Sunitinib|sunitinib|mesh-list
14239011|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239012|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14198634|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14198635|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198636|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14492836|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492837|NCT02691572|Narcotics|narcotics|mesh-ancestor
14492838|NCT02691572|Analgesics|analgesics|mesh-ancestor
14492839|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14492840|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14492841|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
14198637|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198638|NCT04570592|Dexamethasone|dexamethasone|mesh-list
14198639|NCT04570592|Granisetron|granisetron|mesh-list
14198640|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14198641|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198642|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
14198643|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
14198644|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198645|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198646|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14198647|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
14198648|NCT04570592|Hormones|hormones|mesh-ancestor
14198649|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14198650|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14198651|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198652|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14198653|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
14198654|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198655|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198656|NCT04570475|Vitamin D|vitamin d|mesh-list
14198657|NCT04570475|Vitamins|vitamins|mesh-ancestor
14198658|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
14198659|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198660|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14198661|NCT04570683|Nivolumab|nivolumab|mesh-list
14198662|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14198663|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198664|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14198665|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198666|NCT04570449|Fluoxetine|fluoxetine|mesh-list
14198667|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14198668|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14198669|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198670|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198671|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198672|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
14198673|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198674|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14198675|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
14198676|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14492842|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14492843|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
14492844|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14492845|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492846|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492847|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14492848|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492849|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492850|NCT02691702|Melatonin|melatonin|mesh-list
14492851|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
14492852|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772133|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14772134|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14772135|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14772136|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14772137|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
14492853|NCT02691702|Protective Agents|protective agents|mesh-ancestor
14492854|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492855|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492856|NCT02691936|Estrogens|estrogens|mesh-list
14492857|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14492858|NCT02691936|Hormones|hormones|mesh-ancestor
14492859|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492860|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492861|NCT02692391|Indomethacin|indomethacin|mesh-list
14492862|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14492863|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14492864|NCT02692391|Analgesics|analgesics|mesh-ancestor
14492865|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
14492866|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198677|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14198678|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14198679|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492867|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492868|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492869|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492870|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
14492871|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
14772138|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492872|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14492873|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14492874|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492875|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492876|NCT02692755|Letrozole|letrozole|mesh-list
14492877|NCT02692755|Fulvestrant|fulvestrant|mesh-list
14492878|NCT02692755|Palbociclib|palbociclib|mesh-list
14492879|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198680|NCT04570410|Gemcitabine|gemcitabine|mesh-list
14198681|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198682|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14198683|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
14198684|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198685|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
14198686|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492880|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14492881|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14492882|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492883|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492884|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14492885|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14492886|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492887|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492888|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14492889|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14492890|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14492891|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14492892|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14492893|NCT02694328|Olanzapine|olanzapine|mesh-list
14492894|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
14772139|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492895|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
14492896|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492897|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492898|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14492899|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14492900|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14198687|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198688|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198689|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
14198690|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198691|NCT04570397|Ravulizumab|ravulizumab|mesh-list
14198692|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14198693|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198694|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
14198695|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198696|NCT04570345|Aspirin|aspirin|mesh-list
14198697|NCT04570345|Ticagrelor|ticagrelor|mesh-list
14198698|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14198699|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198700|NCT04570345|Analgesics|analgesics|mesh-ancestor
14198701|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
14198702|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198703|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198704|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198705|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198706|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14198707|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14198708|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492901|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492902|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14492903|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14492904|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14492905|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492906|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492907|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492908|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
14492909|NCT02694523|Adalimumab|adalimumab|mesh-list
14492910|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14492911|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492912|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492913|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
14492914|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492915|NCT02694536|Gemcitabine|gemcitabine|mesh-list
14492916|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14492917|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14492918|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
14492919|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492920|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492921|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
14492922|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492923|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492924|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14492925|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
14492926|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492927|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14198709|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14198710|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14198711|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198712|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
14198713|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14198714|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14492928|NCT02694601|Caffeine|caffeine|mesh-list
14492929|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14492930|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492931|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14492932|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492933|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492934|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14772140|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772141|NCT00648466|Sumatriptan|sumatriptan|mesh-list
14772142|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14198715|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14492935|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14940531|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14940532|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14940533|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940534|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
14940535|NCT01493973|Hematinics|hematinics|mesh-ancestor
14940536|NCT01493986|Ropivacaine|ropivacaine|mesh-list
14940537|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
14492936|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
14492937|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14492938|NCT02694718|Capecitabine|capecitabine|mesh-list
14772143|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14772144|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14772145|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
14772146|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772147|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772148|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772149|NCT00648492|Metformin|metformin|mesh-list
14772150|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772151|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772152|NCT00648505|Metformin|metformin|mesh-list
14772153|NCT00648505|Glipizide|glipizide|mesh-list
14772154|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772155|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772156|NCT00648518|Metformin|metformin|mesh-list
14772157|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772158|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772159|NCT00648531|Balsalazide|balsalazide|mesh-list
14772160|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14772161|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14772162|NCT00648531|Analgesics|analgesics|mesh-ancestor
14198716|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
14198717|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198718|NCT04570293|Lidocaine|lidocaine|mesh-list
14198719|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
14198720|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
14198721|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198722|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198723|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
14198724|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772163|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
14772164|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772165|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772166|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772167|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772168|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14807298|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807299|NCT00820963|Temozolomide|temozolomide|mesh-list
14807300|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14807301|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
14807302|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807303|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807304|NCT00821028|Paclitaxel|paclitaxel|mesh-list
14198725|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14198726|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14198727|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14492939|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
14807305|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14807306|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807307|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807308|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14807309|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14807310|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807311|NCT00821054|Lapatinib|lapatinib|mesh-list
14492940|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14492941|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
14492942|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492943|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492944|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14492945|NCT02694978|Hematinics|hematinics|mesh-ancestor
14492946|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14492947|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14807312|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940538|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
14492948|NCT02695290|Afatinib|afatinib|mesh-list
14492949|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492950|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14492951|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14492952|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492953|NCT02695446|Minocycline|minocycline|mesh-list
14492954|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14492955|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492956|NCT02695537|Cannabidiol|cannabidiol|mesh-list
14492957|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
14492958|NCT02695628|Misonidazole|misonidazole|mesh-list
14492959|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14492960|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14492961|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14492962|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14492963|NCT02695719|Lubiprostone|lubiprostone|mesh-list
14492964|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14492965|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14492966|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14492967|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14492968|NCT02696434|Naltrexone|naltrexone|mesh-list
14492969|NCT02696434|Buprenorphine|buprenorphine|mesh-list
14492970|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14492971|NCT02696434|Narcotics|narcotics|mesh-ancestor
14492972|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14492973|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492974|NCT02696434|Analgesics|analgesics|mesh-ancestor
14492975|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
14492976|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492977|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14492978|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14492979|NCT02696785|Adalimumab|adalimumab|mesh-list
14492980|NCT02696785|Ixekizumab|ixekizumab|mesh-list
14492981|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492982|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14492983|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14492984|NCT02696798|Ixekizumab|ixekizumab|mesh-list
14492985|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
14492986|NCT02696850|Budesonide|budesonide|mesh-list
14198728|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14198729|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198730|NCT04570254|Vitamins|vitamins|mesh-list
14198731|NCT04570254|Vitamin E|vitamin e|mesh-list
14492987|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14492988|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14492989|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
14492990|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14492991|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14492992|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14492993|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
14492994|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
14492995|NCT02696850|Hormones|hormones|mesh-ancestor
14492996|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14492997|NCT02697071|Ketamine|ketamine|mesh-list
14492998|NCT02697071|Analgesics|analgesics|mesh-ancestor
14492999|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
14198732|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
14198733|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
14198734|NCT04570254|Melatonin|melatonin|mesh-list
14198735|NCT04570254|Antioxidants|antioxidants|mesh-list
14198736|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14198737|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
14198738|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198739|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198740|NCT04570254|Protective Agents|protective agents|mesh-ancestor
14198741|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198742|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14198743|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198744|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14198745|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14198746|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
14198747|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14198748|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
14493000|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198749|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198750|NCT04570254|Expectorants|expectorants|mesh-ancestor
14493001|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493002|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14493003|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14493004|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
14493005|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
14493006|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493007|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14493008|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14493009|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493010|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772169|NCT00648544|Pravastatin|pravastatin|mesh-list
14772170|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14772171|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14772172|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
14772173|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772174|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14772175|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14772176|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772177|NCT00648570|Dexetimide|dexetimide|mesh-list
14198751|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
14198752|NCT04570254|Antidotes|antidotes|mesh-ancestor
14198753|NCT04570150|Neostigmine|neostigmine|mesh-list
14198754|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14198755|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198756|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198757|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
14198758|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198759|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198760|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14198761|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
14940539|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940540|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940541|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
14940542|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198762|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198763|NCT04570306|Belimumab|belimumab|mesh-list
14198764|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198765|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
14198766|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198767|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
14198768|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14198769|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198770|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14198771|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14198772|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
14198773|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198774|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772178|NCT00648570|Citalopram|citalopram|mesh-list
14772179|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14493011|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
14493012|NCT02697188|Testosterone|testosterone|mesh-list
14493013|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
14493014|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
14493015|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14493016|NCT02697188|Androgens|androgens|mesh-ancestor
14493017|NCT02697188|Hormones|hormones|mesh-ancestor
14772180|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772181|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772182|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772183|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940543|NCT01493999|Clopidogrel|clopidogrel|mesh-list
14198775|NCT04569877|Molgramostim|molgramostim|mesh-list
14198776|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14198777|NCT04569877|Sargramostim|sargramostim|mesh-list
14198778|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198779|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
14198780|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198781|NCT04569916|Irinotecan|irinotecan|mesh-list
14198782|NCT04569916|Apatinib|apatinib|mesh-list
14198783|NCT04569916|Antibodies|antibodies|mesh-list
14198784|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
14198785|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198786|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14493018|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493019|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198787|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14772184|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
14198788|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940544|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14198789|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198790|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198791|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14198792|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
14198793|NCT04569890|Prednisone|prednisone|mesh-list
14198794|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
14198795|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493020|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14493021|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493022|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
14493023|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
14493024|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14493025|NCT02697292|Antibodies|antibodies|mesh-list
14493026|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
14493027|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14493028|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
14493029|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493030|NCT02697617|Pioglitazone|pioglitazone|mesh-list
14493031|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493032|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493033|NCT02697773|Tanezumab|tanezumab|mesh-list
14493034|NCT02697773|Analgesics|analgesics|mesh-ancestor
14493035|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
14493036|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493037|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493038|NCT02697916|Aspirin|aspirin|mesh-list
14493039|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14493040|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14493041|NCT02697916|Analgesics|analgesics|mesh-ancestor
14493042|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
14493043|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493044|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493045|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493046|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493047|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14493048|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14493049|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493050|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14493051|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14493052|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493053|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
14528105|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
14528106|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198796|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
14198797|NCT04569890|Hormones|hormones|mesh-ancestor
14198798|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14198799|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198800|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14528107|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528108|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14528109|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14528110|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
14528111|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14528112|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14528113|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14528114|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14528115|NCT03921723|Dolutegravir|dolutegravir|mesh-list
14528116|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14528117|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14528118|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528119|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528120|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14528121|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14528122|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
14528123|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528124|NCT03921190|Anesthetics|anesthetics|mesh-list
14528125|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528126|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528127|NCT03920865|Risdiplam|risdiplam|mesh-list
14528128|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14528129|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528130|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493054|NCT02698215|Naltrexone|naltrexone|mesh-list
14493055|NCT02698215|Varenicline|varenicline|mesh-list
14493056|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14493057|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14493058|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493059|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
14493060|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493061|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14493062|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14493063|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
14493064|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493065|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493066|NCT02698410|Temozolomide|temozolomide|mesh-list
14493067|NCT02698410|Lanreotide|lanreotide|mesh-list
14493068|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14493069|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
14493070|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493071|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493072|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14493073|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493074|NCT02698475|Ustekinumab|ustekinumab|mesh-list
14198801|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198802|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
14198803|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14198804|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14198805|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198806|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198807|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198808|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493075|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493076|NCT02698566|Ranibizumab|ranibizumab|mesh-list
14493077|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14493078|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14493079|NCT02698566|Growth Substances|growth substances|mesh-ancestor
14493080|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493081|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
14493082|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493083|NCT02698735|Gentamicins|gentamicins|mesh-list
14493084|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14493085|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493086|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14493087|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493088|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493089|NCT02699099|Vitamin A|vitamin a|mesh-list
14493090|NCT02699099|Vaccines|vaccines|mesh-list
14493091|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
14493092|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493093|NCT02699099|Vitamins|vitamins|mesh-ancestor
14493094|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
14940545|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14940546|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14940547|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13963936|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
13963937|NCT03140553|Carboplatin|carboplatin|mesh-list
13963938|NCT03140553|Docetaxel|docetaxel|mesh-list
13963939|NCT03140553|Trastuzumab|trastuzumab|mesh-list
13963940|NCT03140553|Epirubicin|epirubicin|mesh-list
14493095|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14772185|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772186|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14772187|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
14772188|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772189|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14772190|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14772191|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
13963941|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963942|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
13963943|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963944|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13963945|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13963946|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
13963947|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963948|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963949|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13963950|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
13963951|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
14940548|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14198809|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198810|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
14198811|NCT04569994|Insulin|insulin|mesh-list
14198812|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14198813|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198814|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
14198815|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14198816|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493096|NCT02699125|Guanfacine|guanfacine|mesh-list
14493097|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14493098|NCT02699125|Diuretics|diuretics|mesh-ancestor
14493099|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
14493100|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493101|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14493102|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493103|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493104|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14493105|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14493106|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14493107|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
14493108|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493109|NCT02699450|Ranibizumab|ranibizumab|mesh-list
14493110|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14493111|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14493112|NCT02699450|Growth Substances|growth substances|mesh-ancestor
14493113|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493114|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14493115|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493116|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14493117|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14493118|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14493119|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493120|NCT02699892|Rituximab|rituximab|mesh-list
14493121|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493122|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493123|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
14493124|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493125|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493126|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
14493127|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14493128|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493129|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493130|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493131|NCT02700412|Cannabidiol|cannabidiol|mesh-list
14493132|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
14493133|NCT02700815|Diclofenac|diclofenac|mesh-list
14493134|NCT02700815|Capsaicin|capsaicin|mesh-list
14493135|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14493136|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14493137|NCT02700815|Analgesics|analgesics|mesh-ancestor
14493138|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
14493139|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493140|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493141|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493142|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493143|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14493144|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940549|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
14940550|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940551|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940552|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940553|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14940554|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14940555|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940556|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14493145|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493146|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
14493147|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493148|NCT02701062|Warfarin|warfarin|mesh-list
14198817|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14198818|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239013|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14239014|NCT00137449|Growth Substances|growth substances|mesh-ancestor
14239015|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239016|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
14493149|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
14493150|NCT02701062|Dabigatran|dabigatran|mesh-list
14493151|NCT02701062|Apixaban|apixaban|mesh-list
14493152|NCT02701062|Anticoagulants|anticoagulants|mesh-list
14493153|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14493154|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
14493155|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14493156|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
14493157|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493158|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493159|NCT02701257|Glucagon|glucagon|mesh-list
14493160|NCT02701257|Pancrelipase|pancrelipase|mesh-list
14493161|NCT02701257|Pancreatin|pancreatin|mesh-list
14493162|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14493163|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493164|NCT02701257|Hormones|hormones|mesh-ancestor
14493165|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493166|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493167|NCT02701257|Incretins|incretins|mesh-ancestor
14493168|NCT02701296|Epinephrine|epinephrine|mesh-list
14493169|NCT02701296|Ropivacaine|ropivacaine|mesh-list
14493170|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
14493171|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
14493172|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493173|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493174|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
14493175|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493176|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14493177|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14493178|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
14493179|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493180|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493181|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14493182|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14493183|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
14493184|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14493185|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
14493186|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
14772192|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
14772193|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772194|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14772195|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14772196|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772197|NCT00648583|Ondansetron|ondansetron|mesh-list
14772198|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
14772199|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
14772200|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239017|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14239018|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239019|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239020|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14239021|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239022|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14239023|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239024|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493187|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
14493188|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14493189|NCT02701400|Durvalumab|durvalumab|mesh-list
14493190|NCT02701400|Ipilimumab|ipilimumab|mesh-list
14493191|NCT02701400|Tremelimumab|tremelimumab|mesh-list
14493192|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493193|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493194|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14493195|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493196|NCT02701582|Phenylephrine|phenylephrine|mesh-list
14493197|NCT02701582|Epinephrine|epinephrine|mesh-list
14493198|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
14940557|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14940558|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14940559|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
14940560|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940561|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14493199|NCT02701582|Synephrine|synephrine|mesh-list
14493200|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14493201|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14493202|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
14493203|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493204|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493205|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493206|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14493207|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14493208|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
14493209|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493210|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14493211|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
14493212|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
14493213|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
14493214|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14493215|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14493216|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
14493217|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14493218|NCT02701582|Protective Agents|protective agents|mesh-ancestor
14493219|NCT02701764|Pregabalin|pregabalin|mesh-list
14493220|NCT02701764|Analgesics|analgesics|mesh-ancestor
14493221|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
14493222|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493223|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493224|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
14493225|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14493226|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493227|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493228|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14493229|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14493230|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14493231|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493232|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493233|NCT02702011|Empagliflozin|empagliflozin|mesh-list
14493234|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14493235|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493236|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493237|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493238|NCT02702388|Lenvatinib|lenvatinib|mesh-list
14493239|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493240|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14772201|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772202|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772203|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
14772204|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
14772205|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14772206|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
14772207|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772208|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940562|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14198819|NCT04569214|PAZ320|paz320|mesh-list
14198820|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14198821|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198822|NCT04569279|Warfarin|warfarin|mesh-list
14198823|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
14493241|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198824|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
14198825|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14198826|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
14198827|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14198828|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
14198829|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198830|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198831|NCT04568863|Melatonin|melatonin|mesh-list
14198832|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
14198833|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198834|NCT04568863|Protective Agents|protective agents|mesh-ancestor
14493242|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493243|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
14493244|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493245|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493246|NCT02703259|Acetaminophen|acetaminophen|mesh-list
14493247|NCT02703259|Celecoxib|celecoxib|mesh-list
14493248|NCT02703259|Gabapentin|gabapentin|mesh-list
14493249|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198835|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198836|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198837|NCT04568772|Atovaquone|atovaquone|mesh-list
14198838|NCT04568772|Proguanil|proguanil|mesh-list
14198839|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14198840|NCT04568772|Esomeprazole|esomeprazole|mesh-list
14198841|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14198842|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14198843|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14198844|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198845|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198846|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198847|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
14198848|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14198849|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14198850|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
14198851|NCT04568603|Islatravir|islatravir|mesh-list
14198852|NCT04568603|Methadone|methadone|mesh-list
14198853|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14198854|NCT04568603|Narcotics|narcotics|mesh-ancestor
14198855|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198856|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198857|NCT04568603|Analgesics|analgesics|mesh-ancestor
14198858|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
14493250|NCT02703259|Analgesics|analgesics|mesh-ancestor
14493251|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
14493252|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493253|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493254|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
14493255|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14493256|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493257|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493258|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14493259|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14493260|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493261|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772209|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14198859|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198860|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
14198861|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
14198862|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
14198863|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198864|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198865|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198866|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14198867|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14198868|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14198869|NCT04568876|Palmidrol|palmidrol|mesh-list
14198870|NCT04568876|Analgesics|analgesics|mesh-ancestor
14198871|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
14493262|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
14772210|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772211|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772212|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772213|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14772214|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
14198872|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198873|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198874|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14198875|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14198876|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198877|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493263|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14493264|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14493265|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493266|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493267|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14493268|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14493269|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493270|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
14493271|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
14493272|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493273|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493274|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
14493275|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493276|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493277|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
14493278|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493279|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493280|NCT02703636|Rivastigmine|rivastigmine|mesh-list
14493281|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14493282|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493283|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493284|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14493285|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198878|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
14198879|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198880|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14198881|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14198882|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198883|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198884|NCT04568876|Hormones|hormones|mesh-ancestor
14198885|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14198886|NCT04568837|Dexamethasone|dexamethasone|mesh-list
14198887|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
14198888|NCT04568837|Prednisone|prednisone|mesh-list
14198889|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14198890|NCT04568837|BB 1101|bb 1101|mesh-list
14198891|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198892|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
14198893|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
14198894|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198895|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198896|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14198897|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
14198898|NCT04568837|Hormones|hormones|mesh-ancestor
14493286|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493287|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14493288|NCT02703636|Protective Agents|protective agents|mesh-ancestor
14493289|NCT02703779|Plerixafor|plerixafor|mesh-list
14493290|NCT02703779|Bortezomib|bortezomib|mesh-list
14493291|NCT02703779|Lenograstim|lenograstim|mesh-list
14493292|NCT02703779|Sargramostim|sargramostim|mesh-list
14493293|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14493294|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
14493295|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493296|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493297|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14772215|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
14198899|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493298|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14940563|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940564|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
14940565|NCT01494155|Capecitabine|capecitabine|mesh-list
15026706|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
14198900|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14198901|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198902|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
14198903|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198904|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198905|NCT04568265|Entecavir|entecavir|mesh-list
14198906|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
14198907|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198908|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14198909|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
15026707|NCT01945437|Analgesics|analgesics|mesh-ancestor
15026708|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
15026709|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026710|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026711|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
15026712|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026713|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15026714|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
14198910|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198911|NCT04568304|Gemcitabine|gemcitabine|mesh-list
14198912|NCT04568304|Carboplatin|carboplatin|mesh-list
14198913|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198914|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14198915|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
14198916|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198917|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
14198918|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14198919|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198920|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198921|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
14198922|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198923|NCT04568096|Tamoxifen|tamoxifen|mesh-list
14198924|NCT04568096|Tretinoin|tretinoin|mesh-list
14198925|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14198926|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
14198927|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14198928|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239025|NCT00137969|Acetaminophen|acetaminophen|mesh-list
14239026|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
14239027|NCT00137969|Promethazine|promethazine|mesh-list
14239028|NCT00137969|Prednisone|prednisone|mesh-list
14239029|NCT00137969|Rituximab|rituximab|mesh-list
14239030|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239031|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239032|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
14239033|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239034|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239035|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239036|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
14239037|NCT00137969|Hormones|hormones|mesh-ancestor
14239038|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239039|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239040|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14239041|NCT00137969|Analgesics|analgesics|mesh-ancestor
14239042|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
14239043|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239044|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
14239045|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14239046|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14239047|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14239048|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
14239049|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
14239050|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
14239051|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
14493299|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
14493300|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493301|NCT02703909|Rocuronium|rocuronium|mesh-list
14493302|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14493303|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14493304|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14493305|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493306|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493307|NCT02703948|Lidocaine|lidocaine|mesh-list
14493308|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
14493309|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
14493310|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493311|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493312|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
14493313|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493314|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14493315|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14493316|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14493317|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493318|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493319|NCT02704104|Hemostatics|hemostatics|mesh-list
14493320|NCT02704104|Coagulants|coagulants|mesh-ancestor
14493321|NCT02704156|Gemcitabine|gemcitabine|mesh-list
14493322|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
14493323|NCT02704156|Trametinib|trametinib|mesh-list
14493324|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14493325|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
14493326|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493327|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493328|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
14493329|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493330|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493331|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14493332|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
14493333|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493334|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493335|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14493336|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14493337|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14493338|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14493339|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
14493340|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493341|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14493342|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14493343|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493344|NCT02705105|Nivolumab|nivolumab|mesh-list
14493345|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
14493346|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493347|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493348|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14493349|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772216|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14772217|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14772218|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772219|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772220|NCT00648596|Urological Agents|urological agents|mesh-ancestor
14772221|NCT00648622|Carvedilol|carvedilol|mesh-list
14772222|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14772223|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14772224|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772225|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772226|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772227|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772228|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772229|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
14772230|NCT00648622|Protective Agents|protective agents|mesh-ancestor
14772231|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14772232|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772233|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14772234|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
14772235|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14772236|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14772237|NCT00648661|Dexetimide|dexetimide|mesh-list
14493350|NCT02705352|Fluorouracil|fluorouracil|mesh-list
14493351|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
14493352|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493353|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14493354|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493355|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14493356|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
14493357|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493358|NCT02705716|Fluorides|fluorides|mesh-list
14493359|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
14493360|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
14493361|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
14493362|NCT02705716|Protective Agents|protective agents|mesh-ancestor
14493363|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493364|NCT02705807|Epoprostenol|epoprostenol|mesh-list
14493365|NCT02705807|Tezosentan|tezosentan|mesh-list
14493366|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14493367|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14493368|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
14493369|NCT02706249|Enoxaparin|enoxaparin|mesh-list
14493370|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
14493371|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14493372|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14493373|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493374|NCT02706483|Plecanatide|plecanatide|mesh-list
14493375|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14493376|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
14493377|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198929|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14198930|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198931|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14198932|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14198933|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14198934|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
14198935|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
14198936|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
14198937|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14198938|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
14198939|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198940|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14198941|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14198942|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
14198943|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198944|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198945|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14198946|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14198947|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
14198948|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
14198949|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
14198950|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14198951|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
14198952|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14198953|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198954|NCT04567290|Ticagrelor|ticagrelor|mesh-list
14198955|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14198956|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14198957|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14198958|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14198959|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
14198960|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493378|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493379|NCT02706873|Methotrexate|methotrexate|mesh-list
14493380|NCT02706873|Upadacitinib|upadacitinib|mesh-list
14493381|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14493382|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
14493383|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14493384|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493385|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14493386|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
14493387|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493388|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493389|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493390|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493391|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14493392|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14493393|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
14493394|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493395|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14493396|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14493397|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14493398|NCT02706899|Azacitidine|azacitidine|mesh-list
14493399|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14493400|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
14493401|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772238|NCT00648661|Citalopram|citalopram|mesh-list
14772239|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14772240|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772241|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772242|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772243|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772244|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
14772245|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198961|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198962|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198963|NCT04567108|Benzocaine|benzocaine|mesh-list
14198964|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
14198965|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
14198966|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14198967|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198968|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
14198969|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14198970|NCT04566952|Olaparib|olaparib|mesh-list
14198971|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14198972|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772246|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14772247|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
14772248|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772249|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14772250|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14772251|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
14772252|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
14772253|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772254|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14772255|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14772256|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772257|NCT00648713|Terbinafine|terbinafine|mesh-list
14772258|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
14772259|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772260|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772261|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772262|NCT00648726|Azithromycin|azithromycin|mesh-list
14772263|NCT00648726|Erythromycin|erythromycin|mesh-list
14772264|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
14772265|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14772266|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
14772267|NCT00648726|Cefuroxime|cefuroxime|mesh-list
14772268|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
14772269|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772270|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772271|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772272|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14772273|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772274|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772275|NCT00648765|Anagrelide|anagrelide|mesh-list
14772276|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14772277|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14198973|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198974|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14198975|NCT04567069|Vaccines|vaccines|mesh-list
14198976|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
14198977|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198978|NCT04566796|Neostigmine|neostigmine|mesh-list
14198979|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14493402|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493403|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772278|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772279|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14493404|NCT02706951|Methotrexate|methotrexate|mesh-list
14493405|NCT02706951|Upadacitinib|upadacitinib|mesh-list
14493406|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14493407|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
14493408|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14493409|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493410|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14493411|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
14493412|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198980|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14198981|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198982|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
14198983|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14198984|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198985|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14198986|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
14198987|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239052|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239053|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14239054|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
14239055|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
14239056|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239057|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239058|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14239059|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
14239060|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14239061|NCT00138125|Trastuzumab|trastuzumab|mesh-list
14239062|NCT00138125|Fulvestrant|fulvestrant|mesh-list
14239063|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239064|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493413|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493414|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493415|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493416|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14493417|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14493418|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
14493419|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493420|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14493421|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14493422|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14493423|NCT02707523|Azithromycin|azithromycin|mesh-list
14493424|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14493425|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528131|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14528132|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14528133|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14528134|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528135|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528136|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14528137|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14528138|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14528139|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14528140|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
14528141|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528142|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528143|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14528144|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14528145|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
14528146|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14528147|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14528148|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
14528149|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
14528150|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
14528151|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528152|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528153|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528154|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
14528155|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
14528156|NCT03911843|Vitamin D|vitamin d|mesh-list
14528157|NCT03911843|Vitamins|vitamins|mesh-ancestor
14528158|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
14528159|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239065|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239066|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14493426|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
14493427|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14493428|NCT02707601|Ledipasvir|ledipasvir|mesh-list
14493429|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14940566|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14940567|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
14940568|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14198988|NCT04566770|Vaccines|vaccines|mesh-list
14198989|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
14198990|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198991|NCT04566718|Metformin|metformin|mesh-list
14198992|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14198993|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14198994|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
14198995|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
14198996|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
14198997|NCT04566211|Amoxicillin|amoxicillin|mesh-list
14198998|NCT04566211|Metronidazole|metronidazole|mesh-list
14198999|NCT04566211|Clarithromycin|clarithromycin|mesh-list
14940569|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940570|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
14940571|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14940572|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14940573|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940574|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940575|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940576|NCT01494259|Epinephrine|epinephrine|mesh-list
14199000|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14493430|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
14493431|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493432|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14493433|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14493434|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
14493435|NCT02707640|Pirfenidone|pirfenidone|mesh-list
14493436|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14493437|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
14493438|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493439|NCT02707640|Expectorants|expectorants|mesh-ancestor
14493440|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
14493441|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14493442|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
14493443|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493444|NCT02707640|Protective Agents|protective agents|mesh-ancestor
14493445|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493446|NCT02707640|Antidotes|antidotes|mesh-ancestor
14493447|NCT02707640|Analgesics|analgesics|mesh-ancestor
14493448|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
14493449|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493450|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14493451|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14493452|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493453|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14493454|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493455|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14493456|NCT02707757|Hematinics|hematinics|mesh-ancestor
14493457|NCT02707861|Ibalizumab|ibalizumab|mesh-list
14493458|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14493459|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
14493460|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493461|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14493462|NCT02707952|Ritonavir|ritonavir|mesh-list
14493463|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14493464|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14772280|NCT00648778|Loxapine|loxapine|mesh-list
14772281|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14772282|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772283|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772284|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772285|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772286|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14772287|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
14772288|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199001|NCT04566211|Pantoprazole|pantoprazole|mesh-list
14493465|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
14940577|NCT01494259|Bupivacaine|bupivacaine|mesh-list
14199002|NCT04566211|Bismuth|bismuth|mesh-list
14940578|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
14493466|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493467|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493468|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14493469|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14493470|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
14493471|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493472|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14493473|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14493474|NCT02707965|Topiramate|topiramate|mesh-list
14493475|NCT02707965|Lamotrigine|lamotrigine|mesh-list
14493476|NCT02707965|Zonisamide|zonisamide|mesh-list
14493477|NCT02707965|Carbamazepine|carbamazepine|mesh-list
14493478|NCT02707965|Phenytoin|phenytoin|mesh-list
14493479|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
14493480|NCT02707965|Levetiracetam|levetiracetam|mesh-list
14493481|NCT02707965|Valproic Acid|valproic acid|mesh-list
14493482|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
14493483|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493484|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493485|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
14493486|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14493487|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493488|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493489|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14493490|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14772289|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772290|NCT00648791|Finasteride|finasteride|mesh-list
14772291|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14772292|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14772293|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772294|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772295|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
14772296|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772297|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772298|NCT00648791|Urological Agents|urological agents|mesh-ancestor
14772299|NCT00648804|Ondansetron|ondansetron|mesh-list
14772300|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
14772301|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
14199003|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14199004|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199005|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14199006|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14199007|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14199008|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199009|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239067|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14239068|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
14239069|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239070|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239071|NCT00138203|Vorinostat|vorinostat|mesh-list
14239072|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239073|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14239074|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239075|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239076|NCT00138424|Cidofovir|cidofovir|mesh-list
14239077|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
14239078|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239079|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239080|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239081|NCT00138671|Insulin|insulin|mesh-list
14239082|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14239083|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239084|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239085|NCT00139477|Metformin|metformin|mesh-list
14239086|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239087|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239088|NCT00139659|Insulin|insulin|mesh-list
14239089|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14239090|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239091|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239092|NCT00139737|Ziprasidone|ziprasidone|mesh-list
14239093|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14772302|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772303|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772304|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772305|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
14772306|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
14772307|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14772308|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
14772309|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199010|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14199011|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14199012|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14199013|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199014|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14199015|NCT04566211|Antacids|antacids|mesh-ancestor
14199016|NCT04565847|Albuterol|albuterol|mesh-list
14199017|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14199018|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
14199019|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199020|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199021|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14199022|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
14199023|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
14772310|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772311|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14199024|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14199025|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14199026|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14199027|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14199028|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
14199029|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199030|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199031|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
14199032|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14772312|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772313|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940579|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
14940580|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940581|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940582|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
14199033|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199034|NCT04565301|Dexamethasone|dexamethasone|mesh-list
14199035|NCT04565301|Neostigmine|neostigmine|mesh-list
14199036|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199037|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
14199038|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
14199039|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199040|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199041|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199042|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
14199043|NCT04565301|Hormones|hormones|mesh-ancestor
14199044|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199045|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199046|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199047|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14199048|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199049|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199050|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
14239094|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
14239095|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239096|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239097|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239098|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14239099|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14239100|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14239101|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239102|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14239103|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
14239104|NCT00139776|Celecoxib|celecoxib|mesh-list
14239105|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14239106|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14239107|NCT00139776|Analgesics|analgesics|mesh-ancestor
14239108|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
14239109|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199051|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199052|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14199053|NCT04565431|Natalizumab|natalizumab|mesh-list
14199054|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
14199055|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199056|NCT04565184|Artesunate|artesunate|mesh-list
14199057|NCT04565184|Lumefantrine|lumefantrine|mesh-list
14493491|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14493492|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493493|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493494|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14493495|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
14493496|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14493497|NCT02707965|Analgesics|analgesics|mesh-ancestor
14493498|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
14493499|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493500|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14493501|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14493502|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493503|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
14493504|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493505|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14493506|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14493507|NCT02708238|Simethicone|simethicone|mesh-list
14493508|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
14493509|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493510|NCT02708238|Emollients|emollients|mesh-ancestor
14493511|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493512|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
14493513|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14493514|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493515|NCT02708355|Esomeprazole|esomeprazole|mesh-list
14493516|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14493517|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493518|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14493519|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493520|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493521|NCT02708433|Lidocaine|lidocaine|mesh-list
14493522|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
14493523|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
14493524|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493525|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493526|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
14493527|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493528|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14199058|NCT04565184|Artemether|artemether|mesh-list
14199059|NCT04565184|Amodiaquine|amodiaquine|mesh-list
14199060|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14199061|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
14199062|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
14199063|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14199064|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14199065|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493529|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14493530|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14493531|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493532|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493533|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
14493534|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493535|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493536|NCT02709005|Monolaurin|monolaurin|mesh-list
14493537|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
14493538|NCT02709005|Protective Agents|protective agents|mesh-ancestor
14493539|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493540|NCT02709018|Losartan|losartan|mesh-list
14772314|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14199066|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199067|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
14493541|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14493542|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14493543|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14493544|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14199068|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
14493545|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493546|NCT02709109|Ivacaftor|ivacaftor|mesh-list
13963952|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
14493547|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14493548|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493549|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493550|NCT02709486|Tanezumab|tanezumab|mesh-list
14493551|NCT02709486|Analgesics|analgesics|mesh-ancestor
14493552|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
14493553|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493554|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493555|NCT02709746|Vortioxetine|vortioxetine|mesh-list
14493556|NCT02709746|Fluoxetine|fluoxetine|mesh-list
14493557|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14493558|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14493559|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493560|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493561|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493562|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
14493563|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493564|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14493565|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
14493566|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493567|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14493568|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14493569|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493570|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14493571|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14493572|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493573|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14493574|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14493575|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14493576|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14493577|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
14493578|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14493579|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493580|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
14493581|NCT02709889|Dexamethasone|dexamethasone|mesh-list
14493582|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493583|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
14493584|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
14493585|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493586|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493587|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493588|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
14493589|NCT02709889|Hormones|hormones|mesh-ancestor
14493590|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493591|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14493592|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493593|NCT02710045|Vaccines|vaccines|mesh-list
14493594|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
14493595|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493596|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14493597|NCT02710071|Nebivolol|nebivolol|mesh-list
14493598|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14493599|NCT02710071|Diuretics|diuretics|mesh-ancestor
14493600|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
14493601|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493602|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14493603|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13963953|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493604|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493605|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
14493606|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14493607|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14493608|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14493609|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
14493610|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493611|NCT02710214|Estrogens|estrogens|mesh-list
14493612|NCT02710214|Hormones|hormones|mesh-ancestor
14493613|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493614|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493615|NCT02710526|Buprenorphine|buprenorphine|mesh-list
14493616|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14493617|NCT02710526|Narcotics|narcotics|mesh-ancestor
14493618|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493619|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493620|NCT02710526|Analgesics|analgesics|mesh-ancestor
14493621|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
14493622|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493623|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14493624|NCT02710630|Dabigatran|dabigatran|mesh-list
14493625|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
14493626|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14493627|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
14493628|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493629|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493630|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
14493631|NCT02710669|Propafenone|propafenone|mesh-list
14493632|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14493633|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14493634|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14493635|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493636|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493637|NCT02710890|Lacosamide|lacosamide|mesh-list
14493638|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
14493639|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14493640|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14493641|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493642|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493643|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
14493644|NCT02710981|Clomiphene|clomiphene|mesh-list
14493645|NCT02710981|Enclomiphene|enclomiphene|mesh-list
14493646|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
14493647|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493648|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
14493649|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14493650|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14493651|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493652|NCT02710981|Urological Agents|urological agents|mesh-ancestor
14493653|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14493654|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
14493655|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493656|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493657|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14493658|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
14199069|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14199070|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
14199071|NCT04565171|Yimitasvir|yimitasvir|mesh-list
14199072|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
14199073|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199074|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
14199075|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
14199076|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14199077|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14199078|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
14199079|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199080|NCT04564872|Linagliptin|linagliptin|mesh-list
14199081|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493659|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14493660|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14493661|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14493662|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14199082|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199083|NCT04564872|Incretins|incretins|mesh-ancestor
14199084|NCT04564872|Hormones|hormones|mesh-ancestor
14493663|NCT02711306|Cathartics|cathartics|mesh-ancestor
14493664|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493665|NCT02711553|Gemcitabine|gemcitabine|mesh-list
14493666|NCT02711553|Ramucirumab|ramucirumab|mesh-list
14493667|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772315|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14772316|NCT00648817|Tenofovir|tenofovir|mesh-list
14772317|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
14772318|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772319|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14772320|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14772321|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772322|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772323|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14772324|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14772325|NCT00648830|Clarithromycin|clarithromycin|mesh-list
14772326|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772327|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772328|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14772329|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772330|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772331|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14772332|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14772333|NCT00648843|Oxybutynin|oxybutynin|mesh-list
14772334|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
14772335|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
14772336|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772337|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772338|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14772339|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14199085|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199086|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14199087|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
14199088|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199089|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199090|NCT04564638|Cyclosporine|cyclosporine|mesh-list
14199091|NCT04564638|Cyclosporins|cyclosporins|mesh-list
14199092|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199093|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199094|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199095|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
14199096|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199097|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
14199098|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199099|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
14199100|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14199101|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14199102|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
14199103|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
14239110|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239111|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239112|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239113|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14239114|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14239115|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239116|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239117|NCT00140140|Paclitaxel|paclitaxel|mesh-list
14239118|NCT00140140|Vinorelbine|vinorelbine|mesh-list
14239119|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14239120|NCT00140140|Trastuzumab|trastuzumab|mesh-list
14239121|NCT00140140|Sargramostim|sargramostim|mesh-list
14239122|NCT00140140|Lenograstim|lenograstim|mesh-list
14239123|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14493668|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14493669|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
14493670|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493671|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
14493672|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493673|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493674|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14493675|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
14493676|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493677|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14493678|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
14772340|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
14493679|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14493680|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493681|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493682|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
14493683|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493684|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493685|NCT02711995|Laxatives|laxatives|mesh-ancestor
14493686|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493687|NCT02712008|Aflibercept|aflibercept|mesh-list
14493688|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14493689|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14493690|NCT02712008|Growth Substances|growth substances|mesh-ancestor
14493691|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493692|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
14493693|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493694|NCT02712047|Fluticasone|fluticasone|mesh-list
14493695|NCT02712047|Xhance|xhance|mesh-list
14493696|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493697|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14493698|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
14493699|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493700|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493701|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14493702|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14493703|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493704|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14493705|NCT02712788|Milrinone|milrinone|mesh-list
14493706|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14493707|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14493708|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
14493709|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14493710|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14493711|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493712|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493713|NCT02712788|Protective Agents|protective agents|mesh-ancestor
14772341|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772342|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772343|NCT00648843|Urological Agents|urological agents|mesh-ancestor
14772344|NCT00648856|Sertraline|sertraline|mesh-list
14772345|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
14772346|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772347|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14772348|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772349|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772350|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772351|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772352|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
14772353|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772354|NCT00648869|Metformin|metformin|mesh-list
14772355|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772356|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772357|NCT00648921|Olanzapine|olanzapine|mesh-list
14772358|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
14772359|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
14772360|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772361|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772362|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772363|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14772364|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772365|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772366|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493714|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493715|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14493716|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14199104|NCT04564326|Fentanyl|fentanyl|mesh-list
14199105|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14199106|NCT04564326|Narcotics|narcotics|mesh-ancestor
14199107|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199108|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199109|NCT04564326|Analgesics|analgesics|mesh-ancestor
14199110|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
14199111|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199112|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14199113|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14493717|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493718|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14493719|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14493720|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493721|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493722|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
14493723|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493724|NCT02713178|Bupivacaine|bupivacaine|mesh-list
14493725|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
14493726|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
14493727|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493728|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493729|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
14493730|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493731|NCT02713204|Aflibercept|aflibercept|mesh-list
14493732|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14493733|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14493734|NCT02713204|Growth Substances|growth substances|mesh-ancestor
14493735|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493736|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
14493737|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493738|NCT02713230|Bupivacaine|bupivacaine|mesh-list
14493739|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
14493740|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
14493741|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493742|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493743|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
14493744|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493745|NCT02713490|Bupivacaine|bupivacaine|mesh-list
14493746|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
14493747|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
14493748|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493749|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493750|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
14493751|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493752|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
14493753|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493754|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493755|NCT02713698|Propofol|propofol|mesh-list
14493756|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14493757|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493758|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493759|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14493760|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
14493761|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
14493762|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
14493763|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14493764|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493765|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493766|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
14493767|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493768|NCT02714283|Azithromycin|azithromycin|mesh-list
14493769|NCT02714283|Erythromycin|erythromycin|mesh-list
14493770|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14493771|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493772|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199114|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
14199115|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
14199116|NCT04564690|Vitamin E|vitamin e|mesh-list
14199117|NCT04564690|Selenium|selenium|mesh-list
14199118|NCT04564690|Vitamins|vitamins|mesh-ancestor
14199119|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
14493773|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14493774|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493775|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493776|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14493777|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14493778|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14493779|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493780|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493781|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493782|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493783|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14493784|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
14493785|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493786|NCT02714504|Voriconazole|voriconazole|mesh-list
14493787|NCT02714504|Posaconazole|posaconazole|mesh-list
14493788|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
14493789|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493790|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14493791|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14493792|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493793|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493794|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14493795|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
14493796|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493797|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199120|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199121|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
14199122|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199123|NCT04564690|Protective Agents|protective agents|mesh-ancestor
14199124|NCT04564690|Trace Elements|trace elements|mesh-ancestor
14199125|NCT04564469|Furosemide|furosemide|mesh-list
14199126|NCT04564469|Diuretics|diuretics|mesh-ancestor
14493798|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14493799|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14493800|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14493801|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14493802|NCT02714569|Atorvastatin|atorvastatin|mesh-list
14493803|NCT02714569|Simvastatin|simvastatin|mesh-list
14493804|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14493805|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14493806|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
14493807|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493808|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14493809|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14493810|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493811|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
14493812|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14493813|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493814|NCT02715700|Methadone|methadone|mesh-list
14493815|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14493816|NCT02715700|Narcotics|narcotics|mesh-ancestor
14493817|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493818|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493819|NCT02715700|Analgesics|analgesics|mesh-ancestor
14493820|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
14493821|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493822|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
14493823|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
14493824|NCT02715726|Atorvastatin|atorvastatin|mesh-list
14493825|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14493826|NCT02715726|Simvastatin|simvastatin|mesh-list
14493827|NCT02715726|Ezetimibe|ezetimibe|mesh-list
14493828|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14493829|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14493830|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14493831|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
14493832|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199127|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
14199128|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493833|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14493834|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14493835|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493836|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
14493837|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493838|NCT02715804|Gemcitabine|gemcitabine|mesh-list
14493839|NCT02715804|Paclitaxel|paclitaxel|mesh-list
14493840|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14493841|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493842|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
14493843|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
14493844|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
14493845|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493846|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14493847|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
14493848|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
14493849|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493850|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493851|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14493852|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
14493853|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493854|NCT02716194|Factor VIII|factor viii|mesh-list
14493855|NCT02716194|Coagulants|coagulants|mesh-ancestor
14528160|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14528161|NCT03896633|Brinzolamide|brinzolamide|mesh-list
14528162|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14528163|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528164|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528165|NCT03894813|Metronidazole|metronidazole|mesh-list
14528166|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528167|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14528168|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14528169|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14528170|NCT03906448|Temozolomide|temozolomide|mesh-list
14528171|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14528172|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
14528173|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528174|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528175|NCT03909763|Danazol|danazol|mesh-list
14528176|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14528177|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
14528178|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528179|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528180|NCT03903822|PF-06700841|pf-06700841|mesh-list
14772367|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14772368|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772369|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772370|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772371|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772372|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
14772373|NCT00648934|Topiramate|topiramate|mesh-list
14772374|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
14772375|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772376|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772377|NCT00648947|Clopidogrel|clopidogrel|mesh-list
14772378|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14772379|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14772380|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14772381|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14772382|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
14772383|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772384|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772385|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772386|NCT00648960|Clarithromycin|clarithromycin|mesh-list
14772387|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772388|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772389|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14772390|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772391|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772392|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14199129|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14199130|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199131|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772393|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14772394|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
14772395|NCT00648973|Promethazine|promethazine|mesh-list
14199135|NCT04564456|Fluticasone|fluticasone|mesh-list
14199136|NCT04564456|Xhance|xhance|mesh-list
14199137|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14493856|NCT02716779|Interferons|interferons|mesh-list
14493857|NCT02716779|Ribavirin|ribavirin|mesh-list
14493858|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493859|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
14493860|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493861|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
14493862|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493863|NCT02716805|Melphalan|melphalan|mesh-list
14493864|NCT02716805|Durvalumab|durvalumab|mesh-list
14493865|NCT02716805|Tremelimumab|tremelimumab|mesh-list
14493866|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14493867|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
14493868|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199138|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14199139|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199140|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14199141|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
14199142|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199143|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199144|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14199145|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
14199146|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
14199147|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14199148|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14199149|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14199150|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14199151|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
14199152|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199153|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940583|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940584|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14940585|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14940586|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
14940587|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940588|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199154|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
14199155|NCT04564456|Hormones|hormones|mesh-ancestor
14493869|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493870|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14493871|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14493872|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
14493873|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493874|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493875|NCT02716818|Dexamethasone|dexamethasone|mesh-list
14493876|NCT02716818|Prednisone|prednisone|mesh-list
14493877|NCT02716818|Prednisolone|prednisolone|mesh-list
14493878|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
14493879|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14493880|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14493881|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14493882|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
14493883|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14493884|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
14493885|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
14493886|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493887|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493888|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493889|NCT02716818|Hormones|hormones|mesh-ancestor
14493890|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493891|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14493892|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493893|NCT02717195|Olanzapine|olanzapine|mesh-list
14493894|NCT02717195|Risperidone|risperidone|mesh-list
14199156|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493895|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14493896|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
14199157|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
14199158|NCT04564430|Clonidine|clonidine|mesh-list
14199159|NCT04564430|Analgesics|analgesics|mesh-ancestor
14199160|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
14199161|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493897|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493898|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493899|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493900|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14493901|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14493902|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14493903|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493904|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14493905|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
14493906|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
14493907|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
14493908|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493909|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14493910|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14493911|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14493912|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493913|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14493914|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14493915|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493916|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
14493917|NCT02717754|Oseltamivir|oseltamivir|mesh-list
14493918|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
14493919|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493920|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493921|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493922|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14493923|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14493924|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14493925|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14493926|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493927|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
14199162|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199163|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14199164|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
14940589|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14940590|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14940591|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
14940592|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14199165|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
14940593|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
14199166|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14199167|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14199168|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14199169|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
14199170|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199171|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199172|NCT04564144|Meclizine|meclizine|mesh-list
14199173|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
14199174|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
14199175|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199176|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199177|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199178|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14199179|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
14199180|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
14199181|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199182|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199183|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14199184|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
14199185|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199186|NCT04564222|Micronutrients|micronutrients|mesh-list
14199187|NCT04564222|Trace Elements|trace elements|mesh-list
14199188|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199189|NCT04563936|Goserelin|goserelin|mesh-list
14199190|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199191|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199192|NCT04563975|Paclitaxel|paclitaxel|mesh-list
14940594|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
14199193|NCT04563975|Docetaxel|docetaxel|mesh-list
14199194|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14493928|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493929|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493930|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14493931|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493932|NCT02718326|Aflibercept|aflibercept|mesh-list
14493933|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14493934|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14493935|NCT02718326|Growth Substances|growth substances|mesh-ancestor
14493936|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493937|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
14493938|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493939|NCT02718417|Paclitaxel|paclitaxel|mesh-list
14493940|NCT02718417|Carboplatin|carboplatin|mesh-list
14493941|NCT02718417|Avelumab|avelumab|mesh-list
14493942|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14493943|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14493944|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493945|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14493946|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14493947|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14493948|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493949|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14493950|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
14493951|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493952|NCT02718898|Ixekizumab|ixekizumab|mesh-list
14493953|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
14493954|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
14493955|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14493956|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14493957|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14493958|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14493959|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14493960|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493961|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14493962|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14493963|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14493964|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14493965|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
14493966|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493967|NCT02720081|Albuterol|albuterol|mesh-list
14493968|NCT02720081|Montelukast|montelukast|mesh-list
14493969|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14493970|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
14493971|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14493972|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14493973|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14493974|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493975|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14493976|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14493977|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493978|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14493979|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
14493980|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14493981|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
14493982|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14772396|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
13963954|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13963955|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13963956|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13963957|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963958|NCT03140826|Meropenem|meropenem|mesh-list
14493983|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14493984|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14493985|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14493986|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14493987|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14493988|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14493989|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14493990|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14493991|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14772397|NCT00648973|Ephedrine|ephedrine|mesh-list
14772398|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14772399|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14772400|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772401|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772402|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
14772403|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
14772404|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
14772405|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772406|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
14772407|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
14772408|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772409|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14772410|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
14772411|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
14772412|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772413|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772414|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14772415|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
14772416|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
14772417|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14772418|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14772419|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
14772420|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
14772421|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14772422|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14772423|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
14772424|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772425|NCT00648986|Tazarotene|tazarotene|mesh-list
14772426|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
14772427|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
14772428|NCT00648999|Ritonavir|ritonavir|mesh-list
14772429|NCT00648999|Lopinavir|lopinavir|mesh-list
14199195|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199196|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
14199197|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
14199198|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
14199199|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199200|NCT04563962|Methamphetamine|methamphetamine|mesh-list
14199201|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14199202|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199203|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
14199204|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
14199205|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199206|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
14199207|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199208|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199209|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
14199210|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14199211|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772430|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14772431|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14772432|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772433|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772434|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772435|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14493992|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
14493993|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14493994|NCT02720198|Milnacipran|milnacipran|mesh-list
14493995|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14493996|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
14493997|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
14493998|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14493999|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14494000|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772436|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14772437|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
14494001|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494002|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494003|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14494004|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14494005|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494006|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494007|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494008|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14494009|NCT02720198|Analgesics|analgesics|mesh-ancestor
14494010|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
14494011|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494012|NCT02720484|Nivolumab|nivolumab|mesh-list
14494013|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494014|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494015|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14494016|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494017|NCT02720523|Upadacitinib|upadacitinib|mesh-list
14494018|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14494019|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14494020|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494021|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494022|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494023|NCT02720536|Deferasirox|deferasirox|mesh-list
14494024|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14494025|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
14494026|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
14494027|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494028|NCT02721017|Fentanyl|fentanyl|mesh-list
14494029|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14494030|NCT02721017|Narcotics|narcotics|mesh-ancestor
14494031|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199212|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494032|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494033|NCT02721017|Analgesics|analgesics|mesh-ancestor
14494034|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
14494035|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494036|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14494037|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14494038|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
14494039|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
14494040|NCT02721641|Trastuzumab|trastuzumab|mesh-list
14772438|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772439|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14772440|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14772441|NCT00649012|Pioglitazone|pioglitazone|mesh-list
14772442|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772443|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772444|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14772445|NCT00649038|Benazepril|benazepril|mesh-list
14772446|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772447|NCT00649038|Diuretics|diuretics|mesh-ancestor
14772448|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772449|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772450|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13963959|NCT03140826|Tazobactam|tazobactam|mesh-list
13963960|NCT03140826|Piperacillin|piperacillin|mesh-list
13963961|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13963962|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13963963|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963964|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13963965|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13963966|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199213|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14199214|NCT04563871|Osimertinib|osimertinib|mesh-list
14494041|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494042|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494043|NCT02721875|Azacitidine|azacitidine|mesh-list
14494044|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14494045|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
14494046|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494047|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494048|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494049|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14494050|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
14494051|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494052|NCT02722044|Adalimumab|adalimumab|mesh-list
14494053|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494054|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494055|NCT02722239|Metformin|metformin|mesh-list
14494056|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
14494057|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14199215|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199216|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199217|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199218|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494058|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494059|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14494060|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494061|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
14494062|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14494063|NCT02722278|Testosterone|testosterone|mesh-list
14494064|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
14494065|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
14772451|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772452|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772453|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14772454|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772455|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772456|NCT00649051|Metolazone|metolazone|mesh-list
13963967|NCT03140787|Lidocaine|lidocaine|mesh-list
13963968|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
13963969|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
13963970|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13963971|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963972|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
13963973|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13963974|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13963975|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13963976|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14772457|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772458|NCT00649051|Diuretics|diuretics|mesh-ancestor
14772459|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772460|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772461|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14772462|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772463|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963977|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199219|NCT04564001|Infliximab|infliximab|mesh-list
14199220|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
14199221|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199222|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14199223|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
14199224|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14199225|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199226|NCT04563299|Prednisolone|prednisolone|mesh-list
14199227|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14494066|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14772464|NCT00649064|Ziprasidone|ziprasidone|mesh-list
14772465|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14772466|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
14940595|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
14940596|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14940597|NCT01494311|Lidocaine|lidocaine|mesh-list
14940598|NCT01494311|Tetracaine|tetracaine|mesh-list
14940599|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
14940600|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
14199228|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
14199229|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14199230|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
14940601|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199231|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14199232|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
14199233|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199234|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
14199235|NCT04563299|Hormones|hormones|mesh-ancestor
14199236|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199237|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199238|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199239|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199240|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
14199241|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
14199242|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199243|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199244|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14199245|NCT04563299|Protective Agents|protective agents|mesh-ancestor
14199246|NCT04563260|Palonosetron|palonosetron|mesh-list
14199247|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
14199248|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
14199249|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199250|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199251|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199252|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14199253|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14199254|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
14199255|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239124|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239125|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239126|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239127|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239128|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239129|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239130|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
14239131|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239132|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14239133|NCT00140426|Risperidone|risperidone|mesh-list
14239134|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14239135|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
14239136|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239137|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239138|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239139|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14239140|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14239141|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14239142|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239143|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14239144|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
14239145|NCT00140556|Bevacizumab|bevacizumab|mesh-list
14239146|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14239147|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239148|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239149|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14239150|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14239151|NCT00140556|Growth Substances|growth substances|mesh-ancestor
14239152|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239153|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
14239154|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14239155|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239156|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239157|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14239158|NCT00140855|Ipilimumab|ipilimumab|mesh-list
14239159|NCT00140855|Antibodies|antibodies|mesh-list
14239160|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
14239161|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14239162|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
14494067|NCT02722278|Androgens|androgens|mesh-ancestor
14494068|NCT02722278|Hormones|hormones|mesh-ancestor
14494069|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494070|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494071|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14494072|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494073|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
14494074|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
14494075|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14494076|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494077|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494078|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14494079|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14494080|NCT02722564|Ethanol|ethanol|mesh-list
14494081|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14494082|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199256|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199257|NCT04563533|Vaccines|vaccines|mesh-list
14199258|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
14199259|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199260|NCT04563494|Dexamethasone|dexamethasone|mesh-list
14199261|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199262|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
14199263|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
14199264|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199265|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199266|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199267|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
14199268|NCT04563494|Hormones|hormones|mesh-ancestor
14199269|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199270|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199271|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199272|NCT04563351|Anesthetics|anesthetics|mesh-list
14199273|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
14199274|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199275|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199276|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
14494083|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494084|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494085|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
14494086|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14494087|NCT02722837|Velpatasvir|velpatasvir|mesh-list
14494088|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
14494089|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940602|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940603|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
14940604|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940605|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14940606|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14940607|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14940608|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940609|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963978|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963979|NCT03140384|Misoprostol|misoprostol|mesh-list
13963980|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13963981|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
13963982|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13963983|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963984|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13963985|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494090|NCT02722967|Aripiprazole|aripiprazole|mesh-list
14494091|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
14199277|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199278|NCT04563507|Letrozole|letrozole|mesh-list
14494092|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494093|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14494094|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14494095|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494096|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494097|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
14494098|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
14494099|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494100|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494101|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14494102|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14494103|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
14494104|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14494105|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14494106|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14494107|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14494108|NCT02723006|Nivolumab|nivolumab|mesh-list
14494109|NCT02723006|Ipilimumab|ipilimumab|mesh-list
14494110|NCT02723006|Vedolizumab|vedolizumab|mesh-list
14494111|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494112|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494113|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14494114|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494115|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494116|NCT02723084|Ribavirin|ribavirin|mesh-list
14494117|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
14494118|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
14494119|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494120|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
14494121|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494122|NCT02723591|Tacrolimus|tacrolimus|mesh-list
14494123|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494124|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
14494125|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494126|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14494127|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494128|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494129|NCT02723630|Lenvatinib|lenvatinib|mesh-list
14494130|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494131|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14494132|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494133|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494134|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
14494135|NCT02723786|Azathioprine|azathioprine|mesh-list
14494136|NCT02723786|Tacrolimus|tacrolimus|mesh-list
14494137|NCT02723786|Basiliximab|basiliximab|mesh-list
14494138|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494139|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
14494140|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494141|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14940610|NCT01494363|Leucovorin|leucovorin|mesh-list
14940611|NCT01494363|Fluorouracil|fluorouracil|mesh-list
14940612|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
14940613|NCT01494363|Irinotecan|irinotecan|mesh-list
14940614|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
14940615|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940616|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14199279|NCT04563507|Palbociclib|palbociclib|mesh-list
14199280|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199281|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14199282|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14199283|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199284|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199285|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14199286|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
14199287|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199288|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199289|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199290|NCT04563429|Vitamin A|vitamin a|mesh-list
14199291|NCT04563429|Vitamins|vitamins|mesh-ancestor
14199292|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
14199293|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199294|NCT04563000|Ascorbic Acid|ascorbic acid|mesh-list
14940617|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940618|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940619|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
14940620|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940621|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14940622|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14940623|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940624|NCT01494363|Antidotes|antidotes|mesh-ancestor
14940625|NCT01494363|Protective Agents|protective agents|mesh-ancestor
14940626|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
14940627|NCT01494363|Vitamins|vitamins|mesh-ancestor
14940628|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
14940629|NCT01494402|Aspirin|aspirin|mesh-list
14940630|NCT01494402|Esomeprazole|esomeprazole|mesh-list
14199295|NCT04563000|Vitamins|vitamins|mesh-ancestor
14199296|NCT04563000|Micronutrients|micronutrients|mesh-ancestor
14199297|NCT04563000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199298|NCT04563000|Antioxidants|antioxidants|mesh-ancestor
14199299|NCT04563000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199300|NCT04563000|Protective Agents|protective agents|mesh-ancestor
14199301|NCT04562532|Sirolimus|sirolimus|mesh-list
14494142|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494143|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494144|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14494145|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494146|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14494147|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
14494148|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494149|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494150|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
14494151|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14494152|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494153|NCT02724020|Everolimus|everolimus|mesh-list
14494154|NCT02724020|Serabelisib|serabelisib|mesh-list
14494155|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940631|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14940632|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199302|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14940633|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14940634|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494156|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494157|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
14494158|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494159|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494160|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494161|NCT02724033|Dexamethasone|dexamethasone|mesh-list
14494162|NCT02724033|Ondansetron|ondansetron|mesh-list
14494163|NCT02724033|Antiemetics|antiemetics|mesh-list
14494164|NCT02724033|Bupivacaine|bupivacaine|mesh-list
14494165|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494166|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
14494167|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494168|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494169|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494170|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
14494171|NCT02724033|Hormones|hormones|mesh-ancestor
14494172|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494173|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14494174|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494175|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494176|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
14494177|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
14772467|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772468|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772469|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772470|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14772471|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772472|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772473|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772474|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14772475|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
14772476|NCT00649077|Meloxicam|meloxicam|mesh-list
14772477|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14772478|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14772479|NCT00649077|Analgesics|analgesics|mesh-ancestor
15026715|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13963986|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
14772480|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
14772481|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772482|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772483|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772484|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772485|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14772486|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14772487|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772488|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772489|NCT00649090|Exemestane|exemestane|mesh-list
14772490|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772491|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14772492|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14772493|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772494|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772495|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14772496|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
14772497|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772498|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772499|NCT00649103|Quinapril|quinapril|mesh-list
14772500|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14772501|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772502|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772503|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772504|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772505|NCT00649116|Metoprolol|metoprolol|mesh-list
14772506|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14772507|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772508|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
14772509|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
14772510|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772511|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772512|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14772513|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13963987|NCT03140449|Calcitriol|calcitriol|mesh-list
14494178|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494179|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
14494180|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
14494181|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
14494182|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14494183|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
14772514|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14772515|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772516|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772517|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772518|NCT00649129|Oxybutynin|oxybutynin|mesh-list
14772519|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
14772520|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
14772521|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772522|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772523|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14772524|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14772525|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772526|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772527|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772528|NCT00649129|Urological Agents|urological agents|mesh-ancestor
14772529|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
14772530|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772531|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772532|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14772533|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14772534|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772535|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772536|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772537|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14772538|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14772539|NCT00649168|Bromocriptine|bromocriptine|mesh-list
14772540|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14772541|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14772542|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
14772543|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772544|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772545|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
14772546|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
14772547|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199303|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199304|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14199305|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199306|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
14199307|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199308|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
14199309|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199310|NCT04562441|Avelumab|avelumab|mesh-list
14199311|NCT04562441|Axitinib|axitinib|mesh-list
14199312|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14772548|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772549|NCT00649181|Metolazone|metolazone|mesh-list
14772550|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772551|NCT00649181|Diuretics|diuretics|mesh-ancestor
14772552|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772553|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772554|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14772555|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772556|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772557|NCT00649194|Rabeprazole|rabeprazole|mesh-list
14772558|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14940635|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940636|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14940637|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14940638|NCT01494402|Analgesics|analgesics|mesh-ancestor
14199313|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494184|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494185|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14494186|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14494187|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494188|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14494189|NCT02724111|Rocuronium|rocuronium|mesh-list
14494190|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14199314|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199315|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199316|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239163|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239164|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239165|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14239166|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239167|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
14239168|NCT00141037|Trimethoprim|trimethoprim|mesh-list
14239169|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
14239170|NCT00141037|Valganciclovir|valganciclovir|mesh-list
14239171|NCT00141037|Ganciclovir|ganciclovir|mesh-list
14239172|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14239173|NCT00141037|Prednisone|prednisone|mesh-list
14239174|NCT00141037|Tacrolimus|tacrolimus|mesh-list
14239175|NCT00141037|Daclizumab|daclizumab|mesh-list
14239176|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239177|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
14239178|NCT00141037|Hormones|hormones|mesh-ancestor
14239179|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239180|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239181|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239182|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494191|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14494192|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14494193|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494194|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494195|NCT02724423|Diazepam|diazepam|mesh-list
14494196|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14494197|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
14494198|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
14494199|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
14494200|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494201|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494202|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494203|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14494204|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494205|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14494206|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14494207|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14494208|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14494209|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494210|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14494211|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
14494212|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
14494213|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
14494214|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
14494215|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494216|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494217|NCT02724592|Fluorides|fluorides|mesh-list
14494218|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
14494219|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
14494220|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
14494221|NCT02724592|Protective Agents|protective agents|mesh-ancestor
14494222|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494223|NCT02725008|Dexamethasone|dexamethasone|mesh-list
14494224|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494225|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
14239183|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494226|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
14494227|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494228|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494229|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494230|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
14494231|NCT02725008|Hormones|hormones|mesh-ancestor
14494232|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494233|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14494234|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772559|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772560|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14772561|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772562|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772563|NCT00649207|Veliparib|veliparib|mesh-list
14772564|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14772565|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199317|NCT04561934|Fluorides|fluorides|mesh-list
14199318|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
14199319|NCT04561934|Protective Agents|protective agents|mesh-ancestor
14199320|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199321|NCT04561960|Fluorides|fluorides|mesh-list
14199322|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
14199323|NCT04561960|Protective Agents|protective agents|mesh-ancestor
14199324|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199325|NCT04562103|Epinephrine|epinephrine|mesh-list
14199326|NCT04562103|Ropivacaine|ropivacaine|mesh-list
14199327|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
14199328|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
14199329|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199330|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199331|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
14199332|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199333|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14199334|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14199335|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
14199336|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199337|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494235|NCT02725268|Paclitaxel|paclitaxel|mesh-list
14940639|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
14940640|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940641|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940642|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940643|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940644|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14940645|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14940646|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14940647|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14940648|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
14940649|NCT01494415|Paclitaxel|paclitaxel|mesh-list
14940650|NCT01494415|Carboplatin|carboplatin|mesh-list
14940651|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14940652|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494236|NCT02725268|Serabelisib|serabelisib|mesh-list
14494237|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14494238|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494239|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
14494240|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
14494241|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
14494242|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494243|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494244|NCT02725411|Celecoxib|celecoxib|mesh-list
14494245|NCT02725411|Tanezumab|tanezumab|mesh-list
14494246|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14494247|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14494248|NCT02725411|Analgesics|analgesics|mesh-ancestor
14494249|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
14199338|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14199339|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14199340|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
14199341|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14199342|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
14199343|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
14199344|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
14199345|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14199346|NCT04561635|Micronutrients|micronutrients|mesh-list
14199347|NCT04561635|Trace Elements|trace elements|mesh-list
14199348|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199349|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
14199350|NCT04561921|Nordefrin|nordefrin|mesh-list
14199351|NCT04561921|Mepivacaine|mepivacaine|mesh-list
14199352|NCT04561921|Analgesics|analgesics|mesh-ancestor
14199353|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
14199354|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199355|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494250|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494251|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494252|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199356|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
14494253|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494254|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14940653|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
14199357|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199358|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14199359|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
14494255|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14494256|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494257|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494258|NCT02725710|Gabapentin|gabapentin|mesh-list
14494259|NCT02725710|Analgesics|analgesics|mesh-ancestor
14494260|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
14494261|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494262|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494263|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
14199360|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14199361|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199362|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199363|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14199364|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
14199365|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14199366|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
14199367|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14199368|NCT04561687|Azelastine|azelastine|mesh-list
14494264|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14494265|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14494266|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494267|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494268|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14494269|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14494270|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199369|NCT04561687|Budesonide|budesonide|mesh-list
14199370|NCT04561687|Montelukast|montelukast|mesh-list
14199371|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199372|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14199373|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
14199374|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199375|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199376|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14199377|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14199378|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
14199379|NCT04561687|Hormones|hormones|mesh-ancestor
14199380|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199381|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14199382|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
14199383|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14199384|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14199385|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199386|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14199387|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940654|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
14494271|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494272|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
14494273|NCT02725866|Ritonavir|ritonavir|mesh-list
14494274|NCT02725866|Ribavirin|ribavirin|mesh-list
14494275|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14494276|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14494277|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
14494278|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494279|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494280|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14494281|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14494282|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
14494283|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494284|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14494285|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14494286|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
14494287|NCT02726022|Ribavirin|ribavirin|mesh-list
14494288|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14494289|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
14494290|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940655|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
14940656|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940657|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
14940658|NCT01494441|Calcium|calcium|mesh-list
14940659|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14940660|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940661|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14940662|NCT01494597|Cyclosporine|cyclosporine|mesh-list
14199388|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14199389|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14199390|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14199391|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
14199392|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
14199393|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199394|NCT04561947|Mitogens|mitogens|mesh-list
14199395|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
14199396|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199397|NCT04561739|Aspirin|aspirin|mesh-list
14199398|NCT04561739|Sirolimus|sirolimus|mesh-list
14199399|NCT04561739|Paclitaxel|paclitaxel|mesh-list
14199400|NCT04561739|Clopidogrel|clopidogrel|mesh-list
14199401|NCT04561739|Ticagrelor|ticagrelor|mesh-list
14199402|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14199403|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199404|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
14199405|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
14494291|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
14940663|NCT01494597|Isavuconazole|isavuconazole|mesh-list
14940664|NCT01494597|Cyclosporins|cyclosporins|mesh-list
14940665|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494292|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528181|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14528182|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528183|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528184|NCT03905096|Donepezil|donepezil|mesh-list
14528185|NCT03905096|BI 425809|bi 425809|mesh-list
14528186|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14528187|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528188|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528189|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
14528190|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528191|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528192|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
14528193|NCT03894969|Vaccines|vaccines|mesh-list
14528194|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
14528195|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530013|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530014|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
14530015|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530016|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14530017|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14530018|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14530019|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530020|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530021|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530022|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
14530023|NCT03382925|Hormones|hormones|mesh-ancestor
14530024|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530025|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530026|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
14530027|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772566|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772567|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772568|NCT00649233|Metoprolol|metoprolol|mesh-list
14772569|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14772570|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772571|NCT00649233|Diuretics|diuretics|mesh-ancestor
14199406|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
14199407|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772572|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772573|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772574|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14772575|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772576|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494293|NCT02726113|Vitamin D|vitamin d|mesh-list
14494294|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
14494295|NCT02726113|Vitamins|vitamins|mesh-ancestor
14494296|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
14494297|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199408|NCT04561739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14199409|NCT04561739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14494298|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14494299|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14494300|NCT02726178|Ibuprofen|ibuprofen|mesh-list
14494301|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14494302|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14494303|NCT02726178|Analgesics|analgesics|mesh-ancestor
14494304|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
14494305|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494306|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494307|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494308|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494309|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14494310|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494311|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494312|NCT02726620|Lidocaine|lidocaine|mesh-list
14494313|NCT02726620|Atropine|atropine|mesh-list
14494314|NCT02726620|Terlipressin|terlipressin|mesh-list
14494315|NCT02726620|Phenylephrine|phenylephrine|mesh-list
14494316|NCT02726620|Dobutamine|dobutamine|mesh-list
14772577|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14772578|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
14772579|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
14199410|NCT04561739|Analgesics|analgesics|mesh-ancestor
14199411|NCT04561739|Sensory System Agents|sensory system agents|mesh-ancestor
14199412|NCT04561739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199413|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199414|NCT04561739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199415|NCT04561739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14199416|NCT04561739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14199417|NCT04561739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14199418|NCT04561739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14199419|NCT04561739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14199420|NCT04561739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199421|NCT04561739|Antipyretics|antipyretics|mesh-ancestor
14199422|NCT04561739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14199423|NCT04561739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14199424|NCT04561739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14199425|NCT04561739|Purinergic Agents|purinergic agents|mesh-ancestor
14199426|NCT04561739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199427|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14199428|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199429|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14199430|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
14199431|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199432|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
14199433|NCT04561466|Bezafibrate|bezafibrate|mesh-list
14199434|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14199435|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
14199436|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199437|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14199438|NCT04561856|Dexamethasone|dexamethasone|mesh-list
14199439|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
14199440|NCT04561856|BB 1101|bb 1101|mesh-list
14199441|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494317|NCT02726620|Dopamine|dopamine|mesh-list
14494318|NCT02726620|Milrinone|milrinone|mesh-list
14772580|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772581|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14772582|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14199442|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
14494319|NCT02726620|Isoproterenol|isoproterenol|mesh-list
14494320|NCT02726620|Vasopressins|vasopressins|mesh-list
14494321|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
14494322|NCT02726620|Epinephrine|epinephrine|mesh-list
14494323|NCT02726620|Norepinephrine|norepinephrine|mesh-list
14494324|NCT02726620|Ephedrine|ephedrine|mesh-list
14494325|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
14494326|NCT02726620|Bupivacaine|bupivacaine|mesh-list
14494327|NCT02726620|Ropivacaine|ropivacaine|mesh-list
14494328|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
14494329|NCT02726620|Tetracaine|tetracaine|mesh-list
14494330|NCT02726620|Prilocaine|prilocaine|mesh-list
14494331|NCT02726620|Mepivacaine|mepivacaine|mesh-list
14494332|NCT02726620|Benzocaine|benzocaine|mesh-list
14494333|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
14494334|NCT02726620|Procaine|procaine|mesh-list
14494335|NCT02726620|Anesthetics|anesthetics|mesh-list
14199443|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
14199444|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199445|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199446|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199447|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
14199448|NCT04561856|Hormones|hormones|mesh-ancestor
14199449|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199450|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199451|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199452|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
14199453|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199454|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494336|NCT02726620|Propofol|propofol|mesh-list
14940666|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940667|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14940668|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
14940669|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940670|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
14940671|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940672|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
14940673|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14199455|NCT04561817|Paclitaxel|paclitaxel|mesh-list
14199456|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14199457|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199458|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
14940674|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14940675|NCT01494636|Lidocaine|lidocaine|mesh-list
14940676|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14940677|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
14940678|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
14940679|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940680|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940681|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
14940682|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494337|NCT02726620|Sevoflurane|sevoflurane|mesh-list
14494338|NCT02726620|Desflurane|desflurane|mesh-list
14494339|NCT02726620|Isoflurane|isoflurane|mesh-list
14494340|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14494341|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
14494342|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
14494343|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494344|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494345|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
14494346|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494347|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14494348|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14494349|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14494350|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494351|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494352|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14494353|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14494354|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
14494355|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14494356|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14199459|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
14494357|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14494358|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14494359|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
14199460|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
14199461|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199462|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
14199463|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14199464|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199465|NCT04561336|Cetuximab|cetuximab|mesh-list
14199466|NCT04561336|Avelumab|avelumab|mesh-list
14199467|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14199468|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199469|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
14199470|NCT04561076|Paraproteins|paraproteins|mesh-list
14940683|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14940684|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14940685|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14940686|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199471|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
14199472|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199473|NCT04560894|Sorafenib|sorafenib|mesh-list
14199474|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199475|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199476|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940687|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940688|NCT01494688|Paclitaxel|paclitaxel|mesh-list
14940689|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14940690|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940691|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
14940692|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
14940693|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
14940694|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940695|NCT01494714|Petrolatum|petrolatum|mesh-list
14940696|NCT01494714|Emollients|emollients|mesh-ancestor
14940697|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14940698|NCT01494727|Amlodipine|amlodipine|mesh-list
14494360|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494361|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14494362|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14494363|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
14494364|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14494365|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
14494366|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
14494367|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
14494368|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14494369|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14494370|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
14494371|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14494372|NCT02726620|Protective Agents|protective agents|mesh-ancestor
14494373|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14494374|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
14199477|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199478|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
14199479|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
14199480|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
14199481|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199482|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14199483|NCT04560660|Midazolam|midazolam|mesh-list
14199484|NCT04560660|Ketamine|ketamine|mesh-list
14199485|NCT04560660|Analgesics|analgesics|mesh-ancestor
14199486|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
14199487|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199488|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199489|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14199490|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14199491|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
14199492|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
14199493|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199494|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14199495|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14199496|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199497|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199498|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14199499|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14199500|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14199501|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14494375|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14199502|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940699|NCT01494727|Valsartan|valsartan|mesh-list
14494376|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14199503|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
14199504|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
14199507|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
14199508|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14199509|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14199510|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199511|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
14199512|NCT04560465|Coagulants|coagulants|mesh-ancestor
14199513|NCT04560322|Venetoclax|venetoclax|mesh-list
14199514|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
14199515|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
14199516|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199517|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14199518|NCT04560751|Lenvatinib|lenvatinib|mesh-list
14199519|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199520|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199521|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199522|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239184|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
14239185|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14239186|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239187|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239188|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14239189|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14239190|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
14239191|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14239192|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239193|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14239194|NCT00141037|Renal Agents|renal agents|mesh-ancestor
14239195|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
14239196|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14239197|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14239198|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14239199|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14239200|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14239201|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239202|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
14239203|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14239204|NCT00141102|Celecoxib|celecoxib|mesh-list
14239205|NCT00141102|Diclofenac|diclofenac|mesh-list
14239206|NCT00141102|Omeprazole|omeprazole|mesh-list
14239207|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14239208|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14239209|NCT00141102|Analgesics|analgesics|mesh-ancestor
14239210|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
14239211|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239212|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239213|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239214|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239215|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14239216|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14239217|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239218|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239219|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14239220|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239221|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14239222|NCT00141115|Levetiracetam|levetiracetam|mesh-list
14239223|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
14239224|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
14239225|NCT00141219|Pregabalin|pregabalin|mesh-list
14239226|NCT00141219|Analgesics|analgesics|mesh-ancestor
14239227|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
14239228|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239229|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239230|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
14239231|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14239232|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14239233|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239234|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14239235|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14239236|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14239237|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199523|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
14199524|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14199525|NCT04560816|Choline|choline|mesh-list
14199526|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494377|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
14494378|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
14494379|NCT02726620|Coagulants|coagulants|mesh-ancestor
14494380|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14494381|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
14494382|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14494383|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14494384|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14772583|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14772584|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772585|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772586|NCT00649259|Oxybutynin|oxybutynin|mesh-list
14772587|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
14772588|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
14772589|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772590|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772591|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14772592|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14772593|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772594|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772595|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772596|NCT00649259|Urological Agents|urological agents|mesh-ancestor
14772597|NCT00649272|Oxybutynin|oxybutynin|mesh-list
14772598|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
14772599|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
14772600|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772601|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772602|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14772603|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14772604|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772605|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772606|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772607|NCT00649272|Urological Agents|urological agents|mesh-ancestor
14772608|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
14772609|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14772610|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772611|NCT00649285|Renal Agents|renal agents|mesh-ancestor
14772612|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772613|NCT00649311|Losartan|losartan|mesh-list
14772614|NCT00649311|Eplerenone|eplerenone|mesh-list
14772615|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14772616|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772617|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14772618|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14772619|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772620|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14772621|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
14772622|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772623|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772624|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14772625|NCT00649311|Diuretics|diuretics|mesh-ancestor
14772626|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772627|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14772628|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772629|NCT00649324|Diuretics|diuretics|mesh-ancestor
14772630|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772631|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772632|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14940700|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14199527|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199528|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14494385|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
14494386|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
14494387|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14494388|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14494389|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494390|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14772633|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772634|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13963988|NCT03140449|Sirolimus|sirolimus|mesh-list
13963989|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494391|NCT02726789|Interferons|interferons|mesh-list
14199529|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14199530|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199531|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199532|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199533|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199534|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
14199535|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14199536|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
14199537|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199538|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14199539|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
14199540|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
14199541|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
14199542|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14199543|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14199544|NCT04560816|Growth Substances|growth substances|mesh-ancestor
14199545|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
14199546|NCT04560569|Antibodies|antibodies|mesh-list
14199547|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
14199548|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199549|NCT04560556|Antibodies|antibodies|mesh-list
14199550|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
14239238|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239239|NCT00141271|Ziprasidone|ziprasidone|mesh-list
14239240|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14239241|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
14494392|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
14494393|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
14494394|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14494395|NCT02726789|Entecavir|entecavir|mesh-list
14494396|NCT02726789|REP 2139|rep 2139|mesh-list
14494397|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494398|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
14494399|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494400|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
14494401|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494402|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
14494403|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13963990|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13963991|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14239242|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239243|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239244|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239245|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14239246|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14239247|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14239248|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239249|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14239250|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
14239251|NCT00141297|Palbociclib|palbociclib|mesh-list
14239252|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239253|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14239254|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239255|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239256|NCT00141453|Olmesartan|olmesartan|mesh-list
14239257|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14494404|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494405|NCT02727322|Renal Agents|renal agents|mesh-ancestor
14494406|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494407|NCT02727660|Budesonide|budesonide|mesh-list
14494408|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
14494409|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494410|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14494411|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
14494412|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494413|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494414|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14494415|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
14494416|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
14494417|NCT02727660|Hormones|hormones|mesh-ancestor
14494418|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494419|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14494420|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14494421|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14494422|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
14494423|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494424|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494425|NCT02728089|Tazobactam|tazobactam|mesh-list
14494426|NCT02728089|Ceftolozane|ceftolozane|mesh-list
14494427|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494428|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494429|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14494430|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494431|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494432|NCT02728102|Lenalidomide|lenalidomide|mesh-list
14494433|NCT02728102|Melphalan|melphalan|mesh-list
14772635|NCT00649350|Metformin|metformin|mesh-list
14772636|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772637|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772638|NCT00649363|Ondansetron|ondansetron|mesh-list
14772639|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
14772640|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
14772641|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772642|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772643|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772644|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
14772645|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
14772646|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14772647|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
13963992|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13963993|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
13963994|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13963995|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
13963996|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13963997|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13963998|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13963999|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964000|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964001|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13964002|NCT03140449|Vitamins|vitamins|mesh-ancestor
13964003|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
13964004|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13964005|NCT03140709|Oxytocin|oxytocin|mesh-list
13964006|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
13964007|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13964008|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964009|NCT03140488|Oxytocin|oxytocin|mesh-list
13964010|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
13964011|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13964012|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964013|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14494434|NCT02728102|Molgramostim|molgramostim|mesh-list
14772648|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807313|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199551|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199552|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
14199553|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14494435|NCT02728102|Vaccines|vaccines|mesh-list
14494436|NCT02728102|Sargramostim|sargramostim|mesh-list
14494437|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
14494438|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494439|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14494440|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14494441|NCT02728102|Growth Substances|growth substances|mesh-ancestor
14494442|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14494443|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494444|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14494445|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
14494446|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494447|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14494448|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494449|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
14494450|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14199554|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199555|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14199556|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14199557|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14199558|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199559|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494451|NCT02728206|Velpatasvir|velpatasvir|mesh-list
14494452|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
14494453|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494454|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
14494455|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494456|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494457|NCT02728895|Vedolizumab|vedolizumab|mesh-list
14494458|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494459|NCT02729025|Evolocumab|evolocumab|mesh-list
14494460|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14494461|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14494462|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
14494463|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494464|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14494465|NCT02729051|Albuterol|albuterol|mesh-list
14494466|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14494467|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
14494468|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494469|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494470|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14494471|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
14494472|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
14494473|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14494474|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14494475|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14199560|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199561|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199562|NCT04560673|Analgesics|analgesics|mesh-ancestor
14199563|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
14199564|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199565|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
14199566|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14199567|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
14494476|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14494477|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
14494478|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494479|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494480|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
14494481|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14494482|NCT02729545|Cyproterone|cyproterone|mesh-list
14494483|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14494484|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14494485|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14494486|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
14494487|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14494488|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528196|NCT03892707|Folic Acid|folic acid|mesh-list
14494489|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14494490|NCT02729545|Estrogens|estrogens|mesh-ancestor
14494491|NCT02729545|Hormones|hormones|mesh-ancestor
14494492|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494493|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
14494494|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
14494495|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494496|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14494497|NCT02729896|Rituximab|rituximab|mesh-list
14494498|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
14494499|NCT02729896|Atezolizumab|atezolizumab|mesh-list
14494500|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494501|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494502|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
14494503|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494504|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494505|NCT02729909|Lubiprostone|lubiprostone|mesh-list
14494506|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14494507|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494508|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494509|NCT02730195|Pioglitazone|pioglitazone|mesh-list
14494510|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14494511|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494512|NCT02730208|Ivacaftor|ivacaftor|mesh-list
14494513|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14494514|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199568|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
14199569|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14199570|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14199571|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199572|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
14199573|NCT04559880|Coagulants|coagulants|mesh-ancestor
14199574|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
14199575|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14199576|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14199577|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199578|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
14199579|NCT04560010|Coagulants|coagulants|mesh-ancestor
14494515|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494516|NCT02730247|Paclitaxel|paclitaxel|mesh-list
14494517|NCT02730247|Ramucirumab|ramucirumab|mesh-list
14494518|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14494519|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199580|NCT04560231|Remdesivir|remdesivir|mesh-list
14199581|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
14199582|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199583|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
14199584|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199585|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
14199586|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14199587|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14199588|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14199589|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199590|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199591|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
14199592|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199593|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199594|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14199595|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199596|NCT04560218|Misoprostol|misoprostol|mesh-list
14199597|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14199598|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
14199599|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14199600|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199601|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14199602|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199603|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
14199604|NCT04560049|Phenol|phenol|mesh-list
14494520|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
14494521|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
14940701|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14940702|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14199605|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
14199606|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14494522|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
14528197|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
14940703|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940704|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940705|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14940706|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940707|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
14940708|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14940709|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14940710|NCT01494740|Vaccines|vaccines|mesh-list
14940711|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
14940712|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940713|NCT01494805|Ranibizumab|ranibizumab|mesh-list
14940714|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14940715|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14940716|NCT01494805|Growth Substances|growth substances|mesh-ancestor
14494523|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494524|NCT02730351|Fluticasone|fluticasone|mesh-list
14494525|NCT02730351|Xhance|xhance|mesh-list
14494526|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494527|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14494528|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
14494529|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494530|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494531|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14494532|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
14494533|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
14494534|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14494535|NCT02730377|Liraglutide|liraglutide|mesh-list
14494536|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14494537|NCT02730377|Meglitinide|meglitinide|mesh-list
14494538|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14494539|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14494540|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14494541|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14494542|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494543|NCT02730377|Incretins|incretins|mesh-ancestor
14494544|NCT02730377|Hormones|hormones|mesh-ancestor
14494545|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494546|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494547|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
14494548|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494549|NCT02730455|Natalizumab|natalizumab|mesh-list
14494550|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
14494551|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494552|NCT02730871|Timolol|timolol|mesh-list
14494553|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14494554|NCT02730871|Travoprost|travoprost|mesh-list
14494555|NCT02730871|Brinzolamide|brinzolamide|mesh-list
14494556|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14494557|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14494558|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
14494559|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494560|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494561|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772649|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772650|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14772651|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772652|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772653|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772654|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14772655|NCT00649376|Fexofenadine|fexofenadine|mesh-list
14772656|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14772657|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14772658|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14199607|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199608|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
14199609|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14199610|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14199611|NCT04559841|Simvastatin|simvastatin|mesh-list
14199612|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14199613|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14199614|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
14772659|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
14772660|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
14807314|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494562|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14494563|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14494564|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14494565|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14494566|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14494567|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14494568|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494569|NCT02730884|ON 01910|on 01910|mesh-list
14494570|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494571|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14494572|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494573|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494574|NCT02730962|Vancomycin|vancomycin|mesh-list
14494575|NCT02730962|Clindamycin|clindamycin|mesh-list
14494576|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
14494577|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
14494578|NCT02730962|Neomycin|neomycin|mesh-list
14494579|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494580|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494581|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14199615|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199616|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14199617|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14199618|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199619|NCT04559425|Dexamethasone|dexamethasone|mesh-list
14199620|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
14494582|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494583|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494584|NCT02731131|Ribavirin|ribavirin|mesh-list
14494585|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14494586|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
14494587|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494588|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
14199621|NCT04559425|BB 1101|bb 1101|mesh-list
14199622|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199623|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
14199624|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
14494589|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494590|NCT02731313|Trastuzumab|trastuzumab|mesh-list
14494591|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494592|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494593|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
14494594|NCT02731469|Hematinics|hematinics|mesh-ancestor
14494595|NCT02731638|Voriconazole|voriconazole|mesh-list
14494596|NCT02731638|Natamycin|natamycin|mesh-list
14494597|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
14494598|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494599|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14494600|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14494601|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494602|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494603|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14494604|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
14494605|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772661|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199625|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494606|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494607|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14494608|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14494609|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494610|NCT02731729|Nivolumab|nivolumab|mesh-list
14494611|NCT02731729|Ipilimumab|ipilimumab|mesh-list
14940717|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940718|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
14940719|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940720|NCT01494857|Adalimumab|adalimumab|mesh-list
14494612|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494613|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494614|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14494615|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494616|NCT02731820|Vitamin D|vitamin d|mesh-list
14494617|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
14494618|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
14494619|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
14494620|NCT02731820|Calcium|calcium|mesh-list
14494621|NCT02731820|Vitamins|vitamins|mesh-ancestor
14494622|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
14494623|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494624|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14494625|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14772662|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772663|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772664|NCT00649402|Amlodipine|amlodipine|mesh-list
14772665|NCT00649402|Benazepril|benazepril|mesh-list
14772666|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772667|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14772668|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772669|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772670|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14772671|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772672|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
14772673|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14772674|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772675|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772676|NCT00649415|Valdecoxib|valdecoxib|mesh-list
14772677|NCT00649415|Piroxicam|piroxicam|mesh-list
14772678|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14772679|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14772680|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772681|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772682|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13964014|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964015|NCT03140358|Atropine|atropine|mesh-list
13964016|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13964017|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13964018|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14772683|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14772684|NCT00649415|Analgesics|analgesics|mesh-ancestor
14772685|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
14772686|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772687|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772688|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772689|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772690|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14772691|NCT00649441|Quinapril|quinapril|mesh-list
14772692|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14940721|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940722|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940723|NCT01495026|Tamsulosin|tamsulosin|mesh-list
14940724|NCT01495026|Dutasteride|dutasteride|mesh-list
14940725|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14940726|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13964019|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
13964020|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964021|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964022|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13964023|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
13964024|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
13964025|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
13964026|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13964027|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14494626|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494627|NCT02731820|Antacids|antacids|mesh-ancestor
14494628|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494629|NCT02731820|Diuretics|diuretics|mesh-ancestor
14494630|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
14494631|NCT02731820|Expectorants|expectorants|mesh-ancestor
14494632|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
14494633|NCT02731833|Fluorides|fluorides|mesh-list
14494634|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
14494635|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
14494636|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
14494637|NCT02731833|Protective Agents|protective agents|mesh-ancestor
14494638|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494639|NCT02732015|Dexamethasone|dexamethasone|mesh-list
14494640|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
14494641|NCT02732015|Doxorubicin|doxorubicin|mesh-list
14494642|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14494643|NCT02732015|Vincristine|vincristine|mesh-list
14494644|NCT02732015|Daunorubicin|daunorubicin|mesh-list
14494645|NCT02732015|Ifosfamide|ifosfamide|mesh-list
14494646|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
14494647|NCT02732015|Ondansetron|ondansetron|mesh-list
14494648|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
14494649|NCT02732015|Aprepitant|aprepitant|mesh-list
14494650|NCT02732015|BB 1101|bb 1101|mesh-list
14494651|NCT02732015|Rolapitant|rolapitant|mesh-list
14494652|NCT02732015|Mesna|mesna|mesh-list
14199626|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494653|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494654|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
14494655|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
14494656|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494657|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494658|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494659|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
14940727|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14940728|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
14940729|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940730|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494660|NCT02732015|Hormones|hormones|mesh-ancestor
14772693|NCT00649441|Diuretics|diuretics|mesh-ancestor
14772694|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772695|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772696|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14772697|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494661|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494662|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14494663|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494664|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
14494665|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494666|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494667|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14772698|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772699|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14199627|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199628|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
14199629|NCT04559425|Hormones|hormones|mesh-ancestor
14199630|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199631|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199632|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199633|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
14199634|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199635|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199636|NCT04559607|Apatinib|apatinib|mesh-list
14199637|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199638|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199639|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199640|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199641|NCT04559412|Etanercept|etanercept|mesh-list
14199642|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14494668|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14494669|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14494670|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14494671|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14494672|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
14199643|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14199644|NCT04559412|Analgesics|analgesics|mesh-ancestor
14199645|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
14199646|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199647|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199648|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199649|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14199650|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199651|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199652|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
14494673|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14494674|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
14494675|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
14494676|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14494677|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
14494678|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494679|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14494680|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14494681|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494682|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494683|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14494684|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14494685|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
14494686|NCT02732015|Protective Agents|protective agents|mesh-ancestor
14494687|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14494688|NCT02732119|Everolimus|everolimus|mesh-list
14199653|NCT04559568|Midazolam|midazolam|mesh-list
14199654|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14199655|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14199656|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199657|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199658|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14199659|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14199660|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14199661|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14199662|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
14199663|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
14199664|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
14199665|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
14199666|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199667|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199668|NCT04559308|Metformin|metformin|mesh-list
14199669|NCT04559308|Paclitaxel|paclitaxel|mesh-list
14199670|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
14199671|NCT04559308|Doxorubicin|doxorubicin|mesh-list
14199672|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14199673|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199674|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
14199675|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
14199676|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
14199677|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199678|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199679|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
14494689|NCT02732119|Exemestane|exemestane|mesh-list
14494690|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494691|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494692|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
14494693|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494694|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14494695|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14199680|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494696|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528198|NCT03892707|Celecoxib|celecoxib|mesh-list
14528199|NCT03892707|Etoricoxib|etoricoxib|mesh-list
14528200|NCT03892707|Meloxicam|meloxicam|mesh-list
14528201|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14528202|NCT03892707|Nimesulide|nimesulide|mesh-list
14528203|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14528204|NCT03892707|Benphothiamine|benphothiamine|mesh-list
14528205|NCT03892707|Vitamins|vitamins|mesh-ancestor
14528206|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
14528207|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528208|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14528209|NCT03892707|Analgesics|analgesics|mesh-ancestor
14528210|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
14528211|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528212|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528213|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14494697|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494698|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14494699|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
14494700|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494701|NCT02732587|Saracatinib|saracatinib|mesh-list
14494702|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494703|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494704|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494705|NCT02732639|Interferons|interferons|mesh-list
14494706|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494707|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
14494708|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494709|NCT02732899|Sirolimus|sirolimus|mesh-list
14494710|NCT02732899|Aflibercept|aflibercept|mesh-list
14494711|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14494712|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494713|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14494714|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494715|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
14494716|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494717|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
14494718|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494719|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14494720|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14494721|NCT02732899|Growth Substances|growth substances|mesh-ancestor
14494722|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
14494723|NCT02732912|Zopiclone|zopiclone|mesh-list
14494724|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14494725|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494726|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940731|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940732|NCT01495026|Urological Agents|urological agents|mesh-ancestor
14940733|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14940734|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14940735|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940736|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
14494727|NCT02732938|Gemcitabine|gemcitabine|mesh-list
14494728|NCT02732938|Paclitaxel|paclitaxel|mesh-list
14494729|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14494730|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494731|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
14199681|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14199682|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14199683|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
14199684|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14199685|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14199686|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14199687|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14199688|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14494732|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
14494733|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
14494734|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494735|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14494736|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
14494737|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
14494738|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494739|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494740|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199689|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199690|NCT04559165|Chitosan|chitosan|mesh-list
14199691|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14199692|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14199693|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
14199694|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199695|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14199696|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
14494741|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
14494742|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494743|NCT02733588|Glucagon|glucagon|mesh-list
14940737|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199697|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
14494744|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14494745|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494746|NCT02733588|Hormones|hormones|mesh-ancestor
14940738|NCT01495039|Nystatin|nystatin|mesh-list
14199698|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
14199699|NCT04559165|Coagulants|coagulants|mesh-ancestor
14199700|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
14199701|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
14199702|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199703|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
14199704|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199705|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199706|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
14199707|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14199708|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14199709|NCT04559113|Prednisolone|prednisolone|mesh-list
14494747|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494748|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494749|NCT02733588|Incretins|incretins|mesh-ancestor
14494750|NCT02733757|Clonidine|clonidine|mesh-list
14494751|NCT02733757|Analgesics|analgesics|mesh-ancestor
14494752|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
14494753|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494754|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494755|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14494756|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
14494757|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
14494758|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14494759|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14494760|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14494761|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772700|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772701|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772702|NCT00649454|Metformin|metformin|mesh-list
14772703|NCT00649454|Glipizide|glipizide|mesh-list
14772704|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772705|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772706|NCT00649467|Topiramate|topiramate|mesh-list
14772707|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
14772708|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772709|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772710|NCT00649480|Balsalazide|balsalazide|mesh-list
14772711|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14199710|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
14199711|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14199712|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
14199713|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199714|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
14199715|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
14199716|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199717|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199718|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199719|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
14199720|NCT04559113|Hormones|hormones|mesh-ancestor
14199721|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199722|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14199723|NCT04559113|Protective Agents|protective agents|mesh-ancestor
14199724|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199725|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199726|NCT04559074|Amlodipine|amlodipine|mesh-list
14199727|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14199728|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14199729|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199730|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199731|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14199732|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199733|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
14199734|NCT04559048|Tacrolimus|tacrolimus|mesh-list
14199735|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199736|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
14199737|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199738|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14199739|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199740|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199741|NCT04558892|Enoxaparin|enoxaparin|mesh-list
14199742|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
14199743|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14494762|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494763|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772712|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14494764|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
14494765|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
14494766|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494767|NCT02734147|Protective Agents|protective agents|mesh-ancestor
14494768|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494769|NCT02734147|Vitamins|vitamins|mesh-ancestor
14494770|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
14494771|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
14494772|NCT02734238|Testosterone|testosterone|mesh-list
14494773|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
14494774|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
14494775|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14494776|NCT02734238|Androgens|androgens|mesh-ancestor
14494777|NCT02734238|Hormones|hormones|mesh-ancestor
14494778|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494779|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494780|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14494781|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494782|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
14494783|NCT02734355|Amlodipine|amlodipine|mesh-list
14494784|NCT02734355|Telmisartan|telmisartan|mesh-list
14494785|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14494786|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14494787|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14494788|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494789|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494790|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14494791|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494792|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
14494793|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14494794|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14494795|NCT02734862|Fluconazole|fluconazole|mesh-list
14494796|NCT02734862|Caspofungin|caspofungin|mesh-list
14494797|NCT02734862|Rezafungin|rezafungin|mesh-list
14494798|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
14494799|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199744|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14199745|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199746|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
14199747|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14199748|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199749|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
14199750|NCT04558736|Fludarabine|fludarabine|mesh-list
14199751|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
14199752|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14199753|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199754|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
14199755|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199756|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494800|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14494801|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14494802|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494803|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494804|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14772713|NCT00649480|Analgesics|analgesics|mesh-ancestor
14772714|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
14772715|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772716|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772717|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772718|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772719|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772720|NCT00649493|Rabeprazole|rabeprazole|mesh-list
14772721|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14772722|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772723|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14772724|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772725|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772726|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
14772727|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14772728|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772729|NCT00649506|Renal Agents|renal agents|mesh-ancestor
14199757|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14199758|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
14772730|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772731|NCT00649519|Amlodipine|amlodipine|mesh-list
14199759|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199760|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199761|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14199762|NCT04558580|Rufinamide|rufinamide|mesh-list
14199763|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
14199764|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14199765|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14199766|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14199767|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199768|NCT04558463|Oseltamivir|oseltamivir|mesh-list
14199769|NCT04558463|Favipiravir|favipiravir|mesh-list
14494805|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
14494806|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494807|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494808|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14494809|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14494810|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
14199770|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
14199771|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199772|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199773|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239258|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14239259|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14239260|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14239261|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239262|NCT00141518|Levodopa|levodopa|mesh-list
14239263|NCT00141518|Carbidopa|carbidopa|mesh-list
14239264|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14239265|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14239266|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14239267|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
14239268|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239269|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239270|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239271|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14239272|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239273|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14239274|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
14239275|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
14494811|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14494812|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
14239276|NCT00141726|Etanercept|etanercept|mesh-list
14239277|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14239278|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14239279|NCT00141726|Analgesics|analgesics|mesh-ancestor
14239280|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
14239281|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239282|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239283|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239284|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239285|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239286|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14494813|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494814|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494815|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14494816|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
14494817|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14494818|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
14494819|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494820|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494821|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14494822|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
14494823|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
14494824|NCT02734953|Protective Agents|protective agents|mesh-ancestor
14239287|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
14239288|NCT00141739|Etanercept|etanercept|mesh-list
14494825|NCT02735187|Vitamin D|vitamin d|mesh-list
14494826|NCT02735187|Vitamins|vitamins|mesh-ancestor
14494827|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
14494828|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239289|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14494829|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14494830|NCT02735200|Vitamin D|vitamin d|mesh-list
14494831|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
14494832|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
14494833|NCT02735200|Vitamins|vitamins|mesh-list
14494834|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
14494835|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494836|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14494837|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14199774|NCT04558268|Folic Acid|folic acid|mesh-list
14199775|NCT04558268|Prednisone|prednisone|mesh-list
14199776|NCT04558268|Progesterone|progesterone|mesh-list
14199777|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199778|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
14199779|NCT04558268|Hormones|hormones|mesh-ancestor
14199780|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199781|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199782|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199783|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199784|NCT04558268|Progestins|progestins|mesh-ancestor
14494838|NCT02735421|Adapalene|adapalene|mesh-list
14494839|NCT02735421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14494840|NCT02735421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14494841|NCT02735421|Analgesics|analgesics|mesh-ancestor
14494842|NCT02735421|Sensory System Agents|sensory system agents|mesh-ancestor
14494843|NCT02735421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494844|NCT02735421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494845|NCT02735421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494846|NCT02735421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14494847|NCT02735421|Dermatologic Agents|dermatologic agents|mesh-ancestor
14528214|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14528215|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528216|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528217|NCT03892707|Hematinics|hematinics|mesh-ancestor
14528218|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14528219|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
14528220|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
14528221|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
14528222|NCT03889444|Dexamethasone|dexamethasone|mesh-list
14528223|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528224|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
14528225|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
14528226|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528227|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528228|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528229|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
14528230|NCT03889444|Hormones|hormones|mesh-ancestor
14528231|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528232|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14528233|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528234|NCT03888755|Icatibant|icatibant|mesh-list
14528235|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14528236|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14528237|NCT03888755|Analgesics|analgesics|mesh-ancestor
14528238|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
14528239|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528240|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528241|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528242|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528243|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14528244|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14528245|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528246|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14528247|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14528248|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
14528249|NCT03888365|Treprostinil|treprostinil|mesh-list
14528250|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14528251|NCT03887442|Paclitaxel|paclitaxel|mesh-list
14528252|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14528253|NCT03887442|Cetuximab|cetuximab|mesh-list
14528254|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14528255|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528256|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14528257|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14528258|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14530028|NCT03370536|Ibutilide|ibutilide|mesh-list
14199785|NCT04558268|Hematinics|hematinics|mesh-ancestor
14199786|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
14494848|NCT02735577|Disulfiram|disulfiram|mesh-list
14494849|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14494850|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14494851|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494852|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494853|NCT02736175|Dexamethasone|dexamethasone|mesh-list
14494854|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494855|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
14494856|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
14199787|NCT04558268|Vitamins|vitamins|mesh-ancestor
14199788|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
14199789|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
14199790|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
14199791|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199792|NCT04558424|Protective Agents|protective agents|mesh-ancestor
14199793|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199794|NCT04558424|Vitamins|vitamins|mesh-ancestor
14199795|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
14199796|NCT04558281|Ropivacaine|ropivacaine|mesh-list
14494857|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494858|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494859|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14494860|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
14494861|NCT02736175|Hormones|hormones|mesh-ancestor
14494862|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494863|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14494864|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494865|NCT02736409|Budesonide|budesonide|mesh-list
14494866|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14494867|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14494868|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
14494869|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494870|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494871|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14494872|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
14494873|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
14494874|NCT02736409|Hormones|hormones|mesh-ancestor
14494875|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494876|NCT02736474|Naltrexone|naltrexone|mesh-list
14494877|NCT02736474|Bupropion|bupropion|mesh-list
14494878|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14494879|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14494880|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494881|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
14494882|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494883|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14494884|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
14494885|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494886|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14494887|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772732|NCT00649519|Benazepril|benazepril|mesh-list
14772733|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772734|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14772735|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772736|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772737|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14772738|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940739|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14940740|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940741|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
14940742|NCT01495039|Ionophores|ionophores|mesh-ancestor
14940743|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964028|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
13964029|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964030|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964031|NCT03140293|Lidocaine|lidocaine|mesh-list
13964032|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
13964033|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
13964034|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
13964035|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199797|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
14199798|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
14199799|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199800|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199801|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
14494888|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494889|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494890|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
14494891|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494892|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14494893|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14494894|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494895|NCT02736578|Cetuximab|cetuximab|mesh-list
14494896|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494897|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494898|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14494899|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
14494900|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494901|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
14494902|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14494903|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14494904|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14772739|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
14772740|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14199802|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199803|NCT04558021|Niclosamide|niclosamide|mesh-list
14199804|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
14199805|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14199806|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
14199807|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14199808|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199809|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
14772741|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772742|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199810|NCT04557878|Mitogens|mitogens|mesh-list
14494905|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494906|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494907|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
14494908|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494909|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494910|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14199811|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
14199812|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199813|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
14199814|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14199815|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
14199816|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199817|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
14199818|NCT04557943|Protective Agents|protective agents|mesh-ancestor
14199819|NCT04557475|Aspirin|aspirin|mesh-list
14199820|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14494911|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494912|NCT02737072|Durvalumab|durvalumab|mesh-list
14494913|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14494914|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494915|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
14494916|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199821|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14199822|NCT04557475|Analgesics|analgesics|mesh-ancestor
14199823|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
14199824|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494917|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14494918|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494919|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494920|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
14494921|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14494922|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494923|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14494924|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
14494925|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14494926|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
14494927|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494928|NCT02737358|Expectorants|expectorants|mesh-ancestor
14199825|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199826|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199827|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14199828|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14199829|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14199830|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199831|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14199832|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14199833|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199834|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
14199835|NCT04557397|Itraconazole|itraconazole|mesh-list
14199836|NCT04557397|Rifampin|rifampin|mesh-list
14199837|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
14199838|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199839|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14199840|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14494929|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
14772743|NCT00649532|Ondansetron|ondansetron|mesh-list
14772744|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
14772745|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
14772746|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772747|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772748|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772749|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
14772750|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
14772751|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14772752|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
14772753|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772754|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772755|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14772756|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772757|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772758|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772759|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14772760|NCT00649545|Adalimumab|adalimumab|mesh-list
14772761|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772762|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772763|NCT00649558|Pioglitazone|pioglitazone|mesh-list
14772764|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772765|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772766|NCT00649571|Doxycycline|doxycycline|mesh-list
14772767|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772768|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772769|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
14772770|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14772771|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14772772|NCT00649584|Gemcitabine|gemcitabine|mesh-list
14772773|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14772774|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14772775|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
14772776|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199841|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199842|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199843|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14199844|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
14199845|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199846|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494930|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14772777|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772778|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
14494931|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
14494932|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494933|NCT02737358|Protective Agents|protective agents|mesh-ancestor
14494934|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494935|NCT02737358|Antidotes|antidotes|mesh-ancestor
14494936|NCT02737501|Crizotinib|crizotinib|mesh-list
14494937|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14494938|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14199847|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14199848|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14199849|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
14199850|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14199851|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
14199852|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14199853|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14199854|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14199855|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14199856|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14199857|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14199858|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14199859|NCT04557384|Ramucirumab|ramucirumab|mesh-list
14199860|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199861|NCT04557163|Itraconazole|itraconazole|mesh-list
14199862|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
14199863|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199864|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14494939|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494940|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494941|NCT02737826|Buprenorphine|buprenorphine|mesh-list
14494942|NCT02737826|Gabapentin|gabapentin|mesh-list
14494943|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14494944|NCT02737826|Narcotics|narcotics|mesh-ancestor
14199865|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14199866|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199867|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199868|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14199869|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
14494945|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14494946|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199870|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199871|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199872|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14199873|NCT04557137|Somatostatin|somatostatin|mesh-list
14199874|NCT04557137|Hormones|hormones|mesh-ancestor
14199875|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199876|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199877|NCT04557202|Tamsulosin|tamsulosin|mesh-list
14199878|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14199879|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14199880|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14199881|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
14199882|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199883|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199884|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199885|NCT04557202|Urological Agents|urological agents|mesh-ancestor
14199886|NCT04557020|Gemcitabine|gemcitabine|mesh-list
14772779|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772780|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772781|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14772782|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
14772783|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772784|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14772785|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14772786|NCT00649597|Benazepril|benazepril|mesh-list
14772787|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772788|NCT00649597|Diuretics|diuretics|mesh-ancestor
14772789|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772790|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772791|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14772792|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772793|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494947|NCT02737826|Analgesics|analgesics|mesh-ancestor
14494948|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
14494949|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494950|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14494951|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
14494952|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14494953|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14494954|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494955|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14494956|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14494957|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494958|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494959|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
14494960|NCT02737891|Metoprolol|metoprolol|mesh-list
14494961|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14494962|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14494963|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
14494964|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
14494965|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14494966|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494967|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14494968|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14494969|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14494970|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14494971|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199887|NCT04557020|Cisplatin|cisplatin|mesh-list
14199888|NCT04557020|Antibodies|antibodies|mesh-list
14199889|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
14199890|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199891|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14199892|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
14199893|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199894|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199895|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
14199896|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199897|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199898|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199899|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14199900|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14199901|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
14199902|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
14199903|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14199904|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199905|NCT04556760|Prednisolone|prednisolone|mesh-list
14199906|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199907|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
14199908|NCT04556760|Hormones|hormones|mesh-ancestor
14199909|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199910|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199911|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199912|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199913|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
14199914|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14199915|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199916|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
14239290|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14239291|NCT00141739|Analgesics|analgesics|mesh-ancestor
14239292|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
14239293|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239294|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239295|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239296|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239297|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239298|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239299|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
14239300|NCT00141778|Ramipril|ramipril|mesh-list
14239301|NCT00141778|Spironolactone|spironolactone|mesh-list
14239302|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14494972|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494973|NCT02737930|Fluoxetine|fluoxetine|mesh-list
14239303|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14239304|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14239305|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
14494974|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14199917|NCT04556110|Perindopril|perindopril|mesh-list
14199918|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14199919|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
14199920|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199921|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199922|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14494975|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14494976|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14494977|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494978|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14494979|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
14494980|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14494981|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14494982|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
14494983|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14494984|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14494985|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14494986|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494987|NCT02738008|Tenofovir|tenofovir|mesh-list
14494988|NCT02738008|Entecavir|entecavir|mesh-list
14494989|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
14494990|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14494991|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
14494992|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14494993|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14494994|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14494995|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14494996|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14494997|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14494998|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14494999|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
14940744|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940745|NCT01495104|Valproic Acid|valproic acid|mesh-list
14940746|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
14940747|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940748|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940749|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
14199923|NCT04556136|Vitamin D|vitamin d|mesh-list
14199924|NCT04556136|Vitamins|vitamins|mesh-ancestor
14495000|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940750|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940751|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940752|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
14940753|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14495001|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495002|NCT02738151|Insulin|insulin|mesh-list
14495003|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14199925|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
14199926|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199927|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14199928|NCT04556058|Perindopril|perindopril|mesh-list
14199929|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14199930|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
14199931|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199932|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495004|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
14495005|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14495006|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495007|NCT02738203|Lidocaine|lidocaine|mesh-list
14495008|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
14495009|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
14199933|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14199934|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14199935|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
14199936|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199937|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199938|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14199939|NCT04556279|Diuretics|diuretics|mesh-ancestor
14199940|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
14199941|NCT04556032|Ergothioneine|ergothioneine|mesh-list
14199942|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
14495010|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199943|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199944|NCT04556032|Protective Agents|protective agents|mesh-ancestor
14199945|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199946|NCT04556071|Bevacizumab|bevacizumab|mesh-list
14199947|NCT04556071|Niraparib|niraparib|mesh-list
14199948|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495011|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495012|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
14495013|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495014|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14495015|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14495016|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14495017|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14495018|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495019|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
14495020|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
14495021|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495022|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14495023|NCT02738580|Hormones|hormones|mesh-ancestor
14495024|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495025|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495026|NCT02738879|Metformin|metformin|mesh-list
14495027|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
14495028|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14495029|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14495030|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495031|NCT02738879|Incretins|incretins|mesh-ancestor
14495032|NCT02738879|Hormones|hormones|mesh-ancestor
14495033|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495034|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14495035|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
14495036|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495037|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495038|NCT02739360|Idelalisib|idelalisib|mesh-list
14495039|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495040|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495041|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495042|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
14495043|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
14495044|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14495045|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495046|NCT02739698|Paclitaxel|paclitaxel|mesh-list
14199949|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199950|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14199951|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14199952|NCT04556071|Growth Substances|growth substances|mesh-ancestor
14199953|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199954|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
14199955|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14199956|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199957|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199958|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
14199959|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14199960|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199961|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14199962|NCT04555694|Cyclosporine|cyclosporine|mesh-list
14199963|NCT04555694|Dexamethasone|dexamethasone|mesh-list
14199964|NCT04555694|Cyclosporins|cyclosporins|mesh-list
14199965|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14199966|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
14199967|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
14199968|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199969|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495047|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14495048|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495049|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
14772794|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14772795|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772796|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772797|NCT00649610|Diclofenac|diclofenac|mesh-list
14772798|NCT00649610|Valdecoxib|valdecoxib|mesh-list
14772799|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14772800|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14772801|NCT00649610|Analgesics|analgesics|mesh-ancestor
14495050|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
14495051|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
14495052|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495053|NCT02739828|Adalimumab|adalimumab|mesh-list
14495054|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495055|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772802|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
14772803|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772804|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772805|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772806|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772807|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14772808|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495056|NCT02739984|Evolocumab|evolocumab|mesh-list
14495057|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14495058|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14495059|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14495060|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
14495061|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495062|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14772809|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772810|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14772811|NCT00649623|Olmesartan|olmesartan|mesh-list
14772812|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14772813|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772814|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14772815|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14772816|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940754|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940755|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14199970|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14199971|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
14495063|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
14495064|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495065|NCT02739997|Metronidazole|metronidazole|mesh-list
14495066|NCT02739997|Tazobactam|tazobactam|mesh-list
14199972|NCT04555694|Hormones|hormones|mesh-ancestor
14199973|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14199974|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14199975|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14199976|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199977|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199978|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14199979|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
14199980|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
14199981|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14199982|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
14199983|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495067|NCT02739997|Ceftolozane|ceftolozane|mesh-list
14495068|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495069|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14495070|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14495071|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14495072|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14495073|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495074|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495075|NCT02740114|Oxycodone|oxycodone|mesh-list
14495076|NCT02740114|Bupivacaine|bupivacaine|mesh-list
14495077|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
14495078|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
14495079|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495080|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495081|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
14495082|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495083|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14495084|NCT02740114|Narcotics|narcotics|mesh-ancestor
14495085|NCT02740114|Analgesics|analgesics|mesh-ancestor
14495086|NCT02740543|Fluticasone|fluticasone|mesh-list
14495087|NCT02740543|Xhance|xhance|mesh-list
14495088|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495089|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14495090|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
14495091|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495092|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495093|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14495094|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495095|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
14772817|NCT00649636|Fluoxetine|fluoxetine|mesh-list
14772818|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14772819|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14772820|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772821|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772822|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772823|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
14772824|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772825|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14772826|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
14772827|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772828|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14772829|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14772830|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772831|NCT00649649|Quinapril|quinapril|mesh-list
14772832|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14772833|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
14772834|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772835|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772836|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772837|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
14772838|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772839|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772840|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14772841|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14772842|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772843|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772844|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14772845|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14772846|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14772847|NCT00649675|Meloxicam|meloxicam|mesh-list
14772848|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14772849|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14772850|NCT00649675|Analgesics|analgesics|mesh-ancestor
14772851|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
14772852|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772853|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772854|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772855|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772856|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14772857|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14772858|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772859|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772860|NCT00649688|Metoprolol|metoprolol|mesh-list
14772861|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14495096|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14495097|NCT02740582|Tolcapone|tolcapone|mesh-list
14495098|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14495099|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14495100|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14495101|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495102|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495103|NCT02740660|Caffeine|caffeine|mesh-list
14495104|NCT02740660|Albuterol|albuterol|mesh-list
14495105|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14495106|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495107|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14495108|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14199984|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14199985|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14199986|NCT04555733|Lemborexant|lemborexant|mesh-list
14199987|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14495109|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495110|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14495111|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14495112|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
14495113|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495114|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14495115|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
14495116|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495117|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14495118|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495119|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
14495120|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14495121|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14495122|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14495123|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14495124|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
14495125|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
14495126|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495127|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495128|NCT02741076|Oxymorphone|oxymorphone|mesh-list
14772862|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14772863|NCT00649688|Diuretics|diuretics|mesh-ancestor
14772864|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
14772865|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772866|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14772867|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940756|NCT01495117|Iodine|iodine|mesh-list
14940757|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
14495129|NCT02741076|Morphine|morphine|mesh-list
14495130|NCT02741076|Oxycodone|oxycodone|mesh-list
14495131|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
14495132|NCT02741076|Narcotics|narcotics|mesh-ancestor
14495133|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495134|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495135|NCT02741076|Analgesics|analgesics|mesh-ancestor
14495136|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
14495137|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199988|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14199989|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14199990|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14199991|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14199992|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14199993|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14199994|NCT04555707|Betamethasone|betamethasone|mesh-list
14199995|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
14199996|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14199997|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
14495138|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14495139|NCT02741310|Sumatriptan|sumatriptan|mesh-list
14495140|NCT02741310|Erenumab|erenumab|mesh-list
14495141|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14495142|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14495143|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14495144|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
14495145|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495146|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495147|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495148|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14495149|NCT02741310|Analgesics|analgesics|mesh-ancestor
14495150|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
14495151|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495152|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14495153|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
14495154|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495155|NCT02741687|Insulin|insulin|mesh-list
14495156|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14495157|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
14940758|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14495158|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14940759|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
14495159|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
14940760|NCT01495117|Povidone|povidone|mesh-list
14772868|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772869|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14772870|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
14772871|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
14772872|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772873|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14772874|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14772875|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14772876|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772877|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772878|NCT00649714|Zonisamide|zonisamide|mesh-list
14772879|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
14772880|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14772881|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772882|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772883|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14772884|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772885|NCT00649727|Oxybutynin|oxybutynin|mesh-list
14772886|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
14772887|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
14772888|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772889|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772890|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14940761|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14940762|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14940763|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940764|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
14940765|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
14940766|NCT01495117|Trace Elements|trace elements|mesh-ancestor
14940767|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
14940768|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964036|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964037|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
13964038|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14199998|NCT04555707|Apremilast|apremilast|mesh-list
14199999|NCT04555707|Calcipotriene|calcipotriene|mesh-list
14200000|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14200001|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200002|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
14200003|NCT04555707|Hormones|hormones|mesh-ancestor
14200004|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200005|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200006|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14239306|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
14239307|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239308|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239309|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14239310|NCT00141778|Diuretics|diuretics|mesh-ancestor
14239311|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
14239312|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
14239313|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239314|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14239315|NCT00141778|Hormones|hormones|mesh-ancestor
14239316|NCT00141817|Pantoprazole|pantoprazole|mesh-list
14239317|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14239318|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239319|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14239320|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964039|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13964040|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13964041|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13964042|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964043|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964044|NCT03140332|Sorafenib|sorafenib|mesh-list
13964045|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964046|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13964047|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964048|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964049|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
13964050|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
13964051|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13964052|NCT03140397|Estrogens|estrogens|mesh-ancestor
13964053|NCT03140397|Hormones|hormones|mesh-ancestor
14495160|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
14495161|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
14495162|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14495163|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495164|NCT02741687|Incretins|incretins|mesh-ancestor
14495165|NCT02741687|Hormones|hormones|mesh-ancestor
14495166|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495167|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14495168|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
14495169|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495170|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495171|NCT02741713|Lidocaine|lidocaine|mesh-list
14495172|NCT02741713|Clonidine|clonidine|mesh-list
14495173|NCT02741713|Epinephrine|epinephrine|mesh-list
14495174|NCT02741713|Racepinephrine|racepinephrine|mesh-list
14495175|NCT02741713|Bupivacaine|bupivacaine|mesh-list
14495176|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14495177|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
14495178|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
14495179|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
14495180|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200007|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495181|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495182|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
14495183|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495184|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14495185|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14495186|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14495187|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14495188|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495189|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14495190|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14495191|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
14495192|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495193|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14495194|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14495195|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
14495196|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14495197|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495198|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
14495199|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
14495200|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14495201|NCT02741713|Analgesics|analgesics|mesh-ancestor
14495202|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14495203|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
14495204|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14495205|NCT02742519|Ivacaftor|ivacaftor|mesh-list
14495206|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14495207|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14495208|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495209|NCT02742532|Oxytocin|oxytocin|mesh-list
14495210|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
14495211|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14495212|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495213|NCT02742649|Timolol|timolol|mesh-list
14495214|NCT02742649|Bimatoprost|bimatoprost|mesh-list
14495215|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14495216|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14495217|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14495218|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200008|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14200009|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14200010|NCT04555707|Analgesics|analgesics|mesh-ancestor
14200011|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
14200012|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200013|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200014|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14200015|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14200016|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200017|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200018|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200019|NCT04555525|Sarecycline|sarecycline|mesh-list
14200020|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14200021|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200022|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200023|NCT04555304|Paclitaxel|paclitaxel|mesh-list
14495219|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495220|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495221|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14200024|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14200025|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14200026|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200027|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
14200028|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200029|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200030|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200031|NCT04555291|Ropivacaine|ropivacaine|mesh-list
14200032|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
14200033|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
14200034|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200035|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495222|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14495223|NCT02742987|Clopidogrel|clopidogrel|mesh-list
14495224|NCT02742987|Ticagrelor|ticagrelor|mesh-list
14495225|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14495226|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14495227|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14495228|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14495229|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
14495230|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495231|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495232|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495233|NCT02743078|Bevacizumab|bevacizumab|mesh-list
14495234|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495235|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495236|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14200036|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
14200037|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200038|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14200039|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
14200040|NCT04554979|Anticoagulants|anticoagulants|mesh-list
14200041|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200042|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
14200043|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14200044|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14200045|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200046|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200047|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200048|NCT04554654|Progesterone|progesterone|mesh-list
14200049|NCT04554654|Progestins|progestins|mesh-ancestor
14200050|NCT04554654|Hormones|hormones|mesh-ancestor
14200051|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200052|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200053|NCT04554680|Trametinib|trametinib|mesh-list
14200054|NCT04554680|Dabrafenib|dabrafenib|mesh-list
14200055|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200056|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14200057|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200058|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200059|NCT04554615|Insulin|insulin|mesh-list
14200060|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14200061|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200062|NCT04554862|Ketorolac|ketorolac|mesh-list
14200063|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14200064|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
14200065|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14200066|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14200067|NCT04554862|Analgesics|analgesics|mesh-ancestor
14200068|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
14200069|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200070|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200071|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200072|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200073|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14200074|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495237|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14495238|NCT02743078|Growth Substances|growth substances|mesh-ancestor
14495239|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495240|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
14495241|NCT02743221|Trifluridine|trifluridine|mesh-list
14495242|NCT02743221|Bevacizumab|bevacizumab|mesh-list
14495243|NCT02743221|Capecitabine|capecitabine|mesh-list
14495244|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495245|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495246|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14495247|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14495248|NCT02743221|Growth Substances|growth substances|mesh-ancestor
14495249|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495250|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
14495251|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14495252|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
14495253|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495254|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
14495255|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495256|NCT02743377|Rolipram|rolipram|mesh-list
14495257|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
14495258|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14495259|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14495260|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14495261|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495262|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495263|NCT02743780|MGV354|mgv354|mesh-list
14200075|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200076|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
14200077|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200078|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14200079|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
14200080|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14200081|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14200082|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200083|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
14200084|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14200085|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
14200086|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14495264|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
14495265|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495266|NCT02743949|Esomeprazole|esomeprazole|mesh-list
14495267|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14495268|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14495269|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14495270|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495271|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495272|NCT02744391|Levodopa|levodopa|mesh-list
14495273|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14495274|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14495275|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
14495276|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495277|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495278|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495279|NCT02744755|Adalimumab|adalimumab|mesh-list
14940769|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
14940770|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
14940771|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
14940772|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940773|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14940774|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200087|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14495280|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940775|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495281|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495282|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14495283|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495284|NCT02744898|Paclitaxel|paclitaxel|mesh-list
14495285|NCT02744898|Carboplatin|carboplatin|mesh-list
14495286|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14495287|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14495288|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495289|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
14495290|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
14495291|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
14940776|NCT01495169|Iloperidone|iloperidone|mesh-list
14940777|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14940778|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14940779|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940780|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940781|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940782|NCT01495195|Selegiline|selegiline|mesh-list
14200088|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14200089|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
14200090|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200091|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200092|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200093|NCT04554433|Ethanol|ethanol|mesh-list
14200094|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14200095|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200096|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200097|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200098|NCT04554524|Paclitaxel|paclitaxel|mesh-list
14200099|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
14200100|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14200101|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200102|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
14200103|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200104|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200105|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200106|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239321|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239322|NCT00141921|Etanercept|etanercept|mesh-list
14239323|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14239324|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14495292|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528259|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528260|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14528261|NCT03873987|Oritavancin|oritavancin|mesh-list
14528262|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14528263|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528264|NCT03887299|Disinfectants|disinfectants|mesh-list
14528265|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940783|NCT01495195|Donepezil|donepezil|mesh-list
14940784|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14940785|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940786|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940787|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
14940788|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940789|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940790|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
14940791|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
14940792|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14940793|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14239325|NCT00141921|Analgesics|analgesics|mesh-ancestor
14239326|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
14239327|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239328|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239329|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239330|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239331|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239332|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239333|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
14239334|NCT00142116|Thalidomide|thalidomide|mesh-list
14239335|NCT00142116|Rituximab|rituximab|mesh-list
14239336|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14940794|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14200107|NCT04554303|Amlodipine|amlodipine|mesh-list
14200108|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14200109|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14200110|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14200111|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940795|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14940796|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14940797|NCT01495195|Protective Agents|protective agents|mesh-ancestor
14940798|NCT01495208|Aflibercept|aflibercept|mesh-list
14940799|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14940800|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14940801|NCT01495208|Growth Substances|growth substances|mesh-ancestor
14940802|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940803|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
14940804|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940805|NCT01495260|Vitamin E|vitamin e|mesh-list
14940806|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
14940807|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
14940808|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14940809|NCT01495260|Vitamins|vitamins|mesh-ancestor
14940810|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
14940811|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940812|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
14940813|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940814|NCT01495260|Expectorants|expectorants|mesh-ancestor
14940815|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
14940816|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14940817|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
14940818|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495293|NCT02745080|Adalimumab|adalimumab|mesh-list
14495294|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495295|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495296|NCT02745353|Naloxegol|naloxegol|mesh-list
14495297|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14495298|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495299|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
14495300|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495301|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
14495302|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14495303|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14495304|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
14495305|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495306|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495307|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495308|NCT02746575|Metoprolol|metoprolol|mesh-list
14495309|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14495310|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14495311|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
14772891|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14772892|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
14772893|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772894|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772895|NCT00649727|Urological Agents|urological agents|mesh-ancestor
14772896|NCT00649740|Topiramate|topiramate|mesh-list
14772897|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
14772898|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772899|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200112|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200113|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200114|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
14200115|NCT04554771|Paclitaxel|paclitaxel|mesh-list
14200116|NCT04554771|Carboplatin|carboplatin|mesh-list
14200117|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14200118|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200119|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14495312|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
14495313|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495314|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495315|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14495316|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14495317|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14772900|NCT00649779|Albuterol|albuterol|mesh-list
14940819|NCT01495260|Protective Agents|protective agents|mesh-ancestor
14772901|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14940820|NCT01495260|Antidotes|antidotes|mesh-ancestor
14495318|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
14495319|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495320|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200120|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200121|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200122|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495321|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14495322|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495323|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
14495324|NCT02746991|Hormones|hormones|mesh-ancestor
14495325|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495326|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495327|NCT02747004|Tamoxifen|tamoxifen|mesh-list
14495328|NCT02747004|Loperamide|loperamide|mesh-list
14495329|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
14495330|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14495331|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
14495332|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495333|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495334|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14495335|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495336|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14495337|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14495338|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14495339|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14495340|NCT02747043|Rituximab|rituximab|mesh-list
14495341|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495342|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495343|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
14495344|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495345|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495346|NCT02747186|Lidocaine|lidocaine|mesh-list
14495347|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
14495348|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
14495349|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495350|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495351|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
14495352|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495353|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14495354|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14495355|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14495356|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14495357|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495358|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
14495359|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14495360|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14495361|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495362|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
14495363|NCT02747615|Coagulants|coagulants|mesh-ancestor
14495364|NCT02747628|Melatonin|melatonin|mesh-list
14495365|NCT02747628|Nicotine|nicotine|mesh-list
14495366|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14200142|NCT04553705|Quinine|quinine|mesh-list
14200143|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
14200144|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14200145|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14200146|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200147|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14200148|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200149|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14200150|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200151|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14200152|NCT04553705|Analgesics|analgesics|mesh-ancestor
14200153|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
14200154|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14200155|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14200156|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200157|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
14200158|NCT04553263|Naltrexone|naltrexone|mesh-list
14200159|NCT04553263|Bupropion|bupropion|mesh-list
14200160|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14200161|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14200162|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200163|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
14200164|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200165|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14200166|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
14495367|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
14495368|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495369|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495370|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14495371|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14495372|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
14495373|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495374|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495375|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
14495376|NCT02747628|Protective Agents|protective agents|mesh-ancestor
14495377|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495378|NCT02747875|Fentanyl|fentanyl|mesh-list
14495379|NCT02747875|Methadone|methadone|mesh-list
14495380|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14772902|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
14772903|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772904|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772905|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14772906|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
14200167|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14200168|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14200169|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14200170|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14200171|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200172|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
14200173|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200174|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14200175|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14200176|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200177|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14200178|NCT04553380|Insulin|insulin|mesh-list
14200179|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
14200180|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14200181|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200182|NCT04553393|Decitabine|decitabine|mesh-list
14200183|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14200184|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
14200185|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200186|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200187|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200188|NCT04553510|Bevacizumab|bevacizumab|mesh-list
14200189|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14200190|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200191|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14200192|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14200193|NCT04553510|Growth Substances|growth substances|mesh-ancestor
14200194|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200195|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
14200196|NCT04553458|Ethanol|ethanol|mesh-list
14495381|NCT02747875|Narcotics|narcotics|mesh-ancestor
14495382|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495383|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495384|NCT02747875|Analgesics|analgesics|mesh-ancestor
14495385|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
14495386|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495387|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14495388|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14495389|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
14495390|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
14495391|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
14495392|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495393|NCT02748070|Fluticasone|fluticasone|mesh-list
14495394|NCT02748070|Prednisone|prednisone|mesh-list
14495395|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495396|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
14200197|NCT04553458|Sorafenib|sorafenib|mesh-list
14200198|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200199|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14200200|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200201|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200202|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14200203|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200204|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200205|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200206|NCT04553328|Bupivacaine|bupivacaine|mesh-list
14200207|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
14200208|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
14200209|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200210|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200211|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
14200212|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200213|NCT04552782|Ethanol|ethanol|mesh-list
14200214|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14200215|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200216|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200217|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200218|NCT04552977|Temozolomide|temozolomide|mesh-list
14200219|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14200220|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
14200221|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200222|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495397|NCT02748070|Hormones|hormones|mesh-ancestor
14495398|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495399|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495400|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14495401|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495402|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14495403|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
14495404|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200246|NCT04552951|Vitamin D|vitamin d|mesh-list
14495405|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14495406|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495407|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
14495408|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14495409|NCT02748213|Docetaxel|docetaxel|mesh-list
14495410|NCT02748213|Capecitabine|capecitabine|mesh-list
14495411|NCT02748213|Trastuzumab|trastuzumab|mesh-list
14495412|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495413|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
14495414|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
14495415|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
14495416|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495417|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14495418|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
14495419|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14200247|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
14200248|NCT04552951|Vitamins|vitamins|mesh-ancestor
14495420|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14495421|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495422|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
14495423|NCT02748512|Hormones|hormones|mesh-ancestor
14495424|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495425|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495426|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
14495427|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14495428|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14495429|NCT02748785|Methotrexate|methotrexate|mesh-list
14495430|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14495431|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
14495432|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14495433|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495434|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14772907|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
14772908|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14772909|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14772910|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14772911|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14772912|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14772913|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772914|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772915|NCT00649805|Verapamil|verapamil|mesh-list
14772916|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14200249|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
14200250|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200251|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14200252|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200253|NCT04552808|Yimitasvir|yimitasvir|mesh-list
14200254|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
14200255|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200256|NCT04552743|Plerixafor|plerixafor|mesh-list
14200257|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14200258|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14772917|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14772918|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14772919|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772920|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14772921|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772922|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
14772923|NCT00649818|Lorazepam|lorazepam|mesh-list
14772924|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
14772925|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
14772926|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
14772927|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772928|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772929|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14772930|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14495435|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
14772931|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200259|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
14200260|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200261|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
14200262|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14200263|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200264|NCT04552444|Biapenem|biapenem|mesh-list
14200265|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200266|NCT04552613|Carboplatin|carboplatin|mesh-list
14200267|NCT04552613|Pemetrexed|pemetrexed|mesh-list
14200268|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200269|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200270|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200271|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14200272|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14239337|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239338|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
14239339|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239340|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239341|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239342|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
14239343|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14239344|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239345|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14239346|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14239347|NCT00142116|Growth Substances|growth substances|mesh-ancestor
14239348|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
14239349|NCT00142168|Rituximab|rituximab|mesh-list
14239350|NCT00142168|Lenalidomide|lenalidomide|mesh-list
14239351|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239352|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239353|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
14239354|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239355|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239356|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14239357|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14239358|NCT00142168|Growth Substances|growth substances|mesh-ancestor
14239359|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
14239360|NCT00142298|Telbivudine|telbivudine|mesh-list
14239361|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
14495436|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495437|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495438|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14495439|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495440|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14495441|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14495442|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
14495443|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495444|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14495445|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14495446|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
14495447|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495448|NCT02748889|Carboplatin|carboplatin|mesh-list
14495449|NCT02748889|Etoposide|etoposide|mesh-list
14495450|NCT02748889|Atezolizumab|atezolizumab|mesh-list
14495451|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495452|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14495453|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14495454|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14495455|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495456|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495457|NCT02749370|Etanercept|etanercept|mesh-list
14495458|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14495459|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14495460|NCT02749370|Analgesics|analgesics|mesh-ancestor
14495461|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
14495462|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495463|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495464|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495465|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495466|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14495467|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14772932|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14772933|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14239362|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239363|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14239364|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239365|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200273|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14495468|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
14495469|NCT02749721|Vortioxetine|vortioxetine|mesh-list
14495470|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
14495471|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14495472|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14495473|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14495474|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495475|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495476|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14495477|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14495478|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14495479|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495480|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495481|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
14495482|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14495483|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14495484|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14495485|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14495486|NCT02749799|Betamethasone|betamethasone|mesh-list
14495487|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
14495488|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14495489|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
14495490|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14495491|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495492|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
14200274|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
14200275|NCT04552431|Tamsulosin|tamsulosin|mesh-list
14200276|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14200277|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495493|NCT02749799|Hormones|hormones|mesh-ancestor
14495494|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495495|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495496|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14495497|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495498|NCT02750306|Suvorexant|suvorexant|mesh-list
14495499|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14495500|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14495501|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495502|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495503|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14495504|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495505|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495506|NCT02750332|Nitisinone|nitisinone|mesh-list
14495507|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495508|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495509|NCT02750345|Nitisinone|nitisinone|mesh-list
14495510|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495511|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495512|NCT02750410|Dulaglutide|dulaglutide|mesh-list
14495513|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14495514|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495515|NCT02750514|Nivolumab|nivolumab|mesh-list
14495516|NCT02750514|Ipilimumab|ipilimumab|mesh-list
14495517|NCT02750514|Dasatinib|dasatinib|mesh-list
14495518|NCT02750514|Linrodostat|linrodostat|mesh-list
14495519|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495520|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495521|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14495522|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495523|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14200278|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14200279|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14200280|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200281|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200282|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200283|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14495524|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495525|NCT02750709|Nitisinone|nitisinone|mesh-list
14495526|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772934|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772935|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
14772936|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
14772937|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772938|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772939|NCT00649831|Amoxicillin|amoxicillin|mesh-list
14772940|NCT00649831|Azithromycin|azithromycin|mesh-list
14772941|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772942|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772943|NCT00649844|Ziprasidone|ziprasidone|mesh-list
14772944|NCT00649844|Clozapine|clozapine|mesh-list
14772945|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14200284|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14200285|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14200286|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14200287|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14200288|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200289|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200290|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772946|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
14772947|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772948|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772949|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772950|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14772951|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14772952|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14772953|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14772954|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14772955|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
14772956|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
14772957|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
14772958|NCT00649857|Cetirizine|cetirizine|mesh-list
14772959|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14772960|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14772961|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14772962|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
14772963|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
14772964|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14772965|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772966|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772967|NCT00649870|Valacyclovir|valacyclovir|mesh-list
14772968|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
14772969|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772970|NCT00649883|Vaccines|vaccines|mesh-list
14772971|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
14772972|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772973|NCT00649896|Estradiol|estradiol|mesh-list
14772974|NCT00649896|Estrogens|estrogens|mesh-ancestor
14772975|NCT00649896|Hormones|hormones|mesh-ancestor
14772976|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14772977|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772978|NCT00649922|Adalimumab|adalimumab|mesh-list
14772979|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14772980|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14772981|NCT00649935|Azithromycin|azithromycin|mesh-list
14772982|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14772983|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14772984|NCT00649948|Metformin|metformin|mesh-list
14772985|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14772986|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772987|NCT00649974|Valacyclovir|valacyclovir|mesh-list
14772988|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
14200291|NCT04552431|Urological Agents|urological agents|mesh-ancestor
14200292|NCT04552093|Floxuridine|floxuridine|mesh-list
14495527|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495528|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
14495529|NCT02750761|Tedizolid|tedizolid|mesh-list
14495530|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
14495531|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14495532|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495533|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14495534|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14772989|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807315|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807316|NCT00821080|Sirolimus|sirolimus|mesh-list
14807317|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14495535|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495536|NCT02750800|Adalimumab|adalimumab|mesh-list
14495537|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495538|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495539|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
14495540|NCT02750930|Incretins|incretins|mesh-ancestor
14495541|NCT02750930|Hormones|hormones|mesh-ancestor
14495542|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495543|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495544|NCT02750943|Fluorides|fluorides|mesh-list
14495545|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
14495546|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
14495547|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
14495548|NCT02750943|Protective Agents|protective agents|mesh-ancestor
14495549|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495550|NCT02751320|Citric Acid|citric acid|mesh-list
14495551|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
14200293|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14200294|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
14200295|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200296|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200297|NCT04551924|Ropivacaine|ropivacaine|mesh-list
14200298|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
14200299|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
14200300|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200301|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200302|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
14200303|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200304|NCT04552067|Enoxaparin|enoxaparin|mesh-list
14495552|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
14495553|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14495554|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
14495555|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
14495556|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495557|NCT02751359|Cannabidiol|cannabidiol|mesh-list
14495558|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
14495559|NCT02751385|Nintedanib|nintedanib|mesh-list
14495560|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14495561|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14495562|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495563|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14495564|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495565|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495566|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14495567|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
14495568|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14495569|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495570|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14495571|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14200305|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
14200306|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14200307|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14200308|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200309|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
14200310|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
14200311|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
14200312|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200313|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495572|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14495573|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14495574|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14495575|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14495576|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14200314|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
14200315|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200316|NCT04551755|Doxycycline|doxycycline|mesh-list
14200317|NCT04551755|Ivermectin|ivermectin|mesh-list
14200318|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14200319|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200320|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
14200321|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14200322|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14200323|NCT04551703|Epinephrine|epinephrine|mesh-list
14495577|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14495578|NCT02751450|Fluorides|fluorides|mesh-list
14495579|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
14495580|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
14495581|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
14495582|NCT02751450|Protective Agents|protective agents|mesh-ancestor
14495583|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495584|NCT02751931|Mirabegron|mirabegron|mesh-list
14495585|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14495586|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14495587|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14495588|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
14495589|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495590|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495591|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495592|NCT02751931|Urological Agents|urological agents|mesh-ancestor
14495593|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
14495594|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495595|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495596|NCT02752256|Plasminogen|plasminogen|mesh-list
14495597|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14495598|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14495599|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14495600|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495601|NCT02752633|Allopurinol|allopurinol|mesh-list
14495602|NCT02752633|Febuxostat|febuxostat|mesh-list
14495603|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
14495604|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14772990|NCT00649987|Albuterol|albuterol|mesh-list
14200324|NCT04551703|Racepinephrine|racepinephrine|mesh-list
14200325|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
14200326|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14200327|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14200328|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200329|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200330|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200331|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200332|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14495605|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495606|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
14495607|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495608|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14495609|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
14495610|NCT02752633|Protective Agents|protective agents|mesh-ancestor
14495611|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495612|NCT02752958|Fluorides|fluorides|mesh-list
14495613|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
14495614|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
14495615|NCT02752958|Protective Agents|protective agents|mesh-ancestor
14495616|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495617|NCT02753075|Fluorides|fluorides|mesh-list
14495618|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
14495619|NCT02753075|Protective Agents|protective agents|mesh-ancestor
14495620|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495621|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
14495622|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14495623|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14528266|NCT03886701|Isoniazid|isoniazid|mesh-list
14528267|NCT03886701|Rifapentine|rifapentine|mesh-list
14528268|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
14528269|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14528270|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528271|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14528272|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14528273|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
14528274|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528275|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14528276|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14528277|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
14528278|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14528279|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
14528280|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528281|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
14528282|NCT03885154|Valproic Acid|valproic acid|mesh-list
14528283|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
14528284|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528285|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528286|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
14495624|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495625|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
14495626|NCT02753816|Coagulants|coagulants|mesh-ancestor
14495627|NCT02753881|Doxorubicin|doxorubicin|mesh-list
14495628|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14495629|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14495630|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495631|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14495632|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14495633|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495634|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495635|NCT02753946|Tazobactam|tazobactam|mesh-list
14495636|NCT02753946|Piperacillin|piperacillin|mesh-list
14495637|NCT02753946|Fosfomycin|fosfomycin|mesh-list
14495638|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14495639|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14495640|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495641|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14495642|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495643|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495644|NCT02754518|Valsartan|valsartan|mesh-list
14495645|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14495646|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14495647|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14495648|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14495649|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495650|NCT02754570|Pilocarpine|pilocarpine|mesh-list
14495651|NCT02754570|Miotics|miotics|mesh-ancestor
14495652|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
14495653|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495654|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772991|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14772992|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
14772993|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14772994|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14772995|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14772996|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
14772997|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
14772998|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14772999|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14773000|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14773001|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773002|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773003|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773004|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773005|NCT00650000|Modafinil|modafinil|mesh-list
14773006|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14773007|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773008|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14773009|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14773010|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14773011|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773012|NCT00650013|Midodrine|midodrine|mesh-list
14773013|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
14773014|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
14773015|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773016|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773017|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14773018|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14773019|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14773020|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14940821|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
14940822|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14940823|NCT01495338|Cetirizine|cetirizine|mesh-list
14940824|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14940825|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14940826|NCT01495338|Analgesics|analgesics|mesh-ancestor
14940827|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
14940828|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940829|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940830|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940831|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495655|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14495656|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14495657|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
14495658|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495659|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495660|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
14495661|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14495662|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
14495663|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
14495664|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495665|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495666|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14495667|NCT02755090|Analgesics|analgesics|mesh-ancestor
14495668|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
14495669|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495670|NCT02755116|Olanzapine|olanzapine|mesh-list
14495671|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
14495672|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
14495673|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495674|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495675|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14495676|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14495677|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14495678|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495679|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14495680|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14495681|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14495682|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14495683|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495684|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495685|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
14528287|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528288|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528289|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
14528290|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14528291|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528292|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14528293|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14200333|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14200334|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
14200335|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200336|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14200337|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
14200338|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
14200339|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
14200340|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14200341|NCT04551950|Paclitaxel|paclitaxel|mesh-list
14200342|NCT04551950|Bevacizumab|bevacizumab|mesh-list
14200343|NCT04551950|Carboplatin|carboplatin|mesh-list
14528294|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
14528295|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
14528296|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14528297|NCT03885154|Analgesics|analgesics|mesh-ancestor
14528298|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
14528299|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528300|NCT03883386|Loratadine|loratadine|mesh-list
14528301|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
14528302|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200344|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14773021|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773022|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773023|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773024|NCT00650026|Adalimumab|adalimumab|mesh-list
14773025|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773026|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773027|NCT00650039|Valdecoxib|valdecoxib|mesh-list
14773028|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14773029|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14773030|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773031|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773032|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14773033|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14773034|NCT00650039|Analgesics|analgesics|mesh-ancestor
14773035|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
14773036|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200345|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200346|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
14495686|NCT02755818|Heparin|heparin|mesh-list
14495687|NCT02755818|Calcium heparin|calcium heparin|mesh-list
14495688|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
14495689|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14495690|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14495691|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495692|NCT02756013|Paclitaxel|paclitaxel|mesh-list
14495693|NCT02756013|Carboplatin|carboplatin|mesh-list
14495694|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14495695|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495696|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14495697|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14495698|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14495699|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495700|NCT02756364|Fulvestrant|fulvestrant|mesh-list
14495701|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14495702|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495703|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14495704|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14495705|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
14495706|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495707|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495708|NCT02756572|Cytarabine|cytarabine|mesh-list
14495709|NCT02756572|Cyclosporine|cyclosporine|mesh-list
14495710|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
14495711|NCT02756572|Sirolimus|sirolimus|mesh-list
14495712|NCT02756572|Fludarabine|fludarabine|mesh-list
14495713|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
14495714|NCT02756572|Melphalan|melphalan|mesh-list
14495715|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
14495716|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
14495717|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14495718|NCT02756572|Cladribine|cladribine|mesh-list
14495719|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14495720|NCT02756572|Cyclosporins|cyclosporins|mesh-list
14200347|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200348|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200349|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200350|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14200351|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14495721|NCT02756572|Lenograstim|lenograstim|mesh-list
14495722|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495723|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14495724|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
14495725|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495726|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14495727|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
14495728|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495729|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
14495730|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495731|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14495732|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495733|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
14495734|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
14495735|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495736|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14495737|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14495738|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14495739|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
14495740|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14495741|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14495742|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
14495743|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14495744|NCT02756572|Analgesics|analgesics|mesh-ancestor
14495745|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
14495746|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495747|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14495748|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14495749|NCT02756624|Cetirizine|cetirizine|mesh-list
14495750|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14495751|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14495752|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14773037|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200352|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14200353|NCT04551950|Growth Substances|growth substances|mesh-ancestor
14200354|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200355|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
14200356|NCT04551768|Ribavirin|ribavirin|mesh-list
14200357|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
14200358|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200359|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
14200360|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200361|NCT04551781|Prednisone|prednisone|mesh-list
14200362|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200363|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
14200364|NCT04551781|Hormones|hormones|mesh-ancestor
14200365|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200366|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200367|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14200368|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200369|NCT04551573|Rifapentine|rifapentine|mesh-list
14200370|NCT04551573|Rifampin|rifampin|mesh-list
14200371|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14495753|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
14495754|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
14495755|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495756|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200372|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
14200373|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14200374|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200375|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
14200376|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14200377|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200378|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200379|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14200380|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14200381|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14200382|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14200383|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14200384|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14200385|NCT04551170|Theophylline|theophylline|mesh-list
14200386|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14200387|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
14200388|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200389|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495757|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495758|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14495759|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14495760|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14495761|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495762|NCT02756832|Alogliptin|alogliptin|mesh-list
14495763|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14495764|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495765|NCT02756832|Incretins|incretins|mesh-ancestor
14495766|NCT02756832|Hormones|hormones|mesh-ancestor
14495767|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495768|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14495769|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
14495770|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495771|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495772|NCT02757105|Ondansetron|ondansetron|mesh-list
14495773|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
14495774|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
14495775|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773038|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200390|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14200391|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
14200392|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14773039|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773040|NCT00650052|Zonisamide|zonisamide|mesh-list
14773041|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
14773042|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14773043|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773044|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773045|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14773046|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773047|NCT00650065|Cetirizine|cetirizine|mesh-list
14773048|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14495776|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495777|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14200393|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200394|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200395|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
14200396|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14200397|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14200398|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
14200399|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200400|NCT04551261|Ritonavir|ritonavir|mesh-list
14200401|NCT04551261|Tenofovir|tenofovir|mesh-list
14200402|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14200403|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14200404|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
14200405|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200406|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200407|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14200408|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14200409|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
14200410|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200411|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14200412|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14200413|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14200414|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14200415|NCT04551248|Vaccines|vaccines|mesh-list
14200416|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14200417|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
14200418|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200419|NCT04551040|Terazosin|terazosin|mesh-list
14200420|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14200421|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14200422|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14200423|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200424|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200425|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495778|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
14495779|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
14495780|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14495781|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
14495782|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495783|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495784|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14495785|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14495786|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495787|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14495788|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14495789|NCT02757352|Ixekizumab|ixekizumab|mesh-list
14495790|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
14495791|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
14495792|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14495793|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495794|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495795|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14495796|NCT02757625|Analgesics|analgesics|mesh-ancestor
14200426|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200427|NCT04551040|Urological Agents|urological agents|mesh-ancestor
14200428|NCT04550936|Isavuconazole|isavuconazole|mesh-list
14200429|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
14200430|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495797|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
14495798|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495799|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14495800|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14495801|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14495802|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
14495803|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495804|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495805|NCT02757768|Tamsulosin|tamsulosin|mesh-list
14495806|NCT02757768|Mirabegron|mirabegron|mesh-list
14495807|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14495808|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14495809|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14495810|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200431|NCT04550949|Denosumab|denosumab|mesh-list
14200432|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14200433|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200434|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
14200435|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14200436|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14200437|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200438|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
14495811|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495812|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495813|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495814|NCT02757768|Urological Agents|urological agents|mesh-ancestor
14495815|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14200439|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200440|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200441|NCT04550858|Rebamipide|rebamipide|mesh-list
14200442|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14200443|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14200444|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
14200445|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200446|NCT04550858|Protective Agents|protective agents|mesh-ancestor
14200447|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200448|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200449|NCT04551196|Acetaminophen|acetaminophen|mesh-list
14200450|NCT04551196|Ibuprofen|ibuprofen|mesh-list
14200451|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14200452|NCT04551196|Analgesics|analgesics|mesh-ancestor
14200453|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
14200454|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495816|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14495817|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14495818|NCT02758171|Empagliflozin|empagliflozin|mesh-list
14495819|NCT02758171|Linagliptin|linagliptin|mesh-list
14495820|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14495821|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495822|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14495823|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495824|NCT02758171|Incretins|incretins|mesh-ancestor
14773049|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14773050|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14773051|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
14773052|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
14773053|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773054|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773055|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773056|NCT00650117|Fentanyl|fentanyl|mesh-list
14773057|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14200455|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200456|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
14200457|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14200458|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200459|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200460|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14495825|NCT02758171|Hormones|hormones|mesh-ancestor
14773058|NCT00650117|Narcotics|narcotics|mesh-ancestor
14773059|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773060|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773061|NCT00650117|Analgesics|analgesics|mesh-ancestor
14773062|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
14200461|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495826|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495827|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14495828|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
14495829|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495830|NCT02759016|BI 836826|bi 836826|mesh-list
14495831|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495832|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495833|NCT02759120|Doxycycline|doxycycline|mesh-list
14495834|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14495835|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14495836|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
14495837|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
14495838|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14495839|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14495840|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14495841|NCT02759120|Renal Agents|renal agents|mesh-ancestor
14495842|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
14495843|NCT02759315|Ruzasvir|ruzasvir|mesh-list
14495844|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
14495845|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495846|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
14495847|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495848|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14495849|NCT02760069|Ondansetron|ondansetron|mesh-list
14495850|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
14495851|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
14495852|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200462|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200463|NCT04550702|Mirabegron|mirabegron|mesh-list
14200464|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14200465|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14200466|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14200467|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200468|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495853|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200469|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200470|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200471|NCT04550702|Urological Agents|urological agents|mesh-ancestor
14200472|NCT04550442|Azacitidine|azacitidine|mesh-list
14200473|NCT04550442|Venetoclax|venetoclax|mesh-list
14200474|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14200475|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
14200476|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200477|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200478|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200479|NCT04550351|Vaccines|vaccines|mesh-list
14200480|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
14200481|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239366|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14239367|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
14239368|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
14239369|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239370|NCT00142454|Imiquimod|imiquimod|mesh-list
14239371|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14239372|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
14239373|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239374|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239375|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
14239376|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
14239377|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239378|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
14495854|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14495855|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
14495856|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14495857|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14495858|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
14495859|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495860|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773063|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239379|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14239380|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14239381|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239382|NCT00142506|Urological Agents|urological agents|mesh-ancestor
14239383|NCT00142818|Naltrexone|naltrexone|mesh-list
14239384|NCT00142818|Modafinil|modafinil|mesh-list
14239385|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14239386|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14239387|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239388|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
14239389|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239390|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14239391|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14239392|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14495861|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14495862|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773064|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14773065|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14495863|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495864|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14495865|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14495866|NCT02760407|Adalimumab|adalimumab|mesh-list
14495867|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495868|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495869|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
14495870|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14495871|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14495872|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14495873|NCT02760862|Mannitol|mannitol|mesh-list
14495874|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495875|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14773066|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
14773067|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
14773068|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14773069|NCT00650143|Lenograstim|lenograstim|mesh-list
14773070|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14200482|NCT04550637|Apixaban|apixaban|mesh-list
14200483|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14200484|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
14200485|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14200486|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
14200487|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200488|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200489|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
14940832|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14940833|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14773071|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773072|NCT00650143|Incretins|incretins|mesh-ancestor
14773073|NCT00650143|Hormones|hormones|mesh-ancestor
14773074|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495876|NCT02760862|Diuretics|diuretics|mesh-ancestor
14495877|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
14495878|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495879|NCT02761252|Montelukast|montelukast|mesh-list
14495880|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14495881|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
14495882|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14495883|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
14495884|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773075|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14495885|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495886|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14495887|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14495888|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495889|NCT02761330|Ketamine|ketamine|mesh-list
14495890|NCT02761330|Analgesics|analgesics|mesh-ancestor
14495891|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
14495892|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495893|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495894|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14773076|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
14773077|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940834|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14940835|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
14940836|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
14940837|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940838|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940839|NCT01495351|Bortezomib|bortezomib|mesh-list
14940840|NCT01495351|Veliparib|veliparib|mesh-list
14940841|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940842|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14940843|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200490|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
14200491|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14200492|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14200493|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200494|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
14200495|NCT04550338|Coagulants|coagulants|mesh-ancestor
14200496|NCT04550520|Glucagon|glucagon|mesh-list
14200497|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14940844|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200498|NCT04550520|Hormones|hormones|mesh-ancestor
14200499|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495895|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14495896|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
14200500|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200501|NCT04550234|Allopurinol|allopurinol|mesh-list
14200502|NCT04550234|Verinurad|verinurad|mesh-list
14200503|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
14200504|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200505|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200506|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
14200507|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200508|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14200509|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
14200510|NCT04550234|Protective Agents|protective agents|mesh-ancestor
14200511|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200512|NCT04550585|Insulin|insulin|mesh-list
14200513|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14200514|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14200515|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200516|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
14200517|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14200518|NCT04550611|Antibodies|antibodies|mesh-list
14200519|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
14773078|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773079|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14773080|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
14773081|NCT00650156|Adalimumab|adalimumab|mesh-list
14495897|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
14495898|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495899|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14495900|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14495901|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14495902|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495903|NCT02761629|Interferons|interferons|mesh-list
14495904|NCT02761629|Ribavirin|ribavirin|mesh-list
14200520|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14200521|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
14200522|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200523|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
14773082|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773083|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495905|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
14495906|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
14495907|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14495908|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773084|NCT00650169|Clopidogrel|clopidogrel|mesh-list
14773085|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14773086|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14940845|NCT01495377|Remifentanil|remifentanil|mesh-list
14200524|NCT04550624|Lenvatinib|lenvatinib|mesh-list
14200525|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14200526|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200527|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14200528|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200529|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200530|NCT04550104|Olaparib|olaparib|mesh-list
14200531|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14200532|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200533|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200534|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200535|NCT04549935|Prednisolone|prednisolone|mesh-list
14200536|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200537|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
14200538|NCT04549935|Hormones|hormones|mesh-ancestor
14200539|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200540|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200541|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14200542|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200543|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
14200544|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
14200545|NCT04550078|Calcium|calcium|mesh-list
14200546|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200547|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200548|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14200549|NCT04550078|Antacids|antacids|mesh-ancestor
14200550|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495909|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
14940846|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14940847|NCT01495377|Narcotics|narcotics|mesh-ancestor
14495910|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14495911|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
14495912|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495913|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
14495914|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495915|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
14200551|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14200552|NCT04549844|Bupivacaine|bupivacaine|mesh-list
14200553|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
14200554|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
14495916|NCT02761642|Hematinics|hematinics|mesh-ancestor
14495917|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
14495918|NCT02761915|Fludarabine|fludarabine|mesh-list
14495919|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14495920|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
14200555|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200556|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200557|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
14200558|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200559|NCT04549467|Tenofovir|tenofovir|mesh-list
14200560|NCT04549467|Lamivudine|lamivudine|mesh-list
14200561|NCT04549467|Emtricitabine|emtricitabine|mesh-list
14200562|NCT04549467|Dolutegravir|dolutegravir|mesh-list
14200563|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
14200564|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200565|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14200566|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14200567|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200568|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495921|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495922|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495923|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14495924|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
14773087|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14773088|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14773089|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
14773090|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773091|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773092|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773093|NCT00650182|Fentanyl|fentanyl|mesh-list
14773094|NCT00650182|Naltrexone|naltrexone|mesh-list
14773095|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14773096|NCT00650182|Narcotics|narcotics|mesh-ancestor
14773097|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773098|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773099|NCT00650182|Analgesics|analgesics|mesh-ancestor
14773100|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
14773101|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773102|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14773103|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14773104|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
14773105|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
14773106|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14773107|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14773108|NCT00650195|Metolazone|metolazone|mesh-list
14773109|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773110|NCT00650195|Diuretics|diuretics|mesh-ancestor
14773111|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
14773112|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773113|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14773114|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773115|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773116|NCT00650208|Lamotrigine|lamotrigine|mesh-list
14773117|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
14773118|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14940848|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940849|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940850|NCT01495377|Analgesics|analgesics|mesh-ancestor
14940851|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
14940852|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940853|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
14200569|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14773119|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14200570|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14940854|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
14495925|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940855|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14200571|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14495926|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495927|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14495928|NCT02761980|Acetaminophen|acetaminophen|mesh-list
14495929|NCT02761980|Ibuprofen|ibuprofen|mesh-list
14495930|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14495931|NCT02761980|Analgesics|analgesics|mesh-ancestor
14495932|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
14495933|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14495934|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495935|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
14495936|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14495937|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495938|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495939|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14200572|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14773120|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773121|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200575|NCT04549415|Metformin|metformin|mesh-list
14200576|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14200577|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200578|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
14495940|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495941|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495942|NCT02762071|Bupivacaine|bupivacaine|mesh-list
14495943|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
14773122|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773123|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14773124|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773125|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773126|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773127|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14773128|NCT00650221|Pravastatin|pravastatin|mesh-list
14773129|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14773130|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14773131|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
14773132|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773133|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14495944|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
14495945|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14495946|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495947|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
14495948|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773134|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14773135|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773136|NCT00650234|Metformin|metformin|mesh-list
14773137|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14773138|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773139|NCT00650247|Sumatriptan|sumatriptan|mesh-list
14773140|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14773141|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14773142|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14773143|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
14773144|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773145|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773146|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773147|NCT00650273|Azithromycin|azithromycin|mesh-list
14773148|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773149|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773150|NCT00650286|Modafinil|modafinil|mesh-list
14773151|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14773152|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773153|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14773154|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14940856|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14495949|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
14495950|NCT02762331|Vitamins|vitamins|mesh-ancestor
14495951|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
14495952|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495953|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
14495954|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200579|NCT04549012|Oxytocin|oxytocin|mesh-list
14200580|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
14495955|NCT02762331|Protective Agents|protective agents|mesh-ancestor
14200581|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14495956|NCT02762370|Triamcinolone|triamcinolone|mesh-list
14495957|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14495958|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14495959|NCT02762370|FX006|fx006|mesh-list
14495960|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14495961|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14495962|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
14495963|NCT02762370|Hormones|hormones|mesh-ancestor
14495964|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14495965|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495966|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14773155|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14773156|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200582|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200583|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14200584|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14773157|NCT00650299|Alprazolam|alprazolam|mesh-list
14773158|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14495967|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
14495968|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495969|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200585|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200586|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
14200587|NCT04549012|Coagulants|coagulants|mesh-ancestor
14200588|NCT04548700|Prednisone|prednisone|mesh-list
14200589|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
14200590|NCT04548700|Vincristine|vincristine|mesh-list
14200591|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
14200592|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14200593|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
14200594|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200595|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495970|NCT02762513|Axitinib|axitinib|mesh-list
14495971|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495972|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14495973|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495974|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495975|NCT02762578|Insulin|insulin|mesh-list
14495976|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14495977|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
14495978|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
14495979|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14495980|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
14495981|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14495982|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495983|NCT02762799|Lenograstim|lenograstim|mesh-list
14773159|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773160|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773161|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14773162|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773163|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14200596|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14200597|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
14200598|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200599|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200600|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14200601|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200602|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
14200603|NCT04548700|Hormones|hormones|mesh-ancestor
14200604|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200605|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14200606|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14200607|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14200608|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200609|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200610|NCT04548700|Analgesics|analgesics|mesh-ancestor
14200611|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
14200612|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200613|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14773164|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
14773165|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
14495984|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14495985|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
14200614|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14773166|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773167|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495986|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495987|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14495988|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
14773168|NCT00650312|Metformin|metformin|mesh-list
14773169|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940857|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14940858|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940859|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940860|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14495989|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14495990|NCT02763566|Letrozole|letrozole|mesh-list
14495991|NCT02763566|Fulvestrant|fulvestrant|mesh-list
14495992|NCT02763566|Anastrozole|anastrozole|mesh-list
14495993|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14495994|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14495995|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14495996|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14495997|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14495998|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14495999|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
14496000|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496001|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496002|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14496003|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14496004|NCT02763579|Carboplatin|carboplatin|mesh-list
14496005|NCT02763579|Etoposide|etoposide|mesh-list
14496006|NCT02763579|Atezolizumab|atezolizumab|mesh-list
14496007|NCT02763579|Antibodies|antibodies|mesh-list
14496008|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14496009|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
14496010|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496011|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496012|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14496013|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14496014|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14496015|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496016|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496017|NCT02764333|Durvalumab|durvalumab|mesh-list
14496018|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14496019|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496020|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14496021|NCT02764697|Hormones|hormones|mesh-ancestor
14496022|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773170|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773171|NCT00650325|Sertraline|sertraline|mesh-list
14773172|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
14773173|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773174|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14940861|NCT01495468|Hormones|hormones|mesh-list
14940862|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940863|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026716|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026717|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026718|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15026719|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
15026720|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15026721|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15026722|NCT01945450|Clindamycin|clindamycin|mesh-list
15026723|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
14496023|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496024|NCT02764762|Adalimumab|adalimumab|mesh-list
14496025|NCT02764762|Methotrexate|methotrexate|mesh-list
14496026|NCT02764762|Vedolizumab|vedolizumab|mesh-list
14496027|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14496028|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
14496029|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14496030|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773175|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14773176|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773177|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773178|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773179|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
14773180|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773181|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14773182|NCT00650338|Latanoprost|latanoprost|mesh-list
14773183|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14773184|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
14773185|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773186|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200615|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239393|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14239394|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239395|NCT00142909|Lofexidine|lofexidine|mesh-list
14239396|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14239397|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14239398|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239399|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
14239400|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773187|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14773188|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14773189|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773190|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773191|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773192|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14773193|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14773194|NCT00650364|Midodrine|midodrine|mesh-list
14773195|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
14773196|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
14940864|NCT01495520|Ranolazine|ranolazine|mesh-list
14940865|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14940866|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940867|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940868|NCT01495624|Dexamethasone|dexamethasone|mesh-list
14940869|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
14940870|NCT01495624|Ropivacaine|ropivacaine|mesh-list
14940871|NCT01495624|Anesthetics|anesthetics|mesh-list
14940872|NCT01495624|BB 1101|bb 1101|mesh-list
14940873|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239401|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14239402|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14239403|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14239404|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
14940874|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
14940875|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
14940876|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239405|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239406|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239407|NCT00143247|Insulin|insulin|mesh-list
14239408|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239409|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239410|NCT00143312|Voriconazole|voriconazole|mesh-list
14239411|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
14239412|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239413|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14239414|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239415|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239416|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239417|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14239418|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
14239419|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496031|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14940877|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026724|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
14496032|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
14773197|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773198|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773199|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14773200|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14773201|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14773202|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773203|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773204|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496033|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496034|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496035|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14496036|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496037|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14773205|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773206|NCT00650377|Finasteride|finasteride|mesh-list
14773207|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14773208|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14773209|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200616|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
14496038|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14496039|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
14496040|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14496041|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14496042|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496043|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14200617|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14496044|NCT02765100|Minocycline|minocycline|mesh-list
14496045|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14496046|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496047|NCT02765165|Lomustine|lomustine|mesh-list
14496048|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14496049|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
14496050|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496051|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496052|NCT02765256|Promethazine|promethazine|mesh-list
14496053|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
14496054|NCT02765256|Vancomycin|vancomycin|mesh-list
14496055|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
14496056|NCT02765256|Neomycin|neomycin|mesh-list
14496057|NCT02765256|Fluconazole|fluconazole|mesh-list
14496058|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14496059|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14496060|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496061|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14496062|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14496063|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496064|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496065|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496066|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14496067|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14496068|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
14496069|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14496070|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14496071|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
14496072|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496073|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773210|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200618|NCT04548557|Antibodies|antibodies|mesh-list
14200619|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
14200620|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14200621|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
14200622|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200623|NCT04548440|Paclitaxel|paclitaxel|mesh-list
14200624|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14200625|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14200626|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200627|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
14200628|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200629|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200630|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200631|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14200632|NCT04548518|Vaccines|vaccines|mesh-list
14200633|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
14496074|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14496075|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14496076|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
14200634|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200635|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14200636|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200637|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
14200638|NCT04548284|Hormones|hormones|mesh-ancestor
14200639|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200640|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200641|NCT04548271|Apatinib|apatinib|mesh-list
14200642|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200643|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14200644|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200645|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200646|NCT04548219|Mirikizumab|mirikizumab|mesh-list
14200647|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14200648|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14496077|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
14773211|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
14773212|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773213|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496078|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14200649|NCT04548219|Analgesics|analgesics|mesh-ancestor
14200650|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
14200651|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200652|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200653|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200654|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200655|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14200656|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14200657|NCT04547829|Sargramostim|sargramostim|mesh-list
14200658|NCT04547829|Lenograstim|lenograstim|mesh-list
14496079|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
14496080|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
14496081|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496082|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14496083|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14496084|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14496085|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496086|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
14496087|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
14496088|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
14496089|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496090|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
14496091|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
14496092|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14496093|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14496094|NCT02765256|Laxatives|laxatives|mesh-ancestor
14528303|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14528304|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14528305|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14528306|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
14528307|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
14528308|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528309|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528310|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528311|NCT03882424|Bevacizumab|bevacizumab|mesh-list
14528312|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14528313|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773214|NCT00650377|Urological Agents|urological agents|mesh-ancestor
14773215|NCT00650390|Adalimumab|adalimumab|mesh-list
14773216|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773217|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773218|NCT00650403|Paroxetine|paroxetine|mesh-list
14773219|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14773220|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14773221|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773222|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773223|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773224|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
14773225|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026725|NCT01945450|Gentamicins|gentamicins|mesh-list
14528314|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14496095|NCT02765490|Simeprevir|simeprevir|mesh-list
14496096|NCT02765490|Odalasvir|odalasvir|mesh-list
14496097|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
14496098|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496099|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
14496100|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496101|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496102|NCT02766023|Metronidazole|metronidazole|mesh-list
14496103|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496104|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14496105|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14496106|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14496107|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14496108|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496109|NCT02766517|Capsaicin|capsaicin|mesh-list
14496110|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
14496111|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
14496112|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
14496113|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496114|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496115|NCT02766608|Budesonide|budesonide|mesh-list
14496116|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
14496117|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14496118|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496119|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14496120|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
14496121|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496122|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496123|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14496124|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
14496125|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
14496126|NCT02766608|Hormones|hormones|mesh-ancestor
14496127|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496128|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14496129|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14496130|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14496131|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
14496132|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496133|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496134|NCT02766673|Albuterol|albuterol|mesh-list
14773226|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14940878|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14940879|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
14940880|NCT01495624|Hormones|hormones|mesh-ancestor
14940881|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14940882|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14940883|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940884|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
14940885|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940886|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940887|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
14200659|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
14200660|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200661|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14200662|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14200663|NCT04547764|Calcium|calcium|mesh-list
14200664|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200665|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200666|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200667|NCT04547907|Paclitaxel|paclitaxel|mesh-list
14200668|NCT04547907|Docetaxel|docetaxel|mesh-list
14496135|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14496136|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
14773227|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
14773228|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773229|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14773230|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14773231|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773232|NCT00650416|Carvedilol|carvedilol|mesh-list
14773233|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14773234|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14200669|NCT04547907|Carboplatin|carboplatin|mesh-list
14496137|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773235|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773236|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496138|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496139|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14496140|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
14496141|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
14496142|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14496143|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14496144|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14496145|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14496146|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200670|NCT04547907|Trastuzumab|trastuzumab|mesh-list
14200671|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14200672|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200673|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14200674|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200675|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200676|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200677|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14200678|NCT04547855|Temozolomide|temozolomide|mesh-list
14200679|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14200680|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
14200681|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200682|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200683|NCT04547842|Dexamethasone|dexamethasone|mesh-list
14200684|NCT04547842|Mirtazapine|mirtazapine|mesh-list
14200685|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200686|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
14200687|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
14200688|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200689|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496147|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496148|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496149|NCT02766777|Lubiprostone|lubiprostone|mesh-list
14496150|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14496151|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14496152|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496153|NCT02767128|Citric Acid|citric acid|mesh-list
14496154|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
14496155|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
14496156|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14496157|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
14496158|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
14496159|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496160|NCT02767271|Luliconazole|luliconazole|mesh-list
14496161|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
14496162|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496163|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
14496164|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14773237|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773238|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773239|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773240|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
14773241|NCT00650416|Protective Agents|protective agents|mesh-ancestor
14773242|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14773243|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773244|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200690|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14200691|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
14773245|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
14773246|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14773247|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14773248|NCT00650429|Ziprasidone|ziprasidone|mesh-list
14773249|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14773250|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
14773251|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773252|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773253|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773254|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14773255|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773256|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200692|NCT04547842|Hormones|hormones|mesh-ancestor
14773257|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773258|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14200693|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200694|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14200695|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200696|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
14200697|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14200698|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14200699|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
14200700|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
14200701|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200702|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200703|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14200704|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14200705|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496165|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14496166|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496167|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
14496168|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
14496169|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14496170|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496171|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
14496172|NCT02767492|Hormones|hormones|mesh-ancestor
14496173|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496174|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496175|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14496176|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
14496177|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
14496178|NCT02767765|Hematinics|hematinics|mesh-ancestor
14496179|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
14496180|NCT02767869|Antacids|antacids|mesh-ancestor
14496181|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200706|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14200707|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14200708|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14200709|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200710|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14200711|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14200712|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
14200713|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14200714|NCT04547621|Temozolomide|temozolomide|mesh-list
14200715|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14200716|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
14496182|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14496183|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
14496184|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14496185|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026726|NCT01945450|Ampicillin|ampicillin|mesh-list
14200717|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496186|NCT02767947|Luliconazole|luliconazole|mesh-list
14496187|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
14496188|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496189|NCT02768194|Fluorides|fluorides|mesh-list
14496190|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
14496191|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
14496192|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
14496193|NCT02768194|Protective Agents|protective agents|mesh-ancestor
14496194|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496195|NCT02768298|Enalapril|enalapril|mesh-list
14496196|NCT02768298|Enalaprilat|enalaprilat|mesh-list
14496197|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14496198|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14200718|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200719|NCT04547608|Propofol|propofol|mesh-list
14200720|NCT04547608|Rocuronium|rocuronium|mesh-list
14200721|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14200722|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200723|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200724|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14200725|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
14200726|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
14200727|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14496199|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
14496200|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773259|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
14773260|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14773261|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14496201|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496202|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14496203|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14496204|NCT02768558|Nivolumab|nivolumab|mesh-list
14200728|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14200729|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14200730|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200731|NCT04547348|Denosumab|denosumab|mesh-list
14200732|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14200733|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200734|NCT04547426|Nicotine|nicotine|mesh-list
14200735|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14200736|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
14200737|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200738|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200739|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14200740|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14200741|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
14200742|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200743|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200744|NCT04547452|Antibodies|antibodies|mesh-list
14200745|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
14200746|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200747|NCT04547335|Voriconazole|voriconazole|mesh-list
14200748|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
14200749|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200750|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14200751|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14200752|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200753|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200754|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14200755|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
14200756|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200757|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496205|NCT02768558|Etoposide|etoposide|mesh-list
14496206|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496207|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14496208|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14200758|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14200759|NCT04547439|Melatonin|melatonin|mesh-list
14200760|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
14200761|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200762|NCT04547439|Protective Agents|protective agents|mesh-ancestor
14200763|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200764|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200765|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14200766|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
14200767|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14200768|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200769|NCT04547530|Vitamin D|vitamin d|mesh-list
14200770|NCT04547530|Vitamins|vitamins|mesh-ancestor
14200771|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
14200772|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200773|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14200774|NCT04546802|Grazoprevir|grazoprevir|mesh-list
14200775|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
14200776|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200777|NCT04547153|Docetaxel|docetaxel|mesh-list
14200778|NCT04547153|Fluorouracil|fluorouracil|mesh-list
14200779|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200780|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
14200781|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
14200782|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
14200783|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200784|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
14200785|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14200786|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14200787|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
14200788|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200789|NCT04546815|Daptomycin|daptomycin|mesh-list
14200790|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14200791|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773262|NCT00650442|Estradiol|estradiol|mesh-list
14200792|NCT04547088|Apatinib|apatinib|mesh-list
14200793|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200794|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14496209|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496210|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14496211|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14496212|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14496213|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773263|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14773264|NCT00650442|Estrogens|estrogens|mesh-ancestor
14773265|NCT00650442|Hormones|hormones|mesh-ancestor
14773266|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773267|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773268|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14773269|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
14200795|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200796|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200797|NCT04547179|Erenumab|erenumab|mesh-list
14200798|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14200799|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200800|NCT04547179|Analgesics|analgesics|mesh-ancestor
14200801|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
14773270|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14773271|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14773272|NCT00650455|Naproxen|naproxen|mesh-list
14773273|NCT00650455|Valdecoxib|valdecoxib|mesh-list
14773274|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14773275|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14773276|NCT00650455|Analgesics|analgesics|mesh-ancestor
14773277|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
14773278|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773279|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773280|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773281|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200802|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200803|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200804|NCT04546828|Gemcitabine|gemcitabine|mesh-list
14773282|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
14773283|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14773284|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773285|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773286|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14773287|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
14773288|NCT00650468|Prednisone|prednisone|mesh-list
14773289|NCT00650468|Tacrolimus|tacrolimus|mesh-list
14773290|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773291|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
14773292|NCT00650468|Hormones|hormones|mesh-ancestor
14773293|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773294|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773295|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14773296|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773297|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14773298|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
14773299|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14773300|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773301|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773302|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14773303|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14200805|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200806|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14200807|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
14200808|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200809|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
14496214|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
14496215|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14496216|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496217|NCT02769065|Donepezil|donepezil|mesh-list
14200810|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200811|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200812|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14200813|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
14200814|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200815|NCT04547049|Cytarabine|cytarabine|mesh-list
14200816|NCT04547049|Cyclosporine|cyclosporine|mesh-list
14200817|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
14200818|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
14200819|NCT04547049|Busulfan|busulfan|mesh-list
14200820|NCT04547049|Cyclosporins|cyclosporins|mesh-list
14200821|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14200822|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
14200823|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14200824|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
14200825|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200826|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200827|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13964054|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964055|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964056|NCT03140176|Sunitinib|sunitinib|mesh-list
13964057|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964058|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13964059|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13964060|NCT03140176|Growth Substances|growth substances|mesh-ancestor
13964061|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200828|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
14239420|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239421|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14239422|NCT00143390|Anastrozole|anastrozole|mesh-list
14239423|NCT00143390|Exemestane|exemestane|mesh-list
14239424|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239425|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239426|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14239427|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14239428|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239429|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239430|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14239431|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
14239432|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239433|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239434|NCT00143403|Leucovorin|leucovorin|mesh-list
14239435|NCT00143403|Folic Acid|folic acid|mesh-list
14239436|NCT00143403|Irinotecan|irinotecan|mesh-list
14239437|NCT00143403|Fluorouracil|fluorouracil|mesh-list
14239438|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
14239439|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14239440|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14239441|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239442|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239443|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239444|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
14239445|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14239446|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239447|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
14239448|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239449|NCT00143403|Antidotes|antidotes|mesh-ancestor
14239450|NCT00143403|Protective Agents|protective agents|mesh-ancestor
14239451|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
14239452|NCT00143403|Vitamins|vitamins|mesh-ancestor
14239453|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
14239454|NCT00143403|Hematinics|hematinics|mesh-ancestor
14239455|NCT00143455|Cisplatin|cisplatin|mesh-list
14239456|NCT00143455|Irinotecan|irinotecan|mesh-list
14239457|NCT00143455|Etoposide|etoposide|mesh-list
14239458|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239459|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14239460|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14239461|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239462|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239463|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14239464|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14239465|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14239466|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
14239467|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200829|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200830|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200831|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14200832|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14200833|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
14200834|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
14200835|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200836|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496218|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14496219|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496220|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496221|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
14496222|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496223|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496224|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
14496225|NCT02769247|Naproxen|naproxen|mesh-list
14496226|NCT02769247|Lidocaine|lidocaine|mesh-list
14496227|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
14496228|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
14496229|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496230|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496231|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
14496232|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496233|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14496234|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14496235|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14496236|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14496237|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496238|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14496239|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14496240|NCT02769247|Analgesics|analgesics|mesh-ancestor
14496241|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773304|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
14773305|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773306|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773307|NCT00650481|Oxybutynin|oxybutynin|mesh-list
14773308|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
14496242|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14496243|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
14496244|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14496245|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496246|NCT02769481|Glimepiride|glimepiride|mesh-list
14496247|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
14496248|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14496249|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496250|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496251|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14496252|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
14496253|NCT02769624|Treprostinil|treprostinil|mesh-list
14496254|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773309|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
14773310|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773311|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940888|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940889|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
14940890|NCT01495715|Idebenone|idebenone|mesh-list
14940891|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
14940892|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940893|NCT01495715|Protective Agents|protective agents|mesh-ancestor
14940894|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940895|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14940896|NCT01495806|Cathartics|cathartics|mesh-ancestor
14940897|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14940898|NCT01495845|Clopidogrel|clopidogrel|mesh-list
14940899|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14496255|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14773312|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14200837|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
14496256|NCT02769702|Hormones|hormones|mesh-ancestor
14496257|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496258|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496259|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14496260|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496261|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14496262|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496263|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496264|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14496265|NCT02770248|Brinzolamide|brinzolamide|mesh-list
14496266|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14496267|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14496268|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14773313|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14773314|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
14773315|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773316|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773317|NCT00650481|Urological Agents|urological agents|mesh-ancestor
14773318|NCT00650494|Valacyclovir|valacyclovir|mesh-list
14773319|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
14773320|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773321|NCT00650520|Bromocriptine|bromocriptine|mesh-list
14773322|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14773323|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14773324|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
14773325|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773326|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773327|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
14773328|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
14773329|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200838|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200839|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14200840|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14200841|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14200842|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
14200843|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14200844|NCT04546672|Neostigmine|neostigmine|mesh-list
14200845|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14200846|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200847|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200848|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
14200849|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200850|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200851|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14200852|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
14200853|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239468|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
14239469|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14239470|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14239471|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239472|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239473|NCT00144170|Ritonavir|ritonavir|mesh-list
14239474|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14239475|NCT00144170|Tipranavir|tipranavir|mesh-list
14239476|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
14239477|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14239478|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239479|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239480|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14239481|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14239482|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
14239483|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239484|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14239485|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239486|NCT00144300|Pramipexole|pramipexole|mesh-list
14239487|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
14239488|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496269|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14496270|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
14496271|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496272|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773330|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773331|NCT00650533|Glimepiride|glimepiride|mesh-list
14239489|NCT00144300|Protective Agents|protective agents|mesh-ancestor
14773332|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14773333|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496273|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496274|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14496275|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496276|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14496277|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14496278|NCT02770365|Estradiol|estradiol|mesh-list
14496279|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14200854|NCT04546373|Niraparib|niraparib|mesh-list
14200855|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14200856|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200857|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200858|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496280|NCT02770365|Estrogens|estrogens|mesh-ancestor
14496281|NCT02770365|Hormones|hormones|mesh-ancestor
14773334|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773335|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14773336|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
14773337|NCT00650598|Diclofenac|diclofenac|mesh-list
14773338|NCT00650598|Valdecoxib|valdecoxib|mesh-list
14773339|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14773340|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14773341|NCT00650598|Analgesics|analgesics|mesh-ancestor
14773342|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
14773343|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940900|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14940901|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14940902|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14940903|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
14940904|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940905|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940906|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940907|NCT01495884|Lapatinib|lapatinib|mesh-list
14940908|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940909|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14940910|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940911|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940912|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
14940913|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14940914|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14940915|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940916|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940917|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
14940918|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964062|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
14773344|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773345|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773346|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773347|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14773348|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773349|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773350|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14773351|NCT00650611|Ziprasidone|ziprasidone|mesh-list
14773352|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14773353|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
14773354|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773355|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773356|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773357|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14200859|NCT04546282|Osimertinib|osimertinib|mesh-list
13964063|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13964064|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964065|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964066|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
13964067|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
14200860|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200861|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14496282|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496283|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496284|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14496285|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
14496286|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14496287|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14496288|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
14496289|NCT02770521|Treprostinil|treprostinil|mesh-list
14496290|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496291|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496292|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14496293|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
14496294|NCT02770612|Narcotics|narcotics|mesh-ancestor
14496295|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496296|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496297|NCT02770612|Analgesics|analgesics|mesh-ancestor
14496298|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
14496299|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496300|NCT02770820|Aldesleukin|aldesleukin|mesh-list
14496301|NCT02770820|Interleukin-2|interleukin-2|mesh-list
14496302|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496303|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14496304|NCT02770820|Analgesics|analgesics|mesh-ancestor
14496305|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
14496306|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496307|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496308|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14496309|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14496310|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
14496311|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496312|NCT02771093|Alogliptin|alogliptin|mesh-list
14496313|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496314|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496315|NCT02771093|Incretins|incretins|mesh-ancestor
14496316|NCT02771093|Hormones|hormones|mesh-ancestor
14496317|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496318|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14773358|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773359|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773360|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773361|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14773362|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
14773363|NCT00650624|Valdecoxib|valdecoxib|mesh-list
14773364|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14773365|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14773366|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964068|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13964069|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
13964070|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964071|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13964072|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13964073|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
13964074|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964075|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964076|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13964077|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964078|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13964079|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964080|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
13964081|NCT03139708|Phenylephrine|phenylephrine|mesh-list
13964082|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
13964083|NCT03139708|Tropicamide|tropicamide|mesh-list
13964084|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13964085|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
13964086|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
14773367|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773368|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14773369|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14773370|NCT00650624|Analgesics|analgesics|mesh-ancestor
14773371|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
14773372|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773373|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773374|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773375|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773376|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
14200862|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14200863|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200864|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14496319|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
14496320|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496321|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496322|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14496323|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14496324|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
14496325|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496326|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
14496327|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
14496328|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496329|NCT02772783|Insulin|insulin|mesh-list
14496330|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14496331|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496332|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496333|NCT02772978|Tolcapone|tolcapone|mesh-list
14496334|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14496335|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14496336|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14496337|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496338|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496339|NCT02773368|Insulin|insulin|mesh-list
14496340|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14496341|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
14496342|NCT02773368|Liraglutide|liraglutide|mesh-list
14496343|NCT02773368|Xultophy|xultophy|mesh-list
14496344|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496345|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496346|NCT02773368|Incretins|incretins|mesh-ancestor
14496347|NCT02773368|Hormones|hormones|mesh-ancestor
14496348|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200865|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
14200866|NCT04546334|Analgesics|analgesics|mesh-ancestor
14200867|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
14200868|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200869|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200870|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
14200871|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200872|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14200873|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
14200874|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14200875|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14496349|NCT02773758|Fluorides|fluorides|mesh-list
14496350|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
14496351|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
14496352|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
14496353|NCT02773758|Protective Agents|protective agents|mesh-ancestor
14496354|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496355|NCT02774226|Vitamins|vitamins|mesh-list
14496356|NCT02774226|Vitamin E|vitamin e|mesh-list
14496357|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
14496358|NCT02774226|Antioxidants|antioxidants|mesh-list
14496359|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
14496360|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496361|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496362|NCT02774226|Protective Agents|protective agents|mesh-ancestor
14496363|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
14496364|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14496365|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496366|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14200876|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200877|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14200878|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
14200879|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14200880|NCT04546256|Fluticasone|fluticasone|mesh-list
14200881|NCT04546256|Xhance|xhance|mesh-list
14496367|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496368|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200882|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14496369|NCT02774343|Pioglitazone|pioglitazone|mesh-list
14496370|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496371|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496372|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14496373|NCT02774681|Trastuzumab|trastuzumab|mesh-list
14496374|NCT02774681|Palbociclib|palbociclib|mesh-list
14200883|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14200884|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200885|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14200886|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
14200887|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200888|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200889|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14496375|NCT02774681|Antibodies|antibodies|mesh-list
14496376|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
14496377|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14496378|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
14496379|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496380|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496381|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14496382|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496383|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773377|NCT00650637|Lamivudine|lamivudine|mesh-list
14773378|NCT00650637|Zidovudine|zidovudine|mesh-list
14773379|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14773380|NCT00650637|Nelfinavir|nelfinavir|mesh-list
14773381|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
14773382|NCT00650637|Loperamide|loperamide|mesh-list
14773383|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
14773384|NCT00650637|Calcium|calcium|mesh-list
14773385|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14773386|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773387|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14773388|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14773389|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14773390|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773391|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773392|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
14773393|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496384|NCT02775240|Maribavir|maribavir|mesh-list
14496385|NCT02775240|Digoxin|digoxin|mesh-list
14496386|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
14496387|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14496388|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14496389|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773394|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14773395|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14773396|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
14940919|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940920|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14940921|NCT01495949|Thiopental|thiopental|mesh-list
14940922|NCT01495949|Etomidate|etomidate|mesh-list
14940923|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14940924|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940925|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940926|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14940927|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
14496390|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496391|NCT02775240|Protective Agents|protective agents|mesh-ancestor
14496392|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496393|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
14496394|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
14496395|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14496396|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14496397|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496398|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
14200890|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14496399|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496400|NCT02775617|Azithromycin|azithromycin|mesh-list
14496401|NCT02775617|Ivermectin|ivermectin|mesh-list
14496402|NCT02775617|Permethrin|permethrin|mesh-list
14496403|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14496404|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496405|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14496406|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496407|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496408|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
14496409|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
14773397|NCT00650637|Antacids|antacids|mesh-ancestor
14940928|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
14496410|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14496411|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14496412|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496413|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496414|NCT02775903|Azacitidine|azacitidine|mesh-list
14496415|NCT02775903|Durvalumab|durvalumab|mesh-list
14496416|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14496417|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
14496418|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496419|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496420|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496421|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14200891|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200892|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14200893|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14200894|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14200895|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14496422|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14496423|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
14496424|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14496425|NCT02776683|Bevacizumab|bevacizumab|mesh-list
14496426|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14496427|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496428|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14496429|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14496430|NCT02776683|Growth Substances|growth substances|mesh-ancestor
14496431|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496432|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
14496433|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
14496434|NCT02777242|Testosterone|testosterone|mesh-list
14496435|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
14496436|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
14773398|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14773399|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14773400|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14773401|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
14773402|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14200896|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
14200897|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200898|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200899|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
14200900|NCT04546256|Hormones|hormones|mesh-ancestor
14200901|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14200902|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
14496437|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14496438|NCT02777242|Androgens|androgens|mesh-ancestor
14496439|NCT02777242|Hormones|hormones|mesh-ancestor
14496440|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496441|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496442|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14496443|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496444|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
14496445|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
14496446|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528315|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14528316|NCT03882424|Growth Substances|growth substances|mesh-ancestor
14200903|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14200904|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
14200905|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14200906|NCT04545970|Protective Agents|protective agents|mesh-ancestor
14200907|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200908|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200909|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14200910|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
14200911|NCT04545931|Coagulants|coagulants|mesh-ancestor
14200912|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14200913|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
14200914|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200915|NCT04545944|Midazolam|midazolam|mesh-list
14200916|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14200917|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14200918|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200919|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200920|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14200921|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14200922|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14200923|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14200924|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
14200925|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
14200926|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
14200927|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
14200928|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200929|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200930|NCT04545879|Allicin|allicin|mesh-list
14200931|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200932|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14200933|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
14200934|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528317|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528318|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
14528319|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
14528320|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14528321|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
14528322|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528323|NCT03881163|Expectorants|expectorants|mesh-ancestor
14528324|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
14528325|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14528326|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
14528327|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528328|NCT03881163|Protective Agents|protective agents|mesh-ancestor
14528329|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528330|NCT03881163|Antidotes|antidotes|mesh-ancestor
14496447|NCT05350124|Vitamins|vitamins|mesh-list
14496448|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
14496449|NCT05350124|Vitamin E|vitamin e|mesh-list
14496450|NCT05350124|Tocopherols|tocopherols|mesh-list
14496451|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
14496452|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496453|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
14496454|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496455|NCT05350124|Protective Agents|protective agents|mesh-ancestor
14496456|NCT05350085|Midazolam|midazolam|mesh-list
14496457|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14496458|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14200935|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14200936|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
14200937|NCT04545879|Protective Agents|protective agents|mesh-ancestor
14200938|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200939|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14200940|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14200941|NCT04545892|Capsaicin|capsaicin|mesh-list
14200942|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
14200943|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
14200944|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
14200945|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14200946|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200947|NCT04545801|Ketamine|ketamine|mesh-list
14496459|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496460|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496461|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14496462|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14496463|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14496464|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14496465|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
14496466|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
14496467|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
14496468|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
14496469|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496470|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773403|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14200948|NCT04545801|Analgesics|analgesics|mesh-ancestor
14200949|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
14200950|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496471|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
14496472|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14496473|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14496474|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14496475|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496476|NCT05349929|Ibuprofen|ibuprofen|mesh-list
14496477|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14496478|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14496479|NCT05349929|Analgesics|analgesics|mesh-ancestor
14496480|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
14496481|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496482|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496483|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773404|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
14773405|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773406|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14773407|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14773408|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773409|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773410|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773411|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773412|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14773413|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14773414|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
14773415|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773416|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773417|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14773418|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14773419|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
14773420|NCT00650871|Casopitant|casopitant|mesh-list
14200951|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496484|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14496485|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14496486|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496487|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496488|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14496489|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
14496490|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496491|NCT05349903|Protective Agents|protective agents|mesh-ancestor
14496492|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496493|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14496494|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14496495|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200952|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14200953|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14200954|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
14200955|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
14200956|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14200957|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14200958|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14496496|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14496497|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
14496498|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14496499|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496500|NCT05349838|Dolutegravir|dolutegravir|mesh-list
14496501|NCT05349838|Rilpivirine|rilpivirine|mesh-list
14496502|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
14496503|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14496504|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14496505|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496506|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496507|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14496508|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14200959|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14200960|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200961|NCT04545762|Vidarabine|vidarabine|mesh-list
14200962|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
14200963|NCT04545762|Fludarabine|fludarabine|mesh-list
14200964|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
14200965|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14200966|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
14200967|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200968|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14200969|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14200970|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
14200971|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14200972|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14200973|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14200974|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14200975|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
14200976|NCT04545762|Antiviral Agents|antiviral agents|mesh-ancestor
14200977|NCT04545762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200978|NCT04545788|Linezolid|linezolid|mesh-list
14200979|NCT04545788|Cycloserine|cycloserine|mesh-list
14200980|NCT04545788|Bedaquiline|bedaquiline|mesh-list
14200981|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14200982|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14200983|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14496509|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
14496510|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496511|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14496512|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14496513|NCT05349825|Losartan|losartan|mesh-list
14496514|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14773421|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
14773422|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
14200984|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773423|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773424|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14200985|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496515|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14496516|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14496517|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14496518|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496519|NCT05349474|Metformin|metformin|mesh-list
14496520|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14496521|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496522|NCT05349448|Dexamethasone|dexamethasone|mesh-list
14496523|NCT05349448|Dexamethasone acetate|dexamethasone acetate|mesh-list
14496524|NCT05349448|BB 1101|bb 1101|mesh-list
14496525|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14200986|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14200987|NCT04545788|Renal Agents|renal agents|mesh-ancestor
14200988|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14200989|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
14200990|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
14200991|NCT04545463|Psyllium|psyllium|mesh-list
14200992|NCT04545463|Cathartics|cathartics|mesh-ancestor
14200993|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14200994|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
14200995|NCT04545450|Testosterone|testosterone|mesh-list
14200996|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
14200997|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
14200998|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14200999|NCT04545450|Dutasteride|dutasteride|mesh-list
14201000|NCT04545450|Androgens|androgens|mesh-ancestor
14201001|NCT04545450|Hormones|hormones|mesh-ancestor
14496526|NCT05349448|Antiemetics|antiemetics|mesh-ancestor
14496527|NCT05349448|Autonomic Agents|autonomic agents|mesh-ancestor
14496528|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496529|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496530|NCT05349448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14496531|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
14496532|NCT05349448|Hormones|hormones|mesh-ancestor
14773425|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14773426|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14773427|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773428|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773429|NCT00650897|Citalopram|citalopram|mesh-list
14773430|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14773431|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14773432|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773433|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773434|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773435|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
14773436|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773437|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14773438|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
14773439|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773440|NCT00650910|Lapatinib|lapatinib|mesh-list
14773441|NCT00650910|Digoxin|digoxin|mesh-list
14773442|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773443|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14201002|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201003|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496533|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496534|NCT05349448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14496535|NCT05349448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496536|NCT05349448|Protease Inhibitors|protease inhibitors|mesh-ancestor
14496537|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496538|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496539|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14496540|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496541|NCT05349396|Eszopiclone|eszopiclone|mesh-list
14773444|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773445|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773446|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14773447|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14773448|NCT00650910|Protective Agents|protective agents|mesh-ancestor
14773449|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773450|NCT00650923|Temozolomide|temozolomide|mesh-list
14773451|NCT00650923|Aflibercept|aflibercept|mesh-list
14773452|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
14940929|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
14940930|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
14496542|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14496543|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496544|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496545|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
14496546|NCT05349383|Antibodies|antibodies|mesh-list
14496547|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
14496548|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
14201004|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14201005|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201006|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
14201007|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14201008|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14201009|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201010|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201011|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
14201012|NCT04545710|Osimertinib|osimertinib|mesh-list
14201013|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201014|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14201015|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201016|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773453|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14940931|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
14940932|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940933|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940934|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
14201017|NCT04545099|Neostigmine|neostigmine|mesh-list
14773454|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
14773455|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773456|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773457|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14773458|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14773459|NCT00650923|Growth Substances|growth substances|mesh-ancestor
14773460|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773461|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
14773462|NCT00651066|Ritonavir|ritonavir|mesh-list
14773463|NCT00651066|Lopinavir|lopinavir|mesh-list
14773464|NCT00651066|Rifabutin|rifabutin|mesh-list
14940935|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14201018|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14773465|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14940936|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14496549|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
13964087|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964088|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496550|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496551|NCT05349188|Melatonin|melatonin|mesh-list
14496552|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
14773466|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14773467|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
14773468|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773469|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773470|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14773471|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14773472|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
14773473|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773474|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14773475|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14773476|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773477|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14773478|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
14773479|NCT00651105|Vildagliptin|vildagliptin|mesh-list
14773480|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14940937|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14496553|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496554|NCT05349188|Protective Agents|protective agents|mesh-ancestor
14496555|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940938|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940939|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940940|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
14940941|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940942|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940943|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14940944|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940945|NCT01496105|Lidocaine|lidocaine|mesh-list
14940946|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
14940947|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
14940948|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940949|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940950|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
14940951|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940952|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14940953|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14773481|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940954|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14940955|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14940956|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940957|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
14940958|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14940959|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14940960|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940961|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
14940962|NCT01496196|Coagulants|coagulants|mesh-ancestor
14940963|NCT01496261|Aspirin|aspirin|mesh-list
14940964|NCT01496261|Clopidogrel|clopidogrel|mesh-list
14940965|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14940966|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14940967|NCT01496261|Analgesics|analgesics|mesh-ancestor
14940968|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
14940969|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940970|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14940971|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14940972|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940973|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14940974|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14940975|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773482|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14773483|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
14773484|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773485|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201019|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201020|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201021|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
14201022|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201023|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201024|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14201025|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
14201026|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201027|NCT04544943|Gentamicins|gentamicins|mesh-list
14496556|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496557|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
14496558|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14201028|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14201029|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201030|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14201031|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201032|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201033|NCT04544969|Gemcitabine|gemcitabine|mesh-list
14201034|NCT04544969|Cisplatin|cisplatin|mesh-list
14201035|NCT04544969|Docetaxel|docetaxel|mesh-list
14201036|NCT04544969|Fluorouracil|fluorouracil|mesh-list
14201037|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201038|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14201039|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
14201040|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201041|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
14201042|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201043|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201044|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201045|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
14496559|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14496560|NCT05349071|Prednisolone|prednisolone|mesh-list
14496561|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
14496562|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14496563|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
14201046|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201047|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
14201048|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
14201049|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
14201050|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14201051|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201052|NCT04544683|Dexamethasone|dexamethasone|mesh-list
14201053|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
14201054|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14201055|NCT04544683|BB 1101|bb 1101|mesh-list
14201056|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201057|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
14201058|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
14201059|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201060|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201061|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201062|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
14201063|NCT04544683|Hormones|hormones|mesh-ancestor
14201064|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201065|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14201066|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201067|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
14201068|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201069|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201070|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
14201071|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14201072|NCT04544228|Ketamine|ketamine|mesh-list
14201073|NCT04544228|Bupivacaine|bupivacaine|mesh-list
14201074|NCT04544228|Neostigmine|neostigmine|mesh-list
14201075|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
14201076|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
14201077|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201078|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201079|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
14201080|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201081|NCT04544228|Analgesics|analgesics|mesh-ancestor
14201082|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14201083|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201084|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
14201085|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14201086|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14201087|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201088|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201089|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14201090|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201091|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
14201092|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14201093|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
14239490|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239491|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14239492|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14239493|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
14239494|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
14239495|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239496|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
14239497|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14239498|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
14239499|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239500|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239501|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14239502|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
14239503|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
14239504|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14239505|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
14239506|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239507|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239508|NCT00144391|Testosterone|testosterone|mesh-list
14239509|NCT00144391|Androgens|androgens|mesh-ancestor
14239510|NCT00144391|Hormones|hormones|mesh-ancestor
14239511|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239512|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239513|NCT00144963|Dexamethasone|dexamethasone|mesh-list
14239514|NCT00144963|Vincristine|vincristine|mesh-list
14239515|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239516|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
14239517|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
14239518|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239519|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239520|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239521|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
14239522|NCT00144963|Hormones|hormones|mesh-ancestor
14239523|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239524|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239525|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239526|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14239527|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239528|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239529|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239530|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239531|NCT00145041|Vincristine|vincristine|mesh-list
14239532|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14239533|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239534|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239535|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239536|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239537|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239538|NCT00145249|Fluconazole|fluconazole|mesh-list
14239539|NCT00145249|Amphotericin B|amphotericin b|mesh-list
14239540|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14239541|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
14239542|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239543|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14239544|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239545|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239546|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239547|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14239548|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
14239549|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201094|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
14201095|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14201096|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201097|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14201098|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201099|NCT04544059|Lenalidomide|lenalidomide|mesh-list
14201100|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
14201101|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201102|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14201103|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14201104|NCT04544059|Growth Substances|growth substances|mesh-ancestor
14496564|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496565|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
14496566|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
14496567|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496568|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496569|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14496570|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
14496571|NCT05349071|Hormones|hormones|mesh-ancestor
14496572|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496573|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14496574|NCT05349071|Protective Agents|protective agents|mesh-ancestor
14496575|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14496576|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496577|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14496578|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496579|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496580|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14496581|NCT05349045|Antibodies|antibodies|mesh-list
14496582|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
14496583|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773486|NCT00651131|Daptomycin|daptomycin|mesh-list
14773487|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773488|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773489|NCT00651209|Tenofovir|tenofovir|mesh-list
14773490|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
14773491|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773492|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14773493|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14773494|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773495|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773496|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14773497|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14773498|NCT00651235|Losartan|losartan|mesh-list
14773499|NCT00651235|Propranolol|propranolol|mesh-list
14773500|NCT00651235|Atenolol|atenolol|mesh-list
14773501|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14773502|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773503|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14773504|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14773505|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773506|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14773507|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14773508|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773509|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773510|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773511|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
14773512|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
14773513|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
14773514|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773515|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14773516|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14773517|NCT00651287|Quinapril|quinapril|mesh-list
14773518|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773519|NCT00651287|Diuretics|diuretics|mesh-ancestor
14773520|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
14773521|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773522|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14773523|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773524|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773525|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14773526|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
14773527|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496584|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14496585|NCT05349045|Growth Substances|growth substances|mesh-ancestor
14496586|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
14496587|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496588|NCT05349032|Curcumin|curcumin|mesh-list
14496589|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14496590|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14496591|NCT05349032|Analgesics|analgesics|mesh-ancestor
14496592|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
14496593|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496594|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773528|NCT00651300|Parecoxib|parecoxib|mesh-list
14201105|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
14201106|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201107|NCT04544163|Lidocaine|lidocaine|mesh-list
14773529|NCT00651300|Valdecoxib|valdecoxib|mesh-list
14773530|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14773531|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14201108|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
14201109|NCT04544163|Fentanyl|fentanyl|mesh-list
14201110|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
14201111|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
14201112|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14940976|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14201113|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201114|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
14201115|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201116|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14201117|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14201118|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14496595|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496596|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773532|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773533|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201119|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201120|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201121|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14201122|NCT04544163|Narcotics|narcotics|mesh-ancestor
14201123|NCT04544163|Analgesics|analgesics|mesh-ancestor
14201124|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14201125|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201126|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
14201127|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
14201128|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14201129|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14201130|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
14201131|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14201132|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
14773534|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14773535|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14773536|NCT00651300|Analgesics|analgesics|mesh-ancestor
14773537|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
14773538|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773539|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773540|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773541|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773542|NCT00651326|Docetaxel|docetaxel|mesh-list
14773543|NCT00651326|Leuprolide|leuprolide|mesh-list
14773544|NCT00651326|Goserelin|goserelin|mesh-list
14773545|NCT00651326|Bicalutamide|bicalutamide|mesh-list
14773546|NCT00651326|Flutamide|flutamide|mesh-list
14773547|NCT00651326|Buserelin|buserelin|mesh-list
14773548|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496597|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496598|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496599|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496600|NCT05349006|Azathioprine|azathioprine|mesh-list
14496601|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
14496602|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496603|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14496604|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496605|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14496606|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
14773549|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
14773550|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
14201133|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14201134|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201135|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
14201136|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
14201137|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201138|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
14201139|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773551|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14773552|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773553|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14773554|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
14496607|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496608|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14496609|NCT05348980|Phenylephrine|phenylephrine|mesh-list
14201140|NCT04543968|Protective Agents|protective agents|mesh-ancestor
14201141|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201142|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14201143|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14201144|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
14201145|NCT04543916|Irinotecan|irinotecan|mesh-list
14496610|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
14496611|NCT05348980|Synephrine|synephrine|mesh-list
14496612|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14496613|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
14496614|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
14773555|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14773556|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773557|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14773558|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
14773559|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
14940977|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14940978|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940979|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
14496615|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496616|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496617|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
14496618|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14496619|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
14940980|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14940981|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14940982|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14201146|NCT04543916|Venetoclax|venetoclax|mesh-list
14201147|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14201148|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14201149|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201150|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201151|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201152|NCT04543890|Etoposide|etoposide|mesh-list
14201153|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201154|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14201155|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14201156|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14201157|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201158|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201159|NCT04543942|Ethanol|ethanol|mesh-list
14496620|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
14201160|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14496621|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14496622|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14496623|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14496624|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
14496625|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201161|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496626|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496627|NCT05348980|Protective Agents|protective agents|mesh-ancestor
14496628|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14496629|NCT05348824|Eusol|eusol|mesh-list
14496630|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
14496631|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496635|NCT05348577|Docetaxel|docetaxel|mesh-list
14496636|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496637|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
14940983|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
14940984|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940985|NCT01496326|Ibuprofen|ibuprofen|mesh-list
14773560|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773561|NCT00651352|Nicotine|nicotine|mesh-list
14773562|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14773563|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
14773564|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773565|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773566|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14773567|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14496638|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
14496639|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
14496640|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496641|NCT05348434|Ether|ether|mesh-list
14496642|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14496643|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
14496644|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
14496645|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496646|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496647|NCT05348239|Copper|copper|mesh-list
14496648|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
14496649|NCT05348239|Trace Elements|trace elements|mesh-ancestor
14496650|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
14496651|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201162|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201163|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201164|NCT04543565|Tenofovir|tenofovir|mesh-list
14201165|NCT04543565|Pradefovir|pradefovir|mesh-list
14201166|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
14201167|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201168|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14201169|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14201170|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496652|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14496653|NCT05348239|Protective Agents|protective agents|mesh-ancestor
14496654|NCT05348213|Decitabine|decitabine|mesh-list
14496655|NCT05348213|Pomalidomide|pomalidomide|mesh-list
14496656|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
14496657|NCT05348213|Tofacitinib|tofacitinib|mesh-list
14496658|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14496659|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
14496660|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496661|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496662|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496663|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
14496664|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496665|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14496666|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14496667|NCT05348213|Growth Substances|growth substances|mesh-ancestor
14496668|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
14496669|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14773568|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
14773569|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496670|NCT05348200|Clobetasol|clobetasol|mesh-list
14496671|NCT05348200|Lidocaine|lidocaine|mesh-list
14496672|NCT05348200|Halobetasol|halobetasol|mesh-list
14496673|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
14496674|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
14496675|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496676|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496677|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
14496678|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496679|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14496680|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14496681|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14496682|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14496683|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496684|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14496685|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496686|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
14940986|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14201171|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496687|NCT05348200|Hormones|hormones|mesh-ancestor
14496688|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14496689|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
14496690|NCT05348148|Cetirizine|cetirizine|mesh-list
14496691|NCT05348148|Phenylephrine|phenylephrine|mesh-list
14496692|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
14496693|NCT05348148|Levocetirizine|levocetirizine|mesh-list
14496694|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201172|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14201173|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14201174|NCT04543370|Deflazacort|deflazacort|mesh-list
14201175|NCT04543370|Midazolam|midazolam|mesh-list
14201176|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14201177|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14201178|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201179|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201180|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14496695|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
14496696|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14496697|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14201181|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14201182|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14201183|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201184|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
14201185|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
14201186|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
14201187|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
14201188|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201189|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201190|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201191|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201192|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
14201193|NCT04543110|Durvalumab|durvalumab|mesh-list
14201194|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14201195|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201196|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
14201197|NCT04543227|Narcotics|narcotics|mesh-ancestor
14201198|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201199|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201200|NCT04543227|Analgesics|analgesics|mesh-ancestor
14201201|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
14201202|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201203|NCT04543188|Midazolam|midazolam|mesh-list
14201204|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14201205|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14201206|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201207|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201208|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14201209|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14201210|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14201211|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201212|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
14201213|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
14201214|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
14201215|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
14201216|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201217|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201218|NCT04543123|Citalopram|citalopram|mesh-list
14201219|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
14201220|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14201221|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14201222|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201223|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201224|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201225|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
14201226|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201227|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14201228|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14496698|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14496699|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
14496700|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
14496701|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496702|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496703|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201229|NCT04542694|Favipiravir|favipiravir|mesh-list
14496704|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14496705|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14496706|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
14496707|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
14496708|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
14496709|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496710|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
14496711|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14496712|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
14496713|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14496714|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
14496715|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14496716|NCT05348148|Protective Agents|protective agents|mesh-ancestor
14496717|NCT05347979|Dabigatran|dabigatran|mesh-list
14496718|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
14496719|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14496720|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
14496721|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496722|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496723|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
14496724|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
14496725|NCT05339581|Lenvatinib|lenvatinib|mesh-list
14496726|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14496727|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496728|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14496729|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496730|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496731|NCT05337436|Calcium|calcium|mesh-list
14496732|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14496733|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496734|NCT05334017|Cocaine|cocaine|mesh-list
14496735|NCT05334017|Xylometazoline|xylometazoline|mesh-list
14496736|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
14496737|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
14496738|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496739|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496740|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
14496741|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496742|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14496743|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14496744|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14496745|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14496746|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496747|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
14496748|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496749|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
14496750|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
14201230|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
14201231|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201232|NCT04542993|Zinc|zinc|mesh-list
14201233|NCT04542993|Resveratrol|resveratrol|mesh-list
14201234|NCT04542993|Picolinic acid|picolinic acid|mesh-list
14496751|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14496752|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14496753|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
14496754|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496755|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496756|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201235|NCT04542993|Trace Elements|trace elements|mesh-ancestor
14201236|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
14201237|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201238|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
14201239|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201240|NCT04542993|Protective Agents|protective agents|mesh-ancestor
14201241|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201242|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14201243|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14201244|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
14201245|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
14201246|NCT04542837|Lenvatinib|lenvatinib|mesh-list
14201247|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201248|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14773570|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773571|NCT00651443|Galiximab|galiximab|mesh-list
14773572|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773573|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773574|NCT00651456|Bevacizumab|bevacizumab|mesh-list
14773575|NCT00651456|Cisplatin|cisplatin|mesh-list
14773576|NCT00651456|Pemetrexed|pemetrexed|mesh-list
14773577|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14773578|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773579|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14773580|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14773581|NCT00651456|Growth Substances|growth substances|mesh-ancestor
14773582|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773583|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
14773584|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773585|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773586|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14201249|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201250|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201251|NCT04542629|Trace Elements|trace elements|mesh-list
14201252|NCT04542629|Rituximab|rituximab|mesh-list
14201253|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14201254|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201255|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
14201256|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201257|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201258|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
14201259|NCT04542759|Besifloxacin|besifloxacin|mesh-list
14201260|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14201261|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14201262|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14201263|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201264|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14201265|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14201266|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496783|NCT05320718|Ropivacaine|ropivacaine|mesh-list
14496784|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
14496785|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
14496786|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496787|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496788|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
14496789|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496790|NCT05319353|Maribavir|maribavir|mesh-list
14496791|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
14496792|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201267|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201268|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201269|NCT04542733|Everolimus|everolimus|mesh-list
14201270|NCT04542733|Tacrolimus|tacrolimus|mesh-list
14201271|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201272|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
14201273|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201274|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14201275|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201276|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201277|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201278|NCT04542395|Vaccines|vaccines|mesh-list
14201279|NCT04542395|Immunologic Factors|immunologic factors|mesh-ancestor
14201280|NCT04542395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239550|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239551|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14239552|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14239553|NCT00145249|Amebicides|amebicides|mesh-ancestor
14773587|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14773588|NCT00651547|Budesonide|budesonide|mesh-list
14773589|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
14773590|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773591|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14773592|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
14773593|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773594|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773595|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14239554|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14239555|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14239556|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14239557|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
14239558|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14239559|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239560|NCT00145418|Docetaxel|docetaxel|mesh-list
14239561|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
14239562|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239563|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239564|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239565|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239566|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239567|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14773596|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
14239568|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14239569|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14239570|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
14773597|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
14496831|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14496832|NCT05283395|Latanoprost|latanoprost|mesh-list
14496833|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14496834|NCT05279937|Lidocaine|lidocaine|mesh-list
14496835|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14496836|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
14496837|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
14496838|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14496839|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496840|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
14496841|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496842|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14496843|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14496844|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14496845|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14496846|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496847|NCT05273359|Benralizumab|benralizumab|mesh-list
14496848|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14496849|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
14773598|NCT00651547|Hormones|hormones|mesh-ancestor
14773599|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773600|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14773601|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14773602|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773603|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773604|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14940987|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14940988|NCT01496326|Analgesics|analgesics|mesh-ancestor
14940989|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
14940990|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14940991|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201281|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14201282|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14201283|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201284|NCT04542226|Bromides|bromides|mesh-list
14201285|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
14201286|NCT04542213|Insulin|insulin|mesh-list
14201287|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14201288|NCT04542213|Linagliptin|linagliptin|mesh-list
14201289|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14201290|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201291|NCT04542213|Incretins|incretins|mesh-ancestor
14201292|NCT04542213|Hormones|hormones|mesh-ancestor
14201293|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201294|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14201295|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
14201296|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201297|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773605|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773606|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
14773607|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
14773608|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14773609|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14496850|NCT05267613|Esomeprazole|esomeprazole|mesh-list
14773610|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773611|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773612|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14773613|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14773614|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14940992|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13964089|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
13964090|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13964091|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
13964092|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
13964093|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13964094|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13964095|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13964096|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
13964097|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964098|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964099|NCT03139708|Protective Agents|protective agents|mesh-ancestor
13964100|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13964101|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13964102|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14773615|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773616|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773617|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14940993|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14940994|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14940995|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496851|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14496852|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14496853|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14496854|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496855|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496856|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14496857|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14496858|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
14496859|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773618|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14773619|NCT00651599|Drospirenone|drospirenone|mesh-list
14773620|NCT00651599|Estradiol|estradiol|mesh-list
14940996|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14940997|NCT01496417|Abatacept|abatacept|mesh-list
14940998|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14940999|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941000|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941001|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941002|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
14941003|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941004|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14941005|NCT01496443|Glimepiride|glimepiride|mesh-list
14941006|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14941007|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941008|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941009|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941010|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
14941011|NCT01496521|Aspirin|aspirin|mesh-list
14941012|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14941013|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14941014|NCT01496521|Analgesics|analgesics|mesh-ancestor
14941015|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
14941016|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941017|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941018|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941019|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14941020|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14941021|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14941022|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941023|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14941024|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14941025|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941026|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
14941027|NCT01496534|Carboplatin|carboplatin|mesh-list
14941028|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941029|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
14941030|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14941031|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941032|NCT01496690|Pregabalin|pregabalin|mesh-list
14941033|NCT01496690|Analgesics|analgesics|mesh-ancestor
14773621|NCT00651599|Estrogens|estrogens|mesh-ancestor
14773622|NCT00651599|Hormones|hormones|mesh-ancestor
14773623|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773624|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773625|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14201306|NCT04542369|Etoposide|etoposide|mesh-list
14201307|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201308|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14201309|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14201310|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14201311|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201312|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201313|NCT04542304|Metolazone|metolazone|mesh-list
14201314|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14201315|NCT04542304|Diuretics|diuretics|mesh-ancestor
14201316|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
14201317|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201318|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14496860|NCT05263206|Loratadine|loratadine|mesh-list
14496861|NCT05263206|Fexofenadine|fexofenadine|mesh-list
14496862|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
14496863|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
14496864|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14496865|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14496866|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14496867|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
14201319|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201320|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201321|NCT04542252|Cyclosporine|cyclosporine|mesh-list
14201322|NCT04542252|Cyclosporins|cyclosporins|mesh-list
14201323|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201324|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201325|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14496868|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
14496869|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496870|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496871|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496872|NCT05259527|Vitamin D|vitamin d|mesh-list
14496873|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
14496874|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
14496875|NCT05259527|Vitamins|vitamins|mesh-list
14496876|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
14496877|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496878|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14496879|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14496880|NCT05257590|Nivolumab|nivolumab|mesh-list
14496881|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14201326|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
14201327|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201328|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
14496882|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496883|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14496884|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496885|NCT05256108|Oxycodone|oxycodone|mesh-list
14496886|NCT05256108|Tramadol|tramadol|mesh-list
14496887|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14496888|NCT05256108|Narcotics|narcotics|mesh-ancestor
14496889|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773626|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
14773627|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14773628|NCT00651599|Diuretics|diuretics|mesh-ancestor
14201329|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201330|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
14201331|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201332|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14201333|NCT04541719|Remifentanil|remifentanil|mesh-list
14201334|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14201335|NCT04541719|Narcotics|narcotics|mesh-ancestor
14201336|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201337|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201338|NCT04541719|Analgesics|analgesics|mesh-ancestor
14773629|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
14773630|NCT00651612|Timolol|timolol|mesh-list
14773631|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14773632|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14201339|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
14201340|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496890|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496891|NCT05256108|Analgesics|analgesics|mesh-ancestor
14773633|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14773634|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14773635|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14773636|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773637|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496892|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
14496893|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496894|NCT05245071|Maytansine|maytansine|mesh-list
14496895|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14496896|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496897|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
14201341|NCT04541732|Anesthetics|anesthetics|mesh-list
14201342|NCT04541732|Propofol|propofol|mesh-list
14201343|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201344|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201345|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14201346|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201347|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
14201348|NCT04541823|Propofol|propofol|mesh-list
14201349|NCT04541823|Desflurane|desflurane|mesh-list
14201350|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14201351|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201352|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201353|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201354|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
14201355|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
14496898|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
14496899|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
14496900|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496901|NCT05236231|Tadalafil|tadalafil|mesh-list
14496902|NCT05236231|Macitentan|macitentan|mesh-list
14773638|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773639|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773640|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14201356|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14201359|NCT04541680|Nintedanib|nintedanib|mesh-list
14201360|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201361|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14201362|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201363|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201364|NCT04542005|Albuterol|albuterol|mesh-list
14201365|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14201366|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
14201367|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201368|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201369|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14201370|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
14201371|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
14201372|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14201373|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14201374|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14201375|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14201376|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
14496903|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
14496904|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14496905|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14773641|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773642|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14773643|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14773644|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773645|NCT00651651|Budesonide|budesonide|mesh-list
14496906|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496907|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496908|NCT05236231|Urological Agents|urological agents|mesh-ancestor
14496909|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14773646|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
14773647|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773648|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14941034|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
14201377|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201378|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773649|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
14773650|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773651|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773652|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14773653|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
14773654|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
14773655|NCT00651651|Hormones|hormones|mesh-ancestor
14201379|NCT04541173|Bevacizumab|bevacizumab|mesh-list
14941035|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773656|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773657|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14941036|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941037|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
14941038|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14941039|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14941040|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201380|NCT04541173|Atezolizumab|atezolizumab|mesh-list
14201381|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14201382|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201383|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14201384|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14201385|NCT04541173|Growth Substances|growth substances|mesh-ancestor
14201386|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201387|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
14201388|NCT04541147|Dexamethasone|dexamethasone|mesh-list
14201389|NCT04541147|Analgesics|analgesics|mesh-list
14201390|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201391|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
14201392|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
14201393|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201394|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201395|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201396|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
14201397|NCT04541147|Hormones|hormones|mesh-ancestor
14242963|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14242964|NCT00191724|Enoxaparin|enoxaparin|mesh-list
14242965|NCT00191724|Protein C|protein c|mesh-list
14242966|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
14242967|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14242968|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14242969|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242970|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242971|NCT00191789|Gemcitabine|gemcitabine|mesh-list
14242972|NCT00191789|Doxorubicin|doxorubicin|mesh-list
14242973|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242974|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242975|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
14242976|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242977|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
14242978|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242979|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242980|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242981|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
14242982|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242983|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14242984|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14242985|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243392|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243393|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14243394|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14243395|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14243396|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
14243397|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243398|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14243399|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14243400|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14243401|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14243402|NCT00194792|Paclitaxel|paclitaxel|mesh-list
14773658|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14773659|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773660|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773661|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773662|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773663|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
14773664|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14773665|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14773666|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14496910|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14496911|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14496912|NCT05223231|Antibodies|antibodies|mesh-list
14496913|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
14496914|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
14496915|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496916|NCT05221658|Cisplatin|cisplatin|mesh-list
14496917|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496918|NCT05221021|Mirabegron|mirabegron|mesh-list
14773667|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14496919|NCT05221021|Estradiol|estradiol|mesh-list
14496920|NCT05221021|Estrogens|estrogens|mesh-list
14496921|NCT05221021|Hormones|hormones|mesh-ancestor
14496922|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773668|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773669|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
14773670|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941041|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14941042|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14941043|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14201398|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941044|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941045|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14941046|NCT01496742|Paclitaxel|paclitaxel|mesh-list
14201399|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14201400|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201401|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
14201402|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
14201403|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14201404|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14201405|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201406|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
14201407|NCT04541303|Coagulants|coagulants|mesh-ancestor
14201408|NCT04541277|Cytarabine|cytarabine|mesh-list
14201409|NCT04541277|Azacitidine|azacitidine|mesh-list
14201410|NCT04541277|Decitabine|decitabine|mesh-list
14201411|NCT04541277|Idarubicin|idarubicin|mesh-list
14201412|NCT04541277|Sargramostim|sargramostim|mesh-list
14201413|NCT04541277|Lenograstim|lenograstim|mesh-list
14201414|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14201415|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
14201416|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201417|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201418|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
14201419|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201420|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201421|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
14201422|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201423|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496923|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496924|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14496925|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14496926|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14496927|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
14496928|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14496929|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496930|NCT05221021|Urological Agents|urological agents|mesh-ancestor
14496931|NCT05215535|Liver Extracts|liver extracts|mesh-list
14496932|NCT05215535|Hematinics|hematinics|mesh-ancestor
14941047|NCT01496742|Bevacizumab|bevacizumab|mesh-list
14941048|NCT01496742|Carboplatin|carboplatin|mesh-list
14941049|NCT01496742|Pemetrexed|pemetrexed|mesh-list
14941050|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14941051|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941052|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
14941053|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
14941054|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
14201424|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14201425|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14201426|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14201427|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14201428|NCT04540926|Cyclosporine|cyclosporine|mesh-list
14201429|NCT04540926|Cyclosporins|cyclosporins|mesh-list
14201430|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201431|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201432|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14773671|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773672|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14773673|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773674|NCT00651703|Imiquimod|imiquimod|mesh-list
14773675|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14773676|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
14773677|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773678|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773679|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
14773680|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
14773681|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14773682|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14773683|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14773684|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807318|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201433|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
14201434|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201435|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
14201436|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201437|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
14201438|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201439|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14201440|NCT04541251|Paclitaxel|paclitaxel|mesh-list
14201441|NCT04541251|Carboplatin|carboplatin|mesh-list
14201442|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14201443|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201444|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14201445|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14201446|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14201447|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201448|NCT04540861|Siponimod|siponimod|mesh-list
14242986|NCT00191815|Gemcitabine|gemcitabine|mesh-list
14242987|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242988|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242989|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
14242990|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242991|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
14242992|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242993|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242994|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242995|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
14242996|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242997|NCT00191854|Gemcitabine|gemcitabine|mesh-list
14242998|NCT00191854|Paclitaxel|paclitaxel|mesh-list
14242999|NCT00191854|Carboplatin|carboplatin|mesh-list
14243000|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14243001|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243002|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243003|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243004|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243005|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243006|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243007|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
14243008|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
14243009|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243010|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243011|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243012|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
14243013|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243014|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14243015|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14243016|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14243017|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14243018|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243019|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773685|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773686|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
14773687|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201449|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14201450|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201451|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14496953|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14496954|NCT05206500|Amoxicillin|amoxicillin|mesh-list
14496955|NCT05206500|Metronidazole|metronidazole|mesh-list
14496956|NCT05206500|Clindamycin|clindamycin|mesh-list
14496957|NCT05206500|Linezolid|linezolid|mesh-list
14496958|NCT05206500|Tetracycline|tetracycline|mesh-list
14496959|NCT05206500|Penicillins|penicillins|mesh-list
14496960|NCT05206500|Ampicillin|ampicillin|mesh-list
14496961|NCT05206500|Fosfomycin|fosfomycin|mesh-list
14496962|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
14496963|NCT05206500|Cephalosporins|cephalosporins|mesh-list
14496964|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
14496965|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496966|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14496967|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14496968|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14496969|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773688|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496970|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496971|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14496972|NCT05206500|Renal Agents|renal agents|mesh-ancestor
14496973|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14496974|NCT05201183|Fludarabine|fludarabine|mesh-list
14496975|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496976|NCT05195918|Pirfenidone|pirfenidone|mesh-list
14496977|NCT05195918|Nintedanib|nintedanib|mesh-list
14496978|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14496979|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14496980|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14496981|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14496982|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14496983|NCT05195918|Analgesics|analgesics|mesh-ancestor
14496984|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
14496985|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14496986|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14496987|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14496988|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14496989|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14496990|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14496991|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
14496992|NCT05195918|Protective Agents|protective agents|mesh-ancestor
14496993|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14773689|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14773690|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773691|NCT00651768|Budesonide|budesonide|mesh-list
14773692|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
14773693|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14773694|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773695|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14773696|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
14201452|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
14201453|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201454|NCT04540965|Famotidine|famotidine|mesh-list
14201455|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14201456|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201457|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14201458|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
14201459|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
14201460|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201461|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201462|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201463|NCT04540653|Vaccines|vaccines|mesh-list
14201464|NCT04540653|Immunologic Factors|immunologic factors|mesh-ancestor
14201465|NCT04540653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201466|NCT04540666|Propofol|propofol|mesh-list
14201467|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14201468|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201469|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201470|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201471|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
14496994|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14773697|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773698|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773699|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14496995|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14496996|NCT05191446|Ethanol|ethanol|mesh-list
14496997|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14496998|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14496999|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497000|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773700|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
14773701|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
14773702|NCT00651768|Hormones|hormones|mesh-ancestor
14773703|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201472|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
14201473|NCT04540744|Tadalafil|tadalafil|mesh-list
14201474|NCT04540744|Macitentan|macitentan|mesh-list
14497008|NCT05180318|Ketamine|ketamine|mesh-list
14497009|NCT05180318|Esketamine|esketamine|mesh-list
14497010|NCT05180318|Analgesics|analgesics|mesh-ancestor
14497011|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
14497012|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497013|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497014|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14497015|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14201475|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
14201476|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14201477|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14201478|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201479|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201480|NCT04540744|Urological Agents|urological agents|mesh-ancestor
14201481|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14201482|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14201483|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14201484|NCT04540692|Paclitaxel|paclitaxel|mesh-list
14201485|NCT04540692|Docetaxel|docetaxel|mesh-list
14201486|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
14497016|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
14497017|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
14497018|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497019|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14497020|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14497021|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497022|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497023|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
14497024|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14497025|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
14497026|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497027|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497028|NCT05177991|Bupivacaine|bupivacaine|mesh-list
14497029|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
14497030|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
14497031|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497032|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497033|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
14497034|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497038|NCT05167825|Macitentan|macitentan|mesh-list
14497039|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14497040|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14497041|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497042|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14497043|NCT05158153|Furosemide|furosemide|mesh-list
14497044|NCT05158153|Diuretics|diuretics|mesh-ancestor
14497045|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
14497046|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497047|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14497048|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14497049|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201487|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14201488|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201489|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
14201490|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
14201491|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
14201492|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201493|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201494|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
14201495|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201496|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201497|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14201498|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
14201499|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14201500|NCT04540627|Palivizumab|palivizumab|mesh-list
14201501|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
14201502|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239571|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239572|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14243020|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243021|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243022|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14243023|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14243024|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14243025|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14243026|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243027|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
14497058|NCT05152147|Fluorouracil|fluorouracil|mesh-list
14243028|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243029|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497059|NCT05152147|Capecitabine|capecitabine|mesh-list
14497060|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
14497061|NCT05152147|Trastuzumab|trastuzumab|mesh-list
14497062|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497063|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
14497064|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497065|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14497066|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243030|NCT00191984|Irinotecan|irinotecan|mesh-list
14243031|NCT00191984|Pemetrexed|pemetrexed|mesh-list
14243032|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14243033|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243034|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243035|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243036|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243037|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14497067|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
14773704|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14773705|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14773706|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773707|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773708|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773709|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807319|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14807320|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807321|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
14807322|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807323|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
14807324|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807325|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14807326|NCT00821158|Antioxidants|antioxidants|mesh-list
14807327|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807328|NCT00821158|Protective Agents|protective agents|mesh-ancestor
14807329|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807330|NCT00821262|Propofol|propofol|mesh-list
14807331|NCT00821262|Sevoflurane|sevoflurane|mesh-list
14807332|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14201503|NCT04539977|Cisplatin|cisplatin|mesh-list
14201504|NCT04539977|Etoposide|etoposide|mesh-list
14201505|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
14201506|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201507|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14201508|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14201509|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14201510|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201511|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807333|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807334|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807335|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14807336|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
14807337|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
14941055|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941056|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14941057|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14941058|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14941059|NCT01496742|Growth Substances|growth substances|mesh-ancestor
14941060|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201512|NCT04540055|Anesthetics|anesthetics|mesh-list
14239573|NCT00145587|Antibodies|antibodies|mesh-list
14239574|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
14239575|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239576|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
14239577|NCT00145626|Melphalan|melphalan|mesh-list
14239578|NCT00145626|Thiotepa|thiotepa|mesh-list
14239579|NCT00145626|Fludarabine|fludarabine|mesh-list
14239580|NCT00145626|Antibodies|antibodies|mesh-list
14239581|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239582|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
14239583|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239584|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239585|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14239586|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
14239587|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239588|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239589|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14239590|NCT00145795|Ritonavir|ritonavir|mesh-list
14239591|NCT00145795|Lopinavir|lopinavir|mesh-list
14239592|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14239593|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14239594|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
14239595|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239596|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239597|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14239598|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14239599|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
14239600|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239601|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14239602|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239603|NCT00145977|Vitamin D|vitamin d|mesh-list
14239604|NCT00145977|Alendronate|alendronate|mesh-list
14497068|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497069|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497070|NCT05149131|Leuprolide|leuprolide|mesh-list
14497071|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14497072|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
14497073|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14497074|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497075|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14497076|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497083|NCT05144854|Capecitabine|capecitabine|mesh-list
14497084|NCT05144854|Tegafur|tegafur|mesh-list
14201513|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201514|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201515|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
14201516|NCT04540185|Vaccines|vaccines|mesh-list
14497085|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
14497086|NCT05144854|Nivolumab|nivolumab|mesh-list
14497087|NCT05144854|Ipilimumab|ipilimumab|mesh-list
14497088|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14497089|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
14497090|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497091|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497092|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497093|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14497094|NCT05142241|Temozolomide|temozolomide|mesh-list
14497095|NCT05142241|Talazoparib|talazoparib|mesh-list
14201517|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
14201518|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201519|NCT04540185|Protective Agents|protective agents|mesh-ancestor
14201520|NCT04539951|Memantine|memantine|mesh-list
14201521|NCT04539951|Aripiprazole|aripiprazole|mesh-list
14201522|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
14497096|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14497097|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
14497098|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497099|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497100|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14497101|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497102|NCT05130463|Empagliflozin|empagliflozin|mesh-list
14497103|NCT05130463|Linagliptin|linagliptin|mesh-list
14497104|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14497105|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497106|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14201523|NCT04539951|Sertraline|sertraline|mesh-list
14201524|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14201525|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
14201526|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14201527|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14201528|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14201529|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201530|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201531|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
14201532|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
14528331|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
14528332|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14201533|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201534|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528333|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14528334|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14528335|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
14528336|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528337|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528338|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528339|NCT03848871|Betamethasone|betamethasone|mesh-list
14528340|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
14528341|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14528342|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
14528343|NCT03848871|Calcipotriene|calcipotriene|mesh-list
14528344|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14201535|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14201536|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14201537|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
14201538|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14201539|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14201540|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14201541|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14201542|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14497107|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497108|NCT05130463|Incretins|incretins|mesh-ancestor
14497109|NCT05130463|Hormones|hormones|mesh-ancestor
14201543|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14201544|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201545|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14201546|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14201547|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14201548|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14201549|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14201550|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14201551|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14201552|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14201553|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14201554|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201555|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14201556|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14201557|NCT04539626|Estradiol|estradiol|mesh-list
14201558|NCT04539626|Estrogens|estrogens|mesh-list
14497110|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497111|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14497112|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
14497113|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497114|NCT05128773|Tamoxifen|tamoxifen|mesh-list
14497115|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14497116|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14497117|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497118|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497119|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14497120|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497121|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14497122|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14497123|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14497124|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
14497125|NCT05114590|Lixisenatide|lixisenatide|mesh-list
14497126|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14497127|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497128|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
14497129|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14201559|NCT04539626|Hormones|hormones|mesh-ancestor
14201560|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497130|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14497131|NCT05113901|Prednisolone|prednisolone|mesh-list
14497132|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
14497133|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14497134|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
14497135|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14497136|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
14497137|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
14497138|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497139|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497140|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14497141|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
14497142|NCT05113901|Hormones|hormones|mesh-ancestor
14497143|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497144|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14497145|NCT05113901|Protective Agents|protective agents|mesh-ancestor
14497146|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14773710|NCT00651781|Bortezomib|bortezomib|mesh-list
14773711|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773712|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14773713|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14773714|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14497147|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497154|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
14497155|NCT05104567|Cetuximab|cetuximab|mesh-list
14497156|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497157|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497158|NCT05103904|Lenvatinib|lenvatinib|mesh-list
14497159|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497160|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14497161|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497162|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773715|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773716|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14773717|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
14773718|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14773719|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14773720|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14773721|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14773722|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14773723|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14773724|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14773725|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14773726|NCT00651859|Bimatoprost|bimatoprost|mesh-list
14773727|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14773728|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14773729|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773730|NCT00651885|Treprostinil|treprostinil|mesh-list
14773731|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773732|NCT00651911|Rasburicase|rasburicase|mesh-list
14773733|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
14773734|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773735|NCT00651976|Letrozole|letrozole|mesh-list
14773736|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773737|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14773738|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14773739|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773740|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773741|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14773742|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
14773743|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773744|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773745|NCT00652002|Budesonide|budesonide|mesh-list
14773746|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
14773747|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773748|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14773749|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
14773750|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773751|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773752|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14773753|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
14773754|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
14773755|NCT00652002|Hormones|hormones|mesh-ancestor
14773756|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941061|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
14201561|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201562|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14201563|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
14201564|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14201565|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14201566|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14201567|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14201568|NCT04539301|Anticoagulants|anticoagulants|mesh-list
14201569|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
14773757|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14773758|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14773759|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773760|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
14941062|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941063|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14201570|NCT04539314|Bupivacaine|bupivacaine|mesh-list
14497163|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
14497164|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14941064|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14941065|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
14497165|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
14497166|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497167|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497168|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14497169|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497170|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14497171|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
14497172|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773761|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773762|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773763|NCT00652041|Thalidomide|thalidomide|mesh-list
14773764|NCT00652041|Bortezomib|bortezomib|mesh-list
14773765|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773766|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14497173|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497174|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14497175|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
14497176|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
14497177|NCT05101746|Protective Agents|protective agents|mesh-ancestor
14497178|NCT05097326|Misoprostol|misoprostol|mesh-list
14497179|NCT05097326|Mifepristone|mifepristone|mesh-list
14497180|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14497181|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
14497182|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14497183|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497184|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14497185|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14497186|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
14497187|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14497188|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14497189|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14497190|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14497191|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
14773767|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
14773768|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201571|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14201572|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
14497192|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14497193|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14497194|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
14497195|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497196|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
14497197|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14497198|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14497199|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
14497200|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14497201|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14497202|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
14497203|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497204|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497205|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14497206|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497207|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14497208|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
14497209|NCT05088369|Protective Agents|protective agents|mesh-ancestor
14497210|NCT05080322|Fluticasone|fluticasone|mesh-list
14497211|NCT05080322|Xhance|xhance|mesh-list
14201573|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201574|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497212|NCT05080322|Azelastine|azelastine|mesh-list
14497213|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14497214|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14497215|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
14497216|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497217|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497218|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14497219|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497220|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
14497221|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14497222|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14497223|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497224|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497225|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14773769|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
14497226|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14497227|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
14773770|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773771|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773772|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14773773|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14773774|NCT00652041|Growth Substances|growth substances|mesh-ancestor
14773775|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
14773776|NCT00652106|Timolol|timolol|mesh-list
14773777|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14773778|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14773779|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14773780|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14773781|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14773782|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773783|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773784|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201575|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
14201576|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201577|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14201578|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14201579|NCT04539314|Analgesics|analgesics|mesh-ancestor
14201580|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14201581|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14201582|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14201583|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
14201584|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201585|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201586|NCT04539405|Sevoflurane|sevoflurane|mesh-list
14201587|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14201588|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14201589|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
14201590|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
14201591|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201592|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201593|NCT04539327|Rucaparib|rucaparib|mesh-list
14201594|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14201595|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201596|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773785|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773786|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14773787|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773788|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14941066|NCT01496911|Levocetirizine|levocetirizine|mesh-list
14497228|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
14497229|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497235|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
14201597|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201598|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
14201599|NCT04539249|Pentazocine|pentazocine|mesh-list
14201600|NCT04539249|Analgesics|analgesics|mesh-ancestor
14201601|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
14201602|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201603|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201604|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
14497236|NCT05063396|Anesthetics|anesthetics|mesh-list
14497237|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497238|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497239|NCT05063396|Narcotics|narcotics|mesh-ancestor
14497240|NCT05063396|Analgesics|analgesics|mesh-ancestor
14497241|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
14497242|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941067|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14941068|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14941069|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
14941070|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
14941071|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497243|NCT05062317|Leucovorin|leucovorin|mesh-list
14773789|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14941072|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941073|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941074|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
14941075|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
14941076|NCT01496989|Interleukin-12|interleukin-12|mesh-list
14941077|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14497244|NCT05062317|Bevacizumab|bevacizumab|mesh-list
14497245|NCT05062317|Fluorouracil|fluorouracil|mesh-list
14497246|NCT05062317|Capecitabine|capecitabine|mesh-list
14497247|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
14497248|NCT05062317|Irinotecan|irinotecan|mesh-list
14497249|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497250|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497251|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14497252|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14497253|NCT05062317|Growth Substances|growth substances|mesh-ancestor
14497254|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497255|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
14497256|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
14497257|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497258|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14497259|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14497260|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
14497261|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14497262|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14497263|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497264|NCT05062317|Antidotes|antidotes|mesh-ancestor
14497265|NCT05062317|Protective Agents|protective agents|mesh-ancestor
14497266|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
14497267|NCT05062317|Vitamins|vitamins|mesh-ancestor
14497268|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
14497269|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
14497270|NCT05061420|Cetuximab|cetuximab|mesh-list
14497271|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497272|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941078|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
14941079|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201605|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201606|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14201607|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
14201608|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14201609|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201610|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201611|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14497293|NCT05055752|Aspirin|aspirin|mesh-list
14497294|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14497295|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14497296|NCT05055752|Analgesics|analgesics|mesh-ancestor
14497297|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
14497298|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497299|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201612|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
14201613|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14201614|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14497300|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14497301|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14497302|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14497303|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14497304|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497305|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14497306|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14497307|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497308|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
14497309|NCT05051527|Silymarin|silymarin|mesh-list
14497310|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
14497311|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497312|NCT05051527|Protective Agents|protective agents|mesh-ancestor
14497313|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497314|NCT05050942|Octreotide|octreotide|mesh-list
14497315|NCT05050942|Lanreotide|lanreotide|mesh-list
14497316|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14497317|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14497318|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497324|NCT05045937|Vitamin D|vitamin d|mesh-list
14497325|NCT05045937|Vitamins|vitamins|mesh-list
14497326|NCT05045937|Ivermectin|ivermectin|mesh-list
14497327|NCT05045937|Remdesivir|remdesivir|mesh-list
14497328|NCT05045937|Ibuprofen|ibuprofen|mesh-list
14497329|NCT05045937|Budesonide|budesonide|mesh-list
14497330|NCT05045937|Melatonin|melatonin|mesh-list
14497331|NCT05045937|Albuterol|albuterol|mesh-list
14497332|NCT05045937|Quercetin|quercetin|mesh-list
14497333|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497334|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
14497335|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14497336|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14497337|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14497338|NCT05045937|Analgesics|analgesics|mesh-ancestor
14201615|NCT04539249|Narcotics|narcotics|mesh-ancestor
14201616|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14201617|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14773790|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773791|NCT00652119|Paclitaxel|paclitaxel|mesh-list
14773792|NCT00652119|Bevacizumab|bevacizumab|mesh-list
14773793|NCT00652119|Carboplatin|carboplatin|mesh-list
14773794|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14773795|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497339|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
14497340|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497341|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14497342|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14497343|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497344|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14497345|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497346|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14497347|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
14497348|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14773796|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14773797|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14773798|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14773799|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773800|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14773801|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14773802|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14773803|NCT00652119|Growth Substances|growth substances|mesh-ancestor
14941080|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14497349|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497350|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
14497351|NCT05045937|Hormones|hormones|mesh-ancestor
14941081|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14941082|NCT01496989|Growth Substances|growth substances|mesh-ancestor
14941083|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
14201618|NCT04539119|Tenofovir|tenofovir|mesh-list
14201619|NCT04539119|Entecavir|entecavir|mesh-list
14201620|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
14201621|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201622|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14497352|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941084|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941085|NCT01497002|Cytarabine|cytarabine|mesh-list
14941086|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14497353|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
14497354|NCT05045937|Protective Agents|protective agents|mesh-ancestor
14497355|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497356|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
14497357|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14941087|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
14941088|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941089|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941090|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
14941091|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773804|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773805|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
14941092|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941093|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
14941094|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941095|NCT01497041|Docetaxel|docetaxel|mesh-list
14941096|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
14941097|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941098|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
14941099|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
14941100|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
14941101|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941102|NCT01497093|Thalidomide|thalidomide|mesh-list
14941103|NCT01497093|Dexamethasone|dexamethasone|mesh-list
14941104|NCT01497093|Bortezomib|bortezomib|mesh-list
14941105|NCT01497093|Pomalidomide|pomalidomide|mesh-list
14941106|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941107|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
14201623|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14201624|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201625|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201626|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14201627|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14201628|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
14201629|NCT04539379|Analgesics|analgesics|mesh-ancestor
14201630|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
14201631|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201632|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201633|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
14497358|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14497359|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14201634|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201635|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14201636|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
14201637|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14201638|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201639|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201640|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14201641|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
14201642|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14201643|NCT04539106|Ranibizumab|ranibizumab|mesh-list
14201644|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14201645|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14201646|NCT04539106|Growth Substances|growth substances|mesh-ancestor
14201647|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201648|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
14201649|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201650|NCT04538820|Dexamethasone|dexamethasone|mesh-list
14201651|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
14201652|NCT04538820|BB 1101|bb 1101|mesh-list
14201653|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201654|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
14201655|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
14497360|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14497361|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
14497362|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497363|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14201656|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201657|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201658|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201659|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
14201660|NCT04538820|Hormones|hormones|mesh-ancestor
14201661|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497364|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14497365|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
14497366|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
14773806|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
14773807|NCT00652132|Antidotes|antidotes|mesh-ancestor
14773808|NCT00652132|Protective Agents|protective agents|mesh-ancestor
14773809|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773810|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
14773811|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773812|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
14773813|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773814|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941108|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
14773815|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
14201662|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14201663|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201664|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
14201665|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201666|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201667|NCT04539054|Caffeine|caffeine|mesh-list
14201668|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14201669|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201670|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14497367|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14497368|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773816|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
14773817|NCT00652171|Lamotrigine|lamotrigine|mesh-list
14773818|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
14201671|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201672|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201673|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14201674|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14201675|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
14201676|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201677|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14201678|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201679|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201680|NCT04539418|Vitamin K|vitamin k|mesh-list
14201681|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
14773819|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14941109|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941110|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941111|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201682|NCT04539418|Vitamins|vitamins|mesh-ancestor
14201683|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
14201684|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201685|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14201686|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14201687|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201688|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
14201689|NCT04539418|Coagulants|coagulants|mesh-ancestor
14201690|NCT04538521|Niacin|niacin|mesh-list
14201691|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
14201692|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14201693|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
14201694|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201695|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14201696|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
14773820|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773821|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773822|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14773823|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773824|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14773825|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773826|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773827|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773828|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14773829|NCT00652184|Valacyclovir|valacyclovir|mesh-list
14773830|NCT00652184|Sorivudine|sorivudine|mesh-list
14773831|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
14941112|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
14941113|NCT01497093|Hormones|hormones|mesh-ancestor
14201697|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
14497369|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497370|NCT05037032|Naltrexone|naltrexone|mesh-list
14497371|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14497372|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14497373|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497374|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
14497375|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773832|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773833|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773834|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773835|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14941114|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941115|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14773836|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
14773837|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14773838|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14773839|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773840|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773841|NCT00652262|Urological Agents|urological agents|mesh-ancestor
14773842|NCT00652288|Insulin|insulin|mesh-list
14773843|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14773844|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
14773845|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
14773846|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
14773847|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14773848|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
14773849|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
14773850|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14773851|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773852|NCT00652379|Octreotide|octreotide|mesh-list
14773853|NCT00652379|Lanreotide|lanreotide|mesh-list
14773854|NCT00652379|Somatostatin|somatostatin|mesh-list
14773855|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14773856|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14773857|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773858|NCT00652379|Hormones|hormones|mesh-ancestor
14773859|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773860|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773861|NCT00652392|Budesonide|budesonide|mesh-list
14201698|NCT04538521|Vitamins|vitamins|mesh-ancestor
14201699|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
14201700|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201701|NCT04538391|Bupivacaine|bupivacaine|mesh-list
14201702|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
14201703|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
14201704|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201705|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201706|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
14201707|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201708|NCT04538365|Triclosan|triclosan|mesh-list
14201709|NCT04538365|Propranolol|propranolol|mesh-list
14201710|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14201711|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14201712|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201713|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14201714|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14201715|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
14201716|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201717|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14201718|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14201719|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14201720|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
14201721|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201722|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497392|NCT05029726|Clonidine|clonidine|mesh-list
14497393|NCT05029726|Epinephrine|epinephrine|mesh-list
14497394|NCT05029726|Bupivacaine|bupivacaine|mesh-list
14497395|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
14497396|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
14497397|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497398|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497399|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
14201723|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14201724|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773862|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
14773863|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773864|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14773865|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
14773866|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201725|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
14239605|NCT00145977|Calcium|calcium|mesh-list
14239606|NCT00145977|Vitamins|vitamins|mesh-ancestor
14239607|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
14239608|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239609|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14239610|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14239611|NCT00146328|Tipranavir|tipranavir|mesh-list
14239612|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14239613|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14239614|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
14239615|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239616|NCT00146640|Prednisone|prednisone|mesh-list
14239617|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239618|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
14239619|NCT00146640|Hormones|hormones|mesh-ancestor
14239620|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239621|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239622|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239623|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239624|NCT00147199|Treprostinil|treprostinil|mesh-list
14239625|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14239626|NCT00147212|Trabectedin|trabectedin|mesh-list
14239627|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14239628|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
14239629|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239630|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239631|NCT00147225|Carboplatin|carboplatin|mesh-list
14239632|NCT00147225|Doxorubicin|doxorubicin|mesh-list
14239633|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14239634|NCT00147225|Ifosfamide|ifosfamide|mesh-list
14239635|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239636|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14239637|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14239638|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14239639|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239640|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239641|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14239642|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
14239643|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14239644|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14239645|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14239646|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239647|NCT00147498|Tofacitinib|tofacitinib|mesh-list
14239648|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14239649|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239650|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239651|NCT00147537|Paclitaxel|paclitaxel|mesh-list
14239652|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14239653|NCT00147537|Carboplatin|carboplatin|mesh-list
14239654|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14239655|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14239656|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14239657|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239658|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239659|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239660|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239661|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239662|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14239663|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239664|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
14239665|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239666|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
14239667|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14239668|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239669|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239670|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14239671|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14239672|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
14239673|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773867|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773868|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14201726|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
14201727|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
14201728|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14201729|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14201730|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201731|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201732|NCT04538976|Urological Agents|urological agents|mesh-ancestor
14201733|NCT04538053|Cefazolin|cefazolin|mesh-list
14201734|NCT04538053|Cephalexin|cephalexin|mesh-list
14201735|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14201736|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201737|NCT04537780|Montelukast|montelukast|mesh-list
14201738|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14201739|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
14201740|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14201741|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
14201742|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201743|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201744|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14201745|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14201746|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201747|NCT04537767|Esmolol|esmolol|mesh-list
14201748|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14201749|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14201750|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14201751|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
14201752|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201753|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201754|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201755|NCT04537689|Cyclosporine|cyclosporine|mesh-list
14201756|NCT04537689|Methotrexate|methotrexate|mesh-list
14201757|NCT04537689|Ixekizumab|ixekizumab|mesh-list
14201758|NCT04537689|Acitretin|acitretin|mesh-list
14201759|NCT04537689|Cyclosporins|cyclosporins|mesh-list
14201760|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14201761|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
14201762|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14201763|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201764|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14201765|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
14201766|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201767|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497400|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497401|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14497402|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14497403|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
14497404|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497405|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497406|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14497407|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14497408|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
14497409|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14497410|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497411|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
14497412|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
14497413|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14497414|NCT05029726|Analgesics|analgesics|mesh-ancestor
14497415|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14497416|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
14497417|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14497418|NCT05029050|Clonidine|clonidine|mesh-list
14497419|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
14497420|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14497421|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497422|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497423|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14497424|NCT05029050|Analgesics|analgesics|mesh-ancestor
14497425|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
14497426|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497427|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14497428|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14497429|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773869|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497430|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
14497431|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497432|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941116|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941117|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
14941118|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14941119|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14941120|NCT01497093|Growth Substances|growth substances|mesh-ancestor
14941121|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
14941122|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941123|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
14941124|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14941125|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941126|NCT01497132|Vitamin D|vitamin d|mesh-list
14941127|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
14497433|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14497434|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
14497435|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
14528345|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528346|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
14528347|NCT03848871|Hormones|hormones|mesh-ancestor
14528348|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528349|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528350|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14528351|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
14528352|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
14528353|NCT03848403|Ixekizumab|ixekizumab|mesh-list
14528354|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14528355|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14528356|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14528357|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
14528358|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528359|NCT03879603|Antacids|antacids|mesh-ancestor
14528360|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528361|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528362|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
14528363|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14528364|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528365|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14528366|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528367|NCT03866434|Anagrelide|anagrelide|mesh-list
14528368|NCT03866434|Omeprazole|omeprazole|mesh-list
14528369|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14528370|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528371|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14528372|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528373|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528374|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14528375|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14528376|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14528377|NCT03855059|Dexamethasone|dexamethasone|mesh-list
14528378|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
14528379|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14528380|NCT03855059|BB 1101|bb 1101|mesh-list
14528381|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528382|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
14528383|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
14528384|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528385|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528386|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528387|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
14528388|NCT03855059|Hormones|hormones|mesh-ancestor
14528389|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528390|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14528391|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528392|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
14528393|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528394|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528395|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
14201768|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
14201769|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201770|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14201771|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201772|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
14201773|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201774|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14201775|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
14201776|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201777|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14201778|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
14201779|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
14201780|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14201781|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14201782|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201783|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
14201784|NCT04537533|Coagulants|coagulants|mesh-ancestor
14201785|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14201786|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
14201787|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
14201788|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201789|NCT04537065|Mydriatics|mydriatics|mesh-list
14201790|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
14201791|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201792|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201793|NCT04536922|Aldesleukin|aldesleukin|mesh-list
14201794|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
14201795|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
14201796|NCT04536922|Fludarabine|fludarabine|mesh-list
14201797|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201798|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
14201799|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201800|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201801|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14201802|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
14201803|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201804|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201805|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14201806|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14201807|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14201808|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14773870|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
14773871|NCT00652392|Hormones|hormones|mesh-ancestor
14773872|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14773873|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14773874|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14773875|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14773876|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773877|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773878|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773879|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14773880|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14773881|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14773882|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773883|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14773884|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14773885|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14201809|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
14201810|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201811|NCT04536961|BMS-986165|bms-986165|mesh-list
14201812|NCT04536961|Famotidine|famotidine|mesh-list
14201813|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14773886|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773887|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773888|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773889|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773890|NCT00652496|Bimatoprost|bimatoprost|mesh-list
14773891|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14773892|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14773893|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773894|NCT00652600|Propranolol|propranolol|mesh-list
14773895|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14773896|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14773897|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
14773898|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773899|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773900|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773901|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14773902|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14773903|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
14773904|NCT00652639|Clonazepam|clonazepam|mesh-list
14773905|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
14773906|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
14773907|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
14773908|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201814|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201815|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14201816|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
14201817|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
14201818|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201819|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497468|NCT05020665|Cytarabine|cytarabine|mesh-list
14497469|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14497470|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
14497471|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497472|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497473|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
14497474|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14497475|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14497476|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
14497477|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497489|NCT05007652|Plerixafor|plerixafor|mesh-list
14497490|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14497491|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14497492|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
14497493|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773909|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773910|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201820|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201821|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
14201822|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14201823|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201824|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
14201825|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201826|NCT04536805|Metformin|metformin|mesh-list
14201827|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14201828|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201829|NCT04536831|Vitamin D|vitamin d|mesh-list
14201830|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
14201831|NCT04536831|Vitamins|vitamins|mesh-list
14201832|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
14201833|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201834|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14773911|NCT00652652|Furosemide|furosemide|mesh-list
14773912|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14497522|NCT05006079|Morphine|morphine|mesh-list
14497523|NCT05006079|Alprazolam|alprazolam|mesh-list
14497524|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14497525|NCT05006079|Narcotics|narcotics|mesh-ancestor
14497526|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497527|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497528|NCT05006079|Analgesics|analgesics|mesh-ancestor
14497529|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
14497530|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497531|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14497532|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14497533|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14497534|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14497535|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
14497536|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
14497537|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497538|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497550|NCT04998604|Omalizumab|omalizumab|mesh-list
14497551|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14497552|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14497553|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497554|NCT04982237|Paclitaxel|paclitaxel|mesh-list
14201835|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14201836|NCT04536558|Olanzapine|olanzapine|mesh-list
14201837|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
14497555|NCT04982237|Bevacizumab|bevacizumab|mesh-list
14497556|NCT04982237|Carboplatin|carboplatin|mesh-list
14497557|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14497558|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497559|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14497560|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14497561|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14497562|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773913|NCT00652652|Diuretics|diuretics|mesh-ancestor
14773914|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
14773915|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773916|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14773917|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14773918|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773919|NCT00652665|Leflunomide|leflunomide|mesh-list
14773920|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773921|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773922|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14773923|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
14773924|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773925|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
14773926|NCT00652691|Carboplatin|carboplatin|mesh-list
14773927|NCT00652691|Topotecan|topotecan|mesh-list
14773928|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14773929|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
14773930|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773931|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773932|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14773933|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
14773934|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773935|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773936|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14773937|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14773938|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14773939|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773940|NCT00652704|Doxycycline|doxycycline|mesh-list
14773941|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773942|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773943|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
14773944|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14773945|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14773946|NCT00652730|Buspirone|buspirone|mesh-list
14773947|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14773948|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14773949|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773950|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773951|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14773952|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14773953|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
14773954|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14773955|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773956|NCT00652782|Rolofylline|rolofylline|mesh-list
14201838|NCT04536558|Aprepitant|aprepitant|mesh-list
14201839|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
14201840|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
14201841|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201842|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201843|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201844|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14201845|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14201846|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201847|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14201848|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14201849|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14201850|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201851|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201852|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201853|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
14201854|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14201855|NCT04536662|Dexamethasone|dexamethasone|mesh-list
14201856|NCT04536662|Prednisone|prednisone|mesh-list
14497563|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497564|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14201857|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
14201858|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201859|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
14201860|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
14201861|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201862|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201863|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14201864|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
14201865|NCT04536662|Hormones|hormones|mesh-ancestor
14201866|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201867|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14201868|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201869|NCT04536675|Bromides|bromides|mesh-list
14201870|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
14201871|NCT04536363|Alprostadil|alprostadil|mesh-list
14201872|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14201873|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
14201874|NCT04536363|Urological Agents|urological agents|mesh-ancestor
14201875|NCT04536532|Entecavir|entecavir|mesh-list
14201876|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
14201877|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201878|NCT04536415|Oseltamivir|oseltamivir|mesh-list
14201879|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
14201880|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201881|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201882|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239674|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14239675|NCT00147966|Rituximab|rituximab|mesh-list
14239676|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239677|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239678|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
14239679|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239680|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239681|NCT00148109|Cetuximab|cetuximab|mesh-list
14239682|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239683|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239684|NCT00148122|Docetaxel|docetaxel|mesh-list
14239685|NCT00148122|Capecitabine|capecitabine|mesh-list
14239686|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239687|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239688|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239689|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239690|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239691|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14239692|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
14239693|NCT00148317|Dexamethasone|dexamethasone|mesh-list
14239694|NCT00148317|Doxorubicin|doxorubicin|mesh-list
14239695|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14239696|NCT00148317|Bortezomib|bortezomib|mesh-list
14239697|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239698|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
14239699|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
14239700|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239701|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239702|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239703|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
14497565|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14497566|NCT04982237|Growth Substances|growth substances|mesh-ancestor
14773957|NCT00652782|Diuretics|diuretics|mesh-ancestor
14239704|NCT00148317|Hormones|hormones|mesh-ancestor
14239705|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239706|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239707|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239708|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14239709|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14239710|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14239711|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497567|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497568|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
14497569|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14497570|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14773958|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
14239712|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239713|NCT00148668|Carboplatin|carboplatin|mesh-list
14239714|NCT00148668|Docetaxel|docetaxel|mesh-list
14497571|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14497572|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14497573|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497574|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497575|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497576|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14497577|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
14201883|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
14201884|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201885|NCT04535973|Hormones|hormones|mesh-list
14201886|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201887|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201888|NCT04536051|Acetaminophen|acetaminophen|mesh-list
14201889|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14201890|NCT04536051|Analgesics|analgesics|mesh-ancestor
14201891|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
14201892|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201893|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201894|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
14201895|NCT04536493|Lidocaine|lidocaine|mesh-list
14201896|NCT04536493|Epinephrine|epinephrine|mesh-list
14201897|NCT04536493|Racepinephrine|racepinephrine|mesh-list
14201898|NCT04536493|Tetracaine|tetracaine|mesh-list
14201899|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
14201900|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
14201901|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
14201902|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14201903|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201904|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
14201905|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201906|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14201907|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14201908|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14201909|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14201910|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201911|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14201912|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14201913|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14201914|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14201915|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14201916|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14201917|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
14201918|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14201919|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
14201920|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
14201921|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
14201922|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14201923|NCT04535960|Liraglutide|liraglutide|mesh-list
14201924|NCT04535960|Empagliflozin|empagliflozin|mesh-list
14201925|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14201926|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201927|NCT04535960|Incretins|incretins|mesh-ancestor
14201928|NCT04535960|Hormones|hormones|mesh-ancestor
14497578|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14497579|NCT04963296|Acetaminophen|acetaminophen|mesh-list
14497580|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
14497581|NCT04963296|Promethazine|promethazine|mesh-list
14497582|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
14497583|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
14497584|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14497585|NCT04963296|Analgesics|analgesics|mesh-ancestor
14497586|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
14497587|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497588|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497589|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
14497590|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14497591|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
14497592|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
14497593|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14497594|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
14497595|NCT04963296|Hormones|hormones|mesh-ancestor
14497596|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201929|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201930|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14201931|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497597|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14497598|NCT04963296|Protective Agents|protective agents|mesh-ancestor
14497599|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497600|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497601|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14497602|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14497603|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497604|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
14497605|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
14497606|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14497607|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
14497608|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
14773959|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773960|NCT00652795|Doxycycline|doxycycline|mesh-list
14773961|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14773962|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14773963|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
14773964|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14773965|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14773966|NCT00652808|Naproxen|naproxen|mesh-list
14497609|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497610|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497611|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14497612|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
14497613|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
14497634|NCT04958811|Bevacizumab|bevacizumab|mesh-list
14497635|NCT04958811|Atezolizumab|atezolizumab|mesh-list
14497636|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497637|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497638|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14497639|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14497640|NCT04958811|Growth Substances|growth substances|mesh-ancestor
14497641|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497642|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
14497643|NCT04949828|Pancrelipase|pancrelipase|mesh-list
14497644|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14497645|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
14497646|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497647|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773967|NCT00652808|Valdecoxib|valdecoxib|mesh-list
14773968|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14773969|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14941128|NCT01497132|Vitamins|vitamins|mesh-ancestor
14941129|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
14941130|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773970|NCT00652808|Analgesics|analgesics|mesh-ancestor
14941131|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14941132|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14497648|NCT04936230|Atezolizumab|atezolizumab|mesh-list
14497649|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14497650|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773971|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
14773972|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941133|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
14941134|NCT01497145|Hematinics|hematinics|mesh-ancestor
14941135|NCT01497288|Fentanyl|fentanyl|mesh-list
14941136|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14941137|NCT01497288|Narcotics|narcotics|mesh-ancestor
14941138|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941139|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941140|NCT01497288|Analgesics|analgesics|mesh-ancestor
14941141|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
14941142|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941143|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14941144|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14941145|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
14941146|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
14941147|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
14941148|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
14941149|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026727|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026728|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15026729|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773973|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773974|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14773975|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14773976|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
14773977|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14773978|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773979|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14773980|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14773981|NCT00652821|Tramadol|tramadol|mesh-list
14773982|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14773983|NCT00652821|Narcotics|narcotics|mesh-ancestor
14773984|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14773985|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14773986|NCT00652821|Analgesics|analgesics|mesh-ancestor
14773987|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
14773988|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14773989|NCT00652860|Doxorubicin|doxorubicin|mesh-list
14773990|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14773991|NCT00652860|Ifosfamide|ifosfamide|mesh-list
14773992|NCT00652860|Molgramostim|molgramostim|mesh-list
14773993|NCT00652860|Mitomycins|mitomycins|mesh-list
14773994|NCT00652860|Mitomycin|mitomycin|mesh-list
14497651|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
14497652|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201932|NCT04536181|Prednisone|prednisone|mesh-list
14201933|NCT04536181|Prednisolone|prednisolone|mesh-list
14201934|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201935|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
14201936|NCT04536181|Hormones|hormones|mesh-ancestor
14201937|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14201938|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201939|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14201940|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201941|NCT04536428|Hemostatics|hemostatics|mesh-list
14201942|NCT04536428|Coagulants|coagulants|mesh-ancestor
14201943|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14201944|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14201945|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
14201946|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
14201947|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201948|NCT04535817|Omalizumab|omalizumab|mesh-list
14773995|NCT00652860|Sargramostim|sargramostim|mesh-list
14201949|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14201950|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14201951|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
14201952|NCT04535804|Aspirin|aspirin|mesh-list
14201953|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14201954|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14201955|NCT04535804|Analgesics|analgesics|mesh-ancestor
14201956|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
14201957|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14201958|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201959|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14201960|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14201961|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14201962|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14201963|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201964|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14773996|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14201965|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14201966|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14773997|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14773998|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14201967|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
14201968|NCT04535713|Gemcitabine|gemcitabine|mesh-list
14201969|NCT04535713|Docetaxel|docetaxel|mesh-list
14201970|NCT04535713|Doxorubicin|doxorubicin|mesh-list
14201971|NCT04535713|Nivolumab|nivolumab|mesh-list
14201972|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14201973|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
14201974|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14201975|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14773999|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14774000|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774001|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774002|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14774003|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
14774004|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
14774005|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774006|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14774007|NCT00652873|Cabergoline|cabergoline|mesh-list
14774008|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14941150|NCT01497392|Gemcitabine|gemcitabine|mesh-list
14941151|NCT01497392|Capecitabine|capecitabine|mesh-list
14941152|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14201976|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
14201977|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14201978|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14201979|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14201980|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
14201981|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14201982|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
14201983|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
14201984|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
14201985|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14201986|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14201987|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14201988|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14201989|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14201990|NCT04535518|Aspirin|aspirin|mesh-list
14201991|NCT04535518|Infliximab|infliximab|mesh-list
14201992|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
14201993|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14201994|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
14201995|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14201996|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14201997|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14201998|NCT04535518|Analgesics|analgesics|mesh-ancestor
14774009|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14774010|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
14941153|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
14941154|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941155|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941156|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
14941157|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941158|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941159|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941160|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
14201999|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
14202000|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202001|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202002|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202003|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202004|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14202005|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14202006|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202007|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14774011|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
14774012|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774013|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774014|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774015|NCT00652886|Oxandrolone|oxandrolone|mesh-list
14774016|NCT00652886|Androgens|androgens|mesh-ancestor
14774017|NCT00652886|Hormones|hormones|mesh-ancestor
14774018|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774019|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497703|NCT04914897|Paclitaxel|paclitaxel|mesh-list
14497704|NCT04914897|Carboplatin|carboplatin|mesh-list
14497705|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
14497706|NCT04914897|Pemetrexed|pemetrexed|mesh-list
14774020|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
14774021|NCT00652912|Clonazepam|clonazepam|mesh-list
14774022|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
14774023|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
14774024|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
14774025|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774026|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774027|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774028|NCT00652925|Celecoxib|celecoxib|mesh-list
14774029|NCT00652925|Naproxen|naproxen|mesh-list
14497707|NCT04914897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14497708|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497709|NCT04914897|Tubulin Modulators|tubulin modulators|mesh-ancestor
14497710|NCT04914897|Antimitotic Agents|antimitotic agents|mesh-ancestor
14497711|NCT04914897|Mitosis Modulators|mitosis modulators|mesh-ancestor
14497712|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497713|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14774030|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14202008|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14497714|NCT04914897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497715|NCT04914897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14497716|NCT04914897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14497717|NCT04911062|Epinephrine|epinephrine|mesh-list
14497718|NCT04911062|Bupivacaine|bupivacaine|mesh-list
14497719|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
14497720|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
14497721|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497722|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497723|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
14497724|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497725|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14497726|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14497727|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14774031|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14774032|NCT00652925|Analgesics|analgesics|mesh-ancestor
14774033|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
14774034|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774035|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774036|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774037|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774038|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14774039|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14774040|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774041|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774042|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
14774043|NCT00653003|Leflunomide|leflunomide|mesh-list
14774044|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774045|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774046|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774047|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
14774048|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774049|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14774050|NCT00653016|Norelgestromin|norelgestromin|mesh-list
14774051|NCT00653016|Estradiol|estradiol|mesh-list
14774052|NCT00653016|Estrogens|estrogens|mesh-ancestor
14774053|NCT00653016|Hormones|hormones|mesh-ancestor
14774054|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774055|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774056|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14774057|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
14774058|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14774059|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14774060|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14774061|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14774062|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14774063|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
14774064|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774065|NCT00653055|Cabergoline|cabergoline|mesh-list
14774066|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14774067|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14941161|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941162|NCT01497431|Selenium|selenium|mesh-list
14941163|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
14202009|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202010|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
14202011|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
14202012|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
14202013|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202014|NCT04535700|Pioglitazone|pioglitazone|mesh-list
14202015|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14202016|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202017|NCT04535362|Nicotine|nicotine|mesh-list
14202018|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14202019|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
14497728|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497729|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497730|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14497731|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14497732|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
14497733|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14774068|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
14941164|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
14202020|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202021|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034868|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14774069|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
14774070|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774071|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774072|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774073|NCT00653120|Propranolol|propranolol|mesh-list
14774074|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14774075|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14202022|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14202023|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14202024|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
14202025|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202026|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202027|NCT04535271|Gemcitabine|gemcitabine|mesh-list
14202028|NCT04535271|Dacarbazine|dacarbazine|mesh-list
14202029|NCT04535271|Trabectedin|trabectedin|mesh-list
14202030|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14202031|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
14202032|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202033|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202034|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
14202035|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202036|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202037|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202038|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
14202039|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202040|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14202041|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
14202042|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14202043|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
14202044|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774076|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
14774077|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774078|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774079|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774080|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14774081|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14774082|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774083|NCT00653172|Streptogramin A|streptogramin a|mesh-list
14774084|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14774085|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774086|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
14941165|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941166|NCT01497431|Protective Agents|protective agents|mesh-ancestor
14941167|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941168|NCT01497431|Trace Elements|trace elements|mesh-ancestor
14941169|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
14497734|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497735|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
14497736|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
14497737|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14941170|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14941171|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941172|NCT01497444|Sorafenib|sorafenib|mesh-list
14941173|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941174|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14941175|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941176|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941177|NCT01497470|Paclitaxel|paclitaxel|mesh-list
14941178|NCT01497470|Carboplatin|carboplatin|mesh-list
14941179|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14941180|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941181|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14202045|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
14202046|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14202047|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
14202048|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774087|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14941182|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14941183|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14202049|NCT04534725|Interferons|interferons|mesh-list
14202050|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
14202051|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202052|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
14202053|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202054|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
14202055|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774088|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774089|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
14774090|NCT00653250|Celecoxib|celecoxib|mesh-list
14774091|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14774092|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14774093|NCT00653250|Analgesics|analgesics|mesh-ancestor
14774094|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
14774095|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774096|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774097|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941184|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202056|NCT04534491|Oxybutynin|oxybutynin|mesh-list
14202057|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
14202058|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
14202059|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202060|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202061|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14202062|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14202063|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
14202064|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202065|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202066|NCT04534491|Urological Agents|urological agents|mesh-ancestor
14941185|NCT01497483|Cyclosporine|cyclosporine|mesh-list
14941186|NCT01497483|Pravastatin|pravastatin|mesh-list
14941187|NCT01497483|Cyclosporins|cyclosporins|mesh-list
14941188|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941189|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941190|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941191|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
14941192|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941193|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
14941194|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941195|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
14941196|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14941197|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14941198|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14941199|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14941200|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
14941201|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14941202|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14941203|NCT01497522|Vildagliptin|vildagliptin|mesh-list
14941204|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941205|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941206|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14941207|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
14941208|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941209|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941210|NCT01497535|Insulin|insulin|mesh-list
14941211|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14202067|NCT04534478|Prednisone|prednisone|mesh-list
14202068|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202069|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
14774098|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774099|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14941212|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
14941213|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
14202070|NCT04534478|Hormones|hormones|mesh-ancestor
14202071|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202072|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239715|NCT00148668|Trastuzumab|trastuzumab|mesh-list
14239716|NCT00148668|Vinorelbine|vinorelbine|mesh-list
14239717|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239718|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239719|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239720|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239721|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239722|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239723|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14202073|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202074|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202075|NCT04534465|Mannitol|mannitol|mesh-list
14202076|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14202077|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14202078|NCT04534465|Diuretics|diuretics|mesh-ancestor
14202079|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
14202080|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202081|NCT04534465|Laxatives|laxatives|mesh-ancestor
14202082|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774100|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14774101|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774102|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774103|NCT00653302|Metformin|metformin|mesh-list
14774104|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
14774105|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239724|NCT00148798|Cisplatin|cisplatin|mesh-list
14497750|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
14497751|NCT04901169|Giapreza|giapreza|mesh-list
14497752|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
14497753|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14774106|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774107|NCT00653315|Tramadol|tramadol|mesh-list
14774108|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14774109|NCT00653315|Narcotics|narcotics|mesh-ancestor
14774110|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774111|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774112|NCT00653315|Analgesics|analgesics|mesh-ancestor
14774113|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
14774114|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774115|NCT00653341|Insulin|insulin|mesh-list
14774116|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14774117|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
14774118|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
14774119|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
14774120|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
14774121|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14774122|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774123|NCT00653354|Valdecoxib|valdecoxib|mesh-list
14774124|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14941214|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239725|NCT00148798|Cetuximab|cetuximab|mesh-list
14774125|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14774126|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774127|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774128|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14774129|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14774130|NCT00653354|Analgesics|analgesics|mesh-ancestor
14774131|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
14774132|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774133|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774134|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774135|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774136|NCT00653380|Doxycycline|doxycycline|mesh-list
14774137|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14774138|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774139|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
14941215|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941216|NCT01497548|Methylphenidate|methylphenidate|mesh-list
14239726|NCT00148798|Vinorelbine|vinorelbine|mesh-list
14239727|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239728|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239729|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14239730|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239731|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239732|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239733|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239734|NCT00148941|Vaccines|vaccines|mesh-list
14497754|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14774140|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14774141|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14941217|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14941218|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941219|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14941220|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14941221|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034869|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
14497755|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
14497756|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497757|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497758|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
14497759|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14497760|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14497761|NCT04900220|Prednisolone|prednisolone|mesh-list
14497762|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
14497763|NCT04900220|Betamethasone|betamethasone|mesh-list
14497764|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14497765|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
14497766|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14497767|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
14497768|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
14497769|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497770|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497771|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774142|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
14774143|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
14774144|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14774145|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14774146|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774147|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774148|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14774149|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14774150|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941222|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941223|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
14941224|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941225|NCT01497561|Insulin|insulin|mesh-list
14941226|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14941227|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
14941228|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
14941229|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
14941230|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
14941231|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941232|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941233|NCT01497574|Insulin|insulin|mesh-list
14202088|NCT04534231|Nicotine|nicotine|mesh-list
14202089|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14202090|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
14202091|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202092|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202093|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14941234|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14202094|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14497772|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
14497773|NCT04900220|Hormones|hormones|mesh-ancestor
14497774|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497775|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14497776|NCT04900220|Protective Agents|protective agents|mesh-ancestor
14497777|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14497778|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497779|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14497780|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
14774151|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774152|NCT00653406|Risperidone|risperidone|mesh-list
14774153|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14774154|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
14774155|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941235|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
14941236|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
14202095|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
14202096|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202097|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202098|NCT04534257|Sirolimus|sirolimus|mesh-list
14202099|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14774156|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774157|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941237|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941238|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941239|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
14941240|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14202100|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202101|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14202102|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202103|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
14202104|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14497796|NCT04887194|Nivolumab|nivolumab|mesh-list
14497797|NCT04887194|Digoxin|digoxin|mesh-list
14497798|NCT04887194|Midazolam|midazolam|mesh-list
14497799|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
14497800|NCT04887194|Warfarin|warfarin|mesh-list
14497801|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14497802|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14497803|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497804|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14497805|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497806|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14497807|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14497808|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497809|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497810|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14497811|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14497812|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14497813|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14497814|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
14497815|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
14497816|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
14497817|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
14497818|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497819|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14497820|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14497821|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
14497822|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14497823|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14497824|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497825|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
14497826|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14497827|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14497828|NCT04887194|Protective Agents|protective agents|mesh-ancestor
14497829|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
14497830|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
14497831|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14497832|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14497833|NCT04886232|Lidocaine|lidocaine|mesh-list
14497834|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
14497835|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
14497836|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497837|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497838|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
14497839|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774158|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14774159|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14774160|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774161|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14774162|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14774163|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
14497840|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14774164|NCT00653419|Buspirone|buspirone|mesh-list
14774165|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14941241|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941242|NCT01497600|Insulin|insulin|mesh-list
14941243|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14941244|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
14941245|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
14941246|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
14941247|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
14941248|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14497841|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14497842|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14497843|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14497844|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497851|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
14497852|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202105|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
14202106|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202107|NCT04534452|Phenylephrine|phenylephrine|mesh-list
14202108|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
14202109|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14202110|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
14202111|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
14202112|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202113|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202114|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
14202115|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14202116|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
14202117|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
14202118|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14202119|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14202120|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14202121|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202122|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202123|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202124|NCT04534452|Protective Agents|protective agents|mesh-ancestor
14202125|NCT04534322|Dexamethasone|dexamethasone|mesh-list
14202126|NCT04534322|Melphalan|melphalan|mesh-list
14202127|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202128|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
14202129|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
14497853|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14497854|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497855|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774166|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15034870|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
14202130|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202131|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497856|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
14497857|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14497858|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497859|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14497860|NCT04863950|Lomustine|lomustine|mesh-list
14497861|NCT04863950|Imipramine|imipramine|mesh-list
14497862|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14497863|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
14497864|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497865|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497866|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14497867|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
14497868|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14774167|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774168|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774169|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14774170|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14774171|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
14774172|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774173|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774174|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774175|NCT00653445|Ezetimibe|ezetimibe|mesh-list
14774176|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774177|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774178|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
14774179|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774180|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774181|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774182|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034871|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034872|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15034873|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15034874|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034875|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202132|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202133|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
14202134|NCT04534322|Hormones|hormones|mesh-ancestor
14202135|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202136|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202137|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202138|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14202139|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
14202140|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202141|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14202142|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202143|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
14202144|NCT04534582|Denosumab|denosumab|mesh-list
14497869|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14497870|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14497871|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14497872|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
14497873|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774183|NCT00653458|Ondansetron|ondansetron|mesh-list
14774184|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
14774185|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
14774186|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202145|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14202146|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202147|NCT04533646|Insulin|insulin|mesh-list
14202148|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14202149|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202150|NCT04533841|Propranolol|propranolol|mesh-list
14202151|NCT04533841|Misoprostol|misoprostol|mesh-list
14202152|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14202153|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
14202154|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14202155|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202156|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14202157|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202158|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
14202159|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14774187|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774188|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774189|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
14774190|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14774191|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14774192|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
14202160|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14202161|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202162|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202163|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202164|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14202165|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14202166|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
14202167|NCT04533984|Teriparatide|teriparatide|mesh-list
14202168|NCT04533984|Calcium|calcium|mesh-list
14202169|NCT04533984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14202170|NCT04533984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941249|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941250|NCT01497626|Bortezomib|bortezomib|mesh-list
14941251|NCT01497626|Lapatinib|lapatinib|mesh-list
14941252|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941253|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14941254|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941255|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941256|NCT01497652|Rasagiline|rasagiline|mesh-list
14941257|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14941258|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202171|NCT04533984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14497874|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941259|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941260|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14497880|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14497881|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
14497882|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497883|NCT04848220|APD791|apd791|mesh-list
14497884|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14497885|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14497886|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
14497887|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497888|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202172|NCT04533724|Amisulpride|amisulpride|mesh-list
14202173|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14202174|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14202175|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202176|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202177|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14202178|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14202179|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
14202180|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202181|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202182|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14497889|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202183|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
14202184|NCT04533867|Ondansetron|ondansetron|mesh-list
14202185|NCT04533867|Palonosetron|palonosetron|mesh-list
14202186|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
14202187|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
14202188|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202189|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202190|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202191|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
14202192|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
14202193|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14202194|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
14202195|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202196|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202197|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14202198|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14202199|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202200|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14202201|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14202202|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14202203|NCT04533685|Vaccines|vaccines|mesh-list
14774193|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202204|NCT04533685|Immunologic Factors|immunologic factors|mesh-ancestor
14202205|NCT04533685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202206|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
14202207|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14202208|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202209|NCT04533347|Tafenoquine|tafenoquine|mesh-list
14202210|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
14202211|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14202212|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14202213|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202214|NCT04533243|Fentanyl|fentanyl|mesh-list
14202215|NCT04533243|Morphine|morphine|mesh-list
14202216|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14202217|NCT04533243|Narcotics|narcotics|mesh-ancestor
14941261|NCT01497652|Protective Agents|protective agents|mesh-ancestor
14941262|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941263|NCT01497717|Adalimumab|adalimumab|mesh-list
14941264|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941265|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14941266|NCT01497873|Topotecan|topotecan|mesh-list
14941267|NCT01497873|Belotecan|belotecan|mesh-list
14941268|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14941269|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14941270|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941271|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941272|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941273|NCT01497912|Atorvastatin|atorvastatin|mesh-list
14941274|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14941275|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774194|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774195|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14774196|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14774197|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774198|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14774199|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14774200|NCT00653510|Insulin|insulin|mesh-list
14774201|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14774202|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14774203|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774204|NCT00653549|Torsemide|torsemide|mesh-list
14774205|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14774206|NCT00653549|Diuretics|diuretics|mesh-ancestor
14774207|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
14774208|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202218|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202219|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202220|NCT04533243|Analgesics|analgesics|mesh-ancestor
14202221|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
14202222|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202223|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14202224|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14202225|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
14202226|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
14774209|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14774210|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774211|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774212|NCT00653562|Zolpidem|zolpidem|mesh-list
14774213|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14774214|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14774215|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774216|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774217|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14774218|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
13964103|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14774219|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
14202227|NCT04533321|Afatinib|afatinib|mesh-list
14202228|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202229|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14202230|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202231|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202232|NCT04532931|Acetaminophen|acetaminophen|mesh-list
14202233|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
14202234|NCT04532931|Artesunate|artesunate|mesh-list
14202235|NCT04532931|Favipiravir|favipiravir|mesh-list
14202236|NCT04532931|Amodiaquine|amodiaquine|mesh-list
14202237|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
14202238|NCT04532931|Pyronaridine|pyronaridine|mesh-list
14202239|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14202240|NCT04532931|Analgesics|analgesics|mesh-ancestor
14202241|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
14202242|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202243|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202244|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
13964104|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
13964105|NCT03140033|Misoprostol|misoprostol|mesh-list
13964106|NCT03140033|Ranitidine|ranitidine|mesh-list
13964107|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
13964108|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13964109|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
13964110|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13964111|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964112|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13964113|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13964114|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
14202245|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
14202246|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202247|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
14202248|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14202249|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14202250|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202251|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
14202252|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14202253|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
14202254|NCT04532918|Cyclosporine|cyclosporine|mesh-list
14202255|NCT04532918|Rifampin|rifampin|mesh-list
14202256|NCT04532918|Allopurinol|allopurinol|mesh-list
14202257|NCT04532918|Verinurad|verinurad|mesh-list
14202258|NCT04532918|Cyclosporins|cyclosporins|mesh-list
14202259|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202260|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202261|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202262|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
14202263|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202264|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
14202265|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202266|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
14202267|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202268|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14202269|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14202270|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
14202271|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202272|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
14202273|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14202274|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14202275|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14202276|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14202277|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14202278|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14202279|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14202280|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
14202281|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
14202282|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14202283|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
14202284|NCT04532918|Protective Agents|protective agents|mesh-ancestor
14202285|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
14202286|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14202287|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14202288|NCT04532775|Prednisolone|prednisolone|mesh-list
14202289|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
14202290|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
14202291|NCT04532775|Bupivacaine|bupivacaine|mesh-list
14774220|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774221|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774222|NCT00653588|Atorvastatin|atorvastatin|mesh-list
14774223|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774224|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774225|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14497920|NCT04840823|Enoxacin|enoxacin|mesh-list
14497921|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14497922|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14497923|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14497924|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14497925|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14497926|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497927|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497928|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14497929|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14774226|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
14202292|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14202293|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
14202294|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
14202295|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
14202296|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202297|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497935|NCT04827056|Ethanol|ethanol|mesh-list
14497936|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
14497937|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14497938|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497939|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497940|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14497941|NCT04827056|Analgesics|analgesics|mesh-ancestor
14497942|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
14497943|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14497944|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14497945|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14497946|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14774227|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774228|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774229|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774230|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807338|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14807339|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14807340|NCT00821301|Fluphenazine|fluphenazine|mesh-list
14807341|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
14807342|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14807343|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14807344|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807345|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14497947|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
14497948|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14497949|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497950|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14497951|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14497952|NCT04825522|Vancomycin|vancomycin|mesh-list
14497953|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14497954|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14497955|NCT04817501|Edetic Acid|edetic acid|mesh-list
14497956|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
14497957|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14497958|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
14497959|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
14497960|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202298|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
14202299|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202300|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202301|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
14202302|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
14202303|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202304|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
14202305|NCT04532775|Hormones|hormones|mesh-ancestor
14202306|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202307|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14202308|NCT04532775|Protective Agents|protective agents|mesh-ancestor
14202309|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202310|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202311|NCT04532775|Analgesics|analgesics|mesh-ancestor
14202312|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14202313|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
14202314|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14497978|NCT04799275|Prednisone|prednisone|mesh-list
14497979|NCT04799275|Cortisone|cortisone|mesh-list
14497980|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
14497981|NCT04799275|Rituximab|rituximab|mesh-list
14497982|NCT04799275|Doxorubicin|doxorubicin|mesh-list
14497983|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14497984|NCT04799275|Vincristine|vincristine|mesh-list
14497985|NCT04799275|Azacitidine|azacitidine|mesh-list
14497986|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14497987|NCT04799275|Antibodies|antibodies|mesh-list
14497988|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
14497989|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14497990|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14497991|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
14497992|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14497993|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14497994|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14497995|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
14497996|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14497997|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14497998|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14202315|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14202316|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202317|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14202318|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
14202319|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14202320|NCT04532671|Ether|ether|mesh-list
14202321|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14202322|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
14497999|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14498000|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14498001|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14498002|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498003|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202323|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
14202324|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498004|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
14498005|NCT04799275|Hormones|hormones|mesh-ancestor
14498006|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14498007|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14498008|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14498009|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
14498010|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
14498011|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
14774231|NCT00653614|Drospirenone|drospirenone|mesh-list
14774232|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14774233|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
14774234|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964115|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13964116|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
13964117|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
14774235|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774236|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14774237|NCT00653614|Diuretics|diuretics|mesh-ancestor
13964118|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964119|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964120|NCT03139474|Hormones|hormones|mesh-list
13964121|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
13964122|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964123|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964124|NCT03139487|Dalteparin|dalteparin|mesh-list
13964125|NCT03139487|Tinzaparin|tinzaparin|mesh-list
14498012|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14498013|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
13964126|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14498014|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14498015|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498016|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
14498017|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14498018|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
14498019|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498020|NCT04792021|Expectorants|expectorants|mesh-ancestor
14498021|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
14498022|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14498023|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
14498024|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498025|NCT04792021|Protective Agents|protective agents|mesh-ancestor
14498026|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498027|NCT04792021|Antidotes|antidotes|mesh-ancestor
14498028|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14498029|NCT04776980|Hematinics|hematinics|mesh-ancestor
14498030|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14498031|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14498032|NCT04771299|Cariprazine|cariprazine|mesh-list
14498033|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14498034|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14498035|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498036|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498037|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14498038|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
14498039|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14498040|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
14498041|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498042|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
14498043|NCT04766918|Protective Agents|protective agents|mesh-ancestor
14498044|NCT04763226|Furosemide|furosemide|mesh-list
14498045|NCT04763226|Diuretics|diuretics|mesh-ancestor
14498046|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
14498047|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498048|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14498049|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498050|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498051|NCT04762758|Naltrexone|naltrexone|mesh-list
14498052|NCT04762758|Baclofen|baclofen|mesh-list
14498053|NCT04762758|Sorbitol|sorbitol|mesh-list
14498054|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14498055|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14498056|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774238|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
14774239|NCT00653744|Atorvastatin|atorvastatin|mesh-list
14774240|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774241|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774242|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774243|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
14774244|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774245|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774246|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774247|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774248|NCT00653757|Leuprolide|leuprolide|mesh-list
14774249|NCT00653757|Goserelin|goserelin|mesh-list
14774250|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14774251|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
14774252|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14774253|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774254|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202325|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202326|NCT04532684|Pregabalin|pregabalin|mesh-list
14202327|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14202328|NCT04532684|Analgesics|analgesics|mesh-ancestor
14202329|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
14202330|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774255|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774256|NCT00653822|Alefacept|alefacept|mesh-list
14774257|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
14774258|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
14774259|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941276|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
14941277|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941278|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14941279|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14202331|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202332|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
14202333|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14202334|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14202335|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202336|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14202337|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14202338|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14202339|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202340|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14498057|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
14498058|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498059|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14498060|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14498061|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14498062|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
14498063|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
14498064|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498065|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498066|NCT04762758|Cathartics|cathartics|mesh-ancestor
14498067|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14498068|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
14498069|NCT04757675|Ketamine|ketamine|mesh-list
14498070|NCT04757675|Esketamine|esketamine|mesh-list
14774260|NCT00653848|Docetaxel|docetaxel|mesh-list
14202341|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14202342|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14202343|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202344|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
14202345|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
14202346|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
14202347|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
14202348|NCT04532736|Methotrexate|methotrexate|mesh-list
14202349|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14202350|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
14202351|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14202352|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202353|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14202354|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
14202355|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202356|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202357|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
14202358|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202359|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14202360|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202361|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
14202362|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202363|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14202364|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498071|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14498072|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498073|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202365|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
14202366|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
14202367|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202368|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14498074|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14498075|NCT04757675|Analgesics|analgesics|mesh-ancestor
14498076|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
14498077|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498078|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14498079|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14498080|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14498081|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
14498082|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498083|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498084|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14498085|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14498086|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
14498087|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
14498088|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14498089|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14498090|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
14498091|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14498092|NCT04755712|Sufentanil|sufentanil|mesh-list
14498093|NCT04755712|Morphine|morphine|mesh-list
14498094|NCT04755712|Bupivacaine|bupivacaine|mesh-list
14498095|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
14498096|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
14498097|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498098|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498099|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
14498100|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498101|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14498102|NCT04755712|Narcotics|narcotics|mesh-ancestor
14498103|NCT04755712|Analgesics|analgesics|mesh-ancestor
14774261|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774262|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
14774263|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
14774264|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
14774265|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774266|NCT00653874|Bilirubin|bilirubin|mesh-list
14941280|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941281|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
14941282|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14941283|NCT01497977|Estrogens|estrogens|mesh-ancestor
14941284|NCT01497977|Hormones|hormones|mesh-ancestor
14941285|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941286|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941287|NCT01497990|Ertapenem|ertapenem|mesh-list
14941288|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14941289|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941290|NCT01498003|Tirofiban|tirofiban|mesh-list
14941291|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14941292|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14202369|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
14202370|NCT04532736|Hormones|hormones|mesh-ancestor
14202371|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202372|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14202373|NCT04532736|Protective Agents|protective agents|mesh-ancestor
14202374|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14202375|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14202376|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14202377|NCT04532606|Anesthetics|anesthetics|mesh-list
14202378|NCT04532606|Propofol|propofol|mesh-list
14498104|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14498105|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14498106|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
14498107|NCT04752475|Furosemide|furosemide|mesh-list
14498108|NCT04752475|Diuretics|diuretics|mesh-ancestor
14498109|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
14498110|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498111|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14498112|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498113|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498114|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
14498115|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498116|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498117|NCT04751812|Narcotics|narcotics|mesh-ancestor
14498118|NCT04751812|Analgesics|analgesics|mesh-ancestor
14498119|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
14498120|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202379|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202380|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202381|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14202382|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14774267|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
14774268|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774269|NCT00653874|Protective Agents|protective agents|mesh-ancestor
14774270|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941293|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941294|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14498146|NCT04739761|Trastuzumab|trastuzumab|mesh-list
14498147|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498148|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498149|NCT04733937|Caseins|caseins|mesh-list
14774271|NCT00653926|Epinephrine|epinephrine|mesh-list
14774272|NCT00653926|Ropivacaine|ropivacaine|mesh-list
14774273|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
14774274|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
14774275|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774276|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774277|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
14774278|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774279|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14774280|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14774281|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
14774282|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774283|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774284|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14774285|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14774286|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
14774287|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14774288|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
14774289|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
14774290|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
14774291|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14774292|NCT00653952|Paclitaxel|paclitaxel|mesh-list
14774293|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14774294|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774295|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
14774296|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
14774297|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
14774298|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774299|NCT00653965|Atorvastatin|atorvastatin|mesh-list
14774300|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774301|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774302|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774303|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
14774304|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774305|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774306|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774307|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774308|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
14774309|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774310|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14774311|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14774312|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774313|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774314|NCT00654017|Urological Agents|urological agents|mesh-ancestor
14774315|NCT00654043|Torsemide|torsemide|mesh-list
14774316|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14774317|NCT00654043|Diuretics|diuretics|mesh-ancestor
14774318|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
14774319|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774320|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14774321|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774322|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774323|NCT00654056|Insulin|insulin|mesh-list
14774324|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14774325|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14774326|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774327|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
14774328|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774329|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14774330|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14774331|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941295|NCT01498016|Busulfan|busulfan|mesh-list
14498150|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
14941296|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
14941297|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941298|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941299|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
14941300|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941301|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14941302|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498151|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
14498152|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498153|NCT04729959|Atezolizumab|atezolizumab|mesh-list
14498154|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
14498155|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14498156|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
14498157|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498158|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
14498159|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498160|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
14498161|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
14498162|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498163|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498169|NCT04705662|Lactulose|lactulose|mesh-list
14498170|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14498171|NCT04696029|Eflornithine|eflornithine|mesh-list
14498172|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498173|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14498174|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14498175|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14498176|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498177|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14498178|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498179|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498180|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14498181|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
14498182|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498183|NCT04682366|Tamsulosin|tamsulosin|mesh-list
14498184|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14498185|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14498186|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14498187|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
14498188|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498189|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498190|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498191|NCT04682366|Urological Agents|urological agents|mesh-ancestor
14498192|NCT04677569|Azithromycin|azithromycin|mesh-list
14498193|NCT04677569|Amikacin|amikacin|mesh-list
14498194|NCT04677569|Ethambutol|ethambutol|mesh-list
14202383|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
14239735|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
14239736|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498195|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14498196|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498197|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
14239737|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
14239738|NCT00149214|Docetaxel|docetaxel|mesh-list
14239739|NCT00149214|Doxorubicin|doxorubicin|mesh-list
14239740|NCT00149214|Pemetrexed|pemetrexed|mesh-list
14239741|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239742|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
14239743|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239744|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239745|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14239746|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
14239747|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239748|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239749|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14239750|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
14239751|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
14239752|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
14239753|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14239754|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14239755|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14239756|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239757|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14239758|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14239759|NCT00149227|Valsartan|valsartan|mesh-list
14498198|NCT04677543|Azithromycin|azithromycin|mesh-list
14498199|NCT04677543|Amikacin|amikacin|mesh-list
14498200|NCT04677543|Ethambutol|ethambutol|mesh-list
14498201|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202384|NCT04532372|Leflunomide|leflunomide|mesh-list
14202385|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202386|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202387|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202388|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
14498202|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498203|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
14498204|NCT04665089|Erythromycin|erythromycin|mesh-list
14498205|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
14498206|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14498207|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
14498208|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14498209|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498210|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202389|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202390|NCT04532554|Hormones|hormones|mesh-list
14202391|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202392|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202393|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
14202394|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498211|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14498212|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498213|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498214|NCT04654988|Prednisone|prednisone|mesh-list
14498215|NCT04654988|Azathioprine|azathioprine|mesh-list
14498216|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498217|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
14498218|NCT04654988|Hormones|hormones|mesh-ancestor
14498219|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14498220|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498221|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14498222|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498223|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
14498224|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498225|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14498226|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498227|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
14498228|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14498229|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
14498230|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14498231|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498232|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498233|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
14498234|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498235|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14498236|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
14498237|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
14498238|NCT04647721|Protective Agents|protective agents|mesh-ancestor
14498239|NCT04645823|Lidocaine|lidocaine|mesh-list
14498240|NCT04645823|Fentanyl|fentanyl|mesh-list
14498241|NCT04645823|Citric Acid|citric acid|mesh-list
14498242|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
14498243|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
14498244|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
14202395|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202396|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
14202397|NCT04532060|Nystatin|nystatin|mesh-list
14202398|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14202399|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
14202400|NCT04532060|Ionophores|ionophores|mesh-ancestor
14202401|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14202402|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202403|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
14202404|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14202405|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202406|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
14202407|NCT04532164|Clotrimazole|clotrimazole|mesh-list
14202408|NCT04532164|Miconazole|miconazole|mesh-list
14202409|NCT04532164|Butenafine|butenafine|mesh-list
14202410|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202411|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14202412|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14498245|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498246|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498247|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
14498248|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498249|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14498250|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14498251|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14498252|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498253|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498254|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14498255|NCT04645823|Narcotics|narcotics|mesh-ancestor
14498256|NCT04645823|Analgesics|analgesics|mesh-ancestor
14498257|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14498258|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14498259|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
14498260|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
14498261|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14498262|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
14498263|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
14498264|NCT04644068|Paclitaxel|paclitaxel|mesh-list
14498265|NCT04644068|Carboplatin|carboplatin|mesh-list
14498266|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14498267|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498268|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
14498269|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
14498270|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
14498271|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498272|NCT04640545|Axitinib|axitinib|mesh-list
14498273|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498274|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14498275|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498276|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202413|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14202414|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202415|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964127|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
13964128|NCT03139487|Apixaban|apixaban|mesh-list
13964129|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13964130|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
13964131|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13964132|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
13964133|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964134|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964135|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
13964136|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13964137|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13964138|NCT03139253|Amoxicillin|amoxicillin|mesh-list
13964139|NCT03139253|Clarithromycin|clarithromycin|mesh-list
13964140|NCT03139253|Levofloxacin|levofloxacin|mesh-list
13964141|NCT03139253|Ofloxacin|ofloxacin|mesh-list
13964142|NCT03139253|Tetracycline|tetracycline|mesh-list
13964143|NCT03139253|Tinidazole|tinidazole|mesh-list
14202416|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14202417|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
14202418|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202419|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202420|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14202421|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14202422|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14202423|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14202424|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202425|NCT04532333|Heparin|heparin|mesh-list
14498302|NCT04630808|Latanoprost|latanoprost|mesh-list
14498303|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14498304|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14498305|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
14498306|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14498307|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14498308|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14498309|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14498310|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498311|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774332|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202426|NCT04532333|Bivalirudin|bivalirudin|mesh-list
14202427|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
14202428|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14498312|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
14498313|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498314|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774333|NCT00654082|Urological Agents|urological agents|mesh-ancestor
14774334|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
14774335|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
14202429|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14202430|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202431|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
14202432|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14202433|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
14202434|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202435|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14202436|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202437|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
14202438|NCT04531865|Rituximab|rituximab|mesh-list
14202439|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14202440|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202441|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
14202442|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202443|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202444|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14202445|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14202446|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
14202447|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202448|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202449|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202450|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202451|NCT04531800|Mitogens|mitogens|mesh-list
14202452|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
14774336|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14774337|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202453|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498315|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14498316|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498317|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
14498318|NCT04606901|Neostigmine|neostigmine|mesh-list
14498319|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14498320|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498321|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498322|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
14498323|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498324|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498325|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14498326|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
14774338|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14774339|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14774340|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774341|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774342|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774343|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14774344|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14774345|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
14774346|NCT00654108|Protective Agents|protective agents|mesh-ancestor
14774347|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498327|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498328|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14774348|NCT00654108|Vitamins|vitamins|mesh-ancestor
14774349|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
14774350|NCT00654121|Insulin|insulin|mesh-list
14774351|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14774352|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14498329|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14498330|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14498331|NCT04606771|Osimertinib|osimertinib|mesh-list
14498332|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498333|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14498334|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498335|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498341|NCT04594694|Bezafibrate|bezafibrate|mesh-list
14498342|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14498343|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
14498344|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498345|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14498346|NCT04585958|Trastuzumab|trastuzumab|mesh-list
14498347|NCT04585958|Olaparib|olaparib|mesh-list
14498348|NCT04585958|Camptothecin|camptothecin|mesh-list
14498349|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14498350|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
14498351|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498352|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498353|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498354|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498355|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14498356|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14498357|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14498358|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
14498359|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498367|NCT04573946|Vitamin D|vitamin d|mesh-list
14498368|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
14498369|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
14498370|NCT04573946|Vitamins|vitamins|mesh-list
14202454|NCT04531813|Butenafine|butenafine|mesh-list
14202455|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
14202456|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202457|NCT04531748|Toremifene|toremifene|mesh-list
14202458|NCT04531748|Melatonin|melatonin|mesh-list
14202459|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
14202460|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202461|NCT04531748|Protective Agents|protective agents|mesh-ancestor
14202462|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202463|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202464|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202465|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202466|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14202467|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14202468|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
14202469|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202470|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14202471|NCT04531527|Butenafine|butenafine|mesh-list
14202472|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
14498371|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
14774353|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774354|NCT00654160|Leucovorin|leucovorin|mesh-list
14774355|NCT00654160|Fluorouracil|fluorouracil|mesh-list
14774356|NCT00654160|Irinotecan|irinotecan|mesh-list
14774357|NCT00654160|Calcium|calcium|mesh-list
14498372|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498373|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14498374|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14498375|NCT04573751|Verapamil|verapamil|mesh-list
14498376|NCT04573751|Epinephrine|epinephrine|mesh-list
14498377|NCT04573751|Racepinephrine|racepinephrine|mesh-list
14498378|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
14498379|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14498380|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14498381|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
14498382|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774358|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
14774359|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14202473|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202474|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
14202475|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14774360|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202476|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202477|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202478|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14202479|NCT04531371|Analgesics|analgesics|mesh-ancestor
14202480|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
14202481|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202482|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14202483|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14202484|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14202485|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202486|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243403|NCT00194792|Vinorelbine|vinorelbine|mesh-list
14243404|NCT00194792|Capecitabine|capecitabine|mesh-list
14243405|NCT00194792|Methotrexate|methotrexate|mesh-list
14243406|NCT00194792|Exemestane|exemestane|mesh-list
14243407|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14243408|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14243409|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243410|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243411|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243412|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243413|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243414|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243415|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
14243416|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14243417|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
14243418|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14243419|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243420|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14243421|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243422|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14243423|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243424|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
14243425|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243426|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14243427|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14243428|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14243429|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14243430|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
14243431|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243432|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
14243433|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14243434|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
14243435|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14243436|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14243437|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
14243438|NCT00194896|Glyburide|glyburide|mesh-list
14243439|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14243440|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243441|NCT00194987|Prednisone|prednisone|mesh-list
14243442|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
14243443|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14243444|NCT00194987|Antibodies|antibodies|mesh-list
14243445|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
14243446|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14243447|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243448|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
14243449|NCT00194987|Hormones|hormones|mesh-ancestor
14774361|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
14774362|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774363|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14774364|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774365|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774366|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
14774367|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14774368|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14498383|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498384|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498385|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14498386|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14498387|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
14498388|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498389|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14498390|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
14498391|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
14498392|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
14498393|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14498394|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14498395|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14498396|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498397|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14498398|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
14498410|NCT04565990|Selexipag|selexipag|mesh-list
14498411|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14498412|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
14774369|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774370|NCT00654160|Antidotes|antidotes|mesh-ancestor
14774371|NCT00654160|Protective Agents|protective agents|mesh-ancestor
14202487|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202488|NCT04531540|Butenafine|butenafine|mesh-list
14202489|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
14202490|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202491|NCT04531423|Golimumab|golimumab|mesh-list
14202492|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14202493|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202494|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498413|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498414|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498415|NCT04549428|Atezolizumab|atezolizumab|mesh-list
14498416|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498417|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
14498418|NCT04548752|Olaparib|olaparib|mesh-list
14498419|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14498420|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498421|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498422|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498423|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498427|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14498428|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14498429|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14498430|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
14498431|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498432|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14498433|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14498434|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774372|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
14774373|NCT00654160|Vitamins|vitamins|mesh-ancestor
14202495|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
14774374|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
14774375|NCT00654173|Atorvastatin|atorvastatin|mesh-list
14774376|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774377|NCT00654173|Simvastatin|simvastatin|mesh-list
14774378|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774379|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774380|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
14774381|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774382|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774383|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774384|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774385|NCT00654225|Atorvastatin|atorvastatin|mesh-list
14774386|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774387|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774388|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774389|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
14941303|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14941304|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
14498435|NCT04541407|Temozolomide|temozolomide|mesh-list
14498436|NCT04541407|Osimertinib|osimertinib|mesh-list
14498437|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14498438|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
14774390|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774391|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774392|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774393|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774394|NCT00654277|Ondansetron|ondansetron|mesh-list
14774395|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
14774396|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
14941305|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14941306|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
14202496|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202497|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
14202498|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14202499|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14202500|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202501|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14202502|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202503|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14202504|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202505|NCT04531267|Calcium|calcium|mesh-list
14202506|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14202507|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202508|NCT04531475|Lansoprazole|lansoprazole|mesh-list
14202509|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
14202510|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14202511|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202512|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14202513|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498439|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498440|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498441|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14498442|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498443|NCT04538664|Carboplatin|carboplatin|mesh-list
14498444|NCT04538664|Pemetrexed|pemetrexed|mesh-list
14498445|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
14498446|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498447|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498448|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498449|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14498450|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14498451|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498459|NCT04532645|Olaparib|olaparib|mesh-list
14498460|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14774397|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941307|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941308|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941309|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14941310|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
14941311|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
14941312|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14941313|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14941314|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034876|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
14498461|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498462|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498463|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498464|NCT04527900|Paclitaxel|paclitaxel|mesh-list
14498465|NCT04527900|Carboplatin|carboplatin|mesh-list
14498466|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14774398|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774399|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774400|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
14498467|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498468|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
14498469|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
14498470|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
14498471|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498472|NCT04524910|Aflibercept|aflibercept|mesh-list
14498473|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14498474|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14498475|NCT04524910|Growth Substances|growth substances|mesh-ancestor
14498476|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498477|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
14498478|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498479|NCT04520217|Imipramine|imipramine|mesh-list
14498480|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14498481|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
14498482|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14498483|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14498484|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14498485|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498486|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498487|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
14498488|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498489|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498490|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
14498491|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14498492|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
14498493|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14498494|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
14498495|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498496|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498497|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
14498498|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14498499|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14498500|NCT04507022|Estradiol|estradiol|mesh-list
14498501|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14498502|NCT04507022|Progesterone|progesterone|mesh-list
14498503|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14498504|NCT04507022|Estrogens|estrogens|mesh-ancestor
14498505|NCT04507022|Hormones|hormones|mesh-ancestor
14498506|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14498507|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498508|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14498509|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
14498510|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14498511|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14498512|NCT04507022|Progestins|progestins|mesh-ancestor
14498513|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14774401|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
14202514|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202515|NCT04531228|Lenvatinib|lenvatinib|mesh-list
14202516|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202517|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14202518|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202519|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202520|NCT04531332|Linezolid|linezolid|mesh-list
14202521|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202522|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202523|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14202524|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202525|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202526|NCT04530877|Infliximab|infliximab|mesh-list
14202527|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
14498514|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498515|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498516|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14498517|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
14498518|NCT04504175|Ketamine|ketamine|mesh-list
14498519|NCT04504175|Analgesics|analgesics|mesh-ancestor
14498520|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
14498521|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498522|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498523|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14498524|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14498525|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
14498526|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
14498527|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498528|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14498529|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14498530|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498531|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498532|NCT04501614|Ponatinib|ponatinib|mesh-list
14498533|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498534|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14498535|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498536|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498537|NCT04497844|Prednisone|prednisone|mesh-list
14498538|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
14498539|NCT04497844|Niraparib|niraparib|mesh-list
14498540|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498541|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
14498542|NCT04497844|Hormones|hormones|mesh-ancestor
14498543|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14498544|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498545|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14498546|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498547|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14498548|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498549|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498550|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
13964144|NCT03139253|Furazolidone|furazolidone|mesh-list
14774402|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14774403|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
14774404|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774405|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774406|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14774407|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14774408|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774409|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14774410|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14774411|NCT00654290|Propranolol|propranolol|mesh-list
14774412|NCT00654290|Amiodarone|amiodarone|mesh-list
14774413|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14774414|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14774415|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
14774416|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774417|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774418|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774419|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14774420|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14774421|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774422|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14774423|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774424|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14774425|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14774426|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14774427|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774428|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14774429|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14774430|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14774431|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13964145|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14498551|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14498552|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14498553|NCT04497116|Gemcitabine|gemcitabine|mesh-list
14498554|NCT04497116|Talazoparib|talazoparib|mesh-list
14498555|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14498556|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
14498557|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498558|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498559|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
14498560|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498561|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498562|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498563|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
14498564|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498565|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14498570|NCT04487080|Osimertinib|osimertinib|mesh-list
14498571|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
14498572|NCT04487080|Lazertinib|lazertinib|mesh-list
14498573|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498574|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14202528|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202529|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202530|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
14498575|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498576|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498577|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14774432|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774433|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774434|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
14774435|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774436|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774437|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774438|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774439|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774440|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774441|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774442|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
14774443|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774444|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14202531|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14202532|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
14202533|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202534|NCT04531163|Expectorants|expectorants|mesh-ancestor
14202535|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
14202536|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14202537|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
14774445|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774446|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774447|NCT00654407|Atorvastatin|atorvastatin|mesh-list
14941315|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941316|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
14941317|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14941318|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941319|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941320|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14941321|NCT01498380|Analgesics|analgesics|mesh-ancestor
14941322|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
14941323|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941324|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14941325|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14941326|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14941327|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
14941328|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941329|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941330|NCT01498406|Vitamin D|vitamin d|mesh-list
14941331|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
14774448|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774449|NCT00654407|Simvastatin|simvastatin|mesh-list
14774450|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774451|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774452|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
14498616|NCT04445519|Latanoprost|latanoprost|mesh-list
14498617|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14498618|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14774453|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774454|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774455|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774456|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774457|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14202538|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202539|NCT04531163|Protective Agents|protective agents|mesh-ancestor
14202540|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202541|NCT04531163|Antidotes|antidotes|mesh-ancestor
14202542|NCT04531072|Ritonavir|ritonavir|mesh-list
14202543|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14202544|NCT04531072|Lumefantrine|lumefantrine|mesh-list
14498631|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
14774458|NCT00654446|Simvastatin|simvastatin|mesh-list
14774459|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774460|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774461|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
14774462|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774463|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14202545|NCT04531072|Artemether|artemether|mesh-list
14202546|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14202547|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14774464|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774465|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774466|NCT00654459|Policosanol|policosanol|mesh-list
14774467|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774468|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774469|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
14774470|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774471|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774472|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14774473|NCT00654485|Atorvastatin|atorvastatin|mesh-list
14774474|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774475|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774476|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774477|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
14774478|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774479|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774480|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14498632|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14498633|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498634|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498635|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
14498636|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498637|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498638|NCT04430959|Candesartan|candesartan|mesh-list
14498639|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14498640|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14498641|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14498642|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498643|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
14498644|NCT04421196|Analgesics|analgesics|mesh-list
14498645|NCT04421196|Narcotics|narcotics|mesh-ancestor
14498646|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498647|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498648|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
14202548|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14202549|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
14202550|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202551|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202552|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14202553|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14202554|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
14202555|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202556|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14202557|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14202558|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
14202559|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14202560|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14202561|NCT04530864|Dexamethasone|dexamethasone|mesh-list
14202562|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
14202563|NCT04530864|BB 1101|bb 1101|mesh-list
14202564|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202565|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
14202566|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
14202567|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202568|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202569|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202570|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
14202571|NCT04530864|Hormones|hormones|mesh-ancestor
14202572|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202573|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202574|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202575|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
14202576|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202577|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202578|NCT04531098|Vaccines|vaccines|mesh-list
14202579|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
14202580|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202581|NCT04530903|Clonidine|clonidine|mesh-list
14202582|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
14202583|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
14202584|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
14202585|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202586|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498649|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202587|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
14202588|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202589|NCT04530903|Analgesics|analgesics|mesh-ancestor
14202590|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14202591|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
14202592|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
14202593|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14202594|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14202595|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14202596|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202597|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202598|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202599|NCT04530474|Ivermectin|ivermectin|mesh-list
14202600|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14202601|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202602|NCT04530500|Androgens|androgens|mesh-list
14202603|NCT04530500|Hormones|hormones|mesh-ancestor
14202604|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202605|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202606|NCT04530578|Heparin|heparin|mesh-list
14202607|NCT04530578|Calcium heparin|calcium heparin|mesh-list
14202608|NCT04530578|Enoxaparin|enoxaparin|mesh-list
14202609|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14202610|NCT04530578|Tinzaparin|tinzaparin|mesh-list
14202611|NCT04530578|Dalteparin|dalteparin|mesh-list
14202612|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
14202613|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14202614|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14202615|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202616|NCT04530422|Azithromycin|azithromycin|mesh-list
14202617|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
14202618|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
14202619|NCT04530422|Oseltamivir|oseltamivir|mesh-list
14202620|NCT04530422|Ledipasvir|ledipasvir|mesh-list
14202621|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202622|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202623|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
14202624|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14202625|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14202626|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202627|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202628|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202629|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
14498662|NCT04394546|Anticoagulants|anticoagulants|mesh-list
14498663|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
14498664|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
14498665|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14498666|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14498667|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498668|NCT04372628|Ritonavir|ritonavir|mesh-list
14498669|NCT04372628|Lopinavir|lopinavir|mesh-list
14498670|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14498671|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14498672|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
14498673|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498674|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498675|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14498676|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14498677|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
14498678|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498679|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14498680|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14774481|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774482|NCT00654524|Vitamin D|vitamin d|mesh-list
14774483|NCT00654524|Goserelin|goserelin|mesh-list
14774484|NCT00654524|Hormones|hormones|mesh-list
14774485|NCT00654524|Vitamins|vitamins|mesh-ancestor
14774486|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
14941332|NCT01498406|Vitamins|vitamins|mesh-list
14941333|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
14941334|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941335|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14941336|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14941337|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14941338|NCT01498562|Gefitinib|gefitinib|mesh-list
14941339|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
14941340|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941341|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14941342|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941343|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202630|NCT04530617|Camostat|camostat|mesh-list
14202631|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
14202632|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202633|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202634|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14202635|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14239760|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
14239761|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14498695|NCT04367090|Docetaxel|docetaxel|mesh-list
14498696|NCT04367090|Trastuzumab|trastuzumab|mesh-list
14774487|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774488|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14774489|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774490|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14774491|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941344|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14941345|NCT01498718|Vaccines|vaccines|mesh-list
14941346|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
14941347|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941348|NCT01498783|Fluorouracil|fluorouracil|mesh-list
14941349|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
14941350|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941351|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14941352|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941353|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941354|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
14941355|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941356|NCT01498796|Ketorolac|ketorolac|mesh-list
13964146|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964147|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13964148|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964149|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239762|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13964150|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13964151|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239763|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239764|NCT00149630|Disulfiram|disulfiram|mesh-list
14239765|NCT00149630|Methadone|methadone|mesh-list
14239766|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14239767|NCT00149630|Narcotics|narcotics|mesh-ancestor
14239768|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14239769|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239770|NCT00149630|Analgesics|analgesics|mesh-ancestor
14239771|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
14498697|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498698|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
14498699|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
14498700|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
14498701|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498702|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14498703|NCT04344873|Abatacept|abatacept|mesh-list
14498704|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14498705|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498706|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498707|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498708|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
14498709|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498710|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14498711|NCT04340856|Bisacodyl|bisacodyl|mesh-list
14498712|NCT04340856|Laxatives|laxatives|mesh-list
14498713|NCT04340856|Cathartics|cathartics|mesh-ancestor
14202636|NCT04530487|Cyclosporine|cyclosporine|mesh-list
14202637|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
14202638|NCT04530487|Fludarabine|fludarabine|mesh-list
14498714|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774492|NCT00654537|Atorvastatin|atorvastatin|mesh-list
14774493|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774494|NCT00654537|Simvastatin|simvastatin|mesh-list
14774495|NCT00654537|Pravastatin|pravastatin|mesh-list
14774496|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774497|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774498|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
14774499|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774500|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774501|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774502|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774503|NCT00654576|Olanzapine|olanzapine|mesh-list
14774504|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
14941357|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14941358|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14941359|NCT01498796|Analgesics|analgesics|mesh-ancestor
14941360|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
14941361|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202639|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
14202640|NCT04530487|Etoposide|etoposide|mesh-list
14202641|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
14202642|NCT04530487|Melphalan|melphalan|mesh-list
14202643|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
14202644|NCT04530487|Thiotepa|thiotepa|mesh-list
14202645|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
14202646|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14202647|NCT04530487|Tacrolimus|tacrolimus|mesh-list
14202648|NCT04530487|Cyclosporins|cyclosporins|mesh-list
14202649|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
14202650|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14202651|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
14941362|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941363|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202652|NCT04530487|Antibodies|antibodies|mesh-list
14202653|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
14202654|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14774505|NCT00654576|Risperidone|risperidone|mesh-list
14774506|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14941364|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202655|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14202656|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774507|NCT00654576|Clozapine|clozapine|mesh-list
14774508|NCT00654576|Sulpiride|sulpiride|mesh-list
14202657|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14202658|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
14202659|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202660|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202661|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
14202662|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202663|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14202664|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14202665|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14202666|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202667|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14202668|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
14202669|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202670|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
14202671|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202672|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14202673|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14202674|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
14202675|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202676|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14202677|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
14202678|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14202679|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
14202680|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
14774509|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14774510|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
14774511|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774512|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774513|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774514|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14774515|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14774516|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774517|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14941365|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14941366|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941367|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941368|NCT01498809|Midodrine|midodrine|mesh-list
14941369|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
14941370|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
14941371|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941372|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941373|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14941374|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14941375|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14941376|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13964152|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13964153|NCT03139253|Renal Agents|renal agents|mesh-ancestor
13964154|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13964155|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13964156|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964157|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13964158|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13964159|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13964160|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13964161|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13964162|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13964163|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
13964164|NCT03139591|Dexamethasone|dexamethasone|mesh-list
14202681|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
14774518|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14774519|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
14774520|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
14774521|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
14774522|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774523|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774524|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14774525|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14774526|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774527|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
14202682|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
14941377|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
14941378|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14498754|NCT04338022|Teriflunomide|teriflunomide|mesh-list
14498755|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14498756|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14498757|NCT04338022|Analgesics|analgesics|mesh-ancestor
14498758|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
14498759|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498760|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774528|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
14774529|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
14941379|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941380|NCT01498835|Sunitinib|sunitinib|mesh-list
14941381|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941382|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14941383|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14941384|NCT01498835|Growth Substances|growth substances|mesh-ancestor
14941385|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941386|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
14941387|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13964165|NCT03139591|Lidocaine|lidocaine|mesh-list
13964166|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13964167|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
13964168|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
13964169|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964170|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964171|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13964172|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
13964173|NCT03139591|Hormones|hormones|mesh-ancestor
13964174|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964175|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13964176|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964177|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
13964178|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
13964179|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964180|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
13964181|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13964182|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13964183|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13964184|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14202683|NCT04529954|Valproic Acid|valproic acid|mesh-list
14202684|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
14202685|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202686|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202687|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
14202688|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202689|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202690|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
14202691|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14202692|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202693|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14202694|NCT04530045|Piperacillin|piperacillin|mesh-list
14202695|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202696|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202697|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14202698|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14202699|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202700|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
14202701|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202702|NCT04530188|Propofol|propofol|mesh-list
14498761|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498762|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14498763|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498764|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
14498765|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
14498766|NCT04336189|Piperaquine|piperaquine|mesh-list
14498767|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
14498768|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14498769|NCT04336189|Artenimol|artenimol|mesh-list
14498770|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
14498771|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14498772|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14498773|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498774|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14498775|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498776|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498777|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14202703|NCT04530188|Sevoflurane|sevoflurane|mesh-list
14202704|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14202705|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202706|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202707|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14202708|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
14202709|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
14202710|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14202711|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14202712|NCT04530227|Paclitaxel|paclitaxel|mesh-list
14202713|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14202714|NCT04530227|Pemetrexed|pemetrexed|mesh-list
14498778|NCT04336189|Renal Agents|renal agents|mesh-ancestor
14498779|NCT04332497|Ibuprofen|ibuprofen|mesh-list
14498780|NCT04332497|Fentanyl|fentanyl|mesh-list
14498781|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14498782|NCT04332497|Narcotics|narcotics|mesh-ancestor
14498783|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498784|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498785|NCT04332497|Analgesics|analgesics|mesh-ancestor
14498786|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
14202715|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14202716|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202717|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14202718|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14202719|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14498787|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498788|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14498789|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14774530|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14774531|NCT00654589|Deferasirox|deferasirox|mesh-list
14774532|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14774533|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
14774534|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
14774535|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774536|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14774537|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774538|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14498790|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
14498791|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
14774539|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
14498792|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14807346|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202720|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202721|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202722|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14498793|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14202723|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14202724|NCT04529811|Rifaximin|rifaximin|mesh-list
14202725|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202726|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202727|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14498794|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498795|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14498796|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14498797|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498798|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498799|NCT04311567|Methotrexate|methotrexate|mesh-list
14498800|NCT04311567|Tofacitinib|tofacitinib|mesh-list
14498801|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14498802|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
14774540|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774541|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774542|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774543|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202728|NCT04529785|Ethanol|ethanol|mesh-list
14202729|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14202730|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202731|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202732|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202733|NCT04529668|Vitamin D|vitamin d|mesh-list
14202734|NCT04529668|Vitamins|vitamins|mesh-ancestor
14202735|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
14202736|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202737|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14202738|NCT04529525|Ivermectin|ivermectin|mesh-list
14202739|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14202740|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202741|NCT04529512|Dexamethasone|dexamethasone|mesh-list
14202742|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202743|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
14202744|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
14202745|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202746|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202747|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202748|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
14202749|NCT04529512|Hormones|hormones|mesh-ancestor
14202750|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202751|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202752|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202753|NCT04529356|Acetaminophen|acetaminophen|mesh-list
14202754|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14202755|NCT04529356|Analgesics|analgesics|mesh-ancestor
14202756|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
14774544|NCT00654667|Resveratrol|resveratrol|mesh-list
14941388|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941389|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941390|NCT01498861|Dolutegravir|dolutegravir|mesh-list
14941391|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
14941392|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14941393|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14941394|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14941395|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941396|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941397|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14941398|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14202757|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202758|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202759|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
14202760|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14774545|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
14774546|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202761|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202762|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14774547|NCT00654667|Protective Agents|protective agents|mesh-ancestor
14807347|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14202763|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
14202764|NCT04529135|Remifentanil|remifentanil|mesh-list
14202765|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14202766|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202767|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202768|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14774548|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774549|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774550|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14774551|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14774552|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
14941399|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
14941400|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941401|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14941402|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14941403|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14498803|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14498804|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498805|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14498806|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
14498807|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498808|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498809|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
14498810|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498811|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14498812|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498813|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
14498814|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14498815|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14498816|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14498817|NCT04310007|Gemcitabine|gemcitabine|mesh-list
14498818|NCT04310007|Paclitaxel|paclitaxel|mesh-list
14498819|NCT04310007|Docetaxel|docetaxel|mesh-list
14941404|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941405|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14941406|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
15034877|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14202769|NCT04529135|Analgesics|analgesics|mesh-ancestor
14202770|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
14202771|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202772|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14202773|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14202774|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14202775|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202776|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202777|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202778|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14202779|NCT04529135|Narcotics|narcotics|mesh-ancestor
14202780|NCT04529187|Midazolam|midazolam|mesh-list
14202781|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
14202782|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14498820|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14498821|NCT04310007|Nivolumab|nivolumab|mesh-list
14498822|NCT04310007|Ramucirumab|ramucirumab|mesh-list
14498823|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14498824|NCT04310007|Antibodies|antibodies|mesh-list
14498825|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
14498826|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14498827|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14498828|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498829|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
14498830|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
14498831|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
14498832|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498833|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
14498834|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774553|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14774554|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14774555|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774556|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774557|NCT00654680|Urological Agents|urological agents|mesh-ancestor
14774558|NCT00654758|Paclitaxel|paclitaxel|mesh-list
14774559|NCT00654758|Carboplatin|carboplatin|mesh-list
14774560|NCT00654758|Volociximab|volociximab|mesh-list
14774561|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14774562|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14774563|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774564|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
14774565|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
14774566|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
14807348|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14498835|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14498836|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
14498837|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
14498838|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498839|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498840|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498841|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14498842|NCT04307953|Saracatinib|saracatinib|mesh-list
14498843|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498844|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498845|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202783|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202784|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202785|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14202786|NCT04529187|Analgesics|analgesics|mesh-ancestor
14202787|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
14202788|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202789|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14202790|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14202791|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14202792|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202793|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202794|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498859|NCT04301843|Eflornithine|eflornithine|mesh-list
14498860|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498861|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14498862|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14498863|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14498864|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14498865|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14498866|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498867|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498868|NCT04301076|Prednisone|prednisone|mesh-list
14498869|NCT04301076|Cortisone|cortisone|mesh-list
14498870|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
14498871|NCT04301076|Doxorubicin|doxorubicin|mesh-list
14498872|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14498873|NCT04301076|Etoposide|etoposide|mesh-list
14498874|NCT04301076|Vincristine|vincristine|mesh-list
14498875|NCT04301076|Lenalidomide|lenalidomide|mesh-list
14498876|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
14498877|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
14498878|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14498879|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
14498880|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498881|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14498882|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14498883|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
14498884|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498885|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498886|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14498887|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14498888|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14498889|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14498890|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14498891|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498892|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
14498893|NCT04301076|Hormones|hormones|mesh-ancestor
14498894|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14498895|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14498896|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14498897|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
14498898|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
14498899|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
14498900|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14774567|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774568|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14774569|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14774570|NCT00654758|Growth Substances|growth substances|mesh-ancestor
14202795|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14202796|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14202797|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14202798|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14202799|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14202800|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
14202801|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
14202802|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
14498901|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14498902|NCT04301076|Growth Substances|growth substances|mesh-ancestor
14498903|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14498904|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
14498905|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
14498906|NCT04298567|Aspirin|aspirin|mesh-list
14498907|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
14498908|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14498909|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
14498910|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14498911|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
14498912|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202803|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
14202804|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
14202805|NCT04529005|Giapreza|giapreza|mesh-list
14202806|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
14202807|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14202808|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14202809|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
14202810|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202811|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202812|NCT04529226|Haloperidol|haloperidol|mesh-list
14202813|NCT04529226|Pimozide|pimozide|mesh-list
14202814|NCT04529226|Olanzapine|olanzapine|mesh-list
14202815|NCT04529226|Risperidone|risperidone|mesh-list
14202816|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
14202817|NCT04529226|Clozapine|clozapine|mesh-list
14202818|NCT04529226|Amisulpride|amisulpride|mesh-list
14202819|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14498913|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498914|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
14498915|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14774571|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774572|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
14774573|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
14774574|NCT00654888|Mitomycins|mitomycins|mesh-list
14774575|NCT00654888|Mitomycin|mitomycin|mesh-list
14774576|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14774577|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774578|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
14774579|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774580|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14774581|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774582|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14774583|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774584|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14774585|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14774586|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774587|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774588|NCT00654914|Urological Agents|urological agents|mesh-ancestor
14774589|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
14774590|NCT00655018|Tocopherols|tocopherols|mesh-list
14774591|NCT00655018|Vitamin E|vitamin e|mesh-list
14774592|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
14774593|NCT00655018|Vitamins|vitamins|mesh-ancestor
14774594|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
14774595|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774596|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
14498916|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14202820|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
14202821|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202822|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202823|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498917|NCT04298567|Analgesics|analgesics|mesh-ancestor
14498918|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
14498919|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498920|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202824|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14202825|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14202826|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202827|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14202828|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14202829|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
14202830|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
14202831|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
14202832|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498921|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498922|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774597|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774598|NCT00655018|Protective Agents|protective agents|mesh-ancestor
14774599|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
14774600|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14774601|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774602|NCT00655109|Fluticasone|fluticasone|mesh-list
14774603|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14774604|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
14774605|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774606|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14774607|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
14774608|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774609|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202833|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14498923|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14498924|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14774610|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14774611|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
14774612|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
14774613|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14774614|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14774615|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14774616|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14774617|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14774618|NCT00655109|Analgesics|analgesics|mesh-ancestor
14774619|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
14774620|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774621|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14774622|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14774623|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
14774624|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
14774625|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774626|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774627|NCT00655122|Dalteparin|dalteparin|mesh-list
14774628|NCT00655122|Tinzaparin|tinzaparin|mesh-list
14202834|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14202835|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14202836|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14202837|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14202838|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
14202839|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
14202840|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14774629|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14774630|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
14774631|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14774632|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14774633|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774634|NCT00655135|Vedolizumab|vedolizumab|mesh-list
14774635|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774636|NCT00655148|Vaccines|vaccines|mesh-list
14774637|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
14774638|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202841|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
14202842|NCT04528628|Norepinephrine|norepinephrine|mesh-list
14202843|NCT04528628|Serotonin|serotonin|mesh-list
14202844|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14202845|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
14774639|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
14941407|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14941408|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774640|NCT00655174|Sertraline|sertraline|mesh-list
14202846|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14202847|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14202848|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202849|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202850|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202851|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202852|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
14202853|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
14202854|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202855|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14202856|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14202857|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
14202858|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14202859|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14202860|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
14498925|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14202861|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202862|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
14202863|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14202864|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14202865|NCT04528797|Prednisolone|prednisolone|mesh-list
14202866|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
14202867|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14202868|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
14202869|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202870|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
14202871|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
14202872|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202873|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202874|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202875|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
14202876|NCT04528797|Hormones|hormones|mesh-ancestor
14202877|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202878|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14202879|NCT04528797|Protective Agents|protective agents|mesh-ancestor
14202880|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202881|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202882|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
14202883|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14202884|NCT04528888|Heparin|heparin|mesh-list
14202885|NCT04528888|Enoxaparin|enoxaparin|mesh-list
14202886|NCT04528888|Calcium heparin|calcium heparin|mesh-list
14202887|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202888|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
14202889|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
14202890|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202891|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202892|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202893|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
14202894|NCT04528888|Hormones|hormones|mesh-ancestor
14202895|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14202896|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14202897|NCT04528888|Protective Agents|protective agents|mesh-ancestor
14202898|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14202899|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202900|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
14498926|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14498927|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
14498928|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
14498929|NCT04291001|Etonogestrel|etonogestrel|mesh-list
14498930|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14498931|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
14498932|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14498933|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498934|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14498935|NCT04288778|Metformin|metformin|mesh-list
14498936|NCT04288778|Canagliflozin|canagliflozin|mesh-list
14498937|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14498938|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14498939|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14202901|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14202902|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14202903|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202904|NCT04528927|Azithromycin|azithromycin|mesh-list
14498940|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202905|NCT04528927|Doxycycline|doxycycline|mesh-list
14202906|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202907|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202908|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
14202909|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14202910|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14202911|NCT04528277|Isoniazid|isoniazid|mesh-list
14202912|NCT04528277|Rifapentine|rifapentine|mesh-list
14498941|NCT04273945|Macitentan|macitentan|mesh-list
14498942|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14498943|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14498944|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498945|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14774641|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
14774642|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14941409|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14941410|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14941411|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14941412|NCT01498900|Repaglinide|repaglinide|mesh-list
14498946|NCT04271475|Macitentan|macitentan|mesh-list
14498947|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14202913|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
14202914|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14202915|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202916|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14202917|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14202918|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
14202919|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202920|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14202921|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14202922|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
14239772|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239773|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
14239774|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14239775|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14239776|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14239777|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239778|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239779|NCT00149643|Fluoxetine|fluoxetine|mesh-list
14239780|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14239781|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14239782|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14239783|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239784|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239785|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
14239786|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239787|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14239788|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
14239789|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239790|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14239791|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239792|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239793|NCT00149734|Ondansetron|ondansetron|mesh-list
14239794|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
14239795|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
14239796|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239797|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239798|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239799|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
14239800|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
14239801|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14239802|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
14239803|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202923|NCT04528290|Ozanimod|ozanimod|mesh-list
14202924|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14202925|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202926|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14202927|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
14202928|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202929|NCT04528173|Ketorolac|ketorolac|mesh-list
14202930|NCT04528173|Fentanyl|fentanyl|mesh-list
14202931|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
14202932|NCT04528173|Morphine|morphine|mesh-list
14202933|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14202934|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202935|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774643|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14774644|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14774645|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774646|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774647|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774648|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
14774649|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774650|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14774651|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14774652|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774653|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14202936|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14498948|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14498949|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14498950|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14498951|NCT04269902|Venetoclax|venetoclax|mesh-list
14498952|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
14498953|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14498954|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14202937|NCT04528173|Analgesics|analgesics|mesh-ancestor
14202938|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
14202939|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202940|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14202941|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14202942|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14202943|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14202944|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202945|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202946|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14498979|NCT04260659|Lidocaine|lidocaine|mesh-list
14498980|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
14498981|NCT04260659|Fentanyl|fentanyl|mesh-list
14498982|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
14498983|NCT04260659|Ketamine|ketamine|mesh-list
14202947|NCT04528173|Narcotics|narcotics|mesh-ancestor
14202948|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14498984|NCT04260659|Remifentanil|remifentanil|mesh-list
14498985|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
14498986|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
14498987|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14498988|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202949|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14202950|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
14202951|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
14202952|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14498989|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
14498990|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14498991|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14498992|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14498993|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14498994|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14498995|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202953|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14202954|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202955|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14202956|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14202957|NCT04528095|Clozapine|clozapine|mesh-list
14202958|NCT04528095|Amisulpride|amisulpride|mesh-list
14202959|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14202960|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
14202961|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14202962|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202963|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202964|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14202965|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14202966|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14202967|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14202968|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
14202969|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
14202970|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14202971|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
14202972|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14202973|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
14202974|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
14202975|NCT04528056|Ambrisentan|ambrisentan|mesh-list
14202976|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14202977|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14202978|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14202979|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14202980|NCT04528056|Analgesics|analgesics|mesh-ancestor
14202981|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
14202982|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14202983|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202984|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14498996|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14498997|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14498998|NCT04260659|Analgesics|analgesics|mesh-ancestor
14498999|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14499000|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14499001|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14499002|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
14499003|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14499004|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14499005|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14499006|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
14499007|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14499008|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14499009|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14499010|NCT04260659|Narcotics|narcotics|mesh-ancestor
14499011|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14499012|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
14499013|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14499014|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14499015|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
14499016|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14499017|NCT04259775|Insulin|insulin|mesh-list
14499018|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941413|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941414|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941415|NCT01498913|Repaglinide|repaglinide|mesh-list
14941416|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941417|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941418|NCT01498926|Insulin|insulin|mesh-list
14941419|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14202985|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14202986|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14202987|NCT04528004|Niacinamide|niacinamide|mesh-list
14499019|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499020|NCT04258397|Pirfenidone|pirfenidone|mesh-list
14499021|NCT04258397|Analgesics|analgesics|mesh-ancestor
14499022|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
14499023|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499024|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499025|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14499026|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14499027|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14499028|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14499029|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499030|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
14499031|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499032|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14202988|NCT04528004|Niacin|niacin|mesh-list
14202989|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
14202990|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
14202991|NCT04528004|Vitamins|vitamins|mesh-ancestor
14202992|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
14202993|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14202994|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14202995|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
14202996|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14202997|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14202998|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
14202999|NCT04527562|Colchicine|colchicine|mesh-list
14203000|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
14203001|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203002|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
14203003|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
14203004|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14203005|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203006|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203007|NCT04527679|Lenvatinib|lenvatinib|mesh-list
14203008|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203009|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203010|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203011|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774654|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14774655|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14774656|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774657|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14774658|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
14774659|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14774660|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499033|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
14499034|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499055|NCT04231877|Prednisone|prednisone|mesh-list
14774661|NCT00655252|Everolimus|everolimus|mesh-list
14499056|NCT04231877|Cortisone|cortisone|mesh-list
14499057|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
14499058|NCT04231877|Rituximab|rituximab|mesh-list
14203020|NCT04527432|Antibodies|antibodies|mesh-list
14203021|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
14499059|NCT04231877|Doxorubicin|doxorubicin|mesh-list
14203022|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203023|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
14203024|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14203025|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203026|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
14203027|NCT04527666|Anticoagulants|anticoagulants|mesh-list
14203028|NCT04527211|Ivermectin|ivermectin|mesh-list
14203029|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14203030|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203031|NCT05140811|Azacitidine|azacitidine|mesh-list
14203032|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203033|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
14203034|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203035|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203036|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203037|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14203038|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14203039|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203040|NCT05140655|Fulvestrant|fulvestrant|mesh-list
14203041|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14203042|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203043|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14203044|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14203045|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
14203046|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203047|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203048|NCT05140525|Macitentan|macitentan|mesh-list
14203049|NCT05140525|Riociguat|riociguat|mesh-list
14499060|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14499061|NCT04231877|Etoposide|etoposide|mesh-list
14499062|NCT04231877|Daunorubicin|daunorubicin|mesh-list
14499063|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
14499064|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14499065|NCT04231877|Antibodies|antibodies|mesh-list
14499066|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
14499067|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14499068|NCT04231877|Lenograstim|lenograstim|mesh-list
14499069|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
14499070|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499071|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
14499072|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499073|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14499074|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14499075|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
14499076|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499077|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499078|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14499079|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14499080|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14499081|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14499082|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499083|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774662|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774663|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774664|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
14774665|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774666|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14774667|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774668|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774669|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
14774670|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964185|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964186|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
13964187|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13964188|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964189|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
13964190|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
13964191|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
13964192|NCT03139422|Calcium|calcium|mesh-list
13964193|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13964194|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964195|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13964196|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14499084|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
14499085|NCT04231877|Hormones|hormones|mesh-ancestor
14774671|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14203050|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14203051|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14203052|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203053|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14203054|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
14203055|NCT05140512|Goserelin|goserelin|mesh-list
14203056|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14203057|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203058|NCT05140096|Fluconazole|fluconazole|mesh-list
14203059|NCT05140096|Isavuconazole|isavuconazole|mesh-list
14203060|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
14203061|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
14203062|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203063|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14203064|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14203065|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203066|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203067|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14203068|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
14203069|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203070|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203071|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14203072|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14203073|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203074|NCT05139966|Fluorides|fluorides|mesh-list
14203075|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
14203076|NCT05139966|Protective Agents|protective agents|mesh-ancestor
14499086|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14499087|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14499088|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14499089|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14499090|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
14499091|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
14499092|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
14499093|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
14499094|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
14499095|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
14499096|NCT04231708|Yohimbine|yohimbine|mesh-list
14499097|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774672|NCT00655330|Valsartan|valsartan|mesh-list
14774673|NCT00655330|Probucol|probucol|mesh-list
14774674|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14774675|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14774676|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14774677|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774678|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774679|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14774680|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
14774681|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774682|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
14774683|NCT00655330|Protective Agents|protective agents|mesh-ancestor
14774684|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774685|NCT00655408|Iron|iron|mesh-list
14203077|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239804|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239805|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14239806|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14239807|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14239808|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239809|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14239810|NCT00149799|Citalopram|citalopram|mesh-list
14239811|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14239812|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14239813|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14239814|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239815|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239816|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
14239817|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239818|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14239819|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
14499098|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
14774686|NCT00655408|Trace Elements|trace elements|mesh-ancestor
14774687|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
14499099|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
14499100|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499101|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499102|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14499103|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14499104|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14499105|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
14499106|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14499107|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499108|NCT04231708|Urological Agents|urological agents|mesh-ancestor
14499109|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
14499110|NCT04225078|Loperamide|loperamide|mesh-list
14499111|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
14499112|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14499113|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14499114|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14499115|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14499116|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499117|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499118|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499119|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14203078|NCT05139667|Tacrolimus|tacrolimus|mesh-list
14203079|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14203080|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
14203081|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203082|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14203083|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203084|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203085|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
14203086|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
14203087|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499146|NCT04188665|Lectins|lectins|mesh-list
14499147|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
14499148|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
14499149|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499150|NCT04188665|Coagulants|coagulants|mesh-ancestor
14499151|NCT04186247|Azithromycin|azithromycin|mesh-list
14499152|NCT04186247|Metronidazole|metronidazole|mesh-list
14499153|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14499154|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14499155|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14499156|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14499157|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
14499158|NCT04181515|Yohimbine|yohimbine|mesh-list
14499159|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14499160|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
14499161|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
14499162|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203088|NCT05139472|Empagliflozin|empagliflozin|mesh-list
14499163|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807349|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
14499164|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14499165|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14499166|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14499167|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
14499168|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14499169|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499170|NCT04181515|Urological Agents|urological agents|mesh-ancestor
14499171|NCT04181255|Poractant alfa|poractant alfa|mesh-list
14499172|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14499173|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
14203089|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14203090|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203091|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14203092|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203093|NCT05139238|Labetalol|labetalol|mesh-list
14203094|NCT05139238|Nifedipine|nifedipine|mesh-list
14203095|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14203096|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14203097|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203098|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14203099|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203100|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
14203101|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
14203102|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14203103|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14203104|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14203105|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
14203106|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203107|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14499174|NCT04181060|Bevacizumab|bevacizumab|mesh-list
14499175|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14499176|NCT04181060|Osimertinib|osimertinib|mesh-list
14499177|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
14499178|NCT04181060|Antibodies|antibodies|mesh-list
14499179|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
14499180|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14499181|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
14499182|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499183|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14774688|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774689|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
14203108|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
14499184|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14499185|NCT04181060|Growth Substances|growth substances|mesh-ancestor
14499186|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499187|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
14499188|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
14499189|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499190|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14499191|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499192|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
14499193|NCT04180969|Yohimbine|yohimbine|mesh-list
14774690|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
14499194|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14499195|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
14499196|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
14499197|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499198|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499199|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14499200|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14499201|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14499202|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
14499203|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14499204|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499205|NCT04180969|Urological Agents|urological agents|mesh-ancestor
14499206|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
14499207|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14499208|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499209|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499210|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774691|NCT00655421|Coagulants|coagulants|mesh-ancestor
14499222|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
14499223|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14203109|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
14203110|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203111|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14203112|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14203113|NCT05139095|Apatinib|apatinib|mesh-list
14203114|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203115|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203116|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203117|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203118|NCT05138978|Listerine|listerine|mesh-list
14203119|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
14203120|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
14203121|NCT05138978|Protective Agents|protective agents|mesh-ancestor
14203122|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203123|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14203124|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203125|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14203126|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14203127|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14499224|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
14499225|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14499226|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
14499227|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499228|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499229|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
14203128|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14203129|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14203130|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499230|NCT04172675|Gemcitabine|gemcitabine|mesh-list
14499231|NCT04172675|Mitomycins|mitomycins|mesh-list
14499232|NCT04172675|Mitomycin|mitomycin|mesh-list
14774692|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
14774693|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807350|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807351|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807352|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14807353|NCT00821392|Febuxostat|febuxostat|mesh-list
14807354|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
14807355|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807356|NCT00821444|Ziprasidone|ziprasidone|mesh-list
14807357|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14807358|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
14807359|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807360|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807361|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807362|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14807363|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807364|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807365|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14807366|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14807367|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
14807368|NCT00821457|Mitogens|mitogens|mesh-list
14807369|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14807370|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807371|NCT00821483|Frovatriptan|frovatriptan|mesh-list
14807372|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14807373|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
14203131|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499233|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14499234|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
14499235|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499236|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807374|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807375|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499237|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
14499238|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774694|NCT00655512|Clobetasol|clobetasol|mesh-list
14774695|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
14774696|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941420|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
14941421|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941422|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941423|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
14941424|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941425|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941426|NCT01499004|Tofacitinib|tofacitinib|mesh-list
14941427|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14941428|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941429|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203132|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14203133|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14203134|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203135|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
14203136|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203137|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14203138|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14203139|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203140|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
14203141|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14203142|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14203143|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203144|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
14203145|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14203146|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14203147|NCT05126121|Amoxicillin|amoxicillin|mesh-list
14203148|NCT05126121|Clarithromycin|clarithromycin|mesh-list
14203149|NCT05126121|Levofloxacin|levofloxacin|mesh-list
14203150|NCT05126121|Ofloxacin|ofloxacin|mesh-list
14203151|NCT05126121|Tetracycline|tetracycline|mesh-list
14203152|NCT05126121|Tinidazole|tinidazole|mesh-list
14203153|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14203154|NCT05126121|Furazolidone|furazolidone|mesh-list
14203155|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203156|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
14203157|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14203158|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203159|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203160|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14203161|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14203162|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14203163|NCT05126121|Renal Agents|renal agents|mesh-ancestor
14499239|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499240|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941430|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
14941431|NCT01499069|Fesoterodine|fesoterodine|mesh-list
14941432|NCT01499069|Propiverine|propiverine|mesh-list
14499241|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
14499242|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499243|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14774697|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
14774698|NCT00655512|Hormones|hormones|mesh-ancestor
14774699|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774700|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774701|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14774702|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14774703|NCT00655512|Analgesics|analgesics|mesh-ancestor
14774704|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
14774705|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774706|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774707|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
14774708|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774709|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
14774710|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14941433|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14203164|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14499244|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
14499245|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14774711|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774712|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774713|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
14774714|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14774715|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774716|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14203165|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14203166|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203167|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14203168|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14203169|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14203170|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14203171|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14203172|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14203173|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
14203174|NCT05108688|Sumatriptan|sumatriptan|mesh-list
14203175|NCT05108688|Mirtazapine|mirtazapine|mesh-list
14203176|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14203177|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14203178|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14203179|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
14203180|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203181|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203182|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499259|NCT04164082|Gemcitabine|gemcitabine|mesh-list
14499260|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
14499261|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14499262|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
14499263|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499264|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499265|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
14499266|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774717|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14774718|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774719|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774720|NCT00655590|Urological Agents|urological agents|mesh-ancestor
14499267|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499268|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499269|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
14499270|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499271|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499272|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
14499273|NCT04164069|Leucovorin|leucovorin|mesh-list
14499274|NCT04164069|Folic Acid|folic acid|mesh-list
14499275|NCT04164069|Bevacizumab|bevacizumab|mesh-list
14499276|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14499277|NCT04164069|Fluorouracil|fluorouracil|mesh-list
14499278|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
14499279|NCT04164069|Dasatinib|dasatinib|mesh-list
14774721|NCT00655603|Pancrelipase|pancrelipase|mesh-list
14774722|NCT00655603|Hormones|hormones|mesh-list
14774723|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774724|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774725|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774726|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14774727|NCT00655616|Montelukast|montelukast|mesh-list
14774728|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14774729|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
14774730|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203183|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
14499280|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
14499281|NCT04164069|Antibodies|antibodies|mesh-list
14499282|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
14499283|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14499284|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
14499285|NCT04164069|Calcium|calcium|mesh-list
14499286|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
14499287|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499288|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203184|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14203185|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14203186|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
14203187|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
14203188|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14203189|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14499289|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14774731|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774732|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14774733|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
14774734|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14774735|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14774736|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14774737|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
14203190|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14203191|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14203192|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14203193|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14203194|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14203195|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14203196|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14203197|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14203198|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
14203199|NCT05080790|Interleukin-2|interleukin-2|mesh-list
14203200|NCT05080790|Dinutuximab|dinutuximab|mesh-list
14203201|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203202|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14203203|NCT05080790|Analgesics|analgesics|mesh-ancestor
14203204|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
14203205|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203206|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203207|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14203208|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
14203209|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
14203210|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203211|NCT04918017|Esomeprazole|esomeprazole|mesh-list
14203212|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14203213|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14203214|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14203215|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203216|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203217|NCT04590248|Adavosertib|adavosertib|mesh-list
14203218|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203219|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203220|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
14203221|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
14203222|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203223|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203224|NCT04502693|Vaccines|vaccines|mesh-list
14203225|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
14203226|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203227|NCT04459871|Thrombin|thrombin|mesh-list
14203228|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
14203229|NCT04459871|Coagulants|coagulants|mesh-ancestor
14203230|NCT04455139|Melphalan|melphalan|mesh-list
14203231|NCT04455139|Topotecan|topotecan|mesh-list
14203232|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203233|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
14203234|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203235|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203236|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14203237|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499290|NCT04164069|Growth Substances|growth substances|mesh-ancestor
14499291|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499292|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
14499293|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
14499294|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14499295|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14499296|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
14499297|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499298|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14499299|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499300|NCT04164069|Antidotes|antidotes|mesh-ancestor
14203238|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
14203239|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203240|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14203241|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14203242|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499301|NCT04164069|Protective Agents|protective agents|mesh-ancestor
14499302|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
14499303|NCT04164069|Vitamins|vitamins|mesh-ancestor
14499304|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
14499305|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14499306|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499307|NCT04164069|Hematinics|hematinics|mesh-ancestor
14499308|NCT04145115|Nivolumab|nivolumab|mesh-list
14499309|NCT04145115|Ipilimumab|ipilimumab|mesh-list
14499310|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499311|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499312|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14499313|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499314|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14499315|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
14499316|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14499317|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14499318|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14499319|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499320|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499321|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14499322|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14774738|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14774739|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774740|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14774741|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
14774742|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774743|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14203243|NCT04447183|Iodine|iodine|mesh-list
14203244|NCT04447183|Hormones|hormones|mesh-list
14203245|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203246|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239820|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239821|NCT00149825|Dexetimide|dexetimide|mesh-list
14239822|NCT00149825|Citalopram|citalopram|mesh-list
14239823|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14239824|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14239825|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14239826|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239827|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239828|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
14239829|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239830|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14239831|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
14239832|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239833|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14239834|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14239835|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
14239836|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
14239837|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239838|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14239839|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14774744|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14774745|NCT00655655|Everolimus|everolimus|mesh-list
14774746|NCT00655655|Vatalanib|vatalanib|mesh-list
14774747|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203247|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14203248|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203249|NCT04447183|Trace Elements|trace elements|mesh-ancestor
14499345|NCT04133636|Dexamethasone|dexamethasone|mesh-list
14203250|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
14203251|NCT04417088|Carboplatin|carboplatin|mesh-list
14203252|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203253|NCT04380545|Interferons|interferons|mesh-list
14203254|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
14203255|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
14203256|NCT04380545|Fluorouracil|fluorouracil|mesh-list
14203257|NCT04380545|Nivolumab|nivolumab|mesh-list
14203258|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
14203259|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203260|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203261|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203262|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14203263|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
14203264|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203265|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203266|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14203267|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
14499346|NCT04133636|Lenalidomide|lenalidomide|mesh-list
14499347|NCT04133636|Bortezomib|bortezomib|mesh-list
14499348|NCT04133636|Daratumumab|daratumumab|mesh-list
14499349|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14499350|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
14499351|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
14499352|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499353|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499354|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14499355|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
14499356|NCT04133636|Hormones|hormones|mesh-ancestor
14499357|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14499358|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14499359|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499360|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
14499361|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14499362|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14499363|NCT04133636|Growth Substances|growth substances|mesh-ancestor
14499364|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
14499365|NCT04129502|Carboplatin|carboplatin|mesh-list
14499366|NCT04129502|Pemetrexed|pemetrexed|mesh-list
14499367|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499368|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499369|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499370|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14499371|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14499372|NCT04108208|Androgens|androgens|mesh-list
14499373|NCT04108208|Hormones|hormones|mesh-ancestor
14499374|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14499375|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774748|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774749|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
14774750|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203268|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203269|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
14774751|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203270|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14203271|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
14203272|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203273|NCT04312594|Expectorants|expectorants|mesh-ancestor
14203274|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
14203275|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14203276|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
14203277|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203278|NCT04312594|Protective Agents|protective agents|mesh-ancestor
14941434|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14941435|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
14203279|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203280|NCT04312594|Antidotes|antidotes|mesh-ancestor
14203281|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
14203282|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203283|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203284|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203285|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203286|NCT04265755|Erenumab|erenumab|mesh-list
14203287|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14203288|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203289|NCT04265755|Analgesics|analgesics|mesh-ancestor
14203290|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
14203291|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203292|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239840|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
14239841|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
14239842|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14239843|NCT00149890|Cyclosporine|cyclosporine|mesh-list
14239844|NCT00149890|Cyclosporins|cyclosporins|mesh-list
14239845|NCT00149890|Basiliximab|basiliximab|mesh-list
14239846|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239847|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239848|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239849|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
14239850|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239851|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
14239852|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239853|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
14239854|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239855|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14239856|NCT00149994|Cyclosporine|cyclosporine|mesh-list
14239857|NCT00149994|Prednisone|prednisone|mesh-list
14239858|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
14239859|NCT00149994|Tacrolimus|tacrolimus|mesh-list
14239860|NCT00149994|Cyclosporins|cyclosporins|mesh-list
14239861|NCT00149994|Basiliximab|basiliximab|mesh-list
14239862|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239863|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
14239864|NCT00149994|Hormones|hormones|mesh-ancestor
14239865|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239866|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239867|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239868|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239869|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14239870|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
14239871|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14239872|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239873|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239874|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
14239875|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239876|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
14239877|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239878|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
14239879|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
14239880|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239881|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239882|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14239883|NCT00149994|Protective Agents|protective agents|mesh-ancestor
14239884|NCT00150345|Voriconazole|voriconazole|mesh-list
14239885|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
14239886|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239887|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14239888|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14239889|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774752|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774753|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774754|NCT00655681|Pamidronate|pamidronate|mesh-list
14774755|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14774756|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774757|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
14941436|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941437|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774758|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
14774759|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
14774760|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774761|NCT00655785|Gemcitabine|gemcitabine|mesh-list
14941438|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203293|NCT04238416|Lactulose|lactulose|mesh-list
14203294|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14203295|NCT04201496|Empagliflozin|empagliflozin|mesh-list
14203296|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14203297|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203298|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14203299|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203300|NCT04129216|Tamoxifen|tamoxifen|mesh-list
14203301|NCT04129216|Letrozole|letrozole|mesh-list
14203302|NCT04129216|Exemestane|exemestane|mesh-list
14203303|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203304|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203305|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14941439|NCT01499069|Urological Agents|urological agents|mesh-ancestor
14941440|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
14941441|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
14203306|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14203307|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203308|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14203309|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
14203310|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203311|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203312|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14203313|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14203314|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14203315|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14203316|NCT04106414|Nivolumab|nivolumab|mesh-list
14203317|NCT04106414|Linrodostat|linrodostat|mesh-list
14203318|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203319|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203320|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14203321|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203322|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203323|NCT04102618|Trastuzumab|trastuzumab|mesh-list
14203324|NCT04102618|Atezolizumab|atezolizumab|mesh-list
14203325|NCT04102618|Letrozole|letrozole|mesh-list
14774762|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14941442|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203326|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203327|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203328|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14499392|NCT04101877|Bevacizumab|bevacizumab|mesh-list
14499393|NCT04101877|Aflibercept|aflibercept|mesh-list
14499394|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499395|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499396|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14499397|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14499398|NCT04101877|Growth Substances|growth substances|mesh-ancestor
14499399|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499400|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
14499401|NCT04090398|Paclitaxel|paclitaxel|mesh-list
14499402|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14499403|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14941443|NCT01499108|Liraglutide|liraglutide|mesh-list
14941444|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941445|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941446|NCT01499108|Incretins|incretins|mesh-ancestor
14941447|NCT01499108|Hormones|hormones|mesh-ancestor
14941448|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14499404|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14499405|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499406|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
14499407|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
14499408|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
14499409|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774763|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
14774764|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774765|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774766|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
14774767|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774768|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774769|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774770|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
14774771|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774772|NCT00655798|Antioxidants|antioxidants|mesh-list
14774773|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774774|NCT00655798|Protective Agents|protective agents|mesh-ancestor
14774775|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774776|NCT00655824|Ofatumumab|ofatumumab|mesh-list
14774777|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774778|NCT00655837|Gemcitabine|gemcitabine|mesh-list
14941449|NCT01499121|Sunitinib|sunitinib|mesh-list
14941450|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941451|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14941452|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14941453|NCT01499121|Growth Substances|growth substances|mesh-ancestor
14941454|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941455|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
14941456|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14941457|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203329|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14203330|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203331|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774779|NCT00655837|Rituximab|rituximab|mesh-list
14774780|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
14774781|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14774782|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774783|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
14774784|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774785|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774786|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14774787|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
14774788|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774789|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
14774790|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774791|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774792|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774793|NCT00655915|Betamethasone|betamethasone|mesh-list
14774794|NCT00655915|Lidocaine|lidocaine|mesh-list
14774795|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
14774796|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
14774797|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774798|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774799|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
14774800|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774801|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14774802|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14774803|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14774804|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774805|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774806|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774807|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
14774808|NCT00655915|Hormones|hormones|mesh-ancestor
14774809|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774810|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14774811|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
14774812|NCT00655967|Acamprosate|acamprosate|mesh-list
14774813|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14203332|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14203333|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
14203334|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203335|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203336|NCT04052880|Dexamethasone|dexamethasone|mesh-list
14203337|NCT04052880|Lenalidomide|lenalidomide|mesh-list
14203338|NCT04052880|Bortezomib|bortezomib|mesh-list
14203339|NCT04052880|Daratumumab|daratumumab|mesh-list
14203340|NCT04052880|Ixazomib|ixazomib|mesh-list
14203341|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14203342|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
14203343|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
14203344|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203345|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203346|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14203347|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
14203348|NCT04052880|Hormones|hormones|mesh-ancestor
14203349|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203350|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14203351|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203352|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
14203353|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203354|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14203355|NCT04052880|Growth Substances|growth substances|mesh-ancestor
14499415|NCT04079712|Nivolumab|nivolumab|mesh-list
14499416|NCT04079712|Ipilimumab|ipilimumab|mesh-list
14499417|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499418|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499419|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14499420|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499421|NCT04077463|Carboplatin|carboplatin|mesh-list
14499422|NCT04077463|Pemetrexed|pemetrexed|mesh-list
14499423|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
14499424|NCT04077463|Lazertinib|lazertinib|mesh-list
14499425|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499426|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499427|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499428|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14499429|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14499430|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14499431|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499432|NCT04074161|Liraglutide|liraglutide|mesh-list
14499433|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14499434|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499435|NCT04074161|Incretins|incretins|mesh-ancestor
14499436|NCT04074161|Hormones|hormones|mesh-ancestor
14499437|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774814|NCT00655993|Simvastatin|simvastatin|mesh-list
14774815|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14774816|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14499438|NCT04061330|Ketamine|ketamine|mesh-list
14499439|NCT04061330|Morphine|morphine|mesh-list
14499440|NCT04061330|Analgesics|analgesics|mesh-ancestor
14499441|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
14499442|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499443|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499444|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14499445|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14499446|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
14499447|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
14499448|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14499449|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14499450|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14499451|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14499452|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499453|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14499454|NCT04061330|Narcotics|narcotics|mesh-ancestor
14499455|NCT04057898|Ibudilast|ibudilast|mesh-list
14774817|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
14774818|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203356|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
14203357|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
14203358|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499456|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14774819|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14774820|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14774821|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774822|NCT00656006|Ribavirin|ribavirin|mesh-list
14203359|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203360|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14203361|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203362|NCT03993379|Ipilimumab|ipilimumab|mesh-list
14203363|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203364|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203365|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14203366|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203367|NCT03921866|Palbociclib|palbociclib|mesh-list
14203368|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203369|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13964197|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964198|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
13964199|NCT03139422|Coagulants|coagulants|mesh-ancestor
13964200|NCT03139513|Vemurafenib|vemurafenib|mesh-list
13964201|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964202|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13964203|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964204|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964205|NCT03139565|Vaccines|vaccines|mesh-list
13964206|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
14203370|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243038|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14243039|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14243040|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14243041|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14243042|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14243043|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243044|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
14243045|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243046|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243047|NCT00192036|Gemcitabine|gemcitabine|mesh-list
14243048|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243049|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243050|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
14243051|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243052|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
14243053|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243054|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243055|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243056|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
14243057|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243058|NCT00192075|Leucovorin|leucovorin|mesh-list
14243059|NCT00192075|Folic Acid|folic acid|mesh-list
14243060|NCT00192075|Gemcitabine|gemcitabine|mesh-list
14243061|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
14243062|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
14243063|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243064|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
14243065|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243066|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243067|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
14243068|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243069|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243070|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243071|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
14243072|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243073|NCT00192075|Antidotes|antidotes|mesh-ancestor
14243074|NCT00192075|Protective Agents|protective agents|mesh-ancestor
14243075|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
14243076|NCT00192075|Vitamins|vitamins|mesh-ancestor
14774823|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
14774824|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203371|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203372|NCT03772158|Cetirizine|cetirizine|mesh-list
14203373|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14203374|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14203375|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14203376|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
14203377|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
14203378|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203379|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243077|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
14243078|NCT00192075|Hematinics|hematinics|mesh-ancestor
14243079|NCT00192647|Ribavirin|ribavirin|mesh-list
14243080|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14243081|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
14243082|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
14243083|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243084|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
14243085|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243086|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243087|NCT00193037|Docetaxel|docetaxel|mesh-list
14243088|NCT00193037|Doxorubicin|doxorubicin|mesh-list
14243089|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14243090|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243091|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243092|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243093|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243094|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243095|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14243096|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14243097|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243098|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243099|NCT00193050|Gemcitabine|gemcitabine|mesh-list
14243100|NCT00193050|Docetaxel|docetaxel|mesh-list
14243101|NCT00193050|Epirubicin|epirubicin|mesh-list
14243102|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243103|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
14243104|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243105|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243106|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
14243107|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243108|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243109|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243110|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
14243111|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243112|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243113|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243114|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243115|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14243116|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14243117|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243118|NCT00193063|Gemcitabine|gemcitabine|mesh-list
14243119|NCT00193063|Trastuzumab|trastuzumab|mesh-list
14243120|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243121|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
14243122|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243123|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243124|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
14243125|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243126|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243127|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243128|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
14243129|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243130|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243131|NCT00193128|Docetaxel|docetaxel|mesh-list
14243132|NCT00193128|Capecitabine|capecitabine|mesh-list
14243133|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
14243134|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243135|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243136|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243137|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243138|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243139|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14499457|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
14499458|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499459|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499460|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14499461|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
14499462|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14499463|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499464|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499465|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14774825|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
14774826|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774827|NCT00656032|Cinacalcet|cinacalcet|mesh-list
14499466|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774828|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14774829|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774830|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14774831|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
14774832|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774833|NCT00656110|Ethanol|ethanol|mesh-list
14499470|NCT04040790|Phenylephrine|phenylephrine|mesh-list
14774834|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
14774835|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14774836|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14774837|NCT00656110|Prednisolone|prednisolone|mesh-list
14774838|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
14774839|NCT00656110|Lidocaine|lidocaine|mesh-list
14774840|NCT00656110|Bupivacaine|bupivacaine|mesh-list
14774841|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14774842|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
14774843|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
14774844|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
14774845|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774846|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774847|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
14774848|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774849|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14774850|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14774851|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14774852|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774853|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774854|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774855|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
14774856|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
14774857|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14774858|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
14774859|NCT00656110|Hormones|hormones|mesh-ancestor
14941458|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941459|NCT01499225|Doxycycline|doxycycline|mesh-list
14941460|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14941461|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941462|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
14941463|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14941464|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14941465|NCT01499251|Temozolomide|temozolomide|mesh-list
14941466|NCT01499251|Macitentan|macitentan|mesh-list
14941467|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14941468|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
13964207|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968019|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968020|NCT03113708|Heparin|heparin|mesh-list
13968021|NCT03113708|Calcium heparin|calcium heparin|mesh-list
13968022|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
13968023|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13968024|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13968025|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968026|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
13968027|NCT03113617|Bombesin|bombesin|mesh-list
13968028|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968029|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968030|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968031|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14499471|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
14499472|NCT04040790|Tropicamide|tropicamide|mesh-list
14499473|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14499474|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
14499475|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
14499476|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499477|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499478|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
14499479|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14499480|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
14499481|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
14499482|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14499483|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14203380|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203381|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
14203382|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14203383|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
14203384|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203385|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
14203386|NCT03723590|Protective Agents|protective agents|mesh-ancestor
14203387|NCT03697512|Rituximab|rituximab|mesh-list
14203388|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499484|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14499485|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
14499486|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14499487|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499488|NCT04040790|Protective Agents|protective agents|mesh-ancestor
14499489|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14499490|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14774860|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14774861|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14774862|NCT00656110|Protective Agents|protective agents|mesh-ancestor
14941469|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941470|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499491|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
14774863|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14774864|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774865|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14774866|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941471|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14941472|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14941473|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15026730|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026731|NCT01945476|Midazolam|midazolam|mesh-list
14774867|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
14774868|NCT00656123|Molgramostim|molgramostim|mesh-list
14774869|NCT00656123|Sargramostim|sargramostim|mesh-list
14774870|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
15026732|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15026733|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15026734|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026735|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026736|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15026737|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026738|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964208|NCT03139305|Glucagon|glucagon|mesh-list
13964209|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13964210|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14203389|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964211|NCT03139305|Hormones|hormones|mesh-ancestor
13964212|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964213|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964214|NCT03139305|Incretins|incretins|mesh-ancestor
13964215|NCT03139500|Midazolam|midazolam|mesh-list
14203390|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
14203391|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203392|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203393|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
14203394|NCT03613727|Vitamins|vitamins|mesh-ancestor
14203395|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
14203396|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203397|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
14203398|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203399|NCT03613727|Protective Agents|protective agents|mesh-ancestor
14203400|NCT03558854|Aspirin|aspirin|mesh-list
14499502|NCT04033354|Paclitaxel|paclitaxel|mesh-list
14499503|NCT04033354|Carboplatin|carboplatin|mesh-list
14499504|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14499505|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499506|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
14499507|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
14499508|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
14774871|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774872|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774873|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14499509|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499510|NCT04029688|Cytarabine|cytarabine|mesh-list
14499511|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
14499512|NCT04029688|Fludarabine|fludarabine|mesh-list
14499513|NCT04029688|Topotecan|topotecan|mesh-list
14499514|NCT04029688|Venetoclax|venetoclax|mesh-list
14499515|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499516|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
14499517|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499518|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14499519|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14499520|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
14499521|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499522|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499523|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14499524|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14774874|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14774875|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
14774876|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774877|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774878|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14774879|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14774880|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774881|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14774882|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14774883|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941474|NCT01499407|Abciximab|abciximab|mesh-list
14941475|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
14941476|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14203401|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14941477|NCT01499433|Caspofungin|caspofungin|mesh-list
14203402|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14203403|NCT03558854|Analgesics|analgesics|mesh-ancestor
14203404|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
14203405|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203406|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203407|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14203408|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203409|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14203410|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14203411|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203412|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14499525|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
14941478|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
14941479|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941480|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941481|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941482|NCT01499446|Fluticasone|fluticasone|mesh-list
14941483|NCT01499446|Xhance|xhance|mesh-list
14941484|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941485|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14941486|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
14499526|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
14499527|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941487|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203413|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14203414|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203415|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
14203416|NCT03495960|Rituximab|rituximab|mesh-list
14203417|NCT03495960|Methotrexate|methotrexate|mesh-list
14203418|NCT03495960|Lenalidomide|lenalidomide|mesh-list
14203419|NCT03495960|Temozolomide|temozolomide|mesh-list
14203420|NCT03495960|Procarbazine|procarbazine|mesh-list
14941488|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941489|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14941490|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
14941491|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
14774884|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774885|NCT00656188|Urological Agents|urological agents|mesh-ancestor
14774886|NCT00656214|Lycopene|lycopene|mesh-list
14774887|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14774888|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
14774889|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774890|NCT00656214|Protective Agents|protective agents|mesh-ancestor
14774891|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774892|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14941492|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14499528|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14499529|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14499530|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499531|NCT04028063|Doxorubicin|doxorubicin|mesh-list
14774893|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14774894|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774895|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14774896|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14774897|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
14774898|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14774899|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499532|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14499533|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499534|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14203421|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203422|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203423|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
14203424|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203425|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203426|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14203427|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
14203428|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14203429|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203430|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
14203431|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203432|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
14203433|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203434|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14203435|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14203436|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14203437|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203438|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14499535|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14499536|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499537|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941493|NCT01499485|Acetazolamide|acetazolamide|mesh-list
14499541|NCT04027894|Rifamycins|rifamycins|mesh-list
14499542|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
14499543|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14499544|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14499545|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14499546|NCT04026984|Rifamycins|rifamycins|mesh-list
14499547|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
14499548|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14499549|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14499550|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203439|NCT03495960|Growth Substances|growth substances|mesh-ancestor
14203440|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
14774900|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14941494|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
14941495|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14941496|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203441|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203442|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
14203443|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
14203444|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203445|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203446|NCT03444753|Nivolumab|nivolumab|mesh-list
14203447|NCT03444753|Ipilimumab|ipilimumab|mesh-list
14203448|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499553|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
14499554|NCT04025216|Fludarabine|fludarabine|mesh-list
14499555|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499556|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
14499557|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499558|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14499559|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14499560|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
14499561|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499562|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203449|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203450|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14203451|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499563|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14499564|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
14499565|NCT04024761|Fludarabine|fludarabine|mesh-list
14499566|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499567|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
14499568|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499569|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14499570|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14499571|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
14499572|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499573|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499574|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14774901|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
14774902|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14774903|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774904|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774905|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774906|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
14774907|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
14203452|NCT03430895|Durvalumab|durvalumab|mesh-list
14203453|NCT03430895|Tremelimumab|tremelimumab|mesh-list
14203454|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203455|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203456|NCT03409458|Avelumab|avelumab|mesh-list
14203457|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203458|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203459|NCT03366272|Gemcitabine|gemcitabine|mesh-list
14203460|NCT03366272|Rituximab|rituximab|mesh-list
14203461|NCT03366272|Nivolumab|nivolumab|mesh-list
14203462|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
14203463|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203464|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203465|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
14203466|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774908|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14774909|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14774910|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774911|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14774912|NCT00656331|Amlodipine|amlodipine|mesh-list
14774913|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14774914|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14774915|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774916|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774917|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14774918|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774919|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
14774920|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14774921|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
14774922|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774923|NCT00656422|Insulin|insulin|mesh-list
14774924|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14774925|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
14774926|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14774927|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774928|NCT00656435|Bevacizumab|bevacizumab|mesh-list
14774929|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14774930|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774931|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14774932|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14774933|NCT00656435|Growth Substances|growth substances|mesh-ancestor
14774934|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774935|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
14774936|NCT00656526|Lidocaine|lidocaine|mesh-list
14774937|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
14774938|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
14774939|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14774940|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774941|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
14774942|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14774943|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14774944|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14774945|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14774946|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774947|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774948|NCT00656552|Citalopram|citalopram|mesh-list
14774949|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14774950|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14774951|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14774952|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203467|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203468|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203469|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
14203470|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203471|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
14203472|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203473|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203474|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14203475|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14203476|NCT03243058|Aldesleukin|aldesleukin|mesh-list
14774953|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203477|NCT03243058|Interleukin-2|interleukin-2|mesh-list
14499631|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
14499632|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14203478|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203479|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14499664|NCT03942211|Selexipag|selexipag|mesh-list
14499665|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14774954|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
14203480|NCT03243058|Analgesics|analgesics|mesh-ancestor
14203481|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
14203482|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203483|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203484|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14203485|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14203486|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
14203487|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203488|NCT03230838|Meropenem|meropenem|mesh-list
14203489|NCT03230838|Tazobactam|tazobactam|mesh-list
14203490|NCT03230838|Ceftolozane|ceftolozane|mesh-list
14203491|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14203492|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14203493|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203494|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14203495|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203496|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203497|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14203498|NCT03230838|Renal Agents|renal agents|mesh-ancestor
14203499|NCT03113955|Epirubicin|epirubicin|mesh-list
14203500|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14203501|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203502|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14203503|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14203504|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203505|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203506|NCT03034096|Propofol|propofol|mesh-list
14203507|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14203508|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14203509|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203510|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14203511|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
14203512|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
14203513|NCT03029234|Dexamethasone|dexamethasone|mesh-list
14203514|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14203515|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
14203516|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
14203517|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203518|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203519|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14203520|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
14203521|NCT03029234|Hormones|hormones|mesh-ancestor
14203522|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203523|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14203524|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203525|NCT03016338|Niraparib|niraparib|mesh-list
14203526|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14203527|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203528|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203529|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203530|NCT02995694|Estradiol|estradiol|mesh-list
14203531|NCT02995694|Estrogens|estrogens|mesh-ancestor
14203532|NCT02995694|Hormones|hormones|mesh-ancestor
14203533|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14203534|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203535|NCT02983045|Paclitaxel|paclitaxel|mesh-list
14203536|NCT02983045|Cisplatin|cisplatin|mesh-list
14203537|NCT02983045|Carboplatin|carboplatin|mesh-list
14203538|NCT02983045|Nivolumab|nivolumab|mesh-list
14203539|NCT02983045|Pemetrexed|pemetrexed|mesh-list
14203540|NCT02983045|Ipilimumab|ipilimumab|mesh-list
14203541|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14203542|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203543|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
14203544|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
14203545|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
14203546|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203547|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203548|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14203549|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203550|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14203551|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14203552|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
14203553|NCT02926833|Fludarabine|fludarabine|mesh-list
14203554|NCT02926833|Atezolizumab|atezolizumab|mesh-list
14203555|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14203556|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
14203557|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203558|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203559|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203560|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
14203561|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203562|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203563|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14239890|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239891|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14239892|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
14239893|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239894|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239895|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14239896|NCT00150462|Dexamethasone|dexamethasone|mesh-list
14239897|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239898|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
14239899|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
14239900|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239901|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239902|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14239903|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
14239904|NCT00150462|Hormones|hormones|mesh-ancestor
14239905|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239906|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239907|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239908|NCT00150592|Guanfacine|guanfacine|mesh-list
14239909|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14239910|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14239911|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14239912|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14239913|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
14239914|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239915|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239916|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239917|NCT00150618|Guanfacine|guanfacine|mesh-list
14239918|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14239919|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14239920|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14239921|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14239922|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
14239923|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14239924|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499682|NCT03923725|Artesunate|artesunate|mesh-list
14499683|NCT03923725|Lumefantrine|lumefantrine|mesh-list
14499684|NCT03923725|Artemether|artemether|mesh-list
14499685|NCT03923725|Piperaquine|piperaquine|mesh-list
14499686|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14499687|NCT03923725|Amodiaquine|amodiaquine|mesh-list
14499688|NCT03923725|Mefloquine|mefloquine|mesh-list
14499689|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
14774955|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774956|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14774957|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
14774958|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14774959|NCT00656591|Methotrexate|methotrexate|mesh-list
14774960|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13964216|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13964217|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13964218|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964219|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964220|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13964221|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13964222|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964223|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13964224|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
13964225|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
14774961|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
14499690|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14499691|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14499692|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14499693|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499694|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
14499695|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
14499696|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14499697|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
14499698|NCT03923270|Durvalumab|durvalumab|mesh-list
14499699|NCT03923270|Olaparib|olaparib|mesh-list
14499700|NCT03923270|Tremelimumab|tremelimumab|mesh-list
14499701|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14499702|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499703|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499704|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14499705|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499706|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499707|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
14499708|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499709|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14499710|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14499711|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14203564|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
14203565|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14203566|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
14203567|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203568|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
14203569|NCT02698865|Protective Agents|protective agents|mesh-ancestor
14774962|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14774963|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774964|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14774965|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
14774966|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774967|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774968|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
14774969|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774970|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14774971|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774972|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
14774973|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774974|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14774975|NCT00656643|Sirolimus|sirolimus|mesh-list
14774976|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14774977|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774978|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14774979|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14774980|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
14203589|NCT02535325|Cisplatin|cisplatin|mesh-list
14203590|NCT02535325|Pemetrexed|pemetrexed|mesh-list
14499712|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499713|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499714|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14499715|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14499716|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499717|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
14499718|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203591|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499743|NCT03910621|Miglustat|miglustat|mesh-list
14499744|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499745|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499746|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14499747|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14499748|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
14499749|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203592|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203593|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203594|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14203595|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14203596|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
14203597|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499750|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14499751|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14499752|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774981|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14774982|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
14774983|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774984|NCT00656695|Cyclosporine|cyclosporine|mesh-list
14774985|NCT00656695|Cyclosporins|cyclosporins|mesh-list
14774986|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
14774987|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14774988|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
14774989|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14774990|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203598|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203599|NCT02257567|Rituximab|rituximab|mesh-list
14203600|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
14203601|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14203602|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14203603|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
14203604|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203605|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203606|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
14499771|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
14499772|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14499773|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14499774|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499775|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
14499776|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14499777|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774991|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14203607|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203608|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203609|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203610|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
14203611|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203612|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
14203613|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203614|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
14203615|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203616|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499807|NCT03904693|Tadalafil|tadalafil|mesh-list
14499808|NCT03904693|Macitentan|macitentan|mesh-list
14499809|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
14499810|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14499811|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14499812|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499813|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14774992|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
14774993|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14774994|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14774995|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14774996|NCT00656747|Amoxicillin|amoxicillin|mesh-list
14774997|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
14774998|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
14499814|NCT03904693|Urological Agents|urological agents|mesh-ancestor
14499815|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14499816|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14499817|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14499818|NCT03901963|Lenalidomide|lenalidomide|mesh-list
14499819|NCT03901963|Daratumumab|daratumumab|mesh-list
14499820|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
14499821|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499822|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14499823|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14499824|NCT03901963|Growth Substances|growth substances|mesh-ancestor
14774999|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
14203617|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14203618|NCT02129647|Axitinib|axitinib|mesh-list
14203619|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203620|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203621|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203622|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203623|NCT01959139|Leucovorin|leucovorin|mesh-list
14203624|NCT01959139|Fluorouracil|fluorouracil|mesh-list
14775000|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14775001|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14941497|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941498|NCT01499485|Diuretics|diuretics|mesh-ancestor
14941499|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
14941500|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499825|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
14499826|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941501|NCT01499589|Anesthetics|anesthetics|mesh-list
14203625|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
14203626|NCT01959139|Irinotecan|irinotecan|mesh-list
14203627|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
14203628|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775002|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14775003|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775004|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14203629|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
14203630|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203631|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203632|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203633|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14203634|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
14203635|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14203636|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14203637|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203638|NCT01959139|Antidotes|antidotes|mesh-ancestor
14203639|NCT01959139|Protective Agents|protective agents|mesh-ancestor
14203640|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
14203641|NCT01959139|Vitamins|vitamins|mesh-ancestor
14499827|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
14499828|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14775005|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14775006|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941502|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941503|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941504|NCT01499602|Norethindrone|norethindrone|mesh-list
14499829|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14499830|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499831|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
14499832|NCT03897621|Coagulants|coagulants|mesh-ancestor
14499833|NCT03897127|Cytarabine|cytarabine|mesh-list
14499834|NCT03897127|Daunorubicin|daunorubicin|mesh-list
14499835|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14499836|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
14499837|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499838|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499839|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
14499840|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14499841|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499842|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
14499843|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499844|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14499845|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14499846|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14499847|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499848|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
14499849|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14499850|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
14499851|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14499852|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
14499853|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499854|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499855|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
14499856|NCT03871829|Dexamethasone|dexamethasone|mesh-list
14775007|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775008|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775009|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14775010|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
14775011|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14775012|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775013|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14775014|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14941505|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
14941506|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14941507|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
14941508|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14775015|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14775016|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14775017|NCT00656773|Sufentanil|sufentanil|mesh-list
14775018|NCT00656773|Morphine|morphine|mesh-list
14775019|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14941509|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203642|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
14203643|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
14499857|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
14499858|NCT03871829|BB 1101|bb 1101|mesh-list
14775020|NCT00656773|Narcotics|narcotics|mesh-ancestor
14775021|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775022|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775023|NCT00656773|Analgesics|analgesics|mesh-ancestor
14775024|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
14203644|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14499859|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14499860|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
14499861|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
14499862|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14499863|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499864|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14499865|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
14499866|NCT03871829|Hormones|hormones|mesh-ancestor
14499867|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14499868|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14499869|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499870|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
14499871|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499872|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203645|NCT01870193|Glycine|glycine|mesh-list
14203646|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
14203647|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203648|NCT01870193|Expectorants|expectorants|mesh-ancestor
14203649|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
14203650|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14203651|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
14203652|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203653|NCT01870193|Protective Agents|protective agents|mesh-ancestor
14203654|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203655|NCT01870193|Antidotes|antidotes|mesh-ancestor
14499908|NCT03847649|Prednisone|prednisone|mesh-list
14499909|NCT03847649|Durvalumab|durvalumab|mesh-list
14499910|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14499911|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
14499912|NCT03847649|Hormones|hormones|mesh-ancestor
14499913|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14499914|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203656|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
14499915|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14499916|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499917|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499921|NCT03816345|Nivolumab|nivolumab|mesh-list
14499922|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14499923|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14499924|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14499925|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775025|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775026|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14775027|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14775028|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
14775029|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
14941510|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14203657|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203658|NCT01805284|Linezolid|linezolid|mesh-list
14203659|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14203660|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203661|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14203662|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203663|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203664|NCT01522976|Lenalidomide|lenalidomide|mesh-list
14203665|NCT01522976|Azacitidine|azacitidine|mesh-list
14203666|NCT01522976|Vorinostat|vorinostat|mesh-list
14203667|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
14203668|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203669|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203670|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14203671|NCT01522976|Growth Substances|growth substances|mesh-ancestor
14203672|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
14775030|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
14775031|NCT00656786|Vitamin K|vitamin k|mesh-list
14775032|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14775033|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14941511|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14941512|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14941513|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14941514|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
14775034|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775035|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
14775036|NCT00656786|Coagulants|coagulants|mesh-ancestor
14775037|NCT00656786|Vitamins|vitamins|mesh-ancestor
14775038|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
14775039|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775040|NCT00656812|Rituximab|rituximab|mesh-list
14775041|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14775042|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775043|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
14775044|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775045|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203673|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203674|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203675|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
14941515|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14941516|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14941517|NCT01499641|Prednisolone|prednisolone|mesh-list
14941518|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
14941519|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14941520|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
14941521|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941522|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
14941523|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
14941524|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941525|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941526|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14941527|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
14941528|NCT01499641|Hormones|hormones|mesh-ancestor
14941529|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941530|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14941531|NCT01499641|Protective Agents|protective agents|mesh-ancestor
14941532|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14941533|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941534|NCT01499693|Pantoprazole|pantoprazole|mesh-list
14941535|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14941536|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14941537|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14941538|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941539|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203676|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203677|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203678|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14499981|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
14499982|NCT03797196|Everolimus|everolimus|mesh-list
14499983|NCT03797196|Tacrolimus|tacrolimus|mesh-list
14499984|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14499985|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
14499986|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14499987|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14499988|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14499989|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14499990|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775046|NCT00656864|Pioglitazone|pioglitazone|mesh-list
14775047|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775048|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775049|NCT00656929|Vitamin D|vitamin d|mesh-list
14775050|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
14499991|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14499992|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14499993|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
14499994|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14499995|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500031|NCT03782415|Temozolomide|temozolomide|mesh-list
14500032|NCT03782415|Ibudilast|ibudilast|mesh-list
14500033|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14500034|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
14500035|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500036|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500037|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14500038|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
14500039|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500040|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500041|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14500042|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
14500043|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14500044|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500045|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14500046|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
14203691|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
14203692|NCT01286272|Bortezomib|bortezomib|mesh-list
14203693|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14203694|NCT01286272|Ofatumumab|ofatumumab|mesh-list
14203695|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14203696|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14203697|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203698|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203699|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
14203700|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203701|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14203702|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
14203703|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
14203704|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203705|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
14203706|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203707|NCT01145495|Rituximab|rituximab|mesh-list
14203708|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14203709|NCT01145495|Lenalidomide|lenalidomide|mesh-list
14203710|NCT01145495|Antibodies|antibodies|mesh-list
14203711|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
14203712|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14203713|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
14203714|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203715|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203716|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203717|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203718|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14203719|NCT01145495|Growth Substances|growth substances|mesh-ancestor
14203720|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
14203721|NCT01139970|Temozolomide|temozolomide|mesh-list
14203722|NCT01139970|Veliparib|veliparib|mesh-list
14203723|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203724|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
14203725|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203726|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203727|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14203728|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203729|NCT01134601|Capecitabine|capecitabine|mesh-list
14203730|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203731|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
14203732|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203733|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203734|NCT00731731|Temozolomide|temozolomide|mesh-list
14203735|NCT00731731|Vorinostat|vorinostat|mesh-list
14203736|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203737|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
14203738|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203739|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203740|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14203741|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203742|NCT00588991|Carboplatin|carboplatin|mesh-list
14203743|NCT00588991|Topotecan|topotecan|mesh-list
14203744|NCT00588991|Veliparib|veliparib|mesh-list
14203745|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203746|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14203747|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14203748|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203749|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203750|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14500067|NCT03773302|Gemcitabine|gemcitabine|mesh-list
14500068|NCT03773302|Infigratinib|infigratinib|mesh-list
14500069|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500070|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14500071|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
14500072|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500073|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
14500074|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500075|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500076|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500077|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
14500078|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500079|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14500080|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14500081|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775051|NCT00656929|Vitamins|vitamins|mesh-ancestor
14775052|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
14775053|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775054|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14775055|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14775056|NCT00657007|Belimumab|belimumab|mesh-list
14775057|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775058|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
14941540|NCT01499758|Atorvastatin|atorvastatin|mesh-list
14941541|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14941542|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14941543|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
14941544|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941545|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14941546|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14203751|NCT00336063|Azacitidine|azacitidine|mesh-list
14203752|NCT00336063|Vorinostat|vorinostat|mesh-list
14203753|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203754|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
14203755|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203756|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203757|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203758|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14203767|NCT00095784|Decitabine|decitabine|mesh-list
14203768|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203769|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
14203770|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203771|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203772|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941547|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203773|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
14203774|NCT00070499|Dasatinib|dasatinib|mesh-list
14203775|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203776|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203777|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203778|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239925|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239926|NCT00150800|Brivaracetam|brivaracetam|mesh-list
14239927|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
14239928|NCT00150813|Levetiracetam|levetiracetam|mesh-list
14239929|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
14239930|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
14239931|NCT00150969|Vitamin K|vitamin k|mesh-list
14239932|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
14941548|NCT01499771|Atorvastatin|atorvastatin|mesh-list
14239933|NCT00150969|Vitamins|vitamins|mesh-ancestor
14239934|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
14941549|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14203779|NCT04515134|Ubiquinone|ubiquinone|mesh-list
14203780|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
14203781|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
14203782|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203783|NCT04515134|Vitamins|vitamins|mesh-ancestor
14203784|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14203785|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14203786|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203787|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
14203788|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
14203789|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14775059|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775060|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14775061|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775062|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14775063|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14775064|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775065|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775066|NCT00657033|Urological Agents|urological agents|mesh-ancestor
14775067|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
14775068|NCT00657059|Prednisone|prednisone|mesh-list
14775069|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
14775070|NCT00657059|Irbesartan|irbesartan|mesh-list
14775071|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775072|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
14775073|NCT00657059|Hormones|hormones|mesh-ancestor
14775074|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775075|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775076|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14775077|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775078|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14775079|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14775080|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
14941550|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14941551|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
14941552|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941553|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14203790|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14500098|NCT03743766|Nivolumab|nivolumab|mesh-list
14500099|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500100|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500101|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14500102|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775081|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14203791|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203792|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203793|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203794|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239935|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239936|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14239937|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14239938|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239939|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
14239940|NCT00150969|Coagulants|coagulants|mesh-ancestor
14239941|NCT00151281|Thalidomide|thalidomide|mesh-list
14239942|NCT00151281|Prednisone|prednisone|mesh-list
14239943|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
14239944|NCT00151281|Rituximab|rituximab|mesh-list
14239945|NCT00151281|Etoposide|etoposide|mesh-list
14239946|NCT00151281|Procarbazine|procarbazine|mesh-list
14239947|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775082|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941554|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14239948|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
14239949|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239950|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14941555|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941556|NCT01499875|Penicillin V|penicillin v|mesh-list
14941557|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14941558|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775083|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775084|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775085|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
14775086|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
14775087|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775088|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14775089|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14775090|NCT00657059|Protective Agents|protective agents|mesh-ancestor
14775091|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14775092|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14775093|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14775094|NCT00657137|Capecitabine|capecitabine|mesh-list
14775095|NCT00657137|Lapatinib|lapatinib|mesh-list
14775096|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775097|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
14775098|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775099|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775100|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14775101|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775102|NCT00657163|Fluoxetine|fluoxetine|mesh-list
14775103|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14775104|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14775105|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14775106|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941559|NCT01499914|Vaccines|vaccines|mesh-list
14203795|NCT04489433|Trametinib|trametinib|mesh-list
14203796|NCT04489433|Dabrafenib|dabrafenib|mesh-list
14203797|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203798|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203799|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203800|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203801|NCT04488237|Vitamin D|vitamin d|mesh-list
14203802|NCT04488237|Vitamins|vitamins|mesh-ancestor
14203803|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
14941560|NCT01499914|Immunologic Factors|immunologic factors|mesh-ancestor
14941561|NCT01499914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941562|NCT01499953|PENTA|penta|mesh-list
14941563|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
14941564|NCT01499953|Fondaparinux|fondaparinux|mesh-list
14941565|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14941566|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
14941567|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14941568|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
14941569|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941570|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941571|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
14941572|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14203804|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203805|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14203806|NCT04484363|Azacitidine|azacitidine|mesh-list
14203807|NCT04484363|Pevonedistat|pevonedistat|mesh-list
14203808|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203809|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
14203810|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203811|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203812|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203813|NCT04482361|Antibodies|antibodies|mesh-list
14203814|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
14203815|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203816|NCT04477382|Tretinoin|tretinoin|mesh-list
14203817|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203818|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
14203819|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14239951|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14239952|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
14239953|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239954|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239955|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14239956|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239957|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239958|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
14239959|NCT00151281|Hormones|hormones|mesh-ancestor
14239960|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14239961|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14239962|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14203820|NCT04455776|Propofol|propofol|mesh-list
14203821|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14203822|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775107|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203823|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203824|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14203825|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
14203826|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
14239963|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14775108|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
14775109|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775110|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14775111|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
14775112|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14500120|NCT03735628|Nivolumab|nivolumab|mesh-list
14500121|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239964|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14239965|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500122|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500123|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14500124|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775113|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14239966|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
14239967|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14239968|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14239969|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14239970|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14239971|NCT00151281|Growth Substances|growth substances|mesh-ancestor
14239972|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
14239973|NCT00151320|Rituximab|rituximab|mesh-list
14239974|NCT00151320|Bortezomib|bortezomib|mesh-list
14239975|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14239976|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14239977|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
14239978|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239979|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239980|NCT00151411|Metformin|metformin|mesh-list
14239981|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14239982|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239983|NCT00151476|Celecoxib|celecoxib|mesh-list
14239984|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14239985|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14239986|NCT00151476|Analgesics|analgesics|mesh-ancestor
14239987|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
14239988|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14239989|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14239990|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14239991|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14239992|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14239993|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14239994|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14239995|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14239996|NCT00151775|Olmesartan|olmesartan|mesh-list
14239997|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14239998|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14239999|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14500133|NCT03701763|Apremilast|apremilast|mesh-list
14500134|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14500135|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14500136|NCT03701763|Analgesics|analgesics|mesh-ancestor
14500137|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
14500138|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500139|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500140|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14500141|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14500142|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14500143|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14500144|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500145|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500146|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14500147|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500148|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775114|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14775115|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775116|NCT00657202|Ranibizumab|ranibizumab|mesh-list
14775117|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14775118|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14775119|NCT00657202|Growth Substances|growth substances|mesh-ancestor
14775120|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775121|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
14775122|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941573|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14941574|NCT01500005|Vitamin D|vitamin d|mesh-list
14941575|NCT01500005|Vitamins|vitamins|mesh-ancestor
14500161|NCT03628716|Atezolizumab|atezolizumab|mesh-list
14500162|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500163|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
14500164|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14500165|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500166|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14500167|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500168|NCT03611738|Docetaxel|docetaxel|mesh-list
14500169|NCT03611738|Ceritinib|ceritinib|mesh-list
14500170|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500171|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
14500172|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
14500173|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
14500174|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500175|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14500176|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941576|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
14941577|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941578|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14941579|NCT01500018|Phentermine|phentermine|mesh-list
14941580|NCT01500018|Ketamine|ketamine|mesh-list
14941581|NCT01500018|Analgesics|analgesics|mesh-ancestor
14941582|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
14941583|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941584|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941585|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14941586|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14941587|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
14203827|NCT04446793|Bevacizumab|bevacizumab|mesh-list
14203828|NCT04446793|Onvansertib|onvansertib|mesh-list
14203829|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203830|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203831|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203832|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14203833|NCT04446793|Growth Substances|growth substances|mesh-ancestor
14203834|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203835|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
14203836|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14203837|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203838|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203839|NCT04445415|Antibodies|antibodies|mesh-list
14203840|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
14203841|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240000|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14240001|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240002|NCT00151814|Olmesartan|olmesartan|mesh-list
14240003|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14240004|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14240005|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14240006|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14240007|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240008|NCT00151892|Mesalamine|mesalamine|mesh-list
14240009|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14240010|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14240011|NCT00151892|Analgesics|analgesics|mesh-ancestor
14240012|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
14240013|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240014|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240015|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240016|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240017|NCT00151996|Guanfacine|guanfacine|mesh-list
14240018|NCT00151996|Methylphenidate|methylphenidate|mesh-list
14240019|NCT00151996|Amphetamine|amphetamine|mesh-list
14240020|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14240021|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500201|NCT03598309|Curcumin|curcumin|mesh-list
14500202|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14500203|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14500204|NCT03598309|Analgesics|analgesics|mesh-ancestor
14500205|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
14500206|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500207|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500208|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14500209|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14500210|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500211|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500212|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500213|NCT03581409|Aspirin|aspirin|mesh-list
14500214|NCT03581409|Cilostazol|cilostazol|mesh-list
14775123|NCT00657228|Heparin|heparin|mesh-list
14775124|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
14240022|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14240023|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14240024|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240025|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240026|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
14240027|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240028|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
14240029|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
14243140|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
14500215|NCT03581409|Clopidogrel|clopidogrel|mesh-list
14775125|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14775126|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14775127|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775128|NCT00657241|Valsartan|valsartan|mesh-list
14775129|NCT00657241|Carvedilol|carvedilol|mesh-list
14775130|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14775131|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14775132|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14775133|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775134|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14775135|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14775136|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
14775137|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775138|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775139|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
14775140|NCT00657241|Protective Agents|protective agents|mesh-ancestor
14775141|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14500216|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14203842|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14203843|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
14203844|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500217|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14500218|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14500219|NCT03581409|Analgesics|analgesics|mesh-ancestor
14500220|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
14500221|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500222|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500223|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14500224|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14500225|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14500226|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14500227|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500228|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14500229|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14500230|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500231|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
14500232|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14941588|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
14941589|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941590|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14941591|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14941592|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941593|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941594|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14500233|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14941595|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
14941596|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14941597|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
14941598|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
14203845|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
14240030|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240031|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14240032|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14240033|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14240034|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14240035|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14240036|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14240037|NCT00152009|Guanfacine|guanfacine|mesh-list
14500234|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14500235|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
14500236|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14500237|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14500238|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
14500239|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14500240|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
14500241|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
14500242|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14500243|NCT03581409|Protective Agents|protective agents|mesh-ancestor
14203846|NCT04407572|Vitamin D|vitamin d|mesh-list
14203847|NCT04407572|Vitamins|vitamins|mesh-list
14203848|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
14203849|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
14203850|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
14203851|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203852|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14203853|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
14203854|NCT04407572|Hematinics|hematinics|mesh-ancestor
14203855|NCT04405284|Disinfectants|disinfectants|mesh-list
14500244|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14500245|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14500246|NCT03574779|Paclitaxel|paclitaxel|mesh-list
14500247|NCT03574779|Bevacizumab|bevacizumab|mesh-list
14500248|NCT03574779|Carboplatin|carboplatin|mesh-list
14500249|NCT03574779|Niraparib|niraparib|mesh-list
14500250|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14500251|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500252|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
14500253|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
14500254|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
14500255|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500256|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500257|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14500258|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14500259|NCT03574779|Growth Substances|growth substances|mesh-ancestor
14500260|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500261|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
14203856|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240038|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14500262|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14500263|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500264|NCT03566667|Metoprolol|metoprolol|mesh-list
14500265|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14500266|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14500267|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
14500268|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
14500269|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500270|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500271|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14500272|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14500273|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14500274|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
14500275|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14500276|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500277|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14500278|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14500279|NCT03556800|Estradiol|estradiol|mesh-list
14500280|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14240039|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14240040|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14240041|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14240042|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
14240043|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240044|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240045|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240046|NCT00152464|Levocetirizine|levocetirizine|mesh-list
14240047|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14240048|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14500281|NCT03556800|Estrogens|estrogens|mesh-ancestor
14500282|NCT03556800|Hormones|hormones|mesh-ancestor
14500283|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14500284|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500285|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14500286|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
14500287|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14500288|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14240049|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
14240050|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
14243141|NCT00193180|Docetaxel|docetaxel|mesh-list
14500298|NCT03532217|Nivolumab|nivolumab|mesh-list
14500299|NCT03532217|Ipilimumab|ipilimumab|mesh-list
14500300|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500301|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500302|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14500303|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775142|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14775143|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14775144|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775145|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14775146|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14775147|NCT00657254|Sorafenib|sorafenib|mesh-list
14775148|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775149|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14775150|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775151|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775152|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
14775153|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775154|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
14775155|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
14775156|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14775157|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775158|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775159|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
14775160|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14775161|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14775162|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775163|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
14775164|NCT00657384|Coagulants|coagulants|mesh-ancestor
14775165|NCT00657397|Methadone|methadone|mesh-list
14775166|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14775167|NCT00657397|Narcotics|narcotics|mesh-ancestor
14775168|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775169|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775170|NCT00657397|Analgesics|analgesics|mesh-ancestor
14775171|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
14775172|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775173|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
14775174|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
14775175|NCT00657410|Dexamethasone|dexamethasone|mesh-list
14775176|NCT00657410|Prednisone|prednisone|mesh-list
14775177|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775178|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
14775179|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
14775180|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775181|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775182|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14775183|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
14775184|NCT00657410|Hormones|hormones|mesh-ancestor
14775185|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775186|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14775187|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775188|NCT00657423|Cisplatin|cisplatin|mesh-list
14775189|NCT00657423|Docetaxel|docetaxel|mesh-list
14775190|NCT00657423|Endostar protein|endostar protein|mesh-list
14775191|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775192|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
14775193|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
14775194|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
14775195|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775196|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14775197|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14775198|NCT00657423|Growth Substances|growth substances|mesh-ancestor
14775199|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203857|NCT04397302|Valsartan|valsartan|mesh-list
14203858|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14500317|NCT03519256|Nivolumab|nivolumab|mesh-list
14500318|NCT03519256|Linrodostat|linrodostat|mesh-list
14500319|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500320|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500321|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14500322|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500323|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500324|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
14500325|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
14203859|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14500326|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14500327|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
14500328|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500329|NCT03510741|Expectorants|expectorants|mesh-ancestor
14500330|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
14500331|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14500332|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
14500333|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500334|NCT03510741|Protective Agents|protective agents|mesh-ancestor
14500335|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500336|NCT03510741|Antidotes|antidotes|mesh-ancestor
14500337|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
14500355|NCT03503513|Gentamicins|gentamicins|mesh-list
14500356|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14500357|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500358|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14500359|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500360|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500361|NCT03492177|Selexipag|selexipag|mesh-list
14500362|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14775200|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
14807376|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203860|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14203861|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203862|NCT04396587|Sufentanil|sufentanil|mesh-list
14203863|NCT04396587|Oxycodone|oxycodone|mesh-list
14203864|NCT04396587|Hydromorphone|hydromorphone|mesh-list
14203865|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14203866|NCT04396587|Narcotics|narcotics|mesh-ancestor
14775201|NCT00657449|Valdecoxib|valdecoxib|mesh-list
14775202|NCT00657449|Rofecoxib|rofecoxib|mesh-list
14775203|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14775204|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14775205|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775206|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775207|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14775208|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14775209|NCT00657449|Analgesics|analgesics|mesh-ancestor
14941599|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
14941600|NCT01500070|Everolimus|everolimus|mesh-list
14941601|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941602|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941603|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
14941604|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941605|NCT01500161|Cytarabine|cytarabine|mesh-list
14941606|NCT01500161|Fludarabine|fludarabine|mesh-list
14941607|NCT01500161|Etoposide|etoposide|mesh-list
14941608|NCT01500161|Melphalan|melphalan|mesh-list
14941609|NCT01500161|Busulfan|busulfan|mesh-list
14941610|NCT01500161|Carmustine|carmustine|mesh-list
14941611|NCT01500161|Clofarabine|clofarabine|mesh-list
14941612|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941613|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14941614|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
14941615|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941616|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941617|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
14941618|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941619|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14941620|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14941621|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14941622|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941623|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
14941624|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941625|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14941626|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
14941627|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14941628|NCT01500408|Interferons|interferons|mesh-list
14941629|NCT01500408|Interferon-beta|interferon-beta|mesh-list
14941630|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
14941631|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941632|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
14941633|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941634|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
14941635|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203867|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14203868|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203869|NCT04396587|Analgesics|analgesics|mesh-ancestor
14203870|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
14203871|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203872|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14203873|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14203874|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
14203875|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
14203876|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14203877|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14203878|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
14203879|NCT04389294|Antibodies|antibodies|mesh-list
14203880|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
14203881|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203882|NCT04381091|Idebenone|idebenone|mesh-list
14203883|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
13964226|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
13964227|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
13964228|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964229|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964230|NCT03139331|Irinotecan|irinotecan|mesh-list
13964231|NCT03139331|Temozolomide|temozolomide|mesh-list
13964232|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13964233|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13964234|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964235|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964236|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964237|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13964238|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
14775210|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
14775211|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775212|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775213|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775214|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14775215|NCT00657475|Heparin|heparin|mesh-list
14775216|NCT00657475|Calcium heparin|calcium heparin|mesh-list
14775217|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
14775218|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14775219|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14775220|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775221|NCT00657488|Thalidomide|thalidomide|mesh-list
14775222|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775223|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
14775224|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775225|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
14775226|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14775227|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775228|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14775229|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14775230|NCT00657488|Growth Substances|growth substances|mesh-ancestor
14775231|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
14775232|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775233|NCT00657514|Ranolazine|ranolazine|mesh-list
14775234|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14775235|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14775236|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775237|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14775238|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14941636|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14941637|NCT01500473|Desogestrel|desogestrel|mesh-list
14941638|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14941639|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14203884|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203885|NCT04381091|Protective Agents|protective agents|mesh-ancestor
14203886|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240051|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240052|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240053|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240054|NCT00152516|Levetiracetam|levetiracetam|mesh-list
14240055|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
14240056|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
14240057|NCT00152971|Enoxaparin|enoxaparin|mesh-list
14240058|NCT00152971|Dabigatran|dabigatran|mesh-list
14240059|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
14240060|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14240061|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14240062|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240063|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
14240064|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14240065|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
14240066|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240067|NCT00153062|Telmisartan|telmisartan|mesh-list
14240068|NCT00153062|Clopidogrel|clopidogrel|mesh-list
14240069|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
14240070|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14240071|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14240072|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14240073|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14240074|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
14240075|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240076|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240077|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240078|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14240079|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14240080|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14240081|NCT00153101|Telmisartan|telmisartan|mesh-list
14240082|NCT00153101|Ramipril|ramipril|mesh-list
14240083|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14240084|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14240085|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14240086|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775239|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14500383|NCT03473743|Carboplatin|carboplatin|mesh-list
14500384|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500385|NCT03472495|Diltiazem|diltiazem|mesh-list
14500386|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14500387|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14500388|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14500389|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203887|NCT04377295|Ranibizumab|ranibizumab|mesh-list
14203888|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203889|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14203890|NCT04377295|Growth Substances|growth substances|mesh-ancestor
14203891|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500390|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14500391|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500392|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775240|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
14775241|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775242|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14500393|NCT03451851|Etanercept|etanercept|mesh-list
14500394|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14500395|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14500396|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14500397|NCT03451851|Analgesics|analgesics|mesh-ancestor
14775243|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14775244|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775245|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14775246|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14203892|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
14203893|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203894|NCT04374123|Antibodies|antibodies|mesh-list
14203895|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
14775247|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775248|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
14775249|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14775250|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14775251|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14775252|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775253|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14203896|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
14203897|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775254|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14775255|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775256|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775257|NCT00657644|Urological Agents|urological agents|mesh-ancestor
14775258|NCT00657748|Triacetin|triacetin|mesh-list
14775259|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
14775260|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
14775261|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775262|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775263|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775264|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
14941640|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14941641|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
14941642|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14941643|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941644|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14941645|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14941646|NCT01500473|Progestins|progestins|mesh-ancestor
14941647|NCT01500473|Hormones|hormones|mesh-ancestor
14941648|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941649|NCT01500538|Vorinostat|vorinostat|mesh-list
14941650|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941651|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14941652|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941653|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941654|NCT01500577|Nimesulide|nimesulide|mesh-list
14941655|NCT01500577|Simvastatin|simvastatin|mesh-list
14941656|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14203898|NCT04367688|Tenofovir|tenofovir|mesh-list
14203899|NCT04367688|Emtricitabine|emtricitabine|mesh-list
14203900|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
14203901|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203902|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14203903|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14203904|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203905|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775265|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14775266|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775267|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203906|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14203907|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14203908|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
14203909|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14203910|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
14203911|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203912|NCT04365725|Remdesivir|remdesivir|mesh-list
14203913|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
14203914|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203915|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
14203916|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240087|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14240088|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
14775268|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
14775269|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775270|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
14775271|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14775272|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14775273|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775274|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14775275|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14775276|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
14775277|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775278|NCT00657774|Prednisone|prednisone|mesh-list
14775279|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775280|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
14775281|NCT00657774|Hormones|hormones|mesh-ancestor
14775282|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775283|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775284|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14775285|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775286|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14775287|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775288|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14775289|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14775290|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775291|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775292|NCT00657839|Urological Agents|urological agents|mesh-ancestor
14941657|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14240089|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240090|NCT00153166|Pioglitazone|pioglitazone|mesh-list
14240091|NCT00153166|Atorvastatin|atorvastatin|mesh-list
14240092|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14240093|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14240094|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
14240095|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240096|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14240097|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14240098|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240099|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14240100|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240101|NCT00153179|Acipimox|acipimox|mesh-list
14240102|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14240103|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
14240104|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240105|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14240106|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14240107|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240108|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14240109|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240110|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240111|NCT00153816|Vitamin D|vitamin d|mesh-list
14240112|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
14240113|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
14203917|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
14203918|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14203919|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
14203920|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203921|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203922|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14203923|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
14500398|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
14500399|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500400|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500401|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14500402|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14500403|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14500404|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500405|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
14500427|NCT03425643|Gemcitabine|gemcitabine|mesh-list
14500428|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
14775293|NCT00657852|Pamidronate|pamidronate|mesh-list
14775294|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14775295|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775296|NCT00657865|Ramipril|ramipril|mesh-list
14775297|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14775298|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
14775299|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203924|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14203925|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
14203926|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775300|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775301|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14775302|NCT00657878|Gemcitabine|gemcitabine|mesh-list
14775303|NCT00657878|Paclitaxel|paclitaxel|mesh-list
14775304|NCT00657878|Carboplatin|carboplatin|mesh-list
14775305|NCT00657878|Doxorubicin|doxorubicin|mesh-list
14775306|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14775307|NCT00657878|Topotecan|topotecan|mesh-list
14203927|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14203928|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14203929|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
14203930|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
14203931|NCT04358588|Protective Agents|protective agents|mesh-ancestor
14203932|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14203933|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14203934|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14203935|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14203936|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203937|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
14203938|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775308|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14203939|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203940|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
14203941|NCT04350021|Capecitabine|capecitabine|mesh-list
14775309|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775310|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
14203942|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500429|NCT03425643|Pemetrexed|pemetrexed|mesh-list
14500430|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500431|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14500432|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
14500433|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500434|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
14500435|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500436|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500437|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500438|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
14775311|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
14775312|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
14775313|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775314|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775315|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
14775316|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
14775317|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775318|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775319|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775320|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
14775321|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775322|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14775323|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14203943|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
14203944|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203945|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14203946|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14203947|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
14203948|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775324|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14775325|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14775326|NCT00657891|Omalizumab|omalizumab|mesh-list
13964239|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13964240|NCT03138759|Probenecid|probenecid|mesh-list
13964241|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
14203949|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203950|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14203951|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14203952|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
14203953|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14203954|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
14203955|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240114|NCT00153816|Calcium|calcium|mesh-list
14240115|NCT00153816|Vitamins|vitamins|mesh-ancestor
14240116|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
14240117|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240118|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13964242|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
13964243|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13964244|NCT03138759|Renal Agents|renal agents|mesh-ancestor
13964245|NCT03138603|Metoprolol|metoprolol|mesh-list
13964246|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13964247|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13964248|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
14240119|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14240120|NCT00153816|Antacids|antacids|mesh-ancestor
14240121|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240122|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240123|NCT00153842|Bexarotene|bexarotene|mesh-list
14240124|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240125|NCT00153920|Bortezomib|bortezomib|mesh-list
14240126|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240127|NCT00153985|Fludarabine|fludarabine|mesh-list
14240128|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
14240129|NCT00153985|Busulfan|busulfan|mesh-list
14240130|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240131|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240132|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240133|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
14240134|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240135|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240136|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
14240137|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14240138|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14240139|NCT00154102|Leucovorin|leucovorin|mesh-list
14240140|NCT00154102|Folic Acid|folic acid|mesh-list
14775327|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14775328|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14775329|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
14775330|NCT00657904|Bicalutamide|bicalutamide|mesh-list
14500439|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500440|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500441|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14500442|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14500443|NCT03422328|Macitentan|macitentan|mesh-list
14500444|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14500445|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14500446|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500447|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14775331|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
14775332|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
14775333|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775334|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775335|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775336|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
14775337|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775338|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775339|NCT00657943|Insulin|insulin|mesh-list
14775340|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14941658|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
14203956|NCT04334837|Copper|copper|mesh-list
14500466|NCT03392376|Haloperidol|haloperidol|mesh-list
14500467|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
14500468|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
14500469|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
14500470|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500471|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500472|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14500473|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14500474|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14500475|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14500476|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14500477|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14500478|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
14500479|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941659|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203957|NCT04334837|Trace Elements|trace elements|mesh-ancestor
14203958|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
14203959|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203960|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
14240141|NCT00154102|Fluorouracil|fluorouracil|mesh-list
14240142|NCT00154102|Irinotecan|irinotecan|mesh-list
14240143|NCT00154102|Cetuximab|cetuximab|mesh-list
14240144|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
14240145|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
14240146|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240147|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14240148|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240149|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240150|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
14500480|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500481|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14775341|NCT00657943|Metformin|metformin|mesh-list
14941660|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14240151|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941661|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14941662|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941663|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14941664|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14941665|NCT01500577|Analgesics|analgesics|mesh-ancestor
14941666|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
14941667|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941668|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941669|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941670|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14941671|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14941672|NCT01500590|Ramipril|ramipril|mesh-list
14941673|NCT01500590|Irbesartan|irbesartan|mesh-list
14941674|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14941675|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14775342|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
14775343|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
14775344|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14775345|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
14775346|NCT00657943|Protamines|protamines|mesh-list
14775347|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775348|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203961|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14203962|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203963|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203964|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14203965|NCT04321733|Amoxicillin|amoxicillin|mesh-list
14203966|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
14203967|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
14203968|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14203969|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14203970|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14203971|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14203972|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14203973|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14203974|NCT04319341|Autoantibodies|autoantibodies|mesh-list
14203975|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
14203976|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203977|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14203978|NCT04318405|Hematinics|hematinics|mesh-ancestor
14203979|NCT04314336|Coal Tar|coal tar|mesh-list
14203980|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
14203981|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14203982|NCT04312555|Alprostadil|alprostadil|mesh-list
14203983|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14203984|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
14203985|NCT04312555|Urological Agents|urological agents|mesh-ancestor
14203986|NCT04310631|Ranibizumab|ranibizumab|mesh-list
14203987|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14203988|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14203989|NCT04310631|Growth Substances|growth substances|mesh-ancestor
14203990|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203991|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
14243142|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
14243143|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243144|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243145|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243146|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243147|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243148|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14243149|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243150|NCT00193206|Gemcitabine|gemcitabine|mesh-list
14243151|NCT00193206|Paclitaxel|paclitaxel|mesh-list
14243152|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14243153|NCT00193206|Epirubicin|epirubicin|mesh-list
14243154|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14243155|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243156|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243157|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243158|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243159|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243160|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243161|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
14243162|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
14243163|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243164|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243165|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243166|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
14243167|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243168|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14243169|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14243170|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243171|NCT00193258|Bevacizumab|bevacizumab|mesh-list
14243172|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14243173|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
14243174|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243175|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243176|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14243177|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14243178|NCT00193258|Growth Substances|growth substances|mesh-ancestor
14203992|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240152|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14240153|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14240154|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240155|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240156|NCT00154102|Antidotes|antidotes|mesh-ancestor
14240157|NCT00154102|Protective Agents|protective agents|mesh-ancestor
14240158|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
14240159|NCT00154102|Vitamins|vitamins|mesh-ancestor
14240160|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
14240161|NCT00154102|Hematinics|hematinics|mesh-ancestor
14240162|NCT00154284|Cyclosporine|cyclosporine|mesh-list
14240163|NCT00154284|Prednisone|prednisone|mesh-list
14240164|NCT00154284|Everolimus|everolimus|mesh-list
14240165|NCT00154284|Cyclosporins|cyclosporins|mesh-list
14240166|NCT00154284|Basiliximab|basiliximab|mesh-list
14240167|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240168|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
14500488|NCT03381183|Durvalumab|durvalumab|mesh-list
14500489|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500490|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500491|NCT03377699|Insulin|insulin|mesh-list
14240169|NCT00154284|Hormones|hormones|mesh-ancestor
14240170|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240171|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240172|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14240173|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240174|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240175|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240176|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240177|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
14240178|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
14240179|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240180|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
14240181|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240182|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14240183|NCT00154297|Everolimus|everolimus|mesh-list
14240184|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240185|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240186|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
14240187|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240188|NCT00154310|Cyclosporine|cyclosporine|mesh-list
14240189|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
14240190|NCT00154310|Everolimus|everolimus|mesh-list
14240191|NCT00154310|Cyclosporins|cyclosporins|mesh-list
14240192|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240193|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240194|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240195|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
14500492|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14500493|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
14500494|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
14775349|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
14775350|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775351|NCT00657943|Coagulants|coagulants|mesh-ancestor
14775352|NCT00657982|Everolimus|everolimus|mesh-list
14775353|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775354|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500495|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14500496|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500497|NCT03377023|Nivolumab|nivolumab|mesh-list
14500498|NCT03377023|Ipilimumab|ipilimumab|mesh-list
14500499|NCT03377023|Nintedanib|nintedanib|mesh-list
14500500|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500501|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500502|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14500503|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240196|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240197|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
14240198|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500504|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14500505|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775355|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
14775356|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775357|NCT00657995|Pancrelipase|pancrelipase|mesh-list
14775358|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14775359|NCT00658099|Insulin|insulin|mesh-list
14775360|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14775361|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
14203993|NCT04302012|Mydriatics|mydriatics|mesh-list
14775362|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
14775363|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
14775364|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
14775365|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775366|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775367|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14775368|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
14500506|NCT03369223|Nivolumab|nivolumab|mesh-list
14500507|NCT03369223|Ipilimumab|ipilimumab|mesh-list
14500508|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14203994|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
14203995|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14203996|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14203997|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14203998|NCT04296253|Mitogens|mitogens|mesh-list
14203999|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
14204000|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204001|NCT04288713|Eculizumab|eculizumab|mesh-list
14204002|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14204003|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14204004|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
14204005|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204006|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14204007|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14204008|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204009|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
14240199|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
14240200|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240201|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14240202|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240203|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14240204|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14240205|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
14240206|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14240207|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
14240208|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
14240209|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775369|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14775370|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14240210|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14240211|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240212|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240213|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
14240214|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14500509|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500510|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14500511|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775371|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807377|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13964249|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
13964250|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964251|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964252|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13964253|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13964254|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13964255|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
13964256|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964257|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964258|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
14204010|NCT04267601|Anagliptin|anagliptin|mesh-list
14204011|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14204012|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
14204013|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204014|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204015|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14204016|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204017|NCT04264884|Daratumumab|daratumumab|mesh-list
14204018|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775372|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775373|NCT00658177|Urological Agents|urological agents|mesh-ancestor
14775374|NCT00658255|Budesonide|budesonide|mesh-list
14775375|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
14775376|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775377|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14775378|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
14941676|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941677|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941678|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14240215|NCT00156013|Clofarabine|clofarabine|mesh-list
14240216|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775379|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775380|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775381|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14775382|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
14775383|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
14775384|NCT00658255|Hormones|hormones|mesh-ancestor
14775385|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775386|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14775387|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14775388|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14775389|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
14941679|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14240217|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
14240218|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240219|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240220|NCT00156247|Acitretin|acitretin|mesh-list
14240221|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
14240222|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
14240223|NCT00156533|Zolpidem|zolpidem|mesh-list
14240224|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14240225|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14240226|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14240227|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240228|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14240229|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
14240230|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
14240231|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240232|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240233|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14240234|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
14240235|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240236|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14240237|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14240238|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14240239|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240240|NCT00156819|Fluticasone|fluticasone|mesh-list
14240241|NCT00156819|Xhance|xhance|mesh-list
14240242|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14240243|NCT00156819|Montelukast|montelukast|mesh-list
14240244|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240245|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14240246|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
14240247|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240248|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500527|NCT03365687|Vitamin D|vitamin d|mesh-list
14500528|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
14500529|NCT03365687|Vitamins|vitamins|mesh-ancestor
14500530|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
14500531|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500532|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14500533|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14500534|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
14500535|NCT03337087|Leucovorin|leucovorin|mesh-list
14500536|NCT03337087|Folic Acid|folic acid|mesh-list
14500537|NCT03337087|Fluorouracil|fluorouracil|mesh-list
14500538|NCT03337087|Irinotecan|irinotecan|mesh-list
14500539|NCT03337087|Rucaparib|rucaparib|mesh-list
14775390|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775391|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775392|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
14775393|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14775394|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775395|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14775396|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14775397|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14775398|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
14775399|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775400|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14775401|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14775402|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775403|NCT00658580|Etoposide|etoposide|mesh-list
14775404|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
14775405|NCT00658580|Epirubicin|epirubicin|mesh-list
14775406|NCT00658580|Ifosfamide|ifosfamide|mesh-list
14775407|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775408|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14775409|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14775410|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14775411|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775412|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204019|NCT04261231|Anesthetics|anesthetics|mesh-list
14204020|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204021|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204022|NCT04260139|Metronidazole|metronidazole|mesh-list
14775413|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14775414|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14775415|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
14775416|NCT00658593|Gemcitabine|gemcitabine|mesh-list
14775417|NCT00658593|Capecitabine|capecitabine|mesh-list
14775418|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775419|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
14775420|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775421|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941680|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14941681|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
14941682|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
14941683|NCT01500785|Simendan|simendan|mesh-list
14941684|NCT01500785|Vitamins|vitamins|mesh-ancestor
14941685|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
14941686|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941687|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
14941688|NCT01500785|Hematinics|hematinics|mesh-ancestor
14941689|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14204023|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204024|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14204025|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14204026|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14204027|NCT04256265|Risdiplam|risdiplam|mesh-list
14204028|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14204029|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204030|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204031|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14204032|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
14204033|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204034|NCT04240509|Tenofovir|tenofovir|mesh-list
14204035|NCT04240509|Emtricitabine|emtricitabine|mesh-list
14204036|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
14204037|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204038|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14204039|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14500540|NCT03337087|Calcium|calcium|mesh-list
14775422|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
14775423|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775424|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775425|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775426|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
14775427|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500541|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
14500542|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14500543|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500544|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14500545|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
14500546|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500547|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14500548|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204040|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204041|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204042|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14204043|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14240249|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14240250|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
14240251|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
14240252|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14240253|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14240254|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14240255|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14240256|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
14240257|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240258|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240259|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14240260|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
14240261|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240262|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14240263|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14240264|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
14240265|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14240266|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14240267|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14240268|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14500549|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775428|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14775429|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
14775430|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775431|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14775432|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14775433|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775434|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775435|NCT00658840|Capecitabine|capecitabine|mesh-list
14240269|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500550|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
14500551|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14500552|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14240270|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
14240271|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14500553|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500554|NCT03337087|Antidotes|antidotes|mesh-ancestor
14500555|NCT03337087|Protective Agents|protective agents|mesh-ancestor
14240272|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240273|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14240274|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240275|NCT00156923|Naltrexone|naltrexone|mesh-list
14240276|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14500556|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
14500557|NCT03337087|Vitamins|vitamins|mesh-ancestor
14500558|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
14500559|NCT03337087|Hematinics|hematinics|mesh-ancestor
14500560|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14500561|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
14500562|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500563|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775436|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775437|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
14204044|NCT04238741|Anesthetics|anesthetics|mesh-list
14204045|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14500583|NCT03275350|Naltrexone|naltrexone|mesh-list
14500584|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14500585|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14500586|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500587|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
14500588|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500589|NCT03272347|Tenofovir|tenofovir|mesh-list
14500590|NCT03272347|Lamivudine|lamivudine|mesh-list
14500591|NCT03272347|Islatravir|islatravir|mesh-list
14500592|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
14500593|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500594|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14500595|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14500596|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500597|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500598|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14204046|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204047|NCT04233047|Fostemsavir|fostemsavir|mesh-list
14204048|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14204049|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14204050|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
14204051|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204052|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14204053|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14204054|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204055|NCT04230707|Melatonin|melatonin|mesh-list
14204056|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
14204057|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204058|NCT04230707|Protective Agents|protective agents|mesh-ancestor
14204059|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204060|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204061|NCT04221568|Fentanyl|fentanyl|mesh-list
14204062|NCT04221568|Bupivacaine|bupivacaine|mesh-list
14204063|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
14204064|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
14204065|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
14204066|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204067|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500599|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14204068|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
14204069|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775438|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775439|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775440|NCT00658892|Antibodies|antibodies|mesh-list
14204070|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14204071|NCT04221568|Narcotics|narcotics|mesh-ancestor
14204072|NCT04221568|Analgesics|analgesics|mesh-ancestor
14204073|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14204074|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14204075|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
14204076|NCT04220203|Capecitabine|capecitabine|mesh-list
14204077|NCT04220203|Trastuzumab|trastuzumab|mesh-list
14204078|NCT04220203|Tucatinib|tucatinib|mesh-list
14775441|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
14775442|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775443|NCT00658918|Ciclesonide|ciclesonide|mesh-list
14775444|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
14775445|NCT00658918|Hormones|hormones|mesh-ancestor
14775446|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941690|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
14204079|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204080|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
14204081|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204082|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204083|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204084|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14204085|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240277|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14240278|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240279|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
14240280|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240281|NCT00156936|Naltrexone|naltrexone|mesh-list
14240282|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14240283|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14240284|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240285|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
14240286|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240287|NCT00157014|Cyclosporine|cyclosporine|mesh-list
14240288|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
14240289|NCT00157014|Prednisone|prednisone|mesh-list
14240290|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
14240291|NCT00157014|Tacrolimus|tacrolimus|mesh-list
14240292|NCT00157014|Cyclosporins|cyclosporins|mesh-list
14240293|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240294|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
14240295|NCT00157014|Hormones|hormones|mesh-ancestor
14941691|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14941692|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14240296|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240297|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500622|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
14500623|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500624|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500625|NCT03250832|Bevacizumab|bevacizumab|mesh-list
14500626|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500627|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500628|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14500629|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14500630|NCT03250832|Growth Substances|growth substances|mesh-ancestor
14500631|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500632|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
14500633|NCT03246906|Cyclosporine|cyclosporine|mesh-list
14500634|NCT03246906|Sirolimus|sirolimus|mesh-list
14500635|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
14500636|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
14500637|NCT03246906|Cyclosporins|cyclosporins|mesh-list
14500638|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775447|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941693|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240298|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14941694|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941695|NCT01500785|Protective Agents|protective agents|mesh-ancestor
14941696|NCT01500824|Crizotinib|crizotinib|mesh-list
14941697|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204086|NCT04204928|Pralsetinib|pralsetinib|mesh-list
14204087|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204088|NCT04195009|Anesthetics|anesthetics|mesh-list
14204089|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204090|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240299|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240300|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240301|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
14500639|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
14500640|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500641|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14500642|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14500643|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
14775448|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14775449|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14775450|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14775451|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14775452|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240302|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14240303|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240304|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240305|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
14240306|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240307|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
14240308|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240309|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14240310|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14240311|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
14240312|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14240313|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
14240314|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
14500644|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775453|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775454|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775455|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775456|NCT00658931|Analgesics|analgesics|mesh-ancestor
14775457|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
14775458|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775459|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
14775460|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775461|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
14775462|NCT00658957|Gentamicins|gentamicins|mesh-list
14500645|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500646|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14500647|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500648|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
14500649|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500650|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14500651|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14500652|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14500653|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14500654|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
14500655|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14240315|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240316|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240317|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14500668|NCT03232073|Ponesimod|ponesimod|mesh-list
14500669|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14500670|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775463|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14240318|NCT00157014|Protective Agents|protective agents|mesh-ancestor
14204091|NCT04187248|Asparaginase|asparaginase|mesh-list
14204092|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204093|NCT04179266|Ketamine|ketamine|mesh-list
14204094|NCT04179266|Analgesics|analgesics|mesh-ancestor
14204095|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
14204096|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204097|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204098|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14204099|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14204100|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
14204101|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
14204102|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204103|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14204104|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14204105|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204106|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204107|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14204108|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240319|NCT00157157|Factor VIII|factor viii|mesh-list
14240320|NCT00157157|Coagulants|coagulants|mesh-ancestor
14240321|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
14240322|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240323|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
14240324|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240325|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240326|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14240327|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
14240328|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240329|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240330|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14240331|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
14240332|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240333|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
14240334|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240335|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240336|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14240337|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
14240338|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240339|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240340|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14240341|NCT00157248|Dabigatran|dabigatran|mesh-list
14240342|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
14240343|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14240344|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
14240345|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240346|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240347|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
14243179|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243180|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
14243181|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14243182|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243183|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243184|NCT00193375|Bevacizumab|bevacizumab|mesh-list
14243185|NCT00193375|Carboplatin|carboplatin|mesh-list
14243186|NCT00193375|Irinotecan|irinotecan|mesh-list
14243187|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243188|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243189|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14243190|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14243191|NCT00193375|Growth Substances|growth substances|mesh-ancestor
14243192|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243193|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
14243194|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14243195|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243196|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243197|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243198|NCT00193453|Gemcitabine|gemcitabine|mesh-list
14243199|NCT00193453|Docetaxel|docetaxel|mesh-list
14243200|NCT00193453|Cetuximab|cetuximab|mesh-list
14243201|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243202|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
14500671|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500672|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
14243203|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500673|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775464|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775465|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14775466|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775467|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775468|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
14775469|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775470|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204109|NCT04163224|Imidacloprid|imidacloprid|mesh-list
14204110|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
14204111|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204112|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204113|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204114|NCT04152941|Olaparib|olaparib|mesh-list
14204115|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14775471|NCT00659022|Bevacizumab|bevacizumab|mesh-list
14775472|NCT00659022|Capecitabine|capecitabine|mesh-list
14775473|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
14941698|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14941699|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941700|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204116|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204117|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204118|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240348|NCT00157573|Sargramostim|sargramostim|mesh-list
14240349|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
14240350|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240351|NCT00158184|Oxycodone|oxycodone|mesh-list
14240352|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14240353|NCT00158184|Narcotics|narcotics|mesh-ancestor
14240354|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14240355|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240356|NCT00158184|Analgesics|analgesics|mesh-ancestor
14500691|NCT03216967|Everolimus|everolimus|mesh-list
14941701|NCT01500837|Levofloxacin|levofloxacin|mesh-list
14941702|NCT01500837|Ofloxacin|ofloxacin|mesh-list
14941703|NCT01500837|Rifampin|rifampin|mesh-list
14941704|NCT01500837|Clindamycin|clindamycin|mesh-list
14941705|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
14941706|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
14941707|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14500692|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500693|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500694|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
14500695|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775474|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14775475|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775476|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14775477|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14775478|NCT00659022|Growth Substances|growth substances|mesh-ancestor
14775479|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204119|NCT04138641|Cangrelor|cangrelor|mesh-list
14204120|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14941708|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941709|NCT01500837|Renal Agents|renal agents|mesh-ancestor
14941710|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14775480|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
14775481|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775482|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
14204121|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14204122|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14204123|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14204124|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
14204125|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204126|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204127|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204128|NCT04135092|Aldesleukin|aldesleukin|mesh-list
14204129|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
14204130|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
14204131|NCT04135092|Fludarabine|fludarabine|mesh-list
14204132|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14204133|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
14204134|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204135|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14941711|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14941712|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14941713|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941714|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941715|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941716|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14941717|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14941718|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14941719|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
14941720|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
14941721|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14941722|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14941723|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14941724|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14941725|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14941726|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14941727|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14941728|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14941729|NCT01500850|Insulin|insulin|mesh-list
14941730|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14941731|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
14941732|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
14941733|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
14941734|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
14941735|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
14941736|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14204136|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14204137|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
14500722|NCT03197194|Aspirin|aspirin|mesh-list
14500723|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14500724|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14775483|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204138|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204139|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500725|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14500726|NCT03197194|Analgesics|analgesics|mesh-ancestor
14500727|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
14500728|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500729|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500730|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14500731|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14204140|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14204141|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204142|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14204143|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14204144|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
14204145|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204146|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
14204147|NCT04132882|Antidotes|antidotes|mesh-ancestor
14204148|NCT04132882|Protective Agents|protective agents|mesh-ancestor
14204149|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204150|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
14204151|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204152|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
14204153|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14204154|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204155|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
14204156|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
14204157|NCT04130776|Kallikreins|kallikreins|mesh-list
14204158|NCT04130776|Coagulants|coagulants|mesh-ancestor
14500732|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14500733|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14500734|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500735|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14775484|NCT00659048|Ciclesonide|ciclesonide|mesh-list
14775485|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
14775486|NCT00659048|Hormones|hormones|mesh-ancestor
14775487|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775488|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775489|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14775490|NCT00659074|Ondansetron|ondansetron|mesh-list
14775491|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
14775492|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
14775493|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775494|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775495|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14775496|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
14775497|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
14775498|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14775499|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
14775500|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775501|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775502|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14775503|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14775504|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775505|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775506|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14775507|NCT00659100|Gabapentin|gabapentin|mesh-list
14775508|NCT00659100|Analgesics|analgesics|mesh-ancestor
14775509|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
14775510|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775511|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775512|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
14775513|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14204159|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14500736|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14500737|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500738|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
14204160|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
14204161|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14204162|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204163|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
14204164|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14204165|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
14204166|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
14204167|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204168|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204169|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204170|NCT04124562|Analgesics|analgesics|mesh-ancestor
14204171|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
14204172|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204173|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
14500776|NCT03170518|Canagliflozin|canagliflozin|mesh-list
14500777|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14500778|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500779|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14204174|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14204175|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
14204176|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204177|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
14204178|NCT04124133|Protective Agents|protective agents|mesh-ancestor
14500780|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775514|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14775515|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14240357|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
14240358|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240359|NCT00158223|Pimozide|pimozide|mesh-list
14240360|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14240361|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14240362|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14240363|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240364|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240365|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14240366|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
14240367|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240368|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240369|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14240370|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14240371|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
14240372|NCT00158262|Propranolol|propranolol|mesh-list
14240373|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14240374|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14240375|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
14240376|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14500781|NCT03168880|Paclitaxel|paclitaxel|mesh-list
14500782|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14500783|NCT03168880|Carboplatin|carboplatin|mesh-list
14500784|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14500785|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500786|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
14500787|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
14500788|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
14500789|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204179|NCT04114500|Estradiol|estradiol|mesh-list
14204180|NCT04114500|Progesterone|progesterone|mesh-list
14204181|NCT04114500|Estrogens|estrogens|mesh-ancestor
14204182|NCT04114500|Hormones|hormones|mesh-ancestor
14204183|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14204184|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204185|NCT04114500|Progestins|progestins|mesh-ancestor
14500821|NCT03092895|Apatinib|apatinib|mesh-list
14500822|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500823|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14500824|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500825|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775516|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775517|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14775518|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14775519|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775520|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204186|NCT04112277|Morphine|morphine|mesh-list
14775521|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
14775522|NCT00659113|Tegafur|tegafur|mesh-list
14775523|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775524|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204187|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14204188|NCT04112277|Narcotics|narcotics|mesh-ancestor
14204189|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204190|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204191|NCT04112277|Analgesics|analgesics|mesh-ancestor
14204192|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
14204193|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204194|NCT04102319|Hepcidins|hepcidins|mesh-list
14204195|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240377|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240378|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240379|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14240380|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14240381|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
14240382|NCT00158379|Paclitaxel|paclitaxel|mesh-list
14240383|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14240384|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240385|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
14240386|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
14240387|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
14240388|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240389|NCT00158743|Digoxin|digoxin|mesh-list
14240390|NCT00158743|Antibodies|antibodies|mesh-list
14240391|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
14240392|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
14240393|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240394|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14240395|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14240396|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240397|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240398|NCT00158743|Protective Agents|protective agents|mesh-ancestor
14240399|NCT00158756|Vaccines|vaccines|mesh-list
14240400|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
14240401|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240402|NCT00158860|Valacyclovir|valacyclovir|mesh-list
14240403|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
14240404|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240405|NCT00159263|Budesonide|budesonide|mesh-list
14240406|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
14240407|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240408|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14240409|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
14240410|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775525|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
14775526|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775527|NCT00659178|Doxorubicin|doxorubicin|mesh-list
14240411|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500870|NCT03074045|Drospirenone|drospirenone|mesh-list
14500871|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
14500872|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14500873|NCT03074045|Estradiol|estradiol|mesh-list
14500874|NCT03074045|Estrogens|estrogens|mesh-ancestor
14500875|NCT03074045|Hormones|hormones|mesh-ancestor
14500876|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14500877|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500878|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14500879|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
14500880|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14500881|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14500882|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14500883|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14500884|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14500885|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14500886|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
14500887|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14500888|NCT03074045|Diuretics|diuretics|mesh-ancestor
14500889|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
14775528|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14775529|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14775530|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775531|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14775532|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14775533|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775534|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775535|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
14775536|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
14941737|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941738|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14941739|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14941740|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14941741|NCT01500863|Estradiol|estradiol|mesh-list
14941742|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14941743|NCT01500863|Progesterone|progesterone|mesh-list
14941744|NCT01500863|Estrogens|estrogens|mesh-ancestor
14941745|NCT01500863|Hormones|hormones|mesh-ancestor
14941746|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14204196|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
14204197|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14204198|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
14204199|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
14204200|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204201|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204202|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204203|NCT04095494|Analgesics|analgesics|mesh-ancestor
14204204|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
14204205|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240412|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14240413|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
14240414|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
14240415|NCT00159263|Hormones|hormones|mesh-ancestor
14240416|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240417|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14240418|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14240419|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14240420|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
14240421|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775537|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14775538|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775539|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775540|NCT00659321|Nicotine|nicotine|mesh-list
14775541|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14775542|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
14204206|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14941747|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941748|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14941749|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
14775543|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775544|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775545|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14775546|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14775547|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
14775548|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775549|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775550|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
14775551|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14775552|NCT00659386|Antibodies|antibodies|mesh-list
14941750|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14204207|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14204208|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204209|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14204210|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14204211|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14204212|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204213|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204214|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14204215|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14204216|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14204217|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
14204218|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204219|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204220|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14204221|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14204222|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
14240422|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240423|NCT00159419|Alendronate|alendronate|mesh-list
14240424|NCT00159419|Pamidronate|pamidronate|mesh-list
14240425|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14240426|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240427|NCT00159432|Bevacizumab|bevacizumab|mesh-list
14240428|NCT00159432|Capecitabine|capecitabine|mesh-list
14240429|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
14240430|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240431|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240432|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14240433|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14240434|NCT00159432|Growth Substances|growth substances|mesh-ancestor
14240435|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240436|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
14240437|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14240438|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
14240439|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240440|NCT00159822|Voriconazole|voriconazole|mesh-list
14240441|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
14240442|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240443|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14240444|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14240445|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240446|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240447|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14941751|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14941752|NCT01500863|Progestins|progestins|mesh-ancestor
14941753|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
14941754|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14941755|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941756|NCT01500915|Ranibizumab|ranibizumab|mesh-list
14941757|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14941758|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14775553|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
14775554|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14775555|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
14775556|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807378|NCT00821496|Norethindrone|norethindrone|mesh-list
14807379|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
14204223|NCT04059991|Vaccines|vaccines|mesh-list
14204224|NCT04059991|Immunologic Factors|immunologic factors|mesh-ancestor
14204225|NCT04059991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204226|NCT04045171|Tacrolimus|tacrolimus|mesh-list
14204227|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14204228|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
14204229|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204230|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14204231|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204232|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240448|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
14240449|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240450|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240451|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14240452|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
14240453|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240454|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
14240455|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14240456|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14240457|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240458|NCT00159861|Urological Agents|urological agents|mesh-ancestor
14240459|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
14240460|NCT00159874|Citric Acid|citric acid|mesh-list
14240461|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
14240462|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
14240463|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14807380|NCT00821496|Norinyl|norinyl|mesh-list
14807381|NCT00821496|Estradiol|estradiol|mesh-list
14807382|NCT00821496|Estrogens|estrogens|mesh-ancestor
14807383|NCT00821496|Hormones|hormones|mesh-ancestor
14807384|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14807385|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240464|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
14240465|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
14240466|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240467|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
14240468|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14240469|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14240470|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240471|NCT00159874|Urological Agents|urological agents|mesh-ancestor
14240472|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
14240473|NCT00159913|Citric Acid|citric acid|mesh-list
14240474|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
14240475|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
14240476|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14240477|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
14240478|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
14240479|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240480|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
14240481|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14240482|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14240483|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240484|NCT00159913|Urological Agents|urological agents|mesh-ancestor
14807386|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14807387|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
14807388|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14807389|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14204233|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
14204234|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14204235|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204236|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204237|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14204238|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
14204239|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14204240|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204241|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204242|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240485|NCT00159965|Sertraline|sertraline|mesh-list
14240486|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
14500918|NCT03036098|Gemcitabine|gemcitabine|mesh-list
14500919|NCT03036098|Carboplatin|carboplatin|mesh-list
14500920|NCT03036098|Nivolumab|nivolumab|mesh-list
14500921|NCT03036098|Ipilimumab|ipilimumab|mesh-list
14500922|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500923|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14500924|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
14500925|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14500926|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
14500927|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14500928|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500929|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14500930|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
14500931|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500932|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14500933|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14775557|NCT00659399|PENTA|penta|mesh-list
14775558|NCT00659399|Fondaparinux|fondaparinux|mesh-list
14775559|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14775560|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
14775561|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14775562|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
14775563|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941759|NCT01500915|Growth Substances|growth substances|mesh-ancestor
14240487|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240488|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14240489|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14240490|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240491|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240492|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240493|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
14240494|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240495|NCT00160199|Progesterone|progesterone|mesh-list
14775564|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775565|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
13964259|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14240496|NCT00160199|Progestins|progestins|mesh-ancestor
14775566|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14941760|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941761|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
14941762|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941763|NCT01500928|Insulin|insulin|mesh-list
14941764|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941765|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941766|NCT01500980|Chloroquine|chloroquine|mesh-list
14941767|NCT01500980|Primaquine|primaquine|mesh-list
14941768|NCT01500980|Amebicides|amebicides|mesh-ancestor
14941769|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14941770|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14941771|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964260|NCT03138681|Protective Agents|protective agents|mesh-ancestor
13964261|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964262|NCT03138668|Ropivacaine|ropivacaine|mesh-list
13964263|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
13964264|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
13964265|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964266|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964267|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
13964268|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964269|NCT03138785|Itraconazole|itraconazole|mesh-list
13964270|NCT03138785|Voriconazole|voriconazole|mesh-list
13964271|NCT03138785|Levofloxacin|levofloxacin|mesh-list
13964272|NCT03138785|Ofloxacin|ofloxacin|mesh-list
13964273|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
14941772|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
14941773|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14775567|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14775568|NCT00659412|Methotrexate|methotrexate|mesh-list
14775569|NCT00659412|Alefacept|alefacept|mesh-list
14775570|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14775571|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
14775572|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14775573|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775574|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775575|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
14775576|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775577|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775578|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14775579|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775580|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14775581|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775582|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
14775583|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14775584|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14775585|NCT00659451|Losartan|losartan|mesh-list
14775586|NCT00659451|Amlodipine|amlodipine|mesh-list
14775587|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14775588|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14775589|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14775590|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775591|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14775592|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775593|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775594|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14775595|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14775596|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14775597|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
14775598|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775599|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775600|NCT00659503|Ciclesonide|ciclesonide|mesh-list
14204243|NCT03994419|Anesthetics|anesthetics|mesh-list
14204244|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204245|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204246|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14204247|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204248|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204249|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
14204250|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204251|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204252|NCT03979625|Heparin|heparin|mesh-list
14204253|NCT03979625|Antibodies|antibodies|mesh-list
14204254|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
14204255|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204256|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
14204257|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14204258|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14204259|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240497|NCT00160199|Hormones|hormones|mesh-ancestor
14240498|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240499|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240500|NCT00160251|Ribavirin|ribavirin|mesh-list
14240501|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14240502|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
14240503|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240504|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
14240505|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240506|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
14240507|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240508|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
14240509|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240510|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240511|NCT00160615|Levetiracetam|levetiracetam|mesh-list
14240512|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
14240513|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
14240514|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
14240515|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240516|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
14240517|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240518|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240519|NCT00160654|Levetiracetam|levetiracetam|mesh-list
14240520|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
14240521|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
14240522|NCT00160667|Brivaracetam|brivaracetam|mesh-list
14240523|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
14240524|NCT00160680|Levocetirizine|levocetirizine|mesh-list
14240525|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14240526|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14240527|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
14240528|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
14240529|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240530|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240531|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240532|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
14240533|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240534|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
14240535|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240536|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240537|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
14240538|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240539|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
14240540|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240541|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240542|NCT00161213|Gemcitabine|gemcitabine|mesh-list
14240543|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
14240544|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14240545|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
14240546|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240547|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204260|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
14204261|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
14204262|NCT03974464|Coagulants|coagulants|mesh-ancestor
14204263|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14204264|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14204265|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
14204266|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204267|NCT03970265|Meropenem|meropenem|mesh-list
14204268|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14204269|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204270|NCT03967483|Indomethacin|indomethacin|mesh-list
14204271|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14204272|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204273|NCT03967483|Analgesics|analgesics|mesh-ancestor
14204274|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
14204275|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204276|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204277|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204278|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14204279|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
14204280|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
14775601|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
14775602|NCT00659503|Hormones|hormones|mesh-ancestor
14775603|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775604|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775605|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14775606|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14775607|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14775608|NCT00659568|Metformin|metformin|mesh-list
14775609|NCT00659568|Sirolimus|sirolimus|mesh-list
14775610|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14775611|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775612|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14500985|NCT02984384|Aspirin|aspirin|mesh-list
14500986|NCT02984384|Heparin|heparin|mesh-list
14500987|NCT02984384|Enoxaparin|enoxaparin|mesh-list
14500988|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14775613|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775614|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14775615|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14500989|NCT02984384|Tinzaparin|tinzaparin|mesh-list
14500990|NCT02984384|Dalteparin|dalteparin|mesh-list
14500991|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14500992|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14500993|NCT02984384|Analgesics|analgesics|mesh-ancestor
14204281|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14500994|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
14204282|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14204283|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14500995|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14500996|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14500997|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14500998|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14500999|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14501000|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14501001|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941774|NCT01500993|Fluorouracil|fluorouracil|mesh-list
14941775|NCT01500993|Capecitabine|capecitabine|mesh-list
14941776|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
14941777|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941778|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14941779|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941780|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941781|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
14941782|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941783|NCT01501032|Pancrelipase|pancrelipase|mesh-list
14941784|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14941785|NCT01501084|Exenatide|exenatide|mesh-list
14941786|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941787|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501002|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14501003|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14501004|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501005|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
14501006|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
14501016|NCT02977299|Aripiprazole|aripiprazole|mesh-list
14501017|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14501018|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
14501019|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14501020|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14501021|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14501022|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14501023|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501024|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
14501025|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
14501026|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14501027|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501028|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14501029|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14501030|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
14501031|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14501032|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14501033|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14501034|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14501035|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14501036|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14501037|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14501038|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14528396|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14528397|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14528398|NCT03852537|Prednisolone|prednisolone|mesh-list
14528399|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
14528400|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14528401|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
14528402|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528403|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
14528404|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
14528405|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528406|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528407|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528408|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
14528409|NCT03852537|Hormones|hormones|mesh-ancestor
14204284|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240548|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
14240549|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240550|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240551|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240552|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
14240553|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240554|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14240555|NCT00161473|Prazosin|prazosin|mesh-list
14240556|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14501051|NCT02932410|Macitentan|macitentan|mesh-list
14501052|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14501053|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14501054|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501055|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14501056|NCT02923466|Interferon-beta|interferon-beta|mesh-list
14501057|NCT02923466|Avelumab|avelumab|mesh-list
14501058|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501059|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501060|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
14240557|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14501061|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501062|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
14501063|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501064|NCT02915198|Metformin|metformin|mesh-list
14501065|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14501066|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240558|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14240559|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14240560|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14240561|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240562|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240563|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240564|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14240565|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14240566|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240567|NCT00162097|Efavirenz|efavirenz|mesh-list
14240568|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14240569|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14204285|NCT03947099|Ketamine|ketamine|mesh-list
14204286|NCT03947099|Analgesics|analgesics|mesh-ancestor
14204287|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
14204288|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204289|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204290|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14204291|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14775616|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
14775617|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775618|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
14775619|NCT00659594|Ciclesonide|ciclesonide|mesh-list
14775620|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
14775621|NCT00659594|Hormones|hormones|mesh-ancestor
14775622|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775623|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775624|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14775625|NCT00659659|Benralizumab|benralizumab|mesh-list
14775626|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14775627|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
14775628|NCT00659685|Ondansetron|ondansetron|mesh-list
14775629|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
14775630|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
14775631|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775632|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775633|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14775634|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
14775635|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
14775636|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14775637|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
14204292|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
14204293|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
14204294|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775638|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775639|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204295|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14775640|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14775641|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14775642|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775643|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775644|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14204296|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14204297|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204298|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240570|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14240571|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240572|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240573|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
14240574|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240575|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14240576|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14240577|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14240578|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14240579|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14240580|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14240581|NCT00162123|Ipilimumab|ipilimumab|mesh-list
14240582|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240583|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240584|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14240585|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240586|NCT00162266|Abatacept|abatacept|mesh-list
14240587|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14240588|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501140|NCT02853305|Gemcitabine|gemcitabine|mesh-list
14501141|NCT02853305|Carboplatin|carboplatin|mesh-list
14501142|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
14775645|NCT00659698|Pancrelipase|pancrelipase|mesh-list
14775646|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14775647|NCT00659750|Ciclesonide|ciclesonide|mesh-list
14775648|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
14775649|NCT00659750|Hormones|hormones|mesh-ancestor
14501143|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501144|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14501145|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
14501146|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501147|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
14501148|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501149|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501150|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807390|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14807391|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14807392|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14807393|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14807394|NCT00821535|Maraviroc|maraviroc|mesh-list
14807395|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14807396|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14807397|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807398|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14807399|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14807400|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
14807401|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807402|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14807403|NCT00821574|Valsartan|valsartan|mesh-list
14807404|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14807405|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14807406|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14807407|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14807408|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807409|NCT00821574|Diuretics|diuretics|mesh-ancestor
14807410|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
14807411|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501151|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
14501152|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501153|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204299|NCT03930017|Vaccines|vaccines|mesh-list
14204300|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
14204301|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204302|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14204303|NCT03920566|Dalteparin|dalteparin|mesh-list
14204304|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
14204305|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14204306|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14204307|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204308|NCT03914170|Cetuximab|cetuximab|mesh-list
14204309|NCT03914170|Folfirinox|folfirinox|mesh-list
14501154|NCT02850874|Gemcitabine|gemcitabine|mesh-list
14501155|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14501156|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
14501157|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501158|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501159|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
14501160|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501161|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501162|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14501163|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
14501164|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204310|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204311|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240589|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240590|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240591|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
14240592|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240593|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240594|NCT00162981|Clobazam|clobazam|mesh-list
14240595|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
14240596|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14240597|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14240598|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14240599|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240600|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240601|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14240602|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
14240603|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
14240604|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240605|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501181|NCT02827838|Durvalumab|durvalumab|mesh-list
14501182|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
14501183|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14501184|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
14501185|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501186|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501187|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
14501188|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240606|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14240607|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14240608|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14240609|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
14240610|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240611|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240612|NCT00163020|Progestins|progestins|mesh-ancestor
14240613|NCT00163020|Hormones|hormones|mesh-ancestor
14240614|NCT00163293|Ciclesonide|ciclesonide|mesh-list
14240615|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
14240616|NCT00163293|Hormones|hormones|mesh-ancestor
14240617|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240618|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240619|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14240620|NCT00163657|Cyclosporine|cyclosporine|mesh-list
14240621|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
14240622|NCT00163657|Tacrolimus|tacrolimus|mesh-list
14240623|NCT00163657|Cyclosporins|cyclosporins|mesh-list
14240624|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240625|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
14240626|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240627|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14240628|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240629|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240630|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
14240631|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240632|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
14941788|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14240633|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240634|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14240635|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941789|NCT01501084|Incretins|incretins|mesh-ancestor
14941790|NCT01501084|Hormones|hormones|mesh-ancestor
14941791|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941792|NCT01501123|Midazolam|midazolam|mesh-list
14941793|NCT01501123|Haloperidol|haloperidol|mesh-list
14941794|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
14941795|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14941796|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14941797|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941798|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941799|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14941800|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14941801|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14941802|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14941803|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
14941804|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
14941805|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
14941806|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
14941807|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775650|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775651|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775652|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14775653|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14775654|NCT00659776|Hematinics|hematinics|mesh-ancestor
14775655|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14775656|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14775657|NCT00659841|Ciclesonide|ciclesonide|mesh-list
14775658|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
14775659|NCT00659841|Hormones|hormones|mesh-ancestor
14775660|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775661|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775662|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14775663|NCT00659919|Trazodone|trazodone|mesh-list
14775664|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14775665|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14775666|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204312|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
14204313|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14204314|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
14204315|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204316|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204317|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14204318|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
14204319|NCT03907605|Hormones|hormones|mesh-list
14204320|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14204321|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204322|NCT03903406|Dexamethasone|dexamethasone|mesh-list
14204323|NCT03903406|Lenalidomide|lenalidomide|mesh-list
14204324|NCT03903406|Ixazomib|ixazomib|mesh-list
14204325|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204326|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
14204327|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
14204328|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204329|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204330|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14204331|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
14204332|NCT03903406|Hormones|hormones|mesh-ancestor
14204333|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14204334|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14204335|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204336|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
14204337|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14204338|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14204339|NCT03903406|Growth Substances|growth substances|mesh-ancestor
14204340|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
14204341|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
14204342|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775667|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775668|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775669|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14775670|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14775671|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14775672|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775673|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775674|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
14775675|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14775676|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
14775677|NCT00659958|Zonisamide|zonisamide|mesh-list
14775678|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
14775679|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14775680|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14204343|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204344|NCT03897192|Bevacizumab|bevacizumab|mesh-list
14204345|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204346|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204347|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14204348|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14204349|NCT03897192|Growth Substances|growth substances|mesh-ancestor
14204350|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204351|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
14204352|NCT03896815|INCB054329|incb054329|mesh-list
14204353|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240636|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14240637|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
14240638|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14240639|NCT00165646|Rabeprazole|rabeprazole|mesh-list
14240640|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14240641|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240642|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14240643|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240644|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240645|NCT00165672|Rabeprazole|rabeprazole|mesh-list
14240646|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14240647|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240648|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14240649|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501232|NCT02794337|Sorafenib|sorafenib|mesh-list
14501233|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501234|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14501235|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501236|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501258|NCT02773485|Gemcitabine|gemcitabine|mesh-list
14501259|NCT02773485|Cisplatin|cisplatin|mesh-list
14243204|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501260|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501261|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14501262|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
14501263|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501264|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
14501265|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501266|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501267|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14501268|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
14501269|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204354|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
14204355|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204356|NCT03881917|Cystatins|cystatins|mesh-list
14204357|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14501280|NCT02759588|Bevacizumab|bevacizumab|mesh-list
14501281|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501282|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501283|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14501284|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14501285|NCT02759588|Growth Substances|growth substances|mesh-ancestor
14501286|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501287|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
14501288|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
14501289|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501290|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501291|NCT02721459|Vemurafenib|vemurafenib|mesh-list
14501292|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501293|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14501294|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501295|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204358|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
14204359|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204360|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240650|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240651|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
14240652|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14240653|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14240654|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240655|NCT00165698|Vitamins|vitamins|mesh-ancestor
14240656|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
14240657|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14240658|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
14240659|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14501315|NCT02652455|Aldesleukin|aldesleukin|mesh-list
14501316|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
14501317|NCT02652455|Nivolumab|nivolumab|mesh-list
14501318|NCT02652455|Fludarabine|fludarabine|mesh-list
14501319|NCT02652455|Interleukin-2|interleukin-2|mesh-list
14501320|NCT02652455|Antibodies|antibodies|mesh-list
14240660|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14204361|NCT03851965|Plasminogen|plasminogen|mesh-list
14204362|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14204363|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14204364|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204365|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14204366|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240661|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14240662|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240663|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240664|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
14240665|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240666|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240667|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14240668|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240669|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14240670|NCT00165841|Rabeprazole|rabeprazole|mesh-list
14240671|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14240672|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240673|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14240674|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240675|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240676|NCT00166036|Atorvastatin|atorvastatin|mesh-list
14240677|NCT00166036|Pravastatin|pravastatin|mesh-list
14501321|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
14240678|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14240679|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14240680|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
14240681|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240682|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14240683|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14240684|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240685|NCT00166114|Citalopram|citalopram|mesh-list
14240686|NCT00166114|Desipramine|desipramine|mesh-list
14240687|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14501322|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
14501323|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14501324|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
14501325|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501326|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14501327|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14501328|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
14501329|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501330|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501331|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14240688|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14775681|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775682|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14775683|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775684|NCT00659997|Albendazole|albendazole|mesh-list
14775685|NCT00659997|Levamisole|levamisole|mesh-list
14204367|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
14204368|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14501332|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501333|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14501334|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14501335|NCT02652455|Analgesics|analgesics|mesh-ancestor
14501336|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
14501337|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14501338|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14501339|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14501340|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
14501341|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501347|NCT02638701|Infliximab|infliximab|mesh-list
14204369|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
14204370|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204371|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
14204372|NCT05278897|Protective Agents|protective agents|mesh-ancestor
14204373|NCT05278884|Anesthetics|anesthetics|mesh-list
14204374|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204375|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204376|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
14204377|NCT05278793|Trace Elements|trace elements|mesh-ancestor
14204378|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
14204379|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204380|NCT05278728|Irinotecan|irinotecan|mesh-list
14204381|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
14501348|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14501349|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14501350|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14501351|NCT02631733|Irinotecan|irinotecan|mesh-list
14501352|NCT02631733|Veliparib|veliparib|mesh-list
14501353|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14501354|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14501355|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14501356|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501357|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501358|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501359|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14501360|NCT02631733|Hematinics|hematinics|mesh-ancestor
14501361|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14501362|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14775686|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
14775687|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14204382|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14204383|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14204384|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775688|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204385|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204386|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204387|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204388|NCT05278715|Carboplatin|carboplatin|mesh-list
14204389|NCT05278715|Vincristine|vincristine|mesh-list
14204390|NCT05278715|Endostatins|endostatins|mesh-list
14204391|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204392|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14204393|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
14204394|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
14204395|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
14204396|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204397|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14204398|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14204399|NCT05278715|Growth Substances|growth substances|mesh-ancestor
14204400|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204401|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
14204402|NCT05278637|Aspirin|aspirin|mesh-list
14204403|NCT05278637|Ticagrelor|ticagrelor|mesh-list
14204404|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14204405|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204406|NCT05278637|Analgesics|analgesics|mesh-ancestor
14204407|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
14204408|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14501381|NCT02611037|Gemcitabine|gemcitabine|mesh-list
14501382|NCT02611037|Methotrexate|methotrexate|mesh-list
14501383|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501384|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14501385|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
14501386|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501387|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
14501388|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501389|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501390|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14501391|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
14204409|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204410|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204411|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14204412|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14204413|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14501392|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501393|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14204414|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204415|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14204416|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14204417|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204418|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
14204419|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14204420|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14204421|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14204422|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
14204423|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204424|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
14204425|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
14204426|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
14204427|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14204428|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14204429|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204430|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204431|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204432|NCT05278338|Denosumab|denosumab|mesh-list
14204433|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14204434|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204438|NCT05278065|Nicotine|nicotine|mesh-list
14204439|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14204440|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
14204441|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204442|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204443|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14501394|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
14501395|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14501396|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
14204444|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14204445|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
14204446|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204447|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204448|NCT05277974|Dexamethasone|dexamethasone|mesh-list
14204449|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204450|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
14204451|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
14204452|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204453|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204454|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14204455|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
14204456|NCT05277974|Hormones|hormones|mesh-ancestor
14204457|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14204458|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14204459|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204460|NCT05277701|Lazertinib|lazertinib|mesh-list
14204461|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14204462|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204463|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775689|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
14775690|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14775691|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14775692|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
14775693|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
14775694|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
14775695|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775696|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941808|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941809|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
14941810|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
14941811|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204464|NCT05277675|Bevacizumab|bevacizumab|mesh-list
14204465|NCT05277675|Lenvatinib|lenvatinib|mesh-list
14204466|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204467|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204468|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14204469|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14204470|NCT05277675|Growth Substances|growth substances|mesh-ancestor
14204471|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501397|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14501398|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14501399|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14204472|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
14204473|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14204474|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501400|NCT02609776|Carboplatin|carboplatin|mesh-list
14204475|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240689|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240690|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240691|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240692|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
14240693|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240694|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14240695|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
14240696|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240697|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14240698|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240699|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14240700|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
14240701|NCT00166166|Fluconazole|fluconazole|mesh-list
14240702|NCT00166166|Nitroprusside|nitroprusside|mesh-list
14501401|NCT02609776|Pemetrexed|pemetrexed|mesh-list
14501402|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
14501403|NCT02609776|Lazertinib|lazertinib|mesh-list
14501404|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14501405|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501406|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501407|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501408|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14501409|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14501410|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14240703|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
14775697|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14775698|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
14775699|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501411|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501412|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
14501413|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501414|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
14501415|NCT02590523|Vancomycin|vancomycin|mesh-list
14501416|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14501417|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501418|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14501419|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14501420|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501421|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501422|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501423|NCT02582125|Nivolumab|nivolumab|mesh-list
14501424|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501425|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501426|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14775700|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
14204476|NCT05277038|Clonidine|clonidine|mesh-list
14204477|NCT05277038|Zopiclone|zopiclone|mesh-list
14204478|NCT05277038|Analgesics|analgesics|mesh-ancestor
14204479|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
14204480|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204481|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204482|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14204483|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
14204484|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
14204485|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14204486|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14204487|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14775701|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14775702|NCT00660036|Etoposide|etoposide|mesh-list
14775703|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
14204488|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
14204489|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14501427|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204490|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204491|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14204492|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204493|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
14204494|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14204495|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204496|NCT05276960|Vitamins|vitamins|mesh-ancestor
14204497|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
14204498|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14204499|NCT05276908|Bupivacaine|bupivacaine|mesh-list
14204500|NCT05276908|Anesthetics|anesthetics|mesh-list
14775704|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
14775705|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14204501|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
14204502|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775706|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775707|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14775708|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14775709|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775710|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775711|NCT00660036|Analgesics|analgesics|mesh-ancestor
14775712|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
14775713|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775714|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204503|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204504|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
14204505|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204506|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
14204507|NCT05276895|Quercetin|quercetin|mesh-list
14204508|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
14204509|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775715|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14775716|NCT00660062|Dexetimide|dexetimide|mesh-list
14941812|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14941813|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14204510|NCT05276895|Protective Agents|protective agents|mesh-ancestor
14204511|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204512|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204513|NCT05275738|Niacinamide|niacinamide|mesh-list
14204514|NCT05275738|Niacin|niacin|mesh-list
14204515|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
14204516|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
14204517|NCT05275738|Vitamins|vitamins|mesh-ancestor
14204518|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
14204519|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204520|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14204521|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
14204522|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204523|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14204524|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
14204525|NCT05258851|Ceftazidime|ceftazidime|mesh-list
14204526|NCT05258851|Colistin|colistin|mesh-list
14204527|NCT05258851|Avibactam|avibactam|mesh-list
14204528|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14204529|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14204530|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204531|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14204532|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204533|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204534|NCT05257213|Heparin|heparin|mesh-list
14204535|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
14204536|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14204537|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14204538|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204539|NCT05255107|Riboflavin|riboflavin|mesh-list
14204540|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
14204541|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
14941814|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14941815|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
14941816|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14941817|NCT01501136|Gemcitabine|gemcitabine|mesh-list
14941818|NCT01501136|Dexamethasone|dexamethasone|mesh-list
14204542|NCT05255107|Vitamins|vitamins|mesh-ancestor
14204543|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
14204544|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204545|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14204546|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
14204547|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14204548|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14204549|NCT05255016|Riboflavin|riboflavin|mesh-list
14204550|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
14204551|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
14204552|NCT05255016|Vitamins|vitamins|mesh-ancestor
14204553|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
14204554|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204555|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14204556|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
14204557|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14204558|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14204559|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
14204560|NCT05254548|Midazolam|midazolam|mesh-list
14204561|NCT05254548|Omeprazole|omeprazole|mesh-list
14204562|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14204563|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14775717|NCT00660062|Citalopram|citalopram|mesh-list
14775718|NCT00660062|Nortriptyline|nortriptyline|mesh-list
14775719|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14204564|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204565|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204566|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14204567|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14204568|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14204569|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14204570|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
14204571|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
14204572|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
14204573|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
14204574|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204575|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775720|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14775721|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14775722|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775723|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775724|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
14775725|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775726|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14941819|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
14941820|NCT01501136|Cisplatin|cisplatin|mesh-list
14204576|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14204577|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14204578|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14204579|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204580|NCT05254548|Analgesics|analgesics|mesh-ancestor
14204581|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
14204582|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204583|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14501489|NCT02440854|Afatinib|afatinib|mesh-list
14501490|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501491|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14501492|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501493|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941821|NCT01501136|Etoposide|etoposide|mesh-list
14204584|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14941822|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
14941823|NCT01501136|Ifosfamide|ifosfamide|mesh-list
14941824|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
14204585|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204586|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14204587|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14204588|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
14204589|NCT05232851|Vaccines|vaccines|mesh-list
14204590|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
14204591|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204592|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204593|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204594|NCT05230368|Decitabine|decitabine|mesh-list
14204595|NCT05230368|Romidepsin|romidepsin|mesh-list
14501525|NCT02367040|Rituximab|rituximab|mesh-list
14501526|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501527|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501528|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
14501529|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501530|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14501531|NCT02365597|Metformin|metformin|mesh-list
14501532|NCT02365597|Midazolam|midazolam|mesh-list
14501533|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14501534|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501535|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14501536|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14501537|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14501538|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14501539|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14501540|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14501541|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14501542|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
14501543|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
14501544|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
14501545|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
14501546|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14501547|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204596|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204597|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
14501564|NCT02344498|Tenofovir|tenofovir|mesh-list
14501565|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
14501566|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501567|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14501568|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14501569|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501570|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501571|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14501572|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14204598|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501587|NCT02278185|Leuprolide|leuprolide|mesh-list
14501588|NCT02278185|Goserelin|goserelin|mesh-list
14501589|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14775727|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
14775728|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775729|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14775730|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14775731|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
14775732|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
14775733|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775734|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14775735|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14775736|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
14775737|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14775738|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14775739|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14775740|NCT00660140|Gemcitabine|gemcitabine|mesh-list
14775741|NCT00660140|Carboplatin|carboplatin|mesh-list
14775742|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775743|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204599|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775744|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
14775745|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204600|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204601|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14204602|NCT05212454|Capecitabine|capecitabine|mesh-list
14204603|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204604|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
14204605|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204606|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204607|NCT05198843|Dasatinib|dasatinib|mesh-list
14204608|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14775746|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
14775747|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204609|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204610|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14204611|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204612|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204613|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14204614|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14204615|NCT05198830|Cisplatin|cisplatin|mesh-list
14204616|NCT05198830|Pemetrexed|pemetrexed|mesh-list
14204617|NCT05198830|Durvalumab|durvalumab|mesh-list
14204618|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
14204619|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14204620|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
14204621|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204622|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204623|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204624|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14204625|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14204626|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204627|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
14204628|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204629|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
14204630|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14204631|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
14204632|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204633|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
14204634|NCT05198544|Protective Agents|protective agents|mesh-ancestor
14204635|NCT05176223|Edetic Acid|edetic acid|mesh-list
14204636|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14204637|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
14204638|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
14204639|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204640|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
14204641|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14501590|NCT02278185|Tryptophan|tryptophan|mesh-list
14501591|NCT02278185|Androgens|androgens|mesh-list
14501592|NCT02278185|Hormones|hormones|mesh-ancestor
14501593|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14501594|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501595|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14501596|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
14501597|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14501598|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14501599|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501600|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
14501601|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14501602|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
14501603|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14501604|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14501605|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
14501606|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14501623|NCT02208375|Olaparib|olaparib|mesh-list
14501624|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14501625|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501626|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501627|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204642|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14775748|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775749|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775750|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
14775751|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775752|NCT00660231|Gemcitabine|gemcitabine|mesh-list
14775753|NCT00660231|Bexarotene|bexarotene|mesh-list
14775754|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775755|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
14775756|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775757|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775758|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
14204643|NCT05174884|Etonogestrel|etonogestrel|mesh-list
14204644|NCT05174884|Desogestrel|desogestrel|mesh-list
14204645|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14204646|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
14204647|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14204648|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204649|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14204650|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14204651|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14204652|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14204653|NCT05174884|Progestins|progestins|mesh-ancestor
14204654|NCT05174884|Hormones|hormones|mesh-ancestor
14775759|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775760|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775761|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775762|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
14775763|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775764|NCT00660244|Anastrozole|anastrozole|mesh-list
14775765|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14775766|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775767|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14775768|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14775769|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775770|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775771|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14775772|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
14775773|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775774|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775775|NCT00660257|Vaccines|vaccines|mesh-list
14775776|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
14775777|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775778|NCT00660270|Gemcitabine|gemcitabine|mesh-list
14775779|NCT00660270|Interferons|interferons|mesh-list
14775780|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
14775781|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14775782|NCT00660270|Fluorouracil|fluorouracil|mesh-list
14775783|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775784|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775785|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
14775786|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775787|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
14775788|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775789|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775790|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775791|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
14775792|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775793|NCT00660283|Temozolomide|temozolomide|mesh-list
14204655|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775794|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14941825|NCT01501136|Pegaspargase|pegaspargase|mesh-list
14941826|NCT01501136|Asparaginase|asparaginase|mesh-list
14941827|NCT01501136|BB 1101|bb 1101|mesh-list
14204656|NCT05173493|Amoxicillin|amoxicillin|mesh-list
14204657|NCT05173493|Levofloxacin|levofloxacin|mesh-list
14204658|NCT05173493|Ofloxacin|ofloxacin|mesh-list
14204659|NCT05173493|Tetracycline|tetracycline|mesh-list
14204660|NCT05173493|Furazolidone|furazolidone|mesh-list
14204661|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14204662|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204663|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14204664|NCT05173493|Renal Agents|renal agents|mesh-ancestor
14204665|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14204666|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14204667|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204668|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204669|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204670|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14204671|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14204672|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14204673|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14204674|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14204675|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14204676|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14204677|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14204678|NCT05168618|Atezolizumab|atezolizumab|mesh-list
14204679|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14204680|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204681|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
14204682|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941828|NCT01501136|Mesna|mesna|mesh-list
14941829|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941830|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941831|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
14941832|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
14941833|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941834|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941835|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14941836|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
14941837|NCT01501136|Hormones|hormones|mesh-ancestor
14941838|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941839|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14941840|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
14204683|NCT05168202|Azacitidine|azacitidine|mesh-list
14204684|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204685|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
14204686|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941841|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941842|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941843|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14941844|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
14941845|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
14941846|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941847|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941848|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
14941849|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14941850|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14204687|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775795|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
14775796|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775797|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775798|NCT00660335|Secretin|secretin|mesh-list
14775799|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14204688|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204689|NCT05326555|Imidacloprid|imidacloprid|mesh-list
14204690|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
14204691|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204692|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204693|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240704|NCT00166166|Acetylcholine|acetylcholine|mesh-list
14240705|NCT00166166|Bradykinin|bradykinin|mesh-list
14240706|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14240707|NCT00166166|Kininogens|kininogens|mesh-list
14240708|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
14240709|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240710|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14240711|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14240712|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240713|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240714|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14240715|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
14775800|NCT00660335|Hormones|hormones|mesh-ancestor
14775801|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775802|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775803|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
14775804|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
14941851|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14775805|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
14775806|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14941852|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14941853|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
14941854|NCT01501136|Protective Agents|protective agents|mesh-ancestor
14501692|NCT02154529|Trastuzumab|trastuzumab|mesh-list
14501693|NCT02154529|XL647|xl647|mesh-list
14501694|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501695|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501696|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14501697|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501698|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501699|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14501700|NCT02154490|Nivolumab|nivolumab|mesh-list
14501701|NCT02154490|Ipilimumab|ipilimumab|mesh-list
14775807|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775808|NCT00660426|Gemcitabine|gemcitabine|mesh-list
14775809|NCT00660426|Capecitabine|capecitabine|mesh-list
14775810|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
14775811|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14941855|NCT01501149|Gemcitabine|gemcitabine|mesh-list
14501702|NCT02154490|Durvalumab|durvalumab|mesh-list
14501703|NCT02154490|Rilotumumab|rilotumumab|mesh-list
14501704|NCT02154490|Docetaxel|docetaxel|mesh-list
14501705|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14501706|NCT02154490|Palbociclib|palbociclib|mesh-list
14501707|NCT02154490|Tremelimumab|tremelimumab|mesh-list
14501708|NCT02154490|Talazoparib|talazoparib|mesh-list
14941856|NCT01501149|Dexamethasone|dexamethasone|mesh-list
14941857|NCT01501149|Etoposide|etoposide|mesh-list
14941858|NCT01501149|Pegaspargase|pegaspargase|mesh-list
14941859|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941860|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941861|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
14501709|NCT02154490|Antibodies|antibodies|mesh-list
14501710|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
14775812|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
14775813|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204694|NCT05326464|Tofacitinib|tofacitinib|mesh-list
14204695|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14204696|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204697|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204698|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
14204699|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
14204700|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204701|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204702|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204703|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
14204704|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
14204705|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
14204706|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501711|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14501712|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
14501713|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
14501714|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501715|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501716|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14501717|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
14501718|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14501719|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501720|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14501721|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14501722|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501723|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14501724|NCT02149277|Lenograstim|lenograstim|mesh-list
14501725|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14775814|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941862|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
14941863|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204707|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14204708|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204709|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775815|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
14775816|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14941864|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941865|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14941866|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
14204710|NCT05326269|Terbutaline|terbutaline|mesh-list
14204711|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14204712|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
14204713|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204714|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501726|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
14941867|NCT01501149|Hormones|hormones|mesh-ancestor
14941868|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941869|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14941870|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14941871|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
14941872|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941873|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
14941874|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501727|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501728|NCT02143466|Durvalumab|durvalumab|mesh-list
14501729|NCT02143466|Osimertinib|osimertinib|mesh-list
14501730|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14501731|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501732|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501733|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
14501734|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501735|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14501736|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501737|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501754|NCT02120807|Pemetrexed|pemetrexed|mesh-list
14501755|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
14501756|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501757|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501758|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501759|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14501760|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14501761|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14501762|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
14501763|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775817|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775818|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941875|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941876|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14941877|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
14941878|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14941879|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14941880|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15026739|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14775819|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
14775820|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775821|NCT00660582|Leucovorin|leucovorin|mesh-list
14775822|NCT00660582|Folic Acid|folic acid|mesh-list
15026740|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
14775823|NCT00660582|Fluorouracil|fluorouracil|mesh-list
14775824|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
14775825|NCT00660582|Cetuximab|cetuximab|mesh-list
14775826|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
14775827|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
14775828|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775829|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775830|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775831|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14501764|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14775832|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
14775833|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775834|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14775835|NCT00660582|Antidotes|antidotes|mesh-ancestor
14775836|NCT00660582|Protective Agents|protective agents|mesh-ancestor
14941881|NCT01501214|Atosiban|atosiban|mesh-list
14941882|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
14941883|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941884|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941885|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
14941886|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14941887|NCT01501253|Amlodipine|amlodipine|mesh-list
14941888|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14941889|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14941890|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14941891|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941892|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14204715|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14204716|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
14204717|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
14204718|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
14204719|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14204720|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14204721|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14204722|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14204723|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
14204724|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941893|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204725|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204726|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
14204727|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14204728|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14204729|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204730|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
14204731|NCT05326139|Coagulants|coagulants|mesh-ancestor
14204732|NCT05326087|Cetrorelix|cetrorelix|mesh-list
14204733|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14204734|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
14204735|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14204736|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204737|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
14204738|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14204739|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
14204740|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204741|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204742|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
14204743|NCT05325762|Propofol|propofol|mesh-list
14204744|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14204745|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204746|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204747|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14204748|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
14204749|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
14204750|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204751|NCT05325762|Analgesics|analgesics|mesh-ancestor
14204752|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
14204753|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204754|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14204755|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14204756|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14204757|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
14204758|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204759|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204760|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14204761|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204762|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204763|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
14501792|NCT02062489|Tamoxifen|tamoxifen|mesh-list
14941894|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14204764|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
14204765|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204766|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204767|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204768|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
14204769|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
14204770|NCT05325632|Paclitaxel|paclitaxel|mesh-list
14204771|NCT05325632|Trastuzumab|trastuzumab|mesh-list
14204772|NCT05325632|Pertuzumab|pertuzumab|mesh-list
14501793|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14501794|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
14501795|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14501796|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501797|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14501798|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501799|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14501800|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14501801|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14501802|NCT02060721|Macitentan|macitentan|mesh-list
14501803|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14204773|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14204774|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204775|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
14204776|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
14204777|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
14204778|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204779|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204780|NCT05325593|Dexamethasone|dexamethasone|mesh-list
14204781|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
14204782|NCT05325593|BB 1101|bb 1101|mesh-list
14204783|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204784|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
14204785|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
14204786|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204787|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204788|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14501804|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14501805|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501806|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14941895|NCT01501344|Calcium|calcium|mesh-list
14941896|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14941897|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941898|NCT01501370|Dexamethasone|dexamethasone|mesh-list
14941899|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
14941900|NCT01501370|Lenalidomide|lenalidomide|mesh-list
14941901|NCT01501370|Vorinostat|vorinostat|mesh-list
14941902|NCT01501370|BB 1101|bb 1101|mesh-list
14941903|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14941904|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
14941905|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
14941906|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14941907|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941908|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14941909|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
14204789|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
14204790|NCT05325593|Hormones|hormones|mesh-ancestor
14204791|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14204792|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14204793|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204794|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
14204795|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204796|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204797|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
14204798|NCT05325580|Analgesics|analgesics|mesh-ancestor
14204799|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
14204800|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204801|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204802|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
14204803|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204804|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14204805|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
14204806|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14204807|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14204808|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204809|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14204810|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
14204811|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14204812|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
14204813|NCT05325528|Tegafur|tegafur|mesh-list
14204814|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204815|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204816|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
14204817|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204818|NCT05325515|Alendronate|alendronate|mesh-list
14204819|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14204820|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204821|NCT05325502|Mannitol|mannitol|mesh-list
14204822|NCT05325502|Caffeine|caffeine|mesh-list
14204823|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14775837|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
14775838|NCT00660582|Vitamins|vitamins|mesh-ancestor
14204824|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775839|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
14775840|NCT00660582|Hematinics|hematinics|mesh-ancestor
14775841|NCT00660621|Bevacizumab|bevacizumab|mesh-list
14775842|NCT00660621|Temozolomide|temozolomide|mesh-list
14775843|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14775844|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775845|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14775846|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14775847|NCT00660621|Growth Substances|growth substances|mesh-ancestor
14775848|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775849|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
14775850|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14775851|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
14775852|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775853|NCT00660647|Adalimumab|adalimumab|mesh-list
14775854|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775855|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14775856|NCT00660725|Gemcitabine|gemcitabine|mesh-list
14775857|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
14775858|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775859|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
14775860|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775861|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775862|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
14775863|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775864|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775865|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775866|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
14775867|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775868|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14775869|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14775870|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14775871|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14775872|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204825|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14204826|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204827|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243205|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
14941910|NCT01501370|Hormones|hormones|mesh-ancestor
14941911|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941912|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14941913|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941914|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
14941915|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243206|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243207|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243208|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243209|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
14243210|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243211|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243212|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243213|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243214|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243215|NCT00193492|Bevacizumab|bevacizumab|mesh-list
14243216|NCT00193492|Rituximab|rituximab|mesh-list
14243217|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14941916|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941917|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
14941918|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14941919|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14941920|NCT01501370|Growth Substances|growth substances|mesh-ancestor
14941921|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
14941922|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14941923|NCT01501396|Megestrol|megestrol|mesh-list
14941924|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
14941925|NCT01501396|Mirtazapine|mirtazapine|mesh-list
14941926|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
14941927|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14941928|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14941929|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
14941930|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
14941931|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14941932|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775873|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204828|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14775874|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775875|NCT00660751|Analgesics|analgesics|mesh-ancestor
14775876|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
14775877|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775878|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
14775879|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14775880|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
14775881|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14775882|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14775883|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14775884|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
14775885|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775886|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14775887|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14775888|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14941933|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941934|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14941935|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14941936|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14941937|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14941938|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14941939|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14941940|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
14941941|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14941942|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14941943|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
14941944|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14941945|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14941946|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14941947|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14941948|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
14941949|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14941950|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14501885|NCT01878617|Gemcitabine|gemcitabine|mesh-list
14501886|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
14501887|NCT01878617|Vincristine|vincristine|mesh-list
14501888|NCT01878617|Pemetrexed|pemetrexed|mesh-list
14501889|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14501890|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
14501891|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501892|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14501893|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14501894|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
14501895|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501896|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501897|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14204829|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14204830|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
14204831|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204832|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14204833|NCT05325502|Diuretics|diuretics|mesh-ancestor
14204834|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
14204835|NCT05325346|Argatroban|argatroban|mesh-list
14204836|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
14501898|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775889|NCT00660803|Fulvestrant|fulvestrant|mesh-list
14775890|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14775891|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775892|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14775893|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14204837|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14204838|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
14204839|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204840|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204841|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
14204842|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14775894|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
14775895|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14775896|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775897|NCT00660842|Paclitaxel|paclitaxel|mesh-list
14775898|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14204843|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
14204844|NCT05325281|Gemcitabine|gemcitabine|mesh-list
14204845|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204846|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
14204847|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204848|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204849|NCT05325281|Antiviral Agents|antiviral agents|mesh-ancestor
14204850|NCT05325281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204851|NCT05325281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501899|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
14775899|NCT00660842|Carboplatin|carboplatin|mesh-list
14775900|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14775901|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775902|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
14775903|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
14775904|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
14775905|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775906|NCT00660855|Parecoxib|parecoxib|mesh-list
14775907|NCT00660855|Valdecoxib|valdecoxib|mesh-list
14775908|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14775909|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14501900|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
14501901|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14501902|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14501903|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14775910|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775911|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775912|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14501904|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
14501905|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
14501906|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
14501907|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14501908|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14775913|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204852|NCT05325281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14775914|NCT00660855|Analgesics|analgesics|mesh-ancestor
14775915|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
14941951|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14204853|NCT05325281|Immunologic Factors|immunologic factors|mesh-ancestor
14204854|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204855|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
14204856|NCT05325281|Protective Agents|protective agents|mesh-ancestor
14204857|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
14204858|NCT05325281|Vitamins|vitamins|mesh-ancestor
14204859|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
14204860|NCT05325229|Bevacizumab|bevacizumab|mesh-list
14204861|NCT05325229|Docetaxel|docetaxel|mesh-list
14204862|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204863|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204864|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14204865|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14204866|NCT05325229|Growth Substances|growth substances|mesh-ancestor
14204867|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204868|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14204869|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
14204870|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
14204871|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
14204872|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204873|NCT05325190|Granisetron|granisetron|mesh-list
14204874|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
14204875|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
14204876|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204877|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204878|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14775916|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775917|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775918|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14775919|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14775920|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
14775921|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14775922|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775923|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775924|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14775925|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14775926|NCT00660868|Protective Agents|protective agents|mesh-ancestor
14775927|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941952|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14941953|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941954|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
14941955|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14204879|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14204880|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
14941956|NCT01501422|Estrogens|estrogens|mesh-list
14941957|NCT01501422|Hormones|hormones|mesh-ancestor
14941958|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941959|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941960|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
14941961|NCT01501435|Fenofibrate|fenofibrate|mesh-list
14941962|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14941963|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14775928|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775929|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14775930|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
14775931|NCT00660894|Leucovorin|leucovorin|mesh-list
14775932|NCT00660894|Tegafur|tegafur|mesh-list
14775933|NCT00660894|Calcium|calcium|mesh-list
14775934|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
14775935|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14775936|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204881|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204882|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775937|NCT00660894|Antidotes|antidotes|mesh-ancestor
14775938|NCT00660894|Protective Agents|protective agents|mesh-ancestor
14775939|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
14941964|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
14941965|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941966|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14941967|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14941968|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14941969|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
14941970|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14941971|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14941972|NCT01501448|Estradiol|estradiol|mesh-list
14941973|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14941974|NCT01501448|Estrogens|estrogens|mesh-ancestor
14941975|NCT01501448|Hormones|hormones|mesh-ancestor
14941976|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14941977|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941978|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14941979|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
14204883|NCT05325177|Ibuprofen|ibuprofen|mesh-list
14204884|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14204885|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204886|NCT05325177|Analgesics|analgesics|mesh-ancestor
14204887|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
14204888|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204889|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204890|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14204891|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14204892|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14204893|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204894|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204895|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
14204896|NCT05325073|Hematinics|hematinics|mesh-ancestor
14204897|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
14204898|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14204899|NCT05325008|Antibodies|antibodies|mesh-list
14204900|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
14204901|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14775940|NCT00660894|Vitamins|vitamins|mesh-ancestor
14204902|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
14204903|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240716|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240717|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240718|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14240719|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14240720|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14240721|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
14240722|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14775941|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
14775942|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14775943|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
14941980|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14204904|NCT05324917|Rituximab|rituximab|mesh-list
14204905|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204906|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204907|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
14204908|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204909|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14204910|NCT05324904|Vitamin D|vitamin d|mesh-list
14204911|NCT05324904|Acyclovir|acyclovir|mesh-list
14204912|NCT05324904|Vitamins|vitamins|mesh-ancestor
14204913|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
14204914|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204915|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14204916|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
14204917|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204918|NCT05324891|Fentanyl|fentanyl|mesh-list
14204919|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
14204920|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14204921|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14204922|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204923|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14204924|NCT05324891|Analgesics|analgesics|mesh-ancestor
14204925|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
14204926|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204927|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14204928|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14204929|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14204930|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14204931|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14501961|NCT01821781|Fludarabine|fludarabine|mesh-list
14501962|NCT01821781|Melphalan|melphalan|mesh-list
14501963|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
14501964|NCT01821781|Thiotepa|thiotepa|mesh-list
14501965|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501966|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14501967|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14204932|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204933|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14204934|NCT05324891|Narcotics|narcotics|mesh-ancestor
14204935|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14204936|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14204937|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
14204938|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
14501968|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
14501969|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14501970|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14501971|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
14501972|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14501973|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14775944|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775945|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775946|NCT00660920|Ponatinib|ponatinib|mesh-list
14775947|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14775948|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14775949|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775950|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775951|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14775952|NCT00660933|Hematinics|hematinics|mesh-ancestor
14775953|NCT00660972|Tenofovir|tenofovir|mesh-list
14775954|NCT00660972|Emtricitabine|emtricitabine|mesh-list
14775955|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
14204939|NCT05323058|Benzydamine|benzydamine|mesh-list
14807412|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14204940|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15026741|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
13964274|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775956|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14775957|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
14775958|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775959|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14775960|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13964275|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14501989|NCT01785420|Trastuzumab|trastuzumab|mesh-list
14501990|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14501991|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14501992|NCT01734928|Thalidomide|thalidomide|mesh-list
14501993|NCT01734928|Dexamethasone|dexamethasone|mesh-list
14501994|NCT01734928|Bortezomib|bortezomib|mesh-list
14501995|NCT01734928|Pomalidomide|pomalidomide|mesh-list
14501996|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14501997|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
14501998|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
14501999|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502000|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502001|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14502002|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
14502003|NCT01734928|Hormones|hormones|mesh-ancestor
14502004|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14502005|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14502006|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502007|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
14502008|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502009|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502010|NCT01734928|Growth Substances|growth substances|mesh-ancestor
14502011|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502012|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14502013|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
14502014|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14502015|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14775961|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775962|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775963|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14775964|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14775965|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14775966|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14775967|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14775968|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
14775969|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14775970|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14775971|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14775972|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964276|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13964277|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964278|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964279|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13964280|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
13964281|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026742|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
15026743|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
15026744|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026745|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026746|NCT01945528|Lidocaine|lidocaine|mesh-list
15026747|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
15026748|NCT01945528|Anesthetics|anesthetics|mesh-list
15026749|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775973|NCT00660998|Urological Agents|urological agents|mesh-ancestor
14775974|NCT00661063|Clonidine|clonidine|mesh-list
14775975|NCT00661063|Ketamine|ketamine|mesh-list
14775976|NCT00661063|Analgesics|analgesics|mesh-ancestor
14775977|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
14775978|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775979|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502024|NCT01704859|Vitamin D|vitamin d|mesh-list
14502025|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
14502026|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
14502027|NCT01704859|Vitamins|vitamins|mesh-list
14502028|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
14502029|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502030|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14502031|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14775980|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14775981|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14502032|NCT01685814|Lenalidomide|lenalidomide|mesh-list
14502033|NCT01685814|Bortezomib|bortezomib|mesh-list
14502034|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
14502035|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502036|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502037|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502038|NCT01685814|Growth Substances|growth substances|mesh-ancestor
14502039|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
14775982|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
14775983|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
14775984|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14775985|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14502040|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204941|NCT05317403|Cytarabine|cytarabine|mesh-list
14204942|NCT05317403|Fludarabine|fludarabine|mesh-list
14204943|NCT05317403|Venetoclax|venetoclax|mesh-list
14204944|NCT05317403|Vorinostat|vorinostat|mesh-list
14204945|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204946|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14204947|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
14204948|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204949|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14204950|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
14204951|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14775986|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14775987|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14775988|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14775989|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14775990|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
14775991|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
14775992|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14775993|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14204952|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
14204953|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204954|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14204955|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204956|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
14204957|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14204958|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204959|NCT05311579|Niraparib|niraparib|mesh-list
14204960|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14204961|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204962|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204963|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204964|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
14204965|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14204966|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14204967|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
14204968|NCT05306873|Cyclosporine|cyclosporine|mesh-list
14204969|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14204970|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14204971|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14204972|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
14204973|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14204974|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14204975|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204976|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502096|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
14502097|NCT01547468|Narcotics|narcotics|mesh-ancestor
14502098|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14502099|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502100|NCT01547468|Analgesics|analgesics|mesh-ancestor
14502101|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
14502102|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14775994|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14775995|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
14775996|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14775997|NCT00661076|Adefovir|adefovir|mesh-list
14775998|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14775999|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
14776000|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776001|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14776002|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14776003|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776004|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776005|NCT00661102|Capecitabine|capecitabine|mesh-list
14776006|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14776007|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
14776008|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776009|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776010|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776011|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776012|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776013|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14502113|NCT01485861|Prednisone|prednisone|mesh-list
14502114|NCT01485861|Prednisolone|prednisolone|mesh-list
14502115|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502116|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
14502117|NCT01485861|Hormones|hormones|mesh-ancestor
14502118|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14502119|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502120|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14502121|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776014|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776015|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776016|NCT00661115|Urological Agents|urological agents|mesh-ancestor
14776017|NCT00661154|Bevacizumab|bevacizumab|mesh-list
14776018|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14776019|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776020|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14776021|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14776022|NCT00661154|Growth Substances|growth substances|mesh-ancestor
14776023|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776024|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
14776025|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14776026|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776027|NCT00661180|Sorafenib|sorafenib|mesh-list
14204977|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
14204978|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
14776028|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776029|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14776030|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776031|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776032|NCT00661206|Clopidogrel|clopidogrel|mesh-list
14941981|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14941982|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14204979|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14776033|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14776034|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14776035|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14776036|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14776037|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
14941983|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14941984|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14941985|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14941986|NCT01501487|Paclitaxel|paclitaxel|mesh-list
14941987|NCT01501487|Docetaxel|docetaxel|mesh-list
14941988|NCT01501487|Trastuzumab|trastuzumab|mesh-list
14941989|NCT01501487|Pertuzumab|pertuzumab|mesh-list
14204980|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
14204981|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14941990|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14204982|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14204983|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14204984|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14204985|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14776038|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776039|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776040|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776041|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776042|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776043|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776044|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776045|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776046|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776047|NCT00661219|Urological Agents|urological agents|mesh-ancestor
14776048|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776049|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776050|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776051|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776052|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14204986|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14204987|NCT05294328|Aceclidine|aceclidine|mesh-list
14204988|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14204989|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14204990|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14776053|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776054|NCT00661297|Urological Agents|urological agents|mesh-ancestor
14941991|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14941992|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
14941993|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
14941994|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
14941995|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14941996|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14941997|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14941998|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14941999|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942000|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942001|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14942002|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14204991|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14204992|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
14204993|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14204994|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14204995|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14204996|NCT05294328|Miotics|miotics|mesh-ancestor
14204997|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
14204998|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14204999|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14776055|NCT00661336|Melphalan|melphalan|mesh-list
14776056|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
14776057|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14776058|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
14776059|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776060|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776061|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14776062|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14776063|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
14776064|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205000|NCT05285683|Levodopa|levodopa|mesh-list
14205001|NCT05285683|Carbidopa|carbidopa|mesh-list
14205002|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14205003|NCT05285683|Methylphenidate|methylphenidate|mesh-list
14205004|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14205005|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205006|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14205007|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14205008|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14205009|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205010|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
14205011|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205012|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14205013|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14776065|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
14776066|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14776067|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776068|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14776069|NCT00661336|Protective Agents|protective agents|mesh-ancestor
14807413|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807414|NCT00821600|Risperidone|risperidone|mesh-list
14807415|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14807416|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
14807417|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807418|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807419|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807420|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14807421|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807422|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807423|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14807424|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14807425|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
14807426|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
14807427|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14807428|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
14807429|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807430|NCT00821782|Azithromycin|azithromycin|mesh-list
14807431|NCT00821782|Levofloxacin|levofloxacin|mesh-list
14807432|NCT00821782|Ofloxacin|ofloxacin|mesh-list
14807433|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14807434|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807435|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14807436|NCT00821782|Renal Agents|renal agents|mesh-ancestor
14807437|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14807438|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14807439|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807440|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807441|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807442|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14807443|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14807444|NCT00821834|Ticlopidine|ticlopidine|mesh-list
14807445|NCT00821834|Clopidogrel|clopidogrel|mesh-list
14807446|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14205014|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14205015|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205016|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14205017|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
14205018|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
14205019|NCT05275023|Tenofovir|tenofovir|mesh-list
14502166|NCT01387763|Interferons|interferons|mesh-list
14502167|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
14502168|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
14502169|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14502170|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14502171|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
14502172|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502173|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
14502174|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502175|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
14502176|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502177|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
14502178|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502179|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502180|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205020|NCT05275023|Entecavir|entecavir|mesh-list
14205021|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14205022|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
14205023|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205024|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205025|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205026|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205027|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205028|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205029|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205030|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205031|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
14205032|NCT05272254|Povidone|povidone|mesh-list
14205033|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
14205034|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
14205035|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14205036|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205037|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
14205038|NCT05263492|Lenvatinib|lenvatinib|mesh-list
14205039|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205040|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205041|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14205042|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205043|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205044|NCT05253937|Epinephrine|epinephrine|mesh-list
14205045|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14205046|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14205047|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
14205048|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205049|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502198|NCT01349881|Eflornithine|eflornithine|mesh-list
14502199|NCT01349881|Sulindac|sulindac|mesh-list
14502200|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502201|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14502202|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14502203|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14502204|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502205|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14502206|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502207|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205050|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776070|NCT00661349|Ritonavir|ritonavir|mesh-list
14776071|NCT00661349|Lopinavir|lopinavir|mesh-list
14776072|NCT00661349|Nevirapine|nevirapine|mesh-list
14776073|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14776074|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14776075|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
14776076|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205051|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14205052|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14205053|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
14205054|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205055|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14205056|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14205057|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
14205058|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
14205059|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14205060|NCT05236673|Empagliflozin|empagliflozin|mesh-list
14205061|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14205062|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502208|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14502209|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14502210|NCT01349881|Analgesics|analgesics|mesh-ancestor
14502211|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
14502212|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502213|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502214|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502215|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14502216|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14502217|NCT01330446|Modafinil|modafinil|mesh-list
14502218|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14502219|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502220|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14502221|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14502222|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14502223|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776077|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776078|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14776079|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14776080|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
14776081|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776082|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14776083|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14776084|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14776085|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14776086|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14776087|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14776088|NCT00661375|Sorafenib|sorafenib|mesh-list
14776089|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776090|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14776091|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964282|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964283|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13964284|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13964285|NCT03138785|Renal Agents|renal agents|mesh-ancestor
13964286|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14205063|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14205064|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205065|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14205066|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14205067|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205068|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
14205069|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
14205070|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205071|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205072|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14205073|NCT05204147|Antibodies|antibodies|mesh-list
14205074|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
14205075|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14205076|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14205077|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
14205078|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205079|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205080|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
14205081|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
14205082|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205083|NCT05202860|Vaccines|vaccines|mesh-list
14205084|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
14205085|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205086|NCT05197075|Darunavir|darunavir|mesh-list
14205087|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14205088|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14205089|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
14205090|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205091|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964287|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13964288|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13964289|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964290|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13964291|NCT03138616|Vitamin D|vitamin d|mesh-list
14205092|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205093|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205094|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
14205095|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205096|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
14205097|NCT05185739|Lenvatinib|lenvatinib|mesh-list
14205098|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205099|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205100|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14205101|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205102|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205103|NCT05176418|Nicotine|nicotine|mesh-list
14205104|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14205105|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
14205106|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205107|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205108|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14205109|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14776092|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776093|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
14776094|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
14776095|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776096|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776097|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776098|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14205110|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
14205111|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205112|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205115|NCT05171777|Atezolizumab|atezolizumab|mesh-list
14205116|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205117|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
14205118|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205119|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205120|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
14205121|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205122|NCT05153239|Irinotecan|irinotecan|mesh-list
14205123|NCT05153239|Topotecan|topotecan|mesh-list
14205124|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14205125|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14205126|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205127|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205128|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240723|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14240724|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
14240725|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240726|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14240727|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
14240728|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14240729|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240730|NCT00166296|Citalopram|citalopram|mesh-list
14240731|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14240732|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14240733|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240734|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240735|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240736|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
14240737|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240738|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14240739|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
14240740|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240741|NCT00166439|Cytarabine|cytarabine|mesh-list
14240742|NCT00166439|Dexamethasone|dexamethasone|mesh-list
14240743|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
14240744|NCT00166439|Rituximab|rituximab|mesh-list
14240745|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240746|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
14240747|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
14240748|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240749|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240750|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240751|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
14240752|NCT00166439|Hormones|hormones|mesh-ancestor
14240753|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240754|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14205129|NCT05146804|Sulforaphane|sulforaphane|mesh-list
14205130|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14205131|NCT05146804|Protective Agents|protective agents|mesh-ancestor
14205132|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205133|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205134|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
14205135|NCT05140941|Velpatasvir|velpatasvir|mesh-list
14205136|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
14205137|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205138|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
14205139|NCT05134441|Calcium|calcium|mesh-list
14205140|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14502261|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
14502262|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14502263|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14502264|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502265|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14502266|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14502267|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
14502268|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14502269|NCT01295645|Cidofovir|cidofovir|mesh-list
14502270|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
14776099|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776100|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502271|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502272|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502273|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502274|NCT01283997|Minocycline|minocycline|mesh-list
14502275|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14502276|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502277|NCT01254864|Prednisone|prednisone|mesh-list
14502278|NCT01254864|Sunitinib|sunitinib|mesh-list
14502279|NCT01254864|Dasatinib|dasatinib|mesh-list
14502280|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
14502281|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502282|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
14502283|NCT01254864|Hormones|hormones|mesh-ancestor
14502284|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14502285|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502286|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14502287|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502288|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502289|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502290|NCT01254864|Growth Substances|growth substances|mesh-ancestor
14502291|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502292|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502293|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502294|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502295|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14502296|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
14502297|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14502298|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
14502299|NCT01246869|Imidazole|imidazole|mesh-list
14502300|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502301|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502302|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
14502303|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
14502304|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502305|NCT01198067|Pomalidomide|pomalidomide|mesh-list
14502306|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
14502307|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502308|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502309|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502310|NCT01198067|Growth Substances|growth substances|mesh-ancestor
14502311|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502312|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502313|NCT01187199|Sirolimus|sirolimus|mesh-list
14502314|NCT01187199|Paclitaxel|paclitaxel|mesh-list
14502315|NCT01187199|Bevacizumab|bevacizumab|mesh-list
14776101|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776102|NCT00661596|Urological Agents|urological agents|mesh-ancestor
14776103|NCT00661635|Valdecoxib|valdecoxib|mesh-list
14205141|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502316|NCT01187199|Carboplatin|carboplatin|mesh-list
14502317|NCT01187199|Sorafenib|sorafenib|mesh-list
14205142|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14205143|NCT05112939|Rilpivirine|rilpivirine|mesh-list
14205144|NCT05112939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205145|NCT05112939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205146|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205147|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205148|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
14205149|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205150|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205151|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205152|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
14205153|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
14205154|NCT05094128|Upadacitinib|upadacitinib|mesh-list
14205155|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14205156|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14205157|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205158|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205159|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205160|NCT05071313|Vaccines|vaccines|mesh-list
14205161|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
14205162|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205163|NCT05071053|Ramucirumab|ramucirumab|mesh-list
14205164|NCT05071053|Maytansine|maytansine|mesh-list
14205165|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205166|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14205167|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205168|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
14502318|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14502319|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502320|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14502321|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14502322|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205169|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205170|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205171|NCT05067998|Vitamins|vitamins|mesh-list
14205172|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
14205173|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205174|NCT05054140|Calcium|calcium|mesh-list
14205175|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14205176|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205177|NCT05053659|Venetoclax|venetoclax|mesh-list
14205178|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14205179|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205180|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205181|NCT05047250|Gemcitabine|gemcitabine|mesh-list
14205182|NCT05047250|Paclitaxel|paclitaxel|mesh-list
14205183|NCT05047250|Carboplatin|carboplatin|mesh-list
14205184|NCT05047250|Pemetrexed|pemetrexed|mesh-list
14205185|NCT05047250|Atezolizumab|atezolizumab|mesh-list
14205186|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14205187|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205188|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205189|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205190|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205191|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502323|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502324|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14502325|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502326|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502327|NCT01187199|Growth Substances|growth substances|mesh-ancestor
14502328|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776104|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14776105|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776106|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776107|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776108|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776109|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776110|NCT00661635|Analgesics|analgesics|mesh-ancestor
14776111|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
14776112|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776113|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776114|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776115|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776116|NCT00661648|Pancrelipase|pancrelipase|mesh-list
14776117|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14776118|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14942003|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942004|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
14942005|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942006|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
14942007|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
14942008|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
14205192|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14942009|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14942010|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
14942011|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
14942012|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942013|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942014|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502329|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502330|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502331|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502332|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14502333|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502334|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14502335|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
14502336|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14502337|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
14502338|NCT01176474|Nivolumab|nivolumab|mesh-list
14502339|NCT01176474|Ipilimumab|ipilimumab|mesh-list
14502340|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205193|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
14205194|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
14205195|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205196|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205197|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205198|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
14205199|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205200|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14205201|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205202|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14205203|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
14205204|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205205|NCT05036980|Protective Agents|protective agents|mesh-ancestor
14205206|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205207|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14205208|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205209|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14205210|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
14205211|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14502341|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502342|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14502343|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942015|NCT01501669|Capecitabine|capecitabine|mesh-list
14942016|NCT01501669|Irinotecan|irinotecan|mesh-list
14205212|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
14205213|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14205214|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205215|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14205216|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14205217|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776119|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776120|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776121|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776122|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776123|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776124|NCT00661700|Urological Agents|urological agents|mesh-ancestor
14776125|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14776126|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14942017|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14776127|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
14776128|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776129|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205218|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
14205219|NCT05014646|Leflunomide|leflunomide|mesh-list
14776130|NCT00661765|Varenicline|varenicline|mesh-list
14776131|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14776132|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14776133|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
14776134|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776135|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776136|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776137|NCT00661856|Genistein|genistein|mesh-list
14776138|NCT00661856|Daidzein|daidzein|mesh-list
14776139|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14776140|NCT00661856|Protective Agents|protective agents|mesh-ancestor
14776141|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776142|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776143|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14776144|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776145|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776146|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
14776147|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14776148|NCT00661856|Estrogens|estrogens|mesh-ancestor
14776149|NCT00661856|Hormones|hormones|mesh-ancestor
14776150|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14776151|NCT00661973|Budesonide|budesonide|mesh-list
14776152|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776153|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14776154|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
14776155|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776156|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776157|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14776158|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
14776159|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
14776160|NCT00661973|Hormones|hormones|mesh-ancestor
14776161|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14776162|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
14776163|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14776164|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776165|NCT00662220|Ribavirin|ribavirin|mesh-list
14776166|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14776167|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
14776168|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
14205220|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205221|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205222|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205223|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
14205224|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205225|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14205226|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14502377|NCT01154920|Paclitaxel|paclitaxel|mesh-list
14502378|NCT01154920|Docetaxel|docetaxel|mesh-list
14502379|NCT01154920|Cisplatin|cisplatin|mesh-list
14502380|NCT01154920|Carboplatin|carboplatin|mesh-list
14502381|NCT01154920|Fluorouracil|fluorouracil|mesh-list
14502382|NCT01154920|Cetuximab|cetuximab|mesh-list
14502383|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14502384|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502385|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
14502386|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
14502387|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
14502388|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502389|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
14502390|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14502391|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14502392|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
14502393|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502394|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205227|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
14205228|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14776169|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205229|NCT05011513|Ritonavir|ritonavir|mesh-list
14205230|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14205231|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14205232|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
14205233|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205234|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205235|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205236|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205237|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
14205238|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205239|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14205240|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14205241|NCT04996719|Sirolimus|sirolimus|mesh-list
14205242|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14205243|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205244|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14205245|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205246|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
14205247|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205248|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
14205249|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205250|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
14205251|NCT04973566|Etanercept|etanercept|mesh-list
14205252|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
14205253|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14205254|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14205255|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205256|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205257|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205258|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205259|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14205260|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14502407|NCT01113476|Gemcitabine|gemcitabine|mesh-list
14502408|NCT01113476|Paclitaxel|paclitaxel|mesh-list
14776170|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
14205261|NCT04973566|Analgesics|analgesics|mesh-ancestor
14502409|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14205262|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
14205263|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502410|NCT01113476|Bevacizumab|bevacizumab|mesh-list
14502411|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14502412|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502413|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205264|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205265|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205266|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14205267|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205268|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
14502414|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205276|NCT04961541|Vaccines|vaccines|mesh-list
14205277|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
14205278|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205279|NCT04956627|Itraconazole|itraconazole|mesh-list
14205280|NCT04956627|Phenytoin|phenytoin|mesh-list
14205281|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
14205282|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
14205283|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205284|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14205285|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14205286|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205287|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205288|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14205289|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
14205290|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205291|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205292|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14205293|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
14502415|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
14502416|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502417|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14502418|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502419|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502420|NCT01113476|Growth Substances|growth substances|mesh-ancestor
14502421|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502422|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502423|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14502424|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
14502425|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
14502426|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502427|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502428|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205294|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14205295|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14205296|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14502429|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
14205297|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14205298|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14205299|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14205300|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
14205301|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14205302|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14205303|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14205304|NCT04931615|Thrombin|thrombin|mesh-list
14205305|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
14205306|NCT04931615|Coagulants|coagulants|mesh-ancestor
14205307|NCT04907968|Carboplatin|carboplatin|mesh-list
14205308|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205309|NCT04873362|Trastuzumab|trastuzumab|mesh-list
14205310|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14205311|NCT04873362|Atezolizumab|atezolizumab|mesh-list
14205312|NCT04873362|Maytansine|maytansine|mesh-list
14205313|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205314|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205315|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14205316|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205317|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205318|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205319|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205324|NCT04754334|Insulin|insulin|mesh-list
14205325|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14205326|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240755|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240756|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240757|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
14240758|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240759|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14240760|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
14240761|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240762|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
14240763|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240764|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240765|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
14240766|NCT00166712|Sirolimus|sirolimus|mesh-list
14240767|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
14240768|NCT00166712|Tacrolimus|tacrolimus|mesh-list
14240769|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240770|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
14240771|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240772|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14240773|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240774|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240775|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14240776|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240777|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14240778|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
14240779|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14240780|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240781|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
14240782|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240783|NCT00167102|Alefacept|alefacept|mesh-list
14776171|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14240784|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
14240785|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
14502443|NCT01015222|Paclitaxel|paclitaxel|mesh-list
14502444|NCT01015222|Bevacizumab|bevacizumab|mesh-list
14502445|NCT01015222|Dasatinib|dasatinib|mesh-list
14502446|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14240786|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240787|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
14240788|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240789|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
14240790|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240791|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240792|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14240793|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
14240794|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240795|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776172|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
14776173|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776174|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
14776175|NCT00662233|Ifosfamide|ifosfamide|mesh-list
14502447|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776176|NCT00662233|Doxorubicin|doxorubicin|mesh-list
14240796|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14205327|NCT04722575|Atezolizumab|atezolizumab|mesh-list
14205328|NCT04722575|Vemurafenib|vemurafenib|mesh-list
14205329|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205330|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14205331|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205332|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205333|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
14205334|NCT04717375|Cetuximab|cetuximab|mesh-list
14205335|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205336|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205337|NCT04677504|Gemcitabine|gemcitabine|mesh-list
14205338|NCT04677504|Bevacizumab|bevacizumab|mesh-list
14205339|NCT04677504|Atezolizumab|atezolizumab|mesh-list
14205340|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205341|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205342|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14205343|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14205344|NCT04677504|Growth Substances|growth substances|mesh-ancestor
14205345|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205346|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14205347|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14502448|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
14502449|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
14502450|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
14502451|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502452|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14502453|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502454|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502455|NCT01015222|Growth Substances|growth substances|mesh-ancestor
14502456|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502457|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502458|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502459|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205348|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
14205349|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205350|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
14205351|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205352|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205353|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205354|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
14205355|NCT04667312|Durvalumab|durvalumab|mesh-list
14205356|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205357|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776177|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14776178|NCT00662233|Etoposide|etoposide|mesh-list
14776179|NCT00662233|Vincristine|vincristine|mesh-list
14776180|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14776181|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
14776182|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776183|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942018|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
14942019|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942020|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942021|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14942022|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14942023|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205358|NCT04667104|Tenofovir|tenofovir|mesh-list
14776184|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14942024|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
14942025|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14942026|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14942027|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942028|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942029|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942030|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14942031|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
14942032|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942033|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942034|NCT01501708|Voriconazole|voriconazole|mesh-list
14942035|NCT01501708|Amphotericin B|amphotericin b|mesh-list
14942036|NCT01501708|Caspofungin|caspofungin|mesh-list
14942037|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
14205359|NCT04667104|Entecavir|entecavir|mesh-list
14205360|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14776185|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
14776186|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776187|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776188|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14776189|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14776190|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14776191|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14776192|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776193|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14776194|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
14502497|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
14502498|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
14502499|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502500|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
14502501|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502502|NCT00800514|Amantadine|amantadine|mesh-list
14502503|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14502504|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14502505|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
14502506|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502507|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
14502508|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14502509|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502510|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502511|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14502512|NCT00800514|Analgesics|analgesics|mesh-ancestor
14502513|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
14776195|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
14776196|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
14776197|NCT00662272|Vaccines|vaccines|mesh-list
14776198|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
14776199|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776200|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
14942038|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942039|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14942040|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13964292|NCT03138616|Vitamins|vitamins|mesh-ancestor
13964293|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
13964294|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964295|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13964296|NCT03138499|Nivolumab|nivolumab|mesh-list
13964297|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13964298|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964299|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964300|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13964301|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964302|NCT03138447|Insulin|insulin|mesh-list
13964303|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13968032|NCT03113344|Amoxicillin|amoxicillin|mesh-list
14205361|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
14205362|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205363|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205364|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205365|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205366|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205367|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205368|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205369|NCT04660344|Atezolizumab|atezolizumab|mesh-list
14942041|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942042|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942043|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14942044|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
14942045|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942046|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502514|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502515|NCT00788125|Carboplatin|carboplatin|mesh-list
14502516|NCT00788125|Etoposide|etoposide|mesh-list
14502517|NCT00788125|Ifosfamide|ifosfamide|mesh-list
14502518|NCT00788125|Dasatinib|dasatinib|mesh-list
14502519|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
14502520|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502521|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14502522|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14502523|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14502524|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502525|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502526|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14502527|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
14502528|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502529|NCT00745134|Curcumin|curcumin|mesh-list
14502530|NCT00745134|Capecitabine|capecitabine|mesh-list
14502531|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14502532|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
14502533|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502534|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502535|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14502536|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14502537|NCT00745134|Analgesics|analgesics|mesh-ancestor
14502538|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
14502539|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502540|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502541|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502542|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14502543|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502546|NCT00715442|Sunitinib|sunitinib|mesh-list
14502547|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502548|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502549|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502550|NCT00715442|Growth Substances|growth substances|mesh-ancestor
14502551|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205370|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205371|NCT04655586|Heparin|heparin|mesh-list
14205372|NCT04655586|Protein C|protein c|mesh-list
14205373|NCT04655586|Anticoagulants|anticoagulants|mesh-list
14205374|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14205375|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14205376|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205377|NCT04641975|Mirabegron|mirabegron|mesh-list
14502552|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
14205378|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14205379|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14205380|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14205381|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
14205382|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205383|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205384|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205385|NCT04641975|Urological Agents|urological agents|mesh-ancestor
14205386|NCT04630145|Clarithromycin|clarithromycin|mesh-list
14205387|NCT04630145|Rifampin|rifampin|mesh-list
14205388|NCT04630145|Ethambutol|ethambutol|mesh-list
14205389|NCT04630145|Rifabutin|rifabutin|mesh-list
14205390|NCT04630145|Bedaquiline|bedaquiline|mesh-list
14205391|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14205392|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205393|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14205394|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205395|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205396|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14205397|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14205398|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14205399|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
14205400|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
14205401|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205402|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14205403|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14205404|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14502553|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502554|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502555|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502556|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
14502557|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
14502558|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502559|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
14502560|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502561|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
14502562|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
14502563|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502564|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
14502565|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776201|NCT00662337|Promethazine|promethazine|mesh-list
14776202|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14942047|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14942048|NCT01501708|Amebicides|amebicides|mesh-ancestor
14942049|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14942050|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14942051|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942052|NCT01501747|Acetaminophen|acetaminophen|mesh-list
14942053|NCT01501747|Cephalexin|cephalexin|mesh-list
14942054|NCT01501747|Ibuprofen|ibuprofen|mesh-list
14942055|NCT01501747|Caffeine|caffeine|mesh-list
14942056|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14942057|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942058|NCT01501747|Analgesics|analgesics|mesh-ancestor
14942059|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
14942060|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942061|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942062|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942063|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942064|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14942065|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942066|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942067|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
14942068|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14942069|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14942070|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14942071|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14942072|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
14942073|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942074|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942075|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942076|NCT01501760|Bevacizumab|bevacizumab|mesh-list
14776203|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14776204|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776205|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776206|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
14776207|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
14776208|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
14776209|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776210|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
14776211|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
14776212|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14776213|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14776214|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
14776215|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
14776216|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776217|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776218|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14942077|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205405|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14205406|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14205407|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14205408|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14205409|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14205410|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776219|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
14776220|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
14776221|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776222|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776223|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776224|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776225|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776226|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776227|NCT00662441|Urological Agents|urological agents|mesh-ancestor
14776228|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14502583|NCT00329043|Sunitinib|sunitinib|mesh-list
14502584|NCT00329043|Leuprolide|leuprolide|mesh-list
14502585|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502586|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502587|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502588|NCT00329043|Growth Substances|growth substances|mesh-ancestor
14502589|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502590|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502591|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502592|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502593|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502594|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14502595|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
14502596|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14502597|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14502598|NCT00200200|Bevacizumab|bevacizumab|mesh-list
14502599|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14502600|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502601|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14502602|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502603|NCT00200200|Growth Substances|growth substances|mesh-ancestor
14776229|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14776230|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
14776231|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14776232|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14776233|NCT00662454|Estradiol|estradiol|mesh-list
14776234|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14776235|NCT00662454|Estrogens|estrogens|mesh-ancestor
14776236|NCT00662454|Hormones|hormones|mesh-ancestor
14776237|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14776238|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776239|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14776240|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
14776241|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14776242|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14205411|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205412|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
14776243|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14776244|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14776245|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14776246|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14776247|NCT00662467|Aspirin|aspirin|mesh-list
14776248|NCT00662467|Warfarin|warfarin|mesh-list
14776249|NCT00662467|Clopidogrel|clopidogrel|mesh-list
14776250|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776251|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776252|NCT00662467|Analgesics|analgesics|mesh-ancestor
14776253|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
14776254|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776255|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776256|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776257|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776258|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14502604|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502605|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502606|NCT00199862|Antibodies|antibodies|mesh-list
14502607|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
14502608|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502609|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14502610|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502611|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502612|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502613|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14205413|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205414|NCT04620733|Seladelpar|seladelpar|mesh-list
14205415|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14205416|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
14205417|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205418|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14205419|NCT04603183|Paclitaxel|paclitaxel|mesh-list
14205420|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14205421|NCT04603183|Letrozole|letrozole|mesh-list
13968033|NCT03113344|Azithromycin|azithromycin|mesh-list
13968034|NCT03113344|Meropenem|meropenem|mesh-list
13968035|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
13968036|NCT03113344|Imipenem|imipenem|mesh-list
13968037|NCT03113344|Penicillins|penicillins|mesh-list
14205422|NCT04603183|Fulvestrant|fulvestrant|mesh-list
14205423|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14205424|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205425|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205426|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205427|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205428|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205429|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14205430|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14205431|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205432|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14205433|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
14205434|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14776259|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14776260|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776261|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14776262|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776263|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776264|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
13968038|NCT03113344|Erythromycin|erythromycin|mesh-list
13968039|NCT03113344|Ceftazidime|ceftazidime|mesh-list
13968040|NCT03113344|Ampicillin|ampicillin|mesh-list
13968041|NCT03113344|Cephalosporins|cephalosporins|mesh-list
13968042|NCT03113344|Acyclovir|acyclovir|mesh-list
13968043|NCT03113344|Ganciclovir|ganciclovir|mesh-list
13968044|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
13968045|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13968046|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968047|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968048|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968049|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968050|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14205435|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205436|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14205437|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14205438|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
14205439|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205440|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
14205441|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14205442|NCT04585789|Tenofovir|tenofovir|mesh-list
14205443|NCT04585789|Entecavir|entecavir|mesh-list
14205444|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14205445|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
14205446|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205447|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205448|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205449|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205450|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205451|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205452|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205453|NCT04546425|Vaccines|vaccines|mesh-list
14205454|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14205455|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
14776265|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14776266|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14776267|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14776268|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
14776269|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776270|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
14776271|NCT00662519|Sargramostim|sargramostim|mesh-list
14776272|NCT00662519|Lenograstim|lenograstim|mesh-list
14776273|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
14776274|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942078|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942079|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14942080|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14942081|NCT01501760|Growth Substances|growth substances|mesh-ancestor
14942082|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942083|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
14942084|NCT01501786|Ketamine|ketamine|mesh-list
14942085|NCT01501786|Propofol|propofol|mesh-list
14942086|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14942087|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942088|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942089|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14942090|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
14942091|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
14942092|NCT01501786|Analgesics|analgesics|mesh-ancestor
14942093|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
14942094|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942095|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14942096|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14942097|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14942098|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942099|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942100|NCT01501799|Adapalene|adapalene|mesh-list
14942101|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14240797|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
14240798|NCT00167206|Fludarabine|fludarabine|mesh-list
14240799|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240800|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
14240801|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240802|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14240803|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14240804|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
14240805|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240806|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240807|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14240808|NCT00167245|Topiramate|topiramate|mesh-list
14240809|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
14240810|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14240811|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240812|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
14240813|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240814|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
14240815|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240816|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240817|NCT00167934|Valproic Acid|valproic acid|mesh-list
14240818|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
14240819|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240820|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240821|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
14240822|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240823|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205456|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205457|NCT04544267|Vaccines|vaccines|mesh-list
14205458|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
14776275|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14776276|NCT00662571|Acamprosate|acamprosate|mesh-list
14776277|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14776278|NCT00662610|Naproxen|naproxen|mesh-list
14776279|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14776280|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776281|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776282|NCT00662610|Analgesics|analgesics|mesh-ancestor
14776283|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
14776284|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776285|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968051|NCT03113123|Tenofovir|tenofovir|mesh-list
14942102|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
14942103|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14942104|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942105|NCT01501799|Analgesics|analgesics|mesh-ancestor
14942106|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
14942107|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942108|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942109|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942110|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942111|NCT01501890|Algestone|algestone|mesh-list
14942112|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14942113|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14942114|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14942115|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
14942116|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942117|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942118|NCT01501890|Progestins|progestins|mesh-ancestor
14942119|NCT01501890|Hormones|hormones|mesh-ancestor
14942120|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14942121|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14942122|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14942123|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
14942124|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14942125|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14942126|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14942127|NCT01501916|Vitamin D|vitamin d|mesh-list
14942128|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
14942129|NCT01501916|Vitamins|vitamins|mesh-ancestor
14942130|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
14942131|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942132|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14942133|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14942134|NCT01501942|Glycine|glycine|mesh-list
14942135|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
14942136|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942137|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942138|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942139|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
14205459|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205460|NCT04535544|Tenofovir|tenofovir|mesh-list
14205461|NCT04535544|Entecavir|entecavir|mesh-list
14205462|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
14205463|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205464|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205465|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205466|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205467|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205468|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205469|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205470|NCT04510038|Colchicine|colchicine|mesh-list
14205471|NCT04510038|Gout Suppressants|gout suppressants|mesh-ancestor
14205472|NCT04510038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205473|NCT04510038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205474|NCT04510038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205475|NCT04510038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205476|NCT04510038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205477|NCT04510038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205478|NCT04498923|Dexamethasone|dexamethasone|mesh-list
14205479|NCT04498923|Epinephrine|epinephrine|mesh-list
14205480|NCT04498923|Bupivacaine|bupivacaine|mesh-list
14205481|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205482|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
14776286|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776287|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776288|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
14776289|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776290|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776291|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776292|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14776293|NCT00662636|Dasatinib|dasatinib|mesh-list
14776294|NCT00662636|Lapatinib|lapatinib|mesh-list
14776295|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776296|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14776297|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776298|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776299|NCT00662714|Insulin|insulin|mesh-list
14776300|NCT00662714|Repaglinide|repaglinide|mesh-list
14205483|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
14205484|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205485|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205486|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14205487|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
14205488|NCT04498923|Hormones|hormones|mesh-ancestor
14205489|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205490|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14205491|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205492|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
14942140|NCT01501968|Colistin|colistin|mesh-list
14205493|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
14205494|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776301|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14776302|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
14942141|NCT01501968|Vitamins|vitamins|mesh-ancestor
14942142|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
14942143|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942144|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
14942145|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942146|NCT01501968|Protective Agents|protective agents|mesh-ancestor
14942147|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942148|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942149|NCT01502020|Imiquimod|imiquimod|mesh-list
14942150|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14942151|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
14942152|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942153|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942154|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
14942155|NCT01502046|Dronabinol|dronabinol|mesh-list
14942156|NCT01502046|Cannabidiol|cannabidiol|mesh-list
14776303|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14776304|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776305|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
14776306|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14205495|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
14205496|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14205497|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14205498|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
14205499|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776307|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
14776308|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776309|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776310|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14776311|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
14776312|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14205500|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205501|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14205502|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14205503|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14205504|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
14205505|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
14205506|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
14205507|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14205508|NCT04469556|Leucovorin|leucovorin|mesh-list
14205509|NCT04469556|Gemcitabine|gemcitabine|mesh-list
14205510|NCT04469556|Paclitaxel|paclitaxel|mesh-list
14205511|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
14205512|NCT04469556|Irinotecan|irinotecan|mesh-list
14205513|NCT04469556|Folfirinox|folfirinox|mesh-list
14205514|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14205515|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205516|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205517|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205518|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205519|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205520|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14205521|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
14205522|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
14205523|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205524|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205525|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205526|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
14205527|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205528|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14205529|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14205530|NCT04469556|Antidotes|antidotes|mesh-ancestor
14205531|NCT04469556|Protective Agents|protective agents|mesh-ancestor
14205532|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
14205533|NCT04469556|Vitamins|vitamins|mesh-ancestor
14205534|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
14205535|NCT04461795|Erenumab|erenumab|mesh-list
14205536|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14205537|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
14205538|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205539|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14205540|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205541|NCT04461795|Analgesics|analgesics|mesh-ancestor
14205542|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
14205543|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205544|NCT04458831|Dexamethasone|dexamethasone|mesh-list
14205545|NCT04458831|Pomalidomide|pomalidomide|mesh-list
14240824|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
14240825|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14240826|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14240827|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14240828|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
14240829|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14240830|NCT00168038|Antibodies|antibodies|mesh-list
14240831|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
14240832|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240833|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
14240834|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14240835|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
14240836|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240837|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14240838|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205546|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205547|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
14205548|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
14205549|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776313|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14776314|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14776315|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
14776316|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776317|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776318|NCT00662805|Fluticasone|fluticasone|mesh-list
14776319|NCT00662805|Xhance|xhance|mesh-list
14776320|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14776321|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776322|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14776323|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
14776324|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776325|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776326|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14776327|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
14776328|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
14776329|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14776330|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14776331|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14776332|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14776333|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
14776334|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776335|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776336|NCT00662844|Vitamin D|vitamin d|mesh-list
14776337|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
14776338|NCT00662844|Vitamins|vitamins|mesh-ancestor
14776339|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
14776340|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964304|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205550|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205551|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14205552|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
14205553|NCT04458831|Hormones|hormones|mesh-ancestor
14205554|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205555|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14205556|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776341|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14776342|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14776343|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
13964305|NCT03138356|Metformin|metformin|mesh-list
13964306|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
13964307|NCT03138356|Saxagliptin|saxagliptin|mesh-list
13964308|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13964309|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964310|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13964311|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964312|NCT03138356|Incretins|incretins|mesh-ancestor
13964313|NCT03138356|Hormones|hormones|mesh-ancestor
13968052|NCT03113123|Emtricitabine|emtricitabine|mesh-list
14776344|NCT00662883|Ketamine|ketamine|mesh-list
14776345|NCT00662883|Analgesics|analgesics|mesh-ancestor
14205557|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
14205558|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14776346|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
14776347|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776348|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776349|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14776350|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14776351|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
14776352|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
14528410|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528411|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14528412|NCT03852537|Protective Agents|protective agents|mesh-ancestor
14528413|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14528414|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528415|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
14528416|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
14528417|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528418|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14528419|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
14528420|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528421|NCT03873116|Berotralstat|berotralstat|mesh-list
14528422|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528423|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528424|NCT03872843|Ibuprofen|ibuprofen|mesh-list
14528425|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14528426|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14528427|NCT03872843|Analgesics|analgesics|mesh-ancestor
14776353|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776354|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14776355|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14776356|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776357|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776358|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776359|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
14776360|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14776361|NCT00662896|Ibuprofen|ibuprofen|mesh-list
14205559|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14205560|NCT04458831|Growth Substances|growth substances|mesh-ancestor
14205561|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
14205562|NCT04439539|Tenofovir|tenofovir|mesh-list
14205563|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14205564|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
14205565|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205566|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205567|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205568|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205569|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205570|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205571|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205572|NCT04439188|GSK2636771|gsk2636771|mesh-list
14205573|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205574|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14205575|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205576|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205577|NCT04439149|GSK2636771|gsk2636771|mesh-list
14205578|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205579|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14205580|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502747|NCT02777554|Thalidomide|thalidomide|mesh-list
14502748|NCT02777554|Apremilast|apremilast|mesh-list
14502749|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14502750|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14502751|NCT02777554|Analgesics|analgesics|mesh-ancestor
14502752|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
14502753|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502754|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502755|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502756|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14502757|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14502758|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14502759|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502760|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502761|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14502762|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
14776362|NCT00662896|Naproxen|naproxen|mesh-list
14776363|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14776364|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776365|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776366|NCT00662896|Analgesics|analgesics|mesh-ancestor
14205581|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502763|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
14502764|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14502765|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502766|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14776367|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
14776368|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776369|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776370|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205582|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
14776371|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776372|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14205583|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
14205584|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14205585|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14205586|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205587|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205588|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776373|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776374|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776375|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
14776376|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14776377|NCT00662948|Rituximab|rituximab|mesh-list
14776378|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14776379|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776380|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
14776381|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776382|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776383|NCT00662987|Amoxicillin|amoxicillin|mesh-list
14776384|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14776385|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776386|NCT00663052|Etanercept|etanercept|mesh-list
14776387|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776388|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776389|NCT00663052|Analgesics|analgesics|mesh-ancestor
14776390|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
14776391|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205589|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205590|NCT04416386|Ascorbic Acid|ascorbic acid|mesh-list
14205591|NCT04416386|Vitamins|vitamins|mesh-ancestor
14205592|NCT04416386|Micronutrients|micronutrients|mesh-ancestor
14205593|NCT04416386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205594|NCT04416386|Antioxidants|antioxidants|mesh-ancestor
14205595|NCT04416386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205596|NCT04416386|Protective Agents|protective agents|mesh-ancestor
14205597|NCT04410965|Teriflunomide|teriflunomide|mesh-list
14502767|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14502768|NCT02777554|Growth Substances|growth substances|mesh-ancestor
14502769|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
14502770|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502771|NCT02777749|Bupivacaine|bupivacaine|mesh-list
14502772|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
14502773|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
14502774|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14502775|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502776|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
14502777|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502778|NCT02777970|Acetaminophen|acetaminophen|mesh-list
14502779|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14502780|NCT02777970|Tramadol|tramadol|mesh-list
14502781|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14502782|NCT02777970|Analgesics|analgesics|mesh-ancestor
14502783|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
14502784|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502785|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502786|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
14502787|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14502788|NCT02777970|Narcotics|narcotics|mesh-ancestor
14502789|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14502790|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14502791|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502792|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14502793|NCT02778100|Phenylephrine|phenylephrine|mesh-list
14502794|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
14502795|NCT02778100|Glucagon|glucagon|mesh-list
14502796|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14502797|NCT02778100|Hormones|hormones|mesh-ancestor
14502798|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14502799|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502800|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14502801|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14502802|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
14502803|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205598|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14205599|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14205600|NCT04410965|Analgesics|analgesics|mesh-ancestor
14205601|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
14205602|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205603|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205604|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205605|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205606|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205607|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
14502804|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502805|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
14502806|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
14502807|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502808|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
14502809|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14502810|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
14776392|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776393|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205608|NCT04405999|Bromhexine|bromhexine|mesh-list
14502811|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14502812|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
14502813|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14502814|NCT02778100|Protective Agents|protective agents|mesh-ancestor
14502815|NCT02778113|Glucagon|glucagon|mesh-list
14502816|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14502817|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14502818|NCT02778113|Hormones|hormones|mesh-ancestor
14502819|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14502820|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502821|NCT02778113|Incretins|incretins|mesh-ancestor
14502822|NCT02778867|Fluticasone|fluticasone|mesh-list
14502823|NCT02778867|Xhance|xhance|mesh-list
14502824|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502825|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14502826|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
14502827|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502828|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205609|NCT04405999|Expectorants|expectorants|mesh-ancestor
14502829|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14502830|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
14502831|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
14502832|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14502833|NCT02778880|Fentanyl|fentanyl|mesh-list
14502834|NCT02778880|Ketamine|ketamine|mesh-list
14502835|NCT02778880|Analgesics|analgesics|mesh-ancestor
14502836|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
14502837|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502838|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502839|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14502840|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14502841|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
14502842|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
14502843|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14502844|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14502845|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14502846|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14502847|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502848|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14502849|NCT02778880|Narcotics|narcotics|mesh-ancestor
14502850|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14502851|NCT02779166|Celecoxib|celecoxib|mesh-list
14502852|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14502853|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14502854|NCT02779166|Analgesics|analgesics|mesh-ancestor
14502855|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
14502856|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14502857|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502858|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502859|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14502860|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14502861|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14205610|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
14205611|NCT04364555|Clobetasol|clobetasol|mesh-list
14205612|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205613|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
14205614|NCT04364555|Hormones|hormones|mesh-ancestor
14205615|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205616|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205617|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14205618|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14502862|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502863|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502864|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14502865|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14502866|NCT02780167|Abrocitinib|abrocitinib|mesh-list
14502867|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502868|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502869|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502870|NCT02780622|Oseltamivir|oseltamivir|mesh-list
14502871|NCT02780622|Warfarin|warfarin|mesh-list
14502872|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
14502873|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
14502874|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502875|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502876|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502877|NCT02780687|Afatinib|afatinib|mesh-list
14502878|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502879|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502880|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502881|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776394|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776395|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14776396|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14776397|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
14776398|NCT00663130|Tadalafil|tadalafil|mesh-list
14502882|NCT02780700|Capecitabine|capecitabine|mesh-list
14502883|NCT02780700|Nintedanib|nintedanib|mesh-list
14502884|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14502885|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
14776399|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776400|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776401|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776402|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14942157|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
14942158|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
14942159|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942160|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942161|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942162|NCT01502046|Analgesics|analgesics|mesh-ancestor
14942163|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
14942164|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942165|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14942166|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14942167|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942168|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942169|NCT01502046|Hormones|hormones|mesh-ancestor
14942170|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942171|NCT01502202|Pemetrexed|pemetrexed|mesh-list
14502886|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502887|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502888|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14502889|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502890|NCT02780869|Thrombin|thrombin|mesh-list
14502891|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14502892|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
14502893|NCT02780869|Coagulants|coagulants|mesh-ancestor
14502894|NCT02781311|Finasteride|finasteride|mesh-list
14776403|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776404|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776405|NCT00663130|Urological Agents|urological agents|mesh-ancestor
14776406|NCT00663182|Entecavir|entecavir|mesh-list
14942172|NCT01502202|Gefitinib|gefitinib|mesh-list
14205619|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205620|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205621|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
14205622|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205623|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942173|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776407|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
14776408|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776409|NCT00663195|Furosemide|furosemide|mesh-list
14776410|NCT00663195|Spironolactone|spironolactone|mesh-list
14776411|NCT00663195|Diuretics|diuretics|mesh-ancestor
14776412|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
14776413|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776414|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14776415|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14776416|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776417|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14776418|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
14776419|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14776420|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14776421|NCT00663221|Vitamin D|vitamin d|mesh-list
14776422|NCT00663221|Calcium|calcium|mesh-list
14776423|NCT00663221|Vitamins|vitamins|mesh-ancestor
14776424|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
14776425|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776426|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14776427|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14776428|NCT00663247|Mesalamine|mesalamine|mesh-list
14776429|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776430|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942174|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942175|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240839|NCT00168103|Complement C1s|complement c1s|mesh-list
14240840|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14240841|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14240842|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
14240843|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240844|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14240845|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14240846|NCT00168298|Dexamethasone|dexamethasone|mesh-list
14240847|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
14942176|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14942177|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13964314|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205635|NCT04280536|Trifluridine|trifluridine|mesh-list
14205636|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
14205637|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205638|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
14205639|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205640|NCT04277858|Cisplatin|cisplatin|mesh-list
14205641|NCT04277858|Docetaxel|docetaxel|mesh-list
14205642|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205643|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205644|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205645|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205646|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205647|NCT04249401|Warfarin|warfarin|mesh-list
14205648|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
14205649|NCT04249401|Dabigatran|dabigatran|mesh-list
14205650|NCT04249401|Apixaban|apixaban|mesh-list
14205651|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
14502895|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14502896|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14205652|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14205653|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
14205654|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14205655|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
14205656|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205657|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205658|NCT04232657|Denosumab|denosumab|mesh-list
14205659|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14205660|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240848|NCT00168298|BB 1101|bb 1101|mesh-list
14240849|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240850|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
14240851|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
14240852|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240853|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240854|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240855|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
14240856|NCT00168298|Hormones|hormones|mesh-ancestor
14240857|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240858|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14240859|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240860|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
14240861|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240862|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240863|NCT00168324|Dexamethasone|dexamethasone|mesh-list
14240864|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
14240865|NCT00168324|BB 1101|bb 1101|mesh-list
14240866|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240867|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
14240868|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
14240869|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240870|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240871|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240872|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
14240873|NCT00168324|Hormones|hormones|mesh-ancestor
14240874|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240875|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14240876|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240877|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
14240878|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240879|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502897|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964315|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13964316|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
13964317|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964318|NCT03138252|Oxytocin|oxytocin|mesh-list
13964319|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
13964320|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14240880|NCT00168337|Dexamethasone|dexamethasone|mesh-list
14240881|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240882|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
14502898|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502899|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
14502900|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14502901|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502902|NCT02781311|Urological Agents|urological agents|mesh-ancestor
14502903|NCT02781454|Mexiletine|mexiletine|mesh-list
14502904|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14502905|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14502906|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14502907|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14502908|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502909|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
14502910|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14502911|NCT02781558|Velpatasvir|velpatasvir|mesh-list
14502912|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
14502913|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502914|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
14502915|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14502916|NCT02781571|Velpatasvir|velpatasvir|mesh-list
14502917|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
14776431|NCT00663247|Analgesics|analgesics|mesh-ancestor
14776432|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
14502918|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502919|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14502920|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502921|NCT02781649|Ribavirin|ribavirin|mesh-list
14502922|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
14776433|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776434|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776435|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776436|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776437|NCT00663286|Clindamycin|clindamycin|mesh-list
14776438|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
14776439|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
14776440|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14776441|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14776442|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776443|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14942178|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14942179|NCT01502241|Temozolomide|temozolomide|mesh-list
14942180|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14942181|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
14942182|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942183|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502923|NCT02781649|Grazoprevir|grazoprevir|mesh-list
14502924|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14942184|NCT01502267|Rituximab|rituximab|mesh-list
14942185|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14942186|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942187|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942188|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
14942189|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942190|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942191|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
14942192|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14942193|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
14942194|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942195|NCT01502280|Protective Agents|protective agents|mesh-ancestor
14942196|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942197|NCT01502280|Vitamins|vitamins|mesh-ancestor
14942198|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
14942199|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14942200|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
14942201|NCT01502358|Vaccines|vaccines|mesh-list
14942202|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
14205661|NCT04216043|Caseins|caseins|mesh-list
14205662|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
14205663|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
14205664|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205665|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
14205666|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14205667|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14205668|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776444|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205669|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776445|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942203|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942204|NCT01502592|Ipilimumab|ipilimumab|mesh-list
14205670|NCT04206059|Analgesics|analgesics|mesh-ancestor
14205671|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
14205672|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776446|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
14205673|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14205674|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14502925|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
14502926|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502927|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
14502928|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14502929|NCT02781818|Triamcinolone|triamcinolone|mesh-list
14502930|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14502931|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14502932|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14502933|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14502934|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
14502935|NCT02781818|Hormones|hormones|mesh-ancestor
14502936|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14502937|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502938|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14502939|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
14205675|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14205676|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14205677|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205678|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502940|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502941|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502942|NCT02782169|Pregabalin|pregabalin|mesh-list
14502943|NCT02782169|Analgesics|analgesics|mesh-ancestor
14502944|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
14502945|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776447|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14776448|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776449|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776450|NCT00663338|Rotigotine|rotigotine|mesh-list
14776451|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
14776452|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
14776453|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776454|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776455|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807447|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14807448|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14807449|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14807450|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
14807451|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807452|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807453|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807454|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14807455|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14807456|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14807457|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14807458|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807459|NCT00821912|Docetaxel|docetaxel|mesh-list
14807460|NCT00821912|Capecitabine|capecitabine|mesh-list
14807461|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807462|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807463|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
14807464|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
14807465|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807466|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14807467|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
14807468|NCT00822029|Alendronate|alendronate|mesh-list
14807469|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14807470|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807471|NCT00822055|Timolol|timolol|mesh-list
14807472|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14807473|NCT00822055|Dorzolamide|dorzolamide|mesh-list
14807474|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
14807475|NCT00822055|Maleic acid|maleic acid|mesh-list
14502946|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502947|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
14502948|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14205679|NCT04184622|Tirzepatide|tirzepatide|mesh-list
14205680|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14205681|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502949|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14502950|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502951|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14502952|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14502953|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14502954|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14502955|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14502956|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
14502957|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14502958|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
14502959|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502960|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
14502961|NCT02782676|Protective Agents|protective agents|mesh-ancestor
14502962|NCT02783170|Vaccines|vaccines|mesh-list
14502963|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
14502964|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502965|NCT02783443|Anesthetics|anesthetics|mesh-list
14502966|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14502967|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502968|NCT02783599|Doxorubicin|doxorubicin|mesh-list
14502969|NCT02783599|Olaratumab|olaratumab|mesh-list
14502970|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14502971|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14502972|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14502973|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14502974|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14502975|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502976|NCT02783729|Zolpidem|zolpidem|mesh-list
14502977|NCT02783729|Lemborexant|lemborexant|mesh-list
14502978|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14502979|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14502980|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14502981|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502982|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14502983|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
14502984|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
14502985|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14502986|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14502987|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14502988|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14502989|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14502990|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14502991|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
14502992|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14502993|NCT02785159|Tazarotene|tazarotene|mesh-list
14502994|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14502995|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
14502996|NCT02785172|Clobetasol|clobetasol|mesh-list
14502997|NCT02785172|Halobetasol|halobetasol|mesh-list
14502998|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14502999|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503000|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
14503001|NCT02785172|Hormones|hormones|mesh-ancestor
14503002|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503003|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503004|NCT02785185|Clobetasol|clobetasol|mesh-list
14503005|NCT02785185|Halobetasol|halobetasol|mesh-list
14503006|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14503007|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503008|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
14503009|NCT02785185|Hormones|hormones|mesh-ancestor
14503010|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205682|NCT04184622|Incretins|incretins|mesh-ancestor
14205683|NCT04184622|Hormones|hormones|mesh-ancestor
14205684|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205685|NCT04170738|Amphetamine|amphetamine|mesh-list
14205686|NCT04170738|Adderall|adderall|mesh-list
14205687|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
14205688|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14205689|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503011|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503012|NCT02785406|Suvorexant|suvorexant|mesh-list
14503013|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14503014|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14503015|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776456|NCT00663377|Losartan|losartan|mesh-list
14776457|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14776458|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14776459|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14776460|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14776461|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776462|NCT00663442|Methylphenidate|methylphenidate|mesh-list
14776463|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14776464|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776465|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14776466|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14776467|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14205690|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
14205691|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
14205692|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205693|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
14205694|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205695|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205696|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
14205697|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14205698|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14205699|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14205700|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14205701|NCT04155424|Eculizumab|eculizumab|mesh-list
14205702|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14205703|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205704|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
14205705|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205706|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14205707|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
14205708|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776468|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776469|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
14776470|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776471|NCT00663455|Cyclosporine|cyclosporine|mesh-list
14776472|NCT00663455|Cyclosporins|cyclosporins|mesh-list
14776473|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776474|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942205|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942206|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942207|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14942208|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942209|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14942210|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14942211|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
15026750|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026751|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
15026752|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503016|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503017|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14503018|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503019|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503020|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
14503021|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14503022|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503023|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14503024|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14503025|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026753|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15026754|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15026755|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15026756|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026757|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026758|NCT01945554|Bupivacaine|bupivacaine|mesh-list
15026759|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
14776475|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14776476|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
14205715|NCT04142658|Warfarin|warfarin|mesh-list
14205716|NCT04142658|Apixaban|apixaban|mesh-list
14205717|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
14205718|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14503026|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503027|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503028|NCT02785900|Azacitidine|azacitidine|mesh-list
14503029|NCT02785900|Decitabine|decitabine|mesh-list
14205719|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
14205720|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14205721|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
14205722|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205723|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205724|NCT04133792|Simvastatin|simvastatin|mesh-list
14205725|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14205726|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14205727|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
14205728|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503030|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14503031|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
14503032|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503033|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503034|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776477|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776478|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
14776479|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776480|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
14776481|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776482|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14776483|NCT00663481|Leucovorin|leucovorin|mesh-list
14776484|NCT00663481|Antidotes|antidotes|mesh-ancestor
14776485|NCT00663481|Protective Agents|protective agents|mesh-ancestor
14776486|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776487|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
14776488|NCT00663481|Vitamins|vitamins|mesh-ancestor
14776489|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
14776490|NCT00663559|Sunitinib|sunitinib|mesh-list
14776491|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776492|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14776493|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14776494|NCT00663559|Growth Substances|growth substances|mesh-ancestor
14776495|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776496|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
14776497|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14942212|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
14942213|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14942214|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
14205729|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14205730|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14205731|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205732|NCT04129554|Tenofovir|tenofovir|mesh-list
14205733|NCT04129554|Entecavir|entecavir|mesh-list
14205734|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
14205735|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205736|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205737|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205738|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205739|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205740|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205741|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205742|NCT04099849|Zinc|zinc|mesh-list
14205743|NCT04099849|Trace Elements|trace elements|mesh-ancestor
14205744|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
14503035|NCT02785939|Docetaxel|docetaxel|mesh-list
14503036|NCT02785939|Palbociclib|palbociclib|mesh-list
14503037|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503038|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14503039|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14503040|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14503041|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503042|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14503043|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503044|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
14503045|NCT02786719|Doxorubicin|doxorubicin|mesh-list
14503046|NCT02786719|Etoposide|etoposide|mesh-list
14776498|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942215|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205745|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205746|NCT04095442|Benzocaine|benzocaine|mesh-list
14205747|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
14205748|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
14205749|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14205750|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205751|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
14503047|NCT02786719|Vincristine|vincristine|mesh-list
14503048|NCT02786719|Topotecan|topotecan|mesh-list
14503049|NCT02786719|Sargramostim|sargramostim|mesh-list
14503050|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503051|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
14503052|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503053|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503054|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14503055|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
14205752|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205753|NCT04091867|Cetuximab|cetuximab|mesh-list
14205754|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205755|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205756|NCT04082910|Etanercept|etanercept|mesh-list
14205757|NCT04082910|Infliximab|infliximab|mesh-list
14205758|NCT04082910|Metoprolol|metoprolol|mesh-list
14205759|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14205760|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14205761|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205762|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14205763|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14205764|NCT04082910|Analgesics|analgesics|mesh-ancestor
14503056|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503057|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503058|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14503059|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14205765|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
14205766|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205767|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205768|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205769|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205770|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
14205771|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14205772|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14205773|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
14205774|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
14205775|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14205776|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14205777|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14205778|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
14205779|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205780|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205781|NCT04074330|Rituximab|rituximab|mesh-list
14205782|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205783|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205784|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
14205785|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205786|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205787|NCT04035473|Paclitaxel|paclitaxel|mesh-list
14205788|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14205789|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205790|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205791|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205792|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205793|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205794|NCT04035382|Misoprostol|misoprostol|mesh-list
14503060|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14503061|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14503062|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503063|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14503064|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
14503065|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
14503066|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
14503067|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14503068|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14503069|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14205795|NCT04035382|Oxytocin|oxytocin|mesh-list
14205796|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
14503070|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
14503071|NCT02787057|Vancomycin|vancomycin|mesh-list
14503072|NCT02787057|Ceftazidime|ceftazidime|mesh-list
14503073|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14503074|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503075|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14205797|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14205798|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205799|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14205800|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
14205801|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14205802|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14205803|NCT04012931|Rilpivirine|rilpivirine|mesh-list
14205804|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205805|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205806|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503076|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14503077|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503078|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503079|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503080|NCT02787083|Mirabegron|mirabegron|mesh-list
14503081|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14503082|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14503083|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14503084|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503085|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503086|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503087|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503088|NCT02787083|Urological Agents|urological agents|mesh-ancestor
14503089|NCT02787304|Volixibat|volixibat|mesh-list
14503090|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14528428|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
14528429|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528430|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528431|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528432|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528433|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14528434|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528435|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528436|NCT03861338|Buprenorphine|buprenorphine|mesh-list
14528437|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14528438|NCT03861338|Narcotics|narcotics|mesh-ancestor
14528439|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528440|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528441|NCT03861338|Analgesics|analgesics|mesh-ancestor
14528442|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
14528443|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528444|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14528445|NCT03848416|Ixekizumab|ixekizumab|mesh-list
14528446|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
14528447|NCT03853551|Osimertinib|osimertinib|mesh-list
14528448|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528449|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14528450|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528451|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528452|NCT03869450|Lidocaine|lidocaine|mesh-list
14528453|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
14528454|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
14528455|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
14528456|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528457|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528458|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
14528459|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528460|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14528461|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14528462|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14528463|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528464|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528465|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14528466|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
14528467|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
14528468|NCT03869450|Protective Agents|protective agents|mesh-ancestor
14528469|NCT03859960|Insulin|insulin|mesh-list
14528470|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14528471|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14528472|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503091|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14503092|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
14503093|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503094|NCT02788019|Ropivacaine|ropivacaine|mesh-list
14776499|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776500|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776501|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776502|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776503|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776504|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776505|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776506|NCT00663598|Urological Agents|urological agents|mesh-ancestor
14776507|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
14776508|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14776509|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776510|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14776511|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776512|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14776513|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776514|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503095|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
14503096|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
14503097|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14503098|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503099|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
14503100|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503101|NCT02788097|Progesterone|progesterone|mesh-list
14503102|NCT02788097|Progestins|progestins|mesh-ancestor
14503103|NCT02788097|Hormones|hormones|mesh-ancestor
14503104|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503105|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503106|NCT02788175|Vedolizumab|vedolizumab|mesh-list
14503107|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14503108|NCT02788279|Atezolizumab|atezolizumab|mesh-list
14503109|NCT02788279|Antibodies|antibodies|mesh-list
14503110|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
14503111|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503112|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503113|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14503114|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14503115|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14503116|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14503117|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503118|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503119|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503120|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503121|NCT02788474|Nintedanib|nintedanib|mesh-list
14503122|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503123|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14503124|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503125|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503126|NCT02788513|BI 425809|bi 425809|mesh-list
14503127|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
14503128|NCT02788656|Valsartan|valsartan|mesh-list
14503129|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
14503130|NCT02788656|Giapreza|giapreza|mesh-list
14503131|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
14503132|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14503133|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14503134|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14503135|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
14503136|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14503137|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503138|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
14503139|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14503140|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14503141|NCT02789033|Isosorbide|isosorbide|mesh-list
14503142|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14503143|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14503144|NCT02789033|Chitosan|chitosan|mesh-list
14503145|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14503146|NCT02789033|Diuretics|diuretics|mesh-ancestor
14503147|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
14503148|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205807|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503149|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
14503150|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14503151|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776515|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776516|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776517|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14205808|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
14503152|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14503153|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14503154|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
14503155|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14503156|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
14503157|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
14503158|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
14503159|NCT02789033|Coagulants|coagulants|mesh-ancestor
14503160|NCT02789111|Alvimopan|alvimopan|mesh-list
14503161|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14503162|NCT02789410|Morphine|morphine|mesh-list
14503163|NCT02789410|Hydromorphone|hydromorphone|mesh-list
14503164|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14503165|NCT02789410|Narcotics|narcotics|mesh-ancestor
14503166|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14503167|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503168|NCT02789410|Analgesics|analgesics|mesh-ancestor
14503169|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
14503170|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503171|NCT02790736|Propranolol|propranolol|mesh-list
14503172|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14503173|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14503174|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503175|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503176|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503177|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503178|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14503179|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14205809|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205810|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14205811|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14205812|NCT04001881|Anesthetics|anesthetics|mesh-list
14205813|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14205814|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205815|NCT03993457|Citalopram|citalopram|mesh-list
14205816|NCT03993457|Bupropion|bupropion|mesh-list
14205817|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14205818|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14205819|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14205820|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205821|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14205822|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
14205823|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205824|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14205825|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
14205826|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14205827|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14205828|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
14205829|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14205830|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14503180|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14503181|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
14503182|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14205831|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503183|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14503184|NCT02790788|Prednisolone|prednisolone|mesh-list
14503185|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
14503186|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
14503187|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14503188|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14503189|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
14503190|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503191|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
14503192|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
14205832|NCT03891264|Cannabidiol|cannabidiol|mesh-list
14503193|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503194|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528473|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
14503195|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14503196|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
14503197|NCT02790788|Hormones|hormones|mesh-ancestor
14503198|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503199|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14503200|NCT02790788|Protective Agents|protective agents|mesh-ancestor
14503201|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14503202|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503203|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14503204|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
14503205|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503206|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
14503207|NCT02791308|Tacrolimus|tacrolimus|mesh-list
14503208|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14503209|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503210|NCT02791308|Analgesics|analgesics|mesh-ancestor
14503211|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
14503212|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503213|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503214|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503215|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503216|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
14503217|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503218|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
14503219|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14503220|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503221|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503222|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14503223|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14503224|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14503225|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503226|NCT02791490|Metformin|metformin|mesh-list
14503227|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14503228|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14503229|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503230|NCT02791490|Incretins|incretins|mesh-ancestor
14503231|NCT02791490|Hormones|hormones|mesh-ancestor
14503232|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503233|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14503234|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
14503235|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503236|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503237|NCT02791763|Glycine|glycine|mesh-list
14503238|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
14503239|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503240|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503241|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503242|NCT02791906|Ascorbic Acid|ascorbic acid|mesh-list
14503243|NCT02791906|Vitamins|vitamins|mesh-ancestor
14503244|NCT02791906|Micronutrients|micronutrients|mesh-ancestor
14503245|NCT02791906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503246|NCT02791906|Antioxidants|antioxidants|mesh-ancestor
14776518|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776519|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776520|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776521|NCT00663728|Urological Agents|urological agents|mesh-ancestor
14776522|NCT00663741|Sorafenib|sorafenib|mesh-list
14776523|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776524|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14776525|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776526|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776527|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
14942216|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942217|NCT01502774|Cyclosporine|cyclosporine|mesh-list
14942218|NCT01502774|Cyclosporins|cyclosporins|mesh-list
14942219|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942220|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942221|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503247|NCT02791906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503248|NCT02791906|Protective Agents|protective agents|mesh-ancestor
14503249|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
14776528|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942222|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
14942223|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503250|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14205833|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
14205834|NCT03860428|Acetaminophen|acetaminophen|mesh-list
14205835|NCT03860428|Ibuprofen|ibuprofen|mesh-list
14205836|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
14776529|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776530|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14776531|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14205837|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14205838|NCT03860428|Analgesics|analgesics|mesh-ancestor
14205839|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
14503251|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
14503252|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503253|NCT02791945|Expectorants|expectorants|mesh-ancestor
14503254|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503255|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14503256|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
14503257|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503258|NCT02791945|Protective Agents|protective agents|mesh-ancestor
14503259|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503260|NCT02791945|Antidotes|antidotes|mesh-ancestor
14503261|NCT02792062|Relugolix|relugolix|mesh-list
14503262|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
14503263|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
14776532|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776533|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776534|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942224|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
14942225|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942226|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
14942227|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942228|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14942229|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
14942230|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503264|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503265|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503266|NCT02792192|Atezolizumab|atezolizumab|mesh-list
14503267|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503268|NCT02792218|Teriflunomide|teriflunomide|mesh-list
14503269|NCT02792218|Ofatumumab|ofatumumab|mesh-list
14503270|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14503271|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503272|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
14503273|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503274|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14503275|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503276|NCT02792218|Analgesics|analgesics|mesh-ancestor
14503277|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
14503278|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776535|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14776536|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14776537|NCT00663832|Panobinostat|panobinostat|mesh-list
14776538|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776539|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14776540|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205840|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205841|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205842|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
14205843|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14205844|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503279|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503280|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503281|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503282|NCT02792231|Teriflunomide|teriflunomide|mesh-list
14776541|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776542|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776543|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
14942231|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14205845|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14205846|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205847|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503283|NCT02792231|Ofatumumab|ofatumumab|mesh-list
14503284|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14503285|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503286|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
14503287|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503288|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14503289|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503290|NCT02792231|Analgesics|analgesics|mesh-ancestor
14503291|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
14503292|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503293|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503294|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503295|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503296|NCT02792517|Erenumab|erenumab|mesh-list
14503297|NCT02792517|Norgestimate|norgestimate|mesh-list
14503298|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
14776544|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776545|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776546|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776547|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776548|NCT00663845|Urological Agents|urological agents|mesh-ancestor
14942232|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14942233|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942234|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942235|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
14942236|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
14503299|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
14503300|NCT02792517|Estradiol|estradiol|mesh-list
14503301|NCT02792517|Estrogens|estrogens|mesh-ancestor
14503302|NCT02792517|Hormones|hormones|mesh-ancestor
14503303|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503304|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503305|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14503306|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14503307|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14503308|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14503309|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776549|NCT00663884|Voglibose|voglibose|mesh-list
14776550|NCT00663884|Mitiglinide|mitiglinide|mesh-list
14776551|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14776552|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776553|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14776554|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776555|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776556|NCT00663897|Lansoprazole|lansoprazole|mesh-list
14776557|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
14776558|NCT00663897|Mosapride|mosapride|mesh-list
14776559|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14776560|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14776561|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14776562|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776563|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776564|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14776565|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
14776566|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776567|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205848|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
14205849|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205850|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205851|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14205852|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
14205853|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205854|NCT03796676|Abrocitinib|abrocitinib|mesh-list
14205855|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14205856|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205857|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205858|NCT03796273|Ketoconazole|ketoconazole|mesh-list
14205859|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
14205860|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205861|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14503310|NCT02792517|Analgesics|analgesics|mesh-ancestor
14776568|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14776569|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14776570|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14205862|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14776571|NCT00663949|Captopril|captopril|mesh-list
14776572|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
14503311|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
14503312|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503313|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14503314|NCT02792699|Rituximab|rituximab|mesh-list
14503315|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14503316|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503317|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
14503318|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503319|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503320|NCT02792829|Lenvatinib|lenvatinib|mesh-list
14205863|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205864|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205865|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14205866|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
14205867|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205868|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205869|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14205870|NCT03742102|Paclitaxel|paclitaxel|mesh-list
14205871|NCT03742102|Trastuzumab|trastuzumab|mesh-list
14205872|NCT03742102|Durvalumab|durvalumab|mesh-list
14205873|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14205874|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205875|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205876|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205877|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205878|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205879|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240883|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
14240884|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240885|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240886|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240887|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
14240888|NCT00168337|Hormones|hormones|mesh-ancestor
14240889|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14240890|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14240891|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503321|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503322|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14503323|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503324|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503325|NCT02793128|Mitomycins|mitomycins|mesh-list
14503326|NCT02793128|Mitomycin|mitomycin|mesh-list
14503327|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14503328|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503329|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
14503330|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503331|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14503332|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503333|NCT02793154|Exenatide|exenatide|mesh-list
14503334|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
14776573|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776574|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776575|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776576|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14776577|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14776578|NCT00663949|Protective Agents|protective agents|mesh-ancestor
14776579|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776580|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776581|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14240892|NCT00168389|Dexamethasone|dexamethasone|mesh-list
14240893|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14240894|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
14240895|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
14240896|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240897|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240898|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14240899|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
14240900|NCT00168389|Hormones|hormones|mesh-ancestor
14240901|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503335|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14776582|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
14807476|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14776583|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14776584|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
14776585|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14776586|NCT00664001|Antioxidants|antioxidants|mesh-list
14776587|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776588|NCT00664001|Protective Agents|protective agents|mesh-ancestor
14776589|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205880|NCT03702270|Penicillins|penicillins|mesh-list
14205881|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14205882|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776590|NCT00664014|Tolvaptan|tolvaptan|mesh-list
14942237|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
14503336|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503337|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14503338|NCT02793154|Incretins|incretins|mesh-ancestor
14503339|NCT02793154|Hormones|hormones|mesh-ancestor
14503340|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503341|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
14503342|NCT02793622|Piperaquine|piperaquine|mesh-list
14503343|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
14503344|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14503345|NCT02793622|Artenimol|artenimol|mesh-list
14503346|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
14503347|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14503348|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14503349|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503350|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14503351|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503352|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503353|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14503354|NCT02793622|Renal Agents|renal agents|mesh-ancestor
14503355|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14503356|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14503357|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
14503358|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503359|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
14503360|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503361|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503362|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14503363|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
14503364|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503365|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503366|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14503367|NCT02793947|Epinephrine|epinephrine|mesh-list
14503368|NCT02793947|Morphine|morphine|mesh-list
14503369|NCT02793947|Ropivacaine|ropivacaine|mesh-list
14503370|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14942238|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14205883|NCT03691610|Vaccines|vaccines|mesh-list
14205884|NCT03691610|Immunoglobulins|immunoglobulins|mesh-list
14205885|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
14205886|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205887|NCT03667443|Inositol|inositol|mesh-list
14205888|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
14205889|NCT03667443|Vitamins|vitamins|mesh-ancestor
14205890|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
14205891|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205892|NCT03622515|Anesthetics|anesthetics|mesh-list
14205893|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14205894|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205895|NCT03556332|Dexamethasone|dexamethasone|mesh-list
14205896|NCT03556332|Lenalidomide|lenalidomide|mesh-list
14205897|NCT03556332|Daratumumab|daratumumab|mesh-list
14205898|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205899|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
14205900|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
14205901|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205902|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205903|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14205904|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
14205905|NCT03556332|Hormones|hormones|mesh-ancestor
14205906|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942239|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503371|NCT02793947|Narcotics|narcotics|mesh-ancestor
14503372|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14205907|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14205908|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205909|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
14776591|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14942240|NCT01502904|Sirolimus|sirolimus|mesh-list
14205910|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14205911|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14205912|NCT03556332|Growth Substances|growth substances|mesh-ancestor
14205913|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14205914|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
14205915|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205916|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205917|NCT03519074|Cisplatin|cisplatin|mesh-list
14942241|NCT01502904|Pravastatin|pravastatin|mesh-list
14942242|NCT01502904|Pitavastatin|pitavastatin|mesh-list
14942243|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942244|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942245|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14942246|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205918|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205919|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
14205920|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205921|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205922|NCT03473756|Atezolizumab|atezolizumab|mesh-list
14205923|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205924|NCT03441048|Cytarabine|cytarabine|mesh-list
14205925|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
14503373|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503374|NCT02793947|Analgesics|analgesics|mesh-ancestor
14503375|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
14503376|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503377|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
14503378|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
14503379|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14503380|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14503381|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503382|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503383|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503384|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14503385|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14503386|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
14503387|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14503388|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503389|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
14503390|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
14503391|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14503392|NCT02794441|Dexamethasone|dexamethasone|mesh-list
14503393|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503394|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
14503395|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
14503396|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503397|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503398|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14776592|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776593|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
14205926|NCT03441048|Cladribine|cladribine|mesh-list
14205927|NCT03441048|Lintuzumab|lintuzumab|mesh-list
14205928|NCT03441048|Sargramostim|sargramostim|mesh-list
14776594|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776595|NCT00664040|Aspirin|aspirin|mesh-list
14776596|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776597|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776598|NCT00664040|Analgesics|analgesics|mesh-ancestor
14776599|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
14776600|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776601|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205929|NCT03441048|Lenograstim|lenograstim|mesh-list
14205930|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14503399|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
14776602|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14205931|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
14942247|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
14205932|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205933|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205934|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
14205935|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205936|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205937|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
14205938|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205939|NCT03441048|Analgesics|analgesics|mesh-ancestor
14205940|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
14205941|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14205942|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14205943|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14205944|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205945|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205946|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13964321|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964322|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13964323|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13964324|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964325|NCT03138161|Nivolumab|nivolumab|mesh-list
13964326|NCT03138161|Ipilimumab|ipilimumab|mesh-list
13964327|NCT03138161|Trabectedin|trabectedin|mesh-list
13964328|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964329|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964330|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14205947|NCT03384641|Bedaquiline|bedaquiline|mesh-list
14205948|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
14205949|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14205950|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205951|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
14205952|NCT03345576|Testosterone|testosterone|mesh-list
14503400|NCT02794441|Hormones|hormones|mesh-ancestor
14503401|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503402|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14503403|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503404|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14503405|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503406|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503407|NCT02794974|Anesthetics|anesthetics|mesh-list
14503408|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14503409|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503410|NCT02795117|Ivermectin|ivermectin|mesh-list
14503411|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14503412|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503413|NCT02796144|Metformin|metformin|mesh-list
14205953|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
14205954|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
14205955|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14205956|NCT03345576|Androgens|androgens|mesh-ancestor
14205957|NCT03345576|Hormones|hormones|mesh-ancestor
14503414|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14503415|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503416|NCT02796352|Interleukin-2|interleukin-2|mesh-list
14503417|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503418|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503419|NCT02796352|Analgesics|analgesics|mesh-ancestor
14503420|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
14503421|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503422|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503423|NCT02796560|Travoprost|travoprost|mesh-list
14503424|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14503425|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14503426|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
14503427|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14503428|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
14503429|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503430|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776603|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776604|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14776605|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14776606|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776607|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14776608|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776609|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776610|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
14503431|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14503432|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503433|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14503434|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14503435|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14503436|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503437|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503438|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503439|NCT02796677|Bromides|bromides|mesh-list
14205958|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205959|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205960|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14205961|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205962|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
14205963|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
14205964|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205965|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205966|NCT03337698|Linagliptin|linagliptin|mesh-list
14205967|NCT03337698|Gemcitabine|gemcitabine|mesh-list
14205968|NCT03337698|Bevacizumab|bevacizumab|mesh-list
14205969|NCT03337698|Carboplatin|carboplatin|mesh-list
14205970|NCT03337698|Docetaxel|docetaxel|mesh-list
14205971|NCT03337698|Pemetrexed|pemetrexed|mesh-list
14205972|NCT03337698|Atezolizumab|atezolizumab|mesh-list
14205973|NCT03337698|Evolocumab|evolocumab|mesh-list
14503440|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
14503441|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
14503442|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14503443|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
14503444|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503445|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503446|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14503447|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503448|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14503449|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14503450|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14503451|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503452|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503453|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503454|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
14503455|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14503456|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
14776611|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14503457|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
14503458|NCT02796755|Riluzole|riluzole|mesh-list
14503459|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
14503460|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14503461|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14503462|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503463|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503464|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503465|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14503466|NCT02796755|Protective Agents|protective agents|mesh-ancestor
14503467|NCT02797080|Interferons|interferons|mesh-list
14503468|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
14503469|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776612|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14776613|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
14776614|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776615|NCT00664144|Rasburicase|rasburicase|mesh-list
14776616|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
14776617|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776618|NCT00664170|Docetaxel|docetaxel|mesh-list
14776619|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503470|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
14503471|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503472|NCT02797522|Acetaminophen|acetaminophen|mesh-list
14205974|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14205975|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14205976|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14205977|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14205978|NCT03337698|Growth Substances|growth substances|mesh-ancestor
14205979|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14205980|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
14205981|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14205982|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
14503473|NCT02797522|Tenofovir|tenofovir|mesh-list
14503474|NCT02797522|Entecavir|entecavir|mesh-list
14503475|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
14503476|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14503477|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
14503478|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503479|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14503480|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14503481|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503482|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776620|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205983|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14205984|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
14205985|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14205986|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14205987|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14205988|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
14205989|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
14205990|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
14205991|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
14205992|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14205993|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14205994|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14205995|NCT03337698|Incretins|incretins|mesh-ancestor
14205996|NCT03337698|Hormones|hormones|mesh-ancestor
14205997|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14205998|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14205999|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
14206000|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14206001|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14206002|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14206003|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
14206004|NCT03333486|Fludarabine|fludarabine|mesh-list
14206005|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
14206006|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206007|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
14206008|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206009|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206010|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206011|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
14206012|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206013|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206014|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206015|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206016|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
14206017|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14206018|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14206019|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206020|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14206021|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206022|NCT03283878|Cefazolin|cefazolin|mesh-list
14206023|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14206024|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206025|NCT03259503|Gemcitabine|gemcitabine|mesh-list
14206026|NCT03259503|Rituximab|rituximab|mesh-list
14206027|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14206028|NCT03259503|Melphalan|melphalan|mesh-list
14206029|NCT03259503|Busulfan|busulfan|mesh-list
14206030|NCT03259503|Olaparib|olaparib|mesh-list
14206031|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
14206032|NCT03259503|Vorinostat|vorinostat|mesh-list
14206033|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14206034|NCT03259503|Antibodies|antibodies|mesh-list
14206035|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
14206036|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14206037|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
14503483|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14503484|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14503485|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503486|NCT02797522|Analgesics|analgesics|mesh-ancestor
14503487|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
14503488|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503489|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503490|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
14503491|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
14206038|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206039|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206040|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206041|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206042|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
14206043|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206044|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
14206045|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206046|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206047|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206048|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206049|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
14206050|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206051|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14206052|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14206053|NCT03235739|Naloxegol|naloxegol|mesh-list
14206054|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14206055|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206056|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
14503492|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503493|NCT02797808|Sertraline|sertraline|mesh-list
14503494|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
14776621|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206057|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206058|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
14206059|NCT03215810|Nivolumab|nivolumab|mesh-list
14206060|NCT03215810|Fludarabine|fludarabine|mesh-list
14206061|NCT03215810|Interleukin-2|interleukin-2|mesh-list
14206062|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206063|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
14206064|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206065|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206066|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206067|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
14206068|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206069|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206070|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206071|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206072|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14206073|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14206074|NCT03215810|Analgesics|analgesics|mesh-ancestor
14206075|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
14503495|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14503496|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14503497|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14503498|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14503499|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503500|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503501|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
14503502|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503503|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14503504|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
14503505|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528474|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14776622|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14776623|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776624|NCT00664196|Hormones|hormones|mesh-list
14776625|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14776626|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776627|NCT00664222|Furosemide|furosemide|mesh-list
14776628|NCT00664222|Spironolactone|spironolactone|mesh-list
14776629|NCT00664222|Diuretics|diuretics|mesh-ancestor
14776630|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
14776631|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776632|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14776633|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14776634|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776635|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14776636|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
14776637|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14776638|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14776639|NCT00664248|Clindamycin|clindamycin|mesh-list
14776640|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
14776641|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
14776642|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14776643|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14776644|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776645|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14776646|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776647|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776648|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14776649|NCT00664287|Niacin|niacin|mesh-list
14776650|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14776651|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
14776652|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776653|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14776654|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776655|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
14776656|NCT00664287|Vitamins|vitamins|mesh-ancestor
14776657|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
14776658|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776659|NCT00664313|Linezolid|linezolid|mesh-list
14776660|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14776661|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776662|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14776663|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026760|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
14503506|NCT02798835|Dexamethasone|dexamethasone|mesh-list
14503507|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
14503508|NCT02798835|Fentanyl|fentanyl|mesh-list
14503509|NCT02798835|Bupivacaine|bupivacaine|mesh-list
14503510|NCT02798835|Ropivacaine|ropivacaine|mesh-list
14503511|NCT02798835|BB 1101|bb 1101|mesh-list
14503512|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503513|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
14503514|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
14503515|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503516|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503517|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14503518|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
14503519|NCT02798835|Hormones|hormones|mesh-ancestor
14503520|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503521|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14503522|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503523|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
14503524|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503525|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503526|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
14776664|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776665|NCT00664417|Vaccines|vaccines|mesh-list
14776666|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
14776667|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776668|NCT00664469|Atorvastatin|atorvastatin|mesh-list
14776669|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14776670|NCT00664469|Simvastatin|simvastatin|mesh-list
14776671|NCT00664469|Ezetimibe|ezetimibe|mesh-list
14776672|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14776673|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14776674|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
14776675|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776676|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14776677|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14776678|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776679|NCT00664586|Masoprocol|masoprocol|mesh-list
14776680|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
14776681|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776682|NCT00664586|Protective Agents|protective agents|mesh-ancestor
14776683|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776684|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14776685|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776686|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776687|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776688|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776689|NCT00664586|Analgesics|analgesics|mesh-ancestor
14776690|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
14776691|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503527|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
14503528|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776692|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503529|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
14503530|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14503531|NCT02798835|Narcotics|narcotics|mesh-ancestor
14503532|NCT02798835|Analgesics|analgesics|mesh-ancestor
14503533|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14503534|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14503535|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
14503536|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14503537|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14503538|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14503539|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14503540|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14503541|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
14503542|NCT02799381|Levodopa|levodopa|mesh-list
14206076|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206077|NCT03179761|Vaccines|vaccines|mesh-list
14206078|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
14206079|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206080|NCT03176277|Venetoclax|venetoclax|mesh-list
14206081|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206082|NCT03150004|Cytarabine|cytarabine|mesh-list
14206083|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
14206084|NCT03150004|Cladribine|cladribine|mesh-list
14206085|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206086|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
14206087|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206088|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206089|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
14206090|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206091|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206092|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
14206093|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206094|NCT03150004|Analgesics|analgesics|mesh-ancestor
14206095|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
14206096|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503543|NCT02799381|Carbidopa|carbidopa|mesh-list
14503544|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14503545|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
14503546|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14503547|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
14503548|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503549|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503550|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776693|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776694|NCT00664599|Rituximab|rituximab|mesh-list
14776695|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14776696|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776697|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
14776698|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776699|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776700|NCT00664677|Masoprocol|masoprocol|mesh-list
14776701|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
14776702|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776703|NCT00664677|Protective Agents|protective agents|mesh-ancestor
14776704|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776705|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14776706|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503551|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14503552|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503553|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14206097|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14206098|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14206099|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206100|NCT03125811|Ethanol|ethanol|mesh-list
14206101|NCT03125811|Ondansetron|ondansetron|mesh-list
14206102|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14206103|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206104|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206105|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776707|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776708|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776709|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776710|NCT00664677|Analgesics|analgesics|mesh-ancestor
14206106|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
14206107|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
14206108|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503554|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
14503555|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
14776711|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
14776712|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776713|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776714|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942248|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14942249|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
14942250|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942251|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14942252|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14942253|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
14942254|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503556|NCT02799784|Albuterol|albuterol|mesh-list
14503557|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14503558|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
14503559|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503560|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503561|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14503562|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503563|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
14503564|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14503565|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14503566|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14503567|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14776715|NCT00664690|Celecoxib|celecoxib|mesh-list
14776716|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776717|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776718|NCT00664690|Analgesics|analgesics|mesh-ancestor
14942255|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14942256|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14942257|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942258|NCT01502943|Aspirin|aspirin|mesh-list
14942259|NCT01502943|Atorvastatin|atorvastatin|mesh-list
14942260|NCT01502943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942261|NCT01502943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14942262|NCT01502943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942263|NCT01502943|Analgesics|analgesics|mesh-ancestor
14206109|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14776719|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
14776720|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776721|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776722|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776723|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776724|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14776725|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776726|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776727|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776728|NCT00664703|Methylphenidate|methylphenidate|mesh-list
14776729|NCT00664703|Lobeline|lobeline|mesh-list
14776730|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14776731|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776732|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14942264|NCT01502943|Sensory System Agents|sensory system agents|mesh-ancestor
14942265|NCT01502943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942266|NCT01502943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942267|NCT01502943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942268|NCT01502943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14942269|NCT01502943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14942270|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942271|NCT01502943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14942272|NCT01502943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14206110|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
14206111|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206112|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14206113|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
14206114|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206115|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206116|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14206117|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14206118|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14206119|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14206120|NCT03081143|Paclitaxel|paclitaxel|mesh-list
14206121|NCT03081143|Ramucirumab|ramucirumab|mesh-list
14776733|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14776734|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14503568|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503569|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503570|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503571|NCT02800148|Azelaic acid|azelaic acid|mesh-list
14776735|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776736|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
14776737|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776738|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14776739|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
14776740|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776741|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14776742|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14776743|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
14776744|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
14776745|NCT00664781|Rucaparib|rucaparib|mesh-list
14776746|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14776747|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776748|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776749|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776750|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776751|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776752|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776753|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776754|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776755|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776756|NCT00664833|Urological Agents|urological agents|mesh-ancestor
14776757|NCT00664846|Aspirin|aspirin|mesh-list
14776758|NCT00664846|Clopidogrel|clopidogrel|mesh-list
14942273|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942274|NCT01502943|Antipyretics|antipyretics|mesh-ancestor
14942275|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14942276|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14776759|NCT00664846|Atorvastatin|atorvastatin|mesh-list
14776760|NCT00664846|Simvastatin|simvastatin|mesh-list
14776761|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776762|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776763|NCT00664846|Analgesics|analgesics|mesh-ancestor
14776764|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
14503572|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503573|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
14503574|NCT02800642|Aflibercept|aflibercept|mesh-list
14776765|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776766|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776767|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776768|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776769|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14776770|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14776771|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942277|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
14942278|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14942279|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14942280|NCT01503008|Metformin|metformin|mesh-list
14503575|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14503576|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14503577|NCT02800642|Growth Substances|growth substances|mesh-ancestor
14503578|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503579|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
14503580|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503581|NCT02800928|Aticaprant|aticaprant|mesh-list
14503582|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14503583|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503584|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
14503585|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206122|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14206123|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206124|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206125|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206126|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
14206127|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206128|NCT03036930|Vaccines|vaccines|mesh-list
14206129|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
14503586|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
14503587|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14503588|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503589|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14503590|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14503591|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503592|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503593|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503594|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14503595|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14503596|NCT02801617|Latanoprost|latanoprost|mesh-list
14503597|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14503598|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14503599|NCT02801669|Edoxaban|edoxaban|mesh-list
14503600|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14503601|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
14503602|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14503603|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
14503604|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503605|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503606|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
14503607|NCT02802111|Albuterol|albuterol|mesh-list
14503608|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14503609|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
14776772|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14776773|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776774|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776775|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
14776776|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14776777|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14776778|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
14776779|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14776780|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14776781|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14776782|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14206130|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206131|NCT02998645|Cyclosporine|cyclosporine|mesh-list
14503610|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503611|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206132|NCT02998645|Cyclosporins|cyclosporins|mesh-list
14206133|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206134|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503612|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14503613|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503614|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
14503615|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14503616|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14503617|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14503618|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14503619|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503620|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503621|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503622|NCT02802241|Peppermint oil|peppermint oil|mesh-list
14503623|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
14503624|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
14503625|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503626|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503627|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14503628|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
14503629|NCT02802345|Nintedanib|nintedanib|mesh-list
14503630|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
14503631|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
14503632|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14503633|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776783|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14503634|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942281|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14503635|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503636|NCT02802345|Urological Agents|urological agents|mesh-ancestor
14503637|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503638|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14503639|NCT02802449|Vitamin D|vitamin d|mesh-list
14503640|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
14503641|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
14503642|NCT02802449|Calcifediol|calcifediol|mesh-list
14503643|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14503644|NCT02802449|Vitamins|vitamins|mesh-list
14503645|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
14503646|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503647|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14503648|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14503649|NCT02802501|Piperaquine|piperaquine|mesh-list
14503650|NCT02802501|Primaquine|primaquine|mesh-list
14503651|NCT02802501|Artenimol|artenimol|mesh-list
14503652|NCT02802501|Tafenoquine|tafenoquine|mesh-list
14503653|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
14503654|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14503655|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14503656|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503657|NCT02802514|Exenatide|exenatide|mesh-list
14503658|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
14503659|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14503660|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14503661|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503662|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14503663|NCT02802514|Incretins|incretins|mesh-ancestor
14503664|NCT02802514|Hormones|hormones|mesh-ancestor
14503665|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503666|NCT02802735|Apremilast|apremilast|mesh-list
14206135|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206136|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
14206137|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206138|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
14206139|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206140|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206141|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206142|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14206143|NCT02989857|Ivosidenib|ivosidenib|mesh-list
14206144|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206145|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206146|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206147|NCT02983799|Olaparib|olaparib|mesh-list
14206148|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14206149|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206150|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206151|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206152|NCT02974725|Trametinib|trametinib|mesh-list
14206153|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206154|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14206155|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206156|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503667|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14503668|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503669|NCT02802735|Analgesics|analgesics|mesh-ancestor
14503670|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
14503671|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503672|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503673|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503674|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503675|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14503676|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14503677|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503678|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206157|NCT02971683|Abatacept|abatacept|mesh-list
14503679|NCT02802865|Letrozole|letrozole|mesh-list
14503680|NCT02802865|Clomiphene|clomiphene|mesh-list
14503681|NCT02802865|Enclomiphene|enclomiphene|mesh-list
14503682|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
14503683|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503684|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503685|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14503686|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14503687|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503688|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14503689|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
14206158|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14206159|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206160|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206161|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206162|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
14206163|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206164|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206165|NCT02845271|Acetaminophen|acetaminophen|mesh-list
14206166|NCT02845271|Tramadol|tramadol|mesh-list
14206167|NCT02845271|Codeine|codeine|mesh-list
14206168|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14206169|NCT02845271|Analgesics|analgesics|mesh-ancestor
14206170|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
14206171|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206172|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206173|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
14206174|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14206175|NCT02845271|Narcotics|narcotics|mesh-ancestor
14206176|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206177|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
14206178|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
14206179|NCT02842359|Irbesartan|irbesartan|mesh-list
14503690|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503691|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503692|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14503693|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
14503694|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14503695|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14776784|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
14776785|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776786|NCT00664898|Bortezomib|bortezomib|mesh-list
14776787|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776788|NCT00664963|Sirolimus|sirolimus|mesh-list
14776789|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14776790|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776791|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14776792|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776793|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
14776794|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14776795|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
14776796|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776797|NCT00665041|Quinagolide|quinagolide|mesh-list
14776798|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
14776799|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
14776800|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776801|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776802|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776803|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776804|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776805|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776806|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776807|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776808|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776809|NCT00665054|Urological Agents|urological agents|mesh-ancestor
14776810|NCT00665093|Insulin|insulin|mesh-list
14776811|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14776812|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
14776813|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
14206180|NCT02842359|Atorvastatin|atorvastatin|mesh-list
14206181|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14776814|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
14776815|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14776816|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14776817|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206182|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14942282|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14206183|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
14776818|NCT00665119|Remifentanil|remifentanil|mesh-list
14942283|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
14942284|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14503696|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14503697|NCT02803138|Ritonavir|ritonavir|mesh-list
14503698|NCT02803138|Ribavirin|ribavirin|mesh-list
14503699|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14503700|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14503701|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
14503702|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206184|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206185|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14206186|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14206187|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206188|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14206189|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14206190|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14206191|NCT02825160|Iloprost|iloprost|mesh-list
14206192|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14206193|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
14206194|NCT02813785|Docetaxel|docetaxel|mesh-list
14206195|NCT02813785|Atezolizumab|atezolizumab|mesh-list
14503703|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503704|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14503705|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14503706|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
14503707|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503708|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14942285|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942286|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942287|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942288|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
14942289|NCT01503060|Lidocaine|lidocaine|mesh-list
14942290|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
14206196|NCT02813785|Antibodies|antibodies|mesh-list
14206197|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
14206198|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206199|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206200|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206201|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
14942291|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
14942292|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206202|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
14503709|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14503710|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
14503711|NCT02803229|Amphetamine|amphetamine|mesh-list
14503712|NCT02803229|Adderall|adderall|mesh-list
14503713|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14503714|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503715|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
14503716|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
14503717|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503718|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
14503719|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503720|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503721|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
14503722|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14503723|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14503724|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14503725|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14503726|NCT02803749|Buspirone|buspirone|mesh-list
14503727|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14776819|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14776820|NCT00665119|Narcotics|narcotics|mesh-ancestor
14776821|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776822|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776823|NCT00665119|Analgesics|analgesics|mesh-ancestor
14776824|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
14776825|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776826|NCT00665314|Plerixafor|plerixafor|mesh-list
14776827|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14776828|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14776829|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
14776830|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776831|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
14206203|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206204|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14206205|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206206|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14206207|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14206208|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14206209|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
14206210|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206211|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206212|NCT02679508|Lansoprazole|lansoprazole|mesh-list
14206213|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
14206214|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14206215|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14206216|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14206217|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206218|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206219|NCT02678312|Enalapril|enalapril|mesh-list
14206220|NCT02678312|Enalaprilat|enalaprilat|mesh-list
14206221|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14206222|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14206223|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
14206224|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206225|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206226|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14503728|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14503729|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14503730|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503731|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14503732|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14503733|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
14503734|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14503735|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503736|NCT02804399|Rifampin|rifampin|mesh-list
14503737|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14503738|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
14503739|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14503740|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776832|NCT00665327|Levofloxacin|levofloxacin|mesh-list
14776833|NCT00665327|Ofloxacin|ofloxacin|mesh-list
14503741|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
14503742|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14503743|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503744|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503745|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14503746|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14503747|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14503748|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14503749|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14503750|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14503751|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
14503752|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14503753|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
14503754|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503755|NCT02804594|Expectorants|expectorants|mesh-ancestor
14503756|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503757|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14503758|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
14503759|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503760|NCT02804594|Protective Agents|protective agents|mesh-ancestor
14503761|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503762|NCT02804594|Antidotes|antidotes|mesh-ancestor
14503763|NCT02805179|Temozolomide|temozolomide|mesh-list
14503764|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14503765|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
14503766|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503767|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503768|NCT02805660|Durvalumab|durvalumab|mesh-list
14503769|NCT02805660|Mocetinostat|mocetinostat|mesh-list
14503770|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14503771|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503772|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14503773|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503774|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503775|NCT02805907|Calcifediol|calcifediol|mesh-list
14503776|NCT02805907|Vitamins|vitamins|mesh-ancestor
14503777|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
14503778|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503779|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14503780|NCT02805972|Naloxone|naloxone|mesh-list
14503781|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14503782|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503783|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
14503784|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503785|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
14503786|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14503787|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14503788|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503789|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
14503790|NCT02806024|Coagulants|coagulants|mesh-ancestor
14503791|NCT02806232|Praziquantel|praziquantel|mesh-list
14503792|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
14503793|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14503794|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503795|NCT02806414|Ivermectin|ivermectin|mesh-list
14503796|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14503797|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503798|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14503799|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
14503800|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503801|NCT02806544|Tamoxifen|tamoxifen|mesh-list
14503802|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14503803|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
14503804|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503805|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503806|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14503807|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503808|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14503809|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14503810|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14503811|NCT02806869|Ibuprofen|ibuprofen|mesh-list
14503812|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14503813|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503814|NCT02806869|Analgesics|analgesics|mesh-ancestor
14503815|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
14503816|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503817|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503818|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503819|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503820|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14503821|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503822|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503823|NCT02806947|Sirolimus|sirolimus|mesh-list
14503824|NCT02806947|Prednisone|prednisone|mesh-list
14503825|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503826|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
14503827|NCT02806947|Hormones|hormones|mesh-ancestor
14503828|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503829|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503830|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14503831|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503832|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14503833|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503834|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14503835|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
14503836|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503837|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
14503838|NCT02806973|Glucagon|glucagon|mesh-list
14503839|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14503840|NCT02806973|Hormones|hormones|mesh-ancestor
14503841|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14503842|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503843|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
14503844|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
14503845|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14503846|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14503847|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
14503848|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503849|NCT02807623|Ibuprofen|ibuprofen|mesh-list
14503850|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14206227|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14206228|NCT02633059|Dexamethasone|dexamethasone|mesh-list
14206229|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
14776834|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14776835|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14776836|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776837|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14776838|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14776839|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503851|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503852|NCT02807623|Analgesics|analgesics|mesh-ancestor
14503853|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
14503854|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503855|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503856|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503857|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503858|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14503859|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503860|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503861|NCT02807844|Spartalizumab|spartalizumab|mesh-list
14503862|NCT02807844|Sargramostim|sargramostim|mesh-list
14503863|NCT02807844|Immunologic Factors|immunologic factors|mesh-ancestor
14503864|NCT02807844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503865|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14503866|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503867|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776840|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776841|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776842|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14776843|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
14776844|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14942293|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942294|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
14942295|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942296|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14942297|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14942298|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14503868|NCT02808052|Minocycline|minocycline|mesh-list
14503869|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14503870|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503871|NCT02808819|Benralizumab|benralizumab|mesh-list
14503872|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14503873|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503874|NCT02808975|Adalimumab|adalimumab|mesh-list
14503875|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503876|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776845|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776846|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14776847|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14776848|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14776849|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14942299|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942300|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942301|NCT01503216|Vitamin D|vitamin d|mesh-list
14942302|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
14942303|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
14942304|NCT01503216|Vitamins|vitamins|mesh-ancestor
14942305|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
14942306|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776850|NCT00665327|Renal Agents|renal agents|mesh-ancestor
14776851|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14942307|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14206230|NCT02633059|Ixazomib|ixazomib|mesh-list
14206231|NCT02633059|Ichthammol|ichthammol|mesh-list
14206232|NCT02633059|BB 1101|bb 1101|mesh-list
14206233|NCT02633059|Glycine|glycine|mesh-list
14206234|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206235|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
14206236|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
14206237|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206238|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206239|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14503877|NCT02809053|Rituximab|rituximab|mesh-list
14503878|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14503879|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503880|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
14503881|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503882|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503883|NCT02810392|Insulin|insulin|mesh-list
14503884|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14503885|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14503886|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503887|NCT02810873|Copper|copper|mesh-list
14776852|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14776853|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14776854|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776855|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776856|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776857|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776858|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942308|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14942309|NCT01503242|Cyclosporine|cyclosporine|mesh-list
14942310|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
14942311|NCT01503242|Fludarabine|fludarabine|mesh-list
14942312|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
14942313|NCT01503242|Antibodies|antibodies|mesh-list
14942314|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14942315|NCT01503242|Cyclosporins|cyclosporins|mesh-list
14942316|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
14776859|NCT00665340|Urological Agents|urological agents|mesh-ancestor
14776860|NCT00665418|Sevoflurane|sevoflurane|mesh-list
14776861|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14776862|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14942317|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942318|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942319|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14942320|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
14942321|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942322|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14942323|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942324|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
14942325|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942326|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206240|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
14206241|NCT02633059|Hormones|hormones|mesh-ancestor
14206242|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206243|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14206244|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206245|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206246|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
14206247|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206248|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206249|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
14206250|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206251|NCT02631577|Lenalidomide|lenalidomide|mesh-list
14206252|NCT02631577|Atezolizumab|atezolizumab|mesh-list
14206253|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
14206254|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
14206255|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206256|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14206257|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14206258|NCT02631577|Growth Substances|growth substances|mesh-ancestor
14206259|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
14206260|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206261|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206262|NCT02494986|Rilpivirine|rilpivirine|mesh-list
14206263|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14776863|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
14776864|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
14776865|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776866|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942327|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942328|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14942329|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14206264|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14206265|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503888|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
14776867|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14503889|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14206266|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206267|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
14206268|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503890|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14503891|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503892|NCT02810873|Trace Elements|trace elements|mesh-ancestor
14503893|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
14503894|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503895|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
14776868|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
14776869|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14776870|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14776871|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776872|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503896|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
14503897|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503898|NCT02810964|Sulforaphane|sulforaphane|mesh-list
14503899|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14503900|NCT02810964|Protective Agents|protective agents|mesh-ancestor
14503901|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503902|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528475|NCT03868059|Testosterone|testosterone|mesh-list
14528476|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
14528477|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
14528478|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14528479|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528480|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
14528481|NCT03868059|Hormones|hormones|mesh-ancestor
14528482|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528483|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528484|NCT03868059|Androgens|androgens|mesh-ancestor
14528485|NCT03865407|Allopurinol|allopurinol|mesh-list
14528486|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
14528487|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528488|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528489|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
14528490|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528491|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14528492|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
14528493|NCT03865407|Protective Agents|protective agents|mesh-ancestor
14528494|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528495|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14528496|NCT03857230|Hormones|hormones|mesh-ancestor
14528497|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528498|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530029|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14530030|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
14530031|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14530032|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14206269|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14206270|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14240902|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14240903|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240904|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
14240905|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14240906|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14240907|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14240908|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240909|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530033|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
14530034|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530035|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530036|NCT03360903|Caffeine|caffeine|mesh-list
14530037|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14530038|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530039|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14530040|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530041|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530042|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14530043|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14530044|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
14776873|NCT00665496|Urological Agents|urological agents|mesh-ancestor
14503903|NCT02812186|Rocuronium|rocuronium|mesh-list
14503904|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14503905|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14503906|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14503907|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503908|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503909|NCT02812238|Niacinamide|niacinamide|mesh-list
14503910|NCT02812238|Niacin|niacin|mesh-list
14503911|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
14503912|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
14503913|NCT02812238|Vitamins|vitamins|mesh-ancestor
14503914|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
14503915|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503916|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14503917|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
14776874|NCT00665522|Fentanyl|fentanyl|mesh-list
14776875|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14776876|NCT00665522|Narcotics|narcotics|mesh-ancestor
14776877|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14776878|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776879|NCT00665522|Analgesics|analgesics|mesh-ancestor
14776880|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
14776881|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503918|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503919|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14503920|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
14503921|NCT02812342|Tofacitinib|tofacitinib|mesh-list
14503922|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14206271|NCT02408315|Misoprostol|misoprostol|mesh-list
14206272|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14503923|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503924|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503925|NCT02812771|Efinaconazole|efinaconazole|mesh-list
14503926|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
14206273|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
14206274|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14503927|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503928|NCT02813070|Flutemetamol|flutemetamol|mesh-list
14503929|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14503930|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503931|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14503932|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14503933|NCT02813551|Torsemide|torsemide|mesh-list
14503934|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14503935|NCT02813551|Diuretics|diuretics|mesh-ancestor
14503936|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
14503937|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503938|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14503939|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14503940|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503941|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
14503942|NCT02813694|Lefamulin|lefamulin|mesh-list
14503943|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14503944|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503945|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14503946|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14503947|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503948|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503949|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503950|NCT02814175|Adalimumab|adalimumab|mesh-list
14776882|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14776883|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14206275|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206276|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14206277|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14206278|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
14206279|NCT02354014|Bedaquiline|bedaquiline|mesh-list
14206280|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
14206281|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
14206282|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14206283|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206284|NCT02125461|Durvalumab|durvalumab|mesh-list
14206285|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206286|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206287|NCT02022592|Midazolam|midazolam|mesh-list
14206288|NCT02022592|Lormetazepam|lormetazepam|mesh-list
14503951|NCT02814175|Methotrexate|methotrexate|mesh-list
14503952|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14503953|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
14503954|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14503955|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503956|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206289|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14206290|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14206291|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206292|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206293|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14206294|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14206295|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14206296|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14206297|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
14206298|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
14206299|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
14206300|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
14206301|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206302|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206303|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
14206304|NCT01854814|Losartan|losartan|mesh-list
14206305|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14206306|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206307|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14206308|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
14206309|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14206310|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206311|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206312|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206313|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14206314|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14206315|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14206316|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14206317|NCT01837862|Mebendazole|mebendazole|mesh-list
14206318|NCT01837862|Piperazine|piperazine|mesh-list
14206319|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
14206320|NCT01837862|Bevacizumab|bevacizumab|mesh-list
14206321|NCT01837862|Carboplatin|carboplatin|mesh-list
14206322|NCT01837862|Irinotecan|irinotecan|mesh-list
14206323|NCT01837862|Vincristine|vincristine|mesh-list
14206324|NCT01837862|Temozolomide|temozolomide|mesh-list
14503957|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
14503958|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503959|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14503960|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
14503961|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14503962|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14503963|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14503964|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
14503965|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503966|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14503967|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503968|NCT02814279|Dipyrone|dipyrone|mesh-list
14503969|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
14503970|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14503971|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14503972|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
14503973|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14503974|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14503975|NCT02814279|Analgesics|analgesics|mesh-ancestor
14503976|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
14503977|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503978|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503979|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14503980|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14503981|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
14503982|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
14503983|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14503984|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
14503985|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14503986|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14206325|NCT01837862|DMP 777|dmp 777|mesh-list
14206326|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14503987|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14503988|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14528499|NCT03847610|Penicillins|penicillins|mesh-list
14503989|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14503990|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14503991|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14503992|NCT02814643|Benralizumab|benralizumab|mesh-list
14503993|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14206327|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206328|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14206329|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14206330|NCT01837862|Growth Substances|growth substances|mesh-ancestor
14206331|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206332|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
14503994|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
14503995|NCT02815644|Empagliflozin|empagliflozin|mesh-list
14503996|NCT02815644|Linagliptin|linagliptin|mesh-list
14503997|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14503998|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14503999|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504000|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504001|NCT02815644|Incretins|incretins|mesh-ancestor
14504002|NCT02815644|Hormones|hormones|mesh-ancestor
14504003|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504004|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14504005|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
14504006|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504007|NCT02815709|Morphine|morphine|mesh-list
14504008|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14504009|NCT02815709|Narcotics|narcotics|mesh-ancestor
14504010|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504011|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504012|NCT02815709|Analgesics|analgesics|mesh-ancestor
14504013|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
14504014|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504015|NCT02816138|Nicotine|nicotine|mesh-list
14504016|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14504017|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
14504018|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504019|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504020|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14504021|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14504022|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14504023|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504024|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776884|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
14206333|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14206334|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14206335|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206336|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206337|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14206338|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206339|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206340|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
14206341|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206342|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
14206343|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
14504025|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
14504026|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
14504027|NCT02817555|Hematinics|hematinics|mesh-ancestor
14504028|NCT02817763|Dipyrone|dipyrone|mesh-list
14504029|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14504030|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504031|NCT02817763|Analgesics|analgesics|mesh-ancestor
14504032|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
14504033|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504034|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504035|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504036|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776885|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
14776886|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14776887|NCT00665600|Albuterol|albuterol|mesh-list
14776888|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14776889|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
14776890|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504037|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
14776891|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776892|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14504038|NCT02817828|Drospirenone|drospirenone|mesh-list
14504039|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14504040|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
14504041|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504042|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776893|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
14776894|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
14776895|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14776896|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14776897|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14776898|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14776899|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
14776900|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776901|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776902|NCT00665639|Caspofungin|caspofungin|mesh-list
14776903|NCT00665639|Micafungin|micafungin|mesh-list
14776904|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
14776905|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776906|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776907|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776908|NCT00665678|Paroxetine|paroxetine|mesh-list
14776909|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14776910|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14776911|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14776912|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776913|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14776914|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
14776915|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776916|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14776917|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
14776918|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14776919|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14776920|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14776921|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776922|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
14776923|NCT00665717|Pravastatin|pravastatin|mesh-list
14776924|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14776925|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14776926|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
14942330|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14942331|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
14942332|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942333|NCT01503359|Glycine|glycine|mesh-list
14942334|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
14942335|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942336|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942337|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942338|NCT01503372|Leucovorin|leucovorin|mesh-list
14942339|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
14942340|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942341|NCT01503372|Antidotes|antidotes|mesh-ancestor
13964331|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964332|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13964333|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
13964334|NCT03138031|Ethanol|ethanol|mesh-list
13964335|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13964336|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964337|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964338|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504043|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14504044|NCT02817828|Diuretics|diuretics|mesh-ancestor
14504045|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
14504046|NCT02817841|Drospirenone|drospirenone|mesh-list
14504047|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14504048|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
14504049|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504050|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504051|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14504052|NCT02817841|Diuretics|diuretics|mesh-ancestor
14504053|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
14504054|NCT02818036|Naltrexone|naltrexone|mesh-list
14504055|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14504056|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14206344|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
14776927|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776928|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14776929|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14776930|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776931|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776932|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14776933|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14776934|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
14776935|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14776936|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14504057|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504058|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
14504059|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504060|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
14504061|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14776937|NCT00665743|Naproxen|naproxen|mesh-list
14776938|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14776939|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14776940|NCT00665743|Analgesics|analgesics|mesh-ancestor
14776941|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
14776942|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14776943|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942342|NCT01503372|Protective Agents|protective agents|mesh-ancestor
14942343|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942344|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
14504062|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504063|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504064|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504065|NCT02818569|Analgesics|analgesics|mesh-ancestor
14504066|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
14504067|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504068|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14504069|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14504070|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14504071|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
14504072|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504073|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504074|NCT02818777|Cannabidiol|cannabidiol|mesh-list
14504075|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
14504076|NCT02818998|Aflibercept|aflibercept|mesh-list
14504077|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14504078|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14504079|NCT02818998|Growth Substances|growth substances|mesh-ancestor
14504080|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504081|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
14504082|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776944|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14776945|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14776946|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
14776947|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14776948|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776949|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776950|NCT00665756|Mitomycins|mitomycins|mesh-list
14942345|NCT01503372|Vitamins|vitamins|mesh-ancestor
14776951|NCT00665756|Mitomycin|mitomycin|mesh-list
14776952|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14776953|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776954|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
14776955|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776956|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14776957|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776958|NCT00665808|Insulin|insulin|mesh-list
14942346|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
14206345|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14206346|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206347|NCT01813227|Dexamethasone|dexamethasone|mesh-list
14206348|NCT01813227|Rituximab|rituximab|mesh-list
14206349|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206350|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
14206351|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
14206352|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206353|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206354|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14206355|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
14776959|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14776960|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
14776961|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
14776962|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
14776963|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
14776964|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14776965|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776966|NCT00665834|Atorvastatin|atorvastatin|mesh-list
14776967|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14776968|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14206356|NCT01813227|Hormones|hormones|mesh-ancestor
14206357|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206358|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14206359|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206360|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206361|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
14206362|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206363|NCT01791478|Letrozole|letrozole|mesh-list
14206364|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
14206365|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206366|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14206367|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14206368|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206369|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206370|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14206371|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
14206372|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206373|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206374|NCT01698840|Vitamin D|vitamin d|mesh-list
14206375|NCT01698840|Vitamins|vitamins|mesh-ancestor
14206376|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
14206377|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206378|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14206379|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
14206380|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
14206381|NCT01695317|Vitamins|vitamins|mesh-ancestor
14206382|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
14206383|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206384|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
14206385|NCT01652092|Vidarabine|vidarabine|mesh-list
14206386|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
14206387|NCT01652092|Melphalan|melphalan|mesh-list
14206388|NCT01652092|Busulfan|busulfan|mesh-list
14206389|NCT01652092|Fludarabine|fludarabine|mesh-list
14206390|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
14206391|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
14206392|NCT01652092|Mesna|mesna|mesh-list
14206393|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206394|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
14240910|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
14240911|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240912|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240913|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14240914|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240915|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
14240916|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14240917|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14240918|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14240919|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14240920|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240921|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
14240922|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240923|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240924|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14240925|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240926|NCT00168805|Enoxaparin|enoxaparin|mesh-list
14240927|NCT00168805|Dabigatran|dabigatran|mesh-list
14240928|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
14240929|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14240930|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14240931|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240932|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
14240933|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14240934|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
14240935|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240936|NCT00168818|Enoxaparin|enoxaparin|mesh-list
14240937|NCT00168818|Dabigatran|dabigatran|mesh-list
14504083|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14504084|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14504085|NCT02819297|Laxatives|laxatives|mesh-list
14504086|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14504087|NCT02819310|Laxatives|laxatives|mesh-list
14504088|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14504089|NCT02819479|Bevacizumab|bevacizumab|mesh-list
14504090|NCT02819479|Mannitol|mannitol|mesh-list
14504091|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14504092|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504093|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14504094|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14504095|NCT02819479|Growth Substances|growth substances|mesh-ancestor
14504096|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14776969|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14776970|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
14776971|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776972|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14776973|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14776974|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776975|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14776976|NCT00665873|Amoxicillin|amoxicillin|mesh-list
14504097|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
14504098|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14504099|NCT02819479|Diuretics|diuretics|mesh-ancestor
14504100|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
14504101|NCT02819726|Rituximab|rituximab|mesh-list
14206395|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206396|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206397|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206398|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
14206399|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206400|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206401|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206402|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206403|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
14206404|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
14504102|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14504103|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504104|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
14504105|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504106|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504107|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
14504108|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504109|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504110|NCT02820324|Morphine|morphine|mesh-list
14504111|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14504112|NCT02820324|Narcotics|narcotics|mesh-ancestor
14504113|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504114|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504115|NCT02820324|Analgesics|analgesics|mesh-ancestor
14504116|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
14504117|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504118|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14504119|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504120|NCT02821338|Lamotrigine|lamotrigine|mesh-list
14504121|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
14504122|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14504123|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504124|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504125|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14776977|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
14776978|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
14776979|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14776980|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776981|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
14776982|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776983|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776984|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14504126|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504127|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14776985|NCT00665951|Ritonavir|ritonavir|mesh-list
14504128|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14504129|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206405|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776986|NCT00665951|Lopinavir|lopinavir|mesh-list
14206406|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206407|NCT01652092|Protective Agents|protective agents|mesh-ancestor
14206408|NCT01515748|Docetaxel|docetaxel|mesh-list
14206409|NCT01515748|Fluorouracil|fluorouracil|mesh-list
14206410|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
14206411|NCT01515748|Tegafur|tegafur|mesh-list
14206412|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206413|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206414|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206415|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14206416|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206417|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
14206418|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206419|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206420|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
14206421|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206422|NCT01505569|Etoposide|etoposide|mesh-list
14206423|NCT01505569|Carboplatin|carboplatin|mesh-list
14206424|NCT01505569|Melphalan|melphalan|mesh-list
14206425|NCT01505569|Busulfan|busulfan|mesh-list
14206426|NCT01505569|Ifosfamide|ifosfamide|mesh-list
14206427|NCT01505569|Thiotepa|thiotepa|mesh-list
14206428|NCT01505569|Lenograstim|lenograstim|mesh-list
14206429|NCT01505569|Mesna|mesna|mesh-list
14206430|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14206431|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206432|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206433|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14206434|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14504130|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964339|NCT03137927|Vaccines|vaccines|mesh-list
13964340|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
13964341|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964342|NCT03137966|Deferoxamine|deferoxamine|mesh-list
13964343|NCT03137966|Siderophores|siderophores|mesh-ancestor
13964344|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13964345|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
13964346|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
13964347|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968053|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14206435|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240938|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
14240939|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14240940|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14240941|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240942|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
14240943|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14240944|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
14240945|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240946|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
14240947|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14240948|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
14240949|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240950|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240951|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14240952|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
14240953|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
14240954|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14240955|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
14240956|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240957|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240958|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
14240959|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14240960|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
14240961|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14240962|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240963|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14240964|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
14240965|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
14240966|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14240967|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
14240968|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14240969|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240970|NCT00169104|Trastuzumab|trastuzumab|mesh-list
14240971|NCT00169104|Vinorelbine|vinorelbine|mesh-list
14240972|NCT00169104|Lenograstim|lenograstim|mesh-list
14206436|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14504131|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14504132|NCT02821416|Benralizumab|benralizumab|mesh-list
14504133|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14504134|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
14776987|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14776988|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14776989|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
14776990|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14776991|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14776992|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14776993|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14776994|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
14206437|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
14206438|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206439|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206440|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
14206441|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206442|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14206443|NCT01505569|Protective Agents|protective agents|mesh-ancestor
14206444|NCT01196936|Tamoxifen|tamoxifen|mesh-list
14206445|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14206446|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
14206447|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206448|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206449|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14206450|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206451|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14206452|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14206453|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14206454|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
14206455|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14776995|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14776996|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14776997|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14206456|NCT01068249|Everolimus|everolimus|mesh-list
14206457|NCT01068249|Letrozole|letrozole|mesh-list
14206458|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206459|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206460|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
14206461|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206462|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14206463|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14206464|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206465|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206466|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14206467|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
14206468|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206469|NCT01054196|Lenalidomide|lenalidomide|mesh-list
14206470|NCT01054196|Melphalan|melphalan|mesh-list
14504135|NCT02821715|Flecainide|flecainide|mesh-list
14776998|NCT00665977|Triamcinolone|triamcinolone|mesh-list
14776999|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14777000|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14504136|NCT02821715|Modafinil|modafinil|mesh-list
14504137|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14504138|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504139|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14504140|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14504141|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14777001|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14504142|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504143|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14504144|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14504145|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14504146|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504147|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14504148|NCT02821819|Hormones|hormones|mesh-ancestor
14504149|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504150|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504151|NCT02821910|Metformin|metformin|mesh-list
14504152|NCT02821910|Empagliflozin|empagliflozin|mesh-list
14504153|NCT02821910|Linagliptin|linagliptin|mesh-list
14504154|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504155|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504156|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14504157|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777002|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14777003|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
14777004|NCT00665977|Hormones|hormones|mesh-ancestor
14777005|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777006|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777007|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777008|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
14777009|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777010|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777011|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
14777012|NCT00665990|Bevacizumab|bevacizumab|mesh-list
14777013|NCT00665990|Sorafenib|sorafenib|mesh-list
14777014|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777015|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
14777016|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777017|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777018|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14777019|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
14777020|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777021|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504158|NCT02821910|Incretins|incretins|mesh-ancestor
14504159|NCT02821910|Hormones|hormones|mesh-ancestor
14504160|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504161|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14504162|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
14504163|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504164|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
14206471|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
14504165|NCT02822222|Cathartics|cathartics|mesh-ancestor
14504166|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14504167|NCT02822794|Ribavirin|ribavirin|mesh-list
14504168|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
14504169|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14504170|NCT02822794|Velpatasvir|velpatasvir|mesh-list
14504171|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
14504172|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504173|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
14504174|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504175|NCT02822950|Ceftazidime|ceftazidime|mesh-list
14504176|NCT02822950|Avibactam|avibactam|mesh-list
14504177|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14504178|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14504179|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504180|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14504181|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504182|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504183|NCT02823080|Cetrorelix|cetrorelix|mesh-list
14504184|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14504185|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
14504186|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14504187|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504188|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
14504189|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504190|NCT02823431|Lidocaine|lidocaine|mesh-list
14504191|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
14504192|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
14504193|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504194|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504195|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
14504196|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942347|NCT01503385|Celecoxib|celecoxib|mesh-list
14942348|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14206472|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206473|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14206474|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14206475|NCT01054196|Growth Substances|growth substances|mesh-ancestor
14206476|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
14206477|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206478|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14504197|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14504198|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14504199|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14504200|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504201|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504202|NCT02823470|Ivacaftor|ivacaftor|mesh-list
14504203|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14504204|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504205|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504206|NCT02824224|Tamoxifen|tamoxifen|mesh-list
14504207|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14504208|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
14504209|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504210|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504211|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14504212|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504213|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14504214|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14504215|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14504216|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14504217|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14504218|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
14777022|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14777023|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14777024|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14777025|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14777026|NCT00665990|Growth Substances|growth substances|mesh-ancestor
14777027|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14777028|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14777029|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777030|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
14777031|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14777032|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14777033|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14777034|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777035|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777036|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14777037|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777038|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777039|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777040|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777041|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14777042|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
14777043|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777044|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777045|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14777046|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14777047|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14777048|NCT00666055|Ritonavir|ritonavir|mesh-list
14777049|NCT00666055|Lopinavir|lopinavir|mesh-list
14777050|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14777051|NCT00666055|Tenofovir|tenofovir|mesh-list
14777052|NCT00666055|Lamivudine|lamivudine|mesh-list
14777053|NCT00666055|Zidovudine|zidovudine|mesh-list
14777054|NCT00666055|Emtricitabine|emtricitabine|mesh-list
14777055|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
14777056|NCT00666055|Maraviroc|maraviroc|mesh-list
14777057|NCT00666055|Efavirenz|efavirenz|mesh-list
14777058|NCT00666055|Etravirine|etravirine|mesh-list
14777059|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14777060|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14777061|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
14777062|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777063|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777064|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14942349|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942350|NCT01503385|Analgesics|analgesics|mesh-ancestor
14942351|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
14942352|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777065|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14777066|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
14942353|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942354|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942355|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777067|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504219|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14504220|NCT02825212|Ledipasvir|ledipasvir|mesh-list
14777068|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14777069|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14777070|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14777071|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777072|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
14504221|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14504222|NCT02825212|Velpatasvir|velpatasvir|mesh-list
14504223|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
14504224|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504225|NCT02825251|Insulin|insulin|mesh-list
14504226|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14504227|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
14504228|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
14504229|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14504230|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504231|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504232|NCT02825420|Trabectedin|trabectedin|mesh-list
14504233|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14504234|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
14504235|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504236|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528500|NCT03847610|Penicillin V|penicillin v|mesh-list
14528501|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14528502|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206479|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
14206480|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206481|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206482|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206483|NCT01004874|Bevacizumab|bevacizumab|mesh-list
14206484|NCT01004874|Temozolomide|temozolomide|mesh-list
14206485|NCT01004874|Topotecan|topotecan|mesh-list
14206486|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206487|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206488|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14206489|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14206490|NCT01004874|Growth Substances|growth substances|mesh-ancestor
14528503|NCT03850093|Bisoprolol|bisoprolol|mesh-list
14528504|NCT03850093|Gabapentin|gabapentin|mesh-list
14528505|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528506|NCT03850093|Analgesics|analgesics|mesh-ancestor
14528507|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
14528508|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528509|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
14528510|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14528511|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14528512|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528513|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14528514|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14528515|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14528516|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528517|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528518|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
14528519|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14528520|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
14206491|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206492|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
14206493|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206494|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
14206495|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206496|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14206497|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14206498|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206499|NCT00799864|Tenofovir|tenofovir|mesh-list
14206500|NCT00799864|Lamivudine|lamivudine|mesh-list
14206501|NCT00799864|Zidovudine|zidovudine|mesh-list
14206502|NCT00799864|Emtricitabine|emtricitabine|mesh-list
14206503|NCT00799864|Abacavir|abacavir|mesh-list
14206504|NCT00799864|Rilpivirine|rilpivirine|mesh-list
14528521|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
14206505|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
14206506|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206507|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14206508|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14206509|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206510|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206511|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14206512|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14206513|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
14206514|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
14206515|NCT00268476|Metformin|metformin|mesh-list
14206516|NCT00268476|Prednisone|prednisone|mesh-list
14206517|NCT00268476|Prednisolone|prednisolone|mesh-list
14206518|NCT00268476|Celecoxib|celecoxib|mesh-list
14206519|NCT00268476|Docetaxel|docetaxel|mesh-list
14206520|NCT00268476|Estradiol|estradiol|mesh-list
14206521|NCT00268476|Androgens|androgens|mesh-list
14504237|NCT02826603|Ustekinumab|ustekinumab|mesh-list
14504238|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
14504239|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
14504240|NCT02828358|Leucovorin|leucovorin|mesh-list
14504241|NCT02828358|Folic Acid|folic acid|mesh-list
14504242|NCT02828358|Cytarabine|cytarabine|mesh-list
14504243|NCT02828358|Dexamethasone|dexamethasone|mesh-list
14504244|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
14504245|NCT02828358|Prednisolone|prednisolone|mesh-list
14504246|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14504247|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
14504248|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14504249|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
14504250|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
14504251|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14504252|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14504253|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14504254|NCT02828358|Cortisone|cortisone|mesh-list
14504255|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
14504256|NCT02828358|Methotrexate|methotrexate|mesh-list
14504257|NCT02828358|Vincristine|vincristine|mesh-list
14504258|NCT02828358|Azacitidine|azacitidine|mesh-list
14504259|NCT02828358|Daunorubicin|daunorubicin|mesh-list
14504260|NCT02828358|Asparaginase|asparaginase|mesh-list
14504261|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
14504262|NCT02828358|Pegaspargase|pegaspargase|mesh-list
14504263|NCT02828358|Thioguanine|thioguanine|mesh-list
14504264|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14504265|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
14504266|NCT02828358|BB 1101|bb 1101|mesh-list
14504267|NCT02828358|Calcium|calcium|mesh-list
14504268|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
14206522|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504269|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
14504270|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777073|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14777074|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14777075|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14777076|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14777077|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14777078|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14777079|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14777080|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14777081|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14777082|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14777083|NCT00666068|Hormones|hormones|mesh-list
14777084|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14504271|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
14504272|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504273|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504274|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14777085|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14777086|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777087|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777088|NCT00666107|Vaccines|vaccines|mesh-list
14777089|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
14206523|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504275|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
14504276|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504277|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206524|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206525|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
14504278|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14504279|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504280|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
14504281|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
14504282|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504283|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14504284|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
14504285|NCT02828358|Hormones|hormones|mesh-ancestor
14504286|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504287|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14504288|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
14504289|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504290|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14504291|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14504292|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14504293|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
14504294|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14504295|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14504296|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
14504297|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
14504298|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14504299|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14504300|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
14504301|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504302|NCT02828358|Antidotes|antidotes|mesh-ancestor
14504303|NCT02828358|Protective Agents|protective agents|mesh-ancestor
14504304|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
14504305|NCT02828358|Vitamins|vitamins|mesh-ancestor
14504306|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
14504307|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14504308|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206526|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206527|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
14206528|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206529|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206530|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
14206531|NCT00268476|Hormones|hormones|mesh-ancestor
14206532|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504309|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14504310|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14504311|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14504312|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14504313|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14504314|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14504315|NCT02828358|Hematinics|hematinics|mesh-ancestor
14777090|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777091|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
14777092|NCT00666159|Tacrolimus|tacrolimus|mesh-list
14777093|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777094|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
14777095|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777096|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14777097|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777098|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777099|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14777100|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942356|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14942357|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14942358|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942359|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942360|NCT01503398|Olanzapine|olanzapine|mesh-list
14942361|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
14942362|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
14942363|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942364|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504316|NCT02829034|Ranolazine|ranolazine|mesh-list
14777101|NCT00666159|Analgesics|analgesics|mesh-ancestor
14206533|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14206534|NCT00268476|Estrogens|estrogens|mesh-ancestor
14206535|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206536|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14206537|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14206538|NCT00268476|Analgesics|analgesics|mesh-ancestor
14206539|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
14206540|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206541|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14206542|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14206543|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504317|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14504318|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504319|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504320|NCT02829775|Interferons|interferons|mesh-list
14504321|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
14504322|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
14504323|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14206544|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14206545|NCT05136677|Carboplatin|carboplatin|mesh-list
14206546|NCT05136677|Nivolumab|nivolumab|mesh-list
14206547|NCT05136677|Pemetrexed|pemetrexed|mesh-list
14206548|NCT05136677|Ipilimumab|ipilimumab|mesh-list
14206549|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504324|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504325|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
14504326|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504327|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
14504328|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504329|NCT02829944|Ketorolac|ketorolac|mesh-list
14504330|NCT02829944|Ropivacaine|ropivacaine|mesh-list
14504331|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
14504332|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
14504333|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504334|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504335|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
14504336|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504337|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14504338|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504339|NCT02829944|Analgesics|analgesics|mesh-ancestor
14504340|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504341|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504342|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14504343|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504344|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504345|NCT02829983|Clarithromycin|clarithromycin|mesh-list
14504346|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14504347|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206550|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206551|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14206552|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206553|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206554|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14206555|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14206556|NCT05127304|Bromides|bromides|mesh-list
14206557|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
14206558|NCT05127304|Olodaterol|olodaterol|mesh-list
14206559|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14206560|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
14206561|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206562|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206563|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14206564|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
14206565|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
14206566|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14206567|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
14206568|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206569|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206570|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
14206571|NCT05102162|Meropenem|meropenem|mesh-list
14206572|NCT05102162|Tazobactam|tazobactam|mesh-list
14206573|NCT05102162|Piperacillin|piperacillin|mesh-list
14206574|NCT05102162|Cefepime|cefepime|mesh-list
14206575|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14206576|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14206577|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206578|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14206579|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504348|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14504349|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504350|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504351|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14206580|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206581|NCT05094336|Docetaxel|docetaxel|mesh-list
14504352|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14206582|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504353|NCT02829996|Latanoprost|latanoprost|mesh-list
14504354|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14504355|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14504356|NCT02830776|Bimatoprost|bimatoprost|mesh-list
14504357|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14504358|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14504359|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14504360|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14777102|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
14777103|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504361|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14504362|NCT02831569|Loxoprofen|loxoprofen|mesh-list
14504363|NCT02831569|Methocarbamol|methocarbamol|mesh-list
14504364|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14504365|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504366|NCT02831569|Analgesics|analgesics|mesh-ancestor
14504367|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
14504368|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504369|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504370|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504371|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777104|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14777105|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777106|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14777107|NCT00666185|Fluconazole|fluconazole|mesh-list
14777108|NCT00666185|Micafungin|micafungin|mesh-list
14777109|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
14777110|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777111|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14777112|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14777113|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777114|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942365|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942366|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14942367|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14942368|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942369|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942370|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14942371|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14942372|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14777115|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14777116|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
14777117|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777118|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777119|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14777120|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14777121|NCT00666237|Mitomycins|mitomycins|mesh-list
14777122|NCT00666237|Mitomycin|mitomycin|mesh-list
14777123|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14777124|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777125|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
14777126|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777127|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777128|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777129|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
14777130|NCT00666302|Tacrolimus|tacrolimus|mesh-list
14777131|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777132|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
14777133|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777134|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14777135|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777136|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777137|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14777138|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14777139|NCT00666302|Analgesics|analgesics|mesh-ancestor
14777140|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
14777141|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777142|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206583|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206584|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206585|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
14504372|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14504373|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14504374|NCT02831816|Ethanol|ethanol|mesh-list
14504375|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
14504376|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14504377|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14504378|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504379|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504380|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504381|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
14504382|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
14504383|NCT02831855|Methotrexate|methotrexate|mesh-list
14504384|NCT02831855|Tofacitinib|tofacitinib|mesh-list
14504385|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14504386|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
14504387|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14504388|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504389|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14504390|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
14504391|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504392|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504393|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
14504394|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504395|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14504396|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14504397|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
14504398|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504399|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14504400|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14504401|NCT02831998|Ethanol|ethanol|mesh-list
14504402|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
14504403|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14504404|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14777143|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206586|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206587|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
14206588|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206589|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206590|NCT05049980|Mifepristone|mifepristone|mesh-list
14206591|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14206592|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
14206593|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14206594|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206595|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14206596|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14206597|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14206598|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
14206599|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14206600|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14206601|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
14206602|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206603|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
14206604|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14206605|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14206606|NCT05023980|Rituximab|rituximab|mesh-list
14206607|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14206608|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206609|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206610|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
14206611|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206612|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206613|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206614|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
14206615|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206620|NCT05003258|Dexamethasone|dexamethasone|mesh-list
14504405|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206621|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206622|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
14206623|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
14206624|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206625|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206626|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14206627|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
14206628|NCT05003258|Hormones|hormones|mesh-ancestor
14206629|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206630|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14206631|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206632|NCT04986631|Topiramate|topiramate|mesh-list
14206633|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
14206634|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14206635|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240973|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240974|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240975|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14240976|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
14240977|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240978|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14240979|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
14240980|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
14240981|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
14504406|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504407|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504408|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
14504409|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
14504410|NCT02832037|BI 425809|bi 425809|mesh-list
14504411|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
14504412|NCT02832115|Lidocaine|lidocaine|mesh-list
14504413|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
14504414|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
14504415|NCT02832115|Anesthetics|anesthetics|mesh-list
14504416|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504417|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504418|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
14504419|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504420|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14504421|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14504422|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14504423|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504424|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504425|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
14504426|NCT02832375|Fluorides|fluorides|mesh-list
14504427|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
14504428|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
14504429|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
14504430|NCT02832375|Protective Agents|protective agents|mesh-ancestor
14504431|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504432|NCT02833350|Folic Acid|folic acid|mesh-list
14504433|NCT02833350|Adalimumab|adalimumab|mesh-list
14504434|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504435|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504436|NCT02833350|Hematinics|hematinics|mesh-ancestor
14504437|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
14504438|NCT02833350|Vitamins|vitamins|mesh-ancestor
14504439|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
14504440|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504441|NCT02833415|Empagliflozin|empagliflozin|mesh-list
14504442|NCT02833415|Glycerol|glycerol|mesh-list
14504443|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14504444|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504445|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504446|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504447|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14504448|NCT02833415|Protective Agents|protective agents|mesh-ancestor
14504449|NCT02833844|Evolocumab|evolocumab|mesh-list
14504450|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14504451|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14504452|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
14504453|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243218|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504454|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14504455|NCT02833948|Aspirin|aspirin|mesh-list
14504456|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
14504457|NCT02833948|Clopidogrel|clopidogrel|mesh-list
14504458|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14504459|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14504460|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14504461|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14504462|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
14504463|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504464|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504465|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504466|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14504467|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
14504468|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14504469|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
14504470|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504471|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
14504472|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14504473|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504474|NCT02833948|Analgesics|analgesics|mesh-ancestor
14504475|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
14206636|NCT04961190|Paroxetine|paroxetine|mesh-list
14206637|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14206638|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14206639|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14206640|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14206641|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206642|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206643|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
14206644|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206645|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14206646|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
14206647|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14206648|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14206649|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14206650|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206651|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14206652|NCT04944017|Ketamine|ketamine|mesh-list
14206653|NCT04944017|Analgesics|analgesics|mesh-ancestor
14504476|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504477|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504478|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504479|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14504480|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14504481|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14504482|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
14504483|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14504484|NCT02834247|Nivolumab|nivolumab|mesh-list
14504485|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14504486|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504487|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14504488|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504489|NCT02834390|Cytarabine|cytarabine|mesh-list
14504490|NCT02834390|Daunorubicin|daunorubicin|mesh-list
14504491|NCT02834390|Idarubicin|idarubicin|mesh-list
14504492|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14504493|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
14504494|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504495|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504496|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
14504497|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504498|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14504499|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
14504500|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504501|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14504502|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14504503|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14504504|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504505|NCT02834624|Poractant alfa|poractant alfa|mesh-list
14504506|NCT02834624|Calfactant|calfactant|mesh-list
14504507|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14504508|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
14206654|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
14504509|NCT02834663|Ranibizumab|ranibizumab|mesh-list
14504510|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14504511|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14504512|NCT02834663|Growth Substances|growth substances|mesh-ancestor
14504513|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504514|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14504515|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504516|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
14504517|NCT02835339|Analgesics|analgesics|mesh-ancestor
14504518|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
14504519|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504520|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504521|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
14504522|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504523|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14504524|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
14504525|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14504526|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504527|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504528|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14504529|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
14504530|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14504531|NCT02835846|Estrogens|estrogens|mesh-list
14504532|NCT02835846|Hormones|hormones|mesh-ancestor
14504533|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504534|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504535|NCT02836496|Prednisone|prednisone|mesh-list
14504536|NCT02836496|Prednisolone|prednisolone|mesh-list
14504537|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504538|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
14504539|NCT02836496|Hormones|hormones|mesh-ancestor
14504540|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504541|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504542|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14777144|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
14777145|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
14777146|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777147|NCT00666354|Methotrexate|methotrexate|mesh-list
14777148|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14777149|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
14777150|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777151|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777152|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14777153|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
14777154|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777155|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777156|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
14777157|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777158|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13964348|NCT03137667|Vaccines|vaccines|mesh-list
14504543|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504544|NCT02836652|Aspirin|aspirin|mesh-list
14504545|NCT02836652|Warfarin|warfarin|mesh-list
14504546|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14206655|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206656|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206657|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14206658|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14206659|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
14206660|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
14206661|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964349|NCT03137667|Immunologic Factors|immunologic factors|mesh-ancestor
13964350|NCT03137667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964351|NCT03137615|Anesthetics|anesthetics|mesh-list
13964352|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
13964353|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964354|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964355|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
13964356|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964357|NCT03137498|Ketorolac|ketorolac|mesh-list
13964358|NCT03137498|Lidocaine|lidocaine|mesh-list
13964359|NCT03137498|Prilocaine|prilocaine|mesh-list
13964360|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
13964361|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
13964362|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964363|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206662|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14504547|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504548|NCT02836652|Analgesics|analgesics|mesh-ancestor
14504549|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
14504550|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504551|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504552|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504553|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504554|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14504555|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14504556|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504557|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14504558|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14504559|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504560|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
14504561|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
14777159|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777160|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
14777161|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777162|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777163|NCT00666393|Fentanyl|fentanyl|mesh-list
14777164|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14777165|NCT00666393|Narcotics|narcotics|mesh-ancestor
14777166|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777167|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777168|NCT00666393|Analgesics|analgesics|mesh-ancestor
14777169|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
14777170|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777171|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14777172|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14777173|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
14777174|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
14777175|NCT00666484|Prednisolone|prednisolone|mesh-list
14777176|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
14777177|NCT00666484|Doxorubicin|doxorubicin|mesh-list
14777178|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14777179|NCT00666484|Etoposide|etoposide|mesh-list
14777180|NCT00666484|Vincristine|vincristine|mesh-list
14777181|NCT00666484|Procarbazine|procarbazine|mesh-list
14777182|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777183|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
14777184|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777185|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777186|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14777187|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
14777188|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777189|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777190|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14777191|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14777192|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14777193|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777194|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777195|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14777196|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
14777197|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
14777198|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
14777199|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14777200|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
14777201|NCT00666484|Hormones|hormones|mesh-ancestor
14777202|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777203|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14777204|NCT00666575|Gabapentin|gabapentin|mesh-list
14777205|NCT00666575|Analgesics|analgesics|mesh-ancestor
13964364|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
13964365|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964366|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13964367|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13964368|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13964369|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964370|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964371|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14504562|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
14777206|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
14777207|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777208|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777209|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
14777210|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14777211|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14777212|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777213|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14777214|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14777215|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14777216|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777217|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777218|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
14777219|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
14777220|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942373|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206663|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14206664|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206665|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206666|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
14206667|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14206668|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
14206669|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206670|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14206671|NCT04929080|Antibodies|antibodies|mesh-list
14206672|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
14206673|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14206674|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
14206675|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
14206676|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206677|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206678|NCT04909801|Adalimumab|adalimumab|mesh-list
14206679|NCT04909801|Methotrexate|methotrexate|mesh-list
14206680|NCT04909801|Abatacept|abatacept|mesh-list
14206681|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14206682|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
14206683|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14504563|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504564|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504565|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
14504566|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14504567|NCT02837237|Hormones|hormones|mesh-ancestor
14504568|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504569|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504570|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
14504571|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14504572|NCT02837237|Diuretics|diuretics|mesh-ancestor
14504573|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
14504574|NCT02837744|Hemostatics|hemostatics|mesh-list
14504575|NCT02837744|Coagulants|coagulants|mesh-ancestor
14504576|NCT02838134|Rocuronium|rocuronium|mesh-list
14504577|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14504578|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14504579|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14504580|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504581|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504582|NCT02838420|Crizotinib|crizotinib|mesh-list
14504583|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504584|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14504585|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504586|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504587|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
14504588|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504589|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504590|NCT02839200|Zolpidem|zolpidem|mesh-list
14504591|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14504592|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14504593|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504594|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504595|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14504596|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
14504597|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
14504598|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504599|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504600|NCT02839681|Maytansine|maytansine|mesh-list
14504601|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14206684|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504602|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504603|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
14504604|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
14504605|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14504606|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504607|NCT02839772|Glycerol|glycerol|mesh-list
14504608|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14504609|NCT02839772|Protective Agents|protective agents|mesh-ancestor
14504610|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504611|NCT02839876|Acetaminophen|acetaminophen|mesh-list
14504612|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504613|NCT02839876|Analgesics|analgesics|mesh-ancestor
14504614|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
14504615|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504616|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504617|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
14504618|NCT02839889|Naloxegol|naloxegol|mesh-list
14504619|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14504620|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504621|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
14504622|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504623|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
14504624|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14504625|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14504626|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504627|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
14504628|NCT02840097|Coagulants|coagulants|mesh-ancestor
14504629|NCT02840461|Ivermectin|ivermectin|mesh-list
14504630|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14504631|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528522|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14528523|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14528524|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14528525|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
14528526|NCT03847389|Clobetasol|clobetasol|mesh-list
14528527|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528528|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
14528529|NCT03847389|Hormones|hormones|mesh-ancestor
14528530|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528531|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528532|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14528533|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528534|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
14528535|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14528536|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14777221|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777222|NCT00666627|Alendronate|alendronate|mesh-list
14777223|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
14777224|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
14528537|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14528538|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528539|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528540|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
14528541|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528542|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528543|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14777225|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14777226|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777227|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14777228|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14777229|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777230|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14942374|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942375|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
14942376|NCT01503424|Olanzapine|olanzapine|mesh-list
14942377|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
14206685|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206686|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
14206687|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206688|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206689|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206690|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206691|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14206692|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206693|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
14504632|NCT02841033|Daratumumab|daratumumab|mesh-list
14504633|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504634|NCT02841241|Esmolol|esmolol|mesh-list
14504635|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14504636|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14206694|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206695|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14206696|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206697|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14206698|NCT04903353|Risperidone|risperidone|mesh-list
14206699|NCT04903353|Aripiprazole|aripiprazole|mesh-list
14206700|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14206701|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
14206702|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206703|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206704|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206705|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14206706|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14206707|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206708|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14206709|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14206710|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
14206711|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14206712|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
14206713|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14206714|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14206715|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14206716|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14206717|NCT04850599|Pomalidomide|pomalidomide|mesh-list
14206718|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14504637|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14504638|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
14504639|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504640|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504641|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504642|NCT02842073|Naltrexone|naltrexone|mesh-list
14777231|NCT00666653|Pramipexole|pramipexole|mesh-list
14777232|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
14777233|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777234|NCT00666653|Protective Agents|protective agents|mesh-ancestor
14777235|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777236|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14777237|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14206719|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
14504643|NCT02842073|Bupropion|bupropion|mesh-list
14504644|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14504645|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14504646|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504647|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
14504648|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504649|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14504650|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
14504651|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14504652|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14504653|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14504654|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504655|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504656|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
14504657|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504658|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14504659|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14504660|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504661|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14504662|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14504663|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14504664|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14504665|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504666|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777238|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
14777239|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
14777240|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777241|NCT00666692|Paclitaxel|paclitaxel|mesh-list
14777242|NCT00666692|Bevacizumab|bevacizumab|mesh-list
14504667|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
14504668|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504669|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14504670|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14504671|NCT02844439|XL647|xl647|mesh-list
14504672|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504673|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14504674|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504675|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504676|NCT02844582|Prednisone|prednisone|mesh-list
14504677|NCT02844582|Cortisone|cortisone|mesh-list
14504678|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504679|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
14206720|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206721|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14206722|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14504680|NCT02844582|Hormones|hormones|mesh-ancestor
14504681|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504682|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504683|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14504684|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504685|NCT02845336|Celecoxib|celecoxib|mesh-list
14504686|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
14504687|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14777243|NCT00666692|Carboplatin|carboplatin|mesh-list
14777244|NCT00666692|Volociximab|volociximab|mesh-list
14777245|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14777246|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14777247|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777248|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
14777249|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
14777250|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
14777251|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777252|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14777253|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14777254|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14777255|NCT00666692|Growth Substances|growth substances|mesh-ancestor
14777256|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777257|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
14777258|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
14777259|NCT00666770|Gabapentin|gabapentin|mesh-list
14777260|NCT00666770|Analgesics|analgesics|mesh-ancestor
14777261|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
14777262|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777263|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777264|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
14777265|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14777266|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14777267|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777268|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14777269|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14777270|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14777271|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777272|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777273|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
14777274|NCT00666783|Palonosetron|palonosetron|mesh-list
14206723|NCT04850599|Growth Substances|growth substances|mesh-ancestor
14206724|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
14206725|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206726|NCT04844762|Menthol|menthol|mesh-list
14206727|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
14206728|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206729|NCT04829903|Liraglutide|liraglutide|mesh-list
14206730|NCT04829903|Dulaglutide|dulaglutide|mesh-list
14206731|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14206732|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206733|NCT04829903|Incretins|incretins|mesh-ancestor
14206734|NCT04829903|Hormones|hormones|mesh-ancestor
14206735|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206736|NCT04813822|Miconazole|miconazole|mesh-list
14206737|NCT04813822|Clotrimazole|clotrimazole|mesh-list
14206738|NCT04813822|Bromides|bromides|mesh-list
14206739|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
14206740|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
14206741|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206742|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14942378|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
14942379|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942380|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942381|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942382|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14504688|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14504689|NCT02845336|Analgesics|analgesics|mesh-ancestor
14504690|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
14504691|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504692|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504693|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504694|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504695|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14504696|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14504697|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504698|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504699|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14504700|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14504701|NCT02845375|Neostigmine|neostigmine|mesh-list
14504702|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14504703|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942383|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14942384|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942385|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942386|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14942387|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14942388|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942389|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942390|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942391|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
14942392|NCT01503437|Olanzapine|olanzapine|mesh-list
14942393|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
14942394|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
14942395|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942396|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942397|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942398|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14942399|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14942400|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942401|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942402|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14942403|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14942404|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942405|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942406|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942407|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
14504704|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504705|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
14504706|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942408|NCT01503450|Olanzapine|olanzapine|mesh-list
14942409|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
14942410|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
14942411|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942412|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942413|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942414|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14942415|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14942416|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942417|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968054|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
14504707|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504708|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14504709|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
14504710|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504711|NCT02845752|Bromides|bromides|mesh-list
14504712|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
14504713|NCT02845752|Olodaterol|olodaterol|mesh-list
14504714|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14504715|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
14504716|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504717|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504718|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14504719|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
14504720|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
14504721|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14504722|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
14504723|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504724|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504725|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
14504726|NCT02846233|Metformin|metformin|mesh-list
14504727|NCT02846233|Empagliflozin|empagliflozin|mesh-list
14504728|NCT02846233|Dulaglutide|dulaglutide|mesh-list
14504729|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14504730|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
14504731|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504732|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504733|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504734|NCT02846233|Incretins|incretins|mesh-ancestor
14504735|NCT02846233|Hormones|hormones|mesh-ancestor
14504736|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504737|NCT02846792|Nivolumab|nivolumab|mesh-list
14504738|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14504739|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504740|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14504741|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504742|NCT02847260|Treprostinil|treprostinil|mesh-list
14504743|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14504744|NCT02847494|Dexamethasone|dexamethasone|mesh-list
14504745|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
14504746|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14504747|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14504748|NCT02847494|Prednisolone|prednisolone|mesh-list
14504749|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
14504750|NCT02847494|Metoclopramide|metoclopramide|mesh-list
14504751|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14504752|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
14504753|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504754|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
14504755|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
14504756|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504757|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777275|NCT00666783|Granisetron|granisetron|mesh-list
14777276|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
14777277|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
14777278|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777279|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777280|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14777281|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14777282|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14777283|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
14777284|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777285|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777286|NCT00666796|Ethanol|ethanol|mesh-list
14777287|NCT00666796|Gabapentin|gabapentin|mesh-list
14777288|NCT00666796|Analgesics|analgesics|mesh-ancestor
14777289|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
14777290|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777291|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777292|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
14777293|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14777294|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14777295|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777296|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964372|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13964373|NCT03137498|Analgesics|analgesics|mesh-ancestor
13964374|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13964375|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13964376|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13964377|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964378|NCT03137160|Ixekizumab|ixekizumab|mesh-list
13964379|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
13964380|NCT03137316|Hormones|hormones|mesh-list
13964381|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
13964382|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964383|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964384|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13964385|NCT03137134|Crizotinib|crizotinib|mesh-list
14504758|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14504759|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
14504760|NCT02847494|Hormones|hormones|mesh-ancestor
14777297|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14777298|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13964386|NCT03137134|Esomeprazole|esomeprazole|mesh-list
13964387|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14504761|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504762|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14504763|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504764|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14504765|NCT02847494|Protective Agents|protective agents|mesh-ancestor
14504766|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14504767|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14504768|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
13964388|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13964389|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13964390|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964391|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964392|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964393|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13964394|NCT03137368|Tamoxifen|tamoxifen|mesh-list
14504769|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504770|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504771|NCT02848599|Morphine|morphine|mesh-list
14504772|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
14504773|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14504774|NCT02848599|Narcotics|narcotics|mesh-ancestor
14504775|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504776|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504777|NCT02848599|Analgesics|analgesics|mesh-ancestor
14504778|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
14504779|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504780|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
14504781|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
14504782|NCT02848651|Atezolizumab|atezolizumab|mesh-list
14504783|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504784|NCT02848729|Acetaminophen|acetaminophen|mesh-list
14504785|NCT02848729|Morphine|morphine|mesh-list
14504786|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14504787|NCT02848729|Narcotics|narcotics|mesh-ancestor
14504788|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504789|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504790|NCT02848729|Analgesics|analgesics|mesh-ancestor
14504791|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
14504792|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504793|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14777299|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777300|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777301|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
14777302|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14777303|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777304|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777305|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777306|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777307|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777308|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777309|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777310|NCT00666809|Urological Agents|urological agents|mesh-ancestor
14807477|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14807478|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
14807479|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807480|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807481|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807482|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807483|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14206743|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14206744|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206745|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206746|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14206747|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
14206748|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14206749|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206750|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14206751|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14206752|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14206753|NCT04791228|Doxorubicin|doxorubicin|mesh-list
14504794|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
14504795|NCT02848833|Empagliflozin|empagliflozin|mesh-list
14504796|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14504797|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504798|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504799|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777311|NCT00666887|Minocycline|minocycline|mesh-list
14777312|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777313|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206754|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14206755|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14206756|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206757|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14206758|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14206759|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206760|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206761|NCT04784754|Melatonin|melatonin|mesh-list
14206762|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
14206763|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206764|NCT04784754|Protective Agents|protective agents|mesh-ancestor
14206765|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206766|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206767|NCT04762771|Colchicine|colchicine|mesh-list
14206768|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
14206769|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206770|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206771|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206772|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14206773|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206774|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206775|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
14206776|NCT04732845|Fludarabine|fludarabine|mesh-list
14206777|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206778|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
14206779|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206780|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504800|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14504801|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504802|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504803|NCT02849080|Incretins|incretins|mesh-ancestor
14504804|NCT02849080|Hormones|hormones|mesh-ancestor
14504805|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504806|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14504807|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
14504808|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504809|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504810|NCT02849184|Suvorexant|suvorexant|mesh-list
14504811|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14504812|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14504813|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504814|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504815|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14504816|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504817|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504818|NCT02849509|Vitamin K|vitamin k|mesh-list
14504819|NCT02849509|Dabigatran|dabigatran|mesh-list
14504820|NCT02849509|Vitamins|vitamins|mesh-ancestor
14504821|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
14504822|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504823|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
14777314|NCT00666939|Gabapentin|gabapentin|mesh-list
14777315|NCT00666939|Analgesics|analgesics|mesh-ancestor
14206781|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206782|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
14206783|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206784|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206785|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206786|NCT04718389|Benralizumab|benralizumab|mesh-list
14206787|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14206788|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
14206789|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
14206790|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
14777316|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
14777317|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777318|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777319|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
14777320|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14777321|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14777322|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777323|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14777324|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14777325|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14777326|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777327|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777328|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
14777329|NCT00666991|Paclitaxel|paclitaxel|mesh-list
14777330|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14777331|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777332|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
14777333|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
14777334|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
14777335|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777336|NCT00667043|Fentanyl|fentanyl|mesh-list
14777337|NCT00667043|Midazolam|midazolam|mesh-list
14777338|NCT00667043|Remifentanil|remifentanil|mesh-list
14777339|NCT00667043|Propofol|propofol|mesh-list
14777340|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14807484|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243219|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14243220|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14243221|NCT00193492|Growth Substances|growth substances|mesh-ancestor
14243222|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243223|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
14243224|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
14243225|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243226|NCT00193596|Gemcitabine|gemcitabine|mesh-list
14243227|NCT00193596|Paclitaxel|paclitaxel|mesh-list
14243228|NCT00193596|Etoposide|etoposide|mesh-list
14243229|NCT00193596|Carboplatin|carboplatin|mesh-list
14243230|NCT00193596|Irinotecan|irinotecan|mesh-list
14243231|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14243232|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243233|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243234|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243235|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243236|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243237|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243238|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
14243239|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
14243240|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243241|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243242|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243243|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
14243244|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243245|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14243246|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243247|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14243248|NCT00193609|Capecitabine|capecitabine|mesh-list
14243249|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
14243250|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243251|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
14243252|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243253|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243254|NCT00194012|Aripiprazole|aripiprazole|mesh-list
14206791|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206792|NCT04715022|Protective Agents|protective agents|mesh-ancestor
14504824|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14504825|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
14504826|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504827|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504828|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
14504829|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14504830|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14504831|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
14504832|NCT02849509|Coagulants|coagulants|mesh-ancestor
14504833|NCT02849678|Lidocaine|lidocaine|mesh-list
14504834|NCT02849678|Ropivacaine|ropivacaine|mesh-list
14504835|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
14504836|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
14504837|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504838|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504839|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
14504840|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504841|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14504842|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14504843|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14504844|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504845|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504846|NCT02849704|Pancrelipase|pancrelipase|mesh-list
14206793|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206794|NCT04715022|Vitamins|vitamins|mesh-ancestor
14206795|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
14206796|NCT04695080|Cladribine|cladribine|mesh-list
14206797|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206798|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206799|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
14206800|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206801|NCT04693715|RNS60|rns60|mesh-list
14206802|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14206803|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14206804|NCT04693715|Analgesics|analgesics|mesh-ancestor
14206805|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
14206806|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206807|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504847|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14504848|NCT02850276|Bromides|bromides|mesh-list
14504849|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14504850|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
14504851|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14504852|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504853|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504854|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
14504855|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504856|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206808|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206809|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504857|NCT02850601|Dexamethasone|dexamethasone|mesh-list
14206810|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14206811|NCT04683575|Selenium|selenium|mesh-list
14206812|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
14206813|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206814|NCT04683575|Protective Agents|protective agents|mesh-ancestor
14206815|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206816|NCT04683575|Trace Elements|trace elements|mesh-ancestor
14206817|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
14206818|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14206819|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14504858|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504859|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
14504860|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
14777341|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777342|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777343|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14777344|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
14777345|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
14777346|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14777347|NCT00667043|Narcotics|narcotics|mesh-ancestor
14777348|NCT00667043|Analgesics|analgesics|mesh-ancestor
14206820|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
14504861|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504862|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504863|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14504864|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
14504865|NCT02850601|Hormones|hormones|mesh-ancestor
14504866|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504867|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14504868|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504869|NCT02850965|Adalimumab|adalimumab|mesh-list
14504870|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504871|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504872|NCT02851108|Primaquine|primaquine|mesh-list
14504873|NCT02851108|Phenothiazine|phenothiazine|mesh-list
14504874|NCT02851108|Methylene Blue|methylene blue|mesh-list
14504875|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
14504876|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14504877|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14777349|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
14777350|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777351|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14777352|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14777353|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14777354|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14504878|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14504879|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504880|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504881|NCT02852005|Vaccines|vaccines|mesh-list
14504882|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
14504883|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504884|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
14504885|NCT02852265|Etonogestrel|etonogestrel|mesh-list
14504886|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14504887|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504888|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14504889|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14504890|NCT02852434|Lidocaine|lidocaine|mesh-list
14504891|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
14504892|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
14504893|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14504894|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504895|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
14504896|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504897|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14504898|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14504899|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14504900|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504901|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504902|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
14504903|NCT02853123|Olodaterol|olodaterol|mesh-list
14504904|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14504905|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
14504906|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14504907|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504908|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14504909|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
14504910|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
14504911|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14504912|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
14504913|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504914|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504915|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
14504916|NCT02853318|Bevacizumab|bevacizumab|mesh-list
14504917|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
14504918|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14504919|NCT02853318|Antibodies|antibodies|mesh-list
14504920|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
14777355|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
14777356|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
14777357|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777358|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777359|NCT00667056|Tacrolimus|tacrolimus|mesh-list
14777360|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777361|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
14777362|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777363|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14777364|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777365|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206821|NCT04566380|Capecitabine|capecitabine|mesh-list
14206822|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
14206823|NCT04566380|Nivolumab|nivolumab|mesh-list
14206824|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206825|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
14777366|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14777367|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
14777368|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14777369|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
14777370|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777371|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777372|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14777373|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14777374|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777375|NCT00667082|Vorinostat|vorinostat|mesh-list
14777376|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14777377|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14777378|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777379|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777380|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777381|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
14206826|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206827|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206828|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206829|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14240982|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240983|NCT00170157|Ipilimumab|ipilimumab|mesh-list
14240984|NCT00170157|Leuprolide|leuprolide|mesh-list
14240985|NCT00170157|Goserelin|goserelin|mesh-list
14240986|NCT00170157|Bicalutamide|bicalutamide|mesh-list
14777382|NCT00667108|Gabapentin|gabapentin|mesh-list
14777383|NCT00667108|Analgesics|analgesics|mesh-ancestor
14777384|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
13964395|NCT03137368|Exemestane|exemestane|mesh-list
14240987|NCT00170157|Flutamide|flutamide|mesh-list
14777385|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777386|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942418|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14942419|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14942420|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942421|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942422|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942423|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
14942424|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
14942425|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
13964396|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13964397|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
13964398|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964399|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964400|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13964401|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964402|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13964403|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13964404|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13964405|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13964406|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13964407|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14240988|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14240989|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14240990|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14240991|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14240992|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14240993|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
14240994|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777387|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
14777388|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14206830|NCT04492475|Interferons|interferons|mesh-list
14206831|NCT04492475|Interferon-beta|interferon-beta|mesh-list
14206832|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
14206833|NCT04492475|Remdesivir|remdesivir|mesh-list
14206834|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206835|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
14206836|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206837|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
14206838|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206839|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14206840|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
14206841|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206842|NCT04491383|Tocovid|tocovid|mesh-list
14206843|NCT04491383|Vitamins|vitamins|mesh-ancestor
14206844|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
14206845|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206846|NCT04489888|Paclitaxel|paclitaxel|mesh-list
14206847|NCT04489888|Carboplatin|carboplatin|mesh-list
14206848|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
14206849|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14206850|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206851|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206852|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206853|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14206854|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206855|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206856|NCT04486911|Letrozole|letrozole|mesh-list
14206857|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206858|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14206859|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14206860|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206861|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206862|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14206863|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
14206864|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777389|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14777390|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777391|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14777392|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14777393|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14777394|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777395|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777396|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
14777397|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14777398|NCT00667147|Paclitaxel|paclitaxel|mesh-list
14777399|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777400|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14777401|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206865|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206866|NCT04483206|Melphalan|melphalan|mesh-list
14206867|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14206868|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
14206869|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206870|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206871|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14206872|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206873|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
14206874|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206875|NCT04478838|Olanzapine|olanzapine|mesh-list
14206876|NCT04478838|Risperidone|risperidone|mesh-list
14206877|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14777402|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
14777403|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
14777404|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777405|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
14777406|NCT00667160|Tacrolimus|tacrolimus|mesh-list
14777407|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206878|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
14206879|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14206880|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206881|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206882|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14206883|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14206884|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206885|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14206886|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14206887|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
14206888|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
14206889|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
14206890|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14206891|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14206892|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14206893|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14206894|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14206895|NCT04474483|Melatonin|melatonin|mesh-list
14206896|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
14206897|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206898|NCT04474483|Protective Agents|protective agents|mesh-ancestor
14206899|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777408|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
14777409|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777410|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14777411|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777412|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777413|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14777414|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14777415|NCT00667160|Analgesics|analgesics|mesh-ancestor
14777416|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
14942426|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942427|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14942428|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942429|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942430|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
14942431|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14942432|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14942433|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14942434|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
14942435|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942436|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942437|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942438|NCT01503580|Urological Agents|urological agents|mesh-ancestor
14942439|NCT01503593|Calcium|calcium|mesh-list
14942440|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14942441|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942442|NCT01503658|Aspirin|aspirin|mesh-list
14942443|NCT01503658|Clopidogrel|clopidogrel|mesh-list
14942444|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14942445|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942446|NCT01503658|Analgesics|analgesics|mesh-ancestor
14942447|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
14942448|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942449|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942450|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942451|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777417|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777418|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14777419|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942452|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14777420|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
14942453|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14206900|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14206901|NCT04452136|Edetic Acid|edetic acid|mesh-list
14206902|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14206903|NCT04452136|Anticoagulants|anticoagulants|mesh-ancestor
14206904|NCT04452136|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14206905|NCT04452136|Chelating Agents|chelating agents|mesh-ancestor
14777421|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14777422|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777423|NCT00667264|Ropivacaine|ropivacaine|mesh-list
14777424|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
14777425|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
14777426|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777427|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942454|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942455|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14942456|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14942457|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942458|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
14942459|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14942460|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14942461|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14942462|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
14942463|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942464|NCT01503671|Atorvastatin|atorvastatin|mesh-list
14942465|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14206906|NCT04452136|Sequestering Agents|sequestering agents|mesh-ancestor
14206907|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504921|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14504922|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
14504923|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
14504924|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14504925|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
14504926|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504927|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504928|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14504929|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
14504930|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504931|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504932|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14504933|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14504934|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14504935|NCT02853318|Growth Substances|growth substances|mesh-ancestor
14504936|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
14504937|NCT02854527|Metformin|metformin|mesh-list
14504938|NCT02854527|Digoxin|digoxin|mesh-list
14504939|NCT02854527|Furosemide|furosemide|mesh-list
14504940|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14504941|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14504942|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504943|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14504944|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14504945|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
14504946|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504947|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14504948|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14777428|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
14777429|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777430|NCT00667303|Antibodies|antibodies|mesh-list
14777431|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
14777432|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777433|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14777434|NCT00667407|Albuterol|albuterol|mesh-list
14777435|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14777436|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
14777437|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777438|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777439|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14942466|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14777440|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
14777441|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
14777442|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777443|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14777444|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14777445|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14777446|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
14777447|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777448|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777449|NCT00667433|Tenofovir|tenofovir|mesh-list
14777450|NCT00667433|Emtricitabine|emtricitabine|mesh-list
14777451|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
14777452|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14777453|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
14777454|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777455|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14777456|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777457|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777458|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777459|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14777460|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14777461|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14777462|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14777463|NCT00667472|Ranibizumab|ranibizumab|mesh-list
14777464|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14777465|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14777466|NCT00667472|Growth Substances|growth substances|mesh-ancestor
14777467|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777468|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
14777469|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777470|NCT00667485|Sirolimus|sirolimus|mesh-list
14777471|NCT00667485|Bevacizumab|bevacizumab|mesh-list
14777472|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14777473|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777474|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14777475|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14777476|NCT00667485|Growth Substances|growth substances|mesh-ancestor
14777477|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777478|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
14777479|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777480|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777481|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14777482|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
14777483|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777484|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
14777485|NCT00667498|Metformin|metformin|mesh-list
14777486|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14777487|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777488|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14777489|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777490|NCT00667641|Paclitaxel|paclitaxel|mesh-list
14777491|NCT00667641|Bortezomib|bortezomib|mesh-list
14777492|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14777493|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777494|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
14777495|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
14777496|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
14777497|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777498|NCT00667758|Cetrorelix|cetrorelix|mesh-list
14777499|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14777500|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
14777501|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777502|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777503|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
14777504|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777505|NCT00667771|Naltrexone|naltrexone|mesh-list
14777506|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14777507|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14777508|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777509|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
14777510|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777511|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14777512|NCT00667797|Albuterol|albuterol|mesh-list
14777513|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14777514|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
14206908|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14206909|NCT04424966|Infigratinib|infigratinib|mesh-list
14206910|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206911|NCT04401579|Remdesivir|remdesivir|mesh-list
14206912|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
14206913|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206914|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
14777515|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777516|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777517|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14777518|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
14777519|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
14777520|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777521|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14777522|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14777523|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14777524|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
14777525|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777526|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777527|NCT00667901|Riluzole|riluzole|mesh-list
14777528|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
14777529|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14777530|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14777531|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777532|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942467|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
14942468|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942469|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14942470|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14942471|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942472|NCT01503736|Citric Acid|citric acid|mesh-list
14942473|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
14777533|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777534|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14777535|NCT00667901|Protective Agents|protective agents|mesh-ancestor
14777536|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
14206915|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206916|NCT04383743|Cisplatin|cisplatin|mesh-list
14206917|NCT04383743|Doxorubicin|doxorubicin|mesh-list
14206918|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14206919|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
14206920|NCT04383743|Methotrexate|methotrexate|mesh-list
14777537|NCT00667927|Busulfan|busulfan|mesh-list
14777538|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777539|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
14777540|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206921|NCT04383743|Daunorubicin|daunorubicin|mesh-list
14206922|NCT04383743|Vinblastine|vinblastine|mesh-list
14206923|NCT04383743|Lenograstim|lenograstim|mesh-list
14206924|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206925|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14206926|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14206927|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14206928|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206929|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206930|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206931|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14206932|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
14206933|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777541|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777542|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14777543|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
14777544|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777545|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206934|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206935|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14206936|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
14777546|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14777547|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777548|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777549|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777550|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777551|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777552|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942474|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
14942475|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
14942476|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14942477|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
14942478|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
14942479|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942480|NCT01503736|Hematinics|hematinics|mesh-ancestor
14942481|NCT01503788|Midazolam|midazolam|mesh-list
14942482|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14942483|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14942484|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942485|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942486|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14942487|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14942488|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942489|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14942490|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
14942491|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
14942492|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
14942493|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
14942494|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942495|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942496|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
14942497|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
14942498|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14942499|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
14942500|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942501|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942502|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14942503|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
14942504|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14942505|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
14942506|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942507|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942508|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
14942509|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
14942510|NCT01503801|Protective Agents|protective agents|mesh-ancestor
14942511|NCT01503905|Tamoxifen|tamoxifen|mesh-list
14942512|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
14942513|NCT01503905|Docetaxel|docetaxel|mesh-list
14942514|NCT01503905|Trastuzumab|trastuzumab|mesh-list
14942515|NCT01503905|Epirubicin|epirubicin|mesh-list
14942516|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14942517|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
14942518|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942519|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942520|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14942521|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
14942522|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942523|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942524|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14942525|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
14942526|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
14942527|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
14942528|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942529|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14942530|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14942531|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14942532|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777553|NCT00667966|Urological Agents|urological agents|mesh-ancestor
14942533|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14942534|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
14777554|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777555|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777556|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777557|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777558|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777559|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777560|NCT00667979|Urological Agents|urological agents|mesh-ancestor
14777561|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777562|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777563|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777564|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777565|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777566|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777567|NCT00668005|Urological Agents|urological agents|mesh-ancestor
14777568|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777569|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777570|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777571|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777572|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777573|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777574|NCT00668018|Urological Agents|urological agents|mesh-ancestor
14206937|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206938|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14206939|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206940|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
14206941|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206942|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14206943|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14206944|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14206945|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
14206946|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
14206947|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
14206948|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
14206949|NCT04344184|Vitamins|vitamins|mesh-ancestor
14206950|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
14206951|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206952|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
14206953|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206954|NCT04344184|Protective Agents|protective agents|mesh-ancestor
14206955|NCT04336982|Azacitidine|azacitidine|mesh-list
14206956|NCT04336982|Venetoclax|venetoclax|mesh-list
14777575|NCT00668031|Aprotinin|aprotinin|mesh-list
14777576|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
14777577|NCT00668031|Coagulants|coagulants|mesh-ancestor
14777578|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14777579|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14777580|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
14777581|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777582|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777583|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
14777584|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777585|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777586|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14777587|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777588|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777589|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777590|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777591|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14777592|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14777593|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777594|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777595|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777596|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777597|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777598|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777599|NCT00668057|Urological Agents|urological agents|mesh-ancestor
14777600|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777601|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777602|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777603|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14942535|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942536|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14206957|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14777604|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777605|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777606|NCT00668096|Urological Agents|urological agents|mesh-ancestor
14777607|NCT00668109|Tadalafil|tadalafil|mesh-list
14777608|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777609|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777610|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777611|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777612|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777613|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777614|NCT00668109|Urological Agents|urological agents|mesh-ancestor
14777615|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
14777616|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777617|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777618|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14777619|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777620|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777621|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777622|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777623|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14777624|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14777625|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14777626|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777627|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14777628|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14777629|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777630|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777631|NCT00668135|Urological Agents|urological agents|mesh-ancestor
14777632|NCT00668239|Triamcinolone|triamcinolone|mesh-list
14777633|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942537|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14942538|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14942539|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14942540|NCT01503918|Valacyclovir|valacyclovir|mesh-list
14942541|NCT01503918|Valganciclovir|valganciclovir|mesh-list
14206958|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
14206959|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777634|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
14777635|NCT00668239|Hormones|hormones|mesh-ancestor
14777636|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777637|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777638|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
14777639|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14777640|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777641|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777642|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14942542|NCT01503918|Acyclovir|acyclovir|mesh-list
14942543|NCT01503918|Ganciclovir|ganciclovir|mesh-list
14942544|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14206960|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206961|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206962|NCT04328727|Cyclosporine|cyclosporine|mesh-list
14206963|NCT04328727|Cyclosporins|cyclosporins|mesh-list
14942545|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
14942546|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942547|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14942548|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942549|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942550|NCT01503983|Capecitabine|capecitabine|mesh-list
14942551|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
14942552|NCT01503983|Trastuzumab|trastuzumab|mesh-list
14942553|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14942554|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
14942555|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206964|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14942556|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942557|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942558|NCT01504074|Triamcinolone|triamcinolone|mesh-list
14942559|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14942560|NCT01504074|Levobunolol|levobunolol|mesh-list
14942561|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942562|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
14942563|NCT01504074|Hormones|hormones|mesh-ancestor
14206965|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
14777643|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777644|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777645|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777646|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777647|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14777648|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
14777649|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777650|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777651|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14777652|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14777653|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14777654|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
14777655|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
14777656|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
14777657|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14777658|NCT00668330|Calcium|calcium|mesh-list
14777659|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14777660|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777661|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14777662|NCT00668330|Vitamins|vitamins|mesh-ancestor
14777663|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
14777664|NCT00668343|Simvastatin|simvastatin|mesh-list
14777665|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14777666|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14777667|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
14777668|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777669|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14777670|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14777671|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777672|NCT00668356|Didanosine|didanosine|mesh-list
14777673|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
14777674|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777675|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14777676|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777677|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777678|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
14777679|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777680|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14777681|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14777682|NCT00668499|Pemetrexed|pemetrexed|mesh-list
14777683|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777684|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777685|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777686|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14777687|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777688|NCT00668538|Miconazole|miconazole|mesh-list
14777689|NCT00668538|Clotrimazole|clotrimazole|mesh-list
14777690|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
14777691|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777692|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14777693|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14777694|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777695|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777696|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14777697|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
14777698|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777699|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777700|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14777701|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14777702|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14777703|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14777704|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14777705|NCT00668603|Estradiol|estradiol|mesh-list
14777706|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14777707|NCT00668603|Estrogens|estrogens|mesh-ancestor
14777708|NCT00668603|Hormones|hormones|mesh-ancestor
14777709|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777710|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777711|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14777712|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
14942564|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942565|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206966|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206967|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206968|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14206969|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
14206970|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206971|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
14206972|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206973|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
14206974|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206975|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14206976|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14206977|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14206978|NCT04280705|Remdesivir|remdesivir|mesh-list
14206979|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
14206980|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206981|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
14504949|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504950|NCT02854527|Diuretics|diuretics|mesh-ancestor
14504951|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
14504952|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14504953|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14504954|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14504955|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14504956|NCT02854527|Protective Agents|protective agents|mesh-ancestor
14504957|NCT02854631|Prednisolone|prednisolone|mesh-list
14504958|NCT02854631|Selonsertib|selonsertib|mesh-list
14504959|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14504960|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
14504961|NCT02854631|Hormones|hormones|mesh-ancestor
14504962|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14504963|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504964|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14504965|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504966|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14504967|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14504968|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504969|NCT02854800|Varenicline|varenicline|mesh-list
14504970|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14504971|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14504972|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
14504973|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14504974|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504975|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504976|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14504977|NCT02855086|Cetuximab|cetuximab|mesh-list
14504978|NCT02855086|Antibodies|antibodies|mesh-list
14504979|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
14504980|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14504981|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
14504982|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504983|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504984|NCT02855359|Prednisone|prednisone|mesh-list
14504985|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
14504986|NCT02855359|Rituximab|rituximab|mesh-list
14504987|NCT02855359|Doxorubicin|doxorubicin|mesh-list
14504988|NCT02855359|Vincristine|vincristine|mesh-list
14504989|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14504990|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
14504991|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14504992|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14504993|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14504994|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
14504995|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14504996|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14504997|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14504998|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14504999|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14505000|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14505001|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14505002|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505003|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14206982|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505004|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
14777713|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777714|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14777715|NCT00668616|Paclitaxel|paclitaxel|mesh-list
14777716|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14777717|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
14777718|NCT00668616|Epirubicin|epirubicin|mesh-list
14777719|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14206983|NCT04258046|Trametinib|trametinib|mesh-list
14777720|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777721|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
14777722|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
14777723|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
14777724|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777725|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777726|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
14777727|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777728|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777729|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14777730|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
14777731|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14777732|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14777733|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14777734|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777735|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777736|NCT00668642|Dutasteride|dutasteride|mesh-list
14777737|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14777738|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14777739|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777740|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777741|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
14777742|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777743|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777744|NCT00668655|Metronidazole|metronidazole|mesh-list
14777745|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777746|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777747|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14777748|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14777749|NCT00668759|Amiodarone|amiodarone|mesh-list
14777750|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14777751|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777752|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14777753|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14777754|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777755|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14777756|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14777757|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14777758|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777759|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14777760|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14777761|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14777762|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14777763|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14777764|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14777765|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14777766|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777767|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14777768|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14777769|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14777770|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
14777771|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777772|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777773|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14777774|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14777775|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
14777776|NCT00668850|Insulin|insulin|mesh-list
14777777|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14777778|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14777779|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777780|NCT00668941|Vitamin D|vitamin d|mesh-list
14777781|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
14777782|NCT00668941|Alendronate|alendronate|mesh-list
14777783|NCT00668941|Teriparatide|teriparatide|mesh-list
14942566|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206984|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206985|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14206986|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14206987|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14206988|NCT04224493|Rituximab|rituximab|mesh-list
14206989|NCT04224493|Lenalidomide|lenalidomide|mesh-list
14206990|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14206991|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14206992|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
14206993|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206994|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14206995|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14206996|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14206997|NCT04224493|Growth Substances|growth substances|mesh-ancestor
14777784|NCT00668941|Calcium|calcium|mesh-list
14777785|NCT00668941|Vitamins|vitamins|mesh-ancestor
14777786|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
14777787|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777788|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14777789|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14807485|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14807486|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13964408|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964409|NCT03137290|Neostigmine|neostigmine|mesh-list
13964410|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13964411|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964412|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964413|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
13964414|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964415|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964416|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13964417|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
14206998|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
14807487|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14807488|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14807489|NCT00822081|Timolol|timolol|mesh-list
14807490|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14807491|NCT00822081|Dorzolamide|dorzolamide|mesh-list
14807492|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
14807493|NCT00822081|Maleic acid|maleic acid|mesh-list
14807494|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14807495|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14807496|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14807497|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807498|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807499|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807500|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807501|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14807502|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807503|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14807504|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14807505|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14807506|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14807507|NCT00822133|Lidocaine|lidocaine|mesh-list
14807508|NCT00822133|Ketamine|ketamine|mesh-list
14807509|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
14807510|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
14807511|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807512|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807513|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
14807514|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807515|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807516|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14807517|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14807518|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807519|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807520|NCT00822133|Analgesics|analgesics|mesh-ancestor
14807521|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14807522|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14807523|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
14777790|NCT00668967|Verapamil|verapamil|mesh-list
14777791|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14777792|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14777793|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14777794|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777795|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14777796|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777797|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777798|NCT00669149|Aspirin|aspirin|mesh-list
14777799|NCT00669149|Heparin|heparin|mesh-list
14777800|NCT00669149|Enoxaparin|enoxaparin|mesh-list
14777801|NCT00669149|Bivalirudin|bivalirudin|mesh-list
14777802|NCT00669149|Clopidogrel|clopidogrel|mesh-list
14942567|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14942568|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942569|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14942570|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14942571|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
14942572|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942573|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
14942574|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
14942575|NCT01504126|Propranolol|propranolol|mesh-list
14942576|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14942577|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14942578|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
14942579|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942580|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942581|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942582|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14942583|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14942584|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
14942585|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14942586|NCT01504139|Estradiol|estradiol|mesh-list
14942587|NCT01504139|Progesterone|progesterone|mesh-list
14942588|NCT01504139|Estrogens|estrogens|mesh-ancestor
14942589|NCT01504139|Hormones|hormones|mesh-ancestor
14942590|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942591|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942592|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14942593|NCT01504139|Progestins|progestins|mesh-ancestor
14942594|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14942595|NCT01504178|Levodopa|levodopa|mesh-list
14942596|NCT01504178|Apomorphine|apomorphine|mesh-list
14942597|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14942598|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14942599|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14942600|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942601|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942602|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942603|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942604|NCT01504178|Analgesics|analgesics|mesh-ancestor
14942605|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
14942606|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942607|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
14942608|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942609|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
14942610|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14942611|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14942612|NCT01504178|Emetics|emetics|mesh-ancestor
14942613|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
14942614|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942615|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
15026761|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026762|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026763|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
15026764|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026765|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
15026766|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15026767|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15026768|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15026769|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026770|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777803|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14777804|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14777805|NCT00669149|Analgesics|analgesics|mesh-ancestor
14777806|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
14777807|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777808|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14206999|NCT04218409|Oxycodone|oxycodone|mesh-list
14777809|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14777810|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777811|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14207000|NCT04218409|Oxytocin|oxytocin|mesh-list
14207001|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
14207002|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14207003|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207004|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14207005|NCT04218409|Narcotics|narcotics|mesh-ancestor
14207006|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207007|NCT04218409|Analgesics|analgesics|mesh-ancestor
14207008|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
14207009|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207010|NCT04162210|Dexamethasone|dexamethasone|mesh-list
14207011|NCT04162210|Pomalidomide|pomalidomide|mesh-list
14505005|NCT02855359|Hormones|hormones|mesh-ancestor
14505006|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505007|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14505008|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14505009|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
14505010|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
14505011|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
14505012|NCT02856555|Firsocostat|firsocostat|mesh-list
14505013|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505014|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505015|NCT02856802|Sumatriptan|sumatriptan|mesh-list
14505016|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14505017|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14505018|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14777812|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14777813|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777814|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14777815|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14942616|NCT01504256|Leucovorin|leucovorin|mesh-list
14942617|NCT01504256|Docetaxel|docetaxel|mesh-list
14942618|NCT01504256|Fluorouracil|fluorouracil|mesh-list
14942619|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
14942620|NCT01504256|Catumaxomab|catumaxomab|mesh-list
14942621|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14942622|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
14942623|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942624|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14942625|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14942626|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14505019|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
14505020|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505021|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505022|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528544|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528545|NCT03857750|Rocuronium|rocuronium|mesh-list
14528546|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14528547|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14528548|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14528549|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528550|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528551|NCT03860753|Pioglitazone|pioglitazone|mesh-list
14528552|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14528553|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528554|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14528555|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14528556|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
14528557|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14528558|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14528559|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528560|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
14528561|NCT03856164|Coagulants|coagulants|mesh-ancestor
14528562|NCT03849690|Esomeprazole|esomeprazole|mesh-list
14528563|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14942627|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207012|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942628|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
14207013|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
14777816|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777817|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
14777818|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14777819|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14777820|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14777821|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
14777822|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777823|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
14777824|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
14207014|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
14207015|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207016|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207017|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207018|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
14207019|NCT04162210|Hormones|hormones|mesh-ancestor
14207020|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207021|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14207022|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207023|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
14207024|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14207025|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14207026|NCT04162210|Growth Substances|growth substances|mesh-ancestor
14777825|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14777826|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
14777827|NCT00669344|Rivastigmine|rivastigmine|mesh-list
14777828|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14777829|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777830|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777831|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
14777832|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14777833|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777834|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14777835|NCT00669344|Protective Agents|protective agents|mesh-ancestor
14777836|NCT00669370|Docetaxel|docetaxel|mesh-list
14777837|NCT00669370|Capecitabine|capecitabine|mesh-list
14777838|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777839|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
14777840|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
14942629|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14942630|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14942631|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
14942632|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942633|NCT01504256|Antidotes|antidotes|mesh-ancestor
14942634|NCT01504256|Protective Agents|protective agents|mesh-ancestor
14942635|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
14942636|NCT01504256|Vitamins|vitamins|mesh-ancestor
14942637|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
14942638|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942639|NCT01504282|Mitomycins|mitomycins|mesh-list
14207027|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
14207028|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
14207029|NCT04153565|Pemetrexed|pemetrexed|mesh-list
14207030|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207031|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207032|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207033|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207034|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14942640|NCT01504282|Mitomycin|mitomycin|mesh-list
13964418|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964419|NCT03137186|Metformin|metformin|mesh-list
14207035|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14207036|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14207037|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
14207038|NCT04151017|Coagulants|coagulants|mesh-ancestor
14207039|NCT04126733|Nivolumab|nivolumab|mesh-list
14777841|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
14942641|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13964420|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13964421|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964422|NCT03137030|Acetaminophen|acetaminophen|mesh-list
13964423|NCT03137030|Hydrocodone|hydrocodone|mesh-list
13964424|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942642|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964425|NCT03137030|Analgesics|analgesics|mesh-ancestor
13964426|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
13964427|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942643|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
14207040|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207041|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207042|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14207043|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207044|NCT04116398|Dexamethasone|dexamethasone|mesh-list
14207045|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207046|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
14207047|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
14207048|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207049|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207050|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207051|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
14207052|NCT04116398|Hormones|hormones|mesh-ancestor
14207053|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207054|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14207055|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207056|NCT04112589|Cytarabine|cytarabine|mesh-list
14207057|NCT04112589|Fludarabine|fludarabine|mesh-list
14207058|NCT04112589|Idarubicin|idarubicin|mesh-list
14207059|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207060|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14207061|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
14207062|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207063|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207064|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
14207065|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207066|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
14207067|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207068|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14207069|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14207070|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14207071|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207072|NCT04080427|Dronabinol|dronabinol|mesh-list
14207073|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
14207074|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207075|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14207076|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14207077|NCT04080427|Analgesics|analgesics|mesh-ancestor
14207078|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
14207079|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14777842|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942644|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942645|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14942646|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942647|NCT01504295|Metadoxine|metadoxine|mesh-list
14942648|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14942649|NCT01504321|Moxonidine|moxonidine|mesh-list
14942650|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14942651|NCT01504334|Pirfenidone|pirfenidone|mesh-list
14942652|NCT01504334|Analgesics|analgesics|mesh-ancestor
14942653|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
14942654|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942655|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942656|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14942657|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942658|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207080|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14777843|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14777844|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
14777845|NCT00669435|Losartan|losartan|mesh-list
14777846|NCT00669435|Amlodipine|amlodipine|mesh-list
14777847|NCT00669435|Simvastatin|simvastatin|mesh-list
14777848|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14777849|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14777850|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14777851|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777852|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14777853|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777854|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
14777855|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14777856|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14777857|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
14777858|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14942659|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777859|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14777860|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777861|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14777862|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14777863|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14777864|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14777865|NCT00669487|Lamivudine|lamivudine|mesh-list
14777866|NCT00669487|Stavudine|stavudine|mesh-list
14777867|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14777868|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777869|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207081|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14207082|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207083|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207084|NCT04080427|Hormones|hormones|mesh-ancestor
14207085|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207086|NCT04070157|Lofexidine|lofexidine|mesh-list
14207087|NCT04070157|Clonidine|clonidine|mesh-list
14207088|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14207089|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14777870|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777871|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
14777872|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777873|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14777874|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14777875|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
14777876|NCT00669565|Bavituximab|bavituximab|mesh-list
14777877|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14777878|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777879|NCT00669591|Bavituximab|bavituximab|mesh-list
14777880|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14777881|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777882|NCT00669643|Rifampin|rifampin|mesh-list
14777883|NCT00669643|Dapsone|dapsone|mesh-list
14777884|NCT00669643|Clofazimine|clofazimine|mesh-list
14777885|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14777886|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
14777887|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14777888|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14777889|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
14777890|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14777891|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777892|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777893|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14777894|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14777895|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14777896|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14777897|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14777898|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14777899|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
14777900|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14777901|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14777902|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14777903|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14777904|NCT00669656|Vitamin D|vitamin d|mesh-list
14777905|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
14942660|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942661|NCT01504347|Vaccines|vaccines|mesh-list
14942662|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
14942663|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942664|NCT01504386|Ropivacaine|ropivacaine|mesh-list
14942665|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
14942666|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
14207090|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942667|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942668|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942669|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
14942670|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942671|NCT01504490|Bexarotene|bexarotene|mesh-list
14942672|NCT01504490|Efatutazone|efatutazone|mesh-list
14942673|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942674|NCT01504503|Donepezil|donepezil|mesh-list
14942675|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14942676|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777906|NCT00669656|Vitamins|vitamins|mesh-list
14777907|NCT00669656|Vitamin E|vitamin e|mesh-list
14777908|NCT00669656|Tocopherols|tocopherols|mesh-list
14777909|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
14777910|NCT00669656|Selenium|selenium|mesh-list
14777911|NCT00669656|Lycopene|lycopene|mesh-list
14777912|NCT00669656|Daidzein|daidzein|mesh-list
14777913|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
14777914|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777915|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14777916|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14777917|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
14777918|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777919|NCT00669656|Protective Agents|protective agents|mesh-ancestor
14777920|NCT00669656|Trace Elements|trace elements|mesh-ancestor
14777921|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14777922|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14777923|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14207091|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
14207092|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207093|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14207094|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14207095|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14207096|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14207097|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207098|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207099|NCT04070157|Analgesics|analgesics|mesh-ancestor
14207100|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
14207101|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
14240995|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14240996|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14240997|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
14240998|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
14240999|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241000|NCT00170625|Topotecan|topotecan|mesh-list
14241001|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14241002|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14241003|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777924|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777925|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
14777926|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14777927|NCT00669656|Estrogens|estrogens|mesh-ancestor
14777928|NCT00669656|Hormones|hormones|mesh-ancestor
14777929|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777930|NCT00669695|Atorvastatin|atorvastatin|mesh-list
14777931|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14777932|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14777933|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
14942677|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942678|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
14942679|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942680|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241004|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241005|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241006|NCT00170846|Everolimus|everolimus|mesh-list
14241007|NCT00170846|Azathioprine|azathioprine|mesh-list
14241008|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14241009|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241010|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241011|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
14241012|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241013|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241014|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241015|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
14241016|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14241017|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241018|NCT00170950|Amlodipine|amlodipine|mesh-list
14241019|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14241020|NCT00170950|Benazepril|benazepril|mesh-list
14241021|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14241022|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14241023|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241024|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241025|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14777934|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777935|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14777936|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14777937|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777938|NCT00669721|Heparin|heparin|mesh-list
14777939|NCT00669721|Calcium heparin|calcium heparin|mesh-list
14777940|NCT00669721|Nadroparin|nadroparin|mesh-list
14777941|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
14777942|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14942681|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
14942682|NCT01504516|Donepezil|donepezil|mesh-list
14942683|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14942684|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942685|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942686|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
14207102|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
14207103|NCT04002401|Rituximab|rituximab|mesh-list
14777943|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14777944|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777945|NCT00669747|Carboplatin|carboplatin|mesh-list
14777946|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777947|NCT00669773|Docetaxel|docetaxel|mesh-list
14777948|NCT00669773|Doxorubicin|doxorubicin|mesh-list
14777949|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14777950|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942687|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942688|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942689|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
14942690|NCT01504542|Vaccines|vaccines|mesh-list
14942691|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
14942692|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942693|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14777951|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
14777952|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
14777953|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
14777954|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14777955|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14777956|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14777957|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777958|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777959|NCT00669786|Menotropins|menotropins|mesh-list
14777960|NCT00669786|Hormones|hormones|mesh-list
14777961|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14777962|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14777963|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14777964|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14777965|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
14777966|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777967|NCT00669812|Cytarabine|cytarabine|mesh-list
14777968|NCT00669812|Prednisolone|prednisolone|mesh-list
14777969|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
14777970|NCT00669812|Melphalan|melphalan|mesh-list
14777971|NCT00669812|Ifosfamide|ifosfamide|mesh-list
14777972|NCT00669812|Carmustine|carmustine|mesh-list
14777973|NCT00669812|Doxorubicin|doxorubicin|mesh-list
14777974|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14777975|NCT00669812|Methotrexate|methotrexate|mesh-list
14777976|NCT00669812|Etoposide|etoposide|mesh-list
14777977|NCT00669812|Vincristine|vincristine|mesh-list
14777978|NCT00669812|Epirubicin|epirubicin|mesh-list
14777979|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14777980|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
14777981|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942694|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
14207104|NCT04002401|Fludarabine|fludarabine|mesh-list
14207105|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207106|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
14207107|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207108|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14207109|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14207110|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
14207111|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207112|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207113|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14777982|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14777983|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14777984|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
14777985|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942695|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207114|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207115|NCT03976362|Paclitaxel|paclitaxel|mesh-list
14207116|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14207117|NCT03976362|Carboplatin|carboplatin|mesh-list
14207118|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
14207119|NCT03976362|Olaparib|olaparib|mesh-list
14207120|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14207121|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207122|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
14207123|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207124|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
14207125|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207126|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207127|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14207128|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207129|NCT03973333|Atezolizumab|atezolizumab|mesh-list
14207130|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207131|NCT03971877|Polymyxins|polymyxins|mesh-list
14207132|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14207133|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207134|NCT03963414|Carboplatin|carboplatin|mesh-list
14207135|NCT03963414|Etoposide|etoposide|mesh-list
14207136|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
14207137|NCT03963414|Durvalumab|durvalumab|mesh-list
14207138|NCT03963414|Tremelimumab|tremelimumab|mesh-list
14207139|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14207140|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207141|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14207142|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14505023|NCT02856880|Zinc|zinc|mesh-list
14505024|NCT02856880|Trace Elements|trace elements|mesh-ancestor
14505025|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
14505026|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505027|NCT02858076|Aflibercept|aflibercept|mesh-list
14505028|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
14505029|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14505030|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14505031|NCT02858076|Growth Substances|growth substances|mesh-ancestor
14505032|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505033|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14505034|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505035|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
14505036|NCT02858180|Ledipasvir|ledipasvir|mesh-list
14505037|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
14505038|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505039|NCT02858401|Vesatolimod|vesatolimod|mesh-list
14505040|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
14505041|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505042|NCT02858713|Betamethasone|betamethasone|mesh-list
14505043|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
14505044|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14505045|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
14505046|NCT02858713|Calcipotriene|calcipotriene|mesh-list
14505047|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14505048|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505049|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
14505050|NCT02858713|Hormones|hormones|mesh-ancestor
14505051|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505052|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505053|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14505054|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
14505055|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505056|NCT02859142|Nicotine|nicotine|mesh-list
14505057|NCT02859142|Varenicline|varenicline|mesh-list
14505058|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14505059|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
14505060|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505061|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505062|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14505063|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14505064|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505065|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505066|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505067|NCT02859246|Guaifenesin|guaifenesin|mesh-list
14505068|NCT02859246|Expectorants|expectorants|mesh-ancestor
14505069|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
14505070|NCT02859324|Nivolumab|nivolumab|mesh-list
14777986|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14777987|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14777988|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14777989|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14777990|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14777991|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14777992|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14777993|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
14777994|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14777995|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14777996|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
14777997|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
14777998|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14777999|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14778000|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14778001|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
14778002|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778003|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14778004|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14778005|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14778006|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207143|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14207144|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207145|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207146|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14778007|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
14778008|NCT00669812|Hormones|hormones|mesh-ancestor
14778009|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778010|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14778011|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
14778012|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
14778013|NCT00669890|Busulfan|busulfan|mesh-list
14778014|NCT00669890|Methotrexate|methotrexate|mesh-list
14778015|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
14778016|NCT00669890|Tacrolimus|tacrolimus|mesh-list
14778017|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
14942696|NCT01504620|Insulin|insulin|mesh-list
14942697|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14942698|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942699|NCT01504646|Lyprinol|lyprinol|mesh-list
14942700|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14942701|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14942702|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942703|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942704|NCT01504659|Ketamine|ketamine|mesh-list
14942705|NCT01504659|Analgesics|analgesics|mesh-ancestor
14942706|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
14942707|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942708|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942709|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14942710|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14942711|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
14942712|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
14942713|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942714|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14942715|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14942716|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942717|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942718|NCT01504724|Bevacizumab|bevacizumab|mesh-list
14942719|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942720|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942721|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14942722|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14942723|NCT01504724|Growth Substances|growth substances|mesh-ancestor
14942724|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942725|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
14942726|NCT01504776|Bortezomib|bortezomib|mesh-list
14942727|NCT01504776|Panobinostat|panobinostat|mesh-list
14942728|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942729|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14942730|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942731|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942732|NCT01504815|Cisplatin|cisplatin|mesh-list
14778018|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778019|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
14778020|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778021|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14778022|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14778023|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
14778024|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778025|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778026|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14778027|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14778028|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
14778029|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778030|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778031|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
14778032|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778033|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778034|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14778035|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14778036|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14778037|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14778038|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14778039|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
14778040|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14207147|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
14207148|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207149|NCT03955211|Acetaminophen|acetaminophen|mesh-list
14207150|NCT03955211|Ibuprofen|ibuprofen|mesh-list
14207151|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14207152|NCT03955211|Analgesics|analgesics|mesh-ancestor
14207153|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
14207154|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207155|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207156|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
14207157|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14207158|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14778041|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778042|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14778043|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
14778044|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778045|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778046|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14778047|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778048|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778049|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778050|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778051|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14778052|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14778053|NCT00670124|Menthol|menthol|mesh-list
14778054|NCT00670124|Antipruritics|antipruritics|mesh-ancestor
14778055|NCT00670124|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778056|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
14778057|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778058|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
14778059|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778060|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778061|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14778062|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778063|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778064|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778065|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207159|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14207160|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14778066|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14778067|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14778068|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
14778069|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207161|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207162|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207163|NCT03943927|Metoprolol|metoprolol|mesh-list
14207164|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14207165|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14778070|NCT00670293|Raclopride|raclopride|mesh-list
14778071|NCT00670293|Methylphenidate|methylphenidate|mesh-list
14207166|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
14207167|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
14207168|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207169|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207170|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14207171|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14207172|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14207173|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
14207174|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207175|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207176|NCT03900884|Letrozole|letrozole|mesh-list
14207177|NCT03900884|Venetoclax|venetoclax|mesh-list
14207178|NCT03900884|Palbociclib|palbociclib|mesh-list
14207179|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207180|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14778072|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14778073|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942733|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942734|NCT01504828|Ramipril|ramipril|mesh-list
14505071|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505072|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505073|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14778074|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14505074|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778075|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14778076|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778077|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778078|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
14778079|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778080|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14778081|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14778082|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778083|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778084|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14778085|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14778086|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14778087|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
14778088|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778089|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778090|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15026771|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505075|NCT02859441|Ranibizumab|ranibizumab|mesh-list
14505076|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14505077|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14505078|NCT02859441|Growth Substances|growth substances|mesh-ancestor
14505079|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505080|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
14505081|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505082|NCT02859454|Avelumab|avelumab|mesh-list
14505083|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505084|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505085|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
14505086|NCT02860507|Neostigmine|neostigmine|mesh-list
14505087|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14505088|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505089|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505090|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505091|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505092|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505093|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14505094|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
14505095|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505096|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14505097|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14505098|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14505099|NCT02860546|Nivolumab|nivolumab|mesh-list
14505100|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505101|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505102|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14505103|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505104|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14505105|NCT02860845|Clindamycin|clindamycin|mesh-list
14505106|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
14207181|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14778091|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14778092|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14778093|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
14778094|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14778095|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14778096|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778097|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
14778098|NCT00670345|Coagulants|coagulants|mesh-ancestor
14778099|NCT00670410|Fludarabine|fludarabine|mesh-list
14778100|NCT00670410|Busulfan|busulfan|mesh-list
14505107|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
14505108|NCT02860845|Clotrimazole|clotrimazole|mesh-list
14505109|NCT02860845|Miconazole|miconazole|mesh-list
14505110|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
14505111|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505112|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14505113|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505114|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505115|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14505116|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14505117|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14505118|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14505119|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
14505120|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505121|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505122|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14505123|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14505124|NCT02861131|Neostigmine|neostigmine|mesh-list
14505125|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14505126|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505127|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505128|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505129|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505130|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505131|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14505132|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
14505133|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505134|NCT02861586|Vaccines|vaccines|mesh-list
14505135|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
14505136|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505137|NCT02861664|Fluorides|fluorides|mesh-list
14505138|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
14505139|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
14505140|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
14505141|NCT02861664|Protective Agents|protective agents|mesh-ancestor
14505142|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505143|NCT02862106|Vaccines|vaccines|mesh-list
14505144|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
14505145|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505146|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
14505147|NCT02862535|Nivolumab|nivolumab|mesh-list
14505148|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505149|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505150|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14505151|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505152|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
14505153|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505154|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14505155|NCT02862574|Methotrexate|methotrexate|mesh-list
14505156|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14505157|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
14505158|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14505159|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505160|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14505161|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
14505162|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505163|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505164|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505165|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505166|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14778101|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
14942735|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14778102|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778103|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778104|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778105|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
14778106|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778107|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
14778108|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14778109|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14778110|NCT00670423|Sirolimus|sirolimus|mesh-list
14778111|NCT00670423|Bortezomib|bortezomib|mesh-list
14778112|NCT00670423|Tacrolimus|tacrolimus|mesh-list
14778113|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778114|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
14778115|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778116|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14778117|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778118|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778119|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778120|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778121|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778122|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14778123|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
14778124|NCT00670436|Paclitaxel|paclitaxel|mesh-list
14778125|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14778126|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14778127|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778128|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
14778129|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
14778130|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
14778131|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778132|NCT00670475|Piroxicam|piroxicam|mesh-list
14778133|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14778134|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14778135|NCT00670475|Analgesics|analgesics|mesh-ancestor
14778136|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
14778137|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778138|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778139|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207182|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207183|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778140|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14778141|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14942736|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
14942737|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942738|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942739|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14942740|NCT01504906|Cyclosporine|cyclosporine|mesh-list
14942741|NCT01504906|Ticagrelor|ticagrelor|mesh-list
14942742|NCT01504906|Cyclosporins|cyclosporins|mesh-list
14942743|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942744|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942745|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14942746|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
14942747|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207184|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14207185|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
14207186|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778142|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778143|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942748|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
14942749|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778144|NCT00670501|Vitamin D|vitamin d|mesh-list
14778145|NCT00670501|Teriparatide|teriparatide|mesh-list
14778146|NCT00670501|Calcium|calcium|mesh-list
14778147|NCT00670501|Vitamins|vitamins|mesh-ancestor
14942750|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14942751|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14942752|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14942753|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14942754|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14942755|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14942756|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14942757|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
14778148|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
14778149|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778150|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14778151|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14778152|NCT00670553|Panobinostat|panobinostat|mesh-list
14778153|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778154|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14778155|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942758|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942759|NCT01504919|Nicotine|nicotine|mesh-list
14942760|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14942761|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
14942762|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942763|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942764|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14942765|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14942766|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
14942767|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942768|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942769|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
14942770|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942771|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14942772|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942773|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942774|NCT01505049|Vaccines|vaccines|mesh-list
14942775|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
14942776|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942777|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14942778|NCT01505088|Dexamethasone|dexamethasone|mesh-list
14942779|NCT01505088|Prednisolone|prednisolone|mesh-list
14942780|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14942781|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
14942782|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14942783|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
14942784|NCT01505088|Citric Acid|citric acid|mesh-list
14942785|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
14942786|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14942787|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14942788|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14942789|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
14942790|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14942791|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942792|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
14942793|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
14942794|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942795|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942796|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942797|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
14942798|NCT01505088|Hormones|hormones|mesh-ancestor
14942799|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14942800|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14942801|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942802|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
14942803|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14942804|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
14942805|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
14942806|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942807|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14942808|NCT01505088|Protective Agents|protective agents|mesh-ancestor
14942809|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14942810|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942811|NCT01505127|Amoxicillin|amoxicillin|mesh-list
14942812|NCT01505127|Clarithromycin|clarithromycin|mesh-list
14942813|NCT01505127|Lansoprazole|lansoprazole|mesh-list
14942814|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
14942815|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14942816|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942817|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13964428|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964429|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
13964430|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13964431|NCT03137030|Narcotics|narcotics|mesh-ancestor
14207187|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942818|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942819|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942820|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14778156|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778157|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14207188|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14207189|NCT03874897|Antibodies|antibodies|mesh-list
14207190|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14207191|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
14207192|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207193|NCT03853330|Bupivacaine|bupivacaine|mesh-list
14207194|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
14207195|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
14778158|NCT00670566|Irbesartan|irbesartan|mesh-list
14778159|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14778160|NCT00670566|Diuretics|diuretics|mesh-ancestor
14778161|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
14778162|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778163|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14778164|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778165|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778166|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14778167|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14778168|NCT00670618|Fluorides|fluorides|mesh-list
14778169|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
14778170|NCT00670618|Protective Agents|protective agents|mesh-ancestor
14778171|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778172|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14778173|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
14778174|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778175|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14778176|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14778177|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
14942821|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14942822|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14942823|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942824|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14207196|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207197|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207198|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
14207199|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207200|NCT03850691|Aldesleukin|aldesleukin|mesh-list
14207201|NCT03850691|Nivolumab|nivolumab|mesh-list
14207202|NCT03850691|Ipilimumab|ipilimumab|mesh-list
14207203|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207204|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207205|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14207206|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207207|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14207208|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14207209|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
14207210|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207211|NCT03834740|Everolimus|everolimus|mesh-list
14207212|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207213|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207214|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
14207215|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207216|NCT03805100|Ranibizumab|ranibizumab|mesh-list
14207217|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14207218|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14207219|NCT03805100|Growth Substances|growth substances|mesh-ancestor
14207220|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207221|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
14207222|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207223|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
14778178|NCT00670670|Caseins|caseins|mesh-list
14778179|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14778180|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
14778181|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778182|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778183|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778184|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
14778185|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
14778186|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
14942825|NCT01505218|Propofol|propofol|mesh-list
14778187|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14207224|NCT03769532|Azacitidine|azacitidine|mesh-list
14207225|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942826|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14778188|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778189|NCT00670696|Tetracaine|tetracaine|mesh-list
14778190|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
14778191|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
14778192|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778193|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778194|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
14778195|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778196|NCT00670722|Insulin|insulin|mesh-list
14778197|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14778198|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
14778199|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
14778200|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14778201|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
14778202|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
14778203|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14778204|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778205|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778206|NCT00670761|Misoprostol|misoprostol|mesh-list
14778207|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14778208|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
14778209|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778210|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778211|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14778212|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778213|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
14778214|NCT00670787|Losartan|losartan|mesh-list
14778215|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14778216|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14207226|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207227|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14207228|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
14778217|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14778218|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14778219|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14778220|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778221|NCT00670787|Diuretics|diuretics|mesh-ancestor
14778222|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
14778223|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207229|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207230|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207231|NCT03764098|Guanfacine|guanfacine|mesh-list
14207232|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14207233|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14207234|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14207235|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14207236|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14778224|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14778225|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778226|NCT00670813|Modafinil|modafinil|mesh-list
14778227|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14207237|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207238|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207239|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207240|NCT03739710|Docetaxel|docetaxel|mesh-list
14207241|NCT03739710|Ipilimumab|ipilimumab|mesh-list
14207242|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207243|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
14207244|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207245|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
14207246|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207247|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207248|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14207249|NCT03661645|Dexamethasone|dexamethasone|mesh-list
14207250|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
14207251|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
14505167|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505168|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
14505169|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505170|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14505171|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505172|NCT02862600|Perhexiline|perhexiline|mesh-list
14505173|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14505174|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14207252|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14207253|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14942827|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942828|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942829|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13964432|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207254|NCT03661645|BB 1101|bb 1101|mesh-list
14778228|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778229|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14778230|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14778231|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14778232|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778233|NCT00670878|Gemcitabine|gemcitabine|mesh-list
14778234|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778235|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
14778236|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778237|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778238|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
14778239|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778240|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778241|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778242|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
14778243|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807524|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14807525|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14807526|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807527|NCT00822211|Vildagliptin|vildagliptin|mesh-list
14807528|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14807529|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807530|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14807531|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
14807532|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807533|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807534|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
14207255|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207256|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
14207257|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
14807535|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14807536|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
14807537|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807538|NCT00822263|Expectorants|expectorants|mesh-ancestor
14807539|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
14807540|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14807541|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
14807542|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807543|NCT00822263|Protective Agents|protective agents|mesh-ancestor
14807544|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807545|NCT00822263|Antidotes|antidotes|mesh-ancestor
14942830|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
14942831|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
14942832|NCT01505231|Vasopressins|vasopressins|mesh-list
14942833|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
14942834|NCT01505231|Norepinephrine|norepinephrine|mesh-list
14942835|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14942836|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14942837|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
14942838|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942839|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942840|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942841|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
14942842|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
14942843|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942844|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14942845|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
13964433|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
13964434|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
13964435|NCT03137017|Acetaminophen|acetaminophen|mesh-list
13964436|NCT03137017|Hydrocodone|hydrocodone|mesh-list
13964437|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13964438|NCT03137017|Analgesics|analgesics|mesh-ancestor
13964439|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
13964440|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964441|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964442|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
14207258|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778244|NCT00671008|Insulin|insulin|mesh-list
14778245|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14778246|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
14778247|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
14778248|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
14207259|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207260|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207261|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
14207262|NCT03661645|Hormones|hormones|mesh-ancestor
14207263|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207264|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14207265|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207266|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
14207267|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207268|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207269|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14207270|NCT03661645|Protective Agents|protective agents|mesh-ancestor
14207271|NCT03647566|Listerine|listerine|mesh-list
14207272|NCT03647566|Fluorides|fluorides|mesh-list
14207273|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
14207274|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
14207275|NCT03647566|Protective Agents|protective agents|mesh-ancestor
14207276|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207277|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14207278|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207279|NCT03576313|Ivermectin|ivermectin|mesh-list
14207280|NCT03576313|Piperaquine|piperaquine|mesh-list
14778249|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14778250|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778251|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778252|NCT00671112|Everolimus|everolimus|mesh-list
14778253|NCT00671112|Bortezomib|bortezomib|mesh-list
14778254|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778255|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778256|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
14778257|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778258|NCT00671138|Vaccines|vaccines|mesh-list
14778259|NCT00671138|Immunologic Factors|immunologic factors|mesh-ancestor
14778260|NCT00671138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778261|NCT00671151|Theophylline|theophylline|mesh-list
14778262|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14778263|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
14778264|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778265|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778266|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14778267|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
14778268|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14778269|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778270|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778271|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
14778272|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14778273|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14778274|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
14778275|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778276|NCT00671203|Erythromycin|erythromycin|mesh-list
14778277|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
14778278|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14778279|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
14778280|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778281|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778282|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778283|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14778284|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778285|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778286|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
14778287|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14778288|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14778289|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778290|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
14778291|NCT00671281|Coagulants|coagulants|mesh-ancestor
14778292|NCT00671320|Diclofenac|diclofenac|mesh-list
14942846|NCT01505231|Coagulants|coagulants|mesh-ancestor
14942847|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14207281|NCT03576313|Artenimol|artenimol|mesh-list
14778293|NCT00671320|Valdecoxib|valdecoxib|mesh-list
14778294|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14778295|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14778296|NCT00671320|Analgesics|analgesics|mesh-ancestor
14942848|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
14942849|NCT01505283|Lidocaine|lidocaine|mesh-list
14942850|NCT01505283|Sufentanil|sufentanil|mesh-list
14942851|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
14942852|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
14942853|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778297|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
14778298|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778299|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778300|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14778301|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14778302|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14778303|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778304|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778305|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14778306|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
14778307|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14207282|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14207283|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207284|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
14207285|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14207286|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14207287|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14207288|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14207289|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207290|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207291|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
14207292|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207293|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14207294|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14207295|NCT03533010|Vitamin D|vitamin d|mesh-list
14207296|NCT03533010|Vitamins|vitamins|mesh-ancestor
14207297|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
14207298|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207299|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14207300|NCT03512275|Antibodies|antibodies|mesh-list
14778308|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778309|NCT00671372|Bevacizumab|bevacizumab|mesh-list
14778310|NCT00671372|Cetuximab|cetuximab|mesh-list
14778311|NCT00671372|Irinotecan|irinotecan|mesh-list
14778312|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14778313|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778314|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14778315|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778316|NCT00671372|Growth Substances|growth substances|mesh-ancestor
14778317|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778318|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
14778319|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14778320|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778321|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778322|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942854|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942855|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
14207301|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14207302|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
14505175|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505176|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14505177|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505178|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
14505179|NCT02862730|Pancrelipase|pancrelipase|mesh-list
14505180|NCT02862730|Pancreatin|pancreatin|mesh-list
14505181|NCT02862730|Hormones|hormones|mesh-list
14505182|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505183|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505184|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505185|NCT02862912|Fentanyl|fentanyl|mesh-list
14505186|NCT02862912|Bupivacaine|bupivacaine|mesh-list
14505187|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
14505188|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
14505189|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
14505190|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505191|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942856|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207303|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207304|NCT03485729|TIC10 compound|tic10 compound|mesh-list
14207305|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207306|NCT03435003|Dexamethasone|dexamethasone|mesh-list
14207307|NCT03435003|Fentanyl|fentanyl|mesh-list
14207308|NCT03435003|Scopolamine|scopolamine|mesh-list
14207309|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
14207310|NCT03435003|Ondansetron|ondansetron|mesh-list
14207311|NCT03435003|Aprepitant|aprepitant|mesh-list
14207312|NCT03435003|Metoclopramide|metoclopramide|mesh-list
14207313|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
14207314|NCT03435003|Propofol|propofol|mesh-list
14207315|NCT03435003|Sevoflurane|sevoflurane|mesh-list
14207316|NCT03435003|Desflurane|desflurane|mesh-list
14207317|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14207318|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207319|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
14207320|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
14207321|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207322|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207323|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778323|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
14778324|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14778325|NCT00671424|Furosemide|furosemide|mesh-list
14778326|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14778327|NCT00671424|Diuretics|diuretics|mesh-ancestor
14778328|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
14778329|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778330|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14778331|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942857|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14942858|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14942859|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14942860|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942861|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942862|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14942863|NCT01505283|Narcotics|narcotics|mesh-ancestor
14942864|NCT01505283|Analgesics|analgesics|mesh-ancestor
14942865|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14942866|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14942867|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
14942868|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14942869|NCT01505413|Gemcitabine|gemcitabine|mesh-list
14942870|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
14207324|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
14207325|NCT03435003|Hormones|hormones|mesh-ancestor
14942871|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14942872|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14942873|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
14942874|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942875|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14942876|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
14942877|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14942878|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942879|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14942880|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
13964443|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13964444|NCT03137017|Narcotics|narcotics|mesh-ancestor
13964445|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964446|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
13964447|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
13964448|NCT03137082|Guanfacine|guanfacine|mesh-list
13964449|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13964450|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14207326|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207327|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14207328|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207329|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
14207330|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207331|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14207332|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14207333|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
14207334|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14207335|NCT03435003|Analgesics|analgesics|mesh-ancestor
14207336|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
14207337|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14207338|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14942881|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942882|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14942883|NCT01505426|Metformin|metformin|mesh-list
14942884|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
14778332|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778333|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14778334|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14778335|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778336|NCT00671476|Doxorubicin|doxorubicin|mesh-list
14778337|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14778338|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14778339|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778340|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14778341|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778342|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778343|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778344|NCT00671541|Gentamicins|gentamicins|mesh-list
14778345|NCT00671541|Bacitracin|bacitracin|mesh-list
14778346|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778347|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778348|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14778349|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778350|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778351|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14778352|NCT00671593|Phenol|phenol|mesh-list
14778353|NCT00671593|Glycerol|glycerol|mesh-list
14778354|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14778355|NCT00671593|Protective Agents|protective agents|mesh-ancestor
14778356|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778357|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14778358|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778359|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
14778360|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14778361|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14778362|NCT00671632|Triazolam|triazolam|mesh-list
14778363|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14778364|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14778365|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14778366|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778367|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778368|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778369|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
14778370|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
14778371|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778372|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778373|NCT00671645|Bevacizumab|bevacizumab|mesh-list
14778374|NCT00671645|Capecitabine|capecitabine|mesh-list
14778375|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942885|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14942886|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942887|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14942888|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942889|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
14942890|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14942891|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14942892|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14778376|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778377|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14778378|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778379|NCT00671645|Growth Substances|growth substances|mesh-ancestor
14778380|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778381|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
14778382|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778383|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
14778384|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778385|NCT00671697|Decitabine|decitabine|mesh-list
14778386|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
14778387|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778388|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
14778389|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778390|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778391|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778392|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14778393|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14778394|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778395|NCT00671801|Irinotecan|irinotecan|mesh-list
14778396|NCT00671801|Lenalidomide|lenalidomide|mesh-list
14778397|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14778398|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778399|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778400|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778401|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778402|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
14778403|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778404|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14778405|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778406|NCT00671801|Growth Substances|growth substances|mesh-ancestor
14778407|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
14778408|NCT00671814|Linezolid|linezolid|mesh-list
14778409|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778410|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778411|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14778412|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778413|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778414|NCT00672022|Miglustat|miglustat|mesh-list
14778415|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778416|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778417|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14778418|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14778419|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
14778420|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778421|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14778422|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778423|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778424|NCT00672113|Nifedipine|nifedipine|mesh-list
14778425|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14942893|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942894|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942895|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942896|NCT01505439|Urological Agents|urological agents|mesh-ancestor
14942897|NCT01505504|Mirtazapine|mirtazapine|mesh-list
14942898|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
14942899|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14942900|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14942901|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
14942902|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
14207339|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14778426|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778427|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778428|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14778429|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778430|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
14778431|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
14778432|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778433|NCT00672165|Antibodies|antibodies|mesh-list
14778434|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14778435|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
14778436|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778437|NCT00672282|Bicalutamide|bicalutamide|mesh-list
14778438|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
14778439|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
14778440|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778441|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778442|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778443|NCT00672295|Paclitaxel|paclitaxel|mesh-list
14778444|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14778445|NCT00672295|Carboplatin|carboplatin|mesh-list
14778446|NCT00672295|Dasatinib|dasatinib|mesh-list
14778447|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14778448|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778449|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
14778450|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207340|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
14778451|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
14778452|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778453|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14778454|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778455|NCT00672347|Clonidine|clonidine|mesh-list
14778456|NCT00672347|Morphine|morphine|mesh-list
14778457|NCT00672347|Bupivacaine|bupivacaine|mesh-list
14778458|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
14778459|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
14778460|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778461|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778462|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
14778463|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778464|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14778465|NCT00672347|Narcotics|narcotics|mesh-ancestor
14778466|NCT00672347|Analgesics|analgesics|mesh-ancestor
14778467|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14778468|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
14778469|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
14778470|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14778471|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13964451|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14207341|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207342|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207343|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14207344|NCT03435003|Narcotics|narcotics|mesh-ancestor
14207345|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14778472|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14778473|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14778474|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778475|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778476|NCT00672360|Folic Acid|folic acid|mesh-list
14778477|NCT00672360|Hematinics|hematinics|mesh-ancestor
14778478|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
14778479|NCT00672360|Vitamins|vitamins|mesh-ancestor
14778480|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
14778481|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778482|NCT00672399|Exenatide|exenatide|mesh-list
14207346|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14207347|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14207348|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
14207349|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
14207350|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14207351|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
14207352|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14207353|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14207354|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778483|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
14778484|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778485|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778486|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14778487|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778488|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778489|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778490|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778491|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778492|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778493|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14778494|NCT00672399|Incretins|incretins|mesh-ancestor
14778495|NCT00672399|Hormones|hormones|mesh-ancestor
13964452|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13964453|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
13964454|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964455|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964456|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964457|NCT03137004|Docetaxel|docetaxel|mesh-list
13964458|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964459|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
13964460|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
13964461|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
13964462|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964463|NCT03136666|Candesartan|candesartan|mesh-list
13964464|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
13964465|NCT03136666|Nifedipine|nifedipine|mesh-list
14207355|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14778496|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778497|NCT00672464|Metformin|metformin|mesh-list
14778498|NCT00672464|Olanzapine|olanzapine|mesh-list
14778499|NCT00672464|Simvastatin|simvastatin|mesh-list
14778500|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778501|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778502|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14778503|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14778504|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
14778505|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778506|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14778507|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14778508|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207356|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14207357|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14778509|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
14778510|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
14778511|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778512|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778513|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14778514|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14207358|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14207359|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
14207360|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
14207361|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14207362|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
14207363|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14207364|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
14207365|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
14207366|NCT03434769|Fludarabine|fludarabine|mesh-list
14207367|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207368|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
14207369|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207370|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14207371|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14207372|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
14207373|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207374|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807546|NCT00822315|Efavirenz|efavirenz|mesh-list
14807547|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
14807548|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14807549|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14807550|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807551|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807552|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
14807553|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807554|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14807555|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14807556|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14807557|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14807558|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14807559|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14807560|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14807561|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14807562|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14807563|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14807564|NCT00822380|Iron|iron|mesh-list
14807565|NCT00822380|Trace Elements|trace elements|mesh-list
14807566|NCT00822380|Folic Acid|folic acid|mesh-list
14207375|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14207376|NCT03414983|Leucovorin|leucovorin|mesh-list
14207377|NCT03414983|Bevacizumab|bevacizumab|mesh-list
14207378|NCT03414983|Nivolumab|nivolumab|mesh-list
14778515|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778516|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778517|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14207379|NCT03414983|Fluorouracil|fluorouracil|mesh-list
14207380|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
14207381|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207382|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207383|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14207384|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14207385|NCT03414983|Growth Substances|growth substances|mesh-ancestor
14207386|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207387|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
14207388|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
14207389|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778518|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14778519|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778520|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778521|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
14778522|NCT00672568|Capsaicin|capsaicin|mesh-list
14778523|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
14778524|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778525|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
14778526|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778527|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778528|NCT00672659|Dexetimide|dexetimide|mesh-list
14778529|NCT00672659|Pipamperone|pipamperone|mesh-list
14505192|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
14505193|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505194|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14505195|NCT02862912|Narcotics|narcotics|mesh-ancestor
14505196|NCT02862912|Analgesics|analgesics|mesh-ancestor
14505197|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14505198|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14505199|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
14778530|NCT00672659|Citalopram|citalopram|mesh-list
14778531|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14778532|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14778533|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778534|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778535|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778536|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
14778537|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778538|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14778539|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
14778540|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778541|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14778542|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14942903|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026772|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505200|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
14505201|NCT02863263|Povidone|povidone|mesh-list
14505202|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
14505203|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
14505204|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14505205|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505206|NCT02863328|Empagliflozin|empagliflozin|mesh-list
14505207|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14505208|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505209|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14505210|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505211|NCT02863354|Aflibercept|aflibercept|mesh-list
14505212|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14505213|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14505214|NCT02863354|Growth Substances|growth substances|mesh-ancestor
14505215|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505216|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
14505217|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505218|NCT02863419|Liraglutide|liraglutide|mesh-list
14207390|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14505219|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14505220|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207391|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207392|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
14207393|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14207394|NCT03414983|Antidotes|antidotes|mesh-ancestor
14207395|NCT03414983|Protective Agents|protective agents|mesh-ancestor
14207396|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
14207397|NCT03414983|Vitamins|vitamins|mesh-ancestor
14207398|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
14207399|NCT03383692|Ritonavir|ritonavir|mesh-list
14207400|NCT03383692|Itraconazole|itraconazole|mesh-list
14207401|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14207402|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14207403|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
14207404|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207405|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207406|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14778543|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
14778544|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
14778545|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778546|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14778547|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14778548|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
14778549|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14778550|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14778551|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14778552|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778553|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
14778554|NCT00672763|Vitamin D|vitamin d|mesh-list
14778555|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
14778556|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
14778557|NCT00672763|Vitamins|vitamins|mesh-list
14778558|NCT00672763|Calcium|calcium|mesh-list
14778559|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
14778560|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778561|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14778562|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14778563|NCT00672776|Paroxetine|paroxetine|mesh-list
14778564|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14778565|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14778566|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778567|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778568|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778569|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
14778570|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778571|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14778572|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
14778573|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778574|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14778575|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14778576|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778577|NCT00672867|Adefovir|adefovir|mesh-list
14207407|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14207408|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
14207409|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207410|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14207411|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14207412|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
14207413|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14207414|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14207415|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
14207416|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207417|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207418|NCT03377361|Nivolumab|nivolumab|mesh-list
14207419|NCT03377361|Ipilimumab|ipilimumab|mesh-list
14207420|NCT03377361|Trametinib|trametinib|mesh-list
14207421|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207422|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207423|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14207424|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207425|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14207426|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778578|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14778579|NCT00672867|Clevudine|clevudine|mesh-list
14778580|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
14778581|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778582|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14778583|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14778584|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778585|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807567|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
14807568|NCT00822380|Micronutrients|micronutrients|mesh-list
14807569|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807570|NCT00822380|Hematinics|hematinics|mesh-ancestor
14807571|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
14807572|NCT00822380|Vitamins|vitamins|mesh-ancestor
14807573|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
14807574|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807575|NCT00822380|Protective Agents|protective agents|mesh-ancestor
14807576|NCT00822393|Busulfan|busulfan|mesh-list
14807577|NCT00822393|Treosulfan|treosulfan|mesh-list
14807578|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
14807579|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207433|NCT03349268|Xenon|xenon|mesh-list
14207434|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14207435|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
14207436|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
14207437|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207438|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207439|NCT03321656|Tacrolimus|tacrolimus|mesh-list
14207440|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207441|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
14207442|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207443|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14207444|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207445|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207446|NCT03307785|Paclitaxel|paclitaxel|mesh-list
14807580|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807581|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
14807582|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807583|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14807584|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807585|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14807586|NCT00822419|Lidocaine|lidocaine|mesh-list
14807587|NCT00822419|Ketamine|ketamine|mesh-list
14807588|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
14807589|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
14807590|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807591|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807592|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
14807593|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807594|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807595|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14807596|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14807597|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807598|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807599|NCT00822419|Analgesics|analgesics|mesh-ancestor
14807600|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14807601|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14807602|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
14807603|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14807604|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14807605|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807606|NCT00822536|Aspirin|aspirin|mesh-list
14807607|NCT00822536|Clopidogrel|clopidogrel|mesh-list
14807608|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14807609|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14807610|NCT00822536|Analgesics|analgesics|mesh-ancestor
14807611|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
14807612|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807613|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807614|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14807615|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807616|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14807617|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14807618|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807619|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14807620|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14807621|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807622|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
14207447|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14207448|NCT03307785|Bevacizumab|bevacizumab|mesh-list
14207449|NCT03307785|Carboplatin|carboplatin|mesh-list
14207450|NCT03307785|Pemetrexed|pemetrexed|mesh-list
14207451|NCT03307785|Niraparib|niraparib|mesh-list
14207452|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14207453|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207454|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
14207455|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207456|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
14207457|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778586|NCT00672919|Pioglitazone|pioglitazone|mesh-list
14778587|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778588|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778589|NCT00672971|Permethrin|permethrin|mesh-list
14778590|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505221|NCT02863419|Incretins|incretins|mesh-ancestor
14505222|NCT02863419|Hormones|hormones|mesh-ancestor
14505223|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505224|NCT02863575|Ibuprofen|ibuprofen|mesh-list
14505225|NCT02863575|Caffeine|caffeine|mesh-list
14505226|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14505227|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14505228|NCT02863575|Analgesics|analgesics|mesh-ancestor
14505229|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
14505230|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778591|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778592|NCT00673088|Ropinirole|ropinirole|mesh-list
14778593|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14778594|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14778595|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
14778596|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
14778597|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778598|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778599|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778600|NCT00673205|Bicalutamide|bicalutamide|mesh-list
14778601|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
14778602|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
14778603|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778604|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778605|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778606|NCT00673218|Omalizumab|omalizumab|mesh-list
14778607|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14778608|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14778609|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
14778610|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
14778611|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14778612|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14778613|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14778614|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
14778615|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14778616|NCT00673296|Bevacizumab|bevacizumab|mesh-list
14778617|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14778618|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778619|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14778620|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778621|NCT00673296|Growth Substances|growth substances|mesh-ancestor
14778622|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778623|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
14778624|NCT00673335|Letrozole|letrozole|mesh-list
14778625|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778626|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14778627|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14778628|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778629|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778630|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14778631|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
14778632|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778633|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778634|NCT00673426|Enoxaparin|enoxaparin|mesh-list
14778635|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
14778636|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14942904|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207458|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14778637|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14778638|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778639|NCT00673504|Gemcitabine|gemcitabine|mesh-list
14778640|NCT00673504|Sunitinib|sunitinib|mesh-list
14778641|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778642|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
14778643|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778644|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778645|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
14778646|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778647|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778648|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778649|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
14778650|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778651|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14778652|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778653|NCT00673504|Growth Substances|growth substances|mesh-ancestor
14778654|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14778655|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14778656|NCT00673556|Alefacept|alefacept|mesh-list
14778657|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778658|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
14778659|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778660|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14778661|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778662|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14778663|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207459|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14207460|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14207461|NCT03307785|Growth Substances|growth substances|mesh-ancestor
14207462|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207463|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
14207464|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207465|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14207466|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14207467|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14207468|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
14207469|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207470|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241026|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241027|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
14241028|NCT00170950|Diuretics|diuretics|mesh-ancestor
14241029|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
14241030|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14241031|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14241032|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
14241033|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241034|NCT00171054|Amlodipine|amlodipine|mesh-list
14241035|NCT00171054|Valsartan|valsartan|mesh-list
14241036|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14241037|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14241038|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14241039|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241040|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505231|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505232|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505233|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505234|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14505235|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505236|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505237|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14505238|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14505239|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14505240|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14505241|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
14505242|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505243|NCT02864316|Nivolumab|nivolumab|mesh-list
14505244|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505245|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505246|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14778664|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207471|NCT03182166|Golimumab|golimumab|mesh-list
14207472|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14207473|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207474|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207475|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
14207476|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207477|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
14207478|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
14207479|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207480|NCT03161028|Protective Agents|protective agents|mesh-ancestor
14207481|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207482|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
14207483|NCT03161028|Vitamins|vitamins|mesh-ancestor
14505247|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207484|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
14505248|NCT02864368|Temozolomide|temozolomide|mesh-list
14505249|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14505250|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
14505251|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505252|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505253|NCT02864381|Nivolumab|nivolumab|mesh-list
14505254|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505255|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505256|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14505257|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505258|NCT02864394|Docetaxel|docetaxel|mesh-list
14505259|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
14505260|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505261|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
14505262|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
14505263|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
14505264|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505265|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505266|NCT02864706|Cyclosporine|cyclosporine|mesh-list
14505267|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
14505268|NCT02864706|Everolimus|everolimus|mesh-list
14505269|NCT02864706|Cyclosporins|cyclosporins|mesh-list
14505270|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505271|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505272|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505273|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
14505274|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505275|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
14505276|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505277|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505278|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505279|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14505280|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505281|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14505282|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14505283|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
14505284|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14505285|NCT02865499|Acarbose|acarbose|mesh-list
14505286|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14505287|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505288|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505289|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14505290|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505291|NCT02865590|Cimetidine|cimetidine|mesh-list
14505292|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14505293|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505294|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14505295|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
14505296|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
14505297|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505298|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505299|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505300|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14505301|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14505302|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505303|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14505304|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14505305|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778665|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14778666|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14778667|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14778668|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
14778669|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778670|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14778671|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14778672|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778673|NCT00673608|Deferasirox|deferasirox|mesh-list
14778674|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14778675|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
14778676|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
14778677|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778678|NCT00673621|Albuterol|albuterol|mesh-list
14778679|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
14778680|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778681|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14778682|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
14778683|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778684|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14778685|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
14778686|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
14778687|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778688|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14778689|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14778690|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14778691|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14778692|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778693|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778694|NCT00673621|Miotics|miotics|mesh-ancestor
14778695|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14778696|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14778697|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14778698|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14778699|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
14942905|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942906|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14942907|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14942908|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942909|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14942910|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14942911|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14942912|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
14942913|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14942914|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14942915|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
14942916|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14778700|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14778701|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778702|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778703|NCT00673829|Interleukin-2|interleukin-2|mesh-list
14778704|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778705|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14942917|NCT01505777|Mosapride|mosapride|mesh-list
14942918|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14942919|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14942920|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
14942921|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942922|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942923|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942924|NCT01505790|Clopidogrel|clopidogrel|mesh-list
14942925|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14942926|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14942927|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14942928|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14942929|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14942930|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
14942931|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942932|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942933|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942934|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14942935|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
14778706|NCT00673829|Analgesics|analgesics|mesh-ancestor
14778707|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
14778708|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778709|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778710|NCT00674011|Bevacizumab|bevacizumab|mesh-list
14778711|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14778712|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778713|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14778714|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778715|NCT00674011|Growth Substances|growth substances|mesh-ancestor
14778716|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778717|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
14778718|NCT00674050|Fluticasone|fluticasone|mesh-list
14778719|NCT00674050|Albuterol|albuterol|mesh-list
14778720|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778721|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14778722|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14778723|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
14778724|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778725|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14778726|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14778727|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778728|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14778729|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
14778730|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778731|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14778732|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14778733|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14778734|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
14778735|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778736|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778737|NCT00674063|Alefacept|alefacept|mesh-list
14778738|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778739|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
14778740|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778741|NCT00674089|Vitamin A|vitamin a|mesh-list
14778742|NCT00674089|Vitamins|vitamins|mesh-ancestor
14778743|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
14778744|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778745|NCT00674102|Vadimezan|vadimezan|mesh-list
14778746|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778747|NCT00674141|Dexamethasone|dexamethasone|mesh-list
14778748|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14778749|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
14778750|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
14778751|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778752|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778753|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778754|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
14778755|NCT00674141|Hormones|hormones|mesh-ancestor
14778756|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778757|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14778758|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778759|NCT00674167|Docetaxel|docetaxel|mesh-list
14778760|NCT00674167|Capecitabine|capecitabine|mesh-list
14778761|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778762|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
14778763|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
14778764|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
14778765|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778766|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778767|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
14778768|NCT00674232|Misoprostol|misoprostol|mesh-list
14778769|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14778770|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
14778771|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778772|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778773|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14778774|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778775|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
14778776|NCT00674245|Pantoprazole|pantoprazole|mesh-list
14778777|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14778778|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778779|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14778780|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778781|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778782|NCT00674310|Ropinirole|ropinirole|mesh-list
14778783|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14778784|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14778785|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
14778786|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
14778787|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778788|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778789|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778790|NCT00674414|Trastuzumab|trastuzumab|mesh-list
14778791|NCT00674414|Everolimus|everolimus|mesh-list
14942936|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942937|NCT01505894|BI 409306|bi 409306|mesh-list
14942938|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14942939|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942940|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026773|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026774|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15026775|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026776|NCT01945736|Methadone|methadone|mesh-list
15026777|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15026778|NCT01945736|Narcotics|narcotics|mesh-ancestor
15026779|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026780|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026781|NCT01945736|Analgesics|analgesics|mesh-ancestor
15026782|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
15026783|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026784|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
15026785|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
15026786|NCT01945788|Teriparatide|teriparatide|mesh-list
15026787|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15026788|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026789|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15026790|NCT01945801|Furosemide|furosemide|mesh-list
15026791|NCT01945801|Spironolactone|spironolactone|mesh-list
15026792|NCT01945801|Diuretics|diuretics|mesh-ancestor
15026793|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
15026794|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026795|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15026796|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026797|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026798|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15026799|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
15026800|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026801|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15026802|NCT01945840|Hormones|hormones|mesh-list
15026803|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026804|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026805|NCT01945879|Heparin|heparin|mesh-list
15026806|NCT01945879|Enoxaparin|enoxaparin|mesh-list
15026807|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15026808|NCT01945879|Tinzaparin|tinzaparin|mesh-list
15026809|NCT01945879|Dalteparin|dalteparin|mesh-list
15026810|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
15026811|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15026812|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15026813|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026814|NCT01945892|Dexamethasone|dexamethasone|mesh-list
15026815|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15026816|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
15026817|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
15026818|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026819|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207485|NCT03134131|TIC10 compound|tic10 compound|mesh-list
14207486|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026820|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026821|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
15026822|NCT01945892|Hormones|hormones|mesh-ancestor
15026823|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026824|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15026825|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026826|NCT01945957|Oxytocin|oxytocin|mesh-list
15026827|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
15026828|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15026829|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778792|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14942941|NCT01505920|Lidocaine|lidocaine|mesh-list
14207487|NCT03090737|Nivolumab|nivolumab|mesh-list
14207488|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207489|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207490|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14207491|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207492|NCT03088826|Acetaminophen|acetaminophen|mesh-list
14207493|NCT03088826|Morphine|morphine|mesh-list
14207494|NCT03088826|Oxycodone|oxycodone|mesh-list
14207495|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14207496|NCT03088826|Narcotics|narcotics|mesh-ancestor
14207497|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207498|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207499|NCT03088826|Analgesics|analgesics|mesh-ancestor
14207500|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
14207501|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207502|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14207503|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
14942942|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
14942943|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
14942944|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14942945|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942946|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
14942947|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942948|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14942949|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14942950|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14207504|NCT03043872|Carboplatin|carboplatin|mesh-list
14207505|NCT03043872|Etoposide|etoposide|mesh-list
14207506|NCT03043872|Durvalumab|durvalumab|mesh-list
14207507|NCT03043872|Tremelimumab|tremelimumab|mesh-list
14942951|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942952|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942953|NCT01505946|Thrombin|thrombin|mesh-list
14942954|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
14942955|NCT01505946|Coagulants|coagulants|mesh-ancestor
14942956|NCT01505998|Amlodipine|amlodipine|mesh-list
14942957|NCT01505998|Benazepril|benazepril|mesh-list
14942958|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14942959|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14942960|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942961|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942962|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14942963|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942964|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
14942965|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14942966|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
14942967|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942968|NCT01506011|Amlodipine|amlodipine|mesh-list
14942969|NCT01506011|Benazepril|benazepril|mesh-list
14942970|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14942971|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14207508|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207509|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14207510|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14207511|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14207512|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207513|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207514|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207515|NCT03034018|Suvorexant|suvorexant|mesh-list
14207516|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14207517|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14207518|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505306|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
14505307|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505308|NCT02865811|Doxorubicin|doxorubicin|mesh-list
14505309|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14505310|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
14505311|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14505312|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505313|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14505314|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14505315|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505316|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505317|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14778793|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778794|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778795|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
14778796|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778797|NCT00674557|Exemestane|exemestane|mesh-list
14778798|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14778799|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778800|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14778801|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14778802|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778803|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778804|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14778805|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
14778806|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778807|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778808|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
14778809|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
14778810|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14778811|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778812|NCT00674557|Growth Substances|growth substances|mesh-ancestor
14778813|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
14778814|NCT00674596|Ramipril|ramipril|mesh-list
14778815|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14778816|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
14778817|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778818|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778819|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14778820|NCT00674674|Topotecan|topotecan|mesh-list
14778821|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14778822|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778823|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778824|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778825|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778826|NCT00674687|Gabapentin|gabapentin|mesh-list
14778827|NCT00674687|Analgesics|analgesics|mesh-ancestor
14778828|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
14778829|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778830|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778831|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
14778832|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14778833|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14778834|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778835|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778836|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14778837|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14778838|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778839|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778840|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
14778841|NCT00674713|Ondansetron|ondansetron|mesh-list
14778842|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14778843|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
14778844|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
14778845|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778846|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778847|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14778848|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
14778849|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
14778850|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14778851|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
14778852|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778853|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778854|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14778855|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14778856|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778857|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778858|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14778859|NCT00674752|Gabapentin|gabapentin|mesh-list
14778860|NCT00674752|Analgesics|analgesics|mesh-ancestor
14778861|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
14778862|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778863|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778864|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
14778865|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14778866|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026830|NCT01945983|Norepinephrine|norepinephrine|mesh-list
14778867|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778868|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778869|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14778870|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14778871|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778872|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778873|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
14778874|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
14778875|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14778876|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778877|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14778878|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14778879|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778880|NCT00674921|Renal Agents|renal agents|mesh-ancestor
14778881|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778882|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
14778883|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14778884|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14807623|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14807624|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14807625|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14807626|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
14807627|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807628|NCT00822549|Morphine|morphine|mesh-list
14807629|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14807630|NCT00822549|Narcotics|narcotics|mesh-ancestor
14807631|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807632|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807633|NCT00822549|Analgesics|analgesics|mesh-ancestor
14807634|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
14807635|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807636|NCT00822614|Fentanyl|fentanyl|mesh-list
14807637|NCT00822614|Morphine|morphine|mesh-list
14807638|NCT00822614|Oxycodone|oxycodone|mesh-list
13964466|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14207519|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207520|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14207521|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807639|NCT00822614|Hydromorphone|hydromorphone|mesh-list
14807640|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14807641|NCT00822614|Narcotics|narcotics|mesh-ancestor
14807642|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807643|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807644|NCT00822614|Analgesics|analgesics|mesh-ancestor
14807645|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
14807646|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807647|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14807648|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14807649|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
14807650|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
14807651|NCT00822627|Vaccines|vaccines|mesh-list
14807652|NCT00822627|Immunologic Factors|immunologic factors|mesh-ancestor
14807653|NCT00822627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807654|NCT00822666|Clopidogrel|clopidogrel|mesh-list
14807655|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14807656|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14807657|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14807658|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14207522|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207523|NCT03024437|Bevacizumab|bevacizumab|mesh-list
14207524|NCT03024437|Atezolizumab|atezolizumab|mesh-list
14807659|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
14807660|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807661|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964467|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13964468|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13964469|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964470|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13964471|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964472|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13964473|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964474|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
13964475|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
14778885|NCT00674999|Bacitracin|bacitracin|mesh-list
14207525|NCT03024437|Entinostat|entinostat|mesh-list
14207526|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207527|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207528|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14207529|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14778886|NCT00674999|Nystatin|nystatin|mesh-list
14778887|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14778888|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778889|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778890|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
14778891|NCT00674999|Ionophores|ionophores|mesh-ancestor
14778892|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14778893|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778894|NCT00675012|Capecitabine|capecitabine|mesh-list
14942972|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14942973|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207530|NCT03024437|Growth Substances|growth substances|mesh-ancestor
14207531|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207532|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
14207533|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14207534|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207535|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207536|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
14207537|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207538|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207539|NCT02989402|Rivastigmine|rivastigmine|mesh-list
14207540|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14207541|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207542|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207543|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
14207544|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207545|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207546|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14207547|NCT02989402|Protective Agents|protective agents|mesh-ancestor
14207548|NCT02908750|Fexofenadine|fexofenadine|mesh-list
14207549|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14207550|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14207551|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14207552|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
14207553|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
14207554|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207555|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207556|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207557|NCT02892123|Paclitaxel|paclitaxel|mesh-list
14207558|NCT02892123|Vinorelbine|vinorelbine|mesh-list
14207559|NCT02892123|Capecitabine|capecitabine|mesh-list
14207560|NCT02892123|Tucatinib|tucatinib|mesh-list
14207561|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14207562|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207563|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
14207564|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207565|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
14505318|NCT02866175|Vitamin K|vitamin k|mesh-list
14505319|NCT02866175|Edoxaban|edoxaban|mesh-list
14505320|NCT02866175|Clopidogrel|clopidogrel|mesh-list
14505321|NCT02866175|Ticagrelor|ticagrelor|mesh-list
14505322|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14505323|NCT02866175|Vitamins|vitamins|mesh-ancestor
14505324|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
14505325|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505326|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14505327|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14505328|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14505329|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14505330|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
14505331|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505332|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505333|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14778895|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
14778896|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778897|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
14778898|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778899|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778900|NCT00675181|Melatonin|melatonin|mesh-list
14778901|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
14778902|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778903|NCT00675181|Protective Agents|protective agents|mesh-ancestor
14778904|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778905|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14778906|NCT00675194|Capecitabine|capecitabine|mesh-list
14778907|NCT00675194|Irinotecan|irinotecan|mesh-list
14778908|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778909|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14778910|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
14778911|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778912|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14942974|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14942975|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778913|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14778914|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778915|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14778916|NCT00675207|Dorzolamide|dorzolamide|mesh-list
14778917|NCT00675207|Brinzolamide|brinzolamide|mesh-list
14778918|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14778919|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14778920|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14778921|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14778922|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
14778923|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14778924|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778925|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778926|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14778927|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778928|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
14778929|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778930|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778931|NCT00675246|Betamethasone|betamethasone|mesh-list
14778932|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
14778933|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14942976|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
14942977|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14942978|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
14942979|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942980|NCT01506024|Tacrine|tacrine|mesh-list
14942981|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14942982|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14942983|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942984|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
14942985|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942986|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942987|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14942988|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
14942989|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14942990|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
14942991|NCT01506037|Desloratadine|desloratadine|mesh-list
14942992|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14942993|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
14942994|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14942995|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14942996|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14942997|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14942998|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14942999|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
14943000|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
14943001|NCT01506050|Desloratadine|desloratadine|mesh-list
14943002|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14943003|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
14943004|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943005|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943006|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943007|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14943008|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14943009|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
14943010|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
14943011|NCT01506063|Levocetirizine|levocetirizine|mesh-list
14778934|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
14778935|NCT00675246|Hormones|hormones|mesh-ancestor
14778936|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778937|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778938|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14778939|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
14778940|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14778941|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
14207566|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207567|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14207568|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
14207569|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14207570|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207571|NCT02819596|Durvalumab|durvalumab|mesh-list
14207572|NCT02819596|Tremelimumab|tremelimumab|mesh-list
14207573|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207574|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207575|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
14207576|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207577|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207578|NCT02639702|Clozapine|clozapine|mesh-list
14207579|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14207580|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
14207581|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207582|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207583|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207584|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14207585|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14207586|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207587|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14778942|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14778943|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
14778944|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14778945|NCT00675285|Montelukast|montelukast|mesh-list
14778946|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14778947|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
14778948|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14778949|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
14778950|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778951|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778952|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14778953|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14778954|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778955|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
14778956|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14778957|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778958|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14207588|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
14778959|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778960|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778961|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
14778962|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
14778963|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14778964|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14778965|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778966|NCT00675545|Carboplatin|carboplatin|mesh-list
14778967|NCT00675545|Docetaxel|docetaxel|mesh-list
14778968|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778969|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
14778970|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
14778971|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
14778972|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778973|NCT00675649|Golimumab|golimumab|mesh-list
14778974|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14778975|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14778976|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14778977|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
14778978|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778979|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14778980|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
14778981|NCT00675688|Estrogens|estrogens|mesh-list
14778982|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14778983|NCT00675688|Hormones|hormones|mesh-ancestor
14207589|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
14778984|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14778985|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14778986|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14778987|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
14778988|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14778989|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14207590|NCT02596997|Brincidofovir|brincidofovir|mesh-list
14207591|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
14207592|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207593|NCT02595879|Cisplatin|cisplatin|mesh-list
14207594|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207595|NCT02555254|Methamphetamine|methamphetamine|mesh-list
14207596|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14207597|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207598|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
14207599|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
14207600|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207601|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
14207602|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207603|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207604|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
14207605|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14207606|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14207607|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14207608|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14207609|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
14207610|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
14207611|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
14207612|NCT02444728|Azathioprine|azathioprine|mesh-list
14207613|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207614|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
14207615|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207616|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14207617|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14207618|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
14207619|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207620|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207621|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14207622|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207623|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
14207624|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
14207625|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207626|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207627|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
14207628|NCT02444728|Hormones|hormones|mesh-ancestor
14207629|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207630|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14207631|NCT02444728|Protective Agents|protective agents|mesh-ancestor
14207632|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
14207633|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14207634|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14207635|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207636|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207637|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
14207638|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14207639|NCT02381353|Bupivacaine|bupivacaine|mesh-list
14207640|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
14207641|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
14207642|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207643|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207644|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
14207645|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207646|NCT02296918|Rituximab|rituximab|mesh-list
14207647|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
14207648|NCT02296918|Venetoclax|venetoclax|mesh-list
14207649|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
14207650|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207651|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207652|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
14207653|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207654|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14207655|NCT01828112|Docetaxel|docetaxel|mesh-list
14207656|NCT01828112|Pemetrexed|pemetrexed|mesh-list
14207657|NCT01828112|Ceritinib|ceritinib|mesh-list
14207658|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207659|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
14778990|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14778991|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
14778992|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14778993|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14778994|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14778995|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14943012|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14943013|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14943014|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
14943015|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
14943016|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943017|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943018|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943019|NCT01506076|Levocetirizine|levocetirizine|mesh-list
14943020|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14943021|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14943022|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
14943023|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
14943024|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943025|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943026|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943027|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14943028|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14943029|NCT01506115|Trioxsalen|trioxsalen|mesh-list
14943030|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943031|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
14943032|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14943033|NCT01506167|Leucovorin|leucovorin|mesh-list
14943034|NCT01506167|Folic Acid|folic acid|mesh-list
14943035|NCT01506167|Bevacizumab|bevacizumab|mesh-list
14943036|NCT01506167|Fluorouracil|fluorouracil|mesh-list
14943037|NCT01506167|Capecitabine|capecitabine|mesh-list
14943038|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
14943039|NCT01506167|Irinotecan|irinotecan|mesh-list
14943040|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
14943041|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943042|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943043|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14943044|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14943045|NCT01506167|Growth Substances|growth substances|mesh-ancestor
14943046|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943047|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943048|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
14943049|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943050|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14943051|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943052|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
14943053|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14943054|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14943055|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943056|NCT01506167|Antidotes|antidotes|mesh-ancestor
14943057|NCT01506167|Protective Agents|protective agents|mesh-ancestor
14943058|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
14943059|NCT01506167|Vitamins|vitamins|mesh-ancestor
14943060|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
14943061|NCT01506167|Hematinics|hematinics|mesh-ancestor
14943062|NCT01506336|Sunitinib|sunitinib|mesh-list
14943063|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943064|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14943065|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14943066|NCT01506336|Growth Substances|growth substances|mesh-ancestor
14943067|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943068|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943069|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14943070|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943071|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943072|NCT01506388|Misoprostol|misoprostol|mesh-list
14943073|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14943074|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
14943075|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14778996|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14778997|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14778998|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14778999|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
14779000|NCT00675714|Itraconazole|itraconazole|mesh-list
14943076|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779001|NCT00675714|Fluconazole|fluconazole|mesh-list
14779002|NCT00675714|Ketoconazole|ketoconazole|mesh-list
14779003|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
14779004|NCT00675714|Propranolol|propranolol|mesh-list
14779005|NCT00675714|Metoprolol|metoprolol|mesh-list
14779006|NCT00675714|Hormones|hormones|mesh-list
14779007|NCT00675714|Testosterone|testosterone|mesh-list
14779008|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
14779009|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
14779010|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14779011|NCT00675714|Oxandrolone|oxandrolone|mesh-list
14779012|NCT00675714|Nandrolone|nandrolone|mesh-list
14207660|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207661|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
14207662|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207663|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207664|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14207665|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14207666|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14207667|NCT01787409|Vitamin D|vitamin d|mesh-list
14207668|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
14207669|NCT01787409|Vitamins|vitamins|mesh-ancestor
14207670|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
14207671|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207672|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14207673|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14207674|NCT01750281|Docetaxel|docetaxel|mesh-list
14207675|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207676|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14207677|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207678|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14207679|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207680|NCT01426529|Norepinephrine|norepinephrine|mesh-list
14207681|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
14207682|NCT01426529|Giapreza|giapreza|mesh-list
14207683|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
14207684|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14207685|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14207686|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779013|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
14779014|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779015|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779016|NCT00675714|Androgens|androgens|mesh-ancestor
14779017|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14779018|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779019|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
14779020|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14779021|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14779022|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779023|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943077|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14943078|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943079|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
14943080|NCT01506414|Rituximab|rituximab|mesh-list
14943081|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943082|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943083|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
14943084|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943085|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14943086|NCT01506505|Aspirin|aspirin|mesh-list
14943087|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14943088|NCT01506505|Lisinopril|lisinopril|mesh-list
14943089|NCT01506505|Simvastatin|simvastatin|mesh-list
14943090|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14943091|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14943092|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
14943093|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943094|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14943095|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14943096|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943097|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14943098|NCT01506505|Diuretics|diuretics|mesh-ancestor
14207687|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779024|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779025|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14243255|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
14943099|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
14943100|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779026|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779027|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
14779028|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
14779029|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943101|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14943102|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14943103|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14207688|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207689|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207690|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
14207691|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
14207692|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207693|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14207694|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14207695|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
14207696|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207697|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
14943104|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14943105|NCT01506505|Analgesics|analgesics|mesh-ancestor
14943106|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
14943107|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943108|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943109|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14943110|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14943111|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14943112|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14943113|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14943114|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
14943115|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14943116|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
14943117|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14943118|NCT01506505|Protective Agents|protective agents|mesh-ancestor
14943119|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
14943120|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943121|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
14943122|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943123|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943124|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14943125|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
14943126|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14207698|NCT01252953|Anacetrapib|anacetrapib|mesh-list
14207699|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14207700|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14207701|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
14207702|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207703|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14207704|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207705|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14207706|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207707|NCT01012609|Irinotecan|irinotecan|mesh-list
14207708|NCT01012609|Cetuximab|cetuximab|mesh-list
14207709|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14207710|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14207711|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207712|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207713|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207714|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207715|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
14207716|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
14207717|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207718|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14207719|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14207720|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
14207721|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943127|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943128|NCT01506557|Vitamins|vitamins|mesh-ancestor
14943129|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
14207722|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207723|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14779030|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14779031|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779032|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779033|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14779034|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
14779035|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14779036|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
14779037|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
14779038|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779039|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14779040|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14779041|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14779042|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14779043|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
14779044|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14779045|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779046|NCT00675779|Atorvastatin|atorvastatin|mesh-list
14779047|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
14779048|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
14779049|NCT00675779|Dacuronium|dacuronium|mesh-list
14779050|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14943130|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14943131|NCT01506570|Vaccines|vaccines|mesh-list
14943132|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
14943133|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943134|NCT01506622|Fentanyl|fentanyl|mesh-list
14943135|NCT01506622|Propofol|propofol|mesh-list
14943136|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14943137|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14943138|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943139|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14943140|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
14943141|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
14943142|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14943143|NCT01506622|Narcotics|narcotics|mesh-ancestor
14943144|NCT01506622|Analgesics|analgesics|mesh-ancestor
14943145|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
14943146|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943147|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14943148|NCT01506635|Timolol|timolol|mesh-list
14943149|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14943150|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14943151|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
14943152|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943153|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943154|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943155|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14943156|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14943157|NCT01506713|Clopidogrel|clopidogrel|mesh-list
14943158|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14943159|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14943160|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14779051|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779052|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
14779053|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943161|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14943162|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
14943163|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943164|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207724|NCT00494234|Olaparib|olaparib|mesh-list
14207725|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14207726|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943165|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943166|NCT01506739|Donepezil|donepezil|mesh-list
14943167|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14943168|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943169|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943170|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
14943171|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964476|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13964477|NCT03136705|Niacinamide|niacinamide|mesh-list
13964478|NCT03136705|Niacin|niacin|mesh-list
13964479|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
13964480|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
13964481|NCT03136705|Vitamins|vitamins|mesh-ancestor
13964482|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
13964483|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964484|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14243256|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964485|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
14779054|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779055|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14943172|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943173|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
14943174|NCT01506752|Donepezil|donepezil|mesh-list
14943175|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14943176|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943177|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943178|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
14943179|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943180|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943181|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
14943182|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
14943183|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14943184|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
14943185|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943186|NCT01506765|Expectorants|expectorants|mesh-ancestor
14943187|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
14943188|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14943189|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
14943190|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943191|NCT01506765|Protective Agents|protective agents|mesh-ancestor
14943192|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943193|NCT01506765|Antidotes|antidotes|mesh-ancestor
14943194|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
14943195|NCT01506791|Ephedrine|ephedrine|mesh-list
14943196|NCT01506791|Desloratadine|desloratadine|mesh-list
14943197|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14943198|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
14207727|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943199|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943200|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943201|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943202|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14943203|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14943204|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
14943205|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
14943206|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14943207|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
14943208|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943209|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14943210|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
14943211|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
14943212|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14943213|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14943214|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
14943215|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
14207728|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207729|NCT00458835|Ciclesonide|ciclesonide|mesh-list
14207730|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
14207731|NCT00458835|Hormones|hormones|mesh-ancestor
14207732|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207733|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207734|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14207735|NCT00403559|Ketoconazole|ketoconazole|mesh-list
14207736|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
14207737|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
14207738|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207739|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14207740|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14207741|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207742|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207743|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14779056|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779057|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14779058|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779059|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14779060|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14779061|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14779062|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14779063|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779064|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14943216|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
14943217|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14207744|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
14207745|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207746|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207747|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14207748|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14207749|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14779065|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
14779066|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14779067|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14779068|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14779069|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779070|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779071|NCT00675961|Naltrexone|naltrexone|mesh-list
14779072|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14779073|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14779074|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779075|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
14779076|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779077|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14943218|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14943219|NCT01506804|Prednisolone|prednisolone|mesh-list
14207750|NCT00403559|Analgesics|analgesics|mesh-ancestor
14207751|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
14207752|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207753|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207754|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14943220|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
14943221|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14943222|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
14943223|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943224|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
14943225|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
14943226|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943227|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943228|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943229|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
14943230|NCT01506804|Hormones|hormones|mesh-ancestor
14943231|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943232|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14943233|NCT01506804|Protective Agents|protective agents|mesh-ancestor
14943234|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14943235|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943236|NCT01506856|Paclitaxel|paclitaxel|mesh-list
14943237|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13964486|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207755|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
14207756|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207757|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
14207758|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14207759|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14779078|NCT00676039|Citalopram|citalopram|mesh-list
14943238|NCT01506856|Carboplatin|carboplatin|mesh-list
14943239|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14943240|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943241|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
14943242|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
14943243|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
14943244|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943245|NCT01506895|Darapladib|darapladib|mesh-list
14943246|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14943247|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943248|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943249|NCT01506921|Ketamine|ketamine|mesh-list
13964487|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13964488|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
13964489|NCT03136796|Meropenem|meropenem|mesh-list
13964490|NCT03136796|Piperacillin|piperacillin|mesh-list
13964491|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13964492|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964493|NCT03136510|Apixaban|apixaban|mesh-list
13964494|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13964495|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
13964496|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13964497|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
13964498|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779079|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14779080|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14779081|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14779082|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779083|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779084|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779085|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14779086|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
14779087|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14779088|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14779089|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
14943250|NCT01506921|Esketamine|esketamine|mesh-list
14943251|NCT01506921|Analgesics|analgesics|mesh-ancestor
14943252|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
14943253|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943254|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943255|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14943256|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14943257|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
14943258|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
14943259|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14943260|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14943261|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14943262|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943263|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943264|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
14943265|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14943266|NCT01506986|Metronidazole|metronidazole|mesh-list
14943267|NCT01506986|Clarithromycin|clarithromycin|mesh-list
14943268|NCT01506986|Lansoprazole|lansoprazole|mesh-list
14207760|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
14207761|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207762|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14207763|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
14207764|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207765|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207766|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14207767|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14207768|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14207769|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
14207770|NCT00006436|Rituximab|rituximab|mesh-list
14207771|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207772|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207773|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
14207774|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207775|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505334|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14505335|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
14505336|NCT02866175|Coagulants|coagulants|mesh-ancestor
14505337|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14505338|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
14505339|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14505340|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
14505341|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505342|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
14505343|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
14505344|NCT02866643|Etonogestrel|etonogestrel|mesh-list
14505345|NCT02866643|Desogestrel|desogestrel|mesh-list
14505346|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14505347|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505348|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14505349|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14505350|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14505351|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14505352|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14505353|NCT02866643|Progestins|progestins|mesh-ancestor
14505354|NCT02866643|Hormones|hormones|mesh-ancestor
14505355|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505356|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
14505357|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14505358|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14505359|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505360|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
14779090|NCT00676117|Loxoprofen|loxoprofen|mesh-list
14779091|NCT00676117|Esomeprazole|esomeprazole|mesh-list
14779092|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14779093|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779094|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14779095|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779096|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779097|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14779098|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14779099|NCT00676117|Analgesics|analgesics|mesh-ancestor
14779100|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
14779101|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779102|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779103|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14779104|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14779105|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
14779106|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
14779107|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779108|NCT00676156|Protective Agents|protective agents|mesh-ancestor
14779109|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779110|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
14779111|NCT00676156|Vitamins|vitamins|mesh-ancestor
14779112|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
14779113|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
14779114|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14779115|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779116|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14779117|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
14779118|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14779119|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779120|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779121|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779122|NCT00676260|Pioglitazone|pioglitazone|mesh-list
14779123|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14779124|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779125|NCT00676286|Choline|choline|mesh-list
14779126|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
14779127|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779128|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
14779129|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779130|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779131|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779132|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
14779133|NCT00676377|Neostigmine|neostigmine|mesh-list
14779134|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14943269|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
14943270|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943271|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14943272|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14943273|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14943274|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14207776|NCT05283304|Buprenorphine|buprenorphine|mesh-list
14207777|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14207778|NCT05283304|Narcotics|narcotics|mesh-ancestor
14207779|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207780|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207781|NCT05283304|Analgesics|analgesics|mesh-ancestor
14207782|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
14207783|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207784|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14207785|NCT05283278|Lactoferrin|lactoferrin|mesh-list
14207786|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207787|NCT05283226|Paclitaxel|paclitaxel|mesh-list
14207788|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14943275|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943276|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943277|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14207789|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943278|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14943279|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14943280|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207790|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
14207791|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
14779135|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779136|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779137|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14779138|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779139|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779140|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14779141|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
14779142|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779143|NCT00676416|Propofol|propofol|mesh-list
14779144|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14779145|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779146|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779147|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14779148|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
14779149|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
14779150|NCT00676429|Ziprasidone|ziprasidone|mesh-list
14779151|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14779152|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
14779153|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779154|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779155|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779156|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14779157|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13964499|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964500|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
13964501|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13964502|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13964503|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13964504|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964505|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964506|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
13964507|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964508|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207792|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
14779158|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207793|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207794|NCT05283109|Vaccines|vaccines|mesh-list
14207795|NCT05283109|Poly ICLC|poly iclc|mesh-list
14207796|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
14207797|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207798|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
14207799|NCT05283057|Empagliflozin|empagliflozin|mesh-list
14207800|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14243257|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14779159|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14779160|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14505361|NCT02867163|Coagulants|coagulants|mesh-ancestor
14505362|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
14505363|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14505364|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505365|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
14505366|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14505367|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
14505368|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505369|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
14505370|NCT02867605|Protective Agents|protective agents|mesh-ancestor
14505371|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14505372|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14505373|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
14505374|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14505375|NCT02868242|Ledipasvir|ledipasvir|mesh-list
14505376|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
14505377|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505378|NCT02869438|Benralizumab|benralizumab|mesh-list
14505379|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14505380|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
14505381|NCT02869451|Bupropion|bupropion|mesh-list
14505382|NCT02869451|Nicotine|nicotine|mesh-list
14505383|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14505384|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
14779161|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
14779162|NCT00676468|Montelukast|montelukast|mesh-list
14243258|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14243259|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14243260|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243261|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
14243262|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
14243263|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14207801|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207802|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14207803|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241041|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14241042|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241043|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
14241044|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14241045|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14241046|NCT00171054|Diuretics|diuretics|mesh-ancestor
14241047|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
14241048|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14241049|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
14241050|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241051|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14241052|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241053|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243264|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243265|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14243266|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14243267|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
14243268|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14243269|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14243270|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14243271|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14243272|NCT00194025|Valproic Acid|valproic acid|mesh-list
14243273|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
14243274|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243275|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243276|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
14243277|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243278|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243279|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
14243280|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14243281|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14243282|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14243283|NCT00194077|Aripiprazole|aripiprazole|mesh-list
14243284|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
14243285|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14243286|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14243287|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14243288|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14243289|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243290|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
14243291|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
14243292|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243293|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243294|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14243295|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14243296|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
14243297|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14243298|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14243299|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14243300|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14243301|NCT00194116|Valproic Acid|valproic acid|mesh-list
14243302|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
14243303|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243304|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243305|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
14243306|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243307|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243308|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
14243309|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14243310|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14243311|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14243312|NCT00194129|Valproic Acid|valproic acid|mesh-list
14243313|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
14243314|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
14243315|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14243316|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779163|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14243317|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243318|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
14779164|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
14779165|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14779166|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
14779167|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779168|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779169|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14779170|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14779171|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779172|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
14779173|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14779174|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779175|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14779176|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14779177|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779178|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779179|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779180|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14779181|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779182|NCT00676559|Ranibizumab|ranibizumab|mesh-list
14779183|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14779184|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14779185|NCT00676559|Growth Substances|growth substances|mesh-ancestor
14779186|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779187|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
14779188|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779189|NCT00676637|Timolol|timolol|mesh-list
14779190|NCT00676637|Travoprost|travoprost|mesh-list
14779191|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14779192|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14779193|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14779194|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14207804|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
14207805|NCT05282771|Clobetasol|clobetasol|mesh-list
14207806|NCT05282771|Halobetasol|halobetasol|mesh-list
14207807|NCT05282771|Tazarotene|tazarotene|mesh-list
14207808|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
14207809|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
14207810|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
14207811|NCT05282771|Vitamins|vitamins|mesh-ancestor
14207812|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
14207813|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207814|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14207815|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207816|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
14207817|NCT05282771|Hormones|hormones|mesh-ancestor
14207818|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207819|NCT05282719|Azacitidine|azacitidine|mesh-list
14207820|NCT05282719|Venetoclax|venetoclax|mesh-list
14207821|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14207822|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
14207823|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207824|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207825|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207826|NCT05282706|Peppermint oil|peppermint oil|mesh-list
14207827|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
14207828|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
14207829|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207830|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207831|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207832|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
14207833|NCT05282420|Ranibizumab|ranibizumab|mesh-list
14505385|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505386|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505387|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14505388|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14505389|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505390|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505391|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505392|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14505393|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
14505394|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14505395|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14207834|NCT05282420|Aflibercept|aflibercept|mesh-list
14207835|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14207836|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14779195|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779196|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779197|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779198|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207837|NCT05282420|Growth Substances|growth substances|mesh-ancestor
14207838|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207839|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
14207840|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207841|NCT05282407|Tenofovir|tenofovir|mesh-list
14207842|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
14207843|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14207844|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14207845|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14207846|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207847|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207848|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14207849|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14207850|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
14207851|NCT05282251|Bupivacaine|bupivacaine|mesh-list
14207852|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
14207853|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
14207854|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779199|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14779200|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779201|NCT00676702|Vitamin K|vitamin k|mesh-list
14779202|NCT00676702|Pancrelipase|pancrelipase|mesh-list
14779203|NCT00676702|Pancreatin|pancreatin|mesh-list
14779204|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779205|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14779206|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14207855|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207856|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
14207857|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207858|NCT05281965|Tretinoin|tretinoin|mesh-list
14207859|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207860|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
14207861|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
14207862|NCT05281926|Nivolumab|nivolumab|mesh-list
14207863|NCT05281926|Poly ICLC|poly iclc|mesh-list
14207864|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207865|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207866|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14207867|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207868|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
14207869|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
14207870|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207871|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
14207872|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
14207873|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14207874|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207875|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207876|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
14207877|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14207878|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207879|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207880|NCT05281770|Erenumab|erenumab|mesh-list
14207881|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14207882|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207883|NCT05281770|Analgesics|analgesics|mesh-ancestor
14207884|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
14207885|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207886|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207887|NCT05281614|Etanercept|etanercept|mesh-list
14207888|NCT05281614|Vedolizumab|vedolizumab|mesh-list
14207889|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14207890|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14207891|NCT05281614|Analgesics|analgesics|mesh-ancestor
14207892|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
14207893|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207894|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505396|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14505397|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14505398|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
14505399|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14779207|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779208|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
14779209|NCT00676702|Coagulants|coagulants|mesh-ancestor
14779210|NCT00676702|Vitamins|vitamins|mesh-ancestor
14779211|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
14779212|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207895|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207896|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14207897|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207898|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207899|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
14207900|NCT05281419|Triamcinolone|triamcinolone|mesh-list
14779213|NCT00676741|Insulin|insulin|mesh-list
14779214|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14779215|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
14779216|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
14779217|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14207901|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14207902|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14207903|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14207904|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207905|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
14207906|NCT05281419|Hormones|hormones|mesh-ancestor
14207907|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207908|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207909|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14207910|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
14207911|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207912|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207913|NCT05281406|Carboplatin|carboplatin|mesh-list
14207914|NCT05281406|Pemetrexed|pemetrexed|mesh-list
14207915|NCT05281406|Osimertinib|osimertinib|mesh-list
14207916|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207917|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207918|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207919|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14207920|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14207921|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14207922|NCT05281328|Octreotide|octreotide|mesh-list
14207923|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207924|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14207925|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207926|NCT05281276|Celecoxib|celecoxib|mesh-list
14207927|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14207928|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14207929|NCT05281276|Analgesics|analgesics|mesh-ancestor
14207930|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
14207931|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207932|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207933|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207934|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14207935|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14207936|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14207937|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14207938|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207939|NCT05281185|Factor VIII|factor viii|mesh-list
14207940|NCT05281185|Coagulants|coagulants|mesh-ancestor
14241054|NCT00171210|Deferasirox|deferasirox|mesh-list
14241055|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14241056|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
14241057|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
14241058|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241059|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
14241060|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241061|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14241062|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241063|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241064|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
14241065|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241066|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14241067|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241068|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943281|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14241069|NCT00171301|Deferasirox|deferasirox|mesh-list
14241070|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14779218|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
14779219|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
14779220|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14779221|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14779222|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779223|NCT00676819|Insulin|insulin|mesh-list
14779224|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14779225|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
14779226|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14779227|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779228|NCT00676845|Olmesartan|olmesartan|mesh-list
14779229|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14779230|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779231|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14779232|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14779233|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779234|NCT00676871|Blinatumomab|blinatumomab|mesh-list
14779235|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807662|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807663|NCT00822744|Citalopram|citalopram|mesh-list
14807664|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14207941|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
14207942|NCT05281107|Vitamin D|vitamin d|mesh-list
14207943|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
14207944|NCT05281107|Vitamins|vitamins|mesh-list
14207945|NCT05281107|Calcium|calcium|mesh-list
14207946|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
14207947|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207948|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14207949|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14207950|NCT05281081|Morphine|morphine|mesh-list
14207951|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
14207952|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14207953|NCT05281081|Narcotics|narcotics|mesh-ancestor
14207954|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14207955|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207956|NCT05281081|Analgesics|analgesics|mesh-ancestor
14207957|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
14207958|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207959|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
14207960|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
14207961|NCT05281068|Danazol|danazol|mesh-list
14207962|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14207963|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
14207964|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207965|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207966|NCT05281003|Paclitaxel|paclitaxel|mesh-list
14207967|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
14207968|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14207969|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207970|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
14207971|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
14207972|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
14207973|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14207974|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14207975|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
14207976|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14207977|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14207978|NCT05280873|Prednisolone|prednisolone|mesh-list
14207979|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
14207980|NCT05280873|Pirfenidone|pirfenidone|mesh-list
14207981|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14207982|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
14207983|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14207984|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
14207985|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
14207986|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14207987|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14207988|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14207989|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
14207990|NCT05280873|Hormones|hormones|mesh-ancestor
14207991|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14207992|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14807665|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14207993|NCT05280873|Protective Agents|protective agents|mesh-ancestor
14207994|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14779236|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
14779237|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14779238|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14779239|NCT00676936|Prednisolone|prednisolone|mesh-list
14779240|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
14779241|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14779242|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
14779243|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14779244|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
14779245|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
14779246|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779247|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779248|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779249|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
14779250|NCT00676936|Hormones|hormones|mesh-ancestor
14779251|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779252|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14779253|NCT00676936|Protective Agents|protective agents|mesh-ancestor
14779254|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14779255|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779256|NCT00677001|R 306465|r 306465|mesh-list
14779257|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14207995|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14207996|NCT05280873|Analgesics|analgesics|mesh-ancestor
14207997|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
14207998|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14207999|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14208000|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208001|NCT05280769|Lobeline|lobeline|mesh-list
14208002|NCT05280769|Nicotine|nicotine|mesh-list
14208003|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14208004|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
14208005|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208006|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208007|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14208008|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14208009|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
14208010|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208011|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208012|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
14208013|NCT05280704|Lidocaine|lidocaine|mesh-list
14208014|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
14208015|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
14208016|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208017|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208018|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
14208019|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208020|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14208021|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14208022|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14208023|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208024|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208025|NCT05280626|Prednisolone|prednisolone|mesh-list
14208026|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14208027|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
14208028|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14208029|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
14208030|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
14208031|NCT05280626|Rituximab|rituximab|mesh-list
14208032|NCT05280626|Doxorubicin|doxorubicin|mesh-list
14208033|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14208034|NCT05280626|Vincristine|vincristine|mesh-list
14208035|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14208036|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
14208037|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14208038|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
14208039|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208040|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208041|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14208042|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
14208043|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208044|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779258|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779259|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779260|NCT00677027|Lentinan|lentinan|mesh-list
14779261|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14779262|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
14779263|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779264|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779265|NCT00677118|Cisplatin|cisplatin|mesh-list
14779266|NCT00677118|Fluorouracil|fluorouracil|mesh-list
14779267|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779268|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
14943282|NCT01507064|Sorafenib|sorafenib|mesh-list
13964509|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13964510|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208045|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14208046|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14208047|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13964511|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
13964512|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14208048|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14208049|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14208050|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208051|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208052|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
14208053|NCT05280626|Hormones|hormones|mesh-ancestor
14208054|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208055|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208056|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
14208057|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
14208058|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208059|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208060|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14208061|NCT05280626|Protective Agents|protective agents|mesh-ancestor
14208062|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14208063|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14208064|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14208065|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14208066|NCT05280496|Metformin|metformin|mesh-list
14208067|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14208068|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208074|NCT05280444|Idarubicin|idarubicin|mesh-list
14208075|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14505400|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14505401|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505402|NCT02869893|Secretin|secretin|mesh-list
14505403|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505404|NCT02869893|Hormones|hormones|mesh-ancestor
14505405|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505406|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505407|NCT02870283|Carbamazepine|carbamazepine|mesh-list
14505408|NCT02870283|Valproic Acid|valproic acid|mesh-list
14505409|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14505410|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505411|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505412|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
14505413|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14807666|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14943283|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943284|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14943285|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964513|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13964514|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964515|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
13964516|NCT03136445|Coagulants|coagulants|mesh-ancestor
13964517|NCT03136237|Cyclosporine|cyclosporine|mesh-list
13964518|NCT03136237|Digoxin|digoxin|mesh-list
13964519|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13964520|NCT03136237|Cyclosporins|cyclosporins|mesh-list
13964521|NCT03136237|Berotralstat|berotralstat|mesh-list
13964522|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964523|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943286|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943287|NCT01507077|CKD732|ckd732|mesh-list
14943288|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13964524|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13964525|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
13964526|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964527|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
13964528|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208076|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208077|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14208078|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14208079|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208080|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208081|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14208082|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208083|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
14208084|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14208085|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208086|NCT05280275|Dexamethasone|dexamethasone|mesh-list
14208087|NCT05280275|Lenalidomide|lenalidomide|mesh-list
14208088|NCT05280275|Daratumumab|daratumumab|mesh-list
14208089|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208090|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
14208091|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
14208092|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208093|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208094|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208095|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
14208096|NCT05280275|Hormones|hormones|mesh-ancestor
14208097|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208098|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208099|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208100|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
14208101|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14208102|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14208103|NCT05280275|Growth Substances|growth substances|mesh-ancestor
14208104|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
14208105|NCT05280236|Propofol|propofol|mesh-list
14208106|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208107|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208108|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208109|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14208110|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
14208111|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
14208112|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
14208113|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208114|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14943289|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14208115|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208116|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14208117|NCT05280223|Analgesics|analgesics|mesh-ancestor
14208118|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
14208119|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208120|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14208121|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14208122|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14208123|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
14208124|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208125|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208126|NCT05280197|Bupivacaine|bupivacaine|mesh-list
14208127|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
14208128|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
14208129|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208130|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208131|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
14208132|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208133|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14505414|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505415|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505416|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
14505417|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
14505418|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505419|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14505420|NCT02870283|Analgesics|analgesics|mesh-ancestor
14505421|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
14505422|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505423|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14505424|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14505425|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14505426|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14208134|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14505427|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14779269|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779270|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14779271|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779272|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
14208135|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208136|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
14208137|NCT05280054|Probenecid|probenecid|mesh-list
14208138|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
14208139|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
14208140|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208141|NCT05280054|Renal Agents|renal agents|mesh-ancestor
14208142|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14208143|NCT05280028|Tibolone|tibolone|mesh-list
14208144|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14208145|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14208146|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
14208147|NCT05280028|Estradiol|estradiol|mesh-list
14208148|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14208149|NCT05280028|Estrogens|estrogens|mesh-ancestor
14208150|NCT05280028|Hormones|hormones|mesh-ancestor
14208151|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208152|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208153|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14208154|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
14779273|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779274|NCT00677144|Capecitabine|capecitabine|mesh-list
14779275|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
14779276|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14208155|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14208156|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14208157|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14208158|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14208159|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14208160|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14208161|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208162|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208163|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
14208164|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
14208165|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14208166|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14208167|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
14779277|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
14779278|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779279|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779280|NCT00677170|Pevonedistat|pevonedistat|mesh-list
14779281|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779282|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779283|NCT00677248|Ezetimibe|ezetimibe|mesh-list
14779284|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14779285|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779286|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
14779287|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779288|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779289|NCT00677261|Anesthetics|anesthetics|mesh-list
14208181|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
14208182|NCT05279898|Ketamine|ketamine|mesh-list
14208183|NCT05279898|Remifentanil|remifentanil|mesh-list
14208184|NCT05279898|Propofol|propofol|mesh-list
14208185|NCT05279898|Ropivacaine|ropivacaine|mesh-list
14208186|NCT05279898|Rocuronium|rocuronium|mesh-list
14505428|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14505429|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14505430|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
14505431|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779290|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
14505432|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505433|NCT02870972|Berotralstat|berotralstat|mesh-list
14505434|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505435|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505436|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
14505437|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14505438|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
14779291|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779292|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208187|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208188|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779293|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
14779294|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779295|NCT00677300|Ritonavir|ritonavir|mesh-list
14779296|NCT00677300|Darunavir|darunavir|mesh-list
14779297|NCT00677300|Tenofovir|tenofovir|mesh-list
14779298|NCT00677300|Emtricitabine|emtricitabine|mesh-list
14779299|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
14779300|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14779301|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14779302|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
14779303|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779304|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779305|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14779306|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14779307|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
14779308|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779309|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14779310|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779311|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14779312|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14779313|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14208189|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208190|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14208191|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
14208192|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
14208193|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14208194|NCT05279898|Analgesics|analgesics|mesh-ancestor
14208195|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
14208196|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208197|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14208198|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14208199|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14208200|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
14208201|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208202|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208203|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14208204|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14208205|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14208206|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
14208207|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14208208|NCT05279898|Narcotics|narcotics|mesh-ancestor
14208209|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14208210|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14208211|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14208212|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
14208213|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208214|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14208215|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208216|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208217|NCT05279807|Amlodipine|amlodipine|mesh-list
14208218|NCT05279807|Zofenopril|zofenopril|mesh-list
14208219|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14208220|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14208221|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208222|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208223|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14208224|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208225|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
14208226|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14208227|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
14208228|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208229|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14208230|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14208231|NCT05279703|Epinephrine|epinephrine|mesh-list
14208232|NCT05279703|Racepinephrine|racepinephrine|mesh-list
14208233|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
14208234|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14208235|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14208236|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
14208237|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208238|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208239|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208240|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14779314|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14208241|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14208242|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
14208243|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208244|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14208245|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
14208246|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
14208247|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
14208248|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14208249|NCT05279690|Colchicine|colchicine|mesh-list
14208250|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
14208251|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208252|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14208253|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14208254|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14208255|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208256|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208257|NCT05279586|Colistin|colistin|mesh-list
14208258|NCT05279586|Lactulose|lactulose|mesh-list
14208259|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208260|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14208261|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241071|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
14241072|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
14241073|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241074|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
14241075|NCT00171314|Letrozole|letrozole|mesh-list
14241076|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241077|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14241078|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14241079|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241080|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241081|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14241082|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
14241083|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241084|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241085|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14241086|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
14241087|NCT00171340|Letrozole|letrozole|mesh-list
14241088|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241089|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14241090|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14241091|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241092|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241093|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14241094|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
14241095|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241096|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241097|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14241098|NCT00171704|Tamoxifen|tamoxifen|mesh-list
14241099|NCT00171704|Letrozole|letrozole|mesh-list
14241100|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241101|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14241102|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14241103|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241104|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241105|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14241106|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
14241107|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241108|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241109|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14241110|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14241111|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14241112|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14241113|NCT00171730|Pasireotide|pasireotide|mesh-list
14241114|NCT00171730|Hormones|hormones|mesh-ancestor
14241115|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241116|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241117|NCT00171834|Epothilones|epothilones|mesh-list
14241118|NCT00171834|Epothilone B|epothilone b|mesh-list
14505439|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505440|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505441|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14505442|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
14779315|NCT00677339|Vitamin D|vitamin d|mesh-list
14779316|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
14779317|NCT00677339|Vitamins|vitamins|mesh-list
14779318|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
14779319|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779320|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14779321|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14779322|NCT00677391|Sibutramine|sibutramine|mesh-list
14779323|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
14779324|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14779325|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
14779326|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14779327|NCT00677443|Capecitabine|capecitabine|mesh-list
14208262|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
14208263|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14208264|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14208265|NCT05279482|Prednisolone|prednisolone|mesh-list
14208266|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
14208267|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14208268|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
14208269|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208270|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
14208271|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
14208272|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208273|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208274|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208275|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
14208276|NCT05279482|Hormones|hormones|mesh-ancestor
14208277|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208278|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14208279|NCT05279482|Protective Agents|protective agents|mesh-ancestor
14208280|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208281|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208282|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
14208283|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14208284|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14208285|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208286|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
14208287|NCT05279469|Coagulants|coagulants|mesh-ancestor
14208288|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
14208289|NCT05279456|Paraproteins|paraproteins|mesh-list
14208290|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
14208291|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208292|NCT05279417|Methotrexate|methotrexate|mesh-list
14208293|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14208294|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
14208295|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14208296|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208297|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14208298|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
14208299|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208300|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208301|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
14208302|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208303|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14208304|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14208305|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
14208306|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208307|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14208308|NCT05279391|Dexamethasone|dexamethasone|mesh-list
14208309|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14208310|NCT05279391|Heparin|heparin|mesh-list
14208311|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14208312|NCT05279391|Tinzaparin|tinzaparin|mesh-list
14208313|NCT05279391|Dalteparin|dalteparin|mesh-list
14208314|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208315|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
14208316|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
14208317|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208318|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208319|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779328|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
14208320|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
14208321|NCT05279391|Hormones|hormones|mesh-ancestor
14208322|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779329|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14779330|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
13964529|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
13964530|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13964531|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13964532|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13964533|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13964534|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
13964535|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14208323|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208324|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208325|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
14208326|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14208327|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14208328|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208329|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208330|NCT05279235|Favipiravir|favipiravir|mesh-list
14208331|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
14208332|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208333|NCT05279183|Erythritol|erythritol|mesh-list
14208334|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
14208335|NCT05279092|Dexamethasone|dexamethasone|mesh-list
14208336|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
14208337|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14208338|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14208339|NCT05279092|Prednisolone|prednisolone|mesh-list
14208340|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
14208341|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
14208342|NCT05279092|Bupivacaine|bupivacaine|mesh-list
14208343|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14208344|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
14208345|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14208346|NCT05279092|BB 1101|bb 1101|mesh-list
14208347|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208348|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
14208349|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
14208350|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208351|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208352|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208353|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
14208354|NCT05279092|Hormones|hormones|mesh-ancestor
14208355|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208356|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208357|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208358|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
14208359|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
14208360|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208361|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
14208362|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14208363|NCT05279092|Protective Agents|protective agents|mesh-ancestor
14208364|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
14208365|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208366|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208367|NCT05279040|Ivacaftor|ivacaftor|mesh-list
14208368|NCT05279040|Elexacaftor|elexacaftor|mesh-list
14208369|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14208370|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208371|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208372|NCT05278975|Thiostrepton|thiostrepton|mesh-list
14208373|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14208374|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208375|NCT05267886|Dobutamine|dobutamine|mesh-list
14208376|NCT05267886|Milrinone|milrinone|mesh-list
14208377|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14208378|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
14208379|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
14241119|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
14779331|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779332|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779333|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
14779334|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14779335|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13964536|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13964537|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14779336|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
14208380|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779337|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779338|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779339|NCT00677521|Acarbose|acarbose|mesh-list
14779340|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14779341|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779342|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779343|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14779344|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779345|NCT00677586|Liver Extracts|liver extracts|mesh-list
14779346|NCT00677586|Hematinics|hematinics|mesh-ancestor
14208381|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208382|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14208383|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14208384|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14208385|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14505443|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14505444|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
14505445|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505446|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505447|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14505448|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
14505449|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
14505450|NCT02871011|Protective Agents|protective agents|mesh-ancestor
14505451|NCT02871492|Acyclovir|acyclovir|mesh-list
14505452|NCT02871492|Pritelivir|pritelivir|mesh-list
14505453|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
14505454|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505455|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505456|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505457|NCT02871635|Adalimumab|adalimumab|mesh-list
14505458|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505459|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528564|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528565|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14528566|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528567|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528568|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14528569|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14528570|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
14528571|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
14528572|NCT03840811|Cefixime|cefixime|mesh-list
14528573|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14528574|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528575|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14528576|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14528577|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528578|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528579|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528580|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14528581|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14528582|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
14528583|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14528584|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14528585|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528586|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
14528587|NCT03825939|Coagulants|coagulants|mesh-ancestor
14528588|NCT03841331|Serlopitant|serlopitant|mesh-list
14528589|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14528590|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528591|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528592|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528593|NCT03840278|Pancrelipase|pancrelipase|mesh-list
14528594|NCT03840278|Pancreatin|pancreatin|mesh-list
14528595|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528596|NCT03839355|Warfarin|warfarin|mesh-list
14528597|NCT03839355|Apixaban|apixaban|mesh-list
14528598|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
14528599|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14779347|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
14779348|NCT00677664|Mannitol|mannitol|mesh-list
14208386|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208387|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208388|NCT05267886|Protective Agents|protective agents|mesh-ancestor
14779349|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
14779350|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14779351|NCT00677664|Diuretics|diuretics|mesh-ancestor
14779352|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
14208389|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14208390|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
14208391|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14208392|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14208393|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208394|NCT05266586|Ezetimibe|ezetimibe|mesh-list
14208395|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14208396|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14208397|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
14208398|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208399|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14208400|NCT05266469|Ofatumumab|ofatumumab|mesh-list
14208401|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
14208402|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208403|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
14208404|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208405|NCT05262257|Metformin|metformin|mesh-list
14208406|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
14208407|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14208408|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208409|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14208410|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208411|NCT05260671|Cetuximab|cetuximab|mesh-list
14208412|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14208413|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208414|NCT05260359|Ethanol|ethanol|mesh-list
14208415|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
14208416|NCT05260359|Petrolatum|petrolatum|mesh-list
14208417|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14208418|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208419|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208420|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208421|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14208422|NCT05260359|Protective Agents|protective agents|mesh-ancestor
14208423|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14208424|NCT05260359|Emollients|emollients|mesh-ancestor
14208425|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
14208426|NCT05254912|Petrolatum|petrolatum|mesh-list
14208427|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14208428|NCT05254912|Protective Agents|protective agents|mesh-ancestor
14208429|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208430|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14208431|NCT05254912|Emollients|emollients|mesh-ancestor
14208432|NCT05254808|Fosfomycin|fosfomycin|mesh-list
14208433|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
14208434|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14208435|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208436|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14208437|NCT05254808|Renal Agents|renal agents|mesh-ancestor
14208438|NCT05250596|Colchicine|colchicine|mesh-list
14208439|NCT05250596|Atorvastatin|atorvastatin|mesh-list
14208440|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14208441|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14208442|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
14208443|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208444|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14208445|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14208446|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208447|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
14208448|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208449|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
14208450|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
14208451|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
14208452|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208453|NCT05249634|Testosterone|testosterone|mesh-list
14208454|NCT05249634|Androgens|androgens|mesh-ancestor
14208455|NCT05249634|Hormones|hormones|mesh-ancestor
14208456|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208457|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208458|NCT05247970|Midazolam|midazolam|mesh-list
14208459|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14208460|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208461|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208462|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779353|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779354|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14779355|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
14779356|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779357|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14779358|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14779359|NCT00677729|Albuterol|albuterol|mesh-list
14779360|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14779361|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
14779362|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779363|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779364|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14779365|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
14779366|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
14779367|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14779368|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14779369|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14779370|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14779371|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779372|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779373|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779374|NCT00677755|Misoprostol|misoprostol|mesh-list
14779375|NCT00677755|Mifepristone|mifepristone|mesh-list
14779376|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14779377|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
14779378|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14779379|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779380|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14779381|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779382|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
14779383|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14779384|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14779385|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14779386|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14779387|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
14779388|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14779389|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14779390|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
14779391|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779392|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
14779393|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14779394|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14779395|NCT00678106|Dalbavancin|dalbavancin|mesh-list
14779396|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14779397|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779398|NCT00678132|Gemcitabine|gemcitabine|mesh-list
14779399|NCT00678132|Olaparib|olaparib|mesh-list
14779400|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779401|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14779402|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
14779403|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779404|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
14779405|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779406|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779407|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779408|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
14779409|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779410|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14779411|NCT00678145|Epinephrine|epinephrine|mesh-list
14779412|NCT00678145|Morphine|morphine|mesh-list
14779413|NCT00678145|Naloxone|naloxone|mesh-list
14779414|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779415|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14779416|NCT00678145|Narcotics|narcotics|mesh-ancestor
14779417|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779418|NCT00678145|Analgesics|analgesics|mesh-ancestor
14779419|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
14779420|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779421|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14779422|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14779423|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
14943290|NCT01507077|Growth Substances|growth substances|mesh-ancestor
14779424|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779425|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779426|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14208463|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14208464|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14208465|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14208466|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14208467|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
14208468|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
14208469|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
14505460|NCT02872012|Lidocaine|lidocaine|mesh-list
14505461|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
14505462|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
14505463|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505464|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505465|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
14505466|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505467|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14505468|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14505469|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14779427|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14779428|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
14779429|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14779430|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
14779431|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
14779432|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
14943291|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943292|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943293|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943294|NCT01507194|Ondansetron|ondansetron|mesh-list
14943295|NCT01507194|Vestipitant|vestipitant|mesh-list
14779433|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14779434|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14779435|NCT00678184|Atorvastatin|atorvastatin|mesh-list
14779436|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14779437|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779438|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
14779439|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779440|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779441|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14779442|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779443|NCT00678236|Gentamicins|gentamicins|mesh-list
14779444|NCT00678236|Cimetidine|cimetidine|mesh-list
14779445|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14779446|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779447|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14505470|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14779448|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
14779449|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
14779450|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943296|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
14943297|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
14943298|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943299|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943300|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943301|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
13964538|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13964539|NCT03136237|Protective Agents|protective agents|mesh-ancestor
13964540|NCT03136406|Leucovorin|leucovorin|mesh-list
13964541|NCT03136406|Paclitaxel|paclitaxel|mesh-list
14505471|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505472|NCT02872311|Vaccines|vaccines|mesh-list
13964542|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
14505473|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
14505474|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964543|NCT03136406|Bevacizumab|bevacizumab|mesh-list
13964544|NCT03136406|Fluorouracil|fluorouracil|mesh-list
13964545|NCT03136406|Capecitabine|capecitabine|mesh-list
13964546|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
13964547|NCT03136406|Avelumab|avelumab|mesh-list
13964548|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13964549|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964550|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
13964551|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
13964552|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
13964553|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964554|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13964555|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
13964556|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964557|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14779451|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779452|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779453|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14779454|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779455|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779456|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14779457|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779458|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14779459|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14779460|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
14779461|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779462|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779463|NCT00678314|Ropivacaine|ropivacaine|mesh-list
14779464|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14779465|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
14779466|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779467|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779468|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
14779469|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779470|NCT00678327|Prednisolone|prednisolone|mesh-list
14779471|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
14779472|NCT00678327|Dacarbazine|dacarbazine|mesh-list
14779473|NCT00678327|Doxorubicin|doxorubicin|mesh-list
14779474|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14779475|NCT00678327|Etoposide|etoposide|mesh-list
14779476|NCT00678327|Vincristine|vincristine|mesh-list
14779477|NCT00678327|Bleomycin|bleomycin|mesh-list
14779478|NCT00678327|Vinblastine|vinblastine|mesh-list
14943302|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
14943303|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14943304|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
14943305|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779479|NCT00678327|Procarbazine|procarbazine|mesh-list
14779480|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779481|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
14779482|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779483|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14779484|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14779485|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
14779486|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779487|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779488|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14779489|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14779490|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14779491|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14779492|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779493|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14779494|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
14779495|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
14779496|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
14779497|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943306|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943307|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14943308|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14943309|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14943310|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14943311|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14943312|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14943313|NCT01507272|Liraglutide|liraglutide|mesh-list
14943314|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943315|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943316|NCT01507272|Incretins|incretins|mesh-ancestor
14943317|NCT01507272|Hormones|hormones|mesh-ancestor
14943318|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943319|NCT01507285|Liraglutide|liraglutide|mesh-list
14943320|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943321|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943322|NCT01507285|Incretins|incretins|mesh-ancestor
14943323|NCT01507285|Hormones|hormones|mesh-ancestor
14943324|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943325|NCT01507311|Liraglutide|liraglutide|mesh-list
14943326|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943327|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779498|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
14779499|NCT00678327|Hormones|hormones|mesh-ancestor
14779500|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779501|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14779502|NCT00678431|Resveratrol|resveratrol|mesh-list
14779503|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
14779504|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779505|NCT00678431|Protective Agents|protective agents|mesh-ancestor
14779506|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779507|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779508|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14779509|NCT00678457|Ondansetron|ondansetron|mesh-list
14779510|NCT00678457|Olanzapine|olanzapine|mesh-list
14779511|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
14779512|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
14779513|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779514|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779515|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208470|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
14208471|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208472|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208473|NCT05243329|Psilocybin|psilocybin|mesh-list
14208474|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
14208475|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208476|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14208477|NCT05241288|Albuterol|albuterol|mesh-list
14208478|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14208479|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
14208480|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208481|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208482|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14208483|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
14208484|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
14208485|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14208486|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14208487|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14208488|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14208489|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
14208490|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208491|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208492|NCT05239637|Heparin|heparin|mesh-list
14208493|NCT05239637|Calcium heparin|calcium heparin|mesh-list
14208494|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
14208495|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14208496|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14208497|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208498|NCT05238142|Insulin|insulin|mesh-list
14208499|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14208500|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208501|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
14208502|NCT05232825|Promethazine|promethazine|mesh-list
14208503|NCT05232825|Dexamethasone|dexamethasone|mesh-list
14208504|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
14779516|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
14779517|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14779518|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14779519|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
14779520|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779521|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779522|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14779523|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14779524|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779525|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14779526|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14779527|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14779528|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14779529|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14779530|NCT00678483|Rimonabant|rimonabant|mesh-list
14779531|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14779532|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14779533|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14779534|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943328|NCT01507311|Incretins|incretins|mesh-ancestor
14208505|NCT05232825|Desloratadine|desloratadine|mesh-list
14208506|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
14208507|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208508|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
14779535|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779536|NCT00678483|Hormones|hormones|mesh-ancestor
14779537|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208509|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
14505475|NCT02872857|Galantamine|galantamine|mesh-list
14505476|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14505477|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505478|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505479|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505480|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505481|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505482|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14505483|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
14505484|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505485|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
14505486|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
14505487|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14505488|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14505489|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14505490|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505491|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505492|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505493|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505494|NCT02873338|Cytarabine|cytarabine|mesh-list
14505495|NCT02873338|Idarubicin|idarubicin|mesh-list
14505496|NCT02873338|Heparin|heparin|mesh-list
14505497|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14505498|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
14505499|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505500|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505501|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
14505502|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505503|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505504|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
14505505|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505506|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
14505507|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14505508|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14779538|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779539|NCT00678522|Atorvastatin|atorvastatin|mesh-list
14779540|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14779541|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779542|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
14779543|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779544|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779545|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14779546|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779547|NCT00678613|Norfloxacin|norfloxacin|mesh-list
14779548|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14779549|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779550|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14779551|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14779552|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779553|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779554|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779555|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14779556|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779557|NCT00678626|Docetaxel|docetaxel|mesh-list
14779558|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943329|NCT01507311|Hormones|hormones|mesh-ancestor
14208510|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208511|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208512|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208513|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
14208514|NCT05232825|Hormones|hormones|mesh-ancestor
14208515|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208516|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208517|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208518|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14208519|NCT05232825|Protective Agents|protective agents|mesh-ancestor
14208520|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14208521|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14505509|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14779559|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14779560|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14779561|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14779562|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779563|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14779564|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
14779565|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14779566|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14779567|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779568|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779569|NCT00678704|Urological Agents|urological agents|mesh-ancestor
14807667|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807668|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807669|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
14807670|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807671|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14807672|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
14807673|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14807674|NCT00822783|Omalizumab|omalizumab|mesh-list
14807675|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14807676|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14807677|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
14807678|NCT00822809|Prednisolone|prednisolone|mesh-list
14807679|NCT00822809|Catumaxomab|catumaxomab|mesh-list
14807680|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14807681|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
14807682|NCT00822809|Hormones|hormones|mesh-ancestor
14807683|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14807684|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807685|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14807686|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807687|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14807688|NCT00822848|Sorafenib|sorafenib|mesh-list
14807689|NCT00822848|Epirubicin|epirubicin|mesh-list
14807690|NCT00822848|Ifosfamide|ifosfamide|mesh-list
14807691|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807692|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14807693|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807694|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807695|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14807696|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14807697|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14807698|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14807699|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
14807700|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14807701|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14807702|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14807703|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807704|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807705|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14807706|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807707|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807708|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
14807709|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807710|NCT00823004|Letrozole|letrozole|mesh-list
14807711|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
14807712|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
14807713|NCT00823004|Buserelin|buserelin|mesh-list
14807714|NCT00823004|Ganirelix|ganirelix|mesh-list
14807715|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807716|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14807717|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14807718|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807719|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807720|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14807721|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
14807722|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14807723|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807724|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14807725|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14807726|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14807727|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
14807728|NCT00823030|Lidocaine|lidocaine|mesh-list
14807729|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
14779570|NCT00678743|Simvastatin|simvastatin|mesh-list
14779571|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14779572|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779573|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
14779574|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779575|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779576|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14208522|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208523|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
14208524|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
14208525|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
14208526|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14208527|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
14208528|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
14208529|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208530|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208531|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14208532|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
14208533|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
14208534|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
14208535|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14208536|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
14208537|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14208538|NCT05232630|Fenfluramine|fenfluramine|mesh-list
14208539|NCT05232630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14505510|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14505511|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14505512|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505513|NCT02873377|Nicotine|nicotine|mesh-list
14505514|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14505515|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
14505516|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505517|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505518|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14505519|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14505520|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505521|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505522|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505523|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
14505524|NCT02873689|Lansoprazole|lansoprazole|mesh-list
14505525|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14505526|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505527|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14505528|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505529|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505530|NCT02873702|Lansoprazole|lansoprazole|mesh-list
14505531|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
14505532|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14505533|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505534|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14505535|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505536|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505537|NCT02873754|Bupropion|bupropion|mesh-list
14505538|NCT02873754|Nicotine|nicotine|mesh-list
14505539|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14505540|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
14505541|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505542|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505543|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14779577|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779578|NCT00678756|Ketoconazole|ketoconazole|mesh-list
14779579|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
14779580|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505544|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14505545|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505546|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505547|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505548|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14505549|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
14505550|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14208540|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14505551|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14505552|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14528600|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
14779581|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14779582|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779583|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779584|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779585|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14779586|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
14779587|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779588|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779589|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14779590|NCT00678769|Sirolimus|sirolimus|mesh-list
14779591|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14779592|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14779593|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779594|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14779595|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208541|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208542|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208543|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208544|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
14208545|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208546|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
14208547|NCT05232357|Methylene Blue|methylene blue|mesh-list
14208548|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208549|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208550|NCT05232357|Antidotes|antidotes|mesh-ancestor
14208551|NCT05232357|Protective Agents|protective agents|mesh-ancestor
14779596|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
14779597|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779598|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
14779599|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779600|NCT00678782|Etanercept|etanercept|mesh-list
14779601|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14779602|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14779603|NCT00678782|Analgesics|analgesics|mesh-ancestor
14779604|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
14779605|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779606|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779607|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14779608|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14779609|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779610|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779611|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
14779612|NCT00678964|Carboplatin|carboplatin|mesh-list
14779613|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14779614|NCT00678964|Vinorelbine|vinorelbine|mesh-list
14779615|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779616|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14779617|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779618|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779619|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14779620|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
14943330|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943331|NCT01507337|Liraglutide|liraglutide|mesh-list
14943332|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943333|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943334|NCT01507337|Incretins|incretins|mesh-ancestor
14943335|NCT01507337|Hormones|hormones|mesh-ancestor
14943336|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943337|NCT01507363|Gabapentin|gabapentin|mesh-list
14943338|NCT01507363|Analgesics|analgesics|mesh-ancestor
14943339|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
14943340|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943341|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208552|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208553|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
14779621|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
14779622|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
14779623|NCT00678977|Gemcitabine|gemcitabine|mesh-list
14779624|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779625|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14779626|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
14779627|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779628|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
14779629|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779630|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779631|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779632|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
14779633|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779634|NCT00678990|Heparin|heparin|mesh-list
14779635|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
14779636|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14779637|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14779638|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779639|NCT00679068|Bosentan|bosentan|mesh-list
14779640|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779641|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14779642|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779643|NCT00679120|Cimetidine|cimetidine|mesh-list
14208554|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
14208555|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14208556|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208557|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
14208558|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
14241120|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
14779644|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14779645|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779646|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14779647|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
14779648|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
14779649|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779650|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779651|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779652|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14779653|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779654|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779655|NCT00679146|Ketoprofen|ketoprofen|mesh-list
14779656|NCT00679146|Colchicine|colchicine|mesh-list
14779657|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14779658|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14779659|NCT00679146|Analgesics|analgesics|mesh-ancestor
14779660|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
14779661|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779662|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779663|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14779664|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14779665|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14779666|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779667|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779668|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
14779669|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14779670|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14779671|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14779672|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779673|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14779674|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
14779675|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779676|NCT00679224|Ambrisentan|ambrisentan|mesh-list
14779677|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779678|NCT00679237|Metformin|metformin|mesh-list
14779679|NCT00679237|Glimepiride|glimepiride|mesh-list
14779680|NCT00679237|Ezetimibe|ezetimibe|mesh-list
14779681|NCT00679237|Diuretics|diuretics|mesh-list
14779682|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14779683|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779684|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14779685|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779686|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
14779687|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779688|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779689|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14779690|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779691|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
14779692|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
14779693|NCT00679250|Cetirizine|cetirizine|mesh-list
14779694|NCT00679250|Levocetirizine|levocetirizine|mesh-list
14779695|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14779696|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14779697|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
14779698|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
14779699|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779700|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779701|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779702|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14779703|NCT00679315|Alfuzosin|alfuzosin|mesh-list
14779704|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14779705|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14779706|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14779707|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779708|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779709|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779710|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779711|NCT00679315|Urological Agents|urological agents|mesh-ancestor
14779712|NCT00679458|Buprenorphine|buprenorphine|mesh-list
14779713|NCT00679458|Naloxone|naloxone|mesh-list
14779714|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14779715|NCT00679458|Narcotics|narcotics|mesh-ancestor
14779716|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779717|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779718|NCT00679458|Analgesics|analgesics|mesh-ancestor
14779719|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
14779720|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779721|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14779722|NCT00679484|Candesartan|candesartan|mesh-list
14779723|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
14779724|NCT00679484|Olmesartan|olmesartan|mesh-list
14779725|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14943342|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
14943343|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14943344|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14943345|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14943346|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14943347|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14943348|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14943349|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943350|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943351|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
14943352|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14943353|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14943354|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943355|NCT01507389|Liraglutide|liraglutide|mesh-list
14943356|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943357|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943358|NCT01507389|Incretins|incretins|mesh-ancestor
14943359|NCT01507389|Hormones|hormones|mesh-ancestor
14943360|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943361|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
14943362|NCT01507428|Misonidazole|misonidazole|mesh-list
14943363|NCT01507428|Paclitaxel|paclitaxel|mesh-list
14943364|NCT01507428|Carboplatin|carboplatin|mesh-list
14943365|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14943366|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14943367|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14943368|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943369|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14943370|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
14943371|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14943372|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943373|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14943374|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
14943375|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
14943376|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943377|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14943378|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14943379|NCT01507454|Estradiol|estradiol|mesh-list
14943380|NCT01507454|Estrogens|estrogens|mesh-ancestor
14943381|NCT01507454|Hormones|hormones|mesh-ancestor
14943382|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779726|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779727|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14779728|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14779729|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779730|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14779731|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14779732|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14779733|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
14779734|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779735|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14779736|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14779737|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779738|NCT00679523|Tavaborole|tavaborole|mesh-list
14779739|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14779740|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
14779741|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779742|NCT00679536|Fludarabine|fludarabine|mesh-list
14779743|NCT00679536|Busulfan|busulfan|mesh-list
14779744|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
14779745|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779746|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779747|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14779748|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
14779749|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779750|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
14779751|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14779752|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14779753|NCT00679601|Tavaborole|tavaborole|mesh-list
14779754|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
14779755|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779756|NCT00679614|Acetaminophen|acetaminophen|mesh-list
14779757|NCT00679614|Tramadol|tramadol|mesh-list
14779758|NCT00679614|Naloxone|naloxone|mesh-list
14779759|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14943383|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943384|NCT01507467|Nimorazole|nimorazole|mesh-list
14943385|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14943386|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14943387|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14943388|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943389|NCT01507480|Bevacizumab|bevacizumab|mesh-list
14208559|NCT05229003|Irinotecan|irinotecan|mesh-list
14208560|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14208561|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14208562|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208563|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208564|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208565|NCT05218668|Fasudil|fasudil|mesh-list
14208566|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14208567|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208568|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208569|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14208570|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208571|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
14943390|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943391|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943392|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14943393|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14943394|NCT01507480|Growth Substances|growth substances|mesh-ancestor
14943395|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943396|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943397|NCT01507519|Sirolimus|sirolimus|mesh-list
14943398|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14943399|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208572|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14943400|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14943401|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943402|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
14943403|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943404|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
14943405|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779760|NCT00679614|Analgesics|analgesics|mesh-ancestor
14943406|NCT01507558|Dexamethasone|dexamethasone|mesh-list
14943407|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
14779761|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
14943408|NCT01507558|BB 1101|bb 1101|mesh-list
14779762|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779763|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779764|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
14779765|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14779766|NCT00679614|Narcotics|narcotics|mesh-ancestor
14779767|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779768|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14779769|NCT00679640|Candesartan|candesartan|mesh-list
14779770|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779771|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14779772|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14779773|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779774|NCT00679653|Sibutramine|sibutramine|mesh-list
14779775|NCT00679653|Metoprolol|metoprolol|mesh-list
14779776|NCT00679653|Verapamil|verapamil|mesh-list
14779777|NCT00679653|Felodipine|felodipine|mesh-list
14779778|NCT00679653|Ramipril|ramipril|mesh-list
14779779|NCT00679653|Trandolapril|trandolapril|mesh-list
14779780|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14779781|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779782|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
14779783|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
14779784|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779785|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779786|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14779787|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14779788|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14779789|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779790|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779791|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779792|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14779793|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
14779794|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779795|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14779796|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14779797|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14779798|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
14779799|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
14779800|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14779801|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
14779802|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14779803|NCT00679666|Riboflavin|riboflavin|mesh-list
14779804|NCT00679666|Vitamins|vitamins|mesh-ancestor
14779805|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
14779806|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779807|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
14779808|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14779809|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
14779810|NCT00679679|Metformin|metformin|mesh-list
14779811|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14779812|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779813|NCT00679705|Atosiban|atosiban|mesh-list
14779814|NCT00679705|Ritodrine|ritodrine|mesh-list
14779815|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
14779816|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779817|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779818|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
14779819|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14779820|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
14779821|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
14779822|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779823|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14779824|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14779825|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14779826|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779827|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779828|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779829|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14779830|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14779831|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
14779832|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
14779833|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14779834|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14779835|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779836|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14779837|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779838|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779839|NCT00679770|Tavaborole|tavaborole|mesh-list
14779840|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
14943409|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943410|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
14943411|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
14208573|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208574|NCT05215405|Venetoclax|venetoclax|mesh-list
14208575|NCT05215405|Navitoclax|navitoclax|mesh-list
14208576|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208577|NCT05213221|Lenvatinib|lenvatinib|mesh-list
14208578|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208579|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14208580|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208581|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208582|NCT05212857|Leuprolide|leuprolide|mesh-list
14208583|NCT05212857|Goserelin|goserelin|mesh-list
14208584|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14208585|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
14208586|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14208587|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
14208588|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14208589|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208590|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208591|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208592|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14208593|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208594|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208595|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14208596|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208597|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14208598|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
14208599|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14943412|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943413|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943414|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943415|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
14943416|NCT01507558|Hormones|hormones|mesh-ancestor
14943417|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943418|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14943419|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943420|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
14943421|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943422|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943423|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
14943424|NCT01507597|Glucagon|glucagon|mesh-list
14943425|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14943426|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943427|NCT01507597|Hormones|hormones|mesh-ancestor
14943428|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943429|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943430|NCT01507597|Incretins|incretins|mesh-ancestor
14943431|NCT01507610|Sumatriptan|sumatriptan|mesh-list
14943432|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14943433|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14943434|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14208600|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
14208601|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14208602|NCT05209425|Vitamin D|vitamin d|mesh-list
14208603|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
14208604|NCT05209425|Vitamins|vitamins|mesh-ancestor
14208605|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
14208606|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208607|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14779841|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779842|NCT00679835|Daptomycin|daptomycin|mesh-list
14779843|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14779844|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779845|NCT00679900|SR 46349B|sr 46349b|mesh-list
14779846|NCT00679900|Lormetazepam|lormetazepam|mesh-list
14779847|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14779848|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14779849|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779850|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14779851|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14779852|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
14779853|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779854|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807757|NCT00823290|Sorafenib|sorafenib|mesh-list
14807758|NCT00823290|Panobinostat|panobinostat|mesh-list
14807759|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807760|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14807761|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779855|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14779856|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779857|NCT00679965|Tavaborole|tavaborole|mesh-list
14779858|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
14779859|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779860|NCT00680095|Tavaborole|tavaborole|mesh-list
14779861|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
14779862|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779863|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14779864|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14779865|NCT00680134|Tavaborole|tavaborole|mesh-list
14779866|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
14779867|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779868|NCT00680160|Tavaborole|tavaborole|mesh-list
14779869|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
14779870|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779871|NCT00680173|Interferons|interferons|mesh-list
14779872|NCT00680173|Ribavirin|ribavirin|mesh-list
14779873|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
14779874|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
14779875|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14779876|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779877|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
14779878|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779879|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
14779880|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779881|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
14779882|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779883|NCT00680212|Beta Carotene|beta carotene|mesh-list
14779884|NCT00680212|Carotenoids|carotenoids|mesh-list
14779885|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
14779886|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779887|NCT00680212|Protective Agents|protective agents|mesh-ancestor
14779888|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779889|NCT00680212|Provitamins|provitamins|mesh-ancestor
14208608|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14779890|NCT00680212|Vitamins|vitamins|mesh-ancestor
14779891|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
14779892|NCT00680277|Carotenoids|carotenoids|mesh-list
14779893|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
14807730|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
14807731|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807732|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807733|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
14807734|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807735|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807736|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14807737|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14807738|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807739|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807740|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14807741|NCT00823121|Buserelin|buserelin|mesh-list
14807742|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14807743|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807744|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14807745|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
14807746|NCT00823186|Paclitaxel|paclitaxel|mesh-list
14807747|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14807748|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807749|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807750|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
14807751|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
14807752|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807753|NCT00823238|Tobramycin|tobramycin|mesh-list
14807754|NCT00823238|Ceftazidime|ceftazidime|mesh-list
14807755|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14807756|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779894|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779895|NCT00680277|Protective Agents|protective agents|mesh-ancestor
14779896|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779897|NCT00680329|Timolol|timolol|mesh-list
14779898|NCT00680329|Travoprost|travoprost|mesh-list
14779899|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14779900|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14779901|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14779902|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14779903|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779904|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779905|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779906|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779907|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14779908|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14779909|NCT00680355|Carotenoids|carotenoids|mesh-list
14779910|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
14779911|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779912|NCT00680355|Protective Agents|protective agents|mesh-ancestor
14779913|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779914|NCT00680394|Misoprostol|misoprostol|mesh-list
14779915|NCT00680394|Mifepristone|mifepristone|mesh-list
14779916|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14779917|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
14779918|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14779919|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779920|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14779921|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14779922|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
14779923|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14807762|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807763|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14807764|NCT00823342|Tenofovir|tenofovir|mesh-list
14807765|NCT00823342|Clevudine|clevudine|mesh-list
14807766|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
14208609|NCT05203822|Itraconazole|itraconazole|mesh-list
14208610|NCT05203822|Tepotinib|tepotinib|mesh-list
14208611|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
14208612|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779924|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14779925|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14779926|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14779927|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
14779928|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14779929|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14779930|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
14779931|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779932|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
14779933|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14779934|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14779935|NCT00680433|Ketamine|ketamine|mesh-list
14208613|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14208614|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14208615|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208616|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208617|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14208618|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
14208619|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208620|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208621|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14208622|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208623|NCT05199311|Dexamethasone|dexamethasone|mesh-list
14807767|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943435|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
14208624|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208625|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
14208626|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
14208627|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779936|NCT00680433|Analgesics|analgesics|mesh-ancestor
14779937|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
14779938|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779939|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779940|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14779941|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14779942|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
14779943|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
14779944|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14779945|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14779946|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14779947|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779948|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779949|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
14779950|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14779951|NCT00680446|Antibodies|antibodies|mesh-list
14779952|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
14779953|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
14779954|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779955|NCT00680485|Ketoconazole|ketoconazole|mesh-list
14779956|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
14779957|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14779958|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14779959|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14779960|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14779961|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779962|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14779963|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
14807768|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14208628|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208629|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208630|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
14208631|NCT05199311|Hormones|hormones|mesh-ancestor
14208632|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208633|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14208634|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208635|NCT05193968|Nitroprusside|nitroprusside|mesh-list
14208636|NCT05193968|Norepinephrine|norepinephrine|mesh-list
14208637|NCT05193968|Acetylcholine|acetylcholine|mesh-list
14208638|NCT05193968|Terbutaline|terbutaline|mesh-list
14208639|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14208640|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14208641|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
14208642|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208643|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208644|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208645|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
14208646|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
14208647|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208648|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14208649|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14208650|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
14208651|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14208652|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14208653|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
14208654|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14505553|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208655|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14505554|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
14505555|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14505556|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14505557|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505558|NCT02874092|Ticagrelor|ticagrelor|mesh-list
14505559|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14505560|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14505561|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14505562|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14779964|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14779965|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807769|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14807770|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807771|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807772|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14807773|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14807774|NCT00823381|Resveratrol|resveratrol|mesh-list
14807775|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
14208656|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
14208657|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
14208658|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14807776|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807777|NCT00823381|Protective Agents|protective agents|mesh-ancestor
14807778|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807779|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807780|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14807781|NCT00823433|Penicillins|penicillins|mesh-list
14807782|NCT00823433|Penicillin V|penicillin v|mesh-list
14807783|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14807784|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943436|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943437|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943438|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026831|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15026832|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15026833|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
15026834|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026835|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026836|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026837|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
15026838|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
15026839|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026840|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15026841|NCT01946009|Cidofovir|cidofovir|mesh-list
15026842|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
15026843|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026844|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026845|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026846|NCT01946035|Doxazosin|doxazosin|mesh-list
15026847|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15026848|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15026849|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15026850|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15026851|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
15026852|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026853|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026854|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026855|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
15026856|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026857|NCT01946256|Amoxicillin|amoxicillin|mesh-list
15026858|NCT01946256|Erythromycin|erythromycin|mesh-list
15026859|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
15026860|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15026861|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
15026862|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15026863|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208659|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14779966|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14779967|NCT00680498|Ranibizumab|ranibizumab|mesh-list
14779968|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14779969|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14779970|NCT00680498|Growth Substances|growth substances|mesh-ancestor
14779971|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779972|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
14208660|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14208661|NCT05193851|Ricolinostat|ricolinostat|mesh-list
14208662|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208663|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14208664|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208665|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208666|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
14208667|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14208668|NCT05190705|Dexamethasone|dexamethasone|mesh-list
14208669|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
14779973|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14779974|NCT00680511|Methamphetamine|methamphetamine|mesh-list
14779975|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14779976|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14779977|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
14779978|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
14779979|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14779980|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
14779981|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14779982|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14779983|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
14779984|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14779985|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14779986|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208670|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14779987|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14779988|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
14779989|NCT00680563|Hematinics|hematinics|mesh-ancestor
14779990|NCT00680602|Sertraline|sertraline|mesh-list
14779991|NCT00680602|Fluoxetine|fluoxetine|mesh-list
14779992|NCT00680602|Paroxetine|paroxetine|mesh-list
14208671|NCT05190705|BB 1101|bb 1101|mesh-list
14208672|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208673|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
14208674|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
14208675|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208676|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208677|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208678|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
14779993|NCT00680602|Citalopram|citalopram|mesh-list
14779994|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
14779995|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14779996|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14779997|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14779998|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14779999|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780000|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780001|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
14780002|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780003|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14780004|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14780005|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14780006|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943439|NCT01507701|Clonidine|clonidine|mesh-list
14943440|NCT01507701|Analgesics|analgesics|mesh-ancestor
14943441|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
14943442|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943443|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943444|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14943445|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
14943446|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
14943447|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14943448|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14943449|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14943450|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
14943451|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943452|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943453|NCT01507727|Tolvaptan|tolvaptan|mesh-list
14943454|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14943455|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943456|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
14208679|NCT05190705|Hormones|hormones|mesh-ancestor
14208680|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14208681|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14780007|NCT00680641|Simvastatin|simvastatin|mesh-list
14780008|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14780009|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14780010|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
14780011|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780012|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14780013|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14780014|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780015|NCT00680654|Riociguat|riociguat|mesh-list
14780016|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
14780017|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780018|NCT00680680|Dutasteride|dutasteride|mesh-list
14780019|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14780020|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14780021|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780022|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780023|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
14780024|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780025|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780026|NCT00680732|Folic Acid|folic acid|mesh-list
14780027|NCT00680732|Micronutrients|micronutrients|mesh-list
14780028|NCT00680732|Trace Elements|trace elements|mesh-list
14780029|NCT00680732|Chloroquine|chloroquine|mesh-list
14780030|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
14780031|NCT00680732|Hematinics|hematinics|mesh-ancestor
14780032|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
14780033|NCT00680732|Vitamins|vitamins|mesh-ancestor
14780034|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780035|NCT00680732|Amebicides|amebicides|mesh-ancestor
14780036|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14780037|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14780038|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780039|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
14780040|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780041|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14780042|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780043|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780044|NCT00680758|Paclitaxel|paclitaxel|mesh-list
14780045|NCT00680758|Everolimus|everolimus|mesh-list
14780046|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14780047|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780048|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780049|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
14780050|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
14943457|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943458|NCT01507740|Bevacizumab|bevacizumab|mesh-list
14943459|NCT01507740|Sorafenib|sorafenib|mesh-list
14943460|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943461|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943462|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14943463|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14943464|NCT01507740|Growth Substances|growth substances|mesh-ancestor
14943465|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943466|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943467|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14943468|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943469|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943470|NCT01507792|Loratadine|loratadine|mesh-list
14943471|NCT01507792|Omeprazole|omeprazole|mesh-list
14943472|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14943473|NCT01507792|Histamine|histamine|mesh-list
14943474|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14208682|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208683|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
14208684|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943475|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208685|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208686|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14208687|NCT05187715|Simvastatin|simvastatin|mesh-list
14208688|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14208689|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14208690|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
14208691|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208692|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14780051|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943476|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780052|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780053|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
14780054|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780055|NCT00680940|Paclitaxel|paclitaxel|mesh-list
14780056|NCT00680940|Cisplatin|cisplatin|mesh-list
14780057|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14780058|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780059|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780060|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
14780061|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
14780062|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780063|NCT00681005|Rabeprazole|rabeprazole|mesh-list
14780064|NCT00681005|Pantoprazole|pantoprazole|mesh-list
14780065|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14780066|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14780067|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14780068|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780069|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780070|NCT00681135|Olaflur|olaflur|mesh-list
14780071|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
14780072|NCT00681135|Protective Agents|protective agents|mesh-ancestor
14780073|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780074|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14780075|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14780076|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780077|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780078|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14780079|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14780080|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780081|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
14780082|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780083|NCT00681174|Acetaminophen|acetaminophen|mesh-list
14780084|NCT00681174|Morphine|morphine|mesh-list
14780085|NCT00681174|Remifentanil|remifentanil|mesh-list
14780086|NCT00681174|Oxycodone|oxycodone|mesh-list
14780087|NCT00681174|Propofol|propofol|mesh-list
14780088|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14780089|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780090|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780091|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14780092|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
14780093|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
14780094|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14780095|NCT00681174|Narcotics|narcotics|mesh-ancestor
14780096|NCT00681174|Analgesics|analgesics|mesh-ancestor
14780097|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
14780098|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780099|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14780100|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
14780101|NCT00681213|Sirolimus|sirolimus|mesh-list
14780102|NCT00681213|Tacrolimus|tacrolimus|mesh-list
14780103|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780104|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
14780105|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780106|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14780107|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780108|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780109|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14780110|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780111|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14780112|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780113|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
14780114|NCT00681226|Ramipril|ramipril|mesh-list
14780115|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14780116|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
14780117|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780118|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780119|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14780120|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
14780121|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
14780122|NCT00681343|Daclizumab|daclizumab|mesh-list
14780123|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
14780124|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780125|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780126|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14780127|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780128|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14780129|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14780130|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14780131|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
14780132|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780133|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14780134|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14780135|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780136|NCT00681460|Metformin|metformin|mesh-list
14780137|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14780138|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780139|NCT00681525|Atorvastatin|atorvastatin|mesh-list
14780140|NCT00681525|Ezetimibe|ezetimibe|mesh-list
14780141|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
14780142|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14780143|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14780144|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
14780145|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780146|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14780147|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14780148|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780149|NCT00681603|Bevacizumab|bevacizumab|mesh-list
14780150|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14780151|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780152|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14780153|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14780154|NCT00681603|Growth Substances|growth substances|mesh-ancestor
14780155|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780156|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
14780157|NCT00681720|Flumazenil|flumazenil|mesh-list
14780158|NCT00681720|Antidotes|antidotes|mesh-ancestor
14780159|NCT00681720|Protective Agents|protective agents|mesh-ancestor
14780160|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780161|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
14780162|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
14780163|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780164|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780165|NCT00681733|Pioglitazone|pioglitazone|mesh-list
14780166|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
14780167|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14780168|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780169|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14780170|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780171|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780172|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14780173|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14780174|NCT00681733|Protective Agents|protective agents|mesh-ancestor
14780175|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
14780176|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14780177|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
14780178|NCT00681746|Flumazenil|flumazenil|mesh-list
14780179|NCT00681746|Antidotes|antidotes|mesh-ancestor
14780180|NCT00681746|Protective Agents|protective agents|mesh-ancestor
14780181|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780182|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
14780183|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
14780184|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780185|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780186|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14780187|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
14780188|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14943477|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208693|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14208694|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208695|NCT05179876|Selexipag|selexipag|mesh-list
14208696|NCT05179876|Tadalafil|tadalafil|mesh-list
14943478|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
14943479|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14208697|NCT05179876|Macitentan|macitentan|mesh-list
14780189|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14780190|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780191|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208698|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
14780192|NCT00681772|Urological Agents|urological agents|mesh-ancestor
14208699|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14780193|NCT00681785|Dalteparin|dalteparin|mesh-list
14780194|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14780195|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
14780196|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14780197|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14780198|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780199|NCT00681876|Bevacizumab|bevacizumab|mesh-list
14780200|NCT00681876|Cetuximab|cetuximab|mesh-list
14943480|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14208700|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14208701|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208702|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208703|NCT05179876|Urological Agents|urological agents|mesh-ancestor
14208704|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14208705|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14208706|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14208707|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14208708|NCT05177731|Cytarabine|cytarabine|mesh-list
14208709|NCT05177731|Decitabine|decitabine|mesh-list
14208710|NCT05177731|Venetoclax|venetoclax|mesh-list
14208711|NCT05177731|Idarubicin|idarubicin|mesh-list
14208712|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14208713|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
14208714|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208715|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208716|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
14208717|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208718|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14208719|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
14208720|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208721|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208722|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14208723|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14208724|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14208725|NCT05159830|Cannabidiol|cannabidiol|mesh-list
14208726|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
14208727|NCT05158309|Capsaicin|capsaicin|mesh-list
14208728|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
14208729|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
14208730|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
14208731|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208732|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208733|NCT05147376|Curcumin|curcumin|mesh-list
14208734|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14208735|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14208736|NCT05147376|Analgesics|analgesics|mesh-ancestor
14208737|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
14208738|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208739|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208740|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208741|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208742|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208743|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208744|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208745|NCT05144945|Vaccines|vaccines|mesh-list
14208746|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
14208747|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505563|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
14505564|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505565|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505566|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505567|NCT02874794|Valsartan|valsartan|mesh-list
14505568|NCT02874794|Enalapril|enalapril|mesh-list
14505569|NCT02874794|Enalaprilat|enalaprilat|mesh-list
14505570|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14505571|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14505572|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14505573|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14505574|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780201|NCT00681876|Irinotecan|irinotecan|mesh-list
14780202|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14780203|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780204|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14780205|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14208748|NCT05137587|Ketamine|ketamine|mesh-list
14780206|NCT00681876|Growth Substances|growth substances|mesh-ancestor
14780207|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780208|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
14780209|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14780210|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14780211|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780212|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780213|NCT00681902|Lidocaine|lidocaine|mesh-list
14780214|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
14780215|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
14780216|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780217|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780218|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
14780219|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780220|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14780221|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14780222|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14780223|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14780224|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780225|NCT00681928|Letrozole|letrozole|mesh-list
14780226|NCT00681928|Anastrozole|anastrozole|mesh-list
14780227|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780228|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14780229|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14780230|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780231|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780232|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14780233|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
14780234|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780235|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780236|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14780237|NCT00681941|Sevelamer|sevelamer|mesh-list
14780238|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
14780239|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
14780240|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780241|NCT00681967|Gefitinib|gefitinib|mesh-list
14780242|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780243|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14780244|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780245|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780246|NCT00681980|Valproic Acid|valproic acid|mesh-list
14780247|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
14780248|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780249|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780250|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
14780251|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780252|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780253|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
14780254|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14780255|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208749|NCT05137587|Propofol|propofol|mesh-list
14208750|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208751|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208752|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208753|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14208754|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
14208755|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
14208756|NCT05137587|Analgesics|analgesics|mesh-ancestor
14208757|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
14208758|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208759|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14208760|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14208761|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14208762|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208763|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208764|NCT05137574|Ketamine|ketamine|mesh-list
14208765|NCT05137574|Propofol|propofol|mesh-list
14208766|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208767|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208768|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208769|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14780256|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14780257|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
14780258|NCT00681993|Carboplatin|carboplatin|mesh-list
14780259|NCT00681993|Docetaxel|docetaxel|mesh-list
14780260|NCT00681993|Trastuzumab|trastuzumab|mesh-list
14780261|NCT00681993|Doxorubicin|doxorubicin|mesh-list
14780262|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14780263|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780264|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
14780265|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780266|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780267|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14780268|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
14780269|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780270|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780271|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14780272|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780273|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14780274|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14780275|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14780276|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14780277|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14780278|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14780279|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780280|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
14780281|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14780282|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14780283|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780284|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
14780285|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
14780286|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14780287|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
14780288|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14780289|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14780290|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780291|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780292|NCT00682019|Urological Agents|urological agents|mesh-ancestor
14780293|NCT00682136|Ropivacaine|ropivacaine|mesh-list
14780294|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
14780295|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
14780296|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780297|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780298|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
14780299|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780300|NCT00682149|Ascorbic Acid|ascorbic acid|mesh-list
14780301|NCT00682149|Vitamins|vitamins|mesh-ancestor
14780302|NCT00682149|Micronutrients|micronutrients|mesh-ancestor
14780303|NCT00682149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780304|NCT00682149|Antioxidants|antioxidants|mesh-ancestor
14780305|NCT00682149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780306|NCT00682149|Protective Agents|protective agents|mesh-ancestor
14780307|NCT00682214|Vitamin D|vitamin d|mesh-list
14780308|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
14780309|NCT00682214|Vitamins|vitamins|mesh-ancestor
14780310|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
14780311|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780312|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14780313|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14208770|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
14505575|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14505576|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
14505577|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505578|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14505579|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14505580|NCT02874924|Sirolimus|sirolimus|mesh-list
14505581|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14505582|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505583|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14505584|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505585|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
14505586|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505587|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
14505588|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505589|NCT02875028|Vorapaxar|vorapaxar|mesh-list
14505590|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14505591|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
14505592|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
14780314|NCT00682279|Topotecan|topotecan|mesh-list
14780315|NCT00682279|Lapatinib|lapatinib|mesh-list
14780316|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14505593|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505594|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505595|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505596|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
14505597|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
14505598|NCT02875340|Risperidone|risperidone|mesh-list
14943481|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14943482|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14943483|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
14943484|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
14943485|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943486|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943487|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
14943488|NCT01507857|Vaccines|vaccines|mesh-list
14943489|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
14943490|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943491|NCT01507922|Fenoverine|fenoverine|mesh-list
14943492|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
14943493|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
14943494|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505599|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14505600|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
14505601|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505602|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505603|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505604|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14505605|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14505606|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505607|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14505608|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14780317|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14780318|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780319|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780320|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780321|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14780322|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
14780323|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14505609|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
14505610|NCT02875366|Ivacaftor|ivacaftor|mesh-list
14505611|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14505612|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14505613|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505614|NCT02875392|Fucoidan|fucoidan|mesh-list
14505615|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14505616|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505617|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
14505618|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505619|NCT02875613|Avelumab|avelumab|mesh-list
14505620|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505621|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505622|NCT02876601|Defibrotide|defibrotide|mesh-list
14505623|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14505624|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14505625|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505626|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14505627|NCT02876900|Asenapine|asenapine|mesh-list
14505628|NCT02876900|Maleic acid|maleic acid|mesh-list
14505629|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505630|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505631|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14505632|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14505633|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505634|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505635|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14505636|NCT02877082|Bortezomib|bortezomib|mesh-list
14505637|NCT02877082|Tacrolimus|tacrolimus|mesh-list
14505638|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
14505639|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14505640|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780324|NCT00682292|Daclizumab|daclizumab|mesh-list
14943495|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943496|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14943497|NCT01507974|Amoxicillin|amoxicillin|mesh-list
14943498|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
14943499|NCT01507974|Cephalexin|cephalexin|mesh-list
14943500|NCT01507974|Cefuroxime|cefuroxime|mesh-list
14943501|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
14943502|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14943503|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14943504|NCT01507974|Trimethoprim|trimethoprim|mesh-list
14780325|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
14780326|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780327|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780328|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
14780329|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
14780330|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
14780331|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780332|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780333|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
14780334|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780335|NCT00682383|Docetaxel|docetaxel|mesh-list
14780336|NCT00682383|Etoposide|etoposide|mesh-list
14780337|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780338|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780339|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
14780340|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
14780341|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780342|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14780343|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14780344|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14780345|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943505|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
14943506|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943507|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
14943508|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14943509|NCT01507974|Renal Agents|renal agents|mesh-ancestor
14943510|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
14943511|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14943512|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14943513|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14943514|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943515|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943516|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14943517|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14943518|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14943519|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14943520|NCT01508000|Bevacizumab|bevacizumab|mesh-list
14943521|NCT01508000|Panitumumab|panitumumab|mesh-list
14943522|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943523|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943524|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14943525|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14943526|NCT01508000|Growth Substances|growth substances|mesh-ancestor
14943527|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943528|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943529|NCT01508104|Everolimus|everolimus|mesh-list
14943530|NCT01508104|Dactolisib|dactolisib|mesh-list
14943531|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943532|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943533|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
14943534|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943535|NCT01508143|Misoprostol|misoprostol|mesh-list
14943536|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14943537|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
14505641|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
14505642|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505643|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14505644|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505645|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505646|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505647|NCT02877095|Furosemide|furosemide|mesh-list
14505648|NCT02877095|Diuretics|diuretics|mesh-ancestor
14505649|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
14505650|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505651|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14505652|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14505653|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780346|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
14780347|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14780348|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14780349|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14780350|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14780351|NCT00682500|Calfactant|calfactant|mesh-list
14780352|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14780353|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780354|NCT00682578|Artesunate|artesunate|mesh-list
14780355|NCT00682578|Chloroquine|chloroquine|mesh-list
14780356|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
14780357|NCT00682578|Piperaquine|piperaquine|mesh-list
14780358|NCT00682578|Artenimol|artenimol|mesh-list
14208771|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
14208772|NCT05137574|Analgesics|analgesics|mesh-ancestor
14208773|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
14208774|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208775|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14208776|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14208777|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14208778|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208779|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208780|NCT05132829|Azithromycin|azithromycin|mesh-list
14208781|NCT05132829|Cefazolin|cefazolin|mesh-list
14208782|NCT05132829|Indomethacin|indomethacin|mesh-list
14208783|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14208784|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208785|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14208786|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14208787|NCT05132829|Analgesics|analgesics|mesh-ancestor
14208788|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
14208789|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208790|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208791|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208792|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780359|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
14780360|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14780361|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14780362|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780363|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780364|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
14780365|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
14780366|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14780367|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
14780368|NCT00682578|Amebicides|amebicides|mesh-ancestor
14780369|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780370|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14780371|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780372|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780373|NCT00682630|Artesunate|artesunate|mesh-list
14780374|NCT00682630|Pyronaridine|pyronaridine|mesh-list
14780375|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
14780376|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14780377|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14780378|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780379|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780380|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
14780381|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
14780382|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14780383|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
14780384|NCT00682656|Azithromycin|azithromycin|mesh-list
14780385|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14780386|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14780387|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780388|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14943538|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14943539|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943540|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14943541|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943542|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
14943543|NCT01508182|Metformin|metformin|mesh-list
14208793|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
14780389|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14943544|NCT01508182|Canagliflozin|canagliflozin|mesh-list
14780390|NCT00682721|Valacyclovir|valacyclovir|mesh-list
14943545|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14780391|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
14780392|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780393|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
14943546|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208794|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
14208795|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14208796|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14208797|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208798|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241121|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241122|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241123|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241124|NCT00171873|Octreotide|octreotide|mesh-list
14241125|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14241126|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14241127|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241128|NCT00171925|Vitamin D|vitamin d|mesh-list
14241129|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
14241130|NCT00171925|Calcium|calcium|mesh-list
14241131|NCT00171925|Vitamins|vitamins|mesh-ancestor
14241132|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
14241133|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241134|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14241135|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14241136|NCT00171951|Pasireotide|pasireotide|mesh-list
14241137|NCT00171951|Hormones|hormones|mesh-ancestor
14241138|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241139|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241140|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
14241141|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14241142|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241143|NCT00172185|Teduglutide|teduglutide|mesh-list
14241144|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14780394|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14780395|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14780396|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14780397|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14780398|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780399|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
14780400|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780401|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780402|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14780403|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780404|NCT00682825|Anesthetics|anesthetics|mesh-list
14780405|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
14780406|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780407|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780408|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
14780409|NCT00682955|Zinc|zinc|mesh-list
14780410|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
14780411|NCT00682955|Trace Elements|trace elements|mesh-ancestor
14780412|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
14780413|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780414|NCT00682955|Astringents|astringents|mesh-ancestor
14780415|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
14780416|NCT00683059|Paclitaxel|paclitaxel|mesh-list
14505654|NCT02877485|Triamcinolone|triamcinolone|mesh-list
14505655|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14243319|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14505656|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14505657|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14505658|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505659|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
14505660|NCT02877485|Hormones|hormones|mesh-ancestor
14505661|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505662|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505663|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505664|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
14505665|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505666|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505667|NCT02877927|Linezolid|linezolid|mesh-list
14505668|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14505669|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505670|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14505671|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505672|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505673|NCT02878057|Apatinib|apatinib|mesh-list
14505674|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780417|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14780418|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780419|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780420|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14780421|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14780422|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780423|NCT00683111|Esomeprazole|esomeprazole|mesh-list
14780424|NCT00683111|Famotidine|famotidine|mesh-list
14780425|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14780426|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14780427|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14780428|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780429|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780430|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14780431|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
14780432|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
14780433|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780434|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780435|NCT00683124|Losartan|losartan|mesh-list
14780436|NCT00683124|Nebivolol|nebivolol|mesh-list
14780437|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14780438|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14780439|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14780440|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14208799|NCT05126966|Ranibizumab|ranibizumab|mesh-list
14208800|NCT05126966|Aflibercept|aflibercept|mesh-list
14208801|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14208802|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14208803|NCT05126966|Growth Substances|growth substances|mesh-ancestor
14208804|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208805|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
14208806|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208807|NCT05125237|Amiloride|amiloride|mesh-list
14208808|NCT05125237|Triamterene|triamterene|mesh-list
14208809|NCT05125237|Diuretics|diuretics|mesh-ancestor
14208810|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
14208811|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208812|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14208813|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14208814|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208815|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208816|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14208817|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14208818|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14780441|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780442|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
14780443|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14780444|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780445|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780446|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780447|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780448|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780449|NCT00683137|Valdecoxib|valdecoxib|mesh-list
14780450|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14780451|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14780452|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780453|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780454|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14780455|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14780456|NCT00683137|Analgesics|analgesics|mesh-ancestor
14780457|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
14780458|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780459|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780460|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14780461|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780462|NCT00683176|Choline|choline|mesh-list
14780463|NCT00683176|Fenofibrate|fenofibrate|mesh-list
14780464|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14780465|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
14780466|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780467|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14780468|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
14208819|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
14208820|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
14780469|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14780470|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
14780471|NCT00683189|Warfarin|warfarin|mesh-list
14780472|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
14780473|NCT00683202|Aspirin|aspirin|mesh-list
14780474|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14780475|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14780476|NCT00683202|Analgesics|analgesics|mesh-ancestor
14780477|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
14780478|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780479|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780480|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14780481|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780482|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14780483|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14780484|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780485|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14780486|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14780487|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780488|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
14780489|NCT00683267|Capsaicin|capsaicin|mesh-list
14780490|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
14780491|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
14780492|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
14780493|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780494|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780495|NCT00683306|Gefitinib|gefitinib|mesh-list
14780496|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780497|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14780498|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780499|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780500|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
14780501|NCT00683319|Carboplatin|carboplatin|mesh-list
14780502|NCT00683319|Methotrexate|methotrexate|mesh-list
14780503|NCT00683319|Vincristine|vincristine|mesh-list
14780504|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780505|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
14780506|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780507|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780508|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14780509|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
14780510|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780511|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780512|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14780513|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14780514|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
14780515|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780516|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14780517|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
14780518|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
14780519|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780520|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14780521|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14780522|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14780523|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780524|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
14780525|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
14780526|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14780527|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780528|NCT00683436|Adipiplon|adipiplon|mesh-list
14780529|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780530|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780531|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
14780532|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
14780533|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780534|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780535|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14780536|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14780537|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14780538|NCT00683514|Cisplatin|cisplatin|mesh-list
14780539|NCT00683514|Vinorelbine|vinorelbine|mesh-list
14780540|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780541|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14780542|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780543|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
14780544|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
14208821|NCT05125224|Calcium|calcium|mesh-list
14208822|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14208823|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208824|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14208825|NCT05125224|Diuretics|diuretics|mesh-ancestor
14208826|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
14208827|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14208828|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208829|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780545|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780546|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
14780547|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780548|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
14780549|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780550|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780551|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14780552|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
14780553|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780554|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780555|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14780556|NCT00683735|Metformin|metformin|mesh-list
14780557|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14780558|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14780559|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780560|NCT00683735|Incretins|incretins|mesh-ancestor
14780561|NCT00683735|Hormones|hormones|mesh-ancestor
14780562|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780563|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14780564|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
14780565|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780566|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780567|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
14780568|NCT00683865|Ofloxacin|ofloxacin|mesh-list
14780569|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14943547|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14943548|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943549|NCT01508195|Metformin|metformin|mesh-list
14943550|NCT01508195|Canagliflozin|canagliflozin|mesh-list
14943551|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943552|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943553|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14943554|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943555|NCT01508221|Vitamin E|vitamin e|mesh-list
14943556|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
14208830|NCT05122819|Anesthetics|anesthetics|mesh-list
14780570|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14780571|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780572|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14780573|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14780574|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780575|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780576|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780577|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14780578|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
14780579|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780580|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780581|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14780582|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14780583|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14780584|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14780585|NCT00683865|Renal Agents|renal agents|mesh-ancestor
14780586|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14780587|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14780588|NCT00683891|Clozapine|clozapine|mesh-list
14780589|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14780590|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
14780591|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780592|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780593|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780594|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14780595|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14943557|NCT01508221|Vitamins|vitamins|mesh-ancestor
14208831|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208832|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208833|NCT05116917|Nivolumab|nivolumab|mesh-list
14208834|NCT05116917|Ipilimumab|ipilimumab|mesh-list
14208835|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14208836|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208837|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14208838|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208839|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
14208840|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14208841|NCT05114941|Antibodies|antibodies|mesh-list
14208842|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
14208843|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14208844|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
14208845|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208846|NCT05102591|Ketorolac|ketorolac|mesh-list
14208847|NCT05102591|Metoclopramide|metoclopramide|mesh-list
14208848|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14208849|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14208850|NCT05102591|Analgesics|analgesics|mesh-ancestor
14208851|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
14208852|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208853|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208854|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14208855|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208856|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14208857|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208858|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208859|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
14208860|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
14208861|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208862|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14208863|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14208864|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
14208865|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208866|NCT05088252|Propofol|propofol|mesh-list
14208867|NCT05088252|Desflurane|desflurane|mesh-list
14208868|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208869|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208870|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208871|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14208872|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
14208873|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
14780596|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780597|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14780598|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
14780599|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
14780600|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
14780601|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
14780602|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14780603|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780604|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780605|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
14780606|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14780607|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780608|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780609|NCT00683956|Propofol|propofol|mesh-list
14780610|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
14780611|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780612|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780613|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14780614|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14780615|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
14780616|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
14780617|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14780618|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780619|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14780620|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
14780621|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14780622|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780623|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780624|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780625|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
14780626|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14780627|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208874|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14208875|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
14208876|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14208877|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14208878|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780628|NCT00683995|Fentanyl|fentanyl|mesh-list
14943558|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
14943559|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943560|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
14943561|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943562|NCT01508221|Protective Agents|protective agents|mesh-ancestor
14943563|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14943564|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943565|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14943566|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14943567|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
14208879|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
14208880|NCT05075200|Coagulants|coagulants|mesh-ancestor
14208881|NCT05071937|Talazoparib|talazoparib|mesh-list
14208882|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14208883|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208884|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208885|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208886|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
14943568|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14943569|NCT01508260|Furosemide|furosemide|mesh-list
14943570|NCT01508260|Diuretics|diuretics|mesh-ancestor
14208887|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208888|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14208889|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208890|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208891|NCT05065866|Azacitidine|azacitidine|mesh-list
14208892|NCT05065866|Cc-486|cc-486|mesh-list
14780629|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14780630|NCT00683995|Narcotics|narcotics|mesh-ancestor
14780631|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780632|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780633|NCT00683995|Analgesics|analgesics|mesh-ancestor
14780634|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
14780635|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780636|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14780637|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14780638|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
14780639|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
14780640|NCT00684099|Docetaxel|docetaxel|mesh-list
14780641|NCT00684099|Pemetrexed|pemetrexed|mesh-list
14780642|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780643|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780644|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
14943571|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
14943572|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943573|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14943574|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14943575|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943576|NCT01508286|Ribavirin|ribavirin|mesh-list
14943577|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
14943578|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943579|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
14943580|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943581|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14943582|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14943583|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943584|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943585|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
14943586|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943587|NCT01508364|Sorafenib|sorafenib|mesh-list
14943588|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943589|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14943590|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943591|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943592|NCT01508429|Misoprostol|misoprostol|mesh-list
14943593|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14943594|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
14943595|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14943596|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943597|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14943598|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943599|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
14943600|NCT01508468|Rituximab|rituximab|mesh-list
14943601|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
14943602|NCT01508468|Giapreza|giapreza|mesh-list
14780645|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
14780646|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780647|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780648|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14780649|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14780650|NCT00684112|Gabapentin|gabapentin|mesh-list
14780651|NCT00684112|Analgesics|analgesics|mesh-ancestor
14780652|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
14780653|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780654|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780655|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
14780656|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14780657|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14780658|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780659|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14780660|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14780661|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14780662|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943603|NCT01508468|Calcium|calcium|mesh-list
14943604|NCT01508468|Diuretics|diuretics|mesh-list
14780663|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780664|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
14780665|NCT00684164|Conivaptan|conivaptan|mesh-list
14780666|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14780667|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780668|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
14780669|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780670|NCT00684190|Esomeprazole|esomeprazole|mesh-list
14780671|NCT00684190|Lesogaberan|lesogaberan|mesh-list
14780672|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14780673|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14780674|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14780675|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780676|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780677|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14780678|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
14780679|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
14780680|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780681|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780682|NCT00684216|Tamoxifen|tamoxifen|mesh-list
14780683|NCT00684216|Capecitabine|capecitabine|mesh-list
14780684|NCT00684216|Letrozole|letrozole|mesh-list
14780685|NCT00684216|Anastrozole|anastrozole|mesh-list
14780686|NCT00684216|Exemestane|exemestane|mesh-list
14780687|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14780688|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
14780689|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780690|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780691|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14780692|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14780693|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943605|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14780694|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14780695|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
14780696|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780697|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780698|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14780699|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14780700|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14780701|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14780702|NCT00684229|Anesthetics|anesthetics|mesh-list
14780703|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780704|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780705|NCT00684268|Silybin|silybin|mesh-list
14780706|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14780707|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780708|NCT00684268|Protective Agents|protective agents|mesh-ancestor
14780709|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780710|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14780711|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14780712|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943606|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14943607|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
14943608|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14943609|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943610|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943611|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
14943612|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943613|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14943614|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14943615|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
14943616|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14780713|NCT00684372|Leflunomide|leflunomide|mesh-list
14780714|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780715|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780716|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780717|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
14780718|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780719|NCT00684385|Gefitinib|gefitinib|mesh-list
14780720|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780721|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14780722|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943617|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780723|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780724|NCT00684450|Protamines|protamines|mesh-list
14780725|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
14780726|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780727|NCT00684450|Coagulants|coagulants|mesh-ancestor
14943618|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943619|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943620|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14943621|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14943622|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
14943623|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
14943624|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943625|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14943626|NCT01508494|Galantamine|galantamine|mesh-list
14943627|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14943628|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943629|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943630|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
14208893|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14208894|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
14208895|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208896|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208897|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208898|NCT05063604|Citalopram|citalopram|mesh-list
14208899|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14208900|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14208901|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14208902|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208903|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14208904|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
14208905|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208906|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14208907|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
14208908|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14208909|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
14208910|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
14208911|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208912|NCT05060003|Atezolizumab|atezolizumab|mesh-list
14505675|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14943631|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943632|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943633|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14943634|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
14943635|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943636|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
14943637|NCT01508572|Bevacizumab|bevacizumab|mesh-list
14943638|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943639|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943640|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14943641|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14943642|NCT01508572|Growth Substances|growth substances|mesh-ancestor
14943643|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943644|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943645|NCT01508611|Fluorides|fluorides|mesh-list
14943646|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
14943647|NCT01508611|Protective Agents|protective agents|mesh-ancestor
14943648|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943649|NCT01508637|Terazosin|terazosin|mesh-list
14943650|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14943651|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14943652|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14943653|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
14505676|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505677|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505678|NCT02878382|Calcipotriene|calcipotriene|mesh-list
14505679|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505680|NCT02879318|Gemcitabine|gemcitabine|mesh-list
14505681|NCT02879318|Paclitaxel|paclitaxel|mesh-list
14505682|NCT02879318|Durvalumab|durvalumab|mesh-list
14505683|NCT02879318|Tremelimumab|tremelimumab|mesh-list
14505684|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14505685|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505686|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14780728|NCT00684463|Palonosetron|palonosetron|mesh-list
14780729|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
14780730|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
14780731|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780732|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780733|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14780734|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14780735|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14780736|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
14780737|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780738|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780739|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
14780740|NCT00684489|Coal Tar|coal tar|mesh-list
14943654|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943655|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943656|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943657|NCT01508637|Urological Agents|urological agents|mesh-ancestor
14943658|NCT01508663|Everolimus|everolimus|mesh-list
14943659|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14943660|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943661|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943662|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
14943663|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943664|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
14943665|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943666|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943667|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14943668|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14943669|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
14943670|NCT01508806|Liraglutide|liraglutide|mesh-list
14943671|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943672|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943673|NCT01508806|Incretins|incretins|mesh-ancestor
14943674|NCT01508806|Hormones|hormones|mesh-ancestor
14943675|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943676|NCT01508845|Vitamin D|vitamin d|mesh-list
14943677|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
14943678|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
14943679|NCT01508845|Vitamins|vitamins|mesh-list
14943680|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
14943681|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943682|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14943683|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14943684|NCT01508858|Liraglutide|liraglutide|mesh-list
14943685|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
14943686|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14943687|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943688|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943689|NCT01508858|Incretins|incretins|mesh-ancestor
14943690|NCT01508858|Hormones|hormones|mesh-ancestor
14943691|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943692|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14943693|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
14943694|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14943695|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14943696|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14943697|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14943698|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14943699|NCT01508858|Estrogens|estrogens|mesh-ancestor
14943700|NCT01508884|Imiquimod|imiquimod|mesh-list
14943701|NCT01508884|Vaccines|vaccines|mesh-list
14943702|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
14943703|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943704|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14943705|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943706|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
14943707|NCT01508897|Liraglutide|liraglutide|mesh-list
14943708|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943709|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943710|NCT01508897|Incretins|incretins|mesh-ancestor
14943711|NCT01508897|Hormones|hormones|mesh-ancestor
14943712|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943713|NCT01508923|Liraglutide|liraglutide|mesh-list
14943714|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943715|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780741|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
14780742|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
14780743|NCT00684528|Metformin|metformin|mesh-list
14780744|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14780745|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780746|NCT00684606|Oxytocin|oxytocin|mesh-list
14780747|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
14780748|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780749|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780750|NCT00684632|Fentanyl|fentanyl|mesh-list
14780751|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14780752|NCT00684632|Narcotics|narcotics|mesh-ancestor
14780753|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780754|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780755|NCT00684632|Analgesics|analgesics|mesh-ancestor
14780756|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
14780757|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780758|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14780759|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14780760|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
14780761|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
14780762|NCT00684827|Albuterol|albuterol|mesh-list
14780763|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780764|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
14780765|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780766|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780767|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780768|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780769|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
14780770|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780771|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14780772|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780773|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780774|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780775|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780776|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780777|NCT00684853|Bevacizumab|bevacizumab|mesh-list
14943716|NCT01508923|Incretins|incretins|mesh-ancestor
14943717|NCT01508923|Hormones|hormones|mesh-ancestor
14943718|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943719|NCT01508949|Liraglutide|liraglutide|mesh-list
14943720|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943721|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943722|NCT01508949|Incretins|incretins|mesh-ancestor
14943723|NCT01508949|Hormones|hormones|mesh-ancestor
14943724|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943725|NCT01509001|Metformin|metformin|mesh-list
14943726|NCT01509001|Glimepiride|glimepiride|mesh-list
14943727|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943728|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943729|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14943730|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943731|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
14943732|NCT01509131|Bisacodyl|bisacodyl|mesh-list
14943733|NCT01509131|Cathartics|cathartics|mesh-ancestor
14943734|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943735|NCT01509131|Laxatives|laxatives|mesh-ancestor
14943736|NCT01509144|Vaccines|vaccines|mesh-list
14943737|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
14943738|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943739|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
14943740|NCT01509209|Ephedrine|ephedrine|mesh-list
14943741|NCT01509209|Levocetirizine|levocetirizine|mesh-list
14943742|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14943743|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14943744|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
14943745|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
14943746|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943747|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943748|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943749|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14943750|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
14943751|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943752|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780778|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14780779|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943753|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14943754|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
14780780|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14780781|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14780782|NCT00684853|Growth Substances|growth substances|mesh-ancestor
14780783|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780784|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
14780785|NCT00684866|Albuterol|albuterol|mesh-list
14780786|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780787|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
14780788|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780789|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780790|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780791|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780792|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
14780793|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780794|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14780795|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780796|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780797|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780798|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780799|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780800|NCT00684905|Leuprolide|leuprolide|mesh-list
14780801|NCT00684905|Bicalutamide|bicalutamide|mesh-list
14780802|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14780803|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
14780804|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780805|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943755|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14943756|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14780806|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14780807|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780808|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
14780809|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
14780810|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780811|NCT00684957|Hormones|hormones|mesh-list
14780812|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780813|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780814|NCT00685009|Hormones|hormones|mesh-list
14780815|NCT00685009|Progesterone|progesterone|mesh-list
14780816|NCT00685009|Estrogens|estrogens|mesh-list
14780817|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943757|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
14943758|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14943759|NCT01509261|Lansoprazole|lansoprazole|mesh-list
14943760|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
14780818|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780819|NCT00685009|Progestins|progestins|mesh-ancestor
14780820|NCT00685022|Albuterol|albuterol|mesh-list
14780821|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780822|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
14943761|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14943762|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943763|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14943764|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943765|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943766|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
14943767|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
14943768|NCT01509300|Rituximab|rituximab|mesh-list
14943769|NCT01509300|Fludarabine|fludarabine|mesh-list
14943770|NCT01509300|Tacrolimus|tacrolimus|mesh-list
14943771|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14943772|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780823|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780824|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780825|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780826|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780827|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
14780828|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780829|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14780830|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780831|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780832|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780833|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780834|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780835|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
14780836|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
14780837|NCT00685061|Daclizumab|daclizumab|mesh-list
14780838|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
14780839|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780840|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14780841|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14780842|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780843|NCT00685100|Triamcinolone|triamcinolone|mesh-list
14780844|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943773|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
14943774|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943775|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14943776|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14943777|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
14943778|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943779|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943780|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14943781|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943782|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14943783|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943784|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14943785|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14943786|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
14943787|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14943788|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026864|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026865|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15026866|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026867|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026868|NCT01946295|Famotidine|famotidine|mesh-list
15026869|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15026870|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026871|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15026872|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
15026873|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
15026874|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026875|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026876|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026877|NCT01946373|Vidarabine|vidarabine|mesh-list
15026878|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
15026879|NCT01946373|Fludarabine|fludarabine|mesh-list
15026880|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
15026881|NCT01946373|Interleukin-2|interleukin-2|mesh-list
15026882|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15026883|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
15026884|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026885|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15026886|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15026887|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
15026888|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026889|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026890|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15026891|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026892|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
15026893|NCT01946373|Antiviral Agents|antiviral agents|mesh-ancestor
15026894|NCT01946373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026895|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15026896|NCT01946373|Analgesics|analgesics|mesh-ancestor
15026897|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
15026898|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026899|NCT01946386|Betamethasone|betamethasone|mesh-list
15026900|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
15026901|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15026902|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
15026903|NCT01946386|Clobetasol|clobetasol|mesh-list
14780845|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
14780846|NCT00685100|Hormones|hormones|mesh-ancestor
14780847|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780848|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780849|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14780850|NCT00685126|Albuterol|albuterol|mesh-list
14780851|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780852|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
14780853|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780854|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780855|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780856|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780857|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
14780858|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780859|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14780860|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14208913|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208914|NCT05040568|Vidarabine|vidarabine|mesh-list
14208915|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
14208916|NCT05040568|Fludarabine|fludarabine|mesh-list
14208917|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
14208918|NCT05040568|Cetuximab|cetuximab|mesh-list
14208919|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14208920|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
14208921|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208922|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14208923|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14208924|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
14208925|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208926|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208927|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14208928|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14208929|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
14208930|NCT05040568|Antiviral Agents|antiviral agents|mesh-ancestor
14208931|NCT05040568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208932|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14780861|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780862|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780863|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780864|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780865|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
14780866|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14780867|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14780868|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
14780869|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14780870|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14780871|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14780872|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208933|NCT05036317|Empagliflozin|empagliflozin|mesh-list
14208934|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14208935|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208936|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14208937|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208938|NCT05034367|Mannitol|mannitol|mesh-list
14208939|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14208940|NCT05034367|Diuretics|diuretics|mesh-ancestor
14208941|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
14208942|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208943|NCT05026905|Leucovorin|leucovorin|mesh-list
14208944|NCT05026905|Gemcitabine|gemcitabine|mesh-list
14780873|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780874|NCT00685230|Antivenins|antivenins|mesh-list
14780875|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
14780876|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780877|NCT00685269|Eszopiclone|eszopiclone|mesh-list
14780878|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14780879|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14780880|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780881|NCT00685347|Albuterol|albuterol|mesh-list
14780882|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780883|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
14780884|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780885|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780886|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780887|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780888|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
14780889|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780890|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14780891|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780892|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780893|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780894|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780895|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780896|NCT00685425|Albuterol|albuterol|mesh-list
14780897|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780898|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
14780899|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780900|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780901|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780902|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780903|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
14780904|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14780905|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14780906|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780907|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780908|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780909|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780910|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780911|NCT00685464|Abciximab|abciximab|mesh-list
14780912|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
14780913|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14780914|NCT00685503|Ranibizumab|ranibizumab|mesh-list
14780915|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14780916|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14780917|NCT00685503|Growth Substances|growth substances|mesh-ancestor
14780918|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780919|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
14780920|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780921|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
14780922|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780923|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
14780924|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780925|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780926|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780927|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780928|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14780929|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780930|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780931|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780932|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780933|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780934|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
14780935|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14780936|NCT00685568|Celecoxib|celecoxib|mesh-list
14780937|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14780938|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14780939|NCT00685568|Analgesics|analgesics|mesh-ancestor
14780940|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
14780941|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780942|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780943|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14780944|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14780945|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14780946|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14780947|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14780948|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780949|NCT00685594|Vitamin D|vitamin d|mesh-list
14780950|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
14780951|NCT00685594|Vitamins|vitamins|mesh-ancestor
14780952|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
14780953|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780954|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14780955|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14780956|NCT00685607|Simethicone|simethicone|mesh-list
14780957|NCT00685607|Loperamide|loperamide|mesh-list
14780958|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
14780959|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14208945|NCT05026905|Paclitaxel|paclitaxel|mesh-list
14780960|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
14780961|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780962|NCT00685607|Emollients|emollients|mesh-ancestor
14780963|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
14780964|NCT00685633|Bicalutamide|bicalutamide|mesh-list
14780965|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
14780966|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
14780967|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780968|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780969|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14780970|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
14780971|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
14780972|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14943789|NCT01509365|Clopidogrel|clopidogrel|mesh-list
14943790|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14943791|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14943792|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14943793|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14943794|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
14943795|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943796|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943797|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943798|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14943799|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14943800|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
14943801|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943802|NCT01509469|Caseins|caseins|mesh-list
14943803|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
14943804|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
14943805|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943806|NCT01509521|Phenylephrine|phenylephrine|mesh-list
14943807|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
14943808|NCT01509521|Ephedrine|ephedrine|mesh-list
14943809|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
14943810|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14943811|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
14943812|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
14943813|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943814|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943815|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
14943816|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14943817|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
14943818|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
14943819|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14943820|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14943821|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14943822|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
14943823|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943824|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943825|NCT01509521|Protective Agents|protective agents|mesh-ancestor
14943826|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14943827|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14943828|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14943829|NCT01509560|Everolimus|everolimus|mesh-list
14943830|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943831|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943832|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
14943833|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780973|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780974|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
14780975|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14780976|NCT00685672|Epinephrine|epinephrine|mesh-list
14780977|NCT00685672|Racepinephrine|racepinephrine|mesh-list
14780978|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
14780979|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14780980|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14780981|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
14780982|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14780983|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780984|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14780985|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14780986|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14780987|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
14780988|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14780989|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14780990|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
14780991|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
14780992|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
14780993|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14780994|NCT00685776|Anacetrapib|anacetrapib|mesh-list
14780995|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14780996|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14780997|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
14780998|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14780999|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781000|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
14781001|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781002|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14781003|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781004|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781005|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14781006|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
14781007|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14781008|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14781009|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
14781010|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781011|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781012|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14781013|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
14781014|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14781015|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14781016|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14781017|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
14781018|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781019|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781020|NCT00685854|Ranibizumab|ranibizumab|mesh-list
14781021|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14781022|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14781023|NCT00685854|Growth Substances|growth substances|mesh-ancestor
14781024|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781025|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
14781026|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781027|NCT00685906|Ticagrelor|ticagrelor|mesh-list
14781028|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
14781029|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14781030|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14781031|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14781032|NCT00685906|Estradiol|estradiol|mesh-list
14781033|NCT00685906|Estrogens|estrogens|mesh-ancestor
14781034|NCT00685906|Hormones|hormones|mesh-ancestor
14781035|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781036|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781037|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14781038|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
14781039|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14781040|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14781041|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14781042|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14781043|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14781044|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14208946|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14208947|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
14208948|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14208949|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208950|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
14208951|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
14208952|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
14208953|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208954|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14208955|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
14208956|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
14208957|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14208958|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14208959|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14208960|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
14781045|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14781046|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14781047|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14781048|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
14781049|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781050|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781051|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14781052|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14781053|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14781054|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14781055|NCT00685958|Enoxaparin|enoxaparin|mesh-list
14781056|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
14781057|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14781058|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14781059|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781060|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
14781061|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14781062|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781063|NCT00685971|Vitamins|vitamins|mesh-ancestor
14781064|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
14781065|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14781066|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
14781067|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781068|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781069|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
14781070|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781071|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781072|NCT00686114|Paclitaxel|paclitaxel|mesh-list
14781073|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14781074|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14208961|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208962|NCT05026905|Antidotes|antidotes|mesh-ancestor
14208963|NCT05026905|Protective Agents|protective agents|mesh-ancestor
14208964|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
14208965|NCT05026905|Vitamins|vitamins|mesh-ancestor
14208966|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
14208967|NCT05025397|Propofol|propofol|mesh-list
14208968|NCT05025397|Sevoflurane|sevoflurane|mesh-list
14208969|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14208970|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208971|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208972|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14208973|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
14208974|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
14208975|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14208976|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14208977|NCT05020769|Osimertinib|osimertinib|mesh-list
14208978|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14208979|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14208980|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781075|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781076|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781077|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781078|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781079|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781080|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14781081|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781082|NCT00686140|Celecoxib|celecoxib|mesh-list
14943834|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
14943835|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781083|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14781084|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14781085|NCT00686140|Analgesics|analgesics|mesh-ancestor
14781086|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
14781087|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781088|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781089|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781090|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781091|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14781092|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14781093|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781094|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781095|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
14781096|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14781097|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781098|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781099|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781100|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781101|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943836|NCT01509742|Liraglutide|liraglutide|mesh-list
14781102|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781103|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
14781104|NCT00686192|Calcium|calcium|mesh-list
14781105|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14781106|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781107|NCT00686192|Antacids|antacids|mesh-ancestor
14781108|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781109|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14781110|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
14781111|NCT00686218|Panobinostat|panobinostat|mesh-list
14781112|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14781113|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781114|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14781115|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781116|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781117|NCT00686322|Paclitaxel|paclitaxel|mesh-list
14781118|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14781119|NCT00686322|Cisplatin|cisplatin|mesh-list
14781120|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14781121|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781122|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781123|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781124|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781125|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781126|NCT00686361|Choline|choline|mesh-list
14781127|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
14781128|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781129|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
14781130|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781131|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14781132|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14943837|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943838|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943839|NCT01509742|Incretins|incretins|mesh-ancestor
14943840|NCT01509742|Hormones|hormones|mesh-ancestor
14943841|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943842|NCT01509755|Liraglutide|liraglutide|mesh-list
14943843|NCT01509755|Glimepiride|glimepiride|mesh-list
14943844|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943845|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943846|NCT01509755|Incretins|incretins|mesh-ancestor
14943847|NCT01509755|Hormones|hormones|mesh-ancestor
14943848|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781133|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
14781134|NCT00686374|Adalimumab|adalimumab|mesh-list
14781135|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781136|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14943849|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14943850|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14208981|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14208982|NCT05019638|Ketorolac|ketorolac|mesh-list
14208983|NCT05019638|Epinephrine|epinephrine|mesh-list
14208984|NCT05019638|Racepinephrine|racepinephrine|mesh-list
14208985|NCT05019638|Morphine|morphine|mesh-list
14208986|NCT05019638|Bupivacaine|bupivacaine|mesh-list
14208987|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
14208988|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
14208989|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
14208990|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14208991|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14208992|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
14208993|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14208994|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14208995|NCT05019638|Narcotics|narcotics|mesh-ancestor
14208996|NCT05019638|Analgesics|analgesics|mesh-ancestor
14208997|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14208998|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14208999|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
14209000|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209001|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209002|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14209003|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14943851|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
14943852|NCT01509911|Gemcitabine|gemcitabine|mesh-list
14943853|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14943854|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
14943855|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943856|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943857|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
14943858|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943859|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943860|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943861|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
14943862|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943863|NCT01509976|Triclosan|triclosan|mesh-list
14943864|NCT01509976|Triclocarban|triclocarban|mesh-list
14943865|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14943866|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943867|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14943868|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14943869|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
14943870|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943871|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14943872|NCT01510015|Risperidone|risperidone|mesh-list
14943873|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14943874|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
14943875|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943876|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943877|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943878|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14943879|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14943880|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14943881|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14943882|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14943883|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
14943884|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
14943885|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943886|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943887|NCT01510132|Timolol|timolol|mesh-list
14943888|NCT01510132|Travoprost|travoprost|mesh-list
14943889|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14943890|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14943891|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
14943892|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943893|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943894|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943895|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14209004|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
14209005|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14943896|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14943897|NCT01510171|Ticagrelor|ticagrelor|mesh-list
14781137|NCT00686439|Adalimumab|adalimumab|mesh-list
14781138|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781139|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781140|NCT00686478|Interferons|interferons|mesh-list
14781141|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
14781142|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
14781143|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781144|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
14781145|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781146|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
14781147|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781148|NCT00686556|Cyclosporine|cyclosporine|mesh-list
14781149|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
14781150|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
14781151|NCT00686556|Fludarabine|fludarabine|mesh-list
14781152|NCT00686556|Cyclosporins|cyclosporins|mesh-list
14781153|NCT00686556|Sargramostim|sargramostim|mesh-list
14781154|NCT00686556|Lenograstim|lenograstim|mesh-list
14781155|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781156|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
14781157|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781158|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781159|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14781160|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
14781161|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781162|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781163|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14781164|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781165|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
14781166|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781167|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
14781168|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14781169|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14781170|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14781171|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
14781172|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14781173|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14781174|NCT00686621|Posaconazole|posaconazole|mesh-list
14781175|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
14781176|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781177|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14781178|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14781179|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14781180|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14781181|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14781182|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781183|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781184|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14781185|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
14781186|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781187|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781188|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
14781189|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781190|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781191|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
13964558|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13964559|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
13964560|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13964561|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964562|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14781192|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781193|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781194|NCT00686868|Ofatumumab|ofatumumab|mesh-list
14781195|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781196|NCT00686985|Carboplatin|carboplatin|mesh-list
14781197|NCT00686985|Docetaxel|docetaxel|mesh-list
14781198|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781199|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781200|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781201|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781202|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781203|NCT00687011|Dexamethasone|dexamethasone|mesh-list
14781204|NCT00687011|Palonosetron|palonosetron|mesh-list
14781205|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781206|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
14781207|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
14781208|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781209|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781210|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14781211|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
14781212|NCT00687011|Hormones|hormones|mesh-ancestor
14781213|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781214|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14781215|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781216|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14781217|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14781218|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
14781219|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781220|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781221|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
14781222|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14943898|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14943899|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14943900|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14943901|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14943902|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14943903|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
14943904|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14943905|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943906|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943907|NCT01510288|Ipilimumab|ipilimumab|mesh-list
14943908|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14943909|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943910|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14943911|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943912|NCT01510366|Vaccines|vaccines|mesh-list
14943913|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
14943914|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943915|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
14943916|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943917|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
14943918|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943919|NCT01510509|Everolimus|everolimus|mesh-list
14943920|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943921|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943922|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
14943923|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943924|NCT01510522|Metformin|metformin|mesh-list
14943925|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14943926|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943927|NCT01510548|Adalimumab|adalimumab|mesh-list
14943928|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943929|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14943930|NCT01510561|Gemcitabine|gemcitabine|mesh-list
14943931|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14943932|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14943933|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14943934|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
14943935|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943936|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943937|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
14943938|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14943939|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14943940|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14943941|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
14943942|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943943|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
14943944|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
14943945|NCT01510574|Misoprostol|misoprostol|mesh-list
14943946|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14943947|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
14943948|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14943949|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943950|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14943951|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943952|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
14943953|NCT01510613|Dexamethasone|dexamethasone|mesh-list
14943954|NCT01510613|Pomalidomide|pomalidomide|mesh-list
14943955|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14943956|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
14943957|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
14781223|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781224|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
14781225|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14781226|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781227|NCT00687206|Valsartan|valsartan|mesh-list
14781228|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14781229|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14781230|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14781231|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781232|NCT00687245|Esomeprazole|esomeprazole|mesh-list
14781233|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14781234|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14781235|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14781236|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781237|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781238|NCT00687258|Vitamin E|vitamin e|mesh-list
14781239|NCT00687258|Vitamins|vitamins|mesh-ancestor
14781240|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
14781241|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781242|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
14781243|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781244|NCT00687258|Protective Agents|protective agents|mesh-ancestor
14781245|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
14781246|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14781247|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781248|NCT00687388|Celecoxib|celecoxib|mesh-list
14781249|NCT00687388|Doxazosin|doxazosin|mesh-list
14781250|NCT00687388|Prazosin|prazosin|mesh-list
14781251|NCT00687388|Tamsulosin|tamsulosin|mesh-list
14781252|NCT00687388|Alfuzosin|alfuzosin|mesh-list
14781253|NCT00687388|Terazosin|terazosin|mesh-list
14781254|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14781255|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14943958|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14943959|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943960|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943961|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
14943962|NCT01510613|Hormones|hormones|mesh-ancestor
14943963|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943964|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14943965|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14943966|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
14943967|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14943968|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14943969|NCT01510613|Growth Substances|growth substances|mesh-ancestor
14943970|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
14943971|NCT01510626|Omalizumab|omalizumab|mesh-list
14943972|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14781256|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14781257|NCT00687388|Analgesics|analgesics|mesh-ancestor
14781258|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
14781259|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781260|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781261|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781262|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781263|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14781264|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14781265|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781266|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781267|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14781268|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14781269|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
14781270|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781271|NCT00687388|Urological Agents|urological agents|mesh-ancestor
14781272|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14781273|NCT00687466|Insulin|insulin|mesh-list
14781274|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14781275|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781276|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
14781277|NCT00687518|Hematinics|hematinics|mesh-ancestor
14781278|NCT00687622|Trametinib|trametinib|mesh-list
14209006|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
14209007|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
14209008|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
14209009|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14209010|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14209011|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209012|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209013|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209014|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14209015|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209016|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
14209017|NCT05016609|Velpatasvir|velpatasvir|mesh-list
14209018|NCT05016609|Antibodies|antibodies|mesh-list
14209019|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
14209020|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
14209021|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209022|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
14209023|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781279|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781280|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14781281|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781282|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781283|NCT00687648|Prednisolone|prednisolone|mesh-list
14781284|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
14781285|NCT00687648|Methotrexate|methotrexate|mesh-list
14781286|NCT00687648|Letrozole|letrozole|mesh-list
14781287|NCT00687648|Anastrozole|anastrozole|mesh-list
14781288|NCT00687648|Exemestane|exemestane|mesh-list
14781289|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781290|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
14781291|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241145|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14241146|NCT00172185|Protective Agents|protective agents|mesh-ancestor
14241147|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241148|NCT00174382|Donepezil|donepezil|mesh-list
14241149|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14241150|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241151|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241152|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
14241153|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241154|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241155|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
14781292|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781293|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14781294|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
14781295|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781296|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781297|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14781298|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14781299|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
14781300|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14781301|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14781302|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
14781303|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
14781304|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781305|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14241156|NCT00174447|Ziprasidone|ziprasidone|mesh-list
14781306|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14781307|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781308|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
14781309|NCT00687648|Hormones|hormones|mesh-ancestor
14781310|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781311|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14781312|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14781313|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14781314|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14781315|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
14781316|NCT00687661|Diphosphonates|diphosphonates|mesh-list
14781317|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14241157|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14241158|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
14241159|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781318|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781319|NCT00687700|Propranolol|propranolol|mesh-list
14781320|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14781321|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14781322|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
14781323|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781324|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781325|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781326|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14781327|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14781328|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
14781329|NCT00687765|Temozolomide|temozolomide|mesh-list
14781330|NCT00687765|Iniparib|iniparib|mesh-list
14781331|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14781332|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
14781333|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781334|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781335|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14781336|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781337|NCT00687817|Paclitaxel|paclitaxel|mesh-list
14781338|NCT00687817|Carboplatin|carboplatin|mesh-list
14781339|NCT00687817|Bavituximab|bavituximab|mesh-list
14781340|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14781341|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781342|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781343|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781344|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781345|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781346|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14781347|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
14781348|NCT00687843|Tegafur|tegafur|mesh-list
14781349|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14781350|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
14781351|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781352|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781353|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14781354|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
14781355|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781356|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14781357|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
14781358|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781359|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
14781360|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14781361|NCT00687843|Protective Agents|protective agents|mesh-ancestor
14781362|NCT00687999|Interferons|interferons|mesh-list
14781363|NCT00687999|Ribavirin|ribavirin|mesh-list
14781364|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
14781365|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781366|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
14781367|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781368|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
14781369|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781370|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
14781371|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781372|NCT00688077|Calcitonin|calcitonin|mesh-list
14781373|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
14781374|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14781375|NCT00688077|Katacalcin|katacalcin|mesh-list
14781376|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14781377|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781378|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14781379|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
14781380|NCT00688194|Letrozole|letrozole|mesh-list
14781381|NCT00688194|Fulvestrant|fulvestrant|mesh-list
14781382|NCT00688194|Lapatinib|lapatinib|mesh-list
14781383|NCT00688194|Anastrozole|anastrozole|mesh-list
14781384|NCT00688194|Exemestane|exemestane|mesh-list
14781385|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781386|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14209024|NCT05013216|Poly ICLC|poly iclc|mesh-list
14209025|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
14209026|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
14209027|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781387|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14209028|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
14781388|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781389|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209029|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781390|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14781391|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
14781392|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209030|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14209031|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209032|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209033|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
14209034|NCT05005559|Paraproteins|paraproteins|mesh-list
14781393|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781394|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14781395|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14781396|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14781397|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
14781398|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14781399|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781400|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
14781401|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14781402|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781403|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781404|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781405|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781406|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14943973|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14943974|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
14943975|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
14943976|NCT01510665|Cathartics|cathartics|mesh-ancestor
14943977|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943978|NCT01510795|Spironolactone|spironolactone|mesh-list
14943979|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14943980|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
14943981|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943982|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943983|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14943984|NCT01510795|Diuretics|diuretics|mesh-ancestor
14943985|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
14943986|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
14943987|NCT01510847|Androgens|androgens|mesh-ancestor
14943988|NCT01510847|Hormones|hormones|mesh-ancestor
14943989|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14943990|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14943991|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14943992|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14943993|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943994|NCT01510977|Bisacodyl|bisacodyl|mesh-list
14943995|NCT01510977|Cathartics|cathartics|mesh-ancestor
14943996|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14943997|NCT01510977|Laxatives|laxatives|mesh-ancestor
14943998|NCT01510990|Gefitinib|gefitinib|mesh-list
14943999|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944000|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14944001|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944002|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944003|NCT01511003|Tacrolimus|tacrolimus|mesh-list
14944004|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944005|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
14944006|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944007|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14944008|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944009|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944010|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
14944011|NCT01511029|Pramipexole|pramipexole|mesh-list
14944012|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944013|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944014|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14944015|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14944016|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944017|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944018|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944019|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944020|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
14944021|NCT01511029|Protective Agents|protective agents|mesh-ancestor
14944022|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14209035|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
14944023|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14781407|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781408|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14781409|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14781410|NCT00688298|Imidacloprid|imidacloprid|mesh-list
14781411|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
14781412|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781413|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781414|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781415|NCT00688402|Lesogaberan|lesogaberan|mesh-list
14781416|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14781417|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14781418|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
14781419|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
14781420|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781421|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781422|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781423|NCT00688428|Aspirin|aspirin|mesh-list
14781424|NCT00688428|Esomeprazole|esomeprazole|mesh-list
14944024|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
14944025|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
14944026|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944027|NCT01511042|Norepinephrine|norepinephrine|mesh-list
14944028|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
14944029|NCT01511042|Giapreza|giapreza|mesh-list
14944030|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
14944031|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14944032|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14944033|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
14944034|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944035|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944036|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944037|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
14944038|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
14944039|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944040|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14944041|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14944042|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
14944043|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026904|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15026905|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209036|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209037|NCT05004259|Daratumumab|daratumumab|mesh-list
14209038|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209039|NCT05002816|Elotuzumab|elotuzumab|mesh-list
14209040|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026906|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
15026907|NCT01946386|Hormones|hormones|mesh-ancestor
14209044|NCT04997941|Tamoxifen|tamoxifen|mesh-list
14505687|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
15026908|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026909|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026910|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15026911|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
13964563|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13964564|NCT03136406|Growth Substances|growth substances|mesh-ancestor
13964565|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
13964566|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
13964567|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13964568|NCT03136406|Antidotes|antidotes|mesh-ancestor
13964569|NCT03136406|Protective Agents|protective agents|mesh-ancestor
13964570|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
13964571|NCT03136406|Vitamins|vitamins|mesh-ancestor
13964572|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
13964573|NCT03136146|Dexamethasone|dexamethasone|mesh-list
14209045|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14505688|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14505689|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505690|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14505691|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
14505692|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
14505693|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505694|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505695|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505696|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
14781425|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14781426|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14781427|NCT00688428|Analgesics|analgesics|mesh-ancestor
14781428|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
14781429|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781430|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781431|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781432|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781433|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14781434|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14781435|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781436|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14781437|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14781438|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781439|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
14781440|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14781441|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14781442|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14781443|NCT00688480|Allopurinol|allopurinol|mesh-list
14781444|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
14781445|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781446|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781447|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
14781448|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781449|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14781450|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
14781451|NCT00688480|Protective Agents|protective agents|mesh-ancestor
14781452|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781453|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
14781454|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
14781455|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14781456|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944044|NCT01511146|Gemcitabine|gemcitabine|mesh-list
14944045|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
14944046|NCT01511146|Mitomycins|mitomycins|mesh-list
14944047|NCT01511146|Mitomycin|mitomycin|mesh-list
14944048|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14944049|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
14944050|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944051|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944052|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
14944053|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944054|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944055|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944056|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
14944057|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944058|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14944059|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
14944060|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14944061|NCT01511159|Insulin|insulin|mesh-list
14944062|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14944063|NCT01511159|Liraglutide|liraglutide|mesh-list
14944064|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944065|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944066|NCT01511159|Incretins|incretins|mesh-ancestor
14944067|NCT01511159|Hormones|hormones|mesh-ancestor
14944068|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944069|NCT01511172|Metformin|metformin|mesh-list
14944070|NCT01511172|Liraglutide|liraglutide|mesh-list
14944071|NCT01511172|Glimepiride|glimepiride|mesh-list
14944072|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944073|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944074|NCT01511172|Incretins|incretins|mesh-ancestor
14944075|NCT01511172|Hormones|hormones|mesh-ancestor
14944076|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944077|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14944078|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944079|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
14944080|NCT01511185|Liraglutide|liraglutide|mesh-list
14944081|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944082|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944083|NCT01511185|Incretins|incretins|mesh-ancestor
14781457|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944084|NCT01511185|Hormones|hormones|mesh-ancestor
14944085|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944086|NCT01511198|Metformin|metformin|mesh-list
14944087|NCT01511198|Liraglutide|liraglutide|mesh-list
14781458|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781459|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781460|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781461|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781462|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781463|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14781464|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
14781465|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14781466|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781467|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14781468|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14781469|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14781470|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14781471|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944088|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944089|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944090|NCT01511198|Incretins|incretins|mesh-ancestor
14944091|NCT01511198|Hormones|hormones|mesh-ancestor
14944092|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944093|NCT01511211|Dexamethasone|dexamethasone|mesh-list
14944094|NCT01511211|Ropivacaine|ropivacaine|mesh-list
14944095|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944096|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
14944097|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
14944098|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944099|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944100|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944101|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
14944102|NCT01511211|Hormones|hormones|mesh-ancestor
14944103|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944104|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14944105|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944106|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14944107|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
14944108|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944109|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
14944110|NCT01511237|Lamivudine|lamivudine|mesh-list
14944111|NCT01511237|Zidovudine|zidovudine|mesh-list
14944112|NCT01511237|Nevirapine|nevirapine|mesh-list
14944113|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14944114|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14944115|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944116|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944117|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
14209046|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
14209047|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209048|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209049|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14209050|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209051|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14209052|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14209053|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14209054|NCT04996004|Doxorubicin|doxorubicin|mesh-list
14209055|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14209056|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209057|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14209058|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14209059|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209060|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209061|NCT04994444|Nicotine|nicotine|mesh-list
14209062|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14209063|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
14944118|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944119|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14944120|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14944121|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
14944122|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14944123|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14944124|NCT01511263|Amiodarone|amiodarone|mesh-list
14944125|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14944126|NCT01511263|Diuretics|diuretics|mesh-list
14944127|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
14944128|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944129|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
14781472|NCT00688558|Simvastatin|simvastatin|mesh-list
14781473|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
14781474|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781475|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781476|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
14781477|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781478|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781479|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14781480|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781481|NCT00688805|Propranolol|propranolol|mesh-list
14781482|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14781483|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14781484|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
14781485|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781486|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781487|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781488|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14781489|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14781490|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
14781491|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14781492|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
14944130|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14944131|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14944132|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209064|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209065|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209066|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14209067|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14209068|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
14209069|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209070|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209071|NCT04993677|Carboplatin|carboplatin|mesh-list
14209072|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
14209073|NCT04993677|Pemetrexed|pemetrexed|mesh-list
14209074|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209075|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14781493|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14781494|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14781495|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14781496|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14781497|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781498|NCT00688857|Diazoxide|diazoxide|mesh-list
14781499|NCT00688857|Choline|choline|mesh-list
14781500|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
14781501|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781502|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
14781503|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781504|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14781505|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14944133|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14944134|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14944135|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14944136|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944137|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14944138|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14944139|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14944140|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
14944141|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944142|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14944143|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944144|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944145|NCT01511302|Budesonide|budesonide|mesh-list
14944146|NCT01511302|RNS60|rns60|mesh-list
14944147|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944148|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14944149|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
14944150|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944151|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944152|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14944153|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
14944154|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
14944155|NCT01511302|Hormones|hormones|mesh-ancestor
14781506|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
14781507|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14781508|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
14781509|NCT00688883|Fludarabine|fludarabine|mesh-list
14781510|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
14781511|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781512|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14781513|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
14781514|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781515|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781516|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
14781517|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781518|NCT00688896|Pravastatin|pravastatin|mesh-list
14781519|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
14781520|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781521|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781522|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
14781523|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781524|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781525|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14781526|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781527|NCT00688922|Pravastatin|pravastatin|mesh-list
14781528|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781529|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781530|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
14944156|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944157|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14944158|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944159|NCT01511302|Analgesics|analgesics|mesh-ancestor
14944160|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
14944161|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944162|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14944163|NCT01511367|Fluticasone|fluticasone|mesh-list
14944164|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14944165|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14944166|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
14944167|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944168|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944169|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14944170|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
14944171|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
14944172|NCT01511367|Hormones|hormones|mesh-ancestor
14944173|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944174|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
14944175|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944176|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
14944177|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14944178|NCT01511471|Ticagrelor|ticagrelor|mesh-list
14944179|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14944180|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14944181|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14944182|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14944183|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
14944184|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944185|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944186|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944187|NCT01511562|Cytarabine|cytarabine|mesh-list
14944188|NCT01511562|Etoposide|etoposide|mesh-list
14944189|NCT01511562|Thiotepa|thiotepa|mesh-list
14944190|NCT01511562|Carmustine|carmustine|mesh-list
14944191|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14944192|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944193|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14944194|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14944195|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505697|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505698|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505699|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
14505700|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505701|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505702|NCT02880228|Dexamethasone|dexamethasone|mesh-list
14505703|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
14505704|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
14505705|NCT02880228|Lenalidomide|lenalidomide|mesh-list
14505706|NCT02880228|Ichthammol|ichthammol|mesh-list
14505707|NCT02880228|BB 1101|bb 1101|mesh-list
14781531|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781532|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781533|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14781534|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781535|NCT00688948|Alfuzosin|alfuzosin|mesh-list
14781536|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14781537|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14781538|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14781539|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
14781540|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781541|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781542|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781543|NCT00688948|Urological Agents|urological agents|mesh-ancestor
14781544|NCT00688961|Aspirin|aspirin|mesh-list
14781545|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14781546|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14781547|NCT00688961|Analgesics|analgesics|mesh-ancestor
14944196|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944197|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14944198|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
14944199|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
14944200|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944201|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944202|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
14944203|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944204|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14944205|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
14944206|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14944207|NCT01511627|Anesthetics|anesthetics|mesh-list
14944208|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944209|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209076|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209077|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209078|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14209079|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14209080|NCT04979338|Bupivacaine|bupivacaine|mesh-list
14209081|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
14209082|NCT04979338|Anesthetics|anesthetics|mesh-list
14209083|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209084|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209085|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
14209086|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209087|NCT04979052|Interferons|interferons|mesh-list
14209088|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
14209089|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505708|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505709|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
14505710|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
14505711|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505712|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505713|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505714|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
14505715|NCT02880228|Hormones|hormones|mesh-ancestor
14505716|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505717|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14505718|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505719|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505720|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
14505721|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14505722|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14505723|NCT02880228|Growth Substances|growth substances|mesh-ancestor
14505724|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
14505725|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
14505726|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505727|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505728|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505729|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
14505730|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505731|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505732|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14505733|NCT02880852|Belimumab|belimumab|mesh-list
14505734|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781548|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
14781549|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781550|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781551|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944210|NCT01511692|Liraglutide|liraglutide|mesh-list
14944211|NCT01511692|Glimepiride|glimepiride|mesh-list
14944212|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944213|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944214|NCT01511692|Incretins|incretins|mesh-ancestor
14944215|NCT01511692|Hormones|hormones|mesh-ancestor
14944216|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944217|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14944218|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944219|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
14944220|NCT01511705|Ondansetron|ondansetron|mesh-list
14944221|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
14944222|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
14944223|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944224|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944225|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944226|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
14944227|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
14944228|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14944229|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
14944230|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944231|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944232|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14944233|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14944234|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944235|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14944236|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14944237|NCT01511718|Ondansetron|ondansetron|mesh-list
14944238|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
14944239|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
14944240|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944241|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944242|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944243|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
14944244|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
14944245|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14944246|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
14944247|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944248|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944249|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14781552|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781553|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14781554|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14781555|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781556|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14781557|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14781558|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781559|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
14781560|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
14781561|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781562|NCT00689000|Tosedostat|tosedostat|mesh-list
14781563|NCT00689000|Glycine|glycine|mesh-list
14781564|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781565|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781566|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
14781567|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781568|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781569|NCT00689143|Sargramostim|sargramostim|mesh-list
14781570|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
14781571|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781572|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
14781573|NCT00689156|Docetaxel|docetaxel|mesh-list
14781574|NCT00689156|Epirubicin|epirubicin|mesh-list
14781575|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781576|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
14781577|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781578|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781579|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14781580|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
14944250|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14944251|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944252|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14781581|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781582|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781583|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14781584|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781585|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781586|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781587|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14781588|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781589|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781590|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781591|NCT00689169|Cytarabine|cytarabine|mesh-list
14781592|NCT00689169|Rituximab|rituximab|mesh-list
14781593|NCT00689169|Etoposide|etoposide|mesh-list
14781594|NCT00689169|Melphalan|melphalan|mesh-list
14781595|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14781596|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781597|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
14781598|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781599|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781600|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14781601|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781602|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781603|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781604|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781605|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14781606|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
14781607|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14781608|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781609|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14209090|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
14209091|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209092|NCT04973150|Anesthetics|anesthetics|mesh-list
14209093|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209094|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209095|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
14209096|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209097|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209098|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209099|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209100|NCT04973124|Analgesics|analgesics|mesh-ancestor
14209101|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
14209102|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209103|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14209104|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14209105|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14209106|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
14209107|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209108|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209109|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
14209110|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
14209111|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209112|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781610|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
14781611|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
14781612|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781613|NCT00689195|Curcumin|curcumin|mesh-list
14781614|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14781615|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14781616|NCT00689195|Analgesics|analgesics|mesh-ancestor
14781617|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
14781618|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781619|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781620|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781621|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781622|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781623|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781624|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781625|NCT00689208|Atropine|atropine|mesh-list
14781626|NCT00689208|Physostigmine|physostigmine|mesh-list
14781627|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14781628|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14781629|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14209113|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
14781630|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
14944253|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14781631|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781632|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781633|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14781634|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
14781635|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
14781636|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
14781637|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14781638|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14781639|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
14781640|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781641|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781642|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14781643|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781644|NCT00689208|Miotics|miotics|mesh-ancestor
14781645|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14781646|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781647|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781648|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
14209114|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209115|NCT04969276|Vaccines|vaccines|mesh-list
14209116|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
14209117|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209118|NCT04969120|Metoclopramide|metoclopramide|mesh-list
14209119|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
14209120|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
14505735|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
14505736|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944254|NCT01511731|Famotidine|famotidine|mesh-list
14944255|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14944256|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944257|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14944258|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
14944259|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
14944260|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944261|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944262|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944263|NCT01511757|Fluconazole|fluconazole|mesh-list
14944264|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
14944265|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944266|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14944267|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14944268|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944269|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944270|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14944271|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
14944272|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944273|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944274|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14944275|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14209121|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505737|NCT02880865|Vaccines|vaccines|mesh-list
14505738|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
14505739|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505740|NCT02881008|Entecavir|entecavir|mesh-list
14505741|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
14505742|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505743|NCT02881567|Daclizumab|daclizumab|mesh-list
14505744|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505745|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
14505746|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505747|NCT02881957|Vitamin D|vitamin d|mesh-list
14505748|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
14505749|NCT02881957|Vitamins|vitamins|mesh-ancestor
14505750|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
14505751|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505752|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14505753|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14505754|NCT02881996|Acetaminophen|acetaminophen|mesh-list
14505755|NCT02881996|Ketorolac|ketorolac|mesh-list
14505756|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14505757|NCT02881996|Analgesics|analgesics|mesh-ancestor
14505758|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
14505759|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505760|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505761|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
14781649|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781650|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781651|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14781652|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781653|NCT00689442|Atorvastatin|atorvastatin|mesh-list
14781654|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
14781655|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781656|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781657|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
14781658|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781659|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781660|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14781661|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781662|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
14781663|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14781664|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
14781665|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14781666|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781667|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14781668|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14781669|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14781670|NCT00689520|Vitamin K|vitamin k|mesh-list
14781671|NCT00689520|Tinzaparin|tinzaparin|mesh-list
14781672|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14781673|NCT00689520|Dalteparin|dalteparin|mesh-list
14781674|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
14781675|NCT00689520|Vitamins|vitamins|mesh-ancestor
14781676|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
14781677|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781678|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14781679|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14781680|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781681|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
14781682|NCT00689520|Coagulants|coagulants|mesh-ancestor
14781683|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
14781684|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14781685|NCT00689559|Aripiprazole|aripiprazole|mesh-list
14781686|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
14781687|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14781688|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14781689|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14781690|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944276|NCT01511770|Fluconazole|fluconazole|mesh-list
14944277|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
14944278|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944279|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14944280|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14944281|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944282|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944283|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14944284|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
14944285|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944286|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944287|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14944288|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14944289|NCT01511822|Inositol|inositol|mesh-list
14944290|NCT01511822|Drospirenone|drospirenone|mesh-list
14944291|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14944292|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14944293|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14944294|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14944295|NCT01511822|Estradiol|estradiol|mesh-list
14944296|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14944297|NCT01511822|Estrogens|estrogens|mesh-ancestor
14944298|NCT01511822|Hormones|hormones|mesh-ancestor
14781691|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781692|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
14781693|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
14781694|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781695|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781696|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14944299|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781697|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14781698|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
14209122|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781699|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14781700|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14781701|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14781702|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14781703|NCT00689585|Ethosuximide|ethosuximide|mesh-list
14781704|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
14781705|NCT00689598|Spironolactone|spironolactone|mesh-list
14781706|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14781707|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
14781708|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781709|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781710|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14781711|NCT00689598|Diuretics|diuretics|mesh-ancestor
14781712|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
14781713|NCT00689624|Leucovorin|leucovorin|mesh-list
14781714|NCT00689624|Fluorouracil|fluorouracil|mesh-list
14781715|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
14781716|NCT00689624|Irinotecan|irinotecan|mesh-list
14781717|NCT00689624|Cetuximab|cetuximab|mesh-list
14781718|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
14781719|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781720|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14781721|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781722|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781723|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
14781724|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781725|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14781726|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781727|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781728|NCT00689624|Antidotes|antidotes|mesh-ancestor
14781729|NCT00689624|Protective Agents|protective agents|mesh-ancestor
14781730|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
14781731|NCT00689624|Vitamins|vitamins|mesh-ancestor
14781732|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
14781733|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14781734|NCT00689637|Warfarin|warfarin|mesh-list
14781735|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
14781736|NCT00689702|Capecitabine|capecitabine|mesh-list
14781737|NCT00689702|Cetuximab|cetuximab|mesh-list
14781738|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14781739|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
14781740|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781741|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781742|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14781743|NCT00689715|Ethanol|ethanol|mesh-list
14781744|NCT00689715|Paclitaxel|paclitaxel|mesh-list
14781745|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14781746|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14781747|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781748|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781749|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781750|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781751|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781752|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14781753|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781754|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14781755|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781756|NCT00689780|Midazolam|midazolam|mesh-list
14781757|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14781758|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14781759|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14781760|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781761|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14781762|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14781763|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14781764|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14781765|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
14781766|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
13964574|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
13964575|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
13964576|NCT03136146|Rituximab|rituximab|mesh-list
13964577|NCT03136146|Etoposide|etoposide|mesh-list
13964578|NCT03136146|Vincristine|vincristine|mesh-list
13964579|NCT03136146|Bortezomib|bortezomib|mesh-list
13964580|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
13964581|NCT03136146|Clofarabine|clofarabine|mesh-list
13964582|NCT03136146|Ofatumumab|ofatumumab|mesh-list
14781767|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
14781768|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
14781769|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781770|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781771|NCT00689806|Lovastatin|lovastatin|mesh-list
14781772|NCT00689806|L 647318|l 647318|mesh-list
14781773|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
14781774|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14781775|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14781776|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
14781777|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944300|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944301|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14944302|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
14944303|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14944304|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14944305|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14944306|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14944307|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
14944308|NCT01511822|Vitamins|vitamins|mesh-ancestor
14944309|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
14944310|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14944311|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
14944312|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14944313|NCT01511822|Diuretics|diuretics|mesh-ancestor
14944314|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
14944315|NCT01511835|Folic Acid|folic acid|mesh-list
14944316|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
14944317|NCT01511835|Inositol|inositol|mesh-list
14944318|NCT01511835|Hematinics|hematinics|mesh-ancestor
14944319|NCT01511835|Vitamins|vitamins|mesh-ancestor
14944320|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
14944321|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944322|NCT01511848|Deferasirox|deferasirox|mesh-list
14944323|NCT01511848|Deferiprone|deferiprone|mesh-list
14944324|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14944325|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
14944326|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
14944327|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944328|NCT01511874|Leuprolide|leuprolide|mesh-list
14944329|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14944330|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
14944331|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14944332|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944333|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14944334|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944335|NCT01511887|Ibuprofen|ibuprofen|mesh-list
14944336|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14944337|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944338|NCT01511887|Analgesics|analgesics|mesh-ancestor
14944339|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
14944340|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944341|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944342|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944343|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944344|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14944345|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944346|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944347|NCT01511991|Sevoflurane|sevoflurane|mesh-list
14944348|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14944349|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14944350|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
14944351|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
14944352|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944353|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944354|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14944355|NCT01512004|Propiverine|propiverine|mesh-list
14944356|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14944357|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14944358|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
14944359|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944360|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964583|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
13964584|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13964585|NCT03136146|Antibodies|antibodies|mesh-list
14944361|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944362|NCT01512004|Urological Agents|urological agents|mesh-ancestor
14209123|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14209124|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14209125|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14781778|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14781779|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14781780|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781781|NCT00689832|Fluticasone|fluticasone|mesh-list
14781782|NCT00689832|Tacrolimus|tacrolimus|mesh-list
14781783|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781784|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
14781785|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781786|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14781787|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781788|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781789|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781790|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14781791|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
14781792|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781793|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14781794|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
14781795|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
14781796|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14781797|NCT00689845|Cytarabine|cytarabine|mesh-list
14781798|NCT00689845|Prednisone|prednisone|mesh-list
14781799|NCT00689845|Prednisolone|prednisolone|mesh-list
14781800|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
14944363|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
14781801|NCT00689845|Ifosfamide|ifosfamide|mesh-list
14781802|NCT00689845|Rituximab|rituximab|mesh-list
14781803|NCT00689845|Doxorubicin|doxorubicin|mesh-list
14781804|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14781805|NCT00689845|Methotrexate|methotrexate|mesh-list
14781806|NCT00689845|Etoposide|etoposide|mesh-list
14781807|NCT00689845|Vincristine|vincristine|mesh-list
14781808|NCT00689845|Bleomycin|bleomycin|mesh-list
14781809|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
14781810|NCT00689845|Vindesine|vindesine|mesh-list
14781811|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781812|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
14781813|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781814|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781815|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14781816|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
14781817|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781818|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781819|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14781820|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14781821|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14781822|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781823|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781824|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781825|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781826|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
14781827|NCT00689845|Hormones|hormones|mesh-ancestor
14781828|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781829|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14781830|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14781831|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
14209126|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
14209127|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209128|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209129|NCT04951947|Lenvatinib|lenvatinib|mesh-list
14209130|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209131|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14209132|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209133|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781832|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14781833|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14781834|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
14781835|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
14781836|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14944364|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
14781837|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14781838|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14781839|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
14944365|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781840|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781841|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781842|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781843|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781844|NCT00689858|Cilostazol|cilostazol|mesh-list
14781845|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14781846|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
14781847|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781848|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781849|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14781850|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
14781851|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14781852|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14781853|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781854|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14781855|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
14781856|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14781857|NCT00689858|Protective Agents|protective agents|mesh-ancestor
14781858|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14781859|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14209149|NCT04914676|Cytarabine|cytarabine|mesh-list
14209150|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14944366|NCT01512017|Petrolatum|petrolatum|mesh-list
14944367|NCT01512017|Emollients|emollients|mesh-ancestor
14944368|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
14781860|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781861|NCT00689949|Folic Acid|folic acid|mesh-list
14781862|NCT00689949|Hematinics|hematinics|mesh-ancestor
14781863|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
14781864|NCT00689949|Vitamins|vitamins|mesh-ancestor
14781865|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
14944369|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
14944370|NCT01512147|Propofol|propofol|mesh-list
14944371|NCT01512147|Isoflurane|isoflurane|mesh-list
14944372|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14944373|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944374|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944375|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14944376|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
14944377|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
14944378|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944379|NCT01512147|Analgesics|analgesics|mesh-ancestor
14944380|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
14944381|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944382|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14944383|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14944384|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14944385|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
14944386|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944387|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944388|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14944389|NCT01512173|Propranolol|propranolol|mesh-list
14944390|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14944391|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14944392|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14944393|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944394|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944395|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944396|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14781866|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209151|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
14944397|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14209152|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781867|NCT00690014|Probenecid|probenecid|mesh-list
14781868|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
14781869|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
14781870|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781871|NCT00690014|Renal Agents|renal agents|mesh-ancestor
14781872|NCT00690105|Fluticasone|fluticasone|mesh-list
14781873|NCT00690105|Tacrolimus|tacrolimus|mesh-list
14781874|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781875|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
14781876|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781877|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14781878|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781879|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781880|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781881|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14781882|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
14781883|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781884|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14781885|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
14781886|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
14781887|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14781888|NCT00690118|Pioglitazone|pioglitazone|mesh-list
14781889|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14781890|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781891|NCT00690170|Ketamine|ketamine|mesh-list
14781892|NCT00690170|Nicotine|nicotine|mesh-list
14781893|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14781894|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
14781895|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781896|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781897|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14781898|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14781899|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
14781900|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14781901|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781902|NCT00690170|Analgesics|analgesics|mesh-ancestor
14781903|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
14781904|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14944398|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
14944399|NCT01512199|Paclitaxel|paclitaxel|mesh-list
14944400|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14944401|NCT01512199|Trastuzumab|trastuzumab|mesh-list
14944402|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14944403|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14944404|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944405|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14944406|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14944407|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14944408|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944409|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14944410|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
14944411|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944412|NCT01512316|Cycloserine|cycloserine|mesh-list
14944413|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14944414|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944415|NCT01512316|Renal Agents|renal agents|mesh-ancestor
14944416|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14944417|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
14944418|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14781905|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14781906|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
14781907|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
14781908|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14781909|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14781910|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14781911|NCT00690222|Mydriatics|mydriatics|mesh-list
14781912|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
14781913|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14781914|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781915|NCT00690300|Docetaxel|docetaxel|mesh-list
14781916|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
14944419|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
14944420|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781917|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781918|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781919|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
14944421|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
14781920|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781921|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781922|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
14781923|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14781924|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14781925|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14781926|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781927|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781928|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781929|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781930|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781931|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14781932|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
14781933|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14781934|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781935|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14781936|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14781937|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14944422|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14944423|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944424|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944425|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944426|NCT01512355|Analgesics|analgesics|mesh-ancestor
14944427|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
14944428|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944429|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14944430|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14944431|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14944432|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
14944433|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944434|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944435|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14944436|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14944437|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14944438|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14944439|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944440|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944441|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944442|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14944443|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
14944444|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14209153|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209154|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
14209155|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944445|NCT01512485|Clopidogrel|clopidogrel|mesh-list
14944446|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14944447|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14209156|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209157|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
14209158|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209159|NCT04912505|Aspirin|aspirin|mesh-list
14209160|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14209161|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209162|NCT04912505|Analgesics|analgesics|mesh-ancestor
14209163|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
14209164|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209165|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209166|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209167|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209168|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14209169|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14209170|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209171|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14209172|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14209173|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209174|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
14209175|NCT04912492|Ethanol|ethanol|mesh-list
14944448|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14944449|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14944450|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
14209176|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14781938|NCT00690417|Vitamin D|vitamin d|mesh-list
14781939|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
14781940|NCT00690417|Vitamins|vitamins|mesh-ancestor
14781941|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
14781942|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781943|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14781944|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14781945|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14781946|NCT00690521|Metolazone|metolazone|mesh-list
14781947|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14781948|NCT00690521|Diuretics|diuretics|mesh-ancestor
14781949|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
14781950|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781951|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14781952|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14781953|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781954|NCT00690534|Insulin|insulin|mesh-list
14781955|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14944451|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944452|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944453|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944454|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
14944455|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14944456|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
14944457|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
14944458|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944459|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944460|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944461|NCT01512511|Analgesics|analgesics|mesh-ancestor
14944462|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
14944463|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944464|NCT01512537|Vitamin D|vitamin d|mesh-list
14505762|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14505763|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505764|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505765|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14505766|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944465|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
14944466|NCT01512537|Vitamins|vitamins|mesh-list
14944467|NCT01512537|Calcium|calcium|mesh-list
14944468|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
14944469|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944470|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14944471|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14944472|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14944473|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
14944474|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
14944475|NCT01512680|Insulin|insulin|mesh-list
14944476|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944477|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026912|NCT01946399|Dexamethasone|dexamethasone|mesh-list
15026913|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15026914|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
15026915|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
14505767|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026916|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026917|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026918|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026919|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
15026920|NCT01946399|Hormones|hormones|mesh-ancestor
15026921|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026922|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15026923|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026924|NCT01946555|Fentanyl|fentanyl|mesh-list
15026925|NCT01946555|Morphine|morphine|mesh-list
15026926|NCT01946555|Oxycodone|oxycodone|mesh-list
15026927|NCT01946555|Buprenorphine|buprenorphine|mesh-list
15026928|NCT01946555|Methadone|methadone|mesh-list
15026929|NCT01946555|Hydromorphone|hydromorphone|mesh-list
15026930|NCT01946555|Tapentadol|tapentadol|mesh-list
14505768|NCT02882152|Morphine|morphine|mesh-list
14505769|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14505770|NCT02882152|Narcotics|narcotics|mesh-ancestor
14781956|NCT00690534|Nitroprusside|nitroprusside|mesh-list
15026931|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15026932|NCT01946555|Narcotics|narcotics|mesh-ancestor
15026933|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026934|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781957|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14781958|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781959|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14781960|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
14781961|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14781962|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781963|NCT00690560|Prednisone|prednisone|mesh-list
14781964|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
14944478|NCT01512784|Vaccines|vaccines|mesh-list
14209177|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209178|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209179|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944479|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
14944480|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944481|NCT01512862|Calcitriol|calcitriol|mesh-list
14944482|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14944483|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944484|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14944485|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14944486|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944487|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14944488|NCT01512862|Vitamins|vitamins|mesh-ancestor
14944489|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
14944490|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14944491|NCT01512901|Betamethasone|betamethasone|mesh-list
14944492|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
14944493|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14944494|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
14944495|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14944496|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944497|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
14944498|NCT01512901|Hormones|hormones|mesh-ancestor
14944499|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944500|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944501|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14944502|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
14944503|NCT01512914|Ropivacaine|ropivacaine|mesh-list
14944504|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
14944505|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
14944506|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944507|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944508|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
14944509|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944510|NCT01512953|Lansoprazole|lansoprazole|mesh-list
14944511|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
14944512|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14944513|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944514|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14944515|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944516|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944517|NCT01512966|Aflibercept|aflibercept|mesh-list
14944518|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14944519|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14944520|NCT01512966|Growth Substances|growth substances|mesh-ancestor
14944521|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944522|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
14944523|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944524|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
14944525|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14944526|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944527|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14209180|NCT04910711|Dolutegravir|dolutegravir|mesh-list
14209181|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14209182|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
14209183|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
14209184|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14209185|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
14209186|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14209187|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944528|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
14944529|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944530|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944531|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781965|NCT00690560|Rituximab|rituximab|mesh-list
14781966|NCT00690560|Doxorubicin|doxorubicin|mesh-list
14781967|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14781968|NCT00690560|Vincristine|vincristine|mesh-list
14781969|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14781970|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
14781971|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14781972|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14781973|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14781974|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
14781975|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781976|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781977|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14781978|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14781979|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14781980|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14781981|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14781982|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781983|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14781984|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
14781985|NCT00690560|Hormones|hormones|mesh-ancestor
14781986|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14781987|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14781988|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14781989|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
14781990|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
14781991|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
14781992|NCT00690677|Panobinostat|panobinostat|mesh-list
14781993|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781994|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14781995|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14781996|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14781997|NCT00690768|Bevacizumab|bevacizumab|mesh-list
14209188|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14209189|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14209190|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14781998|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14944532|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944533|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
14944534|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14944535|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944536|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14944537|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
14944538|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944539|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944540|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944541|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944542|NCT01513070|Aspirin|aspirin|mesh-list
14944543|NCT01513070|Isosorbide|isosorbide|mesh-list
14944544|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14944545|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14944546|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14944547|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944548|NCT01513070|Analgesics|analgesics|mesh-ancestor
14944549|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
14944550|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944551|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944552|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944553|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944554|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14944555|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14944556|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944557|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14944558|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14944559|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944560|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
14944561|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14944562|NCT01513070|Diuretics|diuretics|mesh-ancestor
14944563|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
14944564|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
14944565|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14944566|NCT01513083|Trastuzumab|trastuzumab|mesh-list
14944567|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14944568|NCT01513083|Maytansine|maytansine|mesh-list
14944569|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14944570|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14781999|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782000|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14782001|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14782002|NCT00690768|Growth Substances|growth substances|mesh-ancestor
14782003|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782004|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
14782005|NCT00690781|Caseins|caseins|mesh-list
14782006|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
14782007|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
14782008|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782009|NCT00690846|Adalimumab|adalimumab|mesh-list
14209191|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14782010|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782011|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14782012|NCT00690872|Gemcitabine|gemcitabine|mesh-list
14782013|NCT00690872|Carboplatin|carboplatin|mesh-list
14782014|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782015|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14782016|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
14782017|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782018|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
14782019|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782020|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782021|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782022|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
14782023|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782024|NCT00690885|Interferons|interferons|mesh-list
14782025|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
14782026|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
14782027|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14782028|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782029|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
14782030|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782031|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
14782032|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782033|NCT00690911|Adalimumab|adalimumab|mesh-list
14782034|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782035|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14782036|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14782037|NCT00690937|Sevelamer|sevelamer|mesh-list
13964586|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
13964587|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14782038|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
14782039|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
14782040|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782041|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14782042|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14782043|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
14782044|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14782045|NCT00690950|Dutasteride|dutasteride|mesh-list
14782046|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14782047|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14782048|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782049|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782050|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
14782051|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782052|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782053|NCT00691067|Mifepristone|mifepristone|mesh-list
14782054|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14782055|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
14782056|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14782057|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782058|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14782059|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14782060|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14782061|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
14782062|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14782063|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14782064|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
14782065|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944571|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782066|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
14782067|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14782068|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14782069|NCT00691145|Tacrolimus|tacrolimus|mesh-list
14782070|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782071|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
14782072|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782073|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14782074|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782075|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782076|NCT00691158|Pramlintide|pramlintide|mesh-list
14782077|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
14782078|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14782079|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782080|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
14782081|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14782082|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
14782083|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782084|NCT00691184|Terbinafine|terbinafine|mesh-list
14782085|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
14782086|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782087|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782088|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782089|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
14782090|NCT00691236|Doxorubicin|doxorubicin|mesh-list
14782091|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782092|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782093|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14782094|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14782095|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782096|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782097|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14782098|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782099|NCT00691262|Tacrolimus|tacrolimus|mesh-list
14782100|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782101|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
14782102|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782103|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14782104|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782105|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782106|NCT00691275|Ondansetron|ondansetron|mesh-list
14782107|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
14782108|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
14782109|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782110|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782111|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944572|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14944573|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14944574|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14944575|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944576|NCT01513174|Olaparib|olaparib|mesh-list
14944577|NCT01513174|Gefitinib|gefitinib|mesh-list
14944578|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14944579|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944580|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944581|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944582|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14944583|NCT01513200|Heparin|heparin|mesh-list
14944584|NCT01513200|Calcium heparin|calcium heparin|mesh-list
14944585|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
14944586|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14944587|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14944588|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944589|NCT01513499|Oxytocin|oxytocin|mesh-list
14944590|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
14944591|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14944592|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944593|NCT01513525|Liraglutide|liraglutide|mesh-list
14944594|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944595|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944596|NCT01513525|Incretins|incretins|mesh-ancestor
14944597|NCT01513525|Hormones|hormones|mesh-ancestor
14944598|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782112|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
14782113|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
14944599|NCT01513564|Morphine|morphine|mesh-list
14944600|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782114|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14782115|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
14782116|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782117|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782118|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14782119|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14782120|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782121|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14782122|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14782123|NCT00691379|Paclitaxel|paclitaxel|mesh-list
14782124|NCT00691379|Bevacizumab|bevacizumab|mesh-list
14782125|NCT00691379|Carboplatin|carboplatin|mesh-list
14782126|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782127|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782128|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782129|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782130|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
14782131|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782132|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14782133|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14782134|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14782135|NCT00691379|Growth Substances|growth substances|mesh-ancestor
14782136|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782137|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
14782138|NCT00691392|Linezolid|linezolid|mesh-list
14782139|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782140|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209192|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14209193|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209194|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209195|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14209196|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14782141|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14782142|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782143|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782144|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14782145|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
14782146|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14782147|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
14782148|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782149|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782150|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14782151|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
14782152|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14782153|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14782154|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14782155|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
14782156|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782157|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782158|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
14782159|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14782160|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
14505771|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505772|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505773|NCT02882152|Analgesics|analgesics|mesh-ancestor
14782161|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782162|NCT00691470|Warfarin|warfarin|mesh-list
14782163|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
14782164|NCT00691548|Cetuximab|cetuximab|mesh-list
13964588|NCT03136146|Lenograstim|lenograstim|mesh-list
14505774|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
14505775|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964589|NCT03136146|BB 1101|bb 1101|mesh-list
13964590|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505776|NCT02882633|Bupivacaine|bupivacaine|mesh-list
13964591|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
13964592|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505777|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
14505778|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
14505779|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505780|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505781|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
14505782|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505783|NCT02882711|Ketamine|ketamine|mesh-list
14505784|NCT02882711|Analgesics|analgesics|mesh-ancestor
14782165|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14782166|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782167|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
14782168|NCT00691613|Hematinics|hematinics|mesh-ancestor
14782169|NCT00691795|Clonidine|clonidine|mesh-list
14782170|NCT00691795|Fentanyl|fentanyl|mesh-list
14782171|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14782172|NCT00691795|Narcotics|narcotics|mesh-ancestor
14782173|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782174|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782175|NCT00691795|Analgesics|analgesics|mesh-ancestor
14782176|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
14782177|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782178|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14782179|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14782180|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
14505785|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
14782181|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
14782182|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14782183|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
14782184|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
14782185|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14782186|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14782187|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14782188|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
14782189|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782190|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782191|NCT00691873|Omalizumab|omalizumab|mesh-list
14782192|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14782193|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14782194|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
14782195|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
14782196|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14782197|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782198|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782199|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14782200|NCT00691886|Analgesics|analgesics|mesh-ancestor
14782201|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
14944601|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944602|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14782202|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782203|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14782204|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14782205|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14782206|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14782207|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944603|NCT01513564|Narcotics|narcotics|mesh-ancestor
14944604|NCT01513564|Analgesics|analgesics|mesh-ancestor
13964593|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13964594|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13964595|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
13964596|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964597|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964598|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13964599|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13964600|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
13964601|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
13964602|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964603|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13964604|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
13964605|NCT03136146|Hormones|hormones|mesh-ancestor
13964606|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964607|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13964608|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
13964609|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964610|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14505786|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505787|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505788|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14505789|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14505790|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
14505791|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
14505792|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14505793|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14782208|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782209|NCT00691912|Paclitaxel|paclitaxel|mesh-list
14782210|NCT00691912|Doxorubicin|doxorubicin|mesh-list
14782211|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14782212|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782213|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782214|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782215|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782216|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
14782217|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782218|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782219|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14782220|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14782221|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782222|NCT00691951|Budesonide|budesonide|mesh-list
14944605|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
14209197|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
14209198|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209199|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14209200|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14209201|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14209202|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209203|NCT04908189|Apremilast|apremilast|mesh-list
14209204|NCT04908189|BMS-986165|bms-986165|mesh-list
14209205|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14209206|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209207|NCT04908189|Analgesics|analgesics|mesh-ancestor
14944606|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944607|NCT01513603|Cytarabine|cytarabine|mesh-list
14944608|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
14944609|NCT01513603|Cladribine|cladribine|mesh-list
14944610|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14944611|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
14944612|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944613|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944614|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
14944615|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944616|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944617|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
14944618|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944619|NCT01513603|Analgesics|analgesics|mesh-ancestor
14944620|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
14944621|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944622|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14944623|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14944624|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944625|NCT01513668|Acetaminophen|acetaminophen|mesh-list
14944626|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944627|NCT01513668|Analgesics|analgesics|mesh-ancestor
14944628|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
14944629|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944630|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944631|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
14944632|NCT01513681|Lamotrigine|lamotrigine|mesh-list
14944633|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
14944634|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14944635|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14944636|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944637|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14944638|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944639|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14944640|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14944641|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944642|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14944643|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14944644|NCT01513720|Lamotrigine|lamotrigine|mesh-list
14944645|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
14944646|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14944647|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14944648|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944649|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14944650|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209208|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
14209209|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782223|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
14782224|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782225|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14782226|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
14782227|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782228|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782229|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14782230|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
14782231|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
14782232|NCT00691951|Hormones|hormones|mesh-ancestor
14782233|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782234|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14782235|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14782236|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14782237|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
14782238|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782239|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782240|NCT00692016|Naproxen|naproxen|mesh-list
14782241|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14944651|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14944652|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14944653|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944654|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14944655|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14944656|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
14944657|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14944658|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944659|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944660|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944661|NCT01513772|Analgesics|analgesics|mesh-ancestor
14944662|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
14944663|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944664|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14944665|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14944666|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14944667|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
14944668|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944669|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782242|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14782243|NCT00692016|Analgesics|analgesics|mesh-ancestor
14782244|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
14782245|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782246|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782247|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782248|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14782249|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
14944670|NCT01513785|Amoxicillin|amoxicillin|mesh-list
14944671|NCT01513785|Rabeprazole|rabeprazole|mesh-list
14944672|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944673|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944674|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13964611|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13964612|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13964613|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13964614|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
13964615|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
13964616|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
13964617|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13964618|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
13964619|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
13964620|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
14944675|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944676|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14944677|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944678|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944679|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14944680|NCT01513863|Metronidazole|metronidazole|mesh-list
14944681|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944682|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944683|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14944684|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14782250|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14944685|NCT01513941|Interferons|interferons|mesh-list
14944686|NCT01513941|Ribavirin|ribavirin|mesh-list
14209210|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782251|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782252|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782253|NCT00692055|Naproxen|naproxen|mesh-list
14782254|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14782255|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944687|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
14944688|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
14944689|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14944690|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944691|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
14944692|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944693|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
14944694|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209211|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209212|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209213|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14944695|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
14944696|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944697|NCT01514019|Acebutolol|acebutolol|mesh-list
14944698|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14944699|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14944700|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
14944701|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
14944702|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209214|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14209215|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209216|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209217|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209218|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14209219|NCT04905810|Azacitidine|azacitidine|mesh-list
14209220|NCT04905810|Decitabine|decitabine|mesh-list
14944703|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944704|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14944705|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14944706|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14944707|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14944708|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944709|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944710|NCT01514110|Paclitaxel|paclitaxel|mesh-list
14944711|NCT01514110|Carboplatin|carboplatin|mesh-list
14944712|NCT01514110|Everolimus|everolimus|mesh-list
14944713|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14944714|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964621|NCT03135977|Etoposide|etoposide|mesh-list
13964622|NCT03135977|Apatinib|apatinib|mesh-list
13964623|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13964624|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964625|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13964626|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13964627|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964628|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964629|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14782256|NCT00692055|Analgesics|analgesics|mesh-ancestor
14782257|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
14782258|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782259|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782260|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782261|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14782262|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
14782263|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14782264|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782265|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782266|NCT00692120|Vitamin D|vitamin d|mesh-list
14782267|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
14782268|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
14782269|NCT00692120|Vitamins|vitamins|mesh-list
14782270|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
14782271|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782272|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14782273|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14782274|NCT00692159|Pemetrexed|pemetrexed|mesh-list
14782275|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782276|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782277|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944715|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14944716|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14944717|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14944718|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944719|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944720|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
14944721|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944722|NCT01514123|Bevacizumab|bevacizumab|mesh-list
14944723|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14944724|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944725|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14944726|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14944727|NCT01514123|Growth Substances|growth substances|mesh-ancestor
14782278|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14782279|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14782280|NCT00692172|Alefacept|alefacept|mesh-list
14782281|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
14782282|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
14782283|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944728|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944729|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
14944730|NCT01514175|Ibuprofen|ibuprofen|mesh-list
14944731|NCT01514175|Ketorolac|ketorolac|mesh-list
14944732|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14944733|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944734|NCT01514175|Analgesics|analgesics|mesh-ancestor
14944735|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
14944736|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944737|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944738|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944739|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944740|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14944741|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944742|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944743|NCT01514188|Doxorubicin|doxorubicin|mesh-list
14944744|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14944745|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944746|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14944747|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14944748|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944749|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944750|NCT01514227|Aspirin|aspirin|mesh-list
14944751|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14944752|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944753|NCT01514227|Analgesics|analgesics|mesh-ancestor
14209221|NCT04905810|Venetoclax|venetoclax|mesh-list
14944754|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
14944755|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944756|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944757|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944758|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944759|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14944760|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14944761|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944762|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14944763|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14944764|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944765|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
14944766|NCT01514266|Curcumin|curcumin|mesh-list
14944767|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14944768|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14944769|NCT01514266|Analgesics|analgesics|mesh-ancestor
14944770|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
14944771|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944772|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944773|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944774|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944775|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944776|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944777|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944778|NCT01514344|Rituximab|rituximab|mesh-list
14944779|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14944780|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944781|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
14782284|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14782285|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14782286|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14782287|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
14782288|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782289|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14782290|NCT00692263|Tramadol|tramadol|mesh-list
14782291|NCT00692263|Citalopram|citalopram|mesh-list
14782292|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14782293|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14782294|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782295|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782296|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782297|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
14782298|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782299|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14782300|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
14782301|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14782302|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782303|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14782304|NCT00692263|Narcotics|narcotics|mesh-ancestor
14782305|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782306|NCT00692263|Analgesics|analgesics|mesh-ancestor
14782307|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
14782308|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
14782309|NCT00692315|Vitamins|vitamins|mesh-ancestor
14782310|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
14782311|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782312|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
14782313|NCT00692328|Levodopa|levodopa|mesh-list
14782314|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14782315|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14782316|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
14782317|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782318|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782319|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782320|NCT00692354|Tosedostat|tosedostat|mesh-list
14782321|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782322|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782323|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
14782324|NCT00692510|Midazolam|midazolam|mesh-list
14782325|NCT00692510|Caffeine|caffeine|mesh-list
14782326|NCT00692510|Bupropion|bupropion|mesh-list
14782327|NCT00692510|Omeprazole|omeprazole|mesh-list
14782328|NCT00692510|Bilirubin|bilirubin|mesh-list
14782329|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14782330|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14782331|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782332|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782333|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14782334|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14944782|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944783|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944784|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
14944785|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14944786|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
14944787|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14944788|NCT01514487|Liraglutide|liraglutide|mesh-list
14944789|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944790|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944791|NCT01514487|Incretins|incretins|mesh-ancestor
14944792|NCT01514487|Hormones|hormones|mesh-ancestor
14944793|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026935|NCT01946555|Analgesics|analgesics|mesh-ancestor
15026936|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
15026937|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026938|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15026939|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15026940|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
15026941|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
15026942|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15026943|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
15026944|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
14782335|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14782336|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14782337|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
14782338|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
14782339|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
14782340|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
14782341|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782342|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782343|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14782344|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14782345|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14782346|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782347|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14782348|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14782349|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14782350|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14782351|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
14782352|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14782353|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
14782354|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14782355|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14782356|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782357|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
14782358|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14782359|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14782360|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14782361|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
14782362|NCT00692510|Protective Agents|protective agents|mesh-ancestor
14782363|NCT00692601|Capsaicin|capsaicin|mesh-list
14782364|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
14782365|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
14782366|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
14782367|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782368|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782369|NCT00692614|Triamcinolone|triamcinolone|mesh-list
14782370|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14944794|NCT01514695|Fentanyl|fentanyl|mesh-list
14944795|NCT01514695|Midazolam|midazolam|mesh-list
14944796|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14944797|NCT01514695|Narcotics|narcotics|mesh-ancestor
14944798|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14944799|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944800|NCT01514695|Analgesics|analgesics|mesh-ancestor
14944801|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
14944802|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944803|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14944804|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14944805|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
14944806|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
14944807|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14944808|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14944809|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14944810|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14944811|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
14944812|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
14944813|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944814|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944815|NCT01514721|Timolol|timolol|mesh-list
14944816|NCT01514721|Travoprost|travoprost|mesh-list
14944817|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14944818|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14944819|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14944820|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944821|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944822|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944823|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14944824|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14944825|NCT01514812|Digoxin|digoxin|mesh-list
14944826|NCT01514812|Darexaban|darexaban|mesh-list
14944827|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14944828|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14944829|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944830|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944831|NCT01514812|Protective Agents|protective agents|mesh-ancestor
14944832|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944833|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14944834|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
14944835|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14944836|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
14944837|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
14782371|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14782372|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14782373|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782374|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
14782375|NCT00692614|Hormones|hormones|mesh-ancestor
14782376|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782377|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782378|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782379|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
14782380|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944838|NCT01514825|Darexaban|darexaban|mesh-list
14944839|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14944840|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
14944841|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14944842|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
14944843|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944844|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944845|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
14944846|NCT01514838|Acarbose|acarbose|mesh-list
14944847|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
14944848|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14944849|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944850|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944851|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944852|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944853|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14944854|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
14944855|NCT01514851|Calcium|calcium|mesh-list
14944856|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14944857|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944858|NCT01514851|Antacids|antacids|mesh-ancestor
14944859|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944860|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944861|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
14944862|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
14944863|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14944864|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14944865|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944866|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944867|NCT01514903|Urological Agents|urological agents|mesh-ancestor
14944868|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
14944869|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944870|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944871|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14944872|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14944873|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944874|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944875|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944876|NCT01514942|Folic Acid|folic acid|mesh-list
14944877|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
14944878|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
14944879|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
14944880|NCT01514942|Inositol|inositol|mesh-list
14944881|NCT01514942|Manganese|manganese|mesh-list
14944882|NCT01514942|Hematinics|hematinics|mesh-ancestor
14944883|NCT01514942|Vitamins|vitamins|mesh-ancestor
14944884|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
14944885|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944886|NCT01514942|Trace Elements|trace elements|mesh-ancestor
14944887|NCT01514968|Cyclosporine|cyclosporine|mesh-list
14944888|NCT01514968|Ritonavir|ritonavir|mesh-list
14944889|NCT01514968|Cyclosporins|cyclosporins|mesh-list
14944890|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944891|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944892|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944893|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
14944894|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944895|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
14944896|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944897|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
14944898|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944899|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14944900|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14209222|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14944901|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14944902|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
14944903|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14782381|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782382|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14782383|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782384|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14782385|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782386|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782387|NCT00692731|Caffeine|caffeine|mesh-list
14782388|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14782389|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782390|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14782391|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782392|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782393|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14782394|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14782395|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
14782396|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782397|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
14782398|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14782399|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782400|NCT00692900|Docetaxel|docetaxel|mesh-list
14782401|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
14782402|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782403|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782404|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782405|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
14782406|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782407|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
14782408|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
14782409|NCT00692952|Nonoxynol|nonoxynol|mesh-list
14782410|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14782411|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782412|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14782413|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782414|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14782415|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14782416|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14782417|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14782418|NCT00693004|Donepezil|donepezil|mesh-list
14782419|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14782420|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782421|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782422|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
14782423|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782424|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782425|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
14782426|NCT00693030|Sirolimus|sirolimus|mesh-list
14782427|NCT00693030|Paclitaxel|paclitaxel|mesh-list
14782428|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782429|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782430|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782431|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782432|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
14209223|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
14209224|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209225|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209226|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209227|NCT04904965|Propofol|propofol|mesh-list
14209228|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209229|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209230|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209231|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209232|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
14209233|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
14209234|NCT04883242|Dexamethasone|dexamethasone|mesh-list
14209235|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
14209236|NCT04883242|Pomalidomide|pomalidomide|mesh-list
14209237|NCT04883242|Ichthammol|ichthammol|mesh-list
14209238|NCT04883242|BB 1101|bb 1101|mesh-list
14782433|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782434|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782435|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782436|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14944904|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14209239|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14209240|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782437|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
14782438|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782439|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
14944905|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
14944906|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14944907|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14944908|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
14944909|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944910|NCT01515020|Vancomycin|vancomycin|mesh-list
14209241|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
14209242|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
14209243|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209244|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209245|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14209246|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
14209247|NCT04883242|Hormones|hormones|mesh-ancestor
14944911|NCT01515020|Daptomycin|daptomycin|mesh-list
14944912|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14944913|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14944914|NCT01515137|Sulindac|sulindac|mesh-list
14944915|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14944916|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944917|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14944918|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944919|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944920|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14209248|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209249|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14944921|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209250|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209251|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
14209252|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209253|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209254|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
14209255|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14209256|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14209257|NCT04883242|Growth Substances|growth substances|mesh-ancestor
14782440|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782441|NCT00693043|Lidocaine|lidocaine|mesh-list
14782442|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
14782443|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
14782444|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782445|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782446|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
14782447|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782448|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14782449|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14782450|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14782451|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782452|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782453|NCT00693056|beta-Lactams|beta-lactams|mesh-list
14782454|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782455|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782456|NCT00693069|Clopidogrel|clopidogrel|mesh-list
14782457|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14782458|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14782459|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14782460|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14782461|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
14782462|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782463|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782464|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782465|NCT00693108|Testosterone|testosterone|mesh-list
14782466|NCT00693108|Androgens|androgens|mesh-ancestor
14782467|NCT00693108|Hormones|hormones|mesh-ancestor
14782468|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782469|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782470|NCT00693121|Amantadine|amantadine|mesh-list
14782471|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14782472|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14782473|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
14782474|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782475|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
14782476|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782477|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782478|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782479|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14782480|NCT00693121|Analgesics|analgesics|mesh-ancestor
14782481|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
14782482|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782483|NCT00693199|Amlodipine|amlodipine|mesh-list
14782484|NCT00693199|Prazosin|prazosin|mesh-list
14782485|NCT00693199|Terazosin|terazosin|mesh-list
14782486|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14782487|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14782488|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782489|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782490|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14209258|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
14209259|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209260|NCT04880980|Itraconazole|itraconazole|mesh-list
14209261|NCT04880980|Terbinafine|terbinafine|mesh-list
14209262|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
14209263|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209264|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14209265|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14209266|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209267|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209268|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14209269|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
14209270|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782491|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782492|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
14782493|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14782494|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14782495|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14782496|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
14782497|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782498|NCT00693199|Urological Agents|urological agents|mesh-ancestor
14782499|NCT00693212|Methylphenidate|methylphenidate|mesh-list
14782500|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14782501|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782502|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14782503|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14782504|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782505|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782506|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
14782507|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782508|NCT00693251|Sirolimus|sirolimus|mesh-list
14782509|NCT00693251|Paclitaxel|paclitaxel|mesh-list
14782510|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14782511|NCT00693251|Everolimus|everolimus|mesh-list
14782512|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782513|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782514|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782515|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782516|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14782517|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782518|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782519|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
14782520|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782521|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782522|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209271|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782523|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782524|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
14944922|NCT01515137|Analgesics|analgesics|mesh-ancestor
14944923|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
14944924|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944925|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944926|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944927|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14944928|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14944929|NCT01515228|Paclitaxel|paclitaxel|mesh-list
14209272|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14241160|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241161|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241162|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14241163|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14241164|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241165|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241166|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14944930|NCT01515228|Everolimus|everolimus|mesh-list
14944931|NCT01515228|Cilostazol|cilostazol|mesh-list
14944932|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14944933|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14944934|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
14944935|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
14944936|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
14944937|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944938|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14944939|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
14944940|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241167|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
14782525|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
14782526|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
14782527|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782528|NCT00693355|Butyric Acid|butyric acid|mesh-list
14782529|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
14782530|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
14782531|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241168|NCT00174785|Dronedarone|dronedarone|mesh-list
14241169|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14241170|NCT00174915|Allopurinol|allopurinol|mesh-list
14241171|NCT00174915|Febuxostat|febuxostat|mesh-list
14241172|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
14241173|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241174|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241175|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
14241176|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241177|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14241178|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
14241179|NCT00174915|Protective Agents|protective agents|mesh-ancestor
14241180|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241181|NCT00174941|Febuxostat|febuxostat|mesh-list
14241182|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
14241183|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241184|NCT00174967|Febuxostat|febuxostat|mesh-list
14241185|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
14241186|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241187|NCT00175019|Allopurinol|allopurinol|mesh-list
14241188|NCT00175019|Febuxostat|febuxostat|mesh-list
14241189|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
14241190|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241191|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241192|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
14241193|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241194|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14782532|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782533|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782534|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
14782535|NCT00693381|Prednisone|prednisone|mesh-list
14782536|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
14241195|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
14782537|NCT00693381|Tacrolimus|tacrolimus|mesh-list
14782538|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944941|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14241196|NCT00175019|Protective Agents|protective agents|mesh-ancestor
14241197|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241198|NCT00175825|Brivaracetam|brivaracetam|mesh-list
14782539|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
14782540|NCT00693381|Hormones|hormones|mesh-ancestor
14209273|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
14209274|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
14209275|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209276|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14209277|NCT04876131|Gentamicins|gentamicins|mesh-list
14209278|NCT04876131|Cephalexin|cephalexin|mesh-list
14209279|NCT04876131|Penicillin G|penicillin g|mesh-list
14209280|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14209281|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
14209282|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209283|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14782541|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782542|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782543|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14782544|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782545|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782546|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
14782547|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14782548|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782549|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782550|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782551|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14782552|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
14782553|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782554|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209284|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209285|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209286|NCT04872257|Vitamin D|vitamin d|mesh-list
14209287|NCT04872257|Vitamins|vitamins|mesh-ancestor
14209288|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
14209289|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209290|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14782555|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
14782556|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
14782557|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782558|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14782559|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14782560|NCT00693381|Protective Agents|protective agents|mesh-ancestor
14782561|NCT00693407|Capsaicin|capsaicin|mesh-list
14782562|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
14782563|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
14782564|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
14782565|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782566|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782567|NCT00693433|Sirolimus|sirolimus|mesh-list
14782568|NCT00693433|Dexamethasone|dexamethasone|mesh-list
14782569|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14944942|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
14944943|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944944|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14782570|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
14782571|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
14782572|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782573|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782574|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14209291|NCT04867928|Azacitidine|azacitidine|mesh-list
14209292|NCT04867928|Venetoclax|venetoclax|mesh-list
14209293|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14209294|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
14782575|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
14782576|NCT00693433|Hormones|hormones|mesh-ancestor
14782577|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782578|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14782579|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782580|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782581|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782582|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782583|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
14782584|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782585|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
14782586|NCT00693446|Sirolimus|sirolimus|mesh-list
14782587|NCT00693446|Tacrolimus|tacrolimus|mesh-list
14782588|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782589|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
14782590|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944945|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
14944946|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14782591|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14782592|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782593|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782594|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782595|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782596|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782597|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782598|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
14782599|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
14782600|NCT00693524|Prednisone|prednisone|mesh-list
14782601|NCT00693524|Tacrolimus|tacrolimus|mesh-list
14782602|NCT00693524|Daclizumab|daclizumab|mesh-list
14782603|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782604|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
14782605|NCT00693524|Hormones|hormones|mesh-ancestor
14782606|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944947|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14944948|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14944949|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
14944950|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14944951|NCT01515228|Protective Agents|protective agents|mesh-ancestor
14944952|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14944953|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14944954|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14944955|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14944956|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14944957|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14944958|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944959|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14944960|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14944961|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944962|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
14944963|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944964|NCT01515397|Polygeline|polygeline|mesh-list
14944965|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
14944966|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
14944967|NCT01515553|Liraglutide|liraglutide|mesh-list
14944968|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944969|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944970|NCT01515553|Incretins|incretins|mesh-ancestor
14944971|NCT01515553|Hormones|hormones|mesh-ancestor
14944972|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944973|NCT01515579|Liraglutide|liraglutide|mesh-list
14209295|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209296|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209297|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209298|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
14209299|NCT04846348|Promethazine|promethazine|mesh-list
14209300|NCT04846348|Salicylates|salicylates|mesh-list
14209301|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
14209302|NCT04846348|Emollients|emollients|mesh-list
14209303|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14209304|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209305|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209306|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209307|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
14209308|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
14209309|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
14209310|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209311|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
14209312|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
14209313|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14944974|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944975|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944976|NCT01515579|Incretins|incretins|mesh-ancestor
14944977|NCT01515579|Hormones|hormones|mesh-ancestor
14944978|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14944979|NCT01515592|Liraglutide|liraglutide|mesh-list
14944980|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14944981|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944982|NCT01515592|Incretins|incretins|mesh-ancestor
14944983|NCT01515592|Hormones|hormones|mesh-ancestor
14209314|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14944984|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209315|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
14782607|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964630|NCT03136029|Antioxidants|antioxidants|mesh-list
13964631|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964632|NCT03136029|Protective Agents|protective agents|mesh-ancestor
14782608|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14782609|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782610|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782611|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
14782612|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14782613|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782614|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964633|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968055|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968056|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13968057|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14209316|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
14209317|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209318|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209319|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14782615|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782616|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14782617|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
14782618|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782619|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782620|NCT00693576|Simvastatin|simvastatin|mesh-list
14782621|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14782622|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14782623|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
14782624|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782625|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14782626|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14782627|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782628|NCT00693589|Folic Acid|folic acid|mesh-list
14782629|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
14782630|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
14782631|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14782632|NCT00693589|Vitamins|vitamins|mesh-ancestor
14782633|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
14782634|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782635|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14782636|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14782637|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
14782638|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782639|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14782640|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14782641|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782642|NCT00693589|Hematinics|hematinics|mesh-ancestor
14782643|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
14782644|NCT00693602|Asparaginase|asparaginase|mesh-list
14782645|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782646|NCT00693615|Vaccines|vaccines|mesh-list
14782647|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
14782648|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782649|NCT00693680|Imipramine|imipramine|mesh-list
14782650|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14782651|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
14782652|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14944985|NCT01515683|Anesthetics|anesthetics|mesh-list
14944986|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209320|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
14209321|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209322|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14209323|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209324|NCT04846348|Analgesics|analgesics|mesh-ancestor
14209325|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782653|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14782654|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14944987|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944988|NCT01515774|Pramipexole|pramipexole|mesh-list
14944989|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
14944990|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944991|NCT01515774|Protective Agents|protective agents|mesh-ancestor
14944992|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14944993|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14944994|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14944995|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
14782655|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782656|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782657|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
14782658|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782659|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782660|NCT00693732|Citalopram|citalopram|mesh-list
14782661|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14782662|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14782663|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782664|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782665|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782666|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
14782667|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782668|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14782669|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
14944996|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
14944997|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14944998|NCT01515813|Tenofovir|tenofovir|mesh-list
14782670|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14782671|NCT00693758|Adenosine|adenosine|mesh-list
14782672|NCT00693758|Analgesics|analgesics|mesh-ancestor
14782673|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
14782674|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782675|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782676|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14782677|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
14782678|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14782679|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
14782680|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
14782681|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782682|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782683|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
14782684|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14782685|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782686|NCT00693849|Citalopram|citalopram|mesh-list
14782687|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14782688|NCT00693849|Sertraline|sertraline|mesh-list
14782689|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14782690|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14782691|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782692|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14944999|NCT01515813|Emtricitabine|emtricitabine|mesh-list
14945000|NCT01515813|Efavirenz|efavirenz|mesh-list
14945001|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14945002|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14945003|NCT01515813|Pravastatin|pravastatin|mesh-list
14945004|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
14945005|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945006|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14945007|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14945008|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945009|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945010|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14782693|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782694|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
14782695|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782696|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14945011|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14945012|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14782697|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
14782698|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14782699|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14782700|NCT00693862|Levodopa|levodopa|mesh-list
14782701|NCT00693862|Carbidopa|carbidopa|mesh-list
14782702|NCT00693862|Entacapone|entacapone|mesh-list
14782703|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14782704|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14782705|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
14782706|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782707|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782708|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782709|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14782710|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782711|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14782712|NCT00693927|Fludarabine|fludarabine|mesh-list
14782713|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945013|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14945014|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14945015|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14945016|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14945017|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14945018|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14945019|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14945020|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
14945021|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14945022|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14945023|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
14945024|NCT01515826|Dexamethasone|dexamethasone|mesh-list
14945025|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
14945026|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14945027|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14945028|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14945029|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14945030|NCT01515826|BB 1101|bb 1101|mesh-list
14945031|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14945032|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
14945033|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
14945034|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945035|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945036|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945037|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
14945038|NCT01515826|Hormones|hormones|mesh-ancestor
14945039|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945040|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14945041|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945042|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945043|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945044|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945045|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945046|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945047|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14945048|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945049|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14945050|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
14945051|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14945052|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14945053|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14945054|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14945055|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
14945056|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
14945057|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
14945058|NCT01515839|Vinpocetine|vinpocetine|mesh-list
14945059|NCT01515839|Huperzine A|huperzine a|mesh-list
14945060|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
14945061|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945062|NCT01515839|Protective Agents|protective agents|mesh-ancestor
14945063|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945064|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
14945065|NCT01515839|Vitamins|vitamins|mesh-ancestor
14945066|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
14945067|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
14945068|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14945069|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945070|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
14945071|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945072|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14945073|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
14945074|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209326|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209327|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14945075|NCT01515839|Expectorants|expectorants|mesh-ancestor
14945076|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
14209328|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945077|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14945078|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14945079|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
14782714|NCT00693966|Vaccines|vaccines|mesh-list
14782715|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
14782716|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782717|NCT00693979|Paclitaxel|paclitaxel|mesh-list
14782718|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782719|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782720|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782721|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782722|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14782723|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782724|NCT00694005|Sirolimus|sirolimus|mesh-list
14782725|NCT00694005|Paclitaxel|paclitaxel|mesh-list
14782726|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14782727|NCT00694005|Everolimus|everolimus|mesh-list
14782728|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782729|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782730|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782731|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782732|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14782733|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782734|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782735|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
14782736|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782737|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782738|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782739|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782740|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
14782741|NCT00694044|Varenicline|varenicline|mesh-list
14782742|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14782743|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14782744|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
14782745|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782746|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782747|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782748|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14782749|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14782750|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782751|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782752|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14782753|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14782754|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782755|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
14782756|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782757|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14782758|NCT00694187|Zaleplon|zaleplon|mesh-list
14782759|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
14782760|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14782761|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782762|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782763|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
14782764|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
14782765|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782766|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782767|NCT00694200|Bevacizumab|bevacizumab|mesh-list
14782768|NCT00694200|Vinorelbine|vinorelbine|mesh-list
14782769|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14782770|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782771|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14782772|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14782773|NCT00694200|Growth Substances|growth substances|mesh-ancestor
14782774|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782775|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
14782776|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14782777|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782778|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14782779|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14782780|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782781|NCT00694252|Lapatinib|lapatinib|mesh-list
14782782|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782783|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14945080|NCT01515852|Anesthetics|anesthetics|mesh-list
14782784|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945081|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945082|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945083|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14945084|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
14945085|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14945086|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945087|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14945088|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945089|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945090|NCT01516060|Efavirenz|efavirenz|mesh-list
14945091|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14945092|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14945093|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945094|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945095|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
14945096|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945097|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14945098|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14945099|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14945100|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14945101|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14945102|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14945103|NCT01516138|Insulin|insulin|mesh-list
14945104|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945105|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945106|NCT01516255|Liraglutide|liraglutide|mesh-list
14945107|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
14945108|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945109|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782785|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782786|NCT00694291|Sorafenib|sorafenib|mesh-list
14945110|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14945111|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945112|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945113|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945114|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945115|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945116|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945117|NCT01516255|Incretins|incretins|mesh-ancestor
14945118|NCT01516255|Hormones|hormones|mesh-ancestor
14945119|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945120|NCT01516346|Hydralazine|hydralazine|mesh-list
14945121|NCT01516346|Isosorbide|isosorbide|mesh-list
14945122|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14945123|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14945124|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14945125|NCT01516346|Diuretics|diuretics|mesh-ancestor
14945126|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
14945127|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782787|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782788|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14782789|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782790|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782791|NCT00694317|Zaleplon|zaleplon|mesh-list
14782792|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
14782793|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14782794|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782795|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782796|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
14782797|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
14782798|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14782799|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782800|NCT00694330|Vaccines|vaccines|mesh-list
14782801|NCT00694330|Immunologic Factors|immunologic factors|mesh-ancestor
14209329|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14209330|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
14209331|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14209332|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
14209333|NCT04840472|Panitumumab|panitumumab|mesh-list
14209334|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209335|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209336|NCT04825223|Vaccines|vaccines|mesh-list
14209337|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
14209338|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209339|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
14209340|NCT04823091|Fludarabine|fludarabine|mesh-list
14209341|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209342|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
14209343|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209344|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209345|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14209346|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
14209347|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209348|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209349|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14209350|NCT04815902|Losartan|losartan|mesh-list
14505794|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14505795|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505796|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505797|NCT02882854|Guanfacine|guanfacine|mesh-list
14505798|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14505799|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14505800|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14505801|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14505802|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
14505803|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505804|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505805|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505806|NCT02883452|Infliximab|infliximab|mesh-list
14505807|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505808|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505809|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505810|NCT02884089|Metformin|metformin|mesh-list
14505811|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14505812|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505813|NCT02885012|Ambrisentan|ambrisentan|mesh-list
14505814|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14505815|NCT02885025|Fluticasone|fluticasone|mesh-list
14505816|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505817|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14505818|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
14505819|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505820|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505821|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14505822|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
14505823|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505824|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14505825|NCT02885181|Methotrexate|methotrexate|mesh-list
14505826|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14505827|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
14505828|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14505829|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505830|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14505831|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
14505832|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505833|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505834|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505835|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782802|NCT00694330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782803|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14782804|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
14782805|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14782806|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14782807|NCT00694408|Prednisolone|prednisolone|mesh-list
14782808|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
14782809|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
14782810|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14782811|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14782812|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13964634|NCT03135912|Terbinafine|terbinafine|mesh-list
14782813|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14782814|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
14782815|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14782816|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
14782817|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
14782818|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782819|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782820|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14782821|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
14782822|NCT00694408|Hormones|hormones|mesh-ancestor
14782823|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782824|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14782825|NCT00694408|Protective Agents|protective agents|mesh-ancestor
14782826|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14782827|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782828|NCT00694460|Vaccines|vaccines|mesh-list
14782829|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
14782830|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505836|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14505837|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14505838|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
14505839|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505840|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14528601|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14528602|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
14528603|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528604|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782831|NCT00694590|Plerixafor|plerixafor|mesh-list
14782832|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14782833|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14945128|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
14945129|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14945130|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945131|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14945132|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
14945133|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14945134|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945135|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945136|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14945137|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945138|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945139|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945140|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945141|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14945142|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
14945143|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14945144|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945145|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14945146|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14945147|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14528605|NCT03838874|Bupivacaine|bupivacaine|mesh-list
14528606|NCT03838874|Mepivacaine|mepivacaine|mesh-list
14528607|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
14528608|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
14528609|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528610|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528611|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
14528612|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528613|NCT03822078|Denosumab|denosumab|mesh-list
14528614|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14528615|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528616|NCT03811951|Insulin|insulin|mesh-list
14528617|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14528618|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528619|NCT03810235|Lidocaine|lidocaine|mesh-list
14528620|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
14528621|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
14528622|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528623|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528624|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
14528625|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528626|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14528627|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14528628|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14528629|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528630|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528631|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
14528632|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14528633|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14945148|NCT01516450|Belimumab|belimumab|mesh-list
14945149|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14945150|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
14945151|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782834|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
14782835|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945152|NCT01516463|Bacitracin|bacitracin|mesh-list
14945153|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14945154|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945155|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15026945|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15026946|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15026947|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026948|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026949|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
15026950|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026951|NCT01946568|Dalbavancin|dalbavancin|mesh-list
15026952|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15026953|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026954|NCT01946594|Acetaminophen|acetaminophen|mesh-list
15026955|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15026956|NCT01946594|Analgesics|analgesics|mesh-ancestor
15026957|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
15026958|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026959|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026960|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
15026961|NCT01946607|Citalopram|citalopram|mesh-list
15026962|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15026963|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15026964|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026965|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026966|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964635|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
13964636|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964637|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026967|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
15026968|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026969|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15026970|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
15026971|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026972|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
15026973|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15026974|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
15026975|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026976|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026977|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15026978|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
15026979|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15026980|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15026981|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15026982|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
15026983|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026984|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026985|NCT01946815|Atorvastatin|atorvastatin|mesh-list
15026986|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15026987|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15026988|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
15026989|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026990|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15026991|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15026992|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026993|NCT01946906|Rifaximin|rifaximin|mesh-list
15026994|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15026995|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026996|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026997|NCT01946971|Lansoprazole|lansoprazole|mesh-list
14782836|NCT00694629|Rifampin|rifampin|mesh-list
14782837|NCT00694629|Rifapentine|rifapentine|mesh-list
14782838|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14782839|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
14782840|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782841|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782842|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
14782843|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14782844|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782845|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782846|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14782847|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14782848|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14782849|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14782850|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14782851|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14782852|NCT00694694|Azithromycin|azithromycin|mesh-list
14782853|NCT00694694|Artesunate|artesunate|mesh-list
14782854|NCT00694694|Lumefantrine|lumefantrine|mesh-list
14782855|NCT00694694|Artemether|artemether|mesh-list
14782856|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14782857|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782858|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782859|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
14782860|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14782861|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14782862|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782863|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
14782864|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
14782865|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14782866|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
14782867|NCT00694733|Anastrozole|anastrozole|mesh-list
14782868|NCT00694733|Leuprolide|leuprolide|mesh-list
14782869|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
14782870|NCT00694733|Estradiol|estradiol|mesh-list
14782871|NCT00694733|Estrogens|estrogens|mesh-list
14782872|NCT00694733|Testosterone|testosterone|mesh-list
14782873|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
14782874|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
14782875|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14782876|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14782877|NCT00694733|Hormones|hormones|mesh-ancestor
14782878|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782879|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782880|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14782881|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14782882|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782883|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14782884|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782885|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782886|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14782887|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
14782888|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14782889|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
14945156|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
14945157|NCT01516554|Testosterone|testosterone|mesh-list
14945158|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
14945159|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
14945160|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14945161|NCT01516554|Androgens|androgens|mesh-ancestor
14945162|NCT01516554|Hormones|hormones|mesh-ancestor
14945163|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945164|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945165|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14945166|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945167|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
14945168|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
14945169|NCT01516567|Rituximab|rituximab|mesh-list
14945170|NCT01516567|Doxorubicin|doxorubicin|mesh-list
14945171|NCT01516567|Etoposide|etoposide|mesh-list
14945172|NCT01516567|Vincristine|vincristine|mesh-list
14945173|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14945174|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
14945175|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945176|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14945177|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14945178|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
14945179|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945180|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945181|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14945182|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14945183|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14945184|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14945185|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945186|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945187|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14945188|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
14782890|NCT00694733|Androgens|androgens|mesh-ancestor
14782891|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
14782892|NCT00694759|Metformin|metformin|mesh-list
14782893|NCT00694759|Pioglitazone|pioglitazone|mesh-list
14782894|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14782895|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782896|NCT00694837|Nelfinavir|nelfinavir|mesh-list
14782897|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14782898|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14782899|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
14782900|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782901|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782902|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14782903|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14782904|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
14782905|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782906|NCT00694863|Cosyntropin|cosyntropin|mesh-list
14782907|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
14782908|NCT00694863|Hormones|hormones|mesh-ancestor
14782909|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782910|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782911|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
14782912|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14782913|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
14782914|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782915|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14782916|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14209351|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14209352|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14209353|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14209354|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14209355|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209356|NCT04814602|Proglumide|proglumide|mesh-list
14209357|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14209358|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14209359|NCT04799431|Poly I-C|poly i-c|mesh-list
14209360|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14209361|NCT04799431|Poly ICLC|poly iclc|mesh-list
14209362|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
14782917|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14782918|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
14782919|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782920|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782921|NCT00694967|Progestins|progestins|mesh-ancestor
14782922|NCT00694967|Hormones|hormones|mesh-ancestor
14782923|NCT00694980|Etrolizumab|etrolizumab|mesh-list
14782924|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14782925|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
14782926|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782927|NCT00695032|Ifosfamide|ifosfamide|mesh-list
14782928|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782929|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14782930|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
14782931|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782932|NCT00695045|Morphine|morphine|mesh-list
14782933|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14782934|NCT00695045|Narcotics|narcotics|mesh-ancestor
14782935|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209363|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
14209364|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209365|NCT04799431|Laxatives|laxatives|mesh-ancestor
14209366|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505841|NCT02885636|Albuterol|albuterol|mesh-list
14505842|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14782936|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505843|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
14505844|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505845|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505846|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14505847|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
14505848|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
14782937|NCT00695045|Analgesics|analgesics|mesh-ancestor
14782938|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
14782939|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782940|NCT00695071|Itraconazole|itraconazole|mesh-list
14782941|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
14782942|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782943|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14782944|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14782945|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782946|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782947|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14782948|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
14782949|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14782950|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782951|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14782952|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
14782953|NCT00695201|Irinotecan|irinotecan|mesh-list
14782954|NCT00695201|Floxuridine|floxuridine|mesh-list
14782955|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782956|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14782957|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945189|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
14945190|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
14945191|NCT01516580|Cytarabine|cytarabine|mesh-list
14782958|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782959|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782960|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14782961|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
14782962|NCT00695214|Propofol|propofol|mesh-list
14782963|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14782964|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782965|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782966|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14782967|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
14782968|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
14782969|NCT00695240|Bupivacaine|bupivacaine|mesh-list
14782970|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
14782971|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
14782972|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14782973|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782974|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
14782975|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14782976|NCT00695331|Misoprostol|misoprostol|mesh-list
14782977|NCT00695331|Oxytocin|oxytocin|mesh-list
14782978|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
14945192|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
14945193|NCT01516580|Rituximab|rituximab|mesh-list
14945194|NCT01516580|Doxorubicin|doxorubicin|mesh-list
14945195|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14945196|NCT01516580|Methotrexate|methotrexate|mesh-list
14945197|NCT01516580|Vincristine|vincristine|mesh-list
14945198|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14945199|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
14945200|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945201|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14945202|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14945203|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
14945204|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945205|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945206|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14945207|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14945208|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14945209|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14945210|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945211|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945212|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14945213|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
14945214|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14945215|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14782979|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14782980|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782981|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14782982|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
14782983|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14782984|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14782985|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
14782986|NCT00695344|Everolimus|everolimus|mesh-list
14782987|NCT00695344|Azathioprine|azathioprine|mesh-list
14782988|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14782989|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14782990|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
14945216|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
14945217|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
14782991|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14782992|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14782993|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14782994|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
14782995|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14782996|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14782997|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14782998|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14782999|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
14783000|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14783001|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783002|NCT00695604|Fluticasone|fluticasone|mesh-list
14783003|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783004|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14783005|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
14783006|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783007|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783008|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14783009|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
14783010|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
14783011|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14783012|NCT00695630|Flumazenil|flumazenil|mesh-list
14783013|NCT00695630|Antidotes|antidotes|mesh-ancestor
14783014|NCT00695630|Protective Agents|protective agents|mesh-ancestor
14945218|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14945219|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14945220|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
14945221|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945222|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14783015|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783016|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
14783017|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
14783018|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783019|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783020|NCT00695643|Mesalamine|mesalamine|mesh-list
14783021|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14783022|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14783023|NCT00695643|Analgesics|analgesics|mesh-ancestor
14783024|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
14783025|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783026|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783027|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783028|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783029|NCT00695682|Infliximab|infliximab|mesh-list
14783030|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
14783031|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783032|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14945223|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
14945224|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
14945225|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
14945226|NCT01516593|Cytarabine|cytarabine|mesh-list
14945227|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14945228|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
14945229|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945230|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945231|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
14945232|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945233|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14945234|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
14945235|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945236|NCT01516606|Clarithromycin|clarithromycin|mesh-list
14945237|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945238|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945239|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14945240|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945241|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945242|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14945243|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14945244|NCT01516710|Liver Extracts|liver extracts|mesh-list
14945245|NCT01516710|Hematinics|hematinics|mesh-ancestor
14945246|NCT01516723|Sirolimus|sirolimus|mesh-list
14945247|NCT01516723|Everolimus|everolimus|mesh-list
14945248|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945249|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14945250|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
15026998|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
14945251|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945252|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945253|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945254|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14945255|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
14945256|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14945257|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945258|NCT01516814|Heparin|heparin|mesh-list
14945259|NCT01516814|Calcium heparin|calcium heparin|mesh-list
14945260|NCT01516814|Warfarin|warfarin|mesh-list
14945261|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
14945262|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
14209367|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
14783033|NCT00695929|Simendan|simendan|mesh-list
14783034|NCT00695929|Milrinone|milrinone|mesh-list
14783035|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14783036|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
14783037|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14783038|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14783039|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783040|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783041|NCT00695929|Protective Agents|protective agents|mesh-ancestor
14783042|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783043|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14783044|NCT00695994|Gemcitabine|gemcitabine|mesh-list
14783045|NCT00695994|Carboplatin|carboplatin|mesh-list
14783046|NCT00695994|Docetaxel|docetaxel|mesh-list
14783047|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783048|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14945263|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14209368|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209369|NCT04798755|Adalimumab|adalimumab|mesh-list
14209370|NCT04798755|Methotrexate|methotrexate|mesh-list
14209371|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14209372|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
14209373|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14209374|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209375|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14209376|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
14209377|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209378|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209379|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209380|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209381|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14209382|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209383|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
14209384|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209385|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14209386|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209387|NCT04792801|Choline|choline|mesh-list
14209388|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
14209389|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14209390|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
14209391|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209392|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14209393|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14209394|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
14209395|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
14209396|NCT04788108|Progestins|progestins|mesh-ancestor
14209397|NCT04788108|Hormones|hormones|mesh-ancestor
14209398|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209399|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209400|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
14209401|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14209402|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
14209403|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209404|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209405|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14209406|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
14209407|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14209408|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
14209409|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209410|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209411|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14783049|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
14945264|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15026999|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14783050|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783051|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
14783052|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783053|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783054|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783055|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
14783056|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783057|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
14783058|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
14783059|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
14783060|NCT00696007|Gemcitabine|gemcitabine|mesh-list
14783061|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783062|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14783063|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
14783064|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783065|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
14783066|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783067|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783068|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783069|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
14783070|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783071|NCT00696033|Diazepam|diazepam|mesh-list
14783072|NCT00696033|Lorazepam|lorazepam|mesh-list
14783073|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
14783074|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
14783075|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
14783076|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783077|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783078|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783079|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14783080|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783081|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14783082|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14783083|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14783084|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
14783085|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
14783086|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783087|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783088|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14783089|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14783090|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14783091|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14783092|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
14783093|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
14783094|NCT00696059|Adalimumab|adalimumab|mesh-list
14783095|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783096|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505849|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14783097|NCT00696098|Butyric Acid|butyric acid|mesh-list
14783098|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
14783099|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
14783100|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783101|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783102|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783103|NCT00696111|Leuprolide|leuprolide|mesh-list
14783104|NCT00696111|Progesterone|progesterone|mesh-list
14783105|NCT00696111|Estrogens|estrogens|mesh-list
14783106|NCT00696111|Progestins|progestins|mesh-ancestor
14783107|NCT00696111|Hormones|hormones|mesh-ancestor
14783108|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783109|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783110|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14783111|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
14783112|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14783113|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14783114|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505850|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14505851|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14505852|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14505853|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
14505854|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14505855|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505856|NCT02886624|Grazoprevir|grazoprevir|mesh-list
14505857|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
14505858|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783115|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
14783116|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
14783117|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14783118|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783119|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783120|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
14783121|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14783122|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
14783123|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14783124|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783125|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14945265|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945266|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14945267|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
14945268|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14209412|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
14209413|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
14209414|NCT04776408|Protective Agents|protective agents|mesh-ancestor
14209415|NCT04774120|Propofol|propofol|mesh-list
14209416|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209417|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209418|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209419|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209420|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
14209421|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
14209422|NCT04773002|Anesthetics|anesthetics|mesh-list
14209423|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209424|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209425|NCT04762472|Montelukast|montelukast|mesh-list
14209426|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14209427|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
14209428|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14209429|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
14209430|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209431|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209432|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14209433|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14783126|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14945269|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945270|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945271|NCT01516840|Heparin|heparin|mesh-list
14945272|NCT01516840|Calcium heparin|calcium heparin|mesh-list
14945273|NCT01516840|Warfarin|warfarin|mesh-list
14945274|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
14945275|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
14945276|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14945277|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14945278|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945279|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14945280|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
14945281|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14945282|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945283|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945284|NCT01516866|Listerine|listerine|mesh-list
14945285|NCT01516866|Fluorides|fluorides|mesh-list
14945286|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
14945287|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
14945288|NCT01516866|Protective Agents|protective agents|mesh-ancestor
14945289|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945290|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14945291|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945292|NCT01516944|Capecitabine|capecitabine|mesh-list
14945293|NCT01516944|Tegafur|tegafur|mesh-list
14945294|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
14783127|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14783128|NCT00696215|Rasagiline|rasagiline|mesh-list
14783129|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14783130|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783131|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783132|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14945295|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14945296|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
14945297|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945298|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209434|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209435|NCT04753879|Gemcitabine|gemcitabine|mesh-list
14783133|NCT00696215|Protective Agents|protective agents|mesh-ancestor
14783134|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783135|NCT00696475|Diazoxide|diazoxide|mesh-list
14783136|NCT00696475|Choline|choline|mesh-list
14783137|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
14783138|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14783139|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
14783140|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945299|NCT01516996|Docetaxel|docetaxel|mesh-list
14945300|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
14945301|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945302|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
14945303|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
14945304|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
14945305|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945306|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14945307|NCT01517009|Docetaxel|docetaxel|mesh-list
14945308|NCT01517009|Capecitabine|capecitabine|mesh-list
14945309|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945310|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14945311|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14945312|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14945313|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945314|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14945315|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
14945316|NCT01517022|Nicotine|nicotine|mesh-list
14945317|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14945318|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
14945319|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945320|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945321|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14945322|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14945323|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
14945324|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945325|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945326|NCT01517165|Pioglitazone|pioglitazone|mesh-list
14945327|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945328|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945329|NCT01517308|Interferons|interferons|mesh-list
14945330|NCT01517308|Ribavirin|ribavirin|mesh-list
14945331|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
14945332|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
14945333|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14945334|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945335|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
14945336|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945337|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
14945338|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945339|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
14945340|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945341|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14945342|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945343|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945344|NCT01517321|Incretins|incretins|mesh-ancestor
14945345|NCT01517321|Hormones|hormones|mesh-ancestor
14945346|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945347|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14945348|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945349|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945350|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945351|NCT01517334|Minocycline|minocycline|mesh-list
14945352|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945353|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945354|NCT01517347|Interleukin-2|interleukin-2|mesh-list
14945355|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945356|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14945357|NCT01517347|Analgesics|analgesics|mesh-ancestor
14945358|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
14945359|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945360|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945361|NCT01517360|Oxytocin|oxytocin|mesh-list
14945362|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
14945363|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14945364|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945365|NCT01517399|Vitamin K|vitamin k|mesh-list
14945366|NCT01517399|Digoxin|digoxin|mesh-list
14945367|NCT01517399|Midazolam|midazolam|mesh-list
14945368|NCT01517399|Caffeine|caffeine|mesh-list
14783141|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783142|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14783143|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
14783144|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14783145|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
14783146|NCT00696514|Vitamin D|vitamin d|mesh-list
14783147|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
14783148|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
14783149|NCT00696514|Vitamins|vitamins|mesh-list
14783150|NCT00696514|Folic Acid|folic acid|mesh-list
14783151|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
14783152|NCT00696514|Hydroxocobalamin|hydroxocobalamin|mesh-list
14783153|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
14783154|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783155|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14783156|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14783157|NCT00696514|Hematinics|hematinics|mesh-ancestor
14783158|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
14783159|NCT00696540|Albuterol|albuterol|mesh-list
14783160|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14783161|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
14783162|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783163|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783164|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14783165|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
14783166|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
14209436|NCT04753879|Paclitaxel|paclitaxel|mesh-list
14209437|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
14783167|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14783168|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14783169|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14783170|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14783171|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14783172|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783173|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783174|NCT00696566|Rifampin|rifampin|mesh-list
14783175|NCT00696566|Clopidogrel|clopidogrel|mesh-list
14783176|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14783177|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14783178|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14783179|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14783180|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
14783181|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783182|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783183|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783184|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14783185|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
14783186|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14783187|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783188|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
14783189|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14783190|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945369|NCT01517399|Omeprazole|omeprazole|mesh-list
14945370|NCT01517399|Warfarin|warfarin|mesh-list
14945371|NCT01517399|Vitamins|vitamins|mesh-ancestor
14945372|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
14945373|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945374|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14945375|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14945376|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945377|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14945378|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14945379|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14945380|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14945381|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
14945382|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
14945383|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
14945384|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
14945385|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964638|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964639|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13964640|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
13964641|NCT03136003|Coagulants|coagulants|mesh-ancestor
13964642|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13964643|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
13964644|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209438|NCT04753879|Capecitabine|capecitabine|mesh-list
15027000|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13964645|NCT03135795|Parecoxib|parecoxib|mesh-list
13964646|NCT03135795|Sufentanil|sufentanil|mesh-list
13964647|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
13964648|NCT03135795|Remifentanil|remifentanil|mesh-list
14783191|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14783192|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14783193|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14783194|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14783195|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14783196|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14783197|NCT00696579|Gemcitabine|gemcitabine|mesh-list
14783198|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14783199|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
14783200|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945386|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945387|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
13964649|NCT03135795|Dsuvia|dsuvia|mesh-list
13964650|NCT03135795|Bromides|bromides|mesh-list
13964651|NCT03135795|Propofol|propofol|mesh-list
13964652|NCT03135795|Sevoflurane|sevoflurane|mesh-list
14783201|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783202|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
14783203|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964653|NCT03135795|Citric Acid|citric acid|mesh-list
14209439|NCT04753879|Irinotecan|irinotecan|mesh-list
14945388|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14945389|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945390|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14945391|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209440|NCT04753879|Olaparib|olaparib|mesh-list
14783204|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945392|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14945393|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14945394|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14945395|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14945396|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
14945397|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14945398|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14945399|NCT01517399|Protective Agents|protective agents|mesh-ancestor
14945400|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14945401|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14945402|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
14945403|NCT01517399|Coagulants|coagulants|mesh-ancestor
14945404|NCT01517451|Androgens|androgens|mesh-list
14945405|NCT01517451|Hormones|hormones|mesh-ancestor
14783205|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783206|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
14783207|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783208|NCT00696592|Bevacizumab|bevacizumab|mesh-list
14783209|NCT00696592|Verteporfin|verteporfin|mesh-list
14783210|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14783211|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783212|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14783213|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14945406|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945407|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945408|NCT01517490|Insulin|insulin|mesh-list
14945409|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14945410|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945411|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945412|NCT01517555|Acetaminophen|acetaminophen|mesh-list
14945413|NCT01517555|Liraglutide|liraglutide|mesh-list
14945414|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14945415|NCT01517555|Analgesics|analgesics|mesh-ancestor
14945416|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
14783214|NCT00696592|Growth Substances|growth substances|mesh-ancestor
14783215|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783216|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
14783217|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14783218|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
14783219|NCT00696631|Dronedarone|dronedarone|mesh-list
14783220|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14945417|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964654|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
13964655|NCT03135795|Rocuronium|rocuronium|mesh-list
13964656|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13964657|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783221|NCT00696644|Teriparatide|teriparatide|mesh-list
14783222|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14209441|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14783223|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783224|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14783225|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14209442|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783226|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14783227|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14783228|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
14783229|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783230|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783231|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14783232|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14783233|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
14783234|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783235|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
14783236|NCT00696748|Testosterone|testosterone|mesh-list
14783237|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
14783238|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
14783239|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14783240|NCT00696748|Androgens|androgens|mesh-ancestor
14783241|NCT00696748|Hormones|hormones|mesh-ancestor
14783242|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783243|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964658|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783244|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14783245|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783246|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
14783247|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14783248|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783249|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783250|NCT00696826|Incretins|incretins|mesh-ancestor
14783251|NCT00696826|Hormones|hormones|mesh-ancestor
14783252|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783253|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14783254|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
14783255|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783256|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783257|NCT00696930|Edotreotide|edotreotide|mesh-list
14783258|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14783259|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783260|NCT00696956|Paclitaxel|paclitaxel|mesh-list
14783261|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14783262|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783263|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
14783264|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
14783265|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
14783266|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783267|NCT00696969|Amphotericin B|amphotericin b|mesh-list
14783268|NCT00696969|Paromomycin|paromomycin|mesh-list
14783269|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14783270|NCT00696969|Miltefosine|miltefosine|mesh-list
13964659|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13964660|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
13964661|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
13964662|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13964663|NCT03135795|Analgesics|analgesics|mesh-ancestor
13964664|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
13964665|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964666|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13964667|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14783271|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
14209443|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
14209444|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
14209445|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
14209446|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241199|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
14783272|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
14783273|NCT00696969|Amebicides|amebicides|mesh-ancestor
14783274|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14783275|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14783276|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783277|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14783278|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
14783279|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783280|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14783281|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783282|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14783283|NCT00696982|Glyburide|glyburide|mesh-list
14783284|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783285|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783286|NCT00696982|Incretins|incretins|mesh-ancestor
14783287|NCT00696982|Hormones|hormones|mesh-ancestor
14783288|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783289|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14783290|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
14783291|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783292|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783293|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
14783294|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
14783295|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14783296|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783297|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783298|NCT00697021|Aspirin|aspirin|mesh-list
14783299|NCT00697021|Clopidogrel|clopidogrel|mesh-list
14783300|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14945418|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945419|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
14945420|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945421|NCT01517555|Incretins|incretins|mesh-ancestor
14945422|NCT01517555|Hormones|hormones|mesh-ancestor
14945423|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945424|NCT01517568|Liraglutide|liraglutide|mesh-list
14945425|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783301|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14783302|NCT00697021|Analgesics|analgesics|mesh-ancestor
14783303|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
14783304|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783305|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783306|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783307|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783308|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14783309|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14945426|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945427|NCT01517568|Incretins|incretins|mesh-ancestor
14945428|NCT01517568|Hormones|hormones|mesh-ancestor
14945429|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945430|NCT01517607|Mesalamine|mesalamine|mesh-list
14945431|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14945432|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14945433|NCT01517607|Analgesics|analgesics|mesh-ancestor
14945434|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
14945435|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945436|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945437|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14945438|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14945439|NCT01517711|Tramadol|tramadol|mesh-list
13964668|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13964669|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
13964670|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964671|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964672|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
13964673|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14945440|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14945441|NCT01517711|Narcotics|narcotics|mesh-ancestor
13964674|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
14783310|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783311|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14783312|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14783313|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783314|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
14783315|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14783316|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14783317|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14783318|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
14783319|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783320|NCT00697034|Capsaicin|capsaicin|mesh-list
14783321|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
14783322|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14783323|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
14783324|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783325|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783326|NCT00697060|Docetaxel|docetaxel|mesh-list
14783327|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783328|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
14783329|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
14783330|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
14783331|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783332|NCT00697086|Dronedarone|dronedarone|mesh-list
14783333|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14783334|NCT00697125|Vaccines|vaccines|mesh-list
14783335|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
14783336|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783337|NCT00697138|Amphetamine|amphetamine|mesh-list
14783338|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
14783339|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14783340|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14783341|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14783342|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14783343|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783344|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
14783345|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783346|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783347|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14783348|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
14783349|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
14783350|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783351|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
14783352|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14783353|NCT00697151|Aspirin|aspirin|mesh-list
14783354|NCT00697151|Warfarin|warfarin|mesh-list
14783355|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14783356|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14783357|NCT00697151|Analgesics|analgesics|mesh-ancestor
14783358|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
14783359|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783360|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783361|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783362|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783363|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14783364|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14783365|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783366|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14945442|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945443|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945444|NCT01517711|Analgesics|analgesics|mesh-ancestor
14945445|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
14945446|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945447|NCT01517724|Bortezomib|bortezomib|mesh-list
14945448|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945449|NCT01517802|Prednisone|prednisone|mesh-list
14945450|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
14945451|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14945452|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
14945453|NCT01517802|Hormones|hormones|mesh-ancestor
14945454|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945455|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945456|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14783367|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14783368|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945457|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945458|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14945459|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945460|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945461|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
14783369|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
14783370|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
14783371|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
14783372|NCT00697164|Hematinics|hematinics|mesh-ancestor
14783373|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
14783374|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14783375|NCT00697281|Growth Substances|growth substances|mesh-ancestor
14783376|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783377|NCT00697372|Sirolimus|sirolimus|mesh-list
14783378|NCT00697372|Everolimus|everolimus|mesh-list
14783379|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783380|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783381|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
14783382|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783383|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14783384|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783385|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14945462|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14945463|NCT01517815|Tazobactam|tazobactam|mesh-list
14945464|NCT01517815|Piperacillin|piperacillin|mesh-list
14945465|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14783386|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
14783387|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
14783388|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14783389|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14783390|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783391|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
14783392|NCT00697385|Coagulants|coagulants|mesh-ancestor
14783393|NCT00697437|Ketoconazole|ketoconazole|mesh-list
14783394|NCT00697437|Docetaxel|docetaxel|mesh-list
14783395|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783396|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
14783397|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
14783398|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
14783399|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783400|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
14783401|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783402|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14783403|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14783404|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783405|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14945466|NCT01517815|Doripenem|doripenem|mesh-list
14783406|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
14783407|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783408|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783409|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14783410|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
14783411|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783412|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783413|NCT00697476|Topotecan|topotecan|mesh-list
14783414|NCT00697476|Vorinostat|vorinostat|mesh-list
14783415|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14783416|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14783417|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783418|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783419|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783420|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14783421|NCT00697502|Capecitabine|capecitabine|mesh-list
14783422|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14783423|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
14783424|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945467|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945468|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945469|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14945470|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945471|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945472|NCT01517828|Midazolam|midazolam|mesh-list
14945473|NCT01517828|Ketamine|ketamine|mesh-list
14945474|NCT01517828|Analgesics|analgesics|mesh-ancestor
14783425|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945475|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
14945476|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945477|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945478|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14945479|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14945480|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
14945481|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
14945482|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945483|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14945484|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14945485|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945486|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945487|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14945488|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14945489|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14945490|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14945491|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14945492|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
14945493|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
14945494|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
14945495|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
14945496|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14945497|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14945498|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945499|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945500|NCT01517854|Urological Agents|urological agents|mesh-ancestor
14945501|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
14945502|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14945503|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945504|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945505|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14945506|NCT01517932|Analgesics|analgesics|mesh-ancestor
14945507|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
14945508|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945509|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14945510|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14945511|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14945512|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
14945513|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945514|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505859|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
14505860|NCT02886702|Tazarotene|tazarotene|mesh-list
14505861|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505862|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
14505863|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
14505864|NCT02886702|Vitamins|vitamins|mesh-ancestor
14505865|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
14505866|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505867|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
14505868|NCT02886715|Tazarotene|tazarotene|mesh-list
14505869|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
14505870|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
14945515|NCT01517997|Paclitaxel|paclitaxel|mesh-list
14945516|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14945517|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945518|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
14945519|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
14945520|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
14945521|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945522|NCT01518062|Estrogens|estrogens|mesh-list
14945523|NCT01518062|Hormones|hormones|mesh-ancestor
14945524|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945525|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945526|NCT01518101|Metformin|metformin|mesh-list
14945527|NCT01518101|Liraglutide|liraglutide|mesh-list
14945528|NCT01518101|Vildagliptin|vildagliptin|mesh-list
13964675|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
14505871|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
14505872|NCT02886715|Vitamins|vitamins|mesh-ancestor
14783426|NCT00697554|Vaccines|vaccines|mesh-list
14783427|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
14783428|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783429|NCT00697567|Vaccines|vaccines|mesh-list
14783430|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
14783431|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783432|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14783433|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14783434|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14783435|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783436|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783437|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14783438|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14783439|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14783440|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
14783441|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783442|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783443|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14945529|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945530|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945531|NCT01518101|Incretins|incretins|mesh-ancestor
14945532|NCT01518101|Hormones|hormones|mesh-ancestor
14945533|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945534|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14945535|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945536|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945537|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945538|NCT01518166|Liraglutide|liraglutide|mesh-list
14945539|NCT01518166|Griseofulvin|griseofulvin|mesh-list
14945540|NCT01518166|Digoxin|digoxin|mesh-list
14945541|NCT01518166|Lisinopril|lisinopril|mesh-list
14945542|NCT01518166|Atorvastatin|atorvastatin|mesh-list
14783444|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14783445|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
14783446|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
14783447|NCT00697671|Etoposide|etoposide|mesh-list
14783448|NCT00697671|Interleukin-2|interleukin-2|mesh-list
14783449|NCT00697671|Clofarabine|clofarabine|mesh-list
14783450|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783451|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
14783452|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783453|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783454|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14783455|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
14783456|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783457|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783458|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14783459|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14783460|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14783461|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14783462|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783463|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14783464|NCT00697671|Analgesics|analgesics|mesh-ancestor
14783465|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
14783466|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783467|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14783468|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
14783469|NCT00697775|Vaccines|vaccines|mesh-list
14783470|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
14783471|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783472|NCT00697814|Clomiphene|clomiphene|mesh-list
14783473|NCT00697814|Enclomiphene|enclomiphene|mesh-list
14783474|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
14783475|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14783476|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
14783477|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783478|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783479|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14945543|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14945544|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14945545|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
14783480|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
14945546|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783481|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14783482|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14783483|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14783484|NCT00697866|Vaccines|vaccines|mesh-list
14783485|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
14783486|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783487|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14783488|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783489|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783490|NCT00697892|Ritonavir|ritonavir|mesh-list
14783491|NCT00697892|Lopinavir|lopinavir|mesh-list
14783492|NCT00697892|Efavirenz|efavirenz|mesh-list
14783493|NCT00697892|Lumefantrine|lumefantrine|mesh-list
14783494|NCT00697892|Artemether|artemether|mesh-list
14783495|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14783496|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14783497|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14783498|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
14783499|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783500|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783501|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14783502|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14783503|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
14783504|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783505|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14783506|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14783507|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14783508|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14783509|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14783510|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14783511|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14783512|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14783513|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14783514|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
14783515|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14783516|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14783517|NCT00697905|Gemcitabine|gemcitabine|mesh-list
14783518|NCT00697905|Carboplatin|carboplatin|mesh-list
14783519|NCT00697905|Fluorouracil|fluorouracil|mesh-list
14783520|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783521|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14783522|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
14783523|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783524|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
14783525|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783526|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783527|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783528|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
14783529|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783530|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14783531|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
14783532|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783533|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14783534|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14783535|NCT00697996|Rituximab|rituximab|mesh-list
14783536|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14783537|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783538|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
14783539|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783540|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783541|NCT00698126|Insulin|insulin|mesh-list
14783542|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14783543|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
14783544|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
14783545|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783546|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783547|NCT00698269|Insulin|insulin|mesh-list
14783548|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14783549|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
14783550|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
14783551|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14783552|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
14783553|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
14783554|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14783555|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783556|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783557|NCT00698334|Rifampin|rifampin|mesh-list
14783558|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
14783559|NCT00698334|Ethambutol|ethambutol|mesh-list
14783560|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14783561|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
14783562|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14783563|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783564|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
14945547|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14945548|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14945549|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945550|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945551|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945552|NCT01518166|Incretins|incretins|mesh-ancestor
14945553|NCT01518166|Hormones|hormones|mesh-ancestor
14945554|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945555|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14945556|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14945557|NCT01518166|Protective Agents|protective agents|mesh-ancestor
14945558|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14783565|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14783566|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783567|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783568|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14783569|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14783570|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14783571|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14783572|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14783573|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14783574|NCT00698425|Citric Acid|citric acid|mesh-list
14783575|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
14783576|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
14783577|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14783578|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
14783579|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
14783580|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783581|NCT00698464|Pasireotide|pasireotide|mesh-list
14783582|NCT00698464|Hormones|hormones|mesh-ancestor
14783583|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783584|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783585|NCT00698607|Sirolimus|sirolimus|mesh-list
14783586|NCT00698607|Everolimus|everolimus|mesh-list
14783587|NCT00698607|Clopidogrel|clopidogrel|mesh-list
14783588|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783589|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783590|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
14783591|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783592|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14783593|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14783594|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14783595|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14783596|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
14783597|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783598|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783599|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14783600|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783601|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14783602|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
14783603|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
14783604|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14783605|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
14783606|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14783607|NCT00698724|Prednisolone|prednisolone|mesh-list
14783608|NCT00698724|Bromfenac|bromfenac|mesh-list
14783609|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14783610|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
14783611|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783612|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
14783613|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
14783614|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783615|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945559|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945560|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14209447|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14209448|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
14209449|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
14209450|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783616|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783617|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
14783618|NCT00698724|Hormones|hormones|mesh-ancestor
14783619|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783620|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14783621|NCT00698724|Protective Agents|protective agents|mesh-ancestor
14783622|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14783623|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783624|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14783625|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14783626|NCT00698724|Analgesics|analgesics|mesh-ancestor
14783627|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
14783628|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783629|NCT00698763|Simendan|simendan|mesh-list
14783630|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14783631|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
14783632|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14783633|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14783634|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783635|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783636|NCT00698763|Protective Agents|protective agents|mesh-ancestor
14783637|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783638|NCT00698776|Lenalidomide|lenalidomide|mesh-list
14783639|NCT00698776|KRN 7000|krn 7000|mesh-list
14783640|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
14783641|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783642|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14783643|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14783644|NCT00698776|Growth Substances|growth substances|mesh-ancestor
14945561|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
14945562|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027001|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15027002|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027003|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209451|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209452|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209453|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
14209454|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209455|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505873|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
15027004|NCT01946984|Diclofenac|diclofenac|mesh-list
15027005|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
15027006|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15027007|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15027008|NCT01946984|Analgesics|analgesics|mesh-ancestor
15027009|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
15027010|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027011|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027012|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027013|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027014|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15027015|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027016|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027017|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15027018|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
15027019|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034878|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034879|NCT01997840|Dexamethasone|dexamethasone|mesh-list
15034880|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
15034881|NCT01997840|Pomalidomide|pomalidomide|mesh-list
15034882|NCT01997840|Ricolinostat|ricolinostat|mesh-list
15034883|NCT01997840|BB 1101|bb 1101|mesh-list
14209456|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14505874|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505875|NCT02887183|Valsartan|valsartan|mesh-list
14505876|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14505877|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14505878|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14505879|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14783645|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
14783646|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783647|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14783648|NCT00698802|Insulin|insulin|mesh-list
14783649|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14783650|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783651|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783652|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14783653|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14783654|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14783655|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14783656|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14783657|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
14783658|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783659|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783660|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783661|NCT00699023|Simvastatin|simvastatin|mesh-list
14783662|NCT00699023|Ezetimibe|ezetimibe|mesh-list
14783663|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14783664|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14783665|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
14783666|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783667|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14783668|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14783669|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783670|NCT00699036|Metformin|metformin|mesh-list
14945563|NCT01518231|Aspirin|aspirin|mesh-list
14945564|NCT01518231|Edaravone|edaravone|mesh-list
14783671|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
14783672|NCT00699036|Losartan|losartan|mesh-list
14783673|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783674|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783675|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14783676|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14783677|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14783678|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14783679|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783680|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
14783681|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14783682|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14783683|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14783684|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
14783685|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783686|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783687|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783688|NCT00699049|Urological Agents|urological agents|mesh-ancestor
14783689|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14783690|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
14783691|NCT00699062|Montelukast|montelukast|mesh-list
14783692|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14783693|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
14783694|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14783695|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
14783696|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783697|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783698|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14783699|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14783700|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783701|NCT00699114|Acetaminophen|acetaminophen|mesh-list
14783702|NCT00699114|Ibuprofen|ibuprofen|mesh-list
14783703|NCT00699114|Codeine|codeine|mesh-list
14783704|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14783705|NCT00699114|Analgesics|analgesics|mesh-ancestor
14783706|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
14783707|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783708|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783709|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
14783710|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14783711|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783712|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783713|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14783714|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945565|NCT01518231|Warfarin|warfarin|mesh-list
14945566|NCT01518231|Atorvastatin|atorvastatin|mesh-list
15027020|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
14783715|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783716|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14783717|NCT00699114|Narcotics|narcotics|mesh-ancestor
14783718|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783719|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
14783720|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
14945567|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14945568|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14945569|NCT01518231|Analgesics|analgesics|mesh-ancestor
14945570|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
14945571|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945572|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945573|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14945574|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14945575|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14945576|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14945577|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945578|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14945579|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14945580|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945581|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
14945582|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14945583|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14945584|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
14945585|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14945586|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14945587|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
14945588|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14945589|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
14945590|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14945591|NCT01518231|Protective Agents|protective agents|mesh-ancestor
14945592|NCT01518413|Irinotecan|irinotecan|mesh-list
14945593|NCT01518413|Sorafenib|sorafenib|mesh-list
14945594|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14945595|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945596|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945597|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945598|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945599|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14945600|NCT01518465|Dexamethasone|dexamethasone|mesh-list
14945601|NCT01518465|Lenalidomide|lenalidomide|mesh-list
14945602|NCT01518465|Dalteparin|dalteparin|mesh-list
14945603|NCT01518465|Tinzaparin|tinzaparin|mesh-list
14945604|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14945605|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14945606|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
14945607|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
14945608|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945609|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945610|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945611|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
14945612|NCT01518465|Hormones|hormones|mesh-ancestor
14945613|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945614|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14945615|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945616|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
14945617|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14945618|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14945619|NCT01518465|Growth Substances|growth substances|mesh-ancestor
14945620|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
14945621|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
14945622|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14945623|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14945624|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945625|NCT01518569|Urinastatin|urinastatin|mesh-list
14945626|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14945627|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14945628|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945629|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945630|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945631|NCT01518595|Bosentan|bosentan|mesh-list
14945632|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13968058|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783721|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
14945633|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14783722|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
14783723|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14783724|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783725|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783726|NCT00699244|Anesthetics|anesthetics|mesh-list
14783727|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783728|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783729|NCT00699296|Panobinostat|panobinostat|mesh-list
14783730|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783731|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14783732|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783733|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783734|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14783735|NCT00699322|Glimepiride|glimepiride|mesh-list
14783736|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783737|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783738|NCT00699322|Incretins|incretins|mesh-ancestor
14783739|NCT00699322|Hormones|hormones|mesh-ancestor
14783740|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783741|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14783742|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
14783743|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783744|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783745|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14783746|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783747|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
14783748|NCT00699361|Pantoprazole|pantoprazole|mesh-list
14783749|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14783750|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783751|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14783752|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783753|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945634|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945635|NCT01518608|Alfentanil|alfentanil|mesh-list
14945636|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14945637|NCT01518608|Narcotics|narcotics|mesh-ancestor
14945638|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945639|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945640|NCT01518608|Analgesics|analgesics|mesh-ancestor
14945641|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
14945642|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945643|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209457|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14209458|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14209459|NCT04752540|Olorofim|olorofim|mesh-list
14209460|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
14209461|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209462|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
14209463|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14209464|NCT04749459|Protective Agents|protective agents|mesh-ancestor
14209465|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209466|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209467|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
14209468|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209469|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209470|NCT04734652|Tenofovir|tenofovir|mesh-list
14209471|NCT04734652|Lamivudine|lamivudine|mesh-list
14209472|NCT04734652|Dolutegravir|dolutegravir|mesh-list
14209473|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
14209474|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209475|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14209476|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14209477|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209478|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209479|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14209480|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14209481|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14209482|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14209483|NCT04732260|Letermovir|letermovir|mesh-list
14209484|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14945644|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
14945645|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
14209485|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209486|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783754|NCT00699387|Benzonidazole|benzonidazole|mesh-list
14783755|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14783756|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
14783757|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783758|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14783759|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14783760|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14783761|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783762|NCT00699426|Esomeprazole|esomeprazole|mesh-list
14783763|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14783764|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783765|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14783766|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783767|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783768|NCT00699452|Candesartan|candesartan|mesh-list
14783769|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14783770|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14783771|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14783772|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783773|NCT00699465|Enoxaparin|enoxaparin|mesh-list
14783774|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
14783775|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
14783776|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14783777|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14783778|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783779|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
14783780|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
14783781|NCT00699478|Vitamins|vitamins|mesh-ancestor
14783782|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
14783783|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783784|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
14783785|NCT00699504|Cangrelor|cangrelor|mesh-list
14783786|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14783787|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783788|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14783789|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14783790|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783791|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783792|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783793|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783794|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14209487|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209488|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
14209489|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783795|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14783796|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14783797|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14783798|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
14783799|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783800|NCT00699530|Cabergoline|cabergoline|mesh-list
14783801|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14783802|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14783803|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
14783804|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
14783805|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783806|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783807|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783808|NCT00699634|Nabilone|nabilone|mesh-list
14783809|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
14945646|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14945647|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945648|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14241200|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
14241201|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241202|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
14945649|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945650|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945651|NCT01518634|Imipramine|imipramine|mesh-list
14945652|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14945653|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
14945654|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027021|NCT01947062|Cisplatin|cisplatin|mesh-list
14241203|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783810|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
15027022|NCT01947062|Etoposide|etoposide|mesh-list
14783811|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783812|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783813|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14783814|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14783815|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14783816|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783817|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14783818|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
14783819|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
14783820|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783821|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783822|NCT00699764|Vaccines|vaccines|mesh-list
14783823|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
14783824|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783825|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
14783826|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
14783827|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14783828|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14783829|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783830|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14783831|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783832|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14783833|NCT00699881|Cetuximab|cetuximab|mesh-list
14783834|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14945655|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14945656|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14945657|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14945658|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783835|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209490|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14209491|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14209492|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209493|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14209494|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
14209495|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209496|NCT04701281|Capecitabine|capecitabine|mesh-list
14209497|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14209498|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
14209499|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209500|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783836|NCT00699894|Ondansetron|ondansetron|mesh-list
14783837|NCT00699894|Aprepitant|aprepitant|mesh-list
14783838|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
14783839|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
14783840|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783841|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783842|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945659|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14945660|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945661|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945662|NCT01518712|Metformin|metformin|mesh-list
14783843|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
14783844|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
14783845|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14783846|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
14783847|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783848|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783849|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14783850|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14783851|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783852|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14783853|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14783854|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14783855|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14783856|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
14945663|NCT01518712|Canagliflozin|canagliflozin|mesh-list
14945664|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13964676|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13964677|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13964678|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13964679|NCT03135795|Narcotics|narcotics|mesh-ancestor
13964680|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
13964681|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13964682|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14783857|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14783858|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14783859|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783860|NCT00699946|Olanzapine|olanzapine|mesh-list
14783861|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
14783862|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
14783863|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783864|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783865|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945665|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945666|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14945667|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945668|NCT01518725|Vitamin D|vitamin d|mesh-list
14945669|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
14945670|NCT01518725|Vitamins|vitamins|mesh-ancestor
14945671|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
14783866|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14783867|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14783868|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14783869|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14783870|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14783871|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14783872|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14783873|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783874|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783875|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
14783876|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
14783877|NCT00700024|Testosterone|testosterone|mesh-list
14783878|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
14783879|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
14783880|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14783881|NCT00700024|Androgens|androgens|mesh-ancestor
14783882|NCT00700024|Hormones|hormones|mesh-ancestor
14783883|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783884|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783885|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14783886|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14783887|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
14783888|NCT00700037|Atorvastatin|atorvastatin|mesh-list
14783889|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14783890|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14783891|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
14783892|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783893|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14783894|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14783895|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783896|NCT00700128|Frovatriptan|frovatriptan|mesh-list
14783897|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14945672|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945673|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14945674|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14945675|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14945676|NCT01518790|Laxatives|laxatives|mesh-ancestor
14945677|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945678|NCT01518855|Amlodipine|amlodipine|mesh-list
14945679|NCT01518855|Nifedipine|nifedipine|mesh-list
14945680|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14945681|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14945682|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14945683|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945684|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14945685|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945686|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
14945687|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
13964683|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14783898|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
14783899|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783900|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783901|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783902|NCT00700154|Insulin|insulin|mesh-list
14783903|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14783904|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
14783905|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783906|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783907|NCT00700193|Vaccines|vaccines|mesh-list
14783908|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
14945688|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14783909|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783910|NCT00700284|Dapivirine|dapivirine|mesh-list
14783911|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14783912|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14783913|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
14783914|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14783915|NCT00700297|Colchicine|colchicine|mesh-list
14783916|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
14783917|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783918|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
14783919|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
14783920|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
14783921|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783922|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505880|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505881|NCT02887404|Analgesics|analgesics|mesh-list
14505882|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
14783923|NCT00700362|Insulin|insulin|mesh-list
14783924|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783925|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783926|NCT00700466|Metoprolol|metoprolol|mesh-list
14783927|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14783928|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14783929|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14783930|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
14783931|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
14783932|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14783933|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783934|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14783935|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14783936|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
14783937|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783938|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783939|NCT00700492|Progesterone|progesterone|mesh-list
14783940|NCT00700492|Progestins|progestins|mesh-ancestor
14783941|NCT00700492|Hormones|hormones|mesh-ancestor
14783942|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783943|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783944|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
14783945|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
14783946|NCT00700544|Norethandrolone|norethandrolone|mesh-list
14783947|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
14783948|NCT00700544|Hormones|hormones|mesh-ancestor
14783949|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14783950|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783951|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14783952|NCT00700583|Terazosin|terazosin|mesh-list
14783953|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14783954|NCT00700583|Diuretics|diuretics|mesh-ancestor
14783955|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
14783956|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783957|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14783958|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14783959|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783960|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14505883|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505884|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505885|NCT02888106|Tenofovir|tenofovir|mesh-list
14505886|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14505887|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
14505888|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
14505889|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505890|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14209501|NCT04690231|Etoposide|etoposide|mesh-list
14209502|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
14783961|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14783962|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14783963|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
14783964|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14783965|NCT00700583|Urological Agents|urological agents|mesh-ancestor
14783966|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
14783967|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783968|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783969|NCT00700687|Aspirin|aspirin|mesh-list
14783970|NCT00700687|Celecoxib|celecoxib|mesh-list
14783971|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14783972|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14783973|NCT00700687|Analgesics|analgesics|mesh-ancestor
14783974|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
14783975|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209503|NCT04690231|Apatinib|apatinib|mesh-list
14209504|NCT04690231|Ifosfamide|ifosfamide|mesh-list
14209505|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
14783976|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783977|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14783978|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14783979|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14783980|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14783981|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14783982|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14783983|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14783984|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14783985|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
14783986|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14783987|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
14783988|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945689|NCT01518933|Silybin|silybin|mesh-list
14945690|NCT01518933|Silymarin|silymarin|mesh-list
14945691|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
14945692|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945693|NCT01518933|Protective Agents|protective agents|mesh-ancestor
14945694|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945695|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14945696|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945697|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
14945698|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14945699|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945700|NCT01518959|Vitamins|vitamins|mesh-ancestor
14945701|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
14945702|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14945703|NCT01518998|Amlodipine|amlodipine|mesh-list
14945704|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14945705|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14945706|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14945707|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945708|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14945709|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945710|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
14945711|NCT01519011|Azacitidine|azacitidine|mesh-list
14945712|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14945713|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
14945714|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945715|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945716|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945717|NCT01519037|Cinacalcet|cinacalcet|mesh-list
14945718|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14945719|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945720|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14945721|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
14945722|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945723|NCT01519076|Coal Tar|coal tar|mesh-list
14945724|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
14945725|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
14945726|NCT01519102|Hormones|hormones|mesh-list
14945727|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209506|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14783989|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783990|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
14783991|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783992|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783993|NCT00700856|Pioglitazone|pioglitazone|mesh-list
14945728|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945729|NCT01519128|Rilpivirine|rilpivirine|mesh-list
14945730|NCT01519128|Digoxin|digoxin|mesh-list
14945731|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14945732|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14945733|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945734|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945735|NCT01519128|Protective Agents|protective agents|mesh-ancestor
14945736|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945737|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14945738|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14945739|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
14945740|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945741|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14945742|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14945743|NCT01519154|Ketamine|ketamine|mesh-list
14945744|NCT01519154|Propofol|propofol|mesh-list
14945745|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14945746|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945747|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945748|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14945749|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
14945750|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
14945751|NCT01519154|Analgesics|analgesics|mesh-ancestor
14945752|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
14945753|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945754|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14945755|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14945756|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14945757|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945758|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945759|NCT01519297|Irbesartan|irbesartan|mesh-list
14945760|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14945761|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14945762|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14945763|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945764|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14209507|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209508|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14209509|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14209510|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209511|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209512|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14209513|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14209514|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
14209515|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
14209516|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14209517|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209518|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209519|NCT04675827|Trastuzumab|trastuzumab|mesh-list
14209520|NCT04675827|Pertuzumab|pertuzumab|mesh-list
14945765|NCT01519310|Metronidazole|metronidazole|mesh-list
14945766|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
14945767|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945768|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14945769|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14945770|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14945771|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945772|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945773|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945774|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945775|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14209521|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14783994|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14783995|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14783996|NCT00700895|Warfarin|warfarin|mesh-list
14783997|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
14783998|NCT00700921|Lovastatin|lovastatin|mesh-list
14783999|NCT00700921|L 647318|l 647318|mesh-list
14784000|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
14945776|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14784001|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14784002|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784003|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
14784004|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784005|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14945777|NCT01519336|Ritonavir|ritonavir|mesh-list
14945778|NCT01519336|Darunavir|darunavir|mesh-list
14945779|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14945780|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14945781|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
14945782|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945783|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945784|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14945785|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14945786|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
14945787|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945788|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14945789|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14945790|NCT01519401|Drospirenone|drospirenone|mesh-list
14945791|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14945792|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14945793|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14945794|NCT01519401|Estradiol|estradiol|mesh-list
14945795|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14945796|NCT01519401|Estrogens|estrogens|mesh-ancestor
14945797|NCT01519401|Hormones|hormones|mesh-ancestor
14945798|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945799|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945800|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14945801|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
14945802|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14945803|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14945804|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14945805|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14945806|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14945807|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
14945808|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14945809|NCT01519401|Diuretics|diuretics|mesh-ancestor
14945810|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
14945811|NCT01519544|Acetazolamide|acetazolamide|mesh-list
14945812|NCT01519544|Temazepam|temazepam|mesh-list
14945813|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
14945814|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14945815|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945816|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945817|NCT01519544|Diuretics|diuretics|mesh-ancestor
14945818|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
14945819|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945820|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14945821|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945822|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14945823|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14945824|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14945825|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
14945826|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
14945827|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945828|NCT01519687|Tofisopam|tofisopam|mesh-list
14945829|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
14945830|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14945831|NCT01519726|Midazolam|midazolam|mesh-list
14945832|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14945833|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14945834|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945835|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945836|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14784006|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14784007|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784008|NCT00700947|Metoprolol|metoprolol|mesh-list
14784009|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14784010|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14784011|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
14784012|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784013|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784014|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945837|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14945838|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14784015|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14784016|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784017|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
14784018|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
14784019|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784020|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14784021|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
14784022|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14784023|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784024|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
14784025|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14784026|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784027|NCT00701220|Atorvastatin|atorvastatin|mesh-list
14784028|NCT00701220|Calcium|calcium|mesh-list
14784029|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14784030|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784031|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14784032|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784033|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
14784034|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784035|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784036|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14784037|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784038|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
14784039|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14784040|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14784041|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784042|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
14784043|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784044|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784045|NCT00701246|Folic Acid|folic acid|mesh-list
14784046|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
14784047|NCT00701246|Hematinics|hematinics|mesh-ancestor
14784048|NCT00701246|Vitamins|vitamins|mesh-ancestor
14784049|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
14784050|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784051|NCT00701259|Lansoprazole|lansoprazole|mesh-list
14784052|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
14784053|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14784054|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14784055|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14784056|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784057|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784058|NCT00701285|Pravastatin|pravastatin|mesh-list
14784059|NCT00701285|Pitavastatin|pitavastatin|mesh-list
14784060|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14784061|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784062|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
14784063|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784064|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784065|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14784066|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784067|NCT00701298|Interferons|interferons|mesh-list
14784068|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
14784069|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
14784070|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14784071|NCT00701298|Decitabine|decitabine|mesh-list
14784072|NCT00701298|Azacitidine|azacitidine|mesh-list
14784073|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784074|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
14784075|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784076|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
14784077|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784078|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14784079|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
14784080|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784081|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784082|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14784083|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14945839|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14945840|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
14945841|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
14945842|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
14945843|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
14945844|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784084|NCT00701337|Estradiol|estradiol|mesh-list
15027023|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
14784085|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14784086|NCT00701337|Estrogens|estrogens|mesh-ancestor
14784087|NCT00701337|Hormones|hormones|mesh-ancestor
14784088|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14784089|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784090|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14784091|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
14784092|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14784093|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14209522|NCT04675827|Maytansine|maytansine|mesh-list
14209523|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209524|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209525|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14209526|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
14209527|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
14209528|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
14209529|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209530|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14209531|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
14209532|NCT04669678|Etonogestrel|etonogestrel|mesh-list
14209533|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14209534|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14209535|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14209536|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
14209537|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14209538|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209539|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14209540|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14209541|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14209542|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14209543|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209544|NCT04652700|Tenofovir|tenofovir|mesh-list
14209545|NCT04652700|Emtricitabine|emtricitabine|mesh-list
14209546|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14209547|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14209548|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
14209549|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209550|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14209551|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14209552|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209553|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784094|NCT00701428|Losartan|losartan|mesh-list
14784095|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14784096|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784097|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14784098|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14784099|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784100|NCT00701493|Topiramate|topiramate|mesh-list
14784101|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
14784102|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14784103|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945845|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945846|NCT01519752|Oxiconazole|oxiconazole|mesh-list
14945847|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
14945848|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14945849|NCT01519856|Piribedil|piribedil|mesh-list
14945850|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14945851|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14945852|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
14945853|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
14945854|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945855|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945856|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945857|NCT01519986|Vitamin D|vitamin d|mesh-list
14945858|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
14945859|NCT01519986|Vitamins|vitamins|mesh-ancestor
14945860|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
14945861|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945862|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14945863|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14945864|NCT01520012|Esomeprazole|esomeprazole|mesh-list
14945865|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14209554|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14784104|NCT00701532|Modafinil|modafinil|mesh-list
14784105|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14784106|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784107|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14784108|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14784109|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14784110|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784111|NCT00701597|Bosentan|bosentan|mesh-list
14784112|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784113|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14784114|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784115|NCT00701623|Heparin|heparin|mesh-list
14784116|NCT00701623|Calcium heparin|calcium heparin|mesh-list
14784117|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
14784118|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14784119|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14784120|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784121|NCT00701740|Isotretinoin|isotretinoin|mesh-list
14784122|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
14784123|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209555|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14209556|NCT04651439|Lenograstim|lenograstim|mesh-list
14209557|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14209558|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
14209559|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209560|NCT04650581|Fulvestrant|fulvestrant|mesh-list
14209561|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14209562|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209563|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14209564|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14209565|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
14209566|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209567|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209568|NCT04650087|Apixaban|apixaban|mesh-list
14209569|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14209570|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
14209571|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14209572|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
14784124|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
14784125|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14784126|NCT00701740|Protective Agents|protective agents|mesh-ancestor
14209573|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209574|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209575|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
14209576|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
14209577|NCT04642430|Apixaban|apixaban|mesh-list
14209578|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14209579|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
14209580|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14209581|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
14209582|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209583|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209584|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
14209585|NCT04633564|Bevacizumab|bevacizumab|mesh-list
14505891|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14784127|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784128|NCT00701792|Liver Extracts|liver extracts|mesh-list
14784129|NCT00701792|Hematinics|hematinics|mesh-ancestor
14784130|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
14784131|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14209586|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14505892|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505893|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505894|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14505895|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14505896|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505897|NCT02888665|Doxorubicin|doxorubicin|mesh-list
14505898|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14505899|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
14505900|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14505901|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14505902|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14505903|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14505904|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784132|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784133|NCT00701857|Pemetrexed|pemetrexed|mesh-list
14784134|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784135|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784136|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784137|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14784138|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14784139|NCT00701909|Ketamine|ketamine|mesh-list
14784140|NCT00701909|Morphine|morphine|mesh-list
14784141|NCT00701909|Analgesics|analgesics|mesh-ancestor
14784142|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
14784143|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784144|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784145|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14784146|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14784147|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
14784148|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
14784149|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14784150|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14209587|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209588|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14209589|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14209590|NCT04633564|Growth Substances|growth substances|mesh-ancestor
14209591|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209592|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
14209593|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
14209594|NCT04602845|Fentanyl|fentanyl|mesh-list
14784151|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14784152|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784153|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784154|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14784155|NCT00701909|Narcotics|narcotics|mesh-ancestor
14784156|NCT00701961|Artesunate|artesunate|mesh-list
14784157|NCT00701961|Mefloquine|mefloquine|mesh-list
14784158|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
14784159|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14784160|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14784161|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784162|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784163|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
14784164|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
14784165|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14784166|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
14784167|NCT00702091|Ramipril|ramipril|mesh-list
14784168|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14784169|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14784170|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784171|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784172|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784173|NCT00702117|Flecainide|flecainide|mesh-list
14784174|NCT00702117|Procainamide|procainamide|mesh-list
14209595|NCT04602845|Midazolam|midazolam|mesh-list
14209596|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14505905|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505906|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209597|NCT04602845|Narcotics|narcotics|mesh-ancestor
14505907|NCT02889393|Teduglutide|teduglutide|mesh-list
14505908|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14505909|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14505910|NCT02889393|Protective Agents|protective agents|mesh-ancestor
14505911|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505912|NCT02889510|Liraglutide|liraglutide|mesh-list
14505913|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14505914|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505915|NCT02889510|Incretins|incretins|mesh-ancestor
14505916|NCT02889510|Hormones|hormones|mesh-ancestor
14505917|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14505918|NCT02889562|Warfarin|warfarin|mesh-list
14505919|NCT02889562|Apixaban|apixaban|mesh-list
14505920|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
14505921|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14505922|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
14505923|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14505924|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
14505925|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505926|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505927|NCT02889796|Adalimumab|adalimumab|mesh-list
14784175|NCT00702117|Ajmaline|ajmaline|mesh-list
14784176|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14784177|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14784178|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14784179|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14784180|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784181|NCT00702130|Pravastatin|pravastatin|mesh-list
14784182|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14784183|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784184|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
14784185|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209598|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209599|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209600|NCT04602845|Analgesics|analgesics|mesh-ancestor
14209601|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
14209602|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209603|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14209604|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209605|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
14209606|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
14784186|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784187|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14784188|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784189|NCT00702156|Bisoprolol|bisoprolol|mesh-list
14784190|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784191|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
14784192|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
14784193|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784194|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784195|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14784196|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14784197|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14784198|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
14784199|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784200|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784201|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14209607|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209608|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14209609|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14209610|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14505928|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14784202|NCT00702182|Vinorelbine|vinorelbine|mesh-list
13964684|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13964685|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13964686|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13964687|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964688|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13964689|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505929|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505930|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
14505931|NCT02890992|Niacin|niacin|mesh-list
14505932|NCT02890992|Niacinamide|niacinamide|mesh-list
14505933|NCT02890992|Ezetimibe|ezetimibe|mesh-list
14505934|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
14505935|NCT02890992|Fenofibrate|fenofibrate|mesh-list
14505936|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14505937|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14505938|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
14505939|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505940|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14505941|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
13964690|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13964691|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
13964692|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14505942|NCT02890992|Vitamins|vitamins|mesh-ancestor
14505943|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
14505944|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505945|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
14505946|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14505947|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
14505948|NCT02891070|Coagulants|coagulants|mesh-ancestor
13964693|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
13964694|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505949|NCT02891174|Acetaminophen|acetaminophen|mesh-list
14505950|NCT02891174|Ibuprofen|ibuprofen|mesh-list
14505951|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14784203|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784204|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14784205|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784206|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784207|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14784208|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784209|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784210|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784211|NCT00702260|Ramipril|ramipril|mesh-list
14784212|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14945866|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945867|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14945868|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945869|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945870|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14945871|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14945872|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945873|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14945874|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14945875|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14945876|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
14945877|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945878|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14945879|NCT01520103|Everolimus|everolimus|mesh-list
14945880|NCT01520103|Vinorelbine|vinorelbine|mesh-list
14945881|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945882|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14945883|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
14945884|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945885|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14945886|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
14945887|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
14945888|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
14945889|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027024|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15027025|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
15027026|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027027|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027028|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15027029|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
15027030|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027031|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027032|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15027033|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15027034|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15027035|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15027036|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027037|NCT01947114|Ketamine|ketamine|mesh-list
15027038|NCT01947114|Remifentanil|remifentanil|mesh-list
15027039|NCT01947114|Propofol|propofol|mesh-list
14209611|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
14209612|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
14209613|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209614|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209615|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14505952|NCT02891174|Analgesics|analgesics|mesh-ancestor
15027040|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15027041|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027042|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505953|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
14505954|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14505955|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505956|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
14505957|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14505958|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505959|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14505960|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14505961|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505962|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505963|NCT02891408|Fenofibrate|fenofibrate|mesh-list
14505964|NCT02891408|Firsocostat|firsocostat|mesh-list
14505965|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784213|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
14784214|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784215|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784216|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784217|NCT00702416|Acetaminophen|acetaminophen|mesh-list
14784218|NCT00702416|Fentanyl|fentanyl|mesh-list
14784219|NCT00702416|Morphine|morphine|mesh-list
14784220|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
14784221|NCT00702416|Narcotics|narcotics|mesh-list
14784222|NCT00702416|Analgesics|analgesics|mesh-list
14784223|NCT00702416|Anesthetics|anesthetics|mesh-list
14784224|NCT00702416|Ropivacaine|ropivacaine|mesh-list
14784225|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
14784226|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14784227|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784228|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
14784229|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784230|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14784231|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14784232|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
14784233|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14784234|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
14784235|NCT00702442|Droperidol|droperidol|mesh-list
14784236|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14784237|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
14784238|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
14784239|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784240|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784241|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14784242|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14784243|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14784244|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14784245|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14784246|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14784247|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14784248|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
14784249|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784250|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784251|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
14784252|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784253|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784254|NCT00702572|Paclitaxel|paclitaxel|mesh-list
14784255|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14784256|NCT00702572|Bevacizumab|bevacizumab|mesh-list
14784257|NCT00702572|Carboplatin|carboplatin|mesh-list
14784258|NCT00702572|Vorinostat|vorinostat|mesh-list
14784259|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14784260|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784261|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784262|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784263|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784264|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784265|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784266|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784267|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784268|NCT00702572|Growth Substances|growth substances|mesh-ancestor
14784269|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784270|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
14784271|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14784272|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784273|NCT00702637|Modafinil|modafinil|mesh-list
14784274|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14784275|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784276|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14784277|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14784278|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14784279|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784280|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14784281|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
14784282|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14784283|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14784284|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14784285|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14784286|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784287|NCT00702728|Furosemide|furosemide|mesh-list
14784288|NCT00702728|Diuretics|diuretics|mesh-ancestor
14784289|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
14784290|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784291|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14784292|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14784293|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784294|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14784295|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14784296|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14784297|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14784298|NCT00702793|Varenicline|varenicline|mesh-list
14784299|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14784300|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14784301|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
14784302|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784303|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784304|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784305|NCT00702819|Bevacizumab|bevacizumab|mesh-list
14784306|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784307|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784308|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784309|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784310|NCT00702819|Growth Substances|growth substances|mesh-ancestor
14784311|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784312|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
14784313|NCT00702871|Ranitidine|ranitidine|mesh-list
14784314|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14784315|NCT00702871|Sucralfate|sucralfate|mesh-list
14784316|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14784317|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14945890|NCT01520116|Timolol|timolol|mesh-list
14945891|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14945892|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14945893|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
14945894|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784318|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14784319|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
14784320|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
14784321|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784322|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784323|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784324|NCT00702936|Telmisartan|telmisartan|mesh-list
14784325|NCT00702936|Ramipril|ramipril|mesh-list
14784326|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784327|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14784328|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14784329|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945895|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945896|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945897|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14784330|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14784331|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
14784332|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784333|NCT00702975|Paclitaxel|paclitaxel|mesh-list
14784334|NCT00702975|Bevacizumab|bevacizumab|mesh-list
14784335|NCT00702975|Carboplatin|carboplatin|mesh-list
14784336|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14784337|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14784338|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784339|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784340|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
14945898|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14945899|NCT01520181|Lactams|lactams|mesh-list
14945900|NCT01520181|beta-Lactams|beta-lactams|mesh-list
14945901|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14945902|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964695|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784341|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784342|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784343|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784344|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784345|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784346|NCT00702975|Growth Substances|growth substances|mesh-ancestor
14945903|NCT01520285|Felodipine|felodipine|mesh-list
14945904|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14784347|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784348|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
14784349|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14784350|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784351|NCT00703066|Vaccines|vaccines|mesh-list
14784352|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
14209616|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209617|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209618|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784353|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209619|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14209620|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209621|NCT04598477|Prednisone|prednisone|mesh-list
14209622|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209623|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
14209624|NCT04598477|Hormones|hormones|mesh-ancestor
14209625|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14784354|NCT00703079|Octreotide|octreotide|mesh-list
14784355|NCT00703079|Lanreotide|lanreotide|mesh-list
14784356|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14784357|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14784358|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784359|NCT00703105|Vaccines|vaccines|mesh-list
14784360|NCT00703105|Immunologic Factors|immunologic factors|mesh-ancestor
14784361|NCT00703105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784362|NCT00703144|Tazobactam|tazobactam|mesh-list
14784363|NCT00703144|Piperacillin|piperacillin|mesh-list
14784364|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14784365|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14784366|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784367|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14784368|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784369|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784370|NCT00703170|Sirolimus|sirolimus|mesh-list
14784371|NCT00703170|Doxorubicin|doxorubicin|mesh-list
14784372|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14784373|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14784374|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784375|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14784376|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14784377|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784378|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784379|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14784380|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784381|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
14784382|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784383|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
14784384|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784385|NCT00703196|Folic Acid|folic acid|mesh-list
14784386|NCT00703196|Hematinics|hematinics|mesh-ancestor
14784387|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
14784388|NCT00703196|Vitamins|vitamins|mesh-ancestor
14784389|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
14784390|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784391|NCT00703235|Bevacizumab|bevacizumab|mesh-list
14784392|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784393|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784394|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784395|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784396|NCT00703235|Growth Substances|growth substances|mesh-ancestor
14784397|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784398|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
14945905|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14945906|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14945907|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14945908|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945909|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14945910|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945911|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
14945912|NCT01520298|Acetaminophen|acetaminophen|mesh-list
14945913|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209626|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945914|NCT01520298|Analgesics|analgesics|mesh-ancestor
14241204|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784399|NCT00703300|Bortezomib|bortezomib|mesh-list
14784400|NCT00703300|Decitabine|decitabine|mesh-list
14784401|NCT00703300|Azacitidine|azacitidine|mesh-list
14784402|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784403|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14784404|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
14784405|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784406|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209627|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14209628|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209629|NCT04598451|Prednisone|prednisone|mesh-list
14209630|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209631|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
14784407|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
14784408|NCT00703313|Levofloxacin|levofloxacin|mesh-list
14784409|NCT00703313|Ofloxacin|ofloxacin|mesh-list
14784410|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
14784411|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14784412|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14784413|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14784414|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14784415|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784416|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14784417|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14784418|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784419|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784420|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784421|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14784422|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
14784423|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14209632|NCT04598451|Hormones|hormones|mesh-ancestor
14209633|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209634|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209635|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14209636|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209637|NCT04597476|Fucoidan|fucoidan|mesh-list
14209638|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14209639|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14209640|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
14784424|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784425|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14784426|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14784427|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14784428|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14784429|NCT00703313|Renal Agents|renal agents|mesh-ancestor
14784430|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14784431|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14784432|NCT00703352|Eplerenone|eplerenone|mesh-list
14784433|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14784434|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
14784435|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14784436|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784437|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14784438|NCT00703352|Diuretics|diuretics|mesh-ancestor
14784439|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
14784440|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14784441|NCT00703365|Gemcitabine|gemcitabine|mesh-list
14784442|NCT00703365|Sorafenib|sorafenib|mesh-list
14784443|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14784444|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
14784445|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784446|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784447|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
14784448|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784449|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784450|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784451|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
14784452|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945915|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
14945916|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945917|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945918|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
14945919|NCT01520350|Aripiprazole|aripiprazole|mesh-list
14945920|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
14945921|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241205|NCT00175916|Brivaracetam|brivaracetam|mesh-list
14241206|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
14784453|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14784454|NCT00703378|Docetaxel|docetaxel|mesh-list
14784455|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784456|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784457|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784458|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784459|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784460|NCT00703430|Memantine|memantine|mesh-list
14784461|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14784462|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14784463|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
14784464|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784465|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784466|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784467|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14784468|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14784469|NCT00703469|Nivolumab|nivolumab|mesh-list
14784470|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784471|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784472|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14784473|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784474|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
14784475|NCT00703482|Ubiquinone|ubiquinone|mesh-list
14784476|NCT00703482|Fenofibrate|fenofibrate|mesh-list
14784477|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784478|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
14784479|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784480|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784481|NCT00703482|Vitamins|vitamins|mesh-ancestor
14784482|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
14784483|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784484|NCT00703586|Maraviroc|maraviroc|mesh-list
14784485|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14784486|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14784487|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784488|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14784489|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14784490|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
14784491|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784492|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14784493|NCT00703625|Sirolimus|sirolimus|mesh-list
14784494|NCT00703625|Docetaxel|docetaxel|mesh-list
14784495|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784496|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784497|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784498|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784499|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784500|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14784501|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784502|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14784503|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
14784504|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784505|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
14784506|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945922|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14945923|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14945924|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945925|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945926|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
14945927|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
14945928|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945929|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945930|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14945931|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14945932|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
14945933|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14945934|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14945935|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14945936|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14945937|NCT01520389|Irinotecan|irinotecan|mesh-list
14945938|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14945939|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14945940|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14945941|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784507|NCT00703638|Pemetrexed|pemetrexed|mesh-list
14784508|NCT00703638|Sorafenib|sorafenib|mesh-list
14784509|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784510|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784511|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784512|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14784513|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14784514|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14784515|NCT00703651|Vaccines|vaccines|mesh-list
14784516|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
14784517|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784518|NCT00703690|Fenofibrate|fenofibrate|mesh-list
14784519|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784520|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
14784521|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784522|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784523|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14784524|NCT00703703|Darifenacin|darifenacin|mesh-list
14784525|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14784526|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14784527|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
14784528|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784529|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784530|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784531|NCT00703703|Urological Agents|urological agents|mesh-ancestor
14784532|NCT00703742|Citalopram|citalopram|mesh-list
14784533|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14784534|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14784535|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14784536|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784537|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784538|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
14784539|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784540|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14784541|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
14784542|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14784543|NCT00703755|Metformin|metformin|mesh-list
14784544|NCT00703755|Fenofibrate|fenofibrate|mesh-list
14784545|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14784546|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784547|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784548|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
14784549|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784550|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784551|NCT00703807|Everolimus|everolimus|mesh-list
14784552|NCT00703807|Topotecan|topotecan|mesh-list
14784553|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784554|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784555|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
14784556|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784557|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14784558|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14784559|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784560|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784561|NCT00703872|Interferons|interferons|mesh-list
14784562|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784563|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
14784564|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784565|NCT00703898|Nevirapine|nevirapine|mesh-list
14784566|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14784567|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14784568|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784569|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784570|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
14784571|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784572|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14784573|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14784574|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14784575|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14784576|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
14784577|NCT00703989|Benphothiamine|benphothiamine|mesh-list
14784578|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
14209641|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209642|NCT04597320|Fentanyl|fentanyl|mesh-list
14784579|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209643|NCT04597320|Midazolam|midazolam|mesh-list
14209644|NCT04597320|Esketamine|esketamine|mesh-list
14209645|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14209646|NCT04597320|Narcotics|narcotics|mesh-ancestor
14209647|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209648|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209649|NCT04597320|Analgesics|analgesics|mesh-ancestor
14784580|NCT00703989|Protective Agents|protective agents|mesh-ancestor
14784581|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784582|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
14784583|NCT00703989|Vitamins|vitamins|mesh-ancestor
14784584|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
14784585|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14784586|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
14784587|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
14784588|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
14784589|NCT00704080|Temozolomide|temozolomide|mesh-list
14784590|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14784591|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
14784592|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784593|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784594|NCT00704106|Entecavir|entecavir|mesh-list
14784595|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
14945942|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945943|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945944|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
14945945|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945946|NCT01520415|Lidocaine|lidocaine|mesh-list
14945947|NCT01520415|Bupivacaine|bupivacaine|mesh-list
14945948|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
14945949|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
14945950|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14945951|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945952|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
14945953|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945954|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14945955|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14784596|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784597|NCT00704145|Paclitaxel|paclitaxel|mesh-list
14784598|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14784599|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784600|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
14945956|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14945957|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14945958|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945959|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14945960|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14945961|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945962|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945963|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14945964|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14945965|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945966|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
14209650|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
14784601|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784602|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784603|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784604|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
14784605|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
14784606|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14784607|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784608|NCT00704249|Nevirapine|nevirapine|mesh-list
14784609|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14784610|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14784611|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784612|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784613|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
14784614|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784615|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14784616|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14784617|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14784618|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14209651|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784619|NCT00704275|Cyclosporine|cyclosporine|mesh-list
14784620|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14784621|NCT00704275|Cyclosporins|cyclosporins|mesh-list
14784622|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784623|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784624|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784625|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
14784626|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784627|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
14784628|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784629|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
14784630|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784631|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14784632|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14784633|NCT00704301|Rivastigmine|rivastigmine|mesh-list
14784634|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14784635|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784636|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784637|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
14784638|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784639|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784640|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14784641|NCT00704301|Protective Agents|protective agents|mesh-ancestor
14784642|NCT00704314|Simvastatin|simvastatin|mesh-list
14784643|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14784644|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784645|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
14784646|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784647|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784648|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14945967|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945968|NCT01520467|Anastrozole|anastrozole|mesh-list
14945969|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14945970|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14945971|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14945972|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14945973|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14945974|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945975|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14945976|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
14945977|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14945978|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945979|NCT01520584|Vitamins|vitamins|mesh-list
14945980|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
14945981|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945982|NCT01520753|Insulin|insulin|mesh-list
14945983|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14945984|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
14945985|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
14945986|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14945987|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
14945988|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14945989|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945990|NCT01520766|Methamphetamine|methamphetamine|mesh-list
14945991|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14945992|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14945993|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
14945994|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
14945995|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14945996|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
14945997|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14945998|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14945999|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
14946000|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14946001|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14946002|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14946003|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14946004|NCT01520792|Acetaminophen|acetaminophen|mesh-list
14946005|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946006|NCT01520792|Analgesics|analgesics|mesh-ancestor
14946007|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
14946008|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946009|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209652|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14946010|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
14784649|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784650|NCT00704366|Saracatinib|saracatinib|mesh-list
14784651|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784652|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784653|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784654|NCT00704392|XL647|xl647|mesh-list
14784655|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784656|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14784657|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784658|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784659|NCT00704431|Darapladib|darapladib|mesh-list
14784660|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14784661|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784662|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784663|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14784664|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
14784665|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14784666|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14784667|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14784668|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14784669|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784670|NCT00704548|Simvastatin|simvastatin|mesh-list
14784671|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14784672|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14784673|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
14784674|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784675|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14784676|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14784677|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784678|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
14784679|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14784680|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784681|NCT00704600|Nelfinavir|nelfinavir|mesh-list
14784682|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14784683|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14784684|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
14784685|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209653|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209654|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
14209655|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
14209656|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209657|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14209658|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14209659|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14209660|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
14209661|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
14209662|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209663|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209664|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
14209665|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
14209666|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209667|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14784686|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784687|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14784688|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14784689|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
14784690|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784691|NCT00704639|Carboplatin|carboplatin|mesh-list
14784692|NCT00704639|Cetuximab|cetuximab|mesh-list
14784693|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784694|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784695|NCT00704665|Methocarbamol|methocarbamol|mesh-list
14784696|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14784697|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784698|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14784699|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784700|NCT00704678|Sevelamer|sevelamer|mesh-list
14784701|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
14784702|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
14784703|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784704|NCT00704691|Lenalidomide|lenalidomide|mesh-list
14946011|NCT01520818|Insulin|insulin|mesh-list
14946012|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14209668|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14209669|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14209670|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946013|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
14784705|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
14784706|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784707|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784708|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784709|NCT00704691|Growth Substances|growth substances|mesh-ancestor
14784710|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
14784711|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209671|NCT04587128|Irinotecan|irinotecan|mesh-list
14209672|NCT04587128|Cetuximab|cetuximab|mesh-list
14209673|NCT04587128|Panitumumab|panitumumab|mesh-list
14209674|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14209675|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14209676|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209677|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209678|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209679|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209680|NCT04573920|Atrasentan|atrasentan|mesh-list
14209681|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209682|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14209683|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14209684|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209685|NCT04568200|Paclitaxel|paclitaxel|mesh-list
14209686|NCT04568200|Carboplatin|carboplatin|mesh-list
14209687|NCT04568200|Durvalumab|durvalumab|mesh-list
14209688|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14209689|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209690|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14209691|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14209692|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14209693|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209694|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209695|NCT04564339|Ravulizumab|ravulizumab|mesh-list
14784712|NCT00704704|Thalidomide|thalidomide|mesh-list
14784713|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784714|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
14784715|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784716|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
14784717|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14784718|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784719|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784720|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784721|NCT00704704|Growth Substances|growth substances|mesh-ancestor
14784722|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14784723|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784724|NCT00704743|Calpastatin|calpastatin|mesh-list
14784725|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14784726|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
14784727|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784728|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784729|NCT00704756|Ribavirin|ribavirin|mesh-list
14784730|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14784731|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
14784732|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
14784733|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784734|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
14784735|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946014|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
14946015|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14946016|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
14946017|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946018|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209696|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14209697|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209698|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
14209699|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209700|NCT04559529|Levetiracetam|levetiracetam|mesh-list
14209701|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
14209702|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
14209703|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14209704|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14946019|NCT01520831|Insulin|insulin|mesh-list
14946020|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14946021|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
14209705|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14946022|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
14209706|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14209707|NCT04553692|Leucovorin|leucovorin|mesh-list
14784736|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
14209708|NCT04553692|Bevacizumab|bevacizumab|mesh-list
14209709|NCT04553692|Fluorouracil|fluorouracil|mesh-list
14209710|NCT04553692|Irinotecan|irinotecan|mesh-list
14209711|NCT04553692|Venetoclax|venetoclax|mesh-list
14209712|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209713|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209714|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14209715|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14209716|NCT04553692|Growth Substances|growth substances|mesh-ancestor
14209717|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209718|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
14209719|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
14209720|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209721|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14209722|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209723|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
14209724|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14209725|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14209726|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209727|NCT04553692|Antidotes|antidotes|mesh-ancestor
14209728|NCT04553692|Protective Agents|protective agents|mesh-ancestor
14784737|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784738|NCT00704821|Docetaxel|docetaxel|mesh-list
14784739|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784740|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784741|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784742|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784743|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784744|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
14784745|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14784746|NCT00704899|Amitriptyline|amitriptyline|mesh-list
14784747|NCT00704899|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14784748|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14784749|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
14784750|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14784751|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14784752|NCT00704899|Analgesics|analgesics|mesh-ancestor
14784753|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
14784754|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784755|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784756|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14784757|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14784758|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14784759|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784760|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
14946023|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14946024|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
14946025|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14946026|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946027|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946028|NCT01520896|Ketoconazole|ketoconazole|mesh-list
14946029|NCT01520896|Naloxegol|naloxegol|mesh-list
14946030|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
14946031|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946032|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14946033|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14946034|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946035|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946036|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14946037|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
14946038|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946039|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946040|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14946041|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14946042|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
14946043|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946044|NCT01521130|Levetiracetam|levetiracetam|mesh-list
14946045|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
14209729|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
14209730|NCT04553692|Vitamins|vitamins|mesh-ancestor
14784761|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14784762|NCT00704899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14209731|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
14209732|NCT04544995|Niraparib|niraparib|mesh-list
14209733|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14209734|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209735|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209736|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784763|NCT00704899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14784764|NCT00704899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14784765|NCT00704925|Amifampridine|amifampridine|mesh-list
14784766|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14784767|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784768|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784769|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14946046|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
14946047|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
14946048|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946049|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
14946050|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946051|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946052|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14946053|NCT01521312|Saxagliptin|saxagliptin|mesh-list
14946054|NCT01521312|Incretins|incretins|mesh-ancestor
14946055|NCT01521312|Hormones|hormones|mesh-ancestor
14946056|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946057|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946058|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14946059|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
14946060|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946061|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946062|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946063|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14946064|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
14946065|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946066|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
14946067|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14946068|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14946069|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946070|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14946071|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14946072|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946073|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946074|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946075|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14946076|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
14946077|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14946078|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964696|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13964697|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
13964698|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13964699|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
13964700|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964701|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964702|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13964703|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
13964704|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
13964705|NCT03135860|Protective Agents|protective agents|mesh-ancestor
13964706|NCT03136120|Bromides|bromides|mesh-list
13964707|NCT03136120|Ipratropium|ipratropium|mesh-list
13964708|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
13964709|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13964710|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
13964711|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964712|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946079|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14946080|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14946081|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14946082|NCT01521403|Metronidazole|metronidazole|mesh-list
14946083|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946084|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14946085|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14946086|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13964713|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14209737|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
14784770|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14784771|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784772|NCT00704951|Posaconazole|posaconazole|mesh-list
14784773|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
14784774|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784775|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14784776|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14784777|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14784778|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14784779|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14784780|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784781|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946087|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14946088|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14946089|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
14946090|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946091|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946092|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14946093|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
14946094|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
14946095|NCT01521455|Hormones|hormones|mesh-ancestor
14946096|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946097|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
14946098|NCT01521481|Anesthetics|anesthetics|mesh-list
14946099|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946100|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946101|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14946102|NCT01521520|Hematinics|hematinics|mesh-ancestor
14946103|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14946104|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14946105|NCT01521572|Albuterol|albuterol|mesh-list
14946106|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14946107|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
14946108|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946109|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946110|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14946111|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
14946112|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
14946113|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14946114|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14946115|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14946116|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14946117|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
14946118|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946119|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946120|NCT01521624|Metformin|metformin|mesh-list
14946121|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946122|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946123|NCT01521689|Rituximab|rituximab|mesh-list
14946124|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14946125|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946126|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
14946127|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946128|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946129|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14946130|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14946131|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14946132|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
14946133|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946134|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946135|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946136|NCT01521767|Urological Agents|urological agents|mesh-ancestor
14946137|NCT01521793|Retinol acetate|retinol acetate|mesh-list
14946138|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14946139|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
14946140|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946141|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14946142|NCT01521793|Protective Agents|protective agents|mesh-ancestor
14946143|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027043|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15027044|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
15027045|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
15027046|NCT01947114|Analgesics|analgesics|mesh-ancestor
14784782|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14784783|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
14784784|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14784785|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784786|NCT00704990|Vitamins|vitamins|mesh-list
14784787|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
14784788|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
14784789|NCT00704990|Pyridoxal|pyridoxal|mesh-list
14784790|NCT00704990|Pyridoxine|pyridoxine|mesh-list
14784791|NCT00704990|Zinc|zinc|mesh-list
14946144|NCT01521819|Ranibizumab|ranibizumab|mesh-list
14946145|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14946146|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14946147|NCT01521819|Growth Substances|growth substances|mesh-ancestor
14946148|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946149|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
14946150|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946151|NCT01521936|Vitamin D|vitamin d|mesh-list
14946152|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
14946153|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
14946154|NCT01521936|Vitamins|vitamins|mesh-list
14946155|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
14946156|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946157|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14946158|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14946159|NCT01521962|Alogliptin|alogliptin|mesh-list
14784792|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
14784793|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
14784794|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784795|NCT00704990|Trace Elements|trace elements|mesh-ancestor
14784796|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
14784797|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784798|NCT00704990|Protective Agents|protective agents|mesh-ancestor
14784799|NCT00705042|Etanercept|etanercept|mesh-list
14784800|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14784801|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14784802|NCT00705042|Analgesics|analgesics|mesh-ancestor
14784803|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
14784804|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14784805|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784806|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14784807|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784808|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14784809|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784810|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
14946160|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946161|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946162|NCT01521962|Incretins|incretins|mesh-ancestor
14946163|NCT01521962|Hormones|hormones|mesh-ancestor
14946164|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946165|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14946166|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
14946167|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946168|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946169|NCT01521975|Adefovir|adefovir|mesh-list
14946170|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14946171|NCT01521975|Telbivudine|telbivudine|mesh-list
14946172|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
14946173|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946174|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14946175|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14946176|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964714|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
13964715|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14209738|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
14946177|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964716|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
13964717|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964718|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964719|NCT03135769|Avelumab|avelumab|mesh-list
13964720|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964721|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964722|NCT03135340|Anesthetics|anesthetics|mesh-list
14784811|NCT00705120|Cyclosporine|cyclosporine|mesh-list
14784812|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
14784813|NCT00705120|Busulfan|busulfan|mesh-list
14784814|NCT00705120|Cyclosporins|cyclosporins|mesh-list
14784815|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784816|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
14784817|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784818|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784819|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14784820|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
14784821|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784822|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784823|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14784824|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784825|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
14784826|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784827|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209739|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14209740|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14209741|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209742|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209743|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784828|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13964723|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964724|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964725|NCT03135301|Metformin|metformin|mesh-list
13964726|NCT03135301|Letrozole|letrozole|mesh-list
13964727|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13964728|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964729|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964730|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13964731|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13964732|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964733|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964734|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13964735|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
13964736|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14784829|NCT00705198|Temozolomide|temozolomide|mesh-list
14784830|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14784831|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
14784832|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964737|NCT03135171|Trastuzumab|trastuzumab|mesh-list
14784833|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784834|NCT00705315|Bevacizumab|bevacizumab|mesh-list
14784835|NCT00705315|Docetaxel|docetaxel|mesh-list
14784836|NCT00705315|Epirubicin|epirubicin|mesh-list
14784837|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14784838|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784839|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784840|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784841|NCT00705315|Growth Substances|growth substances|mesh-ancestor
14784842|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784843|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
14784844|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784845|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784846|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784847|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784848|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14784849|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14784850|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14784851|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964738|NCT03135171|Pertuzumab|pertuzumab|mesh-list
13964739|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964740|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964741|NCT03135184|Coal Tar|coal tar|mesh-list
13964742|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
13964743|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
13964744|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
14784852|NCT00705354|Bacitracin|bacitracin|mesh-list
14784853|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14784854|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784855|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14784856|NCT00705419|Tenofovir|tenofovir|mesh-list
14784857|NCT00705419|Emtricitabine|emtricitabine|mesh-list
14784858|NCT00705419|Maleic acid|maleic acid|mesh-list
14784859|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
14784860|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784861|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14784862|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14784863|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784864|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784865|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14784866|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14784867|NCT00705445|Zinc|zinc|mesh-list
14784868|NCT00705445|Trace Elements|trace elements|mesh-list
14784869|NCT00705445|Micronutrients|micronutrients|mesh-list
14784870|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784871|NCT00705471|Infliximab|infliximab|mesh-list
14784872|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
14784873|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14784874|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784875|NCT00705510|Cyclosporine|cyclosporine|mesh-list
14784876|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14784877|NCT00705510|Cyclosporins|cyclosporins|mesh-list
14784878|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784879|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784880|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784881|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
14784882|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784883|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
14784884|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784885|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
14784886|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784887|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14784888|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14784889|NCT00705549|Gemcitabine|gemcitabine|mesh-list
14784890|NCT00705549|Cisplatin|cisplatin|mesh-list
14784891|NCT00705549|Docetaxel|docetaxel|mesh-list
14784892|NCT00705549|Vinorelbine|vinorelbine|mesh-list
14784893|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784894|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14784895|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
14784896|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784897|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
14784898|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784899|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946178|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
14946179|NCT01522040|Analgesics|analgesics|mesh-ancestor
14946180|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
14946181|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946182|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946183|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
14946184|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946185|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14946186|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
14946187|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14946188|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14946189|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946190|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14946191|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
14946192|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14946193|NCT01522092|Citalopram|citalopram|mesh-list
14784900|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14784901|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
14784902|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784903|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784904|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784905|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784906|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14784907|NCT00705562|Caseins|caseins|mesh-list
14784908|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
14784909|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
14784910|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784911|NCT00705588|Tadalafil|tadalafil|mesh-list
14784912|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14784913|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
14784914|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14784915|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14784916|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14784917|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784918|NCT00705588|Urological Agents|urological agents|mesh-ancestor
14784919|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
14784920|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14784921|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
14784922|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784923|NCT00705692|Levamisole|levamisole|mesh-list
14784924|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14784925|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
14784926|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784927|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
14784928|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
14784929|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14784930|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784931|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14784932|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
14784933|NCT00705770|Anecortave|anecortave|mesh-list
14784934|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14784935|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14784936|NCT00705770|Growth Substances|growth substances|mesh-ancestor
14784937|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784938|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
14784939|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784940|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14784941|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
14784942|NCT00705796|Testosterone|testosterone|mesh-list
14784943|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
14784944|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
14784945|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14784946|NCT00705796|Androgens|androgens|mesh-ancestor
14784947|NCT00705796|Hormones|hormones|mesh-ancestor
14784948|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14784949|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946194|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14946195|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14946196|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14946197|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946198|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946199|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
14946200|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946201|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14946202|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
14946203|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14946204|NCT01522105|Daptomycin|daptomycin|mesh-list
14946205|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14946206|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946207|NCT01522326|Ibuprofen|ibuprofen|mesh-list
14946208|NCT01522326|Metoclopramide|metoclopramide|mesh-list
14946209|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14946210|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946211|NCT01522326|Analgesics|analgesics|mesh-ancestor
14946212|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
14946213|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946214|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946215|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946216|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946217|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14946218|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946219|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946220|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
14946221|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
14784950|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14784951|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784952|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
14784953|NCT00705822|Prednisone|prednisone|mesh-list
14784954|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
14784955|NCT00705822|Docetaxel|docetaxel|mesh-list
14784956|NCT00705822|Estramustine|estramustine|mesh-list
14784957|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784958|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784959|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
14946222|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946223|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14946224|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14946225|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
14946226|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946227|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14946228|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946229|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946230|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946231|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14946232|NCT01522534|Morphine|morphine|mesh-list
14946233|NCT01522534|Mepivacaine|mepivacaine|mesh-list
14946234|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14946235|NCT01522534|Narcotics|narcotics|mesh-ancestor
14946236|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946237|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946238|NCT01522534|Analgesics|analgesics|mesh-ancestor
14946239|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
14946240|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946241|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
14946242|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
14946243|NCT01522547|Pomalidomide|pomalidomide|mesh-list
14946244|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
14946245|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946246|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14946247|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14946248|NCT01522547|Growth Substances|growth substances|mesh-ancestor
14946249|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
14946250|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946251|NCT01522612|Leucovorin|leucovorin|mesh-list
14946252|NCT01522612|Fluorouracil|fluorouracil|mesh-list
14946253|NCT01522612|Cetuximab|cetuximab|mesh-list
14946254|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
14946255|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946256|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14946257|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946258|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946259|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
14946260|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946261|NCT01522612|Antidotes|antidotes|mesh-ancestor
14946262|NCT01522612|Protective Agents|protective agents|mesh-ancestor
14946263|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
14946264|NCT01522612|Vitamins|vitamins|mesh-ancestor
14946265|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
14946266|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14946267|NCT01522625|Tenofovir|tenofovir|mesh-list
14946268|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
14946269|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946270|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14946271|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14946272|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946273|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946274|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14946275|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14946276|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14946277|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14946278|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
14946279|NCT01522729|Fentanyl|fentanyl|mesh-list
14946280|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14946281|NCT01522729|Narcotics|narcotics|mesh-ancestor
14946282|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946283|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946284|NCT01522729|Analgesics|analgesics|mesh-ancestor
14946285|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
14946286|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946287|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14946288|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14946289|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
14946290|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
14784960|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784961|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784962|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14784963|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
14784964|NCT00705822|Hormones|hormones|mesh-ancestor
14784965|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14784966|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784967|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14784968|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14784969|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
14784970|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14784971|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14784972|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
14784973|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784974|NCT00705835|Antacids|antacids|mesh-ancestor
14784975|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784976|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946291|NCT01522768|Paclitaxel|paclitaxel|mesh-list
14946292|NCT01522768|Afatinib|afatinib|mesh-list
14946293|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14946294|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946295|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
14946296|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
14946297|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
14946298|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946299|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14946300|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946301|NCT01522820|Sirolimus|sirolimus|mesh-list
14946302|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14946303|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946304|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14946305|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946306|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
14946307|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946308|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
14946309|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209744|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209745|NCT04530747|Metformin|metformin|mesh-list
14209746|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946310|NCT01522846|Heparin|heparin|mesh-list
14946311|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
14946312|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14946313|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14946314|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946315|NCT01522872|Dexamethasone|dexamethasone|mesh-list
14946316|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
14946317|NCT01522872|Bortezomib|bortezomib|mesh-list
14946318|NCT01522872|Pomalidomide|pomalidomide|mesh-list
14946319|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
14946320|NCT01522872|BB 1101|bb 1101|mesh-list
14946321|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946322|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
14946323|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
14946324|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946325|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946326|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946327|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
14946328|NCT01522872|Hormones|hormones|mesh-ancestor
14946329|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946330|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14946331|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946332|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
14946333|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946334|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946335|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
14946336|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14946337|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14946338|NCT01522872|Growth Substances|growth substances|mesh-ancestor
14946339|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
14946340|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14946341|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
14946342|NCT01522989|Fluorouracil|fluorouracil|mesh-list
13964745|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13964746|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209747|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784977|NCT00705900|Calcipotriene|calcipotriene|mesh-list
14784978|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
14784979|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14784980|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
14784981|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14784982|NCT00705978|Pancreatin|pancreatin|mesh-list
14784983|NCT00705978|Pancrelipase|pancrelipase|mesh-list
14784984|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14784985|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
14784986|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14784987|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946343|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
14946344|NCT01522989|Palbociclib|palbociclib|mesh-list
14946345|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
14946346|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946347|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14946348|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946349|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946350|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
14946351|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946352|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14946353|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946354|NCT01523002|Artesunate|artesunate|mesh-list
14946355|NCT01523002|Pyronaridine|pyronaridine|mesh-list
14946356|NCT01523002|Metoprolol|metoprolol|mesh-list
14946357|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14946358|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14946359|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
14946360|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
14946361|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946362|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946363|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14946364|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14946365|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14946366|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
14946367|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946368|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946369|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
14946370|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14946371|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14946372|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946373|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946374|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
14946375|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
14946376|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14946377|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
14946378|NCT01523015|Docetaxel|docetaxel|mesh-list
14946379|NCT01523015|Fluorouracil|fluorouracil|mesh-list
14946380|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
14946381|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946382|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14946383|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
14946384|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14946385|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946386|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
14946387|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14946388|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946389|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
14946390|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946391|NCT01523041|Insulin|insulin|mesh-list
14946392|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14946393|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
14946394|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
14946395|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14946396|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
14946397|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946398|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946399|NCT01523054|Metoprolol|metoprolol|mesh-list
14946400|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14946401|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14946402|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
14784988|NCT00706069|Capecitabine|capecitabine|mesh-list
14784989|NCT00706069|Vinorelbine|vinorelbine|mesh-list
14784990|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14784991|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
14946403|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
14946404|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946405|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14784992|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14784993|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14784994|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14784995|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14784996|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14784997|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14784998|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
14784999|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785000|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
14785001|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14785002|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14785003|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
14785004|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
14785005|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785006|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785007|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
14785008|NCT00706225|Estrogens|estrogens|mesh-list
14785009|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14785010|NCT00706225|Hormones|hormones|mesh-ancestor
14785011|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785012|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785013|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14785014|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14785015|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
14785016|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14785017|NCT00706277|Fentanyl|fentanyl|mesh-list
14785018|NCT00706277|Remifentanil|remifentanil|mesh-list
14785019|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
14785020|NCT00706277|Propofol|propofol|mesh-list
14785021|NCT00706277|Sevoflurane|sevoflurane|mesh-list
14785022|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14785023|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785024|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785025|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14785026|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
14785027|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
14785028|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14785029|NCT00706277|Narcotics|narcotics|mesh-ancestor
14785030|NCT00706277|Analgesics|analgesics|mesh-ancestor
14785031|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
14785032|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785033|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14785034|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14946406|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14946407|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14946408|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14946409|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
14946410|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946411|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946412|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
14946413|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
14946414|NCT01523080|Acetaminophen|acetaminophen|mesh-list
14946415|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946416|NCT01523080|Analgesics|analgesics|mesh-ancestor
14946417|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
14785035|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14785036|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14785037|NCT00706576|Mitogens|mitogens|mesh-list
14785038|NCT00706576|Enkephalin, Methionine|enkephalin, methionine|mesh-list
14785039|NCT00706576|Enkephalins|enkephalins|mesh-list
14785040|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785041|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14785042|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785043|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785044|NCT00706680|Cyclosporine|cyclosporine|mesh-list
14785045|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
14785046|NCT00706680|Prednisone|prednisone|mesh-list
14785047|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14785048|NCT00706680|Cyclosporins|cyclosporins|mesh-list
14785049|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
14785050|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785051|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
14785052|NCT00706680|Hormones|hormones|mesh-ancestor
14785053|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785054|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785055|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14785056|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785057|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785058|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785059|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785060|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
14785061|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
14785062|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785063|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14785064|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14785065|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14785066|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14946418|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946419|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946420|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
14946421|NCT01523093|Ondansetron|ondansetron|mesh-list
14946422|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
14946423|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
14946424|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785067|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14946425|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946426|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946427|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
14946428|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
14946429|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14946430|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
14946431|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946432|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946433|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14946434|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14946435|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946436|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14946437|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14946438|NCT01523119|Ondansetron|ondansetron|mesh-list
14946439|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
14946440|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
14946441|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946442|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946443|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946444|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
14946445|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
14946446|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14946447|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
14946448|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946449|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946450|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14946451|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14946452|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946453|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14946454|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14946455|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
14946456|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946457|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14946458|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14946459|NCT01523314|Dexamethasone|dexamethasone|mesh-list
14946460|NCT01523314|Bevacizumab|bevacizumab|mesh-list
14946461|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14946462|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946463|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
14946464|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
14946465|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946466|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946467|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946468|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
14946469|NCT01523314|Hormones|hormones|mesh-ancestor
14946470|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946471|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14946472|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946473|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14946474|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14946475|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14946476|NCT01523314|Growth Substances|growth substances|mesh-ancestor
14946477|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
14946478|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14946479|NCT01523327|Uric Acid|uric acid|mesh-list
14946480|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
14785068|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
14785069|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785070|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14785071|NCT00706680|Protective Agents|protective agents|mesh-ancestor
14785072|NCT00706862|Lactoferrin|lactoferrin|mesh-list
14785073|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
14785074|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785075|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785076|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
14785077|NCT00706888|Pyridoxal|pyridoxal|mesh-list
14785078|NCT00706888|Pyridoxine|pyridoxine|mesh-list
14785079|NCT00706888|Vitamins|vitamins|mesh-ancestor
14785080|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
14785081|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785082|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
14785083|NCT00706927|Timolol|timolol|mesh-list
14785084|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14785085|NCT00706927|Latanoprost|latanoprost|mesh-list
14785086|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14785087|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14785088|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
14785089|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785090|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785091|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785092|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14785093|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14785094|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14785095|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14785096|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14785097|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14785098|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14785099|NCT00706953|Doxorubicin|doxorubicin|mesh-list
14785100|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14785101|NCT00706953|Bortezomib|bortezomib|mesh-list
14785102|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14785103|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785104|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14785105|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14785106|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785107|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785108|NCT00707070|Acitretin|acitretin|mesh-list
14785109|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14785110|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
14785111|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946481|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946482|NCT01523327|Protective Agents|protective agents|mesh-ancestor
14946483|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946484|NCT01523379|Parecoxib|parecoxib|mesh-list
14946485|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14946486|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14946487|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946488|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946489|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14946490|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946491|NCT01523379|Analgesics|analgesics|mesh-ancestor
14946492|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
14946493|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946494|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946495|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946496|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946497|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
14946498|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14946499|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
14946500|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14785112|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
14785113|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
14785114|NCT00707083|Dexamethasone|dexamethasone|mesh-list
14785115|NCT00707083|Methotrexate|methotrexate|mesh-list
14946501|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
14785116|NCT00707083|Vincristine|vincristine|mesh-list
14785117|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
14785118|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946502|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946503|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785119|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
14785120|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
14785121|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785122|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785123|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14785124|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
14785125|NCT00707083|Hormones|hormones|mesh-ancestor
14785126|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785127|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14785128|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785129|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14785130|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
14785131|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14785132|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14785133|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
14785134|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785135|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
14785136|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785137|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14785138|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785139|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
14785140|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14785141|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14785142|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14785143|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14785144|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14785145|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14785146|NCT00707135|Sirolimus|sirolimus|mesh-list
14785147|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785148|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785149|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14785150|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785151|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
14785152|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785153|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
14785154|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785155|NCT00707187|Tadalafil|tadalafil|mesh-list
14785156|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
14785157|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14785158|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14785159|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785160|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785161|NCT00707187|Urological Agents|urological agents|mesh-ancestor
14785162|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14785163|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785164|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14785165|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785166|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785167|NCT00707278|Capecitabine|capecitabine|mesh-list
14785168|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
14785169|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14785170|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
14785171|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785172|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946504|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
14946505|NCT01523431|Leucovorin|leucovorin|mesh-list
14946506|NCT01523431|Fluorouracil|fluorouracil|mesh-list
14946507|NCT01523431|Irinotecan|irinotecan|mesh-list
14946508|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
14946509|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946510|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14785173|NCT00707330|Clarithromycin|clarithromycin|mesh-list
14785174|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785175|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785176|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14785177|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785178|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785179|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14785180|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14785181|NCT00707369|Amoxicillin|amoxicillin|mesh-list
14785182|NCT00707369|Metronidazole|metronidazole|mesh-list
14946511|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785183|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785184|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785185|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14785186|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14785187|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
14785188|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785189|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14785190|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785191|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785192|NCT00707421|Fluorometholone|fluorometholone|mesh-list
14785193|NCT00707421|Ketorolac|ketorolac|mesh-list
14785194|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14785195|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14785196|NCT00707421|Analgesics|analgesics|mesh-ancestor
14785197|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
14785198|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785199|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785200|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785201|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14785202|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14785203|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785204|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785205|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
14785206|NCT00707421|Hormones|hormones|mesh-ancestor
14785207|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785208|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14785209|NCT00707473|Cisplatin|cisplatin|mesh-list
14785210|NCT00707473|Carboplatin|carboplatin|mesh-list
14785211|NCT00707473|Docetaxel|docetaxel|mesh-list
14785212|NCT00707473|Fluorouracil|fluorouracil|mesh-list
14785213|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785214|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
14785215|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
14785216|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
14785217|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785218|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
14785219|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14785220|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785221|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
14785222|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785223|NCT00707512|Natalizumab|natalizumab|mesh-list
14785224|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
14785225|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785226|NCT00707551|Ketoconazole|ketoconazole|mesh-list
14785227|NCT00707551|Verapamil|verapamil|mesh-list
14785228|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
14785229|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785230|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14785231|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14785232|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785233|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785234|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14785235|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
14785236|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785237|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946512|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785238|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14946513|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
14785239|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14785240|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14785241|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14785242|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14785243|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
14785244|NCT00707642|Vaccines|vaccines|mesh-list
14785245|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
14785246|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785247|NCT00707707|Paclitaxel|paclitaxel|mesh-list
14785248|NCT00707707|Olaparib|olaparib|mesh-list
14785249|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14785250|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785251|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
14785252|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14785253|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14785254|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785255|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14785256|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785257|NCT00707772|Ribavirin|ribavirin|mesh-list
14785258|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14785259|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
14785260|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
14785261|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785262|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
14785263|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785264|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
14785265|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785266|NCT00707785|Vitamin A|vitamin a|mesh-list
14785267|NCT00707785|Vitamins|vitamins|mesh-ancestor
14785268|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
14785269|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785270|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14785271|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
14785272|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785273|NCT00707824|Nalbuphine|nalbuphine|mesh-list
14785274|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14785275|NCT00707824|Narcotics|narcotics|mesh-ancestor
14946514|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946515|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14946516|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14946517|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946518|NCT01523431|Antidotes|antidotes|mesh-ancestor
14946519|NCT01523431|Protective Agents|protective agents|mesh-ancestor
14946520|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
14946521|NCT01523431|Vitamins|vitamins|mesh-ancestor
14946522|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
14946523|NCT01523483|Progesterone|progesterone|mesh-list
13964747|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14785276|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785277|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785278|NCT00707824|Analgesics|analgesics|mesh-ancestor
14946524|NCT01523483|Progestins|progestins|mesh-ancestor
14946525|NCT01523483|Hormones|hormones|mesh-ancestor
14785279|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
14785280|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785281|NCT00707850|Ribavirin|ribavirin|mesh-list
14785282|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14785283|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
14785284|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
14785285|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785286|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
14785287|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785288|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
14785289|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785290|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14785291|NCT00707876|Hematinics|hematinics|mesh-ancestor
14785292|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14785293|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14785294|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
14785295|NCT00707902|Lidocaine|lidocaine|mesh-list
14785296|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
14785297|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
14785298|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785299|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785300|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
14785301|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785302|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14785303|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14785304|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14785305|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14785306|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785307|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14785308|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785309|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
13964748|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964749|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964750|NCT03135106|Itraconazole|itraconazole|mesh-list
13964751|NCT03135106|Fluconazole|fluconazole|mesh-list
13964752|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
13964753|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964754|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14946526|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946527|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027047|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
15027048|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027049|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15027050|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14785310|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
14785311|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
14785312|NCT00707941|Oseltamivir|oseltamivir|mesh-list
14785313|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
14785314|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785315|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785316|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785317|NCT00708149|Lansoprazole|lansoprazole|mesh-list
14785318|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
14785319|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15027051|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15027052|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027053|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027054|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15027055|NCT01947114|Narcotics|narcotics|mesh-ancestor
15027056|NCT01947140|Romidepsin|romidepsin|mesh-list
15027057|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15027058|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027059|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
15027060|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15027061|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785320|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14785321|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14785322|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785323|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027062|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
15027063|NCT01947205|Acetaminophen|acetaminophen|mesh-list
15027064|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13964755|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15027065|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14785324|NCT00708240|Citalopram|citalopram|mesh-list
14785325|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14785326|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14785327|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14785328|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785329|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785330|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
14785331|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785332|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14785333|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
14785334|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14785335|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14785336|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14785337|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14785338|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14785339|NCT00708318|Fentanyl|fentanyl|mesh-list
14785340|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14785341|NCT00708318|Narcotics|narcotics|mesh-ancestor
14785342|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785343|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785344|NCT00708318|Analgesics|analgesics|mesh-ancestor
14785345|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
14785346|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785347|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14785348|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14785349|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
14785350|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
14785351|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14785352|NCT00708344|Irbesartan|irbesartan|mesh-list
14785353|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14946528|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
14946529|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
14946530|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946531|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
14946532|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946533|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946534|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
14946535|NCT01523574|Vitamin E|vitamin e|mesh-list
14946536|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
14946537|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
14946538|NCT01523574|Calcium|calcium|mesh-list
14946539|NCT01523574|Vitamins|vitamins|mesh-ancestor
14946540|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
14946541|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946542|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14946543|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14946544|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946545|NCT01523574|Analgesics|analgesics|mesh-ancestor
14946546|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
14946547|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946548|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
14946549|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946550|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14946551|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
14946552|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14946553|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14946554|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946555|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
14946556|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14946557|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
14946558|NCT01523574|Protective Agents|protective agents|mesh-ancestor
14946559|NCT01523639|Metformin|metformin|mesh-list
14946560|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946561|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946562|NCT01523678|Paclitaxel|paclitaxel|mesh-list
14946563|NCT01523678|Carboplatin|carboplatin|mesh-list
14946564|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14946565|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946566|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
14946567|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
14946568|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
14946569|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946570|NCT01523847|Doxorubicin|doxorubicin|mesh-list
14785354|NCT00708344|Diuretics|diuretics|mesh-ancestor
14946571|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14946572|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785355|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
14946573|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14209748|NCT04524702|Gemcitabine|gemcitabine|mesh-list
14209749|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
14209750|NCT04524702|Paclitaxel|paclitaxel|mesh-list
14209751|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14209752|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14946574|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14946575|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946576|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946577|NCT01523860|Rituximab|rituximab|mesh-list
14946578|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14946579|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
14946580|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14946581|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946582|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
14946583|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946584|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946585|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14946586|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
14946587|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946588|NCT01523860|Analgesics|analgesics|mesh-ancestor
14946589|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
14946590|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946591|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14946592|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14946593|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946594|NCT01524068|Rituximab|rituximab|mesh-list
14946595|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14946596|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946597|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
14946598|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946599|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946600|NCT01524081|Amoxicillin|amoxicillin|mesh-list
14946601|NCT01524081|Metronidazole|metronidazole|mesh-list
14946602|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
14946603|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
14946604|NCT01524081|Cefuroxime|cefuroxime|mesh-list
14946605|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
14946606|NCT01524081|Fluconazole|fluconazole|mesh-list
14946607|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14946608|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14946609|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946610|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14946611|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14946612|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
14946613|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14946614|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14946615|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946616|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946617|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14946618|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14209753|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209754|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
14209755|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14209756|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14209757|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209758|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14785356|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785357|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14785358|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14785359|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785360|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14785361|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14785362|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14785363|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785364|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785365|NCT00708396|Citalopram|citalopram|mesh-list
14785366|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14785367|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14946619|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027066|NCT01947205|Analgesics|analgesics|mesh-ancestor
14209759|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
14785368|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14785369|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785370|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785371|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
14785372|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785373|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14785374|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
14785375|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14785376|NCT00708539|Progesterone|progesterone|mesh-list
14785377|NCT00708539|Progestins|progestins|mesh-ancestor
14785378|NCT00708539|Hormones|hormones|mesh-ancestor
14209760|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
14209761|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209762|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209763|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209764|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
14209765|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209766|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
14785379|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785380|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785381|NCT00708565|Iloprost|iloprost|mesh-list
14785382|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14785383|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
14785384|NCT00708578|Metformin|metformin|mesh-list
14785385|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
14785386|NCT00708578|Glimepiride|glimepiride|mesh-list
14785387|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14785388|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785389|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14785390|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785391|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
14785392|NCT00708591|Sirolimus|sirolimus|mesh-list
14785393|NCT00708591|Ketoconazole|ketoconazole|mesh-list
14785394|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785395|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785396|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14785397|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785398|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
14946620|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946621|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14946622|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14946623|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14946624|NCT01524094|Leucovorin|leucovorin|mesh-list
14946625|NCT01524094|Fluorouracil|fluorouracil|mesh-list
14946626|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
14946627|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
14946628|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
14946629|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946630|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14946631|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946632|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946633|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
14946634|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946635|NCT01524094|Antidotes|antidotes|mesh-ancestor
14946636|NCT01524094|Protective Agents|protective agents|mesh-ancestor
14946637|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
14946638|NCT01524094|Vitamins|vitamins|mesh-ancestor
14946639|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
14946640|NCT01524237|Ketamine|ketamine|mesh-list
14946641|NCT01524237|Analgesics|analgesics|mesh-ancestor
14946642|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
14946643|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946644|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946645|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14946646|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14946647|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
14946648|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
14946649|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946650|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14946651|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14946652|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209767|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14209768|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14946653|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946654|NCT01524315|Vitamins|vitamins|mesh-list
14209769|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946655|NCT01524315|Thiamine|thiamine|mesh-list
14209770|NCT04509414|Midazolam|midazolam|mesh-list
14209771|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
14209772|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209773|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209774|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209775|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209776|NCT04509414|Analgesics|analgesics|mesh-ancestor
14785399|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785400|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
14785401|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785402|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14785403|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14785404|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785405|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785406|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14785407|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
14785408|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785409|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14785410|NCT00708656|Mesalamine|mesalamine|mesh-list
14785411|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14785412|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14785413|NCT00708656|Analgesics|analgesics|mesh-ancestor
14785414|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
14946656|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
14946657|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
14946658|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946659|NCT01524354|Anesthetics|anesthetics|mesh-list
14946660|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946661|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946662|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
14946663|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14946664|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946665|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946666|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946667|NCT01524367|Analgesics|analgesics|mesh-ancestor
14946668|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
14946669|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946670|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14946671|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14946672|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14946673|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
14946674|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946675|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946676|NCT01524432|Clotrimazole|clotrimazole|mesh-list
14946677|NCT01524432|Miconazole|miconazole|mesh-list
14785415|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785416|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785417|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785418|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14785419|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
14785420|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14785421|NCT00708747|Antibodies|antibodies|mesh-list
14785422|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
14785423|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785424|NCT00708773|Irinotecan|irinotecan|mesh-list
14785425|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14785426|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14785427|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946678|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
14946679|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14946680|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946681|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14209777|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
14785428|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785429|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785430|NCT00708799|Azithromycin|azithromycin|mesh-list
14785431|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14946682|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14209778|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209779|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14209780|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14946683|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027067|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
14785432|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785433|NCT00708812|Paclitaxel|paclitaxel|mesh-list
14785434|NCT00708812|Carboplatin|carboplatin|mesh-list
14785435|NCT00708812|Endostar protein|endostar protein|mesh-list
14785436|NCT00708812|Endostatins|endostatins|mesh-list
14785437|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14785438|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785439|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14785440|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14785441|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14785442|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785443|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14785444|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14785445|NCT00708812|Growth Substances|growth substances|mesh-ancestor
14785446|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785447|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
14785448|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
14785449|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785450|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785451|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14785452|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14785453|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785454|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785455|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785456|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14785457|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
14785458|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785459|NCT00709046|Pantoprazole|pantoprazole|mesh-list
14785460|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14785461|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14785462|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14785463|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785464|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785465|NCT00709137|Amiloride|amiloride|mesh-list
14785466|NCT00709137|Spironolactone|spironolactone|mesh-list
14785467|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14785468|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
14785469|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785470|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785471|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14946684|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946685|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14946686|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
14946687|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946688|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946689|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14946690|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14946691|NCT01524445|Bortezomib|bortezomib|mesh-list
14946692|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946693|NCT01524497|Trazodone|trazodone|mesh-list
14946694|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14946695|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14946696|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946697|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946698|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14946699|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14946700|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14946701|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14946702|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946703|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14946704|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
14946705|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14946706|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
14946707|NCT01524575|Gemcitabine|gemcitabine|mesh-list
14946708|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
14946709|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14946710|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
14946711|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946712|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946713|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
14946714|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964756|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785472|NCT00709137|Diuretics|diuretics|mesh-ancestor
14785473|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
14785474|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14785475|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14785476|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14785477|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785478|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14785479|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14785480|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
14785481|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785482|NCT00709189|Folic Acid|folic acid|mesh-list
14785483|NCT00709189|Norgestimate|norgestimate|mesh-list
14785484|NCT00709189|Estradiol|estradiol|mesh-list
14785485|NCT00709189|Estrogens|estrogens|mesh-ancestor
14785486|NCT00709189|Hormones|hormones|mesh-ancestor
14785487|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785488|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785489|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14785490|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
14785491|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14785492|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14785493|NCT00709189|Hematinics|hematinics|mesh-ancestor
14209781|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14209782|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
14209783|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209784|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209785|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14209786|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14209787|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14209788|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14209789|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209790|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
14209791|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
14209792|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
14209793|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
14209794|NCT04505059|Anesthetics|anesthetics|mesh-list
14209795|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209796|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209797|NCT04500574|Latanoprost|latanoprost|mesh-list
14209798|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14785494|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
14785495|NCT00709189|Vitamins|vitamins|mesh-ancestor
14785496|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
14785497|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14785498|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14785499|NCT00709215|Cordycepin|cordycepin|mesh-list
14785500|NCT00709215|Pentostatin|pentostatin|mesh-list
14785501|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785502|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14785503|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785504|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785505|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
14785506|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785507|NCT00709254|Fentanyl|fentanyl|mesh-list
14785508|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14785509|NCT00709254|Narcotics|narcotics|mesh-ancestor
14785510|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785511|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785512|NCT00709254|Analgesics|analgesics|mesh-ancestor
14785513|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
14209799|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14209800|NCT04493151|Imipenem|imipenem|mesh-list
14209801|NCT04493151|Relebactam|relebactam|mesh-list
14209802|NCT04493151|Cilastatin|cilastatin|mesh-list
14209803|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14209804|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209805|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
14209806|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209807|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209808|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14785514|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785515|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14209812|NCT04485325|Etanercept|etanercept|mesh-list
14209813|NCT04485325|Tofacitinib|tofacitinib|mesh-list
14209814|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14785516|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14785517|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
14785518|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
14785519|NCT00709267|Folic Acid|folic acid|mesh-list
14785520|NCT00709267|Hematinics|hematinics|mesh-ancestor
14785521|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
14785522|NCT00709267|Vitamins|vitamins|mesh-ancestor
14785523|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
14785524|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785525|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14785526|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
14785527|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785528|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785529|NCT00709332|Folic Acid|folic acid|mesh-list
14785530|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14785531|NCT00709332|Norgestimate|norgestimate|mesh-list
14785532|NCT00709332|Estradiol|estradiol|mesh-list
14785533|NCT00709332|Estrogens|estrogens|mesh-ancestor
14785534|NCT00709332|Hormones|hormones|mesh-ancestor
14785535|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785536|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785537|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14785538|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
14209815|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209816|NCT04485325|Analgesics|analgesics|mesh-ancestor
14209817|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
14209818|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209819|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209820|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209821|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14209822|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14209823|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14209824|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
14209825|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14209826|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209827|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209828|NCT04484428|Menthol|menthol|mesh-list
14209829|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
14209830|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
14209831|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
14209832|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14785539|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14785540|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14785541|NCT00709332|Hematinics|hematinics|mesh-ancestor
14785542|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
14785543|NCT00709332|Vitamins|vitamins|mesh-ancestor
14785544|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
14785545|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14785546|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14785547|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14785548|NCT00709423|Moxaverine|moxaverine|mesh-list
14785549|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
14785550|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
14785551|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785552|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785553|NCT00709436|Ketamine|ketamine|mesh-list
14785554|NCT00709436|Analgesics|analgesics|mesh-ancestor
14785555|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
14785556|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785557|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785558|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14785559|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14785560|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
14785561|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
14785562|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785563|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14785564|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14785565|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785566|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785567|NCT00709449|Papaverine|papaverine|mesh-list
14785568|NCT00709449|Moxaverine|moxaverine|mesh-list
14785569|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
14209833|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
14209834|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785570|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
14209835|NCT04481035|Expectorants|expectorants|mesh-ancestor
14785571|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785572|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785573|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14785574|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785575|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785576|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
14785577|NCT00709449|Urological Agents|urological agents|mesh-ancestor
14785578|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
14785579|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14785580|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785581|NCT00709488|Talaporfin|talaporfin|mesh-list
14785582|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785583|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14785584|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
14785585|NCT00709553|Midazolam|midazolam|mesh-list
14785586|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14785587|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14785588|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785589|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785590|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14785591|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14785592|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14785593|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14785594|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
14785595|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
14785596|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
14785597|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
14785598|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785599|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785600|NCT00709644|Folic Acid|folic acid|mesh-list
14785601|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14785602|NCT00709644|Norgestimate|norgestimate|mesh-list
14785603|NCT00709644|Estradiol|estradiol|mesh-list
14946715|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209836|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
14209837|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14209838|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
14209839|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785604|NCT00709644|Estrogens|estrogens|mesh-ancestor
14946716|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946717|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
14946718|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946719|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14946720|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14946721|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14946722|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
14946723|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946724|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14946725|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14946726|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946727|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14946728|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14946729|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14946730|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
14946731|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946732|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14946733|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14946734|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946735|NCT01524705|Insulin|insulin|mesh-list
14946736|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14946737|NCT01524705|Metformin|metformin|mesh-list
14946738|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
14946739|NCT01524705|Exenatide|exenatide|mesh-list
14946740|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14946741|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946742|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946743|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14946744|NCT01524705|Incretins|incretins|mesh-ancestor
14946745|NCT01524705|Hormones|hormones|mesh-ancestor
14946746|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946747|NCT01524731|Dexamethasone|dexamethasone|mesh-list
14946748|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
14946749|NCT01524731|BB 1101|bb 1101|mesh-list
14946750|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946751|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
14209840|NCT04481035|Protective Agents|protective agents|mesh-ancestor
14785605|NCT00709644|Hormones|hormones|mesh-ancestor
14946752|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
14785606|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785607|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785608|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14785609|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
14785610|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14785611|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14785612|NCT00709644|Hematinics|hematinics|mesh-ancestor
14785613|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
14785614|NCT00709644|Vitamins|vitamins|mesh-ancestor
14785615|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
14785616|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14785617|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14785618|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14785619|NCT00709657|Bevacizumab|bevacizumab|mesh-list
14785620|NCT00709657|Ranibizumab|ranibizumab|mesh-list
14785621|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14785622|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785623|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14785624|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14785625|NCT00709657|Growth Substances|growth substances|mesh-ancestor
14785626|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785627|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14785628|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
14785629|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
14785630|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14785631|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946753|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946754|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946755|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946756|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
14946757|NCT01524731|Hormones|hormones|mesh-ancestor
14946758|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946759|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14946760|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946761|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
14946762|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946763|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946764|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
14946765|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14946766|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946767|NCT01524744|Analgesics|analgesics|mesh-ancestor
14946768|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
14946769|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946770|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946771|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946772|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946773|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
14946774|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946775|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
14946776|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14946777|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946778|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946779|NCT01524757|Pantoprazole|pantoprazole|mesh-list
14946780|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14946781|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14946782|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14946783|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946784|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946785|NCT01524809|Insulin|insulin|mesh-list
14946786|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14946787|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
14946788|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
14946789|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14946790|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
14946791|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14946792|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946793|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964757|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964758|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13964759|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
14241207|NCT00176202|Valproic Acid|valproic acid|mesh-list
14785632|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785633|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
14785634|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785635|NCT00709917|Repaglinide|repaglinide|mesh-list
14785636|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14785637|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785638|NCT00709969|Lumefantrine|lumefantrine|mesh-list
13964760|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964761|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964762|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13964763|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13964764|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14785639|NCT00709969|Artemether|artemether|mesh-list
14785640|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14785641|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
14785642|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14785643|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14785644|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785645|NCT00709982|Folic Acid|folic acid|mesh-list
14785646|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14785647|NCT00709982|Norgestimate|norgestimate|mesh-list
14785648|NCT00709982|Estradiol|estradiol|mesh-list
14785649|NCT00709982|Estrogens|estrogens|mesh-ancestor
14785650|NCT00709982|Hormones|hormones|mesh-ancestor
14785651|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946794|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
14946795|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
14946796|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
14946797|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946798|NCT01524861|Protective Agents|protective agents|mesh-ancestor
14946799|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946800|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
14946801|NCT01524861|Vitamins|vitamins|mesh-ancestor
14946802|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
14946803|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
14946804|NCT01524874|Vitamin D|vitamin d|mesh-list
14946805|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
14946806|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
14946807|NCT01524874|Calcitriol|calcitriol|mesh-list
14946808|NCT01524874|Vitamins|vitamins|mesh-list
14946809|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
14946810|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946811|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14946812|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14946813|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13964765|NCT03134872|Carboplatin|carboplatin|mesh-list
13964766|NCT03134872|Pemetrexed|pemetrexed|mesh-list
13964767|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964768|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946814|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964769|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964770|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14209841|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209842|NCT04481035|Antidotes|antidotes|mesh-ancestor
14209843|NCT04476420|Betamethasone|betamethasone|mesh-list
14209844|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
14209845|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14209846|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
14209847|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14209848|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14209849|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
14209850|NCT04476420|Hormones|hormones|mesh-ancestor
14946815|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946816|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14946817|NCT01524926|Crizotinib|crizotinib|mesh-list
14946818|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964771|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13964772|NCT03134677|Bupivacaine|bupivacaine|mesh-list
13964773|NCT03134677|Sevoflurane|sevoflurane|mesh-list
14946819|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14946820|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946821|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946822|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
14946823|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14241208|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
14785652|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785653|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14946824|NCT01524939|Antibodies|antibodies|mesh-list
14946825|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
14785654|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
14785655|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14785656|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14785657|NCT00709982|Hematinics|hematinics|mesh-ancestor
14785658|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
14785659|NCT00709982|Vitamins|vitamins|mesh-ancestor
14785660|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
14785661|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14785662|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14785663|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14785664|NCT00710086|Remifentanil|remifentanil|mesh-list
14785665|NCT00710086|Hydromorphone|hydromorphone|mesh-list
14785666|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14785667|NCT00710086|Narcotics|narcotics|mesh-ancestor
14785668|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785669|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785670|NCT00710086|Analgesics|analgesics|mesh-ancestor
14946826|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
14946827|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946828|NCT01525004|Vaccines|vaccines|mesh-list
14946829|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
14946830|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946831|NCT01525043|Naproxen|naproxen|mesh-list
14946832|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14946833|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946834|NCT01525043|Analgesics|analgesics|mesh-ancestor
14946835|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
14946836|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946837|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946838|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946839|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946840|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
14946841|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14946842|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209851|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209852|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209853|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14209854|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
14209855|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14209856|NCT04476030|Citalopram|citalopram|mesh-list
14209857|NCT04476030|Sertraline|sertraline|mesh-list
14209858|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14209859|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14209860|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14209861|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14209862|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209863|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209864|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
14209865|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785671|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
14946843|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946844|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14946845|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14946846|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14946847|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946848|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
14946849|NCT01525394|Lenvatinib|lenvatinib|mesh-list
14946850|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14946851|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946852|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14946853|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14946854|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946855|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946856|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946857|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15027068|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027069|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027070|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
15027071|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15027072|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027073|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027074|NCT01947309|Lenalidomide|lenalidomide|mesh-list
14785672|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785673|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
14785674|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
14785675|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14785676|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14785677|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785678|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785679|NCT00710099|Urological Agents|urological agents|mesh-ancestor
14785680|NCT00710125|Doxorubicin|doxorubicin|mesh-list
14785681|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14785682|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785683|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14785684|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14785685|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785686|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785687|NCT00710138|Vitamins|vitamins|mesh-list
14785688|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
14946858|NCT01525537|Sufentanil|sufentanil|mesh-list
14946859|NCT01525537|Dsuvia|dsuvia|mesh-list
14946860|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14946861|NCT01525537|Narcotics|narcotics|mesh-ancestor
14946862|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946863|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946864|NCT01525537|Analgesics|analgesics|mesh-ancestor
14946865|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
14946866|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946867|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14946868|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14946869|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
13964774|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
13964775|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
13964776|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964777|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964778|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
13964779|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964780|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14946870|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
14946871|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
14946872|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14946873|NCT01525706|Ethanol|ethanol|mesh-list
14946874|NCT01525706|Paclitaxel|paclitaxel|mesh-list
14946875|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13964781|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13964782|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
14785689|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
14785690|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
14785691|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
14785692|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785693|NCT00710138|Hematinics|hematinics|mesh-ancestor
14946876|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14946877|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946878|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
13964783|NCT03134729|Ropivacaine|ropivacaine|mesh-list
13964784|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
13964785|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
13964786|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209866|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14946879|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
14946880|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
14946881|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946882|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14946883|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946884|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14946885|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946886|NCT01525719|Everolimus|everolimus|mesh-list
14946887|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946888|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946889|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
14209867|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
14946890|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946891|NCT01525771|Cisplatin|cisplatin|mesh-list
14946892|NCT01525771|Docetaxel|docetaxel|mesh-list
14946893|NCT01525771|Capecitabine|capecitabine|mesh-list
14946894|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946895|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14946896|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14946897|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14946898|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946899|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14785694|NCT00710216|Lamivudine|lamivudine|mesh-list
14785695|NCT00710216|Telbivudine|telbivudine|mesh-list
14785696|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14785697|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14785698|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785699|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785700|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
14785701|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785702|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14785703|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14785704|NCT00710229|Bevacizumab|bevacizumab|mesh-list
14785705|NCT00710229|Ranibizumab|ranibizumab|mesh-list
14785706|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14785707|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785708|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14785709|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14785710|NCT00710229|Growth Substances|growth substances|mesh-ancestor
14785711|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785712|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
14785713|NCT00710268|Bevacizumab|bevacizumab|mesh-list
14785714|NCT00710268|Olaparib|olaparib|mesh-list
14785715|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14785716|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785717|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14785718|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14785719|NCT00710268|Growth Substances|growth substances|mesh-ancestor
14785720|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785721|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
14785722|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14785723|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785724|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785725|NCT00710320|Anesthetics|anesthetics|mesh-list
14785726|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785727|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785728|NCT00710359|Vitamins|vitamins|mesh-list
14785729|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
14785730|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
14785731|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
14785732|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
14785733|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785734|NCT00710359|Hematinics|hematinics|mesh-ancestor
14785735|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
14946900|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
14946901|NCT01525823|Metformin|metformin|mesh-list
14946902|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14946903|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946904|NCT01525836|Rituximab|rituximab|mesh-list
14209868|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14209869|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209870|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14209871|NCT04476030|Analgesics|analgesics|mesh-ancestor
14946905|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209872|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
14209873|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
14209874|NCT04475705|Propofol|propofol|mesh-list
14209875|NCT04475705|Sevoflurane|sevoflurane|mesh-list
14209876|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209877|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209878|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209879|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209880|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
14209881|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
14209882|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14209883|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14209884|NCT04473508|Ropivacaine|ropivacaine|mesh-list
14209885|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
14209886|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
14209887|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209888|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209889|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
14209890|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209891|NCT04471818|Ketamine|ketamine|mesh-list
14209892|NCT04471818|Analgesics|analgesics|mesh-ancestor
14946906|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209893|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
14946907|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
14785736|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14785737|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785738|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785739|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14785740|NCT00710437|Analgesics|analgesics|mesh-ancestor
14785741|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
14785742|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785743|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14785744|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14785745|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14785746|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
14785747|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785748|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785749|NCT00710528|Idelalisib|idelalisib|mesh-list
14785750|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785751|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785752|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785753|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
14785754|NCT00710619|Coagulants|coagulants|mesh-ancestor
14785755|NCT00710736|Fluorouracil|fluorouracil|mesh-list
14785756|NCT00710736|Capecitabine|capecitabine|mesh-list
14785757|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
14785758|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785759|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14785760|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785761|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14785762|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
14785763|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785764|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
14785765|NCT00710788|Calcium|calcium|mesh-list
14785766|NCT00710788|Sevelamer|sevelamer|mesh-list
14785767|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14785768|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785769|NCT00710788|Antacids|antacids|mesh-ancestor
14785770|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785771|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14785772|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
14785773|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
14785774|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
14785775|NCT00710827|Androgens|androgens|mesh-ancestor
14785776|NCT00710827|Hormones|hormones|mesh-ancestor
14785777|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785778|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785779|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14785780|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14785781|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785782|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14785783|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14785784|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
14785785|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785786|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
14785787|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785788|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
14785789|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14785790|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14785791|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14785792|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14209894|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209895|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209896|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14785793|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14785794|NCT00711204|Donepezil|donepezil|mesh-list
14785795|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14785796|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209897|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14209898|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
14209899|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
14209900|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209901|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14209902|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14209903|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241209|NCT00176202|Risperidone|risperidone|mesh-list
14785797|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785798|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
14785799|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785800|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785801|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
14785802|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
14785803|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14785804|NCT00711256|Protective Agents|protective agents|mesh-ancestor
14785805|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785806|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
14785807|NCT00711295|Vaccines|vaccines|mesh-list
14785808|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
14785809|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785810|NCT00711308|Vitamin K|vitamin k|mesh-list
14785811|NCT00711308|Tinzaparin|tinzaparin|mesh-list
14785812|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14785813|NCT00711308|Dalteparin|dalteparin|mesh-list
14785814|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
14785815|NCT00711308|Vitamins|vitamins|mesh-ancestor
14785816|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
14785817|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785818|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14785819|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14785820|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785821|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
14785822|NCT00711308|Coagulants|coagulants|mesh-ancestor
14785823|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
14785824|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14785825|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14785826|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14785827|NCT00711620|Thymalfasin|thymalfasin|mesh-list
14785828|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14785829|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
14785830|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785831|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
14785832|NCT00711698|Narcotics|narcotics|mesh-ancestor
14785833|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785834|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785835|NCT00711698|Analgesics|analgesics|mesh-ancestor
14785836|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
14785837|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785838|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
14785839|NCT00711789|Giapreza|giapreza|mesh-list
14785840|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
14946908|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946909|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946910|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14946911|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14946912|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14946913|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946914|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
14946915|NCT01525901|Mitogens|mitogens|mesh-list
14946916|NCT01525901|Mecasermin|mecasermin|mesh-list
14946917|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946918|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14946919|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946920|NCT01525901|Growth Substances|growth substances|mesh-ancestor
14946921|NCT01525914|Dutasteride|dutasteride|mesh-list
14946922|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14946923|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14946924|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946925|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946926|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
14946927|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14946928|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946929|NCT01525966|Paclitaxel|paclitaxel|mesh-list
14946930|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14946931|NCT01525966|Carboplatin|carboplatin|mesh-list
14946932|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14946933|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946934|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
14946935|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
14946936|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
14785841|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14785842|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14785843|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
14785844|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785845|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785846|NCT00711841|Dexamethasone|dexamethasone|mesh-list
14785847|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
14785848|NCT00711841|BB 1101|bb 1101|mesh-list
14785849|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785850|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
14785851|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
14785852|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785853|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785854|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14785855|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
14785856|NCT00711841|Hormones|hormones|mesh-ancestor
14785857|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14785858|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14785859|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785860|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
14946937|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946938|NCT01526005|Nicotine|nicotine|mesh-list
14946939|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14946940|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
14946941|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946942|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946943|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14946944|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14946945|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
14209904|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209905|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
14209906|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14209907|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209908|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209909|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14209910|NCT04471402|Analgesics|analgesics|mesh-ancestor
14209911|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
14209912|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209913|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14785861|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785862|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785863|NCT00711854|Rifampin|rifampin|mesh-list
14785864|NCT00711854|Linezolid|linezolid|mesh-list
14785865|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14785866|NCT00711854|Trimethoprim|trimethoprim|mesh-list
14785867|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
14785868|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14785869|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
14785870|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785871|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785872|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
14785873|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14785874|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785875|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785876|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14785877|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14785878|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14785879|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14785880|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14785881|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14785882|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14785883|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14785884|NCT00711854|Renal Agents|renal agents|mesh-ancestor
14785885|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
14785886|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14785887|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14785888|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14785889|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14785890|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14785891|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14785892|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
14785893|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
14785894|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14785895|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14946946|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785896|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
14785897|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14785898|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14785899|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785900|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14785901|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785902|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785903|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14785904|NCT00711906|Renal Agents|renal agents|mesh-ancestor
14785905|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14785906|NCT00711919|Pitavastatin|pitavastatin|mesh-list
14785907|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14785908|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14785909|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14785910|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
14785911|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785912|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785913|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14785914|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
14946947|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946948|NCT01526070|Aflibercept|aflibercept|mesh-list
14946949|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14946950|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14946951|NCT01526070|Growth Substances|growth substances|mesh-ancestor
14946952|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946953|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
14946954|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946955|NCT01526083|Lacosamide|lacosamide|mesh-list
14946956|NCT01526083|Warfarin|warfarin|mesh-list
14946957|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
14946958|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
14946959|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14946960|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14946961|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14946962|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946963|NCT01526096|Plerixafor|plerixafor|mesh-list
13964787|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964788|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
13964789|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946964|NCT01526096|Melphalan|melphalan|mesh-list
14946965|NCT01526096|Basiliximab|basiliximab|mesh-list
14946966|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14946967|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
14946968|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946969|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946970|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14946971|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14946972|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
14946973|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946974|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14946975|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14946976|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
14946977|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14946978|NCT01526122|Aspirin|aspirin|mesh-list
14946979|NCT01526122|Clopidogrel|clopidogrel|mesh-list
14946980|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14946981|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14946982|NCT01526122|Analgesics|analgesics|mesh-ancestor
14946983|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
14946984|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14946985|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14946986|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13964790|NCT03134651|Propofol|propofol|mesh-list
13964791|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13964792|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964793|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964794|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13964795|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
13964796|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
13964797|NCT03134638|Carboplatin|carboplatin|mesh-list
13964798|NCT03134638|Fulvestrant|fulvestrant|mesh-list
13964799|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964800|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13964801|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13964802|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14209914|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14209915|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14209916|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14209917|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209918|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209919|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
14209920|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209921|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209922|NCT04462952|Adavosertib|adavosertib|mesh-list
14209923|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209924|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785915|NCT00712049|Niacin|niacin|mesh-list
14785916|NCT00712049|Niacinamide|niacinamide|mesh-list
14785917|NCT00712049|Simvastatin|simvastatin|mesh-list
14785918|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14785919|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14785920|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
14785921|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785922|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14785923|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14785924|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785925|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
14785926|NCT00712049|Vitamins|vitamins|mesh-ancestor
14785927|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
14785928|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785929|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
14209925|NCT04462328|Durvalumab|durvalumab|mesh-list
14209926|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
14209927|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209928|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209929|NCT04459234|Ketamine|ketamine|mesh-list
14209930|NCT04459234|Analgesics|analgesics|mesh-ancestor
14209931|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
14209932|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209933|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209934|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14505966|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
14505967|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505968|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14505969|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505970|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
14505971|NCT02891850|Tadalafil|tadalafil|mesh-list
14505972|NCT02891850|Riociguat|riociguat|mesh-list
14505973|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
14505974|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14505975|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14505976|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505977|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505978|NCT02891850|Urological Agents|urological agents|mesh-ancestor
14505979|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
14505980|NCT02891915|Amoxicillin|amoxicillin|mesh-list
14505981|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
14505982|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
14505983|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14505984|NCT02891915|Cefdinir|cefdinir|mesh-list
14505985|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14505986|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14505987|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14505988|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14505989|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14505990|NCT02892110|Varenicline|varenicline|mesh-list
14505991|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14505992|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14505993|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
14505994|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785930|NCT00712062|Pemetrexed|pemetrexed|mesh-list
14785931|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14785932|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785933|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785934|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14785935|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14785936|NCT00712101|Abciximab|abciximab|mesh-list
14785937|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
14785938|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14530045|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785939|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14785940|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14785941|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
14785942|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785943|NCT00712140|Trastuzumab|trastuzumab|mesh-list
14785944|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14785945|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14946987|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14946988|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14946989|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14946990|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14946991|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14946992|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14946993|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14946994|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
14946995|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14946996|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14946997|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14946998|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
14946999|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947000|NCT01526161|Fluticasone|fluticasone|mesh-list
14947001|NCT01526161|Xhance|xhance|mesh-list
14947002|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14947003|NCT01526161|Montelukast|montelukast|mesh-list
14947004|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947005|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14947006|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
14947007|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14209935|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14947008|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947009|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14947010|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
14947011|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
14947012|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14947013|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14947014|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14947015|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14947016|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
14947017|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947018|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947019|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14947020|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
14947021|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947022|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14947023|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14947024|NCT01526174|Golimumab|golimumab|mesh-list
14947025|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14947026|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947027|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947028|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
14947029|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947030|NCT01526278|Alendronate|alendronate|mesh-list
14947031|NCT01526278|Calcitriol|calcitriol|mesh-list
14947032|NCT01526278|Maxmarvil|maxmarvil|mesh-list
14947033|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14947034|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947035|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14947036|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14947037|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947038|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947039|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14947040|NCT01526278|Vitamins|vitamins|mesh-ancestor
14947041|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
14947042|NCT01526317|Metformin|metformin|mesh-list
14209936|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
14209937|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
14209938|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14209939|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14209940|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14947043|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14947044|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14785946|NCT00712205|Calcitriol|calcitriol|mesh-list
14785947|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14785948|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785949|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14785950|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14785951|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785952|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14785953|NCT00712205|Vitamins|vitamins|mesh-ancestor
14785954|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
14785955|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14785956|NCT00712257|Heparin|heparin|mesh-list
14785957|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
14785958|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14785959|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14785960|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785961|NCT00712322|Darifenacin|darifenacin|mesh-list
14785962|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14785963|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14785964|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
14785965|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209941|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14209942|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209943|NCT04457284|Nivolumab|nivolumab|mesh-list
14209944|NCT04457284|Temozolomide|temozolomide|mesh-list
14209945|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209946|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209947|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14209948|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209949|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14209950|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
14209951|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
14785966|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785967|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785968|NCT00712322|Urological Agents|urological agents|mesh-ancestor
14785969|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
14785970|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
14785971|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14785972|NCT00712374|Amodiaquine|amodiaquine|mesh-list
14785973|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
14785974|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14785975|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14785976|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14785977|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14785978|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14785979|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785980|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14785981|NCT00712374|Renal Agents|renal agents|mesh-ancestor
14209952|NCT04441034|Convulsants|convulsants|mesh-list
14209953|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
14209954|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14209955|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14209956|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209957|NCT04432376|Miconazole|miconazole|mesh-list
14209958|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
14209959|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14209960|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14785982|NCT00712400|Latanoprost|latanoprost|mesh-list
14785983|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14785984|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13964803|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
13964804|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964805|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964806|NCT03134547|Sevoflurane|sevoflurane|mesh-list
13964807|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13964808|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13964809|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
13964810|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
13964811|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785985|NCT00712439|Gabapentin|gabapentin|mesh-list
14785986|NCT00712439|Analgesics|analgesics|mesh-ancestor
14785987|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
14785988|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14785989|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14785990|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
14785991|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13964812|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964813|NCT03134443|Andrographolide|andrographolide|mesh-list
13964814|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14785992|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14785993|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14785994|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14785995|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14785996|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14785997|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14785998|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14785999|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
14786000|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
14786001|NCT00712452|Vinblastine|vinblastine|mesh-list
14786002|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786003|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
14786004|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786005|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14786006|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14786007|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
14786008|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786009|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786010|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14786011|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14786012|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
14786013|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786014|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
14786015|NCT00712465|Digoxin|digoxin|mesh-list
14786016|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14786017|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14786018|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786019|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786020|NCT00712465|Protective Agents|protective agents|mesh-ancestor
14786021|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786022|NCT00712478|Insulin|insulin|mesh-list
14786023|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14786024|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786025|NCT00712491|Sirolimus|sirolimus|mesh-list
14786026|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14786027|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786028|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14786029|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786030|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
14786031|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786032|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
14786033|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786034|NCT00712504|Docetaxel|docetaxel|mesh-list
14786035|NCT00712504|Sunitinib|sunitinib|mesh-list
14786036|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786037|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
14786038|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786039|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
14786040|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786041|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14786042|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14786043|NCT00712504|Growth Substances|growth substances|mesh-ancestor
14786044|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786045|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14786046|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14786047|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786048|NCT00712517|Propofol|propofol|mesh-list
14786049|NCT00712517|Sevoflurane|sevoflurane|mesh-list
14786050|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14786051|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786052|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786053|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14786054|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
14786055|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
14209961|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14209962|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14209963|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14209964|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14209965|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
14209966|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209967|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209968|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14209969|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14209970|NCT04429321|Nivolumab|nivolumab|mesh-list
14786056|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14786057|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14786058|NCT00712556|Fluorides|fluorides|mesh-list
14786059|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
14786060|NCT00712556|Protective Agents|protective agents|mesh-ancestor
14786061|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786062|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
14786063|NCT00712582|Ifosfamide|ifosfamide|mesh-list
14786064|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
14786065|NCT00712582|Carmustine|carmustine|mesh-list
14786066|NCT00712582|Rituximab|rituximab|mesh-list
14786067|NCT00712582|Carboplatin|carboplatin|mesh-list
14786068|NCT00712582|Etoposide|etoposide|mesh-list
14786069|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
14786070|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
14786071|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786072|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
14786073|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786074|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14786075|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14786076|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
14786077|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786078|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786079|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14209971|NCT04429321|Ipilimumab|ipilimumab|mesh-list
14209972|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14209973|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209974|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14209975|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786080|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14786081|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14786082|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14786083|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14209976|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
14209977|NCT04424654|Testosterone|testosterone|mesh-list
14209978|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
14209979|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
14209980|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14209981|NCT04424654|Androgens|androgens|mesh-ancestor
14209982|NCT04424654|Hormones|hormones|mesh-ancestor
14209983|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14209984|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14209985|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14209986|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14209987|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
14786084|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786085|NCT00712582|Analgesics|analgesics|mesh-ancestor
15027075|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
15027076|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027077|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15027078|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14786086|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
14786087|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786088|NCT00712595|Mifepristone|mifepristone|mesh-list
14786089|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14786090|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
14786091|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14786092|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786093|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14786094|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14786095|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14786096|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
14786097|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14786098|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14786099|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
14786100|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14786101|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
13964815|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13964816|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13964817|NCT03134443|Analgesics|analgesics|mesh-ancestor
13964818|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
14505995|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947045|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947046|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14947047|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14947048|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
14947049|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947050|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14947051|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14786102|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14786103|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14786104|NCT00712647|Beta Carotene|beta carotene|mesh-list
14786105|NCT00712647|Vitamin A|vitamin a|mesh-list
14786106|NCT00712647|Carotenoids|carotenoids|mesh-list
14786107|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
14786108|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786109|NCT00712647|Protective Agents|protective agents|mesh-ancestor
14505996|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14505997|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
14505998|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14505999|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
14506000|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14506001|NCT02892409|Amoxicillin|amoxicillin|mesh-list
14506002|NCT02892409|Clarithromycin|clarithromycin|mesh-list
14947052|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947053|NCT01526369|Paclitaxel|paclitaxel|mesh-list
14947054|NCT01526369|Trastuzumab|trastuzumab|mesh-list
14947055|NCT01526369|Lapatinib|lapatinib|mesh-list
14947056|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14947057|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947058|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
14947059|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
14947060|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
14947061|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786110|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786111|NCT00712647|Provitamins|provitamins|mesh-ancestor
14786112|NCT00712647|Vitamins|vitamins|mesh-ancestor
14786113|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
14786114|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
14786115|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14786116|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786117|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786118|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786119|NCT00712686|Olanzapine|olanzapine|mesh-list
14786120|NCT00712686|Aripiprazole|aripiprazole|mesh-list
14786121|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
14786122|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
14786123|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786124|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786125|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786126|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14786127|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14786128|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506003|NCT02892409|Lansoprazole|lansoprazole|mesh-list
14506004|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
14506005|NCT02892409|Bismuth|bismuth|mesh-list
14506006|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14506007|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14506008|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14506009|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506010|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506011|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14786129|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786130|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14786131|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14786132|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786133|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786134|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786135|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
14786136|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
14786137|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
14786138|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
14786139|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14786140|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14786141|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14786142|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14786143|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14786144|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14786145|NCT00712738|Nifedipine|nifedipine|mesh-list
14786146|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14786147|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947062|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14947063|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14209999|NCT04398706|Vaccines|vaccines|mesh-list
14210000|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14210001|NCT04398706|Immunoglobulins|immunoglobulins|mesh-list
14210002|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
14210003|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210004|NCT04392622|Cisplatin|cisplatin|mesh-list
14210005|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210006|NCT04390958|Paclitaxel|paclitaxel|mesh-list
14210007|NCT04390958|Capecitabine|capecitabine|mesh-list
14530046|NCT03359174|Tretinoin|tretinoin|mesh-list
14947064|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947065|NCT01526395|Propofol|propofol|mesh-list
14947066|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14947067|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947068|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947069|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14947070|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
14947071|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
14947072|NCT01526460|Atorvastatin|atorvastatin|mesh-list
14210008|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14210009|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210010|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
14210011|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
14210012|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
14210013|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210014|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14210015|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
14241210|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
14241211|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14241212|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
14241213|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241214|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241215|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241216|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506012|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14506013|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14947073|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14947074|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14947075|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14947076|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
14947077|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947078|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14947079|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14947080|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947081|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
14947082|NCT01526499|Docetaxel|docetaxel|mesh-list
14947083|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947084|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
14947085|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947086|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14947087|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14947088|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
14947089|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947090|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947091|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14947092|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
14947093|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
14947094|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
14947095|NCT01526525|Acetaminophen|acetaminophen|mesh-list
14947096|NCT01526525|Parecoxib|parecoxib|mesh-list
14947097|NCT01526525|Ketamine|ketamine|mesh-list
14947098|NCT01526525|Morphine|morphine|mesh-list
14947099|NCT01526525|Tramadol|tramadol|mesh-list
14947100|NCT01526525|Analgesics|analgesics|mesh-ancestor
14947101|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
14947102|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947103|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947104|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14947105|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14947106|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
14947107|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
14947108|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947109|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14506014|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506015|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14506016|NCT02892409|Antacids|antacids|mesh-ancestor
14506017|NCT02892734|Nivolumab|nivolumab|mesh-list
14506018|NCT02892734|Ipilimumab|ipilimumab|mesh-list
14506019|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14506020|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506021|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14506022|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506023|NCT02895035|Ketorolac|ketorolac|mesh-list
14506024|NCT02895035|Phenylephrine|phenylephrine|mesh-list
14506025|NCT02895035|Epinephrine|epinephrine|mesh-list
14506026|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
14786148|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786149|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14786150|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786151|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
14786152|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
14786153|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14786154|NCT00712764|Adenosine|adenosine|mesh-list
14786155|NCT00712764|Analgesics|analgesics|mesh-ancestor
14786156|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
14786157|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786158|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786159|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14786160|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
14786161|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14786162|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
14786163|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
14786164|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786165|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786166|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14786167|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14786168|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14786169|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14786170|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14786171|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
14786172|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786173|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786174|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786175|NCT00712790|Sorafenib|sorafenib|mesh-list
14210016|NCT04367233|Anesthetics|anesthetics|mesh-list
14210017|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210018|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210019|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
14210020|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14210021|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14210022|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14210023|NCT04359147|Yohimbine|yohimbine|mesh-list
14210024|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210025|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
14786176|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786177|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14786178|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786179|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786180|NCT00712855|Sorafenib|sorafenib|mesh-list
14786181|NCT00712855|Mapatumumab|mapatumumab|mesh-list
14786182|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786183|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14786184|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786185|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786186|NCT00712894|Verapamil|verapamil|mesh-list
14786187|NCT00712894|Diltiazem|diltiazem|mesh-list
14786188|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
14786189|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
14786190|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14786191|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14786192|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786193|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786194|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14786195|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786196|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14786197|NCT00712907|Ascorbic Acid|ascorbic acid|mesh-list
14786198|NCT00712907|Vitamins|vitamins|mesh-ancestor
14786199|NCT00712907|Micronutrients|micronutrients|mesh-ancestor
14786200|NCT00712907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786201|NCT00712907|Antioxidants|antioxidants|mesh-ancestor
14786202|NCT00712907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786203|NCT00712907|Protective Agents|protective agents|mesh-ancestor
14786204|NCT00712933|Belimumab|belimumab|mesh-list
14786205|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947110|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14947111|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947112|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786206|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
14210026|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
14786207|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786208|NCT00713011|Nifedipine|nifedipine|mesh-list
14786209|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14786210|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786211|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786212|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14786213|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786214|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
14786215|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
14786216|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14786217|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
14786218|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14786219|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786220|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
14786221|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786222|NCT00713167|Protective Agents|protective agents|mesh-ancestor
14786223|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786224|NCT00713193|Cyclosporine|cyclosporine|mesh-list
14786225|NCT00713193|Prednisone|prednisone|mesh-list
14786226|NCT00713193|Cyclosporins|cyclosporins|mesh-list
14786227|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786228|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
14786229|NCT00713193|Hormones|hormones|mesh-ancestor
14786230|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14786231|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786232|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14786233|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786234|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786235|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786236|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786237|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
14786238|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
14786239|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786240|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
14786241|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14786242|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14786243|NCT00713271|AZD-3199|azd-3199|mesh-list
14210027|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210028|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210029|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14210030|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14210031|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14210032|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210033|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210034|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210035|NCT04359147|Urological Agents|urological agents|mesh-ancestor
14210036|NCT04355585|Colchicine|colchicine|mesh-list
14210037|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
14210038|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210039|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14210040|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
14210041|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14210042|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210043|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210044|NCT04352166|Buprenorphine|buprenorphine|mesh-list
14786244|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14786245|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14786246|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14786247|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14786248|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786249|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786250|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786251|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
14210045|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14786252|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14786253|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14786254|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786255|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14786256|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14786257|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786258|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786259|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786260|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14786261|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
14786262|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14786263|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786264|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14786265|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14786266|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14786267|NCT00713440|Acetaminophen|acetaminophen|mesh-list
14786268|NCT00713440|Prednisolone|prednisolone|mesh-list
14786269|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14786270|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
14786271|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14786272|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
14786273|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14786274|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
14786275|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786276|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
14786277|NCT00713440|Hormones|hormones|mesh-ancestor
14210046|NCT04352166|Narcotics|narcotics|mesh-ancestor
14210047|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210048|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210049|NCT04352166|Analgesics|analgesics|mesh-ancestor
14210050|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
14210051|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210052|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14210053|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
14210054|NCT04345666|Testosterone|testosterone|mesh-list
14786278|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14786279|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786280|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14786281|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786282|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
14786283|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
14786284|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786285|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786286|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14786287|NCT00713440|Protective Agents|protective agents|mesh-ancestor
14786288|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14786289|NCT00713440|Analgesics|analgesics|mesh-ancestor
14786290|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
14786291|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
14786292|NCT00713557|Tirofiban|tirofiban|mesh-list
14786293|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14786294|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14786295|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786296|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14786297|NCT00713622|Zonisamide|zonisamide|mesh-list
14786298|NCT00713622|Valproic Acid|valproic acid|mesh-list
14786299|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
14786300|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786301|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786302|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
14786303|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786304|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786305|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
14786306|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947113|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14947114|NCT01526525|Narcotics|narcotics|mesh-ancestor
14947115|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14947116|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
14947117|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14947118|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14947119|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947120|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14947121|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210055|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
14210056|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
14947122|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14786307|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786308|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786309|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14786310|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786311|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14786312|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14786313|NCT00713674|Mupirocin|mupirocin|mesh-list
14786314|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786315|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14786316|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786317|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786318|NCT00713687|Gemcitabine|gemcitabine|mesh-list
14786319|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
14786320|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14786321|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
14786322|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786323|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786324|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
14786325|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786326|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786327|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786328|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
14786329|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786330|NCT00713726|Fentanyl|fentanyl|mesh-list
14786331|NCT00713726|Tramadol|tramadol|mesh-list
14786332|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14786333|NCT00713726|Narcotics|narcotics|mesh-ancestor
14786334|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786335|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786336|NCT00713726|Analgesics|analgesics|mesh-ancestor
14786337|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
14786338|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786339|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14786340|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14786341|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
14786342|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
14786343|NCT00713739|Prazosin|prazosin|mesh-list
14786344|NCT00713739|Doxazosin|doxazosin|mesh-list
14786345|NCT00713739|Nifedipine|nifedipine|mesh-list
14786346|NCT00713739|Alfuzosin|alfuzosin|mesh-list
14786347|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14786348|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786349|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786350|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14786351|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786352|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
14947123|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
14947124|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
14947125|NCT01526564|Vitamins|vitamins|mesh-ancestor
14947126|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
14947127|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964819|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964820|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786353|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
14786354|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14786355|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14786356|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14786357|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14786358|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14786359|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
14786360|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786361|NCT00713739|Urological Agents|urological agents|mesh-ancestor
14786362|NCT00713765|Donepezil|donepezil|mesh-list
14786363|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14786364|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786365|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786366|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
14786367|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786368|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786369|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
14786370|NCT00713921|Fesoterodine|fesoterodine|mesh-list
14786371|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14786372|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14786373|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
14947128|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
14947129|NCT01526616|Metformin|metformin|mesh-list
14947130|NCT01526616|Spironolactone|spironolactone|mesh-list
14786374|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786375|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786376|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964821|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14947131|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947132|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947133|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14947134|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
14947135|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947136|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14947137|NCT01526616|Diuretics|diuretics|mesh-ancestor
14947138|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
14947139|NCT01526694|Thalidomide|thalidomide|mesh-list
14947140|NCT01526694|Dexamethasone|dexamethasone|mesh-list
14947141|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14947142|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947143|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
14947144|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
14947145|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947146|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947147|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14947148|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
14947149|NCT01526694|Hormones|hormones|mesh-ancestor
14947150|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947151|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14947152|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947153|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14947154|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
14947155|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947156|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947157|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
14947158|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
14786377|NCT00713921|Urological Agents|urological agents|mesh-ancestor
14786378|NCT00713947|Amoxicillin|amoxicillin|mesh-list
14786379|NCT00713947|Metronidazole|metronidazole|mesh-list
14786380|NCT00713947|Clarithromycin|clarithromycin|mesh-list
14786381|NCT00713947|Pantoprazole|pantoprazole|mesh-list
14786382|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14947159|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14947160|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947161|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14947162|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947163|NCT01526694|Growth Substances|growth substances|mesh-ancestor
14947164|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
14210057|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14210058|NCT04345666|Androgens|androgens|mesh-ancestor
14786383|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786384|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14786385|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14786386|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14786387|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786388|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786389|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14786390|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14786391|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14786392|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786393|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14786394|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
14786395|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
14786396|NCT00713986|Protective Agents|protective agents|mesh-ancestor
14786397|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947165|NCT01526837|Bevacizumab|bevacizumab|mesh-list
14947166|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14947167|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947168|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14947169|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947170|NCT01526837|Growth Substances|growth substances|mesh-ancestor
14947171|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947172|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
14947173|NCT01526850|Cyclosporine|cyclosporine|mesh-list
14947174|NCT01526850|Cyclosporins|cyclosporins|mesh-list
14947175|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
14947176|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964822|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14210059|NCT04345666|Hormones|hormones|mesh-ancestor
14786398|NCT00713999|Praziquantel|praziquantel|mesh-list
14786399|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
14786400|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14786401|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786402|NCT00714025|Everolimus|everolimus|mesh-list
14786403|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786404|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786405|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
14786406|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786407|NCT00714064|Edetic Acid|edetic acid|mesh-list
14947177|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947178|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947179|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
14947180|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947181|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
14947182|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947183|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
14947184|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14947185|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14947186|NCT01526850|Hormones|hormones|mesh-ancestor
14947187|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947188|NCT01526876|Clevidipine|clevidipine|mesh-list
14947189|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14947190|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947191|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947192|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14947193|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947194|NCT01526941|Insulin|insulin|mesh-list
14947195|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14947196|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
14947197|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
14947198|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14947199|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
14947200|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14947201|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947202|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786408|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
14786409|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14786410|NCT00714064|Antidotes|antidotes|mesh-ancestor
14786411|NCT00714064|Protective Agents|protective agents|mesh-ancestor
14786412|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947203|NCT01526980|Insulin|insulin|mesh-list
14947204|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14947205|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
14947206|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
14947207|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14947208|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
14947209|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14210060|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14210061|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210062|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14210063|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210064|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
14210065|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
14210066|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
14210067|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14210068|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210069|NCT04338529|Vitamins|vitamins|mesh-ancestor
14210070|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
14210071|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14210072|NCT04338529|Antacids|antacids|mesh-ancestor
14210073|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210074|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14210075|NCT04336241|Nivolumab|nivolumab|mesh-list
14210076|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210077|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210078|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210079|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210080|NCT04332367|Paclitaxel|paclitaxel|mesh-list
14210081|NCT04332367|Carboplatin|carboplatin|mesh-list
14210082|NCT04332367|Ramucirumab|ramucirumab|mesh-list
14210083|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14786413|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
14786414|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
14786415|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786416|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14786417|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
14786418|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14786419|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
14786420|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14786421|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14786422|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14947210|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947211|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947212|NCT01527019|Cephalosporins|cephalosporins|mesh-list
14947213|NCT01527019|Norfloxacin|norfloxacin|mesh-list
14947214|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14947215|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947216|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14947217|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14947218|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947219|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947220|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947221|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14947222|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14947223|NCT01527032|Thalidomide|thalidomide|mesh-list
14947224|NCT01527032|Dexamethasone|dexamethasone|mesh-list
14947225|NCT01527032|Melphalan|melphalan|mesh-list
14947226|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947227|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
14947228|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
14947229|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947230|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947231|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14947232|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
14947233|NCT01527032|Hormones|hormones|mesh-ancestor
14947234|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947235|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14947236|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947237|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14947238|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
14947239|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947240|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14947241|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947242|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
14947243|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
14947244|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14947245|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947246|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14210084|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210085|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
14947247|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947248|NCT01527032|Growth Substances|growth substances|mesh-ancestor
14947249|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
14947250|NCT01527097|Atorvastatin|atorvastatin|mesh-list
14947251|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14947252|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14947253|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
14947254|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947255|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14947256|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14947257|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027079|NCT01947309|Growth Substances|growth substances|mesh-ancestor
15027080|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
15027081|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027082|NCT01947465|Vaccines|vaccines|mesh-list
15027083|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
15027084|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210086|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
14210087|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
14210088|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210089|NCT04324463|Aspirin|aspirin|mesh-list
14210090|NCT04324463|Interferons|interferons|mesh-list
14210091|NCT04324463|Interferon-beta|interferon-beta|mesh-list
15027085|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
15027086|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14210092|NCT04324463|Colchicine|colchicine|mesh-list
14210093|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
14786423|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947258|NCT01527279|Antazoline|antazoline|mesh-list
14947259|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14947260|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
14947261|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
14947262|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947263|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947264|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947265|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14947266|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14947267|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14947268|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947269|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947270|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947271|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947272|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14947273|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14947274|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
14947275|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947276|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947277|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14947278|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14947279|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
14947280|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
14947281|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14947282|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14947283|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
14947284|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947285|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14947286|NCT01527422|Prednisone|prednisone|mesh-list
14947287|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
14947288|NCT01527422|Doxorubicin|doxorubicin|mesh-list
14947289|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14947290|NCT01527422|Vincristine|vincristine|mesh-list
14947291|NCT01527422|Sargramostim|sargramostim|mesh-list
14947292|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947293|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
14947294|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964823|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13964824|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964825|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
14947295|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14947296|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14947297|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
14947298|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964826|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13964827|NCT03134612|Lidocaine|lidocaine|mesh-list
13964828|NCT03134612|Ondansetron|ondansetron|mesh-list
13964829|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
13964830|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
13964831|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964832|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964833|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
14210094|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210095|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
14210096|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210097|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14210098|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210099|NCT04324463|Analgesics|analgesics|mesh-ancestor
14210100|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
14210101|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210102|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210103|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210104|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210105|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14786424|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786425|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786426|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786427|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14786428|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
14786429|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786430|NCT00714103|Adenosine|adenosine|mesh-list
14786431|NCT00714103|Analgesics|analgesics|mesh-ancestor
14947299|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947300|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14786432|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
14786433|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786434|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786435|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14786436|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
14786437|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14786438|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
14786439|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
14786440|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786441|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786442|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
14786443|NCT00714181|Temozolomide|temozolomide|mesh-list
14786444|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14786445|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
14786446|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786447|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786448|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
14786449|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14786450|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14786451|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786452|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786453|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14786454|NCT00714246|Carboplatin|carboplatin|mesh-list
14786455|NCT00714246|Docetaxel|docetaxel|mesh-list
14786456|NCT00714246|Bortezomib|bortezomib|mesh-list
14786457|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786458|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
14786459|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786460|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
14786461|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786462|NCT00714376|Docetaxel|docetaxel|mesh-list
14786463|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786464|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
14786465|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786466|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
14786467|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786468|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
14210106|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14947301|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14947302|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14947303|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14210107|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786469|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14786470|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
14210108|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14786471|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210109|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14210110|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210111|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
14210112|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14210113|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
14210114|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14210115|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
14210116|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
14210117|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
14210118|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
14210119|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
14210120|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786472|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786473|NCT00714519|Castor Oil|castor oil|mesh-list
14786474|NCT00714519|Cathartics|cathartics|mesh-ancestor
14786475|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786476|NCT00714558|Fentanyl|fentanyl|mesh-list
14786477|NCT00714558|Naltrexone|naltrexone|mesh-list
14786478|NCT00714558|Naloxone|naloxone|mesh-list
14786479|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14786480|NCT00714558|Narcotics|narcotics|mesh-ancestor
14786481|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786482|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786483|NCT00714558|Analgesics|analgesics|mesh-ancestor
14786484|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
14786485|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786486|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14786487|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14947304|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947305|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947306|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
14786488|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
14786489|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
14786490|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14786491|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14786492|NCT00714584|Naltrexone|naltrexone|mesh-list
14786493|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14210121|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
14210122|NCT04322357|Prednisone|prednisone|mesh-list
14210123|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
14210124|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210125|NCT04322357|Hormones|hormones|mesh-ancestor
14210126|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14210127|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210128|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14786494|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14786495|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786496|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
14786497|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786498|NCT00714623|Sirolimus|sirolimus|mesh-list
14786499|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14786500|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786501|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14786502|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786503|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
14786504|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786505|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
14210129|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210130|NCT04322305|Pregabalin|pregabalin|mesh-list
14210131|NCT04322305|Analgesics|analgesics|mesh-ancestor
14210132|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
14786506|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786507|NCT00714649|Cetuximab|cetuximab|mesh-list
14786508|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14786509|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786510|NCT00714740|Acetazolamide|acetazolamide|mesh-list
14786511|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
14786512|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14786513|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786514|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786515|NCT00714740|Diuretics|diuretics|mesh-ancestor
14786516|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
14786517|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786518|NCT00714779|Fluoxetine|fluoxetine|mesh-list
14786519|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14786520|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14786521|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786522|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786523|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786524|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
14786525|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786526|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14210133|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210134|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210135|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
14210136|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14210137|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14210138|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210139|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14210140|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14210141|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14210142|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210143|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14210144|NCT04314895|Paclitaxel|paclitaxel|mesh-list
14210145|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14210146|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14210147|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786527|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
14786528|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786529|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14947307|NCT01527422|Hormones|hormones|mesh-ancestor
14210148|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
14210149|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
14210150|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
14786530|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14786531|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786532|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
14786533|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14786534|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786535|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786536|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14786537|NCT00714857|Analgesics|analgesics|mesh-ancestor
14786538|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
14786539|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786540|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14947308|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947309|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14210151|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210152|NCT04307511|Aspirin|aspirin|mesh-list
14210153|NCT04307511|Ticagrelor|ticagrelor|mesh-list
14210154|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14210155|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210156|NCT04307511|Analgesics|analgesics|mesh-ancestor
14210157|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
14210158|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210159|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210160|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210161|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210162|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14210163|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14210164|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210165|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14210166|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14210167|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210168|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
14210169|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14786541|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14786542|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14786543|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
14786544|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786545|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786546|NCT00714883|Sirolimus|sirolimus|mesh-list
14786547|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14786548|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786549|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14786550|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786551|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
14786552|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786553|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
14786554|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786555|NCT00714961|Clopidogrel|clopidogrel|mesh-list
14786556|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14786557|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14786558|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14786559|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14786560|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
14786561|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786562|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786563|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786564|NCT00715013|Epothilone B|epothilone b|mesh-list
14786565|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786566|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14786567|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786568|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14786569|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786570|NCT00715039|Lorazepam|lorazepam|mesh-list
14786571|NCT00715039|Paroxetine|paroxetine|mesh-list
14786572|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14786573|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14786574|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786575|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786576|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786577|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
14786578|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947310|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14786579|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14786580|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
14786581|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786582|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14786583|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14786584|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786585|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
14786586|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
14786587|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
14786588|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786589|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786590|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14786591|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786592|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14786593|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14786594|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
14786595|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
14786596|NCT00715091|Diclofenac|diclofenac|mesh-list
14786597|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14786598|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14786599|NCT00715091|Analgesics|analgesics|mesh-ancestor
14786600|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
14786601|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786602|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786603|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786604|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14786605|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14786606|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786607|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786608|NCT00715273|Niacin|niacin|mesh-list
14786609|NCT00715273|Niacinamide|niacinamide|mesh-list
14786610|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
14786611|NCT00715273|Atorvastatin|atorvastatin|mesh-list
14786612|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14786613|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14786614|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14786615|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
14786616|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786617|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14786618|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14786619|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786620|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
14786621|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
14786622|NCT00715273|Vitamins|vitamins|mesh-ancestor
14786623|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
14786624|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947311|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
14947312|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
14947313|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
14947314|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14947315|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
14947316|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14210170|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14210171|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14210172|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
14947317|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14947318|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947319|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947320|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947321|NCT01527474|Citalopram|citalopram|mesh-list
14947322|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14210173|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210174|NCT04307485|Ticagrelor|ticagrelor|mesh-list
14210175|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14210176|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14210177|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14210178|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14210179|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
14210180|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210181|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210182|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210183|NCT04301778|Durvalumab|durvalumab|mesh-list
14786625|NCT00715351|Insulin|insulin|mesh-list
14786626|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14786627|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
14786628|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
14786629|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
14786630|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
14786631|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14786632|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786633|NCT00715377|Benztropine|benztropine|mesh-list
14786634|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14786635|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14786636|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
14786637|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
14786638|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786639|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786640|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14786641|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14786642|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14786643|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786644|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786645|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14786646|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14786647|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786648|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
14786649|NCT00715455|Heparin|heparin|mesh-list
14786650|NCT00715455|Calcium heparin|calcium heparin|mesh-list
14786651|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
14786652|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14786653|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14786654|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786655|NCT00715637|Cytarabine|cytarabine|mesh-list
14786656|NCT00715637|Amonafide|amonafide|mesh-list
14786657|NCT00715637|Daunorubicin|daunorubicin|mesh-list
14786658|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14786659|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
14786660|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786661|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786662|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
14786663|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786664|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786665|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
14786666|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786667|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14786668|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14786669|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14210184|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210185|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210186|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
14210187|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
14210188|NCT04300985|Anesthetics|anesthetics|mesh-list
14210189|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210190|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210191|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14210192|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210193|NCT04300985|Analgesics|analgesics|mesh-ancestor
14210194|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
14210195|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210196|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14210197|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14210198|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14210199|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210200|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210201|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210202|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14210203|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
14210204|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14210205|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14210206|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14210207|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
14210208|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14210209|NCT04296006|Amphetamine|amphetamine|mesh-list
14210210|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
14210211|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14210212|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210213|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
14210214|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
14786670|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786671|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
14210215|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210216|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
14210217|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210218|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210219|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210220|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14210221|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14210222|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14210223|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14210224|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
14210225|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14210226|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210227|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210228|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210229|NCT04289142|Analgesics|analgesics|mesh-ancestor
14210230|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
14786672|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
14786673|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14786674|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14786675|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786676|NCT00715689|Hormones|hormones|mesh-list
14786677|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947323|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14947324|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947325|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947326|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947327|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
14947328|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210231|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210232|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14210233|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14210234|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14210235|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210236|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210237|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210238|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
14210239|NCT04276792|Narcotics|narcotics|mesh-ancestor
14210240|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210241|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210242|NCT04276792|Analgesics|analgesics|mesh-ancestor
14210243|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
14210244|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210245|NCT04275531|Anesthetics|anesthetics|mesh-list
14210246|NCT04275531|Propofol|propofol|mesh-list
14210247|NCT04275531|Sevoflurane|sevoflurane|mesh-list
14210248|NCT04275531|Isoflurane|isoflurane|mesh-list
14210249|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210250|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210251|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14210252|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14210253|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
14210254|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14210255|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14210256|NCT04265950|Vaccines|vaccines|mesh-list
14210257|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
14210258|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210259|NCT04263922|Valsartan|valsartan|mesh-list
14210260|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14210261|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14210262|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14210263|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210264|NCT04263909|Sufentanil|sufentanil|mesh-list
14210265|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14210266|NCT04263909|Narcotics|narcotics|mesh-ancestor
14210267|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506027|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14506028|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14506029|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
14506030|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506031|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506032|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506033|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14786678|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786679|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14786680|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14786681|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786682|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14786683|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14786684|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
14786685|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786686|NCT00715715|Prednisone|prednisone|mesh-list
14786687|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786688|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
14786689|NCT00715715|Hormones|hormones|mesh-ancestor
14786690|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14786691|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786692|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14786693|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947329|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14947330|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
14947331|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947332|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
14947333|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
14947334|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14947335|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947336|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947337|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
14947338|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
14947339|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947340|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947341|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
14947342|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
14947343|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947344|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947345|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14947346|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
14947347|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964834|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964835|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13964836|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13964837|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13964838|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947348|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
14947349|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
14947350|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947351|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947352|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
14947353|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
14947354|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947355|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210268|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210269|NCT04263909|Analgesics|analgesics|mesh-ancestor
14210270|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
14947356|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
14947357|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
14947358|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947359|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947360|NCT01527669|Lovastatin|lovastatin|mesh-list
14947361|NCT01527669|L 647318|l 647318|mesh-list
14947362|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
14210271|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210272|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14210273|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14210274|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
14210275|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
14210276|NCT04263064|Clonidine|clonidine|mesh-list
14210277|NCT04263064|Analgesics|analgesics|mesh-ancestor
14210278|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
14947363|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14947364|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14947365|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
13964839|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964840|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
13964841|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
13964842|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14210279|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786694|NCT00715780|Insulin|insulin|mesh-list
14786695|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14786696|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
14786697|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
14786698|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14947366|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947367|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14947368|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14947369|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947370|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
14947371|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
14947372|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
14947373|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947374|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947375|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
14947376|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947377|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14947378|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947379|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947380|NCT01527747|Saxagliptin|saxagliptin|mesh-list
14947381|NCT01527747|Incretins|incretins|mesh-ancestor
14947382|NCT01527747|Hormones|hormones|mesh-ancestor
14947383|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947384|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947385|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14947386|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
14947387|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947388|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947389|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947390|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14947391|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14947392|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13964843|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
13964844|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
13964845|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14210280|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210281|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14210282|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
14210283|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
14210284|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14210285|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14210286|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14210287|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210288|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947393|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14210289|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210290|NCT04252105|Antioxidants|antioxidants|mesh-list
14210291|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210292|NCT04252105|Protective Agents|protective agents|mesh-ancestor
14210293|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210294|NCT04251585|Insulin|insulin|mesh-list
14210295|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14210296|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210297|NCT04240054|Dexamethasone|dexamethasone|mesh-list
14210298|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
14786699|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
14786700|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
14786701|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
14786702|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
14947394|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947395|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947396|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947397|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
13964846|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
13964847|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964848|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13964849|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13964850|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964851|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13964852|NCT03134573|Interferons|interferons|mesh-list
13964853|NCT03134573|Interferon-beta|interferon-beta|mesh-list
13964854|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
13964855|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786703|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
14786704|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14786705|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786706|NCT00715832|Vaccines|vaccines|mesh-list
14786707|NCT00715832|Immunologic Factors|immunologic factors|mesh-ancestor
14786708|NCT00715832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786709|NCT00715858|Doxycycline|doxycycline|mesh-list
14786710|NCT00715858|Rifampin|rifampin|mesh-list
14786711|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14786712|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786713|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
14786714|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14786715|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14786716|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14786717|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
14786718|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
14786719|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14786720|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786721|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786722|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14210299|NCT04240054|Bortezomib|bortezomib|mesh-list
14210300|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210301|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
14210302|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210303|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210304|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14210305|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
14210306|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210307|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786723|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14786724|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14786725|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14786726|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14786727|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14786728|NCT00715871|Nicotine|nicotine|mesh-list
14786729|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14786730|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
14786731|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786732|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786733|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14786734|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14786735|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
14786736|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786737|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786738|NCT00715975|Clobetasol|clobetasol|mesh-list
14786739|NCT00715975|Halobetasol|halobetasol|mesh-list
14786740|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786741|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
14786742|NCT00715975|Hormones|hormones|mesh-ancestor
14786743|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14786744|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786745|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14786746|NCT00715988|Methadone|methadone|mesh-list
14786747|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14786748|NCT00715988|Narcotics|narcotics|mesh-ancestor
14786749|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786750|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786751|NCT00715988|Analgesics|analgesics|mesh-ancestor
14786752|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
13964856|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
13964857|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786753|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786754|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
14210308|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14210309|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210310|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
14210311|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
14210312|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210313|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13964858|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
13964859|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964860|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13964861|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
13964862|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14786755|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
14786756|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
14786757|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14786758|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
14786759|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786760|NCT00716001|Expectorants|expectorants|mesh-ancestor
14786761|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
14786762|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14786763|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
14786764|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786765|NCT00716001|Protective Agents|protective agents|mesh-ancestor
14786766|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786767|NCT00716001|Antidotes|antidotes|mesh-ancestor
14786768|NCT00716170|Glucagon|glucagon|mesh-list
14210314|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
14786769|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14786770|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14786771|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786772|NCT00716170|Hormones|hormones|mesh-ancestor
14786773|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14786774|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786775|NCT00716170|Incretins|incretins|mesh-ancestor
14786776|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14786777|NCT00716183|Amoxicillin|amoxicillin|mesh-list
14786778|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
14786779|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
14786780|NCT00716183|Lactams|lactams|mesh-list
14786781|NCT00716183|beta-Lactams|beta-lactams|mesh-list
14786782|NCT00716183|Cloxacillin|cloxacillin|mesh-list
14786783|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786784|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786785|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786786|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14786787|NCT00716248|Bucillamine|bucillamine|mesh-list
14786788|NCT00716248|Methotrexate|methotrexate|mesh-list
14786789|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14786790|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
14786791|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14786792|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786793|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14786794|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
14786795|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786796|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786797|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14786798|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786799|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14786800|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786801|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
14786802|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14786803|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14786804|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14786805|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14786806|NCT00716248|Analgesics|analgesics|mesh-ancestor
14786807|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
14786808|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786809|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786810|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
14786811|NCT00716248|Protective Agents|protective agents|mesh-ancestor
14210315|NCT04240054|Hormones|hormones|mesh-ancestor
14210316|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14210317|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14210318|NCT04239716|Anesthetics|anesthetics|mesh-list
14210319|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210320|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210321|NCT04235634|Alprostadil|alprostadil|mesh-list
14210322|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14210323|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
14210324|NCT04235634|Urological Agents|urological agents|mesh-ancestor
14210325|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
14210326|NCT04234906|Amiodarone|amiodarone|mesh-list
14786812|NCT00716391|Cisplatin|cisplatin|mesh-list
14786813|NCT00716391|Cetuximab|cetuximab|mesh-list
14786814|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947398|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14210327|NCT04234906|Procainamide|procainamide|mesh-list
14786815|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14786816|NCT00716469|Talaporfin|talaporfin|mesh-list
14786817|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947399|NCT01527864|Paclitaxel|paclitaxel|mesh-list
14786818|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14786819|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
14786820|NCT00716521|Zolpidem|zolpidem|mesh-list
14786821|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14786822|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14786823|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786824|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786825|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14786826|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
14786827|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
14786828|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786829|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786830|NCT00716547|Celecoxib|celecoxib|mesh-list
14210328|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
14210329|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14210330|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210331|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210332|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210333|NCT04234906|Analgesics|analgesics|mesh-ancestor
14210334|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
14210335|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210336|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14210337|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14210338|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14210339|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210340|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210341|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210342|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
14210343|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14210344|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
14210345|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14210346|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14210347|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14506034|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14506035|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
14506036|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506037|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14506038|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
14506039|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
14506040|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
14506041|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14506042|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506043|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506044|NCT02895035|Analgesics|analgesics|mesh-ancestor
14506045|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
14506046|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506047|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506048|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14506049|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506050|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14506051|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
14506052|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14506053|NCT02895035|Protective Agents|protective agents|mesh-ancestor
14506054|NCT02895945|Factor VIII|factor viii|mesh-list
14506055|NCT02895945|Coagulants|coagulants|mesh-ancestor
14506056|NCT02896296|Buprenorphine|buprenorphine|mesh-list
14506057|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14506058|NCT02896296|Narcotics|narcotics|mesh-ancestor
14506059|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506060|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506061|NCT02896296|Analgesics|analgesics|mesh-ancestor
14506062|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
14506063|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506064|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14506065|NCT02896400|Nicotine|nicotine|mesh-list
14506066|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14506067|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
14786831|NCT00716547|Ketoprofen|ketoprofen|mesh-list
14786832|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14786833|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14786834|NCT00716547|Analgesics|analgesics|mesh-ancestor
14786835|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
14506068|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506069|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506070|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14506071|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14210348|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
14210349|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14210350|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
14210351|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14210352|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14210353|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14210354|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14210355|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210356|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14210357|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14210358|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14210359|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14210360|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14210361|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14210362|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210363|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
14210364|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
14210365|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
14210366|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
14210367|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210368|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210369|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
14210370|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210371|NCT04205409|Nivolumab|nivolumab|mesh-list
14210372|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210373|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210374|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210375|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210376|NCT04199572|Acetaminophen|acetaminophen|mesh-list
14210377|NCT04199572|Diclofenac|diclofenac|mesh-list
14210378|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210379|NCT04199572|Analgesics|analgesics|mesh-ancestor
14210380|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
14210381|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210382|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210383|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
14210384|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14210385|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210386|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210387|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14210388|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210389|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210390|NCT04195958|Omalizumab|omalizumab|mesh-list
14210391|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14210392|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14210393|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
14210394|NCT04188860|Paclitaxel|paclitaxel|mesh-list
14210395|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14210396|NCT04188860|Antibodies|antibodies|mesh-list
14210397|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14210398|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210399|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
14210400|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
14210401|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
14210402|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210403|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
14210404|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210405|NCT04188847|Apatinib|apatinib|mesh-list
14210406|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210407|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14210408|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210409|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210410|NCT04173949|Ramipril|ramipril|mesh-list
14210411|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14210412|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
14210413|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210414|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210415|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14210416|NCT04170556|Nivolumab|nivolumab|mesh-list
14210417|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210418|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210419|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210420|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210421|NCT04166487|Paclitaxel|paclitaxel|mesh-list
14210422|NCT04166487|Carboplatin|carboplatin|mesh-list
14210423|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
14210424|NCT04166487|Pemetrexed|pemetrexed|mesh-list
14210425|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14210426|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210427|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
14210428|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
14210429|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
14210430|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210431|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210432|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210433|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14210434|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14210435|NCT04161066|Psilocybin|psilocybin|mesh-list
14210436|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
14210437|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210438|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14210439|NCT04155411|Dasatinib|dasatinib|mesh-list
14210440|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210441|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14210442|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210443|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210444|NCT04152473|Proglumide|proglumide|mesh-list
14210445|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14210446|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14210447|NCT04143061|Vaccines|vaccines|mesh-list
14210448|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
14210449|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210450|NCT04135989|Everolimus|everolimus|mesh-list
14210451|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210452|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210453|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
14210454|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210455|NCT04130802|Dexamethasone|dexamethasone|mesh-list
14210456|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210457|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
14210458|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
14210459|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210460|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210461|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14210462|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
14210463|NCT04130802|Hormones|hormones|mesh-ancestor
14210464|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14210465|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14210466|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210467|NCT04130659|Omeprazole|omeprazole|mesh-list
14210468|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14210469|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14210470|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14210471|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210472|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210473|NCT04128436|Progesterone|progesterone|mesh-list
14210474|NCT04128436|Progestins|progestins|mesh-ancestor
14210475|NCT04128436|Hormones|hormones|mesh-ancestor
14210476|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14210477|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210478|NCT04121468|Metformin|metformin|mesh-list
14210479|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14210480|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210481|NCT04117932|Ustekinumab|ustekinumab|mesh-list
14506072|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506073|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506074|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506075|NCT02896595|Anesthetics|anesthetics|mesh-list
14506076|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506077|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506078|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
14506079|NCT02896907|Vitamins|vitamins|mesh-list
14506080|NCT02896907|Leucovorin|leucovorin|mesh-list
14506081|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
14506082|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14506083|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
14506084|NCT02896907|Fluorouracil|fluorouracil|mesh-list
14506085|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
14506086|NCT02896907|Irinotecan|irinotecan|mesh-list
14210482|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
14210483|NCT04117087|Nivolumab|nivolumab|mesh-list
14210484|NCT04117087|Ipilimumab|ipilimumab|mesh-list
14210485|NCT04117087|Poly ICLC|poly iclc|mesh-list
14210486|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210487|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210488|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210489|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210490|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
14210491|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
14210492|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210493|NCT04116073|Antibodies|antibodies|mesh-list
14210494|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
14210495|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210496|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
14210497|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
14210498|NCT04108104|Prazosin|prazosin|mesh-list
14210499|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14210500|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14210501|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14210502|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14210503|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210504|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210505|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210506|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210507|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
14210508|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
14210509|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14210510|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14210511|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
14210512|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
14210513|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14210514|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
14210515|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14210516|NCT04098393|Fludarabine|fludarabine|mesh-list
14210517|NCT04098393|Melphalan|melphalan|mesh-list
14210518|NCT04098393|Busulfan|busulfan|mesh-list
14210519|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14210520|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210521|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210522|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210523|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
14210524|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210525|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14210526|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
14210527|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14210528|NCT04098250|Erenumab|erenumab|mesh-list
14210529|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14210530|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210531|NCT04098250|Analgesics|analgesics|mesh-ancestor
14210532|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
14210533|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210534|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210535|NCT04088513|Aspirin|aspirin|mesh-list
14210536|NCT04088513|Clopidogrel|clopidogrel|mesh-list
14210537|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14210538|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210539|NCT04088513|Analgesics|analgesics|mesh-ancestor
14210540|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
14210541|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210542|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210543|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14210544|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210545|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14210546|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14210547|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210548|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14210549|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14210550|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210551|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
14210552|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14210553|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14210554|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14210555|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
14210556|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210557|NCT04080947|Montelukast|montelukast|mesh-list
14210558|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14210559|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
14210560|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14210561|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
14210562|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14210563|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210564|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14210565|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14210566|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210567|NCT04064931|Niacin|niacin|mesh-list
14210568|NCT04064931|Vitamins|vitamins|mesh-ancestor
14210569|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
14210570|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210571|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14210572|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
14210573|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210574|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14210575|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
14210576|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
14210577|NCT04056910|Nivolumab|nivolumab|mesh-list
14210578|NCT04056910|Ivosidenib|ivosidenib|mesh-list
14210579|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210580|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210581|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210582|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210583|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210584|NCT04056624|Carotenoids|carotenoids|mesh-list
14210585|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
14210586|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210587|NCT04056624|Protective Agents|protective agents|mesh-ancestor
14210588|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210589|NCT04053478|Phenylephrine|phenylephrine|mesh-list
14210590|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
14210591|NCT04053478|Norepinephrine|norepinephrine|mesh-list
14210592|NCT04053478|Ephedrine|ephedrine|mesh-list
14210593|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14210594|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
14210595|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
14210596|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210597|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210598|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
14210599|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14210600|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
14210601|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
14210602|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14210603|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14210604|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14210605|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210606|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210607|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210608|NCT04053478|Protective Agents|protective agents|mesh-ancestor
14210609|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14210610|NCT04046549|Abatacept|abatacept|mesh-list
14210611|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210612|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210613|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210614|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210615|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
14210616|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210617|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210618|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
14210619|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210620|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210621|NCT04027309|Midostaurin|midostaurin|mesh-list
14210622|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210623|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14210624|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210625|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210626|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
14210627|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14210628|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14210629|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14210630|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210631|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
14210632|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14210633|NCT04002297|Rituximab|rituximab|mesh-list
14210634|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14210635|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
14210636|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210637|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210638|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
14210639|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210640|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210641|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14210642|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
14210643|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210644|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14210645|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210646|NCT03985540|Methamphetamine|methamphetamine|mesh-list
14210647|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14210648|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210649|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
14210650|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
14210651|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210652|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
14506087|NCT02896907|Camptothecin|camptothecin|mesh-list
14506088|NCT02896907|Calcium|calcium|mesh-list
14506089|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
14506090|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
14506091|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506092|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14506093|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14506094|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
14506095|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506096|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14506097|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506098|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14506099|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
14506100|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14506101|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14506102|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506103|NCT02896907|Antidotes|antidotes|mesh-ancestor
14506104|NCT02896907|Protective Agents|protective agents|mesh-ancestor
14506105|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
14506106|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
14506107|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14506108|NCT02897115|Adalimumab|adalimumab|mesh-list
14506109|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14506110|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14506111|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506112|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506113|NCT02897115|Analgesics|analgesics|mesh-ancestor
14506114|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
14506115|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506116|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506117|NCT02897349|Linagliptin|linagliptin|mesh-list
14506118|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506119|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506120|NCT02897349|Incretins|incretins|mesh-ancestor
14506121|NCT02897349|Hormones|hormones|mesh-ancestor
14506122|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506123|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14506124|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
14506125|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506126|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506127|NCT02898077|Paclitaxel|paclitaxel|mesh-list
14506128|NCT02898077|Ramucirumab|ramucirumab|mesh-list
14506129|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14506130|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506131|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
14506132|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
14506133|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
14506134|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506135|NCT02898116|Durvalumab|durvalumab|mesh-list
14506136|NCT02898116|Ensartinib|ensartinib|mesh-list
14506137|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14506138|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786836|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210653|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210654|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210655|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
14210656|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14210657|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14210658|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14210659|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14210660|NCT03980483|Methotrexate|methotrexate|mesh-list
14210661|NCT03980483|Tofacitinib|tofacitinib|mesh-list
14210662|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14210663|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
14210664|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14210665|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210666|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14210667|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
14210668|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210669|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210670|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
14210671|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210672|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14210673|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210674|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
14210675|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210676|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14210677|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14210678|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
14210679|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14210680|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
14210681|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210682|NCT03976973|Expectorants|expectorants|mesh-ancestor
14210683|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
14210684|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14210685|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
14210686|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210687|NCT03976973|Protective Agents|protective agents|mesh-ancestor
14210688|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210689|NCT03976973|Antidotes|antidotes|mesh-ancestor
14210690|NCT03970837|Tofacitinib|tofacitinib|mesh-list
14210691|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14210692|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210693|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210694|NCT03968406|Talazoparib|talazoparib|mesh-list
14210695|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14210696|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210697|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210698|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210699|NCT03964532|Avelumab|avelumab|mesh-list
14210700|NCT03964532|Talazoparib|talazoparib|mesh-list
14210701|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210702|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210703|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14210704|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210705|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210706|NCT03963895|Thrombin|thrombin|mesh-list
14210707|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
14210708|NCT03963895|Coagulants|coagulants|mesh-ancestor
14241217|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241218|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241219|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14241220|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
14241221|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241222|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
14241223|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
14241224|NCT00176228|Lamotrigine|lamotrigine|mesh-list
14241225|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
14241226|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14241227|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241228|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241229|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14241230|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241231|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14241232|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14241233|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241234|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14210709|NCT03920293|Ravulizumab|ravulizumab|mesh-list
14210710|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14210711|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210712|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
14210713|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210714|NCT03920267|BMS-986165|bms-986165|mesh-list
14210715|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
14210716|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14210717|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210718|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210719|NCT03904199|Insulin|insulin|mesh-list
14210720|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14210721|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14210722|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210723|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
14210724|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14210725|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210726|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14210727|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
14210728|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210729|NCT03873311|Cytarabine|cytarabine|mesh-list
14210730|NCT03873311|Azacitidine|azacitidine|mesh-list
14210731|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14210732|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
14210733|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210734|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210735|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
14210736|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210737|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210738|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
14210739|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210740|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210741|NCT03847428|Bevacizumab|bevacizumab|mesh-list
14210742|NCT03847428|Durvalumab|durvalumab|mesh-list
14210743|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210744|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210745|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14210746|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14210747|NCT03847428|Growth Substances|growth substances|mesh-ancestor
14210748|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210749|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
14210750|NCT03841292|Varenicline|varenicline|mesh-list
14210751|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14210752|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14210753|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506139|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14506140|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506141|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506142|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
14506143|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506144|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
14506145|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14506146|NCT02899156|Flumazenil|flumazenil|mesh-list
14506147|NCT02899156|Antidotes|antidotes|mesh-ancestor
14506148|NCT02899156|Protective Agents|protective agents|mesh-ancestor
14506149|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506150|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
14506151|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
14506152|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506153|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506154|NCT02899195|Durvalumab|durvalumab|mesh-list
14506155|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14786837|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786838|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786839|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210754|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506156|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528634|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964863|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947400|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14947401|NCT01527864|Carboplatin|carboplatin|mesh-list
14947402|NCT01527864|Endostatins|endostatins|mesh-list
14947403|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14210755|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210756|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210757|NCT03840291|Edoxaban|edoxaban|mesh-list
14210758|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14210759|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
14210760|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14210761|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
14210762|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210763|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210764|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
14210765|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14210766|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14210767|NCT03824106|Vitamin D|vitamin d|mesh-list
14210768|NCT03824106|Vitamins|vitamins|mesh-ancestor
14210769|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
14210770|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210771|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14210772|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
14210773|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
14210774|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14210775|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14210776|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210777|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210778|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947404|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947405|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
14947406|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
14947407|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
14947408|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947409|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14947410|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947411|NCT01527864|Growth Substances|growth substances|mesh-ancestor
14210779|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210780|NCT03818776|Durvalumab|durvalumab|mesh-list
14210781|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210782|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210783|NCT03817515|Sirolimus|sirolimus|mesh-list
14210784|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14210785|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210786|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14210787|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210788|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
14210789|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210790|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
14210791|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210792|NCT03786796|Olaparib|olaparib|mesh-list
14210793|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14210794|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210795|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210796|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210797|NCT03779074|Amoxicillin|amoxicillin|mesh-list
14210798|NCT03779074|Metronidazole|metronidazole|mesh-list
14210799|NCT03779074|Clarithromycin|clarithromycin|mesh-list
14210800|NCT03779074|Tetracycline|tetracycline|mesh-list
14210801|NCT03779074|Rabeprazole|rabeprazole|mesh-list
14210802|NCT03779074|Bismuth|bismuth|mesh-list
14210803|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14210804|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210805|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14210806|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14947412|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964864|NCT03134417|Vitamin D|vitamin d|mesh-list
13964865|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
13964866|NCT03134417|Vitamins|vitamins|mesh-list
13964867|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
13964868|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964869|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13964870|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14210807|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14210808|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528635|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
14210809|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210810|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14210811|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14210812|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14210813|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14210814|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14210815|NCT03779074|Antacids|antacids|mesh-ancestor
14210816|NCT03773666|Durvalumab|durvalumab|mesh-list
14210817|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210818|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210819|NCT03768570|Durvalumab|durvalumab|mesh-list
14210820|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210821|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210822|NCT03761095|Dacarbazine|dacarbazine|mesh-list
14210823|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14210824|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
14210825|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210826|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210827|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
14210828|NCT03760575|Pemetrexed|pemetrexed|mesh-list
14210829|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210830|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210831|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210832|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210833|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14210834|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14210835|NCT03756961|Lidocaine|lidocaine|mesh-list
14210836|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
14210837|NCT03756961|Remifentanil|remifentanil|mesh-list
14210838|NCT03756961|Oxycodone|oxycodone|mesh-list
14210839|NCT03756961|Propofol|propofol|mesh-list
14210840|NCT03756961|Desflurane|desflurane|mesh-list
14210841|NCT03756961|Esketamine|esketamine|mesh-list
14210842|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
14210843|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
14210844|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14210845|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210846|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
14210847|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14210848|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14210849|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14210850|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14210851|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14210852|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210853|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14210854|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14210855|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
14210856|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14210857|NCT03756961|Analgesics|analgesics|mesh-ancestor
14210858|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14210859|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14210860|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14210861|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14528636|NCT03806556|Coagulants|coagulants|mesh-ancestor
14210862|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14210863|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14210864|NCT03756961|Narcotics|narcotics|mesh-ancestor
14210865|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14210866|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
14210867|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14210868|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
14210869|NCT03735537|Teriparatide|teriparatide|mesh-list
14210870|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14210871|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14210872|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210873|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14210874|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
14210875|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210876|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210877|NCT03723967|Paclitaxel|paclitaxel|mesh-list
14210878|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14210879|NCT03723967|Carboplatin|carboplatin|mesh-list
14210880|NCT03723967|Durvalumab|durvalumab|mesh-list
14210881|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14210882|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14210883|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210884|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
14210885|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
14210886|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
14210887|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210888|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210889|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
14210890|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210891|NCT03711058|Nivolumab|nivolumab|mesh-list
14210892|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210893|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210894|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210895|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210896|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
14210897|NCT03704298|Fludarabine|fludarabine|mesh-list
14210898|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210899|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
14210900|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210901|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14210902|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14210903|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
14210904|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210905|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210906|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14210907|NCT03692325|Nivolumab|nivolumab|mesh-list
14210908|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210909|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210910|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210911|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210912|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
14210913|NCT03682536|Luspatercept|luspatercept|mesh-list
14210914|NCT03682536|Hematinics|hematinics|mesh-ancestor
14241235|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14241236|NCT00176254|Paclitaxel|paclitaxel|mesh-list
14241237|NCT00176254|Carboplatin|carboplatin|mesh-list
14241238|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14241239|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241240|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241241|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241242|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241243|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241244|NCT00176306|Levofloxacin|levofloxacin|mesh-list
14241245|NCT00176306|Ofloxacin|ofloxacin|mesh-list
14241246|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14241247|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241248|NCT00176306|Renal Agents|renal agents|mesh-ancestor
14241249|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14241250|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14241251|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14241252|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241253|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241254|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241255|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14528637|NCT03836664|Timolol|timolol|mesh-list
14210915|NCT03668392|Asparaginase|asparaginase|mesh-list
14210916|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210917|NCT03668119|Nivolumab|nivolumab|mesh-list
14210918|NCT03668119|Ipilimumab|ipilimumab|mesh-list
14210919|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210920|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210921|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210922|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210923|NCT03661723|Bevacizumab|bevacizumab|mesh-list
14210924|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
14210925|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210926|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210927|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14210928|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14210929|NCT03661723|Growth Substances|growth substances|mesh-ancestor
14210930|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210931|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14210932|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14210933|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14210934|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210935|NCT03659461|Incretins|incretins|mesh-ancestor
14210936|NCT03659461|Hormones|hormones|mesh-ancestor
14210937|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14210938|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14210939|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
14210940|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210941|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210942|NCT03643133|Mifamurtide|mifamurtide|mesh-list
14210943|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14210944|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
14210945|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210946|NCT03642067|Nivolumab|nivolumab|mesh-list
14210947|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210948|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210949|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210950|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210951|NCT03632720|Vaccines|vaccines|mesh-list
14210952|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
14210953|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210954|NCT03607890|Nivolumab|nivolumab|mesh-list
14210955|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14210956|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210957|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14210958|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210959|NCT03605927|Sirolimus|sirolimus|mesh-list
14210960|NCT03605927|Tacrolimus|tacrolimus|mesh-list
14210961|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14210962|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
14210963|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14210964|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14210965|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14210966|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14210967|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14210968|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14210969|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14210970|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14210971|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
14528638|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14210997|NCT03583307|Sirolimus|sirolimus|mesh-list
14210998|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14210999|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211000|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14211001|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211002|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
14211003|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211004|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
14211005|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786840|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14786841|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14786842|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786843|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786844|NCT00716573|Everolimus|everolimus|mesh-list
14786845|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786846|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786847|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
14786848|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786849|NCT00716612|Ubiquinone|ubiquinone|mesh-list
14786850|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
14786851|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
14786852|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786853|NCT00716612|Vitamins|vitamins|mesh-ancestor
14786854|NCT00716755|Olanzapine|olanzapine|mesh-list
14506157|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14506158|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506159|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
14506160|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
14506161|NCT02899988|Mirikizumab|mirikizumab|mesh-list
14506162|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506163|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506164|NCT02899988|Analgesics|analgesics|mesh-ancestor
14506165|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
14506166|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506167|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506168|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506169|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506170|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14506171|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506172|NCT02900092|Ganaxolone|ganaxolone|mesh-list
14506173|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
14506174|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506175|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506176|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506177|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
14506178|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
14506179|NCT02900378|Valsartan|valsartan|mesh-list
14506180|NCT02900378|Enalapril|enalapril|mesh-list
14506181|NCT02900378|Enalaprilat|enalaprilat|mesh-list
14506182|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14506183|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14506184|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14506185|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14506186|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506187|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14506188|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
14506189|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506190|NCT02901054|Ondansetron|ondansetron|mesh-list
14506191|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
14506192|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
14506193|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506194|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506195|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506196|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
14786855|NCT00716755|Risperidone|risperidone|mesh-list
14786856|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14786857|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
14947413|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
14211024|NCT03546894|Ceritinib|ceritinib|mesh-list
14211025|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211026|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211027|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211028|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211029|NCT03535727|Gemcitabine|gemcitabine|mesh-list
14211030|NCT03535727|Paclitaxel|paclitaxel|mesh-list
14211031|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14211032|NCT03535727|Cisplatin|cisplatin|mesh-list
14211033|NCT03535727|Capecitabine|capecitabine|mesh-list
14211034|NCT03535727|Irinotecan|irinotecan|mesh-list
14211035|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211036|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211037|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211038|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211039|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211040|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211041|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211042|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
14211043|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
14211044|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211045|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211046|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211047|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
14211048|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211049|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14211050|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14211051|NCT03526874|Lidocaine|lidocaine|mesh-list
14211052|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
14211053|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
14211054|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211055|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211056|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
14211057|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211058|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14211059|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14211060|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14211061|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14211062|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211063|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
14211064|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211065|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211066|NCT03487666|Capecitabine|capecitabine|mesh-list
14211067|NCT03487666|Nivolumab|nivolumab|mesh-list
14211068|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211069|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
14211070|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211071|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211072|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211073|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14211074|NCT03485950|Meropenem|meropenem|mesh-list
14211075|NCT03485950|Tazobactam|tazobactam|mesh-list
14211076|NCT03485950|Piperacillin|piperacillin|mesh-list
14211077|NCT03485950|Cefepime|cefepime|mesh-list
14211078|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14211079|NCT03485950|Ceftolozane|ceftolozane|mesh-list
14211080|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14211081|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211082|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14211083|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211084|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211085|NCT03467958|Ozanimod|ozanimod|mesh-list
14211086|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14211087|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211088|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13964871|NCT03134378|Amoxicillin|amoxicillin|mesh-list
13964872|NCT03134378|Clarithromycin|clarithromycin|mesh-list
13964873|NCT03134378|Rabeprazole|rabeprazole|mesh-list
13964874|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13964875|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964876|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13964877|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964878|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964879|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14211089|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
14211090|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211091|NCT03467867|Rituximab|rituximab|mesh-list
14506197|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
14506198|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14506199|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
14506200|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506201|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506202|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14506203|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506204|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506205|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506206|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14506207|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
14506208|NCT02901249|Sertraline|sertraline|mesh-list
14506209|NCT02901249|Nortriptyline|nortriptyline|mesh-list
14506210|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
14506211|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506212|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14506213|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14506214|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506215|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506216|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506217|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
14506218|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506219|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506220|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
14506221|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506222|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506223|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14506224|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14506225|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
14506226|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
14506227|NCT02901899|Guadecitabine|guadecitabine|mesh-list
14506228|NCT02901899|Azacitidine|azacitidine|mesh-list
14506229|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14506230|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506231|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14506232|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
14506233|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506234|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506235|NCT02902081|Cannabidiol|cannabidiol|mesh-list
14506236|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
14506237|NCT02902172|Acetaminophen|acetaminophen|mesh-list
14506238|NCT02902172|Ibuprofen|ibuprofen|mesh-list
14506239|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506240|NCT02902172|Analgesics|analgesics|mesh-ancestor
14506241|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
14506242|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506243|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506244|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
14506245|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506246|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506247|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506248|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14506249|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506250|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506251|NCT02902237|Thromboplastin|thromboplastin|mesh-list
14506252|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
14506253|NCT02902237|Coagulants|coagulants|mesh-ancestor
14506254|NCT02902770|Ketorolac|ketorolac|mesh-list
14506255|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14506256|NCT02902770|Lidocaine|lidocaine|mesh-list
14506257|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
14506258|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
14506259|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506260|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211092|NCT03467867|Venetoclax|venetoclax|mesh-list
14211093|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211094|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211095|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
14211096|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211097|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211098|NCT03457701|Iron|iron|mesh-list
14211099|NCT03457701|Trace Elements|trace elements|mesh-ancestor
14211100|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
14506261|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
14211101|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211102|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
14211103|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14211104|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14211105|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211106|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211107|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14211108|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14211109|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
14211110|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211111|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211112|NCT03448783|Apixaban|apixaban|mesh-list
14211113|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14211114|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
14211115|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14211116|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14211117|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211118|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211119|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
14211120|NCT03435458|Misoprostol|misoprostol|mesh-list
14211121|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14211122|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
14211123|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14211124|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211125|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14211126|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211127|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
14211128|NCT03434444|Propranolol|propranolol|mesh-list
14211129|NCT03434444|Oxytocin|oxytocin|mesh-list
14211130|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
14211131|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14211132|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211133|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14211134|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14211135|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14211136|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211137|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211138|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14211139|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14211140|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
14211141|NCT03431948|Nivolumab|nivolumab|mesh-list
14211142|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211143|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211144|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14211145|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211146|NCT03427463|Morphine|morphine|mesh-list
14211147|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14211148|NCT03427463|Narcotics|narcotics|mesh-ancestor
13964880|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13964881|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13964882|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13964883|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13964884|NCT03134846|Cetuximab|cetuximab|mesh-list
13964885|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964886|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968059|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968060|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13968061|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13968062|NCT03113084|Heparin|heparin|mesh-list
13968063|NCT03113084|Calcium heparin|calcium heparin|mesh-list
13968064|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
13968065|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13968066|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13968067|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968068|NCT03113266|Antibodies|antibodies|mesh-list
13968069|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14211149|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211150|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211151|NCT03427463|Analgesics|analgesics|mesh-ancestor
14211152|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
14211153|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211154|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
14211155|NCT03426891|Temozolomide|temozolomide|mesh-list
14211156|NCT03426891|Vorinostat|vorinostat|mesh-list
14211157|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14211158|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211159|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211160|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14211161|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
14211162|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211163|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211164|NCT03417544|Trastuzumab|trastuzumab|mesh-list
14211165|NCT03417544|Pertuzumab|pertuzumab|mesh-list
14211166|NCT03417544|Atezolizumab|atezolizumab|mesh-list
14211167|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211168|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211169|NCT03410615|Durvalumab|durvalumab|mesh-list
14211170|NCT03410615|Tremelimumab|tremelimumab|mesh-list
14211171|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211172|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14241256|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14241257|NCT00176423|Galantamine|galantamine|mesh-list
14241258|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14241259|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241260|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241261|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
14241262|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241263|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241264|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14241265|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
14241266|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241267|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
14241268|NCT00176462|Leucovorin|leucovorin|mesh-list
14241269|NCT00176462|Cytarabine|cytarabine|mesh-list
14241270|NCT00176462|Dexamethasone|dexamethasone|mesh-list
14241271|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
14241272|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
14241273|NCT00176462|Methotrexate|methotrexate|mesh-list
14241274|NCT00176462|Vincristine|vincristine|mesh-list
14241275|NCT00176462|Asparaginase|asparaginase|mesh-list
14241276|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
14241277|NCT00176462|Thioguanine|thioguanine|mesh-list
14241278|NCT00176462|Daunorubicin|daunorubicin|mesh-list
14241279|NCT00176462|Aminopterin|aminopterin|mesh-list
14241280|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241281|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
14241282|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241283|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241284|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241285|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
14241286|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241287|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241288|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241289|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14241290|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
14241291|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
14241292|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241293|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14241294|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
14241295|NCT00176462|Hormones|hormones|mesh-ancestor
14241296|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241297|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14241298|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14241299|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
14241300|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14241301|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14241302|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
14241303|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
14241304|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241305|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14241306|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14241307|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
14211173|NCT03404518|Acetaminophen|acetaminophen|mesh-list
14211174|NCT03404518|Ibuprofen|ibuprofen|mesh-list
14211175|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14211176|NCT03404518|Hydrocodone|hydrocodone|mesh-list
14211177|NCT03404518|Narcotics|narcotics|mesh-list
14211178|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14211179|NCT03404518|Analgesics|analgesics|mesh-ancestor
14211180|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
14211181|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211182|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211183|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
14211184|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14211185|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211186|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211187|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14211188|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211189|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211190|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14211191|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211192|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
14211193|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
14211194|NCT03402841|Olaparib|olaparib|mesh-list
14211195|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14211196|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211197|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211198|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211199|NCT03376672|Dexamethasone|dexamethasone|mesh-list
14211200|NCT03376672|Lenalidomide|lenalidomide|mesh-list
14211201|NCT03376672|Ixazomib|ixazomib|mesh-list
14211202|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211203|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
14211204|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
14211205|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211206|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211207|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211208|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
14211209|NCT03376672|Hormones|hormones|mesh-ancestor
14211210|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211211|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211212|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211213|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
14211214|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14211215|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14211216|NCT03376672|Growth Substances|growth substances|mesh-ancestor
14211217|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14211218|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
14211219|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211220|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211221|NCT03374800|Pantoprazole|pantoprazole|mesh-list
14211222|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14211223|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211224|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14211225|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211226|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211227|NCT03367312|Xenon|xenon|mesh-list
14211228|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14211229|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
14211230|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
14211231|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211232|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211233|NCT03361852|Rituximab|rituximab|mesh-list
14211234|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
14211235|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211236|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211237|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
14211238|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211239|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211240|NCT03358706|Vitamin K|vitamin k|mesh-list
14211241|NCT03358706|Midazolam|midazolam|mesh-list
14211242|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
14211243|NCT03358706|Caffeine|caffeine|mesh-list
14211244|NCT03358706|Ustekinumab|ustekinumab|mesh-list
14211245|NCT03358706|Omeprazole|omeprazole|mesh-list
14211246|NCT03358706|Warfarin|warfarin|mesh-list
14506262|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506263|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14506264|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14506265|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14506266|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506267|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506268|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506269|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506270|NCT02902770|Analgesics|analgesics|mesh-ancestor
14506271|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506272|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506273|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14506274|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528639|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14528640|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14528641|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14528642|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
14528643|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528644|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528645|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528646|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14528647|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14528648|NCT03823391|Adalimumab|adalimumab|mesh-list
14528649|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528650|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528651|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
14528652|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14528653|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14528654|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528655|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14786858|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786859|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528656|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14528657|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528658|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528659|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528660|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14528661|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
14528662|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14528663|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528664|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14528665|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14528666|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14528667|NCT03836729|Tenofovir|tenofovir|mesh-list
14528668|NCT03836729|Emtricitabine|emtricitabine|mesh-list
14528669|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
14528670|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528671|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14528672|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14528673|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528674|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528675|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14528676|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14528677|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14528678|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
14528679|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528680|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
14528681|NCT03801148|Lansoprazole|lansoprazole|mesh-list
14528682|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14528683|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528684|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14528685|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786860|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786861|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14211247|NCT03358706|Vitamins|vitamins|mesh-ancestor
14211248|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
14211249|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211250|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14211251|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14211252|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211253|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14211254|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14211255|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14211256|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14211257|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
14211258|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
14211259|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
14211260|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
14211261|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211262|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211263|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
14211264|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14211265|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211266|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14211267|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211268|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14211269|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14211270|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14211271|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14211272|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
14211273|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
14211274|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14211275|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14211276|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
14211277|NCT03358706|Coagulants|coagulants|mesh-ancestor
14211278|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
14211279|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
14211280|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14211281|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14211282|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
14211283|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
14211284|NCT03350516|Calcium|calcium|mesh-list
14211285|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14211286|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211287|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14211288|NCT03350516|Antacids|antacids|mesh-ancestor
14211289|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211290|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211291|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
14211292|NCT03323476|Prednisone|prednisone|mesh-list
14211293|NCT03323476|Rituximab|rituximab|mesh-list
14211294|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14211295|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211296|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211297|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
14211298|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211299|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211300|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14211301|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14211302|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
14211303|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14211304|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211305|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211306|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211307|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211308|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
14211309|NCT03323476|Hormones|hormones|mesh-ancestor
14211310|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211311|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211312|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
14211313|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211314|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211315|NCT03318094|Nitroprusside|nitroprusside|mesh-list
14211316|NCT03318094|Phentolamine|phentolamine|mesh-list
14211317|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14211318|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14211319|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14211320|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
14211321|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14211322|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211323|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
14211324|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211325|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211326|NCT03314181|Dexamethasone|dexamethasone|mesh-list
14211327|NCT03314181|Bortezomib|bortezomib|mesh-list
14211328|NCT03314181|Venetoclax|venetoclax|mesh-list
14211329|NCT03314181|Daratumumab|daratumumab|mesh-list
14211330|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211331|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
14211332|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
14211333|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211334|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211335|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211336|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
14211337|NCT03314181|Hormones|hormones|mesh-ancestor
14211338|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211339|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211340|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211341|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
14211342|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14211343|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211344|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14211345|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
14211346|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14211347|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211348|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211349|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211350|NCT03301038|Rifampin|rifampin|mesh-list
14211351|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14506275|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14506276|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
14506277|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506278|NCT02902913|Ibuprofen|ibuprofen|mesh-list
14506279|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506280|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506281|NCT02902913|Analgesics|analgesics|mesh-ancestor
14506282|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
14506283|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506284|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506285|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506286|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506287|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14506288|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506289|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506290|NCT02902965|Dexamethasone|dexamethasone|mesh-list
14506291|NCT02902965|Bortezomib|bortezomib|mesh-list
14506292|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506293|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
14506294|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
14506295|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506296|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506297|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506298|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
14506299|NCT02902965|Hormones|hormones|mesh-ancestor
14506300|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506301|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14506302|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506303|NCT02903030|Silicon|silicon|mesh-list
14506304|NCT02903030|Trace Elements|trace elements|mesh-ancestor
14506305|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
14506306|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506307|NCT02903121|Tamoxifen|tamoxifen|mesh-list
14506308|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14506309|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
14506310|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506311|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506312|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14506313|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506314|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14506315|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14506316|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14506317|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14506318|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14211352|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
14211353|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14506319|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14211354|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211355|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
14211356|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14211357|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211358|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211359|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14211360|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14211361|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14211362|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14211363|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14211364|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14211365|NCT03297606|Nivolumab|nivolumab|mesh-list
14211366|NCT03297606|Trastuzumab|trastuzumab|mesh-list
14211367|NCT03297606|Ipilimumab|ipilimumab|mesh-list
14211368|NCT03297606|Pertuzumab|pertuzumab|mesh-list
14211369|NCT03297606|Sunitinib|sunitinib|mesh-list
14211370|NCT03297606|Dasatinib|dasatinib|mesh-list
14211371|NCT03297606|Olaparib|olaparib|mesh-list
14211372|NCT03297606|Palbociclib|palbociclib|mesh-list
14211373|NCT03297606|Axitinib|axitinib|mesh-list
14211374|NCT03297606|Vemurafenib|vemurafenib|mesh-list
14211375|NCT03297606|Crizotinib|crizotinib|mesh-list
14211376|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211377|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211378|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14211379|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211380|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211381|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211382|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14211383|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14211384|NCT03297606|Growth Substances|growth substances|mesh-ancestor
14211385|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211386|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
14211387|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14211388|NCT03283605|Durvalumab|durvalumab|mesh-list
14211389|NCT03283605|Tremelimumab|tremelimumab|mesh-list
14211390|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211391|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211392|NCT03270020|Denosumab|denosumab|mesh-list
14211393|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14211394|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211395|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
14211396|NCT03266783|Apixaban|apixaban|mesh-list
14211397|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14211398|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
14211399|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14211400|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14211401|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211402|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211403|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
14211404|NCT03253679|Adavosertib|adavosertib|mesh-list
14211405|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211406|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211407|NCT03233633|Cannabidiol|cannabidiol|mesh-list
14211408|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
14211409|NCT03218683|Venetoclax|venetoclax|mesh-list
14211410|NCT03218683|AZD5991|azd5991|mesh-list
14211411|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211412|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
14211413|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211414|NCT03199040|Durvalumab|durvalumab|mesh-list
14211415|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211416|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211417|NCT03187509|Torsemide|torsemide|mesh-list
14211418|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14211419|NCT03187509|Diuretics|diuretics|mesh-ancestor
14211420|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
14211421|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211422|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14211423|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14211424|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211425|NCT03158090|Lanreotide|lanreotide|mesh-list
14211426|NCT03158090|Octreotide|octreotide|mesh-list
14211427|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211428|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211429|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211430|NCT03156504|Ketamine|ketamine|mesh-list
14211431|NCT03156504|Analgesics|analgesics|mesh-ancestor
14211432|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
14211433|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211434|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211435|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14211436|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14211437|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
14211438|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
14211439|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211440|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14211441|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14211442|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211443|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211444|NCT03155100|Dexamethasone|dexamethasone|mesh-list
14211445|NCT03155100|Elotuzumab|elotuzumab|mesh-list
14211446|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14211447|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211448|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
14211449|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
14211450|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211451|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211452|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211453|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
14211454|NCT03155100|Hormones|hormones|mesh-ancestor
14211455|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211456|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211457|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211458|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
14211459|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211460|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211461|NCT03142893|Ketoconazole|ketoconazole|mesh-list
14211462|NCT03142893|Dexamethasone|dexamethasone|mesh-list
14211463|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
14211464|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
14211465|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14211466|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14211467|NCT03142893|Hormones|hormones|mesh-list
14211468|NCT03142893|Cosyntropin|cosyntropin|mesh-list
14211469|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14211470|NCT03142893|BB 1101|bb 1101|mesh-list
14211471|NCT03142893|Ganirelix|ganirelix|mesh-list
14211472|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211473|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
14211474|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
14211475|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211476|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211477|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211478|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
14211479|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211480|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211481|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211482|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
14211483|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211484|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211485|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
14211486|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211487|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14211488|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14211489|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14211490|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
14211491|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14211492|NCT03104283|Apatinib|apatinib|mesh-list
14211493|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211494|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211495|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211496|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211497|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
14211498|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14211499|NCT03086044|Velpatasvir|velpatasvir|mesh-list
14211500|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
14211501|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211502|NCT03084939|Capecitabine|capecitabine|mesh-list
14211503|NCT03084939|Trastuzumab|trastuzumab|mesh-list
14211504|NCT03084939|Lapatinib|lapatinib|mesh-list
14211505|NCT03084939|Maytansine|maytansine|mesh-list
14211506|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14786862|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14211507|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211508|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
14211509|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211510|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211511|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211512|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211513|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211514|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211515|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211516|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211517|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211518|NCT03067571|Daratumumab|daratumumab|mesh-list
14211519|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211520|NCT03049306|Propranolol|propranolol|mesh-list
14211521|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14211522|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14211523|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14211524|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211525|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211526|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211527|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14211528|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14211529|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
14211530|NCT03047928|Nivolumab|nivolumab|mesh-list
14211531|NCT03047928|Vaccines|vaccines|mesh-list
14211532|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
14211533|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211534|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211535|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211536|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14211537|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211538|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
14211539|NCT03006926|Lenvatinib|lenvatinib|mesh-list
14211540|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211541|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211542|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211543|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211544|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211545|NCT02998528|Gemcitabine|gemcitabine|mesh-list
14211546|NCT02998528|Paclitaxel|paclitaxel|mesh-list
14211547|NCT02998528|Vinorelbine|vinorelbine|mesh-list
14211548|NCT02998528|Docetaxel|docetaxel|mesh-list
14211549|NCT02998528|Carboplatin|carboplatin|mesh-list
14211550|NCT02998528|Nivolumab|nivolumab|mesh-list
14211551|NCT02998528|Pemetrexed|pemetrexed|mesh-list
14211552|NCT02998528|Ipilimumab|ipilimumab|mesh-list
14211553|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211554|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211555|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211556|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211557|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211558|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211559|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211560|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
14211561|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
14211562|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211563|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211564|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211565|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
14211566|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211567|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14786863|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14786864|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786865|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14786866|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
14786867|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
14786868|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
14786869|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786870|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786871|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14786872|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14786873|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786874|NCT00716846|Atorvastatin|atorvastatin|mesh-list
14211568|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14211569|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14211570|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14211571|NCT02993926|Leuprolide|leuprolide|mesh-list
14211572|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14211573|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
14211574|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14211575|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211576|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211577|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211578|NCT02967640|Ketamine|ketamine|mesh-list
14211579|NCT02967640|Analgesics|analgesics|mesh-ancestor
14211580|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
14211581|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211582|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211583|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14211584|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14211585|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
14211586|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
14211587|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211588|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14211589|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14211590|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211591|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211592|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
14211593|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211594|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14211595|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14211596|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
14211597|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211598|NCT02941783|Factor VIII|factor viii|mesh-list
14211599|NCT02941783|Coagulants|coagulants|mesh-ancestor
14211600|NCT02938442|Paclitaxel|paclitaxel|mesh-list
14211601|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14211602|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
14211603|NCT02938442|Doxorubicin|doxorubicin|mesh-list
14211604|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14211605|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
14211606|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211607|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211608|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211609|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211610|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211611|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211612|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211613|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
14211614|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211615|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211616|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14211617|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
14211618|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14211619|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14211620|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14211621|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14211622|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211623|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14211624|NCT02932579|Acetaminophen|acetaminophen|mesh-list
14211625|NCT02932579|Ibuprofen|ibuprofen|mesh-list
14211626|NCT02932579|Oxycodone|oxycodone|mesh-list
14211627|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506320|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506321|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506322|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506323|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506324|NCT02903238|Analgesics|analgesics|mesh-ancestor
14506325|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
14506326|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506327|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
14506328|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506329|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
14506330|NCT02903368|Prednisone|prednisone|mesh-list
14506331|NCT02903368|Leuprolide|leuprolide|mesh-list
14506332|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
14506333|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506334|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
14506335|NCT02903368|Hormones|hormones|mesh-ancestor
14506336|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506337|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211628|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14211629|NCT02932579|Analgesics|analgesics|mesh-ancestor
14211630|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
14211631|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211632|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211633|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211634|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211635|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14211636|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211637|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211638|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14211639|NCT02932579|Narcotics|narcotics|mesh-ancestor
14211640|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14211641|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
14211642|NCT02928224|Leucovorin|leucovorin|mesh-list
14211643|NCT02928224|Folic Acid|folic acid|mesh-list
14211644|NCT02928224|Fluorouracil|fluorouracil|mesh-list
14211645|NCT02928224|Irinotecan|irinotecan|mesh-list
14211646|NCT02928224|Cetuximab|cetuximab|mesh-list
14211647|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
14211648|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
14211649|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211650|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211651|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211652|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211653|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
14211654|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211655|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14211656|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14211657|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211658|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211659|NCT02928224|Antidotes|antidotes|mesh-ancestor
14211660|NCT02928224|Protective Agents|protective agents|mesh-ancestor
14211661|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
14211662|NCT02928224|Vitamins|vitamins|mesh-ancestor
14211663|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
14211664|NCT02928224|Hematinics|hematinics|mesh-ancestor
14211665|NCT02927067|Valganciclovir|valganciclovir|mesh-list
14211666|NCT02927067|Maribavir|maribavir|mesh-list
14211667|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
14211668|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211669|NCT02905799|Resveratrol|resveratrol|mesh-list
14211670|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
14211671|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211672|NCT02905799|Protective Agents|protective agents|mesh-ancestor
14211673|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211674|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506338|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14506339|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506340|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14506341|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
14506342|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14506343|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14506344|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506345|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506346|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
14506347|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14506348|NCT02903407|Midazolam|midazolam|mesh-list
14506349|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
14506350|NCT02903407|Propofol|propofol|mesh-list
14506351|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14506352|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506353|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506354|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14506355|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
14506356|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
14506357|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506358|NCT02903407|Analgesics|analgesics|mesh-ancestor
14506359|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
14506360|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506361|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14506362|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14211675|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14211676|NCT02897375|Carboplatin|carboplatin|mesh-list
14211677|NCT02897375|Palbociclib|palbociclib|mesh-list
14211678|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211679|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14506363|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14211680|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211681|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241308|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241309|NCT00176462|Antidotes|antidotes|mesh-ancestor
14241310|NCT00176462|Protective Agents|protective agents|mesh-ancestor
14241311|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
14241312|NCT00176462|Vitamins|vitamins|mesh-ancestor
14241313|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
14241314|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14241315|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241316|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241317|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241318|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14241319|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14241320|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14241321|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
14241322|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
14241323|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
14241324|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14241325|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
14241326|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241327|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241328|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241329|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
14241330|NCT00176605|Etoposide|etoposide|mesh-list
14241331|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241332|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
14241333|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241334|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241335|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241336|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
14241337|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241338|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241339|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241340|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14241341|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14241342|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14241343|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241344|NCT00176644|Estradiol|estradiol|mesh-list
14241345|NCT00176644|Estrogens|estrogens|mesh-ancestor
14241346|NCT00176644|Hormones|hormones|mesh-ancestor
14241347|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241348|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241349|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
14241350|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
14241351|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
14241352|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241353|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241354|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14241355|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14241356|NCT00176800|Growth Substances|growth substances|mesh-ancestor
14241357|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241358|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
14241359|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241360|NCT00176826|Busulfan|busulfan|mesh-list
14241361|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
14241362|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241363|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241364|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
14241365|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241366|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241367|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241368|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241369|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
14241370|NCT00176839|Melphalan|melphalan|mesh-list
14241371|NCT00176839|Busulfan|busulfan|mesh-list
14241372|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14241373|NCT00176839|Sargramostim|sargramostim|mesh-list
14241374|NCT00176839|Lenograstim|lenograstim|mesh-list
14241375|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241376|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
14241377|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241378|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241379|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241380|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
14506364|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
14786875|NCT00716846|Simvastatin|simvastatin|mesh-list
14786876|NCT00716846|Pitavastatin|pitavastatin|mesh-list
14786877|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14786878|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14786879|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
14947414|NCT01527890|Fentanyl|fentanyl|mesh-list
14211682|NCT02856113|Alogliptin|alogliptin|mesh-list
14211683|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14211684|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211685|NCT02856113|Incretins|incretins|mesh-ancestor
14211686|NCT02856113|Hormones|hormones|mesh-ancestor
14211687|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211688|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14211689|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
14211690|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211691|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211692|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
14211693|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14211694|NCT02810418|Paclitaxel|paclitaxel|mesh-list
14211695|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211696|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211697|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211698|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211699|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211700|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211701|NCT02788981|Paclitaxel|paclitaxel|mesh-list
14211702|NCT02788981|Mifepristone|mifepristone|mesh-list
14211703|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211704|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211705|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211706|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211707|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211708|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211709|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14211710|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
14211711|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14211712|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211713|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14211714|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14211715|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14211716|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
14211717|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14211718|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14211719|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
14211720|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211721|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
14211722|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14211723|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14211724|NCT02788773|Durvalumab|durvalumab|mesh-list
14211725|NCT02788773|Tremelimumab|tremelimumab|mesh-list
14211726|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211727|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211728|NCT02782468|Azacitidine|azacitidine|mesh-list
14211729|NCT02782468|Pevonedistat|pevonedistat|mesh-list
14211730|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211731|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
14211732|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211733|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211734|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211735|NCT02781584|Firsocostat|firsocostat|mesh-list
14211736|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211737|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211738|NCT02772965|Methotrexate|methotrexate|mesh-list
14211739|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14211740|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
14211741|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14211742|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211743|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211744|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
14211745|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211746|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211747|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
14211748|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211749|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14211750|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211751|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
14211752|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211753|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14211754|NCT02767557|Gemcitabine|gemcitabine|mesh-list
14211755|NCT02767557|Paclitaxel|paclitaxel|mesh-list
14211756|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211757|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211758|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211759|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211760|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211761|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211762|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14211763|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
14211764|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
14211765|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211766|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211767|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211768|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
14211769|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211770|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
14211771|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211772|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211773|NCT02714062|Topiramate|topiramate|mesh-list
14211774|NCT02714062|Phentermine|phentermine|mesh-list
14211775|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
14211776|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14211777|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211778|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14211779|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
14211780|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14211781|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
14211782|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
14211783|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211784|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14211785|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211786|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211787|NCT02689427|Paclitaxel|paclitaxel|mesh-list
14211788|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14211789|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211790|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211791|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211792|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211793|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211794|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211795|NCT02682004|Serotonin|serotonin|mesh-list
14211796|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14211797|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
14211798|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211799|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211800|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211801|NCT02656797|Amphotericin B|amphotericin b|mesh-list
14211802|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14211803|NCT02656797|Amebicides|amebicides|mesh-ancestor
14211804|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14211805|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14211806|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211807|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14211808|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
14211809|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
14211810|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211811|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
14211812|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211813|NCT02625441|Trastuzumab|trastuzumab|mesh-list
14211814|NCT02625441|Pertuzumab|pertuzumab|mesh-list
14211815|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211816|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211817|NCT02617407|Listerine|listerine|mesh-list
14211818|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
14211819|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
14211820|NCT02617407|Protective Agents|protective agents|mesh-ancestor
14211821|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506365|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211822|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14211823|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211824|NCT02616393|XL647|xl647|mesh-list
14211825|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211826|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211827|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211828|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211829|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
14211830|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211831|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211832|NCT02602288|Nicotine|nicotine|mesh-list
14211833|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14211834|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
14211835|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211836|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211837|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14211838|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14211839|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
14211840|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211841|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211842|NCT02593786|Nivolumab|nivolumab|mesh-list
14211843|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211844|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211845|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14211846|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211847|NCT02584478|Paclitaxel|paclitaxel|mesh-list
14211848|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14211849|NCT02584478|Carboplatin|carboplatin|mesh-list
14211850|NCT02584478|Doxorubicin|doxorubicin|mesh-list
14211851|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14211852|NCT02584478|Topotecan|topotecan|mesh-list
14211853|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211854|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211855|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
14211856|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
14211857|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
14211858|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211859|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14211860|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14211861|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14211862|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211863|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14211864|NCT02577523|Levodopa|levodopa|mesh-list
14211865|NCT02577523|Carbidopa|carbidopa|mesh-list
14211866|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14211867|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14211868|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14211869|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
14211870|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14211871|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211872|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211873|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14211874|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211875|NCT02563002|Bevacizumab|bevacizumab|mesh-list
14211876|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
14211877|NCT02563002|Cetuximab|cetuximab|mesh-list
13964887|NCT03134339|Nicotine|nicotine|mesh-list
14211878|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211879|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211880|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14211881|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14211882|NCT02563002|Growth Substances|growth substances|mesh-ancestor
14211883|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211884|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
14211885|NCT02542657|Clarithromycin|clarithromycin|mesh-list
14211886|NCT02542657|Dexamethasone|dexamethasone|mesh-list
14211887|NCT02542657|Pomalidomide|pomalidomide|mesh-list
13964888|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13964889|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
13964890|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964891|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964892|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13964893|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13964894|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
13964895|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964896|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964897|NCT03134118|Nivolumab|nivolumab|mesh-list
13964898|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14211888|NCT02542657|Ixazomib|ixazomib|mesh-list
14211889|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211890|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
14211891|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
14211892|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211893|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211894|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14211895|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
14211896|NCT02542657|Hormones|hormones|mesh-ancestor
14211897|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211898|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211899|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211900|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506366|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506367|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14506368|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14506369|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506370|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506371|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
14506372|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
14506373|NCT02903446|Denosumab|denosumab|mesh-list
14786880|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786881|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14786882|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14786883|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786884|NCT00716911|Ganciclovir|ganciclovir|mesh-list
14786885|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14786886|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
14506374|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14506375|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506376|NCT02903511|Metformin|metformin|mesh-list
14506377|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506378|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506379|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
14506380|NCT02903836|Nafithromycin|nafithromycin|mesh-list
14506381|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14506382|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14506383|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14506384|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14506385|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506386|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506387|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506388|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14506389|NCT02904096|Lidocaine|lidocaine|mesh-list
14506390|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
14506391|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
14506392|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506393|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506394|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
14506395|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506396|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14506397|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14506398|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14506399|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506400|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506401|NCT02904200|Silicon|silicon|mesh-list
14506402|NCT02904200|Trace Elements|trace elements|mesh-ancestor
14506403|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
14506404|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506405|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
14506406|NCT02904226|Nivolumab|nivolumab|mesh-list
14506407|NCT02904226|Ipilimumab|ipilimumab|mesh-list
14506408|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14506409|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506410|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14506411|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506412|NCT02904265|Acetazolamide|acetazolamide|mesh-list
14506413|NCT02904265|Diazepam|diazepam|mesh-list
14506414|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
14506415|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14506416|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786887|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947415|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14530047|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211901|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14211902|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211903|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14211904|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211905|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14211906|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14211907|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
14211908|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14211909|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14211910|NCT02542657|Growth Substances|growth substances|mesh-ancestor
14211911|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
14211912|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
14211913|NCT02427958|Leuprolide|leuprolide|mesh-list
14211914|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14211915|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
14211916|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14211917|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211918|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211919|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211920|NCT02425826|Thalidomide|thalidomide|mesh-list
14211921|NCT02425826|Apremilast|apremilast|mesh-list
14211922|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14211923|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14211924|NCT02425826|Analgesics|analgesics|mesh-ancestor
14211925|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
14211926|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211927|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211928|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14211929|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211930|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14211931|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14211932|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211933|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211934|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211935|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
14211936|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
14211937|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14211938|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14211939|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14211940|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14211941|NCT02425826|Growth Substances|growth substances|mesh-ancestor
14211942|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14211943|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211944|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
14211945|NCT02400567|Letrozole|letrozole|mesh-list
14211946|NCT02400567|Epirubicin|epirubicin|mesh-list
14211947|NCT02400567|Palbociclib|palbociclib|mesh-list
14211948|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14211949|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
14211950|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211951|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14211952|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14211953|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
14211954|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211955|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211956|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14211957|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14211958|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14211959|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211960|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14211961|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
14211962|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211963|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14211964|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14211965|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14211966|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211967|NCT02384239|Tamoxifen|tamoxifen|mesh-list
14211968|NCT02384239|Fulvestrant|fulvestrant|mesh-list
14211969|NCT02384239|Palbociclib|palbociclib|mesh-list
14211970|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14211971|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
14211972|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14211973|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211974|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14211975|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211976|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14211977|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14211978|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14211979|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14211980|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14211981|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211982|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211983|NCT02372409|Doxorubicin|doxorubicin|mesh-list
14786888|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14786889|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211984|NCT02372409|Etoposide|etoposide|mesh-list
14211985|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
14211986|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14211987|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14211988|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14211989|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14211990|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14211991|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14211992|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14211993|NCT02361801|Dobutamine|dobutamine|mesh-list
14211994|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14211995|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
14211996|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
14211997|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14211998|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14211999|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14212000|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14212001|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14212002|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14212003|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14212004|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212005|NCT02361801|Protective Agents|protective agents|mesh-ancestor
14212006|NCT02356705|Lidocaine|lidocaine|mesh-list
14212007|NCT02356705|Midazolam|midazolam|mesh-list
14212008|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14212009|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14212010|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14212011|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212012|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14212013|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14212014|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14212015|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14212016|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
14212017|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
14212018|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
14212019|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
14212020|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14212021|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212022|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
14212023|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
14212024|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212025|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14212026|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14212027|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14212028|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14212029|NCT02353247|Norethindrone|norethindrone|mesh-list
14212030|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
14212031|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14212032|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14212033|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14212034|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
14212035|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14212036|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212037|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14212038|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14212039|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
14212040|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14212041|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212042|NCT02285959|Bevacizumab|bevacizumab|mesh-list
14212043|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14212044|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212045|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14786890|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212046|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14212047|NCT02285959|Growth Substances|growth substances|mesh-ancestor
14212048|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212049|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
14212050|NCT02285140|Vancomycin|vancomycin|mesh-list
14212051|NCT02285140|Cefazolin|cefazolin|mesh-list
14212052|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14212053|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212054|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14212055|NCT02254941|Antibodies|antibodies|mesh-list
14212056|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
14212057|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14212058|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
14212059|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212060|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212061|NCT02229084|Paclitaxel|paclitaxel|mesh-list
14212062|NCT02229084|Docetaxel|docetaxel|mesh-list
14212063|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
14212064|NCT02229084|Doxorubicin|doxorubicin|mesh-list
14212065|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
14212066|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212067|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212068|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212069|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212070|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212071|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212072|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212073|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
14212074|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212075|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212076|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212077|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
14212078|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14212079|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212080|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14212081|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212082|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212083|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14212084|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
14212085|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212086|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
14212087|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212088|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212089|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212090|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
14212091|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212092|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212093|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241381|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241382|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241383|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241384|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14241385|NCT00176852|Vidarabine|vidarabine|mesh-list
14241386|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
14241387|NCT00176852|Busulfan|busulfan|mesh-list
14241388|NCT00176852|Fludarabine|fludarabine|mesh-list
14241389|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
14241390|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
14241391|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14241392|NCT00176852|Sargramostim|sargramostim|mesh-list
14506417|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506418|NCT02904265|Diuretics|diuretics|mesh-ancestor
14506419|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
14506420|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506421|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14506422|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
14506423|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
14506424|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506425|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506426|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14506427|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506428|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14506429|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14241393|NCT00176852|Lenograstim|lenograstim|mesh-list
14241394|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241395|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
14241396|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212094|NCT02098954|Gemcitabine|gemcitabine|mesh-list
14212095|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14212096|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212097|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
14212098|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212099|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212100|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
14212101|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212102|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212103|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212104|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
14212105|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212106|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212107|NCT02097225|Trametinib|trametinib|mesh-list
14212108|NCT02097225|Dabrafenib|dabrafenib|mesh-list
14212109|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212110|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212111|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212112|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212113|NCT02000622|Olaparib|olaparib|mesh-list
14212114|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14212115|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212116|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212117|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212118|NCT01933932|Docetaxel|docetaxel|mesh-list
14212119|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212120|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212121|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212122|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212123|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212124|NCT01927068|Paclitaxel|paclitaxel|mesh-list
14212125|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212126|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212127|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212128|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212129|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212130|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212143|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14212144|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212145|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212146|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212147|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212148|NCT01849146|Temozolomide|temozolomide|mesh-list
14212149|NCT01849146|Adavosertib|adavosertib|mesh-list
14212150|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212151|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
14212152|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212153|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212154|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212155|NCT01837277|Efavirenz|efavirenz|mesh-list
13968070|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
13968071|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968072|NCT03113019|Vaccines|vaccines|mesh-list
13968073|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
13968074|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968075|NCT03113110|Empagliflozin|empagliflozin|mesh-list
13968076|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13968077|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968078|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13968079|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968080|NCT03113162|Cytarabine|cytarabine|mesh-list
13968081|NCT03113162|Etoposide|etoposide|mesh-list
13968082|NCT03113162|Melphalan|melphalan|mesh-list
14212156|NCT01837277|Dolutegravir|dolutegravir|mesh-list
14212157|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14212158|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14212159|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212160|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212161|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
14212162|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212163|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14212164|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14212165|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14212166|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14212167|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14212168|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14212169|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14212170|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14212171|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14212172|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14212173|NCT01813435|Aspirin|aspirin|mesh-list
14212174|NCT01813435|Clopidogrel|clopidogrel|mesh-list
14212175|NCT01813435|Ticagrelor|ticagrelor|mesh-list
14212176|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14212177|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14212178|NCT01813435|Analgesics|analgesics|mesh-ancestor
14212179|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
14212180|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212181|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212182|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212183|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212184|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14212185|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14212186|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212187|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14212188|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14212189|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212190|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
14212191|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14212192|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14212193|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14212194|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
14212195|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14212196|NCT01779050|Paclitaxel|paclitaxel|mesh-list
14212197|NCT01779050|Docetaxel|docetaxel|mesh-list
14212198|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
14212199|NCT01779050|Carboplatin|carboplatin|mesh-list
14212200|NCT01779050|Doxorubicin|doxorubicin|mesh-list
14212201|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14212202|NCT01779050|Fluorouracil|fluorouracil|mesh-list
14212203|NCT01779050|Trastuzumab|trastuzumab|mesh-list
14212204|NCT01779050|Epirubicin|epirubicin|mesh-list
14212205|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212206|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212207|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212208|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212209|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212210|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212211|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212212|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
14212213|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212214|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212215|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212216|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
14212217|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14212218|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212219|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14212220|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212221|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212222|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
14212223|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212224|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14212246|NCT01765218|Topiramate|topiramate|mesh-list
14212247|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
14212248|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14212249|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212250|NCT01745757|Paclitaxel|paclitaxel|mesh-list
14212251|NCT01745757|Bevacizumab|bevacizumab|mesh-list
14212252|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212253|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506430|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14506431|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506432|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506433|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14506434|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
14506435|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
14506436|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
14506437|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
14506438|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506439|NCT02904902|Adalimumab|adalimumab|mesh-list
14506440|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506441|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506442|NCT02904915|Lidocaine|lidocaine|mesh-list
14506443|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
14506444|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
14506445|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506446|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506447|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
14506448|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506449|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14506450|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14506451|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14506452|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506453|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506454|NCT02904954|Durvalumab|durvalumab|mesh-list
14506455|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14506456|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14506457|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506458|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
14506459|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506460|NCT02905266|Nivolumab|nivolumab|mesh-list
14506461|NCT02905266|Ipilimumab|ipilimumab|mesh-list
14506462|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14506463|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506464|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14506465|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506466|NCT02905981|Citric Acid|citric acid|mesh-list
14506467|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
14506468|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
14506469|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14506470|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
14506471|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
14506472|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506473|NCT02906566|Vitamin A|vitamin a|mesh-list
14506474|NCT02906566|Vitamins|vitamins|mesh-ancestor
14506475|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
14506476|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506477|NCT02906579|Praliciguat|praliciguat|mesh-list
14506478|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14506479|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
14506480|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212254|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212255|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
14506481|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14212256|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212257|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212258|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14212259|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14212260|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14212261|NCT01745757|Growth Substances|growth substances|mesh-ancestor
14212262|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212263|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
14212264|NCT01729455|Belimumab|belimumab|mesh-list
14212265|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212266|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
14212267|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212268|NCT01711554|Vitamin A|vitamin a|mesh-list
14212269|NCT01711554|Lenalidomide|lenalidomide|mesh-list
14212270|NCT01711554|Tretinoin|tretinoin|mesh-list
14212271|NCT01711554|Dinutuximab|dinutuximab|mesh-list
14212272|NCT01711554|Isotretinoin|isotretinoin|mesh-list
14212273|NCT01711554|Vitamins|vitamins|mesh-ancestor
14212274|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
14212275|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212276|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
14212277|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14212278|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14212279|NCT01711554|Growth Substances|growth substances|mesh-ancestor
14212280|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
14212281|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212282|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
14212283|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
14212296|NCT01690299|Etanercept|etanercept|mesh-list
14212297|NCT01690299|Apremilast|apremilast|mesh-list
14212298|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14212299|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14212300|NCT01690299|Analgesics|analgesics|mesh-ancestor
14212301|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
14212302|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212303|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212304|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212305|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212306|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14212307|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212308|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
14212309|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14212310|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14212311|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212312|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212313|NCT01659658|Thalidomide|thalidomide|mesh-list
14212314|NCT01659658|Dexamethasone|dexamethasone|mesh-list
14212315|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
14212316|NCT01659658|Melphalan|melphalan|mesh-list
14212317|NCT01659658|Lenalidomide|lenalidomide|mesh-list
14212318|NCT01659658|Ixazomib|ixazomib|mesh-list
14212319|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212320|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
14212321|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212322|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212323|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212324|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
14212325|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212326|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212327|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14212328|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212329|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
14212330|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
14212331|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212332|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14212333|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
14212334|NCT01659658|Hormones|hormones|mesh-ancestor
14212335|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14212336|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14212337|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14212338|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14212339|NCT01659658|Growth Substances|growth substances|mesh-ancestor
14212340|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
14212341|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
14506482|NCT02906644|Nicotine|nicotine|mesh-list
14506483|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14506484|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
14506485|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506486|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506487|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14506488|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14506489|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506490|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506491|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506492|NCT02906709|Insulin|insulin|mesh-list
14506493|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506494|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506495|NCT02906917|Insulin|insulin|mesh-list
14506496|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14506497|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
14506498|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
14506499|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
14506500|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14506501|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506502|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506503|NCT02907177|Ponesimod|ponesimod|mesh-list
14506504|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14506505|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506506|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14506507|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
14506508|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506509|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14506510|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14506511|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14506512|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506513|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506514|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14506515|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506516|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506517|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506518|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506519|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14506520|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14506521|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14506522|NCT02907918|Trastuzumab|trastuzumab|mesh-list
14506523|NCT02907918|Letrozole|letrozole|mesh-list
14506524|NCT02907918|Palbociclib|palbociclib|mesh-list
14506525|NCT02907918|Goserelin|goserelin|mesh-list
14506526|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14506527|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506528|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14506529|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14506530|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506531|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506532|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14506533|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
14506534|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506535|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506536|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14506537|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14506538|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
14506539|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
14506540|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14506541|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14506542|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506543|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506544|NCT02908490|Urological Agents|urological agents|mesh-ancestor
14506545|NCT02908529|Oxybutynin|oxybutynin|mesh-list
14530048|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
14212342|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14212343|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212344|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
14212345|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212346|NCT01653925|Dutasteride|dutasteride|mesh-list
14212347|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14212348|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14212349|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212350|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212351|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
14212352|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14212353|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212354|NCT01525329|Fluorouracil|fluorouracil|mesh-list
14212355|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
14212356|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212357|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212358|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212359|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212360|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
14212361|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212362|NCT01482286|Metformin|metformin|mesh-list
14212363|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14212364|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212365|NCT01452152|Clopidogrel|clopidogrel|mesh-list
14212366|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14212367|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14212368|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14212369|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14212370|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14212371|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
14212372|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14212373|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212374|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212375|NCT01420926|Bortezomib|bortezomib|mesh-list
14212376|NCT01420926|Decitabine|decitabine|mesh-list
14212377|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212378|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212379|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
14212380|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212381|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212382|NCT01386385|Paclitaxel|paclitaxel|mesh-list
14212383|NCT01386385|Carboplatin|carboplatin|mesh-list
14212384|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14212385|NCT01386385|Veliparib|veliparib|mesh-list
14212386|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212387|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212388|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212389|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212390|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212391|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212392|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14212393|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212394|NCT01375829|Sirolimus|sirolimus|mesh-list
14212395|NCT01375829|Epothilone B|epothilone b|mesh-list
14212396|NCT01375829|Epothilones|epothilones|mesh-list
14212397|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14212398|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212399|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212400|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212401|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
14212402|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212403|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
14212404|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212405|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212406|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212407|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212408|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212409|NCT01364051|Cediranib|cediranib|mesh-list
14212410|NCT01364051|Maleic acid|maleic acid|mesh-list
14212411|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212412|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212413|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212414|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212415|NCT01358877|Paclitaxel|paclitaxel|mesh-list
14212416|NCT01358877|Docetaxel|docetaxel|mesh-list
14212417|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
14212418|NCT01358877|Carboplatin|carboplatin|mesh-list
14212419|NCT01358877|Doxorubicin|doxorubicin|mesh-list
14212420|NCT01358877|Fluorouracil|fluorouracil|mesh-list
14212421|NCT01358877|Trastuzumab|trastuzumab|mesh-list
14212422|NCT01358877|Epirubicin|epirubicin|mesh-list
14212423|NCT01358877|Pertuzumab|pertuzumab|mesh-list
14212424|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212425|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212426|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212427|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212428|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212429|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212430|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212431|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
14212432|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212433|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212434|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212435|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
14212436|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14212437|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14786891|NCT00716924|Clopidogrel|clopidogrel|mesh-list
14786892|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14786893|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14786894|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14786895|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14786896|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
14947416|NCT01527890|Narcotics|narcotics|mesh-ancestor
14212438|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14212439|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212440|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212441|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
14212442|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212443|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14212444|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
14212445|NCT01256398|Leucovorin|leucovorin|mesh-list
14212446|NCT01256398|Folic Acid|folic acid|mesh-list
14212447|NCT01256398|Cytarabine|cytarabine|mesh-list
14212448|NCT01256398|Dexamethasone|dexamethasone|mesh-list
14212449|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
14212450|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
14212451|NCT01256398|Melphalan|melphalan|mesh-list
14212452|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
14212453|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14212454|NCT01256398|Methotrexate|methotrexate|mesh-list
14212455|NCT01256398|Fludarabine|fludarabine|mesh-list
14212456|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
14212457|NCT01256398|Etoposide|etoposide|mesh-list
14212458|NCT01256398|Vincristine|vincristine|mesh-list
14212459|NCT01256398|Daunorubicin|daunorubicin|mesh-list
14212460|NCT01256398|Dasatinib|dasatinib|mesh-list
14212461|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
14212462|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
14212463|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
14212464|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14212465|NCT01256398|Tacrolimus|tacrolimus|mesh-list
14212466|NCT01256398|Antibodies|antibodies|mesh-list
14212467|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
14212468|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14212469|NCT01256398|Lenograstim|lenograstim|mesh-list
14212470|NCT01256398|BB 1101|bb 1101|mesh-list
14212471|NCT01256398|Calcium|calcium|mesh-list
14212472|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
14212473|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212474|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
14212475|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212476|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212477|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212478|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
14212479|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212480|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212481|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14212482|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212483|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
14212484|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
14212485|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212486|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14212487|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
14212488|NCT01256398|Hormones|hormones|mesh-ancestor
14212489|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14212490|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14212491|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
14212492|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212493|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14212494|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14212495|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14212496|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
14212497|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14212498|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212499|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
14212500|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
14212501|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14212502|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14212503|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212504|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14212505|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212506|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
14212507|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212508|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14212509|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14212510|NCT01256398|Antidotes|antidotes|mesh-ancestor
14212511|NCT01256398|Protective Agents|protective agents|mesh-ancestor
14212512|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
14212513|NCT01256398|Vitamins|vitamins|mesh-ancestor
14212514|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
14212515|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212516|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212517|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212518|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212519|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212520|NCT01256398|Hematinics|hematinics|mesh-ancestor
14212521|NCT01253070|Cytarabine|cytarabine|mesh-list
14212522|NCT01253070|Sorafenib|sorafenib|mesh-list
14212523|NCT01253070|Daunorubicin|daunorubicin|mesh-list
14212524|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212525|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
14212526|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212527|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212528|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
14212529|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212530|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212531|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
14212532|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212533|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212534|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212535|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212536|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14212537|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212538|NCT01232283|Apremilast|apremilast|mesh-list
14212539|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14212540|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14212541|NCT01232283|Analgesics|analgesics|mesh-ancestor
14212542|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
14212543|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212544|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212545|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212546|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212547|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14212548|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14212549|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212550|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212551|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
14212552|NCT01231516|Dolutegravir|dolutegravir|mesh-list
14212553|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14212554|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14212555|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
14212556|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212557|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14212558|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14212559|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212560|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212561|NCT01229943|Bevacizumab|bevacizumab|mesh-list
14212562|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14212563|NCT01229943|Everolimus|everolimus|mesh-list
14212564|NCT01229943|Octreotide|octreotide|mesh-list
14212565|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
14212566|NCT01229943|Antibodies|antibodies|mesh-list
14212567|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
14212568|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14212569|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
14212570|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506546|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14506547|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14506548|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14506549|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506550|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506551|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
14506552|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506553|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506554|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
14506555|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
14506556|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506557|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14506558|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14506559|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506560|NCT02908529|Urological Agents|urological agents|mesh-ancestor
14506561|NCT02908620|Anesthetics|anesthetics|mesh-list
14506562|NCT02908620|Tetracaine|tetracaine|mesh-list
14506563|NCT02908620|Benzocaine|benzocaine|mesh-list
14506564|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506565|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506566|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
14506567|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
14506568|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506569|NCT02909140|Lidocaine|lidocaine|mesh-list
14506570|NCT02909140|Phenylephrine|phenylephrine|mesh-list
14506571|NCT02909140|Epinephrine|epinephrine|mesh-list
14506572|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
14506573|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
14506574|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
14506575|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
14506576|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506577|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506578|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
14506579|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506580|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14506581|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14506582|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14506583|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506584|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506585|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14506586|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14506587|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
14506588|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506589|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14506590|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14506591|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
14506592|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14506593|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
14506594|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
14506595|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
14506596|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14506597|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14506598|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
14506599|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14506600|NCT02909140|Protective Agents|protective agents|mesh-ancestor
14506601|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
14506602|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14506603|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14506604|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506605|NCT02909439|Neostigmine|neostigmine|mesh-list
14506606|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14506607|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506608|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506609|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506610|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14212571|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14212572|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14212573|NCT01229943|Growth Substances|growth substances|mesh-ancestor
14212574|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212575|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
14212576|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
14212577|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212578|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14212579|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14212580|NCT01194219|Apremilast|apremilast|mesh-list
14212581|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14212582|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14212583|NCT01194219|Analgesics|analgesics|mesh-ancestor
14212584|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
14212585|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212586|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212587|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212588|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212589|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14212590|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14212591|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212592|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212593|NCT01193842|Prednisone|prednisone|mesh-list
14212594|NCT01193842|Cortisone|cortisone|mesh-list
14212595|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
14212596|NCT01193842|Rituximab|rituximab|mesh-list
14212597|NCT01193842|Doxorubicin|doxorubicin|mesh-list
14212598|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14212599|NCT01193842|Etoposide|etoposide|mesh-list
14212600|NCT01193842|Vincristine|vincristine|mesh-list
14212601|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
14212602|NCT01193842|Vorinostat|vorinostat|mesh-list
14212603|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
14212604|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14212605|NCT01193842|Antibodies|antibodies|mesh-list
14212606|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
14212607|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14212608|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212609|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
14212610|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212611|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212612|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212613|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
14212614|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212615|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212616|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14212617|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212618|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14212619|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212620|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212621|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212622|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
14212623|NCT01193842|Hormones|hormones|mesh-ancestor
14212624|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14212625|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14212626|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212627|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212628|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212629|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212630|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14212631|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
14212632|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
14212633|NCT01064648|Cisplatin|cisplatin|mesh-list
14212634|NCT01064648|Pemetrexed|pemetrexed|mesh-list
14212635|NCT01064648|Cediranib|cediranib|mesh-list
14212636|NCT01064648|Maleic acid|maleic acid|mesh-list
14212637|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212638|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212639|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212640|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14212641|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14212642|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212643|NCT01061840|Molgramostim|molgramostim|mesh-list
14212644|NCT01061840|Modafinil|modafinil|mesh-list
14212645|NCT01061840|Vaccines|vaccines|mesh-list
14212646|NCT01061840|Sargramostim|sargramostim|mesh-list
14212647|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
14212648|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212649|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212650|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14212651|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14212652|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14212653|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14241397|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212654|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212655|NCT01012817|Topotecan|topotecan|mesh-list
14212656|NCT01012817|Veliparib|veliparib|mesh-list
14212657|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14212658|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212659|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212660|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212661|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212662|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14212678|NCT00980538|Etravirine|etravirine|mesh-list
14212679|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14212680|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14212681|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212682|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212683|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
14212684|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212685|NCT00878163|Gemcitabine|gemcitabine|mesh-list
14212686|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14212687|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212688|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
14212689|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212690|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212691|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
14212692|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212693|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212694|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212695|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
14212696|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212697|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14786897|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14786898|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786899|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786900|NCT00716950|Losartan|losartan|mesh-list
14786901|NCT00716950|Valsartan|valsartan|mesh-list
14786902|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14786903|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14786904|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14786905|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786906|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14786907|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
14786908|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
14212711|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
14212712|NCT00792948|Leucovorin|leucovorin|mesh-list
14212713|NCT00792948|Folic Acid|folic acid|mesh-list
14212714|NCT00792948|Cytarabine|cytarabine|mesh-list
14212715|NCT00792948|Sirolimus|sirolimus|mesh-list
14212716|NCT00792948|Dexamethasone|dexamethasone|mesh-list
14212717|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
14212718|NCT00792948|Prednisone|prednisone|mesh-list
14212719|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
14212720|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14212721|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14212722|NCT00792948|Prednisolone|prednisolone|mesh-list
14212723|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
14212724|NCT00792948|Cortisone|cortisone|mesh-list
14212725|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
14212726|NCT00792948|Doxorubicin|doxorubicin|mesh-list
14212727|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14212728|NCT00792948|Methotrexate|methotrexate|mesh-list
14212729|NCT00792948|Etoposide|etoposide|mesh-list
14212730|NCT00792948|Vincristine|vincristine|mesh-list
14212731|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
14212732|NCT00792948|Dasatinib|dasatinib|mesh-list
14212733|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
14212734|NCT00792948|Tacrolimus|tacrolimus|mesh-list
14212735|NCT00792948|Lenograstim|lenograstim|mesh-list
14212736|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14212737|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
14212738|NCT00792948|BB 1101|bb 1101|mesh-list
14212739|NCT00792948|Calcium|calcium|mesh-list
14212740|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
14212741|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14212742|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
14212743|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212744|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14212745|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14212746|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
14212747|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212748|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212749|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14212750|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212751|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
14212752|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
14212753|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212754|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14212755|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
14212756|NCT00792948|Hormones|hormones|mesh-ancestor
14212757|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14212758|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14212759|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
14212760|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212761|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212762|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14212763|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14212764|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14212765|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14212766|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14212767|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
14212768|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14212769|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212770|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
14212771|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
14212772|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14212773|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14212774|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212775|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
14212776|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212777|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14212778|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14212779|NCT00792948|Antidotes|antidotes|mesh-ancestor
14212780|NCT00792948|Protective Agents|protective agents|mesh-ancestor
14212781|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
14212782|NCT00792948|Vitamins|vitamins|mesh-ancestor
14212783|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
14212784|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212785|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212786|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212787|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14212788|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
14212789|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14212790|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212791|NCT00792948|Hematinics|hematinics|mesh-ancestor
14212792|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
14212793|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
14212794|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14212795|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14212796|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212797|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
14212798|NCT00740116|Coagulants|coagulants|mesh-ancestor
14212799|NCT00715611|Carboplatin|carboplatin|mesh-list
14212800|NCT00715611|Pemetrexed|pemetrexed|mesh-list
14212801|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212802|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212803|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212804|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14212805|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14212806|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
14212807|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14212808|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
14530049|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
14212809|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14212810|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212811|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14212812|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14212813|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14212814|NCT00516724|Paclitaxel|paclitaxel|mesh-list
14212815|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14212816|NCT00516724|Carboplatin|carboplatin|mesh-list
14212817|NCT00516724|Olaparib|olaparib|mesh-list
14212818|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14212819|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212820|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212821|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212822|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212823|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212824|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212825|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212826|NCT00470704|Trastuzumab|trastuzumab|mesh-list
14212827|NCT00470704|Lapatinib|lapatinib|mesh-list
14212828|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14212829|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212830|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212831|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212832|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212833|NCT00142584|Metoprolol|metoprolol|mesh-list
14212834|NCT00142584|Nebivolol|nebivolol|mesh-list
14212835|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14212836|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14212837|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
14212838|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
14212839|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212840|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212841|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14212842|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14212843|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14212844|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
14212845|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14212846|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212847|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
14212848|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14212849|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14212850|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14786909|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14786910|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14786911|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786912|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14212856|NCT00107250|Paclitaxel|paclitaxel|mesh-list
14212857|NCT00107250|Carboplatin|carboplatin|mesh-list
14212858|NCT00107250|Capecitabine|capecitabine|mesh-list
14212859|NCT00107250|Cediranib|cediranib|mesh-list
14212860|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14212861|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212862|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
14212863|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
14212864|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
14212865|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212866|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14212867|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
14212868|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212869|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14241398|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241399|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
14241400|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241401|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241402|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241403|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14241404|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
14241405|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
14241406|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241407|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14241408|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14241409|NCT00176865|Cyclosporine|cyclosporine|mesh-list
14241410|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
14241411|NCT00176865|Fludarabine|fludarabine|mesh-list
14212870|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14212871|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14212872|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
14212873|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14212874|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
14212875|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14212876|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212877|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14506611|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506612|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14506613|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
14506614|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506615|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
14506616|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
14506617|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506618|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506619|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506620|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
14506621|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506622|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506623|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506624|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
14506625|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14506626|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506627|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506628|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506629|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506630|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506631|NCT02909959|Sulforaphane|sulforaphane|mesh-list
14506632|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14506633|NCT02909959|Protective Agents|protective agents|mesh-ancestor
14506634|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506635|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506636|NCT02910011|Doxycycline|doxycycline|mesh-list
14506637|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14506638|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14506639|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
14506640|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14506641|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14506642|NCT02910063|Blinatumomab|blinatumomab|mesh-list
14506643|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506644|NCT02910167|Acetaminophen|acetaminophen|mesh-list
14506645|NCT02910167|Scopolamine|scopolamine|mesh-list
14506646|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14506647|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506648|NCT02910167|Analgesics|analgesics|mesh-ancestor
14506649|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
14506650|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506651|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506652|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
14506653|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14506654|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
14506655|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
14506656|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506657|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
14506658|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14506659|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506660|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506661|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506662|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14506663|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
14506664|NCT02911116|Ustekinumab|ustekinumab|mesh-list
14506665|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
14506666|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
14506667|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14506668|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
14506669|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14506670|NCT02911285|Expectorants|expectorants|mesh-ancestor
14506671|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
14506672|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14506673|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
14506674|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212878|NCT05285566|Lidocaine|lidocaine|mesh-list
14506675|NCT02911285|Protective Agents|protective agents|mesh-ancestor
14506676|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506677|NCT02911285|Antidotes|antidotes|mesh-ancestor
14212879|NCT05285566|Bupivacaine|bupivacaine|mesh-list
14212880|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
14212881|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
14212882|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14212883|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212884|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
14212885|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14212886|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14212887|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14212888|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14212889|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14212890|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212891|NCT05285449|Cannabidiol|cannabidiol|mesh-list
14212892|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
14212893|NCT05285397|Liraglutide|liraglutide|mesh-list
14212894|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14212895|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212896|NCT05285397|Incretins|incretins|mesh-ancestor
14212897|NCT05285397|Hormones|hormones|mesh-ancestor
14212898|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14212899|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
14212900|NCT05285384|Paraproteins|paraproteins|mesh-list
14212901|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
14212902|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212903|NCT05285293|Vitamin A|vitamin a|mesh-list
14212904|NCT05285293|Vitamins|vitamins|mesh-ancestor
14212905|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
14212906|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212907|NCT05285228|Fluorides|fluorides|mesh-list
14212908|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
14212909|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
14212910|NCT05285228|Protective Agents|protective agents|mesh-ancestor
14212911|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212912|NCT05285124|Melatonin|melatonin|mesh-list
14212913|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
14212914|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212915|NCT05285124|Protective Agents|protective agents|mesh-ancestor
14212916|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212917|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14212918|NCT05285085|Atorvastatin|atorvastatin|mesh-list
14212919|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14212920|NCT05285085|Simvastatin|simvastatin|mesh-list
14212921|NCT05285085|Pravastatin|pravastatin|mesh-list
14212922|NCT05285085|Pitavastatin|pitavastatin|mesh-list
14212923|NCT05285085|Lovastatin|lovastatin|mesh-list
14212924|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14212925|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14212926|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
14212927|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212928|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14212929|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14212930|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212931|NCT05284994|Osimertinib|osimertinib|mesh-list
14212932|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212933|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14212934|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212935|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212936|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
14212937|NCT05284942|Prednisone|prednisone|mesh-list
14212938|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212939|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
14212940|NCT05284942|Hormones|hormones|mesh-ancestor
14212941|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14212942|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212943|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14212944|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212945|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14212946|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14212947|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
14212948|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14212949|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14212950|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212951|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212952|NCT05284851|Vaccines|vaccines|mesh-list
14506678|NCT02911324|Nabilone|nabilone|mesh-list
14212953|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
14506679|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
14212954|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212955|NCT05284812|Vaccines|vaccines|mesh-list
14212956|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
14212957|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212958|NCT05284747|Evolocumab|evolocumab|mesh-list
14212959|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14212960|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14212961|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
14212962|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212963|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14212964|NCT05284734|Anesthetics|anesthetics|mesh-list
14212965|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14212966|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212967|NCT05284643|Bevacizumab|bevacizumab|mesh-list
14212968|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14212969|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14212970|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14212971|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14212972|NCT05284643|Growth Substances|growth substances|mesh-ancestor
14212973|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212974|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
14212975|NCT05284552|Tinzaparin|tinzaparin|mesh-list
14212976|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14212977|NCT05284552|Dalteparin|dalteparin|mesh-list
14212978|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
14212979|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14212980|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14212981|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212982|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
14212983|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14212984|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14212985|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14212986|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14212987|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14212988|NCT05284448|Protective Agents|protective agents|mesh-ancestor
14212989|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14212990|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
14212991|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14212992|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
14212993|NCT05284409|Acetaminophen|acetaminophen|mesh-list
14212994|NCT05284409|Dexamethasone|dexamethasone|mesh-list
14212995|NCT05284409|Meperidine|meperidine|mesh-list
14212996|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14212997|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
14212998|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
14212999|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213000|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213001|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14213002|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
14213003|NCT05284409|Hormones|hormones|mesh-ancestor
14213004|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213005|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213006|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213007|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14213008|NCT05284409|Analgesics|analgesics|mesh-ancestor
14213009|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
14213010|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
14213011|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14213012|NCT05284409|Narcotics|narcotics|mesh-ancestor
14213013|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213014|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14213015|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14213016|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213017|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14213018|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213019|NCT05284136|Prednisolone|prednisolone|mesh-list
14213020|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213021|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
14213022|NCT05284136|Hormones|hormones|mesh-ancestor
14213023|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213024|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213025|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213026|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213027|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
14213028|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
14213029|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
14213030|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213031|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213032|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213033|NCT05284019|Erenumab|erenumab|mesh-list
14213034|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14213035|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14213036|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14213037|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213038|NCT05284019|Analgesics|analgesics|mesh-ancestor
14213039|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
14213040|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213041|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213042|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14213043|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14213044|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14213045|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
14213046|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241412|NCT00176865|Melphalan|melphalan|mesh-list
14241413|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
14241414|NCT00176865|Cyclosporins|cyclosporins|mesh-list
14241415|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14241416|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
14241417|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14241418|NCT00176865|Antibodies|antibodies|mesh-list
14241419|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
14241420|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14241421|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241422|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241423|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241424|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
14241425|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241426|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241427|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
14241428|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241429|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
14241430|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241431|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14241432|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14241433|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14241434|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
14241435|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14241436|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241437|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
14241438|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241439|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14241440|NCT00176878|Fludarabine|fludarabine|mesh-list
14241441|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
14241442|NCT00176878|Busulfan|busulfan|mesh-list
14241443|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14241444|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241445|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14241446|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
14241447|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241448|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241449|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
14241450|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241451|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
14241452|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241453|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241454|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
14241455|NCT00176904|Busulfan|busulfan|mesh-list
14241456|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14241457|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241458|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
14241459|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241460|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241461|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241462|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
14241463|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241464|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241465|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241466|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
14241467|NCT00176917|Busulfan|busulfan|mesh-list
14241468|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
14241469|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213047|NCT05283980|Bupivacaine|bupivacaine|mesh-list
14213048|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
14213049|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
14213050|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213051|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213052|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
14213053|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213054|NCT05283954|Ascorbic Acid|ascorbic acid|mesh-list
14213055|NCT05283954|Ivermectin|ivermectin|mesh-list
14213056|NCT05283954|Albendazole|albendazole|mesh-list
14213057|NCT05283954|Prednisolone|prednisolone|mesh-list
14213058|NCT05283954|Fluoxetine|fluoxetine|mesh-list
14213059|NCT05283954|Vitamins|vitamins|mesh-ancestor
14213060|NCT05283954|Micronutrients|micronutrients|mesh-ancestor
14213061|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213062|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213063|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
14213064|NCT05283954|Hormones|hormones|mesh-ancestor
14213065|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213066|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213067|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213068|NCT05283954|Protective Agents|protective agents|mesh-ancestor
14213069|NCT05283954|Antioxidants|antioxidants|mesh-ancestor
14213070|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213071|NCT05283954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14213072|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14213073|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14213074|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213075|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
14213076|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14213077|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
14213078|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14213079|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14213080|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14213081|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213082|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14213083|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213084|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
14213085|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
14506680|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
14506681|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506682|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506683|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506684|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14506685|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506686|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506687|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506688|NCT02911688|Vitamin E|vitamin e|mesh-list
14506689|NCT02911688|Tocopherols|tocopherols|mesh-list
14506690|NCT02911688|Tocotrienols|tocotrienols|mesh-list
14506691|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
14506692|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
14506693|NCT02911688|Vitamins|vitamins|mesh-ancestor
14506694|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
14506695|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506696|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
14506697|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506698|NCT02911688|Protective Agents|protective agents|mesh-ancestor
14506699|NCT02911818|Liraglutide|liraglutide|mesh-list
14506700|NCT02911818|Phentermine|phentermine|mesh-list
14506701|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506702|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506703|NCT02911818|Incretins|incretins|mesh-ancestor
14506704|NCT02911818|Hormones|hormones|mesh-ancestor
14506705|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506706|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14506707|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
14506708|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14506709|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
14506710|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
14506711|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506712|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
14506713|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506714|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506715|NCT02911844|Fulvestrant|fulvestrant|mesh-list
14506716|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14506717|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213086|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14213087|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14213088|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
14213089|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14213090|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14213091|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
14213092|NCT05283850|Calcium|calcium|mesh-list
14213093|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14213094|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213095|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14213096|NCT05283837|Pertuzumab|pertuzumab|mesh-list
14213097|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213098|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213099|NCT05283720|Prednisone|prednisone|mesh-list
14213100|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
14213101|NCT05283720|Rituximab|rituximab|mesh-list
14213102|NCT05283720|Doxorubicin|doxorubicin|mesh-list
14213103|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14213104|NCT05283720|Lenalidomide|lenalidomide|mesh-list
14213105|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213106|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
14213107|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213108|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14213109|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14213110|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
14213111|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213112|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213113|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14213114|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213115|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213116|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14506718|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14506719|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14506720|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
14506721|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506722|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506723|NCT02911948|Insulin|insulin|mesh-list
14506724|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14506725|NCT02911948|Liraglutide|liraglutide|mesh-list
14506726|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
14506727|NCT02911948|Xultophy|xultophy|mesh-list
14506728|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506729|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506730|NCT02911948|Incretins|incretins|mesh-ancestor
14506731|NCT02911948|Hormones|hormones|mesh-ancestor
14506732|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506733|NCT02912195|Lidocaine|lidocaine|mesh-list
14506734|NCT02912195|Morphine|morphine|mesh-list
14506735|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
14506736|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
14506737|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506738|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506739|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
14506740|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506741|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14506742|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14506743|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14506744|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506745|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506746|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14506747|NCT02912195|Narcotics|narcotics|mesh-ancestor
14506748|NCT02912195|Analgesics|analgesics|mesh-ancestor
14506749|NCT02912364|Carbamazepine|carbamazepine|mesh-list
14506750|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14506751|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
14506752|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
14506753|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506754|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506755|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506756|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506757|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506758|NCT02912364|Analgesics|analgesics|mesh-ancestor
14213117|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14506759|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
14506760|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213118|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213119|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213120|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
14213121|NCT05283720|Hormones|hormones|mesh-ancestor
14213122|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213123|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213124|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14213125|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14213126|NCT05283720|Growth Substances|growth substances|mesh-ancestor
14213127|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
14213128|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14213129|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
14213130|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213131|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14213132|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
14213133|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213134|NCT05283551|Famciclovir|famciclovir|mesh-list
14213135|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
14213136|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213137|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14213138|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213139|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213140|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
14213141|NCT05283499|Analgesics|analgesics|mesh-list
14213142|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
14213143|NCT05283499|Narcotics|narcotics|mesh-ancestor
14213144|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213145|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213146|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
14213147|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213148|NCT05283421|Estrogens|estrogens|mesh-list
14213149|NCT05283421|Hormones|hormones|mesh-ancestor
14213150|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213151|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213152|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
14213153|NCT05283408|Esketamine|esketamine|mesh-list
14213154|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14213155|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213156|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213157|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14213158|NCT05283408|Analgesics|analgesics|mesh-ancestor
14213159|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
14213160|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213161|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14213162|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14213163|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14213164|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
14213165|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213166|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213167|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
14213168|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14786913|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786914|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14786915|NCT00717210|Temozolomide|temozolomide|mesh-list
14213172|NCT05283382|Cannabidiol|cannabidiol|mesh-list
14213173|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
14213174|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
14213175|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14213176|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
14213177|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213178|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14213179|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
14213180|NCT05265325|Hematinics|hematinics|mesh-ancestor
14213181|NCT05262205|Anesthetics|anesthetics|mesh-list
14213182|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213183|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213184|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
14213185|NCT05252884|Calcitriol|calcitriol|mesh-list
14213186|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
14213187|NCT05252884|Calcium|calcium|mesh-list
14213188|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14213189|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213190|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14213191|NCT05252884|Antacids|antacids|mesh-ancestor
14213192|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213193|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14213194|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14213195|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14213196|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14213197|NCT05252884|Vitamins|vitamins|mesh-ancestor
14213198|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
14213199|NCT05251376|Morphine|morphine|mesh-list
14213200|NCT05251376|Methadone|methadone|mesh-list
14213201|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14213202|NCT05251376|Narcotics|narcotics|mesh-ancestor
14213203|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213204|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213205|NCT05251376|Analgesics|analgesics|mesh-ancestor
14213206|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
14213207|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213208|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
14213209|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
14213210|NCT05233163|Empagliflozin|empagliflozin|mesh-list
14213211|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14213212|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213213|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14213214|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213215|NCT05220293|Betamethasone|betamethasone|mesh-list
14213216|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
14213217|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14213218|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
14213219|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14213220|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213221|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
14213222|NCT05220293|Hormones|hormones|mesh-ancestor
14213223|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213224|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213225|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14213226|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
14213227|NCT05216744|Doxycycline|doxycycline|mesh-list
14213228|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
14213229|NCT05216744|Cefixime|cefixime|mesh-list
14213230|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14213231|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213232|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
14213233|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14213234|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14213235|NCT05206084|Sirolimus|sirolimus|mesh-list
14213236|NCT05206084|Everolimus|everolimus|mesh-list
14213237|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213238|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213239|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
14213240|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213241|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14213242|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213243|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213244|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
14213245|NCT05183178|Ticagrelor|ticagrelor|mesh-list
14213246|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14213247|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14213248|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14213249|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14213250|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14213251|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
14213252|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213253|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213254|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786916|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14786917|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
14786918|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786919|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786920|NCT00717340|Paclitaxel|paclitaxel|mesh-list
14786921|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14786922|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786923|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
14786924|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786925|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
14786926|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786927|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
14786928|NCT00717379|Prednisone|prednisone|mesh-list
14786929|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
14786930|NCT00717379|Tacrolimus|tacrolimus|mesh-list
14786931|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786932|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
14213272|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14213273|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14213274|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
14213275|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213276|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213277|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213278|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14213279|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14213280|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213281|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
14213282|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14213283|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
14213284|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213285|NCT05161351|Vitamin D|vitamin d|mesh-list
14213286|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
14213287|NCT05161351|Baclofen|baclofen|mesh-list
14213288|NCT05161351|Vitamins|vitamins|mesh-ancestor
14213289|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
14213290|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213291|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14213292|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14213293|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14213294|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14213295|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213296|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14213297|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
14213298|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
14213299|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213300|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213301|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14213302|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14213303|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14213304|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213305|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213306|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14213307|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14213308|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213309|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
14213310|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213311|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14213312|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14213313|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14213314|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213315|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213316|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14241470|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
14213317|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506761|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14506762|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506763|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506764|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14506765|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14506766|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14506767|NCT02912455|Canagliflozin|canagliflozin|mesh-list
14506768|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14506769|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506770|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506771|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506772|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
14506773|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506774|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
14506775|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14506776|NCT02912650|Acetaminophen|acetaminophen|mesh-list
14506777|NCT02912650|Ibuprofen|ibuprofen|mesh-list
14506778|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506779|NCT02912650|Analgesics|analgesics|mesh-ancestor
14506780|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
14506781|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506782|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506783|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
14506784|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506785|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506786|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506787|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14506788|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506789|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506790|NCT02913326|Warfarin|warfarin|mesh-list
14506791|NCT02913326|Dabigatran|dabigatran|mesh-list
14506792|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
14506793|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
14506794|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14506795|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
14506796|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506797|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506798|NCT02913521|Diclofenac|diclofenac|mesh-list
14506799|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14506800|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14506801|NCT02913521|Analgesics|analgesics|mesh-ancestor
14506802|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
14506803|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506804|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506805|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506806|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506807|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14506808|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506809|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506810|NCT02913924|Clonazepam|clonazepam|mesh-list
14506811|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
14506812|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
14506813|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
14506814|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530050|NCT03348904|Gemcitabine|gemcitabine|mesh-list
14213318|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213319|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
14213320|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241471|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241472|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241473|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241474|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
14241475|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241476|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241477|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241478|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
14241479|NCT00176930|Busulfan|busulfan|mesh-list
14241480|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241481|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
14241482|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241483|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241484|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14213321|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14213322|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14213323|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213324|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
14213325|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213326|NCT05141708|Talazoparib|talazoparib|mesh-list
14213327|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14213328|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213329|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213330|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213331|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
14213332|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14213333|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14213334|NCT05137496|Prednisolone|prednisolone|mesh-list
14213335|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
14213336|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14213337|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
14213338|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213339|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
14213340|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
14213341|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213342|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213343|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14213344|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
14213345|NCT05137496|Hormones|hormones|mesh-ancestor
14213346|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213347|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14213348|NCT05137496|Protective Agents|protective agents|mesh-ancestor
14213349|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213350|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213351|NCT05061563|Esomeprazole|esomeprazole|mesh-list
14213352|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14213353|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14213354|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14213355|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213356|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213357|NCT05053126|Pregabalin|pregabalin|mesh-list
14213358|NCT05053126|Oxycodone|oxycodone|mesh-list
14213359|NCT05053126|Analgesics|analgesics|mesh-ancestor
14213360|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
14213361|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213362|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213363|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
14213364|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14213365|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14213366|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213367|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14213368|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14213369|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14213370|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213371|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14213372|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14213373|NCT05053126|Narcotics|narcotics|mesh-ancestor
14213374|NCT05047952|Vortioxetine|vortioxetine|mesh-list
14213375|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
14213376|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14213377|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14213378|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14213379|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213380|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213381|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14213382|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14213383|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14213384|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213385|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213386|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
14213387|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14213388|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14506815|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506816|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528686|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528687|NCT03831854|Lamotrigine|lamotrigine|mesh-list
14528688|NCT03831854|Ketamine|ketamine|mesh-list
14213389|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14213390|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14213391|NCT05037123|Ketamine|ketamine|mesh-list
14213392|NCT05037123|Analgesics|analgesics|mesh-ancestor
14213393|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
14213394|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213395|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213396|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14213397|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14213398|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
14213399|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
14213400|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213401|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14213402|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14213403|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213404|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213405|NCT05030818|Aspirin|aspirin|mesh-list
14213406|NCT05030818|Ramipril|ramipril|mesh-list
14213407|NCT05030818|Atorvastatin|atorvastatin|mesh-list
14213408|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14213409|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14213410|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
14213411|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213412|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14213413|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14213414|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213415|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14213416|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14213417|NCT05030818|Analgesics|analgesics|mesh-ancestor
14213418|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
14213419|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213420|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213421|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213422|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14213423|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14213424|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14213425|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14213426|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14213427|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
14213428|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14213429|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
14213430|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14213441|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14213442|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14213443|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
14213444|NCT04987892|Tamsulosin|tamsulosin|mesh-list
14213445|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14213446|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14213447|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14213448|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
14213449|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213450|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213451|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213452|NCT04987892|Urological Agents|urological agents|mesh-ancestor
14213453|NCT04977167|Antibodies|antibodies|mesh-list
14213454|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
14213455|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213456|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
14213457|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213458|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213459|NCT04939935|Metformin|metformin|mesh-list
14213460|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14213461|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213462|NCT04933721|Berotralstat|berotralstat|mesh-list
14213463|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213464|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213465|NCT04908202|BMS-986165|bms-986165|mesh-list
14506817|NCT02914119|Rocuronium|rocuronium|mesh-list
14506818|NCT02914119|Mivacurium|mivacurium|mesh-list
14506819|NCT02914119|Cisatracurium|cisatracurium|mesh-list
14506820|NCT02914119|Succinylcholine|succinylcholine|mesh-list
14506821|NCT02914119|Neostigmine|neostigmine|mesh-list
14506822|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14506823|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14506824|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14506825|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506826|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506827|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14506828|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506829|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506830|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
14506831|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506832|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14506833|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
14506834|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14506835|NCT02914275|Vaccines|vaccines|mesh-list
14506836|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
14506837|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506838|NCT02914509|Travoprost|travoprost|mesh-list
14506839|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14506845|NCT02915159|Abatacept|abatacept|mesh-list
14506846|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14506847|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506848|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506849|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14506850|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
14506851|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506852|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14506853|NCT02915705|Vitamin D|vitamin d|mesh-list
14506854|NCT02915705|Vitamins|vitamins|mesh-ancestor
14506855|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
14506856|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506857|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14506858|NCT02915744|Gemcitabine|gemcitabine|mesh-list
14506859|NCT02915744|Paclitaxel|paclitaxel|mesh-list
14506860|NCT02915744|Vinorelbine|vinorelbine|mesh-list
14506861|NCT02915744|Docetaxel|docetaxel|mesh-list
14506862|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14506863|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
14506864|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14506865|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506866|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14506867|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14506868|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14506869|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506870|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14506871|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
14506872|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
14506873|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14506874|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506875|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14506876|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
14506877|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506878|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14506879|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14506880|NCT02915835|Riociguat|riociguat|mesh-list
14506881|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
14506882|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506883|NCT02915978|Fentanyl|fentanyl|mesh-list
14506884|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14213466|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14213467|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14213468|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213469|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213470|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14213471|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213472|NCT04857138|Atezolizumab|atezolizumab|mesh-list
14213473|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213474|NCT04856215|Antibodies|antibodies|mesh-list
14213475|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14213476|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
14213477|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213478|NCT04849325|Sirolimus|sirolimus|mesh-list
14213479|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14213480|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213481|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213482|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213483|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
14213484|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213485|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
14213486|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213487|NCT04843111|Vaccines|vaccines|mesh-list
14213488|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
14213489|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213490|NCT04837768|Progesterone|progesterone|mesh-list
14213491|NCT04837768|Progestins|progestins|mesh-ancestor
14213492|NCT04837768|Hormones|hormones|mesh-ancestor
14213493|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213494|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213495|NCT04833426|Testosterone|testosterone|mesh-list
14213496|NCT04833426|Androgens|androgens|mesh-ancestor
14213497|NCT04833426|Hormones|hormones|mesh-ancestor
14213498|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213499|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241485|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
14241486|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241487|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241488|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241489|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
14241490|NCT00177047|Melphalan|melphalan|mesh-list
14241491|NCT00177047|Sargramostim|sargramostim|mesh-list
14241492|NCT00177047|Lenograstim|lenograstim|mesh-list
14241493|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241494|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
14241495|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241496|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241497|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241498|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
14241499|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241500|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241501|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241502|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14241503|NCT00177164|Olanzapine|olanzapine|mesh-list
14241504|NCT00177164|Risperidone|risperidone|mesh-list
14241505|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14241506|NCT00177164|Aripiprazole|aripiprazole|mesh-list
14241507|NCT00177164|Ziprasidone|ziprasidone|mesh-list
14241508|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
14241509|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14241510|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
14241511|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241512|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241513|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241514|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14241515|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241516|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241517|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14241518|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
14241519|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
14241520|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
14241521|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241522|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14241523|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14241524|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241525|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241526|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
14241527|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
14241528|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14241529|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14241530|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14241531|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14241532|NCT00177216|Zolpidem|zolpidem|mesh-list
14213500|NCT04769388|Carboplatin|carboplatin|mesh-list
14213501|NCT04769388|Pemetrexed|pemetrexed|mesh-list
14213502|NCT04769388|Osimertinib|osimertinib|mesh-list
14213503|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213504|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213505|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213506|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14213507|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14213508|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14213509|NCT04759248|Trastuzumab|trastuzumab|mesh-list
14213510|NCT04759248|Atezolizumab|atezolizumab|mesh-list
14213511|NCT04759248|Vinorelbine|vinorelbine|mesh-list
14213512|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213513|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213514|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14213515|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
14213516|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
14213517|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
14213518|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213519|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
14213520|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213521|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213522|NCT04745351|Remdesivir|remdesivir|mesh-list
14213523|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
14213524|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213525|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
14213526|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213527|NCT04738643|Varenicline|varenicline|mesh-list
14213528|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14213529|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14213530|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
14213531|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213532|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213533|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213534|NCT04733183|Dacarbazine|dacarbazine|mesh-list
14213535|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14213536|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
14213537|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213538|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213539|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
14213540|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14213541|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213542|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14213543|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213544|NCT04707430|Progesterone|progesterone|mesh-list
14213545|NCT04707430|Progestins|progestins|mesh-ancestor
14213546|NCT04707430|Hormones|hormones|mesh-ancestor
14213547|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213548|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213549|NCT04679623|Midazolam|midazolam|mesh-list
14213550|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14213551|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14213552|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213553|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213554|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14213555|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14213556|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14213557|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14213558|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
14213559|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
14213560|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
14213561|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
14213562|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213563|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213564|NCT04673448|Niraparib|niraparib|mesh-list
14213565|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
14213566|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
14213567|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
14213568|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213569|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14213570|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213571|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213572|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213573|NCT04669665|Ketamine|ketamine|mesh-list
14213574|NCT04669665|Analgesics|analgesics|mesh-ancestor
14213575|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
14213576|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213577|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213578|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14213579|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14213580|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
14213581|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
14213582|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213583|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14213584|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14213585|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213586|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213587|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
14213588|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
14213589|NCT04665856|Carboplatin|carboplatin|mesh-list
14213590|NCT04665856|Etoposide|etoposide|mesh-list
14213591|NCT04665856|Atezolizumab|atezolizumab|mesh-list
14213592|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213593|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14213594|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14213595|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14213596|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213597|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213598|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
14213599|NCT04660539|Azathioprine|azathioprine|mesh-list
14213600|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213601|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213602|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14213603|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
14213604|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14213605|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213606|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213607|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213608|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
14213609|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14213610|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213611|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
14213612|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213613|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14213614|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
14213615|NCT04656067|Ethamsylate|ethamsylate|mesh-list
14213616|NCT04656067|Oxytocin|oxytocin|mesh-list
14213617|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
14213618|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14213619|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213620|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14213621|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14213622|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213623|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
14506885|NCT02915978|Narcotics|narcotics|mesh-ancestor
14506886|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506887|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506888|NCT02915978|Analgesics|analgesics|mesh-ancestor
14506889|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
14506890|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506891|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14506892|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14786933|NCT00717379|Hormones|hormones|mesh-ancestor
14786934|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14786935|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786936|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14786937|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964899|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964900|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13964901|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964902|NCT03133975|Vitamin D|vitamin d|mesh-list
13964903|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
13964904|NCT03133975|Vitamins|vitamins|mesh-ancestor
13964905|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
13964906|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964907|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13964908|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13964909|NCT03133832|Praziquantel|praziquantel|mesh-list
13964910|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
14213624|NCT04656067|Coagulants|coagulants|mesh-ancestor
14213625|NCT04640168|Remdesivir|remdesivir|mesh-list
14213626|NCT04640168|Dexamethasone|dexamethasone|mesh-list
14213627|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213628|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
14213629|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
14213630|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213631|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213632|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14213633|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
14213634|NCT04640168|Hormones|hormones|mesh-ancestor
14213635|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213636|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213637|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213638|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
14213639|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213640|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
14213641|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213642|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
14213643|NCT04608630|Denosumab|denosumab|mesh-list
14213644|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14213645|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213646|NCT04584112|Paclitaxel|paclitaxel|mesh-list
14213647|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14213648|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
14213649|NCT04584112|Carboplatin|carboplatin|mesh-list
14213650|NCT04584112|Doxorubicin|doxorubicin|mesh-list
14213651|NCT04584112|Atezolizumab|atezolizumab|mesh-list
14213652|NCT04584112|Molgramostim|molgramostim|mesh-list
14213653|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14213654|NCT04584112|Sargramostim|sargramostim|mesh-list
14213655|NCT04584112|Lenograstim|lenograstim|mesh-list
14213656|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14213657|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213658|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
14213659|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
14213660|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
14213661|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213662|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213663|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
14213664|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213665|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14213666|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14213667|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
14213668|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14213669|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213670|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14213671|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14213672|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213673|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14213674|NCT04572815|Interleukin-12|interleukin-12|mesh-list
14213675|NCT04572815|Ustekinumab|ustekinumab|mesh-list
14213676|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
14213677|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
14213678|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
14213679|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213680|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14213681|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14213682|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14213683|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14213684|NCT04572815|Growth Substances|growth substances|mesh-ancestor
14213685|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14213686|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213687|NCT04533737|Brodalumab|brodalumab|mesh-list
14213688|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
14213689|NCT04531943|Progesterone|progesterone|mesh-list
14213690|NCT04531943|Estrogens|estrogens|mesh-list
14213691|NCT04531943|Progestins|progestins|mesh-ancestor
14213692|NCT04531943|Hormones|hormones|mesh-ancestor
14213693|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213694|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213695|NCT04522323|Lenvatinib|lenvatinib|mesh-list
14947417|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213696|NCT04522323|Axitinib|axitinib|mesh-list
14213697|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213698|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14213699|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213700|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213701|NCT04487067|Bevacizumab|bevacizumab|mesh-list
14213702|NCT04487067|Atezolizumab|atezolizumab|mesh-list
14213703|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213704|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213705|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14213706|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14213707|NCT04487067|Growth Substances|growth substances|mesh-ancestor
14213708|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213709|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
14241533|NCT00177216|Citalopram|citalopram|mesh-list
14241534|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14241535|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241536|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241537|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241538|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241539|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
14241540|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241541|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14241542|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
14241543|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241544|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14241545|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14241546|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241547|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14241548|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
14241549|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
14241550|NCT00177255|Docetaxel|docetaxel|mesh-list
14241551|NCT00177255|Capecitabine|capecitabine|mesh-list
14241552|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241553|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241554|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241555|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241556|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241557|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14241558|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
14241559|NCT00177294|Citalopram|citalopram|mesh-list
14241560|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14241561|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241562|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241563|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241564|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241565|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
14241566|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241567|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14241568|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
14241569|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241570|NCT00177307|Bevacizumab|bevacizumab|mesh-list
14241571|NCT00177307|Capecitabine|capecitabine|mesh-list
14241572|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
14241573|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14241574|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241575|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14241576|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14241577|NCT00177307|Growth Substances|growth substances|mesh-ancestor
14241578|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241579|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
14241580|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14241581|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
14241582|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241583|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14241584|NCT00177671|Donepezil|donepezil|mesh-list
14241585|NCT00177671|Citalopram|citalopram|mesh-list
14241586|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14241587|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14506893|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
14506894|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
14506895|NCT02916407|Sevoflurane|sevoflurane|mesh-list
14506896|NCT02916407|Desflurane|desflurane|mesh-list
14506897|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14506898|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14506899|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
14506900|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
14947418|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213710|NCT04469075|Clindamycin|clindamycin|mesh-list
14213711|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
14213712|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
14213713|NCT04469075|Triamcinolone|triamcinolone|mesh-list
14213714|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14213715|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14213716|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14213717|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213718|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
14213719|NCT04469075|Hormones|hormones|mesh-ancestor
14213720|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213721|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213722|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213723|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
14213724|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213725|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213726|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14213727|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213728|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14213729|NCT04465487|Cemiplimab|cemiplimab|mesh-list
14213730|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213731|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213732|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
14213733|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14213734|NCT04419519|Venetoclax|venetoclax|mesh-list
14213735|NCT04419519|Antibodies|antibodies|mesh-list
14213736|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14213737|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
14213738|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213739|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213743|NCT04400539|Nivolumab|nivolumab|mesh-list
14213744|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213745|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213746|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14213747|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213748|NCT04394117|Losartan|losartan|mesh-list
14213749|NCT04394117|Valsartan|valsartan|mesh-list
14213750|NCT04394117|Telmisartan|telmisartan|mesh-list
14213751|NCT04394117|Candesartan|candesartan|mesh-list
14213752|NCT04394117|Olmesartan|olmesartan|mesh-list
14213753|NCT04394117|Irbesartan|irbesartan|mesh-list
14213754|NCT04394117|Eprosartan|eprosartan|mesh-list
14213755|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14213756|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14213757|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14213758|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213759|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14213760|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
14213761|NCT04393753|Avelumab|avelumab|mesh-list
14213762|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213763|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213764|NCT04372108|Ustekinumab|ustekinumab|mesh-list
14213765|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
14213766|NCT04335890|Vaccines|vaccines|mesh-list
14213767|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
14213768|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213769|NCT04256941|Letrozole|letrozole|mesh-list
14213770|NCT04256941|Fulvestrant|fulvestrant|mesh-list
14213771|NCT04256941|Palbociclib|palbociclib|mesh-list
14213772|NCT04256941|Anastrozole|anastrozole|mesh-list
14213773|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213774|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14213775|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14213776|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213777|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213778|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14213779|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
14213780|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213781|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213782|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213783|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14213784|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14213785|NCT04256421|Carboplatin|carboplatin|mesh-list
14213786|NCT04256421|Etoposide|etoposide|mesh-list
14213787|NCT04256421|Atezolizumab|atezolizumab|mesh-list
14213788|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213789|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14213790|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14213791|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14213792|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213793|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213794|NCT04203641|Doxorubicin|doxorubicin|mesh-list
14213795|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213796|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213797|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14213798|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14213799|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213800|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213801|NCT04203290|Bupivacaine|bupivacaine|mesh-list
14213802|NCT04203290|Sevoflurane|sevoflurane|mesh-list
14213803|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
14213804|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
14213805|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213806|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213807|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
14213808|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213809|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14213810|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14213811|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
14213812|NCT04195945|Cytarabine|cytarabine|mesh-list
14213813|NCT04195945|Daunorubicin|daunorubicin|mesh-list
14213814|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
14213815|NCT04195945|Cladribine|cladribine|mesh-list
14213816|NCT04195945|Sargramostim|sargramostim|mesh-list
14213817|NCT04195945|Lenograstim|lenograstim|mesh-list
14213818|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14213819|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
14213820|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213821|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213822|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
14213823|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213824|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213825|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
14213826|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213827|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213828|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14213829|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14213830|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213831|NCT04195945|Analgesics|analgesics|mesh-ancestor
14213832|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
14213833|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213834|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14213835|NCT04195633|Cyclosporine|cyclosporine|mesh-list
14213836|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
14213837|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
14213838|NCT04195633|Treosulfan|treosulfan|mesh-list
14213839|NCT04195633|Busulfan|busulfan|mesh-list
14213840|NCT04195633|Fludarabine|fludarabine|mesh-list
14213841|NCT04195633|Cyclosporins|cyclosporins|mesh-list
14213842|NCT04195633|Lenograstim|lenograstim|mesh-list
14213843|NCT04195633|Sargramostim|sargramostim|mesh-list
14213844|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213845|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
14213846|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213847|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14213848|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14213849|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
14213850|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213851|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213852|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14213853|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14213854|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213855|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
14213856|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213857|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
14213858|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14213859|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14213860|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14213861|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
14213862|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14213863|NCT04180371|Nivolumab|nivolumab|mesh-list
14213864|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213865|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213866|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14213867|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213868|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
14213869|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213870|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213871|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
14213872|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213873|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213874|NCT04125550|Propofol|propofol|mesh-list
14213875|NCT04125550|Sevoflurane|sevoflurane|mesh-list
14213876|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14213877|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213878|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213879|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14213880|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
14213881|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
14213882|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14213883|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14213884|NCT04123561|Dexamethasone|dexamethasone|mesh-list
14213885|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
14213886|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14213887|NCT04123561|BB 1101|bb 1101|mesh-list
14213888|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14213889|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
14213890|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
14213891|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213892|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213893|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14213894|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
14213895|NCT04123561|Hormones|hormones|mesh-ancestor
14213896|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14213897|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14213898|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213899|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
14213900|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213901|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213902|NCT04109066|Paclitaxel|paclitaxel|mesh-list
14213903|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
14213904|NCT04109066|Nivolumab|nivolumab|mesh-list
14213905|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14213906|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213907|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
14213908|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
14213909|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
14213910|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213911|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14213912|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
14213913|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213914|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14213915|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14213916|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
14213917|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14213918|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213919|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14213920|NCT04106856|Losartan|losartan|mesh-list
14213921|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14213922|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14213923|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14213924|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14213925|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213926|NCT04098744|Artesunate|artesunate|mesh-list
14213927|NCT04098744|Artemisinins|artemisinins|mesh-list
14213928|NCT04098744|Artemisinin|artemisinin|mesh-list
14213929|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
14213930|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14213931|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14213932|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14213933|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213934|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
14213935|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
14213936|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14213937|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
14213938|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
14213939|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14213940|NCT04090190|Oxybutynin|oxybutynin|mesh-list
14213941|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14213942|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14213943|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
14213944|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213945|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213946|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213947|NCT04090190|Urological Agents|urological agents|mesh-ancestor
14213948|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
14213949|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
14213950|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213951|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
14213952|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14213953|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14213954|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213955|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14213956|NCT04040439|Analgesics|analgesics|mesh-ancestor
14213957|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
14213958|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213959|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14213960|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14213961|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14213962|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
14213963|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213964|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213965|NCT04038255|Nicotine|nicotine|mesh-list
14213966|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14213967|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
14213968|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14213969|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14213970|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14213971|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14213972|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
14213973|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14213974|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213975|NCT04028050|Carboplatin|carboplatin|mesh-list
14213976|NCT04028050|Etoposide|etoposide|mesh-list
14213977|NCT04028050|Atezolizumab|atezolizumab|mesh-list
14213978|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213979|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14213980|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14213981|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14213982|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213983|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241588|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241589|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241590|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241591|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241592|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
14241593|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241594|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14241595|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
14241596|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241597|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241598|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
14241599|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14241600|NCT00177671|Analgesics|analgesics|mesh-ancestor
14241601|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
14241602|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
14241603|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14241604|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241605|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
14241606|NCT00178178|Bupivacaine|bupivacaine|mesh-list
14241607|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
14241608|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
14241609|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241610|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241611|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
14241612|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241613|NCT00178256|Paclitaxel|paclitaxel|mesh-list
14528689|NCT03831854|Analgesics|analgesics|mesh-ancestor
14213984|NCT03976375|Docetaxel|docetaxel|mesh-list
14213985|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
14213986|NCT03976375|Lenvatinib|lenvatinib|mesh-list
14213987|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213988|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
14213989|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
14213990|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
14213991|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14213992|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14213993|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14947419|NCT01527890|Analgesics|analgesics|mesh-ancestor
14947420|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
14947421|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947422|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14213994|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506901|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506902|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506903|NCT02916433|Octreotide|octreotide|mesh-list
14506904|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506905|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14506906|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506907|NCT02916693|Mirabegron|mirabegron|mesh-list
14506908|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14506909|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14506910|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14506911|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
14506912|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506913|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506914|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506915|NCT02916693|Urological Agents|urological agents|mesh-ancestor
14506916|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14506917|NCT02916745|Trioxsalen|trioxsalen|mesh-list
14506918|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506919|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
14506920|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14506921|NCT02916927|Ketamine|ketamine|mesh-list
14506922|NCT02916927|Analgesics|analgesics|mesh-ancestor
14506923|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
14506924|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506925|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506926|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14506927|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14506928|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
14506929|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
14506930|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506931|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14506932|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14506933|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506934|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506935|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14506936|NCT02917031|Saxagliptin|saxagliptin|mesh-list
14506937|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14506938|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506939|NCT02917031|Incretins|incretins|mesh-ancestor
14506940|NCT02917031|Hormones|hormones|mesh-ancestor
14506941|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506942|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14506943|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
14506944|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506945|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506946|NCT02917122|Sertraline|sertraline|mesh-list
14506947|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
14506948|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506949|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14506950|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14506951|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14506952|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506953|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506954|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
14506955|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506956|NCT02917941|Dexamethasone|dexamethasone|mesh-list
14506957|NCT02917941|Lenalidomide|lenalidomide|mesh-list
14506958|NCT02917941|Ixazomib|ixazomib|mesh-list
14530051|NCT03348904|Paclitaxel|paclitaxel|mesh-list
14213995|NCT03954782|Nintedanib|nintedanib|mesh-list
14213996|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14213997|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14213998|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14213999|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214000|NCT03922997|Atezolizumab|atezolizumab|mesh-list
14214001|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214002|NCT03899428|Sorafenib|sorafenib|mesh-list
14214003|NCT03899428|Durvalumab|durvalumab|mesh-list
14214004|NCT03899428|Lenvatinib|lenvatinib|mesh-list
14214005|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214006|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14214007|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214008|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214009|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214010|NCT03885713|Adalimumab|adalimumab|mesh-list
14214011|NCT03885713|Golimumab|golimumab|mesh-list
14214012|NCT03885713|Infliximab|infliximab|mesh-list
14214013|NCT03885713|Ustekinumab|ustekinumab|mesh-list
14214014|NCT03885713|Vedolizumab|vedolizumab|mesh-list
14214015|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214016|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214017|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214018|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14214019|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14214020|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214021|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
14214022|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214023|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
14214024|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214025|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214026|NCT03862716|Insulin|insulin|mesh-list
14214027|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14214028|NCT03862716|Metformin|metformin|mesh-list
14214029|NCT03862716|Liraglutide|liraglutide|mesh-list
14214030|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
14214031|NCT03862716|Xultophy|xultophy|mesh-list
14214032|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14214033|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214034|NCT03862716|Incretins|incretins|mesh-ancestor
14214035|NCT03862716|Hormones|hormones|mesh-ancestor
14214036|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214037|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
14214038|NCT03862170|Cefazolin|cefazolin|mesh-list
14214039|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214040|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214041|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14214042|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14214043|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214044|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214045|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214046|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14214047|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14214048|NCT03844997|Palbociclib|palbociclib|mesh-list
14214049|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214050|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14214051|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214052|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214053|NCT03825302|Mannitol|mannitol|mesh-list
14214054|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
14214055|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14214056|NCT03825302|Diuretics|diuretics|mesh-ancestor
14214057|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
14214058|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214059|NCT03825302|Miotics|miotics|mesh-ancestor
14214060|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
14214061|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214062|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14214063|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14214064|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
14214065|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14214066|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14214067|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
14214068|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214069|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214070|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14214071|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
14214072|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
14214073|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14214074|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14214075|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14214076|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
14214077|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14214078|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214079|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14214080|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14214081|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14214082|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214083|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214084|NCT03675139|Progestins|progestins|mesh-ancestor
14214085|NCT03675139|Hormones|hormones|mesh-ancestor
14214086|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214096|NCT03537599|Daratumumab|daratumumab|mesh-list
14214097|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214098|NCT03537508|Vaccines|vaccines|mesh-list
14214099|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
14214100|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214101|NCT03464097|Ozanimod|ozanimod|mesh-list
14214102|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14214103|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214104|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214105|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
14214106|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214107|NCT03440385|Ozanimod|ozanimod|mesh-list
14214108|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14214109|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214110|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214111|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
14214112|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214113|NCT03440372|Ozanimod|ozanimod|mesh-list
14214114|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14214115|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214116|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214117|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
14214118|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214119|NCT03434730|Cyclosporine|cyclosporine|mesh-list
14214120|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
14214121|NCT03434730|Lenograstim|lenograstim|mesh-list
14214122|NCT03434730|Cyclosporins|cyclosporins|mesh-list
14214123|NCT03434730|Sargramostim|sargramostim|mesh-list
14214124|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14214125|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
14214126|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214127|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214128|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214129|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214130|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
14214131|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214132|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214133|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214134|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14214135|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14214136|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214137|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14214138|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
14214139|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214140|NCT03418779|Prednisolone|prednisolone|mesh-list
14214141|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
14214142|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14214143|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
14214144|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214145|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14530052|NCT03348904|Carboplatin|carboplatin|mesh-list
14214146|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14214147|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
14214148|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214149|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214150|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14214151|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214152|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
14214153|NCT03418779|Hormones|hormones|mesh-ancestor
14214154|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214155|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214156|NCT03388138|Ketotifen|ketotifen|mesh-list
14214157|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
14214158|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214159|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14214160|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
14214161|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
14214162|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214163|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214164|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214165|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14214166|NCT03351348|Bupivacaine|bupivacaine|mesh-list
14214167|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
14214168|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
14214169|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214170|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214171|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
14214172|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214173|NCT03289039|Fulvestrant|fulvestrant|mesh-list
14214174|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214175|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214176|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14214177|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14214178|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
14214179|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214180|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214190|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
14214191|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214192|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214193|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
14214194|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214195|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214196|NCT03226301|Venetoclax|venetoclax|mesh-list
14214197|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214198|NCT03199924|Diclofenac|diclofenac|mesh-list
14214199|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14214200|NCT03199924|Lidocaine|lidocaine|mesh-list
14214201|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
14214202|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
14214203|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
14214204|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214205|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214206|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
14214207|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214208|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14214209|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14214210|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14214211|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14214212|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214213|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14214214|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14214215|NCT03199924|Analgesics|analgesics|mesh-ancestor
14214216|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214217|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14214218|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214219|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
14214220|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14214221|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14214222|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
14214223|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14214224|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
14214225|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14214226|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241614|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14241615|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241616|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241617|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241618|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241619|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241620|NCT00178464|Aspirin|aspirin|mesh-list
14241621|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14241622|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14241623|NCT00178464|Analgesics|analgesics|mesh-ancestor
14241624|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
14241625|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786938|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786939|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
14786940|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14786941|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786942|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786943|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14786944|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14241626|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241627|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14241628|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241629|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14241630|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14241631|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241632|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14241633|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14241634|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241635|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
14241636|NCT00178503|Methylphenidate|methylphenidate|mesh-list
14241637|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14241638|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241639|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14241640|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241641|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241642|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241643|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
14241644|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241645|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
14241646|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14241647|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14241648|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14241649|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241650|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241651|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
14241652|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241653|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241654|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14241655|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786945|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
14786946|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14786947|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786948|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
14786949|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
14786950|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14786951|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786952|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14786953|NCT00717379|Protective Agents|protective agents|mesh-ancestor
14786954|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
14786955|NCT00717470|Prednisone|prednisone|mesh-list
14786956|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
14786957|NCT00717470|Tacrolimus|tacrolimus|mesh-list
14786958|NCT00717470|Basiliximab|basiliximab|mesh-list
14786959|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14786960|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
14786961|NCT00717470|Hormones|hormones|mesh-ancestor
14214227|NCT03171025|Nivolumab|nivolumab|mesh-list
14214228|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214229|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214230|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14214231|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214232|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
14214233|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214234|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
14214235|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214236|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214237|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14214238|NCT03140423|Mupirocin|mupirocin|mesh-list
14214239|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214240|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214241|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14214242|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214243|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214244|NCT03101722|Huperzine A|huperzine a|mesh-list
14214245|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14214246|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214247|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214248|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
14214249|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214250|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786962|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214251|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14214252|NCT03101722|Protective Agents|protective agents|mesh-ancestor
14214253|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
14214254|NCT03088852|Cathartics|cathartics|mesh-ancestor
14214255|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14214256|NCT03067610|Paclitaxel|paclitaxel|mesh-list
14214257|NCT03067610|Cisplatin|cisplatin|mesh-list
14214258|NCT03067610|Carboplatin|carboplatin|mesh-list
14214259|NCT03067610|Cetuximab|cetuximab|mesh-list
14214260|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14214261|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214262|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14214263|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14214264|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14214265|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214266|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214267|NCT03037385|Pralsetinib|pralsetinib|mesh-list
14214268|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214269|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14214270|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214271|NCT03015090|Theophylline|theophylline|mesh-list
14214272|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14214273|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
14214274|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214275|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214276|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14214277|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
14214278|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14214279|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214280|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786963|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786964|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14786965|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786966|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14786967|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
14786968|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14786969|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786970|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786971|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14786972|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14786973|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
14786974|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14786975|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14786976|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
14786977|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
14214281|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
14214282|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14214283|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14214284|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
14214285|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214286|NCT03000374|Leucovorin|leucovorin|mesh-list
14214287|NCT03000374|Fluorouracil|fluorouracil|mesh-list
14214288|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
14214289|NCT03000374|Panitumumab|panitumumab|mesh-list
14214290|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
14214291|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214292|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14214293|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214294|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214295|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
14214296|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214297|NCT03000374|Antidotes|antidotes|mesh-ancestor
14214298|NCT03000374|Protective Agents|protective agents|mesh-ancestor
14214299|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
14214300|NCT03000374|Vitamins|vitamins|mesh-ancestor
14214301|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
14506959|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14506960|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
14506961|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
14506962|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14506963|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506964|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14506965|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
14506966|NCT02917941|Hormones|hormones|mesh-ancestor
14506967|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14506968|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14506969|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14506970|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
14506971|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14506972|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14506973|NCT02917941|Growth Substances|growth substances|mesh-ancestor
14506974|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
14506975|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
14506976|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14506977|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506978|NCT02918071|Benralizumab|benralizumab|mesh-list
14506979|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14506980|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
14506981|NCT02918097|Risperidone|risperidone|mesh-list
14506982|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
14506983|NCT02918097|Sertraline|sertraline|mesh-list
14506984|NCT02918097|Nortriptyline|nortriptyline|mesh-list
14506985|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14506986|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
14506987|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14506988|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14506989|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14506990|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14506991|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14506992|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14506993|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14506994|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14506995|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
14506996|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
14506997|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14506998|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14506999|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507000|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507001|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
14507002|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14507003|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14507004|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
14507005|NCT02918266|Scopolamine|scopolamine|mesh-list
14507006|NCT02918266|Donepezil|donepezil|mesh-list
14507007|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14507008|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14507009|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214302|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214303|NCT02994836|Adalimumab|adalimumab|mesh-list
14214304|NCT02994836|Infliximab|infliximab|mesh-list
14507010|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507011|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
14214305|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14214306|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214307|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214308|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214309|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14214310|NCT02985957|Prednisone|prednisone|mesh-list
14786978|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214311|NCT02985957|Nivolumab|nivolumab|mesh-list
14214312|NCT02985957|Ipilimumab|ipilimumab|mesh-list
14214313|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214314|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
14214315|NCT02985957|Hormones|hormones|mesh-ancestor
14214316|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214317|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214318|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214319|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214320|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214321|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14214322|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214323|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14214324|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214325|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214326|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
14214327|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214328|NCT02916771|Dexamethasone|dexamethasone|mesh-list
14214329|NCT02916771|Lenalidomide|lenalidomide|mesh-list
14214330|NCT02916771|Ixazomib|ixazomib|mesh-list
14214331|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214332|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
14214333|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
14214334|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214335|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214336|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14214337|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
14214338|NCT02916771|Hormones|hormones|mesh-ancestor
14214339|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214340|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214341|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214342|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
14214343|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14214344|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14214345|NCT02916771|Growth Substances|growth substances|mesh-ancestor
14214346|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
14214347|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
14214348|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214349|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214350|NCT02831673|Tenofovir|tenofovir|mesh-list
14214351|NCT02831673|Lamivudine|lamivudine|mesh-list
14214352|NCT02831673|Emtricitabine|emtricitabine|mesh-list
14214353|NCT02831673|Dolutegravir|dolutegravir|mesh-list
14214354|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
14214355|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214356|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14214357|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14214358|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214359|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214360|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14214361|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14214362|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14214363|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14214364|NCT02800941|Warfarin|warfarin|mesh-list
14214365|NCT02800941|Anticoagulants|anticoagulants|mesh-list
14214366|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
14214367|NCT02800941|Fluindione|fluindione|mesh-list
14214368|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
14214369|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214370|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214371|NCT02477826|Gemcitabine|gemcitabine|mesh-list
14214372|NCT02477826|Paclitaxel|paclitaxel|mesh-list
14214373|NCT02477826|Carboplatin|carboplatin|mesh-list
14214374|NCT02477826|Nivolumab|nivolumab|mesh-list
14214375|NCT02477826|Pemetrexed|pemetrexed|mesh-list
14214376|NCT02477826|Ipilimumab|ipilimumab|mesh-list
14214377|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14214378|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214379|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14214380|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14214381|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
14214382|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214383|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14214384|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
14214385|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
14214386|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214387|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214388|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214389|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
14214390|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214391|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214392|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14214393|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14214394|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14214395|NCT02359994|Hemostatics|hemostatics|mesh-list
14214396|NCT02359994|Coagulants|coagulants|mesh-ancestor
14214397|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14214398|NCT02359097|Hematinics|hematinics|mesh-ancestor
14214399|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14214400|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14214401|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
14214402|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214403|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
14214404|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214405|NCT02334865|Lenalidomide|lenalidomide|mesh-list
14214406|NCT02334865|Sargramostim|sargramostim|mesh-list
14214407|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
14214408|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
14214409|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214410|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14214411|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14214412|NCT02334865|Growth Substances|growth substances|mesh-ancestor
14214413|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
14214414|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214415|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14214416|NCT02188745|Letrozole|letrozole|mesh-list
14214417|NCT02188745|Anastrozole|anastrozole|mesh-list
14214418|NCT02188745|Exemestane|exemestane|mesh-list
14214419|NCT02188745|Estradiol|estradiol|mesh-list
14214420|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14214421|NCT02188745|Estrogens|estrogens|mesh-ancestor
14214422|NCT02188745|Hormones|hormones|mesh-ancestor
14214423|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214424|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214425|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214426|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14214427|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214428|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214429|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14214430|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
14214431|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214432|NCT02041533|Gemcitabine|gemcitabine|mesh-list
14214433|NCT02041533|Paclitaxel|paclitaxel|mesh-list
14214434|NCT02041533|Carboplatin|carboplatin|mesh-list
14214435|NCT02041533|Nivolumab|nivolumab|mesh-list
14214436|NCT02041533|Pemetrexed|pemetrexed|mesh-list
14214437|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14214438|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214439|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
14214440|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
14214441|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
14214442|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214443|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14214444|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
14214445|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
14214446|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214447|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214448|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214449|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
14214450|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214451|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214452|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14214453|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14214454|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14214455|NCT02032823|Olaparib|olaparib|mesh-list
14214456|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14214457|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241656|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
14214458|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214459|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214460|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
14214461|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14214462|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14214463|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214464|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
14214465|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
14214466|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214467|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
14214468|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
14214469|NCT01904136|Melphalan|melphalan|mesh-list
14214470|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
14214471|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14214472|NCT01904136|Fludarabine|fludarabine|mesh-list
14214473|NCT01904136|Tacrolimus|tacrolimus|mesh-list
14214474|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214475|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
14214476|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214477|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214478|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14214479|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
14214480|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214481|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214482|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14214483|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14214484|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214485|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14214486|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14214487|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
14214488|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214489|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214490|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14214491|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14214492|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14214493|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214494|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214495|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14214496|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14214497|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14214498|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
14214499|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214500|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214501|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14214502|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14214503|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
14214504|NCT01310010|Dasatinib|dasatinib|mesh-list
14214505|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214506|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14214507|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214508|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214509|NCT00719888|Cyclosporine|cyclosporine|mesh-list
14214510|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
14214511|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
14214512|NCT00719888|Thiotepa|thiotepa|mesh-list
14214513|NCT00719888|Fludarabine|fludarabine|mesh-list
14214514|NCT00719888|Cyclosporins|cyclosporins|mesh-list
14214515|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214516|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
14214517|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214518|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214519|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14214520|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
14214521|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214522|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214523|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14214524|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214525|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
14214526|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214527|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214528|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14214529|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14214530|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14214531|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
14214532|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214533|NCT00503035|Celecoxib|celecoxib|mesh-list
14214534|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14214535|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14214536|NCT00503035|Analgesics|analgesics|mesh-ancestor
14214537|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
14214538|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214539|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214540|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214541|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214542|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14214543|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14214544|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214545|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214546|NCT00378482|Tremelimumab|tremelimumab|mesh-list
14214547|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214548|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
14214549|NCT00303849|Carboplatin|carboplatin|mesh-list
14214550|NCT00303849|Etoposide|etoposide|mesh-list
14214551|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
14214552|NCT00303849|Melphalan|melphalan|mesh-list
14214553|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
14214554|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
14214555|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14214556|NCT00303849|Mannitol|mannitol|mesh-list
14214557|NCT00303849|Antidotes|antidotes|mesh-list
14214558|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214559|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14214560|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14214561|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14214562|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214563|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214564|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14214565|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
14214566|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14214567|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214568|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
14214569|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214570|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14214571|NCT00303849|Diuretics|diuretics|mesh-ancestor
14214572|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
14214573|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
14214574|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214575|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
14214576|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
14214577|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
14214578|NCT00303849|Protective Agents|protective agents|mesh-ancestor
14214579|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
14214580|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
14214581|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214582|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214583|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
14214584|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
14214585|NCT00161044|Galantamine|galantamine|mesh-list
14214586|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14214587|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214588|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214589|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
14214590|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214591|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214592|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14214593|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
14214594|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214595|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
14241657|NCT00178841|Bexarotene|bexarotene|mesh-list
14241658|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14241659|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241660|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241661|NCT00178919|Trimethaphan|trimethaphan|mesh-list
14241662|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
14241663|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241664|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14241665|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14241666|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14241667|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
14241668|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241669|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241670|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14214596|NCT03833323|Treprostinil|treprostinil|mesh-list
14214597|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14214598|NCT03829579|Esketamine|esketamine|mesh-list
14214599|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
14214600|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14214601|NCT03828162|Anticoagulants|anticoagulants|mesh-list
14214602|NCT03819413|Antibodies|antibodies|mesh-list
14214603|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
14214604|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
14214605|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214606|NCT03819452|Vitamin D|vitamin d|mesh-list
14214607|NCT03819452|Vitamins|vitamins|mesh-ancestor
14214608|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
14214609|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214610|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14214611|NCT03815422|Anesthetics|anesthetics|mesh-list
14214612|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214613|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241671|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14241672|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
14241673|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241674|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
14241675|NCT00179010|Adenosine|adenosine|mesh-list
14241676|NCT00179010|Analgesics|analgesics|mesh-ancestor
14241677|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
14241678|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241679|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241680|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14241681|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
14241682|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14241683|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
14241684|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
14241685|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241686|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241687|NCT00179309|Docetaxel|docetaxel|mesh-list
14241688|NCT00179309|Sargramostim|sargramostim|mesh-list
14241689|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241690|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241691|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241692|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241693|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241694|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
14241695|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241696|NCT00179413|Interferons|interferons|mesh-list
14241697|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
14241698|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
14241699|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14241700|NCT00179413|Colchicine|colchicine|mesh-list
14241701|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241702|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
14241703|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241704|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
14241705|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241706|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
14241707|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241708|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241709|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241710|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241711|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241712|NCT00179478|Interferons|interferons|mesh-list
14241713|NCT00179478|Interferon-beta|interferon-beta|mesh-list
14241714|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
14241715|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241716|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
14241717|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241718|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
14241719|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241720|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14241721|NCT00179517|Anastrozole|anastrozole|mesh-list
14241722|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14241723|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241724|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14241725|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14241726|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241727|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241728|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14947423|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14241729|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
14214614|NCT03811366|Prednisone|prednisone|mesh-list
14214615|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214616|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
14214617|NCT03811366|Hormones|hormones|mesh-ancestor
14214618|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214619|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214620|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214621|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214622|NCT03806543|Vancomycin|vancomycin|mesh-list
14214623|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214624|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947424|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
14947425|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
14947426|NCT01527903|Midazolam|midazolam|mesh-list
14947427|NCT01527903|Propofol|propofol|mesh-list
14947428|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14947429|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947430|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947431|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14947432|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
14507012|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507013|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507014|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
14507015|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14507016|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
14507017|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
14507018|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507019|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507020|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
14507021|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14507022|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14507023|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
14507024|NCT02918279|Liraglutide|liraglutide|mesh-list
14507025|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14507026|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507027|NCT02918279|Incretins|incretins|mesh-ancestor
14507028|NCT02918279|Hormones|hormones|mesh-ancestor
14507029|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507030|NCT02918318|Esketamine|esketamine|mesh-list
14507031|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
14507032|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14507033|NCT02918357|Edetic Acid|edetic acid|mesh-list
14507034|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
14507035|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
14507036|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507037|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
14507038|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14507039|NCT02918617|Fluorides|fluorides|mesh-list
14507040|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
14507041|NCT02918617|Protective Agents|protective agents|mesh-ancestor
14507042|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507043|NCT02918630|Nicotine|nicotine|mesh-list
14507044|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14507045|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
14507046|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507047|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507048|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14507049|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14507050|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
14507051|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507052|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507053|NCT02918721|Lidocaine|lidocaine|mesh-list
14507054|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
14507055|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
14507056|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
14507057|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507058|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507059|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
14507060|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507061|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14507062|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14507063|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14507064|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507065|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507066|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14214625|NCT03804099|Aflibercept|aflibercept|mesh-list
14947433|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
14214626|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14214627|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14214628|NCT03804099|Growth Substances|growth substances|mesh-ancestor
14214629|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214630|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
14214631|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214632|NCT03797547|Aflibercept|aflibercept|mesh-list
14214633|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14214634|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14214635|NCT03797547|Growth Substances|growth substances|mesh-ancestor
14214636|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214637|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
14214638|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214639|NCT03793400|Bevacizumab|bevacizumab|mesh-list
14214640|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214641|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214642|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14214643|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14214644|NCT03793400|Growth Substances|growth substances|mesh-ancestor
14214645|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214646|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
14214647|NCT03792334|Anesthetics|anesthetics|mesh-list
14214648|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214649|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241730|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241731|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241732|NCT00179621|Lenalidomide|lenalidomide|mesh-list
14241733|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
14241734|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241735|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14241736|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14241737|NCT00179621|Growth Substances|growth substances|mesh-ancestor
14241738|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
14241739|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241740|NCT00179647|Dexamethasone|dexamethasone|mesh-list
14241741|NCT00179647|Lenalidomide|lenalidomide|mesh-list
14241742|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14241743|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
14241744|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
14241745|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241746|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241747|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14241748|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
14241749|NCT00179647|Hormones|hormones|mesh-ancestor
14241750|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241751|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14241752|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241753|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
14241754|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14241755|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14241756|NCT00179647|Growth Substances|growth substances|mesh-ancestor
14241757|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
14241758|NCT00179660|Lenalidomide|lenalidomide|mesh-list
14241759|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
14241760|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241761|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14241762|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14241763|NCT00179660|Growth Substances|growth substances|mesh-ancestor
14241764|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
14241765|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241766|NCT00179673|Lenalidomide|lenalidomide|mesh-list
14241767|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
14241768|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241769|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14241770|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14241771|NCT00179673|Growth Substances|growth substances|mesh-ancestor
14241772|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14241773|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241774|NCT00179959|Mupirocin|mupirocin|mesh-list
14241775|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14241776|NCT00179959|Eusol|eusol|mesh-list
14241777|NCT00179959|Petrolatum|petrolatum|mesh-list
14241778|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14241779|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241780|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14241781|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214650|NCT03789968|Tenofovir|tenofovir|mesh-list
14214651|NCT03789968|Emtricitabine|emtricitabine|mesh-list
14214652|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14214653|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
14214654|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214655|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14214656|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14214657|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214658|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214659|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14214660|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14241782|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964911|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13964912|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964913|NCT03133845|Fentanyl|fentanyl|mesh-list
14241783|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
14241784|NCT00179959|Emollients|emollients|mesh-ancestor
14241785|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
14241786|NCT00180479|Paclitaxel|paclitaxel|mesh-list
14241787|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14241788|NCT00180479|Everolimus|everolimus|mesh-list
14241789|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14241790|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241791|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241792|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241793|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241794|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241795|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241796|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
14241797|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241798|NCT00180674|Warfarin|warfarin|mesh-list
14241799|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
14241800|NCT00180687|Bupivacaine|bupivacaine|mesh-list
14241801|NCT00180687|Coal Tar|coal tar|mesh-list
14241802|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
14241803|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
14241804|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241805|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241806|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
14241807|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241808|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
14241809|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
14241810|NCT00180713|Simvastatin|simvastatin|mesh-list
14241811|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14241812|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14241813|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
14241814|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241815|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14241816|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14241817|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241818|NCT00181155|Allopurinol|allopurinol|mesh-list
14241819|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
14241820|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241821|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241822|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
14241823|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241824|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14241825|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
14241826|NCT00181155|Protective Agents|protective agents|mesh-ancestor
14241827|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241828|NCT00181714|Methylphenidate|methylphenidate|mesh-list
14241829|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14241830|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241831|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14241832|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241833|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241834|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241835|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
13964914|NCT03133845|Midazolam|midazolam|mesh-list
13964915|NCT03133845|Morphine|morphine|mesh-list
13964916|NCT03133845|Anesthetics|anesthetics|mesh-list
13964917|NCT03133845|Propofol|propofol|mesh-list
13964918|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964919|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964920|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13964921|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14214661|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14214662|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14214663|NCT03767712|Antibodies|antibodies|mesh-list
14214664|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
14214665|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
14214666|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214667|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
14214668|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
14214669|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214670|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
14214671|NCT03760562|Hormones|hormones|mesh-ancestor
14214672|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214673|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214674|NCT03751397|Cystatins|cystatins|mesh-list
14214675|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14214676|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
14214677|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214678|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214679|NCT03748095|Tazobactam|tazobactam|mesh-list
14214680|NCT03748095|Piperacillin|piperacillin|mesh-list
14214681|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214682|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214683|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14214684|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214685|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241836|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241837|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14241838|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14241839|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241840|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241841|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241842|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
14241843|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241844|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241845|NCT00181844|Lamotrigine|lamotrigine|mesh-list
14241846|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
14241847|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14241848|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13964922|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
14241849|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241850|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14241851|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241852|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14241853|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14241854|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241855|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241856|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14241857|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14241858|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
14241859|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241860|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14507067|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
13964923|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13964924|NCT03133845|Narcotics|narcotics|mesh-ancestor
13964925|NCT03133845|Analgesics|analgesics|mesh-ancestor
13964926|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
13964927|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964928|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13964929|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13964930|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13964931|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964932|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
13964933|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
13964934|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13964935|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964936|NCT03133897|Dexamethasone|dexamethasone|mesh-list
13964937|NCT03133897|Prednisone|prednisone|mesh-list
13964938|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13964939|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
13964940|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
13964941|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964942|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964943|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14241861|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14214686|NCT03744546|Tilavonemab|tilavonemab|mesh-list
14507068|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
14507069|NCT02918721|Protective Agents|protective agents|mesh-ancestor
14507070|NCT02918877|Propofol|propofol|mesh-list
14507071|NCT02918877|Sevoflurane|sevoflurane|mesh-list
14507072|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14507073|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507074|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507075|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14507076|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
14507077|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
14507078|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14507079|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14507080|NCT02918968|Flutamide|flutamide|mesh-list
14507081|NCT02918968|Androgens|androgens|mesh-list
14507082|NCT02918968|Hormones|hormones|mesh-ancestor
14507083|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507084|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507085|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
14507086|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
14507087|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507088|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507089|NCT02919111|Edetic Acid|edetic acid|mesh-list
14507090|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
14507091|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
14507092|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507093|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
14507094|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14507095|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14507096|NCT02919761|Hormones|hormones|mesh-ancestor
14507097|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507098|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507099|NCT02920528|Ketamine|ketamine|mesh-list
14507100|NCT02920528|Analgesics|analgesics|mesh-ancestor
14507101|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
14507102|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507103|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507104|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14507105|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14507106|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
14507107|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
14507108|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507109|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14507110|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14507111|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507112|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507113|NCT02920749|Anesthetics|anesthetics|mesh-list
14507114|NCT02920749|Propofol|propofol|mesh-list
14507115|NCT02920749|Sevoflurane|sevoflurane|mesh-list
14507116|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507117|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507118|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14507119|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14507120|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
14507121|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14786979|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14786980|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14786981|NCT00717470|Protective Agents|protective agents|mesh-ancestor
14786982|NCT00717561|Amoxicillin|amoxicillin|mesh-list
14786983|NCT00717561|Azithromycin|azithromycin|mesh-list
14786984|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
14786985|NCT00717561|Clarithromycin|clarithromycin|mesh-list
14786986|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
14947434|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14947435|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14947436|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947437|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14214687|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
14214688|NCT03738683|Tazobactam|tazobactam|mesh-list
14214689|NCT03738683|Piperacillin|piperacillin|mesh-list
14214690|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14214691|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214692|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214693|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14214694|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786987|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
14786988|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
14214695|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214696|NCT03738553|Trastuzumab|trastuzumab|mesh-list
14214697|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214698|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241862|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241863|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243320|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14243321|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243322|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
14243323|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
14243324|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243325|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
14243326|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
14243327|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
14243328|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14243329|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243330|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14243331|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243332|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243333|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243334|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243335|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14243336|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14243337|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
14243338|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14243339|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14243340|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14243341|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243342|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
14243343|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243344|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243345|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14243346|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243347|NCT00194675|Testosterone|testosterone|mesh-list
14243348|NCT00194675|Dutasteride|dutasteride|mesh-list
14243349|NCT00194675|Androgens|androgens|mesh-ancestor
14243350|NCT00194675|Hormones|hormones|mesh-ancestor
14243351|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243352|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243353|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14243354|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14243355|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243356|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243357|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
14243358|NCT00194779|Tamoxifen|tamoxifen|mesh-list
14243359|NCT00194779|Vinorelbine|vinorelbine|mesh-list
14243360|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
14243361|NCT00194779|Doxorubicin|doxorubicin|mesh-list
14243362|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14243363|NCT00194779|Capecitabine|capecitabine|mesh-list
14243364|NCT00194779|Methotrexate|methotrexate|mesh-list
14243365|NCT00194779|Trastuzumab|trastuzumab|mesh-list
14243366|NCT00194779|Letrozole|letrozole|mesh-list
14243367|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14243368|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243369|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243370|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243371|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243372|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243373|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243374|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
14243375|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243376|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243377|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14243378|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
14243379|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14243380|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14243381|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14243382|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14243383|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243384|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243385|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
14243386|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14214699|NCT05142319|Vaccines|vaccines|mesh-list
14214700|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
14214701|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214702|NCT05142085|Mineral Oil|mineral oil|mesh-list
14214703|NCT05142085|Emollients|emollients|mesh-ancestor
14214704|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
14214705|NCT05141968|Vitamin D|vitamin d|mesh-list
14214706|NCT05141968|Vitamins|vitamins|mesh-ancestor
14214707|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
14214708|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214709|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14214710|NCT05141877|Anesthetics|anesthetics|mesh-list
14214711|NCT05141877|Propofol|propofol|mesh-list
14214712|NCT05141877|Sevoflurane|sevoflurane|mesh-list
14214713|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214714|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214715|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14214716|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14214717|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
14214718|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14214719|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14214720|NCT05141864|Lidocaine|lidocaine|mesh-list
14214721|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
14214722|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
14214723|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214724|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214725|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
14214726|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214727|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14214728|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14214729|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14214730|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14214731|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214732|NCT05141474|Aldesleukin|aldesleukin|mesh-list
14214733|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
14214734|NCT05141474|Fludarabine|fludarabine|mesh-list
14214735|NCT05141474|Interleukin-2|interleukin-2|mesh-list
14214736|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214737|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
14214738|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214739|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214740|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14214741|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
14214742|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214743|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214744|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14214745|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14214746|NCT05141474|Analgesics|analgesics|mesh-ancestor
14214747|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
14214748|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214749|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14214750|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14214751|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
14214752|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214753|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14214754|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
14214755|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214756|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14214757|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14214758|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214759|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214760|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14214761|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14214762|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
14214763|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
14214764|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
14214765|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214766|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214767|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
14214768|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214769|NCT05114460|Naloxone|naloxone|mesh-list
14214770|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14214771|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214772|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
14214773|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241864|NCT00182000|Cycloserine|cycloserine|mesh-list
14214774|NCT05089175|Aspirin|aspirin|mesh-list
14214775|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14214776|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14214777|NCT05089175|Analgesics|analgesics|mesh-ancestor
14214778|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
14214779|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214780|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214781|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214782|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214783|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14214784|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14214785|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214786|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14214787|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14214788|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214789|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
14214790|NCT05075993|Paclitaxel|paclitaxel|mesh-list
14214791|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14214792|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
14214793|NCT05075993|Bevacizumab|bevacizumab|mesh-list
14214794|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14214795|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214796|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14214797|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14214798|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14214799|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214800|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214801|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
14214802|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214803|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214804|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14214805|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
14214806|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14214807|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214808|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14214809|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14214810|NCT05075993|Growth Substances|growth substances|mesh-ancestor
14214811|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
14214812|NCT05066997|Dexamethasone|dexamethasone|mesh-list
14214813|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
14214814|NCT05066997|BB 1101|bb 1101|mesh-list
14214815|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214816|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
14214817|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
14214818|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214819|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214820|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14214821|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
14214822|NCT05066997|Hormones|hormones|mesh-ancestor
14214823|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214824|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214825|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214826|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
14214827|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214828|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214829|NCT05064449|Itraconazole|itraconazole|mesh-list
14214830|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
14214831|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
14214832|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214833|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14214834|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14214835|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214836|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214837|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14214838|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
14507122|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14507123|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14507124|NCT02920918|Canagliflozin|canagliflozin|mesh-list
14507125|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14507126|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507127|NCT02920918|Incretins|incretins|mesh-ancestor
14507128|NCT02920918|Hormones|hormones|mesh-ancestor
14507129|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507130|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14214839|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214840|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214841|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14214842|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14214843|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14214844|NCT05064449|Analgesics|analgesics|mesh-ancestor
14214845|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
14214846|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214847|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214848|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214849|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14214850|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14214851|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214852|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214853|NCT05046639|Lidocaine|lidocaine|mesh-list
14214854|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
14214855|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
14214856|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214857|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214858|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
14214859|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214860|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14214861|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14214862|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14214863|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14214864|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214865|NCT05045066|Vitamin D|vitamin d|mesh-list
14214866|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
14214867|NCT05045066|Vitamins|vitamins|mesh-ancestor
14214868|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
14214869|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214870|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14214871|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14214872|NCT05033639|Melatonin|melatonin|mesh-list
14214873|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
14214874|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214875|NCT05033639|Protective Agents|protective agents|mesh-ancestor
14214876|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214877|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14214878|NCT04970355|Erenumab|erenumab|mesh-list
14214879|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14214880|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214881|NCT04970355|Analgesics|analgesics|mesh-ancestor
14214882|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
14214883|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214884|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214885|NCT04963283|Nivolumab|nivolumab|mesh-list
14214886|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14214887|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214888|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14214889|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214890|NCT04912921|Palmidrol|palmidrol|mesh-list
14214891|NCT04912921|Analgesics|analgesics|mesh-ancestor
14214892|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
14214893|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214894|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214895|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14214896|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14214897|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214898|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14214899|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
14214900|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214901|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14214902|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14214903|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214904|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214905|NCT04912921|Hormones|hormones|mesh-ancestor
14214906|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214907|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
14214908|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14214909|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214910|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14214911|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214912|NCT04870138|Azithromycin|azithromycin|mesh-list
14214913|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
14214914|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
14214915|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14214916|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214917|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14214918|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14214919|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214920|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214921|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214922|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14214923|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14214924|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
14214925|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14214926|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214927|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14214928|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214929|NCT04789616|Maraviroc|maraviroc|mesh-list
14214930|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14214931|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14214932|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214933|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14214934|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14214935|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
14214936|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214937|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14214938|NCT04729296|Golimumab|golimumab|mesh-list
14214939|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14214940|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214941|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214942|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
14214943|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214944|NCT04686786|PF-06372865|pf-06372865|mesh-list
14214945|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
14214946|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
14214947|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14214948|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214949|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214950|NCT04649060|Dexamethasone|dexamethasone|mesh-list
14214951|NCT04649060|Melphalan|melphalan|mesh-list
14214952|NCT04649060|Daratumumab|daratumumab|mesh-list
14214953|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214954|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
14214955|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
14214956|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214957|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214958|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14214959|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
14214960|NCT04649060|Hormones|hormones|mesh-ancestor
14214961|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214962|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214963|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214964|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14214965|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
14214966|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14214967|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14214968|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14214969|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
14214970|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
14214971|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14214972|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14214973|NCT04628338|Interferons|interferons|mesh-list
14214974|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
14214975|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214976|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
14214977|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14214978|NCT04566328|Dexamethasone|dexamethasone|mesh-list
14214979|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
14214980|NCT04566328|Lenalidomide|lenalidomide|mesh-list
14214981|NCT04566328|Bortezomib|bortezomib|mesh-list
14214982|NCT04566328|Daratumumab|daratumumab|mesh-list
14214983|NCT04566328|Ichthammol|ichthammol|mesh-list
14214984|NCT04566328|BB 1101|bb 1101|mesh-list
14214985|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14214986|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14214987|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
14214988|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
14214989|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14214990|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14214991|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14214992|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
14214993|NCT04566328|Hormones|hormones|mesh-ancestor
14214994|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14214995|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14214996|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14214997|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
14214998|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14214999|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215000|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
14215001|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215002|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215003|NCT04566328|Growth Substances|growth substances|mesh-ancestor
14215004|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215005|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215006|NCT04558190|Ubiquinone|ubiquinone|mesh-list
14215007|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14215008|NCT04558190|Albuterol|albuterol|mesh-list
14215009|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14215010|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
14215011|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215012|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14786989|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14786990|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14786991|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14215013|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14215014|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
14215015|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
14215016|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14215017|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14215018|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14215019|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14215020|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14215021|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215022|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215023|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14215024|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14215025|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14215026|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
14215027|NCT04551365|Chitosan|chitosan|mesh-list
14215028|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14507131|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
14507132|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507133|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507134|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14507135|NCT02921061|Cytarabine|cytarabine|mesh-list
14507136|NCT02921061|Decitabine|decitabine|mesh-list
14507137|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14507138|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
14507139|NCT02921061|Cladribine|cladribine|mesh-list
14507140|NCT02921061|Lenograstim|lenograstim|mesh-list
14507141|NCT02921061|Sargramostim|sargramostim|mesh-list
14507142|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14507143|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
14507144|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507145|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215029|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14215030|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
14215031|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215032|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14215033|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
14215034|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
14215035|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
14215036|NCT04551365|Coagulants|coagulants|mesh-ancestor
14215037|NCT04535089|Lidocaine|lidocaine|mesh-list
14215038|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
14507146|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
14215039|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
14215040|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
14215041|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215042|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215043|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
14215044|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215045|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14215046|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14215047|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14215048|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14215049|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507147|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507148|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14507149|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
14507150|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507151|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14507152|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507153|NCT02921061|Analgesics|analgesics|mesh-ancestor
14507154|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
14507155|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507156|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14507157|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14507158|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
14507159|NCT02921386|Testosterone|testosterone|mesh-list
14507160|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
14507161|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
14507162|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14507163|NCT02921386|Androgens|androgens|mesh-ancestor
14507164|NCT02921386|Hormones|hormones|mesh-ancestor
14507165|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507166|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507167|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507168|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507169|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
14507170|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14507171|NCT02921750|Laxatives|laxatives|mesh-ancestor
14507172|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507173|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
14507174|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14507175|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14507176|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507177|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
14507178|NCT02922582|Coagulants|coagulants|mesh-ancestor
14507179|NCT02922959|Naloxone|naloxone|mesh-list
14507180|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507181|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
14507182|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507183|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14507184|NCT02923115|Enoxaparin|enoxaparin|mesh-list
14507185|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
14507186|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14507187|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14507188|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507189|NCT02923895|Fluorides|fluorides|mesh-list
14507190|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
14507191|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
14507192|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
14507193|NCT02923895|Protective Agents|protective agents|mesh-ancestor
14507194|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507195|NCT02923921|Leucovorin|leucovorin|mesh-list
14507196|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
14507197|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507198|NCT02923921|Antidotes|antidotes|mesh-ancestor
14507199|NCT02923921|Protective Agents|protective agents|mesh-ancestor
14786992|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947438|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
14215050|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14215051|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14215052|NCT04535089|Analgesics|analgesics|mesh-ancestor
14215053|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14215054|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14215055|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14215056|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
14215057|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215058|NCT04462471|Vemurafenib|vemurafenib|mesh-list
14215059|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215060|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14215061|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215062|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241865|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14241866|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241867|NCT00182000|Renal Agents|renal agents|mesh-ancestor
14241868|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14241869|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
14241870|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14241871|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
14241872|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241873|NCT00182078|Sertraline|sertraline|mesh-list
14241874|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
14241875|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241876|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14241877|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241878|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241879|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241880|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241881|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
14241882|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241883|NCT00182091|Hormones|hormones|mesh-list
14241884|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14241885|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241886|NCT00182689|Sorafenib|sorafenib|mesh-list
14241887|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241888|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14241889|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241890|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241891|NCT00182754|Octreotide|octreotide|mesh-list
14241892|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14241893|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14241894|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241895|NCT00182767|Doxorubicin|doxorubicin|mesh-list
14241896|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14241897|NCT00182767|Epothilone B|epothilone b|mesh-list
14241898|NCT00182767|Epothilones|epothilones|mesh-list
14241899|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14241900|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241901|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14241902|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14241903|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241904|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241905|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
14241906|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
14241907|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
14241908|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
14241909|NCT00182793|Melphalan|melphalan|mesh-list
14241910|NCT00182793|Thiotepa|thiotepa|mesh-list
14241911|NCT00182793|Carboplatin|carboplatin|mesh-list
14241912|NCT00182793|Trastuzumab|trastuzumab|mesh-list
14241913|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241914|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
14241915|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241916|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14241917|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14241918|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
14241919|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241920|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241921|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14241922|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14241923|NCT00183092|Quinacrine|quinacrine|mesh-list
14241924|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
14241925|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14786993|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14215063|NCT04444869|Cisplatin|cisplatin|mesh-list
14215064|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215065|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
14215066|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14215067|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14215068|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
14215069|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215070|NCT04392505|Durvalumab|durvalumab|mesh-list
14215071|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215072|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215073|NCT04374630|Paclitaxel|paclitaxel|mesh-list
14215074|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215075|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215076|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
14215077|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
14215078|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
14215079|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215080|NCT04329325|Dexamethasone|dexamethasone|mesh-list
14215081|NCT04329325|Methotrexate|methotrexate|mesh-list
14215082|NCT04329325|Dasatinib|dasatinib|mesh-list
14215083|NCT04329325|Blinatumomab|blinatumomab|mesh-list
14215084|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215085|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
14215086|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
14215087|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215088|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215089|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215090|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
14215091|NCT04329325|Hormones|hormones|mesh-ancestor
14215092|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215093|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14215094|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215095|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14215096|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
14215097|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14215098|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215099|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
14215100|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215101|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215102|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215103|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14215104|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215105|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
14215106|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215107|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14215108|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14215109|NCT04308694|Methadone|methadone|mesh-list
14215110|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14215111|NCT04308694|Narcotics|narcotics|mesh-ancestor
14215112|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215113|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215114|NCT04308694|Analgesics|analgesics|mesh-ancestor
14215115|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
14215116|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215117|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
14215118|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
14215119|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14215120|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
14215121|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14215122|NCT04223765|Fludarabine|fludarabine|mesh-list
14215123|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215124|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
14215125|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215126|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215127|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215128|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
14215129|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215130|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215131|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14215132|NCT04216524|Cytarabine|cytarabine|mesh-list
14215133|NCT04216524|Dexamethasone|dexamethasone|mesh-list
14215134|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
14215135|NCT04216524|Prednisone|prednisone|mesh-list
14215136|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
14215137|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14215138|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14215139|NCT04216524|Prednisolone|prednisolone|mesh-list
14215140|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
14215141|NCT04216524|Cortisone|cortisone|mesh-list
14215142|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
14215143|NCT04216524|Rituximab|rituximab|mesh-list
14215144|NCT04216524|Doxorubicin|doxorubicin|mesh-list
14215145|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14215146|NCT04216524|Methotrexate|methotrexate|mesh-list
14215147|NCT04216524|Vincristine|vincristine|mesh-list
14507200|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507201|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
14507202|NCT02923921|Vitamins|vitamins|mesh-ancestor
14507203|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
14507204|NCT02924350|Fluorides|fluorides|mesh-list
14507205|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
14507206|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
14507207|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
14507208|NCT02924350|Protective Agents|protective agents|mesh-ancestor
14507209|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507210|NCT02924688|Fluticasone|fluticasone|mesh-list
14507211|NCT02924688|Albuterol|albuterol|mesh-list
14507212|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14507213|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14507214|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507215|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14507216|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
14507217|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507218|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507219|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14507220|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
14507221|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507222|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14507223|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14507224|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14507225|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14507226|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
14507227|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507228|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507229|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
14215148|NCT04216524|Daunorubicin|daunorubicin|mesh-list
14215149|NCT04216524|Venetoclax|venetoclax|mesh-list
14215150|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
14507230|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14507231|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
14507232|NCT02924688|Hormones|hormones|mesh-ancestor
14507233|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507234|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
14528690|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
14528691|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528692|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528693|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14528694|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14528695|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
14528696|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
14528697|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528698|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14528699|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14528700|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528701|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528702|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
14528703|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14528704|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528705|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14528706|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14528707|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14528708|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14528709|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14528710|NCT03824912|Ketoconazole|ketoconazole|mesh-list
14528711|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
14528712|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528713|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14528714|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14528715|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528716|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14786994|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14786995|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14786996|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215151|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14215152|NCT04216524|Antibodies|antibodies|mesh-list
14215153|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
14215154|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14215155|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14215156|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
14215157|NCT04216524|BB 1101|bb 1101|mesh-list
14215158|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215159|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
14215160|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215161|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215162|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215163|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
14215164|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215165|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215166|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14215167|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215168|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
14215169|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
14215170|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215171|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215172|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
14215173|NCT04216524|Hormones|hormones|mesh-ancestor
14215174|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215175|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14215176|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
14215177|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215178|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14215179|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14215180|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14215181|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14786997|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14786998|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14215182|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
14215183|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14215184|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215185|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
14215186|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215187|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14215188|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14215189|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
14215190|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215191|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215192|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
14215193|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
14507235|NCT02924883|Trastuzumab|trastuzumab|mesh-list
14507236|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14507237|NCT02924883|Atezolizumab|atezolizumab|mesh-list
14507238|NCT02924883|Maytansine|maytansine|mesh-list
14507239|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14507240|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507241|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14507242|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
14507243|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
14786999|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
14947439|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
14507244|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
14530053|NCT03348904|Nivolumab|nivolumab|mesh-list
14215194|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
14215195|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14215196|NCT04216524|Protective Agents|protective agents|mesh-ancestor
14215197|NCT04187196|Propofol|propofol|mesh-list
14215198|NCT04187196|Methohexital|methohexital|mesh-list
14215199|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14215200|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215201|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215202|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14215203|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
14215204|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
14215205|NCT04174196|Lenalidomide|lenalidomide|mesh-list
14215206|NCT04174196|Cc-486|cc-486|mesh-list
14215207|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
14215208|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215209|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215210|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215211|NCT04174196|Growth Substances|growth substances|mesh-ancestor
14215212|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215213|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215214|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
14215215|NCT04109885|Promethazine|promethazine|mesh-list
14215216|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
14215217|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14215218|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14215219|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215220|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215221|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
14215222|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
14215223|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
14215224|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215225|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
14215226|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
14215227|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215228|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14215229|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
14215230|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
14215231|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215232|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215233|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14215234|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
14215235|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215236|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14215237|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14215238|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14215239|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14215240|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
14215241|NCT04089553|Durvalumab|durvalumab|mesh-list
14215242|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215243|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215244|NCT04078737|Aspirin|aspirin|mesh-list
14215245|NCT04078737|Clopidogrel|clopidogrel|mesh-list
14215246|NCT04078737|Ticagrelor|ticagrelor|mesh-list
14787000|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14215247|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14215248|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14215249|NCT04078737|Analgesics|analgesics|mesh-ancestor
14215250|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
14215251|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787001|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787002|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14787003|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14787004|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14787005|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14787006|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14787007|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14787008|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14947440|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947441|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947442|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
14947443|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
14947444|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14947445|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14947446|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947447|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
14947448|NCT01527968|Coagulants|coagulants|mesh-ancestor
14947449|NCT01527994|Aprepitant|aprepitant|mesh-list
14215252|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215253|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215254|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215255|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14215256|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14215257|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215258|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14215259|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14215260|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215261|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
14215262|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14215263|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14215264|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14215265|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
14215266|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215267|NCT04058197|Deferoxamine|deferoxamine|mesh-list
14215268|NCT04058197|Siderophores|siderophores|mesh-ancestor
14215269|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14215270|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
14215271|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
14215272|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215273|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14215274|NCT03999411|Nicotine|nicotine|mesh-list
14215275|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
14215276|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215277|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14215278|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
14215279|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215280|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215281|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14215282|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14215283|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
14215284|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215285|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215286|NCT03958981|Castor Oil|castor oil|mesh-list
14215287|NCT03958981|Cathartics|cathartics|mesh-ancestor
14215288|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215289|NCT03937635|Dexamethasone|dexamethasone|mesh-list
14215290|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
14215291|NCT03937635|Lenalidomide|lenalidomide|mesh-list
14215292|NCT03937635|Daratumumab|daratumumab|mesh-list
14215293|NCT03937635|Ichthammol|ichthammol|mesh-list
14215294|NCT03937635|BB 1101|bb 1101|mesh-list
14215295|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215296|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
14215297|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
14215298|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215299|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215300|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215301|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
14215302|NCT03937635|Hormones|hormones|mesh-ancestor
14215303|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215304|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14215305|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215306|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
14215307|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215308|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215309|NCT03937635|Growth Substances|growth substances|mesh-ancestor
14215310|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215311|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
14215312|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215313|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215314|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215326|NCT03892369|Ethanol|ethanol|mesh-list
14215327|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14215328|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215329|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215330|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215331|NCT03878589|Oxytocin|oxytocin|mesh-list
14215332|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
14215333|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14215334|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215335|NCT03803605|Vorinostat|vorinostat|mesh-list
14215336|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215337|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14215338|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215339|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215340|NCT03774394|Clopidogrel|clopidogrel|mesh-list
14215341|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14215342|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14215343|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14215344|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14215345|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
14215346|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215347|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215348|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215349|NCT03770728|Metformin|metformin|mesh-list
14215350|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
14215351|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14215352|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215353|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14215354|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
14215355|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215356|NCT03737110|Rilonacept|rilonacept|mesh-list
14215357|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215358|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
14215359|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14215360|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215361|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
14215362|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215363|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215364|NCT03524235|Rituximab|rituximab|mesh-list
14215365|NCT03524235|Fludarabine|fludarabine|mesh-list
14215366|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14215367|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215368|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215369|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
14215370|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215371|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215372|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215373|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215374|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
14241926|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
14241927|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14241928|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241929|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
14241930|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14241931|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
14241932|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241933|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241934|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241935|NCT00183196|Naltrexone|naltrexone|mesh-list
14241936|NCT00183196|Gabapentin|gabapentin|mesh-list
14241937|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14241938|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14241939|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241940|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
14241941|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241942|NCT00183196|Analgesics|analgesics|mesh-ancestor
14241943|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
14241944|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14241945|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14241946|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14241947|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241948|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14241949|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14241950|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241951|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241952|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
14241953|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
14241954|NCT00183248|Sirolimus|sirolimus|mesh-list
14215375|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
14215376|NCT03514901|Nivolumab|nivolumab|mesh-list
14215377|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215378|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215379|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14787009|NCT00717587|Sunitinib|sunitinib|mesh-list
14787010|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
14787011|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787012|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215380|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215381|NCT03471624|Tenofovir|tenofovir|mesh-list
14215382|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
14215383|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215384|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14215385|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14215386|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215387|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215388|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14215389|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14215390|NCT03462966|Rifaximin|rifaximin|mesh-list
14215391|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14215392|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215393|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215394|NCT03462251|Paclitaxel|paclitaxel|mesh-list
14215395|NCT03462251|Bevacizumab|bevacizumab|mesh-list
14215396|NCT03462251|Capecitabine|capecitabine|mesh-list
14215397|NCT03462251|Fulvestrant|fulvestrant|mesh-list
14215398|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14215399|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215400|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215401|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
14215402|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
14215403|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
14215404|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215405|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215406|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215407|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215408|NCT03462251|Growth Substances|growth substances|mesh-ancestor
14215409|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215410|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215411|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215412|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
14215413|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14215414|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14215415|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14215416|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
14215417|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215418|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14215419|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215420|NCT03369197|Anesthetics|anesthetics|mesh-list
14215421|NCT03369197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215422|NCT03369197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215423|NCT03338647|Doxorubicin|doxorubicin|mesh-list
14215424|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14215425|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215426|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14215427|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14215428|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215429|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215430|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
14215431|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215432|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215433|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
14215434|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14215435|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215436|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
14215437|NCT03220477|Guadecitabine|guadecitabine|mesh-list
14215438|NCT03220477|Mocetinostat|mocetinostat|mesh-list
14215439|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215440|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215441|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14215442|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215443|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787013|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215444|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
14215445|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215446|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215447|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14215448|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14215449|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215450|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14215451|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
14215452|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215453|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
14215454|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215455|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215456|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215457|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14215458|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
14215459|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215460|NCT02894398|Letrozole|letrozole|mesh-list
14215461|NCT02894398|Fulvestrant|fulvestrant|mesh-list
14215462|NCT02894398|Palbociclib|palbociclib|mesh-list
14215463|NCT02894398|Anastrozole|anastrozole|mesh-list
14215464|NCT02894398|Exemestane|exemestane|mesh-list
14215465|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215466|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14215467|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14215468|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215469|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215470|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14215471|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
14215472|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215473|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215474|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14215475|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14215476|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14215477|NCT02852057|Timolol|timolol|mesh-list
14215478|NCT02852057|Dorzolamide|dorzolamide|mesh-list
14215479|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14215480|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14215481|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14215482|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215483|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215484|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215485|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14215486|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14215487|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215488|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14215489|NCT02734537|Cisplatin|cisplatin|mesh-list
14507245|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507246|NCT02925117|Upadacitinib|upadacitinib|mesh-list
14507247|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14507248|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14507249|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507250|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507251|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14507252|NCT02925494|Norethindrone|norethindrone|mesh-list
14507253|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
14507254|NCT02925494|Estradiol|estradiol|mesh-list
14507255|NCT02925494|Estrogens|estrogens|mesh-ancestor
14507256|NCT02925494|Hormones|hormones|mesh-ancestor
14507257|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507258|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507259|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14507260|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
14507261|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14507262|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14507263|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14507264|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14507265|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14507266|NCT02925611|Desflurane|desflurane|mesh-list
14507267|NCT02925611|Isoflurane|isoflurane|mesh-list
14507268|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14215490|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215491|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14215492|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14215493|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215494|NCT02710734|Doxorubicin|doxorubicin|mesh-list
14215495|NCT02710734|Methotrexate|methotrexate|mesh-list
14215496|NCT02710734|Mitomycins|mitomycins|mesh-list
14215497|NCT02710734|Mitomycin|mitomycin|mesh-list
14215498|NCT02710734|Vinblastine|vinblastine|mesh-list
14215499|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215500|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14215501|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14215502|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14215503|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215504|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215505|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14215506|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
14215507|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14215508|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215509|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215510|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
14507269|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
14507270|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
14507271|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507272|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507273|NCT02925858|Ketamine|ketamine|mesh-list
14507274|NCT02925858|Analgesics|analgesics|mesh-ancestor
14507275|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
14507276|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507277|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507278|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14507279|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14507280|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
14507281|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
14507282|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507283|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14507284|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14507285|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507286|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507287|NCT02925923|Clopidogrel|clopidogrel|mesh-list
14507288|NCT02925923|Ticagrelor|ticagrelor|mesh-list
14507289|NCT02925923|Eptifibatide|eptifibatide|mesh-list
14507290|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14507291|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14507292|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14507293|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14507294|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
14507295|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507296|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507297|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507298|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14507299|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14507300|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14507301|NCT02926573|Gabapentin|gabapentin|mesh-list
14507302|NCT02926573|Analgesics|analgesics|mesh-ancestor
14507303|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
14507304|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507305|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507306|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
14507307|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14507308|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14215511|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215512|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14215513|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215514|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
14215515|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215516|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14215517|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
14215518|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215519|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14215520|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14215521|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14215522|NCT02611024|Irinotecan|irinotecan|mesh-list
14215523|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14215524|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14215525|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215526|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215527|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215528|NCT02564796|Iron|iron|mesh-list
14215529|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
14215530|NCT02564796|Trace Elements|trace elements|mesh-ancestor
14215531|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
14215532|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215533|NCT02564796|Hematinics|hematinics|mesh-ancestor
14215534|NCT02562716|Gemcitabine|gemcitabine|mesh-list
14215535|NCT02562716|Paclitaxel|paclitaxel|mesh-list
14215536|NCT02562716|Camptothecin|camptothecin|mesh-list
14215537|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14215538|NCT02562716|Fluorouracil|fluorouracil|mesh-list
14215539|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
14215540|NCT02562716|Irinotecan|irinotecan|mesh-list
14215541|NCT02562716|Pancrelipase|pancrelipase|mesh-list
14215542|NCT02562716|Pancreatin|pancreatin|mesh-list
14215543|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215544|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215545|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14215546|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14215547|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14215548|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215549|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215550|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
14215551|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
14215552|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215553|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215554|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215555|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
14215556|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215557|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14215558|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14215559|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215560|NCT02558010|Morphine|morphine|mesh-list
14215561|NCT02558010|Methadone|methadone|mesh-list
14215562|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14215563|NCT02558010|Narcotics|narcotics|mesh-ancestor
14215564|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215565|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215566|NCT02558010|Analgesics|analgesics|mesh-ancestor
14215567|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
14215568|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215569|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
14215570|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
14215571|NCT02502006|Celecoxib|celecoxib|mesh-list
14215572|NCT02502006|Naproxen|naproxen|mesh-list
14215573|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14215574|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14215575|NCT02502006|Analgesics|analgesics|mesh-ancestor
14215576|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
14215577|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215578|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215579|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215580|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215581|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14215582|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14215583|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215584|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215585|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
14215586|NCT02481245|Bezafibrate|bezafibrate|mesh-list
14215587|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14215588|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
14215589|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215590|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14215591|NCT02477384|Propranolol|propranolol|mesh-list
14215592|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14215593|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14215594|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
14215595|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215596|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215597|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215598|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14215599|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14215600|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
14215601|NCT02427724|Lidocaine|lidocaine|mesh-list
14215602|NCT02427724|Tetracaine|tetracaine|mesh-list
14215603|NCT02427724|Prilocaine|prilocaine|mesh-list
14215604|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
14215605|NCT02427724|Anesthetics|anesthetics|mesh-list
14215606|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215607|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215608|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
14215609|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215610|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14215611|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14215612|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14215613|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14215614|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215615|NCT02393794|Nivolumab|nivolumab|mesh-list
14215616|NCT02393794|Romidepsin|romidepsin|mesh-list
14215617|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14215618|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215619|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215620|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14215621|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215622|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14215623|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215624|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
14215625|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14215626|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215627|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215628|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14215629|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215630|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215631|NCT02047513|Gemcitabine|gemcitabine|mesh-list
14215632|NCT02047513|Paclitaxel|paclitaxel|mesh-list
14215633|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14215634|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215635|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215636|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
14215637|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
14215638|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
14215639|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215640|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215641|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
14215642|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
14215643|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215644|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215645|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215646|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
14215647|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215648|NCT02043847|Melphalan|melphalan|mesh-list
14215649|NCT02043847|Lenograstim|lenograstim|mesh-list
14215650|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14215651|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
14215652|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215653|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215654|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
14215655|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215656|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215657|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14215658|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215659|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
14215660|NCT01976286|Salicylates|salicylates|mesh-list
14215661|NCT01976286|Glycolic acid|glycolic acid|mesh-list
14947450|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
14215662|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215663|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
14215664|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
14215665|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
14215666|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14215667|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14215668|NCT01976286|Analgesics|analgesics|mesh-ancestor
14215669|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
14215670|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215671|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215672|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215673|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215674|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14215675|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215676|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215677|NCT01775644|Bevacizumab|bevacizumab|mesh-list
14215678|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215679|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215680|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215681|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215682|NCT01775644|Growth Substances|growth substances|mesh-ancestor
14215683|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215684|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215685|NCT01472081|Nivolumab|nivolumab|mesh-list
14215686|NCT01472081|Ipilimumab|ipilimumab|mesh-list
14215687|NCT01472081|Sunitinib|sunitinib|mesh-list
14215688|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215689|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215690|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14215691|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215692|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215693|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215694|NCT01472081|Growth Substances|growth substances|mesh-ancestor
14215695|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215696|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215697|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14215698|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215699|NCT01367002|Paclitaxel|paclitaxel|mesh-list
14215700|NCT01367002|Carboplatin|carboplatin|mesh-list
14215701|NCT01367002|Trastuzumab|trastuzumab|mesh-list
14215702|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215703|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215704|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
14215705|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
14215706|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
14215707|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215708|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14215709|NCT01309672|Prednisone|prednisone|mesh-list
14215710|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
14215711|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215712|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
14215713|NCT01309672|Hormones|hormones|mesh-ancestor
14215714|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215715|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215716|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14215717|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215718|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14215719|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964944|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
13964945|NCT03133897|Hormones|hormones|mesh-ancestor
13964946|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13964947|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13964948|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13964949|NCT03133923|Vaccines|vaccines|mesh-list
13964950|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
13964951|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964952|NCT03134001|Analgesics|analgesics|mesh-list
13964953|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
13964954|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964955|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964956|NCT03133780|Midazolam|midazolam|mesh-list
13964957|NCT03133780|Ketamine|ketamine|mesh-list
13964958|NCT03133780|Analgesics|analgesics|mesh-ancestor
13964959|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
13964960|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13964961|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215720|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215721|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
14215722|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14215723|NCT01131169|Vidarabine|vidarabine|mesh-list
14215724|NCT01131169|Fludarabine|fludarabine|mesh-list
14215725|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
14215726|NCT01131169|Melphalan|melphalan|mesh-list
14215727|NCT01131169|Busulfan|busulfan|mesh-list
14215728|NCT01131169|Lenograstim|lenograstim|mesh-list
14215729|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215730|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215731|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
14215732|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215733|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215734|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
14215735|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215736|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
14215737|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215738|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215739|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
14215740|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14215741|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14215742|NCT00882505|Vitamin D|vitamin d|mesh-list
14215743|NCT00882505|Vitamins|vitamins|mesh-ancestor
14215744|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
14215745|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215746|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14215747|NCT00871013|Thalidomide|thalidomide|mesh-list
14215748|NCT00871013|Dexamethasone|dexamethasone|mesh-list
14215749|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
14215750|NCT00871013|Melphalan|melphalan|mesh-list
14215751|NCT00871013|Doxorubicin|doxorubicin|mesh-list
14215752|NCT00871013|Etoposide|etoposide|mesh-list
14215753|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14215754|NCT00871013|Bortezomib|bortezomib|mesh-list
14215755|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215756|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
14215757|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215758|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215759|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215760|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
14215761|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215762|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215763|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14215764|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215765|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
14215766|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
14215767|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215768|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215769|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
14215770|NCT00871013|Hormones|hormones|mesh-ancestor
14215771|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215772|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507309|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507310|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14507311|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14507312|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14507313|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507314|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507315|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
14507316|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14507317|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14507318|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507319|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14507320|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507321|NCT02926950|Metformin|metformin|mesh-list
14507322|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14507323|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14507324|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507325|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14507326|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215773|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14215774|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14215775|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14215776|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215777|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14215778|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
14215779|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14215780|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215781|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215782|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215783|NCT00871013|Growth Substances|growth substances|mesh-ancestor
14215784|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215785|NCT00774345|Lenalidomide|lenalidomide|mesh-list
14215786|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
14215787|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215788|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14215789|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14215790|NCT00774345|Growth Substances|growth substances|mesh-ancestor
14215791|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
14215792|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241955|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
14241956|NCT00183248|Tacrolimus|tacrolimus|mesh-list
14241957|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14241958|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
14241959|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241960|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14241961|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14241962|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241963|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14241964|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14241965|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14241966|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
14241967|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14241968|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14241969|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
14241970|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14241971|NCT00183274|Norepinephrine|norepinephrine|mesh-list
14241972|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14241973|NCT00183274|Serotonin|serotonin|mesh-list
14241974|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
14241975|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14241976|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14241977|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
14241978|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241979|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241980|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14241981|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
14241982|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
14241983|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14241984|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14241985|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241986|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241987|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14241988|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
14241989|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14241990|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14241991|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
14241992|NCT00183339|Fluoxetine|fluoxetine|mesh-list
14241993|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14241994|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14241995|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14241996|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14241997|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14241998|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
14241999|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242000|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14242001|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
14242002|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242003|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14242004|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14242005|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242006|NCT00183391|Methylphenidate|methylphenidate|mesh-list
14242007|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14243387|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
14215793|NCT00735657|Iodine|iodine|mesh-list
14215794|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14215795|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215796|NCT00735657|Trace Elements|trace elements|mesh-ancestor
14215797|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
14215798|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215799|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
14215800|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
14215801|NCT00258427|Busulfan|busulfan|mesh-list
14215802|NCT00258427|Fludarabine|fludarabine|mesh-list
14215803|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
14215804|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14215805|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14215806|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
14215807|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215808|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215809|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14215810|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
14215811|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215812|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14215813|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14215814|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14215815|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
14215816|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215817|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
14215818|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
14215819|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215820|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14215821|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
14215822|NCT00258427|Hormones|hormones|mesh-ancestor
14215823|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215824|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14215825|NCT00258427|Protective Agents|protective agents|mesh-ancestor
14215826|NCT00250341|Beclomethasone|beclomethasone|mesh-list
14215827|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14215828|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215829|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
14215830|NCT00250341|Hormones|hormones|mesh-ancestor
14215831|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215832|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215833|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14215834|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
14215835|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14215836|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
14215837|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215838|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
14215839|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
14215840|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14215841|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14215842|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215843|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14215844|NCT03723538|Analgesics|analgesics|mesh-ancestor
14215845|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
14215846|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215847|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14215848|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14215849|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14215850|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
14215851|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215852|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215853|NCT00000102|Nifedipine|nifedipine|mesh-list
14215854|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14215855|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507327|NCT02927223|Atropine|atropine|mesh-list
14215856|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215857|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14215858|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215859|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
14215860|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
14215861|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14215862|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
14215863|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14215864|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14215865|NCT00000134|Ganciclovir|ganciclovir|mesh-list
14215866|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14215867|NCT00000134|Foscarnet|foscarnet|mesh-list
14215868|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
14215869|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215870|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14215871|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215872|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215873|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14215874|NCT00000136|Ganciclovir|ganciclovir|mesh-list
14215875|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14215876|NCT00000136|Foscarnet|foscarnet|mesh-list
14215877|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
14215878|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215879|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14215880|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215881|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215882|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14215883|NCT00000142|Cidofovir|cidofovir|mesh-list
14215884|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
14215885|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215886|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215887|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215888|NCT00000143|Ganciclovir|ganciclovir|mesh-list
14215889|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14215890|NCT00000143|Cidofovir|cidofovir|mesh-list
14215891|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
14215892|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215893|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14215894|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215895|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215896|NCT00000371|Cycloserine|cycloserine|mesh-list
14215897|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14215898|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14215899|NCT00000371|Renal Agents|renal agents|mesh-ancestor
14215900|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14215901|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
14215902|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14215903|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
14215904|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215905|NCT00000378|Sertraline|sertraline|mesh-list
14215906|NCT00000378|Nortriptyline|nortriptyline|mesh-list
14215907|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
14215908|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14215909|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14215910|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14215911|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14215912|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215913|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14215914|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
14215915|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215916|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14215917|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14215918|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
14215919|NCT00000479|Aspirin|aspirin|mesh-list
14787014|NCT00717587|Growth Substances|growth substances|mesh-ancestor
14787015|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787016|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
14787017|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14787018|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787019|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787020|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14787021|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
14787022|NCT00717652|Triamcinolone|triamcinolone|mesh-list
14787023|NCT00717652|Tretinoin|tretinoin|mesh-list
14787024|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787025|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
14787026|NCT00717652|Hormones|hormones|mesh-ancestor
14787027|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787028|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787029|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787030|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
14787031|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
14787032|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
14787033|NCT00717678|Tacrolimus|tacrolimus|mesh-list
14787034|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787035|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
14787036|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787037|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14787038|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215920|NCT00000479|Vitamin E|vitamin e|mesh-list
14215921|NCT00000479|Vitamins|vitamins|mesh-ancestor
14215922|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
14215923|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215924|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14215925|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14215926|NCT00000479|Analgesics|analgesics|mesh-ancestor
14215927|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
14215928|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215929|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215930|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14215931|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14215932|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14215933|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215934|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14215935|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14215936|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14215937|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
14215938|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
14215939|NCT00000479|Protective Agents|protective agents|mesh-ancestor
14215940|NCT00000575|Nedocromil|nedocromil|mesh-list
14215941|NCT00000575|Budesonide|budesonide|mesh-list
14215942|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14215943|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14215944|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
14215945|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14215946|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215947|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14215948|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14215949|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
14215950|NCT00000575|Hormones|hormones|mesh-ancestor
14215951|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14215952|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14215953|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
14215954|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14215955|NCT00000620|Insulin|insulin|mesh-list
14215956|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14215957|NCT00000620|Metformin|metformin|mesh-list
14215958|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
14215959|NCT00000620|Pioglitazone|pioglitazone|mesh-list
14215960|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
14215961|NCT00000620|Glimepiride|glimepiride|mesh-list
14215962|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
14215963|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
14215964|NCT00000620|Acarbose|acarbose|mesh-list
14215965|NCT00000620|Repaglinide|repaglinide|mesh-list
14215966|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14215967|NCT00000620|Metoprolol|metoprolol|mesh-list
14215968|NCT00000620|Felodipine|felodipine|mesh-list
14215969|NCT00000620|Amlodipine|amlodipine|mesh-list
14787039|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215970|NCT00000620|Valsartan|valsartan|mesh-list
14215971|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14215972|NCT00000620|Carvedilol|carvedilol|mesh-list
14215973|NCT00000620|Candesartan|candesartan|mesh-list
14215974|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
14507328|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14507329|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14507330|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14507331|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
14507332|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507333|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507334|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14507335|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
14507336|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
14507337|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
14507338|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14507339|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14507340|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
14507341|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507342|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507343|NCT02927301|Atezolizumab|atezolizumab|mesh-list
14507344|NCT02927301|Antibodies|antibodies|mesh-list
14507345|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14507346|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
14507347|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507348|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507349|NCT02927431|Oseltamivir|oseltamivir|mesh-list
14507350|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
14507351|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507352|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507353|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507354|NCT02927457|GSK2646264|gsk2646264|mesh-list
14507355|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14507356|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507357|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507358|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14507359|NCT02927834|Prednisone|prednisone|mesh-list
14507360|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507361|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
14507362|NCT02927834|Hormones|hormones|mesh-ancestor
14507363|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507364|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507365|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507366|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507367|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14507368|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507369|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14507370|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507371|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507372|NCT02927873|Vaccines|vaccines|mesh-list
14507373|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
14507374|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507375|NCT02927925|Daratumumab|daratumumab|mesh-list
14507376|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507377|NCT02928029|Dexamethasone|dexamethasone|mesh-list
14507378|NCT02928029|Bortezomib|bortezomib|mesh-list
14507379|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14507380|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507381|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
14507382|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
14215975|NCT00000620|Lisinopril|lisinopril|mesh-list
14215976|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
14215977|NCT00000620|Diltiazem|diltiazem|mesh-list
14215978|NCT00000620|Benazepril|benazepril|mesh-list
14215979|NCT00000620|Hydralazine|hydralazine|mesh-list
14215980|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
14215981|NCT00000620|Reserpine|reserpine|mesh-list
14215982|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
14507383|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507384|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215983|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
14215984|NCT00000620|Triamterene|triamterene|mesh-list
14215985|NCT00000620|Furosemide|furosemide|mesh-list
14215986|NCT00000620|Simvastatin|simvastatin|mesh-list
14215987|NCT00000620|Fenofibrate|fenofibrate|mesh-list
14215988|NCT00000620|Terazosin|terazosin|mesh-list
14215989|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14215990|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14215991|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14215992|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14215993|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14215994|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
14215995|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14215996|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14215997|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
14215998|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14215999|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14216000|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216001|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14216002|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14216003|NCT00000620|Diuretics|diuretics|mesh-ancestor
14216004|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
14216005|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14216006|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14216007|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216008|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
14216009|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
14216010|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
14216011|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216012|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14216013|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14216014|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14216015|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
14216016|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216017|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14216018|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
14216019|NCT00000620|Protective Agents|protective agents|mesh-ancestor
14216020|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14216021|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14216022|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14216023|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
14216024|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14216025|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14216026|NCT00000620|Urological Agents|urological agents|mesh-ancestor
14216027|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14216028|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14216029|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216030|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14216031|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14216032|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14216033|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14216034|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14216035|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14216036|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14216037|NCT00001151|Calcitriol|calcitriol|mesh-list
14216038|NCT00001151|Vitamins|vitamins|mesh-ancestor
14216039|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
14216040|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216041|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14216042|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14216043|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14216044|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14216045|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216046|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14216047|NCT00001213|Cysteamine|cysteamine|mesh-list
14216048|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14216049|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216050|NCT00001262|Copper|copper|mesh-list
14216051|NCT00001262|Trace Elements|trace elements|mesh-ancestor
14216052|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
14216053|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216054|NCT00001304|Vitamin D|vitamin d|mesh-list
14216055|NCT00001304|Calcitriol|calcitriol|mesh-list
14216056|NCT00001304|Calcium|calcium|mesh-list
14216057|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
14216058|NCT00001304|Hormones|hormones|mesh-list
14216059|NCT00001304|Vitamins|vitamins|mesh-ancestor
14216060|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
14216061|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216062|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14216063|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14216064|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216065|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14216066|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14216067|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216068|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14216069|NCT00001566|Indinavir|indinavir|mesh-list
14947451|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
14947452|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947453|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216070|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14216071|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14216072|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
14216073|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216074|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216075|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14216076|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14216077|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
14216078|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216079|NCT00001575|Edetic Acid|edetic acid|mesh-list
14216080|NCT00001575|Calcium|calcium|mesh-list
14216081|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
14216082|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14216083|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216084|NCT00001575|Antidotes|antidotes|mesh-ancestor
14216085|NCT00001575|Protective Agents|protective agents|mesh-ancestor
14216086|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
14216087|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
14787040|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787041|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787042|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14787043|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
14787044|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787045|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787046|NCT00717704|Dasatinib|dasatinib|mesh-list
14787047|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947454|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14947455|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14947456|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947457|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947458|NCT01528007|Naltrexone|naltrexone|mesh-list
14947459|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14947460|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14947461|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947462|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
14947463|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947464|NCT01528137|Lactoferrin|lactoferrin|mesh-list
14947465|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
14947466|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947467|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947468|NCT01528163|Methotrexate|methotrexate|mesh-list
14947469|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14242008|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14242009|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242010|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14242011|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242012|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242013|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242014|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
14242015|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242016|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14242017|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
14242018|NCT00183430|Prazosin|prazosin|mesh-list
14242019|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14216088|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216089|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14216090|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
14216091|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14216092|NCT00001586|Vidarabine|vidarabine|mesh-list
14216093|NCT00001586|Rituximab|rituximab|mesh-list
14216094|NCT00001586|Fludarabine|fludarabine|mesh-list
14216095|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
14216096|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14216097|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216098|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
14216099|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216100|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216101|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14216102|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
14216103|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216104|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216105|NCT00001586|Antiviral Agents|antiviral agents|mesh-ancestor
14216106|NCT00001586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216107|NCT00001596|Pirfenidone|pirfenidone|mesh-list
14216108|NCT00001596|Analgesics|analgesics|mesh-ancestor
14216109|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
14216110|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216111|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216112|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14216113|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216114|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216115|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216116|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216117|NCT00001656|Olanzapine|olanzapine|mesh-list
14216118|NCT00001656|Clozapine|clozapine|mesh-list
14216119|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
14216120|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
14216121|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216122|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216123|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14216124|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14216125|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14216126|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216127|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14216128|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14216129|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14216130|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14216131|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216132|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216133|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
14216134|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14216135|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
14216136|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
14216137|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
14216138|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14216139|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
14216140|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216141|NCT00001723|Orlistat|orlistat|mesh-list
14216142|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216143|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216144|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14216145|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14216146|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
14216147|NCT00001832|Fludarabine|fludarabine|mesh-list
14216148|NCT00001832|Interleukin-2|interleukin-2|mesh-list
14216149|NCT00001832|Sargramostim|sargramostim|mesh-list
14216150|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216151|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
14216152|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216153|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216154|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216155|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
14216156|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216157|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216158|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14216159|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216160|NCT00001832|Analgesics|analgesics|mesh-ancestor
14216161|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
14216162|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216163|NCT00001849|Edetic Acid|edetic acid|mesh-list
14216164|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
14216165|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216166|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216167|NCT00001849|Antidotes|antidotes|mesh-ancestor
14216168|NCT00001849|Protective Agents|protective agents|mesh-ancestor
14216169|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
14216170|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
14216171|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14216172|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
14216173|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14216174|NCT00001880|Cyclosporine|cyclosporine|mesh-list
14216175|NCT00001880|Methotrexate|methotrexate|mesh-list
14216176|NCT00001880|Cyclosporins|cyclosporins|mesh-list
14216177|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14216178|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
14216179|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14216180|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216181|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14216182|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
14216183|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216184|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216185|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
14216186|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216187|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14216188|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216189|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
14216190|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216191|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14216192|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
14216193|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216194|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14216195|NCT00001941|Daclizumab|daclizumab|mesh-list
14216196|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216197|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
14216198|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216199|NCT00001959|Pirfenidone|pirfenidone|mesh-list
14216200|NCT00001959|Analgesics|analgesics|mesh-ancestor
14216201|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
14216202|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216203|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216204|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14216205|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216206|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216207|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216208|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216209|NCT00001962|Daclizumab|daclizumab|mesh-list
14216210|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216211|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
14216212|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216213|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
14216214|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14216215|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216216|NCT00002525|Leucovorin|leucovorin|mesh-list
14216217|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14216218|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
14216219|NCT00002525|Fluorouracil|fluorouracil|mesh-list
14216220|NCT00002525|Calcium|calcium|mesh-list
14216221|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
14216222|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14216223|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216224|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
14216225|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216226|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14216227|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216228|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216229|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
14216230|NCT00002525|Antidotes|antidotes|mesh-ancestor
14216231|NCT00002525|Protective Agents|protective agents|mesh-ancestor
14216232|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
14216233|NCT00002525|Vitamins|vitamins|mesh-ancestor
14216234|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
14507385|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14216235|NCT00002558|Paclitaxel|paclitaxel|mesh-list
14216236|NCT00002558|Etoposide|etoposide|mesh-list
14216237|NCT00002558|Carboplatin|carboplatin|mesh-list
14216238|NCT00002558|Ifosfamide|ifosfamide|mesh-list
14216239|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14216240|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216241|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
14216242|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
14216243|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
14216244|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216245|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14216246|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216247|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216248|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216249|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
14216250|NCT00002597|Leuprolide|leuprolide|mesh-list
14216251|NCT00002597|Goserelin|goserelin|mesh-list
14216252|NCT00002597|Flutamide|flutamide|mesh-list
14216253|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14216254|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
14216255|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14216256|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216257|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14216258|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216259|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
14216260|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
14216261|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216262|NCT00002601|Doxorubicin|doxorubicin|mesh-list
14216263|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14216264|NCT00002601|Melphalan|melphalan|mesh-list
14216265|NCT00002601|Ifosfamide|ifosfamide|mesh-list
14216266|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216267|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14216268|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14216269|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216270|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216271|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216272|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
14216273|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216274|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216275|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
14216276|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14216277|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216278|NCT00002651|Goserelin|goserelin|mesh-list
14216279|NCT00002651|Bicalutamide|bicalutamide|mesh-list
14216280|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14216281|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216282|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
14216283|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
14216284|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216285|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216286|NCT00002766|Cytarabine|cytarabine|mesh-list
14216287|NCT00002766|Dactinomycin|dactinomycin|mesh-list
14216288|NCT00002766|Prednisone|prednisone|mesh-list
14216289|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
14216290|NCT00002766|Carmustine|carmustine|mesh-list
14216291|NCT00002766|Doxorubicin|doxorubicin|mesh-list
14216292|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14216293|NCT00002766|Methotrexate|methotrexate|mesh-list
14216294|NCT00002766|Etoposide|etoposide|mesh-list
14216295|NCT00002766|Vincristine|vincristine|mesh-list
14216296|NCT00002766|Daunorubicin|daunorubicin|mesh-list
14216297|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
14216298|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
14216299|NCT00002766|Pegaspargase|pegaspargase|mesh-list
14216300|NCT00002766|Sargramostim|sargramostim|mesh-list
14216301|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216302|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
14216303|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216304|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216305|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216306|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
14216307|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216308|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216309|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14216310|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14216311|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14216312|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216313|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216314|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216315|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
14216316|NCT00002766|Hormones|hormones|mesh-ancestor
14216317|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507386|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
14216318|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14216319|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14216320|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
14216321|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14216322|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14216323|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
14216324|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
14216325|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14216326|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14216327|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14216328|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
14216329|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216330|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
14216331|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
14216332|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
14216333|NCT00002766|Analgesics|analgesics|mesh-ancestor
14216334|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
14216335|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216336|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14216337|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14216338|NCT00002842|Leucovorin|leucovorin|mesh-list
14216339|NCT00002842|Fluorouracil|fluorouracil|mesh-list
14216340|NCT00002842|Floxuridine|floxuridine|mesh-list
14216341|NCT00002842|Calcium|calcium|mesh-list
14216342|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
14216343|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14216344|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216345|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
14216346|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216347|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14216348|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216349|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216350|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
14216351|NCT00002842|Antidotes|antidotes|mesh-ancestor
14216352|NCT00002842|Protective Agents|protective agents|mesh-ancestor
14216353|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
14216354|NCT00002842|Vitamins|vitamins|mesh-ancestor
14216355|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
14216356|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
14216357|NCT00002850|Ofloxacin|ofloxacin|mesh-list
14216358|NCT00002850|Trimethoprim|trimethoprim|mesh-list
14216359|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
14216360|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14216361|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216362|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14216363|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216364|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216365|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216366|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216367|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14216368|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14216369|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14216370|NCT00002850|Renal Agents|renal agents|mesh-ancestor
14216371|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
14216372|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14216373|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14216374|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14216375|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14216376|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14216377|NCT00002931|Paclitaxel|paclitaxel|mesh-list
14216378|NCT00002931|Etoposide|etoposide|mesh-list
14216379|NCT00002931|Carboplatin|carboplatin|mesh-list
14216380|NCT00002931|Ifosfamide|ifosfamide|mesh-list
14216381|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14216382|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216383|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
14216384|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
14216385|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
14216386|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216387|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14216388|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216389|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507387|NCT02928029|Hormones|hormones|mesh-ancestor
14507388|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507389|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507390|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216390|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216391|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
14216392|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
14216393|NCT00003138|Lenograstim|lenograstim|mesh-list
14216394|NCT00003138|Sargramostim|sargramostim|mesh-list
14216395|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14216396|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
14216397|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216398|NCT00003138|Hematinics|hematinics|mesh-ancestor
14216399|NCT00003199|Tamoxifen|tamoxifen|mesh-list
14216400|NCT00003199|Aldesleukin|aldesleukin|mesh-list
14216401|NCT00003199|Melphalan|melphalan|mesh-list
14216402|NCT00003199|Busulfan|busulfan|mesh-list
14216403|NCT00003199|Thiotepa|thiotepa|mesh-list
14216404|NCT00003199|Interleukin-2|interleukin-2|mesh-list
14216405|NCT00003199|Sargramostim|sargramostim|mesh-list
14216406|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216407|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216408|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
14216409|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216410|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14216411|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13964962|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13964963|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13964964|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
14947470|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
14947471|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13964965|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
14216412|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
14216413|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216414|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216415|NCT00003199|Analgesics|analgesics|mesh-ancestor
14216416|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
14216417|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216418|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14216419|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
14216420|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216421|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14216422|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14216423|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14216424|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14216425|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14216426|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14216427|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
14216428|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216429|NCT00003222|Aldesleukin|aldesleukin|mesh-list
14216430|NCT00003222|Interleukin-2|interleukin-2|mesh-list
14216431|NCT00003222|Sargramostim|sargramostim|mesh-list
14216432|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
14507391|NCT02929498|Azacitidine|azacitidine|mesh-list
14507392|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14507393|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
14507394|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507395|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507396|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507397|NCT02929667|Fluoxetine|fluoxetine|mesh-list
14507398|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14507399|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14507400|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507401|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507402|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507403|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
14507404|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507405|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14507406|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
14507407|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14507408|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14507409|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14507410|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507411|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13964966|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13964967|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13964968|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13964969|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216433|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216434|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216435|NCT00003222|Analgesics|analgesics|mesh-ancestor
14216436|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
14216437|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216438|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216439|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
14216440|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14216441|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14216442|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
14216443|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216444|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14216445|NCT00003224|Vaccines|vaccines|mesh-list
14216446|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
14216447|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
14216448|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216449|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14216450|NCT00003270|Cyclosporine|cyclosporine|mesh-list
14216451|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
14216452|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
14216453|NCT00003270|Busulfan|busulfan|mesh-list
14216454|NCT00003270|Cyclosporins|cyclosporins|mesh-list
14216455|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14216456|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216457|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
14216458|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216459|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216460|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216461|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
14216462|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216463|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216464|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14216465|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216466|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
14216467|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216468|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
14216469|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14216470|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216471|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
14216472|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
14216473|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216474|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14216475|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
14216476|NCT00003270|Hormones|hormones|mesh-ancestor
14216477|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216478|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14216479|NCT00003270|Protective Agents|protective agents|mesh-ancestor
14216480|NCT05235100|Apatinib|apatinib|mesh-list
14216481|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216482|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14216483|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216484|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216485|NCT05234840|Triamcinolone|triamcinolone|mesh-list
14216486|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216487|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
14216488|NCT05234840|Hormones|hormones|mesh-ancestor
14216489|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216490|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216491|NCT05234697|Remifentanil|remifentanil|mesh-list
14216492|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14216493|NCT05234697|Narcotics|narcotics|mesh-ancestor
14216494|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216495|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216496|NCT05234697|Analgesics|analgesics|mesh-ancestor
14216497|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
14216498|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216499|NCT05234684|Prednisone|prednisone|mesh-list
14216500|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
14216501|NCT05234684|Vincristine|vincristine|mesh-list
14216502|NCT05234684|Rituximab|rituximab|mesh-list
14216503|NCT05234684|Doxorubicin|doxorubicin|mesh-list
14216504|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216505|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
14216506|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216507|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216508|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14216509|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
14507412|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14507413|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
14216510|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216511|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216512|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14216513|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216514|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
14216515|NCT05234684|Hormones|hormones|mesh-ancestor
14216516|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216517|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14216518|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14216519|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
14216520|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
14216521|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
14216522|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14216523|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14216524|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14216525|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216526|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216527|NCT05234619|Ketorolac|ketorolac|mesh-list
14216528|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14216529|NCT05234619|Lidocaine|lidocaine|mesh-list
14216530|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
14216531|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
14216532|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216533|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216534|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
14216535|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216536|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14216537|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14216538|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14216539|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14216540|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216541|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14216542|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216543|NCT05234619|Analgesics|analgesics|mesh-ancestor
14216544|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216545|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216546|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14216547|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216548|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14242020|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14242021|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14242022|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14242023|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
14242024|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242025|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242026|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242027|NCT00183443|Valproic Acid|valproic acid|mesh-list
14242028|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14242029|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
14242030|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242031|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14242032|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14242033|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242034|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242035|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242036|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242037|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
14242038|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
14242039|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
14242040|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242041|NCT00183469|Lamotrigine|lamotrigine|mesh-list
14242042|NCT00183469|Valproic Acid|valproic acid|mesh-list
13964970|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964971|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13964972|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13964973|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13964974|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13964975|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13964976|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
13964977|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
13964978|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
13964979|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13964980|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13964981|NCT03133234|Osimertinib|osimertinib|mesh-list
14216549|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14216550|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14216551|NCT05234307|Nivolumab|nivolumab|mesh-list
14216552|NCT05234307|Adenosine|adenosine|mesh-list
14216553|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
14216554|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14216555|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216556|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14216557|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947472|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947473|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14947474|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
14947475|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947476|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947477|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
14947478|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947479|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14507414|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
14507415|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
14507416|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14507417|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14507418|NCT02930005|Analgesics|analgesics|mesh-ancestor
14507419|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
14507420|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507421|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507422|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507423|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14507424|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14507425|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507426|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507427|NCT02930343|Folic Acid|folic acid|mesh-list
14507428|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
14507429|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
13964982|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507430|NCT02930343|Prednisolone|prednisolone|mesh-list
14507431|NCT02930343|Methotrexate|methotrexate|mesh-list
14507432|NCT02930343|Leflunomide|leflunomide|mesh-list
14507433|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
14507434|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14507435|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
14787048|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14787049|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787050|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787051|NCT00717730|Vitamins|vitamins|mesh-list
14787052|NCT00717730|Folic Acid|folic acid|mesh-list
14787053|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
14787054|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
14787055|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
14787056|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
14787057|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787058|NCT00717730|Hematinics|hematinics|mesh-ancestor
14787059|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
14787060|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14787061|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14787062|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787063|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
13964983|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13964984|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964985|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964986|NCT03133546|Bevacizumab|bevacizumab|mesh-list
13964987|NCT03133546|Osimertinib|osimertinib|mesh-list
13964988|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13964989|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216558|NCT05234307|Analgesics|analgesics|mesh-ancestor
14216559|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
14507436|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14216560|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216561|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216562|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14216563|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
14216564|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14216565|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
14216566|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
14216567|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216568|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14216569|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14216570|NCT05234112|Acetic Acid|acetic acid|mesh-list
14216571|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14216572|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216573|NCT05233735|Betamethasone|betamethasone|mesh-list
14216574|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216575|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
14216576|NCT05233735|Hormones|hormones|mesh-ancestor
14216577|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216578|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216579|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14216580|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
14216581|NCT05233722|Sirolimus|sirolimus|mesh-list
14216582|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216583|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14216584|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216585|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14216586|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216587|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
14216588|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216589|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
14216590|NCT05233709|Fesoterodine|fesoterodine|mesh-list
14216591|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14216592|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14216593|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
14216594|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216595|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216596|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216597|NCT05233709|Urological Agents|urological agents|mesh-ancestor
14216598|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
14216599|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14216600|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216601|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216602|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216603|NCT05233605|Analgesics|analgesics|mesh-ancestor
14216604|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
14216605|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216606|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14216607|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14216608|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14216609|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14216610|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216611|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216612|NCT05233579|Sulforaphane|sulforaphane|mesh-list
14216613|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14216614|NCT05233579|Protective Agents|protective agents|mesh-ancestor
14216615|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216616|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216617|NCT05233514|Metformin|metformin|mesh-list
14216618|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14216619|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216620|NCT05233462|Bupivacaine|bupivacaine|mesh-list
14216621|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
14216622|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
14216623|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216624|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216625|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
14216626|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216627|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
14216628|NCT05233358|Nivolumab|nivolumab|mesh-list
14216629|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14216630|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14216631|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216632|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216633|NCT05233332|Vemurafenib|vemurafenib|mesh-list
14216634|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216635|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14216636|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216637|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216638|NCT05233228|Nicotine|nicotine|mesh-list
14216639|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14216640|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
14216641|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216642|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216643|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14216644|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14216645|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
14216646|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216647|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216648|NCT05233202|Simendan|simendan|mesh-list
14216649|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14216650|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
14216651|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14216652|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14216653|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216654|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216655|NCT05233202|Protective Agents|protective agents|mesh-ancestor
14216656|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216657|NCT05233124|Aspirin|aspirin|mesh-list
14216658|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
14216659|NCT05233124|Clopidogrel|clopidogrel|mesh-list
14216660|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14216661|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216662|NCT05233124|Analgesics|analgesics|mesh-ancestor
14216663|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
14216664|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216665|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216666|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216667|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216668|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14216669|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14216670|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216671|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14216672|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14216673|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216674|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
14216675|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14216676|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14216677|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14216678|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
14216679|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216680|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14216681|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
14216682|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14216683|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
14216684|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
14216685|NCT05232994|Metformin|metformin|mesh-list
14216686|NCT05232994|Esomeprazole|esomeprazole|mesh-list
14216687|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14216688|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216689|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14216690|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14216691|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14216692|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216693|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216694|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
14216695|NCT05232461|Celecoxib|celecoxib|mesh-list
14216696|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14216697|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216698|NCT05232461|Analgesics|analgesics|mesh-ancestor
14216699|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
14216700|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216701|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216702|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216703|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216704|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14216705|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14216706|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216707|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216708|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14216709|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216710|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14216711|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216712|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216713|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14216714|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14216715|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
14216716|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14216717|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216718|NCT05232370|Losartan|losartan|mesh-list
14216719|NCT05232370|Enalapril|enalapril|mesh-list
14216720|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14216721|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14216722|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14216723|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14216724|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14216725|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14216726|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216727|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
14242043|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
14242044|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14242045|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242046|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242047|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14242048|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242049|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14242050|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14242051|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242052|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242053|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14947480|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947481|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
14947482|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14947483|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14947484|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
14242054|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242055|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
14242056|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242057|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
14242058|NCT00183625|Olanzapine|olanzapine|mesh-list
14242059|NCT00183625|Risperidone|risperidone|mesh-list
14242060|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14242061|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
14242062|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242063|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242064|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242065|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14242066|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14242067|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242068|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242069|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14242070|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
14242071|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
14242072|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
14242073|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242074|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14242075|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14242076|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242077|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242078|NCT00183677|Citalopram|citalopram|mesh-list
14242079|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14242080|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242081|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242082|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242083|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242084|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
14242085|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242086|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14242087|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
14242088|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242089|NCT00183729|Memantine|memantine|mesh-list
14947485|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14216728|NCT05232227|Primaquine|primaquine|mesh-list
14216729|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
14216730|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14216731|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14216732|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216733|NCT05232123|Cannabidiol|cannabidiol|mesh-list
14216734|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
14216735|NCT05232084|Fentanyl|fentanyl|mesh-list
14216736|NCT05232084|Bupivacaine|bupivacaine|mesh-list
14216737|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
14216738|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
14216739|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216740|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216741|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
14216742|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216743|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14216744|NCT05232084|Narcotics|narcotics|mesh-ancestor
14216745|NCT05232084|Analgesics|analgesics|mesh-ancestor
14216746|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14216747|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14216748|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
14216749|NCT05231460|Narcotics|narcotics|mesh-list
14216750|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216751|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216752|NCT05231460|Analgesics|analgesics|mesh-ancestor
14216753|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
14216754|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216755|NCT05231330|Fluorides|fluorides|mesh-list
14216756|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
14216757|NCT05231330|Protective Agents|protective agents|mesh-ancestor
14216758|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216759|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14216760|NCT05231148|Calcium|calcium|mesh-list
14216761|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14216762|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216763|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216764|NCT05230901|Dihydralazine|dihydralazine|mesh-list
14507437|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507438|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14507439|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
14507440|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507441|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507442|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507443|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507444|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14507445|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947486|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947487|NCT01528176|Vitamins|vitamins|mesh-ancestor
14947488|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
14947489|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14947490|NCT01528280|Vaccines|vaccines|mesh-list
14947491|NCT01528280|Immunologic Factors|immunologic factors|mesh-ancestor
14947492|NCT01528280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947493|NCT01528371|Midazolam|midazolam|mesh-list
14947494|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14947495|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14947496|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947497|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947498|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14947499|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947500|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947501|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14947502|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
14947503|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
14947504|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
14947505|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
14947506|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947507|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947508|NCT01528501|Panobinostat|panobinostat|mesh-list
14947509|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947510|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14947511|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507446|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
14507447|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14947512|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216765|NCT05230901|Spironolactone|spironolactone|mesh-list
14216766|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14216767|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
14216768|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216769|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216770|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14216771|NCT05230901|Diuretics|diuretics|mesh-ancestor
14216772|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
14216773|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14216774|NCT05230797|Zinc|zinc|mesh-list
14216775|NCT05230797|Propolis|propolis|mesh-list
14216776|NCT05230797|Eugenol|eugenol|mesh-list
14216777|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
14216778|NCT05230797|Trace Elements|trace elements|mesh-ancestor
14216779|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
14216780|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216781|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216782|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
14216783|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
14216784|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14216785|NCT05230797|Protective Agents|protective agents|mesh-ancestor
14216786|NCT05230758|Metformin|metformin|mesh-list
14216787|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14216788|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216789|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
14216790|NCT05230654|Aprepitant|aprepitant|mesh-list
14216791|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
14216792|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
14216793|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216794|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216795|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14216796|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14216797|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216798|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216799|NCT05230472|Simvastatin|simvastatin|mesh-list
14216800|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14216801|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14216802|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
14216803|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216804|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14216805|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14216806|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216807|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
14216808|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216809|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
14216810|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
14216811|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
14216812|NCT05211570|Azacitidine|azacitidine|mesh-list
14216813|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14216814|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
14216815|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216816|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216817|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216818|NCT05211154|Diclofenac|diclofenac|mesh-list
14216819|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14216820|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216821|NCT05211154|Analgesics|analgesics|mesh-ancestor
14216822|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
14216823|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216824|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216825|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14216826|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216827|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14216828|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216829|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242090|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14242091|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14242092|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
14242093|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242094|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242095|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242096|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14242097|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14242098|NCT00183794|Gemcitabine|gemcitabine|mesh-list
14242099|NCT00183794|Docetaxel|docetaxel|mesh-list
14242100|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242101|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
14242102|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216830|NCT05209555|Pilocarpine|pilocarpine|mesh-list
14216831|NCT05209555|Miotics|miotics|mesh-ancestor
14216832|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
13964990|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13964991|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14507448|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13964992|NCT03133546|Growth Substances|growth substances|mesh-ancestor
14507449|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507450|NCT02930343|Hormones|hormones|mesh-ancestor
14507451|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507452|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507453|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507454|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507455|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
14507456|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14507457|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14507458|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507459|NCT02930343|Hematinics|hematinics|mesh-ancestor
14507460|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
14507461|NCT02930343|Vitamins|vitamins|mesh-ancestor
14507462|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
14507463|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14507464|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14507465|NCT02930343|Analgesics|analgesics|mesh-ancestor
14507466|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
14507467|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14507468|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14507469|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14507470|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507471|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
14507472|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14507473|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14507474|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507475|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
14507476|NCT02930941|Coagulants|coagulants|mesh-ancestor
14507477|NCT02931045|Clopidogrel|clopidogrel|mesh-list
14507478|NCT02931045|Ticagrelor|ticagrelor|mesh-list
14507479|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14507480|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14507481|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14507482|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14507483|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
14507484|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507485|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507486|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507487|NCT02931253|Metformin|metformin|mesh-list
14507488|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14507489|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507490|NCT02931539|Valganciclovir|valganciclovir|mesh-list
14507491|NCT02931539|Ganciclovir|ganciclovir|mesh-list
14507492|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14507493|NCT02931539|Cidofovir|cidofovir|mesh-list
14507494|NCT02931539|Foscarnet|foscarnet|mesh-list
13964993|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13964994|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
13964995|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14216833|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216834|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216835|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14216836|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14216837|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
14216838|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216839|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216840|NCT05209074|Ivosidenib|ivosidenib|mesh-list
14216841|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216842|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216843|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216844|NCT05208034|Methotrexate|methotrexate|mesh-list
14216845|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14216846|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
14216847|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14216848|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216849|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14216850|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
14216851|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216852|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216853|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
14216854|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216855|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14216856|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14216857|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
14216858|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14216859|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14216860|NCT05203276|Endostar protein|endostar protein|mesh-list
14216861|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14216862|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14216863|NCT05203276|Growth Substances|growth substances|mesh-ancestor
14216864|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216865|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
14216866|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216867|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14216868|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216869|NCT05202158|Gentamicins|gentamicins|mesh-list
14216870|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14216871|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216872|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14216873|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216874|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216875|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
14216876|NCT05199493|Giapreza|giapreza|mesh-list
14216877|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
14216878|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14216879|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14216880|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
14216881|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216882|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216883|NCT05188170|Niclosamide|niclosamide|mesh-list
14216884|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
14216885|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14216886|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
14216887|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14216888|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14216889|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
14216890|NCT05184777|Estradiol|estradiol|mesh-list
14216891|NCT05184777|Progesterone|progesterone|mesh-list
14216892|NCT05184777|Estrogens|estrogens|mesh-ancestor
14216893|NCT05184777|Hormones|hormones|mesh-ancestor
14216894|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14216895|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216896|NCT05184777|Progestins|progestins|mesh-ancestor
14216897|NCT05174455|Niraparib|niraparib|mesh-list
14216898|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14216899|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242103|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216900|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216901|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216902|NCT05153174|Sulforaphane|sulforaphane|mesh-list
14216903|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14216904|NCT05153174|Protective Agents|protective agents|mesh-ancestor
14216905|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216906|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216907|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14216908|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
14216909|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216910|NCT05135650|Myeloma Proteins|myeloma proteins|mesh-list
14216911|NCT05135650|Paraproteins|paraproteins|mesh-list
14216912|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
14216913|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216914|NCT05124171|Vaccines|vaccines|mesh-list
14216915|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
14216916|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216917|NCT05120895|Pravastatin|pravastatin|mesh-list
14216918|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14507495|NCT02931539|Maribavir|maribavir|mesh-list
14507496|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
14507497|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507498|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14507499|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507500|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507501|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14507502|NCT02931838|BMS-986165|bms-986165|mesh-list
14507503|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507504|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14507505|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507506|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507507|NCT02932267|Adapalene|adapalene|mesh-list
14507508|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14507509|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14507510|NCT02932267|Analgesics|analgesics|mesh-ancestor
14507511|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
14507512|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507513|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507514|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507515|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787064|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787065|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787066|NCT00717808|Tranilast|tranilast|mesh-list
14787067|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
14787068|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14787069|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14787070|NCT00717808|Analgesics|analgesics|mesh-ancestor
14787071|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
14787072|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787073|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507516|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507517|NCT02932904|Vortioxetine|vortioxetine|mesh-list
14507518|NCT02932904|Paroxetine|paroxetine|mesh-list
14507519|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14507520|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14507521|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507522|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507523|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507524|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
14507525|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530054|NCT03348904|Pemetrexed|pemetrexed|mesh-list
14947513|NCT01528540|Pregabalin|pregabalin|mesh-list
14947514|NCT01528540|Antioxidants|antioxidants|mesh-list
13964996|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13964997|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13964998|NCT03133325|Lidocaine|lidocaine|mesh-list
13964999|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
13965000|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
13965001|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965002|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965003|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
13965004|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965005|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13965006|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13965007|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14216919|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14216920|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
14216921|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216922|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14216923|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14216924|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242104|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
14242105|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242106|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242107|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242108|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
14242109|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242110|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242111|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242112|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242113|NCT00183872|Docetaxel|docetaxel|mesh-list
14242114|NCT00183872|Irinotecan|irinotecan|mesh-list
14242115|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242116|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242117|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242118|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242119|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242120|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14242121|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14242122|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242123|NCT00184002|Prednisone|prednisone|mesh-list
14242124|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
14242125|NCT00184002|Doxorubicin|doxorubicin|mesh-list
14242126|NCT00184002|Vincristine|vincristine|mesh-list
14242127|NCT00184002|Rituximab|rituximab|mesh-list
14242128|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242129|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
14242130|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242131|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242132|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14242133|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
14242134|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242135|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242136|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14242137|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14242138|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14242139|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14242140|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242141|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14242142|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
14242143|NCT00184002|Hormones|hormones|mesh-ancestor
14242144|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242145|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14242146|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14242147|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242148|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242149|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242150|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14242151|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
14242152|NCT00184028|Docetaxel|docetaxel|mesh-list
14242153|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242154|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242155|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242156|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242157|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242158|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
14242159|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
14242160|NCT00184054|Vitamins|vitamins|mesh-ancestor
14242161|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
14242162|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242163|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
14242164|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242165|NCT00184054|Protective Agents|protective agents|mesh-ancestor
14242166|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242167|NCT00184093|Gemcitabine|gemcitabine|mesh-list
14242168|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242169|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
14242170|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947515|NCT01528540|Analgesics|analgesics|mesh-ancestor
14242171|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242172|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
14216925|NCT05093296|Naltrexone|naltrexone|mesh-list
14216926|NCT05093296|Oxytocin|oxytocin|mesh-list
14216927|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
14216928|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14216929|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216930|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14216931|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14216932|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
14216933|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216934|NCT05075876|Granisetron|granisetron|mesh-list
14216935|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
14216936|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
14216937|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216938|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216939|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14216940|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14216941|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
14216942|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216943|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507526|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14507527|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
14507528|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14507529|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14507530|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14507531|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507532|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14507533|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14507534|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507535|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14507536|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14507537|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14507538|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14507539|NCT02933034|Manganese|manganese|mesh-list
14507540|NCT02933034|Trace Elements|trace elements|mesh-ancestor
14507541|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
14507542|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507543|NCT02933320|Rituximab|rituximab|mesh-list
14507544|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14507545|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507546|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
14507547|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507548|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14507549|NCT02933372|Varenicline|varenicline|mesh-list
14507550|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14507551|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14507552|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
14507553|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507554|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507555|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507556|NCT02934191|Acetaminophen|acetaminophen|mesh-list
14507557|NCT02934191|Celecoxib|celecoxib|mesh-list
14507558|NCT02934191|Oxycodone|oxycodone|mesh-list
14507559|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
14507560|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507561|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14507562|NCT02934191|Analgesics|analgesics|mesh-ancestor
14507563|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
14507564|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507565|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
14507566|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14507567|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507568|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14507569|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14507570|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14507571|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507572|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507573|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14507574|NCT02934191|Narcotics|narcotics|mesh-ancestor
14507575|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507576|NCT02934191|Antacids|antacids|mesh-ancestor
14507577|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507578|NCT02934698|Ivacaftor|ivacaftor|mesh-list
14507579|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14507580|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507581|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216944|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
14216945|NCT05045170|Propofol|propofol|mesh-list
14216946|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
14216947|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216948|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216949|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14216950|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14216951|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
14216952|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216953|NCT05045170|Analgesics|analgesics|mesh-ancestor
14216954|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
14216955|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216956|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14216957|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14216958|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14216959|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
14216960|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216961|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216962|NCT05042934|Irinotecan|irinotecan|mesh-list
14216963|NCT05042934|Camptothecin|camptothecin|mesh-list
14216964|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14216965|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14216966|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14216967|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216968|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216969|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14216970|NCT05034627|Asparaginase|asparaginase|mesh-list
14216971|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216972|NCT05027204|Docetaxel|docetaxel|mesh-list
14216973|NCT05027204|Nivolumab|nivolumab|mesh-list
14216974|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216975|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
14216976|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
14216977|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
14216978|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216979|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14216980|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14216981|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
14216982|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14216983|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14216984|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14216985|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14216986|NCT05025605|Analgesics|analgesics|mesh-ancestor
14216987|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
14216988|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14216989|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14216990|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14216991|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14216992|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
14216993|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14216994|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14216995|NCT05023070|Cannabidiol|cannabidiol|mesh-list
14216996|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
14216997|NCT05018273|Atezolizumab|atezolizumab|mesh-list
14216998|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14216999|NCT05014282|Nicotine|nicotine|mesh-list
14217000|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14217001|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
14217002|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217003|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217004|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14217005|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14217006|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
14217007|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217008|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217009|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
14217010|NCT05014230|Narcotics|narcotics|mesh-ancestor
14217011|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217012|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217013|NCT05014230|Analgesics|analgesics|mesh-ancestor
14217014|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
14217015|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217016|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14217017|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14217018|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14217019|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217020|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217021|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14217022|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14217023|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217024|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
14217025|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217026|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14217027|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14217028|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217029|NCT05005507|Tenofovir|tenofovir|mesh-list
14217030|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14217031|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
14217032|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217033|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14217034|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14217035|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217036|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217037|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14217038|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14217039|NCT05004987|Dexetimide|dexetimide|mesh-list
14217040|NCT05004987|Citalopram|citalopram|mesh-list
14217041|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14217042|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14217043|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14217044|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217045|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217046|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
14217047|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217048|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14217049|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
14217050|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217051|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14217052|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14217053|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
14217054|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
14217055|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217056|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14217057|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14217058|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
14217059|NCT05004805|Methylene Blue|methylene blue|mesh-list
14217060|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217061|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217062|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
14217063|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14217064|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217065|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217066|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14217067|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14217068|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
14217069|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217070|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217071|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
14217072|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217073|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217074|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14217075|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14217076|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14217077|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
14217078|NCT04965220|Trametinib|trametinib|mesh-list
14217079|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217080|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14217081|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217082|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217083|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
14217084|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14217085|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217086|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14217087|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217088|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14217089|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14217090|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217091|NCT04945655|Vaccines|vaccines|mesh-list
14217092|NCT04945655|Immunologic Factors|immunologic factors|mesh-ancestor
14217093|NCT04945655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217094|NCT04937166|Azacitidine|azacitidine|mesh-list
14217095|NCT04937166|Venetoclax|venetoclax|mesh-list
14217096|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217097|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
14217098|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217099|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217100|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217101|NCT04928950|Charcoal|charcoal|mesh-list
14217102|NCT04928950|Antidotes|antidotes|mesh-ancestor
14217103|NCT04928950|Protective Agents|protective agents|mesh-ancestor
14217104|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217105|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
14507582|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
14507583|NCT02935699|Promethazine|promethazine|mesh-list
14507584|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14507585|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14507586|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507587|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507588|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
14507589|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
14507590|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
14507591|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507592|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
14507593|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
14947516|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
14947517|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947518|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947519|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
14947520|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14947521|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947522|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947523|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14947524|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14947525|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14507594|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507595|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14507596|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
14507597|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
14507598|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507599|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507600|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14507601|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
14507602|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507603|NCT02935738|Prednisolone|prednisolone|mesh-list
14507604|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507605|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
14507606|NCT02935738|Hormones|hormones|mesh-ancestor
14507607|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507608|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507609|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507610|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507611|NCT02935894|Ibuprofen|ibuprofen|mesh-list
14507612|NCT02935894|Pilocarpine|pilocarpine|mesh-list
14507613|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14507614|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965008|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13965009|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965010|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
13965011|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965012|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
13965013|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13965014|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
13965015|NCT03133312|Povidone|povidone|mesh-list
13965016|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13965017|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965018|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
13965019|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14217106|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14507615|NCT02935894|Analgesics|analgesics|mesh-ancestor
14217107|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14217108|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14217109|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
14217110|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217111|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217112|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217113|NCT04920539|Dronabinol|dronabinol|mesh-list
14217114|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
14217115|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217116|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217117|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14217118|NCT04920539|Analgesics|analgesics|mesh-ancestor
14217119|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
14217120|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217121|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14217122|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14217123|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217124|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217125|NCT04920539|Hormones|hormones|mesh-ancestor
14217126|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217127|NCT04919382|Temozolomide|temozolomide|mesh-list
14217128|NCT04919382|Atezolizumab|atezolizumab|mesh-list
14217129|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14217130|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14217131|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
14217132|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217133|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217134|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
14217135|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242173|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242174|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242175|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242176|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
14242177|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242178|NCT00184600|Insulin|insulin|mesh-list
14242179|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14242180|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
14242181|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
14242182|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14242183|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
14242184|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
14242185|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14242186|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242187|NCT00185211|Interferons|interferons|mesh-list
14242188|NCT00185211|Interferon-beta|interferon-beta|mesh-list
14242189|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
14242190|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242191|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
14242192|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242193|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
14242194|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242195|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14242196|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
14242197|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14242198|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
14242199|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14242200|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242201|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14242202|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14242203|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14242204|NCT00185588|Gemcitabine|gemcitabine|mesh-list
14242205|NCT00185588|Vatalanib|vatalanib|mesh-list
14242206|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242207|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
14242208|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242209|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242210|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
14242211|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242212|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242213|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242214|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
14242215|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242216|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14242217|NCT00185614|Cyclosporine|cyclosporine|mesh-list
14242218|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
14217136|NCT04864743|Factor VIII|factor viii|mesh-list
14217137|NCT04864743|Coagulants|coagulants|mesh-ancestor
14217138|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14217139|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
14217140|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
14217141|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217142|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217143|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
14217144|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217145|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14217146|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
14217147|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217148|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217154|NCT04852003|Morphine|morphine|mesh-list
14217155|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14217156|NCT04852003|Narcotics|narcotics|mesh-ancestor
14217157|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217158|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217159|NCT04852003|Analgesics|analgesics|mesh-ancestor
14217160|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
14217161|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217171|NCT04845035|Cytarabine|cytarabine|mesh-list
14217172|NCT04845035|Methotrexate|methotrexate|mesh-list
14217173|NCT04845035|Dasatinib|dasatinib|mesh-list
14217174|NCT04845035|Ponatinib|ponatinib|mesh-list
14217175|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14217176|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
14217177|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14217178|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217179|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217180|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
14217181|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217182|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217183|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
14217184|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217185|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14217186|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217187|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
14217188|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14507616|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
14507617|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507618|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507619|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507620|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14507621|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14507622|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507623|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507624|NCT02935894|Miotics|miotics|mesh-ancestor
14507625|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
14507626|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14507627|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14507628|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
14507629|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507630|NCT02936037|Biotin|biotin|mesh-list
14507631|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
14507632|NCT02936037|Vitamins|vitamins|mesh-ancestor
14507633|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
14507634|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507635|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14507636|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14217189|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14217190|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
14217191|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217192|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14217193|NCT04810598|Venetoclax|venetoclax|mesh-list
14217194|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217195|NCT04796922|Rituximab|rituximab|mesh-list
14217196|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
14217197|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217198|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217199|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
14217200|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217201|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217202|NCT04790513|Evolocumab|evolocumab|mesh-list
14217203|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14217204|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14217205|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
14217206|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217207|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14217208|NCT04786210|Triamcinolone|triamcinolone|mesh-list
14217209|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14217210|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14217211|NCT04786210|Fluorouracil|fluorouracil|mesh-list
14217212|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14217213|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
14217214|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217215|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217216|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217217|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217218|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
14217219|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217220|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14217221|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
14217222|NCT04786210|Hormones|hormones|mesh-ancestor
14217223|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217224|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217225|NCT04782778|Bupivacaine|bupivacaine|mesh-list
14217226|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
14217227|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
14217228|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217229|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217230|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
14217231|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217232|NCT04763512|Caseins|caseins|mesh-list
14217233|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
14217234|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
14217235|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217236|NCT04761861|Vildagliptin|vildagliptin|mesh-list
14217237|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14217238|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217239|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14217240|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
14217241|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217242|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217243|NCT04761094|Insulin|insulin|mesh-list
14217244|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14217245|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217246|NCT04756271|Antibodies|antibodies|mesh-list
14217247|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
14217248|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
14217249|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217250|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
14217251|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217252|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217253|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14217254|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14217255|NCT04729023|Temazepam|temazepam|mesh-list
14217256|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14217257|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217258|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217259|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14217260|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14217261|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217262|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
14217263|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
14217264|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217265|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217266|NCT04718350|Simendan|simendan|mesh-list
14217267|NCT04718350|Milrinone|milrinone|mesh-list
14217268|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14217269|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
14217270|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14217271|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14217272|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217273|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217274|NCT04718350|Protective Agents|protective agents|mesh-ancestor
14217275|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217276|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14217277|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
14217278|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14217279|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
14217280|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217281|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217282|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14217283|NCT04714710|Diuretics|diuretics|mesh-ancestor
14217284|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
14217285|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14217286|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
14217287|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217288|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217289|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14217290|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
14217291|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217292|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217293|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14217294|NCT04698434|Esketamine|esketamine|mesh-list
14217295|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
14217296|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217297|NCT04696575|Lamivudine|lamivudine|mesh-list
14217298|NCT04696575|Carboplatin|carboplatin|mesh-list
14217299|NCT04696575|Etoposide|etoposide|mesh-list
14217300|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
14217301|NCT04696575|Atezolizumab|atezolizumab|mesh-list
14217302|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
14217303|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14217304|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217305|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14217306|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14217307|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14217308|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217309|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217310|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14217311|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14217312|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
14217313|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217314|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14217315|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14217316|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
14217317|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217318|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
14217319|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
14217320|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
14217321|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
14217322|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
14217323|NCT04681430|Gabexate|gabexate|mesh-list
14217324|NCT04681430|Camostat|camostat|mesh-list
14217325|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
14217326|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217327|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217328|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14217329|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14217330|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
14217331|NCT04677816|Vitamin D|vitamin d|mesh-list
14217332|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
14217333|NCT04677816|Vitamins|vitamins|mesh-ancestor
14217334|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
14217335|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217336|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14217337|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14217338|NCT04674774|Lansoprazole|lansoprazole|mesh-list
14217339|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
14217340|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14217341|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14217342|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14217343|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217344|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217345|NCT04672512|Prednisone|prednisone|mesh-list
14217346|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14217347|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
14217348|NCT04672512|Hormones|hormones|mesh-ancestor
14217349|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217350|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217351|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14217352|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242219|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
14242220|NCT00185614|Melphalan|melphalan|mesh-list
14242221|NCT00185614|Cyclosporins|cyclosporins|mesh-list
14242222|NCT00185614|Lenograstim|lenograstim|mesh-list
14242223|NCT00185614|Sargramostim|sargramostim|mesh-list
14242224|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242225|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
14242226|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242227|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242228|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14242229|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
14242230|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242231|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242232|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14242233|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14242234|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242235|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
14242236|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242237|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
14242238|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14242239|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14242240|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14242241|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
14242242|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14242243|NCT00185640|Cyclosporine|cyclosporine|mesh-list
14242244|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
14242245|NCT00185640|Lenograstim|lenograstim|mesh-list
14242246|NCT00185640|Cyclosporins|cyclosporins|mesh-list
14242247|NCT00185640|Sargramostim|sargramostim|mesh-list
14242248|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
14242249|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14242250|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14242251|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
14242252|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242253|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242254|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242255|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242256|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
14242257|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242258|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
14242259|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242260|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14242261|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14242262|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242263|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14242264|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
14242265|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14242266|NCT00185692|Acetaminophen|acetaminophen|mesh-list
14242267|NCT00185692|Cyclosporine|cyclosporine|mesh-list
14242268|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
14242269|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
14242270|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14242271|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14242272|NCT00185692|Prednisolone|prednisolone|mesh-list
14242273|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
14242274|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
14242275|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14242276|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14242277|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14242278|NCT00185692|Cyclosporins|cyclosporins|mesh-list
14242279|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14242280|NCT00185692|Lenograstim|lenograstim|mesh-list
14242281|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14242282|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
14242283|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242284|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507637|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14217353|NCT04650217|Levodopa|levodopa|mesh-list
14217354|NCT04650217|Carbidopa|carbidopa|mesh-list
14217355|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14217356|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14217357|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14217358|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
14217359|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217360|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217361|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217362|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14217363|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217364|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14217365|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
14217366|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
14217367|NCT04650074|Lidocaine|lidocaine|mesh-list
14217368|NCT04650074|Ketamine|ketamine|mesh-list
14217369|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
14217370|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
14217371|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217372|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217373|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
14217374|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217375|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14217376|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14217377|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14217378|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14217379|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217380|NCT04650074|Analgesics|analgesics|mesh-ancestor
14217381|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14217382|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14217383|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
14217384|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14217385|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14217386|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217387|NCT04641195|Vitamin D|vitamin d|mesh-list
14217388|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
14217389|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
14217390|NCT04641195|Vitamins|vitamins|mesh-list
14217391|NCT04641195|Zinc|zinc|mesh-list
14217392|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
14217393|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217394|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14217395|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14217396|NCT04641195|Trace Elements|trace elements|mesh-ancestor
14217397|NCT04634539|Gemcitabine|gemcitabine|mesh-list
14217398|NCT04634539|Paclitaxel|paclitaxel|mesh-list
14217399|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14217400|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217401|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
14217402|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
14217403|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
14217404|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217405|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217406|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
14217407|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
14217408|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217409|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217410|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217411|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
14217412|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217413|NCT04618523|Artesunate|artesunate|mesh-list
14217414|NCT04618523|Lumefantrine|lumefantrine|mesh-list
14217415|NCT04618523|Artemether|artemether|mesh-list
14217416|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14217417|NCT04618523|Amodiaquine|amodiaquine|mesh-list
14217418|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
14217419|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14217420|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14217421|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217422|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217423|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
14217424|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
14217425|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14217426|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
14217427|NCT04608266|Camostat|camostat|mesh-list
14217428|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
14217429|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965020|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
14217430|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217431|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14217432|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14217433|NCT04599816|Simendan|simendan|mesh-list
14217434|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14217435|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
14217436|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14217437|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14217438|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217439|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217440|NCT04599816|Protective Agents|protective agents|mesh-ancestor
14217441|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217442|NCT04599777|Sorafenib|sorafenib|mesh-list
14217443|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217444|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14217445|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217446|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217447|NCT04582669|Triamcinolone|triamcinolone|mesh-list
14217448|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14217449|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14217450|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14217451|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14217452|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
14217453|NCT04582669|Hormones|hormones|mesh-ancestor
14217454|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217455|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217456|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217457|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
14217458|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217459|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217460|NCT04567407|Ropivacaine|ropivacaine|mesh-list
14507638|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14507639|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
14507640|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528717|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14528718|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
14528719|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528720|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528721|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14528722|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
14528723|NCT03822884|Hematinics|hematinics|mesh-ancestor
14528724|NCT03806270|Midazolam|midazolam|mesh-list
14528725|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
14528726|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14528727|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14528728|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528729|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528730|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14528731|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14528732|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14528733|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14528734|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
14528735|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
14528736|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
14528737|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
14528738|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528739|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528740|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
14528741|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
13965021|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
13965022|NCT03133195|Vitamin D|vitamin d|mesh-list
13965023|NCT03133195|Teriparatide|teriparatide|mesh-list
13965024|NCT03133195|Calcium|calcium|mesh-list
13965025|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
13965026|NCT03133195|Vitamins|vitamins|mesh-ancestor
13965027|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
13965028|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965029|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13965030|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13965031|NCT03133299|Vitamin D|vitamin d|mesh-list
13965032|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
13965033|NCT03133299|Vitamins|vitamins|mesh-ancestor
14217461|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
14217462|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
14217463|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217464|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217465|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
14217466|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217467|NCT04562285|Antibodies|antibodies|mesh-list
14217468|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
14217469|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217470|NCT04562246|Antibodies|antibodies|mesh-list
14217471|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
14217472|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217473|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14217474|NCT04551495|Letrozole|letrozole|mesh-list
14217475|NCT04551495|Goserelin|goserelin|mesh-list
14217476|NCT04551495|Entrectinib|entrectinib|mesh-list
14217477|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217478|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14217479|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14217480|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217481|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217482|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14217483|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
14217484|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217485|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217486|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14217487|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14947526|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947527|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13965034|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
13965035|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965036|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14217488|NCT04541290|Tacrolimus|tacrolimus|mesh-list
14217489|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217490|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
14217491|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217492|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14217493|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217494|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217495|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
14217496|NCT04539808|Leucovorin|leucovorin|mesh-list
14217497|NCT04539808|Folic Acid|folic acid|mesh-list
14507641|NCT02937116|Gemcitabine|gemcitabine|mesh-list
14787074|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787075|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787076|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14787077|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14787078|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787079|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14787080|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14787081|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
14787082|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
14787083|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787084|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13965037|NCT03133299|Hormones|hormones|mesh-ancestor
13965038|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965039|NCT03132688|Propofol|propofol|mesh-list
13965040|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13965041|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965042|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965043|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13965044|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
13965045|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
14217498|NCT04539808|Fluorouracil|fluorouracil|mesh-list
14217499|NCT04539808|Capecitabine|capecitabine|mesh-list
14507642|NCT02937116|Cisplatin|cisplatin|mesh-list
14507643|NCT02937116|Capecitabine|capecitabine|mesh-list
14507644|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
14507645|NCT02937116|Irinotecan|irinotecan|mesh-list
14507646|NCT02937116|Etoposide|etoposide|mesh-list
14507647|NCT02937116|Pemetrexed|pemetrexed|mesh-list
14507648|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507649|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14507650|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
14507651|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217500|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
14217501|NCT04539808|Irinotecan|irinotecan|mesh-list
14217502|NCT04539808|Camptothecin|camptothecin|mesh-list
14217503|NCT04539808|Losartan|losartan|mesh-list
14217504|NCT04539808|Calcium|calcium|mesh-list
14217505|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
14217506|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14217507|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217508|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14217509|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
14217510|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217511|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217512|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217513|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217514|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
14217515|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14217516|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14217517|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217518|NCT04539808|Antidotes|antidotes|mesh-ancestor
14217519|NCT04539808|Protective Agents|protective agents|mesh-ancestor
14217520|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
14787085|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14787086|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
14787087|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
14787088|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
14787089|NCT00717821|Hematinics|hematinics|mesh-ancestor
14787090|NCT00717834|Formaldehyde|formaldehyde|mesh-list
14787091|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
14787092|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787093|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14787094|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14787095|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787096|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787097|NCT00717938|Carboplatin|carboplatin|mesh-list
14787098|NCT00717938|Etoposide|etoposide|mesh-list
14217521|NCT04539808|Vitamins|vitamins|mesh-ancestor
14217522|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
14217523|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14217524|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14217525|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14217526|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14217527|NCT04539808|Hematinics|hematinics|mesh-ancestor
14787099|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
14787100|NCT00717938|Cisplatin|cisplatin|mesh-list
14217528|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14217529|NCT04535505|Erythromycin|erythromycin|mesh-list
14787101|NCT00717938|Enoxaparin|enoxaparin|mesh-list
14787102|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
14787103|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217530|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
14217531|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14217532|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
14217533|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14217534|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217535|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14217536|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14217537|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217538|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217539|NCT04527393|Morphine|morphine|mesh-list
14217540|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14217541|NCT04527393|Narcotics|narcotics|mesh-ancestor
14217542|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217543|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217544|NCT04527393|Analgesics|analgesics|mesh-ancestor
14217545|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
14217546|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217547|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
14787104|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14787105|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787106|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787107|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787108|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787109|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
14787110|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14787111|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14787112|NCT00717951|Capecitabine|capecitabine|mesh-list
14787113|NCT00717951|Docetaxel|docetaxel|mesh-list
14787114|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787115|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217548|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217549|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
14217550|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217551|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
14217552|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217553|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217554|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
14217555|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217556|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217557|NCT04504864|Aspirin|aspirin|mesh-list
14217558|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14217559|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14217560|NCT04504864|Analgesics|analgesics|mesh-ancestor
14217561|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
14217562|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217563|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217564|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14217565|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217566|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14217567|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14217568|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217569|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14217570|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14217571|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217572|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
14217573|NCT04497155|Norepinephrine|norepinephrine|mesh-list
14217574|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14217575|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14787116|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
14787117|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787118|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
14787119|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
14787120|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
14217576|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
14217577|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217578|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217579|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217580|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
14217581|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
14217582|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217583|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14217584|NCT04496999|Midostaurin|midostaurin|mesh-list
14217585|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217586|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14217587|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217588|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242285|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242286|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
14242287|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242288|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
14242289|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242290|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
14787121|NCT00717990|Bevacizumab|bevacizumab|mesh-list
14787122|NCT00717990|Capecitabine|capecitabine|mesh-list
14787123|NCT00717990|Irinotecan|irinotecan|mesh-list
14787124|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14787125|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787126|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14787127|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14787128|NCT00717990|Growth Substances|growth substances|mesh-ancestor
14787129|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787130|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14787131|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14787132|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
14787133|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787134|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14787135|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787136|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787137|NCT00718146|Vaccines|vaccines|mesh-list
14787138|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
14787139|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787140|NCT00718172|Ribavirin|ribavirin|mesh-list
14787141|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
14787142|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787143|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
14787144|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787145|NCT00718276|Vitamin D|vitamin d|mesh-list
14787146|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
14787147|NCT00718276|Vitamins|vitamins|mesh-ancestor
14947528|NCT01528540|Protective Agents|protective agents|mesh-ancestor
14947529|NCT01528618|Gemcitabine|gemcitabine|mesh-list
14947530|NCT01528618|Cisplatin|cisplatin|mesh-list
14947531|NCT01528618|Fluorouracil|fluorouracil|mesh-list
14242291|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242292|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14242293|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14242294|NCT00185692|Analgesics|analgesics|mesh-ancestor
14242295|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
14242296|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242297|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
14242298|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14242299|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242300|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14242301|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
14242302|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14242303|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14242304|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
14242305|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
14242306|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14242307|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
14242308|NCT00185692|Hormones|hormones|mesh-ancestor
14243388|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14217589|NCT04493320|Levodopa|levodopa|mesh-list
14217590|NCT04493320|Carbidopa|carbidopa|mesh-list
14217591|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14217592|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14217593|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14217594|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
14217595|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217596|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217597|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217598|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14217599|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217600|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14217601|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
14217602|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
14217603|NCT04491968|Methadone|methadone|mesh-list
14217604|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14217605|NCT04491968|Narcotics|narcotics|mesh-ancestor
14217606|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217607|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217608|NCT04491968|Analgesics|analgesics|mesh-ancestor
14217609|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
14217610|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217611|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
14217612|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
14217613|NCT04483505|Fulvestrant|fulvestrant|mesh-list
14217614|NCT04483505|Palbociclib|palbociclib|mesh-list
14217615|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14217616|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217617|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14217618|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14217619|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
14217620|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217621|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217622|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14217623|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217624|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217625|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
14217626|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217627|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217628|NCT04443348|Paclitaxel|paclitaxel|mesh-list
14217629|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
13965046|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
13965047|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13965048|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13965049|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13965050|NCT03132623|Andrographolide|andrographolide|mesh-list
13965051|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965052|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965053|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965054|NCT03132623|Analgesics|analgesics|mesh-ancestor
13965055|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
13965056|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965057|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217630|NCT04443348|Carboplatin|carboplatin|mesh-list
14217631|NCT04443348|Doxorubicin|doxorubicin|mesh-list
14217632|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
14217633|NCT04443348|Capecitabine|capecitabine|mesh-list
14217634|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14217635|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217636|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
14217637|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
14507652|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
14507653|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507654|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507655|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14507656|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
14507657|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507658|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14507659|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14507660|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14507661|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14507662|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14507663|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14507664|NCT02937168|Reslizumab|reslizumab|mesh-list
14507665|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14507666|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14507667|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507668|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14507669|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
14507670|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14507671|NCT02937350|Calcifediol|calcifediol|mesh-list
14507672|NCT02937350|Vitamins|vitamins|mesh-ancestor
14507673|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
14507674|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507675|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14507676|NCT02937506|Fentanyl|fentanyl|mesh-list
14507677|NCT02937506|Midazolam|midazolam|mesh-list
14507678|NCT02937506|Propofol|propofol|mesh-list
14507679|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14507680|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507681|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507682|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14507683|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
14507684|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
14507685|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14507686|NCT02937506|Narcotics|narcotics|mesh-ancestor
14507687|NCT02937506|Analgesics|analgesics|mesh-ancestor
14507688|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
14507689|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507690|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14507691|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14507692|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14507693|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14507694|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
14507695|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
14507696|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507697|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507698|NCT02937558|Glucagon|glucagon|mesh-list
14507699|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14507700|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507701|NCT02937558|Hormones|hormones|mesh-ancestor
14507702|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507703|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507704|NCT02937558|Incretins|incretins|mesh-ancestor
14507705|NCT02937623|Calcium|calcium|mesh-list
14507706|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14507707|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507708|NCT02937636|Fluorides|fluorides|mesh-list
14507709|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
14507710|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
14507711|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
14507712|NCT02937636|Protective Agents|protective agents|mesh-ancestor
14507713|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507714|NCT02937701|Infliximab|infliximab|mesh-list
14507715|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507716|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507717|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217638|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
14217639|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217640|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217641|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
14217642|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217643|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217644|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14217645|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
14217646|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14217647|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14217648|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14217649|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14217650|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217651|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217652|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14947532|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947533|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14947534|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
14947535|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947536|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
14947537|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947538|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947539|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14217653|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
14217654|NCT04437303|Anticoagulants|anticoagulants|mesh-list
14217655|NCT04413786|Oxytocin|oxytocin|mesh-list
14217656|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
14217657|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14217658|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217659|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
14217660|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14217661|NCT04400383|Antibodies|antibodies|mesh-list
14217662|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
14217663|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14217664|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
14217665|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217666|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217667|NCT04394624|Ramucirumab|ramucirumab|mesh-list
14217668|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217669|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
14217670|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217671|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217672|NCT04378959|Lidocaine|lidocaine|mesh-list
14217673|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
14217674|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
14217675|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217676|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217677|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
14217678|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217679|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14217680|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14217681|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14217682|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14217683|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947540|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
14217684|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
14217685|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217686|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217687|NCT04358393|Azacitidine|azacitidine|mesh-list
14217688|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217689|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
14217690|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217691|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217692|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217693|NCT04347486|Atropine|atropine|mesh-list
14217694|NCT04347486|Neostigmine|neostigmine|mesh-list
14217695|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14217696|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14217697|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14217698|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
14217699|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217700|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217701|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14217702|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
14217703|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
14217704|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
14217705|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14217706|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14217707|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
14217708|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217709|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217710|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14217711|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217712|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14217713|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
14217714|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
14217715|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14217716|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14217717|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217718|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217719|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217720|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217721|NCT04338698|Azithromycin|azithromycin|mesh-list
14217722|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
14217723|NCT04338698|Oseltamivir|oseltamivir|mesh-list
14217724|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14217725|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217726|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
14217727|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14217728|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14217729|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217730|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217731|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217732|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
14217733|NCT04331938|Anesthetics|anesthetics|mesh-list
14217734|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217735|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217736|NCT04326738|Midazolam|midazolam|mesh-list
14217737|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14217738|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14217739|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217740|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217741|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14217742|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14217743|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217744|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14217745|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
14217746|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
14217747|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
14217748|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
14217749|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217750|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217751|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
14217752|NCT04305041|Lenvatinib|lenvatinib|mesh-list
14217753|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217754|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507718|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
14947541|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947542|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
14947543|NCT01528644|Iron|iron|mesh-list
14217755|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14947544|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
14947545|NCT01528644|Calcium|calcium|mesh-list
14217756|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217757|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217758|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
14217759|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217760|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217761|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
14217762|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14217763|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
14217764|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217765|NCT04300920|Expectorants|expectorants|mesh-ancestor
14217766|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
14217767|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14217768|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
14217769|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217770|NCT04300920|Protective Agents|protective agents|mesh-ancestor
14217771|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217772|NCT04300920|Antidotes|antidotes|mesh-ancestor
14217773|NCT04288427|Finasteride|finasteride|mesh-list
14217774|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14217775|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14217776|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217777|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217778|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
14217779|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217780|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217781|NCT04288427|Urological Agents|urological agents|mesh-ancestor
14217782|NCT04282668|Tretinoin|tretinoin|mesh-list
14217783|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217784|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
14217785|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
14217786|NCT04274894|Testosterone|testosterone|mesh-list
14217787|NCT04274894|Androgens|androgens|mesh-ancestor
14217788|NCT04274894|Hormones|hormones|mesh-ancestor
14217789|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217790|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217791|NCT04263090|Nivolumab|nivolumab|mesh-list
14217792|NCT04263090|ON 01910|on 01910|mesh-list
14217793|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217794|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217795|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14217796|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217797|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14217798|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217799|NCT04258852|Nicotine|nicotine|mesh-list
14217800|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14217801|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
14217802|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217803|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217804|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14217805|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14217806|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
14217807|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217808|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217809|NCT04255381|Pancrelipase|pancrelipase|mesh-list
14217810|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14217811|NCT04236141|Rituximab|rituximab|mesh-list
14217812|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14217813|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217814|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217815|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
14217816|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217817|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217818|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14217819|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
14217820|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217821|NCT04229381|Coal Tar|coal tar|mesh-list
14217822|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
14217823|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
14217824|NCT04210037|Paclitaxel|paclitaxel|mesh-list
14787148|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
14787149|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787150|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14217825|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14217826|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217827|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14217828|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14217829|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14217830|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217831|NCT04203927|Empagliflozin|empagliflozin|mesh-list
14217832|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14217833|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217834|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14217835|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217836|NCT04200066|Tamoxifen|tamoxifen|mesh-list
14217837|NCT04200066|Temozolomide|temozolomide|mesh-list
14217838|NCT04200066|Maprotiline|maprotiline|mesh-list
14217839|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14217840|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
14217841|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217842|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217843|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14217844|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
14217845|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217846|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217847|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14217848|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14217849|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14217850|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14217851|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14217852|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
14217853|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217854|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14217855|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14217856|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14217857|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
14217858|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217859|NCT04183712|Gemcitabine|gemcitabine|mesh-list
14217860|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
14217861|NCT04183712|Afatinib|afatinib|mesh-list
14217862|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14217863|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
14217864|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217865|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217866|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
14217867|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217868|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217869|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14507719|NCT02937740|Testosterone|testosterone|mesh-list
14507720|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
14507721|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
14507722|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14507723|NCT02937740|Androgens|androgens|mesh-ancestor
14507724|NCT02937740|Hormones|hormones|mesh-ancestor
14507725|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507726|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507727|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14507728|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507729|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
14507730|NCT02938494|Tazarotene|tazarotene|mesh-list
14507731|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507732|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
14507733|NCT02938520|Rilpivirine|rilpivirine|mesh-list
14507734|NCT02938520|Cabotegravir|cabotegravir|mesh-list
14507735|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14507736|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14507737|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507738|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507739|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
14507740|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507741|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14507742|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14507743|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14507744|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14507745|NCT02938585|Factor VIII|factor viii|mesh-list
14507746|NCT02938585|Coagulants|coagulants|mesh-ancestor
14507747|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14507748|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14507749|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507750|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14217870|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
14217871|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217872|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14217873|NCT04180813|Linagliptin|linagliptin|mesh-list
14217874|NCT04180813|Acarbose|acarbose|mesh-list
14217875|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14217876|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217877|NCT04180813|Incretins|incretins|mesh-ancestor
14217878|NCT04180813|Hormones|hormones|mesh-ancestor
14217879|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14217880|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14217881|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
14217882|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217883|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217884|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14217885|NCT04171167|Fluticasone|fluticasone|mesh-list
14217886|NCT04171167|Xhance|xhance|mesh-list
14217887|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14217888|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14217889|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
14217890|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217891|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217892|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14217893|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
14217894|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
14217895|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14217896|NCT04160546|Aspirin|aspirin|mesh-list
14217897|NCT04160546|Ponatinib|ponatinib|mesh-list
14217898|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14217899|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14217900|NCT04160546|Analgesics|analgesics|mesh-ancestor
14217901|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
14217902|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217903|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217904|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14217905|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14217906|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14217907|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14217908|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217909|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14217910|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14217911|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217912|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
14217913|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217914|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14242309|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242310|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14242311|NCT00185692|Protective Agents|protective agents|mesh-ancestor
14242312|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14242313|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14242314|NCT00185731|Atorvastatin|atorvastatin|mesh-list
14242315|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14242316|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14242317|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
14242318|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242319|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14242320|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14242321|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242322|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
14242323|NCT00185900|Nifedipine|nifedipine|mesh-list
14242324|NCT00185900|Analgesics|analgesics|mesh-ancestor
14242325|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
14242326|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243389|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
14217915|NCT04134000|Atezolizumab|atezolizumab|mesh-list
14217916|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217917|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
14217918|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14217919|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217920|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217921|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14217922|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14217923|NCT04094207|Protective Agents|protective agents|mesh-ancestor
14217924|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217925|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
14217926|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14217927|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
14217933|NCT04069819|Cilostazol|cilostazol|mesh-list
14217934|NCT04069819|Citalopram|citalopram|mesh-list
14217935|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14217936|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14217937|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14217938|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217939|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217940|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
14217941|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217942|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14217943|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
14217944|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14217945|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
14217946|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217947|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14217948|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14217949|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
14217950|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14217951|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14217952|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14217953|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
14217954|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14217955|NCT04069819|Protective Agents|protective agents|mesh-ancestor
14217956|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14217957|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14217958|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217959|NCT04017468|Vancomycin|vancomycin|mesh-list
14217960|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14217961|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217962|NCT04015739|Bevacizumab|bevacizumab|mesh-list
14217963|NCT04015739|Durvalumab|durvalumab|mesh-list
14217964|NCT04015739|Olaparib|olaparib|mesh-list
14217965|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217966|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217967|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14217968|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14217969|NCT04015739|Growth Substances|growth substances|mesh-ancestor
14217970|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217971|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
14217972|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14217973|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14217974|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217975|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
14217976|NCT03952299|Oxybutynin|oxybutynin|mesh-list
14217977|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
14217978|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
14217979|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14217980|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217981|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14217982|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14217983|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
14217984|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14217985|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14217986|NCT03952299|Urological Agents|urological agents|mesh-ancestor
14217987|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14217988|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14217989|NCT03952299|Renal Agents|renal agents|mesh-ancestor
14217990|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
14217991|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14217992|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14217993|NCT03948464|Morphine|morphine|mesh-list
14787151|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14787152|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
14787153|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14787154|NCT00718354|Cisplatin|cisplatin|mesh-list
14787155|NCT00718354|Carboplatin|carboplatin|mesh-list
14787156|NCT00718354|Fluorouracil|fluorouracil|mesh-list
14787157|NCT00718354|Capecitabine|capecitabine|mesh-list
14787158|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
14787159|NCT00718354|Epirubicin|epirubicin|mesh-list
14787160|NCT00718354|Enoxaparin|enoxaparin|mesh-list
14787161|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787162|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
14787163|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787164|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14787165|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787166|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
14787167|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787168|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787169|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787170|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787171|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787172|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
14787173|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14787174|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14787175|NCT00718406|Metoprolol|metoprolol|mesh-list
14787176|NCT00718406|Morphine|morphine|mesh-list
14787177|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14787178|NCT00718406|Narcotics|narcotics|mesh-ancestor
14787179|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14787180|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787181|NCT00718406|Analgesics|analgesics|mesh-ancestor
14787182|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
14787183|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787184|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14787185|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14787186|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
14217994|NCT03948464|Methadone|methadone|mesh-list
14217995|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14217996|NCT03948464|Narcotics|narcotics|mesh-ancestor
14217997|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14217998|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14217999|NCT03948464|Analgesics|analgesics|mesh-ancestor
14218000|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
14218001|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218002|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
14218003|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
14218004|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14218005|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14218006|NCT03941730|Estradiol|estradiol|mesh-list
14218007|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14218008|NCT03941730|Estrogens|estrogens|mesh-ancestor
14218009|NCT03941730|Hormones|hormones|mesh-ancestor
14218010|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218011|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218012|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14218013|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
14218014|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218015|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14218016|NCT03933384|Tenofovir|tenofovir|mesh-list
14218017|NCT03933384|Entecavir|entecavir|mesh-list
14218018|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
14218019|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218020|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14218021|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14218022|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218023|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218024|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14787187|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
14787188|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14218025|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14218031|NCT03907969|AZD7648|azd7648|mesh-list
14218032|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14218033|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218034|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218035|NCT03901469|Talazoparib|talazoparib|mesh-list
14218036|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14218037|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218038|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218039|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218040|NCT03899987|Aspirin|aspirin|mesh-list
14218041|NCT03899987|Interferons|interferons|mesh-list
14218042|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
14218043|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
14218044|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14218045|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218046|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
14218047|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218048|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14218049|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14218050|NCT03899987|Analgesics|analgesics|mesh-ancestor
14218051|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
14218052|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218053|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218054|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218055|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14218056|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14218057|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14218058|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218059|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14218060|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14218061|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218062|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
14218063|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
14218064|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
14218065|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14218066|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14218067|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14218068|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218069|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
14218070|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218071|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218072|NCT03882047|Fluticasone|fluticasone|mesh-list
14787189|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14787190|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14787191|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
14787192|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787193|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787194|NCT00718471|Heparin|heparin|mesh-list
14787195|NCT00718471|Enoxaparin|enoxaparin|mesh-list
14787196|NCT00718471|Calcium heparin|calcium heparin|mesh-list
14787197|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
14787198|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14787199|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14787200|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787201|NCT00718484|Doxorubicin|doxorubicin|mesh-list
14787202|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14787203|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
14787204|NCT00718484|Ifosfamide|ifosfamide|mesh-list
14787205|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787206|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787207|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14218073|NCT03882047|Xhance|xhance|mesh-list
14218074|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
14218075|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218076|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14218077|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
14218078|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218079|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218080|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14787208|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14218081|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14218082|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
14218083|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14218084|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
14218085|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
14218086|NCT03879772|Beclomethasone|beclomethasone|mesh-list
14218087|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218088|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507751|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14507752|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507753|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14507754|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
14507755|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507756|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
14507757|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14507758|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507759|NCT02939937|Phenytoin|phenytoin|mesh-list
14507760|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
14507761|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14507762|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14507763|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507764|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507765|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14507766|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14507775|NCT02940574|Oxytocin|oxytocin|mesh-list
14507776|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
14507777|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14507778|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507779|NCT02940691|Grazoprevir|grazoprevir|mesh-list
14507780|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
14507781|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507782|NCT02940730|Dalbavancin|dalbavancin|mesh-list
14507783|NCT02940730|Teicoplanin|teicoplanin|mesh-list
14507784|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787209|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787210|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787211|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14787212|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
14787213|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
14787214|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14507785|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507786|NCT02940860|Iron|iron|mesh-list
14507787|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14507788|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14507789|NCT02940860|Trace Elements|trace elements|mesh-ancestor
14507790|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
14507791|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507792|NCT02940860|Hematinics|hematinics|mesh-ancestor
14507793|NCT02940886|Iron|iron|mesh-list
14507794|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14218089|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
14507795|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14507796|NCT02940886|Trace Elements|trace elements|mesh-ancestor
14507797|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
14507798|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507799|NCT02940886|Hematinics|hematinics|mesh-ancestor
14507800|NCT02941523|Carboplatin|carboplatin|mesh-list
14507801|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507802|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14507803|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
14787215|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14787216|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
14787217|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787218|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14787219|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14787220|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787221|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787222|NCT00718601|Imetelstat|imetelstat|mesh-list
14218090|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14218091|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
14218092|NCT03879772|Hormones|hormones|mesh-ancestor
14218093|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218094|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218095|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14218096|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
14218097|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
14218098|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14218099|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
14218100|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
14218101|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787223|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
14787224|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787225|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787226|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14787227|NCT00718705|Josamycin|josamycin|mesh-list
14787228|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787229|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218102|NCT03873402|Nivolumab|nivolumab|mesh-list
14218103|NCT03873402|Ipilimumab|ipilimumab|mesh-list
14218104|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218105|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218106|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218107|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218108|NCT03871465|Triamcinolone|triamcinolone|mesh-list
14218109|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14218110|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14787230|NCT00718757|Dexamethasone|dexamethasone|mesh-list
14787231|NCT00718757|Irinotecan|irinotecan|mesh-list
14787232|NCT00718757|Vincristine|vincristine|mesh-list
14218111|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14218112|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218113|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
14218114|NCT03871465|Hormones|hormones|mesh-ancestor
14218115|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218116|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218117|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787233|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787234|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
14787235|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
14787236|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218118|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
14218119|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218120|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218121|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
14218122|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218123|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
14218124|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14218125|NCT03860233|Oxytocin|oxytocin|mesh-list
14218126|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
14218127|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218128|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218129|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
14218130|NCT03855228|Loratadine|loratadine|mesh-list
14218131|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218132|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
14218133|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14218134|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
14218135|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14218136|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14218137|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
14218138|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
14218139|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507804|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
14507805|NCT02941640|Hormones|hormones|mesh-ancestor
14507806|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507807|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507808|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507809|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507810|NCT02941692|Oxytocin|oxytocin|mesh-list
14507811|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
14507812|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14507813|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507814|NCT02942264|Temozolomide|temozolomide|mesh-list
14218140|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218141|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218142|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
14218143|NCT03855189|Beclomethasone|beclomethasone|mesh-list
14218144|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218145|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14218146|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14218147|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
14218148|NCT03855189|Hormones|hormones|mesh-ancestor
14218149|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218150|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218151|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14218152|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
14947546|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14947547|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947548|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14947549|NCT01528644|Trace Elements|trace elements|mesh-ancestor
14947550|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
14947551|NCT01528644|Hematinics|hematinics|mesh-ancestor
14947552|NCT01528722|Bupivacaine|bupivacaine|mesh-list
14947553|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
14947554|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
14947555|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14218153|NCT03845543|Paclitaxel|paclitaxel|mesh-list
14218154|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14218155|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218156|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218157|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218158|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218159|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218160|NCT03840200|Rucaparib|rucaparib|mesh-list
14218161|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14218162|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218163|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218164|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218165|NCT03830918|Temozolomide|temozolomide|mesh-list
14218166|NCT03830918|Atezolizumab|atezolizumab|mesh-list
14218167|NCT03830918|Niraparib|niraparib|mesh-list
14218168|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14218169|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14218170|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
14218171|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218172|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787237|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787238|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14787239|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
14787240|NCT00718757|Hormones|hormones|mesh-ancestor
14787241|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787242|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14787243|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787244|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14787245|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787246|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787247|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787248|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14787249|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
14787250|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
14787251|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
14787252|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
14787253|NCT00718796|Ubiquinone|ubiquinone|mesh-list
14787254|NCT00718796|Atorvastatin|atorvastatin|mesh-list
14787255|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14787256|NCT00718796|Simvastatin|simvastatin|mesh-list
14787257|NCT00718796|Pravastatin|pravastatin|mesh-list
14787258|NCT00718796|Lovastatin|lovastatin|mesh-list
14787259|NCT00718796|L 647318|l 647318|mesh-list
14787260|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
14947556|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787261|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
14787262|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14218173|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
14218174|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218175|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14218176|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218177|NCT03828292|Dexamethasone|dexamethasone|mesh-list
14218178|NCT03828292|Bortezomib|bortezomib|mesh-list
14218179|NCT03828292|Pomalidomide|pomalidomide|mesh-list
14218180|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218181|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
14218182|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
14218183|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218184|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218185|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218186|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
14787263|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
14787264|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787265|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14787266|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14787267|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218187|NCT03828292|Hormones|hormones|mesh-ancestor
14218188|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218189|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14218190|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218191|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
14218192|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14218193|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947557|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
14947558|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947559|NCT01528800|Vitamin K|vitamin k|mesh-list
14947560|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
14947561|NCT01528800|Vitamins|vitamins|mesh-ancestor
14947562|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
14947563|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947564|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14947565|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14947566|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218194|NCT03828292|Growth Substances|growth substances|mesh-ancestor
14787268|NCT00718796|Vitamins|vitamins|mesh-ancestor
14787269|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
14787270|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787271|NCT00718913|Docetaxel|docetaxel|mesh-list
14787272|NCT00718913|Capecitabine|capecitabine|mesh-list
14787273|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787274|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
14787275|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
14787276|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
14947567|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
14218195|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
14242327|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242328|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
14242329|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242330|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14242331|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
14242332|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14242333|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242334|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242335|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14947568|NCT01528800|Coagulants|coagulants|mesh-ancestor
14242336|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
14242337|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14242338|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
14242339|NCT00186017|Olanzapine|olanzapine|mesh-list
14218196|NCT03769285|Niacinamide|niacinamide|mesh-list
14218197|NCT03769285|Niacin|niacin|mesh-list
14218198|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
14218199|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
14218200|NCT03769285|Vitamins|vitamins|mesh-ancestor
14218201|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
14947569|NCT01528813|Amorolfine|amorolfine|mesh-list
14507815|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14507816|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
14507817|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507818|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507819|NCT02942407|Warfarin|warfarin|mesh-list
14507820|NCT02942407|Apixaban|apixaban|mesh-list
14507821|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
14507822|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14507823|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
14507824|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14507825|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
14507826|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507827|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507828|NCT02942485|Metronidazole|metronidazole|mesh-list
14507829|NCT02942485|Tinidazole|tinidazole|mesh-list
14507830|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507831|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14507832|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14507833|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14507834|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
14507835|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507836|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14507837|NCT02942576|Warfarin|warfarin|mesh-list
14507838|NCT02942576|Edoxaban|edoxaban|mesh-list
14507839|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
14507840|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
14507841|NCT02942576|Fluindione|fluindione|mesh-list
14507842|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
14507843|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14218202|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507844|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
14507845|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14507846|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
14507847|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218203|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14218204|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
14787277|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787278|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14787279|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
14218205|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218206|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14218207|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
14218208|NCT03768492|Caffeine|caffeine|mesh-list
14218209|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14218210|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218211|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14218212|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218213|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218214|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14218215|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14218216|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
14218217|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218218|NCT03764631|Empagliflozin|empagliflozin|mesh-list
14218219|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14218220|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14218221|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218222|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14218223|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218224|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
14218225|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218226|NCT03761030|Levodopa|levodopa|mesh-list
14218227|NCT03761030|Carbidopa|carbidopa|mesh-list
14218228|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14218229|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14218230|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14218231|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
14218232|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218233|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218234|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218235|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14218236|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218237|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14218238|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
14507848|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507849|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
14507850|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14507851|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787280|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14787281|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
14787282|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14787283|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14787284|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787285|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787286|NCT00718952|Urological Agents|urological agents|mesh-ancestor
14787287|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
14787288|NCT00719056|Lactams|lactams|mesh-list
14787289|NCT00719056|Cephalosporins|cephalosporins|mesh-list
14787290|NCT00719056|Teicoplanin|teicoplanin|mesh-list
14787291|NCT00719056|beta-Lactams|beta-lactams|mesh-list
14787292|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787293|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787294|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787295|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14507852|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
14507853|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
14507854|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
14507855|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507856|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507857|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14507858|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14507859|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14507860|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507861|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14507862|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14507863|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
14507864|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507865|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507866|NCT02943668|Deferasirox|deferasirox|mesh-list
14507867|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14787296|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787297|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218239|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
14218240|NCT03747120|Paclitaxel|paclitaxel|mesh-list
14218241|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
14218242|NCT03747120|Trastuzumab|trastuzumab|mesh-list
14218243|NCT03747120|Pertuzumab|pertuzumab|mesh-list
14218244|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14218245|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218246|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218247|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218248|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218249|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218250|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218251|NCT03745144|Cladribine|cladribine|mesh-list
14218252|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14218253|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14218254|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218255|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218256|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
14218257|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787298|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787299|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14787300|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14787301|NCT00719095|Naltrexone|naltrexone|mesh-list
14787302|NCT00719095|Buprenorphine|buprenorphine|mesh-list
14787303|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14787304|NCT00719095|Narcotics|narcotics|mesh-ancestor
14787305|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14787306|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787307|NCT00719095|Analgesics|analgesics|mesh-ancestor
14787308|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
14787309|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787310|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14787311|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14787312|NCT00719108|Insulin|insulin|mesh-list
14787313|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14787314|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14787315|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787316|NCT00719121|Adapalene|adapalene|mesh-list
14787317|NCT00719121|R 115866|r 115866|mesh-list
14787318|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14787319|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14218258|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14218259|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
14218260|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218261|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14218262|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14947570|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
14947571|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947572|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
14947573|NCT01528826|Vinorelbine|vinorelbine|mesh-list
14947574|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947575|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14947576|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
14947577|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
14947578|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
14947579|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218263|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14218264|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14218265|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14218266|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14218267|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14218268|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14218269|NCT03736720|Leucovorin|leucovorin|mesh-list
14218270|NCT03736720|Fluorouracil|fluorouracil|mesh-list
14218271|NCT03736720|Irinotecan|irinotecan|mesh-list
14218272|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
14218273|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218274|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218275|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218276|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218277|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
14242340|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
14947580|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
14218278|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218279|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14218280|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14218281|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218282|NCT03736720|Antidotes|antidotes|mesh-ancestor
14787320|NCT00719121|Analgesics|analgesics|mesh-ancestor
14787321|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
14787322|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787323|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787324|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787325|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787326|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
14787327|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14787328|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787329|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787330|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
14787331|NCT00719173|Aprepitant|aprepitant|mesh-list
14787332|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787333|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
14787334|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787335|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787336|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14787337|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
14787338|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787339|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787340|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14787341|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
14787342|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
14787343|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787344|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218283|NCT03736720|Protective Agents|protective agents|mesh-ancestor
14218284|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
14507868|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
14507869|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
14507870|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507871|NCT02944461|Dapsone|dapsone|mesh-list
14507872|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507873|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
14507874|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14507875|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14507876|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14507877|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507878|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507879|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
14507880|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14507881|NCT02944565|Daratumumab|daratumumab|mesh-list
14507882|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14507883|NCT02944656|Gabapentin|gabapentin|mesh-list
14507884|NCT02944656|Analgesics|analgesics|mesh-ancestor
14507885|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
14507886|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507887|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507888|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
14507889|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14507890|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14507891|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507892|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14507893|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14787345|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14218285|NCT03736720|Vitamins|vitamins|mesh-ancestor
14218286|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
14218287|NCT03703375|Gemcitabine|gemcitabine|mesh-list
14218288|NCT03703375|Azacitidine|azacitidine|mesh-list
14218289|NCT03703375|Romidepsin|romidepsin|mesh-list
14218290|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218291|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
14218292|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218293|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218294|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
14218295|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218296|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218297|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218298|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
14218299|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218300|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14218301|NCT03656081|Itraconazole|itraconazole|mesh-list
14218302|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14218303|NCT03656081|Amphotericin B|amphotericin b|mesh-list
14218304|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
14218305|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218306|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14218307|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14218308|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787346|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787347|NCT00719199|Cetuximab|cetuximab|mesh-list
14787348|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14787349|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787350|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
14787351|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14787352|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
14787353|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787354|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
14787355|NCT00719290|Protective Agents|protective agents|mesh-ancestor
14787356|NCT00719381|Pioglitazone|pioglitazone|mesh-list
14787357|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14787358|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787359|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
14787360|NCT00719407|Hematinics|hematinics|mesh-ancestor
14787361|NCT00719420|Amoxicillin|amoxicillin|mesh-list
14787362|NCT00719420|Metronidazole|metronidazole|mesh-list
14787363|NCT00719420|Clarithromycin|clarithromycin|mesh-list
14787364|NCT00719420|Omeprazole|omeprazole|mesh-list
14787365|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787366|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787367|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14787368|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14787369|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14787370|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14787371|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14787372|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787373|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787374|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14787375|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14787376|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14787377|NCT00719433|Armin|armin|mesh-list
14787378|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14787379|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787380|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787381|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
14787382|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787383|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242341|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
14947581|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14947582|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14787384|NCT00719459|Iron|iron|mesh-list
14787385|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14787386|NCT00719459|Trace Elements|trace elements|mesh-ancestor
14787387|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
14787388|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787389|NCT00719459|Hematinics|hematinics|mesh-ancestor
14787390|NCT00719602|Ritonavir|ritonavir|mesh-list
14787391|NCT00719602|Lopinavir|lopinavir|mesh-list
14787392|NCT00719602|Lamivudine|lamivudine|mesh-list
14787393|NCT00719602|Zidovudine|zidovudine|mesh-list
14787394|NCT00719602|Nevirapine|nevirapine|mesh-list
14787395|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14787396|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14787397|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
14787398|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787399|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787400|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14787401|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14787402|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
14787403|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507894|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14507895|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507896|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507897|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
14507898|NCT02945150|Grazoprevir|grazoprevir|mesh-list
14507899|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
14507900|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507901|NCT02945410|Vitamin D|vitamin d|mesh-list
14507902|NCT02945410|Calcium|calcium|mesh-list
14507903|NCT02945410|Vitamins|vitamins|mesh-ancestor
14507904|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
14507905|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507906|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14507907|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14507908|NCT02946034|Ribavirin|ribavirin|mesh-list
14507909|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
14507910|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507911|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
14507912|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507913|NCT02946073|Buprenorphine|buprenorphine|mesh-list
14507914|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14507915|NCT02946073|Narcotics|narcotics|mesh-ancestor
14507916|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507917|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507918|NCT02946073|Analgesics|analgesics|mesh-ancestor
14507919|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
14507920|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507921|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14507922|NCT02946385|Vaccines|vaccines|mesh-list
14507923|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
14507924|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507925|NCT02946463|Eculizumab|eculizumab|mesh-list
14507926|NCT02946463|Ravulizumab|ravulizumab|mesh-list
14507927|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14507928|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14507929|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
14507930|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507931|NCT02946489|Ketamine|ketamine|mesh-list
14507932|NCT02946489|Analgesics|analgesics|mesh-ancestor
14507933|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
14507934|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507935|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507936|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14507937|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14507938|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
14507939|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
14507940|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14507941|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14507942|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14507943|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507944|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787404|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14787405|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14507945|NCT02946580|Naloxegol|naloxegol|mesh-list
14507946|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14507947|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787406|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14787407|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14787408|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
14218309|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218310|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14218311|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14218312|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218313|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218314|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14218315|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14218316|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14218317|NCT03656081|Amebicides|amebicides|mesh-ancestor
14218318|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14218319|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14218320|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14218321|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218322|NCT03645408|Exenatide|exenatide|mesh-list
14218323|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14218324|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218325|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14218326|NCT03645408|Incretins|incretins|mesh-ancestor
14218327|NCT03645408|Hormones|hormones|mesh-ancestor
14218328|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218329|NCT03639935|Nivolumab|nivolumab|mesh-list
14218330|NCT03639935|Rucaparib|rucaparib|mesh-list
14787409|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14787410|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14787411|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
14787412|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14787413|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
14787414|NCT00719693|Fenofibrate|fenofibrate|mesh-list
14787415|NCT00719693|Calcium|calcium|mesh-list
14787416|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14218331|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218332|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218333|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218334|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218335|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14218336|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218337|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
14787417|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787418|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14787419|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14787420|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14787421|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
14787422|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787423|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14787424|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14787425|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787426|NCT00719745|Tacrolimus|tacrolimus|mesh-list
14787427|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787428|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
14787429|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787430|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14787431|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787432|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947583|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947584|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
14947585|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14947586|NCT01528865|Tenofovir|tenofovir|mesh-list
14947587|NCT01528865|Lamivudine|lamivudine|mesh-list
14218338|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14787433|NCT00719758|Beraprost|beraprost|mesh-list
14787434|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14787435|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
14787436|NCT00719797|Leucovorin|leucovorin|mesh-list
14787437|NCT00719797|Bevacizumab|bevacizumab|mesh-list
14787438|NCT00719797|Fluorouracil|fluorouracil|mesh-list
14787439|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
14787440|NCT00719797|Irinotecan|irinotecan|mesh-list
14787441|NCT00719797|Calcium|calcium|mesh-list
14787442|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
14787443|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14787444|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787445|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14787446|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14787447|NCT00719797|Growth Substances|growth substances|mesh-ancestor
14787448|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218339|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
14218340|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14218341|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
14218342|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218343|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218344|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
14218345|NCT03623828|Apomorphine|apomorphine|mesh-list
14218346|NCT03623828|Emetics|emetics|mesh-ancestor
14218347|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218348|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
14218349|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218350|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218351|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
14218352|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
14218353|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218354|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218355|NCT03586609|Cytarabine|cytarabine|mesh-list
14218356|NCT03586609|Azacitidine|azacitidine|mesh-list
14218357|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14218358|NCT03586609|Venetoclax|venetoclax|mesh-list
14787449|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
14787450|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14787451|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
14787452|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787453|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14787454|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787455|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
14787456|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14787457|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787458|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787459|NCT00719797|Antidotes|antidotes|mesh-ancestor
14787460|NCT00719797|Protective Agents|protective agents|mesh-ancestor
14787461|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
14787462|NCT00719797|Vitamins|vitamins|mesh-ancestor
14787463|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
14787464|NCT00719823|Maraviroc|maraviroc|mesh-list
14787465|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14787466|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14787467|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787468|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14787469|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14787470|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
14787471|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787472|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14787473|NCT00719875|Vorinostat|vorinostat|mesh-list
14787474|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14787475|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787476|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787477|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787478|NCT00720018|Sumatriptan|sumatriptan|mesh-list
14787479|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14787480|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14787481|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14218359|NCT03586609|Cladribine|cladribine|mesh-list
14218360|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218361|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
14787482|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
14787483|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787484|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218362|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218363|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218364|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
14218365|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218366|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218367|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
14218368|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218369|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218370|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14218371|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14218372|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
14218373|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
14218374|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
14218375|NCT03565913|Calcium|calcium|mesh-list
14787485|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787486|NCT00720135|Rituximab|rituximab|mesh-list
14787487|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14787488|NCT00720135|Interleukin-2|interleukin-2|mesh-list
14787489|NCT00720135|Antibodies|antibodies|mesh-list
14787490|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
14218376|NCT03565913|Calcium acetate|calcium acetate|mesh-list
14218377|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14218378|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218379|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14218380|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
14218381|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
14218382|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507948|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
14507949|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14507950|NCT02946892|Carvedilol|carvedilol|mesh-list
14507951|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14507952|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14507953|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
14507954|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507955|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507956|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14507957|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14507958|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
14507959|NCT02946892|Protective Agents|protective agents|mesh-ancestor
14507960|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14507961|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14507962|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14507963|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
14507964|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14507965|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14507966|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
14507967|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
14507968|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507969|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
14507970|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14507971|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14507972|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14507973|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14507974|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
14507975|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14507976|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507977|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528742|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14528743|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
14528744|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
14528745|NCT03830892|Nicotine|nicotine|mesh-list
14528746|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14528747|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
14528748|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787491|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14787492|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
14787493|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787494|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787495|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787496|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14787497|NCT00720135|Analgesics|analgesics|mesh-ancestor
14787498|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
14787499|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787500|NCT00720148|Bortezomib|bortezomib|mesh-list
14787501|NCT00720148|Sunitinib|sunitinib|mesh-list
14787502|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787503|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14787504|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14218383|NCT03565913|Cathartics|cathartics|mesh-ancestor
14218384|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218385|NCT03546686|Nivolumab|nivolumab|mesh-list
14218386|NCT03546686|Ipilimumab|ipilimumab|mesh-list
14218387|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218388|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218389|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218390|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218391|NCT03528642|Temozolomide|temozolomide|mesh-list
14218392|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14218393|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
14218394|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218395|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218396|NCT03523156|Azithromycin|azithromycin|mesh-list
14218397|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14218398|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218399|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14218400|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14218401|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14218402|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218403|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218404|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14218405|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14218406|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218407|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
14218408|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218409|NCT03497689|Treprostinil|treprostinil|mesh-list
14218410|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14218411|NCT03476317|Vancomycin|vancomycin|mesh-list
14218412|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
14218413|NCT03476317|Neomycin|neomycin|mesh-list
14218414|NCT03476317|Fluconazole|fluconazole|mesh-list
14218415|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14218416|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14218417|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218418|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14218419|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14218420|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218421|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218422|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218423|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14218424|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14218425|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
14218426|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14218427|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14218428|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
14242342|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242343|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242344|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14242345|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14242346|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14242347|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242348|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242349|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14242350|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242351|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242352|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218429|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218430|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218431|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14947588|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
14947589|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947590|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14947591|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14947592|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947593|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947594|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14787505|NCT00720148|Growth Substances|growth substances|mesh-ancestor
14787506|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787507|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
14787508|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14787509|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787510|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787511|NCT00720161|Metformin|metformin|mesh-list
14787512|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14787513|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787514|NCT00720174|Doxorubicin|doxorubicin|mesh-list
14787515|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14787516|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14787517|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787518|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787519|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787520|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14947595|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14218432|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14218433|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14218434|NCT03476317|Laxatives|laxatives|mesh-ancestor
14507978|NCT02948777|Evolocumab|evolocumab|mesh-list
14507979|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14507980|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14507981|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
14507982|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507983|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14507984|NCT02949011|Oseltamivir|oseltamivir|mesh-list
14507985|NCT02949011|Baloxavir|baloxavir|mesh-list
14507986|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
14507987|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14507988|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14507989|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14507990|NCT02949024|Triamcinolone|triamcinolone|mesh-list
14507991|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14507992|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14218435|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218436|NCT03472274|Durvalumab|durvalumab|mesh-list
14218437|NCT03472274|Tremelimumab|tremelimumab|mesh-list
14218438|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218439|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218440|NCT03442556|Carboplatin|carboplatin|mesh-list
14218441|NCT03442556|Docetaxel|docetaxel|mesh-list
14218442|NCT03442556|Rucaparib|rucaparib|mesh-list
14218443|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218444|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218445|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218446|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218447|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218448|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14218449|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218450|NCT03436654|Prednisone|prednisone|mesh-list
14218451|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
14218452|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218453|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
14218454|NCT03436654|Hormones|hormones|mesh-ancestor
14218455|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218456|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218457|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14218458|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218459|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14218460|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218461|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218462|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
14218463|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14218464|NCT03434158|Olaparib|olaparib|mesh-list
14218465|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14218466|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218467|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218468|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218469|NCT03425201|Niraparib|niraparib|mesh-list
14218470|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14218471|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218472|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218473|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218474|NCT03416153|Paclitaxel|paclitaxel|mesh-list
14218475|NCT03416153|Carboplatin|carboplatin|mesh-list
14218476|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14218477|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218478|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218479|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218480|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218481|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218482|NCT03408340|Fentanyl|fentanyl|mesh-list
14218483|NCT03408340|Ketamine|ketamine|mesh-list
14218484|NCT03408340|Propofol|propofol|mesh-list
14787521|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787522|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787523|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
14787524|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787525|NCT00720265|Tacrolimus|tacrolimus|mesh-list
14218485|NCT03408340|Sevoflurane|sevoflurane|mesh-list
14218486|NCT03408340|Rocuronium|rocuronium|mesh-list
14218487|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
14218488|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14218489|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218490|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
14218491|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218492|NCT03408340|Analgesics|analgesics|mesh-ancestor
14218493|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14218494|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14218495|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
14218496|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14218497|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14218498|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218499|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218500|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14218501|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14218502|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14218503|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14218504|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14218505|NCT03408340|Narcotics|narcotics|mesh-ancestor
14218506|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14218507|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14218508|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14218509|NCT03397004|Doxycycline|doxycycline|mesh-list
14218510|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14218511|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218512|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
14218513|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14218514|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14218515|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14507993|NCT02949024|Aflibercept|aflibercept|mesh-list
14507994|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14507995|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14507996|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
14507997|NCT02949024|Hormones|hormones|mesh-ancestor
14507998|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14507999|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508000|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787526|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787527|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
14787528|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218516|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
14218517|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218518|NCT03362190|Ranibizumab|ranibizumab|mesh-list
14218519|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14787529|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14787530|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787531|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787532|NCT00720291|Metronidazole|metronidazole|mesh-list
14787533|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787534|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787535|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14787536|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14787537|NCT00720304|Docetaxel|docetaxel|mesh-list
14787538|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14787539|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787540|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
14787541|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218520|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14218521|NCT03362190|Growth Substances|growth substances|mesh-ancestor
14218522|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218523|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
14218524|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218525|NCT03347929|Naproxen|naproxen|mesh-list
14218526|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14218527|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14218528|NCT03347929|Analgesics|analgesics|mesh-ancestor
14218529|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
14218530|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218531|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218532|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218533|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14218534|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
14218535|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14218536|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218537|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218538|NCT03346668|Gabapentin|gabapentin|mesh-list
14218539|NCT03346668|Analgesics|analgesics|mesh-ancestor
14218540|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
14218541|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218542|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218543|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
14218544|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14218545|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14218546|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14218547|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14218548|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14218549|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14787542|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
14787543|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787544|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14787545|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218550|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218551|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218552|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
14218553|NCT03338790|Prednisone|prednisone|mesh-list
14218554|NCT03338790|Docetaxel|docetaxel|mesh-list
14218555|NCT03338790|Nivolumab|nivolumab|mesh-list
14218556|NCT03338790|Rucaparib|rucaparib|mesh-list
14218557|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218558|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218559|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218560|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218561|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218562|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218563|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
14218564|NCT03338790|Hormones|hormones|mesh-ancestor
14218565|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218566|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218567|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508001|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
14508002|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508003|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508004|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14508005|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14508006|NCT02949024|Growth Substances|growth substances|mesh-ancestor
14508007|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
14508008|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508009|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
14508010|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14508011|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947596|NCT01528930|Amikacin|amikacin|mesh-list
14947597|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14947598|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947599|NCT01528943|Epoprostenol|epoprostenol|mesh-list
14947600|NCT01528943|Tezosentan|tezosentan|mesh-list
14508012|NCT02949271|Fentanyl|fentanyl|mesh-list
14508013|NCT02949271|Ropivacaine|ropivacaine|mesh-list
14508014|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508015|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
14508016|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508017|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508018|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
14508019|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508020|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14508021|NCT02949271|Narcotics|narcotics|mesh-ancestor
14508022|NCT02949271|Analgesics|analgesics|mesh-ancestor
14508023|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14508024|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14508025|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
14508026|NCT02949362|Teduglutide|teduglutide|mesh-list
14508027|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508028|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14508029|NCT02949362|Protective Agents|protective agents|mesh-ancestor
14508030|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508031|NCT02949674|Bupivacaine|bupivacaine|mesh-list
14508032|NCT02949674|Ropivacaine|ropivacaine|mesh-list
14508033|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508034|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
14508035|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508036|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508037|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
14508038|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508039|NCT02949921|Lidocaine|lidocaine|mesh-list
14508040|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508041|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
14508042|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508043|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508044|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
14508045|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508046|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14508047|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14508048|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14947601|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14947602|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14218568|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218569|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218570|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14787546|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
14787547|NCT00720408|Tacrolimus|tacrolimus|mesh-list
14787548|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787549|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
14787550|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787551|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14787552|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787553|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787554|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787555|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787556|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14218571|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242353|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242354|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
14242355|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14242356|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
14242357|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242358|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14242359|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14242360|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242361|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242362|NCT00186056|Mifepristone|mifepristone|mesh-list
14242363|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14242364|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
14242365|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14242366|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242367|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14242368|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14242369|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14242370|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
14242371|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14242372|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14242373|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
14242374|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787557|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
14787558|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787559|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242375|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
14242376|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14242377|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14242378|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
14242379|NCT00186069|Analgesics|analgesics|mesh-ancestor
14242380|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
14242381|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242382|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242383|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
14242384|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242385|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14242386|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
14242387|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14242388|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242389|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243390|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13965058|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965059|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13965060|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13965061|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965062|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
13965063|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13965064|NCT03132714|Amoxicillin|amoxicillin|mesh-list
13965065|NCT03132714|Metronidazole|metronidazole|mesh-list
13965066|NCT03132714|Clarithromycin|clarithromycin|mesh-list
13965067|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13965068|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965069|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13965070|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13965071|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13965072|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965073|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965074|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14218572|NCT03332797|Palbociclib|palbociclib|mesh-list
14218573|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218574|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14218575|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218576|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218577|NCT03309150|Paclitaxel|paclitaxel|mesh-list
14218578|NCT03309150|Carboplatin|carboplatin|mesh-list
14218579|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14218580|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787560|NCT00720421|Lorazepam|lorazepam|mesh-list
14787561|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
14787562|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
14787563|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
14787564|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787565|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787566|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218581|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218582|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218583|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218584|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218585|NCT03304717|Tenofovir|tenofovir|mesh-list
14218586|NCT03304717|Emtricitabine|emtricitabine|mesh-list
14218587|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
14218588|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218589|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14218590|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14218591|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218592|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218593|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14218594|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14218595|NCT03289299|Dexamethasone|dexamethasone|mesh-list
14218596|NCT03289299|Lenalidomide|lenalidomide|mesh-list
14218597|NCT03289299|Daratumumab|daratumumab|mesh-list
14218598|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218599|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
14218600|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
14787567|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14787568|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14787569|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14787570|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14218601|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218602|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787571|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14787572|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
14787573|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
14787574|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787575|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218603|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218604|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
14947603|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
14218605|NCT03289299|Hormones|hormones|mesh-ancestor
14218606|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218607|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14218608|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787576|NCT00720447|Cytarabine|cytarabine|mesh-list
14787577|NCT00720447|Etoposide|etoposide|mesh-list
14787578|NCT00720447|Melphalan|melphalan|mesh-list
14787579|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
14787580|NCT00720447|Carmustine|carmustine|mesh-list
14787581|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14787582|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787583|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787584|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787585|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787586|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787587|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14787588|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
14787589|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
14787590|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787591|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787592|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
14787593|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787594|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14787595|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
14787596|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14787597|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14787598|NCT00720512|Leucovorin|leucovorin|mesh-list
14787599|NCT00720512|Bevacizumab|bevacizumab|mesh-list
14787600|NCT00720512|Fluorouracil|fluorouracil|mesh-list
14787601|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
14787602|NCT00720512|Irinotecan|irinotecan|mesh-list
14787603|NCT00720512|Calcium|calcium|mesh-list
14787604|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
14787605|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14787606|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787607|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14947604|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
14947605|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14947606|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947607|NCT01529125|Lamivudine|lamivudine|mesh-list
14947608|NCT01529125|Zidovudine|zidovudine|mesh-list
14947609|NCT01529125|Nevirapine|nevirapine|mesh-list
14947610|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14947611|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14947612|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947613|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947614|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
14947615|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947616|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14218609|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
14218610|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14218611|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14218612|NCT03289299|Growth Substances|growth substances|mesh-ancestor
14218613|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
14218614|NCT03272685|Nicotine|nicotine|mesh-list
14218615|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14218616|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
14218617|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218618|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218619|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14218620|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14218621|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
14218622|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218623|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787608|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14787609|NCT00720512|Growth Substances|growth substances|mesh-ancestor
14947617|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14787610|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787611|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
14787612|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14787613|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
14787614|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787615|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218624|NCT03252522|Micronutrients|micronutrients|mesh-list
14218625|NCT03252522|Trace Elements|trace elements|mesh-list
14218626|NCT03252522|Antioxidants|antioxidants|mesh-list
14218627|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218628|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218629|NCT03252522|Protective Agents|protective agents|mesh-ancestor
14218630|NCT03223155|Nivolumab|nivolumab|mesh-list
14218631|NCT03223155|Ipilimumab|ipilimumab|mesh-list
14218632|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218633|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218634|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218635|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218636|NCT03217201|Methamphetamine|methamphetamine|mesh-list
14218637|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14218638|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508049|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508050|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508051|NCT02950467|Psilocybin|psilocybin|mesh-list
14508052|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
14508053|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
14508054|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508055|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14508056|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14508057|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
14508058|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508059|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508060|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14508061|NCT02950558|Ropivacaine|ropivacaine|mesh-list
14508062|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508063|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
14508064|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508065|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508066|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
14508067|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508068|NCT02951156|Gemcitabine|gemcitabine|mesh-list
14787616|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787617|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
14787618|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14787619|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787620|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787621|NCT00720512|Antidotes|antidotes|mesh-ancestor
14787622|NCT00720512|Protective Agents|protective agents|mesh-ancestor
14218639|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
14218640|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
14218641|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218642|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
14218643|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218644|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787623|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
14787624|NCT00720512|Vitamins|vitamins|mesh-ancestor
14787625|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
14787626|NCT00720538|Thalidomide|thalidomide|mesh-list
14787627|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787628|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
14787629|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787630|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
14787631|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787632|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787633|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14787634|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14787635|NCT00720538|Growth Substances|growth substances|mesh-ancestor
14787636|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
14218645|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
14218646|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14218647|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14218648|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14218649|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14218655|NCT03182179|Ondansetron|ondansetron|mesh-list
14218656|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
14218657|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
14218658|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218659|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218660|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218661|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
14218662|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
14218663|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14218664|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
14218665|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787637|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787638|NCT00720564|Temozolomide|temozolomide|mesh-list
14787639|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
14787640|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14787641|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
14947618|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
13965075|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13965076|NCT03132610|Andrographolide|andrographolide|mesh-list
13965077|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965078|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965079|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965080|NCT03132610|Analgesics|analgesics|mesh-ancestor
13965081|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
13965082|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965083|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965084|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965085|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13965086|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13965087|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965088|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
13965089|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13968083|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13968084|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968085|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13968086|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13968087|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968088|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968089|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13968090|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
13968091|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
14787642|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787643|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787644|NCT00720577|Pioglitazone|pioglitazone|mesh-list
14787645|NCT00720577|Losartan|losartan|mesh-list
14787646|NCT00720577|Simvastatin|simvastatin|mesh-list
14787647|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14787648|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14787649|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
14787650|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787651|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14787652|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14787653|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787654|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14787655|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787656|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14787657|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14787658|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14787659|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14787660|NCT00720590|Ritonavir|ritonavir|mesh-list
14787661|NCT00720590|Lopinavir|lopinavir|mesh-list
14787662|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14787663|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14787664|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14787665|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14787666|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787667|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787668|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14787669|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14787670|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
14787671|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787672|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14787673|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14787674|NCT00720603|Plerixafor|plerixafor|mesh-list
14218666|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218667|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14218668|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14218669|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14218670|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14218671|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14218672|NCT03167242|Lumefantrine|lumefantrine|mesh-list
14218673|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14218674|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
14218675|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14218676|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14218677|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218678|NCT03164473|Rituximab|rituximab|mesh-list
14218679|NCT03164473|Azathioprine|azathioprine|mesh-list
14218680|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218681|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218682|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
14218683|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218684|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787675|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14787676|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14787677|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
14787678|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787679|NCT00720616|Insulin|insulin|mesh-list
14787680|NCT00720616|Hormones|hormones|mesh-list
14787681|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14787682|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787683|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787684|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
14787685|NCT00720772|Antidotes|antidotes|mesh-ancestor
14787686|NCT00720772|Protective Agents|protective agents|mesh-ancestor
14787687|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218685|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
14218686|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218687|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218688|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218689|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
14218690|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218691|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218692|NCT03153280|Capecitabine|capecitabine|mesh-list
14218693|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
14787688|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
14218694|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218695|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
14218696|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218697|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218698|NCT03147612|Cytarabine|cytarabine|mesh-list
14218699|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
14218700|NCT03147612|Rituximab|rituximab|mesh-list
14218701|NCT03147612|Methotrexate|methotrexate|mesh-list
14218702|NCT03147612|Vincristine|vincristine|mesh-list
14218703|NCT03147612|Blinatumomab|blinatumomab|mesh-list
14218704|NCT03147612|Ponatinib|ponatinib|mesh-list
14218705|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14218706|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
14218707|NCT03147612|Antibodies|antibodies|mesh-list
14218708|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
14218709|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14218710|NCT03147612|Lenograstim|lenograstim|mesh-list
14218711|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14218712|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218713|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
14218714|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218715|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14218716|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14218717|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
14218718|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218719|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218720|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14218721|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14218722|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
14218723|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218724|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218725|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
14218726|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
14218727|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218728|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14787689|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787690|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
14787691|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787692|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787693|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
14787694|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
14787695|NCT00720811|Acetaminophen|acetaminophen|mesh-list
14787696|NCT00720811|Amoxicillin|amoxicillin|mesh-list
14218729|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14218730|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
14787697|NCT00720811|Lumefantrine|lumefantrine|mesh-list
14787698|NCT00720811|Artemether|artemether|mesh-list
14218731|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218732|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14218733|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14218734|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218735|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218736|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218737|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14218753|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
14218754|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14218755|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14218756|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218757|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
14218758|NCT03113253|Coagulants|coagulants|mesh-ancestor
14218759|NCT03111992|Spartalizumab|spartalizumab|mesh-list
14218760|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218761|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218762|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218763|NCT03101046|Docetaxel|docetaxel|mesh-list
14218764|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218765|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218766|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218767|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218768|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218769|NCT03059173|Inositol|inositol|mesh-list
14218770|NCT03059173|Clomiphene|clomiphene|mesh-list
14218771|NCT03059173|Enclomiphene|enclomiphene|mesh-list
14218772|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
14218773|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14218774|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
14218775|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218776|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218777|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14218778|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
14218779|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218780|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14218781|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14218782|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
14218783|NCT03059173|Vitamins|vitamins|mesh-ancestor
14218784|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
14218785|NCT03057106|Durvalumab|durvalumab|mesh-list
14218786|NCT03057106|Tremelimumab|tremelimumab|mesh-list
14218787|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218788|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218789|NCT03015129|Durvalumab|durvalumab|mesh-list
14218790|NCT03015129|Tremelimumab|tremelimumab|mesh-list
14218791|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218792|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218793|NCT03013491|Ipilimumab|ipilimumab|mesh-list
14218794|NCT03013491|Vemurafenib|vemurafenib|mesh-list
14508069|NCT02951156|Rituximab|rituximab|mesh-list
14508070|NCT02951156|Avelumab|avelumab|mesh-list
14508071|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
14508072|NCT02951156|Azacitidine|azacitidine|mesh-list
14508073|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14508074|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14508075|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508076|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
14508077|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508078|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508079|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14508080|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
14218795|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218796|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787699|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14787700|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787701|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787702|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14787703|NCT00720811|Analgesics|analgesics|mesh-ancestor
14787704|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
14787705|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787706|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787707|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
14787708|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
14787709|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14787710|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14787711|NCT00720824|Anesthetics|anesthetics|mesh-list
14787712|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14787713|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
14787714|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14787715|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787716|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
14218797|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218798|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218799|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14218800|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218801|NCT03008369|Lenvatinib|lenvatinib|mesh-list
14218802|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218803|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14218804|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218805|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218806|NCT02963493|Dexamethasone|dexamethasone|mesh-list
14218807|NCT02963493|Melphalan|melphalan|mesh-list
14218808|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218809|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
14218810|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
14218811|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218812|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218813|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218814|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
14218815|NCT02963493|Hormones|hormones|mesh-ancestor
14218816|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218817|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14218818|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218819|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14218820|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
14218821|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218822|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14508081|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508082|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
14508083|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508084|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508085|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14508086|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14508087|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
14508088|NCT02951182|Ivacaftor|ivacaftor|mesh-list
14508089|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14787717|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787718|NCT00720850|Lenalidomide|lenalidomide|mesh-list
14787719|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
14787720|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787721|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14787722|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14787723|NCT00720850|Growth Substances|growth substances|mesh-ancestor
14787724|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
14787725|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787726|NCT00720902|Hormones|hormones|mesh-list
14787727|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14787728|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787729|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787730|NCT00720915|Anticoagulants|anticoagulants|mesh-list
14787731|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
14787732|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14218823|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218824|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
14218825|NCT02947503|Metformin|metformin|mesh-list
14218826|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14218827|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218828|NCT02930902|Gemcitabine|gemcitabine|mesh-list
14218829|NCT02930902|Paclitaxel|paclitaxel|mesh-list
14218830|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14218831|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
14218832|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14218833|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218834|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
14218835|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
14218836|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
14218837|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218838|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218839|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
14947619|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14947620|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14947621|NCT01529138|Sirolimus|sirolimus|mesh-list
14947622|NCT01529138|Axitinib|axitinib|mesh-list
14947623|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14947624|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947625|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14947626|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947627|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
14947628|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947629|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
14947630|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508090|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508091|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508092|NCT02951195|Ivacaftor|ivacaftor|mesh-list
14508093|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14508094|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508095|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508096|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
14508097|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14508098|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14508099|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14508100|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14508101|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
14508102|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508103|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508104|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508105|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
14508106|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508107|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
14508108|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508109|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508110|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
14508111|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508112|NCT02951429|Pirfenidone|pirfenidone|mesh-list
14508113|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
14508114|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
14508115|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14508116|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14508117|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508118|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508119|NCT02951429|Urological Agents|urological agents|mesh-ancestor
14508120|NCT02951429|Analgesics|analgesics|mesh-ancestor
14508121|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
14508122|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508123|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947631|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14218840|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
14218841|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218842|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218843|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218844|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
14218845|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218846|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218847|NCT02921555|Prednisone|prednisone|mesh-list
14787733|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14787734|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787735|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
14787736|NCT00720915|Coagulants|coagulants|mesh-ancestor
14787737|NCT00721032|Amiodarone|amiodarone|mesh-list
14218848|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
14218849|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14218850|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14218851|NCT02921555|Prednisolone|prednisolone|mesh-list
14218852|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
14218853|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14218854|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
14218855|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218856|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
14218857|NCT02921555|Hormones|hormones|mesh-ancestor
14218858|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218859|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218860|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14787738|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14787739|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
14787740|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14787741|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14787742|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787743|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14218861|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218862|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
14218863|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
14218864|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218865|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218866|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14218867|NCT02921555|Protective Agents|protective agents|mesh-ancestor
14218868|NCT02899078|Nivolumab|nivolumab|mesh-list
14218869|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218870|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218871|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218872|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218873|NCT02895373|Alprostadil|alprostadil|mesh-list
14218874|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14218875|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
14218876|NCT02895373|Urological Agents|urological agents|mesh-ancestor
14218877|NCT02869789|Nivolumab|nivolumab|mesh-list
14218878|NCT02869789|Ipilimumab|ipilimumab|mesh-list
14218879|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14218880|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218881|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14218882|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787744|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14787745|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14787746|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787747|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14787748|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14787749|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14787750|NCT00721201|Mifepristone|mifepristone|mesh-list
14787751|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14787752|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
14787753|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14787754|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787755|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14787756|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14787757|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14787758|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
14787759|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14787760|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14787761|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
14947632|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787762|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787763|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
14218883|NCT02861417|Vidarabine|vidarabine|mesh-list
14218884|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
14218885|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
14218886|NCT02861417|Busulfan|busulfan|mesh-list
14218887|NCT02861417|Thiotepa|thiotepa|mesh-list
14218888|NCT02861417|Fludarabine|fludarabine|mesh-list
14218889|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
14218890|NCT02861417|Tacrolimus|tacrolimus|mesh-list
14218891|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787764|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14787765|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14787766|NCT00721240|Montelukast|montelukast|mesh-list
14787767|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14787768|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
14787769|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14787770|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
14787771|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787772|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787773|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14787774|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14787775|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787776|NCT00721305|Lovastatin|lovastatin|mesh-list
14787777|NCT00721305|L 647318|l 647318|mesh-list
14787778|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
14787779|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14218892|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
14218893|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218894|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14218895|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14218896|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
14218897|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218898|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218899|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14218900|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14218901|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
14787780|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14787781|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
14787782|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787783|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14787784|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14218902|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
14218903|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218904|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14218905|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218906|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14218907|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14218908|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
14218909|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14218910|NCT02788591|Esomeprazole|esomeprazole|mesh-list
14787785|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218911|NCT02788591|Omeprazole|omeprazole|mesh-list
14218912|NCT02788591|Pantoprazole|pantoprazole|mesh-list
14218913|NCT02788591|Lansoprazole|lansoprazole|mesh-list
14218914|NCT02788591|Sucralfate|sucralfate|mesh-list
14218915|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14218916|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14218917|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14218918|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218919|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218920|NCT02772588|Leuprolide|leuprolide|mesh-list
14218921|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14218922|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
14218923|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218924|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218925|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14218926|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218927|NCT02766478|Genistein|genistein|mesh-list
14218928|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14218929|NCT02766478|Protective Agents|protective agents|mesh-ancestor
14218930|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218931|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218932|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14218933|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218934|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787786|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
14787787|NCT00721331|Loratadine|loratadine|mesh-list
14787788|NCT00721331|Nortriptyline|nortriptyline|mesh-list
14787789|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787790|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
14787791|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14787792|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
14787793|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14218935|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
14218936|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14218937|NCT02766478|Estrogens|estrogens|mesh-ancestor
14218938|NCT02766478|Hormones|hormones|mesh-ancestor
14508124|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14508125|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14508126|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508127|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508128|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508129|NCT02951702|Vancomycin|vancomycin|mesh-list
14508130|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14508131|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508132|NCT02951819|Dexamethasone|dexamethasone|mesh-list
14508133|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
14508134|NCT02951819|Bortezomib|bortezomib|mesh-list
14508135|NCT02951819|Daratumumab|daratumumab|mesh-list
14508136|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14508137|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
14508138|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508139|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508140|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14508141|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
14508142|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508143|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218939|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508144|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14508145|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787794|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14787795|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
14218940|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14218941|NCT02748057|Ezetimibe|ezetimibe|mesh-list
14218942|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14218943|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14218944|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
14787796|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
14787797|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787798|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787799|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787800|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14218945|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218946|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14218947|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14218948|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218949|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
14218950|NCT02741271|Prednisone|prednisone|mesh-list
14218951|NCT02741271|Prednisolone|prednisolone|mesh-list
14218952|NCT02741271|Albuterol|albuterol|mesh-list
14218953|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14218954|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
14218955|NCT02741271|Hormones|hormones|mesh-ancestor
14218956|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14218957|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14218958|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14218959|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218960|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
14218961|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14218962|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14787801|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
14787802|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14787803|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14787804|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14787805|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14787806|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
14787807|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
14218963|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14218964|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
14218965|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
14218966|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218967|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14218968|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14218969|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14218970|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
14218971|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14218972|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218973|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
14787808|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14787809|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787810|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787811|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787812|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787813|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787814|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787815|NCT00721448|Ticagrelor|ticagrelor|mesh-list
14787816|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14787817|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14787818|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14787819|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14787820|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
14787821|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787822|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787823|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787824|NCT00721487|Fluconazole|fluconazole|mesh-list
14787825|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
14787826|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787827|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14787828|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14787829|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787830|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787831|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14787832|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
14787833|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787834|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787835|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14787836|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14787837|NCT00721526|Disulfiram|disulfiram|mesh-list
14787838|NCT00721526|Lorazepam|lorazepam|mesh-list
14787839|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
14787840|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
14787841|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
14787842|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787843|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947633|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947634|NCT01529164|Leucovorin|leucovorin|mesh-list
14947635|NCT01529164|Fluorouracil|fluorouracil|mesh-list
14947636|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
14508146|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
14508147|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
14508148|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508149|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508150|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
14508151|NCT02951819|Hormones|hormones|mesh-ancestor
13965090|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
13965091|NCT03132701|Analgesics|analgesics|mesh-ancestor
13965092|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
13965093|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965094|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965095|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
13965096|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965097|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13965098|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
13965099|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13965100|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508152|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508153|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508154|NCT02951884|Bupivacaine|bupivacaine|mesh-list
14508155|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508156|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
14508157|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508158|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508159|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
14508160|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965101|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218974|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14218975|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14218976|NCT02741245|Ezetimibe|ezetimibe|mesh-list
14218977|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14218978|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14218979|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
14218980|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218981|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14218982|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14218983|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14218984|NCT02728050|Cytarabine|cytarabine|mesh-list
14508161|NCT02952001|Triamcinolone|triamcinolone|mesh-list
14218985|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14218986|NCT02728050|Sorafenib|sorafenib|mesh-list
14218987|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
14218988|NCT02728050|Cladribine|cladribine|mesh-list
14218989|NCT02728050|Lenograstim|lenograstim|mesh-list
14787844|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14787845|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14787846|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14787847|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14947637|NCT01529164|Endostar protein|endostar protein|mesh-list
14947638|NCT01529164|Endostatins|endostatins|mesh-list
14947639|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
14947640|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947641|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14947642|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947643|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947644|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
14947645|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947646|NCT01529164|Antidotes|antidotes|mesh-ancestor
14947647|NCT01529164|Protective Agents|protective agents|mesh-ancestor
14947648|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
14947649|NCT01529164|Vitamins|vitamins|mesh-ancestor
14947650|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
14947651|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14947652|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947653|NCT01529164|Growth Substances|growth substances|mesh-ancestor
14947654|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
14947655|NCT01529177|Metformin|metformin|mesh-list
14947656|NCT01529177|Citric Acid|citric acid|mesh-list
14947657|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
14947658|NCT01529177|Clomiphene|clomiphene|mesh-list
14947659|NCT01529177|Enclomiphene|enclomiphene|mesh-list
14947660|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
14947661|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947662|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947663|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
14947664|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14947665|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
14947666|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
14947667|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947668|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14947669|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
14947670|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947671|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14947672|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
14947673|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14947674|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14947675|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14947676|NCT01529190|Pregabalin|pregabalin|mesh-list
14947677|NCT01529190|Analgesics|analgesics|mesh-ancestor
14947678|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
14947679|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947680|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947681|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
14947682|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14947683|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947684|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947685|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14947686|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14947687|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947688|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947689|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947690|NCT01529229|Prednisolone|prednisolone|mesh-list
14947691|NCT01529229|Betamethasone|betamethasone|mesh-list
14947692|NCT01529229|Desloratadine|desloratadine|mesh-list
14947693|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14218990|NCT02728050|Sargramostim|sargramostim|mesh-list
14218991|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14787848|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14787849|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14787850|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
14787851|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
14787852|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787853|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787854|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14787855|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14787856|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787857|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14787858|NCT00721552|Prednisolone|prednisolone|mesh-list
14787859|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14787860|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
14787861|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14787862|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
14787863|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14787864|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
14787865|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787866|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
14787867|NCT00721552|Hormones|hormones|mesh-ancestor
14787868|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14787869|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787870|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14787871|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787872|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
14787873|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
14787874|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787875|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14787876|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14787877|NCT00721552|Protective Agents|protective agents|mesh-ancestor
14787878|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14787879|NCT00721552|Incretins|incretins|mesh-ancestor
14787880|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14787881|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
14787882|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787883|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947694|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947695|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
14947696|NCT01529229|Hormones|hormones|mesh-ancestor
14947697|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947698|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947699|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14947700|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947701|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14947702|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
14947703|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14947704|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
14947705|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947706|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947707|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14947708|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14947709|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
14947710|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
14947711|NCT01529242|Prednisolone|prednisolone|mesh-list
14947712|NCT01529242|Betamethasone|betamethasone|mesh-list
14947713|NCT01529242|Desloratadine|desloratadine|mesh-list
14947714|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14947715|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947716|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
14947717|NCT01529242|Hormones|hormones|mesh-ancestor
14947718|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947719|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947720|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14947721|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947722|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14947723|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
14947724|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14947725|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
14947726|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947727|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947728|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14947729|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14947730|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
14947731|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
14947732|NCT01529255|Telbivudine|telbivudine|mesh-list
14947733|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
14947734|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947735|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14947736|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947737|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947738|NCT01529294|Iloperidone|iloperidone|mesh-list
14947739|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14947740|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14787884|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14787885|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
14787886|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
14787887|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
14787888|NCT00721747|Docetaxel|docetaxel|mesh-list
14787889|NCT00721747|Doxorubicin|doxorubicin|mesh-list
14787890|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14787891|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14787892|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
14787893|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787894|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787895|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14787896|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
14787897|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787898|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787899|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14787900|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
14787901|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
14787902|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
14787903|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787904|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787905|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787906|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787907|NCT00721773|Valsartan|valsartan|mesh-list
14787908|NCT00721773|Benazepril|benazepril|mesh-list
14787909|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14787910|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14787911|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14787912|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787913|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14787914|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
14787915|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787916|NCT00721877|Resveratrol|resveratrol|mesh-list
14787917|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
14787918|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787919|NCT00721877|Protective Agents|protective agents|mesh-ancestor
14787920|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787921|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787922|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14787923|NCT00721916|Leucovorin|leucovorin|mesh-list
14787924|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
14787925|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787926|NCT00721916|Antidotes|antidotes|mesh-ancestor
14787927|NCT00721916|Protective Agents|protective agents|mesh-ancestor
14787928|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787929|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
14787930|NCT00721916|Vitamins|vitamins|mesh-ancestor
14787931|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
14787932|NCT00722033|Indomethacin|indomethacin|mesh-list
14787933|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14787934|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14787935|NCT00722033|Analgesics|analgesics|mesh-ancestor
14787936|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
14787937|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14787938|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787939|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14787940|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787941|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
14787942|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
14787943|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14218992|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
14508162|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14508163|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14508164|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14508165|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508166|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
14508167|NCT02952001|Hormones|hormones|mesh-ancestor
14508168|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508169|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508170|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14508171|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
14508172|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508173|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14218993|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787944|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14787945|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787946|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787947|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
14787948|NCT00722098|Vaccines|vaccines|mesh-list
14787949|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
14787950|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508174|NCT02952586|Avelumab|avelumab|mesh-list
14508175|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14508176|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508177|NCT02952820|Lemborexant|lemborexant|mesh-list
14947741|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947742|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947743|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947744|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
14947745|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14947746|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14947747|NCT01529320|Prednisolone|prednisolone|mesh-list
14947748|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
14508178|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14508179|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508180|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508181|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14508182|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14508183|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508184|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508185|NCT02952898|Diclofenac|diclofenac|mesh-list
14508186|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14508187|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14508188|NCT02952898|Analgesics|analgesics|mesh-ancestor
14508189|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
14508190|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508191|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508192|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508193|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508194|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14508195|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508196|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508197|NCT02953314|Ivacaftor|ivacaftor|mesh-list
14508198|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14508199|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508200|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508201|NCT02953548|Cannabidiol|cannabidiol|mesh-list
14508202|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
14508203|NCT02953561|Azacitidine|azacitidine|mesh-list
14508204|NCT02953561|Avelumab|avelumab|mesh-list
14508205|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14508206|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14508207|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
14787951|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218994|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14218995|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
14218996|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14218997|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14218998|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
14218999|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219000|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14219001|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14219002|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787952|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14787953|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14787954|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
14787955|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787956|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787957|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14787958|NCT00722150|Artesunate|artesunate|mesh-list
14787959|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
14787960|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14787961|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14787962|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14787963|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787964|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
14787965|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
14787966|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14787967|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
14787968|NCT00722176|Risperidone|risperidone|mesh-list
14787969|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14787970|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
14787971|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14787972|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787973|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219003|NCT02728050|Analgesics|analgesics|mesh-ancestor
14219004|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
14219005|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219006|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14219007|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14219008|NCT02705963|Trametinib|trametinib|mesh-list
14787974|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14787975|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14787976|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14787977|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947749|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
14947750|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14947751|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
14947752|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947753|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
14787978|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14787979|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
14787980|NCT00722215|Nifedipine|nifedipine|mesh-list
14787981|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
14787982|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14787983|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14787984|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14787985|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14787986|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14787987|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
14787988|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
14787989|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14787990|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14787991|NCT00722293|Doxorubicin|doxorubicin|mesh-list
14787992|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14787993|NCT00722293|Epirubicin|epirubicin|mesh-list
14947754|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
14219009|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14787994|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14787995|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14787996|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14787997|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14787998|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14787999|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788000|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
14219010|NCT02705963|Norethindrone|norethindrone|mesh-list
14219011|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
14219012|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
14219013|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
14788001|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14788002|NCT00722475|Antibodies|antibodies|mesh-list
14788003|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
14788004|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14788005|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
14788006|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219014|NCT02705963|Estradiol|estradiol|mesh-list
14219015|NCT02705963|Estrogens|estrogens|mesh-ancestor
14219016|NCT02705963|Hormones|hormones|mesh-ancestor
14219017|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219018|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219019|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14788007|NCT00722488|Pevonedistat|pevonedistat|mesh-list
14788008|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788009|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788010|NCT00722579|Cobalt|cobalt|mesh-list
14788011|NCT00722579|Chromium|chromium|mesh-list
14788012|NCT00722579|Trace Elements|trace elements|mesh-ancestor
14219020|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14219021|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14219022|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219023|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14219024|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219025|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219026|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14219027|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14242390|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14242391|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
14242392|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14788013|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
14788014|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788015|NCT00722631|Pioglitazone|pioglitazone|mesh-list
14788016|NCT00722631|Glimepiride|glimepiride|mesh-list
14788017|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14788018|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788019|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14788020|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788021|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
14788022|NCT00722709|Ropivacaine|ropivacaine|mesh-list
14788023|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
14788024|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
14788025|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788026|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242393|NCT00186121|Anastrozole|anastrozole|mesh-list
14788027|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
14788028|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788029|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
14788030|NCT00722735|Finafloxacin|finafloxacin|mesh-list
14788031|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14788032|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788033|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14788034|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14788035|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788036|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788037|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788038|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14788039|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14788040|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14788041|NCT00722735|Renal Agents|renal agents|mesh-ancestor
14788042|NCT00722839|Vaccines|vaccines|mesh-list
14788043|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
14788044|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788045|NCT00722852|Ketoprofen|ketoprofen|mesh-list
14788046|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219028|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
14219029|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219030|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219031|NCT02675231|Trastuzumab|trastuzumab|mesh-list
14219032|NCT02675231|Fulvestrant|fulvestrant|mesh-list
14219033|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219034|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219035|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14219036|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14219037|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14219038|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219039|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219040|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219041|NCT02662257|Propofol|propofol|mesh-list
14219042|NCT02662257|Sevoflurane|sevoflurane|mesh-list
14219043|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14219044|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219045|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219046|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14219047|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
14219048|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
14219049|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14219050|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14219051|NCT02650401|Entrectinib|entrectinib|mesh-list
14219052|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14788047|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14788048|NCT00722852|Analgesics|analgesics|mesh-ancestor
14788049|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
14788050|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788051|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788052|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788053|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788054|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14788055|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788056|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788057|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14788058|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
14788059|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788060|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14788061|NCT00722956|Atorvastatin|atorvastatin|mesh-list
14788062|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219053|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219054|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219055|NCT02648477|Doxorubicin|doxorubicin|mesh-list
14788063|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14788064|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
14788065|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788066|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14788067|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14219056|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14219057|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
14219058|NCT02648477|Letrozole|letrozole|mesh-list
14219059|NCT02648477|Anastrozole|anastrozole|mesh-list
14219060|NCT02648477|Exemestane|exemestane|mesh-list
14219061|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14219062|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219063|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14219064|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14219065|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219066|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788068|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788069|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14788070|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14219067|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219068|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14219069|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14219070|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14219071|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219072|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219073|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219074|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14219075|NCT02626507|Fulvestrant|fulvestrant|mesh-list
14219076|NCT02626507|Goserelin|goserelin|mesh-list
14219077|NCT02626507|Palbociclib|palbociclib|mesh-list
14219078|NCT02626507|Gedatolisib|gedatolisib|mesh-list
14219079|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14788071|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14788072|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
14788073|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788074|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14788075|NCT00722969|Sorafenib|sorafenib|mesh-list
14219080|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219081|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14219082|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14219083|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219084|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219085|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219086|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14219087|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219088|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219089|NCT02605967|Spartalizumab|spartalizumab|mesh-list
14219090|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14219091|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219092|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219093|NCT02584634|Avelumab|avelumab|mesh-list
14219094|NCT02584634|Crizotinib|crizotinib|mesh-list
14219095|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219096|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219097|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14219098|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788076|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788077|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14788078|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788079|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788080|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14788081|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
14788082|NCT00723047|Coagulants|coagulants|mesh-ancestor
14219099|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219100|NCT02581137|Metformin|metformin|mesh-list
14219101|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14219102|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219103|NCT02570503|Ketorolac|ketorolac|mesh-list
14219104|NCT02570503|Clonidine|clonidine|mesh-list
14219105|NCT02570503|Epinephrine|epinephrine|mesh-list
14219106|NCT02570503|Ropivacaine|ropivacaine|mesh-list
14219107|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
14219108|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
14219109|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219110|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219111|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
14219112|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219113|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14219114|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14219115|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14219116|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219117|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219118|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14219119|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14219120|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
14219121|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14219122|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219123|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
14219124|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
14219125|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14219126|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219127|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219128|NCT02570503|Analgesics|analgesics|mesh-ancestor
14219129|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219130|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219131|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219132|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219133|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14219134|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
14219135|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14219136|NCT02564068|Oxytocin|oxytocin|mesh-list
14788083|NCT00723060|Citalopram|citalopram|mesh-list
14508208|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508209|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508210|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508211|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14508212|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
14508213|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508214|NCT02953678|Prednisone|prednisone|mesh-list
14508215|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
14508216|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14508217|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14508218|NCT02953678|Prednisolone|prednisolone|mesh-list
14508219|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
14219137|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
14788084|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14788085|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14788086|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788087|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788088|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788089|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
14788090|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788091|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14788092|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
14788093|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14788094|NCT00723086|Docetaxel|docetaxel|mesh-list
14788095|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788096|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
14788097|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
14788098|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14788099|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788100|NCT00723164|Fentanyl|fentanyl|mesh-list
14788101|NCT00723164|Midazolam|midazolam|mesh-list
14788102|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14788103|NCT00723164|Narcotics|narcotics|mesh-ancestor
14788104|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788105|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947755|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947756|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947757|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14947758|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
14947759|NCT01529320|Hormones|hormones|mesh-ancestor
14788106|NCT00723164|Analgesics|analgesics|mesh-ancestor
14219138|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14219139|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219140|NCT02553265|Carbidopa|carbidopa|mesh-list
14219141|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14219142|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14219143|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
14219144|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219145|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219146|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219147|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14219148|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219149|NCT02550288|Atorvastatin|atorvastatin|mesh-list
14219150|NCT02550288|Ezetimibe|ezetimibe|mesh-list
14219151|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219152|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14219153|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
14219154|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219155|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14219156|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14219157|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219158|NCT02546661|Durvalumab|durvalumab|mesh-list
14219159|NCT02546661|Olaparib|olaparib|mesh-list
14219160|NCT02546661|Adavosertib|adavosertib|mesh-list
14219161|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219162|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219163|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14219164|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219165|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219166|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
14219167|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14219168|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508220|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14508221|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
14508222|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508223|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
14508224|NCT02953678|Hormones|hormones|mesh-ancestor
14508225|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508226|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508227|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508228|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508229|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
14508230|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
14508231|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219169|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219170|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219171|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219172|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219173|NCT02499328|Durvalumab|durvalumab|mesh-list
14219174|NCT02499328|Tremelimumab|tremelimumab|mesh-list
14219175|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219176|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219177|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
14219178|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14219179|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219180|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219181|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219182|NCT02492269|Analgesics|analgesics|mesh-ancestor
14219183|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
14219184|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219185|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14219186|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14219187|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14219188|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
14219189|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219190|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219191|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14219192|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219193|NCT02469753|Analgesics|analgesics|mesh-ancestor
14508232|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788107|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
14788108|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788109|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14788110|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14788111|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
14788112|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
14788113|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14788114|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14788115|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14788116|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14788117|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
14788118|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
14788119|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788120|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788121|NCT00723216|Enoxaparin|enoxaparin|mesh-list
14508233|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14508234|NCT02953678|Protective Agents|protective agents|mesh-ancestor
14508235|NCT02953782|Cetuximab|cetuximab|mesh-list
14508236|NCT02953782|Magrolimab|magrolimab|mesh-list
14508237|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14508238|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508239|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14508240|NCT02953821|Hormones|hormones|mesh-ancestor
14508241|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508242|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508243|NCT02953860|Fulvestrant|fulvestrant|mesh-list
14508244|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508245|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508246|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14508247|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14508248|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
14508249|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508250|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508251|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
14508252|NCT02953873|Prednisone|prednisone|mesh-list
14508253|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
14508254|NCT02953873|Tacrolimus|tacrolimus|mesh-list
14508255|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508256|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
14508257|NCT02953873|Hormones|hormones|mesh-ancestor
14788122|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
14788123|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14788124|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14788125|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788126|NCT00723242|Ribavirin|ribavirin|mesh-list
14947760|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947761|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14947762|NCT01529320|Protective Agents|protective agents|mesh-ancestor
14947763|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14947764|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947765|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
14947766|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947767|NCT01529476|Levofloxacin|levofloxacin|mesh-list
14947768|NCT01529476|Ofloxacin|ofloxacin|mesh-list
14947769|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14947770|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947771|NCT01529476|Renal Agents|renal agents|mesh-ancestor
14788127|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
14788128|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788129|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
14788130|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788131|NCT00723268|Prednisolone|prednisolone|mesh-list
14788132|NCT00723268|Colchicine|colchicine|mesh-list
14788133|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788134|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
14788135|NCT00723268|Hormones|hormones|mesh-ancestor
14788136|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14788137|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219194|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
14219195|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219196|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219197|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219198|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219199|NCT02467153|Vitamin D|vitamin d|mesh-list
14219200|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
14219201|NCT02467153|Vitamins|vitamins|mesh-ancestor
14219202|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
14788138|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14788139|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788140|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
14788141|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788142|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
14788143|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
14788144|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
14788145|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788146|NCT00723307|Metformin|metformin|mesh-list
14788147|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14788148|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788149|NCT00723320|Atorvastatin|atorvastatin|mesh-list
14788150|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14788151|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14788152|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
14788153|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788154|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14788155|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14788156|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788157|NCT00723346|Asparaginase|asparaginase|mesh-list
14788158|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788159|NCT00723385|Vitamin D|vitamin d|mesh-list
14788160|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
14788161|NCT00723385|Vitamins|vitamins|mesh-ancestor
14788162|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
14788163|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788164|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14788165|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14788166|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
14788167|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14788168|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
14788169|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788170|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14788171|NCT00723424|Digoxin|digoxin|mesh-list
14788172|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14788173|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14947772|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14219203|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788174|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788175|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788176|NCT00723424|Protective Agents|protective agents|mesh-ancestor
14788177|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788178|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14788179|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14788180|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14788181|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
14788182|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788183|NCT00723437|Acitretin|acitretin|mesh-list
14788184|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
14788185|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14947773|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14947774|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14219204|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14219205|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14219206|NCT02460224|Spartalizumab|spartalizumab|mesh-list
14219207|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14219208|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219209|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219210|NCT02459457|Paclitaxel|paclitaxel|mesh-list
14219211|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14219212|NCT02459457|Carboplatin|carboplatin|mesh-list
14219213|NCT02459457|Fluorouracil|fluorouracil|mesh-list
14219214|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14219215|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219216|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
14219217|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
14219218|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
14219219|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219220|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
14219221|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14219222|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14219223|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
14219224|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219225|NCT02407236|Ustekinumab|ustekinumab|mesh-list
14219226|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219227|NCT02397083|Everolimus|everolimus|mesh-list
14219228|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
14219229|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219230|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14219231|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
14219232|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219233|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14947775|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947776|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947777|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219234|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
14219235|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14219236|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14219237|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14219238|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14219239|NCT02386774|Benoxinate|benoxinate|mesh-list
14219240|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14219241|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14219242|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
14219243|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
14219244|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219245|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219246|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
14219247|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219248|NCT02320435|Trastuzumab|trastuzumab|mesh-list
14219249|NCT02320435|Pertuzumab|pertuzumab|mesh-list
14219250|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219251|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219252|NCT02320396|Desloratadine|desloratadine|mesh-list
14219253|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14219254|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219255|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219256|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219257|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219258|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219259|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219260|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219261|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
14219262|NCT02299505|Ceritinib|ceritinib|mesh-list
14219263|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219264|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14219265|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219266|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219267|NCT02282345|Talazoparib|talazoparib|mesh-list
14219268|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14219269|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788186|NCT00723502|Amoxicillin|amoxicillin|mesh-list
14788187|NCT00723502|Finafloxacin|finafloxacin|mesh-list
14788188|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
14788189|NCT00723502|Esomeprazole|esomeprazole|mesh-list
14788190|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14788191|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14219270|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219271|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219272|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14219273|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14219274|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219275|NCT02250014|Sargramostim|sargramostim|mesh-list
14219276|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
14219277|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219278|NCT02235701|Ifosfamide|ifosfamide|mesh-list
14219279|NCT02235701|Doxorubicin|doxorubicin|mesh-list
14219280|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14219281|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
14219282|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219283|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788192|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14788193|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788194|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14788195|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788196|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788197|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14788198|NCT00723502|Renal Agents|renal agents|mesh-ancestor
14788199|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14788200|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14788201|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788202|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14788203|NCT00723515|Listerine|listerine|mesh-list
14788204|NCT00723515|Calcium|calcium|mesh-list
14788205|NCT00723515|Fluorides|fluorides|mesh-list
14788206|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
14788207|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14788208|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788209|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
14788210|NCT00723515|Protective Agents|protective agents|mesh-ancestor
14788211|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14788212|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788213|NCT00723658|Cytarabine|cytarabine|mesh-list
14788214|NCT00723658|Thalidomide|thalidomide|mesh-list
14788215|NCT00723658|Dexamethasone|dexamethasone|mesh-list
14788216|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
14788217|NCT00723658|Melphalan|melphalan|mesh-list
14788218|NCT00723658|Carmustine|carmustine|mesh-list
14219284|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14219285|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14219286|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14219287|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219288|NCT02235688|Gemcitabine|gemcitabine|mesh-list
14219289|NCT02235688|Doxorubicin|doxorubicin|mesh-list
14219290|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14219291|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
14219292|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219293|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219294|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
14219295|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14219296|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788219|NCT00723658|Rituximab|rituximab|mesh-list
14788220|NCT00723658|Doxorubicin|doxorubicin|mesh-list
14788221|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14788222|NCT00723658|Etoposide|etoposide|mesh-list
14788223|NCT00723658|Bortezomib|bortezomib|mesh-list
14788224|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14219297|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14219298|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
14219299|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219300|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14219301|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14219302|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14788225|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
14788226|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788227|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788228|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14788229|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
14219311|NCT02115074|Celecoxib|celecoxib|mesh-list
14219312|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219313|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219314|NCT02115074|Analgesics|analgesics|mesh-ancestor
14219315|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
14219316|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219317|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219318|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219319|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219320|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219321|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219322|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219323|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219324|NCT02070549|Trametinib|trametinib|mesh-list
14219325|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219326|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14219327|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219328|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219329|NCT02066636|Nivolumab|nivolumab|mesh-list
14219330|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219331|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219332|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14788230|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788231|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788232|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14788233|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788234|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
14788235|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
14788236|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788237|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788238|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
14788239|NCT00723658|Hormones|hormones|mesh-ancestor
14788240|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219333|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219334|NCT02053246|Nebivolol|nebivolol|mesh-list
14219335|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14788241|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14788242|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14788243|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14788244|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14947778|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14947779|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14947780|NCT01529528|Anagliptin|anagliptin|mesh-list
14947781|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14947782|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
14947783|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947784|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219336|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
14219337|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14219338|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14219339|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14219340|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
14508258|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508259|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508260|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508261|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508262|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14219341|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508263|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
14508264|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14508265|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508266|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508267|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14508268|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14508269|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
14508270|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14508271|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508272|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
14508273|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
14508274|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508275|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508276|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14508277|NCT02953873|Protective Agents|protective agents|mesh-ancestor
14508278|NCT02953886|Fluorides|fluorides|mesh-list
14508279|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
14508280|NCT02953886|Protective Agents|protective agents|mesh-ancestor
14508281|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508282|NCT02953938|Ranibizumab|ranibizumab|mesh-list
14508283|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14508284|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14508285|NCT02953938|Growth Substances|growth substances|mesh-ancestor
14508286|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508287|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
14508288|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508289|NCT02954172|Paclitaxel|paclitaxel|mesh-list
14508290|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14508291|NCT02954172|Bevacizumab|bevacizumab|mesh-list
14508292|NCT02954172|Carboplatin|carboplatin|mesh-list
14508293|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14508294|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508295|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
14508296|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
14508297|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14508298|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508299|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14508300|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14508301|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14508302|NCT02954172|Growth Substances|growth substances|mesh-ancestor
14508303|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508304|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
14508305|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
14508306|NCT02954198|Prednisone|prednisone|mesh-list
14508307|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
14947785|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947786|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947787|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14947788|NCT01529541|Anagliptin|anagliptin|mesh-list
14947789|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947790|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947791|NCT01529541|Incretins|incretins|mesh-ancestor
14947792|NCT01529541|Hormones|hormones|mesh-ancestor
14947793|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14947794|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14947795|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
14947796|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219342|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219343|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219344|NCT02005471|Rituximab|rituximab|mesh-list
14219345|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14219346|NCT02005471|Venetoclax|venetoclax|mesh-list
14219347|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219348|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219349|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
14508308|NCT02954198|Everolimus|everolimus|mesh-list
14219350|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219351|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788245|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14788246|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788247|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14788248|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14788249|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
14788250|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
14788251|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788252|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
14788253|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14788254|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14788255|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14788256|NCT00723658|Growth Substances|growth substances|mesh-ancestor
14947797|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947798|NCT01529554|Everolimus|everolimus|mesh-list
14947799|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947800|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947801|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
14947802|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947803|NCT01529619|Rivastigmine|rivastigmine|mesh-list
14947804|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14947805|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947806|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947807|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
14947808|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947809|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947810|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14947811|NCT01529619|Protective Agents|protective agents|mesh-ancestor
14947812|NCT01529710|Praziquantel|praziquantel|mesh-list
14947813|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
14947814|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14947815|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947816|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14947817|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14947818|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14947819|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947820|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947821|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14947822|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947823|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947824|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
14947825|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947826|NCT01529892|Methamphetamine|methamphetamine|mesh-list
14947827|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14947828|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947829|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
14947830|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
14947831|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947832|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
14947833|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947834|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947835|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
14947836|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14947837|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14947838|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947839|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14947840|NCT01530009|Amoxicillin|amoxicillin|mesh-list
14947841|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14947842|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14947843|NCT01530022|Lacosamide|lacosamide|mesh-list
14947844|NCT01530022|Carbamazepine|carbamazepine|mesh-list
14947845|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
14947846|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14947847|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14947848|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947849|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947850|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
14947851|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947852|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788257|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
14788258|NCT00723775|Lopinavir|lopinavir|mesh-list
14947853|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788259|NCT00723775|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14788260|NCT00723775|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14788261|NCT00723775|Protease Inhibitors|protease inhibitors|mesh-ancestor
14788262|NCT00723775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788263|NCT00723775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788264|NCT00723775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14788265|NCT00723775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14788266|NCT00723775|Antiviral Agents|antiviral agents|mesh-ancestor
14788267|NCT00723775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788268|NCT00723775|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14788269|NCT00723775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14788270|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14788271|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14788272|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14788273|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219352|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14219353|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
14219354|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788274|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788275|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14788276|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788277|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788278|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
14788279|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788280|NCT00723879|Ribavirin|ribavirin|mesh-list
14788281|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14219355|NCT01980940|Etoricoxib|etoricoxib|mesh-list
14219356|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14219357|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219358|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219359|NCT01980940|Analgesics|analgesics|mesh-ancestor
14219360|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
14219361|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219362|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219363|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219364|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219365|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219366|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219367|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219368|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219369|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14788282|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
14788283|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788284|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
14788285|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14219370|NCT01980940|Protective Agents|protective agents|mesh-ancestor
14219371|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14219372|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
14219373|NCT01923298|Estradiol|estradiol|mesh-list
14219374|NCT01923298|Estrogens|estrogens|mesh-ancestor
14219375|NCT01923298|Hormones|hormones|mesh-ancestor
14219376|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219377|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219378|NCT01918033|Desloratadine|desloratadine|mesh-list
14219379|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14219380|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219381|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219382|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219383|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219384|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219385|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219386|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219387|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
14219388|NCT01916980|Desloratadine|desloratadine|mesh-list
14788286|NCT00723918|Methadone|methadone|mesh-list
14788287|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14788288|NCT00723918|Narcotics|narcotics|mesh-ancestor
14788289|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788290|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788291|NCT00723918|Analgesics|analgesics|mesh-ancestor
14788292|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
14788293|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788294|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
14788295|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
14788296|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14788297|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
14788298|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14788299|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14788300|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14788301|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788302|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788303|NCT00723983|Sumatriptan|sumatriptan|mesh-list
14788304|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14788305|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14788306|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14788307|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
14788308|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788309|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788310|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788311|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
14788312|NCT00724022|Prednisolone|prednisolone|mesh-list
14788313|NCT00724022|Tacrolimus|tacrolimus|mesh-list
14788314|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
14788315|NCT00724022|Basiliximab|basiliximab|mesh-list
14788316|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788317|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
14788318|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788319|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14788320|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788321|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788322|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788323|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
14788324|NCT00724022|Hormones|hormones|mesh-ancestor
14788325|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14788326|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14788327|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788328|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14788329|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14219389|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14219390|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219391|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219392|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219393|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219394|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219395|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219396|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219397|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
14219398|NCT01916967|Desloratadine|desloratadine|mesh-list
14219399|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14219400|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219401|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219402|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219403|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219404|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219405|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219406|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219407|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
14219408|NCT01910402|Ritonavir|ritonavir|mesh-list
14219409|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14219410|NCT01910402|Tenofovir|tenofovir|mesh-list
14219411|NCT01910402|Lamivudine|lamivudine|mesh-list
14219412|NCT01910402|Emtricitabine|emtricitabine|mesh-list
14219413|NCT01910402|Abacavir|abacavir|mesh-list
14219414|NCT01910402|Dolutegravir|dolutegravir|mesh-list
14219415|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14219416|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14219417|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
14219418|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788330|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
14242394|NCT00186121|Goserelin|goserelin|mesh-list
14219419|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219420|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14219421|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14219422|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
14788331|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14788332|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788333|NCT00724035|Fentanyl|fentanyl|mesh-list
14788334|NCT00724035|Midazolam|midazolam|mesh-list
14788335|NCT00724035|Analgesics|analgesics|mesh-list
14788336|NCT00724035|Anesthetics|anesthetics|mesh-list
14788337|NCT00724035|Ropivacaine|ropivacaine|mesh-list
14788338|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
14788339|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788340|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788341|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
14788342|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788343|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14788344|NCT00724035|Narcotics|narcotics|mesh-ancestor
14788345|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14788346|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14788347|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
14788348|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14788349|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14788350|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14788351|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14788352|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
14788353|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
14788354|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788355|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788356|NCT00724074|Bupivacaine|bupivacaine|mesh-list
14788357|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
14788358|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
14788359|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788360|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788361|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
14788362|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788363|NCT00724113|Lidocaine|lidocaine|mesh-list
14788364|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
14788365|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
14788366|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788367|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788368|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
14788369|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788370|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14788371|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14788372|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14788373|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788374|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788375|NCT00724178|Vitamin D|vitamin d|mesh-list
14788376|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
14788377|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
14788378|NCT00724178|Calcium|calcium|mesh-list
14788379|NCT00724178|Vitamins|vitamins|mesh-ancestor
14788380|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
14788381|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788382|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14788383|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14788384|NCT00724178|Antacids|antacids|mesh-ancestor
14788385|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788386|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788387|NCT00724230|Ribavirin|ribavirin|mesh-list
14788388|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14788389|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
14788390|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
14788391|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788392|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
14788393|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788394|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
14788395|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788396|NCT00724256|Ceftibuten|ceftibuten|mesh-list
14788397|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14788398|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788399|NCT00724295|Ribavirin|ribavirin|mesh-list
14788400|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14788401|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
14788402|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788403|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
14788404|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788405|NCT00724321|Iloprost|iloprost|mesh-list
14788406|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14788407|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
14788408|NCT00724360|Trastuzumab|trastuzumab|mesh-list
14788409|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14788410|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788411|NCT00724386|Paclitaxel|paclitaxel|mesh-list
14788412|NCT00724386|Vinorelbine|vinorelbine|mesh-list
14788413|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14788414|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788415|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
14788416|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
14788417|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
14788418|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788419|NCT00724529|Infliximab|infliximab|mesh-list
14788420|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
14788421|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788422|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788423|NCT00724542|Voglibose|voglibose|mesh-list
14219423|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14219424|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14219425|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14219426|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14219427|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14219428|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14219429|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14219430|NCT01893320|Decitabine|decitabine|mesh-list
14219431|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14219432|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
14788424|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14788425|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788426|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14788427|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219433|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219434|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219435|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219436|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
14219437|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14219438|NCT01867606|Antibodies|antibodies|mesh-list
14219439|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
14219440|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219441|NCT01857063|Montelukast|montelukast|mesh-list
14788428|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947854|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947855|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14947856|NCT01530022|Analgesics|analgesics|mesh-ancestor
14947857|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
14947858|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947859|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14947860|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14788429|NCT00724581|Amiodarone|amiodarone|mesh-list
14788430|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14788431|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
14788432|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14788433|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788434|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788435|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14788436|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14788437|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14788438|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788439|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14788440|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14788441|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14788442|NCT00724620|Ribavirin|ribavirin|mesh-list
14788443|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14788444|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
14788445|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788446|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
14788447|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788448|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
14788449|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14788450|NCT00724672|Adalimumab|adalimumab|mesh-list
14788451|NCT00724672|Etanercept|etanercept|mesh-list
14788452|NCT00724672|Infliximab|infliximab|mesh-list
14788453|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788454|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788455|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14788456|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788457|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14788458|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14788459|NCT00724672|Analgesics|analgesics|mesh-ancestor
14788460|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
14788461|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788462|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788463|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788464|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
14788465|NCT00724685|Ropivacaine|ropivacaine|mesh-list
14788466|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
14788467|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
14788468|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788469|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788470|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
14788471|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219442|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14219443|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219444|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14219445|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219446|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219447|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788472|NCT00724724|Aspirin|aspirin|mesh-list
14788473|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
14947861|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
14947862|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14947863|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947864|NCT01530126|Becaplermin|becaplermin|mesh-list
14947865|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
14947866|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14947867|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947868|NCT01530126|Growth Substances|growth substances|mesh-ancestor
14947869|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947870|NCT01530152|Lidocaine|lidocaine|mesh-list
14788474|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14788475|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219448|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14219449|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14219450|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219451|NCT01854268|Capsaicin|capsaicin|mesh-list
14219452|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
14219453|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219454|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
14219455|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219456|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788476|NCT00724724|Analgesics|analgesics|mesh-ancestor
14947871|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
14219457|NCT01852812|Montelukast|montelukast|mesh-list
14219458|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14219459|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219460|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14219461|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219462|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219463|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219464|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14219465|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14219466|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219467|NCT01844986|Olaparib|olaparib|mesh-list
14219468|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14788477|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
14788478|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788479|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788480|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788481|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788482|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14788483|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14788484|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788485|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14788486|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14788487|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788488|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
14788489|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14788490|NCT00724724|Protective Agents|protective agents|mesh-ancestor
14788491|NCT00724802|Triacetin|triacetin|mesh-list
14788492|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
14788493|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788494|NCT00724880|Clopidogrel|clopidogrel|mesh-list
14788495|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14788496|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14788497|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14788498|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14788499|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
14788500|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788501|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788502|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788503|NCT00725036|Insulin|insulin|mesh-list
14788504|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14788505|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
14788506|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
14788507|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
14788508|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
14788509|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14788510|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788511|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
14788512|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
14788513|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
14788514|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788515|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788516|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
14788517|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788518|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14788519|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788520|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788521|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
14788522|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
14788523|NCT00725218|Analgesics|analgesics|mesh-ancestor
14788524|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
14788525|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788526|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788527|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14788528|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14788529|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788530|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788531|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14788532|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788533|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788534|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
14788535|NCT00725231|Doxorubicin|doxorubicin|mesh-list
14788536|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14788537|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14788538|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788539|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14788540|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14788541|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14788542|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788543|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788544|NCT00725348|R 115866|r 115866|mesh-list
14788545|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14788546|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788547|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788548|NCT00725400|Cetuximab|cetuximab|mesh-list
14788549|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14788550|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788551|NCT00725439|R 115866|r 115866|mesh-list
14788552|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14788553|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788554|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219469|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219470|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219471|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219472|NCT01828021|Margetuximab|margetuximab|mesh-list
14219473|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219474|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14219475|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14219476|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14219477|NCT01709318|Etonogestrel|etonogestrel|mesh-list
14219478|NCT01709318|Estradiol|estradiol|mesh-list
14219479|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14219480|NCT01709318|Estrogens|estrogens|mesh-ancestor
14788555|NCT00725478|Piribedil|piribedil|mesh-list
14788556|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14508309|NCT02954198|Tacrolimus|tacrolimus|mesh-list
14508310|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508311|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
14508312|NCT02954198|Hormones|hormones|mesh-ancestor
14508313|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508314|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508315|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508316|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508317|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14508318|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
14508319|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14508320|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508321|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508322|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14508323|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14508324|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
14508325|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14508326|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508327|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
14508328|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
14508329|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947872|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
14947873|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947874|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947875|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
14947876|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947877|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14947878|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14947879|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14947880|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947881|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947882|NCT01530217|Ibuprofen|ibuprofen|mesh-list
14947883|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14947884|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14947885|NCT01530217|Analgesics|analgesics|mesh-ancestor
14947886|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
14219481|NCT01709318|Hormones|hormones|mesh-ancestor
14788557|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14788558|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
14788559|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
14788560|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788561|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788562|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788563|NCT00725517|Icodextrin|icodextrin|mesh-list
14788564|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
14788565|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14788566|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14788567|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14788568|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788569|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14788570|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788571|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788572|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
14788573|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947887|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947888|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947889|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14947890|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14947891|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14947892|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947893|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947894|NCT01530230|Oxytocin|oxytocin|mesh-list
14947895|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
14947896|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14947897|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947898|NCT01530295|Docetaxel|docetaxel|mesh-list
14947899|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947900|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
14947901|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
14947902|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
14947903|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947904|NCT01530308|Dopamine|dopamine|mesh-list
14947905|NCT01530308|Haloperidol|haloperidol|mesh-list
14219482|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219483|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219484|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14219485|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
14219486|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14219487|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14508330|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14947906|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
14947907|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
14947908|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
14947909|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
14947910|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
14947911|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947912|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947913|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14947914|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14947915|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947916|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14947917|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
14947918|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947919|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508331|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14508332|NCT02954198|Protective Agents|protective agents|mesh-ancestor
14508333|NCT02954354|Oseltamivir|oseltamivir|mesh-list
14508334|NCT02954354|Baloxavir|baloxavir|mesh-list
14508335|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
14508336|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508337|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508338|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508339|NCT02954575|Factor VIII|factor viii|mesh-list
14508340|NCT02954575|Coagulants|coagulants|mesh-ancestor
14508341|NCT02954601|Insulin|insulin|mesh-list
14508342|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14508343|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14508344|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508345|NCT02954653|Cytarabine|cytarabine|mesh-list
14508346|NCT02954653|Azacitidine|azacitidine|mesh-list
14508347|NCT02954653|Decitabine|decitabine|mesh-list
14508348|NCT02954653|Daunorubicin|daunorubicin|mesh-list
14947920|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14788574|NCT00725777|Lumefantrine|lumefantrine|mesh-list
14788575|NCT00725777|Artemether|artemether|mesh-list
14788576|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14788577|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
14788578|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14788579|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14788580|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788581|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14788582|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
14788583|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14788584|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14788585|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788586|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788587|NCT00725790|Urological Agents|urological agents|mesh-ancestor
14788588|NCT00725829|Simvastatin|simvastatin|mesh-list
14788589|NCT00725829|Ezetimibe|ezetimibe|mesh-list
14788590|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14788591|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14788592|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
14788593|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788594|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14788595|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14788596|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788597|NCT00725946|Iodine|iodine|mesh-list
14788598|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
14219488|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14219489|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14219490|NCT01698918|Dexamethasone|dexamethasone|mesh-list
14219491|NCT01698918|Everolimus|everolimus|mesh-list
14219492|NCT01698918|Letrozole|letrozole|mesh-list
14219493|NCT01698918|Exemestane|exemestane|mesh-list
14219494|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219495|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
14219496|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
14219497|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788599|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14788600|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788601|NCT00725946|Trace Elements|trace elements|mesh-ancestor
14788602|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
14219498|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219499|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14219500|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
14219501|NCT01698918|Hormones|hormones|mesh-ancestor
14219502|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219503|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14219504|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219505|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14219506|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
14219507|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14219508|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14219509|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219510|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219511|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14788603|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788604|NCT00725985|Cladribine|cladribine|mesh-list
14788605|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788606|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788607|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
14788608|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788609|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
14788610|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
14219512|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
14788611|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
14219513|NCT01673620|Loratadine|loratadine|mesh-list
14788612|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788613|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788614|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
14788615|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788616|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14788617|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788618|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788619|NCT00726258|Ketamine|ketamine|mesh-list
14788620|NCT00726258|Analgesics|analgesics|mesh-ancestor
14788621|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
14788622|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788623|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788624|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14788625|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14788626|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
14788627|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
14788628|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788629|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14788630|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14788631|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788632|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788633|NCT00726466|Ranibizumab|ranibizumab|mesh-list
14788634|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14788635|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14788636|NCT00726466|Growth Substances|growth substances|mesh-ancestor
14788637|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788638|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
14788639|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788640|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
14788641|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14788642|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788643|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14788644|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788645|NCT00726570|Heparin|heparin|mesh-list
14788646|NCT00726570|Calcium heparin|calcium heparin|mesh-list
14788647|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14788648|NCT00726570|Tinzaparin|tinzaparin|mesh-list
14788649|NCT00726570|Dalteparin|dalteparin|mesh-list
14788650|NCT00726570|Anticoagulants|anticoagulants|mesh-list
14788651|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14788652|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14788653|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788654|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
14788655|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
14788656|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14788657|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14788658|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788659|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788660|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788661|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788662|NCT00726687|Capecitabine|capecitabine|mesh-list
14788663|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14788664|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
14788665|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788666|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788667|NCT00726700|Prednisone|prednisone|mesh-list
14788668|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
14788669|NCT00726700|Rituximab|rituximab|mesh-list
14788670|NCT00726700|Doxorubicin|doxorubicin|mesh-list
14788671|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14788672|NCT00726700|Vincristine|vincristine|mesh-list
14788673|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788674|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
14788675|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788676|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788677|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14788678|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
14788679|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788680|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788681|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14788682|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14219514|NCT01673620|Montelukast|montelukast|mesh-list
14219515|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14788683|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14788684|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14788685|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14788686|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219516|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219517|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14219518|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219519|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219520|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219521|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14219522|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14219523|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219524|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
14219525|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219526|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219527|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14788687|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788688|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
14788689|NCT00726700|Hormones|hormones|mesh-ancestor
14788690|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14788691|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14788692|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14788693|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14788694|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14788695|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14219528|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219529|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219530|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
14219531|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219532|NCT01617187|Olanzapine|olanzapine|mesh-list
14219533|NCT01617187|Asenapine|asenapine|mesh-list
14219534|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
14219535|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
14219536|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219537|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788696|NCT00726726|Vitamin K|vitamin k|mesh-list
14788697|NCT00726726|Midazolam|midazolam|mesh-list
14947921|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14947922|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
14947923|NCT01530308|Protective Agents|protective agents|mesh-ancestor
14947924|NCT01530373|Clonidine|clonidine|mesh-list
14947925|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
14947926|NCT01530373|Analgesics|analgesics|mesh-ancestor
14947927|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
14947928|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947929|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947930|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14947931|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
14947932|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
14947933|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14947934|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14947935|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14947936|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
14947937|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14947938|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947939|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14947940|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14947941|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
14947942|NCT01530373|Urological Agents|urological agents|mesh-ancestor
14947943|NCT01530386|Lacosamide|lacosamide|mesh-list
14947944|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
14788698|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
14947945|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14947946|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14947947|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14947948|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788699|NCT00726726|Caffeine|caffeine|mesh-list
14788700|NCT00726726|Omeprazole|omeprazole|mesh-list
14947949|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14947950|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14947951|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947952|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14947953|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
14788701|NCT00726726|Warfarin|warfarin|mesh-list
14788702|NCT00726726|Vitamins|vitamins|mesh-ancestor
14788703|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
14788704|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788705|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14788706|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14788707|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788708|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14788709|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14788710|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14788711|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14788712|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
14788713|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
14788714|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
14788715|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
14788716|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788717|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788718|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
14788719|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14947954|NCT01530451|Coagulants|coagulants|mesh-ancestor
14947955|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14947956|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
14947957|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947958|NCT01530490|Cabergoline|cabergoline|mesh-list
14219538|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508349|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14508350|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
14508351|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508352|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508353|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
14508354|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508355|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14508356|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
14508357|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508358|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219539|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14219540|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14219541|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219542|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14219543|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14219544|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14219545|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14219546|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219547|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219548|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
14219549|NCT01611883|Ezetimibe|ezetimibe|mesh-list
14219550|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219551|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14219552|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
14219553|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219554|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14219555|NCT01572675|Celecoxib|celecoxib|mesh-list
14219556|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219557|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219558|NCT01572675|Analgesics|analgesics|mesh-ancestor
14219559|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
14219560|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219561|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219562|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219563|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219564|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219565|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219566|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219567|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219568|NCT01554163|Celecoxib|celecoxib|mesh-list
14219569|NCT01554163|Etoricoxib|etoricoxib|mesh-list
14219570|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219571|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219572|NCT01554163|Analgesics|analgesics|mesh-ancestor
14219573|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
14219574|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219575|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219576|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219577|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219578|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219579|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219580|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219581|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219582|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
14788720|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788721|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14788722|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788723|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14788724|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14788725|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14788726|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14788727|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
14788728|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14788729|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14788730|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
14788731|NCT00726726|Coagulants|coagulants|mesh-ancestor
14788732|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
14788733|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
14788734|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14788735|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14219583|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219584|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219585|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219586|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14219587|NCT01490190|Etonogestrel|etonogestrel|mesh-list
14219588|NCT01490190|NuvaRing|nuvaring|mesh-list
14219589|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14219590|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14219591|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14219592|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
14219593|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14219594|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219595|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14219596|NCT01490190|Estrogens|estrogens|mesh-ancestor
14219597|NCT01490190|Hormones|hormones|mesh-ancestor
14219598|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242395|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14242396|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242397|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14242398|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14242399|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242400|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242401|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14242402|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
14242403|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242404|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242405|NCT00186186|Valproic Acid|valproic acid|mesh-list
14242406|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
14242407|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242408|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242409|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
14242410|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242411|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242412|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
14242413|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14242414|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242415|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242416|NCT00186446|Bupropion|bupropion|mesh-list
14242417|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14788736|NCT00726804|Adalimumab|adalimumab|mesh-list
14219599|NCT01473108|Eplerenone|eplerenone|mesh-list
14219600|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14219601|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219602|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219603|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219604|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14219605|NCT01473108|Diuretics|diuretics|mesh-ancestor
14219606|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
14219607|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14219608|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
14219609|NCT01471340|Prednisone|prednisone|mesh-list
14219610|NCT01471340|Prednisolone|prednisolone|mesh-list
14219611|NCT01471340|Albuterol|albuterol|mesh-list
14788737|NCT00726804|Etanercept|etanercept|mesh-list
14788738|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788739|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788740|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14788741|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14788742|NCT00726804|Analgesics|analgesics|mesh-ancestor
14788743|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
14788744|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788745|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788746|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14947959|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14947960|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14947961|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14947962|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
14947963|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
14947964|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219612|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
14219613|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
14219614|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219615|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
14219616|NCT01471340|Hormones|hormones|mesh-ancestor
14219617|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219618|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219619|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14219620|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219621|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
14219622|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219623|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14219624|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14219625|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219626|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14219627|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14947965|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947966|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947967|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
14947968|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
14947969|NCT01530503|Capecitabine|capecitabine|mesh-list
14947970|NCT01530503|Mitomycins|mitomycins|mesh-list
14947971|NCT01530503|Mitomycin|mitomycin|mesh-list
14947972|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14947973|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
14947974|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14947975|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14947976|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14508359|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14508360|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14508361|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14508362|NCT02954887|Cannabidiol|cannabidiol|mesh-list
14508363|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
14508364|NCT02955069|Spartalizumab|spartalizumab|mesh-list
14508365|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14508366|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508367|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508368|NCT02955147|Prednisone|prednisone|mesh-list
14508369|NCT02955147|Ustekinumab|ustekinumab|mesh-list
14219628|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14788747|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788748|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
14788749|NCT00726869|Elotuzumab|elotuzumab|mesh-list
14788750|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788751|NCT00726960|Buprenorphine|buprenorphine|mesh-list
14788752|NCT00726960|Aprepitant|aprepitant|mesh-list
14788753|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14788754|NCT00726960|Narcotics|narcotics|mesh-ancestor
14788755|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788756|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788757|NCT00726960|Analgesics|analgesics|mesh-ancestor
14788758|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
14788759|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788760|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14788761|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
14219629|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
14219630|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219631|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219632|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
14219633|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14219634|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219635|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219636|NCT01462370|Acetaminophen|acetaminophen|mesh-list
14219637|NCT01462370|Ibuprofen|ibuprofen|mesh-list
14219638|NCT01462370|Etoricoxib|etoricoxib|mesh-list
14219639|NCT01462370|Caffeine|caffeine|mesh-list
14219640|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219641|NCT01462370|Analgesics|analgesics|mesh-ancestor
14219642|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
14219643|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219644|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219645|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
14219646|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219647|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219648|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219649|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219650|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219651|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219652|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14219653|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14219654|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14219655|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14219656|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
14219657|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219658|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219659|NCT01381679|Ezetimibe|ezetimibe|mesh-list
14219660|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219661|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14219662|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
14219663|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508370|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508371|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
14508372|NCT02955147|Hormones|hormones|mesh-ancestor
14508373|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508374|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508375|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508376|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508377|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
14508378|NCT02955186|Saracatinib|saracatinib|mesh-list
14508379|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508380|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508381|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508382|NCT02955212|Upadacitinib|upadacitinib|mesh-list
14508383|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14508384|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14508385|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508386|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508387|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508388|NCT02955329|Nicotine|nicotine|mesh-list
14788762|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
14788763|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788764|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14788765|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788766|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788767|NCT00726973|Ranibizumab|ranibizumab|mesh-list
14788768|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14788769|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14788770|NCT00726973|Growth Substances|growth substances|mesh-ancestor
14788771|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788772|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
14788773|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788774|NCT00727038|Ranibizumab|ranibizumab|mesh-list
14788775|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14788776|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14788777|NCT00727038|Growth Substances|growth substances|mesh-ancestor
14788778|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788779|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
14788780|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788781|NCT00727077|Interferons|interferons|mesh-list
14788782|NCT00727077|Ribavirin|ribavirin|mesh-list
14788783|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
14788784|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
14788785|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788786|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
14788787|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788788|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
14788789|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788790|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
14788791|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788792|NCT00727103|Varenicline|varenicline|mesh-list
14788793|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14788794|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14788795|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
14788796|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788797|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788798|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788799|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14788800|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14788801|NCT00727129|Estradiol|estradiol|mesh-list
14788802|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14788803|NCT00727129|Estrogens|estrogens|mesh-ancestor
14788804|NCT00727129|Hormones|hormones|mesh-ancestor
14219664|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14219665|NCT01379989|Carboplatin|carboplatin|mesh-list
14219666|NCT01379989|Doxorubicin|doxorubicin|mesh-list
14219667|NCT01379989|Trabectedin|trabectedin|mesh-list
14219668|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219669|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14219670|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14219671|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14219672|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219673|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219674|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14219675|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
14219676|NCT01370603|Atorvastatin|atorvastatin|mesh-list
14219677|NCT01370603|Ezetimibe|ezetimibe|mesh-list
14219678|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219679|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14219680|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
14219681|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219682|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14219683|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14219684|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219685|NCT01370590|Atorvastatin|atorvastatin|mesh-list
14219686|NCT01370590|Ezetimibe|ezetimibe|mesh-list
14219687|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219688|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14219689|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
14219690|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219691|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14219692|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14219693|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219694|NCT01349907|Asenapine|asenapine|mesh-list
14219695|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14219696|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14219697|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947977|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
14219698|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219699|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14219700|NCT01345656|Spironolactone|spironolactone|mesh-list
14219701|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14219702|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219703|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219704|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219705|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14219706|NCT01345656|Diuretics|diuretics|mesh-ancestor
14219707|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
14219708|NCT01277822|Losartan|losartan|mesh-list
14219709|NCT01277822|Amlodipine|amlodipine|mesh-list
14219710|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14219711|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14219712|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14219713|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219714|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14219715|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219716|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
14219717|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14219718|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14219719|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14219720|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14788805|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14788806|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788807|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14788808|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
14788809|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14219721|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14219722|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
14219723|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219724|NCT01261247|Panobinostat|panobinostat|mesh-list
14508389|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14788810|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14788811|NCT00727207|Everolimus|everolimus|mesh-list
14788812|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788813|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788814|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
14788815|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788816|NCT00727233|Sorafenib|sorafenib|mesh-list
14788817|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788818|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14788819|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788820|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788821|NCT00727493|Alendronate|alendronate|mesh-list
14788822|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14788823|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788824|NCT00727545|Chelating Agents|chelating agents|mesh-list
14788825|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
14788826|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788827|NCT00727727|Piribedil|piribedil|mesh-list
14788828|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14788829|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14788830|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
14788831|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
14788832|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788833|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788834|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508390|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
14508391|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508392|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508393|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14508394|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14508395|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
14508396|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508397|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508398|NCT02956044|Metformin|metformin|mesh-list
14508399|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14508400|NCT02956044|Glimepiride|glimepiride|mesh-list
14508401|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
14508402|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14788835|NCT00727753|Bevacizumab|bevacizumab|mesh-list
14788836|NCT00727753|Ranibizumab|ranibizumab|mesh-list
14788837|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14788838|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788839|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14788840|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14788841|NCT00727753|Growth Substances|growth substances|mesh-ancestor
14788842|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788843|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
14947978|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14947979|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14947980|NCT01530542|Oxycodone|oxycodone|mesh-list
14947981|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14947982|NCT01530542|Narcotics|narcotics|mesh-ancestor
14947983|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14947984|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947985|NCT01530542|Analgesics|analgesics|mesh-ancestor
14947986|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
14947987|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14947988|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
14947989|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
14947990|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947991|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14947992|NCT01530594|Lenalidomide|lenalidomide|mesh-list
14947993|NCT01530594|Bortezomib|bortezomib|mesh-list
14947994|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
14947995|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14947996|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14947997|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14947998|NCT01530594|Growth Substances|growth substances|mesh-ancestor
14947999|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14948000|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948001|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
14948002|NCT01530607|Goserelin|goserelin|mesh-list
14948003|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948004|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
14948005|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948006|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948007|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14948008|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
14948009|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948010|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948011|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14948012|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14948013|NCT01530620|Propiverine|propiverine|mesh-list
14948014|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
14948015|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
14948016|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948017|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948018|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14948019|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14948020|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
14948021|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948022|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948023|NCT01530620|Urological Agents|urological agents|mesh-ancestor
14948024|NCT01530698|Vaccines|vaccines|mesh-list
14948025|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
14948026|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948027|NCT01530711|Terlipressin|terlipressin|mesh-list
14948028|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14948029|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14948030|NCT01530737|Antithrombins|antithrombins|mesh-list
14948031|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
14948032|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14948033|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
14948034|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948035|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948036|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
15027087|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027088|NCT01947608|Ceritinib|ceritinib|mesh-list
15027089|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027090|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15027091|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027092|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027093|NCT01947660|Anesthetics|anesthetics|mesh-list
15027094|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027095|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788844|NCT00727766|Clofarabine|clofarabine|mesh-list
14788845|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14788846|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
14788847|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788848|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788849|NCT00727831|Leucovorin|leucovorin|mesh-list
14788850|NCT00727831|Methotrexate|methotrexate|mesh-list
14788851|NCT00727831|Calcium|calcium|mesh-list
14788852|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
14788853|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14788854|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788855|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14788856|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
14788857|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14788858|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14788859|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
14788860|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788861|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788862|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
14508403|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508404|NCT02956044|Incretins|incretins|mesh-ancestor
14788863|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788864|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14788865|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788866|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
14788867|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788868|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14788869|NCT00727831|Antidotes|antidotes|mesh-ancestor
14788870|NCT00727831|Protective Agents|protective agents|mesh-ancestor
14788871|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
14788872|NCT00727831|Vitamins|vitamins|mesh-ancestor
14788873|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
14788874|NCT00727870|Glycerol|glycerol|mesh-list
14788875|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14788876|NCT00727870|Protective Agents|protective agents|mesh-ancestor
14788877|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788878|NCT00727935|Lidocaine|lidocaine|mesh-list
14788879|NCT00727935|Ropivacaine|ropivacaine|mesh-list
14508405|NCT02956044|Hormones|hormones|mesh-ancestor
14508406|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508407|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14508408|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
14508409|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508410|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508411|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14508412|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14508413|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
14508414|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
14508415|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
14508416|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
14508417|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508418|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
14508419|NCT02956057|Protective Agents|protective agents|mesh-ancestor
14508420|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508421|NCT02956057|Vitamins|vitamins|mesh-ancestor
14788880|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
14788881|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
14788882|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788883|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788884|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
14788885|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788886|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14788887|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14788888|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14788889|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788890|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788891|NCT00727948|Aspirin|aspirin|mesh-list
14788892|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14788893|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14788894|NCT00727948|Analgesics|analgesics|mesh-ancestor
14788895|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
14788896|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788897|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788898|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788899|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788900|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14788901|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14788902|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788903|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14788904|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14788905|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788906|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
14788907|NCT00727987|Golimumab|golimumab|mesh-list
14788908|NCT00727987|Methotrexate|methotrexate|mesh-list
14788909|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14788910|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
14788911|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14788912|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788913|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14788914|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
14788915|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788916|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788917|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14788918|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788919|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14788920|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788921|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
14788922|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14788923|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14788924|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14788925|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14788926|NCT00728000|Gemcitabine|gemcitabine|mesh-list
14788927|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
14788928|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14788929|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14788930|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
14788931|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788932|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788933|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
14788934|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788935|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788936|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788937|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
14788938|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788939|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14788940|NCT00728013|Atorvastatin|atorvastatin|mesh-list
14788941|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14788942|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14788943|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
14788944|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788945|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14788946|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14788947|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14788948|NCT00728078|Thalidomide|thalidomide|mesh-list
14788949|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14788950|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
14788951|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788952|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
14788953|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14788954|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14788955|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14788956|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14219725|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14219726|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14219727|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219728|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219729|NCT01208207|Naproxen|naproxen|mesh-list
14219730|NCT01208207|Etoricoxib|etoricoxib|mesh-list
14219731|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219732|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219733|NCT01208207|Analgesics|analgesics|mesh-ancestor
14219734|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
14219735|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219736|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219737|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219738|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219739|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
14788957|NCT00728078|Growth Substances|growth substances|mesh-ancestor
14788958|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
14788959|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14788960|NCT00728156|Clopidogrel|clopidogrel|mesh-list
14788961|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14788962|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14788963|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14788964|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14788965|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
14788966|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788967|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788968|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788969|NCT00728195|Olanzapine|olanzapine|mesh-list
14788970|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
14788971|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
14788972|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
14788973|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14788974|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788975|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14788976|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14788977|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14788978|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788979|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14788980|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14788981|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14788982|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14788983|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14788984|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14788985|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
14788986|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14788987|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14788988|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
14788989|NCT00728273|Micronutrients|micronutrients|mesh-list
14788990|NCT00728273|Trace Elements|trace elements|mesh-list
14788991|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788992|NCT00728312|Aripiprazole|aripiprazole|mesh-list
14788993|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
14788994|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14788995|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14788996|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14788997|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14788998|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14788999|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
14789000|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
14789001|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789002|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789003|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14789004|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14789005|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
14508422|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
14508423|NCT02956057|Cathartics|cathartics|mesh-ancestor
14789006|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14508424|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508425|NCT02956070|Dexamethasone|dexamethasone|mesh-list
14508426|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
14508427|NCT02956070|BB 1101|bb 1101|mesh-list
14508428|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508429|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
14508430|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
14508431|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508432|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508433|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789007|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14789008|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14789009|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14789010|NCT00728520|Azacitidine|azacitidine|mesh-list
14789011|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14789012|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
14789013|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789014|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789015|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789016|NCT00728546|Isoniazid|isoniazid|mesh-list
14789017|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
14789018|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14219740|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219741|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219742|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219743|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219744|NCT01208181|Etoricoxib|etoricoxib|mesh-list
14219745|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14789019|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789020|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14789021|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14789022|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
14789023|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789024|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14789025|NCT00728559|Bupivacaine|bupivacaine|mesh-list
14789026|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
14789027|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
14789028|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14789029|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789030|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
14789031|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789032|NCT00728585|Mitogens|mitogens|mesh-list
14789033|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14789034|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789035|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
14789036|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14789037|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
14789038|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789039|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
14789040|NCT00728611|Protective Agents|protective agents|mesh-ancestor
14789041|NCT00728663|Docetaxel|docetaxel|mesh-list
14789042|NCT00728663|Cetuximab|cetuximab|mesh-list
14789043|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789044|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
14789045|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
14789046|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
14789047|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789048|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14789049|NCT00728715|Budesonide|budesonide|mesh-list
14789050|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
14789051|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789052|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14789053|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
14789054|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789055|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789056|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14789057|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
14789058|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
14789059|NCT00728715|Hormones|hormones|mesh-ancestor
14789060|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789061|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14789062|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14789063|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14789064|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14789065|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789066|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789067|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14789068|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14789069|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14948037|NCT01530763|Amoxicillin|amoxicillin|mesh-list
14948038|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
14948039|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
14948040|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
14948041|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14948042|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14948043|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948044|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948045|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14948046|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948047|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948048|NCT01530815|Bupivacaine|bupivacaine|mesh-list
14948049|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
14948050|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
14948051|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948052|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948053|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
14948054|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948055|NCT01530984|Ipilimumab|ipilimumab|mesh-list
14219746|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219747|NCT01208181|Analgesics|analgesics|mesh-ancestor
14219748|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
14219749|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219750|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219751|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219752|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219753|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219754|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14948056|NCT01530984|Sargramostim|sargramostim|mesh-list
14948057|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948058|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948059|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14948060|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948061|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
14948062|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948063|NCT01531049|Nicotine|nicotine|mesh-list
14948064|NCT01531049|Varenicline|varenicline|mesh-list
14948065|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14948066|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
14948067|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948068|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948069|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14948070|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14948071|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
14948072|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948073|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948074|NCT01531114|Ticagrelor|ticagrelor|mesh-list
14948075|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14948076|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14948077|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14948078|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14948079|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14948080|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
14219755|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219756|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219757|NCT01206517|Asenapine|asenapine|mesh-list
14219758|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14789070|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
14948081|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948082|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948083|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948084|NCT01531140|Bisacodyl|bisacodyl|mesh-list
14948085|NCT01531140|Senna Extract|senna extract|mesh-list
14789071|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789072|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14789073|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14789074|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789075|NCT00728832|Morphine|morphine|mesh-list
14789076|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14789077|NCT00728832|Narcotics|narcotics|mesh-ancestor
14789078|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14789079|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789080|NCT00728832|Analgesics|analgesics|mesh-ancestor
14789081|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
14789082|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789083|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14789084|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
14789085|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789086|NCT00729118|Lenalidomide|lenalidomide|mesh-list
14789087|NCT00729118|Vorinostat|vorinostat|mesh-list
14789088|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
14789089|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789090|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14789091|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14789092|NCT00729118|Growth Substances|growth substances|mesh-ancestor
14219759|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14219760|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219761|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219762|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14219763|NCT01190267|Asenapine|asenapine|mesh-list
14219764|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14219765|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14789093|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
14789094|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789095|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14789096|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789097|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789098|NCT00729131|Etanercept|etanercept|mesh-list
14789099|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14789100|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14789101|NCT00729131|Analgesics|analgesics|mesh-ancestor
14789102|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
14789103|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789104|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789105|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789106|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219766|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219767|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219768|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14219769|NCT01190254|Asenapine|asenapine|mesh-list
14219770|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14219771|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14219772|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219773|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219774|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14219775|NCT01154036|Atorvastatin|atorvastatin|mesh-list
14219776|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14219777|NCT01154036|Ezetimibe|ezetimibe|mesh-list
14219778|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219779|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14219780|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
14219781|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219782|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14219783|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14789107|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789108|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14219784|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219785|NCT01101464|Asenapine|asenapine|mesh-list
14219786|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14219787|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14219788|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219789|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219790|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14219791|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
14219792|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219793|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219794|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219795|NCT01030341|Insulin|insulin|mesh-list
14789109|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
14789110|NCT00729170|Calcium|calcium|mesh-list
14789111|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14219796|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14789112|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789113|NCT00729222|Rolofylline|rolofylline|mesh-list
14789114|NCT00729222|Diuretics|diuretics|mesh-ancestor
14789115|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
14789116|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789117|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14789118|NCT00729287|Selenium|selenium|mesh-list
14789119|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
14789120|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789121|NCT00729287|Protective Agents|protective agents|mesh-ancestor
14789122|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789123|NCT00729287|Trace Elements|trace elements|mesh-ancestor
14789124|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
14789125|NCT00729300|Disulfiram|disulfiram|mesh-list
14789126|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14789127|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14789128|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789129|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789130|NCT00729313|Lanreotide|lanreotide|mesh-list
14789131|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789132|NCT00729339|Mosapride|mosapride|mesh-list
14789133|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789134|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14789135|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
14789136|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789137|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789138|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789139|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14789140|NCT00729404|Gestodene|gestodene|mesh-list
14789141|NCT00729404|Femovan|femovan|mesh-list
14789142|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14789143|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14789144|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14789145|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
14789146|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14789147|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789148|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14789149|NCT00729404|Estrogens|estrogens|mesh-ancestor
14789150|NCT00729404|Hormones|hormones|mesh-ancestor
14789151|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789152|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14789153|NCT00729404|Progestins|progestins|mesh-ancestor
14789154|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14789155|NCT00729495|Celecoxib|celecoxib|mesh-list
14789156|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14789157|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14789158|NCT00729495|Analgesics|analgesics|mesh-ancestor
14789159|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
14789160|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789161|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789162|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789163|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14789164|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14789165|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14789166|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789167|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789168|NCT00729573|Tenofovir|tenofovir|mesh-list
14789169|NCT00729573|Emtricitabine|emtricitabine|mesh-list
14789170|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14789171|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
14789172|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789173|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14789174|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14789175|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219797|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14219798|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219799|NCT00979901|Loratadine|loratadine|mesh-list
14789176|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789177|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14789178|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14789179|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
14789180|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14789181|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948086|NCT01531140|Sennosides|sennosides|mesh-list
14948087|NCT01531140|Cathartics|cathartics|mesh-ancestor
14789182|NCT00729638|Lenalidomide|lenalidomide|mesh-list
14789183|NCT00729638|Everolimus|everolimus|mesh-list
14789184|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
14789185|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789186|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14508434|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
14508435|NCT02956070|Hormones|hormones|mesh-ancestor
14508436|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508437|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508438|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508439|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14508440|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508441|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508442|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
14508443|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14508444|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14508445|NCT02956122|Prednisolone|prednisolone|mesh-list
14508446|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
14508447|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14508448|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
14508449|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
14508450|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14508451|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508452|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
14508453|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
14508454|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508455|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508456|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508457|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
14508458|NCT02956122|Hormones|hormones|mesh-ancestor
14508459|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508460|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14508461|NCT02956122|Protective Agents|protective agents|mesh-ancestor
14508462|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508463|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508464|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508465|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508466|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14508467|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14508468|NCT02956278|Allopurinol|allopurinol|mesh-list
14508469|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
14508470|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508471|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508472|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
14508473|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508474|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14508475|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
14508476|NCT02956278|Protective Agents|protective agents|mesh-ancestor
14508477|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508478|NCT02956616|Ketorolac|ketorolac|mesh-list
14508479|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14508480|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14508481|NCT02956616|Analgesics|analgesics|mesh-ancestor
14508482|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
14508483|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508484|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789187|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14789188|NCT00729638|Growth Substances|growth substances|mesh-ancestor
14789189|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
14789190|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508485|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508486|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508487|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14508488|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508489|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508490|NCT02956629|Ribavirin|ribavirin|mesh-list
14508491|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
14508492|NCT02956629|Ruzasvir|ruzasvir|mesh-list
14508493|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
14508494|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508495|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
14508496|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508497|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
14508498|NCT02956746|Antibodies|antibodies|mesh-list
14508499|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
14508500|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14508501|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14508502|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
14508503|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508504|NCT02956837|Vaccines|vaccines|mesh-list
14508505|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
14508506|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508507|NCT02957305|Misoprostol|misoprostol|mesh-list
14508508|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14508509|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
14508510|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14508511|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508512|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14508513|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508514|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
14508515|NCT02957331|Propranolol|propranolol|mesh-list
14508516|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14508517|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14508518|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
14508519|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508520|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508521|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508522|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14508523|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14508524|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
14508525|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
14508526|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14508527|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
14508528|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508529|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
14508530|NCT02958267|Protective Agents|protective agents|mesh-ancestor
14508531|NCT02958345|Vaccines|vaccines|mesh-list
14508532|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
14508533|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508534|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14508535|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14508536|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14508537|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508538|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508539|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508540|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508541|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14508542|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
14508543|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14789191|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789192|NCT00729664|Atezolizumab|atezolizumab|mesh-list
14789193|NCT00729664|BMS-936559|bms-936559|mesh-list
14789194|NCT00729664|Antibodies|antibodies|mesh-list
14789195|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
14789196|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14789197|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
14789198|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789199|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789200|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14789201|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14789202|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789203|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14508544|NCT02958956|Pioglitazone|pioglitazone|mesh-list
14789204|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789205|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789206|NCT00729768|Cyclosporine|cyclosporine|mesh-list
14789207|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
14789208|NCT00729768|Cyclosporins|cyclosporins|mesh-list
14789209|NCT00729768|Basiliximab|basiliximab|mesh-list
14789210|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789211|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789212|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789213|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
14789214|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789215|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
14789216|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789217|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
14789218|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14789219|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14789220|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14789221|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789222|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14789223|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
14789224|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14789225|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
14789226|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
14789227|NCT00729794|Vasopressins|vasopressins|mesh-list
14789228|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
14789229|NCT00729794|Epinephrine|epinephrine|mesh-list
14789230|NCT00729794|Racepinephrine|racepinephrine|mesh-list
14789231|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
14789232|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789233|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
14789234|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
14789235|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789236|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789237|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789238|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
14789239|NCT00729794|Hormones|hormones|mesh-ancestor
14789240|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789241|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14789242|NCT00729794|Protective Agents|protective agents|mesh-ancestor
14789243|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14789244|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14789245|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
14789246|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789247|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789248|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14789249|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14789250|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14789251|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
14789252|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
14789253|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
14789254|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14789255|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
14789256|NCT00729794|Coagulants|coagulants|mesh-ancestor
14789257|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14219800|NCT00979901|Montelukast|montelukast|mesh-list
14219801|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14219802|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219803|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14219804|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219805|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219806|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219807|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14219808|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14219809|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219810|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
14219811|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219812|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219813|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219814|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219815|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219816|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
14219817|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789258|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
14219848|NCT00963599|Loratadine|loratadine|mesh-list
14219849|NCT00963599|Montelukast|montelukast|mesh-list
14219850|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14219851|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219852|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14219853|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
14219854|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14219855|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219856|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14219857|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14219858|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219859|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
14219860|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219861|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219862|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219863|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219864|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219865|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
14219866|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219867|NCT00953680|Losartan|losartan|mesh-list
14219868|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14219869|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14219870|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14219871|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14219872|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14219873|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219874|NCT00953680|Diuretics|diuretics|mesh-ancestor
14219875|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
14219876|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219877|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14219878|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14219879|NCT00945035|Etoricoxib|etoricoxib|mesh-list
14219880|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219881|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219882|NCT00945035|Analgesics|analgesics|mesh-ancestor
14219883|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
14219884|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219885|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219886|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219887|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219888|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219889|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219890|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219891|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219892|NCT00943852|Losartan|losartan|mesh-list
14219893|NCT00943852|Isosorbide|isosorbide|mesh-list
14219894|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14219895|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14219896|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14219897|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14219898|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14219899|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14219900|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219901|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14219902|NCT00943852|Diuretics|diuretics|mesh-ancestor
14219903|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
14219904|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219905|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
14219906|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14219907|NCT00909389|Simvastatin|simvastatin|mesh-list
14219908|NCT00909389|Ezetimibe|ezetimibe|mesh-list
14219909|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14219910|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14219911|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14219912|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
14219913|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219914|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14219915|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14219916|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219917|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14219918|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
14219919|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14219920|NCT00820027|Ibuprofen|ibuprofen|mesh-list
14219921|NCT00820027|Etoricoxib|etoricoxib|mesh-list
14219922|NCT00820027|Morphine|morphine|mesh-list
14219923|NCT00820027|Oxycodone|oxycodone|mesh-list
14219924|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14219925|NCT00820027|Narcotics|narcotics|mesh-ancestor
14219926|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219927|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219928|NCT00820027|Analgesics|analgesics|mesh-ancestor
14219929|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
14219930|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219931|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219932|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219933|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219934|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219935|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219936|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219937|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219938|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219939|NCT00788710|Etoricoxib|etoricoxib|mesh-list
14219940|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14219941|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14219942|NCT00788710|Analgesics|analgesics|mesh-ancestor
14219943|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
14219944|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219945|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219946|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219947|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14219948|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14219949|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14219950|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14219951|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219952|NCT00783224|Fluticasone|fluticasone|mesh-list
14219953|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
14219954|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14219955|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14219956|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
14219957|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14219958|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219959|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14219960|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
14219961|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
14219962|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219963|NCT00780403|Cetirizine|cetirizine|mesh-list
14219964|NCT00780403|Desloratadine|desloratadine|mesh-list
14219965|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219966|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219967|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14948088|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14948089|NCT01531140|Laxatives|laxatives|mesh-ancestor
14219968|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219969|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
14219970|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219971|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219972|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219973|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14219974|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219975|NCT00779116|Cetirizine|cetirizine|mesh-list
14219976|NCT00779116|Desloratadine|desloratadine|mesh-list
14219977|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14219978|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14219979|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14219980|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
14219981|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
14508545|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14508546|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508547|NCT02958969|Apixaban|apixaban|mesh-list
14508548|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14508549|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
14508550|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14508551|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
14508552|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508553|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508554|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
14528749|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528750|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14528751|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14528752|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
14528753|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528754|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528755|NCT03823378|Upadacitinib|upadacitinib|mesh-list
14528756|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14528757|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14528758|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528759|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528760|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528761|NCT03830281|Insulin|insulin|mesh-list
14528762|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14528763|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
14948090|NCT01531166|Interferons|interferons|mesh-list
14948091|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
14948092|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
14948093|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14948094|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948095|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
14948096|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948097|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
14948098|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948099|NCT01531192|Nystatin|nystatin|mesh-list
14948100|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948101|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948102|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
14948103|NCT01531192|Ionophores|ionophores|mesh-ancestor
14948104|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14948105|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948106|NCT01531218|Azithromycin|azithromycin|mesh-list
14528764|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14528765|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528766|NCT03818815|Amoxicillin|amoxicillin|mesh-list
14528767|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
14528768|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
14528769|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14948107|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948108|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948109|NCT01531244|Dactinomycin|dactinomycin|mesh-list
14219982|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219983|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219984|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219985|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14219986|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219987|NCT00764478|Asenapine|asenapine|mesh-list
14219988|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14219989|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14219990|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14219991|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14219992|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14219993|NCT00761527|Desloratadine|desloratadine|mesh-list
14219994|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14219995|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
14219996|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14219997|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14219998|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508555|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
14508556|NCT02959437|Azacitidine|azacitidine|mesh-list
14508557|NCT02959437|INCB057643|incb057643|mesh-list
14508558|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14508559|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508560|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14508561|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
14508562|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508563|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508564|NCT02959840|Ondansetron|ondansetron|mesh-list
14508565|NCT02959840|Metoclopramide|metoclopramide|mesh-list
14508566|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
14508567|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
14508568|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508569|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508570|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508571|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
14508572|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
14508573|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14508574|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
14508575|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508576|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508577|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14508578|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14508579|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508580|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14508581|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14508582|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14508583|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14508584|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
14508585|NCT02959853|Anastrozole|anastrozole|mesh-list
14508586|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508587|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508588|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14508589|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14508590|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508591|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508592|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14508593|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
14508594|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508595|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508596|NCT02959892|Amphetamine|amphetamine|mesh-list
14508597|NCT02959892|Naxagolide|naxagolide|mesh-list
14508598|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14508599|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508600|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
14508601|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
14508602|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508603|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
14508604|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508605|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508606|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
14508607|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14508608|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14508609|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508610|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14508611|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
14219999|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14220000|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14220001|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
14220002|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
14220003|NCT00757627|Etoricoxib|etoricoxib|mesh-list
14220004|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14220005|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14220006|NCT00757627|Analgesics|analgesics|mesh-ancestor
14220007|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
14220008|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220009|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220010|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220011|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220012|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14220013|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14220014|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220015|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220016|NCT00756938|Losartan|losartan|mesh-list
14220017|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14220018|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14220019|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14220020|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14220021|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220022|NCT00746590|Tretazicar|tretazicar|mesh-list
14220023|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220024|NCT00730132|Ezetimibe|ezetimibe|mesh-list
14220025|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220026|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220027|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
14220028|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220029|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220030|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
14220031|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220032|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220033|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14220034|NCT00723736|Desloratadine|desloratadine|mesh-list
14220035|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14220036|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
14220037|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220038|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220039|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220040|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14220041|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14220042|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
14220043|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
14220044|NCT00705081|Ezetimibe|ezetimibe|mesh-list
14220045|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220046|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220047|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
14220048|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220049|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220050|NCT00704769|Desloratadine|desloratadine|mesh-list
14220051|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14220052|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
14220053|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220054|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220055|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220056|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14220057|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14220058|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
14220059|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
14220060|NCT00704535|Ezetimibe|ezetimibe|mesh-list
14220061|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220062|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220063|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
14220064|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220065|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220066|NCT00694369|Acetaminophen|acetaminophen|mesh-list
14220067|NCT00694369|Ibuprofen|ibuprofen|mesh-list
14220068|NCT00694369|Etoricoxib|etoricoxib|mesh-list
14220069|NCT00694369|Codeine|codeine|mesh-list
14220070|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14220071|NCT00694369|Analgesics|analgesics|mesh-ancestor
14220072|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
14220073|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220074|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220075|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
14220076|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14220077|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220078|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220079|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14220080|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220081|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220082|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14220083|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14220084|NCT00694369|Narcotics|narcotics|mesh-ancestor
14220085|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14220086|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
14220087|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
14220088|NCT00671528|Gentamicins|gentamicins|mesh-list
14220089|NCT00671528|Clotrimazole|clotrimazole|mesh-list
14220090|NCT00671528|Miconazole|miconazole|mesh-list
14220091|NCT00671528|Betamethasone|betamethasone|mesh-list
14220092|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
14220093|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14220094|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
14220095|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14220096|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220097|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
14220098|NCT00671528|Hormones|hormones|mesh-ancestor
14220099|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220100|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220101|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14220102|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
14220103|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14220104|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220105|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14220106|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220107|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220108|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14220109|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
14220110|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14220111|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14220112|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14220113|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
14220114|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14220115|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14220116|NCT00667823|Macitentan|macitentan|mesh-list
14220117|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14220118|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14220119|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220120|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14220121|NCT00652327|Atorvastatin|atorvastatin|mesh-list
14220122|NCT00652327|Simvastatin|simvastatin|mesh-list
14220123|NCT00652327|Ezetimibe|ezetimibe|mesh-list
14220124|NCT00652327|Pravastatin|pravastatin|mesh-list
14220125|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14220126|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220127|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220128|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
14220129|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220130|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220131|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220132|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
14220133|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
14220134|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14220135|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
14220136|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220137|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220138|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14220139|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
14220140|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14220141|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14220142|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14220143|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
14220144|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508612|NCT02959970|Dapsone|dapsone|mesh-list
14948110|NCT01531244|Cactinomycin|cactinomycin|mesh-list
14948111|NCT01531244|Melphalan|melphalan|mesh-list
14220145|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220146|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220147|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220148|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14220149|NCT00568178|Losartan|losartan|mesh-list
14220150|NCT00568178|Amlodipine|amlodipine|mesh-list
14220151|NCT00568178|Enalapril|enalapril|mesh-list
14220152|NCT00568178|Enalaprilat|enalaprilat|mesh-list
14220153|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14220154|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14220155|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14220156|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220157|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14220158|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220159|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
14220160|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14220161|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14220162|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14220163|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220164|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14220165|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
14220166|NCT00549848|Cytarabine|cytarabine|mesh-list
14220167|NCT00549848|Dexamethasone|dexamethasone|mesh-list
14220168|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
14220169|NCT00549848|Prednisone|prednisone|mesh-list
14220170|NCT00549848|Prednisolone|prednisolone|mesh-list
14220171|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
14220172|NCT00549848|Doxorubicin|doxorubicin|mesh-list
14220173|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14220174|NCT00549848|Methotrexate|methotrexate|mesh-list
14220175|NCT00549848|Etoposide|etoposide|mesh-list
14220176|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
14220177|NCT00549848|Vincristine|vincristine|mesh-list
14220178|NCT00549848|Daunorubicin|daunorubicin|mesh-list
14220179|NCT00549848|Asparaginase|asparaginase|mesh-list
14220180|NCT00549848|Dasatinib|dasatinib|mesh-list
14220181|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
14220182|NCT00549848|Clofarabine|clofarabine|mesh-list
14220183|NCT00549848|Pegaspargase|pegaspargase|mesh-list
14220184|NCT00549848|Thioguanine|thioguanine|mesh-list
14220185|NCT00549848|BB 1101|bb 1101|mesh-list
14220186|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220187|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
14220188|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220189|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220190|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220191|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
14220192|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220193|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220194|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220195|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220196|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
14220197|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
14220198|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220199|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14220200|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
14220201|NCT00549848|Hormones|hormones|mesh-ancestor
14220202|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220203|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220204|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
14220205|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220206|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220207|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220208|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220209|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14220210|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
14220211|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14220212|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220213|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
14220214|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220215|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14220216|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14220217|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220218|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
14220219|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220220|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220221|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220222|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220223|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14220224|NCT00545844|Montelukast|montelukast|mesh-list
14220225|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14220226|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
14220227|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14220228|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
14220229|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220230|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220231|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14220232|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14220233|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220234|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
14220235|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14220236|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14220237|NCT00511355|Estradiol|estradiol|mesh-list
14220238|NCT00511355|Estrogens|estrogens|mesh-ancestor
14220239|NCT00511355|Hormones|hormones|mesh-ancestor
14220240|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220241|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220242|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14220243|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
14220244|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14220245|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14220246|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14220247|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14220248|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14220249|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14220250|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
14220251|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220252|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220253|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14220254|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
14220255|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508613|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948112|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14948113|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
14948114|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948115|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948116|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14948117|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948118|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
14948119|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948120|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948121|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948122|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14948123|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14948124|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948125|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14948126|NCT01531309|S 20098|s 20098|mesh-list
14948127|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14948128|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948129|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948130|NCT01531322|Vaccines|vaccines|mesh-list
14948131|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14508614|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
14508615|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14508616|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14508617|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14508618|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508619|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508620|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
14508621|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14508622|NCT02959983|Eluxadoline|eluxadoline|mesh-list
14508623|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508624|NCT02959996|Bupivacaine|bupivacaine|mesh-list
14508625|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508626|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
14508627|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508628|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508629|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
14220256|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220257|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14220258|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
14220259|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220260|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220261|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14220262|NCT00447603|Losartan|losartan|mesh-list
14220263|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14220264|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14220265|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14220266|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14220267|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14220268|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220269|NCT00447603|Diuretics|diuretics|mesh-ancestor
14220270|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
14220271|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220272|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14220273|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14220274|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
14220275|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220276|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220277|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14220278|NCT00423488|Simvastatin|simvastatin|mesh-list
14220279|NCT00423488|Ezetimibe|ezetimibe|mesh-list
14220280|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220281|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220282|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
14220283|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220284|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220285|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14220286|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220287|NCT00413972|Simvastatin|simvastatin|mesh-list
14220288|NCT00413972|Ezetimibe|ezetimibe|mesh-list
14220289|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220290|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220291|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
14220292|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220293|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220294|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14220295|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220296|NCT00391170|Dexamethasone|dexamethasone|mesh-list
14220297|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220298|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
14220299|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
14220300|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220301|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220302|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14220303|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
14220304|NCT00391170|Hormones|hormones|mesh-ancestor
14220305|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220306|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220307|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220308|NCT00359138|Cetirizine|cetirizine|mesh-list
14220309|NCT00359138|Loratadine|loratadine|mesh-list
14220310|NCT00359138|Levocetirizine|levocetirizine|mesh-list
14220311|NCT00359138|Desloratadine|desloratadine|mesh-list
14220312|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14220313|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14220314|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
14220315|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
14220316|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220317|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220318|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220319|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14220320|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14220321|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14220322|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
14220323|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220324|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
14220325|NCT00350701|Testosterone|testosterone|mesh-list
14220326|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
14220327|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
14220328|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14220329|NCT00350701|Androgens|androgens|mesh-ancestor
14220330|NCT00350701|Hormones|hormones|mesh-ancestor
14220331|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220332|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220333|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220334|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220335|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
14220336|NCT00335816|Leucovorin|leucovorin|mesh-list
14220337|NCT00335816|Fluorouracil|fluorouracil|mesh-list
14220338|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
14220339|NCT00335816|Calcium|calcium|mesh-list
14220340|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
14220341|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14220342|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220343|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
14220344|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220345|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220346|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220347|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220348|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
14220349|NCT00335816|Antidotes|antidotes|mesh-ancestor
14220350|NCT00335816|Protective Agents|protective agents|mesh-ancestor
14220351|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
14220352|NCT00335816|Vitamins|vitamins|mesh-ancestor
14220353|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
14220354|NCT00319449|Atorvastatin|atorvastatin|mesh-list
14220355|NCT00319449|Ezetimibe|ezetimibe|mesh-list
14220356|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220357|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220358|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
14220359|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220360|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220361|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14220362|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220363|NCT00305344|Vaccines|vaccines|mesh-list
14220364|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
14220365|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220366|NCT00289887|Losartan|losartan|mesh-list
14220367|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14220368|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14220369|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14220370|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14220371|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220372|NCT00281320|Asenapine|asenapine|mesh-list
14220373|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14220374|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14220375|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14220376|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508630|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508631|NCT02960438|Quetmolimab|quetmolimab|mesh-list
14508632|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508633|NCT02960490|Quetmolimab|quetmolimab|mesh-list
14508634|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508635|NCT02960854|Nivolumab|nivolumab|mesh-list
14220377|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14220378|NCT00276016|Phenylephrine|phenylephrine|mesh-list
14508636|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14220379|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
14220380|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
14220381|NCT00276016|Ephedrine|ephedrine|mesh-list
14220382|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14220383|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
14220384|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
14220385|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220386|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220387|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
14220388|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14220389|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
14220390|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14220391|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14220392|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14220393|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14220394|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
14220395|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220396|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220397|NCT00276016|Protective Agents|protective agents|mesh-ancestor
14220398|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14220399|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14220400|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14242418|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
14242419|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242420|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14242421|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242422|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242423|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242424|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
14242425|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242426|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242427|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14242428|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14242429|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242430|NCT00186498|Memantine|memantine|mesh-list
14242431|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14242432|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14242433|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
14242434|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242435|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242436|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242437|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14242438|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14242439|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
14242440|NCT00186537|Fenofibrate|fenofibrate|mesh-list
14242441|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14242442|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242443|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14242444|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
14242445|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242446|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14242447|NCT00186628|Acetaminophen|acetaminophen|mesh-list
13965102|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13965103|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
13965104|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13965105|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
13965106|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
13965107|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13965108|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
13965109|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965110|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965111|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13965112|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
13965113|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965114|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965115|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13965116|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13965117|NCT03132272|Autoantibodies|autoantibodies|mesh-list
13965118|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
13965119|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965120|NCT03132493|Nivolumab|nivolumab|mesh-list
13965121|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13965122|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220401|NCT00265343|Olanzapine|olanzapine|mesh-list
14220402|NCT00265343|Asenapine|asenapine|mesh-list
14220403|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
14220404|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
14220405|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220406|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220407|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14220408|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14220409|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14220410|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14220411|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14220412|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14220413|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14220414|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14220415|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220416|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220417|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
14220418|NCT00264147|Diclofenac|diclofenac|mesh-list
14220419|NCT00264147|Etoricoxib|etoricoxib|mesh-list
14220420|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14220421|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14220422|NCT00264147|Analgesics|analgesics|mesh-ancestor
14220423|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
14220424|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220425|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220426|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220427|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220428|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14220429|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220430|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220431|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14220432|NCT00202878|Simvastatin|simvastatin|mesh-list
14220433|NCT00202878|Ezetimibe|ezetimibe|mesh-list
14220434|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14220435|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220436|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220437|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
14220438|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220439|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220440|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14220441|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220442|NCT00174265|Olanzapine|olanzapine|mesh-list
14220443|NCT00174265|Asenapine|asenapine|mesh-list
14220444|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
14220445|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
14220446|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220447|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220448|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14220449|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14220450|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14220451|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14220452|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14220453|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14220454|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14220455|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14220456|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220457|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220458|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
14220459|NCT00159783|Olanzapine|olanzapine|mesh-list
14220460|NCT00159783|Asenapine|asenapine|mesh-list
14220461|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
14220462|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
14220463|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220464|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220465|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14220466|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14220467|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14220468|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14220469|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14220470|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14220471|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14220472|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14220473|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220474|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220475|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
14220476|NCT00114101|Lenalidomide|lenalidomide|mesh-list
14220477|NCT00114101|Melphalan|melphalan|mesh-list
14220478|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
14220479|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14220480|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
14220481|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220482|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14220483|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14948132|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
14948133|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948134|NCT01531361|Sorafenib|sorafenib|mesh-list
14948135|NCT01531361|Vemurafenib|vemurafenib|mesh-list
14948136|NCT01531361|Crizotinib|crizotinib|mesh-list
14948137|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948138|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14220484|NCT00114101|Growth Substances|growth substances|mesh-ancestor
14220485|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
14220486|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220487|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220488|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
14220489|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220490|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220491|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220492|NCT00092677|Simvastatin|simvastatin|mesh-list
14220493|NCT00092677|Ezetimibe|ezetimibe|mesh-list
14220494|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14220495|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14220496|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
14220497|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220498|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14220499|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14220500|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220501|NCT00090259|Losartan|losartan|mesh-list
14220502|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14220503|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14220504|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14220505|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14220506|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220507|NCT00003298|Leucovorin|leucovorin|mesh-list
14220508|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14220509|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
14220510|NCT00003298|Paclitaxel|paclitaxel|mesh-list
14220511|NCT00003298|Cisplatin|cisplatin|mesh-list
14220512|NCT00003298|Fluorouracil|fluorouracil|mesh-list
14220513|NCT00003298|Calcium|calcium|mesh-list
14220514|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
14220515|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220516|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948139|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948140|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948141|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
14948142|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948143|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
14220517|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220518|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220519|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220520|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220521|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14220522|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220523|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
14220524|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220525|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220526|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
14220527|NCT00003298|Antidotes|antidotes|mesh-ancestor
14220528|NCT00003298|Protective Agents|protective agents|mesh-ancestor
14220529|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
14220530|NCT00003298|Vitamins|vitamins|mesh-ancestor
14220531|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
14220532|NCT00003377|Paclitaxel|paclitaxel|mesh-list
14220533|NCT00003377|Cisplatin|cisplatin|mesh-list
14220534|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220535|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220536|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220537|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220538|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14948144|NCT01531517|Propolis|propolis|mesh-list
14948145|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
14220539|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220540|NCT00003389|Prednisone|prednisone|mesh-list
14220541|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
14220542|NCT00003389|Dacarbazine|dacarbazine|mesh-list
14220543|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
14220544|NCT00003389|Doxorubicin|doxorubicin|mesh-list
14220545|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14220546|NCT00003389|Etoposide|etoposide|mesh-list
14220547|NCT00003389|Vincristine|vincristine|mesh-list
14508637|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508638|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14508639|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508640|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14508641|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508642|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14508643|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508644|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508645|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
14508646|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14508647|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508648|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14508649|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14508650|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508651|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508652|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508653|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14508654|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14508655|NCT02961764|Dalbavancin|dalbavancin|mesh-list
14508656|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14508657|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508658|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
14508659|NCT02961790|Oxybutynin|oxybutynin|mesh-list
14508660|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
14508661|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
14508662|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508663|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508664|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14508665|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14508666|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
14508667|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508668|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508669|NCT02961790|Urological Agents|urological agents|mesh-ancestor
14508670|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14508671|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508672|NCT02961790|Renal Agents|renal agents|mesh-ancestor
14508673|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
14508674|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
14508675|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
14508676|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14508677|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14508678|NCT02962284|Prednisolone|prednisolone|mesh-list
14508679|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
14508680|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
14508681|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14508682|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
14508683|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508684|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
14220548|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
14789259|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
14789260|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
14789261|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14789262|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14789263|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789264|NCT00729911|Amiodarone|amiodarone|mesh-list
14789265|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14789266|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
13965123|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14220549|NCT00003389|Bleomycin|bleomycin|mesh-list
14220550|NCT00003389|Vinblastine|vinblastine|mesh-list
14220551|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
14220552|NCT00003389|Imidazole|imidazole|mesh-list
14220553|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220554|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
14220555|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220556|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220557|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220558|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
14220559|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220560|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965124|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965125|NCT03132519|Remifentanil|remifentanil|mesh-list
13965126|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13965127|NCT03132519|Narcotics|narcotics|mesh-ancestor
13965128|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965129|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965130|NCT03132519|Analgesics|analgesics|mesh-ancestor
13965131|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
13965132|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965133|NCT03132233|Calcium|calcium|mesh-list
13965134|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13965135|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965136|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
13965137|NCT03132142|Capsaicin|capsaicin|mesh-list
13965138|NCT03132142|Menthol|menthol|mesh-list
14220561|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220562|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220563|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220564|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220565|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220566|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220567|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
14508685|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
14508686|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508687|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508688|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508689|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
14508690|NCT02962284|Hormones|hormones|mesh-ancestor
14508691|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508692|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14508693|NCT02962284|Protective Agents|protective agents|mesh-ancestor
14508694|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508695|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508696|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14508697|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508698|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508699|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
14508700|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14508701|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14508702|NCT02962648|Hematinics|hematinics|mesh-ancestor
14508703|NCT02962739|Tenofovir|tenofovir|mesh-list
14508704|NCT02962739|Emtricitabine|emtricitabine|mesh-list
14508705|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
14508706|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508707|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14508708|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14508709|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508710|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508711|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14508712|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14508713|NCT02963701|Ibuprofen|ibuprofen|mesh-list
14508714|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
14508715|NCT02963701|Ephedrine|ephedrine|mesh-list
14220568|NCT00003389|Hormones|hormones|mesh-ancestor
14508716|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14220569|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220570|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220571|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220572|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220573|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
14789267|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14789268|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14789269|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220574|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220575|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
14220576|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220577|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
14220578|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220579|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
14220580|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220581|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220582|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14220583|NCT00003631|Cytarabine|cytarabine|mesh-list
14220584|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
14220585|NCT00003631|Melphalan|melphalan|mesh-list
14220586|NCT00003631|Ifosfamide|ifosfamide|mesh-list
14220587|NCT00003631|Carmustine|carmustine|mesh-list
14220588|NCT00003631|Carboplatin|carboplatin|mesh-list
14220589|NCT00003631|Etoposide|etoposide|mesh-list
14220590|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220591|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
14220592|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220593|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220594|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220595|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
14220596|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220597|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220598|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220599|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220600|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220601|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220602|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220603|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220604|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
14220605|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
14220606|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220607|NCT00003641|Interferons|interferons|mesh-list
14220608|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
14220609|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
14220610|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220611|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
14220612|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220613|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
14220614|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220615|NCT00003644|Paclitaxel|paclitaxel|mesh-list
14220616|NCT00003644|Carboplatin|carboplatin|mesh-list
14220617|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220618|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220619|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220620|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220621|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220622|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220623|NCT00003645|Leuprolide|leuprolide|mesh-list
14220624|NCT00003645|Goserelin|goserelin|mesh-list
14220625|NCT00003645|Flutamide|flutamide|mesh-list
14220626|NCT00003645|Bicalutamide|bicalutamide|mesh-list
14220627|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14220628|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
14220629|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14220630|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220631|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220632|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220633|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
14220634|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
14220635|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220636|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
14220637|NCT00003659|Rituximab|rituximab|mesh-list
14220638|NCT00003659|Fludarabine|fludarabine|mesh-list
14789270|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14220639|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
14220640|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220641|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
14220642|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220643|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220644|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220645|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
14220646|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220647|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220648|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220649|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14220650|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220651|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
14220652|NCT00003702|Dactinomycin|dactinomycin|mesh-list
14220653|NCT00003702|Cactinomycin|cactinomycin|mesh-list
14220654|NCT00003702|Methotrexate|methotrexate|mesh-list
14220655|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14220656|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
14220657|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14220658|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220659|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220660|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
14220661|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220662|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220663|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220664|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220665|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14220666|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220667|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
14220668|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220669|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14220670|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14220671|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220672|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220673|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14220674|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
14220675|NCT00003782|Docetaxel|docetaxel|mesh-list
14220676|NCT00003782|Doxorubicin|doxorubicin|mesh-list
14220677|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220678|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
14220679|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220680|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220681|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220682|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
14220683|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220684|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220685|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220686|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220687|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220688|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220689|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220690|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220691|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220692|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220693|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
14220694|NCT00003816|Melphalan|melphalan|mesh-list
14220695|NCT00003816|Busulfan|busulfan|mesh-list
14220696|NCT00003816|Thiotepa|thiotepa|mesh-list
14220697|NCT00003816|Carboplatin|carboplatin|mesh-list
14220698|NCT00003816|Fludarabine|fludarabine|mesh-list
14220699|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
14220700|NCT00003816|Etoposide|etoposide|mesh-list
14220701|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14220702|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220703|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
14220704|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220705|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220706|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220707|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
14220708|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220709|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220710|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220711|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220712|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
14220713|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220714|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220715|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220716|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220717|NCT00003820|Rituximab|rituximab|mesh-list
14220718|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14220719|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220720|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
14220721|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220722|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220723|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
14220724|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220725|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14220726|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14220727|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220728|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14220729|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220730|NCT00003875|Aldesleukin|aldesleukin|mesh-list
14220731|NCT00003875|Etoposide|etoposide|mesh-list
14220732|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
14220733|NCT00003875|Busulfan|busulfan|mesh-list
14220734|NCT00003875|Interleukin-2|interleukin-2|mesh-list
14220735|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220736|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220737|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220738|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220739|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220740|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220741|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
14220742|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220743|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
14220744|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220745|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220746|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220747|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14220748|NCT00003875|Analgesics|analgesics|mesh-ancestor
14220749|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
14220750|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220751|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14220752|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14220753|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
14220754|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220755|NCT00003896|Paclitaxel|paclitaxel|mesh-list
14220756|NCT00003896|Doxorubicin|doxorubicin|mesh-list
14220757|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14220758|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220759|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220760|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220761|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220762|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220763|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220764|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220765|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220766|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220767|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220768|NCT00003907|Cisplatin|cisplatin|mesh-list
14220769|NCT00003907|Doxorubicin|doxorubicin|mesh-list
14220770|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14220771|NCT00003907|Mitomycins|mitomycins|mesh-list
14220772|NCT00003907|Mitomycin|mitomycin|mesh-list
14220773|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220774|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220775|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220776|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220777|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220778|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508717|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14508718|NCT02963701|Analgesics|analgesics|mesh-ancestor
14508719|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
14508720|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508721|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508722|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508723|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508724|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14508725|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508726|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508727|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14508728|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
14508729|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14508730|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
14508731|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
14508732|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14508733|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14508734|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
14508735|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
14508736|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508737|NCT02963922|Liraglutide|liraglutide|mesh-list
14508738|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14508739|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508740|NCT02963922|Incretins|incretins|mesh-ancestor
14508741|NCT02963922|Hormones|hormones|mesh-ancestor
14508742|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508743|NCT02963935|Liraglutide|liraglutide|mesh-list
14508744|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14508745|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508746|NCT02963935|Incretins|incretins|mesh-ancestor
14508747|NCT02963935|Hormones|hormones|mesh-ancestor
14508748|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948146|NCT01531517|Vitamins|vitamins|mesh-ancestor
14948147|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
14948148|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948149|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948150|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
14948151|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
14948152|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14948153|NCT01531569|Estrogens|estrogens|mesh-ancestor
14948154|NCT01531569|Hormones|hormones|mesh-ancestor
14948155|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948156|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948157|NCT01531582|Minocycline|minocycline|mesh-list
14948158|NCT01531582|Tetracycline|tetracycline|mesh-list
15027096|NCT01947699|Glyburide|glyburide|mesh-list
14220779|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
14220780|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14220781|NCT00003910|Prednisone|prednisone|mesh-list
14220782|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
14789271|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14789272|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14789273|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789274|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14789275|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14789276|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14789277|NCT00729950|Ipilimumab|ipilimumab|mesh-list
14789278|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14789279|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789280|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14948159|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14220783|NCT00003910|Methotrexate|methotrexate|mesh-list
14220784|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220785|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
14220786|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220787|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220788|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220789|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
14220790|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220791|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220792|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220793|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220794|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
14220795|NCT00003910|Hormones|hormones|mesh-ancestor
14220796|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220797|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220798|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14220799|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
14220800|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14220801|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220802|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
14220803|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220804|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220805|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14220806|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14220807|NCT00004031|Prednisone|prednisone|mesh-list
14220808|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
14220809|NCT00004031|Carmustine|carmustine|mesh-list
14220810|NCT00004031|Rituximab|rituximab|mesh-list
14220811|NCT00004031|Doxorubicin|doxorubicin|mesh-list
14220812|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14220813|NCT00004031|Etoposide|etoposide|mesh-list
14220814|NCT00004031|Vincristine|vincristine|mesh-list
14220815|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220816|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
14220817|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220818|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220819|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220820|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
14220821|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220822|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220823|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220824|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14220825|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220826|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220827|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220828|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220829|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220830|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
14220831|NCT00004031|Hormones|hormones|mesh-ancestor
14220832|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220833|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220834|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220835|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220836|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220837|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220838|NCT00004054|Paclitaxel|paclitaxel|mesh-list
14220839|NCT00004054|Etoposide|etoposide|mesh-list
14220840|NCT00004054|Bicalutamide|bicalutamide|mesh-list
14220841|NCT00004054|Flutamide|flutamide|mesh-list
14220842|NCT00004054|Estramustine|estramustine|mesh-list
14220843|NCT00004054|Warfarin|warfarin|mesh-list
14220844|NCT00004054|Hormones|hormones|mesh-list
14220845|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14220846|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220847|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220848|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220849|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220850|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220851|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220852|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220853|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220854|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220855|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220856|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220857|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
14220858|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
14220859|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
14220860|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220861|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220862|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
14220863|NCT00004088|Pamidronate|pamidronate|mesh-list
14220864|NCT00004088|Interferons|interferons|mesh-list
14220865|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
14220866|NCT00004088|Thalidomide|thalidomide|mesh-list
14220867|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
14220868|NCT00004088|Melphalan|melphalan|mesh-list
14220869|NCT00004088|Busulfan|busulfan|mesh-list
14220870|NCT00004088|Lenograstim|lenograstim|mesh-list
14220871|NCT00004088|Sargramostim|sargramostim|mesh-list
14789281|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789282|NCT00729963|Sibutramine|sibutramine|mesh-list
14789283|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
14789284|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14789285|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
14789286|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14789287|NCT00729976|Ibuprofen|ibuprofen|mesh-list
14789288|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14789289|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14789290|NCT00729976|Analgesics|analgesics|mesh-ancestor
14789291|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
14789292|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789293|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789294|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789295|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14789296|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14789297|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789298|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789299|NCT00730054|Clonidine|clonidine|mesh-list
14789300|NCT00730054|Remifentanil|remifentanil|mesh-list
14789301|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14789302|NCT00730054|Narcotics|narcotics|mesh-ancestor
15027097|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14220872|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220873|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
14220874|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220875|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220876|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220877|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
14220878|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220879|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220880|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220881|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
14220882|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220883|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14220884|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
14220885|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14220886|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14220887|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14220888|NCT00004088|Growth Substances|growth substances|mesh-ancestor
14220889|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
14220890|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14220891|NCT00004092|Paclitaxel|paclitaxel|mesh-list
14220892|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
14220893|NCT00004092|Carboplatin|carboplatin|mesh-list
14220894|NCT00004092|Doxorubicin|doxorubicin|mesh-list
14220895|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14220896|NCT00004092|Thiotepa|thiotepa|mesh-list
14220897|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220898|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220899|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220900|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220901|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220902|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220903|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220904|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
14220905|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220906|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220907|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220908|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
14948160|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948161|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14948162|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508749|NCT02964247|Liraglutide|liraglutide|mesh-list
14508750|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14508751|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508752|NCT02964247|Incretins|incretins|mesh-ancestor
14508753|NCT02964247|Hormones|hormones|mesh-ancestor
14508754|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508755|NCT02964416|Tramadol|tramadol|mesh-list
14508756|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14508757|NCT02964416|Narcotics|narcotics|mesh-ancestor
14508758|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508759|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508760|NCT02964416|Analgesics|analgesics|mesh-ancestor
14508761|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
14508762|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789303|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508763|NCT02965378|Docetaxel|docetaxel|mesh-list
14508764|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789304|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789305|NCT00730054|Analgesics|analgesics|mesh-ancestor
14789306|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
14789307|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789308|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14789309|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
14789310|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
14789311|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14789312|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14789313|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14789314|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
14789315|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14220909|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220910|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220911|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220912|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220913|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220914|NCT00004124|Prednisone|prednisone|mesh-list
14220915|NCT00004124|Goserelin|goserelin|mesh-list
14220916|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
14220917|NCT00004124|Bicalutamide|bicalutamide|mesh-list
14220918|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220919|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
14220920|NCT00004124|Hormones|hormones|mesh-ancestor
14220921|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220922|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220923|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220924|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220925|NCT00004124|Analgesics|analgesics|mesh-ancestor
14220926|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
14220927|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220928|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220929|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220930|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220931|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220932|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
14220933|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14220934|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
14220935|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14220936|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220937|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
14220938|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220939|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14220940|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14220941|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220942|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14220943|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220944|NCT00004228|Leucovorin|leucovorin|mesh-list
14220945|NCT00004228|Cytarabine|cytarabine|mesh-list
14220946|NCT00004228|Dexamethasone|dexamethasone|mesh-list
14220947|NCT00004228|Prednisone|prednisone|mesh-list
14220948|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
14220949|NCT00004228|Doxorubicin|doxorubicin|mesh-list
14220950|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14220951|NCT00004228|Methotrexate|methotrexate|mesh-list
14220952|NCT00004228|Vincristine|vincristine|mesh-list
14220953|NCT00004228|Daunorubicin|daunorubicin|mesh-list
14220954|NCT00004228|Asparaginase|asparaginase|mesh-list
14220955|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
14220956|NCT00004228|Thioguanine|thioguanine|mesh-list
14220957|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
14220958|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14220959|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
14220960|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14220961|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14220962|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14220963|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
14220964|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14220965|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14220966|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14220967|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14220968|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
14220969|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
14220970|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14220971|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14220972|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
14220973|NCT00004228|Hormones|hormones|mesh-ancestor
14220974|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14220975|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14220976|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14220977|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14220978|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14220979|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14220980|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14220981|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
14220982|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14220983|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14220984|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
14220985|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
14220986|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14220987|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14220988|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
14220989|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14220990|NCT00004228|Antidotes|antidotes|mesh-ancestor
14220991|NCT00004228|Protective Agents|protective agents|mesh-ancestor
14220992|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
14220993|NCT00004228|Vitamins|vitamins|mesh-ancestor
14220994|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
14220995|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14220996|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
14220997|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
14220998|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
14220999|NCT00004259|Carmustine|carmustine|mesh-list
14221000|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14221001|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
14221002|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221003|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221004|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
14221005|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221006|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14221007|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
14221008|NCT00004547|Paclitaxel|paclitaxel|mesh-list
14221009|NCT00004547|Cisplatin|cisplatin|mesh-list
14221010|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221011|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221012|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221013|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221014|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221015|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221016|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14221017|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14221018|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14221019|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14221020|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
14221021|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14221022|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221023|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221024|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221025|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
14221026|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
14221027|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221028|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
14221029|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221030|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221031|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14221032|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
14221033|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221034|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221035|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14221036|NCT00004635|Thalidomide|thalidomide|mesh-list
14221037|NCT00004635|Leuprolide|leuprolide|mesh-list
14221038|NCT00004635|Goserelin|goserelin|mesh-list
14221039|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221040|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
14221041|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221042|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
14221043|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14221044|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221045|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14221046|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14221047|NCT00004635|Growth Substances|growth substances|mesh-ancestor
14221048|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
14221049|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221050|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14221051|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
14221052|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14221053|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14221054|NCT00004859|Thalidomide|thalidomide|mesh-list
14221055|NCT00004859|Paclitaxel|paclitaxel|mesh-list
14221056|NCT00004859|Carboplatin|carboplatin|mesh-list
14221057|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221058|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221059|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221060|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221061|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221062|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221063|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221064|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
14221065|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221066|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
14221067|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14221068|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221069|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14221070|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14221071|NCT00004859|Growth Substances|growth substances|mesh-ancestor
14221072|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
14221073|NCT00004888|Docetaxel|docetaxel|mesh-list
14221074|NCT00004888|Doxorubicin|doxorubicin|mesh-list
14221075|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14221076|NCT00004888|Trastuzumab|trastuzumab|mesh-list
14221077|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221078|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221079|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221080|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221081|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221082|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14221083|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221084|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221085|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221086|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14221087|NCT00004978|Aldesleukin|aldesleukin|mesh-list
14221088|NCT00004978|Interleukin-2|interleukin-2|mesh-list
14221089|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221090|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14221091|NCT00004978|Analgesics|analgesics|mesh-ancestor
14221092|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
14221093|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221094|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221095|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14221096|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14221097|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
14221098|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221099|NCT00005044|Bicalutamide|bicalutamide|mesh-list
14221100|NCT00005044|Flutamide|flutamide|mesh-list
14508765|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
14508766|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
14508767|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
14508768|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508769|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
14508770|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14508771|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
14508772|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508773|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
14508774|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14508775|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
14508776|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508777|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14508778|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
14508779|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14508780|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14508781|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508782|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
14508783|NCT02965924|Phenylephrine|phenylephrine|mesh-list
14508784|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
14508785|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14508786|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
14508787|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
14508788|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508789|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508790|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
14508791|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14508792|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
14508793|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
14508794|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14508795|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14508796|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14508797|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
14508798|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508799|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221101|NCT00005044|Hormones|hormones|mesh-list
14221102|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14221103|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221104|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221105|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
14221106|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
14221107|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221108|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14221109|NCT00005047|Doxorubicin|doxorubicin|mesh-list
14221110|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14221111|NCT00005047|Methotrexate|methotrexate|mesh-list
14221112|NCT00005047|Vinblastine|vinblastine|mesh-list
14221113|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221114|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14221115|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221116|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221117|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221118|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221119|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14221120|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
14221121|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14221122|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221123|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14221124|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
14221125|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
14221126|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14221127|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221128|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
14221129|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221130|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14221131|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221132|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221133|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221134|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221135|NCT00005669|Metformin|metformin|mesh-list
14221136|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14221137|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221138|NCT00005803|Cytarabine|cytarabine|mesh-list
14221139|NCT00005803|Cyclosporine|cyclosporine|mesh-list
14221140|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
14221141|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
14221142|NCT00005803|Melphalan|melphalan|mesh-list
14221143|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
14221144|NCT00005803|Carmustine|carmustine|mesh-list
14221145|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14221146|NCT00005803|Fludarabine|fludarabine|mesh-list
14221147|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
14221148|NCT00005803|Etoposide|etoposide|mesh-list
14221149|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
14221150|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
14221151|NCT00005803|Cyclosporins|cyclosporins|mesh-list
14221152|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221153|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
14221154|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221155|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221156|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14221157|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
14221158|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221159|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221160|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14221161|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14221162|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
14221163|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221164|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221165|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221166|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221167|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
14221168|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221169|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
14221170|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
14221171|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14221172|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14221173|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14221174|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
14221175|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14221176|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
14221177|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221178|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221179|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221180|NCT00005901|Pamidronate|pamidronate|mesh-list
14221181|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14221182|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221183|NCT00005906|Octreotide|octreotide|mesh-list
14221184|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221185|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14221186|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221187|NCT00005908|Tamoxifen|tamoxifen|mesh-list
14221188|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
14221189|NCT00005908|Docetaxel|docetaxel|mesh-list
14221190|NCT00005908|Doxorubicin|doxorubicin|mesh-list
14221191|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14221192|NCT00005908|Capecitabine|capecitabine|mesh-list
14221193|NCT00005908|Anastrozole|anastrozole|mesh-list
14221194|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221195|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
14221196|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221197|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221198|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14221199|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
14221200|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221201|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221202|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14221203|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221204|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221205|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221206|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14221207|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221208|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221209|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221210|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14221211|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
14221212|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14221213|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
14221214|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221215|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14221216|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14221217|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14221218|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14221219|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14221220|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14221221|NCT00005937|Cyclosporine|cyclosporine|mesh-list
14221222|NCT00005937|Cyclosporins|cyclosporins|mesh-list
14221223|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14221224|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221225|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221226|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221227|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
14221228|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221229|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
14221230|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221231|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14221232|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221233|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14221234|NCT00006011|Paclitaxel|paclitaxel|mesh-list
14221235|NCT00006011|Doxorubicin|doxorubicin|mesh-list
14221236|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14221237|NCT00006011|Lenograstim|lenograstim|mesh-list
14221238|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14508800|NCT02965924|Protective Agents|protective agents|mesh-ancestor
14508801|NCT02966002|Aspirin|aspirin|mesh-list
14508802|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14508803|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14508804|NCT02966002|Analgesics|analgesics|mesh-ancestor
14508805|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
14508806|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508807|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508808|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14508809|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508810|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14508811|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14508812|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221239|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221240|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221241|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14508813|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14221242|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221243|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221244|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14221245|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221246|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221247|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221248|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14221249|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
14221250|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221251|NCT00006046|Antibodies|antibodies|mesh-list
14221252|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14221253|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
14221254|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221255|NCT00006099|Antibodies|antibodies|mesh-list
14221256|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14221257|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
14221258|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221259|NCT00006101|Eflornithine|eflornithine|mesh-list
14221260|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221261|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14221262|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14221263|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14221264|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221265|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14221266|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221267|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221268|NCT00006110|Paclitaxel|paclitaxel|mesh-list
14221269|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
14221270|NCT00006110|Doxorubicin|doxorubicin|mesh-list
14221271|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14221272|NCT00006110|Trastuzumab|trastuzumab|mesh-list
14221273|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221274|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221275|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221276|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221277|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221278|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221279|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221280|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
14221281|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221282|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221283|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14221284|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
14221285|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14221286|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14221287|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221288|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221289|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221290|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14221291|NCT00006164|Ribavirin|ribavirin|mesh-list
14221292|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14221293|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
14221294|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
14221295|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221296|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
14221297|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221298|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
14221299|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221300|NCT00006170|Bupropion|bupropion|mesh-list
14221301|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14221302|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
14221303|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14221304|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14221305|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14221306|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14221307|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221308|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
14221309|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221310|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221311|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14221312|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14221313|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242448|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
14242449|NCT00186628|Promethazine|promethazine|mesh-list
14242450|NCT00186628|Cyclosporine|cyclosporine|mesh-list
14221314|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14221315|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
14221316|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221317|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
14221318|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14221319|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14221320|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221321|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14221322|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14221323|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
14221324|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14221325|NCT05347641|Cytarabine|cytarabine|mesh-list
14221326|NCT05347641|Methotrexate|methotrexate|mesh-list
14221327|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221328|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
14221329|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221330|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221331|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14221332|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
14221333|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14221334|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14221335|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
14221336|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221337|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14221338|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221339|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14221340|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221341|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14221342|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
14221343|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221344|NCT05347498|Febuxostat|febuxostat|mesh-list
14221345|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
14221346|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221347|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
14221348|NCT05347485|Fludarabine|fludarabine|mesh-list
14221349|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221350|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
14508814|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14508815|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508816|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
14508817|NCT02966275|Glucagon|glucagon|mesh-list
14508818|NCT02966275|Pancrelipase|pancrelipase|mesh-list
14508819|NCT02966275|Pancreatin|pancreatin|mesh-list
14508820|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14508821|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508822|NCT02966275|Hormones|hormones|mesh-ancestor
14508823|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508824|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508825|NCT02966275|Incretins|incretins|mesh-ancestor
14508826|NCT02966314|Omalizumab|omalizumab|mesh-list
14508827|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14508828|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14508829|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
14508830|NCT02966340|Prazosin|prazosin|mesh-list
14508831|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14508832|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14508833|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14508834|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14508835|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
14508836|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508837|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508838|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508839|NCT02967354|Tryptophan|tryptophan|mesh-list
14508840|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
14508841|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14508842|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
14508843|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14508844|NCT02967679|Biotin|biotin|mesh-list
14508845|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
14508846|NCT02967679|Vitamins|vitamins|mesh-ancestor
14508847|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
14221351|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221352|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14508848|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221353|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14221354|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
14221355|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221356|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221357|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14221358|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14221359|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
14221360|NCT05347459|Empagliflozin|empagliflozin|mesh-list
14221361|NCT05347459|Linagliptin|linagliptin|mesh-list
14221362|NCT05347459|Vildagliptin|vildagliptin|mesh-list
14221363|NCT05347459|Saxagliptin|saxagliptin|mesh-list
14221364|NCT05347459|Canagliflozin|canagliflozin|mesh-list
14221365|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14221366|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221367|NCT05347459|Incretins|incretins|mesh-ancestor
14221368|NCT05347459|Hormones|hormones|mesh-ancestor
14221369|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221370|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14221371|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
14221372|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221373|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221374|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14221375|NCT05347381|Dexamethasone|dexamethasone|mesh-list
14221376|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14221377|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
14221378|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
14221379|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221380|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221381|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221382|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
14221383|NCT05347381|Hormones|hormones|mesh-ancestor
14221384|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221385|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14221386|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221387|NCT05347316|Colchicine|colchicine|mesh-list
14221388|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
14221389|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221390|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221391|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221392|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221393|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221394|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221395|NCT05347238|Dopamine|dopamine|mesh-list
14221396|NCT05347238|Norepinephrine|norepinephrine|mesh-list
14221397|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14221398|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14221399|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
14221400|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221401|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221402|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221403|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
14221404|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
14221405|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221406|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14221407|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14221408|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
14221409|NCT05347238|Protective Agents|protective agents|mesh-ancestor
14221410|NCT05347212|Nivolumab|nivolumab|mesh-list
14221411|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14221412|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221413|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14221414|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221415|NCT05347199|Amisulpride|amisulpride|mesh-list
14221416|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14789316|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965139|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
13965140|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
13965141|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
13965142|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965143|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965144|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13965145|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965146|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
13965147|NCT03132142|Protective Agents|protective agents|mesh-ancestor
13965148|NCT03132194|Dapsone|dapsone|mesh-list
14221417|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14221418|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221419|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221420|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14221421|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14221422|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
14221423|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221424|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221425|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14221426|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
14221427|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
14221428|NCT05347173|Nalbuphine|nalbuphine|mesh-list
14221429|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14221430|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221431|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221432|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14221433|NCT05347173|Analgesics|analgesics|mesh-ancestor
14221434|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
14221435|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221436|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14221437|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14221438|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14221439|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
14221440|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221441|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221442|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14221443|NCT05347173|Narcotics|narcotics|mesh-ancestor
14221444|NCT05347160|Calcium|calcium|mesh-list
14221445|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14221446|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221447|NCT05347134|Gemcitabine|gemcitabine|mesh-list
14221448|NCT05347134|Capecitabine|capecitabine|mesh-list
14221449|NCT05347134|Vinorelbine|vinorelbine|mesh-list
14221450|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14221451|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
14221452|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221453|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221454|NCT05347134|Antiviral Agents|antiviral agents|mesh-ancestor
14221455|NCT05347134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221456|NCT05347134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221457|NCT05347134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221458|NCT05347134|Immunologic Factors|immunologic factors|mesh-ancestor
14221459|NCT05347134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221460|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221461|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221462|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221463|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221464|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
14221465|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14221466|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221467|NCT05347082|Vitamins|vitamins|mesh-ancestor
14221468|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
14221469|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14221470|NCT05347069|Aspirin|aspirin|mesh-list
14221471|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14221472|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14221473|NCT05347069|Analgesics|analgesics|mesh-ancestor
14221474|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
14221475|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221476|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221477|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14221478|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221479|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14221480|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14221481|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221482|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14221483|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14221484|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221485|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
14221486|NCT05347004|BI 425809|bi 425809|mesh-list
14221487|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
14221488|NCT05346952|Carboplatin|carboplatin|mesh-list
14221489|NCT05346952|Pemetrexed|pemetrexed|mesh-list
14221490|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221491|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221492|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221493|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14221494|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14221495|NCT05346926|Calpastatin|calpastatin|mesh-list
14221496|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14221497|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
14221498|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221499|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221500|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
14221501|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221502|NCT05346861|Trastuzumab|trastuzumab|mesh-list
14221503|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14221504|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221505|NCT05346731|Dexamethasone|dexamethasone|mesh-list
14221506|NCT05346731|Ondansetron|ondansetron|mesh-list
14221507|NCT05346731|Olanzapine|olanzapine|mesh-list
14221508|NCT05346731|Aprepitant|aprepitant|mesh-list
14221509|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14221510|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
14221511|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
14221512|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221513|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221514|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221515|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
14221516|NCT05346731|Hormones|hormones|mesh-ancestor
14221517|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221518|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14221519|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221520|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
14221521|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
14221522|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14221523|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
14221524|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221525|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221526|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14221527|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14221528|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221529|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14221530|NCT05346731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14221531|NCT05346731|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14221532|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14221533|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14221534|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14221535|NCT05346666|Midazolam|midazolam|mesh-list
14221536|NCT05346666|Phenobarbital|phenobarbital|mesh-list
14221537|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14221538|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14221539|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221540|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221541|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14221542|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14221543|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14221544|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14221545|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
14221546|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
14221547|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
14221548|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
14221549|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789317|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
14789318|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
14789319|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14789320|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14789321|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789322|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789323|NCT00730067|Urological Agents|urological agents|mesh-ancestor
14789324|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
14221550|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221551|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
14221552|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14789325|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
14789326|NCT00730093|Vitamins|vitamins|mesh-ancestor
14221553|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14221554|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14221555|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14221556|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14221557|NCT05346601|Chiauranib|chiauranib|mesh-list
14221558|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221559|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14221560|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221561|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221562|NCT05346588|Propofol|propofol|mesh-list
14221563|NCT05346588|Anesthetics|anesthetics|mesh-list
14221564|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14221565|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221566|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221567|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14221568|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
14221569|NCT05346562|Cannabidiol|cannabidiol|mesh-list
14221570|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
14221571|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
14221572|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14221573|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221574|NCT05346445|Fluoxetine|fluoxetine|mesh-list
14221575|NCT05346445|Citalopram|citalopram|mesh-list
14221576|NCT05346445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14508849|NCT02968134|Posaconazole|posaconazole|mesh-list
14508850|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
14508851|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508852|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14508853|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14508854|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14508855|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14508856|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14508857|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508858|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508859|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14508860|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
14508861|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508862|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508863|NCT02968173|Palivizumab|palivizumab|mesh-list
14508864|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
14508865|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508866|NCT02968368|Ferric maltol|ferric maltol|mesh-list
14508867|NCT02968368|Hematinics|hematinics|mesh-ancestor
14508868|NCT02968576|Tenofovir|tenofovir|mesh-list
14508869|NCT02968576|Emtricitabine|emtricitabine|mesh-list
14789327|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
14789328|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508870|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14508871|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
14508872|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14508873|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14508874|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14508875|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508876|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508877|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14508878|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14508879|NCT02968914|Benralizumab|benralizumab|mesh-list
14508880|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14508881|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
14528770|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14221577|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14221578|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14221579|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221580|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221581|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
14221582|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221583|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14221584|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
14221585|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14221586|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14221587|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14221588|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221589|NCT05346419|Vitamin D|vitamin d|mesh-list
14508882|NCT02969018|PF-06700841|pf-06700841|mesh-list
14508883|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14508884|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14508885|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508886|NCT02969187|Bupivacaine|bupivacaine|mesh-list
14508887|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
14508888|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
14508889|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508890|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508891|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
14508892|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508893|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
14508894|NCT02969317|Olodaterol|olodaterol|mesh-list
14508895|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14508896|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
14508897|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508898|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508899|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14508900|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
14508901|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
14508902|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14508903|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
14508904|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508905|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508906|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
14508907|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14508908|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14508909|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14508910|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508911|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508912|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
14508913|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508914|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508915|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14508916|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508917|NCT02969408|Albuterol|albuterol|mesh-list
14508918|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14508919|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
14508920|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508921|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508922|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14508923|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
14508924|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
14508925|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14508926|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14508927|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14508928|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14508929|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
14508930|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508931|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508932|NCT02969590|Leuprolide|leuprolide|mesh-list
14508933|NCT02969590|Norethindrone|norethindrone|mesh-list
14508934|NCT02969590|Estradiol|estradiol|mesh-list
14508935|NCT02969590|Estrogens|estrogens|mesh-list
14508936|NCT02969590|Progesterone|progesterone|mesh-list
14508937|NCT02969590|Progestins|progestins|mesh-list
14508938|NCT02969590|Hormones|hormones|mesh-ancestor
14508939|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14508940|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508941|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14508942|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
14508943|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14221590|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
14221591|NCT05346419|Vitamins|vitamins|mesh-ancestor
14221592|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
14221593|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221594|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14221595|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14221596|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14221597|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221598|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14221599|NCT05346393|Terlipressin|terlipressin|mesh-list
14221600|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14221601|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14221602|NCT05346354|Ravulizumab|ravulizumab|mesh-list
14221603|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14221604|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221605|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
14221606|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221607|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14221608|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
14221609|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221610|NCT05346224|Pertuzumab|pertuzumab|mesh-list
14221611|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14221612|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221613|NCT05346211|Curcumin|curcumin|mesh-list
14221614|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14221615|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14221616|NCT05346211|Analgesics|analgesics|mesh-ancestor
14221617|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
14221618|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221619|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221620|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14221621|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221622|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221623|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221624|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221625|NCT05346159|Androgens|androgens|mesh-list
14221626|NCT05346159|Hormones|hormones|mesh-ancestor
14221627|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221628|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221629|NCT05346146|Gemcitabine|gemcitabine|mesh-list
14221630|NCT05346146|Paclitaxel|paclitaxel|mesh-list
14221631|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221632|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221633|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221634|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221635|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221636|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221637|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14221638|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
14221639|NCT05346146|Antiviral Agents|antiviral agents|mesh-ancestor
14221640|NCT05346146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221641|NCT05346146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221642|NCT05346146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221643|NCT05346146|Immunologic Factors|immunologic factors|mesh-ancestor
14221644|NCT05346146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221645|NCT05346107|Paclitaxel|paclitaxel|mesh-list
14221646|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
14221647|NCT05346107|Doxorubicin|doxorubicin|mesh-list
14221648|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14221649|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14221650|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221651|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
14221652|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
14221653|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
14221654|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221655|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221656|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
14221657|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221658|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221659|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14221660|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
14221661|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14221662|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14221663|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221664|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221665|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221666|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
14221667|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14221668|NCT05345990|Antibodies|antibodies|mesh-list
14221669|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
14221670|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221671|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
14221672|NCT05345938|Analgesics|analgesics|mesh-ancestor
14221673|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
14221674|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221675|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221676|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221677|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221678|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221679|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221680|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221681|NCT05345899|Ascorbic Acid|ascorbic acid|mesh-list
14221682|NCT05345899|Vitamins|vitamins|mesh-ancestor
14221683|NCT05345899|Micronutrients|micronutrients|mesh-ancestor
14221684|NCT05345899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221685|NCT05345899|Antioxidants|antioxidants|mesh-ancestor
14221686|NCT05345899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221687|NCT05345899|Protective Agents|protective agents|mesh-ancestor
14221688|NCT05345808|Triamcinolone|triamcinolone|mesh-list
14221689|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14221690|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14221691|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14221692|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14221693|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
14221694|NCT05345808|Hormones|hormones|mesh-ancestor
14221695|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221696|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221697|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221698|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
14221699|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221700|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221701|NCT05345782|Bupivacaine|bupivacaine|mesh-list
14221702|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
14221703|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
14221704|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221705|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221706|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
14221707|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221708|NCT05345717|Abatacept|abatacept|mesh-list
14221709|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14221710|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14221711|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221712|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221713|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14221714|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
14221715|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221716|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221717|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
14221718|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221719|NCT05345691|Denosumab|denosumab|mesh-list
14221720|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14221721|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221722|NCT05345678|Durvalumab|durvalumab|mesh-list
14221723|NCT05345678|Tremelimumab|tremelimumab|mesh-list
14221724|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14221725|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221726|NCT05345639|Ropivacaine|ropivacaine|mesh-list
14221727|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
14221728|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221729|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221730|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
14221731|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
14221732|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221733|NCT05345613|Epinephrine|epinephrine|mesh-list
14221734|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
14221735|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14221736|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14789329|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
14221737|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
14221738|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221739|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221740|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221741|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14221742|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14221743|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
14221744|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221745|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14221746|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
14221747|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
14221748|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
14221749|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14221750|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14221751|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14221752|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
14221753|NCT05345613|Coagulants|coagulants|mesh-ancestor
14221754|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
14221755|NCT05345574|Remifentanil|remifentanil|mesh-list
14221756|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14221757|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221758|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221759|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14221760|NCT05345574|Analgesics|analgesics|mesh-ancestor
14221761|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
14221762|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221763|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14221764|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14221765|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14221766|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
14221767|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221768|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221769|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14508944|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14508945|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14508946|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
14508947|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14508948|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508949|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14508950|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14508951|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14508952|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
14508953|NCT02969655|Glycine|glycine|mesh-list
14508954|NCT02969655|Hematinics|hematinics|mesh-ancestor
14508955|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
14508956|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508957|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508958|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508959|NCT02969863|Pancrelipase|pancrelipase|mesh-list
14508960|NCT02969863|Pancreatin|pancreatin|mesh-list
14508961|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14508962|NCT02969876|Vortioxetine|vortioxetine|mesh-list
14508963|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
14508964|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14508965|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14508966|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14508967|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508968|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508969|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14508970|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14508971|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508972|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508973|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14508974|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
14508975|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14508976|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14508977|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14508978|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14508979|NCT02970032|Heparin|heparin|mesh-list
14508980|NCT02970032|Calcium heparin|calcium heparin|mesh-list
14508981|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
14508982|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14221770|NCT05345574|Narcotics|narcotics|mesh-ancestor
14789330|NCT00730093|Hematinics|hematinics|mesh-ancestor
14789331|NCT00730197|Albuterol|albuterol|mesh-list
14789332|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14789333|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
14789334|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221771|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14221772|NCT05345522|Antibodies|antibodies|mesh-list
14221773|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
14221774|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14221775|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
14221776|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221777|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221778|NCT05345509|Donepezil|donepezil|mesh-list
14221779|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14221780|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221781|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221782|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
14221783|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221784|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221785|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
14221786|NCT05345457|Amoxicillin|amoxicillin|mesh-list
14221787|NCT05345457|Azithromycin|azithromycin|mesh-list
14221788|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14221789|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221790|NCT05343117|Palbociclib|palbociclib|mesh-list
14221791|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221792|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14221793|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221794|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221795|NCT05335109|Xenon|xenon|mesh-list
14221796|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14221797|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
14221798|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
14948163|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948164|NCT01531595|Bevacizumab|bevacizumab|mesh-list
14948165|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
14948166|NCT01531595|Irinotecan|irinotecan|mesh-list
14948167|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948168|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948169|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14948170|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14948171|NCT01531595|Growth Substances|growth substances|mesh-ancestor
14948172|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221799|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221800|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221801|NCT05334433|Anesthetics|anesthetics|mesh-list
14221802|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221803|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221804|NCT05334056|Cocaine|cocaine|mesh-list
14221805|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
14221806|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
14221807|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221808|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221809|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
14789335|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789336|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14789337|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
14789338|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
14789339|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14789340|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14789341|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14789342|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14789343|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
14789344|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789345|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789346|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
14789347|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14789348|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789349|NCT00730223|Efavirenz|efavirenz|mesh-list
14789350|NCT00730223|Nevirapine|nevirapine|mesh-list
14789351|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14789352|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14789353|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789354|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789355|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
14789356|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789357|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14789358|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14789359|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14221810|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221811|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14221812|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14221813|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14221814|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14221815|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221816|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
14221817|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221818|NCT05333549|Istradefylline|istradefylline|mesh-list
14221819|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14221820|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14221821|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14221822|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
14221823|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221824|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221825|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221826|NCT05333458|Atezolizumab|atezolizumab|mesh-list
14221827|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14221828|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221829|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
14221830|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221831|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14221832|NCT05332444|Amoxicillin|amoxicillin|mesh-list
14221833|NCT05332444|Metronidazole|metronidazole|mesh-list
14221834|NCT05332444|Clarithromycin|clarithromycin|mesh-list
14221835|NCT05332444|Levofloxacin|levofloxacin|mesh-list
14221836|NCT05332444|Tetracycline|tetracycline|mesh-list
14221837|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14221838|NCT05332444|Rabeprazole|rabeprazole|mesh-list
14221839|NCT05332444|Bismuth|bismuth|mesh-list
14221840|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14221841|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221842|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
14221843|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14221844|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14221845|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14221846|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221847|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221848|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14221849|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14221850|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14221851|NCT05332444|Renal Agents|renal agents|mesh-ancestor
14221852|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14221853|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14221854|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14221855|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14221856|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14221857|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221858|NCT05332444|Antacids|antacids|mesh-ancestor
14789360|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14789361|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14789362|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14789363|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14789364|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14789365|NCT00730249|Methylphenidate|methylphenidate|mesh-list
14789366|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14789367|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789368|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14789369|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14789370|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14789371|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789372|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
14789373|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242451|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
14789374|NCT00730288|Vaccines|vaccines|mesh-list
14789375|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
14789376|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789377|NCT00730366|Chloroquine|chloroquine|mesh-list
14789378|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
14789379|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
14789380|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14948173|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
14789381|NCT00730366|Amebicides|amebicides|mesh-ancestor
14789382|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14789383|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14221885|NCT05326373|Fluorides|fluorides|mesh-list
14221886|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
14221887|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
14221888|NCT05326373|Protective Agents|protective agents|mesh-ancestor
14221889|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221890|NCT05322954|Psilocybin|psilocybin|mesh-list
14221891|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
14221892|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221893|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14221894|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
14221895|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221896|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221897|NCT05321576|Narcotics|narcotics|mesh-ancestor
14221898|NCT05321576|Analgesics|analgesics|mesh-ancestor
14221899|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
14221900|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221901|NCT05320133|Bismuth|bismuth|mesh-list
14221902|NCT05320133|Antacids|antacids|mesh-ancestor
14221903|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221904|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221905|NCT05315336|Antibodies|antibodies|mesh-list
14221906|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
14221907|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221908|NCT05312255|Propranolol|propranolol|mesh-list
14221909|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14221910|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
14221911|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
14221912|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221913|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221914|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221915|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14221916|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14508983|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14789384|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789385|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
14789386|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14789387|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14789388|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789389|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789390|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14789391|NCT00730366|Renal Agents|renal agents|mesh-ancestor
14789392|NCT00730392|Etanercept|etanercept|mesh-list
14789393|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14789394|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14789395|NCT00730392|Analgesics|analgesics|mesh-ancestor
14789396|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
14789397|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789398|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789399|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789400|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14221917|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
14221918|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14508984|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508985|NCT02970162|Amifampridine|amifampridine|mesh-list
14508986|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14508987|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14508988|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508989|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14508990|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14508991|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14508992|NCT02970292|Pimavanserin|pimavanserin|mesh-list
14508993|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14508994|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14508995|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14789401|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221919|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14221920|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
14221921|NCT05294835|Ketamine|ketamine|mesh-list
14221922|NCT05294835|Analgesics|analgesics|mesh-ancestor
14221923|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
14221924|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14221925|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221926|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14221927|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14221928|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
14221929|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
14221930|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14221931|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14221932|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14221933|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14221934|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221935|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14221936|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
14221937|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14221938|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14221939|NCT05292755|Laxatives|laxatives|mesh-ancestor
14221940|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221941|NCT05290753|Erythromycin|erythromycin|mesh-list
14221942|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14221943|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14221944|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14221945|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14221946|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14221947|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14221948|NCT05288166|Prednisone|prednisone|mesh-list
14221949|NCT05288166|Prednisolone|prednisolone|mesh-list
14221950|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14221951|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
14221952|NCT05288166|Hormones|hormones|mesh-ancestor
14221953|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14221954|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14221955|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14221956|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14508996|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14508997|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14508998|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14508999|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509000|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14509001|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14509002|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
14509003|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509004|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509005|NCT02970305|Pimavanserin|pimavanserin|mesh-list
14509006|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14509007|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14509008|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14509009|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509010|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509011|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509012|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509013|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14509014|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14509015|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
14509016|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509017|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509018|NCT02970552|Progesterone|progesterone|mesh-list
14509019|NCT02970552|Progestins|progestins|mesh-ancestor
14509020|NCT02970552|Hormones|hormones|mesh-ancestor
14509021|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509022|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509023|NCT02970669|Valsartan|valsartan|mesh-list
14509024|NCT02970669|Enalapril|enalapril|mesh-list
14509025|NCT02970669|Enalaprilat|enalaprilat|mesh-list
14509026|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14509027|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14509028|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14509029|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14221995|NCT05277896|Ketamine|ketamine|mesh-list
14221996|NCT05277896|Etomidate|etomidate|mesh-list
14221997|NCT05277896|Analgesics|analgesics|mesh-ancestor
14221998|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
14221999|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14222000|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222001|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14222002|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14222003|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
14222004|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
14222005|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14222006|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14222007|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14222008|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14222009|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222010|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14222020|NCT05254184|Nivolumab|nivolumab|mesh-list
14222021|NCT05254184|Ipilimumab|ipilimumab|mesh-list
14222022|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222023|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222024|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14222025|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222026|NCT05253794|Colchicine|colchicine|mesh-list
14222027|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
14222028|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14222029|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222030|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
14222031|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222032|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222033|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222034|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
14222035|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222036|NCT05221840|Durvalumab|durvalumab|mesh-list
14509030|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509031|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14509032|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
14509033|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509034|NCT02971007|Fluconazole|fluconazole|mesh-list
14789402|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789403|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
14789404|NCT00730418|Doxazosin|doxazosin|mesh-list
14789405|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14789406|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14789407|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14789408|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14789409|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948174|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14948175|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14948176|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948177|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948178|NCT01531647|Ritonavir|ritonavir|mesh-list
14948179|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
14948180|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14948181|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14948182|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
14948183|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948184|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948185|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14948186|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14948187|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
14948188|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948189|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14222037|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222038|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222039|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
14222040|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222041|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789410|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789411|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789412|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789413|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14789414|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789415|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789416|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789417|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14789418|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
14789419|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
14789420|NCT00730509|Vitamins|vitamins|mesh-ancestor
14789421|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
14789422|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789423|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
14789424|NCT00730509|Hematinics|hematinics|mesh-ancestor
14789425|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14789426|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14789427|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14789428|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
14789429|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789430|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789431|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789432|NCT00730535|Urological Agents|urological agents|mesh-ancestor
14789433|NCT00730574|Vitamins|vitamins|mesh-list
14789434|NCT00730574|Folic Acid|folic acid|mesh-list
14789435|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
14789436|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
14222069|NCT05185024|Iron|iron|mesh-list
14789437|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
14789438|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
14948190|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14948191|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14948192|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14948193|NCT01531712|Gemcitabine|gemcitabine|mesh-list
14948194|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
14948195|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14948196|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14948197|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
14948198|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948199|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948200|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
14948201|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948202|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948203|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222070|NCT05185024|Trace Elements|trace elements|mesh-ancestor
14222071|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
14222072|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222073|NCT05171647|Gemcitabine|gemcitabine|mesh-list
14222074|NCT05171647|Rituximab|rituximab|mesh-list
14222075|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
14222076|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222077|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222078|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
14222079|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222080|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14222081|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14222082|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
14222083|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222084|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
14222085|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222086|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222087|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789439|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789440|NCT00730574|Hematinics|hematinics|mesh-ancestor
14789441|NCT00730769|Valganciclovir|valganciclovir|mesh-list
14222091|NCT05169944|Magrolimab|magrolimab|mesh-list
14222092|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222093|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222094|NCT05168865|Letrozole|letrozole|mesh-list
14222095|NCT05168865|Estradiol|estradiol|mesh-list
14222096|NCT05168865|Progesterone|progesterone|mesh-list
14222097|NCT05168865|Estrogens|estrogens|mesh-ancestor
14222098|NCT05168865|Hormones|hormones|mesh-ancestor
14222099|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222100|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222101|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222102|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14222103|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14222104|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222105|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222106|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14222107|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222108|NCT05168865|Progestins|progestins|mesh-ancestor
14222109|NCT05167734|Dextrans|dextrans|mesh-list
14222110|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
14222111|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
14222112|NCT05167734|Hematinics|hematinics|mesh-ancestor
14222113|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
14222114|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
14222115|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
14222116|NCT05163041|Nivolumab|nivolumab|mesh-list
14222117|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222118|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222119|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14222120|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222121|NCT05160363|Piperaquine|piperaquine|mesh-list
14222122|NCT05160363|Pyronaridine|pyronaridine|mesh-list
14222123|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
14222124|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14222125|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14222126|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222127|NCT05158062|Paclitaxel|paclitaxel|mesh-list
14222128|NCT05158062|Docetaxel|docetaxel|mesh-list
14222129|NCT05158062|Bevacizumab|bevacizumab|mesh-list
14222130|NCT05158062|Carboplatin|carboplatin|mesh-list
14222131|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
14222132|NCT05158062|Olaparib|olaparib|mesh-list
14222133|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14222134|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222135|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222136|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14222137|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222138|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222139|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222140|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14222141|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14222142|NCT05158062|Growth Substances|growth substances|mesh-ancestor
14222143|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222144|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
14222145|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14222146|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789442|NCT00730769|Ganciclovir|ganciclovir|mesh-list
14789443|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14789444|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
14789445|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789446|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14789447|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789448|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789449|NCT00730821|Nintedanib|nintedanib|mesh-list
14789450|NCT00730821|Afatinib|afatinib|mesh-list
14789451|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789452|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14789453|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789454|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789455|NCT00730938|Cefuroxime|cefuroxime|mesh-list
14789456|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
14222161|NCT05132582|Trastuzumab|trastuzumab|mesh-list
14222162|NCT05132582|Pertuzumab|pertuzumab|mesh-list
14222163|NCT05132582|Tucatinib|tucatinib|mesh-list
14222164|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222165|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222166|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14222167|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222168|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222169|NCT05125016|Cemiplimab|cemiplimab|mesh-list
14222170|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222171|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222172|NCT05112965|Atezolizumab|atezolizumab|mesh-list
14222173|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222174|NCT05111353|Poly ICLC|poly iclc|mesh-list
14222175|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
14222176|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
14222177|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789457|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14789458|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789459|NCT00730977|Mannitol|mannitol|mesh-list
14789460|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14222182|NCT05098938|Acyclovir|acyclovir|mesh-list
14222183|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
14222184|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222185|NCT05079360|Everolimus|everolimus|mesh-list
14222186|NCT05079360|Exemestane|exemestane|mesh-list
14222187|NCT05079360|Estrogens|estrogens|mesh-list
14222188|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
14222189|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
14222190|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222191|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222192|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
14222193|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222194|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14222195|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14222196|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222197|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222198|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14222199|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222200|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222201|NCT05079360|Hormones|hormones|mesh-ancestor
14789461|NCT00730977|Diuretics|diuretics|mesh-ancestor
14789462|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
14789463|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789464|NCT00731003|Tryptophan|tryptophan|mesh-list
14789465|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
14222207|NCT05078827|Fluorouracil|fluorouracil|mesh-list
14222208|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
14222209|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222210|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14222211|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222212|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222213|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
14222214|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222215|NCT05065411|Everolimus|everolimus|mesh-list
14222216|NCT05065411|Fulvestrant|fulvestrant|mesh-list
14222217|NCT05065411|Exemestane|exemestane|mesh-list
14222218|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222219|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222220|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
14222221|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222222|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222223|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14789466|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14222224|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14222225|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222226|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222227|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14222228|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14222229|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222230|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222231|NCT05051566|Esomeprazole|esomeprazole|mesh-list
14222232|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14222233|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14222234|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14222235|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222236|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789467|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
14789468|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14789469|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
14789470|NCT00731016|Pravastatin|pravastatin|mesh-list
14789471|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14222242|NCT05050084|Leuprolide|leuprolide|mesh-list
14222243|NCT05050084|Goserelin|goserelin|mesh-list
14222244|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14222245|NCT05050084|Flutamide|flutamide|mesh-list
14222246|NCT05050084|Bicalutamide|bicalutamide|mesh-list
14222247|NCT05050084|Tryptophan|tryptophan|mesh-list
14222248|NCT05050084|Buserelin|buserelin|mesh-list
14222249|NCT05050084|Hormones|hormones|mesh-list
14222250|NCT05050084|Relugolix|relugolix|mesh-list
14222251|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222252|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222253|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14222254|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
14222255|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14222256|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222257|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222258|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
14222259|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222260|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
14222261|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14222262|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
14222263|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14222264|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14222265|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
14222266|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14222267|NCT05048797|Carboplatin|carboplatin|mesh-list
14222268|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
14222269|NCT05048797|Trastuzumab|trastuzumab|mesh-list
14222270|NCT05048797|Pemetrexed|pemetrexed|mesh-list
14222271|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222272|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222273|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222274|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222275|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14222276|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14222277|NCT05039619|Acetaminophen|acetaminophen|mesh-list
14222278|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
14222279|NCT05039619|Promethazine|promethazine|mesh-list
14222280|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
14222281|NCT05039619|Prednisone|prednisone|mesh-list
14222282|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
14222283|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
14222284|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14222285|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
14222286|NCT05039619|Hormones|hormones|mesh-ancestor
14222287|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222288|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222289|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222290|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222291|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14222292|NCT05039619|Analgesics|analgesics|mesh-ancestor
14222293|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
14222294|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14222295|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
14222296|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14222297|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14222298|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
14222299|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14222300|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222301|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222302|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222303|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
14222304|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
14222305|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509035|NCT02971007|Amphotericin B|amphotericin b|mesh-list
14509036|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14509037|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
14509038|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509039|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14509040|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14509041|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509042|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509043|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14509044|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
14509045|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509046|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509047|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14509048|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14509049|NCT02971007|Amebicides|amebicides|mesh-ancestor
14509050|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14509051|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14509052|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14509053|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
14509054|NCT02971228|Glucagon|glucagon|mesh-list
14509055|NCT02971228|Pancrelipase|pancrelipase|mesh-list
14509056|NCT02971228|Pancreatin|pancreatin|mesh-list
14509057|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14509058|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509059|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509060|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509061|NCT02971228|Hormones|hormones|mesh-ancestor
14509062|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509063|NCT02971228|Incretins|incretins|mesh-ancestor
14509064|NCT02971605|Psilocybin|psilocybin|mesh-list
14509065|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
14509066|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509067|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509068|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
14509069|NCT02972502|Promethazine|promethazine|mesh-list
14509070|NCT02972502|Haloperidol|haloperidol|mesh-list
14509071|NCT02972502|Metoclopramide|metoclopramide|mesh-list
14509072|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
14509073|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14509074|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14509075|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509076|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509077|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
14509078|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
14509079|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
14509080|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509081|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
14509082|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
14509083|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509084|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14509085|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
14509086|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
14509087|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509088|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509089|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14509090|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
14509091|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
14509092|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14509093|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509094|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509095|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14509096|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
14509097|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14509098|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14509099|NCT02972554|Propranolol|propranolol|mesh-list
14222306|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14222307|NCT05039619|Protective Agents|protective agents|mesh-ancestor
14222308|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222309|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14222310|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14509100|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14222311|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14222312|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
14222313|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
14222314|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14222315|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
14222316|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
14222317|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14222318|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14222319|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
14222320|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
14222321|NCT05038735|Fulvestrant|fulvestrant|mesh-list
14222322|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222323|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222324|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14222325|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14222326|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222327|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222328|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789472|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789473|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14789474|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14789475|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
14789476|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789477|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14789478|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14789479|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789480|NCT00731068|Mitogens|mitogens|mesh-list
14789481|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
14789482|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789483|NCT00731146|Anesthetics|anesthetics|mesh-list
14789484|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14789485|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242452|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
14242453|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14242454|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14242455|NCT00186628|Prednisolone|prednisolone|mesh-list
14242456|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
14242457|NCT00186628|Rituximab|rituximab|mesh-list
14242458|NCT00186628|Granisetron|granisetron|mesh-list
14242459|NCT00186628|Lenograstim|lenograstim|mesh-list
14242460|NCT00186628|Cyclosporins|cyclosporins|mesh-list
14242461|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
14242462|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14242463|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14242464|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
14242465|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14242466|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242467|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
14242468|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242469|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242470|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14242471|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242472|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242473|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242474|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
14242475|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242476|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
14242477|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14242478|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14242479|NCT00186628|Analgesics|analgesics|mesh-ancestor
14242480|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
14242481|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242482|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
14242483|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14242484|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
14242485|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
14242486|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14242487|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
14242488|NCT00186628|Hormones|hormones|mesh-ancestor
14242489|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242490|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14242491|NCT00186628|Protective Agents|protective agents|mesh-ancestor
14242492|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14242493|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14789486|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
14789487|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
14789488|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14789489|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
14789490|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789491|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789492|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14789493|NCT00731224|Rivastigmine|rivastigmine|mesh-list
14789494|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14789495|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789496|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789497|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
14789498|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789499|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789500|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14789501|NCT00731224|Protective Agents|protective agents|mesh-ancestor
14789502|NCT00731276|Irinotecan|irinotecan|mesh-list
14789503|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14789504|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14789505|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789506|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789507|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789508|NCT00731289|Triamcinolone|triamcinolone|mesh-list
14789509|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14789510|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14789511|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
14789512|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14789513|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789514|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
14789515|NCT00731289|Hormones|hormones|mesh-ancestor
14222374|NCT05016310|Vitamin D|vitamin d|mesh-list
14222375|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
14222376|NCT05016310|Vitamins|vitamins|mesh-list
14222377|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
14222378|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222379|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14222380|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14222381|NCT05010122|Decitabine|decitabine|mesh-list
14222382|NCT05010122|Venetoclax|venetoclax|mesh-list
14222383|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14222384|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
14222385|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222386|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222387|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789516|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789517|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789518|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222391|NCT05007392|Febuxostat|febuxostat|mesh-list
14222392|NCT05007392|Dotinurad|dotinurad|mesh-list
14222393|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
14222394|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14222395|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
14222396|NCT05007392|Renal Agents|renal agents|mesh-ancestor
14789519|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
14789520|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789521|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789522|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14789523|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
14789524|NCT00731289|Protective Agents|protective agents|mesh-ancestor
14789525|NCT00731302|Aspirin|aspirin|mesh-list
14789526|NCT00731302|Meloxicam|meloxicam|mesh-list
14789527|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14789528|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14789529|NCT00731302|Analgesics|analgesics|mesh-ancestor
14222408|NCT04980222|Prednisone|prednisone|mesh-list
14222409|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
14222410|NCT04980222|Rituximab|rituximab|mesh-list
14222411|NCT04980222|Doxorubicin|doxorubicin|mesh-list
14222412|NCT04980222|Vincristine|vincristine|mesh-list
14222413|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222414|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
14222415|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222416|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14222417|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14222418|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
14222419|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222420|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789530|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
14222421|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14222422|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222423|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14222424|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14222425|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14222426|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222427|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14222428|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
14222429|NCT04980222|Hormones|hormones|mesh-ancestor
14222430|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222431|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222432|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14222433|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222434|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
14509101|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14509102|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
14509103|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509104|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509105|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509106|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14509107|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14509108|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
14509109|NCT02972632|Vortioxetine|vortioxetine|mesh-list
14509110|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
14509111|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509112|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14509113|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509114|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509115|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509116|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14509117|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14509118|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14509119|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509120|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509121|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
14509122|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14509123|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14509124|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14509125|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14509126|NCT02973048|Bupivacaine|bupivacaine|mesh-list
14509127|NCT02973048|Prilocaine|prilocaine|mesh-list
14509128|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
14509129|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
14509130|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509131|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509132|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
14509133|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509134|NCT02973087|Factor VIII|factor viii|mesh-list
14509135|NCT02973087|Coagulants|coagulants|mesh-ancestor
14509136|NCT02973100|Dulaglutide|dulaglutide|mesh-list
14509137|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509138|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509139|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
14509140|NCT02973477|Glimepiride|glimepiride|mesh-list
14509141|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14509142|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509143|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509144|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509145|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14509146|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14509147|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
14509148|NCT02973503|Grazoprevir|grazoprevir|mesh-list
14509149|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
14509150|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509151|NCT02974010|Cycloserine|cycloserine|mesh-list
14509152|NCT02974010|Ketamine|ketamine|mesh-list
14789531|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789532|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789533|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789534|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14789535|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14948204|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
14222435|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222436|NCT04973605|Dexamethasone|dexamethasone|mesh-list
14222437|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14222438|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
14222439|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
14222440|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14222441|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222442|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14222443|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
14222444|NCT04973605|Hormones|hormones|mesh-ancestor
14222445|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222446|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222447|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222448|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
14222449|NCT04972968|Hormones|hormones|mesh-ancestor
14222450|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222451|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222452|NCT04959266|Itraconazole|itraconazole|mesh-list
14222453|NCT04959266|Rifampin|rifampin|mesh-list
14222454|NCT04959266|Omeprazole|omeprazole|mesh-list
14222455|NCT04959266|Adavosertib|adavosertib|mesh-list
14222456|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14222457|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14222458|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14222459|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222460|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222461|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
14222462|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222463|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14222464|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14222465|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14222466|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222467|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222468|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222469|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14222470|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14222471|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
14222472|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14222473|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
14222474|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14222475|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14222476|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14222477|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14222478|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14222479|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14222480|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14222501|NCT04939272|Venetoclax|venetoclax|mesh-list
14222502|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222503|NCT04935229|Nivolumab|nivolumab|mesh-list
14222504|NCT04935229|Ipilimumab|ipilimumab|mesh-list
14222505|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222506|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222507|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14509153|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14509154|NCT02974010|Analgesics|analgesics|mesh-ancestor
14509155|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
14509156|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509157|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509158|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14509159|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14509160|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
14509161|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
14509162|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509163|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14509164|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14509165|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509166|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509167|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14509168|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509169|NCT02974010|Renal Agents|renal agents|mesh-ancestor
14509170|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14509171|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
14222508|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789536|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14789537|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789538|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14789539|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14789540|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789541|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
14789542|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14789543|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14789544|NCT00731367|Laxatives|laxatives|mesh-ancestor
14789545|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789546|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14789547|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789548|NCT00731393|Vaccines|vaccines|mesh-list
14789549|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
14789550|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948205|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948206|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14948207|NCT01531764|Vinorelbine|vinorelbine|mesh-list
14948208|NCT01531764|Afatinib|afatinib|mesh-list
14948209|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14948210|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948211|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
14948212|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
14948213|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
14948214|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948215|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14948216|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948217|NCT01531777|Apatinib|apatinib|mesh-list
14948218|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948219|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14948220|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948221|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948222|NCT01531790|Carboplatin|carboplatin|mesh-list
14948223|NCT01531790|Pemetrexed|pemetrexed|mesh-list
14948224|NCT01531790|Endostar protein|endostar protein|mesh-list
14948225|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948226|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948227|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948228|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14948229|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14948230|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14948231|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14222551|NCT04925479|Niacinamide|niacinamide|mesh-list
14222552|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
14222553|NCT04925479|Vitamins|vitamins|mesh-ancestor
14222554|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
14222555|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222556|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
14222557|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14222558|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14222559|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222560|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14222561|NCT04916197|Analgesics|analgesics|mesh-ancestor
14222562|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
14222563|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14222564|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14222565|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14222566|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14222567|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
14222568|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14222569|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948232|NCT01531790|Growth Substances|growth substances|mesh-ancestor
14948233|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948234|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
14948235|NCT01531829|Heparin|heparin|mesh-list
14948236|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14948237|NCT01531829|Tinzaparin|tinzaparin|mesh-list
14948238|NCT01531829|Dalteparin|dalteparin|mesh-list
14948239|NCT01531829|Plasminogen|plasminogen|mesh-list
14222578|NCT04912063|Azacitidine|azacitidine|mesh-list
14222579|NCT04912063|Venetoclax|venetoclax|mesh-list
14222580|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14222581|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
14222582|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222583|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222584|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222585|NCT04910568|Dexamethasone|dexamethasone|mesh-list
14222586|NCT04910568|Daratumumab|daratumumab|mesh-list
14222587|NCT04910568|Pomalidomide|pomalidomide|mesh-list
14222588|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14222589|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
14222590|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
14222591|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14222592|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222593|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14222594|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
14222595|NCT04910568|Hormones|hormones|mesh-ancestor
14222596|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222597|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222598|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222599|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
14222600|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14222601|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14222602|NCT04910568|Growth Substances|growth substances|mesh-ancestor
14222603|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
14789551|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14789552|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14789553|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789554|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789555|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
14789556|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789557|NCT00731562|Varenicline|varenicline|mesh-list
14789558|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14789559|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14789560|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
14789561|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789562|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789563|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789564|NCT00731575|Prednisolone|prednisolone|mesh-list
14789565|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14789566|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
14509172|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14509173|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
14509174|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14509175|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509176|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509177|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14509178|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14509179|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14509180|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
14509181|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14509182|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14509183|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
14509184|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14509185|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14509186|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
14509187|NCT02974114|Acetaminophen|acetaminophen|mesh-list
14509188|NCT02974114|Caffeine|caffeine|mesh-list
14509189|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14509190|NCT02974114|Analgesics|analgesics|mesh-ancestor
14509191|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
14509192|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509193|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509194|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
14509195|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14509196|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14509197|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509198|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509199|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14509200|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14509201|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
14509202|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509203|NCT02974868|PF-06700841|pf-06700841|mesh-list
14509204|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14509205|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509206|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509207|NCT02975206|Serlopitant|serlopitant|mesh-list
14509208|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14789567|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14789568|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
14789569|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14789570|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
14789571|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789572|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
14789573|NCT00731575|Hormones|hormones|mesh-ancestor
14789574|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789575|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789576|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14789577|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789578|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
14789579|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
14789580|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789581|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789582|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14789583|NCT00731575|Protective Agents|protective agents|mesh-ancestor
14222637|NCT04862663|Fulvestrant|fulvestrant|mesh-list
14222638|NCT04862663|Palbociclib|palbociclib|mesh-list
14222639|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14789584|NCT00731601|Pantoprazole|pantoprazole|mesh-list
14789585|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14789586|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789587|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14789588|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222640|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222641|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14222642|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14222643|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222644|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222645|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222646|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14222647|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222648|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222649|NCT04853355|Spironolactone|spironolactone|mesh-list
14222650|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14222651|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222652|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222653|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222654|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14222655|NCT04853355|Diuretics|diuretics|mesh-ancestor
14222656|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
14789589|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789590|NCT00731627|Simvastatin|simvastatin|mesh-list
14789591|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14789592|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14789593|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
14789594|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789595|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14789596|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14789597|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789598|NCT00731861|Paclitaxel|paclitaxel|mesh-list
14789599|NCT00731861|Vatalanib|vatalanib|mesh-list
14789600|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14789601|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789602|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
14789603|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
14789604|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
14789605|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789606|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14789607|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789608|NCT00731926|Vitamins|vitamins|mesh-list
14789609|NCT00731926|Ascorbic Acid|ascorbic acid|mesh-list
14789610|NCT00731926|Vitamin E|vitamin e|mesh-list
14789611|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
14789612|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789613|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
14789614|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789615|NCT00731926|Protective Agents|protective agents|mesh-ancestor
14789616|NCT00731952|Bortezomib|bortezomib|mesh-list
14789617|NCT00731952|Vorinostat|vorinostat|mesh-list
14789618|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789619|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14789620|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789621|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789622|NCT00731965|Vaccines|vaccines|mesh-list
14789623|NCT00731965|Immunologic Factors|immunologic factors|mesh-ancestor
14789624|NCT00731965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789625|NCT00732082|Gemcitabine|gemcitabine|mesh-list
14222692|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
14222693|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222694|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222695|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
14222696|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222697|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
14222698|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222699|NCT04822350|Avelumab|avelumab|mesh-list
14222700|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222701|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789626|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14789627|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
14789628|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789629|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789630|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
14789631|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222708|NCT04813991|Ibuprofen|ibuprofen|mesh-list
14222709|NCT04813991|Oxycodone|oxycodone|mesh-list
14222710|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14222711|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14222712|NCT04813991|Analgesics|analgesics|mesh-ancestor
14222713|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
14222714|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14222715|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222716|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14222717|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14222718|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14222719|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222720|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222721|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14222722|NCT04813991|Narcotics|narcotics|mesh-ancestor
14222723|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14789632|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789633|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789634|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
14789635|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789636|NCT00732108|Topiramate|topiramate|mesh-list
14789637|NCT00732108|Lactulose|lactulose|mesh-list
14789638|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
14222735|NCT04797767|Cytarabine|cytarabine|mesh-list
14222736|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14222737|NCT04797767|Venetoclax|venetoclax|mesh-list
14222738|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
14222739|NCT04797767|Cladribine|cladribine|mesh-list
14222740|NCT04797767|Sargramostim|sargramostim|mesh-list
14222741|NCT04797767|Lenograstim|lenograstim|mesh-list
14222742|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14222743|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
14222744|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509209|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509210|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509211|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509212|NCT02975297|Exenatide|exenatide|mesh-list
14509213|NCT02975297|Nicotine|nicotine|mesh-list
14222745|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509214|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14509215|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
14509216|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509217|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509218|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14222746|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
14222747|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222748|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222749|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
14222750|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222751|NCT04797767|Analgesics|analgesics|mesh-ancestor
14222752|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
14222753|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14222754|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14222755|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14222756|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222757|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14222761|NCT04745689|Carboplatin|carboplatin|mesh-list
14222762|NCT04745689|Etoposide|etoposide|mesh-list
14222763|NCT04745689|Durvalumab|durvalumab|mesh-list
14222764|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222765|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14222766|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14222767|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14222768|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222769|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222770|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222771|NCT04740918|Trastuzumab|trastuzumab|mesh-list
14222772|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14222773|NCT04740918|Atezolizumab|atezolizumab|mesh-list
14222774|NCT04740918|Maytansine|maytansine|mesh-list
14222775|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222776|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222777|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14222778|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222779|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
14222780|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222781|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789639|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14789640|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789641|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789642|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14789643|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14789644|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789645|NCT00732121|Incretins|incretins|mesh-ancestor
14789646|NCT00732121|Hormones|hormones|mesh-ancestor
14789647|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789648|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14789649|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
14789650|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789651|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789652|NCT00732147|Pramlintide|pramlintide|mesh-list
14789653|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14789654|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789655|NCT00732186|Ipilimumab|ipilimumab|mesh-list
14222799|NCT04729608|Paclitaxel|paclitaxel|mesh-list
14222800|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14222801|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222802|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222803|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
14222804|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222805|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222806|NCT04721015|Docetaxel|docetaxel|mesh-list
14222807|NCT04721015|Osimertinib|osimertinib|mesh-list
14222808|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222809|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222810|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
14222811|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222812|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222813|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14222814|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222815|NCT04715646|Brivaracetam|brivaracetam|mesh-list
14222816|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
14789656|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14789657|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789658|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14789659|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222822|NCT04697628|Gemcitabine|gemcitabine|mesh-list
14222823|NCT04697628|Irinotecan|irinotecan|mesh-list
14222824|NCT04697628|Pemetrexed|pemetrexed|mesh-list
14222825|NCT04697628|Topotecan|topotecan|mesh-list
14222826|NCT04697628|Vinorelbine|vinorelbine|mesh-list
14222827|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
14222828|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14222829|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
14222830|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222831|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222832|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
14222833|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14222834|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222835|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222836|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
14222837|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222838|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14222839|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14222840|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14222841|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14222842|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14222843|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222844|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
14222845|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222846|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222847|NCT04671667|Cisplatin|cisplatin|mesh-list
14222848|NCT04671667|Carboplatin|carboplatin|mesh-list
14222849|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
14222850|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222851|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222852|NCT04661358|Fenofibrate|fenofibrate|mesh-list
14222853|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14222854|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
14222855|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222856|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14222857|NCT04658784|Cyclopropane|cyclopropane|mesh-list
14222858|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
14222859|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14222860|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789660|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
14789661|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14789662|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14789663|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14789664|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789665|NCT00732290|Fluoxetine|fluoxetine|mesh-list
14789666|NCT00732290|Clopidogrel|clopidogrel|mesh-list
14789667|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14789668|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14789669|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14789670|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14789671|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
14789672|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789673|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789674|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789675|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14789676|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14789677|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14789678|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
14789679|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14789680|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
14789681|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14789682|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14789683|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14789684|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789685|NCT00732407|Losartan|losartan|mesh-list
14789686|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14789687|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14789688|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14789689|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14222886|NCT04619797|Carboplatin|carboplatin|mesh-list
14222887|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
14222888|NCT04619797|Pemetrexed|pemetrexed|mesh-list
14222889|NCT04619797|Atezolizumab|atezolizumab|mesh-list
14222890|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222891|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222892|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222893|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222894|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14222895|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14789690|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789691|NCT00732420|Topotecan|topotecan|mesh-list
14789692|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14789693|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14789694|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222901|NCT04579380|Trastuzumab|trastuzumab|mesh-list
14222902|NCT04579380|Fulvestrant|fulvestrant|mesh-list
14222903|NCT04579380|Tucatinib|tucatinib|mesh-list
14509219|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14509220|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
14509221|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509222|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509223|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509224|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14509225|NCT02975297|Incretins|incretins|mesh-ancestor
14509226|NCT02975297|Hormones|hormones|mesh-ancestor
14509227|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509228|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14509229|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
14509230|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14509231|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
14509232|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509233|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14509234|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
14509235|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14509236|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14509237|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14509238|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14509239|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
14509240|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509241|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509242|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789695|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789696|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789697|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
14789698|NCT00732446|Dexamethasone|dexamethasone|mesh-list
14789699|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
14789700|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14789701|NCT00732446|BB 1101|bb 1101|mesh-list
14789702|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509243|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14509244|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14509245|NCT02976103|Analgesics|analgesics|mesh-list
14509246|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
14509247|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509248|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509249|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
14509250|NCT02977507|Hydroquinone|hydroquinone|mesh-list
14509251|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14509252|NCT02977507|Protective Agents|protective agents|mesh-ancestor
14509253|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789703|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
14222904|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222905|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222906|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222907|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14222908|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14222909|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222910|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222911|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222912|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14222913|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222914|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222915|NCT04572295|Fulvestrant|fulvestrant|mesh-list
14222916|NCT04572295|Exemestane|exemestane|mesh-list
14222917|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222918|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222919|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14222920|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14222921|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
14222922|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222923|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222924|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14222925|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14222926|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222927|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222928|NCT04569032|Prednisone|prednisone|mesh-list
14222929|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
14222930|NCT04569032|Doxorubicin|doxorubicin|mesh-list
14222931|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14222932|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14222933|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
14222934|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14222935|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14222936|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14222937|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
14222938|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222939|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222940|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14222941|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14222942|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14222943|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14222944|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14222945|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14222946|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
14222947|NCT04569032|Hormones|hormones|mesh-ancestor
14222948|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14222949|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14222950|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14789704|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
14789705|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789706|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789707|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789708|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
14789709|NCT00732446|Hormones|hormones|mesh-ancestor
14789710|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789711|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14789712|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789713|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
14789714|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789715|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789716|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14789717|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789718|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14789719|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14789720|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14789721|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
14789722|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14222972|NCT04504669|Durvalumab|durvalumab|mesh-list
14222973|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222974|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222975|NCT04499924|Paclitaxel|paclitaxel|mesh-list
14222976|NCT04499924|Trastuzumab|trastuzumab|mesh-list
14222977|NCT04499924|Ramucirumab|ramucirumab|mesh-list
14222978|NCT04499924|Tucatinib|tucatinib|mesh-list
14222979|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14222980|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222981|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
14222982|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
14222983|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
14222984|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14222985|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14222986|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14222987|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789723|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14789724|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14789725|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14789726|NCT00732485|Fenofibrate|fenofibrate|mesh-list
14789727|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14789728|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
14789729|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789730|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14789731|NCT00732511|Metoprolol|metoprolol|mesh-list
14222997|NCT04472598|Navitoclax|navitoclax|mesh-list
14222998|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14222999|NCT04468815|Esomeprazole|esomeprazole|mesh-list
14223000|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14223001|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14223002|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14223003|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223004|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223005|NCT04449874|Bevacizumab|bevacizumab|mesh-list
14223006|NCT04449874|Cetuximab|cetuximab|mesh-list
14223007|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14223008|NCT04449874|Atezolizumab|atezolizumab|mesh-list
14223009|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223010|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223011|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14223012|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14223013|NCT04449874|Growth Substances|growth substances|mesh-ancestor
14223014|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223015|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
14223016|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14223017|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223018|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789732|NCT00732511|Carvedilol|carvedilol|mesh-list
14789733|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14789734|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14789735|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
14789736|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
14789737|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789738|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789739|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14789740|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14789741|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14789742|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
14789743|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789744|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789745|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
14789746|NCT00732511|Protective Agents|protective agents|mesh-ancestor
14789747|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14789748|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14789749|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14789750|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
14789751|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14789752|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14789753|NCT00732524|Glipizide|glipizide|mesh-list
14789754|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509254|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
14509255|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
14509256|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509257|NCT02978157|Amoxicillin|amoxicillin|mesh-list
14509258|NCT02978157|Levofloxacin|levofloxacin|mesh-list
14509259|NCT02978157|Ofloxacin|ofloxacin|mesh-list
14509260|NCT02978157|Tetracycline|tetracycline|mesh-list
14509261|NCT02978157|Esomeprazole|esomeprazole|mesh-list
14509262|NCT02978157|Bismuth|bismuth|mesh-list
14509263|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14509264|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509265|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14789755|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789756|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
14789757|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14789758|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
14789759|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789760|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789761|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14789762|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
14789763|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14789764|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
14789765|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223064|NCT04435600|Ustekinumab|ustekinumab|mesh-list
14223065|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
14223066|NCT04404283|Rituximab|rituximab|mesh-list
14223067|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14223068|NCT04404283|Lenalidomide|lenalidomide|mesh-list
14223069|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223070|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223071|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
14223072|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223073|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14223074|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14223075|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14223076|NCT04404283|Growth Substances|growth substances|mesh-ancestor
14223077|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
14789766|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789767|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14789768|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
14223086|NCT04373785|Temozolomide|temozolomide|mesh-list
14223087|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14223088|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
14223089|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223090|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789769|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
14789770|NCT00732537|Protective Agents|protective agents|mesh-ancestor
14789771|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14789772|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14789773|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789774|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
14789775|NCT00732576|Vitamin K|vitamin k|mesh-list
14789776|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
14789777|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14789778|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14789779|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789780|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
14789781|NCT00732576|Coagulants|coagulants|mesh-ancestor
14789782|NCT00732576|Vitamins|vitamins|mesh-ancestor
14789783|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
14789784|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789785|NCT00732589|Lidocaine|lidocaine|mesh-list
14789786|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
14789787|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
14789788|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509266|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509267|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14509268|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509269|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509270|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14509271|NCT02978157|Renal Agents|renal agents|mesh-ancestor
14509272|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14509273|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14509274|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509275|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14509276|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14509277|NCT02978157|Antacids|antacids|mesh-ancestor
14509278|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14509279|NCT02978339|Curcumin|curcumin|mesh-list
14509280|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14509281|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14509282|NCT02978339|Analgesics|analgesics|mesh-ancestor
14789789|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789790|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
14789791|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789792|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14789793|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14789794|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14789795|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14223118|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
14223119|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14223120|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
14223121|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14223122|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
14223123|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223124|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223125|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
14223126|NCT04340193|Nivolumab|nivolumab|mesh-list
14223127|NCT04340193|Ipilimumab|ipilimumab|mesh-list
14223128|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223129|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223130|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14223131|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789796|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789797|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14789798|NCT00732693|Norethindrone|norethindrone|mesh-list
14789799|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
14789800|NCT00732693|Estradiol|estradiol|mesh-list
14789801|NCT00732693|Progesterone|progesterone|mesh-list
14789802|NCT00732693|Estrogens|estrogens|mesh-ancestor
14789803|NCT00732693|Hormones|hormones|mesh-ancestor
14789804|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789805|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789806|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14789807|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
14789808|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14789809|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14789810|NCT00732693|Progestins|progestins|mesh-ancestor
14789811|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14789812|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14789813|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14789814|NCT00732745|Docetaxel|docetaxel|mesh-list
14789815|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
14789816|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789817|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
14789818|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
14789819|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
14789820|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789821|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
14789822|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
14789823|NCT00732784|Calcium|calcium|mesh-list
14789824|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14789825|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789826|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789827|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14789828|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789829|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789830|NCT00732784|Antacids|antacids|mesh-ancestor
14789831|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789832|NCT00732810|Capecitabine|capecitabine|mesh-list
14789833|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14789834|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14789835|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
14789836|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223173|NCT04266301|Azacitidine|azacitidine|mesh-list
14223174|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14223175|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
14223176|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223177|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223178|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789837|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789838|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14789839|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789840|NCT00732836|Paclitaxel|paclitaxel|mesh-list
14789841|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14789842|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14789843|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789844|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
14789845|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
14789846|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
14789847|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789848|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
14789849|NCT00732888|Calcium|calcium|mesh-list
14789850|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14789851|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789852|NCT00732888|Antacids|antacids|mesh-ancestor
14789853|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789854|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789855|NCT00732914|Sorafenib|sorafenib|mesh-list
14789856|NCT00732914|Sunitinib|sunitinib|mesh-list
14223199|NCT04221477|Acetaminophen|acetaminophen|mesh-list
14223200|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
14223201|NCT04221477|Promethazine|promethazine|mesh-list
14223202|NCT04221477|Prednisone|prednisone|mesh-list
14223203|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
14223204|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
14223205|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14223206|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
14223207|NCT04221477|Hormones|hormones|mesh-ancestor
14223208|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14223209|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223210|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14223211|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223212|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14223213|NCT04221477|Analgesics|analgesics|mesh-ancestor
14223214|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
14223215|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14223216|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
14223217|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
14223218|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
14223219|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14223220|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14223221|NCT04221477|Protective Agents|protective agents|mesh-ancestor
14223222|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223223|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14223224|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14223225|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14223226|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
14223227|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
14223228|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14223229|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
14223230|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
14223231|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14223232|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223233|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14223234|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
14223235|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
14223236|NCT04218565|Golimumab|golimumab|mesh-list
14223237|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14223238|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14223239|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14223240|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
14223241|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789857|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789858|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14789859|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789860|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789861|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14223247|NCT04216290|Gemcitabine|gemcitabine|mesh-list
14223248|NCT04216290|Cisplatin|cisplatin|mesh-list
14223249|NCT04216290|Fluorouracil|fluorouracil|mesh-list
14223250|NCT04216290|Durvalumab|durvalumab|mesh-list
14223251|NCT04216290|Mitomycins|mitomycins|mesh-list
14223252|NCT04216290|Mitomycin|mitomycin|mesh-list
14223253|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
14223254|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14223255|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
14223256|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223257|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14223258|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
14223259|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223260|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
14223261|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14223262|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223263|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14223264|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
14223265|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223266|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223267|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14223268|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
14223269|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14789862|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14789863|NCT00732914|Growth Substances|growth substances|mesh-ancestor
14789864|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789865|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
14789866|NCT00732927|Aspirin|aspirin|mesh-list
14789867|NCT00732927|Parnaparin|parnaparin|mesh-list
14789868|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14789869|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14789870|NCT00732927|Analgesics|analgesics|mesh-ancestor
14789871|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
14789872|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789873|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789874|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14223283|NCT04197986|Infigratinib|infigratinib|mesh-list
14223284|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223285|NCT04191499|Fulvestrant|fulvestrant|mesh-list
14223286|NCT04191499|Palbociclib|palbociclib|mesh-list
14223287|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14223288|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223289|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14223290|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14223291|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
14223292|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14223293|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223294|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14223295|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223296|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223297|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
14223298|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789875|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14789876|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14789877|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14789878|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789879|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14223304|NCT04161599|Metronidazole|metronidazole|mesh-list
14223305|NCT04161599|Cefuroxime|cefuroxime|mesh-list
14223306|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
14223307|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
14223308|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
14223309|NCT04161599|Citric Acid|citric acid|mesh-list
14223310|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
14223311|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14223312|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14223313|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14223314|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14223315|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
14223316|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14223317|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
14223318|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
14223319|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223320|NCT04161599|Cathartics|cathartics|mesh-ancestor
14223321|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14223322|NCT04161599|Antacids|antacids|mesh-ancestor
14223323|NCT04153760|Aspirin|aspirin|mesh-list
14223324|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14223325|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14223326|NCT04153760|Analgesics|analgesics|mesh-ancestor
14223327|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
14223328|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14223329|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223330|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14223331|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14223332|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14223333|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14223334|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223335|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14223336|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14223337|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223338|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
14223339|NCT04150029|Azacitidine|azacitidine|mesh-list
14223340|NCT04150029|Venetoclax|venetoclax|mesh-list
14223341|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14223342|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
14223343|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223344|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223345|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223346|NCT04148911|Paclitaxel|paclitaxel|mesh-list
14223347|NCT04148911|Atezolizumab|atezolizumab|mesh-list
14223348|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14223349|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223350|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14223351|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
14223352|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
14223353|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789880|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14789881|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789882|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
14789883|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
14789884|NCT00732953|Paclitaxel|paclitaxel|mesh-list
14789885|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14789886|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789887|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14789888|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14789889|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14789890|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789891|NCT00732966|Losartan|losartan|mesh-list
14509283|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
14509284|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509285|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509286|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509287|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14509288|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509289|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509290|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509291|NCT02978417|Naltrexone|naltrexone|mesh-list
14509292|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14509293|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14509294|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509295|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
14509296|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509297|NCT02978508|Permethrin|permethrin|mesh-list
14509298|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509299|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509300|NCT02979197|Celecoxib|celecoxib|mesh-list
14509301|NCT02979197|Amlodipine|amlodipine|mesh-list
14509302|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14509303|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14509304|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14509305|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509306|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14509307|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509308|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
14509309|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14509310|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14509311|NCT02979197|Analgesics|analgesics|mesh-ancestor
14509312|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
14509313|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509314|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509315|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14509316|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14509317|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14509318|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509319|NCT02979301|Tamoxifen|tamoxifen|mesh-list
14509320|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14789892|NCT00732966|Valsartan|valsartan|mesh-list
14789893|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14789894|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14789895|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14789896|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789897|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14789898|NCT00733031|Gemcitabine|gemcitabine|mesh-list
14789899|NCT00733031|Pemetrexed|pemetrexed|mesh-list
14789900|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14789901|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
14789902|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223376|NCT04134936|Lenalidomide|lenalidomide|mesh-list
14223377|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
14223378|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223379|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14223380|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14223381|NCT04134936|Growth Substances|growth substances|mesh-ancestor
14223382|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
14223383|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223384|NCT04110145|Linaclotide|linaclotide|mesh-list
14223385|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14223386|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
14223387|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223388|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14223389|NCT04109391|Trastuzumab|trastuzumab|mesh-list
14223390|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223391|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789903|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789904|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
14789905|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789906|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789907|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14789908|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
14789909|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789910|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14789911|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14789912|NCT00733057|Minocycline|minocycline|mesh-list
14789913|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14789914|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789915|NCT00733083|Dexamethasone|dexamethasone|mesh-list
14789916|NCT00733083|Morphine|morphine|mesh-list
14789917|NCT00733083|Oxycodone|oxycodone|mesh-list
14223408|NCT04100018|Prednisone|prednisone|mesh-list
14223409|NCT04100018|Docetaxel|docetaxel|mesh-list
14509321|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
14509322|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509323|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509324|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14509325|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509326|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14509327|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14509328|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14509329|NCT02979431|Gontivimab|gontivimab|mesh-list
14509330|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
14509331|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509332|NCT02979522|Doxorubicin|doxorubicin|mesh-list
14509333|NCT02979522|Dacarbazine|dacarbazine|mesh-list
14509334|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14509335|NCT02979522|Vinblastine|vinblastine|mesh-list
14509336|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14509337|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509338|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14509339|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14509340|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509341|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509342|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14509343|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
14509344|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14509345|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14509346|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
14509347|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
14509348|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
14509349|NCT02980042|Rituximab|rituximab|mesh-list
14509350|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
14509351|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223410|NCT04100018|Nivolumab|nivolumab|mesh-list
14509352|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223411|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223412|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
14223413|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
14223414|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
14223415|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223416|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14223417|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
14223418|NCT04100018|Hormones|hormones|mesh-ancestor
14223419|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14223420|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223421|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14223422|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223423|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14223424|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
14223425|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223426|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223455|NCT04088305|Vancomycin|vancomycin|mesh-list
14223456|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14223457|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789918|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789919|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
14789920|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
14789921|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789922|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223463|NCT04073784|Gemcitabine|gemcitabine|mesh-list
14223464|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14223465|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
14223466|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223467|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223468|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
14223469|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14223470|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223471|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14223472|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
14223473|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789923|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14789924|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
14789925|NCT00733083|Hormones|hormones|mesh-ancestor
14948240|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14948241|NCT01531829|Nadroparin|nadroparin|mesh-list
14948242|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
14948243|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14948244|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14948245|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948246|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14948247|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948248|NCT01531855|Insulin|insulin|mesh-list
14948249|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
14948250|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
14223492|NCT04036435|BMS-986165|bms-986165|mesh-list
14223493|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14223494|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14223495|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223496|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789926|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789927|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14789928|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14789929|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14789930|NCT00733083|Narcotics|narcotics|mesh-ancestor
14789931|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14789932|NCT00733083|Analgesics|analgesics|mesh-ancestor
14789933|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
14789934|NCT00733148|Insulin|insulin|mesh-list
14789935|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14789936|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789937|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
14789938|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14789939|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789940|NCT00733239|Cycloserine|cycloserine|mesh-list
14223512|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14789941|NCT00733239|Verapamil|verapamil|mesh-list
14789942|NCT00733239|Diltiazem|diltiazem|mesh-list
14789943|NCT00733239|Isradipine|isradipine|mesh-list
14789944|NCT00733239|Nifedipine|nifedipine|mesh-list
14789945|NCT00733239|Gabapentin|gabapentin|mesh-list
14789946|NCT00733239|Naloxone|naloxone|mesh-list
14789947|NCT00733239|Analgesics|analgesics|mesh-ancestor
14789948|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
14789949|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789950|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789951|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
14789952|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14789953|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14789954|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14789955|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14789956|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14789957|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14789958|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789959|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789960|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
14789961|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14789962|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14789963|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14789964|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14789965|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
14789966|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
14789967|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14789968|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14789969|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14789970|NCT00733239|Renal Agents|renal agents|mesh-ancestor
14223543|NCT03975647|Tucatinib|tucatinib|mesh-list
14223544|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223545|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223546|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14223547|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14789971|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14789972|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
14789973|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14789974|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
14789975|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14223553|NCT03970330|Naltrexone|naltrexone|mesh-list
14948251|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14223554|NCT03970330|Norethindrone|norethindrone|mesh-list
14948252|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027098|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027099|NCT01947777|Rifampin|rifampin|mesh-list
15027100|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15027101|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
15027102|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15027103|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027104|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
15027105|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15027106|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027107|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027108|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14223555|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
14223556|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14223557|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14223558|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223559|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
14223560|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14223561|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14223562|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14223563|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14223564|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
14223565|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14223566|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14223567|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14789976|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14789977|NCT00733265|Ticagrelor|ticagrelor|mesh-list
14789978|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14789979|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14789980|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14789981|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14789982|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
14789983|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14789984|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14789985|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789986|NCT00733317|Budesonide|budesonide|mesh-list
14789987|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14789988|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14789989|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
14789990|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14789991|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14789992|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14789993|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
14789994|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
14789995|NCT00733317|Hormones|hormones|mesh-ancestor
14789996|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14789997|NCT00733434|Alprostadil|alprostadil|mesh-list
14789998|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14789999|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
14790000|NCT00733434|Urological Agents|urological agents|mesh-ancestor
14790001|NCT00733473|Budesonide|budesonide|mesh-list
14790002|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790003|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14790004|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
14790005|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509353|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
14509354|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509355|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14509356|NCT02980133|Fluticasone|fluticasone|mesh-list
14509357|NCT02980133|Xhance|xhance|mesh-list
14509358|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14509359|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509360|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14509361|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
14509362|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509363|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509364|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14509365|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
14509366|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
14509367|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14509368|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14509369|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14509370|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14509371|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
14509372|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509373|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790006|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790007|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14790008|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
14790009|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
14790010|NCT00733473|Hormones|hormones|mesh-ancestor
14790011|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948253|NCT01531920|Ethanol|ethanol|mesh-list
14948254|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14948255|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14223630|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
14223631|NCT03935893|Fludarabine|fludarabine|mesh-list
14223632|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14223633|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
14223634|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223635|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14223636|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14223637|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
14223638|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223639|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223640|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14223641|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
14223642|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14223643|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14223644|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223645|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14223646|NCT03933306|Analgesics|analgesics|mesh-ancestor
14223647|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
14223648|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14223649|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14223650|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14223651|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14223652|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14223653|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14223654|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948256|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948257|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948258|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14948259|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509374|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
14509375|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
14509376|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
14509377|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14509378|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
14509379|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14509380|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14509381|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509382|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14509383|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14509384|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509385|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509386|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509387|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509388|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14509389|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
14509390|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
14509391|NCT02980523|Protective Agents|protective agents|mesh-ancestor
14509392|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
14528771|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528772|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14528773|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528774|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528775|NCT03828539|Topiramate|topiramate|mesh-list
14528776|NCT03828539|Erenumab|erenumab|mesh-list
14528777|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14528778|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
14528779|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14528780|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790012|NCT00733525|Fluoxetine|fluoxetine|mesh-list
14790013|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14790014|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14790015|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14790016|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790017|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790018|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
14790019|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790020|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14790021|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
14790022|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790023|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14790024|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14790025|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790026|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
14790027|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14790028|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790029|NCT00733564|Lidocaine|lidocaine|mesh-list
14790030|NCT00733564|Propofol|propofol|mesh-list
14790031|NCT00733564|Sevoflurane|sevoflurane|mesh-list
14790032|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
14790033|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
14790034|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790035|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790036|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
14790037|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790038|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14223686|NCT03898934|Vitamin D|vitamin d|mesh-list
14223687|NCT03898934|Vitamins|vitamins|mesh-ancestor
14223688|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
14223689|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223690|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14223691|NCT03884556|Gemcitabine|gemcitabine|mesh-list
14223692|NCT03884556|Paclitaxel|paclitaxel|mesh-list
14223693|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
14223694|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14223695|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223696|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14948260|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14948261|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948262|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223697|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14223698|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14223699|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223700|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14223701|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
14223702|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
14223703|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14223704|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223705|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14223706|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
14223707|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223708|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14790039|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14790040|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14790041|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14790042|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790043|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14790044|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14790045|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
14790046|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14790047|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14790048|NCT00733616|Docetaxel|docetaxel|mesh-list
14790049|NCT00733616|Capecitabine|capecitabine|mesh-list
14790050|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
14790051|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790052|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790053|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790054|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790055|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790056|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14790057|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
14790058|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14948263|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14790059|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
14790060|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790061|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14790062|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14790063|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790064|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790065|NCT00733720|Naltrexone|naltrexone|mesh-list
14223738|NCT03859869|Pancrelipase|pancrelipase|mesh-list
14223739|NCT03859869|Pancreatin|pancreatin|mesh-list
14223740|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14223741|NCT03851588|Dolutegravir|dolutegravir|mesh-list
14223742|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14223743|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14223744|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223745|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223746|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14223747|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14223748|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
14223749|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790066|NCT00733720|Buprenorphine|buprenorphine|mesh-list
14790067|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14790068|NCT00733720|Naloxone|naloxone|mesh-list
14223753|NCT03836105|Cemiplimab|cemiplimab|mesh-list
14223754|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223755|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790069|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14790070|NCT00733720|Narcotics|narcotics|mesh-ancestor
14790071|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790072|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790073|NCT00733720|Analgesics|analgesics|mesh-ancestor
14790074|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
14790075|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790076|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14790077|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14790078|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
14790079|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14790080|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790081|NCT00733811|Deferiprone|deferiprone|mesh-list
14790082|NCT00733811|Deferoxamine|deferoxamine|mesh-list
14790083|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14790084|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
14790085|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
14790086|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790087|NCT00733811|Siderophores|siderophores|mesh-ancestor
14790088|NCT00733850|Gemcitabine|gemcitabine|mesh-list
14790089|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14790090|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
14790091|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790092|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790093|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
14790094|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790095|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223789|NCT03798639|Nivolumab|nivolumab|mesh-list
14223790|NCT03798639|Ipilimumab|ipilimumab|mesh-list
14223791|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223792|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223793|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14223794|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790096|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790097|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
14790098|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790099|NCT00733889|Docetaxel|docetaxel|mesh-list
14790100|NCT00733889|Fluorouracil|fluorouracil|mesh-list
14790101|NCT00733889|Cetuximab|cetuximab|mesh-list
14790102|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790103|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790104|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790105|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790106|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790107|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
14790108|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14790109|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790110|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
14790111|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790112|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14790113|NCT00733967|Varenicline|varenicline|mesh-list
14790114|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14790115|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14790116|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14790117|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790118|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790119|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790120|NCT00734123|Aspirin|aspirin|mesh-list
14790121|NCT00734123|Rimonabant|rimonabant|mesh-list
14790122|NCT00734123|Enalapril|enalapril|mesh-list
14223821|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
14223822|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14223823|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14223824|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223825|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
14223826|NCT03780894|Coagulants|coagulants|mesh-ancestor
14223827|NCT03775486|Gemcitabine|gemcitabine|mesh-list
14223828|NCT03775486|Paclitaxel|paclitaxel|mesh-list
14223829|NCT03775486|Cisplatin|cisplatin|mesh-list
14223830|NCT03775486|Carboplatin|carboplatin|mesh-list
14223831|NCT03775486|Pemetrexed|pemetrexed|mesh-list
14223832|NCT03775486|Durvalumab|durvalumab|mesh-list
14223833|NCT03775486|Olaparib|olaparib|mesh-list
14223834|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14223835|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14223836|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223837|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
14223838|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
14223839|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
14223840|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223841|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14223842|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
14223843|NCT03775486|Antiviral Agents|antiviral agents|mesh-ancestor
14223844|NCT03775486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14223845|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223846|NCT03775486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14223847|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
14223848|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223849|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14223850|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14223851|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223852|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14223853|NCT03769090|Budesonide|budesonide|mesh-list
14223854|NCT03769090|Albuterol|albuterol|mesh-list
14223855|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14223856|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14223857|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
14223858|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14223859|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223860|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14223861|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
14223862|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
14223863|NCT03769090|Hormones|hormones|mesh-ancestor
14223864|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14223865|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
14223866|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14223867|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14223868|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14223869|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14223870|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
14223871|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14223872|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223873|NCT03763162|Dexamethasone|dexamethasone|mesh-list
14223874|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
14223875|NCT03763162|Bortezomib|bortezomib|mesh-list
14223876|NCT03763162|Daratumumab|daratumumab|mesh-list
14223877|NCT03763162|Ixazomib|ixazomib|mesh-list
14223878|NCT03763162|Ichthammol|ichthammol|mesh-list
14223879|NCT03763162|BB 1101|bb 1101|mesh-list
14223880|NCT03763162|Glycine|glycine|mesh-list
14223881|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509393|NCT02980783|Lidocaine|lidocaine|mesh-list
14509394|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
14509395|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
14509396|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509397|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509398|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
14509399|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509400|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14509401|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14509402|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14509403|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14509404|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509405|NCT02980874|Triamcinolone|triamcinolone|mesh-list
14509406|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14509407|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14509408|NCT02980874|Aflibercept|aflibercept|mesh-list
14509409|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14509410|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509411|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
14509412|NCT02980874|Hormones|hormones|mesh-ancestor
14509413|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509414|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509415|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948264|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
14948265|NCT01532076|Coagulants|coagulants|mesh-ancestor
14948266|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
14948267|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948268|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
14948269|NCT01532115|Opicapone|opicapone|mesh-list
14948270|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948271|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509416|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
14509417|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509418|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509419|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14509420|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14509421|NCT02980874|Growth Substances|growth substances|mesh-ancestor
14509422|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
14509423|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509424|NCT02981342|Gemcitabine|gemcitabine|mesh-list
14948272|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14948273|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14223882|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
14223883|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
14223884|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14223885|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223886|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14223887|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
14223888|NCT03763162|Hormones|hormones|mesh-ancestor
14223889|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14223890|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14223891|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223892|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
14223893|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223894|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223895|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14223896|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
14223897|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14223898|NCT03752216|Niraparib|niraparib|mesh-list
14223899|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14223900|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223901|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223902|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223903|NCT03751124|Norethindrone|norethindrone|mesh-list
14223904|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
14223905|NCT03751124|Estradiol|estradiol|mesh-list
14223906|NCT03751124|Relugolix|relugolix|mesh-list
14223907|NCT03751124|Estrogens|estrogens|mesh-ancestor
14223908|NCT03751124|Hormones|hormones|mesh-ancestor
14223909|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14223910|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14223911|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14223912|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
14223913|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14223914|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14223915|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14223916|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14223917|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14223918|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
14223919|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
14790123|NCT00734123|Clopidogrel|clopidogrel|mesh-list
14790124|NCT00734123|Atorvastatin|atorvastatin|mesh-list
14790125|NCT00734123|Simvastatin|simvastatin|mesh-list
14790126|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14790127|NCT00734123|Diuretics|diuretics|mesh-list
14790128|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14790129|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14790130|NCT00734123|Analgesics|analgesics|mesh-ancestor
14790131|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
14790132|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509425|NCT02981342|Capecitabine|capecitabine|mesh-list
14509426|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14790133|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509427|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
14509428|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509429|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509430|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
14509431|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509432|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509433|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14509434|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
14509435|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509436|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
14509437|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
14509438|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
14509439|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509440|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14509441|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14509442|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14509443|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
14509444|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509445|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509446|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14509447|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14509448|NCT02982590|Warfarin|warfarin|mesh-list
14790134|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509449|NCT02982590|Apixaban|apixaban|mesh-list
14509450|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
14509451|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14790135|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14790136|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14790137|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14790138|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790139|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14790140|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14790141|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790142|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
14790143|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14223940|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14223941|NCT03735095|Trioxsalen|trioxsalen|mesh-list
14223942|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223943|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
14223944|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14790144|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14790145|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
14790146|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14790147|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14790148|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14790149|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14790150|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14790151|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
14223959|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14223960|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14223961|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223962|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14223963|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
14223964|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790152|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790153|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
14790154|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14790155|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
14790156|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14790157|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14790158|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14790159|NCT00734123|Hormones|hormones|mesh-ancestor
14790160|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14790161|NCT00734279|Leuprolide|leuprolide|mesh-list
14790162|NCT00734279|Ganirelix|ganirelix|mesh-list
14223977|NCT03646123|Doxorubicin|doxorubicin|mesh-list
14223978|NCT03646123|Nivolumab|nivolumab|mesh-list
14223979|NCT03646123|Dacarbazine|dacarbazine|mesh-list
14223980|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14223981|NCT03646123|Vinblastine|vinblastine|mesh-list
14223982|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14223983|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14223984|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14223985|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14223986|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14223987|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14223988|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14223989|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14223990|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14223991|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
14223992|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14223993|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
14223994|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
14223995|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
14223996|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
14223997|NCT03629483|Ropivacaine|ropivacaine|mesh-list
14223998|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14223999|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14224000|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224001|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14224002|NCT03629483|Analgesics|analgesics|mesh-ancestor
14224003|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
14224004|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224005|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14224006|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14224007|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14224008|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
14224009|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509452|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
14509453|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14509454|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14509455|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509456|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509457|NCT02982772|Nicotine|nicotine|mesh-list
14509458|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14509459|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
14509460|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509461|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509462|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14509463|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14509464|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
14509465|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509466|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509467|NCT02982954|Nivolumab|nivolumab|mesh-list
14509468|NCT02982954|Ipilimumab|ipilimumab|mesh-list
14509469|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14509470|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509471|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14509472|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509473|NCT02983604|Fulvestrant|fulvestrant|mesh-list
14509474|NCT02983604|Exemestane|exemestane|mesh-list
14509475|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14509476|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509477|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14509478|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14509479|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
14509480|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509481|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509482|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14509483|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14509484|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509485|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509486|NCT02983981|Desoximetasone|desoximetasone|mesh-list
14509487|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509488|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
14509489|NCT02983981|Hormones|hormones|mesh-ancestor
14509490|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509491|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509492|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
14509493|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14509494|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509495|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509496|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509497|NCT02984982|Anticoagulants|anticoagulants|mesh-list
14509498|NCT02984982|Atorvastatin|atorvastatin|mesh-list
14509499|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14509500|NCT02984982|Ezetimibe|ezetimibe|mesh-list
14509501|NCT02984982|Fenofibrate|fenofibrate|mesh-list
14509502|NCT02984982|Bezafibrate|bezafibrate|mesh-list
14509503|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14224010|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224011|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
14224012|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
14224013|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
14224014|NCT03622788|Fludarabine|fludarabine|mesh-list
14224015|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14224016|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14224017|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
14224018|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224019|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14224020|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14224021|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
14224022|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224023|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224024|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14790163|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14790164|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
14790165|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14790166|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790167|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14790168|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790169|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
14790170|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14790171|NCT00734318|Fluticasone|fluticasone|mesh-list
14790172|NCT00734318|Xhance|xhance|mesh-list
14790173|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
14790174|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14790175|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
14790176|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790177|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790178|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14790179|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
14790180|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14790181|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14790182|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14790183|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
14790184|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790185|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790186|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948274|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948275|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948276|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948277|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14224054|NCT03595059|Paclitaxel|paclitaxel|mesh-list
14224055|NCT03595059|Docetaxel|docetaxel|mesh-list
14224056|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14224057|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224058|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
14224059|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
14224060|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
14224061|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790187|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
14790188|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14790189|NCT00734383|Propofol|propofol|mesh-list
14790190|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14790191|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790192|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790193|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14790194|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
14948278|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14224071|NCT03553810|Valsartan|valsartan|mesh-list
14224072|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14224073|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14224074|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14224075|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14224076|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224077|NCT03527264|Nivolumab|nivolumab|mesh-list
14224078|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948279|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14948280|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
14948281|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14948282|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14224079|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224080|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14224081|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790195|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
14790196|NCT00734448|Inositol|inositol|mesh-list
14790197|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
14790198|NCT00734448|Vitamins|vitamins|mesh-ancestor
14790199|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
14790200|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790201|NCT00734526|Temozolomide|temozolomide|mesh-list
14790202|NCT00734526|Sorafenib|sorafenib|mesh-list
14790203|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14790204|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
14790205|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790206|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790207|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14224095|NCT03519308|Gemcitabine|gemcitabine|mesh-list
14224096|NCT03519308|Paclitaxel|paclitaxel|mesh-list
14224097|NCT03519308|Nivolumab|nivolumab|mesh-list
14224098|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14224099|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224100|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
14224101|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
14224102|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
14224103|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224104|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14224105|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
14224106|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
14224107|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14224108|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224109|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14224110|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
14224111|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224112|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224113|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14790208|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790209|NCT00734669|Glyburide|glyburide|mesh-list
14790210|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14790211|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790212|NCT00734682|Irinotecan|irinotecan|mesh-list
14790213|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14790214|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14790215|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790216|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790217|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790218|NCT00734695|Vitamins|vitamins|mesh-list
14790219|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
14790220|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
14790221|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790222|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
14790223|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790224|NCT00734695|Protective Agents|protective agents|mesh-ancestor
14224131|NCT03483038|Irinotecan|irinotecan|mesh-list
14224132|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14224133|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14224134|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224135|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224136|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790225|NCT00734773|Cytarabine|cytarabine|mesh-list
14790226|NCT00734773|Rituximab|rituximab|mesh-list
14790227|NCT00734773|Methotrexate|methotrexate|mesh-list
14790228|NCT00734773|Vincristine|vincristine|mesh-list
14790229|NCT00734773|Procarbazine|procarbazine|mesh-list
14790230|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
14790231|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948283|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948284|NCT01532232|Varenicline|varenicline|mesh-list
14948285|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14948286|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14948287|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
14948288|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948289|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790232|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790233|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
14790234|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790235|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14790236|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14790237|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
14790238|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14790239|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14790240|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
14790241|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790242|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
14790243|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790244|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14790245|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14224157|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
14224158|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14224159|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14224160|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224161|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
14224162|NCT03475342|Coagulants|coagulants|mesh-ancestor
14790246|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14790247|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
14790248|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790249|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14790250|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790251|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790252|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790253|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14790254|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
14790255|NCT00734877|Thalidomide|thalidomide|mesh-list
14790256|NCT00734877|Dexamethasone|dexamethasone|mesh-list
14224174|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
14224175|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224176|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790257|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
14790258|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
14790259|NCT00734877|Melphalan|melphalan|mesh-list
14790260|NCT00734877|Cisplatin|cisplatin|mesh-list
14790261|NCT00734877|Etoposide|etoposide|mesh-list
14790262|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
14790263|NCT00734877|Doxorubicin|doxorubicin|mesh-list
14790264|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14790265|NCT00734877|Bortezomib|bortezomib|mesh-list
14790266|NCT00734877|BB 1101|bb 1101|mesh-list
14790267|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790268|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
14790269|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790270|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14790271|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14790272|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
14790273|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790274|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790275|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14790276|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790277|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
14790278|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
14790279|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790280|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790281|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
14790282|NCT00734877|Hormones|hormones|mesh-ancestor
14790283|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14790284|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14790285|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
14790286|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790287|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14790288|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14509504|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14509505|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
14509506|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509507|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14509508|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14509509|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509510|NCT02985021|Carboplatin|carboplatin|mesh-list
14509511|NCT02985021|Docetaxel|docetaxel|mesh-list
14790289|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14790290|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14790291|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
14224215|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
14224216|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224217|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790292|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14790293|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790294|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14790295|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14790296|NCT00734877|Growth Substances|growth substances|mesh-ancestor
14790297|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
14790298|NCT00734890|Bevacizumab|bevacizumab|mesh-list
14790299|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14790300|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790301|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14790302|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14790303|NCT00734890|Growth Substances|growth substances|mesh-ancestor
14790304|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790305|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
14790306|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14790307|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14790308|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14790309|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14790310|NCT00735020|Vaccines|vaccines|mesh-list
14790311|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
14790312|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790313|NCT00735124|Gabapentin|gabapentin|mesh-list
14790314|NCT00735124|Analgesics|analgesics|mesh-ancestor
14790315|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
14790316|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790317|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790318|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
14790319|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14790320|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14790321|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790322|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790323|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14790324|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14790325|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224252|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14224253|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14224254|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14224255|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14509512|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509513|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
14509514|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
14509515|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
14509516|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509517|NCT02985879|Tilavonemab|tilavonemab|mesh-list
14509518|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
14509519|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14509520|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14509521|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14509522|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14509523|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790326|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790327|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
14790328|NCT00735228|Pancrelipase|pancrelipase|mesh-list
14790329|NCT00735228|Pancreatin|pancreatin|mesh-list
14790330|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790331|NCT00735241|Leucovorin|leucovorin|mesh-list
14790332|NCT00735241|Folic Acid|folic acid|mesh-list
14509524|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509525|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
14509526|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509527|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14509528|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14509529|NCT02986139|Etanercept|etanercept|mesh-list
14509530|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14509531|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14509532|NCT02986139|Analgesics|analgesics|mesh-ancestor
14790333|NCT00735241|Bevacizumab|bevacizumab|mesh-list
14790334|NCT00735241|Fluorouracil|fluorouracil|mesh-list
14224256|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224257|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224258|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224259|NCT03271151|Analgesics|analgesics|mesh-ancestor
14224260|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
14224261|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224262|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
14224263|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14224264|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
14790335|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
14790336|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
14790337|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14790338|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790339|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14790340|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14790341|NCT00735241|Growth Substances|growth substances|mesh-ancestor
14790342|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790343|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
14790344|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
14790345|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224276|NCT03265405|Prednisolone|prednisolone|mesh-list
14224277|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14224278|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
14224279|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14224280|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
14224281|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14224282|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
14224283|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14224284|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
14224285|NCT03265405|Hormones|hormones|mesh-ancestor
14224286|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14224287|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224288|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14224289|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224290|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
14224291|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
14224292|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224293|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14224294|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14224295|NCT03265405|Protective Agents|protective agents|mesh-ancestor
14790346|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14790347|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790348|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
14790349|NCT00735241|Antidotes|antidotes|mesh-ancestor
14790350|NCT00735241|Protective Agents|protective agents|mesh-ancestor
14790351|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
14790352|NCT00735241|Vitamins|vitamins|mesh-ancestor
14790353|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
14790354|NCT00735241|Hematinics|hematinics|mesh-ancestor
14790355|NCT00735280|Heparin|heparin|mesh-list
14790356|NCT00735280|Calcium heparin|calcium heparin|mesh-list
14790357|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
14790358|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14790359|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14790360|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790361|NCT00735345|Docetaxel|docetaxel|mesh-list
14790362|NCT00735345|Cetuximab|cetuximab|mesh-list
14790363|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790364|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790365|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790366|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790367|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790368|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224319|NCT03228537|Cisplatin|cisplatin|mesh-list
14224320|NCT03228537|Pemetrexed|pemetrexed|mesh-list
14790369|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
14790370|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14790371|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948290|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948291|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
14948292|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14948293|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15027109|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15027110|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14224321|NCT03228537|Atezolizumab|atezolizumab|mesh-list
15027111|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14224322|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14224323|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224324|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224325|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224326|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14224327|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14224328|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
14224329|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790372|NCT00735527|Lorazepam|lorazepam|mesh-list
14790373|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
14790374|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
14790375|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
14790376|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790377|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790378|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790379|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14790380|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790381|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14790382|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14790383|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790384|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
14790385|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
14790386|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790387|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790388|NCT00735748|Tramadol|tramadol|mesh-list
14790389|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14790390|NCT00735748|Narcotics|narcotics|mesh-ancestor
14790391|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790392|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790393|NCT00735748|Analgesics|analgesics|mesh-ancestor
14790394|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
14790395|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790396|NCT00735761|Acyclovir|acyclovir|mesh-list
14790397|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
14790398|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
14790399|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790400|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790401|NCT00735813|Heparin|heparin|mesh-list
14790402|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
14790403|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14790404|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14790405|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790406|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14790407|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
14790408|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14790409|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
14790410|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14790411|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790412|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14790413|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14790414|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790415|NCT00735930|Lenalidomide|lenalidomide|mesh-list
14790416|NCT00735930|Alvocidib|alvocidib|mesh-list
14790417|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
14790418|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224391|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
14509533|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
14224392|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14224393|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509534|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509535|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509536|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509537|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14509538|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509539|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14509540|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
14509541|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
14509542|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
14509543|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
14509544|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509545|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509546|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14509547|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
14509548|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509549|NCT02988050|Lidocaine|lidocaine|mesh-list
14224394|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224395|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14224396|NCT03172897|Analgesics|analgesics|mesh-ancestor
14224397|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
14224398|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224399|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14224400|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14224401|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14224402|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
14224403|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224404|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790419|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14790420|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14790421|NCT00735930|Growth Substances|growth substances|mesh-ancestor
14790422|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
14790423|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790424|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14790425|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224412|NCT03141177|Nivolumab|nivolumab|mesh-list
14224413|NCT03141177|Ipilimumab|ipilimumab|mesh-list
14224414|NCT03141177|Sunitinib|sunitinib|mesh-list
14224415|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224416|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224417|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14224418|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224419|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14224420|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14224421|NCT03141177|Growth Substances|growth substances|mesh-ancestor
14224422|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224423|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
14224424|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14224425|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224426|NCT03117049|Paclitaxel|paclitaxel|mesh-list
14224427|NCT03117049|Bevacizumab|bevacizumab|mesh-list
14224428|NCT03117049|Carboplatin|carboplatin|mesh-list
14224429|NCT03117049|Nivolumab|nivolumab|mesh-list
14224430|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14224431|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224432|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
14224433|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
14224434|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
14224435|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224436|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224437|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14224438|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14224439|NCT03117049|Growth Substances|growth substances|mesh-ancestor
14224440|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224441|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
14224442|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14790426|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790427|NCT00736021|Citalopram|citalopram|mesh-list
14790428|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14790429|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14790430|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14790431|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790432|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790433|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
14790434|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790435|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14790436|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
14790437|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790438|NCT00736164|Selenium|selenium|mesh-list
14790439|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
14790440|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790441|NCT00736164|Protective Agents|protective agents|mesh-ancestor
14224467|NCT03102723|Cangrelor|cangrelor|mesh-list
14224468|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14509550|NCT02988050|Epinephrine|epinephrine|mesh-list
14509551|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
14509552|NCT02988050|Remifentanil|remifentanil|mesh-list
14509553|NCT02988050|Bupivacaine|bupivacaine|mesh-list
14509554|NCT02988050|Propofol|propofol|mesh-list
14509555|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
14509556|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
14509557|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14224469|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14224470|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14224471|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14224472|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
14224473|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224474|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224475|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790442|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790443|NCT00736164|Trace Elements|trace elements|mesh-ancestor
14790444|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
14790445|NCT00736294|Ramipril|ramipril|mesh-list
14790446|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14790447|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
14790448|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790449|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790450|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14790451|NCT00736320|Vincristine|vincristine|mesh-list
14790452|NCT00736320|Doxorubicin|doxorubicin|mesh-list
14790453|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14790454|NCT00736320|Dacarbazine|dacarbazine|mesh-list
14790455|NCT00736320|Bleomycin|bleomycin|mesh-list
14790456|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14790457|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790458|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790459|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790460|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790461|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790462|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14790463|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14790464|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14790465|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790466|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14790467|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
14790468|NCT00736346|Paroxetine|paroxetine|mesh-list
14790469|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14790470|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14790471|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14790472|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790473|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790474|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
14790475|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790476|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14790477|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
14790478|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790479|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14790480|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14790481|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790482|NCT00736463|Atorvastatin|atorvastatin|mesh-list
14790483|NCT00736463|Simvastatin|simvastatin|mesh-list
14790484|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14790485|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14224520|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
14224521|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224522|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790486|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
14790487|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790488|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14790489|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14790490|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790491|NCT00736515|Insulin|insulin|mesh-list
14790492|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14790493|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
14790494|NCT00736515|Gliclazide|gliclazide|mesh-list
14790495|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14790496|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790497|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
14790498|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14790499|NCT00736541|Cystatins|cystatins|mesh-list
14790500|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
14790501|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790502|NCT00736541|Expectorants|expectorants|mesh-ancestor
14790503|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
14790504|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14790505|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
14948294|NCT01532466|Rocuronium|rocuronium|mesh-list
14790506|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790507|NCT00736541|Protective Agents|protective agents|mesh-ancestor
14790508|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790509|NCT00736541|Antidotes|antidotes|mesh-ancestor
14790510|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14790511|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
14790512|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790513|NCT00736606|Simvastatin|simvastatin|mesh-list
14790514|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14790515|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14790516|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
14790517|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790518|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14790519|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14790520|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790521|NCT00736619|Paclitaxel|paclitaxel|mesh-list
14790522|NCT00736619|Cetuximab|cetuximab|mesh-list
14790523|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14790524|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14790525|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790526|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790527|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790528|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
14224569|NCT03018080|Paclitaxel|paclitaxel|mesh-list
14224570|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
14224571|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14224572|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224573|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
14224574|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
14224575|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
14224576|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224577|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224578|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
14224579|NCT03012984|Morphine|morphine|mesh-list
14224580|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14224581|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14224582|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224583|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14224584|NCT03012984|Analgesics|analgesics|mesh-ancestor
14224585|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
14224586|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224587|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14224588|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14224589|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14224590|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
14224591|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224592|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224593|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14224594|NCT03012984|Narcotics|narcotics|mesh-ancestor
14224595|NCT02993822|Maleic acid|maleic acid|mesh-list
14224596|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224597|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790529|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790530|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14790531|NCT00736697|Moxidectin|moxidectin|mesh-list
14790532|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
14790533|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14790534|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790535|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
14790536|NCT00736801|Fluticasone|fluticasone|mesh-list
14790537|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14790538|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790539|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14790540|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
14790541|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790542|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790543|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14790544|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
14790545|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14790546|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14790547|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14790548|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14790549|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14790550|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
14224607|NCT02972840|Rituximab|rituximab|mesh-list
14224608|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14224609|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
14224610|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224611|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224612|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
14224613|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224614|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14224615|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14224616|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
14224617|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790551|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790552|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790553|NCT00736814|Gemcitabine|gemcitabine|mesh-list
14790554|NCT00736814|Carboplatin|carboplatin|mesh-list
14790555|NCT00736814|Docetaxel|docetaxel|mesh-list
14790556|NCT00736814|Vinorelbine|vinorelbine|mesh-list
14790557|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224625|NCT02957019|Rituximab|rituximab|mesh-list
14224626|NCT02957019|Interleukin-2|interleukin-2|mesh-list
14224627|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224628|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224629|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
14224630|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224631|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14224632|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14224633|NCT02957019|Analgesics|analgesics|mesh-ancestor
14224634|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
14224635|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224636|NCT02948660|Melatonin|melatonin|mesh-list
14224637|NCT02948660|Zolpidem|zolpidem|mesh-list
14224638|NCT02948660|Antioxidants|antioxidants|mesh-ancestor
14224639|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224640|NCT02948660|Protective Agents|protective agents|mesh-ancestor
14224641|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224642|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14224643|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14224644|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14224645|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14224646|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
14224647|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
14224648|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224649|NCT02942355|Palbociclib|palbociclib|mesh-list
14224650|NCT02942355|Anastrozole|anastrozole|mesh-list
14224651|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224652|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14224653|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224654|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224655|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14224656|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14224657|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14224658|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14224659|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
14224660|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14224661|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224662|NCT02938793|Durvalumab|durvalumab|mesh-list
14224663|NCT02938793|Tremelimumab|tremelimumab|mesh-list
14224664|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224665|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790558|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14509558|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509559|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
14509560|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509561|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14509562|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14509563|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14509564|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14790559|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
14790560|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790561|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
14790562|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790563|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224671|NCT02924441|Lidocaine|lidocaine|mesh-list
14224672|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
14224673|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
14224674|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14224675|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224676|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
14224677|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224678|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14224679|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14224680|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14224681|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14224682|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224683|NCT02924324|Propofol|propofol|mesh-list
14224684|NCT02924324|Ropivacaine|ropivacaine|mesh-list
14224685|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14224686|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14224687|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224688|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14224689|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
14224690|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
14224691|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
14224692|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
14224693|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790564|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790565|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
14790566|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790567|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790568|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790569|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790570|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14790571|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
14509565|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509566|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14509567|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14509568|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
14509569|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14509570|NCT02988050|Analgesics|analgesics|mesh-ancestor
14509571|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14509572|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14509573|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14509574|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
14509575|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509576|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14509577|NCT02988050|Narcotics|narcotics|mesh-ancestor
14509578|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14509579|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14509580|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
14509581|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14509582|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
14509583|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
14509584|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
14509585|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14509586|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14509587|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14509588|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
14509589|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509590|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14509591|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509592|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509593|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509594|NCT02988219|Epinephrine|epinephrine|mesh-list
14509595|NCT02988219|Fentanyl|fentanyl|mesh-list
14509596|NCT02988219|Bupivacaine|bupivacaine|mesh-list
14509597|NCT02988219|Anesthetics|anesthetics|mesh-list
14509598|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
14509599|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509600|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509601|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
14790572|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14790573|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
14509602|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790574|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790575|NCT00736866|Expectorants|expectorants|mesh-ancestor
14790576|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
14790577|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14790578|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
14790579|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790580|NCT00736866|Protective Agents|protective agents|mesh-ancestor
14790581|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790582|NCT00736866|Antidotes|antidotes|mesh-ancestor
14790583|NCT00736905|Rilpivirine|rilpivirine|mesh-list
14790584|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14790585|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14790586|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790587|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790588|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
14790589|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790590|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14790591|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14790592|NCT00736931|Levetiracetam|levetiracetam|mesh-list
14790593|NCT00736931|Lorazepam|lorazepam|mesh-list
14790594|NCT00736931|Brivaracetam|brivaracetam|mesh-list
14790595|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
14790596|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
14790597|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
14790598|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
14790599|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790600|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790601|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790602|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14790603|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790604|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14790605|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14790606|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790607|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
14790608|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
14790609|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790610|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790611|NCT00736970|Sirolimus|sirolimus|mesh-list
14790612|NCT00736970|Trastuzumab|trastuzumab|mesh-list
14224727|NCT02901041|Zonisamide|zonisamide|mesh-list
14224728|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
14224729|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14224730|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14224731|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224732|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14224733|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790613|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14790614|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790615|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14790616|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790617|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14790618|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
14790619|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790620|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
14790621|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790622|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
14790623|NCT00736983|Adalimumab|adalimumab|mesh-list
14790624|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790625|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14790626|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14790627|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509603|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14509604|NCT02988219|Narcotics|narcotics|mesh-ancestor
14509605|NCT02988219|Analgesics|analgesics|mesh-ancestor
14509606|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14509607|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14509608|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
14509609|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14509610|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14509611|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
14509612|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509613|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509614|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14509615|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14509616|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
14509617|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14790628|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14790629|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14790630|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790631|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790632|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790633|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14790634|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14790635|NCT00737113|Hormones|hormones|mesh-list
14790636|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14790637|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790638|NCT00737126|Folic Acid|folic acid|mesh-list
14790639|NCT00737126|Hematinics|hematinics|mesh-ancestor
14790640|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
14790641|NCT00737126|Vitamins|vitamins|mesh-ancestor
14790642|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
14790643|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790644|NCT00737139|Epinephrine|epinephrine|mesh-list
14790645|NCT00737139|Bupivacaine|bupivacaine|mesh-list
14790646|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14790647|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14790648|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
14790649|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790650|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790651|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790652|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14790653|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14790654|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
14790655|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224788|NCT02807454|Dexamethasone|dexamethasone|mesh-list
14224789|NCT02807454|Durvalumab|durvalumab|mesh-list
14224790|NCT02807454|Daratumumab|daratumumab|mesh-list
14224791|NCT02807454|Pomalidomide|pomalidomide|mesh-list
14224792|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14224793|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
14224794|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
14224795|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224796|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224797|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14224798|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
14224799|NCT02807454|Hormones|hormones|mesh-ancestor
14224800|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14224801|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14224802|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224803|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224804|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
14224805|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14224806|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14224807|NCT02807454|Growth Substances|growth substances|mesh-ancestor
14224808|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
14790656|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14790657|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
14790658|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
14790659|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
14790660|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14790661|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
14790662|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
14790663|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790664|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
14790665|NCT00737191|Olanzapine|olanzapine|mesh-list
14790666|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
14790667|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
14790668|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790669|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790670|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790671|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14790672|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14790673|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790674|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790675|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14790676|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14790677|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14790678|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790679|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790680|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
14790681|NCT00737256|Aripiprazole|aripiprazole|mesh-list
14790682|NCT00737256|Perphenazine|perphenazine|mesh-list
14790683|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
14790684|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790685|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14790686|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14790687|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790688|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790689|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
14790690|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
14790691|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790692|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790693|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14790694|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14790695|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
14790696|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14790697|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14790698|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14790699|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14790700|NCT00737373|Leucovorin|leucovorin|mesh-list
14790701|NCT00737373|Folic Acid|folic acid|mesh-list
14790702|NCT00737373|Docetaxel|docetaxel|mesh-list
14790703|NCT00737373|Fluorouracil|fluorouracil|mesh-list
14790704|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
14790705|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
14790706|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790707|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
14224861|NCT02753127|Leucovorin|leucovorin|mesh-list
14224862|NCT02753127|Bevacizumab|bevacizumab|mesh-list
14224863|NCT02753127|Fluorouracil|fluorouracil|mesh-list
14224864|NCT02753127|Irinotecan|irinotecan|mesh-list
14224865|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14224866|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14224867|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14224868|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14224869|NCT02753127|Growth Substances|growth substances|mesh-ancestor
14224870|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224871|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
14224872|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
14224873|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224874|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14224875|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14224876|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
14224877|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14224878|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14224879|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224880|NCT02753127|Antidotes|antidotes|mesh-ancestor
14224881|NCT02753127|Protective Agents|protective agents|mesh-ancestor
14224882|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
14224883|NCT02753127|Vitamins|vitamins|mesh-ancestor
14224884|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
14224885|NCT02744430|Mirabegron|mirabegron|mesh-list
14224886|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14224887|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14224888|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14224889|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
14224890|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224891|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224892|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224893|NCT02744430|Urological Agents|urological agents|mesh-ancestor
14224894|NCT02720445|Nicotine|nicotine|mesh-list
14224895|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14224896|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
14224897|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224898|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224899|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14224900|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14224901|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
14224902|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224903|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790708|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790709|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790710|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790711|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
14790712|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14224908|NCT02674958|Aspirin|aspirin|mesh-list
14224909|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14224910|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14224911|NCT02674958|Analgesics|analgesics|mesh-ancestor
14224912|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
14224913|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14224914|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224915|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14224916|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14224917|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14224918|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14224919|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224920|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14224921|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14224922|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224923|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
14224924|NCT02668562|Ticagrelor|ticagrelor|mesh-list
14224925|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14224926|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14224927|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14224928|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14224929|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
14224930|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14224931|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14224932|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790713|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790714|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
14790715|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790716|NCT00737373|Antidotes|antidotes|mesh-ancestor
14790717|NCT00737373|Protective Agents|protective agents|mesh-ancestor
14790718|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
14790719|NCT00737373|Vitamins|vitamins|mesh-ancestor
14790720|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
14790721|NCT00737373|Hematinics|hematinics|mesh-ancestor
14790722|NCT00737542|Lidocaine|lidocaine|mesh-list
14790723|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14790724|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
14790725|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790726|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790727|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
14224948|NCT02659241|Adavosertib|adavosertib|mesh-list
14224949|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224950|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790728|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790729|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14790730|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14790731|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14790732|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14790733|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948295|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14948296|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14948297|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14948298|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948299|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948300|NCT01532518|MEN 11420|men 11420|mesh-list
14948301|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14948302|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
14948303|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948304|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948305|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14948306|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
14948307|NCT01532544|Heparin|heparin|mesh-list
14948308|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14948309|NCT01532544|Tinzaparin|tinzaparin|mesh-list
14948310|NCT01532544|Dalteparin|dalteparin|mesh-list
14948311|NCT01532544|Eptifibatide|eptifibatide|mesh-list
14948312|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
14948313|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14948314|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14948315|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948316|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14948317|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
14790734|NCT00737555|Tosedostat|tosedostat|mesh-list
14790735|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790736|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790737|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
14790738|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14790739|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790740|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14790741|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
14790742|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14790743|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790744|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14224991|NCT02538744|Doxazosin|doxazosin|mesh-list
14224992|NCT02538744|Cocaine|cocaine|mesh-list
14224993|NCT02538744|Modafinil|modafinil|mesh-list
14224994|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14224995|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14224996|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14224997|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14224998|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14224999|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225000|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
14225001|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
14225002|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14225003|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
14225004|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14225005|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14225006|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14225007|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14225008|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14225009|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
14225010|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14225011|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14225012|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14225013|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14225014|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14225015|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
14790745|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790746|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
14790747|NCT00737685|Fludarabine|fludarabine|mesh-list
14790748|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
14790749|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790750|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
14790751|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790752|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14790753|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14790754|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
14790755|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790756|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509618|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
14509619|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
14509620|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
14509621|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14509622|NCT02988349|Listerine|listerine|mesh-list
14509623|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
14509624|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
14509625|NCT02988349|Protective Agents|protective agents|mesh-ancestor
14509626|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509627|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14509628|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509629|NCT02988843|Bevacizumab|bevacizumab|mesh-list
14509630|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14509631|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14509632|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509633|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14509634|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14509635|NCT02988843|Growth Substances|growth substances|mesh-ancestor
14509636|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509637|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
14509638|NCT02988882|Dexamethasone|dexamethasone|mesh-list
14509639|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509640|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
14509641|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
14509642|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509643|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948318|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14790757|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14225029|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
14225030|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14225031|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790758|NCT00737724|Efavirenz|efavirenz|mesh-list
14790759|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14790760|NCT00737724|Isoniazid|isoniazid|mesh-list
14790761|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14790762|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14790763|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790764|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790765|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
14790766|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790767|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14790768|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14790769|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14790770|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14790771|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14790772|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14790773|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14790774|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14790775|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
14790776|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14790777|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14790778|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14790779|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
14790780|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14790781|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
14790782|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
14790783|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14790784|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14790785|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790786|NCT00737789|Mesalamine|mesalamine|mesh-list
14790787|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14790788|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14790789|NCT00737789|Analgesics|analgesics|mesh-ancestor
14790790|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
14790791|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790792|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790793|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790794|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14790795|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
14790796|NCT00737815|Cathartics|cathartics|mesh-ancestor
14790797|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790798|NCT00737867|Gemcitabine|gemcitabine|mesh-list
14790799|NCT00737867|Carboplatin|carboplatin|mesh-list
14790800|NCT00737867|Vinorelbine|vinorelbine|mesh-list
14790801|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790802|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14790803|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
14790804|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225082|NCT02421939|Cytarabine|cytarabine|mesh-list
14225083|NCT02421939|Fludarabine|fludarabine|mesh-list
14225084|NCT02421939|Etoposide|etoposide|mesh-list
14225085|NCT02421939|Azacitidine|azacitidine|mesh-list
14225086|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
14225087|NCT02421939|Idarubicin|idarubicin|mesh-list
14225088|NCT02421939|Sargramostim|sargramostim|mesh-list
14225089|NCT02421939|Lenograstim|lenograstim|mesh-list
14225090|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225091|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14225092|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
14225093|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225094|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14225095|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
14225096|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225097|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14225098|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14225099|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14225100|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225101|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
14225102|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14225103|NCT02421939|Analgesics|analgesics|mesh-ancestor
14225104|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
14225105|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14225106|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14225107|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14790805|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
14790806|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790807|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790808|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790809|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
14790810|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790811|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14790812|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790813|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790814|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790815|NCT00737880|Pancrelipase|pancrelipase|mesh-list
14790816|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790817|NCT00737971|Triamcinolone|triamcinolone|mesh-list
14790818|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14790819|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14790820|NCT00737971|Bevacizumab|bevacizumab|mesh-list
14790821|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14790822|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14790823|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790824|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14790825|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14790826|NCT00737971|Growth Substances|growth substances|mesh-ancestor
14790827|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790828|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
14790829|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790830|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
14790831|NCT00737971|Hormones|hormones|mesh-ancestor
14790832|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14225136|NCT02308202|Perindopril|perindopril|mesh-list
14225137|NCT02308202|Doxazosin|doxazosin|mesh-list
14225138|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14225139|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
14225140|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225141|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225142|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14225143|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14225144|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14225145|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14225146|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
14225147|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14225148|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225149|NCT02297698|Trastuzumab|trastuzumab|mesh-list
14225150|NCT02297698|Sargramostim|sargramostim|mesh-list
14225151|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14225152|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225153|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
14225154|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790833|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790834|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
14790835|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790836|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790837|NCT00737997|Morphine|morphine|mesh-list
14790838|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14790839|NCT00737997|Narcotics|narcotics|mesh-ancestor
14790840|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790841|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790842|NCT00737997|Analgesics|analgesics|mesh-ancestor
14790843|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
14790844|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790845|NCT00738088|Gliclazide|gliclazide|mesh-list
14790846|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14790847|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790848|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
14225171|NCT02207712|Ranibizumab|ranibizumab|mesh-list
14225172|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14225173|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14225174|NCT02207712|Growth Substances|growth substances|mesh-ancestor
14225175|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225176|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
14225177|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790849|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14790850|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790851|NCT00738192|Fentanyl|fentanyl|mesh-list
14790852|NCT00738192|Sufentanil|sufentanil|mesh-list
14790853|NCT00738192|Dsuvia|dsuvia|mesh-list
14790854|NCT00738192|Butorphanol|butorphanol|mesh-list
14790855|NCT00738192|Citric Acid|citric acid|mesh-list
14790856|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
14790857|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14790858|NCT00738192|Narcotics|narcotics|mesh-ancestor
14790859|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790860|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790861|NCT00738192|Analgesics|analgesics|mesh-ancestor
14790862|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
14790863|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790864|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14790865|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14790866|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
14790867|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
14790868|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
14790869|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14790870|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
14790871|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
14790872|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790873|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
14790874|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
14790875|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14790876|NCT00738257|Pamidronate|pamidronate|mesh-list
14790877|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14790878|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790879|NCT00738296|Simvastatin|simvastatin|mesh-list
14790880|NCT00738296|Ezetimibe|ezetimibe|mesh-list
14790881|NCT00738296|Pravastatin|pravastatin|mesh-list
14790882|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14790883|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14790884|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
14790885|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790886|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14225214|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14225215|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790887|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14790888|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790889|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14790890|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790891|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14790892|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790893|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790894|NCT00738413|Deferasirox|deferasirox|mesh-list
14790895|NCT00738413|Deferoxamine|deferoxamine|mesh-list
14790896|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14790897|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
14790898|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
14790899|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790900|NCT00738413|Siderophores|siderophores|mesh-ancestor
14790901|NCT00738452|Antibodies|antibodies|mesh-list
14790902|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14225232|NCT02119468|Dexamethasone|dexamethasone|mesh-list
14225233|NCT02119468|Pomalidomide|pomalidomide|mesh-list
14225234|NCT02119468|Ixazomib|ixazomib|mesh-list
14225235|NCT02119468|Glycine|glycine|mesh-list
14225236|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
14790903|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
14790904|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790905|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
14225237|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14225238|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
14225239|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
14225240|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14225241|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225242|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14225243|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
14225244|NCT02119468|Hormones|hormones|mesh-ancestor
14225245|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14225246|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14225247|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225248|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225249|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
14225250|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14225251|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14225252|NCT02119468|Growth Substances|growth substances|mesh-ancestor
14225253|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
14225254|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
14225255|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225256|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
14225257|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790906|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14790907|NCT00738517|Antibodies|antibodies|mesh-list
14790908|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
14790909|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790910|NCT00738556|Sirolimus|sirolimus|mesh-list
14790911|NCT00738556|Paclitaxel|paclitaxel|mesh-list
14790912|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14225265|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
14225266|NCT02106572|Mitomycins|mitomycins|mesh-list
14225267|NCT02106572|Mitomycin|mitomycin|mesh-list
14225268|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14225269|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225270|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
14225271|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225272|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14225273|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225274|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14225275|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14225276|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
14225277|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790913|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790914|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14790915|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14790916|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14790917|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790918|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14790919|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790920|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14790921|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
14790922|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14790923|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
14790924|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790925|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
14790926|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14790927|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14790928|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
14790929|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14790930|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14790931|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14790932|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790933|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790934|NCT00738595|Nicotine|nicotine|mesh-list
14790935|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14790936|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
14790937|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790938|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790939|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14790940|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14790941|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
14790942|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790943|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790944|NCT00738621|Dexamethasone|dexamethasone|mesh-list
14790945|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
14790946|NCT00738621|Ondansetron|ondansetron|mesh-list
14790947|NCT00738621|Aprepitant|aprepitant|mesh-list
14790948|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
14790949|NCT00738621|BB 1101|bb 1101|mesh-list
14790950|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14790951|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
14790952|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
14790953|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14790954|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790955|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14790956|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
14790957|NCT00738621|Hormones|hormones|mesh-ancestor
14790958|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14790959|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14790960|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225326|NCT01960530|Dexamethasone|dexamethasone|mesh-list
14225327|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
14225328|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14225329|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14225330|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14225331|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14225332|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
14225333|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
14225334|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14225335|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225336|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14225337|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
14509644|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509645|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
14509646|NCT02988882|Hormones|hormones|mesh-ancestor
14509647|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509648|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14509649|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509650|NCT02988986|Tamoxifen|tamoxifen|mesh-list
14509651|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14509652|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
14509653|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509654|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509655|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14509656|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509657|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14509658|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14509659|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14509660|NCT02989389|Itraconazole|itraconazole|mesh-list
14509661|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
14509662|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509663|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14509664|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14509665|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509666|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509667|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14509668|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
14509669|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509670|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509671|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14509672|NCT02989493|Doxazosin|doxazosin|mesh-list
14509673|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14509674|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14509675|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14509676|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14509677|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
14509678|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509679|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509680|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509681|NCT02989649|Metformin|metformin|mesh-list
14509682|NCT02989649|Pioglitazone|pioglitazone|mesh-list
14509683|NCT02989649|Alogliptin|alogliptin|mesh-list
14509684|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509685|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509686|NCT02989649|Incretins|incretins|mesh-ancestor
14509687|NCT02989649|Hormones|hormones|mesh-ancestor
14509688|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509689|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14790961|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
14225338|NCT01960530|Hormones|hormones|mesh-ancestor
14225339|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14225340|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14225341|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790962|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790963|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790964|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
14790965|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
14790966|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14790967|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
14225392|NCT01892722|Interferons|interferons|mesh-list
14225393|NCT01892722|Interferon-beta|interferon-beta|mesh-list
14225394|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
14225395|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14225396|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225397|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
14225398|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14225399|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
14225400|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225401|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14225402|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14225403|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225404|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14225405|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14225406|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
14225407|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509690|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
14509691|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509692|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509693|NCT02989714|Nivolumab|nivolumab|mesh-list
14509694|NCT02989714|Interleukin-2|interleukin-2|mesh-list
14509695|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14509696|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509697|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14509698|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509699|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14509700|NCT02989714|Analgesics|analgesics|mesh-ancestor
14509701|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
14509702|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509703|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509704|NCT02989727|Lamotrigine|lamotrigine|mesh-list
14509705|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
14509706|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14509707|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14509708|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509709|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14509710|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509711|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14509712|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509713|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509714|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509715|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14509716|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
14509717|NCT02990910|Narcotics|narcotics|mesh-ancestor
14509718|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509719|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509720|NCT02990910|Analgesics|analgesics|mesh-ancestor
14509721|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
14509722|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509723|NCT02991040|Lidocaine|lidocaine|mesh-list
14509724|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
14509725|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
14509726|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509727|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509728|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
14509729|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509730|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14509731|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14509732|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14509733|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14509734|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790968|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14790969|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14790970|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14790971|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14790972|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14790973|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14790974|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14790975|NCT00738660|Telmisartan|telmisartan|mesh-list
14790976|NCT00738660|Ramipril|ramipril|mesh-list
14790977|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14790978|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14790979|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14790980|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790981|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14790982|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
14790983|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790984|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14790985|NCT00738751|Panobinostat|panobinostat|mesh-list
14790986|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14790987|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14790988|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14790989|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14790990|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14790991|NCT00738777|Tamoxifen|tamoxifen|mesh-list
14790992|NCT00738777|Fulvestrant|fulvestrant|mesh-list
14790993|NCT00738777|Anastrozole|anastrozole|mesh-list
14790994|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14790995|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
14790996|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14790997|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14790998|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14790999|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791000|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14791001|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14791002|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14791003|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14791004|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14791005|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14791006|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791007|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791008|NCT00738829|Vidarabine|vidarabine|mesh-list
14791009|NCT00738829|Rituximab|rituximab|mesh-list
14791010|NCT00738829|Fludarabine|fludarabine|mesh-list
14791011|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
14791012|NCT00738829|Lenalidomide|lenalidomide|mesh-list
14791013|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14791014|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791015|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
14791016|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791017|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791018|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14791019|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
14791020|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509735|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14509736|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14509737|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
14509738|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509739|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14509740|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509741|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14509742|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509743|NCT02991859|Fluticasone|fluticasone|mesh-list
14509744|NCT02991859|Xhance|xhance|mesh-list
14509745|NCT02991859|Budesonide|budesonide|mesh-list
14509746|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509747|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14509748|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
14509749|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509750|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509751|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14509752|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
14509753|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
14509754|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14509755|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
14791021|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791022|NCT00738829|Antiviral Agents|antiviral agents|mesh-ancestor
14791023|NCT00738829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791024|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14791025|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14225475|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
14225476|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225477|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14225478|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225479|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225480|NCT01716806|Nivolumab|nivolumab|mesh-list
14225481|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14225482|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14225483|NCT01716806|Dacarbazine|dacarbazine|mesh-list
14225484|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14225485|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225486|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14225487|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225488|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14225489|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
14791026|NCT00738829|Growth Substances|growth substances|mesh-ancestor
14791027|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
14791028|NCT00738842|Ticagrelor|ticagrelor|mesh-list
14791029|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14791030|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14791031|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14791032|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14791033|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
14791034|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791035|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791036|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791037|NCT00738868|Cetuximab|cetuximab|mesh-list
14791038|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14791039|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791040|NCT00738985|Simvastatin|simvastatin|mesh-list
14791041|NCT00738985|Ezetimibe|ezetimibe|mesh-list
14791042|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14791043|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14791044|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14791045|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
14791046|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791047|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14791048|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14791049|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791050|NCT00739128|Vaccines|vaccines|mesh-list
14791051|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
14791052|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791053|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
14791054|NCT00739141|Thiotepa|thiotepa|mesh-list
14791055|NCT00739141|Fludarabine|fludarabine|mesh-list
14791056|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791057|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
14791058|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791059|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791060|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14791061|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
14791062|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791063|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791064|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14509756|NCT02991859|Hormones|hormones|mesh-ancestor
14509757|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509758|NCT02992132|Pimavanserin|pimavanserin|mesh-list
14509759|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14509760|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14509761|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14509762|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509763|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509764|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509765|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509766|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14509767|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14509768|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
14509769|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791065|NCT00739193|Amiodarone|amiodarone|mesh-list
14791066|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14791067|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
14791068|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14791069|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791070|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791071|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14791072|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14791073|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14791074|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225555|NCT01516216|Vitamin D|vitamin d|mesh-list
14225556|NCT01516216|Leucovorin|leucovorin|mesh-list
14225557|NCT01516216|Bevacizumab|bevacizumab|mesh-list
14225558|NCT01516216|Fluorouracil|fluorouracil|mesh-list
14225559|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
14225560|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14225561|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225562|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14225563|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14225564|NCT01516216|Growth Substances|growth substances|mesh-ancestor
14225565|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225566|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
14225567|NCT01516216|Vitamins|vitamins|mesh-ancestor
14225568|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
14225569|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14225570|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
14225571|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225572|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14225573|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14225574|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
14225575|NCT01516216|Antidotes|antidotes|mesh-ancestor
14225576|NCT01516216|Protective Agents|protective agents|mesh-ancestor
14225577|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
14791075|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14791076|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14791077|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14948319|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14948320|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
14948321|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14948322|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14948323|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14948324|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948325|NCT01532804|Bevacizumab|bevacizumab|mesh-list
14948326|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
14948327|NCT01532804|Raltitrexed|raltitrexed|mesh-list
14948328|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948329|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948330|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14948331|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14948332|NCT01532804|Growth Substances|growth substances|mesh-ancestor
14948333|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948334|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
14948335|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14948336|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
14948337|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948338|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14948339|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948340|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14948341|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
14948342|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948343|NCT01532856|Thalidomide|thalidomide|mesh-list
14948344|NCT01532856|Dexamethasone|dexamethasone|mesh-list
14948345|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
14948346|NCT01532856|Prednisone|prednisone|mesh-list
14948347|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
14948348|NCT01532856|Melphalan|melphalan|mesh-list
14948349|NCT01532856|BB 1101|bb 1101|mesh-list
14948350|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948351|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
14948352|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948353|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948354|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14948355|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
14948356|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948357|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791078|NCT00739388|Azacitidine|azacitidine|mesh-list
14791079|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14791080|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
14791081|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791082|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791083|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791084|NCT00739414|Panobinostat|panobinostat|mesh-list
14791085|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791086|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14791087|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791088|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791089|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14791090|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791091|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14791092|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791093|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791094|NCT00739466|Alendronate|alendronate|mesh-list
14791095|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14791096|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791097|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
14791098|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
14791099|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791100|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
14791101|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14791102|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
14791103|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791104|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791105|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14791106|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
14791107|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14791108|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
14791109|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791110|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791111|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14791112|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
14791113|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
14791114|NCT00739531|Protective Agents|protective agents|mesh-ancestor
14791115|NCT00739609|Tryptophan|tryptophan|mesh-list
14791116|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14791117|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
14791118|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14791119|NCT00739622|Rilpivirine|rilpivirine|mesh-list
14791120|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14791121|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14791122|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791123|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791124|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
14791125|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791126|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791127|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14791128|NCT00739830|Sirolimus|sirolimus|mesh-list
14791129|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14791130|NCT00739830|Megestrol|megestrol|mesh-list
14791131|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
14791132|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
14791133|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14791134|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14791135|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14791136|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
14791137|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14791138|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791139|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14791140|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14791141|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14791142|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14791143|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791144|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
14791145|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14791146|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791147|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791148|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14791149|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
14791150|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791151|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
14791152|NCT00739986|Semapimod|semapimod|mesh-list
14791153|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14791154|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14791155|NCT00739986|Analgesics|analgesics|mesh-ancestor
14791156|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
14791157|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791158|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791159|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791160|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791161|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791162|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
14791163|NCT00740064|Lamivudine|lamivudine|mesh-list
14791164|NCT00740064|Abacavir|abacavir|mesh-list
14791165|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
14791166|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14791167|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14791168|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791169|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791170|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
14791171|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791172|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791173|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14791174|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14791175|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14791176|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14791177|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14791178|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
14791179|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791180|NCT00740090|Antacids|antacids|mesh-ancestor
14791181|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791182|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791183|NCT00740103|Semapimod|semapimod|mesh-list
14791184|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14225729|NCT01062451|Candesartan|candesartan|mesh-list
14225730|NCT01062451|Perindopril|perindopril|mesh-list
14225731|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14225732|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14225733|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14225734|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225735|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14225736|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
14225737|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791185|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14791186|NCT00740103|Analgesics|analgesics|mesh-ancestor
14791187|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
14791188|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791189|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791190|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791191|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791192|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791193|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
14791194|NCT00740142|Lactulose|lactulose|mesh-list
14791195|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
14791196|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791197|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14791198|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14791199|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791200|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791201|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791202|NCT00740168|Bevacizumab|bevacizumab|mesh-list
14791203|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14791204|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791205|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14791206|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14791207|NCT00740168|Growth Substances|growth substances|mesh-ancestor
14791208|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791209|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
14791210|NCT00740194|Estradiol|estradiol|mesh-list
14791211|NCT00740194|Estrogens|estrogens|mesh-ancestor
14791212|NCT00740194|Hormones|hormones|mesh-ancestor
14791213|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791214|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791215|NCT00740259|Flunarizine|flunarizine|mesh-list
14791216|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
14791217|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14791218|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791219|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791220|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791221|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791222|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14791223|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
14791224|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
14791225|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791226|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
14791227|NCT00740285|Lidocaine|lidocaine|mesh-list
14791228|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
14791229|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
14791230|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791231|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791232|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
14791233|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791234|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14791235|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14791236|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14791237|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791238|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225790|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
14225791|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14225792|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14225793|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14225794|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14225795|NCT00381641|Sunitinib|sunitinib|mesh-list
14225796|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225797|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14225798|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14225799|NCT00381641|Growth Substances|growth substances|mesh-ancestor
14225800|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225801|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
14225802|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14225803|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225804|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791239|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14791240|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791241|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791242|NCT00740363|Incretins|incretins|mesh-ancestor
14791243|NCT00740363|Hormones|hormones|mesh-ancestor
14791244|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791245|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14791246|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
14791247|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791248|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791249|NCT00740389|Etravirine|etravirine|mesh-list
14791250|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14530055|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14530056|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530057|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
14530058|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
14530059|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
14530060|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530061|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14530062|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
14530063|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
14530064|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530065|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791251|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14791252|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791253|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791254|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
14791255|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791256|NCT00740415|Dexamethasone|dexamethasone|mesh-list
14791257|NCT00740415|Rituximab|rituximab|mesh-list
14509770|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509771|NCT02993224|Deferasirox|deferasirox|mesh-list
14791258|NCT00740415|Bortezomib|bortezomib|mesh-list
14791259|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14791260|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791261|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
14791262|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
14791263|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509772|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14509773|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
14509774|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
14509775|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509776|NCT02993250|Simeprevir|simeprevir|mesh-list
14509777|NCT02993250|Odalasvir|odalasvir|mesh-list
14509778|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
14509779|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509780|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
14509781|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509782|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509783|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
14509784|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
14509785|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14509786|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509787|NCT02993302|Vitamins|vitamins|mesh-ancestor
14509788|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
14528781|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14528782|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528783|NCT03828539|Analgesics|analgesics|mesh-ancestor
14528784|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
14528785|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528786|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
14528787|NCT03824704|Nivolumab|nivolumab|mesh-list
14528788|NCT03824704|Rucaparib|rucaparib|mesh-list
14528789|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14528790|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528791|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14528792|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528793|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14528794|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530066|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530067|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
14530068|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530069|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530070|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14530071|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14530072|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14530073|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
14530074|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14530075|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
14530076|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
14530077|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530078|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
14530079|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530080|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14530081|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14530082|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
14530083|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530084|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530085|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14791264|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791265|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791266|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
14791267|NCT00740415|Hormones|hormones|mesh-ancestor
14791268|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791269|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14791270|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791271|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14791272|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
14791273|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791274|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14791275|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
14791276|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791277|NCT00740467|Cyclosporine|cyclosporine|mesh-list
14791278|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
14791279|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
14791280|NCT00740467|Busulfan|busulfan|mesh-list
14791281|NCT00740467|Fludarabine|fludarabine|mesh-list
14791282|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
14791283|NCT00740467|Cyclosporins|cyclosporins|mesh-list
14791284|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14791285|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791286|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
14791287|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791288|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791289|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14791290|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
14791291|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791292|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791293|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14791294|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14791295|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
14791296|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791297|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
14791298|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791299|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
14791300|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14791301|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14791302|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14791303|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
14791304|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791305|NCT00740493|Warfarin|warfarin|mesh-list
14791306|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
14791307|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
14791308|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791309|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791310|NCT00740545|Enoxaparin|enoxaparin|mesh-list
14791311|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
14791312|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14791313|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14791314|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791315|NCT00740571|Pregabalin|pregabalin|mesh-list
14791316|NCT00740571|Amitriptyline|amitriptyline|mesh-list
14791317|NCT00740571|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14791318|NCT00740571|Analgesics|analgesics|mesh-ancestor
14791319|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
14791320|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791321|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791322|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
14791323|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14791324|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791325|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791326|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791327|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14509789|NCT02993471|Vitamin K|vitamin k|mesh-list
14509790|NCT02993471|Midazolam|midazolam|mesh-list
14509791|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
14509792|NCT02993471|Caffeine|caffeine|mesh-list
14509793|NCT02993471|Ixekizumab|ixekizumab|mesh-list
14509794|NCT02993471|Omeprazole|omeprazole|mesh-list
14509795|NCT02993471|Warfarin|warfarin|mesh-list
14509796|NCT02993471|Vitamins|vitamins|mesh-ancestor
14509797|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
14509798|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509799|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14509800|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14509801|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791328|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14791329|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791330|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14791331|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14791332|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14791333|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14791334|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14791335|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14791336|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
14791337|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791338|NCT00740571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14791339|NCT00740883|Warfarin|warfarin|mesh-list
14791340|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
14791341|NCT00740922|Becaplermin|becaplermin|mesh-list
14791342|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
14791343|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14791344|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14791345|NCT00740922|Growth Substances|growth substances|mesh-ancestor
14791346|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791347|NCT00740948|Rituximab|rituximab|mesh-list
14791348|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14791349|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791350|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
14791351|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791352|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791353|NCT00741052|Azithromycin|azithromycin|mesh-list
14791354|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
14791355|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791356|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791357|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14791358|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14791359|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791360|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791361|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791362|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14791363|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14791364|NCT00741078|Amlodipine|amlodipine|mesh-list
14791365|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14791366|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14791367|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791368|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791369|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791370|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791371|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
14791372|NCT00741117|Bilirubin|bilirubin|mesh-list
14791373|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
14791374|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791375|NCT00741117|Protective Agents|protective agents|mesh-ancestor
14791376|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242494|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14242495|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242496|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
14242497|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
14242498|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14242499|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
14242500|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
14242501|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242502|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14242503|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
14242504|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14242505|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
14242506|NCT00186875|Cytarabine|cytarabine|mesh-list
14242507|NCT00186875|Dexamethasone|dexamethasone|mesh-list
14242508|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
14242509|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
14242510|NCT00186875|Methotrexate|methotrexate|mesh-list
14242511|NCT00186875|Etoposide|etoposide|mesh-list
14242512|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
14242513|NCT00186875|Vincristine|vincristine|mesh-list
14242514|NCT00186875|Asparaginase|asparaginase|mesh-list
14242515|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
14242516|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
14242517|NCT00186875|Vinblastine|vinblastine|mesh-list
14242518|NCT00186875|Pegaspargase|pegaspargase|mesh-list
14242519|NCT00186875|Teniposide|teniposide|mesh-list
14242520|NCT00186875|BB 1101|bb 1101|mesh-list
14242521|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242522|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
14225955|NCT00006178|Sirolimus|sirolimus|mesh-list
14225956|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
14225957|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14225958|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14225959|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14225960|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225961|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
14225962|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14225963|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
14225964|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225965|NCT00006184|Cyclosporine|cyclosporine|mesh-list
14225966|NCT00006184|Prednisone|prednisone|mesh-list
14225967|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
14225968|NCT00006184|Doxorubicin|doxorubicin|mesh-list
14225969|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14225970|NCT00006184|Methotrexate|methotrexate|mesh-list
14225971|NCT00006184|Fludarabine|fludarabine|mesh-list
14225972|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
14225973|NCT00006184|Etoposide|etoposide|mesh-list
14225974|NCT00006184|Vincristine|vincristine|mesh-list
14225975|NCT00006184|Bortezomib|bortezomib|mesh-list
14225976|NCT00006184|Molgramostim|molgramostim|mesh-list
14225977|NCT00006184|Cyclosporins|cyclosporins|mesh-list
14225978|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
14225979|NCT00006184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14225980|NCT00006184|Antibodies|antibodies|mesh-list
14225981|NCT00006184|Sargramostim|sargramostim|mesh-list
14225982|NCT00006184|Lenograstim|lenograstim|mesh-list
14225983|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
14225984|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14225985|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
14225986|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14225987|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14225988|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14225989|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
14225990|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14225991|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14225992|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14225993|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14225994|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14225995|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14791377|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
14791378|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14791379|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
14791380|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
14791381|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791382|NCT00741169|Rifampin|rifampin|mesh-list
14791383|NCT00741169|Simeprevir|simeprevir|mesh-list
14225996|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14225997|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14225998|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
14225999|NCT00006184|Hormones|hormones|mesh-ancestor
14226000|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226001|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226002|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14226003|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
14226004|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14226005|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226006|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
14226007|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
14226008|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14226009|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14226010|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226011|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226012|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226013|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226014|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
14226015|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226016|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14226017|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14226018|NCT00006227|Paclitaxel|paclitaxel|mesh-list
14226019|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226020|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226021|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226022|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226023|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226024|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791384|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14226025|NCT00006237|Interferons|interferons|mesh-list
14226026|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
14226027|NCT00006237|Aldesleukin|aldesleukin|mesh-list
14226028|NCT00006237|Interleukin-2|interleukin-2|mesh-list
14226029|NCT00006237|Dacarbazine|dacarbazine|mesh-list
14226030|NCT00006237|Vinblastine|vinblastine|mesh-list
14226031|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226032|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
14226033|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226034|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
14226035|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226036|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14226037|NCT00006237|Analgesics|analgesics|mesh-ancestor
14226038|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
14226039|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226040|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226041|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226042|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226043|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
14226044|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226045|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226046|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226047|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226048|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226049|NCT00006244|Interferons|interferons|mesh-list
14226050|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
14226051|NCT00006244|Aldesleukin|aldesleukin|mesh-list
14226052|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
14226053|NCT00006244|Melphalan|melphalan|mesh-list
14226054|NCT00006244|Interleukin-2|interleukin-2|mesh-list
14226055|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226056|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
14226057|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226058|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226059|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
14226060|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226061|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226062|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226063|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
14226064|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226065|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14226066|NCT00006244|Analgesics|analgesics|mesh-ancestor
14226067|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
14226068|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226069|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226070|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226071|NCT00006289|Neurotropin|neurotropin|mesh-list
14226072|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14226073|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
14226074|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226075|NCT00006289|Analgesics|analgesics|mesh-ancestor
14226076|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
14226077|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226078|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
14226079|NCT00006305|Biguanides|biguanides|mesh-list
14226080|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
14226081|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
14226082|NCT00006305|Calcium|calcium|mesh-list
14226083|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14226084|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14226085|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14226086|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14226087|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226088|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14226089|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14226090|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
14226091|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14226092|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226093|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
14226094|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226095|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14948358|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226096|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
14226097|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226098|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14226099|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
14226100|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226101|NCT00006392|Vitamins|vitamins|mesh-list
14226102|NCT00006392|Vitamin E|vitamin e|mesh-list
14226103|NCT00006392|Tocopherols|tocopherols|mesh-list
14226104|NCT00006392|Tocotrienols|tocotrienols|mesh-list
14226105|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
14226106|NCT00006392|Selenium|selenium|mesh-list
14226107|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
14226108|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226109|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
14226110|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226111|NCT00006392|Protective Agents|protective agents|mesh-ancestor
14226112|NCT00006392|Trace Elements|trace elements|mesh-ancestor
14226113|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
14226114|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226115|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
14226116|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226117|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226118|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14226119|NCT00006489|Naltrexone|naltrexone|mesh-list
14226120|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14226121|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14226122|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226123|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
14226124|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226125|NCT00006604|Ritonavir|ritonavir|mesh-list
14226126|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14226127|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14226128|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
14226129|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226130|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226131|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226132|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226133|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
14226134|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226135|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14226136|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14226137|NCT00006721|Prednisone|prednisone|mesh-list
14509802|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14509803|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509804|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509805|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14509806|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
14509807|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
14509808|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
14509809|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
14509810|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509811|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509812|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
14509813|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14509814|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509815|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14509816|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509817|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14509818|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14509819|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14509820|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14509821|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
14509822|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14226138|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
14226139|NCT00006721|Rituximab|rituximab|mesh-list
14226140|NCT00006721|Doxorubicin|doxorubicin|mesh-list
14226141|NCT00006721|Vincristine|vincristine|mesh-list
14226142|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226143|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
14226144|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226145|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226146|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226147|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
14226148|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226149|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226150|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226151|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226152|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226153|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226154|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226155|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226156|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14226157|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
14226158|NCT00006721|Hormones|hormones|mesh-ancestor
14226159|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226160|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226161|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226162|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226163|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226164|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226165|NCT00006903|Fulvestrant|fulvestrant|mesh-list
14226166|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226167|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226168|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14509823|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14509824|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
14509825|NCT02993471|Coagulants|coagulants|mesh-ancestor
14509826|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
14509827|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
14509828|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14509829|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14509830|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
14509831|NCT02993783|Vedolizumab|vedolizumab|mesh-list
14509832|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509833|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
14509834|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14509835|NCT02994056|Velpatasvir|velpatasvir|mesh-list
14509836|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
14509837|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509838|NCT02994394|Tolvaptan|tolvaptan|mesh-list
14509839|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14509840|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509841|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
14509842|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509843|NCT02994940|Acetaminophen|acetaminophen|mesh-list
14509844|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14509845|NCT02994940|Analgesics|analgesics|mesh-ancestor
14509846|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
14509847|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509848|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509849|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
14509850|NCT02995915|Bupropion|bupropion|mesh-list
14509851|NCT02995915|Nicotine|nicotine|mesh-list
14509852|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14509853|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
14509854|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509855|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509856|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14509857|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14509858|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
14509859|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509860|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509861|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14509862|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
14509863|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509864|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14509865|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14509866|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14509867|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
14509868|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14509869|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14509870|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226169|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14226170|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
14226171|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226172|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226173|NCT00007020|Cholic Acids|cholic acids|mesh-list
14226174|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14226175|NCT00007345|Romidepsin|romidepsin|mesh-list
14226176|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226177|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226178|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
14226179|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226180|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
14226181|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226182|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226183|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226184|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
14226185|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226186|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226187|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226188|NCT00008138|Paclitaxel|paclitaxel|mesh-list
14226189|NCT00008138|Carboplatin|carboplatin|mesh-list
14226190|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226191|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226192|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226193|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226194|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226195|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226196|NCT00008385|Selenium|selenium|mesh-list
14226197|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
14226198|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226199|NCT00008385|Protective Agents|protective agents|mesh-ancestor
14226200|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226201|NCT00008385|Trace Elements|trace elements|mesh-ancestor
14226202|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
14226203|NCT00009737|Leucovorin|leucovorin|mesh-list
14226204|NCT00009737|Fluorouracil|fluorouracil|mesh-list
14226205|NCT00009737|Capecitabine|capecitabine|mesh-list
14226206|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
14226207|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226208|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226209|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226210|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226211|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
14226212|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226213|NCT00009737|Antidotes|antidotes|mesh-ancestor
14226214|NCT00009737|Protective Agents|protective agents|mesh-ancestor
14226215|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
14226216|NCT00009737|Vitamins|vitamins|mesh-ancestor
14226217|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
14226218|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
14226219|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14226220|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226221|NCT00010257|Paclitaxel|paclitaxel|mesh-list
14226222|NCT00010257|Carboplatin|carboplatin|mesh-list
14226223|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226224|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226225|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226226|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226227|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226228|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226229|NCT00010439|Alendronate|alendronate|mesh-list
14226230|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14226231|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226232|NCT00011986|Gemcitabine|gemcitabine|mesh-list
14226233|NCT00011986|Paclitaxel|paclitaxel|mesh-list
14226234|NCT00011986|Carboplatin|carboplatin|mesh-list
14226235|NCT00011986|Doxorubicin|doxorubicin|mesh-list
14226236|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14226237|NCT00011986|Topotecan|topotecan|mesh-list
14509871|NCT02996097|Triamcinolone|triamcinolone|mesh-list
14226238|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226239|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226240|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226241|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226242|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226243|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226244|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226245|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
14226246|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
14226247|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226248|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226249|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226250|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
14226251|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226252|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226253|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226254|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226255|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14226256|NCT00012012|Amifostine|amifostine|mesh-list
14226257|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14226258|NCT00012012|Protective Agents|protective agents|mesh-ancestor
14226259|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226260|NCT00012298|Rituximab|rituximab|mesh-list
14226261|NCT00012298|Oprelvekin|oprelvekin|mesh-list
14226262|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14226263|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226264|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226265|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
14226266|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226267|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226268|NCT00013611|Aldesleukin|aldesleukin|mesh-list
14226269|NCT00013611|Interleukin-2|interleukin-2|mesh-list
14226270|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226271|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14226272|NCT00013611|Analgesics|analgesics|mesh-ancestor
14226273|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
14226274|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226275|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226276|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226277|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226278|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
14226279|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226280|NCT00014222|Paclitaxel|paclitaxel|mesh-list
14226281|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
14226282|NCT00014222|Doxorubicin|doxorubicin|mesh-list
14226283|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14226284|NCT00014222|Fluorouracil|fluorouracil|mesh-list
14226285|NCT00014222|Epirubicin|epirubicin|mesh-list
14226286|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
14226287|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226288|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226289|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226290|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226291|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226292|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226293|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226294|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
14226295|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226296|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948359|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14226297|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226298|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
14226299|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226300|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226301|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226302|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226303|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226304|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
14226305|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226306|NCT00014222|Hematinics|hematinics|mesh-ancestor
14226307|NCT00014495|Cytarabine|cytarabine|mesh-list
14226308|NCT00014495|Bismuth|bismuth|mesh-list
14226309|NCT00014495|Antibodies|antibodies|mesh-list
14226310|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14226311|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
14226312|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226313|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226314|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
14226315|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226316|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226317|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
14226318|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226319|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226320|NCT00014495|Antacids|antacids|mesh-ancestor
14226321|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14226322|NCT00014911|Sirolimus|sirolimus|mesh-list
14226323|NCT00014911|Pentamidine|pentamidine|mesh-list
14226324|NCT00014911|Trimethoprim|trimethoprim|mesh-list
14226325|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
14226326|NCT00014911|Ganciclovir|ganciclovir|mesh-list
14226327|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14226328|NCT00014911|Tacrolimus|tacrolimus|mesh-list
14791385|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
14791386|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791387|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948360|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
14948361|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
14948362|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948363|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14948364|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
14948365|NCT01532856|Hormones|hormones|mesh-ancestor
14948366|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948367|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14948368|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
14226329|NCT00014911|Daclizumab|daclizumab|mesh-list
14226330|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226331|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
14226332|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226333|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14226334|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226335|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226336|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14226337|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226338|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226339|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226340|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
14226341|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14226342|NCT00014911|Renal Agents|renal agents|mesh-ancestor
14226343|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
14226344|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14791388|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
14791389|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14791390|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791391|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791392|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14791393|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14791394|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14791395|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14791396|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14791397|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14791398|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
13965149|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965150|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
13965151|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13965152|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13965153|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13965154|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226345|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14226346|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14226347|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14948369|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948370|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
13965155|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965156|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
13965157|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13965158|NCT03132311|Vaccines|vaccines|mesh-list
13965159|NCT03132311|Immunologic Factors|immunologic factors|mesh-ancestor
13965160|NCT03132311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965161|NCT03132376|Caseins|caseins|mesh-list
13965162|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
13965163|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
13965164|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965165|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
13965166|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14226348|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14226349|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14226350|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
14226351|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14226352|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14226353|NCT00015457|Amlodipine|amlodipine|mesh-list
14226354|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
14226355|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14226356|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14226357|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226358|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
14226359|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14226360|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226361|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14226362|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14226363|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14226364|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
14226365|NCT00015847|Interferons|interferons|mesh-list
14226366|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
14226367|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
14226368|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226369|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
14226370|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226371|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
14226372|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226373|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14226374|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226375|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226376|NCT00016718|Emtricitabine|emtricitabine|mesh-list
14226377|NCT00016718|Efavirenz|efavirenz|mesh-list
14226378|NCT00016718|Didanosine|didanosine|mesh-list
14226379|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
14226380|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226381|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14226382|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14226383|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226384|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226385|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226386|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226387|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14226388|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14226389|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14226390|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14226391|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14226392|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14226393|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
14226394|NCT00016913|Paclitaxel|paclitaxel|mesh-list
14226395|NCT00016913|Carboplatin|carboplatin|mesh-list
14226396|NCT00016913|Leuprolide|leuprolide|mesh-list
14226397|NCT00016913|Goserelin|goserelin|mesh-list
14226398|NCT00016913|Estramustine|estramustine|mesh-list
14226399|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226400|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226401|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226402|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226403|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226404|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226405|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14226406|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
14226407|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14226408|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226409|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226410|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226411|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
14226412|NCT00017563|Docetaxel|docetaxel|mesh-list
14226413|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
14226414|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226415|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226416|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226417|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226418|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226419|NCT00017563|Analgesics|analgesics|mesh-ancestor
14226420|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
14226421|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528795|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
14226422|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226423|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226424|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226425|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226426|NCT00018031|Ribavirin|ribavirin|mesh-list
14226427|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14226428|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
14226429|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
14226430|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226431|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
14226432|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226433|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
14226434|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226435|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14226436|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14226437|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226438|NCT00019682|Aldesleukin|aldesleukin|mesh-list
14226439|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226440|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226441|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226442|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
14226443|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226444|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
14226445|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226446|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14226447|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226448|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226449|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
14226450|NCT00021255|Carboplatin|carboplatin|mesh-list
14226451|NCT00021255|Docetaxel|docetaxel|mesh-list
14226452|NCT00021255|Doxorubicin|doxorubicin|mesh-list
14226453|NCT00021255|Trastuzumab|trastuzumab|mesh-list
14226454|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226455|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
14226456|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226457|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226458|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226459|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
14226460|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226461|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226462|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226463|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226464|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226465|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226466|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226467|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226468|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226469|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226470|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226471|NCT00021541|Tipifarnib|tipifarnib|mesh-list
14226472|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226473|NCT00022490|Cytarabine|cytarabine|mesh-list
14226474|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
14226475|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226476|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
14226477|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226478|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226479|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
14226480|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226481|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226482|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
14226483|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226484|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14226485|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226486|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
14226487|NCT00022516|Methotrexate|methotrexate|mesh-list
14226488|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226489|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
14226490|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226491|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226492|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226493|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
14226494|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226495|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226496|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14528796|NCT03827473|Prednisone|prednisone|mesh-list
14226497|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14226498|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
14226499|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14226500|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226501|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
14226502|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
14226503|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226504|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14226505|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14226506|NCT00022633|Gemcitabine|gemcitabine|mesh-list
14226507|NCT00022633|Paclitaxel|paclitaxel|mesh-list
14226508|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226509|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226510|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226511|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226512|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226513|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226514|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226515|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
14226516|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
14226517|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226518|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226519|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226520|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
14226521|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226522|NCT00022659|Bevacizumab|bevacizumab|mesh-list
14226523|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14226524|NCT00022659|Antibodies|antibodies|mesh-list
14226525|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
14226526|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14226527|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226528|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14226529|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14226530|NCT00022659|Growth Substances|growth substances|mesh-ancestor
14226531|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226532|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
14226533|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
14226534|NCT00022672|Trastuzumab|trastuzumab|mesh-list
14226535|NCT00022672|Anastrozole|anastrozole|mesh-list
14226536|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226537|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226538|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226539|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14226540|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14226541|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509872|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14509873|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14509874|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14509875|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791399|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
14791400|NCT00741182|Teriparatide|teriparatide|mesh-list
14791401|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791402|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509876|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
14509877|NCT02996097|Hormones|hormones|mesh-ancestor
14509878|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509879|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509880|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14509881|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
14509882|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509883|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509884|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
14509885|NCT02996474|Decitabine|decitabine|mesh-list
14509886|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14509887|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509888|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14509889|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
14509890|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509891|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509892|NCT02996500|Tofacitinib|tofacitinib|mesh-list
14509893|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14509894|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528797|NCT03827473|Cortisone|cortisone|mesh-list
14791403|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14226542|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226543|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14226544|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
14226545|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226546|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226547|NCT00022698|Capecitabine|capecitabine|mesh-list
14226548|NCT00022698|Irinotecan|irinotecan|mesh-list
14226549|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226550|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
14226551|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226552|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226553|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14226554|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226555|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226556|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
14226557|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14226558|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14226559|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226560|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226561|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226562|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
14226563|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226564|NCT00023309|Lamivudine|lamivudine|mesh-list
14226565|NCT00023309|Adefovir|adefovir|mesh-list
14226566|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14226567|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14226568|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14226569|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226570|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226571|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
14226572|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226573|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14226574|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14226575|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14226576|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
14226577|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226578|NCT00023452|Isoniazid|isoniazid|mesh-list
14226579|NCT00023452|Rifapentine|rifapentine|mesh-list
14226580|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
14226581|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14226582|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226583|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14509895|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509896|NCT02996591|Dexamethasone|dexamethasone|mesh-list
14509897|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
14791404|NCT00741195|Bevacizumab|bevacizumab|mesh-list
14791405|NCT00741195|Docetaxel|docetaxel|mesh-list
14791406|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14791407|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791408|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14791409|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14791410|NCT00741195|Growth Substances|growth substances|mesh-ancestor
14791411|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791412|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
14791413|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
14791414|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
14791415|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226584|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14226585|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
14226586|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226587|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14509898|NCT02996591|Midazolam|midazolam|mesh-list
14509899|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
14509900|NCT02996591|Ketamine|ketamine|mesh-list
14509901|NCT02996591|Bupivacaine|bupivacaine|mesh-list
14509902|NCT02996591|Mepivacaine|mepivacaine|mesh-list
14509903|NCT02996591|Anesthetics|anesthetics|mesh-list
14509904|NCT02996591|Propofol|propofol|mesh-list
14509905|NCT02996591|Sevoflurane|sevoflurane|mesh-list
14509906|NCT02996591|BB 1101|bb 1101|mesh-list
14509907|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14509908|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
14509909|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
14509910|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509911|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509912|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509913|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
14509914|NCT02996591|Hormones|hormones|mesh-ancestor
14948371|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14226588|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14226589|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
14226590|NCT00023673|Paclitaxel|paclitaxel|mesh-list
14226591|NCT00023673|Carboplatin|carboplatin|mesh-list
14226592|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226593|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226594|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226595|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226596|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226597|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226598|NCT00023712|Bortezomib|bortezomib|mesh-list
14226599|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226600|NCT00023764|Bortezomib|bortezomib|mesh-list
14226601|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226602|NCT00024102|Doxorubicin|doxorubicin|mesh-list
14226603|NCT00024102|Capecitabine|capecitabine|mesh-list
14226604|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226605|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226606|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226607|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226608|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226609|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226610|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226611|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
14226612|NCT00024167|Ketoconazole|ketoconazole|mesh-list
14226613|NCT00024167|Dexamethasone|dexamethasone|mesh-list
14226614|NCT00024167|Prednisone|prednisone|mesh-list
14226615|NCT00024167|Estramustine|estramustine|mesh-list
14226616|NCT00024167|Docetaxel|docetaxel|mesh-list
14226617|NCT00024167|Doxorubicin|doxorubicin|mesh-list
14226618|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14226619|NCT00024167|Vinblastine|vinblastine|mesh-list
14226620|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14226621|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
14226622|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
14226623|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226624|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226625|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14226626|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
14226627|NCT00024167|Hormones|hormones|mesh-ancestor
14226628|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226629|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226630|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226631|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226632|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226633|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226634|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226635|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226636|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226637|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226638|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226639|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
14226640|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226641|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14226642|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14226643|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14226644|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
14226645|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14226646|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226647|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226648|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
14226649|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
14226650|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226651|NCT00025155|Epothilones|epothilones|mesh-list
14226652|NCT00025155|Epothilone B|epothilone b|mesh-list
14226653|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226654|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226655|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226656|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226657|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226658|NCT00025233|Bevacizumab|bevacizumab|mesh-list
14226659|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14528798|NCT03827473|Docetaxel|docetaxel|mesh-list
14226660|NCT00025233|Antibodies|antibodies|mesh-list
14226661|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
14226662|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14226663|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226664|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14226665|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14226666|NCT00025233|Growth Substances|growth substances|mesh-ancestor
14226667|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226668|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
14226669|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
14226670|NCT00025259|Cytarabine|cytarabine|mesh-list
14226671|NCT00025259|Dexamethasone|dexamethasone|mesh-list
14226672|NCT00025259|Prednisone|prednisone|mesh-list
14226673|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
14226674|NCT00025259|Cortisone|cortisone|mesh-list
14226675|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
14226676|NCT00025259|Cisplatin|cisplatin|mesh-list
14226677|NCT00025259|Doxorubicin|doxorubicin|mesh-list
14226678|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14226679|NCT00025259|Etoposide|etoposide|mesh-list
14226680|NCT00025259|Vincristine|vincristine|mesh-list
14226681|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
14226682|NCT00025259|Bleomycin|bleomycin|mesh-list
14226683|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
14226684|NCT00025259|Lenograstim|lenograstim|mesh-list
14226685|NCT00025259|BB 1101|bb 1101|mesh-list
14226686|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226687|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
14226688|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226689|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226690|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226691|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
14226692|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226693|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226694|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226695|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14226696|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
14226697|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
14226698|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226699|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14226700|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
14226701|NCT00025259|Hormones|hormones|mesh-ancestor
14226702|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226703|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226704|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226705|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226706|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226707|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226708|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226709|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226710|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
14226711|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
14226712|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226713|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14226714|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226715|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226716|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226717|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
14226718|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
14226719|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
14226720|NCT00025506|Thalidomide|thalidomide|mesh-list
14226721|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226722|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
14226723|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226724|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
14226725|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14226726|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226727|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14226728|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14226729|NCT00025506|Growth Substances|growth substances|mesh-ancestor
14226730|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
14226731|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226732|NCT00025662|Interleukin-2|interleukin-2|mesh-list
14226733|NCT00025662|Immunotoxins|immunotoxins|mesh-list
14226734|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226735|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14226736|NCT00025662|Analgesics|analgesics|mesh-ancestor
14226737|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
14226738|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226739|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226740|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
14226741|NCT00026208|Prednisone|prednisone|mesh-list
14226742|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
14226743|NCT00026208|Doxorubicin|doxorubicin|mesh-list
14226744|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14226745|NCT00026208|Etoposide|etoposide|mesh-list
14226746|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
14226747|NCT00026208|Vincristine|vincristine|mesh-list
14226748|NCT00026208|Bleomycin|bleomycin|mesh-list
14226749|NCT00026208|Vinblastine|vinblastine|mesh-list
14226750|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226751|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
14226752|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226753|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226754|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226755|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
14226756|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226757|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226758|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226759|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14226760|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226761|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226762|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226763|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14226764|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
14226765|NCT00026208|Hormones|hormones|mesh-ancestor
14226766|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226767|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226768|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226769|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226770|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226771|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226772|NCT00026221|Interferons|interferons|mesh-list
14226773|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
14226774|NCT00026221|Bevacizumab|bevacizumab|mesh-list
14226775|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226776|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226777|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14226778|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14226779|NCT00026221|Growth Substances|growth substances|mesh-ancestor
14226780|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226781|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
14226782|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
14226783|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226784|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
14226785|NCT00026494|Temozolomide|temozolomide|mesh-list
14226786|NCT00026494|Vinorelbine|vinorelbine|mesh-list
14226787|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226788|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
14226789|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226790|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226791|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226792|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226793|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226794|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226795|NCT00027027|Pertuzumab|pertuzumab|mesh-list
14226796|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226797|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226798|NCT00027378|Fluoxetine|fluoxetine|mesh-list
14226799|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14226800|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14226801|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14226802|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226803|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14226804|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
14226805|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226806|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14226807|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
14226808|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14226809|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14226810|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14226811|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226812|NCT00027560|Cyclosporine|cyclosporine|mesh-list
14226813|NCT00027560|Fludarabine|fludarabine|mesh-list
14226814|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
14226815|NCT00027560|Melphalan|melphalan|mesh-list
14226816|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
14226817|NCT00027560|Cyclosporins|cyclosporins|mesh-list
14226818|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226819|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226820|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
14226821|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226822|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226823|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
14226824|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226825|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226826|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
14226827|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226828|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
14226829|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226830|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14226831|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226832|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
14226833|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226834|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226835|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
14226836|NCT00027846|Carboplatin|carboplatin|mesh-list
14226837|NCT00027846|Etoposide|etoposide|mesh-list
14226838|NCT00027846|Vincristine|vincristine|mesh-list
14226839|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
14226840|NCT00027846|Lenograstim|lenograstim|mesh-list
14226841|NCT00027846|Sargramostim|sargramostim|mesh-list
14226842|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226843|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
14226844|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226845|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226846|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226847|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
14226848|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226849|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226850|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14226851|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226852|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226853|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226854|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226855|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14226856|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226857|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226858|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226859|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
14226860|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
14226861|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
14226862|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509915|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509916|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14509917|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509918|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
14509919|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509920|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509921|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
14509922|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509923|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
14509924|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14509925|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14509926|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
14509927|NCT02996591|Analgesics|analgesics|mesh-ancestor
14509928|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14509929|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14509930|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14509931|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509932|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14509933|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14509934|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14509935|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14509936|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
14509937|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
14509938|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14509939|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14509940|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14509941|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14509942|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
14509943|NCT02996682|Ribavirin|ribavirin|mesh-list
14509944|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14509945|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
14509946|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226863|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14226864|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226865|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226866|NCT00028093|Ribavirin|ribavirin|mesh-list
14226867|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14226868|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
14226869|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
14226870|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226871|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
14226872|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226873|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
14226874|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226875|NCT00028262|Cysteamine|cysteamine|mesh-list
14226876|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14226877|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226878|NCT00028769|Paclitaxel|paclitaxel|mesh-list
14226879|NCT00028769|Etoposide|etoposide|mesh-list
14226880|NCT00028769|Leuprolide|leuprolide|mesh-list
14226881|NCT00028769|Goserelin|goserelin|mesh-list
14226882|NCT00028769|Bicalutamide|bicalutamide|mesh-list
14226883|NCT00028769|Flutamide|flutamide|mesh-list
14226884|NCT00028769|Estramustine|estramustine|mesh-list
14226885|NCT00028769|Nilutamide|nilutamide|mesh-list
14226886|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226887|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226888|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226889|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226890|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226891|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226892|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14226893|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14226894|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226895|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14226896|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
14226897|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14226898|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226899|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14226900|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
14226901|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
14226902|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226903|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14226904|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
14226905|NCT00029107|Rituximab|rituximab|mesh-list
14226906|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14226907|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226908|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
14226909|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226910|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226911|NCT00029536|Progesterone|progesterone|mesh-list
14226912|NCT00029536|Progestins|progestins|mesh-ancestor
14226913|NCT00029536|Hormones|hormones|mesh-ancestor
14226914|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226915|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226916|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14226917|NCT00030147|Estradiol|estradiol|mesh-list
14226918|NCT00030147|Estrogens|estrogens|mesh-ancestor
14226919|NCT00030147|Hormones|hormones|mesh-ancestor
14226920|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14226921|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226922|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14226923|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
14226924|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14226925|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14226926|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14226927|NCT00030264|Methotrexate|methotrexate|mesh-list
14226928|NCT00030264|Vinblastine|vinblastine|mesh-list
14226929|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14226930|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
14226931|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14226932|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226933|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14226934|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
14226935|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226936|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14226937|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
14226938|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14226939|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14226940|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14226941|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
14226942|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226943|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14226944|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14226945|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
14226946|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
14226947|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
14226948|NCT00030901|Selenium|selenium|mesh-list
14226949|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
14226950|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226951|NCT00030901|Protective Agents|protective agents|mesh-ancestor
14226952|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226953|NCT00030901|Trace Elements|trace elements|mesh-ancestor
14226954|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
14226955|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
14226956|NCT00030992|Promethazine|promethazine|mesh-list
14226957|NCT00030992|Ranitidine|ranitidine|mesh-list
14226958|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14226959|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14226960|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14226961|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14226962|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226963|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
14226964|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
14226965|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
14226966|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226967|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
14226968|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
14226969|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14509947|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
14509948|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965167|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509949|NCT02997163|Talazoparib|talazoparib|mesh-list
14509950|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14509951|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509952|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509953|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509954|NCT02997176|Talazoparib|talazoparib|mesh-list
14509955|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14509956|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509957|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965168|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965169|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965170|NCT03132259|Analgesics|analgesics|mesh-ancestor
13965171|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
13965172|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965173|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13965174|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13965175|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13965176|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
13965177|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965178|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965179|NCT03132181|Empagliflozin|empagliflozin|mesh-list
14948372|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948373|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14948374|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14948375|NCT01532856|Growth Substances|growth substances|mesh-ancestor
14509958|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14509959|NCT02997722|Ketamine|ketamine|mesh-list
14509960|NCT02997722|Analgesics|analgesics|mesh-ancestor
14226970|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14226971|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
14226972|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
14226973|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14226974|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14226975|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14226976|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
14226977|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
14226978|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14226979|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14226980|NCT00031447|Acyclovir|acyclovir|mesh-list
14226981|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
14226982|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226983|NCT00031460|Acyclovir|acyclovir|mesh-list
14226984|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
14226985|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226986|NCT00031486|Valacyclovir|valacyclovir|mesh-list
14226987|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
14226988|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14226989|NCT00031551|Etanercept|etanercept|mesh-list
14226990|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14226991|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14226992|NCT00031551|Analgesics|analgesics|mesh-ancestor
14226993|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
14226994|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14226995|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14226996|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14226997|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14226998|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14226999|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227000|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
14227001|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
14227002|NCT00031590|Lomustine|lomustine|mesh-list
14227003|NCT00031590|Etoposide|etoposide|mesh-list
14227004|NCT00031590|Vincristine|vincristine|mesh-list
14227005|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227006|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
14227007|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227008|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227009|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227010|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
14227011|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227012|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227013|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227014|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227015|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227016|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227017|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227018|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227019|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227020|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227021|NCT00031694|Paclitaxel|paclitaxel|mesh-list
14227022|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
14227023|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227024|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227025|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227026|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227027|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227028|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227029|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14227030|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
14227031|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227032|NCT00032487|Metformin|metformin|mesh-list
14227033|NCT00032487|Glimepiride|glimepiride|mesh-list
14227034|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
14227035|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14227036|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227037|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14227038|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227039|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
14227040|NCT00032591|Thrombin|thrombin|mesh-list
14227041|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
14227042|NCT00032591|Coagulants|coagulants|mesh-ancestor
14242523|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242524|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242525|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14242526|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
14242527|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227043|NCT00033371|Eflornithine|eflornithine|mesh-list
14227044|NCT00033371|Celecoxib|celecoxib|mesh-list
14227045|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14227046|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14227047|NCT00033371|Analgesics|analgesics|mesh-ancestor
14227048|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
14227049|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227050|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227051|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227052|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227053|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14227054|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14227055|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227056|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227057|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227058|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14227059|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14227060|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14227061|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227062|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14227063|NCT00033514|Trastuzumab|trastuzumab|mesh-list
14227064|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14227065|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227066|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227067|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227068|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227069|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227070|NCT00033540|Gemcitabine|gemcitabine|mesh-list
14227071|NCT00033540|Capecitabine|capecitabine|mesh-list
14227072|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227073|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
14227074|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227075|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227076|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
14227077|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227078|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227079|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227080|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
14227081|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227082|NCT00033657|Paclitaxel|paclitaxel|mesh-list
14227083|NCT00033657|Camptothecin|camptothecin|mesh-list
14227084|NCT00033657|Cisplatin|cisplatin|mesh-list
14227085|NCT00033657|Irinotecan|irinotecan|mesh-list
14227086|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227087|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227088|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227089|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227090|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227091|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227092|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14227093|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14509961|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
14509962|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509963|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14509964|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14509965|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14509966|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
14509967|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
14509968|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14509969|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14509970|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14509971|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509972|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509973|NCT02998151|Minocycline|minocycline|mesh-list
14227094|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227095|NCT00033917|Indomethacin|indomethacin|mesh-list
14227096|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14227097|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14227098|NCT00033917|Analgesics|analgesics|mesh-ancestor
14227099|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
14227100|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227101|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227102|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227103|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227104|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
14227105|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
14227106|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14227107|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14227108|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227109|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227110|NCT00035555|Cyclosporine|cyclosporine|mesh-list
14227111|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
14227112|NCT00035555|Abatacept|abatacept|mesh-list
14227113|NCT00035555|Cyclosporins|cyclosporins|mesh-list
14227114|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227115|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227116|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227117|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
14227118|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227119|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
14227120|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227121|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227122|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227123|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227124|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227125|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227126|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14227127|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
14227128|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227129|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14227130|NCT00035815|Mitogens|mitogens|mesh-list
14227131|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227132|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227133|NCT00035932|Ritonavir|ritonavir|mesh-list
14227134|NCT00035932|Lopinavir|lopinavir|mesh-list
14227135|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14227136|NCT00035932|Saquinavir|saquinavir|mesh-list
14227137|NCT00035932|Tenofovir|tenofovir|mesh-list
14227138|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14227139|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14227140|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
14227141|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227142|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227143|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14227144|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14227145|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
14227146|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227147|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14227148|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14227149|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14227150|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14227151|NCT00036270|Tamoxifen|tamoxifen|mesh-list
14227152|NCT00036270|Exemestane|exemestane|mesh-list
14227153|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14227154|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
14227155|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227156|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227157|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227158|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227159|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14227160|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14227161|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14227162|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14227163|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14227164|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227165|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227166|NCT00036569|Interferons|interferons|mesh-list
14227167|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
14227168|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227169|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
14227170|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227171|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
14227172|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227173|NCT00036738|Cyclosporine|cyclosporine|mesh-list
14227174|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
14227175|NCT00036738|Fludarabine|fludarabine|mesh-list
14227176|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
14227177|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
14227178|NCT00036738|Dasatinib|dasatinib|mesh-list
14227179|NCT00036738|Cyclosporins|cyclosporins|mesh-list
14227180|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227181|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227182|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
14227183|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227184|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227185|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
14227186|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227187|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227188|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
14227189|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227190|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227191|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227192|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227193|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227194|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14227195|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
14948376|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
14948377|NCT01532895|Hydromorphone|hydromorphone|mesh-list
14948378|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14948379|NCT01532895|Narcotics|narcotics|mesh-ancestor
14948380|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948381|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227196|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227197|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227198|NCT00038103|Celecoxib|celecoxib|mesh-list
14227199|NCT00038103|Exemestane|exemestane|mesh-list
14227200|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14227201|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14227202|NCT00038103|Analgesics|analgesics|mesh-ancestor
14227203|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
14227204|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227205|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227206|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227207|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227208|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14227209|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14227210|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227211|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227212|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227213|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14227214|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14227215|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14227216|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
14227217|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227218|NCT00038467|Tamoxifen|tamoxifen|mesh-list
14227219|NCT00038467|Exemestane|exemestane|mesh-list
14227220|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14227221|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
14227222|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227223|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227224|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227225|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227226|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14227227|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14227228|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14227229|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14227230|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14227231|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227232|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227233|NCT00038610|Cytarabine|cytarabine|mesh-list
14227234|NCT00038610|Dexamethasone|dexamethasone|mesh-list
14227235|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
14227236|NCT00038610|Doxorubicin|doxorubicin|mesh-list
14227237|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14227238|NCT00038610|Methotrexate|methotrexate|mesh-list
14948382|NCT01532895|Analgesics|analgesics|mesh-ancestor
14948383|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
14227239|NCT00038610|Vincristine|vincristine|mesh-list
14227240|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
14227241|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227242|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
14227243|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227244|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227245|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227246|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
14227247|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227248|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227249|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227250|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227251|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
14227252|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
14227253|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227254|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14227255|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
14227256|NCT00038610|Hormones|hormones|mesh-ancestor
14227257|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227258|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227259|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227260|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227261|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227262|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227263|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14227264|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
14227265|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14227266|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227267|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
14227268|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227269|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14227270|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14227271|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
14227272|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227273|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227274|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227275|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227276|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227277|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227278|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
14227279|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227280|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227281|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227282|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227283|NCT00038857|Vidarabine|vidarabine|mesh-list
14227284|NCT00038857|Fludarabine|fludarabine|mesh-list
14227285|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
14227286|NCT00038857|Melphalan|melphalan|mesh-list
14227287|NCT00038857|Thiotepa|thiotepa|mesh-list
14227288|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
14227289|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14227290|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227291|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227292|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
14227293|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227294|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227295|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
14227296|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227297|NCT00038857|Antiviral Agents|antiviral agents|mesh-ancestor
14227298|NCT00038857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227299|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227300|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
14227301|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227302|NCT00038948|Cyclosporine|cyclosporine|mesh-list
14227303|NCT00038948|Sirolimus|sirolimus|mesh-list
14227304|NCT00038948|Tacrolimus|tacrolimus|mesh-list
14227305|NCT00038948|Cyclosporins|cyclosporins|mesh-list
14227306|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227307|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
14227308|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227309|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227310|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227311|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227312|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
14227313|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227314|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227315|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227316|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227317|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227318|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227319|NCT00039130|Leucovorin|leucovorin|mesh-list
14227320|NCT00039130|Cytarabine|cytarabine|mesh-list
14227321|NCT00039130|Dexamethasone|dexamethasone|mesh-list
14227322|NCT00039130|Prednisone|prednisone|mesh-list
14227323|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
14227324|NCT00039130|Ifosfamide|ifosfamide|mesh-list
14227325|NCT00039130|Rituximab|rituximab|mesh-list
14227326|NCT00039130|Doxorubicin|doxorubicin|mesh-list
14227327|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14227328|NCT00039130|Methotrexate|methotrexate|mesh-list
14227329|NCT00039130|Etoposide|etoposide|mesh-list
14227330|NCT00039130|Vincristine|vincristine|mesh-list
14227331|NCT00039130|Allopurinol|allopurinol|mesh-list
14227332|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
14227333|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227334|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
14227335|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227336|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227337|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227338|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
14227339|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227340|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227341|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227342|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227343|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
14227344|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
14227345|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227346|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14227347|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
14227348|NCT00039130|Hormones|hormones|mesh-ancestor
14227349|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227350|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227351|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227352|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227353|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227354|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227355|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227356|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14227357|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
14227358|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14227359|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227360|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
14227361|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227362|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14227363|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14227364|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227365|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
14227366|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227367|NCT00039130|Antidotes|antidotes|mesh-ancestor
14227368|NCT00039130|Protective Agents|protective agents|mesh-ancestor
14227369|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
14227370|NCT00039130|Vitamins|vitamins|mesh-ancestor
14227371|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
14227372|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227373|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227374|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227375|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
14227376|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14227377|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
14227378|NCT00039195|Prednisone|prednisone|mesh-list
14227379|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
14227380|NCT00039195|Ifosfamide|ifosfamide|mesh-list
14227381|NCT00039195|Rituximab|rituximab|mesh-list
14227382|NCT00039195|Carboplatin|carboplatin|mesh-list
14227383|NCT00039195|Doxorubicin|doxorubicin|mesh-list
14227384|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14227385|NCT00039195|Etoposide|etoposide|mesh-list
14227386|NCT00039195|Vincristine|vincristine|mesh-list
14227387|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14509974|NCT02998151|Acamprosate|acamprosate|mesh-list
14227388|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
14227389|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227390|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227391|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227392|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
14509975|NCT02998151|Baclofen|baclofen|mesh-list
14227393|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227394|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227395|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227396|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227397|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227398|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227399|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227400|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509976|NCT02998151|Lovastatin|lovastatin|mesh-list
14509977|NCT02998151|L 647318|l 647318|mesh-list
14509978|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
14509979|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14509980|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14509981|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14509982|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791416|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948384|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948385|NCT01532960|Poly ICLC|poly iclc|mesh-list
14948386|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
14948387|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
14948388|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948389|NCT01533090|Bisacodyl|bisacodyl|mesh-list
14948390|NCT01533090|Cathartics|cathartics|mesh-ancestor
14948391|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14948392|NCT01533090|Laxatives|laxatives|mesh-ancestor
14948393|NCT01533129|Testosterone|testosterone|mesh-list
14948394|NCT01533129|Androgens|androgens|mesh-ancestor
14948395|NCT01533129|Hormones|hormones|mesh-ancestor
14948396|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14509983|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14509984|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14509985|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14509986|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
14509987|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
14509988|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14509989|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14509990|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14509991|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14509992|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
14509993|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14509994|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14509995|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14509996|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14509997|NCT02998996|Endocine|endocine|mesh-list
14509998|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14509999|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
14510000|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510001|NCT02999100|Oxytocin|oxytocin|mesh-list
14510002|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
14510003|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14510004|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510005|NCT02999178|Nintedanib|nintedanib|mesh-list
14510006|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510007|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14510008|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510009|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510010|NCT02999672|Trastuzumab|trastuzumab|mesh-list
14510011|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14510012|NCT02999672|Maytansine|maytansine|mesh-list
14510013|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14510014|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510015|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14510016|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
14510017|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
14510018|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
14510019|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510020|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14510021|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
14510022|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510023|NCT03000283|Conivaptan|conivaptan|mesh-list
14510024|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14510025|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948397|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948398|NCT01533155|Quinidine|quinidine|mesh-list
14227401|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227402|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
14227403|NCT00039195|Hormones|hormones|mesh-ancestor
14227404|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227405|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227406|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227407|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227408|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227409|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227410|NCT00039377|Leucovorin|leucovorin|mesh-list
14227411|NCT00039377|Cytarabine|cytarabine|mesh-list
14227412|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
14227413|NCT00039377|Methotrexate|methotrexate|mesh-list
14227414|NCT00039377|Etoposide|etoposide|mesh-list
14227415|NCT00039377|Vincristine|vincristine|mesh-list
14227416|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
14227417|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
14227418|NCT00039377|Tacrolimus|tacrolimus|mesh-list
14227419|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
14227420|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227421|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
14227422|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227423|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227424|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227425|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
14227426|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227427|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227428|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227429|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14227430|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
14227431|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14227432|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227433|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
14227434|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227435|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227436|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14227437|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14227438|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227439|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227440|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227441|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
14227442|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227443|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227444|NCT00039377|Antidotes|antidotes|mesh-ancestor
14227445|NCT00039377|Protective Agents|protective agents|mesh-ancestor
14227446|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
14227447|NCT00039377|Vitamins|vitamins|mesh-ancestor
14227448|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
14227449|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227450|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227451|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227452|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227453|NCT00039871|Ribavirin|ribavirin|mesh-list
14227454|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14227455|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
14227456|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
14227457|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227458|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
14227459|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227460|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
14227461|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227462|NCT00040365|Amifostine|amifostine|mesh-list
14227463|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14227464|NCT00040365|Protective Agents|protective agents|mesh-ancestor
14227465|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227466|NCT00040664|Ritonavir|ritonavir|mesh-list
14227467|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
14227468|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14227469|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14227470|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
14227471|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227472|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227473|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14227474|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14227475|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
14227476|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227477|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14227478|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14227479|NCT00040846|Cyclosporine|cyclosporine|mesh-list
14227480|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
14227481|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14227482|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
14227483|NCT00040846|Fludarabine|fludarabine|mesh-list
14227484|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
14227485|NCT00040846|Antibodies|antibodies|mesh-list
14227486|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
14227487|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14227488|NCT00040846|Cyclosporins|cyclosporins|mesh-list
14227489|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
14227490|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227491|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227492|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227493|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
14227494|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227495|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227496|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227497|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
14227498|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227499|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227500|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227501|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227502|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227503|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14227504|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
14227505|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227506|NCT00040937|Thalidomide|thalidomide|mesh-list
14227507|NCT00040937|Dexamethasone|dexamethasone|mesh-list
14227508|NCT00040937|Prednisone|prednisone|mesh-list
14227509|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
14227510|NCT00040937|Melphalan|melphalan|mesh-list
14227511|NCT00040937|Sargramostim|sargramostim|mesh-list
14227512|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227513|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
14227514|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227515|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227516|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227517|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
14227518|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227519|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227520|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227521|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227522|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
14227523|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
14227524|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227525|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14227526|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
14227527|NCT00040937|Hormones|hormones|mesh-ancestor
14227528|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227529|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227530|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
14227531|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227532|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227533|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14227534|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14227535|NCT00040937|Growth Substances|growth substances|mesh-ancestor
14227536|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
14227537|NCT00041067|Docetaxel|docetaxel|mesh-list
14227538|NCT00041067|Trastuzumab|trastuzumab|mesh-list
14227539|NCT00041067|Vinorelbine|vinorelbine|mesh-list
14227540|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227541|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227542|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227543|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227544|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227545|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227546|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227547|NCT00041080|Tamoxifen|tamoxifen|mesh-list
14510026|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
14510027|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510028|NCT03000309|Apremilast|apremilast|mesh-list
14510029|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14510030|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510031|NCT03000309|Analgesics|analgesics|mesh-ancestor
14510032|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
14510033|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528799|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
14227548|NCT00041080|Thalidomide|thalidomide|mesh-list
14227549|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14227550|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
14227551|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227552|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227553|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227554|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227555|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14227556|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14227557|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14227558|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227559|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
14227560|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
14227561|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227562|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227563|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14227564|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14227565|NCT00041080|Growth Substances|growth substances|mesh-ancestor
14227566|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
14227567|NCT00041119|Paclitaxel|paclitaxel|mesh-list
14227568|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
14227569|NCT00041119|Doxorubicin|doxorubicin|mesh-list
14227570|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14227571|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227572|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227573|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227574|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227575|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227576|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227577|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227578|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
14227579|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227580|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227581|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227582|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
14227583|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227584|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227585|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227586|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227587|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227588|NCT00041132|Leucovorin|leucovorin|mesh-list
14227589|NCT00041132|Cytarabine|cytarabine|mesh-list
14227590|NCT00041132|Dexamethasone|dexamethasone|mesh-list
14227591|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
14227592|NCT00041132|Rituximab|rituximab|mesh-list
14227593|NCT00041132|Doxorubicin|doxorubicin|mesh-list
14227594|NCT00041132|Methotrexate|methotrexate|mesh-list
14227595|NCT00041132|Vincristine|vincristine|mesh-list
14227596|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
14227597|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227598|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
14227599|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227600|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227601|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227602|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
14227603|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227604|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227605|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227606|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227607|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
14227608|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
14227609|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227610|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14227611|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
14227612|NCT00041132|Hormones|hormones|mesh-ancestor
14227613|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227614|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227615|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227616|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227617|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227618|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227619|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227620|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14227621|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
14227622|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14227623|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227624|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
14227625|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227626|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14227627|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14227628|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
14227629|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227630|NCT00041132|Antidotes|antidotes|mesh-ancestor
14227631|NCT00041132|Protective Agents|protective agents|mesh-ancestor
14227632|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
14227633|NCT00041132|Vitamins|vitamins|mesh-ancestor
14227634|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
14227635|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227636|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227637|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227638|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227639|NCT00041470|Paclitaxel|paclitaxel|mesh-list
14227640|NCT00041470|Vinorelbine|vinorelbine|mesh-list
14227641|NCT00041470|Trastuzumab|trastuzumab|mesh-list
14227642|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227643|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227644|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227645|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227646|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227647|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227648|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227649|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
14227650|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14227651|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14227652|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227653|NCT00041938|Aspirin|aspirin|mesh-list
14227654|NCT00041938|Warfarin|warfarin|mesh-list
14227655|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14227656|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14227657|NCT00041938|Analgesics|analgesics|mesh-ancestor
14227658|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
14227659|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227660|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227661|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227662|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227663|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14227664|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14227665|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227666|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14227667|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14227668|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227669|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
14227670|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
14227671|NCT00042224|Clozapine|clozapine|mesh-list
14227672|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14227673|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
14227674|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14227675|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227676|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227677|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14227678|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14227679|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14227680|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14227681|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
14227682|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
14227683|NCT00042432|Cinacalcet|cinacalcet|mesh-list
14227684|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14227685|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227686|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14227687|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
14227688|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227689|NCT00042939|Docetaxel|docetaxel|mesh-list
14227690|NCT00042939|Irinotecan|irinotecan|mesh-list
14227691|NCT00042939|Cetuximab|cetuximab|mesh-list
14227692|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227693|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227694|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227695|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227696|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227697|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14227698|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227699|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227700|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227701|NCT00042991|Gefitinib|gefitinib|mesh-list
14227702|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227703|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227704|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227705|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227706|NCT00043186|Denosumab|denosumab|mesh-list
14227707|NCT00043186|Alendronate|alendronate|mesh-list
14227708|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14227709|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227710|NCT00043550|Sertraline|sertraline|mesh-list
14227711|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14227712|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
14227713|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14227714|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14227715|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14227716|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14227717|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227718|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14227719|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
14227720|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227721|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14227722|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14227723|NCT00043979|Cyclosporine|cyclosporine|mesh-list
14227724|NCT00043979|Sirolimus|sirolimus|mesh-list
14227725|NCT00043979|Prednisone|prednisone|mesh-list
14227726|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
14227727|NCT00043979|Melphalan|melphalan|mesh-list
14227728|NCT00043979|Doxorubicin|doxorubicin|mesh-list
14227729|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14227730|NCT00043979|Fludarabine|fludarabine|mesh-list
14227731|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
14227732|NCT00043979|Etoposide|etoposide|mesh-list
14227733|NCT00043979|Vincristine|vincristine|mesh-list
14227734|NCT00043979|Tacrolimus|tacrolimus|mesh-list
14227735|NCT00043979|Cyclosporins|cyclosporins|mesh-list
14227736|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14227737|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227738|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
14227739|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227740|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510034|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510035|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510036|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510037|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14510038|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14510039|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510040|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510041|NCT03000348|Cysteamine|cysteamine|mesh-list
14510042|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14510043|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510044|NCT03000452|Durvalumab|durvalumab|mesh-list
14510045|NCT03000452|Daratumumab|daratumumab|mesh-list
14510046|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14510047|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510048|NCT03000673|Heparin|heparin|mesh-list
14510049|NCT03000673|Enoxaparin|enoxaparin|mesh-list
14510050|NCT03000673|Calcium heparin|calcium heparin|mesh-list
14510051|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
14510052|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14510053|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14510054|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510055|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14510056|NCT03001076|Ezetimibe|ezetimibe|mesh-list
14510057|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14510058|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14510059|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
14510060|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510061|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14510062|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510063|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510064|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510065|NCT03001219|Methotrexate|methotrexate|mesh-list
14227741|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14227742|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
14227743|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227744|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227745|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14227746|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227747|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227748|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227749|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227750|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14227751|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
14227752|NCT00043979|Hormones|hormones|mesh-ancestor
14227753|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227754|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14227755|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227756|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
14227757|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227758|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227759|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227760|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227761|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227762|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
14227763|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227764|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227765|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227766|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14227767|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14227768|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14227769|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14227770|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14227771|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227772|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14227773|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14227774|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14227775|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14227776|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
14227777|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14227778|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227779|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14227780|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14227781|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
14227782|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14227783|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14227784|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
14227785|NCT00044044|Haloperidol|haloperidol|mesh-list
14227786|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
14227787|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14227788|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
14227789|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
14227790|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227791|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227792|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14227793|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14227794|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14227795|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14227796|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14227797|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14227798|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
14227799|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14227800|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227801|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14227802|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14227803|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14227804|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14227805|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
14227806|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14227807|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14227808|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
14227809|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14227810|NCT00044083|Tolcapone|tolcapone|mesh-list
14227811|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14227812|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14227813|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14227814|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227815|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227816|NCT00044213|Vitamins|vitamins|mesh-list
14227817|NCT00044213|Edetic Acid|edetic acid|mesh-list
14227818|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
14227819|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
14227820|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227821|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
14227822|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14227823|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
14227824|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
14227825|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227826|NCT00044213|Antidotes|antidotes|mesh-ancestor
14227827|NCT00044213|Protective Agents|protective agents|mesh-ancestor
14227828|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14227829|NCT00044512|Sorafenib|sorafenib|mesh-list
14227830|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227831|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227832|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227833|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227834|NCT00044655|Olanzapine|olanzapine|mesh-list
14227835|NCT00044655|Risperidone|risperidone|mesh-list
14227836|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14227837|NCT00044655|Aripiprazole|aripiprazole|mesh-list
14227838|NCT00044655|Ziprasidone|ziprasidone|mesh-list
14227839|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14227840|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
14227841|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14227842|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227843|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227844|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14227845|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14227846|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14227847|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14227848|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14227849|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
14227850|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
14227851|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
14227852|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227853|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14227854|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14227855|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14227856|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14227857|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
14227858|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
14227859|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14227860|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14227861|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14227862|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14227863|NCT00045032|Trastuzumab|trastuzumab|mesh-list
14227864|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14227865|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227866|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14227867|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227868|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227869|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227870|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227871|NCT00045162|Irinotecan|irinotecan|mesh-list
14227872|NCT00045162|Etoposide|etoposide|mesh-list
14227873|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227874|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14227875|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14227876|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227877|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227878|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227879|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14227880|NCT00045305|Cyclosporine|cyclosporine|mesh-list
14227881|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
14227882|NCT00045305|Methotrexate|methotrexate|mesh-list
14227883|NCT00045305|Pentostatin|pentostatin|mesh-list
14227884|NCT00045305|Methoxsalen|methoxsalen|mesh-list
14227885|NCT00045305|Cyclosporins|cyclosporins|mesh-list
14227886|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14227887|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
14227888|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14227889|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227890|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227891|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
14227892|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227893|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227894|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227895|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227896|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14227897|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227898|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
14227899|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227900|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14227901|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
14227902|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227903|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227904|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227905|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14227906|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
14227907|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227908|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14227909|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14227910|NCT00045435|Cyclosporine|cyclosporine|mesh-list
14227911|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
14227912|NCT00045435|Fludarabine|fludarabine|mesh-list
14227913|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
14227914|NCT00045435|Cyclosporins|cyclosporins|mesh-list
14227915|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227916|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227917|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
14227918|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227919|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227920|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
14227921|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227922|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227923|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
14227924|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227925|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14227926|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14227927|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14227928|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14227929|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14227930|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
14227931|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14227932|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14227933|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227934|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227935|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227936|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227937|NCT00045630|Gemcitabine|gemcitabine|mesh-list
14227938|NCT00045630|Paclitaxel|paclitaxel|mesh-list
14227939|NCT00045630|Carboplatin|carboplatin|mesh-list
14227940|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14227941|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227942|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227943|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
14948399|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
14948400|NCT01533155|Morphine|morphine|mesh-list
14948401|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14948402|NCT01533155|Narcotics|narcotics|mesh-ancestor
14948403|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948404|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948405|NCT01533155|Analgesics|analgesics|mesh-ancestor
14948406|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
14948407|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948408|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14948409|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14948410|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948411|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948412|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948413|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14948414|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
14948415|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14948416|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14948417|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948418|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948419|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14227944|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
14948420|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14242528|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948421|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
14948422|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14948423|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14948424|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14948425|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14948426|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14948427|NCT01533220|Pheniramine|pheniramine|mesh-list
14227945|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227946|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14227947|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
14227948|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
14227949|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227950|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227951|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14227952|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
14227953|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227954|NCT00045708|Epothilones|epothilones|mesh-list
14227955|NCT00045708|Epothilone B|epothilone b|mesh-list
14227956|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
14227957|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
14227958|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
14227959|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
14227960|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227961|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227962|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
14227963|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227964|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227965|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227966|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227967|NCT00045942|Itraconazole|itraconazole|mesh-list
14227968|NCT00045942|Midostaurin|midostaurin|mesh-list
14227969|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
14227970|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14227971|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14227972|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14227973|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14227974|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227975|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14227976|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
14227977|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14227978|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227979|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14227980|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14227981|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14227982|NCT00046228|Reteplase|reteplase|mesh-list
14227983|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14227984|NCT00046228|Abciximab|abciximab|mesh-list
14227985|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
14227986|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14227987|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14227988|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14227989|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14227990|NCT00046475|Midodrine|midodrine|mesh-list
14227991|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
14227992|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
14227993|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14227994|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14227995|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14227996|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14227997|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14227998|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14227999|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
14228000|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228001|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228002|NCT00046566|Caseins|caseins|mesh-list
14228003|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
14228004|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
14228005|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228006|NCT00046839|Celecoxib|celecoxib|mesh-list
14228007|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14228008|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948428|NCT01533220|Naphazoline|naphazoline|mesh-list
15027112|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14228009|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14228010|NCT00046839|Analgesics|analgesics|mesh-ancestor
14228011|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
14228012|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14228013|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228014|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228015|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228016|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14228017|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228018|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228019|NCT00046930|Cytarabine|cytarabine|mesh-list
14228020|NCT00046930|Daunorubicin|daunorubicin|mesh-list
14228021|NCT00046930|Molgramostim|molgramostim|mesh-list
14228022|NCT00046930|Lenograstim|lenograstim|mesh-list
14228023|NCT00046930|Sargramostim|sargramostim|mesh-list
14228024|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228025|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
14228026|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228027|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228028|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
14228029|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228030|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228031|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
14228032|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228033|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14228034|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228035|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228036|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228037|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228038|NCT00047008|Cisplatin|cisplatin|mesh-list
14228039|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228040|NCT00047060|Cyclosporine|cyclosporine|mesh-list
14228041|NCT00047060|Fludarabine|fludarabine|mesh-list
14228042|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
14228043|NCT00047060|Cyclosporins|cyclosporins|mesh-list
14228044|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228045|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228046|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228047|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
14228048|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228049|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228050|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
14228051|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228052|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
14228053|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228054|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14228055|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228056|NCT00047320|Carboplatin|carboplatin|mesh-list
14228057|NCT00047320|Etoposide|etoposide|mesh-list
14228058|NCT00047320|Ifosfamide|ifosfamide|mesh-list
14228059|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
14228060|NCT00047320|Thiotepa|thiotepa|mesh-list
14228061|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228062|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228063|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228064|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228065|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228066|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228067|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228068|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
14228069|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228070|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228071|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
14228072|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228073|NCT00047697|Donepezil|donepezil|mesh-list
14228074|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14228075|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228076|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228077|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
14228078|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228079|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228080|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
14228081|NCT00047879|Interferons|interferons|mesh-list
14228082|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
14228083|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
14228084|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14228085|NCT00047879|Thalidomide|thalidomide|mesh-list
14228086|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228087|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
14228088|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228089|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
14228090|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228091|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228092|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
14228093|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228094|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14228095|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14228096|NCT00047879|Growth Substances|growth substances|mesh-ancestor
14228097|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
14228098|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
14228099|NCT00048035|Hematinics|hematinics|mesh-ancestor
14228100|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
14228101|NCT00048048|Hematinics|hematinics|mesh-ancestor
14228102|NCT00048061|Vitamin D|vitamin d|mesh-list
14228103|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
14228104|NCT00048061|Calcium|calcium|mesh-list
14228105|NCT00048061|Vitamins|vitamins|mesh-ancestor
14228106|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
14228107|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228108|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14228109|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14228110|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
14228111|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14228112|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228113|NCT00048165|Cyclosporine|cyclosporine|mesh-list
14228114|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
14228115|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
14228116|NCT00048165|Cyclosporins|cyclosporins|mesh-list
14228117|NCT00048165|Daclizumab|daclizumab|mesh-list
14228118|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228119|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228120|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228121|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
14228122|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228123|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
14510066|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14510067|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
14510068|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14510069|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510070|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14510071|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
14510072|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510073|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510074|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
14510075|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510076|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14510077|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14510078|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
14510079|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510080|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14510081|NCT03001453|Epinephrine|epinephrine|mesh-list
14510082|NCT03001453|Bupivacaine|bupivacaine|mesh-list
14510083|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510084|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
14510085|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510086|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510087|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
14510088|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510089|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14510090|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14510091|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
14510092|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510093|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510094|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14510095|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14510096|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
14510097|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14510098|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
14510099|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
14228124|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228125|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
14228126|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228127|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14228128|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228129|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228130|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14228131|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
14228132|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228133|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228134|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
14228135|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
14228136|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14228137|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14228138|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
14228139|NCT00048165|Hormones|hormones|mesh-ancestor
14228140|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228141|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14228142|NCT00048165|Protective Agents|protective agents|mesh-ancestor
14228143|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
14228144|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14228145|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
14228146|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228147|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228148|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
14228149|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228150|NCT00048542|Adalimumab|adalimumab|mesh-list
14228151|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228152|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228153|NCT00048568|Methotrexate|methotrexate|mesh-list
14228154|NCT00048568|Abatacept|abatacept|mesh-list
14228155|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14228156|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
14228157|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14228158|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228159|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228160|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
14228161|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228162|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228163|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
14228164|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228165|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14228166|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228167|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
14228168|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228169|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14228170|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14228171|NCT00048581|Abatacept|abatacept|mesh-list
14228172|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14228173|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228174|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228175|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228176|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
14228177|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228178|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228179|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14228180|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
14228181|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228182|NCT00048737|Vidarabine|vidarabine|mesh-list
14228183|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
14228184|NCT00048737|Rituximab|rituximab|mesh-list
14228185|NCT00048737|Fludarabine|fludarabine|mesh-list
14228186|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
14228187|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228188|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
14228189|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228190|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228191|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228192|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
14228193|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228194|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228195|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228196|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228197|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228198|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
14228199|NCT00048737|Antiviral Agents|antiviral agents|mesh-ancestor
14228200|NCT00048737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228201|NCT00048815|Citalopram|citalopram|mesh-list
14228202|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14228203|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14228204|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14228205|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228206|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228207|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
14228208|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228209|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14228210|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
14228211|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228212|NCT00048893|Metronidazole|metronidazole|mesh-list
14228213|NCT00048893|Paclitaxel|paclitaxel|mesh-list
14228214|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
14228215|NCT00048893|Doxorubicin|doxorubicin|mesh-list
14228216|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14228217|NCT00048893|Fludarabine|fludarabine|mesh-list
14228218|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
14228219|NCT00048893|Vaccines|vaccines|mesh-list
14228220|NCT00048893|Sargramostim|sargramostim|mesh-list
14228221|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
14228222|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228223|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228224|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228225|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228226|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228227|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228228|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228229|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228230|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228231|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228232|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
14228233|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228234|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228235|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228236|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228237|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228238|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228239|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
14228240|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228241|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228242|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14228243|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14228244|NCT00048932|Abatacept|abatacept|mesh-list
14228245|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14228246|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228247|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228248|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228249|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
14228250|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228251|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228252|NCT00049036|Prednisone|prednisone|mesh-list
14228253|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
14228254|NCT00049036|Rituximab|rituximab|mesh-list
14228255|NCT00049036|Doxorubicin|doxorubicin|mesh-list
14228256|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14228257|NCT00049036|Etoposide|etoposide|mesh-list
14228258|NCT00049036|Vincristine|vincristine|mesh-list
14228259|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
14228260|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228261|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
14228262|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228263|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228264|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228265|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
14228266|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228267|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228268|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228269|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228270|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228271|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228272|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228273|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228274|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228275|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
14228276|NCT00049036|Hormones|hormones|mesh-ancestor
14228277|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228278|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14228279|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228280|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228281|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228282|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228283|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
14228284|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228285|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14228286|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228287|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228288|NCT00049257|Paclitaxel|paclitaxel|mesh-list
14228289|NCT00049257|Carboplatin|carboplatin|mesh-list
14228290|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228291|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228292|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228293|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228294|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228295|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228296|NCT00049322|Bevacizumab|bevacizumab|mesh-list
14228297|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228298|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228299|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14228300|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14228301|NCT00049322|Growth Substances|growth substances|mesh-ancestor
14228302|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228303|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
14228304|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
14228305|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
14228306|NCT00049504|Fludarabine|fludarabine|mesh-list
14228307|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
14228308|NCT00049504|Tacrolimus|tacrolimus|mesh-list
14228309|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228310|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
14228311|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228312|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228313|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228314|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
14228315|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228316|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228317|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228318|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228319|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
14228320|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14228321|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228322|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228323|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14228324|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
14228325|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228326|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228327|NCT00049517|Cytarabine|cytarabine|mesh-list
14228328|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
14228329|NCT00049517|Busulfan|busulfan|mesh-list
14228330|NCT00049517|Daunorubicin|daunorubicin|mesh-list
14228331|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
14228332|NCT00049517|Sargramostim|sargramostim|mesh-list
14228333|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228334|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
14228335|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228336|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228337|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228338|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
14228339|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228340|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228341|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228342|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228343|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
14228344|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
14228345|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228346|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228347|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228348|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228349|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228350|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228351|NCT00049530|Interferons|interferons|mesh-list
14228352|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
14228353|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
14228354|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14228355|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228356|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
14228357|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228358|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
14228359|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228360|NCT00049543|Gefitinib|gefitinib|mesh-list
14228361|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228362|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14228363|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228364|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242529|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14242530|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14242531|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
14242532|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
14242533|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242534|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14242535|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
14242536|NCT00186875|Hormones|hormones|mesh-ancestor
14242537|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242538|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14242539|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
14242540|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242541|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14242542|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
14242543|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14242544|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242545|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
14242546|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
14242547|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14242548|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14242549|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14242550|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14242551|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14242552|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
14242553|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242554|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242555|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242556|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242557|NCT00186875|Analgesics|analgesics|mesh-ancestor
14242558|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
14242559|NCT00186901|Vitamin D|vitamin d|mesh-list
14242560|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
14242561|NCT00186901|Calcium|calcium|mesh-list
14242562|NCT00186901|Vitamins|vitamins|mesh-ancestor
14242563|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
14242564|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242565|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14242566|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14242567|NCT00186901|Antacids|antacids|mesh-ancestor
14242568|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242569|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14242570|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
14242571|NCT00187096|Fludarabine|fludarabine|mesh-list
14242572|NCT00187096|Etoposide|etoposide|mesh-list
14242573|NCT00187096|Interleukin-2|interleukin-2|mesh-list
14242574|NCT00187096|Clofarabine|clofarabine|mesh-list
14242575|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242576|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
14242577|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242578|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242579|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14242580|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
14242581|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242582|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242583|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14242584|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242585|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
14242586|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14242587|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14242588|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14242589|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242590|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14242591|NCT00187096|Analgesics|analgesics|mesh-ancestor
14242592|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
14242593|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242594|NCT00187135|Fentanyl|fentanyl|mesh-list
14242595|NCT00187135|Propofol|propofol|mesh-list
14242596|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14242597|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14228365|NCT00049673|Thalidomide|thalidomide|mesh-list
14228366|NCT00049673|Prednisone|prednisone|mesh-list
14228367|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228368|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
14228369|NCT00049673|Hormones|hormones|mesh-ancestor
14228370|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228371|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228372|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14228373|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510100|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
14510101|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14510102|NCT03001557|Lemborexant|lemborexant|mesh-list
14510103|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14510104|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510105|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510106|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14510107|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14510108|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510109|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510110|NCT03001843|Ketamine|ketamine|mesh-list
14510111|NCT03001843|Narcotics|narcotics|mesh-list
14510112|NCT03001843|Analgesics|analgesics|mesh-ancestor
14510113|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
14510114|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510115|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510116|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14510117|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14510118|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
14510119|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
14510120|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510121|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14510122|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14510123|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510124|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510125|NCT03002012|Fluconazole|fluconazole|mesh-list
14510126|NCT03002012|Sertraline|sertraline|mesh-list
14510127|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
14510128|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14510129|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14510130|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14510131|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14510132|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510133|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510134|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
14510135|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510136|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
14510137|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510138|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14510139|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14510140|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510141|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14510142|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
14510143|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510144|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14510145|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14510146|NCT03002038|Rituximab|rituximab|mesh-list
14510147|NCT03002038|Azathioprine|azathioprine|mesh-list
14510148|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14510149|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510150|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
14510151|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510152|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510153|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
14510154|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510155|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14510156|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14510157|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
14510158|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
14510159|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14510160|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510161|NCT03002506|Tazobactam|tazobactam|mesh-list
14510162|NCT03002506|Ceftolozane|ceftolozane|mesh-list
14228374|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228375|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
14228376|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
14228377|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228378|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228379|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14228380|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14228381|NCT00049673|Growth Substances|growth substances|mesh-ancestor
14228382|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14228383|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14228384|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
14510163|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14510164|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14510165|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510166|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14510167|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510168|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510169|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14510170|NCT03002506|Renal Agents|renal agents|mesh-ancestor
14510171|NCT03002974|Triamcinolone|triamcinolone|mesh-list
14510172|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14510173|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14510174|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14510175|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14510176|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510177|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
14510178|NCT03002974|Hormones|hormones|mesh-ancestor
14510179|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510180|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510181|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14510182|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
14510183|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510184|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510185|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510186|NCT03003000|Ibuprofen|ibuprofen|mesh-list
14510187|NCT03003000|Caffeine|caffeine|mesh-list
14510188|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14510189|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510190|NCT03003000|Analgesics|analgesics|mesh-ancestor
14510191|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
14510192|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510193|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510194|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510195|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510196|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14510197|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510198|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510199|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14510200|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14510201|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14510202|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14510203|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
14510204|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510205|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
14510206|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14510207|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
14510208|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510209|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
14510210|NCT03003130|Protective Agents|protective agents|mesh-ancestor
14510211|NCT03003390|Enoxaparin|enoxaparin|mesh-list
14510212|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
14510213|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14510214|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14510215|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510216|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
14510217|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
14510218|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14510219|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
14510220|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510221|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510222|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14510223|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
14510224|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510225|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510226|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228385|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228386|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
14228387|NCT00050011|Letrozole|letrozole|mesh-list
14228388|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228389|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14228390|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14228391|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228392|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228393|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14228394|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
14228395|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228396|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228397|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14228398|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14228399|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
14228400|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228401|NCT00050167|Paclitaxel|paclitaxel|mesh-list
14228402|NCT00050167|Docetaxel|docetaxel|mesh-list
14228403|NCT00050167|Capecitabine|capecitabine|mesh-list
14228404|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228405|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228406|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228407|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228408|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228409|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228410|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228411|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
14228412|NCT00050622|Methylphenidate|methylphenidate|mesh-list
14228413|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14228414|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228415|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14228416|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14228417|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14228418|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228419|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
14228420|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228421|NCT00050778|Interferons|interferons|mesh-list
14228422|NCT00050778|Interferon-beta|interferon-beta|mesh-list
14228423|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
14228424|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
14228425|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228426|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
14228427|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228428|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228429|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
14228430|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228431|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14228432|NCT00050960|Paclitaxel|paclitaxel|mesh-list
14228433|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14228434|NCT00050960|Carboplatin|carboplatin|mesh-list
14228435|NCT00050960|Bexarotene|bexarotene|mesh-list
14228436|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228437|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228438|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228439|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228440|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228441|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228442|NCT00050986|Temozolomide|temozolomide|mesh-list
14228443|NCT00050986|Tipifarnib|tipifarnib|mesh-list
14228444|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228445|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
14228446|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228447|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228448|NCT00051168|Travoprost|travoprost|mesh-list
14228449|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14228450|NCT00051311|Cyclosporine|cyclosporine|mesh-list
14228451|NCT00051311|Prednisone|prednisone|mesh-list
14228452|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
14228453|NCT00051311|Doxorubicin|doxorubicin|mesh-list
14228454|NCT00051311|Methotrexate|methotrexate|mesh-list
14228455|NCT00051311|Fludarabine|fludarabine|mesh-list
14228456|NCT00051311|Etoposide|etoposide|mesh-list
14510227|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228457|NCT00051311|Vincristine|vincristine|mesh-list
14228458|NCT00051311|Cyclosporins|cyclosporins|mesh-list
14228459|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228460|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
14228461|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228462|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228463|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228464|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
14228465|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228466|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228467|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228468|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228469|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228470|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228471|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228472|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228473|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
14228474|NCT00051311|Hormones|hormones|mesh-ancestor
14228475|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228476|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14228477|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14228478|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
14228479|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14228480|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228481|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
14228482|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14228483|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14228484|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14228485|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228486|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228487|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228488|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228489|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
14228490|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228491|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14228492|NCT00051558|Alendronate|alendronate|mesh-list
14228493|NCT00051558|Teriparatide|teriparatide|mesh-list
14228494|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14228495|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228496|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14228497|NCT00051636|Vitamin D|vitamin d|mesh-list
14228498|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
14228499|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
14228500|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
14228501|NCT00051636|Calcium|calcium|mesh-list
14228502|NCT00051636|Vitamins|vitamins|mesh-ancestor
14228503|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
14228504|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228505|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14228506|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14228507|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14228508|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14228509|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228510|NCT00052078|Sertraline|sertraline|mesh-list
14228511|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
14228512|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228513|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14228514|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14228515|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14228516|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228517|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228518|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
14228519|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228520|NCT00052429|Fluorouracil|fluorouracil|mesh-list
14228521|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228522|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
14228523|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228524|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228525|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228526|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
14228527|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228528|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
14228529|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228530|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14228531|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228532|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228533|NCT00052715|Poly ICLC|poly iclc|mesh-list
14228534|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
14228535|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
14228536|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228537|NCT00052910|Leucovorin|leucovorin|mesh-list
14228538|NCT00052910|Fluorouracil|fluorouracil|mesh-list
14228539|NCT00052910|Epirubicin|epirubicin|mesh-list
14228540|NCT00052910|Calcium|calcium|mesh-list
14228541|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
14228542|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228543|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14228544|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228545|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
14228546|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228547|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228548|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228549|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
14228550|NCT00052910|Antidotes|antidotes|mesh-ancestor
14228551|NCT00052910|Protective Agents|protective agents|mesh-ancestor
14228552|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
14228553|NCT00052910|Vitamins|vitamins|mesh-ancestor
14228554|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
14228555|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228556|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228557|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228558|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228559|NCT00053014|Cyclosporine|cyclosporine|mesh-list
14228560|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
14228561|NCT00053014|Fludarabine|fludarabine|mesh-list
14228562|NCT00053014|Cyclosporins|cyclosporins|mesh-list
14228563|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228564|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228565|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228566|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
14228567|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228568|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228569|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
14228570|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228571|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
14228572|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228573|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14948429|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228574|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228575|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14228576|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
14228577|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228578|NCT00053352|Etoposide|etoposide|mesh-list
14228579|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
14228580|NCT00053352|Bleomycin|bleomycin|mesh-list
14228581|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228582|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14791417|NCT00741221|Bevacizumab|bevacizumab|mesh-list
14791418|NCT00741221|Pemetrexed|pemetrexed|mesh-list
14791419|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14791420|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791421|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14791422|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14791423|NCT00741221|Growth Substances|growth substances|mesh-ancestor
14791424|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791425|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
14791426|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791427|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791428|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14791429|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14791430|NCT00741234|Azacitidine|azacitidine|mesh-list
14791431|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14791432|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
14791433|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791434|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791435|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791436|NCT00741325|Plerixafor|plerixafor|mesh-list
14791437|NCT00741325|Sargramostim|sargramostim|mesh-list
14228583|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228584|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228585|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228586|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228587|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228588|NCT00053365|Irofulven|irofulven|mesh-list
14228589|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228590|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
14228591|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228592|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228593|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
14228594|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14228595|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14228596|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228597|NCT00053482|Vaccines|vaccines|mesh-list
14228598|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
14228599|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228600|NCT00053677|Naltrexone|naltrexone|mesh-list
14228601|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14228602|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14228603|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228604|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
14228605|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14228606|NCT00053703|Olanzapine|olanzapine|mesh-list
14228607|NCT00053703|Risperidone|risperidone|mesh-list
14228608|NCT00053703|Molindone|molindone|mesh-list
14228609|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14228610|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
14228611|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228612|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228613|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228614|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14228615|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14228616|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14228617|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228618|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14228619|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
14228620|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
14228621|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
14228622|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14228623|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14228624|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14228625|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14228626|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14228627|NCT00053846|Buspirone|buspirone|mesh-list
14228628|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14228629|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14228630|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14228631|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228632|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228633|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14228634|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
14228635|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228636|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228637|NCT00053898|Tamoxifen|tamoxifen|mesh-list
14228638|NCT00053898|Anastrozole|anastrozole|mesh-list
14228639|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228640|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14228641|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
14228642|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228643|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228644|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14228645|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228646|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14228647|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14228648|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14228649|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14228650|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14228651|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228652|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
14228653|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
14228654|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
14228655|NCT00053989|Fludarabine|fludarabine|mesh-list
14228656|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
14228657|NCT00053989|Tacrolimus|tacrolimus|mesh-list
14228658|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14228659|NCT00053989|Sargramostim|sargramostim|mesh-list
14228660|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228661|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
14228662|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228663|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228664|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228665|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
14228666|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228667|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228668|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228669|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228670|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
14228671|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14228672|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228673|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228674|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14228675|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
14228676|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228677|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228678|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228679|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
14228680|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
14228681|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14228682|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14228683|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
14228684|NCT00053989|Hormones|hormones|mesh-ancestor
14228685|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228686|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14228687|NCT00053989|Protective Agents|protective agents|mesh-ancestor
14228688|NCT00054028|Suramin|suramin|mesh-list
14228689|NCT00054028|Paclitaxel|paclitaxel|mesh-list
14228690|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228691|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228692|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228693|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228694|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228695|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228696|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
14228697|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
14228698|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14228699|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228700|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14228701|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14228702|NCT00054132|Bevacizumab|bevacizumab|mesh-list
14228703|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14228704|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14228705|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
14228706|NCT00054132|Antibodies|antibodies|mesh-list
14228707|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
14228708|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14228709|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
14228710|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228711|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14228712|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14228713|NCT00054132|Growth Substances|growth substances|mesh-ancestor
14228714|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228715|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
14228716|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
14228717|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14228718|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228719|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228720|NCT00054275|Docetaxel|docetaxel|mesh-list
14228721|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14228722|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228723|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228724|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228725|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228726|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228727|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14228728|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228729|NCT00054327|Cytarabine|cytarabine|mesh-list
14228730|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
14228731|NCT00054327|Busulfan|busulfan|mesh-list
14228732|NCT00054327|Etoposide|etoposide|mesh-list
14228733|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
14228734|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228735|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
14510228|NCT03003949|Estradiol|estradiol|mesh-list
14228736|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228737|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510229|NCT03003949|Progesterone|progesterone|mesh-list
14228738|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228739|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
14228740|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228741|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228742|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228743|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228744|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228745|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228746|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510230|NCT03003949|Estrogens|estrogens|mesh-ancestor
14510231|NCT03003949|Hormones|hormones|mesh-ancestor
14510232|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510233|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510234|NCT03003949|Progestins|progestins|mesh-ancestor
14510235|NCT03004469|Finasteride|finasteride|mesh-list
14510236|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14510237|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14510238|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510239|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510240|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
14510241|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510242|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510243|NCT03004469|Urological Agents|urological agents|mesh-ancestor
14510244|NCT03006341|Telmisartan|telmisartan|mesh-list
14510245|NCT03006341|Warfarin|warfarin|mesh-list
14510246|NCT03006341|Dabigatran|dabigatran|mesh-list
14510247|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
14510248|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14510249|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14510250|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14510251|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510252|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
14510253|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14510254|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510255|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510256|NCT03006393|Infliximab|infliximab|mesh-list
14510257|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14510258|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510259|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510260|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
14510261|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14510262|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510263|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510264|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510265|NCT03006562|Heparin|heparin|mesh-list
14510266|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
14510267|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14510268|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14510269|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510270|NCT03006848|Avelumab|avelumab|mesh-list
14510271|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14510272|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510273|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
14510274|NCT03006887|Lenvatinib|lenvatinib|mesh-list
14510275|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14510276|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510277|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14510278|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510279|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510280|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
14510281|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14510282|NCT03007225|Estrogens|estrogens|mesh-ancestor
14510283|NCT03007225|Hormones|hormones|mesh-ancestor
14510284|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510285|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528800|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
14791438|NCT00741325|Lenograstim|lenograstim|mesh-list
14791439|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
14791440|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791441|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14791442|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791443|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14791444|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
14791445|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228747|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228748|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
14228749|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
14228750|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228751|NCT00054353|Cyclosporine|cyclosporine|mesh-list
14228752|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
14228753|NCT00054353|Fludarabine|fludarabine|mesh-list
14228754|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
14228755|NCT00054353|Melphalan|melphalan|mesh-list
14228756|NCT00054353|Cyclosporins|cyclosporins|mesh-list
14228757|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228758|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228759|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
14228760|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228761|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228762|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
14228763|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228764|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228765|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
14228766|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228767|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
14228768|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228769|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14228770|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228771|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14228772|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
14228773|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14228774|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228775|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
14228776|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228777|NCT00054639|Rituximab|rituximab|mesh-list
14228778|NCT00054639|Oblimersen|oblimersen|mesh-list
14228779|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228780|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228781|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
14228782|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228783|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228784|NCT00054665|Prednisone|prednisone|mesh-list
14228785|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
14228786|NCT00054665|Doxorubicin|doxorubicin|mesh-list
14228787|NCT00054665|Etoposide|etoposide|mesh-list
14228788|NCT00054665|Vincristine|vincristine|mesh-list
14228789|NCT00054665|Bortezomib|bortezomib|mesh-list
14228790|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228791|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
14228792|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228793|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228794|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14228795|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
14228796|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228797|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228798|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14228799|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228800|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14228801|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14228802|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228803|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228804|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
14228805|NCT00054665|Hormones|hormones|mesh-ancestor
14228806|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228807|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14228808|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228809|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228810|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228811|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228812|NCT00054691|Gefitinib|gefitinib|mesh-list
14228813|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228814|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14228815|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228816|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228817|NCT00054704|Riluzole|riluzole|mesh-list
14228818|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
14228819|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14228820|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14228821|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228822|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228823|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228824|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14228825|NCT00054704|Protective Agents|protective agents|mesh-ancestor
14228826|NCT00054717|Ritonavir|ritonavir|mesh-list
14228827|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14228828|NCT00054717|Tipranavir|tipranavir|mesh-list
14228829|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
14228830|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14228831|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228832|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228833|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14228834|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14228835|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
14228836|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228837|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14228838|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14228839|NCT00054756|Hormones|hormones|mesh-list
14228840|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
14228841|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228842|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228843|NCT00055237|Bevacizumab|bevacizumab|mesh-list
14228844|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14228845|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228846|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14228847|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14228848|NCT00055237|Growth Substances|growth substances|mesh-ancestor
14228849|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228850|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
14228851|NCT00055497|Adalimumab|adalimumab|mesh-list
14228852|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228853|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14228854|NCT00055601|Gemcitabine|gemcitabine|mesh-list
14228855|NCT00055601|Paclitaxel|paclitaxel|mesh-list
14228856|NCT00055601|Fluorouracil|fluorouracil|mesh-list
14228857|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14228858|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228859|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
14228860|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
14228861|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
14228862|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228863|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228864|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
14228865|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
14228866|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228867|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228868|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228869|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
14228870|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228871|NCT00055692|Bevacizumab|bevacizumab|mesh-list
14228872|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14228873|NCT00055692|Antibodies|antibodies|mesh-list
14228874|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
14228875|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14228876|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228877|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14228878|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14228879|NCT00055692|Growth Substances|growth substances|mesh-ancestor
14228880|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228881|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
14228882|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
14228883|NCT00056160|Dexamethasone|dexamethasone|mesh-list
14228884|NCT00056160|Lenalidomide|lenalidomide|mesh-list
14228885|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14228886|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
14228887|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
14228888|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14228889|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228890|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14228891|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
14228892|NCT00056160|Hormones|hormones|mesh-ancestor
14228893|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228894|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14228895|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228896|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
14228897|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14228898|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14228899|NCT00056160|Growth Substances|growth substances|mesh-ancestor
14228900|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
14228901|NCT00056407|Dutasteride|dutasteride|mesh-list
14228902|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14228903|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14228904|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228905|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228906|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
14228907|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14228908|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228909|NCT00056472|Olanzapine|olanzapine|mesh-list
14228910|NCT00056472|Sertraline|sertraline|mesh-list
14228911|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
14228912|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
14228913|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14228914|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228915|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14228916|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14228917|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14228918|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14228919|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228920|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14228921|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14228922|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14228923|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228924|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228925|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
14228926|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
14228927|NCT00056498|Risperidone|risperidone|mesh-list
14228928|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14228929|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
14228930|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228931|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228932|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228933|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14228934|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14228935|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14228936|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228937|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14228938|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
14228939|NCT00056550|Antithrombins|antithrombins|mesh-list
14228940|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
14228941|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14228942|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
14228943|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228944|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228945|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
14228946|NCT00056862|Ribavirin|ribavirin|mesh-list
14228947|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14228948|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
14228949|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
14228950|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228951|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
14228952|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228953|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
14228954|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228955|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
14228956|NCT00057330|Vaccines|vaccines|mesh-list
14228957|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
14228958|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
14228959|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228960|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14228961|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14228962|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228963|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
14228964|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14228965|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
14228966|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14228967|NCT00057330|Protective Agents|protective agents|mesh-ancestor
14228968|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
14791446|NCT00741351|Fentanyl|fentanyl|mesh-list
14791447|NCT00741351|Remifentanil|remifentanil|mesh-list
14228969|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228970|NCT00057681|Valproic Acid|valproic acid|mesh-list
14228971|NCT00057681|Risperidone|risperidone|mesh-list
14791448|NCT00741351|Propofol|propofol|mesh-list
14791449|NCT00741351|Sevoflurane|sevoflurane|mesh-list
14791450|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14791451|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791452|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791453|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14791454|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
14228972|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
14228973|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14228974|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
14228975|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14228976|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228977|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228978|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14228979|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14228980|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14228981|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14228982|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14228983|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
14228984|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
14228985|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14228986|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
14228987|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
14228988|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
14228989|NCT00057785|Fluorouracil|fluorouracil|mesh-list
14228990|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14228991|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
14228992|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14228993|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14228994|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14228995|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
14228996|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14228997|NCT00057811|Leucovorin|leucovorin|mesh-list
14228998|NCT00057811|Cytarabine|cytarabine|mesh-list
14228999|NCT00057811|Prednisone|prednisone|mesh-list
14229000|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
14229001|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14229002|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14229003|NCT00057811|Prednisolone|prednisolone|mesh-list
14229004|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
14229005|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
14229006|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14229007|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14229008|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14229009|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
14229010|NCT00057811|Rituximab|rituximab|mesh-list
14229011|NCT00057811|Doxorubicin|doxorubicin|mesh-list
14229012|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14229013|NCT00057811|Methotrexate|methotrexate|mesh-list
14229014|NCT00057811|Etoposide|etoposide|mesh-list
14229015|NCT00057811|Vincristine|vincristine|mesh-list
14229016|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
14229017|NCT00057811|Rasburicase|rasburicase|mesh-list
14229018|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14229019|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
14229020|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
14229021|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229022|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
14229023|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229024|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229025|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14229026|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
14229027|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229028|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229029|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14229030|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229031|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14791455|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
14791456|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14791457|NCT00741351|Narcotics|narcotics|mesh-ancestor
14791458|NCT00741351|Analgesics|analgesics|mesh-ancestor
14791459|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
14791460|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791461|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14791462|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14791463|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14229032|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14791464|NCT00741364|Vitamin D|vitamin d|mesh-list
14229033|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14791465|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
14229034|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229035|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229036|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
14229037|NCT00057811|Hormones|hormones|mesh-ancestor
14229038|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229039|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229040|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14229041|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
14229042|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14229043|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229044|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
14229045|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229046|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14229047|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14229048|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229049|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
14229050|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229051|NCT00057811|Antidotes|antidotes|mesh-ancestor
14229052|NCT00057811|Protective Agents|protective agents|mesh-ancestor
14229053|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
14229054|NCT00057811|Vitamins|vitamins|mesh-ancestor
14229055|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
14229056|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229057|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229058|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229059|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
14229060|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
14229061|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229062|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14229063|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14229064|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
14229065|NCT00057837|Cisplatin|cisplatin|mesh-list
14229066|NCT00057837|Irinotecan|irinotecan|mesh-list
14229067|NCT00057837|Etoposide|etoposide|mesh-list
14229068|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
14229069|NCT00057837|Topotecan|topotecan|mesh-list
14229070|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
14229071|NCT00057837|Camptothecin|camptothecin|mesh-list
14229072|NCT00057837|Sargramostim|sargramostim|mesh-list
14229073|NCT00057837|Lenograstim|lenograstim|mesh-list
14229074|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229075|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14229076|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229077|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229078|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229079|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229080|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229081|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
14229082|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229083|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14229084|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
14229085|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229086|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229087|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229088|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229089|NCT00057863|Paclitaxel|paclitaxel|mesh-list
14229090|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
14229091|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229092|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229093|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229094|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229095|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229096|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229097|NCT00057876|Gemcitabine|gemcitabine|mesh-list
14229098|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229099|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
14229100|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229101|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229102|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
14229103|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229104|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510286|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229105|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229106|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
14229107|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229108|NCT00057941|Fulvestrant|fulvestrant|mesh-list
14229109|NCT00057941|Anastrozole|anastrozole|mesh-list
14229110|NCT00057941|Gefitinib|gefitinib|mesh-list
14229111|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229112|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229113|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14229114|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14229115|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
14229116|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229117|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229118|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14229119|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229120|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229121|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14229122|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14510287|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510288|NCT03007966|Clonidine|clonidine|mesh-list
14510289|NCT03007966|Epinephrine|epinephrine|mesh-list
14510290|NCT03007966|Bupivacaine|bupivacaine|mesh-list
14510291|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510292|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
14510293|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510294|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510295|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
14510296|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510297|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14510298|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14510299|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
14510300|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510301|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510302|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14510303|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14510304|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
14510305|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14510306|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
14510307|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
14510308|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
14510309|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14510310|NCT03007966|Analgesics|analgesics|mesh-ancestor
14510311|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14510312|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
14510313|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14528801|NCT03827473|Hormones|hormones|mesh-list
14528802|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14528803|NCT03827473|Androgens|androgens|mesh-list
14528804|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
14528805|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528806|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
14528807|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
14528808|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
14528809|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528810|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528811|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
14528812|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528813|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528814|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14528815|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14528816|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791466|NCT00741364|Vitamins|vitamins|mesh-ancestor
14791467|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
14791468|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791469|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14791470|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791471|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
14791472|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14791473|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229123|NCT00057954|Cyclosporine|cyclosporine|mesh-list
14229124|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
14229125|NCT00057954|Methotrexate|methotrexate|mesh-list
14229126|NCT00057954|Pentostatin|pentostatin|mesh-list
14229127|NCT00057954|Cyclosporins|cyclosporins|mesh-list
14229128|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14229129|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
14229130|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14229131|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229132|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229133|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
14229134|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229135|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229136|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229137|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229138|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14229139|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229140|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
14229141|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229142|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14229143|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
14229144|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229145|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14229146|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229147|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14229148|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
14229149|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229150|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14229151|NCT00058019|Epothilones|epothilones|mesh-list
14229152|NCT00058019|Epothilone B|epothilone b|mesh-list
14229153|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229154|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229155|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229156|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229157|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229158|NCT00058123|Poly ICLC|poly iclc|mesh-list
14229159|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
14229160|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
14229161|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229162|NCT00058240|Alvocidib|alvocidib|mesh-list
14229163|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229164|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
14229165|NCT00058240|Growth Substances|growth substances|mesh-ancestor
14229166|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229167|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14229168|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229169|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229170|NCT00058370|Vincristine|vincristine|mesh-list
14229171|NCT00058370|Lomustine|lomustine|mesh-list
14229172|NCT00058370|Antibodies|antibodies|mesh-list
14229173|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14229174|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
14229175|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229176|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229177|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229178|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229179|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229180|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229181|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229182|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14229183|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
14229184|NCT00058422|Prednisone|prednisone|mesh-list
14229185|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
14229186|NCT00058422|Rituximab|rituximab|mesh-list
14229187|NCT00058422|Doxorubicin|doxorubicin|mesh-list
14229188|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14229189|NCT00058422|Vincristine|vincristine|mesh-list
14229190|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
14229191|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14229192|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229193|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
14229194|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229195|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229196|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14229197|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
14229198|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229199|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229200|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14229201|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229202|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229203|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229204|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229205|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229206|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229207|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
14229208|NCT00058422|Hormones|hormones|mesh-ancestor
14242598|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229209|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229210|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229211|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229212|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229213|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229214|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229215|NCT00058422|Hematinics|hematinics|mesh-ancestor
14229216|NCT00058539|Pertuzumab|pertuzumab|mesh-list
14229217|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229218|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229219|NCT00058552|Pertuzumab|pertuzumab|mesh-list
14229220|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229221|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229222|NCT00058825|Cyclosporine|cyclosporine|mesh-list
14229223|NCT00058825|Fludarabine|fludarabine|mesh-list
14229224|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
14229225|NCT00058825|Tacrolimus|tacrolimus|mesh-list
14229226|NCT00058825|Cyclosporins|cyclosporins|mesh-list
14229227|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229228|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229229|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229230|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
14229231|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229232|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14229233|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229234|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
14229235|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229236|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229237|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229238|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229239|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14229240|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14229241|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14229242|NCT00059215|Clopidogrel|clopidogrel|mesh-list
14229243|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14229244|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14229245|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14229246|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14229247|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14229248|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
14229249|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14229250|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229251|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229252|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14229253|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14229254|NCT00059228|Estradiol|estradiol|mesh-list
14229255|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14229256|NCT00059228|Estrogens|estrogens|mesh-ancestor
14229257|NCT00059228|Hormones|hormones|mesh-ancestor
14229258|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229259|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229260|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14229261|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
14229262|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14229263|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14229264|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
14229265|NCT00059332|Analgesics|analgesics|mesh-ancestor
14229266|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
14229267|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229268|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229269|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
14229270|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14229271|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14229272|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
14229273|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14229274|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14229275|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229276|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14229277|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
14229278|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14229279|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
14229280|NCT00059475|Interleukin-2|interleukin-2|mesh-list
14791474|NCT00741429|Insulin|insulin|mesh-list
14229281|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229282|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14229283|NCT00059475|Analgesics|analgesics|mesh-ancestor
14229284|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
14229285|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229286|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229287|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14229288|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
14229289|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229290|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
14229291|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229292|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
14229293|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14229294|NCT00059475|Protective Agents|protective agents|mesh-ancestor
14229295|NCT00059787|Paclitaxel|paclitaxel|mesh-list
14229296|NCT00059787|Carboplatin|carboplatin|mesh-list
14229297|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14229298|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229299|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229300|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229301|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229302|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229303|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229304|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14229305|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229306|NCT00059839|Prednisone|prednisone|mesh-list
14229307|NCT00059839|Doxorubicin|doxorubicin|mesh-list
14229308|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14229309|NCT00059839|Methotrexate|methotrexate|mesh-list
14229310|NCT00059839|Vincristine|vincristine|mesh-list
14229311|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
14229312|NCT00059839|Vinblastine|vinblastine|mesh-list
14229313|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229314|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229315|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229316|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229317|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229318|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229319|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229320|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
14229321|NCT00059839|Hormones|hormones|mesh-ancestor
14229322|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229323|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229324|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229325|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14229326|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
14229327|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14229328|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229329|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
14229330|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229331|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14229332|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229333|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
14229334|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229335|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14229336|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229337|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229338|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229339|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229340|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14229341|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14229342|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229343|NCT00060346|Prednisone|prednisone|mesh-list
14229344|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
14229345|NCT00060346|Rituximab|rituximab|mesh-list
14229346|NCT00060346|Doxorubicin|doxorubicin|mesh-list
14229347|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14229348|NCT00060346|Vincristine|vincristine|mesh-list
14229349|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229350|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
14229351|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229352|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229353|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14229354|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
14229355|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229356|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229357|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14229358|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229359|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229360|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229361|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229362|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229363|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229364|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
14229365|NCT00060346|Hormones|hormones|mesh-ancestor
14229366|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229367|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229368|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229369|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229370|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229371|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229372|NCT00060424|Cyclosporine|cyclosporine|mesh-list
14229373|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
14229374|NCT00060424|Fludarabine|fludarabine|mesh-list
14229375|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
14229376|NCT00060424|Cyclosporins|cyclosporins|mesh-list
14229377|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229378|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229379|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
14229380|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229381|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229382|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
14229383|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229384|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229385|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
14229386|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229387|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229388|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229389|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14229390|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229391|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14229392|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
14229393|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229394|NCT00060528|Metronidazole|metronidazole|mesh-list
14229395|NCT00060528|Molgramostim|molgramostim|mesh-list
14229396|NCT00060528|Sargramostim|sargramostim|mesh-list
14229397|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
14229398|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229399|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229400|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229401|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229402|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14229403|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14229404|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
14229405|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14229406|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
14229407|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229408|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229409|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14229410|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14229411|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14229412|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
14229413|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229414|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14229415|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14229416|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
14229417|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
14229418|NCT00060840|Protective Agents|protective agents|mesh-ancestor
14229419|NCT00060944|Dexamethasone|dexamethasone|mesh-list
14229420|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
14229421|NCT00060944|Trabectedin|trabectedin|mesh-list
14229422|NCT00060944|BB 1101|bb 1101|mesh-list
14229423|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229424|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
14229425|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
14229426|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229427|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229428|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14229429|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
14229430|NCT00060944|Hormones|hormones|mesh-ancestor
14229431|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229432|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229433|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229434|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14229435|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229436|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229437|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14229438|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
14229439|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
14229440|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229441|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229442|NCT00061373|Aspirin|aspirin|mesh-list
14229443|NCT00061373|Tinzaparin|tinzaparin|mesh-list
14229444|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14229445|NCT00061373|Dalteparin|dalteparin|mesh-list
14229446|NCT00061373|Eptifibatide|eptifibatide|mesh-list
14229447|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14229448|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14229449|NCT00061373|Analgesics|analgesics|mesh-ancestor
14229450|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
14229451|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229452|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229453|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229454|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229455|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14229456|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14229457|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229458|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14229459|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14229460|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229461|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
14229462|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
14229463|NCT00061633|Vancomycin|vancomycin|mesh-list
14229464|NCT00061633|Penicillins|penicillins|mesh-list
14229465|NCT00061633|Telavancin|telavancin|mesh-list
14229466|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229467|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229468|NCT00061893|Celecoxib|celecoxib|mesh-list
14229469|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
14229470|NCT00061893|Ifosfamide|ifosfamide|mesh-list
14229471|NCT00061893|Doxorubicin|doxorubicin|mesh-list
14229472|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14229473|NCT00061893|Etoposide|etoposide|mesh-list
14229474|NCT00061893|Vincristine|vincristine|mesh-list
14229475|NCT00061893|Vinblastine|vinblastine|mesh-list
14229476|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229477|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
14229478|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229479|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229480|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14229481|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
14229482|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229483|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229484|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14229485|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229486|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229487|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229488|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229489|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229490|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229491|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229492|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229493|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14229494|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14229495|NCT00061893|Analgesics|analgesics|mesh-ancestor
14229496|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
14229497|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229498|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229499|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14229500|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14229501|NCT00061932|Irinotecan|irinotecan|mesh-list
14229502|NCT00061932|Bortezomib|bortezomib|mesh-list
14229503|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14229504|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229505|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229506|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510314|NCT03008213|Palonosetron|palonosetron|mesh-list
14510315|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
14229507|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510316|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
14528817|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
14229508|NCT00061945|Leucovorin|leucovorin|mesh-list
14229509|NCT00061945|Cytarabine|cytarabine|mesh-list
14229510|NCT00061945|Acyclovir|acyclovir|mesh-list
14229511|NCT00061945|Trimethoprim|trimethoprim|mesh-list
14229512|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
14229513|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14229514|NCT00061945|Dexamethasone|dexamethasone|mesh-list
14229515|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
14229516|NCT00061945|Methotrexate|methotrexate|mesh-list
14229517|NCT00061945|Vincristine|vincristine|mesh-list
14229518|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
14229519|NCT00061945|Daunorubicin|daunorubicin|mesh-list
14229520|NCT00061945|Asparaginase|asparaginase|mesh-list
14229521|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
14229522|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
14229523|NCT00061945|Allopurinol|allopurinol|mesh-list
14229524|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
14229525|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229526|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
14229527|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229528|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229529|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14510317|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510318|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510319|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510320|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14510321|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14510322|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
14510323|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510324|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510325|NCT03008590|Naltrexone|naltrexone|mesh-list
14510326|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14510327|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14510328|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510329|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
14510330|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510331|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
14510332|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14510333|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
14510334|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510335|NCT03008889|Expectorants|expectorants|mesh-ancestor
14510336|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
14510337|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14510338|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
14510339|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510340|NCT03008889|Protective Agents|protective agents|mesh-ancestor
14791475|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791476|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791477|NCT00741507|Ethanol|ethanol|mesh-list
14791478|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14791479|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791480|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791481|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791482|NCT00741585|Atenolol|atenolol|mesh-list
14791483|NCT00741585|Amlodipine|amlodipine|mesh-list
14791484|NCT00741585|Valsartan|valsartan|mesh-list
14791485|NCT00741585|Telmisartan|telmisartan|mesh-list
14791486|NCT00741585|Carvedilol|carvedilol|mesh-list
14791487|NCT00741585|Candesartan|candesartan|mesh-list
14791488|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
14791489|NCT00741585|Ramipril|ramipril|mesh-list
14791490|NCT00741585|Olmesartan|olmesartan|mesh-list
14791491|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14791492|NCT00741585|Enalapril|enalapril|mesh-list
14791493|NCT00741585|Enalaprilat|enalaprilat|mesh-list
14791494|NCT00741585|Lisinopril|lisinopril|mesh-list
14791495|NCT00741585|Irbesartan|irbesartan|mesh-list
14791496|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
14791497|NCT00741585|Quinapril|quinapril|mesh-list
14791498|NCT00741585|Lercanidipine|lercanidipine|mesh-list
14791499|NCT00741585|Manidipine|manidipine|mesh-list
14791500|NCT00741585|Doxazosin|doxazosin|mesh-list
14948430|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14229530|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
14229531|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229532|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510341|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510342|NCT03008889|Antidotes|antidotes|mesh-ancestor
14791501|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14791502|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791503|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229533|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14229534|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229535|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
14229536|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
14229537|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229538|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14229539|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
14229540|NCT00061945|Hormones|hormones|mesh-ancestor
14229541|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229542|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229543|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14229544|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
14229545|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14229546|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229547|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
14229548|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229549|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229550|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14229551|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14229552|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
14229553|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229554|NCT00061945|Antidotes|antidotes|mesh-ancestor
14229555|NCT00061945|Protective Agents|protective agents|mesh-ancestor
14229556|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
14229557|NCT00061945|Vitamins|vitamins|mesh-ancestor
14229558|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
14229559|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229560|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229561|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229562|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229563|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14229564|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229565|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229566|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229567|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229568|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
14229569|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14229570|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
14229571|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14229572|NCT00061945|Renal Agents|renal agents|mesh-ancestor
14229573|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
14229574|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14229575|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14229576|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14229577|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14229578|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14229579|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14242599|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14242600|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
14242601|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
14242602|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14242603|NCT00187135|Narcotics|narcotics|mesh-ancestor
14242604|NCT00187135|Analgesics|analgesics|mesh-ancestor
14242605|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
14242606|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242607|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14242608|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14242609|NCT00187486|Temozolomide|temozolomide|mesh-list
14242610|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242611|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14242612|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242613|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242614|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14242615|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
14242616|NCT00187655|Cefotaxime|cefotaxime|mesh-list
14242617|NCT00187655|Cefoxitin|cefoxitin|mesh-list
14242618|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14242619|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242620|NCT00187681|Metformin|metformin|mesh-list
14242621|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14242622|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242623|NCT00187720|Metformin|metformin|mesh-list
14242624|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510343|NCT03008915|Aspirin|aspirin|mesh-list
14242625|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242626|NCT00187889|Eplerenone|eplerenone|mesh-list
14242627|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14229580|NCT00062010|Interferons|interferons|mesh-list
14229581|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
14229582|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
14229583|NCT00062010|Paclitaxel|paclitaxel|mesh-list
14229584|NCT00062010|Tretinoin|tretinoin|mesh-list
14229585|NCT00062010|Isotretinoin|isotretinoin|mesh-list
14229586|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229587|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229588|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229589|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229590|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229591|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229592|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
14229593|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229594|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
14229595|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229596|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
14229597|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229598|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
14229599|NCT00062374|Alovudine|alovudine|mesh-list
14229600|NCT00062374|Cisplatin|cisplatin|mesh-list
14229601|NCT00062374|Irinotecan|irinotecan|mesh-list
14229602|NCT00062374|Camptothecin|camptothecin|mesh-list
14229603|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14229604|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229605|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14229606|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229607|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229608|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229609|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14229610|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229611|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
14229612|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
14510344|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14510345|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
14510346|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14510347|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510348|NCT03008915|Analgesics|analgesics|mesh-ancestor
14510349|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
14510350|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510351|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510352|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510353|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510354|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14510355|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14510356|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510357|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14510358|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14510359|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510360|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
14510361|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14510362|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14510363|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510364|NCT03009162|Lasmiditan|lasmiditan|mesh-list
14510365|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14510366|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
14510367|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510368|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510369|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510370|NCT03009396|Clarithromycin|clarithromycin|mesh-list
14510371|NCT03009396|Rifabutin|rifabutin|mesh-list
14510372|NCT03009396|Clofazimine|clofazimine|mesh-list
14510373|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14510374|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510375|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14510376|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510377|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510378|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14510379|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14510380|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14510381|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
14510382|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948431|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14229613|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229614|NCT00062439|Docetaxel|docetaxel|mesh-list
14229615|NCT00062439|Etoposide|etoposide|mesh-list
14229616|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229617|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229618|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229619|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229620|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229621|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229622|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229623|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229624|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229625|NCT00062647|Vancomycin|vancomycin|mesh-list
14229626|NCT00062647|Cloxacillin|cloxacillin|mesh-list
14229627|NCT00062647|Oxacillin|oxacillin|mesh-list
14229628|NCT00062647|Telavancin|telavancin|mesh-list
14229629|NCT00062647|Nafcillin|nafcillin|mesh-list
14229630|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229631|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229632|NCT00062738|Paroxetine|paroxetine|mesh-list
14229633|NCT00062738|Nortriptyline|nortriptyline|mesh-list
14229634|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14229635|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14229636|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14229637|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229638|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14229639|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
14229640|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229641|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14229642|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
14229643|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14229644|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14229645|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14229646|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229647|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14229648|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14229649|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
14229650|NCT00062764|Pioglitazone|pioglitazone|mesh-list
14229651|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14229652|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229653|NCT00063154|Pertuzumab|pertuzumab|mesh-list
14229654|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229655|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229656|NCT00063232|Metformin|metformin|mesh-list
14229657|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14229658|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229659|NCT00063258|Paclitaxel|paclitaxel|mesh-list
14229660|NCT00063258|Carboplatin|carboplatin|mesh-list
14229661|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14229662|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229663|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229664|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229665|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229666|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229667|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229668|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14229669|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229670|NCT00063362|Lamotrigine|lamotrigine|mesh-list
14229671|NCT00063362|Valproic Acid|valproic acid|mesh-list
14229672|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
14791504|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791505|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229673|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
14229674|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14229675|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229676|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229677|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
14229678|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14229679|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14229680|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229681|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
14229682|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14229683|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14229684|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14229685|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14229686|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14229687|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
14229688|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14229689|NCT00063570|Gemcitabine|gemcitabine|mesh-list
14229690|NCT00063570|Pemetrexed|pemetrexed|mesh-list
14229691|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229692|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
14229693|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229694|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229695|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
14229696|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229697|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229698|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229699|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
14229700|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229701|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14229702|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14229703|NCT00063622|Vitamin E|vitamin e|mesh-list
14229704|NCT00063622|Pioglitazone|pioglitazone|mesh-list
14229705|NCT00063622|Vitamins|vitamins|mesh-ancestor
14229706|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
14229707|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229708|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14229709|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
14229710|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229711|NCT00063622|Protective Agents|protective agents|mesh-ancestor
14229712|NCT00063635|Vitamin E|vitamin e|mesh-list
14229713|NCT00063635|Metformin|metformin|mesh-list
14229714|NCT00063635|Vitamins|vitamins|mesh-ancestor
14229715|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
14229716|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229717|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14229718|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
14229719|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229720|NCT00063635|Protective Agents|protective agents|mesh-ancestor
14229721|NCT00063934|Docetaxel|docetaxel|mesh-list
14229722|NCT00063934|Doxorubicin|doxorubicin|mesh-list
14229723|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14229724|NCT00063934|Oblimersen|oblimersen|mesh-list
14229725|NCT00063934|Lenograstim|lenograstim|mesh-list
14229726|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229727|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229728|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229729|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229730|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229731|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229732|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229733|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229734|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229735|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14229736|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
14229737|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229738|NCT00063999|Paclitaxel|paclitaxel|mesh-list
14229739|NCT00063999|Cisplatin|cisplatin|mesh-list
14229740|NCT00063999|Carboplatin|carboplatin|mesh-list
14229741|NCT00063999|Doxorubicin|doxorubicin|mesh-list
14229742|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14229743|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14229744|NCT00063999|Lenograstim|lenograstim|mesh-list
14229745|NCT00063999|Sargramostim|sargramostim|mesh-list
14229746|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229747|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229748|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229749|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229750|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229751|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229752|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229753|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14229754|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229755|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229756|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14229757|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
14229758|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229759|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14229760|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
14229761|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14229762|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14229763|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14229764|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
14229765|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14229766|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229767|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14229768|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14229769|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14229770|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229771|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229772|NCT00064038|Dexamethasone|dexamethasone|mesh-list
14229773|NCT00064038|Lenalidomide|lenalidomide|mesh-list
14229774|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229775|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
14229776|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
14229777|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229778|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229779|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14229780|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
14229781|NCT00064038|Hormones|hormones|mesh-ancestor
14229782|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229783|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229784|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229785|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
14229786|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14229787|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14229788|NCT00064038|Growth Substances|growth substances|mesh-ancestor
14229789|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
14229790|NCT00064077|Gemcitabine|gemcitabine|mesh-list
14229791|NCT00064077|Paclitaxel|paclitaxel|mesh-list
14229792|NCT00064077|Vinorelbine|vinorelbine|mesh-list
14229793|NCT00064077|Cisplatin|cisplatin|mesh-list
14229794|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14229795|NCT00064077|Topotecan|topotecan|mesh-list
14229796|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229797|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229798|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229799|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229800|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229801|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229802|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14510383|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
14510384|NCT03010631|Lubiprostone|lubiprostone|mesh-list
14510385|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14510386|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14510387|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510388|NCT03010683|Metformin|metformin|mesh-list
14510389|NCT03010683|Liraglutide|liraglutide|mesh-list
14510390|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510391|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510392|NCT03010683|Incretins|incretins|mesh-ancestor
14510393|NCT03010683|Hormones|hormones|mesh-ancestor
14510394|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510395|NCT03011333|Epinephrine|epinephrine|mesh-list
14510396|NCT03011333|Bupivacaine|bupivacaine|mesh-list
14510397|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510398|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
14510399|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510400|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510401|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
14510402|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510403|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14510404|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14510405|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
14510406|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510407|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510408|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14510409|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14510410|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
14510411|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14510412|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
14510413|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
14510414|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
14510415|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14510416|NCT03011892|Triamcinolone|triamcinolone|mesh-list
14510417|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510418|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
14229803|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
14229804|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
14229805|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510419|NCT03011892|Hormones|hormones|mesh-ancestor
14510420|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229806|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229807|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229808|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
14229809|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229810|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14229811|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229812|NCT00064259|Fluorouracil|fluorouracil|mesh-list
14229813|NCT00064259|Oblimersen|oblimersen|mesh-list
14229814|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229815|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
14229816|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229817|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14229818|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229819|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
14229820|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229821|NCT00064337|Thalidomide|thalidomide|mesh-list
14229822|NCT00064337|Dexamethasone|dexamethasone|mesh-list
14229823|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
14229824|NCT00064337|Melphalan|melphalan|mesh-list
14229825|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229826|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
14229827|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229828|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229829|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14229830|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
14229831|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229832|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229833|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14229834|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229835|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
14229836|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
14229837|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229838|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14229839|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
14229840|NCT00064337|Hormones|hormones|mesh-ancestor
14229841|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229842|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229843|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
14229844|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229845|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229846|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14229847|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14229848|NCT00064337|Growth Substances|growth substances|mesh-ancestor
14229849|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
14229850|NCT00064350|Sorafenib|sorafenib|mesh-list
14229851|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229852|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14229853|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229854|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229855|NCT00064701|Cyclosporine|cyclosporine|mesh-list
14229856|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
14229857|NCT00064701|Tacrolimus|tacrolimus|mesh-list
14229858|NCT00064701|Cyclosporins|cyclosporins|mesh-list
14229859|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229860|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
14229861|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229862|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14229863|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229864|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229865|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
14229866|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229867|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229868|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229869|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229870|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229871|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14229872|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
14229873|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229874|NCT00064792|Simvastatin|simvastatin|mesh-list
14229875|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14229876|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14229877|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
14229878|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229879|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14229880|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14229881|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229882|NCT00064844|Nicotine|nicotine|mesh-list
14229883|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14229884|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
14229885|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229886|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229887|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14229888|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14229889|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
14229890|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14229891|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229892|NCT00064987|Hormones|hormones|mesh-list
14229893|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14229894|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229895|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229896|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
14229897|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14229898|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229899|NCT00065156|Lenalidomide|lenalidomide|mesh-list
14229900|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
14229901|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229902|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14229903|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14229904|NCT00065156|Growth Substances|growth substances|mesh-ancestor
14229905|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
14229906|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229907|NCT00065182|Docetaxel|docetaxel|mesh-list
14229908|NCT00065182|Topotecan|topotecan|mesh-list
14229909|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229910|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
14229911|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
14229912|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
14229913|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229914|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14229915|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14229916|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229917|NCT00065260|Cyclosporine|cyclosporine|mesh-list
14229918|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
14229919|NCT00065260|Cyclosporins|cyclosporins|mesh-list
14229920|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
14229921|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14229922|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229923|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229924|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229925|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
14229926|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229927|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
14229928|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229929|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
14229930|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14229931|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14229932|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229933|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229934|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
14229935|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14229936|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229937|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14229938|NCT00065468|Interferons|interferons|mesh-list
14229939|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
14229940|NCT00065468|Sirolimus|sirolimus|mesh-list
14229941|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229942|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
14229943|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229944|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
14510421|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229945|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229946|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14510422|NCT03012061|Fluticasone|fluticasone|mesh-list
14229947|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14229948|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
14229949|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14229950|NCT00065507|Entecavir|entecavir|mesh-list
14229951|NCT00065507|Adefovir|adefovir|mesh-list
14229952|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
14229953|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229954|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14229955|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14229956|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229957|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510423|NCT03012061|Xhance|xhance|mesh-list
14510424|NCT03012061|Albuterol|albuterol|mesh-list
14510425|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510426|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14510427|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
14510428|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510429|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510430|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14510431|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
14510432|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
14510433|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14510434|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
14510435|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14510436|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14510437|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14510438|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14510439|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
14510440|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510441|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510442|NCT03012191|Gentamicins|gentamicins|mesh-list
14510443|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14510444|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510445|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14510446|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510447|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510448|NCT03012334|Alprazolam|alprazolam|mesh-list
14510449|NCT03012334|Lasmiditan|lasmiditan|mesh-list
14510450|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14510451|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510452|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510453|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14510454|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14510455|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14510456|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
14510457|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
14510458|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510459|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510460|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14510461|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
14510462|NCT03012477|Adavosertib|adavosertib|mesh-list
14510463|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510464|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510465|NCT03012594|Lanreotide|lanreotide|mesh-list
14510466|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510467|NCT03012828|Moxidectin|moxidectin|mesh-list
14510468|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
14510469|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14510470|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510471|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
14510472|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
14510473|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
14510474|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510475|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948432|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948433|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948434|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510476|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14510477|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510478|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14510479|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510480|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510481|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510482|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791506|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
14791507|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14229958|NCT00065611|Dexamethasone|dexamethasone|mesh-list
14229959|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14229960|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
14229961|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
14229962|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14229963|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229964|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14229965|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
14229966|NCT00065611|Hormones|hormones|mesh-ancestor
14229967|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14229968|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14229969|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14229970|NCT00065806|Atorvastatin|atorvastatin|mesh-list
14229971|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14229972|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14229973|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
14229974|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229975|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14229976|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14229977|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14229978|NCT00066066|Amoxicillin|amoxicillin|mesh-list
14229979|NCT00066066|Metronidazole|metronidazole|mesh-list
14229980|NCT00066066|Doxycycline|doxycycline|mesh-list
14229981|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14229982|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14229983|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14229984|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14229985|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
14229986|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
14229987|NCT00066170|Modafinil|modafinil|mesh-list
14229988|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14229989|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14229990|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14229991|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14229992|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14229993|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14229994|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14229995|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14229996|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
14229997|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
14229998|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14229999|NCT00066222|Etoposide|etoposide|mesh-list
14230000|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230001|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230002|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230003|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230004|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230005|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230006|NCT00066365|Molgramostim|molgramostim|mesh-list
14230007|NCT00066365|Sargramostim|sargramostim|mesh-list
14948435|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
14948436|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14948437|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
14948438|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
14948439|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
14948440|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14948441|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
14948442|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
14948443|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14230008|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
14230009|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230010|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230011|NCT00066469|Prednisone|prednisone|mesh-list
14230012|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
14230013|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14230014|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14230015|NCT00066469|Prednisolone|prednisolone|mesh-list
14230016|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
14230017|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
14230018|NCT00066469|Rituximab|rituximab|mesh-list
14230019|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14230020|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
14230021|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230022|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
14948444|NCT01533272|Tenofovir|tenofovir|mesh-list
14230023|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948445|NCT01533272|Emtricitabine|emtricitabine|mesh-list
14230024|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230025|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230026|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
14230027|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230028|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230029|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230030|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230031|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14230032|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
14230033|NCT00066469|Hormones|hormones|mesh-ancestor
14230034|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230035|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14510483|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510484|NCT03015220|Dulaglutide|dulaglutide|mesh-list
14510485|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510486|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510487|NCT03015532|Bupivacaine|bupivacaine|mesh-list
14510488|NCT03015532|Ropivacaine|ropivacaine|mesh-list
14510489|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510490|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
14510491|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510492|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510493|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
14510494|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510495|NCT03015961|Bupivacaine|bupivacaine|mesh-list
14510496|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510497|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
14510498|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510499|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510500|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
14510501|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510502|NCT03016598|Oxytocin|oxytocin|mesh-list
14510503|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
14510504|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14510505|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510506|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
14510507|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
14510508|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
14510509|NCT03017235|Citric Acid|citric acid|mesh-list
14510510|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
14510511|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14510512|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
14510513|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
14510514|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510515|NCT03017235|Cathartics|cathartics|mesh-ancestor
14510516|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510517|NCT03017235|Antacids|antacids|mesh-ancestor
14510518|NCT03017508|Riluzole|riluzole|mesh-list
14510519|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
14510520|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14510521|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14510522|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14230036|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
14230037|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
14230038|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14230039|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14230040|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14230041|NCT00066469|Protective Agents|protective agents|mesh-ancestor
14230042|NCT00066573|Anastrozole|anastrozole|mesh-list
14230043|NCT00066573|Exemestane|exemestane|mesh-list
14230044|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14230045|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230046|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14230047|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14230048|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230049|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230050|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14230051|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
14230052|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230053|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230054|NCT00066677|Docetaxel|docetaxel|mesh-list
14230055|NCT00066677|Bevacizumab|bevacizumab|mesh-list
14230056|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230057|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230058|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230059|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230060|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230061|NCT00066677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230062|NCT00066677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14230063|NCT00066677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14230064|NCT00066677|Growth Substances|growth substances|mesh-ancestor
14230065|NCT00066677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230066|NCT00066677|Growth Inhibitors|growth inhibitors|mesh-ancestor
14230067|NCT00066690|Tamoxifen|tamoxifen|mesh-list
14230068|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14230069|NCT00066690|Exemestane|exemestane|mesh-list
14230070|NCT00066690|Tryptophan|tryptophan|mesh-list
14230071|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230072|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230073|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230074|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14230075|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
14230076|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14230077|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230078|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14230079|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14230080|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14230081|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14230082|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14230083|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230084|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
14230085|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14230086|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
14230087|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14230088|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14230089|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14230090|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
14230091|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14230092|NCT00066703|Tamoxifen|tamoxifen|mesh-list
14230093|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14230094|NCT00066703|Exemestane|exemestane|mesh-list
14230095|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14230096|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
14230097|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230098|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230099|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14230100|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230101|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14230102|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14230103|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14230104|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14230105|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14230106|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230107|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230108|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
14230109|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14230110|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
14230111|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14230112|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14230113|NCT00066742|Etoposide|etoposide|mesh-list
14230114|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
14230115|NCT00066742|Tirapazamine|tirapazamine|mesh-list
14230116|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230117|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230118|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230119|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230120|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230121|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230122|NCT00066781|Gemcitabine|gemcitabine|mesh-list
14230123|NCT00066781|Irinotecan|irinotecan|mesh-list
14230124|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230125|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
14230126|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230127|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230128|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
14230129|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230130|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230131|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230132|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
14230133|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230134|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14230135|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230136|NCT00066937|Benztropine|benztropine|mesh-list
14230137|NCT00066937|Nortriptyline|nortriptyline|mesh-list
14230138|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14230139|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
14230140|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14230141|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14230142|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14230143|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14230144|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230145|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
14230146|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14230147|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230148|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14230149|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14230150|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
14230151|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
14230152|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14230153|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14230154|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14230155|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
14230156|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14230157|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
14230158|NCT00067002|Vidarabine|vidarabine|mesh-list
14230159|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
14230160|NCT00067002|Melphalan|melphalan|mesh-list
14230161|NCT00067002|Thiotepa|thiotepa|mesh-list
14230162|NCT00067002|Rituximab|rituximab|mesh-list
14230163|NCT00067002|Fludarabine|fludarabine|mesh-list
14230164|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
14230165|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230166|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
14230167|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230168|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230169|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230170|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
14230171|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230172|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230173|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230174|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230175|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230176|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
14230177|NCT00067002|Antiviral Agents|antiviral agents|mesh-ancestor
14230178|NCT00067002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230179|NCT00067028|Cytarabine|cytarabine|mesh-list
14230180|NCT00067028|Clofarabine|clofarabine|mesh-list
14230181|NCT00067028|Idarubicin|idarubicin|mesh-list
14230182|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230183|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
14230184|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230185|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230186|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
14230187|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230188|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230189|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
14230190|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230191|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14230192|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230193|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230194|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230195|NCT00067808|Decitabine|decitabine|mesh-list
14230196|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230197|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
14230198|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230199|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230200|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230201|NCT00067990|Losartan|losartan|mesh-list
14230202|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14230203|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14230204|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14230205|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14230206|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230207|NCT00068250|Rituximab|rituximab|mesh-list
14230208|NCT00068250|Methotrexate|methotrexate|mesh-list
14510523|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510524|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510525|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14510526|NCT03017508|Protective Agents|protective agents|mesh-ancestor
14510527|NCT03017846|Cantharidin|cantharidin|mesh-list
14510528|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510529|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510530|NCT03018028|Liraglutide|liraglutide|mesh-list
14510531|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510532|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510533|NCT03018028|Incretins|incretins|mesh-ancestor
14510534|NCT03018028|Hormones|hormones|mesh-ancestor
14510535|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510536|NCT03018106|Estrogens|estrogens|mesh-list
14510537|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14510538|NCT03018106|Hormones|hormones|mesh-ancestor
14510539|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510540|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510541|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
14510542|NCT03018223|Sirolimus|sirolimus|mesh-list
14510543|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
14510544|NCT03018223|Busulfan|busulfan|mesh-list
14510545|NCT03018223|Fludarabine|fludarabine|mesh-list
14510546|NCT03018223|Sargramostim|sargramostim|mesh-list
14510547|NCT03018223|Lenograstim|lenograstim|mesh-list
14510548|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14510549|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
14510550|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510551|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510552|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14510553|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
14510554|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510555|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510556|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14510557|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14510558|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14510559|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
14510560|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14510561|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510562|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510563|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
14510564|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14510565|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14230209|NCT00068250|Temozolomide|temozolomide|mesh-list
14230210|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230211|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230212|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
14230213|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230214|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230215|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14230216|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
14230217|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14230218|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230219|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
14230220|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230221|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14230222|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230223|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14230224|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230225|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14230226|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230227|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
14230228|NCT00068341|Carboplatin|carboplatin|mesh-list
14230229|NCT00068341|Docetaxel|docetaxel|mesh-list
14230230|NCT00068341|Trastuzumab|trastuzumab|mesh-list
14230231|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230232|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230233|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230234|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230235|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230236|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230237|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14230238|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230239|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230240|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230241|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230242|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
14230243|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230244|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230245|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230246|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230247|NCT00068393|Gemcitabine|gemcitabine|mesh-list
14230248|NCT00068393|Doxorubicin|doxorubicin|mesh-list
14230249|NCT00068393|Sargramostim|sargramostim|mesh-list
14230250|NCT00068393|Lenograstim|lenograstim|mesh-list
14230251|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230252|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
14230253|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230254|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230255|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
14230256|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230257|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230258|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230259|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
14230260|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230261|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14230262|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230263|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230264|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14230265|NCT00068406|Cisplatin|cisplatin|mesh-list
14230266|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230267|NCT00068419|Tamoxifen|tamoxifen|mesh-list
14230268|NCT00068419|Sulindac|sulindac|mesh-list
14230269|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230270|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14230271|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
14230272|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230273|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230274|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14230275|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230276|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14230277|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14230278|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14230279|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14230280|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14230281|NCT00068419|Analgesics|analgesics|mesh-ancestor
14230282|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
14230283|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14230284|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14230285|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230286|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14230287|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230288|NCT00068445|Lamotrigine|lamotrigine|mesh-list
14230289|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
14230290|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14230291|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14230292|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230293|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14230294|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230295|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14230296|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14230297|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14230298|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14230299|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14230300|NCT00068575|Interferons|interferons|mesh-list
14230301|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
14230302|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
14230303|NCT00068575|Cisplatin|cisplatin|mesh-list
14230304|NCT00068575|Fluorouracil|fluorouracil|mesh-list
14230305|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230306|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
14230307|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230308|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230309|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230310|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
14230311|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230312|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
14230313|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230314|NCT00068588|Capecitabine|capecitabine|mesh-list
14230315|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230316|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
14230317|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230318|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230319|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
14230320|NCT00068601|Goserelin|goserelin|mesh-list
14230321|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230322|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
14230323|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230324|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230325|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230326|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
14230327|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230328|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230329|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230330|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14230331|NCT00068692|Leucovorin|leucovorin|mesh-list
14230332|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14230333|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
14230334|NCT00068692|Fluorouracil|fluorouracil|mesh-list
14230335|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
14230336|NCT00068692|Irinotecan|irinotecan|mesh-list
14230337|NCT00068692|Camptothecin|camptothecin|mesh-list
14230338|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
14230339|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230340|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
14230341|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230342|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230343|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230344|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230345|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
14230346|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14230347|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230348|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230349|NCT00068692|Antidotes|antidotes|mesh-ancestor
14230350|NCT00068692|Protective Agents|protective agents|mesh-ancestor
14230351|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
14230352|NCT00068692|Vitamins|vitamins|mesh-ancestor
14230353|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
14230354|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230355|NCT00068770|Celecoxib|celecoxib|mesh-list
14230356|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14230357|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14230358|NCT00068770|Analgesics|analgesics|mesh-ancestor
14230359|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
14230360|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510566|NCT03018249|Entinostat|entinostat|mesh-list
14510567|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
14510568|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14510569|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14510570|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14510571|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14510572|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
14510573|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14510574|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510575|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14510576|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14510577|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14510578|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14510579|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510580|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510581|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510582|NCT03018340|Pimavanserin|pimavanserin|mesh-list
14510583|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14510584|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14510585|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14510586|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14510587|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510588|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510589|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14510590|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14510591|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14510592|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
14510593|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510594|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510595|NCT03018925|Golimumab|golimumab|mesh-list
14510596|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14230361|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230362|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14230363|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230364|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14230365|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14230366|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230367|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230368|NCT00069095|Leucovorin|leucovorin|mesh-list
14230369|NCT00069095|Bevacizumab|bevacizumab|mesh-list
14230370|NCT00069095|Fluorouracil|fluorouracil|mesh-list
14230371|NCT00069095|Capecitabine|capecitabine|mesh-list
14230372|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
14230373|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230374|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230375|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14230376|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14230377|NCT00069095|Growth Substances|growth substances|mesh-ancestor
14230378|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230379|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
14230380|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
14230381|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230382|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230383|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230384|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
14230385|NCT00069095|Antidotes|antidotes|mesh-ancestor
14230386|NCT00069095|Protective Agents|protective agents|mesh-ancestor
14230387|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
14230388|NCT00069095|Vitamins|vitamins|mesh-ancestor
14230389|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
14230390|NCT00069108|Leucovorin|leucovorin|mesh-list
14230391|NCT00069108|Capecitabine|capecitabine|mesh-list
14230392|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
14230393|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230394|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
14230395|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230396|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230397|NCT00069108|Antidotes|antidotes|mesh-ancestor
14230398|NCT00069108|Protective Agents|protective agents|mesh-ancestor
14230399|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230400|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
14230401|NCT00069108|Vitamins|vitamins|mesh-ancestor
14230402|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
14230403|NCT00069121|Leucovorin|leucovorin|mesh-list
14230404|NCT00069121|Fluorouracil|fluorouracil|mesh-list
14230405|NCT00069121|Capecitabine|capecitabine|mesh-list
14230406|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
14230407|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
14230408|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230409|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230410|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230411|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230412|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
14230413|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230414|NCT00069121|Antidotes|antidotes|mesh-ancestor
14230415|NCT00069121|Protective Agents|protective agents|mesh-ancestor
14230416|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
14230417|NCT00069121|Vitamins|vitamins|mesh-ancestor
14230418|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
14230419|NCT00069160|Docetaxel|docetaxel|mesh-list
14230420|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14230421|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230422|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230423|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230424|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230425|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230426|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14230427|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14230428|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230429|NCT00069784|Insulin|insulin|mesh-list
14230430|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14230431|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
14230432|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14230433|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230434|NCT00069823|Esomeprazole|esomeprazole|mesh-list
14230435|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14230436|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14230437|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14230438|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230439|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230440|NCT00069953|Paclitaxel|paclitaxel|mesh-list
14230441|NCT00069953|Fluorouracil|fluorouracil|mesh-list
14230442|NCT00069953|Lenograstim|lenograstim|mesh-list
14230443|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230444|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230445|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230446|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230447|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230448|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230449|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
14230450|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230451|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230452|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
14230453|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230454|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14230455|NCT00070070|Sargramostim|sargramostim|mesh-list
14230456|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
14230457|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
14230458|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230459|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14230460|NCT00070109|Trabectedin|trabectedin|mesh-list
14230461|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230462|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
14230463|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230464|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230465|NCT00070135|Methotrexate|methotrexate|mesh-list
14230466|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
14230467|NCT00070135|Fludarabine|fludarabine|mesh-list
14230468|NCT00070135|Busulfan|busulfan|mesh-list
14230469|NCT00070135|Tacrolimus|tacrolimus|mesh-list
14230470|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14230471|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14230472|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
14230473|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14230474|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230475|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230476|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
14230477|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230478|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230479|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
14230480|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230481|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14230482|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230483|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
14230484|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230485|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14230486|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14230487|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
14230488|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230489|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230490|NCT00070291|Cyclosporine|cyclosporine|mesh-list
14230491|NCT00070291|Cyclosporins|cyclosporins|mesh-list
14230492|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230493|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230494|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230495|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
14230496|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230497|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
14230498|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230499|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
14230500|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230501|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14230502|NCT00070317|Methylene Blue|methylene blue|mesh-list
14230503|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14230504|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230505|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948446|NCT01533272|Lopinavir|lopinavir|mesh-list
14948447|NCT01533272|Maraviroc|maraviroc|mesh-list
14948448|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
14948449|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948450|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14948451|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14230506|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14230507|NCT00070941|Citalopram|citalopram|mesh-list
14230508|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14230509|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14510597|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510598|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14510599|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
14510600|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510601|NCT03018938|Insulin|insulin|mesh-list
14510602|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14510603|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510604|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510605|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14510606|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14510607|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14510608|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
14510609|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510610|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14510611|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14230510|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14230511|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230512|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14230513|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
14230514|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230515|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14230516|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
14230517|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14230518|NCT00071006|Axitinib|axitinib|mesh-list
14230519|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230520|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230521|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230522|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242628|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
14242629|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242630|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242631|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14242632|NCT00187889|Diuretics|diuretics|mesh-ancestor
14242633|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
14242634|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14242635|NCT00189098|Trimethoprim|trimethoprim|mesh-list
14242636|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14242637|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
14791508|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14791509|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14791510|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14791511|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
14791512|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791513|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
14791514|NCT00741585|Protective Agents|protective agents|mesh-ancestor
14791515|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14791516|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14791517|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14791518|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
14791519|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791520|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14791521|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14791522|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
14242638|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14242639|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242640|NCT00189098|Renal Agents|renal agents|mesh-ancestor
14242641|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
14242642|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14242643|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14242644|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14242645|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242646|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242647|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14242648|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14242649|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14242650|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14242651|NCT00189137|Gemcitabine|gemcitabine|mesh-list
14242652|NCT00189137|Docetaxel|docetaxel|mesh-list
14242653|NCT00189137|Doxorubicin|doxorubicin|mesh-list
14242654|NCT00189137|Ifosfamide|ifosfamide|mesh-list
14242655|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242656|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
14242657|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242658|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242659|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
14242660|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242661|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242662|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242663|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
14242664|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242665|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
14242666|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
14242667|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242668|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14242669|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14242670|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14242671|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14242672|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
14242673|NCT00189202|Sirolimus|sirolimus|mesh-list
14230523|NCT00071396|Rituximab|rituximab|mesh-list
14230524|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
14230525|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230526|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230527|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
14230528|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230529|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230530|NCT00071487|Belimumab|belimumab|mesh-list
14230531|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230532|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
14230533|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230534|NCT00071721|Valproic Acid|valproic acid|mesh-list
14230535|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
14230536|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230537|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230538|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
14230539|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14230540|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230541|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
14230542|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14230543|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14230544|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14230545|NCT00071760|Ritonavir|ritonavir|mesh-list
14230546|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
14230547|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14230548|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14230549|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
14230550|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230551|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230552|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14230553|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14230554|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
14230555|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230556|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14230557|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14230558|NCT00071799|Cytarabine|cytarabine|mesh-list
14230559|NCT00071799|Azacitidine|azacitidine|mesh-list
14230560|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230561|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
14230562|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230563|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230564|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
14230565|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230566|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230567|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
14230568|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230569|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230570|NCT00071812|Belimumab|belimumab|mesh-list
14230571|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230572|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
14230573|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230574|NCT00071890|Aldesleukin|aldesleukin|mesh-list
14230575|NCT00071890|Interleukin-2|interleukin-2|mesh-list
14230576|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230577|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14230578|NCT00071890|Analgesics|analgesics|mesh-ancestor
14230579|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
14230580|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14230581|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230582|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14230583|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14230584|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
14230585|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230586|NCT00071981|Molgramostim|molgramostim|mesh-list
14230587|NCT00071981|Vaccines|vaccines|mesh-list
14230588|NCT00071981|Sargramostim|sargramostim|mesh-list
14230589|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
14230590|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
14230591|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230592|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230593|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14510612|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230594|NCT00072176|Sirolimus|sirolimus|mesh-list
14510613|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14510614|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14510615|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14510616|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510617|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230595|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14230596|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230597|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14230598|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230599|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
14230600|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230601|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
14230602|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230603|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14230604|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230605|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230606|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230607|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230608|NCT00072280|Dactinomycin|dactinomycin|mesh-list
14230609|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
14230610|NCT00072280|Ifosfamide|ifosfamide|mesh-list
14230611|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
14230612|NCT00072280|Etoposide|etoposide|mesh-list
14230613|NCT00072280|Vincristine|vincristine|mesh-list
14230614|NCT00072280|Lenograstim|lenograstim|mesh-list
14230615|NCT00072280|Sargramostim|sargramostim|mesh-list
14230616|NCT00072280|Mesna|mesna|mesh-list
14230617|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230618|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
14230619|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230620|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230621|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230622|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
14230623|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230624|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230625|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230626|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230627|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230628|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230629|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230630|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14230631|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230632|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230633|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230634|NCT00072280|Protective Agents|protective agents|mesh-ancestor
14230635|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14510618|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510619|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791523|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
14791524|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791525|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14791526|NCT00741663|Furosemide|furosemide|mesh-list
14791527|NCT00741663|Spironolactone|spironolactone|mesh-list
14791528|NCT00741663|Diuretics|diuretics|mesh-ancestor
14791529|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
14791530|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791531|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14791532|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791533|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791534|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14791535|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
14791536|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791537|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14791538|NCT00741741|Rilpivirine|rilpivirine|mesh-list
14791539|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14791540|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14791541|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230636|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510620|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14510621|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
14510622|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510623|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
14510624|NCT03019887|Haloperidol|haloperidol|mesh-list
14510625|NCT03019887|Olanzapine|olanzapine|mesh-list
14510626|NCT03019887|Risperidone|risperidone|mesh-list
14510627|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14510628|NCT03019887|Aripiprazole|aripiprazole|mesh-list
14510629|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14510630|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
14510631|NCT03019887|Perphenazine|perphenazine|mesh-list
14230637|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14230638|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14230639|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14230640|NCT00072384|Carboplatin|carboplatin|mesh-list
14230641|NCT00072384|Etoposide|etoposide|mesh-list
14230642|NCT00072384|Vincristine|vincristine|mesh-list
14230643|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
14230644|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230645|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230646|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230647|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230648|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230649|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230650|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230651|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230652|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230653|NCT00072449|Rituximab|rituximab|mesh-list
14230654|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230655|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230656|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
14230657|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230658|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230659|NCT00072475|Vatalanib|vatalanib|mesh-list
14230660|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230661|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230662|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510632|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14510633|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
14510634|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510635|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510636|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510637|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14510638|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14510639|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510640|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14510641|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14510642|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
14510643|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
14510644|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
14510645|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510646|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510647|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14510648|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14510649|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14510650|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
14510651|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
14510652|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14510653|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14510654|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14510655|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14510656|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14510657|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510658|NCT03019887|Analgesics|analgesics|mesh-ancestor
14510659|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
14510660|NCT03019939|Isavuconazole|isavuconazole|mesh-list
14510661|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
14510662|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510663|NCT03019965|Meropenem|meropenem|mesh-list
14510664|NCT03019965|Tazobactam|tazobactam|mesh-list
14510665|NCT03019965|Piperacillin|piperacillin|mesh-list
14510666|NCT03019965|Imipenem|imipenem|mesh-list
14510667|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14510668|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14510669|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510670|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14510671|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510672|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510673|NCT03020004|Ritonavir|ritonavir|mesh-list
14510674|NCT03020004|Ribavirin|ribavirin|mesh-list
14510675|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14510676|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14510677|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14510678|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510679|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230663|NCT00072514|Gemcitabine|gemcitabine|mesh-list
14528818|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14230664|NCT00072514|Dexamethasone|dexamethasone|mesh-list
14230665|NCT00072514|Rituximab|rituximab|mesh-list
14230666|NCT00072514|Carboplatin|carboplatin|mesh-list
14230667|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14230668|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
14230669|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
14230670|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14230671|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230672|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14230673|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
14230674|NCT00072514|Hormones|hormones|mesh-ancestor
14230675|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230676|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14230677|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230678|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230679|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
14230680|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230681|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230682|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
14230683|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230684|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
14230685|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230686|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230687|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230688|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
14230689|NCT00072566|Bevacizumab|bevacizumab|mesh-list
14230690|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14230691|NCT00072566|Antibodies|antibodies|mesh-list
14230692|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
14230693|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14230694|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
14230695|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
14230696|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230697|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
14230698|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230699|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230700|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230701|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
14230702|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230703|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230704|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230705|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14230706|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14230707|NCT00072566|Growth Substances|growth substances|mesh-ancestor
14230708|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
14230709|NCT00073008|Lapatinib|lapatinib|mesh-list
14230710|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230711|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230712|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230713|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230714|NCT00073021|Mesalamine|mesalamine|mesh-list
14230715|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14230716|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14230717|NCT00073021|Analgesics|analgesics|mesh-ancestor
14230718|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
14230719|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14230720|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230721|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14230722|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230723|NCT00073073|Vitamin D|vitamin d|mesh-list
14230724|NCT00073073|Exemestane|exemestane|mesh-list
14230725|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
14230726|NCT00073073|Calcium|calcium|mesh-list
14230727|NCT00073073|Vitamins|vitamins|mesh-ancestor
14230728|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
14230729|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230730|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14230731|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14230732|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230733|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14230734|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14230735|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230736|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948452|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230737|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14230738|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
14230739|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230740|NCT00073073|Antacids|antacids|mesh-ancestor
14230741|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14230742|NCT00073307|Sorafenib|sorafenib|mesh-list
14230743|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230744|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230745|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230746|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230747|NCT00073528|Letrozole|letrozole|mesh-list
14230748|NCT00073528|Lapatinib|lapatinib|mesh-list
14230749|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230750|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14230751|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14230752|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230753|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230754|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14230755|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
14230756|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230757|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230758|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230759|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14230760|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230761|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230762|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14230763|NCT00073918|Iodine|iodine|mesh-list
14230764|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
14230765|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
14230766|NCT00073918|Etoposide|etoposide|mesh-list
14230767|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
14230768|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
14230769|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14230770|NCT00073918|Antibodies|antibodies|mesh-list
14230771|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
14230772|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14230773|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230774|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
14230775|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230776|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230777|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230778|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
14230779|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230780|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230781|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230782|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230783|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230784|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230785|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230786|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14230787|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230788|NCT00073918|Trace Elements|trace elements|mesh-ancestor
14230789|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
14230790|NCT00073957|Cytarabine|cytarabine|mesh-list
14230791|NCT00073957|Rituximab|rituximab|mesh-list
14230792|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230793|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230794|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
14230795|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230796|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230797|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230798|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
14230799|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230800|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
14230801|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230802|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230803|NCT00073983|Gemcitabine|gemcitabine|mesh-list
14230804|NCT00073983|Docetaxel|docetaxel|mesh-list
14230805|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230806|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
14230807|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230808|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230809|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
14230810|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230811|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230812|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230813|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
14230814|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230815|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230816|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230817|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230818|NCT00074035|Pentostatin|pentostatin|mesh-list
14230819|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230820|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14230821|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230822|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230823|NCT00074165|Cytarabine|cytarabine|mesh-list
14791542|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791543|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
14791544|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791545|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791546|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14791547|NCT00741767|Fluticasone|fluticasone|mesh-list
14791548|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14791549|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14791550|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948453|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948454|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14948455|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14948456|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14948457|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14948458|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
14948459|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14948460|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14948461|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14948462|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14948463|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14948464|NCT01533324|Leucovorin|leucovorin|mesh-list
14948465|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14948466|NCT01533324|Antidotes|antidotes|mesh-ancestor
14948467|NCT01533324|Protective Agents|protective agents|mesh-ancestor
14948468|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948469|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
14948470|NCT01533324|Vitamins|vitamins|mesh-ancestor
14948471|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
14948472|NCT01533376|Timolol|timolol|mesh-list
14948473|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
14948474|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14948475|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14948476|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948477|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14230824|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
14230825|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
14230826|NCT00074165|Rituximab|rituximab|mesh-list
14230827|NCT00074165|Carboplatin|carboplatin|mesh-list
14230828|NCT00074165|Etoposide|etoposide|mesh-list
14230829|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
14230830|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230831|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
14230832|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230833|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948478|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948479|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948480|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14948481|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14948482|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14230834|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230835|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
14230836|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230837|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230838|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230839|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230840|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230841|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230842|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230843|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230844|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230845|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
14230846|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
14230847|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791551|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14791552|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
14230848|NCT00074165|Antidotes|antidotes|mesh-ancestor
14230849|NCT00074165|Protective Agents|protective agents|mesh-ancestor
14230850|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
14230851|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
14230852|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14230853|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
14230854|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
14230855|NCT00074269|Cyclosporine|cyclosporine|mesh-list
14230856|NCT00074269|Methotrexate|methotrexate|mesh-list
14230857|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
14230858|NCT00074269|Fludarabine|fludarabine|mesh-list
14230859|NCT00074269|Melphalan|melphalan|mesh-list
14230860|NCT00074269|Cyclosporins|cyclosporins|mesh-list
14230861|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14230862|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14230863|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
14230864|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14230865|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230866|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14230867|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
14230868|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230869|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230870|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
14230871|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230872|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14230873|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230874|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
14230875|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230876|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14230877|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
14230878|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230879|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14230880|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230881|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
14230882|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230883|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
14230884|NCT00074282|Rituximab|rituximab|mesh-list
14230885|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
14230886|NCT00074282|Pentostatin|pentostatin|mesh-list
14230887|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230888|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
14230889|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230890|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230891|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230892|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
14230893|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230894|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230895|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230896|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230897|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14230898|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230899|NCT00074308|Bevacizumab|bevacizumab|mesh-list
14230900|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14230901|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
14230902|NCT00074308|Antibodies|antibodies|mesh-list
14230903|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
14230904|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14230905|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14230906|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14230907|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14230908|NCT00074308|Growth Substances|growth substances|mesh-ancestor
14230909|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230910|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
14230911|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
14230912|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14230913|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230914|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230915|NCT00074412|Nevirapine|nevirapine|mesh-list
14230916|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14230917|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14230918|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230919|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230920|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
14230921|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230922|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14230923|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14230924|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14230925|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14230926|NCT00074490|Prednisone|prednisone|mesh-list
14230927|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
14230928|NCT00074490|Rituximab|rituximab|mesh-list
14230929|NCT00074490|Doxorubicin|doxorubicin|mesh-list
14230930|NCT00074490|Fludarabine|fludarabine|mesh-list
14230931|NCT00074490|Etoposide|etoposide|mesh-list
14230932|NCT00074490|Vincristine|vincristine|mesh-list
14230933|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14230934|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
14230935|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230936|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230937|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14230938|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
14510680|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510681|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14510682|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14510683|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
14510684|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510685|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14510686|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14510687|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
14510688|NCT03020082|Ritonavir|ritonavir|mesh-list
14510689|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14510690|NCT03020082|Ribavirin|ribavirin|mesh-list
14510691|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14510692|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14510693|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510694|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510695|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510696|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14510697|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14510698|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
14510699|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510700|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14510701|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14510702|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
14510703|NCT03020095|Ritonavir|ritonavir|mesh-list
14510704|NCT03020095|Ribavirin|ribavirin|mesh-list
14510705|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14510706|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14510707|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510708|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510709|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510710|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14510711|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14510712|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
14510713|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510714|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14510715|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14510716|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
14510717|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14510718|NCT03020407|Dopamine|dopamine|mesh-list
14510719|NCT03020407|Epinephrine|epinephrine|mesh-list
14510720|NCT03020407|Norepinephrine|norepinephrine|mesh-list
14510721|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14510722|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510723|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14510724|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14510725|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
14510726|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791553|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791554|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791555|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14791556|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
14791557|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14791558|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14791559|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14791560|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14230939|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230940|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528819|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
14230941|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14230942|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14230943|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14230944|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14230945|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14230946|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230947|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14230948|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
14230949|NCT00074490|Hormones|hormones|mesh-ancestor
14230950|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14230951|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14230952|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14230953|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
14230954|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
14230955|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
14230956|NCT00074581|Ritonavir|ritonavir|mesh-list
14230957|NCT00074581|Lopinavir|lopinavir|mesh-list
14230958|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14230959|NCT00074581|Tenofovir|tenofovir|mesh-list
14230960|NCT00074581|Lamivudine|lamivudine|mesh-list
14230961|NCT00074581|Zidovudine|zidovudine|mesh-list
14230962|NCT00074581|Emtricitabine|emtricitabine|mesh-list
14230963|NCT00074581|Nevirapine|nevirapine|mesh-list
14230964|NCT00074581|Stavudine|stavudine|mesh-list
14230965|NCT00074581|Didanosine|didanosine|mesh-list
14230966|NCT00074581|Efavirenz|efavirenz|mesh-list
14230967|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14230968|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14230969|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
14230970|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14230971|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230972|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14230973|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14230974|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
14230975|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14230976|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14230977|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14230978|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14230979|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14510727|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510728|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510729|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14510730|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14510731|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
14510732|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510733|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14510734|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
14510735|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
14510736|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
14510737|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14510738|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
14510739|NCT03020407|Protective Agents|protective agents|mesh-ancestor
14510740|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
14510741|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510742|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
14510743|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510744|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510745|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14510746|NCT03020966|Acetaminophen|acetaminophen|mesh-list
14510747|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510748|NCT03020966|Analgesics|analgesics|mesh-ancestor
14510749|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
14510750|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510751|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510752|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
14510753|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
14510754|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14510755|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
14510756|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510757|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14230980|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
14230981|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14230982|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14230983|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14230984|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14230985|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14230986|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
14230987|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
14230988|NCT00074711|Calcium|calcium|mesh-list
14230989|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14230990|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14230991|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14230992|NCT00074711|Antacids|antacids|mesh-ancestor
14230993|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14230994|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14230995|NCT00074802|Paroxetine|paroxetine|mesh-list
14230996|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14230997|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14230998|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14230999|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231000|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231001|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
14231002|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231003|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14231004|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
14231005|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14231006|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14231007|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14231008|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231009|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
14231010|NCT00074815|Citalopram|citalopram|mesh-list
14231011|NCT00074815|Fluoxetine|fluoxetine|mesh-list
14231012|NCT00074815|Paroxetine|paroxetine|mesh-list
14231013|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14231014|NCT00074815|Sertraline|sertraline|mesh-list
14231015|NCT00074815|Clomipramine|clomipramine|mesh-list
14231016|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14231017|NCT00074815|Serotonin|serotonin|mesh-list
14231018|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14231019|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14231020|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231021|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231022|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
14231023|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231024|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14231025|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
14231026|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14231027|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14231028|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14231029|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231030|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14231031|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14231032|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14231033|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14231034|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14231035|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14231036|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14231037|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14231038|NCT00075023|Thalidomide|thalidomide|mesh-list
14231039|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231040|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
14231041|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231042|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
14231043|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231044|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231045|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14231046|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14231047|NCT00075023|Growth Substances|growth substances|mesh-ancestor
14231048|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
14231049|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231050|NCT00075218|Sunitinib|sunitinib|mesh-list
14231051|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231052|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14231053|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14510758|NCT03021018|Lorazepam|lorazepam|mesh-list
14231054|NCT00075218|Growth Substances|growth substances|mesh-ancestor
14231055|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231056|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
14231057|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14231058|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231059|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231060|NCT00075270|Paclitaxel|paclitaxel|mesh-list
14231061|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14231062|NCT00075270|Lapatinib|lapatinib|mesh-list
14231063|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14231064|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231065|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231066|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231067|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231068|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231069|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14231070|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231071|NCT00075335|Plerixafor|plerixafor|mesh-list
14231072|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14231073|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14231074|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
14231075|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231076|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
14231077|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231078|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14231079|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231080|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231081|NCT00075478|Cyclosporine|cyclosporine|mesh-list
14231082|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
14231083|NCT00075478|Fludarabine|fludarabine|mesh-list
14231084|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
14231085|NCT00075478|Cyclosporins|cyclosporins|mesh-list
14231086|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231087|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231088|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
14231089|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231090|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231091|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
14231092|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231093|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231094|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
14231095|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231096|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
14231097|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231098|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14231099|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14231100|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14231101|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
14231102|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231103|NCT00075504|Gemcitabine|gemcitabine|mesh-list
14231104|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231105|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
14231106|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231107|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231108|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
14231109|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231110|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231111|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231112|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
14231113|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231114|NCT00075582|Dactinomycin|dactinomycin|mesh-list
14231115|NCT00075582|Cactinomycin|cactinomycin|mesh-list
14231116|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
14231117|NCT00075582|Vincristine|vincristine|mesh-list
14231118|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231119|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
14510759|NCT03021018|Brivaracetam|brivaracetam|mesh-list
14231120|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231121|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510760|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
14510761|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
14510762|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
14528820|NCT03827473|Protective Agents|protective agents|mesh-ancestor
14231122|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14231123|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
14231124|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231125|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231126|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14231127|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14231128|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231129|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231130|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231131|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231132|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231133|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14231134|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14231135|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231136|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14231137|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
14231138|NCT00075725|Leucovorin|leucovorin|mesh-list
14231139|NCT00075725|Folic Acid|folic acid|mesh-list
14231140|NCT00075725|Cytarabine|cytarabine|mesh-list
14231141|NCT00075725|Dexamethasone|dexamethasone|mesh-list
14231142|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
14231143|NCT00075725|Prednisone|prednisone|mesh-list
14231144|NCT00075725|Cortisone|cortisone|mesh-list
14231145|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
14231146|NCT00075725|Doxorubicin|doxorubicin|mesh-list
14231147|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14231148|NCT00075725|Methotrexate|methotrexate|mesh-list
14231149|NCT00075725|Vincristine|vincristine|mesh-list
14231150|NCT00075725|Daunorubicin|daunorubicin|mesh-list
14231151|NCT00075725|Asparaginase|asparaginase|mesh-list
14231152|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
14231153|NCT00075725|Pegaspargase|pegaspargase|mesh-list
14231154|NCT00075725|Thioguanine|thioguanine|mesh-list
14231155|NCT00075725|BB 1101|bb 1101|mesh-list
14510763|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510764|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510765|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510766|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14510767|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510768|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14510769|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14510770|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14510771|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
14510772|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
14510773|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510774|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528821|NCT03827473|Vitamins|vitamins|mesh-ancestor
14528822|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
14528823|NCT03827473|Estrogens|estrogens|mesh-ancestor
14528824|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
14528825|NCT03812328|Enoxaparin|enoxaparin|mesh-list
14528826|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
14528827|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14528828|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14528829|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528830|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14528831|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14528832|NCT03822182|Dexamethasone|dexamethasone|mesh-list
14528833|NCT03822182|Bupivacaine|bupivacaine|mesh-list
14528834|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14528835|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
14528836|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
14528837|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528838|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528839|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528840|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
14528841|NCT03822182|Hormones|hormones|mesh-ancestor
14528842|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14528843|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14528844|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14528845|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
14528846|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
14791561|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14231156|NCT00075725|Calcium|calcium|mesh-list
14528847|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14231157|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
14231158|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
14231159|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14528848|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
14528849|NCT03822416|Nicotine|nicotine|mesh-list
14791562|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
14231160|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
14231161|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231162|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231163|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14231164|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
14231165|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231166|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231167|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14231168|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231169|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
14231170|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
14231171|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231172|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14231173|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
14231174|NCT00075725|Hormones|hormones|mesh-ancestor
14231175|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231176|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14231177|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
14231178|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231179|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14231180|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14231181|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14231182|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14231183|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14231184|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14231185|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
14231186|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14231187|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231188|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
14231189|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
14231190|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14231191|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14231192|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
14231193|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231194|NCT00075725|Antidotes|antidotes|mesh-ancestor
14231195|NCT00075725|Protective Agents|protective agents|mesh-ancestor
14231196|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
14231197|NCT00075725|Vitamins|vitamins|mesh-ancestor
14231198|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
14231199|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14231200|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
14510775|NCT03021343|Colchicine|colchicine|mesh-list
14510776|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
14510777|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510778|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
14510779|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
14510780|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
14510781|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510782|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510783|NCT03021642|Tepotinib|tepotinib|mesh-list
14510784|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510785|NCT03022526|Fentanyl|fentanyl|mesh-list
14510786|NCT03022526|Bupivacaine|bupivacaine|mesh-list
14510787|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510788|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
14510789|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510790|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510791|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
14510792|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510793|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14510794|NCT03022526|Narcotics|narcotics|mesh-ancestor
14510795|NCT03022526|Analgesics|analgesics|mesh-ancestor
14510796|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14510797|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14510798|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
14510799|NCT03022617|Apremilast|apremilast|mesh-list
14510800|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14510801|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510802|NCT03022617|Analgesics|analgesics|mesh-ancestor
14510803|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
14510804|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510805|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510806|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510807|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510808|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14231201|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231202|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231203|NCT00075725|Hematinics|hematinics|mesh-ancestor
14231204|NCT00075764|Fulvestrant|fulvestrant|mesh-list
14231205|NCT00075764|Anastrozole|anastrozole|mesh-list
14231206|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14231207|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231208|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14231209|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14231210|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
14231211|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231212|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231213|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14231214|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14231215|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231216|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231217|NCT00075803|Fluconazole|fluconazole|mesh-list
14231218|NCT00075803|Voriconazole|voriconazole|mesh-list
14231219|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
14231220|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231221|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14231222|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14231223|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231224|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231225|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14231226|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
14231227|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231228|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231229|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14231230|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14231231|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14231232|NCT00075829|Thalidomide|thalidomide|mesh-list
14231233|NCT00075829|Dexamethasone|dexamethasone|mesh-list
14231234|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231235|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
14231236|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
14231237|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231238|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231239|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14231240|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
14231241|NCT00075829|Hormones|hormones|mesh-ancestor
14231242|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231243|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14231244|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231245|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231246|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
14231247|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
14231248|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231249|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231250|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14231251|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14231252|NCT00075829|Growth Substances|growth substances|mesh-ancestor
14231253|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
14231254|NCT00075881|Bortezomib|bortezomib|mesh-list
14231255|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231256|NCT00075946|Rituximab|rituximab|mesh-list
14231257|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14231258|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231259|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
14231260|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231261|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231262|NCT00076011|Mitogens|mitogens|mesh-list
14231263|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
14231264|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231265|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231266|NCT00076011|Growth Substances|growth substances|mesh-ancestor
14231267|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231268|NCT00076024|Docetaxel|docetaxel|mesh-list
14231269|NCT00076024|Axitinib|axitinib|mesh-list
14231270|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231271|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231272|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231273|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231274|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231275|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14231276|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231277|NCT00076102|Pirfenidone|pirfenidone|mesh-list
14231278|NCT00076102|Analgesics|analgesics|mesh-ancestor
14231279|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
14231280|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231281|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231282|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14231283|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14231284|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231285|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231286|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231287|NCT00076336|Lamivudine|lamivudine|mesh-list
14231288|NCT00076336|Telbivudine|telbivudine|mesh-list
14231289|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14231290|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14231291|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231292|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231293|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
14231294|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231295|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14231296|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14231297|NCT00076570|Sirolimus|sirolimus|mesh-list
14231298|NCT00076570|Tacrolimus|tacrolimus|mesh-list
14231299|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231300|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
14231301|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231302|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14231303|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231304|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231305|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231306|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231307|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14231308|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231309|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
14231310|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
14231311|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14231312|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
14231313|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14231314|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14231315|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14231316|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14231317|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231318|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
14231319|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231320|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231321|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14231322|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231323|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
14231324|NCT00076752|Promethazine|promethazine|mesh-list
14231325|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
14231326|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
14231327|NCT00076752|Rituximab|rituximab|mesh-list
14231328|NCT00076752|Fludarabine|fludarabine|mesh-list
14231329|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
14231330|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231331|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
14231332|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231333|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231334|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14231335|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
14231336|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231337|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231338|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14231339|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14231340|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231341|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
14231342|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231343|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
14510809|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14510810|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510811|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510812|NCT03022916|Efinaconazole|efinaconazole|mesh-list
14510813|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14510814|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
14231344|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
14231345|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231346|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14231347|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
14231348|NCT00076752|Hormones|hormones|mesh-ancestor
14231349|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231350|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14231351|NCT00076752|Protective Agents|protective agents|mesh-ancestor
14231352|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14231353|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14231354|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14231355|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
14231356|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
14231357|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
14231358|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14231359|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
14231360|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
14231361|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231362|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14231363|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
14231364|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
14231365|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14231366|NCT00077064|Captopril|captopril|mesh-list
14231367|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14231368|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
14231369|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231370|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231371|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14231372|NCT00077207|Carboplatin|carboplatin|mesh-list
14231373|NCT00077207|Vincristine|vincristine|mesh-list
14231374|NCT00077207|Temozolomide|temozolomide|mesh-list
14231375|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231376|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14231377|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231378|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231379|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231380|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231381|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14231382|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
14231383|NCT00077376|Carboplatin|carboplatin|mesh-list
14231384|NCT00077376|Trastuzumab|trastuzumab|mesh-list
14231385|NCT00077376|Epothilone B|epothilone b|mesh-list
14231386|NCT00077376|Epothilones|epothilones|mesh-list
14231387|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231388|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14231389|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231390|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231391|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231392|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231393|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
14231394|NCT00077610|Hematinics|hematinics|mesh-ancestor
14231395|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
14231396|NCT00077623|Hematinics|hematinics|mesh-ancestor
14231397|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14231398|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
14231399|NCT00077636|Ribavirin|ribavirin|mesh-list
14231400|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
14231401|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231402|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
14231403|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231404|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
14231405|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231406|NCT00077649|Ribavirin|ribavirin|mesh-list
14231407|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14231408|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
14231409|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
14231410|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14231411|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
14231412|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231413|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
14231414|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231415|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
14231416|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791563|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231417|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231418|NCT00077675|Vancomycin|vancomycin|mesh-list
14231419|NCT00077675|Penicillins|penicillins|mesh-list
14231420|NCT00077675|Telavancin|telavancin|mesh-list
14231421|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231422|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231423|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
14231424|NCT00077766|Hematinics|hematinics|mesh-ancestor
14231425|NCT00077857|Docetaxel|docetaxel|mesh-list
14231426|NCT00077857|Capecitabine|capecitabine|mesh-list
14231427|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231428|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231429|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231430|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231431|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231432|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231433|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
14231434|NCT00077974|Sunitinib|sunitinib|mesh-list
14231435|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231436|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14231437|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14231438|NCT00077974|Growth Substances|growth substances|mesh-ancestor
14231439|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231440|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
14231441|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14231442|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231443|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231444|NCT00078286|Sertraline|sertraline|mesh-list
14231445|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
14231446|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14231447|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14231448|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14231449|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14231450|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231451|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231452|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
14231453|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231454|NCT00078312|Modafinil|modafinil|mesh-list
14231455|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14231456|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231457|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14231458|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14231459|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14231460|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231461|NCT00078325|Modafinil|modafinil|mesh-list
14231462|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14231463|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231464|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14231465|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14231466|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14231467|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231468|NCT00078338|Interferons|interferons|mesh-list
14231469|NCT00078338|Interferon-beta|interferon-beta|mesh-list
14231470|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
14231471|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
14231472|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
14231473|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231474|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
14231475|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231476|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
14231477|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231478|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14231479|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231480|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231481|NCT00078377|Modafinil|modafinil|mesh-list
14231482|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14231483|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231484|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14231485|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14231486|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14231487|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231488|NCT00078403|Ribavirin|ribavirin|mesh-list
14231489|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14231490|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
14231491|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231492|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
14231493|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231494|NCT00078559|Acetaminophen|acetaminophen|mesh-list
14231495|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
14231496|NCT00078559|Promethazine|promethazine|mesh-list
14231497|NCT00078559|Sirolimus|sirolimus|mesh-list
14231498|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14231499|NCT00078559|Nystatin|nystatin|mesh-list
14231500|NCT00078559|Clotrimazole|clotrimazole|mesh-list
14231501|NCT00078559|Miconazole|miconazole|mesh-list
14231502|NCT00078559|Pentamidine|pentamidine|mesh-list
14231503|NCT00078559|Trimethoprim|trimethoprim|mesh-list
14231504|NCT00078559|Valganciclovir|valganciclovir|mesh-list
14231505|NCT00078559|Acyclovir|acyclovir|mesh-list
14510815|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510816|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
14510817|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14510818|NCT03022981|Velpatasvir|velpatasvir|mesh-list
14510819|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
14510820|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510821|NCT03023423|Atezolizumab|atezolizumab|mesh-list
14510822|NCT03023423|Daratumumab|daratumumab|mesh-list
14510823|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510824|NCT03023722|Maytansine|maytansine|mesh-list
14510825|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14510826|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510827|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
14510828|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
14510829|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
14510830|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510831|NCT03023878|Dexamethasone|dexamethasone|mesh-list
14510832|NCT03023878|Blinatumomab|blinatumomab|mesh-list
14510833|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510834|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
14510835|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
14510836|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510837|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510838|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510839|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
14510840|NCT03023878|Hormones|hormones|mesh-ancestor
14510841|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510842|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14510843|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510844|NCT03023891|Prednisone|prednisone|mesh-list
14510845|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510846|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
14510847|NCT03023891|Hormones|hormones|mesh-ancestor
14510848|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510849|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510850|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14510851|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510852|NCT03025945|Nepafenac|nepafenac|mesh-list
14510853|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14510854|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510855|NCT03025945|Analgesics|analgesics|mesh-ancestor
14510856|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
14510857|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510858|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510859|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510860|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510861|NCT03026088|Bisoprolol|bisoprolol|mesh-list
14510862|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14510863|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
14510864|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
14510865|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231506|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
14231507|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
14231508|NCT00078559|Tacrolimus|tacrolimus|mesh-list
14510866|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231509|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231510|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
14231511|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231512|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14231513|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231514|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231515|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14231516|NCT00078559|Analgesics|analgesics|mesh-ancestor
14231517|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
14231518|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231519|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
14231520|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231521|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231522|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14231523|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231524|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
14231525|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231526|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
14231527|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
14231528|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14231529|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
14231530|NCT00078559|Hormones|hormones|mesh-ancestor
14231531|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231532|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14231533|NCT00078559|Protective Agents|protective agents|mesh-ancestor
14231534|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14231535|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14231536|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14231537|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14231538|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
14231539|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
14231540|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14231541|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
14231542|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
14231543|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231544|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14231545|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
14231546|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
14231547|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14231548|NCT00078559|Renal Agents|renal agents|mesh-ancestor
14231549|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
14231550|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14231551|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14231552|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14231553|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14231554|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14231555|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14231556|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
14231557|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14231558|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14231559|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14231560|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
14231561|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14231562|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14231563|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14231564|NCT00078559|Ionophores|ionophores|mesh-ancestor
14231565|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14231566|NCT00078715|Yohimbine|yohimbine|mesh-list
14231567|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
14231568|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
14231569|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231570|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231571|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14231572|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14231573|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14231574|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14231575|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231576|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231577|NCT00078715|Urological Agents|urological agents|mesh-ancestor
14231578|NCT00078754|Valproic Acid|valproic acid|mesh-list
14231579|NCT00078754|Fluoxetine|fluoxetine|mesh-list
14231580|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14231581|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14231582|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242674|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231583|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231584|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231585|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
14231586|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231587|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14231588|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
14231589|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14231590|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14231591|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14231592|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231593|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
14231594|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
14231595|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
14231596|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14231597|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14231598|NCT00078767|Sertraline|sertraline|mesh-list
14231599|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
14231600|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14231601|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14231602|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14231603|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14231604|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231605|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14231606|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
14231607|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231608|NCT00078819|Etanercept|etanercept|mesh-list
14231609|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14231610|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14231611|NCT00078819|Analgesics|analgesics|mesh-ancestor
14231612|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
14231613|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231614|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231615|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231616|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231617|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14231618|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231619|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
14231620|NCT00078897|Selenium|selenium|mesh-list
14231621|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
14231622|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231623|NCT00078897|Protective Agents|protective agents|mesh-ancestor
14231624|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231625|NCT00078897|Trace Elements|trace elements|mesh-ancestor
14231626|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
14231627|NCT00078949|Gemcitabine|gemcitabine|mesh-list
14231628|NCT00078949|Cytarabine|cytarabine|mesh-list
14231629|NCT00078949|Dexamethasone|dexamethasone|mesh-list
14231630|NCT00078949|Rituximab|rituximab|mesh-list
14231631|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231632|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231633|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
14231634|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
14231635|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231636|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231637|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14231638|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
14231639|NCT00078949|Hormones|hormones|mesh-ancestor
14231640|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231641|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14231642|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14231643|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
14231644|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231645|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231646|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
14231647|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231648|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
14231649|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231650|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231651|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231652|NCT00079001|Vitamin D|vitamin d|mesh-list
14231653|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
14231654|NCT00079001|Calcium|calcium|mesh-list
14231655|NCT00079001|Androgens|androgens|mesh-list
14231656|NCT00079001|Vitamins|vitamins|mesh-ancestor
14231657|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
14231658|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231659|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14231660|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14231661|NCT00079001|Hormones|hormones|mesh-ancestor
14231662|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242675|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242676|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14242677|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242678|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
14242679|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242680|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
14242681|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242682|NCT00189228|Omalizumab|omalizumab|mesh-list
14242683|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14242684|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14242685|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
14242686|NCT00189306|Imiquimod|imiquimod|mesh-list
14242687|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14242688|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
14242689|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242690|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242691|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
14242692|NCT00189436|Budesonide|budesonide|mesh-list
14242693|NCT00189436|Albuterol|albuterol|mesh-list
14242694|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14242695|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14242696|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
14242697|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242698|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242699|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14242700|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
14242701|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
14242702|NCT00189436|Hormones|hormones|mesh-ancestor
14242703|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242704|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
14242705|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14242706|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14242707|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14242708|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14242709|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14242710|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242711|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242712|NCT00189462|Montelukast|montelukast|mesh-list
14242713|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14242714|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
14242715|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14242716|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
14242717|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242718|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242719|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14242720|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14242721|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242722|NCT00189475|Montelukast|montelukast|mesh-list
14242723|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14242724|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
14242725|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14242726|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
14242727|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242728|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242729|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14242730|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14242731|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242732|NCT00189488|Methotrexate|methotrexate|mesh-list
14242733|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14242734|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
14242735|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14242736|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242737|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242738|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
14242739|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242740|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242741|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
14231663|NCT00079040|Bevacizumab|bevacizumab|mesh-list
14231664|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14231665|NCT00079040|Etoposide|etoposide|mesh-list
14231666|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
14231667|NCT00079040|Antibodies|antibodies|mesh-list
14231668|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
14231669|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14231670|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231671|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14231672|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14231673|NCT00079040|Growth Substances|growth substances|mesh-ancestor
14231674|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231675|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
14948483|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14948484|NCT01533389|Silodosin|silodosin|mesh-list
14948485|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14231676|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
14231677|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14231678|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14231679|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14231680|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510867|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14510868|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14510869|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14510870|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
14510871|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510872|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510873|NCT03026166|Nivolumab|nivolumab|mesh-list
14510874|NCT03026166|Ipilimumab|ipilimumab|mesh-list
14510875|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14510876|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510877|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14510878|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510879|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14510880|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
14510881|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14510882|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14510883|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510884|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
14510885|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
14510886|NCT03026556|Apixaban|apixaban|mesh-list
14510887|NCT03026556|Dabigatran|dabigatran|mesh-list
14510888|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14510889|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
14510890|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14510891|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
14510892|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510893|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510894|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
14510895|NCT03026803|Capecitabine|capecitabine|mesh-list
14510896|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
14510897|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14510898|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
14510899|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510900|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510901|NCT03027557|Denosumab|denosumab|mesh-list
14510902|NCT03027557|Cinacalcet|cinacalcet|mesh-list
14510903|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14510904|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510905|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14510906|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14510907|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
14510908|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510909|NCT03027661|Bupivacaine|bupivacaine|mesh-list
14510910|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510911|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
14510912|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510913|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242742|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231681|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231682|NCT00079183|Sirolimus|sirolimus|mesh-list
14231683|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231684|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231685|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14231686|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231687|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
14231688|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231689|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
14231690|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231691|NCT00079274|Leucovorin|leucovorin|mesh-list
14231692|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14231693|NCT00079274|Cetuximab|cetuximab|mesh-list
14231694|NCT00079274|Fluorouracil|fluorouracil|mesh-list
14231695|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
14231696|NCT00079274|Irinotecan|irinotecan|mesh-list
14231697|NCT00079274|Antibodies|antibodies|mesh-list
14231698|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
14231699|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14231700|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
14231701|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
14231702|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231703|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231704|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
14231705|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231706|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231707|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231708|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14231709|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14231710|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231711|NCT00079274|Antidotes|antidotes|mesh-ancestor
14231712|NCT00079274|Protective Agents|protective agents|mesh-ancestor
14231713|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
14231714|NCT00079274|Vitamins|vitamins|mesh-ancestor
14231715|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
14231716|NCT00079326|Trastuzumab|trastuzumab|mesh-list
14231717|NCT00079326|Epothilone B|epothilone b|mesh-list
14231718|NCT00079326|Epothilones|epothilones|mesh-list
14231719|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14231720|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231721|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231722|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231723|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231724|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231725|NCT00079339|Tipifarnib|tipifarnib|mesh-list
14231726|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231727|NCT00079417|Iodine|iodine|mesh-list
14231728|NCT00079417|Carboplatin|carboplatin|mesh-list
14231729|NCT00079417|Vincristine|vincristine|mesh-list
14231730|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231731|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14231732|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231733|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231734|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231735|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231736|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14231737|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231738|NCT00079417|Trace Elements|trace elements|mesh-ancestor
14231739|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
14231740|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231741|NCT00079677|Modafinil|modafinil|mesh-list
14231742|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14231743|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231744|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14231745|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14231746|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14231747|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231748|NCT00079937|Fluticasone|fluticasone|mesh-list
14231749|NCT00079937|Omalizumab|omalizumab|mesh-list
14231750|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231751|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14231752|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
14231753|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231754|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231755|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14231756|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
14231757|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14231758|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14231759|NCT00080119|Isoniazid|isoniazid|mesh-list
14231760|NCT00080119|Trimethoprim|trimethoprim|mesh-list
14231761|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
14510914|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
14510915|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231762|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
14510916|NCT03028012|Dexamethasone|dexamethasone|mesh-list
14510917|NCT03028012|Ketorolac|ketorolac|mesh-list
14510918|NCT03028012|Lidocaine|lidocaine|mesh-list
14510919|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14510920|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
14510921|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
14510922|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510923|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510924|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510925|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
14510926|NCT03028012|Hormones|hormones|mesh-ancestor
14510927|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510928|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14510929|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510930|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
14510931|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
14510932|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14510933|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
14510934|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14510935|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14510936|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14510937|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14510938|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510939|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14510940|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14510941|NCT03028012|Analgesics|analgesics|mesh-ancestor
14510942|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14510943|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14510944|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510945|NCT03028025|Hemostatics|hemostatics|mesh-list
14510946|NCT03028025|Coagulants|coagulants|mesh-ancestor
14510947|NCT03028103|Repaglinide|repaglinide|mesh-list
14510948|NCT03028103|Fluconazole|fluconazole|mesh-list
14510949|NCT03028103|Omeprazole|omeprazole|mesh-list
14510950|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14510951|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14510952|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14510953|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510954|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510955|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
14510956|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510957|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14510958|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14510959|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14510960|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
14231763|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231764|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231765|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14231766|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14231767|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
14231768|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231769|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14231770|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14231771|NCT00080119|Renal Agents|renal agents|mesh-ancestor
14231772|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
14231773|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14231774|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14231775|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14231776|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231777|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14231778|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14231779|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14231780|NCT00080223|Pirfenidone|pirfenidone|mesh-list
14231781|NCT00080223|Analgesics|analgesics|mesh-ancestor
14231782|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
14231783|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231784|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231785|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14231786|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14231787|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231788|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231789|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231790|NCT00080288|Modafinil|modafinil|mesh-list
14231791|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14231792|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231793|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14231794|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14231795|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14231796|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231797|NCT00080301|Capecitabine|capecitabine|mesh-list
14231798|NCT00080301|Epothilones|epothilones|mesh-list
14231799|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231800|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
14231801|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231802|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231803|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231804|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231805|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231806|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
14231807|NCT00080483|Testosterone|testosterone|mesh-list
14231808|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
14231809|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
14231810|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14231811|NCT00080483|Androgens|androgens|mesh-ancestor
14231812|NCT00080483|Hormones|hormones|mesh-ancestor
14231813|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231814|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231815|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14231816|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231817|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
14231818|NCT00080899|Fenretinide|fenretinide|mesh-list
14231819|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231820|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14231821|NCT00080899|Protective Agents|protective agents|mesh-ancestor
14231822|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231823|NCT00080938|Temozolomide|temozolomide|mesh-list
14231824|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14231825|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
14231826|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231827|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231828|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
14231829|NCT00081159|Doxorubicin|doxorubicin|mesh-list
14231830|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14231831|NCT00081159|Leuprolide|leuprolide|mesh-list
14231832|NCT00081159|Goserelin|goserelin|mesh-list
14231833|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14231834|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231835|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14231836|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14231837|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231838|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231839|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14231840|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231841|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14231842|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
14231843|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14231844|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14231845|NCT00081263|Celecoxib|celecoxib|mesh-list
14231846|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
14231847|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14231848|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14231849|NCT00081263|Analgesics|analgesics|mesh-ancestor
14231850|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
14231851|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231852|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231853|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14231854|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231855|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14231856|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14231857|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231858|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231859|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14231860|NCT00081289|Leucovorin|leucovorin|mesh-list
14231861|NCT00081289|Folic Acid|folic acid|mesh-list
14231862|NCT00081289|Fluorouracil|fluorouracil|mesh-list
14231863|NCT00081289|Capecitabine|capecitabine|mesh-list
14231864|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
14231865|NCT00081289|Irinotecan|irinotecan|mesh-list
14231866|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
14231867|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
14231868|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231869|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231870|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231871|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231872|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
14231873|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231874|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14231875|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14231876|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791564|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791565|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
14791566|NCT00741767|Hormones|hormones|mesh-ancestor
14231877|NCT00081289|Antidotes|antidotes|mesh-ancestor
14231878|NCT00081289|Protective Agents|protective agents|mesh-ancestor
14231879|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
14231880|NCT00081289|Vitamins|vitamins|mesh-ancestor
14231881|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
14231882|NCT00081289|Hematinics|hematinics|mesh-ancestor
14231883|NCT00081328|Metformin|metformin|mesh-list
14231884|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
14231885|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14231886|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231887|NCT00081458|Teduglutide|teduglutide|mesh-list
14231888|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14231889|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14231890|NCT00081458|Protective Agents|protective agents|mesh-ancestor
14231891|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231892|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
14231893|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14231894|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231895|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
14231896|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14231897|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14231898|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14231899|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231900|NCT00081770|Ribavirin|ribavirin|mesh-list
14231901|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14231902|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
14231903|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14231904|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
14231905|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231906|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
14231907|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231908|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
14231909|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231910|NCT00081861|Bevacizumab|bevacizumab|mesh-list
14231911|NCT00081861|Rituximab|rituximab|mesh-list
14231912|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14231913|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231914|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14231915|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14231916|NCT00081861|Growth Substances|growth substances|mesh-ancestor
14231917|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231918|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
14791567|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231919|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
14231920|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14231921|NCT00081939|Thalidomide|thalidomide|mesh-list
14231922|NCT00081939|Bortezomib|bortezomib|mesh-list
14231923|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231924|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14231925|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
14231926|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231927|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
14510961|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14510962|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510963|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14510964|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14510965|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14510966|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14510967|NCT03028129|Isoniazid|isoniazid|mesh-list
14510968|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14510969|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
14510970|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14510971|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14510972|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
14510973|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510974|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14510975|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
14510976|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14510977|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
14510978|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14510979|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510980|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14510981|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
14510982|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
14510983|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14510984|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
14510985|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14510986|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510987|NCT03028467|Folic Acid|folic acid|mesh-list
14510988|NCT03028467|Methotrexate|methotrexate|mesh-list
14510989|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14510990|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
14510991|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14510992|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14510993|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14510994|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
14510995|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14510996|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14510997|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
14510998|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14510999|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14511000|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14511001|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
14511002|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14511003|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14511004|NCT03028467|Hematinics|hematinics|mesh-ancestor
14511005|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
14511006|NCT03028467|Vitamins|vitamins|mesh-ancestor
14511007|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
14511008|NCT03028870|Naproxen|naproxen|mesh-list
14231928|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14511009|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14511010|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14511011|NCT03028870|Analgesics|analgesics|mesh-ancestor
14511012|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
14511013|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511014|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511015|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511016|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14511017|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
14511018|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14511019|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511020|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511021|NCT03029091|Losartan|losartan|mesh-list
14511022|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14511023|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14511024|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14231929|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231930|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14231931|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14231932|NCT00081939|Growth Substances|growth substances|mesh-ancestor
14231933|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
14231934|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14231935|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231936|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14231937|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231938|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231939|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
14231940|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14231941|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231942|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14231943|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14231944|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14231945|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231946|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231947|NCT00082329|Plerixafor|plerixafor|mesh-list
14231948|NCT00082329|Lenograstim|lenograstim|mesh-list
14231949|NCT00082329|Sargramostim|sargramostim|mesh-list
14231950|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14231951|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
14231952|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231953|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14231954|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14231955|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
14231956|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14231957|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14231958|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14231959|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14231960|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231961|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
14231962|NCT00082381|Exenatide|exenatide|mesh-list
14231963|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14231964|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231965|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14231966|NCT00082381|Incretins|incretins|mesh-ancestor
14231967|NCT00082381|Hormones|hormones|mesh-ancestor
14231968|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231969|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
14231970|NCT00082407|Exenatide|exenatide|mesh-list
14231971|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
14231972|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14231973|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231974|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14231975|NCT00082407|Incretins|incretins|mesh-ancestor
14231976|NCT00082407|Hormones|hormones|mesh-ancestor
14231977|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231978|NCT00082433|Capecitabine|capecitabine|mesh-list
14231979|NCT00082433|Epothilones|epothilones|mesh-list
14231980|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14231981|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
14231982|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14231983|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14231984|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
14231985|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
14231986|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
14231987|NCT00082628|Hormones|hormones|mesh-list
14231988|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14231989|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511025|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14511026|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511027|NCT03029143|Vedolizumab|vedolizumab|mesh-list
14511028|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511029|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
14511030|NCT03029208|Hematinics|hematinics|mesh-ancestor
14511031|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
14511032|NCT03029247|Hematinics|hematinics|mesh-ancestor
14511033|NCT03029650|Scopolamine|scopolamine|mesh-list
14511034|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14948486|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14948487|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14231990|NCT00082758|Interleukin-2|interleukin-2|mesh-list
14231991|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
14231992|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511035|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14511036|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
14231993|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14231994|NCT00082758|Analgesics|analgesics|mesh-ancestor
14231995|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
14231996|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14231997|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14231998|NCT00082810|Fulvestrant|fulvestrant|mesh-list
14231999|NCT00082810|Tipifarnib|tipifarnib|mesh-list
14232000|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14232001|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232002|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14232003|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14232004|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
14232005|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232006|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232007|NCT00082888|Tipifarnib|tipifarnib|mesh-list
14232008|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232009|NCT00083122|Cisplatin|cisplatin|mesh-list
14232010|NCT00083122|Alvocidib|alvocidib|mesh-list
14232011|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232012|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
14232013|NCT00083122|Growth Substances|growth substances|mesh-ancestor
14232014|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232015|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14232016|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232017|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232018|NCT00083174|Exemestane|exemestane|mesh-list
14232019|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232020|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14232021|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14232022|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232023|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232024|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14232025|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
14232026|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232027|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232028|NCT00083226|Doxorubicin|doxorubicin|mesh-list
14232029|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14232030|NCT00083226|Bortezomib|bortezomib|mesh-list
14232031|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232032|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232033|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14232034|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232035|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232036|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232037|NCT00083382|Pamidronate|pamidronate|mesh-list
14232038|NCT00083382|Thalidomide|thalidomide|mesh-list
14232039|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232040|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
14232041|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232042|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
14232043|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14232044|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232045|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14232046|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14232047|NCT00083382|Growth Substances|growth substances|mesh-ancestor
14232048|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
14232049|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232050|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14511037|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
14511038|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511039|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511040|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511041|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
14511042|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14511043|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
13968092|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968093|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13968094|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
13968095|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968096|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13968097|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
13968098|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13968099|NCT03112889|Valproic Acid|valproic acid|mesh-list
13968100|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
13968101|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232051|NCT00083551|Interferons|interferons|mesh-list
14232052|NCT00083551|Cytarabine|cytarabine|mesh-list
14232053|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
14232054|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
14232055|NCT00083551|Thalidomide|thalidomide|mesh-list
14232056|NCT00083551|Dexamethasone|dexamethasone|mesh-list
14232057|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
14232058|NCT00083551|Melphalan|melphalan|mesh-list
14232059|NCT00083551|Carmustine|carmustine|mesh-list
14232060|NCT00083551|Cisplatin|cisplatin|mesh-list
14232061|NCT00083551|Doxorubicin|doxorubicin|mesh-list
14232062|NCT00083551|Etoposide|etoposide|mesh-list
14232063|NCT00083551|Vincristine|vincristine|mesh-list
14232064|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232065|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
14232066|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232067|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232068|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14232069|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
14232070|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232071|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232072|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14232073|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14232074|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
14232075|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
14232076|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232077|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14232078|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
14232079|NCT00083551|Hormones|hormones|mesh-ancestor
14232080|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232081|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14232082|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232083|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14232084|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232085|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232086|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232087|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
14232088|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232089|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232090|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
14232091|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232092|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232093|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232094|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
14232095|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14232096|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14232097|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14232098|NCT00083551|Growth Substances|growth substances|mesh-ancestor
14232099|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
14232100|NCT00083616|Panitumumab|panitumumab|mesh-list
14232101|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232102|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232103|NCT00083720|Cetuximab|cetuximab|mesh-list
14232104|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232105|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232106|NCT00083889|Interferons|interferons|mesh-list
14232107|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
14232108|NCT00083889|Sunitinib|sunitinib|mesh-list
14232109|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232110|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
14232111|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232112|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
14232113|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232114|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14232115|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14232116|NCT00083889|Growth Substances|growth substances|mesh-ancestor
14232117|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14232118|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14232119|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232120|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232121|NCT00084136|Tenofovir|tenofovir|mesh-list
14232122|NCT00084136|Lamivudine|lamivudine|mesh-list
14232123|NCT00084136|Zidovudine|zidovudine|mesh-list
14232124|NCT00084136|Emtricitabine|emtricitabine|mesh-list
14232125|NCT00084136|Efavirenz|efavirenz|mesh-list
14232126|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14232127|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14232128|NCT00084136|Didanosine|didanosine|mesh-list
14232129|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14232130|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
14232131|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232132|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14232133|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14232134|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232135|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232136|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791568|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
14791569|NCT00741780|Plerixafor|plerixafor|mesh-list
14791570|NCT00741780|Sargramostim|sargramostim|mesh-list
14791571|NCT00741780|Lenograstim|lenograstim|mesh-list
14791572|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
14791573|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791574|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14791575|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791576|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14791577|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
14791578|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791579|NCT00741845|Metronidazole|metronidazole|mesh-list
14791580|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232137|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14232138|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
14232139|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14232140|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14232141|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14232142|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14232143|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14232144|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14232145|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14232146|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14232147|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
14232148|NCT00084149|Ritonavir|ritonavir|mesh-list
14232149|NCT00084149|Lopinavir|lopinavir|mesh-list
14232150|NCT00084149|Lamivudine|lamivudine|mesh-list
14232151|NCT00084149|Zidovudine|zidovudine|mesh-list
14232152|NCT00084149|Abacavir|abacavir|mesh-list
14232153|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14232154|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14232155|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
14232156|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232157|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232158|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14232159|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14232160|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
14232161|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232162|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14232163|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14232164|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14232165|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14232166|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
14232167|NCT00084266|Vancomycin|vancomycin|mesh-list
14232168|NCT00084266|Linezolid|linezolid|mesh-list
14232169|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14232170|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232171|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14232172|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232173|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232174|NCT00084318|Docetaxel|docetaxel|mesh-list
14232175|NCT00084318|Cetuximab|cetuximab|mesh-list
14232176|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232177|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232178|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232179|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232180|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232181|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232182|NCT00084409|Iloprost|iloprost|mesh-list
14232183|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14232184|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
14232185|NCT00084617|Capecitabine|capecitabine|mesh-list
14232186|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
14232187|NCT00084617|Irinotecan|irinotecan|mesh-list
14232188|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232189|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
14232190|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791581|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791582|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14791583|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14232191|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232192|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14232193|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232194|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232195|NCT00084682|Romidepsin|romidepsin|mesh-list
14232196|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232197|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232198|NCT00084747|Bortezomib|bortezomib|mesh-list
14232199|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232200|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
14232201|NCT00084838|Leucovorin|leucovorin|mesh-list
14232202|NCT00084838|Cytarabine|cytarabine|mesh-list
14232203|NCT00084838|Dactinomycin|dactinomycin|mesh-list
14232204|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
14232205|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14232206|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14232207|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14232208|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
14232209|NCT00084838|Temozolomide|temozolomide|mesh-list
14232210|NCT00084838|Cisplatin|cisplatin|mesh-list
14232211|NCT00084838|Doxorubicin|doxorubicin|mesh-list
14232212|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14232213|NCT00084838|Methotrexate|methotrexate|mesh-list
14232214|NCT00084838|Etoposide|etoposide|mesh-list
14232215|NCT00084838|Vincristine|vincristine|mesh-list
14232216|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
14232217|NCT00084838|Razoxane|razoxane|mesh-list
14232218|NCT00084838|Lenograstim|lenograstim|mesh-list
14232219|NCT00084838|Calcium|calcium|mesh-list
14232220|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
14232221|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232222|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
14232223|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232224|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232225|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14232226|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
14232227|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232228|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232229|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14511044|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511045|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511046|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14511047|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
14511048|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
14511049|NCT03029715|Remifentanil|remifentanil|mesh-list
14511050|NCT03029715|Propofol|propofol|mesh-list
14511051|NCT03029715|Desflurane|desflurane|mesh-list
14511052|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14511053|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511054|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511055|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14511056|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
14511057|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
14511058|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14511059|NCT03029715|Analgesics|analgesics|mesh-ancestor
14511060|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
14511061|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511062|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14511063|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14511064|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14511065|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511066|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511067|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511068|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14511069|NCT03029715|Narcotics|narcotics|mesh-ancestor
14511070|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14511071|NCT03029780|Nivolumab|nivolumab|mesh-list
14511072|NCT03029780|Ipilimumab|ipilimumab|mesh-list
14511073|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14511074|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511075|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14511076|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511077|NCT03029819|Nicotine|nicotine|mesh-list
14232230|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232231|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14232232|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232233|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511078|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14232234|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14232235|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14232236|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14232237|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
14232238|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14232239|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232240|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
14232241|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14232242|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14232243|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14232244|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232245|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
14232246|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232247|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14232248|NCT00084838|Antidotes|antidotes|mesh-ancestor
14232249|NCT00084838|Protective Agents|protective agents|mesh-ancestor
14232250|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
14232251|NCT00084838|Vitamins|vitamins|mesh-ancestor
14232252|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
14232253|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232254|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232255|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232256|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14232257|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14232258|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14232259|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14232260|NCT00084864|Calcitriol|calcitriol|mesh-list
14232261|NCT00084864|Dexamethasone|dexamethasone|mesh-list
14232262|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14232263|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
14232264|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
14232265|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232266|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232267|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14232268|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
14232269|NCT00084864|Hormones|hormones|mesh-ancestor
14232270|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232271|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14232272|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232273|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14232274|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14232275|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232276|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232277|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14232278|NCT00084864|Vitamins|vitamins|mesh-ancestor
14232279|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
14232280|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14232281|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
14232282|NCT00085098|Cisplatin|cisplatin|mesh-list
14232283|NCT00085098|Carboplatin|carboplatin|mesh-list
14232284|NCT00085098|Etoposide|etoposide|mesh-list
14232285|NCT00085098|Lenograstim|lenograstim|mesh-list
14232286|NCT00085098|Sargramostim|sargramostim|mesh-list
14232287|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232288|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
14232289|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232290|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232291|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14232292|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
14232293|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232294|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232295|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14232296|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232297|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14232298|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232299|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232300|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14232301|NCT00085254|Temozolomide|temozolomide|mesh-list
14232302|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14232303|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
14232304|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232305|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232306|NCT00085293|Decitabine|decitabine|mesh-list
14232307|NCT00085293|Azacitidine|azacitidine|mesh-list
14232308|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14232309|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232310|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
14232311|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232312|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232313|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232314|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14232315|NCT00085410|Bortezomib|bortezomib|mesh-list
14232316|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232317|NCT00085423|Aldesleukin|aldesleukin|mesh-list
14232318|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
14232319|NCT00085423|Fludarabine|fludarabine|mesh-list
14232320|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
14232321|NCT00085423|Interleukin-2|interleukin-2|mesh-list
14232322|NCT00085423|Molgramostim|molgramostim|mesh-list
14232323|NCT00085423|Sargramostim|sargramostim|mesh-list
14232324|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232325|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
14232326|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232327|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232328|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14232329|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
14232330|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232331|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232332|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14232333|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232334|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
14232335|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14232336|NCT00085423|Analgesics|analgesics|mesh-ancestor
14232337|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
14232338|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232339|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14232340|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14232341|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
14232342|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232343|NCT00085436|Interferons|interferons|mesh-list
14232344|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
14232345|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
14232346|NCT00085436|Aldesleukin|aldesleukin|mesh-list
14232347|NCT00085436|Vaccines|vaccines|mesh-list
14232348|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
14232349|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232350|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232351|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
14232352|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232353|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14232354|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14232355|NCT00085540|Romidepsin|romidepsin|mesh-list
14232356|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232357|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232358|NCT00085566|Everolimus|everolimus|mesh-list
14232359|NCT00085566|Gefitinib|gefitinib|mesh-list
14232360|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232361|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232362|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
14232363|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232364|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14232365|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232366|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232367|NCT00085644|Adalimumab|adalimumab|mesh-list
14232368|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14232369|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232370|NCT00085709|Cytarabine|cytarabine|mesh-list
14232371|NCT00085709|Daunorubicin|daunorubicin|mesh-list
14232372|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
14232373|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232374|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
14511079|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
14232375|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232376|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232377|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
14232378|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232379|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232380|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
14232381|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232382|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232383|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14232384|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232385|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232386|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232387|NCT00085839|Paclitaxel|paclitaxel|mesh-list
14232388|NCT00085839|Carboplatin|carboplatin|mesh-list
14232389|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14232390|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232391|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232392|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232393|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232394|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232395|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232396|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14232397|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232398|NCT00085917|Interferons|interferons|mesh-list
14232399|NCT00085917|Ribavirin|ribavirin|mesh-list
14232400|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
14232401|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14232402|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232403|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
14232404|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232405|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
14232406|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232407|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
14232408|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232409|NCT00086138|Sertraline|sertraline|mesh-list
14232410|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
14232411|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232412|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14232413|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14232414|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232415|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232416|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232417|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
14232418|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232419|NCT00086190|Paroxetine|paroxetine|mesh-list
14232420|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14232421|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14232422|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14232423|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232424|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232425|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232426|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
14232427|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232428|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14232429|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
14232430|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232431|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14232432|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14232433|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232434|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14232435|NCT00086281|Zolpidem|zolpidem|mesh-list
14232436|NCT00086281|Modafinil|modafinil|mesh-list
14232437|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14232438|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232439|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14232440|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14232441|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14232442|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232443|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14232444|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14232445|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14232446|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14232447|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
14232448|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
14232449|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232450|NCT00086307|Pramipexole|pramipexole|mesh-list
14232451|NCT00086307|Citalopram|citalopram|mesh-list
14232452|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14232453|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14232454|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232455|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232456|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232457|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
14232458|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232459|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14791584|NCT00741884|Varenicline|varenicline|mesh-list
14791585|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14791586|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14791587|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
14791588|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232460|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
14232461|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232462|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14511080|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511081|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511082|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14511083|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14511084|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
14511085|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511086|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511087|NCT03030638|Olodaterol|olodaterol|mesh-list
14511088|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14511089|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
14511090|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511091|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511092|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14511093|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
14511094|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
14511095|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14511096|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14511097|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511098|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
14511099|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
14511100|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14511101|NCT03031496|Amiloride|amiloride|mesh-list
14511102|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
14511103|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14511104|NCT03031496|Diuretics|diuretics|mesh-ancestor
14511105|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
14511106|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511107|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14511108|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14511109|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511110|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14511111|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14511112|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14511113|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14511114|NCT03031795|Ketorolac|ketorolac|mesh-list
14511115|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14511116|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14511117|NCT03031795|Analgesics|analgesics|mesh-ancestor
14511118|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
14511119|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511120|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511121|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511122|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14511123|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14511124|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511125|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511126|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
14511127|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
14511128|NCT03031899|Coagulants|coagulants|mesh-ancestor
14791589|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791590|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791591|NCT00741897|Fexofenadine|fexofenadine|mesh-list
14791592|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14791593|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14791594|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14791595|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
14791596|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
14791597|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232463|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14232464|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
14232465|NCT00086307|Protective Agents|protective agents|mesh-ancestor
14232466|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
14232467|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
14232468|NCT00086346|Cyclosporine|cyclosporine|mesh-list
14232469|NCT00086346|Sirolimus|sirolimus|mesh-list
14232470|NCT00086346|Tacrolimus|tacrolimus|mesh-list
14232471|NCT00086346|Cyclosporins|cyclosporins|mesh-list
14232472|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232473|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
14232474|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232475|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14232476|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232477|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232478|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
14232479|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232480|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
14232481|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232482|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14232483|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232484|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232485|NCT00086385|Bupropion|bupropion|mesh-list
14232486|NCT00086385|Nicotine|nicotine|mesh-list
14232487|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14232488|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
14232489|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232490|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232491|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14232492|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14232493|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
14232494|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232495|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232496|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14232497|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
14232498|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232499|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14232500|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14232501|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232502|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
14232503|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14232504|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14232505|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232506|NCT00086411|Bupropion|bupropion|mesh-list
14232507|NCT00086411|Nicotine|nicotine|mesh-list
14232508|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14232509|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
14232510|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232511|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232512|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14232513|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14232514|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
14232515|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232516|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232517|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14232518|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
14232519|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232520|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14232521|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14232522|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232523|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
14232524|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14232525|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14232526|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232527|NCT00086502|Metformin|metformin|mesh-list
14232528|NCT00086502|Pioglitazone|pioglitazone|mesh-list
14232529|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14232530|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511129|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
14232531|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511130|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511131|NCT03032380|Meropenem|meropenem|mesh-list
14511132|NCT03032380|Linezolid|linezolid|mesh-list
14511133|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14511134|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511135|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14511136|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511137|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511138|NCT03032965|Adenosine|adenosine|mesh-list
14511139|NCT03032965|Isoproterenol|isoproterenol|mesh-list
14511140|NCT03032965|Analgesics|analgesics|mesh-ancestor
14511141|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
14511142|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511143|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511144|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14511145|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
14511146|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14511147|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
14511148|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
14511149|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511150|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511151|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14511152|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14511153|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511154|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14511155|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
14511156|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14511157|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
14511158|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14511159|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
14511160|NCT03032965|Protective Agents|protective agents|mesh-ancestor
14511161|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14511162|NCT03033394|Penicillins|penicillins|mesh-list
14511163|NCT03033394|Lactams|lactams|mesh-list
14511164|NCT03033394|beta-Lactams|beta-lactams|mesh-list
14511165|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511166|NCT03033511|Dexamethasone|dexamethasone|mesh-list
14511167|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
14511168|NCT03033511|BB 1101|bb 1101|mesh-list
14511169|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
14511170|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511171|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
14511172|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
14511173|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511174|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511175|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511176|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
14511177|NCT03033511|Hormones|hormones|mesh-ancestor
14511178|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511179|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14511180|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511181|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
14511182|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511183|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511184|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
14511185|NCT03033784|Oxytocin|oxytocin|mesh-list
14511186|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
14511187|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14511188|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511189|NCT03034135|Copper|copper|mesh-list
14511190|NCT03034135|Temozolomide|temozolomide|mesh-list
14511191|NCT03034135|Disulfiram|disulfiram|mesh-list
14948488|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948489|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232532|NCT00086502|Incretins|incretins|mesh-ancestor
14232533|NCT00086502|Hormones|hormones|mesh-ancestor
14232534|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232535|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14232536|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
14232537|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232538|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232539|NCT00086515|Metformin|metformin|mesh-list
14232540|NCT00086515|Pioglitazone|pioglitazone|mesh-list
14232541|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14232542|NCT00086515|Glipizide|glipizide|mesh-list
14232543|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14232544|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232545|NCT00086515|Incretins|incretins|mesh-ancestor
14232546|NCT00086515|Hormones|hormones|mesh-ancestor
14232547|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232548|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14232549|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
14232550|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232551|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232552|NCT00086580|Vidarabine|vidarabine|mesh-list
14232553|NCT00086580|Fludarabine|fludarabine|mesh-list
14232554|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
14232555|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
14232556|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232557|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232558|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
14232559|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232560|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232561|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
14232562|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232563|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
14232564|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232565|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232566|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
14232567|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232568|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14232569|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
14232570|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
14232571|NCT00086957|Docetaxel|docetaxel|mesh-list
14232572|NCT00086957|Trastuzumab|trastuzumab|mesh-list
14232573|NCT00086957|Gefitinib|gefitinib|mesh-list
14232574|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232575|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232576|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232577|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232578|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232579|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232580|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14232581|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232582|NCT00086996|Fluorouracil|fluorouracil|mesh-list
14232583|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
14232584|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
14232585|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232586|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232587|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232588|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232589|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
14232590|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232591|NCT00087126|Topotecan|topotecan|mesh-list
14232592|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14232593|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232594|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232595|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232596|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232597|NCT00087139|Epothilones|epothilones|mesh-list
14232598|NCT00087139|Epothilone B|epothilone b|mesh-list
14232599|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232600|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232601|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232602|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232603|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232604|NCT00087152|Capecitabine|capecitabine|mesh-list
14232605|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
14232606|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232607|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
14232608|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232609|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232610|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14232611|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242743|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14242744|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242745|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
14242746|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232612|NCT00087490|Vancomycin|vancomycin|mesh-list
14232613|NCT00087490|Linezolid|linezolid|mesh-list
14232614|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14232615|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232616|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14232617|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232618|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232619|NCT00087516|Metformin|metformin|mesh-list
14232620|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14232621|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14232622|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232623|NCT00087516|Incretins|incretins|mesh-ancestor
14232624|NCT00087516|Hormones|hormones|mesh-ancestor
14232625|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232626|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14232627|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
14232628|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232629|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232630|NCT00087529|Rituximab|rituximab|mesh-list
14232631|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232632|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232633|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
14232634|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232635|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232636|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
14232637|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14232638|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14232639|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14232640|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
14232641|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
14232642|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14232643|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232644|NCT00087568|Ribavirin|ribavirin|mesh-list
14232645|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14232646|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
14232647|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232648|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
14232649|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232650|NCT00087594|Ribavirin|ribavirin|mesh-list
14232651|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14232652|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
14232653|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232654|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
14232655|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232656|NCT00087607|Ribavirin|ribavirin|mesh-list
14232657|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14232658|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14232659|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
14232660|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232661|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
14232662|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232663|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14232664|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
14232665|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232666|NCT00087646|Ribavirin|ribavirin|mesh-list
14232667|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14232668|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
14232669|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
14232670|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232671|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
14232672|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232673|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
14232674|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232675|NCT00087672|Lenalidomide|lenalidomide|mesh-list
14232676|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
14232677|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232678|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14232679|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14232680|NCT00087672|Growth Substances|growth substances|mesh-ancestor
14232681|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14232682|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232683|NCT00087685|Everolimus|everolimus|mesh-list
14232684|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232685|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232686|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
14232687|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232688|NCT00087698|Pemetrexed|pemetrexed|mesh-list
14232689|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232690|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232691|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232692|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14232693|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14232694|NCT00088153|Progesterone|progesterone|mesh-list
14232695|NCT00088153|Estrogens|estrogens|mesh-list
14232696|NCT00088153|Progestins|progestins|mesh-ancestor
14232697|NCT00088153|Hormones|hormones|mesh-ancestor
14232698|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232699|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232700|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14232701|NCT00088166|Hormones|hormones|mesh-ancestor
14232702|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511192|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14511193|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
14511194|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511195|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511196|NCT03034135|Trace Elements|trace elements|mesh-ancestor
14511197|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
14511198|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511199|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14511200|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14511201|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14528850|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14528851|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
14528852|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528853|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528854|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14528855|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14528856|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
14528857|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528858|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528859|NCT03806231|Dinoprostone|dinoprostone|mesh-list
14528860|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
14528861|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14528862|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528863|NCT03822377|Ticagrelor|ticagrelor|mesh-list
14528864|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14528865|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14528866|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14528867|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14528868|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
14528869|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528870|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528871|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528872|NCT03820388|Propofol|propofol|mesh-list
14528873|NCT03820388|Etomidate|etomidate|mesh-list
14528874|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14528875|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528876|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528877|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14528878|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
14528879|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
14528880|NCT03809182|Fentanyl|fentanyl|mesh-list
14528881|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
14528882|NCT03809182|Morphine|morphine|mesh-list
14528883|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14528884|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528885|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528886|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14528887|NCT03809182|Analgesics|analgesics|mesh-ancestor
14528888|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
14528889|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528890|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14528891|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14528892|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14528893|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
14528894|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232703|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232704|NCT00088218|Cytarabine|cytarabine|mesh-list
14232705|NCT00088218|Clofarabine|clofarabine|mesh-list
14232706|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232707|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
14232708|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232709|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232710|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
14232711|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232712|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232713|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
14232714|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232715|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14232716|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14232717|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232718|NCT00088413|Molgramostim|molgramostim|mesh-list
14232719|NCT00088413|Sargramostim|sargramostim|mesh-list
14232720|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
14232721|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232722|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232723|NCT00088452|Lamotrigine|lamotrigine|mesh-list
14232724|NCT00088452|Valproic Acid|valproic acid|mesh-list
14232725|NCT00088452|Ethosuximide|ethosuximide|mesh-list
14232726|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
14232727|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14232728|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232729|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232730|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14232731|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232732|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14232733|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14232734|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14232735|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232736|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14232737|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232738|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
14232739|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232740|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
14232741|NCT00088465|Olanzapine|olanzapine|mesh-list
14232742|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
14232743|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
14232744|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232745|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232746|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14232747|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14232748|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14232749|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14232750|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232751|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14232752|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14232753|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14232754|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232755|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232756|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
14232757|NCT00088530|Gemcitabine|gemcitabine|mesh-list
14232758|NCT00088530|Prednisone|prednisone|mesh-list
14232759|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
14232760|NCT00088530|Rituximab|rituximab|mesh-list
14232761|NCT00088530|Etoposide|etoposide|mesh-list
14232762|NCT00088530|Vincristine|vincristine|mesh-list
14232763|NCT00088530|Vinorelbine|vinorelbine|mesh-list
14232764|NCT00088530|Pixantrone|pixantrone|mesh-list
14232765|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232766|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
14232767|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232768|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232769|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14232770|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
14232771|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232772|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232773|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14232774|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232775|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232776|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
14232777|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
14232778|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232779|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232780|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14232781|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
14232782|NCT00088530|Hormones|hormones|mesh-ancestor
14232783|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232784|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14232785|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232786|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14232787|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232788|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232789|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232790|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232791|NCT00088595|Pasireotide|pasireotide|mesh-list
14232792|NCT00088595|Hormones|hormones|mesh-ancestor
14232793|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232794|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232795|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14232796|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14232797|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14232798|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14232799|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232800|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232801|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14232802|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14232803|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14232804|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
14232805|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232806|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232807|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14232808|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14232809|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
14232810|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14232811|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14232812|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
14232813|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14232814|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14232815|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14232816|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14232817|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232818|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14232819|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14232820|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14232821|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14232822|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14232823|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232824|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232825|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14232826|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14232827|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
14232828|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14232829|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14232830|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
14232831|NCT00088699|Ketamine|ketamine|mesh-list
14232832|NCT00088699|Analgesics|analgesics|mesh-ancestor
14232833|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
14232834|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232835|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232836|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14232837|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14232838|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
14232839|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
14232840|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14232841|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14232842|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14232843|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14232844|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232845|NCT00088881|Prednisone|prednisone|mesh-list
14232846|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
14232847|NCT00088881|Rituximab|rituximab|mesh-list
14232848|NCT00088881|Doxorubicin|doxorubicin|mesh-list
14232849|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14232850|NCT00088881|Vincristine|vincristine|mesh-list
14232851|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232852|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
14232853|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232854|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232855|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14232856|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
14232857|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232858|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232859|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14232860|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232861|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232862|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14232863|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232864|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232865|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14232866|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
14232867|NCT00088881|Hormones|hormones|mesh-ancestor
14232868|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14232869|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14232870|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232871|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232872|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232873|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232874|NCT00088907|Docetaxel|docetaxel|mesh-list
14232875|NCT00088907|Gefitinib|gefitinib|mesh-list
14232876|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511202|NCT03034577|Neostigmine|neostigmine|mesh-list
14511203|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14511204|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511205|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511206|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
14511207|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511208|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511209|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14511210|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
14511211|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511212|NCT03034772|Timolol|timolol|mesh-list
14511213|NCT03034772|Dorzolamide|dorzolamide|mesh-list
14511214|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
14511215|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14511216|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14511217|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511218|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511219|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511220|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511221|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14511222|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14511223|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14511224|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14511225|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14511226|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511227|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14511228|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14511229|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
14511230|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511231|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511232|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14511233|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
14511234|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14511235|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14791598|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791599|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791600|NCT00741910|Semapimod|semapimod|mesh-list
14791601|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14791602|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14791603|NCT00741910|Analgesics|analgesics|mesh-ancestor
14791604|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
14791605|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14232877|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232878|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232879|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232880|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232881|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14232882|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232883|NCT00088985|Trastuzumab|trastuzumab|mesh-list
14232884|NCT00088985|Vinorelbine|vinorelbine|mesh-list
14232885|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232886|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232887|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232888|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232889|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232890|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232891|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232892|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
14232893|NCT00089011|Fludarabine|fludarabine|mesh-list
14232894|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
14232895|NCT00089011|Tacrolimus|tacrolimus|mesh-list
14232896|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232897|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232898|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
14232899|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232900|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232901|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
14232902|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232903|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14232904|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232905|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14232906|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14511236|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14511237|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511238|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511239|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511240|NCT03035032|Leuprolide|leuprolide|mesh-list
14511241|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14511242|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
14511243|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14511244|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511245|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14511246|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511247|NCT03035708|Varenicline|varenicline|mesh-list
14511248|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14511249|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14511250|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
14511251|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511252|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511253|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511254|NCT03035760|Oxfendazole|oxfendazole|mesh-list
14511255|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
14511256|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14511257|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511258|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
14511259|NCT03035916|Anesthetics|anesthetics|mesh-list
14511260|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511261|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511262|NCT03035929|Dexamethasone|dexamethasone|mesh-list
14511263|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
14511264|NCT03035929|BB 1101|bb 1101|mesh-list
14511265|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511266|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
14511267|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
14232907|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
14232908|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14232909|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232910|NCT00089024|Leucovorin|leucovorin|mesh-list
14232911|NCT00089024|Gemcitabine|gemcitabine|mesh-list
14232912|NCT00089024|Fluorouracil|fluorouracil|mesh-list
14232913|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
14232914|NCT00089024|Calcium|calcium|mesh-list
14232915|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
14232916|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232917|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
14232918|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232919|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232920|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
14232921|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232922|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232923|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232924|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
14232925|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232926|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14232927|NCT00089024|Antidotes|antidotes|mesh-ancestor
14232928|NCT00089024|Protective Agents|protective agents|mesh-ancestor
14232929|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
14232930|NCT00089024|Vitamins|vitamins|mesh-ancestor
14232931|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
14232932|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14232933|NCT00089076|Ipilimumab|ipilimumab|mesh-list
14232934|NCT00089076|Antibodies|antibodies|mesh-list
14232935|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
14232936|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14232937|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
14232938|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232939|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232940|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14232941|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232942|NCT00089102|Gemcitabine|gemcitabine|mesh-list
14232943|NCT00089102|Irinotecan|irinotecan|mesh-list
14232944|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232945|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
14232946|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232947|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232948|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
14232949|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232950|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232951|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14232952|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
14232953|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232954|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14232955|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14232956|NCT00089284|Rituximab|rituximab|mesh-list
14232957|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
14232958|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232959|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232960|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
14232961|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14232962|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14232963|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14232964|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
14232965|NCT00089297|Paclitaxel|paclitaxel|mesh-list
14232966|NCT00089297|Carboplatin|carboplatin|mesh-list
14232967|NCT00089297|Cetuximab|cetuximab|mesh-list
14232968|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14232969|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232970|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232971|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232972|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232973|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232974|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14232975|NCT00089479|Capecitabine|capecitabine|mesh-list
14232976|NCT00089479|Docetaxel|docetaxel|mesh-list
14232977|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14232978|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
14232979|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232980|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14232981|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
14232982|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
14232983|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
14232984|NCT00089505|Ritonavir|ritonavir|mesh-list
14232985|NCT00089505|Lopinavir|lopinavir|mesh-list
14232986|NCT00089505|Tenofovir|tenofovir|mesh-list
14232987|NCT00089505|Emtricitabine|emtricitabine|mesh-list
14232988|NCT00089505|Nevirapine|nevirapine|mesh-list
14232989|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14232990|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14232991|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14232992|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
14232993|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14232994|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14232995|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14232996|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14232997|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
14232998|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14232999|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14233000|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14233001|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14233002|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233003|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14233004|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14233005|NCT00089544|Thalidomide|thalidomide|mesh-list
14233006|NCT00089544|Doxorubicin|doxorubicin|mesh-list
14233007|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14233008|NCT00089544|Ifosfamide|ifosfamide|mesh-list
14233009|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
14233010|NCT00089544|Dacarbazine|dacarbazine|mesh-list
14233011|NCT00089544|Imidazole|imidazole|mesh-list
14233012|NCT00089544|Lenograstim|lenograstim|mesh-list
14233013|NCT00089544|Sargramostim|sargramostim|mesh-list
14233014|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233015|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233016|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14233017|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14233018|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233019|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233020|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14233021|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
14233022|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233023|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233024|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
14233025|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233026|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
14233027|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14233028|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233029|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233030|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233031|NCT00089544|Growth Substances|growth substances|mesh-ancestor
14233032|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233033|NCT00089583|Ritonavir|ritonavir|mesh-list
14233034|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
14233035|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14233036|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14233037|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
14233038|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233039|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233040|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14233041|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14233042|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
14233043|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233044|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14233045|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14233046|NCT00089609|Thalidomide|thalidomide|mesh-list
14233047|NCT00089609|Prednisone|prednisone|mesh-list
14233048|NCT00089609|Bevacizumab|bevacizumab|mesh-list
14233049|NCT00089609|Docetaxel|docetaxel|mesh-list
14233050|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233051|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233052|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233053|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233054|NCT00089609|Growth Substances|growth substances|mesh-ancestor
14233055|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233056|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233057|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233058|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233059|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233060|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233061|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14233062|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
14233063|NCT00089609|Hormones|hormones|mesh-ancestor
14233064|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233065|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233066|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233067|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
14233068|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
14233069|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14233070|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233071|NCT00089635|Panitumumab|panitumumab|mesh-list
14233072|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233073|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233074|NCT00089648|Sunitinib|sunitinib|mesh-list
14233075|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233076|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233077|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233078|NCT00089648|Growth Substances|growth substances|mesh-ancestor
14233079|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233080|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233081|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233082|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233083|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233084|NCT00089661|Denosumab|denosumab|mesh-list
14233085|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14233086|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233087|NCT00089674|Denosumab|denosumab|mesh-list
14233088|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14233089|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233090|NCT00089778|Aldesleukin|aldesleukin|mesh-list
14233091|NCT00089778|Interleukin-2|interleukin-2|mesh-list
14233092|NCT00089778|Mitogens|mitogens|mesh-list
14233093|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233094|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14233095|NCT00089778|Analgesics|analgesics|mesh-ancestor
14233096|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
14233097|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14233098|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233099|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233100|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233101|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14233102|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14233103|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
14233104|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233105|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
14233106|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
14233107|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
14233108|NCT00089843|Testosterone|testosterone|mesh-list
14233109|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
14233110|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
14233111|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14233112|NCT00089843|Androgens|androgens|mesh-ancestor
14233113|NCT00089843|Hormones|hormones|mesh-ancestor
14233114|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233115|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233116|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233117|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233118|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
14233119|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14233120|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14233121|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233122|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14233123|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14233124|NCT00089999|Lapatinib|lapatinib|mesh-list
14233125|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233126|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233127|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233128|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233129|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
14233130|NCT00090051|Rituximab|rituximab|mesh-list
14233131|NCT00090051|Fludarabine|fludarabine|mesh-list
14233132|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
14233133|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233134|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
14233135|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233136|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233137|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233138|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
14233139|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233140|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233141|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14233142|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233143|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233144|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
14233145|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14233146|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
14233147|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233148|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14233149|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
14233150|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14233151|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233152|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14233153|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14233154|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14233155|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
14233156|NCT00090103|Tamsulosin|tamsulosin|mesh-list
14233157|NCT00090103|Dutasteride|dutasteride|mesh-list
14233158|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14233159|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14233160|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14233161|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
14233162|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14233163|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511268|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511269|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511270|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511271|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
14511272|NCT03035929|Hormones|hormones|mesh-ancestor
14511273|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511274|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14511275|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511276|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
14511277|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511278|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511279|NCT03035942|Dexamethasone|dexamethasone|mesh-list
14511280|NCT03035942|Ondansetron|ondansetron|mesh-list
14511281|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511282|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
14511283|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
14511284|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511285|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511286|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511287|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
14511288|NCT03035942|Hormones|hormones|mesh-ancestor
14511289|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511290|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14511291|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511292|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
14511293|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
14511294|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14511295|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
14511296|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511297|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511298|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14511299|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14511300|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511301|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14511302|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14511303|NCT03035955|Azelaic acid|azelaic acid|mesh-list
14511304|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511305|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
14511306|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
14511307|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14511308|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511309|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511310|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511311|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
14233164|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233165|NCT00090103|Urological Agents|urological agents|mesh-ancestor
14233166|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14233167|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14233168|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233169|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
14233170|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233171|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
14233172|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
14233173|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233174|NCT00090402|Protective Agents|protective agents|mesh-ancestor
14233175|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233176|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
14233177|NCT00090402|Vitamins|vitamins|mesh-ancestor
14233178|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
14233179|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
14233180|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233181|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233182|NCT00090545|Sorafenib|sorafenib|mesh-list
14233183|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233184|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233185|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233186|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233187|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14233188|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14233189|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14233190|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
14233191|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14233192|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233193|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233194|NCT00090584|Urological Agents|urological agents|mesh-ancestor
14233195|NCT00090610|Carboplatin|carboplatin|mesh-list
14233196|NCT00090610|Docetaxel|docetaxel|mesh-list
14233197|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233198|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233199|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233200|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233201|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233202|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
14233203|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
14233204|NCT00090753|Hematinics|hematinics|mesh-ancestor
14233205|NCT00090766|Valganciclovir|valganciclovir|mesh-list
14233206|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
14233207|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233208|NCT00090779|Ritonavir|ritonavir|mesh-list
14233209|NCT00090779|Lopinavir|lopinavir|mesh-list
14233210|NCT00090779|Tenofovir|tenofovir|mesh-list
14233211|NCT00090779|Emtricitabine|emtricitabine|mesh-list
14233212|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14233213|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14233214|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14233215|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
14233216|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233217|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233218|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14233219|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14233220|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
14233221|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233222|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14233223|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14233224|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14233225|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233226|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14233227|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
14233228|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14233229|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
14233230|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14233231|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233232|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14233233|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233234|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233235|NCT00090857|Letrozole|letrozole|mesh-list
14233236|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233237|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14233238|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14233239|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233240|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233241|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14233242|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14233243|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233244|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233245|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
14233246|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233247|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233248|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233249|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233250|NCT00091026|Gemcitabine|gemcitabine|mesh-list
14233251|NCT00091026|Bevacizumab|bevacizumab|mesh-list
14233252|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14233253|NCT00091026|Cetuximab|cetuximab|mesh-list
14233254|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14233255|NCT00091026|Antibodies|antibodies|mesh-list
14233256|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
14233257|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14233258|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233259|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233260|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233261|NCT00091026|Growth Substances|growth substances|mesh-ancestor
14233262|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233263|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233264|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
14233265|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233266|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
14233267|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233268|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
14233269|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233270|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233271|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233272|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233273|NCT00091260|Dexamethasone|dexamethasone|mesh-list
14233274|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
14233275|NCT00091260|Lenalidomide|lenalidomide|mesh-list
14233276|NCT00091260|BB 1101|bb 1101|mesh-list
14233277|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14233278|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
14233279|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
14233280|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14233281|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233282|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14233283|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
14233284|NCT00091260|Hormones|hormones|mesh-ancestor
14233285|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233286|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233287|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233288|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
14233289|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233290|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233291|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
14233292|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233293|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233294|NCT00091260|Growth Substances|growth substances|mesh-ancestor
14233295|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233296|NCT00091273|Sargramostim|sargramostim|mesh-list
14233297|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
14233298|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
14233299|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233300|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14233301|NCT00091442|Docetaxel|docetaxel|mesh-list
14233302|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14233303|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233304|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233305|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233306|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233307|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233308|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233309|NCT00091507|Insulin|insulin|mesh-list
14233310|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14233311|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233312|NCT00091572|Temozolomide|temozolomide|mesh-list
14530086|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14233313|NCT00091572|Dacarbazine|dacarbazine|mesh-list
14233314|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233315|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
14233316|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233317|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233318|NCT00091793|Denosumab|denosumab|mesh-list
14233319|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14233320|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233321|NCT00091819|Vancomycin|vancomycin|mesh-list
14233322|NCT00091819|Telavancin|telavancin|mesh-list
14233323|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14233324|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233325|NCT00091832|Denosumab|denosumab|mesh-list
14233326|NCT00091832|Diphosphonates|diphosphonates|mesh-list
14233327|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14233328|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233329|NCT00091949|Pioglitazone|pioglitazone|mesh-list
14233330|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14233331|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233332|NCT00092417|Vaccines|vaccines|mesh-list
14233333|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
14233334|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233335|NCT00092534|Vaccines|vaccines|mesh-list
14233336|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
14233337|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233338|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
14233339|NCT00093015|Hematinics|hematinics|mesh-ancestor
14233340|NCT00093041|Zalutumumab|zalutumumab|mesh-list
14233341|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233342|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233343|NCT00093145|Paclitaxel|paclitaxel|mesh-list
14233344|NCT00093145|Carboplatin|carboplatin|mesh-list
14233345|NCT00093145|Trastuzumab|trastuzumab|mesh-list
14233346|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14233347|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233348|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233349|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233350|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233351|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233352|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233353|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233354|NCT00093379|Capecitabine|capecitabine|mesh-list
14233355|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
14233356|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233357|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
14233358|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233359|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233360|NCT00093470|Tipifarnib|tipifarnib|mesh-list
14233361|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233362|NCT00093496|Gemcitabine|gemcitabine|mesh-list
14233363|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233364|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
14233365|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233366|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233367|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
14233368|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233369|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233370|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233371|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
14233372|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233373|NCT00093756|Paclitaxel|paclitaxel|mesh-list
14233374|NCT00093756|Carboplatin|carboplatin|mesh-list
14233375|NCT00093756|Bortezomib|bortezomib|mesh-list
14233376|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233377|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233378|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233379|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233380|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233381|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233382|NCT00093782|Sirolimus|sirolimus|mesh-list
14233383|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14233384|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233385|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233386|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233387|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
14233388|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233389|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
14530087|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
14233390|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233391|NCT00093795|Gemcitabine|gemcitabine|mesh-list
14233392|NCT00093795|Paclitaxel|paclitaxel|mesh-list
14233393|NCT00093795|Docetaxel|docetaxel|mesh-list
14233394|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
14233395|NCT00093795|Doxorubicin|doxorubicin|mesh-list
14233396|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233397|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233398|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233399|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233400|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233401|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233402|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233403|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
14233404|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233405|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233406|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233407|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
14233408|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14233409|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233410|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
14233411|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
14233412|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233413|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233414|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233415|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14233416|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14233417|NCT00093808|Capecitabine|capecitabine|mesh-list
14233418|NCT00093808|Trastuzumab|trastuzumab|mesh-list
14233419|NCT00093808|Vinorelbine|vinorelbine|mesh-list
14233420|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233421|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
14233422|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233423|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233424|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233425|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233426|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233427|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233428|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242747|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14242748|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
14242749|NCT00190671|Pemetrexed|pemetrexed|mesh-list
14242750|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242751|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
14242752|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242753|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14242754|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14242755|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
14242756|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242757|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242758|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14242759|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242760|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14242761|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14242762|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14242763|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14242764|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242765|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242766|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242767|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
14242768|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242769|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242770|NCT00190749|Olanzapine|olanzapine|mesh-list
14242771|NCT00190749|Risperidone|risperidone|mesh-list
14242772|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14242773|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
14242774|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242775|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242776|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242777|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14242778|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14242779|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14242780|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14242781|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14233429|NCT00094055|Axitinib|axitinib|mesh-list
14233430|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233431|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233432|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233433|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233434|NCT00094094|Axitinib|axitinib|mesh-list
14511312|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14511313|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511314|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511315|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511316|NCT03036163|Macozinone|macozinone|mesh-list
14511317|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
14511318|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14511319|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511320|NCT03036384|Sufentanil|sufentanil|mesh-list
14511321|NCT03036384|Morphine|morphine|mesh-list
14511322|NCT03036384|Prilocaine|prilocaine|mesh-list
14511323|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14511324|NCT03036384|Narcotics|narcotics|mesh-ancestor
14511325|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511326|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511327|NCT03036384|Analgesics|analgesics|mesh-ancestor
14511328|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
14511329|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511330|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14511331|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14511332|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
14511333|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
14511334|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
14511335|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
14511336|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14511337|NCT03036839|Ledipasvir|ledipasvir|mesh-list
14511338|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
14511339|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511340|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
14511341|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14511342|NCT03036852|Velpatasvir|velpatasvir|mesh-list
14511343|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
14511344|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511345|NCT03037580|Treprostinil|treprostinil|mesh-list
14511346|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14511347|NCT03038308|Ropinirole|ropinirole|mesh-list
14511348|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14511349|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14511350|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
14511351|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
14511352|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511353|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233435|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233436|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233437|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233438|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233439|NCT00094107|Axitinib|axitinib|mesh-list
14233440|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233441|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233442|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233443|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233444|NCT00094172|Atorvastatin|atorvastatin|mesh-list
14233445|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14233446|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14233447|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
14242782|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
14233448|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233449|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14233450|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14233451|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233452|NCT00094302|Spironolactone|spironolactone|mesh-list
14233453|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14233454|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
14233455|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233456|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233457|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14233458|NCT00094302|Diuretics|diuretics|mesh-ancestor
14233459|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
14233460|NCT00094328|Anastrozole|anastrozole|mesh-list
14233461|NCT00094328|Bicalutamide|bicalutamide|mesh-list
14233462|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233463|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233464|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14233465|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14233466|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233467|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233468|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14233469|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
14233470|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233471|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233472|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
14233473|NCT00094445|Curcumin|curcumin|mesh-list
14233474|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14233475|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14511354|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511355|NCT03038620|Liraglutide|liraglutide|mesh-list
14511356|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511357|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511358|NCT03038620|Incretins|incretins|mesh-ancestor
14511359|NCT03038620|Hormones|hormones|mesh-ancestor
14511360|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511361|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14511362|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14511363|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14511364|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14511365|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511366|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511367|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511368|NCT03038867|Analgesics|analgesics|mesh-ancestor
14511369|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
14511370|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511371|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
14511372|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14511373|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
14511374|NCT03038880|Ranibizumab|ranibizumab|mesh-list
14511375|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14511376|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14511377|NCT03038880|Growth Substances|growth substances|mesh-ancestor
14511378|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511379|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
14511380|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511381|NCT03039023|Choline|choline|mesh-list
14511382|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
14511383|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14511384|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
14511385|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511386|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511387|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14511388|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
14511389|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14511390|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14511391|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511392|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511393|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511394|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511395|NCT03039192|Esketamine|esketamine|mesh-list
14511396|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
14511397|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14233476|NCT00094445|Analgesics|analgesics|mesh-ancestor
14233477|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
14233478|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14233479|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233480|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14233481|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233482|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233483|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233484|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233485|NCT00094458|Azathioprine|azathioprine|mesh-list
14233486|NCT00094458|Infliximab|infliximab|mesh-list
14233487|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
14233488|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14233489|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233490|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
14233491|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233492|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233493|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233494|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233495|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
14233496|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233497|NCT00094497|Doxorubicin|doxorubicin|mesh-list
14233498|NCT00094497|Etoposide|etoposide|mesh-list
14233499|NCT00094497|Mitotane|mitotane|mesh-list
14233500|NCT00094497|Streptozocin|streptozocin|mesh-list
14233501|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233502|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233503|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14233504|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14233505|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233506|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233507|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233508|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233509|NCT00094653|Ipilimumab|ipilimumab|mesh-list
14233510|NCT00094653|Vaccines|vaccines|mesh-list
14233511|NCT00094653|Antibodies|antibodies|mesh-list
14233512|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14233513|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
14233514|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233515|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233516|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233517|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14233518|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233519|NCT00094757|Pioglitazone|pioglitazone|mesh-list
14233520|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14233521|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14233522|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233523|NCT00094757|Incretins|incretins|mesh-ancestor
14233524|NCT00094757|Hormones|hormones|mesh-ancestor
14233525|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233526|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14233527|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
14233528|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233529|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233530|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14233531|NCT00094770|Glipizide|glipizide|mesh-list
14233532|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14233533|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233534|NCT00094770|Incretins|incretins|mesh-ancestor
14233535|NCT00094770|Hormones|hormones|mesh-ancestor
14233536|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233537|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14233538|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
14233539|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233540|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233541|NCT00094835|Paclitaxel|paclitaxel|mesh-list
14233542|NCT00094835|Carboplatin|carboplatin|mesh-list
14233543|NCT00094835|Panitumumab|panitumumab|mesh-list
14233544|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
14233545|NCT00094835|Imetelstat|imetelstat|mesh-list
14233546|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233547|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233548|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233549|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233550|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242783|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
14233551|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233552|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233553|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233554|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233555|NCT00094861|Paclitaxel|paclitaxel|mesh-list
14233556|NCT00094861|Carboplatin|carboplatin|mesh-list
14233557|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233558|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233559|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233560|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233561|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233562|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233563|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
14233564|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14233565|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
14233566|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14233567|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233568|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14233569|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
14233570|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14233571|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
14233572|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233573|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14233574|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14233575|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
14233576|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
14233577|NCT00094887|Protective Agents|protective agents|mesh-ancestor
14233578|NCT00094900|Rilonacept|rilonacept|mesh-list
14233579|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14233580|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14233581|NCT00095056|Glipizide|glipizide|mesh-list
14233582|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14233583|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233584|NCT00095056|Incretins|incretins|mesh-ancestor
14233585|NCT00095056|Hormones|hormones|mesh-ancestor
14233586|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233587|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14233588|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
14233589|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233590|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233591|NCT00095121|Lamivudine|lamivudine|mesh-list
14233592|NCT00095121|Adefovir|adefovir|mesh-list
14233593|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14233594|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14233595|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233596|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233597|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233598|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
14233599|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233600|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14233601|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14233602|NCT00095147|Methotrexate|methotrexate|mesh-list
14233603|NCT00095147|Abatacept|abatacept|mesh-list
14233604|NCT00095147|Infliximab|infliximab|mesh-list
14233605|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14233606|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
14233607|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14233608|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233609|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233610|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
14233611|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233612|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233613|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
14233614|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233615|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14233616|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233617|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
14233618|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233619|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233620|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14233621|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14233622|NCT00095173|Abatacept|abatacept|mesh-list
14233623|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14233624|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233625|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233626|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233627|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
14233628|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233629|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233630|NCT00095199|Docetaxel|docetaxel|mesh-list
14233631|NCT00095199|Pemetrexed|pemetrexed|mesh-list
14233632|NCT00095199|Cetuximab|cetuximab|mesh-list
14233633|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233634|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233635|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233636|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233637|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233638|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233639|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14233640|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233641|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233642|NCT00095212|Testosterone|testosterone|mesh-list
14233643|NCT00095212|Androgens|androgens|mesh-ancestor
14233644|NCT00095212|Hormones|hormones|mesh-ancestor
14233645|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233646|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233647|NCT00095238|Irbesartan|irbesartan|mesh-list
14233648|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14233649|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14233650|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14233651|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233652|NCT00095498|Denosumab|denosumab|mesh-list
14233653|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14233654|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233655|NCT00095563|Lapatinib|lapatinib|mesh-list
14233656|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233657|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233658|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233659|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233660|NCT00095836|Gefitinib|gefitinib|mesh-list
14233661|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233662|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233663|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233664|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233665|NCT00095875|Carboplatin|carboplatin|mesh-list
14233666|NCT00095875|Docetaxel|docetaxel|mesh-list
14233667|NCT00095875|Fluorouracil|fluorouracil|mesh-list
14233668|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233669|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233670|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233671|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233672|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233673|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
14233674|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233675|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233676|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
14233677|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233678|NCT00095940|Lapatinib|lapatinib|mesh-list
14233679|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233680|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233681|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233682|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233683|NCT00095979|Epothilones|epothilones|mesh-list
14233684|NCT00095979|Epothilone B|epothilone b|mesh-list
14233685|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233686|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233687|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233688|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233689|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233690|NCT00096018|Thalidomide|thalidomide|mesh-list
14233691|NCT00096018|Fludarabine|fludarabine|mesh-list
14233692|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
14233693|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233694|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233695|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
14233696|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233697|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233698|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
14233699|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233700|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
14233701|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14233702|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233703|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233704|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233705|NCT00096018|Growth Substances|growth substances|mesh-ancestor
14233706|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233707|NCT00096031|Cetuximab|cetuximab|mesh-list
14233708|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233709|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233710|NCT00096044|Rituximab|rituximab|mesh-list
14233711|NCT00096044|Lenalidomide|lenalidomide|mesh-list
14233712|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233713|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233714|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
14233715|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233716|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233717|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233718|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233719|NCT00096044|Growth Substances|growth substances|mesh-ancestor
14233720|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233721|NCT00096122|Cytarabine|cytarabine|mesh-list
14233722|NCT00096122|Idarubicin|idarubicin|mesh-list
14233723|NCT00096122|Tipifarnib|tipifarnib|mesh-list
14233724|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233725|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
14233726|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233727|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233728|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
14233729|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233730|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233731|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
14233732|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233733|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233734|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14233735|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14233736|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233737|NCT00096135|Leucovorin|leucovorin|mesh-list
14233738|NCT00096135|Cytarabine|cytarabine|mesh-list
14233739|NCT00096135|Dexamethasone|dexamethasone|mesh-list
14233740|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
14233741|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14233742|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14233743|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14233744|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
14233745|NCT00096135|Methotrexate|methotrexate|mesh-list
14233746|NCT00096135|Etoposide|etoposide|mesh-list
14233747|NCT00096135|Vincristine|vincristine|mesh-list
14233748|NCT00096135|Daunorubicin|daunorubicin|mesh-list
14233749|NCT00096135|Asparaginase|asparaginase|mesh-list
14233750|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
14233751|NCT00096135|Pegaspargase|pegaspargase|mesh-list
14233752|NCT00096135|Lenograstim|lenograstim|mesh-list
14233753|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
14233754|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233755|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
14233756|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233757|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233758|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233759|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
14233760|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233761|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233762|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14233763|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511398|NCT03039543|Rocuronium|rocuronium|mesh-list
14511399|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14511400|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14511401|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14511402|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511403|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511404|NCT03040011|Dexamethasone|dexamethasone|mesh-list
14511405|NCT03040011|Bupivacaine|bupivacaine|mesh-list
14233764|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
14233765|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
14233766|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14233767|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14233768|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
14233769|NCT00096135|Hormones|hormones|mesh-ancestor
14242784|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
14233770|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233771|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233772|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14233773|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
14233774|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14233775|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233776|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
14233777|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
14233778|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233779|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14233780|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233781|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233782|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14233783|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14233784|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
14233785|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233786|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14233787|NCT00096135|Antidotes|antidotes|mesh-ancestor
14233788|NCT00096135|Protective Agents|protective agents|mesh-ancestor
14233789|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
14233790|NCT00096135|Vitamins|vitamins|mesh-ancestor
14233791|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
14233792|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233793|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233794|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233795|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233796|NCT00096161|Cyclosporine|cyclosporine|mesh-list
14233797|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
14233798|NCT00096161|Vidarabine|vidarabine|mesh-list
14233799|NCT00096161|Pentostatin|pentostatin|mesh-list
14233800|NCT00096161|Cyclosporins|cyclosporins|mesh-list
14233801|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233802|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233803|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233804|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
14233805|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511406|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511407|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
14511408|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
14511409|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511410|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511411|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511412|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
14511413|NCT03040011|Hormones|hormones|mesh-ancestor
14511414|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511415|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14511416|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511417|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
14511418|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
14511419|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511420|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
14511421|NCT03040024|Ketamine|ketamine|mesh-list
14511422|NCT03040024|Analgesics|analgesics|mesh-ancestor
14511423|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
14511424|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511425|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511426|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14511427|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14511428|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
14511429|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
14511430|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511431|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14511432|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14511433|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511434|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511435|NCT03040362|Lasmiditan|lasmiditan|mesh-list
14511436|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14511437|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
14511438|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511439|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511440|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511441|NCT03040479|Lasmiditan|lasmiditan|mesh-list
14511442|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14511443|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
14233806|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
14233807|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233808|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
14233809|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233810|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14233811|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14233812|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233813|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14233814|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
14233815|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14233816|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14233817|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
14233818|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
14233819|NCT00096174|Cisplatin|cisplatin|mesh-list
14233820|NCT00096174|Cetuximab|cetuximab|mesh-list
14233821|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233822|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233823|NCT00096226|Paclitaxel|paclitaxel|mesh-list
14233824|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14233825|NCT00096226|Carboplatin|carboplatin|mesh-list
14233826|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233827|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233828|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
14233829|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
14233830|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
14233831|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233832|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14233833|NCT00096265|Temozolomide|temozolomide|mesh-list
14233834|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233835|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233836|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233837|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233838|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233839|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
14233840|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
14233841|NCT00096278|Leucovorin|leucovorin|mesh-list
14233842|NCT00096278|Folic Acid|folic acid|mesh-list
14233843|NCT00096278|Bevacizumab|bevacizumab|mesh-list
14233844|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14233845|NCT00096278|Fluorouracil|fluorouracil|mesh-list
14233846|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
14233847|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
14233848|NCT00096278|Antibodies|antibodies|mesh-list
14233849|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
14233850|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14233851|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
14233852|NCT00096278|Calcium|calcium|mesh-list
14233853|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
14233854|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233855|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14233856|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14233857|NCT00096278|Growth Substances|growth substances|mesh-ancestor
14233858|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233859|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
14233860|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
14233861|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14233862|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14233863|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
14233864|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233865|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233866|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233867|NCT00096278|Antidotes|antidotes|mesh-ancestor
14233868|NCT00096278|Protective Agents|protective agents|mesh-ancestor
14233869|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
14233870|NCT00096278|Vitamins|vitamins|mesh-ancestor
14233871|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
14233872|NCT00096278|Hematinics|hematinics|mesh-ancestor
14233873|NCT00096356|Vitamins|vitamins|mesh-list
14233874|NCT00096356|Vitamin E|vitamin e|mesh-list
14233875|NCT00096356|Tocopherols|tocopherols|mesh-list
14233876|NCT00096356|Tocotrienols|tocotrienols|mesh-list
14233877|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
14233878|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
14233879|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233880|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
14233881|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233882|NCT00096356|Protective Agents|protective agents|mesh-ancestor
14233883|NCT00096382|Aldesleukin|aldesleukin|mesh-list
14233884|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
14233885|NCT00096382|Fludarabine|fludarabine|mesh-list
14233886|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
14233887|NCT00096382|Interleukin-2|interleukin-2|mesh-list
14233888|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233889|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
14233890|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233891|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233892|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233893|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
14233894|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233895|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233896|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14233897|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233898|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
14233899|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14233900|NCT00096382|Analgesics|analgesics|mesh-ancestor
14233901|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
14233902|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14233903|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14233904|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14233905|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
14233906|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233907|NCT00096447|Lapatinib|lapatinib|mesh-list
14233908|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233909|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233910|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233911|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233912|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
14233913|NCT00096460|Carmustine|carmustine|mesh-list
14233914|NCT00096460|Rituximab|rituximab|mesh-list
14233915|NCT00096460|Methotrexate|methotrexate|mesh-list
14233916|NCT00096460|Fludarabine|fludarabine|mesh-list
14233917|NCT00096460|Etoposide|etoposide|mesh-list
14233918|NCT00096460|Tacrolimus|tacrolimus|mesh-list
14233919|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233920|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
14233921|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233922|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14233923|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14233924|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
14233925|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233926|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233927|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14233928|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233929|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14233930|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
14233931|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14233932|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233933|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
14233934|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
14233935|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233936|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14233937|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233938|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14233939|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14233940|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14233941|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14233942|NCT00096486|Everolimus|everolimus|mesh-list
14233943|NCT00096486|Gefitinib|gefitinib|mesh-list
14233944|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233945|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233946|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
14233947|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233948|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14233949|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233950|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233951|NCT00096538|Valganciclovir|valganciclovir|mesh-list
14233952|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
14233953|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233954|NCT00096785|Entecavir|entecavir|mesh-list
14233955|NCT00096785|Adefovir|adefovir|mesh-list
14233956|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
14233957|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233958|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14233959|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14233960|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233961|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233962|NCT00096941|Pertuzumab|pertuzumab|mesh-list
14233963|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233964|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233965|NCT00096954|Omalizumab|omalizumab|mesh-list
14233966|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14233967|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14233968|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
14233969|NCT00096993|Gemcitabine|gemcitabine|mesh-list
14233970|NCT00096993|Pertuzumab|pertuzumab|mesh-list
14233971|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14233972|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
14233973|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14233974|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233975|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
14233976|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14233977|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14233978|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14233979|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
14233980|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233981|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14233982|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
14233983|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233984|NCT00097448|Prednisone|prednisone|mesh-list
14233985|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
14233986|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14233987|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14233988|NCT00097448|Prednisolone|prednisolone|mesh-list
14233989|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
14233990|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14233991|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
14233992|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14233993|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
14233994|NCT00097448|Hormones|hormones|mesh-ancestor
14233995|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14233996|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14233997|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14233998|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14233999|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
14234000|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
14234001|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14234002|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14234003|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14234004|NCT00097448|Protective Agents|protective agents|mesh-ancestor
14234005|NCT00097500|Metformin|metformin|mesh-list
14234006|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
14234007|NCT00097500|Exenatide|exenatide|mesh-list
14234008|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14234009|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234010|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14234011|NCT00097500|Incretins|incretins|mesh-ancestor
14234012|NCT00097500|Hormones|hormones|mesh-ancestor
14234013|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234014|NCT00097591|Clopidogrel|clopidogrel|mesh-list
14234015|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14234016|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14234017|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14234018|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14234019|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14234020|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
14234021|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234022|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234023|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234024|NCT00097669|Folic Acid|folic acid|mesh-list
14234025|NCT00097669|Hematinics|hematinics|mesh-ancestor
14234026|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
14234027|NCT00097669|Vitamins|vitamins|mesh-ancestor
14234028|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
14234029|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234030|NCT00097695|Icatibant|icatibant|mesh-list
14234031|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14234032|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14234033|NCT00097695|Analgesics|analgesics|mesh-ancestor
14234034|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
14234035|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14234036|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234037|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14234038|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234039|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14234040|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14234041|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234042|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14234043|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234044|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
14511444|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511445|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511446|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511447|NCT03041181|Gemcitabine|gemcitabine|mesh-list
14511448|NCT03041181|Docetaxel|docetaxel|mesh-list
14511449|NCT03041181|Nivolumab|nivolumab|mesh-list
14511450|NCT03041181|Pemetrexed|pemetrexed|mesh-list
14511451|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14511452|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
14511453|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511454|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511455|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
14511456|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511457|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511458|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14511459|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
14511460|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511461|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14511462|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
14511463|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14511464|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14511465|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14511466|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14511467|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14511468|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14511469|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
14511470|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
14511471|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511472|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14511473|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14511474|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511475|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511476|NCT03041792|Liraglutide|liraglutide|mesh-list
14511477|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511478|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511479|NCT03041792|Incretins|incretins|mesh-ancestor
14511480|NCT03041792|Hormones|hormones|mesh-ancestor
14511481|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511482|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14511483|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14511484|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14511485|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511486|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
14511487|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14511488|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511489|NCT03042910|Talazoparib|talazoparib|mesh-list
14511490|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14511491|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511492|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511493|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511494|NCT03043105|Thalidomide|thalidomide|mesh-list
14511495|NCT03043105|Prednisone|prednisone|mesh-list
14511496|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
14511497|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14511498|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
14511499|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511500|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14511501|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14511502|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
14511503|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511504|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511505|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14511506|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511507|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
14234045|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
14234046|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14234047|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14234048|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234049|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14234050|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
14234051|NCT00097773|Tobramycin|tobramycin|mesh-list
14234052|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14234053|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234054|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14234055|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234056|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234057|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234058|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234059|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14234060|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14234061|NCT00097786|Nateglinide|nateglinide|mesh-list
14234062|NCT00097786|Valsartan|valsartan|mesh-list
14234063|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14234064|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14234065|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14234066|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234067|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14234068|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234069|NCT00097981|Thalidomide|thalidomide|mesh-list
14234070|NCT00097981|Dexamethasone|dexamethasone|mesh-list
14234071|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14234072|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
14234073|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
14234074|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14234075|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234076|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14234077|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
14234078|NCT00097981|Hormones|hormones|mesh-ancestor
14234079|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234080|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14234081|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234082|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234083|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
14234084|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
14234085|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14234086|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234087|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14234088|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14234089|NCT00097981|Growth Substances|growth substances|mesh-ancestor
14234090|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
14234091|NCT00098020|Isotretinoin|isotretinoin|mesh-list
14234092|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
14234093|NCT00098059|Famciclovir|famciclovir|mesh-list
14511508|NCT03043105|Hormones|hormones|mesh-ancestor
14511509|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511510|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14511511|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
14511512|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14511513|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511514|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14511515|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14511516|NCT03043105|Growth Substances|growth substances|mesh-ancestor
14511517|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
14511518|NCT03043274|Cangrelor|cangrelor|mesh-list
14511519|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14511520|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14511521|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14511522|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14511523|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
14511524|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511525|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511526|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234094|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
14234095|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234096|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234097|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234098|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234099|NCT00098254|Sorafenib|sorafenib|mesh-list
14234100|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234101|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234102|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234103|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234104|NCT00098293|Lamivudine|lamivudine|mesh-list
14234105|NCT00098293|Zidovudine|zidovudine|mesh-list
14234106|NCT00098293|Efavirenz|efavirenz|mesh-list
14234107|NCT00098293|Maraviroc|maraviroc|mesh-list
14234108|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14234109|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234110|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234111|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234112|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
14234113|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234114|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234115|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234116|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
14234117|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14234118|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14234119|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14234120|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14234121|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14234122|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14234123|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14234124|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14234125|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14234126|NCT00098306|Maraviroc|maraviroc|mesh-list
14234127|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14234128|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14234129|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234130|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234131|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234132|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
14234133|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234134|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14234135|NCT00098371|Alvocidib|alvocidib|mesh-list
14234136|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234137|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
14234138|NCT00098371|Growth Substances|growth substances|mesh-ancestor
14234139|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234140|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234141|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234142|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791606|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234173|NCT00098670|Rituximab|rituximab|mesh-list
14234174|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14234175|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
14234176|NCT00098670|Fludarabine|fludarabine|mesh-list
14234177|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
14234178|NCT00098670|Antibodies|antibodies|mesh-list
14234179|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
14234180|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14234181|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
14234182|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234183|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234184|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234185|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234186|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
14234187|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234188|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234189|NCT00098722|Maraviroc|maraviroc|mesh-list
14234190|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14234191|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14234192|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234193|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234194|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234195|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
14234196|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234197|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14234198|NCT00098748|Maraviroc|maraviroc|mesh-list
14234199|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14234200|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14234201|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234202|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234203|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234204|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
14234205|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234206|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14234207|NCT00098774|Leucovorin|leucovorin|mesh-list
14234208|NCT00098774|Cytarabine|cytarabine|mesh-list
14234209|NCT00098774|Rituximab|rituximab|mesh-list
14234210|NCT00098774|Methotrexate|methotrexate|mesh-list
14234211|NCT00098774|Etoposide|etoposide|mesh-list
14234212|NCT00098774|Temozolomide|temozolomide|mesh-list
14234213|NCT00098774|Calcium|calcium|mesh-list
14234214|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
14234215|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234216|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234217|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
14234218|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234219|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234220|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14234221|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14234222|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
14234223|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14234224|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234225|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
14234226|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234227|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
14234228|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234229|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14234230|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234231|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234232|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14948490|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948491|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948492|NCT01533389|Urological Agents|urological agents|mesh-ancestor
14948493|NCT01533441|Vitamin K|vitamin k|mesh-list
14948494|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
14948495|NCT01533441|Vitamins|vitamins|mesh-ancestor
14948496|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
14234233|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14234234|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234235|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
14948497|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234236|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234237|NCT00098774|Antidotes|antidotes|mesh-ancestor
14234238|NCT00098774|Protective Agents|protective agents|mesh-ancestor
14234239|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
14234240|NCT00098774|Vitamins|vitamins|mesh-ancestor
14234241|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
14234242|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14234243|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
14234244|NCT00098787|Leucovorin|leucovorin|mesh-list
14234245|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
14234246|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
14234247|NCT00098787|Bevacizumab|bevacizumab|mesh-list
14234248|NCT00098787|Fluorouracil|fluorouracil|mesh-list
14234249|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
14234250|NCT00098787|Irinotecan|irinotecan|mesh-list
14234251|NCT00098787|Camptothecin|camptothecin|mesh-list
14234252|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
14234253|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234254|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234255|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14234256|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14234257|NCT00098787|Growth Substances|growth substances|mesh-ancestor
14234258|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234259|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
14234260|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
14234261|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234262|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234263|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234264|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
14234265|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14234266|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234267|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234268|NCT00098787|Antidotes|antidotes|mesh-ancestor
14234269|NCT00098787|Protective Agents|protective agents|mesh-ancestor
14234270|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
14234271|NCT00098787|Vitamins|vitamins|mesh-ancestor
14234272|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
14234273|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14234274|NCT00098813|Romidepsin|romidepsin|mesh-list
14234275|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14234276|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234277|NCT00098839|Leucovorin|leucovorin|mesh-list
14234278|NCT00098839|Cytarabine|cytarabine|mesh-list
14234279|NCT00098839|Prednisone|prednisone|mesh-list
14234280|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
14234281|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14234282|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14234283|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14234284|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
14234285|NCT00098839|Doxorubicin|doxorubicin|mesh-list
14234286|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14234287|NCT00098839|Methotrexate|methotrexate|mesh-list
14234288|NCT00098839|Etoposide|etoposide|mesh-list
14234289|NCT00098839|Vincristine|vincristine|mesh-list
14234290|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
14234291|NCT00098839|Asparaginase|asparaginase|mesh-list
14234292|NCT00098839|Pegaspargase|pegaspargase|mesh-list
14234293|NCT00098839|Epratuzumab|epratuzumab|mesh-list
14234294|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
14234295|NCT00098839|Razoxane|razoxane|mesh-list
14234296|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
14234297|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234298|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
14234299|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234300|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234301|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14234302|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
14234303|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234304|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234305|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14234306|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14234307|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14234308|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234309|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234310|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511527|NCT03043560|Ezogabine|ezogabine|mesh-list
14234311|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
14234312|NCT00098839|Hormones|hormones|mesh-ancestor
14234313|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511528|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
14511529|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791607|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791608|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791609|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791610|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
14791611|NCT00741949|Propofol|propofol|mesh-list
14791612|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14791613|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791614|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234314|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14234315|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14234316|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
14234317|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14234318|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234319|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
14234320|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14234321|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14234322|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234323|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14234324|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
14234325|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234326|NCT00098839|Antidotes|antidotes|mesh-ancestor
14234327|NCT00098839|Protective Agents|protective agents|mesh-ancestor
14234328|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
14234329|NCT00098839|Vitamins|vitamins|mesh-ancestor
14234330|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
14234331|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
14234332|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
14234333|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
14234334|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234335|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14234336|NCT00098865|Thalidomide|thalidomide|mesh-list
14234337|NCT00098865|Temozolomide|temozolomide|mesh-list
14234338|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14234339|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
14234340|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234341|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234342|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234343|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
14234344|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234345|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
14234346|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14234347|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234348|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14234349|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14234350|NCT00098865|Growth Substances|growth substances|mesh-ancestor
14234351|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
14234352|NCT00098956|Topotecan|topotecan|mesh-list
14234353|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
14234354|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14234355|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234356|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234357|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234358|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234359|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234360|NCT00099021|Pioglitazone|pioglitazone|mesh-list
14234361|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14234362|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234363|NCT00099047|Celecoxib|celecoxib|mesh-list
14234364|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14234365|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14234366|NCT00099047|Analgesics|analgesics|mesh-ancestor
14234367|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
14234368|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14234369|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234370|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14234371|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234372|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14234373|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14234374|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234375|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234376|NCT00099268|Levodopa|levodopa|mesh-list
14234377|NCT00099268|Carbidopa|carbidopa|mesh-list
14791615|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14234378|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14234379|NCT00099268|Entacapone|entacapone|mesh-list
14234380|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14234381|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14234382|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
14234383|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234384|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234385|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234386|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14234387|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234388|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14234389|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
14234390|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
14234391|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14234392|NCT00099359|Lamivudine|lamivudine|mesh-list
14234393|NCT00099359|Zidovudine|zidovudine|mesh-list
14234394|NCT00099359|Nevirapine|nevirapine|mesh-list
14234395|NCT00099359|Nelfinavir|nelfinavir|mesh-list
14234396|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14234397|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234398|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234399|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234400|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
14234401|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234402|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234403|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234404|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
14234405|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14234406|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14234407|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14234408|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14234409|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
14234410|NCT00099632|Ritonavir|ritonavir|mesh-list
14234411|NCT00099632|Lopinavir|lopinavir|mesh-list
14234412|NCT00099632|Tenofovir|tenofovir|mesh-list
14234413|NCT00099632|Lamivudine|lamivudine|mesh-list
14234414|NCT00099632|Zidovudine|zidovudine|mesh-list
14234415|NCT00099632|Emtricitabine|emtricitabine|mesh-list
14234416|NCT00099632|Nevirapine|nevirapine|mesh-list
14234417|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14234418|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14234419|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14234420|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14234421|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
14234422|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234423|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234424|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234425|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234426|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
14234427|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234428|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14234429|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14234430|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14234431|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234432|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
14234433|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14234434|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14511530|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511531|NCT03043651|Treprostinil|treprostinil|mesh-list
14511532|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14528895|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528896|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14528897|NCT03809182|Narcotics|narcotics|mesh-ancestor
14528898|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14528899|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14528900|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
14528901|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
14528902|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
14528903|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14528904|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528905|NCT03805672|Enoxaparin|enoxaparin|mesh-list
14528906|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
14528907|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
14528908|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14234435|NCT00099983|Risperidone|risperidone|mesh-list
14234436|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14234437|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
14234438|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234439|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234440|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234441|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14234442|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14234443|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14234444|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14234445|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14234446|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
14234447|NCT00100048|Tenofovir|tenofovir|mesh-list
14234448|NCT00100048|Lamivudine|lamivudine|mesh-list
14234449|NCT00100048|Efavirenz|efavirenz|mesh-list
14234450|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
14234451|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
14234452|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234453|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14234454|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234455|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234456|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234457|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234458|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234459|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14234460|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14234461|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14234462|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14234463|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14234464|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14234465|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14234466|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14234467|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
14234468|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14234469|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14234470|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
14234471|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234472|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234473|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234474|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
14234475|NCT00100178|Daclizumab|daclizumab|mesh-list
14234476|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14234477|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234478|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14234479|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
14234480|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14234481|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234482|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234483|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234484|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234485|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
14234486|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242785|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14242786|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14242787|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14242788|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242789|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242790|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14242791|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14242792|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14242793|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14242794|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242795|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
14242796|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14242797|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242798|NCT00190983|Pemetrexed|pemetrexed|mesh-list
14242799|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242800|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242801|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242802|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14242803|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14242804|NCT00191100|Gemcitabine|gemcitabine|mesh-list
14234487|NCT00100659|Interferons|interferons|mesh-list
14234488|NCT00100659|Ribavirin|ribavirin|mesh-list
14234489|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234490|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
14234491|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234492|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
14234493|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234494|NCT00100698|Hormones|hormones|mesh-list
14234495|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234496|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234497|NCT00100789|Gemcitabine|gemcitabine|mesh-list
14234498|NCT00100789|Paclitaxel|paclitaxel|mesh-list
14234499|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14234500|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234501|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
14234502|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
14234503|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
14234504|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234505|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234506|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
14234507|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
14234508|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234509|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234510|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234511|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
14234512|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234513|NCT00100802|Temozolomide|temozolomide|mesh-list
14234514|NCT00100802|Lomustine|lomustine|mesh-list
14234515|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14234516|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
14234517|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234518|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234519|NCT00100815|Gemcitabine|gemcitabine|mesh-list
14234520|NCT00100815|Bevacizumab|bevacizumab|mesh-list
14234521|NCT00100815|Capecitabine|capecitabine|mesh-list
14234522|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234523|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234524|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14234525|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14234526|NCT00100815|Growth Substances|growth substances|mesh-ancestor
14234527|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234528|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14234529|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234530|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
14234531|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234532|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
14234533|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234534|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234535|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234536|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
14234537|NCT00100841|Leucovorin|leucovorin|mesh-list
14234538|NCT00100841|Bevacizumab|bevacizumab|mesh-list
14234539|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14234540|NCT00100841|Cetuximab|cetuximab|mesh-list
14234541|NCT00100841|Fluorouracil|fluorouracil|mesh-list
14234542|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
14234543|NCT00100841|Antibodies|antibodies|mesh-list
14234544|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
14234545|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14234546|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
14234547|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234548|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14234549|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14234550|NCT00100841|Growth Substances|growth substances|mesh-ancestor
14234551|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234552|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
14234553|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
14234554|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
14234555|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234556|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234557|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234558|NCT00100841|Antidotes|antidotes|mesh-ancestor
14234559|NCT00100841|Protective Agents|protective agents|mesh-ancestor
14234560|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
14234561|NCT00100841|Vitamins|vitamins|mesh-ancestor
14234562|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
14234563|NCT00101010|Prednisone|prednisone|mesh-list
14234564|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
14234565|NCT00101010|Rituximab|rituximab|mesh-list
14234566|NCT00101010|Doxorubicin|doxorubicin|mesh-list
14234567|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14234568|NCT00101010|Vincristine|vincristine|mesh-list
14234569|NCT00101010|Lenograstim|lenograstim|mesh-list
14234570|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234571|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
14234572|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234573|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234574|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14234575|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
14234576|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234577|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234578|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14234579|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234580|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14234581|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14234582|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234583|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234584|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14234585|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
14234586|NCT00101010|Hormones|hormones|mesh-ancestor
14234587|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234588|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14234589|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14234590|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14234591|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14234592|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14234593|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14234594|NCT00101036|Lapatinib|lapatinib|mesh-list
14234595|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234596|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234597|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234598|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234599|NCT00101101|Aldesleukin|aldesleukin|mesh-list
14234600|NCT00101101|Dexamethasone|dexamethasone|mesh-list
14234601|NCT00101101|Prednisone|prednisone|mesh-list
14234602|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
14234603|NCT00101101|Doxorubicin|doxorubicin|mesh-list
14234604|NCT00101101|Vincristine|vincristine|mesh-list
14234605|NCT00101101|Interleukin-2|interleukin-2|mesh-list
14234606|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234607|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
14234608|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234609|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234610|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14234611|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
14234612|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511533|NCT03044418|Propofol|propofol|mesh-list
14511534|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
14511535|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511536|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511537|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14511538|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14511539|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
14511540|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
14511541|NCT03044730|Capecitabine|capecitabine|mesh-list
14511542|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948498|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14948499|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14234613|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791616|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
14791617|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
14791618|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
14791619|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
14791620|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14791621|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14791622|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234614|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14530088|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
14791623|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791624|NCT00742014|Urological Agents|urological agents|mesh-ancestor
14791625|NCT00742040|Captopril|captopril|mesh-list
14791626|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14234615|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14234616|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
14234617|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
14234618|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14234619|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14234620|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
14234621|NCT00101101|Hormones|hormones|mesh-ancestor
14234622|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234623|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14234624|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14234625|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14234626|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234627|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234628|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14234629|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
14234630|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
14234631|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
14234632|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14234633|NCT00101101|Analgesics|analgesics|mesh-ancestor
14234634|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
14234635|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234636|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234637|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
14234638|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234639|NCT00101166|Vaccines|vaccines|mesh-list
14234640|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
14234641|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234642|NCT00101192|Cetuximab|cetuximab|mesh-list
14234643|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234644|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234645|NCT00101283|Gemcitabine|gemcitabine|mesh-list
14234646|NCT00101283|Carboplatin|carboplatin|mesh-list
14234647|NCT00101283|Pemetrexed|pemetrexed|mesh-list
14234648|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234649|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234650|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
14234651|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234652|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
14234653|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234654|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234655|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234656|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
14234657|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234658|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14234659|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234660|NCT00101361|Oxandrolone|oxandrolone|mesh-list
14234661|NCT00101361|Androgens|androgens|mesh-ancestor
14234662|NCT00101361|Hormones|hormones|mesh-ancestor
14234663|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234664|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234665|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
14234666|NCT00101400|Sorafenib|sorafenib|mesh-list
14234667|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234668|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234669|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234670|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234671|NCT00101413|Sorafenib|sorafenib|mesh-list
14234672|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234673|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234674|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234675|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234676|NCT00101452|Citalopram|citalopram|mesh-list
14234677|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14234678|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14234679|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14234680|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234681|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234682|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
14234683|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234684|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14234685|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
14234686|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14234687|NCT00101582|Cisplatin|cisplatin|mesh-list
14234688|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234689|NCT00101647|Dasatinib|dasatinib|mesh-list
14234690|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234691|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234692|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234693|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234694|NCT00101660|Dasatinib|dasatinib|mesh-list
14234695|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234696|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234697|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234698|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234699|NCT00101686|Bevacizumab|bevacizumab|mesh-list
14234700|NCT00101686|Capecitabine|capecitabine|mesh-list
14234701|NCT00101686|Irinotecan|irinotecan|mesh-list
14234702|NCT00101686|Fluorouracil|fluorouracil|mesh-list
14234703|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234704|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234705|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14234706|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14234707|NCT00101686|Growth Substances|growth substances|mesh-ancestor
14234708|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234709|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
14234710|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234711|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
14234712|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234713|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14234714|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234715|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234716|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234717|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
14234718|NCT00101816|Dasatinib|dasatinib|mesh-list
14234719|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234720|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234721|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234722|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234723|NCT00101907|Gemcitabine|gemcitabine|mesh-list
14234724|NCT00101907|Panitumumab|panitumumab|mesh-list
14234725|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
14234726|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234727|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234728|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
14234729|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234730|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
14234731|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234732|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234733|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234734|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
14234735|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234736|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234737|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234738|NCT00102063|Aripiprazole|aripiprazole|mesh-list
14234739|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
14234740|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14234741|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14234742|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14234743|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14234744|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234745|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
14234746|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
14234747|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234748|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234749|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14234750|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14234751|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
14234752|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14234753|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14234754|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14234755|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14234756|NCT00102440|Allopurinol|allopurinol|mesh-list
14234757|NCT00102440|Febuxostat|febuxostat|mesh-list
14234758|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
14234759|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234760|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234761|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
14234762|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234763|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14234764|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
14234765|NCT00102440|Protective Agents|protective agents|mesh-ancestor
14234766|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234767|NCT00102518|Aripiprazole|aripiprazole|mesh-list
14234768|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
14234769|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14234770|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14234771|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14234772|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14234773|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234774|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
14234775|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
14234776|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234777|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234778|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14234779|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14234780|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
14234781|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14234782|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14234783|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14234784|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14234785|NCT00102531|Cisplatin|cisplatin|mesh-list
14234786|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234787|NCT00102687|Azacitidine|azacitidine|mesh-list
14234788|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14948500|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948501|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
14948502|NCT01533441|Coagulants|coagulants|mesh-ancestor
14948503|NCT01533506|Stiripentol|stiripentol|mesh-list
14948504|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
14948505|NCT01533545|Epinephrine|epinephrine|mesh-list
14948506|NCT01533545|Mepivacaine|mepivacaine|mesh-list
14948507|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14948508|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14948509|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948510|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948511|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234789|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
14234790|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234791|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234792|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234793|NCT00102804|Pemetrexed|pemetrexed|mesh-list
14234794|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234795|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234796|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234797|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14234798|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234799|NCT00102960|Ritonavir|ritonavir|mesh-list
14234800|NCT00102960|Lopinavir|lopinavir|mesh-list
14234801|NCT00102960|Lamivudine|lamivudine|mesh-list
14234802|NCT00102960|Zidovudine|zidovudine|mesh-list
14234803|NCT00102960|Nevirapine|nevirapine|mesh-list
14234804|NCT00102960|Abacavir|abacavir|mesh-list
14234805|NCT00102960|Didanosine|didanosine|mesh-list
14234806|NCT00102960|Efavirenz|efavirenz|mesh-list
14234807|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14234808|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14234809|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
14234810|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234811|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234812|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234813|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234814|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
14234815|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234816|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14234817|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14234818|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14234819|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234820|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
14234821|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14948512|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234822|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14234823|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14234824|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14234825|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14234826|NCT00103116|Vaccines|vaccines|mesh-list
14234827|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
14234828|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234829|NCT00103142|Sargramostim|sargramostim|mesh-list
14234830|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
14234831|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234832|NCT00103194|Lapatinib|lapatinib|mesh-list
14234833|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234834|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234835|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234836|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234837|NCT00103207|Cetuximab|cetuximab|mesh-list
14234838|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14234839|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234840|NCT00103259|Irinotecan|irinotecan|mesh-list
14234841|NCT00103259|Bortezomib|bortezomib|mesh-list
14234842|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14234843|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234844|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234845|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234846|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234847|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
14234848|NCT00103285|Leucovorin|leucovorin|mesh-list
14234849|NCT00103285|Folic Acid|folic acid|mesh-list
14234850|NCT00103285|Cytarabine|cytarabine|mesh-list
14234851|NCT00103285|Dexamethasone|dexamethasone|mesh-list
14234852|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
14234853|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
14234854|NCT00103285|Doxorubicin|doxorubicin|mesh-list
14234855|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14234856|NCT00103285|Methotrexate|methotrexate|mesh-list
14234857|NCT00103285|Vincristine|vincristine|mesh-list
14234858|NCT00103285|Asparaginase|asparaginase|mesh-list
14234859|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
14234860|NCT00103285|Pegaspargase|pegaspargase|mesh-list
14234861|NCT00103285|Thioguanine|thioguanine|mesh-list
14234862|NCT00103285|BB 1101|bb 1101|mesh-list
14234863|NCT00103285|Calcium|calcium|mesh-list
14234864|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
14234865|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
14234866|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14234867|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
14234868|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234869|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14234870|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14234871|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
14234872|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234873|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234874|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14234875|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14234876|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
14234877|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
14234878|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14234879|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14234880|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
14234881|NCT00103285|Hormones|hormones|mesh-ancestor
14234882|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234883|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14234884|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
14234885|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234886|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14234887|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14234888|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234889|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14234890|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14234891|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14234892|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
14234893|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14234894|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14234895|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
14234896|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
14234897|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14234898|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14234899|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
14234900|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234901|NCT00103285|Antidotes|antidotes|mesh-ancestor
14234902|NCT00103285|Protective Agents|protective agents|mesh-ancestor
14234903|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
14234904|NCT00103285|Vitamins|vitamins|mesh-ancestor
14234905|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
14234906|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14234907|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
14234908|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
14234909|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
14234910|NCT00103285|Hematinics|hematinics|mesh-ancestor
14234911|NCT00103376|Bortezomib|bortezomib|mesh-list
14234912|NCT00103376|Androgens|androgens|mesh-list
14234913|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
14234914|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234915|NCT00103376|Hormones|hormones|mesh-ancestor
14234916|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234917|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234918|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
14234919|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
14234920|NCT00103402|Alfuzosin|alfuzosin|mesh-list
14234921|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14234922|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14234923|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14234924|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14234925|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14234926|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234927|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234928|NCT00103402|Urological Agents|urological agents|mesh-ancestor
14234929|NCT00103506|Doxorubicin|doxorubicin|mesh-list
14234930|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14234931|NCT00103506|Bortezomib|bortezomib|mesh-list
14234932|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14234933|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234934|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14234935|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14234936|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234937|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234938|NCT00103610|Plerixafor|plerixafor|mesh-list
14234939|NCT00103610|Sargramostim|sargramostim|mesh-list
14234940|NCT00103610|Lenograstim|lenograstim|mesh-list
14234941|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
14234942|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234943|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14234944|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234945|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234946|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
14234947|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234948|NCT00103662|Plerixafor|plerixafor|mesh-list
14234949|NCT00103662|Sargramostim|sargramostim|mesh-list
14234950|NCT00103662|Lenograstim|lenograstim|mesh-list
14234951|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
14234952|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234953|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14234954|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14234955|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14234956|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
14234957|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234958|NCT00103740|Vitamin D|vitamin d|mesh-list
14234959|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
14234960|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
14234961|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
14234962|NCT00103740|Calcium|calcium|mesh-list
14234963|NCT00103740|Vitamins|vitamins|mesh-ancestor
14234964|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
14234965|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234966|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14234967|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14234968|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14234969|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14234970|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234971|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
14234972|NCT00103844|Dasatinib|dasatinib|mesh-list
14234973|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14234974|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14234975|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234976|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234977|NCT00103857|Metformin|metformin|mesh-list
14234978|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14234979|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14234980|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234981|NCT00103857|Incretins|incretins|mesh-ancestor
14234982|NCT00103857|Hormones|hormones|mesh-ancestor
14234983|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14234984|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14234985|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
14234986|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14234987|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234988|NCT00104052|Ribavirin|ribavirin|mesh-list
14234989|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14234990|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
14234991|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
14234992|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14234993|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
14234994|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14234995|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
14234996|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14234997|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
14234998|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14234999|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235000|NCT00104247|Verapamil|verapamil|mesh-list
14235001|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14235002|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14235003|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235004|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235005|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235006|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235007|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
14235008|NCT00104299|Prednisone|prednisone|mesh-list
14235009|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
14235010|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
14235011|NCT00104299|Rituximab|rituximab|mesh-list
14235012|NCT00104299|Azathioprine|azathioprine|mesh-list
14235013|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
14235014|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235015|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
14235016|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235017|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235018|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235019|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
14235020|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235021|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511543|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511544|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14511545|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
14511546|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511547|NCT03044886|Vitamin D|vitamin d|mesh-list
14511548|NCT03044886|Vitamins|vitamins|mesh-ancestor
14511549|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
14511550|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791627|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
14791628|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791629|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791630|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14791631|NCT00742066|Felodipine|felodipine|mesh-list
14511551|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14511552|NCT03045328|Venetoclax|venetoclax|mesh-list
14511553|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511554|NCT03045861|Cobicistat|cobicistat|mesh-list
14791632|NCT00742066|Irbesartan|irbesartan|mesh-list
14791633|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14791634|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14791635|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14791636|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791637|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14235022|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14235023|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235024|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235025|NCT00104299|Hormones|hormones|mesh-ancestor
14235026|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235027|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235028|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
14235029|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
14235030|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235031|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14235032|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14511555|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
14511556|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14511557|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14511558|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
14511559|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511560|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14511561|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14511562|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511563|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511564|NCT03046446|FX006|fx006|mesh-list
14511565|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511566|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
14511567|NCT03046446|Hormones|hormones|mesh-ancestor
14511568|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511569|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511570|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14511571|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
14511572|NCT03047980|Sirolimus|sirolimus|mesh-list
14511573|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14511574|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511575|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14511576|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511577|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
14511578|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235033|NCT00104299|Protective Agents|protective agents|mesh-ancestor
14511579|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
14511580|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511581|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14511582|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
14511583|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
14511584|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511585|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14511586|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14511587|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14511588|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14511589|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14511590|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511591|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511592|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511593|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511594|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14511595|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14511596|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14511597|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511598|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511599|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14511600|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791638|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14235034|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
14235035|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235036|NCT00104416|Lamotrigine|lamotrigine|mesh-list
14235037|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
14235038|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14235039|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235040|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235041|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235042|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235043|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14235044|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14235045|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14235046|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14235047|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14235048|NCT00104572|Vitamin D|vitamin d|mesh-list
14235049|NCT00104572|Anastrozole|anastrozole|mesh-list
14235050|NCT00104572|Calcium|calcium|mesh-list
14235051|NCT00104572|Testosterone|testosterone|mesh-list
14235052|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14235053|NCT00104572|Vitamins|vitamins|mesh-ancestor
14235054|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
14235055|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235056|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235057|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14235058|NCT00104572|Androgens|androgens|mesh-ancestor
14235059|NCT00104572|Hormones|hormones|mesh-ancestor
14235060|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235061|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235062|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235063|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14235064|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235065|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235066|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14235067|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
14235068|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
14235069|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235070|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
14235071|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14235072|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14235073|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235074|NCT00104637|Urological Agents|urological agents|mesh-ancestor
14235075|NCT00104650|Denosumab|denosumab|mesh-list
14235076|NCT00104650|Diphosphonates|diphosphonates|mesh-list
14235077|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14235078|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235079|NCT00104676|Paclitaxel|paclitaxel|mesh-list
14235080|NCT00104676|Etoposide|etoposide|mesh-list
14235081|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
14235082|NCT00104676|Ifosfamide|ifosfamide|mesh-list
14235083|NCT00104676|Bleomycin|bleomycin|mesh-list
14235084|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235085|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235086|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235087|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
14235088|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
14235089|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235090|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14235091|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235092|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235093|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235094|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
14235095|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235096|NCT00104858|Cyclosporine|cyclosporine|mesh-list
14235097|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
14235098|NCT00104858|Rituximab|rituximab|mesh-list
14235099|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14235100|NCT00104858|Fludarabine|fludarabine|mesh-list
14235101|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
14235102|NCT00104858|Antibodies|antibodies|mesh-list
14235103|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
14235104|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14235105|NCT00104858|Cyclosporins|cyclosporins|mesh-list
14235106|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
14235107|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235108|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235109|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235110|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235111|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
14235112|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235113|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235114|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235115|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
14235116|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235117|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
14235118|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14235119|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235120|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14235121|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
14235122|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235123|NCT00104871|Bortezomib|bortezomib|mesh-list
14235124|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235125|NCT00104884|Romidepsin|romidepsin|mesh-list
14235126|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235127|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235128|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
14235129|NCT00105001|Sirolimus|sirolimus|mesh-list
14235130|NCT00105001|Fludarabine|fludarabine|mesh-list
14235131|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
14235132|NCT00105001|Tacrolimus|tacrolimus|mesh-list
14235133|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235134|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235135|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
14235136|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235137|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235138|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
14235139|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235140|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14235141|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235142|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235143|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14235144|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
14235145|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235146|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235147|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
14235148|NCT00105027|Triamcinolone|triamcinolone|mesh-list
14235149|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14235150|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14235151|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14235152|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235153|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
14235154|NCT00105027|Hormones|hormones|mesh-ancestor
14235155|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235156|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235157|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235158|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
14235159|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235160|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235161|NCT00105066|Metformin|metformin|mesh-list
14235162|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14235163|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235164|NCT00105079|Ritonavir|ritonavir|mesh-list
14235165|NCT00105079|Lopinavir|lopinavir|mesh-list
14235166|NCT00105079|Saquinavir|saquinavir|mesh-list
14235167|NCT00105079|Tenofovir|tenofovir|mesh-list
14235168|NCT00105079|Emtricitabine|emtricitabine|mesh-list
14235169|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14235170|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14235171|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14235172|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
14235173|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235174|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235175|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14235176|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14235177|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
14235178|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235179|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14235180|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14235181|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14235182|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14235183|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
14235184|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14235185|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14235186|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
14235187|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235188|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14235189|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14235190|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235191|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235192|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
14235193|NCT00105183|Antibodies|antibodies|mesh-list
14235194|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
14235195|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14235196|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14235197|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
14235198|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14235199|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
14235200|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235201|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235202|NCT00105196|Aripiprazole|aripiprazole|mesh-list
14235203|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235204|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14235205|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14235206|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14235207|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14235208|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235209|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
14235210|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
14235211|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235212|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235213|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14235214|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14235215|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
14235216|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14235217|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14235218|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14235219|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14235220|NCT00105235|Cyclosporine|cyclosporine|mesh-list
14235221|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
14235222|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
14235223|NCT00105235|Tacrolimus|tacrolimus|mesh-list
14511601|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511602|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
14511603|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511604|NCT03048500|Metformin|metformin|mesh-list
14511605|NCT03048500|Nivolumab|nivolumab|mesh-list
14511606|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511607|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511608|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14511609|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511610|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14511611|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511612|NCT03048747|Tolvaptan|tolvaptan|mesh-list
14511613|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14511614|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511615|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
14511616|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511617|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14511618|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14511619|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
14511620|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511621|NCT03049488|Antacids|antacids|mesh-ancestor
14511622|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511623|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511624|NCT03050294|Desoximetasone|desoximetasone|mesh-list
14511625|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511626|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
14511627|NCT03050294|Hormones|hormones|mesh-ancestor
14511628|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14511629|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511630|NCT03050307|Lansoprazole|lansoprazole|mesh-list
14511631|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
14511632|NCT03050307|Bismuth|bismuth|mesh-list
14511633|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14511634|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511635|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14511636|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511637|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511638|NCT03050307|Antacids|antacids|mesh-ancestor
14235224|NCT00105235|Cyclosporins|cyclosporins|mesh-list
14511639|NCT03050359|Lansoprazole|lansoprazole|mesh-list
14235225|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235226|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
14235227|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235228|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14235229|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235230|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235231|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
14235232|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235233|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
14235234|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235235|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235236|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235237|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14235238|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
14235239|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235240|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235241|NCT00105443|Sorafenib|sorafenib|mesh-list
14235242|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235243|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14511640|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
14511641|NCT03050359|Bismuth|bismuth|mesh-list
14511642|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14511643|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511644|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14511645|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511646|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511647|NCT03050359|Antacids|antacids|mesh-ancestor
14511648|NCT03050450|Lenalidomide|lenalidomide|mesh-list
14511649|NCT03050450|Vorinostat|vorinostat|mesh-list
14511650|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
14511651|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511652|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14511653|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14511654|NCT03050450|Growth Substances|growth substances|mesh-ancestor
14511655|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14511656|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511657|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14511658|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511659|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511660|NCT03050619|Empagliflozin|empagliflozin|mesh-list
14511661|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14511662|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511663|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511664|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511665|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14511666|NCT03051100|Atorvastatin|atorvastatin|mesh-list
14511667|NCT03051100|Ezetimibe|ezetimibe|mesh-list
14511668|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14511669|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14511670|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
14511671|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511672|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14511673|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14511674|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511675|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511676|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511677|NCT03051256|Methadone|methadone|mesh-list
14511678|NCT03051256|D-methadone|d-methadone|mesh-list
14511679|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14511680|NCT03051256|Narcotics|narcotics|mesh-ancestor
14511681|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511682|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511683|NCT03051256|Analgesics|analgesics|mesh-ancestor
14511684|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
14511685|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511686|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
14511687|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
14511688|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14511689|NCT03051620|Alendronate|alendronate|mesh-list
14511690|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14511691|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511692|NCT03051646|Aspirin|aspirin|mesh-list
14511693|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14511694|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14235244|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235245|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235246|NCT00105469|Tobramycin|tobramycin|mesh-list
14235247|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235248|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235249|NCT00105482|Naltrexone|naltrexone|mesh-list
14235250|NCT00105482|Nicotine|nicotine|mesh-list
14235251|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14235252|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
14235253|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511695|NCT03051646|Analgesics|analgesics|mesh-ancestor
14511696|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
14511697|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511698|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511699|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235254|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511700|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14511701|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14511702|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14511703|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511704|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14511705|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14511706|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511707|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
14511708|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
14511709|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14511710|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511711|NCT03052322|Adalimumab|adalimumab|mesh-list
14511712|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511713|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14511714|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
14511715|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14511716|NCT03052517|Growth Substances|growth substances|mesh-ancestor
14511717|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511718|NCT03052725|Reslizumab|reslizumab|mesh-list
14511719|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14511720|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
14511721|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
14511722|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14511723|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
14511724|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511725|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
14511726|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14511727|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14511728|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14511729|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14511730|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511731|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
14511732|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511733|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511734|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14511735|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511736|NCT03052816|Hydromorphone|hydromorphone|mesh-list
14511737|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14511738|NCT03052816|Narcotics|narcotics|mesh-ancestor
14511739|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511740|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511741|NCT03052816|Analgesics|analgesics|mesh-ancestor
14511742|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
14511743|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511744|NCT03053050|Selonsertib|selonsertib|mesh-list
14511745|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14511746|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511747|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511748|NCT03053063|Selonsertib|selonsertib|mesh-list
14511749|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14511750|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235255|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14235256|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14235257|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
14235258|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235259|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235260|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14235261|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14235262|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
14235263|NCT00105534|Azithromycin|azithromycin|mesh-list
14235264|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235265|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235266|NCT00105586|Citalopram|citalopram|mesh-list
14235267|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14235268|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14235269|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235270|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235271|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235272|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
14235273|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511751|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511752|NCT03053401|Anesthetics|anesthetics|mesh-list
14511753|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
14511754|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511755|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511756|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
14511757|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511758|NCT03053427|Gabapentin|gabapentin|mesh-list
14511759|NCT03053427|Analgesics|analgesics|mesh-ancestor
14511760|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
14948513|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14948514|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14948515|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
14948516|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948517|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14948518|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
14948519|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
14948520|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
14948521|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14948522|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
14948523|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
14948524|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948525|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
14948526|NCT01533558|Caspofungin|caspofungin|mesh-list
14948527|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
14948528|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948529|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948530|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948531|NCT01533662|Phenylephrine|phenylephrine|mesh-list
14948532|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
14511761|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511762|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511763|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
14511764|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14511765|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14511766|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511767|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14511768|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14511769|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14511770|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511771|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511772|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
14511773|NCT03054103|Midazolam|midazolam|mesh-list
14511774|NCT03054103|Ketamine|ketamine|mesh-list
14511775|NCT03054103|Analgesics|analgesics|mesh-ancestor
14511776|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
14511777|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511778|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511779|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14511780|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14511781|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
14511782|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
14511783|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511784|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14511785|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14511786|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511787|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511788|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14511789|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14511790|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14511791|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14511792|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14511793|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
14511794|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
14511795|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14511796|NCT03054506|Laxatives|laxatives|mesh-ancestor
14511797|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511798|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
14511799|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
14511800|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
14511801|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511802|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511803|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
14511804|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511805|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
14511806|NCT03054805|Antacids|antacids|mesh-ancestor
14511807|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511808|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511809|NCT03054844|Lidocaine|lidocaine|mesh-list
14511810|NCT03054844|Midazolam|midazolam|mesh-list
14511811|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
14511812|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
14511813|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511814|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511815|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
14511816|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511817|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14511818|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14511819|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14511820|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14511821|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511822|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14511823|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14511824|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14511825|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14511826|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14511827|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14511828|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
14511829|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
14511830|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
14511831|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511832|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
14511833|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14511834|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511835|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511836|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14511837|NCT03054857|Analgesics|analgesics|mesh-ancestor
14511838|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
14511839|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511840|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14511841|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14511842|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14511843|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511844|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511845|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511846|NCT03054870|Xenon|xenon|mesh-list
14511847|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14511848|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
14511849|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
14511850|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511851|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511852|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
14511853|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14511854|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14511855|NCT03055221|Treprostinil|treprostinil|mesh-list
14511856|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14511857|NCT03055338|Risperidone|risperidone|mesh-list
14511858|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14511859|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
14511860|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511861|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511862|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511863|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14511864|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14511865|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511866|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14511867|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14511868|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
14528909|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14528910|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791639|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14528911|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14528912|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14528913|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528914|NCT03802994|Vaccines|vaccines|mesh-list
14528915|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14528916|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
14528917|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528918|NCT03809611|Choline|choline|mesh-list
14528919|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
14528920|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14528921|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
14528922|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528923|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528924|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14528925|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
14528926|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14528927|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14528928|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
14528929|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528930|NCT03807245|Antacids|antacids|mesh-ancestor
14528931|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528932|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528933|NCT03802916|Deferiprone|deferiprone|mesh-list
14528934|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14528935|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
14528936|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
14528937|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528938|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
14528939|NCT03805386|Narcotics|narcotics|mesh-ancestor
14528940|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528941|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528942|NCT03805386|Analgesics|analgesics|mesh-ancestor
14528943|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
14528944|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528945|NCT03803475|Edetic Acid|edetic acid|mesh-list
14528946|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
14528947|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
14528948|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528949|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
14528950|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14528951|NCT03802227|Oxycodone|oxycodone|mesh-list
14528952|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14528953|NCT03802227|Narcotics|narcotics|mesh-ancestor
14528954|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528955|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528956|NCT03802227|Analgesics|analgesics|mesh-ancestor
14528957|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
14528958|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948533|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14511869|NCT03055936|Levodopa|levodopa|mesh-list
14511870|NCT03055936|Carbidopa|carbidopa|mesh-list
14511871|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14511872|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14511873|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
14511874|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511875|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511876|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511877|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14511878|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511879|NCT03055988|Fluticasone|fluticasone|mesh-list
14511880|NCT03055988|Xhance|xhance|mesh-list
14511881|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
14511882|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14511883|NCT03055988|Olodaterol|olodaterol|mesh-list
14511884|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14511885|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14511886|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
14511887|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511888|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511889|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14511890|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
14511891|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
14511892|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14511893|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
14511894|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14511895|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
14511896|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511897|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511898|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14511899|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14511900|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14511901|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
14511902|NCT03056040|Eculizumab|eculizumab|mesh-list
14511903|NCT03056040|Ravulizumab|ravulizumab|mesh-list
14511904|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14511905|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14511906|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
14511907|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511908|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
14511909|NCT03056352|Promethazine|promethazine|mesh-list
14511910|NCT03056352|Metoclopramide|metoclopramide|mesh-list
14511911|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14511912|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14511913|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511914|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511915|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
14511916|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
14511917|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
14511918|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511919|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
14511920|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
14511921|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511922|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14511923|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
14511924|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
14511925|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14511926|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511927|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14511928|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
14511929|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
14511930|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14511931|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14511932|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
14511933|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
14511934|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511935|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511936|NCT03057132|Protective Agents|protective agents|mesh-list
14511937|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511938|NCT03057366|Paclitaxel|paclitaxel|mesh-list
14511939|NCT03057366|Docetaxel|docetaxel|mesh-list
14511940|NCT03057366|Carboplatin|carboplatin|mesh-list
14511941|NCT03057366|Pevonedistat|pevonedistat|mesh-list
14511942|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14511943|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511944|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
14511945|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
14511946|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
14511947|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511948|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511949|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
14511950|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14511951|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511952|NCT03057704|Lidocaine|lidocaine|mesh-list
14511953|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
14511954|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
14511955|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14511956|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511957|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
14511958|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511959|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14511960|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14511961|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14511962|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14511963|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511964|NCT03057977|Empagliflozin|empagliflozin|mesh-list
14511965|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14511966|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511967|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511968|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511969|NCT03058692|Vaccines|vaccines|mesh-list
14511970|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
14511971|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511972|NCT03060447|Vesatolimod|vesatolimod|mesh-list
14511973|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
14511974|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511975|NCT03060486|Hybenx|hybenx|mesh-list
14511976|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
14511977|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
14511978|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14511979|NCT03060512|Naloxegol|naloxegol|mesh-list
14511980|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14511981|NCT03060512|Laxatives|laxatives|mesh-ancestor
14511982|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14511983|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14511984|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511985|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
14791640|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791641|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791642|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
14511986|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14511987|NCT03061188|Nivolumab|nivolumab|mesh-list
14511988|NCT03061188|Veliparib|veliparib|mesh-list
14511989|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14511990|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14511991|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14511992|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14511993|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14511994|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14511995|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14511996|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14511997|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14511998|NCT03061214|Incretins|incretins|mesh-ancestor
14511999|NCT03061214|Hormones|hormones|mesh-ancestor
14512000|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512001|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14512002|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
14512003|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512004|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512005|NCT03061331|Ivacaftor|ivacaftor|mesh-list
14512006|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14512007|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512008|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512009|NCT03061812|Dexamethasone|dexamethasone|mesh-list
14512010|NCT03061812|Topotecan|topotecan|mesh-list
14512011|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512012|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
14512013|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
14512014|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512015|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512016|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512017|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
14512018|NCT03061812|Hormones|hormones|mesh-ancestor
14512019|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512020|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14512021|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512022|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14512023|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14512024|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512025|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512026|NCT03062488|Acetaminophen|acetaminophen|mesh-list
14512027|NCT03062488|Fentanyl|fentanyl|mesh-list
14512028|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14512029|NCT03062488|Narcotics|narcotics|mesh-ancestor
14512030|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512031|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512032|NCT03062488|Analgesics|analgesics|mesh-ancestor
14512033|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
14512034|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512035|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14512036|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14512037|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
14512038|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
14512039|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512040|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
14512041|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
14512042|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14512043|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512044|NCT03063086|Fluticasone|fluticasone|mesh-list
14512045|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14512046|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512047|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14512048|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
14512049|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512050|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512051|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14512052|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
14512053|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512054|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14512055|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14512056|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14512057|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512058|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512059|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512060|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512061|NCT03063255|Anesthetics|anesthetics|mesh-list
14512062|NCT03063255|Mepivacaine|mepivacaine|mesh-list
14512063|NCT03063255|Rocuronium|rocuronium|mesh-list
14512064|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512065|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512066|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14512067|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14512068|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14512069|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512070|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
14512071|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
14512072|NCT03065179|Nivolumab|nivolumab|mesh-list
14512073|NCT03065179|Ipilimumab|ipilimumab|mesh-list
14512074|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512075|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512076|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14512077|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512078|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
14512079|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512080|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512081|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
14512082|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14512083|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512084|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512085|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512086|NCT03065530|Analgesics|analgesics|mesh-ancestor
14512087|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
14512088|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512089|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14512090|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14512091|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512092|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512093|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512094|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512095|NCT03066193|Palmidrol|palmidrol|mesh-list
14512096|NCT03066193|Dronabinol|dronabinol|mesh-list
14512097|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
14512098|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512099|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14512100|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512101|NCT03066193|Analgesics|analgesics|mesh-ancestor
14512102|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
14512103|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512104|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14512105|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14512106|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512107|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512108|NCT03066193|Hormones|hormones|mesh-ancestor
14512109|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512110|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14512111|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512112|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512113|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
14948534|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
14948535|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
14512114|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512115|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14512116|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
14512117|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512118|NCT03066778|Carboplatin|carboplatin|mesh-list
14512119|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
14512120|NCT03066778|Etoposide|etoposide|mesh-list
14512121|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512122|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512123|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14512124|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14512125|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14512126|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512127|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512128|NCT03066804|Valsartan|valsartan|mesh-list
14512129|NCT03066804|Enalapril|enalapril|mesh-list
14512130|NCT03066804|Enalaprilat|enalaprilat|mesh-list
14512131|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14512132|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14512133|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14512134|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14512135|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512136|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14512137|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
14512138|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512139|NCT03066830|Metformin|metformin|mesh-list
14512140|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14512141|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14512142|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512143|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14512144|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512145|NCT03066947|Interferons|interferons|mesh-list
14512146|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
14512147|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
14512148|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
14512149|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14512150|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
14512151|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512152|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512153|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14512154|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
14512155|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512156|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512157|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14512158|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
14512159|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512160|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14512161|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14512162|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
14512163|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512164|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14512165|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512166|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14512167|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512168|NCT03068312|Ivacaftor|ivacaftor|mesh-list
14512169|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14512170|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512171|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512172|NCT03068455|Nivolumab|nivolumab|mesh-list
14512173|NCT03068455|Ipilimumab|ipilimumab|mesh-list
14512174|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512175|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512176|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14512177|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512178|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14512179|NCT03068754|Hormones|hormones|mesh-ancestor
14512180|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512181|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512182|NCT03068767|Vitamin D|vitamin d|mesh-list
14512183|NCT03068767|Vitamins|vitamins|mesh-ancestor
14512184|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
14512185|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512186|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14512187|NCT03068897|Ibuprofen|ibuprofen|mesh-list
14512188|NCT03068897|Tizanidine|tizanidine|mesh-list
14512189|NCT03068897|Baclofen|baclofen|mesh-list
14512190|NCT03068897|Metaxalone|metaxalone|mesh-list
14512191|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14512192|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512193|NCT03068897|Analgesics|analgesics|mesh-ancestor
14512194|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
14512195|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512196|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512197|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512198|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512199|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14512200|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512201|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512202|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14512203|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14512204|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14512205|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
14512206|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
14512207|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512208|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
14512209|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
14512210|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
14512211|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14512212|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14512213|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512214|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512215|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
14512216|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
14512217|NCT03069313|Vitamins|vitamins|mesh-ancestor
14512218|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
14512219|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512220|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
14512221|NCT03069313|Hematinics|hematinics|mesh-ancestor
14512222|NCT03069352|Cytarabine|cytarabine|mesh-list
14512223|NCT03069352|Venetoclax|venetoclax|mesh-list
14512224|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14512225|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
14512226|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512227|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512228|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
14512229|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512230|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14512231|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
14512232|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512233|NCT03069482|Nicotine|nicotine|mesh-list
14512234|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14512235|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
14512236|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512237|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512238|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14512239|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14512240|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
14512241|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512242|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512243|NCT03069677|Midazolam|midazolam|mesh-list
14512244|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14512245|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14512246|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512247|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512248|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14512249|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14512250|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14512251|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14512252|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
14512253|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
14512254|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
14512255|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
14512256|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512257|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512258|NCT03070171|Dabigatran|dabigatran|mesh-list
14948536|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948537|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948538|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
14948539|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14948540|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
14512259|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
14512260|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14512261|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
14512262|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512263|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512264|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
14512265|NCT03070470|Ritonavir|ritonavir|mesh-list
14512266|NCT03070470|Lopinavir|lopinavir|mesh-list
14512267|NCT03070470|Chloroquine|chloroquine|mesh-list
14512268|NCT03070470|Verapamil|verapamil|mesh-list
14512269|NCT03070470|Dofetilide|dofetilide|mesh-list
14512270|NCT03070470|Diltiazem|diltiazem|mesh-list
14512271|NCT03070470|Ranolazine|ranolazine|mesh-list
14512272|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14512273|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14512274|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
14512275|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512276|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512277|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14512278|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14512279|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
14512280|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512281|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14512282|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14512283|NCT03070470|Amebicides|amebicides|mesh-ancestor
14512284|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14512285|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14512286|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
14512287|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512288|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512289|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14512290|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14512291|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512292|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14512293|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
14512294|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14512295|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14512296|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14512297|NCT03070483|Vitamin D|vitamin d|mesh-list
14512298|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
14512299|NCT03070483|Vitamins|vitamins|mesh-ancestor
14512300|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
14512301|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512302|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14512303|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14512304|NCT03070548|Talazoparib|talazoparib|mesh-list
14948541|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
14512305|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14512306|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512307|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512308|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512309|NCT03070730|Atenolol|atenolol|mesh-list
14512310|NCT03070730|Droxidopa|droxidopa|mesh-list
14512311|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14512312|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14512313|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
14512314|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
14512315|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512316|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512317|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14512318|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14512319|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14512320|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512321|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512322|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512323|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14512324|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14528959|NCT03802864|Bupivacaine|bupivacaine|mesh-list
14528960|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
14528961|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
14528962|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528963|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528964|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
14528965|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528966|NCT03801265|Ropivacaine|ropivacaine|mesh-list
14528967|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
14528968|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
14528969|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528970|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528971|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
14528972|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528973|NCT03801928|Infliximab|infliximab|mesh-list
14528974|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
14528975|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14528976|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14528977|NCT03800173|Galidesivir|galidesivir|mesh-list
14528978|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
14528979|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14528980|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
14528981|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14528982|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14528983|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14528984|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14528985|NCT03799783|Analgesics|analgesics|mesh-ancestor
14528986|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
14528987|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14528988|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14528989|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14528990|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14528991|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
14528992|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14528993|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14528994|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
14528995|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
14528996|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14528997|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14528998|NCT03797872|Prednisolone|prednisolone|mesh-list
14528999|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
14529000|NCT03797872|Triamcinolone|triamcinolone|mesh-list
14529001|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14529002|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14529003|NCT03797872|Methotrexate|methotrexate|mesh-list
14529004|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14529005|NCT03797872|Leflunomide|leflunomide|mesh-list
14529006|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14529007|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
14529008|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14529009|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
14529010|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14529011|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529012|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14529013|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
14529014|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529015|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529016|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512325|NCT03071094|Nivolumab|nivolumab|mesh-list
14512326|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512327|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512328|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14512329|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512330|NCT03071263|Spironolactone|spironolactone|mesh-list
14512331|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14512332|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
14512333|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512334|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512335|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14512336|NCT03071263|Diuretics|diuretics|mesh-ancestor
14512337|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
14512338|NCT03071276|Vidarabine|vidarabine|mesh-list
14512339|NCT03071276|Cytarabine|cytarabine|mesh-list
14512340|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
14512341|NCT03071276|Methotrexate|methotrexate|mesh-list
14512342|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
14512343|NCT03071276|Fludarabine|fludarabine|mesh-list
14512344|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14512345|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
14512346|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14512347|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512348|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14512349|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
14512350|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512351|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512352|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512353|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512354|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14512355|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14512356|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
14512357|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512358|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14512359|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
14512360|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512361|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512362|NCT03071744|Fentanyl|fentanyl|mesh-list
14512363|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14512364|NCT03071744|Narcotics|narcotics|mesh-ancestor
14512365|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512366|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512367|NCT03071744|Analgesics|analgesics|mesh-ancestor
14512368|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
14512369|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512370|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14512371|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14512372|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
14512373|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
14512374|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
14512375|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512376|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512377|NCT03072719|Fluorides|fluorides|mesh-list
14512378|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
14512379|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
14512380|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
14512381|NCT03072719|Protective Agents|protective agents|mesh-ancestor
14512382|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512383|NCT03073200|Etanercept|etanercept|mesh-list
14512384|NCT03073200|Ixekizumab|ixekizumab|mesh-list
14512385|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14512386|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512387|NCT03073200|Analgesics|analgesics|mesh-ancestor
14512388|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
14512389|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512390|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512391|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512392|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512393|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512394|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14512395|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
14512396|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512397|NCT03073213|Ixekizumab|ixekizumab|mesh-list
14512398|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512399|NCT03073876|Donepezil|donepezil|mesh-list
14512400|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14512401|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512402|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512403|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
14512404|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512405|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512406|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
14512407|NCT03074162|Diclofenac|diclofenac|mesh-list
14512408|NCT03074162|Capsaicin|capsaicin|mesh-list
14512409|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14512410|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512411|NCT03074162|Analgesics|analgesics|mesh-ancestor
14512412|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
14512413|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512414|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512415|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512416|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512417|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14512418|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512419|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512420|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
14512421|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512422|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
14512423|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14512424|NCT03074331|Velpatasvir|velpatasvir|mesh-list
14512425|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
14512426|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512427|NCT03074409|Oxytocin|oxytocin|mesh-list
14512428|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
14512429|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14512430|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512431|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
14512432|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14512433|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14512434|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14512435|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
14512436|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512437|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14512438|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14512439|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512440|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14512441|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14512442|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512443|NCT03075163|Ondansetron|ondansetron|mesh-list
14512444|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
14512445|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
14512446|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512447|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512448|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512449|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
14512450|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512451|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14512452|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
14512453|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512454|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512455|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14512456|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14512457|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512458|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14512459|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14512460|NCT03075267|Budesonide|budesonide|mesh-list
14512461|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
14512462|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
14512463|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512464|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14512465|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
14512466|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512467|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512468|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14512469|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
14512470|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
14512471|NCT03075267|Hormones|hormones|mesh-ancestor
14512472|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512473|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14512474|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14512475|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512476|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512477|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512478|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512479|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14512480|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14512481|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14512482|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
14512483|NCT03075410|GSK656|gsk656|mesh-list
14512484|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14512485|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512486|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
14512487|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512488|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512489|NCT03075553|Nivolumab|nivolumab|mesh-list
14512490|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512491|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512492|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14512493|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512494|NCT03075891|Doxycycline|doxycycline|mesh-list
14512495|NCT03075891|Ivermectin|ivermectin|mesh-list
14512496|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14512497|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512498|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
14512499|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14512500|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14512501|NCT03076970|Sumatriptan|sumatriptan|mesh-list
14512502|NCT03076970|Lasmiditan|lasmiditan|mesh-list
14512503|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14512504|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14512505|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14512506|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
14512507|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512508|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512509|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512510|NCT03077607|Itraconazole|itraconazole|mesh-list
14512511|NCT03077607|Rifampin|rifampin|mesh-list
14512512|NCT03077607|Talazoparib|talazoparib|mesh-list
14512513|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
14512514|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512515|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14512516|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14512517|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512518|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512519|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14512520|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
14512521|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512522|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512523|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14512524|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14512525|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
14512526|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14512527|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
14512528|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14512529|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14512530|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14512531|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14512532|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14512533|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14512534|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14512535|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14512536|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512537|NCT03077659|Paclitaxel|paclitaxel|mesh-list
14512538|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14512539|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512540|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
14512541|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
14512542|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
14512543|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512544|NCT03077711|Trimethoprim|trimethoprim|mesh-list
14512545|NCT03077711|Methenamine|methenamine|mesh-list
14512546|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
14512547|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
14512548|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14512549|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512550|NCT03077711|Renal Agents|renal agents|mesh-ancestor
14512551|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
14512552|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14512553|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14512554|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14512555|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512556|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512557|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14512558|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14512559|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14512560|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14512561|NCT03077919|Ropivacaine|ropivacaine|mesh-list
14512562|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
14512563|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
14512564|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512565|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512566|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
14512567|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512568|NCT03078075|Naltrexone|naltrexone|mesh-list
14512569|NCT03078075|Bupropion|bupropion|mesh-list
14512570|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14512571|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14512572|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512573|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
14512574|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512575|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14512576|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
14512577|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14512578|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14512579|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14512580|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512581|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512582|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
14512583|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512584|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14512585|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14512586|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512587|NCT03078556|Lamivudine|lamivudine|mesh-list
14512588|NCT03078556|Dolutegravir|dolutegravir|mesh-list
14529017|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512589|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14512590|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14512591|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512592|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512593|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
14512594|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512595|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14512596|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14512597|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14512598|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14512599|NCT03078907|Selexipag|selexipag|mesh-list
14512600|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14512601|NCT03078946|Midazolam|midazolam|mesh-list
14512602|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
14512603|NCT03078946|Morphine|morphine|mesh-list
14512604|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14512605|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512606|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512607|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512608|NCT03078946|Analgesics|analgesics|mesh-ancestor
14512609|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
14512610|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512611|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14512612|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14512613|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512614|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512615|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512616|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512617|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14512618|NCT03078946|Narcotics|narcotics|mesh-ancestor
14512619|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14512620|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14512621|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14512622|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14512623|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14512624|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
14512625|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
14512626|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
14512627|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
14512628|NCT03080142|Bupivacaine|bupivacaine|mesh-list
14512629|NCT03080142|Ropivacaine|ropivacaine|mesh-list
14512630|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
14512631|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
14512632|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512633|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512634|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
14512635|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512636|NCT03080493|Acetaminophen|acetaminophen|mesh-list
14512637|NCT03080493|Ibuprofen|ibuprofen|mesh-list
14512638|NCT03080493|Gabapentin|gabapentin|mesh-list
14512639|NCT03080493|Codeine|codeine|mesh-list
14512640|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14512641|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512642|NCT03080493|Analgesics|analgesics|mesh-ancestor
14512643|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
14512644|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512645|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512646|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
14512647|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14512648|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512649|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512650|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14512651|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512652|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512653|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
14512654|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14512655|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14512656|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512657|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14512658|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14512659|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14948542|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14948543|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14512660|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512661|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
14512662|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14512663|NCT03080493|Narcotics|narcotics|mesh-ancestor
14512664|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
14512665|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
14512666|NCT03080493|Laxatives|laxatives|mesh-ancestor
14512667|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512668|NCT03081117|Insulin|insulin|mesh-list
14512669|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14512670|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512671|NCT03082196|Fluorides|fluorides|mesh-list
14512672|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
14512673|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
14512674|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
14512675|NCT03082196|Protective Agents|protective agents|mesh-ancestor
14512676|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512677|NCT03083132|Modafinil|modafinil|mesh-list
14512678|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14948544|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14948545|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512679|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512680|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14512681|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14512682|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14512683|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512684|NCT03083470|Paclitaxel|paclitaxel|mesh-list
14512685|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14512686|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512687|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14512688|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14512689|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14512690|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512691|NCT03083639|Esomeprazole|esomeprazole|mesh-list
14512692|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14512693|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512694|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14512695|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512696|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512697|NCT03083847|Chloroquine|chloroquine|mesh-list
14512698|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14512699|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
14512700|NCT03083847|Amebicides|amebicides|mesh-ancestor
14512701|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14512702|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14512703|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512704|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
14512705|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512706|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948546|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948547|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948548|NCT01533662|Protective Agents|protective agents|mesh-ancestor
14948549|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14948550|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14948551|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948552|NCT01533740|Leucovorin|leucovorin|mesh-list
14948553|NCT01533740|Folic Acid|folic acid|mesh-list
14948554|NCT01533740|Bevacizumab|bevacizumab|mesh-list
14948555|NCT01533740|Fluorouracil|fluorouracil|mesh-list
14948556|NCT01533740|Irinotecan|irinotecan|mesh-list
14948557|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
14948558|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948559|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948560|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14512707|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512708|NCT03083847|Analgesics|analgesics|mesh-ancestor
14948561|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14948562|NCT01533740|Growth Substances|growth substances|mesh-ancestor
14512709|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
14512710|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512711|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512712|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512713|NCT03083847|Filaricides|filaricides|mesh-ancestor
14512714|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
14512715|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
14512716|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14512717|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512718|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512719|NCT03083990|Bevacizumab|bevacizumab|mesh-list
14512720|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512721|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512722|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14512723|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14512724|NCT03083990|Growth Substances|growth substances|mesh-ancestor
14512725|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512726|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
14512727|NCT03084315|Nicotine|nicotine|mesh-list
14512728|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14512729|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
14512730|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512731|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512732|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14512733|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14512734|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
14512735|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512736|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512737|NCT03084796|Bromides|bromides|mesh-list
14512738|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
14512739|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14512740|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
14512741|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512742|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512743|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14512744|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
14512745|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
14512746|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14512747|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
14512748|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512749|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512750|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
14512751|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
14512752|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512753|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
14512754|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14512755|NCT03085914|Leucovorin|leucovorin|mesh-list
14512756|NCT03085914|Gemcitabine|gemcitabine|mesh-list
14512757|NCT03085914|Paclitaxel|paclitaxel|mesh-list
14512758|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14512759|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
14512760|NCT03085914|Carboplatin|carboplatin|mesh-list
14512761|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
14512762|NCT03085914|Fluorouracil|fluorouracil|mesh-list
14512763|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
14512764|NCT03085914|Pemetrexed|pemetrexed|mesh-list
14512765|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14512766|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512767|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
14512768|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
14512769|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
14512770|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512771|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14512772|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
14512773|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512774|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512775|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14512776|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
14512777|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14512778|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14512779|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
14512780|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
14512781|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512782|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512783|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512784|NCT03085914|Antidotes|antidotes|mesh-ancestor
14512785|NCT03085914|Protective Agents|protective agents|mesh-ancestor
14512786|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
14512787|NCT03085914|Vitamins|vitamins|mesh-ancestor
14512788|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
14512789|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14512790|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14529018|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14529019|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14529020|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
14529021|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14529022|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14529023|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529024|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
14529025|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
14529026|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529027|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529028|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
14529029|NCT03797872|Hormones|hormones|mesh-ancestor
14529030|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529031|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14529032|NCT03797872|Protective Agents|protective agents|mesh-ancestor
14529033|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14529034|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529035|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14529036|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529037|NCT03797872|Analgesics|analgesics|mesh-ancestor
14529038|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
14529039|NCT03799484|Lidocaine|lidocaine|mesh-list
14529040|NCT03799484|Prilocaine|prilocaine|mesh-list
14529041|NCT03799484|Petrolatum|petrolatum|mesh-list
14529042|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
14529043|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14529044|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14529045|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
14529046|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
14529047|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529048|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529049|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
14529050|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529051|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14529052|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14529053|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14529054|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529055|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529056|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14529057|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
14529058|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529059|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14529060|NCT03799484|Emollients|emollients|mesh-ancestor
14529061|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
14529062|NCT03796728|Lidocaine|lidocaine|mesh-list
14529063|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
14529064|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
14529065|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529066|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529067|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
14529068|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529069|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14529070|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14791643|NCT00742092|Miglustat|miglustat|mesh-list
14791644|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791645|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791646|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14529071|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14529072|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529073|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529074|NCT03796260|Entrectinib|entrectinib|mesh-list
14529075|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14529076|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791647|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14512791|NCT03086213|Lidocaine|lidocaine|mesh-list
14512792|NCT03086213|Sufentanil|sufentanil|mesh-list
14512793|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
14512794|NCT03086213|Dsuvia|dsuvia|mesh-list
14512795|NCT03086213|Ropivacaine|ropivacaine|mesh-list
14512796|NCT03086213|Propofol|propofol|mesh-list
14512797|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
14512798|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
14512799|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512800|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512801|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
14512802|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512803|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14512804|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14512805|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14512806|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512807|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512808|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14512809|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14512810|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
14512811|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512812|NCT03086213|Analgesics|analgesics|mesh-ancestor
14512813|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14512814|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14512815|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512816|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512817|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512818|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14512819|NCT03086213|Narcotics|narcotics|mesh-ancestor
14512820|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14512821|NCT03086343|Abatacept|abatacept|mesh-list
14512822|NCT03086343|Upadacitinib|upadacitinib|mesh-list
14512823|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14512824|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512825|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512826|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14512827|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
14512828|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512829|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512830|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14512831|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14512832|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512833|NCT03086356|Dabigatran|dabigatran|mesh-list
14512834|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
14512835|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14512836|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
14512837|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512838|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512839|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
14512840|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
14512841|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14512842|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
14512843|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512844|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512845|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14512846|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
14512847|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14512848|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14512849|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512850|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512851|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512852|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512853|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
14512854|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512855|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512856|NCT03087604|Lidocaine|lidocaine|mesh-list
14512857|NCT03087604|Epinephrine|epinephrine|mesh-list
14512858|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
14512859|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
14512860|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512861|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512862|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
14512863|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512864|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14512865|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14512866|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14512867|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512868|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512869|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14512870|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14512871|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512872|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512873|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14512874|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14512875|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
14512876|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14512877|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
14512878|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
14512879|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
14512880|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14512881|NCT03087786|Nicotine|nicotine|mesh-list
14512882|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14512883|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
14512884|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512885|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512886|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14512887|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14512888|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
14512889|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512890|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512891|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
14512892|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14512893|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512894|NCT03088267|Amphetamine|amphetamine|mesh-list
14512895|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14512896|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512897|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
14512898|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
14512899|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512900|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
14512901|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512902|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512903|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512904|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14512905|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14512906|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512907|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14512908|NCT03088345|Vasopressins|vasopressins|mesh-list
14512909|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
14512910|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
14512911|NCT03088345|Coagulants|coagulants|mesh-ancestor
14512912|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14512913|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14512914|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
14512915|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512916|NCT03088800|Ibuprofen|ibuprofen|mesh-list
14512917|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14512918|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14512919|NCT03088800|Analgesics|analgesics|mesh-ancestor
14512920|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
14512921|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512922|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512923|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14512924|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14512925|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14512926|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512927|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512928|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
14512929|NCT03089216|Calcium|calcium|mesh-list
14512930|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14512931|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512932|NCT03089216|Antacids|antacids|mesh-ancestor
14512933|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512934|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512935|NCT03090620|Lorazepam|lorazepam|mesh-list
14512936|NCT03090620|Physostigmine|physostigmine|mesh-list
14512937|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
14512938|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
14512939|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
14512940|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14512941|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512942|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512943|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14512944|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14512945|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14512946|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14512947|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14512948|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
14512949|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
14512950|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512951|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512952|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14512953|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14512954|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
14512955|NCT03090620|Miotics|miotics|mesh-ancestor
14512956|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
14512957|NCT03091348|Testosterone|testosterone|mesh-list
14512958|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
14512959|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
14512960|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14512961|NCT03091348|Androgens|androgens|mesh-ancestor
14512962|NCT03091348|Hormones|hormones|mesh-ancestor
14512963|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512964|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512965|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14512966|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512967|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
14512968|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14512969|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14512970|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14512971|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14512972|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512973|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
14512974|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14512975|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512976|NCT03091439|Dalbavancin|dalbavancin|mesh-list
14512977|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14512978|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512979|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
14512980|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14512981|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14512982|NCT03091673|Glucagon|glucagon|mesh-list
14512983|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14512984|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512985|NCT03091673|Hormones|hormones|mesh-ancestor
14512986|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14512987|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14512988|NCT03091673|Incretins|incretins|mesh-ancestor
14512989|NCT03091777|Metronidazole|metronidazole|mesh-list
14512990|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14512991|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14512992|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14512993|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14512994|NCT03091920|Praliciguat|praliciguat|mesh-list
14512995|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14512996|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
14512997|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14512998|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14512999|NCT03092375|Ribavirin|ribavirin|mesh-list
14513000|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
14791648|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
14513001|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513002|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
14513003|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513004|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14513005|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513006|NCT03093207|Aspirin|aspirin|mesh-list
14513007|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14513008|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513009|NCT03093207|Analgesics|analgesics|mesh-ancestor
14948563|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948564|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
14948565|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
14948566|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948567|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14948568|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948569|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
14948570|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14948571|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14948572|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948573|NCT01533740|Antidotes|antidotes|mesh-ancestor
14948574|NCT01533740|Protective Agents|protective agents|mesh-ancestor
14948575|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
14948576|NCT01533740|Vitamins|vitamins|mesh-ancestor
14948577|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
14948578|NCT01533740|Hematinics|hematinics|mesh-ancestor
14948579|NCT01533818|Amoxicillin|amoxicillin|mesh-list
14948580|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948581|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948582|NCT01533870|Rifampin|rifampin|mesh-list
14948583|NCT01533870|Naloxegol|naloxegol|mesh-list
14948584|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14948585|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
14948586|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948587|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513010|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
14513011|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513012|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513013|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513014|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14513015|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14513016|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14513017|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513018|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14513019|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14513020|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513021|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
14513022|NCT03093272|Prednisone|prednisone|mesh-list
14513023|NCT03093272|Docetaxel|docetaxel|mesh-list
14513024|NCT03093272|Leuprolide|leuprolide|mesh-list
14513025|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513026|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
14513027|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
14513028|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
14513029|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513030|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513031|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
14513032|NCT03093272|Hormones|hormones|mesh-ancestor
14513033|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513034|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513035|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14513036|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14513037|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
14513038|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14513039|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14513040|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513041|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14513042|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
14513043|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513044|NCT03093415|Grazoprevir|grazoprevir|mesh-list
14513045|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
14513046|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513047|NCT03093870|Capecitabine|capecitabine|mesh-list
14513048|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14513049|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
14948588|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
14948589|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14948590|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513050|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513051|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513052|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14513053|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14513054|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513055|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14513056|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
14513057|NCT03094637|Azacitidine|azacitidine|mesh-list
14513058|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14513059|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513060|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14513061|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
14513062|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513063|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513064|NCT03095118|Daratumumab|daratumumab|mesh-list
14513065|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513066|NCT03095508|Menthol|menthol|mesh-list
14513067|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
14513068|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513069|NCT03095521|Menthol|menthol|mesh-list
14513070|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
14513071|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513072|NCT03095638|Dolutegravir|dolutegravir|mesh-list
14513073|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14513074|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14513075|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513076|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513077|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14513078|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14513079|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
14513080|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513081|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
14513082|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513083|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513084|NCT03096314|Vitamin D|vitamin d|mesh-list
14513085|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
14513086|NCT03096314|Vitamins|vitamins|mesh-ancestor
14513087|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
14513088|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513089|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14513090|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14513091|NCT03096353|Naloxone|naloxone|mesh-list
14513092|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14513093|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513094|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
14513095|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513096|NCT03096444|Lidocaine|lidocaine|mesh-list
14513097|NCT03096444|Ketamine|ketamine|mesh-list
14513098|NCT03096444|Amitriptyline|amitriptyline|mesh-list
14513099|NCT03096444|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14513100|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513101|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
14513102|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513103|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513104|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
14513105|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513106|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14513107|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513108|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14513109|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513110|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513111|NCT03096444|Analgesics|analgesics|mesh-ancestor
14513112|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14513113|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14513114|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
14513115|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14513116|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14513117|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513118|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14513119|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
14513120|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14513121|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513122|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14513123|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14513124|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14513125|NCT03096444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14513126|NCT03096444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14513127|NCT03096730|Sufentanil|sufentanil|mesh-list
14513128|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
14513129|NCT03096730|Remifentanil|remifentanil|mesh-list
14513130|NCT03096730|Dsuvia|dsuvia|mesh-list
14513131|NCT03096730|Nalmefene|nalmefene|mesh-list
14513132|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14513133|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513134|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513135|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513136|NCT03096730|Analgesics|analgesics|mesh-ancestor
14513137|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
14513138|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513139|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14513140|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14513141|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14513142|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
14513143|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513144|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513145|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14513146|NCT03096730|Narcotics|narcotics|mesh-ancestor
14513147|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14513148|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14513149|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
14513150|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
14513151|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14513152|NCT03096847|Letrozole|letrozole|mesh-list
14513153|NCT03096847|Goserelin|goserelin|mesh-list
14513154|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513155|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14513156|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14513157|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513158|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513159|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14513160|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
14513161|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513162|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513163|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14513164|NCT03097133|Esketamine|esketamine|mesh-list
14513165|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
14513166|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14513167|NCT03097315|Triamcinolone|triamcinolone|mesh-list
14513168|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14513169|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14513170|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14513171|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513172|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
14513173|NCT03097315|Hormones|hormones|mesh-ancestor
14513174|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513175|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513176|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14513177|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
14513178|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513179|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513180|NCT03097588|Palonosetron|palonosetron|mesh-list
14513181|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
14513182|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
14513183|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513184|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513185|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513186|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14513187|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14513188|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
14513189|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513190|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513191|NCT03097783|Lidocaine|lidocaine|mesh-list
14513192|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513193|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
14513194|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513195|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513196|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
14513197|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513198|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14513199|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513200|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14513201|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513202|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513203|NCT03097861|Lubiprostone|lubiprostone|mesh-list
14513204|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14513205|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513206|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513207|NCT03098030|Irinotecan|irinotecan|mesh-list
14513208|NCT03098030|Topotecan|topotecan|mesh-list
14513209|NCT03098030|Dinutuximab|dinutuximab|mesh-list
14513210|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14513211|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14513212|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513213|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513214|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513215|NCT03098420|Dexamethasone|dexamethasone|mesh-list
14513216|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
14513217|NCT03098420|Morphine|morphine|mesh-list
14513218|NCT03098420|Bupivacaine|bupivacaine|mesh-list
14513219|NCT03098420|Ropivacaine|ropivacaine|mesh-list
14513220|NCT03098420|BB 1101|bb 1101|mesh-list
14513221|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513222|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
14513223|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
14513224|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513225|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513226|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513227|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
14513228|NCT03098420|Hormones|hormones|mesh-ancestor
14513229|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513230|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14513231|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513232|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
14513233|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513234|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513235|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513236|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
14513237|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513238|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
14513239|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14513240|NCT03098420|Narcotics|narcotics|mesh-ancestor
14513241|NCT03098420|Analgesics|analgesics|mesh-ancestor
14791649|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791650|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14529077|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513242|NCT03098550|Nivolumab|nivolumab|mesh-list
14513243|NCT03098550|Daratumumab|daratumumab|mesh-list
14513244|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14513245|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513246|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14513247|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513248|NCT03098615|Efinaconazole|efinaconazole|mesh-list
14513249|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
14513250|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513251|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
14513252|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14513253|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513254|NCT03099187|Pirfenidone|pirfenidone|mesh-list
14513255|NCT03099187|Analgesics|analgesics|mesh-ancestor
14513256|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
14513257|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513258|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513259|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14513260|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513261|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513262|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14513263|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513264|NCT03099538|Ixekizumab|ixekizumab|mesh-list
14513265|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513266|NCT03100058|Licogliflozin|licogliflozin|mesh-list
14513267|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14513268|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513269|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513270|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513271|NCT03100123|Aspirin|aspirin|mesh-list
14513272|NCT03100123|Heparin|heparin|mesh-list
14513273|NCT03100123|Enoxaparin|enoxaparin|mesh-list
14513274|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14513275|NCT03100123|Tinzaparin|tinzaparin|mesh-list
14513276|NCT03100123|Dalteparin|dalteparin|mesh-list
14513277|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14513278|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513279|NCT03100123|Analgesics|analgesics|mesh-ancestor
14513280|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
15027113|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14513281|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513282|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513283|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513284|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14513285|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14513286|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14513287|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513288|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14513289|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14513290|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513291|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
14513292|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
14513293|NCT03100838|Nifedipine|nifedipine|mesh-list
14513294|NCT03100838|Omeprazole|omeprazole|mesh-list
14513295|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14513296|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513297|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14513298|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513299|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513300|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14513301|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513302|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14513303|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513304|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
14513305|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
14513306|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14513307|NCT03101033|Betamethasone|betamethasone|mesh-list
14513308|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
14513309|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14513310|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
14513311|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14513312|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513313|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
14513314|NCT03101033|Hormones|hormones|mesh-ancestor
14513315|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529078|NCT03780959|Etanercept|etanercept|mesh-list
14513316|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513317|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14513318|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
14513319|NCT03101111|Vaccines|vaccines|mesh-list
14513320|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
14513321|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513322|NCT03101150|Vitamin D|vitamin d|mesh-list
14513323|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
14513324|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
14513325|NCT03101150|Vitamins|vitamins|mesh-list
14513326|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
14513327|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513328|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14513329|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14513330|NCT03101358|Paclitaxel|paclitaxel|mesh-list
14513331|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14513332|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14513333|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513334|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
14513335|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
14513336|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
14513337|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513338|NCT03101371|Iodine|iodine|mesh-list
14513339|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
14513340|NCT03101371|Povidone|povidone|mesh-list
14513341|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14513342|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513343|NCT03101371|Trace Elements|trace elements|mesh-ancestor
14513344|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
14513345|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513346|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
14513347|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
14513348|NCT03101462|Vaccines|vaccines|mesh-list
14513349|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
14513350|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513351|NCT03102190|Verapamil|verapamil|mesh-list
14513352|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14513353|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14513354|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513355|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513356|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14513357|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513358|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
14513359|NCT03102645|Imipramine|imipramine|mesh-list
14513360|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14513361|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
14513362|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14513363|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14513364|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14513365|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513366|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513367|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
14513368|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513369|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513370|NCT03102710|Lidocaine|lidocaine|mesh-list
14513371|NCT03102710|Capsaicin|capsaicin|mesh-list
14513372|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513373|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
14513374|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513375|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513376|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
14513377|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513378|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14513379|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513380|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14513381|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513382|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513383|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
14513384|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513385|NCT03102736|Nitroprusside|nitroprusside|mesh-list
14513386|NCT03102736|Ketamine|ketamine|mesh-list
15027114|NCT01947790|Metformin|metformin|mesh-list
14513387|NCT03102736|Analgesics|analgesics|mesh-ancestor
14513388|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
14513389|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791651|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513390|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513391|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14513392|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14513393|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
14513394|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
14513395|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513396|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14513397|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14513398|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513399|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513400|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14513401|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14513402|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14513403|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
14513404|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14513405|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14513406|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14513407|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513408|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513409|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
14513410|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513411|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513412|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13965180|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13965181|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965182|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513413|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513414|NCT03102918|Cannabidiol|cannabidiol|mesh-list
14513415|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
14513416|NCT03103061|Regadenoson|regadenoson|mesh-list
14513417|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14513418|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14513419|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
14513420|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
14513421|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513422|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513423|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513424|NCT03103100|Lidocaine|lidocaine|mesh-list
14513425|NCT03103100|Bupivacaine|bupivacaine|mesh-list
14513426|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513427|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
14513428|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513429|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513430|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
14513431|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513432|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14513433|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513434|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14513435|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513436|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513437|NCT03103763|Warfarin|warfarin|mesh-list
14513438|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
13965183|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965184|NCT03132103|Vitamin D|vitamin d|mesh-list
13965185|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
13965186|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
13965187|NCT03132103|Vitamins|vitamins|mesh-list
13965188|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
13965189|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235274|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14235275|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235276|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14235277|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14235278|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14235279|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14235280|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235281|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235282|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235283|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235284|NCT00105989|Analgesics|analgesics|mesh-ancestor
14235285|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
14513439|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
14513440|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14513441|NCT03103906|Protective Agents|protective agents|mesh-ancestor
14513442|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513443|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513444|NCT03103919|Rotigotine|rotigotine|mesh-list
14513445|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
14513446|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
14513447|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513448|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513449|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513450|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
14513451|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14513452|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
14513453|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513454|NCT03104725|Expectorants|expectorants|mesh-ancestor
14948591|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948592|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14948593|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14948594|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14948595|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14948596|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14948597|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14948598|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14948599|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948600|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
14513455|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
14513456|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14948601|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513457|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
14513458|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513459|NCT03104725|Protective Agents|protective agents|mesh-ancestor
14513460|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513461|NCT03104725|Antidotes|antidotes|mesh-ancestor
14513462|NCT03104738|Insulin|insulin|mesh-list
14513463|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513464|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513465|NCT03104816|Acetaminophen|acetaminophen|mesh-list
14513466|NCT03104816|Hydromorphone|hydromorphone|mesh-list
14513467|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513468|NCT03104816|Analgesics|analgesics|mesh-ancestor
14513469|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
14513470|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513471|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513472|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
14513473|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14513474|NCT03104816|Narcotics|narcotics|mesh-ancestor
14513475|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513476|NCT03105479|Vancomycin|vancomycin|mesh-list
14513477|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14513478|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513479|NCT03105518|Acetaminophen|acetaminophen|mesh-list
14513480|NCT03105518|Fentanyl|fentanyl|mesh-list
14513481|NCT03105518|Oxycodone|oxycodone|mesh-list
14513482|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14513483|NCT03105518|Narcotics|narcotics|mesh-ancestor
14513484|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513485|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513486|NCT03105518|Analgesics|analgesics|mesh-ancestor
14513487|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
14513488|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513489|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14513490|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14513491|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
14513492|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
14513493|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513494|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
14513495|NCT03106077|Maytansine|maytansine|mesh-list
14513496|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14513497|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513498|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
14513499|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
14513500|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
14513501|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513502|NCT03106753|Bupivacaine|bupivacaine|mesh-list
14513503|NCT03106753|Terbutaline|terbutaline|mesh-list
14513504|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513505|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
14513506|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513507|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513508|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
14513509|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513510|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14513511|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
14513512|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14513513|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
14513514|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
14513515|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
14513516|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14513517|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14513518|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14513519|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14513520|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
14513521|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513522|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513523|NCT03106870|Insulin|insulin|mesh-list
14513524|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14513525|NCT03106870|Metformin|metformin|mesh-list
14513526|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
14513527|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513528|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513529|NCT03107091|Terlipressin|terlipressin|mesh-list
14513530|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14513531|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14513532|NCT03107754|Lidocaine|lidocaine|mesh-list
14513533|NCT03107754|Anesthetics|anesthetics|mesh-list
14513534|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513535|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513536|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513537|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
14513538|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513539|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14791652|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791653|NCT00742144|Ofatumumab|ofatumumab|mesh-list
14513540|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513541|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14791654|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791655|NCT00742157|Hormones|hormones|mesh-list
14948602|NCT01534026|Aspirin|aspirin|mesh-list
14513542|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513543|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513544|NCT03107793|Ustekinumab|ustekinumab|mesh-list
14513545|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513546|NCT03108482|Celecoxib|celecoxib|mesh-list
14513547|NCT03108482|Tramadol|tramadol|mesh-list
14513548|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14513549|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513550|NCT03108482|Analgesics|analgesics|mesh-ancestor
13965190|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13965191|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14513551|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
14513552|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513553|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513554|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513555|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14513556|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14513557|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14513558|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513559|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513560|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14513561|NCT03108482|Narcotics|narcotics|mesh-ancestor
14513562|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513563|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14513564|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513565|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513566|NCT03108521|Incretins|incretins|mesh-ancestor
14513567|NCT03108521|Hormones|hormones|mesh-ancestor
14513568|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513569|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14513570|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
14513571|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513572|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513573|NCT03109015|Sunitinib|sunitinib|mesh-list
14513574|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513575|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14513576|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14513577|NCT03109015|Growth Substances|growth substances|mesh-ancestor
14513578|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513579|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
14513580|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14513581|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513582|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513583|NCT03110003|Bupivacaine|bupivacaine|mesh-list
14513584|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513585|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
14513586|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513587|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513588|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
14513589|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513590|NCT03110029|Efinaconazole|efinaconazole|mesh-list
14513591|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
14513592|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513593|NCT03110562|Dexamethasone|dexamethasone|mesh-list
14513594|NCT03110562|Bortezomib|bortezomib|mesh-list
14513595|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513596|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
14513597|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
14513598|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513599|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513600|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513601|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
14513602|NCT03110562|Hormones|hormones|mesh-ancestor
14513603|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513604|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14513605|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513606|NCT03111108|Grazoprevir|grazoprevir|mesh-list
14513607|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
14513608|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513609|NCT03111316|Dinoprostone|dinoprostone|mesh-list
14513610|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
14513611|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14513612|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513613|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14513614|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14513615|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513616|NCT03111381|Analgesics|analgesics|mesh-ancestor
14513617|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
14791656|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513618|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513619|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513620|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513621|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14513622|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14513623|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513624|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529079|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14529080|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529081|NCT03780959|Analgesics|analgesics|mesh-ancestor
14529082|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
14529083|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529084|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529085|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529086|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14529087|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529088|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14529089|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
14529090|NCT03796182|Metformin|metformin|mesh-list
14529091|NCT03796182|Abrocitinib|abrocitinib|mesh-list
14529092|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14529093|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529094|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14529095|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529096|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529097|NCT03796013|Entrectinib|entrectinib|mesh-list
14529098|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14529099|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529100|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529101|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
14529102|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14529103|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529104|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529105|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529106|NCT03793751|Analgesics|analgesics|mesh-ancestor
14529107|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
14529108|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529109|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14529110|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14529111|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14529112|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
14529113|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529114|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529115|NCT03793556|Omeprazole|omeprazole|mesh-list
14529116|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14529117|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529118|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14529119|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529120|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529121|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14529122|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14529123|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14529124|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14529125|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14529126|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14529127|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14529128|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
13965192|NCT03132116|Gentamicins|gentamicins|mesh-list
14529129|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529130|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513625|NCT03111628|Omalizumab|omalizumab|mesh-list
14513626|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14513627|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14513628|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
14513629|NCT03112863|Vitamin A|vitamin a|mesh-list
14513630|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
14513631|NCT03112863|Vitamins|vitamins|mesh-ancestor
14513632|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
14513633|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513634|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
14513635|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513636|NCT03112863|Protective Agents|protective agents|mesh-ancestor
14513637|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14513638|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513639|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14513640|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
14513641|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14513642|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14513643|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
14513644|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14513645|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
14513646|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513647|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513648|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
14513649|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14513650|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
14513651|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513652|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513653|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
14513654|NCT03114969|Hormones|hormones|mesh-ancestor
14948603|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948604|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948605|NCT01534026|Analgesics|analgesics|mesh-ancestor
14948606|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
14948607|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948608|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948609|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513655|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513656|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
14513657|NCT03114995|Tirofiban|tirofiban|mesh-list
14513658|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14513659|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14513660|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513661|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14513662|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14513663|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
14513664|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513665|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513666|NCT03115112|Incretins|incretins|mesh-ancestor
14513667|NCT03115112|Hormones|hormones|mesh-ancestor
14513668|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513669|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14513670|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
14513671|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513672|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513673|NCT03115177|Doxycycline|doxycycline|mesh-list
14513674|NCT03115177|Cefazolin|cefazolin|mesh-list
14513675|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14513676|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513677|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
14513678|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14513679|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14513680|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
14513681|NCT03115801|Nivolumab|nivolumab|mesh-list
14513682|NCT03115801|Atezolizumab|atezolizumab|mesh-list
14513683|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
14513684|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14513685|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513686|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14513687|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513688|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513689|NCT03115827|Carbidopa|carbidopa|mesh-list
14513690|NCT03115827|Droxidopa|droxidopa|mesh-list
14513691|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14513692|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14513693|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
14513694|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513695|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513696|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513697|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14513698|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513699|NCT03116152|Paclitaxel|paclitaxel|mesh-list
14513700|NCT03116152|Irinotecan|irinotecan|mesh-list
14513701|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14513702|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513703|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
14513704|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
14513705|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
14513706|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513707|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14513708|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14513709|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513710|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14513711|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
14513712|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513713|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14513714|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513715|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513716|NCT03117140|Dexamethasone|dexamethasone|mesh-list
14513717|NCT03117140|Clonidine|clonidine|mesh-list
14513718|NCT03117140|Buprenorphine|buprenorphine|mesh-list
14513719|NCT03117140|Ropivacaine|ropivacaine|mesh-list
14513720|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513721|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
14513722|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
14513723|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513724|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513725|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513726|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
14513727|NCT03117140|Hormones|hormones|mesh-ancestor
14513728|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513729|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14513730|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513731|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513732|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
14513733|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513734|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
14513735|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14513736|NCT03117140|Narcotics|narcotics|mesh-ancestor
14513737|NCT03117140|Analgesics|analgesics|mesh-ancestor
14513738|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14513739|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14513740|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
14513741|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14513742|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14513743|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14513744|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
14513745|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513746|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513747|NCT03117361|Dexamethasone|dexamethasone|mesh-list
14513748|NCT03117361|Bortezomib|bortezomib|mesh-list
14513749|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513750|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
14513751|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
14513752|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513753|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513754|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513755|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
14513756|NCT03117361|Hormones|hormones|mesh-ancestor
14513757|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513758|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14513759|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513760|NCT03117517|Metformin|metformin|mesh-list
14513761|NCT03117517|Pioglitazone|pioglitazone|mesh-list
14513762|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14513763|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513764|NCT03117634|Aflibercept|aflibercept|mesh-list
14513765|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14513766|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14513767|NCT03117634|Growth Substances|growth substances|mesh-ancestor
14513768|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513769|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
14513770|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513771|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
14513772|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14513773|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
14513774|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14513775|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513776|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14513777|NCT03118466|Cytarabine|cytarabine|mesh-list
14513778|NCT03118466|Etoposide|etoposide|mesh-list
14513779|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
14513780|NCT03118466|Lenalidomide|lenalidomide|mesh-list
14513781|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14513782|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513783|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14513784|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14513785|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513786|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513787|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14513788|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
14513789|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
14513790|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513791|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14513792|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
14513793|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513794|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14513795|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14513796|NCT03118466|Growth Substances|growth substances|mesh-ancestor
14513797|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
14513798|NCT03118466|Analgesics|analgesics|mesh-ancestor
14513799|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
14513800|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513801|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14513802|NCT03118739|Febuxostat|febuxostat|mesh-list
14513803|NCT03118739|Verinurad|verinurad|mesh-list
14513804|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
14513805|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14513806|NCT03118765|Bromides|bromides|mesh-list
14513807|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14513808|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
14513809|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14513810|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
14513811|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513812|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513813|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14513814|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
14513815|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
14513816|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14513817|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
14513818|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513819|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513820|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
14513821|NCT03118843|Velpatasvir|velpatasvir|mesh-list
14513822|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
14513823|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513824|NCT03118947|Pimavanserin|pimavanserin|mesh-list
14513825|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14513826|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14513827|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14513828|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14513829|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513830|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513831|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14513832|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14948610|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948611|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14948612|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14948613|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948614|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14948615|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14948616|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948617|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
14948618|NCT01534169|Dexamethasone|dexamethasone|mesh-list
14513833|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14513834|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
14513835|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513836|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513837|NCT03119168|Simethicone|simethicone|mesh-list
14948619|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948620|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
14513838|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
14513839|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513840|NCT03119168|Emollients|emollients|mesh-ancestor
14513841|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513842|NCT03119181|Lidocaine|lidocaine|mesh-list
14513843|NCT03119181|Epinephrine|epinephrine|mesh-list
14513844|NCT03119181|Racepinephrine|racepinephrine|mesh-list
14513845|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14513846|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
14513847|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
14513848|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
14513849|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513850|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513851|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
14513852|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513853|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14513854|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513855|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14513856|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513857|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513858|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14513859|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14513860|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
14513861|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513862|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14513863|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14513864|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
14513865|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14513866|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
14513867|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
14513868|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
14513869|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14513870|NCT03119610|Oxytocin|oxytocin|mesh-list
14513871|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
14513872|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14513873|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513874|NCT03119701|Interferons|interferons|mesh-list
14513875|NCT03119701|Interferon-beta|interferon-beta|mesh-list
14513876|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
14948621|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
14513877|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513878|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
14513879|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513880|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
14513881|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513882|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14513883|NCT03119831|Ethanol|ethanol|mesh-list
14513884|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
14513885|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14513886|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14513887|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513888|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513889|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513890|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
14513891|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513892|NCT03120351|Lidocaine|lidocaine|mesh-list
14513893|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
14948622|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948623|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513894|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
14513895|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14513896|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513897|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
14513898|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513899|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14513900|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14513901|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14513902|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14513903|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513904|NCT03120520|Plecanatide|plecanatide|mesh-list
14513905|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14513906|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
14513907|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513908|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513909|NCT03121820|Memantine|memantine|mesh-list
14513910|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14513911|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14513912|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
14513913|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14513914|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513915|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513916|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14513917|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14513918|NCT03122145|Capsaicin|capsaicin|mesh-list
14513919|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
14513920|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513921|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
14513922|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513923|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513924|NCT03122457|C 1027|c 1027|mesh-list
14513925|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14513926|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
14513927|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14513928|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513929|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
14513930|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14513931|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513932|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
14513933|NCT03122587|Vitamins|vitamins|mesh-ancestor
14513934|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
14513935|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513936|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14513937|NCT03122860|Lorecivivint|lorecivivint|mesh-list
14513938|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513939|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14513940|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
14513941|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14513942|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14513943|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
14513944|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948624|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513945|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513946|NCT03123471|Apremilast|apremilast|mesh-list
14513947|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14513948|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14513949|NCT03123471|Analgesics|analgesics|mesh-ancestor
14513950|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
14513951|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513952|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513953|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513954|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14513955|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14513956|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14513957|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513958|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513959|NCT03123588|Anagrelide|anagrelide|mesh-list
14513960|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14513961|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14513962|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513963|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14513964|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14513965|NCT03123614|Prednisolone|prednisolone|mesh-list
14513966|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14513967|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
14513968|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14513969|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
14513970|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14513971|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
14513972|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14513973|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
14513974|NCT03123614|Hormones|hormones|mesh-ancestor
14513975|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14513976|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14513977|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14513978|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14513979|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
14513980|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
14513981|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14513982|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14513983|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14513984|NCT03123614|Protective Agents|protective agents|mesh-ancestor
14513985|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14513986|NCT03123848|Darunavir|darunavir|mesh-list
14513987|NCT03123848|Cobicistat|cobicistat|mesh-list
14513988|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14513989|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14513990|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
14513991|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14513992|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14513993|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14513994|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14513995|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
14513996|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14513997|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14513998|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14513999|NCT03123861|Gabapentin|gabapentin|mesh-list
14514000|NCT03123861|Analgesics|analgesics|mesh-ancestor
14514001|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
14514002|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514003|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514004|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
14514005|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14514006|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14514007|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514008|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14514009|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14514010|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14514011|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514012|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514013|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
14514014|NCT03124121|Golimumab|golimumab|mesh-list
14514015|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14514016|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514017|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948625|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
13965193|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14514018|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
14514019|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514020|NCT03124199|Rifaximin|rifaximin|mesh-list
14514021|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14514022|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514023|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514024|NCT03124407|Capsaicin|capsaicin|mesh-list
14514025|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
14514026|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514027|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
14514028|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514029|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529131|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529132|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
14529133|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
14529134|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
14529135|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529136|NCT03792672|Ketamine|ketamine|mesh-list
14529137|NCT03792672|Analgesics|analgesics|mesh-ancestor
14529138|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
14529139|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529140|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529141|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14529142|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14529143|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
14529144|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
14529145|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529146|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14529147|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14529148|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529149|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529150|NCT03792191|Fentanyl|fentanyl|mesh-list
14529151|NCT03792191|Bupivacaine|bupivacaine|mesh-list
14529152|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
14529153|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
14529154|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529155|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529156|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
14529157|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529158|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14529159|NCT03792191|Narcotics|narcotics|mesh-ancestor
14529160|NCT03792191|Analgesics|analgesics|mesh-ancestor
14529161|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14529162|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14529163|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
14529164|NCT03789175|Niacinamide|niacinamide|mesh-list
14529165|NCT03789175|Niacin|niacin|mesh-list
14529166|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
14529167|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
14529168|NCT03789175|Vitamins|vitamins|mesh-ancestor
14529169|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
14529170|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529171|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14529172|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
14529173|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529174|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14529175|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
14529176|NCT03783702|Acetaminophen|acetaminophen|mesh-list
14529177|NCT03783702|Ibuprofen|ibuprofen|mesh-list
14529178|NCT03783702|Oxycodone|oxycodone|mesh-list
14529179|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529180|NCT03783702|Analgesics|analgesics|mesh-ancestor
14529181|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
14529182|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529183|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529184|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
14529185|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14529186|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529187|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14529188|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14529189|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529190|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529191|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14529192|NCT03783702|Narcotics|narcotics|mesh-ancestor
14514030|NCT03125395|Ivacaftor|ivacaftor|mesh-list
14514031|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14514032|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514033|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514034|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14514035|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14514036|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514037|NCT03125941|Dexamethasone|dexamethasone|mesh-list
14514038|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514039|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
14514040|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
14514041|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514042|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514043|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514044|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
14514045|NCT03125941|Hormones|hormones|mesh-ancestor
14514046|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514047|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14514048|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514049|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
14514050|NCT03126370|Emtricitabine|emtricitabine|mesh-list
14514051|NCT03126370|Tenofovir|tenofovir|mesh-list
14514052|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14514053|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
14514054|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14514055|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14514056|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514057|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514058|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
14514059|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514060|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14514061|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14514062|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14514063|NCT03126539|Sulforaphane|sulforaphane|mesh-list
14514064|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14514065|NCT03126539|Protective Agents|protective agents|mesh-ancestor
14514066|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514067|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514068|NCT03126682|Bupropion|bupropion|mesh-list
14514069|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14514070|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
14514071|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14514072|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14514073|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14514074|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514075|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514076|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
14514077|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514078|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514079|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14514080|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14514081|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514082|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14514083|NCT03126760|Hormones|hormones|mesh-ancestor
14514084|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514085|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514086|NCT03126786|Triamcinolone|triamcinolone|mesh-list
14514087|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14514088|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14514089|NCT03126786|Aflibercept|aflibercept|mesh-list
14514090|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14514091|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514092|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
14514093|NCT03126786|Hormones|hormones|mesh-ancestor
14514094|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948626|NCT01534169|Hormones|hormones|mesh-ancestor
14514095|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514096|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14514097|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
14514098|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514099|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514100|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14514101|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14514102|NCT03126786|Growth Substances|growth substances|mesh-ancestor
14514103|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14514104|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514105|NCT03127384|Lidocaine|lidocaine|mesh-list
14514106|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514107|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
14514108|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514109|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514110|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
14514111|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514112|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14514113|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14514114|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14514115|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514116|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514117|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14514118|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514119|NCT03127943|Lidocaine|lidocaine|mesh-list
14514120|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514121|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
14514122|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514123|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514124|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
14514125|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514126|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14514127|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14514128|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14514129|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514130|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514131|NCT03128008|Paclitaxel|paclitaxel|mesh-list
14514132|NCT03128008|Carboplatin|carboplatin|mesh-list
14514133|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14514134|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514135|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14514136|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14514137|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14514138|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514139|NCT03129100|Ixekizumab|ixekizumab|mesh-list
14514140|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514141|NCT03129945|Indomethacin|indomethacin|mesh-list
14514142|NCT03129945|Nifedipine|nifedipine|mesh-list
14514143|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14514144|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514145|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514146|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14514147|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514148|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
14514149|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
14514150|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14514151|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14514152|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14514153|NCT03129945|Analgesics|analgesics|mesh-ancestor
14514154|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
14514155|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514156|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514157|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14514158|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
14514159|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14514160|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514161|NCT03130738|Miconazole|miconazole|mesh-list
14514162|NCT03130738|Clotrimazole|clotrimazole|mesh-list
14514163|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
14514164|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514165|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14514166|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14514167|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514168|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514169|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14514170|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
14514171|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514172|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514173|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14514174|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14514175|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14514176|NCT03131453|CNP520|cnp520|mesh-list
14514177|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514178|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514179|NCT03131479|Licogliflozin|licogliflozin|mesh-list
14514180|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14514181|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514182|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514183|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514184|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14514185|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
14514186|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514187|NCT03131687|Dulaglutide|dulaglutide|mesh-list
14514188|NCT03131687|Tirzepatide|tirzepatide|mesh-list
14514189|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514190|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514191|NCT03131687|Incretins|incretins|mesh-ancestor
14514192|NCT03131687|Hormones|hormones|mesh-ancestor
14514193|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514194|NCT03131713|Acetaminophen|acetaminophen|mesh-list
14514195|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14514196|NCT03131713|Analgesics|analgesics|mesh-ancestor
14514197|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
14514198|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514199|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514200|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
14514201|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
14514202|NCT03131895|Lansoprazole|lansoprazole|mesh-list
14514203|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14514204|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514205|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14514206|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514207|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514208|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
14514209|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514210|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14514211|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514212|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514213|NCT03132571|Naltrexone|naltrexone|mesh-list
14514214|NCT03132571|Bupropion|bupropion|mesh-list
14514215|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14514216|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14514217|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514218|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
14514219|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514220|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14514221|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14514222|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14514223|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14514224|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14514225|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514226|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514227|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
14514228|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514229|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14514230|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14514231|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514232|NCT03133481|Ropivacaine|ropivacaine|mesh-list
14514233|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514234|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
14514235|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514236|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514237|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
14514238|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027115|NCT01947790|Pioglitazone|pioglitazone|mesh-list
14514239|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14514240|NCT03134183|Misoprostol|misoprostol|mesh-list
14514241|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14514242|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
14514243|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14514244|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514245|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14514246|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514247|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
14514248|NCT03134703|Morphine|morphine|mesh-list
14514249|NCT03134703|Methadone|methadone|mesh-list
14514250|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14514251|NCT03134703|Narcotics|narcotics|mesh-ancestor
14514252|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514253|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514254|NCT03134703|Analgesics|analgesics|mesh-ancestor
14514255|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
14514256|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514257|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
14514258|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
14514259|NCT03135028|Cytarabine|cytarabine|mesh-list
14514260|NCT03135028|Daunorubicin|daunorubicin|mesh-list
14514261|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14514262|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
14514263|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514264|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514265|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
14514266|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514267|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14514268|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
14514269|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514270|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14514271|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14514272|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14514273|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514274|NCT03136068|Digoxin|digoxin|mesh-list
14514275|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14514276|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14514277|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514278|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514279|NCT03136068|Protective Agents|protective agents|mesh-ancestor
14514280|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514281|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
14514282|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14514283|NCT03136107|Protective Agents|protective agents|mesh-ancestor
14514284|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514285|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514286|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
14514287|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14514288|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
14514289|NCT03136198|Diuretics|diuretics|mesh-list
14514290|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14514291|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
14514292|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514293|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514294|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514295|NCT03136328|Edotreotide|edotreotide|mesh-list
14514296|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14514297|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514298|NCT03136484|Canagliflozin|canagliflozin|mesh-list
14514299|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14514300|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514301|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514302|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514303|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14514304|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
14514305|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514306|NCT03137121|Olanzapine|olanzapine|mesh-list
14514307|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
14514308|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
14791657|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791658|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
14791659|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14791660|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
14791661|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791662|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791663|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14791664|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027116|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514309|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514310|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514311|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514312|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14514313|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14514314|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514315|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14514316|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14514317|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14514318|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514319|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514320|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514321|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
14514322|NCT03137303|Albuterol|albuterol|mesh-list
14514323|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14514324|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
14514325|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514326|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514327|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14514328|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
14514329|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
14514330|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14514331|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14514332|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14514333|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14514334|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
14514335|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514336|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514337|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
14514338|NCT03137784|Bromides|bromides|mesh-list
14514339|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
14514340|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14514341|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14514342|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14514343|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514344|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514345|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514346|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514347|NCT03137992|Bromides|bromides|mesh-list
14514348|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
14514349|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14514350|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
14514351|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514352|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514353|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14514354|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
14514355|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
14514356|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14514357|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514358|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514359|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514360|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
14529193|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529194|NCT03781479|Amifampridine|amifampridine|mesh-list
14529195|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14529196|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514361|NCT03138655|Vedolizumab|vedolizumab|mesh-list
14514362|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514363|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
14514364|NCT03138967|Bromides|bromides|mesh-list
14514365|NCT03138967|Rocuronium|rocuronium|mesh-list
14514366|NCT03138967|Neostigmine|neostigmine|mesh-list
14514367|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
14514368|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14514369|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14514370|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14514371|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514372|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514373|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14514374|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514375|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514376|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514377|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514378|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14514379|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
14514380|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14514381|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14514382|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14514383|NCT03139240|Oxycodone|oxycodone|mesh-list
14514384|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14514385|NCT03139240|Narcotics|narcotics|mesh-ancestor
14514386|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514387|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514388|NCT03139240|Analgesics|analgesics|mesh-ancestor
14514389|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
14514390|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514391|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
14514392|NCT03139279|Propofol|propofol|mesh-list
14514393|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14514394|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514395|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514396|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14514397|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
14514398|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
14514399|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14514400|NCT03139279|Analgesics|analgesics|mesh-ancestor
14514401|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
14514402|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514403|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14514404|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14514405|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14514406|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
14514407|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514408|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514409|NCT03139604|Prednisone|prednisone|mesh-list
14514410|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
14514411|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14514412|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14514413|NCT03139604|Prednisolone|prednisolone|mesh-list
14514414|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
14514415|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14514416|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
14514417|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514418|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
14514419|NCT03139604|Hormones|hormones|mesh-ancestor
14514420|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514421|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514422|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14514423|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514424|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
14514425|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
14514426|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514427|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514428|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14514429|NCT03139604|Protective Agents|protective agents|mesh-ancestor
14514430|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
14514431|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14514432|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14514433|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514434|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
14514435|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514436|NCT03140631|Protamines|protamines|mesh-list
14514437|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
14514438|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514439|NCT03140631|Coagulants|coagulants|mesh-ancestor
14514440|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
14514441|NCT03140722|Hematinics|hematinics|mesh-ancestor
14514442|NCT03142451|Minocycline|minocycline|mesh-list
14514443|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14514444|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514445|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
14514446|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
14514447|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514448|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
14514449|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514450|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514451|NCT03143166|Telmisartan|telmisartan|mesh-list
14514452|NCT03143166|Dabigatran|dabigatran|mesh-list
14514453|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14514454|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14514455|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14514456|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514457|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
14514458|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14514459|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
14514460|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514461|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
14514462|NCT03143569|Heparin|heparin|mesh-list
14514463|NCT03143569|Calcium heparin|calcium heparin|mesh-list
14514464|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
14514465|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14514466|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14514467|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514468|NCT03144635|Grazoprevir|grazoprevir|mesh-list
14514469|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
14514470|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514471|NCT03144804|Lamivudine|lamivudine|mesh-list
14514472|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14514473|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14514474|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514475|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514476|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
14514477|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514478|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14514479|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14514480|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
14514481|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514482|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14514483|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514484|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514485|NCT03145207|Lidocaine|lidocaine|mesh-list
14514486|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514487|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
14514488|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514489|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514490|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
14514491|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514492|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14514493|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14514494|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14514495|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514496|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514497|NCT03145259|Diclofenac|diclofenac|mesh-list
14514498|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14514499|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14514500|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14514501|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14514502|NCT03145259|Analgesics|analgesics|mesh-ancestor
14514503|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
14514504|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514505|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514506|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514507|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14514508|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14514509|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514510|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514511|NCT03146403|Vaccines|vaccines|mesh-list
14514512|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
14514513|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514514|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14514515|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
14514516|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514517|NCT03146806|Ketamine|ketamine|mesh-list
14514518|NCT03146806|Analgesics|analgesics|mesh-ancestor
14514519|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
14514520|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514521|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514522|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14514523|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14514524|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
14514525|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
14514526|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514527|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14514528|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14514529|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514530|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514531|NCT03147248|Infliximab|infliximab|mesh-list
14514532|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514533|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514534|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14514535|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
14514536|NCT03148236|Vitamins|vitamins|mesh-ancestor
14514537|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
14514538|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514539|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
14514540|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514541|NCT03148236|Protective Agents|protective agents|mesh-ancestor
14514542|NCT03149055|Isavuconazole|isavuconazole|mesh-list
14514543|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
14514544|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514545|NCT03149848|Rifabutin|rifabutin|mesh-list
14514546|NCT03149848|Cabotegravir|cabotegravir|mesh-list
14514547|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14514548|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514549|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14514550|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
14514551|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14514552|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14514553|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514554|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514555|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14514556|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14514557|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
14514558|NCT03149887|Bupivacaine|bupivacaine|mesh-list
14514559|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514560|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
14514561|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514562|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514563|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
14514564|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514565|NCT03149991|Ketamine|ketamine|mesh-list
14514566|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
14514567|NCT03149991|Analgesics|analgesics|mesh-ancestor
14514568|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
14514569|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514570|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514571|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14514572|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14514573|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
14514574|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
14514575|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514576|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14514577|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14514578|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514579|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514580|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
14514581|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
14514582|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
14514583|NCT03150056|Prednisone|prednisone|mesh-list
14514584|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514585|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
14514586|NCT03150056|Hormones|hormones|mesh-ancestor
14529197|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514587|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514588|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514589|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14514590|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514591|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
14514592|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14514593|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514594|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14514595|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14514596|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514597|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514598|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514599|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14514600|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14514601|NCT03150589|Ranibizumab|ranibizumab|mesh-list
14514602|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14514603|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14514604|NCT03150589|Growth Substances|growth substances|mesh-ancestor
14514605|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514606|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
14514607|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514608|NCT03150719|Ivacaftor|ivacaftor|mesh-list
14514609|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14514610|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514611|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514612|NCT03150875|Docetaxel|docetaxel|mesh-list
14514613|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514614|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
14514615|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
14514616|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
14514617|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514618|NCT03151434|Hydromorphone|hydromorphone|mesh-list
14514619|NCT03151434|Bupivacaine|bupivacaine|mesh-list
14514620|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514621|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
14514622|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514623|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514624|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
14514625|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514626|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14514627|NCT03151434|Narcotics|narcotics|mesh-ancestor
14514628|NCT03151434|Analgesics|analgesics|mesh-ancestor
14514629|NCT03151551|Adalimumab|adalimumab|mesh-list
14514630|NCT03151551|Ixekizumab|ixekizumab|mesh-list
14514631|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514632|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14514633|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514634|NCT03152019|Tacrolimus|tacrolimus|mesh-list
14514635|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14514636|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
14514637|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514638|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14514639|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514640|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514641|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
14514642|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14514643|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514644|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514645|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514646|NCT03152552|Empagliflozin|empagliflozin|mesh-list
14514647|NCT03152552|Licogliflozin|licogliflozin|mesh-list
14514648|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14514649|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514650|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514651|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514652|NCT03152591|Licogliflozin|licogliflozin|mesh-list
14514653|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14514654|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514655|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514656|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514657|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
14514658|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514659|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
14514660|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
14514661|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14514662|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14514663|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514664|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514665|NCT03154476|Urological Agents|urological agents|mesh-ancestor
14514666|NCT03154658|Ropivacaine|ropivacaine|mesh-list
14514667|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514668|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
14514669|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514670|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514671|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
14514672|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514673|NCT03155178|Ethanol|ethanol|mesh-list
14514674|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
14514675|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14514676|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14514677|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514678|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514679|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514680|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
14514681|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
14529198|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14529199|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529200|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529201|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
14529202|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
14529203|NCT03783039|Coagulants|coagulants|mesh-ancestor
14529204|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14529205|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
14529206|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14529207|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
14529208|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529209|NCT03783130|Antacids|antacids|mesh-ancestor
14529210|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529211|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530089|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530090|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530091|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
14530092|NCT03342638|Hormones|hormones|mesh-ancestor
14530093|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530094|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14530095|NCT03342638|Protective Agents|protective agents|mesh-ancestor
14530096|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14530097|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14530098|NCT03342157|Sennosides|sennosides|mesh-list
14530099|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
14530100|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530101|NCT03342157|Laxatives|laxatives|mesh-ancestor
14530102|NCT03339401|Brincidofovir|brincidofovir|mesh-list
14530103|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
14530104|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530105|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14530106|NCT03333746|Nivolumab|nivolumab|mesh-list
14530107|NCT03333746|Lenalidomide|lenalidomide|mesh-list
14530108|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530109|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530110|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14530111|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530112|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
14530113|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530114|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14530115|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14530116|NCT03333746|Growth Substances|growth substances|mesh-ancestor
14530117|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
14530118|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
14530119|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14530120|NCT03325114|Diuretics|diuretics|mesh-ancestor
14530121|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
14530122|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530123|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14530124|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530125|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530126|NCT03305055|Fentanyl|fentanyl|mesh-list
14530127|NCT03305055|Ketamine|ketamine|mesh-list
14530128|NCT03305055|Analgesics|analgesics|mesh-ancestor
14514682|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
14514683|NCT03157089|Afatinib|afatinib|mesh-list
14514684|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14514685|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514686|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14514687|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514688|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514689|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
14514690|NCT03157583|Glycerol|glycerol|mesh-list
14514691|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14514692|NCT03157583|Protective Agents|protective agents|mesh-ancestor
14514693|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514694|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514695|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14514696|NCT03158116|Aztreonam|aztreonam|mesh-list
14514697|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14514698|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514699|NCT03158220|Vaccines|vaccines|mesh-list
14514700|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
14514701|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514702|NCT03158272|Nivolumab|nivolumab|mesh-list
14514703|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14514704|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514705|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14514706|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514707|NCT03158311|Fluticasone|fluticasone|mesh-list
14514708|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
14514709|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14514710|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514711|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14514712|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
14514713|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514714|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514715|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14514716|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
14514717|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514718|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14514719|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
14514720|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14514721|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514722|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514723|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791665|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14791666|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14791667|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14791668|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
14791669|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791670|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791671|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
14791672|NCT00742287|Procyanidin|procyanidin|mesh-list
14791673|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
14791674|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791675|NCT00742287|Protective Agents|protective agents|mesh-ancestor
14791676|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791677|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14791678|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14791679|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791680|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
14791681|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791682|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
14791683|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791684|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791685|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14791686|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
14791687|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791688|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791689|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14791690|NCT00742339|Octreotide|octreotide|mesh-list
14791691|NCT00742339|Terlipressin|terlipressin|mesh-list
14791692|NCT00742339|Midodrine|midodrine|mesh-list
14791693|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791694|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14791695|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514724|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14514725|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14514726|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14514727|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
14514728|NCT03159143|Docetaxel|docetaxel|mesh-list
14514729|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
14514730|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514731|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
14514732|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
14514733|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
14514734|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514735|NCT03159260|Allantoin|allantoin|mesh-list
14514736|NCT03159260|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514737|NCT03160703|Fluorides|fluorides|mesh-list
14514738|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
14514739|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
14514740|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
14514741|NCT03160703|Protective Agents|protective agents|mesh-ancestor
14514742|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514743|NCT03160716|Lidocaine|lidocaine|mesh-list
14514744|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514745|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
14514746|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514747|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514748|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
14514749|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514750|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14514751|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14514752|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14514753|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514754|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514755|NCT03161158|Diuretics|diuretics|mesh-list
14514756|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
14514757|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514758|NCT03161405|Itraconazole|itraconazole|mesh-list
14514759|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514760|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514761|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
14514762|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514763|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14514764|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14514765|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14514766|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
14514767|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514768|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514769|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14514770|NCT03161938|Dexamethasone|dexamethasone|mesh-list
14514771|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514772|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
14514773|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
14514774|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514775|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514776|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14514777|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
14514778|NCT03161938|Hormones|hormones|mesh-ancestor
14514779|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514780|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14514781|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514782|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
14514783|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
14514784|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14514785|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
14514786|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514787|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514788|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14514789|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
14514790|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14514791|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14514792|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14514793|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
14514794|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514795|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514796|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14514797|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14514798|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14514799|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514800|NCT03163303|Nicotine|nicotine|mesh-list
14514801|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14514802|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
14514803|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514804|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514805|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14514806|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14514807|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514808|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514809|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514810|NCT03163472|Anesthetics|anesthetics|mesh-list
14514811|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
14514812|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514813|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514814|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
14514815|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514816|NCT03165981|Vaccines|vaccines|mesh-list
14514817|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14514818|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
14514819|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514820|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
14514821|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514822|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514823|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
14514824|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14514825|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514826|NCT03167411|Exenatide|exenatide|mesh-list
14514827|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
14514828|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514829|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514830|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14514831|NCT03167411|Incretins|incretins|mesh-ancestor
14514832|NCT03167411|Hormones|hormones|mesh-ancestor
14514833|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514834|NCT03168022|Amitriptyline|amitriptyline|mesh-list
14514835|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
14514836|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14514837|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
14514838|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14514839|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14514840|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514841|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14514842|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514843|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14514844|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514845|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14514846|NCT03168022|Analgesics|analgesics|mesh-ancestor
14514847|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
14514848|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14514849|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14514850|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514851|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514852|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
14514853|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514854|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
14514855|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14514856|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514857|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514858|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514859|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
14514860|NCT03168308|Neostigmine|neostigmine|mesh-list
14514861|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14514862|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514863|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514864|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514865|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514866|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514867|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14514868|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
14514869|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514870|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14514871|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14514872|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14514873|NCT03168841|Efinaconazole|efinaconazole|mesh-list
14514874|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
14514875|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514876|NCT03168919|Temozolomide|temozolomide|mesh-list
14514877|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14514878|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
14514879|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514880|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514881|NCT03169244|Bupropion|bupropion|mesh-list
14514882|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14514883|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
14514884|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14514885|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14514886|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14514887|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514888|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514889|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
14514890|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514891|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514892|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14514893|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14514894|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514895|NCT03170219|Furosemide|furosemide|mesh-list
14514896|NCT03170219|Diuretics|diuretics|mesh-ancestor
14514897|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
14514898|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514899|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14514900|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514901|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514902|NCT03170271|Benralizumab|benralizumab|mesh-list
14514903|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14514904|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
14514905|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
14514906|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514907|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514908|NCT03170661|Rocuronium|rocuronium|mesh-list
14514909|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14514910|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14514911|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14514912|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514913|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514914|NCT03172325|Folic Acid|folic acid|mesh-list
14514915|NCT03172325|Prednisolone|prednisolone|mesh-list
14514916|NCT03172325|Adalimumab|adalimumab|mesh-list
14514917|NCT03172325|Methotrexate|methotrexate|mesh-list
14514918|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14514919|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
14514920|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14514921|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514922|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14514923|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
14514924|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514925|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514926|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
14514927|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514928|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14514929|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14514930|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
14514931|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14514932|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14514933|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14514934|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
14514935|NCT03172325|Hormones|hormones|mesh-ancestor
14514936|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514937|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14514938|NCT03172325|Hematinics|hematinics|mesh-ancestor
14948627|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948628|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14948629|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948630|NCT01534247|Metronidazole|metronidazole|mesh-list
14948631|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948632|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948633|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14948634|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14948635|NCT01534312|Mesalamine|mesalamine|mesh-list
14948636|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948637|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948638|NCT01534312|Analgesics|analgesics|mesh-ancestor
14948639|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
14948640|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948641|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948642|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948643|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027117|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027118|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15027119|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15027120|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027121|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027122|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027123|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027124|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15027125|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15027126|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
15027127|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027128|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027129|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15027130|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15027131|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
15027132|NCT01947920|Tramadol|tramadol|mesh-list
15027133|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15027134|NCT01947920|Narcotics|narcotics|mesh-ancestor
15027135|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027136|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027137|NCT01947920|Analgesics|analgesics|mesh-ancestor
15027138|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
14514939|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
14514940|NCT03172325|Vitamins|vitamins|mesh-ancestor
14514941|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
14514942|NCT03172494|Insulin|insulin|mesh-list
14514943|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14514944|NCT03172494|Liraglutide|liraglutide|mesh-list
14514945|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
14514946|NCT03172494|Xultophy|xultophy|mesh-list
14514947|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14514948|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514949|NCT03172494|Incretins|incretins|mesh-ancestor
14514950|NCT03172494|Hormones|hormones|mesh-ancestor
14514951|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514952|NCT03173170|Itraconazole|itraconazole|mesh-list
14514953|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
14514954|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14514955|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14514956|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14514957|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514958|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514959|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14514960|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
14514961|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14514962|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514963|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14514964|NCT03173560|Everolimus|everolimus|mesh-list
14514965|NCT03173560|Lenvatinib|lenvatinib|mesh-list
14514966|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14514967|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14514968|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
14514969|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514970|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14514971|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14514972|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529212|NCT03773796|Nabilone|nabilone|mesh-list
14529213|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
14514973|NCT03174132|Lidocaine|lidocaine|mesh-list
14514974|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
14514975|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
14514976|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
14514977|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14514978|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514979|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
14514980|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514981|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14514982|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14514983|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14514984|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14514985|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14514986|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14514987|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
14514988|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
14514989|NCT03174132|Protective Agents|protective agents|mesh-ancestor
14514990|NCT03174158|Nicotine|nicotine|mesh-list
14514991|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14514992|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
14514993|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14514994|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14514995|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14514996|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14514997|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
14514998|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14514999|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515000|NCT03174366|Denosumab|denosumab|mesh-list
14515001|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14515002|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515003|NCT03175120|Insulin|insulin|mesh-list
14515004|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14515005|NCT03175120|Liraglutide|liraglutide|mesh-list
14515006|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
13965194|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965195|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13965196|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965197|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965198|NCT03132168|Anesthetics|anesthetics|mesh-list
13965199|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965200|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965201|NCT03132025|Capecitabine|capecitabine|mesh-list
13965202|NCT03132025|Apatinib|apatinib|mesh-list
13965203|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13965204|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
13965205|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515007|NCT03175120|Xultophy|xultophy|mesh-list
14515008|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515009|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515010|NCT03175120|Incretins|incretins|mesh-ancestor
14515011|NCT03175120|Hormones|hormones|mesh-ancestor
14515012|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515013|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
14515014|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515015|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515016|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14515017|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515018|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515019|NCT03176238|Everolimus|everolimus|mesh-list
14515020|NCT03176238|Exemestane|exemestane|mesh-list
14515021|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515022|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14515023|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
14515024|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515025|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14515026|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14515027|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515028|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515029|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14515030|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
14515031|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515032|NCT03176459|Bupivacaine|bupivacaine|mesh-list
14515033|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
14515034|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
14515035|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515036|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515037|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
14515038|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515039|NCT03176784|Nicotine|nicotine|mesh-list
14515040|NCT03176784|Varenicline|varenicline|mesh-list
14515041|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14515042|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
14515043|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515044|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515045|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14515046|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14515047|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515048|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515049|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515050|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
14515051|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14515052|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
14515053|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515054|NCT03177395|Expectorants|expectorants|mesh-ancestor
14515055|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
14515056|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14515057|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
14515058|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515059|NCT03177395|Protective Agents|protective agents|mesh-ancestor
14515060|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515061|NCT03177395|Antidotes|antidotes|mesh-ancestor
14515062|NCT03177798|Icatibant|icatibant|mesh-list
14515063|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14515064|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14515065|NCT03177798|Analgesics|analgesics|mesh-ancestor
14515066|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
14515067|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515068|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515069|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14515070|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14515071|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14515072|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14515073|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515074|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14515075|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14515076|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
14515077|NCT03178851|Atezolizumab|atezolizumab|mesh-list
14515078|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14515079|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515080|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
14515081|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515082|NCT03178942|Permethrin|permethrin|mesh-list
14515083|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515084|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515085|NCT03179345|Pregabalin|pregabalin|mesh-list
14515086|NCT03179345|Gabapentin|gabapentin|mesh-list
14515087|NCT03179345|Analgesics|analgesics|mesh-ancestor
14515088|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
14515089|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515090|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515091|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
14515092|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14515093|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14515094|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515095|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14515096|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14515097|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14515098|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515099|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14515100|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14515101|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14515102|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515103|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
14515104|NCT03179410|Avelumab|avelumab|mesh-list
14515105|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515106|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515107|NCT03179787|Aripiprazole|aripiprazole|mesh-list
14515108|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
14515109|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14515110|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14515111|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14515112|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515113|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515114|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
14515115|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
14515116|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515117|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515118|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14515119|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14515120|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
14515121|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14515122|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14515123|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14515124|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14515125|NCT03179891|Diazepam|diazepam|mesh-list
14515126|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14515127|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
14515128|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
14515129|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
14515130|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515131|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515132|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515133|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14515134|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515135|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14515136|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14515137|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14515138|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14515139|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14515140|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14515141|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
14515142|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
14515143|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
14515144|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
14515145|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515146|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515147|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
13965206|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965207|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965208|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965209|NCT03132051|Triamcinolone|triamcinolone|mesh-list
13965210|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13965211|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13965212|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13965213|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965214|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
14515148|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14515149|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515150|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515151|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515152|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
14515153|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
14515154|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965215|NCT03132051|Hormones|hormones|mesh-ancestor
14515155|NCT03181009|Omalizumab|omalizumab|mesh-list
13968253|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515156|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14515157|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14515158|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14515159|NCT03181308|Nivolumab|nivolumab|mesh-list
14515160|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515161|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515162|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14515163|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515164|NCT03181451|Ferric maltol|ferric maltol|mesh-list
14515165|NCT03181451|Hematinics|hematinics|mesh-ancestor
14515166|NCT03181932|Vancomycin|vancomycin|mesh-list
14515167|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14515168|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515169|NCT03182920|Lasmiditan|lasmiditan|mesh-list
14515170|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14515171|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
14515172|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515173|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515174|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515175|NCT03183908|Vaccines|vaccines|mesh-list
14515176|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
14515177|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515178|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
14515179|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515180|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515181|NCT03184987|Albuterol|albuterol|mesh-list
14515182|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14515183|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
14515184|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515185|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515186|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14515187|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
14515188|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
14515189|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14515190|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14515191|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14515192|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14515193|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
14515194|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515195|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515196|NCT03185065|Amantadine|amantadine|mesh-list
14515197|NCT03185065|Methylphenidate|methylphenidate|mesh-list
14515198|NCT03185065|Modafinil|modafinil|mesh-list
14515199|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14515200|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515201|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14515202|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14515203|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14515204|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515205|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
14515206|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515207|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14515208|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14515209|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14515210|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14515211|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14515212|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
14515213|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515214|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14515215|NCT03185065|Analgesics|analgesics|mesh-ancestor
14515216|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
14515217|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515218|NCT03185546|Nicotine|nicotine|mesh-list
14515219|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14515220|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
14515221|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515222|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515223|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14515224|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14515225|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515226|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515227|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515228|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
14515229|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14515230|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14515231|NCT03186261|Fluorides|fluorides|mesh-list
14515232|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
14515233|NCT03186261|Protective Agents|protective agents|mesh-ancestor
14515234|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515235|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14515236|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515237|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
14515238|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
14515239|NCT03187197|Dabigatran|dabigatran|mesh-list
14515240|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
14515241|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14515242|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
14515243|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515244|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515245|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
14515248|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
14515249|NCT03187301|Apomorphine|apomorphine|mesh-list
14515250|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14515251|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515252|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14515253|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14515254|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515255|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515256|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515257|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515258|NCT03187301|Emetics|emetics|mesh-ancestor
14515259|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
14515260|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515261|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515262|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
14515263|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
14515264|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515265|NCT03187678|Selexipag|selexipag|mesh-list
14515266|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14515267|NCT03187730|Nicotine|nicotine|mesh-list
14515268|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14515269|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
14515270|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515271|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515272|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14515273|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14515274|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515275|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515276|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515277|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
14515278|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14515279|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
14515280|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515281|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14515282|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14515283|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
14515284|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515285|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515286|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14515287|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
14515288|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14515289|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
14515290|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515291|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515292|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14515293|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
14515294|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
14515295|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14515296|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515297|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515298|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515299|NCT03188185|Naltrexone|naltrexone|mesh-list
14515300|NCT03188185|Buprenorphine|buprenorphine|mesh-list
14515301|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14515302|NCT03188185|Narcotics|narcotics|mesh-ancestor
14515303|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515304|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515305|NCT03188185|Analgesics|analgesics|mesh-ancestor
14515306|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
14515307|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515308|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14515309|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14515310|NCT03189446|Paclitaxel|paclitaxel|mesh-list
14515311|NCT03189446|Carboplatin|carboplatin|mesh-list
14515312|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14515313|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515314|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
14515315|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
14515316|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
14515317|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515318|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
14515319|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515320|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14515321|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515322|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515323|NCT03189589|Nemiralisib|nemiralisib|mesh-list
14515324|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14515325|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515326|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515327|NCT03190005|Clopidogrel|clopidogrel|mesh-list
14515328|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14515329|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14515330|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14515331|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14515332|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
14515333|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515334|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515335|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515336|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
14515337|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515338|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515339|NCT03191396|Liraglutide|liraglutide|mesh-list
14515340|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515341|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515342|NCT03191396|Incretins|incretins|mesh-ancestor
14515343|NCT03191396|Hormones|hormones|mesh-ancestor
14515344|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529214|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
14529215|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529216|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529217|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529218|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14529219|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14529220|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529221|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529222|NCT03782233|Bromides|bromides|mesh-list
14529223|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14529224|NCT03782233|Rocuronium|rocuronium|mesh-list
14529225|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
14529226|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14529227|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14529228|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14529229|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529230|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529231|NCT03781375|Etanercept|etanercept|mesh-list
14529232|NCT03781375|Methotrexate|methotrexate|mesh-list
14529233|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14529234|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
14529235|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14529236|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529237|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14529238|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
14529239|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529240|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529241|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
14529242|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529243|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14529244|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14529245|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
14529246|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14529247|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14529248|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14515345|NCT03192306|Ethanol|ethanol|mesh-list
14515346|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14515347|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515348|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515349|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515350|NCT03192488|Cetirizine|cetirizine|mesh-list
14515351|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14515352|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14515353|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14515354|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
14515355|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
14515356|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515357|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515358|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515359|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14515360|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
14515361|NCT03192826|Dipivefrin|dipivefrin|mesh-list
14515362|NCT03192826|Brinzolamide|brinzolamide|mesh-list
14515363|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14515364|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14515365|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14515366|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14515367|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
14515368|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515369|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515370|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515371|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14515372|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14515373|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14515374|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515375|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14515376|NCT03193047|Evolocumab|evolocumab|mesh-list
14515377|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14515378|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14515379|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
14515380|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515381|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14515382|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515383|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515384|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515385|NCT03194373|Carboplatin|carboplatin|mesh-list
14515386|NCT03194373|Palbociclib|palbociclib|mesh-list
14515387|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515388|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14515389|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515390|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515391|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
14515392|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515393|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515394|NCT03196349|Warfarin|warfarin|mesh-list
14515395|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
14515396|NCT03196349|Apixaban|apixaban|mesh-list
14515397|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
14515398|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14515399|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
14515400|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14515401|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
14515402|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515403|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515404|NCT03196505|Bupivacaine|bupivacaine|mesh-list
14515405|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
14515406|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
14515407|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515408|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515409|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
14515410|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515411|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14515412|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14515413|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515414|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
14515415|NCT03197025|Aldesleukin|aldesleukin|mesh-list
14515416|NCT03197025|Interleukin-2|interleukin-2|mesh-list
14515417|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515418|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14515419|NCT03197025|Analgesics|analgesics|mesh-ancestor
14791696|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
14515420|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
14515421|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515422|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515423|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14515424|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14515425|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
14515426|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515427|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
14515428|NCT03197324|Digoxin|digoxin|mesh-list
14515429|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14515430|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14515431|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515432|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515433|NCT03197324|Protective Agents|protective agents|mesh-ancestor
14515434|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515435|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515436|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
14515437|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515438|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515439|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
14515440|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14515441|NCT03197883|Protective Agents|protective agents|mesh-ancestor
14515442|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515443|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
14515444|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14515445|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14515446|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
14515447|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
14515448|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14515449|NCT03198221|Citric Acid|citric acid|mesh-list
14515450|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
14515451|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14515452|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
14515453|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
14515454|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515455|NCT03198221|Cathartics|cathartics|mesh-ancestor
14515456|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515457|NCT03198221|Antacids|antacids|mesh-ancestor
14515458|NCT03198221|Laxatives|laxatives|mesh-ancestor
14515459|NCT03198507|Amoxicillin|amoxicillin|mesh-list
14515460|NCT03198507|Rifabutin|rifabutin|mesh-list
14515461|NCT03198507|Omeprazole|omeprazole|mesh-list
14515462|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14515463|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515464|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14515465|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515466|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14515467|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515468|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515469|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14515470|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
14515471|NCT03198767|Licogliflozin|licogliflozin|mesh-list
14515472|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
14515473|NCT03198767|Psyllium|psyllium|mesh-list
14515474|NCT03198767|Calcium|calcium|mesh-list
14515475|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14515476|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515477|NCT03198767|Antacids|antacids|mesh-ancestor
14515478|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515479|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515480|NCT03198767|Cathartics|cathartics|mesh-ancestor
14515481|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14515482|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515483|NCT03198871|Acetaminophen|acetaminophen|mesh-list
14515484|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14515485|NCT03198871|Analgesics|analgesics|mesh-ancestor
14515486|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
14515487|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515488|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515489|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
14515490|NCT03198884|Darunavir|darunavir|mesh-list
14515491|NCT03198884|Dolutegravir|dolutegravir|mesh-list
14515492|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14515493|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14515494|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
14515495|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515496|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515497|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14515498|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14515499|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
14515500|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515501|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14515502|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14515503|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14515504|NCT03199911|Erythromycin|erythromycin|mesh-list
14515505|NCT03199911|Bacitracin|bacitracin|mesh-list
14515506|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515507|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515508|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14515509|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515510|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515511|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14515512|NCT03199963|Tamoxifen|tamoxifen|mesh-list
14515513|NCT03199963|Afimoxifene|afimoxifene|mesh-list
14515514|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14515515|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
14515516|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515517|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515518|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14515519|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515520|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14515521|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14515522|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14515523|NCT03200860|Empagliflozin|empagliflozin|mesh-list
14515524|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14515525|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515526|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515527|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515528|NCT03201211|Vaccines|vaccines|mesh-list
14515529|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
14515530|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515531|NCT03201562|Tropicamide|tropicamide|mesh-list
14515532|NCT03201562|Aceclidine|aceclidine|mesh-list
14515533|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
14515534|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
14515535|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515536|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515537|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14515538|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14515539|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515540|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515541|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515542|NCT03201562|Miotics|miotics|mesh-ancestor
14515543|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14515544|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
14515545|NCT03202134|Anesthetics|anesthetics|mesh-list
14515546|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515547|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515548|NCT03202134|Narcotics|narcotics|mesh-ancestor
14515549|NCT03202134|Analgesics|analgesics|mesh-ancestor
14515550|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
14515551|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515552|NCT03202511|Tenofovir|tenofovir|mesh-list
14515553|NCT03202511|Emtricitabine|emtricitabine|mesh-list
14515554|NCT03202511|Probenecid|probenecid|mesh-list
14515555|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
14515556|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515557|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14515558|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14515559|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515560|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515561|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14515562|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14515563|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
14515564|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
14515565|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14515566|NCT03202511|Renal Agents|renal agents|mesh-ancestor
14515567|NCT03202550|Oxycodone|oxycodone|mesh-list
14515568|NCT03202550|Lorazepam|lorazepam|mesh-list
14515569|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14515570|NCT03202550|Narcotics|narcotics|mesh-ancestor
14515571|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515572|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515573|NCT03202550|Analgesics|analgesics|mesh-ancestor
14515574|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
14515575|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515576|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
14515577|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
14515578|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
14515579|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515580|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14515581|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14515582|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14515583|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14515584|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
14515585|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
14515586|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515587|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515588|NCT03203447|Triamcinolone|triamcinolone|mesh-list
14515589|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14515590|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14515591|NCT03203447|Bevacizumab|bevacizumab|mesh-list
14515592|NCT03203447|Ranibizumab|ranibizumab|mesh-list
14515593|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14515594|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515595|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515596|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14515597|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14515598|NCT03203447|Growth Substances|growth substances|mesh-ancestor
14515599|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515600|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
14515601|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14515602|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
14515603|NCT03203447|Hormones|hormones|mesh-ancestor
14515604|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515605|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14515606|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
14515607|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515608|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515609|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
14515610|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14515611|NCT03203681|Testosterone|testosterone|mesh-list
14515612|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
14515613|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
14515614|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14515615|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515616|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
14515617|NCT03203681|Hormones|hormones|mesh-ancestor
14515618|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515619|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515620|NCT03203681|Androgens|androgens|mesh-ancestor
14515621|NCT03204279|Palonosetron|palonosetron|mesh-list
14515622|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
14515623|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
14515624|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515625|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515626|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515627|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14515628|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14515629|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
14515630|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515631|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515632|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
14515633|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515634|NCT03205150|Licogliflozin|licogliflozin|mesh-list
14515635|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14515636|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515637|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515638|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515639|NCT03205566|Lamivudine|lamivudine|mesh-list
14515640|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
14515641|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14515642|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14515643|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515644|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515645|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
14515646|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515647|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14515648|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14515649|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14515650|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14515651|NCT03206788|Losartan|losartan|mesh-list
14515652|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14515653|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14515654|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14515655|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14515656|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515657|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
14515658|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515659|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14515660|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515661|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515662|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
14515663|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515664|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14515665|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515666|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515667|NCT03207243|Fluticasone|fluticasone|mesh-list
14515668|NCT03207243|Xhance|xhance|mesh-list
14515669|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14515670|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14515671|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14515672|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
14515673|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515674|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515675|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14515676|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
14515677|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
14515678|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14515679|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14515680|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14515681|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14515682|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14515683|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515684|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515685|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14515686|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
14515687|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515688|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14515689|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
14515690|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14515691|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14515692|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14515693|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515694|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515695|NCT03207750|Vaccines|vaccines|mesh-list
14515696|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14515697|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
14515698|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529249|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529250|NCT03781375|Analgesics|analgesics|mesh-ancestor
14529251|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
14948644|NCT01534442|Atropine|atropine|mesh-list
14948645|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14948646|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14948647|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14948648|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
14948649|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948650|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948651|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14948652|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
14948653|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
14948654|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
14948655|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14948656|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14948657|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
14948658|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948659|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948660|NCT01534455|Lapatinib|lapatinib|mesh-list
14948661|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529252|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529253|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529254|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529255|NCT03780010|Paclitaxel|paclitaxel|mesh-list
14529256|NCT03780010|Carboplatin|carboplatin|mesh-list
14515699|NCT03208933|Pirfenidone|pirfenidone|mesh-list
14515700|NCT03208933|Analgesics|analgesics|mesh-ancestor
14515701|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
14515702|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515703|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515704|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14515705|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14515706|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14515707|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14515708|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515709|NCT03209492|Leuprolide|leuprolide|mesh-list
14515710|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14515711|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
14515712|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14515713|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515714|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14515715|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515716|NCT03209518|Leuprolide|leuprolide|mesh-list
14515717|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14515718|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
14515719|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14515720|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515721|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14515722|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515723|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
14515724|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
14515725|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
14515726|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14515727|NCT03209570|Protective Agents|protective agents|mesh-ancestor
14515728|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515729|NCT03210259|Adalimumab|adalimumab|mesh-list
14515730|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14515731|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14515732|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14515733|NCT03210376|Neostigmine|neostigmine|mesh-list
14515734|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14515735|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515736|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515737|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515738|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515739|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515740|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14515741|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
14515742|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515743|NCT03211117|Docetaxel|docetaxel|mesh-list
14515744|NCT03211117|Doxorubicin|doxorubicin|mesh-list
14515745|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14515746|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
14515747|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515748|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14515749|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14515750|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14515751|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515752|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14515753|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14515754|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14515755|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515756|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515757|NCT03211156|Amoxicillin|amoxicillin|mesh-list
14515758|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14515759|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515760|NCT03211234|Ranibizumab|ranibizumab|mesh-list
14515761|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14515762|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14515763|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14515764|NCT03211234|Growth Substances|growth substances|mesh-ancestor
14515765|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515766|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
14515767|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515768|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14515769|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515770|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14515771|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515772|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515773|NCT03214367|Insulin|insulin|mesh-list
14515774|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14515775|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
14515776|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
14515777|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515778|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515779|NCT03214380|Insulin|insulin|mesh-list
14515780|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14515781|NCT03214380|Metformin|metformin|mesh-list
14515782|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
14515783|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
14515784|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14515785|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14515786|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515787|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515788|NCT03215706|Paclitaxel|paclitaxel|mesh-list
14515789|NCT03215706|Carboplatin|carboplatin|mesh-list
14515790|NCT03215706|Nivolumab|nivolumab|mesh-list
14515791|NCT03215706|Pemetrexed|pemetrexed|mesh-list
14515792|NCT03215706|Ipilimumab|ipilimumab|mesh-list
14515793|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14515794|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515795|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
14515796|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
14515797|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
14515798|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515799|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14515800|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14515801|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515802|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14515803|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14515804|NCT03216226|Glucagon|glucagon|mesh-list
14515805|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515806|NCT03216226|Hormones|hormones|mesh-ancestor
14515807|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515808|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515809|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14515810|NCT03216902|Latanoprost|latanoprost|mesh-list
14515811|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14515812|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
14515813|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14515814|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
14515815|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515816|NCT03216954|Expectorants|expectorants|mesh-ancestor
14515817|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
14515818|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14515819|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
14515820|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515821|NCT03216954|Protective Agents|protective agents|mesh-ancestor
14515822|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515823|NCT03216954|Antidotes|antidotes|mesh-ancestor
14515824|NCT03218592|Tenofovir|tenofovir|mesh-list
14515825|NCT03218592|Emtricitabine|emtricitabine|mesh-list
14515826|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14515827|NCT03218592|Maraviroc|maraviroc|mesh-list
14515828|NCT03218592|Dolutegravir|dolutegravir|mesh-list
14515829|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
14515830|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515831|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14515832|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14515833|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515834|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515835|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14515836|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14515837|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14515838|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14515839|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14515840|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13965216|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515841|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14515842|NCT03219294|Bromides|bromides|mesh-list
14515843|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
14515844|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
14515845|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14515846|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14515847|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14515848|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515849|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515850|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14515851|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14515852|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515853|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515854|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515855|NCT03219723|Amoxicillin|amoxicillin|mesh-list
14515856|NCT03219723|Metronidazole|metronidazole|mesh-list
14515857|NCT03219723|Clarithromycin|clarithromycin|mesh-list
14515858|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14515859|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515860|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14515861|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14515862|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14515863|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515864|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515865|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14515866|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14515867|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
14515868|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14515869|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14515870|NCT03219866|Budesonide|budesonide|mesh-list
14515871|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
14515872|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14515873|NCT03219866|Ipratropium|ipratropium|mesh-list
14515874|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14515875|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14515876|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
14515877|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515878|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515879|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14515880|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
14515881|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
14515882|NCT03219866|Hormones|hormones|mesh-ancestor
14515883|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14515884|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
14515885|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14515886|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
14515887|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515888|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515889|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
14515890|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
14515891|NCT03220958|Promethazine|promethazine|mesh-list
14515892|NCT03220958|Metoclopramide|metoclopramide|mesh-list
14515893|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14515894|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14515895|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515896|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515897|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
14515898|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
14515899|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
14515900|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515901|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
14515902|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
14515903|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515904|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14515905|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
14515906|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
14515907|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515908|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791697|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
14791698|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791699|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791700|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14791701|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14791702|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14791703|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14515909|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14515910|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
14515911|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
14515912|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14515913|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14515914|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
14515915|NCT03221764|Amiodarone|amiodarone|mesh-list
14515916|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14515917|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
14515918|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14515919|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14515920|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515921|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14515922|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14515923|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14515924|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515925|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14515926|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14515927|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14515928|NCT03222349|Diazepam|diazepam|mesh-list
14515929|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14515930|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
14515931|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
14515932|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
14515933|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515934|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515935|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14515936|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14515937|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515938|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14515939|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14515940|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14515941|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14515942|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14515943|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14515944|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
14515945|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
14515946|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
14515947|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
14515948|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515949|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515950|NCT03223272|Reserpine|reserpine|mesh-list
14515951|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14515952|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14515953|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14515954|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515955|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515956|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14515957|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14515958|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14515959|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14515960|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515961|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
14515962|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14515963|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
14515964|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14515965|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
14515966|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515967|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
14515968|NCT03223909|Protective Agents|protective agents|mesh-ancestor
14515969|NCT03224182|Apaziquone|apaziquone|mesh-list
14515970|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14515971|NCT03224351|Ivacaftor|ivacaftor|mesh-list
14515972|NCT03224351|VX-659|vx-659|mesh-list
14515973|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14515974|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14515975|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529257|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14529258|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529259|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14529260|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14529261|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14529262|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529263|NCT03774576|Itraconazole|itraconazole|mesh-list
14529264|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
14791704|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
14515976|NCT03224403|Acetaminophen|acetaminophen|mesh-list
14515977|NCT03224403|Ibuprofen|ibuprofen|mesh-list
14515978|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14515979|NCT03224403|Analgesics|analgesics|mesh-ancestor
14515980|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
14515981|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14515982|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515983|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
14515984|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14515985|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14515986|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14515987|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14515988|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14515989|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14515990|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14515991|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14515992|NCT03225313|Bupivacaine|bupivacaine|mesh-list
14515993|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14515994|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
14515995|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
14515996|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14515997|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14515998|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
14515999|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516000|NCT03226223|Methamphetamine|methamphetamine|mesh-list
14516001|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14516002|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516003|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
14516004|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
14516005|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516006|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
14516007|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516008|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516009|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516010|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14516011|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14516012|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516013|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14516014|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
14516015|NCT03226249|Doxorubicin|doxorubicin|mesh-list
14516016|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14516017|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
14516018|NCT03226249|Dacarbazine|dacarbazine|mesh-list
14516019|NCT03226249|Vinblastine|vinblastine|mesh-list
14516020|NCT03226249|Imidazole|imidazole|mesh-list
14516021|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14516022|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14516023|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516024|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14516025|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14516026|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516027|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516028|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14516029|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14516030|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
14516031|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14516032|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14516033|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
14516034|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
14516035|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
14516036|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
14516037|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
14516038|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516039|NCT03226275|Amlodipine|amlodipine|mesh-list
14516040|NCT03226275|Bisoprolol|bisoprolol|mesh-list
14791705|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791706|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791707|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14791708|NCT00742404|Dexamethasone|dexamethasone|mesh-list
14791709|NCT00742404|Doxorubicin|doxorubicin|mesh-list
14791710|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14791711|NCT00742404|Bortezomib|bortezomib|mesh-list
14516041|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14516042|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14516043|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516044|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516045|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14516046|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516047|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
14516048|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
14516049|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
14516050|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516051|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14516052|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14516053|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14516054|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516055|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516056|NCT03226457|Empagliflozin|empagliflozin|mesh-list
14516057|NCT03226457|Furosemide|furosemide|mesh-list
14516058|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14516059|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516060|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516061|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516062|NCT03226457|Diuretics|diuretics|mesh-ancestor
14516063|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
14516064|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14516065|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516066|NCT03226691|Plerixafor|plerixafor|mesh-list
14516067|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14516068|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14516069|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
14516070|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516071|NCT03226899|Colchicine|colchicine|mesh-list
14516072|NCT03226899|Allopurinol|allopurinol|mesh-list
14516073|NCT03226899|Febuxostat|febuxostat|mesh-list
14516074|NCT03226899|Lesinurad|lesinurad|mesh-list
14516075|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
14516076|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14516077|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
14516078|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
14516079|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
14516080|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516081|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516082|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
14516083|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516084|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14516085|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
14516086|NCT03226899|Protective Agents|protective agents|mesh-ancestor
14516087|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516088|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
14516089|NCT03226899|Renal Agents|renal agents|mesh-ancestor
14516090|NCT03228017|Aspirin|aspirin|mesh-list
14516091|NCT03228017|Atorvastatin|atorvastatin|mesh-list
14516092|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14516093|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14516094|NCT03228017|Analgesics|analgesics|mesh-ancestor
14516095|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
14516096|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516097|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516098|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516099|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14516100|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14516101|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14516102|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516103|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14516104|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14516105|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516106|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
14516107|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14516108|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14516109|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
14516110|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14516111|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14516112|NCT03228914|Phenylephrine|phenylephrine|mesh-list
14516113|NCT03228914|Epinephrine|epinephrine|mesh-list
14516114|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
14516115|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14516116|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14516117|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516118|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516119|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516120|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516121|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14516122|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14516123|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
14516124|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516125|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14516126|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
14516127|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
14516128|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
14516129|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14516130|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
14516131|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14516132|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14516133|NCT03228914|Protective Agents|protective agents|mesh-ancestor
14516134|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
14516135|NCT03229486|Neostigmine|neostigmine|mesh-list
14516136|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14516137|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516138|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516139|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516140|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516141|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516142|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14516143|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
14516144|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516145|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14516146|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14516147|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14516148|NCT03229759|Octenidine|octenidine|mesh-list
14516149|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516150|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14516151|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14516152|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516153|NCT03230864|Olanzapine|olanzapine|mesh-list
14948662|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14948663|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948664|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948665|NCT01534494|Psilocybin|psilocybin|mesh-list
14948666|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
14516154|NCT03230864|Risperidone|risperidone|mesh-list
14516155|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14516156|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
14516157|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516158|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516159|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516160|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14516161|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14516162|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516163|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14516164|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14516165|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
14516166|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
14516167|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
14516168|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516169|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14516170|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14516171|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14516172|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516173|NCT03231228|Cefazolin|cefazolin|mesh-list
14516174|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14516175|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516176|NCT03231371|Adenosine|adenosine|mesh-list
14516177|NCT03231371|Analgesics|analgesics|mesh-ancestor
14516178|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
14516179|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516180|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516181|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14516182|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
14516183|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14516184|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
14516185|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
14516186|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948667|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516187|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516188|NCT03231709|Alogliptin|alogliptin|mesh-list
14516189|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516190|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516191|NCT03231709|Incretins|incretins|mesh-ancestor
14516192|NCT03231709|Hormones|hormones|mesh-ancestor
14516193|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516194|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14516195|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
14516196|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516197|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516198|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14516199|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
14516200|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14516201|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
14516202|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14516203|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516204|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14516205|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14516206|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516207|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
14516208|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14516209|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516210|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
14516211|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
14948668|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14948669|NCT01534546|Capecitabine|capecitabine|mesh-list
14948670|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
14948671|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14948672|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
14948673|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516212|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516213|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516214|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14516215|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
14516216|NCT03232749|Hormones|hormones|mesh-ancestor
14516217|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516218|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14516219|NCT03232749|Protective Agents|protective agents|mesh-ancestor
14516220|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
14516221|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516222|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516223|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14516224|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14516225|NCT03233438|Dalbavancin|dalbavancin|mesh-list
14516226|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14516227|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516228|NCT03233737|Anesthetics|anesthetics|mesh-list
14516229|NCT03233737|Tetracaine|tetracaine|mesh-list
14516230|NCT03233737|Benzocaine|benzocaine|mesh-list
14791712|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791713|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
14516231|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791714|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
14791715|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791716|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791717|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791718|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
14791719|NCT00742404|Hormones|hormones|mesh-ancestor
14516232|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516233|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
14516234|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
14516235|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516236|NCT03234036|Ritonavir|ritonavir|mesh-list
14516237|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
14516238|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14516239|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14516240|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
14516241|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516242|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516243|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14516244|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14516245|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
14516246|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516247|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14516248|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14516249|NCT03234374|Bupivacaine|bupivacaine|mesh-list
14516250|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
14516251|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
14516252|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516253|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516254|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
14516255|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516256|NCT03235050|Liraglutide|liraglutide|mesh-list
14516257|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516258|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516259|NCT03235050|Incretins|incretins|mesh-ancestor
14516260|NCT03235050|Hormones|hormones|mesh-ancestor
14516261|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516262|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
14516263|NCT03235154|Velpatasvir|velpatasvir|mesh-list
14516264|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
14516265|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516266|NCT03236168|Ivermectin|ivermectin|mesh-list
14516267|NCT03236168|Permethrin|permethrin|mesh-list
14516268|NCT03236168|Malathion|malathion|mesh-list
14516269|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14516270|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516271|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516272|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516273|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14516274|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516275|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516276|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516277|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
14516278|NCT03236506|Grazoprevir|grazoprevir|mesh-list
14516279|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
14516280|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516281|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14516282|NCT03237065|Hematinics|hematinics|mesh-ancestor
14516283|NCT03237481|Bupivacaine|bupivacaine|mesh-list
14516284|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
14516285|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
14516286|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516287|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516288|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
14516289|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516290|NCT03238352|Listerine|listerine|mesh-list
14516291|NCT03238352|Fluorides|fluorides|mesh-list
14516292|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
14516293|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
14516294|NCT03238352|Protective Agents|protective agents|mesh-ancestor
14516295|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516296|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14516297|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516298|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14516299|NCT03238911|Hematinics|hematinics|mesh-ancestor
14516300|NCT03238924|Oxytocin|oxytocin|mesh-list
14516301|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
14516302|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14516303|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516304|NCT03239106|Apremilast|apremilast|mesh-list
14516305|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14516306|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14516307|NCT03239106|Analgesics|analgesics|mesh-ancestor
14516308|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
14516309|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516310|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516311|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516312|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14516313|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14516314|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14516315|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516316|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516317|NCT03239483|Dapivirine|dapivirine|mesh-list
14516318|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14516319|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14516320|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
14516321|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516322|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14516323|NCT03239522|Glycine|glycine|mesh-list
14516324|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
14948674|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948675|NCT01534585|Paclitaxel|paclitaxel|mesh-list
14948676|NCT01534585|Mitogens|mitogens|mesh-list
14948677|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14948678|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516325|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516326|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516327|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516328|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14516329|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14516330|NCT03240081|Estradiol|estradiol|mesh-list
14516331|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14516332|NCT03240081|Estrogens|estrogens|mesh-ancestor
14516333|NCT03240081|Hormones|hormones|mesh-ancestor
14516334|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516335|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516336|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14516337|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
14516338|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14516339|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14516340|NCT03240133|Berotralstat|berotralstat|mesh-list
14516341|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516342|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529265|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529266|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14529267|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14529268|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529269|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529270|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14529271|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
14529272|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529273|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529274|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14529275|NCT03772041|Tolvaptan|tolvaptan|mesh-list
14529276|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14529277|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529278|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
14529279|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529280|NCT03774745|Mifepristone|mifepristone|mesh-list
14529281|NCT03774745|Progesterone|progesterone|mesh-list
14529282|NCT03774745|Progestins|progestins|mesh-ancestor
14529283|NCT03774745|Hormones|hormones|mesh-ancestor
14529284|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529285|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529286|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14529287|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
14529288|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14529289|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14529290|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14529291|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14529292|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
14529293|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14529294|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14516343|NCT03240575|Fluticasone|fluticasone|mesh-list
14516344|NCT03240575|Xhance|xhance|mesh-list
14516345|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
14516346|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14516347|NCT03240575|Olodaterol|olodaterol|mesh-list
14516348|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516349|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14516350|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
14516351|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516352|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516353|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14516354|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14516355|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
14516356|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14516357|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
14516358|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14516359|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516360|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516361|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516362|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14516363|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14516364|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14516365|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516366|NCT03241030|Acetaminophen|acetaminophen|mesh-list
14516367|NCT03241030|Ibuprofen|ibuprofen|mesh-list
14516368|NCT03241030|Sucralfate|sucralfate|mesh-list
14516369|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14516370|NCT03241030|Analgesics|analgesics|mesh-ancestor
14516371|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
14516372|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516373|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516374|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
14516375|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14516376|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516377|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13968254|NCT03111966|Grazoprevir|grazoprevir|mesh-list
14516378|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14516379|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516380|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516381|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14516382|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14516383|NCT03241485|Morphine|morphine|mesh-list
14516384|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14516385|NCT03241485|Narcotics|narcotics|mesh-ancestor
14516386|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516387|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516388|NCT03241485|Analgesics|analgesics|mesh-ancestor
14516389|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
14516390|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516391|NCT03241810|Fulvestrant|fulvestrant|mesh-list
14516392|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14516393|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516394|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14516395|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14516396|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
14516397|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516398|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516399|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
14516400|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14516401|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516402|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14516403|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14516404|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516405|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516406|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516407|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14516408|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14516409|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516410|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516411|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516412|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
14516413|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14516414|NCT03242408|Testosterone|testosterone|mesh-list
14516415|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
14516416|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
14516417|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14516418|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516419|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
14516420|NCT03242408|Hormones|hormones|mesh-ancestor
14516421|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516422|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516423|NCT03242408|Androgens|androgens|mesh-ancestor
14516424|NCT03242434|Mannitol|mannitol|mesh-list
14516425|NCT03242434|Lactulose|lactulose|mesh-list
14516426|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14516427|NCT03242434|Diuretics|diuretics|mesh-ancestor
14516428|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
14516429|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516430|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14516431|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
14516432|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14516433|NCT03242590|Testosterone|testosterone|mesh-list
14516434|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
14516435|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
14516436|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14516437|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516438|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
14516439|NCT03242590|Hormones|hormones|mesh-ancestor
14516440|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516441|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516442|NCT03242590|Androgens|androgens|mesh-ancestor
14516443|NCT03242759|Pirfenidone|pirfenidone|mesh-list
14516444|NCT03242759|Nintedanib|nintedanib|mesh-list
14516445|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516446|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14516447|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516448|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516449|NCT03242759|Analgesics|analgesics|mesh-ancestor
14516450|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
14516451|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516452|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516453|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14516454|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14516455|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516456|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14516457|NCT03243630|Menthol|menthol|mesh-list
14516458|NCT03243630|Nicotine|nicotine|mesh-list
14516459|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14516460|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
14516461|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516462|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516463|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14516464|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14516465|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516466|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516467|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516468|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
13968255|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
14516469|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
14516470|NCT03244618|Fluorides|fluorides|mesh-list
14516471|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
14516472|NCT03244618|Protective Agents|protective agents|mesh-ancestor
14516473|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516474|NCT03245398|Mebendazole|mebendazole|mesh-list
14516475|NCT03245398|Piperazine|piperazine|mesh-list
14516476|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
14516477|NCT03245398|DMP 777|dmp 777|mesh-list
14516478|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
14516479|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
14516480|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14516481|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516482|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
14516483|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
14516484|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
14516485|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516486|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516487|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516488|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
14516489|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14516490|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
14516491|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516492|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
14516493|NCT03245463|Protective Agents|protective agents|mesh-ancestor
14516494|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
14516495|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14516496|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516497|NCT03245762|Oxytocin|oxytocin|mesh-list
14516498|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
14516499|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14516500|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516501|NCT03246152|Bevacizumab|bevacizumab|mesh-list
14516502|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14516503|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516504|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14516505|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14516506|NCT03246152|Growth Substances|growth substances|mesh-ancestor
14516507|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516508|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
14516509|NCT03246724|Midazolam|midazolam|mesh-list
14516510|NCT03246724|Triazolam|triazolam|mesh-list
14516511|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14516512|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14516513|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516514|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516515|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14516516|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14516517|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14516518|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14516519|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
14516520|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
14516521|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
14516522|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
14516523|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516524|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516525|NCT03247673|Bevacizumab|bevacizumab|mesh-list
14516526|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14516527|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516528|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14516529|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14516530|NCT03247673|Growth Substances|growth substances|mesh-ancestor
14516531|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516532|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14516533|NCT03247738|Cangrelor|cangrelor|mesh-list
14516534|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14516535|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14516536|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14516537|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14516538|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
14516539|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516540|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516541|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516542|NCT03247790|Lasmiditan|lasmiditan|mesh-list
14516543|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14516544|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
14516545|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516546|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516547|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516548|NCT03248947|Buprenorphine|buprenorphine|mesh-list
14516549|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14516550|NCT03248947|Naloxone|naloxone|mesh-list
14516551|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14516552|NCT03248947|Narcotics|narcotics|mesh-ancestor
14516553|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516554|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516555|NCT03248947|Analgesics|analgesics|mesh-ancestor
14516556|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
14516557|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516558|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14516559|NCT03249272|Adenosine|adenosine|mesh-list
14516560|NCT03249272|Regadenoson|regadenoson|mesh-list
14516561|NCT03249272|Analgesics|analgesics|mesh-ancestor
14516562|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
14516563|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516564|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516565|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14516566|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
14516567|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14516568|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
14516569|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
14516570|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516571|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516572|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14516573|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14516574|NCT03249909|Laxatives|laxatives|mesh-ancestor
14516575|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14516576|NCT03249935|Azithromycin|azithromycin|mesh-list
14516577|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14516578|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516579|NCT03250182|Budesonide|budesonide|mesh-list
14516580|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
14516581|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
14516582|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516583|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14516584|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
14516585|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516586|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516587|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14516588|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
14516589|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
14516590|NCT03250182|Hormones|hormones|mesh-ancestor
14516591|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516592|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14516593|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14516594|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14516595|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516596|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516597|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516598|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14516599|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14516600|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14516601|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516602|NCT03251482|Apixaban|apixaban|mesh-list
14516603|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14516604|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
14516605|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14516606|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
14516607|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516608|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516609|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
14516610|NCT03251963|Enoxaparin|enoxaparin|mesh-list
14516611|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
14516612|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
14516613|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14516614|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14516615|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516616|NCT03252015|Lasmiditan|lasmiditan|mesh-list
14516617|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14516618|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
14516619|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516620|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516621|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516622|NCT03252353|Octreotide|octreotide|mesh-list
14516623|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14516624|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14516625|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516626|NCT03253094|Fluconazole|fluconazole|mesh-list
14516627|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
14516628|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
14516629|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516630|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14516631|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14516632|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516633|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516634|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14516635|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
14516636|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516637|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516638|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14516639|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14516640|NCT03254108|Tolvaptan|tolvaptan|mesh-list
14516641|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14516642|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516643|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
14516644|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516645|NCT03254134|Warfarin|warfarin|mesh-list
14516646|NCT03254134|Dabigatran|dabigatran|mesh-list
14516647|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
14516648|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
14516649|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14516650|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
14516651|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516652|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516653|NCT03254147|Warfarin|warfarin|mesh-list
14516654|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
14516655|NCT03254147|Dabigatran|dabigatran|mesh-list
14516656|NCT03254147|Apixaban|apixaban|mesh-list
14516657|NCT03254147|Edoxaban|edoxaban|mesh-list
14516658|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
14516659|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14516660|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
14516661|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14516662|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14516663|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516664|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516665|NCT03254459|Morphine|morphine|mesh-list
14516666|NCT03254459|Oxycodone|oxycodone|mesh-list
14516667|NCT03254459|Buprenorphine|buprenorphine|mesh-list
14516668|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14516669|NCT03254459|Narcotics|narcotics|mesh-ancestor
14516670|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516671|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516672|NCT03254459|Analgesics|analgesics|mesh-ancestor
14516673|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
14516674|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516675|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14516676|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14516677|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
14516678|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14516679|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
14516680|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516681|NCT03255824|Fentanyl|fentanyl|mesh-list
14516682|NCT03255824|Midazolam|midazolam|mesh-list
14516683|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
14516684|NCT03255824|Propofol|propofol|mesh-list
14516685|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14516686|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516687|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516688|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14516689|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
14516690|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
14516691|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14516692|NCT03255824|Analgesics|analgesics|mesh-ancestor
14516693|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
14516694|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516695|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14516696|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14516697|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14516698|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516699|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516700|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516701|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14516702|NCT03255824|Narcotics|narcotics|mesh-ancestor
14516703|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14516704|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14516705|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14516706|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14516707|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
14516708|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
14516709|NCT03256136|Carboplatin|carboplatin|mesh-list
14516710|NCT03256136|Nivolumab|nivolumab|mesh-list
14516711|NCT03256136|Pemetrexed|pemetrexed|mesh-list
14516712|NCT03256136|Ipilimumab|ipilimumab|mesh-list
14516713|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516714|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14516715|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14516716|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516717|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516718|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14516719|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14516720|NCT03256162|Midazolam|midazolam|mesh-list
14516721|NCT03256162|Ketamine|ketamine|mesh-list
14516722|NCT03256162|Analgesics|analgesics|mesh-ancestor
14516723|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
14516724|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516725|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516726|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14516727|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14516728|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
14516729|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
14516730|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516731|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14516732|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14516733|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516734|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516735|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14516736|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14516737|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14516738|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14516739|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14516740|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
14516741|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
14516742|NCT03256253|Pregabalin|pregabalin|mesh-list
14516743|NCT03256253|Analgesics|analgesics|mesh-ancestor
14516744|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
14516745|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516746|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516747|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
14516748|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14516749|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516750|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516751|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14516752|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14516753|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14516754|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516755|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14516756|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
14516757|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14516758|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14516759|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14516760|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516761|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516762|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516763|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516764|NCT03256695|Albuterol|albuterol|mesh-list
14516765|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14516766|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
14516767|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516768|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516769|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14516770|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
14516771|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
14516772|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14516773|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14516774|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14516775|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14516776|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516777|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516778|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516779|NCT03256799|Ivacaftor|ivacaftor|mesh-list
14516780|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14516781|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516782|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529295|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
14529296|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
14529297|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14529298|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14529299|NCT03771560|Leucovorin|leucovorin|mesh-list
14529300|NCT03771560|Folic Acid|folic acid|mesh-list
14529301|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
14529302|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529303|NCT03771560|Antidotes|antidotes|mesh-ancestor
14529304|NCT03771560|Protective Agents|protective agents|mesh-ancestor
14529305|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
14529306|NCT03771560|Vitamins|vitamins|mesh-ancestor
14529307|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
14529308|NCT03771560|Hematinics|hematinics|mesh-ancestor
14529309|NCT03770091|Allantoin|allantoin|mesh-list
13965217|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529310|NCT03770091|Dermatologic Agents|dermatologic agents|mesh-ancestor
14516783|NCT03257202|Clindamycin|clindamycin|mesh-list
14516784|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
14516785|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
14516786|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14516787|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14516788|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516789|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14516790|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516791|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516792|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
14516793|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14516794|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14516795|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516796|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14516797|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
14516798|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516799|NCT03257631|Thalidomide|thalidomide|mesh-list
14516800|NCT03257631|Pomalidomide|pomalidomide|mesh-list
14516801|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
14516802|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516803|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14516804|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14516805|NCT03257631|Growth Substances|growth substances|mesh-ancestor
14516806|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
14516807|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516808|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14516809|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
14516810|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14516811|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516812|NCT03257813|Timolol|timolol|mesh-list
14516813|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14516814|NCT03257813|Dorzolamide|dorzolamide|mesh-list
14516815|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14516816|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14516817|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
14516818|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516819|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516820|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516821|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14516822|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14516823|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14516824|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14516825|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14516826|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14516827|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516828|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
14516829|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
14516830|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516831|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516832|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516833|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
14516834|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
14516835|NCT03257995|Maleic acid|maleic acid|mesh-list
14516836|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516837|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516838|NCT03258645|Dabigatran|dabigatran|mesh-list
14948679|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14516839|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
14529311|NCT03769896|Nabilone|nabilone|mesh-list
14516840|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14516841|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
14516842|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516843|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516844|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
14516845|NCT03258710|Tenofovir|tenofovir|mesh-list
14516846|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
14516847|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516848|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14516849|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14516850|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516851|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516852|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14516853|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14516854|NCT03258762|Leucovorin|leucovorin|mesh-list
14516855|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
14516856|NCT03258762|Calcium|calcium|mesh-list
14516857|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
14516858|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14516859|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516860|NCT03258762|Antidotes|antidotes|mesh-ancestor
14516861|NCT03258762|Protective Agents|protective agents|mesh-ancestor
14516862|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
14516863|NCT03258762|Vitamins|vitamins|mesh-ancestor
14516864|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
14516865|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
14516866|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14516867|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14516868|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516869|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14516870|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516871|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516872|NCT03259425|Nivolumab|nivolumab|mesh-list
14516873|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14516874|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516875|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14516876|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516877|NCT03259490|Metformin|metformin|mesh-list
14516878|NCT03259490|Empagliflozin|empagliflozin|mesh-list
14516879|NCT03259490|Linagliptin|linagliptin|mesh-list
14516880|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516881|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516882|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14516883|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516884|NCT03259490|Incretins|incretins|mesh-ancestor
14516885|NCT03259490|Hormones|hormones|mesh-ancestor
14516886|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516887|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14516888|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
14516889|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516890|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
14516891|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
14516892|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516893|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516894|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516895|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
14516896|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
14516897|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
14516898|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14516899|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516900|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14948680|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
13965218|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14516901|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14516902|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516903|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14516904|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14516905|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516906|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516907|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
14516908|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516909|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14516910|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
14516911|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516912|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
14516913|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14516914|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14516915|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14516916|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516917|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516918|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516919|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516920|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516921|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14516922|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516923|NCT03261336|Vitamin D|vitamin d|mesh-list
14516924|NCT03261336|Calcitriol|calcitriol|mesh-list
14516925|NCT03261336|Ketoconazole|ketoconazole|mesh-list
14516926|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
14516927|NCT03261336|Vitamins|vitamins|mesh-ancestor
14516928|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
14516929|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516930|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14516931|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14516932|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14516933|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
14516934|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516935|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14516936|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14516937|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516938|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516939|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14516940|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
14516941|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14516942|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14516943|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14516944|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14516945|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14516946|NCT03261999|Leuprolide|leuprolide|mesh-list
14516947|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14516948|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
14516949|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14516950|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516951|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14516952|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516953|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14516954|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14516955|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
14516956|NCT03262038|Ondansetron|ondansetron|mesh-list
14516957|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
14516958|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
14516959|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516960|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516961|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14516962|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
14516963|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
14516964|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14516965|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
14516966|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516967|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516968|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14516969|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14516970|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14516971|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14516972|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14516973|NCT03262233|Nicotine|nicotine|mesh-list
14516974|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14516975|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
14516976|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14516977|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14516978|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14516979|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14516980|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
14516981|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14516982|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516983|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14516984|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14516985|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516986|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
14516987|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14516988|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14516989|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14516990|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
14516991|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14516992|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14516993|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14516994|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14516995|NCT03263442|Thiamine|thiamine|mesh-list
14516996|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
14516997|NCT03263442|Vitamins|vitamins|mesh-ancestor
14516998|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
14516999|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517000|NCT03264066|Atezolizumab|atezolizumab|mesh-list
14517001|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14517002|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517003|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
14517004|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517005|NCT03264157|Vaccines|vaccines|mesh-list
14517006|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
14517007|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517008|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14517009|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517010|NCT03266419|Rocuronium|rocuronium|mesh-list
14517011|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14517012|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14517013|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14517014|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517015|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517016|NCT03267576|Metformin|metformin|mesh-list
14517017|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14517018|NCT03267576|Canagliflozin|canagliflozin|mesh-list
14517019|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517020|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517021|NCT03267576|Incretins|incretins|mesh-ancestor
14517022|NCT03267576|Hormones|hormones|mesh-ancestor
14517023|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517024|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14517025|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
14517026|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517027|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517028|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14517029|NCT03267940|Atezolizumab|atezolizumab|mesh-list
14517030|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517031|NCT03268941|Metoclopramide|metoclopramide|mesh-list
14517032|NCT03268941|Maleic acid|maleic acid|mesh-list
14517033|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517034|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517035|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
14517036|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
14517037|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517038|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517039|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517040|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14517041|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14517042|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
14517043|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517044|NCT03269435|Metoclopramide|metoclopramide|mesh-list
14517045|NCT03269435|Bupivacaine|bupivacaine|mesh-list
14517046|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517047|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
14529312|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
14517048|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517049|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517050|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
14517051|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517052|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
14517053|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
14517054|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517055|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14517056|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14517057|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
14517058|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517059|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517060|NCT03269552|Rituximab|rituximab|mesh-list
14517061|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14517062|NCT03269552|Antibodies|antibodies|mesh-list
14948681|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14948682|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948683|NCT01534702|Cytarabine|cytarabine|mesh-list
14948684|NCT01534702|Clofarabine|clofarabine|mesh-list
14948685|NCT01534702|Idarubicin|idarubicin|mesh-list
14948686|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14948687|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
14948688|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948689|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517063|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
14517064|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14517065|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
14517066|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517067|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517068|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517069|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14517070|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14517071|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14517072|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
14517073|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517074|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14517075|NCT03270332|Albuterol|albuterol|mesh-list
14517076|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14517077|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
14517078|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948690|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
14948691|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948692|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948693|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
14517079|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517080|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14517081|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
14517082|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
14517083|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14517084|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14517085|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14517086|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14791720|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791721|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14791722|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791723|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14791724|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14791725|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14791726|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791727|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517087|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
14517088|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517089|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517090|NCT03270514|Bupivacaine|bupivacaine|mesh-list
14517091|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517092|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
14517093|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517094|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517095|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
14517096|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517097|NCT03270644|Propranolol|propranolol|mesh-list
14791728|NCT00742638|Valproic Acid|valproic acid|mesh-list
14517098|NCT03270644|Lasmiditan|lasmiditan|mesh-list
14948694|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517099|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14517100|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14517101|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
14517102|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517103|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517104|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517105|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14517106|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14517107|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
14517108|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14517109|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
14517110|NCT03271528|Lacosamide|lacosamide|mesh-list
14517111|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
14517112|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14517113|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14517114|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14517115|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517116|NCT03272139|Bupivacaine|bupivacaine|mesh-list
14517117|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517118|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
14517119|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517120|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517121|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
14517122|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517123|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
14517124|NCT03273153|Atezolizumab|atezolizumab|mesh-list
14517125|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517126|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517127|NCT03273257|Riociguat|riociguat|mesh-list
14517128|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
14517129|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517130|NCT03273387|Trimetazidine|trimetazidine|mesh-list
14517131|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
14517132|NCT03273946|Fluticasone|fluticasone|mesh-list
14517133|NCT03273946|Xhance|xhance|mesh-list
14517134|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14517135|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14517136|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
14517137|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517138|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517139|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14517140|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
14517141|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
14517142|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14517143|NCT03274076|Tofacitinib|tofacitinib|mesh-list
14517144|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14517145|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517146|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517147|NCT03274453|Ketamine|ketamine|mesh-list
14517148|NCT03274453|Analgesics|analgesics|mesh-ancestor
14517149|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
14517150|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517151|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517152|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14517153|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14517154|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
14517155|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
14517156|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517157|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14517158|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14517159|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517160|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517161|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14517162|NCT03274466|Laxatives|laxatives|mesh-ancestor
14517163|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517164|NCT03274804|Maraviroc|maraviroc|mesh-list
14517165|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
14517166|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517167|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517168|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14517169|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14517170|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517171|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14529313|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
14517172|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14517173|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
14517174|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517175|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14517176|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14517177|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529314|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529315|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529316|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529317|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14529318|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14529319|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529320|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529321|NCT03768726|Ziprasidone|ziprasidone|mesh-list
14529322|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14529323|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
14529324|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529325|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529326|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529327|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14529328|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14529329|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529330|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529331|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14529332|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
14529333|NCT03767738|Aflibercept|aflibercept|mesh-list
14529334|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14529335|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14529336|NCT03767738|Growth Substances|growth substances|mesh-ancestor
14529337|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529338|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
14529339|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529340|NCT03767062|Topiramate|topiramate|mesh-list
14529341|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
14529342|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14529343|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529344|NCT03765502|Glucagon|glucagon|mesh-list
14529345|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14529346|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529347|NCT03765502|Hormones|hormones|mesh-ancestor
14529348|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529349|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529350|NCT03765502|Incretins|incretins|mesh-ancestor
14529351|NCT03765138|Pramipexole|pramipexole|mesh-list
14529352|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
14529353|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529354|NCT03765138|Protective Agents|protective agents|mesh-ancestor
14529355|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529356|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14529357|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14529358|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
14529359|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
14529360|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529361|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14529362|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
14529363|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529364|NCT03763929|Protective Agents|protective agents|mesh-ancestor
14529365|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529366|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14529367|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529368|NCT03763175|Lovastatin|lovastatin|mesh-list
14529369|NCT03763175|L 647318|l 647318|mesh-list
14529370|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
14529371|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14529372|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14529373|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
14529374|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529375|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14529376|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14529377|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529378|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
14529379|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14529380|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529381|NCT03760250|Imiquimod|imiquimod|mesh-list
14529382|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14529383|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
14517178|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
14517179|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
14517180|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14517181|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14517182|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517183|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517184|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517185|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517186|NCT03276026|Neostigmine|neostigmine|mesh-list
14517187|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14517188|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517189|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517190|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
14517191|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517192|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517193|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14517194|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
14517195|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948695|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14948696|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14948697|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14948698|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948699|NCT01534754|Mesalamine|mesalamine|mesh-list
14948700|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948701|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948702|NCT01534754|Analgesics|analgesics|mesh-ancestor
14948703|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
14948704|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948705|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948706|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948707|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948708|NCT01534806|Ketorolac|ketorolac|mesh-list
14948709|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948710|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948711|NCT01534806|Analgesics|analgesics|mesh-ancestor
14948712|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
14948713|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948714|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948715|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948716|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517196|NCT03276078|Bromides|bromides|mesh-list
14517197|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
14517198|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14517199|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
14517200|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517201|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517202|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14517203|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
14517204|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14517205|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14517206|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14517207|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
14517208|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517209|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517210|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
14517211|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14517212|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
14517213|NCT03276975|Coagulants|coagulants|mesh-ancestor
14517214|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
14517215|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517216|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517217|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14517218|NCT03278106|Trifluridine|trifluridine|mesh-list
14517219|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
14517220|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517221|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
14517222|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517223|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14517224|NCT03278886|Naltrexone|naltrexone|mesh-list
14517225|NCT03278886|Nalmefene|nalmefene|mesh-list
14517226|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14517227|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14517228|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517229|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
14517230|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948717|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14517231|NCT03279237|Leucovorin|leucovorin|mesh-list
14517232|NCT03279237|Paclitaxel|paclitaxel|mesh-list
14517233|NCT03279237|Carboplatin|carboplatin|mesh-list
14517234|NCT03279237|Fluorouracil|fluorouracil|mesh-list
14517235|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
14517236|NCT03279237|Irinotecan|irinotecan|mesh-list
14517237|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14517238|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517239|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
14517240|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
14517241|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
14517242|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517243|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
14517244|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14517245|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14517246|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
14517247|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517248|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14517249|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14517250|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517251|NCT03279237|Antidotes|antidotes|mesh-ancestor
14517252|NCT03279237|Protective Agents|protective agents|mesh-ancestor
14517253|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
14517254|NCT03279237|Vitamins|vitamins|mesh-ancestor
14517255|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
14517256|NCT03279731|Liraglutide|liraglutide|mesh-list
14517257|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517258|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517259|NCT03279731|Incretins|incretins|mesh-ancestor
14517260|NCT03279731|Hormones|hormones|mesh-ancestor
14517261|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517262|NCT03280537|Omalizumab|omalizumab|mesh-list
14517263|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14517264|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14517265|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
14517266|NCT03280550|Omalizumab|omalizumab|mesh-list
14517267|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14517268|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14517269|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
14517270|NCT03281200|Nintedanib|nintedanib|mesh-list
14517271|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
14517272|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
14517273|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517274|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517275|NCT03281304|Tofacitinib|tofacitinib|mesh-list
14517276|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14517277|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517278|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517279|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
14517280|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
14517281|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14517282|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14517283|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
14517284|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517285|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517286|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517287|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517288|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14517289|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517290|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
14517291|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517292|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14517293|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
14517294|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
14517295|NCT03282357|Protective Agents|protective agents|mesh-ancestor
14517296|NCT03282591|Serlopitant|serlopitant|mesh-list
14517297|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14517298|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517299|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517300|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517301|NCT03283436|Bupivacaine|bupivacaine|mesh-list
14517302|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517303|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
14517304|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517305|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517306|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
14517307|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517308|NCT03283696|Doxorubicin|doxorubicin|mesh-list
14517309|NCT03283696|Ifosfamide|ifosfamide|mesh-list
14517310|NCT03283696|Olaratumab|olaratumab|mesh-list
14517311|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14517312|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517313|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14517314|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14517315|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517316|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517317|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14517318|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
14517319|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
14517320|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517321|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517322|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
14517323|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
14517324|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517325|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
14517326|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517327|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517328|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
14517329|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517330|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517331|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
14517332|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14517333|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517334|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517335|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14517336|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517337|NCT03285646|Fasinumab|fasinumab|mesh-list
14517338|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14517339|NCT03285646|Analgesics|analgesics|mesh-ancestor
14517340|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
14517341|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517342|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517343|NCT03285984|Listerine|listerine|mesh-list
14517344|NCT03285984|Fluorides|fluorides|mesh-list
14517345|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
14517346|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
14517347|NCT03285984|Protective Agents|protective agents|mesh-ancestor
14517348|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517349|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14517350|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517351|NCT03286218|Alprazolam|alprazolam|mesh-list
14517352|NCT03286218|Lasmiditan|lasmiditan|mesh-list
14517353|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14517354|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517355|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517356|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14517357|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14517358|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14517359|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
14517360|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
14517361|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517362|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517363|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14517364|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
14517365|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
14517366|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517367|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517368|NCT03286829|Metoprolol|metoprolol|mesh-list
14517369|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14517370|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14517371|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
14517372|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
14517373|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517374|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517375|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14517376|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14517377|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14517378|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
14517379|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517380|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517381|NCT03287219|Methylene Blue|methylene blue|mesh-list
14517382|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517383|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517384|NCT03287310|Albuterol|albuterol|mesh-list
14517385|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14517386|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
14517387|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517388|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517389|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14517390|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
14517391|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
14517392|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14517393|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14517394|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14517395|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14517396|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
14517397|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517398|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517399|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14517400|NCT03287635|Hormones|hormones|mesh-ancestor
14517401|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517402|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517403|NCT03287674|Vidarabine|vidarabine|mesh-list
14517404|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
14517405|NCT03287674|Nivolumab|nivolumab|mesh-list
14517406|NCT03287674|Fludarabine|fludarabine|mesh-list
14517407|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
14517408|NCT03287674|Ipilimumab|ipilimumab|mesh-list
14517409|NCT03287674|Interleukin-2|interleukin-2|mesh-list
14517410|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14517411|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
14517412|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517413|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517414|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14517415|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
14517416|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517417|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517418|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14517419|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517420|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14517421|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14517422|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
14517423|NCT03287674|Antiviral Agents|antiviral agents|mesh-ancestor
14517424|NCT03287674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517425|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14517426|NCT03287674|Analgesics|analgesics|mesh-ancestor
14517427|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
14517428|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517429|NCT03287791|Azelaic acid|azelaic acid|mesh-list
14517430|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
14517431|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14517432|NCT03287791|Protective Agents|protective agents|mesh-ancestor
14517433|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517434|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
14517435|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517436|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
14517437|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
14517438|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517439|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517440|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517441|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
14517442|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
14517443|NCT03288987|Leucovorin|leucovorin|mesh-list
14517444|NCT03288987|Bevacizumab|bevacizumab|mesh-list
14517445|NCT03288987|Fluorouracil|fluorouracil|mesh-list
14517446|NCT03288987|Irinotecan|irinotecan|mesh-list
14517447|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517448|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517449|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14517450|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14517451|NCT03288987|Growth Substances|growth substances|mesh-ancestor
14517452|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517453|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
14517454|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
14517455|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517456|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14517457|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14517458|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
14517459|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14517460|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14517461|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517462|NCT03288987|Antidotes|antidotes|mesh-ancestor
14517463|NCT03288987|Protective Agents|protective agents|mesh-ancestor
14517464|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
14517465|NCT03288987|Vitamins|vitamins|mesh-ancestor
14517466|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
14517467|NCT03289208|Edaravone|edaravone|mesh-list
14517468|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14517469|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
14517470|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517471|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14517472|NCT03289208|Protective Agents|protective agents|mesh-ancestor
14517473|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517474|NCT03289234|Edaravone|edaravone|mesh-list
14517475|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14517476|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
14517477|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517478|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14517479|NCT03289234|Protective Agents|protective agents|mesh-ancestor
14517480|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517481|NCT03289533|Avelumab|avelumab|mesh-list
14517482|NCT03289533|Axitinib|axitinib|mesh-list
14517483|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517484|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517485|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14517486|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517487|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517488|NCT03289676|Nicotine|nicotine|mesh-list
14517489|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14517490|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
14517491|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517492|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517493|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14517494|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14517495|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
14517496|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517497|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517498|NCT03289858|Bupivacaine|bupivacaine|mesh-list
14517499|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517500|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
14517501|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517502|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517503|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
14517504|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517505|NCT03290027|Tazarotene|tazarotene|mesh-list
14517506|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
14517507|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
14517508|NCT03290378|Tramadol|tramadol|mesh-list
14517509|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14517510|NCT03290378|Narcotics|narcotics|mesh-ancestor
14517511|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517512|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517513|NCT03290378|Analgesics|analgesics|mesh-ancestor
14517514|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
14517515|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517516|NCT03291080|Tretinoin|tretinoin|mesh-list
14517517|NCT03291080|Isotretinoin|isotretinoin|mesh-list
14517518|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517519|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
14517520|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
14529384|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529385|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529386|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
14529387|NCT03759600|Niraparib|niraparib|mesh-list
14529388|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14529389|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529390|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529391|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529392|NCT03758365|Triamcinolone|triamcinolone|mesh-list
14529393|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14529394|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14529395|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
14529396|NCT03758365|Betamethasone|betamethasone|mesh-list
14529397|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
14529398|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14529399|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
14529400|NCT03758365|Clobetasol|clobetasol|mesh-list
14529401|NCT03758365|Desonide|desonide|mesh-list
14529402|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
14529403|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14529404|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14529405|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529406|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
14529407|NCT03758365|Hormones|hormones|mesh-ancestor
14529408|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529409|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529410|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14529411|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
14529412|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529413|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529414|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14529415|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
14529416|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
14529417|NCT03757234|Levofloxacin|levofloxacin|mesh-list
14529418|NCT03757234|Ofloxacin|ofloxacin|mesh-list
14529419|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14529420|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529421|NCT03757234|Renal Agents|renal agents|mesh-ancestor
14529422|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14529423|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14529424|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14529425|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529426|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529427|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529428|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14529429|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14529430|NCT03756883|Fluticasone|fluticasone|mesh-list
14529431|NCT03756883|Xhance|xhance|mesh-list
14529432|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14529433|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14529434|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529435|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14529436|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
14529437|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529438|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529439|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14529440|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
14529441|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
14529442|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14529443|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14529444|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14529445|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14529446|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
14529447|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529448|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529449|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
14529450|NCT03756883|Hormones|hormones|mesh-ancestor
14529451|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529452|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
14529453|NCT03756129|Ketamine|ketamine|mesh-list
14529454|NCT03756129|Analgesics|analgesics|mesh-ancestor
14529455|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
14529456|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529457|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517521|NCT03291197|Bupivacaine|bupivacaine|mesh-list
14517522|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517523|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
14517524|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517525|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517526|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
14517527|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517528|NCT03291288|Tolbutamide|tolbutamide|mesh-list
14517529|NCT03291288|Midazolam|midazolam|mesh-list
14517530|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14517531|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14517532|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517533|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517534|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14517535|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14517536|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14517537|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14517538|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
14517539|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
14517540|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
14517541|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
14517542|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517543|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517544|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517545|NCT03292016|Apomorphine|apomorphine|mesh-list
14517546|NCT03292016|Emetics|emetics|mesh-ancestor
14517547|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517548|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
14517549|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517550|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517551|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
14517552|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
14517553|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517554|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517555|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
14517556|NCT03292640|Tazarotene|tazarotene|mesh-list
14517557|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
14517558|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
14517559|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
14517560|NCT03292640|Vitamins|vitamins|mesh-ancestor
14517561|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
14517562|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517563|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14517564|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14517565|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517566|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517567|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517568|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14517569|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14517570|NCT03293485|Imipenem|imipenem|mesh-list
14517571|NCT03293485|Relebactam|relebactam|mesh-list
14517572|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14517573|NCT03293485|Cilastatin|cilastatin|mesh-list
14517574|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14517575|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517576|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
14517577|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517578|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517579|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14517580|NCT03293654|Bevacizumab|bevacizumab|mesh-list
14517581|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517582|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517583|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14517584|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14517585|NCT03293654|Growth Substances|growth substances|mesh-ancestor
14517586|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517587|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
14517588|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14517589|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14517590|NCT03294538|Estradiol|estradiol|mesh-list
14517591|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14517592|NCT03294538|Estrogens|estrogens|mesh-ancestor
14517593|NCT03294538|Hormones|hormones|mesh-ancestor
14517594|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517595|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517596|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14517597|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
14517598|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14517599|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14517600|NCT03295721|Bupivacaine|bupivacaine|mesh-list
14517601|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517602|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
14517603|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517604|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517605|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
14517606|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517607|NCT03296072|Listerine|listerine|mesh-list
14517608|NCT03296072|Fluorides|fluorides|mesh-list
14517609|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
14517610|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
14517611|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
14517612|NCT03296072|Protective Agents|protective agents|mesh-ancestor
14517613|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517614|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14517615|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517616|NCT03296163|Paclitaxel|paclitaxel|mesh-list
14517617|NCT03296163|Bevacizumab|bevacizumab|mesh-list
14517618|NCT03296163|Carboplatin|carboplatin|mesh-list
14517619|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14517620|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517621|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14517622|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14517623|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14517624|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517625|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517626|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14517627|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14517628|NCT03296163|Growth Substances|growth substances|mesh-ancestor
14517629|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517630|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
14517631|NCT03296345|Ketamine|ketamine|mesh-list
14517632|NCT03296345|Analgesics|analgesics|mesh-ancestor
14517633|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
14517634|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517635|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517636|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14517637|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14517638|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
14517639|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
14517640|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517641|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14517642|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14517643|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517644|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517645|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14517646|NCT03296527|Hormones|hormones|mesh-ancestor
14517647|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517648|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517649|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
14517650|NCT03296800|Rifampin|rifampin|mesh-list
14517651|NCT03296800|Probenecid|probenecid|mesh-list
14517652|NCT03296800|Verapamil|verapamil|mesh-list
14517653|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14517654|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
14517655|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14517656|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517657|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
14517658|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14517659|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517660|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517661|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14517662|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14517663|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14517664|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14517665|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14517666|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14517667|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14517668|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14517669|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14517670|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14517671|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517672|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
14517673|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
14517674|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
14517675|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517676|NCT03296800|Renal Agents|renal agents|mesh-ancestor
14517677|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517678|NCT03297021|Ondansetron|ondansetron|mesh-list
14517679|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
14517680|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
14517681|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517682|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517683|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517684|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
14517685|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
14517686|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14517687|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
14517688|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517689|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517690|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14517691|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14517692|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517693|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14517694|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14517695|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14517696|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14517697|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14517698|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
14517699|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517700|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517701|NCT03297216|Progestins|progestins|mesh-ancestor
14517702|NCT03297216|Hormones|hormones|mesh-ancestor
14517703|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
14517704|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
14517705|NCT03297398|Androgens|androgens|mesh-list
14517706|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14517707|NCT03297398|Hormones|hormones|mesh-ancestor
14517708|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517709|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517710|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
14517711|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517712|NCT03297398|Protective Agents|protective agents|mesh-ancestor
14517713|NCT03297398|Vitamins|vitamins|mesh-ancestor
14517714|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
14948718|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948719|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948720|NCT01534845|Temozolomide|temozolomide|mesh-list
14948721|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14948722|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
14948723|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948724|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948725|NCT01534858|Polihexanide|polihexanide|mesh-list
14948726|NCT01534858|Betaine|betaine|mesh-list
14948727|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14948728|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
14948729|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14948730|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
14948731|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948732|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14948733|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
14948734|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948735|NCT01534884|Rituximab|rituximab|mesh-list
14948736|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948737|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948738|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
14948739|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948740|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948741|NCT01534949|Rituximab|rituximab|mesh-list
14948742|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948743|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948744|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
14517715|NCT03297398|Estrogens|estrogens|mesh-ancestor
14948745|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791729|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14791730|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
14791731|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14791732|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14791733|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14791734|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791735|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791736|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
14791737|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517716|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14517717|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517718|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
14517719|NCT03297944|Zolpidem|zolpidem|mesh-list
14517720|NCT03297944|Alprazolam|alprazolam|mesh-list
14517721|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14517722|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14517723|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517724|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517725|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14517726|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
14517727|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
14517728|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791738|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791739|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
14791740|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791741|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
14791742|NCT00742690|Terlipressin|terlipressin|mesh-list
14791743|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14791744|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14791745|NCT00742768|Vitamins|vitamins|mesh-list
14791746|NCT00742768|Vitamin K|vitamin k|mesh-list
14791747|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
14791748|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
14791749|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791750|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14791751|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14791752|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791753|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
14791754|NCT00742768|Coagulants|coagulants|mesh-ancestor
14791755|NCT00742807|Alfentanil|alfentanil|mesh-list
14791756|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14791757|NCT00742807|Narcotics|narcotics|mesh-ancestor
14791758|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791759|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791760|NCT00742807|Analgesics|analgesics|mesh-ancestor
14791761|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
14791762|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791763|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14791764|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
14791765|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
14791766|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
14791767|NCT00742820|Calcium|calcium|mesh-list
14791768|NCT00742820|Calcium acetate|calcium acetate|mesh-list
14791769|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791770|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791771|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14791772|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
14791773|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
14791774|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791775|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14791776|NCT00742846|Triamcinolone|triamcinolone|mesh-list
14791777|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14791778|NCT00742846|Lidocaine|lidocaine|mesh-list
14791779|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14791780|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
14791781|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
14791782|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791783|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791784|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
14517729|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517730|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14517731|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14517732|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14517733|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
14517734|NCT03298113|Protective Agents|protective agents|mesh-list
14791785|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948746|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517735|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517736|NCT03298412|Blinatumomab|blinatumomab|mesh-list
14517737|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517738|NCT03299244|Cinacalcet|cinacalcet|mesh-list
14517739|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14517740|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517741|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14517742|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
14517743|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517744|NCT03300570|Dolcanatide|dolcanatide|mesh-list
14517745|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14517746|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
14517747|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517748|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517749|NCT03300674|Lidocaine|lidocaine|mesh-list
14517750|NCT03300674|Hydromorphone|hydromorphone|mesh-list
14517751|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517752|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
14517753|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517754|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517755|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
14517756|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517757|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14517758|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14517759|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14517760|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14517761|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517762|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14517763|NCT03300674|Narcotics|narcotics|mesh-ancestor
14517764|NCT03300674|Analgesics|analgesics|mesh-ancestor
14517765|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14517766|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14517767|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14517768|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517769|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517770|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14517771|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14517772|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517773|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
14517774|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517775|NCT03301649|Ivermectin|ivermectin|mesh-list
14517776|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14517777|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517778|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
14517779|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14517780|NCT03302559|Vitamin A|vitamin a|mesh-list
14517781|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
14517782|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
14517783|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14517784|NCT03302559|Protective Agents|protective agents|mesh-ancestor
14517785|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517786|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
14517787|NCT03302559|Vitamins|vitamins|mesh-ancestor
14517788|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
14517789|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
14517790|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517791|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14517792|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517793|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
14517794|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14517795|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14517796|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517797|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
14517798|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517799|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517800|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14517801|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
14517802|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517803|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14517804|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
14517805|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517806|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14517807|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
14517808|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517809|NCT03303196|Pancrelipase|pancrelipase|mesh-list
14517810|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517811|NCT03303794|Bupivacaine|bupivacaine|mesh-list
14517812|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517813|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
14517814|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517815|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517816|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
14517817|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517818|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
14517819|NCT03303950|Busulfan|busulfan|mesh-list
14517820|NCT03303950|Fludarabine|fludarabine|mesh-list
14517821|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14517822|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
14517823|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517824|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517825|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14517826|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
14517827|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517828|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517829|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14517830|NCT03304054|Amifampridine|amifampridine|mesh-list
14517831|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14517832|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517833|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517834|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14517835|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14517836|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517837|NCT03304626|Prednisone|prednisone|mesh-list
14517838|NCT03304626|Budesonide|budesonide|mesh-list
14517839|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14517840|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
14517841|NCT03304626|Hormones|hormones|mesh-ancestor
14517842|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14517843|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517844|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14517845|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517846|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14517847|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
14517848|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517849|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14517850|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
14517851|NCT03304873|Retapamulin|retapamulin|mesh-list
14517852|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14517853|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517854|NCT03305081|Copper|copper|mesh-list
14517855|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
14517856|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14517857|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
14517858|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14517859|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517860|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14517861|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14517862|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14517863|NCT03305081|Trace Elements|trace elements|mesh-ancestor
14517864|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
14517865|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
14517866|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14517867|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
14517868|NCT03305159|Povidone|povidone|mesh-list
14517869|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14517870|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517871|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
14517872|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14517873|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
14517874|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
14529458|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14529459|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14517875|NCT03305575|Bupivacaine|bupivacaine|mesh-list
14517876|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
14517877|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517878|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
14517879|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517880|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517881|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
14517882|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517883|NCT03305666|Bupivacaine|bupivacaine|mesh-list
14517884|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517885|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
14517886|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517887|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517888|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
14517889|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517890|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
14517891|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517892|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517893|NCT03306589|Molgramostim|molgramostim|mesh-list
14517894|NCT03306589|Sargramostim|sargramostim|mesh-list
14517895|NCT03306589|Cantharidin|cantharidin|mesh-list
14517896|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
14517897|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517898|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517899|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517900|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517901|NCT03307005|Zolpidem|zolpidem|mesh-list
14517902|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14517903|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14517904|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517905|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517906|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14517907|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
14517908|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
14517909|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517910|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517911|NCT03307174|Fentanyl|fentanyl|mesh-list
14517912|NCT03307174|Bupivacaine|bupivacaine|mesh-list
14517913|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
14517914|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
14517915|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14517916|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517917|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
14517918|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14517919|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14517920|NCT03307174|Narcotics|narcotics|mesh-ancestor
14517921|NCT03307174|Analgesics|analgesics|mesh-ancestor
14517922|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14517923|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14517924|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
14517925|NCT03307252|Metformin|metformin|mesh-list
14517926|NCT03307252|Rifampin|rifampin|mesh-list
14517927|NCT03307252|Probenecid|probenecid|mesh-list
14517928|NCT03307252|Digoxin|digoxin|mesh-list
14517929|NCT03307252|Verapamil|verapamil|mesh-list
14517930|NCT03307252|Furosemide|furosemide|mesh-list
14517931|NCT03307252|Cimetidine|cimetidine|mesh-list
14517932|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14517933|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517934|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517935|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14517936|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14517937|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
14517938|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517939|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14517940|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14517941|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517942|NCT03307252|Diuretics|diuretics|mesh-ancestor
14517943|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
14517944|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14517945|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14517946|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14517947|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
14517948|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14517949|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517950|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
14517951|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14517952|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14517953|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14517954|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14517955|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14517956|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14517957|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14517958|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14517959|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14517960|NCT03307252|Protective Agents|protective agents|mesh-ancestor
14517961|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14517962|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14517963|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
14517964|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
14517965|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
14517966|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14517967|NCT03307252|Renal Agents|renal agents|mesh-ancestor
14517968|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14517969|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14517970|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14517971|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
14517972|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
14517973|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517974|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14517975|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14517976|NCT03308669|Topiramate|topiramate|mesh-list
14517977|NCT03308669|Lasmiditan|lasmiditan|mesh-list
14517978|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
14517979|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14517980|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14517981|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14517982|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
14517983|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14517984|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517985|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
14517986|NCT03308942|Niraparib|niraparib|mesh-list
14517987|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14517988|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14517989|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14517990|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517991|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14517992|NCT03309657|Tazobactam|tazobactam|mesh-list
14517993|NCT03309657|Ceftolozane|ceftolozane|mesh-list
14517994|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14517995|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14517996|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14517997|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14517998|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14517999|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518000|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14518001|NCT03309657|Renal Agents|renal agents|mesh-ancestor
14518002|NCT03309943|Propranolol|propranolol|mesh-list
14518003|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14518004|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14518005|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518006|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518007|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518008|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518009|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14518010|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14518011|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
14518012|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
14518013|NCT03310021|Apixaban|apixaban|mesh-list
14518014|NCT03310021|Edoxaban|edoxaban|mesh-list
14518015|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14518016|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
14518017|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14518018|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
14518019|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518020|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518021|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
14518022|NCT03310268|Listerine|listerine|mesh-list
14518023|NCT03310268|Fluorides|fluorides|mesh-list
14518024|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
14518025|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
14518026|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
14518027|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
14518028|NCT03310268|Protective Agents|protective agents|mesh-ancestor
14518029|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518030|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14518031|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518032|NCT03310411|Sumatriptan|sumatriptan|mesh-list
14518033|NCT03310411|Lasmiditan|lasmiditan|mesh-list
14518034|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14518035|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14518036|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14518037|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
14518038|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518039|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518040|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518041|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14518042|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14518043|NCT03310970|Lidocaine|lidocaine|mesh-list
14518044|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
14518045|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
14518046|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518047|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518048|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
14518049|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518050|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14518051|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14518052|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14518053|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518054|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518055|NCT03311646|Nicotine|nicotine|mesh-list
14518056|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14518057|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
14518058|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518059|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518060|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14518061|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14518062|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
14518063|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518064|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518065|NCT03311724|Tirzepatide|tirzepatide|mesh-list
14518066|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518067|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518068|NCT03311724|Incretins|incretins|mesh-ancestor
14518069|NCT03311724|Hormones|hormones|mesh-ancestor
14518070|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518071|NCT03311841|Rifampin|rifampin|mesh-list
14518072|NCT03311841|Midazolam|midazolam|mesh-list
14518073|NCT03311841|Dabigatran|dabigatran|mesh-list
14518074|NCT03311841|Atorvastatin|atorvastatin|mesh-list
14518075|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14518076|NCT03311841|Pitavastatin|pitavastatin|mesh-list
14518077|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14518078|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14518079|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14518080|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
14518081|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518082|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14518083|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14518084|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518085|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14518086|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14518087|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518088|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518089|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14518090|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518091|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518092|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14518093|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
14518094|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
14518095|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
14518096|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
14518097|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518098|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
14518099|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14518100|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
14518101|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
14518102|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14518103|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
14518104|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14518105|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518106|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
14518107|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14518108|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14518109|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14518110|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14518111|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14518112|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14518113|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14518114|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
14518115|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
14518116|NCT03312023|Ledipasvir|ledipasvir|mesh-list
14518117|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
14518118|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518119|NCT03312114|Avelumab|avelumab|mesh-list
14518120|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518121|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518122|NCT03312517|Suvorexant|suvorexant|mesh-list
14518123|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14518124|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14518125|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518126|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518127|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14518128|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518129|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518130|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14518131|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
14518132|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518133|NCT03313076|Vitamin D|vitamin d|mesh-list
14518134|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
14518135|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
14518136|NCT03313076|Vitamins|vitamins|mesh-list
14518137|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
14518138|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518139|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14518140|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14518141|NCT03314662|Vaccines|vaccines|mesh-list
14518142|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14518143|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
14518144|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518145|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14518146|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
14518147|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14518148|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
14518149|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14518150|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
14518151|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518152|NCT03315559|Nemiralisib|nemiralisib|mesh-list
14518153|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14518154|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518155|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518156|NCT03315780|Dulaglutide|dulaglutide|mesh-list
14518157|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518158|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518159|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14518160|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14518161|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14518162|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518163|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791786|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14791787|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14791788|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14791789|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791790|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791791|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791792|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
14791793|NCT00742846|Hormones|hormones|mesh-ancestor
14518164|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518165|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518166|NCT03315793|Analgesics|analgesics|mesh-ancestor
14518167|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
14518168|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518169|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
14518170|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518171|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
14518172|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
14518173|NCT03316131|Febuxostat|febuxostat|mesh-list
14518174|NCT03316131|Verinurad|verinurad|mesh-list
14518175|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14948747|NCT01535027|Alendronate|alendronate|mesh-list
14948748|NCT01535027|Teriparatide|teriparatide|mesh-list
14518176|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518177|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518178|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518179|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
14518180|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14518181|NCT03316378|Ropivacaine|ropivacaine|mesh-list
14518182|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
14518183|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
14518184|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518185|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518186|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
14518187|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518188|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
14518189|NCT03316976|Lansoprazole|lansoprazole|mesh-list
14518190|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14518191|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14518192|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14518193|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518194|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518195|NCT03318315|Vaccines|vaccines|mesh-list
14518196|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
14518197|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518198|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
14518199|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14518200|NCT03319277|Narcotics|narcotics|mesh-ancestor
14518201|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518202|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518203|NCT03319277|Analgesics|analgesics|mesh-ancestor
14518204|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
14518205|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518206|NCT03319719|Lidocaine|lidocaine|mesh-list
14518207|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
14518208|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
14518209|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
14518210|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518211|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518212|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
14518213|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518214|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14948749|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14529460|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
14518215|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14518216|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14518217|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518218|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518219|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14518220|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
14948750|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14948751|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948752|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14948753|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14948754|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
14948755|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948756|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14948757|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14948758|NCT01535079|Ibuprofen|ibuprofen|mesh-list
14948759|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965219|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
13965220|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965221|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965222|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
13965223|NCT03131908|GSK2636771|gsk2636771|mesh-list
14948760|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948761|NCT01535079|Analgesics|analgesics|mesh-ancestor
14948762|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
14948763|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948764|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948765|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948766|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948767|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14948768|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948769|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948770|NCT01535092|Silybin|silybin|mesh-list
14948771|NCT01535092|Protective Agents|protective agents|mesh-ancestor
14948772|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948773|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14948774|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948775|NCT01535157|Ketoconazole|ketoconazole|mesh-list
14948776|NCT01535157|Fenretinide|fenretinide|mesh-list
14948777|NCT01535157|Retinamide|retinamide|mesh-list
14948778|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
14948779|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948780|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14948781|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14948782|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948783|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791794|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791795|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14791796|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
14791797|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791798|NCT00742911|Copper|copper|mesh-list
14791799|NCT00742911|Disulfiram|disulfiram|mesh-list
14791800|NCT00742911|Trace Elements|trace elements|mesh-ancestor
14791801|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
14791802|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948784|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14948785|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
14948786|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948787|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948788|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14948789|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948790|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14948791|NCT01535157|Protective Agents|protective agents|mesh-ancestor
13965224|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518221|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
14518222|NCT03319719|Protective Agents|protective agents|mesh-ancestor
14518223|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
14518224|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14791803|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14791804|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14948792|NCT01535170|Lactoferrin|lactoferrin|mesh-list
14948793|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948794|NCT01535183|Irinotecan|irinotecan|mesh-list
14948795|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14948796|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14948797|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948798|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948799|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948800|NCT01535417|Celecoxib|celecoxib|mesh-list
14948801|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948802|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948803|NCT01535417|Analgesics|analgesics|mesh-ancestor
14948804|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
14948805|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948806|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518225|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14518226|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
14518227|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518228|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
14518229|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518230|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518231|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518232|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518233|NCT03320057|Mifepristone|mifepristone|mesh-list
14518234|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14518235|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
14518236|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14518237|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518238|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14518239|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14518240|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14518241|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
14518242|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14518243|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14518244|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
14518245|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518246|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
14518247|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14518248|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14791805|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791806|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791807|NCT00742937|Vitamin A|vitamin a|mesh-list
14529461|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
14529462|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529463|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14529464|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14529465|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529466|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529467|NCT03756038|Lorazepam|lorazepam|mesh-list
14529468|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
14529469|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
14529470|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
14529471|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529472|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529473|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529474|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14529475|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529476|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14529477|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14791808|NCT00742937|Vitamins|vitamins|mesh-ancestor
14791809|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
14791810|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791811|NCT00742976|Insulin|insulin|mesh-list
14791812|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14791813|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
14791814|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
14791815|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
14791816|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
14791817|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791818|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791819|NCT00743028|Navitoclax|navitoclax|mesh-list
14791820|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948807|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948808|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948809|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14948810|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14518249|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
14518250|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14518251|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14518252|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14518253|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518254|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518255|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
14518256|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518257|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518258|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14518259|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518260|NCT03320941|Licogliflozin|licogliflozin|mesh-list
14518261|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14518262|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518263|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518264|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518265|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14518266|NCT03321006|Citalopram|citalopram|mesh-list
14518267|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14948811|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948812|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518268|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14518269|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518270|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518271|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518272|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
14518273|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518274|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14518275|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
14518276|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518277|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518278|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14518279|NCT03321006|Analgesics|analgesics|mesh-ancestor
14518280|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
14518281|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
14518282|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
14518283|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14518284|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518285|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518286|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
14518287|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518288|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518289|NCT03321396|Calcium|calcium|mesh-list
14518290|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14518291|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518292|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
14518293|NCT03322657|Neostigmine|neostigmine|mesh-list
14518294|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14518295|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518296|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518297|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
14518298|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518299|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518300|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14518301|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
14518302|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518303|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14518304|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14518305|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14518306|NCT03323164|Timolol|timolol|mesh-list
14518307|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14518308|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14791821|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14791822|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14791823|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791824|NCT00743327|Pioglitazone|pioglitazone|mesh-list
14791825|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791826|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791827|NCT00743470|Ritonavir|ritonavir|mesh-list
14791828|NCT00743470|Lopinavir|lopinavir|mesh-list
14791829|NCT00743470|Rifabutin|rifabutin|mesh-list
14791830|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14518309|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14518310|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518311|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948813|NCT01535469|Fluconazole|fluconazole|mesh-list
14948814|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
14948815|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948816|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14948817|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14948818|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518312|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518313|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518314|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14518315|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14518316|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14791831|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14791832|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
14791833|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791834|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791835|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14791836|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14791837|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
14948819|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948820|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13965225|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965226|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965227|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965228|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518317|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14518318|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14518319|NCT03323801|Tretinoin|tretinoin|mesh-list
14518320|NCT03323801|Isotretinoin|isotretinoin|mesh-list
14518321|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791838|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791839|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14791840|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14791841|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791842|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14791843|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
14791844|NCT00743496|Antibodies|antibodies|mesh-list
14791845|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
14518322|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
14518323|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
14518324|NCT03324451|Insulin|insulin|mesh-list
14518325|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518326|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518327|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14518328|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14518329|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14518330|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518331|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518332|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518333|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518334|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518335|NCT03325556|Pimavanserin|pimavanserin|mesh-list
14518336|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14518337|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13965229|NCT03131700|Bevacizumab|bevacizumab|mesh-list
13965230|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13965231|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518338|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14518339|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518340|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518341|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518342|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518343|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14518344|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14518345|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
14518346|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518347|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518348|NCT03325816|Nivolumab|nivolumab|mesh-list
14791846|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791847|NCT00743587|Naproxen|naproxen|mesh-list
14791848|NCT00743587|Oxycodone|oxycodone|mesh-list
14791849|NCT00743587|Tramadol|tramadol|mesh-list
14518349|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
14518350|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518351|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518352|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14518353|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518354|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14518355|NCT03326999|Bupivacaine|bupivacaine|mesh-list
14518356|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
14518357|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
14518358|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518359|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518360|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
14518361|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518362|NCT03327051|Omeprazole|omeprazole|mesh-list
14518363|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14518364|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14518365|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14518366|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518367|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518368|NCT03328325|Vaccines|vaccines|mesh-list
14518369|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
14518370|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518371|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
14518372|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
14518373|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
14518374|NCT03328832|Thrombin|thrombin|mesh-list
14518375|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14518376|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14518377|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518378|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
14518379|NCT03328832|Coagulants|coagulants|mesh-ancestor
14518380|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14518381|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
14518382|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14518383|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
14518384|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518385|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
14518386|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
14518387|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518388|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14518389|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14518390|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518391|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518392|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518393|NCT03328897|Omalizumab|omalizumab|mesh-list
14518394|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14518395|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14518396|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
14518397|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
14518398|NCT03329196|Hematinics|hematinics|mesh-ancestor
14518399|NCT03329209|Vedolizumab|vedolizumab|mesh-list
14518400|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14518401|NCT03329573|Paroxetine|paroxetine|mesh-list
14518402|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14518403|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14518404|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518405|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518406|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518407|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
14518408|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518409|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14518410|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
14518411|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518412|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14518413|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14518414|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518415|NCT03329846|Nivolumab|nivolumab|mesh-list
14518416|NCT03329846|Linrodostat|linrodostat|mesh-list
14518417|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518418|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518419|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14518420|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518421|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518422|NCT03329911|Paclitaxel|paclitaxel|mesh-list
14518423|NCT03329911|Carboplatin|carboplatin|mesh-list
14518424|NCT03329911|Bevacizumab|bevacizumab|mesh-list
14518425|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14518426|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518427|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
14518428|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
14518429|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
14518430|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518431|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518432|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14518433|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14518434|NCT03329911|Growth Substances|growth substances|mesh-ancestor
14518435|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518436|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14518437|NCT03329937|Niraparib|niraparib|mesh-list
14518438|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14518439|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518440|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518441|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965232|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13965233|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14948821|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
14948822|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14948823|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948824|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14948825|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14948826|NCT01535495|Propranolol|propranolol|mesh-list
14948827|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14948828|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14948829|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948830|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948831|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948832|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965234|NCT03131700|Growth Substances|growth substances|mesh-ancestor
14518442|NCT03330236|Anesthetics|anesthetics|mesh-list
14518443|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518444|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518445|NCT03330457|Betrixaban|betrixaban|mesh-list
14518446|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14518447|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
14518448|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14518449|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
14518450|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518451|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518452|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
14518453|NCT03331315|Celecoxib|celecoxib|mesh-list
14518454|NCT03331315|Ketorolac|ketorolac|mesh-list
14518455|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14518456|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14518457|NCT03331315|Analgesics|analgesics|mesh-ancestor
14518458|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
14518459|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518460|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518461|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14518462|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14518463|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14518464|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14518465|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518466|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518467|NCT03331666|Evolocumab|evolocumab|mesh-list
14518468|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14518469|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14518470|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
14518471|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518472|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14518473|NCT03331835|Brodalumab|brodalumab|mesh-list
14518474|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
14518475|NCT03331965|Metoclopramide|metoclopramide|mesh-list
14518476|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
14518477|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
14518478|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518479|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518480|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14518481|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14518482|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14518483|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
14518484|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518485|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518486|NCT03332212|Empagliflozin|empagliflozin|mesh-list
14518487|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14518488|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518489|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518490|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948833|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14948834|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14948835|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
14948836|NCT01535547|Isavuconazole|isavuconazole|mesh-list
14948837|NCT01535547|Tacrolimus|tacrolimus|mesh-list
14948838|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948839|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
14518491|NCT03332771|Metformin|metformin|mesh-list
14518492|NCT03332771|Glimepiride|glimepiride|mesh-list
14518493|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14518494|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518495|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518496|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14518497|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14518498|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
14518499|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14518500|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518501|NCT03333109|Erenumab|erenumab|mesh-list
14518502|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14518503|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518504|NCT03333109|Analgesics|analgesics|mesh-ancestor
14518505|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
14518506|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518507|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518508|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
14518509|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518510|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518511|NCT03334721|Gabapentin|gabapentin|mesh-list
14518512|NCT03334721|Analgesics|analgesics|mesh-ancestor
14518513|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
14518514|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518515|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518516|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
14518517|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14518518|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518519|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518520|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518521|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14518522|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14518523|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518524|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518525|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
14518526|NCT03334734|Isoniazid|isoniazid|mesh-list
14518527|NCT03334734|Macozinone|macozinone|mesh-list
14518528|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
14518529|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14518530|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518531|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14518532|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14518533|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
14518534|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518535|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14518536|NCT03334747|Lumefantrine|lumefantrine|mesh-list
14518537|NCT03334747|Artemether|artemether|mesh-list
14948840|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518538|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14518539|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
14518540|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14518541|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14518542|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518543|NCT03334903|Gabapentin|gabapentin|mesh-list
14518544|NCT03334903|Analgesics|analgesics|mesh-ancestor
14518545|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
14518546|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518547|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518548|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
14518549|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14518550|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518551|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518552|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518553|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14518554|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14518555|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518556|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518557|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
14529478|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529479|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
14529480|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
14529481|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948841|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14948842|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948843|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948844|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
14948845|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529482|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529483|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
14529484|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14529485|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
14529486|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14529487|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529488|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14529489|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14529490|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14529491|NCT03753113|Minoxidil|minoxidil|mesh-list
14529492|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14529493|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
14529494|NCT03751657|Insulin|insulin|mesh-list
14529495|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14529496|NCT03751657|Metformin|metformin|mesh-list
14529497|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
14529498|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14529499|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14529500|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529501|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
14791850|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14791851|NCT00743587|Narcotics|narcotics|mesh-ancestor
14948846|NCT01535612|Insulin|insulin|mesh-list
14948847|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14948848|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948849|NCT01535677|Metformin|metformin|mesh-list
14948850|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
14948851|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14948852|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948853|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14948854|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948855|NCT01535690|Methylene Blue|methylene blue|mesh-list
14948856|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948857|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791852|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791853|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791854|NCT00743587|Analgesics|analgesics|mesh-ancestor
14791855|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
14791856|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791857|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14791858|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948858|NCT01535768|Travoprost|travoprost|mesh-list
14948859|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14529502|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529503|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529504|NCT03747497|Linezolid|linezolid|mesh-list
14791859|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791860|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791861|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
14791862|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14791863|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791864|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791865|NCT00743678|Cetuximab|cetuximab|mesh-list
14791866|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518558|NCT03336450|Midazolam|midazolam|mesh-list
14518559|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14518560|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14518561|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518562|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518563|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14518564|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518565|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518566|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14518567|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
14518568|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
14518569|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
14518570|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
14518571|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518572|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518573|NCT03336502|Posaconazole|posaconazole|mesh-list
14948860|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14948861|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14948862|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14948863|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14948864|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14948865|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14948866|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518574|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
14518575|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518576|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14518577|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14518578|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14518579|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14518580|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14518581|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518582|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518583|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14518584|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
14518585|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518586|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518587|NCT03336645|Midazolam|midazolam|mesh-list
14518588|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14518589|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14518590|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518591|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518592|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14518593|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14948867|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948868|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518594|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518595|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14518596|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
14948869|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948870|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
14948871|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14791867|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791868|NCT00743743|Resveratrol|resveratrol|mesh-list
14791869|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
14791870|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791871|NCT00743743|Protective Agents|protective agents|mesh-ancestor
14791872|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791873|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791874|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14791875|NCT00743782|Hormones|hormones|mesh-list
14791876|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
14948872|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14948873|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948874|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
14948875|NCT01535781|Coagulants|coagulants|mesh-ancestor
14948876|NCT01535820|Ortho Evra|ortho evra|mesh-list
14518597|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
14791877|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791878|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791879|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14791880|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
14791881|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14791882|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14791883|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14791884|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791885|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14791886|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14791887|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14791888|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14791889|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791890|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791891|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
14791892|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14791893|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
14791894|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14791895|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14791896|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791897|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14791898|NCT00743847|Varenicline|varenicline|mesh-list
14791899|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14518598|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
14518599|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
14518600|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518601|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518602|NCT03336853|Hybenx|hybenx|mesh-list
14518603|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
14518604|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
14518605|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518606|NCT03337152|Chloroquine|chloroquine|mesh-list
14518607|NCT03337152|Primaquine|primaquine|mesh-list
14518608|NCT03337152|Amebicides|amebicides|mesh-ancestor
14518609|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14518610|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14518611|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518612|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
14518613|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14518614|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14518615|NCT03337308|Ezetimibe|ezetimibe|mesh-list
14518616|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14518617|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14518618|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
14518619|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518620|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14518621|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518622|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518623|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518624|NCT03337477|Insulin|insulin|mesh-list
14518625|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14791900|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14791901|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
14791902|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791903|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791904|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791905|NCT00743860|Darapladib|darapladib|mesh-list
14791906|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14791907|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791908|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791909|NCT00743873|Mitogens|mitogens|mesh-list
14791910|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
14518626|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518627|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518628|NCT03337490|Ivermectin|ivermectin|mesh-list
14518629|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14518630|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518631|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
14518632|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518633|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948877|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14518634|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
14518635|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518636|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518637|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
14518638|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
14518639|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
14518640|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518641|NCT03338400|Dexamethasone|dexamethasone|mesh-list
14518642|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14518643|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
14518644|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
14518645|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518646|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518647|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14518648|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
14518649|NCT03338400|Hormones|hormones|mesh-ancestor
14518650|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518651|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14518652|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518653|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
14518654|NCT03338569|Vitamins|vitamins|mesh-ancestor
14518655|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
14518656|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518657|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
14518658|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518659|NCT03338569|Protective Agents|protective agents|mesh-ancestor
14518660|NCT03338803|Linagliptin|linagliptin|mesh-list
14518661|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791911|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948878|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
14948879|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14948880|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948881|NCT01535859|Cabergoline|cabergoline|mesh-list
14948882|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14948883|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14948884|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
14948885|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
14948886|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948887|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948888|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948889|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14948890|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14948891|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
14948892|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518662|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518663|NCT03338803|Incretins|incretins|mesh-ancestor
14518664|NCT03338803|Hormones|hormones|mesh-ancestor
14518665|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518666|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14518667|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
14518668|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518669|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518670|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
14518671|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14518672|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948893|NCT01535989|Sirolimus|sirolimus|mesh-list
14948894|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14948895|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948896|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14948897|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14948898|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948899|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
14948900|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948901|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
14948902|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948903|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14948904|NCT01536002|Propofol|propofol|mesh-list
14791912|NCT00743886|Mitogens|mitogens|mesh-list
14791913|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
14791914|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791915|NCT00743912|Rifaximin|rifaximin|mesh-list
14791916|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791917|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791918|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791919|NCT00743964|Capecitabine|capecitabine|mesh-list
14791920|NCT00743964|Epirubicin|epirubicin|mesh-list
14791921|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518673|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518674|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518675|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14518676|NCT03338998|Siponimod|siponimod|mesh-list
14518677|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14518678|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518679|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14518680|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
14518681|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518682|NCT03339297|Defibrotide|defibrotide|mesh-list
14518683|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14518684|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14518685|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518686|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14518687|NCT03339453|Glucagon|glucagon|mesh-list
14518688|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14518689|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14518690|NCT03339453|Hormones|hormones|mesh-ancestor
14518691|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518692|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518693|NCT03339453|Incretins|incretins|mesh-ancestor
14518694|NCT03339583|Zopiclone|zopiclone|mesh-list
14518695|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14948905|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14948906|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948907|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948908|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14518696|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518697|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518698|NCT03339726|Phenylephrine|phenylephrine|mesh-list
14518699|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
14518700|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14518701|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
14518702|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
14518703|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518704|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518705|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
14518706|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14518707|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
14518708|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
14518709|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14518710|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14518711|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14518712|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518713|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518714|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518715|NCT03339726|Protective Agents|protective agents|mesh-ancestor
14518716|NCT03340350|Minocycline|minocycline|mesh-list
14518717|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14518718|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518719|NCT03340961|Doxycycline|doxycycline|mesh-list
14518720|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14518721|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518722|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
14518723|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14518724|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14518725|NCT03341273|Azithromycin|azithromycin|mesh-list
14518726|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14791922|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14791923|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
14791924|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791925|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14791926|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14518727|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518728|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
14518729|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791927|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14791928|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791929|NCT00743990|Camphor|camphor|mesh-list
14791930|NCT00743990|Menthol|menthol|mesh-list
14791931|NCT00743990|Petrolatum|petrolatum|mesh-list
14791932|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
14791933|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
14791934|NCT00743990|Emollients|emollients|mesh-ancestor
14791935|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14518730|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518731|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
14518732|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518733|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518734|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
14518735|NCT03341910|Tazarotene|tazarotene|mesh-list
14518736|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14518737|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
14518738|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
14518739|NCT03341910|Vitamins|vitamins|mesh-ancestor
14518740|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
14518741|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518742|NCT03342404|Luspatercept|luspatercept|mesh-list
14518743|NCT03342404|Hematinics|hematinics|mesh-ancestor
14518744|NCT03342690|Eplerenone|eplerenone|mesh-list
14518745|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14948909|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
14948910|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
14948911|NCT01536028|Insulin|insulin|mesh-list
14948912|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14948913|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
14948914|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
14948915|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14948916|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
14948917|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14518746|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
14518747|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518748|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518749|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14518750|NCT03342690|Diuretics|diuretics|mesh-ancestor
14518751|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
14518752|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14518753|NCT03342963|Aripiprazole|aripiprazole|mesh-list
14518754|NCT03342963|Sertraline|sertraline|mesh-list
14518755|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
14518756|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518757|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14518758|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518759|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518760|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518761|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
14518762|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
14518763|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518764|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518765|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14518766|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14518767|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
14518768|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14518769|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14518770|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14518771|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13965235|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965236|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
14518772|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14518773|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14518774|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518775|NCT03343067|Norethindrone|norethindrone|mesh-list
14518776|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
14518777|NCT03343067|Estradiol|estradiol|mesh-list
14518778|NCT03343067|Estrogens|estrogens|mesh-ancestor
14518779|NCT03343067|Hormones|hormones|mesh-ancestor
14518780|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14518781|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518782|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14518783|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
14518784|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14518785|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14518786|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14518787|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14518788|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14518789|NCT03343080|Lidocaine|lidocaine|mesh-list
14518790|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
14518791|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
14518792|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518793|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518794|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
14518795|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518796|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14518797|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14518798|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14518799|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14518800|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518801|NCT03343639|Serlopitant|serlopitant|mesh-list
14518802|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14518803|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518804|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518805|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518806|NCT03344172|Gemcitabine|gemcitabine|mesh-list
14518807|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
14518808|NCT03344172|Paclitaxel|paclitaxel|mesh-list
14518809|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14518810|NCT03344172|Avelumab|avelumab|mesh-list
14518811|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14518812|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518813|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
14518814|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
14518815|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14518816|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518817|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14518818|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
14518819|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
14791936|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791937|NCT00744016|Mesalamine|mesalamine|mesh-list
14791938|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14518820|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518821|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518822|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14518823|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
14518824|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791939|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14791940|NCT00744016|Analgesics|analgesics|mesh-ancestor
14791941|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
14791942|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791943|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791944|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791945|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14791946|NCT00744081|Topotecan|topotecan|mesh-list
14948918|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14948919|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948920|NCT01536054|Sirolimus|sirolimus|mesh-list
14948921|NCT01536054|Sargramostim|sargramostim|mesh-list
14948922|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948923|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14791947|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
14948924|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14518825|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
14518826|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14518827|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14518828|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14518829|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518830|NCT03344510|Anesthetics|anesthetics|mesh-list
14518831|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518832|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518833|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14518834|NCT03344861|Trioxsalen|trioxsalen|mesh-list
14518835|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518836|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
14518837|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14518838|NCT03345407|Albuterol|albuterol|mesh-list
14518839|NCT03345407|Nemiralisib|nemiralisib|mesh-list
14518840|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13965237|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
13965238|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13965239|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14791948|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14791949|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14791950|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14791951|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518841|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
14518842|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518843|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518844|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14518845|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
14518846|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
14518847|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14518848|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14518849|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14518850|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14518851|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518852|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518853|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518854|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14518855|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518856|NCT03345979|Aripiprazole|aripiprazole|mesh-list
14518857|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14518858|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
14518859|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
14518860|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14518861|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14518862|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14518863|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14518864|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518865|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
14518866|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
14518867|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518868|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518869|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14518870|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14518871|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
14518872|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14518873|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14518874|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14518875|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14518876|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
14518877|NCT03346057|Rocuronium|rocuronium|mesh-list
14518878|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
14518879|NCT03346057|Neostigmine|neostigmine|mesh-list
14518880|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14518881|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14518882|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14518883|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518884|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518885|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14518886|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518887|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791952|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791953|NCT00744081|Analgesics|analgesics|mesh-ancestor
14791954|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
13965240|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14518888|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
14518889|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518890|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14518891|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
14518892|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14518893|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14518894|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14518895|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14518896|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
14518897|NCT03346070|Rocuronium|rocuronium|mesh-list
14518898|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
14518899|NCT03346070|Neostigmine|neostigmine|mesh-list
14518900|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14518901|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14518902|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14518903|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518904|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518905|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14518906|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518907|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518908|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
13965241|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13965242|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965243|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
14948925|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948926|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
14948927|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948928|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
14948929|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948930|NCT01536132|Simendan|simendan|mesh-list
14948931|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14948932|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
14948933|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14948934|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14948935|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948936|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948937|NCT01536132|Protective Agents|protective agents|mesh-ancestor
14948938|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518909|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518910|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14518911|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
14518912|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14518913|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14518914|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14948939|NCT01536158|Acetaminophen|acetaminophen|mesh-list
14948940|NCT01536158|Ibuprofen|ibuprofen|mesh-list
14948941|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14948942|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14948943|NCT01536158|Analgesics|analgesics|mesh-ancestor
14948944|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
14948945|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948946|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948947|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14948948|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14948949|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13965244|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965245|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965246|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13965247|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965248|NCT03131843|Ethanol|ethanol|mesh-list
13965249|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13965250|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14518915|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14518916|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14518917|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
14791955|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791956|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791957|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14791958|NCT00744107|Cobalt|cobalt|mesh-list
14791959|NCT00744107|Trace Elements|trace elements|mesh-ancestor
14791960|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
14791961|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791962|NCT00744185|Propranolol|propranolol|mesh-list
14948950|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14948951|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518918|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518919|NCT03348683|Propranolol|propranolol|mesh-list
14518920|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14518921|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14518922|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518923|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518924|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518925|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948952|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
14948953|NCT01536223|Cisplatin|cisplatin|mesh-list
14948954|NCT01536223|Docetaxel|docetaxel|mesh-list
14948955|NCT01536223|Fluorouracil|fluorouracil|mesh-list
14948956|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14948957|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
14518926|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14518927|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14518928|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
14518929|NCT03349060|Abrocitinib|abrocitinib|mesh-list
14518930|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14518931|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518932|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518933|NCT03349333|Folic Acid|folic acid|mesh-list
14518934|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
14518935|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
14518936|NCT03349333|Vitamins|vitamins|mesh-ancestor
14518937|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
14518938|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518939|NCT03349333|Hematinics|hematinics|mesh-ancestor
14518940|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
14518941|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14518942|NCT03349710|Nivolumab|nivolumab|mesh-list
14518943|NCT03349710|Cetuximab|cetuximab|mesh-list
14518944|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518945|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518946|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14518947|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518948|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14518949|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
14518950|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
14529505|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14948958|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
14948959|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
14948960|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948961|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
14948962|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14948963|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14948964|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
14948965|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948966|NCT01536249|Pramipexole|pramipexole|mesh-list
14948967|NCT01536249|Cimetidine|cimetidine|mesh-list
14529506|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529507|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14529508|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529509|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530129|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
14530130|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948968|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14530131|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530132|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14791963|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14948969|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14948970|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14948971|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
14948972|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
14948973|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948974|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14948975|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948976|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14948977|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14948978|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518951|NCT03351231|Nivolumab|nivolumab|mesh-list
14518952|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14518953|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14518954|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14518955|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518956|NCT03351478|Empagliflozin|empagliflozin|mesh-list
14518957|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14518958|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14518959|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518960|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14518961|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518962|NCT03351608|Atropine|atropine|mesh-list
14518963|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
14518964|NCT03351608|Neostigmine|neostigmine|mesh-list
14948979|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
14948980|NCT01536249|Protective Agents|protective agents|mesh-ancestor
14518965|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14518966|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14518967|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14518968|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
14518969|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14518970|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518971|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14518972|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
14518973|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
14518974|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
14518975|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14518976|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14518977|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
14518978|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518979|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518980|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14518981|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14518982|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14518983|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
14518984|NCT03351933|Antibodies|antibodies|mesh-list
14518985|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
14518986|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14518987|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14518988|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
14518989|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518990|NCT03352323|Phenylephrine|phenylephrine|mesh-list
14518991|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
14518992|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14518993|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14518994|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
14518995|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14518996|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14518997|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14518998|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
14518999|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
14519000|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519001|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
14519002|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14519003|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519004|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14519005|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
14519006|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14519007|NCT03352323|Protective Agents|protective agents|mesh-ancestor
14519008|NCT03352414|Alvimopan|alvimopan|mesh-list
14519009|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519010|NCT03353740|Edetic Acid|edetic acid|mesh-list
14519011|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
14519012|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
14519013|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519014|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
14519015|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14519016|NCT03354429|Ticagrelor|ticagrelor|mesh-list
14519017|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14519018|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14519019|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14519020|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13965251|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965252|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965253|NCT03131973|Leucovorin|leucovorin|mesh-list
13965254|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
13965255|NCT03131973|Methotrexate|methotrexate|mesh-list
14519021|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
14519022|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14948981|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14948982|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14948983|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
14948984|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
14948985|NCT01536301|Morphine|morphine|mesh-list
14948986|NCT01536301|Oxycodone|oxycodone|mesh-list
14948987|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14948988|NCT01536301|Narcotics|narcotics|mesh-ancestor
14948989|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14948990|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948991|NCT01536301|Analgesics|analgesics|mesh-ancestor
14948992|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
14948993|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14948994|NCT01536314|Memantine|memantine|mesh-list
14519023|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519024|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519025|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
14519026|NCT03354598|Probenecid|probenecid|mesh-list
14519027|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519028|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519029|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14519030|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14519031|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519032|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519033|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519034|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14519035|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14519036|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
14519037|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
14519038|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14519039|NCT03354598|Renal Agents|renal agents|mesh-ancestor
14519040|NCT03355326|Glycerol|glycerol|mesh-list
14519041|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14519042|NCT03355326|Protective Agents|protective agents|mesh-ancestor
14519043|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519044|NCT03355820|Antibodies|antibodies|mesh-list
14519045|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
14519046|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519047|NCT03357341|Albuterol|albuterol|mesh-list
14519048|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519049|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
14519050|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519051|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519052|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519053|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519054|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
14519055|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14519056|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14519057|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14519058|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519059|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
14948995|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14948996|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14948997|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
13965256|NCT03131973|Digoxin|digoxin|mesh-list
13965257|NCT03131973|Midazolam|midazolam|mesh-list
13965258|NCT03131973|Caffeine|caffeine|mesh-list
14948998|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027139|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519060|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519061|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519062|NCT03357393|Midazolam|midazolam|mesh-list
14519063|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
14519064|NCT03357393|Scopolamine|scopolamine|mesh-list
14519065|NCT03357393|Morphine|morphine|mesh-list
14791964|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14791965|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
14791966|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14791967|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14791968|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791969|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14791970|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14791971|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
14791972|NCT00744224|Exenatide|exenatide|mesh-list
14791973|NCT00744224|Prednisolone|prednisolone|mesh-list
14791974|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14791975|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
14791976|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14791977|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
14791978|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14791979|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
14791980|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14791981|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
14791982|NCT00744224|Hormones|hormones|mesh-ancestor
14791983|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14791984|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14791985|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14791986|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14791987|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
14791988|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
14791989|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14791990|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791991|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14791992|NCT00744224|Protective Agents|protective agents|mesh-ancestor
14791993|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14791994|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14791995|NCT00744224|Incretins|incretins|mesh-ancestor
14791996|NCT00744250|Pancrelipase|pancrelipase|mesh-list
14791997|NCT00744250|Pancreatin|pancreatin|mesh-list
14791998|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14791999|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
14792000|NCT00744302|Calcium|calcium|mesh-list
14792001|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14792002|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792003|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14792004|NCT00744354|Doxorubicin|doxorubicin|mesh-list
14792005|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14792006|NCT00744354|Bortezomib|bortezomib|mesh-list
14792007|NCT00744354|Vorinostat|vorinostat|mesh-list
14792008|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14792009|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792010|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14792011|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14792012|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792013|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792014|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14792015|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
14792016|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14792017|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14792018|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
14792019|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
14792020|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792021|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14948999|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949000|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949001|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14949002|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14792022|NCT00744406|Sertraline|sertraline|mesh-list
14792023|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14792024|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
14519066|NCT03357393|Propofol|propofol|mesh-list
14519067|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14519068|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14519069|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529510|NCT03743038|Minocycline|minocycline|mesh-list
14792025|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14519070|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519071|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14519072|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
14519073|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
14519074|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14519075|NCT03357393|Narcotics|narcotics|mesh-ancestor
14519076|NCT03357393|Analgesics|analgesics|mesh-ancestor
14519077|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
14519078|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519079|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14519080|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14519081|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14519082|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14519083|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
14519084|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
14519085|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519086|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792026|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14519087|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14519088|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14792027|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14792028|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792029|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792030|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792031|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
14792032|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792033|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14792034|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14792035|NCT00744419|Pantoprazole|pantoprazole|mesh-list
14949003|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14949004|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14949005|NCT01536431|Insulin|insulin|mesh-list
14949006|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14949007|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949008|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027140|NCT01947933|Mirikizumab|mirikizumab|mesh-list
15027141|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15027142|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14519089|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
14519090|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
14519091|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
14519092|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519093|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
14519094|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
14519095|NCT03357614|Amoxicillin|amoxicillin|mesh-list
14519096|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
15027143|NCT01947933|Analgesics|analgesics|mesh-ancestor
15027144|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
15027145|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519097|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
14519098|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
14519099|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14519100|NCT03357614|Ertapenem|ertapenem|mesh-list
14519101|NCT03357614|Lactams|lactams|mesh-list
14519102|NCT03357614|Probenecid|probenecid|mesh-list
14519103|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519104|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792036|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14792037|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792038|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14792039|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792040|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792041|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
14792042|NCT00744445|Hematinics|hematinics|mesh-ancestor
15027146|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027147|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027148|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027149|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15027150|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027151|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
15027152|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15027153|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
15027154|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15027155|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
15027156|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027157|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027158|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
15027159|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
15027160|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15027161|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
15027162|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15027163|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
15027164|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027165|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027166|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
14519105|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14519106|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14519107|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519108|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519109|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519110|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15027167|NCT01947998|Warfarin|warfarin|mesh-list
14519111|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14519112|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14519113|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
14519114|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
14519115|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792043|NCT00744536|Lenalidomide|lenalidomide|mesh-list
14792044|NCT00744536|Melphalan|melphalan|mesh-list
14792045|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
14792046|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792047|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792048|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14792049|NCT00744536|Growth Substances|growth substances|mesh-ancestor
13965259|NCT03131973|Omeprazole|omeprazole|mesh-list
14519116|NCT03357614|Renal Agents|renal agents|mesh-ancestor
15027168|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
14519117|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
14519118|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
14519119|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
14519120|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519121|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
14519122|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519123|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519124|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519125|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519126|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
14519127|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14519128|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
14519129|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519130|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519131|NCT03358472|Carboplatin|carboplatin|mesh-list
14519132|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
14519133|NCT03358472|Fluorouracil|fluorouracil|mesh-list
14519134|NCT03358472|Cetuximab|cetuximab|mesh-list
14519135|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519136|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519137|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
14519138|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519139|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14519140|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519141|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
14519142|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519143|NCT03358576|Amoxicillin|amoxicillin|mesh-list
14519144|NCT03358576|Metronidazole|metronidazole|mesh-list
14519145|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
14519146|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
14519147|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
14519148|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14519149|NCT03358576|Ertapenem|ertapenem|mesh-list
14519150|NCT03358576|Lactams|lactams|mesh-list
14519151|NCT03358576|Probenecid|probenecid|mesh-list
14519152|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519153|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519154|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14519155|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14519156|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14519157|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14519158|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519159|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519160|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519161|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14519162|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14519163|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14519164|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
14519165|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
14519166|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14519167|NCT03358576|Renal Agents|renal agents|mesh-ancestor
14519168|NCT03359395|Alfentanil|alfentanil|mesh-list
14519169|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14519170|NCT03359395|Narcotics|narcotics|mesh-ancestor
14519171|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519172|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519173|NCT03359395|Analgesics|analgesics|mesh-ancestor
14792050|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792051|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792052|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14519174|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
14519175|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792053|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
14792054|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949009|NCT01536470|Norepinephrine|norepinephrine|mesh-list
14949010|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14949011|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14949012|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
14949013|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519176|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14519177|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
14519178|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
14519179|NCT03359473|GSK2881078|gsk2881078|mesh-list
14519180|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
14792055|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14792056|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792057|NCT00744549|Vitamin D|vitamin d|mesh-list
14949014|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949015|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949016|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
14792058|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
14792059|NCT00744549|Vitamins|vitamins|mesh-list
14792060|NCT00744549|Vitamin E|vitamin e|mesh-list
14792061|NCT00744549|Selenium|selenium|mesh-list
14792062|NCT00744549|Lycopene|lycopene|mesh-list
14792063|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
14519181|NCT03359473|Hormones|hormones|mesh-ancestor
14519182|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519183|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519184|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14519185|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519186|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519187|NCT03359590|Incretins|incretins|mesh-ancestor
14519188|NCT03359590|Hormones|hormones|mesh-ancestor
14519189|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519190|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14519191|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14519192|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519193|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519194|NCT03359850|Niraparib|niraparib|mesh-list
14519195|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14519196|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519197|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519198|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519199|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
14519200|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519201|NCT03361176|Triamcinolone|triamcinolone|mesh-list
14519202|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14949017|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
14949018|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519203|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14519204|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
14519205|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14519206|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519207|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
14519208|NCT03361176|Hormones|hormones|mesh-ancestor
14519209|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519210|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519211|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519212|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
14519213|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792064|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949019|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14949020|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
14949021|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
14949022|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14949023|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949024|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949025|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
14949026|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
14949027|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14949028|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949029|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949030|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
14949031|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
14949032|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14949033|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949034|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949035|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
14949036|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
14949037|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14949038|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949039|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949040|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
14949041|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
15027169|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14792065|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14792066|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14792067|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
14949042|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14949043|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949044|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949045|NCT01536665|Liraglutide|liraglutide|mesh-list
14949046|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949047|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949048|NCT01536665|Incretins|incretins|mesh-ancestor
14949049|NCT01536665|Hormones|hormones|mesh-ancestor
14949050|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949051|NCT01536691|Ondansetron|ondansetron|mesh-list
14949052|NCT01536691|Aprepitant|aprepitant|mesh-list
14949053|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
14949054|NCT01536691|Ramosetron|ramosetron|mesh-list
14949055|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
14949056|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
14949057|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949058|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949059|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949060|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
14949061|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14949062|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14949063|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
14949064|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949065|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949066|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14949067|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14949068|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949069|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14949070|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14949071|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14949072|NCT01536717|Carticaine|carticaine|mesh-list
14949073|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
14949074|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
14949075|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949076|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949077|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
14949078|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949079|NCT01536743|Palbociclib|palbociclib|mesh-list
14949080|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949081|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14949082|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949083|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949084|NCT01536873|Dolutegravir|dolutegravir|mesh-list
14949085|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14949086|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14949087|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949088|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949089|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14949090|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14949091|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
14949092|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949093|NCT01536964|Morphine|morphine|mesh-list
14949094|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14949095|NCT01536964|Narcotics|narcotics|mesh-ancestor
14949096|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949097|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949098|NCT01536964|Analgesics|analgesics|mesh-ancestor
14949099|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
14519214|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519215|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14519216|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519217|NCT03361605|Propofol|propofol|mesh-list
14519218|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14519219|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519220|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519221|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14519222|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
14519223|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
14519224|NCT03363776|Nivolumab|nivolumab|mesh-list
14519225|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519226|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519227|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14949100|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519228|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519229|NCT03363906|Dulaglutide|dulaglutide|mesh-list
14519230|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
14519231|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519232|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519233|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
14519234|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
14519235|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519236|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519237|NCT03364309|Ixekizumab|ixekizumab|mesh-list
14519238|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
14519239|NCT03364608|Albuterol|albuterol|mesh-list
14519240|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519241|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
14519242|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519243|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519244|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519245|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519246|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
14519247|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14519248|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14519249|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14519250|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519251|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
14519252|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519253|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519254|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
14519255|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14519256|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
14519257|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
14519258|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519259|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519260|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14519261|NCT03365011|Analgesics|analgesics|mesh-ancestor
14519262|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
14519263|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519264|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14519265|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519266|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
14519267|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519268|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519269|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14519270|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14519271|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519272|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519273|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519274|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14519275|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14519276|NCT03366298|Epinephrine|epinephrine|mesh-list
14519277|NCT03366298|Racepinephrine|racepinephrine|mesh-list
14519278|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
14519279|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14519280|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519281|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14519282|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519283|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519284|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519285|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14519286|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519287|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
14519288|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949101|NCT01537055|Amoxicillin|amoxicillin|mesh-list
14949102|NCT01537055|Levofloxacin|levofloxacin|mesh-list
14949103|NCT01537055|Ofloxacin|ofloxacin|mesh-list
14519289|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519290|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519291|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
14519292|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
14519293|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14519294|NCT03367793|Metronidazole|metronidazole|mesh-list
14519295|NCT03367793|Methamphetamine|methamphetamine|mesh-list
14519296|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14519297|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519298|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
14519299|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
14519300|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519301|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
14519302|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519303|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519304|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
14519305|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14792068|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792069|NCT00744549|Protective Agents|protective agents|mesh-ancestor
14792070|NCT00744549|Trace Elements|trace elements|mesh-ancestor
14792071|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792072|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14792073|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14949104|NCT01537055|Lansoprazole|lansoprazole|mesh-list
14949105|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
14949106|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949107|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949108|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14949109|NCT01537055|Renal Agents|renal agents|mesh-ancestor
14949110|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14949111|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14949112|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949113|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949114|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949115|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14949116|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14949117|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14949118|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949119|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14949120|NCT01537094|Vitamins|vitamins|mesh-list
14949121|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
14949122|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
14792074|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792075|NCT00744640|Gemcitabine|gemcitabine|mesh-list
14792076|NCT00744640|Capecitabine|capecitabine|mesh-list
14949123|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949124|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
14949125|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519306|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14519307|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14519308|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14519309|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519310|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519311|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14519312|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14519313|NCT03368235|Prednisolone|prednisolone|mesh-list
14519314|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519315|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
14519316|NCT03368235|Hormones|hormones|mesh-ancestor
14519317|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519318|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519319|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14519320|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792077|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
14792078|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14792079|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
14792080|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792081|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792082|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
14792083|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792084|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792085|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792086|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
14792087|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792088|NCT00744666|Prednisolone|prednisolone|mesh-list
14949126|NCT01537094|Protective Agents|protective agents|mesh-ancestor
14792089|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14792090|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792091|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
14792092|NCT00744666|Hormones|hormones|mesh-ancestor
14792093|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792094|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949127|NCT01537107|Sirolimus|sirolimus|mesh-list
14949128|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14949129|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949130|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949131|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14949132|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949133|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
14949134|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949135|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
14949136|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949137|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14949138|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949139|NCT01537146|Ropivacaine|ropivacaine|mesh-list
14949140|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
14949141|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
14949142|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949143|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949144|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
14519321|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
14519322|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519323|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519324|NCT03368859|Leucovorin|leucovorin|mesh-list
14519325|NCT03368859|Bevacizumab|bevacizumab|mesh-list
14519326|NCT03368859|Fluorouracil|fluorouracil|mesh-list
14519327|NCT03368859|Irinotecan|irinotecan|mesh-list
14519328|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519329|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519330|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14519331|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14519332|NCT03368859|Growth Substances|growth substances|mesh-ancestor
14519333|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519334|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
14519335|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
14519336|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519337|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14519338|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519339|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
14519340|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14519341|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14519342|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949145|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949146|NCT01537250|Levofloxacin|levofloxacin|mesh-list
14949147|NCT01537250|Ofloxacin|ofloxacin|mesh-list
14949148|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14949149|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792095|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14792096|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792097|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14792098|NCT00744679|Natalizumab|natalizumab|mesh-list
14949150|NCT01537250|Renal Agents|renal agents|mesh-ancestor
14949151|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949152|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14949153|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14949154|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792099|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
14792100|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792101|NCT00744718|Bevacizumab|bevacizumab|mesh-list
14792102|NCT00744718|Carboplatin|carboplatin|mesh-list
14949155|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949156|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949157|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14519343|NCT03368859|Antidotes|antidotes|mesh-ancestor
14519344|NCT03368859|Protective Agents|protective agents|mesh-ancestor
14519345|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
14519346|NCT03368859|Vitamins|vitamins|mesh-ancestor
14519347|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
14519348|NCT03369704|Omalizumab|omalizumab|mesh-list
14519349|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14519350|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14792103|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14949158|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14949159|NCT01537354|Poractant alfa|poractant alfa|mesh-list
14949160|NCT01537354|Beractant|beractant|mesh-list
14949161|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14949162|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
14949163|NCT01537380|Cefazolin|cefazolin|mesh-list
14949164|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949165|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519351|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
13965260|NCT03131973|Pravastatin|pravastatin|mesh-list
13965261|NCT03131973|Montelukast|montelukast|mesh-list
13965262|NCT03131973|Branebrutinib|branebrutinib|mesh-list
13965263|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13965264|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
13965265|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13965266|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965267|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13965268|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
13965269|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949166|NCT01537471|Meclizine|meclizine|mesh-list
14949167|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
14949168|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
14949169|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
14949170|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949171|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949172|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949173|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14949174|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
14949175|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
14949176|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949177|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949178|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14949179|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
14949180|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14949181|NCT01537575|Antibodies|antibodies|mesh-list
14949182|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
14949183|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14949184|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
14949185|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949186|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14949187|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949188|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14949189|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
14949190|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949191|NCT01537744|Azacitidine|azacitidine|mesh-list
14949192|NCT01537744|Romidepsin|romidepsin|mesh-list
14949193|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14792104|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792105|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792106|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14792107|NCT00744718|Growth Substances|growth substances|mesh-ancestor
14792108|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792109|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792110|NCT00744770|Rilpivirine|rilpivirine|mesh-list
14792111|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14949194|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
14519352|NCT03369951|Minocycline|minocycline|mesh-list
14519353|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519354|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519355|NCT03370289|Vaccines|vaccines|mesh-list
14519356|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
14519357|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529511|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949195|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949196|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949197|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949198|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14949199|NCT01537770|Lidocaine|lidocaine|mesh-list
14949200|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
14949201|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
14949202|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965270|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529512|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529513|NCT03742154|Varenicline|varenicline|mesh-list
14529514|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14529515|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14529516|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
14529517|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529518|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529519|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792112|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14792113|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792114|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949203|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949204|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
14519358|NCT03370770|Afatinib|afatinib|mesh-list
14519359|NCT03370770|Osimertinib|osimertinib|mesh-list
14519360|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519361|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14519362|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519363|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519364|NCT03371381|Nivolumab|nivolumab|mesh-list
14519365|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519366|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519367|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14519368|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519369|NCT03371459|Albuterol|albuterol|mesh-list
14519370|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519371|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
14519372|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519373|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519374|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519375|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519376|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
14519377|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14519378|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14519379|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14519380|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519381|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
14949205|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949206|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14949207|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14949208|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14519382|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519383|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519384|NCT03371836|Clobazam|clobazam|mesh-list
14519385|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
14519386|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14519387|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14519388|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519389|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519390|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14519391|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14519392|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
14519393|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
14519394|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519395|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519396|NCT03372083|Deferasirox|deferasirox|mesh-list
14519397|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14519398|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
14519399|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
14519400|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519401|NCT03372382|Acetaminophen|acetaminophen|mesh-list
14519402|NCT03372382|Ibuprofen|ibuprofen|mesh-list
14519403|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14519404|NCT03372382|Analgesics|analgesics|mesh-ancestor
14519405|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
14519406|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519407|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519408|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
14519409|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14519410|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519411|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14519412|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14519413|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519414|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519415|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14519416|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14519417|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14519418|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519419|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519420|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14519421|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14519422|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519423|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
14519424|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519425|NCT03373591|Bupivacaine|bupivacaine|mesh-list
14519426|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
15027170|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
14519427|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
14519428|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519429|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519430|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
14519431|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519432|NCT03374176|Amoxicillin|amoxicillin|mesh-list
14519433|NCT03374176|Metronidazole|metronidazole|mesh-list
14519434|NCT03374176|Clindamycin|clindamycin|mesh-list
14949209|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14949210|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949211|NCT01537809|Vitamin D|vitamin d|mesh-list
14949212|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
14949213|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
14949214|NCT01537809|Vitamins|vitamins|mesh-list
14949215|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
14949216|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949217|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14949218|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14949219|NCT01537861|Thalidomide|thalidomide|mesh-list
14519435|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
14519436|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
14519437|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519438|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519439|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14519440|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14519441|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14519442|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519443|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519444|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
14519445|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14519446|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14519447|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
14519448|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519449|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14519450|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14519451|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519452|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519453|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
14949220|NCT01537861|Dexamethasone|dexamethasone|mesh-list
14949221|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
14949222|NCT01537861|Lenalidomide|lenalidomide|mesh-list
14949223|NCT01537861|Bortezomib|bortezomib|mesh-list
14949224|NCT01537861|Pomalidomide|pomalidomide|mesh-list
14949225|NCT01537861|Lenograstim|lenograstim|mesh-list
14949226|NCT01537861|Sargramostim|sargramostim|mesh-list
13965271|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
14519454|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519455|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519456|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
14519457|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14519458|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
14519459|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
14519460|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519461|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519462|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792115|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
14792116|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792117|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14792118|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14792119|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
14792120|NCT00744809|Efavirenz|efavirenz|mesh-list
14792121|NCT00744809|Rilpivirine|rilpivirine|mesh-list
14792122|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14792123|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792124|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14792125|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14792126|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792127|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792128|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792129|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14792130|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14792131|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
14792132|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14792133|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14949227|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949228|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
14519463|NCT03375294|Analgesics|analgesics|mesh-ancestor
14519464|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
14519465|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519466|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
14519467|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14949229|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949230|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949231|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14949232|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
14949233|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949234|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949235|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14949236|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949237|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
14949238|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
14949239|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949240|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949241|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
14949242|NCT01537861|Hormones|hormones|mesh-ancestor
14949243|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949244|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14949245|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14949246|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14949247|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14949248|NCT01537861|Growth Substances|growth substances|mesh-ancestor
13965272|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965273|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13965274|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13965275|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
14519468|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14949249|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
14949250|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
14949251|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949252|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949253|NCT01538095|Trebananib|trebananib|mesh-list
14949254|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14949255|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14949256|NCT01538095|Growth Substances|growth substances|mesh-ancestor
14949257|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949258|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
14949259|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949260|NCT01538108|Paclitaxel|paclitaxel|mesh-list
14949261|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14949262|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949263|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
14949264|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
14949265|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
14949266|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027171|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15027172|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
15027173|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15027174|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
14519469|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519470|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
14519471|NCT03376061|Coagulants|coagulants|mesh-ancestor
14519472|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
14519473|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519474|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
14519475|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519476|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519477|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519478|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519479|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
14519480|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14519481|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
14519482|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519483|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519484|NCT03377556|Talazoparib|talazoparib|mesh-list
14519485|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14519486|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519487|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519488|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519489|NCT03378076|Triamcinolone|triamcinolone|mesh-list
13965276|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965277|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14519490|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14519491|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14519492|NCT03378076|FX006|fx006|mesh-list
14519493|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14519494|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519495|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
14519496|NCT03378076|Hormones|hormones|mesh-ancestor
14519497|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519498|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519499|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519500|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
14519501|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519502|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519503|NCT03378635|Glucagon|glucagon|mesh-list
14519504|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519505|NCT03378635|Hormones|hormones|mesh-ancestor
14519506|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519507|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519508|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
14519509|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14519510|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519511|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519512|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14519513|NCT03378973|Analgesics|analgesics|mesh-ancestor
14519514|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
14519515|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519516|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14519517|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14519518|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519519|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
14519520|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519521|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949267|NCT01538225|Nabiximols|nabiximols|mesh-list
14949268|NCT01538225|Analgesics|analgesics|mesh-ancestor
14949269|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
14949270|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949271|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949272|NCT01538316|Genistein|genistein|mesh-list
14519522|NCT03379506|Grazoprevir|grazoprevir|mesh-list
14519523|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
14519524|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519525|NCT03380026|Triamcinolone|triamcinolone|mesh-list
14519526|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14519527|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14519528|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
14519529|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14519530|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519531|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
14519532|NCT03380026|Hormones|hormones|mesh-ancestor
14519533|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519534|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519535|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519536|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
14519537|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519538|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519539|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
14519540|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14519541|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519542|NCT03380091|Vitamin D|vitamin d|mesh-list
14792134|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14792135|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14792136|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14792137|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14792138|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14792139|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14792140|NCT00744887|Darunavir|darunavir|mesh-list
14792141|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14792142|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14792143|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
14792144|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519543|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
14519544|NCT03380091|Metformin|metformin|mesh-list
14519545|NCT03380091|Vitamins|vitamins|mesh-ancestor
14519546|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
14949273|NCT01538316|Quercetin|quercetin|mesh-list
14949274|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
14519547|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519548|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519549|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14519550|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14519551|NCT03380390|Phenylephrine|phenylephrine|mesh-list
14519552|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
14519553|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14519554|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519555|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
14519556|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519557|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519558|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519559|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
14519560|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
14519561|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519562|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
14519563|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14519564|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519565|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14519566|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
14519567|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14792145|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792146|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14792147|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14792148|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
14792149|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792150|NCT00744900|Pemetrexed|pemetrexed|mesh-list
14792151|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792152|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792153|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792154|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14792155|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14792156|NCT00744913|Nicotine|nicotine|mesh-list
14792157|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14792158|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
14792159|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792160|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792161|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14792162|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14792163|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
14792164|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792165|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792166|NCT00745004|Ondansetron|ondansetron|mesh-list
14792167|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
14792168|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
14792169|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792170|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792171|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792172|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
14792173|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
14792174|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14792175|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
14792176|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792177|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792178|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14792179|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14792180|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792181|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14792182|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14792183|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
14792184|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14792185|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
14792186|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
14792187|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792188|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792189|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14792190|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
14949275|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949276|NCT01538316|Protective Agents|protective agents|mesh-ancestor
14949277|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949278|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14949279|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949280|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965278|NCT03131973|Antidotes|antidotes|mesh-ancestor
14519568|NCT03380390|Protective Agents|protective agents|mesh-ancestor
14519569|NCT03380429|Albuterol|albuterol|mesh-list
14519570|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14949281|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949282|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
14949283|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14949284|NCT01538316|Estrogens|estrogens|mesh-ancestor
14949285|NCT01538316|Hormones|hormones|mesh-ancestor
14949286|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949287|NCT01538329|Amantadine|amantadine|mesh-list
14949288|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14949289|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14949290|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
14949291|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949292|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
14949293|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949294|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949295|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949296|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14949297|NCT01538329|Analgesics|analgesics|mesh-ancestor
14949298|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
14949299|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949300|NCT01538381|Afatinib|afatinib|mesh-list
14949301|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949302|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14519571|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
14519572|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519573|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519574|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519575|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519576|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
14519577|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14519578|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14519579|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14519580|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519581|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
14519582|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519583|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519584|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
14519585|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14519586|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
14519587|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519588|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
14519589|NCT03381248|Protective Agents|protective agents|mesh-ancestor
14519590|NCT03381742|Clopidogrel|clopidogrel|mesh-list
14519591|NCT03381742|Ticagrelor|ticagrelor|mesh-list
14519592|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14519593|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14949303|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949304|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949305|NCT01538394|Nicotine|nicotine|mesh-list
14949306|NCT01538394|Varenicline|varenicline|mesh-list
14949307|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14949308|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
14949309|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949310|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949311|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14949312|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14949313|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
14949314|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949315|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965279|NCT03131973|Protective Agents|protective agents|mesh-ancestor
14519594|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14949316|NCT01538446|Clopidogrel|clopidogrel|mesh-list
14949317|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14949318|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14949319|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14949320|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14949321|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14949322|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
14949323|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949324|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949325|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949326|NCT01538459|Dexamethasone|dexamethasone|mesh-list
14949327|NCT01538459|Bupivacaine|bupivacaine|mesh-list
14949328|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949329|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
13965280|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
13965281|NCT03131973|Vitamins|vitamins|mesh-ancestor
13965282|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
14519595|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14519596|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
14519597|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519598|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519599|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519600|NCT03382262|Triamcinolone|triamcinolone|mesh-list
14519601|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14519602|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14519603|NCT03382262|FX006|fx006|mesh-list
14519604|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14519605|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519606|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
14792191|NCT00745069|Tapentadol|tapentadol|mesh-list
14792192|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14792193|NCT00745069|Narcotics|narcotics|mesh-ancestor
14792194|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792195|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792196|NCT00745069|Analgesics|analgesics|mesh-ancestor
14792197|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
14792198|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792199|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14792200|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14792201|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792202|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792203|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
14792204|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792205|NCT00745147|Laxatives|laxatives|mesh-list
14792206|NCT00745147|Lactulose|lactulose|mesh-list
14792207|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792208|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14792209|NCT00745173|Estrogens|estrogens|mesh-ancestor
14792210|NCT00745173|Hormones|hormones|mesh-ancestor
14792211|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792212|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792213|NCT00745186|Glucagon|glucagon|mesh-list
14792214|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792215|NCT00745186|Hormones|hormones|mesh-ancestor
14792216|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792217|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792218|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
14792219|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14792220|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
14792221|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792222|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792223|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14792224|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
14792225|NCT00745225|Pioglitazone|pioglitazone|mesh-list
14792226|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519607|NCT03382262|Hormones|hormones|mesh-ancestor
14519608|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519609|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519610|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519611|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
14519612|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519613|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519614|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14792227|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792228|NCT00745407|Fenofibrate|fenofibrate|mesh-list
14792229|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13965283|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14519615|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14519616|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
14519617|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519618|NCT03382418|Antacids|antacids|mesh-ancestor
14519619|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519620|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519621|NCT03382821|Dexamethasone|dexamethasone|mesh-list
14519622|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
14519623|NCT03382821|Triamcinolone|triamcinolone|mesh-list
14519624|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14519625|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14519626|NCT03382821|Lidocaine|lidocaine|mesh-list
14519627|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14519628|NCT03382821|BB 1101|bb 1101|mesh-list
14519629|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14519630|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519631|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
14519632|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
14519633|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519634|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519635|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519636|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
14519637|NCT03382821|Hormones|hormones|mesh-ancestor
14519638|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519639|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14519640|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519641|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
14519642|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519643|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519644|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
14519645|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
14519646|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519647|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
14519648|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14792230|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
14792231|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792232|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14792233|NCT00745433|Metformin|metformin|mesh-list
14792234|NCT00745433|Repaglinide|repaglinide|mesh-list
14792235|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792236|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792237|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
14792238|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14792239|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792240|NCT00745511|Bevacizumab|bevacizumab|mesh-list
14792241|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14792242|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792243|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792244|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14792245|NCT00745511|Growth Substances|growth substances|mesh-ancestor
14792246|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792247|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792248|NCT00745589|Sevelamer|sevelamer|mesh-list
14792249|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
14792250|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
14792251|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792252|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14792253|NCT00745693|BQ 788|bq 788|mesh-list
14792254|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14792255|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14949330|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
14949331|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949332|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949333|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949334|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
14949335|NCT01538459|Hormones|hormones|mesh-ancestor
14949336|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949337|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14949338|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949339|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
14949340|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
14949341|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949342|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
14519649|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14949343|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
14792256|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792257|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
14792258|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
14792259|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
14792260|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792261|NCT00745914|Pioglitazone|pioglitazone|mesh-list
14792262|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792263|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792264|NCT00745953|Valsartan|valsartan|mesh-list
14792265|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14792266|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14792267|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14792268|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14792269|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792270|NCT00745953|Diuretics|diuretics|mesh-ancestor
14792271|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
14792272|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792273|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14792274|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792275|NCT00746031|Goserelin|goserelin|mesh-list
14792276|NCT00746031|Cetrorelix|cetrorelix|mesh-list
14792277|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14792278|NCT00746031|Hormones|hormones|mesh-ancestor
14792279|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792280|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792281|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14792282|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792283|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14792284|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
14792285|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14792286|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
14792287|NCT00746070|Spironolactone|spironolactone|mesh-list
14792288|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14792289|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
14792290|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792291|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792292|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14519650|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14519651|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14519652|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519653|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
14519654|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
14519655|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519656|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519657|NCT03382912|Nivolumab|nivolumab|mesh-list
14519658|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519659|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519660|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14792293|NCT00746070|Diuretics|diuretics|mesh-ancestor
14792294|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
14792295|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
14792296|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949344|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14519661|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519662|NCT03383198|Bupivacaine|bupivacaine|mesh-list
14519663|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
14519664|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
14519665|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519666|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519667|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
14519668|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519669|NCT03383523|Praziquantel|praziquantel|mesh-list
14519670|NCT03383523|Emodepside|emodepside|mesh-list
14519671|NCT03383523|Toltrazuril|toltrazuril|mesh-list
14519672|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
14519673|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14519674|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519675|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
14519676|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14519677|NCT03383588|Epinephrine|epinephrine|mesh-list
14519678|NCT03383588|Fentanyl|fentanyl|mesh-list
14519679|NCT03383588|Morphine|morphine|mesh-list
14519680|NCT03383588|Bupivacaine|bupivacaine|mesh-list
14519681|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
14519682|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
14519683|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519684|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519685|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
14519686|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519687|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14519688|NCT03383588|Narcotics|narcotics|mesh-ancestor
14519689|NCT03383588|Analgesics|analgesics|mesh-ancestor
14519690|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14519691|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14519692|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
14519693|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14792297|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792298|NCT00746447|Mesalamine|mesalamine|mesh-list
14792299|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14792300|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792301|NCT00746447|Analgesics|analgesics|mesh-ancestor
14792302|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
14792303|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792304|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792305|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792306|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792307|NCT00746486|Budesonide|budesonide|mesh-list
14792308|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792309|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519694|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519695|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
14519696|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519697|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519698|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14519699|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14519700|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
14519701|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14519702|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519703|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
14519704|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
14519705|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14519706|NCT03383614|Emodepside|emodepside|mesh-list
14519707|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14519708|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792310|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
14792311|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792312|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792313|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14792314|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
14792315|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
14792316|NCT00746486|Hormones|hormones|mesh-ancestor
14792317|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792318|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
14792319|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14792320|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14792321|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
14519709|NCT03383783|Listerine|listerine|mesh-list
14519710|NCT03383783|Fluorides|fluorides|mesh-list
14519711|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
14519712|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
14519713|NCT03383783|Protective Agents|protective agents|mesh-ancestor
14519714|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792322|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792323|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14519715|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14519716|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519717|NCT03384316|Vaccines|vaccines|mesh-list
14519718|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
14519719|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519720|NCT03384329|Resveratrol|resveratrol|mesh-list
14519721|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
14519722|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519723|NCT03384329|Protective Agents|protective agents|mesh-ancestor
14519724|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792324|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14792325|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792326|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519725|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519726|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14519727|NCT03384693|Defibrotide|defibrotide|mesh-list
14792327|NCT00746655|Cisplatin|cisplatin|mesh-list
14519728|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14519729|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14519730|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519731|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14519732|NCT03384940|Trastuzumab|trastuzumab|mesh-list
14519733|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519734|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519735|NCT03386032|Desonide|desonide|mesh-list
14519736|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519737|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14519738|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14519739|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792328|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792329|NCT00746681|Pregabalin|pregabalin|mesh-list
14792330|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14792331|NCT00746681|Analgesics|analgesics|mesh-ancestor
14792332|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
14792333|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792334|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792335|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
14792336|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14792337|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792338|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792339|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14792340|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14792341|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14792342|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949345|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949346|NCT01538485|Vitamins|vitamins|mesh-ancestor
14949347|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
14949348|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14949349|NCT01538511|Insulin|insulin|mesh-list
14949350|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14949351|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
14949352|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
14949353|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14949354|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
14949355|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14949356|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519740|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519741|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519742|NCT03386448|Scopolamine|scopolamine|mesh-list
14519743|NCT03386448|Naltrexone|naltrexone|mesh-list
14519744|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14519745|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14519746|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14519747|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519748|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
14519749|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519750|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14519751|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
14519752|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
14519753|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519754|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
14519755|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14519756|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
14519757|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519758|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519759|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14519760|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
14519761|NCT03386474|Aflibercept|aflibercept|mesh-list
14519762|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14519763|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14519764|NCT03386474|Growth Substances|growth substances|mesh-ancestor
14519765|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519766|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
14519767|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519768|NCT03387020|Everolimus|everolimus|mesh-list
14519769|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519770|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519771|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
14519772|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792343|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14519773|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
14519774|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14519775|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14519776|NCT03387046|Prednisolone|prednisolone|mesh-list
14519777|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
14519778|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14519779|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
14519780|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519781|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
14519782|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
14519783|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519784|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519785|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519786|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
14519787|NCT03387046|Hormones|hormones|mesh-ancestor
14519788|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519789|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14519790|NCT03387046|Protective Agents|protective agents|mesh-ancestor
14519791|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14519792|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529520|NCT03740659|Levofloxacin|levofloxacin|mesh-list
14529521|NCT03740659|Ofloxacin|ofloxacin|mesh-list
14529522|NCT03740659|Dexamethasone|dexamethasone|mesh-list
14529523|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
14529524|NCT03740659|BB 1101|bb 1101|mesh-list
14529525|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529526|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
14529527|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
14529528|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529529|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529530|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529531|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
14529532|NCT03740659|Hormones|hormones|mesh-ancestor
14529533|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529534|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14529535|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529536|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
14529537|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529538|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529539|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14529540|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529541|NCT03740659|Renal Agents|renal agents|mesh-ancestor
14529542|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14529543|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14529544|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14529545|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14792344|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14792345|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14792346|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
14792347|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792348|NCT00746681|Urological Agents|urological agents|mesh-ancestor
14792349|NCT00746720|Etoricoxib|etoricoxib|mesh-list
14792350|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14792351|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792352|NCT00746720|Analgesics|analgesics|mesh-ancestor
14792353|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
14792354|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792355|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792356|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792357|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792358|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14792359|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14792360|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792361|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792362|NCT00746746|Interferons|interferons|mesh-list
14792363|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
14792364|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
14792365|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14792366|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792367|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
14792368|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792369|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
14529546|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14529547|NCT03739528|Levofloxacin|levofloxacin|mesh-list
14792370|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949357|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792371|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
14519793|NCT03387462|Tenofovir|tenofovir|mesh-list
14519794|NCT03387462|Emtricitabine|emtricitabine|mesh-list
14519795|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
14519796|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519797|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14519798|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14792372|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14792373|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792374|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14519799|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519800|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519801|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14519802|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14519803|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
14519804|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14519805|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519806|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519807|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519808|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
14519809|NCT03388008|Prednisone|prednisone|mesh-list
14792375|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14792376|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
14792377|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519810|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
14519811|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14519812|NCT03388008|Abatacept|abatacept|mesh-list
14519813|NCT03388008|Tacrolimus|tacrolimus|mesh-list
14519814|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
14519815|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519816|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
14519817|NCT03388008|Hormones|hormones|mesh-ancestor
14519818|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14519819|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519820|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14519821|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519822|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14519823|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
14519824|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14519825|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519826|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519827|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14519828|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14519829|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
14519830|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519831|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519832|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
14519833|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
14519834|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949358|NCT01538537|ON 01910|on 01910|mesh-list
14949359|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949360|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14949361|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949362|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949363|NCT01538563|ON 01910|on 01910|mesh-list
14949364|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949365|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14949366|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949367|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949368|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
14949369|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949370|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949371|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
14949372|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949373|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949374|NCT01538641|Gemcitabine|gemcitabine|mesh-list
14949375|NCT01538641|Rituximab|rituximab|mesh-list
14949376|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
14949377|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14949378|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949379|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
14949380|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965284|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14949381|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949382|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14949383|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
14949384|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949385|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
14949386|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949387|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949388|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949389|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
14949390|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949391|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949392|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14949393|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14949394|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949395|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949396|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949397|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14949398|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14949399|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
14949400|NCT01538693|Dexetimide|dexetimide|mesh-list
14949401|NCT01538693|Citalopram|citalopram|mesh-list
14949402|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14949403|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14949404|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14949405|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519835|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519836|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14519837|NCT03388008|Protective Agents|protective agents|mesh-ancestor
14519838|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14519839|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14519840|NCT03388164|Dexetimide|dexetimide|mesh-list
14519841|NCT03388164|Citalopram|citalopram|mesh-list
14519842|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14519843|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14519844|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14519845|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519846|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519847|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
14519848|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519849|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14519850|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
14519851|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14519852|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14519853|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14792378|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
14792379|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
14792380|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14949406|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792381|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14792382|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792383|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792384|NCT00746967|Urological Agents|urological agents|mesh-ancestor
14792385|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
14792386|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14792387|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792388|NCT00747097|Gemcitabine|gemcitabine|mesh-list
14792389|NCT00747097|Cetuximab|cetuximab|mesh-list
14792390|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14949407|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
14949408|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949409|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14949410|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
14949411|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14949412|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14949413|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14949414|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
14949415|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
14949416|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519854|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
14519855|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
14519856|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519857|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14519858|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13965285|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965286|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13965287|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14519859|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
14519860|NCT03388268|Vancomycin|vancomycin|mesh-list
14519861|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14519862|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14519863|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
14519864|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519865|NCT03389555|Vitamins|vitamins|mesh-list
14519866|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
14519867|NCT03389555|Thiamine|thiamine|mesh-list
14519868|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
14519869|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
14519870|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519871|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519872|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
13965288|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13965289|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13965290|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
13965291|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
13965292|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
13965293|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
13965294|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965295|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13965296|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949417|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14949418|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14949419|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
13965297|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13965298|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13965299|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13965300|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14519873|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519874|NCT03389555|Protective Agents|protective agents|mesh-ancestor
14519875|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
14519876|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14519877|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
14519878|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519879|NCT03390166|Vaccines|vaccines|mesh-list
14519880|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
14519881|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519882|NCT03390426|Anesthetics|anesthetics|mesh-list
14519883|NCT03390426|Mepivacaine|mepivacaine|mesh-list
14519884|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
14519885|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519886|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519887|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
14519888|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519889|NCT03391765|Tilavonemab|tilavonemab|mesh-list
14519890|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
13965301|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13965302|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
14519891|NCT03393000|Vitamin A|vitamin a|mesh-list
14519892|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
14519893|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
14519894|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792391|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
14792392|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792393|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792394|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
14792395|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792396|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792397|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792398|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
14792399|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792400|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14792401|NCT00747110|Budesonide|budesonide|mesh-list
14792402|NCT00747110|Mesalamine|mesalamine|mesh-list
14792403|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792404|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14792405|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
14792406|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965303|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13965304|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
14519895|NCT03393000|Protective Agents|protective agents|mesh-ancestor
14519896|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519897|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14519898|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519899|NCT03393000|Vitamins|vitamins|mesh-ancestor
14519900|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
14519901|NCT03393208|Metformin|metformin|mesh-list
14519902|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14519903|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519904|NCT03393494|Adapalene|adapalene|mesh-list
14519905|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14519906|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
14519907|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14519908|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14519909|NCT03393494|Analgesics|analgesics|mesh-ancestor
14519910|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
13965305|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14519911|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519912|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519913|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519914|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14519915|NCT03393754|Vaccines|vaccines|mesh-list
14519916|NCT03393754|Immunologic Factors|immunologic factors|mesh-ancestor
14519917|NCT03393754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519918|NCT03394885|Paclitaxel|paclitaxel|mesh-list
14519919|NCT03394885|Bevacizumab|bevacizumab|mesh-list
14519920|NCT03394885|Carboplatin|carboplatin|mesh-list
14519921|NCT03394885|Atezolizumab|atezolizumab|mesh-list
14519922|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14519923|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519924|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14519925|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
14519926|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
13965306|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
13965307|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965308|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14519927|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949420|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
14949421|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
14949422|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949423|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14949424|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
14949425|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
14949426|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14949427|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14949428|NCT01538732|Alitretinoin|alitretinoin|mesh-list
14949429|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949430|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14949431|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
14949432|NCT01538771|Hematinics|hematinics|mesh-ancestor
14949433|NCT01538797|Ranitidine|ranitidine|mesh-list
14949434|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14519928|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519929|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14529548|NCT03739528|Ofloxacin|ofloxacin|mesh-list
14949435|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14949436|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949437|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14949438|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
14519930|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14519931|NCT03394885|Growth Substances|growth substances|mesh-ancestor
14519932|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519933|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
14519934|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14519935|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14519936|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14519937|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14519938|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519939|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14519940|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949439|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
14949440|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949441|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949442|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949443|NCT01538849|Esomeprazole|esomeprazole|mesh-list
14949444|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14949445|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949446|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14949447|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949448|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949449|NCT01538875|Hydralazine|hydralazine|mesh-list
14949450|NCT01538875|Labetalol|labetalol|mesh-list
14949451|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14949452|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
14949453|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14949454|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14949455|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
14949456|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949457|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949458|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519941|NCT03395353|Analgesics|analgesics|mesh-ancestor
14519942|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
14519943|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519944|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
14519945|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14519946|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
14519947|NCT03395808|Tramadol|tramadol|mesh-list
14519948|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14519949|NCT03395808|Narcotics|narcotics|mesh-ancestor
14519950|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519951|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519952|NCT03395808|Analgesics|analgesics|mesh-ancestor
14519953|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
14519954|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519955|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
14949459|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
14949460|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
14949461|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949462|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14949463|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14949464|NCT01538901|Imiquimod|imiquimod|mesh-list
14949465|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14949466|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
14949467|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949468|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949469|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
14949470|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14949471|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
14949472|NCT01538927|Coagulants|coagulants|mesh-ancestor
14949473|NCT01538940|Vaccines|vaccines|mesh-list
14949474|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
14519956|NCT03395886|Remifentanil|remifentanil|mesh-list
14792407|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792408|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14792409|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
14792410|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
14792411|NCT00747110|Hormones|hormones|mesh-ancestor
14792412|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792413|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14792414|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792415|NCT00747110|Analgesics|analgesics|mesh-ancestor
14519957|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14792416|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
14792417|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14519958|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519959|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519960|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14519961|NCT03395886|Analgesics|analgesics|mesh-ancestor
14519962|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
14519963|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519964|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14519965|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14519966|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14519967|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
14792418|NCT00747279|Insulin|insulin|mesh-list
14792419|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792420|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792421|NCT00747305|Sunitinib|sunitinib|mesh-list
14792422|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792423|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792424|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14792425|NCT00747305|Growth Substances|growth substances|mesh-ancestor
14792426|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792427|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792428|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14792429|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792430|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949475|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949476|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14949477|NCT01538953|Disinfectants|disinfectants|mesh-list
14949478|NCT01538953|Eusol|eusol|mesh-list
14949479|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949480|NCT01539018|Sorafenib|sorafenib|mesh-list
14949481|NCT01539018|Tegafur|tegafur|mesh-list
14949482|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949483|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14949484|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949485|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949486|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14949487|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
14519968|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792431|NCT00747331|Fenoldopam|fenoldopam|mesh-list
14792432|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14792433|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
14792434|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
14792435|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
14792436|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792437|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792438|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792439|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14792440|NCT00747383|Glimepiride|glimepiride|mesh-list
14792441|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792442|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792443|NCT00747383|Incretins|incretins|mesh-ancestor
14792444|NCT00747383|Hormones|hormones|mesh-ancestor
14792445|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792446|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14792447|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
14792448|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792449|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792450|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14792451|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792452|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
14792453|NCT00747409|Insulin|insulin|mesh-list
14792454|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14792455|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
14792456|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
14792457|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
14792458|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14792459|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
14792460|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
14792461|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
14792462|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792463|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529549|NCT03739528|Tobramycin|tobramycin|mesh-list
14792464|NCT00747487|Idebenone|idebenone|mesh-list
14792465|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
14949488|NCT01539031|Donepezil|donepezil|mesh-list
14792466|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792467|NCT00747487|Protective Agents|protective agents|mesh-ancestor
14792468|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792469|NCT00747526|Rabeprazole|rabeprazole|mesh-list
14792470|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14792471|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14519969|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519970|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14519971|NCT03395886|Narcotics|narcotics|mesh-ancestor
14519972|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
14519973|NCT03395990|Procaine|procaine|mesh-list
14519974|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
14519975|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
14792472|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14792473|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792474|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792475|NCT00747539|Interferons|interferons|mesh-list
14792476|NCT00747539|Ribavirin|ribavirin|mesh-list
14792477|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
14792478|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792479|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
14792480|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792481|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
14792482|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519976|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14519977|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519978|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
14519979|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14519980|NCT03396952|Aspirin|aspirin|mesh-list
14949489|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14949490|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949491|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949492|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
14949493|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949494|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949495|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
14519981|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
14519982|NCT03396952|Ipilimumab|ipilimumab|mesh-list
14519983|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14519984|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14519985|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14519986|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14519987|NCT03396952|Analgesics|analgesics|mesh-ancestor
14519988|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
14519989|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792483|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
14792484|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792485|NCT00747604|Mecasermin|mecasermin|mesh-list
14792486|NCT00747604|Growth Substances|growth substances|mesh-ancestor
14949496|NCT01539044|Atropine|atropine|mesh-list
14949497|NCT01539044|Neostigmine|neostigmine|mesh-list
14519990|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14519991|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14519992|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14519993|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14519994|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14519995|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14519996|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14519997|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14519998|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14519999|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
14949498|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14949499|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14949500|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14949501|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
14949502|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949503|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949504|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14949505|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
14949506|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
14949507|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
14949508|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14949509|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14520000|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14792487|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949510|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
14949511|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949512|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949513|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14949514|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949515|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14949516|NCT01539174|Prednisone|prednisone|mesh-list
14949517|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
14949518|NCT01539174|Rituximab|rituximab|mesh-list
14949519|NCT01539174|Doxorubicin|doxorubicin|mesh-list
14520001|NCT03397394|Rucaparib|rucaparib|mesh-list
14520002|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14520003|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520004|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520005|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520006|NCT03398278|Oxycodone|oxycodone|mesh-list
14520007|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14520008|NCT03398278|Narcotics|narcotics|mesh-ancestor
14520009|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520010|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520011|NCT03398278|Analgesics|analgesics|mesh-ancestor
14520012|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
14520013|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520014|NCT03398330|Oxycodone|oxycodone|mesh-list
14520015|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14520016|NCT03398330|Narcotics|narcotics|mesh-ancestor
14520017|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949520|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14949521|NCT01539174|Vincristine|vincristine|mesh-list
14949522|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14520018|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792488|NCT00747669|Lidocaine|lidocaine|mesh-list
14949523|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
14949524|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949525|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949526|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14949527|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
14949528|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949529|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949530|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14949531|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14949532|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14949533|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14949534|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14949535|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949536|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949537|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
14949538|NCT01539174|Hormones|hormones|mesh-ancestor
14949539|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949540|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14949541|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14520019|NCT03398330|Analgesics|analgesics|mesh-ancestor
14520020|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
14520021|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520022|NCT03398356|Metformin|metformin|mesh-list
14520023|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520024|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520025|NCT03398421|Itraconazole|itraconazole|mesh-list
14520026|NCT03398421|Nemiralisib|nemiralisib|mesh-list
14520027|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
14792489|NCT00747669|Tetracaine|tetracaine|mesh-list
14792490|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
14792491|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
14792492|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792493|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792494|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
14792495|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792496|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14792497|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14792498|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14520028|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520029|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14949542|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
14949543|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
14949544|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
14949545|NCT01539265|Silodosin|silodosin|mesh-list
14949546|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14949547|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14949548|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14949549|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
14949550|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949551|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949552|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949553|NCT01539265|Urological Agents|urological agents|mesh-ancestor
14949554|NCT01539330|Voriconazole|voriconazole|mesh-list
14949555|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
14949556|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949557|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14949558|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14949559|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949560|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949561|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14949562|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
14949563|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949564|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520030|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14520031|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520032|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792499|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792500|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949565|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14949566|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
14949567|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14949568|NCT01539408|Misoprostol|misoprostol|mesh-list
13965309|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14520033|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14792501|NCT00747695|Rabeprazole|rabeprazole|mesh-list
13965310|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13965311|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13965312|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13965313|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13965314|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13965315|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13965316|NCT03131973|Analgesics|analgesics|mesh-ancestor
13965317|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
13965318|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520034|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
14949569|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14949570|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
14949571|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14949572|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949573|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14949574|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949575|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
14520035|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792502|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14792503|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792504|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14792505|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792506|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792507|NCT00747708|Sargramostim|sargramostim|mesh-list
14520036|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520037|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14520038|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14792508|NCT00747708|Lenograstim|lenograstim|mesh-list
14792509|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
14792510|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792511|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14792512|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
14792513|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14792514|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949576|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
14949577|NCT01539473|Tedizolid|tedizolid|mesh-list
14949578|NCT01539473|Tyramine|tyramine|mesh-list
14949579|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949580|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949581|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
14949582|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
14949583|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949584|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792515|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792516|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792517|NCT00747721|Analgesics|analgesics|mesh-ancestor
14792518|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
14792519|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792520|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14792521|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14792522|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14949585|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14949586|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14949587|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13965319|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965320|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965321|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949588|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949589|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
14520039|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
14520040|NCT03400033|Hematinics|hematinics|mesh-ancestor
14520041|NCT03400475|Simvastatin|simvastatin|mesh-list
14520042|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14520043|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14949590|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949591|NCT01539564|Minocycline|minocycline|mesh-list
14949592|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949593|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949594|NCT01539577|Dexamethasone|dexamethasone|mesh-list
13965322|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13965323|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965324|NCT03131882|Triamcinolone|triamcinolone|mesh-list
14520044|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
14520045|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520046|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14520047|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14520048|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520049|NCT03400852|Cosyntropin|cosyntropin|mesh-list
14520050|NCT03400852|Hormones|hormones|mesh-ancestor
14520051|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520052|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520053|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
14520054|NCT03401229|Benralizumab|benralizumab|mesh-list
14520055|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520056|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
14520057|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14520058|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14520059|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520060|NCT03401450|Bupivacaine|bupivacaine|mesh-list
14520061|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
14520062|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
14529550|NCT03739528|Dexamethasone|dexamethasone|mesh-list
14792523|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
14792524|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792525|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792526|NCT00747799|Fluorouracil|fluorouracil|mesh-list
14792527|NCT00747799|Sorafenib|sorafenib|mesh-list
14792528|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792529|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
14792530|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792531|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14792532|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792533|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
14792534|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792535|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14792536|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792537|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
14792538|NCT00747877|Melphalan|melphalan|mesh-list
14949595|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520063|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520064|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520065|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
14520066|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520067|NCT03402243|Menthol|menthol|mesh-list
14520068|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
14520069|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
14520070|NCT03403036|Brodalumab|brodalumab|mesh-list
14520071|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
14520072|NCT03403374|Evolocumab|evolocumab|mesh-list
14520073|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14520074|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14520075|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
14520076|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520077|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14520078|NCT03403504|Oxycodone|oxycodone|mesh-list
14520079|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14520080|NCT03403504|Narcotics|narcotics|mesh-ancestor
14792539|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792540|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
14792541|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792542|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792543|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14792544|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
14792545|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520081|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520082|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520083|NCT03403504|Analgesics|analgesics|mesh-ancestor
14520084|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
14520085|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520086|NCT03403517|Dexamethasone|dexamethasone|mesh-list
14520087|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
14520088|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14520089|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14520090|NCT03403517|Prednisolone|prednisolone|mesh-list
14520091|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
14520092|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14520093|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
14520094|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520095|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
14520096|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
14520097|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520098|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520099|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520100|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
14520101|NCT03403517|Hormones|hormones|mesh-ancestor
14520102|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520103|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14520104|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792546|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792547|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14792548|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14792549|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14792550|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
14792551|NCT00747968|Exenatide|exenatide|mesh-list
14792552|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792553|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792554|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14792555|NCT00747968|Incretins|incretins|mesh-ancestor
14792556|NCT00747968|Hormones|hormones|mesh-ancestor
14792557|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792558|NCT00748007|Rivastigmine|rivastigmine|mesh-list
14520105|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14520106|NCT03403517|Protective Agents|protective agents|mesh-ancestor
14520107|NCT03403712|Dexamethasone|dexamethasone|mesh-list
14520108|NCT03403712|Palonosetron|palonosetron|mesh-list
14520109|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520110|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
14520111|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
14520112|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520113|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520114|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520115|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
14520116|NCT03403712|Hormones|hormones|mesh-ancestor
14520117|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520118|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14520119|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520120|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14520121|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14792559|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14792560|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520122|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
14520123|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520124|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520125|NCT03404206|Ibuprofen|ibuprofen|mesh-list
14520126|NCT03404206|Naproxen|naproxen|mesh-list
14520127|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14520128|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520129|NCT03404206|Analgesics|analgesics|mesh-ancestor
14520130|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
14520131|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520132|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520133|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520134|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14520135|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14520136|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520137|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520138|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
14520139|NCT03404648|Choline|choline|mesh-list
14520140|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
14520141|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14520142|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
14520143|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520144|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520145|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14520146|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
14529551|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
14529552|NCT03739528|BB 1101|bb 1101|mesh-list
14529553|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529554|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
14529555|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
14529556|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529557|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529558|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529559|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
14529560|NCT03739528|Hormones|hormones|mesh-ancestor
14529561|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529562|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14529563|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529564|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
14529565|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529566|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529567|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14529568|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529569|NCT03739528|Renal Agents|renal agents|mesh-ancestor
14529570|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14529571|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14529572|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14529573|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14529574|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14792561|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792562|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
14792563|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792564|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792565|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13965325|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14520147|NCT03404843|Fasudil|fasudil|mesh-list
14520148|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14520149|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520150|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520151|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14520152|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520153|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
14520154|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14520155|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520156|NCT03405259|Fluorides|fluorides|mesh-list
14520157|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
14520158|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
14520159|NCT03405259|Protective Agents|protective agents|mesh-ancestor
14520160|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520161|NCT03405818|Tavaborole|tavaborole|mesh-list
14520162|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
14520163|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520164|NCT03406260|Lasmiditan|lasmiditan|mesh-list
14520165|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14520166|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
14520167|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520168|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520169|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520170|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
14520171|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520172|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520173|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
14520174|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14520175|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520176|NCT03407430|Pregabalin|pregabalin|mesh-list
14520177|NCT03407430|Analgesics|analgesics|mesh-ancestor
14520178|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
14520179|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520180|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520181|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
14520182|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14520183|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13965326|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13965327|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
14949596|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
14949597|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
14949598|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949599|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520184|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792566|NCT00748007|Protective Agents|protective agents|mesh-ancestor
14520185|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14520186|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14520187|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14520188|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520189|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14520190|NCT03407625|Misoprostol|misoprostol|mesh-list
14520191|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14520192|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
14520193|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14520194|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520195|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14520196|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520197|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
14520198|NCT03408483|Epinephrine|epinephrine|mesh-list
14792567|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14792568|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792569|NCT00748059|Propranolol|propranolol|mesh-list
14792570|NCT00748059|Atropine|atropine|mesh-list
14792571|NCT00748059|Clonidine|clonidine|mesh-list
14792572|NCT00748059|Nitroprusside|nitroprusside|mesh-list
14792573|NCT00748059|Methyldopa|methyldopa|mesh-list
14792574|NCT00748059|Phenylephrine|phenylephrine|mesh-list
14792575|NCT00748059|Isoproterenol|isoproterenol|mesh-list
14792576|NCT00748059|Metoclopramide|metoclopramide|mesh-list
14792577|NCT00748059|Yohimbine|yohimbine|mesh-list
14792578|NCT00748059|Tyramine|tyramine|mesh-list
13965328|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14520199|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
14520200|NCT03408483|Bupivacaine|bupivacaine|mesh-list
14792579|NCT00748059|Edrophonium|edrophonium|mesh-list
14792580|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14792581|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14520201|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
14520202|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
14520203|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520204|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520205|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
14520206|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520207|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14520208|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14520209|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
14520210|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520211|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520212|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14520213|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14520214|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
14520215|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14520216|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520217|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
14520218|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
14949600|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949601|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
14949602|NCT01539577|Hormones|hormones|mesh-ancestor
14949603|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949604|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14949605|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949606|NCT01539603|Sirolimus|sirolimus|mesh-list
14949607|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949608|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949609|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14949610|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949611|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
14949612|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949613|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
14949614|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949615|NCT01539616|Fenofibrate|fenofibrate|mesh-list
14949616|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14949617|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
14949618|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949619|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14949620|NCT01539655|Omeprazole|omeprazole|mesh-list
14949621|NCT01539655|Ranitidine|ranitidine|mesh-list
14949622|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14520219|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14520220|NCT03408483|Narcotics|narcotics|mesh-ancestor
14520221|NCT03408483|Analgesics|analgesics|mesh-ancestor
14520222|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
14520223|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
14792582|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14792583|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792584|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792585|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792586|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14792587|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14792588|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
14792589|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14792590|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
14792591|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
14792592|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792593|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
14792594|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14792595|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
14792596|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
14792597|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14792598|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14792599|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14792600|NCT00748059|Protective Agents|protective agents|mesh-ancestor
14792601|NCT00748059|Analgesics|analgesics|mesh-ancestor
14792602|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
14792603|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
14792604|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14520224|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
14792605|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14949623|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14949624|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520225|NCT03408639|Vitamins|vitamins|mesh-ancestor
14520226|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
14529575|NCT03738865|Glucagon|glucagon|mesh-list
14520227|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520228|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
14520229|NCT03408639|Hematinics|hematinics|mesh-ancestor
14520230|NCT03408730|Vaccines|vaccines|mesh-list
14520231|NCT03408730|Immunologic Factors|immunologic factors|mesh-ancestor
14520232|NCT03408730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520233|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
14520234|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14520235|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520236|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520237|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14520238|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520239|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14520240|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
14520241|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14520242|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520243|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
14520244|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
14520245|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14520246|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
14520247|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14792606|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14520248|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
14520249|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520250|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520251|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
14520252|NCT03414359|Lidocaine|lidocaine|mesh-list
14520253|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
14792607|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14792608|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
14792609|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14792610|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14792611|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
14792612|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
14792613|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792614|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14792615|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14792616|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
14792617|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14792618|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14792619|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14792620|NCT00748059|Urological Agents|urological agents|mesh-ancestor
14792621|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14792622|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14792623|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14792624|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792625|NCT00748059|Antidotes|antidotes|mesh-ancestor
14792626|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14792627|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792628|NCT00748150|Vaccines|vaccines|mesh-list
14792629|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
14520254|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
14520255|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
14520256|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792630|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520257|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520258|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
14520259|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520260|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14520261|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14520262|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14520263|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520264|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520265|NCT03415178|Atorvastatin|atorvastatin|mesh-list
14520266|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14520267|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14520268|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14520269|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
14520270|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520271|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14520272|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14520273|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520274|NCT03415243|Acetaminophen|acetaminophen|mesh-list
14520275|NCT03415243|Phenylephrine|phenylephrine|mesh-list
14520276|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
14520277|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
14792631|NCT00748163|Paclitaxel|paclitaxel|mesh-list
14792632|NCT00748163|Sunitinib|sunitinib|mesh-list
14792633|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14792634|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14792635|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792636|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
14792637|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
14792638|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
14792639|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792640|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792641|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14792642|NCT00748163|Growth Substances|growth substances|mesh-ancestor
14792643|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792644|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792645|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14792646|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792647|NCT00748176|Anesthetics|anesthetics|mesh-list
14792648|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792649|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792650|NCT00748202|Complement C1s|complement c1s|mesh-list
14792651|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14792652|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14792653|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
14792654|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792655|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14792656|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792657|NCT00748345|Caspofungin|caspofungin|mesh-list
14792658|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
14792659|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792660|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792661|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792662|NCT00748358|Sunitinib|sunitinib|mesh-list
14792663|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792664|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792665|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14792666|NCT00748358|Growth Substances|growth substances|mesh-ancestor
14792667|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792668|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792669|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14520278|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520279|NCT03415243|Analgesics|analgesics|mesh-ancestor
14520280|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
14520281|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520282|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520283|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
14520284|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14792670|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792671|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792672|NCT00748371|Aspirin|aspirin|mesh-list
14792673|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14792674|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792675|NCT00748371|Analgesics|analgesics|mesh-ancestor
14949625|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14949626|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949627|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949628|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14520285|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
14520286|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
14520287|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
14520288|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14520289|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
14520290|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520291|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14520292|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14520293|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14520294|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
14520295|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520296|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520297|NCT03415243|Protective Agents|protective agents|mesh-ancestor
14520298|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
14520299|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14520300|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14520301|NCT03415581|Oxycodone|oxycodone|mesh-list
14520302|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14520303|NCT03415581|Narcotics|narcotics|mesh-ancestor
14520304|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520305|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520306|NCT03415581|Analgesics|analgesics|mesh-ancestor
14520307|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
14520308|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520309|NCT03416127|Metformin|metformin|mesh-list
14520310|NCT03416127|Propolis|propolis|mesh-list
14520311|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520312|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520313|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520314|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
14520315|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
14520316|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520317|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14520318|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520319|NCT03418571|Gontivimab|gontivimab|mesh-list
14520320|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
14520321|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520322|NCT03418714|Salvinorin A|salvinorin a|mesh-list
14520323|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
14520324|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520325|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14520326|NCT03419403|Temozolomide|temozolomide|mesh-list
14520327|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14792676|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
14792677|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792678|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792679|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792680|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792681|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14792682|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14949629|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
14949630|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
14949631|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520328|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14520329|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14520330|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
14520331|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520332|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520333|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14520334|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
14520335|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
14520336|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520337|NCT03421210|Nicotine|nicotine|mesh-list
14520338|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14520339|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
14520340|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520341|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520342|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14520343|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14520344|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
14520345|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520346|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520347|NCT03421379|Glucagon|glucagon|mesh-list
14520348|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14520349|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520350|NCT03421379|Hormones|hormones|mesh-ancestor
14520351|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520352|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520353|NCT03421379|Incretins|incretins|mesh-ancestor
14520354|NCT03421730|Budesonide|budesonide|mesh-list
14520355|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520356|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14520357|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
14520358|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520359|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520360|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14520361|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520362|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
14520363|NCT03421730|Hormones|hormones|mesh-ancestor
14520364|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520365|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
14520366|NCT03422159|Thiamine|thiamine|mesh-list
14520367|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
14520368|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14520369|NCT03422159|Vitamins|vitamins|mesh-ancestor
14520370|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
14520371|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520372|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520373|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
14520374|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520375|NCT03422159|Protective Agents|protective agents|mesh-ancestor
14520376|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
14520377|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
14520378|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520379|NCT03424044|Glucagon|glucagon|mesh-list
14520380|NCT03424044|Pancrelipase|pancrelipase|mesh-list
14520381|NCT03424044|Pancreatin|pancreatin|mesh-list
14520382|NCT03424044|Hormones|hormones|mesh-list
14520383|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520384|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520385|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520386|NCT03424239|Vitamin D|vitamin d|mesh-list
14520387|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
14520388|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
14520389|NCT03424239|Vitamins|vitamins|mesh-list
14520390|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
14520391|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520392|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14520393|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14520394|NCT03424681|Modafinil|modafinil|mesh-list
14520395|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14520396|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520397|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14520398|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14520399|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14520400|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520401|NCT03425097|Fexofenadine|fexofenadine|mesh-list
14520402|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14520403|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14520404|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14520405|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
14520406|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
14520407|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520408|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520409|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520410|NCT03425253|Lidocaine|lidocaine|mesh-list
14949632|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520411|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
14520412|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
14520413|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520414|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520415|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
14520416|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520417|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14520418|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14520419|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14520420|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520421|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520422|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
14520423|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14520424|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520425|NCT03425396|Renal Agents|renal agents|mesh-ancestor
14520426|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14520427|NCT03426228|Progesterone|progesterone|mesh-list
14520428|NCT03426228|Estrogens|estrogens|mesh-list
14520429|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792683|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792684|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14792685|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14792686|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792687|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
14792688|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
14792689|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14792690|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
14949633|NCT01539681|Sorafenib|sorafenib|mesh-list
14949634|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520430|NCT03426228|Hormones|hormones|mesh-ancestor
14520431|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520432|NCT03426228|Progestins|progestins|mesh-ancestor
14529576|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14529577|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949635|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14949636|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949637|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949638|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
14949639|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14949640|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14949641|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
14949642|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949643|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949644|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949645|NCT01539707|Urological Agents|urological agents|mesh-ancestor
14949646|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
14949647|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
14949648|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14949649|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
14949650|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14949651|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949652|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14949653|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14949654|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14529578|NCT03738865|Hormones|hormones|mesh-ancestor
14529579|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529580|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529581|NCT03738865|Incretins|incretins|mesh-ancestor
14529582|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14529583|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14529584|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14529585|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529586|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529587|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
14529588|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529589|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529590|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14529591|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529592|NCT03736785|Insulin|insulin|mesh-list
14529593|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14529594|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529595|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
14792691|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520433|NCT03426995|Cantharidin|cantharidin|mesh-list
14520434|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520435|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520436|NCT03427619|Picibanil|picibanil|mesh-list
14520437|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520438|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
14792692|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792693|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14792694|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
14792695|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14792696|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
14792697|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792698|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792699|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14792700|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
14792701|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
14792702|NCT00748423|Protective Agents|protective agents|mesh-ancestor
14792703|NCT00748436|Betahistine|betahistine|mesh-list
14792704|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
14792705|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
14792706|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
14792707|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792708|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792709|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792710|NCT00748527|Carboplatin|carboplatin|mesh-list
14792711|NCT00748527|Decitabine|decitabine|mesh-list
14792712|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792713|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14792714|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
14792715|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792716|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792717|NCT00748618|Vitamin D|vitamin d|mesh-list
14792718|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
14792719|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
14792720|NCT00748618|Vitamins|vitamins|mesh-list
14792721|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
14792722|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792723|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14792724|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14792725|NCT00748644|Rituximab|rituximab|mesh-list
14949655|NCT01539733|Haloperidol|haloperidol|mesh-list
14949656|NCT01539733|Olanzapine|olanzapine|mesh-list
14949657|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
14949658|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
14949659|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
14949660|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949661|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949662|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520439|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
14520440|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520441|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520442|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520443|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
14520444|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
14520445|NCT03428230|Acetaminophen|acetaminophen|mesh-list
14520446|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
14520447|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14520448|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520449|NCT03428230|Analgesics|analgesics|mesh-ancestor
14520450|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
14520451|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520452|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520453|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
14520454|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
14520455|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
14520456|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520457|NCT03428360|Diazepam|diazepam|mesh-list
14520458|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14520459|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
14520460|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
14520461|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
14520462|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792726|NCT00748644|Azathioprine|azathioprine|mesh-list
14949663|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14949664|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14520463|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520464|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520465|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14520466|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792727|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14792728|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792729|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
14792730|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792731|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792732|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
14792733|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792734|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14792735|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949665|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949666|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14949667|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14949668|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14949669|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14949670|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949671|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949672|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
14949673|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14949674|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
14949675|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15027175|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027176|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027177|NCT01948011|Racecadotril|racecadotril|mesh-list
15027178|NCT01948011|Thiorphan|thiorphan|mesh-list
15027179|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
15027180|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027181|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
15027182|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027183|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027184|NCT01948024|Asenapine|asenapine|mesh-list
15027185|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15027186|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027187|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027188|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027189|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027190|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
15027191|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15027192|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
15027193|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
15027194|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027195|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027196|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15027197|NCT01948115|Analgesics|analgesics|mesh-ancestor
15027198|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
15027199|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027200|NCT01948128|Vitamin D|vitamin d|mesh-list
15027201|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
15027202|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
15027203|NCT01948128|Vitamins|vitamins|mesh-list
15027204|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
15027205|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027206|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15027207|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15027208|NCT01948232|Perindopril|perindopril|mesh-list
15027209|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15027210|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
15027211|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027212|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027213|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15027214|NCT01948245|Taurolidine|taurolidine|mesh-list
15027215|NCT01948245|Heparin|heparin|mesh-list
15027216|NCT01948245|Calcium heparin|calcium heparin|mesh-list
15027217|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
15027218|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027219|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14520467|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14520468|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14520469|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14520470|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14520471|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14520472|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14520473|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
14520474|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
14520475|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
14520476|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
14520477|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520478|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520479|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
14520480|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14520481|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520482|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520483|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
14520484|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520485|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520486|NCT03430050|Progesterone|progesterone|mesh-list
14792736|NCT00748787|Psyllium|psyllium|mesh-list
14792737|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
14520487|NCT03430050|Progestins|progestins|mesh-ancestor
14520488|NCT03430050|Hormones|hormones|mesh-ancestor
14520489|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520490|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520491|NCT03430856|Insulin|insulin|mesh-list
14520492|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14520493|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
14520494|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520495|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520496|NCT03430986|Lidocaine|lidocaine|mesh-list
14520497|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
14520498|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
14520499|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520500|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520501|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
14520502|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520503|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14520504|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14520505|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14520506|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520507|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520508|NCT03431337|Amoxicillin|amoxicillin|mesh-list
14520509|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14520510|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520511|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14520512|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
14520513|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520514|NCT03432858|Vancomycin|vancomycin|mesh-list
14520515|NCT03432858|Cefazolin|cefazolin|mesh-list
14520516|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14520517|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520518|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
14520519|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520520|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520521|NCT03433703|Lenvatinib|lenvatinib|mesh-list
14520522|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520523|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14520524|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520525|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520526|NCT03433755|Evolocumab|evolocumab|mesh-list
14520527|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14520528|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14520529|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
14792738|NCT00748787|Cathartics|cathartics|mesh-ancestor
14792739|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792740|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
14792741|NCT00748891|Cediranib|cediranib|mesh-list
14792742|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792743|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14792744|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520530|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520531|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14520532|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14520533|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14520534|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14520535|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520536|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
14520537|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14520538|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
14792745|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792746|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
14792747|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
14792748|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
14792749|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792750|NCT00749021|Ranibizumab|ranibizumab|mesh-list
14792751|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792752|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14949676|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14949677|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
14949678|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949679|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
14949680|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949681|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949682|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14949683|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
14949684|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949685|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949686|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14949687|NCT01540032|Salicylates|salicylates|mesh-list
14949688|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14520539|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
14520540|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520541|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520542|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520543|NCT03435055|Analgesics|analgesics|mesh-ancestor
14520544|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
14520545|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520546|NCT03435614|Analgesics|analgesics|mesh-list
14520547|NCT03435614|Narcotics|narcotics|mesh-list
14520548|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520549|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520550|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
14520551|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520552|NCT03435692|Acetaminophen|acetaminophen|mesh-list
14520553|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
14520554|NCT03435692|Promethazine|promethazine|mesh-list
14520555|NCT03435692|Fentanyl|fentanyl|mesh-list
14520556|NCT03435692|Morphine|morphine|mesh-list
14520557|NCT03435692|Oxycodone|oxycodone|mesh-list
14520558|NCT03435692|Lorazepam|lorazepam|mesh-list
14520559|NCT03435692|Ondansetron|ondansetron|mesh-list
14520560|NCT03435692|Ropivacaine|ropivacaine|mesh-list
14520561|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14520562|NCT03435692|Narcotics|narcotics|mesh-ancestor
14520563|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520564|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520565|NCT03435692|Analgesics|analgesics|mesh-ancestor
14792753|NCT00749021|Growth Substances|growth substances|mesh-ancestor
14792754|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792755|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792756|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792757|NCT00749047|Pioglitazone|pioglitazone|mesh-list
14792758|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792759|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792760|NCT00749099|Pancrelipase|pancrelipase|mesh-list
14792761|NCT00749099|Pancreatin|pancreatin|mesh-list
14792762|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792763|NCT00749112|Rituximab|rituximab|mesh-list
14792764|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
14949689|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520566|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
14520567|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792765|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14792766|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792767|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
14792768|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792769|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792770|NCT00749138|Tamoxifen|tamoxifen|mesh-list
14792771|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14792772|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
14792773|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949690|NCT01540032|Analgesics|analgesics|mesh-ancestor
14949691|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
13965329|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965330|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
13965331|NCT03131882|Hormones|hormones|mesh-ancestor
14520568|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
14949692|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520569|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
14520570|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14520571|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14520572|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
14520573|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520574|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
14520575|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
14520576|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
14520577|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520578|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
14520579|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
14520580|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14949693|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949694|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949695|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949696|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14949697|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949698|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949699|NCT01540084|Propofol|propofol|mesh-list
14949700|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14949701|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949702|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949703|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14949704|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
14949705|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
14949706|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
14520581|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
14520582|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520583|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520584|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14520585|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14520586|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14949707|NCT01540110|Docetaxel|docetaxel|mesh-list
14949708|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949709|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
14949710|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949711|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949712|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14949713|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
14949714|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949715|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949716|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14949717|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14520587|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14520588|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14520589|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14520590|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14520591|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
14520592|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
14520593|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14520594|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
14520595|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
14520596|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
14520597|NCT03436420|Calcium|calcium|mesh-list
14520598|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14520599|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792774|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949718|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14520600|NCT03437044|Clopidogrel|clopidogrel|mesh-list
14520601|NCT03437044|Ticagrelor|ticagrelor|mesh-list
14520602|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14949719|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14949720|NCT01540136|Nedaplatin|nedaplatin|mesh-list
14520603|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14520604|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14520605|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14520606|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
14520607|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520608|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520609|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520610|NCT03437447|Praziquantel|praziquantel|mesh-list
14520611|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
14520612|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14520613|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520614|NCT03437564|Vortioxetine|vortioxetine|mesh-list
13965332|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520615|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
14520616|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14520617|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14520618|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14520619|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520620|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520621|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14520622|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14520623|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520624|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520625|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520626|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
14792775|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14792776|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792777|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14792778|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14792779|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14792780|NCT00749346|Pemetrexed|pemetrexed|mesh-list
14792781|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792782|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792783|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792784|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13965333|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965334|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13965335|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
14520627|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14520628|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14949721|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949722|NCT01540240|Zidovudine|zidovudine|mesh-list
14949723|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
14949724|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949725|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14949726|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14520629|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14520630|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14520631|NCT03437577|Tacrolimus|tacrolimus|mesh-list
14520632|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14520633|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
14520634|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520635|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14520636|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520637|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520638|NCT03438006|Vaccines|vaccines|mesh-list
14520639|NCT03438006|Immunologic Factors|immunologic factors|mesh-ancestor
14520640|NCT03438006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520641|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
14520642|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14520643|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
14520644|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520645|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
14949727|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520646|NCT03438266|Protective Agents|protective agents|mesh-ancestor
14520647|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
14520648|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14520649|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520650|NCT03439072|Glucagon|glucagon|mesh-list
14520651|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14520652|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520653|NCT03439072|Hormones|hormones|mesh-ancestor
14520654|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520655|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520656|NCT03439072|Incretins|incretins|mesh-ancestor
14520657|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
14520658|NCT03439137|Hematinics|hematinics|mesh-ancestor
14520659|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14520660|NCT03440229|Laxatives|laxatives|mesh-ancestor
14520661|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520662|NCT03440411|Dexamethasone|dexamethasone|mesh-list
14520663|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
14520664|NCT03440411|Pomalidomide|pomalidomide|mesh-list
14520665|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14520666|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
14520667|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520668|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14520669|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14520670|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
14520671|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520672|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520673|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14520674|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520675|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
14520676|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
14520677|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520678|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520679|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
14520680|NCT03440411|Hormones|hormones|mesh-ancestor
14520681|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14520682|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14520683|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14520684|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14520685|NCT03440411|Growth Substances|growth substances|mesh-ancestor
14520686|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
14520687|NCT03440424|Lemborexant|lemborexant|mesh-list
14520688|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14520689|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520690|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520691|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14520692|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14520693|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520694|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520695|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
14520696|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14520697|NCT03441269|Ibuprofen|ibuprofen|mesh-list
14520698|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14520699|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520700|NCT03441269|Analgesics|analgesics|mesh-ancestor
14520701|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
14520702|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520703|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520704|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520705|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14520706|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14520707|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520708|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520709|NCT03441581|Eluxadoline|eluxadoline|mesh-list
14520710|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14520711|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
14520712|NCT03441633|Apixaban|apixaban|mesh-list
14949728|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
14949729|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949730|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14949731|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14949732|NCT01540253|Docetaxel|docetaxel|mesh-list
14949733|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520713|NCT03441633|Dabigatran|dabigatran|mesh-list
14520714|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14520715|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
14520716|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14520717|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
14520718|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520719|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520720|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
14520721|NCT03441789|Betamethasone|betamethasone|mesh-list
14949734|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
14949735|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
14520722|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
14520723|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14949736|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
14949737|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949738|NCT01540435|Bevacizumab|bevacizumab|mesh-list
14949739|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14949740|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949741|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14949742|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14949743|NCT01540435|Growth Substances|growth substances|mesh-ancestor
14949744|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949745|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
14949746|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
14949747|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14949748|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14949749|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949750|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949751|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14949752|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14949753|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14949754|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14949755|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949756|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949757|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
14949758|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14520724|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
14520725|NCT03441789|Calcipotriene|calcipotriene|mesh-list
14520726|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14520727|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520728|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
14520729|NCT03441789|Hormones|hormones|mesh-ancestor
14520730|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792785|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14792786|NCT00749359|Paroxetine|paroxetine|mesh-list
14792787|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14792788|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14792789|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792790|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792791|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792792|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
14792793|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792794|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14792795|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
14520731|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520732|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14520733|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520734|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
14520735|NCT03442569|Nivolumab|nivolumab|mesh-list
14520736|NCT03442569|Ipilimumab|ipilimumab|mesh-list
14520737|NCT03442569|Panitumumab|panitumumab|mesh-list
14520738|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14520739|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520740|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14520741|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529596|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
14529597|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529598|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
14529599|NCT03734601|Tacrolimus|tacrolimus|mesh-list
14529600|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14529601|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14529602|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
14529603|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529604|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14529605|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520742|NCT03443063|Lemborexant|lemborexant|mesh-list
14520743|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14520744|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520745|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520746|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14520747|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14520748|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520749|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520750|NCT03444155|Folic Acid|folic acid|mesh-list
14520751|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
14520752|NCT03444155|Vitamins|vitamins|mesh-ancestor
14520753|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
14520754|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520755|NCT03444155|Hematinics|hematinics|mesh-ancestor
14520756|NCT03444584|Metformin|metformin|mesh-list
14520757|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520758|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520759|NCT03444766|Nivolumab|nivolumab|mesh-list
14520760|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14520761|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520762|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14520763|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792796|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14792797|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14949759|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
14949760|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14949761|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14949762|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949763|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14949764|NCT01540526|Axitinib|axitinib|mesh-list
14520764|NCT03445195|Imipenem|imipenem|mesh-list
14520765|NCT03445195|Sulbactam|sulbactam|mesh-list
14520766|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
14520767|NCT03445195|Cilastatin|cilastatin|mesh-list
14520768|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14520769|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949765|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520770|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
14520771|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520772|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520773|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14520774|NCT03445390|Acetaminophen|acetaminophen|mesh-list
14520775|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520776|NCT03445390|Analgesics|analgesics|mesh-ancestor
14792798|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14792799|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792800|NCT00749385|Naproxen|naproxen|mesh-list
14792801|NCT00749385|Esomeprazole|esomeprazole|mesh-list
14792802|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14792803|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14792804|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14520777|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
14520778|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792805|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949766|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14949767|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949768|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949769|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14949770|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14949771|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14949772|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14949773|NCT01540682|Cetuximab|cetuximab|mesh-list
14949774|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14949775|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949776|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14949777|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14949778|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
14949779|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949780|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949781|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14949782|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
14949783|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
14949784|NCT01540708|Hormones|hormones|mesh-ancestor
14949785|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949786|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
14949787|NCT01540721|Acetaminophen|acetaminophen|mesh-list
14949788|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14949789|NCT01540721|Analgesics|analgesics|mesh-ancestor
14949790|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
14949791|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949792|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949793|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
14949794|NCT01540734|Acetaminophen|acetaminophen|mesh-list
13965336|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520779|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520780|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
14520781|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14520782|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14520783|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520784|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14520785|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14520786|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520787|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520788|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
14520789|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520790|NCT03447249|Ivacaftor|ivacaftor|mesh-list
14520791|NCT03447249|VX-659|vx-659|mesh-list
14520792|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14520793|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14520794|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520795|NCT03447353|Acetaminophen|acetaminophen|mesh-list
14520796|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14520797|NCT03447353|Hydrocodone|hydrocodone|mesh-list
14520798|NCT03447353|Alprazolam|alprazolam|mesh-list
14792806|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792807|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14792808|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792809|NCT00749385|Analgesics|analgesics|mesh-ancestor
14792810|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
14792811|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968256|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520799|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520800|NCT03447353|Analgesics|analgesics|mesh-ancestor
14520801|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
14792812|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792813|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14792814|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792815|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
14792816|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14792817|NCT00749450|Fluorouracil|fluorouracil|mesh-list
14792818|NCT00749450|Capecitabine|capecitabine|mesh-list
14792819|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
14792820|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
14949795|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14949796|NCT01540734|Analgesics|analgesics|mesh-ancestor
14520802|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520803|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520804|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
13965337|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965338|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13965339|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
13965340|NCT03131882|Protective Agents|protective agents|mesh-ancestor
13965341|NCT03131765|Poly I-C|poly i-c|mesh-list
14949797|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
14949798|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949799|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965342|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
13965343|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965344|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
13965345|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
13965346|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965347|NCT03131622|Coal Tar|coal tar|mesh-list
13965348|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
13965349|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
13965350|NCT03131583|Colchicine|colchicine|mesh-list
13965351|NCT03131583|Febuxostat|febuxostat|mesh-list
13965352|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
13965353|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965354|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
13965355|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
13965356|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
14520805|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14520806|NCT03447353|Narcotics|narcotics|mesh-ancestor
14520807|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520808|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
14520809|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520810|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14520811|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14520812|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14520813|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14520814|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
14520815|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
14520816|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520817|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520818|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14520819|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520820|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14520821|NCT03447821|Rifamycins|rifamycins|mesh-list
14520822|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
14520823|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13965357|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520824|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520825|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14520826|NCT03448068|Ketamine|ketamine|mesh-list
14520827|NCT03448068|Analgesics|analgesics|mesh-ancestor
14520828|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
14520829|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520830|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520831|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14520832|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14520833|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
14520834|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
14520835|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520836|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14520837|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14520838|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520839|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520840|NCT03448406|Empagliflozin|empagliflozin|mesh-list
14520841|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14520842|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520843|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520844|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520845|NCT03448419|Empagliflozin|empagliflozin|mesh-list
14520846|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14520847|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520848|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520849|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520850|NCT03448536|Acetaminophen|acetaminophen|mesh-list
13965358|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965359|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
13965360|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
13965361|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
13965362|NCT03131336|Coagulants|coagulants|mesh-ancestor
13965363|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
14520851|NCT03448536|Naproxen|naproxen|mesh-list
14520852|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520853|NCT03448536|Analgesics|analgesics|mesh-ancestor
14520854|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
14520855|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520856|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520857|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
14520858|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14520859|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965364|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13965365|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965366|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520860|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14520861|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
14520862|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14520863|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520864|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520865|NCT03449433|Insulin|insulin|mesh-list
14520866|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14520867|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
14520868|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
13965367|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965368|NCT03131375|Analgesics|analgesics|mesh-ancestor
14520869|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14520870|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
14949800|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
14949801|NCT01540747|Folic Acid|folic acid|mesh-list
14949802|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
14949803|NCT01540747|Inositol|inositol|mesh-list
14949804|NCT01540747|Melatonin|melatonin|mesh-list
14949805|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
14949806|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949807|NCT01540747|Protective Agents|protective agents|mesh-ancestor
14949808|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949809|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949810|NCT01540747|Hematinics|hematinics|mesh-ancestor
14949811|NCT01540747|Vitamins|vitamins|mesh-ancestor
14949812|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
14949813|NCT01540812|Cytarabine|cytarabine|mesh-list
14949814|NCT01540812|Dexamethasone|dexamethasone|mesh-list
14949815|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
14949816|NCT01540812|Prednisone|prednisone|mesh-list
14949817|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
14520871|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14520872|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520873|NCT03449446|Firsocostat|firsocostat|mesh-list
14520874|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520875|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949818|NCT01540812|Fludarabine|fludarabine|mesh-list
14949819|NCT01540812|Vincristine|vincristine|mesh-list
14949820|NCT01540812|Daunorubicin|daunorubicin|mesh-list
14949821|NCT01540812|Idarubicin|idarubicin|mesh-list
14949822|NCT01540812|Methotrexate|methotrexate|mesh-list
14949823|NCT01540812|Pegaspargase|pegaspargase|mesh-list
14949824|NCT01540812|Asparaginase|asparaginase|mesh-list
14949825|NCT01540812|BB 1101|bb 1101|mesh-list
14949826|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949827|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
14949828|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
14949829|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949830|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949831|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949832|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
14949833|NCT01540812|Hormones|hormones|mesh-ancestor
14520909|NCT03450083|Benralizumab|benralizumab|mesh-list
14520910|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14520911|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520912|NCT03451773|Gemcitabine|gemcitabine|mesh-list
14520913|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14520914|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
14520915|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520916|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520917|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
14520918|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520919|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520920|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14520921|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
14520922|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520923|NCT03452189|Vancomycin|vancomycin|mesh-list
14520924|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14520925|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520926|NCT03452527|Aflibercept|aflibercept|mesh-list
14520927|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
14520928|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14520929|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14520930|NCT03452527|Growth Substances|growth substances|mesh-ancestor
14520931|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520932|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
14520933|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14520934|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
14520935|NCT03453060|Thrombin|thrombin|mesh-list
14520936|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
14520937|NCT03453060|Coagulants|coagulants|mesh-ancestor
14520938|NCT03453151|Anesthetics|anesthetics|mesh-list
14520939|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
14792821|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792822|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14792823|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792824|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792825|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
14792826|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792827|NCT00749502|Niraparib|niraparib|mesh-list
14792828|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14792829|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792830|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949834|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949835|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14949836|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949837|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
14949838|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949839|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949840|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14949841|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
14949842|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14949843|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
14949844|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
14949845|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949846|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14949847|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14949848|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14949849|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14949850|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14949851|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14949852|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14520940|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14520941|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520942|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
14520943|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520944|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
14520945|NCT03454048|Piperaquine|piperaquine|mesh-list
14520946|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
14520947|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14520948|NCT03454048|Atovaquone|atovaquone|mesh-list
14520949|NCT03454048|Proguanil|proguanil|mesh-list
14520950|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14520951|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
14520952|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14520953|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14520954|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520955|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14520956|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520957|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520958|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14520959|NCT03454048|Renal Agents|renal agents|mesh-ancestor
14520960|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
14520961|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
14520962|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14520963|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
14520964|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520965|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520966|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14520967|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
14520968|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14520969|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
14520970|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520971|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14520972|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14520973|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14520974|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
14520975|NCT03455218|Protective Agents|protective agents|mesh-ancestor
14520976|NCT03456960|Aspirin|aspirin|mesh-list
14520977|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14520978|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14520979|NCT03456960|Analgesics|analgesics|mesh-ancestor
14520980|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
14520981|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14520982|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14520983|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14520984|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14520985|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14520986|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14520987|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14520988|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14520989|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14949853|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14949854|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
14949855|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14949856|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
14949857|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14949858|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949859|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14949860|NCT01540877|Anesthetics|anesthetics|mesh-list
14949861|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14949862|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
14949863|NCT01540877|Capsaicin|capsaicin|mesh-list
14949864|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949865|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949866|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
14949867|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949868|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
14949869|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
14520990|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14520991|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
14520992|NCT03457636|Doxycycline|doxycycline|mesh-list
14520993|NCT03457636|Adapalene|adapalene|mesh-list
14520994|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14520995|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14520996|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14520997|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14520998|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
14520999|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14521000|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14521001|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
14521002|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521003|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521004|NCT03457636|Analgesics|analgesics|mesh-ancestor
14521005|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
14521006|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521007|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521008|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521009|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521010|NCT03457727|Omeprazole|omeprazole|mesh-list
14521011|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14521012|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521013|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14521014|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521015|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521016|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14521017|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
14521018|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14521019|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14521020|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
14521021|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521022|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521023|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
14792831|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792832|NCT00749567|Bevacizumab|bevacizumab|mesh-list
14792833|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14792834|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14949870|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14949871|NCT01541059|Ropivacaine|ropivacaine|mesh-list
14949872|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
14949873|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
14949874|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949875|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949876|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
14949877|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949878|NCT01541072|Lenograstim|lenograstim|mesh-list
14949879|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14949880|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
14949881|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949882|NCT01541085|Ritonavir|ritonavir|mesh-list
14949883|NCT01541085|Darunavir|darunavir|mesh-list
14949884|NCT01541085|Efavirenz|efavirenz|mesh-list
14949885|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14949886|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14521024|NCT03459612|Promethazine|promethazine|mesh-list
14521025|NCT03459612|Lasmiditan|lasmiditan|mesh-list
14521026|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14521027|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14521028|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521029|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521030|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
14521031|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
14521032|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
14792835|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792836|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14792837|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14792838|NCT00749567|Growth Substances|growth substances|mesh-ancestor
14792839|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792840|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
14792841|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14792842|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949887|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
14521033|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792843|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949888|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521034|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
14521035|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
14521036|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521037|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14521038|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
14521039|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
14521040|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521041|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521042|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14792844|NCT00749619|Taurolidine|taurolidine|mesh-list
14792845|NCT00749619|Heparin|heparin|mesh-list
14792846|NCT00749619|Calcium heparin|calcium heparin|mesh-list
14792847|NCT00749619|Citric Acid|citric acid|mesh-list
14792848|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
14792849|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14792850|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
14521043|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
14792851|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14792852|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
14792853|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
14792854|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792855|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14792856|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14792857|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792858|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14521044|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
14521045|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14521046|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
14521047|NCT03459794|Ivermectin|ivermectin|mesh-list
14521048|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14521049|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521050|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14521051|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521052|NCT03460990|Ivacaftor|ivacaftor|mesh-list
14521053|NCT03460990|VX-659|vx-659|mesh-list
14521054|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14521055|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14521056|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521057|NCT03462680|Niacin|niacin|mesh-list
14521058|NCT03462680|Vitamins|vitamins|mesh-ancestor
14521059|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
14521060|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521061|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
14521062|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14521063|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
14521064|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521065|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14521066|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
14521067|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
14521068|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14521069|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521070|NCT03463512|Racecadotril|racecadotril|mesh-list
14521071|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
14521072|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521073|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
14521074|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521075|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521076|NCT03463889|Edetic Acid|edetic acid|mesh-list
14521077|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14521078|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14521079|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792859|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792860|NCT00749710|Clopidogrel|clopidogrel|mesh-list
14792861|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14792862|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14792863|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14792864|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14792865|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
14792866|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792867|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792868|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792869|NCT00749723|Carboplatin|carboplatin|mesh-list
14792870|NCT00749723|Etoposide|etoposide|mesh-list
14792871|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
13968257|NCT03112031|Tamoxifen|tamoxifen|mesh-list
14521080|NCT03463889|Anticoagulants|anticoagulants|mesh-ancestor
14521081|NCT03463889|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14521082|NCT03463889|Chelating Agents|chelating agents|mesh-ancestor
14792872|NCT00749723|Temozolomide|temozolomide|mesh-list
14521083|NCT03463889|Sequestering Agents|sequestering agents|mesh-ancestor
14521084|NCT03463915|Triamcinolone|triamcinolone|mesh-list
14521085|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14521086|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14521087|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14521088|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521089|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
14521090|NCT03463915|Hormones|hormones|mesh-ancestor
14521091|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521092|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521093|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14521094|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
14792873|NCT00749723|Thiotepa|thiotepa|mesh-list
14792874|NCT00749723|Trofosfamide|trofosfamide|mesh-list
14792875|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
14521095|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521096|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529606|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529607|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14529608|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529609|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14529610|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
14529611|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14529612|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529613|NCT03733899|Anesthetics|anesthetics|mesh-list
14529614|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529615|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529616|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
14529617|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
14529618|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14529619|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14529620|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529621|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529622|NCT03733470|Urological Agents|urological agents|mesh-ancestor
14529623|NCT03732248|Sirolimus|sirolimus|mesh-list
14529624|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14529625|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529626|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14529627|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529628|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
14529629|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14529630|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
14529631|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529632|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14529633|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
14529634|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529635|NCT03730961|Furosemide|furosemide|mesh-list
14529636|NCT03730961|Diuretics|diuretics|mesh-ancestor
14529637|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
14529638|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529639|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14529640|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529641|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529642|NCT03730116|Bisoprolol|bisoprolol|mesh-list
14529643|NCT03730116|Perindopril|perindopril|mesh-list
14529644|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14529645|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
14529646|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
14529647|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529648|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529649|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14529650|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14792876|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792877|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14792878|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14792879|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14792880|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792881|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792882|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14792883|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
14792884|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14792885|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13968258|NCT03112031|Fluconazole|fluconazole|mesh-list
14521097|NCT03464383|Citalopram|citalopram|mesh-list
14521098|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14521099|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14521100|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14521101|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949889|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949890|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14949891|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14949892|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
14949893|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949894|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14521102|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521103|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
14521104|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521105|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14521106|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
14521107|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521108|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
14521109|NCT03465436|Lasmiditan|lasmiditan|mesh-list
14521110|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14949895|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14949896|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14949897|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14949898|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14949899|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14949900|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14949901|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14949902|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14949903|NCT01541124|Morphine|morphine|mesh-list
14521111|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14949904|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14949905|NCT01541124|Narcotics|narcotics|mesh-ancestor
14949906|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949907|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949908|NCT01541124|Analgesics|analgesics|mesh-ancestor
14521112|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14521113|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14521114|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521115|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521116|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521117|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521118|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14521119|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
14521120|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521121|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
14521122|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521123|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521124|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14521125|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14521126|NCT03467217|Losartan|losartan|mesh-list
14521127|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14521128|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14521129|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14521130|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14521131|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949909|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
14949910|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521132|NCT03467685|Anesthetics|anesthetics|mesh-list
14521133|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521134|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521135|NCT03467763|Metformin|metformin|mesh-list
14521136|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521137|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521138|NCT03467945|Metformin|metformin|mesh-list
14521139|NCT03467945|Gliclazide|gliclazide|mesh-list
14521140|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14792886|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
14792887|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792888|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14792889|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
14792890|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14792891|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14792892|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792893|NCT00749736|Vitamins|vitamins|mesh-ancestor
14792894|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
14792895|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14792896|NCT00749814|Melatonin|melatonin|mesh-list
14792897|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
14792898|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792899|NCT00749814|Protective Agents|protective agents|mesh-ancestor
14792900|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792901|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792902|NCT00749853|Buserelin|buserelin|mesh-list
14792903|NCT00749853|Hormones|hormones|mesh-list
14792904|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14792905|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792906|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949911|NCT01541137|Diclofenac|diclofenac|mesh-list
14949912|NCT01541137|Parecoxib|parecoxib|mesh-list
14949913|NCT01541137|Valdecoxib|valdecoxib|mesh-list
14949914|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965369|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
13965370|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521141|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949915|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14949916|NCT01541137|Analgesics|analgesics|mesh-ancestor
14949917|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
14949918|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949919|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949920|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521142|NCT03467971|Metformin|metformin|mesh-list
14521143|NCT03467971|Gliclazide|gliclazide|mesh-list
14521144|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521145|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521146|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
14521147|NCT03468075|Gemcitabine|gemcitabine|mesh-list
14521148|NCT03468075|Vitamins|vitamins|mesh-ancestor
14521149|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
14521150|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949921|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14949922|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14949923|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949924|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949925|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14949926|NCT01541189|Valsartan|valsartan|mesh-list
14949927|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14792907|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14949928|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14949929|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14949930|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949931|NCT01541267|Telmisartan|telmisartan|mesh-list
14949932|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14949933|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14949934|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14949935|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949936|NCT01541280|Azacitidine|azacitidine|mesh-list
14949937|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14949938|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
14521151|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14521152|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
14521153|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521154|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521155|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
14521156|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521157|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521158|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14521159|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
14521160|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
14521161|NCT03468075|Protective Agents|protective agents|mesh-ancestor
14521162|NCT03468543|Memantine|memantine|mesh-list
14521163|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14521164|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14521165|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
14521166|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521167|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521168|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521169|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14521170|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14521171|NCT03468920|Acetaminophen|acetaminophen|mesh-list
14949939|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949940|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949941|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949942|NCT01541293|Lidocaine|lidocaine|mesh-list
14949943|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
14949944|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
14949945|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14949946|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949947|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
14949948|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949949|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14521172|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521173|NCT03468920|Analgesics|analgesics|mesh-ancestor
14949950|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14949951|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14949952|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14949953|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949954|NCT01541332|Dexamethasone|dexamethasone|mesh-list
14949955|NCT01541332|Doxorubicin|doxorubicin|mesh-list
14949956|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14521174|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
14521175|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521176|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521177|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
14521178|NCT03468933|Plasminogen|plasminogen|mesh-list
14521179|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14521180|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14521181|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14521182|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521183|NCT03469336|Betamethasone|betamethasone|mesh-list
14521184|NCT03469336|Calcipotriene|calcipotriene|mesh-list
14521185|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521186|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
14521187|NCT03469336|Hormones|hormones|mesh-ancestor
14521188|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521189|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521190|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14521191|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
14521192|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
14521193|NCT03469349|Actovegin|actovegin|mesh-list
14521194|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14521195|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521196|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14521197|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521198|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
14792908|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
14792909|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14792910|NCT00749866|Gentamicins|gentamicins|mesh-list
14792911|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14792912|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14792913|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14792914|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792915|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792916|NCT00749918|Vitamin D|vitamin d|mesh-list
14792917|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
14521199|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792918|NCT00749918|Vitamins|vitamins|mesh-ancestor
14792919|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
14521200|NCT03469349|Protective Agents|protective agents|mesh-ancestor
14521201|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14521202|NCT03471871|Lemborexant|lemborexant|mesh-list
14521203|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14521204|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521205|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521206|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14521207|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14521208|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521209|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521210|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
14521211|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521212|NCT03472326|GS-9131|gs-9131|mesh-list
14521213|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521214|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521215|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14521216|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14521217|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
14521218|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521219|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14521220|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14521221|NCT03472469|Acetaminophen|acetaminophen|mesh-list
14521222|NCT03472469|Ketorolac|ketorolac|mesh-list
14521223|NCT03472469|Naproxen|naproxen|mesh-list
14521224|NCT03472469|Celecoxib|celecoxib|mesh-list
14521225|NCT03472469|Lidocaine|lidocaine|mesh-list
14521226|NCT03472469|Pregabalin|pregabalin|mesh-list
14521227|NCT03472469|Gabapentin|gabapentin|mesh-list
14521228|NCT03472469|Tramadol|tramadol|mesh-list
14521229|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
14521230|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
14521231|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521232|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521233|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
14521234|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521235|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14521236|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14521237|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14521238|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14521239|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521240|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521241|NCT03472469|Analgesics|analgesics|mesh-ancestor
14521242|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
14521243|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
14521244|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14521245|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14521246|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14521247|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521248|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521249|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14521250|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14521251|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521252|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
14521253|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14521254|NCT03472469|Narcotics|narcotics|mesh-ancestor
14521255|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521256|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521257|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521258|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14521259|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521260|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
14521261|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14521262|NCT03472521|Gabapentin|gabapentin|mesh-list
14521263|NCT03472521|Analgesics|analgesics|mesh-ancestor
14521264|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
14521265|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521266|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521267|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
14521268|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14521269|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521270|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792920|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792921|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14521271|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14792922|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14521272|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14792923|NCT00750048|Acetaminophen|acetaminophen|mesh-list
14949957|NCT01541332|Pomalidomide|pomalidomide|mesh-list
14949958|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949959|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
14521273|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14521274|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521275|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521276|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
14521277|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
14521278|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521279|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
14521280|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521281|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
14521282|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521283|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
14521284|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521285|NCT03473665|Celecoxib|celecoxib|mesh-list
14949960|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
14949961|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521286|NCT03473665|Diclofenac|diclofenac|mesh-list
14521287|NCT03473665|Indomethacin|indomethacin|mesh-list
14521288|NCT03473665|Meloxicam|meloxicam|mesh-list
14521289|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521290|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521291|NCT03473665|Analgesics|analgesics|mesh-ancestor
14521292|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
14521293|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521294|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521295|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521296|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521297|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14521298|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14521299|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521300|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521301|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
14521302|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
14521303|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14521304|NCT03474081|Albuterol|albuterol|mesh-list
14521305|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
14521306|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14521307|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
14521308|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521309|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521310|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14521311|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
14521312|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
14521313|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14521314|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14521315|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792924|NCT00750048|Naloxone|naloxone|mesh-list
14792925|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792926|NCT00750048|Analgesics|analgesics|mesh-ancestor
14792927|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
14792928|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792929|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792930|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
14792931|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14792932|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14792933|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14792934|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792935|NCT00750113|Telmisartan|telmisartan|mesh-list
14792936|NCT00750113|Nifedipine|nifedipine|mesh-list
14792937|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14792938|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14792939|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14792940|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792941|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14792942|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14792943|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14792944|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792945|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
14792946|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
14792947|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14792948|NCT00750126|Fludarabine|fludarabine|mesh-list
14949962|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521316|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521317|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
14521318|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14521319|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14521320|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14521321|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14521322|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
14521323|NCT03476798|Bevacizumab|bevacizumab|mesh-list
14521324|NCT03476798|Rucaparib|rucaparib|mesh-list
14521325|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14521326|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521327|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14521328|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14949963|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14949964|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
14949965|NCT01541332|Hormones|hormones|mesh-ancestor
14949966|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14949967|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14949968|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14949969|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14949970|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14949971|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14949972|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14949973|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14949974|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
14949975|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14949976|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14949977|NCT01541332|Growth Substances|growth substances|mesh-ancestor
14949978|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14521329|NCT03476798|Growth Substances|growth substances|mesh-ancestor
14521330|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521331|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
14521332|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14521333|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521334|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521335|NCT03478163|Clindamycin|clindamycin|mesh-list
14521336|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
14521337|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
14521338|NCT03478163|Cefazolin|cefazolin|mesh-list
14521339|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14521340|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521341|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14521342|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521343|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521344|NCT03478254|Vaccines|vaccines|mesh-list
14521345|NCT03478254|Immunologic Factors|immunologic factors|mesh-ancestor
14521346|NCT03478254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521347|NCT03478683|Budesonide|budesonide|mesh-list
14792949|NCT00750126|Busulfan|busulfan|mesh-list
14949979|NCT01541436|Capsaicin|capsaicin|mesh-list
14949980|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
14949981|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
14949982|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
14949983|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14949984|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027220|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15027221|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027222|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15027223|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027224|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
15027225|NCT01948336|Ketamine|ketamine|mesh-list
15027226|NCT01948336|Propofol|propofol|mesh-list
14521348|NCT03478683|Albuterol|albuterol|mesh-list
14521349|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
14792950|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
14792951|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792952|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792953|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14792954|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
14792955|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792956|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
14792957|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14792958|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14792959|NCT00750178|Vorinostat|vorinostat|mesh-list
14521350|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
15027227|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15027228|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792960|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792961|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14521351|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14521352|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14949985|NCT01541475|Dexetimide|dexetimide|mesh-list
14949986|NCT01541475|Citalopram|citalopram|mesh-list
14949987|NCT01541475|Bupropion|bupropion|mesh-list
14521353|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14521354|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
14521355|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521356|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521357|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14521358|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
14521359|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
14521360|NCT03478683|Hormones|hormones|mesh-ancestor
14521361|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521362|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14521363|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14521364|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14521365|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
14521366|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521367|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521368|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
14521369|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14521370|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
14521371|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
14521372|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14521373|NCT03478696|Budesonide|budesonide|mesh-list
14521374|NCT03478696|Albuterol|albuterol|mesh-list
14521375|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
14521376|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
14521377|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14521378|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521379|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14521380|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
14521381|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521382|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521383|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14521384|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
14521385|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
14521386|NCT03478696|Hormones|hormones|mesh-ancestor
14521387|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521388|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14521389|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14521390|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14521391|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
14521392|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521393|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521394|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
14521395|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14792962|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14792963|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792964|NCT00750217|Buprenorphine|buprenorphine|mesh-list
14792965|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14792966|NCT00750217|Narcotics|narcotics|mesh-ancestor
14792967|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14792968|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792969|NCT00750217|Analgesics|analgesics|mesh-ancestor
14792970|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
14792971|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792972|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14792973|NCT00750334|Clofarabine|clofarabine|mesh-list
14792974|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14792975|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
14792976|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792977|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792978|NCT00750347|Acetaminophen|acetaminophen|mesh-list
14792979|NCT00750347|Rimonabant|rimonabant|mesh-list
14521396|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
14521397|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
14521398|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14792980|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14792981|NCT00750347|Analgesics|analgesics|mesh-ancestor
14521399|NCT03478969|Insulin|insulin|mesh-list
14521400|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521401|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521402|NCT03478982|Alprazolam|alprazolam|mesh-list
14521403|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14521404|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521405|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521406|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14521407|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521408|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521409|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
14521410|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
14521411|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521412|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521413|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
14521414|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
14521415|NCT03479216|Bupivacaine|bupivacaine|mesh-list
14521416|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
14521417|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
14521418|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521419|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521420|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
14521421|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521422|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14521423|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521424|NCT03479216|Analgesics|analgesics|mesh-ancestor
14521425|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14521426|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14521427|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14521428|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
14521429|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521430|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521431|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14521432|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
14521433|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14521434|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14521435|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14792982|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
14792983|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14792984|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14792985|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
14792986|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14792987|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14792988|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13965371|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14521436|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
14521437|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14521438|NCT03480009|Oxycodone|oxycodone|mesh-list
14521439|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
14521440|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14521441|NCT03480009|Narcotics|narcotics|mesh-ancestor
14521442|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521443|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521444|NCT03480009|Analgesics|analgesics|mesh-ancestor
14521445|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
14521446|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521447|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
14521448|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
14521449|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13965372|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13965373|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14521450|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14521451|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949988|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14521452|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521453|NCT03480022|Liraglutide|liraglutide|mesh-list
14949989|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14949990|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14949991|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965374|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
13965375|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965376|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965377|NCT03130933|Amoxicillin|amoxicillin|mesh-list
14521454|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14949992|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14949993|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
14949994|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14949995|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14521455|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521456|NCT03480022|Incretins|incretins|mesh-ancestor
14521457|NCT03480022|Hormones|hormones|mesh-ancestor
14521458|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521459|NCT03480243|Erythromycin|erythromycin|mesh-list
14521460|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
14521461|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14521462|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
14521463|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14521464|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521465|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521466|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14521467|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521468|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521469|NCT03480750|Carboplatin|carboplatin|mesh-list
14521470|NCT03480750|Doxorubicin|doxorubicin|mesh-list
14521471|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14521472|NCT03480750|Trientine|trientine|mesh-list
14521473|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521474|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14521475|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14521476|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14521477|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521478|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521479|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
14521480|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
14521481|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14521482|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
14521483|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521484|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14521485|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
14521486|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521487|NCT03480932|Interferons|interferons|mesh-list
14521488|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
14949996|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
14949997|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14949998|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14949999|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14950000|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
14950001|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
14950002|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950003|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14950004|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14950005|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
14950006|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14950007|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
14521489|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
14521490|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14521491|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
14521492|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521493|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
14521494|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521495|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
14521496|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529651|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14529652|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
14529653|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529654|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529655|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14521497|NCT03481725|Coal Tar|coal tar|mesh-list
14521498|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
14521499|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
14521500|NCT03481816|Vaccines|vaccines|mesh-list
14521501|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
14521502|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521503|NCT03482011|Mirikizumab|mirikizumab|mesh-list
14521504|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521505|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521506|NCT03482011|Analgesics|analgesics|mesh-ancestor
14521507|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
14521508|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521509|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521510|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521511|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521512|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14521513|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521514|NCT03482583|Nicotine|nicotine|mesh-list
14521515|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14521516|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
14521517|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521518|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521519|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14521520|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14521521|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
14521522|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521523|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521524|NCT03482882|Pimavanserin|pimavanserin|mesh-list
14521525|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14521526|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14521527|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14792989|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14792990|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14792991|NCT00750347|Hormones|hormones|mesh-ancestor
14792992|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14792993|NCT00750386|Paclitaxel|paclitaxel|mesh-list
14792994|NCT00750386|Carboplatin|carboplatin|mesh-list
14792995|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14792996|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14792997|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
14792998|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
14792999|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
14793000|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793001|NCT00750399|Ranibizumab|ranibizumab|mesh-list
14793002|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14793003|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14793004|NCT00750399|Growth Substances|growth substances|mesh-ancestor
14793005|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793006|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
14793007|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950008|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14950009|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13965378|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13965379|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965380|NCT03131050|Scopolamine|scopolamine|mesh-list
14793008|NCT00750425|Cediranib|cediranib|mesh-list
14793009|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793010|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14793011|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793012|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793013|NCT00750451|Heparin|heparin|mesh-list
14793014|NCT00750451|Enoxaparin|enoxaparin|mesh-list
14793015|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14793016|NCT00750451|Tinzaparin|tinzaparin|mesh-list
14793017|NCT00750451|Dalteparin|dalteparin|mesh-list
14793018|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
14793019|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
14950010|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950011|NCT01541605|Methylphenidate|methylphenidate|mesh-list
14950012|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14950013|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950014|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13965381|NCT03131050|Citalopram|citalopram|mesh-list
14521528|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521529|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793020|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14521530|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521531|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521532|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14521533|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14521534|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
14521535|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521536|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521537|NCT03482973|Bupivacaine|bupivacaine|mesh-list
13965382|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13965383|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13965384|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13965385|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13965386|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965387|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965388|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
13965389|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965390|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13965391|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
13965392|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13965393|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
13965394|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
13965395|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965396|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13965397|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13965398|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
14521538|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
14521539|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
14521540|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521541|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521542|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
14521543|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521544|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14950015|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14950016|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950017|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950018|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
14950019|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950020|NCT01541631|Albendazole|albendazole|mesh-list
14950021|NCT01541631|Praziquantel|praziquantel|mesh-list
14950022|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
14950023|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14950024|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521545|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
14521546|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950025|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
14950026|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14950027|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14950028|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
14950029|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
14950030|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
14950031|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950032|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521547|NCT03485222|Empagliflozin|empagliflozin|mesh-list
14521548|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14521549|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521550|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521551|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521552|NCT03485976|Ixekizumab|ixekizumab|mesh-list
14521553|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
14521554|NCT03486392|Liraglutide|liraglutide|mesh-list
14521555|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521556|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521557|NCT03486392|Incretins|incretins|mesh-ancestor
14521558|NCT03486392|Hormones|hormones|mesh-ancestor
14521559|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521560|NCT03486834|Vaccines|vaccines|mesh-list
14521561|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
14521562|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521563|NCT03487276|Vilobelimab|vilobelimab|mesh-list
14521564|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14521565|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14521566|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
14521567|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521568|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14950033|NCT01541670|Antibodies|antibodies|mesh-list
14950034|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
14950035|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950036|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14950037|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
14950038|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950039|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14950040|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950041|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950042|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14950043|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14950044|NCT01541943|Losartan|losartan|mesh-list
14950045|NCT01541943|Atorvastatin|atorvastatin|mesh-list
14950046|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14950047|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14950048|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
14950049|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950050|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14950051|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14950052|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521569|NCT03487549|Cantharidin|cantharidin|mesh-list
14521570|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521571|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521572|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
14521573|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
14521574|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521575|NCT03488108|Minoxidil|minoxidil|mesh-list
14521576|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14521577|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
14521578|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
14521579|NCT03488225|Leucovorin|leucovorin|mesh-list
14521580|NCT03488225|Folic Acid|folic acid|mesh-list
14521581|NCT03488225|Cytarabine|cytarabine|mesh-list
14521582|NCT03488225|Dexamethasone|dexamethasone|mesh-list
14521583|NCT03488225|Prednisone|prednisone|mesh-list
14521584|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
14521585|NCT03488225|Cortisone|cortisone|mesh-list
14521586|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
14521587|NCT03488225|Rituximab|rituximab|mesh-list
14521588|NCT03488225|Doxorubicin|doxorubicin|mesh-list
14793021|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14793022|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793023|NCT00750529|Donepezil|donepezil|mesh-list
14793024|NCT00750529|Galantamine|galantamine|mesh-list
14793025|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14793026|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793027|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793028|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
14793029|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950053|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14950054|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14521589|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14521590|NCT03488225|Methotrexate|methotrexate|mesh-list
14521591|NCT03488225|Vincristine|vincristine|mesh-list
14521592|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
14521593|NCT03488225|Ofatumumab|ofatumumab|mesh-list
14950055|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14950056|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14950057|NCT01541956|Metformin|metformin|mesh-list
14950058|NCT01541956|Vildagliptin|vildagliptin|mesh-list
14950059|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950060|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950061|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14950062|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
14950063|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521594|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14521595|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14521596|NCT03488225|Antibodies|antibodies|mesh-list
14521597|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
14521598|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14521599|NCT03488225|BB 1101|bb 1101|mesh-list
14521600|NCT03488225|Calcium|calcium|mesh-list
14521601|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
14521602|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14521603|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
14521604|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521605|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521606|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14521607|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
14521608|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521609|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521610|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14521611|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521612|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
14521613|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
14521614|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521615|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521616|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
14521617|NCT03488225|Hormones|hormones|mesh-ancestor
14521618|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521619|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14521620|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14521621|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14521622|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14521623|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521624|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14521625|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14521626|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14950064|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950065|NCT01542047|Carboplatin|carboplatin|mesh-list
14950066|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950067|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
14950068|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
14950069|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14950070|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950071|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950072|NCT01542099|Remifentanil|remifentanil|mesh-list
14950073|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14950074|NCT01542099|Narcotics|narcotics|mesh-ancestor
14793030|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793031|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
14793032|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14793033|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
14793034|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793035|NCT00750581|Indomethacin|indomethacin|mesh-list
14793036|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14793037|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14793038|NCT00750581|Analgesics|analgesics|mesh-ancestor
14793039|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
14793040|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950075|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950076|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521627|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
14521628|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14521629|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14521630|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
14521631|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
14521632|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14793041|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529656|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
14950077|NCT01542099|Analgesics|analgesics|mesh-ancestor
14521633|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14521634|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
14521635|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521636|NCT03488225|Antidotes|antidotes|mesh-ancestor
14521637|NCT03488225|Protective Agents|protective agents|mesh-ancestor
14521638|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
14521639|NCT03488225|Vitamins|vitamins|mesh-ancestor
14521640|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
14521641|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14521642|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14521643|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14521644|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14521645|NCT03488225|Hematinics|hematinics|mesh-ancestor
14950078|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
14950079|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950080|NCT01542138|Niacinamide|niacinamide|mesh-list
14950081|NCT01542138|Niacin|niacin|mesh-list
14950082|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
14950083|NCT01542138|Desonide|desonide|mesh-list
14950084|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
14950085|NCT01542138|Vitamins|vitamins|mesh-ancestor
14950086|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
14950087|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521646|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
14521647|NCT03489304|Zaleplon|zaleplon|mesh-list
14521648|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
14521649|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14521650|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521651|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521652|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
14521653|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
14521654|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521655|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521656|NCT03489551|Haloperidol|haloperidol|mesh-list
14521657|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
14521658|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
14793042|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793043|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793044|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
14793045|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
14793046|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14793047|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14793048|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793049|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793050|NCT00750620|Mirabegron|mirabegron|mesh-list
14793051|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14793052|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14793053|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14793054|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
14950088|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14950089|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
14950090|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950091|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14521659|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793055|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793056|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793057|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793058|NCT00750620|Urological Agents|urological agents|mesh-ancestor
14793059|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14793060|NCT00750698|Entinostat|entinostat|mesh-list
14793061|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793062|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14793063|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521660|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521661|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521662|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14521663|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521664|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521665|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521666|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14521667|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
14521668|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521669|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950092|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
14521670|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14950093|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950094|NCT01542190|Ketorolac|ketorolac|mesh-list
14521671|NCT03489850|Ibudilast|ibudilast|mesh-list
14521672|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14521673|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
14521674|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521675|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950095|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14950096|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14950097|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14950098|NCT01542190|Analgesics|analgesics|mesh-ancestor
14950099|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
14950100|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950101|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950102|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793064|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793065|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14793066|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
14793067|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14793068|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
14793069|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793070|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
14793071|NCT00750724|Protective Agents|protective agents|mesh-ancestor
14950103|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521676|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14521677|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
14950104|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14950105|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950106|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950107|NCT01542242|Liraglutide|liraglutide|mesh-list
14950108|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950109|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950110|NCT01542242|Incretins|incretins|mesh-ancestor
14950111|NCT01542242|Hormones|hormones|mesh-ancestor
14950112|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950113|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
14950114|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14950115|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950116|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521678|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14521679|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521680|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521681|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14521682|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
14521683|NCT03489863|Ticagrelor|ticagrelor|mesh-list
14521684|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14521685|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14521686|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14521687|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14521688|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14521689|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
14521690|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521691|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521692|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950117|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14950118|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14950119|NCT01542268|Protective Agents|protective agents|mesh-ancestor
14950120|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950121|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
14950122|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14950123|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
14950124|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
14950125|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950126|NCT01542424|Insulin|insulin|mesh-list
14521693|NCT03490942|Glucagon|glucagon|mesh-list
14521694|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14521695|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14521696|NCT03490942|Hormones|hormones|mesh-ancestor
14521697|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521698|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521699|NCT03490942|Incretins|incretins|mesh-ancestor
14521700|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14521701|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14521702|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14521703|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
14521704|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521705|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521706|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521707|NCT03492281|Urological Agents|urological agents|mesh-ancestor
14521708|NCT03493386|Glycine|glycine|mesh-list
14521709|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
14521710|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521711|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521712|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521713|NCT03493542|Vaccines|vaccines|mesh-list
14521714|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
14521715|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521716|NCT03493698|Midazolam|midazolam|mesh-list
14521717|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14521718|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14521719|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521720|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521721|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14521722|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521723|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521724|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14521725|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
14521726|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
14521727|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
14521728|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
14521729|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521730|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793072|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
14793073|NCT00750763|Cathartics|cathartics|mesh-ancestor
14793074|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14793075|NCT00750802|Lorazepam|lorazepam|mesh-list
14793076|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
14793077|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
14793078|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
14950127|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14950128|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
14950129|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
14950130|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
14950131|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14950132|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950133|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950134|NCT01542437|Afatinib|afatinib|mesh-list
14950135|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950136|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14950137|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521731|NCT03493828|Bupivacaine|bupivacaine|mesh-list
14521732|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
14521733|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
14521734|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793079|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793080|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793081|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14793082|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14793083|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521735|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950138|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950139|NCT01542450|Insulin|insulin|mesh-list
14950140|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14950141|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
14950142|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
14950143|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
14950144|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
14950145|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950146|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950147|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
14950148|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950149|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950150|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
14950151|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950152|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521736|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
14521737|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521738|NCT03494816|Axitinib|axitinib|mesh-list
14521739|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521740|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14521741|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521742|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521743|NCT03494985|Muramidase|muramidase|mesh-list
14521744|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521745|NCT03495102|Dulaglutide|dulaglutide|mesh-list
14521746|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521747|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950153|NCT01542489|Insulin|insulin|mesh-list
14950154|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14950155|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
14950156|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
14950157|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950158|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950159|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
14950160|NCT01542697|Analgesics|analgesics|mesh-ancestor
14793084|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14793085|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14793086|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14793087|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
14793088|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
14793089|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793090|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793091|NCT00750997|Dextrans|dextrans|mesh-list
14793092|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
14793093|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
14793094|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
14793095|NCT00751049|Timolol|timolol|mesh-list
14793096|NCT00751049|Latanoprost|latanoprost|mesh-list
14793097|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14793098|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14793099|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
14793100|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793101|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793102|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793103|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793104|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793105|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14793106|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14950161|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
14950162|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950163|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950164|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
14950165|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950166|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14950167|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
14950168|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14950169|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950170|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950171|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14950172|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
14950173|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14521748|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
14950174|NCT01542710|Timolol|timolol|mesh-list
14793107|NCT00751062|Timolol|timolol|mesh-list
14793108|NCT00751062|Latanoprost|latanoprost|mesh-list
14793109|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14950175|NCT01542710|Bimatoprost|bimatoprost|mesh-list
14950176|NCT01542710|Travoprost|travoprost|mesh-list
14950177|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14950178|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14950179|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
14950180|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950181|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950182|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950183|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14950184|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14950185|NCT01542723|Nadroparin|nadroparin|mesh-list
14950186|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
14950187|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14521749|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521750|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521751|NCT03496324|Ibuprofen|ibuprofen|mesh-list
14521752|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521753|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521754|NCT03496324|Analgesics|analgesics|mesh-ancestor
14521755|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
14521756|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793110|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14950188|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14950189|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950190|NCT01542762|Nadroparin|nadroparin|mesh-list
14950191|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
14950192|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14950193|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14950194|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950195|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
14950196|NCT01542801|Norfloxacin|norfloxacin|mesh-list
14950197|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14950198|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950199|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14521757|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521758|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521759|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521760|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14793111|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14793112|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793113|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793114|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793115|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793116|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793117|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14950200|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14950201|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027229|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968259|NCT03112031|Amphotericin B|amphotericin b|mesh-list
14521761|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950202|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950203|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950204|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14950205|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14950206|NCT01542827|Analgesics|analgesics|mesh-list
14950207|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
14950208|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521762|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521763|NCT03496467|Nepafenac|nepafenac|mesh-list
14521764|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521765|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521766|NCT03496467|Analgesics|analgesics|mesh-ancestor
14521767|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
14521768|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521769|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521770|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521771|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521772|NCT03496545|Acetaminophen|acetaminophen|mesh-list
14521773|NCT03496545|Bromocriptine|bromocriptine|mesh-list
14521774|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521775|NCT03496545|Analgesics|analgesics|mesh-ancestor
14521776|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
14521777|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521778|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521779|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
14521780|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14521781|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14521782|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
14950209|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950210|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14950211|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14950212|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14950213|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950214|NCT01542879|Hematinics|hematinics|mesh-ancestor
14950215|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14950216|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14950217|NCT01542918|Rituximab|rituximab|mesh-list
14950218|NCT01542918|Lenalidomide|lenalidomide|mesh-list
14950219|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14950220|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950221|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
14950222|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521783|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14521784|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
14521785|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
14521786|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521787|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521788|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14521789|NCT03496974|Antibodies|antibodies|mesh-list
14521790|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
14521791|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14521792|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
14950223|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14950224|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14521793|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521794|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521795|NCT03497039|Diclofenac|diclofenac|mesh-list
14521796|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521797|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521798|NCT03497039|Analgesics|analgesics|mesh-ancestor
14521799|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
14521800|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521801|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521802|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521803|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521804|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14521805|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521806|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521807|NCT03497429|Niraparib|niraparib|mesh-list
14521808|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14521809|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521810|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950225|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14521811|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521812|NCT03497845|Vaccines|vaccines|mesh-list
14521813|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
14521814|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521815|NCT03498196|Avelumab|avelumab|mesh-list
14521816|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14521817|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521818|NCT03499353|Talazoparib|talazoparib|mesh-list
14521819|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14521820|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521821|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521822|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521823|NCT03499873|Nepafenac|nepafenac|mesh-list
14521824|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14521825|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521826|NCT03499873|Analgesics|analgesics|mesh-ancestor
14521827|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
14521828|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521829|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521830|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521831|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14521832|NCT03500211|Lidocaine|lidocaine|mesh-list
14521833|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
14521834|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
14521835|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521836|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521837|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
14521838|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521839|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14521840|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14521841|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14521842|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14521843|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521844|NCT03500289|Midazolam|midazolam|mesh-list
14521845|NCT03500289|Ketamine|ketamine|mesh-list
14521846|NCT03500289|Analgesics|analgesics|mesh-ancestor
14521847|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
14521848|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521849|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521850|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14521851|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14521852|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
14521853|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
14521854|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521855|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14521856|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14521857|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521858|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521859|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14521860|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14521861|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14521862|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521863|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521864|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
14521865|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
14521866|NCT03500302|Evolocumab|evolocumab|mesh-list
14793118|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14793119|NCT00751127|Timolol|timolol|mesh-list
14793120|NCT00751127|Latanoprost|latanoprost|mesh-list
14950226|NCT01542918|Growth Substances|growth substances|mesh-ancestor
13965399|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13965400|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
13965401|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965402|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
13965403|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13965404|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793121|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14793122|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14793123|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
14793124|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793125|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793126|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793127|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793128|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793129|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14521867|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14521868|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14521869|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
14521870|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521871|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14793130|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14793131|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
13965405|NCT03131037|Valacyclovir|valacyclovir|mesh-list
13965406|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
13965407|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965408|NCT03131141|Lefamulin|lefamulin|mesh-list
13965409|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14950227|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
14529657|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529658|NCT03726996|Desipramine|desipramine|mesh-list
14529659|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14529660|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
14529661|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529662|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529663|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529664|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14529665|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14529666|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529667|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
14529668|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529669|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529670|NCT03725085|Guaifenesin|guaifenesin|mesh-list
14529671|NCT03725085|Expectorants|expectorants|mesh-ancestor
14529672|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
14529673|NCT03724981|Dulaglutide|dulaglutide|mesh-list
14529674|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14529675|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529676|NCT03724968|Nivolumab|nivolumab|mesh-list
14529677|NCT03724968|Ipilimumab|ipilimumab|mesh-list
14529678|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14529679|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529680|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14529681|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529682|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
14529683|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14529684|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529685|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529686|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529687|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14529688|NCT03723980|Propolis|propolis|mesh-list
14529689|NCT03723980|Calcium|calcium|mesh-list
14529690|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14529691|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529692|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793132|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14793133|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14793134|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14793135|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
14793136|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793137|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14793138|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14793139|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793140|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793141|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14793142|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14793143|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
14793144|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
14793145|NCT00751205|Prednisone|prednisone|mesh-list
14793146|NCT00751205|Prednisolone|prednisolone|mesh-list
14793147|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14793148|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
14793149|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14793150|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
14793151|NCT00751205|Sagopilone|sagopilone|mesh-list
14793152|NCT00751205|Epothilones|epothilones|mesh-list
14793153|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14793154|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
13965410|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793155|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793156|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
14793157|NCT00751205|Hormones|hormones|mesh-ancestor
14521872|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14950228|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14950229|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
14950230|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965411|NCT03130855|Carticaine|carticaine|mesh-list
13965412|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
13965413|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
13965414|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965415|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965416|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
13965417|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965418|NCT03130842|Midazolam|midazolam|mesh-list
14950231|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14950232|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14950233|NCT01543139|Valproic Acid|valproic acid|mesh-list
14521873|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14521874|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14521875|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521876|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
14521877|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521878|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521879|NCT03501277|Pioglitazone|pioglitazone|mesh-list
14521880|NCT03501277|Alogliptin|alogliptin|mesh-list
14521881|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14521882|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521883|NCT03501277|Incretins|incretins|mesh-ancestor
14521884|NCT03501277|Hormones|hormones|mesh-ancestor
14521885|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950234|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
14950235|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950236|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950237|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
14950238|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950239|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950240|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
14950241|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14950242|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950243|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14950244|NCT01543165|Ketorolac|ketorolac|mesh-list
14950245|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14950246|NCT01543165|Morphine|morphine|mesh-list
14950247|NCT01543165|Analgesics|analgesics|mesh-list
14950248|NCT01543165|Nefopam|nefopam|mesh-list
14950249|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14950250|NCT01543165|Narcotics|narcotics|mesh-ancestor
14521886|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14521887|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
14521888|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521889|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521890|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14521891|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
14521892|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521893|NCT03502616|Tofacitinib|tofacitinib|mesh-list
14521894|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14521895|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521896|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521897|NCT03502681|Avelumab|avelumab|mesh-list
14521898|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14521899|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14521900|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
14521901|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14521902|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
14521903|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
14521904|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521905|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521906|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521907|NCT03502915|Analgesics|analgesics|mesh-ancestor
14521908|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
14521909|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950251|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950252|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521910|NCT03503292|Ondansetron|ondansetron|mesh-list
14521911|NCT03503292|Granisetron|granisetron|mesh-list
14521912|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
14950253|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
14950254|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521913|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
14521914|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521915|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521916|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14950255|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14950256|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14521917|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
14521918|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
14521919|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14521920|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
14521921|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521922|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521923|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14521924|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14521925|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14521926|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14521927|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14521928|NCT03503578|Ketamine|ketamine|mesh-list
14521929|NCT03503578|Sevoflurane|sevoflurane|mesh-list
14521930|NCT03503578|Analgesics|analgesics|mesh-ancestor
14521931|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
14521932|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521933|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521934|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14521935|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14521936|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
14521937|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
14521938|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965419|NCT03130842|Alprazolam|alprazolam|mesh-list
14521939|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14521940|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14521941|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521942|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521943|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14521944|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14521945|NCT03505021|Simendan|simendan|mesh-list
14521946|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14521947|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
14521948|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14521949|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14521950|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14521951|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521952|NCT03505021|Protective Agents|protective agents|mesh-ancestor
14521953|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521954|NCT03506347|Vancomycin|vancomycin|mesh-list
14521955|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14521956|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14521957|NCT03506724|Labetalol|labetalol|mesh-list
14521958|NCT03506724|Nifedipine|nifedipine|mesh-list
14521959|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14521960|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14521961|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521962|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14521963|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521964|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
14521965|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
14521966|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14521967|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14521968|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14521969|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
14793158|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793159|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793160|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14793161|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793162|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
14793163|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
14793164|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793165|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14793166|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14793167|NCT00751205|Protective Agents|protective agents|mesh-ancestor
14521970|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14521971|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793168|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
14521972|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
14521973|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
14521974|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521975|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14521976|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14521977|NCT03508830|Bupivacaine|bupivacaine|mesh-list
14521978|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
14521979|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
14521980|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950257|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950258|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14950259|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14950260|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950261|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027230|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15027231|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
15027232|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
15027233|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15027234|NCT01948336|Analgesics|analgesics|mesh-ancestor
15027235|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
15027236|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027237|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15027238|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15027239|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15027240|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
15027241|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027242|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521981|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521982|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
14521983|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14521984|NCT03509350|Vitamins|vitamins|mesh-list
14521985|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
14521986|NCT03509350|Thiamine|thiamine|mesh-list
14521987|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
14521988|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14521989|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14521990|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14521991|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
14521992|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14521993|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14521994|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
14521995|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14521996|NCT03509350|Protective Agents|protective agents|mesh-ancestor
14521997|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
14521998|NCT03509675|Ibuprofen|ibuprofen|mesh-list
14521999|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522000|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522001|NCT03509675|Analgesics|analgesics|mesh-ancestor
14522002|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
14522003|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522004|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522005|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793169|NCT00751205|Vitamins|vitamins|mesh-ancestor
14793170|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
14793171|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
14793172|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
14793173|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
14793174|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
14793175|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793176|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
14793177|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14793178|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
14793179|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793180|NCT00751257|Expectorants|expectorants|mesh-ancestor
14793181|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
14793182|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14793183|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
14793184|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793185|NCT00751257|Protective Agents|protective agents|mesh-ancestor
14793186|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522006|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793187|NCT00751257|Antidotes|antidotes|mesh-ancestor
14793188|NCT00751270|Valacyclovir|valacyclovir|mesh-list
14793189|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
14793190|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793191|NCT00751374|Gentamicins|gentamicins|mesh-list
14522007|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14522008|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522009|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793192|NCT00751374|Mupirocin|mupirocin|mesh-list
14793193|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793194|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793195|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14793196|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950262|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
14950263|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14522010|NCT03509766|Histamine|histamine|mesh-list
14522011|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
14522012|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
14522013|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522014|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522015|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522016|NCT03509883|Apixaban|apixaban|mesh-list
14522017|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14522018|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
14522019|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14522020|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
14522021|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522022|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522023|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
14522024|NCT03510455|Infigratinib|infigratinib|mesh-list
14522025|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522026|NCT03510481|Lumefantrine|lumefantrine|mesh-list
14522027|NCT03510481|Artemether|artemether|mesh-list
14522028|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
14522029|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14522030|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14522031|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950264|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14950265|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950266|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522032|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
14522033|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14522034|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965420|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13965421|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13965422|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522035|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14522036|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14522037|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793197|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793198|NCT00751478|Naltrexone|naltrexone|mesh-list
14793199|NCT00751478|Morphine|morphine|mesh-list
13965423|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965424|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14950267|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
14950268|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950269|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950270|NCT01543347|Temocillin|temocillin|mesh-list
14950271|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14950272|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950273|NCT01543386|Curcumin|curcumin|mesh-list
14950274|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14950275|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14950276|NCT01543386|Analgesics|analgesics|mesh-ancestor
13965425|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14522038|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522039|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522040|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
14793200|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14522041|NCT03510715|Niacin|niacin|mesh-list
14522042|NCT03510715|Niacinamide|niacinamide|mesh-list
14522043|NCT03510715|Atorvastatin|atorvastatin|mesh-list
14522044|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14522045|NCT03510715|Simvastatin|simvastatin|mesh-list
14522046|NCT03510715|Ezetimibe|ezetimibe|mesh-list
14522047|NCT03510715|Pravastatin|pravastatin|mesh-list
14522048|NCT03510715|Lovastatin|lovastatin|mesh-list
14522049|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
14522050|NCT03510715|Fenofibrate|fenofibrate|mesh-list
14522051|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14950277|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
14950278|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950279|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522052|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14522053|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
14522054|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522055|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14522056|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14522057|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522058|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
14522059|NCT03510715|Vitamins|vitamins|mesh-ancestor
14522060|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
14522061|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522062|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
14522063|NCT03510910|Acetaminophen|acetaminophen|mesh-list
14522064|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522065|NCT03510910|Analgesics|analgesics|mesh-ancestor
14522066|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
14522067|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522068|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522069|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
14522070|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14522071|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
14522072|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14522073|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
14950280|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950281|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14950282|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950283|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950284|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950285|NCT01543399|Tibolone|tibolone|mesh-list
14950286|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
14950287|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
14950288|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950289|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522074|NCT03511521|Insulin|insulin|mesh-list
14522075|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14522076|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
14522077|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
14522078|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
14522079|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
14522080|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522081|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522082|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14522083|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
14522084|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522085|NCT03512353|Dexamethasone|dexamethasone|mesh-list
14522086|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522087|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
14522088|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
14522089|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522090|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522091|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522092|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
14522093|NCT03512353|Hormones|hormones|mesh-ancestor
14522094|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793201|NCT00751478|Narcotics|narcotics|mesh-ancestor
14793202|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793203|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793204|NCT00751478|Analgesics|analgesics|mesh-ancestor
14793205|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
14793206|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793207|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14793208|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14793209|NCT00751491|Clopidogrel|clopidogrel|mesh-list
14793210|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14793211|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14793212|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14793213|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14793214|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
14522095|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14522096|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522097|NCT03513757|Lidocaine|lidocaine|mesh-list
14950290|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14950291|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14950292|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950293|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14950294|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
14950295|NCT01543399|Hormones|hormones|mesh-ancestor
14950296|NCT01543464|Temozolomide|temozolomide|mesh-list
14950297|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14950298|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
14950299|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950300|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950301|NCT01543555|Atorvastatin|atorvastatin|mesh-list
14793215|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793216|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793217|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793218|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14793219|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
14793220|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14950302|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14950303|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14950304|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
14950305|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950306|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14950307|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14950308|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950309|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
14950310|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
14950311|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14950312|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950313|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950314|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
14950315|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14950316|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950317|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950318|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
14950319|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14950320|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
14950321|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950322|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
14950323|NCT01543737|Protective Agents|protective agents|mesh-ancestor
14950324|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
14950325|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14950326|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950327|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950328|NCT01543763|Abexinostat|abexinostat|mesh-list
14522098|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
14522099|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
14522100|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
14522101|NCT03513757|Propofol|propofol|mesh-list
14522102|NCT03513757|Sevoflurane|sevoflurane|mesh-list
14522103|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
14522104|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
14522105|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522106|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522107|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
14522108|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522109|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14950329|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14950330|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950331|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950332|NCT01543906|Retinol acetate|retinol acetate|mesh-list
14950333|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14950334|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
14950335|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950336|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14950337|NCT01543906|Protective Agents|protective agents|mesh-ancestor
14522110|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14793221|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14793222|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14793223|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793224|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793225|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
14793226|NCT00751517|Methotrexate|methotrexate|mesh-list
14950338|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950339|NCT01543932|Clopidogrel|clopidogrel|mesh-list
14950340|NCT01543932|Ticagrelor|ticagrelor|mesh-list
14950341|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14950342|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14950343|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14950344|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14950345|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14950346|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
14950347|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950348|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950349|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950350|NCT01543945|Dexamethasone|dexamethasone|mesh-list
14950351|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
14793227|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14793228|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
14793229|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793230|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793231|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14950352|NCT01543945|Ondansetron|ondansetron|mesh-list
14950353|NCT01543945|Antiemetics|antiemetics|mesh-list
14950354|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
14950355|NCT01543945|BB 1101|bb 1101|mesh-list
14950356|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950357|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
14950358|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950359|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950360|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14950361|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
14950362|NCT01543945|Hormones|hormones|mesh-ancestor
14950363|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950364|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14950365|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950366|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
14950367|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950368|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950369|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
14522111|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14522112|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522113|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522114|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14793232|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
14793233|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793234|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793235|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14793236|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14793237|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
14793238|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14793239|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14793240|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
14793241|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
14793242|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950370|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
14950371|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14522115|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14522116|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
14522117|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522118|NCT03513757|Analgesics|analgesics|mesh-ancestor
14522119|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14522120|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14522121|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14522122|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
14522123|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522124|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14522125|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14522126|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14950372|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
14950373|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950374|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14950375|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14950376|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950377|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14950378|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14950379|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14950380|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
14950381|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
14522127|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14522128|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14522129|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
14522130|NCT03514277|Bupivacaine|bupivacaine|mesh-list
14522131|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
14522132|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
14522133|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950382|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14950383|NCT01543971|Lenograstim|lenograstim|mesh-list
14950384|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14950385|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
14950386|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950387|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14950388|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
14950389|NCT01544075|Vaccines|vaccines|mesh-list
14950390|NCT01544075|Immunologic Factors|immunologic factors|mesh-ancestor
14950391|NCT01544075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950392|NCT01544140|Midazolam|midazolam|mesh-list
13965426|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13965427|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13965428|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
13965429|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
13965430|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
13965431|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
14793243|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14793244|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14793245|NCT00751556|Naproxen|naproxen|mesh-list
14793246|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522134|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522135|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
14522136|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522137|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
14522138|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522139|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522140|NCT03515941|Leucovorin|leucovorin|mesh-list
14522141|NCT03515941|Fluorouracil|fluorouracil|mesh-list
14522142|NCT03515941|Capecitabine|capecitabine|mesh-list
14522143|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
14522144|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
14522145|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522146|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14522147|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522148|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14522149|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
14522150|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522151|NCT03515941|Antidotes|antidotes|mesh-ancestor
14522152|NCT03515941|Protective Agents|protective agents|mesh-ancestor
14522153|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
14522154|NCT03515941|Vitamins|vitamins|mesh-ancestor
14522155|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
14522156|NCT03518125|Vaccines|vaccines|mesh-list
14522157|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
13965432|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522158|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522159|NCT03519204|Lidocaine|lidocaine|mesh-list
14522160|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
14522161|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
13965433|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793247|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14793248|NCT00751556|Analgesics|analgesics|mesh-ancestor
14793249|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
14793250|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793251|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793252|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522162|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522163|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522164|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
14522165|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522166|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14522167|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14522168|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14522169|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522170|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522171|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
14522172|NCT03519243|Hematinics|hematinics|mesh-ancestor
14522173|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
14522174|NCT03519516|Levofloxacin|levofloxacin|mesh-list
14522175|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14522176|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14522177|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14522178|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522179|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14522180|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14522181|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522182|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522183|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522184|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14522185|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14522186|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14522187|NCT03519516|Renal Agents|renal agents|mesh-ancestor
14522188|NCT03519854|Bromides|bromides|mesh-list
14522189|NCT03519854|Rocuronium|rocuronium|mesh-list
14522190|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
14522191|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14522192|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14522193|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14522194|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522195|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522196|NCT03519867|Bromides|bromides|mesh-list
14522197|NCT03519867|Rocuronium|rocuronium|mesh-list
14522198|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
14522199|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14522200|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14522201|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14522202|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522203|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522204|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
14522205|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
14522206|NCT03520348|Vitamins|vitamins|mesh-ancestor
14522207|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
14522208|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522209|NCT03520920|Rituximab|rituximab|mesh-list
14522210|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
14522211|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14522212|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522213|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
14522214|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522215|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522216|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14522217|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522218|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529693|NCT03723447|Dexamethasone|dexamethasone|mesh-list
14529694|NCT03723447|Epinephrine|epinephrine|mesh-list
14529695|NCT03723447|Bupivacaine|bupivacaine|mesh-list
14529696|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529697|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
14529698|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
14529699|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529700|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529701|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529702|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
14529703|NCT03723447|Hormones|hormones|mesh-ancestor
14529704|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529705|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14529706|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529707|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
13965434|NCT03130829|Fucoidan|fucoidan|mesh-list
13965435|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13965436|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965437|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
13965438|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965439|NCT03130764|Durvalumab|durvalumab|mesh-list
13965440|NCT03130764|Tremelimumab|tremelimumab|mesh-list
13965441|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13965442|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522219|NCT03521141|Nicotine|nicotine|mesh-list
14522220|NCT03521141|Varenicline|varenicline|mesh-list
14522221|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14522222|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
14522223|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522224|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522225|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14522226|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14522227|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
14522228|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522229|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522230|NCT03521193|Aspirin|aspirin|mesh-list
14522231|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522232|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522233|NCT03521193|Analgesics|analgesics|mesh-ancestor
14522234|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
14522235|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522236|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522237|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522238|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522239|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14522240|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14522241|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522242|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14522243|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14522244|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522245|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
14522246|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
14522247|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14522248|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
14522249|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522250|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
14522251|NCT03521505|Propofol|propofol|mesh-list
14522252|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14522253|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522254|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522255|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14522256|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
14522257|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
14522258|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522259|NCT03521505|Analgesics|analgesics|mesh-ancestor
14522260|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
14522261|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522262|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14522263|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14522264|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14522265|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
14522266|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522267|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522268|NCT03521635|Pramipexole|pramipexole|mesh-list
14522269|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
14522270|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522271|NCT03521635|Protective Agents|protective agents|mesh-ancestor
14522272|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522273|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14522274|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13965443|NCT03130504|Progesterone|progesterone|mesh-list
14522275|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
13965444|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
13965445|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14522276|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
14522277|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522278|NCT03521791|Bromfenac|bromfenac|mesh-list
14522279|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522280|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522281|NCT03521791|Analgesics|analgesics|mesh-ancestor
14522282|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
14522283|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522284|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522285|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522286|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522287|NCT03521817|Ethanol|ethanol|mesh-list
14522288|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14522289|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965446|NCT03130504|Progestins|progestins|mesh-ancestor
13965447|NCT03130504|Hormones|hormones|mesh-ancestor
13965448|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965449|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522290|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522291|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965450|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13965451|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
13965452|NCT03130634|Silymarin|silymarin|mesh-list
13965453|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
13965454|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965455|NCT03130634|Protective Agents|protective agents|mesh-ancestor
14950393|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14950394|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14950395|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950396|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950397|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14950398|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14950399|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14950400|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14950401|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
14950402|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
14950403|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
14950404|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
14950405|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950406|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950407|NCT01544192|Tocopherols|tocopherols|mesh-list
14950408|NCT01544192|Vitamin E|vitamin e|mesh-list
14950409|NCT01544192|Tocotrienols|tocotrienols|mesh-list
14950410|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
14950411|NCT01544192|Antioxidants|antioxidants|mesh-list
14950412|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950413|NCT01544192|Protective Agents|protective agents|mesh-ancestor
14950414|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950415|NCT01544192|Vitamins|vitamins|mesh-ancestor
14950416|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
14950417|NCT01544283|Triamcinolone|triamcinolone|mesh-list
14950418|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14950419|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14950420|NCT01544283|Lidocaine|lidocaine|mesh-list
14950421|NCT01544283|Tetracaine|tetracaine|mesh-list
14950422|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14522292|NCT03522441|Clindamycin|clindamycin|mesh-list
14522293|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
14522294|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
14522295|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14950423|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
14950424|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
14522296|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522297|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14522298|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522299|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522300|NCT03522506|Modafinil|modafinil|mesh-list
14522301|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14522302|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522303|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14522304|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14522305|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14522306|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522307|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14522308|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
14522309|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522310|NCT03523988|Acetaminophen|acetaminophen|mesh-list
14522311|NCT03523988|Ibuprofen|ibuprofen|mesh-list
14522312|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522313|NCT03523988|Analgesics|analgesics|mesh-ancestor
14522314|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
14522315|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522316|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522317|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
14522318|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522319|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522320|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522321|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14522322|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522323|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522324|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14522325|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14522326|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
14522327|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14522328|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
14522329|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522330|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
14522331|NCT03524157|Protective Agents|protective agents|mesh-ancestor
14522332|NCT03524339|Tamsulosin|tamsulosin|mesh-list
14522333|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14522334|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14950425|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950426|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950427|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
14950428|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950429|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14522335|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14522336|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
14522337|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522338|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522339|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522340|NCT03524339|Urological Agents|urological agents|mesh-ancestor
14522341|NCT03525119|Vaccines|vaccines|mesh-list
14522342|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
14522343|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793253|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793254|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
14793255|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14793256|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793257|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793258|NCT00751699|Mesalamine|mesalamine|mesh-list
14522344|NCT03525444|Ivacaftor|ivacaftor|mesh-list
14793259|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14793260|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14793261|NCT00751699|Analgesics|analgesics|mesh-ancestor
14793262|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
14793263|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793264|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793265|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793266|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793267|NCT00751738|Azimilide|azimilide|mesh-list
14793268|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793269|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14793270|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14793271|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965456|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965457|NCT03130556|Rabeprazole|rabeprazole|mesh-list
13965458|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13965459|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965460|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13965461|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965462|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965463|NCT03130452|Amoxicillin|amoxicillin|mesh-list
13965464|NCT03130452|Metronidazole|metronidazole|mesh-list
13965465|NCT03130452|Clarithromycin|clarithromycin|mesh-list
13965466|NCT03130452|Lansoprazole|lansoprazole|mesh-list
13965467|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
13965468|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14522345|NCT03525444|Elexacaftor|elexacaftor|mesh-list
14522346|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14522347|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522348|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522349|NCT03525548|Ivacaftor|ivacaftor|mesh-list
14522350|NCT03525548|Elexacaftor|elexacaftor|mesh-list
14522351|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14522352|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522353|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522354|NCT03525834|Everolimus|everolimus|mesh-list
14522355|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522356|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14522357|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
14522358|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522359|NCT03527173|Vaccines|vaccines|mesh-list
14522360|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
14522361|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522362|NCT03527745|Albendazole|albendazole|mesh-list
14522363|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
14522364|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14522365|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522366|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
14522367|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14522368|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14522369|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
14522370|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
14522371|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
14522372|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522373|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522374|NCT03528174|Pancrelipase|pancrelipase|mesh-list
14522375|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522376|NCT03528369|Capsaicin|capsaicin|mesh-list
14522377|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
14522378|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
14522379|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
14522380|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522381|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522382|NCT03528512|Fentanyl|fentanyl|mesh-list
14522383|NCT03528512|Midazolam|midazolam|mesh-list
14522384|NCT03528512|Ketamine|ketamine|mesh-list
14522385|NCT03528512|Analgesics|analgesics|mesh-ancestor
14522386|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
14522387|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522388|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522389|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14522390|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14522391|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
14522392|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
14522393|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522394|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14522395|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14522396|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522397|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522398|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14522399|NCT03528512|Narcotics|narcotics|mesh-ancestor
14522400|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14522401|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14522402|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14522403|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14522404|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14522405|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
14522406|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
14950430|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14522407|NCT03528551|Factor VIII|factor viii|mesh-list
14522408|NCT03528551|Coagulants|coagulants|mesh-ancestor
14522409|NCT03528577|Albuterol|albuterol|mesh-list
14522410|NCT03528577|Procaterol|procaterol|mesh-list
14522411|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14522412|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
14522413|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522414|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522415|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14522416|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
14522417|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
14522418|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14522419|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14522420|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14522421|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14522422|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
14522423|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522424|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522425|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
14522426|NCT03530631|Adderall|adderall|mesh-list
14522427|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14522428|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522429|NCT03531840|Olaparib|olaparib|mesh-list
14522430|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14522431|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522432|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522433|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522434|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
14522435|NCT03531905|Ezetimibe|ezetimibe|mesh-list
14522436|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14522437|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14522438|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
14522439|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522440|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14522441|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522442|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522443|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522444|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
14522445|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14522446|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522447|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
14522448|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
14950431|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14950432|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950433|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965469|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965470|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13965471|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13965472|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14950434|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950435|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
14950436|NCT01544283|Hormones|hormones|mesh-ancestor
14950437|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950438|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14950439|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
14950440|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950441|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
14950442|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950443|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
14950444|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
14950445|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14950446|NCT01544504|Norepinephrine|norepinephrine|mesh-list
14950447|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14950448|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14950449|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
13965473|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965474|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965475|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13965476|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14522449|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
14522450|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
14950450|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950451|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950452|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950453|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
14950454|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
14950455|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950456|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14950457|NCT01544517|Amoxicillin|amoxicillin|mesh-list
14950458|NCT01544517|Levofloxacin|levofloxacin|mesh-list
14950459|NCT01544517|Ofloxacin|ofloxacin|mesh-list
14950460|NCT01544517|Tinidazole|tinidazole|mesh-list
14950461|NCT01544517|Esomeprazole|esomeprazole|mesh-list
14950462|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14950463|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14950464|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950465|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14950466|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522451|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
14522452|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522453|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14522454|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14522455|NCT03535194|Mirikizumab|mirikizumab|mesh-list
14793272|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14793273|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793274|NCT00751751|Losartan|losartan|mesh-list
14793275|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14793276|NCT00751751|Olmesartan|olmesartan|mesh-list
14793277|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14793278|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793279|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793280|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14793281|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14793282|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793283|NCT00751751|Diuretics|diuretics|mesh-ancestor
14793284|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
14793285|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793286|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14793287|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14793288|NCT00751764|Moxidectin|moxidectin|mesh-list
14793289|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
14793290|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14793291|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793292|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
14793293|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14793294|NCT00751829|Olmesartan|olmesartan|mesh-list
14793295|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14793296|NCT00751829|Nitrendipine|nitrendipine|mesh-list
14793297|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793298|NCT00751829|Diuretics|diuretics|mesh-ancestor
14793299|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
14793300|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793301|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14793302|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14793303|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793304|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14793305|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14793306|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14793307|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14793308|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
14522456|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522457|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522458|NCT03535194|Analgesics|analgesics|mesh-ancestor
14522459|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
14522460|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522461|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522462|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522463|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522464|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14522465|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522466|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14950467|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950468|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522467|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14522468|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14522469|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
14522470|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522471|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14793309|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
14793310|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793311|NCT00751907|Atorvastatin|atorvastatin|mesh-list
14793312|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14793313|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14793314|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
14793315|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793316|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14793317|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14793318|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793319|NCT00751959|Poractant alfa|poractant alfa|mesh-list
14793320|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
14793321|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
14793322|NCT00752011|Carboplatin|carboplatin|mesh-list
14793323|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793324|NCT00752024|Hemostatics|hemostatics|mesh-list
14793325|NCT00752024|Coagulants|coagulants|mesh-ancestor
14793326|NCT00752037|Ritonavir|ritonavir|mesh-list
14950469|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14522472|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
14522473|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522474|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522475|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14522476|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14522477|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522478|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
14522479|NCT03537274|Interferons|interferons|mesh-list
14522480|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
14522481|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
14522482|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14522483|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522484|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
14522485|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522486|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
14522487|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522488|NCT03537404|Ritonavir|ritonavir|mesh-list
14522489|NCT03537404|Tenofovir|tenofovir|mesh-list
14522490|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
14522491|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14522492|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14522493|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
14522494|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522495|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522496|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14522497|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14522498|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
14522499|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522500|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14522501|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14522502|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14522503|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14522504|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14522505|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14522506|NCT03537651|Ivacaftor|ivacaftor|mesh-list
14522507|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14522508|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522509|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522510|NCT03538431|Buspirone|buspirone|mesh-list
14522511|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14522512|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14522513|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522514|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950470|NCT01544517|Renal Agents|renal agents|mesh-ancestor
14950471|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14950472|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14950473|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950474|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14522515|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14522516|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14793327|NCT00752037|Lopinavir|lopinavir|mesh-list
14793328|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
14793329|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14793330|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14793331|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
14793332|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793333|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793334|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14793335|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14793336|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
14793337|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793338|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14793339|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14950475|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14950476|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
14950477|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14522517|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
14522518|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522519|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522520|NCT03538808|Varenicline|varenicline|mesh-list
14522521|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14522522|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14522523|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
14522524|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522525|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522526|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950478|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14950479|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14950480|NCT01544634|Beclomethasone|beclomethasone|mesh-list
14522527|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
14522528|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14522529|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
14522530|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522531|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14950481|NCT01544634|Propranolol|propranolol|mesh-list
14950482|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14950483|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14522532|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14522533|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14522534|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522535|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
14522536|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14793340|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14793341|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14950484|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14950485|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950486|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950487|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950488|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793342|NCT00752063|Capecitabine|capecitabine|mesh-list
14793343|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
14793344|NCT00752063|Sorafenib|sorafenib|mesh-list
14793345|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14793346|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
14793347|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793348|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793349|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14793350|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793351|NCT00752115|Paclitaxel|paclitaxel|mesh-list
14793352|NCT00752115|Carboplatin|carboplatin|mesh-list
14793353|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
14793354|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14793355|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793356|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
14793357|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
14793358|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
13965477|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13965478|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965479|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14950489|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14950490|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
14950491|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950492|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
14950493|NCT01544634|Hormones|hormones|mesh-ancestor
14950494|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950495|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14522537|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522538|NCT03540030|Acetaminophen|acetaminophen|mesh-list
14522539|NCT03540030|Celecoxib|celecoxib|mesh-list
14522540|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14522541|NCT03540030|Lidocaine|lidocaine|mesh-list
14522542|NCT03540030|Gabapentin|gabapentin|mesh-list
14522543|NCT03540030|Propofol|propofol|mesh-list
14522544|NCT03540030|Sevoflurane|sevoflurane|mesh-list
14522545|NCT03540030|Desflurane|desflurane|mesh-list
14522546|NCT03540030|Rocuronium|rocuronium|mesh-list
14522547|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
14522548|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
14522549|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
14522550|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522551|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522552|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
14522553|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522554|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14522555|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14950496|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
14950497|NCT01544673|Linezolid|linezolid|mesh-list
14950498|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14950499|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950500|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14950501|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950502|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950503|NCT01544725|Ketamine|ketamine|mesh-list
14950504|NCT01544725|Propofol|propofol|mesh-list
13965480|NCT03130426|Insulin|insulin|mesh-list
13965481|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13965482|NCT03130426|Metformin|metformin|mesh-list
13965483|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
14522556|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14522557|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522558|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522559|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14522560|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14522561|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
14522562|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522563|NCT03540030|Analgesics|analgesics|mesh-ancestor
14522564|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
14522565|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14522566|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14522567|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522568|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522569|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522570|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14793359|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965484|NCT03130426|Lixisenatide|lixisenatide|mesh-list
13965485|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14793360|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
14793361|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14793362|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14793363|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793364|NCT00752115|Urological Agents|urological agents|mesh-ancestor
13965486|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522571|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14522572|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793365|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
14793366|NCT00752141|Oxybutynin|oxybutynin|mesh-list
14793367|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
14793368|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
14522573|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
14522574|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14522575|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14522576|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14522577|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14522578|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14522579|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522580|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
14522581|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14522582|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14522583|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14522584|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14522585|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14522586|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
14522587|NCT03540160|Serlopitant|serlopitant|mesh-list
14522588|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14522589|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522590|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522591|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522592|NCT03541044|Nicotine|nicotine|mesh-list
14522593|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14522594|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
14522595|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522596|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522597|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14522598|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14522599|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
14522600|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522601|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522602|NCT03541356|Carbidopa|carbidopa|mesh-list
14522603|NCT03541356|Levodopa|levodopa|mesh-list
14522604|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
14522605|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14522606|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14522607|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
14522608|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522609|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950505|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14950506|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950507|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950508|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14950509|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
14950510|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
14950511|NCT01544725|Analgesics|analgesics|mesh-ancestor
14950512|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
14950513|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950514|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14950515|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14950516|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14950517|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950518|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522610|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522611|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14522612|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965487|NCT03130582|Etoposide|etoposide|mesh-list
13965488|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14522613|NCT03541941|Bupivacaine|bupivacaine|mesh-list
14950519|NCT01544751|Metformin|metformin|mesh-list
14950520|NCT01544751|Atorvastatin|atorvastatin|mesh-list
14950521|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950522|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950523|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14950524|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14950525|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
14950526|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950527|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14522614|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14522615|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
14522616|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522617|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522618|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
14522619|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027243|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13965489|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522620|NCT03541980|Acetaminophen|acetaminophen|mesh-list
14522621|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522622|NCT03541980|Analgesics|analgesics|mesh-ancestor
14522623|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
14522624|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522625|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522626|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
14522627|NCT03542266|Azacitidine|azacitidine|mesh-list
14522628|NCT03542266|Cc-486|cc-486|mesh-list
14522629|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14522630|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
14522631|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522632|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950528|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14950529|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965490|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13965491|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13965492|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965493|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965494|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
13965495|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13965496|NCT03130517|Antibodies|antibodies|mesh-list
13965497|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
13965498|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13965499|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
13965500|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965501|NCT03130348|Dexamethasone|dexamethasone|mesh-list
13965502|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
14522633|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522634|NCT03543137|Nicotine|nicotine|mesh-list
14950530|NCT01544829|Theobromine|theobromine|mesh-list
14793369|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793370|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793371|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14793372|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14793373|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
14793374|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793375|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793376|NCT00752141|Urological Agents|urological agents|mesh-ancestor
14793377|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14793378|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793379|NCT00752141|Renal Agents|renal agents|mesh-ancestor
14793380|NCT00752154|Curcumin|curcumin|mesh-list
14793381|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14793382|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14793383|NCT00752154|Analgesics|analgesics|mesh-ancestor
14793384|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
14522635|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14522636|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
14522637|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522638|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522639|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14793385|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793386|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793387|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793388|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793389|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793390|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793391|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793392|NCT00752180|Insulin|insulin|mesh-list
14793393|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14793394|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14793395|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793396|NCT00752310|Darunavir|darunavir|mesh-list
14793397|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14793398|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14793399|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
14793400|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793401|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793402|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14793403|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14522640|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14522641|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
14522642|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522643|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529708|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
14529709|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529710|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
14529711|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14529712|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14529713|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
14529714|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529715|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529716|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14529717|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14529718|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14529719|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
14529720|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
14529721|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
14529722|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14529723|NCT03718143|Adavosertib|adavosertib|mesh-list
14529724|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529725|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529726|NCT03709576|Azacitidine|azacitidine|mesh-list
14529727|NCT03709576|Pevonedistat|pevonedistat|mesh-list
14529728|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14529729|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
14529730|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529731|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529732|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529733|NCT03701295|Azacitidine|azacitidine|mesh-list
14529734|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14529735|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
14529736|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529737|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529738|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529739|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
14529740|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14529741|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14529742|NCT03694821|Prednisolone|prednisolone|mesh-list
14529743|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
14529744|NCT03694821|Ketorolac|ketorolac|mesh-list
14529745|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14529746|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14529747|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
14529748|NCT03694821|Hylan|hylan|mesh-list
14529749|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14529750|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
14529751|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
14529752|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529753|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950531|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14529754|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522644|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14522645|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
14522646|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14522647|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522648|NCT03545503|Ketamine|ketamine|mesh-list
14522649|NCT03545503|Etomidate|etomidate|mesh-list
14522650|NCT03545503|Analgesics|analgesics|mesh-ancestor
14522651|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
14522652|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522653|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522654|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14522655|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14950532|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
14950533|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950534|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522656|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
14522657|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
14522658|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522659|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14522660|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14522661|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522662|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950535|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14950536|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
14950537|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
14950538|NCT01544842|Triamcinolone|triamcinolone|mesh-list
14522663|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14522664|NCT03545893|Ibuprofen|ibuprofen|mesh-list
14522665|NCT03545893|Oxycodone|oxycodone|mesh-list
14522666|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522667|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522668|NCT03545893|Analgesics|analgesics|mesh-ancestor
14522669|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
14522670|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522671|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522672|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522673|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522674|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14522675|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522676|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522677|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14522678|NCT03545893|Narcotics|narcotics|mesh-ancestor
14522679|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522680|NCT03546621|Tenofovir|tenofovir|mesh-list
14793404|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
14793405|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793406|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14793407|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14793408|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14793409|NCT00752375|Trimethoprim|trimethoprim|mesh-list
14793410|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14793411|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
14793412|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14793413|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793414|NCT00752375|Renal Agents|renal agents|mesh-ancestor
14793415|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
14793416|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14950539|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14950540|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14950541|NCT01544842|Tacrolimus|tacrolimus|mesh-list
14950542|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14950543|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14950544|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
14950545|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522681|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
14522682|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522683|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14522684|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14522685|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522686|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522687|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14793417|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14793418|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14522688|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14522689|NCT03546816|Serlopitant|serlopitant|mesh-list
14793419|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522690|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14522691|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522692|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522693|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522694|NCT03547154|Interferons|interferons|mesh-list
14522695|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
14522696|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
14522697|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14522698|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522699|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
14522700|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522701|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
14793420|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793421|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14793422|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14793423|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14950546|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14950547|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522702|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522703|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14522704|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
14522705|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522706|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14522707|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14522708|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522709|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14522710|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
14522711|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522712|NCT03551730|Enoxaparin|enoxaparin|mesh-list
14522713|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
14522714|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
14522715|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14522716|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14522717|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522718|NCT03551743|Edoxaban|edoxaban|mesh-list
14522719|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14522720|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
14522721|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14522722|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
14522723|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522724|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522725|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
14522726|NCT03552523|Pancrelipase|pancrelipase|mesh-list
14522727|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522728|NCT03552549|Interferons|interferons|mesh-list
14522729|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
14522730|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
14522731|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14522732|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522733|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
14522734|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522735|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
14522736|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522737|NCT03553758|Ketamine|ketamine|mesh-list
14522738|NCT03553758|Analgesics|analgesics|mesh-ancestor
14793424|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793425|NCT00752401|Vitamin D|vitamin d|mesh-list
14793426|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
14793427|NCT00752401|Vitamins|vitamins|mesh-ancestor
14793428|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
14793429|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793430|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14793431|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14793432|NCT00752414|Levofloxacin|levofloxacin|mesh-list
14793433|NCT00752414|Ofloxacin|ofloxacin|mesh-list
14793434|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14793435|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793436|NCT00752414|Renal Agents|renal agents|mesh-ancestor
14793437|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793438|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14793439|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14793440|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793441|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793442|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522739|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
14522740|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522741|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522742|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14793443|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14793444|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14793445|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14793446|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14793447|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14793448|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793449|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793450|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14793451|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14793452|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14793453|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
14793454|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950548|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522743|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14522744|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
14793455|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793456|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14950549|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950550|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
14950551|NCT01544842|Hormones|hormones|mesh-ancestor
14950552|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950553|NCT01544881|Insulin|insulin|mesh-list
14950554|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950555|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950556|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14950557|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
14950558|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14950559|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
14950560|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950561|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950562|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14793457|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14793458|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
14793459|NCT00752466|Topiramate|topiramate|mesh-list
14793460|NCT00752466|Flunarizine|flunarizine|mesh-list
14793461|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
14793462|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14793463|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793464|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14793465|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14793466|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793467|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14793468|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14793469|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
14793470|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
14793471|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793472|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
14793473|NCT00752479|Cyclosporine|cyclosporine|mesh-list
14793474|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
14793475|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
14793476|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14793477|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14793478|NCT00752479|Prednisolone|prednisolone|mesh-list
14793479|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
14793480|NCT00752479|Cyclosporins|cyclosporins|mesh-list
14793481|NCT00752479|Basiliximab|basiliximab|mesh-list
14793482|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
14793483|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14793484|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
14793485|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793486|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793487|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14793488|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
14793489|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950563|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14950564|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14950565|NCT01544907|Paclitaxel|paclitaxel|mesh-list
14793490|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
14522745|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
14529755|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
14950566|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14950567|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950568|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14950569|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14950570|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14950571|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027244|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15027245|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15027246|NCT01948362|Sulforaphane|sulforaphane|mesh-list
13965503|NCT03130348|Bortezomib|bortezomib|mesh-list
13965504|NCT03130348|Ichthammol|ichthammol|mesh-list
13965505|NCT03130348|BB 1101|bb 1101|mesh-list
13965506|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965507|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
14793491|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793492|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
14793493|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793494|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14793495|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14793496|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793497|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14793498|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
15027247|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15027248|NCT01948362|Protective Agents|protective agents|mesh-ancestor
15027249|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027250|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027251|NCT01948401|Prednisolone|prednisolone|mesh-list
15027252|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027253|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
15027254|NCT01948401|Hormones|hormones|mesh-ancestor
15027255|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027256|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027257|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15027258|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027259|NCT01948505|Acetaminophen|acetaminophen|mesh-list
15027260|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15027261|NCT01948505|Analgesics|analgesics|mesh-ancestor
15027262|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
13965508|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
14529756|NCT03694821|Hormones|hormones|mesh-ancestor
14529757|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529758|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14529759|NCT03694821|Protective Agents|protective agents|mesh-ancestor
14529760|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14529761|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529762|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14529763|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529764|NCT03694821|Analgesics|analgesics|mesh-ancestor
14529765|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
14529766|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793499|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793500|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793501|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
14793502|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
14793503|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793504|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14793505|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
14793506|NCT00752479|Hormones|hormones|mesh-ancestor
14793507|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793508|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14793509|NCT00752479|Protective Agents|protective agents|mesh-ancestor
14793510|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14793511|NCT00752518|Bortezomib|bortezomib|mesh-list
14793512|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793513|NCT00752544|Simeprevir|simeprevir|mesh-list
14793514|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
14793515|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793516|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
14793517|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965509|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793518|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793519|NCT00752596|Azimilide|azimilide|mesh-list
14793520|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793521|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14793522|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14793523|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793524|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14793525|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793526|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
14793527|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
14793528|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14793529|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14793530|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14793531|NCT00752635|Norgestimate|norgestimate|mesh-list
14793532|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14793533|NCT00752635|Estradiol|estradiol|mesh-list
14793534|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14793535|NCT00752635|Cyproterone|cyproterone|mesh-list
14793536|NCT00752635|Estrogens|estrogens|mesh-ancestor
14793537|NCT00752635|Hormones|hormones|mesh-ancestor
14793538|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793539|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793540|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14793541|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
14793542|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14793543|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14793544|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14793545|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14793546|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
14793547|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
14793548|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793549|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14793550|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14793551|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793552|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793553|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14793554|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14793555|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793556|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793557|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14793558|NCT00752648|Simeprevir|simeprevir|mesh-list
14793559|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
14793560|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793561|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
14793562|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793563|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950572|NCT01544959|Fentanyl|fentanyl|mesh-list
14950573|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14950574|NCT01544959|Esmolol|esmolol|mesh-list
14950575|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14950576|NCT01544959|Narcotics|narcotics|mesh-ancestor
14950577|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950578|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950579|NCT01544959|Analgesics|analgesics|mesh-ancestor
14950580|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
14793564|NCT00752661|Tramadol|tramadol|mesh-list
14793565|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14793566|NCT00752661|Narcotics|narcotics|mesh-ancestor
14793567|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793568|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793569|NCT00752661|Analgesics|analgesics|mesh-ancestor
14793570|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
14793571|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793572|NCT00752739|Selenium|selenium|mesh-list
14793573|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
14950581|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950582|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14950583|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14950584|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
14950585|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
14950586|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14950587|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14950588|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950589|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950590|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14950591|NCT01544972|Acetaminophen|acetaminophen|mesh-list
14950592|NCT01544972|Ibuprofen|ibuprofen|mesh-list
14950593|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14950594|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14950595|NCT01544972|Analgesics|analgesics|mesh-ancestor
14950596|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
14950597|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950598|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950599|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14950600|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14950601|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14950602|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950603|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950604|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
14950605|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14950606|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950607|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950608|NCT01545024|Incretins|incretins|mesh-ancestor
14950609|NCT01545024|Hormones|hormones|mesh-ancestor
14950610|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950611|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14950612|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
14950613|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950614|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950615|NCT01545271|Xenon|xenon|mesh-list
14950616|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14950617|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
14950618|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
14950619|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950620|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950621|NCT01545284|Acitretin|acitretin|mesh-list
14950622|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
14950623|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
14950624|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
14950625|NCT01545297|Remifentanil|remifentanil|mesh-list
14950626|NCT01545297|Propofol|propofol|mesh-list
14950627|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14793574|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793575|NCT00752739|Protective Agents|protective agents|mesh-ancestor
14793576|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793577|NCT00752739|Trace Elements|trace elements|mesh-ancestor
14793578|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
14793579|NCT00752843|Mifepristone|mifepristone|mesh-list
14793580|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14793581|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
14793582|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14793583|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793584|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14793585|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14793586|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14793587|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
14793588|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14793589|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14793590|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
14793591|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793592|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
14793593|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14793594|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14793595|NCT00752869|Dutasteride|dutasteride|mesh-list
14793596|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14793597|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14793598|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793599|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793600|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
14793601|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793602|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793603|NCT00752882|Ceftazidime|ceftazidime|mesh-list
14793604|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793605|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793606|NCT00752921|Etoricoxib|etoricoxib|mesh-list
14793607|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14793608|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14793609|NCT00752921|Analgesics|analgesics|mesh-ancestor
14793610|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
14793611|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793612|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793613|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793614|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793615|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14793616|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14793617|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793618|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793619|NCT00752934|Baclofen|baclofen|mesh-list
14793620|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14793621|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793622|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14793623|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793624|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14793625|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
14793626|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
14793627|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793628|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793629|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
14793630|NCT00752947|Metronidazole|metronidazole|mesh-list
14793631|NCT00752947|Levofloxacin|levofloxacin|mesh-list
14793632|NCT00752947|Ofloxacin|ofloxacin|mesh-list
14793633|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793634|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793635|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14793636|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14793637|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793638|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793639|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793640|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14793641|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14793642|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14793643|NCT00752947|Renal Agents|renal agents|mesh-ancestor
14793644|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14793645|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14793646|NCT00753038|Paclitaxel|paclitaxel|mesh-list
14793647|NCT00753038|Carboplatin|carboplatin|mesh-list
14793648|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14793649|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793650|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
14793651|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
14793652|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
14793653|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793654|NCT00753051|Haloperidol|haloperidol|mesh-list
14793655|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
14793656|NCT00753051|Clozapine|clozapine|mesh-list
14793657|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
14793658|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
14793659|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793660|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793661|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14793662|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14793663|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14793664|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793665|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14793666|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14793667|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
14793668|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793669|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793670|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14793671|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14793672|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
14793673|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
14793674|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
14793675|NCT00753064|Prazosin|prazosin|mesh-list
14793676|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14950628|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950629|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950630|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14950631|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
14950632|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
14950633|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14793677|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14793678|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14793679|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14793680|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
14793681|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793682|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793683|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793684|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
14793685|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
14793686|NCT00753103|Prednisolone|prednisolone|mesh-list
14793687|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
14793688|NCT00753103|Azathioprine|azathioprine|mesh-list
14793689|NCT00753103|Infliximab|infliximab|mesh-list
14793690|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14793691|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
14793692|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793693|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793694|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14793695|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
14793696|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793697|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793698|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14793699|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14793700|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14793701|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
14793702|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793703|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793704|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793705|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793706|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
14793707|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
14793708|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793709|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14793710|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
14793711|NCT00753103|Hormones|hormones|mesh-ancestor
14793712|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793713|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14793714|NCT00753103|Protective Agents|protective agents|mesh-ancestor
14793715|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14793716|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
14793717|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
14793718|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14793719|NCT00753168|Timolol|timolol|mesh-list
14793720|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14793721|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14793722|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14793723|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14793724|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
14793725|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793726|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793727|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793728|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793729|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793730|NCT00753207|Epirubicin|epirubicin|mesh-list
14793731|NCT00753207|Lapatinib|lapatinib|mesh-list
14793732|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14793733|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793734|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14793735|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14793736|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793737|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793738|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14793739|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
14793740|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14793741|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793742|NCT00753311|Rizatriptan|rizatriptan|mesh-list
14950634|NCT01545297|Analgesics|analgesics|mesh-ancestor
14950635|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
14950636|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950637|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14793743|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14793744|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
14793745|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793746|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793747|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793748|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14793749|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
14793750|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793751|NCT00753389|Anesthetics|anesthetics|mesh-list
14793752|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14793753|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793754|NCT00753402|Epinephrine|epinephrine|mesh-list
14793755|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14793756|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14793757|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14793758|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793759|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793760|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793761|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14793762|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14950638|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14950639|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14950640|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
14950641|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793763|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
14793764|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793765|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14793766|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
14793767|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
14793768|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
14793769|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14793770|NCT00753467|Interferons|interferons|mesh-list
14793771|NCT00753467|Adefovir|adefovir|mesh-list
14793772|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14793773|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
14793774|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793775|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
14793776|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793777|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14793778|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14793779|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793780|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793781|NCT00753493|Topiramate|topiramate|mesh-list
15027263|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793782|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
14793783|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14793784|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793785|NCT00753532|Vitamin E|vitamin e|mesh-list
14793786|NCT00753532|Tocopherols|tocopherols|mesh-list
14793787|NCT00753532|Tocotrienols|tocotrienols|mesh-list
14793788|NCT00753532|Tocovid|tocovid|mesh-list
14793789|NCT00753532|Vitamins|vitamins|mesh-ancestor
14793790|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
14793791|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793792|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
14793793|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793794|NCT00753532|Protective Agents|protective agents|mesh-ancestor
14793795|NCT00753558|Gentamicins|gentamicins|mesh-list
14793796|NCT00753558|Polymyxins|polymyxins|mesh-list
14793797|NCT00753558|Colistin|colistin|mesh-list
14793798|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14793799|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793800|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14793801|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793802|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793803|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
14793804|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793805|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14793806|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793807|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793808|NCT00753571|Protective Agents|protective agents|mesh-ancestor
14793809|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793810|NCT00753597|Rituximab|rituximab|mesh-list
14793811|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14793812|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793813|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
14793814|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793815|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14793816|NCT00753727|Sunitinib|sunitinib|mesh-list
14793817|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793818|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14793819|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14793820|NCT00753727|Growth Substances|growth substances|mesh-ancestor
14793821|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793822|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
14793823|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14793824|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793825|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793826|NCT00753740|Camptothecin|camptothecin|mesh-list
14793827|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14793828|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793829|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14793830|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14793831|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793832|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793833|NCT00753779|Simvastatin|simvastatin|mesh-list
14793834|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14793835|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14793836|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14793837|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
14793838|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793839|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14793840|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14793841|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793842|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
14793843|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14793844|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14793845|NCT00753792|Prednisolone|prednisolone|mesh-list
14793846|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
14793847|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14793848|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
14793849|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14793850|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
14793851|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
14793852|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14793853|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793854|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14793855|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
14793856|NCT00753792|Hormones|hormones|mesh-ancestor
14793857|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14793858|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14793859|NCT00753792|Protective Agents|protective agents|mesh-ancestor
14793860|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14793861|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793862|NCT00753883|Simvastatin|simvastatin|mesh-list
14793863|NCT00753883|Ezetimibe|ezetimibe|mesh-list
14793864|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14793865|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14793866|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
14793867|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950642|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950643|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14950644|NCT01545297|Narcotics|narcotics|mesh-ancestor
14950645|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
14950646|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950647|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14950648|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950649|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950650|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14950651|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
14950652|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950653|NCT01545479|Captopril|captopril|mesh-list
14950654|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14950655|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
14950656|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950657|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950658|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14950659|NCT01545557|Lidocaine|lidocaine|mesh-list
14950660|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
14950661|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
14950662|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
14950663|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950664|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950665|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
14950666|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950667|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14950668|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14950669|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14950670|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950671|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950672|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14950673|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
14950674|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
14950675|NCT01545557|Protective Agents|protective agents|mesh-ancestor
14950676|NCT01545596|Anesthetics|anesthetics|mesh-list
14950677|NCT01545596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950678|NCT01545596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950679|NCT01545635|Thrombin|thrombin|mesh-list
14950680|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
14950681|NCT01545635|Coagulants|coagulants|mesh-ancestor
14950682|NCT01545778|Oxycodone|oxycodone|mesh-list
14950683|NCT01545778|Tapentadol|tapentadol|mesh-list
14950684|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14950685|NCT01545778|Narcotics|narcotics|mesh-ancestor
14950686|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950687|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950688|NCT01545778|Analgesics|analgesics|mesh-ancestor
14950689|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
14950690|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950691|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14950692|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14950693|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950694|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950695|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
14950696|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950697|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
14950698|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950699|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950700|NCT01545804|Lenalidomide|lenalidomide|mesh-list
14950701|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
14950702|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950703|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14950704|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14793868|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14793869|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14793870|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793871|NCT00753909|Paclitaxel|paclitaxel|mesh-list
14793872|NCT00753909|Bevacizumab|bevacizumab|mesh-list
14793873|NCT00753909|Carboplatin|carboplatin|mesh-list
14793874|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14793875|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793876|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
14793877|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
14793878|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
14793879|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793880|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14793881|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14793882|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14793883|NCT00753909|Growth Substances|growth substances|mesh-ancestor
14793884|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793885|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
14793886|NCT00754039|Fenofibrate|fenofibrate|mesh-list
14793887|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14793888|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14793889|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
14793890|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793891|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14793892|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14793893|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14793894|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793895|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14793896|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793897|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793898|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14793899|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
14793900|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793901|NCT00754260|Caffeine|caffeine|mesh-list
14793902|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14793903|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793904|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14793905|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793906|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793907|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14793908|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14793909|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
14793910|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793911|NCT00754312|Entinostat|entinostat|mesh-list
14793912|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793913|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14793914|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793915|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793916|NCT00754351|Gemcitabine|gemcitabine|mesh-list
14793917|NCT00754351|Bevacizumab|bevacizumab|mesh-list
14793918|NCT00754351|Docetaxel|docetaxel|mesh-list
14793919|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14793920|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793921|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14793922|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14793923|NCT00754351|Growth Substances|growth substances|mesh-ancestor
14793924|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793925|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
14793926|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14793927|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
14793928|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793929|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
14793930|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793931|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793932|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14793933|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
14793934|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
14793935|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
14793936|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
14793937|NCT00754364|Gemcitabine|gemcitabine|mesh-list
14793938|NCT00754364|Carboplatin|carboplatin|mesh-list
14793939|NCT00754364|Pemetrexed|pemetrexed|mesh-list
14793940|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950705|NCT01545804|Growth Substances|growth substances|mesh-ancestor
14793941|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14793942|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
14793943|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793944|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
14793945|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14793946|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793947|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14793948|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
14793949|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793950|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14793951|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14793952|NCT00754403|Metformin|metformin|mesh-list
14793953|NCT00754403|Pioglitazone|pioglitazone|mesh-list
14793954|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14793955|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793956|NCT00754429|Losartan|losartan|mesh-list
14793957|NCT00754429|Amlodipine|amlodipine|mesh-list
14793958|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14793959|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14793960|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14793961|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793962|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14793963|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793964|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
14793965|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14793966|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14793967|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14793968|NCT00754507|Atorvastatin|atorvastatin|mesh-list
14793969|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14793970|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14793971|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14793972|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
14793973|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793974|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14793975|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14793976|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793977|NCT00754689|Metformin|metformin|mesh-list
14793978|NCT00754689|Rimonabant|rimonabant|mesh-list
14793979|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14793980|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14793981|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14793982|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
14793983|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14793984|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14793985|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793986|NCT00754689|Hormones|hormones|mesh-ancestor
14793987|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950706|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
14950707|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950708|NCT01545830|Vitamin D|vitamin d|mesh-list
14950709|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
14950710|NCT01545830|Vitamins|vitamins|mesh-ancestor
14950711|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
14950712|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950713|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14950714|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14950715|NCT01545856|Levodopa|levodopa|mesh-list
14950716|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14950717|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14950718|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
14950719|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950720|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950721|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950722|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14950723|NCT01545947|Azacitidine|azacitidine|mesh-list
14950724|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965510|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965511|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965512|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
13965513|NCT03130348|Hormones|hormones|mesh-ancestor
13965514|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965515|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13965516|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793988|NCT00754702|Vinorelbine|vinorelbine|mesh-list
14793989|NCT00754702|Lapatinib|lapatinib|mesh-list
14793990|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14793991|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14793992|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
14793993|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14793994|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14793995|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14793996|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14793997|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14793998|NCT00754780|Pirfenidone|pirfenidone|mesh-list
14793999|NCT00754780|Analgesics|analgesics|mesh-ancestor
14794000|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
14794001|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950725|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14950726|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950727|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950728|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14950729|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
14794002|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794003|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14794004|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794005|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794006|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794007|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794008|NCT00754819|Colchicine|colchicine|mesh-list
14794009|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
14794010|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794011|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
14794012|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
14794013|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
14794014|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794015|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794016|NCT00754858|Belotecan|belotecan|mesh-list
14794017|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794018|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14794019|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794020|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794021|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794022|NCT00754871|Dienogest|dienogest|mesh-list
14794023|NCT00754871|Nandrolone|nandrolone|mesh-list
14794024|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14794025|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
14794026|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14794027|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794028|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14794029|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14794030|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14794031|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14794032|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
14794033|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794034|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14794035|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794036|NCT00754871|Androgens|androgens|mesh-ancestor
14794037|NCT00754871|Hormones|hormones|mesh-ancestor
14794038|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
14794039|NCT00754884|Calcitonin|calcitonin|mesh-list
14794040|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
14794041|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
14794042|NCT00754884|Glycerol|glycerol|mesh-list
14794043|NCT00754884|Katacalcin|katacalcin|mesh-list
14794044|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14794045|NCT00754884|Protective Agents|protective agents|mesh-ancestor
14794046|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794047|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14794048|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14794049|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
14794050|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14794051|NCT00754910|Trioxsalen|trioxsalen|mesh-list
14794052|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794053|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14794054|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14794055|NCT00754962|Protriptyline|protriptyline|mesh-list
14794056|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14794057|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
14794058|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794059|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14950730|NCT01546051|BCI-838|bci-838|mesh-list
14950731|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14950732|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14950733|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950734|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950735|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950736|NCT01546090|Alprazolam|alprazolam|mesh-list
14950737|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14950738|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950739|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950740|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14950741|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14950742|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14950743|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
14950744|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
14950745|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950746|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950747|NCT01546103|Vitamin D|vitamin d|mesh-list
13965517|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
13965518|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965519|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965520|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
13965521|NCT03130179|Nicotine|nicotine|mesh-list
13965522|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13965523|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
13965524|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965525|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965526|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13965527|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14794060|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794061|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794062|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794063|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
14794064|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794065|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794066|NCT00755014|Ethanol|ethanol|mesh-list
14794067|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14794068|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794069|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965528|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
13965529|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965530|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965531|NCT03130010|Nefopam|nefopam|mesh-list
13965532|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965533|NCT03130010|Analgesics|analgesics|mesh-ancestor
13965534|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
14794070|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794071|NCT00755027|Rasagiline|rasagiline|mesh-list
14794072|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14794073|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794074|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965535|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965536|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965537|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13965538|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13965539|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794075|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14950748|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
14794076|NCT00755027|Protective Agents|protective agents|mesh-ancestor
14794077|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794078|NCT00755053|Clotrimazole|clotrimazole|mesh-list
14794079|NCT00755053|Miconazole|miconazole|mesh-list
14794080|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14794081|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794082|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
14794083|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14794084|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14794085|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794086|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794087|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14794088|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
14794089|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794090|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794091|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14794092|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14794093|NCT00755066|Fluticasone|fluticasone|mesh-list
14794094|NCT00755066|Xhance|xhance|mesh-list
14794095|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794096|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14794097|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
14794098|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950749|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
14950750|NCT01546103|Vitamins|vitamins|mesh-list
14950751|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
14794099|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794100|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14794101|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
14794102|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
14794103|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14794104|NCT00755118|Leucovorin|leucovorin|mesh-list
14794105|NCT00755118|Bevacizumab|bevacizumab|mesh-list
14794106|NCT00755118|Cetuximab|cetuximab|mesh-list
14794107|NCT00755118|Fluorouracil|fluorouracil|mesh-list
14794108|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
14794109|NCT00755118|Irinotecan|irinotecan|mesh-list
14794110|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794111|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794112|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14794113|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14794114|NCT00755118|Growth Substances|growth substances|mesh-ancestor
14794115|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794116|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
14794117|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
14794118|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794119|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14794120|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794121|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
14794122|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14794123|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794124|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794125|NCT00755118|Antidotes|antidotes|mesh-ancestor
14794126|NCT00755118|Protective Agents|protective agents|mesh-ancestor
14794127|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
14794128|NCT00755118|Vitamins|vitamins|mesh-ancestor
14794129|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
14794130|NCT00755157|Bevacizumab|bevacizumab|mesh-list
14794131|NCT00755157|Docetaxel|docetaxel|mesh-list
14950752|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950753|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14794132|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794133|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794134|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14794135|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14794136|NCT00755157|Growth Substances|growth substances|mesh-ancestor
14794137|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794138|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
14794139|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
14794140|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
14794141|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
14794142|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794143|NCT00755170|Bevacizumab|bevacizumab|mesh-list
14794144|NCT00755170|Vinorelbine|vinorelbine|mesh-list
14794145|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794146|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794147|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14794148|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14794149|NCT00755170|Growth Substances|growth substances|mesh-ancestor
14794150|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794151|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
14794152|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14794153|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14794154|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14794155|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14794156|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794157|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
14794158|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14794159|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14794160|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794161|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
14794162|NCT00755209|Coagulants|coagulants|mesh-ancestor
14794163|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
14794164|NCT00755313|Carboplatin|carboplatin|mesh-list
14794165|NCT00755313|Docetaxel|docetaxel|mesh-list
14794166|NCT00755313|Doxorubicin|doxorubicin|mesh-list
14794167|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14794168|NCT00755313|Trastuzumab|trastuzumab|mesh-list
14794169|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14794170|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14794171|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794172|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
14794173|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794174|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794175|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14794176|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
14794177|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794178|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794179|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14794180|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
14794181|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
14794182|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
14794183|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14794184|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14794185|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794186|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794187|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794188|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14794189|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14794190|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14794191|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
14794192|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794193|NCT00755352|Pravastatin|pravastatin|mesh-list
14794194|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14794195|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14794196|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14794197|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
14794198|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794199|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13965540|NCT03130218|Peppermint oil|peppermint oil|mesh-list
13965541|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
13965542|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
13965543|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965544|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965545|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965546|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
13965547|NCT03130153|Aspirin|aspirin|mesh-list
13965548|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
13965549|NCT03130153|Salicylates|salicylates|mesh-list
13965550|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965551|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794200|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14794201|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794202|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14794203|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14794204|NCT00755495|Doxepin|doxepin|mesh-list
13965552|NCT03130153|Analgesics|analgesics|mesh-ancestor
14794205|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14950754|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14950755|NCT01546116|Lamivudine|lamivudine|mesh-list
14950756|NCT01546116|Adefovir|adefovir|mesh-list
14950757|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14794206|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14794207|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794208|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794209|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14794210|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
14794211|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794212|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
14794213|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
14794214|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794215|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794216|NCT00755508|Gabapentin|gabapentin|mesh-list
14794217|NCT00755508|Analgesics|analgesics|mesh-ancestor
14794218|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
14794219|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794220|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794221|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
14794222|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14794223|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14794224|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794225|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794226|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14794227|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14794228|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794229|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794230|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
14794231|NCT00755521|Etoricoxib|etoricoxib|mesh-list
14794232|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14794233|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794234|NCT00755521|Analgesics|analgesics|mesh-ancestor
14794235|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
14794236|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794237|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794238|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794239|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794240|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14794241|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14794242|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794243|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794244|NCT00755534|Capecitabine|capecitabine|mesh-list
14794245|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
14794246|NCT00755534|Irinotecan|irinotecan|mesh-list
14950758|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13965553|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
14794247|NCT00755534|Cetuximab|cetuximab|mesh-list
14794248|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14794249|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
14794250|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794251|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794252|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14794253|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794254|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794255|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794256|NCT00755560|Albendazole|albendazole|mesh-list
14794257|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
14794258|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14794259|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794260|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
14794261|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14794262|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14794263|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
14794264|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
14794265|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
14794266|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794267|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794268|NCT00755573|Pregabalin|pregabalin|mesh-list
14794269|NCT00755573|Analgesics|analgesics|mesh-ancestor
14794270|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
14794271|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794272|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794273|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
14794274|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14794275|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950759|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14794276|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794277|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14794278|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14794279|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14794280|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794281|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794282|NCT00755664|Vitamins|vitamins|mesh-list
14794283|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
14794284|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
14794285|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950760|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950761|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794286|NCT00755781|Cyclosporine|cyclosporine|mesh-list
14794287|NCT00755781|Cyclosporins|cyclosporins|mesh-list
14794288|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794289|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794290|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794291|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
14794292|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794293|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
14794294|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794295|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
14794296|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794297|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14794298|NCT00755820|Cycloserine|cycloserine|mesh-list
14794299|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14950762|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
14950763|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950764|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14950765|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14950766|NCT01546389|Chloroquine|chloroquine|mesh-list
14950767|NCT01546389|Amebicides|amebicides|mesh-ancestor
14950768|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14950769|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14794300|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794301|NCT00755820|Renal Agents|renal agents|mesh-ancestor
14794302|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14794303|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
14794304|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14794305|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
14794306|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794307|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
14794308|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
14794309|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14794310|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794311|NCT00755859|Prednisone|prednisone|mesh-list
14794312|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14794313|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14794314|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
14794315|NCT00755859|Prednisolone|prednisolone|mesh-list
14794316|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
14794317|NCT00755859|Azathioprine|azathioprine|mesh-list
14794318|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14794319|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
14794320|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
14794321|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794322|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14794323|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794324|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794325|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
14794326|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794327|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794328|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794329|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
14794330|NCT00755859|Hormones|hormones|mesh-ancestor
14794331|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794332|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14794333|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14794334|NCT00755859|Protective Agents|protective agents|mesh-ancestor
14794335|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
14794336|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
14794337|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950770|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950771|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
14950772|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14950773|NCT01546558|Metformin|metformin|mesh-list
14950774|NCT01546558|Ranolazine|ranolazine|mesh-list
14950775|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950776|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950777|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14950778|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950779|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950780|NCT01546597|Metformin|metformin|mesh-list
14950781|NCT01546597|Ranolazine|ranolazine|mesh-list
14950782|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950783|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950784|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14950785|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950786|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027264|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027265|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
15027266|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
15027267|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15027268|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
15027269|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027270|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
15027271|NCT01948583|Protective Agents|protective agents|mesh-ancestor
15027272|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
15027273|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14794338|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14794339|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
14794340|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
14794341|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14794342|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794343|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794344|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14794345|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794346|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14794347|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
14794348|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794349|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14794350|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794351|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794352|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
14794353|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794354|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794355|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14794356|NCT00755898|Amantadine|amantadine|mesh-list
15027274|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14794357|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14794358|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14794359|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
14794360|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794361|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
14794362|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794363|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794364|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794365|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794366|NCT00755898|Analgesics|analgesics|mesh-ancestor
14950787|NCT01546701|Morphine|morphine|mesh-list
14950788|NCT01546701|Buprenorphine|buprenorphine|mesh-list
14950789|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14950790|NCT01546701|Narcotics|narcotics|mesh-ancestor
14950791|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950792|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965554|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965555|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965556|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794367|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
14794368|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794369|NCT00755924|Acetic Acid|acetic acid|mesh-list
14794370|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14794371|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794372|NCT00755950|Silymarin|silymarin|mesh-list
14794373|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
14794374|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794375|NCT00755950|Protective Agents|protective agents|mesh-ancestor
14794376|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794377|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14794378|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14794379|NCT00755963|Estradiol|estradiol|mesh-list
14794380|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14794381|NCT00755963|Progesterone|progesterone|mesh-list
14794382|NCT00755963|Estrogens|estrogens|mesh-ancestor
14794383|NCT00755963|Hormones|hormones|mesh-ancestor
14794384|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794385|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965557|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965558|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13965559|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13965560|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965561|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13965562|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13965563|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965564|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
13965565|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965566|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
13965567|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
13965568|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
13965569|NCT03130114|Azithromycin|azithromycin|mesh-list
14794386|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14794387|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
14794388|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14794389|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14794390|NCT00755963|Progestins|progestins|mesh-ancestor
14794391|NCT00755976|Sulindac|sulindac|mesh-list
14794392|NCT00755976|Epirubicin|epirubicin|mesh-list
14794393|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14794394|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794395|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14794396|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794397|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794398|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794399|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14794400|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794401|NCT00755976|Analgesics|analgesics|mesh-ancestor
14794402|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
14794403|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794404|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794405|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794406|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794407|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14794408|NCT00755989|Morphine|morphine|mesh-list
14794409|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14794410|NCT00755989|Narcotics|narcotics|mesh-ancestor
14794411|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794412|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794413|NCT00755989|Analgesics|analgesics|mesh-ancestor
14794414|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
14794415|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794416|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14794417|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
14794418|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794419|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14794420|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14794421|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14794422|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
14794423|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794424|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14794425|NCT00756184|Travoprost|travoprost|mesh-list
14794426|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14794427|NCT00756301|Lidocaine|lidocaine|mesh-list
14794428|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
14794429|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
14794430|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794431|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794432|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
14794433|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794434|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14794435|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14794436|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14794437|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13965570|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13965571|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965572|NCT03130270|Apatinib|apatinib|mesh-list
14794438|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794439|NCT00756340|Bevacizumab|bevacizumab|mesh-list
14794440|NCT00756340|Everolimus|everolimus|mesh-list
14794441|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794442|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794443|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14794444|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14794445|NCT00756340|Growth Substances|growth substances|mesh-ancestor
14794446|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794447|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
14794448|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794449|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
14794450|NCT00756405|Antioxidants|antioxidants|mesh-list
14794451|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794452|NCT00756405|Protective Agents|protective agents|mesh-ancestor
14794453|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794454|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14794455|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14794456|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950793|NCT01546701|Analgesics|analgesics|mesh-ancestor
14950794|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
14950795|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950796|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14950797|NCT01546896|Alprazolam|alprazolam|mesh-list
14950798|NCT01546896|Buspirone|buspirone|mesh-list
14950799|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14950800|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950801|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950802|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14950803|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14950804|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14950805|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
14950806|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
14950807|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14950808|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950809|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14950810|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
14950811|NCT01546909|Vaccines|vaccines|mesh-list
14950812|NCT01546909|Immunologic Factors|immunologic factors|mesh-ancestor
14950813|NCT01546909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950814|NCT01546935|Oseltamivir|oseltamivir|mesh-list
14950815|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
14950816|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950817|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027275|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
14794457|NCT00756847|Paclitaxel|paclitaxel|mesh-list
14794458|NCT00756847|Carboplatin|carboplatin|mesh-list
14794459|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14794460|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794461|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
14794462|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14794463|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14794464|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794465|NCT00756860|Sevelamer|sevelamer|mesh-list
14794466|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
14794467|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
14794468|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794469|NCT00756873|Etoricoxib|etoricoxib|mesh-list
14794470|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14794471|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794472|NCT00756873|Analgesics|analgesics|mesh-ancestor
14794473|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
14794474|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794475|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794476|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794477|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794478|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14794479|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14794480|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794481|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794482|NCT00756990|Naltrexone|naltrexone|mesh-list
14794483|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14794484|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14794485|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794486|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
14794487|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794488|NCT00757016|Triamcinolone|triamcinolone|mesh-list
14794489|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14794490|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14794491|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14794492|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794493|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
14794494|NCT00757016|Hormones|hormones|mesh-ancestor
14794495|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794496|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794497|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794498|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
14794499|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794500|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794501|NCT00757029|Norepinephrine|norepinephrine|mesh-list
14794502|NCT00757029|Methylphenidate|methylphenidate|mesh-list
14794503|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14794504|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794505|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14794506|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794507|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794508|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794509|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
14794510|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794511|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14794512|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14794513|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
14794514|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
14794515|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
14794516|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794517|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14794518|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
14794519|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14794520|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14794521|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
14794522|NCT00757185|Testosterone|testosterone|mesh-list
14794523|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
14794524|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
14794525|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14950818|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950819|NCT01546961|Chloroquine|chloroquine|mesh-list
14950820|NCT01546961|Amebicides|amebicides|mesh-ancestor
14950821|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14794526|NCT00757185|Ganirelix|ganirelix|mesh-list
14794527|NCT00757185|Androgens|androgens|mesh-ancestor
14794528|NCT00757185|Hormones|hormones|mesh-ancestor
14794529|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794530|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794531|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14794532|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794533|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
14794534|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
14794535|NCT00757198|Remifentanil|remifentanil|mesh-list
14794536|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14794537|NCT00757198|Narcotics|narcotics|mesh-ancestor
14794538|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794539|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794540|NCT00757198|Analgesics|analgesics|mesh-ancestor
14794541|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
14794542|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794543|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14794544|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14794545|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
14794546|NCT00757315|Triamcinolone|triamcinolone|mesh-list
14794547|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14794548|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14794549|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14794550|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794551|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
14794552|NCT00757315|Hormones|hormones|mesh-ancestor
14794553|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794554|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794555|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794556|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
14794557|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794558|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794559|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
14794560|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14794561|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14794562|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794563|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14794564|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
14794565|NCT00757393|Vitamin D|vitamin d|mesh-list
14794566|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
14794567|NCT00757393|Vitamins|vitamins|mesh-list
14794568|NCT00757393|Calcium|calcium|mesh-list
14794569|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
14794570|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794571|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14794572|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14794573|NCT00757419|Lesogaberan|lesogaberan|mesh-list
14794574|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14794575|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14794576|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
14794577|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
14794578|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794579|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794580|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794581|NCT00757458|Propofol|propofol|mesh-list
14794582|NCT00757458|Edetic Acid|edetic acid|mesh-list
14794583|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
14794584|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14794585|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794586|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794587|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14794588|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
14794589|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
14794590|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
14794591|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14794592|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
14794593|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
14794594|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794595|NCT00757458|Antidotes|antidotes|mesh-ancestor
14794596|NCT00757458|Protective Agents|protective agents|mesh-ancestor
14794597|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14794598|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
14794599|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14794600|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794601|NCT00757523|Analgesics|analgesics|mesh-ancestor
14794602|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
14794603|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794604|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794605|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794606|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794607|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14794608|NCT00757549|Cetuximab|cetuximab|mesh-list
14950822|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14950823|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950824|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
14950825|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14950826|NCT01546987|Leuprolide|leuprolide|mesh-list
14794609|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14794610|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794611|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794612|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14794613|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794614|NCT00757679|Milnacipran|milnacipran|mesh-list
14794615|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
14794616|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14794617|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794618|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794619|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794620|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794621|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794622|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794623|NCT00757679|Analgesics|analgesics|mesh-ancestor
14794624|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
14794625|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794626|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
14794627|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794628|NCT00757692|Bicalutamide|bicalutamide|mesh-list
14794629|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
14794630|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
14794631|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794632|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794633|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794634|NCT00757731|Milnacipran|milnacipran|mesh-list
14794635|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
14794636|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14794637|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794638|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794639|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794640|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794641|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794642|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14950827|NCT01546987|Goserelin|goserelin|mesh-list
14950828|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14950829|NCT01546987|Flutamide|flutamide|mesh-list
14950830|NCT01546987|Bicalutamide|bicalutamide|mesh-list
14950831|NCT01546987|Buserelin|buserelin|mesh-list
14950832|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14950833|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
14950834|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14794643|NCT00757731|Analgesics|analgesics|mesh-ancestor
14794644|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
14794645|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794646|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
14950835|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794647|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794648|NCT00757835|Timolol|timolol|mesh-list
14794649|NCT00757835|Latanoprost|latanoprost|mesh-list
14794650|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14794651|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14794652|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
14794653|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794654|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794655|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794656|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14794657|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14794658|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14794659|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14950836|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14950837|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950838|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-ancestor
14794660|NCT00757874|Clobetasol|clobetasol|mesh-list
14794661|NCT00757874|Tacrolimus|tacrolimus|mesh-list
14794662|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794663|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
14794664|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794665|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14794666|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794667|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794668|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794669|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
14794670|NCT00757874|Hormones|hormones|mesh-ancestor
14950839|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
14950840|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950841|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
14950842|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14950843|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
14950844|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14950845|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
14950846|NCT01547104|Glimepiride|glimepiride|mesh-list
14950847|NCT01547104|Linagliptin|linagliptin|mesh-list
14950848|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14950849|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950850|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950851|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14950852|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
14950853|NCT01547104|Incretins|incretins|mesh-ancestor
14950854|NCT01547104|Hormones|hormones|mesh-ancestor
14950855|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950856|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14794671|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794672|NCT00757978|Memantine|memantine|mesh-list
14794673|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14794674|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14794675|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
14794676|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794677|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950857|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
14950858|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950859|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950860|NCT01547143|Cyclosporine|cyclosporine|mesh-list
14950861|NCT01547143|Dexamethasone|dexamethasone|mesh-list
14950862|NCT01547143|Etoposide|etoposide|mesh-list
14950863|NCT01547143|Cyclosporins|cyclosporins|mesh-list
14794678|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794679|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14794680|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14794681|NCT00758004|Atorvastatin|atorvastatin|mesh-list
14794682|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14794683|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14794684|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
14794685|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794686|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14794687|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14794688|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794689|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14794690|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14794691|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14794692|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794693|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794694|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794695|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14794696|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14794697|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
14794698|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794699|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794700|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14794701|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14794702|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
14794703|NCT00758134|Trastuzumab|trastuzumab|mesh-list
14794704|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794705|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950864|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
14950865|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794706|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
14950866|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
14794707|NCT00758199|Prednisolone|prednisolone|mesh-list
14794708|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14794709|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
14794710|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14794711|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
14794712|NCT00758199|Bromfenac|bromfenac|mesh-list
14794713|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14794714|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14794715|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
14794716|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794717|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
14794718|NCT00758199|Hormones|hormones|mesh-ancestor
14794719|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794720|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794721|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14794722|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794723|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
14794724|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
14794725|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794726|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14794727|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14794728|NCT00758199|Protective Agents|protective agents|mesh-ancestor
14794729|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14794730|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794731|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14794732|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794733|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794734|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950867|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
14950868|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950869|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950870|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14950871|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
14950872|NCT01547143|Hormones|hormones|mesh-ancestor
14950873|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950874|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13965573|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965574|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965575|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965576|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965577|NCT03130101|Insulin|insulin|mesh-list
14794735|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14794736|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
14794737|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14794738|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14794739|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14794740|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14794741|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14794742|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14794743|NCT00758199|Analgesics|analgesics|mesh-ancestor
14794744|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
13965578|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13965579|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965580|NCT03129646|Paromomycin|paromomycin|mesh-list
13965581|NCT03129646|Miltefosine|miltefosine|mesh-list
13965582|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14794745|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794746|NCT00758212|Vaccines|vaccines|mesh-list
14794747|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
14794748|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794749|NCT00758225|Idebenone|idebenone|mesh-list
14794750|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
14794751|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794752|NCT00758225|Protective Agents|protective agents|mesh-ancestor
13965583|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13965584|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965585|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13965586|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13965587|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
13965588|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965589|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
14794753|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794754|NCT00758277|Levetiracetam|levetiracetam|mesh-list
14794755|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
14794756|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
13965590|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13965591|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
13965592|NCT03129594|Glucagon|glucagon|mesh-list
13965593|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13965594|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965595|NCT03129594|Hormones|hormones|mesh-ancestor
13965596|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965597|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965598|NCT03129594|Incretins|incretins|mesh-ancestor
14794757|NCT00758368|Apomorphine|apomorphine|mesh-list
14794758|NCT00758368|Emetics|emetics|mesh-ancestor
14794759|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794760|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
14794761|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794762|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14794763|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
14794764|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
14794765|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794766|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950875|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950876|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950877|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950878|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14950879|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14950880|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14950881|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14950882|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
14950883|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
14950884|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950885|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
14950886|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14950887|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14950888|NCT01547169|Insulin|insulin|mesh-list
14950889|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14950890|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
14950891|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14950892|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965599|NCT03129867|Ticagrelor|ticagrelor|mesh-list
13965600|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13965601|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13965602|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14950893|NCT01547221|Clotrimazole|clotrimazole|mesh-list
14950894|NCT01547221|Miconazole|miconazole|mesh-list
14950895|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14950896|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950897|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
14950898|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14950899|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14950900|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950901|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950902|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14950903|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
14950904|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14950905|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950906|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14950907|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14950908|NCT01547260|Gemcitabine|gemcitabine|mesh-list
14950909|NCT01547260|Lenalidomide|lenalidomide|mesh-list
14950910|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14950911|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
14950912|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950913|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950914|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
14950915|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950916|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950917|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14950918|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
14950919|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950920|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14950921|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14950922|NCT01547260|Growth Substances|growth substances|mesh-ancestor
14950923|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
13965603|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14950924|NCT01547312|Interferons|interferons|mesh-list
14794767|NCT00758381|Sorafenib|sorafenib|mesh-list
14794768|NCT00758381|Cisplatin|cisplatin|mesh-list
14794769|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794770|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14794771|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794772|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794773|NCT00758407|Methylphenidate|methylphenidate|mesh-list
14794774|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14794775|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794776|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14794777|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794778|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794779|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794780|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
14794781|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794782|NCT00758433|Capsaicin|capsaicin|mesh-list
14794783|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
14794784|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
14794785|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
14794786|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794787|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794788|NCT00758693|Rituximab|rituximab|mesh-list
14794789|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14794790|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14794791|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794792|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
14794793|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794794|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794795|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14794796|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
14794797|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794798|NCT00758732|Carboplatin|carboplatin|mesh-list
14794799|NCT00758732|Docetaxel|docetaxel|mesh-list
14794800|NCT00758732|Doxorubicin|doxorubicin|mesh-list
14794801|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14794802|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794803|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
14794804|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
14794805|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
14950925|NCT01547312|Ribavirin|ribavirin|mesh-list
14794806|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794807|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14794808|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14794809|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794810|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794811|NCT00758914|Vitamin E|vitamin e|mesh-list
14794812|NCT00758914|Vitamins|vitamins|mesh-ancestor
14794813|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
14794814|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794815|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
14794816|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794817|NCT00758914|Protective Agents|protective agents|mesh-ancestor
14794818|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
14794819|NCT00759005|Propranolol|propranolol|mesh-list
14794820|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14794821|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14794822|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
14794823|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794824|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794825|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794826|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14794827|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14794828|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
14794829|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794830|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
14794831|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14794832|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
14794833|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794834|NCT00759070|Ritonavir|ritonavir|mesh-list
14794835|NCT00759070|Lopinavir|lopinavir|mesh-list
14794836|NCT00759070|Tenofovir|tenofovir|mesh-list
14794837|NCT00759070|Emtricitabine|emtricitabine|mesh-list
14794838|NCT00759070|Efavirenz|efavirenz|mesh-list
14794839|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14794840|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14794841|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
14794842|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794843|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794844|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14794845|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14794846|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
14794847|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794848|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14794849|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14794850|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14794851|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14794852|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14794853|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14794854|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14794855|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14794856|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14794857|NCT00759083|Bivalirudin|bivalirudin|mesh-list
14794858|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
14794859|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14794860|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
14794861|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794862|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794863|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
14794864|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14794865|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14794866|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794867|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794868|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794869|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794870|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794871|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14794872|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
14794873|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794874|NCT00759200|Interferons|interferons|mesh-list
14794875|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
14794876|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
14794877|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794878|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
14794879|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794880|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
14794881|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794882|NCT00759226|Leucovorin|leucovorin|mesh-list
14794883|NCT00759226|Folic Acid|folic acid|mesh-list
14950926|NCT01547312|Grazoprevir|grazoprevir|mesh-list
14950927|NCT01547312|Liver Extracts|liver extracts|mesh-list
14950928|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950929|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
14794884|NCT00759226|Gemcitabine|gemcitabine|mesh-list
14794885|NCT00759226|Cisplatin|cisplatin|mesh-list
14794886|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
14794887|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794888|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14794889|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
14794890|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794891|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
14794892|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14794893|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794894|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794895|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
14794896|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794897|NCT00759226|Antidotes|antidotes|mesh-ancestor
14794898|NCT00759226|Protective Agents|protective agents|mesh-ancestor
14794899|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
14794900|NCT00759226|Vitamins|vitamins|mesh-ancestor
14794901|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
14794902|NCT00759226|Hematinics|hematinics|mesh-ancestor
14794903|NCT00759239|Timolol|timolol|mesh-list
14794904|NCT00759239|Travoprost|travoprost|mesh-list
14794905|NCT00759239|Maleic acid|maleic acid|mesh-list
14794906|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14950930|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950931|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
14794907|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14794908|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
14794909|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794910|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794911|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950932|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950933|NCT01547312|Hematinics|hematinics|mesh-ancestor
14950934|NCT01547325|Doxycycline|doxycycline|mesh-list
14950935|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14950936|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14950937|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
14950938|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14950939|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14950940|NCT01547377|Zinc|zinc|mesh-list
14950941|NCT01547377|Selenium|selenium|mesh-list
14950942|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14950943|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14950944|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14950945|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
14950946|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950947|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14950948|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14794912|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14794913|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14794914|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794915|NCT00759291|Acipimox|acipimox|mesh-list
14794916|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14794917|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
14794918|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794919|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14794920|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14794921|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14794922|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14950949|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950950|NCT01547377|Trace Elements|trace elements|mesh-ancestor
14950951|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
14950952|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950953|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
14950954|NCT01547377|Protective Agents|protective agents|mesh-ancestor
14950955|NCT01547416|Fentanyl|fentanyl|mesh-list
14950956|NCT01547416|Ropivacaine|ropivacaine|mesh-list
14950957|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
14950958|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
14794923|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14950959|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794924|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794925|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794926|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794927|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14794928|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
14794929|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794930|NCT00759421|Olanzapine|olanzapine|mesh-list
14794931|NCT00759421|Sertindole|sertindole|mesh-list
14794932|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
14794933|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
14794934|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794935|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794936|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14794937|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14794938|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14794939|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950960|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794940|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14794941|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14794942|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794943|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794944|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794945|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794946|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
14794947|NCT00759460|Olanzapine|olanzapine|mesh-list
14794948|NCT00759460|Sertindole|sertindole|mesh-list
14950961|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
14950962|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950963|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14950964|NCT01547416|Narcotics|narcotics|mesh-ancestor
14950965|NCT01547416|Analgesics|analgesics|mesh-ancestor
14950966|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14950967|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14950968|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
14950969|NCT01547455|Atorvastatin|atorvastatin|mesh-list
14950970|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14950971|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14950972|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
14950973|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950974|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14950975|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14950976|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950977|NCT01547494|Vitamins|vitamins|mesh-list
14950978|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
14950979|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950980|NCT01547520|Meperidine|meperidine|mesh-list
14950981|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13965604|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
14950982|NCT01547520|Narcotics|narcotics|mesh-ancestor
14950983|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14950984|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14950985|NCT01547520|Analgesics|analgesics|mesh-ancestor
14950986|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
14950987|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14950988|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14950989|NCT01547546|GDC-0084|gdc-0084|mesh-list
14950990|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14950991|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14950992|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
14950993|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14950994|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14950995|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14950996|NCT01548001|Methotrexate|methotrexate|mesh-list
14950997|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14950998|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
14950999|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14951000|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951001|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14951002|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
14951003|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794949|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
14794950|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
14794951|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14794952|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794953|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951004|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951005|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
14951006|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951007|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14951008|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951009|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
14951010|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951011|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14951012|NCT01548027|Anesthetics|anesthetics|mesh-list
14951013|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
14794954|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14794955|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14794956|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14794957|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951014|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951015|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951016|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
14951017|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951018|NCT01548066|Valproic Acid|valproic acid|mesh-list
14951019|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
14951020|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951021|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951022|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
14951023|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951024|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951025|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
14951026|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14951027|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951028|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951029|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14951030|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14951031|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951032|NCT01548118|Vaccines|vaccines|mesh-list
14951033|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
14951034|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951035|NCT01548144|Pemetrexed|pemetrexed|mesh-list
14951036|NCT01548144|Crizotinib|crizotinib|mesh-list
14951037|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951038|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951039|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951040|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14951041|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14951042|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14951043|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14951044|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14951045|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14951046|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
14951047|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951048|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14951049|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14951050|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951051|NCT01548170|Ketoconazole|ketoconazole|mesh-list
14951052|NCT01548170|Sunitinib|sunitinib|mesh-list
14951053|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951054|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14951055|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14951056|NCT01548170|Growth Substances|growth substances|mesh-ancestor
14951057|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951058|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
14951059|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14951060|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951061|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951062|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
14951063|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951064|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14951065|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14951066|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14951067|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
14951068|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14794958|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14794959|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14794960|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14794961|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794962|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794963|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
14794964|NCT00759551|Olmesartan|olmesartan|mesh-list
14794965|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14794966|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14794967|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14794968|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14794969|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794970|NCT00759720|Glyburide|glyburide|mesh-list
14794971|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14794972|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794973|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14794974|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
14794975|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794976|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
14794977|NCT00759824|Doxorubicin|doxorubicin|mesh-list
14794978|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14794979|NCT00759824|Vindesine|vindesine|mesh-list
14794980|NCT00759824|Valproic Acid|valproic acid|mesh-list
14794981|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14794982|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
14794983|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14794984|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14794985|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14794986|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
14794987|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14794988|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14794989|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14794990|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14794991|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14794992|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14794993|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14794994|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
14794995|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
14794996|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14794997|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
14794998|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14794999|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795000|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14795001|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14795002|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795003|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795004|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795005|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14795006|NCT00759928|Sorafenib|sorafenib|mesh-list
14795007|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795008|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14795009|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795010|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795011|NCT00759993|Chromium|chromium|mesh-list
14795012|NCT00759993|Trace Elements|trace elements|mesh-ancestor
14795013|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
14795014|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795015|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
14795016|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14795017|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795018|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14795019|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14795020|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795021|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795022|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795023|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14795024|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14795025|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14795026|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
14795027|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14795028|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14795029|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
14795030|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795031|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
14795032|NCT00760045|Protective Agents|protective agents|mesh-ancestor
14795033|NCT00760149|Rifampin|rifampin|mesh-list
14795034|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14795035|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
14795036|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14795037|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795038|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
14795039|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14795040|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795041|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795042|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14795043|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14795044|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14795045|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14951069|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14951070|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
14795046|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14795047|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14795048|NCT00760175|Vaccines|vaccines|mesh-list
14795049|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
14795050|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795051|NCT00760279|Azithromycin|azithromycin|mesh-list
14795052|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14795053|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795054|NCT00760318|Levetiracetam|levetiracetam|mesh-list
14795055|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
14795056|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
14795057|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
14795058|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14795059|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795060|NCT00760448|Insulin|insulin|mesh-list
14795061|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14795062|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
14795063|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
14795064|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
14795065|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
14795066|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795067|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951071|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14951072|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951073|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951074|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951075|NCT01548209|Analgesics|analgesics|mesh-ancestor
14951076|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
14951077|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951078|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14951079|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14951080|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14951081|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14951082|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951083|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027276|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027277|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15034884|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034885|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
15034886|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
15034887|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034888|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034889|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034890|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
15034891|NCT01997840|Hormones|hormones|mesh-ancestor
15034892|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034893|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15034894|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034895|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
15034896|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034897|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034898|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
15034899|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15034900|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15034901|NCT01997840|Growth Substances|growth substances|mesh-ancestor
15034902|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
15034903|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15034904|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14795068|NCT00760695|Dronabinol|dronabinol|mesh-list
14795069|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
14795070|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795071|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14795072|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951084|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
13965605|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965606|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965607|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965608|NCT03129698|Apatinib|apatinib|mesh-list
13965609|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795073|NCT00760695|Analgesics|analgesics|mesh-ancestor
14795074|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
14795075|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795076|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14795077|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14795078|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795079|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795080|NCT00760695|Hormones|hormones|mesh-ancestor
14795081|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795082|NCT00760864|Methotrexate|methotrexate|mesh-list
14795083|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14795084|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
14795085|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14795086|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795087|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14795088|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
14795089|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795090|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795091|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
13965610|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965611|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965612|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795092|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795093|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14795094|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795095|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
14795096|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235286|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235287|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235288|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14235289|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
14235290|NCT00106002|Pemetrexed|pemetrexed|mesh-list
14795097|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14795098|NCT00760916|Treprostinil|treprostinil|mesh-list
14795099|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14795100|NCT00760968|Methotrexate|methotrexate|mesh-list
14795101|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14795102|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
14795103|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14795104|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795105|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14795106|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
14795107|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795108|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795109|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
14795110|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795111|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14795112|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795113|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
14795114|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951085|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
14235291|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235292|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235293|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235294|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14235295|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14951086|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14951087|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14951088|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951089|NCT01548248|Insulin|insulin|mesh-list
14951090|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14951091|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
14951092|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
14951093|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14951094|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951095|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
14951096|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14951097|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14951098|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795115|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14795116|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
14795117|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795118|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14795119|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795120|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795121|NCT00761020|Mefloquine|mefloquine|mesh-list
14951099|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14951100|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14951101|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
14951102|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951103|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951104|NCT01548326|Atorvastatin|atorvastatin|mesh-list
14951105|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14951106|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14951107|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
14951108|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951109|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14951110|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14951111|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951112|NCT01548482|Sirolimus|sirolimus|mesh-list
14951113|NCT01548482|Trebananib|trebananib|mesh-list
14951114|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14951115|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951116|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14951117|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951118|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
14951119|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951120|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
14795122|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
14795123|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14795124|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14795125|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795126|NCT00761228|Apomorphine|apomorphine|mesh-list
14795127|NCT00761228|Emetics|emetics|mesh-ancestor
14795128|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795129|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
14795130|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795131|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795132|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
14795133|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
14795134|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795135|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795136|NCT00761241|Gemcitabine|gemcitabine|mesh-list
14795137|NCT00761241|Interferons|interferons|mesh-list
14795138|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
14795139|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14795140|NCT00761241|Docetaxel|docetaxel|mesh-list
14795141|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
14795142|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14795143|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
14795144|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795145|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795146|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
14795147|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795148|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795149|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795150|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
14795151|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795152|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795153|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795154|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795155|NCT00761254|Domperidone|domperidone|mesh-list
14795156|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
14795157|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
14795158|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795159|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951121|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795160|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951122|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14795161|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14795162|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
14795163|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795164|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795165|NCT00761332|Teriparatide|teriparatide|mesh-list
14795166|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14795167|NCT00761332|Diphosphonates|diphosphonates|mesh-list
14795168|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14951123|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13965613|NCT03129347|Nalmefene|nalmefene|mesh-list
13965614|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13965615|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965616|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
13965617|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965618|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
13965619|NCT03129490|Apixaban|apixaban|mesh-list
14795169|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795170|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14795171|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14795172|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
14795173|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795174|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13965620|NCT03129490|Edoxaban|edoxaban|mesh-list
13965621|NCT03129490|Dabigatran|dabigatran|mesh-list
14951124|NCT01548482|Growth Substances|growth substances|mesh-ancestor
14951125|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
14951126|NCT01548521|Oxytocin|oxytocin|mesh-list
14951127|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
14951128|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14951129|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951130|NCT01548560|Dapivirine|dapivirine|mesh-list
14951131|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14795175|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14795176|NCT00761358|Z 338|z 338|mesh-list
14795177|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14795178|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795179|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795180|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
14795181|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795182|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795183|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795184|NCT00761449|Lenalidomide|lenalidomide|mesh-list
14795185|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
14795186|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795187|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14795188|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14795189|NCT00761449|Growth Substances|growth substances|mesh-ancestor
14795190|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
14795191|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795192|NCT00761501|Naproxen|naproxen|mesh-list
14795193|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14795194|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14795195|NCT00761501|Analgesics|analgesics|mesh-ancestor
14795196|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
14951132|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14951133|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
14951134|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951135|NCT01548612|Nitroprusside|nitroprusside|mesh-list
14951136|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951137|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951138|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14951139|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965622|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13965623|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
13965624|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14951140|NCT01548677|Trastuzumab|trastuzumab|mesh-list
14951141|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14951142|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951143|NCT01548703|BCI-838|bci-838|mesh-list
14951144|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14951145|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14951146|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965625|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
14795197|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795198|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951147|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795199|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795200|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14795201|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
14795202|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14795203|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795204|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795205|NCT00761540|Liraglutide|liraglutide|mesh-list
14795206|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795207|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795208|NCT00761540|Incretins|incretins|mesh-ancestor
14795209|NCT00761540|Hormones|hormones|mesh-ancestor
14795210|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795211|NCT00761644|Sirolimus|sirolimus|mesh-list
14795212|NCT00761644|Bevacizumab|bevacizumab|mesh-list
14795213|NCT00761644|Doxorubicin|doxorubicin|mesh-list
14795214|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14795215|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14795216|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795217|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14795218|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14795219|NCT00761644|Growth Substances|growth substances|mesh-ancestor
14795220|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795221|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
14795222|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14795223|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14795224|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14795225|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795226|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795227|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14795228|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795229|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
14795230|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795231|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
14795232|NCT00761670|Risperidone|risperidone|mesh-list
14795233|NCT00761670|Amisulpride|amisulpride|mesh-list
14795234|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14795235|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
14795236|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795237|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795238|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795239|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14795240|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14795241|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795242|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14795243|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14795244|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
14795245|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14795246|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
14795247|NCT00761722|Azacitidine|azacitidine|mesh-list
14795248|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14795249|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
14795250|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795251|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795252|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795253|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
14795254|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795255|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795256|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14795257|NCT00761904|Simvastatin|simvastatin|mesh-list
14795258|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14795259|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14795260|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
14795261|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795262|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14795263|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14795264|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795265|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14795266|NCT00761904|Diuretics|diuretics|mesh-ancestor
14795267|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
14795268|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795269|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14795270|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14795271|NCT00762060|Anesthetics|anesthetics|mesh-list
14795272|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
14795273|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795274|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795275|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
14795276|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795277|NCT00762099|Pregabalin|pregabalin|mesh-list
14795278|NCT00762099|Analgesics|analgesics|mesh-ancestor
14795279|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
14795280|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795281|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795282|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
14795283|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14795284|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14795285|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795286|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14795287|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14795288|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14795289|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795290|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14795291|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14795292|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795293|NCT00762190|Insulin|insulin|mesh-list
14795294|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14795295|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795296|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795297|NCT00762255|Bevacizumab|bevacizumab|mesh-list
14795298|NCT00762255|Irinotecan|irinotecan|mesh-list
14795299|NCT00762255|Vorinostat|vorinostat|mesh-list
14795300|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14795301|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795302|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14795303|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14795304|NCT00762255|Growth Substances|growth substances|mesh-ancestor
14795305|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795306|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
14795307|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14795308|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14795309|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795310|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795311|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14951148|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951149|NCT01548794|Lidocaine|lidocaine|mesh-list
14951150|NCT01548794|Bupivacaine|bupivacaine|mesh-list
14951151|NCT01548794|Anesthetics|anesthetics|mesh-list
14951152|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
14951153|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951154|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951155|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
14951156|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951157|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14951158|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14795312|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
14795313|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14795314|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795315|NCT00762567|Phenylephrine|phenylephrine|mesh-list
14795316|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
14795317|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
14795318|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14795319|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
14795320|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
14795321|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795322|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795323|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
14795324|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14795325|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
14795326|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14795327|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14795328|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14795329|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
14795330|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795331|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795332|NCT00762567|Protective Agents|protective agents|mesh-ancestor
14795333|NCT00762632|Everolimus|everolimus|mesh-list
14795334|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795335|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795336|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
14795337|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795338|NCT00762658|Betamethasone|betamethasone|mesh-list
14795339|NCT00762658|Tacrolimus|tacrolimus|mesh-list
14795340|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14795341|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795342|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
14795343|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795344|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14795345|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951159|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14951160|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14951161|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951162|NCT01548807|Everolimus|everolimus|mesh-list
14951163|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951164|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951165|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
14951166|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951167|NCT01548859|Midazolam|midazolam|mesh-list
14951168|NCT01548859|Sevoflurane|sevoflurane|mesh-list
14951169|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14951170|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14951171|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951172|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951173|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14951174|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14951175|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951176|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14951177|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
14951178|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
14951179|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
14951180|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
14951181|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795346|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795347|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795348|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
14951182|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795349|NCT00762658|Hormones|hormones|mesh-ancestor
14795350|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795351|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14795352|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
14795353|NCT00762671|Ebselen|ebselen|mesh-list
14795354|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14795355|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14795356|NCT00762671|Analgesics|analgesics|mesh-ancestor
14795357|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
14795358|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795359|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795360|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795361|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14795362|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14795363|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795364|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
14795365|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795366|NCT00762671|Protective Agents|protective agents|mesh-ancestor
14795367|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14795368|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795369|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14795370|NCT00762736|Pioglitazone|pioglitazone|mesh-list
14795371|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14795372|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795373|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795374|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14795375|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14795376|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795377|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
14795378|NCT00762749|Promethazine|promethazine|mesh-list
14951183|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14951184|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14951185|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
14795379|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14795380|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14795381|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951186|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14951187|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
14951188|NCT01548911|Calicheamicins|calicheamicins|mesh-list
14951189|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14951190|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951191|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14795382|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795383|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
14795384|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
14795385|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
14795386|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795387|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
14795388|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
14795389|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795390|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14795391|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
14795392|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
14951192|NCT01548924|Paclitaxel|paclitaxel|mesh-list
14795393|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795394|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795395|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14795396|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
14795397|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14795398|NCT00762775|Vitamin D|vitamin d|mesh-list
14795399|NCT00762775|Calcium|calcium|mesh-list
14795400|NCT00762775|Vitamins|vitamins|mesh-ancestor
14795401|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
14795402|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795403|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14795404|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14795405|NCT00762918|Vitamin D|vitamin d|mesh-list
14795406|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
14795407|NCT00762918|Vitamins|vitamins|mesh-ancestor
14795408|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
14795409|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795410|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14795411|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14795412|NCT00762944|Cimetidine|cimetidine|mesh-list
14795413|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14951193|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14951194|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951195|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
14951196|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
14951197|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
14951198|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965626|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965627|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965628|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
13968102|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968103|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
13968104|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968105|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968106|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
13968107|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13968108|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968109|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968110|NCT03112707|Aspirin|aspirin|mesh-list
13968111|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13968112|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13968113|NCT03112707|Analgesics|analgesics|mesh-ancestor
13968114|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
13968115|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968116|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795414|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795415|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14951199|NCT01548950|Bosentan|bosentan|mesh-list
14951200|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
14951201|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951202|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14951203|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14951204|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027278|NCT01948765|Propofol|propofol|mesh-list
14951205|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951206|NCT01548950|Urological Agents|urological agents|mesh-ancestor
14795416|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
14795417|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
14795418|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795419|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795420|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795421|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14951207|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951208|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14951209|NCT01549093|Gemcitabine|gemcitabine|mesh-list
14795422|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14795423|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795424|NCT00762957|Metformin|metformin|mesh-list
14795425|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795426|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795427|NCT00762983|Loratadine|loratadine|mesh-list
14795428|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
14795429|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
14795430|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14795431|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14795432|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14795433|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
14795434|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
14795435|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795436|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795437|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951210|NCT01549093|Carboplatin|carboplatin|mesh-list
14951211|NCT01549093|Endostar protein|endostar protein|mesh-list
14951212|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951213|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14951214|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
14951215|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951216|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
14951217|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951218|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951219|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951220|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
14951221|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951222|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14951223|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14951224|NCT01549093|Growth Substances|growth substances|mesh-ancestor
14951225|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
14951226|NCT01549158|Torsemide|torsemide|mesh-list
14951227|NCT01549158|Furosemide|furosemide|mesh-list
14951228|NCT01549158|Diuretics|diuretics|mesh-ancestor
14951229|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
14951230|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951231|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14951232|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14951233|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951234|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951235|NCT01549171|Iloprost|iloprost|mesh-list
14951236|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14951237|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951238|NCT01549236|Benzonidazole|benzonidazole|mesh-list
14951239|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951240|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
14951241|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951242|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14951243|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14951244|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14951245|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951246|NCT01549301|Lenograstim|lenograstim|mesh-list
14951247|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14951248|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
14951249|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951250|NCT01549418|Aspirin|aspirin|mesh-list
14951251|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14951252|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951253|NCT01549418|Analgesics|analgesics|mesh-ancestor
14951254|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
14951255|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951256|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795438|NCT00763165|Triclosan|triclosan|mesh-list
14795439|NCT00763165|Fluorides|fluorides|mesh-list
14795440|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
14795441|NCT00763165|Protective Agents|protective agents|mesh-ancestor
14795442|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795443|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14795444|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795445|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14795446|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14795447|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
14795448|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965629|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
13965630|NCT03129555|Apixaban|apixaban|mesh-list
13965631|NCT03129555|Edoxaban|edoxaban|mesh-list
13965632|NCT03129555|Dabigatran|dabigatran|mesh-list
13965633|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13965634|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
14795449|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14795450|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14795451|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14795452|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14795453|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14795454|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795455|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795456|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795457|NCT00763178|Analgesics|analgesics|mesh-ancestor
14795458|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
14795459|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795460|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
14795461|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14795462|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
14795463|NCT00763204|Betamethasone|betamethasone|mesh-list
14795464|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14795465|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795466|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
14951257|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795467|NCT00763204|Hormones|hormones|mesh-ancestor
14795468|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795469|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795470|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14795471|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
14795472|NCT00763347|Alogliptin|alogliptin|mesh-list
14795473|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795474|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795475|NCT00763347|Incretins|incretins|mesh-ancestor
14795476|NCT00763347|Hormones|hormones|mesh-ancestor
14795477|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795478|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14795479|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
14795480|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795481|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795482|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14795483|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14795484|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795485|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
14795486|NCT00763438|Sertindole|sertindole|mesh-list
14795487|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14795488|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14795489|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795490|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951258|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951259|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14951260|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14951261|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951262|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14951263|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14951264|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795491|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14795492|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14795493|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
14795494|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
13965635|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14795495|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965636|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
13965637|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795496|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14795497|NCT00763633|Vitamins|vitamins|mesh-list
14795498|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
14795499|NCT00763633|Pyridoxal|pyridoxal|mesh-list
14795500|NCT00763633|Pyridoxine|pyridoxine|mesh-list
14795501|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
14795502|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
14795503|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795504|NCT00763646|Docetaxel|docetaxel|mesh-list
14795505|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795506|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795507|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795508|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795509|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795510|NCT00763685|Etoricoxib|etoricoxib|mesh-list
14795511|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14795512|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14795513|NCT00763685|Analgesics|analgesics|mesh-ancestor
13965638|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965639|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
13965640|NCT03129542|Midodrine|midodrine|mesh-list
13965641|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
13965642|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
14951265|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
14951266|NCT01549431|Dexamethasone|dexamethasone|mesh-list
14951267|NCT01549431|Panobinostat|panobinostat|mesh-list
14951268|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14951269|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
14951270|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
14951271|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951272|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951273|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951274|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
14951275|NCT01549431|Hormones|hormones|mesh-ancestor
14951276|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965643|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965644|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965645|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13965646|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13965647|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13965648|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13965649|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
13965650|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965651|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795514|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
14795515|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795516|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795517|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795518|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951277|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14951278|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951279|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14951280|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951281|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951282|NCT01549496|Amlodipine|amlodipine|mesh-list
14951283|NCT01549496|Diltiazem|diltiazem|mesh-list
14951284|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951285|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14951286|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14951287|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951288|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14951289|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951290|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951291|NCT01549548|Ponatinib|ponatinib|mesh-list
14951292|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951293|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14951294|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951295|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951296|NCT01549574|Crizotinib|crizotinib|mesh-list
14951297|NCT01549574|Esomeprazole|esomeprazole|mesh-list
14795519|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14795520|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14795521|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795522|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965652|NCT03129256|Apatinib|apatinib|mesh-list
14951298|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13965653|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965654|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965655|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965656|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965657|NCT03129074|Capecitabine|capecitabine|mesh-list
13965658|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13965659|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
13965660|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965661|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965662|NCT03129022|Anesthetics|anesthetics|mesh-list
13965663|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965664|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965665|NCT03129009|Anesthetics|anesthetics|mesh-list
13965666|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965667|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965668|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
14795523|NCT00763763|Interferons|interferons|mesh-list
14951299|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951300|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14951301|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951302|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951303|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951304|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14951305|NCT01549600|Psyllium|psyllium|mesh-list
14795524|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14795525|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
14795526|NCT00763763|Dexamethasone|dexamethasone|mesh-list
14795527|NCT00763763|Vincristine|vincristine|mesh-list
14795528|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
14795529|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795530|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
14795531|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
14795532|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795533|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795534|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795535|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
14795536|NCT00763763|Hormones|hormones|mesh-ancestor
14795537|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795538|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14795539|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795540|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
14795541|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951306|NCT01549600|Cathartics|cathartics|mesh-ancestor
14795542|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14795543|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795544|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795545|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795546|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795547|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14795548|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795549|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
14795550|NCT00763789|Remifentanil|remifentanil|mesh-list
14795551|NCT00763789|Anesthetics|anesthetics|mesh-list
14795552|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795553|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795554|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14795555|NCT00763789|Narcotics|narcotics|mesh-ancestor
14795556|NCT00763789|Analgesics|analgesics|mesh-ancestor
14795557|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
14795558|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795559|NCT00763880|Lidocaine|lidocaine|mesh-list
14795560|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
14795561|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
14795562|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795563|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795564|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
14795565|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795566|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14795567|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14795568|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14795569|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14795570|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795571|NCT00763893|Losartan|losartan|mesh-list
14795572|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14795573|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14795574|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14795575|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14795576|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951307|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951308|NCT01549691|Alprazolam|alprazolam|mesh-list
14951309|NCT01549691|Zopiclone|zopiclone|mesh-list
14951310|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14951311|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951312|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951313|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14795577|NCT00763906|Norepinephrine|norepinephrine|mesh-list
14795578|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14795579|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14795580|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
14795581|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951314|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14951315|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951316|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
14795582|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795583|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795584|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
14795585|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
14795586|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795587|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14795588|NCT00763997|Acetaminophen|acetaminophen|mesh-list
14795589|NCT00763997|Dipyrone|dipyrone|mesh-list
14795590|NCT00763997|Ibuprofen|ibuprofen|mesh-list
14795591|NCT00763997|Parecoxib|parecoxib|mesh-list
14795592|NCT00763997|Valdecoxib|valdecoxib|mesh-list
14795593|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14795594|NCT00763997|Analgesics|analgesics|mesh-ancestor
14795595|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
14795596|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795597|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795598|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
14795599|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14795600|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795601|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14795602|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14795603|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795604|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795605|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14795606|NCT00764036|Artesunate|artesunate|mesh-list
14795607|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
14795608|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14795609|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14795610|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795611|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795612|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
14795613|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
14795614|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14795615|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
14795616|NCT00764062|Amoxicillin|amoxicillin|mesh-list
14795617|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14795618|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795619|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14795620|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795621|NCT00764140|Mitogens|mitogens|mesh-list
14795622|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795623|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795624|NCT00764166|Docetaxel|docetaxel|mesh-list
14795625|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14795626|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795627|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795628|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795629|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795630|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795631|NCT00764166|Hormones|hormones|mesh-ancestor
14951317|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
14951318|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795632|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795633|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795634|NCT00764244|Triamcinolone|triamcinolone|mesh-list
14795635|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14795636|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14795637|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14795638|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795639|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
14795640|NCT00764244|Hormones|hormones|mesh-ancestor
14795641|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795642|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795643|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795644|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
14795645|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795646|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795647|NCT00764374|Z 338|z 338|mesh-list
14951319|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951320|NCT01549704|Ropivacaine|ropivacaine|mesh-list
14951321|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
14951322|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
14951323|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951324|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951325|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
14795648|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14795649|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795650|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795651|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
14795652|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795653|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795654|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795655|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
14795656|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14795657|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14795658|NCT00764413|Prednisolone|prednisolone|mesh-list
14795659|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
14795660|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14795661|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
14795662|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795663|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
14795664|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
14795665|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795666|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795667|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795668|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
14795669|NCT00764413|Hormones|hormones|mesh-ancestor
14795670|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795671|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14795672|NCT00764413|Protective Agents|protective agents|mesh-ancestor
14795673|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14795674|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795675|NCT00764426|Ethanol|ethanol|mesh-list
14795676|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14795677|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795678|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795679|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795680|NCT00764439|Nicotine|nicotine|mesh-list
14795681|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14795682|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
14795683|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795684|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795685|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14795686|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14795687|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
14795688|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795689|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795690|NCT00764556|Insulin|insulin|mesh-list
14795691|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795692|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795693|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
14795694|NCT00764582|Levofloxacin|levofloxacin|mesh-list
14795695|NCT00764582|Ofloxacin|ofloxacin|mesh-list
14795696|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14795697|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14795698|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14795699|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795700|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14795701|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14795702|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795703|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795704|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795705|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14795706|NCT00764582|Renal Agents|renal agents|mesh-ancestor
14795707|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14795708|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14795709|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
14795710|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795711|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14795712|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795713|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795714|NCT00764712|Insulin|insulin|mesh-list
14795715|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14795716|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795717|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
14795718|NCT00764725|Methotrexate|methotrexate|mesh-list
14795719|NCT00764725|Infliximab|infliximab|mesh-list
14795720|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14795721|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
14795722|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14795723|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795724|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14795725|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
14795726|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795727|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795728|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
14795729|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795730|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14795731|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795732|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
14795733|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14795734|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14795735|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795736|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795737|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14795738|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14795739|NCT00764725|Analgesics|analgesics|mesh-ancestor
14795740|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
14795741|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795742|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795743|NCT00764816|Caseins|caseins|mesh-list
14795744|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
14795745|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
14795746|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795747|NCT00764855|Propofol|propofol|mesh-list
14795748|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14795749|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795750|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795751|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14795752|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
14795753|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
14795754|NCT00764907|Leucovorin|leucovorin|mesh-list
14795755|NCT00764907|Cytarabine|cytarabine|mesh-list
14795756|NCT00764907|Dexamethasone|dexamethasone|mesh-list
14795757|NCT00764907|Prednisone|prednisone|mesh-list
14795758|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
14951326|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795759|NCT00764907|Ifosfamide|ifosfamide|mesh-list
14795760|NCT00764907|Doxorubicin|doxorubicin|mesh-list
14795761|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14795762|NCT00764907|Methotrexate|methotrexate|mesh-list
14795763|NCT00764907|Etoposide|etoposide|mesh-list
14795764|NCT00764907|Vincristine|vincristine|mesh-list
14795765|NCT00764907|Daunorubicin|daunorubicin|mesh-list
14795766|NCT00764907|Asparaginase|asparaginase|mesh-list
14795767|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
14795768|NCT00764907|Thioguanine|thioguanine|mesh-list
14795769|NCT00764907|Vindesine|vindesine|mesh-list
14795770|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
14951327|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14795771|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14795772|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
14795773|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795774|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14795775|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14795776|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
14795777|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795778|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795779|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14795780|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14795781|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
14795782|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
14795783|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795784|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795785|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
14795786|NCT00764907|Hormones|hormones|mesh-ancestor
14795787|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14795788|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14795789|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14795790|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14795791|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14795792|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795793|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14795794|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
14795795|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14795796|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14795797|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
14795798|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
14795799|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14795800|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14795801|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14795802|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
14795803|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795804|NCT00764907|Antidotes|antidotes|mesh-ancestor
14795805|NCT00764907|Protective Agents|protective agents|mesh-ancestor
14795806|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
14795807|NCT00764907|Vitamins|vitamins|mesh-ancestor
14795808|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
14795809|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795810|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795811|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
14951328|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14951329|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951330|NCT01549743|Celecoxib|celecoxib|mesh-list
14951331|NCT01549743|Rebamipide|rebamipide|mesh-list
14951332|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14951333|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951334|NCT01549743|Analgesics|analgesics|mesh-ancestor
14951335|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
14951336|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951337|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951338|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14951339|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951340|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14951341|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14951342|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951343|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951344|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14951345|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951346|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
14951347|NCT01549743|Protective Agents|protective agents|mesh-ancestor
14951348|NCT01549795|Capecitabine|capecitabine|mesh-list
14951349|NCT01549795|Liver Extracts|liver extracts|mesh-list
14951350|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14951351|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
14951352|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951353|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951354|NCT01549795|Hematinics|hematinics|mesh-ancestor
14951355|NCT01549847|Piracetam|piracetam|mesh-list
14951356|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14951357|NCT01549847|Protective Agents|protective agents|mesh-ancestor
14951358|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951359|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
15027279|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15027280|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027281|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027282|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15027283|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
15027284|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
14795812|NCT00764972|Sorafenib|sorafenib|mesh-list
14795813|NCT00764972|Vinorelbine|vinorelbine|mesh-list
14795814|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795815|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14795816|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795817|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795818|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14795819|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795820|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795821|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795822|NCT00765011|Cetuximab|cetuximab|mesh-list
14795823|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14795824|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795825|NCT00765024|Ivermectin|ivermectin|mesh-list
14795826|NCT00765024|Albendazole|albendazole|mesh-list
14795827|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14795828|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795829|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
14795830|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
14795831|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14795832|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14795833|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795834|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795835|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795836|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795837|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795838|NCT00765154|Ritonavir|ritonavir|mesh-list
14795839|NCT00765154|Darunavir|darunavir|mesh-list
14795840|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14795841|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14795842|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14795843|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795844|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795845|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14795846|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14795847|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
14795848|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795849|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14795850|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14795851|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
14795852|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14795853|NCT00765167|Triclosan|triclosan|mesh-list
14951360|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
14951361|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14951362|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951363|NCT01549938|Vitamins|vitamins|mesh-ancestor
14951364|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
14951365|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14951366|NCT01549990|Sevoflurane|sevoflurane|mesh-list
14951367|NCT01549990|Desflurane|desflurane|mesh-list
14951368|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14951369|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14951370|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
14951371|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
14951372|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951373|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951374|NCT01550055|Irinotecan|irinotecan|mesh-list
14951375|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14951376|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14951377|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951378|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951379|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951380|NCT01550107|Allopurinol|allopurinol|mesh-list
14951381|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
14951382|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951383|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951384|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
14951385|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951386|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14951387|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
14951388|NCT01550107|Protective Agents|protective agents|mesh-ancestor
14951389|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951390|NCT01550146|Dexamethasone|dexamethasone|mesh-list
14951391|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
14795854|NCT00765167|Fluorides|fluorides|mesh-list
14795855|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
14795856|NCT00765167|Protective Agents|protective agents|mesh-ancestor
14951392|NCT01550146|BB 1101|bb 1101|mesh-list
14795857|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795858|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14795859|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795860|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
14795861|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
14795862|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14795863|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14795864|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
14795865|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795866|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14795867|NCT00765271|Ritonavir|ritonavir|mesh-list
14795868|NCT00765271|Darunavir|darunavir|mesh-list
14795869|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
14795870|NCT00765271|Abacavir|abacavir|mesh-list
14795871|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14795872|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14795873|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
14795874|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795875|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795876|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14795877|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14795878|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
14795879|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795880|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14795881|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14795882|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14795883|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14795884|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14795885|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14795886|NCT00765427|Retinol acetate|retinol acetate|mesh-list
14795887|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14795888|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
14795889|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795890|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14795891|NCT00765427|Protective Agents|protective agents|mesh-ancestor
14795892|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795893|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14795894|NCT00765557|Laxatives|laxatives|mesh-ancestor
14795895|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14795896|NCT00765921|Ranibizumab|ranibizumab|mesh-list
14795897|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14795898|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14795899|NCT00765921|Growth Substances|growth substances|mesh-ancestor
14795900|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795901|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
14795902|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795903|NCT00765934|Lidocaine|lidocaine|mesh-list
14795904|NCT00765934|Tetracaine|tetracaine|mesh-list
14795905|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
14795906|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
14795907|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795908|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795909|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
14795910|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795911|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14795912|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14795913|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14951393|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14951394|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
14951395|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
14795914|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14795915|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795916|NCT00765973|Topotecan|topotecan|mesh-list
14795917|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14795918|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14795919|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795920|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795921|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795922|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14795923|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14795924|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14795925|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951396|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795926|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14795927|NCT00766025|Calcium|calcium|mesh-list
14795928|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14795929|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795930|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14795931|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14795932|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
14795933|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795934|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14795935|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14795936|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795937|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14795938|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14795939|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14795940|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795941|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795942|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14795943|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14795944|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14795945|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
14795946|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14795947|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795948|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14795949|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14795950|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
14795951|NCT00766155|Capecitabine|capecitabine|mesh-list
14795952|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
14795953|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14795954|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
14795955|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795956|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795957|NCT00766181|Lidocaine|lidocaine|mesh-list
14795958|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
14795959|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
14795960|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14795961|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795962|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
14795963|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14795964|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14795965|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14795966|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14795967|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14795968|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795969|NCT00766220|Irinotecan|irinotecan|mesh-list
14795970|NCT00766220|Cetuximab|cetuximab|mesh-list
14795971|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14795972|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14795973|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14795974|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795975|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795976|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14795977|NCT00766246|Bevacizumab|bevacizumab|mesh-list
14795978|NCT00766246|Carboplatin|carboplatin|mesh-list
14795979|NCT00766246|Docetaxel|docetaxel|mesh-list
14795980|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14795981|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14795982|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14795983|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14795984|NCT00766246|Growth Substances|growth substances|mesh-ancestor
14795985|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795986|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
14795987|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
14795988|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
14795989|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
14795990|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14795991|NCT00766285|Vaccines|vaccines|mesh-list
14795992|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
14795993|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14795994|NCT00766337|Sirolimus|sirolimus|mesh-list
14795995|NCT00766337|Ranibizumab|ranibizumab|mesh-list
14795996|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14795997|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14795998|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14795999|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796000|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
14796001|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796002|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
14796003|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796004|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14796005|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14796006|NCT00766337|Growth Substances|growth substances|mesh-ancestor
14796007|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796008|NCT00766350|Amitriptyline|amitriptyline|mesh-list
14796009|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14796010|NCT00766350|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14796011|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
14796012|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14796013|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14796014|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14796015|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796016|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796017|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14796018|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14796019|NCT00766350|Analgesics|analgesics|mesh-ancestor
14796020|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
14796021|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796022|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14796023|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14796024|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796025|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796026|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
14796027|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796028|NCT00766402|Acetaminophen|acetaminophen|mesh-list
14796029|NCT00766402|Diclofenac|diclofenac|mesh-list
14796030|NCT00766402|Tramadol|tramadol|mesh-list
14796031|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14796032|NCT00766402|Analgesics|analgesics|mesh-ancestor
14796033|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
14796034|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796035|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796036|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
14796037|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14796038|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14796039|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14796040|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14796041|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796042|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796043|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14796044|NCT00766402|Narcotics|narcotics|mesh-ancestor
14796045|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796046|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14796047|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796048|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796049|NCT00766441|Incretins|incretins|mesh-ancestor
14796050|NCT00766441|Hormones|hormones|mesh-ancestor
14796051|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796052|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14796053|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796054|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796055|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796056|NCT00766480|Fluorouracil|fluorouracil|mesh-list
14796057|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796058|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
14796059|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796060|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14796061|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796062|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
14796063|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796064|NCT00766545|Cilostazol|cilostazol|mesh-list
14796065|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14796066|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
14796067|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796068|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796069|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14796070|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
14796071|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14796072|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14796073|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796074|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14796075|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796076|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14796077|NCT00766545|Protective Agents|protective agents|mesh-ancestor
14796078|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14796079|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14796080|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796081|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
14796082|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
14796083|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14796084|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
14796085|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14796086|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14796087|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796088|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14796089|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796090|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796091|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14796092|NCT00766662|Renal Agents|renal agents|mesh-ancestor
14796093|NCT00766805|Propranolol|propranolol|mesh-list
14796094|NCT00766805|Isosorbide|isosorbide|mesh-list
14796095|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14796096|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14796097|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14796098|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14796099|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
14796100|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796101|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796102|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796103|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14796104|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14796105|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796106|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14796107|NCT00766805|Diuretics|diuretics|mesh-ancestor
14796108|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
14796109|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14796110|NCT00766818|Lopinavir|lopinavir|mesh-list
14796111|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14796112|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14796113|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796114|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796115|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796116|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14796117|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14796118|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
14796119|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796120|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14951397|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951398|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951399|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
14951400|NCT01550146|Hormones|hormones|mesh-ancestor
14951401|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951402|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14796121|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14796122|NCT00766857|Insulin|insulin|mesh-list
14796123|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14796124|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
14796125|NCT00766857|Exenatide|exenatide|mesh-list
14796126|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796127|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796128|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14796129|NCT00766857|Incretins|incretins|mesh-ancestor
14951403|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951404|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
14951405|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951406|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796130|NCT00766857|Hormones|hormones|mesh-ancestor
14796131|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796132|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14796133|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14796134|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14951407|NCT01550302|Bupivacaine|bupivacaine|mesh-list
14951408|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
14951409|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
14951410|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796135|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796136|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796137|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796138|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796139|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14796140|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
14796141|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951411|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951412|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
14951413|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951414|NCT01550354|Alfentanil|alfentanil|mesh-list
14951415|NCT01550354|Propofol|propofol|mesh-list
14951416|NCT01550354|Rocuronium|rocuronium|mesh-list
14951417|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14951418|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951419|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951420|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14951421|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
14951422|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
14951423|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14951424|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14951425|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14951426|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796142|NCT00766896|Aspirin|aspirin|mesh-list
14796143|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14796144|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14796145|NCT00766896|Analgesics|analgesics|mesh-ancestor
14796146|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
14796147|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796148|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796149|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14796150|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14796151|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14796152|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14796153|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796154|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14796155|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14796156|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796157|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
14796158|NCT00766909|Cyclosporine|cyclosporine|mesh-list
14796159|NCT00766909|Tacrolimus|tacrolimus|mesh-list
14796160|NCT00766909|Cyclosporins|cyclosporins|mesh-list
14796161|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796162|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
14796163|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796164|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14796165|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951427|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14951428|NCT01550354|Narcotics|narcotics|mesh-ancestor
14951429|NCT01550354|Analgesics|analgesics|mesh-ancestor
14951430|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
14796166|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796167|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
14796168|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796169|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
14951431|NCT01550419|Atorvastatin|atorvastatin|mesh-list
14951432|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14951433|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14796170|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951434|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
14951435|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951436|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14951437|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14951438|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951439|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
14951440|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14951441|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
14951442|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951443|NCT01550432|Expectorants|expectorants|mesh-ancestor
14951444|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
14951445|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14951446|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
14951447|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951448|NCT01550432|Protective Agents|protective agents|mesh-ancestor
14951449|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951450|NCT01550432|Antidotes|antidotes|mesh-ancestor
14951451|NCT01550445|Prednisolone|prednisolone|mesh-list
14951452|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14951453|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
14951454|NCT01550445|Hormones|hormones|mesh-ancestor
14951455|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951456|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951457|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14951458|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951459|NCT01550458|Mibefradil|mibefradil|mesh-list
14951460|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951461|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14951462|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14951463|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951464|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14951465|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951466|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951467|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14951468|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14951469|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951470|NCT01550640|Remifentanil|remifentanil|mesh-list
14951471|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14951472|NCT01550640|Narcotics|narcotics|mesh-ancestor
14951473|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951474|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951475|NCT01550640|Analgesics|analgesics|mesh-ancestor
14951476|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
14951477|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951478|NCT01550653|Liraglutide|liraglutide|mesh-list
14951479|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14951480|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951481|NCT01550653|Incretins|incretins|mesh-ancestor
13965669|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13965670|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13965671|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965672|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
13965673|NCT03128866|Coagulants|coagulants|mesh-ancestor
13965674|NCT03128736|Esomeprazole|esomeprazole|mesh-list
13965675|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
13965676|NCT03128736|Lansoprazole|lansoprazole|mesh-list
13965677|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14522746|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522747|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14522748|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14522749|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522750|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522751|NCT03553940|Vaccines|vaccines|mesh-list
14522752|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
14522753|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522754|NCT03554005|Acetaminophen|acetaminophen|mesh-list
14522755|NCT03554005|Interferons|interferons|mesh-list
14522756|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
14522757|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
14522758|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14522759|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522760|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
14522761|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951482|NCT01550653|Hormones|hormones|mesh-ancestor
14951483|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951484|NCT01550770|Propofol|propofol|mesh-list
14951485|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14951486|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951487|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951488|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14951489|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
14951490|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
14951491|NCT01550848|Gemcitabine|gemcitabine|mesh-list
14951492|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14951493|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14951494|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
14951495|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951496|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951497|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
14951498|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951499|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951500|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951501|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
14951502|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951503|NCT01550900|Metformin|metformin|mesh-list
14951504|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796171|NCT00767091|Rivastigmine|rivastigmine|mesh-list
14796172|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
14796173|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796174|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796175|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
14796176|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796177|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796178|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14796179|NCT00767091|Protective Agents|protective agents|mesh-ancestor
14796180|NCT00767117|Ritonavir|ritonavir|mesh-list
14796181|NCT00767117|Lopinavir|lopinavir|mesh-list
14796182|NCT00767117|Etravirine|etravirine|mesh-list
14796183|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14796184|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14796185|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796186|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796187|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951505|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796188|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14796189|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14796190|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
14796191|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796192|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14796193|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14796194|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14796195|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14796196|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
14796197|NCT00767169|Pamidronate|pamidronate|mesh-list
14796198|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14796199|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796200|NCT00767221|Budesonide|budesonide|mesh-list
14796201|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14796202|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14796203|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
14951506|NCT01550926|Orlistat|orlistat|mesh-list
14522762|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522763|NCT03554005|Analgesics|analgesics|mesh-ancestor
14796204|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796205|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796206|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14796207|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
14796208|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
14796209|NCT00767221|Hormones|hormones|mesh-ancestor
14796210|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796211|NCT00767260|Insulin|insulin|mesh-list
14522764|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
14522765|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522766|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522767|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
14522768|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
14522769|NCT03554018|Acetaminophen|acetaminophen|mesh-list
14522770|NCT03554018|Ibuprofen|ibuprofen|mesh-list
14796212|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796213|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796214|NCT00767286|Cobalt|cobalt|mesh-list
14796215|NCT00767286|Goserelin|goserelin|mesh-list
14951507|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951508|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951509|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14951510|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14951511|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
14951512|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
14951513|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14951514|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14951515|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951516|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951517|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796216|NCT00767286|Flutamide|flutamide|mesh-list
14796217|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14796218|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796219|NCT00767286|Trace Elements|trace elements|mesh-ancestor
14796220|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
14796221|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796222|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
14796223|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
14796224|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796225|NCT00767468|Sorafenib|sorafenib|mesh-list
14796226|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796227|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14796228|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796229|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796230|NCT00767481|Travoprost|travoprost|mesh-list
14796231|NCT00767481|Brinzolamide|brinzolamide|mesh-list
14796232|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14796233|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14796234|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796235|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796236|NCT00767494|Travoprost|travoprost|mesh-list
14796237|NCT00767494|Brinzolamide|brinzolamide|mesh-list
14951518|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951519|NCT01551147|Montelukast|montelukast|mesh-list
14951520|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14951521|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
14796238|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14796239|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14796240|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796241|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796242|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
14796243|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14951522|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14951523|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
14951524|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951525|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951526|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14951527|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14951528|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951529|NCT01551225|Citalopram|citalopram|mesh-list
14951530|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14951531|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14951532|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14951533|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965678|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965679|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13965680|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965681|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965682|NCT03128879|Venetoclax|venetoclax|mesh-list
14796244|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796245|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796246|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
13965683|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796247|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796248|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796249|NCT00767559|PENTA|penta|mesh-list
14796250|NCT00767559|Warfarin|warfarin|mesh-list
14796251|NCT00767559|Fondaparinux|fondaparinux|mesh-list
14796252|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
14796253|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14796254|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
14796255|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14796256|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796257|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796258|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796259|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14796260|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14796261|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
14951534|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951535|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
14951536|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796262|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14796263|NCT00767598|Udenafil|udenafil|mesh-list
14796264|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14796265|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796266|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14951537|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14951538|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
14951539|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951540|NCT01551290|Infliximab|infliximab|mesh-list
14951541|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
14951542|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951543|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951544|NCT01551329|Ketamine|ketamine|mesh-list
14951545|NCT01551329|Analgesics|analgesics|mesh-ancestor
14951546|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
14951547|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951548|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951549|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14951550|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14951551|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
14951552|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
14951553|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951554|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14951555|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14951556|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951557|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951558|NCT01551368|Nimodipine|nimodipine|mesh-list
14951559|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951560|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14951561|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14951562|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951563|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14951564|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951565|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951566|NCT01551394|Gentamicins|gentamicins|mesh-list
14951567|NCT01551394|Meropenem|meropenem|mesh-list
14951568|NCT01551394|Ampicillin|ampicillin|mesh-list
14951569|NCT01551394|Cefotaxime|cefotaxime|mesh-list
14951570|NCT01551394|Cefoxitin|cefoxitin|mesh-list
14951571|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14951572|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951573|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14951574|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951575|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951576|NCT01551459|Sunitinib|sunitinib|mesh-list
14951577|NCT01551459|Dacarbazine|dacarbazine|mesh-list
14951578|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951579|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14951580|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14951581|NCT01551459|Growth Substances|growth substances|mesh-ancestor
14951582|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951583|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796267|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796268|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796269|NCT00767598|Urological Agents|urological agents|mesh-ancestor
14796270|NCT00767663|Dipyridamole|dipyridamole|mesh-list
14796271|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14796272|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796273|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796274|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14796275|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796276|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
14796277|NCT00767689|Pyridoxal|pyridoxal|mesh-list
14796278|NCT00767689|Pyridoxine|pyridoxine|mesh-list
14796279|NCT00767689|Vitamins|vitamins|mesh-ancestor
14796280|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
14796281|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796282|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
14796283|NCT00767715|Haloperidol|haloperidol|mesh-list
14796284|NCT00767715|Olanzapine|olanzapine|mesh-list
14796285|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
14796286|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
14796287|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
14796288|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796289|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796290|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14796291|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14796292|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14796293|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796294|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14796295|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14796296|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14796297|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796298|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796299|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951584|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14951585|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951586|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951587|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14951588|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
14951589|NCT01551485|Zolpidem|zolpidem|mesh-list
14951590|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14951591|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14951592|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951593|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951594|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14951595|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
14951596|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
14951597|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951598|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951599|NCT01551511|Dronabinol|dronabinol|mesh-list
14951600|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
14951601|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951602|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951603|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951604|NCT01551511|Analgesics|analgesics|mesh-ancestor
14951605|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
14796300|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
14796301|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14796302|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
14951606|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951607|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14951608|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14951609|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951610|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951611|NCT01551511|Hormones|hormones|mesh-ancestor
14951612|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951613|NCT01551589|Docetaxel|docetaxel|mesh-list
14796303|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14796304|NCT00767728|Mesalamine|mesalamine|mesh-list
14796305|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14796306|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14796307|NCT00767728|Analgesics|analgesics|mesh-ancestor
14796308|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
14951614|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951615|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
14951616|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
14796309|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951617|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
14951618|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796310|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796311|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14796312|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14796313|NCT00767754|Paroxetine|paroxetine|mesh-list
14796314|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14796315|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14796316|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796317|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796318|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796319|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
14796320|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796321|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14796322|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
14796323|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14796324|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14796325|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14796326|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796327|NCT00767871|Citalopram|citalopram|mesh-list
14951619|NCT01551615|Metformin|metformin|mesh-list
14951620|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14951621|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951622|NCT01551628|BCT-100|bct-100|mesh-list
14951623|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951624|NCT01551641|Thalidomide|thalidomide|mesh-list
14951625|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951626|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
13965684|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
13965685|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965686|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
13965687|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965688|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965689|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13965690|NCT03128528|Empagliflozin|empagliflozin|mesh-list
13965691|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13965692|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965693|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13965694|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951627|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951628|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
14951629|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14951630|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951631|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14951632|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14951633|NCT01551641|Growth Substances|growth substances|mesh-ancestor
13965695|NCT03128242|Oxytocin|oxytocin|mesh-list
13965696|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
13965697|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13965698|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965699|NCT03128216|Bupivacaine|bupivacaine|mesh-list
14951634|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
14951635|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951636|NCT01551667|Antibodies|antibodies|mesh-list
14951637|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
14951638|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951639|NCT01551680|Iniparib|iniparib|mesh-list
14951640|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14951641|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951642|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951643|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951644|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14951645|NCT01551719|Vancomycin|vancomycin|mesh-list
14951646|NCT01551719|Linezolid|linezolid|mesh-list
14951647|NCT01551719|Daptomycin|daptomycin|mesh-list
14951648|NCT01551719|Penicillins|penicillins|mesh-list
14951649|NCT01551719|Tigecycline|tigecycline|mesh-list
14951650|NCT01551719|Cephalosporins|cephalosporins|mesh-list
14951651|NCT01551719|Teicoplanin|teicoplanin|mesh-list
14796328|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14796329|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14796330|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796331|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796332|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796333|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
14796334|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796335|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14951652|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951653|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14951654|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951655|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027285|NCT01948804|Letrozole|letrozole|mesh-list
15027286|NCT01948804|Clomiphene|clomiphene|mesh-list
15027287|NCT01948804|Cetrorelix|cetrorelix|mesh-list
15027288|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15027289|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027290|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15027291|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15027292|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027293|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027294|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15027295|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
15027296|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965700|NCT03128216|Ropivacaine|ropivacaine|mesh-list
15027297|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027298|NCT01948804|Hormones|hormones|mesh-ancestor
14796336|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
14796337|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14796338|NCT00767975|Rifampin|rifampin|mesh-list
14796339|NCT00767975|Isoniazid|isoniazid|mesh-list
14796340|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14796341|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
14796342|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796343|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796344|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
14796345|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14951656|NCT01551797|Acetaminophen|acetaminophen|mesh-list
14951657|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951658|NCT01551797|Analgesics|analgesics|mesh-ancestor
14951659|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
14951660|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951661|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951662|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
14951663|NCT01551810|Vaccines|vaccines|mesh-list
14951664|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
14951665|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951666|NCT01551823|Vaccines|vaccines|mesh-list
13965701|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
13965702|NCT03128216|Anesthetics|anesthetics|mesh-list
13965703|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965704|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965705|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
13965706|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965707|NCT03128398|Domperidone|domperidone|mesh-list
13965708|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
13965709|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
13965710|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965711|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965712|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951667|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
14951668|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951669|NCT01551836|Acetaminophen|acetaminophen|mesh-list
14796346|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796347|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796348|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14796349|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14796350|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14951670|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951671|NCT01551836|Analgesics|analgesics|mesh-ancestor
14951672|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
14951673|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951674|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796351|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14796352|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14796353|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14796354|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14796355|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14796356|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
14951675|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
14951676|NCT01552005|Saxagliptin|saxagliptin|mesh-list
14951677|NCT01552005|Incretins|incretins|mesh-ancestor
14951678|NCT01552005|Hormones|hormones|mesh-ancestor
14951679|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951680|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951681|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13965713|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13965714|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
13965715|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965716|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965717|NCT03128346|Aspirin|aspirin|mesh-list
13965718|NCT03128346|Acetaminophen|acetaminophen|mesh-list
13965719|NCT03128346|Fentanyl|fentanyl|mesh-list
13965720|NCT03128346|Hydromorphone|hydromorphone|mesh-list
13965721|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965722|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965723|NCT03128346|Analgesics|analgesics|mesh-ancestor
13965724|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
13965725|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796357|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14796358|NCT00768131|Paclitaxel|paclitaxel|mesh-list
13965726|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951682|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796359|NCT00768131|Carboplatin|carboplatin|mesh-list
14796360|NCT00768131|Cetuximab|cetuximab|mesh-list
13965727|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965728|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965729|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13965730|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13965731|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965732|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13965733|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13965734|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951683|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951684|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951685|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14951686|NCT01552018|Saxagliptin|saxagliptin|mesh-list
14951687|NCT01552018|Incretins|incretins|mesh-ancestor
13965735|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
13965736|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13965737|NCT03128346|Narcotics|narcotics|mesh-ancestor
13965738|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965739|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13965740|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13965741|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
13965742|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
14796361|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14796362|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796363|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
13965743|NCT03128203|Oxytocin|oxytocin|mesh-list
14796364|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
14796365|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
14796366|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796367|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14796368|NCT00768157|Lamivudine|lamivudine|mesh-list
14796369|NCT00768157|Entecavir|entecavir|mesh-list
14796370|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
14796371|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14951688|NCT01552018|Hormones|hormones|mesh-ancestor
14951689|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951690|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951691|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14951692|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
14951693|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951694|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951695|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14951696|NCT01552044|Spironolactone|spironolactone|mesh-list
14796372|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14796373|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796374|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796375|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796376|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14796377|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14796378|NCT00768183|Ethanol|ethanol|mesh-list
14796379|NCT00768183|Morphine|morphine|mesh-list
14796380|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14796381|NCT00768183|Narcotics|narcotics|mesh-ancestor
14796382|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796383|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796384|NCT00768183|Analgesics|analgesics|mesh-ancestor
14796385|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
14796386|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796387|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14796388|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796389|NCT00768209|Topiramate|topiramate|mesh-list
14796390|NCT00768209|Phentermine|phentermine|mesh-list
14796391|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
14951697|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14951698|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
13965744|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
14796392|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796393|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796394|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14951699|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951700|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951701|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14951702|NCT01552044|Diuretics|diuretics|mesh-ancestor
14951703|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
14951704|NCT01552122|Vitamin D|vitamin d|mesh-list
14951705|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
14951706|NCT01552122|Alendronate|alendronate|mesh-list
14951707|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
14951708|NCT01552122|Calcium|calcium|mesh-list
14951709|NCT01552122|Vitamins|vitamins|mesh-ancestor
14951710|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
14951711|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951712|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14951713|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14951714|NCT01552122|Antacids|antacids|mesh-ancestor
14951715|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951716|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965745|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14951717|NCT01552148|Morphine|morphine|mesh-list
14951718|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14951719|NCT01552148|Narcotics|narcotics|mesh-ancestor
14951720|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951721|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951722|NCT01552148|Analgesics|analgesics|mesh-ancestor
14951723|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
14951724|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951725|NCT01552187|Colchicine|colchicine|mesh-list
14951726|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
14951727|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951728|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
14951729|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
13965746|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965747|NCT03127800|Morphine|morphine|mesh-list
13965748|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13965749|NCT03127800|Narcotics|narcotics|mesh-ancestor
14951730|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
14951731|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951732|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951733|NCT01552330|Artesunate|artesunate|mesh-list
14951734|NCT01552330|Primaquine|primaquine|mesh-list
14951735|NCT01552330|Pyronaridine|pyronaridine|mesh-list
14951736|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
13965750|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965751|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965752|NCT03127800|Analgesics|analgesics|mesh-ancestor
13965753|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
13965754|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965755|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
13965756|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13965757|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965758|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13968117|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13968118|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13968119|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13968120|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13968121|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796395|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
14951737|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14951738|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14951739|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951740|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951741|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
14951742|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
14951743|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14796396|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14796397|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
14796398|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
14796399|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796400|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14951744|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
14951745|NCT01552629|Cyclosporine|cyclosporine|mesh-list
14951746|NCT01552629|Cyclosporins|cyclosporins|mesh-list
14951747|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951748|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951749|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951750|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
14951751|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951752|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
14951753|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951754|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14951755|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951756|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14951757|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
14951758|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14951759|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951760|NCT01552798|Aspirin|aspirin|mesh-list
14951761|NCT01552798|Acetaminophen|acetaminophen|mesh-list
14951762|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14951763|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951764|NCT01552798|Analgesics|analgesics|mesh-ancestor
14951765|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
14951766|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951767|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951768|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14951769|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951770|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14951771|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14951772|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951773|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14951774|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14951775|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951776|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
14951777|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14951778|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
14951779|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951780|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14951781|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14951782|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951783|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951784|NCT01552850|Oxycodone|oxycodone|mesh-list
14951785|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14951786|NCT01552850|Narcotics|narcotics|mesh-ancestor
14951787|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951788|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951789|NCT01552850|Analgesics|analgesics|mesh-ancestor
14951790|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
14951791|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951792|NCT01552863|Oxycodone|oxycodone|mesh-list
14951793|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14951794|NCT01552863|Narcotics|narcotics|mesh-ancestor
14951795|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14951796|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951797|NCT01552863|Analgesics|analgesics|mesh-ancestor
14951798|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
14951799|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951800|NCT01552967|Capecitabine|capecitabine|mesh-list
14951801|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14951802|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
14951803|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951804|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951805|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
14951806|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522771|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522772|NCT03554018|Analgesics|analgesics|mesh-ancestor
14522773|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
14522774|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522775|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522776|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
14522777|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522778|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522779|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522780|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14522781|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522782|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522783|NCT03554486|Insulin|insulin|mesh-list
14522784|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14522785|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
14522786|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
13965759|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
13965760|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13965761|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
13965762|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
13965763|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965764|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965765|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14796401|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796402|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796403|NCT00768391|Olaratumab|olaratumab|mesh-list
14796404|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951807|NCT01552993|Acetaminophen|acetaminophen|mesh-list
14796405|NCT00768404|Phentermine|phentermine|mesh-list
14796406|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14951808|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14951809|NCT01552993|Analgesics|analgesics|mesh-ancestor
14951810|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
14951811|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951812|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951813|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
14951814|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
14951815|NCT01553006|Cefditoren|cefditoren|mesh-list
14951816|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796407|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796408|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
14796409|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14796410|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
14796411|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
14796412|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796413|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
14796414|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796415|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796416|NCT00768456|Ropivacaine|ropivacaine|mesh-list
14796417|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
14796418|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
14796419|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796420|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796421|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
14796422|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796423|NCT00768508|Naltrexone|naltrexone|mesh-list
14796424|NCT00768508|Ondansetron|ondansetron|mesh-list
14796425|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14796426|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14796427|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796428|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
14796429|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796430|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
14796431|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
14796432|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14796433|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
14796434|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
14796435|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14796436|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
14796437|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796438|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796439|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14796440|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14796441|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796442|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14796443|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14796444|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
14951817|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796445|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796446|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14796447|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14796448|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965766|NCT03127371|Analgesics|analgesics|mesh-ancestor
13965767|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
14951818|NCT01553019|Gemcitabine|gemcitabine|mesh-list
14951819|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14951820|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
14951821|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951822|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951823|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
14951824|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951825|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951826|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951827|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
14951828|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951829|NCT01553032|Cetuximab|cetuximab|mesh-list
14951830|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14951831|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951832|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
14951833|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14951834|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
14951835|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14951836|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951837|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14951838|NCT01553357|Dexamethasone|dexamethasone|mesh-list
14951839|NCT01553357|Lenalidomide|lenalidomide|mesh-list
14796449|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796450|NCT00768573|Urological Agents|urological agents|mesh-ancestor
14796451|NCT00768612|Risperidone|risperidone|mesh-list
14796452|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14796453|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
14796454|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796455|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796456|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796457|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14796458|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14796459|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796460|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14951840|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14796461|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14796462|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
14796463|NCT00768638|Atorvastatin|atorvastatin|mesh-list
14796464|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14951841|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
14951842|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
14796465|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14796466|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
14796467|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796468|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14796469|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14796470|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796471|NCT00768677|Topiramate|topiramate|mesh-list
14951843|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14951844|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951845|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951846|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
14951847|NCT01553357|Hormones|hormones|mesh-ancestor
14951848|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951849|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14951850|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951851|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
14951852|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14951853|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14951854|NCT01553357|Growth Substances|growth substances|mesh-ancestor
14951855|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
14951856|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
14951857|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
14951858|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
14951859|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14951860|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14951861|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951862|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951863|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951864|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14951865|NCT01553500|Cathartics|cathartics|mesh-ancestor
14951866|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027299|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13965768|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965769|NCT03127449|Aflutinib|aflutinib|mesh-list
13965770|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965771|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796472|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
14796473|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796474|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796475|NCT00768690|Ketoconazole|ketoconazole|mesh-list
14796476|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
14796477|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027300|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
15027301|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15027302|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15027303|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15027304|NCT01948817|Deferasirox|deferasirox|mesh-list
15027305|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15027306|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
15027307|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
15027308|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027309|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15027310|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14796478|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14796479|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14796480|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796481|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796482|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14796483|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
14796484|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796485|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796486|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14796487|NCT00768729|Sirolimus|sirolimus|mesh-list
14796488|NCT00768729|Azathioprine|azathioprine|mesh-list
14796489|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796490|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796491|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14796492|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796493|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
14951867|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14951868|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
14951869|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
14951870|NCT01553721|Udenafil|udenafil|mesh-list
14951871|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14951872|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14951873|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951874|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951875|NCT01553773|Estradiol|estradiol|mesh-list
14951876|NCT01553773|Estrogens|estrogens|mesh-ancestor
14951877|NCT01553773|Hormones|hormones|mesh-ancestor
14951878|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951879|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951880|NCT01553786|Lenalidomide|lenalidomide|mesh-list
13965772|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965773|NCT03127631|Aspirin|aspirin|mesh-list
13965774|NCT03127631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13965775|NCT03127631|Atorvastatin|atorvastatin|mesh-list
13965776|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13965777|NCT03127631|Simvastatin|simvastatin|mesh-list
13965778|NCT03127631|Pravastatin|pravastatin|mesh-list
13965779|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
13965780|NCT03127631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14796494|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796495|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
14796496|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796497|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
14796498|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796499|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14796500|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14796501|NCT00768768|Terbinafine|terbinafine|mesh-list
14796502|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
14796503|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796504|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796505|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951881|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
14951882|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951883|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14951884|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14951885|NCT01553786|Growth Substances|growth substances|mesh-ancestor
14951886|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
14951887|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951888|NCT01553903|Tamoxifen|tamoxifen|mesh-list
14951889|NCT01553903|Letrozole|letrozole|mesh-list
14951890|NCT01553903|Anastrozole|anastrozole|mesh-list
14951891|NCT01553903|Exemestane|exemestane|mesh-list
14951892|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951893|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14951894|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14951895|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951896|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951897|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14951898|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
14951899|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14951900|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951901|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14951902|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14796506|NCT00768859|Paclitaxel|paclitaxel|mesh-list
14796507|NCT00768859|Carboplatin|carboplatin|mesh-list
14796508|NCT00768859|Trastuzumab|trastuzumab|mesh-list
14796509|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14796510|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796511|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
14796512|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
14796513|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
14796514|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796515|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14796516|NCT00768911|Temozolomide|temozolomide|mesh-list
14796517|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14796518|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
14796519|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796520|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796521|NCT00768937|Sorafenib|sorafenib|mesh-list
14796522|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796523|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14796524|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796525|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796526|NCT00768963|Ranibizumab|ranibizumab|mesh-list
14796527|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14796528|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14796529|NCT00768963|Growth Substances|growth substances|mesh-ancestor
14796530|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796531|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796532|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796533|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
14796534|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796535|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796536|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14796537|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14796538|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796539|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796540|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796541|NCT00769054|Ropivacaine|ropivacaine|mesh-list
14796542|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
14796543|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
14796544|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796545|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796546|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
14796547|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796548|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14796549|NCT00769093|Hematinics|hematinics|mesh-ancestor
14796550|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14796551|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14796552|NCT00769145|Ranibizumab|ranibizumab|mesh-list
14796553|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14796554|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14796555|NCT00769145|Growth Substances|growth substances|mesh-ancestor
14796556|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796557|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796558|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796559|NCT00769158|Topiramate|topiramate|mesh-list
14796560|NCT00769158|Naltrexone|naltrexone|mesh-list
14796561|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14796562|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14796563|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796564|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
14796565|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796566|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
14796567|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13965781|NCT03127631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965782|NCT03127631|Analgesics|analgesics|mesh-ancestor
13965783|NCT03127631|Sensory System Agents|sensory system agents|mesh-ancestor
13965784|NCT03127631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965785|NCT03127631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965786|NCT03127631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965787|NCT03127631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235296|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
14796568|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
14796569|NCT00769171|Metronidazole|metronidazole|mesh-list
14796570|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
14796571|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
13965788|NCT03127631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14796572|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796573|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796574|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14796575|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14796576|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796577|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796578|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796579|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14796580|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
14796581|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14796582|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796583|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14796584|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14796585|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14796586|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14796587|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14951903|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14951904|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14951905|NCT01553942|Pemetrexed|pemetrexed|mesh-list
14951906|NCT01553942|Afatinib|afatinib|mesh-list
14951907|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951908|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951909|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951910|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14796588|NCT00769210|Simvastatin|simvastatin|mesh-list
14796589|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14796590|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14796591|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
14796592|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796593|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14796594|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14796595|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796596|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
14796597|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
14796598|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
14796599|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796600|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
14951911|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14951912|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14951913|NCT01553981|Tadalafil|tadalafil|mesh-list
14951914|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951915|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14951916|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14951917|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951918|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951919|NCT01553981|Urological Agents|urological agents|mesh-ancestor
14951920|NCT01554046|Methylphenidate|methylphenidate|mesh-list
14951921|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14951922|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951923|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14951924|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14951925|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796601|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796602|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796603|NCT00769288|Growth Substances|growth substances|mesh-ancestor
14796604|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796605|NCT00769405|Leucovorin|leucovorin|mesh-list
14796606|NCT00769405|Fluorouracil|fluorouracil|mesh-list
14796607|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
14796608|NCT00769405|Calcium|calcium|mesh-list
14796609|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
14796610|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14796611|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796612|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
14796613|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796614|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14796615|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951926|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951927|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
14951928|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14951929|NCT01554059|Bevacizumab|bevacizumab|mesh-list
14951930|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
14951931|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14951932|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951933|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14951934|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14951935|NCT01554059|Growth Substances|growth substances|mesh-ancestor
14951936|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951937|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796616|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796617|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
14796618|NCT00769405|Antidotes|antidotes|mesh-ancestor
14796619|NCT00769405|Protective Agents|protective agents|mesh-ancestor
14796620|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
14796621|NCT00769405|Vitamins|vitamins|mesh-ancestor
14796622|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
14796623|NCT00769470|Carboplatin|carboplatin|mesh-list
14796624|NCT00769470|Docetaxel|docetaxel|mesh-list
14796625|NCT00769470|Trastuzumab|trastuzumab|mesh-list
14796626|NCT00769470|Lapatinib|lapatinib|mesh-list
14796627|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951938|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
14951939|NCT01554111|Cathartics|cathartics|mesh-ancestor
14951940|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14951941|NCT01554124|Meropenem|meropenem|mesh-list
14796628|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14796629|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14796630|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14796631|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796632|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14796633|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14796634|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796635|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
14796636|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14796637|NCT00769522|Rituximab|rituximab|mesh-list
14796638|NCT00769522|Fludarabine|fludarabine|mesh-list
14796639|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951942|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14951943|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951944|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
14951945|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951946|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
14951947|NCT01554345|Vitamin E|vitamin e|mesh-list
14951948|NCT01554345|Selenium|selenium|mesh-list
14951949|NCT01554345|Vitamins|vitamins|mesh-ancestor
14951950|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
14951951|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951952|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
14951953|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951954|NCT01554345|Protective Agents|protective agents|mesh-ancestor
14951955|NCT01554345|Trace Elements|trace elements|mesh-ancestor
14951956|NCT01554397|Cisplatin|cisplatin|mesh-list
14951957|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14951958|NCT01554540|Treprostinil|treprostinil|mesh-list
14951959|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14951960|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14951961|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14951962|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14951963|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
14951964|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951965|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951966|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14951967|NCT01554631|Acarbose|acarbose|mesh-list
14951968|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14951969|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14951970|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951971|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14951972|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951973|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14951974|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14951975|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14951976|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
14951977|NCT01554813|Vaccines|vaccines|mesh-list
14951978|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
14951979|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796640|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
14796641|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951980|NCT01554826|Vaccines|vaccines|mesh-list
14796642|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14796643|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14796644|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
14796645|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796646|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796647|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14796648|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14796649|NCT00769548|Goserelin|goserelin|mesh-list
14796650|NCT00769548|Flutamide|flutamide|mesh-list
14796651|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14796652|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796653|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
14796654|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
14796655|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796656|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796657|NCT00769587|Thalidomide|thalidomide|mesh-list
14796658|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796659|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
14796660|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796661|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
14796662|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796663|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796664|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14796665|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14796666|NCT00769587|Growth Substances|growth substances|mesh-ancestor
14796667|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796668|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796669|NCT00769873|Heparin|heparin|mesh-list
14796670|NCT00769873|Enoxaparin|enoxaparin|mesh-list
14796671|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14796672|NCT00769873|Tinzaparin|tinzaparin|mesh-list
14951981|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
14951982|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14951983|NCT01554852|Thalidomide|thalidomide|mesh-list
14951984|NCT01554852|Dexamethasone|dexamethasone|mesh-list
14951985|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
14951986|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
14951987|NCT01554852|Melphalan|melphalan|mesh-list
14951988|NCT01554852|Lenalidomide|lenalidomide|mesh-list
14951989|NCT01554852|Bortezomib|bortezomib|mesh-list
14796673|NCT00769873|Dalteparin|dalteparin|mesh-list
14796674|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
14796675|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14951990|NCT01554852|Vorinostat|vorinostat|mesh-list
14951991|NCT01554852|BB 1101|bb 1101|mesh-list
14951992|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14951993|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
14951994|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965789|NCT03127631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13965790|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965791|NCT03127631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13965792|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965793|NCT03127631|Antipyretics|antipyretics|mesh-ancestor
13965794|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13965795|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13965796|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
14235297|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14951995|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14951996|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14951997|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
14951998|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14951999|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952000|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14952001|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952002|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
14952003|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
14796676|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14796677|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796678|NCT00769990|Genistein|genistein|mesh-list
14796679|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14796680|NCT00769990|Protective Agents|protective agents|mesh-ancestor
14796681|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796682|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796683|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952004|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952005|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14796684|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796685|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796686|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
14796687|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14796688|NCT00769990|Estrogens|estrogens|mesh-ancestor
14796689|NCT00769990|Hormones|hormones|mesh-ancestor
14796690|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796691|NCT00770042|Ritonavir|ritonavir|mesh-list
14796692|NCT00770042|Ketoconazole|ketoconazole|mesh-list
14796693|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14796694|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14952006|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
14796695|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796696|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796697|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796698|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14796699|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14952007|NCT01554852|Hormones|hormones|mesh-ancestor
14952008|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952009|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14952010|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
14952011|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952012|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14796700|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
14796701|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796702|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14796703|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14796704|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
14952013|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14952014|NCT01554852|Growth Substances|growth substances|mesh-ancestor
14952015|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
14952016|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
14952017|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952018|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965797|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13965798|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13965799|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
13965800|NCT03127137|Triamcinolone|triamcinolone|mesh-list
13965801|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14952019|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14952020|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
14952021|NCT01554930|Mannitol|mannitol|mesh-list
14952022|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
14952023|NCT01554930|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14952024|NCT01554930|Antibodies|antibodies|mesh-list
14952025|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952026|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
14952027|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
14952028|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952029|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952030|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14952031|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
14952032|NCT01554930|Hormones|hormones|mesh-ancestor
14952033|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952034|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14952035|NCT01554930|Protective Agents|protective agents|mesh-ancestor
14952036|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
14952037|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13965802|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13965803|NCT03127137|Lidocaine|lidocaine|mesh-list
13965804|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13965805|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
13965806|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
13965807|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796705|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14796706|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14796707|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
14796708|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796709|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796710|NCT00770107|Thiamine|thiamine|mesh-list
14796711|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
14796712|NCT00770107|Vitamins|vitamins|mesh-ancestor
14796713|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
14796714|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796715|NCT00770172|Lenograstim|lenograstim|mesh-list
14796716|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14952038|NCT01554930|Diuretics|diuretics|mesh-ancestor
14796717|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
14796718|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796719|NCT00770263|Sirolimus|sirolimus|mesh-list
14796720|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14796721|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796722|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14796723|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796724|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796725|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796726|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796727|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14796728|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
14796729|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796730|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
14796731|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796732|NCT00770302|Saxagliptin|saxagliptin|mesh-list
14796733|NCT00770302|Incretins|incretins|mesh-ancestor
14796734|NCT00770302|Hormones|hormones|mesh-ancestor
14796735|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796736|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796737|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14796738|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796739|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796740|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796741|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796742|NCT00770354|Letrozole|letrozole|mesh-list
14796743|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796744|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14796745|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14796746|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796747|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796748|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14796749|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
14796750|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796751|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796752|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
14796753|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14796754|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14796755|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14796756|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796757|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796758|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
14796759|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796760|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796761|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14796762|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796763|NCT00770445|Insulin|insulin|mesh-list
14796764|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14796765|NCT00770445|Metformin|metformin|mesh-list
14952039|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
14952040|NCT01554956|Plasminogen|plasminogen|mesh-list
14952041|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14952042|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14952043|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952044|NCT01554969|Capecitabine|capecitabine|mesh-list
14952045|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14952046|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
14952047|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952048|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952049|NCT01554995|Linezolid|linezolid|mesh-list
14952050|NCT01554995|Delpazolid|delpazolid|mesh-list
14952051|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952052|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952053|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14952054|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952055|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952056|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
14952057|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14952058|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952059|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14952060|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952061|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
14952062|NCT01555060|Hematinics|hematinics|mesh-ancestor
14952063|NCT01555099|Budesonide|budesonide|mesh-list
14952064|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952065|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14235298|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235299|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235300|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235301|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235302|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14235303|NCT00106106|Acamprosate|acamprosate|mesh-list
14796766|NCT00770445|Pioglitazone|pioglitazone|mesh-list
14796767|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796768|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796769|NCT00770471|Temozolomide|temozolomide|mesh-list
14796770|NCT00770471|Veliparib|veliparib|mesh-list
14796771|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14796772|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
14796773|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796774|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796775|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14796776|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796777|NCT00770497|Pioglitazone|pioglitazone|mesh-list
14796778|NCT00770497|Ramipril|ramipril|mesh-list
14796779|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796780|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796781|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14796782|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
14796783|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796784|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796785|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14796786|NCT00770536|Doxorubicin|doxorubicin|mesh-list
14796787|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14796788|NCT00770536|Topotecan|topotecan|mesh-list
14796789|NCT00770536|Trebananib|trebananib|mesh-list
14796790|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14796791|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796792|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14796793|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14796794|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796795|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952066|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
14952067|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796796|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14796797|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14952068|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952069|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14952070|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
14952071|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
14952072|NCT01555099|Hormones|hormones|mesh-ancestor
14952073|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965808|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965809|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
13965810|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13965811|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13965812|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13965813|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13965814|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13965815|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965816|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965817|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
13965818|NCT03127137|Hormones|hormones|mesh-ancestor
14235304|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14952074|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14952075|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14952076|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
14952077|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952078|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952079|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14235305|NCT00106184|Rituximab|rituximab|mesh-list
14952080|NCT01555112|Protective Agents|protective agents|mesh-ancestor
14952081|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14952082|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14952083|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952084|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952085|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
14952086|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027311|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15027312|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15027313|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027314|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027315|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027316|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235306|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235307|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235308|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
14235309|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235310|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027317|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027318|NCT01948921|Meperidine|meperidine|mesh-list
15027319|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14235311|NCT00106353|Sirolimus|sirolimus|mesh-list
14235312|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235313|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027320|NCT01948921|Narcotics|narcotics|mesh-ancestor
15027321|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027322|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235314|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14796798|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14796799|NCT00770536|Growth Substances|growth substances|mesh-ancestor
14796800|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796801|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
14796802|NCT00770575|Pioglitazone|pioglitazone|mesh-list
14796803|NCT00770575|Atorvastatin|atorvastatin|mesh-list
14796804|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14796805|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14796806|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
14796807|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965819|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965820|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13965821|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
13965822|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965823|NCT03127319|Docetaxel|docetaxel|mesh-list
13965824|NCT03127319|Apatinib|apatinib|mesh-list
13965825|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965826|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
13965827|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
13965828|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
14796808|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14796809|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14796810|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796811|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796812|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796813|NCT00770640|Insulin|insulin|mesh-list
14796814|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14796815|NCT00770640|Pioglitazone|pioglitazone|mesh-list
14796816|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796817|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952087|NCT01555190|Folic Acid|folic acid|mesh-list
14952088|NCT01555190|Inositol|inositol|mesh-list
14952089|NCT01555190|Hematinics|hematinics|mesh-ancestor
14952090|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
14952091|NCT01555190|Vitamins|vitamins|mesh-ancestor
14952092|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
13965829|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965830|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965831|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235315|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235316|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
14235317|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235318|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
14235319|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235320|NCT00106392|Tacrolimus|tacrolimus|mesh-list
14235321|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952093|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952094|NCT01555216|Ropivacaine|ropivacaine|mesh-list
14952095|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
14952096|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
14952097|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952098|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235322|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
14235323|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235324|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14952099|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
14952100|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952101|NCT01555268|Cytarabine|cytarabine|mesh-list
14952102|NCT01555268|Trebananib|trebananib|mesh-list
14952103|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14952104|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
14952105|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952106|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952107|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
14952108|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952109|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952110|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
14952111|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952112|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14952113|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14952114|NCT01555268|Growth Substances|growth substances|mesh-ancestor
14952115|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
14952116|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
14952117|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14952118|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14952119|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
14952120|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952121|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14952122|NCT01555476|Ibuprofen|ibuprofen|mesh-list
14952123|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14952124|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14952125|NCT01555476|Analgesics|analgesics|mesh-ancestor
14952126|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
14952127|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027323|NCT01948921|Analgesics|analgesics|mesh-ancestor
13965832|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14235325|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796818|NCT00770666|Bupropion|bupropion|mesh-list
14796819|NCT00770666|Nicotine|nicotine|mesh-list
14796820|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14796821|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
14796822|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796823|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796824|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14796825|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14796826|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
14796827|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796828|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796829|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14796830|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
14796831|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14796832|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14796833|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14796834|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796835|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
14796836|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14796837|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14796838|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796839|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
14796840|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14796841|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14796842|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
14796843|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796844|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796845|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796846|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14796847|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796848|NCT00770718|Thrombin|thrombin|mesh-list
14796849|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
14796850|NCT00770718|Coagulants|coagulants|mesh-ancestor
14796851|NCT00770731|Sirolimus|sirolimus|mesh-list
14796852|NCT00770731|Bortezomib|bortezomib|mesh-list
14796853|NCT00770731|Topotecan|topotecan|mesh-list
14796854|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796855|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14796856|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14796857|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796858|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796859|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235326|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235327|NCT00106431|Romidepsin|romidepsin|mesh-list
14235328|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235329|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235330|NCT00106535|Methotrexate|methotrexate|mesh-list
14796860|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796861|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14796862|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
14796863|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796864|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
14796865|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796866|NCT00770744|Olanzapine|olanzapine|mesh-list
14796867|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
14796868|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
14796869|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796870|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796871|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14796872|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14796873|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14796874|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796875|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14796876|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14796877|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14796878|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14796879|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796880|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796881|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
14796882|NCT00770796|Atorvastatin|atorvastatin|mesh-list
14796883|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14796884|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14952128|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235331|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14796885|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
13965833|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13965834|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13965835|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13965836|NCT03127189|Rilpivirine|rilpivirine|mesh-list
14796886|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796887|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14796888|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14796889|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952129|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952130|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952131|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14952132|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952133|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952134|NCT01555580|Molgramostim|molgramostim|mesh-list
14952135|NCT01555580|Sargramostim|sargramostim|mesh-list
14952136|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
14952137|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965837|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13965838|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13965839|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952138|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952139|NCT01555632|Atorvastatin|atorvastatin|mesh-list
14952140|NCT01555632|Calcium|calcium|mesh-list
13965840|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965841|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
13965842|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965843|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13965844|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13965845|NCT03127124|Leucovorin|leucovorin|mesh-list
14235332|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
14235333|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14235334|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235335|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235336|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
14235337|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235338|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235339|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
14235340|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235341|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14235342|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235343|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
14235344|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235345|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14235346|NCT00106639|Tacrolimus|tacrolimus|mesh-list
14235347|NCT00106639|Tofacitinib|tofacitinib|mesh-list
14235348|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235349|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
14235350|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235351|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14952141|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14952142|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952143|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14952144|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14952145|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
14952146|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952147|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14952148|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14952149|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952150|NCT01555658|Heparin|heparin|mesh-list
14952151|NCT01555658|Bivalirudin|bivalirudin|mesh-list
14952152|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
14952153|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14952154|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14952155|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952156|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
14952157|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14952158|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
14952159|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952160|NCT01555710|Carboplatin|carboplatin|mesh-list
14952161|NCT01555710|Etoposide|etoposide|mesh-list
14952162|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
14952163|NCT01555710|Ifosfamide|ifosfamide|mesh-list
14952164|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952165|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14952166|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14796890|NCT00770835|Metformin|metformin|mesh-list
14796891|NCT00770835|Pioglitazone|pioglitazone|mesh-list
14796892|NCT00770835|Glyburide|glyburide|mesh-list
14796893|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796894|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796895|NCT00770900|Montelukast|montelukast|mesh-list
14796896|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14796897|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
14796898|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14796899|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
14796900|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796901|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796902|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14796903|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14796904|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796905|NCT00770952|Pioglitazone|pioglitazone|mesh-list
14796906|NCT00770952|Glimepiride|glimepiride|mesh-list
14796907|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796908|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796909|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14796910|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796911|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
14796912|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
14796913|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14796914|NCT00770978|Cephalosporins|cephalosporins|mesh-list
14796915|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14796916|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14796917|NCT00771004|Pioglitazone|pioglitazone|mesh-list
14796918|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14796919|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796920|NCT00771017|Leuprolide|leuprolide|mesh-list
14796921|NCT00771017|Goserelin|goserelin|mesh-list
14796922|NCT00771017|Bicalutamide|bicalutamide|mesh-list
14796923|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14796924|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
14952167|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14952168|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952169|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952170|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14952171|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
14952172|NCT01555788|Pancrelipase|pancrelipase|mesh-list
14952173|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14952174|NCT01555814|Amisulpride|amisulpride|mesh-list
14952175|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14952176|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14952177|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952178|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952179|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14952180|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14952181|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
14952182|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235352|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235353|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235354|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952183|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952184|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14952185|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235355|NCT00106704|Pioglitazone|pioglitazone|mesh-list
14235356|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14235357|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14235358|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235359|NCT00106704|Incretins|incretins|mesh-ancestor
14796925|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14796926|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796927|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235360|NCT00106704|Hormones|hormones|mesh-ancestor
14796928|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796929|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
14796930|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
14796931|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14796932|NCT00771043|Natalizumab|natalizumab|mesh-list
14796933|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
14796934|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796935|NCT00771147|Sorafenib|sorafenib|mesh-list
14796936|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796937|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952186|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14952187|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952188|NCT01555866|Isavuconazole|isavuconazole|mesh-list
14952189|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
14952190|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952191|NCT01555879|Abatacept|abatacept|mesh-list
14952192|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14952193|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952194|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14796938|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14796939|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796940|NCT00771199|Fentanyl|fentanyl|mesh-list
14952195|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952196|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
14952197|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952198|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952199|NCT01555918|Isavuconazole|isavuconazole|mesh-list
14952200|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
14952201|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952202|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
13965846|NCT03127124|Fluorouracil|fluorouracil|mesh-list
13965847|NCT03127124|Bevacizumab|bevacizumab|mesh-list
14952203|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14952204|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
14952205|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952206|NCT01555970|Expectorants|expectorants|mesh-ancestor
14952207|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
14952208|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14952209|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
14952210|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965848|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
13965849|NCT03127124|Calcium|calcium|mesh-list
13965850|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
13965851|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14796941|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14952211|NCT01555970|Protective Agents|protective agents|mesh-ancestor
14952212|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952213|NCT01555970|Antidotes|antidotes|mesh-ancestor
14952214|NCT01556035|Lenalidomide|lenalidomide|mesh-list
14952215|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
14952216|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952217|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14952218|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14952219|NCT01556035|Growth Substances|growth substances|mesh-ancestor
14952220|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
14952221|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965852|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965853|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
14796942|NCT00771199|Narcotics|narcotics|mesh-ancestor
14796943|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14796944|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796945|NCT00771199|Analgesics|analgesics|mesh-ancestor
14796946|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
14796947|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796948|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14796949|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14796950|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
14796951|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
14796952|NCT00771251|Golimumab|golimumab|mesh-list
14796953|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14796954|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14796955|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14796956|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
14796957|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796958|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
14952222|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14952223|NCT01556191|Fulvestrant|fulvestrant|mesh-list
14796959|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14796960|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14796961|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796962|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
14796963|NCT00771303|Coagulants|coagulants|mesh-ancestor
14796964|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
14796965|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14796966|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
14796967|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796968|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952224|NCT01556191|Gefitinib|gefitinib|mesh-list
14952225|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952226|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14796969|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14796970|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
14796971|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14796972|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
14796973|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796974|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796975|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14796976|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796977|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
14952227|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952228|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952229|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14952230|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14952231|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14952232|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
14952233|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952234|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952235|NCT01556321|Caffeine|caffeine|mesh-list
14952236|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14952237|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952238|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14952239|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952240|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952241|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13965854|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965855|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13965856|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965857|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13965858|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
13965859|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13965860|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13965861|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13965862|NCT03127124|Growth Substances|growth substances|mesh-ancestor
14235361|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235362|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14235363|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
14235364|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235365|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796978|NCT00771342|Protective Agents|protective agents|mesh-ancestor
14796979|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
14796980|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14796981|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
14796982|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14796983|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14796984|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14796985|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
14796986|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14796987|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
14796988|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14796989|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14796990|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14796991|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
14796992|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
14796993|NCT00771368|Protective Agents|protective agents|mesh-ancestor
14796994|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14235366|NCT00107120|Citalopram|citalopram|mesh-list
14796995|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14796996|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965863|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
13965864|NCT03127124|Antidotes|antidotes|mesh-ancestor
13965865|NCT03127124|Protective Agents|protective agents|mesh-ancestor
13965866|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
13965867|NCT03127124|Vitamins|vitamins|mesh-ancestor
14952242|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14796997|NCT00771394|Tamsulosin|tamsulosin|mesh-list
14796998|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
14796999|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14797000|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14797001|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14797002|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
14797003|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797004|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797005|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797006|NCT00771394|Urological Agents|urological agents|mesh-ancestor
14797007|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14797008|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14797009|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
14797010|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
14952243|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
14952244|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952245|NCT01556334|Azithromycin|azithromycin|mesh-list
14952246|NCT01556334|Erythromycin|erythromycin|mesh-list
14952247|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
14952248|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14952249|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
14952250|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952251|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952252|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14952253|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14952254|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797011|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14797012|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797013|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
14797014|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797015|NCT00771433|Lenograstim|lenograstim|mesh-list
14797016|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14797017|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
14797018|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797019|NCT00771459|Ropivacaine|ropivacaine|mesh-list
14797020|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
14797021|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
14952255|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952256|NCT01556477|Lenalidomide|lenalidomide|mesh-list
14952257|NCT01556477|Azacitidine|azacitidine|mesh-list
14952258|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
14952259|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952260|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13965868|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
13965869|NCT03127046|Aceclofenac|aceclofenac|mesh-list
13965870|NCT03127046|Diclofenac|diclofenac|mesh-list
13965871|NCT03127046|Esomeprazole|esomeprazole|mesh-list
13965872|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13965873|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13965874|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13965875|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965876|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965877|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13965878|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13965879|NCT03127046|Analgesics|analgesics|mesh-ancestor
13965880|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
13965881|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235367|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14235368|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14797022|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797023|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797024|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
14797025|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797026|NCT00771498|Lopinavir|lopinavir|mesh-list
14797027|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14797028|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14797029|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
14797030|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952261|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14952262|NCT01556477|Growth Substances|growth substances|mesh-ancestor
13965882|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797031|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797032|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797033|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797034|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
14797035|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797036|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797037|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797038|NCT00771511|Capsaicin|capsaicin|mesh-list
14952263|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
14952264|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952265|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14952266|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
14952267|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952268|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952269|NCT01556529|Unithiol|unithiol|mesh-list
14952270|NCT01556529|Antidotes|antidotes|mesh-ancestor
14952271|NCT01556529|Protective Agents|protective agents|mesh-ancestor
14952272|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952273|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
14952274|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
14952275|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952276|NCT01556542|Paclitaxel|paclitaxel|mesh-list
14952277|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14952278|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952279|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14952280|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14952281|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14952282|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952283|NCT01556646|Tolvaptan|tolvaptan|mesh-list
14952284|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14952285|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952286|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
14952287|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952288|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
14952289|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
14952290|NCT01556672|Adalimumab|adalimumab|mesh-list
14952291|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952292|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952293|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
14952294|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14952295|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
14952296|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952297|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952298|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14952299|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
14952300|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14952301|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
14952302|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952303|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952304|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14952305|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
14952306|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
14952307|NCT01556698|Protective Agents|protective agents|mesh-ancestor
14952308|NCT01556737|Genistein|genistein|mesh-list
14952309|NCT01556737|Daidzein|daidzein|mesh-list
14952310|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14952311|NCT01556737|Protective Agents|protective agents|mesh-ancestor
14952312|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952313|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952314|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952315|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952316|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952317|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
14952318|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14952319|NCT01556737|Estrogens|estrogens|mesh-ancestor
14952320|NCT01556737|Hormones|hormones|mesh-ancestor
14952321|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952322|NCT01556815|Sorafenib|sorafenib|mesh-list
14952323|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
14952324|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952325|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952326|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952327|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952328|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14952329|NCT01556815|Estrogens|estrogens|mesh-ancestor
14797039|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
14797040|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
14797041|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
14797042|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797043|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797044|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
14797045|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14952330|NCT01556815|Hormones|hormones|mesh-ancestor
14952331|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952332|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952333|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14952334|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14952335|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027324|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
14797046|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797047|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797048|NCT00771563|Cisplatin|cisplatin|mesh-list
14797049|NCT00771563|Docetaxel|docetaxel|mesh-list
14797050|NCT00771563|Enoxaparin|enoxaparin|mesh-list
14797051|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797052|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14797053|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14797054|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14797055|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797056|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
14797057|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14797058|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14797059|NCT00771641|Cobalt|cobalt|mesh-list
14797060|NCT00771641|Trace Elements|trace elements|mesh-ancestor
14797061|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
14797062|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797063|NCT00771680|Insulin|insulin|mesh-list
15027325|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027326|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15027327|NCT01948960|Everolimus|everolimus|mesh-list
15027328|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027329|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15027330|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
15027331|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027332|NCT01948999|Anesthetics|anesthetics|mesh-list
14797064|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14797065|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
14797066|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
14797067|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14797068|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
14797069|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
14797070|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14797071|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14797072|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797073|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
14797074|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
14797075|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14797076|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14797077|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797078|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14797079|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797080|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797081|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
14797082|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
14797083|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797084|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797085|NCT00771823|Maraviroc|maraviroc|mesh-list
14797086|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14797087|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14797088|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797089|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797090|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797091|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
14797092|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797093|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14797094|NCT00771888|Lanreotide|lanreotide|mesh-list
14797095|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797096|NCT00771979|Saracatinib|saracatinib|mesh-list
14797097|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797098|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952336|NCT01557075|Atorvastatin|atorvastatin|mesh-list
14952337|NCT01557075|Pravastatin|pravastatin|mesh-list
14952338|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14952339|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14952340|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14952341|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
14797099|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797100|NCT00772057|Propranolol|propranolol|mesh-list
14797101|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14797102|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14797103|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
14952342|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952343|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14952344|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952345|NCT01557114|Ipilimumab|ipilimumab|mesh-list
14797104|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797105|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797106|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797107|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14797108|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797109|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797110|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
14952346|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14952347|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952348|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14797111|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797112|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797113|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14797114|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14797115|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797116|NCT00772135|Urological Agents|urological agents|mesh-ancestor
14797117|NCT00772161|Methylphenidate|methylphenidate|mesh-list
14797118|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14797119|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797120|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14797121|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14797122|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797123|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797124|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
14797125|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797126|NCT00772174|Metformin|metformin|mesh-list
14797127|NCT00772174|Pioglitazone|pioglitazone|mesh-list
14797128|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14952349|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797129|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797130|NCT00772187|Fentanyl|fentanyl|mesh-list
14797131|NCT00772187|Morphine|morphine|mesh-list
14797132|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
14797133|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797134|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952350|NCT01557127|Sorafenib|sorafenib|mesh-list
14952351|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797135|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14797136|NCT00772187|Narcotics|narcotics|mesh-ancestor
14797137|NCT00772187|Analgesics|analgesics|mesh-ancestor
14797138|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
14797139|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797140|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14797141|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14797142|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
14797143|NCT00772265|Insulin|insulin|mesh-list
14797144|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
14797145|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14797146|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952352|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952353|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952354|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952355|NCT01557140|Carvedilol|carvedilol|mesh-list
14952356|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14952357|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14952358|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
14952359|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952360|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797147|NCT00772291|Pregabalin|pregabalin|mesh-list
14797148|NCT00772291|Analgesics|analgesics|mesh-ancestor
14797149|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
14797150|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797151|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797152|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
14797153|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14797154|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797155|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797156|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14952361|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952362|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14952363|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
14952364|NCT01557140|Protective Agents|protective agents|mesh-ancestor
14952365|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14235369|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235370|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235371|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235372|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
14235373|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952366|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14952367|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14952368|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
14952369|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14952370|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14952371|NCT01557153|Amlodipine|amlodipine|mesh-list
14952372|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14952373|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14952374|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14952375|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952376|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14952377|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952378|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
14952379|NCT01557257|Naltrexone|naltrexone|mesh-list
14952380|NCT01557257|Oxycodone|oxycodone|mesh-list
14952381|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14952382|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14952383|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952384|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
14952385|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952386|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14952387|NCT01557257|Narcotics|narcotics|mesh-ancestor
14952388|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952389|NCT01557257|Analgesics|analgesics|mesh-ancestor
14952390|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
14952391|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14952392|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952393|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952394|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14952395|NCT01557270|Analgesics|analgesics|mesh-ancestor
14952396|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
14952397|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952398|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14952399|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14952400|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14952401|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
14952402|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235374|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14952403|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952404|NCT01557335|Aspirin|aspirin|mesh-list
14235375|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235376|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14235377|NCT00107198|Prednisone|prednisone|mesh-list
14235378|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
14235379|NCT00107198|Doxorubicin|doxorubicin|mesh-list
14235380|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14235381|NCT00107198|Vincristine|vincristine|mesh-list
14235382|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235383|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
14235384|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235385|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235386|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235387|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
14242805|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797157|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14797158|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14797159|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797160|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14797161|NCT00772356|Insulin|insulin|mesh-list
14797162|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14797163|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14797164|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797165|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
14797166|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14797167|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797168|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797169|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14797170|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797171|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14235388|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235389|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235390|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14235391|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235392|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14235393|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235394|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952405|NCT01557335|Omeprazole|omeprazole|mesh-list
14952406|NCT01557335|Clopidogrel|clopidogrel|mesh-list
14952407|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14952408|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14952409|NCT01557335|Analgesics|analgesics|mesh-ancestor
14797172|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
14797173|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14797174|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
14797175|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797176|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797177|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797178|NCT00772499|Atenolol|atenolol|mesh-list
14797179|NCT00772499|Amlodipine|amlodipine|mesh-list
14797180|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14797181|NCT00772499|Olmesartan|olmesartan|mesh-list
14797182|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14797183|NCT00772499|Hydralazine|hydralazine|mesh-list
14797184|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797185|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14797186|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797187|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797188|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14797189|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797190|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797191|NCT00772499|Diuretics|diuretics|mesh-ancestor
14797192|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
14797193|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14797194|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14797195|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14797196|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14797197|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
14797198|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
14797199|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797200|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14797201|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14797202|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14797203|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
14797204|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797205|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
14797206|NCT00772551|Ezetimibe|ezetimibe|mesh-list
14797207|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14797208|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14797209|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
14797210|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797211|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14797212|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797213|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797214|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
14797215|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797216|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14797217|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14235395|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235396|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
14235397|NCT00107198|Hormones|hormones|mesh-ancestor
14235398|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797218|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235399|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14797219|NCT00772564|Atorvastatin|atorvastatin|mesh-list
14797220|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14797221|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14797222|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
14797223|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797224|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14797225|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14797226|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952410|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
14952411|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952412|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952413|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952414|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952415|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14952416|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14952417|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952418|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14952419|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14952420|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952421|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
14952422|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14952423|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14952424|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14952425|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
14952426|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952427|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14952428|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14952429|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14797227|NCT00772616|Sufentanil|sufentanil|mesh-list
14797228|NCT00772616|Remifentanil|remifentanil|mesh-list
14797229|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14797230|NCT00772616|Narcotics|narcotics|mesh-ancestor
14952430|NCT01557374|Abatacept|abatacept|mesh-list
14952431|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14952432|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952433|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952434|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952435|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
14952436|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235400|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235401|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235402|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
14235403|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
14235404|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
14235405|NCT00107276|Capecitabine|capecitabine|mesh-list
14235406|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952437|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952438|NCT01557439|Levocetirizine|levocetirizine|mesh-list
14952439|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14952440|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14952441|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
14952442|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
14797231|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797232|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797233|NCT00772616|Analgesics|analgesics|mesh-ancestor
14797234|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
14797235|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797236|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14797237|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14797238|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
14797239|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
14797240|NCT00772655|Rituximab|rituximab|mesh-list
14797241|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14797242|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797243|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
14797244|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235407|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
14235408|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797245|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797246|NCT00772681|Docetaxel|docetaxel|mesh-list
14797247|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797248|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
14797249|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
14797250|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
14797251|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797252|NCT00772694|Sorafenib|sorafenib|mesh-list
14797253|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797254|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14797255|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797256|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952443|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952444|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952445|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952446|NCT01557478|Melatonin|melatonin|mesh-list
14952447|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
14952448|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952449|NCT01557478|Protective Agents|protective agents|mesh-ancestor
14952450|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952451|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14235409|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235410|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235411|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
14235412|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235413|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235414|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14235415|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14952452|NCT01557634|Insulin|insulin|mesh-list
14952453|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14952454|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235416|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
14235417|NCT00107380|Prednisone|prednisone|mesh-list
14952455|NCT01557647|Treprostinil|treprostinil|mesh-list
14952456|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14235418|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
14235419|NCT00107380|Rituximab|rituximab|mesh-list
14235420|NCT00107380|Doxorubicin|doxorubicin|mesh-list
14235421|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14952457|NCT01557660|Treprostinil|treprostinil|mesh-list
14952458|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14952459|NCT01557712|Ketamine|ketamine|mesh-list
14952460|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14952461|NCT01557712|Analgesics|analgesics|mesh-ancestor
14952462|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
14952463|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952464|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952465|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14952466|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14952467|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
14952468|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
14952469|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952470|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14952471|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14235422|NCT00107380|Vincristine|vincristine|mesh-list
14797257|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
14797258|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797259|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797260|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
14952472|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797261|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797262|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14797263|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14797264|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797265|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952473|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952474|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14952475|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14952476|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14952477|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14952478|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
14952479|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14952480|NCT01557764|Trastuzumab|trastuzumab|mesh-list
14952481|NCT01557764|Lapatinib|lapatinib|mesh-list
14952482|NCT01557764|Antibodies|antibodies|mesh-list
14797266|NCT00772759|AZD-3199|azd-3199|mesh-list
14797267|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14797268|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14797269|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14797270|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
14797271|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797272|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797273|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797274|NCT00772798|Paclitaxel|paclitaxel|mesh-list
14797275|NCT00772798|Carboplatin|carboplatin|mesh-list
14797276|NCT00772798|Vorinostat|vorinostat|mesh-list
14797277|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14797278|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797279|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
14797280|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
14797281|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
14797282|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797283|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14797284|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952483|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14952484|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
14952485|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952486|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14952487|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952488|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952489|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952490|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952491|NCT01557816|Naproxen|naproxen|mesh-list
14952492|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14952493|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14952494|NCT01557816|Analgesics|analgesics|mesh-ancestor
14952495|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
14952496|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952497|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952498|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952499|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952500|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
14952501|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14952502|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952503|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952504|NCT01557829|Silicon|silicon|mesh-list
14952505|NCT01557829|Trace Elements|trace elements|mesh-ancestor
14952506|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
14952507|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952508|NCT01557907|Insulin|insulin|mesh-list
14952509|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14952510|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14952511|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952512|NCT01557985|Bupivacaine|bupivacaine|mesh-list
14952513|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
14952514|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
14952515|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952516|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952517|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
14952518|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797285|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14797286|NCT00772837|Amoxicillin|amoxicillin|mesh-list
14797287|NCT00772837|Clarithromycin|clarithromycin|mesh-list
14797288|NCT00772837|Omeprazole|omeprazole|mesh-list
14797289|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952519|NCT01558011|Docetaxel|docetaxel|mesh-list
14952520|NCT01558011|Capecitabine|capecitabine|mesh-list
14952521|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
14952522|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952523|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
14952524|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
14797290|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14797291|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14797292|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14797293|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797294|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797295|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14797296|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797297|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797298|NCT00772863|Docetaxel|docetaxel|mesh-list
14797299|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797300|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14797301|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14797302|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14797303|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797304|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14797305|NCT00772902|Lopinavir|lopinavir|mesh-list
14797306|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14797307|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14952525|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
14952526|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952527|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14797308|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797309|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797310|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
14797311|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797312|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797313|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797314|NCT00772902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14797315|NCT00772902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14797316|NCT00772902|Protease Inhibitors|protease inhibitors|mesh-ancestor
14797317|NCT00772902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797318|NCT00772902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797319|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
14952528|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
14235423|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
14235424|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235425|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
14235426|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235427|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952529|NCT01558115|Denosumab|denosumab|mesh-list
14952530|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14952531|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952532|NCT01558167|Rituximab|rituximab|mesh-list
14952533|NCT01558167|Lenalidomide|lenalidomide|mesh-list
14952534|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14797320|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
14797321|NCT00773058|Hormones|hormones|mesh-ancestor
14797322|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797323|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797324|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14797325|NCT00773084|Lisinopril|lisinopril|mesh-list
14797326|NCT00773084|Spironolactone|spironolactone|mesh-list
14797327|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14797328|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
14797329|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797330|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952535|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14952536|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952537|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
14797331|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14797332|NCT00773084|Diuretics|diuretics|mesh-ancestor
14797333|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
14797334|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14797335|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
14797336|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797337|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797338|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797339|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14797340|NCT00773084|Protective Agents|protective agents|mesh-ancestor
14797341|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
14797342|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14797343|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797344|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14797345|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
14797346|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14797347|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14797348|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14797349|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797350|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797351|NCT00773188|Bevacizumab|bevacizumab|mesh-list
14797352|NCT00773188|Vinorelbine|vinorelbine|mesh-list
14797353|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14797354|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797355|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14797356|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14797357|NCT00773188|Growth Substances|growth substances|mesh-ancestor
14797358|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797359|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
14797360|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14797361|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
14797362|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
14797363|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
14797364|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797365|NCT00773201|Sotalol|sotalol|mesh-list
14797366|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14797367|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14797368|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
14797369|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797370|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797371|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797372|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14797373|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
14797374|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
14797375|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797376|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
14797377|NCT00773331|Hematinics|hematinics|mesh-ancestor
14797378|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
14797379|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14797380|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14797381|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
14797382|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797383|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797384|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797385|NCT00773552|Urological Agents|urological agents|mesh-ancestor
14797386|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
14797387|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14797388|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
14797389|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797390|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797391|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14797392|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
14797393|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14797394|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
14797395|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797396|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797397|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14797398|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797399|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
14797400|NCT00773578|Protective Agents|protective agents|mesh-ancestor
14952538|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952539|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952540|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14952541|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14952542|NCT01558167|Growth Substances|growth substances|mesh-ancestor
14952543|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
14952544|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14952545|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
14235428|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235429|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
14235430|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235431|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235432|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14235433|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235434|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235435|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14235436|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235437|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235438|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235439|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
14235440|NCT00107380|Hormones|hormones|mesh-ancestor
14235441|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235442|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235443|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235444|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235445|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
14235446|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
14242806|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14242807|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
14242808|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242809|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
14242810|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14242811|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14242812|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14242813|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
14242814|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242815|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14242816|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14797401|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14797402|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
14797403|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14797404|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14797405|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797406|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797407|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14797408|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797409|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14242817|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
14797410|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
14797411|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797412|NCT00773630|Cilostazol|cilostazol|mesh-list
14797413|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14797414|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
14797415|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797416|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797417|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14797418|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
14797419|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14797420|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14797421|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797422|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14797423|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797424|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14797425|NCT00773630|Protective Agents|protective agents|mesh-ancestor
14797426|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14797427|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14797428|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797429|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
14797430|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797431|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797432|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
14797433|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797434|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14797435|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14797436|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797437|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797438|NCT00773812|Mecamylamine|mecamylamine|mesh-list
14797439|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797440|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14797441|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
14797442|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797443|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797444|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14797445|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14797446|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
14797447|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797448|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797449|NCT00773916|Methylphenidate|methylphenidate|mesh-list
14797450|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14797451|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797452|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14797453|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14952546|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952547|NCT01558193|Vitamins|vitamins|mesh-list
14952548|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
14952549|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
14952550|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952551|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14952552|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14952553|NCT01558193|Analgesics|analgesics|mesh-ancestor
14952554|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
14952555|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952556|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952557|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952558|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14952559|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
14952560|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952561|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14952562|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
14952563|NCT01558245|Kallikreins|kallikreins|mesh-list
14952564|NCT01558245|Coagulants|coagulants|mesh-ancestor
14952565|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14952566|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
14952567|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14952568|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952569|NCT01558310|Ustekinumab|ustekinumab|mesh-list
14952570|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
14952571|NCT01558336|Praziquantel|praziquantel|mesh-list
14952572|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
14952573|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14235447|NCT00107536|Lapatinib|lapatinib|mesh-list
14235448|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235449|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14235450|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952574|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952575|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14952576|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952577|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
14952578|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952579|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
14235451|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235452|NCT00107653|Ribavirin|ribavirin|mesh-list
14952580|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
14952581|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14952582|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14952583|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952584|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952585|NCT01558466|Urological Agents|urological agents|mesh-ancestor
14952586|NCT01558622|Ascorbic Acid|ascorbic acid|mesh-list
14952587|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14952588|NCT01558622|Ketoprofen|ketoprofen|mesh-list
14952589|NCT01558622|Meperidine|meperidine|mesh-list
14952590|NCT01558622|Tramadol|tramadol|mesh-list
14952591|NCT01558622|Vitamins|vitamins|mesh-ancestor
14235453|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14952592|NCT01558622|Micronutrients|micronutrients|mesh-ancestor
14952593|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797454|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797455|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797456|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
14797457|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797458|NCT00774007|Mesalamine|mesalamine|mesh-list
14797459|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14797460|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14797461|NCT00774007|Analgesics|analgesics|mesh-ancestor
14797462|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
14797463|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797464|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797465|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14797466|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797467|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
14797468|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14797469|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797470|NCT00774072|Tobramycin|tobramycin|mesh-list
14797471|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797472|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797473|NCT00774111|Dolutegravir|dolutegravir|mesh-list
14797474|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14952594|NCT01558622|Antioxidants|antioxidants|mesh-ancestor
14952595|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952596|NCT01558622|Protective Agents|protective agents|mesh-ancestor
14952597|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14952598|NCT01558622|Narcotics|narcotics|mesh-ancestor
14952599|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952600|NCT01558622|Analgesics|analgesics|mesh-ancestor
14952601|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
14952602|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952603|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14952604|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14952605|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952606|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952607|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14952608|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14952609|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952610|NCT01558648|Analgesics|analgesics|mesh-list
14952611|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
14952612|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952613|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952614|NCT01558713|Fentanyl|fentanyl|mesh-list
14952615|NCT01558713|Bupivacaine|bupivacaine|mesh-list
14952616|NCT01558713|Ropivacaine|ropivacaine|mesh-list
14952617|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
14952618|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
14952619|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
14952620|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952621|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952622|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
14235454|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
14235455|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
14235456|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235457|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
14235458|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235459|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
14235460|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235461|NCT00107744|Caseins|caseins|mesh-list
14235462|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
14235463|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
14235464|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235465|NCT00107783|Nitisinone|nitisinone|mesh-list
14235466|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235467|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952623|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952624|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14952625|NCT01558713|Narcotics|narcotics|mesh-ancestor
14952626|NCT01558713|Analgesics|analgesics|mesh-ancestor
14952627|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14952628|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14952629|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
15027333|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14235468|NCT00107900|Edoxaban|edoxaban|mesh-list
15027334|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027335|NCT01949038|Alprazolam|alprazolam|mesh-list
14952630|NCT01558830|Ranolazine|ranolazine|mesh-list
14952631|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14952632|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14952633|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952634|NCT01558869|Capecitabine|capecitabine|mesh-list
14952635|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
14952636|NCT01558869|Irinotecan|irinotecan|mesh-list
14952637|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14952638|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
14952639|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952640|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952641|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14952642|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14952643|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952644|NCT01558934|Lofexidine|lofexidine|mesh-list
14952645|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14952646|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14952647|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952648|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
14952649|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952650|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14952651|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14952652|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14952653|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
14952654|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952655|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952656|NCT01558960|Melphalan|melphalan|mesh-list
14952657|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14797475|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14797476|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797477|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797478|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797479|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797480|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
14797481|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797482|NCT00774189|Clarithromycin|clarithromycin|mesh-list
14797483|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797484|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797485|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14797486|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797487|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797488|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797489|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797490|NCT00774241|Bevacizumab|bevacizumab|mesh-list
14797491|NCT00774241|Docetaxel|docetaxel|mesh-list
14797492|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14797493|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797494|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14797495|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14797496|NCT00774241|Growth Substances|growth substances|mesh-ancestor
14797497|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797498|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
14797499|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
14797500|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
14797501|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
14797502|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952658|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
14952659|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952660|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952661|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14952662|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14797503|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
14797504|NCT00774280|Busulfan|busulfan|mesh-list
14797505|NCT00774280|Fludarabine|fludarabine|mesh-list
14797506|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14797507|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
14797508|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797509|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797510|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14797511|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
14797512|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797513|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797514|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14797515|NCT00774319|Cisplatin|cisplatin|mesh-list
14797516|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797517|NCT00774358|Aldesleukin|aldesleukin|mesh-list
14797518|NCT00774358|Interleukin-2|interleukin-2|mesh-list
14797519|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797520|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14797521|NCT00774358|Analgesics|analgesics|mesh-ancestor
14797522|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
14797523|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797524|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797525|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797526|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797527|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
14797528|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797529|NCT00774423|Riluzole|riluzole|mesh-list
14797530|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
14797531|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14797532|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14797533|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797534|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797535|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797536|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14797537|NCT00774423|Protective Agents|protective agents|mesh-ancestor
14797538|NCT00774462|Rituximab|rituximab|mesh-list
14797539|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14797540|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797541|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
14797542|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797543|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797544|NCT00774475|Clopidogrel|clopidogrel|mesh-list
14797545|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14797546|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14797547|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14797548|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14797549|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
14797550|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797551|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797552|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797553|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14797554|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14797555|NCT00774488|Incretins|incretins|mesh-ancestor
14797556|NCT00774488|Hormones|hormones|mesh-ancestor
14797557|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797558|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797559|NCT00774501|Anesthetics|anesthetics|mesh-list
14797560|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797561|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797562|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
14797563|NCT00774527|Fludarabine|fludarabine|mesh-list
14797564|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14797565|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14797566|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
14797567|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797568|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797569|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14797570|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
14797571|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797572|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797573|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14797574|NCT00774540|Ketorolac|ketorolac|mesh-list
14797575|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14797576|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14797577|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14797578|NCT00774540|Analgesics|analgesics|mesh-ancestor
14797579|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
14797580|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797581|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797582|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14797583|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797584|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14797585|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797586|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797587|NCT00774605|Varenicline|varenicline|mesh-list
14797588|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14797589|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14797590|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
14797591|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797592|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797593|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797594|NCT00774644|Clarithromycin|clarithromycin|mesh-list
14797595|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952663|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
14952664|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952665|NCT01558986|Cefazolin|cefazolin|mesh-list
14952666|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952667|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952668|NCT01559025|Vildagliptin|vildagliptin|mesh-list
14952669|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14952670|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14952671|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952672|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
14952673|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952674|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952675|NCT01559051|Anesthetics|anesthetics|mesh-list
14952676|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952677|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952678|NCT01559142|Azathioprine|azathioprine|mesh-list
14952679|NCT01559142|Infliximab|infliximab|mesh-list
14952680|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
14952681|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14952682|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952683|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
14952684|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952685|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14952686|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952687|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952688|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
14952689|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952690|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14952691|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14952692|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14952693|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952694|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952695|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14952696|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14952697|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14952698|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
14952699|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952700|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952701|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14952702|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14952703|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
14952704|NCT01559285|Ropivacaine|ropivacaine|mesh-list
14952705|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
14952706|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
14952707|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952708|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952709|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
14952710|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952711|NCT01559298|Aspirin|aspirin|mesh-list
14952712|NCT01559298|Clopidogrel|clopidogrel|mesh-list
14952713|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14952714|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14952715|NCT01559298|Analgesics|analgesics|mesh-ancestor
14952716|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
14952717|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952718|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952719|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952720|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952721|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14952722|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14952723|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952724|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14952725|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14952726|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952727|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
14797596|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797597|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14797598|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797599|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797600|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797601|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14952728|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14952729|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14952730|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14952731|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
14952732|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952733|NCT01559480|Desogestrel|desogestrel|mesh-list
14952734|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14952735|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14952736|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14952737|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
14952738|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14952739|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952740|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14952741|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14952742|NCT01559480|Progestins|progestins|mesh-ancestor
14952743|NCT01559480|Hormones|hormones|mesh-ancestor
14952744|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952745|NCT01559545|Metronidazole|metronidazole|mesh-list
14952746|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952747|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952748|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14952749|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14952750|NCT01559584|Triamcinolone|triamcinolone|mesh-list
14952751|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14952752|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14952753|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14952754|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952755|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
14952756|NCT01559584|Hormones|hormones|mesh-ancestor
14952757|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952758|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952759|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952760|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
14952761|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952762|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952763|NCT01559727|Prednisone|prednisone|mesh-list
14952764|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952765|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
14952766|NCT01559727|Hormones|hormones|mesh-ancestor
14952767|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952768|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952769|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14952770|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952771|NCT01559740|Bupivacaine|bupivacaine|mesh-list
14952772|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
14952773|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
14952774|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952775|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952776|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
14952777|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952778|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14952779|NCT01559753|Amoxicillin|amoxicillin|mesh-list
14952780|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
14952781|NCT01559753|Tobramycin|tobramycin|mesh-list
14952782|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14952783|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
14952784|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
14952785|NCT01559753|Cefotaxime|cefotaxime|mesh-list
14952786|NCT01559753|Cefoxitin|cefoxitin|mesh-list
14952787|NCT01559753|Netilmicin|netilmicin|mesh-list
14952788|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952789|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14952790|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952791|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952792|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14952793|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
14952794|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14952795|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797602|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
14797603|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797604|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797605|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
14797606|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797607|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14797608|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14797609|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797610|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797611|NCT00774696|Clarithromycin|clarithromycin|mesh-list
14797612|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797613|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797614|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14797615|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797616|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797617|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797618|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797619|NCT00774722|Metronidazole|metronidazole|mesh-list
14797620|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797621|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797622|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14797623|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14797624|NCT00774735|Dolutegravir|dolutegravir|mesh-list
14797625|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14797626|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14797627|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797628|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797629|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797630|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797631|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
14797632|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797633|NCT00774813|Citalopram|citalopram|mesh-list
14797634|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14952796|NCT01559974|Vitamins|vitamins|mesh-ancestor
14952797|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
14952798|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14952799|NCT01560013|Naltrexone|naltrexone|mesh-list
14952800|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14952801|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14952802|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797635|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14797636|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797637|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797638|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797639|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
14797640|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797641|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14797642|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
14797643|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14797644|NCT00774878|Fulvestrant|fulvestrant|mesh-list
14797645|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14797646|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797647|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14797648|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14797649|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
14797650|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797651|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797652|NCT00774904|Losartan|losartan|mesh-list
14797653|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14797654|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797655|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14797656|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14797657|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797658|NCT00774969|Metronidazole|metronidazole|mesh-list
14797659|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797660|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952803|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
14952804|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952805|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
14952806|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14952807|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14952808|NCT01560052|Prednisolone|prednisolone|mesh-list
14797661|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14952809|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
14797662|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14797663|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
14797664|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
14797665|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797666|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14797667|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797668|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14797669|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
14797670|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797671|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14797672|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797673|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14797674|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
14797675|NCT00775034|Coagulants|coagulants|mesh-ancestor
14797676|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14797677|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
14797678|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14797679|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
14797680|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14797681|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797682|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14797683|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14797684|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14797685|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797686|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14797687|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14797688|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14797689|NCT00775073|Bevacizumab|bevacizumab|mesh-list
14797690|NCT00775073|Everolimus|everolimus|mesh-list
14797691|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14797692|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797693|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14797694|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14797695|NCT00775073|Growth Substances|growth substances|mesh-ancestor
14797696|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797697|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
14797698|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14797699|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
14797700|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14797701|NCT00775086|Norelgestromin|norelgestromin|mesh-list
14797702|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
14797703|NCT00775086|Estradiol|estradiol|mesh-list
14797704|NCT00775086|Estrogens|estrogens|mesh-ancestor
14797705|NCT00775086|Hormones|hormones|mesh-ancestor
14797706|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797707|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797708|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14797709|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14797710|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14797711|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14797712|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14797713|NCT00775125|Ritonavir|ritonavir|mesh-list
14797714|NCT00775125|Darunavir|darunavir|mesh-list
14797715|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
14797716|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14797717|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14797718|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
14797719|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797720|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797721|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797722|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797723|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
14797724|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797725|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797726|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797727|NCT00775151|Amlodipine|amlodipine|mesh-list
14952810|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14952811|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
14952812|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952813|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
14952814|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
14952815|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952816|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952817|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14952818|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
14952819|NCT01560052|Hormones|hormones|mesh-ancestor
14952820|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797728|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797729|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14797730|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797731|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797732|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14797733|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797734|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797735|NCT00775164|Metformin|metformin|mesh-list
14797736|NCT00775164|Pioglitazone|pioglitazone|mesh-list
14797737|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14797738|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797739|NCT00775177|Doxycycline|doxycycline|mesh-list
14797740|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797741|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797742|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
14797743|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14797744|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14797745|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14797746|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14797747|NCT00775242|Estradiol|estradiol|mesh-list
14797748|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14797749|NCT00775242|Estrogens|estrogens|mesh-list
14797750|NCT00775242|Progesterone|progesterone|mesh-list
14797751|NCT00775242|Progestins|progestins|mesh-list
14797752|NCT00775242|Hormones|hormones|mesh-ancestor
14797753|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797754|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797755|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14797756|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
14797757|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14797758|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14797759|NCT00775255|Clarithromycin|clarithromycin|mesh-list
14797760|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797761|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797762|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14797763|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797764|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797765|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797766|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797767|NCT00775294|Maraviroc|maraviroc|mesh-list
14797768|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14797769|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14797770|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797771|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14797772|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14797773|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
14797774|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952821|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14952822|NCT01560052|Protective Agents|protective agents|mesh-ancestor
14952823|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14952824|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952825|NCT01560065|Folic Acid|folic acid|mesh-list
14952826|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
14952827|NCT01560065|Inositol|inositol|mesh-list
14952828|NCT01560065|Hematinics|hematinics|mesh-ancestor
14235469|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14797775|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14797776|NCT00775359|Fenofibrate|fenofibrate|mesh-list
14797777|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14797778|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
14797779|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797780|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14797781|NCT00775372|Clarithromycin|clarithromycin|mesh-list
14797782|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14797783|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797784|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14797785|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797786|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797787|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14797788|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14797789|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
14797790|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14797791|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
14797792|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797793|NCT00775476|Expectorants|expectorants|mesh-ancestor
14797794|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
14797795|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14797796|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
14797797|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797798|NCT00775476|Protective Agents|protective agents|mesh-ancestor
14797799|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797800|NCT00775476|Antidotes|antidotes|mesh-ancestor
14797801|NCT00775489|Beclomethasone|beclomethasone|mesh-list
14797802|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14797803|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
14797804|NCT00775489|Hormones|hormones|mesh-ancestor
14797805|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797806|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797807|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14797808|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
14797809|NCT00775541|Ascorbic Acid|ascorbic acid|mesh-list
14797810|NCT00775541|Vitamins|vitamins|mesh-ancestor
14797811|NCT00775541|Micronutrients|micronutrients|mesh-ancestor
14797812|NCT00775541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797813|NCT00775541|Antioxidants|antioxidants|mesh-ancestor
14797814|NCT00775541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797815|NCT00775541|Protective Agents|protective agents|mesh-ancestor
14797816|NCT00775580|Atenolol|atenolol|mesh-list
14797817|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14797818|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797819|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
14797820|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
14797821|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797822|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797823|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14797824|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14797825|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14797826|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
14797827|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797828|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797829|NCT00775619|Carvedilol|carvedilol|mesh-list
14797830|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14797831|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14797832|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
14797833|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797834|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797835|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797836|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797837|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
14797838|NCT00775619|Protective Agents|protective agents|mesh-ancestor
14797839|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14797840|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797841|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14797842|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797843|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14797844|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14797845|NCT00775632|Cyclosporine|cyclosporine|mesh-list
14797846|NCT00775632|Methotrexate|methotrexate|mesh-list
14797847|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
14797848|NCT00775632|Cyclosporins|cyclosporins|mesh-list
14797849|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14797850|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
14797851|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14797852|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797853|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14797854|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
14797855|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797856|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797857|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
14797858|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14797859|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14797860|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14797861|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
14797862|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797863|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14797864|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
14797865|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797866|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14797867|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14797868|NCT00775697|Montelukast|montelukast|mesh-list
14797869|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
14797870|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14797871|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
14797872|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
14952829|NCT01560065|Vitamins|vitamins|mesh-ancestor
14952830|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
14952831|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952832|NCT01560091|Tamsulosin|tamsulosin|mesh-list
14952833|NCT01560091|Silodosin|silodosin|mesh-list
14952834|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14952835|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14952836|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14952837|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
14952838|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952839|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952840|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952841|NCT01560091|Urological Agents|urological agents|mesh-ancestor
14952842|NCT01560117|Rituximab|rituximab|mesh-list
14952843|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14952844|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952845|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
14952846|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952847|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14952848|NCT01560221|Buprenorphine|buprenorphine|mesh-list
14952849|NCT01560221|Methadone|methadone|mesh-list
14952850|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14952851|NCT01560221|Narcotics|narcotics|mesh-ancestor
14952852|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952853|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952854|NCT01560221|Analgesics|analgesics|mesh-ancestor
14952855|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
14952856|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952857|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14952858|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
14952859|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
14952860|NCT01560299|Methimazole|methimazole|mesh-list
14952861|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
14952862|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
14952863|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952864|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952865|NCT01560390|Ketamine|ketamine|mesh-list
14952866|NCT01560390|Analgesics|analgesics|mesh-ancestor
14952867|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
14952868|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952869|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952870|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14952871|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14952872|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
14952873|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
14952874|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952875|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14952876|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14797873|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14797874|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797875|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14797876|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14797877|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797878|NCT00775736|Insulin|insulin|mesh-list
14797879|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14952877|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952878|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952879|NCT01560442|Buprenorphine|buprenorphine|mesh-list
14952880|NCT01560442|Methadone|methadone|mesh-list
14952881|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14952882|NCT01560442|Narcotics|narcotics|mesh-ancestor
14952883|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14952884|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952885|NCT01560442|Analgesics|analgesics|mesh-ancestor
14952886|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
14952887|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952888|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14952889|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
14952890|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027336|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15027337|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027338|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027339|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15027340|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027341|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027342|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
15027343|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
15027344|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027345|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027346|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
15027347|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027348|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
15027349|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
15027350|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
15027351|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
15027352|NCT01949129|Busulfan|busulfan|mesh-list
15027353|NCT01949129|Thiotepa|thiotepa|mesh-list
15027354|NCT01949129|Treosulfan|treosulfan|mesh-list
15027355|NCT01949129|Fludarabine|fludarabine|mesh-list
15027356|NCT01949129|Etoposide|etoposide|mesh-list
15027357|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
15027358|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15027359|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
15027360|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15027361|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
15027362|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027363|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027364|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15027365|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
15027366|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027367|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027368|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15027369|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15027370|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15027371|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15027372|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027373|NCT01949168|Ribavirin|ribavirin|mesh-list
15027374|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15027375|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
15027376|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027377|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
15027378|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027379|NCT01949233|Doxycycline|doxycycline|mesh-list
15027380|NCT01949233|Irbesartan|irbesartan|mesh-list
15027381|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15027382|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027383|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
15027384|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15027385|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15027386|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15027387|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15027388|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15027389|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027390|NCT01949363|Cefixime|cefixime|mesh-list
14797880|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
14797881|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
14797882|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14797883|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
14797884|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14797885|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14952891|NCT01560481|Metformin|metformin|mesh-list
14952892|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14952893|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952894|NCT01560546|Testosterone|testosterone|mesh-list
14952895|NCT01560546|Androgens|androgens|mesh-ancestor
14952896|NCT01560546|Hormones|hormones|mesh-ancestor
14952897|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952898|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952899|NCT01560585|Isotretinoin|isotretinoin|mesh-list
14952900|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
14952901|NCT01560637|Treprostinil|treprostinil|mesh-list
14952902|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14952903|NCT01560663|Carboplatin|carboplatin|mesh-list
14952904|NCT01560663|Docetaxel|docetaxel|mesh-list
14952905|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952906|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
14952907|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
14952908|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
14952909|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952910|NCT01560689|Budesonide|budesonide|mesh-list
14952911|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
14952912|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14952913|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14952914|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
14952915|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235470|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
14235471|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14235472|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
14235473|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235474|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235475|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
14235476|NCT00107952|Vancomycin|vancomycin|mesh-list
14235477|NCT00107952|Telavancin|telavancin|mesh-list
14235478|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235479|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235480|NCT00107978|Vancomycin|vancomycin|mesh-list
14235481|NCT00107978|Telavancin|telavancin|mesh-list
14235482|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235483|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235484|NCT00107991|Etanercept|etanercept|mesh-list
14235485|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14797886|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797887|NCT00775749|Nicotine|nicotine|mesh-list
14797888|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14797889|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
14797890|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797891|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797892|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14797893|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14797894|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
14797895|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797896|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797897|NCT00775762|Aspirin|aspirin|mesh-list
14797898|NCT00775762|Clopidogrel|clopidogrel|mesh-list
14797899|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14797900|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14797901|NCT00775762|Analgesics|analgesics|mesh-ancestor
14797902|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
14797903|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14797904|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797905|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14797906|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797907|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14797908|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14797909|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797910|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14797911|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14797912|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952916|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797913|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
14797914|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14797915|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14797916|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14797917|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
14797918|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797919|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14797920|NCT00775814|Candesartan|candesartan|mesh-list
14952917|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14952918|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
14952919|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
14952920|NCT01560689|Hormones|hormones|mesh-ancestor
14952921|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14952922|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14952923|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14952924|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14952925|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
14952926|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952927|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235486|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14235487|NCT00107991|Analgesics|analgesics|mesh-ancestor
14235488|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
14235489|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235490|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235491|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235492|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235493|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14235494|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235495|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
14235496|NCT00108069|Tamoxifen|tamoxifen|mesh-list
14235497|NCT00108069|Bortezomib|bortezomib|mesh-list
14235498|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235499|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14235500|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
14235501|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235502|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235503|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235504|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14235505|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14235506|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14235507|NCT00108082|Atenolol|atenolol|mesh-list
14952928|NCT01560702|Epinephrine|epinephrine|mesh-list
14952929|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14952930|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14952931|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
14952932|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952933|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952934|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952935|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14952936|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14952937|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
14952938|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952939|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14952940|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
14952941|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
14952942|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
14952943|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14952944|NCT01560754|Nicotine|nicotine|mesh-list
14952945|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14952946|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
14952947|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952948|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952949|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14952950|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14952951|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
14952952|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952953|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952954|NCT01560962|Azithromycin|azithromycin|mesh-list
14952955|NCT01560962|Tobramycin|tobramycin|mesh-list
14952956|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
14952957|NCT01560962|Povidone|povidone|mesh-list
14952958|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14952959|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952960|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
14952961|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
14952962|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14952963|NCT01561014|Fluorouracil|fluorouracil|mesh-list
14952964|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
14952965|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14952966|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14952967|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
14952968|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952969|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14952970|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952971|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14952972|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
14952973|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235508|NCT00108082|Carvedilol|carvedilol|mesh-list
14235509|NCT00108082|Lisinopril|lisinopril|mesh-list
14235510|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14235511|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14235512|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
14235513|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235514|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235515|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235516|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14235517|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
14235518|NCT00108082|Protective Agents|protective agents|mesh-ancestor
14235519|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14235520|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235521|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235522|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
14235523|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14235524|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14235525|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14235526|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
14235527|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235528|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14952974|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14952975|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14952976|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14952977|NCT01561040|Vitamin D|vitamin d|mesh-list
14952978|NCT01561040|Vitamin A|vitamin a|mesh-list
14952979|NCT01561040|Vitamins|vitamins|mesh-ancestor
14952980|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
14235529|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14235530|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
14235531|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
14235532|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235533|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14952981|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952982|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14952983|NCT01561066|Octreotide|octreotide|mesh-list
14952984|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14952985|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14952986|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14952987|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14952988|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
14235534|NCT00108160|Mupirocin|mupirocin|mesh-list
14235535|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235536|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14952989|NCT01561066|Coagulants|coagulants|mesh-ancestor
14952990|NCT01561092|Citalopram|citalopram|mesh-list
14952991|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14797921|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797922|NCT00775814|Diuretics|diuretics|mesh-ancestor
14797923|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
14797924|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797925|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14797926|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14952992|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14952993|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235537|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14235538|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235539|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235540|NCT00108355|Octreotide|octreotide|mesh-list
14235541|NCT00108355|Midodrine|midodrine|mesh-list
14235542|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14235543|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235544|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235545|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
14235546|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
14235547|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14952994|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14952995|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14952996|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
14952997|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14952998|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14952999|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
14953000|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953001|NCT01561131|Calcium|calcium|mesh-list
14953002|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235548|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235549|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14235550|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14235551|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14235552|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14235553|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
14235554|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235555|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235556|NCT00108485|Niacin|niacin|mesh-list
14235557|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14235558|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
14235559|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235560|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14953003|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235561|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
14235562|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
14235563|NCT00108485|Vitamins|vitamins|mesh-ancestor
14235564|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
14235565|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235566|NCT00108524|Orlistat|orlistat|mesh-list
14235567|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235568|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235569|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14235570|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14235571|NCT00108550|Gabapentin|gabapentin|mesh-list
14235572|NCT00108550|Analgesics|analgesics|mesh-ancestor
14235573|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
14235574|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235575|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235576|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
14235577|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14235578|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14235579|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14235580|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14797927|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797928|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14797929|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14797930|NCT00775827|Fenofibrate|fenofibrate|mesh-list
14797931|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14797932|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
14797933|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797934|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14235581|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14953004|NCT01561209|Amitriptyline|amitriptyline|mesh-list
14953005|NCT01561209|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14953006|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14953007|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
14797935|NCT00775840|Candesartan|candesartan|mesh-list
14797936|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797937|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14797938|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14797939|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797940|NCT00775879|Sevoflurane|sevoflurane|mesh-list
14797941|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14797942|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14953008|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953009|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953010|NCT01561209|Analgesics|analgesics|mesh-ancestor
14953011|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
14953012|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953013|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953014|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14953015|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14953016|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14953017|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953018|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
14953019|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953020|NCT01561209|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14953021|NCT01561209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14953022|NCT01561209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953023|NCT01561222|Calcitriol|calcitriol|mesh-list
14953024|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14953025|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953026|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14953027|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14953028|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953029|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14953030|NCT01561222|Vitamins|vitamins|mesh-ancestor
14953031|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
14953032|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14953033|NCT01561235|Hormones|hormones|mesh-list
14953034|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14953035|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953036|NCT01561274|Bupivacaine|bupivacaine|mesh-list
14953037|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
14953038|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
14953039|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953040|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953041|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
14235582|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14235583|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235584|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235585|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
14953042|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953043|NCT01561391|Factor VIII|factor viii|mesh-list
14953044|NCT01561391|Coagulants|coagulants|mesh-ancestor
14953045|NCT01561404|Everolimus|everolimus|mesh-list
14953046|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953047|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953048|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
14953049|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953050|NCT01561456|Docetaxel|docetaxel|mesh-list
14953051|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953052|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235586|NCT00108732|Metronidazole|metronidazole|mesh-list
14235587|NCT00108732|Goserelin|goserelin|mesh-list
14235588|NCT00108732|Bicalutamide|bicalutamide|mesh-list
14235589|NCT00108732|Vaccines|vaccines|mesh-list
14235590|NCT00108732|Sargramostim|sargramostim|mesh-list
14235591|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
14953053|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
14953054|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953055|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235592|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235593|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14242818|NCT00191113|Estradiol|estradiol|mesh-list
14797943|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
14797944|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
14797945|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797946|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797947|NCT00775905|Amlodipine|amlodipine|mesh-list
14235594|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235595|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
14235596|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
14235597|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235598|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235599|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235600|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14953056|NCT01561482|Metformin|metformin|mesh-list
14797948|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797949|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14797950|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14797951|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797952|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14797953|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797954|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
14797955|NCT00775918|Doxycycline|doxycycline|mesh-list
14797956|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953057|NCT01561482|Simvastatin|simvastatin|mesh-list
14953058|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14235601|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14235602|NCT00108745|Paclitaxel|paclitaxel|mesh-list
14235603|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14235604|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14235605|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14953059|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953060|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14953061|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14953062|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
14953063|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953064|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14953065|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14953066|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953067|NCT01561508|Butyric Acid|butyric acid|mesh-list
14953068|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
14953069|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
14953070|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953071|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953072|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953073|NCT01561586|Cisplatin|cisplatin|mesh-list
14953074|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953075|NCT01561742|Minocycline|minocycline|mesh-list
14953076|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953077|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953078|NCT01561781|Digoxin|digoxin|mesh-list
14235606|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235607|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
14797957|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14797958|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
14797959|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14797960|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14235608|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
14235609|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
14235610|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235611|NCT00108953|Doxorubicin|doxorubicin|mesh-list
14235612|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14235613|NCT00108953|Sorafenib|sorafenib|mesh-list
14235614|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235615|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797961|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
14797962|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
14953079|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14953080|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14953081|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953082|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953083|NCT01561781|Protective Agents|protective agents|mesh-ancestor
14953084|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235616|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14797963|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14797964|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14953085|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
14953086|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953087|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953088|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14953089|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14953090|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953091|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953092|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953093|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14953094|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14953095|NCT01561911|Antibodies|antibodies|mesh-list
14953096|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14953097|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
14953098|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953099|NCT01561937|Warfarin|warfarin|mesh-list
14953100|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
14953101|NCT01561950|Clopidogrel|clopidogrel|mesh-list
14953102|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14953103|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14953104|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14235617|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235618|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235619|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235620|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14235621|NCT00109005|Lenalidomide|lenalidomide|mesh-list
14235622|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
14522787|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14522788|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522789|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522790|NCT03554772|Celecoxib|celecoxib|mesh-list
14522791|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14522792|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14522793|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522794|NCT03554772|Analgesics|analgesics|mesh-ancestor
14522795|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
14953105|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14953106|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
14953107|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953108|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953109|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953110|NCT01562197|Axitinib|axitinib|mesh-list
14953111|NCT01562197|Lomustine|lomustine|mesh-list
14953112|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953113|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14953114|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953115|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953116|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14953117|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
14953118|NCT01562210|Olaparib|olaparib|mesh-list
14953119|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953120|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14953121|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953122|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953123|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
14953124|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953125|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14953126|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
15027391|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15027392|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027393|NCT01949454|Fluorometholone|fluorometholone|mesh-list
15027394|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14235623|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235624|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14235625|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14235626|NCT00109005|Growth Substances|growth substances|mesh-ancestor
14235627|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
14235628|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235629|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
14235630|NCT00109031|Etoposide|etoposide|mesh-list
14953127|NCT01562301|Carboplatin|carboplatin|mesh-list
14953128|NCT01562301|Docetaxel|docetaxel|mesh-list
14953129|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953130|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
14953131|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
14953132|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953133|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953134|NCT01562405|Dexamethasone|dexamethasone|mesh-list
14953135|NCT01562405|Lenalidomide|lenalidomide|mesh-list
14953136|NCT01562405|Pomalidomide|pomalidomide|mesh-list
14953137|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953138|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
14953139|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
14953140|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953141|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953142|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14953143|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
14953144|NCT01562405|Hormones|hormones|mesh-ancestor
14953145|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14953146|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14953147|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953148|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
14953149|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14953150|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14953151|NCT01562405|Growth Substances|growth substances|mesh-ancestor
14953152|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14953153|NCT01562483|Dronabinol|dronabinol|mesh-list
14953154|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
14953155|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953156|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953157|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953158|NCT01562483|Analgesics|analgesics|mesh-ancestor
14953159|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
14953160|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953161|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14953162|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14953163|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953164|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953165|NCT01562483|Hormones|hormones|mesh-ancestor
14953166|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14953167|NCT01562561|Repaglinide|repaglinide|mesh-list
14953168|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
14953169|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
14953170|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
14953171|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14953172|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953173|NCT01562626|Flucytosine|flucytosine|mesh-list
14953174|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
14953175|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953176|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
14953177|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953178|NCT01562691|Petrolatum|petrolatum|mesh-list
14953179|NCT01562691|Emollients|emollients|mesh-ancestor
14953180|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
14953181|NCT01562704|Acetaminophen|acetaminophen|mesh-list
14953182|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953183|NCT01562704|Analgesics|analgesics|mesh-ancestor
14953184|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
14953185|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953186|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953187|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
14953188|NCT01562717|Ibuprofen|ibuprofen|mesh-list
14953189|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14953190|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953191|NCT01562717|Analgesics|analgesics|mesh-ancestor
14953192|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
14953193|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953194|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953195|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953196|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953197|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14953198|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953199|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953200|NCT01562795|Fluorometholone|fluorometholone|mesh-list
14953201|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14953202|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
14953203|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14953204|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14953205|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
14953206|NCT01562795|Hormones|hormones|mesh-ancestor
14953207|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14953208|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953209|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14953210|NCT01562808|Aripiprazole|aripiprazole|mesh-list
14953211|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
14953212|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953213|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14953214|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14953215|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953216|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953217|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
14953218|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
14953219|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953220|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953221|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14953222|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14953223|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
14953224|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14953225|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14235631|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235632|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
14235633|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235634|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235635|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235636|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
14235637|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235638|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235639|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14235640|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235641|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14235642|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235643|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235644|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14235645|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
14235646|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797965|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14797966|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953226|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14953227|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14953228|NCT01562951|Adalimumab|adalimumab|mesh-list
14953229|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953230|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14797967|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14797968|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
14797969|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
14797970|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797971|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797972|NCT00776022|Cetirizine|cetirizine|mesh-list
14953231|NCT01562977|Gemcitabine|gemcitabine|mesh-list
14953232|NCT01562977|Rituximab|rituximab|mesh-list
14953233|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
14953234|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14953235|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953236|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
14953237|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953238|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953239|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14953240|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
14953241|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953242|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
14953243|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953244|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953245|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953246|NCT01562990|Gemcitabine|gemcitabine|mesh-list
14953247|NCT01562990|Rituximab|rituximab|mesh-list
14953248|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14953249|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
14953250|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14953251|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953252|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
14953253|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953254|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953255|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14953256|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
14953257|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953258|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
14953259|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953260|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953261|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953262|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14953263|NCT01563068|Calcipotriene|calcipotriene|mesh-list
14953264|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
14953265|NCT01563120|Metformin|metformin|mesh-list
14953266|NCT01563120|Glyburide|glyburide|mesh-list
14953267|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14953268|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953269|NCT01563224|Baclofen|baclofen|mesh-list
14953270|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14953271|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953272|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14953273|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953274|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14953275|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
14953276|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
14953277|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953278|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953279|NCT01563289|Ibuprofen|ibuprofen|mesh-list
14953280|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14953281|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953282|NCT01563289|Analgesics|analgesics|mesh-ancestor
14953283|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
14953284|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953285|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953286|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953287|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953288|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14953289|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953290|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953291|NCT01563328|Dolutegravir|dolutegravir|mesh-list
14953292|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14953293|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14953294|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953295|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953296|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14953297|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14953298|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
14953299|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953300|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14953301|NCT01563367|Hematinics|hematinics|mesh-ancestor
14953302|NCT01563601|Carboplatin|carboplatin|mesh-list
14953303|NCT01563601|Etoposide|etoposide|mesh-list
14953304|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
14953305|NCT01563601|Obatoclax|obatoclax|mesh-list
14953306|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953307|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14953308|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14953309|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14953310|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953311|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953312|NCT01563614|Cytarabine|cytarabine|mesh-list
14953313|NCT01563614|Lomustine|lomustine|mesh-list
15027395|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
14235647|NCT00109473|Prednisone|prednisone|mesh-list
14235648|NCT00109473|Hormones|hormones|mesh-list
14235649|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235650|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
14235651|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14953314|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14953315|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
14953316|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953317|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953318|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
14953319|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953320|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953321|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
14953322|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953323|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14953324|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
14953325|NCT01563640|Permethrin|permethrin|mesh-list
14953326|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953327|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953328|NCT01563718|Naltrexone|naltrexone|mesh-list
14953329|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14953330|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14953331|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953332|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
14953333|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953334|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
14953335|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
14953336|NCT01563731|Atorvastatin|atorvastatin|mesh-list
14953337|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14953338|NCT01563731|Simvastatin|simvastatin|mesh-list
14953339|NCT01563731|Pravastatin|pravastatin|mesh-list
14953340|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14953341|NCT01563731|Diuretics|diuretics|mesh-list
14953342|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14953343|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14953344|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14953345|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
14953346|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14953347|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953348|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14953349|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14953350|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
14953351|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953352|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14953353|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14953354|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
14953355|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
14953356|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14953357|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
14953358|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235652|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235653|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235654|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235655|NCT00109590|Ritonavir|ritonavir|mesh-list
14953359|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14953360|NCT01563835|Fentanyl|fentanyl|mesh-list
14953361|NCT01563835|Bupivacaine|bupivacaine|mesh-list
14953362|NCT01563835|Citric Acid|citric acid|mesh-list
14953363|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
14953364|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
14953365|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
14953366|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953367|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953368|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
14953369|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953370|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14953371|NCT01563835|Narcotics|narcotics|mesh-ancestor
14953372|NCT01563835|Analgesics|analgesics|mesh-ancestor
14953373|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14953374|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14953375|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
14235656|NCT00109590|Lopinavir|lopinavir|mesh-list
14953376|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
14953377|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14953378|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
14953379|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
14953380|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953381|NCT01563939|Remifentanil|remifentanil|mesh-list
14953382|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14953383|NCT01563939|Narcotics|narcotics|mesh-ancestor
14953384|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953385|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953386|NCT01563939|Analgesics|analgesics|mesh-ancestor
14953387|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
14953388|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953389|NCT01563952|Sirolimus|sirolimus|mesh-list
14953390|NCT01563952|Umirolimus|umirolimus|mesh-list
14953391|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953392|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953393|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14953394|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953395|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
14953396|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953397|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
14953398|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953399|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027396|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14797973|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14797974|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14797975|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14797976|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
14797977|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
14797978|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797979|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797980|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797981|NCT00776074|Leuprolide|leuprolide|mesh-list
14797982|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14797983|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
14797984|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14797985|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14797986|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14797987|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14797988|NCT00776113|Carvedilol|carvedilol|mesh-list
14797989|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14797990|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14797991|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
14797992|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14797993|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14797994|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027397|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235657|NCT00109590|Zidovudine|zidovudine|mesh-list
14235658|NCT00109590|Nevirapine|nevirapine|mesh-list
14235659|NCT00109590|Didanosine|didanosine|mesh-list
14235660|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14235661|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14235662|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
14235663|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235664|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235665|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15027398|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
15027399|NCT01949454|Hormones|hormones|mesh-ancestor
14235666|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14953400|NCT01564095|Tryptophan|tryptophan|mesh-list
14953401|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14953402|NCT01564095|Tacrolimus|tacrolimus|mesh-list
14953403|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953404|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
14953405|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953406|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14953407|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953408|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953409|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14953410|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
14953411|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953412|NCT01564108|Ranibizumab|ranibizumab|mesh-list
14953413|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14953414|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14953415|NCT01564108|Growth Substances|growth substances|mesh-ancestor
14953416|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953417|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
14953418|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953419|NCT01564199|Fluticasone|fluticasone|mesh-list
14235667|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
14235668|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235669|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14235670|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14235671|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
14235672|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14235673|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14235674|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14235675|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14235676|NCT00109733|Hormones|hormones|mesh-list
14235677|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235678|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235679|NCT00109772|Lenalidomide|lenalidomide|mesh-list
14235680|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
14235681|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235682|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14235683|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14235684|NCT00109772|Growth Substances|growth substances|mesh-ancestor
14235685|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
14235686|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235687|NCT00109837|Leucovorin|leucovorin|mesh-list
14235688|NCT00109837|Cytarabine|cytarabine|mesh-list
14235689|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14235690|NCT00109837|Dexamethasone|dexamethasone|mesh-list
14235691|NCT00109837|Prednisone|prednisone|mesh-list
14235692|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
14235693|NCT00109837|Doxorubicin|doxorubicin|mesh-list
14235694|NCT00109837|Methotrexate|methotrexate|mesh-list
14235695|NCT00109837|Vincristine|vincristine|mesh-list
14235696|NCT00109837|Daunorubicin|daunorubicin|mesh-list
14235697|NCT00109837|Asparaginase|asparaginase|mesh-list
14235698|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
14235699|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
14953420|NCT01564199|Xhance|xhance|mesh-list
14953421|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14953422|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953423|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14953424|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
14953425|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953426|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953427|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14953428|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
14953429|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
14953430|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14953431|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14953432|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14953433|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14953434|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
14953435|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953436|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953437|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
14953438|NCT01564238|Calcium|calcium|mesh-list
14953439|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14953440|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235700|NCT00109837|Thioguanine|thioguanine|mesh-list
14953441|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14235701|NCT00109837|Allopurinol|allopurinol|mesh-list
14953442|NCT01564251|Gemcitabine|gemcitabine|mesh-list
14953443|NCT01564251|GDC-0575|gdc-0575|mesh-list
14953444|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14953445|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
14953446|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953447|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953448|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
14953449|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953450|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953451|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953452|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
14953453|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953454|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14953455|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
14953456|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14953457|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14953458|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
14953459|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953460|NCT01564303|Expectorants|expectorants|mesh-ancestor
14953461|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
14953462|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14953463|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
14953464|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953465|NCT01564303|Protective Agents|protective agents|mesh-ancestor
14953466|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953467|NCT01564303|Antidotes|antidotes|mesh-ancestor
14953468|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14953469|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953470|NCT01564329|Endostar protein|endostar protein|mesh-list
14953471|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14953472|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14953473|NCT01564329|Growth Substances|growth substances|mesh-ancestor
14953474|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953475|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
14953476|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953477|NCT01564355|Triamcinolone|triamcinolone|mesh-list
14953478|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953479|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
14953480|NCT01564355|Hormones|hormones|mesh-ancestor
14953481|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14953482|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953483|NCT01564381|Resveratrol|resveratrol|mesh-list
14953484|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
14953485|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953486|NCT01564381|Protective Agents|protective agents|mesh-ancestor
14953487|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953488|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953489|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14953490|NCT01564550|Insulin|insulin|mesh-list
14953491|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14953492|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14953493|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953494|NCT01564576|Bromides|bromides|mesh-list
14953495|NCT01564576|Rocuronium|rocuronium|mesh-list
14953496|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
14953497|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14953498|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14953499|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14953500|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953501|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953502|NCT01564680|Acetaminophen|acetaminophen|mesh-list
14953503|NCT01564680|Lornoxicam|lornoxicam|mesh-list
14953504|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953505|NCT01564680|Analgesics|analgesics|mesh-ancestor
14953506|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
14953507|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953508|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953509|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
14953510|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14953511|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953512|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953513|NCT01564810|Cetuximab|cetuximab|mesh-list
14953514|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14953515|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953516|NCT01564823|Metronidazole|metronidazole|mesh-list
14953517|NCT01564823|Adalimumab|adalimumab|mesh-list
14953518|NCT01564823|Azathioprine|azathioprine|mesh-list
14953519|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953520|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953521|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953522|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953523|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14953524|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14953525|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
14953526|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953527|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14953528|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953529|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953530|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
14953531|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953532|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
14953533|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953534|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14953535|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953536|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953537|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
14953538|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14953539|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14953540|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14953541|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14953542|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953543|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
14953544|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953545|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953546|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14953547|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953548|NCT01565018|Rotigotine|rotigotine|mesh-list
14953549|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
14953550|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
14953551|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953552|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953553|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953554|NCT01565096|Metformin|metformin|mesh-list
14953555|NCT01565096|Glimepiride|glimepiride|mesh-list
14953556|NCT01565096|Vildagliptin|vildagliptin|mesh-list
14953557|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14953558|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953559|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14953560|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953561|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
14953562|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14953563|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
14953564|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953565|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953566|NCT01565109|Docetaxel|docetaxel|mesh-list
14953567|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953568|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
14953569|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
14953570|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953571|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953572|NCT01565200|Trastuzumab|trastuzumab|mesh-list
14235702|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235703|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
14235704|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235705|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953573|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14953574|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14953575|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953576|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14953577|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14953578|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953579|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953580|NCT01565239|Thrombin|thrombin|mesh-list
14953581|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
14953582|NCT01565239|Coagulants|coagulants|mesh-ancestor
14953583|NCT01565265|Cetrorelix|cetrorelix|mesh-list
14953584|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14953585|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14953586|NCT01565265|Hormones|hormones|mesh-ancestor
14953587|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242819|NCT00191113|Hormones|hormones|mesh-ancestor
14953588|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953589|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14953590|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
14953591|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14235706|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235707|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
14235708|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235709|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235710|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14953592|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
14953593|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14953594|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14235711|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235712|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
14235713|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
14235714|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235715|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14235716|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
14953595|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14953596|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14953597|NCT01565512|Bupivacaine|bupivacaine|mesh-list
14953598|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
14797995|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14797996|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
14797997|NCT00776113|Protective Agents|protective agents|mesh-ancestor
14797998|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14797999|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14235717|NCT00109837|Hormones|hormones|mesh-ancestor
14953599|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
14953600|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953601|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953602|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
14953603|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953604|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
14953605|NCT01565590|Propofol|propofol|mesh-list
14953606|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14953607|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953608|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953609|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14953610|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
14953611|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
14953612|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953613|NCT01565590|Analgesics|analgesics|mesh-ancestor
14953614|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
14953615|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953616|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14953617|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14953618|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14953619|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
14953620|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953621|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953622|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
14953623|NCT01565720|Isavuconazole|isavuconazole|mesh-list
14953624|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953625|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953626|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14953627|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14953628|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953629|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798000|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14798001|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
14798002|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14798003|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14953630|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953631|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
14953632|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
14235718|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235719|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14953633|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
14953634|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14953635|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14953636|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953637|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14953638|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027400|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027401|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027402|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14235720|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235721|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14235722|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235723|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235724|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15027403|NCT01949519|Lycopene|lycopene|mesh-list
15027404|NCT01949519|Docetaxel|docetaxel|mesh-list
15027405|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027406|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
15027407|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
15027408|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
15027409|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027410|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027411|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
15027412|NCT01949519|Protective Agents|protective agents|mesh-ancestor
15027413|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027414|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15027415|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15027416|NCT01949571|Mirtazapine|mirtazapine|mesh-list
15027417|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
15027418|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027419|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15027420|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
15027421|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
15027422|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235725|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
14235726|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14235727|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235728|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
14235729|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
14235730|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14235731|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14235732|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
14235733|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235734|NCT00109837|Antidotes|antidotes|mesh-ancestor
14235735|NCT00109837|Protective Agents|protective agents|mesh-ancestor
14235736|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
14235737|NCT00109837|Vitamins|vitamins|mesh-ancestor
14235738|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
14235739|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235740|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235741|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
15027423|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027424|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027425|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15027426|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027427|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027428|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15027429|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15027430|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15027431|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
15027432|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15027433|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15027434|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
15027435|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15027436|NCT01949675|Vaccines|vaccines|mesh-list
15027437|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
15027438|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953639|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
14953640|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
14953641|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953642|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953643|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953644|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
14953645|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14953646|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953647|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953648|NCT01565772|Etoposide|etoposide|mesh-list
14953649|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953650|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14953651|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14953652|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14953653|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953654|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953655|NCT01565798|Copper|copper|mesh-list
14953656|NCT01565798|Trace Elements|trace elements|mesh-ancestor
14953657|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
14953658|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953659|NCT01565837|Ipilimumab|ipilimumab|mesh-list
14953660|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14953661|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953662|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14953663|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953664|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
14953665|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
14953666|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14953667|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953668|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14953669|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
14953670|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953671|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953672|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953673|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953674|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14953675|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14953676|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953677|NCT01566240|Paclitaxel|paclitaxel|mesh-list
14953678|NCT01566240|Carboplatin|carboplatin|mesh-list
14953679|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14953680|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953681|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
14953682|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
14953683|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953684|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953685|NCT01566253|Acetaminophen|acetaminophen|mesh-list
14953686|NCT01566253|Ketoprofen|ketoprofen|mesh-list
14953687|NCT01566253|Morphine|morphine|mesh-list
14953688|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14953689|NCT01566253|Narcotics|narcotics|mesh-ancestor
14953690|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953691|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953692|NCT01566253|Analgesics|analgesics|mesh-ancestor
14953693|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
14953694|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953695|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953696|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
14953697|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14953698|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953699|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953700|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14953701|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953702|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953703|NCT01566266|Amoxicillin|amoxicillin|mesh-list
14953704|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953705|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953706|NCT01566279|Everolimus|everolimus|mesh-list
14953707|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953708|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953709|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
14953710|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953711|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
14953712|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14953713|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14953714|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14953715|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14953716|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953717|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
14953718|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953719|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953720|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14953721|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953722|NCT01566422|Vancomycin|vancomycin|mesh-list
14953723|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953724|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953725|NCT01566474|Melatonin|melatonin|mesh-list
14953726|NCT01566474|Omeprazole|omeprazole|mesh-list
14953727|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
14953728|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953729|NCT01566474|Protective Agents|protective agents|mesh-ancestor
14953730|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953731|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953732|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14953733|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14953734|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14953735|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953736|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14953737|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
14953738|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953739|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14953740|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14953741|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953742|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953743|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14953744|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
14953745|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953746|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14953747|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14953748|NCT01566565|Theophylline|theophylline|mesh-list
14953749|NCT01566565|Bambuterol|bambuterol|mesh-list
14953750|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14953751|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
14953752|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953753|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953754|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14953755|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
14953756|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14953757|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953758|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953759|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
14953760|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14953761|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14953762|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
14953763|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953764|NCT01566578|Mitogens|mitogens|mesh-list
14953765|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953766|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953767|NCT01566643|Metronidazole|metronidazole|mesh-list
14953768|NCT01566643|Rabeprazole|rabeprazole|mesh-list
14953769|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953770|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14953771|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14953772|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14953773|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14953774|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14953775|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14953776|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953777|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953778|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14953779|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
14953780|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953781|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953782|NCT01566669|Parecoxib|parecoxib|mesh-list
14953783|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14953784|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14953785|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953786|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953787|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14953788|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953789|NCT01566669|Analgesics|analgesics|mesh-ancestor
14953790|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
14953791|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953792|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953793|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953794|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953795|NCT01566734|Cefazolin|cefazolin|mesh-list
14953796|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235742|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953797|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953798|NCT01566760|Fesoterodine|fesoterodine|mesh-list
14235743|NCT00109837|Analgesics|analgesics|mesh-ancestor
14235744|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
14235745|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
14235746|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14235747|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
14235748|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14953799|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14953800|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14953801|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
14953802|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953803|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235749|NCT00109837|Renal Agents|renal agents|mesh-ancestor
14235750|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235751|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
14235752|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14235753|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14235754|NCT00109850|Irinotecan|irinotecan|mesh-list
14235755|NCT00109850|Cetuximab|cetuximab|mesh-list
14235756|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235757|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14235758|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235759|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235760|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235761|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235762|NCT00109928|Gemcitabine|gemcitabine|mesh-list
14235763|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
14235764|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14235765|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14235766|NCT00109928|Prednisolone|prednisolone|mesh-list
14235767|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
14235768|NCT00109928|Etoposide|etoposide|mesh-list
14235769|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14235770|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
14235771|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235772|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235773|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
14235774|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235775|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
14235776|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235777|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235778|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235779|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
14235780|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235781|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235782|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14953804|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953805|NCT01566760|Urological Agents|urological agents|mesh-ancestor
14953806|NCT01566799|Metformin|metformin|mesh-list
14953807|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14953808|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953809|NCT01566825|Amitriptyline|amitriptyline|mesh-list
14953810|NCT01566825|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14953811|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14235783|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14953812|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235784|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14235785|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
14235786|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
14235787|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14235788|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14235789|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
14235790|NCT00109928|Hormones|hormones|mesh-ancestor
14235791|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235792|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14235793|NCT00109928|Protective Agents|protective agents|mesh-ancestor
14235794|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14953813|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953814|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953815|NCT01566825|Analgesics|analgesics|mesh-ancestor
14953816|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
14953817|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953818|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953819|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14798004|NCT00776139|Cetirizine|cetirizine|mesh-list
14798005|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14798006|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14798007|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14798008|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
14798009|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
14953820|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14953821|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14953822|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953823|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
14953824|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953825|NCT01566825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14953826|NCT01566825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14953827|NCT01566825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953828|NCT01566890|Regadenoson|regadenoson|mesh-list
14953829|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14953830|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14953831|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
14953832|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
14235795|NCT00109967|Sirolimus|sirolimus|mesh-list
14235796|NCT00109967|Rituximab|rituximab|mesh-list
14235797|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235798|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235799|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
14235800|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953833|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953834|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953835|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953836|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
14953837|NCT01566942|Irinotecan|irinotecan|mesh-list
14953838|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953839|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14798010|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798011|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798012|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953840|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14953841|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953842|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953843|NCT01567072|Ibuprofen|ibuprofen|mesh-list
14235801|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235802|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14235803|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235804|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14235805|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
14235806|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235807|NCT00110019|Paclitaxel|paclitaxel|mesh-list
14235808|NCT00110019|Carboplatin|carboplatin|mesh-list
14235809|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14235810|NCT00110019|Sorafenib|sorafenib|mesh-list
14235811|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235812|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235813|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235814|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
14798013|NCT00776217|Loratadine|loratadine|mesh-list
14798014|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
14953844|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14235815|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953845|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14953846|NCT01567072|Analgesics|analgesics|mesh-ancestor
14953847|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
14953848|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953849|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953850|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14953851|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953852|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14953853|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953854|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953855|NCT01567111|Metomidate|metomidate|mesh-list
14953856|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14953857|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953858|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953859|NCT01567124|Moxonidine|moxonidine|mesh-list
14953860|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14953861|NCT01567202|Vaccines|vaccines|mesh-list
14953862|NCT01567202|Immunologic Factors|immunologic factors|mesh-ancestor
14953863|NCT01567202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953864|NCT01567215|Ethanol|ethanol|mesh-list
14953865|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
14953866|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14953867|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953868|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953869|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953870|NCT01567358|Infliximab|infliximab|mesh-list
14953871|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
14953872|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14953873|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953874|NCT01567384|Pemetrexed|pemetrexed|mesh-list
14953875|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953876|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953877|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953878|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14953879|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14953880|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14953881|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
14953882|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14953883|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14953884|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953885|NCT01567475|Rituximab|rituximab|mesh-list
14953886|NCT01567475|Everolimus|everolimus|mesh-list
14953887|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14953888|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953889|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
14953890|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953891|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953892|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953893|NCT01567488|Everolimus|everolimus|mesh-list
14953894|NCT01567488|Octreotide|octreotide|mesh-list
14953895|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953896|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953897|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
14953898|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953899|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14953900|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14953901|NCT01567501|Cetirizine|cetirizine|mesh-list
14953902|NCT01567501|Levocetirizine|levocetirizine|mesh-list
14953903|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14798015|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798016|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14798017|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14798018|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14798019|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
14798020|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
14798021|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798022|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798023|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798024|NCT00776282|Loratadine|loratadine|mesh-list
14798025|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
14798026|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798027|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14798028|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14798029|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14798030|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
14953904|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14953905|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
14953906|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
14953907|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953908|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953909|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953910|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14953911|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14953912|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14953913|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953914|NCT01567540|Incretins|incretins|mesh-ancestor
14953915|NCT01567540|Hormones|hormones|mesh-ancestor
14953916|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14953917|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14953918|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
14953919|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953920|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027439|NCT01949714|Epinephrine|epinephrine|mesh-list
15027440|NCT01949714|Racepinephrine|racepinephrine|mesh-list
15027441|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
15027442|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15027443|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15027444|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
15027445|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027446|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027447|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027448|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15027449|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15027450|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
15027451|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027452|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15027453|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027454|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
15027455|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
15027456|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15027457|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
15027458|NCT01949766|Glycerol|glycerol|mesh-list
15027459|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15027460|NCT01949766|Protective Agents|protective agents|mesh-ancestor
15027461|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027462|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027463|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
15027464|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15027465|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
15027466|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027467|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
15027468|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027469|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027470|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15027471|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
15027472|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027473|NCT01949818|Prednisone|prednisone|mesh-list
15027474|NCT01949818|Prednisolone|prednisolone|mesh-list
15027475|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
15027476|NCT01949818|Doxorubicin|doxorubicin|mesh-list
15027477|NCT01949818|Vincristine|vincristine|mesh-list
15027478|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15027479|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
15027480|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027481|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14953921|NCT01567605|Lidocaine|lidocaine|mesh-list
14953922|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
14953923|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
14953924|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953925|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953926|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
14953927|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953928|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14953929|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14953930|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14953931|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14953932|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953933|NCT01567618|Docetaxel|docetaxel|mesh-list
14953934|NCT01567618|Fluorouracil|fluorouracil|mesh-list
14953935|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953936|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
14953937|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
14953938|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
14953939|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953940|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
14953941|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14953942|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14953943|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
14953944|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953945|NCT01567657|Midazolam|midazolam|mesh-list
14953946|NCT01567657|Meperidine|meperidine|mesh-list
14953947|NCT01567657|Propofol|propofol|mesh-list
14953948|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14953949|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14953950|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953951|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14953952|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
14953953|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
14953954|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14953955|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14953956|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14953957|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14953958|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
14953959|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
14953960|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14953961|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953962|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14953963|NCT01567657|Narcotics|narcotics|mesh-ancestor
14953964|NCT01567657|Analgesics|analgesics|mesh-ancestor
14953965|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
14953966|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953967|NCT01567670|Naloxone|naloxone|mesh-list
14953968|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14953969|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953970|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
14953971|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14953972|NCT01567683|Imiquimod|imiquimod|mesh-list
14953973|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14953974|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
14953975|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14953976|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953977|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
14953978|NCT01567709|Vorinostat|vorinostat|mesh-list
14953979|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14953980|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14953981|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953982|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953983|NCT01567735|Simeprevir|simeprevir|mesh-list
14953984|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
14953985|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14953986|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
14953987|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953988|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953989|NCT01567774|Atorvastatin|atorvastatin|mesh-list
14953990|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14953991|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14953992|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14953993|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
14953994|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14953995|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14953996|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14953997|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14953998|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
14953999|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14954000|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954001|NCT01567930|Sirolimus|sirolimus|mesh-list
14954002|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14954003|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954004|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14954005|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954006|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
14954007|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954008|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
14954009|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954010|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
14954011|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954012|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
14954013|NCT01567995|Hormones|hormones|mesh-ancestor
14954014|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954015|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954016|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14954017|NCT01568125|Incretins|incretins|mesh-list
14954018|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954019|NCT01568125|Hormones|hormones|mesh-ancestor
14954020|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954021|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
14954022|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14954023|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954024|NCT01568268|Palonosetron|palonosetron|mesh-list
14954025|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
14954026|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
14235816|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235817|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14235818|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235819|NCT00110084|Gemcitabine|gemcitabine|mesh-list
14235820|NCT00110084|Paclitaxel|paclitaxel|mesh-list
14235821|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14235822|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235823|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235824|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235825|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
14235826|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
14235827|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235828|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235829|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
14235830|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
14235831|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954027|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954028|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954029|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954030|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14954031|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14954032|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
14954033|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954034|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954035|NCT01568281|Anastrozole|anastrozole|mesh-list
14954036|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14954037|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954038|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14954039|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14954040|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954041|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954042|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14954043|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
14954044|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954045|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954046|NCT01568294|Pomalidomide|pomalidomide|mesh-list
14954047|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
14954048|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954049|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14235832|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235833|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235834|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
14235835|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235836|NCT00110149|Rituximab|rituximab|mesh-list
14235837|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235838|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235839|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
14235840|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235841|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954050|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14954051|NCT01568294|Growth Substances|growth substances|mesh-ancestor
14954052|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
14954053|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954054|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
14235842|NCT00110214|Prednisone|prednisone|mesh-list
14235843|NCT00110214|Bevacizumab|bevacizumab|mesh-list
14235844|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14954055|NCT01568307|Serotonin|serotonin|mesh-list
14954056|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14235845|NCT00110214|Docetaxel|docetaxel|mesh-list
14954057|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954058|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14954059|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
14954060|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954061|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954062|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954063|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14954064|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954065|NCT01568333|Decitabine|decitabine|mesh-list
14954066|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14954067|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
14954068|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954069|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954070|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954071|NCT01568411|Itraconazole|itraconazole|mesh-list
14954072|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
14954073|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954074|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14954075|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14954076|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954077|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954078|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14954079|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
14954080|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954081|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954082|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14954083|NCT01568450|Oxycodone|oxycodone|mesh-list
14954084|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14954085|NCT01568450|Narcotics|narcotics|mesh-ancestor
14954086|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954087|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954088|NCT01568450|Analgesics|analgesics|mesh-ancestor
14954089|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
14954090|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954091|NCT01568632|Imetelstat|imetelstat|mesh-list
14954092|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
14954093|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954094|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954095|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14954096|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
14954097|NCT01568645|Carvedilol|carvedilol|mesh-list
14954098|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954099|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14954100|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954101|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954102|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14954103|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14954104|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
14954105|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235846|NCT00110214|Antibodies|antibodies|mesh-list
14235847|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
14954106|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954107|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14954108|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
14954109|NCT01568645|Protective Agents|protective agents|mesh-ancestor
14954110|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14954111|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954112|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235848|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14235849|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235850|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14954113|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
14954114|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14235851|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14235852|NCT00110214|Growth Substances|growth substances|mesh-ancestor
14235853|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235854|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
14235855|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
14235856|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235857|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
14954115|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14954116|NCT01568684|Citalopram|citalopram|mesh-list
14954117|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14954118|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14954119|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954120|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954121|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954122|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
14954123|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954124|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14954125|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
14954126|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954127|NCT01568749|Acetaminophen|acetaminophen|mesh-list
14954128|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14954129|NCT01568749|Analgesics|analgesics|mesh-ancestor
14954130|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
14954131|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954132|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954133|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
14954134|NCT01568788|Vaccines|vaccines|mesh-list
14954135|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
14954136|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954137|NCT01568853|Norepinephrine|norepinephrine|mesh-list
14954138|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14954139|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14954140|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
14954141|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954142|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954143|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954144|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
14954145|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
14954146|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954147|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14954148|NCT01568931|Coal Tar|coal tar|mesh-list
14954149|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
14954150|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
14954151|NCT01568996|Sulforaphane|sulforaphane|mesh-list
14954152|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14954153|NCT01568996|Protective Agents|protective agents|mesh-ancestor
14954154|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954155|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954156|NCT01569035|Warfarin|warfarin|mesh-list
14954157|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
14954158|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
14954159|NCT01569048|Remifentanil|remifentanil|mesh-list
14954160|NCT01569048|Propofol|propofol|mesh-list
14954161|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14954162|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954163|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954164|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14954165|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
14954166|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
14235858|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
14954167|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14954168|NCT01569048|Analgesics|analgesics|mesh-ancestor
14954169|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
14954170|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954171|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14954172|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14954173|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14954174|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14954175|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954176|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954177|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14954178|NCT01569048|Narcotics|narcotics|mesh-ancestor
14954179|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
14954180|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14954181|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
14954182|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14954183|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14954184|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14954185|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
14954186|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14954187|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954188|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14954189|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14954190|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14954191|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14954192|NCT01569113|Estrogens|estrogens|mesh-ancestor
14954193|NCT01569113|Hormones|hormones|mesh-ancestor
14954194|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954195|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14954196|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14954197|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14954198|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14954199|NCT01569165|Fluorides|fluorides|mesh-list
14954200|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
14954201|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
14954202|NCT01569165|Protective Agents|protective agents|mesh-ancestor
14954203|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954204|NCT01569204|Dexamethasone|dexamethasone|mesh-list
14954205|NCT01569204|Prednisone|prednisone|mesh-list
14954206|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
14954207|NCT01569204|Dacarbazine|dacarbazine|mesh-list
14954208|NCT01569204|Doxorubicin|doxorubicin|mesh-list
14954209|NCT01569204|Etoposide|etoposide|mesh-list
14954210|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14954211|NCT01569204|Procarbazine|procarbazine|mesh-list
14954212|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954213|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
14954214|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954215|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954216|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14954217|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
14954218|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954219|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954220|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14954221|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954222|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
14954223|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
14954224|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954225|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954226|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
14954227|NCT01569204|Hormones|hormones|mesh-ancestor
14954228|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954229|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14954230|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14954231|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14954232|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14954233|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954234|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14954235|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14954236|NCT01569256|Cabergoline|cabergoline|mesh-list
14954237|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14954238|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14954239|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
14954240|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
14954241|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954242|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954243|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027482|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15027483|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
15027484|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027485|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027486|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15027487|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15027488|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15027489|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15027490|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027491|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027492|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
15027493|NCT01949818|Hormones|hormones|mesh-ancestor
15027494|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027495|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15027496|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15027497|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
15027498|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
15027499|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
15027500|NCT01949857|Vaccines|vaccines|mesh-list
14798031|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
15027501|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
15027502|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027503|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
15027504|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15027505|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
14235859|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235860|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798032|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798033|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798034|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798035|NCT00776334|Fosinopril|fosinopril|mesh-list
14798036|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14798037|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
14798038|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798039|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798040|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798041|NCT00776347|Donepezil|donepezil|mesh-list
14798042|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14798043|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798044|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798045|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
14798046|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798047|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027506|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027507|NCT01949935|Mupirocin|mupirocin|mesh-list
15027508|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15027509|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027510|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15027511|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027512|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027513|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15027514|NCT01949948|Tenecteplase|tenecteplase|mesh-list
14798048|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
14235861|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
14235862|NCT00110214|Hormones|hormones|mesh-ancestor
14954244|NCT01569633|Erythromycin|erythromycin|mesh-list
14954245|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
14954246|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14954247|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
14954248|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14954249|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954250|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798049|NCT00776360|Oxytocin|oxytocin|mesh-list
14798050|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
14954251|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14954252|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235863|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235864|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235865|NCT00110266|Deferasirox|deferasirox|mesh-list
14235866|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14235867|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
14954253|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954254|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14954255|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14954256|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14235868|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
14235869|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235870|NCT00110305|Efavirenz|efavirenz|mesh-list
14235871|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14235872|NCT00110305|Rilpivirine|rilpivirine|mesh-list
14235873|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14235874|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235875|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235876|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
14235877|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235878|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14235879|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14235880|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14235881|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14235882|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14235883|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14235884|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14235885|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14235886|NCT00110357|Irinotecan|irinotecan|mesh-list
14235887|NCT00110357|Cetuximab|cetuximab|mesh-list
14235888|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14235889|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235890|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235891|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235892|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235893|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14235894|NCT00110396|Interferons|interferons|mesh-list
14235895|NCT00110396|Interferon-beta|interferon-beta|mesh-list
14235896|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
14235897|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235898|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
14235899|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798051|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14798052|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798053|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
14798054|NCT00776425|Hematinics|hematinics|mesh-ancestor
14798055|NCT00776438|Vaccines|vaccines|mesh-list
14798056|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
14798057|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954257|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954258|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954259|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954260|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14235900|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
14235901|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235902|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14235903|NCT00110461|Aripiprazole|aripiprazole|mesh-list
14235904|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
14235905|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798058|NCT00776477|Aspirin|aspirin|mesh-list
14798059|NCT00776477|Clopidogrel|clopidogrel|mesh-list
14798060|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14798061|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14235906|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14235907|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14235908|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14235909|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235910|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
14235911|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
14235912|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14235913|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235914|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14235915|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14235916|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
14235917|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14235918|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14235919|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14235920|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14235921|NCT00110513|Antithrombins|antithrombins|mesh-list
14235922|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
14798062|NCT00776477|Analgesics|analgesics|mesh-ancestor
14798063|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
14798064|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798065|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798066|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798067|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798068|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14798069|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14798070|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798071|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14798072|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14798073|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798074|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
14798075|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14798076|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14798077|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14798078|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
14235923|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14235924|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
14235925|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235926|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235927|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
14235928|NCT00110617|Deferasirox|deferasirox|mesh-list
14235929|NCT00110617|Deferoxamine|deferoxamine|mesh-list
14235930|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14235931|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
14235932|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
14235933|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235934|NCT00110617|Siderophores|siderophores|mesh-ancestor
14235935|NCT00110812|Aldesleukin|aldesleukin|mesh-list
14235936|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235937|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14235938|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14954261|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14954262|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14954263|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
14954264|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954265|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954266|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14954267|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14954268|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
14954269|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14954270|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14954271|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
14954272|NCT01569685|Sertraline|sertraline|mesh-list
14954273|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14954274|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
14954275|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954276|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14954277|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14954278|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954279|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954280|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954281|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
14954282|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954283|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14954284|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14954285|NCT01569919|Folic Acid|folic acid|mesh-list
14954286|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
14954287|NCT01569919|Hydroxocobalamin|hydroxocobalamin|mesh-list
14954288|NCT01569919|Dexamethasone|dexamethasone|mesh-list
14954289|NCT01569919|Pemetrexed|pemetrexed|mesh-list
14954290|NCT01569919|Vitamins|vitamins|mesh-ancestor
14954291|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
14954292|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954293|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954294|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954295|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
14235939|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
14235940|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14235941|NCT00110890|Cinacalcet|cinacalcet|mesh-list
14235942|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14235943|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235944|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14235945|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
14235946|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235947|NCT00110994|Sorafenib|sorafenib|mesh-list
14235948|NCT00110994|Dacarbazine|dacarbazine|mesh-list
14235949|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235950|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14235951|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235952|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235953|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14235954|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
14235955|NCT00111007|Paclitaxel|paclitaxel|mesh-list
14235956|NCT00111007|Carboplatin|carboplatin|mesh-list
14235957|NCT00111007|Sorafenib|sorafenib|mesh-list
14235958|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14235959|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235960|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
14235961|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
14235962|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
14235963|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235964|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14235965|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235966|NCT00111241|Letrozole|letrozole|mesh-list
14235967|NCT00111241|Anastrozole|anastrozole|mesh-list
14235968|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14235969|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235970|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14235971|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954296|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
14954297|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954298|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954299|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
14243391|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14798079|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798080|NCT00776490|Glimepiride|glimepiride|mesh-list
14798081|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14798082|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798083|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954300|NCT01569919|Hormones|hormones|mesh-ancestor
14954301|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954302|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14954303|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954304|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954305|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14954306|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14954307|NCT01569919|Hematinics|hematinics|mesh-ancestor
14954308|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
14235972|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14235973|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14235974|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
14235975|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14235976|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954309|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14954310|NCT01569945|Clomiphene|clomiphene|mesh-list
14954311|NCT01569945|Menotropins|menotropins|mesh-list
14954312|NCT01569945|Estradiol|estradiol|mesh-list
14954313|NCT01569945|Estrogens|estrogens|mesh-ancestor
14235977|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14235978|NCT00111657|Rasburicase|rasburicase|mesh-list
14235979|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
14235980|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14235981|NCT00111761|Leucovorin|leucovorin|mesh-list
14235982|NCT00111761|Fluorouracil|fluorouracil|mesh-list
14235983|NCT00111761|Irinotecan|irinotecan|mesh-list
14954314|NCT01569945|Hormones|hormones|mesh-ancestor
14954315|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954316|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954317|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14954318|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
14954319|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14954320|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14954321|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14235984|NCT00111761|Panitumumab|panitumumab|mesh-list
14954322|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14954323|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14954324|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
14954325|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14954326|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
14954327|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14954328|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14954329|NCT01569984|Bevacizumab|bevacizumab|mesh-list
14954330|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14954331|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954332|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14954333|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14954334|NCT01569984|Growth Substances|growth substances|mesh-ancestor
14954335|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954336|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
14954337|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14954338|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14954339|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
14954340|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954341|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954342|NCT01570088|Folic Acid|folic acid|mesh-list
14954343|NCT01570088|Hematinics|hematinics|mesh-ancestor
14954344|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
14954345|NCT01570088|Vitamins|vitamins|mesh-ancestor
14954346|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
14954347|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954348|NCT01570296|Gefitinib|gefitinib|mesh-list
14235985|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
14235986|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798084|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798085|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
14798086|NCT00776503|Vorinostat|vorinostat|mesh-list
14798087|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798088|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14235987|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14235988|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14235989|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14235990|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
14235991|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14235992|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14235993|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14235994|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14235995|NCT00111761|Antidotes|antidotes|mesh-ancestor
14235996|NCT00111761|Protective Agents|protective agents|mesh-ancestor
14235997|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
14235998|NCT00111761|Vitamins|vitamins|mesh-ancestor
14954349|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954350|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14954351|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954352|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954353|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14954354|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14954355|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
14954356|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954357|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954358|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14954359|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
14954360|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
14954361|NCT01570478|Hormones|hormones|mesh-ancestor
14954362|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954363|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
14954364|NCT01570504|Ivermectin|ivermectin|mesh-list
14954365|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14954366|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954367|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14954368|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954369|NCT01570569|Losartan|losartan|mesh-list
14954370|NCT01570569|Midazolam|midazolam|mesh-list
14954371|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
14235999|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
14236000|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236001|NCT00111813|Bortezomib|bortezomib|mesh-list
14954372|NCT01570569|Caffeine|caffeine|mesh-list
14954373|NCT01570569|Omeprazole|omeprazole|mesh-list
14236002|NCT00111813|Vorinostat|vorinostat|mesh-list
14236003|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236004|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14236005|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236006|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236007|NCT00111839|Pemetrexed|pemetrexed|mesh-list
14236008|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236009|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236010|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236011|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14236012|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14236013|NCT00111917|Infliximab|infliximab|mesh-list
14236014|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
14236015|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236016|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236017|NCT00112047|Tenofovir|tenofovir|mesh-list
14236018|NCT00112047|Lamivudine|lamivudine|mesh-list
14236019|NCT00112047|Zidovudine|zidovudine|mesh-list
14236020|NCT00112047|Emtricitabine|emtricitabine|mesh-list
14236021|NCT00112047|Efavirenz|efavirenz|mesh-list
14236022|NCT00112047|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14236023|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14236024|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
14236025|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236026|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14236027|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14236028|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236029|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236030|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14236031|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14236032|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
14236033|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14236034|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14954374|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14954375|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14236035|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14954376|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954377|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954378|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14954379|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14954380|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954381|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14954382|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
14954383|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
14954384|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
14954385|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
14954386|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954387|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954388|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14954389|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14954390|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14954391|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14954392|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14954393|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954394|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14954395|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236036|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14236037|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14236038|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14236039|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
14236040|NCT00112151|Testosterone|testosterone|mesh-list
14236041|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
14954396|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14954397|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14954398|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14954399|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14954400|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
14954401|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
14954402|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
14954403|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14954404|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14954405|NCT01570582|Gemcitabine|gemcitabine|mesh-list
14954406|NCT01570582|Paclitaxel|paclitaxel|mesh-list
14954407|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14954408|NCT01570582|Carboplatin|carboplatin|mesh-list
14236042|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
14236043|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14236044|NCT00112151|Androgens|androgens|mesh-ancestor
14236045|NCT00112151|Hormones|hormones|mesh-ancestor
14236046|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14236047|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236048|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14236049|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236050|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
14236051|NCT00112294|Paclitaxel|paclitaxel|mesh-list
14236052|NCT00112294|Docetaxel|docetaxel|mesh-list
14236053|NCT00112294|Carboplatin|carboplatin|mesh-list
14236054|NCT00112294|Cetuximab|cetuximab|mesh-list
14236055|NCT00112294|Taxane|taxane|mesh-list
14236056|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14236057|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236058|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
14236059|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236060|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
14236061|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236062|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236063|NCT00112385|Etanercept|etanercept|mesh-list
14954409|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14954410|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954411|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14954412|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14954413|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14954414|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954415|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14954416|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
14954417|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
14954418|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954419|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954420|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954421|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
14236064|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14236065|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14236066|NCT00112385|Analgesics|analgesics|mesh-ancestor
14954422|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954423|NCT01570608|Ranibizumab|ranibizumab|mesh-list
14954424|NCT01570608|Verteporfin|verteporfin|mesh-list
14954425|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14954426|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14954427|NCT01570608|Growth Substances|growth substances|mesh-ancestor
14954428|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954429|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
14954430|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954431|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14954432|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
14954433|NCT01570660|Pioglitazone|pioglitazone|mesh-list
14954434|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14954435|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954436|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
14954437|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954438|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
14954439|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954440|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954441|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14954442|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
14954443|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954444|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954445|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14954446|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
14954447|NCT01570790|Combretastatin|combretastatin|mesh-list
14954448|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14236067|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
14236068|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236069|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236070|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954449|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954450|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
14954451|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
14954452|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
14954453|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954454|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14236071|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236072|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236073|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236074|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
14236075|NCT00112437|Vitamin D|vitamin d|mesh-list
14236076|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
14236077|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
14236078|NCT00112437|Calcium|calcium|mesh-list
14236079|NCT00112437|Vitamins|vitamins|mesh-ancestor
14236080|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
14236081|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954455|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
14954456|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954457|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14954458|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14954459|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954460|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236082|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14236083|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14954461|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14954462|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236084|NCT00112437|Antacids|antacids|mesh-ancestor
14236085|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236086|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236087|NCT00112463|Romidepsin|romidepsin|mesh-list
14236088|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14236089|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236090|NCT00112489|Paclitaxel|paclitaxel|mesh-list
14954463|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954464|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14954465|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14236091|NCT00112489|Carboplatin|carboplatin|mesh-list
14236092|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14236093|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954466|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954467|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236094|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14236095|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236096|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14236097|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236098|NCT00112502|Thalidomide|thalidomide|mesh-list
14236099|NCT00112502|Celecoxib|celecoxib|mesh-list
14236100|NCT00112502|Temozolomide|temozolomide|mesh-list
14236101|NCT00112502|Isotretinoin|isotretinoin|mesh-list
14236102|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14236103|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
14236104|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236105|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236106|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14236107|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14236108|NCT00112502|Analgesics|analgesics|mesh-ancestor
14236109|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
14236110|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236111|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236112|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236113|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236114|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14236115|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14236116|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236117|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236118|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
14236119|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
14236120|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14236121|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236122|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14236123|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14236124|NCT00112502|Growth Substances|growth substances|mesh-ancestor
14236125|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236126|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
14236127|NCT00112580|Ipilimumab|ipilimumab|mesh-list
14236128|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14798089|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236129|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954468|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14954469|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
14954470|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954471|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14954472|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14954473|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954474|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954475|NCT01570985|Triamcinolone|triamcinolone|mesh-list
14954476|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14954477|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14954478|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14954479|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954480|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
14954481|NCT01570985|Hormones|hormones|mesh-ancestor
14954482|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954483|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954484|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954485|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
14954486|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954487|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954488|NCT01571024|Leucovorin|leucovorin|mesh-list
14954489|NCT01571024|Fluorouracil|fluorouracil|mesh-list
14954490|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
14954491|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
14954492|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236130|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14798090|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798091|NCT00776516|Rifampin|rifampin|mesh-list
14798092|NCT00776516|Mirabegron|mirabegron|mesh-list
14798093|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14798094|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
14798095|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798096|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798097|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
14798098|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14798099|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798100|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954493|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236131|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236132|NCT00112593|Cyclosporine|cyclosporine|mesh-list
14236133|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
14236134|NCT00112593|Fludarabine|fludarabine|mesh-list
14954494|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954495|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954496|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
14954497|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954498|NCT01571024|Antidotes|antidotes|mesh-ancestor
14954499|NCT01571024|Protective Agents|protective agents|mesh-ancestor
14954500|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
14954501|NCT01571024|Vitamins|vitamins|mesh-ancestor
14954502|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
14954503|NCT01571037|Milrinone|milrinone|mesh-list
14954504|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14954505|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14954506|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
14954507|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14954508|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14954509|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236135|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
14236136|NCT00112593|Cyclosporins|cyclosporins|mesh-list
14236137|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236138|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236139|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
14236140|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236141|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236142|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
14236143|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236144|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236145|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
14236146|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236147|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
14236148|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236149|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14236150|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14236151|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14236152|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
14236153|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14236154|NCT00112671|Sorafenib|sorafenib|mesh-list
14236155|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236156|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236157|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236158|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236159|NCT00112723|Alvocidib|alvocidib|mesh-list
14236160|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236161|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236162|NCT00112723|Growth Substances|growth substances|mesh-ancestor
14236163|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236164|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236165|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236166|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236167|NCT00112736|Sirolimus|sirolimus|mesh-list
14236168|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14236169|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236170|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236171|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954510|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954511|NCT01571037|Protective Agents|protective agents|mesh-ancestor
14954512|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954513|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
14954514|NCT01571050|Antacids|antacids|mesh-ancestor
14954515|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954516|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954517|NCT01571063|Vitamin D|vitamin d|mesh-list
14954518|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
14954519|NCT01571063|Vitamins|vitamins|mesh-ancestor
14954520|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
14954521|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954522|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14954523|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15027515|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15027516|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15027517|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027518|NCT01950000|Fentanyl|fentanyl|mesh-list
15027519|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14954524|NCT01571167|Varenicline|varenicline|mesh-list
14954525|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14954526|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14954527|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
14954528|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954529|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954530|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954531|NCT01571206|Infliximab|infliximab|mesh-list
14954532|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
14954533|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954534|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954535|NCT01571219|Infliximab|infliximab|mesh-list
14954536|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
14954537|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954538|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954539|NCT01571323|Misoprostol|misoprostol|mesh-list
14954540|NCT01571323|Oxytocin|oxytocin|mesh-list
14954541|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
14954542|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14954543|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954544|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14954545|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
14954546|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14954547|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954548|NCT01571414|Ritonavir|ritonavir|mesh-list
14954549|NCT01571414|Lopinavir|lopinavir|mesh-list
14954550|NCT01571414|Efavirenz|efavirenz|mesh-list
14954551|NCT01571414|Rifampin|rifampin|mesh-list
14954552|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14954553|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14954554|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
14954555|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954556|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954557|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14954558|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14954559|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
14954560|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954561|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14954562|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14954563|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14954564|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14954565|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14954566|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14954567|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14954568|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14954569|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14954570|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14954571|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
14954572|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14954573|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
14954574|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14954575|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14954576|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14954577|NCT01571466|Vaccines|vaccines|mesh-list
14954578|NCT01571466|Immunologic Factors|immunologic factors|mesh-ancestor
14954579|NCT01571466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954580|NCT01571505|Vaccines|vaccines|mesh-list
14954581|NCT01571505|Immunologic Factors|immunologic factors|mesh-ancestor
14954582|NCT01571505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954583|NCT01571570|Simeprevir|simeprevir|mesh-list
14954584|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
14954585|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954586|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
14954587|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954588|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954589|NCT01571583|Interferons|interferons|mesh-list
14954590|NCT01571583|Ribavirin|ribavirin|mesh-list
14954591|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
14954592|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
14236172|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236173|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14236174|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954593|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14954594|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954595|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
14954596|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954597|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
14954598|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954599|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
14954600|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236175|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14236176|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
14236177|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236178|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
14236179|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236180|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
14236181|NCT00112827|Melphalan|melphalan|mesh-list
14236182|NCT00112827|Lenalidomide|lenalidomide|mesh-list
14236183|NCT00112827|Lenograstim|lenograstim|mesh-list
14236184|NCT00112827|Sargramostim|sargramostim|mesh-list
14236185|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236186|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
14236187|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236188|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954601|NCT01571609|Insulin|insulin|mesh-list
14954602|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14236189|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14236190|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
14236191|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236192|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236193|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14236194|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14236195|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14236196|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14236197|NCT00112827|Growth Substances|growth substances|mesh-ancestor
14236198|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236199|NCT00112905|Sorafenib|sorafenib|mesh-list
14236200|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236201|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236202|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236203|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236204|NCT00112918|Leucovorin|leucovorin|mesh-list
14236205|NCT00112918|Bevacizumab|bevacizumab|mesh-list
14236206|NCT00112918|Fluorouracil|fluorouracil|mesh-list
14236207|NCT00112918|Capecitabine|capecitabine|mesh-list
14236208|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
14236209|NCT00112918|Calcium|calcium|mesh-list
14236210|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
14236211|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236212|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236213|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14236214|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14236215|NCT00112918|Growth Substances|growth substances|mesh-ancestor
14954603|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954604|NCT01571648|Azacitidine|azacitidine|mesh-list
14954605|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14954606|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
14954607|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236216|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236217|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236218|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14236219|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
14236220|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236221|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236222|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236223|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
14236224|NCT00112918|Antidotes|antidotes|mesh-ancestor
14236225|NCT00112918|Protective Agents|protective agents|mesh-ancestor
14236226|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
14236227|NCT00112918|Vitamins|vitamins|mesh-ancestor
14236228|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
14236229|NCT00112957|Vaccines|vaccines|mesh-list
14236230|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
14236231|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236232|NCT00113087|Enalapril|enalapril|mesh-list
14236233|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14236234|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
14236235|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236236|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236237|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14236238|NCT00113217|Bevacizumab|bevacizumab|mesh-list
14236239|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236240|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236241|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798101|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14798102|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14798103|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14954608|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954609|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954610|NCT01571687|Antioxidants|antioxidants|mesh-list
14954611|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954612|NCT01571687|Protective Agents|protective agents|mesh-ancestor
14954613|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954614|NCT01571791|Ketorolac|ketorolac|mesh-list
14954615|NCT01571791|Lidocaine|lidocaine|mesh-list
14954616|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
14954617|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
14954618|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954619|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954620|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
14954621|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954622|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14954623|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14954624|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14954625|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954626|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954627|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14954628|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14954629|NCT01571791|Analgesics|analgesics|mesh-ancestor
14954630|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954631|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954632|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14954633|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954634|NCT01571804|Pregabalin|pregabalin|mesh-list
14954635|NCT01571804|Analgesics|analgesics|mesh-ancestor
14954636|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
14954637|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236242|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798104|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14798105|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14798106|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14798107|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14798108|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14798109|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14798110|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
14798111|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954638|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954639|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
14954640|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14954641|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954642|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236243|NCT00113217|Growth Substances|growth substances|mesh-ancestor
14236244|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236245|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236246|NCT00113230|Bevacizumab|bevacizumab|mesh-list
14236247|NCT00113230|Capecitabine|capecitabine|mesh-list
14236248|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236249|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236250|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14236251|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14954643|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14954644|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14954645|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14236252|NCT00113230|Growth Substances|growth substances|mesh-ancestor
14236253|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236254|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236255|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236256|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
14236257|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236258|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
14236259|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
14236260|NCT00113269|Tacrolimus|tacrolimus|mesh-list
14236261|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
14236262|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14236263|NCT00113269|Basiliximab|basiliximab|mesh-list
14236264|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236265|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
14236266|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236267|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14522796|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236268|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954646|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954647|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954648|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
14954649|NCT01571856|Astringents|astringents|mesh-ancestor
14954650|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954651|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
14954652|NCT01571882|Policosanol|policosanol|mesh-list
14954653|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14954654|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14954655|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
14954656|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954657|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14954658|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14954659|NCT01571908|Rocuronium|rocuronium|mesh-list
14954660|NCT01571908|Succinylcholine|succinylcholine|mesh-list
14954661|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14954662|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14954663|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14954664|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954665|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954666|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14954667|NCT01571921|Tocotrienols|tocotrienols|mesh-list
14954668|NCT01571921|Vitamin E|vitamin e|mesh-list
14954669|NCT01571921|Tocopherols|tocopherols|mesh-list
14954670|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
14954671|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954672|NCT01571921|Protective Agents|protective agents|mesh-ancestor
14954673|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954674|NCT01571921|Vitamins|vitamins|mesh-ancestor
14954675|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
14954676|NCT01571960|Vaccines|vaccines|mesh-list
14954677|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
14954678|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954679|NCT01572012|Ondansetron|ondansetron|mesh-list
14954680|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
14954681|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
14954682|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954683|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954684|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954685|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
14954686|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
14954687|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14954688|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
14954689|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954690|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954691|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14954692|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14954693|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954694|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954695|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14954696|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14954697|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14954698|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
14954699|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954700|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14954701|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954702|NCT01572116|Lidocaine|lidocaine|mesh-list
14954703|NCT01572116|Epinephrine|epinephrine|mesh-list
14954704|NCT01572116|Racepinephrine|racepinephrine|mesh-list
14954705|NCT01572116|Sufentanil|sufentanil|mesh-list
14954706|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
14954707|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
14954708|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
14954709|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954710|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954711|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
14954712|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954713|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14954714|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14954715|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14954716|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954717|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954718|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14954719|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14954720|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
14954721|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954722|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14954723|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14954724|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
14954725|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14954726|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
14954727|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
14954728|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
14954729|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14954730|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14954731|NCT01572116|Narcotics|narcotics|mesh-ancestor
14954732|NCT01572116|Analgesics|analgesics|mesh-ancestor
14954733|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14954734|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14954735|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
14954736|NCT01572129|Clopidogrel|clopidogrel|mesh-list
14954737|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14954738|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14954739|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14954740|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14954741|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
14954742|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954743|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954744|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954745|NCT01572181|Fludarabine|fludarabine|mesh-list
14954746|NCT01572181|Busulfan|busulfan|mesh-list
14954747|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
14954748|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954749|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954750|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954751|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
14954752|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954753|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
14954754|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14954755|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14954756|NCT01572259|Hormones|hormones|mesh-list
14954757|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954758|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954759|NCT01572285|Dexamethasone|dexamethasone|mesh-list
14954760|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
14954761|NCT01572285|BB 1101|bb 1101|mesh-list
14954762|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954763|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
14954764|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
14954765|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954766|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954767|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236269|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236270|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14236271|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954768|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
14954769|NCT01572285|Hormones|hormones|mesh-ancestor
14954770|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954771|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14954772|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236272|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14236273|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
14236274|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14236275|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236276|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236277|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14236278|NCT00113295|Paroxetine|paroxetine|mesh-list
14236279|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236280|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236281|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14236282|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14236283|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14236284|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236285|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14236286|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14236287|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14236288|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954773|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
14954774|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954775|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236289|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236290|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
14236291|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14236292|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14236293|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14236294|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236295|NCT00113321|Decitabine|decitabine|mesh-list
14236296|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236297|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
14236298|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236299|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236300|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236301|NCT00113360|Everolimus|everolimus|mesh-list
14236302|NCT00113360|Octreotide|octreotide|mesh-list
14236303|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236304|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236305|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
14236306|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236307|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236308|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14236309|NCT00113373|Lapatinib|lapatinib|mesh-list
14236310|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236311|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236312|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954776|NCT01572324|Leucovorin|leucovorin|mesh-list
14954777|NCT01572324|Fluorouracil|fluorouracil|mesh-list
14236313|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236314|NCT00113490|Palivizumab|palivizumab|mesh-list
14236315|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
14236316|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236317|NCT00113516|Paclitaxel|paclitaxel|mesh-list
14236318|NCT00113516|Carboplatin|carboplatin|mesh-list
14236319|NCT00113516|Sunitinib|sunitinib|mesh-list
14236320|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14236321|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236322|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
14954778|NCT01572324|Capecitabine|capecitabine|mesh-list
14954779|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
14954780|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
14954781|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954782|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14954783|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954784|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954785|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
14236323|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236324|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
14236325|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236326|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14236327|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14236328|NCT00113516|Growth Substances|growth substances|mesh-ancestor
14236329|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954786|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954787|NCT01572324|Antidotes|antidotes|mesh-ancestor
14954788|NCT01572324|Protective Agents|protective agents|mesh-ancestor
14954789|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
14954790|NCT01572324|Vitamins|vitamins|mesh-ancestor
14954791|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
14954792|NCT01572350|Triamcinolone|triamcinolone|mesh-list
14954793|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14954794|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14236330|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236331|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236332|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236333|NCT00113529|Sunitinib|sunitinib|mesh-list
14236334|NCT00113529|Gefitinib|gefitinib|mesh-list
14954795|NCT01572350|Bevacizumab|bevacizumab|mesh-list
14236335|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954796|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14954797|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14954798|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954799|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14954800|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14954801|NCT01572350|Growth Substances|growth substances|mesh-ancestor
14954802|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954803|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
14954804|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954805|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
14954806|NCT01572350|Hormones|hormones|mesh-ancestor
14954807|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954808|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954809|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
14954810|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954811|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954812|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
14954813|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
14954814|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14954815|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14954816|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954817|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954818|NCT01572363|Urological Agents|urological agents|mesh-ancestor
14954819|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
14954820|NCT01572454|Remifentanil|remifentanil|mesh-list
14954821|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14954822|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954823|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954824|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14954825|NCT01572454|Analgesics|analgesics|mesh-ancestor
14954826|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
14954827|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236336|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15027520|NCT01950000|Narcotics|narcotics|mesh-ancestor
14236337|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14954828|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14954829|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14954830|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14954831|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
14954832|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954833|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954834|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14954835|NCT01572454|Narcotics|narcotics|mesh-ancestor
14954836|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
14954837|NCT01572545|Denosumab|denosumab|mesh-list
14954838|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14954839|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954840|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
14954841|NCT01572558|Meropenem|meropenem|mesh-list
14954842|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14954843|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954844|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14954845|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14954846|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954847|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954848|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954849|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14954850|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14954851|NCT01572597|Metronidazole|metronidazole|mesh-list
14954852|NCT01572597|Clarithromycin|clarithromycin|mesh-list
14954853|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
14954854|NCT01572597|Rabeprazole|rabeprazole|mesh-list
14954855|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14954856|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14954857|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14954858|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14954859|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14954860|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954861|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14954862|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954863|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954864|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14954865|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14954866|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14954867|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
14954868|NCT01572597|Expectorants|expectorants|mesh-ancestor
14954869|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
14954870|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14954871|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
14954872|NCT01572597|Protective Agents|protective agents|mesh-ancestor
14954873|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236338|NCT00113529|Growth Substances|growth substances|mesh-ancestor
14236339|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236340|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
14236341|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236342|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236343|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236344|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
14236345|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14236346|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14236347|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236348|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
14236349|NCT00113568|Coagulants|coagulants|mesh-ancestor
14242820|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14242821|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14242822|NCT00191113|Estrogens|estrogens|mesh-ancestor
14242823|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14242824|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
14242825|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14242826|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14242827|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14242828|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14242829|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14242830|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14242831|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14954874|NCT01572623|Clopidogrel|clopidogrel|mesh-list
14954875|NCT01572623|Atorvastatin|atorvastatin|mesh-list
14236350|NCT00113607|Dexamethasone|dexamethasone|mesh-list
14236351|NCT00113607|Trabectedin|trabectedin|mesh-list
14236352|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236353|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
14236354|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
14236355|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236356|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236357|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236358|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
14236359|NCT00113607|Hormones|hormones|mesh-ancestor
14954876|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14954877|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14954878|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
14954879|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954880|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14954881|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14954882|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954883|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14236360|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954884|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14954885|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14954886|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14954887|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
14954888|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954889|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954890|NCT01572649|Lixisenatide|lixisenatide|mesh-list
14954891|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14954892|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954893|NCT01572688|Melphalan|melphalan|mesh-list
14954894|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14954895|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
14954896|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236361|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14236362|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236363|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14236364|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
14236365|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236366|NCT00113763|Panitumumab|panitumumab|mesh-list
14236367|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236368|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236369|NCT00113841|Curcumin|curcumin|mesh-list
14236370|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14236371|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14236372|NCT00113841|Analgesics|analgesics|mesh-ancestor
14236373|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
14798112|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798113|NCT00776516|Urological Agents|urological agents|mesh-ancestor
14954897|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954898|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14954899|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14954900|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
14954901|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027521|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027522|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027523|NCT01950000|Analgesics|analgesics|mesh-ancestor
15027524|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
15027525|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027526|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15027527|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15027528|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
15027529|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
15027530|NCT01950182|Tamoxifen|tamoxifen|mesh-list
15027531|NCT01950182|Gemcitabine|gemcitabine|mesh-list
15027532|NCT01950182|Capecitabine|capecitabine|mesh-list
15027533|NCT01950182|Trastuzumab|trastuzumab|mesh-list
15027534|NCT01950182|Vinorelbine|vinorelbine|mesh-list
15027535|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15027536|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15027537|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
14798114|NCT00776542|Minocycline|minocycline|mesh-list
14798115|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798116|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798117|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
14798118|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14798119|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798120|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798121|NCT00776620|Glimepiride|glimepiride|mesh-list
14798122|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14798123|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798124|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798125|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798126|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
14798127|NCT00776633|Aspirin|aspirin|mesh-list
14798128|NCT00776633|Clopidogrel|clopidogrel|mesh-list
14798129|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14798130|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14954902|NCT01572805|Melatonin|melatonin|mesh-list
14236374|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236375|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236376|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14236377|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236378|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236379|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236380|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236381|NCT00114114|Goserelin|goserelin|mesh-list
14954903|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
14954904|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954905|NCT01572805|Protective Agents|protective agents|mesh-ancestor
14954906|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954907|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14954908|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
14954909|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
14954910|NCT01572831|Protective Agents|protective agents|mesh-ancestor
14954911|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954912|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
14954913|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14954914|NCT01572857|Antibodies|antibodies|mesh-list
14954915|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
14954916|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954917|NCT01572961|Aspirin|aspirin|mesh-list
14954918|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14954919|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14954920|NCT01572961|Analgesics|analgesics|mesh-ancestor
14954921|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
14954922|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14954923|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954924|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14954925|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14954926|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14954927|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14954928|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954929|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14954930|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14954931|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954932|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
14954933|NCT01573013|Iron|iron|mesh-list
14954934|NCT01573013|Trace Elements|trace elements|mesh-ancestor
14236382|NCT00114114|Testosterone|testosterone|mesh-list
14954935|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
14954936|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236383|NCT00114114|Androgens|androgens|mesh-ancestor
14236384|NCT00114114|Hormones|hormones|mesh-ancestor
14236385|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14236386|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236387|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14236388|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236389|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14236390|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14236391|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14236392|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14236393|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236394|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14236395|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236396|NCT00114127|Analgesics|analgesics|mesh-ancestor
14236397|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
14798131|NCT00776633|Analgesics|analgesics|mesh-ancestor
14954937|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14954938|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14236398|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236399|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236400|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14236401|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
14236402|NCT00114140|Temozolomide|temozolomide|mesh-list
14236403|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14954939|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14954940|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
14954941|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954942|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14954943|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14954944|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954945|NCT01573286|Glucagon|glucagon|mesh-list
14954946|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14954947|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14954948|NCT01573286|Hormones|hormones|mesh-ancestor
14954949|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954950|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954951|NCT01573286|Incretins|incretins|mesh-ancestor
14954952|NCT01573338|Carboplatin|carboplatin|mesh-list
14954953|NCT01573338|Etoposide|etoposide|mesh-list
14954954|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954955|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14954956|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14954957|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14954958|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14954959|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954960|NCT01573377|Metformin|metformin|mesh-list
14954961|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
14954962|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14954963|NCT01573377|Cyproterone|cyproterone|mesh-list
14954964|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14954965|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954966|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14954967|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14954968|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14954969|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
14954970|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14954971|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14954972|NCT01573377|Estrogens|estrogens|mesh-ancestor
14954973|NCT01573377|Hormones|hormones|mesh-ancestor
14954974|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14954975|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
14954976|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
14954977|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954978|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14954979|NCT01573468|Capecitabine|capecitabine|mesh-list
14954980|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14954981|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
14954982|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954983|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14954984|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14954985|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
14236404|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
14954986|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14954987|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14954988|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14954989|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14954990|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14954991|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14954992|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
14954993|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14954994|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14954995|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14954996|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14954997|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14954998|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
14954999|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955000|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955001|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14955002|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14955003|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955004|NCT01573663|Dipropizine|dipropizine|mesh-list
14955005|NCT01573663|Ambroxol|ambroxol|mesh-list
14955006|NCT01573663|Expectorants|expectorants|mesh-ancestor
14955007|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
14955008|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
14955009|NCT01573715|Cisatracurium|cisatracurium|mesh-list
14955010|NCT01573715|Atracurium|atracurium|mesh-list
14955011|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14955012|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14955013|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955014|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955015|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14955016|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14955017|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14955018|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
14955019|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955020|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955021|NCT01573741|Ketamine|ketamine|mesh-list
14955022|NCT01573741|Analgesics|analgesics|mesh-ancestor
14955023|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
14955024|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955025|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955026|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14955027|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14955028|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
14955029|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
14955030|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955031|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14955032|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14955033|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955034|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955035|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
14955036|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
14955037|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14955038|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14955039|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955040|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955041|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955042|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14955043|NCT01573780|Gemcitabine|gemcitabine|mesh-list
14955044|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14955045|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
14955046|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955047|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955048|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
14955049|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955050|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955051|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14955052|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
14955053|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955054|NCT01573806|Exenatide|exenatide|mesh-list
14955055|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14955056|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955057|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14955058|NCT01573806|Incretins|incretins|mesh-ancestor
14955059|NCT01573806|Hormones|hormones|mesh-ancestor
14955060|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955061|NCT01573975|Clarithromycin|clarithromycin|mesh-list
14955062|NCT01573975|Rabeprazole|rabeprazole|mesh-list
14955063|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14955064|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955065|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14955066|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955067|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955068|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955069|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955070|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14955071|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14955072|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14955073|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
14955074|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955075|NCT01574027|Vitamin D|vitamin d|mesh-list
14955076|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
14955077|NCT01574027|Vitamins|vitamins|mesh-ancestor
14955078|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
14955079|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955080|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955081|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955082|NCT01574092|Irinotecan|irinotecan|mesh-list
14955083|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955084|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14955085|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14955086|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955087|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955088|NCT01574131|Fenofibrate|fenofibrate|mesh-list
14955089|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14955090|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
14955091|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955092|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14955093|NCT01574261|Inositol|inositol|mesh-list
14955094|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
14955095|NCT01574261|Vitamins|vitamins|mesh-ancestor
14955096|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
14955097|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955098|NCT01574274|Pegaspargase|pegaspargase|mesh-list
14955099|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955100|NCT01574313|Tocopherols|tocopherols|mesh-list
14955101|NCT01574313|Vitamin E|vitamin e|mesh-list
14955102|NCT01574313|Tocotrienols|tocotrienols|mesh-list
14955103|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
14955104|NCT01574313|Niacin|niacin|mesh-list
14955105|NCT01574313|Diphenidol|diphenidol|mesh-list
14955106|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
14955107|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955108|NCT01574313|Protective Agents|protective agents|mesh-ancestor
14955109|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955110|NCT01574313|Vitamins|vitamins|mesh-ancestor
14955111|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
14955112|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14955113|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
14955114|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14955115|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
14955116|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
14955117|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
14955118|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
14955119|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955120|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955121|NCT01574508|Insulin|insulin|mesh-list
14955122|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14955123|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14955124|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027538|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027539|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027540|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
15027541|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027542|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027543|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14955125|NCT01574638|Rifapentine|rifapentine|mesh-list
14955126|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14955127|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
14955128|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955129|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955130|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
14955131|NCT01574742|Minocycline|minocycline|mesh-list
14955132|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955133|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955134|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
14955135|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14955136|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955137|NCT01575158|Citalopram|citalopram|mesh-list
14955138|NCT01575158|Clomipramine|clomipramine|mesh-list
14955139|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15027544|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
14955140|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14955141|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955142|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955143|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955144|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
14955145|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955146|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14955147|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
14955148|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14955149|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14955150|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
14955151|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14955152|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955153|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
14955154|NCT01575301|Liraglutide|liraglutide|mesh-list
14955155|NCT01575301|Exenatide|exenatide|mesh-list
14955156|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14955157|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955158|NCT01575301|Incretins|incretins|mesh-ancestor
14955159|NCT01575301|Hormones|hormones|mesh-ancestor
14955160|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955161|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14955162|NCT01575405|Tenofovir|tenofovir|mesh-list
14955163|NCT01575405|Glycerol|glycerol|mesh-list
14955164|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
14955165|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955166|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14955167|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14955168|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955169|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955170|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14955171|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14955172|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14955173|NCT01575405|Protective Agents|protective agents|mesh-ancestor
14955174|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955175|NCT01575418|Tenofovir|tenofovir|mesh-list
14955176|NCT01575418|Glycerol|glycerol|mesh-list
14955177|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
14955178|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955179|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14955180|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14955181|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955182|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955183|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14955184|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14955185|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14955186|NCT01575418|Protective Agents|protective agents|mesh-ancestor
14955187|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955188|NCT01575483|Saxagliptin|saxagliptin|mesh-list
14955189|NCT01575483|Incretins|incretins|mesh-ancestor
14955190|NCT01575483|Hormones|hormones|mesh-ancestor
14955191|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955192|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955193|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14955194|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
14955195|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955196|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955197|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14955198|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14955199|NCT01575613|Lumefantrine|lumefantrine|mesh-list
14955200|NCT01575613|Artemether|artemether|mesh-list
14955201|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14955202|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
14955203|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14955204|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14955205|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955206|NCT01575626|Sevoflurane|sevoflurane|mesh-list
14955207|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14955208|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14955209|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
14955210|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
14955211|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955212|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955213|NCT01575639|Prednisolone|prednisolone|mesh-list
14955214|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955215|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
14955216|NCT01575639|Hormones|hormones|mesh-ancestor
14955217|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955218|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955219|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955220|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955221|NCT01575652|Lisinopril|lisinopril|mesh-list
14955222|NCT01575652|Perindopril|perindopril|mesh-list
14955223|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14955224|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14955225|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
14955226|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955227|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14955228|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14955229|NCT01575652|Protective Agents|protective agents|mesh-ancestor
14955230|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955231|NCT01575678|Melatonin|melatonin|mesh-list
14955232|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
14955233|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955234|NCT01575678|Protective Agents|protective agents|mesh-ancestor
14955235|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955236|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955237|NCT01575717|Vitamin D|vitamin d|mesh-list
14955238|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
14955239|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
14955240|NCT01575717|Vitamins|vitamins|mesh-list
14955241|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
14955242|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955243|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955244|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955245|NCT01575782|Chloroquine|chloroquine|mesh-list
14955246|NCT01575782|Amebicides|amebicides|mesh-ancestor
14955247|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14955248|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14955249|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955250|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
14955251|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14955252|NCT01575795|Ticagrelor|ticagrelor|mesh-list
14955253|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14955254|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14955255|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14955256|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14955257|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
14955258|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955259|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955260|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955261|NCT01575925|Thalidomide|thalidomide|mesh-list
14955262|NCT01575925|Dexamethasone|dexamethasone|mesh-list
14955263|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
14955264|NCT01575925|Pomalidomide|pomalidomide|mesh-list
14955265|NCT01575925|BB 1101|bb 1101|mesh-list
14955266|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955267|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
14955268|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
14955269|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955270|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955271|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955272|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
14955273|NCT01575925|Hormones|hormones|mesh-ancestor
14955274|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955275|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955276|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955277|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
14955278|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955279|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955280|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
14955281|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14955282|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14955283|NCT01575925|Growth Substances|growth substances|mesh-ancestor
14955284|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
14955285|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14955286|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
14955287|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955288|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955289|NCT01576029|Docetaxel|docetaxel|mesh-list
14955290|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955291|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
14955292|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
14955293|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
14955294|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955295|NCT01576094|Simendan|simendan|mesh-list
14955296|NCT01576094|Milrinone|milrinone|mesh-list
14955297|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14955298|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
14955299|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14955300|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14955301|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955302|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955303|NCT01576094|Protective Agents|protective agents|mesh-ancestor
14955304|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955305|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14955306|NCT01576185|Sorafenib|sorafenib|mesh-list
14955307|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955308|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14955309|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955310|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955311|NCT01576263|Ropivacaine|ropivacaine|mesh-list
14955312|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
14955313|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
14955314|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955315|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955316|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
14955317|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027545|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027546|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15027547|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15027548|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
15027549|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
15027550|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
15027551|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15027552|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
15027553|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027554|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15027555|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15027556|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15027557|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15027558|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15027559|NCT01950195|Ipilimumab|ipilimumab|mesh-list
15027560|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15027561|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027562|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15027563|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027564|NCT01950403|Linaclotide|linaclotide|mesh-list
15027565|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15027566|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
15027567|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027568|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027569|NCT01950416|Clopidogrel|clopidogrel|mesh-list
15027570|NCT01950416|Ticagrelor|ticagrelor|mesh-list
15027571|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15027572|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15027573|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15027574|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15027575|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
15027576|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027577|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955318|NCT01576315|Itraconazole|itraconazole|mesh-list
14955319|NCT01576315|Voriconazole|voriconazole|mesh-list
14955320|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
14955321|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955322|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14955323|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14955324|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955325|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955326|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14955327|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
14955328|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955329|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955330|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14798132|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
14798133|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798134|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798135|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798136|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798137|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14798138|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14798139|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798140|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14798141|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14798142|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798143|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
14955331|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
14955332|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14955333|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955334|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955335|NCT01576419|Celecoxib|celecoxib|mesh-list
14955336|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14955337|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14955338|NCT01576419|Analgesics|analgesics|mesh-ancestor
14955339|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
14955340|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955341|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955342|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955343|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14955344|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14955345|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14955346|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955347|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955348|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14955349|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14955350|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955351|NCT01576627|Zinc|zinc|mesh-list
14955352|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
14955353|NCT01576627|Trace Elements|trace elements|mesh-ancestor
14955354|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
14955355|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955356|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
14955357|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
14955358|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14798144|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14798145|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14798146|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14798147|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
14798148|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798149|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14798150|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798151|NCT00776646|Diuretics|diuretics|mesh-ancestor
14798152|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
14798153|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798154|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14798155|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798156|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798157|NCT00776672|Fosinopril|fosinopril|mesh-list
14798158|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14798159|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
14798160|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798161|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955359|NCT01576627|Protective Agents|protective agents|mesh-ancestor
14955360|NCT01576640|Bupropion|bupropion|mesh-list
14955361|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14955362|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
14955363|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14955364|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14955365|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14955366|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955367|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955368|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
14955369|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955370|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955371|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14955372|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14955373|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955374|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14955375|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14955376|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14955377|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955378|NCT01576692|Aldesleukin|aldesleukin|mesh-list
14955379|NCT01576692|Antibodies|antibodies|mesh-list
14955380|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
14955381|NCT01576692|Sargramostim|sargramostim|mesh-list
14955382|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
14955383|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955384|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955385|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14955386|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14955387|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
14955388|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955389|NCT01576731|Tenofovir|tenofovir|mesh-list
14955390|NCT01576731|Emtricitabine|emtricitabine|mesh-list
14955391|NCT01576731|Lopinavir|lopinavir|mesh-list
14955392|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
14955393|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
14955394|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955395|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14955396|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14955397|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955398|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955399|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14955400|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14955401|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14955402|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14955403|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
14955404|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14955405|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14955406|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14955407|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14955408|NCT01576770|Lidocaine|lidocaine|mesh-list
14955409|NCT01576770|Tetracaine|tetracaine|mesh-list
14955410|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
14955411|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
14955412|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
14955413|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955414|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955415|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
14955416|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955417|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14955418|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14955419|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14955420|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955421|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955422|NCT01576848|Caseins|caseins|mesh-list
14955423|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
14955424|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
14955425|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955426|NCT01577017|Letrozole|letrozole|mesh-list
14955427|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14955428|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955429|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14955430|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955431|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955432|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14955433|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
14955434|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955435|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955436|NCT01577043|Racecadotril|racecadotril|mesh-list
14955437|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
14955438|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955439|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
14955440|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955441|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955442|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
14955443|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14955444|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955445|NCT01577121|Indomethacin|indomethacin|mesh-list
14955446|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14955447|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14955448|NCT01577121|Analgesics|analgesics|mesh-ancestor
14955449|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
14955450|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955451|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955452|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955453|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14955454|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
14955455|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
14955456|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14955457|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14955458|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955459|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955460|NCT01577199|Clomiphene|clomiphene|mesh-list
14955461|NCT01577199|Enclomiphene|enclomiphene|mesh-list
14955462|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
14955463|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14955464|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
14955465|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955466|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955467|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14955468|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
14955469|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14955470|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14955471|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14955472|NCT01577316|Vaccines|vaccines|mesh-list
14955473|NCT01577316|Immunologic Factors|immunologic factors|mesh-ancestor
14955474|NCT01577316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955475|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
14955476|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955477|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955478|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14955479|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14955480|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955481|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955482|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955483|NCT01577368|Tazobactam|tazobactam|mesh-list
14955484|NCT01577368|Piperacillin|piperacillin|mesh-list
14955485|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14955486|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955487|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955488|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14955489|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955490|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955491|NCT01577407|Nefopam|nefopam|mesh-list
14955492|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14955493|NCT01577407|Analgesics|analgesics|mesh-ancestor
14955494|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
14955495|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955496|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955497|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
14955498|NCT01577459|Tedizolid|tedizolid|mesh-list
14955499|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955500|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955501|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
14955502|NCT01577524|Povidone|povidone|mesh-list
14955503|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
14955504|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
14955505|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14955506|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798162|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798163|NCT00776698|Bevacizumab|bevacizumab|mesh-list
14798164|NCT00776698|Etoposide|etoposide|mesh-list
14798165|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14798166|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798167|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798168|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798169|NCT00776698|Growth Substances|growth substances|mesh-ancestor
14798170|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798171|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
14798172|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14798173|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14798174|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14798175|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798176|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798177|NCT00776724|Docetaxel|docetaxel|mesh-list
14798178|NCT00776724|Epirubicin|epirubicin|mesh-list
14798179|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798180|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
14798181|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
14798182|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
14798183|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798184|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14798185|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14798186|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14798187|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798188|NCT00776763|Bevacizumab|bevacizumab|mesh-list
14798189|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14798190|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798191|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798192|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798193|NCT00776763|Growth Substances|growth substances|mesh-ancestor
14798194|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798195|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
14798196|NCT00776802|Dexamethasone|dexamethasone|mesh-list
14798197|NCT00776802|Etoposide|etoposide|mesh-list
14798198|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798199|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
14798200|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
14798201|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798202|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798203|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798204|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
14798205|NCT00776802|Hormones|hormones|mesh-ancestor
14798206|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14798207|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14798208|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798209|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14798210|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14798211|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14798212|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798213|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798214|NCT00776828|Cilostazol|cilostazol|mesh-list
14798215|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14798216|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
14798217|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798218|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798219|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14798220|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
14798221|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14798222|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14798223|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798224|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14798225|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
14798226|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14798227|NCT00776828|Protective Agents|protective agents|mesh-ancestor
14798228|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14798229|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14798230|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798231|NCT00776841|Cholic Acids|cholic acids|mesh-list
14798232|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
14798233|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955507|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14955508|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
14955509|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955510|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14955511|NCT01577589|Cephalosporins|cephalosporins|mesh-list
14955512|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955513|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955514|NCT01577693|Dutasteride|dutasteride|mesh-list
14955515|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14955516|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14955517|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955518|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955519|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
14955520|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955521|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955522|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14955523|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
14955524|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955525|NCT01577849|Vitamin D|vitamin d|mesh-list
14955526|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
14955527|NCT01577849|Vitamins|vitamins|mesh-ancestor
14955528|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
14955529|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955530|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955531|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955532|NCT01577862|Rifampin|rifampin|mesh-list
14955533|NCT01577862|Colistin|colistin|mesh-list
14955534|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14955535|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
14955536|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14955537|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955538|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
14955539|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14955540|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955541|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955542|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14955543|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14955544|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14955545|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14955546|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14955547|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14955548|NCT01577914|Carvedilol|carvedilol|mesh-list
14955549|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14955550|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14955551|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
14955552|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955553|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955554|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955555|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14955556|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
14955557|NCT01577914|Protective Agents|protective agents|mesh-ancestor
14955558|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14955559|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955560|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955561|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
14955562|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14955563|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14955564|NCT01577940|Ropivacaine|ropivacaine|mesh-list
14955565|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
14955566|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
14955567|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955568|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955569|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
14955570|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955571|NCT01577992|Levodopa|levodopa|mesh-list
14955572|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14955573|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14955574|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
14955575|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955576|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955577|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955578|NCT01578057|Ethanol|ethanol|mesh-list
14955579|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14955580|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955581|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955582|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027578|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034905|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15034906|NCT01997944|Interferons|interferons|mesh-list
15034907|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
15034908|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
15034909|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15034910|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034911|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
15034912|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034913|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
15034914|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034915|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
15034916|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15034917|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034918|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034919|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
15034920|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034921|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034922|NCT01998113|Insulin|insulin|mesh-list
15034923|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15034924|NCT01998113|Metformin|metformin|mesh-list
15034925|NCT01998113|Glyburide|glyburide|mesh-list
15034926|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15034927|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034928|NCT01998126|Nivolumab|nivolumab|mesh-list
15034929|NCT01998126|Ipilimumab|ipilimumab|mesh-list
15034930|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15034931|NCT01998126|Crizotinib|crizotinib|mesh-list
15034932|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15034933|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034934|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15034935|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034936|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15034937|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955583|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
14955584|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955585|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
14955586|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
14955587|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
14955588|NCT01578109|Sorafenib|sorafenib|mesh-list
14955589|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955590|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14955591|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955592|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955593|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
14955594|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14955595|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955596|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955597|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14955598|NCT01578161|Analgesics|analgesics|mesh-ancestor
14955599|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
14955600|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955601|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14955602|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14955603|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14955604|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
14955605|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955606|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955607|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
14955608|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14955609|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955610|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955611|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14955612|NCT01578174|Analgesics|analgesics|mesh-ancestor
14955613|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
14955614|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955615|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14955616|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14955617|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14955618|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
14955619|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955620|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955621|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
14955622|NCT01578200|Calcium|calcium|mesh-list
14955623|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955624|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955625|NCT01578200|Antacids|antacids|mesh-ancestor
14955626|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955627|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955628|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
14955629|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955630|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14955631|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955632|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955633|NCT01578252|Ondansetron|ondansetron|mesh-list
14955634|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
14955635|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
14955636|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955637|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955638|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798234|NCT00777114|Bortezomib|bortezomib|mesh-list
14798235|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798236|NCT00777140|Deferoxamine|deferoxamine|mesh-list
14798237|NCT00777140|Siderophores|siderophores|mesh-ancestor
14798238|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14798239|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
14798240|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
14798241|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798242|NCT00777166|Oxytocin|oxytocin|mesh-list
14798243|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
14798244|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14798245|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798246|NCT00777218|Topiramate|topiramate|mesh-list
14798247|NCT00777218|Propranolol|propranolol|mesh-list
14798248|NCT00777218|Zonisamide|zonisamide|mesh-list
14798249|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14798250|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14798251|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
14955639|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
14955640|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
14955641|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14955642|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
14955643|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955644|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955645|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14955646|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14955647|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955648|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14955649|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14955650|NCT01578265|Ondansetron|ondansetron|mesh-list
14955651|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
14955652|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
14955653|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955654|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955655|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955656|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
14955657|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
14955658|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14955659|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
14955660|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955661|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955662|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14955663|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14955664|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14955665|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14955666|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14955667|NCT01578304|Fesoterodine|fesoterodine|mesh-list
14955668|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14955669|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14955670|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
14955671|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955672|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236405|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236406|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236407|NCT00114166|Topotecan|topotecan|mesh-list
14236408|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14236409|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14236410|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236411|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236412|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236413|NCT00114218|Gemcitabine|gemcitabine|mesh-list
14955673|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955674|NCT01578304|Urological Agents|urological agents|mesh-ancestor
14955675|NCT01578343|Vidarabine|vidarabine|mesh-list
14955676|NCT01578343|Dexamethasone|dexamethasone|mesh-list
14955677|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
14955678|NCT01578343|Fludarabine|fludarabine|mesh-list
14955679|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
14955680|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
14955681|NCT01578343|Vorinostat|vorinostat|mesh-list
14955682|NCT01578343|BB 1101|bb 1101|mesh-list
14955683|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955684|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
14955685|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
14955686|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955687|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955688|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955689|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
14955690|NCT01578343|Hormones|hormones|mesh-ancestor
14955691|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955692|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955693|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955694|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
14955695|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955696|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955697|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14955698|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
14955699|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14955700|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
14955701|NCT01578343|Antiviral Agents|antiviral agents|mesh-ancestor
14236414|NCT00114218|Docetaxel|docetaxel|mesh-list
14955702|NCT01578343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955703|NCT01578343|Analgesics|analgesics|mesh-ancestor
14955704|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
14955705|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14955706|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14955707|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14955708|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
14955709|NCT01578434|Vitamin D|vitamin d|mesh-list
14955710|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
14955711|NCT01578434|Vitamins|vitamins|mesh-list
14955712|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
14955713|NCT01578434|Calcium|calcium|mesh-list
14955714|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
14955715|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955716|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955717|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955718|NCT01578434|Antacids|antacids|mesh-ancestor
14955719|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955720|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955721|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14955722|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
14955723|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14955724|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
14955725|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14955726|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955727|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14955728|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14955729|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955730|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955731|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14955732|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14955733|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14955734|NCT01578473|Vitamin D|vitamin d|mesh-list
14955735|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
14955736|NCT01578473|Vitamins|vitamins|mesh-list
14955737|NCT01578473|Vitamin E|vitamin e|mesh-list
14955738|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
14955739|NCT01578473|Testosterone|testosterone|mesh-list
14955740|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
14955741|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
14955742|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14955743|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
14955744|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955745|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955746|NCT01578473|Androgens|androgens|mesh-ancestor
14955747|NCT01578473|Hormones|hormones|mesh-ancestor
14955748|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955749|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955750|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955751|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
14955752|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
14955753|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955754|NCT01578473|Protective Agents|protective agents|mesh-ancestor
14955755|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955756|NCT01578564|SOR-C13|sor-c13|mesh-list
14955757|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955758|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14955759|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955760|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955761|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955762|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955763|NCT01578603|Calcium|calcium|mesh-list
14955764|NCT01578603|Caseins|caseins|mesh-list
14955765|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14955766|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955767|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
14955768|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
14955769|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955770|NCT01578629|Aspirin|aspirin|mesh-list
14955771|NCT01578629|Vitamin E|vitamin e|mesh-list
14955772|NCT01578629|Tocopherols|tocopherols|mesh-list
14955773|NCT01578629|Tocotrienols|tocotrienols|mesh-list
14955774|NCT01578629|Vitamins|vitamins|mesh-ancestor
14955775|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
14955776|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955777|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14955778|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14955779|NCT01578629|Analgesics|analgesics|mesh-ancestor
14955780|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
14955781|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955782|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955783|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14955784|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14955785|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14955786|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955787|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14955788|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14955789|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955790|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
14955791|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
14955792|NCT01578629|Protective Agents|protective agents|mesh-ancestor
14955793|NCT01578668|Pemetrexed|pemetrexed|mesh-list
14955794|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14955795|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955796|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955797|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955798|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14955799|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14955800|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14955801|NCT01578720|Aflibercept|aflibercept|mesh-list
14955802|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14955803|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14955804|NCT01578720|Growth Substances|growth substances|mesh-ancestor
14955805|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955806|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
14955807|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955808|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
14955809|NCT01578824|Miotics|miotics|mesh-ancestor
14955810|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
14955811|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955812|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955813|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14955814|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14955815|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
14955816|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14955817|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14955818|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
14955819|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955820|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955821|NCT01578889|Vaccines|vaccines|mesh-list
14955822|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
14955823|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955824|NCT01578928|Pasireotide|pasireotide|mesh-list
14955825|NCT01578928|Hormones|hormones|mesh-ancestor
14955826|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955827|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955828|NCT01579019|Ritonavir|ritonavir|mesh-list
14955829|NCT01579019|Ribavirin|ribavirin|mesh-list
14955830|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14955831|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14955832|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14955833|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
14955834|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955835|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955836|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14955837|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14955838|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
14955839|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955840|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14955841|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14955842|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
14955843|NCT01579058|Bisoprolol|bisoprolol|mesh-list
14955844|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14955845|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
14955846|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
14955847|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955848|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955849|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14955850|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14955851|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14955852|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
14955853|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955854|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955855|NCT01579110|Levamisole|levamisole|mesh-list
14955856|NCT01579110|Prednisone|prednisone|mesh-list
14955857|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955858|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
14955859|NCT01579110|Hormones|hormones|mesh-ancestor
14955860|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955861|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955862|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955863|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955864|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14955865|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
14955866|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
14955867|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
14955868|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14955869|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955870|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14955871|NCT01579149|Plerixafor|plerixafor|mesh-list
14955872|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14955873|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14955874|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
14955875|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14955876|NCT01579201|Carbetocin|carbetocin|mesh-list
14955877|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
14955878|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14955879|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955880|NCT01579227|Tamoxifen|tamoxifen|mesh-list
14955881|NCT01579227|Tocotrienols|tocotrienols|mesh-list
14955882|NCT01579227|Vitamin E|vitamin e|mesh-list
14955883|NCT01579227|Tocopherols|tocopherols|mesh-list
14955884|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14955885|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
14955886|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955887|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955888|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955889|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955890|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14955891|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14955892|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955893|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
14955894|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955895|NCT01579227|Protective Agents|protective agents|mesh-ancestor
14955896|NCT01579227|Vitamins|vitamins|mesh-ancestor
14955897|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
14955898|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14955899|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14955900|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14955901|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955902|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955903|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955904|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955905|NCT01579279|Analgesics|analgesics|mesh-ancestor
14955906|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
14955907|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955908|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
14955909|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14955910|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
14955911|NCT01579383|Sumatriptan|sumatriptan|mesh-list
14955912|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14955913|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14955914|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14955915|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
14955916|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955917|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955918|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955919|NCT01579448|Vaccines|vaccines|mesh-list
14955920|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
14955921|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955922|NCT01579461|Mirabegron|mirabegron|mesh-list
14955923|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14955924|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14955925|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14955926|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
14955927|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955928|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955929|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955930|NCT01579461|Urological Agents|urological agents|mesh-ancestor
14955931|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
14955932|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14955933|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14955934|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14955935|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14955936|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955937|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
14955938|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14955939|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955940|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14955941|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955942|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
14955943|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14955944|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14955945|NCT01579539|Prednisolone|prednisolone|mesh-list
14955946|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
14955947|NCT01579539|Esomeprazole|esomeprazole|mesh-list
14955948|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14955949|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
14955950|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14955951|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
14955952|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
14955953|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14955954|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955955|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14955956|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
14955957|NCT01579539|Hormones|hormones|mesh-ancestor
14955958|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955959|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14955960|NCT01579539|Protective Agents|protective agents|mesh-ancestor
14955961|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955962|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955963|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14955964|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14955965|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955966|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955967|NCT01579630|Pemetrexed|pemetrexed|mesh-list
14955968|NCT01579630|Gefitinib|gefitinib|mesh-list
14955969|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955970|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14955971|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14955972|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14955973|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14955974|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14955975|NCT01579695|Tesamorelin|tesamorelin|mesh-list
14955976|NCT01579695|Growth Substances|growth substances|mesh-ancestor
14955977|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955978|NCT01579734|Tamoxifen|tamoxifen|mesh-list
14955979|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14955980|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
14955981|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14955982|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955983|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14955984|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14955985|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14955986|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14955987|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14955988|NCT01579760|Aflibercept|aflibercept|mesh-list
14955989|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14955990|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14955991|NCT01579760|Growth Substances|growth substances|mesh-ancestor
14955992|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14955993|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
14955994|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027579|NCT01950481|Ceritinib|ceritinib|mesh-list
15027580|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027581|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15027582|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027583|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027584|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
15027585|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15027586|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027587|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
15027588|NCT01950507|Fluconazole|fluconazole|mesh-list
15027589|NCT01950507|Voriconazole|voriconazole|mesh-list
15027590|NCT01950507|Micafungin|micafungin|mesh-list
15027591|NCT01950507|Budesonide|budesonide|mesh-list
15027592|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027593|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15027594|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
15027595|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027596|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027597|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15027598|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027599|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
15027600|NCT01950507|Hormones|hormones|mesh-ancestor
15027601|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027602|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
15027603|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027604|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15027605|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15027606|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027607|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027608|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15027609|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
15027610|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15027611|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15027612|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15027613|NCT01950546|Fluorides|fluorides|mesh-list
15027614|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
15027615|NCT01950546|Protective Agents|protective agents|mesh-ancestor
15027616|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027617|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
15027618|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027619|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
15027620|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027621|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027622|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15027623|NCT01950611|Bortezomib|bortezomib|mesh-list
15027624|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027625|NCT01950689|Nimorazole|nimorazole|mesh-list
15027626|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15027627|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15027628|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15027629|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027630|NCT01950793|Triamcinolone|triamcinolone|mesh-list
15027631|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15027632|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15027633|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
15027634|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15027635|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027636|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
14955995|NCT01579786|Acetaminophen|acetaminophen|mesh-list
14955996|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14955997|NCT01579786|Analgesics|analgesics|mesh-ancestor
14955998|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
14955999|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956000|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956001|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
14956002|NCT01579838|Eculizumab|eculizumab|mesh-list
14956003|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14956004|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956005|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
14956006|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956007|NCT01579864|Rocuronium|rocuronium|mesh-list
14798252|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798253|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798254|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798255|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14798256|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798257|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
14798258|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
14798259|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798260|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14798261|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798262|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14798263|NCT00777244|Mitotane|mitotane|mesh-list
14798264|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14798265|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798266|NCT00777322|Riboflavin|riboflavin|mesh-list
14798267|NCT00777322|Dextrans|dextrans|mesh-list
14798268|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
14798269|NCT00777322|Vitamins|vitamins|mesh-ancestor
14798270|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
14798271|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798272|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14798273|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798274|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
14798275|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
14798276|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
14798277|NCT00777413|Minocycline|minocycline|mesh-list
14798278|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798279|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798280|NCT00777439|Domperidone|domperidone|mesh-list
14798281|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798282|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
14798283|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
14798284|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798285|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798286|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798287|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14798288|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
14798289|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798290|NCT00777478|Sunitinib|sunitinib|mesh-list
14798291|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798292|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798293|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798294|NCT00777478|Growth Substances|growth substances|mesh-ancestor
14798295|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798296|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
14798297|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14798298|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798299|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798300|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14798301|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798302|NCT00777504|Growth Substances|growth substances|mesh-ancestor
14798303|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798304|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
14798305|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798306|NCT00777517|Atorvastatin|atorvastatin|mesh-list
14798307|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14798308|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14798309|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
14798310|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798311|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14798312|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14956008|NCT01579864|Succinylcholine|succinylcholine|mesh-list
14956009|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14956010|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14956011|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14956012|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956013|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956014|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14798313|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956015|NCT01579890|Diclofenac|diclofenac|mesh-list
14956016|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14956017|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956018|NCT01579890|Analgesics|analgesics|mesh-ancestor
14956019|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
14956020|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956021|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956022|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14956023|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956024|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14956025|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956026|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956027|NCT01579903|Factor VIII|factor viii|mesh-list
14956028|NCT01579903|Coagulants|coagulants|mesh-ancestor
14956029|NCT01579929|Etoposide|etoposide|mesh-list
14956030|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956031|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14956032|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14956033|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14956034|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956035|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956036|NCT01579994|Crizotinib|crizotinib|mesh-list
14956037|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956038|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14956039|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956040|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956041|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
14956042|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14956043|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14956044|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956045|NCT01580007|Vitamins|vitamins|mesh-ancestor
14956046|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
14956047|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14956048|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956049|NCT01580033|Vaccines|vaccines|mesh-list
14956050|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
14956051|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956052|NCT01580163|Methadone|methadone|mesh-list
14956053|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14956054|NCT01580163|Narcotics|narcotics|mesh-ancestor
14956055|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956056|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956057|NCT01580163|Analgesics|analgesics|mesh-ancestor
14956058|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
14956059|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956060|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
14956061|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
14956062|NCT01580202|Lamivudine|lamivudine|mesh-list
14956063|NCT01580202|Entecavir|entecavir|mesh-list
14956064|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14956065|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14956066|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798314|NCT00777543|Ferulic acid|ferulic acid|mesh-list
14956067|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956068|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
14956069|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956070|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14956071|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14956072|NCT01580228|Ofatumumab|ofatumumab|mesh-list
14956073|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956074|NCT01580254|Latanoprost|latanoprost|mesh-list
14956075|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14956076|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14956077|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14956078|NCT01580371|CKD-581|ckd-581|mesh-list
14956079|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956080|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956081|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
14956082|NCT01580501|Tadalafil|tadalafil|mesh-list
14956083|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
14956084|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14956085|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14956086|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956087|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956088|NCT01580501|Urological Agents|urological agents|mesh-ancestor
14956089|NCT01580514|Exenatide|exenatide|mesh-list
14956090|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14956091|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956092|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14956093|NCT01580514|Incretins|incretins|mesh-ancestor
14956094|NCT01580514|Hormones|hormones|mesh-ancestor
14956095|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956096|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
14956097|NCT01580683|Vitamins|vitamins|mesh-ancestor
14798315|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14798316|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14798317|NCT00777543|Analgesics|analgesics|mesh-ancestor
14798318|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
14798319|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798320|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956098|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
14956099|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956100|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
14956101|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956102|NCT01580683|Protective Agents|protective agents|mesh-ancestor
14956103|NCT01580813|Acipimox|acipimox|mesh-list
14956104|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14956105|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
14956106|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956107|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14798321|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798322|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956108|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14956109|NCT01580839|Plasminogen|plasminogen|mesh-list
14956110|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14956111|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14956112|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956113|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
14956114|NCT01580865|Tacrolimus|tacrolimus|mesh-list
14956115|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956116|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
14956117|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956118|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14956119|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956120|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956121|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14956122|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956123|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14956124|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
14956125|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14956126|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956127|NCT01580878|Butenafine|butenafine|mesh-list
14956128|NCT01580878|Clotrimazole|clotrimazole|mesh-list
14956129|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
14956130|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956131|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14956132|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14956133|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14956134|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956135|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956136|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14956137|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
14956138|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956139|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956140|NCT01580891|Naftifine|naftifine|mesh-list
14956141|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
14956142|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956143|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
14956144|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14798323|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
14798324|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798325|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14798326|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798327|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14798328|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
14798329|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798330|NCT00777543|Protective Agents|protective agents|mesh-ancestor
14798331|NCT00777569|Nicotine|nicotine|mesh-list
14798332|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14798333|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
14798334|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798335|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798336|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14798337|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14798338|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
14798339|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798340|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798341|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
14798342|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798343|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798344|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14798345|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14798346|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798347|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798348|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798349|NCT00777673|Paclitaxel|paclitaxel|mesh-list
14956145|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14956146|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956147|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
14956148|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
14956149|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
14956150|NCT01581073|Hematinics|hematinics|mesh-ancestor
14956151|NCT01581151|Dexamethasone|dexamethasone|mesh-list
14956152|NCT01581151|Ranibizumab|ranibizumab|mesh-list
14956153|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14956154|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
14956155|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
14956156|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956157|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956158|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14956159|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
14956160|NCT01581151|Hormones|hormones|mesh-ancestor
14956161|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956162|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14956163|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956164|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14956165|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14956166|NCT01581151|Growth Substances|growth substances|mesh-ancestor
14956167|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
14956168|NCT01581164|Vaccines|vaccines|mesh-list
14956169|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
14956170|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956171|NCT01581242|Adefovir|adefovir|mesh-list
14956172|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14956173|NCT01581242|Clevudine|clevudine|mesh-list
14956174|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
14956175|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956176|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14956177|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14956178|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956179|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956180|NCT01581320|Vitamin D|vitamin d|mesh-list
14956181|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
14956182|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
14956183|NCT01581320|Vitamins|vitamins|mesh-ancestor
14956184|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
14956185|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956186|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14956187|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14956188|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
14956189|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14956190|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14956191|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
14956192|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14956193|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
14956194|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14956195|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956196|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14956197|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14956198|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956199|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14956200|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
14956201|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
14956202|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956203|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
14956204|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956205|NCT01581411|Plasminogen|plasminogen|mesh-list
14956206|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14956207|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14956208|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14956209|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956210|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
14956211|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14956212|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
14956213|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
14956214|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956215|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956216|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956217|NCT01581450|Analgesics|analgesics|mesh-ancestor
14956218|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
14956219|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027637|NCT01950793|Hormones|hormones|mesh-ancestor
15027638|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027639|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027640|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15027641|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
15027642|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027643|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027644|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15027645|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
15027646|NCT01950793|Protective Agents|protective agents|mesh-ancestor
15027647|NCT01950884|Ezetimibe|ezetimibe|mesh-list
15027648|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15027649|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15027650|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
15027651|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027652|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15027653|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
15027654|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027655|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
15027656|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15027657|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15027658|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027659|NCT01950923|Urological Agents|urological agents|mesh-ancestor
15027660|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
15027661|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
15027662|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
15027663|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15027664|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15027665|NCT01951027|Lenograstim|lenograstim|mesh-list
15027666|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15027667|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
15027668|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027669|NCT01951053|Citalopram|citalopram|mesh-list
15027670|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15027671|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15027672|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15027673|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027674|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027675|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
15027676|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027677|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15027678|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
15027679|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027680|NCT01951079|Digoxin|digoxin|mesh-list
15027681|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15027682|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15027683|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027684|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027685|NCT01951079|Protective Agents|protective agents|mesh-ancestor
15027686|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027687|NCT01951144|Lorazepam|lorazepam|mesh-list
15027688|NCT01951144|PF-06372865|pf-06372865|mesh-list
15027689|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
15027690|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
15027691|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
15027692|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027693|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027694|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027695|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15027696|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027697|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15027698|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027699|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027700|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
14798350|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
14798351|NCT00777673|Bevacizumab|bevacizumab|mesh-list
14798352|NCT00777673|Carboplatin|carboplatin|mesh-list
14798353|NCT00777673|Doxorubicin|doxorubicin|mesh-list
14798354|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14798355|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14798356|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798357|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
14798358|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
14798359|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
14798360|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798361|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798362|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
14798363|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798364|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798365|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14798366|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
14798367|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14798368|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14798369|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798370|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798371|NCT00777673|Growth Substances|growth substances|mesh-ancestor
14798372|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
14798373|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14798374|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14798375|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14798376|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798377|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14798378|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798379|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14798380|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798381|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798382|NCT00777738|Bortezomib|bortezomib|mesh-list
14798383|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798384|NCT00777933|Cyclosporine|cyclosporine|mesh-list
14798385|NCT00777933|Tacrolimus|tacrolimus|mesh-list
14798386|NCT00777933|Cyclosporins|cyclosporins|mesh-list
14798387|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798388|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
14798389|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798390|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14798391|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798392|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798393|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
14798394|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798395|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798396|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798397|NCT00777959|Sirolimus|sirolimus|mesh-list
14798398|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798399|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798400|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14798401|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798402|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
14798403|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798404|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
14798405|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798406|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14798407|NCT00777972|Fosinopril|fosinopril|mesh-list
14798408|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798409|NCT00777972|Diuretics|diuretics|mesh-ancestor
14798410|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
14798411|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798412|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14798413|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798414|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798415|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14798416|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
14798417|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798418|NCT00777985|Bosentan|bosentan|mesh-list
14798419|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798420|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14798421|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798422|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
14798423|NCT00777998|Thalidomide|thalidomide|mesh-list
14798424|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798425|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
14798426|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798427|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
14798428|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798429|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798430|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798431|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798432|NCT00777998|Growth Substances|growth substances|mesh-ancestor
14798433|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
14798434|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798435|NCT00777998|Trace Elements|trace elements|mesh-ancestor
14798436|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
14798437|NCT00778011|Ondansetron|ondansetron|mesh-list
14798438|NCT00778011|Metoclopramide|metoclopramide|mesh-list
14798439|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
14798440|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
14798441|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798442|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798443|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798444|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
14798445|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798446|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14798447|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
14798448|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798449|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798450|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14798451|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14798452|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798453|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798454|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14798455|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14798456|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14798457|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
14798458|NCT00778024|Fluoxetine|fluoxetine|mesh-list
14798459|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14798460|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14798461|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798462|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798463|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798464|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
14798465|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798466|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14798467|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
14798468|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798469|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14798470|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14798471|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798472|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
14798473|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14798474|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
14798475|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798476|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14798477|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798478|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14798479|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798480|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14798481|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798482|NCT00778050|Amoxicillin|amoxicillin|mesh-list
14798483|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798484|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798485|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
14798486|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14798487|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798488|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798489|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14798490|NCT00778063|Analgesics|analgesics|mesh-ancestor
14798491|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
14798492|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798493|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14798494|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14798495|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14798496|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
14798497|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798498|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798499|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
14798500|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14798501|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
14798502|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798503|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
14798504|NCT00778076|Protective Agents|protective agents|mesh-ancestor
14798505|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14798506|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
14798507|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14798508|NCT00778089|Protective Agents|protective agents|mesh-ancestor
14798509|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798510|NCT00778115|Simethicone|simethicone|mesh-list
14798511|NCT00778115|Loperamide|loperamide|mesh-list
14798512|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
14798513|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798514|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
14798515|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798516|NCT00778115|Emollients|emollients|mesh-ancestor
14798517|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798518|NCT00778128|Gemcitabine|gemcitabine|mesh-list
14798519|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14798520|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
14798521|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798522|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798523|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
14798524|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798525|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798526|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798527|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
14798528|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798529|NCT00778141|Metformin|metformin|mesh-list
14798530|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798531|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798532|NCT00778180|Furosemide|furosemide|mesh-list
14798533|NCT00778180|Diuretics|diuretics|mesh-ancestor
14798534|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
14798535|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798536|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14798537|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798538|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798539|NCT00778193|Aspirin|aspirin|mesh-list
14798540|NCT00778193|Celecoxib|celecoxib|mesh-list
14798541|NCT00778193|Naproxen|naproxen|mesh-list
14798542|NCT00778193|Clopidogrel|clopidogrel|mesh-list
14798543|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14798544|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14798545|NCT00778193|Analgesics|analgesics|mesh-ancestor
14798546|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
14798547|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798548|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798549|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798550|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798551|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14798552|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14798553|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798554|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14798555|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14798556|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798557|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
14798558|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14798559|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14798560|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14798561|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
14798562|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956220|NCT01581476|Quinapril|quinapril|mesh-list
14956221|NCT01581476|Atorvastatin|atorvastatin|mesh-list
14956222|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14956223|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14956224|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14956225|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
14956226|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956227|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14956228|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14956229|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956230|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
14956231|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14956232|NCT01581515|Everolimus|everolimus|mesh-list
14956233|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956234|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956235|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
14956236|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956237|NCT01581736|Insulin|insulin|mesh-list
14956238|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14956239|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14956240|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956241|NCT01581775|Valproic Acid|valproic acid|mesh-list
14956242|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
14956243|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956244|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956245|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
14956246|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956247|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956248|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
14956249|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14956250|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956251|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956252|NCT01581788|Valproic Acid|valproic acid|mesh-list
14956253|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
14956254|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956255|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956256|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
14956257|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956258|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956259|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
14956260|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14956261|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956262|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956263|NCT01581814|Metformin|metformin|mesh-list
14956264|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14956265|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14956266|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14956267|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956268|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14956269|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14956270|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14956271|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14956272|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
14956273|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14956274|NCT01581814|Estrogens|estrogens|mesh-ancestor
14956275|NCT01581814|Hormones|hormones|mesh-ancestor
14956276|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956277|NCT01581853|Ritonavir|ritonavir|mesh-list
14956278|NCT01581853|Lopinavir|lopinavir|mesh-list
14956279|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14956280|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14956281|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
14956282|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956283|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956284|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14956285|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14956286|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
14956287|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956288|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14956289|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14956290|NCT01581866|Ziprasidone|ziprasidone|mesh-list
14956291|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14956292|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
14956293|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956294|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956295|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956296|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14956297|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14956298|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956299|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956300|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14956301|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
14956302|NCT01581879|Ziprasidone|ziprasidone|mesh-list
14956303|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14956304|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
14956305|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956306|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956307|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956308|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14956309|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14956310|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956311|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956312|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14956313|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
14956314|NCT01581918|Carbamazepine|carbamazepine|mesh-list
14956315|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
14956316|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
14956317|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14956318|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956319|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956320|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956321|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956322|NCT01581918|Analgesics|analgesics|mesh-ancestor
14956323|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
14956324|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956325|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14956326|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14956327|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956328|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14956329|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14956330|NCT01581944|Goserelin|goserelin|mesh-list
14956331|NCT01581944|Hormones|hormones|mesh-list
14956332|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956333|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956334|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14956335|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956336|NCT01582022|Bupivacaine|bupivacaine|mesh-list
14956337|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
14956338|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
14956339|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956340|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956341|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
14956342|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956343|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14956344|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
14956345|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14956346|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14956347|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14956348|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
14956349|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956350|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14956351|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14956352|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956353|NCT01582191|Everolimus|everolimus|mesh-list
14956354|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956355|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956356|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
14956357|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956358|NCT01582230|Vildagliptin|vildagliptin|mesh-list
14956359|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14956360|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956361|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14956362|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
14956363|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956364|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956365|NCT01582321|Cantharidin|cantharidin|mesh-list
14956366|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236415|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15027701|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
14956367|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956368|NCT01582412|Isavuconazole|isavuconazole|mesh-list
14956369|NCT01582412|Digoxin|digoxin|mesh-list
14956370|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14956371|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14956372|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956373|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956374|NCT01582412|Protective Agents|protective agents|mesh-ancestor
14956375|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956376|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
14956377|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956378|NCT01582425|Isavuconazole|isavuconazole|mesh-list
14956379|NCT01582425|Methadone|methadone|mesh-list
14956380|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14956381|NCT01582425|Narcotics|narcotics|mesh-ancestor
14956382|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956383|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956384|NCT01582425|Analgesics|analgesics|mesh-ancestor
14956385|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
14956386|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956387|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
14956388|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
14956389|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
14956390|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956391|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
14956392|NCT01582438|Citric Acid|citric acid|mesh-list
14956393|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
14798563|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14798564|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
14798565|NCT00778232|Gabapentin|gabapentin|mesh-list
14798566|NCT00778232|Analgesics|analgesics|mesh-ancestor
14798567|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
14798568|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798569|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798570|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
14798571|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14798572|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14798573|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798574|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956394|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
14956395|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14956396|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
14956397|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
14956398|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956399|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
14956400|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14956401|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14956402|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956403|NCT01582438|Urological Agents|urological agents|mesh-ancestor
14956404|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14956405|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
14956406|NCT01582542|Coagulants|coagulants|mesh-ancestor
14956407|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14956408|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
14956409|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956410|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
14956411|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14956412|NCT01582555|Antidotes|antidotes|mesh-ancestor
14956413|NCT01582555|Protective Agents|protective agents|mesh-ancestor
14956414|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956415|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
14956416|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236416|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
14798575|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14956417|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
14956418|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956419|NCT01582555|Expectorants|expectorants|mesh-ancestor
14956420|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
14956421|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14956422|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
14956423|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956424|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
14956425|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956426|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956427|NCT01582607|Fentanyl|fentanyl|mesh-list
14956428|NCT01582607|Bupivacaine|bupivacaine|mesh-list
14956429|NCT01582607|Ropivacaine|ropivacaine|mesh-list
14956430|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
14956431|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
14956432|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
14956433|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956434|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956435|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
14956436|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956437|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14798576|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14798577|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798578|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798579|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
14798580|NCT00778245|Cefprozil|cefprozil|mesh-list
14798581|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798582|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798583|NCT00778271|Gabapentin|gabapentin|mesh-list
14798584|NCT00778271|Analgesics|analgesics|mesh-ancestor
14798585|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
14798586|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798587|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798588|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
14798589|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14798590|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14798591|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798592|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798593|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14798594|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14798595|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798596|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956438|NCT01582607|Narcotics|narcotics|mesh-ancestor
14956439|NCT01582607|Analgesics|analgesics|mesh-ancestor
14956440|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14956441|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14956442|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
14956443|NCT01582646|Terbutaline|terbutaline|mesh-list
14956444|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14956445|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
14956446|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956447|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956448|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14956449|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
14956450|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
14956451|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
14956452|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14956453|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14956454|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14956455|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14956456|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
14956457|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956458|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956459|NCT01582672|Sunitinib|sunitinib|mesh-list
14956460|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956461|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14956462|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14956463|NCT01582672|Growth Substances|growth substances|mesh-ancestor
14956464|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956465|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14956466|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14956467|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956468|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956469|NCT01582711|Isoniazid|isoniazid|mesh-list
14956470|NCT01582711|Rifapentine|rifapentine|mesh-list
14956471|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
14956472|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14956473|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956474|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14956475|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14956476|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
14956477|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956478|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14956479|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14956480|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
14956481|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
14956482|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14956483|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
14956484|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14956485|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
14956486|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956487|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956488|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
14956489|NCT01582932|Calcipotriene|calcipotriene|mesh-list
14956490|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
14956491|NCT01582997|Dabrafenib|dabrafenib|mesh-list
14956492|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956493|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14956494|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956495|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956496|NCT01583023|Bupropion|bupropion|mesh-list
14956497|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14956498|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
14956499|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956500|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14956501|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14956502|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14956503|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956504|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
14956505|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956506|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956507|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14956508|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14956509|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956510|NCT01583036|Digoxin|digoxin|mesh-list
14956511|NCT01583036|Ezogabine|ezogabine|mesh-list
14956512|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14956513|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14956514|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956515|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956516|NCT01583036|Protective Agents|protective agents|mesh-ancestor
14956517|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956518|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
14956519|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14956520|NCT01583062|Amoxicillin|amoxicillin|mesh-list
14956521|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
14956522|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
14956523|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14956524|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956525|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956526|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956527|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14956528|NCT01583114|Perindopril|perindopril|mesh-list
14956529|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14956530|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
14956531|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956532|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956533|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14956534|NCT01583244|Abatacept|abatacept|mesh-list
14956535|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14956536|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956537|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956538|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956539|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
14956540|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956541|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027702|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027703|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027704|NCT01951209|Rifaximin|rifaximin|mesh-list
15027705|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15027706|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027707|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027708|NCT01951404|Allopurinol|allopurinol|mesh-list
15027709|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
15027710|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027711|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027712|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
15027713|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027714|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15027715|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
15027716|NCT01951404|Protective Agents|protective agents|mesh-ancestor
15027717|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027718|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15027719|NCT01951430|Cephalosporins|cephalosporins|mesh-list
15027720|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15027721|NCT01951430|Itraconazole|itraconazole|mesh-list
15027722|NCT01951430|Fluconazole|fluconazole|mesh-list
15027723|NCT01951430|Posaconazole|posaconazole|mesh-list
15027724|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
15027725|NCT01951430|Clotrimazole|clotrimazole|mesh-list
15027726|NCT01951430|Miconazole|miconazole|mesh-list
15027727|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027728|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15027729|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15027730|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027731|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027732|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15027733|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
15027734|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027735|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027736|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15027737|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15027738|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15027739|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15027740|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15027741|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15027742|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15027743|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15027744|NCT01951430|Renal Agents|renal agents|mesh-ancestor
15027745|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
15027746|NCT01951482|Bevacizumab|bevacizumab|mesh-list
14236417|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798597|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
14798598|NCT00778284|Amoxicillin|amoxicillin|mesh-list
14798599|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798600|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798601|NCT00778297|Vaccines|vaccines|mesh-list
14798602|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
14798603|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956542|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
14956543|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956544|NCT01583426|Paclitaxel|paclitaxel|mesh-list
14956545|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14956546|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14956547|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956548|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
14956549|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
14956550|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
14956551|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956552|NCT01583439|Ritonavir|ritonavir|mesh-list
14956553|NCT01583439|Lopinavir|lopinavir|mesh-list
14956554|NCT01583439|Tenofovir|tenofovir|mesh-list
14956555|NCT01583439|Lamivudine|lamivudine|mesh-list
14956556|NCT01583439|Zidovudine|zidovudine|mesh-list
14956557|NCT01583439|Emtricitabine|emtricitabine|mesh-list
14956558|NCT01583439|Efavirenz|efavirenz|mesh-list
14956559|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14956560|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14956561|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14956562|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
14956563|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956564|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956565|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14956566|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
14956567|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956568|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14956569|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14956570|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14956571|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14956572|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
14956573|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14956574|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14956575|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14956576|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14956577|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14956578|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14956579|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14956580|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956581|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956582|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14956583|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14956584|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956585|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
14956586|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956587|NCT01583504|Anesthetics|anesthetics|mesh-list
14956588|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
14956589|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956590|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956591|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
14956592|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956593|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
14956594|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14956595|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956596|NCT01583621|Vitamins|vitamins|mesh-ancestor
14956597|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
14956598|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14956599|NCT01583660|Acetaminophen|acetaminophen|mesh-list
14956600|NCT01583660|Celecoxib|celecoxib|mesh-list
14956601|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14956602|NCT01583660|Oxycodone|oxycodone|mesh-list
14956603|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956604|NCT01583660|Analgesics|analgesics|mesh-ancestor
14956605|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
14956606|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956607|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956608|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
14956609|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14956610|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14956611|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956612|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14956613|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14956614|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956615|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956616|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14956617|NCT01583660|Narcotics|narcotics|mesh-ancestor
14956618|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956619|NCT01583777|Belinostat|belinostat|mesh-list
14956620|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956621|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14956622|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956623|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956624|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14956625|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956626|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956627|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956628|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14956629|NCT01583959|Folic Acid|folic acid|mesh-list
14956630|NCT01583959|Hematinics|hematinics|mesh-ancestor
14956631|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
14956632|NCT01583959|Vitamins|vitamins|mesh-ancestor
14956633|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
14956634|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956635|NCT01583972|Vitamin A|vitamin a|mesh-list
14956636|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
14956637|NCT01583972|Vitamins|vitamins|mesh-ancestor
14956638|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
14956639|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956640|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
14956641|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956642|NCT01583972|Protective Agents|protective agents|mesh-ancestor
14956643|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14956644|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956645|NCT01584050|Folic Acid|folic acid|mesh-list
14956646|NCT01584050|Hematinics|hematinics|mesh-ancestor
14956647|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
14956648|NCT01584050|Vitamins|vitamins|mesh-ancestor
14956649|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
14956650|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956651|NCT01584076|Donepezil|donepezil|mesh-list
14956652|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14956653|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956654|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956655|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
14956656|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956657|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956658|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
14956659|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
14956660|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14956661|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
14956662|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956663|NCT01584206|Ezetimibe|ezetimibe|mesh-list
14956664|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14956665|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14956666|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
14956667|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956668|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14956669|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14956670|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
14956671|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956672|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14956673|NCT01584297|Ketoconazole|ketoconazole|mesh-list
14956674|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
14956675|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956676|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14956677|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14956678|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956679|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956680|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14956681|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
14956682|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956683|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956684|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14956685|NCT01584362|Oxfendazole|oxfendazole|mesh-list
14956686|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
14956687|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14956688|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956689|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
14956690|NCT01584492|Beclomethasone|beclomethasone|mesh-list
14956691|NCT01584492|Albuterol|albuterol|mesh-list
14956692|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
14956693|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14956694|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
14956695|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956696|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956697|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14956698|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
14956699|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14956700|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14956701|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14956702|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
14956703|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956704|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956705|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14956706|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
14956707|NCT01584492|Hormones|hormones|mesh-ancestor
14956708|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956709|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
14956710|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14956711|NCT01584557|Tolvaptan|tolvaptan|mesh-list
14956712|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14956713|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956714|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
14956715|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956716|NCT01584687|Omalizumab|omalizumab|mesh-list
14956717|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14956718|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14956719|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14956720|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
14956721|NCT01584726|Analgesics|analgesics|mesh-ancestor
14956722|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
14956723|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956724|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956725|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
14956726|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956727|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14956728|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
14956729|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14956730|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14956731|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956732|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14956733|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
14956734|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14956735|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
14956736|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
15027747|NCT01951482|Cisplatin|cisplatin|mesh-list
14956737|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956738|NCT01584791|Aspirin|aspirin|mesh-list
14956739|NCT01584791|Clopidogrel|clopidogrel|mesh-list
14956740|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14956741|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956742|NCT01584791|Analgesics|analgesics|mesh-ancestor
14956743|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
14956744|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956745|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956746|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14956747|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956748|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14956749|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14956750|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956751|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14956752|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14956753|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956754|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
14956755|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14956756|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14956757|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14956758|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
14956759|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956760|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
14956761|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027748|NCT01951482|Pemetrexed|pemetrexed|mesh-list
15027749|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15027750|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027751|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15027752|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15027753|NCT01951482|Growth Substances|growth substances|mesh-ancestor
15027754|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027755|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
15027756|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027757|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027758|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15027759|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15027760|NCT01951508|Methylphenidate|methylphenidate|mesh-list
15027761|NCT01951508|Modafinil|modafinil|mesh-list
15027762|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15027763|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027764|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15027765|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15027766|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15027767|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027768|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
15027769|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027770|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15027771|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15027772|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15027773|NCT01951560|Valproic Acid|valproic acid|mesh-list
15027774|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
15027775|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027776|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027777|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
15027778|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027779|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027780|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
15027781|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027782|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027783|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027784|NCT01951599|Osimertinib|osimertinib|mesh-list
15027785|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027786|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15027787|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027788|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027789|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15027790|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
15027791|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027792|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15027793|NCT01951677|Antacids|antacids|mesh-ancestor
14956762|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
14956763|NCT01584921|Hematinics|hematinics|mesh-ancestor
14956764|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
14956765|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14956766|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14956767|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
14956768|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
14956769|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956770|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956771|NCT01584947|Bupivacaine|bupivacaine|mesh-list
14956772|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
14956773|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
14956774|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956775|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956776|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
14956777|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956778|NCT01585051|Vitamin D|vitamin d|mesh-list
14956779|NCT01585051|Vitamins|vitamins|mesh-ancestor
14956780|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
14956781|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956782|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14956783|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
14956784|NCT01585350|Poly ICLC|poly iclc|mesh-list
14956785|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14956786|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
14956787|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956788|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
14956789|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
14956790|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14956791|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956792|NCT01585415|Aldesleukin|aldesleukin|mesh-list
14956793|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
14956794|NCT01585415|Fludarabine|fludarabine|mesh-list
14956795|NCT01585415|Vemurafenib|vemurafenib|mesh-list
14956796|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956797|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
14956798|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798604|NCT00778349|Metformin|metformin|mesh-list
14798605|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798606|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798607|NCT00778401|Gabapentin|gabapentin|mesh-list
14798608|NCT00778401|Analgesics|analgesics|mesh-ancestor
14798609|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
14798610|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798611|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798612|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
14798613|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14798614|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14798615|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956799|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956800|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14956801|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
14956802|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956803|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956804|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14956805|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14956806|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14956807|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
14956808|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956809|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14956810|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956811|NCT01585623|Metoprolol|metoprolol|mesh-list
14956812|NCT01585623|Midazolam|midazolam|mesh-list
14956813|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14956814|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14956815|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956816|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956817|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14956818|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14956819|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956820|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14956821|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
14956822|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
14956823|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
14956824|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
14956825|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956826|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956827|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14956828|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14956829|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
14956830|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
14956831|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956832|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14798616|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798617|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14956833|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14956834|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14956835|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
14956836|NCT01585753|Maraviroc|maraviroc|mesh-list
14956837|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14956838|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14956839|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956840|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14956841|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14956842|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
14956843|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956844|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14956845|NCT01585792|Glimepiride|glimepiride|mesh-list
14956846|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14956847|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14956848|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956849|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956850|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
14956851|NCT01585870|Sorafenib|sorafenib|mesh-list
14956852|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956853|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14956854|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956855|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956856|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14956857|NCT01585935|SMOFlipid|smoflipid|mesh-list
14956858|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14956859|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14956860|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14956861|NCT01586013|Propofol|propofol|mesh-list
14956862|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14956863|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956864|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956865|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14956866|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
14956867|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
14956868|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
14956869|NCT01586052|Hematinics|hematinics|mesh-ancestor
14956870|NCT01586117|Amifostine|amifostine|mesh-list
14956871|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14956872|NCT01586117|Protective Agents|protective agents|mesh-ancestor
14956873|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956874|NCT01586143|Acetaminophen|acetaminophen|mesh-list
14956875|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956876|NCT01586143|Analgesics|analgesics|mesh-ancestor
14956877|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
14956878|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956879|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956880|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
14956881|NCT01586169|Azithromycin|azithromycin|mesh-list
14956882|NCT01586169|Ivermectin|ivermectin|mesh-list
14956883|NCT01586169|Albendazole|albendazole|mesh-list
14956884|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14956885|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956886|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14956887|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
14956888|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
14956889|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14956890|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14956891|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
14956892|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
14956893|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
14956894|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956895|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956896|NCT01586208|Phenytoin|phenytoin|mesh-list
14956897|NCT01586208|Valproic Acid|valproic acid|mesh-list
14956898|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
14956899|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956900|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956901|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
14956902|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14956903|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956904|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
14956905|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14956906|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956907|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14956908|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14956909|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14956910|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14956911|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14956912|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14956913|NCT01586286|Nifedipine|nifedipine|mesh-list
14956914|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14956915|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14956916|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956917|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14956918|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956919|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
14956920|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
14956921|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14956922|NCT01586299|Acetaminophen|acetaminophen|mesh-list
14956923|NCT01586299|Ibuprofen|ibuprofen|mesh-list
14956924|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956925|NCT01586299|Analgesics|analgesics|mesh-ancestor
14956926|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
14956927|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956928|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956929|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
14956930|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14956931|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14956932|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956933|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14956934|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956935|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956936|NCT01586442|Eplerenone|eplerenone|mesh-list
14956937|NCT01586442|Spironolactone|spironolactone|mesh-list
14956938|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14956939|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
14956940|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14956941|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956942|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14956943|NCT01586442|Diuretics|diuretics|mesh-ancestor
14956944|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
14956945|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14956946|NCT01586494|Tramadol|tramadol|mesh-list
14956947|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14956948|NCT01586494|Narcotics|narcotics|mesh-ancestor
14956949|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956950|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956951|NCT01586494|Analgesics|analgesics|mesh-ancestor
14956952|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
14956953|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956954|NCT01586507|Tramadol|tramadol|mesh-list
14956955|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14956956|NCT01586507|Narcotics|narcotics|mesh-ancestor
14956957|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14956958|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956959|NCT01586507|Analgesics|analgesics|mesh-ancestor
14956960|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
14956961|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956962|NCT01586533|Mesalamine|mesalamine|mesh-list
14956963|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14956964|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14956965|NCT01586533|Analgesics|analgesics|mesh-ancestor
14956966|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
14956967|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14956968|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956969|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14956970|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14956971|NCT01586572|Vaccines|vaccines|mesh-list
14956972|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
14956973|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956974|NCT01586611|Leucovorin|leucovorin|mesh-list
14956975|NCT01586611|Gemcitabine|gemcitabine|mesh-list
14956976|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
14956977|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14956978|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
14956979|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14956980|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14956981|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
14956982|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14956983|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956984|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956985|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
14956986|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956987|NCT01586611|Antidotes|antidotes|mesh-ancestor
14956988|NCT01586611|Protective Agents|protective agents|mesh-ancestor
14956989|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
14956990|NCT01586611|Vitamins|vitamins|mesh-ancestor
14956991|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
15027794|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027795|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027796|NCT01951729|Atropine|atropine|mesh-list
15027797|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15027798|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15027799|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15027800|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
14956992|NCT01586845|Cyclosporine|cyclosporine|mesh-list
14956993|NCT01586845|Tacrolimus|tacrolimus|mesh-list
14956994|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14956995|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
14956996|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14956997|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14956998|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14956999|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957000|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
14957001|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957002|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798618|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14798619|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798620|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798621|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
14798622|NCT00778414|Amoxicillin|amoxicillin|mesh-list
14798623|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
14957003|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14957004|NCT01587066|Valproic Acid|valproic acid|mesh-list
14957005|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14957006|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
14957007|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957008|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14236418|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236419|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
14236420|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236421|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236422|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236423|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
14236424|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236425|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
14236426|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236427|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
14236428|NCT00114231|Capecitabine|capecitabine|mesh-list
14236429|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
14236430|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14798624|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
14798625|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14798626|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798627|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798628|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798629|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798630|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14798631|NCT00778427|Metformin|metformin|mesh-list
14798632|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798633|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798634|NCT00778466|Metformin|metformin|mesh-list
14798635|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798636|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798637|NCT00778505|Remifentanil|remifentanil|mesh-list
14798638|NCT00778505|Propofol|propofol|mesh-list
14798639|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14798640|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798641|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798642|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14798643|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
14798644|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
14798645|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14798646|NCT00778505|Narcotics|narcotics|mesh-ancestor
14798647|NCT00778505|Analgesics|analgesics|mesh-ancestor
14798648|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
14798649|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798650|NCT00778544|Amoxicillin|amoxicillin|mesh-list
14798651|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
14798652|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
14798653|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14798654|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798655|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798656|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798657|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798658|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14798659|NCT00778557|Cefprozil|cefprozil|mesh-list
14798660|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798661|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798662|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
14957009|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14236431|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
14236432|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236433|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236434|NCT00114244|Gemcitabine|gemcitabine|mesh-list
14236435|NCT00114244|Sorafenib|sorafenib|mesh-list
14236436|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14236437|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
14236438|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236439|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236440|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
14236441|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236442|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236443|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236444|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
14236445|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236446|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236447|NCT00114504|Simvastatin|simvastatin|mesh-list
14236448|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14236449|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14798663|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14798664|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236450|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
14798665|NCT00778583|Renal Agents|renal agents|mesh-ancestor
14798666|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798667|NCT00778596|Prednisolone|prednisolone|mesh-list
14798668|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798669|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
14798670|NCT00778596|Hormones|hormones|mesh-ancestor
14798671|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14798672|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798673|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14798674|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798675|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14798676|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14798677|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14798678|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
14798679|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14798680|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798681|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14798682|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14798683|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14798684|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14798685|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14798686|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14798687|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14798688|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14798689|NCT00778661|Amoxicillin|amoxicillin|mesh-list
14798690|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798691|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798692|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14798693|NCT00778674|Benazepril|benazepril|mesh-list
14798694|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798695|NCT00778674|Diuretics|diuretics|mesh-ancestor
14798696|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
14798697|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798698|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14798699|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798700|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798701|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14798702|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
14798703|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798704|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14798705|NCT00778713|Fosinopril|fosinopril|mesh-list
14798706|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798707|NCT00778713|Diuretics|diuretics|mesh-ancestor
14798708|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
14798709|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798710|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14798711|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798712|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798713|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14798714|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
14798715|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798716|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14798717|NCT00778726|Benazepril|benazepril|mesh-list
14798718|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14798719|NCT00778726|Diuretics|diuretics|mesh-ancestor
14798720|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
14798721|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798722|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14798723|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798724|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798725|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14798726|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
14798727|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798728|NCT00778739|Cefprozil|cefprozil|mesh-list
14798729|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798730|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798731|NCT00778752|Lenalidomide|lenalidomide|mesh-list
14798732|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
14798733|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798734|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798735|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798736|NCT00778752|Growth Substances|growth substances|mesh-ancestor
14798737|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
14798738|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798739|NCT00778765|Gabapentin|gabapentin|mesh-list
14798740|NCT00778765|Analgesics|analgesics|mesh-ancestor
14798741|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
14798742|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798743|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798744|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
14798745|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14798746|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14798747|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798748|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034938|NCT01998165|Remifentanil|remifentanil|mesh-list
14957010|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957011|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957012|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
14957013|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957014|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957015|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
14957016|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957017|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
14957018|NCT01587196|Naltrexone|naltrexone|mesh-list
14957019|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14957020|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14957021|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957022|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
14957023|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957024|NCT01587222|Octreotide|octreotide|mesh-list
14957025|NCT01587222|Midodrine|midodrine|mesh-list
14957026|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957027|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14957028|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957029|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
14957030|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
14957031|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957032|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957033|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14957034|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14957035|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14957036|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14957037|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
14957038|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957039|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957040|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
14957041|NCT01587261|Vitamins|vitamins|mesh-ancestor
14957042|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
14957043|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957044|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
14957045|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957046|NCT01587261|Protective Agents|protective agents|mesh-ancestor
14957047|NCT01587313|Hydralazine|hydralazine|mesh-list
14957048|NCT01587313|Isosorbide|isosorbide|mesh-list
14957049|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14957050|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14957051|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14957052|NCT01587313|Diuretics|diuretics|mesh-ancestor
14957053|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
14957054|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957055|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
14957056|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14957057|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957058|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14957059|NCT01587326|Citalopram|citalopram|mesh-list
14957060|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14957061|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14957062|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957063|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957064|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957065|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
14957066|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957067|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14957068|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
14957069|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957070|NCT01587339|Pregabalin|pregabalin|mesh-list
14957071|NCT01587339|Zonisamide|zonisamide|mesh-list
14957072|NCT01587339|Lacosamide|lacosamide|mesh-list
14957073|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
14957074|NCT01587339|Ezogabine|ezogabine|mesh-list
14957075|NCT01587339|Analgesics|analgesics|mesh-ancestor
14957076|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
14957077|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957078|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957079|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
14957080|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14957081|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957082|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957083|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14957084|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14957085|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14957086|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957087|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957088|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14957089|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14957090|NCT01587378|Metformin|metformin|mesh-list
14957091|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14957092|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957093|NCT01587430|Cytarabine|cytarabine|mesh-list
14957094|NCT01587430|Daunorubicin|daunorubicin|mesh-list
14957095|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
14957096|NCT01587430|Idarubicin|idarubicin|mesh-list
14798749|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14798750|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14798751|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798752|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798753|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
14798754|NCT00778778|Cefprozil|cefprozil|mesh-list
14798755|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798756|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798757|NCT00778791|Metformin|metformin|mesh-list
14798758|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14798759|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798760|NCT00778908|Cisplatin|cisplatin|mesh-list
14798761|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798762|NCT00778973|Sertraline|sertraline|mesh-list
14798763|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
14957097|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14957098|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
14957099|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957100|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957101|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
14957102|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957103|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14957104|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
14957105|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957106|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14957107|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14957108|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14957109|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957110|NCT01587430|Analgesics|analgesics|mesh-ancestor
14957111|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
14957112|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957113|NCT01587482|Paclitaxel|paclitaxel|mesh-list
14957114|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14798764|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798765|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14798766|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14957115|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957116|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
14957117|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
14957118|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
14957119|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957120|NCT01587495|Ertapenem|ertapenem|mesh-list
14957121|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14957122|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957123|NCT01587508|Meloxicam|meloxicam|mesh-list
14957124|NCT01587508|Amitriptyline|amitriptyline|mesh-list
14798767|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798768|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798769|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798770|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
14798771|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798772|NCT00779012|Infliximab|infliximab|mesh-list
14798773|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798774|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14798775|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798776|NCT00779051|Zolpidem|zolpidem|mesh-list
14957125|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
14957126|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14957127|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14957128|NCT01587508|Analgesics|analgesics|mesh-ancestor
14957129|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
14957130|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957131|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957132|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798777|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14798778|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14798779|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798780|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798781|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14798782|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
14798783|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
14798784|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798785|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798786|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
14798787|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14798788|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
14798789|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14798790|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
14798791|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798792|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798793|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
14798794|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
14798795|NCT00779129|Doxorubicin|doxorubicin|mesh-list
14798796|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798797|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
14798798|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798799|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798800|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14798801|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
14798802|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798803|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798804|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14798805|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14798806|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14798807|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14798808|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798809|NCT00779194|Sirolimus|sirolimus|mesh-list
14798810|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14798811|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798812|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14798813|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798814|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
14798815|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798816|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
14798817|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798818|NCT00779220|Methotrexate|methotrexate|mesh-list
14798819|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
14798820|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14798821|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
14798822|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14798823|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798824|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14798825|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
14798826|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798827|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798828|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798829|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798830|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14798831|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798832|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
14798833|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798834|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14798835|NCT00779233|Zidovudine|zidovudine|mesh-list
14798836|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
14798837|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798838|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14798839|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14798840|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798841|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
14798842|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798843|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14798844|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14798845|NCT00779350|Sertraline|sertraline|mesh-list
14798846|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
14798847|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14798848|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14798849|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14798850|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14798851|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798852|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798853|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
14798854|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798855|NCT00779376|Zidovudine|zidovudine|mesh-list
14798856|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
14798857|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798858|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14957133|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14957134|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14957135|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14957136|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957137|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957138|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14957139|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
14957140|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957141|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14957142|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14957143|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14957144|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957145|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14957146|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14957147|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957148|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
14957149|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957150|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14957151|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
14957152|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957153|NCT01587625|Oxytocin|oxytocin|mesh-list
14798859|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14798860|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798861|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
14798862|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798863|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14798864|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14798865|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14798866|NCT00779389|Dasatinib|dasatinib|mesh-list
14798867|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798868|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14798869|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798870|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798871|NCT00779441|Zolpidem|zolpidem|mesh-list
14957154|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
14798872|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14798873|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14798874|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14798875|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798876|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14798877|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
14798878|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
14798879|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957155|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14957156|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957157|NCT01587638|Metoprolol|metoprolol|mesh-list
14957158|NCT01587638|Atenolol|atenolol|mesh-list
14957159|NCT01587638|Carvedilol|carvedilol|mesh-list
14957160|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
14957161|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14957162|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14957163|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
14957164|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
14957165|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957166|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957167|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14957168|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14957169|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
14957170|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957171|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957172|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
14957173|NCT01587638|Protective Agents|protective agents|mesh-ancestor
14957174|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14957175|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957176|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14957177|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
14957178|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14957179|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14957180|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
14957181|NCT01587729|Serotonin|serotonin|mesh-list
14957182|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14957183|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957184|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14957185|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
14957186|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957187|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957188|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957189|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14957190|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957191|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14957192|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957193|NCT01587820|Cisplatin|cisplatin|mesh-list
14957194|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957195|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14957196|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14957197|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957198|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
14957199|NCT01588002|Ritonavir|ritonavir|mesh-list
14957200|NCT01588002|Efavirenz|efavirenz|mesh-list
14957201|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14957202|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14957203|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
14957204|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957205|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957206|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14957207|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14957208|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
14957209|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522797|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522798|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522799|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522800|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14522801|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14522802|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522803|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522804|NCT03555305|Insulin|insulin|mesh-list
14522805|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14522806|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
14522807|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15034939|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14957210|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14957211|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14957212|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14957213|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14957214|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14957215|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14957216|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14957217|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14957218|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14957219|NCT01588093|Mecasermin|mecasermin|mesh-list
14957220|NCT01588093|Growth Substances|growth substances|mesh-ancestor
14957221|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957222|NCT01588171|Enoxaparin|enoxaparin|mesh-list
14957223|NCT01588171|Bemiparin|bemiparin|mesh-list
14957224|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
14957225|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14957226|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14957227|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957228|NCT01588314|Gabapentin|gabapentin|mesh-list
14957229|NCT01588314|Analgesics|analgesics|mesh-ancestor
14957230|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
14957231|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957232|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957233|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
14957234|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14957235|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14957236|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957237|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957238|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14957239|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14957240|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957241|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957242|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
14957243|NCT01588522|Calcitriol|calcitriol|mesh-list
14957244|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14957245|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957246|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14957247|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957248|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957249|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14957250|NCT01588522|Vitamins|vitamins|mesh-ancestor
14957251|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
14957252|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14957253|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14957254|NCT01588587|Vildagliptin|vildagliptin|mesh-list
14957255|NCT01588587|Alogliptin|alogliptin|mesh-list
14957256|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14957257|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957258|NCT01588587|Incretins|incretins|mesh-ancestor
14957259|NCT01588587|Hormones|hormones|mesh-ancestor
14957260|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957261|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14957262|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
14957263|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957264|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957265|NCT01588626|Ticagrelor|ticagrelor|mesh-list
14957266|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14957267|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14957268|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14957269|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14957270|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
14957271|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957272|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957273|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957274|NCT01588639|Insulin|insulin|mesh-list
14957275|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14957276|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14957277|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957278|NCT01588704|Bevacizumab|bevacizumab|mesh-list
14957279|NCT01588704|Pemetrexed|pemetrexed|mesh-list
14957280|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14957281|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957282|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14957283|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14957284|NCT01588704|Growth Substances|growth substances|mesh-ancestor
14957285|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957286|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
14957287|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957288|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957289|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14957290|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15027801|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027802|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027803|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15027804|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027805|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
15027806|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
15027807|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15027808|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15027809|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
15027810|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027811|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027812|NCT01951846|Nintedanib|nintedanib|mesh-list
15027813|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027814|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15027815|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027816|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027817|NCT01951872|Caffeine|caffeine|mesh-list
14957291|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
14957292|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14957293|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14957294|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14957295|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
14957296|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957297|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957298|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957299|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
14957300|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14957301|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957302|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
14957303|NCT01588756|Goralatide|goralatide|mesh-list
14957304|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
14957305|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957306|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14957307|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957308|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
14957309|NCT01588756|Growth Substances|growth substances|mesh-ancestor
14957310|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957311|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14957312|NCT01588756|Protective Agents|protective agents|mesh-ancestor
14957313|NCT01588782|Ketoconazole|ketoconazole|mesh-list
14957314|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
14957315|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957316|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14957317|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14957318|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957319|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957320|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14957321|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
14957322|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957323|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957324|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14957325|NCT01588795|Vitamin D|vitamin d|mesh-list
14957326|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
14957327|NCT01588795|Diuretics|diuretics|mesh-list
14957328|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14957329|NCT01588795|Vitamins|vitamins|mesh-ancestor
14957330|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
14957331|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957332|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14957333|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14957334|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
14957335|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957336|NCT01588847|Sufentanil|sufentanil|mesh-list
14957337|NCT01588847|Bupivacaine|bupivacaine|mesh-list
14957338|NCT01588847|Anesthetics|anesthetics|mesh-list
14957339|NCT01588847|Propofol|propofol|mesh-list
14957340|NCT01588847|Sevoflurane|sevoflurane|mesh-list
14957341|NCT01588847|Rocuronium|rocuronium|mesh-list
14957342|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
14957343|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957344|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957345|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
14957346|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957347|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14957348|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14957349|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
14957350|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14957351|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14957352|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14957353|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14957354|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14957355|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14957356|NCT01588847|Narcotics|narcotics|mesh-ancestor
14957357|NCT01588847|Analgesics|analgesics|mesh-ancestor
14957358|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14957359|NCT01588873|Desogestrel|desogestrel|mesh-list
14957360|NCT01588873|NuvaRing|nuvaring|mesh-list
14957361|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14957362|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14957363|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14957364|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
14957365|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14957366|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957367|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14957368|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14957369|NCT01588873|Progestins|progestins|mesh-ancestor
14798880|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798881|NCT00779454|Gemcitabine|gemcitabine|mesh-list
14798882|NCT00779454|Capecitabine|capecitabine|mesh-list
14798883|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
14798884|NCT00779454|Panitumumab|panitumumab|mesh-list
14798885|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14798886|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
14798887|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798888|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798889|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
14798890|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798891|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798892|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798893|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
14798894|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798895|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14798896|NCT00779493|Curcumin|curcumin|mesh-list
14798897|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798898|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14798899|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14798900|NCT00779493|Analgesics|analgesics|mesh-ancestor
14798901|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
14798902|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798903|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798904|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14798905|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798906|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798907|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957370|NCT01588873|Hormones|hormones|mesh-ancestor
14957371|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957372|NCT01588912|Tenofovir|tenofovir|mesh-list
14957373|NCT01588912|Entecavir|entecavir|mesh-list
14957374|NCT01588912|Telbivudine|telbivudine|mesh-list
14957375|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
14957376|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957377|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14957378|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14957379|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957380|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957381|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14957382|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14957383|NCT01588925|Dexamethasone|dexamethasone|mesh-list
14957384|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
14957385|NCT01588925|BB 1101|bb 1101|mesh-list
14957386|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
14957387|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798908|NCT00779649|Bisacodyl|bisacodyl|mesh-list
14798909|NCT00779649|Cathartics|cathartics|mesh-ancestor
14957388|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
14957389|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
14957390|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957391|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957392|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957393|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
14957394|NCT01588925|Hormones|hormones|mesh-ancestor
14957395|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957396|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14957397|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957398|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
14957399|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957400|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957401|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14957402|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
14957403|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
14957404|NCT01588925|Protective Agents|protective agents|mesh-ancestor
14957405|NCT01589055|Nicotine|nicotine|mesh-list
14798910|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957406|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14957407|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
14957408|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798911|NCT00779649|Laxatives|laxatives|mesh-ancestor
14957409|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957410|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14957411|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14957412|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
14957413|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957414|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957415|NCT01589068|Nicotine|nicotine|mesh-list
14957416|NCT01589068|Progesterone|progesterone|mesh-list
14957417|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14957418|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
14957419|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957420|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957421|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14957422|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14957423|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
14957424|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957425|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957426|NCT01589068|Progestins|progestins|mesh-ancestor
14957427|NCT01589068|Hormones|hormones|mesh-ancestor
14957428|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957429|NCT01589081|Nicotine|nicotine|mesh-list
14957430|NCT01589081|Progesterone|progesterone|mesh-list
14957431|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14957432|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
14957433|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957434|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957435|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14957436|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14957437|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
14957438|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957439|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957440|NCT01589081|Progestins|progestins|mesh-ancestor
14957441|NCT01589081|Hormones|hormones|mesh-ancestor
14957442|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957443|NCT01589146|Heparin|heparin|mesh-list
14957444|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14957445|NCT01589146|Tinzaparin|tinzaparin|mesh-list
14957446|NCT01589146|Dalteparin|dalteparin|mesh-list
14957447|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
14957448|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14957449|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14957450|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957451|NCT01589159|Capecitabine|capecitabine|mesh-list
14957452|NCT01589159|Etoposide|etoposide|mesh-list
14957453|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14957454|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
14957455|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957456|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957457|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14957458|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14957459|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14957460|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957461|NCT01589354|Ropivacaine|ropivacaine|mesh-list
14957462|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
14957463|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
14957464|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957465|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957466|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
14957467|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957468|NCT01589367|Metformin|metformin|mesh-list
14957469|NCT01589367|Letrozole|letrozole|mesh-list
14957470|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14957471|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957472|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957473|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14957474|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14957475|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957476|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957477|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14957478|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
14957479|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957480|NCT01589393|Enoxaparin|enoxaparin|mesh-list
14957481|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
14957482|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14957483|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15034940|NCT01998165|Narcotics|narcotics|mesh-ancestor
14957484|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957485|NCT01589419|Capecitabine|capecitabine|mesh-list
14957486|NCT01589419|Veliparib|veliparib|mesh-list
14957487|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14957488|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
14957489|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957490|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957491|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14957492|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957493|NCT01589432|Lidocaine|lidocaine|mesh-list
14957494|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
14957495|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
14957496|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957497|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957498|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
14957499|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957500|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14957501|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14957502|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14957503|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957504|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957505|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
14957506|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14957507|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14957508|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14957509|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957510|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957511|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
14957512|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957513|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957514|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14957515|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957516|NCT01589523|Cholic Acids|cholic acids|mesh-list
14957517|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
14957518|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957519|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14957520|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
14957521|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14957522|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
14957523|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
14957524|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957525|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957526|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957527|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
14957528|NCT01589549|Hormones|hormones|mesh-ancestor
14957529|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957530|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14957531|NCT01589549|Protective Agents|protective agents|mesh-ancestor
14957532|NCT01589562|Megestrol|megestrol|mesh-list
14957533|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
14957534|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14957535|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14957536|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14957537|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
14957538|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14957539|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957540|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14957541|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14957542|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14957543|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957544|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
14957545|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14957546|NCT01589614|Erythromycin|erythromycin|mesh-list
14957547|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
14957548|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14957549|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
14957550|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14957551|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957552|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957553|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14957554|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957555|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522808|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957556|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14957557|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
14957558|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14957559|NCT01589744|Hemostatics|hemostatics|mesh-list
14957560|NCT01589744|Coagulants|coagulants|mesh-ancestor
14957561|NCT01589809|Niacinamide|niacinamide|mesh-list
14957562|NCT01589809|Niacin|niacin|mesh-list
14957563|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
14957564|NCT01589809|Vitamins|vitamins|mesh-ancestor
14957565|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
14957566|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957567|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
14957568|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14957569|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
14957570|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957571|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14957572|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
14957573|NCT01589861|Lapatinib|lapatinib|mesh-list
14957574|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957575|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14957576|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957577|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957578|NCT01589952|Interferons|interferons|mesh-list
14957579|NCT01589952|Entecavir|entecavir|mesh-list
14957580|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957581|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
14957582|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957583|NCT01590173|Prednisolone|prednisolone|mesh-list
14957584|NCT01590173|Heparin|heparin|mesh-list
14957585|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
14957586|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14957587|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14957588|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957589|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14957590|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
14957591|NCT01590173|Hormones|hormones|mesh-ancestor
14957592|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957593|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957594|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14957595|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957596|NCT01590199|Everolimus|everolimus|mesh-list
14957597|NCT01590199|Pasireotide|pasireotide|mesh-list
14957598|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957599|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14957600|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
14957601|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957602|NCT01590199|Hormones|hormones|mesh-ancestor
14957603|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957604|NCT01590225|Ribavirin|ribavirin|mesh-list
14957605|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14957606|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
14957607|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
14957608|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957609|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
14957610|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957611|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
14957612|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957613|NCT01590277|Ethanol|ethanol|mesh-list
14957614|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14957615|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957616|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957617|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957618|NCT01590303|Ascorbic Acid|ascorbic acid|mesh-list
14957619|NCT01590303|Vitamins|vitamins|mesh-ancestor
14957620|NCT01590303|Micronutrients|micronutrients|mesh-ancestor
14957621|NCT01590303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957622|NCT01590303|Antioxidants|antioxidants|mesh-ancestor
14957623|NCT01590303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957624|NCT01590303|Protective Agents|protective agents|mesh-ancestor
14957625|NCT01590342|Diclofenac|diclofenac|mesh-list
14957626|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14957627|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14957628|NCT01590342|Analgesics|analgesics|mesh-ancestor
14957629|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
14957630|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957631|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957632|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14957633|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14957634|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14957635|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957636|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027818|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15027819|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027820|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15027821|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027822|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027823|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15027824|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15027825|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
15027826|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027827|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
15027828|NCT01951885|Methotrexate|methotrexate|mesh-list
15027829|NCT01951885|Tacrolimus|tacrolimus|mesh-list
15027830|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15027831|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
15027832|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15027833|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027834|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15027835|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
15027836|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027837|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027838|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798912|NCT00779714|Cytarabine|cytarabine|mesh-list
14798913|NCT00779714|Paclitaxel|paclitaxel|mesh-list
14798914|NCT00779714|Cisplatin|cisplatin|mesh-list
14798915|NCT00779714|Dacarbazine|dacarbazine|mesh-list
14798916|NCT00779714|Treosulfan|treosulfan|mesh-list
15027839|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027840|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15027841|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15027842|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
15027843|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027844|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15027845|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15027846|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15027847|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15027848|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
15027849|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15027850|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798917|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14798918|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798919|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
14798920|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
14798921|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
14798922|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027851|NCT01951898|Montelukast|montelukast|mesh-list
14957637|NCT01590537|Copper|copper|mesh-list
14957638|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
14957639|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14957640|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
14957641|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14957642|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957643|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14957644|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14957645|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14957646|NCT01590537|Trace Elements|trace elements|mesh-ancestor
14957647|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
14957648|NCT01590641|Vesatolimod|vesatolimod|mesh-list
14957649|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
14957650|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957651|NCT01590654|Vesatolimod|vesatolimod|mesh-list
14957652|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
14957653|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957654|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14957655|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957656|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957657|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957658|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14957659|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
14957660|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14957661|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14957662|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14957663|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957664|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957665|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
14957666|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957667|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957668|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14957669|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957670|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14957671|NCT01590732|Carboplatin|carboplatin|mesh-list
14957672|NCT01590732|Etoposide|etoposide|mesh-list
14957673|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
14957674|NCT01590732|Ifosfamide|ifosfamide|mesh-list
14957675|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
14957676|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
14957677|NCT01590732|Romidepsin|romidepsin|mesh-list
14957678|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957679|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14957680|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14957681|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14957682|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957683|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957684|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957685|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14957686|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
14957687|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
14957688|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14957689|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
14957690|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
14957691|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
14957692|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14957693|NCT01590823|Dabigatran|dabigatran|mesh-list
14957694|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
14957695|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14957696|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
14957697|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957698|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957699|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
14957700|NCT01590836|Insulin|insulin|mesh-list
14957701|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14957702|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
14957703|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
14957704|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14957705|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957706|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
14957707|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
14957708|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14957709|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14957710|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957711|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14957712|NCT01590901|Probucol|probucol|mesh-list
14957713|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14957714|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14957715|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
14957716|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957717|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14957718|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
14957719|NCT01590901|Protective Agents|protective agents|mesh-ancestor
14957720|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957721|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
14957722|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14957723|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
14957724|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957725|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14957726|NCT01591031|Sevoflurane|sevoflurane|mesh-list
14957727|NCT01591031|Rocuronium|rocuronium|mesh-list
14957728|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14957729|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14957730|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
14957731|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
14957732|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957733|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957734|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14957735|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14957736|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14957737|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957738|NCT01591070|Tacrolimus|tacrolimus|mesh-list
14957739|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14957740|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
14957741|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957742|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14957743|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957744|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957745|NCT01591083|Esomeprazole|esomeprazole|mesh-list
14957746|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14957747|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957748|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14522809|NCT03555565|Metformin|metformin|mesh-list
14522810|NCT03555565|Alogliptin|alogliptin|mesh-list
14522811|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522812|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957749|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957750|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957751|NCT01591122|Prednisone|prednisone|mesh-list
14957752|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
14957753|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14957754|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
14957755|NCT01591122|Hormones|hormones|mesh-ancestor
14957756|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957757|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957758|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14957759|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957760|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14957761|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957762|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957763|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
14957764|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14957765|NCT01591135|Paclitaxel|paclitaxel|mesh-list
14957766|NCT01591135|Fluorouracil|fluorouracil|mesh-list
14957767|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14957768|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957769|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
14957770|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
14957771|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
14957772|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957773|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
14957774|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14957775|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14957776|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
14957777|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957778|NCT01591148|Propofol|propofol|mesh-list
14957779|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14957780|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957781|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957782|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14957783|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
14957784|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
14957785|NCT01591226|Mannitol|mannitol|mesh-list
14957786|NCT01591226|Caffeine|caffeine|mesh-list
14957787|NCT01591226|Citric Acid|citric acid|mesh-list
14957788|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
14957789|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
14957790|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14957791|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
14957792|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
14957793|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957794|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14957795|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957796|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14957797|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957798|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14957799|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14957800|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
14957801|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957802|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14957803|NCT01591226|Diuretics|diuretics|mesh-ancestor
14957804|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
14957805|NCT01591291|Ondansetron|ondansetron|mesh-list
14957806|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
14957807|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
14957808|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957809|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957810|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957811|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
14957812|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
14957813|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14957814|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
14957815|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957816|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957817|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14957818|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14957819|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957820|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957821|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14957822|NCT01591421|Panitumumab|panitumumab|mesh-list
14957823|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14957824|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957825|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14957826|NCT01591434|Laxatives|laxatives|mesh-ancestor
14957827|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957828|NCT01591551|Natalizumab|natalizumab|mesh-list
14957829|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
14957830|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957831|NCT01591668|Vesatolimod|vesatolimod|mesh-list
14957832|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
14957833|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957834|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14957835|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
14957836|NCT01591850|Ritonavir|ritonavir|mesh-list
14957837|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14957838|NCT01591850|Rifampin|rifampin|mesh-list
14957839|NCT01591850|Ketoconazole|ketoconazole|mesh-list
14957840|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14957841|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14957842|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
14957843|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957844|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957845|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14957846|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14957847|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
14957848|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957849|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14957850|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14957851|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14957852|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
14957853|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14957854|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
14957855|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14957856|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14957857|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14957858|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14957859|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14957860|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14957861|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14957862|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
14957863|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14957864|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14957865|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
14957866|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14957867|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957868|NCT01591889|Tinidazole|tinidazole|mesh-list
14957869|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
14957870|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957871|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14957872|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957873|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14957874|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14957875|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14957876|NCT01591902|Tesamorelin|tesamorelin|mesh-list
14957877|NCT01591902|Growth Substances|growth substances|mesh-ancestor
14957878|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957879|NCT01591980|Pregabalin|pregabalin|mesh-list
14957880|NCT01591980|Analgesics|analgesics|mesh-ancestor
14957881|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
14957882|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957883|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957884|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
14957885|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14957886|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957887|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957888|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14957889|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14957890|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14957891|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957892|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957893|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
14957894|NCT01592019|Diclofenac|diclofenac|mesh-list
14957895|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14957896|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14957897|NCT01592019|Analgesics|analgesics|mesh-ancestor
14957898|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
14957899|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957900|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957901|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14957902|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14957903|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14957904|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957905|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957906|NCT01592032|Vancomycin|vancomycin|mesh-list
14957907|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14957908|NCT01592032|Linezolid|linezolid|mesh-list
14957909|NCT01592032|Daptomycin|daptomycin|mesh-list
14957910|NCT01592032|Tigecycline|tigecycline|mesh-list
14957911|NCT01592032|Teicoplanin|teicoplanin|mesh-list
14957912|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
14957913|NCT01592032|Heparin|heparin|mesh-list
14957914|NCT01592032|Calcium heparin|calcium heparin|mesh-list
14957915|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14957916|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
14957917|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14957918|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14957919|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957920|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14957921|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957922|NCT01592110|Risperidone|risperidone|mesh-list
14957923|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14957924|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
14957925|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957926|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957927|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957928|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14957929|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14957930|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957931|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957932|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14957933|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
14957934|NCT01592136|Ponatinib|ponatinib|mesh-list
14957935|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957936|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14957937|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14957938|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957939|NCT01592162|Remifentanil|remifentanil|mesh-list
14957940|NCT01592162|Propofol|propofol|mesh-list
14957941|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14957942|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957943|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957944|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14957945|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
14957946|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
14957947|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14957948|NCT01592162|Narcotics|narcotics|mesh-ancestor
14957949|NCT01592162|Analgesics|analgesics|mesh-ancestor
14957950|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
14957951|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957952|NCT01592201|Olanzapine|olanzapine|mesh-list
14957953|NCT01592201|Risperidone|risperidone|mesh-list
14957954|NCT01592201|Aripiprazole|aripiprazole|mesh-list
14957955|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
14957956|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14957957|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
14957958|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14957959|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14957960|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957961|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14957962|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957963|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14957964|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14957965|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
14957966|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
14957967|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
14957968|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957969|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14957970|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14957971|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14798923|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14798924|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
14798925|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
14798926|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14798927|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798928|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
14798929|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798930|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14798931|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
14798932|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
14798933|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14798934|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14798935|NCT00779792|Triamcinolone|triamcinolone|mesh-list
14798936|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14798937|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14798938|NCT00779792|Clobetasol|clobetasol|mesh-list
14798939|NCT00779792|Mineral Oil|mineral oil|mesh-list
14798940|NCT00779792|Tacrolimus|tacrolimus|mesh-list
14798941|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14798942|NCT00779792|Glycerol|glycerol|mesh-list
14798943|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14798944|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
14798945|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798946|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14798947|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14798948|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798949|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14798950|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
14798951|NCT00779792|Hormones|hormones|mesh-ancestor
14798952|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14798953|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14798954|NCT00779792|Protective Agents|protective agents|mesh-ancestor
14798955|NCT00779792|Emollients|emollients|mesh-ancestor
14798956|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798957|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
14798958|NCT00779805|Ephedrine|ephedrine|mesh-list
14798959|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14798960|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
14798961|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798962|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798963|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14798964|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
14798965|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
14798966|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14798967|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14798968|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
14798969|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
14798970|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798971|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798972|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
14798973|NCT00779831|Ephedrine|ephedrine|mesh-list
14798974|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14798975|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
14798976|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14798977|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798978|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14798979|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
14798980|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
14798981|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14798982|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14798983|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
14798984|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
14798985|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14798986|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14798987|NCT00779896|Tazarotene|tazarotene|mesh-list
14798988|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
14798989|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
14798990|NCT00779922|Lenalidomide|lenalidomide|mesh-list
14798991|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
14798992|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14798993|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14798994|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14798995|NCT00779922|Growth Substances|growth substances|mesh-ancestor
14798996|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
14957972|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14957973|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
14957974|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
14957975|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14957976|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14957977|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14957978|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14957979|NCT01592214|Benzocaine|benzocaine|mesh-list
14957980|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
14957981|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
14957982|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14957983|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957984|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
14957985|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027852|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14798997|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14798998|NCT00779935|Infliximab|infliximab|mesh-list
14798999|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
15027853|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027854|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15027855|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
15027856|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027857|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027858|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15027859|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15027860|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027861|NCT01951911|Ketamine|ketamine|mesh-list
15027862|NCT01951911|Analgesics|analgesics|mesh-ancestor
15027863|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
15027864|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027865|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027866|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15027867|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15027868|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
15027869|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
15027870|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027871|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15027872|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15027873|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027874|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027875|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
15027876|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15027877|NCT01951924|Antibodies|antibodies|mesh-list
15027878|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
15027879|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
15027880|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027881|NCT01952314|Naftopidil|naftopidil|mesh-list
15027882|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15027883|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15027884|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
15027885|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027886|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027887|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027888|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14522813|NCT03555565|Incretins|incretins|mesh-ancestor
14522814|NCT03555565|Hormones|hormones|mesh-ancestor
14522815|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14522816|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14522817|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
14522818|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522819|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522820|NCT03555890|Cetirizine|cetirizine|mesh-list
14522821|NCT03555890|Levocetirizine|levocetirizine|mesh-list
14799000|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14799001|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799002|NCT00780013|Metformin|metformin|mesh-list
14799003|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14799004|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799005|NCT00780039|Carboplatin|carboplatin|mesh-list
14799006|NCT00780039|Doxorubicin|doxorubicin|mesh-list
14799007|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14799008|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799009|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14957986|NCT01592227|Acetaminophen|acetaminophen|mesh-list
14957987|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14957988|NCT01592227|Analgesics|analgesics|mesh-ancestor
14957989|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
14957990|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14957991|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14957992|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
14957993|NCT01592253|Sirolimus|sirolimus|mesh-list
14957994|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14957995|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14957996|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14957997|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14957998|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
14957999|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958000|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
14958001|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958002|NCT01592279|Liraglutide|liraglutide|mesh-list
14958003|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14958004|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958005|NCT01592279|Incretins|incretins|mesh-ancestor
14958006|NCT01592279|Hormones|hormones|mesh-ancestor
14958007|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958008|NCT01592305|Ritonavir|ritonavir|mesh-list
14958009|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14958010|NCT01592305|Tenofovir|tenofovir|mesh-list
14958011|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14958012|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14958013|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
14958014|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958015|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958016|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14958017|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14958018|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
14958019|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958020|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14958021|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14958022|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14958023|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14958024|NCT01592318|Ritonavir|ritonavir|mesh-list
14958025|NCT01592318|Lactams|lactams|mesh-list
14958026|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14958027|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14958028|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
14958029|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958030|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958031|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14958032|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14958033|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
14958034|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958035|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14958036|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14958037|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14958038|NCT01592526|Nicotine|nicotine|mesh-list
14958039|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14958040|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
14958041|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958042|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958043|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14958044|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14958045|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
14958046|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958047|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958048|NCT01592630|Ropivacaine|ropivacaine|mesh-list
14958049|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
14958050|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
14958051|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958052|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958053|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
14958054|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958055|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
14958056|NCT01592981|Rituximab|rituximab|mesh-list
14958057|NCT01592981|Fludarabine|fludarabine|mesh-list
14958058|NCT01592981|Bortezomib|bortezomib|mesh-list
14958059|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958060|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
14958061|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958062|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958063|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14958064|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
14958065|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958066|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958067|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14958068|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14958069|NCT01593033|Micronutrients|micronutrients|mesh-list
14958070|NCT01593033|Trace Elements|trace elements|mesh-list
14958071|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958072|NCT01593046|Cabotegravir|cabotegravir|mesh-list
14958073|NCT01593046|Rilpivirine|rilpivirine|mesh-list
14958074|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14958075|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14958076|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958077|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958078|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14958079|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14958080|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
14958081|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958082|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14958083|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14958084|NCT01593124|Imiquimod|imiquimod|mesh-list
14958085|NCT01593124|Nonoxynol|nonoxynol|mesh-list
14958086|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14958087|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
14958088|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958089|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958090|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
14958091|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14958092|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14958093|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14958094|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
14958095|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958096|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14958097|NCT01593137|Metformin|metformin|mesh-list
14958098|NCT01593137|Liraglutide|liraglutide|mesh-list
14958099|NCT01593137|Glimepiride|glimepiride|mesh-list
14958100|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14958101|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958102|NCT01593137|Incretins|incretins|mesh-ancestor
14958103|NCT01593137|Hormones|hormones|mesh-ancestor
14958104|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958105|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14958106|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958107|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
14958108|NCT01593150|Dabigatran|dabigatran|mesh-list
14958109|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
14958110|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14958111|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
14958112|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958113|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958114|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
14958115|NCT01593163|Ibuprofen|ibuprofen|mesh-list
14958116|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14958117|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14958118|NCT01593163|Analgesics|analgesics|mesh-ancestor
14958119|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
14958120|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958121|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958122|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958123|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958124|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14958125|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958126|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958127|NCT01593280|Morphine|morphine|mesh-list
14958128|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14958129|NCT01593280|Narcotics|narcotics|mesh-ancestor
14958130|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958131|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958132|NCT01593280|Analgesics|analgesics|mesh-ancestor
14958133|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
14958134|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958135|NCT01593293|Pemetrexed|pemetrexed|mesh-list
14958136|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958137|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958138|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958139|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14958140|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14958141|NCT01593306|Paclitaxel|paclitaxel|mesh-list
14958142|NCT01593306|Cisplatin|cisplatin|mesh-list
14958143|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14958144|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958145|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
14958146|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
14958147|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
14958148|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958149|NCT01593319|Ropivacaine|ropivacaine|mesh-list
14958150|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
14958151|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
14958152|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958153|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958154|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
14958155|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958156|NCT01593332|Rituximab|rituximab|mesh-list
14958157|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14958158|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958159|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
14958160|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958161|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958162|NCT01593371|Metformin|metformin|mesh-list
14958163|NCT01593371|Pioglitazone|pioglitazone|mesh-list
14958164|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14958165|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958166|NCT01593397|Fentanyl|fentanyl|mesh-list
14958167|NCT01593397|Propofol|propofol|mesh-list
14958168|NCT01593397|Anesthetics|anesthetics|mesh-list
14958169|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14958170|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958171|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958172|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14958173|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
14958174|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14958175|NCT01593397|Narcotics|narcotics|mesh-ancestor
14958176|NCT01593397|Analgesics|analgesics|mesh-ancestor
14958177|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
14799010|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14799011|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14799012|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799013|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799014|NCT00780104|Cytarabine|cytarabine|mesh-list
14799015|NCT00780104|Sirolimus|sirolimus|mesh-list
14799016|NCT00780104|Etoposide|etoposide|mesh-list
14799017|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
14799018|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14799019|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799020|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14799021|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14799022|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799023|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799024|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14799025|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
14799026|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
14799027|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799028|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799029|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
14799030|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799031|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14799032|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14799033|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
14799034|NCT00780104|Analgesics|analgesics|mesh-ancestor
14799035|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
14799036|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799037|NCT00780169|Sorafenib|sorafenib|mesh-list
14799038|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799039|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14799040|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958178|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958179|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14958180|NCT01593410|Dexamethasone|dexamethasone|mesh-list
14799041|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799042|NCT00780182|Brincidofovir|brincidofovir|mesh-list
14799043|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
14799044|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958181|NCT01593410|Lenalidomide|lenalidomide|mesh-list
14958182|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958183|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
14958184|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
14958185|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958186|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958187|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958188|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
14958189|NCT01593410|Hormones|hormones|mesh-ancestor
14958190|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958191|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14958192|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958193|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
14958194|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14958195|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14958196|NCT01593410|Growth Substances|growth substances|mesh-ancestor
14958197|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
14958198|NCT01593488|Cytarabine|cytarabine|mesh-list
14958199|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14958200|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
14958201|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958202|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958203|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
14958204|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958205|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958206|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
14958207|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958208|NCT01593501|Vitamin D|vitamin d|mesh-list
14958209|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
14958210|NCT01593501|Vitamins|vitamins|mesh-ancestor
14958211|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
14958212|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958213|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14958214|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14958215|NCT01593514|Lactitol|lactitol|mesh-list
14958216|NCT01593514|Vaccines|vaccines|mesh-list
14958217|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
14958218|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958219|NCT01593514|Cathartics|cathartics|mesh-ancestor
14958220|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958221|NCT01593566|Bupivacaine|bupivacaine|mesh-list
14958222|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
14958223|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
14958224|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958225|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958226|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
14958227|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958228|NCT01593605|Resveratrol|resveratrol|mesh-list
14958229|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
14958230|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958231|NCT01593605|Protective Agents|protective agents|mesh-ancestor
14958232|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958233|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958234|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14958235|NCT01593644|Adenosine|adenosine|mesh-list
14958236|NCT01593644|Dipyridamole|dipyridamole|mesh-list
14958237|NCT01593644|Analgesics|analgesics|mesh-ancestor
14958238|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
14958239|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958240|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958241|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14958242|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
14958243|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14958244|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
14799045|NCT00780325|Celecoxib|celecoxib|mesh-list
14799046|NCT00780325|Naproxen|naproxen|mesh-list
14799047|NCT00780325|Acetazolamide|acetazolamide|mesh-list
14799048|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14799049|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14799050|NCT00780325|Analgesics|analgesics|mesh-ancestor
14799051|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
14958245|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
14958246|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958247|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958248|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14958249|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958250|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14958251|NCT01593774|Melatonin|melatonin|mesh-list
14958252|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
14958253|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958254|NCT01593774|Protective Agents|protective agents|mesh-ancestor
14958255|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958256|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958257|NCT01593826|Budesonide|budesonide|mesh-list
14958258|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
14958259|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14958260|NCT01593826|Charcoal|charcoal|mesh-list
14958261|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958262|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14958263|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
14958264|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958265|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958266|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14958267|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
14958268|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
14958269|NCT01593826|Hormones|hormones|mesh-ancestor
14958270|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958271|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14958272|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14958273|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14958274|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
14958275|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958276|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958277|NCT01593826|Antidotes|antidotes|mesh-ancestor
14958278|NCT01593826|Protective Agents|protective agents|mesh-ancestor
14958279|NCT01593930|Lidocaine|lidocaine|mesh-list
14958280|NCT01593930|Carticaine|carticaine|mesh-list
14958281|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
14958282|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
14958283|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958284|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958285|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
14958286|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958287|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14958288|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14958289|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14958290|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14958291|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027889|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15027890|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15027891|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15027892|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15034941|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034942|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034943|NCT01998165|Analgesics|analgesics|mesh-ancestor
15034944|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
15034945|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034946|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
14799052|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799053|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799054|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799055|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958292|NCT01593995|Mitogens|mitogens|mesh-list
14958293|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
14958294|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958295|NCT01594047|Ketamine|ketamine|mesh-list
14958296|NCT01594047|Methadone|methadone|mesh-list
14958297|NCT01594047|Analgesics|analgesics|mesh-ancestor
14958298|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
14958299|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958300|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958301|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14958302|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14958303|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
14958304|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
14958305|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958306|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14958307|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14958308|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958309|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958310|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14958311|NCT01594047|Narcotics|narcotics|mesh-ancestor
14958312|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
14958313|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
14958314|NCT01594060|Insulin|insulin|mesh-list
14958315|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14958316|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
14958317|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
14958318|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14958319|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958320|NCT01594099|Paclitaxel|paclitaxel|mesh-list
14958321|NCT01594099|Cisplatin|cisplatin|mesh-list
14958322|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14958323|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958324|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
14958325|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
14958326|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
14958327|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958328|NCT01594177|Paclitaxel|paclitaxel|mesh-list
14958329|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
14958330|NCT01594177|Trastuzumab|trastuzumab|mesh-list
14958331|NCT01594177|Epirubicin|epirubicin|mesh-list
14958332|NCT01594177|Afatinib|afatinib|mesh-list
14958333|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14958334|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958335|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
14958336|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
14958337|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
14958338|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958339|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958340|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
14958341|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958342|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958343|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14958344|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
14958345|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14958346|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14958347|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14958348|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14958349|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14958350|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958351|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14958352|NCT01594229|Rituximab|rituximab|mesh-list
14958353|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14958354|NCT01594229|Venetoclax|venetoclax|mesh-list
14958355|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14958356|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958357|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
14958358|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958359|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958360|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14958361|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
14958362|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958363|NCT01594242|Bortezomib|bortezomib|mesh-list
14958364|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958365|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
14958366|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15027893|NCT01952561|Dapivirine|dapivirine|mesh-list
14958367|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958368|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14958369|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14958370|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958371|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958372|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958373|NCT01594268|Everolimus|everolimus|mesh-list
14958374|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958375|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958376|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
14958377|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958378|NCT01594346|Vitamin E|vitamin e|mesh-list
14958379|NCT01594346|Tocopherols|tocopherols|mesh-list
14958380|NCT01594346|Tocotrienols|tocotrienols|mesh-list
14958381|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
14958382|NCT01594346|Vitamins|vitamins|mesh-ancestor
14958383|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
14958384|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958385|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
14958386|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958387|NCT01594346|Protective Agents|protective agents|mesh-ancestor
14958388|NCT01594489|Aminophylline|aminophylline|mesh-list
14958389|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14958390|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
14958391|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958392|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958393|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14958394|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
14958395|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14958396|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14958397|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958398|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958399|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14958400|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14958401|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
14958402|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958403|NCT01594489|Protective Agents|protective agents|mesh-ancestor
14958404|NCT01594502|Dutasteride|dutasteride|mesh-list
14958405|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14958406|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14958407|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958408|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958409|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
14958410|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958411|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958412|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
14958413|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14958414|NCT01594619|Diltiazem|diltiazem|mesh-list
14958415|NCT01594619|Naloxegol|naloxegol|mesh-list
14958416|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14958417|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14958418|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14958419|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958420|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14958421|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958422|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
14958423|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14958424|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
14958425|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958426|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
14799056|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14799057|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14799058|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799059|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799060|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
14799061|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
14799062|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14799063|NCT00780325|Diuretics|diuretics|mesh-ancestor
14799064|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
14799065|NCT00780377|Bradykinin|bradykinin|mesh-list
14799066|NCT00780377|Kininogens|kininogens|mesh-list
14799067|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
14799068|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14799069|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
14799070|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799071|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799072|NCT00780598|Tosedostat|tosedostat|mesh-list
14799073|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799074|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799075|NCT00780637|Bradykinin|bradykinin|mesh-list
14799076|NCT00780637|Kininogens|kininogens|mesh-list
14799077|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
14799078|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14799079|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
14799080|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799081|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799082|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14799083|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14799084|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14799085|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14799086|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958427|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14958428|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14958429|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958430|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
14958431|NCT01594671|Coagulants|coagulants|mesh-ancestor
14958432|NCT01594697|Metformin|metformin|mesh-list
14958433|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14958434|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958435|NCT01594775|Oxytocin|oxytocin|mesh-list
14958436|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
14958437|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958438|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958439|NCT01594866|Dexetimide|dexetimide|mesh-list
14958440|NCT01594866|Citalopram|citalopram|mesh-list
14958441|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14958442|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14958443|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14958444|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958445|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958446|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
14958447|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958448|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14958449|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
14958450|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14958451|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14799087|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
14799088|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799089|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799090|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
14799091|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
14799092|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14799093|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14799094|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799095|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799096|NCT00780728|Urological Agents|urological agents|mesh-ancestor
14799097|NCT00780754|Dutasteride|dutasteride|mesh-list
14958452|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14958453|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
14958454|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
14958455|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958456|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14958457|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14958458|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
14958459|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
14958460|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14958461|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
14958462|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958463|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958464|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14958465|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14958466|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14958467|NCT01594905|Tenofovir|tenofovir|mesh-list
14958468|NCT01594905|Entecavir|entecavir|mesh-list
14958469|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
14799098|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14799099|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14958470|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958471|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14958472|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14958473|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958474|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958475|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14958476|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14958477|NCT01594918|Prednisone|prednisone|mesh-list
14958478|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
14958479|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958480|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
14958481|NCT01594918|Hormones|hormones|mesh-ancestor
14958482|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958483|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958484|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14958485|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958486|NCT01594918|Analgesics|analgesics|mesh-ancestor
14958487|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
14958488|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958489|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14958490|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14958491|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958492|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958493|NCT01595009|Everolimus|everolimus|mesh-list
14958494|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958495|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958496|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
14958497|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958498|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
14958499|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
14958500|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958501|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958502|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14958503|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14958504|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14958505|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14958506|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
14958507|NCT01595152|Fesoterodine|fesoterodine|mesh-list
14958508|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14958509|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14958510|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
14958511|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958512|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958513|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958514|NCT01595152|Urological Agents|urological agents|mesh-ancestor
14958515|NCT01595334|Cetrorelix|cetrorelix|mesh-list
14958516|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14958517|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
14958518|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958519|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958520|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
14958521|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958522|NCT01595399|Atropine|atropine|mesh-list
14958523|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14958524|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14958525|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14958526|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
14958527|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958528|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958529|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14958530|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
14958531|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
14958532|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
14958533|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14958534|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14958535|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
14958536|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958537|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958538|NCT01595425|Esomeprazole|esomeprazole|mesh-list
14958539|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14958540|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958541|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14958542|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958543|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958544|NCT01595594|Doxycycline|doxycycline|mesh-list
14958545|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14958546|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958547|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
14958548|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14958549|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14958550|NCT01595633|Tenofovir|tenofovir|mesh-list
14958551|NCT01595633|Adefovir|adefovir|mesh-list
14958552|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
14958553|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958554|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14958555|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14958556|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958557|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958558|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14958559|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14958560|NCT01595685|Entecavir|entecavir|mesh-list
14958561|NCT01595685|Telbivudine|telbivudine|mesh-list
14958562|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
14958563|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958564|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14958565|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958566|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027894|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15027895|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15027896|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
15027897|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027898|NCT01952626|Ondansetron|ondansetron|mesh-list
15027899|NCT01952626|Palonosetron|palonosetron|mesh-list
15027900|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
15027901|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
15027902|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027903|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027904|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027905|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
15027906|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
15027907|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15027908|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
15027909|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027910|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027911|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15027912|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027913|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027914|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027915|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15027916|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15027917|NCT01952652|Naproxen|naproxen|mesh-list
15027918|NCT01952652|Codeine|codeine|mesh-list
15027919|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15027920|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15027921|NCT01952652|Analgesics|analgesics|mesh-ancestor
15027922|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
15027923|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027924|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027925|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15027926|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15027927|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
15027928|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15027929|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027930|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027931|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14799100|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799101|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799102|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799103|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799104|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799105|NCT00780780|Triamcinolone|triamcinolone|mesh-list
14799106|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14799107|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14799108|NCT00780780|Nepafenac|nepafenac|mesh-list
14799109|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14799110|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799111|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
14799112|NCT00780780|Hormones|hormones|mesh-ancestor
15027932|NCT01952652|Narcotics|narcotics|mesh-ancestor
15027933|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027934|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
14958567|NCT01595724|Dienogest|dienogest|mesh-list
14958568|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14958569|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
14958570|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958571|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958572|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14958573|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14958574|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14958575|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14958576|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
14958577|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958578|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14958579|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958580|NCT01595737|Simendan|simendan|mesh-list
14958581|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14958582|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
14958583|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14958584|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14958585|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958586|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958587|NCT01595737|Protective Agents|protective agents|mesh-ancestor
14958588|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958589|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
14958590|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14958591|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14958592|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958593|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
14958594|NCT01595763|Coagulants|coagulants|mesh-ancestor
14958595|NCT01595789|Liraglutide|liraglutide|mesh-list
14958596|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14958597|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958598|NCT01595789|Incretins|incretins|mesh-ancestor
14958599|NCT01595789|Hormones|hormones|mesh-ancestor
14958600|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958601|NCT01595815|Calcium|calcium|mesh-list
14958602|NCT01595815|Ionophores|ionophores|mesh-list
14958603|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
14958604|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14958605|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958606|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14958607|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958608|NCT01595828|Pitavastatin|pitavastatin|mesh-list
14958609|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14958610|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14958611|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14958612|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
14958613|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958614|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958615|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14958616|NCT01595841|Sirolimus|sirolimus|mesh-list
14958617|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14958618|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958619|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14958620|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958621|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
14958622|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958623|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
14958624|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958625|NCT01595867|Naltrexone|naltrexone|mesh-list
14958626|NCT01595867|Morphine|morphine|mesh-list
14958627|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14958628|NCT01595867|Narcotics|narcotics|mesh-ancestor
14958629|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958630|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958631|NCT01595867|Analgesics|analgesics|mesh-ancestor
14958632|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
14958633|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958634|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14958635|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14958636|NCT01595880|Metformin|metformin|mesh-list
14958637|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14958638|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958639|NCT01595893|Vitamin D|vitamin d|mesh-list
14958640|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
14958641|NCT01595893|Vitamins|vitamins|mesh-ancestor
14958642|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
14958643|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958644|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14958645|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14958646|NCT01595958|Cyclosporine|cyclosporine|mesh-list
14799113|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799114|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799115|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799116|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
14799117|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799118|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799119|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14799120|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14799121|NCT00780780|Analgesics|analgesics|mesh-ancestor
14799122|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
14799123|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799124|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799125|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
14799126|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799127|NCT00780832|Caffeine|caffeine|mesh-list
14799128|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14799129|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14799130|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799131|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14799132|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958647|NCT01595958|Cyclosporins|cyclosporins|mesh-list
14958648|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958649|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958650|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958651|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
14958652|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958653|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
14958654|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958655|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
14958656|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958657|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14958658|NCT01595984|Cyclosporine|cyclosporine|mesh-list
14958659|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
14958660|NCT01595984|Everolimus|everolimus|mesh-list
14958661|NCT01595984|Cyclosporins|cyclosporins|mesh-list
14958662|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958663|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958664|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958665|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
14958666|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958667|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
14958668|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958669|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
14958670|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958671|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14958672|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958673|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14958674|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14958675|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
14958676|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14958677|NCT01596010|Norethindrone|norethindrone|mesh-list
14958678|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
14958679|NCT01596010|Estradiol|estradiol|mesh-list
14958680|NCT01596010|Estrogens|estrogens|mesh-ancestor
14958681|NCT01596010|Hormones|hormones|mesh-ancestor
14958682|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14958683|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958684|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14958685|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
14958686|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958687|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14958688|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14799133|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799134|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14799135|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14958689|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14958690|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14958691|NCT01596075|Cannabidiol|cannabidiol|mesh-list
14958692|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
14958693|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
14958694|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
14958695|NCT01596114|Protective Agents|protective agents|mesh-ancestor
14958696|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958697|NCT01596140|Sirolimus|sirolimus|mesh-list
14958698|NCT01596140|Everolimus|everolimus|mesh-list
14958699|NCT01596140|Vemurafenib|vemurafenib|mesh-list
14958700|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958701|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958702|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
14958703|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958704|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958705|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14958706|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958707|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14958708|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
14958709|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14958710|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958711|NCT01596166|Ketorolac|ketorolac|mesh-list
14958712|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14958713|NCT01596166|Metoclopramide|metoclopramide|mesh-list
14958714|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14958715|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14958716|NCT01596166|Analgesics|analgesics|mesh-ancestor
14958717|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
14958718|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958719|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958720|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958721|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958722|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14958723|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958724|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958725|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
14958726|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
14958727|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958728|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14958729|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14958730|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
14958731|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958732|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14958733|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14958734|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958735|NCT01596296|Dinoprostone|dinoprostone|mesh-list
14958736|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
14958737|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958738|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958739|NCT01596387|Propofol|propofol|mesh-list
14958740|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14958741|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958742|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958743|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14958744|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
14958745|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
14958746|NCT01596400|Granisetron|granisetron|mesh-list
14958747|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
14958748|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
14958749|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958750|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958751|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958752|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14958753|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
14958754|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958755|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958756|NCT01596413|Granisetron|granisetron|mesh-list
14958757|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
14958758|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
14958759|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958760|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958761|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958762|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14958763|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
14958764|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958765|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958766|NCT01596426|Granisetron|granisetron|mesh-list
14958767|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
14958768|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
14958769|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958770|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958771|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958772|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14958773|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
14958774|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958775|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958776|NCT01596517|Ribavirin|ribavirin|mesh-list
14958777|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14958778|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
14958779|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
14958780|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958781|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
14958782|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958783|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
14958784|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799136|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
14799137|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799138|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
14799139|NCT00780858|Ganirelix|ganirelix|mesh-list
14799140|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799141|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799142|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799143|NCT00781105|Telbivudine|telbivudine|mesh-list
14799144|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
14799145|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799146|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14799147|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799148|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958785|NCT01596556|Nicotine|nicotine|mesh-list
14958786|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14958787|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
14958788|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958789|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958790|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14958791|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14958792|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
14958793|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958794|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958795|NCT01596634|Lactoferrin|lactoferrin|mesh-list
14958796|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958797|NCT01596647|Diclofenac|diclofenac|mesh-list
14958798|NCT01596647|Midazolam|midazolam|mesh-list
14958799|NCT01596647|Caffeine|caffeine|mesh-list
14958800|NCT01596647|Omeprazole|omeprazole|mesh-list
14958801|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14958802|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14958803|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958804|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958805|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14958806|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14958807|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14958808|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14958809|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
14958810|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
14958811|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
14958812|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
14958813|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958814|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958815|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14958816|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958817|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14958818|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958819|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14958820|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14958821|NCT01596647|Analgesics|analgesics|mesh-ancestor
14958822|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
14958823|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958824|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958825|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958826|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14958827|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14958828|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14958829|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14958830|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14958831|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
14958832|NCT01596660|Bupivacaine|bupivacaine|mesh-list
14958833|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
14958834|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
14958835|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958836|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958837|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
14958838|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958839|NCT01596673|Hydrocodone|hydrocodone|mesh-list
14799149|NCT00781131|Pregabalin|pregabalin|mesh-list
14799150|NCT00781131|Analgesics|analgesics|mesh-ancestor
14799151|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
14799152|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799153|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799154|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
14799155|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14799156|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14799157|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799158|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14799159|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14799160|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14799161|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799162|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14799163|NCT00781157|Phenylephrine|phenylephrine|mesh-list
14799164|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
14799165|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14799166|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
14799167|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
14799168|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799169|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799170|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
14799171|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14958840|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14958841|NCT01596673|Narcotics|narcotics|mesh-ancestor
14958842|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958843|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958844|NCT01596673|Analgesics|analgesics|mesh-ancestor
14958845|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
14958846|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958847|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
14958848|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
14958849|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
14958850|NCT01596686|Cathartics|cathartics|mesh-ancestor
14958851|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958852|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
14958853|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14958854|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14958855|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958856|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
14958857|NCT01596738|Coagulants|coagulants|mesh-ancestor
14958858|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
14958859|NCT01596764|Naloxone|naloxone|mesh-list
14958860|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
14958861|NCT01596764|Loperamide|loperamide|mesh-list
14958862|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
14958863|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14958864|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958865|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
14958866|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958867|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958868|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958869|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14958870|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14958871|NCT01596764|Analgesics|analgesics|mesh-ancestor
14958872|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958873|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958874|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
14958875|NCT01596777|Naltrexone|naltrexone|mesh-list
14958876|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
14958877|NCT01596777|Loperamide|loperamide|mesh-list
14958878|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
14958879|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14958880|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14958881|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958882|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
14958883|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958884|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14958885|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958886|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14958887|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14958888|NCT01596777|Analgesics|analgesics|mesh-ancestor
14958889|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14958890|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14958891|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
14958892|NCT01596803|Vitamin E|vitamin e|mesh-list
14958893|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
14958894|NCT01596803|Tocopherols|tocopherols|mesh-list
14958895|NCT01596803|Antioxidants|antioxidants|mesh-list
14958896|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958897|NCT01596803|Protective Agents|protective agents|mesh-ancestor
14958898|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958899|NCT01596803|Vitamins|vitamins|mesh-ancestor
14958900|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
14958901|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
14958902|NCT01596855|Hematinics|hematinics|mesh-ancestor
14958903|NCT01596868|Gemcitabine|gemcitabine|mesh-list
14958904|NCT01596868|Cisplatin|cisplatin|mesh-list
14958905|NCT01596868|Docetaxel|docetaxel|mesh-list
14958906|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14958907|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14958908|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
14958909|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958910|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
14958911|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958912|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958913|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14958914|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
14958915|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958916|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
14958917|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
14958918|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
14958919|NCT01596894|Azithromycin|azithromycin|mesh-list
14958920|NCT01596894|Metronidazole|metronidazole|mesh-list
14958921|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14958922|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14958923|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14958924|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14958925|NCT01596907|Ephedrine|ephedrine|mesh-list
14958926|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
14958927|NCT01596907|Caffeine|caffeine|mesh-list
14958928|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14958929|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958930|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14958931|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14958932|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958933|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14958934|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14958935|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
14958936|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958937|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
14958938|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
14958939|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958940|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14958941|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
14958942|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14958943|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14958944|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
14958945|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
14958946|NCT01596998|Epinephrine|epinephrine|mesh-list
14958947|NCT01596998|Racepinephrine|racepinephrine|mesh-list
14958948|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
14958949|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
14958950|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14958951|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14958952|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
14958953|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14958954|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958955|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958956|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14958957|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14958958|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
14958959|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958960|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14958961|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
14958962|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
14958963|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
14958964|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14958965|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
14958966|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
14958967|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958968|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
14958969|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14958970|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
14958971|NCT01597011|Coagulants|coagulants|mesh-ancestor
14958972|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
14958973|NCT01597167|Analgesics|analgesics|mesh-ancestor
14958974|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
14958975|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958976|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14958977|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
14958978|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14958979|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14958980|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
14958981|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14958982|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14958983|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958984|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14958985|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
14958986|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14958987|NCT01597206|Cobalt|cobalt|mesh-list
14958988|NCT01597206|Trace Elements|trace elements|mesh-ancestor
14958989|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
14958990|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027935|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
15027936|NCT01952756|Cilostazol|cilostazol|mesh-list
15027937|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15027938|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
15027939|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14958991|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
14958992|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14958993|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14958994|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14958995|NCT01597310|Pramipexole|pramipexole|mesh-list
14958996|NCT01597310|Warfarin|warfarin|mesh-list
14958997|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
14958998|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
14958999|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959000|NCT01597310|Protective Agents|protective agents|mesh-ancestor
14959001|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959002|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14959003|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14959004|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
14959005|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
14959006|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959007|NCT01597336|Plasminogen|plasminogen|mesh-list
14959008|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14959009|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14959010|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14959011|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959012|NCT01597427|Clonidine|clonidine|mesh-list
14959013|NCT01597427|Analgesics|analgesics|mesh-ancestor
14959014|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
14959015|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959016|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959017|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14959018|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
14959019|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
14959020|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14959021|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14959022|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14959023|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
14959024|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959025|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959026|NCT01597518|Riluzole|riluzole|mesh-list
14959027|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
14959028|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14959029|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14959030|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959031|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959032|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959033|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14959034|NCT01597518|Protective Agents|protective agents|mesh-ancestor
14959035|NCT01597531|Liraglutide|liraglutide|mesh-list
14959036|NCT01597531|Orlistat|orlistat|mesh-list
14959037|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14959038|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959039|NCT01597531|Incretins|incretins|mesh-ancestor
14959040|NCT01597531|Hormones|hormones|mesh-ancestor
14959041|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959042|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959043|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959044|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14959045|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14959046|NCT01597609|Sibutramine|sibutramine|mesh-list
14959047|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
14959048|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959049|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
14959050|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14959051|NCT01597648|Maraviroc|maraviroc|mesh-list
14959052|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14959053|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14959054|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14959055|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959056|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14959057|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14959058|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
14959059|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959060|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14959061|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14959062|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14959063|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959064|NCT01597661|Bupropion|bupropion|mesh-list
14959065|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
14959066|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14959067|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959068|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14959069|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14959070|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959071|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959072|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
14959073|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959074|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959075|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14959076|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14959077|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959078|NCT01597700|Ezetimibe|ezetimibe|mesh-list
14959079|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14959080|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14959081|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
14959082|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959083|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14959084|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
14959085|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14959086|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959087|NCT01597726|Misoprostol|misoprostol|mesh-list
14959088|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14959089|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
14959090|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959091|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959092|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14959093|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14959094|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
14959095|NCT01597765|Vitamins|vitamins|mesh-list
14959096|NCT01597765|Vitamin E|vitamin e|mesh-list
14959097|NCT01597765|Tocopherols|tocopherols|mesh-list
14959098|NCT01597765|Tocotrienols|tocotrienols|mesh-list
14959099|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
14959100|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
14959101|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14959102|NCT01597765|Deferiprone|deferiprone|mesh-list
14959103|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
14959104|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959105|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
14959106|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959107|NCT01597765|Expectorants|expectorants|mesh-ancestor
14959108|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
14959109|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14959110|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
14959111|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959112|NCT01597765|Protective Agents|protective agents|mesh-ancestor
14959113|NCT01597765|Antidotes|antidotes|mesh-ancestor
14959114|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14959115|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
14959116|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
14959117|NCT01597817|Chitosan|chitosan|mesh-list
14959118|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14959119|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14959120|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
14959121|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959122|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14959123|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
14959124|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
14959125|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
14959126|NCT01597817|Coagulants|coagulants|mesh-ancestor
14959127|NCT01597895|Maraviroc|maraviroc|mesh-list
14959128|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14959129|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14959130|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959131|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14959132|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14959133|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
14959134|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959135|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14959136|NCT01597934|Tenofovir|tenofovir|mesh-list
14959137|NCT01597934|Entecavir|entecavir|mesh-list
14959138|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14959139|NCT01597934|Adefovir|adefovir|mesh-list
14959140|NCT01597934|Lamivudine|lamivudine|mesh-list
14959141|NCT01597934|Telbivudine|telbivudine|mesh-list
14959142|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
14959143|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799172|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
14799173|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
14799174|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14799175|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14799176|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14799177|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
14799178|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799179|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799180|NCT00781157|Protective Agents|protective agents|mesh-ancestor
14799181|NCT00781196|Folic Acid|folic acid|mesh-list
14799182|NCT00781196|Hematinics|hematinics|mesh-ancestor
14799183|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
14799184|NCT00781196|Vitamins|vitamins|mesh-ancestor
14799185|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
14799186|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799187|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
14799188|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14799189|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799190|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
14799191|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14799192|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14799193|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
14799194|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799195|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14799196|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14959144|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14959145|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14959146|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959147|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959148|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14959149|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14959150|NCT01597986|Isavuconazole|isavuconazole|mesh-list
14959151|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14959152|NCT01597986|Norethindrone|norethindrone|mesh-list
14959153|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
14959154|NCT01597986|Norinyl|norinyl|mesh-list
14959155|NCT01597986|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
14959156|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
14959157|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
14959158|NCT01597986|Estradiol|estradiol|mesh-list
14959159|NCT01597986|Estrogens|estrogens|mesh-ancestor
14959160|NCT01597986|Hormones|hormones|mesh-ancestor
14959161|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959162|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959163|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14959164|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959165|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14959166|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14959167|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14959168|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
14959169|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959170|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14959171|NCT01597986|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
14959172|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
14959173|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14959174|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14959175|NCT01598012|Analgesics|analgesics|mesh-ancestor
14959176|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
14959177|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959178|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959179|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14959180|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799197|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799198|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799199|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14799200|NCT00781300|Dexamethasone|dexamethasone|mesh-list
14799201|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799202|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
14799203|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
14799204|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799205|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799206|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14799207|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
14799208|NCT00781300|Hormones|hormones|mesh-ancestor
14799209|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799210|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14799211|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799212|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14799213|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
14799214|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14799215|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
14799216|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
14799217|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799218|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799219|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14799220|NCT00781352|Analgesics|analgesics|mesh-ancestor
14799221|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
14799222|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799223|NCT00781378|Plasminogen|plasminogen|mesh-list
14799224|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14799225|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14799226|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14799227|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799228|NCT00781404|Adenosine|adenosine|mesh-list
14799229|NCT00781404|Analgesics|analgesics|mesh-ancestor
14799230|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
14799231|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799232|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959181|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14959182|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959183|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959184|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
14959185|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14959186|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
14959187|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14959188|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
14959189|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959190|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959191|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
14959192|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
14959193|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14959194|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
14959195|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14959196|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
14959197|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959198|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959199|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
14959200|NCT01598259|Melatonin|melatonin|mesh-list
14959201|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
14959202|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959203|NCT01598259|Protective Agents|protective agents|mesh-ancestor
14959204|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959205|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959206|NCT01598337|Aspirin|aspirin|mesh-list
14959207|NCT01598337|Tirofiban|tirofiban|mesh-list
14959208|NCT01598337|Clopidogrel|clopidogrel|mesh-list
14959209|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14959210|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14959211|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14959212|NCT01598337|Analgesics|analgesics|mesh-ancestor
14959213|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
14959214|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959215|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959216|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14959217|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14959218|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14959219|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14959220|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959221|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14959222|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14959223|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959224|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
14959225|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14959226|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14959227|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14959228|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
14959229|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959230|NCT01598363|Digoxin|digoxin|mesh-list
14959231|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14959232|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14959233|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14959234|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
14959235|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959236|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14959237|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14959238|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959239|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14959240|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14959241|NCT01598363|Protective Agents|protective agents|mesh-ancestor
14959242|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959243|NCT01598402|Amoxicillin|amoxicillin|mesh-list
14959244|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
14959245|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
14959246|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14959247|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959248|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959249|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959250|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14959251|NCT01598441|Iloprost|iloprost|mesh-list
14959252|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14959253|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
14959254|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
14959255|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14959256|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14959257|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14959258|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
14959259|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14959260|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14959261|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14959262|NCT01598558|Rituximab|rituximab|mesh-list
14959263|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14959264|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959265|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
14959266|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959267|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14959268|NCT01598584|Gemcitabine|gemcitabine|mesh-list
14959269|NCT01598584|Mirtazapine|mirtazapine|mesh-list
14959270|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14959271|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
14959272|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959273|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959274|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
14959275|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959276|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959277|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14959278|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
14959279|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959280|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14959281|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959282|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14959283|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
14959284|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
14959285|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959286|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14959287|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14959288|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959289|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14959290|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14959291|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14959292|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
14959293|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14959294|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14959295|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
14959296|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14959297|NCT01598623|Oxytocin|oxytocin|mesh-list
14959298|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
14959299|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959300|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959301|NCT01598649|Mannitol|mannitol|mesh-list
14959302|NCT01598649|Caseins|caseins|mesh-list
14959303|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14959304|NCT01598649|Diuretics|diuretics|mesh-ancestor
14959305|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
14959306|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959307|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
14959308|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
14959309|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959310|NCT01598675|Methamphetamine|methamphetamine|mesh-list
14959311|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14959312|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959313|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
14959314|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
14959315|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959316|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
14959317|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959318|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959319|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
14959320|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14959321|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14959322|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959323|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14959324|NCT01598883|Heparin|heparin|mesh-list
14959325|NCT01598883|Calcium heparin|calcium heparin|mesh-list
14959326|NCT01598883|Antithrombins|antithrombins|mesh-list
14959327|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
14959328|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14959329|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14959330|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959331|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14959332|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
14959333|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959334|NCT01598948|Mipomersen|mipomersen|mesh-list
14959335|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14959336|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14959337|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
14959338|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959339|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14959340|NCT01599000|Lumefantrine|lumefantrine|mesh-list
14959341|NCT01599000|Artemether|artemether|mesh-list
14959342|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14959343|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
14959344|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14959345|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14959346|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959347|NCT01599013|Gemcitabine|gemcitabine|mesh-list
14959348|NCT01599013|Carboplatin|carboplatin|mesh-list
14959349|NCT01599013|Vinblastine|vinblastine|mesh-list
14959350|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959351|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14959352|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
14959353|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959354|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
14959355|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959356|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959357|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14959358|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
14959359|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959360|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14959361|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
14959362|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
14959363|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
14959364|NCT01599078|Paclitaxel|paclitaxel|mesh-list
14959365|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14959366|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959367|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
14959368|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
14959369|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
14959370|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959371|NCT01599117|Udenafil|udenafil|mesh-list
14959372|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14959373|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14959374|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959375|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959376|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14959377|NCT01599130|Entecavir|entecavir|mesh-list
14959378|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
14959379|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15027940|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027941|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15027942|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
14959380|NCT01599273|Triamcinolone|triamcinolone|mesh-list
14959381|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14959382|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
14959383|NCT01599273|Hormones|hormones|mesh-ancestor
14959384|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959385|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959386|NCT01599312|Cobalt|cobalt|mesh-list
14959387|NCT01599312|Trace Elements|trace elements|mesh-ancestor
14959388|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
14959389|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959390|NCT01599338|Liraglutide|liraglutide|mesh-list
14959391|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14959392|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959393|NCT01599338|Incretins|incretins|mesh-ancestor
14959394|NCT01599338|Hormones|hormones|mesh-ancestor
14959395|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959396|NCT01599364|Ritonavir|ritonavir|mesh-list
14959397|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14959398|NCT01599364|Lamivudine|lamivudine|mesh-list
14959399|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14959400|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14959401|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
14959402|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959403|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959404|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14959405|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14959406|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
14959407|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959408|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14959409|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14959410|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14799233|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14799234|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
14799235|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14799236|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
14799237|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
14799238|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799239|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799240|NCT00781417|Vitamin D|vitamin d|mesh-list
14799241|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
14799242|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
14799243|NCT00781417|Vitamins|vitamins|mesh-list
14799244|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
14799245|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799246|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14799247|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14799248|NCT00781482|Zolpidem|zolpidem|mesh-list
14799249|NCT00781482|Eszopiclone|eszopiclone|mesh-list
14799250|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14799251|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14799252|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799253|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799254|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14799255|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
14799256|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
14799257|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799258|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959411|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14959412|NCT01599377|Tofacitinib|tofacitinib|mesh-list
14959413|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14959414|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959415|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959416|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
14959417|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14959418|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14959419|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959420|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
14959421|NCT01599468|Coagulants|coagulants|mesh-ancestor
14959422|NCT01599572|Zinc|zinc|mesh-list
14959423|NCT01599572|Trace Elements|trace elements|mesh-ancestor
14959424|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
14959425|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959426|NCT01599598|Imidacloprid|imidacloprid|mesh-list
14959427|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
14959428|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959429|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959430|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959431|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14959432|NCT01599702|Hematinics|hematinics|mesh-ancestor
14959433|NCT01599728|Substance P|substance p|mesh-list
14959434|NCT01599728|Neurokinin A|neurokinin a|mesh-list
14959435|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959436|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959437|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959438|NCT01599819|Factor VIII|factor viii|mesh-list
14959439|NCT01599819|BAX 855|bax 855|mesh-list
14959440|NCT01599819|Coagulants|coagulants|mesh-ancestor
14959441|NCT01599858|Omeprazole|omeprazole|mesh-list
14959442|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14959443|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14959444|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14959445|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959446|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959447|NCT01599871|Theophylline|theophylline|mesh-list
14959448|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14959449|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
14959450|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959451|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959452|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14959453|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
14959454|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14959455|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959456|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959457|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
14959458|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14959459|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14959460|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
14959461|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959462|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
14959463|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14959464|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
14959465|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959466|NCT01599884|Expectorants|expectorants|mesh-ancestor
14959467|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
14959468|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14959469|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
14959470|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959471|NCT01599884|Protective Agents|protective agents|mesh-ancestor
14959472|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959473|NCT01599884|Antidotes|antidotes|mesh-ancestor
14959474|NCT01599923|Antivenins|antivenins|mesh-list
14959475|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
14959476|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959477|NCT01599936|Antivenins|antivenins|mesh-list
14959478|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
14959479|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959480|NCT01599962|Cinacalcet|cinacalcet|mesh-list
14959481|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14959482|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959483|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14959484|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
14959485|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959486|NCT01599975|Methylphenidate|methylphenidate|mesh-list
14959487|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14959488|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959489|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14959490|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14959491|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959492|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959493|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
14959494|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959495|NCT01599988|Caseins|caseins|mesh-list
14959496|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
14959497|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
14959498|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959499|NCT01600079|Vaccines|vaccines|mesh-list
14959500|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
14959501|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959502|NCT01600235|Phenylephrine|phenylephrine|mesh-list
14959503|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
14959504|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14959505|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
14959506|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
14959507|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959508|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959509|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
14959510|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14959511|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
14959512|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
14959513|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14959514|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14959515|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14959516|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
14959517|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959518|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959519|NCT01600235|Protective Agents|protective agents|mesh-ancestor
14959520|NCT01600274|Dienogest|dienogest|mesh-list
14959521|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14959522|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14959523|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14959524|NCT01600274|Estradiol|estradiol|mesh-list
14959525|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14959526|NCT01600274|Nandrolone|nandrolone|mesh-list
14799259|NCT00781521|Ofloxacin|ofloxacin|mesh-list
14799260|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14799261|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959527|NCT01600274|Estrogens|estrogens|mesh-ancestor
14959528|NCT01600274|Hormones|hormones|mesh-ancestor
14959529|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959530|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959531|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14959532|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
14959533|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959534|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14959535|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14959536|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14959537|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14959538|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
14959539|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14959540|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959541|NCT01600274|Androgens|androgens|mesh-ancestor
14959542|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
14959543|NCT01600365|Ganciclovir|ganciclovir|mesh-list
14959544|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14959545|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
14959546|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
14959547|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959548|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14959549|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959550|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959551|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14959552|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14959553|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
14959554|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14959555|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
14959556|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959557|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959558|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959559|NCT01600430|Vitamin D|vitamin d|mesh-list
14959560|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
14959561|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
14959562|NCT01600430|Vitamins|vitamins|mesh-list
14799262|NCT00781521|Renal Agents|renal agents|mesh-ancestor
14799263|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14799264|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14799265|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14799266|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799267|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799268|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799269|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14799270|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14799271|NCT00781547|Hormones|hormones|mesh-list
14799272|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799273|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799274|NCT00781573|Clopidogrel|clopidogrel|mesh-list
14799275|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14959563|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
14959564|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959565|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14959566|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14959567|NCT01600456|Sertraline|sertraline|mesh-list
14959568|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
14959569|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959570|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14959571|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14959572|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959573|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959574|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959575|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
14959576|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959577|NCT01600573|Topotecan|topotecan|mesh-list
14959578|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14959579|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14959580|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959581|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959582|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959583|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
14959584|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14959585|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14959586|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959587|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
14959588|NCT01600599|Coagulants|coagulants|mesh-ancestor
14959589|NCT01600612|Oxytocin|oxytocin|mesh-list
14959590|NCT01600612|Carbetocin|carbetocin|mesh-list
14959591|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
14959592|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959593|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959594|NCT01600625|Minocycline|minocycline|mesh-list
14959595|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14959596|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959597|NCT01600742|Vorinostat|vorinostat|mesh-list
14959598|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959599|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14959600|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959601|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959602|NCT01600768|Lactams|lactams|mesh-list
14959603|NCT01600768|beta-Lactams|beta-lactams|mesh-list
14959604|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14959605|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959606|NCT01600807|Gemcitabine|gemcitabine|mesh-list
14959607|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14959608|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14959609|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
14959610|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959611|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959612|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
14959613|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959614|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959615|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14959616|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
14959617|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959618|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15027943|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15027944|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15027945|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027946|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15027947|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
15027948|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15027949|NCT01952756|Protective Agents|protective agents|mesh-ancestor
15027950|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15027951|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15027952|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15027953|NCT01952769|Pidilizumab|pidilizumab|mesh-list
15027954|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15027955|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027956|NCT01952782|Naloxone|naloxone|mesh-list
15027957|NCT01952782|Hormones|hormones|mesh-list
15027958|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15027959|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027960|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14959619|NCT01600963|Bedaquiline|bedaquiline|mesh-list
14959620|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
14959621|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
14959622|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14959623|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959624|NCT01601002|Mirtazapine|mirtazapine|mesh-list
14959625|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
14959626|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959627|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14959628|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
14959629|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
14959630|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959631|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959632|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959633|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14959634|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14959635|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959636|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14959637|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14959638|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14959639|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
14959640|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14959641|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14959642|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
14959643|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14959644|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
14959645|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
14959646|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14959647|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14959648|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959649|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959650|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959651|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14959652|NCT01601093|Sulbactam|sulbactam|mesh-list
14959653|NCT01601093|Cefoperazone|cefoperazone|mesh-list
14959654|NCT01601093|Sulperazone|sulperazone|mesh-list
14959655|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14959656|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959657|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14959658|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959659|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959660|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14959661|NCT01601093|Renal Agents|renal agents|mesh-ancestor
14959662|NCT01601106|Prednisolone|prednisolone|mesh-list
14959663|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14959664|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
14959665|NCT01601106|Hormones|hormones|mesh-ancestor
14959666|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959667|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959668|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14959669|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959670|NCT01601184|Temozolomide|temozolomide|mesh-list
14959671|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14959672|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
14959673|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959674|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959675|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
14959676|NCT01601314|Analgesics|analgesics|mesh-ancestor
14959677|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
14959678|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959679|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959680|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
14959681|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959682|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14959683|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
14959684|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14959685|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959686|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959687|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14959688|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
14959689|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959690|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
14959691|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14959692|NCT01601327|Testosterone|testosterone|mesh-list
14959693|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
14959694|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
14959695|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14959696|NCT01601327|Androgens|androgens|mesh-ancestor
14959697|NCT01601327|Hormones|hormones|mesh-ancestor
14959698|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959699|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959700|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14959701|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959702|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
14959703|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959704|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
14959705|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
14959706|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14959707|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14959708|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959709|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14959710|NCT01601509|Tramazoline|tramazoline|mesh-list
14959711|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
14959712|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
14959713|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959714|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959715|NCT01601561|Insulin|insulin|mesh-list
14959716|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14959717|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14799276|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14799277|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14799278|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14799279|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
14799280|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959718|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959719|NCT01601730|Dexetimide|dexetimide|mesh-list
14959720|NCT01601730|Modafinil|modafinil|mesh-list
14959721|NCT01601730|Citalopram|citalopram|mesh-list
14959722|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14959723|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14959724|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959725|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959726|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959727|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
14959728|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959729|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14959730|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
14959731|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959732|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14959733|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14959734|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
14959735|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
14959736|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959737|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14959738|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14959739|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
14959740|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14959741|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14959742|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14959743|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14959744|NCT01601795|Sevoflurane|sevoflurane|mesh-list
14959745|NCT01601795|Isoflurane|isoflurane|mesh-list
14959746|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14959747|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14959748|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
14799281|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799282|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799283|NCT00781586|Caffeine|caffeine|mesh-list
14799284|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799285|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14799286|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14799287|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959749|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
14959750|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959751|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959752|NCT01601899|Tenofovir|tenofovir|mesh-list
14959753|NCT01601899|Lamivudine|lamivudine|mesh-list
14959754|NCT01601899|Efavirenz|efavirenz|mesh-list
14959755|NCT01601899|Stavudine|stavudine|mesh-list
14959756|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
14959757|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959758|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14959759|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14959760|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959761|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959762|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14959763|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14959764|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14959765|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14959766|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14959767|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14959768|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14959769|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14959770|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
14959771|NCT01601912|Dexetimide|dexetimide|mesh-list
14959772|NCT01601912|Citalopram|citalopram|mesh-list
14959773|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14959774|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14959775|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14959776|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959777|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959778|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959779|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
14959780|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959781|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14959782|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
14959783|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959784|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14959785|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14959786|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
14959787|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
14959788|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959789|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14959790|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14959791|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
14959792|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14959793|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
14959794|NCT01601938|Selenium|selenium|mesh-list
14959795|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
14959796|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959797|NCT01601938|Protective Agents|protective agents|mesh-ancestor
14959798|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959799|NCT01601938|Trace Elements|trace elements|mesh-ancestor
14959800|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
14959801|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14799288|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799289|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14799290|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14799291|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
14799292|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799293|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
14799294|NCT00781625|Methenamine|methenamine|mesh-list
14959802|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14959803|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959804|NCT01602003|Incretins|incretins|mesh-ancestor
14959805|NCT01602003|Hormones|hormones|mesh-ancestor
14959806|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959807|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14959808|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
14959809|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959810|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959811|NCT01602029|Ondansetron|ondansetron|mesh-list
14959812|NCT01602029|Simvastatin|simvastatin|mesh-list
14959813|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14959814|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14799295|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
14959815|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
14959816|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959817|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14959818|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14959819|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959820|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
14959821|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
14959822|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959823|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959824|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14959825|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
14959826|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
14959827|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14959828|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
14959829|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959830|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14959831|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14959832|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959833|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959834|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14959835|NCT01602055|Azithromycin|azithromycin|mesh-list
14959836|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14959837|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959838|NCT01602185|Memantine|memantine|mesh-list
14959839|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
14959840|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
14959841|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14959842|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14959843|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
14959844|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959845|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959846|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959847|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14959848|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14959849|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
14959850|NCT01602250|Ropivacaine|ropivacaine|mesh-list
14959851|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
14959852|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14959853|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
14959854|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
14959855|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959856|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959857|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
14959858|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959859|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14959860|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14959861|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14959862|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14959863|NCT01602289|Gefitinib|gefitinib|mesh-list
14959864|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959865|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14959866|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959867|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959868|NCT01602302|Adalimumab|adalimumab|mesh-list
14959869|NCT01602302|Etanercept|etanercept|mesh-list
14959870|NCT01602302|Golimumab|golimumab|mesh-list
14959871|NCT01602302|Abatacept|abatacept|mesh-list
14959872|NCT01602302|Infliximab|infliximab|mesh-list
14959873|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
14959874|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14959875|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14959876|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
14959877|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14959878|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14959879|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14959880|NCT01602302|Analgesics|analgesics|mesh-ancestor
14959881|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
14959882|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959883|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959884|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14959885|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
14959886|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14959887|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959888|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959889|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14959890|NCT01602406|Trastuzumab|trastuzumab|mesh-list
14959891|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14959892|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959893|NCT01602523|Budesonide|budesonide|mesh-list
14959894|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
14959895|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14959896|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14959897|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
14959898|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959899|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959900|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14959901|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
14959902|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
14959903|NCT01602523|Hormones|hormones|mesh-ancestor
14959904|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959905|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14959906|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14959907|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14959908|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
14959909|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959910|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959911|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
14959912|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
14959913|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14959914|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14959915|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959916|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959917|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959918|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14959919|NCT01602640|Fentanyl|fentanyl|mesh-list
14959920|NCT01602640|Midazolam|midazolam|mesh-list
14959921|NCT01602640|Morphine|morphine|mesh-list
14959922|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14959923|NCT01602640|Narcotics|narcotics|mesh-ancestor
14959924|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959925|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959926|NCT01602640|Analgesics|analgesics|mesh-ancestor
14959927|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
14959928|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959929|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14959930|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14959931|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
14959932|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
14959933|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14959934|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14959935|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14959936|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14959937|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
14959938|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
14959939|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14959940|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959941|NCT01602757|Lidocaine|lidocaine|mesh-list
14959942|NCT01602757|Tetracaine|tetracaine|mesh-list
14959943|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
14799296|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14799297|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799298|NCT00781625|Renal Agents|renal agents|mesh-ancestor
14799299|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14799300|NCT00781755|Varenicline|varenicline|mesh-list
14799301|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14799302|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14799303|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
14799304|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799305|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799306|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799307|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
14799308|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14799309|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799310|NCT00781820|Bifonazole|bifonazole|mesh-list
14799311|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
14799312|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799313|NCT00781846|Sirolimus|sirolimus|mesh-list
14799314|NCT00781846|Bevacizumab|bevacizumab|mesh-list
14799315|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14799316|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959944|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
14959945|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14959946|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799317|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14799318|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14959947|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
14959948|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14959949|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14959950|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14959951|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14959952|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14959953|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027961|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
15027962|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027963|NCT01952886|Ondansetron|ondansetron|mesh-list
14799319|NCT00781846|Growth Substances|growth substances|mesh-ancestor
14799320|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799321|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
14799322|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14799323|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799324|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15027964|NCT01952886|Granisetron|granisetron|mesh-list
15027965|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
15027966|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
15027967|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15027968|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027969|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15027970|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
15027971|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
15027972|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15027973|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
15027974|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15027975|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027976|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15027977|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15027978|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15027979|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15027980|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15027981|NCT01952951|Fluorouracil|fluorouracil|mesh-list
15027982|NCT01952951|Capecitabine|capecitabine|mesh-list
15027983|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
15027984|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
15027985|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027986|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15027987|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027988|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15027989|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
15027990|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027991|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
15027992|NCT01953107|Trace Elements|trace elements|mesh-ancestor
15027993|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
15027994|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15027995|NCT01953120|Abatacept|abatacept|mesh-list
15027996|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15027997|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15027998|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15027999|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15028000|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
15028001|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028002|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15028003|NCT01953172|Tocotrienols|tocotrienols|mesh-list
15028004|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
15028005|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
15028006|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028007|NCT01953172|Protective Agents|protective agents|mesh-ancestor
14959954|NCT01602822|Ritonavir|ritonavir|mesh-list
14959955|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14959956|NCT01602822|Tenofovir|tenofovir|mesh-list
14959957|NCT01602822|Emtricitabine|emtricitabine|mesh-list
14959958|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14959959|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14959960|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14959961|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
14959962|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959963|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959964|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14959965|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14959966|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
14959967|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959968|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14959969|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14959970|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14959971|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14959972|NCT01602861|Spironolactone|spironolactone|mesh-list
14959973|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14959974|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
14959975|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14959976|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14959977|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14959978|NCT01602861|Diuretics|diuretics|mesh-ancestor
14959979|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
14959980|NCT01602874|Metronidazole|metronidazole|mesh-list
14959981|NCT01602874|Clarithromycin|clarithromycin|mesh-list
14959982|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
14959983|NCT01602874|Tigecycline|tigecycline|mesh-list
14959984|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14959985|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14959986|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14959987|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14959988|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14959989|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959990|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959991|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14959992|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14959993|NCT01602887|Palbociclib|palbociclib|mesh-list
14959994|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14959995|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14959996|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14959997|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14959998|NCT01602900|Rolipram|rolipram|mesh-list
14959999|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
14960000|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960001|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14960002|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14960003|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960004|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960005|NCT01602913|Paroxetine|paroxetine|mesh-list
14960006|NCT01602913|Pravastatin|pravastatin|mesh-list
14960007|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14960008|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14960009|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960010|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960011|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960012|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
14960013|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960014|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14960015|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
14960016|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960017|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14960018|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14960019|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960020|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14960021|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14960022|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
14960023|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14960024|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14960025|NCT01602939|Cladribine|cladribine|mesh-list
14960026|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960027|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960028|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
14960029|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960030|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
14960031|NCT01603030|Prednisolone|prednisolone|mesh-list
14960032|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14960033|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
14960034|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14960035|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
14960036|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14960037|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14960038|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
14960039|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960040|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
14960041|NCT01603030|Hormones|hormones|mesh-ancestor
14960042|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14960043|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960044|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14960045|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960046|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
14960047|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
14960048|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960049|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960050|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14960051|NCT01603030|Protective Agents|protective agents|mesh-ancestor
14960052|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14960053|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960054|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14960055|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960056|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960057|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960058|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14960059|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
14960060|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14960061|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14960062|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14960063|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14960064|NCT01603108|Rifaximin|rifaximin|mesh-list
14960065|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14960066|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960067|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960068|NCT01603134|Allopurinol|allopurinol|mesh-list
14960069|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
14960070|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960071|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960072|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
14960073|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960074|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14960075|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
14960076|NCT01603134|Protective Agents|protective agents|mesh-ancestor
14529767|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14960077|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960078|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14960079|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
14960080|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960081|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14960082|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14960083|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960084|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960085|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14960086|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
14960087|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960088|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14960089|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14960090|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960091|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960092|NCT01603212|Interferons|interferons|mesh-list
14960093|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
14960094|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
14960095|NCT01603212|Aldesleukin|aldesleukin|mesh-list
14960096|NCT01603212|Interleukin-2|interleukin-2|mesh-list
14960097|NCT01603212|Vemurafenib|vemurafenib|mesh-list
14960098|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960099|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
14960100|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960101|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
15034947|NCT01998217|Remifentanil|remifentanil|mesh-list
14960102|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960103|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960104|NCT01603212|Analgesics|analgesics|mesh-ancestor
14960105|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
14960106|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960107|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14960108|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14960109|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14960110|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960111|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960112|NCT01603251|Ivermectin|ivermectin|mesh-list
14960113|NCT01603251|Lumefantrine|lumefantrine|mesh-list
14960114|NCT01603251|Artemether|artemether|mesh-list
14960115|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14960116|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14960117|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960118|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
14960119|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14960120|NCT01603264|Trastuzumab|trastuzumab|mesh-list
14960121|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14960122|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960123|NCT01603342|Clopidogrel|clopidogrel|mesh-list
14960124|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14960125|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14960126|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14960127|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14960128|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
14960129|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960130|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960131|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960132|NCT01603498|Dexamethasone|dexamethasone|mesh-list
14960133|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
14960134|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14960135|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14960136|NCT01603498|Prednisolone|prednisolone|mesh-list
14960137|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
14960138|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14960139|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
14960140|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960141|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
14960142|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
14960143|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960144|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960145|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960146|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
14960147|NCT01603498|Hormones|hormones|mesh-ancestor
14960148|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14960149|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14960150|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960151|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14960152|NCT01603498|Protective Agents|protective agents|mesh-ancestor
14960153|NCT01603511|Charcoal|charcoal|mesh-list
14960154|NCT01603511|Antidotes|antidotes|mesh-ancestor
14960155|NCT01603511|Protective Agents|protective agents|mesh-ancestor
14960156|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960157|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
14960158|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
14960159|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
14960160|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960161|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
14960162|NCT01603654|Protective Agents|protective agents|mesh-ancestor
14960163|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960164|NCT01603654|Vitamins|vitamins|mesh-ancestor
14960165|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
14960166|NCT01603654|Cathartics|cathartics|mesh-ancestor
14960167|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960168|NCT01603680|Anesthetics|anesthetics|mesh-list
14960169|NCT01603680|Mepivacaine|mepivacaine|mesh-list
14960170|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
14960171|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960172|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960173|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
14960174|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960175|NCT01603693|Calcium|calcium|mesh-list
14960176|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14960177|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960178|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
14960179|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14960180|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960181|NCT01603758|Ezetimibe|ezetimibe|mesh-list
14960182|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14960183|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14960184|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
14960185|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960186|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14960187|NCT01604031|Lenalidomide|lenalidomide|mesh-list
14960188|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
14960189|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960190|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14960191|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14960192|NCT01604031|Growth Substances|growth substances|mesh-ancestor
14960193|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14960194|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960195|NCT01604057|Teriparatide|teriparatide|mesh-list
14960196|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14960197|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960198|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14799325|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
14799326|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799327|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
14799328|NCT00782041|Leucovorin|leucovorin|mesh-list
14799329|NCT00782041|Folic Acid|folic acid|mesh-list
14799330|NCT00782041|Fluorouracil|fluorouracil|mesh-list
14799331|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
14799332|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
14799333|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
14799334|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799335|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14799336|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799337|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799338|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
14799339|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799340|NCT00782041|Antidotes|antidotes|mesh-ancestor
14799341|NCT00782041|Protective Agents|protective agents|mesh-ancestor
14799342|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
14799343|NCT00782041|Vitamins|vitamins|mesh-ancestor
14799344|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
14799345|NCT00782041|Hematinics|hematinics|mesh-ancestor
14960199|NCT01604135|Riboflavin|riboflavin|mesh-list
14960200|NCT01604135|Dextrans|dextrans|mesh-list
14960201|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
14960202|NCT01604135|Vitamins|vitamins|mesh-ancestor
14960203|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
14960204|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960205|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14960206|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
14960207|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
14960208|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
14960209|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
14960210|NCT01604187|Fentanyl|fentanyl|mesh-list
14960211|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14960212|NCT01604187|Narcotics|narcotics|mesh-ancestor
14960213|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960214|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960215|NCT01604187|Analgesics|analgesics|mesh-ancestor
14960216|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
14960217|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960218|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14960219|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14960220|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
14960221|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
14960222|NCT01604213|Metformin|metformin|mesh-list
14960223|NCT01604213|Vildagliptin|vildagliptin|mesh-list
14960224|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14960225|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960226|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14960227|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
14960228|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960229|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799346|NCT00782093|Volociximab|volociximab|mesh-list
14799347|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14960230|NCT01604330|Baclofen|baclofen|mesh-list
14960231|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14799348|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14960232|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960233|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14960234|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960235|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14960236|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
14960237|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
14960238|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960239|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960240|NCT01604382|Remifentanil|remifentanil|mesh-list
14960241|NCT01604382|Bupivacaine|bupivacaine|mesh-list
14960242|NCT01604382|Anesthetics|anesthetics|mesh-list
14960243|NCT01604382|Propofol|propofol|mesh-list
14960244|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
14960245|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960246|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960247|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
14960248|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960249|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14960250|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14960251|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
14960252|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14960253|NCT01604382|Narcotics|narcotics|mesh-ancestor
14960254|NCT01604382|Analgesics|analgesics|mesh-ancestor
15028008|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028009|NCT01953172|Vitamins|vitamins|mesh-ancestor
15028010|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
15028011|NCT01953367|Tobramycin|tobramycin|mesh-list
15028012|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15028013|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028014|NCT01953406|Fluorouracil|fluorouracil|mesh-list
15028015|NCT01953406|Mitomycins|mitomycins|mesh-list
15028016|NCT01953406|Mitomycin|mitomycin|mesh-list
15028017|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
15028018|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028019|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15028020|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028021|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15028022|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
15028023|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028024|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15028025|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
15028026|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15028027|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028028|NCT01953419|Pemetrexed|pemetrexed|mesh-list
15028029|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028030|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028031|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028032|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15028033|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15028034|NCT01953445|Paclitaxel|paclitaxel|mesh-list
15028035|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15028036|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028037|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
15028038|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
15028039|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
15028040|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028041|NCT01953510|Vaccines|vaccines|mesh-list
15028042|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15028043|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
15028044|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028045|NCT01953536|Folic Acid|folic acid|mesh-list
15028046|NCT01953536|Paclitaxel|paclitaxel|mesh-list
15028047|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15028048|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15028049|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028050|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
15028051|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
15028052|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
15028053|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028054|NCT01953536|Hematinics|hematinics|mesh-ancestor
15028055|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
15028056|NCT01953536|Vitamins|vitamins|mesh-ancestor
15028057|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
15028058|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028059|NCT01953588|Fulvestrant|fulvestrant|mesh-list
15028060|NCT01953588|Anastrozole|anastrozole|mesh-list
15028061|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14960255|NCT01604629|Adalimumab|adalimumab|mesh-list
14960256|NCT01604629|Etanercept|etanercept|mesh-list
14960257|NCT01604629|Golimumab|golimumab|mesh-list
14960258|NCT01604629|Infliximab|infliximab|mesh-list
14960259|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14960260|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960261|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960262|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
14960263|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960264|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14960265|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960266|NCT01604629|Analgesics|analgesics|mesh-ancestor
14960267|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
14960268|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960269|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960270|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960271|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
14960272|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14960273|NCT01604811|Tamsulosin|tamsulosin|mesh-list
14960274|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
14960275|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14960276|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14960277|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14960278|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
14960279|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960280|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960281|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960282|NCT01604811|Urological Agents|urological agents|mesh-ancestor
14960283|NCT01604863|Paclitaxel|paclitaxel|mesh-list
14960284|NCT01604863|Etoposide|etoposide|mesh-list
14960285|NCT01604863|Docetaxel|docetaxel|mesh-list
14960286|NCT01604863|Carboplatin|carboplatin|mesh-list
14960287|NCT01604863|Immunoglobulin G|immunoglobulin g|mesh-list
14960288|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14960289|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960290|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
14960291|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
14960292|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
14960293|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960294|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14960295|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960296|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960297|NCT01604863|Immunologic Factors|immunologic factors|mesh-ancestor
14960298|NCT01604863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960299|NCT01604928|Mirabegron|mirabegron|mesh-list
14960300|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14960301|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14960302|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14960303|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14960304|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
14960305|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960306|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960307|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960308|NCT01604928|Urological Agents|urological agents|mesh-ancestor
14960309|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14960310|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14960311|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
14960312|NCT01605084|Ritonavir|ritonavir|mesh-list
14799349|NCT00782093|Growth Substances|growth substances|mesh-ancestor
14799350|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799351|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
14960313|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14960314|NCT01605084|Darunavir|darunavir|mesh-list
14960315|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14960316|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14960317|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
14960318|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960319|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960320|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14960321|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14960322|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
14960323|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960324|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14960325|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14960326|NCT01605240|Acetaminophen|acetaminophen|mesh-list
14799352|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960327|NCT01605240|Ibuprofen|ibuprofen|mesh-list
14960328|NCT01605240|Codeine|codeine|mesh-list
14960329|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960330|NCT01605240|Analgesics|analgesics|mesh-ancestor
14960331|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
14960332|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960333|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960334|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
14960335|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14960336|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960337|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960338|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14960339|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799353|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
14799354|NCT00782106|Antibodies|antibodies|mesh-list
14799355|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
14799356|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14960340|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960341|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14799357|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14799358|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
14799359|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
14799360|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799361|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
14799362|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14799363|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
14799364|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799365|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
14799366|NCT00782197|Protective Agents|protective agents|mesh-ancestor
14799367|NCT00782301|Maraviroc|maraviroc|mesh-list
14799368|NCT00782301|Etravirine|etravirine|mesh-list
14960342|NCT01605240|Narcotics|narcotics|mesh-ancestor
14960343|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960344|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
14960345|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
14960346|NCT01605253|Eszopiclone|eszopiclone|mesh-list
14960347|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14960348|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960349|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960350|NCT01605279|Dobutamine|dobutamine|mesh-list
14960351|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14960352|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
14960353|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
14799369|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14799370|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14799371|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799372|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14799373|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14960354|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960355|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960356|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14960357|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14960358|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14960359|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
14960360|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960361|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960362|NCT01605279|Protective Agents|protective agents|mesh-ancestor
14960363|NCT01605318|Irinotecan|irinotecan|mesh-list
14960364|NCT01605318|Labetuzumab|labetuzumab|mesh-list
14960365|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
14960366|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
14960367|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960368|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14960369|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960370|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960371|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960372|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960373|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14960374|NCT01605344|Leucovorin|leucovorin|mesh-list
14960375|NCT01605344|Fluorouracil|fluorouracil|mesh-list
14960376|NCT01605344|Irinotecan|irinotecan|mesh-list
14960377|NCT01605344|Atorvastatin|atorvastatin|mesh-list
14960378|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
14960379|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799374|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
14799375|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799376|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14960380|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14960381|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960382|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960383|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
14960384|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960385|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14960386|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960387|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960388|NCT01605344|Antidotes|antidotes|mesh-ancestor
14960389|NCT01605344|Protective Agents|protective agents|mesh-ancestor
14960390|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
14960391|NCT01605344|Vitamins|vitamins|mesh-ancestor
14960392|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
14960393|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14960394|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14960395|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14960396|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14960397|NCT01605357|Mannitol|mannitol|mesh-list
14960398|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14960399|NCT01605357|Diuretics|diuretics|mesh-ancestor
14960400|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
14960401|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960402|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
14960403|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
14960404|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
14960405|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960406|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14960407|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
14960408|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
14960409|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960410|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960411|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960412|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14960413|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
14960414|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14960415|NCT01605513|Interferons|interferons|mesh-list
14960416|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960417|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
14960418|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960419|NCT01605526|Doxorubicin|doxorubicin|mesh-list
14960420|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14960421|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960422|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14960423|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960424|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960425|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960426|NCT01605721|Everolimus|everolimus|mesh-list
14960427|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960428|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960429|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
14960430|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960431|NCT01605734|Sorafenib|sorafenib|mesh-list
14960432|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
14960433|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960434|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14960435|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960436|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960437|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14960438|NCT01605734|Estrogens|estrogens|mesh-ancestor
14960439|NCT01605734|Hormones|hormones|mesh-ancestor
14960440|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14960441|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960442|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14960443|NCT01605773|Glyburide|glyburide|mesh-list
14960444|NCT01605773|Repaglinide|repaglinide|mesh-list
14960445|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14960446|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960447|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14960448|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14960449|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960450|NCT01605929|Mepivacaine|mepivacaine|mesh-list
14960451|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
14960452|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
14960453|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960454|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960455|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
14960456|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960457|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14960458|NCT01605968|Laxatives|laxatives|mesh-ancestor
14960459|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960460|NCT01605994|Antacids|antacids|mesh-list
14960461|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960462|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960463|NCT01606046|Anesthetics|anesthetics|mesh-list
14960464|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
14960465|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14960466|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
14960467|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960468|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960469|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
14960470|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960471|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14960472|NCT01606059|Acetaminophen|acetaminophen|mesh-list
14960473|NCT01606059|Tramadol|tramadol|mesh-list
14960474|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960475|NCT01606059|Analgesics|analgesics|mesh-ancestor
14960476|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
14960477|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960478|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960479|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
14960480|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14960481|NCT01606059|Narcotics|narcotics|mesh-ancestor
14960482|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960483|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14960484|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
14960485|NCT01606072|Coagulants|coagulants|mesh-ancestor
14960486|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14960487|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
14960488|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960489|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
14960490|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14960491|NCT01606111|Protective Agents|protective agents|mesh-ancestor
14960492|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960493|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
15028062|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028063|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15028064|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15028065|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
15028066|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028067|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028068|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15028069|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15028070|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028071|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028072|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
15028073|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15028074|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
15028075|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028076|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028077|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15028078|NCT01953731|Rifampin|rifampin|mesh-list
15028079|NCT01953731|Palbociclib|palbociclib|mesh-list
15028080|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028081|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15028082|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028083|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028084|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15028085|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
15028086|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15028087|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028088|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
15028089|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15028090|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15028091|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15028092|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15028093|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15028094|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15028095|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15028096|NCT01953744|Fluconazole|fluconazole|mesh-list
15028097|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
15028098|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
14960494|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
14960495|NCT01606241|Vaccines|vaccines|mesh-list
14960496|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
14960497|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960498|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960499|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960500|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14960501|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
14960502|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960503|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960504|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14960505|NCT01606345|Valrubicin|valrubicin|mesh-list
14960506|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960507|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14960508|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960509|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960510|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960511|NCT01606358|Carboplatin|carboplatin|mesh-list
14960512|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960513|NCT01606384|Vasopressins|vasopressins|mesh-list
14960514|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
14960515|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
14960516|NCT01606384|Coagulants|coagulants|mesh-ancestor
14960517|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14960518|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14960519|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
14960520|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960521|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
14960522|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14960523|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960524|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14960525|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960526|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960527|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960528|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960529|NCT01606462|Oxytocin|oxytocin|mesh-list
14960530|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
14960531|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14960532|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960533|NCT01606527|Ibuprofen|ibuprofen|mesh-list
14960534|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14960535|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960536|NCT01606527|Analgesics|analgesics|mesh-ancestor
14960537|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
14960538|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960539|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960540|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960541|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960542|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14960543|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960544|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960545|NCT01606540|Ibuprofen|ibuprofen|mesh-list
14960546|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14960547|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960548|NCT01606540|Analgesics|analgesics|mesh-ancestor
14960549|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
14960550|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960551|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960552|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960553|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960554|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14960555|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960556|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960557|NCT01606722|Ritonavir|ritonavir|mesh-list
14960558|NCT01606722|Darunavir|darunavir|mesh-list
14960559|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14960560|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14960561|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
14960562|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960563|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960564|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14960565|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14960566|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
14960567|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960568|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14960569|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14960570|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
14960571|NCT01606878|Doxorubicin|doxorubicin|mesh-list
14960572|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14960573|NCT01606878|Vincristine|vincristine|mesh-list
14960574|NCT01606878|Topotecan|topotecan|mesh-list
14960575|NCT01606878|Crizotinib|crizotinib|mesh-list
14960576|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
14960577|NCT01606878|Razoxane|razoxane|mesh-list
14960578|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960579|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
14960580|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960581|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960582|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14960583|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
14960584|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960585|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960586|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14960587|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14960588|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14960589|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960590|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960591|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14960592|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
14960593|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
14960594|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
14960595|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14960596|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14960597|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14960598|NCT01606878|Protective Agents|protective agents|mesh-ancestor
14960599|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14960600|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
14960601|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14960602|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
14960603|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14960604|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
14960605|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960606|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960607|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
14960608|NCT01607034|Pramipexole|pramipexole|mesh-list
14960609|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
14960610|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960611|NCT01607034|Protective Agents|protective agents|mesh-ancestor
14960612|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960613|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14960614|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14960615|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
14799377|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14799378|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14960616|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
14960617|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960618|NCT01607086|Lamotrigine|lamotrigine|mesh-list
14960619|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
14960620|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14960621|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960622|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960623|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14960624|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960625|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14960626|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14960627|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960628|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960629|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14960630|NCT01607125|Vortioxetine|vortioxetine|mesh-list
14960631|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
14960632|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960633|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14960634|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14960635|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960636|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960637|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14960638|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14960639|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960640|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960641|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960642|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
14960643|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14960644|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14960645|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14960646|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14799379|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799380|NCT00782327|Losartan|losartan|mesh-list
14799381|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14799382|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14799383|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14960647|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14960648|NCT01607333|Lamotrigine|lamotrigine|mesh-list
14960649|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
14960650|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14960651|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960652|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960653|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14960654|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960655|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14960656|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14960657|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960658|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960659|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14960660|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
14960661|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14960662|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14960663|NCT01607580|Prednisolone|prednisolone|mesh-list
14960664|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
14960665|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14960666|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
14960667|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
14960668|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960669|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
14960670|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
14960671|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960672|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960673|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960674|NCT01607580|Hormones|hormones|mesh-ancestor
14960675|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14960676|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14960677|NCT01607580|Protective Agents|protective agents|mesh-ancestor
14960678|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14960679|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960680|NCT01607671|Timolol|timolol|mesh-list
14960681|NCT01607671|Maleic acid|maleic acid|mesh-list
14960682|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14960683|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14960684|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
14960685|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960686|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960687|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960688|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14960689|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14960690|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960691|NCT01607762|Olanzapine|olanzapine|mesh-list
14960692|NCT01607762|Risperidone|risperidone|mesh-list
14960693|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14960694|NCT01607762|Aripiprazole|aripiprazole|mesh-list
14960695|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14960696|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14960697|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
14960698|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960699|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960700|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960701|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14960702|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14960703|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960704|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960705|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14960706|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
14960707|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
14960708|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
14960709|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960710|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960711|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14960712|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14960713|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960714|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
14960715|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
14960716|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14960717|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14960718|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14960719|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14960720|NCT01607879|Androgens|androgens|mesh-list
14960721|NCT01607879|Hormones|hormones|mesh-ancestor
14960722|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14960723|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960724|NCT01607918|Amoxicillin|amoxicillin|mesh-list
14960725|NCT01607918|Metronidazole|metronidazole|mesh-list
14960726|NCT01607918|Clarithromycin|clarithromycin|mesh-list
14960727|NCT01607918|Lansoprazole|lansoprazole|mesh-list
14960728|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
14960729|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14960730|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960731|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14960732|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14960733|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14960734|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960735|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960736|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14960737|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14960738|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14960739|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14960740|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15028099|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028100|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15028101|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15028102|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028103|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028104|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15028105|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
15028106|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028107|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028108|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15028109|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15028110|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15028111|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15028112|NCT01953757|Vitamins|vitamins|mesh-list
15028113|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
15028114|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
15028115|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
15028116|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
15028117|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028118|NCT01953757|Hematinics|hematinics|mesh-ancestor
15028119|NCT01953770|Cytarabine|cytarabine|mesh-list
15028120|NCT01953770|Prednisone|prednisone|mesh-list
15028121|NCT01953770|Methotrexate|methotrexate|mesh-list
15028122|NCT01953770|Daunorubicin|daunorubicin|mesh-list
15028123|NCT01953770|Asparaginase|asparaginase|mesh-list
15028124|NCT01953770|Pegaspargase|pegaspargase|mesh-list
15028125|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15028126|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
15028127|NCT01953770|Hormones|hormones|mesh-ancestor
15028128|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028129|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028130|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15028131|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028132|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15028133|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
15028134|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028135|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15028136|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
15028137|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028138|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
15028139|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028140|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15028141|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15028142|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
15028143|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15028144|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15028145|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
15028146|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028147|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15028148|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15028149|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15028150|NCT01953796|Clomiphene|clomiphene|mesh-list
15028151|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15028152|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
15034948|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14960741|NCT01607970|Oxytocin|oxytocin|mesh-list
14960742|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
14960743|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14960744|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960745|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
14960746|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14960747|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
14960748|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960749|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960750|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14960751|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
14960752|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14960753|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
14960754|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960755|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960756|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14960757|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
14960758|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
14960759|NCT01607983|Protective Agents|protective agents|mesh-ancestor
14960760|NCT01607996|Anesthetics|anesthetics|mesh-list
14960761|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960762|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960763|NCT01608009|Paclitaxel|paclitaxel|mesh-list
14960764|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14960765|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960766|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14960767|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14960768|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14960769|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960770|NCT01608139|Curcumin|curcumin|mesh-list
14960771|NCT01608139|Sorafenib|sorafenib|mesh-list
14960772|NCT01608139|Vorinostat|vorinostat|mesh-list
14960773|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960774|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14960775|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960776|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960777|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14960778|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14960779|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960780|NCT01608139|Analgesics|analgesics|mesh-ancestor
14960781|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
14960782|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960783|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960784|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14960785|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14960786|NCT01608217|Acetaminophen|acetaminophen|mesh-list
14960787|NCT01608217|Dronabinol|dronabinol|mesh-list
14960788|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14960789|NCT01608217|Analgesics|analgesics|mesh-ancestor
14960790|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
14960791|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960792|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960793|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
14960794|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
14960795|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14960796|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14960797|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14960798|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960799|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960800|NCT01608217|Hormones|hormones|mesh-ancestor
14960801|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799384|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14960802|NCT01608269|Lamivudine|lamivudine|mesh-list
14960803|NCT01608269|Abacavir|abacavir|mesh-list
14799385|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799386|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14799387|NCT00782405|Mirtazapine|mirtazapine|mesh-list
14799388|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
14799389|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14799390|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14799391|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14799392|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799393|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960804|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14960805|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14960806|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960807|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960808|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
14960809|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960810|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14960811|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14960812|NCT01608334|Fentanyl|fentanyl|mesh-list
14960813|NCT01608334|Sufentanil|sufentanil|mesh-list
14960814|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14960815|NCT01608334|Narcotics|narcotics|mesh-ancestor
14960816|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960817|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960818|NCT01608334|Analgesics|analgesics|mesh-ancestor
14960819|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
14960820|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960821|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14960822|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14960823|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
14960824|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
14960825|NCT01608347|Folic Acid|folic acid|mesh-list
14960826|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
14960827|NCT01608347|Hematinics|hematinics|mesh-ancestor
14960828|NCT01608347|Vitamins|vitamins|mesh-ancestor
14960829|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
14960830|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960831|NCT01608360|Lidocaine|lidocaine|mesh-list
14960832|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
14960833|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
14960834|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960835|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960836|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
14960837|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960838|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14960839|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14960840|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14960841|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960842|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960843|NCT01608373|Lidocaine|lidocaine|mesh-list
14960844|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
14960845|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
14960846|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14960847|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960848|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
14960849|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960850|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14960851|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14960852|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14960853|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960854|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960855|NCT01608412|Everolimus|everolimus|mesh-list
14960856|NCT01608412|Tacrolimus|tacrolimus|mesh-list
14799394|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14799395|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
14799396|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
14799397|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799398|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799399|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14799400|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14799401|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14799402|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14799403|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
14799404|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14799405|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14799406|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
14799407|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14799408|NCT00782470|Factor VIII|factor viii|mesh-list
14799409|NCT00782470|Coagulants|coagulants|mesh-ancestor
14799410|NCT00782548|Morphine|morphine|mesh-list
14799411|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14799412|NCT00782548|Narcotics|narcotics|mesh-ancestor
14799413|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799414|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960857|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799415|NCT00782548|Analgesics|analgesics|mesh-ancestor
14960858|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
14960859|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960860|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14960861|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960862|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960863|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960864|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
14960865|NCT01608451|Progesterone|progesterone|mesh-list
14960866|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14960867|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960868|NCT01608451|Vitamins|vitamins|mesh-ancestor
14960869|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
14960870|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14960871|NCT01608451|Progestins|progestins|mesh-ancestor
14960872|NCT01608451|Hormones|hormones|mesh-ancestor
14960873|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14960874|NCT01608464|Cisplatin|cisplatin|mesh-list
14960875|NCT01608464|Docetaxel|docetaxel|mesh-list
14960876|NCT01608464|Fluorouracil|fluorouracil|mesh-list
14960877|NCT01608464|Irinotecan|irinotecan|mesh-list
14960878|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960879|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
14960880|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
14960881|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
14960882|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960883|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
14960884|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14960885|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960886|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
14960887|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960888|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14799416|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
14799417|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799418|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
14799419|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14799420|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
14960889|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14960890|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960891|NCT01608555|Tobramycin|tobramycin|mesh-list
14960892|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14960893|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960894|NCT01608594|Ipilimumab|ipilimumab|mesh-list
14960895|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14960896|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960897|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14960898|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960899|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
14960900|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960901|NCT01608698|Drospirenone|drospirenone|mesh-list
14960902|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14960903|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
14960904|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14960905|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14960906|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14960907|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
14960908|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14960909|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960910|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14960911|NCT01608698|Estrogens|estrogens|mesh-ancestor
14960912|NCT01608698|Hormones|hormones|mesh-ancestor
14960913|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14960914|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14960915|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
14960916|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14960917|NCT01608698|Diuretics|diuretics|mesh-ancestor
14960918|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
14960919|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
14960920|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14960921|NCT01608711|Gemcitabine|gemcitabine|mesh-list
14960922|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14960923|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
14960924|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960925|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799421|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799422|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799423|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14960926|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
14960927|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960928|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960929|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14960930|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
14960931|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960932|NCT01608750|Folic Acid|folic acid|mesh-list
14960933|NCT01608750|Hematinics|hematinics|mesh-ancestor
14960934|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
14960935|NCT01608750|Vitamins|vitamins|mesh-ancestor
14960936|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
14960937|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960938|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14960939|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14960940|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14960941|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14960942|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960943|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14960944|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960945|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
14960946|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
14960947|NCT01608893|Metoprolol|metoprolol|mesh-list
14960948|NCT01608893|Carvedilol|carvedilol|mesh-list
14960949|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14960950|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14960951|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
14960952|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
14960953|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960954|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960955|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14960956|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14960957|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14960958|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
14960959|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14960960|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960961|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
14960962|NCT01608893|Protective Agents|protective agents|mesh-ancestor
14960963|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14960964|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14960965|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14960966|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
14960967|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14960968|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14960969|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
14960970|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14960971|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14960972|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14960973|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799424|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
14799425|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14799426|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
14799427|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799428|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799429|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14960974|NCT01608958|Oxytocin|oxytocin|mesh-list
14960975|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
14960976|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14960977|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960978|NCT01608984|Sufentanil|sufentanil|mesh-list
14960979|NCT01608984|Isoflurane|isoflurane|mesh-list
14960980|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14960981|NCT01608984|Narcotics|narcotics|mesh-ancestor
14960982|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799430|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
14799431|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
14799432|NCT00782652|Protective Agents|protective agents|mesh-ancestor
14799433|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
14799434|NCT00782847|Cyproterone|cyproterone|mesh-list
14799435|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
14960983|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14960984|NCT01608984|Analgesics|analgesics|mesh-ancestor
14960985|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
14960986|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14960987|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14799436|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
14960988|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14960989|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
14960990|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
14960991|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14960992|NCT01609049|Ribavirin|ribavirin|mesh-list
14960993|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14960994|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
14960995|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14960996|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
14960997|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14960998|NCT01609088|Erythritol|erythritol|mesh-list
14960999|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
14961000|NCT01609101|Cobalt|cobalt|mesh-list
14961001|NCT01609101|Trace Elements|trace elements|mesh-ancestor
14961002|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
14961003|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961004|NCT01609127|Capecitabine|capecitabine|mesh-list
14961005|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14961006|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
14961007|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961008|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961009|NCT01609153|Olanzapine|olanzapine|mesh-list
14961010|NCT01609153|Amisulpride|amisulpride|mesh-list
14961011|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
14961012|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
14961013|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961014|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961015|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961016|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14961017|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14961018|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799437|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799438|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799439|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799440|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14799441|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
14961019|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14961020|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14961021|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14961022|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14961023|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961024|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961025|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
14961026|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14961027|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
14961028|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14961029|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
14961030|NCT01609166|Allopurinol|allopurinol|mesh-list
14961031|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
14961032|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961033|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961034|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
14961035|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961036|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14799442|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14799443|NCT00782951|Morphine|morphine|mesh-list
14799444|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14799445|NCT00782951|Narcotics|narcotics|mesh-ancestor
14799446|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799447|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799448|NCT00782951|Analgesics|analgesics|mesh-ancestor
14799449|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
14799450|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799451|NCT00783016|Morphine|morphine|mesh-list
14799452|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14961037|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
14961038|NCT01609166|Protective Agents|protective agents|mesh-ancestor
14961039|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961040|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
14961041|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961042|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
14961043|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961044|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961045|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14961046|NCT01609205|Adalimumab|adalimumab|mesh-list
14961047|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961048|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961049|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14961050|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14961051|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961052|NCT01609387|Tocopherols|tocopherols|mesh-list
14961053|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
14799453|NCT00783016|Narcotics|narcotics|mesh-ancestor
14799454|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799455|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799456|NCT00783016|Analgesics|analgesics|mesh-ancestor
14799457|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
14799458|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799459|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14799460|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14961054|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961055|NCT01609387|Protective Agents|protective agents|mesh-ancestor
14961056|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961057|NCT01609387|Vitamins|vitamins|mesh-ancestor
14961058|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
14961059|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
14961060|NCT01609413|Antacids|antacids|mesh-ancestor
14961061|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961062|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961063|NCT01609439|Vitamin D|vitamin d|mesh-list
14961064|NCT01609439|Vitamins|vitamins|mesh-ancestor
14961065|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
14961066|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961067|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14961068|NCT01609491|Phenylephrine|phenylephrine|mesh-list
14961069|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
14961070|NCT01609491|Norepinephrine|norepinephrine|mesh-list
14961071|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14961072|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
14961073|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
14961074|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961075|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961076|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
14961077|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14961078|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
14961079|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
14961080|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14961081|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14961082|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14961083|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
14961084|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961085|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961086|NCT01609491|Protective Agents|protective agents|mesh-ancestor
14961087|NCT01609517|Bupivacaine|bupivacaine|mesh-list
14961088|NCT01609517|Anesthetics|anesthetics|mesh-list
14961089|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
14961090|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961091|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961092|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
14961093|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028153|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028154|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028155|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15028156|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
15028157|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028158|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15028159|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15028160|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15028161|NCT01953835|Simvastatin|simvastatin|mesh-list
14961094|NCT01609647|Clopidogrel|clopidogrel|mesh-list
14961095|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14961096|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14961097|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14961098|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14961099|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14961100|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
14961101|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961102|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961103|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961104|NCT01609673|Everolimus|everolimus|mesh-list
14961105|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961106|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961107|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
14961108|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961109|NCT01609816|Dasatinib|dasatinib|mesh-list
14961110|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961111|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14961112|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961113|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961114|NCT01609855|Scopolamine|scopolamine|mesh-list
14961115|NCT01609855|Bromides|bromides|mesh-list
14961116|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14961117|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
14961118|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14961119|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
14961120|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
14961121|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961122|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961123|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961124|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
14961125|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14961126|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
14961127|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961128|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961129|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14961130|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
14961131|NCT01609881|Ketorolac|ketorolac|mesh-list
14961132|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14961133|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14961134|NCT01609881|Analgesics|analgesics|mesh-ancestor
14961135|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
14961136|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961137|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961138|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961139|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961140|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14961141|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961142|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961143|NCT01609907|Valsartan|valsartan|mesh-list
14961144|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14961145|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14961146|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14961147|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
14961148|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961149|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14961150|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14961151|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961152|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14961153|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14961154|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14961155|NCT01609959|Valsartan|valsartan|mesh-list
14961156|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
14961157|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14961158|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14961159|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14961160|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961161|NCT01609998|Vaccines|vaccines|mesh-list
14961162|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
14961163|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961164|NCT01610141|Warfarin|warfarin|mesh-list
14961165|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
14961166|NCT01610310|Interferon-beta|interferon-beta|mesh-list
14961167|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961168|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
14961169|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961170|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
14961171|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961172|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
14961173|NCT01610362|Antibodies|antibodies|mesh-list
14961174|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
14961175|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14961176|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14961177|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
14961178|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
14961179|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961180|NCT01610401|Metformin|metformin|mesh-list
14961181|NCT01610401|Caffeine|caffeine|mesh-list
14961182|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961183|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961184|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14961185|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14961186|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961187|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961188|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14961189|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14961190|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
14961191|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961192|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
14961193|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961194|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14961195|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14961196|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961197|NCT01610869|Nintedanib|nintedanib|mesh-list
14961198|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961199|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14961200|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961201|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961202|NCT01610921|Adenosine|adenosine|mesh-list
14961203|NCT01610921|Analgesics|analgesics|mesh-ancestor
14961204|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
14961205|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961206|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961207|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14961208|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
14961209|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14961210|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
14961211|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
14961212|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961213|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961214|NCT01610934|Liraglutide|liraglutide|mesh-list
14961215|NCT01610934|Glimepiride|glimepiride|mesh-list
14961216|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961217|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961218|NCT01610934|Incretins|incretins|mesh-ancestor
14961219|NCT01610934|Hormones|hormones|mesh-ancestor
14961220|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961221|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14961222|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961223|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
14961224|NCT01610947|Adalimumab|adalimumab|mesh-list
14961225|NCT01610947|Etanercept|etanercept|mesh-list
14961226|NCT01610947|Golimumab|golimumab|mesh-list
14961227|NCT01610947|Infliximab|infliximab|mesh-list
14961228|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14961229|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961230|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961231|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961232|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961233|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14961234|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14961235|NCT01610947|Analgesics|analgesics|mesh-ancestor
14961236|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
14961237|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961238|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961239|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961240|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
14961241|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14961242|NCT01610999|Plerixafor|plerixafor|mesh-list
14961243|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14961244|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14961245|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
14961246|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961247|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
14961248|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14961249|NCT01611038|Protective Agents|protective agents|mesh-ancestor
14961250|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961251|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961252|NCT01611077|Amlodipine|amlodipine|mesh-list
14961253|NCT01611077|Candesartan|candesartan|mesh-list
14961254|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
14961255|NCT01611077|Olmesartan|olmesartan|mesh-list
14961256|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14961257|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14961258|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14961259|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14961260|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961261|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14961262|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961263|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
14961264|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14961265|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14961266|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
14961267|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961268|NCT01611311|BI 409306|bi 409306|mesh-list
14961269|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14961270|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961271|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028162|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15028163|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15028164|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
15028165|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028166|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15028167|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15028168|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028169|NCT01953848|Tamsulosin|tamsulosin|mesh-list
15028170|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
15028171|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15028172|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15028173|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15028174|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028175|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028176|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028177|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028178|NCT01953848|Urological Agents|urological agents|mesh-ancestor
15028179|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15028180|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15028181|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
15028182|NCT01953887|Tamsulosin|tamsulosin|mesh-list
15028183|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
15028184|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15028185|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15028186|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15028187|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028188|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028189|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028190|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028191|NCT01953887|Urological Agents|urological agents|mesh-ancestor
15028192|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15028193|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15028194|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
15028195|NCT01953952|Cisplatin|cisplatin|mesh-list
15028196|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028197|NCT01953978|Acetaminophen|acetaminophen|mesh-list
15028198|NCT01953978|Dexamethasone|dexamethasone|mesh-list
15028199|NCT01953978|Ibuprofen|ibuprofen|mesh-list
15028200|NCT01953978|Morphine|morphine|mesh-list
15028201|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15028202|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
15028203|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
15028204|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028205|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028206|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028207|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
15028208|NCT01953978|Hormones|hormones|mesh-ancestor
15028209|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961272|NCT01611324|Epinephrine|epinephrine|mesh-list
14961273|NCT01611324|Mepivacaine|mepivacaine|mesh-list
14961274|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14961275|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14961276|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
14961277|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961278|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961279|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961280|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14961281|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14961282|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
14961283|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961284|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14961285|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
14961286|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
14961287|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
14961288|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14961289|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
14961290|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
14961291|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961292|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
14961293|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
14961294|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14961295|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961296|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961297|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961298|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
14961299|NCT01611415|Furosemide|furosemide|mesh-list
14961300|NCT01611415|Diuretics|diuretics|mesh-ancestor
14961301|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
14961302|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961303|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14961304|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14961305|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961306|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14961307|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961308|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
14961309|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14961310|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961311|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961312|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961313|NCT01611480|Imiquimod|imiquimod|mesh-list
14961314|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14961315|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
14961316|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961317|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961318|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
14961319|NCT01611506|Capecitabine|capecitabine|mesh-list
14961320|NCT01611506|Cetuximab|cetuximab|mesh-list
14961321|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961322|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14961323|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
14961324|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961325|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14961326|NCT01611675|Vemurafenib|vemurafenib|mesh-list
14961327|NCT01611675|Leflunomide|leflunomide|mesh-list
14961328|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961329|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14961330|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961331|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961332|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961333|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
14961334|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961335|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14961336|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
14961337|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961338|NCT01611727|Cisplatin|cisplatin|mesh-list
14961339|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961340|NCT01611896|Selenium|selenium|mesh-list
14961341|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
14961342|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961343|NCT01611896|Protective Agents|protective agents|mesh-ancestor
14961344|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961345|NCT01611896|Trace Elements|trace elements|mesh-ancestor
14961346|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
14961347|NCT01611909|Terpin|terpin|mesh-list
14961348|NCT01611909|Expectorants|expectorants|mesh-ancestor
14961349|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
14961350|NCT01611961|Docetaxel|docetaxel|mesh-list
14961351|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961352|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
14961353|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
14961354|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
14961355|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961356|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14961357|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961358|NCT01612065|Misoprostol|misoprostol|mesh-list
14961359|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14961360|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
14961361|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961362|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961363|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14961364|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961365|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
14961366|NCT01612078|Droxidopa|droxidopa|mesh-list
14961367|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14961368|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14961369|NCT01612247|Aspirin|aspirin|mesh-list
14961370|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
14961371|NCT01612247|Methotrexate|methotrexate|mesh-list
14961372|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961373|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
14961374|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961375|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961376|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14961377|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
14961378|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961379|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961380|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14961381|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14961382|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
14961383|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961384|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14961385|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
14961386|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961387|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961388|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14961389|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14961390|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14961391|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14961392|NCT01612247|Analgesics|analgesics|mesh-ancestor
14961393|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
14961394|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961395|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961396|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14961397|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14961398|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14961399|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14961400|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
14961401|NCT01612273|Aspirin|aspirin|mesh-list
14961402|NCT01612273|Triflusal|triflusal|mesh-list
14961403|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14961404|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14961405|NCT01612273|Analgesics|analgesics|mesh-ancestor
14961406|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
14961407|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961408|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961409|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961410|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961411|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14961412|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14961413|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961414|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14961415|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14799461|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14799462|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
14799463|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799464|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14799465|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14799466|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961416|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961417|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
14961418|NCT01612286|Endostatins|endostatins|mesh-list
14961419|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14961420|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14961421|NCT01612286|Growth Substances|growth substances|mesh-ancestor
14961422|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961423|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
14961424|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961425|NCT01612299|Everolimus|everolimus|mesh-list
14961426|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961427|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961428|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
14961429|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961430|NCT01612377|Prednisone|prednisone|mesh-list
14961431|NCT01612377|Prednisolone|prednisolone|mesh-list
14961432|NCT01612377|Dipyridamole|dipyridamole|mesh-list
14961433|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961434|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
14961435|NCT01612377|Hormones|hormones|mesh-ancestor
14961436|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961437|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961438|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14961439|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961440|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14961441|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961442|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961443|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14961444|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
14961445|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
14961446|NCT01612403|Astringents|astringents|mesh-ancestor
14961447|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961448|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961449|NCT01612468|Liraglutide|liraglutide|mesh-list
14961450|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961451|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961452|NCT01612468|Incretins|incretins|mesh-ancestor
14961453|NCT01612468|Hormones|hormones|mesh-ancestor
14961454|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961455|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14961456|NCT01612507|Cephalosporins|cephalosporins|mesh-list
14961457|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14961458|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961459|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14961460|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14961461|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961462|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961463|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14961464|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
14961465|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961466|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529768|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529769|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529770|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
14529771|NCT03682367|Gabapentin|gabapentin|mesh-list
14529772|NCT03682367|Analgesics|analgesics|mesh-ancestor
14529773|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
14529774|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529775|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529776|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
14529777|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14529778|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14529779|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529780|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529781|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14799467|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
14799468|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14529782|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14961467|NCT01612741|Acarbose|acarbose|mesh-list
14961468|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14961469|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961470|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961471|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961472|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961473|NCT01612832|Pregabalin|pregabalin|mesh-list
14961474|NCT01612832|Analgesics|analgesics|mesh-ancestor
14961475|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
14961476|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961477|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961478|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
14961479|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14961480|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14961481|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961482|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14961483|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14961484|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14961485|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961486|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14961487|NCT01612871|Tamoxifen|tamoxifen|mesh-list
14961488|NCT01612871|Letrozole|letrozole|mesh-list
14961489|NCT01612871|Anastrozole|anastrozole|mesh-list
14961490|NCT01612871|Exemestane|exemestane|mesh-list
14961491|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961492|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14961493|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14961494|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961495|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961496|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14961497|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
14961498|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961499|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961500|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14961501|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14961502|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14961503|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14961504|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14961505|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14961506|NCT01612910|Protective Agents|protective agents|mesh-ancestor
14961507|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961508|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961509|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14961510|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14961511|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961512|NCT01612975|Naproxen|naproxen|mesh-list
14961513|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14961514|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14961515|NCT01612975|Analgesics|analgesics|mesh-ancestor
14961516|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
14961517|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961518|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961519|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961520|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961521|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
14961522|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14961523|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961524|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028210|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15028211|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028212|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15028213|NCT01953978|Narcotics|narcotics|mesh-ancestor
15028214|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028215|NCT01953978|Analgesics|analgesics|mesh-ancestor
15028216|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
15028217|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15028218|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15028219|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15028220|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15028221|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028222|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028223|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
15028224|NCT01954030|Bevacizumab|bevacizumab|mesh-list
14961525|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
14961526|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14961527|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14961528|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961529|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14961530|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14961531|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961532|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961533|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961534|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14961535|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
14961536|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961537|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961538|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14961539|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14961540|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14961541|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
14961542|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961543|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14961544|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961545|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961546|NCT01613079|Methotrexate|methotrexate|mesh-list
14961547|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14961548|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
14961549|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961550|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961551|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14961552|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
14961553|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961554|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961555|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961556|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961557|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14961558|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961559|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
14961560|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961561|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14961562|NCT01613092|Vancomycin|vancomycin|mesh-list
14961563|NCT01613092|Clindamycin|clindamycin|mesh-list
14961564|NCT01613092|Cefazolin|cefazolin|mesh-list
14961565|NCT01613092|Cephalexin|cephalexin|mesh-list
14961566|NCT01613092|Bacitracin|bacitracin|mesh-list
14961567|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14961568|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961569|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14961570|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961571|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961572|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14961573|NCT01613105|Acarbose|acarbose|mesh-list
14961574|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14961575|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961576|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961577|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961578|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961579|NCT01613170|Estrogens|estrogens|mesh-list
14961580|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14961581|NCT01613170|Hormones|hormones|mesh-ancestor
14961582|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961583|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961584|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
14961585|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
14961586|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961587|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
14961588|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961589|NCT01613209|Candesartan|candesartan|mesh-list
14961590|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
14961591|NCT01613209|Olmesartan|olmesartan|mesh-list
14961592|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14961593|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14961594|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14961595|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961596|NCT01613300|Ofatumumab|ofatumumab|mesh-list
14961597|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961598|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
14961599|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14961600|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14961601|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961602|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
14799469|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14799470|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
14799471|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799472|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799473|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799474|NCT00783081|Cilostazol|cilostazol|mesh-list
14799475|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14961603|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961604|NCT01613469|Leucovorin|leucovorin|mesh-list
14961605|NCT01613469|Antidotes|antidotes|mesh-ancestor
14961606|NCT01613469|Protective Agents|protective agents|mesh-ancestor
14961607|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961608|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
14961609|NCT01613469|Vitamins|vitamins|mesh-ancestor
14961610|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
14961611|NCT01613482|Trastuzumab|trastuzumab|mesh-list
14961612|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14961613|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961614|NCT01613495|Octreotide|octreotide|mesh-list
14961615|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961616|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14961617|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961618|NCT01613534|Sucralfate|sucralfate|mesh-list
14961619|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14961620|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961621|NCT01613547|Amoxicillin|amoxicillin|mesh-list
14961622|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14961623|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961624|NCT01613573|Hormones|hormones|mesh-list
14961625|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961626|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961627|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14961628|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
14961629|NCT01613664|Coagulants|coagulants|mesh-ancestor
14961630|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
14961631|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14961632|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14961633|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14961634|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
14961635|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961636|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961637|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961638|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14961639|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14961640|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14961641|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
14961642|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961643|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14961644|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14961645|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961646|NCT01613755|Metformin|metformin|mesh-list
14961647|NCT01613755|Dipyridamole|dipyridamole|mesh-list
14961648|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961649|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961650|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14961651|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961652|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961653|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14961654|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
14961655|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14961656|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14961657|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14961658|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
14961659|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961660|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14961661|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14799476|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
14799477|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799478|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799479|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14961662|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961663|NCT01613807|Insulin|insulin|mesh-list
14961664|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14961665|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
14961666|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
14961667|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
14961668|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961669|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961670|NCT01613820|Scopolamine|scopolamine|mesh-list
14961671|NCT01613820|Ketamine|ketamine|mesh-list
14961672|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14961673|NCT01613820|Analgesics|analgesics|mesh-ancestor
14961674|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
14961675|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961676|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961677|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14961678|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14961679|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
14961680|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
14961681|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961682|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14961683|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14961684|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961685|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961686|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14961687|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
14961688|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
14961689|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961690|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
14961691|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14961692|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
14961693|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14961694|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
14961695|NCT01613846|Sorafenib|sorafenib|mesh-list
14961696|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961697|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14961698|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961699|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961700|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14799480|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
14799481|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14799482|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14799483|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799484|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14799485|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
14799486|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14799487|NCT00783081|Protective Agents|protective agents|mesh-ancestor
14799488|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14961701|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961702|NCT01613963|Cyclosporine|cyclosporine|mesh-list
14961703|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
14961704|NCT01613963|Prednisolone|prednisolone|mesh-list
14961705|NCT01613963|Adalimumab|adalimumab|mesh-list
14961706|NCT01613963|Etanercept|etanercept|mesh-list
14961707|NCT01613963|Methotrexate|methotrexate|mesh-list
14961708|NCT01613963|Azathioprine|azathioprine|mesh-list
14961709|NCT01613963|Infliximab|infliximab|mesh-list
14961710|NCT01613963|Cyclosporins|cyclosporins|mesh-list
14961711|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14961712|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961713|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
14961714|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961715|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961716|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14961717|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
14961718|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961719|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14961720|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
14961721|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961722|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961723|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961724|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14961725|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14961726|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
14961727|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961728|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14961729|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14961730|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14961731|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
14961732|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14961733|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961734|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
14961735|NCT01613963|Hormones|hormones|mesh-ancestor
14961736|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961737|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14961738|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961739|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961740|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14961741|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14961742|NCT01613963|Analgesics|analgesics|mesh-ancestor
14961743|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
14961744|NCT01613976|Panobinostat|panobinostat|mesh-list
14961745|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961746|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14961747|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961748|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961749|NCT01614041|Tandospirone|tandospirone|mesh-list
14961750|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14961751|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14961752|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961753|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961754|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14961755|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14961756|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
14961757|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961758|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961759|NCT01614132|Cisplatin|cisplatin|mesh-list
14961760|NCT01614132|Vincristine|vincristine|mesh-list
14961761|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961762|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961763|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14961764|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
14961765|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
14961766|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
14961767|NCT01614197|Cytarabine|cytarabine|mesh-list
14961768|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
14961769|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14961770|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14961771|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14961772|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
14961773|NCT01614197|Methotrexate|methotrexate|mesh-list
14961774|NCT01614197|Etoposide|etoposide|mesh-list
14961775|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
14961776|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961777|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
14961778|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961779|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961780|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14961781|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
14961782|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961783|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961784|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14961785|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14961786|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
14961787|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961788|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14961789|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
14961790|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
14961791|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961792|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14961793|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14961794|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14961795|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14961796|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14961797|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
14961798|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961799|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961800|NCT01614223|Betamethasone|betamethasone|mesh-list
14961801|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961802|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
14961803|NCT01614223|Hormones|hormones|mesh-ancestor
14961804|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961805|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961806|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14961807|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
14961808|NCT01614236|Pregabalin|pregabalin|mesh-list
14961809|NCT01614236|Analgesics|analgesics|mesh-ancestor
14961810|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
14961811|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961812|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961813|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
14961814|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14961815|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14961816|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961817|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14961818|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14961819|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14961820|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961821|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14961822|NCT01614301|Pioglitazone|pioglitazone|mesh-list
14961823|NCT01614301|Sirolimus|sirolimus|mesh-list
14961824|NCT01614301|Etoricoxib|etoricoxib|mesh-list
14961825|NCT01614301|Dacarbazine|dacarbazine|mesh-list
14961826|NCT01614301|Trofosfamide|trofosfamide|mesh-list
14961827|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961828|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961829|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14961830|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961831|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14961832|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961833|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
14961834|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961835|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
14961836|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14961837|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
14961838|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961839|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14961840|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14961841|NCT01614301|Analgesics|analgesics|mesh-ancestor
14961842|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
14961843|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14961844|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14961845|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14961846|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14961847|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14961848|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961849|NCT01614366|Amlodipine|amlodipine|mesh-list
14961850|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14961851|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14961852|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14961853|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961854|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14961855|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961856|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
14961857|NCT01614405|Ritonavir|ritonavir|mesh-list
14961858|NCT01614405|Lopinavir|lopinavir|mesh-list
14961859|NCT01614405|Tenofovir|tenofovir|mesh-list
14961860|NCT01614405|Emtricitabine|emtricitabine|mesh-list
14961861|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14961862|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14961863|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14961864|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
14961865|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961866|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961867|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14961868|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14961869|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
14961870|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961871|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14961872|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14961873|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14961874|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14961875|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
14961876|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14961877|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
14961878|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14961879|NCT01614431|Expectorants|expectorants|mesh-ancestor
14961880|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
14961881|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14961882|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
14961883|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961884|NCT01614431|Protective Agents|protective agents|mesh-ancestor
14961885|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961886|NCT01614431|Antidotes|antidotes|mesh-ancestor
14961887|NCT01614496|Insulin|insulin|mesh-list
14961888|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961889|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961890|NCT01614535|Remifentanil|remifentanil|mesh-list
14961891|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14961892|NCT01614535|Narcotics|narcotics|mesh-ancestor
14961893|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961894|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961895|NCT01614535|Analgesics|analgesics|mesh-ancestor
14961896|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
14961897|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028225|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
15028226|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15028227|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028228|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15028229|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15028230|NCT01954030|Growth Substances|growth substances|mesh-ancestor
15028231|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028232|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
15028233|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15028234|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028235|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028236|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15028237|NCT01954043|Rifampin|rifampin|mesh-list
15028238|NCT01954043|Dabrafenib|dabrafenib|mesh-list
15028239|NCT01954043|Rabeprazole|rabeprazole|mesh-list
15028240|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15028241|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028242|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15028243|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961898|NCT01614665|Tacrolimus|tacrolimus|mesh-list
14961899|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14961900|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
14961901|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961902|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14961903|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961904|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961905|NCT01614938|Cisplatin|cisplatin|mesh-list
14961906|NCT01614938|Docetaxel|docetaxel|mesh-list
14961907|NCT01614938|Cetuximab|cetuximab|mesh-list
14961908|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961909|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
14961910|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
14961911|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
14961912|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961913|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14961914|NCT01614964|Lumefantrine|lumefantrine|mesh-list
14961915|NCT01614964|Artemether|artemether|mesh-list
14961916|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14961917|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
14961918|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14961919|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14961920|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799489|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14799490|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799491|NCT00783107|Cyclosporine|cyclosporine|mesh-list
14799492|NCT00783107|Cyclosporins|cyclosporins|mesh-list
14799493|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799494|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961921|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14961922|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
14961923|NCT01615042|Lenalidomide|lenalidomide|mesh-list
14961924|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
14961925|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961926|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14961927|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14961928|NCT01615042|Growth Substances|growth substances|mesh-ancestor
14961929|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
14961930|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961931|NCT01615055|Fluoxetine|fluoxetine|mesh-list
14961932|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14961933|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14961934|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14961935|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961936|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961937|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
14961938|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961939|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14961940|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
14961941|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14961942|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14961943|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14961944|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961945|NCT01615081|Insulin|insulin|mesh-list
14961946|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14961947|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961948|NCT01615107|Oxytocin|oxytocin|mesh-list
14961949|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
14961950|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961951|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961952|NCT01615185|Amisulpride|amisulpride|mesh-list
14961953|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14961954|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14961955|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14961956|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961957|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14799495|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799496|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
14961958|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14961959|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
14961960|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14961961|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799497|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799498|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
14799499|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799500|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
14799501|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799502|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14799503|NCT00783172|Gemcitabine|gemcitabine|mesh-list
14799504|NCT00783172|Mitogens|mitogens|mesh-list
14799505|NCT00783172|Enkephalin, Methionine|enkephalin, methionine|mesh-list
14799506|NCT00783172|Enkephalins|enkephalins|mesh-list
14799507|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14799508|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
14799509|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799510|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799511|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
14799512|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799513|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799514|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799515|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
14799516|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799517|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
14799518|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799519|NCT00783250|Albuterol|albuterol|mesh-list
14799520|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
14799521|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14799522|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
14799523|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799524|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799525|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14799526|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
14799527|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
14799528|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14799529|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
14799530|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799531|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799532|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
14799533|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14799534|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14799535|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14799536|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14799537|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
14799538|NCT00783380|Vaccines|vaccines|mesh-list
14799539|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
14799540|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799541|NCT00783393|Temozolomide|temozolomide|mesh-list
14961962|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14961963|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
14961964|NCT01615211|Letrozole|letrozole|mesh-list
14961965|NCT01615211|Trilostane|trilostane|mesh-list
14961966|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14961967|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14961968|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14961969|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14961970|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14961971|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14961972|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
14961973|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14961974|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961975|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14961976|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
14961977|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961978|NCT01615224|Misoprostol|misoprostol|mesh-list
14961979|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14961980|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
14961981|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14961982|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961983|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14961984|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14961985|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
14961986|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14961987|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14961988|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14961989|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14961990|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
14961991|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14799542|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14961992|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14961993|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14961994|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14961995|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14961996|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14961997|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14961998|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14961999|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14962000|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14962001|NCT01615393|Ribavirin|ribavirin|mesh-list
14962002|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
14962003|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962004|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
14962005|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962006|NCT01615445|Resveratrol|resveratrol|mesh-list
14962007|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
14962008|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962009|NCT01615445|Protective Agents|protective agents|mesh-ancestor
14962010|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962011|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962012|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14962013|NCT01615510|Tapentadol|tapentadol|mesh-list
14962014|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14962015|NCT01615510|Narcotics|narcotics|mesh-ancestor
14962016|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962017|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962018|NCT01615510|Analgesics|analgesics|mesh-ancestor
14962019|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
14962020|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962021|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14962022|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14962023|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962024|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962025|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962026|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962027|NCT01615601|Ritonavir|ritonavir|mesh-list
14962028|NCT01615601|Darunavir|darunavir|mesh-list
14962029|NCT01615601|Etravirine|etravirine|mesh-list
14962030|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14962031|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14962032|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14962033|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
14962034|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962035|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962036|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14962037|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
14962038|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962039|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14962040|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14962041|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14962042|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14962043|NCT01615614|Rilpivirine|rilpivirine|mesh-list
14962044|NCT01615614|Rifabutin|rifabutin|mesh-list
14962045|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14962046|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14962047|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962048|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962049|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
14962050|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962051|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14962052|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14962053|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14962054|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14962055|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
14962056|NCT01615627|Treprostinil|treprostinil|mesh-list
14962057|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14962058|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962059|NCT01615757|Cytarabine|cytarabine|mesh-list
14962060|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14962061|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
14962062|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962063|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962064|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
14962065|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962066|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962067|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
14962068|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962069|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14962070|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14962071|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962072|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14962073|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14962074|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962075|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962076|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
14962077|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962078|NCT01615913|Ketoconazole|ketoconazole|mesh-list
14962079|NCT01615913|Terbinafine|terbinafine|mesh-list
14962080|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
14799543|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
14799544|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962081|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962082|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14962083|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14962084|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962085|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962086|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14962087|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
14962088|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962089|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962090|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14962091|NCT01615978|Liraglutide|liraglutide|mesh-list
14962092|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962093|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962094|NCT01615978|Incretins|incretins|mesh-ancestor
14962095|NCT01615978|Hormones|hormones|mesh-ancestor
14962096|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962097|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
14962098|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14962099|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
14962100|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
14962101|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962102|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962103|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14962104|NCT01616004|Analgesics|analgesics|mesh-ancestor
14962105|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
14962106|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962107|NCT01616069|Simendan|simendan|mesh-list
14962108|NCT01616069|Epinephrine|epinephrine|mesh-list
14962109|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14962110|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14962111|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962112|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962113|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962114|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962115|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14962116|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14962117|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
14962118|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962119|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14962120|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
14962121|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
14962122|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
14962123|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14962124|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14962125|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
15034949|NCT01998217|Narcotics|narcotics|mesh-ancestor
14799545|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799546|NCT00783471|Docetaxel|docetaxel|mesh-list
14799547|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14799548|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799549|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
14799550|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
14799551|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
14799552|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799553|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14962126|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14962127|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14962128|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962129|NCT01616069|Protective Agents|protective agents|mesh-ancestor
14962130|NCT01616108|Bupivacaine|bupivacaine|mesh-list
14962131|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
14962132|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
14962133|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962134|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962135|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
14962136|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962137|NCT01616186|Everolimus|everolimus|mesh-list
14962138|NCT01616186|Sorafenib|sorafenib|mesh-list
14962139|NCT01616186|Sunitinib|sunitinib|mesh-list
14962140|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962141|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962142|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
14962143|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962144|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14962145|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962146|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962147|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14962148|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14962149|NCT01616186|Growth Substances|growth substances|mesh-ancestor
14962150|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
14962151|NCT01616225|Hormones|hormones|mesh-list
14962152|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962153|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028244|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028245|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15028246|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
15028247|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15028248|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028249|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
15028250|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15028251|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15028252|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15028253|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15028254|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15028255|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15028256|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15028257|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028258|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15028259|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
15028260|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15028261|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
15028262|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028263|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
15028264|NCT01954108|Protective Agents|protective agents|mesh-ancestor
15034950|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034951|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034952|NCT01998217|Analgesics|analgesics|mesh-ancestor
15034953|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
15034954|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034955|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15034956|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15034957|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034958|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034959|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15034960|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034961|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034962|NCT01998295|Lumefantrine|lumefantrine|mesh-list
15034963|NCT01998295|Artemether|artemether|mesh-list
15034964|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15034965|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
15034966|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15034967|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15034968|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034969|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
15034970|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15034971|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
15034972|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034973|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
14962154|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14962155|NCT01616355|Eusol|eusol|mesh-list
14962156|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
14962157|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962158|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
14962159|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
14962160|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14962161|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14962162|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962163|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962164|NCT01616381|Urological Agents|urological agents|mesh-ancestor
14962165|NCT01616407|Methylphenidate|methylphenidate|mesh-list
14962166|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14962167|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14962168|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962169|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14962170|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14962171|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962172|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962173|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
14962174|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962175|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
14962176|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962177|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
14962178|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14962179|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962180|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
14962181|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
14962182|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962183|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
14962184|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14962185|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14962186|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962187|NCT01616485|Urological Agents|urological agents|mesh-ancestor
14962188|NCT01616615|Aspirin|aspirin|mesh-list
14962189|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14962190|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14962191|NCT01616615|Analgesics|analgesics|mesh-ancestor
14962192|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
14962193|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962194|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962195|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14962196|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14962197|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14962198|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14799554|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799555|NCT00783484|Maraviroc|maraviroc|mesh-list
14799556|NCT00783484|Darunavir|darunavir|mesh-list
14799557|NCT00783484|Midazolam|midazolam|mesh-list
14799558|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14799559|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14799560|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799561|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962199|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962200|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14962201|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14962202|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962203|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
14962204|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14962205|NCT01616680|Antibodies|antibodies|mesh-list
14962206|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
14962207|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14962208|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
14962209|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
14962210|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962211|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14962212|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962213|NCT01616732|Testosterone|testosterone|mesh-list
14962214|NCT01616732|Androgens|androgens|mesh-ancestor
14962215|NCT01616732|Hormones|hormones|mesh-ancestor
14962216|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962217|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962218|NCT01616784|Insulin|insulin|mesh-list
14799562|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14962219|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14962220|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
14962221|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962222|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962223|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
14962224|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962225|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14962226|NCT01616875|Cisplatin|cisplatin|mesh-list
14962227|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962228|NCT01616888|Paclitaxel|paclitaxel|mesh-list
14962229|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14962230|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962231|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
14962232|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
14962233|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
14962234|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962235|NCT01616927|Lanreotide|lanreotide|mesh-list
14962236|NCT01616927|Somatostatin|somatostatin|mesh-list
14962237|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962238|NCT01616927|Hormones|hormones|mesh-ancestor
14962239|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962240|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962241|NCT01616966|Remifentanil|remifentanil|mesh-list
14962242|NCT01616966|Propofol|propofol|mesh-list
14962243|NCT01616966|Sevoflurane|sevoflurane|mesh-list
14962244|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14962245|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962246|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962247|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14962248|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
14962249|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
14962250|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14962251|NCT01616966|Narcotics|narcotics|mesh-ancestor
14962252|NCT01616966|Analgesics|analgesics|mesh-ancestor
14962253|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
14962254|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962255|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14962256|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14962257|NCT01616992|Bupivacaine|bupivacaine|mesh-list
14962258|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
14962259|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
14962260|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962261|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962262|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
14962263|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962264|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
14962265|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14962266|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962267|NCT01617135|Levodopa|levodopa|mesh-list
14962268|NCT01617135|Carbidopa|carbidopa|mesh-list
14962269|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14962270|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14962271|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14962272|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
14962273|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962274|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962275|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962276|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14962277|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962278|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14962279|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
14962280|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
14962281|NCT01617200|Olanzapine|olanzapine|mesh-list
14962282|NCT01617200|Asenapine|asenapine|mesh-list
14962283|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
14962284|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
14962285|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962286|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962287|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14962288|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14962289|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14962290|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962291|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962292|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14962293|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14962294|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962295|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799563|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14799564|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14799565|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14799566|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
14799567|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
14962296|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962297|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
14962298|NCT01617213|Lenalidomide|lenalidomide|mesh-list
14962299|NCT01617213|Melphalan|melphalan|mesh-list
14962300|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
14962301|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962302|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14962303|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14962304|NCT01617213|Growth Substances|growth substances|mesh-ancestor
14962305|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
14962306|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962307|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14962308|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
14962309|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962310|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14962311|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962312|NCT01617226|Azacitidine|azacitidine|mesh-list
14962313|NCT01617226|Vorinostat|vorinostat|mesh-list
14962314|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14962315|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
14962316|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962317|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962318|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962319|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14962320|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
14962321|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14962322|NCT01617317|Antibodies|antibodies|mesh-list
14962323|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
14962324|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14962325|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
14962326|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962327|NCT01617356|Lidocaine|lidocaine|mesh-list
14962328|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
14962329|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
14962330|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962331|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962332|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
14962333|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962334|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14962335|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14962336|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14962337|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962338|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962339|NCT01617538|Atorvastatin|atorvastatin|mesh-list
14962340|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14962341|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14962342|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
14962343|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962344|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14962345|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14962346|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962347|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14962348|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962349|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962350|NCT01617564|Bupivacaine|bupivacaine|mesh-list
14962351|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
14962352|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
14962353|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028265|NCT01954186|Oxytocin|oxytocin|mesh-list
14799568|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
14799569|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
14799570|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799571|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799572|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14799573|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14962354|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962355|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
14962356|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962357|NCT01617590|Methotrexate|methotrexate|mesh-list
14962358|NCT01617590|Leflunomide|leflunomide|mesh-list
14962359|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14962360|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
14962361|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14962362|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962363|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14962364|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
14962365|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962366|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962367|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
14962368|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962369|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14962370|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962371|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
14962372|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14962373|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14962374|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
14962375|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14962376|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962377|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962378|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14962379|NCT01617694|Analgesics|analgesics|mesh-ancestor
14962380|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
14962381|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962382|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14962383|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14962384|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14962385|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962386|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962387|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962388|NCT01617707|Midazolam|midazolam|mesh-list
14962389|NCT01617707|Propofol|propofol|mesh-list
14962390|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14962391|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962392|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962393|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14962394|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
14962395|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
14962396|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14962397|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14962398|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14962399|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962400|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
14962401|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
14962402|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962403|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962404|NCT01617733|Pasireotide|pasireotide|mesh-list
14962405|NCT01617733|Hormones|hormones|mesh-ancestor
14962406|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962407|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962408|NCT01617746|Bosentan|bosentan|mesh-list
14962409|NCT01617746|Ambrisentan|ambrisentan|mesh-list
14962410|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962411|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14962412|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962413|NCT01617772|Atorvastatin|atorvastatin|mesh-list
14962414|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14962415|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14962416|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
14962417|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962418|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14962419|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14962420|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962421|NCT01617798|Metolazone|metolazone|mesh-list
14962422|NCT01617798|Furosemide|furosemide|mesh-list
14962423|NCT01617798|Diuretics|diuretics|mesh-ancestor
14962424|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
14962425|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962426|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14962427|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962428|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962429|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962430|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14962431|NCT01617811|Anesthetics|anesthetics|mesh-list
14962432|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962433|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962434|NCT01617824|Linagliptin|linagliptin|mesh-list
14962435|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962436|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962437|NCT01617824|Incretins|incretins|mesh-ancestor
14962438|NCT01617824|Hormones|hormones|mesh-ancestor
14962439|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962440|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14962441|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
14962442|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962443|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962444|NCT01617928|Paclitaxel|paclitaxel|mesh-list
14962445|NCT01617928|Carboplatin|carboplatin|mesh-list
14962446|NCT01617928|Veliparib|veliparib|mesh-list
14962447|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14962448|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962449|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
14962450|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
14962451|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
14962452|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962453|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14962454|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028266|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
15028267|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028268|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028269|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
15028270|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15028271|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
15028272|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15028273|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
15028274|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028275|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028276|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
15028277|NCT01954290|Mannitol|mannitol|mesh-list
15028278|NCT01954290|Conivaptan|conivaptan|mesh-list
15028279|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15028280|NCT01954290|Diuretics|diuretics|mesh-ancestor
15028281|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
15028282|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028283|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15028284|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028285|NCT01954355|Paclitaxel|paclitaxel|mesh-list
15028286|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15028287|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028288|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
15028289|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
15028290|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
15028291|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028292|NCT01954368|Sufentanil|sufentanil|mesh-list
15028293|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15028294|NCT01954368|Narcotics|narcotics|mesh-ancestor
15028295|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028296|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028297|NCT01954368|Analgesics|analgesics|mesh-ancestor
15028298|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
15028299|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028300|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15028301|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15028302|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
15028303|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
15028304|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
15028305|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028306|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15028307|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15028308|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028309|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028310|NCT01954524|Urological Agents|urological agents|mesh-ancestor
15028311|NCT01954693|Everolimus|everolimus|mesh-list
15028312|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028313|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962455|NCT01618006|Aspirin|aspirin|mesh-list
14962456|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14962457|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14962458|NCT01618006|Analgesics|analgesics|mesh-ancestor
14962459|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
14962460|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962461|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962462|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14962463|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14962464|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14962465|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14962466|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962467|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14962468|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14962469|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962470|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
14962471|NCT01618136|Paclitaxel|paclitaxel|mesh-list
14962472|NCT01618136|Carboplatin|carboplatin|mesh-list
14962473|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14962474|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962475|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
14962476|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
14962477|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
14962478|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962479|NCT01618188|Insulin|insulin|mesh-list
14962480|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14962481|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
14962482|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
14962483|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14962484|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962485|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962486|NCT01618253|Sorafenib|sorafenib|mesh-list
14962487|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962488|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14962489|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962490|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962491|NCT01618357|Veliparib|veliparib|mesh-list
14962492|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14962493|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962494|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962495|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962496|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14962497|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962498|NCT01618396|Midazolam|midazolam|mesh-list
14962499|NCT01618396|Propofol|propofol|mesh-list
14962500|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14962501|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962502|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962503|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14962504|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
14962505|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
14962506|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14962507|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14962508|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14962509|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962510|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
14962511|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
14962512|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962513|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962514|NCT01618448|Tolvaptan|tolvaptan|mesh-list
14962515|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14962516|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962517|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
14962518|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962519|NCT01618474|Docetaxel|docetaxel|mesh-list
14962520|NCT01618474|Capecitabine|capecitabine|mesh-list
14962521|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962522|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
14962523|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
14962524|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
14962525|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962526|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14962527|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
14962528|NCT01618513|Octreotide|octreotide|mesh-list
14962529|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14962530|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14962531|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962532|NCT01618539|Propofol|propofol|mesh-list
14962533|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14962534|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962535|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962536|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14962537|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
14962538|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
14962539|NCT01618591|Azithromycin|azithromycin|mesh-list
14962540|NCT01618591|Levofloxacin|levofloxacin|mesh-list
14962541|NCT01618591|Ofloxacin|ofloxacin|mesh-list
14962542|NCT01618591|Rifaximin|rifaximin|mesh-list
14962543|NCT01618591|Loperamide|loperamide|mesh-list
14962544|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
14962545|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14962546|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962547|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14962548|NCT01618591|Renal Agents|renal agents|mesh-ancestor
14962549|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14962550|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14962551|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962552|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962553|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962554|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14962555|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14962556|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14962557|NCT01618643|Acetic Acid|acetic acid|mesh-list
14962558|NCT01618643|Retinol acetate|retinol acetate|mesh-list
14962559|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14962560|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962561|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14962562|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
14962563|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962564|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14962565|NCT01618643|Protective Agents|protective agents|mesh-ancestor
14962566|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962567|NCT01618760|Risperidone|risperidone|mesh-list
14962568|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14962569|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
14962570|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962571|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962572|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962573|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14962574|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14962575|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962576|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962577|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14962578|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
14962579|NCT01618773|Adapalene|adapalene|mesh-list
14962580|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14962581|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
14962582|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14962583|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14962584|NCT01618773|Analgesics|analgesics|mesh-ancestor
14962585|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
14962586|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962587|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962588|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14962589|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14962590|NCT01618799|Lamotrigine|lamotrigine|mesh-list
14962591|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
14962592|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14799574|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14799575|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14799576|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
14799577|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799578|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14799579|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14799580|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14799581|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
14799582|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799583|NCT00783510|Adalimumab|adalimumab|mesh-list
14799584|NCT00783510|Methotrexate|methotrexate|mesh-list
14799585|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14799586|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
14962593|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962594|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962595|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14799587|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14799588|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799589|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14799590|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
14799591|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522822|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14522823|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14522824|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
14522825|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
14522826|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522827|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962596|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962597|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14962598|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14962599|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962600|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962601|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14962602|NCT01618825|Lamotrigine|lamotrigine|mesh-list
14962603|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
14962604|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14962605|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962606|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962607|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14962608|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962609|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14962610|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14962611|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962612|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962613|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14962614|NCT01618877|Levetiracetam|levetiracetam|mesh-list
14962615|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
14962616|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
14962617|NCT01618890|Propranolol|propranolol|mesh-list
14962618|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14962619|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14962620|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962621|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962622|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962623|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962624|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14962625|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962626|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
14962627|NCT01618903|Levetiracetam|levetiracetam|mesh-list
14962628|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
14962629|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
14962630|NCT01618929|Montelukast|montelukast|mesh-list
14962631|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14962632|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
14962633|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14962634|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
14962635|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962636|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962637|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14522828|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799592|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799593|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
14799594|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799595|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14799596|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799597|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
14799598|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799599|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14799600|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799601|NCT00783523|Doxycycline|doxycycline|mesh-list
14799602|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14799603|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962638|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14962639|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962640|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
14962641|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14962642|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
14962643|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14962644|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14962645|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962646|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962647|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
14962648|NCT01619046|Factor VIII|factor viii|mesh-list
14962649|NCT01619046|Coagulants|coagulants|mesh-ancestor
14962650|NCT01619072|Misoprostol|misoprostol|mesh-list
14962651|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14962652|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
14962653|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14962654|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962655|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14962656|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14962657|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
14962658|NCT01619111|Lapatinib|lapatinib|mesh-list
14962659|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962660|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14962661|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962662|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799604|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
14799605|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14962663|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
14962664|NCT01619137|Povidone|povidone|mesh-list
14962665|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
14962666|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
14962667|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14962668|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962669|NCT01619150|Etoricoxib|etoricoxib|mesh-list
14962670|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14962671|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14962672|NCT01619150|Analgesics|analgesics|mesh-ancestor
14962673|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
14962674|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962675|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962676|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14962677|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14962678|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14962679|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14962680|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799606|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14799607|NCT00783536|Etanercept|etanercept|mesh-list
14799608|NCT00783536|Methotrexate|methotrexate|mesh-list
14799609|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14799610|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
14799611|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14799612|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799613|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14799614|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
14799615|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799616|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962681|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962682|NCT01619163|Prednisolone|prednisolone|mesh-list
14962683|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14962684|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
14962685|NCT01619163|Hormones|hormones|mesh-ancestor
14962686|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962687|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962688|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14962689|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962690|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14962691|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14962692|NCT01619176|Methotrexate|methotrexate|mesh-list
14962693|NCT01619176|Leflunomide|leflunomide|mesh-list
14962694|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14962695|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
14962696|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14962697|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962698|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14962699|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
14962700|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962701|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962702|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
14962703|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962704|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14962705|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962706|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
14962707|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14962708|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14962709|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14962710|NCT01619176|Analgesics|analgesics|mesh-ancestor
14962711|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
14962712|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962713|NCT01619280|Nitroprusside|nitroprusside|mesh-list
14962714|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962715|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
14962716|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14962717|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962718|NCT01619436|Clonidine|clonidine|mesh-list
14962719|NCT01619436|Analgesics|analgesics|mesh-ancestor
14962720|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
14962721|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962722|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962723|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962724|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
14962725|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
14962726|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14962727|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14962728|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14962729|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962730|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962731|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962732|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14962733|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
14962734|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962735|NCT01619527|Darunavir|darunavir|mesh-list
14962736|NCT01619527|Cobicistat|cobicistat|mesh-list
14962737|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14962738|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14962739|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
14962740|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962741|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962742|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14962743|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14962744|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
14962745|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962746|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14962747|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14962748|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14962749|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14962750|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14962751|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962752|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962753|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962754|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962755|NCT01619566|Analgesics|analgesics|mesh-ancestor
14962756|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
14962757|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962758|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
14962759|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962760|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
15028314|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
15028315|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028316|NCT01954732|Metformin|metformin|mesh-list
15028317|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15028318|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962761|NCT01619644|Valproic Acid|valproic acid|mesh-list
14962762|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
14962763|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962764|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962765|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
14962766|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962767|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962768|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
14962769|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14962770|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962771|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14962772|NCT01619683|Enclomiphene|enclomiphene|mesh-list
14962773|NCT01619683|Clomiphene|clomiphene|mesh-list
14962774|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
14962775|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14962776|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
14962777|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962778|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962779|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14962780|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
14962781|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14962782|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14962783|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14962784|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
14962785|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
14962786|NCT01619761|Melphalan|melphalan|mesh-list
14962787|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
14962788|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14962789|NCT01619761|Rituximab|rituximab|mesh-list
14962790|NCT01619761|Fludarabine|fludarabine|mesh-list
14962791|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
14962792|NCT01619761|Lenalidomide|lenalidomide|mesh-list
14962793|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14962794|NCT01619761|Tacrolimus|tacrolimus|mesh-list
14962795|NCT01619761|Antibodies|antibodies|mesh-list
14962796|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
14962797|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14962798|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962799|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
14962800|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962801|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799617|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
14799618|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799619|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14799620|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799621|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
14962802|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14962803|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
14962804|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962805|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962806|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14962807|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14962808|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
14962809|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14962810|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799622|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799623|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14799624|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14799625|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14799626|NCT00783536|Analgesics|analgesics|mesh-ancestor
14799627|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
14799628|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799629|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799630|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14799631|NCT00783601|Montelukast|montelukast|mesh-list
14799632|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14799633|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
14799634|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14799635|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799636|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799637|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799638|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14962811|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14962812|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14962813|NCT01619761|Growth Substances|growth substances|mesh-ancestor
14962814|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
14962815|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14962816|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14962817|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
14962818|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14962819|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962820|NCT01619813|Prednisone|prednisone|mesh-list
14962821|NCT01619813|Docetaxel|docetaxel|mesh-list
14962822|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962823|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
14962824|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
14962825|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
14962826|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962827|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14962828|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
14962829|NCT01619813|Hormones|hormones|mesh-ancestor
14962830|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962831|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962832|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14962833|NCT01619891|Vitamin D|vitamin d|mesh-list
14962834|NCT01619891|Vitamins|vitamins|mesh-ancestor
14962835|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
14962836|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962837|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14962838|NCT01620112|Lidocaine|lidocaine|mesh-list
14962839|NCT01620112|Clonidine|clonidine|mesh-list
14962840|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
14962841|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
14962842|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14962843|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962844|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
14962845|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962846|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14962847|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14962848|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14962849|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962850|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962851|NCT01620112|Analgesics|analgesics|mesh-ancestor
14962852|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962853|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
14962854|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
14962855|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14962856|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14962857|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14962858|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962859|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962860|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14962861|NCT01620229|Antibodies|antibodies|mesh-list
14962862|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
14962863|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14962864|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
14962865|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
14962866|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962867|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14962868|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962869|NCT01620268|Leflunomide|leflunomide|mesh-list
14962870|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962871|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962872|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962873|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
14962874|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962875|NCT01620307|Sirolimus|sirolimus|mesh-list
14962876|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14962877|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962878|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14962879|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14962880|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
14962881|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14962882|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
14962883|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962884|NCT01620320|Dobutamine|dobutamine|mesh-list
14962885|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14962886|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
14962887|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
14962888|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14236451|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236452|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14962889|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962890|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14962891|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14962892|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14962893|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
14962894|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14962895|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962896|NCT01620320|Protective Agents|protective agents|mesh-ancestor
14962897|NCT01620333|Insulin|insulin|mesh-list
14962898|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14962899|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
14962900|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
14962901|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14962902|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
14962903|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962904|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962905|NCT01620424|Insulin|insulin|mesh-list
14962906|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14962907|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
14962908|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
14962909|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14962910|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
14962911|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14962912|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962913|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962914|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
14962915|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
14962916|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962917|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962918|NCT01620450|Insulin|insulin|mesh-list
14962919|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14962920|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962921|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962922|NCT01620463|Liraglutide|liraglutide|mesh-list
14962923|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962924|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962925|NCT01620463|Incretins|incretins|mesh-ancestor
14962926|NCT01620463|Hormones|hormones|mesh-ancestor
14962927|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962928|NCT01620476|Liraglutide|liraglutide|mesh-list
14962929|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14962930|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962931|NCT01620476|Incretins|incretins|mesh-ancestor
14962932|NCT01620476|Hormones|hormones|mesh-ancestor
14962933|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14962934|NCT01620684|Metyrapone|metyrapone|mesh-list
14962935|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
14962936|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962937|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962938|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
14962939|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14962940|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14962941|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
14962942|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962943|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14962944|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14962945|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962946|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962947|NCT01620788|Losartan|losartan|mesh-list
14962948|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14962949|NCT01620788|Indapamide|indapamide|mesh-list
14962950|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14962951|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14962952|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14962953|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14962954|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962955|NCT01620788|Diuretics|diuretics|mesh-ancestor
14962956|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
14962957|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962958|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14962959|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962960|NCT01620814|Misoprostol|misoprostol|mesh-list
14962961|NCT01620814|Dinoprostone|dinoprostone|mesh-list
14962962|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14962963|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
14962964|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14962965|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962966|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14962967|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14962968|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
14962969|NCT01620840|Lacosamide|lacosamide|mesh-list
14962970|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
14962971|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14962972|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14962973|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14962974|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962975|NCT01620944|Ritonavir|ritonavir|mesh-list
14962976|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14962977|NCT01620944|Tenofovir|tenofovir|mesh-list
14962978|NCT01620944|Lamivudine|lamivudine|mesh-list
14962979|NCT01620944|Emtricitabine|emtricitabine|mesh-list
14962980|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14962981|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14962982|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14962983|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14962984|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14962985|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14962986|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14962987|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
14962988|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14962989|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14962990|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14962991|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14962992|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14962993|NCT01621022|Bupropion|bupropion|mesh-list
14962994|NCT01621022|Nicotine|nicotine|mesh-list
14962995|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14962996|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
14962997|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14962998|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14962999|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14963000|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14963001|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
14963002|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963003|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963004|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14963005|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
14963006|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14963007|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14963008|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14963009|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14963010|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
14963011|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14963012|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14963013|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963014|NCT01621100|Hydromorphone|hydromorphone|mesh-list
14963015|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14963016|NCT01621100|Narcotics|narcotics|mesh-ancestor
14963017|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963018|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963019|NCT01621100|Analgesics|analgesics|mesh-ancestor
14963020|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
14963021|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963022|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
14963023|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14963024|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14963025|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963026|NCT01621165|Prazosin|prazosin|mesh-list
14963027|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14963028|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14963029|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14963030|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14963031|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
14963032|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963033|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963034|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963035|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
14963036|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14963037|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
14963038|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14963039|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
14963040|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963041|NCT01621217|Cetuximab|cetuximab|mesh-list
14963042|NCT01621217|Mitomycins|mitomycins|mesh-list
14963043|NCT01621217|Mitomycin|mitomycin|mesh-list
14963044|NCT01621217|Fluorouracil|fluorouracil|mesh-list
14963045|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963046|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963047|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963048|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
14963049|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963050|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14963051|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963052|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
14963053|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14963054|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963055|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
14963056|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963057|NCT01621256|Ancrod|ancrod|mesh-list
14963058|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
14963059|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14963060|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14963061|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963062|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14963063|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14963064|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963065|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963066|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
14963067|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963068|NCT01621308|Insulin|insulin|mesh-list
14963069|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14963070|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963071|NCT01621321|Voriconazole|voriconazole|mesh-list
14963072|NCT01621321|Prednisolone|prednisolone|mesh-list
14963073|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963074|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
14963075|NCT01621321|Hormones|hormones|mesh-ancestor
14963076|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963077|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963078|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14963079|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963080|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
14963081|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963082|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14963083|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14963084|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963085|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963086|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14963087|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
14963088|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14963089|NCT01621373|Propofol|propofol|mesh-list
14963090|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14963091|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963092|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963093|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14963094|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
14963095|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
15028319|NCT01954784|Cyclosporine|cyclosporine|mesh-list
15028320|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
15028321|NCT01954784|Fludarabine|fludarabine|mesh-list
15028322|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
15028323|NCT01954784|Lenalidomide|lenalidomide|mesh-list
15028324|NCT01954784|Bortezomib|bortezomib|mesh-list
15028325|NCT01954784|Cyclosporins|cyclosporins|mesh-list
15028326|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028327|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15028328|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
15028329|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028330|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15028331|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
15028332|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028333|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028334|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
15028335|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028336|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
15028337|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15028338|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15028339|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15028340|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14799639|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14799640|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799641|NCT00783653|Sunitinib|sunitinib|mesh-list
14799642|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799643|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14799644|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14799645|NCT00783653|Growth Substances|growth substances|mesh-ancestor
14799646|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799647|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
14799648|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14799649|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028341|NCT01954784|Growth Substances|growth substances|mesh-ancestor
14799650|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799651|NCT00783731|Midazolam|midazolam|mesh-list
14963096|NCT01621386|Prednisone|prednisone|mesh-list
14963097|NCT01621386|Montelukast|montelukast|mesh-list
14963098|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963099|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
14963100|NCT01621386|Hormones|hormones|mesh-ancestor
14963101|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963102|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963103|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14963104|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963105|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14963106|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
14963107|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14963108|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
14963109|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14963110|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14963111|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963112|NCT01621451|Aspirin|aspirin|mesh-list
14963113|NCT01621451|Clopidogrel|clopidogrel|mesh-list
14963114|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14963115|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14963116|NCT01621451|Analgesics|analgesics|mesh-ancestor
14963117|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
14963118|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963119|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963120|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963121|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14963122|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14963123|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14963124|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963125|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14963126|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14963127|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963128|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
14963129|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14963130|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14963131|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14963132|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
14963133|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963134|NCT01621568|Sunitinib|sunitinib|mesh-list
14963135|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963136|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14963137|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14963138|NCT01621568|Growth Substances|growth substances|mesh-ancestor
14963139|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963140|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
14963141|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14963142|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963143|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963144|NCT01621620|Yohimbine|yohimbine|mesh-list
14963145|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
14963146|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
14963147|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963148|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963149|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14799652|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14799653|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14799654|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799655|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799656|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14799657|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14799658|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14799659|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14799660|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
14799661|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
14799662|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
14799663|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
14799664|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799665|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799666|NCT00783744|Insulin|insulin|mesh-list
14799667|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14799668|NCT00783744|Metformin|metformin|mesh-list
14799669|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
14799670|NCT00783744|Glimepiride|glimepiride|mesh-list
14799671|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
14963150|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14963151|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14963152|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
14963153|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963154|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963155|NCT01621620|Urological Agents|urological agents|mesh-ancestor
14963156|NCT01621698|Fentanyl|fentanyl|mesh-list
14963157|NCT01621698|Bupivacaine|bupivacaine|mesh-list
14963158|NCT01621698|Propofol|propofol|mesh-list
14963159|NCT01621698|Atracurium|atracurium|mesh-list
14963160|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
14963161|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
14963162|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963163|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963164|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
14963165|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963166|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14963167|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14963168|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
14963169|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14963170|NCT01621698|Narcotics|narcotics|mesh-ancestor
14963171|NCT01621698|Analgesics|analgesics|mesh-ancestor
14963172|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14963173|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14963174|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14963175|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14963176|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14963177|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14963178|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
14963179|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963180|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963181|NCT01621750|Clopidogrel|clopidogrel|mesh-list
14963182|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14963183|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14963184|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14963185|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14963186|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
14963187|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963188|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963189|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963190|NCT01621763|Clopidogrel|clopidogrel|mesh-list
14963191|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14963192|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14963193|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14799672|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
14799673|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
14799674|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14799675|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799676|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14963194|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14963195|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
14963196|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963197|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963198|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963199|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
14963200|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14963201|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14963202|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963203|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14963204|NCT01621893|Calcium|calcium|mesh-list
14963205|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14963206|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963207|NCT01621906|Alovudine|alovudine|mesh-list
14963208|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
14963209|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963210|NCT01621971|Milrinone|milrinone|mesh-list
14963211|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14963212|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14963213|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028342|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
14799677|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963214|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14963215|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14963216|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963217|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963218|NCT01621971|Protective Agents|protective agents|mesh-ancestor
14963219|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963220|NCT01622075|Paclitaxel|paclitaxel|mesh-list
14963221|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14963222|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14963223|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963224|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
14963225|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
14963226|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
14963227|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963228|NCT01622283|Cetirizine|cetirizine|mesh-list
14963229|NCT01622283|Levocetirizine|levocetirizine|mesh-list
14963230|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14963231|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14963232|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14963233|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
14963234|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
14963235|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963236|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963237|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963238|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
14963239|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14963240|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
14963241|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
14963242|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963243|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963244|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14963245|NCT01622322|Analgesics|analgesics|mesh-ancestor
14963246|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
14963247|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963248|NCT01622361|Tamoxifen|tamoxifen|mesh-list
14963249|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
14963250|NCT01622361|Docetaxel|docetaxel|mesh-list
14963251|NCT01622361|Doxorubicin|doxorubicin|mesh-list
14963252|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14963253|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963254|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
14963255|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963256|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14963257|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14963258|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
14963259|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963260|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963261|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14963262|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
14963263|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
14963264|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
14963265|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963266|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14963267|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14963268|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963269|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14963270|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
14963271|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963272|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14963273|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14963274|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14963275|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14963276|NCT01622439|Prednisone|prednisone|mesh-list
14963277|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
14963278|NCT01622439|Rituximab|rituximab|mesh-list
14963279|NCT01622439|Doxorubicin|doxorubicin|mesh-list
14963280|NCT01622439|Vincristine|vincristine|mesh-list
14963281|NCT01622439|Valproic Acid|valproic acid|mesh-list
14963282|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963283|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
14963284|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963285|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14963286|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14963287|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
14963288|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963289|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963290|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14963291|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963292|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963293|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14963294|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14963295|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963296|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963297|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
14963298|NCT01622439|Hormones|hormones|mesh-ancestor
14963299|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963300|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14963301|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14963302|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
14963303|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
14963304|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
14963305|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
14963306|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
14963307|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963308|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
14963309|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14963310|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963311|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14963312|NCT01622504|Naloxone|naloxone|mesh-list
14963313|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14963314|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963315|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
14963316|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963317|NCT01622556|Fludarabine|fludarabine|mesh-list
14963318|NCT01622556|Busulfan|busulfan|mesh-list
14963319|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
14963320|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963321|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963322|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963323|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
14963324|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963325|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
14963326|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14963327|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14963328|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14963329|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14963330|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14963331|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
14963332|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963333|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14963334|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14963335|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963336|NCT01622790|Lamivudine|lamivudine|mesh-list
14963337|NCT01622790|Abacavir|abacavir|mesh-list
14963338|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
14963339|NCT01622790|Dolutegravir|dolutegravir|mesh-list
14963340|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14963341|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14963342|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963343|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963344|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
14963345|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963346|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14963347|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14963348|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
14963349|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14963350|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14963351|NCT01622881|Nefopam|nefopam|mesh-list
14963352|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14963353|NCT01622881|Analgesics|analgesics|mesh-ancestor
14963354|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
14963355|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963356|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963357|NCT01622933|Interferons|interferons|mesh-list
14963358|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
14963359|NCT01622933|Vaccines|vaccines|mesh-list
14963360|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963361|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
14963362|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963363|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
14963364|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799678|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
14799679|NCT00783900|Metoprolol|metoprolol|mesh-list
14799680|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14799681|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14799682|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
14799683|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
14799684|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799685|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799686|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14799687|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14799688|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14799689|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
14799690|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799691|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799692|NCT00783926|Vaccines|vaccines|mesh-list
14799693|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
14799694|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
14799695|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799696|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
14799697|NCT00784017|Asparaginase|asparaginase|mesh-list
14799698|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963365|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
14963366|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14963367|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14963368|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963369|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
14963370|NCT01622946|Coagulants|coagulants|mesh-ancestor
14963371|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14963372|NCT01622972|Laxatives|laxatives|mesh-ancestor
14963373|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14963374|NCT01623024|Vitamin D|vitamin d|mesh-list
14963375|NCT01623024|Vitamins|vitamins|mesh-ancestor
14963376|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
14963377|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963378|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15028343|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15028344|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15028345|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
15028346|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15028347|NCT01954914|Plerixafor|plerixafor|mesh-list
15028348|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15028349|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15028350|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
15028351|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028352|NCT01954966|Progesterone|progesterone|mesh-list
15028353|NCT01954966|Progestins|progestins|mesh-ancestor
15028354|NCT01954966|Hormones|hormones|mesh-ancestor
15028355|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028356|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028357|NCT01954992|Fluorouracil|fluorouracil|mesh-list
15028358|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
15028359|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028360|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15028361|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028362|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15028363|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
15028364|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028365|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
15028366|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
15028367|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028368|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
15028369|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028370|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028371|NCT01955070|Ketamine|ketamine|mesh-list
15028372|NCT01955070|Analgesics|analgesics|mesh-ancestor
15028373|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
15028374|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028375|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028376|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15028377|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15028378|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
15028379|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
15028380|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028381|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14963379|NCT01623102|Gemcitabine|gemcitabine|mesh-list
14963380|NCT01623102|Bevacizumab|bevacizumab|mesh-list
14963381|NCT01623102|Cisplatin|cisplatin|mesh-list
14963382|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963383|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963384|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14963385|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14963386|NCT01623102|Growth Substances|growth substances|mesh-ancestor
14963387|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963388|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14963389|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14963390|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
14963391|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963392|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
14963393|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963394|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963395|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963396|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
14963397|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14963398|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
14963399|NCT01623206|Coagulants|coagulants|mesh-ancestor
14963400|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14963401|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
14963402|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963403|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14963404|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14963405|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963406|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14963407|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14963408|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
14963409|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
14963410|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963411|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
14963412|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963413|NCT01623349|Olaparib|olaparib|mesh-list
14963414|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14963415|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963416|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963417|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963418|NCT01623362|Fluorides|fluorides|mesh-list
14963419|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
14963420|NCT01623362|Protective Agents|protective agents|mesh-ancestor
14963421|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963422|NCT01623375|Insulin|insulin|mesh-list
14963423|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14963424|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
14963425|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14963426|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963427|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
14963428|NCT01623401|Tedizolid|tedizolid|mesh-list
14963429|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14963430|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963431|NCT01623440|Naltrexone|naltrexone|mesh-list
14963432|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14963433|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14963434|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963435|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
14963436|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963437|NCT01623505|Varenicline|varenicline|mesh-list
14963438|NCT01623505|Nicotine|nicotine|mesh-list
14963439|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14963440|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14963441|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
14963442|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963443|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963444|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963445|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14963446|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
14963447|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963448|NCT01623570|Menotropins|menotropins|mesh-list
14963449|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14963450|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
14963451|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14963452|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963453|NCT01623609|Naloxegol|naloxegol|mesh-list
14963454|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14963455|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963456|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
14963457|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963458|NCT01623635|Ropivacaine|ropivacaine|mesh-list
14963459|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
14963460|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
14963461|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963462|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963463|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
14963464|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963465|NCT01623713|Risperidone|risperidone|mesh-list
14963466|NCT01623713|Iloperidone|iloperidone|mesh-list
14963467|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14963468|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
14963469|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963470|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963471|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963472|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14963473|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14963474|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963475|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14963476|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14963477|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
14963478|NCT01623778|Interferons|interferons|mesh-list
14963479|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
14963480|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
14963481|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963482|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
14963483|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963484|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
14963485|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963486|NCT01623817|Vancomycin|vancomycin|mesh-list
14963487|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14963488|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963489|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
14963490|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14963491|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963492|NCT01623921|Celecoxib|celecoxib|mesh-list
14963493|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14963494|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14963495|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14963496|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
14963497|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963498|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14963499|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14963500|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963501|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14963502|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14963503|NCT01623921|Analgesics|analgesics|mesh-ancestor
14963504|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
14963505|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963506|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963507|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963508|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14963509|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14963510|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14963511|NCT01624025|Docetaxel|docetaxel|mesh-list
14963512|NCT01624025|Epirubicin|epirubicin|mesh-list
14963513|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963514|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
14963515|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
14963516|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
14963517|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963518|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963519|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14963520|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14963521|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963522|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
14963523|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963524|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
14963525|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963526|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963527|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14963528|NCT01624051|Cisplatin|cisplatin|mesh-list
14963529|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963530|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
14963531|NCT01624064|Enalapril|enalapril|mesh-list
14963532|NCT01624064|Calcium|calcium|mesh-list
14963533|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14963534|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14963535|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14963536|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963537|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14963538|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
14963539|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963540|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14963541|NCT01624103|Lidocaine|lidocaine|mesh-list
14963542|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
14963543|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
14963544|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
14963545|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963546|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963547|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
14963548|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963549|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14963550|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14963551|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14963552|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14963553|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963554|NCT01624116|Metformin|metformin|mesh-list
14963555|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14963556|NCT01624116|Acarbose|acarbose|mesh-list
14963557|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14963558|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963559|NCT01624116|Incretins|incretins|mesh-ancestor
14963560|NCT01624116|Hormones|hormones|mesh-ancestor
14963561|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963562|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14963563|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
14963564|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963565|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963566|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14963567|NCT01624129|Fluticasone|fluticasone|mesh-list
14963568|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963569|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14963570|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
14963571|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963572|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963573|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14963574|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
14963575|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
14963576|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14963577|NCT01624207|Atorvastatin|atorvastatin|mesh-list
14963578|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14963579|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14963580|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
14963581|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963582|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14963583|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14963584|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963585|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14963586|NCT01624246|Avibactam|avibactam|mesh-list
14963587|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14963588|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963589|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14963590|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963591|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963592|NCT01624285|Sorafenib|sorafenib|mesh-list
14963593|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963594|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14963595|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963596|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963597|NCT01624337|Piperaquine|piperaquine|mesh-list
14963598|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
14963599|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14963600|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14963601|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963602|NCT01624428|Varenicline|varenicline|mesh-list
14963603|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14963604|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14963605|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
14963606|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963607|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963608|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963609|NCT01624441|Epirubicin|epirubicin|mesh-list
14963610|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963611|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963612|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14963613|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14963614|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963615|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963616|NCT01624493|Gemcitabine|gemcitabine|mesh-list
14963617|NCT01624493|Carboplatin|carboplatin|mesh-list
14963618|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963619|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14963620|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
14963621|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963622|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
14963623|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963624|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963625|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963626|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
14963627|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963628|NCT01624649|Methylphenidate|methylphenidate|mesh-list
14963629|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14963630|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14963631|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963632|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14963633|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14963634|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14963635|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963636|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
14963637|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963638|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14963639|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14963640|NCT01624675|Risperidone|risperidone|mesh-list
14963641|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14963642|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
14963643|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963644|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963645|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963646|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14963647|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14963648|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799699|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
14799700|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799701|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
14799702|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799703|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799704|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14799705|NCT00784186|Misoprostol|misoprostol|mesh-list
14799706|NCT00784186|Mifepristone|mifepristone|mesh-list
14799707|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14799708|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
14799709|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14963649|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14963650|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14963651|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
14963652|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
14963653|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963654|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028382|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15028383|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028384|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028385|NCT01955135|Ketamine|ketamine|mesh-list
14963655|NCT01624766|Denosumab|denosumab|mesh-list
14963656|NCT01624766|Everolimus|everolimus|mesh-list
14963657|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14963658|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963659|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963660|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
14963661|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963662|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14963663|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14963664|NCT01624805|Cyclosporine|cyclosporine|mesh-list
14963665|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
14963666|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14963667|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14963668|NCT01624805|Prednisolone|prednisolone|mesh-list
14963669|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
14963670|NCT01624805|Lenograstim|lenograstim|mesh-list
14963671|NCT01624805|Cyclosporins|cyclosporins|mesh-list
14963672|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
14963673|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14963674|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14963675|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
14963676|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14963677|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
14963678|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963679|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963680|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963681|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963682|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
14963683|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963684|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
14963685|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14963686|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14963687|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963688|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
14963689|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
14963690|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963691|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14963692|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
14963693|NCT01624805|Hormones|hormones|mesh-ancestor
14963694|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963695|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14963696|NCT01624805|Protective Agents|protective agents|mesh-ancestor
14963697|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14963698|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963699|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14963700|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14963701|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14963702|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
14963703|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963704|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14963705|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14963706|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963707|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14963708|NCT01625026|Cathartics|cathartics|mesh-ancestor
14963709|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14963710|NCT01625156|Sirolimus|sirolimus|mesh-list
14963711|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14963712|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963713|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963714|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963715|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
14963716|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963717|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
14963718|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963719|NCT01625260|Gemcitabine|gemcitabine|mesh-list
14963720|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14963721|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
14963722|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963723|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963724|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
14963725|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963726|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963727|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963728|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
14963729|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963730|NCT01625351|Sirolimus|sirolimus|mesh-list
14963731|NCT01625351|Fludarabine|fludarabine|mesh-list
14963732|NCT01625351|Melphalan|melphalan|mesh-list
14963733|NCT01625351|Busulfan|busulfan|mesh-list
14963734|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
14963735|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
14963736|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963737|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963738|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963739|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
14963740|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963741|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14963742|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963743|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963744|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
14963745|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14963746|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
14963747|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14963748|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963749|NCT01625429|Paclitaxel|paclitaxel|mesh-list
14963750|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14963751|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963752|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
14963753|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
14963754|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
14963755|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963756|NCT01625494|Amlodipine|amlodipine|mesh-list
14963757|NCT01625494|Irbesartan|irbesartan|mesh-list
14963758|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14963759|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14963760|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14963761|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963762|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14963763|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963764|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
14963765|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14963766|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14963767|NCT01625520|Everolimus|everolimus|mesh-list
14963768|NCT01625520|Pasireotide|pasireotide|mesh-list
14963769|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963770|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963771|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
14963772|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963773|NCT01625520|Hormones|hormones|mesh-ancestor
14963774|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963775|NCT01625572|Morphine|morphine|mesh-list
14963776|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14963777|NCT01625572|Narcotics|narcotics|mesh-ancestor
14963778|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14963779|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963780|NCT01625572|Analgesics|analgesics|mesh-ancestor
14963781|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
14963782|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963783|NCT01625715|Ketotifen|ketotifen|mesh-list
14963784|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
14963785|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
14963786|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14963787|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
14963788|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
14963789|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963790|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963791|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963792|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14963793|NCT01625741|Rituximab|rituximab|mesh-list
14963794|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963795|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963796|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
14963797|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963798|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14963799|NCT01625793|Interferons|interferons|mesh-list
14963800|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
14963801|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963802|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
14963803|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963804|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
14963805|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963806|NCT01625806|Ketoconazole|ketoconazole|mesh-list
14963807|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
14963808|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963809|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14963810|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14963811|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963812|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963813|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14963814|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
14963815|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963816|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963817|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14963818|NCT01625871|Lumefantrine|lumefantrine|mesh-list
14963819|NCT01625871|Artemether|artemether|mesh-list
14963820|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14963821|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
14963822|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14963823|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14963824|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963825|NCT01625936|Bevacizumab|bevacizumab|mesh-list
14963826|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963827|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963828|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14963829|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14963830|NCT01625936|Growth Substances|growth substances|mesh-ancestor
14963831|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963832|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
14963833|NCT01626222|Everolimus|everolimus|mesh-list
14963834|NCT01626222|Exemestane|exemestane|mesh-list
14963835|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963836|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963837|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
14963838|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963839|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14963840|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14963841|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963842|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963843|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14963844|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
14963845|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963846|NCT01626339|Bevacizumab|bevacizumab|mesh-list
14963847|NCT01626339|Ranibizumab|ranibizumab|mesh-list
14963848|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14963849|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963850|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14963851|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14963852|NCT01626339|Growth Substances|growth substances|mesh-ancestor
14963853|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963854|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
14963855|NCT01626443|Folic Acid|folic acid|mesh-list
14963856|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
14963857|NCT01626443|Inositol|inositol|mesh-list
14963858|NCT01626443|Hematinics|hematinics|mesh-ancestor
14963859|NCT01626443|Vitamins|vitamins|mesh-ancestor
14963860|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
14963861|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963862|NCT01626469|Captopril|captopril|mesh-list
14963863|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14963864|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
14963865|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963866|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963867|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15028386|NCT01955135|Propofol|propofol|mesh-list
15028387|NCT01955135|Sevoflurane|sevoflurane|mesh-list
15028388|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15028389|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028390|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028391|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15028392|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
15028393|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
15028394|NCT01955135|Analgesics|analgesics|mesh-ancestor
15028395|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
15028396|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028397|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15028398|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14963868|NCT01626534|Clopidogrel|clopidogrel|mesh-list
14963869|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14963870|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14963871|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14963872|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14963873|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
14963874|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963875|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963876|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963877|NCT01626560|Vancomycin|vancomycin|mesh-list
14963878|NCT01626560|Daptomycin|daptomycin|mesh-list
14963879|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14963880|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963881|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
14963882|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14963883|NCT01626651|Ketoconazole|ketoconazole|mesh-list
14963884|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
14963885|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963886|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14963887|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14963888|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963889|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963890|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14963891|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
14963892|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963893|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963894|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14799710|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799711|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14799712|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14799713|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
14799714|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14799715|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14799716|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14963895|NCT01626911|Heparin|heparin|mesh-list
14963896|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14963897|NCT01626911|Tinzaparin|tinzaparin|mesh-list
14963898|NCT01626911|Dalteparin|dalteparin|mesh-list
14963899|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
14963900|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14963901|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14963902|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963903|NCT01627041|Cytarabine|cytarabine|mesh-list
14963904|NCT01627041|Decitabine|decitabine|mesh-list
14963905|NCT01627041|Daunorubicin|daunorubicin|mesh-list
14963906|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14963907|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
14963908|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963909|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963910|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
14963911|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963912|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14963913|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
14963914|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963915|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963916|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14963917|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14963918|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14963919|NCT01627106|Amiodarone|amiodarone|mesh-list
14963920|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14963921|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
14963922|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14963923|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14963924|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799717|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14963925|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14963926|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14963927|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14963928|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963929|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14963930|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14963931|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14963932|NCT01627132|Dasatinib|dasatinib|mesh-list
14963933|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14963934|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14963935|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963936|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963937|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
14963938|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14963939|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14963940|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
14963941|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963942|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963943|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963944|NCT01627145|Urological Agents|urological agents|mesh-ancestor
14963945|NCT01627158|Budesonide|budesonide|mesh-list
14963946|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
14963947|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14963948|NCT01627158|Charcoal|charcoal|mesh-list
14963949|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963950|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14963951|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
14963952|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963953|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963954|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14963955|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
14963956|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
14963957|NCT01627158|Hormones|hormones|mesh-ancestor
14963958|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963959|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14963960|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14963961|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14963962|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
14963963|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14963964|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963965|NCT01627158|Antidotes|antidotes|mesh-ancestor
14963966|NCT01627158|Protective Agents|protective agents|mesh-ancestor
14963967|NCT01627171|Bisacodyl|bisacodyl|mesh-list
14963968|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
14963969|NCT01627171|Cathartics|cathartics|mesh-ancestor
14963970|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14963971|NCT01627171|Laxatives|laxatives|mesh-ancestor
14963972|NCT01627223|Lamivudine|lamivudine|mesh-list
14963973|NCT01627223|Entecavir|entecavir|mesh-list
14963974|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14963975|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14963976|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14963977|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14963978|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
14963979|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14963980|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14963981|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14963982|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
14963983|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14963984|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14963985|NCT01627236|Prednisolone|prednisolone|mesh-list
14963986|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
14963987|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14963988|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
14963989|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14963990|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
14963991|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
14963992|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14963993|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14963994|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14963995|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
14963996|NCT01627236|Hormones|hormones|mesh-ancestor
14963997|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14963998|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14963999|NCT01627236|Protective Agents|protective agents|mesh-ancestor
14964000|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14964001|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964002|NCT01627262|Mesalamine|mesalamine|mesh-list
14964003|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14964004|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964005|NCT01627262|Analgesics|analgesics|mesh-ancestor
14964006|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
14964007|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964008|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964009|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964010|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964011|NCT01627353|Dexamethasone|dexamethasone|mesh-list
14964012|NCT01627353|Lidocaine|lidocaine|mesh-list
14964013|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
14964014|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964015|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
14964016|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
14964017|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964018|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964019|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14964020|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
14964021|NCT01627353|Hormones|hormones|mesh-ancestor
14964022|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964023|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14964024|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964025|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964026|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
14964027|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
14964028|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964029|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
14964030|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14964031|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14964032|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14964033|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964034|NCT01627353|Analgesics|analgesics|mesh-ancestor
14964035|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
14964036|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14964037|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964038|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
14964039|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14964040|NCT01627379|Panitumumab|panitumumab|mesh-list
14964041|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964042|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14964043|NCT01627431|Aspirin|aspirin|mesh-list
14964044|NCT01627431|Clopidogrel|clopidogrel|mesh-list
14964045|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14964046|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964047|NCT01627431|Analgesics|analgesics|mesh-ancestor
14964048|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
14964049|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964050|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522829|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14964051|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964052|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964053|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14964054|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14964055|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964056|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14964057|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14964058|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964059|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
14964060|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14964061|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14964062|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14964063|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
14964064|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964065|NCT01627587|Ketoconazole|ketoconazole|mesh-list
14964066|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
14964067|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964068|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14964069|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14964070|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964071|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964072|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14964073|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
14964074|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964075|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964076|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14964077|NCT01627626|Pilocarpine|pilocarpine|mesh-list
14964078|NCT01627626|Miotics|miotics|mesh-ancestor
14964079|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
14964080|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964081|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799718|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
14799719|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14799720|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14799721|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799722|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799723|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
14799724|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14799725|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14799726|NCT00784290|Orantinib|orantinib|mesh-list
14799727|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14799728|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799729|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799730|NCT00784316|Metoprolol|metoprolol|mesh-list
14799731|NCT00784316|Amiodarone|amiodarone|mesh-list
14799732|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14799733|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14799734|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
14799735|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
14799736|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799737|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799738|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14799739|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14799740|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14799741|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
14799742|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799743|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799744|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
14799745|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14799746|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14799747|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14799748|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14799749|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14799750|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799751|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14799752|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14799753|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14799754|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
14799755|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14799756|NCT00784394|Protective Agents|protective agents|mesh-ancestor
14799757|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799758|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799759|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
14799760|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14799761|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14799762|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
14799763|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799764|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14799765|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14799766|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799767|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799768|NCT00784446|Bevacizumab|bevacizumab|mesh-list
14799769|NCT00784446|Capecitabine|capecitabine|mesh-list
14799770|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
14799771|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
14799772|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14799773|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799774|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14799775|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14799776|NCT00784446|Growth Substances|growth substances|mesh-ancestor
14799777|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799778|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
14799779|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14799780|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
14799781|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799782|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14799783|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799784|NCT00784472|Morphine|morphine|mesh-list
14964082|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14964083|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14964084|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964085|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964086|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964087|NCT01627639|Acetazolamide|acetazolamide|mesh-list
14964088|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
14964089|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14964090|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964091|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964092|NCT01627639|Diuretics|diuretics|mesh-ancestor
14964093|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
14964094|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964095|NCT01627678|Molgramostim|molgramostim|mesh-list
14964096|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14964097|NCT01627678|Sargramostim|sargramostim|mesh-list
14964098|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
14964099|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964100|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964101|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14964102|NCT01627678|Antacids|antacids|mesh-ancestor
14964103|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964104|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14964105|NCT01627717|Maraviroc|maraviroc|mesh-list
14964106|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14964107|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14964108|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964109|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14964110|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14964111|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
14964112|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964113|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14964114|NCT01627834|Ropinirole|ropinirole|mesh-list
14964115|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14964116|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14964117|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
14964118|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
14964119|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964120|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964121|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964122|NCT01627847|Ropinirole|ropinirole|mesh-list
14964123|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14964124|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14964125|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
14964126|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
14964127|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964128|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964129|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964130|NCT01627873|Fentanyl|fentanyl|mesh-list
14964131|NCT01627873|Remifentanil|remifentanil|mesh-list
14964132|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14964133|NCT01627873|Narcotics|narcotics|mesh-ancestor
14964134|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964135|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964136|NCT01627873|Analgesics|analgesics|mesh-ancestor
14964137|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
14964138|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964139|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14964140|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14964141|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
14964142|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
14964143|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
14964144|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964145|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964146|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
14964147|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
14964148|NCT01627938|Razoxane|razoxane|mesh-list
14964149|NCT01627938|Analgesics|analgesics|mesh-ancestor
14964150|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
14964151|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964152|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964153|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964154|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14964155|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14964156|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964157|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522830|NCT03556761|Furosemide|furosemide|mesh-list
14522831|NCT03556761|Diuretics|diuretics|mesh-ancestor
14522832|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
14522833|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522834|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14522835|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522836|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522837|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
14522838|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14522839|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
14522840|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
14522841|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522842|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522843|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522844|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522845|NCT03557333|Analgesics|analgesics|mesh-ancestor
14522846|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
14522847|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522848|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
14522849|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522850|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522851|NCT03557931|Olanzapine|olanzapine|mesh-list
14799785|NCT00784472|Oxycodone|oxycodone|mesh-list
14799786|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14799787|NCT00784472|Narcotics|narcotics|mesh-ancestor
14799788|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799789|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799790|NCT00784472|Analgesics|analgesics|mesh-ancestor
14799791|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
14799792|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799793|NCT00784485|Omalizumab|omalizumab|mesh-list
14799794|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14799795|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14799796|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
14799797|NCT00784498|Midazolam|midazolam|mesh-list
14799798|NCT00784498|Ketamine|ketamine|mesh-list
14799799|NCT00784498|Propofol|propofol|mesh-list
14799800|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14799801|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14799802|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799803|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14799804|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
14799805|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
14799806|NCT00784498|Analgesics|analgesics|mesh-ancestor
14799807|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
14799808|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799809|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14799810|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14799811|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14799812|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14799813|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799814|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14799815|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14799816|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14799817|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14799818|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
14799819|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
14799820|NCT00784511|Vitamin D|vitamin d|mesh-list
14799821|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
14964158|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14964159|NCT01627938|Protective Agents|protective agents|mesh-ancestor
14964160|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
14964161|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
14964162|NCT01628029|Melatonin|melatonin|mesh-list
14964163|NCT01628029|Methylphenidate|methylphenidate|mesh-list
14964164|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
14964165|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964166|NCT01628029|Protective Agents|protective agents|mesh-ancestor
14964167|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964168|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964169|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14964170|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14964171|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14964172|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964173|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
14964174|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964175|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
14964176|NCT01628055|Antibodies|antibodies|mesh-list
14964177|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
14964178|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14964179|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14964180|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
14964181|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
14964182|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028399|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15028400|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028401|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028402|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15028403|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15028404|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
15028405|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15028406|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028407|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028408|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
15028409|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028410|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028411|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
15028412|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15028413|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15028414|NCT01955187|Prednisolone|prednisolone|mesh-list
15028415|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
15028416|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
15028417|NCT01955187|Rituximab|rituximab|mesh-list
15028418|NCT01955187|Tacrolimus|tacrolimus|mesh-list
15028419|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15028420|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
15028421|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15028422|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
15028423|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799822|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
14799823|NCT00784511|Vitamins|vitamins|mesh-list
14799824|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
14799825|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799826|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14799827|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14799828|NCT00784589|Rituximab|rituximab|mesh-list
15028424|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15028425|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15028426|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
15028427|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028428|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028429|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15028430|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15028431|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15028432|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028433|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15028434|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
15028435|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
15028436|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028437|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028438|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
14799829|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15028439|NCT01955187|Hormones|hormones|mesh-ancestor
15028440|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964183|NCT01628211|Leucovorin|leucovorin|mesh-list
14964184|NCT01628211|Folic Acid|folic acid|mesh-list
14964185|NCT01628211|Fluorouracil|fluorouracil|mesh-list
14964186|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
14964187|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
14964188|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
14964189|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964190|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964191|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964192|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964193|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
14964194|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964195|NCT01628211|Antidotes|antidotes|mesh-ancestor
14964196|NCT01628211|Protective Agents|protective agents|mesh-ancestor
14964197|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
14964198|NCT01628211|Vitamins|vitamins|mesh-ancestor
14964199|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
14964200|NCT01628211|Hematinics|hematinics|mesh-ancestor
14964201|NCT01628341|Insulin|insulin|mesh-list
14964202|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14964203|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964204|NCT01628354|Ranibizumab|ranibizumab|mesh-list
14964205|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14964206|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14964207|NCT01628354|Growth Substances|growth substances|mesh-ancestor
14964208|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964209|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
14964210|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964211|NCT01628445|Liraglutide|liraglutide|mesh-list
14964212|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14964213|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964214|NCT01628445|Incretins|incretins|mesh-ancestor
14964215|NCT01628445|Hormones|hormones|mesh-ancestor
14964216|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964217|NCT01628471|Decitabine|decitabine|mesh-list
14964218|NCT01628471|Genistein|genistein|mesh-list
14964219|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964220|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
14964221|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964222|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964223|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964224|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14964225|NCT01628471|Protective Agents|protective agents|mesh-ancestor
14964226|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964227|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14964228|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
14964229|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14964230|NCT01628471|Estrogens|estrogens|mesh-ancestor
14964231|NCT01628471|Hormones|hormones|mesh-ancestor
14964232|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964233|NCT01628562|Remifentanil|remifentanil|mesh-list
14964234|NCT01628562|Esmolol|esmolol|mesh-list
14964235|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14964236|NCT01628562|Narcotics|narcotics|mesh-ancestor
14964237|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964238|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964239|NCT01628562|Analgesics|analgesics|mesh-ancestor
14964240|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
14964241|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964242|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14964243|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14964244|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14964245|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
14964246|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964247|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964248|NCT01628640|Interferons|interferons|mesh-list
14964249|NCT01628640|Interferon-beta|interferon-beta|mesh-list
14964250|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964251|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
14964252|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964253|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
14964254|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964255|NCT01628666|Vancomycin|vancomycin|mesh-list
14964256|NCT01628666|Cefazolin|cefazolin|mesh-list
14964257|NCT01628666|Cephalexin|cephalexin|mesh-list
14964258|NCT01628666|Bacitracin|bacitracin|mesh-list
14964259|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14964260|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964261|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14964262|NCT01628731|Furosemide|furosemide|mesh-list
14964263|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
14964264|NCT01628731|Diuretics|diuretics|mesh-ancestor
14964265|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
14964266|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964267|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14964268|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964269|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964270|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964271|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14964272|NCT01628770|Hematinics|hematinics|mesh-ancestor
14964273|NCT01628783|Citalopram|citalopram|mesh-list
14964274|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14964275|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14964276|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964277|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964278|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964279|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
14964280|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964281|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14964282|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
14964283|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14964284|NCT01628952|Curare|curare|mesh-list
14964285|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14964286|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14964287|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14964288|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964289|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964290|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14964291|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14964292|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964293|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964294|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964295|NCT01629082|Lenalidomide|lenalidomide|mesh-list
14964296|NCT01629082|Clofarabine|clofarabine|mesh-list
14964297|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
14964298|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964299|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14964300|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14964301|NCT01629082|Growth Substances|growth substances|mesh-ancestor
14964302|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
14964303|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964304|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964305|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
14964306|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964307|NCT01629173|Ethylene|ethylene|mesh-list
14964308|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14964309|NCT01629173|Growth Substances|growth substances|mesh-ancestor
14964310|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964311|NCT01629199|Mitogens|mitogens|mesh-list
14964312|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14964313|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964314|NCT01629212|Octylonium|octylonium|mesh-list
14964315|NCT01629212|Bromides|bromides|mesh-list
14964316|NCT01629212|Tiropramide|tiropramide|mesh-list
14964317|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
14964318|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
14964319|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
14964320|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964321|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964322|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14964323|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964324|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964325|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964326|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14964327|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14964328|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14964329|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964330|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964331|NCT01629225|Candesartan|candesartan|mesh-list
14964332|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14964333|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14964334|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14964335|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964336|NCT01629251|Insulin|insulin|mesh-list
14964337|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14964338|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964339|NCT01629277|Insulin|insulin|mesh-list
14964340|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14964341|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964342|NCT01629368|Carbamazepine|carbamazepine|mesh-list
14964343|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
14964344|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
14964345|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14964346|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964347|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964348|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14964349|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964350|NCT01629368|Analgesics|analgesics|mesh-ancestor
14964351|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
14964352|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964353|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14964354|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964355|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964356|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14964357|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14964358|NCT01629394|Neostigmine|neostigmine|mesh-list
14964359|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14964360|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964361|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964362|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964363|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964364|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964365|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14964366|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
14964367|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964368|NCT01629446|Lofexidine|lofexidine|mesh-list
14964369|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14964370|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14964371|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964372|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
14964373|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964374|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14964375|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14964376|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14964377|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
14964378|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964379|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964380|NCT01629511|Gemcitabine|gemcitabine|mesh-list
14964381|NCT01629511|Methotrexate|methotrexate|mesh-list
14964382|NCT01629511|Clofarabine|clofarabine|mesh-list
14964383|NCT01629511|Busulfan|busulfan|mesh-list
14964384|NCT01629511|Tacrolimus|tacrolimus|mesh-list
14964385|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
14964386|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14964387|NCT01629511|Lenograstim|lenograstim|mesh-list
14964388|NCT01629511|Sargramostim|sargramostim|mesh-list
14964389|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964390|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
14964391|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964392|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964393|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
14964394|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964395|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964396|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964397|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
14964398|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964399|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14964400|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
14964401|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14964402|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
14964403|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14964404|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964405|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14964406|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14964407|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14964408|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
14964409|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14964410|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14964411|NCT01629628|Adalimumab|adalimumab|mesh-list
14964412|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
14964413|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964414|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964415|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
14964416|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964417|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964418|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964419|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964420|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
14964421|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964422|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14964423|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964424|NCT01629680|Moxaverine|moxaverine|mesh-list
14964425|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
14964426|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
14964427|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964428|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964429|NCT01629732|Ribavirin|ribavirin|mesh-list
14964430|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
14964431|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964432|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
14964433|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964434|NCT01629758|Nivolumab|nivolumab|mesh-list
14964435|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14964436|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964437|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14964438|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964439|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14964440|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14964441|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14964442|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964443|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964444|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14964445|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964446|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964447|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964448|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028441|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15028442|NCT01955187|Protective Agents|protective agents|mesh-ancestor
15028443|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15028444|NCT01955200|Cilostazol|cilostazol|mesh-list
15028445|NCT01955200|Clopidogrel|clopidogrel|mesh-list
15028446|NCT01955200|Ticagrelor|ticagrelor|mesh-list
15028447|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15028448|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15028449|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15028450|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15028451|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
15028452|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028453|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028454|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028455|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15028456|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
15028457|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028458|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15028459|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
15028460|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15028461|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15028462|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028463|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15028464|NCT01955200|Protective Agents|protective agents|mesh-ancestor
15034974|NCT01998308|Protective Agents|protective agents|mesh-ancestor
14964449|NCT01630018|Topotecan|topotecan|mesh-list
14964450|NCT01630018|Belotecan|belotecan|mesh-list
14964451|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14964452|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14964453|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964454|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964455|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964456|NCT01630057|Zonisamide|zonisamide|mesh-list
14964457|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
14964458|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14964459|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964460|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964461|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964462|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964463|NCT01630070|Paclitaxel|paclitaxel|mesh-list
14964464|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14964465|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964466|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
14964467|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
14964468|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14964469|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964470|NCT01630083|Capecitabine|capecitabine|mesh-list
14964471|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
14964472|NCT01630083|Epirubicin|epirubicin|mesh-list
14964473|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964474|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
14964475|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964476|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964477|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14964478|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14964479|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14964480|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964481|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14964482|NCT01630096|Laxatives|laxatives|mesh-ancestor
14964483|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14964484|NCT01630148|Bemiparin|bemiparin|mesh-list
14964485|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
14964486|NCT01630187|Carbetocin|carbetocin|mesh-list
14964487|NCT01630187|Oxytocin|oxytocin|mesh-list
14964488|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
14964489|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14964490|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964491|NCT01630226|Cisplatin|cisplatin|mesh-list
14964492|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964493|NCT01630278|Ibuprofen|ibuprofen|mesh-list
14964494|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14964495|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964496|NCT01630278|Analgesics|analgesics|mesh-ancestor
14964497|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
14964498|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964499|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964500|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964501|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964502|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14964503|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964504|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964505|NCT01630343|Acetaminophen|acetaminophen|mesh-list
14964506|NCT01630343|Tramadol|tramadol|mesh-list
14964507|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964508|NCT01630343|Analgesics|analgesics|mesh-ancestor
14964509|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
14964510|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964511|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964512|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
14964513|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14964514|NCT01630343|Narcotics|narcotics|mesh-ancestor
14964515|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964516|NCT01630369|Insulin|insulin|mesh-list
14964517|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14964518|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14964519|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964520|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
14964521|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964522|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
14964523|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964524|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964525|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14964526|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
14799830|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799831|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
14799832|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799833|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799834|NCT00784667|Cetuximab|cetuximab|mesh-list
14799835|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14799836|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14799837|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799838|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14799839|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799840|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799841|NCT00784680|Tamoxifen|tamoxifen|mesh-list
14799842|NCT00784680|Anastrozole|anastrozole|mesh-list
14799843|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14799844|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
14964527|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964528|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964529|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14964530|NCT01630564|Aldesleukin|aldesleukin|mesh-list
14964531|NCT01630564|Interleukin-2|interleukin-2|mesh-list
14964532|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964533|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964534|NCT01630564|Analgesics|analgesics|mesh-ancestor
14964535|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
14964536|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964537|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964538|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14964539|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14964540|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
14964541|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964542|NCT01630642|Clopidogrel|clopidogrel|mesh-list
14964543|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14964544|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14964545|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14964546|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14964547|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
14964548|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964549|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964550|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964551|NCT01630655|Felodipine|felodipine|mesh-list
14964552|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14964553|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14964554|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14964555|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964556|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964557|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964558|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964559|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
14964560|NCT01630720|Vitamin D|vitamin d|mesh-list
14964561|NCT01630720|Vitamins|vitamins|mesh-list
14964562|NCT01630720|Ascorbic Acid|ascorbic acid|mesh-list
14964563|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
14964564|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964565|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964566|NCT01630720|Antioxidants|antioxidants|mesh-ancestor
14964567|NCT01630720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964568|NCT01630720|Protective Agents|protective agents|mesh-ancestor
14964569|NCT01630733|Docetaxel|docetaxel|mesh-list
14964570|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964571|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
14964572|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
14964573|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
14964574|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964575|NCT01630902|Felodipine|felodipine|mesh-list
14964576|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14964577|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14964578|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14964579|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964580|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964581|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964582|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964583|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
14964584|NCT01630915|Clopidogrel|clopidogrel|mesh-list
14964585|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14964586|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14964587|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14964588|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14964589|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
14964590|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964591|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964592|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964593|NCT01630941|Denosumab|denosumab|mesh-list
14964594|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964595|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964596|NCT01631058|Prednisone|prednisone|mesh-list
14964597|NCT01631058|Everolimus|everolimus|mesh-list
14964598|NCT01631058|Lactitol|lactitol|mesh-list
14964599|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964600|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
14964601|NCT01631058|Hormones|hormones|mesh-ancestor
14964602|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964603|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964604|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14964605|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964606|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964607|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
14964608|NCT01631058|Cathartics|cathartics|mesh-ancestor
14964609|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14964610|NCT01631136|Gemcitabine|gemcitabine|mesh-list
14964611|NCT01631136|Cisplatin|cisplatin|mesh-list
14964612|NCT01631136|Pemetrexed|pemetrexed|mesh-list
14964613|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964614|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964615|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
14964616|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964617|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
14964618|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964619|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964620|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964621|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
14964622|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964623|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14964624|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14964625|NCT01631201|Azithromycin|azithromycin|mesh-list
14964626|NCT01631201|KRM 1648|krm 1648|mesh-list
14964627|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14964628|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964629|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14964630|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
14964631|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
14964632|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
14964633|NCT01631305|Calcium|calcium|mesh-list
14964634|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964635|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964636|NCT01631305|Antacids|antacids|mesh-ancestor
14964637|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964638|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14964639|NCT01631357|Gemcitabine|gemcitabine|mesh-list
14964640|NCT01631357|Cisplatin|cisplatin|mesh-list
14964641|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964642|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964643|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
15034975|NCT01998347|Paclitaxel|paclitaxel|mesh-list
14964644|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964645|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
14964646|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964647|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964648|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964649|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
14964650|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964651|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
14964652|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14964653|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14964654|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14964655|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964656|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964657|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964658|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964659|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14964660|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14964661|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964662|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14964663|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14964664|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
14964665|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964666|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
14964667|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964668|NCT01631383|Analgesics|analgesics|mesh-ancestor
14964669|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
14964670|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964671|NCT01631396|Neostigmine|neostigmine|mesh-list
14964672|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14964673|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964674|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964675|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964676|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964677|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964678|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14964679|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
14964680|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964681|NCT01631409|Aspirin|aspirin|mesh-list
14964682|NCT01631409|Atenolol|atenolol|mesh-list
14964683|NCT01631409|Enalapril|enalapril|mesh-list
14964684|NCT01631409|Enalaprilat|enalaprilat|mesh-list
14964685|NCT01631409|Amlodipine|amlodipine|mesh-list
14964686|NCT01631409|Isosorbide|isosorbide|mesh-list
14964687|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14964688|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14964689|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
14964690|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14964691|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964692|NCT01631409|Analgesics|analgesics|mesh-ancestor
14964693|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
14964694|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964695|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964696|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964697|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964698|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14964699|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14964700|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964701|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14964702|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14964703|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964704|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
14964705|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14964706|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
14964707|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14964708|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14964709|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
14964710|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
14964711|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14964712|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14964713|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14964714|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
14964715|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964716|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14964717|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034976|NCT01998347|Fluorouracil|fluorouracil|mesh-list
14964718|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964719|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
14964720|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14964721|NCT01631409|Diuretics|diuretics|mesh-ancestor
14964722|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
14964723|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14964724|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14964725|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
14964726|NCT01631448|Coagulants|coagulants|mesh-ancestor
14964727|NCT01631513|Tapentadol|tapentadol|mesh-list
14964728|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14964729|NCT01631513|Narcotics|narcotics|mesh-ancestor
14964730|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14964731|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964732|NCT01631513|Analgesics|analgesics|mesh-ancestor
14964733|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
14964734|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964735|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14964736|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14964737|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964738|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964739|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
14964740|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964741|NCT01631526|Vitamin D|vitamin d|mesh-list
14964742|NCT01631526|Vitamins|vitamins|mesh-ancestor
14964743|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
14964744|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964745|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964746|NCT01631539|Irinotecan|irinotecan|mesh-list
14964747|NCT01631539|Cetuximab|cetuximab|mesh-list
14964748|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14964749|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14964750|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964751|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964752|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964753|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15028465|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15028466|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15028467|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028468|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
15028469|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15028470|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028471|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
15028472|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028473|NCT01955252|Azithromycin|azithromycin|mesh-list
15028474|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15028475|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028476|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
15028477|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15028478|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028479|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
15028480|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
15028481|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
15028482|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028483|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028484|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028485|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15028486|NCT01955421|Gefitinib|gefitinib|mesh-list
15028487|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028488|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15028489|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028490|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028491|NCT01955460|Aldesleukin|aldesleukin|mesh-list
15028492|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
14236453|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14236454|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236455|NCT00114517|Estradiol|estradiol|mesh-list
14236456|NCT00114517|Estrogens|estrogens|mesh-list
14236457|NCT00114517|Hormones|hormones|mesh-ancestor
14236458|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14236459|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236460|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
14236461|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236462|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
15028493|NCT01955460|Fludarabine|fludarabine|mesh-list
15028494|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
14236463|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236464|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236465|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14964754|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
14964755|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14964756|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14964757|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964758|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964759|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964760|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964761|NCT01631669|Celecoxib|celecoxib|mesh-list
14964762|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14964763|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14964764|NCT01631669|Analgesics|analgesics|mesh-ancestor
14964765|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
15028495|NCT01955460|Interleukin-2|interleukin-2|mesh-list
14964766|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964767|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964768|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964769|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14964770|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14964771|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14964772|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964773|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964774|NCT01631838|Tocotrienols|tocotrienols|mesh-list
14964775|NCT01631838|Vitamin E|vitamin e|mesh-list
14964776|NCT01631838|Tocopherols|tocopherols|mesh-list
14964777|NCT01631838|Tocovid|tocovid|mesh-list
14964778|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
14964779|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964780|NCT01631838|Protective Agents|protective agents|mesh-ancestor
14964781|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964782|NCT01631838|Vitamins|vitamins|mesh-ancestor
14964783|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
14964784|NCT01631877|Enoxaparin|enoxaparin|mesh-list
14964785|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
14964786|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
14964787|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14964788|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14964789|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964790|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14964791|NCT01631968|Colistin|colistin|mesh-list
14964792|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964793|NCT01631994|Metoclopramide|metoclopramide|mesh-list
14964794|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
14964795|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
14964796|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964797|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964798|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14964799|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14964800|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14964801|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
14964802|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964803|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964804|NCT01632007|Alogliptin|alogliptin|mesh-list
14964805|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14964806|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964807|NCT01632007|Incretins|incretins|mesh-ancestor
14964808|NCT01632007|Hormones|hormones|mesh-ancestor
14964809|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964810|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14964811|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
14964812|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964813|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964814|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
14964815|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14964816|NCT01632163|Lixisenatide|lixisenatide|mesh-list
14964817|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14964818|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964819|NCT01632189|Varenicline|varenicline|mesh-list
14964820|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14964821|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14964822|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964823|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964824|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964825|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964826|NCT01632371|Paclitaxel|paclitaxel|mesh-list
14964827|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14964828|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14964829|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964830|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
14964831|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
14964832|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
14964833|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964834|NCT01632436|Pixantrone|pixantrone|mesh-list
14964835|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14964836|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14964837|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964838|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236466|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
14964839|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964840|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
14964841|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964842|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964843|NCT01632514|Vitamins|vitamins|mesh-ancestor
14964844|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
14964845|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964846|NCT01632540|Beclomethasone|beclomethasone|mesh-list
14964847|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14964848|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
14964849|NCT01632540|Hormones|hormones|mesh-ancestor
14964850|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964851|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964852|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14964853|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
14964854|NCT01632592|Tesamorelin|tesamorelin|mesh-list
14964855|NCT01632592|Growth Substances|growth substances|mesh-ancestor
14964856|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964857|NCT01632605|Sirolimus|sirolimus|mesh-list
14964858|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14964859|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964860|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14964861|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964862|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
14964863|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964864|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
14964865|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964866|NCT01632657|Sumatriptan|sumatriptan|mesh-list
14964867|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14964868|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14964869|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14964870|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
14964871|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964872|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964873|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964874|NCT01632722|Bevacizumab|bevacizumab|mesh-list
14964875|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14964876|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964877|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14964878|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14964879|NCT01632722|Growth Substances|growth substances|mesh-ancestor
14964880|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964881|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
14964882|NCT01632761|Vitamin D|vitamin d|mesh-list
14964883|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
14964884|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
14964885|NCT01632761|Vitamins|vitamins|mesh-list
14964886|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
14964887|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964888|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964889|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964890|NCT01632826|Pomalidomide|pomalidomide|mesh-list
14964891|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
14964892|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964893|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14964894|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14964895|NCT01632826|Growth Substances|growth substances|mesh-ancestor
14964896|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14964897|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964898|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
14964899|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14964900|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
14964901|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14964902|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964903|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14964904|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
14964905|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14964906|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
14964907|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964908|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964909|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14964910|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
14964911|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
14964912|NCT01633086|Protective Agents|protective agents|mesh-ancestor
14964913|NCT01633099|Decitabine|decitabine|mesh-list
14964914|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964915|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
14799845|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799846|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799847|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14799848|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799849|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14799850|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14799851|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14799852|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14799853|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14799854|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799855|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799856|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
14799857|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799858|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
14799859|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14799860|NCT00784745|Dexamethasone|dexamethasone|mesh-list
14799861|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14799862|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
14799863|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
14799864|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799865|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799866|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14799867|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
14799868|NCT00784745|Hormones|hormones|mesh-ancestor
14799869|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799870|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14799871|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799872|NCT00784797|Oxytocin|oxytocin|mesh-list
14799873|NCT00784797|Mifepristone|mifepristone|mesh-list
14799874|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
14799875|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14799876|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799877|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14799878|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
14799879|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14799880|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14799881|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14799882|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
14799883|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14799884|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14799885|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799886|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799887|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
14799888|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14799889|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14799890|NCT00784823|Bortezomib|bortezomib|mesh-list
14799891|NCT00784823|Melphalan|melphalan|mesh-list
14799892|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799893|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14799894|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
14799895|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799896|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14799897|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799898|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
14799899|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799900|NCT00784862|Tamoxifen|tamoxifen|mesh-list
14799901|NCT00784862|Anastrozole|anastrozole|mesh-list
14799902|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14799903|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799904|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799905|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799906|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14799907|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799908|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14799909|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14799910|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14799911|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14799912|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14799913|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964916|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964917|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964918|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964919|NCT01633177|Vitamin D|vitamin d|mesh-list
14964920|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
14964921|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
14964922|NCT01633177|Vitamins|vitamins|mesh-list
14964923|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
14964924|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799914|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799915|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14799916|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14799917|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799918|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799919|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14799920|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799921|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799922|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799923|NCT00784914|Sirolimus|sirolimus|mesh-list
14799924|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14799925|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799926|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14799927|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799928|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
14964925|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964926|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964927|NCT01633203|Capecitabine|capecitabine|mesh-list
14964928|NCT01633203|Epirubicin|epirubicin|mesh-list
14964929|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964930|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964931|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
14964932|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799929|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799930|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
14799931|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799932|NCT00784940|Tamoxifen|tamoxifen|mesh-list
14799933|NCT00784940|Anastrozole|anastrozole|mesh-list
14799934|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14799935|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
14799936|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14799937|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799938|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14964933|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14964934|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14964935|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14964936|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964937|NCT01633294|Gentamicins|gentamicins|mesh-list
14964938|NCT01633294|Ampicillin|ampicillin|mesh-list
14964939|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14964940|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964941|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14964942|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964943|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964944|NCT01633359|Atorvastatin|atorvastatin|mesh-list
14964945|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14964946|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14964947|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14964948|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
14964949|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964950|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14964951|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028496|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15028497|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
15028498|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028499|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15028500|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15028501|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
15028502|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028503|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028504|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15028505|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15028506|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
15028507|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15028508|NCT01955460|Analgesics|analgesics|mesh-ancestor
15028509|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
15028510|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028511|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15028512|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15028513|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
15028514|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028515|NCT01955512|Clopidogrel|clopidogrel|mesh-list
15028516|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15028517|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15028518|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15028519|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15028520|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
15028521|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028522|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028523|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028524|NCT01955577|Vitamin D|vitamin d|mesh-list
15028525|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
15028526|NCT01955577|Vitamins|vitamins|mesh-ancestor
15028527|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
15028528|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028529|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15028530|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15028531|NCT01955642|Clopidogrel|clopidogrel|mesh-list
15028532|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15028533|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15028534|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15028535|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15028536|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
15028537|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028538|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028539|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028540|NCT01955655|Baclofen|baclofen|mesh-list
15028541|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15028542|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028543|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15028544|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028545|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15028546|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
15028547|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
15028548|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028549|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028550|NCT01955694|Eplerenone|eplerenone|mesh-list
15028551|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15028552|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
15028553|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14964952|NCT01633450|Zinc|zinc|mesh-list
14964953|NCT01633450|Trace Elements|trace elements|mesh-ancestor
14964954|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
14964955|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964956|NCT01633476|Valacyclovir|valacyclovir|mesh-list
14964957|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
14964958|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964959|NCT01633593|Donepezil|donepezil|mesh-list
14964960|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14964961|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964962|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964963|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
14964964|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14964965|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964966|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
14964967|NCT01633645|Gemcitabine|gemcitabine|mesh-list
14964968|NCT01633645|Bortezomib|bortezomib|mesh-list
14964969|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14964970|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14964971|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
14964972|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964973|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
14964974|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964975|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964976|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14964977|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
14964978|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964979|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
14964980|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14964981|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964982|NCT01633658|Vitamins|vitamins|mesh-ancestor
14964983|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
14964984|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14964985|NCT01633749|Vaccines|vaccines|mesh-list
14964986|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
14964987|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14964988|NCT01633762|Vancomycin|vancomycin|mesh-list
14964989|NCT01633762|Gentamicins|gentamicins|mesh-list
14964990|NCT01633762|Meropenem|meropenem|mesh-list
14964991|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14964992|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14964993|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14964994|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14964995|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14964996|NCT01633957|Warfarin|warfarin|mesh-list
14964997|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
14964998|NCT01633970|Leucovorin|leucovorin|mesh-list
14964999|NCT01633970|Paclitaxel|paclitaxel|mesh-list
14965000|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14965001|NCT01633970|Bevacizumab|bevacizumab|mesh-list
14965002|NCT01633970|Carboplatin|carboplatin|mesh-list
14965003|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
14965004|NCT01633970|Pemetrexed|pemetrexed|mesh-list
14965005|NCT01633970|Atezolizumab|atezolizumab|mesh-list
14965006|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14965007|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965008|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
14965009|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
14965010|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
14965011|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965012|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14965013|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14965014|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14965015|NCT01633970|Growth Substances|growth substances|mesh-ancestor
14965016|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965017|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
14965018|NCT01633970|Antidotes|antidotes|mesh-ancestor
14965019|NCT01633970|Protective Agents|protective agents|mesh-ancestor
14965020|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
14965021|NCT01633970|Vitamins|vitamins|mesh-ancestor
14965022|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
14965023|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965024|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14965025|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965026|NCT01633983|Methotrexate|methotrexate|mesh-list
14965027|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14965028|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
14965029|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14965030|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965031|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14965032|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
14965033|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965034|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965035|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
14965036|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965037|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14965038|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965039|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
14965040|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14965041|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965042|NCT01634061|Dactolisib|dactolisib|mesh-list
14965043|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965044|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
14965045|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14965046|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
14965047|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965048|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965049|NCT01634295|Niacin|niacin|mesh-list
14965050|NCT01634295|Amlodipine|amlodipine|mesh-list
14965051|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14965052|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14965053|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14965054|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965055|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14965056|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965057|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
14965058|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14965059|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
14965060|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14965061|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
14965062|NCT01634295|Vitamins|vitamins|mesh-ancestor
14965063|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
14965064|NCT01634321|Leuprolide|leuprolide|mesh-list
14799939|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799940|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14799941|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14799942|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14799943|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14799944|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14799945|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14799946|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799947|NCT00784966|Etanercept|etanercept|mesh-list
14799948|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14799949|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965065|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14965066|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
14965067|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14965068|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965069|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14965070|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965071|NCT01634347|Propranolol|propranolol|mesh-list
14965072|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14965073|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14965074|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
14965075|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965076|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965077|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965078|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14965079|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14965080|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
14965081|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14965082|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
14965083|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965084|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14965085|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14965086|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965087|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965088|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14965089|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
14965090|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965091|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14965092|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14799950|NCT00784966|Analgesics|analgesics|mesh-ancestor
14799951|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
14799952|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14799953|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799954|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965093|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965094|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965095|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14965096|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
14965097|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965098|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14965099|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14965100|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965101|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965102|NCT01634412|Amitriptyline|amitriptyline|mesh-list
14965103|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
14965104|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14965105|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
14965106|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965107|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14965108|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965109|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14965110|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965111|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14965112|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965113|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965114|NCT01634412|Analgesics|analgesics|mesh-ancestor
14965115|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
14965116|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14965117|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14965118|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14965119|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799955|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799956|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14799957|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799958|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
14799959|NCT00785018|Complement C1s|complement c1s|mesh-list
14965120|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
14965121|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965122|NCT01634438|Heparin|heparin|mesh-list
14799960|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14799961|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14799962|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
14965123|NCT01634438|Calcium heparin|calcium heparin|mesh-list
14799963|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965124|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
14965125|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14965126|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14965127|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965128|NCT01634594|Nicardipine|nicardipine|mesh-list
14965129|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
14965130|NCT01634594|Remifentanil|remifentanil|mesh-list
14965131|NCT01634594|Sevoflurane|sevoflurane|mesh-list
14965132|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14965133|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965134|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965135|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965136|NCT01634594|Analgesics|analgesics|mesh-ancestor
14965137|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
14965138|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965139|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14965140|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14965141|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14965142|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
14965143|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965144|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965145|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14965146|NCT01634594|Narcotics|narcotics|mesh-ancestor
14965147|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14965148|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14965149|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
14965150|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
14965151|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14965152|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14965153|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14965154|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14965155|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
14965156|NCT01634685|Capecitabine|capecitabine|mesh-list
14965157|NCT01634685|Bavituximab|bavituximab|mesh-list
14965158|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14965159|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
14965160|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965161|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965162|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14965163|NCT01634698|Vitamin A|vitamin a|mesh-list
14965164|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
14965165|NCT01634698|Vitamins|vitamins|mesh-ancestor
14965166|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
14965167|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965168|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
14965169|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965170|NCT01634698|Protective Agents|protective agents|mesh-ancestor
14965171|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14965172|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965173|NCT01634763|Ceritinib|ceritinib|mesh-list
14965174|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965175|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14965176|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965177|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965178|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
14965179|NCT01634789|Estrogens|estrogens|mesh-list
14965180|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14965181|NCT01634789|Hormones|hormones|mesh-ancestor
14965182|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14965183|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965184|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14965185|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14965186|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
14965187|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14965188|NCT01634880|Panitumumab|panitumumab|mesh-list
14965189|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14965190|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965191|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
14965192|NCT01634893|Sorafenib|sorafenib|mesh-list
14965193|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965194|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14965195|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965196|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965197|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
14965198|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14965199|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14965200|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965201|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14965202|NCT01634906|Atorvastatin|atorvastatin|mesh-list
14965203|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14965204|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14965205|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14965206|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
14965207|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965208|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14965209|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14965210|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965211|NCT01634932|Iron|iron|mesh-list
14965212|NCT01634932|Trace Elements|trace elements|mesh-ancestor
14965213|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
14965214|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965215|NCT01634945|Amodiaquine|amodiaquine|mesh-list
14965216|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
14965217|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14965218|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14965219|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965220|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14965221|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14965222|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
14965223|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965224|NCT01634958|Antacids|antacids|mesh-ancestor
14965225|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965226|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028554|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028555|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15028556|NCT01955694|Diuretics|diuretics|mesh-ancestor
15028557|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
15028558|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15028559|NCT01955759|Amiodarone|amiodarone|mesh-list
15028560|NCT01955759|Bisoprolol|bisoprolol|mesh-list
15028561|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15028562|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15028563|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15028564|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15028565|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
15028566|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028567|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15028568|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15028569|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028570|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15028571|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028572|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15028573|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028574|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15028575|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15028576|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15028577|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15028578|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15028579|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15028580|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15028581|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028582|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028583|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028584|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15028585|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
15028586|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
15028587|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028588|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15028589|NCT01955824|Lidocaine|lidocaine|mesh-list
15028590|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
15028591|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
15028592|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028593|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028594|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
15028595|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028596|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15028597|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14799964|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14799965|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799966|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14799967|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14799968|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799969|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799970|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
14799971|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799972|NCT00785109|Vitamin K|vitamin k|mesh-list
14799973|NCT00785109|Vitamins|vitamins|mesh-ancestor
14799974|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
14799975|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799976|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14799977|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14799978|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799979|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
14799980|NCT00785109|Coagulants|coagulants|mesh-ancestor
14799981|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
14799982|NCT00785122|Molgramostim|molgramostim|mesh-list
14799983|NCT00785122|Imiquimod|imiquimod|mesh-list
14799984|NCT00785122|Sargramostim|sargramostim|mesh-list
14799985|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14799986|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
14799987|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14799988|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14799989|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14799990|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
14799991|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14799992|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14799993|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14799994|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14799995|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
14799996|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
14799997|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14799998|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14799999|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
14800000|NCT00785330|Rituximab|rituximab|mesh-list
14800001|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14800002|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800003|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
14800004|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800005|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14800006|NCT00785382|Pregabalin|pregabalin|mesh-list
14800007|NCT00785382|Analgesics|analgesics|mesh-ancestor
14800008|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
14800009|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800010|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800011|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
14800012|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14800013|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800014|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800015|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800016|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14800017|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14800018|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800019|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800020|NCT00785395|Oxytocin|oxytocin|mesh-list
14800021|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
14800022|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14800023|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800024|NCT00785421|Leucovorin|leucovorin|mesh-list
14800025|NCT00785421|Folic Acid|folic acid|mesh-list
14800026|NCT00785421|Gemcitabine|gemcitabine|mesh-list
14800027|NCT00785421|Cisplatin|cisplatin|mesh-list
14800028|NCT00785421|Enoxaparin|enoxaparin|mesh-list
14800029|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
14800030|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
14800031|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800032|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14800033|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
14800034|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800035|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
14800036|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800037|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965227|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
14965228|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965229|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
14965230|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14965231|NCT01635114|Resveratrol|resveratrol|mesh-list
14965232|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
14965233|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965234|NCT01635114|Protective Agents|protective agents|mesh-ancestor
14965235|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965236|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965237|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14965238|NCT01635205|Anesthetics|anesthetics|mesh-list
14965239|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965240|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965241|NCT01635296|Cytarabine|cytarabine|mesh-list
14965242|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14965243|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
14965244|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965245|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965246|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
14965247|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965248|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965249|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
14965250|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965251|NCT01635400|Irinotecan|irinotecan|mesh-list
14965252|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14965253|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14965254|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965255|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965256|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965257|NCT01635426|Aspirin|aspirin|mesh-list
14965258|NCT01635426|Clopidogrel|clopidogrel|mesh-list
14965259|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14965260|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965261|NCT01635426|Analgesics|analgesics|mesh-ancestor
14965262|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
14965263|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965264|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965265|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965266|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14965267|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14965268|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14965269|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965270|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14965271|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14965272|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965273|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
14965274|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14965275|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14965276|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14965277|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
14965278|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965279|NCT01635530|Doxycycline|doxycycline|mesh-list
14965280|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
14965281|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14965282|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965283|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
14965284|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14965285|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14965286|NCT01635608|Acetaminophen|acetaminophen|mesh-list
14965287|NCT01635608|Amoxicillin|amoxicillin|mesh-list
14965288|NCT01635608|Talinolol|talinolol|mesh-list
14965289|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965290|NCT01635608|Analgesics|analgesics|mesh-ancestor
14965291|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
14965292|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965293|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965294|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
14965295|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14965296|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965297|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14965298|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14965299|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
14965300|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965301|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965302|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14800038|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800039|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
14800040|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800041|NCT00785421|Antidotes|antidotes|mesh-ancestor
14800042|NCT00785421|Protective Agents|protective agents|mesh-ancestor
14800043|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
14800044|NCT00785421|Vitamins|vitamins|mesh-ancestor
14800045|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
14800046|NCT00785421|Hematinics|hematinics|mesh-ancestor
14800047|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
14800048|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14800049|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14800050|NCT00785434|Citalopram|citalopram|mesh-list
14800051|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14800052|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14800053|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800054|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800055|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800056|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
14800057|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800058|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14800059|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
14800060|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800061|NCT00785460|Benphothiamine|benphothiamine|mesh-list
14800062|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14800063|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
14800064|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800065|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
14800066|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
14800067|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800068|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
14800069|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
14800070|NCT00785473|Calcium|calcium|mesh-list
14800071|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800072|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800073|NCT00785473|Vitamins|vitamins|mesh-ancestor
14800074|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
14800075|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14800076|NCT00785473|Antacids|antacids|mesh-ancestor
14800077|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800078|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14800079|NCT00785551|Quinine|quinine|mesh-list
14800080|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
14800081|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14800082|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14800083|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800084|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14800085|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800086|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14800087|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800088|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14800089|NCT00785551|Analgesics|analgesics|mesh-ancestor
14800090|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
14965303|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14965304|NCT01635686|Etanercept|etanercept|mesh-list
14965305|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14965306|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965307|NCT01635686|Analgesics|analgesics|mesh-ancestor
14965308|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
14965309|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965310|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965311|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965312|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14965313|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14965314|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965315|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
14965316|NCT01635751|Pregabalin|pregabalin|mesh-list
14965317|NCT01635751|Analgesics|analgesics|mesh-ancestor
14965318|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
14965319|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965320|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965321|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
14965322|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14965323|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14965324|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965325|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14965326|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14965327|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14965328|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965329|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965330|NCT01635777|Miltefosine|miltefosine|mesh-list
14965331|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
14965332|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965333|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965334|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14965335|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14965336|NCT01635790|Bevacizumab|bevacizumab|mesh-list
14965337|NCT01635790|Ranibizumab|ranibizumab|mesh-list
14965338|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14965339|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965340|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14965341|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14965342|NCT01635790|Growth Substances|growth substances|mesh-ancestor
14965343|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965344|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
14965345|NCT01635803|Bevacizumab|bevacizumab|mesh-list
14965346|NCT01635803|Ranibizumab|ranibizumab|mesh-list
14965347|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14965348|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965349|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14965350|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14965351|NCT01635803|Growth Substances|growth substances|mesh-ancestor
14965352|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965353|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
14965354|NCT01635816|Vaccines|vaccines|mesh-list
14965355|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
14965356|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965357|NCT01635829|Carbamazepine|carbamazepine|mesh-list
14965358|NCT01635829|Phenytoin|phenytoin|mesh-list
14965359|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
14800091|NCT00785603|Tramadol|tramadol|mesh-list
14800092|NCT00785603|Paroxetine|paroxetine|mesh-list
14800093|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14800094|NCT00785603|Narcotics|narcotics|mesh-ancestor
14800095|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800096|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800097|NCT00785603|Analgesics|analgesics|mesh-ancestor
14800098|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
14800099|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800100|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14800101|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14800102|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800103|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965360|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
14965361|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14965362|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965363|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965364|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965365|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965366|NCT01635829|Analgesics|analgesics|mesh-ancestor
14965367|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
14965368|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965369|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14965370|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14965371|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965372|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14965373|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14965374|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14965375|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14965376|NCT01635946|Isavuconazole|isavuconazole|mesh-list
14965377|NCT01635946|Atorvastatin|atorvastatin|mesh-list
14965378|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14965379|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14965380|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
14965381|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965382|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14965383|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14965384|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965385|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
14965386|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965387|NCT01635972|Isavuconazole|isavuconazole|mesh-list
14965388|NCT01635972|Bupropion|bupropion|mesh-list
14965389|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14965390|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
14965391|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965392|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14965393|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14965394|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14965395|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965396|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
14965397|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965398|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965399|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14965400|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14965401|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965402|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
14965403|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965404|NCT01636037|Levodopa|levodopa|mesh-list
14965405|NCT01636037|Carbidopa|carbidopa|mesh-list
14965406|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14965407|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14965408|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14965409|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
14965410|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965411|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965412|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965413|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14522852|NCT03557931|Risperidone|risperidone|mesh-list
14522853|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14522854|NCT03557931|Aripiprazole|aripiprazole|mesh-list
14800104|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800105|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
14800106|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14800107|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
14800108|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800109|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14800110|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14800111|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800112|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
14800113|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14522855|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14522856|NCT03557931|Ziprasidone|ziprasidone|mesh-list
14522857|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14522858|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
14522859|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14522860|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
14522861|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529783|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965414|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965415|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14965416|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
14965417|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
14965418|NCT01636128|Eflornithine|eflornithine|mesh-list
14965419|NCT01636128|Sulindac|sulindac|mesh-list
14965420|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965421|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14965422|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14965423|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14965424|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965425|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14965426|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965427|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965428|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14965429|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965430|NCT01636128|Analgesics|analgesics|mesh-ancestor
14965431|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
14965432|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965433|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965434|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965435|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14965436|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14965437|NCT01636141|Dapansutrile|dapansutrile|mesh-list
14965438|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965439|NCT01636180|Clopidogrel|clopidogrel|mesh-list
14965440|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14965441|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14965442|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14965443|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14965444|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
14965445|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965446|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965447|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965448|NCT01636245|Vaccines|vaccines|mesh-list
14965449|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
14965450|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965451|NCT01636271|Darapladib|darapladib|mesh-list
14965452|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14965453|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965454|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965455|NCT01636310|Nicotine|nicotine|mesh-list
14965456|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14965457|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
14965458|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965459|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965460|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14965461|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14965462|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
14965463|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965464|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965465|NCT01636323|Nicotine|nicotine|mesh-list
14965466|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14965467|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
14965468|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965469|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965470|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14965471|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14965472|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
14965473|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965474|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965475|NCT01636336|Nicotine|nicotine|mesh-list
14965476|NCT01636336|Progesterone|progesterone|mesh-list
14965477|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14965478|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
14965479|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965480|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965481|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14965482|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14965483|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
14965484|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965485|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965486|NCT01636336|Progestins|progestins|mesh-ancestor
14965487|NCT01636336|Hormones|hormones|mesh-ancestor
15028598|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14800114|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14800115|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800116|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800117|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800118|NCT00785863|Ketorolac|ketorolac|mesh-list
14800119|NCT00785863|Parecoxib|parecoxib|mesh-list
14800120|NCT00785863|Remifentanil|remifentanil|mesh-list
14800121|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14800122|NCT00785863|Narcotics|narcotics|mesh-ancestor
14800123|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800124|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800125|NCT00785863|Analgesics|analgesics|mesh-ancestor
14800126|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
14800127|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800128|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14800129|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14800130|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14800131|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14800132|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14800133|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800134|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800135|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14965488|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14965489|NCT01636401|Bromides|bromides|mesh-list
14965490|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
14965491|NCT01636505|Cetrorelix|cetrorelix|mesh-list
14965492|NCT01636505|Buserelin|buserelin|mesh-list
14965493|NCT01636505|Ganirelix|ganirelix|mesh-list
14965494|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14965495|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
14965496|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14965497|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965498|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
14965499|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14965500|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14965501|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
14965502|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965503|NCT01636557|Vitamin K|vitamin k|mesh-list
14965504|NCT01636557|Midazolam|midazolam|mesh-list
14965505|NCT01636557|Caffeine|caffeine|mesh-list
14965506|NCT01636557|Omeprazole|omeprazole|mesh-list
14965507|NCT01636557|Warfarin|warfarin|mesh-list
14965508|NCT01636557|Vitamins|vitamins|mesh-ancestor
14965509|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
14965510|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965511|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14965512|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14965513|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965514|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14965515|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14965516|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965517|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14965518|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
14965519|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
14965520|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
14965521|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
14965522|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965523|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965524|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
14965525|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14965526|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14965527|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14965528|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965529|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14965530|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14965531|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14965532|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14965533|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
14965534|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14965535|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14965536|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
14965537|NCT01636557|Coagulants|coagulants|mesh-ancestor
14965538|NCT01636570|Vitamin D|vitamin d|mesh-list
14965539|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
14965540|NCT01636570|Vitamins|vitamins|mesh-ancestor
14965541|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
14965542|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965543|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14965544|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14965545|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
14965546|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14965547|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965548|NCT01636609|Cytarabine|cytarabine|mesh-list
14965549|NCT01636609|Azacitidine|azacitidine|mesh-list
14965550|NCT01636609|Tosedostat|tosedostat|mesh-list
14965551|NCT01636609|Glycine|glycine|mesh-list
14965552|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14965553|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
14965554|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965555|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965556|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
14965557|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965558|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965559|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
14965560|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965561|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965562|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
14965563|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965564|NCT01636622|Paclitaxel|paclitaxel|mesh-list
14965565|NCT01636622|Carboplatin|carboplatin|mesh-list
14965566|NCT01636622|Vemurafenib|vemurafenib|mesh-list
14965567|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14965568|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965569|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
14965570|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
14965571|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
14965572|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965573|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14965574|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965575|NCT01636700|Tramadol|tramadol|mesh-list
14965576|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14965577|NCT01636700|Narcotics|narcotics|mesh-ancestor
14965578|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965579|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965580|NCT01636700|Analgesics|analgesics|mesh-ancestor
14965581|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
14965582|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028599|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028600|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034977|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15034978|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034979|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
15034980|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
15034981|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
15034982|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034983|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
15034984|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15034985|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034986|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
15034987|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034988|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15034989|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15034990|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034991|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
15034992|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
15034993|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034994|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15034995|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034996|NCT01998503|Dexamethasone|dexamethasone|mesh-list
15034997|NCT01998503|Bortezomib|bortezomib|mesh-list
15034998|NCT01998503|Melphalan|melphalan|mesh-list
15034999|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035000|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
15035001|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
15035002|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035003|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035004|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035005|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
15035006|NCT01998503|Hormones|hormones|mesh-ancestor
15035007|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035008|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035009|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035010|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
15035011|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15035012|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
15035013|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035014|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15035015|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035016|NCT01998529|Cisplatin|cisplatin|mesh-list
15035017|NCT01998529|Amifostine|amifostine|mesh-list
15035018|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035019|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15035020|NCT01998529|Protective Agents|protective agents|mesh-ancestor
15035021|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035595|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15035596|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
15035597|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
15035598|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035599|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15035600|NCT02002195|Leucovorin|leucovorin|mesh-list
15035601|NCT02002195|Fluorouracil|fluorouracil|mesh-list
15035602|NCT02002195|Capecitabine|capecitabine|mesh-list
15035603|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
15035604|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
15035605|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035606|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15035607|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035608|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035609|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
15035610|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035611|NCT02002195|Antidotes|antidotes|mesh-ancestor
15035612|NCT02002195|Protective Agents|protective agents|mesh-ancestor
15035613|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
15035614|NCT02002195|Vitamins|vitamins|mesh-ancestor
15035615|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
15035646|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035647|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
14965583|NCT01636869|Bupivacaine|bupivacaine|mesh-list
14965584|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
14965585|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
14965586|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965587|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965588|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
14965589|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965590|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
14965591|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14965592|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
14965593|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
14965594|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14965595|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14965596|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965597|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14965598|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965599|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965600|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14965601|NCT01636895|Renal Agents|renal agents|mesh-ancestor
14965602|NCT01636908|Everolimus|everolimus|mesh-list
14965603|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14965604|NCT01636908|Sorafenib|sorafenib|mesh-list
14965605|NCT01636908|Sunitinib|sunitinib|mesh-list
14965606|NCT01636908|Dasatinib|dasatinib|mesh-list
14965607|NCT01636908|Lapatinib|lapatinib|mesh-list
14965608|NCT01636908|Vemurafenib|vemurafenib|mesh-list
14965609|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965610|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965611|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
14965612|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965613|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14965614|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965615|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965616|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14965617|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14965618|NCT01636908|Growth Substances|growth substances|mesh-ancestor
14965619|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
14965620|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
14965621|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14965622|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
14965623|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
14965624|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965625|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965626|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965627|NCT01636999|Analgesics|analgesics|mesh-ancestor
14965628|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
14965629|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965630|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
14965631|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
14965632|NCT01637025|Coagulants|coagulants|mesh-ancestor
14965633|NCT01637155|Vitamin D|vitamin d|mesh-list
14965634|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
14965635|NCT01637155|Vitamins|vitamins|mesh-ancestor
14965636|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
14965637|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965638|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14965639|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14965640|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14965641|NCT01637194|Cetuximab|cetuximab|mesh-list
14965642|NCT01637194|Everolimus|everolimus|mesh-list
14965643|NCT01637194|Antibodies|antibodies|mesh-list
14965644|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
14965645|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14965646|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
14965647|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965648|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965649|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965650|NCT01637233|Ritonavir|ritonavir|mesh-list
14965651|NCT01637233|Lopinavir|lopinavir|mesh-list
14965652|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14965653|NCT01637233|Darunavir|darunavir|mesh-list
14965654|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
14965655|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14965656|NCT01637233|Tenofovir|tenofovir|mesh-list
14965657|NCT01637233|Lamivudine|lamivudine|mesh-list
14965658|NCT01637233|Zidovudine|zidovudine|mesh-list
14965659|NCT01637233|Emtricitabine|emtricitabine|mesh-list
14965660|NCT01637233|Maraviroc|maraviroc|mesh-list
14965661|NCT01637233|Abacavir|abacavir|mesh-list
14965662|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
14965663|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14965664|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
14965665|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14965666|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965667|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965668|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14965669|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14965670|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
14965671|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965672|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14965673|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14965674|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965675|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
14965676|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14965677|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14965678|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14965679|NCT01637259|Ritonavir|ritonavir|mesh-list
14965680|NCT01637259|Lopinavir|lopinavir|mesh-list
14965681|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14965682|NCT01637259|Darunavir|darunavir|mesh-list
14965683|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
14965684|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
14965685|NCT01637259|Tenofovir|tenofovir|mesh-list
14965686|NCT01637259|Lamivudine|lamivudine|mesh-list
14965687|NCT01637259|Zidovudine|zidovudine|mesh-list
14965688|NCT01637259|Emtricitabine|emtricitabine|mesh-list
14965689|NCT01637259|Maraviroc|maraviroc|mesh-list
14965690|NCT01637259|Abacavir|abacavir|mesh-list
14965691|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
14965692|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14965693|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
14965694|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14965695|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965696|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965697|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14965698|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14965699|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
14965700|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965701|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14965702|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14965703|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965704|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
14965705|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14965706|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14965707|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14965708|NCT01637376|Temoporfin|temoporfin|mesh-list
14965709|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965710|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14965711|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
14965712|NCT01637454|Terlipressin|terlipressin|mesh-list
14800136|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14800137|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
14800138|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800139|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14800140|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
14800141|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800142|NCT00786058|Fluorouracil|fluorouracil|mesh-list
14800143|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
14800144|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965713|NCT01637454|Norepinephrine|norepinephrine|mesh-list
14965714|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14965715|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14965716|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14965717|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14965718|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
14965719|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965720|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965721|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965722|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
14965723|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
14965724|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965725|NCT01637532|Interferons|interferons|mesh-list
14965726|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
14965727|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
14965728|NCT01637532|Carboplatin|carboplatin|mesh-list
14965729|NCT01637532|Doxorubicin|doxorubicin|mesh-list
14965730|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965731|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14965732|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14965733|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14965734|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965735|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965736|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
14965737|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965738|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
14965739|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965740|NCT01637545|Ramosetron|ramosetron|mesh-list
14965741|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
14965742|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
14965743|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965744|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965745|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14965746|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14965747|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
14965748|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965749|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965750|NCT01637558|Ritonavir|ritonavir|mesh-list
14965751|NCT01637558|Lopinavir|lopinavir|mesh-list
14965752|NCT01637558|Nevirapine|nevirapine|mesh-list
14965753|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14800145|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14800146|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800147|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800148|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
14800149|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800150|NCT00786110|Paclitaxel|paclitaxel|mesh-list
14800151|NCT00786110|Sorafenib|sorafenib|mesh-list
14800152|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14800153|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800154|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14800155|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14800156|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14800157|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800158|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14800159|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800160|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14800161|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14800162|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14800163|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
14800164|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800165|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14800166|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14800167|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800168|NCT00786149|Varenicline|varenicline|mesh-list
14800169|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14800170|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14800171|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
14800172|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800173|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800174|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800175|NCT00786240|Fesoterodine|fesoterodine|mesh-list
14800176|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14800177|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14800178|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
14800179|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800180|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800181|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800182|NCT00786240|Urological Agents|urological agents|mesh-ancestor
14800183|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14800184|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14800185|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14800186|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14800187|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800188|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800189|NCT00786253|Urological Agents|urological agents|mesh-ancestor
14800190|NCT00786279|Ethanol|ethanol|mesh-list
14800191|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14800192|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800193|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800194|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800195|NCT00786305|Amikacin|amikacin|mesh-list
14800196|NCT00786305|Ceftazidime|ceftazidime|mesh-list
14800197|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800198|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800199|NCT00786318|Ziprasidone|ziprasidone|mesh-list
14800200|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14800201|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
14800202|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800203|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800204|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800205|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14800206|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14800207|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800208|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800209|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14800210|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
14800211|NCT00786331|Carboplatin|carboplatin|mesh-list
14800212|NCT00786331|Pemetrexed|pemetrexed|mesh-list
14800213|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800214|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800215|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800216|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14965754|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14965755|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
14965756|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965757|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965758|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14965759|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14965760|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
14965761|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965762|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14965763|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14965764|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14965765|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965766|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14965767|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14965768|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
14965769|NCT01637571|Lansoprazole|lansoprazole|mesh-list
14965770|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14965771|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14965772|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14965773|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965774|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965775|NCT01637636|Rifampin|rifampin|mesh-list
14965776|NCT01637636|Ketoconazole|ketoconazole|mesh-list
14965777|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14965778|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
14965779|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14965780|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965781|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
14965782|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965783|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965784|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965785|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14965786|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14965787|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14965788|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14965789|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14965790|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14965791|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
14965792|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14965793|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14965794|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14965795|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
14965796|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14965797|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965798|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14965799|NCT01637675|Tanshinone|tanshinone|mesh-list
14965800|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
14965801|NCT01637675|Citric Acid|citric acid|mesh-list
14965802|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
14965803|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
14965804|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14965805|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
14965806|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
14965807|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965808|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
14965809|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14965810|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14965811|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965812|NCT01637675|Urological Agents|urological agents|mesh-ancestor
14965813|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965814|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14965815|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965816|NCT01637675|Analgesics|analgesics|mesh-ancestor
14965817|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
14965818|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965819|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965820|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965821|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14965822|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14965823|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965824|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965825|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
14965826|NCT01637753|Carmustine|carmustine|mesh-list
14965827|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14965828|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
14965829|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965830|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965831|NCT01637766|Melphalan|melphalan|mesh-list
14965832|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14965833|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
14965834|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965835|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965836|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14965837|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965838|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
14965839|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965840|NCT01637818|Acetaminophen|acetaminophen|mesh-list
14965841|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14965842|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14965843|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965844|NCT01637818|Analgesics|analgesics|mesh-ancestor
14965845|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
14965846|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965847|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965848|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
14965849|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14965850|NCT01637844|Telbivudine|telbivudine|mesh-list
14965851|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
14965852|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965853|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965854|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965855|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965856|NCT01637883|Benzydamine|benzydamine|mesh-list
14965857|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14965858|NCT01637948|Listerine|listerine|mesh-list
14965859|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14965860|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965861|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14965862|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
14965863|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14965864|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
14965865|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14965866|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965867|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14965868|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14965869|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965870|NCT01638078|Thalidomide|thalidomide|mesh-list
14965871|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14965872|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
14965873|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965874|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
14965875|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14965876|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965877|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14965878|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14965879|NCT01638078|Growth Substances|growth substances|mesh-ancestor
14965880|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
14965881|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965882|NCT01638182|Vitamins|vitamins|mesh-list
14965883|NCT01638182|Vitamin K|vitamin k|mesh-list
14965884|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
14965885|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
14965886|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
14965887|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965888|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14965889|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14965890|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965891|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
14965892|NCT01638182|Coagulants|coagulants|mesh-ancestor
14965893|NCT01638234|Melatonin|melatonin|mesh-list
14965894|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
14965895|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965896|NCT01638234|Protective Agents|protective agents|mesh-ancestor
14965897|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965898|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965899|NCT01638247|Tamoxifen|tamoxifen|mesh-list
14965900|NCT01638247|Goserelin|goserelin|mesh-list
14965901|NCT01638247|Exemestane|exemestane|mesh-list
14965902|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14965903|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14965904|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
14965905|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14965906|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965907|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14965908|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14965909|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14965910|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14965911|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14965912|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14965913|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14965914|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965915|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965916|NCT01638247|Hormones|hormones|mesh-ancestor
14965917|NCT01638260|Liraglutide|liraglutide|mesh-list
14965918|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14965919|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965920|NCT01638260|Incretins|incretins|mesh-ancestor
14965921|NCT01638260|Hormones|hormones|mesh-ancestor
14965922|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14965923|NCT01638273|Pregabalin|pregabalin|mesh-list
14965924|NCT01638273|Analgesics|analgesics|mesh-ancestor
14965925|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
14965926|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965927|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965928|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
14965929|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14965930|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14965931|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965932|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14965933|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14236467|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236468|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236469|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14236470|NCT00114738|Rituximab|rituximab|mesh-list
14236471|NCT00114738|Bortezomib|bortezomib|mesh-list
14236472|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14236473|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236474|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
14236475|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236476|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236477|NCT00114777|Cyclosporine|cyclosporine|mesh-list
14236478|NCT00114777|Abatacept|abatacept|mesh-list
14236479|NCT00114777|Cyclosporins|cyclosporins|mesh-list
14965934|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14965935|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965936|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14965937|NCT01638299|Insulin|insulin|mesh-list
14965938|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14965939|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965940|NCT01638325|Insulin|insulin|mesh-list
14236480|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236481|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236482|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236483|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
14236484|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236485|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
14236486|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14236487|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14236488|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14236489|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14236490|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14236491|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236492|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
14965941|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14965942|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
14965943|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14965944|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965945|NCT01638364|Ethanol|ethanol|mesh-list
14965946|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14965947|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965948|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965949|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965950|NCT01638377|Naltrexone|naltrexone|mesh-list
14965951|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14965952|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14965953|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965954|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
14965955|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14965956|NCT01638403|Modafinil|modafinil|mesh-list
14965957|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14965958|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965959|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14965960|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14965961|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14965962|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965963|NCT01638442|Tosedostat|tosedostat|mesh-list
14965964|NCT01638442|Glycine|glycine|mesh-list
14965965|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965966|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965967|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
14965968|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14965969|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028601|NCT01955967|Lidocaine|lidocaine|mesh-list
15028602|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
15028603|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
15028604|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028605|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028606|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
15028607|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028608|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15028609|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15028610|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15028611|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028612|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028613|NCT01956006|Milrinone|milrinone|mesh-list
15028614|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15028615|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15028616|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028617|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15028618|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15028619|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028620|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028621|NCT01956006|Protective Agents|protective agents|mesh-ancestor
15028622|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028623|NCT01956201|Atorvastatin|atorvastatin|mesh-list
15028624|NCT01956201|Fenofibrate|fenofibrate|mesh-list
15028625|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15028626|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15028627|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
15028628|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028629|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15028630|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15028631|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028632|NCT01956305|Metformin|metformin|mesh-list
15028633|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15028634|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028635|NCT01956474|Riboflavin|riboflavin|mesh-list
15028636|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
15028637|NCT01956474|Vitamins|vitamins|mesh-ancestor
14965970|NCT01638624|Propofol|propofol|mesh-list
14965971|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14965972|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14965973|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965974|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14965975|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
14965976|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
14965977|NCT01638650|Ritonavir|ritonavir|mesh-list
14965978|NCT01638650|Saquinavir|saquinavir|mesh-list
14965979|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14965980|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14800217|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14800218|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
14800219|NCT00786370|Propofol|propofol|mesh-list
14800220|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14800221|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800222|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800223|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14800224|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
14800225|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
14800226|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14965981|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14965982|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
14965983|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14965984|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965985|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14965986|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14965987|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
14965988|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14965989|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14965990|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14965991|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14965992|NCT01638663|Tolvaptan|tolvaptan|mesh-list
14965993|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14965994|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14965995|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
14965996|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14965997|NCT01638676|Metformin|metformin|mesh-list
14965998|NCT01638676|Vemurafenib|vemurafenib|mesh-list
14965999|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14966000|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966001|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966002|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14966003|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800227|NCT00786370|Analgesics|analgesics|mesh-ancestor
14966004|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966005|NCT01638689|Citalopram|citalopram|mesh-list
14966006|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14966007|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14966008|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14966009|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966010|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966011|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
14966012|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966013|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14966014|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
14966015|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14966016|NCT01638715|Rituximab|rituximab|mesh-list
14966017|NCT01638715|Abatacept|abatacept|mesh-list
14966018|NCT01638715|Infliximab|infliximab|mesh-list
14966019|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14966020|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966021|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
14966022|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966023|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966024|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
14966025|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966026|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14966027|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966028|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966029|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
14966030|NCT01638767|NuvaRing|nuvaring|mesh-list
14966031|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
15028638|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
14966032|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14966033|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966034|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14966035|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14966036|NCT01638780|Resveratrol|resveratrol|mesh-list
14966037|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
14966038|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966039|NCT01638780|Protective Agents|protective agents|mesh-ancestor
14966040|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966041|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966042|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14966043|NCT01638858|Ranibizumab|ranibizumab|mesh-list
14966044|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14966045|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966046|NCT01638858|Growth Substances|growth substances|mesh-ancestor
14966047|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966048|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
14966049|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966050|NCT01638936|Maytansine|maytansine|mesh-list
14966051|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14966052|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966053|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
14966054|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
14966055|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966056|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966057|NCT01638962|Acetaminophen|acetaminophen|mesh-list
14966058|NCT01638962|Aspirin|aspirin|mesh-list
14966059|NCT01638962|Ibuprofen|ibuprofen|mesh-list
14966060|NCT01638962|Celecoxib|celecoxib|mesh-list
14966061|NCT01638962|Diclofenac|diclofenac|mesh-list
14966062|NCT01638962|Naproxen|naproxen|mesh-list
14966063|NCT01638962|Indomethacin|indomethacin|mesh-list
14966064|NCT01638962|Etoricoxib|etoricoxib|mesh-list
14966065|NCT01638962|Meloxicam|meloxicam|mesh-list
14966066|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14966067|NCT01638962|Etodolac|etodolac|mesh-list
14966068|NCT01638962|Lornoxicam|lornoxicam|mesh-list
14966069|NCT01638962|Nabumetone|nabumetone|mesh-list
14966070|NCT01638962|Tenoxicam|tenoxicam|mesh-list
14966071|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
14966072|NCT01638962|Analgesics|analgesics|mesh-list
14966073|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14966074|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
14966075|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966076|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966077|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
14966078|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14966079|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14966080|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966081|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14966082|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966083|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966084|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14966085|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
14966086|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14966087|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14966088|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14966089|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
14966090|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14966091|NCT01638988|Metformin|metformin|mesh-list
14966092|NCT01638988|Clomiphene|clomiphene|mesh-list
14966093|NCT01638988|Enclomiphene|enclomiphene|mesh-list
14966094|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
14966095|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14966096|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966097|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14966098|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
14966099|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966100|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14966101|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
14966102|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14966103|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14966104|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14966105|NCT01639027|Drotaverin|drotaverin|mesh-list
14966106|NCT01639027|Analgesics|analgesics|mesh-ancestor
14966107|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
14966108|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966109|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966110|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
14966111|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
14966112|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
14966113|NCT01639066|Tenofovir|tenofovir|mesh-list
14966114|NCT01639066|Entecavir|entecavir|mesh-list
14966115|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
14966116|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966117|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14966118|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14966119|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966120|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966121|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14966122|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14966123|NCT01639092|Tenofovir|tenofovir|mesh-list
14966124|NCT01639092|Entecavir|entecavir|mesh-list
14966125|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
14966126|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966127|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14966128|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14966129|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966130|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966131|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14966132|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14966133|NCT01639131|Gemcitabine|gemcitabine|mesh-list
14966134|NCT01639131|Docetaxel|docetaxel|mesh-list
14966135|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966136|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
14966137|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966138|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966139|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
14966140|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966141|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966142|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966143|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
14966144|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966145|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
14966146|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
14966147|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966148|NCT01639261|Interferons|interferons|mesh-list
14966149|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
14966150|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966151|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
14966152|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966153|NCT01639326|Irinotecan|irinotecan|mesh-list
14966154|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14966155|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14966156|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966157|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966158|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966159|NCT01639456|Aldesleukin|aldesleukin|mesh-list
14966160|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
14966161|NCT01639456|Fludarabine|fludarabine|mesh-list
14966162|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966163|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
14966164|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966165|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966166|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14966167|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
14966168|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966169|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966170|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14966171|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14966172|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14966173|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
14966174|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966175|NCT01639521|Gemcitabine|gemcitabine|mesh-list
14966176|NCT01639521|Doxorubicin|doxorubicin|mesh-list
14966177|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14966178|NCT01639521|Methotrexate|methotrexate|mesh-list
14966179|NCT01639521|Vinblastine|vinblastine|mesh-list
14966180|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966181|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966182|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
14966183|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966184|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
14966185|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966186|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966187|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966188|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
14966189|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966190|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14966191|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14966192|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14966193|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14966194|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
14966195|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14966196|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
14966197|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14966198|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966199|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14966200|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14966201|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
14966202|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
14966203|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966204|NCT01639547|Ribavirin|ribavirin|mesh-list
14966205|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14966206|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
14966207|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966208|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
14966209|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966210|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
14966211|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14966212|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966213|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
14966214|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14966215|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14966216|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
14966217|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966218|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966219|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966220|NCT01639794|Urological Agents|urological agents|mesh-ancestor
14966221|NCT01639807|Latanoprost|latanoprost|mesh-list
14966222|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14966223|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14966224|NCT01639885|Interferons|interferons|mesh-list
14966225|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
14966226|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
14966227|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966228|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
14966229|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966230|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
14966231|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966232|NCT01639898|Dexamethasone|dexamethasone|mesh-list
14966233|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
14966234|NCT01639898|Lenalidomide|lenalidomide|mesh-list
14966235|NCT01639898|BB 1101|bb 1101|mesh-list
14966236|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14966237|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
14966238|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
14966239|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966240|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966241|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966242|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
14966243|NCT01639898|Hormones|hormones|mesh-ancestor
14966244|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966245|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14966246|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966247|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
14966248|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966249|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966250|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
14966251|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14800228|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
14800229|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800230|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14800231|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14800232|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14800233|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
14800234|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800235|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966252|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966253|NCT01639898|Growth Substances|growth substances|mesh-ancestor
14966254|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
14966255|NCT01640002|Bromides|bromides|mesh-list
14966256|NCT01640002|Propantheline|propantheline|mesh-list
14966257|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
14966258|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14966259|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966260|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14966261|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14966262|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
14966263|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966264|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966265|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966266|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
14966267|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966268|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14966269|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966270|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966271|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
14966272|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966273|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966274|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14966275|NCT01640210|Insulin|insulin|mesh-list
14966276|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14966277|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028639|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028640|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15028641|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
15028642|NCT01956487|Propafenone|propafenone|mesh-list
15028643|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15028644|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15028645|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14800236|NCT00786383|Ramucirumab|ramucirumab|mesh-list
14800237|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800238|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14800239|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
14800240|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800241|NCT00786448|Darifenacin|darifenacin|mesh-list
14800242|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14800243|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14800244|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
14800245|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966278|NCT01640275|Propofol|propofol|mesh-list
14966279|NCT01640275|Isoflurane|isoflurane|mesh-list
14966280|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14522862|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522863|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522864|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14522865|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14522866|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522867|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14522868|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14800246|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800247|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800248|NCT00786448|Urological Agents|urological agents|mesh-ancestor
14800249|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
14800250|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14800251|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800252|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
14800253|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14800254|NCT00786552|Paclitaxel|paclitaxel|mesh-list
14800255|NCT00786552|Pemetrexed|pemetrexed|mesh-list
14800256|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14800257|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800258|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
14800259|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
14800260|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966281|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14966282|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966283|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14966284|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
14966285|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
14966286|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14966287|NCT01640301|Aldesleukin|aldesleukin|mesh-list
14966288|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
14966289|NCT01640301|Fludarabine|fludarabine|mesh-list
14966290|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
14966291|NCT01640301|Interleukin-2|interleukin-2|mesh-list
14966292|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966293|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
14966294|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966295|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966296|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14966297|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
14966298|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966299|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966300|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14966301|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966302|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
14966303|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14966304|NCT01640301|Analgesics|analgesics|mesh-ancestor
14966305|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
14966306|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966307|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14966308|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14966309|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
14966310|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966311|NCT01640405|Bevacizumab|bevacizumab|mesh-list
14966312|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14966313|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966314|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14966315|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966316|NCT01640405|Growth Substances|growth substances|mesh-ancestor
14966317|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966318|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
14966319|NCT01640444|Bevacizumab|bevacizumab|mesh-list
14966320|NCT01640444|Cetuximab|cetuximab|mesh-list
14966321|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14966322|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966323|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14966324|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966325|NCT01640444|Growth Substances|growth substances|mesh-ancestor
14966326|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966327|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
14966328|NCT01640496|Vitamin D|vitamin d|mesh-list
14966329|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
14966330|NCT01640496|Vitamins|vitamins|mesh-ancestor
14966331|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
14966332|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966333|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14966334|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14966335|NCT01640535|Cetirizine|cetirizine|mesh-list
14966336|NCT01640535|Montelukast|montelukast|mesh-list
14966337|NCT01640535|Levocetirizine|levocetirizine|mesh-list
14966338|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14966339|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
14966340|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14966341|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
14966342|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966343|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966344|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14966345|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14966346|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966347|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14966348|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14966349|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
14966350|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
14966351|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966352|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14966353|NCT01640574|Chloroquine|chloroquine|mesh-list
14966354|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14966355|NCT01640574|Piperaquine|piperaquine|mesh-list
14966356|NCT01640574|Artenimol|artenimol|mesh-list
14966357|NCT01640574|Artemisinins|artemisinins|mesh-list
14966358|NCT01640574|Amebicides|amebicides|mesh-ancestor
14966359|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14966360|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14966361|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966362|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
14966363|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966364|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14966365|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14966366|NCT01640574|Analgesics|analgesics|mesh-ancestor
14966367|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
14966368|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966369|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966370|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14966371|NCT01640574|Filaricides|filaricides|mesh-ancestor
14966372|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
14966373|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
14966374|NCT01640587|Artesunate|artesunate|mesh-list
14966375|NCT01640587|Piperaquine|piperaquine|mesh-list
14966376|NCT01640587|Artenimol|artenimol|mesh-list
14966377|NCT01640587|Mefloquine|mefloquine|mesh-list
14966378|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
14966379|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14966380|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14966381|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966382|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966383|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
14966384|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
14966385|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14966386|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
14966387|NCT01640639|Thalidomide|thalidomide|mesh-list
14966388|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966389|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
14966390|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966391|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
14966392|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14966393|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966394|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14966395|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966396|NCT01640639|Growth Substances|growth substances|mesh-ancestor
14966397|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
14966398|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966399|NCT01640665|Capecitabine|capecitabine|mesh-list
14966400|NCT01640665|Sorafenib|sorafenib|mesh-list
14966401|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966402|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
14966403|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966404|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966405|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14966406|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966407|NCT01640691|Vaccines|vaccines|mesh-list
14966408|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
14966409|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966410|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
14966411|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14966412|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14966413|NCT01640743|Prednisolone|prednisolone|mesh-list
14966414|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
14966415|NCT01640743|Everolimus|everolimus|mesh-list
14966416|NCT01640743|Tacrolimus|tacrolimus|mesh-list
14966417|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14966418|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
14966419|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966420|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
14966421|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966422|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14966423|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966424|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966425|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966426|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14966427|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
14966428|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
14966429|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966430|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966431|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
14966432|NCT01640743|Hormones|hormones|mesh-ancestor
14966433|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966434|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14966435|NCT01640743|Protective Agents|protective agents|mesh-ancestor
14522869|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
14522870|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
14522871|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
14522872|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522873|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522874|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14522875|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14522876|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14966436|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14966437|NCT01640782|Leucovorin|leucovorin|mesh-list
14966438|NCT01640782|Docetaxel|docetaxel|mesh-list
14966439|NCT01640782|Fluorouracil|fluorouracil|mesh-list
14966440|NCT01640782|Irinotecan|irinotecan|mesh-list
14966441|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
14966442|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966443|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
14966444|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
14966445|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966446|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966447|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
14966448|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966449|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966450|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
14966451|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966452|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14966453|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14966454|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966455|NCT01640782|Antidotes|antidotes|mesh-ancestor
14966456|NCT01640782|Protective Agents|protective agents|mesh-ancestor
14966457|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
14966458|NCT01640782|Vitamins|vitamins|mesh-ancestor
14966459|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
14966460|NCT01640990|GW 328267|gw 328267|mesh-list
14966461|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14966462|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14966463|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
14966464|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
14966465|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966466|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966467|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966468|NCT01641016|Efavirenz|efavirenz|mesh-list
14966469|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14966470|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14966471|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966472|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966473|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
14966474|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966475|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14966476|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14966477|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15035022|NCT01998685|Fentanyl|fentanyl|mesh-list
14966478|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14966479|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14966480|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14966481|NCT01641224|Pinaverium|pinaverium|mesh-list
14966482|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14966483|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14966484|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966485|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14966486|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966487|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
14966488|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
14966489|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966490|NCT01641250|Cytarabine|cytarabine|mesh-list
14966491|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966492|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
14966493|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966494|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966495|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
14966496|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966497|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966498|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
14966499|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966500|NCT01641289|Acetaminophen|acetaminophen|mesh-list
14966501|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14966502|NCT01641289|Analgesics|analgesics|mesh-ancestor
14966503|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
14966504|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966505|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966506|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
14966507|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
14966508|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
14966509|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966510|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
14966511|NCT01641341|Pancrelipase|pancrelipase|mesh-list
14966512|NCT01641341|Pancreatin|pancreatin|mesh-list
14966513|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14966514|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966515|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966516|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
14966517|NCT01641406|Bevacizumab|bevacizumab|mesh-list
14966518|NCT01641406|Docetaxel|docetaxel|mesh-list
14966519|NCT01641406|Capecitabine|capecitabine|mesh-list
14966520|NCT01641406|Trastuzumab|trastuzumab|mesh-list
14966521|NCT01641406|Epirubicin|epirubicin|mesh-list
14966522|NCT01641406|Vinorelbine|vinorelbine|mesh-list
14966523|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966524|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
14966525|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966526|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966527|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14966528|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
14966529|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966530|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966531|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14966532|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14966533|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14966534|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966535|NCT01641406|Growth Substances|growth substances|mesh-ancestor
14966536|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
14966537|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
14966538|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
14966539|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966540|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966541|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
14966542|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14966543|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14966544|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14966545|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966546|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14966547|NCT01641419|Dexamethasone|dexamethasone|mesh-list
14966548|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
14966549|NCT01641419|BB 1101|bb 1101|mesh-list
14966550|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14966551|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
14966552|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
14966553|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966554|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966555|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966556|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
14966557|NCT01641419|Hormones|hormones|mesh-ancestor
14966558|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966559|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14966560|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966561|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
14966562|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966563|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966564|NCT01641458|Capecitabine|capecitabine|mesh-list
14966565|NCT01641458|Fluorouracil|fluorouracil|mesh-list
14966566|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966567|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
14966568|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966569|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966570|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966571|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
14966572|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966573|NCT01641510|Clopidogrel|clopidogrel|mesh-list
14966574|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14800261|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966575|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14966576|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14966577|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14966578|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14800262|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800263|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14800264|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14800265|NCT00786669|Cefixime|cefixime|mesh-list
14800266|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
14800267|NCT00786669|Bevacizumab|bevacizumab|mesh-list
14800268|NCT00786669|Irinotecan|irinotecan|mesh-list
14800269|NCT00786669|Vincristine|vincristine|mesh-list
14800270|NCT00786669|Temozolomide|temozolomide|mesh-list
14800271|NCT00786669|Camptothecin|camptothecin|mesh-list
14800272|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14800273|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800274|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14800275|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966579|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
14966580|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966581|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966582|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966583|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
14966584|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
14966585|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14966586|NCT01641523|Protective Agents|protective agents|mesh-ancestor
14966587|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966588|NCT01641536|Entecavir|entecavir|mesh-list
14966589|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
14966590|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966591|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14966592|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14966593|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966594|NCT01641575|Gemcitabine|gemcitabine|mesh-list
14966595|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966596|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966597|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
14966598|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966599|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
14966600|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966601|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966602|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966603|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
14966604|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966605|NCT01641666|Ribavirin|ribavirin|mesh-list
14966606|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14966607|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
14966608|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
14966609|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800276|NCT00786669|Growth Substances|growth substances|mesh-ancestor
14800277|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966610|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
14966611|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966612|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
14966613|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966614|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14966615|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
14966616|NCT01641718|Coagulants|coagulants|mesh-ancestor
14966617|NCT01641783|Paclitaxel|paclitaxel|mesh-list
14966618|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14966619|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14966620|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966621|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
14966622|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
14966623|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966624|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966625|NCT01641796|Paromomycin|paromomycin|mesh-list
14966626|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14966627|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966628|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14966629|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14966630|NCT01642030|Buprenorphine|buprenorphine|mesh-list
14966631|NCT01642030|Hydromorphone|hydromorphone|mesh-list
14966632|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14966633|NCT01642030|Narcotics|narcotics|mesh-ancestor
14966634|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14966635|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966636|NCT01642030|Analgesics|analgesics|mesh-ancestor
14966637|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
14966638|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966639|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14966640|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14966641|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14966642|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966643|NCT01642108|Incretins|incretins|mesh-ancestor
14966644|NCT01642108|Hormones|hormones|mesh-ancestor
14966645|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966646|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14966647|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
14966648|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966649|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966650|NCT01642134|Aspirin|aspirin|mesh-list
14966651|NCT01642134|Clopidogrel|clopidogrel|mesh-list
14966652|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14966653|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14966654|NCT01642134|Analgesics|analgesics|mesh-ancestor
14966655|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
14966656|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966657|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966658|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14966659|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966660|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14966661|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14966662|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966663|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14966664|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14966665|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966666|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
14966667|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14966668|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14966669|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14966670|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
14966671|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966672|NCT01642186|Everolimus|everolimus|mesh-list
14966673|NCT01642186|Letrozole|letrozole|mesh-list
14966674|NCT01642186|Leuprolide|leuprolide|mesh-list
14966675|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966676|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966677|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
14966678|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966679|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14966680|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14966681|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965883|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13965884|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965885|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13965886|NCT03126877|Mitomycins|mitomycins|mesh-list
13965887|NCT03126877|Mitomycin|mitomycin|mesh-list
13965888|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13965889|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965890|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
13965891|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965892|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13965893|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965894|NCT03126864|Vidarabine|vidarabine|mesh-list
13965895|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
13965896|NCT03126864|Fludarabine|fludarabine|mesh-list
13965897|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
13965898|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13965899|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
13965900|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965901|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965902|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13965903|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
13965904|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965905|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965906|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13965907|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13965908|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
13965909|NCT03126864|Antiviral Agents|antiviral agents|mesh-ancestor
13965910|NCT03126864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13965911|NCT03126578|Midazolam|midazolam|mesh-list
13965912|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13965913|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13965914|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965915|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965916|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13965917|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13965918|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13965919|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14966682|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966683|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14966684|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
14966685|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966686|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14966687|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
14966688|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14966689|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15028646|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028647|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028648|NCT01956591|Oxybutynin|oxybutynin|mesh-list
15028649|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
15028650|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
15028651|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028652|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028653|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15028654|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15028655|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
15028656|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028657|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028658|NCT01956591|Urological Agents|urological agents|mesh-ancestor
15028659|NCT01956604|Clonidine|clonidine|mesh-list
15028660|NCT01956604|Analgesics|analgesics|mesh-ancestor
15028661|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
15028662|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028663|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028664|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15028665|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
15028666|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
15028667|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15028668|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15028669|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15028670|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028671|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028672|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028673|NCT01956695|Rituximab|rituximab|mesh-list
15028674|NCT01956695|Lenalidomide|lenalidomide|mesh-list
15028675|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15028676|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028677|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
15028678|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966690|NCT01642433|Prazosin|prazosin|mesh-list
14966691|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14966692|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14966693|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14966694|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14966695|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
14966696|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966697|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966698|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966699|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
14966700|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14966701|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
14966702|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14966703|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966704|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14966705|NCT01642524|Dextrans|dextrans|mesh-list
14966706|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
14966707|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
14966708|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
14966709|NCT01642667|Saruplase|saruplase|mesh-list
14966710|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14966711|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14966712|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966713|NCT01642745|Mannitol|mannitol|mesh-list
14966714|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
14966715|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14966716|NCT01642745|Diuretics|diuretics|mesh-ancestor
14966717|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
14966718|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966719|NCT01642745|Miotics|miotics|mesh-ancestor
14966720|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
14966721|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966722|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14966723|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14966724|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
14966725|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14966726|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14966727|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
14966728|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966729|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966730|NCT01642771|Docetaxel|docetaxel|mesh-list
14966731|NCT01642771|Fluorouracil|fluorouracil|mesh-list
14966732|NCT01642771|Capecitabine|capecitabine|mesh-list
14966733|NCT01642771|Epirubicin|epirubicin|mesh-list
14966734|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966735|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14966736|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14966737|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14966738|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966739|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
14966740|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966741|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966742|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
14966743|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965920|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
13965921|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
13965922|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
13965923|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
13965924|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965925|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965926|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
13965927|NCT03126656|Testosterone|testosterone|mesh-list
13965928|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
13965929|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
13965930|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13965931|NCT03126656|Androgens|androgens|mesh-ancestor
13965932|NCT03126656|Hormones|hormones|mesh-ancestor
13965933|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13965934|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965935|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13965936|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13965937|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
13965938|NCT03126721|Midazolam|midazolam|mesh-list
13965939|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14966744|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15028679|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966745|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14966746|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14966747|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966748|NCT01642862|Simvastatin|simvastatin|mesh-list
14966749|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14966750|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14966751|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
14966752|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966753|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14966754|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14966755|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966756|NCT01642940|Ticagrelor|ticagrelor|mesh-list
14966757|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14966758|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14966759|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14966760|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14966761|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14966762|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
14966763|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966764|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966765|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966766|NCT01642966|Ticagrelor|ticagrelor|mesh-list
14966767|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14966768|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14966769|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13965940|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13965941|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965942|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965943|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13965944|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13965945|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13965946|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14966770|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14966771|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14966772|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
14966773|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966774|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966775|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966776|NCT01642979|Cyclosporine|cyclosporine|mesh-list
14966777|NCT01642979|Levamisole|levamisole|mesh-list
14966778|NCT01642979|Cyclosporins|cyclosporins|mesh-list
14966779|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
14966780|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966781|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966782|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966783|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
14966784|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966785|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
14966786|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966787|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
14966788|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966789|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14966790|NCT01642979|Hormones|hormones|mesh-ancestor
14966791|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966792|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13965947|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
13965948|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
13965949|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
14966793|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
14966794|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
14966795|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14966796|NCT01643031|Clopidogrel|clopidogrel|mesh-list
14966797|NCT01643031|Ticagrelor|ticagrelor|mesh-list
14966798|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14966799|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14966800|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14966801|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14966802|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
14966803|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966804|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966805|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966806|NCT01643070|Capecitabine|capecitabine|mesh-list
14966807|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
13965950|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
14966808|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966809|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
14966810|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966811|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966812|NCT01643083|Rifaximin|rifaximin|mesh-list
14966813|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14966814|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966815|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966816|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
14966817|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
14966818|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14966819|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14966820|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966821|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
14966822|NCT01643135|Coagulants|coagulants|mesh-ancestor
14966823|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
14966824|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14966825|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14800278|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
14800279|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14966826|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966827|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14966828|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14966829|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14966830|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966831|NCT01643187|Vitamins|vitamins|mesh-list
14966832|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
14966833|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966834|NCT01643252|Riboflavin|riboflavin|mesh-list
14966835|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14966836|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14966837|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
14966838|NCT01643252|Vitamins|vitamins|mesh-ancestor
13965951|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13965952|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965953|NCT03126916|Vitamin A|vitamin a|mesh-list
13965954|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
13965955|NCT03126916|Melphalan|melphalan|mesh-list
13965956|NCT03126916|Busulfan|busulfan|mesh-list
13965957|NCT03126916|Thiotepa|thiotepa|mesh-list
13965958|NCT03126916|Cisplatin|cisplatin|mesh-list
13965959|NCT03126916|Carboplatin|carboplatin|mesh-list
13965960|NCT03126916|Doxorubicin|doxorubicin|mesh-list
13965961|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13965962|NCT03126916|Etoposide|etoposide|mesh-list
13965963|NCT03126916|Vincristine|vincristine|mesh-list
13965964|NCT03126916|Topotecan|topotecan|mesh-list
14966839|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
14966840|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966841|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14966842|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
14966843|NCT01643265|Caseins|caseins|mesh-list
14966844|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
14966845|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
14966846|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966847|NCT01643278|Ipilimumab|ipilimumab|mesh-list
14966848|NCT01643278|Dasatinib|dasatinib|mesh-list
14966849|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14966850|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966851|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14966852|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966853|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14966854|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965965|NCT03126916|Tretinoin|tretinoin|mesh-list
13965966|NCT03126916|Crizotinib|crizotinib|mesh-list
14800280|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14800281|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800282|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800283|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14800284|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
14800285|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
14800286|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
14800287|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14800288|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
14800289|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14966855|NCT01643434|Clonidine|clonidine|mesh-list
14966856|NCT01643434|Spironolactone|spironolactone|mesh-list
14966857|NCT01643434|Analgesics|analgesics|mesh-ancestor
14966858|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
14966859|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966860|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966861|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14966862|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
14966863|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
14966864|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14966865|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14966866|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14966867|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
14966868|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966869|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966870|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14966871|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
14966872|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966873|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14966874|NCT01643434|Diuretics|diuretics|mesh-ancestor
14966875|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
14966876|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
14966877|NCT01643447|Urinastatin|urinastatin|mesh-list
14966878|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14966879|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14966880|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
14966881|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966882|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966883|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14966884|NCT01643499|Leucovorin|leucovorin|mesh-list
14966885|NCT01643499|Fluorouracil|fluorouracil|mesh-list
14966886|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
14966887|NCT01643499|Irinotecan|irinotecan|mesh-list
14966888|NCT01643499|Calcium|calcium|mesh-list
14966889|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
14966890|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14966891|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966892|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
14966893|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966894|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14966895|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966896|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14966897|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
14966898|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14966899|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14966900|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966901|NCT01643499|Antidotes|antidotes|mesh-ancestor
14966902|NCT01643499|Protective Agents|protective agents|mesh-ancestor
14966903|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
14966904|NCT01643499|Vitamins|vitamins|mesh-ancestor
14966905|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
14966906|NCT01643603|Dasatinib|dasatinib|mesh-list
13965967|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
13965968|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
13965969|NCT03126916|Dinutuximab|dinutuximab|mesh-list
13965970|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
14966907|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966908|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14966909|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966910|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966911|NCT01643629|Minoxidil|minoxidil|mesh-list
14966912|NCT01643629|Finasteride|finasteride|mesh-list
14966913|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14966914|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
14966915|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14966916|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14966917|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966918|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966919|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
14966920|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966921|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966922|NCT01643629|Urological Agents|urological agents|mesh-ancestor
14966923|NCT01643759|Buprenorphine|buprenorphine|mesh-list
14966924|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14966925|NCT01643759|Narcotics|narcotics|mesh-ancestor
14966926|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13965971|NCT03126916|Razoxane|razoxane|mesh-list
15035023|NCT01998685|Midazolam|midazolam|mesh-list
14966927|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966928|NCT01643759|Analgesics|analgesics|mesh-ancestor
14966929|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
14966930|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966931|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14966932|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
14966933|NCT01643889|Domperidone|domperidone|mesh-list
14966934|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14966935|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14966936|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14966937|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14966938|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14966939|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966940|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966941|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13965972|NCT03126916|Isotretinoin|isotretinoin|mesh-list
13965973|NCT03126916|Sargramostim|sargramostim|mesh-list
13965974|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13965975|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
13965976|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966942|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
14966943|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
14966944|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966945|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14966946|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14966947|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
14966948|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028680|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15028681|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15028682|NCT01956695|Growth Substances|growth substances|mesh-ancestor
15028683|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
15028684|NCT01956734|Temozolomide|temozolomide|mesh-list
15028685|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15028686|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
15028687|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028688|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028689|NCT01956786|Amlodipine|amlodipine|mesh-list
15028690|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15028691|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15028692|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028693|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028694|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15028695|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028696|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028697|NCT01956864|Vitamin D|vitamin d|mesh-list
15028698|NCT01956864|Vitamins|vitamins|mesh-ancestor
15028699|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
15028700|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028701|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15028702|NCT01956929|Metformin|metformin|mesh-list
15028703|NCT01956929|Lactulose|lactulose|mesh-list
15028704|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15028705|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028706|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028707|NCT01956955|Heparin|heparin|mesh-list
15028708|NCT01956955|Enoxaparin|enoxaparin|mesh-list
13965977|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13965978|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13965979|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
13965980|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13965981|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028709|NCT01956955|Calcium heparin|calcium heparin|mesh-list
15028710|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15028711|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
15028712|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15028713|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15028714|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028715|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
15028716|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
15028717|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15028718|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028719|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028720|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15028721|NCT01956981|Analgesics|analgesics|mesh-ancestor
13965982|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14966949|NCT01643941|Vaccines|vaccines|mesh-list
14966950|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
14966951|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966952|NCT01643980|Progesterone|progesterone|mesh-list
14966953|NCT01643980|Progestins|progestins|mesh-ancestor
14966954|NCT01643980|Hormones|hormones|mesh-ancestor
14966955|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14966956|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966957|NCT01644071|Dexetimide|dexetimide|mesh-list
14966958|NCT01644071|Citalopram|citalopram|mesh-list
13965983|NCT03126916|Vitamins|vitamins|mesh-ancestor
13965984|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
13965985|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13965986|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13965987|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13965988|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13965989|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13965990|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
13965991|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
13965992|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
13965993|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13965994|NCT03126916|Protective Agents|protective agents|mesh-ancestor
13965995|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
13965996|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
13965997|NCT03126916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13965998|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13965999|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13966000|NCT03126708|Paclitaxel|paclitaxel|mesh-list
13966001|NCT03126708|Cetuximab|cetuximab|mesh-list
13966002|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13966003|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966004|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
13966005|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
13966006|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
13966007|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966008|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966009|NCT03126695|Ticagrelor|ticagrelor|mesh-list
13966010|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13966011|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13966012|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13966013|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13966014|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
13966015|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966016|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966017|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966018|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
13966019|NCT03126591|Olaratumab|olaratumab|mesh-list
13966020|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966021|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966022|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
13966023|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13966024|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966025|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966026|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966027|NCT03126422|Analgesics|analgesics|mesh-ancestor
14966959|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14966960|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14966961|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
14966962|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
14966963|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14966964|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966965|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14966966|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14966967|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
14966968|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14966969|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966970|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14966971|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14966972|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14966973|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
13966028|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
13966029|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966030|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14966974|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14966975|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
14966976|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14966977|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14966978|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
14966979|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
14966980|NCT01644110|Pomalidomide|pomalidomide|mesh-list
14966981|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
14966982|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966983|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14966984|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14966985|NCT01644110|Growth Substances|growth substances|mesh-ancestor
14966986|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
14966987|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966988|NCT01644253|Rituximab|rituximab|mesh-list
13966031|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13966032|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13966033|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
13966034|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966035|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966036|NCT03126461|Nivolumab|nivolumab|mesh-list
13966037|NCT03126461|Ipilimumab|ipilimumab|mesh-list
13966038|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966039|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966040|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13966041|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14966989|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
14966990|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14966991|NCT01644253|Idelalisib|idelalisib|mesh-list
14966992|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
14966993|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14966994|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14966995|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
14966996|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14966997|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14966998|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14966999|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
14967000|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967001|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967002|NCT01644773|Dasatinib|dasatinib|mesh-list
14967003|NCT01644773|Crizotinib|crizotinib|mesh-list
14967004|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967005|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14967006|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967007|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967008|NCT01644799|Lenalidomide|lenalidomide|mesh-list
14967009|NCT01644799|Idelalisib|idelalisib|mesh-list
14967010|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
14967011|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967012|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14967013|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14967014|NCT01644799|Growth Substances|growth substances|mesh-ancestor
14967015|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
14967016|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967017|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967018|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967019|NCT01644825|Paclitaxel|paclitaxel|mesh-list
14967020|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14967021|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967022|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967023|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
13966042|NCT03126188|Sertraline|sertraline|mesh-list
13966043|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13966044|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
13966045|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13966046|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13966047|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13966048|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966049|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966050|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966051|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
13966052|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966053|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13968122|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14967024|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
13966054|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13966055|NCT03126123|Acetic Acid|acetic acid|mesh-list
13966056|NCT03126123|Retinol acetate|retinol acetate|mesh-list
13966057|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13966058|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966059|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14967025|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967026|NCT01644838|Promethazine|promethazine|mesh-list
14967027|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
14967028|NCT01644838|Scopolamine|scopolamine|mesh-list
14967029|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14967030|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
14967031|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
14967032|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967033|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967034|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14967035|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
14967036|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14522877|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
14522878|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
14522879|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14522880|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14967037|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
14967038|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967039|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967040|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14967041|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
14967042|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
14967043|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14967044|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
13966060|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
13966061|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966062|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13966063|NCT03126123|Protective Agents|protective agents|mesh-ancestor
13966064|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966065|NCT03126084|Acetaminophen|acetaminophen|mesh-list
13966066|NCT03126084|Tramadol|tramadol|mesh-list
13966067|NCT03126084|Bupivacaine|bupivacaine|mesh-list
13966068|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
13966069|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
13966070|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966071|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966072|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
13966073|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966074|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966075|NCT03126084|Analgesics|analgesics|mesh-ancestor
13966076|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
13966077|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13966078|NCT03126084|Narcotics|narcotics|mesh-ancestor
13966079|NCT03126214|Warfarin|warfarin|mesh-list
13966080|NCT03126214|Anticoagulants|anticoagulants|mesh-list
13966081|NCT03125980|Capecitabine|capecitabine|mesh-list
13966082|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
13966083|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966084|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
13966085|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966086|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966087|NCT03126097|Drospirenone|drospirenone|mesh-list
13966088|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13966089|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
13966090|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13966091|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13966092|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13966093|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
13966094|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13966095|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966096|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13966097|NCT03126097|Estrogens|estrogens|mesh-ancestor
13966098|NCT03126097|Hormones|hormones|mesh-ancestor
13966099|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966100|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13966101|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
14967045|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
14967046|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14967047|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13966102|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14967048|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14967049|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14967050|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
14967051|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
14967052|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
13966103|NCT03126097|Diuretics|diuretics|mesh-ancestor
13966104|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
13966105|NCT03126071|Bevacizumab|bevacizumab|mesh-list
13966106|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
13966107|NCT03126071|Irinotecan|irinotecan|mesh-list
13966108|NCT03126071|Raltitrexed|raltitrexed|mesh-list
13966109|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966110|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967053|NCT01644864|Ropivacaine|ropivacaine|mesh-list
14967054|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
14967055|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
14967056|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14967057|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967058|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
14967059|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967060|NCT01644955|Carboplatin|carboplatin|mesh-list
14967061|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967062|NCT01644994|Cisplatin|cisplatin|mesh-list
14967063|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967064|NCT01645085|Mannitol|mannitol|mesh-list
14967065|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14967066|NCT01645085|Diuretics|diuretics|mesh-ancestor
14967067|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
14967068|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967069|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
14967070|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967071|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
14967072|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967073|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967074|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14967075|NCT01645228|Calcium|calcium|mesh-list
14967076|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967077|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967078|NCT01645241|Ganirelix|ganirelix|mesh-list
14967079|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
14967080|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967081|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967082|NCT01645254|Antimalarials|antimalarials|mesh-list
14967083|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14967084|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14967085|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967086|NCT01645384|Atorvastatin|atorvastatin|mesh-list
14967087|NCT01645384|Calcium|calcium|mesh-list
13966111|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13966112|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13966113|NCT03126071|Growth Substances|growth substances|mesh-ancestor
13966114|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966115|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
13966116|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13966117|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13966118|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966119|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966120|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966121|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
13966122|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13966123|NCT03125772|Paclitaxel|paclitaxel|mesh-list
13966124|NCT03125772|Everolimus|everolimus|mesh-list
13966125|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13966126|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966127|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967088|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967089|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967090|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14967091|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14967092|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
14967093|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967094|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13966128|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
13966129|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
13968123|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14967095|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14967096|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967097|NCT01645410|Atorvastatin|atorvastatin|mesh-list
14967098|NCT01645410|Calcium|calcium|mesh-list
14967099|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967100|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967101|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14967102|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14967103|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
13966130|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966131|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966132|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
13966133|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968124|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968125|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
13968126|NCT03112642|Anesthetics|anesthetics|mesh-list
13968127|NCT03112642|Bupivacaine|bupivacaine|mesh-list
13968128|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
13968129|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14967104|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967105|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14967106|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14967107|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967108|NCT01645423|Atorvastatin|atorvastatin|mesh-list
14967109|NCT01645423|Calcium|calcium|mesh-list
14967110|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967111|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967112|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14967113|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14967114|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
14967115|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967116|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14967117|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14967118|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967119|NCT01645449|Atorvastatin|atorvastatin|mesh-list
14967120|NCT01645449|Calcium|calcium|mesh-list
14967121|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967122|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967123|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13968130|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968131|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
13968132|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968133|NCT03112577|Fluticasone|fluticasone|mesh-list
13968134|NCT03112577|Xhance|xhance|mesh-list
14236493|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
14967124|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14967125|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
14967126|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967127|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14967128|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14967129|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967130|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14967131|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
14967132|NCT01645475|Coagulants|coagulants|mesh-ancestor
14967133|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14967134|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
14967135|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967136|NCT01645748|Cisplatin|cisplatin|mesh-list
14967137|NCT01645748|Docetaxel|docetaxel|mesh-list
14967138|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967139|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967140|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14967141|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14967142|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967143|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
14967144|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14967145|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14967146|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
14967147|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967148|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967149|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967150|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
14967151|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
14967152|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967153|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
14967154|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14967155|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
14967156|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
14967157|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14967158|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967159|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967160|NCT01645800|Muramidase|muramidase|mesh-list
14967161|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028722|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
15028723|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028724|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15028725|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15028726|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15028727|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028728|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028729|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028730|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
15028731|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15028732|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
15028733|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15028734|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15028735|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15028736|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
15028737|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028738|NCT01957007|Docetaxel|docetaxel|mesh-list
15028739|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028740|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
15028741|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
15028742|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
15028743|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028744|NCT01957046|Laxatives|laxatives|mesh-list
15028745|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028746|NCT01957189|Tamsulosin|tamsulosin|mesh-list
15028747|NCT01957189|Dutasteride|dutasteride|mesh-list
15028748|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15028749|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15028750|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15028751|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028752|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028753|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028754|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028755|NCT01957189|Urological Agents|urological agents|mesh-ancestor
15028756|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15028757|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15028758|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028759|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
15028760|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028761|NCT01957293|Albuterol|albuterol|mesh-list
15028762|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15028763|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
15028764|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028765|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028766|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15028767|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
15028768|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
13966134|NCT03125694|Pioglitazone|pioglitazone|mesh-list
13966135|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13966136|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13966137|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966138|NCT03125694|Incretins|incretins|mesh-ancestor
13966139|NCT03125694|Hormones|hormones|mesh-ancestor
13966140|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966141|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13966142|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
13966143|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966144|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966145|NCT03125746|Exemestane|exemestane|mesh-list
13966146|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966147|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13966148|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13966149|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966150|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966151|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13966152|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
13966153|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966154|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966155|NCT03125616|Vaccines|vaccines|mesh-list
13966156|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
13966157|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966158|NCT03125486|Belimumab|belimumab|mesh-list
13966159|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966160|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
13966161|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966162|NCT03125473|Vaccines|vaccines|mesh-list
13966163|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
13966164|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966165|NCT03125187|Heparin|heparin|mesh-list
13966166|NCT03125187|Calcium heparin|calcium heparin|mesh-list
14967162|NCT01645826|Diltiazem|diltiazem|mesh-list
14967163|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967164|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14967165|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967166|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967167|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967168|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967169|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
14967170|NCT01645839|Cytarabine|cytarabine|mesh-list
14967171|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14967172|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
14967173|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967174|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967175|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
14967176|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967177|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967178|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
14967179|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966167|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
14967180|NCT01646229|Polymyxins|polymyxins|mesh-list
14967181|NCT01646229|Polymyxin B|polymyxin b|mesh-list
14967182|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14967183|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967184|NCT01646281|Flecainide|flecainide|mesh-list
14967185|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14967186|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14967187|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14967188|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967189|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967190|NCT01646294|Mirabegron|mirabegron|mesh-list
14967191|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14967192|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14967193|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14967194|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
14967195|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967196|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967197|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967198|NCT01646294|Urological Agents|urological agents|mesh-ancestor
14967199|NCT01646307|Atorvastatin|atorvastatin|mesh-list
14967200|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14967201|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14967202|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14967203|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
14967204|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967205|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14967206|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14967207|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967208|NCT01646437|Aspirin|aspirin|mesh-list
14967209|NCT01646437|Vitamin D|vitamin d|mesh-list
14967210|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
14967211|NCT01646437|Vitamins|vitamins|mesh-ancestor
14967212|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
14967213|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967214|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14967215|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14967216|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14967217|NCT01646437|Analgesics|analgesics|mesh-ancestor
14967218|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
14967219|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967220|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967221|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14967222|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14967223|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14967224|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967225|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14967226|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14967227|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967228|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
14967229|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967230|NCT01646515|Udenafil|udenafil|mesh-list
14967231|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14967232|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14967233|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967234|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967235|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
14967236|NCT01646554|Aflibercept|aflibercept|mesh-list
14967237|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967238|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14967239|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14967240|NCT01646554|Growth Substances|growth substances|mesh-ancestor
14967241|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967242|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
14967243|NCT01646567|Betamethasone|betamethasone|mesh-list
14967244|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
13966168|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13966169|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13966170|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966171|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13966172|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
13966173|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967245|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14967246|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
14967247|NCT01646567|Calcipotriene|calcipotriene|mesh-list
14967248|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14967249|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967250|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
14967251|NCT01646567|Hormones|hormones|mesh-ancestor
14967252|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967253|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967254|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14967255|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
14967256|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
14967257|NCT01646580|Ciclopirox|ciclopirox|mesh-list
14967258|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
14967259|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967260|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
14967261|NCT01646619|Analgesics|analgesics|mesh-ancestor
14967262|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
14967263|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967264|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967265|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
14967266|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14967267|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14967268|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
14967269|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14967270|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967271|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967272|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967273|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
14967274|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14967275|NCT01646684|Pasireotide|pasireotide|mesh-list
14967276|NCT01646684|Hormones|hormones|mesh-ancestor
14967277|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967278|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967279|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
13966174|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
13966175|NCT03124680|Narcotics|narcotics|mesh-ancestor
13966176|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966177|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966178|NCT03124680|Analgesics|analgesics|mesh-ancestor
13966179|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
13966180|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967280|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966181|NCT03124524|Dienogest|dienogest|mesh-list
13966182|NCT03124524|Drospirenone|drospirenone|mesh-list
13966183|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13966184|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14967281|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
14967282|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967283|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14967284|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14967285|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
14967286|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967287|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967288|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14967289|NCT01646775|Fentanyl|fentanyl|mesh-list
14967290|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14967291|NCT01646775|Narcotics|narcotics|mesh-ancestor
14967292|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14967293|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967294|NCT01646775|Analgesics|analgesics|mesh-ancestor
14967295|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
14967296|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967297|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14967298|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14967299|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
14967300|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
14967301|NCT01646788|Paclitaxel|paclitaxel|mesh-list
14967302|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14967303|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967304|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967305|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
14967306|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
14967307|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967308|NCT01646853|Fluorouracil|fluorouracil|mesh-list
14967309|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967310|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
14967311|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967312|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14967313|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967314|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
14967315|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967316|NCT01647152|Ustekinumab|ustekinumab|mesh-list
14967317|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
14967318|NCT01647165|Dexamethasone|dexamethasone|mesh-list
14967319|NCT01647165|Lenalidomide|lenalidomide|mesh-list
14967320|NCT01647165|Bortezomib|bortezomib|mesh-list
14967321|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967322|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
14967323|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
14967324|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967325|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967326|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14967327|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
14967328|NCT01647165|Hormones|hormones|mesh-ancestor
14967329|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967330|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14967331|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967332|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
13966185|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13966186|NCT03124524|Estradiol|estradiol|mesh-list
13966187|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13966188|NCT03124524|Estrogens|estrogens|mesh-ancestor
13966189|NCT03124524|Hormones|hormones|mesh-ancestor
13966190|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966191|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966192|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13966193|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
13966194|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13966195|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13966196|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13966197|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13966198|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13966199|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
13966200|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13966201|NCT03124524|Diuretics|diuretics|mesh-ancestor
13966202|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
13966203|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13966204|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13966205|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966206|NCT03124420|Amoxicillin|amoxicillin|mesh-list
13966207|NCT03124420|Clarithromycin|clarithromycin|mesh-list
13966208|NCT03124420|Lansoprazole|lansoprazole|mesh-list
13966209|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
13966210|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13966211|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966212|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13966213|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966214|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966215|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13966216|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13966217|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13966218|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13966219|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13966220|NCT03124082|Lidocaine|lidocaine|mesh-list
13966221|NCT03124082|Clonidine|clonidine|mesh-list
13966222|NCT03124082|Ketamine|ketamine|mesh-list
13966223|NCT03124082|Remifentanil|remifentanil|mesh-list
13966224|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
13966225|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
13966226|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966227|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966228|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
14967333|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14967334|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14967335|NCT01647165|Growth Substances|growth substances|mesh-ancestor
14967336|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
14967337|NCT01647256|Nikkomycin|nikkomycin|mesh-list
14967338|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
14967339|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967340|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967341|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967342|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
14967343|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14967344|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967345|NCT01647412|Curcumin|curcumin|mesh-list
14967346|NCT01647412|Hormones|hormones|mesh-list
14967347|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967348|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967349|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14967350|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14967351|NCT01647412|Analgesics|analgesics|mesh-ancestor
14967352|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
14967353|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967354|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967355|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14967356|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967357|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966229|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966230|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13966231|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13966232|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13966233|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966234|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800290|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800291|NCT00786695|Esomeprazole|esomeprazole|mesh-list
14800292|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14800293|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14800294|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14800295|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800296|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800297|NCT00786734|Pitavastatin|pitavastatin|mesh-list
14800298|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14800299|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14800300|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14800301|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
14800302|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800303|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800304|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14800305|NCT00786851|Lenalidomide|lenalidomide|mesh-list
14800306|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
14800307|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800308|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14967358|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967359|NCT01647529|Ganciclovir|ganciclovir|mesh-list
14967360|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14967361|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
14967362|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967363|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14967364|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967365|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967366|NCT01647555|Cetuximab|cetuximab|mesh-list
14967367|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14967368|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967369|NCT01647633|Calcium|calcium|mesh-list
14967370|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967371|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967372|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14967373|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14967374|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
14967375|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14967376|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
14967377|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967378|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967379|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
14967380|NCT01647646|Hormones|hormones|mesh-ancestor
14967381|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967382|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
14967383|NCT01647659|Trametinib|trametinib|mesh-list
14967384|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967385|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14967386|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967387|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967388|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14967389|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967390|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
14967391|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14967392|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14967393|NCT01647685|Prednisolone|prednisolone|mesh-list
14967394|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
14967395|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14967396|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
14967397|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967398|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
14967399|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
14967400|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967401|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967402|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14967403|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
14967404|NCT01647685|Hormones|hormones|mesh-ancestor
14967405|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967406|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14967407|NCT01647685|Protective Agents|protective agents|mesh-ancestor
14967408|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14967409|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967410|NCT01647828|Gemcitabine|gemcitabine|mesh-list
14967411|NCT01647828|Paclitaxel|paclitaxel|mesh-list
14967412|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14967413|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967414|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967415|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
14967416|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
14967417|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966235|NCT03124082|Analgesics|analgesics|mesh-ancestor
13966236|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13966237|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13966238|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
13966239|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13966240|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13966241|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966242|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13966243|NCT03124082|Narcotics|narcotics|mesh-ancestor
13966244|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13966245|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
14967418|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14967419|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
14967420|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
13966246|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
14967421|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967422|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967423|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967424|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
14967425|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028769|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028770|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15028771|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15028772|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15028773|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
13966247|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13966248|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13966249|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13966250|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
13966251|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
13966252|NCT03123913|Testosterone|testosterone|mesh-list
13966253|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
13966254|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
13966255|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13966256|NCT03123913|Androgens|androgens|mesh-ancestor
13966257|NCT03123913|Hormones|hormones|mesh-ancestor
13966258|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966259|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028774|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028775|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028776|NCT01957319|Vitamin E|vitamin e|mesh-list
15028777|NCT01957319|Silybin|silybin|mesh-list
15028778|NCT01957319|Vitamins|vitamins|mesh-ancestor
15028779|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
15028780|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028781|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
15028782|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028783|NCT01957319|Protective Agents|protective agents|mesh-ancestor
15028784|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15028785|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028786|NCT01957436|Docetaxel|docetaxel|mesh-list
15028787|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
15028788|NCT01957436|Androgens|androgens|mesh-list
15028789|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028790|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
15028791|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
13966260|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13966261|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966262|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
13968135|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13968136|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15028792|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
15028793|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028794|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15028795|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028796|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
15028797|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028798|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028799|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15028800|NCT01957436|Hormones|hormones|mesh-ancestor
15028801|NCT01957449|Propranolol|propranolol|mesh-list
15028802|NCT01957449|Metoprolol|metoprolol|mesh-list
15028803|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15028804|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15028805|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028806|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028807|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028808|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028809|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15028810|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15028811|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028812|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
15028813|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
15028814|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028815|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15028816|NCT01957540|Ticagrelor|ticagrelor|mesh-list
15028817|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15028818|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15028819|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14967426|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14967427|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14967428|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967429|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967430|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
14967431|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967432|NCT01647893|Bivalirudin|bivalirudin|mesh-list
14967433|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
14967434|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14967435|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
14967436|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967437|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967438|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
14967439|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14967440|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967441|NCT01647932|Diuretics|diuretics|mesh-ancestor
14967442|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
14967443|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967444|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13966263|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
13966264|NCT03123770|Docetaxel|docetaxel|mesh-list
13966265|NCT03123770|Doxorubicin|doxorubicin|mesh-list
13966266|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13966267|NCT03123770|Epirubicin|epirubicin|mesh-list
13966268|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966269|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
13966270|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966271|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966272|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13966273|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
14967445|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967446|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967447|NCT01647984|Vitamins|vitamins|mesh-list
14967448|NCT01647984|Vitamin E|vitamin e|mesh-list
14967449|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
14967450|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
14967451|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967452|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
14967453|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967454|NCT01647984|Protective Agents|protective agents|mesh-ancestor
14967455|NCT01648010|Mitomycins|mitomycins|mesh-list
14967456|NCT01648010|Mitomycin|mitomycin|mesh-list
14967457|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14967458|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967459|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
14967460|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967461|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14967462|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967463|NCT01648036|Heparin|heparin|mesh-list
13966274|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966275|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966276|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13966277|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
13966278|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
13966279|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
13966280|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13966281|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13966282|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13966283|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967464|NCT01648036|Calcium heparin|calcium heparin|mesh-list
14967465|NCT01648036|Dalteparin|dalteparin|mesh-list
14967466|NCT01648036|Tinzaparin|tinzaparin|mesh-list
14967467|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14967468|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
14967469|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14967470|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14967471|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967472|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14967473|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14967474|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967475|NCT01648218|Insulin|insulin|mesh-list
14967476|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14967477|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
14967478|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
14967479|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
13966284|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
14967480|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
14967481|NCT01648218|Protamines|protamines|mesh-list
14967482|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14967483|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967484|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
14967485|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967486|NCT01648218|Coagulants|coagulants|mesh-ancestor
14967487|NCT01648231|Losartan|losartan|mesh-list
14967488|NCT01648231|Amlodipine|amlodipine|mesh-list
14967489|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967490|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14967491|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967492|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967493|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967494|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967495|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
14967496|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14967497|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14967498|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14967499|NCT01648257|Cabotegravir|cabotegravir|mesh-list
14967500|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14967501|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14967502|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967503|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967504|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14967505|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14967506|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
14967507|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967508|NCT01648465|Everolimus|everolimus|mesh-list
14967509|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967510|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967511|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
14967512|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967513|NCT01648517|Gemcitabine|gemcitabine|mesh-list
14967514|NCT01648517|Carboplatin|carboplatin|mesh-list
14967515|NCT01648517|Docetaxel|docetaxel|mesh-list
14967516|NCT01648517|Vinorelbine|vinorelbine|mesh-list
14967517|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967518|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14967519|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
14967520|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967521|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
14967522|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967523|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967524|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967525|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
14967526|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967527|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967528|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
14967529|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
14967530|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14967531|NCT01648556|Prednisone|prednisone|mesh-list
14967532|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967533|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
14967534|NCT01648556|Hormones|hormones|mesh-ancestor
14967535|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967536|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966285|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
13966286|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
13966287|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966288|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
14967537|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14967538|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967539|NCT01648595|Fentanyl|fentanyl|mesh-list
14967540|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14967541|NCT01648595|Narcotics|narcotics|mesh-ancestor
14967542|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14967543|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967544|NCT01648595|Analgesics|analgesics|mesh-ancestor
14967545|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
14967546|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967547|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14967548|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14967549|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
14967550|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
14967551|NCT01648608|Exemestane|exemestane|mesh-list
14967552|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967553|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14967554|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14967555|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967556|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967557|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14967558|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
14967559|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967560|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967561|NCT01648634|Nebivolol|nebivolol|mesh-list
14967562|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967563|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
14967564|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14967565|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14967566|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14967567|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
14967568|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967569|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967570|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967571|NCT01648712|Heparin|heparin|mesh-list
13966289|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13966290|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966291|NCT03123744|Palbociclib|palbociclib|mesh-list
13966292|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800309|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14800310|NCT00786851|Growth Substances|growth substances|mesh-ancestor
14800311|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
14800312|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800313|NCT00787007|Equol|equol|mesh-list
14800314|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
14800315|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14800316|NCT00787007|Estrogens|estrogens|mesh-ancestor
14800317|NCT00787007|Hormones|hormones|mesh-ancestor
14800318|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966293|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14967572|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
14967573|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14967574|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14967575|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967576|NCT01648777|Bupivacaine|bupivacaine|mesh-list
14967577|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
14967578|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
14967579|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14967580|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967581|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
14967582|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967583|NCT01648829|Atorvastatin|atorvastatin|mesh-list
14967584|NCT01648829|Pitavastatin|pitavastatin|mesh-list
14967585|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14967586|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14967587|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
13966294|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966295|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966296|NCT03123718|Methotrexate|methotrexate|mesh-list
13966297|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13966298|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
13966299|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13966300|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966301|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966302|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
13966303|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966304|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966305|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
13966306|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966307|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13966308|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966309|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
13966310|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966311|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13966312|NCT03123406|Cinacalcet|cinacalcet|mesh-list
13966313|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800319|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800320|NCT00787111|Fluoxetine|fluoxetine|mesh-list
15028820|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13966314|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966315|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
13966316|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
13966317|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966318|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13966319|NCT03123484|Gefitinib|gefitinib|mesh-list
13966320|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966321|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13966322|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966323|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967588|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967589|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14967590|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14967591|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967592|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14967593|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14967594|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967595|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
14967596|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967597|NCT01649024|Tremelimumab|tremelimumab|mesh-list
14967598|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967599|NCT01649037|Terlipressin|terlipressin|mesh-list
14967600|NCT01649037|Epinephrine|epinephrine|mesh-list
14967601|NCT01649037|Racepinephrine|racepinephrine|mesh-list
14967602|NCT01649037|Norepinephrine|norepinephrine|mesh-list
14967603|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
14967604|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14967605|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14967606|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
14967607|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967608|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967609|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967610|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14967611|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14967612|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
14967613|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967614|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14967615|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
14967616|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
14967617|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
14967618|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14967619|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967620|NCT01649245|Interferons|interferons|mesh-list
14967621|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967622|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
14967623|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967624|NCT01649258|Granisetron|granisetron|mesh-list
14967625|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
14967626|NCT01649258|Aprepitant|aprepitant|mesh-list
14967627|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
14967628|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
14967629|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967630|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967631|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14967632|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14967633|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
14967634|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967635|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967636|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14967637|NCT01649284|Afatinib|afatinib|mesh-list
14967638|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967639|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13966324|NCT03123289|Gallium citrate|gallium citrate|mesh-list
13966325|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800321|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14800322|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14800323|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800324|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800325|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800326|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
14800327|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800328|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14800329|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
14967640|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967641|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967642|NCT01649336|Paclitaxel|paclitaxel|mesh-list
14967643|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
14967644|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14967645|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967646|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967647|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
14967648|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967649|NCT01649466|Insulin|insulin|mesh-list
14967650|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14967651|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14967652|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967653|NCT01649479|Antibodies|antibodies|mesh-list
14967654|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
14967655|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
14967656|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967657|NCT01649544|Amiodarone|amiodarone|mesh-list
14967658|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14967659|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
14967660|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14967661|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967662|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967663|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14967664|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14967665|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14967666|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967667|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14967668|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14967669|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14967670|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
14967671|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14967672|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967673|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14967674|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14967675|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
14967676|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967677|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967678|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
14967679|NCT01649635|Prednisone|prednisone|mesh-list
14967680|NCT01649635|Sargramostim|sargramostim|mesh-list
14967681|NCT01649635|Lenograstim|lenograstim|mesh-list
14967682|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967683|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
14967684|NCT01649635|Hormones|hormones|mesh-ancestor
14967685|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967686|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967687|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14967688|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967689|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
14967690|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14967691|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967692|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14967693|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14967694|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967695|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967696|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14967697|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14967698|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14967699|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
14967700|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
14967701|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14967702|NCT01649674|Cathartics|cathartics|mesh-ancestor
14967703|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14967704|NCT01649713|Vaccines|vaccines|mesh-list
14967705|NCT01649713|Immunologic Factors|immunologic factors|mesh-ancestor
14967706|NCT01649713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028821|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15028822|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
15028823|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028824|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028825|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035024|NCT01998685|Remifentanil|remifentanil|mesh-list
15035025|NCT01998685|Propofol|propofol|mesh-list
14967707|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
14967708|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
14967709|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14967710|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14967711|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967712|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967713|NCT01649739|Urological Agents|urological agents|mesh-ancestor
14967714|NCT01649830|Temozolomide|temozolomide|mesh-list
14967715|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14967716|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
14967717|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967718|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967719|NCT01649895|Cycloserine|cycloserine|mesh-list
14967720|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14967721|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967722|NCT01649895|Renal Agents|renal agents|mesh-ancestor
14967723|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14967724|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
14967725|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14967726|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
14967727|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967728|NCT01649921|Interferons|interferons|mesh-list
14967729|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
14967730|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967731|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
14967732|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967733|NCT01649960|Sirolimus|sirolimus|mesh-list
14967734|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14967735|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966326|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13966327|NCT03123445|Gemcitabine|gemcitabine|mesh-list
13966328|NCT03123445|Endostar protein|endostar protein|mesh-list
13966329|NCT03123445|Endostatins|endostatins|mesh-list
13966330|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966331|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966332|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
13966333|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966334|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
13966335|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966336|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966337|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966338|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
13966339|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967736|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14967737|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967738|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
13966340|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13966341|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13966342|NCT03123445|Growth Substances|growth substances|mesh-ancestor
13966343|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
13966344|NCT03123276|Gemcitabine|gemcitabine|mesh-list
13966345|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
13966346|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966347|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
13966348|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966349|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966350|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
13966351|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966352|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966353|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966354|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
13966355|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966356|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966357|NCT03123211|Veliparib|veliparib|mesh-list
13966358|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13966359|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966360|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966361|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966362|NCT03123016|Apremilast|apremilast|mesh-list
13966363|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13966364|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966365|NCT03123016|Analgesics|analgesics|mesh-ancestor
13966366|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
13966367|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967739|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967740|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
14967741|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967742|NCT01650012|Eplerenone|eplerenone|mesh-list
14967743|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14967744|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
14967745|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967746|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967747|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14967748|NCT01650012|Diuretics|diuretics|mesh-ancestor
14967749|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
14967750|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967751|NCT01650090|Cisplatin|cisplatin|mesh-list
14967752|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967753|NCT01650129|Insulin|insulin|mesh-list
14967754|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14967755|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
14967756|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
14967757|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14967758|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967759|NCT01650181|Selenium|selenium|mesh-list
14967760|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
14967761|NCT01650181|Metformin|metformin|mesh-list
14967762|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14967763|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967764|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
14967765|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967766|NCT01650181|Protective Agents|protective agents|mesh-ancestor
14967767|NCT01650181|Trace Elements|trace elements|mesh-ancestor
14967768|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
14967769|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
14967770|NCT01650181|Vitamins|vitamins|mesh-ancestor
14967771|NCT01650272|Minoxidil|minoxidil|mesh-list
14967772|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14967773|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967774|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
14967775|NCT01650376|Paclitaxel|paclitaxel|mesh-list
14967776|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14967777|NCT01650376|Carboplatin|carboplatin|mesh-list
14967778|NCT01650376|Olaparib|olaparib|mesh-list
14967779|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14967780|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967781|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
14967782|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
13966368|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966369|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966370|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966371|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13966372|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13966373|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966374|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966375|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
13966376|NCT03123107|Vitamins|vitamins|mesh-ancestor
13966377|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
13966378|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966379|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
14967783|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
14967784|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967785|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14967786|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967787|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
14967788|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14967789|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
14967790|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967791|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
14967792|NCT01650415|Hematinics|hematinics|mesh-ancestor
14967793|NCT01650428|Bevacizumab|bevacizumab|mesh-list
14967794|NCT01650428|Fluorouracil|fluorouracil|mesh-list
14967795|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
14967796|NCT01650428|Irinotecan|irinotecan|mesh-list
14967797|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14967798|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967799|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14967800|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13968137|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
14967801|NCT01650428|Growth Substances|growth substances|mesh-ancestor
14967802|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967803|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
14967804|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
15028826|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
14967805|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967806|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14967807|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967808|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
14967809|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14967810|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14967811|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967812|NCT01650441|Beclomethasone|beclomethasone|mesh-list
14967813|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
14967814|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14967815|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
14967816|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967817|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967818|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14800330|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800331|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14800332|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14800333|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967819|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
14967820|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14967821|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14967822|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14967823|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
14967824|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522881|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14522882|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14522883|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14522884|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14522885|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14522886|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
14522887|NCT03558555|Acetaminophen|acetaminophen|mesh-list
14522888|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14522889|NCT03558555|Analgesics|analgesics|mesh-ancestor
14522890|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
14522891|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522892|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522893|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
14522894|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14522895|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
14522896|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522897|NCT03559062|Ivacaftor|ivacaftor|mesh-list
14522898|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14522899|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522900|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522901|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
14522902|NCT03559179|Narcotics|narcotics|mesh-ancestor
14800334|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14800335|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
14967825|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967826|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967827|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
14967828|NCT01650441|Hormones|hormones|mesh-ancestor
14967829|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14967830|NCT01650493|Listerine|listerine|mesh-list
14967831|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
14967832|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
14967833|NCT01650493|Protective Agents|protective agents|mesh-ancestor
14967834|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967835|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14967836|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800336|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
14800337|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800338|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
14800339|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800340|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
14967837|NCT01650506|Metformin|metformin|mesh-list
15035026|NCT01998685|Sevoflurane|sevoflurane|mesh-list
15035027|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15035028|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035029|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035030|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14967838|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14967839|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14967840|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967841|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967842|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14967843|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967844|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967845|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
14967846|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967847|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967848|NCT01650649|Lofexidine|lofexidine|mesh-list
14967849|NCT01650649|Clonidine|clonidine|mesh-list
14967850|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967851|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14967852|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967853|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
14967854|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967855|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14967856|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14967857|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14967858|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
14967859|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967860|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967861|NCT01650649|Analgesics|analgesics|mesh-ancestor
14967862|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
14967863|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
14967864|NCT01650662|Cyclosporine|cyclosporine|mesh-list
14967865|NCT01650662|Cyclosporins|cyclosporins|mesh-list
14967866|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967867|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967868|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14967869|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
14967870|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967871|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
14967872|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14967873|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
14967874|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966380|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966381|NCT03123107|Protective Agents|protective agents|mesh-ancestor
13966382|NCT03122938|Lactoferrin|lactoferrin|mesh-list
13966383|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966384|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
13966385|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13966386|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13966387|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966388|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
13966389|NCT03122782|Coagulants|coagulants|mesh-ancestor
13966390|NCT03122561|Acetaminophen|acetaminophen|mesh-list
13966391|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966392|NCT03122561|Analgesics|analgesics|mesh-ancestor
13966393|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
13966394|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966395|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966396|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
13966397|NCT03122509|Durvalumab|durvalumab|mesh-list
13966398|NCT03122509|Tremelimumab|tremelimumab|mesh-list
14967875|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14967876|NCT01650701|Rituximab|rituximab|mesh-list
14967877|NCT01650701|Lenalidomide|lenalidomide|mesh-list
14967878|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14967879|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14967880|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967881|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
14967882|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967883|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14967884|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14967885|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14967886|NCT01650701|Growth Substances|growth substances|mesh-ancestor
14967887|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
14967888|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14967889|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
14967890|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967891|NCT01650727|Rituximab|rituximab|mesh-list
14967892|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966399|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14967893|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967894|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
14967895|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967896|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14967897|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14967898|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14967899|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14967900|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967901|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967902|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967903|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967904|NCT01650740|Analgesics|analgesics|mesh-ancestor
14967905|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
14967906|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967907|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
14967908|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14967909|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
14967910|NCT01650792|Aspirin|aspirin|mesh-list
14967911|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14967912|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14967913|NCT01650792|Analgesics|analgesics|mesh-ancestor
14967914|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
14967915|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967916|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967917|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14967918|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14967919|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14967920|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14967921|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967922|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14967923|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14967924|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14967925|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
14967926|NCT01650870|Lactulose|lactulose|mesh-list
14967927|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14967928|NCT01650883|Vitamin D|vitamin d|mesh-list
14967929|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
14967930|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
14967931|NCT01650883|Vitamins|vitamins|mesh-list
14967932|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
14967933|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967934|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14967935|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14967936|NCT01650961|Palonosetron|palonosetron|mesh-list
14967937|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
14967938|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
14967939|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14967940|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966400|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966401|NCT03122639|Atorvastatin|atorvastatin|mesh-list
13966402|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13966403|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13966404|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
14967941|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14967942|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14967943|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14967944|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
14967945|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967946|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967947|NCT01651130|Carbetocin|carbetocin|mesh-list
14967948|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
14967949|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14967950|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967951|NCT01651156|Tolvaptan|tolvaptan|mesh-list
14967952|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14967953|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967954|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
14522903|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522904|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966405|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966406|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14522905|NCT03559179|Analgesics|analgesics|mesh-ancestor
13966407|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13966408|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966409|NCT03122652|Teriflunomide|teriflunomide|mesh-list
13966410|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13966411|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966412|NCT03122652|Analgesics|analgesics|mesh-ancestor
13966413|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
13966414|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966415|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800341|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14967955|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967956|NCT01651169|Methylphenidate|methylphenidate|mesh-list
14967957|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14967958|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967959|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14967960|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14967961|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14967962|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967963|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
14967964|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967965|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
14967966|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14967967|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14967968|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967969|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
14967970|NCT01651182|Coagulants|coagulants|mesh-ancestor
14967971|NCT01651312|Mirabegron|mirabegron|mesh-list
14967972|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14967973|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14967974|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14967975|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
14967976|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967977|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967978|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967979|NCT01651312|Urological Agents|urological agents|mesh-ancestor
14800342|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14800343|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800344|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800345|NCT00787410|Gefitinib|gefitinib|mesh-list
14800346|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800347|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14967980|NCT01651325|Isavuconazole|isavuconazole|mesh-list
14967981|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
14967982|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
14967983|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
14967984|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14967985|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14967986|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967987|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967988|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967989|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
14800348|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800349|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800350|NCT00787436|Thalidomide|thalidomide|mesh-list
14800351|NCT00787436|Timolol|timolol|mesh-list
14800352|NCT00787436|Propranolol|propranolol|mesh-list
14800353|NCT00787436|Nadolol|nadolol|mesh-list
14800354|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800355|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
14800356|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800357|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
14800358|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800359|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800360|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14800361|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14800362|NCT00787436|Growth Substances|growth substances|mesh-ancestor
14800363|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
14800364|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800365|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14800366|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14800367|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14800368|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967990|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800369|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800370|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14800371|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14967991|NCT01651364|Cabergoline|cabergoline|mesh-list
14967992|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14967993|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14967994|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
14967995|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
14967996|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14967997|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14967998|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14967999|NCT01651377|Pramipexole|pramipexole|mesh-list
14968000|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
14968001|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800372|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
14800373|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
14800374|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
14800375|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800376|NCT00787462|Pregabalin|pregabalin|mesh-list
14800377|NCT00787462|Analgesics|analgesics|mesh-ancestor
14800378|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
14800379|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800380|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800381|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
14800382|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14800383|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800384|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800385|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800386|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14800387|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14800388|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968002|NCT01651377|Protective Agents|protective agents|mesh-ancestor
14968003|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968004|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14968005|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14968006|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
14968007|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
14968008|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968009|NCT01651390|Sirolimus|sirolimus|mesh-list
14968010|NCT01651390|Paclitaxel|paclitaxel|mesh-list
14968011|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14968012|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968013|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
14968014|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
14968015|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
14968016|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968017|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968018|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968019|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14968020|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
14968021|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968022|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
13966416|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966417|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966418|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966419|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
13966420|NCT03122730|Epoprostenol|epoprostenol|mesh-list
14968023|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968024|NCT01651416|Lumefantrine|lumefantrine|mesh-list
14968025|NCT01651416|Artemether|artemether|mesh-list
14968026|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
14968027|NCT01651416|Piperaquine|piperaquine|mesh-list
14968028|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
14968029|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14968030|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14968031|NCT01651416|Amodiaquine|amodiaquine|mesh-list
14968032|NCT01651416|Artenimol|artenimol|mesh-list
14968033|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
14968034|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14968035|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14968036|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968037|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14968038|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968039|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966421|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14968040|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14968041|NCT01651416|Renal Agents|renal agents|mesh-ancestor
14968042|NCT01651481|Montelukast|montelukast|mesh-list
14968043|NCT01651481|Levocetirizine|levocetirizine|mesh-list
13966422|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13966423|NCT03122613|Curcumin|curcumin|mesh-list
13966424|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13966425|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966426|NCT03122613|Analgesics|analgesics|mesh-ancestor
13966427|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
13966428|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966429|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966430|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966431|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966432|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966433|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966434|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966435|NCT03122756|Dexamethasone|dexamethasone|mesh-list
13966436|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966437|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
13966438|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
13966439|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966440|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966441|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13966442|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
13966443|NCT03122756|Hormones|hormones|mesh-ancestor
14968044|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14968045|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
14968046|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14968047|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
14968048|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968049|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968050|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14968051|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14968052|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968053|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14968054|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14968055|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
14968056|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
14968057|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028827|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15028828|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15028829|NCT01957631|Prednisolone|prednisolone|mesh-list
13966444|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966445|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13966446|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966447|NCT03122678|Thiamine|thiamine|mesh-list
13966448|NCT03122678|Vitamins|vitamins|mesh-ancestor
13966449|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
13966450|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966451|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
13966452|NCT03122717|Gefitinib|gefitinib|mesh-list
13966453|NCT03122717|Osimertinib|osimertinib|mesh-list
13966454|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966455|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13966456|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966457|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966458|NCT03122665|Nefopam|nefopam|mesh-list
14800389|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800390|NCT00787501|Citalopram|citalopram|mesh-list
14800391|NCT00787501|Fluoxetine|fluoxetine|mesh-list
14800392|NCT00787501|Sertraline|sertraline|mesh-list
14800393|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14800394|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14800395|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800396|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800397|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800398|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
14800399|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800400|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14800401|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
14800402|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800403|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14800404|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14800405|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800406|NCT00787553|Cefazolin|cefazolin|mesh-list
14800407|NCT00787553|Tinidazole|tinidazole|mesh-list
14800408|NCT00787553|Imidazole|imidazole|mesh-list
14800409|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800410|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800411|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800412|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800413|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
14800414|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14800415|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14800416|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14800417|NCT00787657|Interferons|interferons|mesh-list
14800418|NCT00787657|Interferon-beta|interferon-beta|mesh-list
14800419|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
14800420|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800421|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
14800422|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800423|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
14800424|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800425|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14968058|NCT01651520|Flumazenil|flumazenil|mesh-list
14968059|NCT01651520|Antidotes|antidotes|mesh-ancestor
14968060|NCT01651520|Protective Agents|protective agents|mesh-ancestor
14968061|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968062|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
14968063|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
14968064|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968065|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968066|NCT01651572|Rocuronium|rocuronium|mesh-list
14968067|NCT01651572|Cisatracurium|cisatracurium|mesh-list
14968068|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14968069|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14968070|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14968071|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968072|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968073|NCT01651585|Valacyclovir|valacyclovir|mesh-list
14968074|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
14968075|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968076|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14968077|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
14968078|NCT01651715|Antibodies|antibodies|mesh-list
13966459|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966460|NCT03122665|Analgesics|analgesics|mesh-ancestor
13966461|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
13966462|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966463|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968079|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
14968080|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968081|NCT01651728|Simvastatin|simvastatin|mesh-list
14968082|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14968083|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14968084|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
14968085|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968086|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14968087|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14968088|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968089|NCT01651754|Vaccines|vaccines|mesh-list
14968090|NCT01651754|Immunologic Factors|immunologic factors|mesh-ancestor
13966464|NCT03122444|Imipramine|imipramine|mesh-list
13966465|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13966466|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
13966467|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13966468|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13966469|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13966470|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966471|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966472|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
13966473|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966474|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966475|NCT03122769|Metformin|metformin|mesh-list
13966476|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13966477|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968091|NCT01651754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968092|NCT01651923|Heparin|heparin|mesh-list
14968093|NCT01651923|Calcium heparin|calcium heparin|mesh-list
13966478|NCT03122353|Calcitriol|calcitriol|mesh-list
13966479|NCT03122353|Betamethasone|betamethasone|mesh-list
14968094|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
14968095|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14968096|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13966480|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
13966481|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14968097|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968098|NCT01651962|Fentanyl|fentanyl|mesh-list
14968099|NCT01651962|Terbutaline|terbutaline|mesh-list
14968100|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14968101|NCT01651962|Narcotics|narcotics|mesh-ancestor
14968102|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968103|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968104|NCT01651962|Analgesics|analgesics|mesh-ancestor
14968105|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
14968106|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968107|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14968108|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14968109|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
14968110|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
14968111|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14968112|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
14968113|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14968114|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
14968115|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
14968116|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
14968117|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14968118|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14968119|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14968120|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14968121|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968122|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968123|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968124|NCT01651988|Propofol|propofol|mesh-list
14968125|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14968126|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968127|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968128|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14968129|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
14968130|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
14968131|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
14968132|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
14968133|NCT01652014|Fludarabine|fludarabine|mesh-list
14968134|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
14968135|NCT01652014|Tacrolimus|tacrolimus|mesh-list
14968136|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968137|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
14968138|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968139|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14968140|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14968141|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
14968142|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968143|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968144|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14968145|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968146|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
13966482|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
13966483|NCT03122353|Calcipotriene|calcipotriene|mesh-list
13966484|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13966485|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966486|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
13966487|NCT03122353|Hormones|hormones|mesh-ancestor
13966488|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14800426|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
14800427|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14800428|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14800429|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
14800430|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800431|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14800432|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14800433|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800434|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800435|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
14800436|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14800437|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
14968147|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14968148|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968149|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14968150|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14968151|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
13966489|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966490|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13966491|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
13966492|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
13966493|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13966494|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13966495|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966496|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966497|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13966498|NCT03122353|Vitamins|vitamins|mesh-ancestor
13966499|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
13966500|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13966501|NCT03122197|Letrozole|letrozole|mesh-list
14800438|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800439|NCT00787813|Expectorants|expectorants|mesh-ancestor
14800440|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
14800441|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14800442|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
14800443|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800444|NCT00787813|Protective Agents|protective agents|mesh-ancestor
14800445|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800446|NCT00787813|Antidotes|antidotes|mesh-ancestor
14800447|NCT00787826|Vaccines|vaccines|mesh-list
14968152|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968153|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968154|NCT01652118|Clarithromycin|clarithromycin|mesh-list
13966502|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966503|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13966504|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13966505|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966506|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966507|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13966508|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
13966509|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966510|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966511|NCT03122262|Tenofovir|tenofovir|mesh-list
13966512|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13966513|NCT03122262|Dolutegravir|dolutegravir|mesh-list
13966514|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13966515|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
13966516|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966517|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13966518|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13966519|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966520|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966521|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13966522|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13966523|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13966524|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13966525|NCT03122158|Citalopram|citalopram|mesh-list
13966526|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13966527|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13966528|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966529|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966530|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966531|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
13966532|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522906|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
14522907|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522908|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
14522909|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14522910|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
14522911|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14522912|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
14522913|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522914|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522915|NCT03560739|Ofatumumab|ofatumumab|mesh-list
14800448|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
14968155|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968156|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968157|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14968158|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968159|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968160|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14968161|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14968162|NCT01652157|Pancrelipase|pancrelipase|mesh-list
14968163|NCT01652157|Pancreatin|pancreatin|mesh-list
14968164|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968165|NCT01652183|Acetaminophen|acetaminophen|mesh-list
14968166|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14968167|NCT01652183|Analgesics|analgesics|mesh-ancestor
14968168|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
14968169|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968170|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968171|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
14968172|NCT01652196|Leucovorin|leucovorin|mesh-list
14968173|NCT01652196|Fluorouracil|fluorouracil|mesh-list
14800449|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800450|NCT00787969|Sirolimus|sirolimus|mesh-list
14800451|NCT00787969|Rituximab|rituximab|mesh-list
14800452|NCT00787969|Cladribine|cladribine|mesh-list
14800453|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14800454|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800455|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
14800456|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800457|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14968174|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
14968175|NCT01652196|Aflibercept|aflibercept|mesh-list
14968176|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
14968177|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14968178|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
14968179|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968180|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968181|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968182|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968183|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
14968184|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968185|NCT01652196|Antidotes|antidotes|mesh-ancestor
14968186|NCT01652196|Protective Agents|protective agents|mesh-ancestor
14968187|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
14968188|NCT01652196|Vitamins|vitamins|mesh-ancestor
13966533|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13966534|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
13966535|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13966536|NCT03121963|Acetaminophen|acetaminophen|mesh-list
13966537|NCT03121963|Celecoxib|celecoxib|mesh-list
13966538|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
13966539|NCT03121963|Oxycodone|oxycodone|mesh-list
13966540|NCT03121963|Gabapentin|gabapentin|mesh-list
13966541|NCT03121963|Hydrocodone|hydrocodone|mesh-list
13966542|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966543|NCT03121963|Analgesics|analgesics|mesh-ancestor
13966544|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
13966545|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966546|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968189|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
14968190|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13966547|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
14968191|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13966548|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13966549|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966550|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966551|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13966552|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13966553|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966554|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966555|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13966556|NCT03121963|Narcotics|narcotics|mesh-ancestor
13966557|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966558|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
13966559|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13966560|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13966561|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13966562|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13966563|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13966564|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966565|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
13966566|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
13966567|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
13966568|NCT03122132|Ritonavir|ritonavir|mesh-list
13966569|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13966570|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13966571|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
13966572|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966573|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522916|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14522917|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522918|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
14522919|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522920|NCT03562377|Vaccines|vaccines|mesh-list
14522921|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
14968192|NCT01652196|Growth Substances|growth substances|mesh-ancestor
14968193|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
14968194|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14968195|NCT01652313|Rasagiline|rasagiline|mesh-list
14968196|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14968197|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968198|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968199|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14968200|NCT01652313|Protective Agents|protective agents|mesh-ancestor
14968201|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968202|NCT01652326|Diazepam|diazepam|mesh-list
14968203|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14968204|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
14968205|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
14968206|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
14968207|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968208|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968209|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968210|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14968211|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968212|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14968213|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14968214|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14968215|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14968216|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14968217|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14968218|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
14968219|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
14968220|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
14968221|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
14968222|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968223|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968224|NCT01652339|Amlodipine|amlodipine|mesh-list
14968225|NCT01652339|Valsartan|valsartan|mesh-list
14968226|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14968227|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14968228|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14968229|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14968230|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968231|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14968232|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968233|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
14522922|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968234|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14968235|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14968236|NCT01652378|Lidocaine|lidocaine|mesh-list
14968237|NCT01652378|Ondansetron|ondansetron|mesh-list
14968238|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
14968239|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
14968240|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966574|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13966575|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13966576|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
13966577|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966578|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13966579|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13968138|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968139|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968140|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13968141|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
13968142|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
13968143|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13968144|NCT03112538|Insulin|insulin|mesh-list
13968145|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13968146|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13968147|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968148|NCT03112785|Cimetidine|cimetidine|mesh-list
13968149|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13968150|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968151|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13968152|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
13968153|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
13968154|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968155|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968156|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968157|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13968158|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13968159|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968160|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
13968161|NCT03112551|Analgesics|analgesics|mesh-ancestor
13968162|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
14522923|NCT03562481|Lidocaine|lidocaine|mesh-list
14522924|NCT03562481|Epinephrine|epinephrine|mesh-list
14522925|NCT03562481|Racepinephrine|racepinephrine|mesh-list
14522926|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
14522927|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
14522928|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
14522929|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14522930|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522931|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
14522932|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522933|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14522934|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14522935|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14522936|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14522937|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522938|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14522939|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14522940|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
14522941|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14522942|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14522943|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14522944|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
14522945|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14522946|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
14522947|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
14522948|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
14522949|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14522950|NCT03562988|Vitamins|vitamins|mesh-list
14968241|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968242|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
14968243|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968244|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14968245|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14968246|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14968247|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14968248|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522951|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
14968249|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
14968250|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
14968251|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968252|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
14968253|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
14968254|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14968255|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
14968256|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968257|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14968258|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14968259|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13966580|NCT03122002|Aspirin|aspirin|mesh-list
13966581|NCT03122002|Clopidogrel|clopidogrel|mesh-list
13966582|NCT03122002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13966583|NCT03122002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966584|NCT03122002|Analgesics|analgesics|mesh-ancestor
13966585|NCT03122002|Sensory System Agents|sensory system agents|mesh-ancestor
13966586|NCT03122002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966587|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966588|NCT03122002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966589|NCT03122002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966590|NCT03122002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13966591|NCT03122002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13966592|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966593|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13966594|NCT03122002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13966595|NCT03122002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966596|NCT03122002|Antipyretics|antipyretics|mesh-ancestor
13966597|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13966598|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13966599|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14968260|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14968261|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
14968262|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14968263|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14968264|NCT01652417|Prednisolone|prednisolone|mesh-list
14968265|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
14968266|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14968267|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
13966600|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
13966601|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966602|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13966603|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13966604|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966605|NCT03122041|Incretins|incretins|mesh-ancestor
13966606|NCT03122041|Hormones|hormones|mesh-ancestor
14968268|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14968269|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
14968270|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
14968271|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968272|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968273|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968274|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
14968275|NCT01652417|Hormones|hormones|mesh-ancestor
14968276|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968277|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14968278|NCT01652417|Protective Agents|protective agents|mesh-ancestor
14968279|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14968280|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968281|NCT01652534|Amantadine|amantadine|mesh-list
14968282|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14968283|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14968284|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
14968285|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968286|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
14968287|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968288|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968289|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968290|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14968291|NCT01652534|Analgesics|analgesics|mesh-ancestor
14968292|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
14968293|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968294|NCT01652547|Pasireotide|pasireotide|mesh-list
14968295|NCT01652547|Somatostatin|somatostatin|mesh-list
14968296|NCT01652547|Hormones|hormones|mesh-ancestor
14522952|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
14968297|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968298|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968299|NCT01652560|Bevacizumab|bevacizumab|mesh-list
14968300|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14968301|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968302|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14968303|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14968304|NCT01652560|Growth Substances|growth substances|mesh-ancestor
13966607|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966608|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13966609|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
14968305|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968306|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
14968307|NCT01652586|Midazolam|midazolam|mesh-list
14968308|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
14968309|NCT01652586|Remifentanil|remifentanil|mesh-list
14968310|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14968311|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968312|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968313|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14968314|NCT01652586|Analgesics|analgesics|mesh-ancestor
14968315|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
14968316|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968317|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14968318|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14968319|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14968320|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968321|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968322|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968323|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14968324|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14968325|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14968326|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14968327|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14968328|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
14968329|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
14968330|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
14968331|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
14968332|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14968333|NCT01652586|Narcotics|narcotics|mesh-ancestor
14968334|NCT01652599|Dexamethasone|dexamethasone|mesh-list
14968335|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14968336|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
13966610|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966611|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966612|NCT03121846|Apatinib|apatinib|mesh-list
13966613|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966614|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13966615|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522953|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522954|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
14522955|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522956|NCT03562988|Protective Agents|protective agents|mesh-ancestor
14522957|NCT03565211|Progesterone|progesterone|mesh-list
14522958|NCT03565211|Progestins|progestins|mesh-ancestor
14522959|NCT03565211|Hormones|hormones|mesh-ancestor
14522960|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14522961|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522962|NCT03565666|Insulin|insulin|mesh-list
14522963|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14522964|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
14522965|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
14522966|NCT03565666|Pancrelipase|pancrelipase|mesh-list
14522967|NCT03565666|Pancreatin|pancreatin|mesh-list
14522968|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522969|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522970|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522971|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14522972|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14968337|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
14968338|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968339|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968340|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14522973|NCT03566485|Atezolizumab|atezolizumab|mesh-list
14968341|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
14968342|NCT01652599|Hormones|hormones|mesh-ancestor
14968343|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968344|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14968345|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968346|NCT01652638|Heparin|heparin|mesh-list
14968347|NCT01652638|Calcium heparin|calcium heparin|mesh-list
14968348|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
14968349|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14968350|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14968351|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968352|NCT01652781|Azacitidine|azacitidine|mesh-list
14968353|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966616|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966617|NCT03122314|Acetaminophen|acetaminophen|mesh-list
13966618|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
13966619|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966620|NCT03122314|Analgesics|analgesics|mesh-ancestor
13966621|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
13966622|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968354|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
14968355|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968356|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968357|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968358|NCT01652794|Gemcitabine|gemcitabine|mesh-list
14968359|NCT01652794|Carboplatin|carboplatin|mesh-list
14968360|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968361|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968362|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
14968363|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968364|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
14968365|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968366|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968367|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14522974|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14522975|NCT03566810|Metformin|metformin|mesh-list
14522976|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14522977|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522978|NCT03566979|Naproxen|naproxen|mesh-list
14522979|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13966623|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966624|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
13966625|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13966626|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966627|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966628|NCT03122067|Oxytocin|oxytocin|mesh-list
13966629|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
13966630|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13966631|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966632|NCT03121833|Endostar protein|endostar protein|mesh-list
13966633|NCT03121833|Endostatins|endostatins|mesh-list
13966634|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13966635|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13966636|NCT03121833|Growth Substances|growth substances|mesh-ancestor
13966637|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966638|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
13966639|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966640|NCT03121807|Leucovorin|leucovorin|mesh-list
13966641|NCT03121807|Fluorouracil|fluorouracil|mesh-list
14522980|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14968368|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
14968369|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968370|NCT01652820|Gemcitabine|gemcitabine|mesh-list
14968371|NCT01652820|Carboplatin|carboplatin|mesh-list
14968372|NCT01652820|Docetaxel|docetaxel|mesh-list
14968373|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968374|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968375|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
13966642|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
13966643|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
14522981|NCT03566979|Analgesics|analgesics|mesh-ancestor
14522982|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
14522983|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14522984|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14522985|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14522986|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14522987|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
14522988|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14968376|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968377|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
14968378|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968379|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968380|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968381|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
14968382|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966644|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966645|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966646|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966647|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966648|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
13966649|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966650|NCT03121807|Antidotes|antidotes|mesh-ancestor
13966651|NCT03121807|Protective Agents|protective agents|mesh-ancestor
13966652|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
13966653|NCT03121807|Vitamins|vitamins|mesh-ancestor
13966654|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
13966655|NCT03121521|Melatonin|melatonin|mesh-list
13966656|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
13966657|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966658|NCT03121521|Protective Agents|protective agents|mesh-ancestor
13966659|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966660|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966661|NCT03121716|Gemcitabine|gemcitabine|mesh-list
13966662|NCT03121716|Cisplatin|cisplatin|mesh-list
13966663|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968383|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
13966664|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
13966665|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966666|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966667|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
13966668|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966669|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966670|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966671|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
13966672|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966673|NCT03121664|Itraconazole|itraconazole|mesh-list
13966674|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
13966675|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966676|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13966677|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13966678|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966679|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966680|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13966681|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
13966682|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966683|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966684|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13966685|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13966686|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13966687|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14968384|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
14968385|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
14968386|NCT01652859|Amphotericin B|amphotericin b|mesh-list
14968387|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14968388|NCT01652859|Amebicides|amebicides|mesh-ancestor
14968389|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14968390|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14968391|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968392|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968393|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
14968394|NCT01652898|Esmolol|esmolol|mesh-list
14968395|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14968396|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14968397|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14968398|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968399|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968400|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968401|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968402|NCT01652924|Anesthetics|anesthetics|mesh-list
14968403|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968404|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968405|NCT01653015|Vaccines|vaccines|mesh-list
14968406|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
15028830|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
14968407|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968408|NCT01653041|Everolimus|everolimus|mesh-list
14968409|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968410|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968411|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
14968412|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968413|NCT01653067|Cytarabine|cytarabine|mesh-list
13966688|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966689|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800458|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968414|NCT01653067|Sirolimus|sirolimus|mesh-list
14968415|NCT01653067|Dexamethasone|dexamethasone|mesh-list
14968416|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
14968417|NCT01653067|Rituximab|rituximab|mesh-list
14968418|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14968419|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
14968420|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
14968421|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968422|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968423|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968424|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
14968425|NCT01653067|Hormones|hormones|mesh-ancestor
14968426|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968427|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14968428|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968429|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968430|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14968431|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
14968432|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14968433|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968434|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
14968435|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
14968436|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968437|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968438|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968439|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14968440|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
14968441|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14968442|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14968443|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14968444|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
14968445|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968446|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14968447|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14968448|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968449|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
14968450|NCT01653171|Simethicone|simethicone|mesh-list
14968451|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14968452|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
14968453|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968454|NCT01653171|Expectorants|expectorants|mesh-ancestor
14968455|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
14800459|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800460|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14800461|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
14800462|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800463|NCT00788034|Vortioxetine|vortioxetine|mesh-list
14800464|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
14800465|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800466|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14800467|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13966690|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966691|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966692|NCT03121573|Analgesics|analgesics|mesh-ancestor
14968456|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14968457|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
14968458|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968459|NCT01653171|Protective Agents|protective agents|mesh-ancestor
14968460|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968461|NCT01653171|Antidotes|antidotes|mesh-ancestor
14968462|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
14968463|NCT01653171|Emollients|emollients|mesh-ancestor
14968464|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
15028831|NCT01957631|Bupivacaine|bupivacaine|mesh-list
15028832|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15028833|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
15028834|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
15028835|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
15028836|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028837|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028838|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
15028839|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966693|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
13966694|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966695|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
13966696|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13966697|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
13966698|NCT03121417|Nivolumab|nivolumab|mesh-list
13966699|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966700|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966701|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13966702|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966703|NCT03121313|Tegafur|tegafur|mesh-list
15028840|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15028841|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
15028842|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
15028843|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028844|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
15028845|NCT01957631|Hormones|hormones|mesh-ancestor
15028846|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15028847|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15028848|NCT01957631|Protective Agents|protective agents|mesh-ancestor
15028849|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15028850|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028851|NCT01957839|Cabergoline|cabergoline|mesh-list
15028852|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15028853|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15028854|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
13966704|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966705|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
13966706|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966707|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966708|NCT03121352|Paclitaxel|paclitaxel|mesh-list
13966709|NCT03121352|Carboplatin|carboplatin|mesh-list
13966710|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
13966711|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13966712|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028855|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
15028856|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028857|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028858|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028859|NCT01957852|Thrombin|thrombin|mesh-list
15028860|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
15028861|NCT01957852|Coagulants|coagulants|mesh-ancestor
15028862|NCT01957943|SMOFlipid|smoflipid|mesh-list
15028863|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15028864|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15028865|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15028866|NCT01957956|Temozolomide|temozolomide|mesh-list
15028867|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15028868|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
15028869|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028870|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028871|NCT01957995|Docetaxel|docetaxel|mesh-list
13966713|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
15028872|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028873|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
14968465|NCT01653236|Ribavirin|ribavirin|mesh-list
14968466|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14968467|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
14968468|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968469|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
14968470|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968471|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
14968472|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968473|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14968474|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968475|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968476|NCT01653457|Memantine|memantine|mesh-list
14968477|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14968478|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14968479|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
13966714|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
13966715|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
13966716|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966717|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13966718|NCT03121599|Alovudine|alovudine|mesh-list
13966719|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
13966720|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966721|NCT03121690|Prednisone|prednisone|mesh-list
13966722|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966723|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
13966724|NCT03121690|Hormones|hormones|mesh-ancestor
13966725|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966726|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968480|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968481|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968482|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968483|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14968484|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14968485|NCT01653470|Leucovorin|leucovorin|mesh-list
14968486|NCT01653470|Paclitaxel|paclitaxel|mesh-list
14968487|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14968488|NCT01653470|Carboplatin|carboplatin|mesh-list
14968489|NCT01653470|Fluorouracil|fluorouracil|mesh-list
14968490|NCT01653470|Irinotecan|irinotecan|mesh-list
14968491|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14968492|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968493|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
14968494|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
14968495|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
14968496|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968497|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
14968498|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968499|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968500|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
14968501|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966727|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13966728|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966729|NCT03121547|Tramadol|tramadol|mesh-list
13966730|NCT03121547|Tapentadol|tapentadol|mesh-list
13966731|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966732|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13966733|NCT03121547|Narcotics|narcotics|mesh-ancestor
13966734|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966735|NCT03121547|Analgesics|analgesics|mesh-ancestor
13966736|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
13966737|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966738|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13966739|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13966740|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966741|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968502|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14968503|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14968504|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968505|NCT01653470|Antidotes|antidotes|mesh-ancestor
14968506|NCT01653470|Protective Agents|protective agents|mesh-ancestor
14968507|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
14968508|NCT01653470|Vitamins|vitamins|mesh-ancestor
14968509|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
14968510|NCT01653522|Doxycycline|doxycycline|mesh-list
14968511|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13966742|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968512|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968513|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
14968514|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14968515|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14968516|NCT01653561|Apatinib|apatinib|mesh-list
14968517|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968518|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14968519|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968520|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968521|NCT01653639|Factor VIII|factor viii|mesh-list
14968522|NCT01653639|Coagulants|coagulants|mesh-ancestor
14968523|NCT01653665|Sargramostim|sargramostim|mesh-list
14968524|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
14968525|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968526|NCT01653678|Vitamin D|vitamin d|mesh-list
13966743|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966744|NCT03121339|Vaccines|vaccines|mesh-list
13966745|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
13966746|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966747|NCT03121261|Clonidine|clonidine|mesh-list
13966748|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
13966749|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
13966750|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
13966751|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966752|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966753|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
13966754|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966755|NCT03121261|Analgesics|analgesics|mesh-ancestor
13966756|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13966757|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
13966758|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
13966759|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13966760|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13966761|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13966762|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968527|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
14968528|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
14968529|NCT01653678|Vitamins|vitamins|mesh-list
14968530|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
13966763|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966764|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966765|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
13966766|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13966767|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
13966768|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966769|NCT03121222|Expectorants|expectorants|mesh-ancestor
13966770|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
13966771|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13966772|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
13966773|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966774|NCT03121222|Protective Agents|protective agents|mesh-ancestor
13966775|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966776|NCT03121222|Antidotes|antidotes|mesh-ancestor
13966777|NCT03121014|Methotrexate|methotrexate|mesh-list
13966778|NCT03121014|Fludarabine|fludarabine|mesh-list
13966779|NCT03121014|Busulfan|busulfan|mesh-list
13966780|NCT03121014|Tacrolimus|tacrolimus|mesh-list
13966781|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
13966782|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13966783|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
13966784|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13966785|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966786|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13966787|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
13966788|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966789|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966790|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
13966791|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966792|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13966793|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966794|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
13966795|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13966796|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13966797|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13966798|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
14968531|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968532|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13966799|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13966800|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13966801|NCT03120962|Famciclovir|famciclovir|mesh-list
14968533|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14968534|NCT01653717|Vidarabine|vidarabine|mesh-list
13966802|NCT03120962|Oxycodone|oxycodone|mesh-list
13966803|NCT03120962|Gabapentin|gabapentin|mesh-list
13966804|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13966805|NCT03120962|Narcotics|narcotics|mesh-ancestor
13966806|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966807|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966808|NCT03120962|Analgesics|analgesics|mesh-ancestor
13966809|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
13966810|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966811|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
13966812|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13966813|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13966814|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13966815|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13966816|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13966817|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966818|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966819|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
13966820|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
13966821|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966822|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14968535|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
14968536|NCT01653717|Fludarabine|fludarabine|mesh-list
14968537|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
14968538|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968539|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
14968540|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968541|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14968542|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14968543|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
14968544|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968545|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968546|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14968547|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968548|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
14968549|NCT01653717|Antiviral Agents|antiviral agents|mesh-ancestor
14968550|NCT01653717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968551|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14968552|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
14968553|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14968554|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968555|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968556|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14968557|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14968558|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968559|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968560|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968561|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14968562|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
14968563|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14968564|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968565|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14968566|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14968567|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14968568|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14968569|NCT01654081|Irinotecan|irinotecan|mesh-list
14968570|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14968571|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14968572|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968573|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968574|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968575|NCT01654120|Liraglutide|liraglutide|mesh-list
14968576|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14968577|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968578|NCT01654120|Incretins|incretins|mesh-ancestor
14968579|NCT01654120|Hormones|hormones|mesh-ancestor
14968580|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968581|NCT01654146|Paclitaxel|paclitaxel|mesh-list
14968582|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14968583|NCT01654146|Carboplatin|carboplatin|mesh-list
14968584|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14968585|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968586|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14968587|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14968588|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14968589|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968590|NCT01654185|Letrozole|letrozole|mesh-list
13966823|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966824|NCT03120936|Tenofovir|tenofovir|mesh-list
13966825|NCT03120936|Emtricitabine|emtricitabine|mesh-list
13966826|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
13966827|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966828|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13966829|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13966830|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966831|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800468|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968591|NCT01654185|Exemestane|exemestane|mesh-list
14968592|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14968593|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13966832|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13966833|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13966834|NCT03121079|Interferons|interferons|mesh-list
13966835|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
13966836|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968594|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14968595|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968596|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968597|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13966837|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
13966838|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966839|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
13966840|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966841|NCT03120923|Triamcinolone|triamcinolone|mesh-list
14968598|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
14968599|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968600|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968601|NCT01654211|Ritonavir|ritonavir|mesh-list
14968602|NCT01654211|Lactams|lactams|mesh-list
14968603|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14968604|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14968605|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
14968606|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522989|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522990|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522991|NCT03567382|Tenofovir|tenofovir|mesh-list
14522992|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
14522993|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14522994|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14522995|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14522996|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14522997|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14522998|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14800469|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968607|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968608|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14968609|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14968610|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
13966842|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13966843|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13966844|NCT03120923|Lidocaine|lidocaine|mesh-list
13966845|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13966846|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
13966847|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
13966848|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966849|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966850|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
14522999|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14800470|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14800471|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14800472|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800473|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800474|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800475|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
13966851|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966852|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13966853|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13966854|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14968611|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968612|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14968613|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14968614|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968615|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
14968616|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14968617|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14968618|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968619|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14968620|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968621|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968622|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14968623|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
14968624|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968625|NCT01654497|HU 211|hu 211|mesh-list
14968626|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14968627|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
14968628|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
13966855|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13966856|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966857|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13966858|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
13966859|NCT03120923|Hormones|hormones|mesh-ancestor
13966860|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966861|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966862|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
13966863|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966864|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13966865|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966866|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14968629|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968630|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966867|NCT03120728|Etonogestrel|etonogestrel|mesh-list
13966868|NCT03120728|NuvaRing|nuvaring|mesh-list
13966869|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
13966870|NCT03120728|Estradiol|estradiol|mesh-list
13966871|NCT03120728|Estrogens|estrogens|mesh-ancestor
13966872|NCT03120728|Hormones|hormones|mesh-ancestor
13966873|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966874|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966875|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13966876|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13966877|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13966878|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13966879|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13966880|NCT03120442|Fentanyl|fentanyl|mesh-list
13966881|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
13966882|NCT03120442|Propofol|propofol|mesh-list
13966883|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14968631|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968632|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14968633|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14968634|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968635|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966884|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966885|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966886|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13966887|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
13966888|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
13966889|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966890|NCT03120442|Analgesics|analgesics|mesh-ancestor
14800476|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14800477|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14800478|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14800479|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14800480|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
14800481|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
14800482|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
13966891|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
14800483|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14800484|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14800485|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800486|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800487|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800488|NCT00788060|Everolimus|everolimus|mesh-list
14800489|NCT00788060|Sunitinib|sunitinib|mesh-list
14800490|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800491|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13966892|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966893|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13966894|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13966895|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13966896|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
13966897|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966898|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966899|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13966900|NCT03120442|Narcotics|narcotics|mesh-ancestor
13966901|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13966902|NCT03120468|Topiramate|topiramate|mesh-list
13966903|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
13966904|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13966905|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
13966906|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13966907|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966908|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
13966909|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966910|NCT03120468|Expectorants|expectorants|mesh-ancestor
13966911|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
13966912|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13966913|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
13966914|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966915|NCT03120468|Protective Agents|protective agents|mesh-ancestor
13966916|NCT03120468|Antidotes|antidotes|mesh-ancestor
13966917|NCT03120715|Heparin|heparin|mesh-list
13966918|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13966919|NCT03120715|Tinzaparin|tinzaparin|mesh-list
13966920|NCT03120715|Dalteparin|dalteparin|mesh-list
13966921|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13966922|NCT03120715|Progesterone|progesterone|mesh-list
13966923|NCT03120715|Estrogens|estrogens|mesh-list
13966924|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
13966925|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13966926|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13966927|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966928|NCT03120715|Progestins|progestins|mesh-ancestor
13966929|NCT03120715|Hormones|hormones|mesh-ancestor
13966930|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13966931|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966932|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13966933|NCT03120533|Treprostinil|treprostinil|mesh-list
13966934|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13966935|NCT03120403|Morphine|morphine|mesh-list
14968636|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14968637|NCT01654497|Protective Agents|protective agents|mesh-ancestor
14968638|NCT01654562|Simvastatin|simvastatin|mesh-list
14968639|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14968640|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14968641|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
14968642|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968643|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14968644|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14968645|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968646|NCT01654575|Methotrexate|methotrexate|mesh-list
14968647|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14968648|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
14968649|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14968650|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968651|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968652|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
14968653|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968654|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968655|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
13966936|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14800492|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
13966937|NCT03120403|Narcotics|narcotics|mesh-ancestor
14968656|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968657|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14968658|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968659|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
14968660|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14968661|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14968662|NCT01654640|Metformin|metformin|mesh-list
14968663|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14968664|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968665|NCT01654692|Ipilimumab|ipilimumab|mesh-list
14968666|NCT01654692|Fotemustine|fotemustine|mesh-list
14968667|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14968668|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968669|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14968670|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968671|NCT01654705|Pantoprazole|pantoprazole|mesh-list
14968672|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14968673|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968674|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14968675|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968676|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968677|NCT01654718|Pantoprazole|pantoprazole|mesh-list
14968678|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14968679|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968680|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14968681|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968682|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968683|NCT01654731|Bezafibrate|bezafibrate|mesh-list
14968684|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14968685|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
14968686|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968687|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13966938|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966939|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966940|NCT03120403|Analgesics|analgesics|mesh-ancestor
13966941|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
13966942|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966943|NCT03120494|Tenofovir|tenofovir|mesh-list
13966944|NCT03120494|Emtricitabine|emtricitabine|mesh-list
13966945|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
13966946|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966947|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13966948|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13966949|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966950|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966951|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13966952|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13968163|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968164|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968165|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
13968166|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968167|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13968168|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
13968169|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13968170|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14968688|NCT01654809|Vaccines|vaccines|mesh-list
14968689|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
14968690|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968691|NCT01654939|Rifaximin|rifaximin|mesh-list
14968692|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968693|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968694|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968695|NCT01654965|Topotecan|topotecan|mesh-list
14968696|NCT01654965|Lenograstim|lenograstim|mesh-list
14968697|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14968698|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
14968699|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968700|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14968701|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14968702|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968703|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968704|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968705|NCT01655004|Exemestane|exemestane|mesh-list
14968706|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968707|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14968708|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14968709|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968710|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968711|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14968712|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
14968713|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968714|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968715|NCT01655056|Darexaban|darexaban|mesh-list
13966953|NCT03120637|Methylene Blue|methylene blue|mesh-list
13966954|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966955|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966956|NCT03120663|Amoxicillin|amoxicillin|mesh-list
13966957|NCT03120663|Clindamycin|clindamycin|mesh-list
13966958|NCT03120663|Meropenem|meropenem|mesh-list
13966959|NCT03120663|Tazobactam|tazobactam|mesh-list
13966960|NCT03120663|Piperacillin|piperacillin|mesh-list
13966961|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
13966962|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
13966963|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13966964|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13966965|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13966966|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13966967|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13966968|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966969|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966970|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13966971|NCT03120273|Lansoprazole|lansoprazole|mesh-list
13966972|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
13966973|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13966974|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13966975|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13966976|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13966977|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966978|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
13966979|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13966980|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966981|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966982|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966983|NCT03120247|Analgesics|analgesics|mesh-ancestor
13966984|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
13966985|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13966986|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13966987|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13966988|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13966989|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
13966990|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13966991|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13966992|NCT03120234|Fentanyl|fentanyl|mesh-list
13966993|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
13966994|NCT03120234|Ketamine|ketamine|mesh-list
13966995|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13966996|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13966997|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13966998|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13966999|NCT03120234|Analgesics|analgesics|mesh-ancestor
13967000|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
13967001|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967002|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13967003|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13967004|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13967005|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967006|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967007|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967008|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14968716|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14968717|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
14968718|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14968719|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
14968720|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968721|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968722|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
14968723|NCT01655082|Nicotine|nicotine|mesh-list
13967009|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14968724|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14968725|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
14968726|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968727|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968728|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14968729|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14968730|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
14968731|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968732|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028874|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
15028875|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
15028876|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028877|NCT01958138|Propofol|propofol|mesh-list
15028878|NCT01958138|Isoflurane|isoflurane|mesh-list
15028879|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15028880|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028881|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028882|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15028883|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
15028884|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
15028885|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15028886|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15028887|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15028888|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15028889|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15028890|NCT01958372|Etoposide|etoposide|mesh-list
15028891|NCT01958372|Pemetrexed|pemetrexed|mesh-list
15028892|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028893|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13967010|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
13967011|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
13967012|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13967013|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13967014|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13967015|NCT03120234|Narcotics|narcotics|mesh-ancestor
13967016|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13967017|NCT03119857|Docetaxel|docetaxel|mesh-list
13967018|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
13967019|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523000|NCT03567616|Dexamethasone|dexamethasone|mesh-list
14523001|NCT03567616|Venetoclax|venetoclax|mesh-list
14523002|NCT03567616|Pomalidomide|pomalidomide|mesh-list
14523003|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523004|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
14523005|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
14523006|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523007|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523008|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523009|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
14523010|NCT03567616|Hormones|hormones|mesh-ancestor
14523011|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523012|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14523013|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523014|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
14523015|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14523016|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14523017|NCT03567616|Growth Substances|growth substances|mesh-ancestor
14523018|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
14523019|NCT03568500|Olanzapine|olanzapine|mesh-list
14523020|NCT03568500|Risperidone|risperidone|mesh-list
14523021|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14523022|NCT03568500|Aripiprazole|aripiprazole|mesh-list
14523023|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14523024|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
15028894|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15028895|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15028896|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028897|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028898|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15028899|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15028900|NCT01958580|Gemcitabine|gemcitabine|mesh-list
15028901|NCT01958580|Docetaxel|docetaxel|mesh-list
15028902|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13967020|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
13967021|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
14523025|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523026|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968733|NCT01655095|Prucalopride|prucalopride|mesh-list
14968734|NCT01655095|Bisacodyl|bisacodyl|mesh-list
14968735|NCT01655095|Laxatives|laxatives|mesh-ancestor
13967022|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
13967023|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967024|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
13967025|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967026|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967027|NCT03120182|Aspirin|aspirin|mesh-list
13967028|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13967029|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967030|NCT03120182|Analgesics|analgesics|mesh-ancestor
14968736|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968737|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14968738|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14968739|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
14968740|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968741|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968742|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968743|NCT01655095|Cathartics|cathartics|mesh-ancestor
14968744|NCT01655108|Minoxidil|minoxidil|mesh-list
14968745|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14968746|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
14968747|NCT01655147|Rifampin|rifampin|mesh-list
14968748|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
14968749|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968750|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14968751|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968752|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968753|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
14968754|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968755|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968756|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14968757|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14968758|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
14968759|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14968760|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968761|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
15028903|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
13967031|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
13967032|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967033|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967034|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967035|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967036|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13967037|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13967038|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967039|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13967040|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13967041|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967042|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
13967043|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
13967044|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13967045|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13967046|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967047|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
13967048|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967049|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967050|NCT03119532|Metronidazole|metronidazole|mesh-list
13967051|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967052|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13967053|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13967054|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13967055|NCT03119623|Valsartan|valsartan|mesh-list
13967056|NCT03119623|Enalapril|enalapril|mesh-list
13967057|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13967058|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13967059|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13967060|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967061|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13967062|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
13967063|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967064|NCT03119454|Betamethasone|betamethasone|mesh-list
13967065|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
13967066|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967067|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
13967068|NCT03119454|Hormones|hormones|mesh-ancestor
13967069|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967070|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967071|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13967072|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
13967073|NCT03119636|Levodopa|levodopa|mesh-list
13967074|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13967075|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13967076|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
13967077|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967078|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967079|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967080|NCT03119714|Pemirolast|pemirolast|mesh-list
13967081|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
13967082|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
13967083|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967084|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967085|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967086|NCT03119428|Nivolumab|nivolumab|mesh-list
13967087|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13967088|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967089|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14968762|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14968763|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14968764|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14968765|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14968766|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14968767|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14968768|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14968769|NCT01655199|Albuterol|albuterol|mesh-list
14968770|NCT01655199|Ipratropium|ipratropium|mesh-list
14968771|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14968772|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
14968773|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968774|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968775|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14968776|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
14968777|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
14968778|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14968779|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14968780|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14968781|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14968782|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968783|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968784|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968785|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14968786|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
14968787|NCT01655212|Valganciclovir|valganciclovir|mesh-list
14968788|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
14968789|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968790|NCT01655303|Propranolol|propranolol|mesh-list
14968791|NCT01655303|Metoprolol|metoprolol|mesh-list
14968792|NCT01655303|Verapamil|verapamil|mesh-list
14968793|NCT01655303|Diltiazem|diltiazem|mesh-list
13967090|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967091|NCT03119012|Aspirin|aspirin|mesh-list
13967092|NCT03119012|Clopidogrel|clopidogrel|mesh-list
14968794|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14968795|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14968796|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968797|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968798|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968799|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968800|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14968801|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14968802|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
14968803|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
14968804|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
14968805|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968806|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14968807|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14968808|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14968809|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14968810|NCT01655316|Verapamil|verapamil|mesh-list
14968811|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14968812|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14968813|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14968814|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968815|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14968816|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968817|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
13967093|NCT03119012|Ticagrelor|ticagrelor|mesh-list
13967094|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13967095|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967096|NCT03119012|Analgesics|analgesics|mesh-ancestor
13967097|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
13967098|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967099|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967100|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967101|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967102|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13967103|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13967104|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967105|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13967106|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13967107|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967108|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
14968818|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
14968819|NCT01655524|Aminophylline|aminophylline|mesh-list
13967109|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13967110|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13967111|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13967112|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
13967113|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967114|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
13967115|NCT03119116|Apixaban|apixaban|mesh-list
13967116|NCT03119116|Dabigatran|dabigatran|mesh-list
13967117|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13967118|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
13967119|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13967120|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
13967121|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967122|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967123|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
13967124|NCT03119077|Itraconazole|itraconazole|mesh-list
13967125|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
13967126|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967127|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13967128|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14968820|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14968821|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
14968822|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968823|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968824|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13967129|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967130|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967131|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13967132|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
13967133|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967134|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967135|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13967136|NCT03119194|Opicapone|opicapone|mesh-list
13967137|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13967138|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967139|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967140|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13967141|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13967142|NCT03119038|Ketorolac|ketorolac|mesh-list
13967143|NCT03119038|Clonidine|clonidine|mesh-list
13967144|NCT03119038|Epinephrine|epinephrine|mesh-list
13967145|NCT03119038|Bupivacaine|bupivacaine|mesh-list
13967146|NCT03119038|Ropivacaine|ropivacaine|mesh-list
13967147|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
13967148|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
13967149|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968825|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
14968826|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14968827|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14968828|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968829|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968830|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14968831|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14968832|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
14968833|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968834|NCT01655524|Protective Agents|protective agents|mesh-ancestor
14968835|NCT01655628|Gemcitabine|gemcitabine|mesh-list
13967150|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967151|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
13967152|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967153|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13967154|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13967155|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967156|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967157|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967158|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13967159|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13967160|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
13967161|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13967162|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
13967163|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
13967164|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
13967165|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13967166|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13967167|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967168|NCT03119038|Analgesics|analgesics|mesh-ancestor
13967169|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967170|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14968836|NCT01655628|Cisplatin|cisplatin|mesh-list
13967171|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13967172|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236494|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236495|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14236496|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236497|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236498|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14236499|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14236500|NCT00114972|Paclitaxel|paclitaxel|mesh-list
14236501|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14236502|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14236503|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14236504|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
14236505|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
14236506|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
14236507|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968837|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968838|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968839|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
14968840|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968841|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
14968842|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967173|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13967174|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
13967175|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13967176|NCT03119324|Nimesulide|nimesulide|mesh-list
13967177|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13967178|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967179|NCT03119324|Analgesics|analgesics|mesh-ancestor
13967180|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
13967181|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967182|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967183|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967184|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967185|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13967186|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967187|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967188|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13967189|NCT03118830|Cetrorelix|cetrorelix|mesh-list
13967190|NCT03118830|Hormones|hormones|mesh-list
13967191|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13967192|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967193|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967194|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
13967195|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13967196|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
13967197|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13967198|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13967199|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13967200|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967201|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13967202|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
13967203|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
13968171|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968172|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13968173|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
13968174|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13968175|NCT03112564|Fentanyl|fentanyl|mesh-list
13968176|NCT03112564|Sevoflurane|sevoflurane|mesh-list
13968177|NCT03112564|Rocuronium|rocuronium|mesh-list
14968843|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968844|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14968845|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
14968846|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968847|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
14968848|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14968849|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14968850|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968851|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
14968852|NCT01655641|Coagulants|coagulants|mesh-ancestor
14968853|NCT01655706|Aripiprazole|aripiprazole|mesh-list
14968854|NCT01655706|Citalopram|citalopram|mesh-list
14968855|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14968856|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14968857|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035031|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
13967204|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
13967205|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
13967206|NCT03118492|Melphalan|melphalan|mesh-list
13967207|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
13967208|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13967209|NCT03118492|Fludarabine|fludarabine|mesh-list
13967210|NCT03118492|Tacrolimus|tacrolimus|mesh-list
13967211|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13967212|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
13967213|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967214|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967215|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13967216|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
13967217|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967218|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968858|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968859|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968860|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
14968861|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968862|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14968863|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
14968864|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14968865|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14968866|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14968867|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968868|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
14968869|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
14968870|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14968871|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14968872|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14968873|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14968874|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14968875|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14968876|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14968877|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14968878|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968879|NCT01655758|Timolol|timolol|mesh-list
13967219|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13967220|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13967221|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967222|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13967223|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14968880|NCT01655758|Bimatoprost|bimatoprost|mesh-list
14968881|NCT01655758|Travoprost|travoprost|mesh-list
14968882|NCT01655758|Dorzolamide|dorzolamide|mesh-list
13967224|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
13967225|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13967226|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967227|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
13967228|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13967229|NCT03118674|Ledipasvir|ledipasvir|mesh-list
13967230|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
13967231|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967232|NCT03118713|Metformin|metformin|mesh-list
13967233|NCT03118713|Glimepiride|glimepiride|mesh-list
13967234|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
13967235|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14968883|NCT01655758|Latanoprost|latanoprost|mesh-list
14968884|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13967236|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967237|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13967238|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13967239|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
13967240|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13967241|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967242|NCT03118479|Anastrozole|anastrozole|mesh-list
13967243|NCT03118479|Testosterone|testosterone|mesh-list
13967244|NCT03118479|Androgens|androgens|mesh-ancestor
13967245|NCT03118479|Hormones|hormones|mesh-ancestor
13967246|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967247|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967248|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13967249|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967250|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13967251|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13967252|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967253|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967254|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13967255|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
13967256|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
13967257|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13967258|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13967259|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
13967260|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14800493|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968885|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14968886|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14968887|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968888|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968889|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968890|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14968891|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14968892|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14968893|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14968894|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14968895|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968896|NCT01655810|Vitamin D|vitamin d|mesh-list
14968897|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
14968898|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
14968899|NCT01655810|Vitamins|vitamins|mesh-list
14968900|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
14968901|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
14968902|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968903|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14968904|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14968905|NCT01655810|Antacids|antacids|mesh-ancestor
14968906|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800494|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14800495|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14800496|NCT00788060|Growth Substances|growth substances|mesh-ancestor
14800497|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
14800498|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14800499|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800500|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800501|NCT00788099|Gemcitabine|gemcitabine|mesh-list
14800502|NCT00788099|Sorafenib|sorafenib|mesh-list
14800503|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14800504|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
14800505|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800506|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800507|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
14800508|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800509|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968907|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14968908|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
14968909|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14968910|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14968911|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14968912|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14968913|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968914|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
14968915|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035032|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
14968916|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968917|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14968918|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968919|NCT01655875|Plerixafor|plerixafor|mesh-list
14968920|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14968921|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14968922|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
14968923|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968924|NCT01655888|Tremelimumab|tremelimumab|mesh-list
14968925|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968926|NCT01655914|Flumazenil|flumazenil|mesh-list
14968927|NCT01655914|Antidotes|antidotes|mesh-ancestor
14968928|NCT01655914|Protective Agents|protective agents|mesh-ancestor
14968929|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968930|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
14968931|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
14968932|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968933|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968934|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
14968935|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14968936|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14968937|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968938|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
14968939|NCT01655927|Coagulants|coagulants|mesh-ancestor
14968940|NCT01655966|Vitamin D|vitamin d|mesh-list
14968941|NCT01655966|Interferons|interferons|mesh-list
14968942|NCT01655966|Ribavirin|ribavirin|mesh-list
14968943|NCT01655966|Vitamins|vitamins|mesh-ancestor
14968944|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
14968945|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968946|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14968947|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968948|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
14968949|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14968950|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
14968951|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968952|NCT01655992|Capecitabine|capecitabine|mesh-list
14968953|NCT01655992|Tegafur|tegafur|mesh-list
14968954|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14968955|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
14968956|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968957|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14968958|NCT01656005|Beclomethasone|beclomethasone|mesh-list
14968959|NCT01656005|Carvedilol|carvedilol|mesh-list
14968960|NCT01656005|Bisoprolol|bisoprolol|mesh-list
14968961|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
14968962|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
14968963|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14968964|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
14968965|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14968966|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967261|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
13967262|NCT03118232|Povidone|povidone|mesh-list
13967263|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14968967|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14968968|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
14968969|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14968970|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14968971|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14968972|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967264|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967265|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
13967266|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
13967267|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
13967268|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
13967269|NCT03118336|Empagliflozin|empagliflozin|mesh-list
13967270|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13967271|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967272|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13967273|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967274|NCT03118167|Antioxidants|antioxidants|mesh-list
13967275|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967276|NCT03118167|Protective Agents|protective agents|mesh-ancestor
13967277|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14968973|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14968974|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14968975|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
14968976|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13967278|NCT03118037|Zaleplon|zaleplon|mesh-list
13967279|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
13967280|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13967281|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968977|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
14968978|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14968979|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13967282|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967283|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
13967284|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
13967285|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967286|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967287|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
13967288|NCT03118076|Ropivacaine|ropivacaine|mesh-list
13967289|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13967290|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14968980|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14968981|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
14968982|NCT01656005|Protective Agents|protective agents|mesh-ancestor
14968983|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14968984|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14968985|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14968986|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
14523027|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523028|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14523029|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14523030|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523031|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14523032|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14523033|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
14523034|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
14523035|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
14523036|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523037|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523038|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14523039|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14523040|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14523041|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
14523042|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
14523043|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14523044|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14523045|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14523046|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14523047|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
14523048|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14523049|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14523050|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
14523051|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14523052|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14523053|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523054|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
14523055|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523056|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523057|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14523058|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523059|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
13967291|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967292|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967293|NCT03118076|Analgesics|analgesics|mesh-ancestor
13967294|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
13967295|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967296|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13967297|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13967298|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13967299|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967300|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967301|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967302|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
13967303|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
13967304|NCT03118128|Metformin|metformin|mesh-list
15035033|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13967305|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13967306|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967307|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
13967308|NCT03117790|Morphine|morphine|mesh-list
13967309|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13967310|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967311|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967312|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967313|NCT03117790|Analgesics|analgesics|mesh-ancestor
13967314|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
13967315|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967316|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13967317|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13967318|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13967319|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967320|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967321|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967322|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13967323|NCT03117790|Narcotics|narcotics|mesh-ancestor
13967324|NCT03117894|Acetaminophen|acetaminophen|mesh-list
13967325|NCT03117894|Etoricoxib|etoricoxib|mesh-list
13967326|NCT03117894|Morphine|morphine|mesh-list
13967327|NCT03117894|Remifentanil|remifentanil|mesh-list
13967328|NCT03117894|Ondansetron|ondansetron|mesh-list
13967329|NCT03117894|Propofol|propofol|mesh-list
13967330|NCT03117894|Ropivacaine|ropivacaine|mesh-list
13967331|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13967332|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967333|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967334|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13967335|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
13967336|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
13967337|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13967338|NCT03117894|Narcotics|narcotics|mesh-ancestor
14968987|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14968988|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14968989|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
14968990|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14968991|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14968992|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
14968993|NCT01656005|Hormones|hormones|mesh-ancestor
14968994|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14968995|NCT01656018|Rilpivirine|rilpivirine|mesh-list
14968996|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14968997|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14968998|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14968999|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969000|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
14969001|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969002|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14969003|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14969004|NCT01656057|Acetaminophen|acetaminophen|mesh-list
14969005|NCT01656057|Metformin|metformin|mesh-list
14969006|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
14969007|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14969008|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13967339|NCT03117894|Analgesics|analgesics|mesh-ancestor
13967340|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
13967341|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967342|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
13967343|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969009|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969010|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969011|NCT01656057|Analgesics|analgesics|mesh-ancestor
14969012|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
14969013|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969014|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
14969015|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14969016|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13967344|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
13967345|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
14969017|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
14969018|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969019|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14969020|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14969021|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969022|NCT01656070|Vitamin D|vitamin d|mesh-list
14969023|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
14969024|NCT01656070|Vitamins|vitamins|mesh-ancestor
14969025|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
14969026|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969027|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14969028|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14969029|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14969030|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13967346|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
13967347|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13967348|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
13967349|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
13967350|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13967351|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
13967352|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967353|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967354|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13967355|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13967356|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13967357|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13967358|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14969031|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14969032|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
14969033|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969034|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969035|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14969036|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14969037|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
13967359|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967360|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967361|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13967362|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13967363|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967364|NCT03117660|Vitamin A|vitamin a|mesh-list
13967365|NCT03117660|Vitamins|vitamins|mesh-ancestor
13967366|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
13967367|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967368|NCT03117972|Leucovorin|leucovorin|mesh-list
14800510|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800511|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
14800512|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800513|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14800514|NCT00788112|Vorinostat|vorinostat|mesh-list
14800515|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800516|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14800517|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969038|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969039|NCT01656122|Abacavir|abacavir|mesh-list
14969040|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14969041|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14969042|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969043|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969044|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
14969045|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969046|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14969047|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13967369|NCT03117972|Bevacizumab|bevacizumab|mesh-list
13967370|NCT03117972|Fluorouracil|fluorouracil|mesh-list
13967371|NCT03117972|Capecitabine|capecitabine|mesh-list
13967372|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
13967373|NCT03117972|Irinotecan|irinotecan|mesh-list
13967374|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
13967375|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13967376|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967377|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13967378|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13967379|NCT03117972|Growth Substances|growth substances|mesh-ancestor
13967380|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967381|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
13967382|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
13967383|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968178|NCT03112564|Cisatracurium|cisatracurium|mesh-list
14969048|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
15035034|NCT01998685|Narcotics|narcotics|mesh-ancestor
13967384|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13967385|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13967386|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
13967387|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13967388|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13967389|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967390|NCT03117972|Antidotes|antidotes|mesh-ancestor
13967391|NCT03117972|Protective Agents|protective agents|mesh-ancestor
13967392|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
13967393|NCT03117972|Vitamins|vitamins|mesh-ancestor
13967394|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
13967395|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
13967396|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13967397|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
13967398|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967399|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967400|NCT03117855|Capecitabine|capecitabine|mesh-list
13967401|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13967402|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
13967403|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967404|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967405|NCT03117998|Volagidemab|volagidemab|mesh-list
13967406|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13967407|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967408|NCT03117595|Fentanyl|fentanyl|mesh-list
14969049|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14969050|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14969051|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969052|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
14969053|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14800518|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800519|NCT00788138|Vitamin D|vitamin d|mesh-list
14800520|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
14800521|NCT00788138|Vitamins|vitamins|mesh-ancestor
14800522|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
14800523|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800524|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14800525|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800526|NCT00788164|Imiquimod|imiquimod|mesh-list
14800527|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14800528|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
14800529|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800530|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800531|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
14800532|NCT00788242|Insulin|insulin|mesh-list
14800533|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14800534|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800535|NCT00788294|Tanezumab|tanezumab|mesh-list
14800536|NCT00788294|Analgesics|analgesics|mesh-ancestor
14800537|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
14800538|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800539|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800540|NCT00788320|Vitamin D|vitamin d|mesh-list
14800541|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
14800542|NCT00788320|Vitamins|vitamins|mesh-ancestor
14800543|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
14800544|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969054|NCT01656226|Protective Agents|protective agents|mesh-ancestor
13967409|NCT03117595|Morphine|morphine|mesh-list
13967410|NCT03117595|Bupivacaine|bupivacaine|mesh-list
13967411|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
13967412|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
13967413|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967414|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967415|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
13967416|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967417|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13967418|NCT03117595|Narcotics|narcotics|mesh-ancestor
13967419|NCT03117595|Analgesics|analgesics|mesh-ancestor
13967420|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13967421|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14969055|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969056|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
13967422|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
14800545|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14969057|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
14969058|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14969059|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
14969060|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14969061|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
14969062|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969063|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969064|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
14969065|NCT01656343|Abatacept|abatacept|mesh-list
14969066|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14969067|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14969068|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969069|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969070|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969071|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
14969072|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969073|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969074|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969075|NCT01656512|Vitamin D|vitamin d|mesh-list
14969076|NCT01656512|Diphosphonates|diphosphonates|mesh-list
14969077|NCT01656512|Calcium|calcium|mesh-list
14969078|NCT01656512|Vitamins|vitamins|mesh-ancestor
14969079|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
14969080|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967423|NCT03117335|Endostatins|endostatins|mesh-list
13967424|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967425|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13967426|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13967427|NCT03117335|Growth Substances|growth substances|mesh-ancestor
13967428|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967429|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
13967430|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
13967431|NCT03117439|Clotrimazole|clotrimazole|mesh-list
13967432|NCT03117439|Miconazole|miconazole|mesh-list
13967433|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967434|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13967435|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13967436|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13967437|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967438|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969081|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14969082|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14969083|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14969084|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
14969085|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969086|NCT01656538|Paclitaxel|paclitaxel|mesh-list
14969087|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14969088|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969089|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
14969090|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
14969091|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
14969092|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969093|NCT01656551|Gemcitabine|gemcitabine|mesh-list
14969094|NCT01656551|Pemetrexed|pemetrexed|mesh-list
14969095|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969096|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14969097|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
14969098|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969099|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
14969100|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969101|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969102|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969103|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
14969104|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969105|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14969106|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14969107|NCT01656616|Antidotes|antidotes|mesh-list
13967439|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13967440|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
13967441|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967442|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967443|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13967444|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13967445|NCT03117530|Minocycline|minocycline|mesh-list
14969108|NCT01656616|Protective Agents|protective agents|mesh-ancestor
14969109|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967446|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13967447|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967448|NCT03117725|Melatonin|melatonin|mesh-list
13967449|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
13967450|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967451|NCT03117725|Protective Agents|protective agents|mesh-ancestor
13967452|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967453|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968179|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13968180|NCT03112564|Narcotics|narcotics|mesh-ancestor
13968181|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968182|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968183|NCT03112564|Analgesics|analgesics|mesh-ancestor
13968184|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
13968185|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968186|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13968187|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13968188|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
13968189|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
13968190|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13968191|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13968192|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13968193|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13968194|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13968195|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
13968196|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13968197|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
13968198|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968260|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14969110|NCT01656642|Atezolizumab|atezolizumab|mesh-list
14969111|NCT01656642|Vemurafenib|vemurafenib|mesh-list
14969112|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969113|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14969114|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968261|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13968262|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
13968263|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13968264|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968265|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13968266|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968267|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13968268|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13968269|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13968270|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
13968271|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968272|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13968273|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13968274|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968275|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968276|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13968277|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13968278|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13968279|NCT03112031|Amebicides|amebicides|mesh-ancestor
13968280|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13968281|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13968282|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13968283|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
13968284|NCT03111901|Interleukin-2|interleukin-2|mesh-list
13968285|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13968286|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968287|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13968288|NCT03111901|Analgesics|analgesics|mesh-ancestor
13968289|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
13968290|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968291|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968292|NCT03111797|Morphine|morphine|mesh-list
13968293|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13968294|NCT03111797|Narcotics|narcotics|mesh-ancestor
13968295|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968296|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968297|NCT03111797|Analgesics|analgesics|mesh-ancestor
13968298|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
13968299|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967454|NCT03117257|Cisplatin|cisplatin|mesh-list
14800546|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800547|NCT00788333|Trastuzumab|trastuzumab|mesh-list
14800548|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14800549|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800550|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14800551|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
14800552|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14800553|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
14800554|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800555|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800556|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14800557|NCT00788424|Protective Agents|protective agents|mesh-ancestor
14969115|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967455|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967456|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
13967457|NCT03117192|Astringents|astringents|mesh-ancestor
13967458|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967459|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
13967460|NCT03117010|Dexamethasone|dexamethasone|mesh-list
13967461|NCT03117010|Etoposide|etoposide|mesh-list
13967462|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967463|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
13967464|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
13967465|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967466|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967467|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13967468|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
13967469|NCT03117010|Hormones|hormones|mesh-ancestor
13967470|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967471|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13967472|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967473|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967474|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967475|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13967476|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13967477|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13967478|NCT03117166|Lidocaine|lidocaine|mesh-list
14969116|NCT01656668|Theobromine|theobromine|mesh-list
14969117|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14969118|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
14969119|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969120|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969121|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969122|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969123|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
14969124|NCT01656720|Methoxamine|methoxamine|mesh-list
14969125|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
14969126|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
14969127|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967479|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
13967480|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
13967481|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967482|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967483|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
13967484|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967485|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13967486|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13967487|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13967488|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13967489|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967490|NCT03116971|Etoposide|etoposide|mesh-list
13967491|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967492|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13967493|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13967494|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13967495|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967496|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967497|NCT03116945|Gallium citrate|gallium citrate|mesh-list
13967498|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967499|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13967500|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
13967501|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13967502|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967503|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967504|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967505|NCT03117023|Analgesics|analgesics|mesh-ancestor
13967506|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
13967507|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967508|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13967509|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13967510|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13967511|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967512|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967513|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967514|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
13967515|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967516|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
13967517|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
13967518|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
14523060|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
14523061|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14523062|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14523063|NCT03570476|Olaparib|olaparib|mesh-list
14523064|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14523065|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523066|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523067|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523068|NCT03570554|Acetaminophen|acetaminophen|mesh-list
14523069|NCT03570554|Celecoxib|celecoxib|mesh-list
14523070|NCT03570554|Naproxen|naproxen|mesh-list
14523071|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14523072|NCT03570554|Analgesics|analgesics|mesh-ancestor
14523073|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
14523074|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523075|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523076|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
13967536|NCT03116893|Itraconazole|itraconazole|mesh-list
13967537|NCT03116893|Rifampin|rifampin|mesh-list
13967538|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
13967539|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967540|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13967541|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13967542|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967543|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967544|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13967545|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
13967546|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967547|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523077|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14523078|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523079|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523080|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14523081|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523082|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523083|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523084|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
14523085|NCT03570697|Evolocumab|evolocumab|mesh-list
14523086|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14523087|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14523088|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
14523089|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523090|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13967548|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13967549|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13967550|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
13967551|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13967552|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
13967553|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13967554|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13967555|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13967556|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13967557|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13967558|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13967559|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13967560|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14969128|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969129|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14969130|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14969131|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14969132|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14969133|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969134|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969135|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028904|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028905|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028906|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
15028907|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028908|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028909|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13967561|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
13967562|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13967563|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13967564|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
13967565|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967566|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
13967567|NCT03116776|Protective Agents|protective agents|mesh-ancestor
13967568|NCT03116737|Benzocaine|benzocaine|mesh-list
13967569|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13967570|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
13967571|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
13967572|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15028910|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
15028911|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028912|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
15028913|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
15028914|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
15028915|NCT01958684|Copper|copper|mesh-list
15028916|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
15028917|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15028918|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
15028919|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028920|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967573|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967574|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
13967575|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967576|NCT03116659|Doxycycline|doxycycline|mesh-list
13967577|NCT03116659|Imiquimod|imiquimod|mesh-list
13967578|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13967579|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967580|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
13967581|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13967582|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13967583|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13967584|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
13967585|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967586|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967587|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
13967588|NCT03116672|Diclofenac|diclofenac|mesh-list
13967589|NCT03116672|Ketorolac|ketorolac|mesh-list
13967590|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13967591|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967592|NCT03116672|Analgesics|analgesics|mesh-ancestor
15028921|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15028922|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15028923|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15028924|NCT01958684|Trace Elements|trace elements|mesh-ancestor
15028925|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
15028926|NCT01958775|Glucagon|glucagon|mesh-list
15028927|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15028928|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15028929|NCT01958775|Hormones|hormones|mesh-ancestor
15028930|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967593|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
13967594|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967595|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967596|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967597|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967598|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13967599|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967600|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967601|NCT03116490|Anesthetics|anesthetics|mesh-list
13967602|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967603|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967604|NCT03116542|Alovudine|alovudine|mesh-list
13967605|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
13967606|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967607|NCT03116347|Immunoglobulins|immunoglobulins|mesh-list
13967608|NCT03116347|Antibodies|antibodies|mesh-list
13967609|NCT03116347|gamma-Globulins|gamma-globulins|mesh-list
13967610|NCT03116347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13967611|NCT03116347|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13967612|NCT03116347|Immunoglobulin G|immunoglobulin g|mesh-list
13967613|NCT03116347|Immunologic Factors|immunologic factors|mesh-ancestor
13967614|NCT03116347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967615|NCT03116555|Irinotecan|irinotecan|mesh-list
13967616|NCT03116555|Apatinib|apatinib|mesh-list
13967617|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13967618|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13967619|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967620|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967621|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967622|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13967623|NCT03116516|Amlodipine|amlodipine|mesh-list
13967624|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13967625|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13967626|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13967627|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13967628|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967629|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13967630|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967631|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
13967632|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13967633|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13967634|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
13967635|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13967636|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13967637|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967638|NCT03116269|Aspirin|aspirin|mesh-list
13967639|NCT03116269|Cilostazol|cilostazol|mesh-list
13967640|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13967641|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967642|NCT03116269|Analgesics|analgesics|mesh-ancestor
13967643|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
13967644|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967645|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967646|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967647|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967648|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13967649|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14969136|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
14969137|NCT01656798|Citric Acid|citric acid|mesh-list
14969138|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
14969139|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
14969140|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14969141|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
14969142|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
14969143|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969144|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
14969145|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14969146|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14969147|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967650|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967651|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13967652|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13967653|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967654|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
13967655|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13967656|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
13967657|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13967658|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
13967659|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
13967660|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14969148|NCT01656798|Urological Agents|urological agents|mesh-ancestor
14969149|NCT01656811|Albuterol|albuterol|mesh-list
15035035|NCT01998685|Analgesics|analgesics|mesh-ancestor
13967661|NCT03116269|Protective Agents|protective agents|mesh-ancestor
13967662|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13967663|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13967664|NCT03116126|Guanfacine|guanfacine|mesh-list
13967665|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13967666|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13967667|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13967668|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13967669|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967670|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967671|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967672|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967673|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
13967674|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
13967675|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13967676|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13967677|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13967678|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967679|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
13967680|NCT03116087|Testosterone|testosterone|mesh-list
13967681|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
13967682|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
13967683|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13967684|NCT03116087|Androgens|androgens|mesh-ancestor
13967685|NCT03116087|Hormones|hormones|mesh-ancestor
13967686|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967687|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967688|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13967689|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967690|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
13967691|NCT03116308|Opicapone|opicapone|mesh-list
13967692|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13967693|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967694|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967695|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13967696|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13967697|NCT03116282|Ethanol|ethanol|mesh-list
13967698|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13967699|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967700|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967701|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967702|NCT03116295|Opicapone|opicapone|mesh-list
13967703|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13967704|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967705|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967706|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13967707|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13967708|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
13967709|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13967710|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967711|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
13967712|NCT03115697|Rifaximin|rifaximin|mesh-list
13967713|NCT03115697|Lactulose|lactulose|mesh-list
14969150|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14969151|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
14969152|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969153|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969154|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969155|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969156|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
14969157|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14969158|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14969159|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14969160|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14969161|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969162|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969163|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969164|NCT01656980|Carmustine|carmustine|mesh-list
14969165|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14969166|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
14969167|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969168|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969169|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
14969170|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
14969171|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
14969172|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969173|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967714|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13967715|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967716|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13967717|NCT03115736|Tenofovir|tenofovir|mesh-list
13967718|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
13967719|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967720|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13967721|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13967722|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967723|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967724|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13967725|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13967726|NCT03115775|Vitamin D|vitamin d|mesh-list
13967727|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
13967728|NCT03115775|Vitamins|vitamins|mesh-list
13967729|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
13967730|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967731|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13967732|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13968199|NCT03112148|Tofacitinib|tofacitinib|mesh-list
13968200|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13968201|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968202|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968203|NCT03112187|Iron|iron|mesh-list
13968204|NCT03112187|Trace Elements|trace elements|mesh-ancestor
13968205|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
13968206|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968207|NCT03112135|Epinephrine|epinephrine|mesh-list
13968208|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
13968209|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13968210|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13968211|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968212|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968213|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968214|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968215|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13968216|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13968217|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
13968218|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968219|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13968220|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
13968221|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
13968222|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
13968223|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13968224|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13968225|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13968226|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
13968227|NCT03112135|Coagulants|coagulants|mesh-ancestor
13968228|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
13968229|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968230|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
13968231|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
13968232|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
13968233|NCT03112382|Vitamins|vitamins|mesh-list
13968234|NCT03112382|Vitamin A|vitamin a|mesh-list
13968235|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
13968236|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
13968237|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968238|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
13968239|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968240|NCT03112382|Protective Agents|protective agents|mesh-ancestor
13968241|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13968242|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968243|NCT03112226|Estradiol|estradiol|mesh-list
13968244|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
13968245|NCT03112226|Estrogens|estrogens|mesh-ancestor
14969174|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969175|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14969176|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
14969177|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
14969178|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968246|NCT03112226|Hormones|hormones|mesh-ancestor
13968300|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
14969179|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969180|NCT01657071|Aspirin|aspirin|mesh-list
14969181|NCT01657071|Clopidogrel|clopidogrel|mesh-list
14969182|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14969183|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969184|NCT01657071|Analgesics|analgesics|mesh-ancestor
14969185|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
14969186|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969187|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969188|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969189|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969190|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14969191|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14969192|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969193|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14969194|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14969195|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969196|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
14969197|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14969198|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14969199|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14969200|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
14969201|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969202|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
14969203|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14969204|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969205|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14969206|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14969207|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969208|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969209|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969210|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969211|NCT01657201|Voriconazole|voriconazole|mesh-list
14969212|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
14969213|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969214|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13967733|NCT03115489|Ketamine|ketamine|mesh-list
13967734|NCT03115489|Propofol|propofol|mesh-list
13967735|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13967736|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967737|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967738|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13967739|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
13967740|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
13967741|NCT03115489|Analgesics|analgesics|mesh-ancestor
13967742|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
13967743|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967744|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13967745|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13967746|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13967747|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967748|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967749|NCT03115762|Bevacizumab|bevacizumab|mesh-list
13967750|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13967751|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967752|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13967753|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13967754|NCT03115762|Growth Substances|growth substances|mesh-ancestor
13967755|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967756|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
13967757|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13967758|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
13967759|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13967760|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
13967761|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13967762|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967763|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13967764|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13967765|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967766|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13967767|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13968301|NCT03112044|Velpatasvir|velpatasvir|mesh-list
14523091|NCT03571516|Teduglutide|teduglutide|mesh-list
13967768|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967769|NCT03115619|Pirfenidone|pirfenidone|mesh-list
13967770|NCT03115619|Analgesics|analgesics|mesh-ancestor
14969215|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14969216|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969217|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969218|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14969219|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
13967771|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
13967772|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967773|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967774|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13967775|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967776|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967777|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967778|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967779|NCT03115567|Triamcinolone|triamcinolone|mesh-list
14969220|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969221|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969222|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14969223|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14969224|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14969225|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14969226|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14969227|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969228|NCT01657240|Analgesics|analgesics|mesh-ancestor
14969229|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
14969230|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969231|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969232|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969233|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969234|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14969235|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14969236|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14969237|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
14969238|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
14969239|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969240|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969241|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14969242|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969243|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14969244|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14969245|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14969246|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
14969247|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969248|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969249|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14969250|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
14969251|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14969252|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969253|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
14969254|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
14969255|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14969256|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14969257|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14969258|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14969259|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14969260|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969261|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
14969262|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969263|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969264|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14969265|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969266|NCT01657448|Methenamine|methenamine|mesh-list
14969267|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
14969268|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
14969269|NCT01657448|Methylene Blue|methylene blue|mesh-list
14969270|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13967780|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967781|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
14969271|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967782|NCT03115567|Hormones|hormones|mesh-ancestor
13968302|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
13967783|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967784|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967785|NCT03115255|Ranibizumab|ranibizumab|mesh-list
13967786|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13967787|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13967788|NCT03115255|Growth Substances|growth substances|mesh-ancestor
13967789|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967790|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
13967791|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967792|NCT03114865|Dexamethasone|dexamethasone|mesh-list
13967793|NCT03114865|Blinatumomab|blinatumomab|mesh-list
13967794|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13967795|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967796|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
13967797|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
13967798|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967799|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967800|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13967801|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
13967802|NCT03114865|Hormones|hormones|mesh-ancestor
13967803|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967804|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13967805|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967806|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
13967807|NCT03115047|Meperidine|meperidine|mesh-list
13967808|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
13967809|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13967810|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967811|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967812|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13967813|NCT03115047|Analgesics|analgesics|mesh-ancestor
13967814|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
13967815|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967816|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13967817|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13967818|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13967819|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967820|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967821|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967822|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13967823|NCT03115047|Narcotics|narcotics|mesh-ancestor
13967824|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13967825|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
13967826|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13967827|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13967828|NCT03115034|Melatonin|melatonin|mesh-list
13967829|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
13967830|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967831|NCT03115034|Protective Agents|protective agents|mesh-ancestor
13967832|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967833|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967834|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
13967835|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967836|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967837|NCT03115073|Clotrimazole|clotrimazole|mesh-list
13967838|NCT03115073|Miconazole|miconazole|mesh-list
13967839|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13967840|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967841|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
13967842|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13967843|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13967844|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967845|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967846|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13967847|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
13967848|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967849|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967850|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13967851|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13967852|NCT03115151|Fentanyl|fentanyl|mesh-list
13967853|NCT03115151|Hydromorphone|hydromorphone|mesh-list
13967854|NCT03115151|Bupivacaine|bupivacaine|mesh-list
13967855|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
13967856|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
13967857|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13967858|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967859|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
13967860|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967861|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13967862|NCT03115151|Narcotics|narcotics|mesh-ancestor
13967863|NCT03115151|Analgesics|analgesics|mesh-ancestor
13967864|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13967865|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13967866|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
13967867|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13967868|NCT03115099|Liraglutide|liraglutide|mesh-list
13967869|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13967870|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967871|NCT03115099|Incretins|incretins|mesh-ancestor
13967872|NCT03115099|Hormones|hormones|mesh-ancestor
13967873|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967874|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13967875|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
13967876|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967877|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967878|NCT03114813|Carvedilol|carvedilol|mesh-list
13967879|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13967880|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13967881|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967882|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967883|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967884|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967885|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13967886|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
13967887|NCT03114813|Protective Agents|protective agents|mesh-ancestor
13967888|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13967889|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13967890|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13967891|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
13967892|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13967893|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13967894|NCT03114527|Everolimus|everolimus|mesh-list
13967895|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967896|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13967897|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
13967898|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967899|NCT03114371|Oxytocin|oxytocin|mesh-list
13967900|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
13967901|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13967902|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967903|NCT03114280|Carboplatin|carboplatin|mesh-list
13967904|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967905|NCT03114228|Midostaurin|midostaurin|mesh-list
13967906|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967907|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13967908|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967909|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967910|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13967911|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13967912|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
13967913|NCT03114085|Capecitabine|capecitabine|mesh-list
13967914|NCT03114085|Apatinib|apatinib|mesh-list
13967915|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13967916|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
13967917|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967918|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967919|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13967920|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967921|NCT03114072|Methamphetamine|methamphetamine|mesh-list
13967922|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13967923|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967924|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
13967925|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
13967926|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967927|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
13967928|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967929|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967930|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
13967931|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14969272|NCT01657448|Renal Agents|renal agents|mesh-ancestor
14969273|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14969274|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969275|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969276|NCT01657487|Fluticasone|fluticasone|mesh-list
14969277|NCT01657487|Xhance|xhance|mesh-list
14969278|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14969279|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14969280|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969281|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14969282|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
14969283|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969284|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969285|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969286|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969287|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
14969288|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14969289|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14969290|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14969291|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14969292|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969293|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969294|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969295|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
14969296|NCT01657487|Hormones|hormones|mesh-ancestor
14969297|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969298|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
14969299|NCT01657578|Omeprazole|omeprazole|mesh-list
14969300|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14969301|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969302|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14969303|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969304|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969305|NCT01657656|Vitamin D|vitamin d|mesh-list
14969306|NCT01657656|Vitamins|vitamins|mesh-ancestor
14969307|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
14969308|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969309|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14969310|NCT01657669|Aflibercept|aflibercept|mesh-list
14969311|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14969312|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14969313|NCT01657669|Growth Substances|growth substances|mesh-ancestor
14969314|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969315|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
14969316|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969317|NCT01657682|Crenolanib|crenolanib|mesh-list
14969318|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969319|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
14969320|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
14969321|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
14969322|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969323|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969324|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14969325|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14969326|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
14969327|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969328|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969329|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
14969330|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14969331|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14969332|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969333|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969334|NCT01657812|Analgesics|analgesics|mesh-ancestor
14969335|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
14969336|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969337|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14969338|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14969339|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14969340|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969341|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969342|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969343|NCT01657825|Isavuconazole|isavuconazole|mesh-list
14969344|NCT01657825|Warfarin|warfarin|mesh-list
14969345|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
14969346|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
14969347|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969348|NCT01657838|Ketoconazole|ketoconazole|mesh-list
14969349|NCT01657838|Isavuconazole|isavuconazole|mesh-list
14969350|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
14969351|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969352|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14969353|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14969354|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969355|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969356|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14969357|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969358|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969359|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969360|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14969361|NCT01657851|Tamsulosin|tamsulosin|mesh-list
14969362|NCT01657851|Dutasteride|dutasteride|mesh-list
14969363|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14969364|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14969365|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14969366|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969367|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969368|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969369|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969370|NCT01657851|Urological Agents|urological agents|mesh-ancestor
14969371|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14969372|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14969373|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969374|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969375|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969376|NCT01657864|Lamotrigine|lamotrigine|mesh-list
14969377|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
14969378|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14969379|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14969380|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969381|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14969382|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969383|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14969384|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14969385|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14969386|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14969387|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14969388|NCT01657890|Isavuconazole|isavuconazole|mesh-list
14969389|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
14969390|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969391|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14969392|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14969393|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
14969394|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969395|NCT01657929|Antacids|antacids|mesh-ancestor
14969396|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969397|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969398|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14969399|NCT01657955|Chlorambucil|chlorambucil|mesh-list
14969400|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14969401|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
14969402|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969403|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969404|NCT01657513|Adalimumab|adalimumab|mesh-list
14969405|NCT01657513|Etanercept|etanercept|mesh-list
14969406|NCT01657513|Infliximab|infliximab|mesh-list
14969407|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969408|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969409|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
14969410|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969411|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14969412|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969413|NCT01657513|Analgesics|analgesics|mesh-ancestor
14969414|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
14969415|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969416|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969417|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969418|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
14969419|NCT01657981|Darexaban|darexaban|mesh-list
14969420|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14969421|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
14969422|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14969423|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
14969424|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969425|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969426|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
14969427|NCT01658007|Sirolimus|sirolimus|mesh-list
14969428|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14969429|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969430|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14969431|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969432|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
14969433|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969434|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
14969435|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969436|NCT01658033|Leucovorin|leucovorin|mesh-list
14969437|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
14969438|NCT01658033|Bevacizumab|bevacizumab|mesh-list
14969439|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969440|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14969441|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14969442|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14969443|NCT01658033|Growth Substances|growth substances|mesh-ancestor
14969444|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969445|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
14969446|NCT01658033|Antidotes|antidotes|mesh-ancestor
14969447|NCT01658033|Protective Agents|protective agents|mesh-ancestor
14969448|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
14969449|NCT01658033|Vitamins|vitamins|mesh-ancestor
14969450|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
14969451|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
14969452|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14969453|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14969454|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969455|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
14969456|NCT01658124|Coagulants|coagulants|mesh-ancestor
14969457|NCT01658176|Exemestane|exemestane|mesh-list
14969458|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969459|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14969460|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14969461|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969462|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969463|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14969464|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969465|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969466|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969467|NCT01658202|Nicotine|nicotine|mesh-list
14969468|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14969469|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
14969470|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969471|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969472|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14969473|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14969474|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
14969475|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969476|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969477|NCT01658215|Nicotine|nicotine|mesh-list
14969478|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14969479|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
14969480|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969481|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969482|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14969483|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14969484|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
14969485|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969486|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969487|NCT01658241|Panobinostat|panobinostat|mesh-list
14969488|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969489|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14969490|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969491|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969492|NCT01658319|Fludarabine|fludarabine|mesh-list
14969493|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
14969494|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969495|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14969496|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
14969497|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969498|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969499|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
14969500|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969501|NCT01658358|Doxorubicin|doxorubicin|mesh-list
14969502|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14969503|NCT01658358|Lapatinib|lapatinib|mesh-list
14969504|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14969505|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969506|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14969507|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14969508|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969509|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969510|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14969511|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
14969512|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14969513|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14969514|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969515|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
14969516|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14969517|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
14969518|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969519|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
14969520|NCT01658449|Protective Agents|protective agents|mesh-ancestor
15028931|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028932|NCT01958775|Incretins|incretins|mesh-ancestor
15028933|NCT01958814|Albuterol|albuterol|mesh-list
15028934|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15028935|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
15028936|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028937|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028938|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15028939|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
15028940|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
15028941|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15028942|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15028943|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15028944|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15028945|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028946|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028947|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028948|NCT01958866|Acetaminophen|acetaminophen|mesh-list
15028949|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15028950|NCT01958866|Analgesics|analgesics|mesh-ancestor
15028951|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
15028952|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028953|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028954|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
15028955|NCT01958905|Lumefantrine|lumefantrine|mesh-list
15028956|NCT01958905|Artemether|artemether|mesh-list
15028957|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15028958|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
15028959|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15028960|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15028961|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028962|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
15028963|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15028964|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
15028965|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15028966|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028967|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15028968|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
15028969|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15028970|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
15028971|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028972|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028973|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15028974|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
15028975|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
15028976|NCT01958944|Protective Agents|protective agents|mesh-ancestor
15028977|NCT01958996|Idarubicin|idarubicin|mesh-list
14969521|NCT01658462|Docetaxel|docetaxel|mesh-list
14969522|NCT01658462|Nintedanib|nintedanib|mesh-list
14969523|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969524|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
14969525|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
14969526|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
14969527|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969528|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14969529|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969530|NCT01658527|Bicalutamide|bicalutamide|mesh-list
14969531|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
14969532|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969533|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969534|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969535|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969536|NCT01658553|Trametinib|trametinib|mesh-list
14969537|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969538|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14969539|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969540|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969541|NCT01658774|Ascorbic Acid|ascorbic acid|mesh-list
14969542|NCT01658774|Albendazole|albendazole|mesh-list
14969543|NCT01658774|Vitamins|vitamins|mesh-ancestor
14969544|NCT01658774|Micronutrients|micronutrients|mesh-ancestor
14969545|NCT01658774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969546|NCT01658774|Antioxidants|antioxidants|mesh-ancestor
14969547|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969548|NCT01658774|Protective Agents|protective agents|mesh-ancestor
14969549|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
14969550|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14969551|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969552|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
14969553|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14969554|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14969555|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
14969556|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
14969557|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
14969558|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969559|NCT01658852|Metronidazole|metronidazole|mesh-list
14969560|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969561|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14969562|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14969563|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14969564|NCT01658878|Nivolumab|nivolumab|mesh-list
14969565|NCT01658878|Ipilimumab|ipilimumab|mesh-list
14969566|NCT01658878|Sorafenib|sorafenib|mesh-list
14969567|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14969568|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969569|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14969570|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969571|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14969572|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969573|NCT01658891|Beclomethasone|beclomethasone|mesh-list
14969574|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
14969575|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14969576|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
14969577|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969578|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969579|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969580|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969581|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14969582|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14969583|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14969584|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969585|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969586|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969587|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969588|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
14969589|NCT01658891|Hormones|hormones|mesh-ancestor
14969590|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969591|NCT01659008|Estradiol|estradiol|mesh-list
14969592|NCT01659008|Estrogens|estrogens|mesh-ancestor
14969593|NCT01659008|Hormones|hormones|mesh-ancestor
14969594|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969595|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969596|NCT01659047|Idelalisib|idelalisib|mesh-list
14969597|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969598|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969599|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969600|NCT01659086|Vaccines|vaccines|mesh-list
14969601|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
14969602|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969603|NCT01659099|Prednisone|prednisone|mesh-list
14969604|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
14969605|NCT01659099|Rituximab|rituximab|mesh-list
14969606|NCT01659099|Doxorubicin|doxorubicin|mesh-list
14969607|NCT01659099|Vincristine|vincristine|mesh-list
14969608|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
14969609|NCT01659099|Bleomycin|bleomycin|mesh-list
14969610|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969611|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
14969612|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969613|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969614|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14969615|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
14969616|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969617|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969618|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14969619|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14969620|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14969621|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14969622|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14969623|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969624|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969625|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
14969626|NCT01659099|Hormones|hormones|mesh-ancestor
14969627|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969628|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14969629|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14969630|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
14969631|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
14969632|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
14969633|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
14969634|NCT01659190|Antacids|antacids|mesh-ancestor
14969635|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969636|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969637|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
14969638|NCT01659242|Methotrexate|methotrexate|mesh-list
14969639|NCT01659242|Leflunomide|leflunomide|mesh-list
14969640|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14969641|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
14969642|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14969643|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969644|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14969645|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
14969646|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969647|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969648|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14969649|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969650|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14969651|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969652|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
14969653|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969654|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14969655|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969656|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14969657|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969658|NCT01659242|Analgesics|analgesics|mesh-ancestor
14969659|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
14969660|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969661|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969662|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969663|NCT01659281|Artesunate|artesunate|mesh-list
14969664|NCT01659281|Mefloquine|mefloquine|mesh-list
14969665|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
14969666|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14969667|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14969668|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969669|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969670|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
14969671|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
14969672|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14969673|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
14969674|NCT01659307|Aspirin|aspirin|mesh-list
14969675|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14969676|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969677|NCT01659307|Analgesics|analgesics|mesh-ancestor
14969678|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
14969679|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969680|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969681|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969682|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969683|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14969684|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14969685|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969686|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14969687|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14969688|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969689|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
14969690|NCT01659346|Carvedilol|carvedilol|mesh-list
14969691|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14969692|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14969693|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969694|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969695|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969696|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969697|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14969698|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
14969699|NCT01659346|Protective Agents|protective agents|mesh-ancestor
14969700|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14969701|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14969702|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14969703|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
14969704|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14969705|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14969706|NCT01659359|Lidocaine|lidocaine|mesh-list
14969707|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
14969708|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
14969709|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14969710|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969711|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
14969712|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969713|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14969714|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14969715|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14969716|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14969717|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969718|NCT01659372|Naproxen|naproxen|mesh-list
14969719|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14969720|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969721|NCT01659372|Analgesics|analgesics|mesh-ancestor
14969722|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
14969723|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969724|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969725|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969726|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969727|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
14969728|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14969729|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969730|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969731|NCT01659437|Clarithromycin|clarithromycin|mesh-list
14236508|NCT00115037|Naltrexone|naltrexone|mesh-list
14969732|NCT01659437|Streptomycin|streptomycin|mesh-list
14969733|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14969734|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969735|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14969736|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969737|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969738|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14969739|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14969740|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
14969741|NCT01659476|Miotics|miotics|mesh-ancestor
14969742|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
14969743|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969744|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969745|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14969746|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14969747|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969748|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14969749|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14969750|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
14969751|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969752|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969753|NCT01659515|Arbekacin|arbekacin|mesh-list
14969754|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969755|NCT01659619|Erythromycin|erythromycin|mesh-list
14969756|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
14969757|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14969758|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
14969759|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14969760|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969761|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969762|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14969763|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969764|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969765|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
14969766|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14969767|NCT01659684|Antibodies|antibodies|mesh-list
14969768|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
14969769|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14969770|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
14969771|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969772|NCT01659775|Ondansetron|ondansetron|mesh-list
14969773|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
14969774|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
14969775|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969776|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969777|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969778|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
14969779|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
14969780|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14969781|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
14969782|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969783|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969784|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14969785|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14969786|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14969787|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14969788|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14969789|NCT01659788|Ubiquinone|ubiquinone|mesh-list
14969790|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
14969791|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
14969792|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969793|NCT01659788|Vitamins|vitamins|mesh-ancestor
14969794|NCT01659827|Bupivacaine|bupivacaine|mesh-list
14969795|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
14969796|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
14969797|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14969798|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969799|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
14969800|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969801|NCT01659892|Montelukast|montelukast|mesh-list
14969802|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969803|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969804|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14969805|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969806|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969807|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969808|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14969809|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14969810|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969811|NCT01659905|Montelukast|montelukast|mesh-list
14969812|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969813|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969814|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14969815|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969816|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969817|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969818|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14969819|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14969820|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969821|NCT01659918|Montelukast|montelukast|mesh-list
14969822|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969823|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969824|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14969825|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969826|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969827|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969828|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14969829|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14969830|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969831|NCT01659931|Montelukast|montelukast|mesh-list
14800558|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14800559|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14800560|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800561|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800562|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
14800563|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800564|NCT00788463|Beclomethasone|beclomethasone|mesh-list
14800565|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14800566|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
14800567|NCT00788463|Hormones|hormones|mesh-ancestor
14800568|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14800569|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969832|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14969833|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
14969834|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14969835|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
14969836|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969837|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969838|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14969839|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14969840|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969841|NCT01659944|Metoprolol|metoprolol|mesh-list
14969842|NCT01659944|Eliglustat|eliglustat|mesh-list
14969843|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14969844|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14969845|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
14969846|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
14969847|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969848|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969849|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14969850|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14969851|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14969852|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969853|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969854|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969855|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028978|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15028979|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028980|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15028981|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15028982|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15028983|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028984|NCT01959022|Doxazosin|doxazosin|mesh-list
15028985|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14236509|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14969856|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14969857|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
14969858|NCT01660295|Certoparin|certoparin|mesh-list
14969859|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
14969860|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14969861|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14969862|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969863|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14969864|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
14969865|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
14969866|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969867|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969868|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14969869|NCT01660295|Analgesics|analgesics|mesh-ancestor
14969870|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
14969871|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969872|NCT01660373|Tirofiban|tirofiban|mesh-list
14969873|NCT01660373|Ticagrelor|ticagrelor|mesh-list
14969874|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14969875|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14969876|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14969877|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14969878|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
14969879|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969880|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969881|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969882|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14969883|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14969884|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14969885|NCT01660386|Glimepiride|glimepiride|mesh-list
14969886|NCT01660386|Saxagliptin|saxagliptin|mesh-list
14969887|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14969888|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969889|NCT01660386|Incretins|incretins|mesh-ancestor
14969890|NCT01660386|Hormones|hormones|mesh-ancestor
14969891|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969892|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14969893|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
14969894|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969895|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969896|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14969897|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969898|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
14969899|NCT01660399|Docetaxel|docetaxel|mesh-list
14969900|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969901|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
14969902|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
14969903|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
14969904|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969905|NCT01660477|Ritonavir|ritonavir|mesh-list
14969906|NCT01660477|Lopinavir|lopinavir|mesh-list
14969907|NCT01660477|Isavuconazole|isavuconazole|mesh-list
14969908|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14969909|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14969910|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
14969911|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969912|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969913|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14969914|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14969915|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
14969916|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969917|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14969918|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14969919|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
14969920|NCT01660542|Docetaxel|docetaxel|mesh-list
14969921|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969922|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
14969923|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
14969924|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
14969925|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969926|NCT01660594|Calcium|calcium|mesh-list
14969927|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14969928|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969929|NCT01660620|Betaxolol|betaxolol|mesh-list
14969930|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14969931|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
14969932|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
14969933|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969934|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969935|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14969936|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14969937|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14969938|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
14969939|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14969940|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969941|NCT01660750|Dexamethasone|dexamethasone|mesh-list
14969942|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
14969943|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14969944|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
14969945|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969946|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14969947|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14969948|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
14969949|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969950|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969951|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14969952|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969953|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
14969954|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
14969955|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969956|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14800570|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14800571|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14800572|NCT00788515|Lormetazepam|lormetazepam|mesh-list
14800573|NCT00788515|Volinanserin|volinanserin|mesh-list
14800574|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14800575|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800576|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800577|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14800578|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
14969957|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
14969958|NCT01660750|Hormones|hormones|mesh-ancestor
15035616|NCT02002247|Selenium|selenium|mesh-list
15035617|NCT02002247|Selenious Acid|selenious acid|mesh-list
15035618|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
15035619|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
15035620|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035621|NCT02002247|Protective Agents|protective agents|mesh-ancestor
15035622|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035623|NCT02002247|Trace Elements|trace elements|mesh-ancestor
15035624|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
14969959|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969960|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14969961|NCT01660854|Proguanil|proguanil|mesh-list
14969962|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14969963|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
14969964|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14969965|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14969966|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14969967|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
14969968|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969969|NCT01660867|Dexamethasone|dexamethasone|mesh-list
14969970|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969971|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
14969972|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
14969973|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14969974|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14969975|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14969976|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
14969977|NCT01660867|Hormones|hormones|mesh-ancestor
14969978|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14969979|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14969980|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14969981|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14969982|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14969983|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14969984|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
14969985|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969986|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14969987|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14969988|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14969989|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14969990|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14969991|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14969992|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
14969993|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14969994|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14969995|NCT01660997|Dexamethasone|dexamethasone|mesh-list
14969996|NCT01660997|Ixazomib|ixazomib|mesh-list
14969997|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14969998|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
14969999|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
14970000|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970001|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970002|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970003|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
14970004|NCT01660997|Hormones|hormones|mesh-ancestor
14970005|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970006|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14970007|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970008|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
14970009|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970010|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970011|NCT01661101|Omeprazole|omeprazole|mesh-list
14970012|NCT01661101|Dabigatran|dabigatran|mesh-list
14970013|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14970014|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970015|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14970016|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970017|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970018|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
14970019|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14970020|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
14970021|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
14970022|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14970023|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
14970024|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14970025|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14970026|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
14970027|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970028|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970029|NCT01661257|Infliximab|infliximab|mesh-list
14970030|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
14970031|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14236510|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14970032|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970033|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
14970034|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14970035|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14970036|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970037|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
14970038|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14970039|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
14970040|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
14970041|NCT01661309|Vitamins|vitamins|mesh-ancestor
14970042|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
14970043|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970044|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
14970045|NCT01661322|Aspirin|aspirin|mesh-list
14970046|NCT01661322|Clopidogrel|clopidogrel|mesh-list
14970047|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14970048|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970049|NCT01661322|Analgesics|analgesics|mesh-ancestor
14970050|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
14970051|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970052|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970053|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970054|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970055|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14970056|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14970057|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970058|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14970059|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14970060|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970061|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
14970062|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14970063|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14970064|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14970065|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
14970066|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970067|NCT01661335|Dexamethasone|dexamethasone|mesh-list
14970068|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
14970069|NCT01661335|Ondansetron|ondansetron|mesh-list
14970070|NCT01661335|Aprepitant|aprepitant|mesh-list
14970071|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
14970072|NCT01661335|BB 1101|bb 1101|mesh-list
14970073|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970074|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
14970075|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
14970076|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970077|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970078|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970079|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
14970080|NCT01661335|Hormones|hormones|mesh-ancestor
14970081|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970082|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14970083|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970084|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
14970085|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970086|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970087|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
14970088|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
14970089|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14970090|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
14970091|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970092|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14970093|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14970094|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970095|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14970096|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14970097|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14970098|NCT01661439|Heparin|heparin|mesh-list
14970099|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14970100|NCT01661439|Tinzaparin|tinzaparin|mesh-list
14970101|NCT01661439|Dalteparin|dalteparin|mesh-list
14970102|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
14970103|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14970104|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14970105|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970106|NCT01661530|Vitamin E|vitamin e|mesh-list
14970107|NCT01661530|Vitamins|vitamins|mesh-ancestor
14970108|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
14970109|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970110|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
14970111|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970112|NCT01661530|Protective Agents|protective agents|mesh-ancestor
14970113|NCT01661556|Miconazole|miconazole|mesh-list
14970114|NCT01661556|Hydroquinone|hydroquinone|mesh-list
14970115|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
14970116|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970117|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14970118|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14970119|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970120|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970121|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14970122|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
14970123|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970124|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970125|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14970126|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14970127|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
14970128|NCT01661556|Protective Agents|protective agents|mesh-ancestor
14970129|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14970130|NCT01661647|Anesthetics|anesthetics|mesh-list
14970131|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970132|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970133|NCT01661751|Vaccines|vaccines|mesh-list
14970134|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
14970135|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970136|NCT01661777|Diuretics|diuretics|mesh-list
14970137|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
14970138|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14970139|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
14970140|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970141|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
14970142|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970143|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970144|NCT01661855|Riluzole|riluzole|mesh-list
14970145|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
14970146|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14970147|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14970148|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970149|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970150|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970151|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14970152|NCT01661855|Protective Agents|protective agents|mesh-ancestor
14970153|NCT01661868|Olaparib|olaparib|mesh-list
14970154|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14970155|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970156|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970157|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970158|NCT01661985|Azithromycin|azithromycin|mesh-list
14970159|NCT01661985|Doxycycline|doxycycline|mesh-list
14970160|NCT01661985|Lymecycline|lymecycline|mesh-list
14970161|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14970162|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970163|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
14970164|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14970165|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14970166|NCT01662037|Bosentan|bosentan|mesh-list
14970167|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14970168|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14970169|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970170|NCT01662050|Cytarabine|cytarabine|mesh-list
14970171|NCT01662050|Rituximab|rituximab|mesh-list
14970172|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14970173|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14970174|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970175|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
14970176|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970177|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970178|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14970179|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
14970180|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970181|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
14970182|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970183|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14970184|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14970185|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
14970186|NCT01662089|Zinc|zinc|mesh-list
14970187|NCT01662089|Trace Elements|trace elements|mesh-ancestor
14970188|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
14970189|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970190|NCT01662128|Capecitabine|capecitabine|mesh-list
14970191|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14970192|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
14970193|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970194|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028986|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15028987|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15028988|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15028989|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
15028990|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15028991|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15028992|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15028993|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
15028994|NCT01959061|Raltitrexed|raltitrexed|mesh-list
15028995|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
15028996|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15028997|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14970195|NCT01662180|Hormones|hormones|mesh-list
14970196|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14970197|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970198|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970199|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
14970200|NCT01662193|Vitamin D|vitamin d|mesh-list
14970201|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
14970202|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
14970203|NCT01662193|Vitamins|vitamins|mesh-list
14970204|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
14970205|NCT01662193|Calcium|calcium|mesh-list
14970206|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
14970207|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970208|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14970209|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14970210|NCT01662193|Antacids|antacids|mesh-ancestor
14970211|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970212|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970213|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
14970214|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14970215|NCT01662401|Bupivacaine|bupivacaine|mesh-list
14970216|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
14970217|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
14970218|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970219|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970220|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
14970221|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970222|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
14970223|NCT01662466|Testosterone|testosterone|mesh-list
14970224|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
14970225|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
14970226|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14970227|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14970228|NCT01662466|Androgens|androgens|mesh-ancestor
14970229|NCT01662466|Hormones|hormones|mesh-ancestor
14970230|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970231|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970232|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14970233|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970234|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
14970235|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14970236|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
14970237|NCT01662518|Dexamethasone|dexamethasone|mesh-list
14970238|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970239|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
14970240|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
14970241|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970242|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970243|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970244|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
14970245|NCT01662518|Hormones|hormones|mesh-ancestor
14970246|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970247|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14970248|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970249|NCT01662622|Sevoflurane|sevoflurane|mesh-list
14970250|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14970251|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14970252|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
14970253|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
14970254|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970255|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970256|NCT01662674|Metformin|metformin|mesh-list
14970257|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14970258|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970259|NCT01662687|Granisetron|granisetron|mesh-list
14970260|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
14970261|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
14970262|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970263|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970264|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970265|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14970266|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
14970267|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970268|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970269|NCT01662700|Artesunate|artesunate|mesh-list
14970270|NCT01662700|Chloroquine|chloroquine|mesh-list
14970271|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
14970272|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14970273|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14970274|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970275|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970276|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
14970277|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
14970278|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14970279|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
14970280|NCT01662700|Amebicides|amebicides|mesh-ancestor
14970281|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970282|NCT01662804|Interleukin-2|interleukin-2|mesh-list
14970283|NCT01662804|Antibodies|antibodies|mesh-list
14970284|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14970285|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
14970286|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970287|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970288|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970289|NCT01662804|Analgesics|analgesics|mesh-ancestor
14970290|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
14970291|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970292|NCT01662869|Leucovorin|leucovorin|mesh-list
14970293|NCT01662869|Folic Acid|folic acid|mesh-list
14970294|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
14970295|NCT01662869|Fluorouracil|fluorouracil|mesh-list
14970296|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
14970297|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970298|NCT01662869|Antidotes|antidotes|mesh-ancestor
14970299|NCT01662869|Protective Agents|protective agents|mesh-ancestor
14970300|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970301|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
14970302|NCT01662869|Vitamins|vitamins|mesh-ancestor
14970303|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
14970304|NCT01662869|Hematinics|hematinics|mesh-ancestor
14970305|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
14970306|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970307|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14970308|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14970309|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
14970310|NCT01662921|Insulin|insulin|mesh-list
14970311|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14970312|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
14970313|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
14970314|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
14970315|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14970316|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970317|NCT01663038|Aspirin|aspirin|mesh-list
14970318|NCT01663038|Clopidogrel|clopidogrel|mesh-list
14970319|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14970320|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970321|NCT01663038|Analgesics|analgesics|mesh-ancestor
14970322|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
14970323|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970324|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970325|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970326|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970327|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14970328|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14970329|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970330|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14970331|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14970332|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970333|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
14970334|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14970335|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14970336|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14970337|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
14970338|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970339|NCT01663077|Clozapine|clozapine|mesh-list
14970340|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14970341|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
14970342|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970343|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970344|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970345|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14970346|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14970347|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970348|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14970349|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
14970350|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
14970351|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14970352|NCT01663090|Hematinics|hematinics|mesh-ancestor
14970353|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14970354|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14970355|NCT01663168|Rifabutin|rifabutin|mesh-list
14970356|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14970357|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970358|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14970359|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
14970360|NCT01663441|Oprelvekin|oprelvekin|mesh-list
14970361|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970362|NCT01663558|Imiquimod|imiquimod|mesh-list
14970363|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14970364|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
14970365|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970366|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970367|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
14970368|NCT01663662|Tolvaptan|tolvaptan|mesh-list
14970369|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14970370|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970371|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
14970372|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970373|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14970374|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14970375|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970376|NCT01663805|Everolimus|everolimus|mesh-list
14970377|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970378|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14970379|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
14970380|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970381|NCT01663961|Digoxin|digoxin|mesh-list
14970382|NCT01663961|Mirabegron|mirabegron|mesh-list
14970383|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14970384|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14970385|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970386|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970387|NCT01663961|Protective Agents|protective agents|mesh-ancestor
14970388|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970389|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14970390|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14970391|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14970392|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
14970393|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970394|NCT01663961|Urological Agents|urological agents|mesh-ancestor
14970395|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
14970396|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14970397|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14970398|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14970399|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14970400|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970401|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
14970402|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970403|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970404|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14970405|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970406|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14970407|NCT01664065|Cephalosporins|cephalosporins|mesh-list
14970408|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14970409|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15028998|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
15028999|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029000|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15029001|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029002|NCT01959074|Aceclofenac|aceclofenac|mesh-list
15029003|NCT01959074|Naftopidil|naftopidil|mesh-list
15029004|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15029005|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15029006|NCT01959074|Analgesics|analgesics|mesh-ancestor
14970410|NCT01664182|Bevacizumab|bevacizumab|mesh-list
14970411|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14970412|NCT01664182|Sunitinib|sunitinib|mesh-list
14970413|NCT01664182|Trebananib|trebananib|mesh-list
14970414|NCT01664182|Sorafenib|sorafenib|mesh-list
14970415|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
14970416|NCT01664182|Antibodies|antibodies|mesh-list
14970417|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
14970418|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14970419|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
14970420|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970421|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14970422|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14970423|NCT01664182|Growth Substances|growth substances|mesh-ancestor
14970424|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970425|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
14970426|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
14970427|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14970428|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970429|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970430|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
14970431|NCT01664195|Hematinics|hematinics|mesh-ancestor
14970432|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
14970433|NCT01664221|Hematinics|hematinics|mesh-ancestor
14970434|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
14970435|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14970436|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
14970437|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970438|NCT01664260|Expectorants|expectorants|mesh-ancestor
14970439|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
14970440|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14970441|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
14970442|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970443|NCT01664260|Protective Agents|protective agents|mesh-ancestor
14970444|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970445|NCT01664260|Antidotes|antidotes|mesh-ancestor
14970446|NCT01664507|Epinephrine|epinephrine|mesh-list
14970447|NCT01664507|Racepinephrine|racepinephrine|mesh-list
14970448|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
14970449|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14970450|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14970451|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
14970452|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970453|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970454|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970455|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14970456|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14970457|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
14970458|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970459|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14970460|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
14970461|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
14970462|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
14970463|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14970464|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
14970465|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14970466|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970467|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970468|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970469|NCT01664520|Analgesics|analgesics|mesh-ancestor
14970470|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
14970471|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970472|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14970473|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14970474|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14970475|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
14970476|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970477|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970478|NCT01664650|Genistein|genistein|mesh-list
14970479|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14970480|NCT01664650|Protective Agents|protective agents|mesh-ancestor
14970481|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970482|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970483|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14970484|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970485|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970486|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
14970487|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14970488|NCT01664650|Estrogens|estrogens|mesh-ancestor
14970489|NCT01664650|Hormones|hormones|mesh-ancestor
14970490|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970491|NCT01664676|Liraglutide|liraglutide|mesh-list
14970492|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14970493|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970494|NCT01664676|Incretins|incretins|mesh-ancestor
14970495|NCT01664676|Hormones|hormones|mesh-ancestor
14970496|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970497|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
14970498|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
14970499|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970500|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14970501|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970502|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970503|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
14970504|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970505|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970506|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14970507|NCT01664728|Hormones|hormones|mesh-ancestor
14970508|NCT01664754|Carboplatin|carboplatin|mesh-list
14970509|NCT01664754|Pemetrexed|pemetrexed|mesh-list
14970510|NCT01664754|Exemestane|exemestane|mesh-list
14970511|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800579|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800580|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800581|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
14800582|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14800583|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800584|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14800585|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
14970512|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970513|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970514|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14970515|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14970516|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14970517|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14970518|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14970519|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
14970520|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970521|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970522|NCT01664819|Antioxidants|antioxidants|mesh-list
14970523|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970524|NCT01664819|Protective Agents|protective agents|mesh-ancestor
14970525|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970526|NCT01664845|Metformin|metformin|mesh-list
14970527|NCT01664845|Ribavirin|ribavirin|mesh-list
14970528|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14970529|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970530|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
14970531|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970532|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
14970533|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970534|NCT01664871|Fluorides|fluorides|mesh-list
14970535|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
14970536|NCT01664871|Protective Agents|protective agents|mesh-ancestor
14970537|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970538|NCT01664910|Rituximab|rituximab|mesh-list
14970539|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14970540|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14970541|NCT01664910|Methotrexate|methotrexate|mesh-list
14970542|NCT01664910|Fludarabine|fludarabine|mesh-list
14970543|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
14970544|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14970545|NCT01664910|Antibodies|antibodies|mesh-list
14970546|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
14970547|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14970548|NCT01664910|Tacrolimus|tacrolimus|mesh-list
14970549|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
14970550|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14970551|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
14970552|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800586|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800587|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800588|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970553|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970554|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970555|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14970556|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
14970557|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14970558|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14970559|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
14970560|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970561|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14970562|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970563|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14970564|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14970565|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14970566|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14970567|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14970568|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
14970569|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14970570|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14970571|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14970572|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970573|NCT01665066|Nicotine|nicotine|mesh-list
14970574|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14970575|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
14970576|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970577|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970578|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14970579|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14970580|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
14970581|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970582|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970583|NCT01665079|Propofol|propofol|mesh-list
14970584|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14970585|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970586|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970587|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14970588|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
14970589|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
14970590|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
14970591|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14970592|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14970593|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970594|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
14970595|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
14970596|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970597|NCT01665209|Morphine|morphine|mesh-list
14970598|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14970599|NCT01665209|Narcotics|narcotics|mesh-ancestor
14970600|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970601|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970602|NCT01665209|Analgesics|analgesics|mesh-ancestor
14970603|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
14970604|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970605|NCT01665222|Morphine|morphine|mesh-list
14970606|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14970607|NCT01665222|Narcotics|narcotics|mesh-ancestor
14970608|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970609|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970610|NCT01665222|Analgesics|analgesics|mesh-ancestor
14970611|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
14970612|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970613|NCT01665235|Aspirin|aspirin|mesh-list
14970614|NCT01665235|Amlodipine|amlodipine|mesh-list
14970615|NCT01665235|Clopidogrel|clopidogrel|mesh-list
14970616|NCT01665235|Atorvastatin|atorvastatin|mesh-list
14970617|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14970618|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970619|NCT01665235|Analgesics|analgesics|mesh-ancestor
14970620|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
14970621|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970622|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970623|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970624|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970625|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14970626|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14970627|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970628|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14970629|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14970630|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970631|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
14970632|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14970633|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14970634|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
14970635|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14970636|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14970637|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14970638|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14970639|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14970640|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
14970641|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970642|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14970643|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14970644|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14970645|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14970646|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
14970647|NCT01665248|Listerine|listerine|mesh-list
14970648|NCT01665248|Fluorides|fluorides|mesh-list
14970649|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
14970650|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
14970651|NCT01665248|Protective Agents|protective agents|mesh-ancestor
14970652|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970653|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14970654|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970655|NCT01665274|Capecitabine|capecitabine|mesh-list
14970656|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
14970657|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14970658|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
14970659|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970660|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970661|NCT01665378|Folic Acid|folic acid|mesh-list
14970662|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
14970663|NCT01665378|Micronutrients|micronutrients|mesh-list
14970664|NCT01665378|Trace Elements|trace elements|mesh-list
14970665|NCT01665378|Hematinics|hematinics|mesh-ancestor
14970666|NCT01665378|Vitamins|vitamins|mesh-ancestor
14970667|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970668|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
14970669|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14970670|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14970671|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970672|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970673|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14970674|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14970675|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14970676|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14970677|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970678|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970679|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
14970680|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14970681|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
14970682|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14970683|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14970684|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970685|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14970686|NCT01665417|Docetaxel|docetaxel|mesh-list
14970687|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970688|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
14970689|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
14970690|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
14970691|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970692|NCT01665469|Lycopene|lycopene|mesh-list
14970693|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970694|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
14970695|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970696|NCT01665469|Protective Agents|protective agents|mesh-ancestor
14970697|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970698|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14970699|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14970700|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970701|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
14970702|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14970703|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970704|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970705|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970706|NCT01665586|Analgesics|analgesics|mesh-ancestor
14970707|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
14970708|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970709|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14970710|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14970711|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14970712|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
14970713|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970714|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970715|NCT01665638|Canagliflozin|canagliflozin|mesh-list
14970716|NCT01665638|Somatostatin|somatostatin|mesh-list
14970717|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14970718|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970719|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14970720|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970721|NCT01665638|Hormones|hormones|mesh-ancestor
14970722|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970723|NCT01665677|Atorvastatin|atorvastatin|mesh-list
14970724|NCT01665677|Calcium|calcium|mesh-list
14970725|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14970726|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970727|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14970728|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14970729|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
14970730|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970731|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14970732|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14970733|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970734|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14970735|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14970736|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970737|NCT01665742|Tocopherols|tocopherols|mesh-list
14970738|NCT01665742|Vitamin E|vitamin e|mesh-list
14970739|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
14970740|NCT01665742|Lycopene|lycopene|mesh-list
14970741|NCT01665742|Vitamins|vitamins|mesh-ancestor
14970742|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
14970743|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970744|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
14970745|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970746|NCT01665742|Protective Agents|protective agents|mesh-ancestor
14970747|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970748|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14970749|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14970750|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970751|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
14970752|NCT01665781|Hematinics|hematinics|mesh-ancestor
14970753|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14970754|NCT01665846|Hematinics|hematinics|mesh-ancestor
14970755|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14970756|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14970757|NCT01666041|Fenofibrate|fenofibrate|mesh-list
14970758|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14970759|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
14970760|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970761|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14970762|NCT01666067|Simvastatin|simvastatin|mesh-list
14970763|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
14970764|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14970765|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14970766|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
14970767|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970768|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14970769|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14970770|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970771|NCT01666080|Fludarabine|fludarabine|mesh-list
14970772|NCT01666080|Busulfan|busulfan|mesh-list
14970773|NCT01666080|Levetiracetam|levetiracetam|mesh-list
14970774|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970775|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970776|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14970777|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
14970778|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970779|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
14970780|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14970781|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14970782|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
14970783|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
15029007|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
15029008|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970784|NCT01666171|Metformin|metformin|mesh-list
14970785|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14970786|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970787|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14970788|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14970789|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14970790|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14970791|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
14970792|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970793|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14970794|NCT01666223|Cathartics|cathartics|mesh-ancestor
14970795|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970796|NCT01666236|Triamcinolone|triamcinolone|mesh-list
14970797|NCT01666236|Ranibizumab|ranibizumab|mesh-list
14970798|NCT01666236|Verteporfin|verteporfin|mesh-list
14970799|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14970800|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14970801|NCT01666236|Growth Substances|growth substances|mesh-ancestor
14970802|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970803|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
14970804|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970805|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970806|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
14970807|NCT01666236|Hormones|hormones|mesh-ancestor
14970808|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970809|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14970810|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
14970811|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
14970812|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14970813|NCT01666249|Antibodies|antibodies|mesh-list
14970814|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
14970815|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970816|NCT01666262|Vaccines|vaccines|mesh-list
14970817|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
14970818|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970819|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
14970820|NCT01666301|Hematinics|hematinics|mesh-ancestor
14970821|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14970822|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14970823|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970824|NCT01666379|Fentanyl|fentanyl|mesh-list
14970825|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14970826|NCT01666379|Narcotics|narcotics|mesh-ancestor
14970827|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970828|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970829|NCT01666379|Analgesics|analgesics|mesh-ancestor
14970830|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
14970831|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970832|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14970833|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14970834|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
14970835|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
14970836|NCT01666418|Paclitaxel|paclitaxel|mesh-list
14970837|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14970838|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970839|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
14970840|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14970841|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
14970842|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970843|NCT01666431|Lapatinib|lapatinib|mesh-list
14970844|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970845|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14970846|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970847|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970848|NCT01666522|Vitamin D|vitamin d|mesh-list
14970849|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
14970850|NCT01666522|Vitamins|vitamins|mesh-ancestor
14970851|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
14970852|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970853|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14970854|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14970855|NCT01666535|Vaccines|vaccines|mesh-list
14970856|NCT01666535|Immunologic Factors|immunologic factors|mesh-ancestor
14970857|NCT01666535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970858|NCT01666587|Ibuprofen|ibuprofen|mesh-list
14970859|NCT01666587|Antioxidants|antioxidants|mesh-list
14970860|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
15035625|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
14970861|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14970862|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970863|NCT01666587|Analgesics|analgesics|mesh-ancestor
14970864|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
14970865|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970866|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970867|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970868|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970869|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14970870|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970871|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970872|NCT01666587|Protective Agents|protective agents|mesh-ancestor
14970873|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
14970874|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970875|NCT01666600|Nintedanib|nintedanib|mesh-list
14970876|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970877|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14970878|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970879|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970880|NCT01666665|Metformin|metformin|mesh-list
14970881|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14970882|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970883|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
14970884|NCT01666678|Promethazine|promethazine|mesh-list
14970885|NCT01666678|Naproxen|naproxen|mesh-list
14970886|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14970887|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970888|NCT01666678|Analgesics|analgesics|mesh-ancestor
14970889|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
14970890|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970891|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970892|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970893|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970894|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
14970895|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14970896|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970897|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970898|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14970899|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14970900|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970901|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
14970902|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
14970903|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
14970904|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
14970905|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14970906|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14970907|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
14970908|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
14970909|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14970910|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14970911|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
14970912|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
14970913|NCT01666691|CKD732|ckd732|mesh-list
14970914|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14970915|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14970916|NCT01666691|Growth Substances|growth substances|mesh-ancestor
14970917|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970918|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
14970919|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970920|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14970921|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14970922|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970923|NCT01666756|Sorafenib|sorafenib|mesh-list
14970924|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970925|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14970926|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970927|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970928|NCT01666769|Micafungin|micafungin|mesh-list
14970929|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
14970930|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970931|NCT01666925|Vaccines|vaccines|mesh-list
14970932|NCT01666925|Immunologic Factors|immunologic factors|mesh-ancestor
14970933|NCT01666925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970934|NCT01667081|Grazoprevir|grazoprevir|mesh-list
14970935|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
14970936|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970937|NCT01667094|Meropenem|meropenem|mesh-list
14970938|NCT01667094|Tazobactam|tazobactam|mesh-list
14970939|NCT01667094|Piperacillin|piperacillin|mesh-list
14970940|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
14970941|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
14970942|NCT01667094|Ceftazidime|ceftazidime|mesh-list
14970943|NCT01667094|Cefepime|cefepime|mesh-list
14970944|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14970945|NCT01667094|Ticarcillin|ticarcillin|mesh-list
14970946|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
14970947|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14970948|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14970949|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14970950|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970951|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970952|NCT01667120|Ketorolac|ketorolac|mesh-list
14970953|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14970954|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14970955|NCT01667120|Analgesics|analgesics|mesh-ancestor
14970956|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
14970957|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970958|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970959|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14970960|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14970961|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14970962|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970963|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970964|NCT01667133|Ponatinib|ponatinib|mesh-list
14970965|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970966|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14970967|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14970968|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970969|NCT01667211|Paclitaxel|paclitaxel|mesh-list
14970970|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14970971|NCT01667211|Nedaplatin|nedaplatin|mesh-list
14970972|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14970973|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970974|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
14970975|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
14970976|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
14970977|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14970978|NCT01667263|Tretinoin|tretinoin|mesh-list
14970979|NCT01667263|Danazol|danazol|mesh-list
14970980|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14970981|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
14970982|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
14970983|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14970984|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
14970985|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14970986|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970987|NCT01667315|Bupivacaine|bupivacaine|mesh-list
14970988|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
14970989|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
14970990|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970991|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970992|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
14970993|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14970994|NCT01667445|Morphine|morphine|mesh-list
14970995|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14970996|NCT01667445|Narcotics|narcotics|mesh-ancestor
14970997|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14970998|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14970999|NCT01667445|Analgesics|analgesics|mesh-ancestor
14971000|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
14971001|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971002|NCT01667484|Adderall|adderall|mesh-list
14971003|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14971004|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971005|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
14971006|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14971007|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14971008|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971009|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
14971010|NCT01667523|Capsaicin|capsaicin|mesh-list
14971011|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
14971012|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971013|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
14971014|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971015|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971016|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14971017|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971018|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14971019|NCT01667523|Protective Agents|protective agents|mesh-ancestor
14971020|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14971021|NCT01667575|Amoxicillin|amoxicillin|mesh-list
14971022|NCT01667575|Clarithromycin|clarithromycin|mesh-list
14971023|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14971024|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
14971025|NCT01667575|Esomeprazole|esomeprazole|mesh-list
14971026|NCT01667575|Bismuth|bismuth|mesh-list
14971027|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14971028|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971029|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971030|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
14971031|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14971032|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971033|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971034|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14971035|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14971036|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14971037|NCT01667575|Antacids|antacids|mesh-ancestor
14971038|NCT01667575|Diuretics|diuretics|mesh-ancestor
14971039|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
14971040|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971041|NCT01667575|Expectorants|expectorants|mesh-ancestor
14971042|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14971043|NCT01667614|Losartan|losartan|mesh-list
14971044|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14971045|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14971046|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14971047|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14971048|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971049|NCT01667692|Azithromycin|azithromycin|mesh-list
14971050|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971051|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971052|NCT01667718|Amoxicillin|amoxicillin|mesh-list
14971053|NCT01667718|Levofloxacin|levofloxacin|mesh-list
14971054|NCT01667718|Ofloxacin|ofloxacin|mesh-list
14971055|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
14971056|NCT01667718|Lansoprazole|lansoprazole|mesh-list
14971057|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
14971058|NCT01667718|Bismuth|bismuth|mesh-list
14971059|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14971060|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971061|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971062|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971063|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14971064|NCT01667718|Renal Agents|renal agents|mesh-ancestor
14971065|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14971066|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971067|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971068|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971069|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14971070|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14971071|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14971072|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971073|NCT01667718|Antacids|antacids|mesh-ancestor
14971074|NCT01667718|Diuretics|diuretics|mesh-ancestor
14971075|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
14971076|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971077|NCT01667718|Expectorants|expectorants|mesh-ancestor
14971078|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
14971079|NCT01667744|Citalopram|citalopram|mesh-list
14971080|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14971081|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14971082|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035626|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14971083|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971084|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971085|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
14971086|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971087|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14971088|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
14971089|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15029009|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029010|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029011|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029012|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15029013|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15029014|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
15029015|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029016|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029017|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15029018|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15029019|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029020|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15029021|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15029022|NCT01959100|Azithromycin|azithromycin|mesh-list
15029023|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15029024|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029025|NCT01959152|Imidacloprid|imidacloprid|mesh-list
15029026|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
15029027|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029028|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029029|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029030|NCT01959191|Aspirin|aspirin|mesh-list
15029031|NCT01959191|Clopidogrel|clopidogrel|mesh-list
15029032|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15029033|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15029034|NCT01959191|Analgesics|analgesics|mesh-ancestor
15029035|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
15029036|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029037|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029038|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029039|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029040|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15029041|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15029042|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029043|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15029044|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15029045|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029046|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
15029047|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15029048|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15029049|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15029050|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
15029051|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029052|NCT01959204|Oxycodone|oxycodone|mesh-list
15029053|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15029054|NCT01959204|Narcotics|narcotics|mesh-ancestor
15029055|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029056|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029057|NCT01959204|Analgesics|analgesics|mesh-ancestor
15029058|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
15029059|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029060|NCT01959386|Trastuzumab|trastuzumab|mesh-list
15029061|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15029062|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029063|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15029064|NCT01959399|Peficitinib|peficitinib|mesh-list
15029065|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15029066|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15029067|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
15029068|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029069|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15029070|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15029071|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029072|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029073|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
15029074|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971090|NCT01667874|Gentamicins|gentamicins|mesh-list
14971091|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971092|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971093|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14971094|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971095|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971096|NCT01668043|UB-421|ub-421|mesh-list
14971097|NCT01668043|Antibodies|antibodies|mesh-list
14971098|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
14971099|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971100|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14971101|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
14971102|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971103|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14971104|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14971105|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971106|NCT01668069|Ondansetron|ondansetron|mesh-list
14971107|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
14971108|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
14971109|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971110|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971111|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971112|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
14971113|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971114|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14971115|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
14971116|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971117|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971118|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14971119|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14971120|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971121|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14971122|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14971123|NCT01668121|Budesonide|budesonide|mesh-list
14971124|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
14971125|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14971126|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971127|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14971128|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
14971129|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971130|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971131|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14971132|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
14971133|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
14971134|NCT01668121|Hormones|hormones|mesh-ancestor
14971135|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971136|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14971137|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14971138|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14971139|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
14971140|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971141|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971142|NCT01668433|Primaquine|primaquine|mesh-list
14971143|NCT01668433|Methylene Blue|methylene blue|mesh-list
14971144|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
14971145|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14971146|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14971147|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971148|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971149|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971150|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
14971151|NCT01668446|Estradiol|estradiol|mesh-list
14971152|NCT01668446|Estrogens|estrogens|mesh-ancestor
14971153|NCT01668446|Hormones|hormones|mesh-ancestor
14971154|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971155|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971156|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
14971157|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14971158|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14971159|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971160|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971161|NCT01668446|Urological Agents|urological agents|mesh-ancestor
14971162|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14971163|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971164|NCT01668498|Doxycycline|doxycycline|mesh-list
14971165|NCT01668498|Erythromycin|erythromycin|mesh-list
14971166|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
14971167|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14971168|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
14971169|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971170|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971171|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
14971172|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14971173|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14971174|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971175|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14971176|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971177|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971178|NCT01668550|AZD-0424|azd-0424|mesh-list
14971179|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14971180|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971181|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971182|NCT01668615|Tretinoin|tretinoin|mesh-list
14971183|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971184|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
14971185|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971186|NCT01668680|Celecoxib|celecoxib|mesh-list
14971187|NCT01668680|Capecitabine|capecitabine|mesh-list
14971188|NCT01668680|Methotrexate|methotrexate|mesh-list
14971189|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14971190|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
14971191|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971192|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971193|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14971194|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
14971195|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14971196|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971197|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971198|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971199|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14971200|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14971201|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
14971202|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971203|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14971204|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14971205|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971206|NCT01668680|Analgesics|analgesics|mesh-ancestor
14971207|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
14971208|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971209|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971210|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14971211|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14971212|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14971213|NCT01668849|Fentanyl|fentanyl|mesh-list
14971214|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14971215|NCT01668849|Narcotics|narcotics|mesh-ancestor
14971216|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971217|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971218|NCT01668849|Analgesics|analgesics|mesh-ancestor
14971219|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
14971220|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971221|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14971222|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14971223|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
14971224|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
14971225|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14971226|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971227|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971228|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971229|NCT01668901|Aspirin|aspirin|mesh-list
14971230|NCT01668901|Warfarin|warfarin|mesh-list
14971231|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14971232|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971233|NCT01668901|Analgesics|analgesics|mesh-ancestor
14971234|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
14971235|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971236|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971237|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971238|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971239|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14971240|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14971241|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971242|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14971243|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14971244|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971245|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
14971246|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
14971247|NCT01668927|Amoxicillin|amoxicillin|mesh-list
14971248|NCT01668927|Metronidazole|metronidazole|mesh-list
14971249|NCT01668927|Tetracycline|tetracycline|mesh-list
14971250|NCT01668927|Furazolidone|furazolidone|mesh-list
14971251|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
14971252|NCT01668927|Lansoprazole|lansoprazole|mesh-list
14971253|NCT01668927|Bismuth|bismuth|mesh-list
14971254|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14971255|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971256|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971257|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971258|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14971259|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14971260|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14971261|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971262|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971263|NCT01668927|Antacids|antacids|mesh-ancestor
14971264|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14971265|NCT01668927|Diuretics|diuretics|mesh-ancestor
14971266|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
14971267|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971268|NCT01668927|Expectorants|expectorants|mesh-ancestor
14971269|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
14971270|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14971271|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14971272|NCT01668927|Renal Agents|renal agents|mesh-ancestor
14971273|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14971274|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14971275|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
14971276|NCT01669044|Propofol|propofol|mesh-list
14971277|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14971278|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971279|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971280|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14971281|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
14971282|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
14971283|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971284|NCT01669044|Analgesics|analgesics|mesh-ancestor
14971285|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
14971286|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971287|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14971288|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14971289|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14971290|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
14971291|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971292|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971293|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
14971294|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971295|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971296|NCT01669135|Anesthetics|anesthetics|mesh-list
14971297|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971298|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971299|NCT01669213|Ondansetron|ondansetron|mesh-list
14971300|NCT01669213|Ramosetron|ramosetron|mesh-list
14971301|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
14971302|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
14971303|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971304|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971305|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971306|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
14971307|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971308|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14971309|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
14971310|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971311|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971312|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14971313|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14971314|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971315|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14971316|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14971317|NCT01669226|Taxane|taxane|mesh-list
14971318|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971319|NCT01669239|Doxorubicin|doxorubicin|mesh-list
14971320|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14971321|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14971322|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971323|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14971324|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971325|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971326|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971327|NCT01669291|Leuprolide|leuprolide|mesh-list
14971328|NCT01669291|Cetrorelix|cetrorelix|mesh-list
14971329|NCT01669291|Menotropins|menotropins|mesh-list
14971330|NCT01669291|Ganirelix|ganirelix|mesh-list
14971331|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14971332|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
14971333|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14971334|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971335|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14971336|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971337|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
14971338|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971339|NCT01669304|Verapamil|verapamil|mesh-list
14971340|NCT01669304|Sertraline|sertraline|mesh-list
14971341|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
14971342|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14971343|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15029075|NCT01959438|Selenious Acid|selenious acid|mesh-list
14971344|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14971345|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14971346|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971347|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971348|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
14971349|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971350|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14971351|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14971352|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14971353|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
14971354|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
14971355|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
14971356|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14971357|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971358|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971359|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
14971360|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14971361|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971362|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971363|NCT01669447|Ranibizumab|ranibizumab|mesh-list
14971364|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14971365|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14971366|NCT01669447|Growth Substances|growth substances|mesh-ancestor
14971367|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971368|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
14971369|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971370|NCT01669499|Dexamethasone|dexamethasone|mesh-list
14971371|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
14971372|NCT01669499|BB 1101|bb 1101|mesh-list
14971373|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971374|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
14971375|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
14971376|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971377|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971378|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971379|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
14971380|NCT01669499|Hormones|hormones|mesh-ancestor
14971381|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971382|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14971383|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971384|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
14971385|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971386|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029076|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
15029077|NCT01959438|Trace Elements|trace elements|mesh-ancestor
15029078|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
15029079|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029080|NCT01959451|Clopidogrel|clopidogrel|mesh-list
15029081|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15029082|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15029083|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15029084|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15029085|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15029086|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
15029087|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029088|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029089|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029090|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
15029091|NCT01959477|Busulfan|busulfan|mesh-list
15029092|NCT01959477|Etoposide|etoposide|mesh-list
15029093|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
15029094|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029095|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
15029096|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029097|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029098|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15029099|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
15029100|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029101|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029102|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15029103|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15029104|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15029105|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971387|NCT01669707|Endostar protein|endostar protein|mesh-list
14971388|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14971389|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14971390|NCT01669707|Growth Substances|growth substances|mesh-ancestor
14971391|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971392|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14971393|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971394|NCT01669824|Aspirin|aspirin|mesh-list
14971395|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14971396|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971397|NCT01669824|Analgesics|analgesics|mesh-ancestor
14971398|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
14971399|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971400|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971401|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971402|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971403|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14971404|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14971405|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971406|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14971407|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14971408|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971409|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
14971410|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14971411|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
14971412|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14971413|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14971414|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971415|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
14971416|NCT01669967|Promethazine|promethazine|mesh-list
14971417|NCT01669967|Lidocaine|lidocaine|mesh-list
14971418|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
14971419|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
14971420|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971421|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971422|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
14971423|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971424|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14971425|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14971426|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14971427|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14971428|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971429|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14971430|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14971431|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
14971432|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
14971433|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971434|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14971435|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
14971436|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
14971437|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971438|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14971439|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
14971440|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971441|NCT01670071|Risperidone|risperidone|mesh-list
14971442|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14971443|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14971444|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
14971445|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971446|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971447|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971448|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14971449|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14971450|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971451|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14971452|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14971453|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
14971454|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14971455|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14971456|NCT01670084|Leucovorin|leucovorin|mesh-list
14971457|NCT01670084|Cytarabine|cytarabine|mesh-list
14971458|NCT01670084|Dexamethasone|dexamethasone|mesh-list
14971459|NCT01670084|Prednisone|prednisone|mesh-list
14971460|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
14971461|NCT01670084|Rituximab|rituximab|mesh-list
14971462|NCT01670084|Doxorubicin|doxorubicin|mesh-list
14971463|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14971464|NCT01670084|Methotrexate|methotrexate|mesh-list
14971465|NCT01670084|Vincristine|vincristine|mesh-list
14971466|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
14971467|NCT01670084|Mesna|mesna|mesh-list
14971468|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14971469|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
14971470|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971471|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971472|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14971473|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
14971474|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971475|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971476|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14971477|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971478|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
14971479|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
14971480|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971481|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971482|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
14971483|NCT01670084|Hormones|hormones|mesh-ancestor
14971484|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971485|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14971486|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14971487|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14971488|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14971489|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971490|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971491|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14971492|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
14971493|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14971494|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14971495|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
14971496|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971497|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14971498|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14971499|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
14971500|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971501|NCT01670084|Antidotes|antidotes|mesh-ancestor
14971502|NCT01670084|Protective Agents|protective agents|mesh-ancestor
14971503|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
14971504|NCT01670084|Vitamins|vitamins|mesh-ancestor
14971505|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
14971506|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14971507|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
14971508|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
14971509|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
14971510|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
14971511|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
14971512|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14971513|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14971514|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971515|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971516|NCT01670136|Urological Agents|urological agents|mesh-ancestor
14971517|NCT01670149|Rifaximin|rifaximin|mesh-list
14971518|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971519|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971520|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971521|NCT01670162|Aflibercept|aflibercept|mesh-list
14971522|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14971523|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14971524|NCT01670162|Growth Substances|growth substances|mesh-ancestor
14971525|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971526|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
14971527|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971528|NCT01670175|Sirolimus|sirolimus|mesh-list
14971529|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
14971530|NCT01670175|Topotecan|topotecan|mesh-list
14971531|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14971532|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
14971533|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971534|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971535|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14971536|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
14971537|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971538|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971539|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14971540|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971541|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971542|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14971543|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
14971544|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14971545|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971546|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971547|NCT01670240|Adalimumab|adalimumab|mesh-list
14971548|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971549|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971550|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
14971551|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971552|NCT01670318|Chromium|chromium|mesh-list
14971553|NCT01670318|Everolimus|everolimus|mesh-list
14971554|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971555|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14971556|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
14971557|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971558|NCT01670318|Trace Elements|trace elements|mesh-ancestor
14971559|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
14971560|NCT01670370|Gemcitabine|gemcitabine|mesh-list
14971561|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
14971562|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971563|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
14971564|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971565|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14971566|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
14971567|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971568|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
14971569|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971570|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971571|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14971572|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
14971573|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971574|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971575|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14971576|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971577|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971578|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971579|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971580|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14971581|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14971582|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14971583|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14971584|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14971585|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971586|NCT01670552|Naproxen|naproxen|mesh-list
14971587|NCT01670552|Nimesulide|nimesulide|mesh-list
14971588|NCT01670552|Esomeprazole|esomeprazole|mesh-list
14971589|NCT01670552|Pantoprazole|pantoprazole|mesh-list
14971590|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14971591|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971592|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14971593|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971594|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971595|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14971596|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971597|NCT01670552|Analgesics|analgesics|mesh-ancestor
14971598|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
14971599|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971600|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971601|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971602|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971603|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
14971604|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14971605|NCT01670565|Belimumab|belimumab|mesh-list
14971606|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14971607|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
14971608|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971609|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
14971610|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14971611|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
14971612|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971613|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
14971614|NCT01670578|Protective Agents|protective agents|mesh-ancestor
14971615|NCT01670669|Prucalopride|prucalopride|mesh-list
14971616|NCT01670669|Laxatives|laxatives|mesh-ancestor
14971617|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971618|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14971619|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14971620|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
14971621|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971622|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971623|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971624|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14971625|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14971626|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971627|NCT01670773|Analgesics|analgesics|mesh-ancestor
14971628|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
14971629|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971630|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971631|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971632|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971633|NCT01670799|Ketorolac|ketorolac|mesh-list
14971634|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14971635|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14971636|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971637|NCT01670799|Analgesics|analgesics|mesh-ancestor
14971638|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
14971639|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971640|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971641|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971642|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971643|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14971644|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971645|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971646|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
14971647|NCT01670812|Rituximab|rituximab|mesh-list
14971648|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14971649|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971650|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
14971651|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971652|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971653|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971654|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
14971655|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
14971656|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971657|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971658|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
14971659|NCT01670812|Hormones|hormones|mesh-ancestor
14971660|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971661|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14971662|NCT01670812|Protective Agents|protective agents|mesh-ancestor
14971663|NCT01670890|Cisplatin|cisplatin|mesh-list
14971664|NCT01670890|Temozolomide|temozolomide|mesh-list
14971665|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971666|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14971667|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
14971668|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971669|NCT01670929|Progesterone|progesterone|mesh-list
14971670|NCT01670929|Progestins|progestins|mesh-ancestor
14971671|NCT01670929|Hormones|hormones|mesh-ancestor
14971672|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971673|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971674|NCT01670955|Folic Acid|folic acid|mesh-list
14971675|NCT01670955|Hematinics|hematinics|mesh-ancestor
14971676|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
14971677|NCT01670955|Vitamins|vitamins|mesh-ancestor
14971678|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
14971679|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971680|NCT01671384|Valproic Acid|valproic acid|mesh-list
14971681|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
14971682|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971683|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971684|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
14971685|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971686|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971687|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
14971688|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14971689|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971690|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15029106|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035036|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
15035037|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035038|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15035039|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15035040|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15035041|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15035042|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
15035043|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
15035044|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035045|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035046|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15035047|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15035048|NCT01998698|Lidocaine|lidocaine|mesh-list
15035049|NCT01998698|Dipivefrin|dipivefrin|mesh-list
15035050|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
15035051|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15035052|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
15035053|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035054|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035055|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035056|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15035057|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
15035058|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
15035059|NCT01998698|Protective Agents|protective agents|mesh-ancestor
15035060|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
15035061|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
15035062|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035063|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
15035064|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035065|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15035066|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15035067|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15035068|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035069|NCT01998763|Vitamin D|vitamin d|mesh-list
15035070|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
15035071|NCT01998763|Vitamins|vitamins|mesh-ancestor
15035072|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
15035073|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035074|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15035075|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15035076|NCT01998776|Misoprostol|misoprostol|mesh-list
15035077|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15035078|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
15035079|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15035080|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035081|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15035082|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035083|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
15035084|NCT01998789|Everolimus|everolimus|mesh-list
15035085|NCT01998789|Tacrolimus|tacrolimus|mesh-list
15035086|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035087|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
15035088|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035089|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15035090|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035091|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035092|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035093|NCT01999153|Ropivacaine|ropivacaine|mesh-list
15035094|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
15035095|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
15035096|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035097|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035098|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
15035099|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035100|NCT01999270|Bevacizumab|bevacizumab|mesh-list
15035101|NCT01999270|Irinotecan|irinotecan|mesh-list
15035102|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15035103|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035104|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15035105|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14971691|NCT01671410|Morphine|morphine|mesh-list
14971692|NCT01671410|Buprenorphine|buprenorphine|mesh-list
14971693|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14971694|NCT01671410|Narcotics|narcotics|mesh-ancestor
14971695|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971696|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971697|NCT01671410|Analgesics|analgesics|mesh-ancestor
14971698|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
14971699|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971700|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14971701|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
14971702|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971703|NCT01671709|Montelukast|montelukast|mesh-list
14971704|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14971705|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
14971706|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14971707|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
14971708|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971709|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971710|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14971711|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14971712|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971713|NCT01671722|Montelukast|montelukast|mesh-list
14971714|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14971715|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14971716|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14971717|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
14971718|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971719|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971720|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14971721|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14971722|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971723|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
14971724|NCT01671774|Interleukin-2|interleukin-2|mesh-list
14971725|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971726|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971727|NCT01671774|Analgesics|analgesics|mesh-ancestor
14971728|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
14971729|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971730|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971731|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14971732|NCT01671787|Tenofovir|tenofovir|mesh-list
14971733|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
14971734|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971735|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14971736|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14800589|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800590|NCT00788580|Sirolimus|sirolimus|mesh-list
14800591|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800592|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800593|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14800594|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800595|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
14800596|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800597|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
14800598|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800599|NCT00788606|Bevacizumab|bevacizumab|mesh-list
14971737|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971738|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971739|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14971740|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14971741|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14971742|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14971743|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14971744|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14971745|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971746|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
14971747|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971748|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971749|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14971750|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
14971751|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14971752|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971753|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
14971754|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971755|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
14971756|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14800600|NCT00788606|Rituximab|rituximab|mesh-list
14800601|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14800602|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800603|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14800604|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14800605|NCT00788606|Growth Substances|growth substances|mesh-ancestor
14800606|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800607|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
14800608|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
14800609|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14800610|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
14800611|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14800612|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
14800613|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14800614|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800615|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14971757|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
14971758|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14971759|NCT01671891|Capecitabine|capecitabine|mesh-list
14971760|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
14971761|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14971762|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
14971763|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971764|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971765|NCT01671904|Rituximab|rituximab|mesh-list
14971766|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
14971767|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14971768|NCT01671904|Venetoclax|venetoclax|mesh-list
14971769|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14971770|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971771|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
14971772|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971773|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14971774|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14971775|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
14971776|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971777|NCT01671982|Tenofovir|tenofovir|mesh-list
14971778|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
14971779|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971780|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14971781|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14971782|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971783|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971784|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14971785|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14971786|NCT01672047|Vitamin D|vitamin d|mesh-list
14971787|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
14971788|NCT01672047|Vitamins|vitamins|mesh-ancestor
14971789|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
14971790|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971791|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14971792|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14971793|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
14971794|NCT01672086|Antacids|antacids|mesh-ancestor
14971795|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971796|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971797|NCT01672112|Oxycodone|oxycodone|mesh-list
14971798|NCT01672112|Codeine|codeine|mesh-list
14971799|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14971800|NCT01672112|Narcotics|narcotics|mesh-ancestor
14971801|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971802|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971803|NCT01672112|Analgesics|analgesics|mesh-ancestor
14971804|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
14971805|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800616|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14971806|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
14971807|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
14971808|NCT01672151|Sirolimus|sirolimus|mesh-list
14971809|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14971810|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971811|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14971812|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971813|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
14971814|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14971815|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
14971816|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971817|NCT01672229|Bortezomib|bortezomib|mesh-list
14971818|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971819|NCT01672307|Minoxidil|minoxidil|mesh-list
14971820|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14971821|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
14971822|NCT01672346|Adenosine|adenosine|mesh-list
14971823|NCT01672346|Analgesics|analgesics|mesh-ancestor
14971824|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
14971825|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971826|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971827|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14971828|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
14971829|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14971830|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
14971831|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
14971832|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971833|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971834|NCT01672359|Choline|choline|mesh-list
14971835|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
14971836|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14971837|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
14971838|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971839|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971840|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14971841|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
14971842|NCT01672450|Ipilimumab|ipilimumab|mesh-list
14971843|NCT01672450|Interleukin-2|interleukin-2|mesh-list
14971844|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14971845|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971846|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14971847|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971848|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14971849|NCT01672450|Analgesics|analgesics|mesh-ancestor
14971850|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
14971851|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971852|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971853|NCT01672476|Valsartan|valsartan|mesh-list
14800617|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14800618|NCT00788749|Fluticasone|fluticasone|mesh-list
14800619|NCT00788749|Xhance|xhance|mesh-list
14800620|NCT00788749|Prednisolone|prednisolone|mesh-list
14800621|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14800622|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14800623|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
14800624|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800625|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971854|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14971855|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14971856|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14971857|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971858|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14971859|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
14971860|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14971861|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14971862|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14971863|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971864|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971865|NCT01672580|Vitamins|vitamins|mesh-list
14971866|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
14971867|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971868|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14971869|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14971870|NCT01672606|Rocuronium|rocuronium|mesh-list
14971871|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14971872|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14971873|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14971874|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971875|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971876|NCT01672671|Paclitaxel|paclitaxel|mesh-list
14971877|NCT01672671|Doxorubicin|doxorubicin|mesh-list
14971878|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14971879|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971880|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
14971881|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
14971882|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
14971883|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971884|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14971885|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14971886|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971887|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971888|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
14971889|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14971890|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971891|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14971892|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971893|NCT01672814|Riboflavin|riboflavin|mesh-list
14971894|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14971895|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14971896|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
14971897|NCT01672814|Vitamins|vitamins|mesh-ancestor
14971898|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
14971899|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971900|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14971901|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029107|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
15029108|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15029109|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
15029110|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029111|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029112|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15029113|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
15029114|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15029115|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
15029116|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029117|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029118|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15029119|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
15029120|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
15029121|NCT01959828|Protective Agents|protective agents|mesh-ancestor
15029122|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15029123|NCT01959854|Laxatives|laxatives|mesh-ancestor
15029124|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029125|NCT01960023|Cetuximab|cetuximab|mesh-list
15029126|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15029127|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029128|NCT01960049|Ropivacaine|ropivacaine|mesh-list
15029129|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029130|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
15029131|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029132|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971902|NCT01673087|Dexamethasone|dexamethasone|mesh-list
14971903|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14971904|NCT01673087|Cosyntropin|cosyntropin|mesh-list
14971905|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14971906|NCT01673087|Metyrapone|metyrapone|mesh-list
14971907|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14971908|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
14971909|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
14971910|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971911|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971912|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14971913|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
14971914|NCT01673087|Hormones|hormones|mesh-ancestor
14971915|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971916|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14971917|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971918|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
14971919|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971920|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971921|NCT01673204|Calcitriol|calcitriol|mesh-list
14971922|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14971923|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971924|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14971925|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14971926|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971927|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14971928|NCT01673204|Vitamins|vitamins|mesh-ancestor
14971929|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
14971930|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14971931|NCT01673217|Doxorubicin|doxorubicin|mesh-list
14971932|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14971933|NCT01673217|Decitabine|decitabine|mesh-list
14971934|NCT01673217|Azacitidine|azacitidine|mesh-list
14971935|NCT01673217|Vaccines|vaccines|mesh-list
14971936|NCT01673217|Sargramostim|sargramostim|mesh-list
14971937|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
14971938|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
14971939|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971940|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14971941|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971942|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14971943|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14971944|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971945|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971946|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14971947|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
14971948|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14971949|NCT01673308|Lenalidomide|lenalidomide|mesh-list
14971950|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
14971951|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971952|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14971953|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14971954|NCT01673308|Growth Substances|growth substances|mesh-ancestor
14971955|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
14971956|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971957|NCT01673399|Atosiban|atosiban|mesh-list
14971958|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
14971959|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971960|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971961|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
14971962|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14971963|NCT01673542|Lidocaine|lidocaine|mesh-list
14971964|NCT01673542|Prilocaine|prilocaine|mesh-list
14971965|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14971966|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
14971967|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
14971968|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14971969|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971970|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
14971971|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14971972|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14971973|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14971974|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14971975|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029133|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
14971976|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971977|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14971978|NCT01673724|Pramipexole|pramipexole|mesh-list
14971979|NCT01673724|Bromocriptine|bromocriptine|mesh-list
14971980|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
14971981|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971982|NCT01673724|Protective Agents|protective agents|mesh-ancestor
14971983|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14971984|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14971985|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14971986|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
14971987|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
14971988|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14971989|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
14971990|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14971991|NCT01673737|Vemurafenib|vemurafenib|mesh-list
14971992|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14971993|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14971994|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14971995|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14971996|NCT01673997|Metoprolol|metoprolol|mesh-list
14971997|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14971998|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14971999|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
14972000|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
14972001|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972002|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972003|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14972004|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14972005|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14972006|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
14972007|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972008|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972009|NCT01674127|Methyldopa|methyldopa|mesh-list
14972010|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14972011|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
14972012|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
14972013|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972014|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972015|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14972016|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14972017|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14972018|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
14972019|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972020|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972021|NCT01674140|Tamoxifen|tamoxifen|mesh-list
14972022|NCT01674140|Everolimus|everolimus|mesh-list
14972023|NCT01674140|Letrozole|letrozole|mesh-list
14972024|NCT01674140|Anastrozole|anastrozole|mesh-list
14972025|NCT01674140|Leuprolide|leuprolide|mesh-list
14972026|NCT01674140|Exemestane|exemestane|mesh-list
14972027|NCT01674140|Goserelin|goserelin|mesh-list
14972028|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972029|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972030|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972031|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
14972032|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972033|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14972034|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14972035|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972036|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14972037|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
14972038|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972039|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14972040|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14972041|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14972042|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14972043|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14972044|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
14972045|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14972046|NCT01674166|Prucalopride|prucalopride|mesh-list
14972047|NCT01674166|Laxatives|laxatives|mesh-ancestor
14972048|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972049|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14972050|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14972051|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
14972052|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972053|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972054|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972055|NCT01674192|Prucalopride|prucalopride|mesh-list
14972056|NCT01674192|Laxatives|laxatives|mesh-ancestor
14972057|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972058|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14972059|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14972060|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
14972061|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972062|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972063|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972064|NCT01674205|Vaccines|vaccines|mesh-list
14972065|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
14972066|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972067|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
14972068|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14972069|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972070|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14972071|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14972072|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972073|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972074|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972075|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14972076|NCT01674257|Fluorides|fluorides|mesh-list
14972077|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
14972078|NCT01674257|Protective Agents|protective agents|mesh-ancestor
14972079|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972080|NCT01674257|Hematinics|hematinics|mesh-ancestor
14972081|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14972082|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14972083|NCT01674270|Bicalutamide|bicalutamide|mesh-list
14972084|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
14972085|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
14972086|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972087|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972088|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972089|NCT01674283|Glucagon|glucagon|mesh-list
14972090|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972091|NCT01674283|Hormones|hormones|mesh-ancestor
14972092|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972093|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972094|NCT01674413|Adalimumab|adalimumab|mesh-list
14972095|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14972096|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972097|NCT01674504|Montelukast|montelukast|mesh-list
14972098|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14972099|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
14972100|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14972101|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
14972102|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972103|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972104|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14972105|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14972106|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972107|NCT01674517|Montelukast|montelukast|mesh-list
14972108|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14972109|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
14972110|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14972111|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
14972112|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972113|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972114|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14972115|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14972116|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972117|NCT01674530|Lubiprostone|lubiprostone|mesh-list
14972118|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14972119|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972120|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972121|NCT01674556|Gemcitabine|gemcitabine|mesh-list
14972122|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14972123|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
14972124|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972125|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972126|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
14972127|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972128|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972129|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972130|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
14972131|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972132|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
14972133|NCT01674686|Atorvastatin|atorvastatin|mesh-list
14972134|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14972135|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14972136|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
14972137|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972138|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14972139|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14972140|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972141|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14972142|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14972143|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14972144|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14972145|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
14972146|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972147|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972148|NCT01674738|Bevacizumab|bevacizumab|mesh-list
14972149|NCT01674738|Pemetrexed|pemetrexed|mesh-list
14972150|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972151|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972152|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14972153|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14972154|NCT01674738|Growth Substances|growth substances|mesh-ancestor
14972155|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972156|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
14972157|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972158|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972159|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14972160|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14972161|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
14972162|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14972163|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972164|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972165|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029134|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029135|NCT01960153|Tadalafil|tadalafil|mesh-list
15029136|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
15029137|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15029138|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15029139|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029140|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029141|NCT01960153|Urological Agents|urological agents|mesh-ancestor
14972166|NCT01674842|Cisplatin|cisplatin|mesh-list
14972167|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972168|NCT01674855|Lenograstim|lenograstim|mesh-list
14972169|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14972170|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
14972171|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972172|NCT01674868|Fluoxetine|fluoxetine|mesh-list
14972173|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14972174|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14972175|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972176|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972177|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972178|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
14972179|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972180|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14972181|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
14972182|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14972183|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14972184|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14972185|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972186|NCT01674933|Listerine|listerine|mesh-list
14972187|NCT01674933|Fluorides|fluorides|mesh-list
14972188|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
14972189|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
14972190|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
14972191|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
14972192|NCT01674933|Protective Agents|protective agents|mesh-ancestor
14972193|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972194|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14972195|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972196|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14972197|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
14972198|NCT01674946|Cathartics|cathartics|mesh-ancestor
14972199|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972200|NCT01675024|Rotigotine|rotigotine|mesh-list
14972201|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
14972202|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
14972203|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972204|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972205|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972206|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
14972207|NCT01675076|Apixaban|apixaban|mesh-list
14972208|NCT01675076|Dabigatran|dabigatran|mesh-list
14972209|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14972210|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
14972211|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14972212|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
14972213|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972214|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972215|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
14972216|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
14972217|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14972218|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972219|NCT01675115|Aspirin|aspirin|mesh-list
14972220|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14972221|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14972222|NCT01675115|Analgesics|analgesics|mesh-ancestor
14972223|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
14972224|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972225|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972226|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14972227|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972228|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14972229|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14972230|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972231|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14972232|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14972233|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972234|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
14972235|NCT01675206|Vitamin K|vitamin k|mesh-list
14972236|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
14972237|NCT01675206|Vitamins|vitamins|mesh-ancestor
14972238|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
14972239|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972240|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14972241|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14972242|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972243|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
14972244|NCT01675206|Coagulants|coagulants|mesh-ancestor
14972245|NCT01675219|Mitomycins|mitomycins|mesh-list
14972246|NCT01675219|Mitomycin|mitomycin|mesh-list
14972247|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14972248|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972249|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
14972250|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972251|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14972252|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972253|NCT01675310|Metformin|metformin|mesh-list
14972254|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972255|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972256|NCT01675362|Selenium|selenium|mesh-list
14972257|NCT01675362|Losartan|losartan|mesh-list
14972258|NCT01675362|Verapamil|verapamil|mesh-list
14972259|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
14972260|NCT01675362|Calcium|calcium|mesh-list
14972261|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14972262|NCT01675362|Antioxidants|antioxidants|mesh-list
14972263|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14972264|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972265|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14972266|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14972267|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14972268|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972269|NCT01675362|Protective Agents|protective agents|mesh-ancestor
14972270|NCT01675362|Trace Elements|trace elements|mesh-ancestor
14972271|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
14972272|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972273|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
14972274|NCT01675466|Anesthetics|anesthetics|mesh-list
14972275|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972276|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972277|NCT01675518|ASP7991|asp7991|mesh-list
14972278|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14972279|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
14972280|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972281|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972282|NCT01675557|Vitamin D|vitamin d|mesh-list
14972283|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
14972284|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
14972285|NCT01675557|Vitamins|vitamins|mesh-list
14972286|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
14972287|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972288|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14972289|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14972290|NCT01675648|Lofexidine|lofexidine|mesh-list
14972291|NCT01675648|Clonidine|clonidine|mesh-list
14972292|NCT01675648|Diazepam|diazepam|mesh-list
14972293|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14972294|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
14972295|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
14972296|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
14972297|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972298|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972299|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972300|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14972301|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972302|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14972303|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14972304|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14972305|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14972306|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14972307|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14972308|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
14972309|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
14972310|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
14972311|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
14972312|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972313|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972314|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14972315|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14972316|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
14972317|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14972318|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14972319|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14972320|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
14972321|NCT01675648|Analgesics|analgesics|mesh-ancestor
14972322|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
14972323|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
14972324|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
14972325|NCT01675804|Methylphenidate|methylphenidate|mesh-list
14972326|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14972327|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972328|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14972329|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14972330|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972331|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972332|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
14972333|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972334|NCT01675895|Lidocaine|lidocaine|mesh-list
14972335|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
14972336|NCT01675895|Anesthetics|anesthetics|mesh-list
14972337|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
14972338|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972339|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972340|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
14972341|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972342|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14972343|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14972344|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14972345|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972346|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972347|NCT01675947|Sirolimus|sirolimus|mesh-list
14972348|NCT01675947|Lidocaine|lidocaine|mesh-list
14972349|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
14972350|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
14972351|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972352|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972353|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
14972354|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972355|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14972356|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14972357|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14972358|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972359|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972360|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14972361|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972362|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14972363|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972364|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
14972365|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972366|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
14972367|NCT01675973|Ranolazine|ranolazine|mesh-list
14972368|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14972369|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972370|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972371|NCT01675986|Pregabalin|pregabalin|mesh-list
14972372|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
14972373|NCT01675986|Analgesics|analgesics|mesh-ancestor
14972374|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
14972375|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972376|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972377|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
14972378|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14972379|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972380|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972381|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14972382|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14972383|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14972384|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972385|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14972386|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
14972387|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
14972388|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14972389|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
14972390|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
14972391|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972392|NCT01675999|Leucovorin|leucovorin|mesh-list
14972393|NCT01675999|Cetuximab|cetuximab|mesh-list
14972394|NCT01675999|Fluorouracil|fluorouracil|mesh-list
14972395|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
14972396|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972397|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972398|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
14972399|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972400|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14972401|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972402|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
14972403|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972404|NCT01675999|Antidotes|antidotes|mesh-ancestor
14972405|NCT01675999|Protective Agents|protective agents|mesh-ancestor
14972406|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
14972407|NCT01675999|Vitamins|vitamins|mesh-ancestor
14972408|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
14972409|NCT01676233|Insulin|insulin|mesh-list
14972410|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14972411|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
14972412|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972413|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972414|NCT01676246|Flupirtine|flupirtine|mesh-list
14972415|NCT01676246|Analgesics|analgesics|mesh-ancestor
14972416|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
14972417|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972418|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972419|NCT01676259|Gemcitabine|gemcitabine|mesh-list
14972420|NCT01676259|Paclitaxel|paclitaxel|mesh-list
14972421|NCT01676259|Folfirinox|folfirinox|mesh-list
14972422|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14972423|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972424|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
14972425|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
14972426|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
14972427|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972428|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14972429|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
14972430|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
14972431|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972432|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972433|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972434|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
14972435|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972436|NCT01676285|Metoprolol|metoprolol|mesh-list
14972437|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14972438|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14972439|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
14972440|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
14972441|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972442|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972443|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14972444|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14972445|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14972446|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
14972447|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972448|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972449|NCT01676363|Diflunisal|diflunisal|mesh-list
14972450|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14972451|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14972452|NCT01676363|Analgesics|analgesics|mesh-ancestor
14972453|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
14972454|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972455|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972456|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14972457|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972458|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14972459|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972460|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972461|NCT01676402|Vaccines|vaccines|mesh-list
14972462|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
14972463|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972464|NCT01676493|Codeine|codeine|mesh-list
14972465|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14972466|NCT01676493|Narcotics|narcotics|mesh-ancestor
14972467|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972468|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972469|NCT01676493|Analgesics|analgesics|mesh-ancestor
14972470|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
14972471|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972472|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
14972473|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
14972474|NCT01676506|Ranibizumab|ranibizumab|mesh-list
14972475|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14972476|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14972477|NCT01676506|Growth Substances|growth substances|mesh-ancestor
14972478|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972479|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
14972480|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972481|NCT01676558|Rituximab|rituximab|mesh-list
14972482|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972483|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972484|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
14972485|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972486|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029142|NCT01960179|Lixisenatide|lixisenatide|mesh-list
15029143|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15029144|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029145|NCT01960205|Metformin|metformin|mesh-list
15029146|NCT01960205|Saxagliptin|saxagliptin|mesh-list
14800626|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14800627|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
14800628|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
14800629|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14800630|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
14800631|NCT00788749|Hormones|hormones|mesh-ancestor
14800632|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14800633|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14800634|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800635|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
14800636|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
14800637|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
14800638|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14800639|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800640|NCT00788918|Interferons|interferons|mesh-list
14800641|NCT00788918|Ribavirin|ribavirin|mesh-list
14972487|NCT01676571|Vortioxetine|vortioxetine|mesh-list
14972488|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14972489|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14972490|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14972491|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14972492|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972493|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972494|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14972495|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14972496|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972497|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972498|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972499|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
14972500|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14972501|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14972502|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14972503|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14972504|NCT01676597|Rifaximin|rifaximin|mesh-list
14972505|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
14972506|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14972507|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972508|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029147|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972509|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14972510|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972511|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972512|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14972513|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14972514|NCT01676597|Protective Agents|protective agents|mesh-ancestor
14972515|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972516|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
14972517|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14972518|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
14972519|NCT01676649|Paclitaxel|paclitaxel|mesh-list
14972520|NCT01676649|Carboplatin|carboplatin|mesh-list
14972521|NCT01676649|Ipilimumab|ipilimumab|mesh-list
14972522|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14972523|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972524|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
14972525|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
14972526|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
14972527|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972528|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972529|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14972530|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
14972531|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972532|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972533|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14972534|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
14972535|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
14972536|NCT01676844|Protective Agents|protective agents|mesh-ancestor
14972537|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972538|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14972539|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
14972540|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972541|NCT01676987|Budesonide|budesonide|mesh-list
14972542|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
14972543|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14972544|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14972545|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
14972546|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972547|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972548|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14972549|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
14972550|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
14972551|NCT01676987|Hormones|hormones|mesh-ancestor
14972552|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972553|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14972554|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14972555|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14972556|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
14972557|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972558|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972559|NCT01677039|Ethanol|ethanol|mesh-list
14972560|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14972561|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972562|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972563|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972564|NCT01677065|Oxycodone|oxycodone|mesh-list
14972565|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14972566|NCT01677065|Narcotics|narcotics|mesh-ancestor
14972567|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972568|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972569|NCT01677065|Analgesics|analgesics|mesh-ancestor
14972570|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
14972571|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972572|NCT01677104|Liraglutide|liraglutide|mesh-list
14972573|NCT01677104|Exenatide|exenatide|mesh-list
14972574|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14972575|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972576|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972577|NCT01677104|Incretins|incretins|mesh-ancestor
14972578|NCT01677104|Hormones|hormones|mesh-ancestor
14972579|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972580|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14972581|NCT01677143|Bupivacaine|bupivacaine|mesh-list
14972582|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
14972583|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
14972584|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972585|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972586|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
14972587|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972588|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14972589|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
14972590|NCT01677247|Glimepiride|glimepiride|mesh-list
14972591|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14972592|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972593|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972594|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972595|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
14972596|NCT01677260|Metformin|metformin|mesh-list
14972597|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972598|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972599|NCT01677273|Caseins|caseins|mesh-list
14972600|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
14972601|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
14972602|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972603|NCT01677351|Clonidine|clonidine|mesh-list
14972604|NCT01677351|Analgesics|analgesics|mesh-ancestor
14972605|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
14972606|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972607|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972608|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14972609|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
14972610|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
14972611|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14972612|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14972613|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14972614|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
14972615|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972616|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972617|NCT01677364|Oxytocin|oxytocin|mesh-list
14972618|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
14972619|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14972620|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972621|NCT01677390|Everolimus|everolimus|mesh-list
14972622|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972623|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972624|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
14972625|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972626|NCT01677403|Tobramycin|tobramycin|mesh-list
14972627|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14972628|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972629|NCT01677442|Anesthetics|anesthetics|mesh-list
14972630|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972631|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972632|NCT01677468|Doxorubicin|doxorubicin|mesh-list
14972633|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14972634|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
14972635|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14972636|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972637|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14972638|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14972639|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972640|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972641|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
14972642|NCT01677468|Coagulants|coagulants|mesh-ancestor
14972643|NCT01677546|Insulin|insulin|mesh-list
14972644|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14972645|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972646|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972647|NCT01677559|Paclitaxel|paclitaxel|mesh-list
14972648|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14972649|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972650|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
14972651|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
14972652|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
14972653|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972654|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
14972655|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
14972656|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972657|NCT01677598|Ustekinumab|ustekinumab|mesh-list
14972658|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
14972659|NCT01677611|Resveratrol|resveratrol|mesh-list
14972660|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
14972661|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972662|NCT01677611|Protective Agents|protective agents|mesh-ancestor
14972663|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972664|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972665|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14972666|NCT01677650|Methadone|methadone|mesh-list
14972667|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14972668|NCT01677650|Narcotics|narcotics|mesh-ancestor
14972669|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972670|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972671|NCT01677650|Analgesics|analgesics|mesh-ancestor
14972672|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
14972673|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972674|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
14972675|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
14972676|NCT01677702|Lactoferrin|lactoferrin|mesh-list
14972677|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972678|NCT01677884|Bevacizumab|bevacizumab|mesh-list
14972679|NCT01677884|Capecitabine|capecitabine|mesh-list
14972680|NCT01677884|Irinotecan|irinotecan|mesh-list
14972681|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972682|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972683|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14972684|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14972685|NCT01677884|Growth Substances|growth substances|mesh-ancestor
14972686|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972687|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
14972688|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14972689|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
14972690|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972691|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14972692|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14972693|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972694|NCT01677897|Metformin|metformin|mesh-list
14972695|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972696|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972697|NCT01677923|Metformin|metformin|mesh-list
14972698|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972699|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972700|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
14972701|NCT01677949|Etoposide|etoposide|mesh-list
14972702|NCT01677949|Clofarabine|clofarabine|mesh-list
14972703|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972704|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
14972705|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972706|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972707|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14972708|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
14972709|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972710|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972711|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14972712|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14972713|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14972714|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14972715|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972716|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14972717|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
14972718|NCT01677962|Poly ICLC|poly iclc|mesh-list
14972719|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
14972720|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
14972721|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972722|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14972723|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14972724|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972725|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972726|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14972727|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972728|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972729|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
14972730|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972731|NCT01678053|Omeprazole|omeprazole|mesh-list
14972732|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
14972733|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14972734|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14972735|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14972736|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14972737|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14972738|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972739|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
14972740|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972741|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972742|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14972743|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972744|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972745|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14972746|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972747|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
14972748|NCT01678079|Calcium|calcium|mesh-list
14972749|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14972750|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972751|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14972752|NCT01678092|Omalizumab|omalizumab|mesh-list
14972753|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14972754|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14972755|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
14972756|NCT01678235|Insulin|insulin|mesh-list
14972757|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14972758|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
14972759|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
14972760|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972761|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029148|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029149|NCT01960205|Incretins|incretins|mesh-ancestor
15029150|NCT01960205|Hormones|hormones|mesh-ancestor
15029151|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029152|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15029153|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
15029154|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029155|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029156|NCT01960283|Methotrexate|methotrexate|mesh-list
15029157|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15029158|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
15029159|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15029160|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029161|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15029162|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
15029163|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029164|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029165|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029166|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029167|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15029168|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029169|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
15029170|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029171|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15029172|NCT01960426|Adalimumab|adalimumab|mesh-list
15029173|NCT01960426|Infliximab|infliximab|mesh-list
15029174|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029175|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029176|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029177|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029178|NCT01960543|Fentanyl|fentanyl|mesh-list
15029179|NCT01960543|Bupivacaine|bupivacaine|mesh-list
15029180|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
15029181|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
14972762|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
14972763|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14972764|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972765|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14972766|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972767|NCT01678352|Imiquimod|imiquimod|mesh-list
14972768|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14972769|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
14972770|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972771|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972772|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
14972773|NCT01678365|Metronidazole|metronidazole|mesh-list
14972774|NCT01678365|Gentamicins|gentamicins|mesh-list
14972775|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
14972776|NCT01678365|Ampicillin|ampicillin|mesh-list
14972777|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972778|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14972779|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14972780|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14972781|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14972782|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972783|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972784|NCT01678404|Rituximab|rituximab|mesh-list
14972785|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972786|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972787|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
14972788|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972789|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972790|NCT01678417|Rituximab|rituximab|mesh-list
14972791|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972792|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972793|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
14972794|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972795|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972796|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14972797|NCT01678430|Chlorambucil|chlorambucil|mesh-list
14972798|NCT01678430|Ofatumumab|ofatumumab|mesh-list
14972799|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14972800|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
14972801|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972802|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972803|NCT01678495|Plasminogen|plasminogen|mesh-list
14972804|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14972805|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14972806|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14972807|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972808|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
14972809|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972810|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14972811|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972812|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972813|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
14972814|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972815|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972816|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14972817|NCT01678599|Benzonidazole|benzonidazole|mesh-list
14972818|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972819|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
14972820|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972821|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14972822|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14972823|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14972824|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972825|NCT01678612|Copper|copper|mesh-list
14972826|NCT01678612|Trace Elements|trace elements|mesh-ancestor
14972827|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
14972828|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972829|NCT01678664|Doxorubicin|doxorubicin|mesh-list
14972830|NCT01678664|Everolimus|everolimus|mesh-list
14972831|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14972832|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972833|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14972834|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14972835|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972836|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972837|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972838|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
14972839|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972840|NCT01678677|Vaccines|vaccines|mesh-list
14972841|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
14972842|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972843|NCT01678690|Gemcitabine|gemcitabine|mesh-list
14972844|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14972845|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
14972846|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972847|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972848|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
14972849|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972850|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972851|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972852|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
14972853|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972854|NCT01678703|Misoprostol|misoprostol|mesh-list
14972855|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14972856|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
14972857|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14972858|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972859|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14972860|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972861|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
14972862|NCT01678716|Micronutrients|micronutrients|mesh-list
14972863|NCT01678716|Trace Elements|trace elements|mesh-list
14972864|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972865|NCT01678937|Cyclosporine|cyclosporine|mesh-list
14972866|NCT01678937|Sirolimus|sirolimus|mesh-list
14972867|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
14972868|NCT01678937|Tacrolimus|tacrolimus|mesh-list
14972869|NCT01678937|Cyclosporins|cyclosporins|mesh-list
14972870|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972871|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
14972872|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972873|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14972874|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972875|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972876|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
14972877|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972878|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14972879|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972880|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14972881|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972882|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14972883|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
14972884|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14972885|NCT01678963|Squalamine|squalamine|mesh-list
14972886|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14972887|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972888|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14972889|NCT01678963|Protective Agents|protective agents|mesh-ancestor
14972890|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972891|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972892|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14972893|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14972894|NCT01678963|Growth Substances|growth substances|mesh-ancestor
14972895|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
14972896|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
14972897|NCT01679041|Fludarabine|fludarabine|mesh-list
14972898|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
14972899|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972900|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
14972901|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972902|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972903|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14972904|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
14972905|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972906|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972907|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14972908|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972909|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
14972910|NCT01679080|Teriparatide|teriparatide|mesh-list
14972911|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15029182|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
14972912|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972913|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14972914|NCT01679093|Dexamethasone|dexamethasone|mesh-list
14972915|NCT01679093|Droperidol|droperidol|mesh-list
14972916|NCT01679093|Ondansetron|ondansetron|mesh-list
14236511|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236512|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
14972917|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14972918|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
14972919|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
14972920|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972921|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972922|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14972923|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
14972924|NCT01679093|Hormones|hormones|mesh-ancestor
14972925|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972926|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14972927|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972928|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
14972929|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
14972930|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14972931|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
14972932|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14972933|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972934|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14972935|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14972936|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972937|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14972938|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14972939|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14972940|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14972941|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14972942|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
14972943|NCT01679106|Fentanyl|fentanyl|mesh-list
14972944|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14972945|NCT01679106|Narcotics|narcotics|mesh-ancestor
14972946|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14972947|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972948|NCT01679106|Analgesics|analgesics|mesh-ancestor
14972949|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
14972950|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14972951|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14972952|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14972953|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
14972954|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
14972955|NCT01679119|Gemcitabine|gemcitabine|mesh-list
14972956|NCT01679119|Prednisolone|prednisolone|mesh-list
14972957|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
14972958|NCT01679119|Rituximab|rituximab|mesh-list
14972959|NCT01679119|Vincristine|vincristine|mesh-list
14972960|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14972961|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14972962|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
14972963|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972964|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14972965|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14972966|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
14972967|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14972968|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972969|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14972970|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972971|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14972972|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
14972973|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
14972974|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14972975|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14972976|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14972977|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
14972978|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
14972979|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
14972980|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14972981|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
14972982|NCT01679119|Hormones|hormones|mesh-ancestor
14972983|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14972984|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14972985|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14972986|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
14972987|NCT01679327|Leucovorin|leucovorin|mesh-list
14972988|NCT01679327|Bevacizumab|bevacizumab|mesh-list
14972989|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
14972990|NCT01679327|Calcium|calcium|mesh-list
14972991|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
14972992|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14972993|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14972994|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14972995|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14972996|NCT01679327|Growth Substances|growth substances|mesh-ancestor
14972997|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14972998|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
14972999|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14973000|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14973001|NCT01679327|Antidotes|antidotes|mesh-ancestor
14973002|NCT01679327|Protective Agents|protective agents|mesh-ancestor
14973003|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
14973004|NCT01679327|Vitamins|vitamins|mesh-ancestor
14973005|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
14973006|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
14973007|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973008|NCT01679392|Ropivacaine|ropivacaine|mesh-list
14973009|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
14973010|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
14973011|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973012|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973013|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
14973014|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973015|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14973016|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14973017|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14973018|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14973019|NCT01679574|Metformin|metformin|mesh-list
14973020|NCT01679574|Letrozole|letrozole|mesh-list
14973021|NCT01679574|Clomiphene|clomiphene|mesh-list
14973022|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973023|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973024|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973025|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14973026|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14973027|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973028|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973029|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14973030|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
14973031|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973032|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14973033|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
14973034|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14973035|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14973036|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14973037|NCT01679639|Rifampin|rifampin|mesh-list
14973038|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14973039|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
14973040|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14973041|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973042|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
14973043|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14973044|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973045|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973046|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14973047|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14973048|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14973049|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14973050|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14973051|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14973052|NCT01679652|Nebivolol|nebivolol|mesh-list
14973053|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14973054|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
14973055|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14973056|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14973057|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14973058|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
14973059|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973060|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973061|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973062|NCT01679691|Anesthetics|anesthetics|mesh-list
14973063|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973064|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973065|NCT01679743|Trastuzumab|trastuzumab|mesh-list
14973066|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14973067|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973068|NCT01679795|Tibolone|tibolone|mesh-list
14973069|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
14973070|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
14973071|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973072|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973073|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14973074|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14973075|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973076|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14973077|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
14973078|NCT01679795|Hormones|hormones|mesh-ancestor
14973079|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
14973080|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
14973081|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973082|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14973083|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973084|NCT01679899|Vildagliptin|vildagliptin|mesh-list
14973085|NCT01679899|Gliclazide|gliclazide|mesh-list
14973086|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973087|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973088|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14973089|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
14973090|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973091|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029183|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029184|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029185|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
15029186|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029187|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15029188|NCT01960543|Narcotics|narcotics|mesh-ancestor
15029189|NCT01960543|Analgesics|analgesics|mesh-ancestor
15029190|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15029191|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15029192|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
15029193|NCT01960569|Hirudins|hirudins|mesh-list
15029194|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
15029195|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15029196|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
15029197|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029198|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029199|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
15029200|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15029201|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15029202|NCT01960595|Fentanyl|fentanyl|mesh-list
15029203|NCT01960595|Bupivacaine|bupivacaine|mesh-list
15029204|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029205|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
15029206|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029207|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029208|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
15029209|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029210|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15029211|NCT01960595|Narcotics|narcotics|mesh-ancestor
15029212|NCT01960595|Analgesics|analgesics|mesh-ancestor
15029213|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15029214|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15029215|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
15029216|NCT01960647|Paclitaxel|paclitaxel|mesh-list
15029217|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15029218|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029219|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
15029220|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
15029221|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
15029222|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029223|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15029224|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029225|NCT01960829|Everolimus|everolimus|mesh-list
15029226|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029227|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029228|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
15029229|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029230|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15029231|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15029232|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15029233|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
15029234|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15029235|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
15029236|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029237|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029238|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
15029239|NCT01961154|Hormones|hormones|mesh-ancestor
15029240|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029241|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
15029242|NCT01961180|Citalopram|citalopram|mesh-list
15029243|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15029244|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14973092|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
14973093|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14973094|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14973095|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
14973096|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973097|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14973098|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14973099|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973100|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973101|NCT01680042|Phenytoin|phenytoin|mesh-list
14973102|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
14973103|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14973104|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14973105|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14973106|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973107|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14973108|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14973109|NCT01680081|Adenosine|adenosine|mesh-list
14973110|NCT01680081|Analgesics|analgesics|mesh-ancestor
14973111|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
14973112|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973113|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973114|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14973115|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
14973116|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14973117|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
14973118|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
14973119|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973120|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973121|NCT01680094|Panobinostat|panobinostat|mesh-list
14973122|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973123|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14973124|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973125|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973126|NCT01680107|Cycloserine|cycloserine|mesh-list
14973127|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14973128|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973129|NCT01680107|Renal Agents|renal agents|mesh-ancestor
14973130|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14973131|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
14973132|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14973133|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
14973134|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973135|NCT01680120|Anesthetics|anesthetics|mesh-list
14973136|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973137|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973138|NCT01680146|Caseins|caseins|mesh-list
14973139|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
14973140|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
14973141|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973142|NCT01680185|Insulin|insulin|mesh-list
14973143|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14973144|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
14973145|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
14973146|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
14973147|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
14973148|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
14973149|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973150|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973151|NCT01680198|Vitamin D|vitamin d|mesh-list
14973152|NCT01680198|Vitamins|vitamins|mesh-ancestor
14973153|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
14973154|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973155|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14973156|NCT01680250|Sirolimus|sirolimus|mesh-list
14973157|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14973158|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973159|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14973160|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973161|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
14973162|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973163|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
14973164|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973165|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14973166|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14973167|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14973168|NCT01680263|Analgesics|analgesics|mesh-ancestor
14973169|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
14973170|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973171|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973172|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973173|NCT01680406|Chloroquine|chloroquine|mesh-list
14973174|NCT01680406|Lumefantrine|lumefantrine|mesh-list
14973175|NCT01680406|Artemether|artemether|mesh-list
14973176|NCT01680406|Primaquine|primaquine|mesh-list
14973177|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14973178|NCT01680406|Amebicides|amebicides|mesh-ancestor
14973179|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14973180|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14973181|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973182|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
14973183|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973184|NCT01680471|Midazolam|midazolam|mesh-list
14973185|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14973186|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14973187|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973188|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973189|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14973190|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14973191|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14973192|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14973193|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
14973194|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
14973195|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
14973196|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
14973197|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973198|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973199|NCT01680536|Maraviroc|maraviroc|mesh-list
14973200|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14973201|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14973202|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973203|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14973204|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14973205|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
14973206|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973207|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14973208|NCT01680679|Vaccines|vaccines|mesh-list
14973209|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
14973210|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973211|NCT01680718|Vasopressins|vasopressins|mesh-list
14973212|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
14973213|NCT01680718|Oxytocin|oxytocin|mesh-list
14973214|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
14973215|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14973216|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973217|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
14973218|NCT01680718|Coagulants|coagulants|mesh-ancestor
14973219|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14973220|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14973221|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
14973222|NCT01680796|Dexamethasone|dexamethasone|mesh-list
14973223|NCT01680796|Bortezomib|bortezomib|mesh-list
14973224|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973225|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
14973226|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
14973227|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973228|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973229|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973230|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
14973231|NCT01680796|Hormones|hormones|mesh-ancestor
14973232|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973233|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14973234|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973235|NCT01680913|Anesthetics|anesthetics|mesh-list
14973236|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973237|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973238|NCT01680939|Ibuprofen|ibuprofen|mesh-list
14973239|NCT01680939|Morphine|morphine|mesh-list
14973240|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14973241|NCT01680939|Narcotics|narcotics|mesh-ancestor
14973242|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973243|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973244|NCT01680939|Analgesics|analgesics|mesh-ancestor
14973245|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
14973246|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973247|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14973248|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14973249|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973250|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973251|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14973252|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973253|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973254|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
14973255|NCT01680952|Sirolimus|sirolimus|mesh-list
14973256|NCT01680952|Tacrolimus|tacrolimus|mesh-list
14973257|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973258|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
14973259|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973260|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14973261|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973262|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973263|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14973264|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973265|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14973266|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
14973267|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14973268|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973269|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
14973270|NCT01681134|Tacrolimus|tacrolimus|mesh-list
14973271|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973272|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
14973273|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973274|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14973275|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973276|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973277|NCT01681446|Interferons|interferons|mesh-list
14973278|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
14973279|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973280|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
14973281|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973282|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
14973283|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973284|NCT01681537|Cytarabine|cytarabine|mesh-list
14973285|NCT01681537|Etoposide|etoposide|mesh-list
14973286|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
14973287|NCT01681537|Lenalidomide|lenalidomide|mesh-list
14973288|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14973289|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973290|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14973291|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14973292|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973293|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973294|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14973295|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
14973296|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
14973297|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973298|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973299|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
14973300|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973301|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14973302|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14973303|NCT01681537|Growth Substances|growth substances|mesh-ancestor
14973304|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
14973305|NCT01681537|Analgesics|analgesics|mesh-ancestor
14973306|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
14973307|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973308|NCT01681550|Incretins|incretins|mesh-list
14973309|NCT01681550|Hormones|hormones|mesh-ancestor
14973310|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973311|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973312|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
14973313|NCT01681563|Ofatumumab|ofatumumab|mesh-list
14973314|NCT01681563|Pentostatin|pentostatin|mesh-list
14973315|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973316|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
14973317|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973318|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973319|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14973320|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
14973321|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973322|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973323|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14973324|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14973325|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973326|NCT01681667|Ibuprofen|ibuprofen|mesh-list
14973327|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14973328|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14973329|NCT01681667|Analgesics|analgesics|mesh-ancestor
14973330|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
14973331|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973332|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973333|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973334|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973335|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14973336|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973337|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029245|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029246|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029247|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029248|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
15029249|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029250|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15029251|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
15029252|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15029253|NCT01961193|Silicon|silicon|mesh-list
15029254|NCT01961193|Trace Elements|trace elements|mesh-ancestor
15029255|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
15029256|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029257|NCT01961219|Anesthetics|anesthetics|mesh-list
15029258|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029259|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029260|NCT01961336|Testosterone|testosterone|mesh-list
15029261|NCT01961336|Androgens|androgens|mesh-ancestor
15029262|NCT01961336|Hormones|hormones|mesh-ancestor
15029263|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029264|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029265|NCT01961388|Metformin|metformin|mesh-list
15029266|NCT01961388|Acarbose|acarbose|mesh-list
15029267|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15029268|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029269|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15029270|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029271|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029272|NCT01961414|Aflibercept|aflibercept|mesh-list
15029273|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15029274|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15029275|NCT01961414|Growth Substances|growth substances|mesh-ancestor
15029276|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029277|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
15029278|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029279|NCT01961453|Isosorbide|isosorbide|mesh-list
15029280|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15029281|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15029282|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15029283|NCT01961453|Diuretics|diuretics|mesh-ancestor
15029284|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
15029285|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029286|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
15029287|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15029288|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035106|NCT01999270|Growth Substances|growth substances|mesh-ancestor
15035107|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035108|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
15035109|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15035110|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15035111|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035112|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035113|NCT01999309|Simvastatin|simvastatin|mesh-list
15035114|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15035115|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15035116|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
15035117|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035118|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15035119|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15035120|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035121|NCT01999413|Cytarabine|cytarabine|mesh-list
15035122|NCT01999413|Daunorubicin|daunorubicin|mesh-list
15035123|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15035124|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
15035125|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035126|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035127|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
15035128|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035129|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035130|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
15035131|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973338|NCT01681680|Metformin|metformin|mesh-list
14973339|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973340|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973341|NCT01681693|Metformin|metformin|mesh-list
14973342|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973343|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973344|NCT01681875|Nicotine|nicotine|mesh-list
14973345|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14973346|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
14973347|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973348|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973349|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14973350|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14973351|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
14973352|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973353|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973354|NCT01681966|Ropivacaine|ropivacaine|mesh-list
14973355|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14973356|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
14973357|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
14973358|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973359|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973360|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
14973361|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973362|NCT01681979|Fluticasone|fluticasone|mesh-list
14973363|NCT01681979|Xhance|xhance|mesh-list
14973364|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14973365|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973366|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14973367|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
14973368|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973369|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973370|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14973371|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
14973372|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
14973373|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14973374|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14973375|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14973376|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14973377|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
14973378|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973379|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973380|NCT01682109|Valacyclovir|valacyclovir|mesh-list
14973381|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
14973382|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973383|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14973384|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14973385|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14973386|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973387|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973388|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14973389|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14973390|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14973391|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
14973392|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973393|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973394|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14973395|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14973396|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
14973397|NCT01682187|Lomustine|lomustine|mesh-list
14973398|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14973399|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
14973400|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973401|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973402|NCT01682343|Calcium|calcium|mesh-list
14973403|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14973404|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973405|NCT01682408|Mannitol|mannitol|mesh-list
14973406|NCT01682408|Ranitidine|ranitidine|mesh-list
14973407|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14973408|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14973409|NCT01682408|Diuretics|diuretics|mesh-ancestor
14973410|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
14973411|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973412|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14973413|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973414|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14973415|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
14973416|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
14973417|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973418|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973419|NCT01682421|Dexamethasone|dexamethasone|mesh-list
14973420|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
14973421|NCT01682421|BB 1101|bb 1101|mesh-list
14973422|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973423|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973424|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973425|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
14973426|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
14973427|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973428|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973429|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
14973430|NCT01682421|Hormones|hormones|mesh-ancestor
14973431|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973432|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14973433|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973434|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
14973435|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973436|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
14973437|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
14973438|NCT01682499|Calcium|calcium|mesh-list
14973439|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14973440|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973441|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14973442|NCT01682499|Analgesics|analgesics|mesh-ancestor
14973443|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
14973444|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973445|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
14973446|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973447|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14973448|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
14973449|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14973450|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14973451|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973452|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
14973453|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14973454|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
14973455|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14973456|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14973457|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14973458|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973459|NCT01682577|Perindopril|perindopril|mesh-list
14973460|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14973461|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
14973462|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973463|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973464|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14973465|NCT01682616|Rituximab|rituximab|mesh-list
14973466|NCT01682616|Venetoclax|venetoclax|mesh-list
14973467|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14973468|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973469|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
14973470|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973471|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973472|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
14973473|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14973474|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14973475|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973476|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
14973477|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973478|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973479|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14973480|NCT01682746|Trioxsalen|trioxsalen|mesh-list
14973481|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973482|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
14973483|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14973484|NCT01682772|Olaparib|olaparib|mesh-list
14973485|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14973486|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973487|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973488|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973489|NCT01682902|Insulin|insulin|mesh-list
14973490|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14973491|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
14973492|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
14973493|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14973494|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973495|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973496|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
14973497|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14973498|NCT01682941|Estrogens|estrogens|mesh-ancestor
14973499|NCT01682941|Hormones|hormones|mesh-ancestor
14973500|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973501|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973502|NCT01683006|Rocuronium|rocuronium|mesh-list
14973503|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14973504|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14973505|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14973506|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973507|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973508|NCT01683032|Methylphenidate|methylphenidate|mesh-list
14973509|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14973510|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973511|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14973512|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14973513|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14973514|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973515|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
14973516|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523092|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523093|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14523094|NCT03571516|Protective Agents|protective agents|mesh-ancestor
14523095|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523096|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14973517|NCT01683149|Sorafenib|sorafenib|mesh-list
14973518|NCT01683149|Topotecan|topotecan|mesh-list
14973519|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
14973520|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973521|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14973522|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973523|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973524|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14973525|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14973526|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14973527|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14973528|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14973529|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14523097|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
14523098|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523099|NCT03571724|Menthol|menthol|mesh-list
14523100|NCT03571724|Nicotine|nicotine|mesh-list
14523101|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14973530|NCT01683175|Cisplatin|cisplatin|mesh-list
14973531|NCT01683175|Vinorelbine|vinorelbine|mesh-list
14973532|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973533|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14973534|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973535|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973536|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14973537|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
14973538|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
14973539|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
14523102|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
14523103|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523104|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523105|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14523106|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14523107|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
14523108|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523109|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523110|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
14523111|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
14523112|NCT03572478|Nivolumab|nivolumab|mesh-list
14973540|NCT01683188|Vemurafenib|vemurafenib|mesh-list
14973541|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973542|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14973543|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973544|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973545|NCT01683253|Dopamine|dopamine|mesh-list
14973546|NCT01683253|Levodopa|levodopa|mesh-list
14973547|NCT01683253|Carbidopa|carbidopa|mesh-list
14973548|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
14973549|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14973550|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14973551|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
14973552|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973553|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973554|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973555|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14973556|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973557|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14973558|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
14973559|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
14973560|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973561|NCT01683253|Protective Agents|protective agents|mesh-ancestor
14973562|NCT01683292|Apomorphine|apomorphine|mesh-list
14973563|NCT01683292|Emetics|emetics|mesh-ancestor
14973564|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973565|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
14973566|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973567|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973568|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
14973569|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
14973570|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973571|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029289|NCT01961635|Cimetidine|cimetidine|mesh-list
15029290|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15029291|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029292|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15029293|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
15029294|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
15029295|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029296|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029297|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029298|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15029299|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14800642|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800643|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
14800644|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800645|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
14800646|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800647|NCT00788931|Paclitaxel|paclitaxel|mesh-list
14800648|NCT00788931|Trastuzumab|trastuzumab|mesh-list
14800649|NCT00788931|Panobinostat|panobinostat|mesh-list
14800650|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15029300|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029301|NCT01961739|Lidocaine|lidocaine|mesh-list
15029302|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029303|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
15029304|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029305|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029306|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
14800651|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800652|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
14800653|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
14800654|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
14800655|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800656|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14800657|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14800658|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800659|NCT00789061|Lansoprazole|lansoprazole|mesh-list
14800660|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14800661|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14800662|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029307|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029308|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15029309|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15029310|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14800663|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800664|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800665|NCT00789165|Quinidine|quinidine|mesh-list
14800666|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14800667|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14800668|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
14800669|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800670|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973572|NCT01683552|Fexofenadine|fexofenadine|mesh-list
14973573|NCT01683552|Prednisone|prednisone|mesh-list
14973574|NCT01683552|Aprepitant|aprepitant|mesh-list
14973575|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973576|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
14973577|NCT01683552|Hormones|hormones|mesh-ancestor
14973578|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973579|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973580|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14973581|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973582|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
14973583|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
14973584|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973585|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973586|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14973587|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973588|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973589|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14973590|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14973591|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14973592|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
14973593|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
14973594|NCT01683656|Niacin|niacin|mesh-list
14973595|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14973596|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
14973597|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973598|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14973599|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
14973600|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
14973601|NCT01683656|Vitamins|vitamins|mesh-ancestor
14973602|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
14973603|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973604|NCT01683682|Carboplatin|carboplatin|mesh-list
14973605|NCT01683682|Vinorelbine|vinorelbine|mesh-list
14973606|NCT01683682|Nintedanib|nintedanib|mesh-list
14973607|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973608|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14973609|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14973610|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14973611|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14973612|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973613|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14973614|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973615|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
14973616|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14973617|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14800671|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973618|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973619|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
14973620|NCT01683747|Coagulants|coagulants|mesh-ancestor
14973621|NCT01683760|Fluconazole|fluconazole|mesh-list
14973622|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
14973623|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973624|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14973625|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14973626|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973627|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973628|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14973629|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
14973630|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973631|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973632|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14973633|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14973634|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14973635|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
14973636|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973637|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
14973638|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14973639|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14973640|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973641|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
14973642|NCT01683955|Coagulants|coagulants|mesh-ancestor
14973643|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
14973644|NCT01684059|Astringents|astringents|mesh-ancestor
14973645|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973646|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
14973647|NCT01684072|Vaccines|vaccines|mesh-list
14973648|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
14973649|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973650|NCT01684085|Lorazepam|lorazepam|mesh-list
14973651|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
14973652|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
14973653|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
14973654|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973655|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973656|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973657|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14973658|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973659|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14973660|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14973661|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14973662|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
14973663|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
14973664|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973665|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973666|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
14973667|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14973668|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973669|NCT01684111|Vinorelbine|vinorelbine|mesh-list
14973670|NCT01684111|Nintedanib|nintedanib|mesh-list
14973671|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14973672|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973673|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
14973674|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
14973675|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
14973676|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973677|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14973678|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973679|NCT01684241|Vaccines|vaccines|mesh-list
14973680|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
14973681|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973682|NCT01684306|Modafinil|modafinil|mesh-list
14973683|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14973684|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973685|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14973686|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14973687|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14973688|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973689|NCT01684319|Caseins|caseins|mesh-list
14973690|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
14973691|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
14973692|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973693|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
14973694|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14973695|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14973696|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973697|NCT01684449|Gemcitabine|gemcitabine|mesh-list
14973698|NCT01684449|Sirolimus|sirolimus|mesh-list
14973699|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14973700|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
14973701|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973702|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973703|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
14973704|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973705|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973706|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973707|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
14973708|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973709|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14973710|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14973711|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
14973712|NCT01684657|Asenapine|asenapine|mesh-list
14973713|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14973714|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14973715|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973716|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973717|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14973718|NCT01684683|Theophylline|theophylline|mesh-list
14973719|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14973720|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
14973721|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973722|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973723|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14973724|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
14973725|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14973726|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973727|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973728|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
14973729|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14973730|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14973731|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
14973732|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973733|NCT01684774|Bupivacaine|bupivacaine|mesh-list
14973734|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
14973735|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
14973736|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973737|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973738|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
14973739|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973740|NCT01684787|Ribavirin|ribavirin|mesh-list
14973741|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14973742|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
14973743|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
14973744|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973745|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
14973746|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973747|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
14973748|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973749|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14973750|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
14973751|NCT01684800|Coagulants|coagulants|mesh-ancestor
14973752|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14973753|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
14973754|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973755|NCT01684813|Clopidogrel|clopidogrel|mesh-list
14973756|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14973757|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14973758|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14973759|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14973760|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14973761|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
14973762|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973763|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973764|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973765|NCT01684865|Rituximab|rituximab|mesh-list
14973766|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14973767|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973768|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
14973769|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973770|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973771|NCT01684969|Haloperidol|haloperidol|mesh-list
14973772|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
14973773|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
14973774|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
14973775|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973776|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973777|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973778|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14973779|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14973780|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973781|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14973782|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14973783|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
14973784|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973785|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973786|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14973787|NCT01684982|Sirolimus|sirolimus|mesh-list
14973788|NCT01684982|Everolimus|everolimus|mesh-list
14973789|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973790|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973791|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
14973792|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973793|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14973794|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973795|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14973796|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
14973797|NCT01684995|Nicotine|nicotine|mesh-list
14973798|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14973799|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
14973800|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973801|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973802|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14973803|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14973804|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
14973805|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973806|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973807|NCT01685125|Prednisone|prednisone|mesh-list
14973808|NCT01685125|Dasatinib|dasatinib|mesh-list
14973809|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
14973810|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973811|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
14973812|NCT01685125|Hormones|hormones|mesh-ancestor
14973813|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973814|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973815|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14973816|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973817|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14973818|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973819|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973820|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14973821|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
14973822|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14973823|NCT01685281|Metadoxine|metadoxine|mesh-list
14973824|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14973825|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
14973826|NCT01685333|Hematinics|hematinics|mesh-ancestor
14973827|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
14973828|NCT01685359|Hematinics|hematinics|mesh-ancestor
15029311|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029312|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029313|NCT01961752|Triamcinolone|triamcinolone|mesh-list
15029314|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15029315|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15029316|NCT01961752|Bupivacaine|bupivacaine|mesh-list
15029317|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15029318|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029319|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
15029320|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029321|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029322|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
15029323|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029324|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029325|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
15029326|NCT01961752|Hormones|hormones|mesh-ancestor
15035627|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
14800672|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14800673|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
14800674|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14800675|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14800676|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800677|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800678|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14800679|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14800680|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
14800681|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14973829|NCT01685398|Timolol|timolol|mesh-list
14973830|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14973831|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14973832|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14973833|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14973834|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
14973835|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973836|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973837|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973838|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14973839|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14973840|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
14973841|NCT01685489|Docetaxel|docetaxel|mesh-list
14973842|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973843|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
14973844|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
14973845|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
14973846|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973847|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14973848|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
14973849|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973850|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14973851|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
14973852|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973853|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
14973854|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14973855|NCT01685489|Protective Agents|protective agents|mesh-ancestor
14973856|NCT01685502|Acarbose|acarbose|mesh-list
14973857|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14973858|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973859|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973860|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973861|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973862|NCT01685515|Decitabine|decitabine|mesh-list
14973863|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
14973864|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14973865|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
14973866|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973867|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973868|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973869|NCT01685658|Acetaminophen|acetaminophen|mesh-list
14973870|NCT01685658|Ketoprofen|ketoprofen|mesh-list
14973871|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14973872|NCT01685658|Analgesics|analgesics|mesh-ancestor
14973873|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
14973874|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973875|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973876|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
14973877|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14973878|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973879|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973880|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14973881|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973882|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973883|NCT01685762|Metformin|metformin|mesh-list
14973884|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973885|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973886|NCT01685827|Eflornithine|eflornithine|mesh-list
14973887|NCT01685827|Nifurtimox|nifurtimox|mesh-list
14973888|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973889|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14973890|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14973891|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14973892|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14973893|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
14973894|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973895|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973896|NCT01685853|Bisacodyl|bisacodyl|mesh-list
14973897|NCT01685853|Cathartics|cathartics|mesh-ancestor
14973898|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973899|NCT01685853|Laxatives|laxatives|mesh-ancestor
14973900|NCT01685892|Venetoclax|venetoclax|mesh-list
14973901|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
14973902|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973903|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14973904|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14973905|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14973906|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14973907|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973908|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973909|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14973910|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14973911|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14973912|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
14973913|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973914|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973915|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14973916|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14973917|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
14973918|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
14973919|NCT01685970|Cathartics|cathartics|mesh-ancestor
14973920|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973921|NCT01686009|Ketamine|ketamine|mesh-list
14973922|NCT01686009|Analgesics|analgesics|mesh-ancestor
14973923|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
14973924|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973925|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973926|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14973927|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14973928|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
14973929|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
14973930|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973931|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14973932|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14973933|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14973934|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973935|NCT01686126|Metformin|metformin|mesh-list
14973936|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
14973937|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14973938|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973939|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14973940|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
14973941|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14973942|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14973943|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14973944|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14973945|NCT01686217|Niacinamide|niacinamide|mesh-list
14973946|NCT01686217|Peficitinib|peficitinib|mesh-list
14973947|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14973948|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973949|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14973950|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
14973951|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973952|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
14973953|NCT01686217|Vitamins|vitamins|mesh-ancestor
14973954|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
14973955|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
14973956|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14973957|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973958|NCT01686321|Rituximab|rituximab|mesh-list
14973959|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15035628|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
14523113|NCT03572478|Rucaparib|rucaparib|mesh-list
14523114|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523115|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523116|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14523117|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523118|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14523119|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523120|NCT03572972|Warfarin|warfarin|mesh-list
14523121|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
14523122|NCT03572972|Dabigatran|dabigatran|mesh-list
14973960|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14973961|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973962|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
14973963|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973964|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14973965|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14973966|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
14973967|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973968|NCT01686347|Ropivacaine|ropivacaine|mesh-list
14973969|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
14973970|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
14973971|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14973972|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973973|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
14973974|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973975|NCT01686386|Dexamethasone|dexamethasone|mesh-list
14973976|NCT01686386|Lenalidomide|lenalidomide|mesh-list
14973977|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14973978|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14973979|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
14973980|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
14973981|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14973982|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14973983|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14973984|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
14973985|NCT01686386|Hormones|hormones|mesh-ancestor
14973986|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14973987|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14973988|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14973989|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
14973990|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14973991|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14973992|NCT01686386|Growth Substances|growth substances|mesh-ancestor
14973993|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
14973994|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14973995|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
14973996|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14973997|NCT01686464|Valacyclovir|valacyclovir|mesh-list
14973998|NCT01686464|Prednisone|prednisone|mesh-list
14973999|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974000|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
14974001|NCT01686464|Hormones|hormones|mesh-ancestor
14974002|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974003|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974004|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14974005|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974006|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
14974007|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974008|NCT01686529|Bevacizumab|bevacizumab|mesh-list
14974009|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14974010|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974011|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14974012|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14974013|NCT01686529|Growth Substances|growth substances|mesh-ancestor
14974014|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974015|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
14974016|NCT01686555|Venetoclax|venetoclax|mesh-list
14974017|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974018|NCT01686594|Methoxsalen|methoxsalen|mesh-list
14974019|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14974020|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
14974021|NCT01686607|Itraconazole|itraconazole|mesh-list
14974022|NCT01686607|Fluconazole|fluconazole|mesh-list
14974023|NCT01686607|Voriconazole|voriconazole|mesh-list
14974024|NCT01686607|Amphotericin B|amphotericin b|mesh-list
14974025|NCT01686607|Caspofungin|caspofungin|mesh-list
14974026|NCT01686607|Micafungin|micafungin|mesh-list
14974027|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
14974028|NCT01686607|Clotrimazole|clotrimazole|mesh-list
14974029|NCT01686607|Miconazole|miconazole|mesh-list
14974030|NCT01686607|Anidulafungin|anidulafungin|mesh-list
14974031|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974032|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14974033|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14974034|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974035|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974036|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14974037|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
14974038|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974039|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974040|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14974041|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14974042|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14974043|NCT01686607|Amebicides|amebicides|mesh-ancestor
14974044|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14974045|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14974046|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974047|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14974048|NCT01686711|Pioglitazone|pioglitazone|mesh-list
14974049|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14974050|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974051|NCT01686789|Interferons|interferons|mesh-list
14974052|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
14974053|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
14974054|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14974055|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974056|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
14974057|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974058|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
14974059|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974060|NCT01686802|Ibuprofen|ibuprofen|mesh-list
14974061|NCT01686802|Morphine|morphine|mesh-list
14974062|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14974063|NCT01686802|Narcotics|narcotics|mesh-ancestor
14974064|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974065|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974066|NCT01686802|Analgesics|analgesics|mesh-ancestor
14974067|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
14974068|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974069|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14974070|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974071|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974072|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14974073|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14974074|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974075|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974076|NCT01687049|Red yeast rice|red yeast rice|mesh-list
14974077|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14974078|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14974079|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14974080|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
14974081|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974082|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974083|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14974084|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
14974085|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14974086|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
14974087|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
14974088|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029327|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029328|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029329|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
15029330|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029331|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029332|NCT01961830|Arbekacin|arbekacin|mesh-list
15029333|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029334|NCT01961843|Prednisone|prednisone|mesh-list
15029335|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
15029336|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029337|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
15029338|NCT01961843|Hormones|hormones|mesh-ancestor
15029339|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029340|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029341|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15029342|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029343|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15029344|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029345|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029346|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
15029347|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15029348|NCT01961856|Clopidogrel|clopidogrel|mesh-list
15029349|NCT01961856|Ticagrelor|ticagrelor|mesh-list
15029350|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15029351|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15029352|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15029353|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15029354|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
15029355|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029356|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029357|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029358|NCT01961947|Vaccines|vaccines|mesh-list
15029359|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
15029360|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029361|NCT01962116|Heparin|heparin|mesh-list
15029362|NCT01962116|Calcium heparin|calcium heparin|mesh-list
15029363|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
15029364|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029365|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15029366|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15029367|NCT01962181|Methylphenidate|methylphenidate|mesh-list
15029368|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15029369|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029370|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15029371|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15029372|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029373|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029374|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
15029375|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029376|NCT01962285|Propofol|propofol|mesh-list
15029377|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14974089|NCT01687127|Folic Acid|folic acid|mesh-list
14974090|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
14974091|NCT01687127|Calcium|calcium|mesh-list
14974092|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14974093|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974094|NCT01687127|Hematinics|hematinics|mesh-ancestor
14974095|NCT01687127|Vitamins|vitamins|mesh-ancestor
14974096|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
14974097|NCT01687140|Cycloserine|cycloserine|mesh-list
14974098|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14974099|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974100|NCT01687140|Renal Agents|renal agents|mesh-ancestor
14974101|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14974102|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
14974103|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974104|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
14974105|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974106|NCT01687205|Tenofovir|tenofovir|mesh-list
14974107|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
14974108|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974109|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14974110|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14974111|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974112|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974113|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14974114|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14974115|NCT01687348|Lidocaine|lidocaine|mesh-list
14974116|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
14974117|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
14974118|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974119|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974120|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
14974121|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974122|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14974123|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14974124|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14974125|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974126|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974127|NCT01687374|Hormones|hormones|mesh-list
14974128|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
14974129|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974130|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974131|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14974132|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14974133|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14974134|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14974135|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14974136|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14974137|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
14974138|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974139|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974140|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974141|NCT01687439|Vinorelbine|vinorelbine|mesh-list
14974142|NCT01687439|Endostar protein|endostar protein|mesh-list
14974143|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974144|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14974145|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
14974146|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
14974147|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
14974148|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974149|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14974150|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14974151|NCT01687439|Growth Substances|growth substances|mesh-ancestor
14974152|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974153|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
14974154|NCT01687491|Enoxaparin|enoxaparin|mesh-list
14974155|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
14974156|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14974157|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14974158|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974159|NCT01687517|Vaccines|vaccines|mesh-list
14974160|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
14974161|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974162|NCT01687582|Liraglutide|liraglutide|mesh-list
14974163|NCT01687582|Exenatide|exenatide|mesh-list
14974164|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14974165|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974166|NCT01687582|Incretins|incretins|mesh-ancestor
14974167|NCT01687582|Hormones|hormones|mesh-ancestor
14974168|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974169|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14974170|NCT01687699|Spironolactone|spironolactone|mesh-list
14974171|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14974172|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
14974173|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974174|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974175|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14974176|NCT01687699|Diuretics|diuretics|mesh-ancestor
14974177|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
14974178|NCT01687751|Midazolam|midazolam|mesh-list
14974179|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
14974180|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14974181|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974182|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974183|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974184|NCT01687751|Analgesics|analgesics|mesh-ancestor
14974185|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
14974186|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974187|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14974188|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14974189|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14974190|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
14974191|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974192|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974193|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14974194|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14974195|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14974196|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14974197|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14974198|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
14974199|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
14974200|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
14974201|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
14974202|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
14974203|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14974204|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974205|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974206|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974207|NCT01687868|Analgesics|analgesics|mesh-ancestor
14974208|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
14974209|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974210|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14974211|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14974212|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14974213|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
14974214|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974215|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974216|NCT01687894|Vasopressins|vasopressins|mesh-list
14974217|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
14974218|NCT01687894|Propofol|propofol|mesh-list
14974219|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
14974220|NCT01687894|Sevoflurane|sevoflurane|mesh-list
14974221|NCT01687894|Anesthetics|anesthetics|mesh-list
14974222|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
14974223|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14974224|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974225|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974226|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14974227|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14974228|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
14974229|NCT01687894|Coagulants|coagulants|mesh-ancestor
14974230|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14974231|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14974232|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
14974233|NCT01688024|Mitomycins|mitomycins|mesh-list
14974234|NCT01688024|Mitomycin|mitomycin|mesh-list
14974235|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14974236|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974237|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
14974238|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974239|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14974240|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974241|NCT01688089|Levodopa|levodopa|mesh-list
14974242|NCT01688089|Carbidopa|carbidopa|mesh-list
14974243|NCT01688089|Entacapone|entacapone|mesh-list
14974244|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14974245|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14974246|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
14974247|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974248|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974249|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974250|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14974251|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974252|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14974253|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
14974254|NCT01688154|Procyanidin|procyanidin|mesh-list
14974255|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
14974256|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974257|NCT01688154|Protective Agents|protective agents|mesh-ancestor
14974258|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974259|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14974260|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14974261|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974262|NCT01688206|Atezolizumab|atezolizumab|mesh-list
14974263|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974264|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
14974265|NCT01688349|Hormones|hormones|mesh-ancestor
14974266|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974267|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974268|NCT01688362|Dexamethasone|dexamethasone|mesh-list
14974269|NCT01688362|Bupivacaine|bupivacaine|mesh-list
14974270|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974271|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
14974272|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
14974273|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974274|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974275|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974276|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
14974277|NCT01688362|Hormones|hormones|mesh-ancestor
14974278|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974279|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14974280|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974281|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
14974282|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
14974283|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974284|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
14974285|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14974286|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14974287|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974288|NCT01688401|Melphalan|melphalan|mesh-list
14974289|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14974290|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
14974291|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974292|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974293|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14974294|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14974295|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
14974296|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974297|NCT01688492|Ipilimumab|ipilimumab|mesh-list
14974298|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14974299|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974300|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14974301|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974302|NCT01688518|Lidocaine|lidocaine|mesh-list
14974303|NCT01688518|Tetracaine|tetracaine|mesh-list
14974304|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
14974305|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
14974306|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974307|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974308|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
14974309|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974310|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14974311|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14974312|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14974313|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974314|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974315|NCT01688544|Benzimidazole|benzimidazole|mesh-list
14974316|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
14974317|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14974318|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974319|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
14974320|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14974321|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14974322|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14974323|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974324|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974325|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974326|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974327|NCT01688570|Analgesics|analgesics|mesh-ancestor
14974328|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
14974329|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974330|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
14974331|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14974332|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
14974333|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
14974334|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
14974335|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974336|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14974337|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
14974338|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
14974339|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14974340|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
14974341|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14974342|NCT01688583|Fentanyl|fentanyl|mesh-list
14974343|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14974344|NCT01688583|Narcotics|narcotics|mesh-ancestor
14974345|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974346|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974347|NCT01688583|Analgesics|analgesics|mesh-ancestor
14974348|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
14974349|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974350|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14974351|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14974352|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
14974353|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
14974354|NCT01688648|Lidocaine|lidocaine|mesh-list
14974355|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
14974356|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
14974357|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
14974358|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974359|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974360|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
14974361|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974362|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14974363|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14974364|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14974365|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974366|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974367|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14974368|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974369|NCT01688648|Analgesics|analgesics|mesh-ancestor
14974370|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14974371|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14974372|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14974373|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
14974374|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974375|NCT01688700|Paclitaxel|paclitaxel|mesh-list
14974376|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
14974377|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14974378|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974379|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14974380|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14974381|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14974382|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974383|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14974384|NCT01688791|Paclitaxel|paclitaxel|mesh-list
14974385|NCT01688791|Carboplatin|carboplatin|mesh-list
14974386|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14974387|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974388|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
14974389|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
14974390|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
14974391|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974392|NCT01688934|Naproxen|naproxen|mesh-list
14974393|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14974394|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974395|NCT01688934|Analgesics|analgesics|mesh-ancestor
14974396|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
14974397|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974398|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974399|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974400|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14974401|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
14974402|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14974403|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974404|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974405|NCT01688947|Pregabalin|pregabalin|mesh-list
14974406|NCT01688947|Analgesics|analgesics|mesh-ancestor
14974407|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
14974408|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974409|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974410|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
14974411|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14974412|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974413|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974414|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14974415|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14974416|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14974417|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974418|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14974419|NCT01688960|Aflibercept|aflibercept|mesh-list
14974420|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14974421|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14974422|NCT01688960|Growth Substances|growth substances|mesh-ancestor
14974423|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974424|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
14974425|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029378|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029379|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029380|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15029381|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
15029382|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
15029383|NCT01962363|Tocotrienols|tocotrienols|mesh-list
15029384|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
15029385|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
15029386|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029387|NCT01962363|Protective Agents|protective agents|mesh-ancestor
15029388|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029389|NCT01962363|Vitamins|vitamins|mesh-ancestor
15029390|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
15029391|NCT01962376|Bevacizumab|bevacizumab|mesh-list
15029392|NCT01962376|Capecitabine|capecitabine|mesh-list
15029393|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
15029394|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15029395|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029396|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15029397|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15029398|NCT01962376|Growth Substances|growth substances|mesh-ancestor
15029399|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029400|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
15029401|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15029402|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
15029403|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029404|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
15029405|NCT01962454|Testosterone|testosterone|mesh-list
15029406|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
15029407|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
15029408|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15029409|NCT01962454|Androgens|androgens|mesh-ancestor
15029410|NCT01962454|Hormones|hormones|mesh-ancestor
15029411|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974426|NCT01689051|Glucagon|glucagon|mesh-list
14974427|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14974428|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974429|NCT01689051|Hormones|hormones|mesh-ancestor
14974430|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974431|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974432|NCT01689051|Incretins|incretins|mesh-ancestor
14974433|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
14974434|NCT01689090|Citric Acid|citric acid|mesh-list
14974435|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
14974436|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14974437|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
14974438|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14974439|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
14974440|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
14974441|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974442|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14974443|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974444|NCT01689090|Analgesics|analgesics|mesh-ancestor
14974445|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
14974446|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974447|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974448|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974449|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14974450|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974451|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
14974452|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14974453|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974454|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974455|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14974456|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14974457|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974458|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974459|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974460|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14974461|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
14974462|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14974463|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974464|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14974465|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14974466|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14974467|NCT01689129|Insulin|insulin|mesh-list
14974468|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14974469|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
14974470|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14974471|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974472|NCT01689142|Insulin|insulin|mesh-list
14974473|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14974474|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
14974475|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14974476|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974477|NCT01689194|Cisplatin|cisplatin|mesh-list
14974478|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974479|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
14974480|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14974481|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
14974482|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14974483|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14974484|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974485|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14974486|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974487|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14974488|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974489|NCT01689285|Valacyclovir|valacyclovir|mesh-list
14974490|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
14974491|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974492|NCT01689298|Oxytocin|oxytocin|mesh-list
14974493|NCT01689298|Carbetocin|carbetocin|mesh-list
14974494|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
14974495|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14974496|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974497|NCT01689311|Alprostadil|alprostadil|mesh-list
14974498|NCT01689311|Misoprostol|misoprostol|mesh-list
14974499|NCT01689311|Oxytocin|oxytocin|mesh-list
14974500|NCT01689311|Ergonovine|ergonovine|mesh-list
14974501|NCT01689311|Dinoprost|dinoprost|mesh-list
14974502|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
14974503|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
14974504|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14974505|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974506|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14974507|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
14974508|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14974509|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974510|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14974511|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14974512|NCT01689311|Urological Agents|urological agents|mesh-ancestor
14974513|NCT01689558|Endostatins|endostatins|mesh-list
14974514|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974515|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14974516|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14974517|NCT01689558|Growth Substances|growth substances|mesh-ancestor
14974518|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974519|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
14974520|NCT01689597|Morphine|morphine|mesh-list
14974521|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14974522|NCT01689597|Narcotics|narcotics|mesh-ancestor
14974523|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974524|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974525|NCT01689597|Analgesics|analgesics|mesh-ancestor
14974526|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
14974527|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974528|NCT01689623|Simeprevir|simeprevir|mesh-list
14974529|NCT01689623|Atorvastatin|atorvastatin|mesh-list
14974530|NCT01689623|Simvastatin|simvastatin|mesh-list
14974531|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14974532|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14974533|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
14974534|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974535|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14974536|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14974537|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974538|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
14974539|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974540|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
14974541|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
14974542|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14974543|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974544|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
14974545|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14974546|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974547|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
14974548|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14974549|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974550|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
14974551|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14974552|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974553|NCT01689753|Citric Acid|citric acid|mesh-list
14974554|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
14974555|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
14974556|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14974557|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
14974558|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
14974559|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974560|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
14974561|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14974562|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974563|NCT01689870|Ipilimumab|ipilimumab|mesh-list
14974564|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14974565|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974566|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14974567|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974568|NCT01689896|Testosterone|testosterone|mesh-list
14974569|NCT01689896|Androgens|androgens|mesh-ancestor
14974570|NCT01689896|Hormones|hormones|mesh-ancestor
14974571|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974572|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974573|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14974574|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14974575|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
14974576|NCT01689987|Sirolimus|sirolimus|mesh-list
14974577|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
14974578|NCT01689987|Dexamethasone|dexamethasone|mesh-list
14974579|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
14974580|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
14974581|NCT01689987|Ichthammol|ichthammol|mesh-list
14974582|NCT01689987|BB 1101|bb 1101|mesh-list
14974583|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14974584|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
14974585|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974586|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14974587|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14974588|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
14974589|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974590|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974591|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14974592|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974593|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
14974594|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
14974595|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974596|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974597|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
14974598|NCT01689987|Hormones|hormones|mesh-ancestor
14974599|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974600|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14974601|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974602|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974603|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14974604|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
14974605|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
14974606|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14974607|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14974608|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974609|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
14974610|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
14974611|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
14974612|NCT01690039|Furosemide|furosemide|mesh-list
14974613|NCT01690039|Diuretics|diuretics|mesh-ancestor
14974614|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
14974615|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974616|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14974617|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974618|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974619|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974620|NCT01690091|Metformin|metformin|mesh-list
14974621|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14974622|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974623|NCT01690104|Rifampin|rifampin|mesh-list
14974624|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14974625|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
14974626|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974627|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974628|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
14974629|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14974630|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974631|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974632|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14974633|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14974634|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14974635|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14974636|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14974637|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14974638|NCT01690221|Diltiazem|diltiazem|mesh-list
14974639|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14974640|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14974641|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974642|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974643|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14974644|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974645|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
14974646|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14974647|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
14974648|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974649|NCT01690286|Ketoconazole|ketoconazole|mesh-list
14974650|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
14974651|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974652|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14974653|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14974654|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974655|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974656|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14974657|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
14974658|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974659|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974660|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14974661|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
14974662|NCT01690325|Bevacizumab|bevacizumab|mesh-list
14974663|NCT01690325|Docetaxel|docetaxel|mesh-list
14236513|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974664|NCT01690325|Trastuzumab|trastuzumab|mesh-list
14974665|NCT01690325|Epirubicin|epirubicin|mesh-list
14974666|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14974667|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
14974668|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974669|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14974670|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14974671|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
14974672|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974673|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974674|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14974675|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14974676|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14974677|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14974678|NCT01690325|Growth Substances|growth substances|mesh-ancestor
14974679|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
14974680|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
14974681|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
14974682|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
14974683|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14974684|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14974685|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14974686|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974687|NCT01690338|Bromides|bromides|mesh-list
14974688|NCT01690338|Rocuronium|rocuronium|mesh-list
14974689|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
14974690|NCT01690338|Cisatracurium|cisatracurium|mesh-list
14974691|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
14974692|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14974693|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14974694|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14974695|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974696|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974697|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14974698|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14974699|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
14974700|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974701|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974702|NCT01690364|Anesthetics|anesthetics|mesh-list
14974703|NCT01690364|Cisatracurium|cisatracurium|mesh-list
14974704|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
14974705|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974706|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974707|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14974708|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14974709|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974710|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14974711|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14974712|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14974713|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
14974714|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974715|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974716|NCT01690403|Rifapentine|rifapentine|mesh-list
14974717|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14974718|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
14974719|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974720|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974721|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
14974722|NCT01690468|Carboplatin|carboplatin|mesh-list
14974723|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974724|NCT01690507|Cytarabine|cytarabine|mesh-list
14974725|NCT01690507|Decitabine|decitabine|mesh-list
14974726|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
14974727|NCT01690507|Sargramostim|sargramostim|mesh-list
14974728|NCT01690507|Lenograstim|lenograstim|mesh-list
14974729|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14974730|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
14974731|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974732|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974733|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
14974734|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974735|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14974736|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
14974737|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974738|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974739|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14974740|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14974741|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
14974742|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14974743|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974744|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974745|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14974746|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14974747|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974748|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974749|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974750|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14974751|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
14974752|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14974753|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974754|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14974755|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14974756|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14974757|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
14974758|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14974759|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974760|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14974761|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14974762|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974763|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974764|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974765|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14974766|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14974767|NCT01690572|Paclitaxel|paclitaxel|mesh-list
14974768|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
14974769|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14974770|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974771|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
14974772|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
14974773|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
14974774|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974775|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14974776|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
14974777|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974778|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
14974779|NCT01690572|Protective Agents|protective agents|mesh-ancestor
14974780|NCT01690598|Topotecan|topotecan|mesh-list
14974781|NCT01690598|Veliparib|veliparib|mesh-list
14974782|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14974783|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14974784|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974785|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974786|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974787|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14974788|NCT01690637|Oseltamivir|oseltamivir|mesh-list
14974789|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
14974790|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14974791|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974792|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029412|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029413|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15029414|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029415|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
15029416|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
15029417|NCT01962571|Hematinics|hematinics|mesh-ancestor
15029418|NCT01962636|Cyclosporine|cyclosporine|mesh-list
15029419|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
15029420|NCT01962636|Fludarabine|fludarabine|mesh-list
15029421|NCT01962636|Cyclosporins|cyclosporins|mesh-list
15029422|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029423|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
15029424|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029425|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029426|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15029427|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
15029428|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029429|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029430|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14974793|NCT01690702|Paclitaxel|paclitaxel|mesh-list
14974794|NCT01690702|Docetaxel|docetaxel|mesh-list
14974795|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
14974796|NCT01690702|Epirubicin|epirubicin|mesh-list
14974797|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14974798|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974799|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
14974800|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14974801|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14974802|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974803|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14974804|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
14974805|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974806|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14974807|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14974808|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
14974809|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14974810|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14974811|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14974812|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14974813|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974814|NCT01690767|Lidocaine|lidocaine|mesh-list
14974815|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
14974816|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
14974817|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974818|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974819|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
14974820|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974821|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14974822|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14974823|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14974824|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974825|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974826|NCT01690780|Ibuprofen|ibuprofen|mesh-list
14974827|NCT01690780|Morphine|morphine|mesh-list
14974828|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14974829|NCT01690780|Narcotics|narcotics|mesh-ancestor
14974830|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974831|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974832|NCT01690780|Analgesics|analgesics|mesh-ancestor
14974833|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
14974834|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974835|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14974836|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974837|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974838|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14974839|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14974840|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974841|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974842|NCT01690832|Fenoldopam|fenoldopam|mesh-list
14974843|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14974844|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
14974845|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
14974846|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
14974847|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974848|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974849|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974850|NCT01690871|Dactolisib|dactolisib|mesh-list
14974851|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974852|NCT01690884|Adenosine|adenosine|mesh-list
14974853|NCT01690884|Analgesics|analgesics|mesh-ancestor
14974854|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
14974855|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974856|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974857|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14974858|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
14974859|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14974860|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
14974861|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
14974862|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974863|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974864|NCT01690962|Vitamins|vitamins|mesh-list
14974865|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
14974866|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
14974867|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
14974868|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
14974869|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974870|NCT01690962|Hematinics|hematinics|mesh-ancestor
14974871|NCT01690975|Benzonatate|benzonatate|mesh-list
14974872|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
14974873|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
14974874|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
14974875|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14974876|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974877|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974878|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14974879|NCT01691001|Analgesics|analgesics|mesh-ancestor
14974880|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
14974881|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974882|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14974883|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14974884|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14974885|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
14974886|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974887|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974888|NCT01691053|Spironolactone|spironolactone|mesh-list
14974889|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14974890|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
14974891|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974892|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974893|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14974894|NCT01691053|Diuretics|diuretics|mesh-ancestor
14974895|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
14974896|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
14974897|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
14974898|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974899|NCT01691365|Vitamins|vitamins|mesh-list
14974900|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
14974901|NCT01691365|Antioxidants|antioxidants|mesh-list
14974902|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
14974903|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974904|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974905|NCT01691365|Protective Agents|protective agents|mesh-ancestor
14974906|NCT01691404|Quercetin|quercetin|mesh-list
14974907|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
14974908|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974909|NCT01691404|Protective Agents|protective agents|mesh-ancestor
14974910|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974911|NCT01691456|Montelukast|montelukast|mesh-list
14974912|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14974913|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
14974914|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14974915|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
14974916|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974917|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974918|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14974919|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14974920|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974921|NCT01691469|Montelukast|montelukast|mesh-list
14974922|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14974923|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
14974924|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14974925|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
14974926|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974927|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974928|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14974929|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14974930|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974931|NCT01691495|PENTA|penta|mesh-list
14974932|NCT01691495|Fondaparinux|fondaparinux|mesh-list
14974933|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14974934|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
14974935|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14974936|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
14974937|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14974938|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974939|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
14974940|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14974941|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14974942|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
14974943|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14974944|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14974945|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14974946|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974947|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974948|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
14974949|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974950|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974951|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14974952|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974953|NCT01691677|Beclomethasone|beclomethasone|mesh-list
14974954|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14974955|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
14974956|NCT01691677|Hormones|hormones|mesh-ancestor
14974957|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974958|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974959|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14974960|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
14974961|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14974962|NCT01691742|Laxatives|laxatives|mesh-list
14974963|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974964|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14974965|NCT01691807|Ofatumumab|ofatumumab|mesh-list
14974966|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14974967|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
14974968|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974969|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14974970|NCT01691872|Ezogabine|ezogabine|mesh-list
14974971|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
14974972|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14974973|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14974974|NCT01691937|Sufentanil|sufentanil|mesh-list
14974975|NCT01691937|Ropivacaine|ropivacaine|mesh-list
14974976|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
14974977|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
14974978|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14974979|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974980|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
14974981|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14974982|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14974983|NCT01691937|Narcotics|narcotics|mesh-ancestor
14974984|NCT01691937|Analgesics|analgesics|mesh-ancestor
14974985|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14974986|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14974987|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
14974988|NCT01691976|Estrogens|estrogens|mesh-list
14974989|NCT01691976|Hormones|hormones|mesh-ancestor
14974990|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14974991|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14974992|NCT01692132|Prucalopride|prucalopride|mesh-list
14974993|NCT01692132|Laxatives|laxatives|mesh-ancestor
14974994|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14974995|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14974996|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14974997|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
14974998|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14974999|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975000|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975001|NCT01692158|Heparin|heparin|mesh-list
14975002|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14975003|NCT01692158|Tinzaparin|tinzaparin|mesh-list
14975004|NCT01692158|Dalteparin|dalteparin|mesh-list
14975005|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
14975006|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14975007|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14975008|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975009|NCT01692171|Heparin|heparin|mesh-list
14975010|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14975011|NCT01692171|Tinzaparin|tinzaparin|mesh-list
14975012|NCT01692171|Dalteparin|dalteparin|mesh-list
14975013|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
14975014|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14975015|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14975016|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975017|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
14975018|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14975019|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975020|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975021|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975022|NCT01692210|Analgesics|analgesics|mesh-ancestor
14975023|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
14975024|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523123|NCT03572972|Apixaban|apixaban|mesh-list
14523124|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
14523125|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14523126|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
14523127|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14523128|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
14523129|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523130|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523131|NCT03573323|Ixekizumab|ixekizumab|mesh-list
14523132|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
14523133|NCT03573908|Linaclotide|linaclotide|mesh-list
14523134|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14523135|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
14523136|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523137|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523138|NCT03574818|Gemcitabine|gemcitabine|mesh-list
14975025|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14975026|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14975027|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975028|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975029|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975030|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975031|NCT01692457|Golimumab|golimumab|mesh-list
14975032|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14975033|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975034|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975035|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
14975036|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975037|NCT01692483|Prednisone|prednisone|mesh-list
14975038|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
14975039|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975040|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
14975041|NCT01692483|Hormones|hormones|mesh-ancestor
14975042|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029431|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523139|NCT03574818|Necitumumab|necitumumab|mesh-list
14975043|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975044|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14975045|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975046|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14975047|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975048|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975049|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
14975050|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15029432|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
15029433|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029434|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029435|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15029436|NCT01962831|Dinoprostone|dinoprostone|mesh-list
15029437|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
15029438|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15029439|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029440|NCT01962948|Paclitaxel|paclitaxel|mesh-list
15029441|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15029442|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029443|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
15029444|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
15029445|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
15029446|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523140|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523141|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14523142|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
14523143|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523144|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
14523145|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029447|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
15029448|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
15029449|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15029450|NCT01963039|Protective Agents|protective agents|mesh-ancestor
15029451|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029452|NCT01963182|Irinotecan|irinotecan|mesh-list
15029453|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15029454|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15029455|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029456|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029457|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029458|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15029459|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15029460|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035132|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15035133|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15035134|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15035135|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035136|NCT01999647|Ropivacaine|ropivacaine|mesh-list
15035137|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
15035138|NCT01999647|Anesthetics|anesthetics|mesh-list
15035139|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035140|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035141|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
15035142|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035143|NCT01999673|Docetaxel|docetaxel|mesh-list
15035144|NCT01999673|Bavituximab|bavituximab|mesh-list
15035145|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15035146|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035147|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035148|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035149|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035150|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035151|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15035152|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
15035153|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035154|NCT01999686|Metformin|metformin|mesh-list
15035155|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15035156|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035157|NCT01999738|Folic Acid|folic acid|mesh-list
15035158|NCT01999738|Hematinics|hematinics|mesh-ancestor
15035159|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
15035160|NCT01999738|Vitamins|vitamins|mesh-ancestor
15035161|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
15035162|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975051|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14975052|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14975053|NCT01692678|Dacarbazine|dacarbazine|mesh-list
14975054|NCT01692678|Trabectedin|trabectedin|mesh-list
14975055|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14975056|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
14975057|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975058|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975059|NCT01692704|Gemcitabine|gemcitabine|mesh-list
14975060|NCT01692704|Floxuridine|floxuridine|mesh-list
14975061|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975062|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14975063|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
14975064|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975065|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
14975066|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975067|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975068|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975069|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
14975070|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975071|NCT01692717|Losartan|losartan|mesh-list
14975072|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14975073|NCT01692717|Atorvastatin|atorvastatin|mesh-list
14975074|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14975075|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14975076|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
14975077|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975078|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14975079|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14975080|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975081|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14975082|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14975083|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14975084|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14975085|NCT01692717|Diuretics|diuretics|mesh-ancestor
14975086|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
14975087|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975088|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14975089|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975090|NCT01692808|Vitamin D|vitamin d|mesh-list
14975091|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
14975092|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
14975093|NCT01692808|Vitamins|vitamins|mesh-list
14975094|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
14975095|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975096|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14975097|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14975098|NCT01692834|Cyclosporine|cyclosporine|mesh-list
14975099|NCT01692834|Cyclosporins|cyclosporins|mesh-list
14975100|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975101|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975102|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975103|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
14975104|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975105|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
14975106|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975107|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14975108|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975109|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14975110|NCT01692886|Vaccines|vaccines|mesh-list
14975111|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14975112|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
14975113|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975114|NCT01692925|Factor VIII|factor viii|mesh-list
14975115|NCT01692925|Coagulants|coagulants|mesh-ancestor
14975116|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
14975117|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14975118|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
14975119|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975120|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975121|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14975122|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
14975123|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
14975124|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14975125|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
14975126|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975127|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975128|NCT01693081|Apomorphine|apomorphine|mesh-list
14975129|NCT01693081|Emetics|emetics|mesh-ancestor
14975130|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975131|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
14975132|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975133|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14975134|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
14975135|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
14975136|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975137|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975138|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
14975139|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
14975140|NCT01693159|Coagulants|coagulants|mesh-ancestor
14975141|NCT01693276|Gemcitabine|gemcitabine|mesh-list
14975142|NCT01693276|Paclitaxel|paclitaxel|mesh-list
14975143|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14975144|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14975145|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975146|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
14975147|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
14975148|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
14975149|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975150|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14975151|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
14975152|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
14975153|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975154|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975155|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975156|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
14975157|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975158|NCT01693289|Metformin|metformin|mesh-list
14975159|NCT01693289|Letrozole|letrozole|mesh-list
14975160|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14975161|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975162|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975163|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14975164|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14975165|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975166|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975167|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14975168|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
14975169|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975170|NCT01693302|Insulin|insulin|mesh-list
14975171|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14975172|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14975173|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975174|NCT01693328|Fentanyl|fentanyl|mesh-list
14975175|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14975176|NCT01693328|Narcotics|narcotics|mesh-ancestor
14975177|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975178|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975179|NCT01693328|Analgesics|analgesics|mesh-ancestor
14975180|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
14975181|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975182|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14975183|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14975184|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
14975185|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
14975186|NCT01693380|Vaccines|vaccines|mesh-list
14975187|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
14975188|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975189|NCT01693393|Cyclosporine|cyclosporine|mesh-list
14975190|NCT01693393|Cyclosporins|cyclosporins|mesh-list
14975191|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975192|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975193|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975194|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
14975195|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975196|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
14975197|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975198|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
14975199|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975200|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14975201|NCT01693419|Gemcitabine|gemcitabine|mesh-list
14975202|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14975203|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14975204|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
14975205|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975206|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975207|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
14975208|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975209|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975210|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975211|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
14975212|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975213|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14975214|NCT01693432|Docetaxel|docetaxel|mesh-list
14975215|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975216|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
14975217|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
14975218|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
14975219|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975220|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
14975221|NCT01693445|Irinotecan|irinotecan|mesh-list
14975222|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975223|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14975224|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14975225|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975226|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975227|NCT01693601|Panobinostat|panobinostat|mesh-list
14975228|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975229|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14975230|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975231|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975232|NCT01693640|Abatacept|abatacept|mesh-list
14975233|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14975234|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975235|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975236|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975237|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
14975238|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975239|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975240|NCT01693679|Lamivudine|lamivudine|mesh-list
14975241|NCT01693679|Adefovir|adefovir|mesh-list
14975242|NCT01693679|Telbivudine|telbivudine|mesh-list
14975243|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14975244|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14975245|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975246|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975247|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
14975248|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975249|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14975250|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14975251|NCT01693718|Fluorouracil|fluorouracil|mesh-list
14975252|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
14975253|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975254|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
14975255|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975256|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14975257|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975258|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
14975259|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975260|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
14975261|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975262|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14975263|NCT01693809|Caffeine|caffeine|mesh-list
14975264|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14975265|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975266|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14975267|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975268|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975269|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14975270|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14975271|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
14975272|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975273|NCT01693822|Axitinib|axitinib|mesh-list
14975274|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975275|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14975276|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975277|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975278|NCT01694017|Tenofovir|tenofovir|mesh-list
14975279|NCT01694017|Zidovudine|zidovudine|mesh-list
14975280|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
14975281|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975282|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14975283|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14975284|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975285|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975286|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14975287|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14975288|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
14975289|NCT05289804|Lidocaine|lidocaine|mesh-list
14975290|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
14975291|NCT05289804|Prilocaine|prilocaine|mesh-list
14975292|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14975293|NCT05289804|Anesthetics|anesthetics|mesh-list
14975294|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975295|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975296|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
14975297|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975298|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14975299|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14975300|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14975301|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975302|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975303|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15029461|NCT01963299|Clonidine|clonidine|mesh-list
15029462|NCT01963299|Ropivacaine|ropivacaine|mesh-list
15029463|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029464|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
15029465|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029466|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029467|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
15029468|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029469|NCT01963299|Analgesics|analgesics|mesh-ancestor
15029470|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15029471|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
15029472|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
15029473|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15029474|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15029475|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15029476|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
15029477|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029478|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029479|NCT01963325|Paclitaxel|paclitaxel|mesh-list
15029480|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15029481|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15029482|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029483|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
15029484|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
15029485|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
15029486|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029487|NCT01963390|Testosterone|testosterone|mesh-list
15029488|NCT01963390|Androgens|androgens|mesh-ancestor
15029489|NCT01963390|Hormones|hormones|mesh-ancestor
15029490|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029491|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029492|NCT01963416|Micronutrients|micronutrients|mesh-list
15029493|NCT01963416|Trace Elements|trace elements|mesh-list
15029494|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029495|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15029496|NCT01963442|Lactams|lactams|mesh-list
15029497|NCT01963442|beta-Lactams|beta-lactams|mesh-list
15029498|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15029499|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029500|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15029501|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029502|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029503|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
15029504|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035163|NCT01999829|Caffeine|caffeine|mesh-list
14975304|NCT05289687|Daratumumab|daratumumab|mesh-list
14975305|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14975306|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975307|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
14975308|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975309|NCT05289648|Niraparib|niraparib|mesh-list
14975310|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14975311|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975312|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975313|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975314|NCT05289492|Dexamethasone|dexamethasone|mesh-list
14975315|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975316|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
14975317|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
14975318|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975319|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975320|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14975321|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
14975322|NCT05289492|Hormones|hormones|mesh-ancestor
14975323|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975324|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14975325|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975326|NCT05289440|Esketamine|esketamine|mesh-list
14975327|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
14975328|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14975329|NCT05289063|Atorvastatin|atorvastatin|mesh-list
14975330|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14975331|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14975332|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
14975333|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975334|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14975335|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14975336|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975337|NCT05288907|Lidocaine|lidocaine|mesh-list
14975338|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
14975339|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
14975340|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975341|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975342|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
14975343|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975344|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14975345|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14975346|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14975347|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975348|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975349|NCT05288829|Ravulizumab|ravulizumab|mesh-list
14975350|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14975351|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975352|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
14975353|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975354|NCT05288816|Ravulizumab|ravulizumab|mesh-list
14975355|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14975356|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975357|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
14975358|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975359|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
14975360|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14975361|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975362|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975363|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975364|NCT05288738|Analgesics|analgesics|mesh-ancestor
14975365|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
14975366|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975367|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14975368|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14975369|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975370|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975371|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975372|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975373|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14975374|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975375|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
14975376|NCT05288725|Hormones|hormones|mesh-ancestor
14975377|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975378|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975379|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975380|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
14975381|NCT05288673|Ravulizumab|ravulizumab|mesh-list
14975382|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14975383|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14236514|NCT00115063|Orlistat|orlistat|mesh-list
14800682|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14800683|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800684|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14800685|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14800686|NCT00789308|Cyclosporine|cyclosporine|mesh-list
14800687|NCT00789308|Sirolimus|sirolimus|mesh-list
14800688|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
14800689|NCT00789308|Etanercept|etanercept|mesh-list
14800690|NCT00789308|Heparin|heparin|mesh-list
14800691|NCT00789308|Dextrans|dextrans|mesh-list
14800692|NCT00789308|Tacrolimus|tacrolimus|mesh-list
14800693|NCT00789308|Cyclosporins|cyclosporins|mesh-list
14800694|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
14800695|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14800696|NCT00789308|Basiliximab|basiliximab|mesh-list
14800697|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800698|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
14800699|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800700|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14800701|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800702|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800703|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
14800704|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800705|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
14800706|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14800707|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14800708|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800709|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14800710|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
14800711|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800712|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
14800713|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14800714|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14800715|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14800716|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14800717|NCT00789308|Analgesics|analgesics|mesh-ancestor
14800718|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
14800719|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800720|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14800721|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14800722|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
14800723|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
14800724|NCT00789386|Midazolam|midazolam|mesh-list
14800725|NCT00789386|Remifentanil|remifentanil|mesh-list
14800726|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14800727|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14800728|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800729|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800730|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14800731|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14800732|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800733|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14800734|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
14800735|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
14800736|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
14800737|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
14800738|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800739|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800740|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14800741|NCT00789386|Narcotics|narcotics|mesh-ancestor
14800742|NCT00789386|Analgesics|analgesics|mesh-ancestor
14800743|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
14800744|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800745|NCT00789399|PENTA|penta|mesh-list
14800746|NCT00789399|Fondaparinux|fondaparinux|mesh-list
14800747|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14800748|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
14800749|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14800750|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
14800751|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800752|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800753|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
14800754|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14800755|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14800756|NCT00789464|Trimethoprim|trimethoprim|mesh-list
14800757|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
14975384|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
14975385|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975386|NCT05288660|Ravulizumab|ravulizumab|mesh-list
14975387|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14975388|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975389|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
14975390|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975391|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
14975392|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14975393|NCT05288465|Protective Agents|protective agents|mesh-ancestor
14975394|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975395|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
14975396|NCT05288400|Amlodipine|amlodipine|mesh-list
14975397|NCT05288400|Bisoprolol|bisoprolol|mesh-list
14975398|NCT05288400|Perindopril|perindopril|mesh-list
14975399|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14975400|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14975401|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975402|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975403|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14975404|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975405|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
14975406|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
14975407|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
14975408|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975409|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14975410|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14975411|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14975412|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975413|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975414|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14975415|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
14975416|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975417|NCT05288374|Celecoxib|celecoxib|mesh-list
14975418|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14975419|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975420|NCT05288374|Analgesics|analgesics|mesh-ancestor
14975421|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
14975422|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975423|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975424|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975425|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975426|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14975427|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14975428|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975429|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975430|NCT05288335|Methamphetamine|methamphetamine|mesh-list
14975431|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14975432|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975433|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
14975434|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
14975435|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975436|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
14975437|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975438|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975439|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975440|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14975441|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14975442|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975443|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14975444|NCT05288283|Cannabidiol|cannabidiol|mesh-list
14975445|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
14975446|NCT05288192|Triamcinolone|triamcinolone|mesh-list
14975447|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14975448|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14975449|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14975450|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975451|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
14975452|NCT05288192|Hormones|hormones|mesh-ancestor
14975453|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975454|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975455|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975456|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
14975457|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975458|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975459|NCT05288179|Pirfenidone|pirfenidone|mesh-list
14975460|NCT05288179|Analgesics|analgesics|mesh-ancestor
14975461|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
14975462|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975463|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975464|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14975465|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975466|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975467|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975468|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975469|NCT05288153|Metformin|metformin|mesh-list
14975470|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14975471|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975472|NCT05288127|Talazoparib|talazoparib|mesh-list
14975473|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14975474|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975475|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975476|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975477|NCT05291455|Lacosamide|lacosamide|mesh-list
14975478|NCT05291455|Phenobarbital|phenobarbital|mesh-list
14975479|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
14975480|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14975481|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14975482|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975483|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975484|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14975485|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975486|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975487|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14975488|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14975489|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975490|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
14975491|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
14975492|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14975493|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14975494|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14975495|NCT05291364|Ethanol|ethanol|mesh-list
14975496|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
14975497|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14975498|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975499|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975500|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975501|NCT05291364|Analgesics|analgesics|mesh-ancestor
14975502|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
14975503|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975504|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14975505|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14975506|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975507|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975508|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975509|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975510|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14975511|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975512|NCT05291338|Doxorubicin|doxorubicin|mesh-list
14975513|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
14975514|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14975515|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975516|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14975517|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14975518|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975519|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029505|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029506|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15029507|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15029508|NCT01963546|Analgesics|analgesics|mesh-ancestor
15029509|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
15029510|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029511|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15029512|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15029513|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975520|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14975521|NCT05291221|Lidocaine|lidocaine|mesh-list
14975522|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
14975523|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
14975524|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
14975525|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975526|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975527|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
14975528|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975529|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14975530|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14975531|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14975532|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975533|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975534|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14975535|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975536|NCT05291221|Analgesics|analgesics|mesh-ancestor
14975537|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14975538|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14975539|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975540|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975541|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975542|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14975543|NCT05291195|Eusol|eusol|mesh-list
14975544|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
14975545|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975546|NCT05291156|Cetuximab|cetuximab|mesh-list
14975547|NCT05291156|Avelumab|avelumab|mesh-list
14975548|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14975549|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975550|NCT05291130|Vitamin E|vitamin e|mesh-list
14975551|NCT05291130|Vitamins|vitamins|mesh-ancestor
14975552|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
14975553|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975554|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
14975555|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975556|NCT05291130|Protective Agents|protective agents|mesh-ancestor
14975557|NCT05291104|Folic Acid|folic acid|mesh-list
14975558|NCT05291104|Choline|choline|mesh-list
14975559|NCT05291104|Hematinics|hematinics|mesh-ancestor
14975560|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
14975561|NCT05291104|Vitamins|vitamins|mesh-ancestor
14975562|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
14975563|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975564|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
14975565|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14975566|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
14975567|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975568|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14975569|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14975570|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
14975571|NCT05291052|Capecitabine|capecitabine|mesh-list
14975572|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
14975573|NCT05291052|Lenvatinib|lenvatinib|mesh-list
14975574|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14975575|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
14975576|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975577|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975578|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14975579|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975580|NCT05291039|Adalimumab|adalimumab|mesh-list
14975581|NCT05291039|Infliximab|infliximab|mesh-list
14975582|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975583|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975584|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
14975585|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14975586|NCT05290948|Bevacizumab|bevacizumab|mesh-list
14975587|NCT05290948|Acetazolamide|acetazolamide|mesh-list
14975588|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14975589|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975590|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14975591|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14975592|NCT05290948|Growth Substances|growth substances|mesh-ancestor
14975593|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975594|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
14975595|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
14975596|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14975597|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800758|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14800759|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800760|NCT00789464|Renal Agents|renal agents|mesh-ancestor
14800761|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
14800762|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14800763|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14800764|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14800765|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029514|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975598|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975599|NCT05290948|Diuretics|diuretics|mesh-ancestor
14975600|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
14975601|NCT05290935|Paclitaxel|paclitaxel|mesh-list
14975602|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14975603|NCT05290935|Antibodies|antibodies|mesh-list
14975604|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14975605|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975606|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
14975607|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14975608|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
14975609|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975610|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
14975611|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975612|NCT05290857|Hemostatics|hemostatics|mesh-list
14975613|NCT05290857|Coagulants|coagulants|mesh-ancestor
14975614|NCT05290740|Norepinephrine|norepinephrine|mesh-list
14975615|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14975616|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975617|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975618|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975619|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975620|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975621|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
14975622|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
14975623|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975624|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14975625|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
14975626|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14975627|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
14975628|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975629|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
14975630|NCT05290727|Protective Agents|protective agents|mesh-ancestor
14975631|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
14975632|NCT05290662|Fludarabine|fludarabine|mesh-list
14975633|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975634|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
14975635|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975636|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975637|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14975638|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
14975639|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975640|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975641|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14975642|NCT05290506|Linagliptin|linagliptin|mesh-list
14975643|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14975644|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14975645|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975646|NCT05290506|Incretins|incretins|mesh-ancestor
14975647|NCT05290506|Hormones|hormones|mesh-ancestor
14975648|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975649|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
14975650|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975651|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975652|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
14975653|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
14975654|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975655|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975656|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
14975657|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975658|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14975659|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975660|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975661|NCT05290324|Midazolam|midazolam|mesh-list
14975662|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14975663|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14975664|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975665|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975666|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14975667|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14975668|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14975669|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14975670|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
14975671|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
14975672|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
14975673|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
14975674|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975675|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975676|NCT05290220|Lenvatinib|lenvatinib|mesh-list
14975677|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975678|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14975679|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975680|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975681|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14975682|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975683|NCT05290129|Oxytocin|oxytocin|mesh-list
14975684|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
14975685|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14975686|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975687|NCT05290116|Apatinib|apatinib|mesh-list
14975688|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975689|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14975690|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975691|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975692|NCT05290090|Rituximab|rituximab|mesh-list
14975693|NCT05290090|Lenalidomide|lenalidomide|mesh-list
14975694|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
14975695|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14975696|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975697|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
14975698|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975699|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975700|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14975701|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14975702|NCT05290090|Growth Substances|growth substances|mesh-ancestor
14975703|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
14975704|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14975705|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975706|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975707|NCT05290025|Nicotine|nicotine|mesh-list
14975708|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14975709|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
14975710|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975711|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975712|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14975713|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14975714|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
14975715|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975716|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029515|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029516|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029517|NCT01963559|Lidocaine|lidocaine|mesh-list
15029518|NCT01963559|Prilocaine|prilocaine|mesh-list
15029519|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15029520|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029521|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
15029522|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029523|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029524|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
15029525|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029526|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15029527|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15029528|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15029529|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029530|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029531|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15029532|NCT01963663|Metformin|metformin|mesh-list
15029533|NCT01963663|Pioglitazone|pioglitazone|mesh-list
15029534|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15029535|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029536|NCT01963702|Capecitabine|capecitabine|mesh-list
15029537|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
15029538|NCT01963702|Docetaxel|docetaxel|mesh-list
15029539|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15029540|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
15029541|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029542|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029543|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
15029544|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
14800766|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800767|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14800768|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14800769|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14800770|NCT00789503|Vitamin D|vitamin d|mesh-list
14800771|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
14800772|NCT00789503|Calcium|calcium|mesh-list
14800773|NCT00789503|Vitamins|vitamins|mesh-ancestor
14800774|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
14800775|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800776|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800777|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14800778|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
14800779|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14800780|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800781|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800782|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14800783|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14800784|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800785|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800786|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800787|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14800788|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
14800789|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14800790|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800791|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14800792|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14800793|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14800794|NCT00789620|Lidocaine|lidocaine|mesh-list
14800795|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
14800796|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
14800797|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800798|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800799|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
14800800|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800801|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14800802|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14800803|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14800804|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800805|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975717|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14975718|NCT05292872|Cathartics|cathartics|mesh-ancestor
14975719|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14975720|NCT05292742|Capecitabine|capecitabine|mesh-list
14975721|NCT05292742|Trastuzumab|trastuzumab|mesh-list
14975722|NCT05292742|Pertuzumab|pertuzumab|mesh-list
14975723|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14975724|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
14975725|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975726|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975727|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14975728|NCT05292690|Caffeine|caffeine|mesh-list
14975729|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15029545|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
14975730|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975731|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14975732|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975733|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975734|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14975735|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14975736|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
14975737|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975738|NCT05292677|Anesthetics|anesthetics|mesh-list
14975739|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975740|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975741|NCT05292664|Leucovorin|leucovorin|mesh-list
14975742|NCT05292664|Cytarabine|cytarabine|mesh-list
14975743|NCT05292664|Dexamethasone|dexamethasone|mesh-list
14975744|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
14975745|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
14975746|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14975747|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14975748|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14975749|NCT05292664|Cortisone|cortisone|mesh-list
14975750|NCT05292664|Doxorubicin|doxorubicin|mesh-list
14975751|NCT05292664|Methotrexate|methotrexate|mesh-list
14975752|NCT05292664|Vincristine|vincristine|mesh-list
14975753|NCT05292664|Azacitidine|azacitidine|mesh-list
14975754|NCT05292664|Venetoclax|venetoclax|mesh-list
14975755|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
14975756|NCT05292664|Razoxane|razoxane|mesh-list
14975757|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14975758|NCT05292664|BB 1101|bb 1101|mesh-list
14975759|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
14975760|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975761|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
14975762|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
14975763|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975764|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975765|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14975766|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
14975767|NCT05292664|Hormones|hormones|mesh-ancestor
14975768|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975769|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14975770|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975771|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
14975772|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975773|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975774|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14975775|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14975776|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14975777|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14975778|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
14975779|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14975780|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14975781|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
14975782|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
14975783|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14975784|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975785|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
14975786|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975787|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14975788|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
14975789|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975790|NCT05292664|Antidotes|antidotes|mesh-ancestor
14975791|NCT05292664|Protective Agents|protective agents|mesh-ancestor
14975792|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
14975793|NCT05292664|Vitamins|vitamins|mesh-ancestor
14975794|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
14975795|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14975796|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
14975797|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
14975798|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
14975799|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14975800|NCT05292586|Beclomethasone|beclomethasone|mesh-list
14975801|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
14975802|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14975803|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
14975804|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975805|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975806|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14975807|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
14975808|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14975809|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14975810|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975811|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975812|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975813|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975814|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975815|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
14975816|NCT05292586|Hormones|hormones|mesh-ancestor
14975817|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975818|NCT05292573|Metformin|metformin|mesh-list
14975819|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14975820|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975821|NCT05292339|Triamcinolone|triamcinolone|mesh-list
14975822|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14975823|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14975824|NCT05292339|Ketorolac|ketorolac|mesh-list
14975825|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
14975826|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14975827|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975828|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
14975829|NCT05292339|Hormones|hormones|mesh-ancestor
14975830|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975831|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975832|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975833|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
14975834|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975835|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975836|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14975837|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975838|NCT05292339|Analgesics|analgesics|mesh-ancestor
14975839|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
14975840|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975841|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975842|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14975843|NCT05292209|Riluzole|riluzole|mesh-list
14975844|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
14975845|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14975846|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14975847|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975848|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975849|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975850|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14975851|NCT05292209|Protective Agents|protective agents|mesh-ancestor
14975852|NCT05292066|Pregabalin|pregabalin|mesh-list
14975853|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14975854|NCT05292066|Analgesics|analgesics|mesh-ancestor
14975855|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
14975856|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975857|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975858|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
14975859|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14975860|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975861|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975862|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14975863|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14975864|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14975865|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975866|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14975867|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14975868|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14975869|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975870|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
14975871|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
14975872|NCT05292001|Dextrans|dextrans|mesh-list
14975873|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
14975874|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
14975875|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
14975876|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
14975877|NCT05292001|Hematinics|hematinics|mesh-ancestor
14975878|NCT05291910|Paclitaxel|paclitaxel|mesh-list
14975879|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14975880|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14975881|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975882|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14975883|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14975884|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14975885|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975886|NCT05291845|Vaccines|vaccines|mesh-list
14975887|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
14975888|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975889|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
14975890|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14975891|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14975892|NCT05291793|Prednisolone|prednisolone|mesh-list
14975893|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
14975894|NCT05291793|Tenoxicam|tenoxicam|mesh-list
14975895|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14975896|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
14975897|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14975898|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
14975899|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
14975900|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975901|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975902|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14975903|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
14975904|NCT05291793|Hormones|hormones|mesh-ancestor
14975905|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14975906|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14975907|NCT05291793|Protective Agents|protective agents|mesh-ancestor
14975908|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14975909|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14975910|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14975911|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14975912|NCT05291793|Analgesics|analgesics|mesh-ancestor
14975913|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
14975914|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14975915|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14975916|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975917|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523146|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523147|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14523148|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
14523149|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523150|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523151|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14523152|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14523153|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14523154|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
14523155|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523156|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523157|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523158|NCT03575702|Urological Agents|urological agents|mesh-ancestor
14523159|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
14523160|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14523161|NCT03575806|Estrogens|estrogens|mesh-ancestor
14523162|NCT03575806|Hormones|hormones|mesh-ancestor
14523163|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523164|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523165|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14523166|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523167|NCT03575871|Abrocitinib|abrocitinib|mesh-list
14523168|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14523169|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523170|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523171|NCT03576066|Tenofovir|tenofovir|mesh-list
14523172|NCT03576066|Entecavir|entecavir|mesh-list
14523173|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
14523174|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523175|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14523176|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14523177|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523178|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523179|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14523180|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14975918|NCT05294965|Fenoterol|fenoterol|mesh-list
14975919|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14975920|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
14800806|NCT00789646|Lidocaine|lidocaine|mesh-list
14800807|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
14800808|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
14975921|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975922|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975923|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14975924|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
14975925|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
14975926|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
14975927|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14975928|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14975929|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14975930|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14975931|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975932|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975933|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975934|NCT05294926|Rocuronium|rocuronium|mesh-list
14975935|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14975936|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14975937|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14975938|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975939|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975940|NCT05294887|Diltiazem|diltiazem|mesh-list
14975941|NCT05294887|Bisoprolol|bisoprolol|mesh-list
14975942|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14975943|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14975944|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
14975945|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14975946|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975947|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975948|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14975949|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14975950|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14975951|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14975952|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
14975953|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
14975954|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
14975955|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14975956|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14975957|NCT05294822|Insulin|insulin|mesh-list
14975958|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14975959|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14236515|NCT00115063|Sibutramine|sibutramine|mesh-list
14800809|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14236516|NCT00115063|Diethylpropion|diethylpropion|mesh-list
14236517|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14236518|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14236519|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14800810|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800811|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
14800812|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800813|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14800814|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14800815|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14800816|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800817|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800818|NCT00789711|Insulin|insulin|mesh-list
14800819|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14800820|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
14800821|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
14800822|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
14800823|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14800824|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14800825|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800826|NCT00789763|Gemcitabine|gemcitabine|mesh-list
14800827|NCT00789763|Sorafenib|sorafenib|mesh-list
14975960|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
14975961|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14975962|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
14975963|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975964|NCT05294744|Expectorants|expectorants|mesh-ancestor
14975965|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
14975966|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14975967|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
14975968|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975969|NCT05294744|Protective Agents|protective agents|mesh-ancestor
14975970|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975971|NCT05294744|Antidotes|antidotes|mesh-ancestor
14975972|NCT05294679|Propofol|propofol|mesh-list
14975973|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14975974|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975975|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975976|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14975977|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
14975978|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
14975979|NCT05294666|Cyclosporine|cyclosporine|mesh-list
14975980|NCT05294666|Tacrolimus|tacrolimus|mesh-list
14975981|NCT05294666|Cyclosporins|cyclosporins|mesh-list
14975982|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14975983|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
14975984|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975985|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14975986|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14975987|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14975988|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
14975989|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14975990|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
14975991|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029546|NCT01963741|Histamine|histamine|mesh-list
15029547|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
15029548|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
15029549|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029550|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029551|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029552|NCT01963754|Epinephrine|epinephrine|mesh-list
15029553|NCT01963754|Racepinephrine|racepinephrine|mesh-list
15029554|NCT01963754|Anesthetics|anesthetics|mesh-list
15029555|NCT01963754|Carticaine|carticaine|mesh-list
15029556|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
15029557|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029558|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029559|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15029560|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15029561|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
15029562|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029563|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029564|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15029565|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15029566|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
15029567|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029568|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15029569|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
15029570|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
15029571|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
15029572|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15029573|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029574|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
15029575|NCT01963832|Fluoxetine|fluoxetine|mesh-list
15029576|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15029577|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15029578|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029579|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029580|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029581|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
15029582|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029583|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15029584|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
15029585|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15029586|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15029587|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15029588|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029589|NCT01963910|Mannitol|mannitol|mesh-list
14975992|NCT05294640|Lidocaine|lidocaine|mesh-list
14975993|NCT05294640|Epinephrine|epinephrine|mesh-list
14975994|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
14975995|NCT05294640|Anesthetics|anesthetics|mesh-list
14975996|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14975997|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14975998|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
14975999|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976000|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14976001|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14976002|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14976003|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976004|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976005|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14976006|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14976007|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976008|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976009|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14976010|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14976011|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
14976012|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14976013|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976014|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
14976015|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
14976016|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14976017|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
14976018|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
14976019|NCT05294588|Cefixime|cefixime|mesh-list
14976020|NCT05294588|Vaccines|vaccines|mesh-list
14976021|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
14976022|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976023|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14976024|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976025|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14976026|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14976027|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976028|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976029|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976030|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14976031|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14976032|NCT05294536|Liraglutide|liraglutide|mesh-list
14976033|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14976034|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976035|NCT05294536|Incretins|incretins|mesh-ancestor
14976036|NCT05294536|Hormones|hormones|mesh-ancestor
14976037|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976038|NCT05294523|Rocuronium|rocuronium|mesh-list
14976039|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14976040|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14976041|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14976042|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976043|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976044|NCT05294484|Indapamide|indapamide|mesh-list
14976045|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14976046|NCT05294484|Diuretics|diuretics|mesh-ancestor
14976047|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
14976048|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976049|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14976050|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976051|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976052|NCT05294406|Piperaquine|piperaquine|mesh-list
14976053|NCT05294406|Artenimol|artenimol|mesh-list
14976054|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
14976055|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14976056|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14976057|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976058|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
14976059|NCT05294393|Ropivacaine|ropivacaine|mesh-list
14976060|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
14976061|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
14976062|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976063|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976064|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
14976065|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976066|NCT05294393|Analgesics|analgesics|mesh-ancestor
14976067|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14976068|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
14976069|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14976070|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976071|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976072|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14976073|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
14976074|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14976075|NCT05294263|Varenicline|varenicline|mesh-list
14976076|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14976077|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14976078|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
14976079|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976080|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976081|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976082|NCT05294146|Clofazimine|clofazimine|mesh-list
14976083|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976084|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
14976085|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14976086|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976087|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
14976088|NCT05294055|Etoposide|etoposide|mesh-list
14976089|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976090|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
14976091|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976092|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976093|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14976094|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
14976095|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976096|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976097|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14976098|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14976099|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14976100|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14976101|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976102|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14976103|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976104|NCT05293964|Palbociclib|palbociclib|mesh-list
14976105|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976106|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14976107|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976108|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976109|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
14976110|NCT05293938|Cathartics|cathartics|mesh-ancestor
14976111|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976112|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14976113|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
14976114|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976115|NCT05293808|Aspirin|aspirin|mesh-list
14976116|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14976117|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14976118|NCT05293808|Analgesics|analgesics|mesh-ancestor
14976119|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
14976120|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976121|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976122|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976123|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976124|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14976125|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14976126|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976127|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14976128|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14976129|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976130|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
14976131|NCT05293704|Mizoribine|mizoribine|mesh-list
14976132|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14976133|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14976134|NCT05293704|Analgesics|analgesics|mesh-ancestor
14976135|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
14976136|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976137|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976138|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976139|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976140|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14976141|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976142|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14976143|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976144|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
14976145|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14976146|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14976147|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976148|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976149|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976150|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
14976151|NCT05293665|Vaccines|vaccines|mesh-list
14976152|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
14976153|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976154|NCT05293600|Acetazolamide|acetazolamide|mesh-list
14976155|NCT05293600|Eszopiclone|eszopiclone|mesh-list
14976156|NCT05293600|Trazodone|trazodone|mesh-list
14976157|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14976158|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14976159|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14976160|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976161|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976162|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976163|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976164|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976165|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
14976166|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14976167|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976168|NCT05293600|Diuretics|diuretics|mesh-ancestor
14976169|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
14976170|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14976171|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976172|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14976173|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14976174|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14976175|NCT05293600|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14976176|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
14976177|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14976178|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
14976179|NCT05293574|Norethindrone|norethindrone|mesh-list
14976180|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
14976181|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14976182|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14976183|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14976184|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
14976185|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14976186|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976187|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14976188|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14976189|NCT05293509|Cyclosporine|cyclosporine|mesh-list
14976190|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
14976191|NCT05293509|Dexamethasone|dexamethasone|mesh-list
14976192|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
14976193|NCT05293509|Busulfan|busulfan|mesh-list
14976194|NCT05293509|Rituximab|rituximab|mesh-list
14976195|NCT05293509|Fludarabine|fludarabine|mesh-list
14976196|NCT05293509|Bortezomib|bortezomib|mesh-list
14976197|NCT05293509|Tacrolimus|tacrolimus|mesh-list
14976198|NCT05293509|Cyclosporins|cyclosporins|mesh-list
14976199|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
14976200|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976201|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
14976202|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976203|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976204|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14976205|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
14976206|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976207|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976208|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14976209|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976210|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
14976211|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
14976212|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976213|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976214|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
14976215|NCT05293509|Hormones|hormones|mesh-ancestor
14976216|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976217|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14976218|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14976219|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14976220|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976221|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
14976222|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976223|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
14976224|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14976225|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14976226|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
14976227|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14976228|NCT05293288|Anesthetics|anesthetics|mesh-list
14976229|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976230|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976231|NCT05293210|Dexamethasone|dexamethasone|mesh-list
14976232|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976233|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
14976234|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
14976235|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976236|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976237|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976238|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
14976239|NCT05293210|Hormones|hormones|mesh-ancestor
14976240|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976241|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14976242|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976243|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
14976244|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14976245|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976246|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14976247|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14976248|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976249|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976250|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976251|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
14976252|NCT05293132|Ubiquinone|ubiquinone|mesh-list
14976253|NCT05293132|Montelukast|montelukast|mesh-list
14976254|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14976255|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976256|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14976257|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
14976258|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976259|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976260|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14976261|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14976262|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976263|NCT05293132|Vitamins|vitamins|mesh-ancestor
14976264|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
14976265|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
14976266|NCT05293119|Tofacitinib|tofacitinib|mesh-list
14976267|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976268|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
14976269|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14976270|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14976271|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976272|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976273|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14976274|NCT05297032|Quercetin|quercetin|mesh-list
14976275|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
14976276|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976277|NCT05297032|Protective Agents|protective agents|mesh-ancestor
14976278|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029590|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15029591|NCT01963910|Diuretics|diuretics|mesh-ancestor
15029592|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
15029593|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029594|NCT01963962|Copper|copper|mesh-list
15029595|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
15029596|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15029597|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
15029598|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15029599|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029600|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15029601|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15029602|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15029603|NCT01963962|Trace Elements|trace elements|mesh-ancestor
15029604|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
15029605|NCT01964001|Vitamins|vitamins|mesh-list
15029606|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
15029607|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
15029608|NCT01964001|Pyridoxal|pyridoxal|mesh-list
15029609|NCT01964001|Pyridoxine|pyridoxine|mesh-list
15029610|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
15029611|NCT01964001|Ubiquinone|ubiquinone|mesh-list
15029612|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
15029613|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029614|NCT01964027|Irinotecan|irinotecan|mesh-list
15029615|NCT01964027|Epirubicin|epirubicin|mesh-list
14976279|NCT05296863|Minoxidil|minoxidil|mesh-list
14523181|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14523182|NCT03576716|Calcifediol|calcifediol|mesh-list
14523183|NCT03576716|Vitamins|vitamins|mesh-ancestor
14523184|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
14523185|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523186|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14523187|NCT03577171|Entecavir|entecavir|mesh-list
14976280|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14976281|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
14976282|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
14976283|NCT05296772|Antibodies|antibodies|mesh-list
14976284|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
14976285|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
14976286|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976287|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14976288|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976289|NCT05296629|Doxycycline|doxycycline|mesh-list
14976290|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14976291|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976292|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
14976293|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14976294|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14976295|NCT05296564|Aldesleukin|aldesleukin|mesh-list
14976296|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
14523188|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
14523189|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523190|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
14523191|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14523192|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523193|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14800828|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14800829|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
14800830|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800831|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800832|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
14800833|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800834|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800835|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800836|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
14800837|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800838|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14800839|NCT00789945|Insulin|insulin|mesh-list
14800840|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14800841|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14523194|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14523195|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523196|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523197|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800842|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800843|NCT00789971|Triamcinolone|triamcinolone|mesh-list
14800844|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14800845|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14800846|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14800847|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14800848|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
14976297|NCT05296564|Interleukin-2|interleukin-2|mesh-list
14976298|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976299|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
14976300|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976301|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976302|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14976303|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
14976304|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976305|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976306|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14976307|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14976308|NCT05296564|Analgesics|analgesics|mesh-ancestor
14976309|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
14976310|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976311|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14976312|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14976313|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
14976314|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976315|NCT05296369|Folic Acid|folic acid|mesh-list
14976316|NCT05296369|Hematinics|hematinics|mesh-ancestor
14976317|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
14976318|NCT05296369|Vitamins|vitamins|mesh-ancestor
14976319|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
14976320|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976321|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
14976322|NCT05296317|Epirubicin|epirubicin|mesh-list
14976323|NCT05296317|Lenograstim|lenograstim|mesh-list
14976324|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976325|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
14976326|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976327|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976328|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14976329|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
14976330|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976331|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976332|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14976333|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14976334|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14976335|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14976336|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14976337|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976338|NCT05296304|Bexarotene|bexarotene|mesh-list
14976339|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976340|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14976341|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14976342|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976343|NCT05296005|Leucovorin|leucovorin|mesh-list
14976344|NCT05296005|Docetaxel|docetaxel|mesh-list
14976345|NCT05296005|Fluorouracil|fluorouracil|mesh-list
14976346|NCT05296005|Capecitabine|capecitabine|mesh-list
14976347|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
14976348|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976349|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
14976350|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
14976351|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
14976352|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976353|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
14976354|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14976355|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976356|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
14976357|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976358|NCT05296005|Antidotes|antidotes|mesh-ancestor
14976359|NCT05296005|Protective Agents|protective agents|mesh-ancestor
14976360|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
14976361|NCT05296005|Vitamins|vitamins|mesh-ancestor
14976362|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
14976363|NCT05295836|Glycerol|glycerol|mesh-list
14976364|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14976365|NCT05295836|Protective Agents|protective agents|mesh-ancestor
14976366|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976367|NCT05295784|Caffeine|caffeine|mesh-list
14976368|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
14976369|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976370|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14976371|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976372|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14976373|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976374|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14976375|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14976376|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
14976377|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976378|NCT05295537|Liver Extracts|liver extracts|mesh-list
14976379|NCT05295537|Hematinics|hematinics|mesh-ancestor
14976380|NCT05295355|Bromides|bromides|mesh-list
14976381|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
14976382|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14976383|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
14976384|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976385|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976386|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14976387|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976388|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
14976389|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14976390|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
14976391|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976392|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976393|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
14976394|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14976395|NCT05295173|Plasminogen|plasminogen|mesh-list
14976396|NCT05295173|Reteplase|reteplase|mesh-list
14976397|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14976398|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14976399|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976400|NCT05294900|Paclitaxel|paclitaxel|mesh-list
14976401|NCT05294900|Carboplatin|carboplatin|mesh-list
14976402|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14976403|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976404|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
14976405|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
14976406|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
14976407|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976408|NCT05289349|Propofol|propofol|mesh-list
14976409|NCT05289349|Sevoflurane|sevoflurane|mesh-list
14976410|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14976411|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976412|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976413|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14976414|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
14976415|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
14976416|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14976417|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14976418|NCT05288062|Dexamethasone|dexamethasone|mesh-list
14976419|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
14976420|NCT05288062|Lenalidomide|lenalidomide|mesh-list
14976421|NCT05288062|Pomalidomide|pomalidomide|mesh-list
14976422|NCT05288062|Ichthammol|ichthammol|mesh-list
14976423|NCT05288062|BB 1101|bb 1101|mesh-list
14976424|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976425|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
14976426|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
14976427|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976428|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976429|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976430|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
14976431|NCT05288062|Hormones|hormones|mesh-ancestor
14976432|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976433|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14976434|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976435|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
14976436|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976437|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976438|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
14976439|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14976440|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14976441|NCT05288062|Growth Substances|growth substances|mesh-ancestor
14976442|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
14976443|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029616|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15029617|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15029618|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029619|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029620|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029621|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15029622|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15029623|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
15029624|NCT01964040|Bupivacaine|bupivacaine|mesh-list
14976444|NCT05280405|Infliximab|infliximab|mesh-list
14976445|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
14976446|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976447|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976448|NCT05275686|Fluticasone|fluticasone|mesh-list
14976449|NCT05275686|Xhance|xhance|mesh-list
14976450|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976451|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14976452|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
14976453|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976454|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976455|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14976456|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976457|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
14976458|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14976459|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14976460|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14976461|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976462|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976463|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14976464|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976465|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976466|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
14976467|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976468|NCT05275491|Calcium|calcium|mesh-list
14976469|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
14976470|NCT05275491|Hormones|hormones|mesh-list
14976471|NCT05275491|Mitogens|mitogens|mesh-list
14976472|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14976473|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976474|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976475|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
14976476|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976477|NCT05275374|Trametinib|trametinib|mesh-list
14976478|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976479|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14976480|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976481|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976482|NCT05274243|Phenol|phenol|mesh-list
14976483|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14976484|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976485|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
14976486|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
14976487|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14976488|NCT05273996|Bupropion|bupropion|mesh-list
14976489|NCT05273996|Sertraline|sertraline|mesh-list
14976490|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14976491|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14976492|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
14976493|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14976494|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14976495|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14976496|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976497|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976498|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
14976499|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976500|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976501|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14976502|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14976503|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976504|NCT05273996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14976505|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
14976506|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14976507|NCT05273242|Artesunate|artesunate|mesh-list
14976508|NCT05273242|Infliximab|infliximab|mesh-list
14976509|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976510|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14976511|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976512|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976513|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
14976514|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14976515|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14976516|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976517|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
14976518|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
14976519|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14976520|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
14976521|NCT05272826|Dexamethasone|dexamethasone|mesh-list
14976522|NCT05272826|Bortezomib|bortezomib|mesh-list
14976523|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976524|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
14976525|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
14976526|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976527|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976528|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976529|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
14976530|NCT05272826|Hormones|hormones|mesh-ancestor
14976531|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976532|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14976533|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976534|NCT05272202|Propofol|propofol|mesh-list
14976535|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14976536|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976537|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976538|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14976539|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
14976540|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
14976541|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14976542|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976543|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976544|NCT05269095|Anesthetics|anesthetics|mesh-list
14976545|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976546|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976547|NCT05267938|Lidocaine|lidocaine|mesh-list
14976548|NCT05267938|Epinephrine|epinephrine|mesh-list
14976549|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
14976550|NCT05267938|Anesthetics|anesthetics|mesh-list
14976551|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976552|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976553|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
14976554|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976555|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14976556|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14976557|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14976558|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976559|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976560|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14976561|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14976562|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976563|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976564|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14976565|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14976566|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
14976567|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14976568|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976569|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
14976570|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
14976571|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14976572|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14976573|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976574|NCT05267431|Methotrexate|methotrexate|mesh-list
14976575|NCT05267431|Hydroquinone|hydroquinone|mesh-list
14976576|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14976577|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
14976578|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14976579|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976580|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14976581|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
14976582|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976583|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976584|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
14976585|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976586|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14976587|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976588|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
14523198|NCT03577730|Caffeine|caffeine|mesh-list
14523199|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
14976589|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976590|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14976591|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
14976592|NCT05267431|Protective Agents|protective agents|mesh-ancestor
14976593|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14976594|NCT05266248|Caffeine|caffeine|mesh-list
14976595|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14976596|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976597|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14976598|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976599|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976600|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14976601|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14976602|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
14976603|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976604|NCT05264896|Leucovorin|leucovorin|mesh-list
14976605|NCT05264896|Docetaxel|docetaxel|mesh-list
14976606|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
14976607|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976608|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
14976609|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
14976610|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
15029625|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
14976611|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976612|NCT05264896|Antidotes|antidotes|mesh-ancestor
14976613|NCT05264896|Protective Agents|protective agents|mesh-ancestor
14976614|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976615|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
14976616|NCT05264896|Vitamins|vitamins|mesh-ancestor
14976617|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
14976618|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
14976619|NCT05264584|Febuxostat|febuxostat|mesh-list
14976620|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14976621|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
14976622|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976623|NCT05264584|Expectorants|expectorants|mesh-ancestor
14976624|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976625|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14976626|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
14976627|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976628|NCT05264584|Protective Agents|protective agents|mesh-ancestor
14976629|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976630|NCT05264584|Antidotes|antidotes|mesh-ancestor
14976631|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
14976632|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976633|NCT05262686|Aldesleukin|aldesleukin|mesh-list
14976634|NCT05262686|Interleukin-2|interleukin-2|mesh-list
14976635|NCT05262686|Belimumab|belimumab|mesh-list
14976636|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976637|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14976638|NCT05262686|Analgesics|analgesics|mesh-ancestor
14976639|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
14976640|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976641|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976642|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976643|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
14976644|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14976645|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14976646|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
14976647|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976648|NCT05261386|Betadex|betadex|mesh-list
14976649|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
14976650|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976651|NCT05260008|Epinephrine|epinephrine|mesh-list
14976652|NCT05260008|Bupivacaine|bupivacaine|mesh-list
14976653|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
14976654|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
14976655|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976656|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976657|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
14976658|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976659|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14976660|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14976661|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976662|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976663|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976664|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14976665|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14976666|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
14976667|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14976668|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976669|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
14976670|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
14976671|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14976672|NCT05259566|Menthol|menthol|mesh-list
14976673|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
14976674|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029626|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
15029627|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029628|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029629|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
15029630|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029631|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15029632|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15029633|NCT01964040|Analgesics|analgesics|mesh-ancestor
15029634|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15029635|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15029636|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15029637|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
15029638|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035629|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14976675|NCT05257447|Baclofen|baclofen|mesh-list
14976676|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
14976677|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14976678|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976679|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14976680|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976681|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14976682|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
14976683|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
14976684|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976685|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976686|NCT05256823|Celecoxib|celecoxib|mesh-list
14976687|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14976688|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14976689|NCT05256823|Analgesics|analgesics|mesh-ancestor
14976690|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
14976691|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976692|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976693|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976694|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976695|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14976696|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14976697|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976698|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976699|NCT05253131|Durvalumab|durvalumab|mesh-list
14976700|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14976701|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976702|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14976703|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14976704|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976705|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976706|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976707|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976708|NCT05250895|Misonidazole|misonidazole|mesh-list
14800849|NCT00789971|Hormones|hormones|mesh-ancestor
14800850|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14800851|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800852|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800853|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
14800854|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800855|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976709|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976710|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14976711|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14976712|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976713|NCT05249920|Edaravone|edaravone|mesh-list
14976714|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14976715|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
14976716|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976717|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14976718|NCT05249920|Protective Agents|protective agents|mesh-ancestor
14976719|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976720|NCT05245669|Denosumab|denosumab|mesh-list
14976721|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14976722|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976723|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
14976724|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
14976725|NCT05243147|Coagulants|coagulants|mesh-ancestor
14976726|NCT05242484|Golimumab|golimumab|mesh-list
14976727|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14976728|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976729|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14976730|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
14976731|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976732|NCT05242029|Psilocybin|psilocybin|mesh-list
14976733|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
14976734|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976735|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14976736|NCT05238844|Tenofovir|tenofovir|mesh-list
14976737|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
14976738|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976739|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14800856|NCT00790075|Risperidone|risperidone|mesh-list
14800857|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14800858|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
14976740|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14976741|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976742|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976743|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14976744|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14976745|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14976746|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14976747|NCT05238506|Lidocaine|lidocaine|mesh-list
14976748|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
14976749|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
14976750|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976751|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976752|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
14976753|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976754|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14976755|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14976756|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14976757|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14976758|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976759|NCT05236608|Nivolumab|nivolumab|mesh-list
14976760|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14976761|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976762|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14976763|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976764|NCT05233566|Ketamine|ketamine|mesh-list
14976765|NCT05233566|Analgesics|analgesics|mesh-ancestor
14976766|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
14976767|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976768|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976769|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14976770|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14976771|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
14976772|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
14976773|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976774|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14976775|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14976776|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976777|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976778|NCT05225402|Norepinephrine|norepinephrine|mesh-list
14976779|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14976780|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14976781|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976782|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976783|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976784|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976785|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
14976786|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
14976787|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976788|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14976789|NCT05225116|Lenvatinib|lenvatinib|mesh-list
14976790|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976791|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14976792|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976793|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976794|NCT05223478|Phentolamine|phentolamine|mesh-list
14976795|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14976796|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14976797|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14976798|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14976799|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976800|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976801|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976802|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976803|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14976804|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
14976805|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
14976806|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14976807|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14976808|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976809|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976810|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976811|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14976812|NCT05221229|Liraglutide|liraglutide|mesh-list
14976813|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14976814|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976815|NCT05221229|Incretins|incretins|mesh-ancestor
14976816|NCT05221229|Hormones|hormones|mesh-ancestor
14976817|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976818|NCT05220826|Ethanol|ethanol|mesh-list
14976819|NCT05220826|Ethylene|ethylene|mesh-list
14976820|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14976821|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976822|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976823|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976824|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14976825|NCT05220826|Growth Substances|growth substances|mesh-ancestor
14976826|NCT05219799|Propranolol|propranolol|mesh-list
14976827|NCT05219799|Nitroprusside|nitroprusside|mesh-list
14976828|NCT05219799|Isoproterenol|isoproterenol|mesh-list
14976829|NCT05219799|Norepinephrine|norepinephrine|mesh-list
14976830|NCT05219799|Acetylcholine|acetylcholine|mesh-list
14976831|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14976832|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14976833|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976834|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976835|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976836|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976837|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14976838|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14976839|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
14976840|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14976841|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14976842|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
14976843|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
14976844|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976845|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14976846|NCT05219799|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14976847|NCT05219799|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14976848|NCT05219799|Cholinergic Agents|cholinergic agents|mesh-ancestor
14976849|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14976850|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14976851|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14976852|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976853|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14976854|NCT05219799|Protective Agents|protective agents|mesh-ancestor
14976855|NCT05217706|Ketamine|ketamine|mesh-list
14976856|NCT05217706|Analgesics|analgesics|mesh-ancestor
14976857|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
14976858|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976859|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976860|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14976861|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14976862|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
14976863|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
14976864|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976865|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14976866|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14976867|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976868|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976869|NCT05216055|Dexamethasone|dexamethasone|mesh-list
14976870|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
14976871|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
14976872|NCT05216055|Bupivacaine|bupivacaine|mesh-list
14976873|NCT05216055|Ropivacaine|ropivacaine|mesh-list
14976874|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14976875|NCT05216055|BB 1101|bb 1101|mesh-list
14976876|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14976877|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
14976878|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
14976879|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976880|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976881|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976882|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
14976883|NCT05216055|Hormones|hormones|mesh-ancestor
14976884|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14976885|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14976886|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976887|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
14976888|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
14976889|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976890|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
14976891|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14976892|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14976893|NCT05216055|Analgesics|analgesics|mesh-ancestor
14976894|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14976895|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14976896|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14976897|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976898|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976899|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976900|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
14976901|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976902|NCT05215548|Afatinib|afatinib|mesh-list
14976903|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976904|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14976905|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976906|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976907|NCT05215327|Vaccines|vaccines|mesh-list
14976908|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
14976909|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029639|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029640|NCT01964079|Losartan|losartan|mesh-list
15029641|NCT01964079|Amlodipine|amlodipine|mesh-list
15029642|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15029643|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15029644|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029645|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029646|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15029647|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029648|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
15029649|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15029650|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15029651|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15029652|NCT01964157|Ceritinib|ceritinib|mesh-list
15029653|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029654|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15029655|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029656|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029657|NCT01964170|Goserelin|goserelin|mesh-list
14976910|NCT05210413|Spartalizumab|spartalizumab|mesh-list
14976911|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14976912|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976913|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976914|NCT05203705|Enoxaparin|enoxaparin|mesh-list
14976915|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
14976916|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14976917|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14976918|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976919|NCT05202561|Vaccines|vaccines|mesh-list
14976920|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
14976921|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976922|NCT05200364|Bevacizumab|bevacizumab|mesh-list
14976923|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14976924|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976925|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14976926|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14976927|NCT05200364|Growth Substances|growth substances|mesh-ancestor
14976928|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976929|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
14976930|NCT05199818|Palonosetron|palonosetron|mesh-list
14976931|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
14976932|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
14976933|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976934|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976935|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976936|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14976937|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14976938|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
14976939|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976940|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976941|NCT05197426|Azacitidine|azacitidine|mesh-list
14976942|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14976943|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
14976944|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976945|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976946|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976947|NCT05192629|Midazolam|midazolam|mesh-list
14976948|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
14976949|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14976950|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14976951|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976952|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14976953|NCT05192629|Analgesics|analgesics|mesh-ancestor
14976954|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
14976955|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14976956|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14976957|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14976958|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14976959|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
14976960|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14976961|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976962|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14976963|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14976964|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14976965|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14976966|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14976967|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
14976968|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
14976969|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
14976970|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
14976971|NCT05189444|Amoxicillin|amoxicillin|mesh-list
14976972|NCT05189444|Clarithromycin|clarithromycin|mesh-list
14976973|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
14976974|NCT05189444|Esomeprazole|esomeprazole|mesh-list
14976975|NCT05189444|Bismuth|bismuth|mesh-list
14976976|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976977|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14976978|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14976979|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14976980|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14976981|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14976982|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976983|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14976984|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15035630|NCT02002260|Estradiol|estradiol|mesh-list
14976985|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14976986|NCT05189444|Antacids|antacids|mesh-ancestor
14976987|NCT05189444|Diuretics|diuretics|mesh-ancestor
14976988|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
14976989|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14976990|NCT05189444|Expectorants|expectorants|mesh-ancestor
14976991|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
14976992|NCT05183828|Letrozole|letrozole|mesh-list
14976993|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14976994|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14976995|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14976996|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14976997|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14976998|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14976999|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
14977000|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977001|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977002|NCT05180006|Bevacizumab|bevacizumab|mesh-list
14977003|NCT05180006|Trastuzumab|trastuzumab|mesh-list
14977004|NCT05180006|Pertuzumab|pertuzumab|mesh-list
14977005|NCT05180006|Atezolizumab|atezolizumab|mesh-list
14977006|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977007|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977008|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14977009|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14977010|NCT05180006|Growth Substances|growth substances|mesh-ancestor
14977011|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977012|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
14977013|NCT05177796|Paclitaxel|paclitaxel|mesh-list
14977014|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
14977015|NCT05177796|Carboplatin|carboplatin|mesh-list
14977016|NCT05177796|Doxorubicin|doxorubicin|mesh-list
14977017|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14977018|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
14977019|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14977020|NCT05177796|Daunorubicin|daunorubicin|mesh-list
14977021|NCT05177796|Panitumumab|panitumumab|mesh-list
14977022|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14977023|NCT05177796|Antibodies|antibodies|mesh-list
14977024|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
14977025|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14977026|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14977027|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977028|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
14977029|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
14977030|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
14977031|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977032|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977033|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
14977034|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977035|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977036|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14977037|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
14977038|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14977039|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14977040|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14977041|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14977042|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977043|NCT05175274|Colchicine|colchicine|mesh-list
14977044|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
14977045|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977046|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
14977047|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
14977048|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
14977049|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977050|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977051|NCT05174611|Vitamin D|vitamin d|mesh-list
14977052|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
14977053|NCT05174611|Vitamins|vitamins|mesh-ancestor
14977054|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
14977055|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977056|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14977057|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14977058|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14977059|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
14977060|NCT05174585|Antibodies|antibodies|mesh-list
14977061|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
14977062|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14977063|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
14977064|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977065|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977066|NCT05171816|Olaparib|olaparib|mesh-list
14977067|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
14977068|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14977069|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977070|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977071|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977072|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14977073|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
14977074|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977075|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977076|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14977077|NCT05169268|Aripiprazole|aripiprazole|mesh-list
14977078|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
14977079|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
14977080|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977081|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14977082|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14977083|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977084|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977085|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
14977086|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
14977087|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977088|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977089|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14977090|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14977091|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
14977092|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14977093|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14977094|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14977095|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14977096|NCT05166876|Brequinar|brequinar|mesh-list
14977097|NCT05166876|Dipyridamole|dipyridamole|mesh-list
14977098|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14977099|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977100|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977101|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14977102|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
14977103|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977104|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977105|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
14977106|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029658|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15029659|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029660|NCT01964183|Mirabegron|mirabegron|mesh-list
15029661|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
15029662|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15029663|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15029664|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15029665|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
15029666|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029667|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029668|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029669|NCT01964183|Urological Agents|urological agents|mesh-ancestor
15029670|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15029671|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15029672|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
15029673|NCT01964248|Lidocaine|lidocaine|mesh-list
15029674|NCT01964248|Prilocaine|prilocaine|mesh-list
15029675|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15029676|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029677|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
15029678|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029679|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029680|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
15029681|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029682|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15029683|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15029684|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15029685|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977107|NCT05159427|Glipizide|glipizide|mesh-list
14977108|NCT05159427|Rifaximin|rifaximin|mesh-list
14977109|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977110|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977111|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14977112|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977113|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977114|NCT05157126|Gentamicins|gentamicins|mesh-list
14977115|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977116|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977117|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14977118|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977119|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977120|NCT05153915|Tacrolimus|tacrolimus|mesh-list
14977121|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977122|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
14977123|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977124|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14977125|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977126|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977127|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
14977128|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977129|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
14977130|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977131|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977132|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14977133|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
14977134|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977135|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977136|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14977137|NCT05150795|Pregabalin|pregabalin|mesh-list
14977138|NCT05150795|Fentanyl|fentanyl|mesh-list
14977139|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14977140|NCT05150795|Narcotics|narcotics|mesh-ancestor
14977141|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977142|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977143|NCT05150795|Analgesics|analgesics|mesh-ancestor
14977144|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
14977145|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977146|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14977147|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14977148|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
14977149|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
14977150|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
14977151|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14977152|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977153|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977154|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14977155|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14977156|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14977157|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977158|NCT05150756|Lidocaine|lidocaine|mesh-list
14977159|NCT05150756|Morphine|morphine|mesh-list
14977160|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
14977161|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
14977162|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977163|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977164|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
14977165|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977166|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14977167|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14977168|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14977169|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977170|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977171|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14977172|NCT05150756|Narcotics|narcotics|mesh-ancestor
14977173|NCT05150756|Analgesics|analgesics|mesh-ancestor
14977174|NCT05148078|Anesthetics|anesthetics|mesh-list
14977175|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977176|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977177|NCT05146778|Lidocaine|lidocaine|mesh-list
14977178|NCT05146778|Fentanyl|fentanyl|mesh-list
14977179|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
14977180|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
14977181|NCT05146778|Anesthetics|anesthetics|mesh-list
14977182|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
14977183|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977184|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977185|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
14977186|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977187|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14977188|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14977189|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14977190|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977191|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977192|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14977193|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14977194|NCT05146778|Analgesics|analgesics|mesh-ancestor
14977195|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14977196|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14977197|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14977198|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
14977199|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977200|NCT05146778|Narcotics|narcotics|mesh-ancestor
14800859|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800860|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800861|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800862|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14800863|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14800864|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800865|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977201|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14977202|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14977203|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
14977204|NCT05141344|Melatonin|melatonin|mesh-list
14977205|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
14977206|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977207|NCT05141344|Protective Agents|protective agents|mesh-ancestor
14977208|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977209|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977210|NCT05140278|Artesunate|artesunate|mesh-list
14977211|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
14977212|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14977213|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14977214|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977215|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977216|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
14977217|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
14977218|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14977219|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
14977220|NCT05139316|Prednisolone|prednisolone|mesh-list
14977221|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977222|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
14977223|NCT05139316|Hormones|hormones|mesh-ancestor
14800866|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14800867|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
14977224|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977225|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977226|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14977227|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977228|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
14977229|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14977230|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977231|NCT05138822|Renal Agents|renal agents|mesh-ancestor
14977232|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977233|NCT05138549|Beta Carotene|beta carotene|mesh-list
14977234|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977235|NCT05138549|Provitamins|provitamins|mesh-ancestor
14977236|NCT05138549|Vitamins|vitamins|mesh-ancestor
14977237|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
14977238|NCT05137067|Cisplatin|cisplatin|mesh-list
14977239|NCT05137067|Docetaxel|docetaxel|mesh-list
14977240|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
14977241|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
14977242|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
14977243|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
14977244|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977245|NCT05136157|Insulin|insulin|mesh-list
14977246|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14977247|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
14977248|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977249|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977250|NCT05134974|Phentolamine|phentolamine|mesh-list
14977251|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14977252|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14977253|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14977254|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14977255|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
14977256|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977257|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977258|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977259|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14977260|NCT05132439|Metformin|metformin|mesh-list
14977261|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977262|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977263|NCT05132114|Lugol's solution|lugol's solution|mesh-list
14977264|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
14977265|NCT05132114|Coagulants|coagulants|mesh-ancestor
14977266|NCT05129137|Acetaminophen|acetaminophen|mesh-list
14977267|NCT05129137|Nefopam|nefopam|mesh-list
14977268|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14977269|NCT05129137|Analgesics|analgesics|mesh-ancestor
14977270|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
14977271|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977272|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977273|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
14977274|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
14977275|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14977276|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977277|NCT05111314|Edetic Acid|edetic acid|mesh-list
14977278|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14977279|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
14977280|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
14977281|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977282|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
14977283|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14977284|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14977285|NCT05110898|Olmesartan|olmesartan|mesh-list
14977286|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14977287|NCT05110898|Indapamide|indapamide|mesh-list
14977288|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14977289|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14977290|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14977291|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977292|NCT05110898|Diuretics|diuretics|mesh-ancestor
14977293|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
14977294|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977295|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14977296|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977297|NCT05110638|Luliconazole|luliconazole|mesh-list
14977298|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
14977299|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977300|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
14977301|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14977302|NCT05110001|Natamycin|natamycin|mesh-list
14977303|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
14977304|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14977305|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977306|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
14977307|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
14977308|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977309|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14977310|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14977311|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977312|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977313|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977314|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
14977315|NCT05109442|Atezolizumab|atezolizumab|mesh-list
14977316|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977317|NCT05108428|Capecitabine|capecitabine|mesh-list
14977318|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14977319|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
14977320|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977321|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977322|NCT05107427|Avelumab|avelumab|mesh-list
14977323|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977324|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977325|NCT05103696|Propofol|propofol|mesh-list
14977326|NCT05103696|Etomidate|etomidate|mesh-list
14977327|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14977328|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977329|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977330|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14977331|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
14977332|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
15029686|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029687|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15029688|NCT01964287|Leucovorin|leucovorin|mesh-list
15029689|NCT01964287|Gemcitabine|gemcitabine|mesh-list
15029690|NCT01964287|Paclitaxel|paclitaxel|mesh-list
15029691|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
15029692|NCT01964287|Irinotecan|irinotecan|mesh-list
15029693|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15029694|NCT01964287|Folfirinox|folfirinox|mesh-list
15029695|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15029696|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029697|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
15029698|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
15029699|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
15029700|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029701|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15029702|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
15029703|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
15029704|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029705|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029706|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029707|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
15029708|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029709|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15029710|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15029711|NCT01964287|Antidotes|antidotes|mesh-ancestor
15029712|NCT01964287|Protective Agents|protective agents|mesh-ancestor
15029713|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
15029714|NCT01964287|Vitamins|vitamins|mesh-ancestor
15029715|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
15029716|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
15029717|NCT01964365|Fenofibrate|fenofibrate|mesh-list
15029718|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15029719|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15029720|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
15029721|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029722|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15029723|NCT01964391|Paclitaxel|paclitaxel|mesh-list
15029724|NCT01964391|Docetaxel|docetaxel|mesh-list
15029725|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
15029726|NCT01964391|Carboplatin|carboplatin|mesh-list
15029727|NCT01964391|Doxorubicin|doxorubicin|mesh-list
15029728|NCT01964391|Trastuzumab|trastuzumab|mesh-list
15029729|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15029730|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977333|NCT05098041|Rifampin|rifampin|mesh-list
14977334|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14977335|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
14977336|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977337|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977338|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
14977339|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14977340|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977341|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977342|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14977343|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14977344|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14977345|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14977346|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14977347|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14977348|NCT05096325|Insulin|insulin|mesh-list
14977349|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977350|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977351|NCT05096065|Leuprolide|leuprolide|mesh-list
14977352|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14977353|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
14977354|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14977355|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977356|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14977357|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977358|NCT05094427|Anesthetics|anesthetics|mesh-list
14977359|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
14977360|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977361|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977362|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
14977363|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977364|NCT05093608|Bevacizumab|bevacizumab|mesh-list
14977365|NCT05093608|Atezolizumab|atezolizumab|mesh-list
14977366|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977367|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977368|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14977369|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14977370|NCT05093608|Growth Substances|growth substances|mesh-ancestor
14977371|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977372|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
14977373|NCT05092373|Paclitaxel|paclitaxel|mesh-list
14977374|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14977375|NCT05092373|Atezolizumab|atezolizumab|mesh-list
14977376|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14977377|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14977378|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977379|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
14977380|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
14977381|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
14977382|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977383|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
14977384|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977385|NCT05090384|Prednisone|prednisone|mesh-list
14977386|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977387|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
14977388|NCT05090384|Hormones|hormones|mesh-ancestor
14977389|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977390|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977391|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14977392|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977393|NCT05085574|Celecoxib|celecoxib|mesh-list
14977394|NCT05085574|Famotidine|famotidine|mesh-list
14977395|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14977396|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14977397|NCT05085574|Analgesics|analgesics|mesh-ancestor
14977398|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
14977399|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977400|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977401|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977402|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977403|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14977404|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14977405|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029731|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
14977406|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977407|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14977408|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14977409|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14977410|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
14977411|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
14977412|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977413|NCT05085002|Letrozole|letrozole|mesh-list
14977414|NCT05085002|Fulvestrant|fulvestrant|mesh-list
14977415|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977416|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14977417|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14977418|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977419|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977420|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14977421|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
14977422|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977423|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977424|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14977425|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14977426|NCT05084248|Vitamin D|vitamin d|mesh-list
14977427|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
14977428|NCT05084248|Vitamins|vitamins|mesh-ancestor
14977429|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
14977430|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977431|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14977432|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14977433|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14977434|NCT05083572|Rifaximin|rifaximin|mesh-list
14977435|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977436|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14977437|NCT05081180|Lenvatinib|lenvatinib|mesh-list
14977438|NCT05081180|Avelumab|avelumab|mesh-list
14977439|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977440|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14977441|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977442|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977443|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977444|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14977445|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14977446|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14977447|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977448|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977449|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
14977450|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977451|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977452|NCT05070364|Interferons|interferons|mesh-list
14977453|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977454|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
14977455|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977456|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
14977457|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14977458|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977459|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977460|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977461|NCT05057819|Empagliflozin|empagliflozin|mesh-list
14977462|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14977463|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977464|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977465|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977466|NCT05057273|Adalimumab|adalimumab|mesh-list
14977467|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977468|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977469|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
14977470|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977471|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977472|NCT05050136|Volixibat|volixibat|mesh-list
14977473|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15029732|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
15029733|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
15029734|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029735|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029736|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
14977474|NCT05039476|Vitamin A|vitamin a|mesh-list
14977475|NCT05039476|Vitamins|vitamins|mesh-ancestor
14977476|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
14977477|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977478|NCT05036018|Anesthetics|anesthetics|mesh-list
14977479|NCT05036018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977480|NCT05036018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977481|NCT05035680|Vaccines|vaccines|mesh-list
14977482|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
14977483|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977484|NCT05033743|Secnidazole|secnidazole|mesh-list
14977485|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14977486|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14977487|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977488|NCT05030025|Lamivudine|lamivudine|mesh-list
14977489|NCT05030025|Abacavir|abacavir|mesh-list
14977490|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
14977491|NCT05030025|Dolutegravir|dolutegravir|mesh-list
14977492|NCT05030025|Triumeq|triumeq|mesh-list
14977493|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14977494|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14977495|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977496|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977497|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
14977498|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977499|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14977500|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14977501|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
14977502|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14977503|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14977504|NCT05027646|Granisetron|granisetron|mesh-list
14977505|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
14977506|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
14977507|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977508|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977509|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14977510|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14977511|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
14977512|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977513|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977514|NCT05022901|Melphalan|melphalan|mesh-list
14977515|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14977516|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
14977517|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977518|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977519|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14977520|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977521|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
14977522|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977523|NCT05022524|Acetic Acid|acetic acid|mesh-list
14977524|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977525|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977526|NCT05021991|Pramoxine|pramoxine|mesh-list
14977527|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
14977528|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
14977529|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977530|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977531|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
14977532|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977533|NCT05021809|Calcium|calcium|mesh-list
14977534|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14977535|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977536|NCT05017584|Bupivacaine|bupivacaine|mesh-list
14977537|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
14977538|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
14977539|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977540|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800868|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
14800869|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14800870|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14800871|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14800872|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800873|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14800874|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800875|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14800876|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14977541|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
14977542|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977543|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
14977544|NCT05014776|Ipilimumab|ipilimumab|mesh-list
14977545|NCT05014776|Tadalafil|tadalafil|mesh-list
14977546|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977547|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977548|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14977549|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977550|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14977551|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14977552|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14977553|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977554|NCT05014776|Urological Agents|urological agents|mesh-ancestor
14977555|NCT05013567|Ibuprofen|ibuprofen|mesh-list
14977556|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14977557|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14977558|NCT05013567|Analgesics|analgesics|mesh-ancestor
14977559|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
14977560|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977561|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977562|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977563|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977564|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14977565|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977566|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977567|NCT05013502|Empagliflozin|empagliflozin|mesh-list
14977568|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14977569|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800877|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
14800878|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14800879|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14800880|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14800881|NCT00790114|Midazolam|midazolam|mesh-list
14800882|NCT00790114|Caffeine|caffeine|mesh-list
14800883|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14800884|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14977570|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977571|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977572|NCT05013229|Insulin|insulin|mesh-list
14977573|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14977574|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
14977575|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
14977576|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977577|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977578|NCT05008926|Naloxegol|naloxegol|mesh-list
14977579|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14977580|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977581|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
14977582|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977583|NCT05007821|Linezolid|linezolid|mesh-list
14977584|NCT05007821|Bedaquiline|bedaquiline|mesh-list
14977585|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
14977586|NCT05007821|Clofazimine|clofazimine|mesh-list
14977587|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977588|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977589|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14977590|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977591|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977592|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
14977593|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977594|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
14977595|NCT05004350|Fluorouracil|fluorouracil|mesh-list
14977596|NCT05004350|Irinotecan|irinotecan|mesh-list
14977597|NCT05004350|Cetuximab|cetuximab|mesh-list
14977598|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
14977599|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977600|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14977601|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977602|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977603|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
14977604|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977605|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14977606|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14977607|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977608|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977609|NCT05001373|Vaccines|vaccines|mesh-list
14977610|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
14977611|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977612|NCT04999644|Nicotine|nicotine|mesh-list
14977613|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14977614|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
14977615|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977616|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977617|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14977618|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14977619|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
14977620|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977621|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977622|NCT04992065|Evolocumab|evolocumab|mesh-list
14977623|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14977624|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14977625|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
14977626|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977627|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14977628|NCT04989621|Rituximab|rituximab|mesh-list
14977629|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977630|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977631|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
14977632|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977633|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977634|NCT04989049|Folic Acid|folic acid|mesh-list
14977635|NCT04989049|Hematinics|hematinics|mesh-ancestor
14977636|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
14977637|NCT04989049|Vitamins|vitamins|mesh-ancestor
14977638|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
14977639|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977640|NCT04988295|Carboplatin|carboplatin|mesh-list
14977641|NCT04988295|Pemetrexed|pemetrexed|mesh-list
14977642|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
14977643|NCT04988295|Lazertinib|lazertinib|mesh-list
14977644|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977645|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977646|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977647|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14977648|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14977649|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14977650|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977651|NCT04984993|Tadalafil|tadalafil|mesh-list
14977652|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
14977653|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14977654|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14977655|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977656|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977657|NCT04984993|Urological Agents|urological agents|mesh-ancestor
14977658|NCT04984044|Vitamin D|vitamin d|mesh-list
14977659|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
14977660|NCT04984044|Vitamins|vitamins|mesh-ancestor
14977661|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
14977662|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977663|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14977664|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15029737|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029738|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029739|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15029740|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
15029741|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15029742|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15029743|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15029744|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15029745|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029746|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15029747|NCT01964404|Dronabinol|dronabinol|mesh-list
15029748|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
15029749|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029750|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15029751|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15029752|NCT01964404|Analgesics|analgesics|mesh-ancestor
15029753|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
15029754|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029755|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15029756|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15029757|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029758|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029759|NCT01964404|Hormones|hormones|mesh-ancestor
15029760|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029761|NCT01964534|Gemcitabine|gemcitabine|mesh-list
15029762|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15029763|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15029764|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
15029765|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029766|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029767|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
15029768|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029769|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029770|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15029771|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
15029772|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029773|NCT01964573|Rotigotine|rotigotine|mesh-list
15029774|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
15029775|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
15029776|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029777|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029778|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029779|NCT01964586|Lidocaine|lidocaine|mesh-list
15029780|NCT01964586|Epinephrine|epinephrine|mesh-list
15029781|NCT01964586|Racepinephrine|racepinephrine|mesh-list
15029782|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
15029783|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
15029784|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029785|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
15029786|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029787|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029788|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
15029789|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029790|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15029791|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15029792|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15029793|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977665|NCT04981912|Rituximab|rituximab|mesh-list
14977666|NCT04981912|Venetoclax|venetoclax|mesh-list
14977667|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977668|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977669|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
14977670|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977671|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977672|NCT04979780|Heparin|heparin|mesh-list
14977673|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14977674|NCT04979780|Tinzaparin|tinzaparin|mesh-list
14977675|NCT04979780|Dalteparin|dalteparin|mesh-list
14977676|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
14977677|NCT04979780|Anticoagulants|anticoagulants|mesh-list
14977678|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14977679|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14977680|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977681|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14977682|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
14977683|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14977684|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
14977685|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977686|NCT04979442|Trabectedin|trabectedin|mesh-list
14977687|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14977688|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
14977689|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977690|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977691|NCT04979065|Vitamin D|vitamin d|mesh-list
14977692|NCT04979065|Vitamins|vitamins|mesh-ancestor
14977693|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
14977694|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977695|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14977696|NCT04976036|Nintedanib|nintedanib|mesh-list
14977697|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977698|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14977699|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977700|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977701|NCT04975802|Caffeine|caffeine|mesh-list
14977702|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14977703|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977704|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14977705|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977706|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977707|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14977708|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14977709|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
14977710|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977711|NCT04973930|Citalopram|citalopram|mesh-list
14977712|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14977713|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14977714|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14977715|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977716|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977717|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977718|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
14977719|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977720|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14977721|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
14977722|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977723|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14977724|NCT04972552|Ubiquinone|ubiquinone|mesh-list
14977725|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
14977726|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
14977727|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977728|NCT04972552|Vitamins|vitamins|mesh-ancestor
14977729|NCT04971499|Dapansutrile|dapansutrile|mesh-list
14977730|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
14977731|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14977732|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977733|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977734|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
14977735|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14977736|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14977737|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
14977738|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14977739|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977740|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977741|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
14977742|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977743|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977744|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14977745|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977746|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
14977747|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14977748|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977749|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977750|NCT04966585|Posaconazole|posaconazole|mesh-list
14977751|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
14977752|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977753|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14977754|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14977755|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14977756|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14977757|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14977758|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977759|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977760|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14977761|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
14977762|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977763|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977764|NCT04964700|Natalizumab|natalizumab|mesh-list
14977765|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
14977766|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977767|NCT04960202|Ritonavir|ritonavir|mesh-list
14977768|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14977769|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14977770|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
14977771|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977772|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977773|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14977774|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14977775|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
14977776|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977777|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14977778|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14977779|NCT04952779|Insulin|insulin|mesh-list
14977780|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14977781|NCT04952779|Liraglutide|liraglutide|mesh-list
14977782|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
14977783|NCT04952779|Xultophy|xultophy|mesh-list
14977784|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977785|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977786|NCT04952779|Incretins|incretins|mesh-ancestor
14977787|NCT04952779|Hormones|hormones|mesh-ancestor
14977788|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977789|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14977790|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
14977791|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977792|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14977793|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14977794|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977795|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977796|NCT04950764|Seladelpar|seladelpar|mesh-list
14977797|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14977798|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
14977799|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977800|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14977801|NCT04941521|Exenatide|exenatide|mesh-list
14977802|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977803|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977804|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14977805|NCT04941521|Incretins|incretins|mesh-ancestor
14977806|NCT04941521|Hormones|hormones|mesh-ancestor
14977807|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977808|NCT04940767|Minocycline|minocycline|mesh-list
14977809|NCT04940767|Isotretinoin|isotretinoin|mesh-list
14977810|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977811|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977812|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14977813|NCT04939597|Memantine|memantine|mesh-list
14977814|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14977815|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14977816|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
14977817|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977818|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977819|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977820|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14977821|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14977822|NCT04936854|Sirolimus|sirolimus|mesh-list
14977823|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
14977824|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14977825|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14977826|NCT04936854|Prednisolone|prednisolone|mesh-list
14977827|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
14977828|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14977829|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
14977830|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977831|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977832|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14977833|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977834|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
14977835|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977836|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
14977837|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977838|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14977839|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
14977840|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
14977841|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977842|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14977843|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
14977844|NCT04936854|Hormones|hormones|mesh-ancestor
14977845|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977846|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14977847|NCT04936854|Protective Agents|protective agents|mesh-ancestor
14977848|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14977849|NCT04933942|Lomustine|lomustine|mesh-list
14977850|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14977851|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
14977852|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977853|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977854|NCT04926181|Androgens|androgens|mesh-list
14977855|NCT04926181|Hormones|hormones|mesh-ancestor
14977856|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977857|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977858|NCT04921527|Paclitaxel|paclitaxel|mesh-list
14977859|NCT04921527|Chiauranib|chiauranib|mesh-list
14977860|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14977861|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977862|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
14977863|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
14977864|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
14977865|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977866|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14977867|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029794|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029795|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15029796|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15029797|NCT01964586|Analgesics|analgesics|mesh-ancestor
15029798|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15029799|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15029800|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15029801|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
15029802|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029803|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15029804|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15029805|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
15029806|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15029807|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
15029808|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
15029809|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
15029810|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15029811|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
15029812|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029813|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029814|NCT01964781|Epinephrine|epinephrine|mesh-list
15029815|NCT01964781|Racepinephrine|racepinephrine|mesh-list
15029816|NCT01964781|Bupivacaine|bupivacaine|mesh-list
15029817|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
15029818|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
15029819|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029820|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
15029821|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029822|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029823|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
15029824|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029825|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15029826|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15029827|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029828|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
15029829|NCT01964781|Coagulants|coagulants|mesh-ancestor
15029830|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15029831|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15029832|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
15029833|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029834|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15029835|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14977868|NCT04908800|Itraconazole|itraconazole|mesh-list
14977869|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
14977870|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977871|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14977872|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14977873|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977874|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977875|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14977876|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
14977877|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977878|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977879|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14977880|NCT04908176|Midazolam|midazolam|mesh-list
14977881|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14977882|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14977883|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14977884|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977885|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14977886|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14977887|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977888|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14977889|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
14977890|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
14977891|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
14977892|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
14977893|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977894|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977895|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
14977896|NCT04899843|Astringents|astringents|mesh-ancestor
14977897|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977898|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
14977899|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
14977900|NCT04899687|Fluoxetine|fluoxetine|mesh-list
14977901|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14977902|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14977903|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14977904|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977905|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14977906|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
14977907|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977908|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14977909|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
14977910|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977911|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14977912|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14977913|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977914|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
14977915|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
14977916|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14977917|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14977918|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
14977919|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14977920|NCT04897802|Exenatide|exenatide|mesh-list
14977921|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14977922|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977923|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14977924|NCT04897802|Incretins|incretins|mesh-ancestor
14977925|NCT04897802|Hormones|hormones|mesh-ancestor
14977926|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14977927|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14977928|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
14977929|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977930|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
14977931|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977932|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
14977933|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
14977934|NCT04882332|Vitamins|vitamins|mesh-ancestor
14977935|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
14977936|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977937|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
14977938|NCT04882332|Hematinics|hematinics|mesh-ancestor
14977939|NCT04882202|Acetaminophen|acetaminophen|mesh-list
14977940|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14977941|NCT04882202|Analgesics|analgesics|mesh-ancestor
14977942|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
14977943|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14977944|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977945|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
14977946|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
14977947|NCT04881240|Fludarabine|fludarabine|mesh-list
14977948|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977949|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
14977950|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977951|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977952|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14977953|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
14977954|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977955|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800885|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14800886|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800887|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14800888|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14800889|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14800890|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14800891|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
14800892|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
14800893|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
14800894|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
14800895|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14800896|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800897|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14800898|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14800899|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800900|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14977956|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14977957|NCT04877990|BMS-986165|bms-986165|mesh-list
14977958|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
14977959|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14977960|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977961|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977962|NCT04877288|Cyclosporine|cyclosporine|mesh-list
14977963|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
14977964|NCT04877288|Abatacept|abatacept|mesh-list
14977965|NCT04877288|Tacrolimus|tacrolimus|mesh-list
14977966|NCT04877288|Cyclosporins|cyclosporins|mesh-list
14977967|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14977968|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
14977969|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977970|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14977971|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14977972|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14977973|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
14977974|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14977975|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
14977976|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14977977|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14977978|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977979|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14977980|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
14977981|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14977982|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14977983|NCT04876248|Lenalidomide|lenalidomide|mesh-list
14977984|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
14977985|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14977986|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14977987|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14977988|NCT04876248|Growth Substances|growth substances|mesh-ancestor
14977989|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
14977990|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14977991|NCT04871607|Cytarabine|cytarabine|mesh-list
14977992|NCT04871607|Etoposide|etoposide|mesh-list
14977993|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
14977994|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
14977995|NCT04871607|Carmustine|carmustine|mesh-list
14977996|NCT04871607|Basiliximab|basiliximab|mesh-list
14977997|NCT04871607|Sargramostim|sargramostim|mesh-list
14977998|NCT04871607|Lenograstim|lenograstim|mesh-list
14977999|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14978000|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978001|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14978002|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14978003|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978004|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978005|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14978006|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
14978007|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
14978008|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978009|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14978010|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
14978011|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978012|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14978013|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14978014|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
14978015|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
14978016|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
14978017|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
14978018|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
14978019|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
14978020|NCT04871425|Fentanyl|fentanyl|mesh-list
14978021|NCT04871425|Ketamine|ketamine|mesh-list
14978022|NCT04871425|Analgesics|analgesics|mesh-ancestor
14978023|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
14978024|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978025|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978026|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14978027|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978028|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
14978029|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
14978030|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978031|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14978032|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14978033|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978034|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978035|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14978036|NCT04871425|Narcotics|narcotics|mesh-ancestor
14978037|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14978038|NCT04862975|Tenofovir|tenofovir|mesh-list
14978039|NCT04862975|Emtricitabine|emtricitabine|mesh-list
14978040|NCT04862975|Efavirenz|efavirenz|mesh-list
14978041|NCT04862975|Dolutegravir|dolutegravir|mesh-list
14978042|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
14978043|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978044|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14978045|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14978046|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978047|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978048|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14978049|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14978050|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14978051|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14978052|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14978053|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14978054|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14978055|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14978056|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14978057|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14978058|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
14978059|NCT04862221|Promethazine|promethazine|mesh-list
14978060|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
15029836|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
14978061|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14978062|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14978063|NCT04862221|Prednisolone|prednisolone|mesh-list
14978064|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
14978065|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14978066|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
14978067|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14978068|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978069|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
14978070|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
14978071|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978072|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978073|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978074|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
14978075|NCT04862221|Hormones|hormones|mesh-ancestor
14978076|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978077|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14978078|NCT04862221|Protective Agents|protective agents|mesh-ancestor
14978079|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978080|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978081|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
14978082|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14978083|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14978084|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978085|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978086|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
14978087|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
14978088|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
14978089|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14978090|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
14978091|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
14978092|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978093|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978094|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14978095|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
14978096|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
14978097|NCT04860960|Betadex|betadex|mesh-list
14978098|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
14978099|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978100|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
14978101|NCT04848337|Lenvatinib|lenvatinib|mesh-list
14978102|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978103|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978104|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14978105|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978106|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978107|NCT04847193|Xanthohumol|xanthohumol|mesh-list
14978108|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978109|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14978110|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14978111|NCT04847193|Growth Substances|growth substances|mesh-ancestor
14978112|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978113|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
15029837|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15029838|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
15029839|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
15029840|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
15029841|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15029842|NCT01964846|Curcumin|curcumin|mesh-list
15029843|NCT01964846|Resveratrol|resveratrol|mesh-list
15029844|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15029845|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15029846|NCT01964846|Analgesics|analgesics|mesh-ancestor
15029847|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
15029848|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029849|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029850|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029851|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15029852|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029853|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029854|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029855|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
15029856|NCT01964846|Protective Agents|protective agents|mesh-ancestor
15029857|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15029858|NCT01964911|Ropivacaine|ropivacaine|mesh-list
15029859|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
14978114|NCT04843631|Ustekinumab|ustekinumab|mesh-list
14978115|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14978116|NCT04840199|Letermovir|letermovir|mesh-list
14978117|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14978118|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978119|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978120|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978121|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
14978122|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978123|NCT04838743|Xultophy|xultophy|mesh-list
14978124|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978125|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978126|NCT04838743|Incretins|incretins|mesh-ancestor
14978127|NCT04838743|Hormones|hormones|mesh-ancestor
14978128|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978129|NCT04835584|Dasatinib|dasatinib|mesh-list
14978130|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978131|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14978132|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978133|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978134|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
14978135|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978136|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978137|NCT04826393|Cemiplimab|cemiplimab|mesh-list
14978138|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978139|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978140|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
14978141|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14978142|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978143|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978144|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978145|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14978146|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
14978147|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14978148|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14978149|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14978150|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14978151|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978152|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14978153|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978154|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978155|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14978156|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978157|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14978158|NCT04812912|Hormones|hormones|mesh-list
14978159|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978160|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978161|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14978162|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14978163|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14978164|NCT04800107|Curcumin|curcumin|mesh-list
14978165|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14978166|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14978167|NCT04800107|Analgesics|analgesics|mesh-ancestor
14978168|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
14978169|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978170|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978171|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978172|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14978173|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978174|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978175|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978176|NCT04793867|Xenon|xenon|mesh-list
14978177|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14978178|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
14978179|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
14978180|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978181|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978182|NCT04791969|Naltrexone|naltrexone|mesh-list
14978183|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14978184|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14978185|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978186|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
15029860|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
14978187|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978188|NCT04790474|Dexamethasone|dexamethasone|mesh-list
14978189|NCT04790474|Pomalidomide|pomalidomide|mesh-list
14978190|NCT04790474|Ixazomib|ixazomib|mesh-list
14978191|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978192|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
14978193|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
14978194|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978195|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978196|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978197|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
14978198|NCT04790474|Hormones|hormones|mesh-ancestor
14978199|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978200|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978201|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978202|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
14978203|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14978204|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14978205|NCT04790474|Growth Substances|growth substances|mesh-ancestor
14978206|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
14978207|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
14978208|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978209|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978210|NCT04781647|Interferons|interferons|mesh-list
14978211|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
14978212|NCT04781647|Entecavir|entecavir|mesh-list
14978213|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978214|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
14978215|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978216|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
14978217|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978218|NCT04781192|Durvalumab|durvalumab|mesh-list
14978219|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978220|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978221|NCT04779320|Vedolizumab|vedolizumab|mesh-list
14978222|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978223|NCT04777539|Natalizumab|natalizumab|mesh-list
14978224|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
14978225|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029861|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029862|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029863|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
15029864|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035164|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035165|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15035166|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035167|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15035168|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035169|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15035170|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15035171|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
15035172|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035173|NCT01999842|Vaccines|vaccines|mesh-list
15035174|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
15035175|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035176|NCT01999907|Vitamin D|vitamin d|mesh-list
15035177|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
15035178|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
15035179|NCT01999907|Vitamins|vitamins|mesh-list
15035180|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
15035181|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035182|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15035183|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15035184|NCT01999933|Cisplatin|cisplatin|mesh-list
15035185|NCT01999933|Docetaxel|docetaxel|mesh-list
15035186|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035187|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035188|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035189|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035190|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035191|NCT02000089|Secretin|secretin|mesh-list
15035192|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035193|NCT02000089|Hormones|hormones|mesh-ancestor
15035194|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035195|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035196|NCT02000102|Aflibercept|aflibercept|mesh-list
14978226|NCT04774380|Carboplatin|carboplatin|mesh-list
14978227|NCT04774380|Etoposide|etoposide|mesh-list
14978228|NCT04774380|Durvalumab|durvalumab|mesh-list
14978229|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978230|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14978231|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14978232|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14978233|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978234|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978235|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978236|NCT04774315|Omalizumab|omalizumab|mesh-list
14978237|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14978238|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14978239|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
14978240|NCT04767503|Propofol|propofol|mesh-list
14978241|NCT04767503|Desflurane|desflurane|mesh-list
14978242|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978243|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978244|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978245|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978246|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
14978247|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
14978248|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14978249|NCT04763564|Liraglutide|liraglutide|mesh-list
14978250|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978251|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978252|NCT04763564|Incretins|incretins|mesh-ancestor
14978253|NCT04763564|Hormones|hormones|mesh-ancestor
14978254|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978255|NCT04763252|Coal Tar|coal tar|mesh-list
14978256|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
14978257|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
14978258|NCT04762888|Edetic Acid|edetic acid|mesh-list
14978259|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14978260|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
14978261|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
14978262|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978263|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
14978264|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14978265|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14978266|NCT04762199|Osimertinib|osimertinib|mesh-list
14978267|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978268|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14978269|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978270|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978271|NCT04761159|Ketamine|ketamine|mesh-list
14978272|NCT04761159|Analgesics|analgesics|mesh-ancestor
14978273|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
14978274|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978275|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978276|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14978277|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978278|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
14978279|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
14978280|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978281|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14978282|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14978283|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978284|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978285|NCT04760496|Oxytocin|oxytocin|mesh-list
14978286|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
14978287|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14978288|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978289|NCT04760288|Pralsetinib|pralsetinib|mesh-list
14978290|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978291|NCT04753216|Bevacizumab|bevacizumab|mesh-list
14978292|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14978293|NCT04753216|Irinotecan|irinotecan|mesh-list
14978294|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
14978295|NCT04753216|Antibodies|antibodies|mesh-list
14978296|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
14978297|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14978298|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
14978299|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978300|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14978301|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14978302|NCT04753216|Growth Substances|growth substances|mesh-ancestor
15029865|NCT01965041|Aflibercept|aflibercept|mesh-list
14978303|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978304|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
14978305|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
14978306|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14978307|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14978308|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978309|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978310|NCT04752033|Morphine|morphine|mesh-list
14978311|NCT04752033|Hydromorphone|hydromorphone|mesh-list
14978312|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14978313|NCT04752033|Narcotics|narcotics|mesh-ancestor
15035631|NCT02002260|Estrogens|estrogens|mesh-ancestor
15035632|NCT02002260|Hormones|hormones|mesh-ancestor
15035633|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035634|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035635|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15035636|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15035637|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15035638|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15035639|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15035640|NCT02002286|Triptolide|triptolide|mesh-list
15035641|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14978314|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978315|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978316|NCT04752033|Analgesics|analgesics|mesh-ancestor
14978317|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
14978318|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978319|NCT04750967|Lidocaine|lidocaine|mesh-list
14978320|NCT04750967|Amitriptyline|amitriptyline|mesh-list
14978321|NCT04750967|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14978322|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
14978323|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
14978324|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978325|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978326|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
14978327|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978328|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14978329|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14978330|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14978331|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14978332|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978333|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14978334|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
14978335|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14978336|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14978337|NCT04750967|Analgesics|analgesics|mesh-ancestor
14978338|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14978339|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14978340|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
14978341|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978342|NCT04750967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14978343|NCT04750967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14978344|NCT04742634|Decitabine|decitabine|mesh-list
14978345|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14978346|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
14978347|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978348|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978349|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978350|NCT04741698|Propranolol|propranolol|mesh-list
14978351|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14978352|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14978353|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
14978354|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978355|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978356|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978357|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14978358|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14978359|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
14978360|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14978361|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
14978362|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14978363|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
14978364|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14978365|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978366|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14978367|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978368|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978369|NCT04733547|Furosemide|furosemide|mesh-list
14978370|NCT04733547|Diuretics|diuretics|mesh-ancestor
14978371|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
14978372|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978373|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14978374|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14978375|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978376|NCT04731480|Propofol|propofol|mesh-list
14978377|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978378|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978379|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978380|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978381|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
14978382|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
14978383|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
14978384|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14978385|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978386|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978387|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978388|NCT04727138|Midazolam|midazolam|mesh-list
14978389|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14978390|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978391|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978392|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978393|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14978394|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14978395|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14978396|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978397|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
14978398|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
14978399|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
14978400|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
14978401|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978402|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978403|NCT04722679|Anticoagulants|anticoagulants|mesh-list
14978404|NCT04718961|Volixibat|volixibat|mesh-list
14978405|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14978406|NCT04716712|Azithromycin|azithromycin|mesh-list
14978407|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14978408|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978409|NCT04711837|Propofol|propofol|mesh-list
14978410|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978411|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978412|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978413|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978414|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
14978415|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
14978416|NCT04707794|Sevoflurane|sevoflurane|mesh-list
14978417|NCT04707794|Desflurane|desflurane|mesh-list
14978418|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14978419|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14978420|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
14978421|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
14978422|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978423|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978424|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
14978425|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978426|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
14978427|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978428|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978429|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14978430|NCT04707196|Fulvestrant|fulvestrant|mesh-list
14978431|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14978432|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978433|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978434|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14978435|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14978436|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
14978437|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978438|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978439|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14978440|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978441|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978442|NCT04706507|Ganciclovir|ganciclovir|mesh-list
14978443|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
14978444|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
14978445|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978446|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14978447|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978448|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978449|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
14978450|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14978451|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
14978452|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978453|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
14978454|NCT04704518|Protective Agents|protective agents|mesh-ancestor
15029866|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15029867|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15029868|NCT01965041|Growth Substances|growth substances|mesh-ancestor
15029869|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029870|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
15029871|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029872|NCT01965080|Exemestane|exemestane|mesh-list
14978455|NCT04699461|Idelalisib|idelalisib|mesh-list
14978456|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14978457|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978458|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978459|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978460|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978461|NCT04696380|Nicotine|nicotine|mesh-list
14978462|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14978463|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
14978464|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978465|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978466|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14978467|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14978468|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
14978469|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978470|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978471|NCT04695847|Antibodies|antibodies|mesh-list
14978472|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
14978473|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
14978474|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14978475|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
14978476|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978477|NCT04690855|Atezolizumab|atezolizumab|mesh-list
14978478|NCT04690855|Talazoparib|talazoparib|mesh-list
14978479|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978480|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14978481|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978482|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978483|NCT04682574|Ascorbic Acid|ascorbic acid|mesh-list
14978484|NCT04682574|Vitamins|vitamins|mesh-ancestor
14978485|NCT04682574|Micronutrients|micronutrients|mesh-ancestor
14978486|NCT04682574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978487|NCT04682574|Antioxidants|antioxidants|mesh-ancestor
14978488|NCT04682574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978489|NCT04682574|Protective Agents|protective agents|mesh-ancestor
14978490|NCT04672772|Paclitaxel|paclitaxel|mesh-list
14978491|NCT04672772|Cetuximab|cetuximab|mesh-list
14523200|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523201|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14523202|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523203|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14523204|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523205|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14523206|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14523207|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
14523208|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523209|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
14523210|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14523211|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
14523212|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14523213|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
14523214|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523215|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523216|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
14523217|NCT03579719|Itraconazole|itraconazole|mesh-list
14523218|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
14978492|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14978493|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978494|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14978495|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14978496|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14978497|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978498|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978499|NCT04671082|Tolperisone|tolperisone|mesh-list
14978500|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14978501|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978502|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14978503|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978504|NCT04669587|Palbociclib|palbociclib|mesh-list
14978505|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978506|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14978507|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978508|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978509|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
14978510|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14978511|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
14978512|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978513|NCT04659382|Bevacizumab|bevacizumab|mesh-list
14978514|NCT04659382|Atezolizumab|atezolizumab|mesh-list
14978515|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978516|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978517|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14978518|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14978519|NCT04659382|Growth Substances|growth substances|mesh-ancestor
14978520|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978521|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
14978522|NCT04658823|Vitamin E|vitamin e|mesh-list
14978523|NCT04658823|Tocopherols|tocopherols|mesh-list
14978524|NCT04658823|Tocotrienols|tocotrienols|mesh-list
14978525|NCT04658823|Tocovid|tocovid|mesh-list
14978526|NCT04658823|Vitamins|vitamins|mesh-ancestor
14978527|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
14978528|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978529|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
14978530|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978531|NCT04658823|Protective Agents|protective agents|mesh-ancestor
14978532|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
14978533|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978534|NCT04657016|Tirzepatide|tirzepatide|mesh-list
14978535|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978536|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978537|NCT04657016|Incretins|incretins|mesh-ancestor
14978538|NCT04657016|Hormones|hormones|mesh-ancestor
14978539|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978540|NCT04655144|Dexamethasone|dexamethasone|mesh-list
14978541|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978542|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
14978543|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
14978544|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978545|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978546|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978547|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
14978548|NCT04655144|Hormones|hormones|mesh-ancestor
14978549|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978550|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978551|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978552|NCT04649476|Cisplatin|cisplatin|mesh-list
14978553|NCT04649476|Docetaxel|docetaxel|mesh-list
14978554|NCT04649476|Fluorouracil|fluorouracil|mesh-list
14978555|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978556|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
14978557|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
14978558|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
14978559|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978560|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
14978561|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14978562|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14978563|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
14978564|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978565|NCT04648241|Vaccines|vaccines|mesh-list
14978566|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
14978567|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978568|NCT04640818|Rituximab|rituximab|mesh-list
14978569|NCT04640818|Cladribine|cladribine|mesh-list
14978570|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
14978571|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978572|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978573|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
14978574|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978575|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14978576|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14978577|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
14978578|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14978579|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978580|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978581|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978582|NCT04638660|Phentolamine|phentolamine|mesh-list
14978583|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14978584|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14978585|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14978586|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14978587|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
14978588|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978589|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978590|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978591|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14978592|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
14978593|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978594|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978595|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978596|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14978597|NCT04635098|Analgesics|analgesics|mesh-ancestor
14978598|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
14978599|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978600|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14978601|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14978602|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14978603|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
14978604|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978605|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978606|NCT04626791|Cytarabine|cytarabine|mesh-list
14978607|NCT04626791|Prednisone|prednisone|mesh-list
14978608|NCT04626791|Cortisone|cortisone|mesh-list
14978609|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
14978610|NCT04626791|Rituximab|rituximab|mesh-list
14978611|NCT04626791|Doxorubicin|doxorubicin|mesh-list
14978612|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14978613|NCT04626791|Bortezomib|bortezomib|mesh-list
14978614|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
14978615|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14978616|NCT04626791|Antibodies|antibodies|mesh-list
14978617|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
14978618|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14978619|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14978620|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
14978621|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978622|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14978623|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14978624|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
14978625|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978626|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978627|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14978628|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14978629|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14978630|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14978631|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978632|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978633|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
14978634|NCT04626791|Hormones|hormones|mesh-ancestor
14978635|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978636|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978637|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14978638|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
14978639|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
14978640|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978641|NCT04626635|Cemiplimab|cemiplimab|mesh-list
14978642|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978643|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978644|NCT04625777|Vaccines|vaccines|mesh-list
14978645|NCT04625777|Immunologic Factors|immunologic factors|mesh-ancestor
14978646|NCT04625777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978647|NCT04623775|Paclitaxel|paclitaxel|mesh-list
14978648|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14978649|NCT04623775|Carboplatin|carboplatin|mesh-list
14978650|NCT04623775|Nivolumab|nivolumab|mesh-list
14978651|NCT04623775|Pemetrexed|pemetrexed|mesh-list
14978652|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14978653|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978654|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
14978655|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
14978656|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
14978657|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978658|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978659|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14978660|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978661|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14978662|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14978663|NCT04616547|Edetic Acid|edetic acid|mesh-list
14978664|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
14978665|NCT04616547|Antidotes|antidotes|mesh-ancestor
14978666|NCT04616547|Protective Agents|protective agents|mesh-ancestor
14978667|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978668|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
14978669|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
14978670|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978671|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14978672|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
14978673|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15029873|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029874|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15029875|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15029876|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029877|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029878|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15029879|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
15029880|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029881|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029882|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15029883|NCT01965275|Gefitinib|gefitinib|mesh-list
15029884|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029885|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15029886|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029887|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029888|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
15029889|NCT01965301|Promethazine|promethazine|mesh-list
15029890|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15029891|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15029892|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029893|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029894|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
15029895|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
15029896|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
15029897|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029898|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
15029899|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
15029900|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029901|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15029902|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
15029903|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
15029904|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029905|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029906|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15029907|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
15029908|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029909|NCT01965353|Dexamethasone|dexamethasone|mesh-list
15029910|NCT01965353|Lenalidomide|lenalidomide|mesh-list
15029911|NCT01965353|Bortezomib|bortezomib|mesh-list
15029912|NCT01965353|Panobinostat|panobinostat|mesh-list
15029913|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029914|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
15029915|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
15029916|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029917|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029918|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029919|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
15029920|NCT01965353|Hormones|hormones|mesh-ancestor
15029921|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029922|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15029923|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029924|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
15029925|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15029926|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15029927|NCT01965353|Growth Substances|growth substances|mesh-ancestor
15029928|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
15029929|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15029930|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029931|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029932|NCT01965405|Bupropion|bupropion|mesh-list
15029933|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15029934|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
15029935|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15029936|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15029937|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14978674|NCT04613830|Tramadol|tramadol|mesh-list
14978675|NCT04613830|Bupivacaine|bupivacaine|mesh-list
14978676|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
14978677|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
14978678|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978679|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978680|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
14978681|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978682|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14978683|NCT04613830|Narcotics|narcotics|mesh-ancestor
14978684|NCT04613830|Analgesics|analgesics|mesh-ancestor
14978685|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
14978686|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14978687|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978688|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978689|NCT04606797|Nicotine|nicotine|mesh-list
14978690|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14978691|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
14978692|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978693|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978694|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14978695|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14978696|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
14978697|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978698|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978699|NCT04602078|Gemcitabine|gemcitabine|mesh-list
14978700|NCT04602078|Atezolizumab|atezolizumab|mesh-list
14978701|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978702|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14978703|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
14978704|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978705|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
14978706|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978707|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978708|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14978709|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
14978710|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978711|NCT04597697|Insulin|insulin|mesh-list
14978712|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978713|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978714|NCT04594811|Nivolumab|nivolumab|mesh-list
14978715|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978716|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978717|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14978718|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978719|NCT04590326|Cemiplimab|cemiplimab|mesh-list
14978720|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978721|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978722|NCT04589611|Amobarbital|amobarbital|mesh-list
14978723|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
14978724|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14978725|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
14978726|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978727|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
14978728|NCT04589611|Protective Agents|protective agents|mesh-ancestor
14978729|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978730|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978731|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
14978732|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
14978733|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978734|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978735|NCT04588857|Dexamethasone|dexamethasone|mesh-list
14978736|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978737|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
14978738|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
14978739|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978740|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978741|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978742|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
14978743|NCT04588857|Hormones|hormones|mesh-ancestor
14978744|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978745|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978746|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978747|NCT04584684|Ethanol|ethanol|mesh-list
14978748|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14978749|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
14978750|NCT04584684|Povidone|povidone|mesh-list
14978751|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14978752|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978753|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978754|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978755|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
14978756|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
14978757|NCT04582435|Insulin|insulin|mesh-list
14978758|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14978759|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978760|NCT04578639|Rituximab|rituximab|mesh-list
14978761|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
14978762|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978763|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978764|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
14978765|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978766|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14978767|NCT04577001|Letrozole|letrozole|mesh-list
14978768|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978769|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14978770|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14978771|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978772|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978773|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14978774|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
14978775|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978776|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978777|NCT04570436|Diazepam|diazepam|mesh-list
14978778|NCT04570436|Gabapentin|gabapentin|mesh-list
14978779|NCT04570436|Analgesics|analgesics|mesh-ancestor
14978780|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
14978781|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978782|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978783|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
14978784|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14978785|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14978786|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978787|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14978788|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14978789|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14978790|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978791|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978792|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
14978793|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14978794|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
14978795|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
14978796|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978797|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14978798|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14978799|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14978800|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978801|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
14978802|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
14978803|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
14978804|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
14978805|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
14978806|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
14978807|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978808|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978809|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978810|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
14978811|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
14978812|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
14978813|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978814|NCT04564885|Meloxicam|meloxicam|mesh-list
14978815|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14978816|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14978817|NCT04564885|Analgesics|analgesics|mesh-ancestor
14978818|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
14978819|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978820|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978821|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978822|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14978823|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14978824|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14978825|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978826|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978827|NCT04564547|Islatravir|islatravir|mesh-list
14978828|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
14978829|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978830|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978831|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978832|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14978833|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14978834|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14978835|NCT04564443|Calcium|calcium|mesh-list
14978836|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14978837|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978838|NCT04562831|Niacinamide|niacinamide|mesh-list
14978839|NCT04562831|Niacin|niacin|mesh-list
14978840|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
14978841|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
14978842|NCT04562831|Vitamins|vitamins|mesh-ancestor
14978843|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
14978844|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978845|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14978846|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
14978847|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978848|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14978849|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
14978850|NCT04561375|Fentanyl|fentanyl|mesh-list
14978851|NCT04561375|Sufentanil|sufentanil|mesh-list
14978852|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14978853|NCT04561375|Narcotics|narcotics|mesh-ancestor
14978854|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978855|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978856|NCT04561375|Analgesics|analgesics|mesh-ancestor
14978857|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
14978858|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978859|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14978860|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14978861|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
14978862|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
14978863|NCT04560972|Carboplatin|carboplatin|mesh-list
14978864|NCT04560972|Etoposide|etoposide|mesh-list
14978865|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
14978866|NCT04560972|Atezolizumab|atezolizumab|mesh-list
14978867|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
14978868|NCT04560972|LB100|lb100|mesh-list
14978869|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14978870|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978871|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14978872|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14978873|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14978874|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978875|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978876|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
14978877|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978878|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
14978879|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
14978880|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
14978881|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
14978882|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
14978883|NCT04560179|Tobramycin|tobramycin|mesh-list
14978884|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14978885|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14978886|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978887|NCT04557735|Ravulizumab|ravulizumab|mesh-list
14978888|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14978889|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14978890|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
14978891|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978892|NCT04557189|Ondansetron|ondansetron|mesh-list
14978893|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
14978894|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
14978895|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978896|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978897|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978898|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
14978899|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14978900|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14978901|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
14978902|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978903|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978904|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14978905|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14978906|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14978907|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14978908|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14978909|NCT04551521|Trastuzumab|trastuzumab|mesh-list
14978910|NCT04551521|Pertuzumab|pertuzumab|mesh-list
14978911|NCT04551521|Atezolizumab|atezolizumab|mesh-list
14978912|NCT04551521|Vemurafenib|vemurafenib|mesh-list
14978913|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14978914|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978915|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978916|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
14978917|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978918|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14978919|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978920|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978921|NCT04551300|Sevelamer|sevelamer|mesh-list
14978922|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
14978923|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
14978924|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978925|NCT04548648|Isavuconazole|isavuconazole|mesh-list
14978926|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
14978927|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978928|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
14978929|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14978930|NCT04545242|Dexamethasone|dexamethasone|mesh-list
14978931|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978932|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
14978933|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
14978934|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978935|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978936|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978937|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
14978938|NCT04545242|Hormones|hormones|mesh-ancestor
14978939|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978940|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978941|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978942|NCT04543409|Benralizumab|benralizumab|mesh-list
14978943|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14978944|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
14978945|NCT04542980|Autoantibodies|autoantibodies|mesh-list
14978946|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
14978947|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978948|NCT04540705|Nivolumab|nivolumab|mesh-list
14978949|NCT04540705|Axitinib|axitinib|mesh-list
14978950|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978951|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978952|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14978953|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978954|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14978955|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978956|NCT04540133|Dexamethasone|dexamethasone|mesh-list
14978957|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
14978958|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14978959|NCT04540133|BB 1101|bb 1101|mesh-list
14978960|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14978961|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
14978962|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
14978963|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14978964|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978965|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14978966|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
14978967|NCT04540133|Hormones|hormones|mesh-ancestor
14978968|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14978969|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14978970|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978971|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
14978972|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978973|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978974|NCT04539938|Trastuzumab|trastuzumab|mesh-list
14978975|NCT04539938|Tucatinib|tucatinib|mesh-list
14978976|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14978977|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14978978|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14978979|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14978980|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978981|NCT04539223|Evolocumab|evolocumab|mesh-list
14978982|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14978983|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14978984|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
14978985|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978986|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15029938|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15029939|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029940|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
15029941|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029942|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029943|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15029944|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15029945|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029946|NCT01965522|Vitamin D|vitamin d|mesh-list
15029947|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
15029948|NCT01965522|Vitamins|vitamins|mesh-list
15029949|NCT01965522|Melatonin|melatonin|mesh-list
15029950|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
15029951|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029952|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15029953|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15029954|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
15029955|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029956|NCT01965522|Protective Agents|protective agents|mesh-ancestor
15029957|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029958|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
15029959|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15029960|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
15029961|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15029962|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029963|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15029964|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15029965|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15029966|NCT01965626|Oseltamivir|oseltamivir|mesh-list
15029967|NCT01965626|Dexamethasone|dexamethasone|mesh-list
15029968|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15029969|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
15029970|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
15029971|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029972|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029973|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029974|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
15029975|NCT01965626|Hormones|hormones|mesh-ancestor
15029976|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15029977|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15029978|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15029979|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
15029980|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15029981|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15029982|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029983|NCT01965704|Ondansetron|ondansetron|mesh-list
15029984|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
15029985|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
15029986|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15029987|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15029988|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15029989|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
15029990|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
15029991|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15029992|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
15029993|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15029994|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15029995|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15029996|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15029997|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15029998|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15029999|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15030000|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
15030001|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15030002|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15030003|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030004|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
15030005|NCT01965730|Coagulants|coagulants|mesh-ancestor
15030006|NCT01965925|Modafinil|modafinil|mesh-list
14978987|NCT04534153|Fexofenadine|fexofenadine|mesh-list
14978988|NCT04534153|Terfenadine|terfenadine|mesh-list
14978989|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14978990|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14978991|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14978992|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
14978993|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
14978994|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14978995|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14978996|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14978997|NCT04529499|Favipiravir|favipiravir|mesh-list
14978998|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
14978999|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979000|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
14979001|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14979002|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14979003|NCT04526132|Analgesics|analgesics|mesh-ancestor
14979004|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
14979005|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979006|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979007|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979008|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979009|NCT04525014|Irinotecan|irinotecan|mesh-list
14979010|NCT04525014|Temozolomide|temozolomide|mesh-list
14979011|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14979012|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14979013|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979014|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979015|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979016|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14979017|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
14979018|NCT04523428|Venetoclax|venetoclax|mesh-list
14979019|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
14979020|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979021|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14979022|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14979023|NCT04521920|Narcotics|narcotics|mesh-ancestor
14979024|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979025|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979026|NCT04521920|Analgesics|analgesics|mesh-ancestor
14979027|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
14979028|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979029|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14979030|NCT04520776|Meloxicam|meloxicam|mesh-list
14979031|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14979032|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14979033|NCT04520776|Analgesics|analgesics|mesh-ancestor
14979034|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
14979035|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979036|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979037|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979038|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979039|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14979040|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14979041|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979042|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979043|NCT04519944|Edoxaban|edoxaban|mesh-list
14979044|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14979045|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
14979046|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14979047|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
14979048|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979049|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979050|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
14979051|NCT04516317|Artesunate|artesunate|mesh-list
14979052|NCT04516317|Quinine|quinine|mesh-list
14979053|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
14979054|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14979055|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14979056|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979057|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979058|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
14979059|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
14979060|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14979061|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
14979062|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14979063|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979064|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14979065|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979066|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14979067|NCT04516317|Analgesics|analgesics|mesh-ancestor
14979068|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
14979069|NCT04515147|Vaccines|vaccines|mesh-list
14979070|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14979071|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
14979072|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979073|NCT04508504|Ropivacaine|ropivacaine|mesh-list
14979074|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
14979075|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
14979076|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979077|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979078|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
14979079|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979080|NCT04505280|Lidocaine|lidocaine|mesh-list
14979081|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
14979082|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
14979083|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979084|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979085|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
14979086|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979087|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14979088|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14979089|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14979090|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14979091|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979092|NCT04504825|Dexamethasone|dexamethasone|mesh-list
14979093|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
14979094|NCT04504825|Bortezomib|bortezomib|mesh-list
14979095|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979096|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
14979097|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979098|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979099|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14979100|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
14979101|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979102|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979103|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14979104|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979105|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
14979106|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
14979107|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979108|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14979109|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
14979110|NCT04504825|Hormones|hormones|mesh-ancestor
14979111|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979112|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14979113|NCT04495179|Durvalumab|durvalumab|mesh-list
14979114|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979115|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979116|NCT04490707|Lenalidomide|lenalidomide|mesh-list
14979117|NCT04490707|Azacitidine|azacitidine|mesh-list
14979118|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
14979119|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979120|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14979121|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14979122|NCT04490707|Growth Substances|growth substances|mesh-ancestor
14979123|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
14979124|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979125|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14979126|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
14979127|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979128|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800901|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14800902|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
14800903|NCT00790153|Insulin|insulin|mesh-list
14800904|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14800905|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800906|NCT00790179|Ropivacaine|ropivacaine|mesh-list
14800907|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
14800908|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
14800909|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979129|NCT04489732|Interferons|interferons|mesh-list
14979130|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
14979131|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979132|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
14979133|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979134|NCT04487145|Piperaquine|piperaquine|mesh-list
14979135|NCT04487145|Artenimol|artenimol|mesh-list
14979136|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
14979137|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14979138|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14979139|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979140|NCT04486716|Ofatumumab|ofatumumab|mesh-list
14979141|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979142|NCT04484350|Enalapril|enalapril|mesh-list
14979143|NCT04484350|Hydralazine|hydralazine|mesh-list
14979144|NCT04484350|Labetalol|labetalol|mesh-list
14979145|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14979146|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
14979147|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979148|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979149|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14979150|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
14979151|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14979152|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14979153|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
14979154|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979155|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979156|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
14979157|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
14979158|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979159|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14979160|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14979161|NCT04471428|Docetaxel|docetaxel|mesh-list
14979162|NCT04471428|Atezolizumab|atezolizumab|mesh-list
14979163|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979164|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
14979165|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
14979166|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
14979167|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979168|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
14979169|NCT04469842|Prednisone|prednisone|mesh-list
14979170|NCT04469842|Azathioprine|azathioprine|mesh-list
14979171|NCT04469842|Tacrolimus|tacrolimus|mesh-list
14979172|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979173|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
14979174|NCT04469842|Hormones|hormones|mesh-ancestor
14979175|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979176|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979177|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14979178|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979179|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979180|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
14979181|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14979182|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979183|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979184|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14979185|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14979186|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
14979187|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14979188|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979189|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
14979190|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14979191|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979192|NCT04464577|Itraconazole|itraconazole|mesh-list
14979193|NCT04464577|Fluconazole|fluconazole|mesh-list
14979194|NCT04464577|Bupropion|bupropion|mesh-list
14979195|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14979196|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
14979197|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14979198|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14979199|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14979200|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14979201|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979202|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
14979203|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979204|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979205|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14979206|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14979207|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979208|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
14979209|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979210|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14979211|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14979212|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
14979213|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979214|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14979215|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14979216|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14979217|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
14979218|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979219|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979220|NCT04454229|Penicillins|penicillins|mesh-list
14979221|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14979222|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030007|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15030008|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030009|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15030010|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15030011|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15030012|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030013|NCT01965977|Bortezomib|bortezomib|mesh-list
15030014|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030015|NCT01966055|Solithromycin|solithromycin|mesh-list
15030016|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15030017|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030018|NCT01966133|Doxorubicin|doxorubicin|mesh-list
15030019|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15030020|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
15030021|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15030022|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030023|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15030024|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15030025|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030026|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030027|NCT01966172|Acetaminophen|acetaminophen|mesh-list
15030028|NCT01966172|Ibuprofen|ibuprofen|mesh-list
15030029|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15030030|NCT01966172|Morphine|morphine|mesh-list
15030031|NCT01966172|Gabapentin|gabapentin|mesh-list
15030032|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15030033|NCT01966172|Narcotics|narcotics|mesh-ancestor
15030034|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030035|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030036|NCT01966172|Analgesics|analgesics|mesh-ancestor
15030037|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
15030038|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030039|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15030040|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15030041|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15030042|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15030043|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030044|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030045|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
15030046|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
15030047|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15030048|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15030049|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15030050|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15030051|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14800910|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800911|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
14800912|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800913|NCT00790244|Doxorubicin|doxorubicin|mesh-list
14800914|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14800915|NCT00790244|Ifosfamide|ifosfamide|mesh-list
14800916|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
14800917|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14800918|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800919|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14800920|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14979223|NCT04430855|Upadacitinib|upadacitinib|mesh-list
14979224|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14979225|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14979226|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979227|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979228|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979229|NCT04430738|Leucovorin|leucovorin|mesh-list
14979230|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
14979231|NCT04430738|Trastuzumab|trastuzumab|mesh-list
14979232|NCT04430738|Fluorouracil|fluorouracil|mesh-list
14979233|NCT04430738|Capecitabine|capecitabine|mesh-list
14979234|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
14979235|NCT04430738|Tucatinib|tucatinib|mesh-list
14979236|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979237|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979238|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
14979239|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979240|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14979241|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979242|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
14979243|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979244|NCT04430738|Antidotes|antidotes|mesh-ancestor
14979245|NCT04430738|Protective Agents|protective agents|mesh-ancestor
14979246|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
14979247|NCT04430738|Vitamins|vitamins|mesh-ancestor
14979248|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
14979249|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14979250|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979251|NCT04430517|Niacinamide|niacinamide|mesh-list
14979252|NCT04430517|Niacin|niacin|mesh-list
14979253|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
14979254|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
14979255|NCT04430517|Vitamins|vitamins|mesh-ancestor
14979256|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
14979257|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979258|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14979259|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
14979260|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979261|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14979262|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
14979263|NCT04421963|Olaparib|olaparib|mesh-list
14979264|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14979265|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979266|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979267|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979268|NCT04417361|Erenumab|erenumab|mesh-list
14979269|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14979270|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979271|NCT04417361|Analgesics|analgesics|mesh-ancestor
14979272|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
14979273|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979274|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979275|NCT04402658|Albuterol|albuterol|mesh-list
14979276|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14979277|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
14979278|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979279|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979280|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14979281|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
14979282|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
14979283|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14979284|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14979285|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14979286|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14979287|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
14523219|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523220|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14523221|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14523222|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523223|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523224|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14979288|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979289|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979290|NCT04398368|Gemcitabine|gemcitabine|mesh-list
14979291|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14979292|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
14979293|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979294|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979295|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
14979296|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979297|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979298|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979299|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
14979300|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979301|NCT04391179|Dipyridamole|dipyridamole|mesh-list
14979302|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14979303|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979304|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979305|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14979306|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
14979307|NCT04387227|Carboplatin|carboplatin|mesh-list
14979308|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
14979309|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979310|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979311|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
14979312|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
14979313|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979314|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14979315|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
14979316|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979317|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
14979318|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14979319|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979320|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979321|NCT04375631|Cytarabine|cytarabine|mesh-list
14979322|NCT04375631|Cyclosporine|cyclosporine|mesh-list
14979323|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
14979324|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
14979325|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
14979326|NCT04375631|Cladribine|cladribine|mesh-list
14979327|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
14979328|NCT04375631|Cyclosporins|cyclosporins|mesh-list
14979329|NCT04375631|Lenograstim|lenograstim|mesh-list
14979330|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979331|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
14979332|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979333|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979334|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14979335|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
14979336|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979337|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979338|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14979339|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14979340|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
14979341|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
14979342|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979343|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14979344|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979345|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
14979346|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14979347|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14979348|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14979349|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14979350|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
14979351|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14979352|NCT04375631|Analgesics|analgesics|mesh-ancestor
14979353|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
14979354|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979355|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14979356|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14979357|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
14979358|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
14979359|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14979360|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14979361|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979362|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
14979363|NCT04373603|Coagulants|coagulants|mesh-ancestor
14979364|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14979365|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
14979366|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979367|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
14979368|NCT04373603|Protective Agents|protective agents|mesh-ancestor
14979369|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
14979370|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14979371|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14979372|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979373|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
14979374|NCT04372940|Coagulants|coagulants|mesh-ancestor
14979375|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14979376|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979377|NCT04356742|Metformin|metformin|mesh-list
14979378|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
14979379|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14979380|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979381|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14979382|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979383|NCT04353284|Gabexate|gabexate|mesh-list
14979384|NCT04353284|Camostat|camostat|mesh-list
14979385|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
14979386|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979387|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979388|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14979389|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14979390|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
14979391|NCT04348864|Antibodies|antibodies|mesh-list
14979392|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
14979393|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979394|NCT04345367|Abrocitinib|abrocitinib|mesh-list
14979395|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14979396|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979397|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979398|NCT04344262|Atracurium|atracurium|mesh-list
14979399|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14979400|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14979401|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14979402|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979403|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979404|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14979405|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14979406|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
14979407|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979408|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979409|NCT04328012|Losartan|losartan|mesh-list
14979410|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14979411|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14979412|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14979413|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14979414|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979415|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
14979416|NCT04322318|Ifosfamide|ifosfamide|mesh-list
14979417|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
14979418|NCT04322318|Carboplatin|carboplatin|mesh-list
14979419|NCT04322318|Doxorubicin|doxorubicin|mesh-list
14979420|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14979421|NCT04322318|Irinotecan|irinotecan|mesh-list
14979422|NCT04322318|Etoposide|etoposide|mesh-list
14979423|NCT04322318|Vincristine|vincristine|mesh-list
14979424|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
14979425|NCT04322318|Topotecan|topotecan|mesh-list
14979426|NCT04322318|Daunorubicin|daunorubicin|mesh-list
14979427|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
14979428|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979429|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
14979430|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979431|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979432|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14979433|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
14979434|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979435|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979436|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14979437|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14979438|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14979439|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14979440|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979441|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14979442|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14979443|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
14979444|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
14979445|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
14979446|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
14979447|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
14979448|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
14979449|NCT04321993|Remdesivir|remdesivir|mesh-list
14979450|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14979451|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979452|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
14979453|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979454|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14979455|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979456|NCT04315948|Interferons|interferons|mesh-list
14979457|NCT04315948|Ritonavir|ritonavir|mesh-list
14979458|NCT04315948|Lopinavir|lopinavir|mesh-list
14979459|NCT04315948|Interferon-beta|interferon-beta|mesh-list
14979460|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
14979461|NCT04315948|Remdesivir|remdesivir|mesh-list
14979462|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
14979463|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979464|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
14979465|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979466|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14979467|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14979468|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
14979469|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979470|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979471|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14979472|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14979473|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14979474|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14979475|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
14979476|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14979477|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14979478|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979479|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
14979480|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979481|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14979482|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
15030052|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030053|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
15030054|NCT01966263|Epinephrine|epinephrine|mesh-list
15030055|NCT01966263|Racepinephrine|racepinephrine|mesh-list
15030056|NCT01966263|Ropivacaine|ropivacaine|mesh-list
15030057|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
15030058|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
15030059|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
15030060|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030061|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030062|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
15030063|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030064|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15030065|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15030066|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
15030067|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030068|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030069|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15030070|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15030071|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
15030072|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15030073|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
15030074|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
15030075|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
15030076|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15030077|NCT01966276|Methylphenidate|methylphenidate|mesh-list
15030078|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15030079|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030080|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15030081|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15030082|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030083|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030084|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
15030085|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030086|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
15030087|NCT01966289|Guadecitabine|guadecitabine|mesh-list
15030088|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
15030089|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030090|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030091|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15030092|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15030093|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
15030094|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030095|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030096|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15030097|NCT01966302|Beraprost|beraprost|mesh-list
15030098|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15030099|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
15030100|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15030101|NCT01966341|Laxatives|laxatives|mesh-list
15030102|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
15030103|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030104|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15030105|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
15030106|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030107|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030108|NCT01966484|Succinylcholine|succinylcholine|mesh-list
15030109|NCT01966484|Mivacurium|mivacurium|mesh-list
15030110|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14979483|NCT04310150|Hemostatics|hemostatics|mesh-list
14979484|NCT04310150|Coagulants|coagulants|mesh-ancestor
14979485|NCT04307329|Trastuzumab|trastuzumab|mesh-list
14979486|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523225|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
14979487|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979488|NCT04305444|Everolimus|everolimus|mesh-list
14979489|NCT04305444|Pomalidomide|pomalidomide|mesh-list
14979490|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979491|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979492|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
14979493|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979494|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14979495|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14979496|NCT04305444|Growth Substances|growth substances|mesh-ancestor
14979497|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
14979498|NCT04299438|Propranolol|propranolol|mesh-list
14979499|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14979500|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14979501|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
14979502|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979503|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979504|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979505|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14979506|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14979507|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
14979508|NCT04298983|Androgens|androgens|mesh-list
14979509|NCT04298983|Hormones|hormones|mesh-ancestor
14979510|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979511|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979512|NCT04295772|Islatravir|islatravir|mesh-list
14979513|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
14979514|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979515|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979516|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979517|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14979518|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14979519|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14979520|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
14979521|NCT04294147|Erenumab|erenumab|mesh-list
14979522|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14979523|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979524|NCT04294147|Analgesics|analgesics|mesh-ancestor
14979525|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
14979526|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979527|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979528|NCT04292873|Vitamin D|vitamin d|mesh-list
14979529|NCT04292873|Vitamins|vitamins|mesh-ancestor
14979530|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
14979531|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979532|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14979533|NCT04291079|Antibodies|antibodies|mesh-list
14979534|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
14979535|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979536|NCT04290624|Listerine|listerine|mesh-list
14979537|NCT04290624|Fluorides|fluorides|mesh-list
14979538|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
14979539|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
14979540|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
14979541|NCT04290624|Protective Agents|protective agents|mesh-ancestor
14979542|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979543|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14979544|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979545|NCT04285866|Durvalumab|durvalumab|mesh-list
14979546|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979547|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979548|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
14979549|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
14979550|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14979551|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979552|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979553|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
14979554|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14979555|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979556|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979557|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
14979558|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14979559|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14979560|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979561|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
14979562|NCT04272606|Coagulants|coagulants|mesh-ancestor
14979563|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
14979564|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14979565|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979566|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979567|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14979568|NCT04266145|Analgesics|analgesics|mesh-ancestor
14979569|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
14979570|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979571|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14979572|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14979573|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14979574|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
14979575|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979576|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979577|NCT04265534|Folic Acid|folic acid|mesh-list
14979578|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
14979579|NCT04265534|Hydroxocobalamin|hydroxocobalamin|mesh-list
14979580|NCT04265534|Dexamethasone|dexamethasone|mesh-list
14979581|NCT04265534|Carboplatin|carboplatin|mesh-list
14979582|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
14523226|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979583|NCT04265534|Pemetrexed|pemetrexed|mesh-list
14979584|NCT04265534|Vitamins|vitamins|mesh-ancestor
14979585|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
14979586|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979587|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979588|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
14979589|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
14979590|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979591|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14979592|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
14979593|NCT04265534|Hormones|hormones|mesh-ancestor
14979594|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979595|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14979596|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979597|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979598|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979599|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979600|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14979601|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14979602|NCT04265534|Hematinics|hematinics|mesh-ancestor
14979603|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
14979604|NCT04264637|Azelastine|azelastine|mesh-list
14979605|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14979606|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
14979607|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979608|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979609|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14979610|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
14979611|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14979612|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979613|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979614|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14979615|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14979616|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14979617|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
14979618|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
14979619|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979620|NCT04262687|Bevacizumab|bevacizumab|mesh-list
14979621|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
14979622|NCT04262687|Capecitabine|capecitabine|mesh-list
14979623|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
14979624|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979625|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979626|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14979627|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14979628|NCT04262687|Growth Substances|growth substances|mesh-ancestor
14979629|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979630|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
14979631|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14979632|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
14979633|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979634|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
14979635|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
14979636|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14979637|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
14979638|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979639|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
14979640|NCT04262336|Protective Agents|protective agents|mesh-ancestor
14979641|NCT04262336|Antidotes|antidotes|mesh-ancestor
14979642|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
14979643|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979644|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
14979645|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14979646|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979647|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
14979648|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
14979649|NCT04262206|Atorvastatin|atorvastatin|mesh-list
14979650|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14979651|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14979652|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
14979653|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979654|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14979655|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14979656|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979657|NCT04261439|Spartalizumab|spartalizumab|mesh-list
14979658|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14979659|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979660|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979661|NCT04248595|Azacitidine|azacitidine|mesh-list
14979662|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
14979663|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14979664|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
14979665|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979666|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979667|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979668|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14979669|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14979670|NCT04246047|Dexamethasone|dexamethasone|mesh-list
14979671|NCT04246047|Bortezomib|bortezomib|mesh-list
14979672|NCT04246047|Daratumumab|daratumumab|mesh-list
14979673|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979674|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
14979675|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
14979676|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979677|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979678|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14979679|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
14979680|NCT04246047|Hormones|hormones|mesh-ancestor
14979681|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979682|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14979683|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979684|NCT04241562|Mitogens|mitogens|mesh-list
14979685|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
14979686|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979687|NCT04239703|Antibodies|antibodies|mesh-list
14979688|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
14979689|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979690|NCT04239313|Vaccines|vaccines|mesh-list
14979691|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
14979692|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979693|NCT04238546|Sirolimus|sirolimus|mesh-list
14979694|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14979695|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979696|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14979697|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979698|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
14979699|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979700|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
14979701|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979702|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14979703|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14979704|NCT04233801|Empagliflozin|empagliflozin|mesh-list
14979705|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14979706|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979707|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14979708|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979709|NCT04233190|Budesonide|budesonide|mesh-list
14979710|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
14979711|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14979712|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
14800921|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800922|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800923|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14800924|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
14800925|NCT00790387|Heparin|heparin|mesh-list
14800926|NCT00790387|Enoxaparin|enoxaparin|mesh-list
14800927|NCT00790387|Calcium heparin|calcium heparin|mesh-list
14800928|NCT00790387|Tirofiban|tirofiban|mesh-list
14800929|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
14800930|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14800931|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14800932|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800933|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14800934|NCT00790413|Rituximab|rituximab|mesh-list
14800935|NCT00790413|Fludarabine|fludarabine|mesh-list
14800936|NCT00790413|Thiotepa|thiotepa|mesh-list
14800937|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14800938|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14800939|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800940|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
14800941|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800942|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979713|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979714|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979715|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14979716|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
14979717|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14979718|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14979719|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14979720|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
14979721|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979722|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979723|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979724|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
14979725|NCT04233190|Hormones|hormones|mesh-ancestor
14979726|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979727|NCT04233112|Melatonin|melatonin|mesh-list
14979728|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
14979729|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979730|NCT04233112|Protective Agents|protective agents|mesh-ancestor
14979731|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979732|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979733|NCT04233034|Verapamil|verapamil|mesh-list
14979734|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14979735|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14979736|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14979737|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979738|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14979739|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979740|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
14979741|NCT04230304|Daratumumab|daratumumab|mesh-list
14979742|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030111|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15030112|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15030113|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030114|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030115|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15030116|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15030117|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
15030118|NCT01966575|Progestins|progestins|mesh-list
15030119|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15030120|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15030121|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15030122|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
15030123|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15030124|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030125|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15030126|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15030127|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15030128|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15030129|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030130|NCT01966575|Hormones|hormones|mesh-ancestor
15030131|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030132|NCT01966627|Liver Extracts|liver extracts|mesh-list
15030133|NCT01966627|Hematinics|hematinics|mesh-ancestor
15030134|NCT01966653|Fosfomycin|fosfomycin|mesh-list
15030135|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
15030136|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15030137|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030138|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15030139|NCT01966653|Renal Agents|renal agents|mesh-ancestor
15030140|NCT01966692|Fluticasone|fluticasone|mesh-list
15030141|NCT01966692|Xhance|xhance|mesh-list
15030142|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15030143|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15030144|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
15030145|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030146|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030147|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15030148|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
15030149|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
15030150|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15030151|NCT01966783|Budesonide|budesonide|mesh-list
15030152|NCT01966783|Mesalamine|mesalamine|mesh-list
15030153|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15030154|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14979743|NCT04224558|Acetaminophen|acetaminophen|mesh-list
14979744|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
14979745|NCT04224558|Promethazine|promethazine|mesh-list
14979746|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
14979747|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14979748|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
14979749|NCT04224558|Fludarabine|fludarabine|mesh-list
14979750|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
14979751|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14979752|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
14979753|NCT04224558|Antibodies|antibodies|mesh-list
14979754|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
14979755|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14979756|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14979757|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979758|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
14979759|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979760|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979761|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14979762|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
14979763|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979764|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979765|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14979766|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14979767|NCT04224558|Analgesics|analgesics|mesh-ancestor
14979768|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
14979769|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979770|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
14979771|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979772|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
14979773|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
14979774|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14979775|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
14523227|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523228|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14523229|NCT03579940|Lasmiditan|lasmiditan|mesh-list
14523230|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14523231|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
14523232|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523233|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523234|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523235|NCT03580343|Tofacitinib|tofacitinib|mesh-list
14523236|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14523237|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523238|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523239|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
14523240|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14523241|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
14523242|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523243|NCT03581084|Expectorants|expectorants|mesh-ancestor
14523244|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
14523245|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14523246|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
14979776|NCT04224558|Hormones|hormones|mesh-ancestor
14979777|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979778|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14979779|NCT04224558|Protective Agents|protective agents|mesh-ancestor
14979780|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14979781|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14979782|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14979783|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979784|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
14979785|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
14979786|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14979787|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
14979788|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
14979789|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979790|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14979791|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
14979792|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
14979793|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
14979794|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14979795|NCT04223570|Levulinic acid|levulinic acid|mesh-list
14979796|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14979797|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
14979798|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979799|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979800|NCT04219774|Aspirin|aspirin|mesh-list
14979801|NCT04219774|Clopidogrel|clopidogrel|mesh-list
14979802|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14979803|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14979804|NCT04219774|Analgesics|analgesics|mesh-ancestor
14979805|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
14979806|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979807|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979808|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979809|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979810|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14979811|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14979812|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979813|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14979814|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14979815|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979816|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
14979817|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14979818|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14979819|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14979820|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
14979821|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979822|NCT04209114|Nivolumab|nivolumab|mesh-list
14979823|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979824|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979825|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14979826|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979827|NCT04201197|Dronabinol|dronabinol|mesh-list
14979828|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
14979829|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979830|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14979831|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14979832|NCT04201197|Analgesics|analgesics|mesh-ancestor
14979833|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
14979834|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979835|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14979836|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14979837|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979838|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979839|NCT04201197|Hormones|hormones|mesh-ancestor
14979840|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979841|NCT04200651|Dexamethasone|dexamethasone|mesh-list
14979842|NCT04200651|Prednisolone|prednisolone|mesh-list
14979843|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14979844|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
14979845|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14979846|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
14979847|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14979848|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
14979849|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14979850|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
14979851|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
15030155|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
14979852|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979853|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979854|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14979855|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
14979856|NCT04200651|Hormones|hormones|mesh-ancestor
14979857|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979858|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14979859|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979860|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14979861|NCT04200651|Protective Agents|protective agents|mesh-ancestor
14979862|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
14979863|NCT04198428|Narcotics|narcotics|mesh-ancestor
14979864|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14979865|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979866|NCT04198428|Analgesics|analgesics|mesh-ancestor
14979867|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
14979868|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14979869|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
14979870|NCT04196491|Fludarabine|fludarabine|mesh-list
14979871|NCT04196491|Lenalidomide|lenalidomide|mesh-list
14979872|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979873|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
14979874|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979875|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979876|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14979877|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
14979878|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979879|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979880|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14979881|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14979882|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14979883|NCT04196491|Growth Substances|growth substances|mesh-ancestor
14979884|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
14979885|NCT04195399|Imidazole|imidazole|mesh-list
14979886|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979887|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979888|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
14979889|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14979890|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
14979891|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979892|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
14979893|NCT04192630|Protective Agents|protective agents|mesh-ancestor
14979894|NCT04187833|Nivolumab|nivolumab|mesh-list
14979895|NCT04187833|Talazoparib|talazoparib|mesh-list
14979896|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979897|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979898|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14979899|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979900|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14979901|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979902|NCT04183205|Sertraline|sertraline|mesh-list
14979903|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
14979904|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14979905|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14979906|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14979907|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14979908|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979909|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14979910|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
14979911|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979912|NCT04180085|Abatacept|abatacept|mesh-list
14979913|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14979914|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979915|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979916|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14979917|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
14979918|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979919|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14979920|NCT04171141|Bevacizumab|bevacizumab|mesh-list
14979921|NCT04171141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979922|NCT04171141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979923|NCT04171141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14979924|NCT04171141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14979925|NCT04171141|Growth Substances|growth substances|mesh-ancestor
14979926|NCT04171141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979927|NCT04171141|Growth Inhibitors|growth inhibitors|mesh-ancestor
14979928|NCT04169451|Letrozole|letrozole|mesh-list
14979929|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979930|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14979931|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14979932|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979933|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979934|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14979935|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
14979936|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14979937|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979938|NCT04169438|Petrolatum|petrolatum|mesh-list
14979939|NCT04169438|Emollients|emollients|mesh-ancestor
14979940|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
14979941|NCT04160494|Atezolizumab|atezolizumab|mesh-list
14979942|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
14979943|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979944|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
14979945|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979946|NCT04159818|Doxorubicin|doxorubicin|mesh-list
14979947|NCT04159818|Nivolumab|nivolumab|mesh-list
14979948|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979949|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14979950|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14979951|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14979952|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979953|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979954|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979955|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14979956|NCT04157881|Rabeprazole|rabeprazole|mesh-list
14979957|NCT04157881|Dabigatran|dabigatran|mesh-list
14979958|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
14979959|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14979960|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
14979961|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14979962|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979963|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
14979964|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14979965|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14979966|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14979967|NCT04157335|Benralizumab|benralizumab|mesh-list
14979968|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14979969|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
14979970|NCT04151563|Docetaxel|docetaxel|mesh-list
14979971|NCT04151563|Nivolumab|nivolumab|mesh-list
14979972|NCT04151563|Ipilimumab|ipilimumab|mesh-list
14979973|NCT04151563|Ramucirumab|ramucirumab|mesh-list
14979974|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979975|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
14979976|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
14979977|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
14979978|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979979|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979980|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14979981|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
14979982|NCT04150900|Bavituximab|bavituximab|mesh-list
14979983|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979984|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979985|NCT04143711|Paclitaxel|paclitaxel|mesh-list
14979986|NCT04143711|Nivolumab|nivolumab|mesh-list
14979987|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14979988|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14979989|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
14979990|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
14979991|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
14979992|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14979993|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14979994|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14979995|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
14979996|NCT04138394|Vitamins|vitamins|mesh-ancestor
14979997|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
14979998|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14979999|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
14980000|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980001|NCT04138394|Protective Agents|protective agents|mesh-ancestor
14980002|NCT04136756|Rituximab|rituximab|mesh-list
14980003|NCT04136756|Daratumumab|daratumumab|mesh-list
14980004|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980005|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980006|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
14980007|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980008|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980009|NCT04136262|Methotrexate|methotrexate|mesh-list
14980010|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14980011|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
14980012|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14980013|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980014|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14980015|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
14980016|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980017|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980018|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
14980019|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980020|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14980021|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980022|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
14980023|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980024|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15030156|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030157|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030158|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15030159|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
15030160|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
15030161|NCT01966783|Hormones|hormones|mesh-ancestor
15030162|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030163|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15030164|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15030165|NCT01966783|Analgesics|analgesics|mesh-ancestor
15030166|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
15030167|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15030168|NCT01966822|Ritonavir|ritonavir|mesh-list
15030169|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
15030170|NCT01966822|Dolutegravir|dolutegravir|mesh-list
14980025|NCT04133922|Insulin|insulin|mesh-list
14980026|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14980027|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980028|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
14980029|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
14980030|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980031|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
14980032|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980033|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980034|NCT04129151|Palbociclib|palbociclib|mesh-list
14980035|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980036|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14980037|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980038|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980039|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
14980040|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14980041|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980042|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980043|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980044|NCT04124497|Dexamethasone|dexamethasone|mesh-list
14980045|NCT04124497|Daratumumab|daratumumab|mesh-list
14980046|NCT04124497|Pomalidomide|pomalidomide|mesh-list
14980047|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980048|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
14980049|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
14980050|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980051|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980052|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980053|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
14980054|NCT04124497|Hormones|hormones|mesh-ancestor
14980055|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980056|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14980057|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980058|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
14980059|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14980060|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14980061|NCT04124497|Growth Substances|growth substances|mesh-ancestor
14980062|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
14980063|NCT04123314|Psilocybin|psilocybin|mesh-list
14980064|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
14980065|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980066|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14980067|NCT04115059|Dasatinib|dasatinib|mesh-list
14980068|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980069|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14980070|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980071|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980072|NCT04114890|Tenofovir|tenofovir|mesh-list
14980073|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
14980074|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980075|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14980076|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14980077|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980078|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980079|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14980080|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14980081|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14980082|NCT04108858|Trastuzumab|trastuzumab|mesh-list
14980083|NCT04108858|Pertuzumab|pertuzumab|mesh-list
14980084|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14980085|NCT04108858|Antibodies|antibodies|mesh-list
14980086|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
14980087|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14980088|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
14980089|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980090|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980091|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14980092|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
14980093|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14980094|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14980095|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14980096|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14980097|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980098|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
14980099|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980100|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980101|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14980102|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980103|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14980104|NCT04099251|Nivolumab|nivolumab|mesh-list
14980105|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980106|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980107|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980108|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980109|NCT04096066|Dexamethasone|dexamethasone|mesh-list
14980110|NCT04096066|Lenalidomide|lenalidomide|mesh-list
14980111|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980112|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
14980113|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
14980114|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980115|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980116|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980117|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
14980118|NCT04096066|Hormones|hormones|mesh-ancestor
14980119|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980120|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14980121|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980122|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
14980123|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14980124|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14980125|NCT04096066|Growth Substances|growth substances|mesh-ancestor
14980126|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
14980127|NCT04084548|Lidocaine|lidocaine|mesh-list
14980128|NCT04084548|Ketamine|ketamine|mesh-list
14980129|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
14980130|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
14980131|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980132|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980133|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
14980134|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980135|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14980136|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14980137|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14980138|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14980139|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980140|NCT04084548|Analgesics|analgesics|mesh-ancestor
14980141|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14980142|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14980143|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
14980144|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14980145|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14980146|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980147|NCT04084210|Nicotine|nicotine|mesh-list
14980148|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14980149|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
14980150|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980151|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980152|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14980153|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14980154|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
14980155|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980156|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980157|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
14980158|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14980159|NCT04083495|Fludarabine|fludarabine|mesh-list
14980160|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980161|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
14980162|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980163|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980164|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14980165|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
14980166|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980167|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980168|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14980169|NCT04082676|Bupivacaine|bupivacaine|mesh-list
14980170|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
14980171|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
14980172|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980173|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030171|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
14523247|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523248|NCT03581084|Protective Agents|protective agents|mesh-ancestor
14523249|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800943|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800944|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800945|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14800946|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
14800947|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14800948|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800949|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14800950|NCT00790439|Cyclosporine|cyclosporine|mesh-list
14800951|NCT00790439|Sirolimus|sirolimus|mesh-list
14800952|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
14800953|NCT00790439|Heparin|heparin|mesh-list
14800954|NCT00790439|Calcium heparin|calcium heparin|mesh-list
14800955|NCT00790439|Dextrans|dextrans|mesh-list
14800956|NCT00790439|Tacrolimus|tacrolimus|mesh-list
14800957|NCT00790439|Cyclosporins|cyclosporins|mesh-list
14800958|NCT00790439|Basiliximab|basiliximab|mesh-list
14523250|NCT03581084|Antidotes|antidotes|mesh-ancestor
14523251|NCT03582215|Salicylates|salicylates|mesh-list
14523252|NCT03582215|Avobenzone|avobenzone|mesh-list
14523253|NCT03582215|Homosalate|homosalate|mesh-list
14523254|NCT03582215|Oxybenzone|oxybenzone|mesh-list
14523255|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
14523256|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
14523257|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
14523258|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14523259|NCT03582215|Protective Agents|protective agents|mesh-ancestor
14523260|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523261|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
14523262|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14523263|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14523264|NCT03582215|Analgesics|analgesics|mesh-ancestor
14980174|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
14980175|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980176|NCT04080895|Lumefantrine|lumefantrine|mesh-list
14800959|NCT00790439|Daclizumab|daclizumab|mesh-list
14800960|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14800961|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
14800962|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800963|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14800964|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800965|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800966|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
14800967|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14800968|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
14800969|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980177|NCT04080895|Artemether|artemether|mesh-list
14980178|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14980179|NCT04080895|Amodiaquine|amodiaquine|mesh-list
14980180|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
14980181|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14980182|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14980183|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980184|NCT04078295|Nivolumab|nivolumab|mesh-list
14980185|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980186|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980187|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980188|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980189|NCT04075747|Venetoclax|venetoclax|mesh-list
14980190|NCT04075747|Midostaurin|midostaurin|mesh-list
14980191|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980192|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14980193|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980194|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980195|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
14980196|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980197|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980198|NCT04069156|Aspirin|aspirin|mesh-list
14980199|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14980200|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14980201|NCT04069156|Analgesics|analgesics|mesh-ancestor
14980202|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
14980203|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980204|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980205|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980206|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980207|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14980208|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14980209|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980210|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14980211|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14980212|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980213|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
14980214|NCT04067648|Sufentanil|sufentanil|mesh-list
14980215|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14980216|NCT04067648|Narcotics|narcotics|mesh-ancestor
14980217|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980218|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980219|NCT04067648|Analgesics|analgesics|mesh-ancestor
14980220|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
14980221|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980222|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14980223|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14980224|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
14980225|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
14980226|NCT04060862|Fulvestrant|fulvestrant|mesh-list
14980227|NCT04060862|Palbociclib|palbociclib|mesh-list
14980228|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14980229|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980230|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14980231|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14980232|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
14980233|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980234|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980235|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14800970|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14980236|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980237|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980238|NCT04060849|Ethanol|ethanol|mesh-list
14980239|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14980240|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14980241|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980242|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980243|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980244|NCT04058756|Spartalizumab|spartalizumab|mesh-list
14980245|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980246|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980247|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980248|NCT04055818|Niacinamide|niacinamide|mesh-list
14980249|NCT04055818|Niacin|niacin|mesh-list
14980250|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
14980251|NCT04055818|Decitabine|decitabine|mesh-list
14980252|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
14980253|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14980254|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
14980255|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980256|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980257|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980258|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
14980259|NCT04055818|Vitamins|vitamins|mesh-ancestor
14980260|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
14980261|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980262|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14980263|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14980264|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
14980265|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
14980266|NCT04049669|Temozolomide|temozolomide|mesh-list
14980267|NCT04049669|Lomustine|lomustine|mesh-list
14980268|NCT04049669|Etoposide|etoposide|mesh-list
14980269|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980270|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
14980271|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980272|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980273|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14980274|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
14980275|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980276|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980277|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14980278|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14980279|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14980280|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14980281|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980282|NCT04047836|Nicotine|nicotine|mesh-list
14980283|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14980284|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
14980285|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980286|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980287|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14980288|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14980289|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
14980290|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980291|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980292|NCT04039607|Nivolumab|nivolumab|mesh-list
14980293|NCT04039607|Ipilimumab|ipilimumab|mesh-list
14980294|NCT04039607|Sorafenib|sorafenib|mesh-list
14980295|NCT04039607|Lenvatinib|lenvatinib|mesh-list
14980296|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980297|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980298|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980299|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980300|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14980301|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980302|NCT04038502|Carboplatin|carboplatin|mesh-list
14980303|NCT04038502|Olaparib|olaparib|mesh-list
14980304|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980305|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14980306|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980307|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030172|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15030173|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030174|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030175|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14980308|NCT04022200|Paclitaxel|paclitaxel|mesh-list
14980309|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14980310|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980311|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980312|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980313|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980314|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980315|NCT04020848|Melatonin|melatonin|mesh-list
14980316|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
14980317|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980318|NCT04020848|Protective Agents|protective agents|mesh-ancestor
14980319|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980320|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980321|NCT04012177|Niacinamide|niacinamide|mesh-list
14980322|NCT04012177|Niacin|niacin|mesh-list
14980323|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
14980324|NCT04012177|Azithromycin|azithromycin|mesh-list
14980325|NCT04012177|Choline|choline|mesh-list
14980326|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14980327|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980328|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
14980329|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14980330|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
14980331|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980332|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980333|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14980334|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
14980335|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
14980336|NCT04012177|Vitamins|vitamins|mesh-ancestor
14980337|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
14980338|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980339|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
14980340|NCT04009109|Dexamethasone|dexamethasone|mesh-list
14980341|NCT04009109|Lenalidomide|lenalidomide|mesh-list
14980342|NCT04009109|Daratumumab|daratumumab|mesh-list
14980343|NCT04009109|Ixazomib|ixazomib|mesh-list
14980344|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980345|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
14980346|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
14980347|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980348|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980349|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980350|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
14980351|NCT04009109|Hormones|hormones|mesh-ancestor
14980352|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980353|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14980354|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980355|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
14980356|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14980357|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14980358|NCT04009109|Growth Substances|growth substances|mesh-ancestor
14980359|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
14980360|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
14980361|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980362|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980363|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
14980364|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980365|NCT04007289|Apixaban|apixaban|mesh-list
14980366|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14980367|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
14980368|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14980369|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
14980370|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980371|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980372|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
14980373|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
14980374|NCT04004416|Lorazepam|lorazepam|mesh-list
14980375|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
14980376|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
14980377|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
14980378|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980379|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980380|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980381|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14980382|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980383|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14980384|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14980385|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14980386|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
14980387|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
14980388|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980389|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980390|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
14980391|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14980392|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14980393|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
14980394|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980395|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980396|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14980397|NCT04002518|Cimetidine|cimetidine|mesh-list
14980398|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14980399|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980400|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14980401|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
14980402|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
14980403|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980404|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980405|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980406|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14980407|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14980408|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980409|NCT04000529|Spartalizumab|spartalizumab|mesh-list
14980410|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980411|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980412|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980413|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
14980414|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14980415|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980416|NCT03993249|Nivolumab|nivolumab|mesh-list
14980417|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980418|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980419|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980420|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980421|NCT03990883|Lidocaine|lidocaine|mesh-list
14980422|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
14980423|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
14980424|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980425|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980426|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
14980427|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980428|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14980429|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14980430|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14980431|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14980432|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980433|NCT03988634|Valsartan|valsartan|mesh-list
14980434|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14980435|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14980436|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14980437|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980438|NCT03984890|Vitamin D|vitamin d|mesh-list
14980439|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
14980440|NCT03984890|Vitamins|vitamins|mesh-ancestor
14980441|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
14980442|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980443|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14980444|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14980445|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14980446|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14980447|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980448|NCT03971071|Erenumab|erenumab|mesh-list
14980449|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14980450|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14980451|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980452|NCT03971071|Analgesics|analgesics|mesh-ancestor
14980453|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
14980454|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980455|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980456|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
14980457|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
14980458|NCT03969446|Decitabine|decitabine|mesh-list
14980459|NCT03969446|Venetoclax|venetoclax|mesh-list
14980460|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980461|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980462|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14980463|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
14980464|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980465|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980466|NCT03960008|Doxorubicin|doxorubicin|mesh-list
14980467|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14980468|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14980469|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980470|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14980471|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14980472|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980473|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980474|NCT03944941|Cetuximab|cetuximab|mesh-list
14980475|NCT03944941|Avelumab|avelumab|mesh-list
14980476|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980477|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980478|NCT03940352|Venetoclax|venetoclax|mesh-list
14980479|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980480|NCT03931551|Trastuzumab|trastuzumab|mesh-list
14980481|NCT03931551|Olaparib|olaparib|mesh-list
14980482|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980483|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980484|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14980485|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980486|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980487|NCT03930615|Letermovir|letermovir|mesh-list
14980488|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14980489|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980490|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980491|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980492|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
14980493|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980494|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14980495|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
14980496|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980497|NCT03928847|Protective Agents|protective agents|mesh-ancestor
14980498|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980499|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14980500|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14980501|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980502|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14980503|NCT03928600|Misoprostol|misoprostol|mesh-list
14980504|NCT03928600|Dinoprostone|dinoprostone|mesh-list
14980505|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14980506|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
14980507|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14980508|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980509|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14980510|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980511|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
14980512|NCT03928314|Paclitaxel|paclitaxel|mesh-list
14980513|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14980514|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980515|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980516|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980517|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980518|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980519|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
14980520|NCT03926091|Docetaxel|docetaxel|mesh-list
14980521|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980522|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
14980523|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980524|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980525|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14980526|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
14980527|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980528|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980529|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14980530|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980531|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980532|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980533|NCT03924427|BMS-986165|bms-986165|mesh-list
14980534|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
14980535|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14980536|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980537|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980538|NCT03922451|Cefazolin|cefazolin|mesh-list
14980539|NCT03922451|Tazobactam|tazobactam|mesh-list
14980540|NCT03922451|Piperacillin|piperacillin|mesh-list
14980541|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14980542|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14980543|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980544|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14980545|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980546|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980547|NCT03916419|Paclitaxel|paclitaxel|mesh-list
14980548|NCT03916419|Carboplatin|carboplatin|mesh-list
14980549|NCT03916419|Durvalumab|durvalumab|mesh-list
14980550|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14980551|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980552|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980553|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980554|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980555|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980556|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980557|NCT03913442|Colchicine|colchicine|mesh-list
14980558|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
14980559|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980560|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980561|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980562|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980563|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980564|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980565|NCT03910244|Pomalidomide|pomalidomide|mesh-list
14980566|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
14980567|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980568|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14980569|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14980570|NCT03910244|Growth Substances|growth substances|mesh-ancestor
14980571|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
14980572|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030176|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15030177|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
15030178|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030179|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15030180|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15030181|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15030182|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15030183|NCT01966913|Bevacizumab|bevacizumab|mesh-list
15030184|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15030185|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030186|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15030187|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15030188|NCT01966913|Growth Substances|growth substances|mesh-ancestor
15030189|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030190|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
15035197|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15035198|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15035199|NCT02000102|Growth Substances|growth substances|mesh-ancestor
15035200|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035201|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
15035202|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035203|NCT02000193|Fulvestrant|fulvestrant|mesh-list
15035204|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035205|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035206|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15035207|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15035208|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
15035209|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035210|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035211|NCT02000206|Ketamine|ketamine|mesh-list
15035212|NCT02000206|Alfentanil|alfentanil|mesh-list
15035213|NCT02000206|Propofol|propofol|mesh-list
15035214|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15035215|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035216|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035217|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15035218|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
15035219|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
15035220|NCT02000206|Analgesics|analgesics|mesh-ancestor
15035221|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
15035222|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035223|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15035224|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15035225|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15035226|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035227|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035228|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15035229|NCT02000206|Narcotics|narcotics|mesh-ancestor
15035230|NCT02000336|Prednisolone|prednisolone|mesh-list
15035231|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980573|NCT03894891|Docetaxel|docetaxel|mesh-list
14980574|NCT03894891|Nivolumab|nivolumab|mesh-list
14980575|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980576|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980577|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980578|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980579|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980580|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980581|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980582|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14980583|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
14980584|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980585|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14980586|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14980587|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14980588|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
14980589|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980590|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14980591|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14980592|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980593|NCT03889275|Durvalumab|durvalumab|mesh-list
14980594|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980595|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980596|NCT03884998|Nivolumab|nivolumab|mesh-list
14980597|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980598|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980599|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980600|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980601|NCT03874052|Venetoclax|venetoclax|mesh-list
14980602|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14980603|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980604|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14980605|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980606|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980607|NCT03873857|Venetoclax|venetoclax|mesh-list
14980608|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980609|NCT03870880|Risperidone|risperidone|mesh-list
14980610|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14980611|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
14980612|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980613|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980614|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980615|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14980616|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14980617|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980618|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14980619|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14980620|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
14980621|NCT03861377|Remifentanil|remifentanil|mesh-list
14980622|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14980623|NCT03861377|Narcotics|narcotics|mesh-ancestor
14980624|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980625|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980626|NCT03861377|Analgesics|analgesics|mesh-ancestor
14980627|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
14980628|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980629|NCT03852992|Minoxidil|minoxidil|mesh-list
14980630|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14980631|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
14980632|NCT03850444|Paclitaxel|paclitaxel|mesh-list
14980633|NCT03850444|Carboplatin|carboplatin|mesh-list
14980634|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
14980635|NCT03850444|Pemetrexed|pemetrexed|mesh-list
14980636|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14980637|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980638|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
14523265|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
14523266|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523267|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523268|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523269|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523270|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523271|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980639|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980640|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980641|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980642|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980643|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980644|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14980645|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14980646|NCT03846570|Beclomethasone|beclomethasone|mesh-list
14980647|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
14980648|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14980649|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
14980650|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980651|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980652|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14980653|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
14980654|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14980655|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14980656|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14980657|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
14980658|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980659|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980660|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980661|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
14980662|NCT03846570|Hormones|hormones|mesh-ancestor
14980663|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980664|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14980665|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14980666|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980667|NCT03838367|Leronlimab|leronlimab|mesh-list
14980668|NCT03838367|Carboplatin|carboplatin|mesh-list
14980669|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
14980670|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980671|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14980672|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14980673|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980674|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14980675|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14980676|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
14980677|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980678|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
14980679|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980680|NCT03837925|Atorvastatin|atorvastatin|mesh-list
14980681|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14980682|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14980683|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
14980684|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980685|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14980686|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14980687|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980688|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
14980689|NCT03836144|Diuretics|diuretics|mesh-ancestor
14980690|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
14980691|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980692|NCT03836144|Expectorants|expectorants|mesh-ancestor
14980693|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
14980694|NCT03836066|Bevacizumab|bevacizumab|mesh-list
14980695|NCT03836066|Atezolizumab|atezolizumab|mesh-list
14980696|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980697|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980698|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14980699|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14980700|NCT03836066|Growth Substances|growth substances|mesh-ancestor
14980701|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980702|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
14980703|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
14980704|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14980705|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14980706|NCT03826628|Sirolimus|sirolimus|mesh-list
14980707|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14980708|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980709|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14980710|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980711|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
14980712|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980713|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
14980714|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980715|NCT03826563|Melatonin|melatonin|mesh-list
14980716|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
14980717|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980718|NCT03826563|Protective Agents|protective agents|mesh-ancestor
14980719|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980720|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980721|NCT03825536|Methamphetamine|methamphetamine|mesh-list
14980722|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14980723|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980724|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
14980725|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
14980726|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980727|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
14980728|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980729|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980730|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
14980731|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14980732|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14980733|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14980734|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14980735|NCT03816397|Adalimumab|adalimumab|mesh-list
14980736|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980737|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980738|NCT03815643|Avelumab|avelumab|mesh-list
14980739|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980740|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980741|NCT03814590|Vaccines|vaccines|mesh-list
14980742|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
14980743|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980744|NCT03809923|Lidocaine|lidocaine|mesh-list
14980745|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
14980746|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
14980747|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
14980748|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14980749|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980750|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
14980751|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980752|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14980753|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14980754|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14980755|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14980756|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980757|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14980758|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14980759|NCT03809923|Analgesics|analgesics|mesh-ancestor
14980760|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14980761|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14980762|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14980763|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
14980764|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14980765|NCT03808961|Vitamins|vitamins|mesh-list
14980766|NCT03808961|Niacin|niacin|mesh-list
14980767|NCT03808961|Niacinamide|niacinamide|mesh-list
14980768|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
14980769|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
14980770|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
14980771|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980772|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14980773|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
14980774|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980775|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14980776|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
14980777|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
14980778|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980779|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
14800971|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14800972|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14800973|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
14800974|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14800975|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
14800976|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14800977|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14800978|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
14800979|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
14800980|NCT00790595|Sunitinib|sunitinib|mesh-list
14800981|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980780|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980781|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980782|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14980783|NCT03804138|Vaccines|vaccines|mesh-list
14980784|NCT03804138|Immunologic Factors|immunologic factors|mesh-ancestor
14980785|NCT03804138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980786|NCT03796416|Misoprostol|misoprostol|mesh-list
14980787|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14980788|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
14980789|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14980790|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980791|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14980792|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980793|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
15030191|NCT01967017|Lidocaine|lidocaine|mesh-list
15030192|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
15030193|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
15030194|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030195|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030196|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
15030197|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030198|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15030199|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15030200|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15030201|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030202|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030203|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15030204|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030205|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15030206|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030207|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030208|NCT01967199|Paclitaxel|paclitaxel|mesh-list
15030209|NCT01967199|Everolimus|everolimus|mesh-list
15030210|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030211|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030212|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030213|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030214|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030215|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030216|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030217|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
15030218|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030219|NCT01967238|Vaccines|vaccines|mesh-list
15030220|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
15030221|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030222|NCT01967251|Udenafil|udenafil|mesh-list
15030223|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15030224|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15030225|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030226|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030227|NCT01967264|Udenafil|udenafil|mesh-list
15030228|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15030229|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15030230|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030231|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030232|NCT01967368|Vaccines|vaccines|mesh-list
15030233|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
15030234|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030235|NCT01967381|Methamphetamine|methamphetamine|mesh-list
15030236|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15030237|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030238|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
15030239|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
15030240|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030241|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
15030242|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030243|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030244|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
15030245|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15030246|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15030247|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030248|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15030249|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
15030250|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15030251|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030252|NCT01967459|Vitamins|vitamins|mesh-ancestor
15030253|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
15030254|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15030255|NCT01967472|Artesunate|artesunate|mesh-list
15030256|NCT01967472|Lumefantrine|lumefantrine|mesh-list
15030257|NCT01967472|Artemether|artemether|mesh-list
15030258|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15030259|NCT01967472|Amodiaquine|amodiaquine|mesh-list
15030260|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
15030261|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15030262|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15030263|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980794|NCT03785106|Vitamins|vitamins|mesh-list
14980795|NCT03785106|Pyridoxine|pyridoxine|mesh-list
14980796|NCT03785106|Pyridoxal|pyridoxal|mesh-list
14980797|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
14980798|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
14980799|NCT03785106|Isoniazid|isoniazid|mesh-list
14980800|NCT03785106|Rifapentine|rifapentine|mesh-list
14980801|NCT03785106|Rifampin|rifampin|mesh-list
14980802|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
14980803|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980804|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
14980805|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14980806|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980807|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14980808|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14980809|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
14980810|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980811|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14980812|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14980813|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
14980814|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14980815|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980816|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14980817|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14980818|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14980819|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14980820|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14980821|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14980822|NCT03782142|Tenofovir|tenofovir|mesh-list
14980823|NCT03782142|Dolutegravir|dolutegravir|mesh-list
14980824|NCT03782142|Rilpivirine|rilpivirine|mesh-list
14980825|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
14980826|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
14980827|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980828|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14980829|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14980830|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980831|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980832|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14980833|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14980834|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14980835|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14980836|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
14980837|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14980838|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14980839|NCT03778931|Fulvestrant|fulvestrant|mesh-list
14980840|NCT03778931|Anastrozole|anastrozole|mesh-list
14980841|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14980842|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980843|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14980844|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14980845|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
14980846|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980847|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980848|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14980849|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14980850|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980851|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980852|NCT03770299|Gemcitabine|gemcitabine|mesh-list
14980853|NCT03770299|Paclitaxel|paclitaxel|mesh-list
14980854|NCT03770299|Vinorelbine|vinorelbine|mesh-list
14980855|NCT03770299|Docetaxel|docetaxel|mesh-list
14980856|NCT03770299|Carboplatin|carboplatin|mesh-list
14980857|NCT03770299|Nivolumab|nivolumab|mesh-list
14980858|NCT03770299|Pemetrexed|pemetrexed|mesh-list
14980859|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14980860|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980861|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980862|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980863|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980864|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980865|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14980866|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
14980867|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
14980868|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14980869|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980870|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980871|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
14980872|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980873|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980874|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14980875|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14980876|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14980877|NCT03767244|Androgens|androgens|mesh-list
14980878|NCT03767244|Hormones|hormones|mesh-ancestor
14980879|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980880|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980881|NCT03762473|Tacrolimus|tacrolimus|mesh-list
14980882|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980883|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
14980884|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980885|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14980886|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980887|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980888|NCT03760835|Dexamethasone|dexamethasone|mesh-list
14980889|NCT03760835|Prednisone|prednisone|mesh-list
14980890|NCT03760835|Prednisolone|prednisolone|mesh-list
14980891|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
14980892|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14980893|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14980894|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14980895|NCT03760835|Cortisone|cortisone|mesh-list
14980896|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
14980897|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980898|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
14980899|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
14980900|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14980901|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980902|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980903|NCT03760835|Hormones|hormones|mesh-ancestor
14980904|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980905|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14980906|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980907|NCT03759496|Durvalumab|durvalumab|mesh-list
14980908|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980909|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980910|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
14980911|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980912|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980913|NCT03754725|Deferiprone|deferiprone|mesh-list
14980914|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14980915|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
14980916|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
14980917|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980918|NCT03750968|Carotenoids|carotenoids|mesh-list
14980919|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
14980920|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980921|NCT03750968|Protective Agents|protective agents|mesh-ancestor
14980922|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980923|NCT03748784|Aflibercept|aflibercept|mesh-list
14980924|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14980925|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14980926|NCT03748784|Growth Substances|growth substances|mesh-ancestor
14980927|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980928|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
14980929|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980930|NCT03744026|Carboplatin|carboplatin|mesh-list
14980931|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980932|NCT03737240|Insulin|insulin|mesh-list
14980933|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14980934|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
14980935|NCT03737240|Liraglutide|liraglutide|mesh-list
14980936|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
14980937|NCT03737240|Xultophy|xultophy|mesh-list
14980938|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14980939|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980940|NCT03737240|Incretins|incretins|mesh-ancestor
14980941|NCT03737240|Hormones|hormones|mesh-ancestor
14980942|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14980943|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
14980944|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14980945|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14980946|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980947|NCT03729349|Golimumab|golimumab|mesh-list
14980948|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14980949|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14980950|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980951|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
14980952|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980953|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
14980954|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980955|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980956|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
14980957|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980958|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980959|NCT03726879|Paclitaxel|paclitaxel|mesh-list
14980960|NCT03726879|Maytansine|maytansine|mesh-list
14980961|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14980962|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
14980963|NCT03726879|Doxorubicin|doxorubicin|mesh-list
14980964|NCT03726879|Trastuzumab|trastuzumab|mesh-list
14980965|NCT03726879|Atezolizumab|atezolizumab|mesh-list
14980966|NCT03726879|Pertuzumab|pertuzumab|mesh-list
14980967|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14980968|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980969|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
14980970|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
14980971|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
14980972|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980973|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14980974|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
14980975|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14980976|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14980977|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14980978|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
14980979|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14980980|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14980981|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14980982|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14980983|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980984|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14980985|NCT03724409|Octreotide|octreotide|mesh-list
14980986|NCT03724409|Edotreotide|edotreotide|mesh-list
14980987|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14980988|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14980989|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14980990|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14980991|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980992|NCT03715829|PF-06700841|pf-06700841|mesh-list
14980993|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14980994|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14980995|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14980996|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
14980997|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
14980998|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14980999|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981000|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981001|NCT03710642|Prazosin|prazosin|mesh-list
14981002|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14981003|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14981004|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14981005|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14981006|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
14981007|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981008|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981009|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981010|NCT03708627|Bimatoprost|bimatoprost|mesh-list
14981011|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14981012|NCT03704441|Bupivacaine|bupivacaine|mesh-list
14981013|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
14981014|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
14981015|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14981016|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981017|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
14981018|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981019|NCT03702725|Dexamethasone|dexamethasone|mesh-list
14981020|NCT03702725|Lenalidomide|lenalidomide|mesh-list
14981021|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981022|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
14981023|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
14981024|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981025|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981026|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14981027|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
14981028|NCT03702725|Hormones|hormones|mesh-ancestor
14981029|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981030|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981031|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981032|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
14981033|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14981034|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14981035|NCT03702725|Growth Substances|growth substances|mesh-ancestor
14981036|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
14981037|NCT03701308|Cytarabine|cytarabine|mesh-list
14981038|NCT03701308|Daunorubicin|daunorubicin|mesh-list
14981039|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981040|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
14981041|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981042|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981043|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
14981044|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981045|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981046|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
14523272|NCT03582553|Naringenin|naringenin|mesh-list
14523273|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14523274|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523275|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14523276|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
14523277|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981047|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981048|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14981049|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14981050|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981051|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981052|NCT03696355|GDC-0084|gdc-0084|mesh-list
14981053|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981054|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981055|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
14981056|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981057|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981058|NCT03693677|Gemcitabine|gemcitabine|mesh-list
14981059|NCT03693677|Paclitaxel|paclitaxel|mesh-list
14981060|NCT03693677|Irinotecan|irinotecan|mesh-list
14981061|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981062|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981063|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981064|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981065|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981066|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981067|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981068|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
14981069|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
14981070|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981071|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981072|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981073|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
14981074|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981075|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14981076|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981077|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14981078|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
14981079|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981080|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
14981081|NCT03680092|Methotrexate|methotrexate|mesh-list
14981082|NCT03680092|Abatacept|abatacept|mesh-list
14981083|NCT03680092|Tacrolimus|tacrolimus|mesh-list
14981084|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981085|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
14981086|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981087|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14981088|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14981089|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
14981090|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981091|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981092|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14981093|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14981094|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
14981095|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14981096|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981097|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
14981098|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981099|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981100|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14981101|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14981102|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14981103|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981104|NCT03678688|Bedaquiline|bedaquiline|mesh-list
14981105|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
14981106|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
14981107|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14981108|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981109|NCT03677934|Ranibizumab|ranibizumab|mesh-list
14981110|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14981111|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14981112|NCT03677934|Growth Substances|growth substances|mesh-ancestor
14981113|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981114|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
14981115|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981116|NCT03677817|Lidocaine|lidocaine|mesh-list
14981117|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
14981118|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
14981119|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14981120|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981121|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
14981122|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981123|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14981124|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14981125|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14981126|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981127|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981128|NCT03673826|Dexamethasone|dexamethasone|mesh-list
14981129|NCT03673826|Lenalidomide|lenalidomide|mesh-list
14981130|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981131|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
14981132|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
14981133|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981134|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981135|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14981136|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
14981137|NCT03673826|Hormones|hormones|mesh-ancestor
14981138|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981139|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981140|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981141|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
14981142|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14981143|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14981144|NCT03673826|Growth Substances|growth substances|mesh-ancestor
14981145|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
14981146|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14981147|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981148|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981149|NCT03662919|Adalimumab|adalimumab|mesh-list
14981150|NCT03662919|Infliximab|infliximab|mesh-list
14981151|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981152|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14981153|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981154|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14981155|NCT03662685|Coal Tar|coal tar|mesh-list
14981156|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
14981157|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
15030264|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030265|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
15030266|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
15030267|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15030268|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
15030269|NCT01967498|Montelukast|montelukast|mesh-list
15030270|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15030271|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
15030272|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15030273|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
15030274|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030275|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030276|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15030277|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15030278|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030279|NCT01967524|Ropivacaine|ropivacaine|mesh-list
15030280|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15030281|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
15030282|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15030283|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
15030284|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
15030285|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030286|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030287|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
15030288|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030289|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15030290|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030291|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030292|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
15030293|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030294|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15030295|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15030296|NCT01967758|Amoxicillin|amoxicillin|mesh-list
15030297|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15030298|NCT01967758|Trimethoprim|trimethoprim|mesh-list
15030299|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
15030300|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030301|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15030302|NCT01967758|Renal Agents|renal agents|mesh-ancestor
15030303|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
15030304|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15030305|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15030306|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15030307|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030308|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030309|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15030310|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15030311|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15030312|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15030313|NCT01967823|Aldesleukin|aldesleukin|mesh-list
15030314|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
15030315|NCT01967823|Fludarabine|fludarabine|mesh-list
15030316|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030317|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
15030318|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030319|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15030320|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15030321|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
15030322|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030323|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030324|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15030325|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15030326|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15030327|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
15030328|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030329|NCT01967875|Docetaxel|docetaxel|mesh-list
15030330|NCT01967875|Capecitabine|capecitabine|mesh-list
15030331|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030332|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030333|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030334|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030335|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981158|NCT03661320|Gemcitabine|gemcitabine|mesh-list
14981159|NCT03661320|Nivolumab|nivolumab|mesh-list
14981160|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981161|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981162|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
14981163|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981164|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
14981165|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981166|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981167|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981168|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
14981169|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981170|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981171|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981172|NCT03660839|Artefenomel|artefenomel|mesh-list
14981173|NCT03660839|Ferroquine|ferroquine|mesh-list
14981174|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
14981175|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14981176|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14981177|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981178|NCT03660241|Abrocitinib|abrocitinib|mesh-list
14981179|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14981180|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981181|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981182|NCT03651271|Nivolumab|nivolumab|mesh-list
14981183|NCT03651271|Ipilimumab|ipilimumab|mesh-list
14981184|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981185|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981186|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981187|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981188|NCT03651102|Thalidomide|thalidomide|mesh-list
14981189|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
14981190|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981191|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
14981192|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981193|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
14981194|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14981195|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981196|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14981197|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14981198|NCT03651102|Growth Substances|growth substances|mesh-ancestor
14981199|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
14981200|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981201|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
14981202|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981203|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981204|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14981205|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
14981206|NCT03649841|Prednisone|prednisone|mesh-list
14981207|NCT03649841|Cortisone|cortisone|mesh-list
14981208|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
14981209|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
14981210|NCT03649841|Hormones|hormones|mesh-list
14981211|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14981212|NCT03649841|Androgens|androgens|mesh-list
14981213|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
14981214|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981215|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
14981216|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981217|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981218|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981219|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981220|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14981221|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981222|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981223|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
14981224|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14981225|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
14981226|NCT03649841|Protective Agents|protective agents|mesh-ancestor
14981227|NCT03649841|Vitamins|vitamins|mesh-ancestor
14981228|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
14981229|NCT03649841|Estrogens|estrogens|mesh-ancestor
14981230|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
14981231|NCT03649802|Vitamin D|vitamin d|mesh-list
14981232|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
14981233|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
14981234|NCT03649802|Vitamins|vitamins|mesh-list
14981235|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
14981236|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981237|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14981238|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14981239|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
14981240|NCT03645928|Nivolumab|nivolumab|mesh-list
14981241|NCT03645928|Ipilimumab|ipilimumab|mesh-list
14981242|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981243|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981244|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981245|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981246|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14981247|NCT03643198|Metronidazole|metronidazole|mesh-list
14981248|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
14981249|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981250|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14981251|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14981252|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14981253|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981254|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981255|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981256|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981257|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14981258|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14981259|NCT03631199|Paclitaxel|paclitaxel|mesh-list
14981260|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14981261|NCT03631199|Carboplatin|carboplatin|mesh-list
14981262|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
14981263|NCT03631199|Pemetrexed|pemetrexed|mesh-list
14981264|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14981265|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981266|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981267|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981268|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981269|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981270|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981271|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981272|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981273|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14981274|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14981275|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
14981276|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981277|NCT03623243|Siponimod|siponimod|mesh-list
14981278|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14981279|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981280|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981281|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
14981282|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981283|NCT03620578|Nivolumab|nivolumab|mesh-list
14981284|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981285|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981286|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981287|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981288|NCT03616587|Everolimus|everolimus|mesh-list
14981289|NCT03616587|Palbociclib|palbociclib|mesh-list
14981290|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981291|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981292|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
14981293|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981294|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14981295|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981296|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981297|NCT03611556|Leucovorin|leucovorin|mesh-list
14981298|NCT03611556|Gemcitabine|gemcitabine|mesh-list
14981299|NCT03611556|Paclitaxel|paclitaxel|mesh-list
14981300|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
14981301|NCT03611556|Fluorouracil|fluorouracil|mesh-list
14981302|NCT03611556|Durvalumab|durvalumab|mesh-list
14981303|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
14981304|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981305|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981306|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981307|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981308|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981309|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981310|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981311|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
14981312|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
14981313|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981314|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981315|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981316|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
14981317|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981318|NCT03611556|Antidotes|antidotes|mesh-ancestor
14981319|NCT03611556|Protective Agents|protective agents|mesh-ancestor
14981320|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
14981321|NCT03611556|Vitamins|vitamins|mesh-ancestor
14981322|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
14981323|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981324|NCT03606980|Dexamethasone|dexamethasone|mesh-list
14981325|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
14981326|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14981327|NCT03606980|BB 1101|bb 1101|mesh-list
14981328|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981329|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
14981330|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
14981331|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981332|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981333|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14981334|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
14981335|NCT03606980|Hormones|hormones|mesh-ancestor
14981336|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981337|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981338|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981339|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
14981340|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981341|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981342|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14981343|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
14981344|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981345|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14981346|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
14981347|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981348|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981349|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14981350|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14981351|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981352|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
14981353|NCT03599622|BMS-986165|bms-986165|mesh-list
14981354|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981355|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14981356|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981357|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981358|NCT03596385|Metoprolol|metoprolol|mesh-list
14981359|NCT03596385|Atenolol|atenolol|mesh-list
14981360|NCT03596385|Carvedilol|carvedilol|mesh-list
14981361|NCT03596385|Bisoprolol|bisoprolol|mesh-list
14981362|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14981363|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14981364|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14981365|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
14981366|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
14981367|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981368|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981369|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14981370|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14981371|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
14981372|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981373|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981374|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
14981375|NCT03596385|Protective Agents|protective agents|mesh-ancestor
14981376|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14981377|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981378|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14981379|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
14981380|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14981381|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14981382|NCT03591731|Nivolumab|nivolumab|mesh-list
14981383|NCT03591731|Ipilimumab|ipilimumab|mesh-list
14981384|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981385|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981386|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981387|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981388|NCT03590652|Dexamethasone|dexamethasone|mesh-list
14981389|NCT03590652|Daratumumab|daratumumab|mesh-list
14981390|NCT03590652|Pomalidomide|pomalidomide|mesh-list
14981391|NCT03590652|Ixazomib|ixazomib|mesh-list
14981392|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981393|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
14981394|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
14981395|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981396|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981397|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14981398|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
14981399|NCT03590652|Hormones|hormones|mesh-ancestor
14981400|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981401|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981402|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981403|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
14981404|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14981405|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14981406|NCT03590652|Growth Substances|growth substances|mesh-ancestor
14981407|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
14981408|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
14981409|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981410|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981411|NCT03584711|Panitumumab|panitumumab|mesh-list
14981412|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981413|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981414|NCT03582475|Cisplatin|cisplatin|mesh-list
14981415|NCT03582475|Carboplatin|carboplatin|mesh-list
14981416|NCT03582475|Docetaxel|docetaxel|mesh-list
14981417|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
14981418|NCT03582475|Etoposide|etoposide|mesh-list
14981419|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
14981420|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
14981421|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981422|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981423|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981424|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981425|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981426|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981427|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981428|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14981429|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981430|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981431|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
14981432|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981433|NCT03582033|Dexamethasone|dexamethasone|mesh-list
14981434|NCT03582033|Pomalidomide|pomalidomide|mesh-list
14981435|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981436|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
14981437|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
14981438|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981439|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981440|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14981441|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
14981442|NCT03582033|Hormones|hormones|mesh-ancestor
14981443|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981444|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981445|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981446|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
14981447|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14981448|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14981449|NCT03582033|Growth Substances|growth substances|mesh-ancestor
14981450|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
14981451|NCT03579316|Olaparib|olaparib|mesh-list
14981452|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14981453|NCT03579316|Adavosertib|adavosertib|mesh-list
14981454|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981455|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981456|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981457|NCT03576417|Nivolumab|nivolumab|mesh-list
14981458|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981459|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981460|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981461|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981462|NCT03573115|Adapalene|adapalene|mesh-list
14981463|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14981464|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981465|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14981466|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14981467|NCT03573115|Analgesics|analgesics|mesh-ancestor
14981468|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
14981469|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981470|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981471|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981472|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14981473|NCT03569475|Milnacipran|milnacipran|mesh-list
14981474|NCT03569475|Fluoxetine|fluoxetine|mesh-list
14981475|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
14981476|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14981477|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14981478|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981479|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981480|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981481|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
14981482|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981483|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14981484|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
14981485|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14981486|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14981487|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14981488|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981489|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14981490|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14981491|NCT03569475|Analgesics|analgesics|mesh-ancestor
14981492|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
14981493|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981494|NCT03560466|Prednisone|prednisone|mesh-list
14981495|NCT03560466|Prednisolone|prednisolone|mesh-list
14981496|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981497|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
14981498|NCT03560466|Hormones|hormones|mesh-ancestor
14981499|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981500|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981501|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981502|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981503|NCT03546556|Alovudine|alovudine|mesh-list
14981504|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
14981505|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
14981506|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981507|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
14981508|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981509|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14981510|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14981511|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981512|NCT03544281|Dexamethasone|dexamethasone|mesh-list
14981513|NCT03544281|Lenalidomide|lenalidomide|mesh-list
14981514|NCT03544281|Bortezomib|bortezomib|mesh-list
14981515|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981516|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
14981517|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
14981518|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981519|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981520|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14981521|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
14981522|NCT03544281|Hormones|hormones|mesh-ancestor
14981523|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14981524|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14981525|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981526|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
14981527|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14981528|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14981529|NCT03544281|Growth Substances|growth substances|mesh-ancestor
14981530|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
14981531|NCT03542175|Rucaparib|rucaparib|mesh-list
14981532|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14981533|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981534|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981535|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981536|NCT03534284|Trazodone|trazodone|mesh-list
14981537|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14981538|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14981539|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14981540|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981541|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14981542|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14981543|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14981544|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981545|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981546|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981547|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
14981548|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14981549|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
14981550|NCT03533712|Folic Acid|folic acid|mesh-list
14981551|NCT03533712|Hematinics|hematinics|mesh-ancestor
14981552|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
14981553|NCT03533712|Vitamins|vitamins|mesh-ancestor
14981554|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
14981555|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981556|NCT03533582|Gemcitabine|gemcitabine|mesh-list
14981557|NCT03533582|Cisplatin|cisplatin|mesh-list
14981558|NCT03533582|Carboplatin|carboplatin|mesh-list
14981559|NCT03533582|Doxorubicin|doxorubicin|mesh-list
14981560|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14981561|NCT03533582|Fluorouracil|fluorouracil|mesh-list
14981562|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
14981563|NCT03533582|Irinotecan|irinotecan|mesh-list
14981564|NCT03533582|Etoposide|etoposide|mesh-list
14981565|NCT03533582|Vincristine|vincristine|mesh-list
14981566|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
14981567|NCT03533582|Sorafenib|sorafenib|mesh-list
14981568|NCT03533582|Daunorubicin|daunorubicin|mesh-list
14981569|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
14981570|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981571|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981572|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
14981573|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981574|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
14981575|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981576|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981577|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981578|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
14981579|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981580|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14981581|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14981582|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981583|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14981584|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981585|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981586|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981587|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981588|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14981589|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
14981590|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981591|NCT03529396|Chloroquine|chloroquine|mesh-list
14981592|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14981593|NCT03529396|Primaquine|primaquine|mesh-list
14981594|NCT03529396|Amebicides|amebicides|mesh-ancestor
14981595|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14981596|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14981597|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981598|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
14981599|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14981600|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14981601|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14981602|NCT03529396|Analgesics|analgesics|mesh-ancestor
14981603|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
14981604|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981605|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981606|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14981607|NCT03529396|Filaricides|filaricides|mesh-ancestor
14981608|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
14981609|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
14981610|NCT03523520|Naltrexone|naltrexone|mesh-list
14981611|NCT03523520|Bromides|bromides|mesh-list
14981612|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
14981613|NCT03523520|Naloxegol|naloxegol|mesh-list
14981614|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
14981615|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14981616|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981617|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
14981618|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981619|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14981620|NCT03521830|Nivolumab|nivolumab|mesh-list
14981621|NCT03521830|Ipilimumab|ipilimumab|mesh-list
14981622|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981623|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981624|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981625|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981626|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
14981627|NCT03518242|Capecitabine|capecitabine|mesh-list
14981628|NCT03518242|Methotrexate|methotrexate|mesh-list
14981629|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981630|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
14981631|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981632|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14981633|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14981634|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
14981635|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981636|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981637|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14981638|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981639|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
14981640|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14981641|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
14981642|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14981643|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981644|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981645|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14981646|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14981647|NCT03508570|Nivolumab|nivolumab|mesh-list
14981648|NCT03508570|Ipilimumab|ipilimumab|mesh-list
14981649|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981650|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981651|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981652|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981653|NCT03504397|Leucovorin|leucovorin|mesh-list
14981654|NCT03504397|Folic Acid|folic acid|mesh-list
14981655|NCT03504397|Fluorouracil|fluorouracil|mesh-list
14981656|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
14981657|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
14981658|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
14981659|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981660|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981661|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981662|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981663|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
14981664|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981665|NCT03504397|Antidotes|antidotes|mesh-ancestor
14981666|NCT03504397|Protective Agents|protective agents|mesh-ancestor
14981667|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
14981668|NCT03504397|Vitamins|vitamins|mesh-ancestor
14981669|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
14981670|NCT03504397|Hematinics|hematinics|mesh-ancestor
14981671|NCT03500549|Eculizumab|eculizumab|mesh-list
14981672|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14981673|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981674|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
14981675|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981676|NCT03498001|Liraglutide|liraglutide|mesh-list
14981677|NCT03498001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14981678|NCT03498001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981679|NCT03498001|Incretins|incretins|mesh-ancestor
14981680|NCT03498001|Hormones|hormones|mesh-ancestor
15030336|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981681|NCT03498001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030337|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
15030338|NCT01967927|Imidazole|imidazole|mesh-list
15030339|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030340|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030341|NCT01967979|Itraconazole|itraconazole|mesh-list
15030342|NCT01967979|Fluoxetine|fluoxetine|mesh-list
15030343|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
15030344|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030345|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15030346|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15030347|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030348|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030349|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15030350|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
15030351|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030352|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030353|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15030354|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15030355|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15030356|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030357|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030358|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
15030359|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15030360|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
15030361|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15030362|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15030363|NCT01968005|Etodolac|etodolac|mesh-list
15030364|NCT01968005|Lidocaine|lidocaine|mesh-list
15030365|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
15030366|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
15030367|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030368|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030369|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
15030370|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030371|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15030372|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15030373|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15030374|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030375|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030376|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15030377|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15030378|NCT01968005|Analgesics|analgesics|mesh-ancestor
15030379|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15030380|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15030381|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15030382|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15030383|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030384|NCT01968018|Acetaminophen|acetaminophen|mesh-list
15030385|NCT01968018|Tramadol|tramadol|mesh-list
15030386|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15030387|NCT01968018|Analgesics|analgesics|mesh-ancestor
15030388|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
15030389|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030390|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030391|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
15030392|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15030393|NCT01968018|Narcotics|narcotics|mesh-ancestor
15030394|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030395|NCT01968044|Linagliptin|linagliptin|mesh-list
15030396|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15030397|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030398|NCT01968044|Incretins|incretins|mesh-ancestor
15030399|NCT01968044|Hormones|hormones|mesh-ancestor
15030400|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030401|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15030402|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
15030403|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030404|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030405|NCT01968083|Vaccines|vaccines|mesh-list
15030406|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
15030407|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030408|NCT01968161|Asenapine|asenapine|mesh-list
14981682|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
14981683|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
14981684|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981685|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
14981686|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981687|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14981688|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14981689|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
14981690|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981691|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981692|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14981693|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981694|NCT03475186|Ramipril|ramipril|mesh-list
14981695|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14981696|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
14981697|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981698|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981699|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14981700|NCT03469960|Nivolumab|nivolumab|mesh-list
14981701|NCT03469960|Ipilimumab|ipilimumab|mesh-list
14981702|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981703|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981704|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981705|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981706|NCT03460379|Citalopram|citalopram|mesh-list
14981707|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14981708|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14981709|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981710|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981711|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981712|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
14981713|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981714|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14981715|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
14981716|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14981717|NCT03460366|Enalapril|enalapril|mesh-list
14981718|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14981719|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
14981720|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981721|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981722|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14981723|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
14981724|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14981725|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981726|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14981727|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14981728|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981729|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981730|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
14981731|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981732|NCT03460327|Candesartan|candesartan|mesh-list
14981733|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14981734|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14981735|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14981736|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981737|NCT03460314|Buprenorphine|buprenorphine|mesh-list
14981738|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14981739|NCT03460314|Narcotics|narcotics|mesh-ancestor
14981740|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14981741|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981742|NCT03460314|Analgesics|analgesics|mesh-ancestor
14981743|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
14981744|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981745|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14981746|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14981747|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14981748|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14981749|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981750|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981751|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
14981752|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981753|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981754|NCT03456700|Sirolimus|sirolimus|mesh-list
14981755|NCT03456700|Auranofin|auranofin|mesh-list
14981756|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14981757|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981758|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14981759|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981760|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
14981761|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981762|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
14981763|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981764|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14981765|NCT03455270|Palbociclib|palbociclib|mesh-list
14981766|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981767|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14981768|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981769|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981770|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14981771|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
14981772|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14981773|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14981774|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14981775|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14981776|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981777|NCT03435185|Lidocaine|lidocaine|mesh-list
14981778|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
14981779|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
14981780|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14981781|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981782|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
14981783|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981784|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14981785|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14981786|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14981787|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981788|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981789|NCT03430882|Paclitaxel|paclitaxel|mesh-list
14981790|NCT03430882|Carboplatin|carboplatin|mesh-list
14981791|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14981792|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981793|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981794|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981795|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981796|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981797|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981798|NCT03430219|Calcium|calcium|mesh-list
14981799|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14981800|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981801|NCT03426293|Heparin|heparin|mesh-list
14981802|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
14981803|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14981804|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14981805|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981806|NCT03421353|Gemcitabine|gemcitabine|mesh-list
14981807|NCT03421353|Paclitaxel|paclitaxel|mesh-list
14981808|NCT03421353|Carboplatin|carboplatin|mesh-list
14981809|NCT03421353|Durvalumab|durvalumab|mesh-list
14981810|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981811|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981812|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981813|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981814|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981815|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981816|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981817|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
14981818|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
14981819|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981820|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981821|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981822|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
14981823|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981824|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981825|NCT03414684|Carboplatin|carboplatin|mesh-list
14981826|NCT03414684|Nivolumab|nivolumab|mesh-list
14981827|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981828|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981829|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981830|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981831|NCT03408574|Mecamylamine|mecamylamine|mesh-list
14981832|NCT03408574|Nicotine|nicotine|mesh-list
14981833|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14981834|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
14981835|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981836|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981837|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14981838|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14981839|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
14981840|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981841|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981842|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14981843|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14981844|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14981845|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14981846|NCT03408119|Vitamin D|vitamin d|mesh-list
14981847|NCT03408119|Calcium|calcium|mesh-list
14981848|NCT03408119|Vitamins|vitamins|mesh-ancestor
14981849|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
14981850|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981851|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14981852|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14981853|NCT03402945|Vancomycin|vancomycin|mesh-list
14981854|NCT03402945|Cefazolin|cefazolin|mesh-list
14981855|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14981856|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981857|NCT03398655|Paclitaxel|paclitaxel|mesh-list
14981858|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14981859|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981860|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981861|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981862|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981863|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981864|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981865|NCT03383458|Nivolumab|nivolumab|mesh-list
14981866|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981867|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981868|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981869|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981870|NCT03383380|Sirolimus|sirolimus|mesh-list
14981871|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14981872|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981873|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14981874|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981875|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
14981876|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981877|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
14981878|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981879|NCT03370133|Ustekinumab|ustekinumab|mesh-list
14981880|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981881|NCT03369041|Irinotecan|irinotecan|mesh-list
14981882|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14981883|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981884|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981885|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981886|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981887|NCT03358030|Riboflavin|riboflavin|mesh-list
14981888|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
14981889|NCT03358030|Vitamins|vitamins|mesh-ancestor
14981890|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
14981891|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981892|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14981893|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14981894|NCT03331341|Doxorubicin|doxorubicin|mesh-list
14981895|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14981896|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
14981897|NCT03331341|Dacarbazine|dacarbazine|mesh-list
14981898|NCT03331341|Vinblastine|vinblastine|mesh-list
14981899|NCT03331341|Imidazole|imidazole|mesh-list
14981900|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14981901|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981902|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14981903|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981904|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981905|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981906|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981907|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14981908|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
14981909|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14981910|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
14981911|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
14981912|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
14981913|NCT03330847|Olaparib|olaparib|mesh-list
14981914|NCT03330847|Adavosertib|adavosertib|mesh-list
14981915|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14981916|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14981917|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981918|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981919|NCT03325439|Brivaracetam|brivaracetam|mesh-list
14981920|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
14981921|NCT03323034|Irinotecan|irinotecan|mesh-list
14981922|NCT03323034|Temozolomide|temozolomide|mesh-list
14981923|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14981924|NCT03323034|Pevonedistat|pevonedistat|mesh-list
14981925|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14981926|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14981927|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981928|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981929|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14981930|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
14981931|NCT03301506|Seladelpar|seladelpar|mesh-list
14981932|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14981933|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
14981934|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981935|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14981936|NCT03300544|Leucovorin|leucovorin|mesh-list
14981937|NCT03300544|Fluorouracil|fluorouracil|mesh-list
14981938|NCT03300544|Capecitabine|capecitabine|mesh-list
14981939|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
14981940|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14981941|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
14981942|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981943|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14981944|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981945|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14981946|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
14981947|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981948|NCT03300544|Antidotes|antidotes|mesh-ancestor
14981949|NCT03300544|Protective Agents|protective agents|mesh-ancestor
14981950|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
14981951|NCT03300544|Vitamins|vitamins|mesh-ancestor
14981952|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
14981953|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15030409|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15030410|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15030411|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030412|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030413|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15030414|NCT01968200|Enalapril|enalapril|mesh-list
15030415|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15030416|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
15030417|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030418|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030419|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15030420|NCT01968239|Ranibizumab|ranibizumab|mesh-list
15030421|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15030422|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15030423|NCT01968239|Growth Substances|growth substances|mesh-ancestor
15030424|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030425|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
15030426|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030427|NCT01968395|Caspofungin|caspofungin|mesh-list
15030428|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
15030429|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030430|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030431|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030432|NCT01968460|Pramipexole|pramipexole|mesh-list
15030433|NCT01968460|Rasagiline|rasagiline|mesh-list
15030434|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
15030435|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030436|NCT01968460|Protective Agents|protective agents|mesh-ancestor
15030437|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030438|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15030439|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15030440|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
15030441|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
15030442|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030443|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15030444|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030445|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15030446|NCT01968486|Ranibizumab|ranibizumab|mesh-list
15030447|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15030448|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15030449|NCT01968486|Growth Substances|growth substances|mesh-ancestor
15030450|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030451|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
15030452|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030453|NCT01968564|Curcumin|curcumin|mesh-list
15030454|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15030455|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15030456|NCT01968564|Analgesics|analgesics|mesh-ancestor
15030457|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
15030458|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030459|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030460|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15030461|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15030462|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030463|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030464|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030465|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15030466|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15030467|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15030468|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
15030469|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030470|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15030471|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15030472|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030473|NCT01968590|Vitamin D|vitamin d|mesh-list
15030474|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
15030475|NCT01968590|Vitamins|vitamins|mesh-ancestor
14981954|NCT03260504|Aldesleukin|aldesleukin|mesh-list
14981955|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
14981956|NCT03260504|Interleukin-2|interleukin-2|mesh-list
14981957|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
14981958|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
14981959|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981960|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981961|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
14981962|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981963|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14981964|NCT03260504|Analgesics|analgesics|mesh-ancestor
14981965|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
14981966|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981967|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14981968|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14981969|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
14981970|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14981971|NCT03251924|Nivolumab|nivolumab|mesh-list
14981972|NCT03251924|Ipilimumab|ipilimumab|mesh-list
14981973|NCT03251924|Antibodies|antibodies|mesh-list
14981974|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
14981975|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
14981976|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
14981977|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981978|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14981979|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14981980|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14981981|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981982|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
14981983|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14981984|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
14981985|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981986|NCT03242772|Amphetamine|amphetamine|mesh-list
14981987|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14981988|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14981989|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
14981990|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
14981991|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14981992|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
14981993|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14981994|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14981995|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
14981996|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14981997|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14981998|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14981999|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14982000|NCT03237702|Carotenoids|carotenoids|mesh-list
14982001|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
14982002|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982003|NCT03237702|Protective Agents|protective agents|mesh-ancestor
14982004|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982005|NCT03236311|Adenosine|adenosine|mesh-list
14982006|NCT03236311|Regadenoson|regadenoson|mesh-list
14982007|NCT03236311|Analgesics|analgesics|mesh-ancestor
14982008|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
14982009|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982010|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982011|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14982012|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14982013|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14982014|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
14982015|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
14982016|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14982017|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982018|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14982019|NCT03234686|Deferiprone|deferiprone|mesh-list
14982020|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14982021|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
14982022|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
14982023|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982024|NCT03233204|Olaparib|olaparib|mesh-list
14982025|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14982026|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030476|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
14982027|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982028|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982029|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
14982030|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14982031|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14982032|NCT03229538|Prednisolone|prednisolone|mesh-list
14982033|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
14982034|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14982035|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
14982036|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14982037|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
14982038|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
14982039|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982040|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982041|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982042|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
14982043|NCT03229538|Hormones|hormones|mesh-ancestor
14982044|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982045|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14982046|NCT03229538|Protective Agents|protective agents|mesh-ancestor
14982047|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14982048|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982049|NCT03229057|Metformin|metformin|mesh-list
14982050|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14982051|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982052|NCT03224767|Vemurafenib|vemurafenib|mesh-list
14982053|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982054|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982055|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982056|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982057|NCT03223974|Paclitaxel|paclitaxel|mesh-list
14982058|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14982059|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982060|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982061|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982062|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982063|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982064|NCT03220035|Vemurafenib|vemurafenib|mesh-list
14982065|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982066|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982067|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982068|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982069|NCT03216343|Chiauranib|chiauranib|mesh-list
14982070|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982071|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982072|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982073|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982074|NCT03201939|Lisinopril|lisinopril|mesh-list
14982075|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14982076|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
14982077|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982078|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982079|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14982080|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14982081|NCT03201939|Protective Agents|protective agents|mesh-ancestor
14982082|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982083|NCT03200587|Avelumab|avelumab|mesh-list
14982084|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982085|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982086|NCT03196427|Vedolizumab|vedolizumab|mesh-list
14982087|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982088|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
14982089|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14982090|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982091|NCT03190369|Hylan|hylan|mesh-list
14982092|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
14982093|NCT03190369|Protective Agents|protective agents|mesh-ancestor
14982094|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982095|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
14982096|NCT03190265|Nivolumab|nivolumab|mesh-list
14982097|NCT03190265|Ipilimumab|ipilimumab|mesh-list
14982098|NCT03190265|Pancrelipase|pancrelipase|mesh-list
14982099|NCT03190265|Vaccines|vaccines|mesh-list
14982100|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
14982101|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982102|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982103|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982104|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982105|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
14982106|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982107|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982108|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14982109|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982110|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982111|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982112|NCT03188432|Carboplatin|carboplatin|mesh-list
14982113|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982114|NCT03186209|Benralizumab|benralizumab|mesh-list
14982115|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14982116|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
14982117|NCT03178487|Upadacitinib|upadacitinib|mesh-list
14982118|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14982119|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982120|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982121|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982122|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982123|NCT03172975|Albendazole|albendazole|mesh-list
14982124|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14982125|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
14982126|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14982127|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982128|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
14982129|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14982130|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14982131|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982132|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982133|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982134|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982135|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982136|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14982137|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
14982138|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982139|NCT03172975|Antacids|antacids|mesh-ancestor
14982140|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982141|NCT03164889|Entecavir|entecavir|mesh-list
14982142|NCT03164889|Molgramostim|molgramostim|mesh-list
14982143|NCT03164889|Sargramostim|sargramostim|mesh-list
14982144|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
14982145|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982146|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
14982147|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982148|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982149|NCT03147287|Fulvestrant|fulvestrant|mesh-list
14982150|NCT03147287|Palbociclib|palbociclib|mesh-list
14982151|NCT03147287|Avelumab|avelumab|mesh-list
14982152|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14982153|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982154|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14982155|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14982156|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
14982157|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982158|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982159|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982160|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982161|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982162|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982163|NCT03147040|Carboplatin|carboplatin|mesh-list
14982164|NCT03147040|Atezolizumab|atezolizumab|mesh-list
14982165|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982166|NCT03133260|Aspirin|aspirin|mesh-list
14982167|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14982168|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14982169|NCT03133260|Analgesics|analgesics|mesh-ancestor
14982170|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
14982171|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982172|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982173|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14982174|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982175|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14982176|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15035232|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
14982177|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982178|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14982179|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14982180|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982181|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
14982182|NCT03132636|Cemiplimab|cemiplimab|mesh-list
14982183|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982184|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982185|NCT03126812|Paclitaxel|paclitaxel|mesh-list
14982186|NCT03126812|Carboplatin|carboplatin|mesh-list
14982187|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
14982188|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14982189|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982190|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982191|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982192|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982193|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982194|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982195|NCT03114319|Nazartinib|nazartinib|mesh-list
14982196|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982197|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
14982198|NCT03110432|Niacin|niacin|mesh-list
14982199|NCT03110432|Ezetimibe|ezetimibe|mesh-list
14982200|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14982201|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14982202|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14982203|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
14982204|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982205|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14982206|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
14982207|NCT03110432|Vitamins|vitamins|mesh-ancestor
14982208|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
14982209|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982210|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
14982211|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
14982212|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982213|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982214|NCT03096834|Erenumab|erenumab|mesh-list
14982215|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14982216|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982217|NCT03096834|Analgesics|analgesics|mesh-ancestor
14982218|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
14982219|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982220|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982221|NCT03095612|Docetaxel|docetaxel|mesh-list
14982222|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982223|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982224|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982225|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982226|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982227|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
14982228|NCT03089203|Fludarabine|fludarabine|mesh-list
14982229|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982230|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
14982231|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982232|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982233|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982234|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
14982235|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982236|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982237|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14982238|NCT03088813|Irinotecan|irinotecan|mesh-list
14982239|NCT03088813|Topotecan|topotecan|mesh-list
14982240|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14982241|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14982242|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982243|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982244|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982245|NCT03086993|Gemcitabine|gemcitabine|mesh-list
14982246|NCT03086993|Melphalan|melphalan|mesh-list
14982247|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982248|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982249|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
14982250|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982251|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
14982252|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982253|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982254|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982255|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
14982256|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982257|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982258|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
14982259|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14982260|NCT03085485|Ivacaftor|ivacaftor|mesh-list
14982261|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14982262|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14982263|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982264|NCT03083197|Azithromycin|azithromycin|mesh-list
14982265|NCT03083197|Doxycycline|doxycycline|mesh-list
14982266|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14982267|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982268|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
14982269|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14982270|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14982271|NCT03082209|Bevacizumab|bevacizumab|mesh-list
14982272|NCT03082209|Venetoclax|venetoclax|mesh-list
14982273|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982274|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982275|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14982276|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14982277|NCT03082209|Growth Substances|growth substances|mesh-ancestor
14982278|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982279|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
14982280|NCT03080883|Apixaban|apixaban|mesh-list
14982281|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14982282|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
14982283|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14982284|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
14982285|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982286|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982287|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
14982288|NCT03078010|Tazobactam|tazobactam|mesh-list
14982289|NCT03078010|Piperacillin|piperacillin|mesh-list
14982290|NCT03078010|Cefepime|cefepime|mesh-list
14982291|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14982292|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14982293|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982294|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14982295|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982296|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982297|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
14982298|NCT03070392|Ipilimumab|ipilimumab|mesh-list
14982299|NCT03070392|Dacarbazine|dacarbazine|mesh-list
14982300|NCT03070392|Imidazole|imidazole|mesh-list
14982301|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982302|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982303|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982304|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982305|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982306|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
14982307|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030477|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030478|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15030479|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15030480|NCT01968616|Ranibizumab|ranibizumab|mesh-list
15030481|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15030482|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15030483|NCT01968616|Growth Substances|growth substances|mesh-ancestor
15030484|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030485|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
15030486|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030487|NCT01968655|Factor VIII|factor viii|mesh-list
15030488|NCT01968655|Coagulants|coagulants|mesh-ancestor
15030489|NCT01968759|Ramipril|ramipril|mesh-list
15030490|NCT01968759|Irbesartan|irbesartan|mesh-list
15030491|NCT01968759|Sevelamer|sevelamer|mesh-list
15030492|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15030493|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
15030494|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030495|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030496|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15030497|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15030498|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15030499|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
15030500|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
15030501|NCT01968798|Aspirin|aspirin|mesh-list
15030502|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15030503|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15030504|NCT01968798|Analgesics|analgesics|mesh-ancestor
15030505|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
15030506|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030507|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030508|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15030509|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982308|NCT03067181|Cisplatin|cisplatin|mesh-list
14982309|NCT03067181|Carboplatin|carboplatin|mesh-list
14982310|NCT03067181|Etoposide|etoposide|mesh-list
14982311|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
14982312|NCT03067181|Bleomycin|bleomycin|mesh-list
14982313|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
14982314|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982315|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14982316|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14982317|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14982318|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982319|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982320|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14982321|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
14982322|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
14982323|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982324|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982325|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982326|NCT03064854|Gemcitabine|gemcitabine|mesh-list
14982327|NCT03064854|Paclitaxel|paclitaxel|mesh-list
14982328|NCT03064854|Carboplatin|carboplatin|mesh-list
14982329|NCT03064854|Pemetrexed|pemetrexed|mesh-list
14982330|NCT03064854|Spartalizumab|spartalizumab|mesh-list
14982331|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14982332|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982333|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982334|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982335|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982336|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982337|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982338|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
14982339|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
14982340|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982341|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982342|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982343|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
14982344|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982345|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14982346|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14982347|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982348|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
14982349|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982350|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982351|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
14982352|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14982353|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
14982354|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982355|NCT03056014|Expectorants|expectorants|mesh-ancestor
14982356|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
14982357|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14982358|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
14982359|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982360|NCT03056014|Protective Agents|protective agents|mesh-ancestor
14982361|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982362|NCT03056014|Antidotes|antidotes|mesh-ancestor
14982363|NCT03054363|Letrozole|letrozole|mesh-list
14982364|NCT03054363|Palbociclib|palbociclib|mesh-list
14982365|NCT03054363|Tucatinib|tucatinib|mesh-list
14982366|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982367|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14982368|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14982369|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982370|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982371|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14982372|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
14982373|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982374|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982375|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982376|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
14982377|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
14982378|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982379|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
14982380|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982381|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
14982382|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982383|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982384|NCT03048578|Liraglutide|liraglutide|mesh-list
14982385|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14982386|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982387|NCT03048578|Incretins|incretins|mesh-ancestor
14982388|NCT03048578|Hormones|hormones|mesh-ancestor
14982389|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982390|NCT03026972|Vaccines|vaccines|mesh-list
14982391|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
14982392|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982393|NCT03017833|Metformin|metformin|mesh-list
14982394|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14982395|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982396|NCT03015792|Dexamethasone|dexamethasone|mesh-list
14982397|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
14982398|NCT03015792|Lenalidomide|lenalidomide|mesh-list
14982399|NCT03015792|Ichthammol|ichthammol|mesh-list
14982400|NCT03015792|BB 1101|bb 1101|mesh-list
14982401|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14982402|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
14982403|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
14982404|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982405|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982406|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982407|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
14982408|NCT03015792|Hormones|hormones|mesh-ancestor
14982409|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982410|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14982411|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982412|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
14982413|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14982414|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14982415|NCT03015792|Growth Substances|growth substances|mesh-ancestor
14982416|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
14982417|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
14982418|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982419|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982420|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
14982421|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
14982422|NCT03012815|Gabapentin|gabapentin|mesh-list
14982423|NCT03012815|Lorazepam|lorazepam|mesh-list
14982424|NCT03012815|Valproic Acid|valproic acid|mesh-list
14982425|NCT03012815|Analgesics|analgesics|mesh-ancestor
14982426|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
14982427|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982428|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982429|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
14982430|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14982431|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14982432|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14982433|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14982434|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14982435|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14982436|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14982437|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982438|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
14982439|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
14982440|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
14982441|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982442|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14982443|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
14982444|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
14982445|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982446|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14982447|NCT03006432|Leucovorin|leucovorin|mesh-list
14982448|NCT03006432|Folic Acid|folic acid|mesh-list
14982449|NCT03006432|Docetaxel|docetaxel|mesh-list
14982450|NCT03006432|Fluorouracil|fluorouracil|mesh-list
14982451|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
14982452|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
14982453|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982454|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982455|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982456|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982457|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982458|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
14982459|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982460|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982461|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
14982462|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982463|NCT03006432|Antidotes|antidotes|mesh-ancestor
14982464|NCT03006432|Protective Agents|protective agents|mesh-ancestor
14982465|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
14982466|NCT03006432|Vitamins|vitamins|mesh-ancestor
14982467|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
14982468|NCT03006432|Hematinics|hematinics|mesh-ancestor
14982469|NCT03003065|Temoporfin|temoporfin|mesh-list
14982470|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982471|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14982472|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
14982473|NCT03001011|Sevelamer|sevelamer|mesh-list
14982474|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
14982475|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
14982476|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982477|NCT02999633|Acetaminophen|acetaminophen|mesh-list
14982478|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
14982479|NCT02999633|Promethazine|promethazine|mesh-list
14982480|NCT02999633|Dexamethasone|dexamethasone|mesh-list
14982481|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
14982482|NCT02999633|Ranitidine|ranitidine|mesh-list
14982483|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14982484|NCT02999633|BB 1101|bb 1101|mesh-list
14982485|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14982486|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
14982487|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
14982488|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982489|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982490|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982491|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
14982492|NCT02999633|Hormones|hormones|mesh-ancestor
14982493|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982494|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14982495|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982496|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
14982497|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982498|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982499|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14982500|NCT02999633|Analgesics|analgesics|mesh-ancestor
14982501|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
14982502|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
14982503|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14982504|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14982505|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14982506|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
14982507|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
14982508|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14982509|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
14982510|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
14982511|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14982512|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14982513|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
14982514|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
14982515|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14982516|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14982517|NCT02993757|Vaccines|vaccines|mesh-list
14982518|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
14982519|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982520|NCT02992418|Vaccines|vaccines|mesh-list
14982521|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
14982522|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982523|NCT02979535|Vaccines|vaccines|mesh-list
14982524|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
14982525|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982526|NCT02978716|Gemcitabine|gemcitabine|mesh-list
14982527|NCT02978716|Carboplatin|carboplatin|mesh-list
14982528|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982529|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982530|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
14982531|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982532|NCT02978716|Antiviral Agents|antiviral agents|mesh-ancestor
14982533|NCT02978716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982534|NCT02978716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982535|NCT02978716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982536|NCT02978716|Immunologic Factors|immunologic factors|mesh-ancestor
14982537|NCT02978716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982538|NCT02977156|Ipilimumab|ipilimumab|mesh-list
14982539|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982540|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982541|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982542|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982543|NCT02975934|Docetaxel|docetaxel|mesh-list
14982544|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
14982545|NCT02975934|Rucaparib|rucaparib|mesh-list
14982546|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982547|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982548|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982549|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982550|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982551|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14982552|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982553|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
14982554|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982555|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982556|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14982557|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14982558|NCT02973321|Metformin|metformin|mesh-list
14982559|NCT02973321|Liraglutide|liraglutide|mesh-list
14982560|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14982561|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982562|NCT02973321|Incretins|incretins|mesh-ancestor
14982563|NCT02973321|Hormones|hormones|mesh-ancestor
14982564|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982565|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14982566|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14982567|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982568|NCT02964585|Canagliflozin|canagliflozin|mesh-list
14982569|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14982570|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982571|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14982572|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982573|NCT02950766|Ipilimumab|ipilimumab|mesh-list
14982574|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982575|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982576|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982577|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982578|NCT02943785|Edoxaban|edoxaban|mesh-list
14982579|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14982580|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
14982581|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14982582|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
14982583|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982584|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982585|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
14982586|NCT02937818|Carboplatin|carboplatin|mesh-list
14982587|NCT02937818|Durvalumab|durvalumab|mesh-list
14982588|NCT02937818|Olaparib|olaparib|mesh-list
14982589|NCT02937818|Tremelimumab|tremelimumab|mesh-list
14982590|NCT02937818|Adavosertib|adavosertib|mesh-list
14982591|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982592|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982593|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14982594|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982595|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982596|NCT02908685|Risdiplam|risdiplam|mesh-list
14982597|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14982598|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982599|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982600|NCT02908334|Sertraline|sertraline|mesh-list
14982601|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
14982602|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14982603|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14982604|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14982605|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14982606|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982607|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14982608|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
14982609|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982610|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
14982611|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982612|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982613|NCT02901067|Aspirin|aspirin|mesh-list
14982614|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14982615|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14982616|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14982617|NCT02901067|Analgesics|analgesics|mesh-ancestor
14982618|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
14982619|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982620|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982621|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14982622|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982623|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14982624|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15030510|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14982625|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982626|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14982627|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14982628|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982629|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
14982630|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14982631|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14982632|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
14982633|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14982634|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14982635|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
14982636|NCT02890355|Leucovorin|leucovorin|mesh-list
14982637|NCT02890355|Folic Acid|folic acid|mesh-list
14982638|NCT02890355|Fluorouracil|fluorouracil|mesh-list
14982639|NCT02890355|Irinotecan|irinotecan|mesh-list
14982640|NCT02890355|Veliparib|veliparib|mesh-list
14982641|NCT02890355|Camptothecin|camptothecin|mesh-list
14982642|NCT02890355|Calcium|calcium|mesh-list
14982643|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
14982644|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14982645|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982646|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14982647|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
14982648|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982649|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982650|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982651|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982652|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
14982653|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14982654|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14982655|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982656|NCT02890355|Antidotes|antidotes|mesh-ancestor
14982657|NCT02890355|Protective Agents|protective agents|mesh-ancestor
14982658|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
14982659|NCT02890355|Vitamins|vitamins|mesh-ancestor
14982660|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
14982661|NCT02890355|Hematinics|hematinics|mesh-ancestor
14982662|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14982663|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14982664|NCT02890329|Ipilimumab|ipilimumab|mesh-list
14982665|NCT02890329|Decitabine|decitabine|mesh-list
14982666|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982667|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982668|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982669|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982670|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982671|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
14982672|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982673|NCT02886286|Fentanyl|fentanyl|mesh-list
14982674|NCT02886286|Morphine|morphine|mesh-list
14982675|NCT02886286|Hydromorphone|hydromorphone|mesh-list
14982676|NCT02886286|Bupivacaine|bupivacaine|mesh-list
14982677|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
14982678|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
14982679|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14982680|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982681|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
14982682|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982683|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14982684|NCT02886286|Narcotics|narcotics|mesh-ancestor
14982685|NCT02886286|Analgesics|analgesics|mesh-ancestor
14982686|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14982687|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14982688|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
14982689|NCT02874742|Dexamethasone|dexamethasone|mesh-list
14982690|NCT02874742|Lenalidomide|lenalidomide|mesh-list
14982691|NCT02874742|Bortezomib|bortezomib|mesh-list
14982692|NCT02874742|Daratumumab|daratumumab|mesh-list
14982693|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14982694|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
14982695|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
14982696|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14982697|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982698|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14982699|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
14982700|NCT02874742|Hormones|hormones|mesh-ancestor
14982701|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982702|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035233|NCT02000336|Hormones|hormones|mesh-ancestor
14982703|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982704|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
14982705|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14982706|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14982707|NCT02874742|Growth Substances|growth substances|mesh-ancestor
14982708|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
14982709|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
14982710|NCT02872259|Trametinib|trametinib|mesh-list
14982711|NCT02872259|Dabrafenib|dabrafenib|mesh-list
14982712|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982713|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982714|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982715|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982716|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982717|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
14982718|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982719|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982720|NCT02865187|Vitamin D|vitamin d|mesh-list
14982721|NCT02865187|Vitamins|vitamins|mesh-ancestor
14982722|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
14982723|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982724|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14982725|NCT02849496|Atezolizumab|atezolizumab|mesh-list
14982726|NCT02849496|Olaparib|olaparib|mesh-list
14982727|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14982728|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14982729|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982730|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982731|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982732|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
14982733|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982734|NCT02832167|Nivolumab|nivolumab|mesh-list
14982735|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982736|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982737|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982738|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030511|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15030512|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030513|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15030514|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15030515|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030516|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
15035234|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035235|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035236|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035237|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035238|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15035239|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15035240|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
15035241|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035242|NCT02000388|Ketorolac|ketorolac|mesh-list
15035243|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15035244|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15035245|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15035246|NCT02000388|Analgesics|analgesics|mesh-ancestor
15035247|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
15035248|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035249|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035250|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035251|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15035252|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15035253|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035254|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035255|NCT02000401|Ketorolac|ketorolac|mesh-list
15035256|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15035257|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15035258|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15035259|NCT02000401|Analgesics|analgesics|mesh-ancestor
15035260|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
15035261|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035262|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035263|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14982739|NCT02829931|Bevacizumab|bevacizumab|mesh-list
14982740|NCT02829931|Nivolumab|nivolumab|mesh-list
14982741|NCT02829931|Ipilimumab|ipilimumab|mesh-list
14982742|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982743|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982744|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14982745|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14982746|NCT02829931|Growth Substances|growth substances|mesh-ancestor
14982747|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982748|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
14982749|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982750|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982751|NCT02829918|Nivolumab|nivolumab|mesh-list
14982752|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982753|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982754|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982755|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982756|NCT02829723|Spartalizumab|spartalizumab|mesh-list
14982757|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982758|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982759|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982760|NCT02826512|Niraparib|niraparib|mesh-list
14982761|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14982762|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982763|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982764|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982765|NCT02821754|Durvalumab|durvalumab|mesh-list
14982766|NCT02821754|Tremelimumab|tremelimumab|mesh-list
14982767|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982768|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982769|NCT02810743|Olaparib|olaparib|mesh-list
14982770|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14982771|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982772|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982773|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982774|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
14982775|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982776|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
14982777|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982778|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982779|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982780|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
14982781|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982782|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982783|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14982784|NCT02787551|Metformin|metformin|mesh-list
14982785|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
14982786|NCT02787551|Pioglitazone|pioglitazone|mesh-list
14982787|NCT02787551|Liraglutide|liraglutide|mesh-list
14982788|NCT02787551|Exenatide|exenatide|mesh-list
14982789|NCT02787551|Dulaglutide|dulaglutide|mesh-list
14982790|NCT02787551|Lixisenatide|lixisenatide|mesh-list
14982791|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14982792|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
14982793|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
14982794|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982795|NCT02787551|Incretins|incretins|mesh-ancestor
14982796|NCT02787551|Hormones|hormones|mesh-ancestor
14982797|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982798|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14982799|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982800|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
14982801|NCT02778685|Letrozole|letrozole|mesh-list
14982802|NCT02778685|Fulvestrant|fulvestrant|mesh-list
14982803|NCT02778685|Palbociclib|palbociclib|mesh-list
14982804|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982805|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982806|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14982807|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14982808|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982809|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982810|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14982811|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
14982812|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982813|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982814|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14982815|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14982816|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982817|NCT02764541|Tamoxifen|tamoxifen|mesh-list
14982818|NCT02764541|Letrozole|letrozole|mesh-list
14982819|NCT02764541|Palbociclib|palbociclib|mesh-list
14982820|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982821|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14982822|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14982823|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982824|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982825|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14982826|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
14982827|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982828|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982829|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14982830|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14982831|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14982832|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14982833|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14982834|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
14982835|NCT02757885|Thiotepa|thiotepa|mesh-list
14982836|NCT02757885|Fludarabine|fludarabine|mesh-list
14982837|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
14982838|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
14982839|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14982840|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
14982841|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982842|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
14982843|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982844|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982845|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982846|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
14982847|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982848|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982849|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14982850|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982851|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
14982852|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
14982853|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982854|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14982855|NCT02754011|Capecitabine|capecitabine|mesh-list
14982856|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982857|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
14982858|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982859|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982860|NCT02753998|Paclitaxel|paclitaxel|mesh-list
14982861|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14982862|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982863|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982864|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982865|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982866|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982867|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
14982868|NCT02750319|Amiodarone|amiodarone|mesh-list
14982869|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14982870|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
14982871|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982872|NCT02750319|Expectorants|expectorants|mesh-ancestor
14982873|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
14982874|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14982875|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
14982876|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982877|NCT02750319|Protective Agents|protective agents|mesh-ancestor
14982878|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982879|NCT02750319|Antidotes|antidotes|mesh-ancestor
14982880|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14982881|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
14982882|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14982883|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14982884|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14982885|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14982886|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14982887|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982888|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14982889|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14982890|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14982891|NCT02741570|Cisplatin|cisplatin|mesh-list
14982892|NCT02741570|Carboplatin|carboplatin|mesh-list
14982893|NCT02741570|Fluorouracil|fluorouracil|mesh-list
14982894|NCT02741570|Nivolumab|nivolumab|mesh-list
14982895|NCT02741570|Cetuximab|cetuximab|mesh-list
14982896|NCT02741570|Ipilimumab|ipilimumab|mesh-list
14982897|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982898|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
14982899|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982900|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982901|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982902|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
14982903|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982904|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982905|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982906|NCT02736656|Viloxazine|viloxazine|mesh-list
14982907|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14982908|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
14982909|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14982910|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14982911|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14982912|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14982913|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982914|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
14982915|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14982916|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982917|NCT02735044|Insulin|insulin|mesh-list
14982918|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14982919|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
14982920|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14982921|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982922|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14982923|NCT02725177|Hormones|hormones|mesh-ancestor
14982924|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14982925|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982926|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
14982927|NCT02724579|Lomustine|lomustine|mesh-list
14982928|NCT02724579|Cisplatin|cisplatin|mesh-list
14982929|NCT02724579|Vincristine|vincristine|mesh-list
14982930|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982931|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
14982932|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982933|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982934|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982935|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
14982936|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982937|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982938|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14982939|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14982940|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
14982941|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
14982942|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
14982943|NCT02724410|Amoxicillin|amoxicillin|mesh-list
14982944|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
14982945|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
14982946|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14982947|NCT02724410|Ertapenem|ertapenem|mesh-list
14982948|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14982949|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982950|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14982951|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982952|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982953|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
14982954|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14982955|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
14982956|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982957|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982958|NCT02713867|Nivolumab|nivolumab|mesh-list
14982959|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14982960|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982961|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14982962|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982963|NCT02692651|Vancomycin|vancomycin|mesh-list
14982964|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
14982965|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14982966|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14982967|NCT02688712|Fluorouracil|fluorouracil|mesh-list
14982968|NCT02688712|Capecitabine|capecitabine|mesh-list
14982969|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
14982970|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982971|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982972|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982973|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982974|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
14982975|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982976|NCT02688140|Cytarabine|cytarabine|mesh-list
14982977|NCT02688140|Methotrexate|methotrexate|mesh-list
14982978|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
14982979|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
14982980|NCT02688140|Idarubicin|idarubicin|mesh-list
14982981|NCT02688140|Tretinoin|tretinoin|mesh-list
14982982|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
14982983|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14982984|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
14982985|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14982986|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14982987|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14982988|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
14982989|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14982990|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14982991|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
14982992|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14982993|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14982994|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14982995|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
14982996|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14982997|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14982998|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
14982999|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983000|NCT02688140|Analgesics|analgesics|mesh-ancestor
14983001|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
14983002|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983003|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14983004|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983005|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14983006|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
14983007|NCT02678572|Melphalan|melphalan|mesh-list
14983008|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983009|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
14983010|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983011|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983012|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983013|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983014|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
14983015|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983016|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
14983017|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983018|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983019|NCT02656706|Nivolumab|nivolumab|mesh-list
14983020|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983021|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983022|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14983023|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983024|NCT02654314|Melatonin|melatonin|mesh-list
14983025|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
14983026|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983027|NCT02654314|Protective Agents|protective agents|mesh-ancestor
14983028|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983029|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14983030|NCT02642042|Docetaxel|docetaxel|mesh-list
14983031|NCT02642042|Trametinib|trametinib|mesh-list
14983032|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983033|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983034|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983035|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983036|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983037|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983038|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983039|NCT02626962|Nivolumab|nivolumab|mesh-list
14983040|NCT02626962|Ipilimumab|ipilimumab|mesh-list
14983041|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983042|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983043|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14983044|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983045|NCT02623998|Metformin|metformin|mesh-list
14983046|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
14983047|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14983048|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14983049|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983050|NCT02623998|Incretins|incretins|mesh-ancestor
14983051|NCT02623998|Hormones|hormones|mesh-ancestor
14983052|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983053|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14983054|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
14983055|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983056|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983057|NCT02608684|Gemcitabine|gemcitabine|mesh-list
14983058|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
14983059|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983060|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983061|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
14983062|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983063|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
14983064|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983065|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983066|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983067|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
14983068|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983069|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983070|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
14983071|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983072|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983073|NCT02599324|Paclitaxel|paclitaxel|mesh-list
14983074|NCT02599324|Docetaxel|docetaxel|mesh-list
14983075|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
14983076|NCT02599324|Cetuximab|cetuximab|mesh-list
14983077|NCT02599324|Everolimus|everolimus|mesh-list
14983078|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983079|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983080|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983081|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983082|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983083|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983084|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983085|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983086|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
14983087|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983088|NCT02595892|Gemcitabine|gemcitabine|mesh-list
14983089|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983090|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
14983091|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983092|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983093|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
14983094|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983095|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983096|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983097|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
14983098|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983099|NCT02587520|Vaccines|vaccines|mesh-list
14983100|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
14983101|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983102|NCT02584829|Interferons|interferons|mesh-list
14983103|NCT02584829|Interferon-beta|interferon-beta|mesh-list
14983104|NCT02584829|Avelumab|avelumab|mesh-list
14983105|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14983106|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983107|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
14983108|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983109|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983110|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
14983111|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030517|NCT01968850|Vitamin D|vitamin d|mesh-list
15030518|NCT01968850|Alendronate|alendronate|mesh-list
15030519|NCT01968850|Vitamins|vitamins|mesh-ancestor
15030520|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
15030521|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030522|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15030523|NCT01968915|Paclitaxel|paclitaxel|mesh-list
15030524|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030525|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030526|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030527|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030528|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030529|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030530|NCT01969006|Bupivacaine|bupivacaine|mesh-list
15030531|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
15030532|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
15030533|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030534|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030535|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
15030536|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030537|NCT01969019|Prednisone|prednisone|mesh-list
15030538|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
15030539|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15030540|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15030541|NCT01969019|Prednisolone|prednisolone|mesh-list
15030542|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
15030543|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15030544|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
15030545|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15030546|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
15030547|NCT01969019|Hormones|hormones|mesh-ancestor
15030548|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030549|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030550|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15030551|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030552|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
15030553|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
15030554|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030555|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15030556|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15030557|NCT01969019|Protective Agents|protective agents|mesh-ancestor
15030558|NCT01969032|Paclitaxel|paclitaxel|mesh-list
15030559|NCT01969032|Doxorubicin|doxorubicin|mesh-list
15030560|NCT01969032|Capecitabine|capecitabine|mesh-list
15030561|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
15030562|NCT01969032|Carboplatin|carboplatin|mesh-list
14983112|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
14983113|NCT02559856|Apixaban|apixaban|mesh-list
14983114|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14983115|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
14983116|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14983117|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
14983118|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983119|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983120|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
14983121|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
14983122|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983123|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983124|NCT02516241|Gemcitabine|gemcitabine|mesh-list
14983125|NCT02516241|Carboplatin|carboplatin|mesh-list
14983126|NCT02516241|Durvalumab|durvalumab|mesh-list
14983127|NCT02516241|Tremelimumab|tremelimumab|mesh-list
14983128|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983129|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983130|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
14983131|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983132|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
14983133|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983134|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983135|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983136|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
14983137|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983138|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983139|NCT02514083|Fludarabine|fludarabine|mesh-list
14983140|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983141|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
14983142|NCT02512172|Azacitidine|azacitidine|mesh-list
14983143|NCT02512172|Romidepsin|romidepsin|mesh-list
14983144|NCT02512172|Cc-486|cc-486|mesh-list
14983145|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983146|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983147|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983148|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
14983149|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983150|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983151|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14983152|NCT02500797|Nivolumab|nivolumab|mesh-list
14983153|NCT02500797|Ipilimumab|ipilimumab|mesh-list
14983154|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983155|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983156|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14983157|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983158|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
14983159|NCT02499367|Doxorubicin|doxorubicin|mesh-list
14983160|NCT02499367|Nivolumab|nivolumab|mesh-list
14983161|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983162|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
14983163|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983164|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983165|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983166|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
14983167|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983168|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983169|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983170|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14983171|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14983172|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983173|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983174|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983175|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14983176|NCT02497612|Artefenomel|artefenomel|mesh-list
14983177|NCT02497612|Ferroquine|ferroquine|mesh-list
14983178|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
14983179|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14983180|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14983181|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983182|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14983183|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983184|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983185|NCT02491333|Metformin|metformin|mesh-list
14983186|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14983187|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983188|NCT02469987|Bevacizumab|bevacizumab|mesh-list
14983189|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983190|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983191|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14983192|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14983193|NCT02469987|Growth Substances|growth substances|mesh-ancestor
14983194|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983195|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
14983196|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
14983197|NCT02453373|Plasminogen|plasminogen|mesh-list
14983198|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14983199|NCT02453373|Propofol|propofol|mesh-list
14983200|NCT02453373|Etomidate|etomidate|mesh-list
14983201|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14983202|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14983203|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983204|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14983205|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
14983206|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
14983207|NCT02453373|Analgesics|analgesics|mesh-ancestor
14983208|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
14983209|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983210|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14983211|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
14983212|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14983213|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14983214|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983215|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14983216|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
14983217|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14983218|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14983219|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14983220|NCT02452268|Spartalizumab|spartalizumab|mesh-list
14983221|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14983222|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983223|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983224|NCT02449031|Tobramycin|tobramycin|mesh-list
14983225|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14983226|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983227|NCT02442349|Osimertinib|osimertinib|mesh-list
14983228|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983229|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983230|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983231|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983232|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14983233|NCT02439307|Rifaximin|rifaximin|mesh-list
14983234|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983235|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983236|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
14983237|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983238|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983239|NCT02404935|Cetuximab|cetuximab|mesh-list
14983240|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983241|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983242|NCT02392572|TIC10 compound|tic10 compound|mesh-list
14983243|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983244|NCT02381652|Triamcinolone|triamcinolone|mesh-list
14983245|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14983246|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14983247|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
14983248|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14983249|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983250|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
14983251|NCT02381652|Hormones|hormones|mesh-ancestor
14983252|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983253|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983254|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983255|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
14983256|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983257|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983258|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14983259|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
14983260|NCT02381652|Protective Agents|protective agents|mesh-ancestor
14983261|NCT02368301|Dexamethasone|dexamethasone|mesh-list
14983262|NCT02368301|Lenalidomide|lenalidomide|mesh-list
14983263|NCT02368301|Elotuzumab|elotuzumab|mesh-list
14983264|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983265|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
14983266|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
14983267|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983268|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983269|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983270|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
14983271|NCT02368301|Hormones|hormones|mesh-ancestor
14983272|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983273|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983274|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983275|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
14983276|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14983277|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14983278|NCT02368301|Growth Substances|growth substances|mesh-ancestor
14983279|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
14983280|NCT02367794|Paclitaxel|paclitaxel|mesh-list
14983281|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14983282|NCT02367794|Carboplatin|carboplatin|mesh-list
14983283|NCT02367794|Atezolizumab|atezolizumab|mesh-list
14983284|NCT02367794|Antibodies|antibodies|mesh-list
14983285|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983286|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983287|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983288|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983289|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983290|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983291|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
14983292|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983293|NCT02367456|Azacitidine|azacitidine|mesh-list
14983294|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983295|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
14983296|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983297|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983298|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983299|NCT02363998|Lofexidine|lofexidine|mesh-list
14983300|NCT02363998|Clonidine|clonidine|mesh-list
14983301|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14983302|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14983303|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983304|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
14983305|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983306|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14983307|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14983308|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14983309|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
14983310|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14983311|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983312|NCT02363998|Analgesics|analgesics|mesh-ancestor
14983313|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
14983314|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
14983315|NCT02358031|Carboplatin|carboplatin|mesh-list
14983316|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
14983317|NCT02358031|Cetuximab|cetuximab|mesh-list
14983318|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983319|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983320|NCT02355379|Capecitabine|capecitabine|mesh-list
14983321|NCT02355379|Fluorouracil|fluorouracil|mesh-list
14983322|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983323|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
14983324|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983325|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983326|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983327|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
14983328|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983329|NCT02332928|Melatonin|melatonin|mesh-list
14983330|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
14983331|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983332|NCT02332928|Protective Agents|protective agents|mesh-ancestor
14983333|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983334|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14983335|NCT02325466|Aspirin|aspirin|mesh-list
14983336|NCT02325466|Ticagrelor|ticagrelor|mesh-list
14983337|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14983338|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14983339|NCT02325466|Analgesics|analgesics|mesh-ancestor
14983340|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
14983341|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983342|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983343|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983344|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983345|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14983346|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14983347|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983348|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14983349|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14983350|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983351|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
14983352|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14983353|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14983354|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14983355|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
14983356|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14983357|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14983358|NCT02323100|Glycerol|glycerol|mesh-list
14983359|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14983360|NCT02323100|Protective Agents|protective agents|mesh-ancestor
14983361|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983362|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983363|NCT02322710|Petrolatum|petrolatum|mesh-list
14983364|NCT02322710|Emollients|emollients|mesh-ancestor
14983365|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
14983366|NCT02285179|Tamoxifen|tamoxifen|mesh-list
14983367|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14983368|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
14983369|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983370|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983371|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983372|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983373|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14983374|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14983375|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14983376|NCT02283281|Dronabinol|dronabinol|mesh-list
14983377|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
14983378|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983379|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14983380|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14983381|NCT02283281|Analgesics|analgesics|mesh-ancestor
14983382|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
14983383|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983384|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14983385|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14983386|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14983387|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983388|NCT02283281|Hormones|hormones|mesh-ancestor
14983389|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983390|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
14983391|NCT02251548|Rituximab|rituximab|mesh-list
14983392|NCT02251548|Fludarabine|fludarabine|mesh-list
14983393|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983394|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
14983395|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983396|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983397|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983398|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
14983399|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983400|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983401|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983402|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983403|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14983404|NCT02240498|Methylene Blue|methylene blue|mesh-list
14983405|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14983406|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14983407|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14983408|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983409|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983410|NCT02215980|Dexamethasone|dexamethasone|mesh-list
14983411|NCT02215980|Lenalidomide|lenalidomide|mesh-list
14983412|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983413|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
14983414|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
14983415|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983416|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983417|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983418|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
14983419|NCT02215980|Hormones|hormones|mesh-ancestor
14983420|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983421|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983422|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983423|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
14983424|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14983425|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14983426|NCT02215980|Growth Substances|growth substances|mesh-ancestor
14983427|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
14983428|NCT02212015|Paclitaxel|paclitaxel|mesh-list
14983429|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983430|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983431|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983432|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983433|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983434|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983435|NCT02204241|Dexamethasone|dexamethasone|mesh-list
14983436|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
14983437|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983438|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
14983439|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983440|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983441|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983442|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
14983443|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983444|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983445|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983446|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983447|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
14983448|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
14983449|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983450|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983451|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
14983452|NCT02204241|Hormones|hormones|mesh-ancestor
14983453|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983454|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983455|NCT02196181|Trametinib|trametinib|mesh-list
14983456|NCT02196181|Dabrafenib|dabrafenib|mesh-list
14983457|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14983458|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983459|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983460|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983461|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983462|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14983463|NCT02196181|Protective Agents|protective agents|mesh-ancestor
14983464|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983465|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14983466|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
14983467|NCT02185820|Dexamethasone|dexamethasone|mesh-list
14983468|NCT02185820|Pomalidomide|pomalidomide|mesh-list
14983469|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983470|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
14983471|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
14983472|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983473|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983474|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983475|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
14983476|NCT02185820|Hormones|hormones|mesh-ancestor
14983477|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983478|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983479|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983480|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
14983481|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14983482|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14983483|NCT02185820|Growth Substances|growth substances|mesh-ancestor
14983484|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14983485|NCT02168829|Aspirin|aspirin|mesh-list
14983486|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
14983487|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14983488|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14983489|NCT02168829|Analgesics|analgesics|mesh-ancestor
14983490|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
14983491|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983492|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983493|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983494|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983495|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14983496|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14983497|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983498|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14983499|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14983500|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983501|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
14983502|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14983503|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
14983504|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14983505|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
14983506|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
14983507|NCT02162563|Leucovorin|leucovorin|mesh-list
14983508|NCT02162563|Bevacizumab|bevacizumab|mesh-list
14983509|NCT02162563|Panitumumab|panitumumab|mesh-list
14983510|NCT02162563|Fluorouracil|fluorouracil|mesh-list
14983511|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
14983512|NCT02162563|Irinotecan|irinotecan|mesh-list
14983513|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
14983514|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983515|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983516|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14983517|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14983518|NCT02162563|Growth Substances|growth substances|mesh-ancestor
14983519|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983520|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
14983521|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
14983522|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983523|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983524|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983525|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
14983526|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14983527|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983528|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983529|NCT02162563|Antidotes|antidotes|mesh-ancestor
14983530|NCT02162563|Protective Agents|protective agents|mesh-ancestor
14983531|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
14983532|NCT02162563|Vitamins|vitamins|mesh-ancestor
14983533|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
14983534|NCT02158234|Cisplatin|cisplatin|mesh-list
14983535|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
14983536|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523278|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523279|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14523280|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14523281|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14523282|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
14523283|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523284|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523285|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523286|NCT03583372|Urological Agents|urological agents|mesh-ancestor
14523287|NCT03583385|Metformin|metformin|mesh-list
14523288|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14523289|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529784|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529785|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
14529786|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
14529787|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14529788|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
14529789|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14529790|NCT03680911|Expectorants|expectorants|mesh-ancestor
14983537|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983538|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
14983539|NCT02158091|Rituximab|rituximab|mesh-list
14983540|NCT02158091|Fludarabine|fludarabine|mesh-list
14983541|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983542|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
14983543|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983544|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983545|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983546|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
14983547|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983548|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983549|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983550|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983551|NCT02141542|Tremelimumab|tremelimumab|mesh-list
14983552|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983553|NCT02127086|Analgesics|analgesics|mesh-list
14983554|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
14983555|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983556|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030563|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030564|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030565|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030566|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030567|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030568|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030569|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15030570|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15030571|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15030572|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030573|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15030574|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
15030575|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030576|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
15030577|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030578|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15030579|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15030580|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
15030581|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15030582|NCT01969071|Simendan|simendan|mesh-list
15030583|NCT01969071|Dobutamine|dobutamine|mesh-list
15030584|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15030585|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
15030586|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15030587|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15030588|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030589|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030590|NCT01969071|Protective Agents|protective agents|mesh-ancestor
15030591|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030592|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
15030593|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
15030594|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030595|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15030596|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15030597|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15030598|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
15030599|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030600|NCT01969149|Insulin|insulin|mesh-list
15030601|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15030602|NCT01969149|Exenatide|exenatide|mesh-list
15030603|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
15030604|NCT01969149|Incretins|incretins|mesh-list
15030605|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15030606|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030607|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15030608|NCT01969149|Hormones|hormones|mesh-ancestor
15030609|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14800982|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14800983|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14800984|NCT00790595|Growth Substances|growth substances|mesh-ancestor
14800985|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800986|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
14800987|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14800988|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14800989|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14800990|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
14800991|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14800992|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
14800993|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14800994|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14800995|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14800996|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
14800997|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14800998|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
14800999|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801000|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801001|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15030610|NCT01969227|Ketamine|ketamine|mesh-list
15030611|NCT01969227|Analgesics|analgesics|mesh-ancestor
14983557|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14983558|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14983559|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
14983560|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14983561|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14983562|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
14983563|NCT02114229|Carboplatin|carboplatin|mesh-list
14983564|NCT02114229|Methotrexate|methotrexate|mesh-list
14983565|NCT02114229|Etoposide|etoposide|mesh-list
14983566|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
14983567|NCT02114229|Vincristine|vincristine|mesh-list
14983568|NCT02114229|Topotecan|topotecan|mesh-list
14983569|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983570|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
14983571|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983572|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983573|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983574|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
14983575|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983576|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983577|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983578|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14983579|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
14983580|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14983581|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983582|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
14983583|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
14983584|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983585|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14983586|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14983587|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983588|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14983589|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983590|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983591|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983592|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983593|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14983594|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
14983595|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983596|NCT02102243|Insulin|insulin|mesh-list
14983597|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14983598|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14983599|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983600|NCT02075840|Crizotinib|crizotinib|mesh-list
14983601|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983602|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983603|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983604|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983605|NCT02075177|Ketoconazole|ketoconazole|mesh-list
14983606|NCT02075177|Fenretinide|fenretinide|mesh-list
14983607|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
14983608|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983609|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14983610|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14983611|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983612|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983613|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14983614|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
14983615|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983616|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983617|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14983618|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983619|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14983620|NCT02075177|Protective Agents|protective agents|mesh-ancestor
14983621|NCT02066181|Sorafenib|sorafenib|mesh-list
14983622|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983623|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983624|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983625|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983626|NCT02050919|Sorafenib|sorafenib|mesh-list
14983627|NCT02050919|Epirubicin|epirubicin|mesh-list
14983628|NCT02050919|Ifosfamide|ifosfamide|mesh-list
14983629|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
14983630|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983631|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983632|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983633|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983634|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14983635|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14983636|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983637|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983638|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
14983639|NCT02040857|Tamoxifen|tamoxifen|mesh-list
14983640|NCT02040857|Letrozole|letrozole|mesh-list
14983641|NCT02040857|Palbociclib|palbociclib|mesh-list
14983642|NCT02040857|Anastrozole|anastrozole|mesh-list
14983643|NCT02040857|Exemestane|exemestane|mesh-list
14983644|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14983645|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983646|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14983647|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983648|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983649|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14983650|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
14983651|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983652|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983653|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983654|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14983655|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14983656|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14983657|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983658|NCT01997463|Albuterol|albuterol|mesh-list
14983659|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14983660|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
14983661|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983662|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983663|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14983664|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14983665|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
14983666|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14983667|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14983668|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14983669|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14983670|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
14983671|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14983672|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983673|NCT01996267|Paclitaxel|paclitaxel|mesh-list
14983674|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
14983675|NCT01996267|Carboplatin|carboplatin|mesh-list
14983676|NCT01996267|Fluorouracil|fluorouracil|mesh-list
14983677|NCT01996267|Trastuzumab|trastuzumab|mesh-list
14983678|NCT01996267|Pertuzumab|pertuzumab|mesh-list
14983679|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983680|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983681|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983682|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983683|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983684|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983685|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983686|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
14983687|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983688|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983689|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983690|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
14801002|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
14801003|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
14801004|NCT00790608|Protective Agents|protective agents|mesh-ancestor
14801005|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801006|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801007|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801008|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801009|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983691|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983692|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
14983693|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983694|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983695|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
14983696|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15035264|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801010|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14983697|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14983698|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983699|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14983700|NCT01976754|Analgesics|analgesics|mesh-ancestor
14983701|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
14983702|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983703|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14983704|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14983705|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14983706|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
14983707|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14983708|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983709|NCT01950390|Bevacizumab|bevacizumab|mesh-list
14983710|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14983711|NCT01950390|Ipilimumab|ipilimumab|mesh-list
14983712|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
14983713|NCT01950390|Antibodies|antibodies|mesh-list
14983714|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
14983715|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14983716|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
14983717|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983718|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14983719|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14983720|NCT01950390|Growth Substances|growth substances|mesh-ancestor
14983721|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983722|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
14983723|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
14983724|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14983725|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983726|NCT01943825|Vaccines|vaccines|mesh-list
14983727|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
14983728|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983729|NCT01916317|Lidocaine|lidocaine|mesh-list
14983730|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
14983731|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
14983732|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14983733|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983734|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
14983735|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983736|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14983737|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14983738|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14983739|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14983740|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983741|NCT01913951|Azacitidine|azacitidine|mesh-list
14983742|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983743|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
14983744|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983745|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983746|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983747|NCT01913730|Dexamethasone|dexamethasone|mesh-list
14983748|NCT01913730|Bortezomib|bortezomib|mesh-list
14983749|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983750|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
14983751|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
14983752|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983753|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983754|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983755|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
14983756|NCT01913730|Hormones|hormones|mesh-ancestor
14983757|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983758|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983759|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983760|NCT01909453|Vemurafenib|vemurafenib|mesh-list
14983761|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983762|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983763|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983764|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983765|NCT01904123|Tyrphostins|tyrphostins|mesh-list
14983766|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983767|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983768|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983769|NCT01898117|Paclitaxel|paclitaxel|mesh-list
14983770|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14983771|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
14983772|NCT01898117|Carboplatin|carboplatin|mesh-list
14983773|NCT01898117|Atezolizumab|atezolizumab|mesh-list
14983774|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14983775|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983776|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983777|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983778|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983779|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983780|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983781|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983782|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
14983783|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983784|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983785|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983786|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
14983787|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983788|NCT01892371|Cytarabine|cytarabine|mesh-list
14983789|NCT01892371|Azacitidine|azacitidine|mesh-list
14983790|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983791|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
14983792|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983793|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983794|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
14983795|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983796|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983797|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
14983798|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983799|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983800|NCT01874353|Olaparib|olaparib|mesh-list
14983801|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14983802|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983803|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983804|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983805|NCT01863186|Lofexidine|lofexidine|mesh-list
14983806|NCT01863186|Clonidine|clonidine|mesh-list
14983807|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14983808|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14983809|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983810|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
14983811|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983812|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14983813|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14983814|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14983815|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
14983816|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14983817|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983818|NCT01863186|Analgesics|analgesics|mesh-ancestor
14983819|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
14983820|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
14983821|NCT01857115|Dexamethasone|dexamethasone|mesh-list
14983822|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
14983823|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983824|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
14983825|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983826|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983827|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983828|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
14983829|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983830|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983831|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983832|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983833|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
14983834|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
14983835|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983836|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983837|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
14983838|NCT01857115|Hormones|hormones|mesh-ancestor
14983839|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983840|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983841|NCT01856192|Prednisone|prednisone|mesh-list
14983842|NCT01856192|Cortisone|cortisone|mesh-list
14983843|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
14983844|NCT01856192|Rituximab|rituximab|mesh-list
14983845|NCT01856192|Doxorubicin|doxorubicin|mesh-list
14983846|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14523290|NCT03584009|Venetoclax|venetoclax|mesh-list
14523291|NCT03584009|Fulvestrant|fulvestrant|mesh-list
14523292|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523293|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14523294|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14523295|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14523296|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
14523297|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523298|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523299|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
14523300|NCT03585504|Etonogestrel|etonogestrel|mesh-list
14523301|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14523302|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523303|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14523304|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14523305|NCT03585712|Norgestrel|norgestrel|mesh-list
14523306|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14523307|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14983847|NCT01856192|Vincristine|vincristine|mesh-list
14983848|NCT01856192|Lenalidomide|lenalidomide|mesh-list
14983849|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14983850|NCT01856192|Antibodies|antibodies|mesh-list
14983851|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
14983852|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14983853|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983854|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
14983855|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983856|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983857|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983858|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
14983859|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983860|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983861|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983862|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14983863|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14983864|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983865|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983866|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14983867|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
14983868|NCT01856192|Hormones|hormones|mesh-ancestor
14983869|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983870|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14983871|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983872|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983873|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983874|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983875|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14983876|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14983877|NCT01856192|Growth Substances|growth substances|mesh-ancestor
14983878|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
14983879|NCT01853748|Paclitaxel|paclitaxel|mesh-list
14983880|NCT01853748|Maytansine|maytansine|mesh-list
14983881|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14983882|NCT01853748|Trastuzumab|trastuzumab|mesh-list
14983883|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983884|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983885|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983886|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983887|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983888|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983889|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14983890|NCT01843374|Tremelimumab|tremelimumab|mesh-list
14983891|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983892|NCT01828840|Fentanyl|fentanyl|mesh-list
14983893|NCT01828840|Morphine|morphine|mesh-list
14983894|NCT01828840|Methadone|methadone|mesh-list
14983895|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14983896|NCT01828840|Narcotics|narcotics|mesh-ancestor
14983897|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14983898|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983899|NCT01828840|Analgesics|analgesics|mesh-ancestor
14983900|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
14983901|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14983902|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14983903|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14983904|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
14983905|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
14983906|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
14983907|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14983908|NCT01817751|Sorafenib|sorafenib|mesh-list
14983909|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
14983910|NCT01817751|Valproic Acid|valproic acid|mesh-list
14983911|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983912|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983913|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983914|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983915|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
14983916|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14983917|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14983918|NCT01817751|Urological Agents|urological agents|mesh-ancestor
14983919|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
14983920|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
14983921|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14983922|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983923|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
14983924|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14983925|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14983926|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14983927|NCT01817426|Infliximab|infliximab|mesh-list
14983928|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
14983929|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983930|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983931|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14983932|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14983933|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983934|NCT01741103|Incretins|incretins|mesh-ancestor
14983935|NCT01741103|Hormones|hormones|mesh-ancestor
14983936|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14983937|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14983938|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
14983939|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983940|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983941|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14983942|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
14983943|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983944|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
14983945|NCT01716117|Antacids|antacids|mesh-ancestor
14983946|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983947|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14983948|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
14983949|NCT01670500|Cisplatin|cisplatin|mesh-list
14983950|NCT01670500|Doxorubicin|doxorubicin|mesh-list
14983951|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983952|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
14983953|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983954|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983955|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983956|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
14983957|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983958|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983959|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983960|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14983961|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14983962|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983963|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983964|NCT01657591|Vemurafenib|vemurafenib|mesh-list
14983965|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983966|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14983967|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983968|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983969|NCT01646034|Gemcitabine|gemcitabine|mesh-list
14983970|NCT01646034|Paclitaxel|paclitaxel|mesh-list
14983971|NCT01646034|Docetaxel|docetaxel|mesh-list
14983972|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
14983973|NCT01646034|Carboplatin|carboplatin|mesh-list
14983974|NCT01646034|Doxorubicin|doxorubicin|mesh-list
14983975|NCT01646034|Thiotepa|thiotepa|mesh-list
14983976|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14983977|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14983978|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
14983979|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
14983980|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
14983981|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14983982|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14983983|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
14983984|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14983985|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14983986|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14983987|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
14983988|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14983989|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14983990|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
14983991|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
14983992|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14983993|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14983994|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14983995|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14983996|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14983997|NCT01630590|Androgens|androgens|mesh-list
14983998|NCT01630590|Hormones|hormones|mesh-ancestor
14983999|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984000|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984001|NCT01619085|Nintedanib|nintedanib|mesh-list
14984002|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984003|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14984004|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984005|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984006|NCT01606098|Bevacizumab|bevacizumab|mesh-list
14984007|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14984008|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984009|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984010|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984011|NCT01606098|Growth Substances|growth substances|mesh-ancestor
14984012|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984013|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984014|NCT01499095|Insulin|insulin|mesh-list
14984015|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14984016|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
14523308|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14523309|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
14523310|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14523311|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523312|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14984017|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14984018|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984019|NCT01499082|Insulin|insulin|mesh-list
14984020|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14984021|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
14984022|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14984023|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984024|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
14984025|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14984026|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14984027|NCT01496976|Prednisolone|prednisolone|mesh-list
14984028|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
14984029|NCT01496976|Lenalidomide|lenalidomide|mesh-list
14984030|NCT01496976|Ofatumumab|ofatumumab|mesh-list
14984031|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14984032|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
14984033|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
14984034|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984035|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984036|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984037|NCT01496976|Growth Substances|growth substances|mesh-ancestor
14984038|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984039|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984040|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984041|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
14984042|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
14984043|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984044|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984045|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
14984046|NCT01496976|Hormones|hormones|mesh-ancestor
14984047|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984048|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14984049|NCT01496976|Protective Agents|protective agents|mesh-ancestor
14984050|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984051|NCT01488890|Vaccines|vaccines|mesh-list
14984052|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
14984053|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984054|NCT01436396|Vaccines|vaccines|mesh-list
14984055|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
14984056|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984057|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
14984058|NCT01428973|Sirolimus|sirolimus|mesh-list
14984059|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984060|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984061|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14984062|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
14984063|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14984064|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984065|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984066|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984067|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
14984068|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984069|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
14984070|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984071|NCT01415882|Dexamethasone|dexamethasone|mesh-list
14984072|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
14984073|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
14984074|NCT01415882|Daratumumab|daratumumab|mesh-list
14984075|NCT01415882|Ixazomib|ixazomib|mesh-list
14984076|NCT01415882|Ichthammol|ichthammol|mesh-list
14984077|NCT01415882|BB 1101|bb 1101|mesh-list
14984078|NCT01415882|Glycine|glycine|mesh-list
14984079|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984080|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
14984081|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984082|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984083|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984084|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
14984085|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984086|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984087|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984088|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984089|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
14984090|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
14984091|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984092|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984093|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
14984094|NCT01415882|Hormones|hormones|mesh-ancestor
14984095|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984096|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984097|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
14984098|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984099|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
14984100|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
14984101|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14984102|NCT01414777|Ondansetron|ondansetron|mesh-list
14984103|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
14984104|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
14984105|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984106|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984107|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984108|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
14984109|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14984110|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14984111|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
14984112|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14984113|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984114|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14984115|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14984116|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14984117|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14984118|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14984119|NCT01411241|Vaccines|vaccines|mesh-list
14984120|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14984121|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
14984122|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984123|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14984124|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801011|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801012|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801013|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
14801014|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801015|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801016|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801017|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801018|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
14801019|NCT00790816|Lapatinib|lapatinib|mesh-list
14801020|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
14801021|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14801022|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801023|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801024|NCT00790881|Lumefantrine|lumefantrine|mesh-list
14801025|NCT00790881|Artemether|artemether|mesh-list
14801026|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14801027|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
14801028|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14801029|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14984125|NCT01396408|Sirolimus|sirolimus|mesh-list
14984126|NCT01396408|Sunitinib|sunitinib|mesh-list
14984127|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984128|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984129|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984130|NCT01396408|Growth Substances|growth substances|mesh-ancestor
14984131|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984132|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984133|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14984134|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984135|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984136|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14984137|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984138|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984139|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
14984140|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984141|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
14984142|NCT01380938|Ribavirin|ribavirin|mesh-list
14984143|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14984144|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
14984145|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
14984146|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984147|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
14984148|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984149|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
14984150|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984151|NCT01374516|Vaccines|vaccines|mesh-list
14984152|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
14984153|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984154|NCT01373281|Vaccines|vaccines|mesh-list
14984155|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
14984156|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984157|NCT01346787|Dexamethasone|dexamethasone|mesh-list
14984158|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
14984159|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984160|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
14984161|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984162|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984163|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984164|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
14984165|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984166|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984167|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984168|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984169|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
14984170|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
14984171|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984172|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984173|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
14984174|NCT01346787|Hormones|hormones|mesh-ancestor
14984175|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984176|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984177|NCT01275677|Paclitaxel|paclitaxel|mesh-list
14984178|NCT01275677|Docetaxel|docetaxel|mesh-list
14984179|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
14984180|NCT01275677|Doxorubicin|doxorubicin|mesh-list
14984181|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14984182|NCT01275677|Trastuzumab|trastuzumab|mesh-list
14984183|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14984184|NCT01275677|Daunorubicin|daunorubicin|mesh-list
14984185|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14984186|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14984187|NCT01275677|Antibodies|antibodies|mesh-list
14984188|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
14984189|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14984190|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984191|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984192|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984193|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984194|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984195|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984196|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984197|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
14984198|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984199|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984200|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984201|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
14984202|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984203|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984204|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984205|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984206|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984207|NCT01272037|Tamoxifen|tamoxifen|mesh-list
14984208|NCT01272037|Letrozole|letrozole|mesh-list
14984209|NCT01272037|Anastrozole|anastrozole|mesh-list
14984210|NCT01272037|Exemestane|exemestane|mesh-list
14984211|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984212|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984213|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14984214|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14984215|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984216|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14984217|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
14984218|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984219|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984220|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984221|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14984222|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14984223|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14984224|NCT01254422|Vaccines|vaccines|mesh-list
14984225|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
14984226|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030612|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
15030613|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030614|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030615|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15030616|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15030617|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
15030618|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
15030619|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030620|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15030621|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15030622|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030623|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030624|NCT01969318|Metformin|metformin|mesh-list
15030625|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15030626|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030627|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15030628|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15030629|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030630|NCT01969357|Incretins|incretins|mesh-ancestor
15030631|NCT01969357|Hormones|hormones|mesh-ancestor
15035265|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14984227|NCT01229878|Vitamin D|vitamin d|mesh-list
14984228|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
14984229|NCT01229878|Vitamins|vitamins|mesh-ancestor
14984230|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
14984231|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984232|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14984233|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14984234|NCT01204242|Lidocaine|lidocaine|mesh-list
14984235|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
14984236|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
14984237|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14984238|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984239|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
14984240|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984241|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14984242|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14984243|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14984244|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14984245|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984246|NCT01196390|Paclitaxel|paclitaxel|mesh-list
14984247|NCT01196390|Carboplatin|carboplatin|mesh-list
14984248|NCT01196390|Trastuzumab|trastuzumab|mesh-list
14984249|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14984250|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14984251|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14984252|NCT01196390|Antibodies|antibodies|mesh-list
14984253|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
14984254|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14984255|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984256|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984257|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984258|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984259|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984260|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984261|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
14984262|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984263|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
14984264|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
14984265|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984266|NCT01190787|Prednisone|prednisone|mesh-list
14984267|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
14984268|NCT01190787|Melphalan|melphalan|mesh-list
14984269|NCT01190787|Bortezomib|bortezomib|mesh-list
14984270|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984271|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
14984272|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984273|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984274|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984275|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
14984276|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984277|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984278|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984279|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984280|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
14984281|NCT01190787|Hormones|hormones|mesh-ancestor
14984282|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984283|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984284|NCT01187433|Vaccines|vaccines|mesh-list
14984285|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
14984286|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984287|NCT01166113|Prednisone|prednisone|mesh-list
14984288|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
14984289|NCT01166113|Pomalidomide|pomalidomide|mesh-list
14984290|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984291|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
14984292|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984293|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984294|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984295|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
14984296|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984297|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984298|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984299|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984300|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
14984301|NCT01166113|Hormones|hormones|mesh-ancestor
14984302|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984303|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984304|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984305|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984306|NCT01166113|Growth Substances|growth substances|mesh-ancestor
14984307|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984308|NCT01160107|Prednisone|prednisone|mesh-list
14984309|NCT01160107|Melphalan|melphalan|mesh-list
14984310|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984311|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
14984312|NCT01160107|Hormones|hormones|mesh-ancestor
14984313|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984314|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984315|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984316|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984317|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984318|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
14984319|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984320|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984321|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984322|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
14984323|NCT01150045|Leucovorin|leucovorin|mesh-list
14984324|NCT01150045|Celecoxib|celecoxib|mesh-list
14984325|NCT01150045|Fluorouracil|fluorouracil|mesh-list
14984326|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
14984327|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
14984328|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984329|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14984330|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984331|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984332|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
14984333|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984334|NCT01150045|Antidotes|antidotes|mesh-ancestor
14984335|NCT01150045|Protective Agents|protective agents|mesh-ancestor
14984336|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
14984337|NCT01150045|Vitamins|vitamins|mesh-ancestor
14984338|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
14984339|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14984340|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14984341|NCT01150045|Analgesics|analgesics|mesh-ancestor
14984342|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
14984343|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984344|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984345|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984346|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14984347|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14984348|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984349|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
14984350|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
14984351|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984352|NCT01098032|Expectorants|expectorants|mesh-ancestor
14984353|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
14984354|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14984355|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
14984356|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984357|NCT01098032|Protective Agents|protective agents|mesh-ancestor
14984358|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984359|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
14984360|NCT01096368|Cisplatin|cisplatin|mesh-list
14984361|NCT01096368|Carboplatin|carboplatin|mesh-list
14984362|NCT01096368|Etoposide|etoposide|mesh-list
14984363|NCT01096368|Vincristine|vincristine|mesh-list
14984364|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
14984365|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
14984366|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984367|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
14984368|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984369|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984370|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984371|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
14984372|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984373|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984374|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984375|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984376|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984377|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984378|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984379|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984380|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984381|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984382|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
14984383|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
14984384|NCT01093196|Dexamethasone|dexamethasone|mesh-list
14984385|NCT01093196|Prednisone|prednisone|mesh-list
14984386|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
14984387|NCT01093196|Melphalan|melphalan|mesh-list
14984388|NCT01093196|Lenalidomide|lenalidomide|mesh-list
14984389|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984390|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
14984391|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984392|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984393|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984394|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
14984395|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984396|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984397|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984398|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984399|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
14984400|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
14984401|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984402|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984403|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
14984404|NCT01093196|Hormones|hormones|mesh-ancestor
14984405|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984406|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984407|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984408|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984409|NCT01093196|Growth Substances|growth substances|mesh-ancestor
14984410|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984411|NCT01054248|Artesunate|artesunate|mesh-list
14984412|NCT01054248|Piperaquine|piperaquine|mesh-list
14984413|NCT01054248|Artenimol|artenimol|mesh-list
14984414|NCT01054248|Mefloquine|mefloquine|mesh-list
14984415|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
14984416|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14984417|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14984418|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984419|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984420|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
14984421|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
14984422|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14984423|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
14984424|NCT01050855|Busulfan|busulfan|mesh-list
14984425|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
14984426|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
14984427|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984428|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984429|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
14984430|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984431|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984432|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984433|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984434|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14984435|NCT01015833|Doxorubicin|doxorubicin|mesh-list
14984436|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14984437|NCT01015833|Sorafenib|sorafenib|mesh-list
14984438|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984439|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984440|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984441|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984442|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984443|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984444|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14984445|NCT01005745|Aldesleukin|aldesleukin|mesh-list
14984446|NCT01005745|Interleukin-2|interleukin-2|mesh-list
14984447|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984448|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14984449|NCT01005745|Analgesics|analgesics|mesh-ancestor
14984450|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
14984451|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984452|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984453|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14984454|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14984455|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
14984456|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984457|NCT00945009|Dactinomycin|dactinomycin|mesh-list
14984458|NCT00945009|Cactinomycin|cactinomycin|mesh-list
14984459|NCT00945009|Doxorubicin|doxorubicin|mesh-list
14984460|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14984461|NCT00945009|Vincristine|vincristine|mesh-list
14984462|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984463|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984464|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984465|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984466|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984467|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984468|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984469|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984470|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984471|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984472|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14984473|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984474|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14984475|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14984476|NCT00942877|Cediranib|cediranib|mesh-list
14984477|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984478|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14984479|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984480|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984481|NCT00942331|Gemcitabine|gemcitabine|mesh-list
14984482|NCT00942331|Bevacizumab|bevacizumab|mesh-list
14984483|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14984484|NCT00942331|Cisplatin|cisplatin|mesh-list
14984485|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
14984486|NCT00942331|Antibodies|antibodies|mesh-list
14984487|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
14984488|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14984489|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
14984490|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984491|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984492|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984493|NCT00942331|Growth Substances|growth substances|mesh-ancestor
14984494|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984495|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984496|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
14984497|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14984498|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
14984499|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984500|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
14984501|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984502|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984503|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984504|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14984505|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14984506|NCT00896389|Diuretics|diuretics|mesh-ancestor
14984507|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
14984508|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984509|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14984510|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14984511|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984512|NCT00887146|Vincristine|vincristine|mesh-list
14984513|NCT00887146|Temozolomide|temozolomide|mesh-list
14984514|NCT00887146|Procarbazine|procarbazine|mesh-list
14984515|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984516|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984517|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984518|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984519|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984520|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984521|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984522|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
14984523|NCT00880893|Vaccines|vaccines|mesh-list
14984524|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
14984525|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984526|NCT00866918|Cytarabine|cytarabine|mesh-list
14984527|NCT00866918|Methotrexate|methotrexate|mesh-list
14984528|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
14984529|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
14984530|NCT00866918|Idarubicin|idarubicin|mesh-list
14984531|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
14984532|NCT00866918|Tretinoin|tretinoin|mesh-list
14984533|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14984534|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
14984535|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14984536|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984537|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14984538|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
14984539|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984540|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984541|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
14984542|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984543|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14984544|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984545|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
14984546|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984547|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14984548|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
14984549|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984550|NCT00866918|Analgesics|analgesics|mesh-ancestor
14984551|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
14984552|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984553|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984554|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984555|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984556|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
14984557|NCT00782574|Olaparib|olaparib|mesh-list
14984558|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984559|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14984560|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984561|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984562|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14984563|NCT00769379|Trastuzumab|trastuzumab|mesh-list
14984564|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
14984565|NCT00769379|Antibodies|antibodies|mesh-list
14984566|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
14984567|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14984568|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
14984569|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984570|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984571|NCT00753545|Olaparib|olaparib|mesh-list
14984572|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14984573|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984574|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984575|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984576|NCT00750841|Cediranib|cediranib|mesh-list
14984577|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984578|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14984579|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984580|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984581|NCT00588770|Bevacizumab|bevacizumab|mesh-list
14984582|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14984583|NCT00588770|Cisplatin|cisplatin|mesh-list
14984584|NCT00588770|Carboplatin|carboplatin|mesh-list
14984585|NCT00588770|Docetaxel|docetaxel|mesh-list
14984586|NCT00588770|Fluorouracil|fluorouracil|mesh-list
14984587|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
14984588|NCT00588770|Antibodies|antibodies|mesh-list
14984589|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
14984590|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14984591|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
14984592|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984593|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984594|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984595|NCT00588770|Growth Substances|growth substances|mesh-ancestor
14984596|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984597|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984598|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
14984599|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984600|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984601|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984602|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984603|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
14984604|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14984605|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984606|NCT00579527|Cyclosporine|cyclosporine|mesh-list
14984607|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
14984608|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
14984609|NCT00579527|Prednisolone|prednisolone|mesh-list
14984610|NCT00579527|Tacrolimus|tacrolimus|mesh-list
14984611|NCT00579527|Cyclosporins|cyclosporins|mesh-list
14984612|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
14984613|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14984614|NCT00579527|Daclizumab|daclizumab|mesh-list
14984615|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
14984616|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984617|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
14984618|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984619|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14984620|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984621|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984622|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
14984623|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984624|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
14984625|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984626|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984627|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801030|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801031|NCT00790894|Epothilones|epothilones|mesh-list
14801032|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
14801033|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
14801034|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
14801035|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801036|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801037|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
14801038|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14801039|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14801040|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801041|NCT00790946|Valsartan|valsartan|mesh-list
14801042|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14801043|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14801044|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14801045|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801046|NCT00790985|Naproxen|naproxen|mesh-list
14801047|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14801048|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14801049|NCT00790985|Analgesics|analgesics|mesh-ancestor
14801050|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
14801051|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801052|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984628|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14984629|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
14984630|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14984631|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984632|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
14984633|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
14984634|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984635|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984636|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
14984637|NCT00579527|Hormones|hormones|mesh-ancestor
14984638|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984639|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14984640|NCT00579527|Protective Agents|protective agents|mesh-ancestor
14984641|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984642|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14984643|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
14984644|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14984645|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984646|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
14984647|NCT00557193|Leucovorin|leucovorin|mesh-list
14984648|NCT00557193|Folic Acid|folic acid|mesh-list
14984649|NCT00557193|Cytarabine|cytarabine|mesh-list
14984650|NCT00557193|Dexamethasone|dexamethasone|mesh-list
14984651|NCT00557193|Prednisone|prednisone|mesh-list
14984652|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
14984653|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14984654|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14984655|NCT00557193|Prednisolone|prednisolone|mesh-list
14984656|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
14984657|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
14984658|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14984659|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14984660|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14984661|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
14984662|NCT00557193|Cortisone|cortisone|mesh-list
14984663|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
14984664|NCT00557193|Methotrexate|methotrexate|mesh-list
14984665|NCT00557193|Etoposide|etoposide|mesh-list
14984666|NCT00557193|Vincristine|vincristine|mesh-list
14984667|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
14984668|NCT00557193|Daunorubicin|daunorubicin|mesh-list
14984669|NCT00557193|Asparaginase|asparaginase|mesh-list
14984670|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
14984671|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
14984672|NCT00557193|Pegaspargase|pegaspargase|mesh-list
14984673|NCT00557193|Lenograstim|lenograstim|mesh-list
14984674|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14984675|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
14984676|NCT00557193|Calcium|calcium|mesh-list
14984677|NCT00557193|BB 1101|bb 1101|mesh-list
14984678|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
14984679|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984680|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
14984681|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984682|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984683|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984684|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
14984685|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984686|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984687|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984688|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984689|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
14984690|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
14984691|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984692|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984693|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
14984694|NCT00557193|Hormones|hormones|mesh-ancestor
14984695|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984696|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984697|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14984698|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14984699|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14984700|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
14984701|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14984702|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14984703|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
14984704|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
14984705|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035266|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984706|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14984707|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14984708|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984709|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984710|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984711|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
14984712|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984713|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14984714|NCT00557193|Antidotes|antidotes|mesh-ancestor
14984715|NCT00557193|Protective Agents|protective agents|mesh-ancestor
14984716|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
14984717|NCT00557193|Vitamins|vitamins|mesh-ancestor
14984718|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
14984719|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984720|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984721|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984722|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14984723|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984724|NCT00557193|Hematinics|hematinics|mesh-ancestor
14984725|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
14984726|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
14984727|NCT00551928|Prednisone|prednisone|mesh-list
14984728|NCT00551928|Lenalidomide|lenalidomide|mesh-list
14984729|NCT00551928|Melphalan|melphalan|mesh-list
14984730|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984731|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
14984732|NCT00551928|Hormones|hormones|mesh-ancestor
14984733|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984734|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984735|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984736|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984737|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
14984738|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14984739|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14984740|NCT00551928|Growth Substances|growth substances|mesh-ancestor
14984741|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
14984742|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984743|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
14984744|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984745|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984746|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984747|NCT00531232|Clofarabine|clofarabine|mesh-list
14984748|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14984749|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
14984750|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984751|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984752|NCT00476606|Ritonavir|ritonavir|mesh-list
14984753|NCT00476606|Nelfinavir|nelfinavir|mesh-list
14984754|NCT00476606|Indinavir|indinavir|mesh-list
14984755|NCT00476606|Saquinavir|saquinavir|mesh-list
14984756|NCT00476606|Lamivudine|lamivudine|mesh-list
14984757|NCT00476606|Zidovudine|zidovudine|mesh-list
14984758|NCT00476606|Nevirapine|nevirapine|mesh-list
14984759|NCT00476606|Stavudine|stavudine|mesh-list
14984760|NCT00476606|Didanosine|didanosine|mesh-list
14984761|NCT00476606|Efavirenz|efavirenz|mesh-list
14984762|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14984763|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14984764|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
14984765|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984766|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984767|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14984768|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14984769|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
14984770|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984771|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14984772|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14984773|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14984774|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14984775|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
14984776|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14984777|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14984778|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14984779|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14984780|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14984781|NCT00379340|Dactinomycin|dactinomycin|mesh-list
14984782|NCT00379340|Cactinomycin|cactinomycin|mesh-list
14984783|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
14984784|NCT00379340|Doxorubicin|doxorubicin|mesh-list
14984785|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14984786|NCT00379340|Etoposide|etoposide|mesh-list
14984787|NCT00379340|Vincristine|vincristine|mesh-list
14984788|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
14984789|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984790|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
14984791|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984792|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984793|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14984794|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
14984795|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984796|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984797|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14984798|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984799|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984800|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984801|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984802|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984803|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984804|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984805|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984806|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14984807|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984808|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14984809|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14984810|NCT00304070|Doxorubicin|doxorubicin|mesh-list
14984811|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14984812|NCT00304070|Etoposide|etoposide|mesh-list
14984813|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
14984814|NCT00304070|Mitotane|mitotane|mesh-list
14984815|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984816|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14984817|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14984818|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14984819|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984820|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984821|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14523313|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14523314|NCT03586544|Albuterol|albuterol|mesh-list
14523315|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14523316|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
14523317|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984822|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984823|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
14984824|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14984825|NCT00066950|Fluorides|fluorides|mesh-list
14984826|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
14984827|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
14984828|NCT00066950|Protective Agents|protective agents|mesh-ancestor
14984829|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984830|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14984831|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984832|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
14984833|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
14984834|NCT00004935|Trastuzumab|trastuzumab|mesh-list
14984835|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14984836|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801053|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14801054|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801055|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
14801056|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14801057|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801058|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801059|NCT00790998|Ivermectin|ivermectin|mesh-list
14801060|NCT00790998|Moxidectin|moxidectin|mesh-list
14801061|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14801062|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801063|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
14523318|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523319|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14523320|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
14523321|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
14801064|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
14801065|NCT00791011|Bortezomib|bortezomib|mesh-list
14801066|NCT00791011|Vorinostat|vorinostat|mesh-list
14984837|NCT00001322|Leuprolide|leuprolide|mesh-list
14984838|NCT00001322|Estradiol|estradiol|mesh-list
14984839|NCT00001322|Progesterone|progesterone|mesh-list
14984840|NCT00001322|Estrogens|estrogens|mesh-ancestor
14984841|NCT00001322|Hormones|hormones|mesh-ancestor
14984842|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984843|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984844|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14984845|NCT00001322|Progestins|progestins|mesh-ancestor
14984846|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14984847|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
14984848|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984849|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984850|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14984851|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
14984852|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14984853|NCT01694134|Prednisolone|prednisolone|mesh-list
14984854|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
14984855|NCT01694134|Lidocaine|lidocaine|mesh-list
14984856|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14984857|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
14984858|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
14984859|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
14984860|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14984861|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984862|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
14984863|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984864|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14984865|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14984866|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14984867|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14984868|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984869|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984870|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
14984871|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
14984872|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14984873|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
14984874|NCT01694134|Hormones|hormones|mesh-ancestor
14984875|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984876|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14984877|NCT01694134|Protective Agents|protective agents|mesh-ancestor
14984878|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984879|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984880|NCT01694212|Diclofenac|diclofenac|mesh-list
14984881|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14984882|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14984883|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14984884|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14984885|NCT01694212|Analgesics|analgesics|mesh-ancestor
14984886|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
14984887|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984888|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984889|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984890|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984891|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14984892|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984893|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984894|NCT01694264|Entecavir|entecavir|mesh-list
14984895|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
14984896|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984897|NCT01694355|Vitamin D|vitamin d|mesh-list
14984898|NCT01694355|Vitamins|vitamins|mesh-ancestor
14984899|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
14984900|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984901|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14984902|NCT01694407|Tenofovir|tenofovir|mesh-list
14984903|NCT01694407|Emtricitabine|emtricitabine|mesh-list
14984904|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
14984905|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14984906|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14984907|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14984908|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984909|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984910|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14984911|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15030632|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030633|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15030634|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
15030635|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030636|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030637|NCT01969578|Paclitaxel|paclitaxel|mesh-list
15030638|NCT01969578|Carboplatin|carboplatin|mesh-list
15030639|NCT01969578|Doxorubicin|doxorubicin|mesh-list
15030640|NCT01969578|Bicalutamide|bicalutamide|mesh-list
15030641|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15030642|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030643|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030644|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030645|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030646|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030647|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030648|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15030649|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15030650|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15030651|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030652|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
15030653|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
15035267|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984912|NCT01694459|Heparin|heparin|mesh-list
14984913|NCT01694459|Calcium heparin|calcium heparin|mesh-list
14984914|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
14984915|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14984916|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14984917|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984918|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14984919|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
14984920|NCT01694498|Coagulants|coagulants|mesh-ancestor
14984921|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14984922|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
14984923|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984924|NCT01694576|Paclitaxel|paclitaxel|mesh-list
14984925|NCT01694576|Nedaplatin|nedaplatin|mesh-list
14984926|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14984927|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984928|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
14984929|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
14984930|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
14984931|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984932|NCT01694693|Abatacept|abatacept|mesh-list
14984933|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14984934|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984935|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984936|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14984937|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
14984938|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984939|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14984940|NCT01694732|Varenicline|varenicline|mesh-list
14984941|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14984942|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14984943|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
14984944|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14984945|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984946|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984947|NCT01694797|Metoprolol|metoprolol|mesh-list
14984948|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14984949|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14984950|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
14984951|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
14984952|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14984953|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984954|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14984955|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14984956|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14984957|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
14984958|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14984959|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984960|NCT01695005|Prednisone|prednisone|mesh-list
14984961|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14984962|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
14984963|NCT01695005|Hormones|hormones|mesh-ancestor
14984964|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984965|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984966|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14984967|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984968|NCT01695057|Vorinostat|vorinostat|mesh-list
14984969|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14984970|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14984971|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984972|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984973|NCT01695070|Melatonin|melatonin|mesh-list
14984974|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
14984975|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984976|NCT01695070|Protective Agents|protective agents|mesh-ancestor
14984977|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984978|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14984979|NCT01695109|Liraglutide|liraglutide|mesh-list
14984980|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14984981|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984982|NCT01695109|Incretins|incretins|mesh-ancestor
14984983|NCT01695109|Hormones|hormones|mesh-ancestor
14984984|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14984985|NCT01695122|Valproic Acid|valproic acid|mesh-list
14984986|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
14984987|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14984988|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984989|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
14984990|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14984991|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14984992|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
14984993|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14984994|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14984995|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14984996|NCT01695148|Carotenoids|carotenoids|mesh-list
14984997|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
14984998|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14984999|NCT01695148|Protective Agents|protective agents|mesh-ancestor
14985000|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985001|NCT01695174|Rifaximin|rifaximin|mesh-list
14985002|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14985003|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985004|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985005|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
14985006|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
14985007|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985008|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985009|NCT01695226|Celecoxib|celecoxib|mesh-list
14985010|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14985011|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14985012|NCT01695226|Analgesics|analgesics|mesh-ancestor
14985013|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
14985014|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985015|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985016|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985017|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14985018|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14985019|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14985020|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985021|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985022|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
14985023|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
14985024|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
14985025|NCT01695356|Avobenzone|avobenzone|mesh-list
14985026|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
14985027|NCT01695356|Benzophenone|benzophenone|mesh-list
14985028|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14985029|NCT01695356|Protective Agents|protective agents|mesh-ancestor
14985030|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985031|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
14985032|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14985033|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
14985034|NCT01695460|Vitamins|vitamins|mesh-list
14985035|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
14985036|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985037|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14985038|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14985039|NCT01695707|Pioglitazone|pioglitazone|mesh-list
14985040|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14985041|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985042|NCT01695733|Vaccines|vaccines|mesh-list
14985043|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
14985044|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985045|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
14985046|NCT01695759|Hematinics|hematinics|mesh-ancestor
14985047|NCT01695798|Vaccines|vaccines|mesh-list
14985048|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
14985049|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985050|NCT01695824|Warfarin|warfarin|mesh-list
14985051|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
14985052|NCT01695850|Sennosides|sennosides|mesh-list
14985053|NCT01695850|Laxatives|laxatives|mesh-ancestor
14985054|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985055|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
14985056|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14985057|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
14985058|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14985059|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985060|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14985061|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14985062|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14985063|NCT01696110|Heparin|heparin|mesh-list
14985064|NCT01696110|Calcium heparin|calcium heparin|mesh-list
14985065|NCT01696110|Tirofiban|tirofiban|mesh-list
14985066|NCT01696110|Bivalirudin|bivalirudin|mesh-list
14985067|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
14985068|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14985069|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14985070|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985071|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
14985072|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14985073|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
14985074|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985075|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15030654|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030655|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030656|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
15030657|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15030658|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
15030659|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15030660|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15030661|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15030662|NCT01969617|Naltrexone|naltrexone|mesh-list
15030663|NCT01969617|Nalmefene|nalmefene|mesh-list
15030664|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15030665|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030666|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
15030667|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030668|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15030669|NCT01969656|Calcitriol|calcitriol|mesh-list
15030670|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15030671|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030672|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15030673|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030674|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030675|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15030676|NCT01969656|Vitamins|vitamins|mesh-ancestor
15030677|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
15030678|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15030679|NCT01969669|Ketoconazole|ketoconazole|mesh-list
15030680|NCT01969669|Venetoclax|venetoclax|mesh-list
15030681|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030682|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
15030683|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030684|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15030685|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15030686|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030687|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030688|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15030689|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
15030690|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030691|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030692|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15030693|NCT01969682|Rifampin|rifampin|mesh-list
15030694|NCT01969682|Venetoclax|venetoclax|mesh-list
15030695|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030696|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15030697|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
15030698|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15030699|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030700|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
15030701|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15030702|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030703|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030704|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15030705|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15030706|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15030707|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15030708|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15030709|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15030710|NCT01969695|Venetoclax|venetoclax|mesh-list
15030711|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030712|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
15030713|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14985076|NCT01696240|Udenafil|udenafil|mesh-list
14985077|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14985078|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14985079|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985080|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985081|NCT01696370|Trimetazidine|trimetazidine|mesh-list
14985082|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
14985083|NCT01696383|Timolol|timolol|mesh-list
14985084|NCT01696383|Travoprost|travoprost|mesh-list
14985085|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14985086|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14985087|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
14985088|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985089|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985090|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801067|NCT00791011|Conatumumab|conatumumab|mesh-list
14801068|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801069|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14801070|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801071|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801072|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14801073|NCT00791024|Lidocaine|lidocaine|mesh-list
14801074|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
14801075|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
14801076|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801077|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030714|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14985091|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14985092|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14985093|NCT01696409|Vitamin D|vitamin d|mesh-list
14985094|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
14985095|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
14985096|NCT01696409|Vitamins|vitamins|mesh-list
14985097|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
14985098|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985099|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14985100|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14985101|NCT01696422|Vaccines|vaccines|mesh-list
14985102|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
14985103|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985104|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
14985105|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
14985106|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985107|NCT01696448|Protective Agents|protective agents|mesh-ancestor
14985108|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985109|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
14985110|NCT01696448|Vitamins|vitamins|mesh-ancestor
14985111|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
14985112|NCT01696461|Plerixafor|plerixafor|mesh-list
14985113|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14985114|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14985115|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
14985116|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985117|NCT01696474|Bortezomib|bortezomib|mesh-list
14985118|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985119|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
14985120|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14985121|NCT01696500|Antibodies|antibodies|mesh-list
14985122|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
14985123|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14985124|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
14985125|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985126|NCT01696526|Vitamin D|vitamin d|mesh-list
14985127|NCT01696526|Vitamins|vitamins|mesh-ancestor
14985128|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
14985129|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985130|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14985131|NCT01696552|Cimetidine|cimetidine|mesh-list
14985132|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14985133|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985134|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14985135|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
14985136|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
14985137|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985138|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985139|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985140|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14985141|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14985142|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985143|NCT01696617|Aripiprazole|aripiprazole|mesh-list
14985144|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
14985145|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14985146|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14985147|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14985148|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985149|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985150|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
14985151|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
14985152|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985153|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985154|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14985155|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14985156|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
14985157|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14985158|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14985159|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14985160|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14985161|NCT01696630|Desflurane|desflurane|mesh-list
14985162|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14985163|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
14985164|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
14985165|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985166|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985167|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14985168|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
14985169|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985170|NCT01696799|Econazole|econazole|mesh-list
14985171|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
14985172|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985173|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14985174|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14985175|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985176|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985177|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14985178|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
14985179|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985180|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985181|NCT01696825|Diazepam|diazepam|mesh-list
14985182|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14985183|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
14985184|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
14985185|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
14985186|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985187|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985188|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985189|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14985190|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985191|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14985192|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14985193|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14985194|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14985195|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14985196|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14985197|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
14985198|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
14523322|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14523323|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14523324|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14523325|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14523326|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
14523327|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523328|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523329|NCT03586726|Rifampin|rifampin|mesh-list
14523330|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14523331|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
14523332|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14523333|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523334|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
14523335|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14523336|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523337|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985199|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
14985200|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
14985201|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985202|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523338|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14523339|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14523340|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14523341|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14523342|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14523343|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14523344|NCT03587207|Vaccines|vaccines|mesh-list
14523345|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
14523346|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523347|NCT03587428|Zinc|zinc|mesh-list
14523348|NCT03587428|Trace Elements|trace elements|mesh-ancestor
14523349|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
14523350|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523351|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14523352|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14523353|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14523354|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14985203|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
14985204|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
14985205|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985206|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14985207|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985208|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985209|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
14985210|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985211|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14985212|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985213|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14985214|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
14985215|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14985216|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14985217|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985218|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985219|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
14985220|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985221|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14985222|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14985223|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14985224|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14985225|NCT01697059|Amoxicillin|amoxicillin|mesh-list
14985226|NCT01697059|Piperacillin|piperacillin|mesh-list
14985227|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14985228|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14985229|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985230|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14985231|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985232|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985233|NCT01697098|Dexamethasone|dexamethasone|mesh-list
14985234|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
14985235|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
14985236|NCT01697098|BB 1101|bb 1101|mesh-list
14985237|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985238|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
14985239|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
14985240|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985241|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985242|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985243|NCT01697098|Hormones|hormones|mesh-ancestor
14985244|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985245|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14985246|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985247|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
14985248|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985249|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985250|NCT01697111|Dienogest|dienogest|mesh-list
14985251|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14985252|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
14985253|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14985254|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985255|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14985256|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14985257|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14985258|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14985259|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
14985260|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985261|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14985262|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985263|NCT01697150|Pancrelipase|pancrelipase|mesh-list
14985264|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985265|NCT01697228|Vitamin D|vitamin d|mesh-list
14985266|NCT01697228|Vitamins|vitamins|mesh-ancestor
14985267|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
14985268|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985269|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14985270|NCT01697280|Vaccines|vaccines|mesh-list
14985271|NCT01697280|Immunologic Factors|immunologic factors|mesh-ancestor
14985272|NCT01697280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985273|NCT01697293|Paclitaxel|paclitaxel|mesh-list
14985274|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
14985275|NCT01697293|Doxorubicin|doxorubicin|mesh-list
14985276|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14985277|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14985278|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14985279|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985280|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
14985281|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
14985282|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
14985283|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985284|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985285|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
14985286|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985287|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14985288|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14985289|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
14985290|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14985291|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14985292|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14985293|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14985294|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985295|NCT01697306|Gemcitabine|gemcitabine|mesh-list
14985296|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
14985297|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14985298|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
14985299|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985300|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985301|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
14985302|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985303|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985304|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985305|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
14985306|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985307|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14985308|NCT01697410|Terlipressin|terlipressin|mesh-list
14985309|NCT01697410|Norepinephrine|norepinephrine|mesh-list
14985310|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14985311|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14985312|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
14985313|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985314|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985315|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985316|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
14985317|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
14985318|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985319|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14985320|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14985321|NCT01697436|Ribavirin|ribavirin|mesh-list
14985322|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
14985323|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985324|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
14985325|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985326|NCT01697566|Metformin|metformin|mesh-list
14985327|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15035268|NCT02000414|Daptomycin|daptomycin|mesh-list
15035269|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15035270|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985328|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985329|NCT01697605|Infigratinib|infigratinib|mesh-list
14985330|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985331|NCT01697618|Insulin|insulin|mesh-list
14985332|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14985333|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
14985334|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
14985335|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14985336|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14985337|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985338|NCT01697631|Insulin|insulin|mesh-list
14985339|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14985340|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
14985341|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
14985342|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14985343|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
14985344|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14985345|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14985346|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985347|NCT01697657|Insulin|insulin|mesh-list
14985348|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14985349|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
14985350|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
14985351|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
14985352|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
14985353|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
14985354|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14985355|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985356|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14985357|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14985358|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14985359|NCT01697722|Beclomethasone|beclomethasone|mesh-list
14985360|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985361|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
14985362|NCT01697722|Hormones|hormones|mesh-ancestor
14985363|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985364|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985365|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14985366|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14985367|NCT01697735|Atorvastatin|atorvastatin|mesh-list
14985368|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14985369|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14985370|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14985371|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
14985372|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985373|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14985374|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14985375|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985376|NCT01697787|Artesunate|artesunate|mesh-list
14985377|NCT01697787|Lumefantrine|lumefantrine|mesh-list
14985378|NCT01697787|Artemether|artemether|mesh-list
14985379|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14985380|NCT01697787|Amodiaquine|amodiaquine|mesh-list
14985381|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
14985382|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14985383|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14985384|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985385|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985386|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
14985387|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
14985388|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14985389|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
14985390|NCT01697826|Clindamycin|clindamycin|mesh-list
14985391|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
14985392|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
14985393|NCT01697826|Clotrimazole|clotrimazole|mesh-list
14985394|NCT01697826|Miconazole|miconazole|mesh-list
14985395|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14985396|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985397|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14985398|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985399|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985400|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14985401|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
14985402|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14985403|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14985404|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14985405|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
14985406|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985407|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985408|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14985409|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15030715|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15030716|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030717|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030718|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
15030719|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030720|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030721|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15030722|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030723|NCT01969877|Cetuximab|cetuximab|mesh-list
15030724|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030725|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15030726|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
15030727|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15030728|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030729|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030730|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15030731|NCT01969903|Analgesics|analgesics|mesh-ancestor
15030732|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
15030733|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030734|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15030735|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15030736|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15030737|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
15030738|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030739|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030740|NCT01969942|Melphalan|melphalan|mesh-list
15030741|NCT01969942|Busulfan|busulfan|mesh-list
15030742|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15030743|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
15030744|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030745|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030746|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15030747|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030748|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
15030749|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030750|NCT01969955|Paclitaxel|paclitaxel|mesh-list
15030751|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15030752|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030753|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030754|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030755|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030756|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030757|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030758|NCT01970046|Metformin|metformin|mesh-list
15030759|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15030760|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030761|NCT01970059|Metoprolol|metoprolol|mesh-list
15030762|NCT01970059|Carvedilol|carvedilol|mesh-list
15030763|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15030764|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15030765|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
15030766|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
15030767|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030768|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030769|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15030770|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15030771|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15030772|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
15030773|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030774|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030775|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
15030776|NCT01970059|Protective Agents|protective agents|mesh-ancestor
15030777|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15030778|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15030779|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15030780|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
14985410|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14985411|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14985412|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14985413|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985414|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985415|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14985416|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14985417|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985418|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
14985419|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985420|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14985421|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14985422|NCT01698164|Estradiol|estradiol|mesh-list
14985423|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14985424|NCT01698164|Progesterone|progesterone|mesh-list
14985425|NCT01698164|Estrogens|estrogens|mesh-ancestor
14985426|NCT01698164|Hormones|hormones|mesh-ancestor
14985427|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985428|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985429|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14985430|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
14985431|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14985432|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14985433|NCT01698164|Progestins|progestins|mesh-ancestor
14985434|NCT01698177|Vaccines|vaccines|mesh-list
14985435|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
14985436|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985437|NCT01698203|Ropivacaine|ropivacaine|mesh-list
14985438|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
14985439|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
14985440|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985441|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985442|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
14985443|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985444|NCT01698476|Vitamin D|vitamin d|mesh-list
14985445|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
14985446|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14985447|NCT01698476|Vitamins|vitamins|mesh-ancestor
14985448|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
14985449|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985450|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14985451|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14985452|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985453|NCT01698541|Tacrolimus|tacrolimus|mesh-list
14985454|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985455|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
14985456|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985457|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14985458|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985459|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985460|NCT01698567|Antithrombins|antithrombins|mesh-list
14985461|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
14985462|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14985463|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
14985464|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985465|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985466|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
14985467|NCT01698593|Epinephrine|epinephrine|mesh-list
14985468|NCT01698593|Bupivacaine|bupivacaine|mesh-list
14985469|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
14985470|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
14985471|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985472|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985473|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
14985474|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985475|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14985476|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14985477|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
14985478|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985479|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985480|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14985481|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14985482|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
14985483|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14985484|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
14985485|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
14985486|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
14985487|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14985488|NCT01698645|Fentanyl|fentanyl|mesh-list
14985489|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14985490|NCT01698645|Narcotics|narcotics|mesh-ancestor
14985491|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985492|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985493|NCT01698645|Analgesics|analgesics|mesh-ancestor
14985494|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
14985495|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985496|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14985497|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14985498|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
14985499|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
14985500|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
14985501|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14985502|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985503|NCT01698723|Ribavirin|ribavirin|mesh-list
14985504|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
14985505|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985506|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
14985507|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985508|NCT01698749|Dexamethasone|dexamethasone|mesh-list
14985509|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985510|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
14985511|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
14985512|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985513|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985514|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985515|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
14985516|NCT01698749|Hormones|hormones|mesh-ancestor
14985517|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985518|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14985519|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985520|NCT01698788|Dexamethasone|dexamethasone|mesh-list
14985521|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
14985522|NCT01698788|BB 1101|bb 1101|mesh-list
14985523|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985524|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
14985525|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
14523355|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523356|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523357|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523358|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14523359|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
14523360|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14523361|NCT03588806|Oxycodone|oxycodone|mesh-list
14523362|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14523363|NCT03588806|Narcotics|narcotics|mesh-ancestor
14523364|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523365|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523366|NCT03588806|Analgesics|analgesics|mesh-ancestor
14985526|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985527|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985528|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985529|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
14985530|NCT01698788|Hormones|hormones|mesh-ancestor
14985531|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985532|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14985533|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985534|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
14985535|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985536|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985537|NCT01698931|Glyburide|glyburide|mesh-list
14985538|NCT01698931|Repaglinide|repaglinide|mesh-list
14985539|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14985540|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985541|NCT01699113|Rabeprazole|rabeprazole|mesh-list
14985542|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14985543|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985544|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14985545|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985546|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985547|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14985548|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14985549|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14985550|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
14985551|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985552|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14985553|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14985554|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985555|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
14985556|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14985557|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
14985558|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985559|NCT01699204|Expectorants|expectorants|mesh-ancestor
14985560|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
14985561|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14985562|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
14985563|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985564|NCT01699204|Protective Agents|protective agents|mesh-ancestor
14985565|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985566|NCT01699204|Antidotes|antidotes|mesh-ancestor
14985567|NCT01699282|Antivitamins K|antivitamins k|mesh-list
14985568|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
14985569|NCT01699347|Picibanil|picibanil|mesh-list
14985570|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985571|NCT01699360|Cyclosporine|cyclosporine|mesh-list
14985572|NCT01699360|Sirolimus|sirolimus|mesh-list
14985573|NCT01699360|Tacrolimus|tacrolimus|mesh-list
14985574|NCT01699360|Cyclosporins|cyclosporins|mesh-list
14985575|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985576|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
14985577|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985578|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14985579|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985580|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985581|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
14985582|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985583|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
14985584|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14985585|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14985586|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14985587|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985588|NCT01699412|Dexamethasone|dexamethasone|mesh-list
14985589|NCT01699412|Clobetasol|clobetasol|mesh-list
14985590|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985591|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
14985592|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
14985593|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985594|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985595|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985596|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
14985597|NCT01699412|Hormones|hormones|mesh-ancestor
14985598|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985599|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14985600|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985601|NCT01699438|Mesalamine|mesalamine|mesh-list
14985602|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14985603|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14985604|NCT01699438|Analgesics|analgesics|mesh-ancestor
14985605|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
14985606|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985607|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985608|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985609|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14985610|NCT01699490|Valsartan|valsartan|mesh-list
14985611|NCT01699490|Fluoxetine|fluoxetine|mesh-list
14985612|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14985613|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14985614|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14985615|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985616|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14985617|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14985618|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14985619|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985620|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
14985621|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985622|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14985623|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
14985624|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14985625|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14985626|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14985627|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985628|NCT01699594|Mannitol|mannitol|mesh-list
14985629|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
14985630|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14985631|NCT01699594|Diuretics|diuretics|mesh-ancestor
14985632|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
14985633|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985634|NCT01699594|Miotics|miotics|mesh-ancestor
14985635|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
14985636|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985637|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14985638|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14985639|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
14985640|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14985641|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14985642|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
14985643|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985644|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030781|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15030782|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15030783|NCT01970072|Midazolam|midazolam|mesh-list
15030784|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15030785|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15030786|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15030787|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030788|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15030789|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15030790|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15030791|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15030792|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
15030793|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
14985645|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14985646|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
14985647|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985648|NCT01699711|Protective Agents|protective agents|mesh-ancestor
14985649|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985650|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14985651|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14985652|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985653|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14985654|NCT01699724|Sertraline|sertraline|mesh-list
14985655|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
14985656|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14985657|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14985658|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14985659|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14985660|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985661|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985662|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
14985663|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985664|NCT01699776|Digoxin|digoxin|mesh-list
14985665|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14985666|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14985667|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985668|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985669|NCT01699776|Protective Agents|protective agents|mesh-ancestor
14985670|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985671|NCT01699802|Anesthetics|anesthetics|mesh-list
14985672|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985673|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985674|NCT01699828|Buspirone|buspirone|mesh-list
14985675|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14985676|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14985677|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985678|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985679|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14985680|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14985681|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
14985682|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985683|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985684|NCT01699854|Capsaicin|capsaicin|mesh-list
14985685|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
14985686|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
14985687|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
14985688|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985689|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985690|NCT01699919|Lidocaine|lidocaine|mesh-list
14985691|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
14985692|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
14985693|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985694|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985695|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
14985696|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985697|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14985698|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14985699|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14985700|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14985701|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985702|NCT01699932|Metformin|metformin|mesh-list
14985703|NCT01699932|Glimepiride|glimepiride|mesh-list
14985704|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14985705|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985706|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14985707|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985708|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
14985709|NCT01699997|Oxytocin|oxytocin|mesh-list
14985710|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
14985711|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14985712|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985713|NCT01700010|Paclitaxel|paclitaxel|mesh-list
14985714|NCT01700010|Lapatinib|lapatinib|mesh-list
14985715|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14985716|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985717|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
14985718|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
14985719|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
14985720|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985721|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14985722|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985723|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
14985724|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14985725|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14985726|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985727|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985728|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14985729|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14985730|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14985731|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14985732|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985733|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985734|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
14985735|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14985736|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
14985737|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14985738|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14985739|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985740|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14985741|NCT01700322|Clopidogrel|clopidogrel|mesh-list
14985742|NCT01700322|Ticagrelor|ticagrelor|mesh-list
14985743|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14985744|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14985745|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14985746|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14985747|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14985748|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
14985749|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14985750|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985751|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985752|NCT01700400|Bevacizumab|bevacizumab|mesh-list
14985753|NCT01700400|Carboplatin|carboplatin|mesh-list
14985754|NCT01700400|Pemetrexed|pemetrexed|mesh-list
14985755|NCT01700400|Everolimus|everolimus|mesh-list
14985756|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14985757|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985758|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14985759|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14985760|NCT01700400|Growth Substances|growth substances|mesh-ancestor
14985761|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985762|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
14985763|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985764|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985765|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14985766|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14985767|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985768|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
14985769|NCT01700413|Idarubicin|idarubicin|mesh-list
14985770|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14985771|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985772|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14985773|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14985774|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985775|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985776|NCT01700426|Vitamins|vitamins|mesh-list
14985777|NCT01700426|Vitamin E|vitamin e|mesh-list
14985778|NCT01700426|Tocopherols|tocopherols|mesh-list
14985779|NCT01700426|Tocotrienols|tocotrienols|mesh-list
14985780|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
14985781|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
14985782|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985783|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
14985784|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985785|NCT01700426|Protective Agents|protective agents|mesh-ancestor
14985786|NCT01700478|Vasopressins|vasopressins|mesh-list
14985787|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
14985788|NCT01700478|Misoprostol|misoprostol|mesh-list
14985789|NCT01700478|Diuretics|diuretics|mesh-list
14985790|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985791|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14985792|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
14985793|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14985794|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14985795|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985796|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
14985797|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
14985798|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
14985799|NCT01700478|Coagulants|coagulants|mesh-ancestor
14985800|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14985801|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14985802|NCT01700491|Ropivacaine|ropivacaine|mesh-list
14985803|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
14985804|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
14985805|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14985806|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985807|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
14985808|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985809|NCT01700504|Gentamicins|gentamicins|mesh-list
14985810|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14985811|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985812|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14985813|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985814|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985815|NCT01700569|Leucovorin|leucovorin|mesh-list
14985816|NCT01700569|Folic Acid|folic acid|mesh-list
14985817|NCT01700569|Temozolomide|temozolomide|mesh-list
14985818|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
14985819|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985820|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14985821|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
14985822|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985823|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985824|NCT01700569|Antidotes|antidotes|mesh-ancestor
14985825|NCT01700569|Protective Agents|protective agents|mesh-ancestor
14985826|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
14985827|NCT01700569|Vitamins|vitamins|mesh-ancestor
14985828|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
14985829|NCT01700569|Hematinics|hematinics|mesh-ancestor
14985830|NCT01700608|Plerixafor|plerixafor|mesh-list
14985831|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14985832|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14985833|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
14985834|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985835|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14985836|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14985837|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985838|NCT01700790|Ritonavir|ritonavir|mesh-list
14985839|NCT01700790|Lopinavir|lopinavir|mesh-list
14985840|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14985841|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14985842|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
14985843|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985844|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985845|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14985846|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14523367|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
14523368|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523369|NCT03588910|Acetaminophen|acetaminophen|mesh-list
14985847|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
14985848|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985849|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14985850|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14985851|NCT01700803|Iodine|iodine|mesh-list
14985852|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
14985853|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
14985854|NCT01700803|Povidone|povidone|mesh-list
14985855|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14985856|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985857|NCT01700803|Trace Elements|trace elements|mesh-ancestor
14985858|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
14985859|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985860|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
14523370|NCT03588910|Ibuprofen|ibuprofen|mesh-list
14523371|NCT03588910|Oxycodone|oxycodone|mesh-list
14523372|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14523373|NCT03588910|Analgesics|analgesics|mesh-ancestor
14523374|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
14523375|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985861|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
14985862|NCT01700881|Vitamin E|vitamin e|mesh-list
14985863|NCT01700881|Vitamins|vitamins|mesh-ancestor
14985864|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
14985865|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985866|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
14985867|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985868|NCT01700881|Protective Agents|protective agents|mesh-ancestor
14985869|NCT01700946|Cytarabine|cytarabine|mesh-list
14985870|NCT01700946|Aldesleukin|aldesleukin|mesh-list
14985871|NCT01700946|Dexamethasone|dexamethasone|mesh-list
14985872|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
14985873|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14985874|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14985875|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14985876|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
14985877|NCT01700946|Rituximab|rituximab|mesh-list
14985878|NCT01700946|Methotrexate|methotrexate|mesh-list
14985879|NCT01700946|Etoposide|etoposide|mesh-list
14985880|NCT01700946|Vincristine|vincristine|mesh-list
14985881|NCT01700946|Interleukin-2|interleukin-2|mesh-list
14985882|NCT01700946|Asparaginase|asparaginase|mesh-list
14985883|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
14985884|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
14985885|NCT01700946|Clofarabine|clofarabine|mesh-list
14985886|NCT01700946|Vinblastine|vinblastine|mesh-list
14985887|NCT01700946|Pegaspargase|pegaspargase|mesh-list
14985888|NCT01700946|Teniposide|teniposide|mesh-list
14985889|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985890|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
14985891|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985892|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14985893|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14985894|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
14985895|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985896|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985897|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14985898|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985899|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
14985900|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
14985901|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985902|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985903|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
14985904|NCT01700946|Hormones|hormones|mesh-ancestor
14985905|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985906|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14985907|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14985908|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14985909|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
14985910|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14985911|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14985912|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
14985913|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
14985914|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985915|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14985916|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14985917|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14985918|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14985919|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14985920|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
14985921|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985922|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
14985923|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
14985924|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
14985925|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14985926|NCT01700946|Analgesics|analgesics|mesh-ancestor
14985927|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
14985928|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14985929|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14985930|NCT01701076|Dexamethasone|dexamethasone|mesh-list
14985931|NCT01701076|Lenalidomide|lenalidomide|mesh-list
14985932|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14985933|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14985934|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
14985935|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
14985936|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14985937|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985938|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14985939|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
14985940|NCT01701076|Hormones|hormones|mesh-ancestor
14985941|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14985942|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14985943|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985944|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985945|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
14985946|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14985947|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14985948|NCT01701076|Growth Substances|growth substances|mesh-ancestor
14985949|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14985950|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14985951|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
14985952|NCT01701089|Selegiline|selegiline|mesh-list
14985953|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
14985954|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14985955|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14985956|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14985957|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14985958|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14985959|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985960|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14985961|NCT01701089|Protective Agents|protective agents|mesh-ancestor
14985962|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985963|NCT01701180|Oxytocin|oxytocin|mesh-list
14985964|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
14985965|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14985966|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985967|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14985968|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14985969|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985970|NCT01701232|Rituximab|rituximab|mesh-list
14985971|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14985972|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985973|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
14985974|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985975|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14985976|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14985977|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14985978|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985979|NCT01701297|Renal Agents|renal agents|mesh-ancestor
14985980|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14985981|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
14985982|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14985983|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14985984|NCT01701323|Cytarabine|cytarabine|mesh-list
14985985|NCT01701323|Fludarabine|fludarabine|mesh-list
14985986|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
14985987|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14985988|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14985989|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
14985990|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14985991|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14985992|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
14985993|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14985994|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
14985995|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14985996|NCT01701336|Cloricromen|cloricromen|mesh-list
14985997|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14985998|NCT01701349|Paclitaxel|paclitaxel|mesh-list
14985999|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
14986000|NCT01701349|Combretastatin|combretastatin|mesh-list
14986001|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14986002|NCT01701349|Carboplatin|carboplatin|mesh-list
14986003|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14986004|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986005|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
14986006|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
14986007|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
14986008|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986009|NCT01701453|Clopidogrel|clopidogrel|mesh-list
14986010|NCT01701453|Ticagrelor|ticagrelor|mesh-list
14986011|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14986012|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14986013|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14986014|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14986015|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14986016|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
14986017|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986018|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986019|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986020|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
14986021|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14986022|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986023|NCT01701479|Aldesleukin|aldesleukin|mesh-list
14986024|NCT01701479|Interleukin-2|interleukin-2|mesh-list
14986025|NCT01701479|Dinutuximab|dinutuximab|mesh-list
14986026|NCT01701479|Isotretinoin|isotretinoin|mesh-list
14986027|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986028|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14986029|NCT01701479|Analgesics|analgesics|mesh-ancestor
14986030|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
14986031|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986032|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986033|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14986034|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14986035|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
14986036|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986037|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
15030794|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
15030795|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
15030796|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030797|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030798|NCT01970202|Enoxaparin|enoxaparin|mesh-list
15030799|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
15030800|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
15030801|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15030802|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15030803|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030804|NCT01970215|Atorvastatin|atorvastatin|mesh-list
15030805|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15030806|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15030807|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15030808|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
15030809|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030810|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15030811|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15030812|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030813|NCT01970280|Enoxaparin|enoxaparin|mesh-list
15030814|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
15030815|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15030816|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15030817|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030818|NCT01970345|Mecasermin|mecasermin|mesh-list
15030819|NCT01970345|Growth Substances|growth substances|mesh-ancestor
15030820|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030821|NCT01970358|Poly ICLC|poly iclc|mesh-list
15030822|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
15030823|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
15030824|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030825|NCT01970449|Vaccines|vaccines|mesh-list
15030826|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
15030827|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030828|NCT01970553|Gemcitabine|gemcitabine|mesh-list
15030829|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15030830|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
15030831|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030832|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986038|NCT01701518|Dexamethasone|dexamethasone|mesh-list
14986039|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14986040|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
14986041|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
14986042|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986043|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986044|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14986045|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
14986046|NCT01701518|Hormones|hormones|mesh-ancestor
14986047|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14986048|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14986049|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986050|NCT01701583|Omalizumab|omalizumab|mesh-list
14986051|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14986052|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14986053|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
14986054|NCT01701739|Digoxin|digoxin|mesh-list
14986055|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14986056|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14986057|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986058|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986059|NCT01701739|Protective Agents|protective agents|mesh-ancestor
14986060|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986061|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
14986062|NCT01701778|Sevoflurane|sevoflurane|mesh-list
14986063|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
14986064|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14986065|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986066|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986067|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14986068|NCT01701778|Analgesics|analgesics|mesh-ancestor
14986069|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
14986070|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986071|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14986072|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14986073|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14986074|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
14986075|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986076|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986077|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14986078|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14986079|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
14986080|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
14986081|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
14986082|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
14986083|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14986084|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
14986085|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986086|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14986087|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14986088|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14986089|NCT01701856|Interferons|interferons|mesh-list
14986090|NCT01701856|Interferon-beta|interferon-beta|mesh-list
14986091|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
14986092|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986093|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
14986094|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986095|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
14986096|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986097|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14986098|NCT01701882|Tenofovir|tenofovir|mesh-list
14986099|NCT01701882|Emtricitabine|emtricitabine|mesh-list
14986100|NCT01701882|Rilpivirine|rilpivirine|mesh-list
14986101|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
14986102|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986103|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14986104|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14986105|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986106|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986107|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14986108|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14986109|NCT01701921|Pregabalin|pregabalin|mesh-list
14986110|NCT01701921|Analgesics|analgesics|mesh-ancestor
14986111|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
14986112|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986113|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986114|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
14986115|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14986116|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14986117|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986118|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14986119|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14986120|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14986121|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986122|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14986123|NCT01702038|Rituximab|rituximab|mesh-list
14986124|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986125|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986126|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
14986127|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986128|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14986129|NCT01702090|Ritonavir|ritonavir|mesh-list
14986130|NCT01702090|Darunavir|darunavir|mesh-list
14986131|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14986132|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14986133|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
14986134|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986135|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986136|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14986137|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14986138|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
14986139|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986140|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14986141|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14986142|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
14986143|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14986144|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
14986145|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14986146|NCT01702129|Doxorubicin|doxorubicin|mesh-list
14986147|NCT01702129|Cetuximab|cetuximab|mesh-list
14986148|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14986149|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986150|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14986151|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14986152|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986153|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986154|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986155|NCT01702181|Tacrolimus|tacrolimus|mesh-list
14986156|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986157|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
14986158|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986159|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14986160|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986161|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986162|NCT01702207|Tacrolimus|tacrolimus|mesh-list
14986163|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986164|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
14986165|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986166|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14986167|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986168|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986169|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
14986170|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14986171|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986172|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14801078|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
14801079|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801080|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14801081|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14801082|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14801083|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14801084|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801085|NCT00791141|Cetuximab|cetuximab|mesh-list
14801086|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14801087|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801088|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801089|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801090|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801091|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801092|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801093|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801094|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801095|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801096|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
14801097|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801098|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801099|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801100|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801101|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
14801102|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801103|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801104|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801105|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801106|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801107|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801108|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801109|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801110|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
14801111|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801112|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986173|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14986174|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986175|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986176|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986177|NCT01702389|Remifentanil|remifentanil|mesh-list
14986178|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14986179|NCT01702389|Narcotics|narcotics|mesh-ancestor
14986180|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986181|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986182|NCT01702389|Analgesics|analgesics|mesh-ancestor
14986183|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
14986184|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986185|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
14986186|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14986187|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986188|NCT01702506|Antacids|antacids|mesh-list
14986189|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986190|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14986191|NCT01702610|Temozolomide|temozolomide|mesh-list
14986192|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14986193|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
14986194|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986195|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986196|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
14986197|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
14986198|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14986199|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14986200|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14986201|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986202|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14986203|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14986204|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
14986205|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14986206|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14986207|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986208|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
14986209|NCT01702636|Coagulants|coagulants|mesh-ancestor
14986210|NCT01702649|Biapenem|biapenem|mesh-list
14986211|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986212|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
14986213|NCT01702688|Giapreza|giapreza|mesh-list
14986214|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
14986215|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14986216|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14986217|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
14986218|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986219|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986220|NCT01702701|Fluticasone|fluticasone|mesh-list
14801113|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801114|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801115|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
14801116|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801117|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801118|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801119|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801120|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801121|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801122|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801123|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14986221|NCT01702701|Montelukast|montelukast|mesh-list
14986222|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14986223|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14986224|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
14986225|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986226|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986227|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14986228|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
14986229|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
14986230|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14986231|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14986232|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
14986233|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14986234|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14986235|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14986236|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986237|NCT01702714|Gemcitabine|gemcitabine|mesh-list
14986238|NCT01702714|Paclitaxel|paclitaxel|mesh-list
14986239|NCT01702714|Carboplatin|carboplatin|mesh-list
14986240|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14986241|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986242|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
14986243|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
14986244|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
14986245|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986246|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14986247|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
14986248|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
14986249|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986250|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986251|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986252|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
14986253|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986254|NCT01702831|Lenalidomide|lenalidomide|mesh-list
14986255|NCT01702831|Melphalan|melphalan|mesh-list
14986256|NCT01702831|Busulfan|busulfan|mesh-list
14986257|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
14986258|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986259|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14986260|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14986261|NCT01702831|Growth Substances|growth substances|mesh-ancestor
14986262|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
14986263|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523376|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523377|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
14986264|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14986265|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
14986266|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986267|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14986268|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986269|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14986270|NCT01702857|Vaccines|vaccines|mesh-list
14986271|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
14986272|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
14986273|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986274|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14986275|NCT01702857|Antacids|antacids|mesh-ancestor
14986276|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986277|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14986278|NCT01702974|Vitamin D|vitamin d|mesh-list
14986279|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
14986280|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14986281|NCT01702974|Vitamins|vitamins|mesh-ancestor
14986282|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
14986283|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986284|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14986285|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14986286|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986287|NCT01703104|Folic Acid|folic acid|mesh-list
14986288|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
14986289|NCT01703104|Proguanil|proguanil|mesh-list
14986290|NCT01703104|Hematinics|hematinics|mesh-ancestor
14986291|NCT01703104|Vitamins|vitamins|mesh-ancestor
14986292|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
14986293|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986294|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
14986295|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14986296|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14986297|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986298|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
14986299|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986300|NCT01703130|Ropivacaine|ropivacaine|mesh-list
14986301|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
14523378|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14523379|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523380|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14986302|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
14986303|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986304|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986305|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
14986306|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986307|NCT01703234|Ramipril|ramipril|mesh-list
14986308|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14986309|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
14986310|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986311|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986312|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15030833|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
15030834|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986313|NCT01703312|Omalizumab|omalizumab|mesh-list
14986314|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14986315|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14986316|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
14986317|NCT01703325|Triamcinolone|triamcinolone|mesh-list
14986318|NCT01703325|Clobetasol|clobetasol|mesh-list
14986319|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14986320|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
14986321|NCT01703325|Hormones|hormones|mesh-ancestor
14986322|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14986323|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986324|NCT01703351|Fentanyl|fentanyl|mesh-list
14986325|NCT01703351|Ropivacaine|ropivacaine|mesh-list
14986326|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
14986327|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
14986328|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986329|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986330|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
14986331|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986332|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14986333|NCT01703351|Narcotics|narcotics|mesh-ancestor
14986334|NCT01703351|Analgesics|analgesics|mesh-ancestor
14986335|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14986336|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14986337|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
14986338|NCT01703364|Lenalidomide|lenalidomide|mesh-list
14986339|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
14986340|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986341|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14986342|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14986343|NCT01703364|Growth Substances|growth substances|mesh-ancestor
14986344|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
14986345|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986346|NCT01703390|Cetuximab|cetuximab|mesh-list
14986347|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986348|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986349|NCT01703455|Sorafenib|sorafenib|mesh-list
14801124|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
14801125|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801126|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801127|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801128|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801129|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
14801130|NCT00791271|Interferons|interferons|mesh-list
14801131|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
14801132|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
14986350|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986351|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14986352|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986353|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986354|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
14986355|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
14986356|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14986357|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14986358|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14986359|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986360|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14986361|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14986362|NCT01703559|Phentolamine|phentolamine|mesh-list
14986363|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14986364|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14986365|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14986366|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14986367|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
14986368|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986369|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986370|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986371|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14986372|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
14986373|NCT01703624|Bromides|bromides|mesh-list
14986374|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
14801133|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14986375|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14986376|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14986377|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14986378|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
14986379|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986380|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986381|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986382|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14986383|NCT01703637|Vildagliptin|vildagliptin|mesh-list
14986384|NCT01703637|Saxagliptin|saxagliptin|mesh-list
14986385|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14986386|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986387|NCT01703637|Incretins|incretins|mesh-ancestor
14986388|NCT01703637|Hormones|hormones|mesh-ancestor
14986389|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14986390|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14986391|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
14986392|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986393|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986394|NCT01703728|Menotropins|menotropins|mesh-list
14986395|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14986396|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
14986397|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14986398|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986399|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
14986400|NCT01703754|Ifosfamide|ifosfamide|mesh-list
14986401|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14986402|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
14986403|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986404|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986405|NCT01703910|Gemcitabine|gemcitabine|mesh-list
14986406|NCT01703910|Paclitaxel|paclitaxel|mesh-list
14986407|NCT01703910|Etoposide|etoposide|mesh-list
14986408|NCT01703910|Vinorelbine|vinorelbine|mesh-list
14986409|NCT01703910|Docetaxel|docetaxel|mesh-list
14986410|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14986411|NCT01703910|Cisplatin|cisplatin|mesh-list
14986412|NCT01703910|Doxorubicin|doxorubicin|mesh-list
14986413|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14986414|NCT01703910|Fluorouracil|fluorouracil|mesh-list
14986415|NCT01703910|Capecitabine|capecitabine|mesh-list
14986416|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
14986417|NCT01703910|Irinotecan|irinotecan|mesh-list
14986418|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
14986419|NCT01703910|Pemetrexed|pemetrexed|mesh-list
14986420|NCT01703910|Cetuximab|cetuximab|mesh-list
14986421|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14986422|NCT01703910|Sorafenib|sorafenib|mesh-list
14986423|NCT01703910|Topotecan|topotecan|mesh-list
14986424|NCT01703910|Dasatinib|dasatinib|mesh-list
14986425|NCT01703910|Mitomycins|mitomycins|mesh-list
14986426|NCT01703910|Mitomycin|mitomycin|mesh-list
14986427|NCT01703910|Raltitrexed|raltitrexed|mesh-list
14986428|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14986429|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986430|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
14986431|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
14986432|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
14986433|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986434|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14986435|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
14986436|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
14986437|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986438|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986439|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986440|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
14986441|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986442|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14986443|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14986444|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14986445|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14986446|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14986447|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14986448|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986449|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14986450|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
14986451|NCT01704027|Androgens|androgens|mesh-list
14986452|NCT01704027|Hormones|hormones|mesh-ancestor
14986453|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14986454|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986455|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
14986456|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14986457|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986458|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986459|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14986460|NCT01704092|Analgesics|analgesics|mesh-ancestor
14986461|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
14986462|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986463|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14986464|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14986465|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14986466|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
14986467|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986468|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986469|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14986470|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14986471|NCT01704339|Capsaicin|capsaicin|mesh-list
14986472|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
14986473|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
14986474|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
14986475|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986476|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986477|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
14986478|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
14986479|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14986480|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986481|NCT01704417|Insulin|insulin|mesh-list
14523381|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523382|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523383|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523384|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14523385|NCT03588910|Narcotics|narcotics|mesh-ancestor
14523386|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523387|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14523388|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523389|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523390|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14523391|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
14523392|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523393|NCT03591068|Fluticasone|fluticasone|mesh-list
14523394|NCT03591068|Xhance|xhance|mesh-list
14523395|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523396|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14523397|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
14523398|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801134|NCT00791271|Decitabine|decitabine|mesh-list
14801135|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801136|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
14801137|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801138|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
14801139|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801140|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14801141|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
14801142|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801143|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801144|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801145|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801146|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14986482|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14986483|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
14986484|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14986485|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986486|NCT01704469|Anesthetics|anesthetics|mesh-list
14986487|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
14986488|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986489|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986490|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
14986491|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986492|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
14986493|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14986494|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
14986495|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986496|NCT01704482|Expectorants|expectorants|mesh-ancestor
14986497|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
14986498|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14986499|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
14986500|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986501|NCT01704482|Protective Agents|protective agents|mesh-ancestor
14986502|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986503|NCT01704482|Antidotes|antidotes|mesh-ancestor
14986504|NCT01704508|Lumefantrine|lumefantrine|mesh-list
14986505|NCT01704508|Artemether|artemether|mesh-list
14986506|NCT01704508|Piperaquine|piperaquine|mesh-list
14986507|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14986508|NCT01704508|Artenimol|artenimol|mesh-list
14986509|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
14986510|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14986511|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14986512|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986513|NCT01704534|Ustekinumab|ustekinumab|mesh-list
14986514|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
14986515|NCT01704612|Ropivacaine|ropivacaine|mesh-list
14801147|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801148|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801149|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801150|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801151|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801152|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
14801153|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801154|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801155|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801156|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801157|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
14986516|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
14986517|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
14986518|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986519|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986520|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
14986521|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986522|NCT01704638|Digoxin|digoxin|mesh-list
14986523|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
14986524|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14986525|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14986526|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986527|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986528|NCT01704638|Protective Agents|protective agents|mesh-ancestor
14986529|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986530|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14986531|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14986532|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986533|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14986534|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14986535|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14986536|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14986537|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986538|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
14986539|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14986540|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
14986541|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14986542|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14986543|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14986544|NCT01704690|Paclitaxel|paclitaxel|mesh-list
14986545|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14986546|NCT01704690|Cisplatin|cisplatin|mesh-list
14986547|NCT01704690|Fluorouracil|fluorouracil|mesh-list
14986548|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14986549|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986550|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14986551|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14986552|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14986553|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986554|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
14986555|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14986556|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986557|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
14986558|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986559|NCT01704703|Panitumumab|panitumumab|mesh-list
14986560|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986561|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986562|NCT01704716|Aldesleukin|aldesleukin|mesh-list
14986563|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
14986564|NCT01704716|Melphalan|melphalan|mesh-list
14986565|NCT01704716|Busulfan|busulfan|mesh-list
14986566|NCT01704716|Carboplatin|carboplatin|mesh-list
14986567|NCT01704716|Doxorubicin|doxorubicin|mesh-list
14986568|NCT01704716|Etoposide|etoposide|mesh-list
14986569|NCT01704716|Vincristine|vincristine|mesh-list
14986570|NCT01704716|Interleukin-2|interleukin-2|mesh-list
14986571|NCT01704716|Dinutuximab|dinutuximab|mesh-list
14986572|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986573|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
14986574|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986575|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14986576|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14986577|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
14986578|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986579|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986580|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14986581|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14986582|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14986583|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14986584|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986585|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14986586|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
14986587|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
14986588|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
14986589|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14986590|NCT01704716|Analgesics|analgesics|mesh-ancestor
14986591|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
14986592|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986593|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14986594|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14986595|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
14986596|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986597|NCT01704794|Folic Acid|folic acid|mesh-list
14986598|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
14986599|NCT01704794|Proguanil|proguanil|mesh-list
14986600|NCT01704794|Hematinics|hematinics|mesh-ancestor
14986601|NCT01704794|Vitamins|vitamins|mesh-ancestor
14986602|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
14986603|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986604|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
14986605|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14986606|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14986607|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986608|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
14986609|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986610|NCT01704872|Dinutuximab|dinutuximab|mesh-list
14986611|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986612|NCT01704898|Efavirenz|efavirenz|mesh-list
14986613|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14986614|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14986615|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986616|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986617|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
14986618|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986619|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14986620|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14986621|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14986622|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14986623|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14986624|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15030835|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030836|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030837|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
15030838|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030839|NCT01970579|Paclitaxel|paclitaxel|mesh-list
15030840|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030841|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030842|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030843|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030844|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030845|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035271|NCT02000596|Trastuzumab|trastuzumab|mesh-list
15035272|NCT02000596|Pertuzumab|pertuzumab|mesh-list
15035273|NCT02000596|Fulvestrant|fulvestrant|mesh-list
15035274|NCT02000596|Anastrozole|anastrozole|mesh-list
15035275|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15035276|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035277|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035278|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15035279|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15035280|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
15035281|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035282|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035283|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15035284|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15035285|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035286|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035287|NCT02000674|Rocuronium|rocuronium|mesh-list
15035288|NCT02000674|Succinylcholine|succinylcholine|mesh-list
15035289|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15035290|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15035291|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15035292|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035293|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035294|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15035295|NCT02000700|Canagliflozin|canagliflozin|mesh-list
15035296|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15035297|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035298|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15035299|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035300|NCT02000726|Citalopram|citalopram|mesh-list
15035301|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
15035302|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15035303|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15035304|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035305|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035306|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035307|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
15035308|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035309|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15035310|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15035311|NCT02000804|Darapladib|darapladib|mesh-list
15035312|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
15035313|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035314|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035315|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
15035316|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035317|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035318|NCT02000947|Durvalumab|durvalumab|mesh-list
15035319|NCT02000947|Tremelimumab|tremelimumab|mesh-list
15035320|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15035321|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15035322|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035323|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
15035324|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035325|NCT02001012|Chloroquine|chloroquine|mesh-list
15035326|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15035327|NCT02001012|Lumefantrine|lumefantrine|mesh-list
15035328|NCT02001012|Artemether|artemether|mesh-list
15035329|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15035330|NCT02001012|Amebicides|amebicides|mesh-ancestor
14986625|NCT01705002|Bevacizumab|bevacizumab|mesh-list
14986626|NCT01705002|Capecitabine|capecitabine|mesh-list
14986627|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986628|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986629|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14986630|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14986631|NCT01705002|Growth Substances|growth substances|mesh-ancestor
14986632|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986633|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
14986634|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14986635|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
14986636|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986637|NCT01705041|Liver Extracts|liver extracts|mesh-list
14986638|NCT01705041|Hematinics|hematinics|mesh-ancestor
14986639|NCT01705158|Carboplatin|carboplatin|mesh-list
14986640|NCT01705158|Doxorubicin|doxorubicin|mesh-list
14986641|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14986642|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986643|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14986644|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14986645|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14986646|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986647|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986648|NCT01705184|Bevacizumab|bevacizumab|mesh-list
14986649|NCT01705184|Pemetrexed|pemetrexed|mesh-list
14986650|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986651|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986652|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14986653|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14986654|NCT01705184|Growth Substances|growth substances|mesh-ancestor
14986655|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986656|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
14986657|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986658|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986659|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14986660|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14986661|NCT01705223|Vaccines|vaccines|mesh-list
14986662|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
14986663|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986664|NCT01705249|Norethindrone|norethindrone|mesh-list
14986665|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
14986666|NCT01705249|Estradiol|estradiol|mesh-list
14986667|NCT01705249|Estrogens|estrogens|mesh-ancestor
14986668|NCT01705249|Hormones|hormones|mesh-ancestor
14986669|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14986670|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986671|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14986672|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
14986673|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14986674|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14986675|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14986676|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14986677|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14986678|NCT01705314|Vitamin D|vitamin d|mesh-list
14986679|NCT01705314|Vitamins|vitamins|mesh-ancestor
14986680|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
14986681|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986682|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14986683|NCT01705340|Trastuzumab|trastuzumab|mesh-list
14986684|NCT01705340|Lapatinib|lapatinib|mesh-list
14986685|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986686|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986687|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14986688|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986689|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986690|NCT01705379|Lactitol|lactitol|mesh-list
14986691|NCT01705379|Cathartics|cathartics|mesh-ancestor
14986692|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14986693|NCT01705392|Bevacizumab|bevacizumab|mesh-list
14986694|NCT01705392|Dacarbazine|dacarbazine|mesh-list
14986695|NCT01705392|Propranolol|propranolol|mesh-list
14986696|NCT01705392|Enalapril|enalapril|mesh-list
14986697|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986698|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986699|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14986700|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14986701|NCT01705392|Growth Substances|growth substances|mesh-ancestor
14986702|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986703|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
14986704|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14986705|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14986706|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
14986707|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986708|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986709|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14986710|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14986711|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
14986712|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14986713|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
14986714|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14986715|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
14986716|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986717|NCT01705457|Vitamin A|vitamin a|mesh-list
14986718|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
14986719|NCT01705457|Vitamins|vitamins|mesh-ancestor
14986720|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
14986721|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986722|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
14986723|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986724|NCT01705457|Protective Agents|protective agents|mesh-ancestor
14986725|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14986726|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986727|NCT01705470|Furosemide|furosemide|mesh-list
14986728|NCT01705470|Diuretics|diuretics|mesh-ancestor
14986729|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
14986730|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986731|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14986732|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14986733|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986734|NCT01705483|Paclitaxel|paclitaxel|mesh-list
14986735|NCT01705483|Docetaxel|docetaxel|mesh-list
14986736|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14986737|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986738|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
14986739|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
14986740|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
14986741|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986742|NCT01705639|Melatonin|melatonin|mesh-list
14986743|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
14986744|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986745|NCT01705639|Protective Agents|protective agents|mesh-ancestor
14986746|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986747|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986748|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
14986749|NCT01705743|Sevoflurane|sevoflurane|mesh-list
14986750|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14986751|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14986752|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
14986753|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
14986754|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986755|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986756|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14986757|NCT01705743|Analgesics|analgesics|mesh-ancestor
14986758|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
14986759|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986760|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14986761|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14986762|NCT01705769|Micronutrients|micronutrients|mesh-list
14986763|NCT01705769|Trace Elements|trace elements|mesh-list
14986764|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986765|NCT01705795|Antibodies|antibodies|mesh-list
14986766|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
14986767|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986768|NCT01705808|Protein C|protein c|mesh-list
14986769|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
14986770|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14986771|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14986772|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986773|NCT01705938|Dolcanatide|dolcanatide|mesh-list
14986774|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14986775|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
14986776|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986777|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14986778|NCT01705951|Nicotine|nicotine|mesh-list
14986779|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14986780|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
14986781|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986782|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986783|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14986784|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14986785|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
14986786|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986787|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986788|NCT01706055|Interferons|interferons|mesh-list
14986789|NCT01706055|Interferon-beta|interferon-beta|mesh-list
14986790|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
14986791|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986792|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
14986793|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986794|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
14986795|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986796|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14986797|NCT01706120|Paclitaxel|paclitaxel|mesh-list
14986798|NCT01706120|Bevacizumab|bevacizumab|mesh-list
14986799|NCT01706120|Carboplatin|carboplatin|mesh-list
14986800|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14986801|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986802|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
14986803|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
14986804|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
14986805|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986806|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14986807|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14986808|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14986809|NCT01706120|Growth Substances|growth substances|mesh-ancestor
14986810|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986811|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
14986812|NCT01706172|Lidocaine|lidocaine|mesh-list
14986813|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
14986814|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
14986815|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986816|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986817|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
14986818|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986819|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14986820|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14986821|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14986822|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14986823|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986824|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
14986825|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14986826|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986827|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14986828|NCT01706354|Anesthetics|anesthetics|mesh-list
14986829|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
14986830|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986831|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986832|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
14986833|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986834|NCT01706367|Vaccines|vaccines|mesh-list
14986835|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
14986836|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986837|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
14986838|NCT01706471|Everolimus|everolimus|mesh-list
14986839|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986840|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986841|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
14986842|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986843|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14986844|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14986845|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
14986846|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14986847|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986848|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986849|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986850|NCT01706510|Clopidogrel|clopidogrel|mesh-list
14986851|NCT01706510|Ticagrelor|ticagrelor|mesh-list
14986852|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14986853|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14986854|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14986855|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14986856|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
14986857|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986858|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523399|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523400|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14523401|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
14523402|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
14523403|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14523404|NCT03591146|Ropivacaine|ropivacaine|mesh-list
14523405|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
14523406|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
14986859|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986860|NCT01706562|Itraconazole|itraconazole|mesh-list
14986861|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
14986862|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986863|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14986864|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14986865|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986866|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986867|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14986868|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
14986869|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14986870|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986871|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14986872|NCT01706627|Melatonin|melatonin|mesh-list
14986873|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
14986874|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986875|NCT01706627|Protective Agents|protective agents|mesh-ancestor
14986876|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986877|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986878|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
14986879|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14986880|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986881|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14986882|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14986883|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986884|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986885|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986886|NCT01706692|Cyclosporine|cyclosporine|mesh-list
14986887|NCT01706692|Adalimumab|adalimumab|mesh-list
14986888|NCT01706692|Etanercept|etanercept|mesh-list
14986889|NCT01706692|Methotrexate|methotrexate|mesh-list
14986890|NCT01706692|Infliximab|infliximab|mesh-list
14986891|NCT01706692|Ustekinumab|ustekinumab|mesh-list
14986892|NCT01706692|Cyclosporins|cyclosporins|mesh-list
14986893|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14986894|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
14986895|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14986896|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986897|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14986898|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
14986899|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986900|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986901|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
14986902|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986903|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14986904|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14986905|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
14986906|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14986907|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14986908|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
14986909|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986910|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14986911|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14986912|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14986913|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14986914|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14986915|NCT01706692|Analgesics|analgesics|mesh-ancestor
14986916|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
14986917|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15030846|NCT01970722|Gemcitabine|gemcitabine|mesh-list
15030847|NCT01970722|Paclitaxel|paclitaxel|mesh-list
15030848|NCT01970722|Cisplatin|cisplatin|mesh-list
15030849|NCT01970722|Carboplatin|carboplatin|mesh-list
15030850|NCT01970722|Doxorubicin|doxorubicin|mesh-list
15030851|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15030852|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15030853|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030854|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030855|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030856|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030857|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030858|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030859|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15030860|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
15030861|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
14986918|NCT01706874|Listerine|listerine|mesh-list
14986919|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14986920|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986921|NCT01706887|Amiloride|amiloride|mesh-list
14986922|NCT01706887|Diuretics|diuretics|mesh-ancestor
14986923|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
14986924|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986925|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
14986926|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14986927|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14986928|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986929|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
14986930|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14986931|NCT01706939|Carboplatin|carboplatin|mesh-list
14986932|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986933|NCT01707082|Midazolam|midazolam|mesh-list
14986934|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14986935|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14986936|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14986937|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986938|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14986939|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14986940|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14986941|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14986942|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
14986943|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
14986944|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
14986945|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
14986946|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14986947|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986948|NCT01707134|Insulin|insulin|mesh-list
14986949|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14986950|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
14986951|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
14986952|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
14986953|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
14986954|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14986955|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986956|NCT01707160|Insulin|insulin|mesh-list
14986957|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14986958|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
14986959|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
14986960|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14986961|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14986962|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986963|NCT01707199|Artesunate|artesunate|mesh-list
14986964|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
14986965|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
14986966|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14986967|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
14986968|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14986969|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14986970|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14986971|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14986972|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
14986973|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
14986974|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14986975|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
14986976|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14986977|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986978|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986979|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14986980|NCT01707199|Renal Agents|renal agents|mesh-ancestor
14986981|NCT01707251|Ibuprofen|ibuprofen|mesh-list
14986982|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14986983|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14986984|NCT01707251|Analgesics|analgesics|mesh-ancestor
14986985|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
14986986|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14986987|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986988|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14986989|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14986990|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14986991|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14986992|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986993|NCT01707316|Canagliflozin|canagliflozin|mesh-list
14986994|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14986995|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14986996|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14986997|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14986998|NCT01707342|Simeprevir|simeprevir|mesh-list
14986999|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
14987000|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987001|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
14987002|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987003|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987004|NCT01707394|Apixaban|apixaban|mesh-list
14523407|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523408|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523409|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
14523410|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523411|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14523412|NCT03591406|Hematinics|hematinics|mesh-ancestor
14523413|NCT03592121|Phenylephrine|phenylephrine|mesh-list
14523414|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14523415|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
14523416|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
14523417|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523418|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523419|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
14523420|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14523421|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
14523422|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
14523423|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14523424|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14523425|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14523426|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
14523427|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523428|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523429|NCT03592121|Protective Agents|protective agents|mesh-ancestor
14523430|NCT03593538|Metformin|metformin|mesh-list
14523431|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14523432|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523433|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
14523434|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14523435|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14523436|NCT03593902|Prednisolone|prednisolone|mesh-list
14523437|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
14523438|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
14987005|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14987006|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
14987007|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14987008|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
14987009|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987010|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987011|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
14987012|NCT01707407|Ketoconazole|ketoconazole|mesh-list
14987013|NCT01707407|Pomalidomide|pomalidomide|mesh-list
14987014|NCT01707407|Carbamazepine|carbamazepine|mesh-list
14987015|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
14987016|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
14987017|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987018|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14987019|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14987020|NCT01707407|Growth Substances|growth substances|mesh-ancestor
14987021|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
14987022|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987023|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
14987024|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987025|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14987026|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14987027|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987028|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987029|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14987030|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
14987031|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987032|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14987033|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
14987034|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
14523439|NCT03593902|Rituximab|rituximab|mesh-list
14987035|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14987036|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987037|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14987038|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987039|NCT01707407|Analgesics|analgesics|mesh-ancestor
14987040|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
14987041|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987042|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14987043|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987044|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14987045|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14987046|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14987047|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14987048|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14987049|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987050|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
14987051|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14987052|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
14987053|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14987054|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14987055|NCT01707537|Vaccines|vaccines|mesh-list
14987056|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
14987057|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987058|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
14987059|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
14987060|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987061|NCT01707615|Protective Agents|protective agents|mesh-ancestor
14987062|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987063|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14987064|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14987065|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987066|NCT01707628|Vaccines|vaccines|mesh-list
14987067|NCT01707628|Immunologic Factors|immunologic factors|mesh-ancestor
14987068|NCT01707628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987069|NCT01707732|Enoxaparin|enoxaparin|mesh-list
14987070|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
14987071|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14987072|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14987073|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987074|NCT01707745|Bevacizumab|bevacizumab|mesh-list
14987075|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14987076|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987077|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14987078|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14987079|NCT01707745|Growth Substances|growth substances|mesh-ancestor
14987080|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987081|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
14987082|NCT01707823|Aspirin|aspirin|mesh-list
14987083|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14987084|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987085|NCT01707823|Analgesics|analgesics|mesh-ancestor
14987086|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
14987087|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987088|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987089|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987090|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987091|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14987092|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14987093|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987094|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14987095|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14987096|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987097|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
14987098|NCT01707849|Everolimus|everolimus|mesh-list
14987099|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987100|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14987101|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
14987102|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987103|NCT01707940|Ketoconazole|ketoconazole|mesh-list
14987104|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
14987105|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987106|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14987107|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14987108|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987109|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987110|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14987111|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
14987112|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987113|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987114|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14987115|NCT01707953|Midodrine|midodrine|mesh-list
14987116|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
14987117|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
14987118|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987119|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987120|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14987121|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14987122|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14987123|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14987124|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
14987125|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987126|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987127|NCT01708005|Vitamin D|vitamin d|mesh-list
14987128|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
14987129|NCT01708005|Vitamins|vitamins|mesh-ancestor
14987130|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
14987131|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987132|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14987133|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14987134|NCT01708044|Pramlintide|pramlintide|mesh-list
14987135|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14987136|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987137|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
14987138|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14987139|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14987140|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987141|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
14987142|NCT01708239|Coagulants|coagulants|mesh-ancestor
14801158|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
14801159|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14801160|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
14801161|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14801162|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801163|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14801164|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801165|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801166|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801167|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987143|NCT01708330|Lidocaine|lidocaine|mesh-list
14987144|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
14987145|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
14987146|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987147|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987148|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
14987149|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987150|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14987151|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14987152|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14987153|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987154|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987155|NCT01708369|Aspirin|aspirin|mesh-list
14987156|NCT01708369|Ethanol|ethanol|mesh-list
14987157|NCT01708369|Oseltamivir|oseltamivir|mesh-list
14987158|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14987159|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987160|NCT01708369|Analgesics|analgesics|mesh-ancestor
14987161|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
14987162|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987163|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987164|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987165|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987166|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14987167|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14987168|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987169|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14987170|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14987171|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987172|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
14987173|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14987174|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987175|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987176|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
14987177|NCT01708447|Lidocaine|lidocaine|mesh-list
14987178|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
14987179|NCT01708447|Anesthetics|anesthetics|mesh-list
14987180|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987181|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987182|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
14987183|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987184|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14987185|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14987186|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14987187|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987188|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030862|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030863|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030864|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030865|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
15030866|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030867|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15030868|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15030869|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15030870|NCT01970748|Propranolol|propranolol|mesh-list
15030871|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15030872|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15030873|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
15030874|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030875|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030876|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030877|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15030878|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15030879|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
15030880|NCT01970800|Hormones|hormones|mesh-list
15030881|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030882|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030883|NCT01970904|Ribavirin|ribavirin|mesh-list
15030884|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15030885|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
15030886|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030887|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
14987189|NCT01708616|Risperidone|risperidone|mesh-list
14987190|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14987191|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
14987192|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987193|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987194|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987195|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14987196|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14987197|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987198|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14987199|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14987200|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
14987201|NCT01708642|Epinephrine|epinephrine|mesh-list
14987202|NCT01708642|Racepinephrine|racepinephrine|mesh-list
14987203|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
14987204|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14987205|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14987206|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
14987207|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987208|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987209|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987210|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14987211|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14987212|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
14987213|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987214|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14987215|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
14987216|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
14987217|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
14987218|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14987219|NCT01708707|Morphine|morphine|mesh-list
14987220|NCT01708707|Buprenorphine|buprenorphine|mesh-list
14987221|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14987222|NCT01708707|Narcotics|narcotics|mesh-ancestor
14987223|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987224|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987225|NCT01708707|Analgesics|analgesics|mesh-ancestor
14987226|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
14987227|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987228|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14987229|NCT01708720|Vaccines|vaccines|mesh-list
14987230|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
14987231|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987232|NCT01708798|Eplerenone|eplerenone|mesh-list
14987233|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14987234|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
14987235|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987236|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987237|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14987238|NCT01708798|Diuretics|diuretics|mesh-ancestor
14987239|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
14987240|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14987241|NCT01708837|Propofol|propofol|mesh-list
14987242|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14987243|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987244|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987245|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14987246|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
14987247|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
14987248|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
14987249|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14987250|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
14987251|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14987252|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
14987253|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987254|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987255|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
14987256|NCT01708876|Artesunate|artesunate|mesh-list
14987257|NCT01708876|Chloroquine|chloroquine|mesh-list
14987258|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14987259|NCT01708876|Primaquine|primaquine|mesh-list
14987260|NCT01708876|Mefloquine|mefloquine|mesh-list
14987261|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
14987262|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14987263|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14987264|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987265|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987266|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
14987267|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
14987268|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14987269|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
14987270|NCT01708876|Amebicides|amebicides|mesh-ancestor
14987271|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987272|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14987273|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987274|NCT01708876|Analgesics|analgesics|mesh-ancestor
14987275|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
14987276|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987277|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987278|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987279|NCT01708876|Filaricides|filaricides|mesh-ancestor
14987280|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
14987281|NCT01708993|Docetaxel|docetaxel|mesh-list
14987282|NCT01708993|Pemetrexed|pemetrexed|mesh-list
14987283|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987284|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14987285|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14987286|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14987287|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987288|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987289|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14987290|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14987291|NCT01709019|Vaccines|vaccines|mesh-list
14987292|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
14987293|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987294|NCT01709071|Vaccines|vaccines|mesh-list
14987295|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
14987296|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987297|NCT01709123|Chromium|chromium|mesh-list
14987298|NCT01709123|Trace Elements|trace elements|mesh-ancestor
14987299|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
14987300|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987301|NCT01709292|Vemurafenib|vemurafenib|mesh-list
14987302|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987303|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14987304|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987305|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987306|NCT01709370|Letrozole|letrozole|mesh-list
14987307|NCT01709370|Palbociclib|palbociclib|mesh-list
14987308|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987309|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14987310|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14987311|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987312|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987313|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14987314|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
14987315|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987316|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987317|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14987318|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
14987319|NCT01709630|Analgesics|analgesics|mesh-ancestor
14987320|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
14987321|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987322|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987323|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
14987324|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987325|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14987326|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
14987327|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14987328|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987329|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987330|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14987331|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
14987332|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14987333|NCT01709656|Celecoxib|celecoxib|mesh-list
14987334|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14987335|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987336|NCT01709656|Analgesics|analgesics|mesh-ancestor
14987337|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
14987338|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987339|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987340|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987341|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987342|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14987343|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14987344|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987345|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987346|NCT01709682|Amiodarone|amiodarone|mesh-list
14987347|NCT01709682|Sotalol|sotalol|mesh-list
14987348|NCT01709682|Flecainide|flecainide|mesh-list
14801168|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801169|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14987349|NCT01709682|Propafenone|propafenone|mesh-list
14987350|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14987351|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
14987352|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14987353|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987354|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987355|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14987356|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14987357|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14987358|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987359|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14987360|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14987361|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14987362|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14987363|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14987364|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
14987365|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987366|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987367|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
14987368|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
14987369|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987370|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14987371|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
14987372|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987373|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987374|NCT01709760|Methotrexate|methotrexate|mesh-list
14987375|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14987376|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
14987377|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14987378|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987379|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14987380|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
14987381|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801170|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801171|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801172|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
14801173|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801174|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987382|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987383|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
14987384|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987385|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14987386|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14987387|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
14987388|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987389|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14987390|NCT01709825|Sulfalene|sulfalene|mesh-list
14987391|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987392|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14987393|NCT01709825|Renal Agents|renal agents|mesh-ancestor
14987394|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
14987395|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14987396|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14987397|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
14987398|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14987399|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987400|NCT01709942|Cetrorelix|cetrorelix|mesh-list
14987401|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14987402|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
14987403|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14987404|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987405|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
14987406|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987407|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
14987408|NCT01709955|Cathartics|cathartics|mesh-ancestor
14987409|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987410|NCT01709994|Aspirin|aspirin|mesh-list
14987411|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14987412|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987413|NCT01709994|Analgesics|analgesics|mesh-ancestor
14987414|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
14987415|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987416|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987417|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987418|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987419|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14987420|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14987421|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987422|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14987423|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14987424|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987425|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
14987426|NCT01710007|Atorvastatin|atorvastatin|mesh-list
14987427|NCT01710007|Pitavastatin|pitavastatin|mesh-list
14987428|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14987429|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14987430|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
14987431|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987432|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14987433|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14987434|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987435|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
14987436|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
14987437|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987438|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987439|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987440|NCT01710072|Aspirin|aspirin|mesh-list
14987441|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14987442|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987443|NCT01710072|Analgesics|analgesics|mesh-ancestor
14987444|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
14987445|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987446|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987447|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987448|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987449|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14987450|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14987451|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987452|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14987453|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14987454|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987455|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
14987456|NCT01710163|Aripiprazole|aripiprazole|mesh-list
14987457|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
14987458|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14987459|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14987460|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14987461|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987462|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987463|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
14987464|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
14987465|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987466|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987467|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14987468|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14987469|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
14987470|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14987471|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14987472|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14987473|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14987474|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
14987475|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987476|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
14987477|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14987478|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14987479|NCT01710228|Prednisolone|prednisolone|mesh-list
14987480|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
14987481|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14987482|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
14987483|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987484|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
14987485|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
14987486|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987487|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987488|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987489|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
14987490|NCT01710228|Hormones|hormones|mesh-ancestor
14987491|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987492|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14987493|NCT01710228|Protective Agents|protective agents|mesh-ancestor
14987494|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14987495|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987496|NCT01710384|Betamethasone|betamethasone|mesh-list
14987497|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987498|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
14987499|NCT01710384|Hormones|hormones|mesh-ancestor
14987500|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987501|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987502|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14987503|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
15030888|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030889|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15030890|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15030891|NCT01971034|Metformin|metformin|mesh-list
15030892|NCT01971034|Paclitaxel|paclitaxel|mesh-list
15030893|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030894|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030895|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030896|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030897|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030898|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030899|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15030900|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030901|NCT01971047|Insulin|insulin|mesh-list
15030902|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
15030903|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15030904|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15030905|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030906|NCT01971190|Aflibercept|aflibercept|mesh-list
15030907|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15030908|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15030909|NCT01971190|Growth Substances|growth substances|mesh-ancestor
15030910|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030911|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
15030912|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030913|NCT01971242|Exenatide|exenatide|mesh-list
15030914|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14987504|NCT01710462|Domperidone|domperidone|mesh-list
14987505|NCT01710462|Pantoprazole|pantoprazole|mesh-list
14987506|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14987507|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987508|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14987509|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987510|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987511|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
14987512|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
14987513|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987514|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987515|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14987516|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
14987517|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987518|NCT01710488|Levofloxacin|levofloxacin|mesh-list
14987519|NCT01710488|Ofloxacin|ofloxacin|mesh-list
14987520|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
14987521|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14987522|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987523|NCT01710488|Renal Agents|renal agents|mesh-ancestor
14987524|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14987525|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14987526|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14987527|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987528|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987529|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987530|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14987531|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14987532|NCT01710540|Metformin|metformin|mesh-list
14987533|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14987534|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987535|NCT01710553|Metformin|metformin|mesh-list
14987536|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14987537|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987538|NCT01710566|Misoprostol|misoprostol|mesh-list
14987539|NCT01710566|Oxytocin|oxytocin|mesh-list
14987540|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
14987541|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14987542|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987543|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14987544|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
14987545|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14987546|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987547|NCT01710592|Docetaxel|docetaxel|mesh-list
14987548|NCT01710592|Capecitabine|capecitabine|mesh-list
14987549|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
14987550|NCT01710592|Epirubicin|epirubicin|mesh-list
14987551|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987552|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
14987553|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
14987554|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
14987555|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987556|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14987557|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
14987558|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14987559|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14987560|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14987561|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987562|NCT01710631|Eszopiclone|eszopiclone|mesh-list
14987563|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14987564|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987565|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987566|NCT01710670|Ethanol|ethanol|mesh-list
14987567|NCT01710670|Brivaracetam|brivaracetam|mesh-list
14987568|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14987569|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987570|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987571|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987572|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
14987573|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14987574|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14987575|NCT01710696|Estradiol|estradiol|mesh-list
14987576|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14987577|NCT01710696|Estrogens|estrogens|mesh-ancestor
14987578|NCT01710696|Hormones|hormones|mesh-ancestor
14987579|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987580|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987581|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14987582|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
14987583|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14987584|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14987585|NCT01710722|Ephedrine|ephedrine|mesh-list
14987586|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
14987587|NCT01710722|Caffeine|caffeine|mesh-list
14801175|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801176|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801177|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
14801178|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801179|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801180|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801181|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801182|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801183|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801184|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801185|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801186|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
14801187|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801188|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801189|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14987588|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14987589|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987590|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14987591|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987592|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987593|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14987594|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14987595|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
14987596|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987597|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
14987598|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
14987599|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987600|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14987601|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
14987602|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14987603|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14987604|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
14987605|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
14987606|NCT01710748|Everolimus|everolimus|mesh-list
14987607|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987608|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14987609|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
14987610|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987611|NCT01710761|Caffeine|caffeine|mesh-list
14987612|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14987613|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987614|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14987615|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987616|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987617|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14987618|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14987619|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
14987620|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987621|NCT01710904|Oxycodone|oxycodone|mesh-list
14987622|NCT01710904|Naloxone|naloxone|mesh-list
14987623|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14987624|NCT01710904|Narcotics|narcotics|mesh-ancestor
14987625|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987626|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987627|NCT01710904|Analgesics|analgesics|mesh-ancestor
14987628|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
14987629|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987630|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14987631|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
14987632|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14987633|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987634|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987635|NCT01711060|Oxytocin|oxytocin|mesh-list
14987636|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
14987637|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14801190|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801191|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
14801192|NCT00791427|Ranibizumab|ranibizumab|mesh-list
14801193|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14801194|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14801195|NCT00791427|Growth Substances|growth substances|mesh-ancestor
14801196|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801197|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
14801198|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801199|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
14801200|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14801201|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
14801202|NCT00791505|Trimethoprim|trimethoprim|mesh-list
14801203|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
14801204|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14801205|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801206|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14801207|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14801208|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801209|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801210|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801211|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14801212|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14801213|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14801214|NCT00791505|Renal Agents|renal agents|mesh-ancestor
14801215|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
14801216|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14801217|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14801218|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14801219|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14801220|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14801221|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14987638|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987639|NCT01711073|Plerixafor|plerixafor|mesh-list
14987640|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14987641|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14987642|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
14987643|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987644|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
14987645|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14987646|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
14987647|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987648|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987649|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14987650|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
14987651|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14987652|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14987653|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14987654|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
14987655|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987656|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987657|NCT01711112|Docetaxel|docetaxel|mesh-list
14987658|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987659|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
14987660|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
14987661|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
14987662|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987663|NCT01711125|Baclofen|baclofen|mesh-list
14987664|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14987665|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987666|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14987667|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987668|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14987669|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
14987670|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
14987671|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987672|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987673|NCT01711229|Acetaminophen|acetaminophen|mesh-list
14987674|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987675|NCT01711229|Analgesics|analgesics|mesh-ancestor
14987676|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
14987677|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987678|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987679|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
14987680|NCT01711242|Capecitabine|capecitabine|mesh-list
14987681|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
14987682|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14987683|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
14987684|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987685|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987686|NCT01711320|Omeprazole|omeprazole|mesh-list
14987687|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14987688|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987689|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14987690|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987691|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987692|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
14987693|NCT01711437|Simethicone|simethicone|mesh-list
14987694|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
14987695|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
14987696|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14987697|NCT01711437|Citric Acid|citric acid|mesh-list
14987698|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
14987699|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14987700|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
14987701|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14987702|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
14987703|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
14987704|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987705|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
14987706|NCT01711437|Protective Agents|protective agents|mesh-ancestor
14987707|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987708|NCT01711437|Vitamins|vitamins|mesh-ancestor
14987709|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
14987710|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
14987711|NCT01711437|Emollients|emollients|mesh-ancestor
14987712|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14987713|NCT01711437|Cathartics|cathartics|mesh-ancestor
14987714|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987715|NCT01711437|Antacids|antacids|mesh-ancestor
14987716|NCT01711437|Laxatives|laxatives|mesh-ancestor
14987717|NCT01711463|Fluticasone|fluticasone|mesh-list
14987718|NCT01711463|Xhance|xhance|mesh-list
14987719|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987720|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14987721|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
14987722|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987723|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987724|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14987725|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14987726|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
14987727|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14987728|NCT01711476|Complement Factor H|complement factor h|mesh-list
14987729|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14987730|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14987731|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
14987732|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987733|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
14987734|NCT01711489|Isavuconazole|isavuconazole|mesh-list
14987735|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14987736|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987737|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14987738|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
14987739|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14987740|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801222|NCT00791531|Methotrexate|methotrexate|mesh-list
14801223|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14801224|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
14987741|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987742|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801225|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14801226|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801227|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14801228|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
14801229|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801230|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801231|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
14801232|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987743|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
14987744|NCT01711515|Cisplatin|cisplatin|mesh-list
14987745|NCT01711515|Ipilimumab|ipilimumab|mesh-list
14987746|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987747|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14987748|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14987749|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987750|NCT01711528|Dexamethasone|dexamethasone|mesh-list
14987751|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
14987752|NCT01711528|Bortezomib|bortezomib|mesh-list
14987753|NCT01711528|Ichthammol|ichthammol|mesh-list
14987754|NCT01711528|BB 1101|bb 1101|mesh-list
14987755|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987756|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
14987757|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
14987758|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987759|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987760|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987761|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
14987762|NCT01711528|Hormones|hormones|mesh-ancestor
14987763|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987764|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14987765|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987766|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
14987767|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987768|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987769|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
14987770|NCT01711567|Tenofovir|tenofovir|mesh-list
14987771|NCT01711567|Entecavir|entecavir|mesh-list
14987772|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
14987773|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987774|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14987775|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14987776|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987777|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987778|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14987779|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14987780|NCT01711632|Vemurafenib|vemurafenib|mesh-list
14987781|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987782|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14987783|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987784|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987785|NCT01711671|Dexamethasone|dexamethasone|mesh-list
14987786|NCT01711671|Lenalidomide|lenalidomide|mesh-list
14987787|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987788|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
14987789|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
14987790|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987791|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987792|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987793|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
14987794|NCT01711671|Hormones|hormones|mesh-ancestor
14987795|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987796|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14987797|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987798|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
14987799|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14987800|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14987801|NCT01711671|Growth Substances|growth substances|mesh-ancestor
14987802|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
14987803|NCT01711697|Paclitaxel|paclitaxel|mesh-list
14987804|NCT01711697|Carboplatin|carboplatin|mesh-list
14987805|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14987806|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987807|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
14987808|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
14987809|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
14987810|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987811|NCT01711723|Darapladib|darapladib|mesh-list
14987812|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14987813|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987814|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987815|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14987816|NCT01711749|Calcium|calcium|mesh-list
14987817|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14987818|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987819|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14987820|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14987821|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
14987822|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987823|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14987824|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14987825|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987826|NCT01711814|Peficitinib|peficitinib|mesh-list
14987827|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987828|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987829|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14987830|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
14987831|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987832|NCT01711827|Isavuconazole|isavuconazole|mesh-list
14987833|NCT01711827|Prednisone|prednisone|mesh-list
14987834|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987835|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
14987836|NCT01711827|Hormones|hormones|mesh-ancestor
14987837|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14987838|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987839|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14987840|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987841|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
14987842|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987843|NCT01711905|Vitamin D|vitamin d|mesh-list
14987844|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
14987845|NCT01711905|Vitamins|vitamins|mesh-ancestor
14987846|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
14987847|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987848|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14987849|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14987850|NCT01711931|Everolimus|everolimus|mesh-list
14987851|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987852|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14987853|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
14987854|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987855|NCT01711957|Liver Extracts|liver extracts|mesh-list
14987856|NCT01711957|Hematinics|hematinics|mesh-ancestor
14987857|NCT01711970|Paclitaxel|paclitaxel|mesh-list
14987858|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14987859|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987860|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
14987861|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
14987862|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
14987863|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987864|NCT01712100|Irbesartan|irbesartan|mesh-list
14987865|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14987866|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14987867|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14987868|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987869|NCT01712113|Irbesartan|irbesartan|mesh-list
14987870|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14987871|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14987872|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14987873|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987874|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14987875|NCT01712126|Irbesartan|irbesartan|mesh-list
14987876|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14987877|NCT01712126|Diuretics|diuretics|mesh-ancestor
14987878|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
14987879|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987880|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14987881|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987882|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987883|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14987884|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14987885|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14987886|NCT01712139|Irbesartan|irbesartan|mesh-list
14987887|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14987888|NCT01712139|Diuretics|diuretics|mesh-ancestor
14987889|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
14987890|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035331|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14987891|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14987892|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987893|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987894|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14987895|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15030915|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030916|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15030917|NCT01971242|Incretins|incretins|mesh-ancestor
15030918|NCT01971242|Hormones|hormones|mesh-ancestor
15030919|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030920|NCT01971268|Cimetidine|cimetidine|mesh-list
15030921|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15030922|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15030923|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15030924|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
15030925|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
15030926|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15030927|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030928|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030929|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15030930|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15030931|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030932|NCT01971281|Gemcitabine|gemcitabine|mesh-list
15030933|NCT01971281|Paclitaxel|paclitaxel|mesh-list
15030934|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15030935|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030936|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
15030937|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
15030938|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
15030939|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030940|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15030941|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
15030942|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
15030943|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030944|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030945|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030946|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
15030947|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030948|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
15030949|NCT01971411|Vitamin D|vitamin d|mesh-list
15030950|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
15030951|NCT01971411|Vitamins|vitamins|mesh-list
15030952|NCT01971411|Calcium|calcium|mesh-list
15030953|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
15030954|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030955|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15030956|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15030957|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
15030958|NCT01971424|Antacids|antacids|mesh-ancestor
15030959|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030960|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15030961|NCT01971450|Iloprost|iloprost|mesh-list
15030962|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15030963|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
15030964|NCT01971489|Gemcitabine|gemcitabine|mesh-list
15030965|NCT01971489|Cisplatin|cisplatin|mesh-list
15030966|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030967|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15030968|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
15030969|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030970|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
15030971|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15030972|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030973|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15030974|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
15030975|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15030976|NCT01971515|Tamoxifen|tamoxifen|mesh-list
15030977|NCT01971515|Trastuzumab|trastuzumab|mesh-list
15030978|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15030979|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15030980|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15030981|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
15030982|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15030983|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987896|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
14987897|NCT01712295|Salicylates|salicylates|mesh-list
14987898|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14987899|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14987900|NCT01712295|Analgesics|analgesics|mesh-ancestor
14987901|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
14987902|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987903|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987904|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14987905|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14987906|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14987907|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14987908|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987909|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987910|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
14987911|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
14987912|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
14987913|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14987914|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
14987915|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14987916|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14987917|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14987918|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14987919|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987920|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987921|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
14987922|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987923|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14987924|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14987925|NCT01712347|Bevacizumab|bevacizumab|mesh-list
14987926|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14987927|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987928|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14987929|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14987930|NCT01712347|Growth Substances|growth substances|mesh-ancestor
14987931|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987932|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
14987933|NCT01712464|Oxytocin|oxytocin|mesh-list
14987934|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
14987935|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14987936|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987937|NCT01712477|Midazolam|midazolam|mesh-list
14987938|NCT01712477|Propofol|propofol|mesh-list
14987939|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14987940|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987941|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987942|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14987943|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
14987944|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
14987945|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14987946|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14987947|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14987948|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14987949|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
14987950|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
14987951|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987952|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987953|NCT01712568|Ropinirole|ropinirole|mesh-list
14987954|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14987955|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14987956|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
14987957|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
14987958|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987959|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14987960|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987961|NCT01712646|Oxytocin|oxytocin|mesh-list
14987962|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
14987963|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14987964|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987965|NCT01712815|Clevudine|clevudine|mesh-list
14987966|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
14987967|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987968|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
14987969|NCT01712828|Promethazine|promethazine|mesh-list
14987970|NCT01712828|Sirolimus|sirolimus|mesh-list
14987971|NCT01712828|Quinidine|quinidine|mesh-list
14987972|NCT01712828|Lenalidomide|lenalidomide|mesh-list
14987973|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
14987974|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14987975|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14987976|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14987977|NCT01712828|Growth Substances|growth substances|mesh-ancestor
14987978|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
14987979|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14987980|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14987981|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14987982|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14987983|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
14987984|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14987985|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14987986|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14987987|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14987988|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
14987989|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
14987990|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
14987991|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14987992|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
14987993|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
14987994|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14987995|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14987996|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
14987997|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
14987998|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14987999|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988000|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14988001|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
14988002|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
14988003|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14988004|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14988005|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
14988006|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988007|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
14988008|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14988009|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14988010|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988011|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14988012|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14988013|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
14988014|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14988015|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14988016|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988017|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14988018|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14988019|NCT01712893|Goserelin|goserelin|mesh-list
14988020|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14988021|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988022|NCT01712919|Paclitaxel|paclitaxel|mesh-list
14988023|NCT01712919|Cetuximab|cetuximab|mesh-list
14988024|NCT01712919|Nedaplatin|nedaplatin|mesh-list
14988025|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14988026|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988027|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
14988028|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
14988029|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
14988030|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988031|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14988032|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
14988033|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14988034|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988035|NCT01712997|Bosentan|bosentan|mesh-list
14988036|NCT01712997|Iloprost|iloprost|mesh-list
14988037|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14988038|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14988039|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988040|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14988041|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
14988042|NCT01713049|Alovudine|alovudine|mesh-list
14988043|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
14988044|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988045|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
14988046|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
14988047|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
14988048|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14988049|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988050|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
14988051|NCT01713101|Coagulants|coagulants|mesh-ancestor
14988052|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
14988053|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14988054|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14988055|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988056|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14988057|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14988058|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988059|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988060|NCT01713127|Remifentanil|remifentanil|mesh-list
14988061|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14988062|NCT01713127|Narcotics|narcotics|mesh-ancestor
14988063|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988064|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988065|NCT01713127|Analgesics|analgesics|mesh-ancestor
14988066|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
14988067|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988068|NCT01713153|Misoprostol|misoprostol|mesh-list
14988069|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14988070|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
14988071|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14988072|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988073|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14988074|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988075|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
14988076|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
14988077|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14988078|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14988079|NCT01713179|Ambroxol|ambroxol|mesh-list
14988080|NCT01713179|Expectorants|expectorants|mesh-ancestor
14988081|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
14988082|NCT01713218|Gemcitabine|gemcitabine|mesh-list
14988083|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14988084|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
14988085|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988086|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988087|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
14988088|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988089|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988090|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988091|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
14988092|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988093|NCT01713231|Vitamin D|vitamin d|mesh-list
14988094|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
14988095|NCT01713231|Vitamins|vitamins|mesh-list
14988096|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
14988097|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988098|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14988099|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14988100|NCT01713309|Lenograstim|lenograstim|mesh-list
14988101|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14988102|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
14988103|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988104|NCT01713361|Enoxaparin|enoxaparin|mesh-list
14988105|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
14988106|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14988107|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14988108|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988109|NCT01713387|Gemcitabine|gemcitabine|mesh-list
14988110|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14988111|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
14988112|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988113|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988114|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
14988115|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988116|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988117|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988118|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
14988119|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988120|NCT01713426|Pregabalin|pregabalin|mesh-list
14988121|NCT01713426|Capsaicin|capsaicin|mesh-list
14988122|NCT01713426|Analgesics|analgesics|mesh-ancestor
14988123|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
14988124|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988125|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988126|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
14988127|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14988128|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988129|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988130|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14988131|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14988132|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14988133|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988134|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14988135|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
14988136|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
14988137|NCT01713556|Propranolol|propranolol|mesh-list
14988138|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14988139|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14988140|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
14988141|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988142|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988143|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988144|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988145|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14988146|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
14988147|NCT01713647|Losartan|losartan|mesh-list
14988148|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988149|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14988150|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14988151|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14988152|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988153|NCT01713725|Omalizumab|omalizumab|mesh-list
14988154|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14988155|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14988156|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
14988157|NCT01713738|Rituximab|rituximab|mesh-list
14988158|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14988159|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988160|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
14988161|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988162|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988163|NCT01713777|Lamotrigine|lamotrigine|mesh-list
14988164|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
14988165|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14988166|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988167|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988168|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14988169|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988170|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14988171|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14988172|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988173|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801233|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14801234|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14801235|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
14801236|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988174|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14988175|NCT01713803|Buprenorphine|buprenorphine|mesh-list
14988176|NCT01713803|Naloxone|naloxone|mesh-list
14988177|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14988178|NCT01713803|Narcotics|narcotics|mesh-ancestor
14988179|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988180|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988181|NCT01713803|Analgesics|analgesics|mesh-ancestor
14988182|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
14988183|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988184|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14988185|NCT01713920|Amlodipine|amlodipine|mesh-list
14988186|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14988187|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14988188|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14801237|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14801238|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14801239|NCT00791544|Sorafenib|sorafenib|mesh-list
14801240|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801241|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14801242|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801243|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801244|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801245|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801246|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14988189|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988190|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14988191|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988192|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
14988193|NCT01713972|Dabrafenib|dabrafenib|mesh-list
14988194|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988195|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14988196|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988197|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030984|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15030985|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15030986|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15030987|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15030988|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15030989|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15030990|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15030991|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
15030992|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15030993|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15030994|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15030995|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15030996|NCT01971632|Oxycodone|oxycodone|mesh-list
15030997|NCT01971632|Naloxone|naloxone|mesh-list
15030998|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15030999|NCT01971632|Narcotics|narcotics|mesh-ancestor
15031000|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031001|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031002|NCT01971632|Analgesics|analgesics|mesh-ancestor
15031003|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
15031004|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031005|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15031006|NCT01971658|Thalidomide|thalidomide|mesh-list
15031007|NCT01971658|Dexamethasone|dexamethasone|mesh-list
15031008|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
15031009|NCT01971658|Bortezomib|bortezomib|mesh-list
15031010|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031011|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
15031012|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031013|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031014|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15031015|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
15031016|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031017|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031018|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15031019|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031020|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
15031021|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
15031022|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031023|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031024|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
15031025|NCT01971658|Hormones|hormones|mesh-ancestor
15031026|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031027|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031028|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
15031029|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15031030|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031031|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15031032|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15031033|NCT01971658|Growth Substances|growth substances|mesh-ancestor
15031034|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
15031035|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
15031036|NCT01971684|Sirolimus|sirolimus|mesh-list
15031037|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
15031038|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031039|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
15031040|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031041|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15031042|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15031043|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
15031044|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15031045|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031046|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031047|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031048|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
14988198|NCT01714011|Aripiprazole|aripiprazole|mesh-list
14988199|NCT01714011|Ziprasidone|ziprasidone|mesh-list
14988200|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
14988201|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14988202|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14988203|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14988204|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988205|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988206|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
14988207|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
14988208|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988209|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988210|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14988211|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14988212|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
14988213|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14988214|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14988215|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14988216|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14988217|NCT01714037|Gemcitabine|gemcitabine|mesh-list
14988218|NCT01714037|Docetaxel|docetaxel|mesh-list
14988219|NCT01714037|Pemetrexed|pemetrexed|mesh-list
14988220|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988221|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14988222|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
14988223|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988224|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
14988225|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988226|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988227|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988228|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
14988229|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988230|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
14988231|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
14988232|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
14988233|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14988234|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14988235|NCT01714089|Interferons|interferons|mesh-list
14988236|NCT01714089|Interferon-beta|interferon-beta|mesh-list
14988237|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
14988238|NCT01714089|RNS60|rns60|mesh-list
14988239|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988240|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
14988241|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988242|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
14988243|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988244|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14988245|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14988246|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14988247|NCT01714089|Analgesics|analgesics|mesh-ancestor
14988248|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
14988249|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988250|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14988251|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988252|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14988253|NCT01714102|Resveratrol|resveratrol|mesh-list
14988254|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
14988255|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988256|NCT01714102|Protective Agents|protective agents|mesh-ancestor
14988257|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988258|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988259|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14988260|NCT01714115|Aflibercept|aflibercept|mesh-list
14988261|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14988262|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14988263|NCT01714115|Growth Substances|growth substances|mesh-ancestor
14988264|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988265|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
14988266|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988267|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14988268|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14988269|NCT01714128|Estradiol|estradiol|mesh-list
14988270|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14988271|NCT01714128|Estrogens|estrogens|mesh-ancestor
14988272|NCT01714128|Hormones|hormones|mesh-ancestor
14988273|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988274|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988275|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14988276|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
14988277|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14988278|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14988279|NCT01714154|Ritonavir|ritonavir|mesh-list
14988280|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14988281|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14988282|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
14988283|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988284|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988285|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14988286|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14988287|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
14988288|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988289|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14988290|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14988291|NCT01714193|Canagliflozin|canagliflozin|mesh-list
14988292|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
14988293|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
14988294|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14988295|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988296|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14988297|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988298|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14988299|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14988300|NCT01714206|Canagliflozin|canagliflozin|mesh-list
14988301|NCT01714206|Digoxin|digoxin|mesh-list
14988302|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988303|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14988304|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988305|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988306|NCT01714206|Protective Agents|protective agents|mesh-ancestor
14988307|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988308|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14988309|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14988310|NCT01714297|Dalteparin|dalteparin|mesh-list
14988311|NCT01714297|Tinzaparin|tinzaparin|mesh-list
14988312|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14988313|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
14988314|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14988315|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14988316|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988317|NCT01714388|Remifentanil|remifentanil|mesh-list
14988318|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14988319|NCT01714388|Narcotics|narcotics|mesh-ancestor
14988320|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988321|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988322|NCT01714388|Analgesics|analgesics|mesh-ancestor
14988323|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
14988324|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988325|NCT01714401|Albuterol|albuterol|mesh-list
14988326|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14988327|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
14988328|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988329|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988330|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14988331|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
14988332|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
14988333|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14988334|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14988335|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14988336|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14988337|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
14988338|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988339|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988340|NCT01714414|Lamivudine|lamivudine|mesh-list
14988341|NCT01714414|Zidovudine|zidovudine|mesh-list
14988342|NCT01714414|Efavirenz|efavirenz|mesh-list
14988343|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14988344|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14988345|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801247|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801248|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801249|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14988346|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988347|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
14988348|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988349|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14988350|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14988351|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
14988352|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14988353|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14988354|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14988355|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14988356|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14988357|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14801250|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801251|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801252|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
14988358|NCT01714427|Dexamethasone|dexamethasone|mesh-list
14988359|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14988360|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
14988361|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
14988362|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988363|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988364|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988365|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
14988366|NCT01714427|Hormones|hormones|mesh-ancestor
14988367|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988368|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14988369|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988370|NCT01714557|Tazobactam|tazobactam|mesh-list
14988371|NCT01714557|Piperacillin|piperacillin|mesh-list
14988372|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14988373|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14988374|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988375|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14988376|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988377|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988378|NCT01714570|Tazobactam|tazobactam|mesh-list
14988379|NCT01714570|Piperacillin|piperacillin|mesh-list
14988380|NCT01714570|Imipenem|imipenem|mesh-list
14988381|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14988382|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14988383|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988384|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14988385|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988386|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988387|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14988388|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988389|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14988390|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
14988391|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14988392|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
14988393|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14988394|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988395|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14988396|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14988397|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988398|NCT01714765|Everolimus|everolimus|mesh-list
14988399|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988400|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988401|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
14988402|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988403|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
14988404|NCT01714817|Prednisone|prednisone|mesh-list
14988405|NCT01714817|Abatacept|abatacept|mesh-list
14988406|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14988407|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
14988408|NCT01714817|Hormones|hormones|mesh-ancestor
15035332|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14801253|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801254|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801255|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801256|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14988409|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988410|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988411|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14988412|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988413|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14988414|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14988415|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
14988416|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14988417|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988418|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988419|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988420|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14988421|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988422|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
14988423|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988424|NCT01714843|Linaclotide|linaclotide|mesh-list
14988425|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
14988426|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
14988427|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988428|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988429|NCT01714856|Ropinirole|ropinirole|mesh-list
14988430|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14988431|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14988432|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
14988433|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
14988434|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988435|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988436|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988437|NCT01714895|Insulin|insulin|mesh-list
14988438|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14988439|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14988440|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988441|NCT01714908|Etoposide|etoposide|mesh-list
14988442|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14988443|NCT01714908|Cisplatin|cisplatin|mesh-list
14988444|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14988445|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988446|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14988447|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14988448|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988449|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988450|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14988451|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14988452|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14988453|NCT01715077|Ipilimumab|ipilimumab|mesh-list
14988454|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14988455|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988456|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14988457|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988458|NCT01715090|Insulin|insulin|mesh-list
14988459|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14988460|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988461|NCT01715142|Gemcitabine|gemcitabine|mesh-list
14988462|NCT01715142|Paclitaxel|paclitaxel|mesh-list
14988463|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14988464|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14988465|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988466|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
14988467|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
14988468|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
14988469|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988470|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14988471|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
14988472|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
14988473|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988474|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988475|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988476|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
14988477|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988478|NCT01715168|Doxorubicin|doxorubicin|mesh-list
14988479|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14988480|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14988481|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988482|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14988483|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14988484|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988485|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988486|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
14988487|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
14988488|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
14988489|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988490|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14988491|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988492|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988493|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
14988494|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988495|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988496|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14988497|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
14988498|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14988499|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
14988500|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988501|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988502|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14988503|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
14988504|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
14988505|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14988506|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
14988507|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988508|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988509|NCT01715363|Leucovorin|leucovorin|mesh-list
14988510|NCT01715363|Folic Acid|folic acid|mesh-list
14988511|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
14988512|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
14988513|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988514|NCT01715363|Antidotes|antidotes|mesh-ancestor
14988515|NCT01715363|Protective Agents|protective agents|mesh-ancestor
14988516|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988517|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
14988518|NCT01715363|Vitamins|vitamins|mesh-ancestor
14988519|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
14988520|NCT01715363|Hematinics|hematinics|mesh-ancestor
14988521|NCT01715441|Irinotecan|irinotecan|mesh-list
14988522|NCT01715441|Sorafenib|sorafenib|mesh-list
14988523|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14988524|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14988525|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988526|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988527|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988528|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14988529|NCT01715493|Muramidase|muramidase|mesh-list
14988530|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988531|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
14988532|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
14988533|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14988534|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14988535|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14988536|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988537|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988538|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988539|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
14988540|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988541|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14988542|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14988543|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
14988544|NCT01715584|Sevoflurane|sevoflurane|mesh-list
14988545|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14988546|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14988547|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
14988548|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
14988549|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988550|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988551|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14988552|NCT01715584|Analgesics|analgesics|mesh-ancestor
14988553|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
14801257|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
14801258|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801259|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801260|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801261|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801262|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801263|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801264|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14801265|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801266|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
14801267|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988554|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988555|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
14988556|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
14988557|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988558|NCT01715597|Protective Agents|protective agents|mesh-ancestor
14988559|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988560|NCT01715597|Vitamins|vitamins|mesh-ancestor
14988561|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
14988562|NCT01715610|Clindamycin|clindamycin|mesh-list
14988563|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
14988564|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
14988565|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14988566|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14988567|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988568|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14988569|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988570|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988571|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14988572|NCT01715636|Tenofovir|tenofovir|mesh-list
14988573|NCT01715636|Emtricitabine|emtricitabine|mesh-list
14988574|NCT01715636|Rilpivirine|rilpivirine|mesh-list
14988575|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
14988576|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988577|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14988578|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14988579|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988580|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988581|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14988582|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14988583|NCT01715688|Lidocaine|lidocaine|mesh-list
14988584|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
14988585|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
14988586|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988587|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988588|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
14988589|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988590|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988591|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14988592|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14988593|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988594|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031049|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031050|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
15031051|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15031052|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15031053|NCT01971801|Vitamin D|vitamin d|mesh-list
15031054|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
15031055|NCT01971801|Vitamins|vitamins|mesh-ancestor
15031056|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
15031057|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031058|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15031059|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15031060|NCT01971814|Infliximab|infliximab|mesh-list
15031061|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
15031062|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031063|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031064|NCT01971918|Antibodies|antibodies|mesh-list
15031065|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
15031066|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031067|NCT01972113|Vitamins|vitamins|mesh-list
15031068|NCT01972113|Vitamin K|vitamin k|mesh-list
15031069|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
15031070|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
15031071|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
15031072|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031073|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15031074|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15031075|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031076|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
15031077|NCT01972113|Coagulants|coagulants|mesh-ancestor
15031078|NCT01972230|Remifentanil|remifentanil|mesh-list
15031079|NCT01972230|Sevoflurane|sevoflurane|mesh-list
15031080|NCT01972230|Propofol|propofol|mesh-list
15031081|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15031082|NCT01972230|Narcotics|narcotics|mesh-ancestor
15031083|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031084|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031085|NCT01972230|Analgesics|analgesics|mesh-ancestor
15031086|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
14988595|NCT01715701|Iodine|iodine|mesh-list
14988596|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14988597|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988598|NCT01715701|Trace Elements|trace elements|mesh-ancestor
14988599|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
14988600|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988601|NCT01715714|Atorvastatin|atorvastatin|mesh-list
14988602|NCT01715714|Simvastatin|simvastatin|mesh-list
14988603|NCT01715714|Pravastatin|pravastatin|mesh-list
14988604|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14988605|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14988606|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
14988607|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988608|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14988609|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14988610|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988611|NCT01715909|Oseltamivir|oseltamivir|mesh-list
14988612|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
14988613|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988614|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988615|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988616|NCT01715922|Fluconazole|fluconazole|mesh-list
14988617|NCT01715922|Flucytosine|flucytosine|mesh-list
14988618|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
14988619|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988620|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14988621|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14988622|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988623|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988624|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14988625|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
14988626|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988627|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988628|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14988629|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14988630|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
14988631|NCT01715935|Everolimus|everolimus|mesh-list
14988632|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988633|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988634|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
14988635|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988636|NCT01715974|Lenograstim|lenograstim|mesh-list
14988637|NCT01715974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14988638|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
14988639|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988640|NCT01715987|Tenofovir|tenofovir|mesh-list
14988641|NCT01715987|Entecavir|entecavir|mesh-list
14988642|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
14988643|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988644|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14988645|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14988646|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988647|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988648|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14988649|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14988650|NCT01716260|Chloroquine|chloroquine|mesh-list
14988651|NCT01716260|Primaquine|primaquine|mesh-list
14988652|NCT01716260|Amebicides|amebicides|mesh-ancestor
14988653|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14988654|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14988655|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988656|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
14988657|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988658|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14988659|NCT01716273|Laxatives|laxatives|mesh-ancestor
14988660|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988661|NCT01716338|Glyburide|glyburide|mesh-list
14801268|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801269|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801270|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801271|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
14801272|NCT00791739|Pregabalin|pregabalin|mesh-list
14801273|NCT00791739|Trazodone|trazodone|mesh-list
14801274|NCT00791739|Analgesics|analgesics|mesh-ancestor
14801275|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
14801276|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988662|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14988663|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988664|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14988665|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14988666|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14988667|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988668|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988669|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988670|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988671|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14988672|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
14988673|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14988674|NCT01716416|Cetuximab|cetuximab|mesh-list
14988675|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14988676|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988677|NCT01716442|Rituximab|rituximab|mesh-list
14988678|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14988679|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988680|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
14988681|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988682|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988683|NCT01716572|Erythromycin|erythromycin|mesh-list
14988684|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
14988685|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14988686|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
14988687|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14988688|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988689|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988690|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14988691|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988692|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988693|NCT01716611|Tolvaptan|tolvaptan|mesh-list
14988694|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14988695|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988696|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
14988697|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988698|NCT01716624|Oxybutynin|oxybutynin|mesh-list
14988699|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
14988700|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14988701|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14988702|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14988703|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988704|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988705|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
14988706|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988707|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988708|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14988709|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988710|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
14988711|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
14988712|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14988713|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14988714|NCT01716624|Urological Agents|urological agents|mesh-ancestor
14988715|NCT01716637|Etanercept|etanercept|mesh-list
14988716|NCT01716637|Curcumin|curcumin|mesh-list
14988717|NCT01716637|Resveratrol|resveratrol|mesh-list
14988718|NCT01716637|Quercetin|quercetin|mesh-list
14988719|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14988720|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14988721|NCT01716637|Analgesics|analgesics|mesh-ancestor
14988722|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
14523440|NCT03593902|Fludarabine|fludarabine|mesh-list
14523441|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
14523442|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14523443|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14523444|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
14523445|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14523446|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
14523447|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523448|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523449|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14523450|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
14523451|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523452|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988723|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988724|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988725|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14988726|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988727|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988728|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988729|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
14988730|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988731|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988732|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988733|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
14988734|NCT01716637|Protective Agents|protective agents|mesh-ancestor
14988735|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14988736|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
14988737|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988738|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
14988739|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988740|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988741|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14988742|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
14988743|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988744|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988745|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14988746|NCT01716767|Analgesics|analgesics|mesh-list
14988747|NCT01716767|Menthol|menthol|mesh-list
14988748|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
14988749|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988750|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988751|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
14988752|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
14988753|NCT01716858|Sulforaphane|sulforaphane|mesh-list
14988754|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14988755|NCT01716858|Protective Agents|protective agents|mesh-ancestor
14988756|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988757|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988758|NCT01716949|Fluorouracil|fluorouracil|mesh-list
14988759|NCT01716949|Capecitabine|capecitabine|mesh-list
14988760|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
14988761|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
14988762|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988763|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14988764|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988765|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988766|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
14988767|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988768|NCT01717027|Oxycodone|oxycodone|mesh-list
14988769|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14988770|NCT01717027|Narcotics|narcotics|mesh-ancestor
14988771|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988772|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988773|NCT01717027|Analgesics|analgesics|mesh-ancestor
14988774|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
14988775|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988776|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
14988777|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14988778|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988779|NCT01717118|Vaccines|vaccines|mesh-list
14988780|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
14988781|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988782|NCT01717157|Fentanyl|fentanyl|mesh-list
14988783|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14988784|NCT01717157|Narcotics|narcotics|mesh-ancestor
14988785|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988786|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988787|NCT01717157|Analgesics|analgesics|mesh-ancestor
14988788|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
14988789|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988790|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14988791|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14988792|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
14988793|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
14988794|NCT01717222|Lidocaine|lidocaine|mesh-list
14988795|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
14988796|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
14988797|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988798|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988799|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
14988800|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988801|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988802|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14988803|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14988804|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988805|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988806|NCT01717235|Ropinirole|ropinirole|mesh-list
14988807|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14988808|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14988809|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
14988810|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
14988811|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988812|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988813|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988814|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
14988815|NCT01717300|Anacetrapib|anacetrapib|mesh-list
14988816|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14988817|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14988818|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
14988819|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988820|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14988821|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988822|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14988823|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988824|NCT01717404|Mexiletine|mexiletine|mesh-list
14988825|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988826|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14988827|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14988828|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988829|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031087|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031088|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15031089|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15031090|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
15031091|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
15031092|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15031093|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15031094|NCT01972269|Lidocaine|lidocaine|mesh-list
15031095|NCT01972269|Fentanyl|fentanyl|mesh-list
15031096|NCT01972269|Bupivacaine|bupivacaine|mesh-list
15031097|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
15031098|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
15031099|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031100|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031101|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
15031102|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031103|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15031104|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15031105|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15031106|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031107|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031108|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15031109|NCT01972269|Narcotics|narcotics|mesh-ancestor
15031110|NCT01972269|Analgesics|analgesics|mesh-ancestor
15031111|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15031112|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15031113|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
15031114|NCT01972347|Trametinib|trametinib|mesh-list
15031115|NCT01972347|Dabrafenib|dabrafenib|mesh-list
15031116|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031117|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15031118|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031119|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031120|NCT01972373|Bevacizumab|bevacizumab|mesh-list
15031121|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15031122|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031123|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15031124|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15031125|NCT01972373|Growth Substances|growth substances|mesh-ancestor
15031126|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031127|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
15035333|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035334|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
14988830|NCT01717599|Diclofenac|diclofenac|mesh-list
14988831|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14988832|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14988833|NCT01717599|Analgesics|analgesics|mesh-ancestor
14988834|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
14988835|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988836|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988837|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14988838|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988839|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14988840|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988841|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988842|NCT01717612|Thrombin|thrombin|mesh-list
14988843|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
14988844|NCT01717612|Coagulants|coagulants|mesh-ancestor
14988845|NCT01717625|Montelukast|montelukast|mesh-list
14988846|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14988847|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
14988848|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14988849|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
14988850|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988851|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988852|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14988853|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14988854|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988855|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
14988856|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14988857|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14988858|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988859|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
14988860|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
14988861|NCT01717729|Iodine|iodine|mesh-list
14988862|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14988863|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988864|NCT01717729|Trace Elements|trace elements|mesh-ancestor
14988865|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
14988866|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988867|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14988868|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988869|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14988870|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988871|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988872|NCT01717846|Abatacept|abatacept|mesh-list
14988873|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14988874|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988875|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988876|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14988877|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
14988878|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988879|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988880|NCT01717911|Metformin|metformin|mesh-list
14988881|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14988882|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
14988883|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14988884|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988885|NCT01717911|Incretins|incretins|mesh-ancestor
14988886|NCT01717911|Hormones|hormones|mesh-ancestor
14988887|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988888|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14988889|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
14988890|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988891|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988892|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14988893|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14988894|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
14988895|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988896|NCT01717950|Antacids|antacids|mesh-ancestor
14988897|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988898|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988899|NCT01717963|Naltrexone|naltrexone|mesh-list
14988900|NCT01717963|Buprenorphine|buprenorphine|mesh-list
14988901|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14988902|NCT01717963|Naloxone|naloxone|mesh-list
14988903|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14988904|NCT01717963|Narcotics|narcotics|mesh-ancestor
14988905|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988906|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988907|NCT01717963|Analgesics|analgesics|mesh-ancestor
14988908|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
14988909|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988910|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14988911|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14988912|NCT01718054|Chloroquine|chloroquine|mesh-list
14988913|NCT01718054|Amebicides|amebicides|mesh-ancestor
14988914|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14988915|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14988916|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988917|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
14988918|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988919|NCT01718093|Metformin|metformin|mesh-list
14988920|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14988921|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14988922|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988923|NCT01718093|Incretins|incretins|mesh-ancestor
14988924|NCT01718093|Hormones|hormones|mesh-ancestor
14988925|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14988926|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14988927|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
14988928|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988929|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988930|NCT01718223|Temoporfin|temoporfin|mesh-list
14988931|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988932|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14988933|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
14988934|NCT01718236|Rocuronium|rocuronium|mesh-list
14988935|NCT01718236|Succinylcholine|succinylcholine|mesh-list
14988936|NCT01718236|Neostigmine|neostigmine|mesh-list
14988937|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14988938|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14988939|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14988940|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988941|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988942|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14988943|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988944|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988945|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
14988946|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14988947|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14988948|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
14988949|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14988950|NCT01718288|Aspirin|aspirin|mesh-list
14988951|NCT01718288|Iloprost|iloprost|mesh-list
14988952|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14988953|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14988954|NCT01718288|Analgesics|analgesics|mesh-ancestor
14988955|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
14988956|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988957|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14988958|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14988959|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14988960|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14988961|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14988962|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988963|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14988964|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14988965|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14988966|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
14988967|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
14988968|NCT01718301|Ribavirin|ribavirin|mesh-list
14988969|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14988970|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14988971|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
14988972|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988973|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
14988974|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14988975|NCT01718314|Lidocaine|lidocaine|mesh-list
14988976|NCT01718314|Misoprostol|misoprostol|mesh-list
14988977|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
14988978|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
14988979|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14988980|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801277|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801278|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
14988981|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
14988982|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14988983|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14988984|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14988985|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14988986|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14988987|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14988988|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14988989|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
14988990|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14988991|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14988992|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14988993|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
14988994|NCT01718327|Sunitinib|sunitinib|mesh-list
14988995|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14988996|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14988997|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14988998|NCT01718327|Growth Substances|growth substances|mesh-ancestor
14988999|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989000|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
14989001|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14989002|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989003|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989004|NCT01718340|Metformin|metformin|mesh-list
14989005|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989006|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801279|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14801280|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14801281|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801282|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14801283|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14989007|NCT01718366|Vitamin D|vitamin d|mesh-list
14989008|NCT01718366|Azacitidine|azacitidine|mesh-list
14989009|NCT01718366|Deferasirox|deferasirox|mesh-list
14989010|NCT01718366|Vitamins|vitamins|mesh-ancestor
14989011|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
14989012|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989013|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14989014|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14989015|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
14989016|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989017|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989018|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989019|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14989020|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
14989021|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
14989022|NCT01718379|Lenalidomide|lenalidomide|mesh-list
14989023|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
14989024|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989025|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989026|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14989027|NCT01718379|Growth Substances|growth substances|mesh-ancestor
14989028|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
14989029|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989030|NCT01718496|Morphine|morphine|mesh-list
14989031|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989032|NCT01718496|Narcotics|narcotics|mesh-ancestor
14989033|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989034|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989035|NCT01718496|Analgesics|analgesics|mesh-ancestor
14989036|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
14989037|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989038|NCT01718587|Lamivudine|lamivudine|mesh-list
14989039|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
14989040|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14989041|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14989042|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989043|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989044|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989045|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14989046|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14989047|NCT01718613|Vasopressins|vasopressins|mesh-list
14989048|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
14989049|NCT01718613|Norepinephrine|norepinephrine|mesh-list
14989050|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14989051|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14989052|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989053|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989054|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989055|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989056|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
14989057|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
14989058|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989059|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14989060|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
14989061|NCT01718613|Coagulants|coagulants|mesh-ancestor
14989062|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14989063|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
14989064|NCT01718626|Docetaxel|docetaxel|mesh-list
14989065|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989066|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
14989067|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
14989068|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
14989069|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989070|NCT01718652|Canagliflozin|canagliflozin|mesh-list
14989071|NCT01718652|Cyclosporine|cyclosporine|mesh-list
14989072|NCT01718652|Cyclosporins|cyclosporins|mesh-list
14989073|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989074|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989075|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14989076|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
14989077|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989078|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
14989079|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989080|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
14989081|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989082|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14989083|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14989084|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989085|NCT01718678|Melatonin|melatonin|mesh-list
14989086|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
14989087|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989088|NCT01718678|Protective Agents|protective agents|mesh-ancestor
14989089|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989090|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989091|NCT01718717|Morphine|morphine|mesh-list
14989092|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989093|NCT01718717|Narcotics|narcotics|mesh-ancestor
14989094|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989095|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989096|NCT01718717|Analgesics|analgesics|mesh-ancestor
14989097|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
14989098|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989099|NCT01718808|Capecitabine|capecitabine|mesh-list
14989100|NCT01718808|Cetuximab|cetuximab|mesh-list
14989101|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14989102|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
14989103|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989104|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989105|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14989106|NCT01718834|Vaccines|vaccines|mesh-list
14989107|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
14989108|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989109|NCT01718873|Leucovorin|leucovorin|mesh-list
14989110|NCT01718873|Folic Acid|folic acid|mesh-list
14989111|NCT01718873|Bevacizumab|bevacizumab|mesh-list
14989112|NCT01718873|Fluorouracil|fluorouracil|mesh-list
14989113|NCT01718873|Capecitabine|capecitabine|mesh-list
14989114|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
14989115|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
14989116|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14989117|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523453|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14523454|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523455|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989118|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989119|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14989120|NCT01718873|Growth Substances|growth substances|mesh-ancestor
14989121|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989122|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
14989123|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
14989124|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989125|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14989126|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14989127|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
14989128|NCT01718873|Antidotes|antidotes|mesh-ancestor
14989129|NCT01718873|Protective Agents|protective agents|mesh-ancestor
14989130|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
14989131|NCT01718873|Vitamins|vitamins|mesh-ancestor
14989132|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
14989133|NCT01718873|Hematinics|hematinics|mesh-ancestor
14989134|NCT01718899|Lenalidomide|lenalidomide|mesh-list
14989135|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
14989136|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989137|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989138|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14989139|NCT01718899|Growth Substances|growth substances|mesh-ancestor
14989140|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
14989141|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989142|NCT01718912|Metronidazole|metronidazole|mesh-list
14989143|NCT01718912|Nystatin|nystatin|mesh-list
14989144|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989145|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989146|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14989147|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14523456|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
14523457|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
14523458|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989148|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
14989149|NCT01718912|Ionophores|ionophores|mesh-ancestor
14989150|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14989151|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989152|NCT01718951|Pamidronate|pamidronate|mesh-list
14989153|NCT01718951|Golimumab|golimumab|mesh-list
14989154|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14989155|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989156|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14989157|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
14989158|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989159|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14989160|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
14989161|NCT01718964|Mannitol|mannitol|mesh-list
14989162|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14989163|NCT01718964|Diuretics|diuretics|mesh-ancestor
14989164|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
14989165|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989166|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989167|NCT01719016|Adenosine|adenosine|mesh-list
14989168|NCT01719016|Analgesics|analgesics|mesh-ancestor
14989169|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
14989170|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989171|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989172|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14989173|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989174|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14989175|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
14989176|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
14989177|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989178|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989179|NCT01719042|Ondansetron|ondansetron|mesh-list
14989180|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
14989181|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
14989182|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989183|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989184|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14989185|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
14989186|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
14989187|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14989188|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
14989189|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989190|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989191|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14989192|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14989193|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989194|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14989195|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15031128|NCT01972490|Bevacizumab|bevacizumab|mesh-list
15031129|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15031130|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031131|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15031132|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15031133|NCT01972490|Growth Substances|growth substances|mesh-ancestor
15031134|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031135|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
15031136|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
15031137|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031138|NCT01972620|Bupivacaine|bupivacaine|mesh-list
15031139|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
15031140|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
15031141|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031142|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031143|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
15031144|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031145|NCT01972711|Amisulpride|amisulpride|mesh-list
15031146|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15031147|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15031148|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031149|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031150|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15031151|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15031152|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
15031153|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031154|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031155|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15031156|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
15031157|NCT01972763|Ranibizumab|ranibizumab|mesh-list
15031158|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989196|NCT01719133|Histamine|histamine|mesh-list
14989197|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
14989198|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
14989199|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
14989200|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989201|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989202|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989203|NCT01719159|Rituximab|rituximab|mesh-list
14989204|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14989205|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989206|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
14989207|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989208|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989209|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
14989210|NCT01719185|Phentermine|phentermine|mesh-list
14989211|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14989212|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989213|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
14989214|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14989215|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
14989216|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
14989217|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989218|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989219|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989220|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989221|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
14989222|NCT01719185|Vitamins|vitamins|mesh-ancestor
14989223|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
14989224|NCT01719237|Ropivacaine|ropivacaine|mesh-list
14989225|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
14989226|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
14989227|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
14989228|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989229|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989230|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
14989231|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989232|NCT01719302|Gemcitabine|gemcitabine|mesh-list
14989233|NCT01719302|Docetaxel|docetaxel|mesh-list
14989234|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14989235|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
14989236|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989237|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989238|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
14989239|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989240|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989241|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14989242|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
14989243|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989244|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
14989245|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
14989246|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
14989247|NCT01719419|Orlistat|orlistat|mesh-list
14989248|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989249|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989250|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14989251|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14989252|NCT01719588|Tapentadol|tapentadol|mesh-list
14989253|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989254|NCT01719588|Narcotics|narcotics|mesh-ancestor
14989255|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989256|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989257|NCT01719588|Analgesics|analgesics|mesh-ancestor
14989258|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
14989259|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989260|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14989261|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14989262|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14989263|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989264|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989265|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989266|NCT01719601|Tapentadol|tapentadol|mesh-list
14989267|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989268|NCT01719601|Narcotics|narcotics|mesh-ancestor
14989269|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989270|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989271|NCT01719601|Analgesics|analgesics|mesh-ancestor
14989272|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
14989273|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989274|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14989275|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14989276|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14989277|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989278|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989279|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989280|NCT01719614|Metformin|metformin|mesh-list
14989281|NCT01719614|Rilpivirine|rilpivirine|mesh-list
14989282|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989283|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989284|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14989285|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14989286|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989287|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989288|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
14989289|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989290|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14989291|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14989292|NCT01719627|Maraviroc|maraviroc|mesh-list
14989293|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14989294|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14989295|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989296|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14989297|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14989298|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
14989299|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989300|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14989301|NCT01719640|Insulin|insulin|mesh-list
14989302|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989303|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989304|NCT01719692|Rituximab|rituximab|mesh-list
14989305|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14989306|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989307|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
14989308|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989309|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989310|NCT01719705|Pregabalin|pregabalin|mesh-list
14989311|NCT01719705|Analgesics|analgesics|mesh-ancestor
14989312|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
14989313|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989314|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989315|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
14989316|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14989317|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14989318|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989319|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14989320|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14989321|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14989322|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989323|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14989324|NCT01719770|Rocuronium|rocuronium|mesh-list
14989325|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14989326|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14989327|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14989328|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989329|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989330|NCT01719835|Gemcitabine|gemcitabine|mesh-list
14989331|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
14989332|NCT01719835|Prednisolone|prednisolone|mesh-list
14989333|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
14989334|NCT01719835|Doxorubicin|doxorubicin|mesh-list
14989335|NCT01719835|Vincristine|vincristine|mesh-list
14989336|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14989337|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
14989338|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989339|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989340|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14989341|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
14989342|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989343|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989344|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14989345|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14989346|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
14989347|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
14989348|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989349|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989350|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14989351|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14989352|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14989353|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14989354|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
14989355|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
14989356|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
14989357|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989358|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
14989359|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
14989360|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989361|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14989362|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
14989363|NCT01719835|Hormones|hormones|mesh-ancestor
14989364|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989365|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14989366|NCT01719835|Protective Agents|protective agents|mesh-ancestor
14989367|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14989368|NCT01719926|Indomethacin|indomethacin|mesh-list
14989369|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14989370|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14989371|NCT01719926|Analgesics|analgesics|mesh-ancestor
14989372|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
14989373|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989374|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989375|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989376|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989377|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
14989378|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
14989379|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14989380|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14989381|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989382|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989383|NCT01719952|Oxytocin|oxytocin|mesh-list
14989384|NCT01719952|Carbetocin|carbetocin|mesh-list
14989385|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
14989386|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14989387|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989388|NCT01719978|Epinephrine|epinephrine|mesh-list
14989389|NCT01719978|Racepinephrine|racepinephrine|mesh-list
14989390|NCT01719978|Mepivacaine|mepivacaine|mesh-list
14989391|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
14989392|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14989393|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14989394|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989395|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989396|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989397|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989398|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14989399|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14989400|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
14989401|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989402|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14989403|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
14989404|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
14989405|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
14989406|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14989407|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
14989408|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
14989409|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989410|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
14989411|NCT01720030|Simendan|simendan|mesh-list
14989412|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14989413|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989414|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14989415|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14989416|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989417|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989418|NCT01720030|Protective Agents|protective agents|mesh-ancestor
14989419|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989420|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14989421|NCT01720056|Verapamil|verapamil|mesh-list
14989422|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989423|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
14989424|NCT01720056|Hormones|hormones|mesh-ancestor
14989425|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989426|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989427|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14989428|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
14989429|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989430|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14989431|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14989432|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14989433|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14989434|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989435|NCT01720095|Niacin|niacin|mesh-list
14989436|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
14989437|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14989438|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
14989439|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989440|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14989441|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989442|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
14989443|NCT01720095|Vitamins|vitamins|mesh-ancestor
14989444|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
14989445|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989446|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
14989447|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14989448|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
14989449|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14989450|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
14989451|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989452|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989453|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
14989454|NCT01720212|Mirabegron|mirabegron|mesh-list
14989455|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14801284|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801285|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801286|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801287|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14801288|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14801289|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801290|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
14801291|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14801292|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
14801293|NCT00791804|Fentanyl|fentanyl|mesh-list
14801294|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14801295|NCT00791804|Narcotics|narcotics|mesh-ancestor
14801296|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989456|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14989457|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14989458|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989459|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989460|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989461|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989462|NCT01720212|Urological Agents|urological agents|mesh-ancestor
14989463|NCT01720238|Lamivudine|lamivudine|mesh-list
14989464|NCT01720238|Adefovir|adefovir|mesh-list
14989465|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14989466|NCT01720238|Entecavir|entecavir|mesh-list
14989467|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14989468|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14989469|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989470|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989471|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
14989472|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989473|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14989474|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14989475|NCT01720290|Metformin|metformin|mesh-list
14989476|NCT01720290|Repaglinide|repaglinide|mesh-list
14989477|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989478|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989479|NCT01720303|Insulin|insulin|mesh-list
14989480|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14989481|NCT01720303|Repaglinide|repaglinide|mesh-list
14989482|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
14989483|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
14989484|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
14989485|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989486|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989487|NCT01720394|Dinoprostone|dinoprostone|mesh-list
14989488|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
14989489|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14989490|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989491|NCT01720407|Imiquimod|imiquimod|mesh-list
14989492|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14989493|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
14989494|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989495|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989496|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
14989497|NCT01720459|Resveratrol|resveratrol|mesh-list
14989498|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
14989499|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989500|NCT01720459|Protective Agents|protective agents|mesh-ancestor
14989501|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989502|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989503|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14989504|NCT01720485|Prednisolone|prednisolone|mesh-list
14989505|NCT01720485|Betamethasone|betamethasone|mesh-list
14989506|NCT01720485|Desloratadine|desloratadine|mesh-list
14989507|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
14989508|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989509|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
14989510|NCT01720485|Hormones|hormones|mesh-ancestor
14989511|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989512|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989513|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14989514|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989515|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14989516|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
14989517|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14989518|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
14989519|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989520|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989521|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14989522|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14989523|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
14989524|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
14989525|NCT01720498|Remifentanil|remifentanil|mesh-list
14989526|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989527|NCT01720498|Narcotics|narcotics|mesh-ancestor
14989528|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989529|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989530|NCT01720498|Analgesics|analgesics|mesh-ancestor
14989531|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
14989532|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989533|NCT01720537|Bococizumab|bococizumab|mesh-list
14989534|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14989535|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14989536|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14989537|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
14989538|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989539|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14989540|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
14989541|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989542|NCT01720563|Leucovorin|leucovorin|mesh-list
14989543|NCT01720563|Tegafur|tegafur|mesh-list
14989544|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989545|NCT01720563|Antidotes|antidotes|mesh-ancestor
14989546|NCT01720563|Protective Agents|protective agents|mesh-ancestor
14989547|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989548|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
14989549|NCT01720563|Vitamins|vitamins|mesh-ancestor
14989550|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
14989551|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14989552|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
14989553|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989554|NCT01720615|Remifentanil|remifentanil|mesh-list
14989555|NCT01720615|Propofol|propofol|mesh-list
14989556|NCT01720615|Sevoflurane|sevoflurane|mesh-list
14989557|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14989558|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989559|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989560|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14989561|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
14989562|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
14989563|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989564|NCT01720615|Narcotics|narcotics|mesh-ancestor
14989565|NCT01720615|Analgesics|analgesics|mesh-ancestor
14989566|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
14989567|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989568|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14989569|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14989570|NCT01720628|Angiogenin|angiogenin|mesh-list
14989571|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14989572|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14989573|NCT01720628|Growth Substances|growth substances|mesh-ancestor
14989574|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989575|NCT01720719|Vitamin E|vitamin e|mesh-list
14989576|NCT01720719|Atorvastatin|atorvastatin|mesh-list
14989577|NCT01720719|Vitamins|vitamins|mesh-ancestor
14989578|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
14989579|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989580|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14989581|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14989582|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
14989583|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989584|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14989585|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14989586|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989587|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
14989588|NCT01720719|Protective Agents|protective agents|mesh-ancestor
15031159|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15031160|NCT01972763|Growth Substances|growth substances|mesh-ancestor
15031161|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031162|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
15031163|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031164|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
15031165|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
15031166|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
15031167|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
15031168|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15031169|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031170|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15031171|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031172|NCT01972906|Ibuprofen|ibuprofen|mesh-list
15031173|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15031174|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15031175|NCT01972906|Analgesics|analgesics|mesh-ancestor
15031176|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
15031177|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031178|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031179|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031180|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031181|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15031182|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031183|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031184|NCT01972984|Anastrozole|anastrozole|mesh-list
15031185|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031186|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031187|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15031188|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15031189|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031190|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031191|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15031192|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
15031193|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031194|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031195|NCT01973010|Ibuprofen|ibuprofen|mesh-list
15031196|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15031197|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15031198|NCT01973010|Analgesics|analgesics|mesh-ancestor
15031199|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
15031200|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031201|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989589|NCT01720836|Poly ICLC|poly iclc|mesh-list
14989590|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
14989591|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
14989592|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989593|NCT01720875|Dexamethasone|dexamethasone|mesh-list
14989594|NCT01720875|Bortezomib|bortezomib|mesh-list
14989595|NCT01720875|Vorinostat|vorinostat|mesh-list
14989596|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989597|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
14989598|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
14989599|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989600|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989601|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14989602|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
14989603|NCT01720875|Hormones|hormones|mesh-ancestor
14989604|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989605|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14989606|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989607|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14989608|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989609|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989610|NCT01720940|Vancomycin|vancomycin|mesh-list
14989611|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989612|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989613|NCT01721031|Tramadol|tramadol|mesh-list
14989614|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989615|NCT01721031|Narcotics|narcotics|mesh-ancestor
14989616|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989617|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989618|NCT01721031|Analgesics|analgesics|mesh-ancestor
14989619|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
14989620|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989621|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
14989622|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14989623|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989624|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989625|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14989626|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14989627|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989628|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989629|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989630|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14989631|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
14989632|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14989633|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989634|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14989635|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14989636|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14989637|NCT01721291|Albuterol|albuterol|mesh-list
14989638|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14989639|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
14989640|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989641|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989642|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14989643|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
14989644|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
14989645|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14989646|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14989647|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14989648|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14989649|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989650|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989651|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801297|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801298|NCT00791804|Analgesics|analgesics|mesh-ancestor
14801299|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
14801300|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801301|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14801302|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14801303|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
14801304|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
14801305|NCT00791830|Irbesartan|irbesartan|mesh-list
14801306|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14801307|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14801308|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14801309|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989652|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14989653|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989654|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989655|NCT01721382|Incretins|incretins|mesh-ancestor
14989656|NCT01721382|Hormones|hormones|mesh-ancestor
14989657|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989658|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14989659|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
14989660|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989661|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989662|NCT01721434|Simendan|simendan|mesh-list
14989663|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14989664|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989665|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14989666|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14989667|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989668|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989669|NCT01721434|Protective Agents|protective agents|mesh-ancestor
14989670|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989671|NCT01721525|Ribavirin|ribavirin|mesh-list
14989672|NCT01721525|Paclitaxel|paclitaxel|mesh-list
14989673|NCT01721525|Carboplatin|carboplatin|mesh-list
14989674|NCT01721525|Afatinib|afatinib|mesh-list
14989675|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14989676|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989677|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
14989678|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
14989679|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
14989680|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989681|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
14989682|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
14989683|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989684|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14989685|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989686|NCT01721616|Azithromycin|azithromycin|mesh-list
14989687|NCT01721616|Cefazolin|cefazolin|mesh-list
14989688|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989689|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989690|NCT01721655|Spironolactone|spironolactone|mesh-list
14989691|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14989692|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
14989693|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989694|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989695|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14989696|NCT01721655|Diuretics|diuretics|mesh-ancestor
14989697|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
14989698|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14989699|NCT01721694|Azithromycin|azithromycin|mesh-list
14989700|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989701|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989702|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14989703|NCT01721707|Latanoprost|latanoprost|mesh-list
14989704|NCT01721707|Brinzolamide|brinzolamide|mesh-list
14989705|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14989706|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14989707|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14989708|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989709|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989710|NCT01721798|Copper|copper|mesh-list
14989711|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
14989712|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14989713|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
14989714|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14989715|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989716|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14989717|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14989718|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14989719|NCT01721798|Trace Elements|trace elements|mesh-ancestor
14989720|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
14989721|NCT01721915|Vitamin D|vitamin d|mesh-list
14989722|NCT01721915|Vitamins|vitamins|mesh-ancestor
14989723|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
14989724|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989725|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14989726|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
15035335|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989727|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14989728|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989729|NCT01722110|Indomethacin|indomethacin|mesh-list
14989730|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14989731|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14989732|NCT01722110|Analgesics|analgesics|mesh-ancestor
14989733|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
14989734|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989735|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989736|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989737|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989738|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
14989739|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
14989740|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14989741|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14989742|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989743|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989744|NCT01722201|Risperidone|risperidone|mesh-list
14989745|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14989746|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
14989747|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989748|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989749|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989750|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14989751|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14989752|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989753|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14989754|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14989755|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
14989756|NCT01722214|Adalimumab|adalimumab|mesh-list
14989757|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989758|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14989759|NCT01722227|Liraglutide|liraglutide|mesh-list
14989760|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989761|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989762|NCT01722227|Incretins|incretins|mesh-ancestor
14989763|NCT01722227|Hormones|hormones|mesh-ancestor
14989764|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989765|NCT01722240|Liraglutide|liraglutide|mesh-list
14989766|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14989767|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989768|NCT01722240|Incretins|incretins|mesh-ancestor
14989769|NCT01722240|Hormones|hormones|mesh-ancestor
14989770|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989771|NCT01722305|Dexamethasone|dexamethasone|mesh-list
14989772|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
14989773|NCT01722305|Pomalidomide|pomalidomide|mesh-list
14989774|NCT01722305|Ichthammol|ichthammol|mesh-list
14989775|NCT01722305|BB 1101|bb 1101|mesh-list
14989776|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989777|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
14989778|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
14989779|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989780|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989781|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14989782|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
14989783|NCT01722305|Hormones|hormones|mesh-ancestor
14801310|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
14801311|NCT00791856|Testosterone|testosterone|mesh-list
14801312|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
14801313|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
14801314|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14801315|NCT00791856|Androgens|androgens|mesh-ancestor
14801316|NCT00791856|Hormones|hormones|mesh-ancestor
14989784|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989785|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14989786|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989787|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
14989788|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989789|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989790|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
14989791|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989792|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14801317|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14989793|NCT01722305|Growth Substances|growth substances|mesh-ancestor
14989794|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
14989795|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
14989796|NCT01722396|Vitamin D|vitamin d|mesh-list
14989797|NCT01722396|Vitamins|vitamins|mesh-ancestor
14989798|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
14989799|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989800|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14989801|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
14989802|NCT01722409|Sevoflurane|sevoflurane|mesh-list
14989803|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14989804|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989805|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989806|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14989807|NCT01722409|Analgesics|analgesics|mesh-ancestor
14989808|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
14989809|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989810|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14989811|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14989812|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14989813|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989814|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989815|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989816|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14989817|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14989818|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
14989819|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
14989820|NCT01722448|Choline|choline|mesh-list
14989821|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
14989822|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14989823|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
14989824|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989825|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14989826|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14989827|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
14989828|NCT01722513|Alprostadil|alprostadil|mesh-list
14989829|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14989830|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989831|NCT01722513|Urological Agents|urological agents|mesh-ancestor
14989832|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
14989833|NCT01722539|Piperaquine|piperaquine|mesh-list
14989834|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
14989835|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14989836|NCT01722539|Albendazole|albendazole|mesh-list
14989837|NCT01722539|Praziquantel|praziquantel|mesh-list
14989838|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
14989839|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14989840|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14989841|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989842|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14989843|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989844|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801318|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801319|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14801320|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801321|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
14989845|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14989846|NCT01722539|Renal Agents|renal agents|mesh-ancestor
14989847|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
14989848|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
14989849|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14989850|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
14989851|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
14989852|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
14989853|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989854|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
14989855|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
14989856|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14989857|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989858|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989859|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989860|NCT01722630|Dopamine|dopamine|mesh-list
14989861|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14989862|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
14989863|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
14989864|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989865|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989866|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
14989867|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989868|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989869|NCT01722630|Protective Agents|protective agents|mesh-ancestor
14989870|NCT01722656|Aflibercept|aflibercept|mesh-list
14989871|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989872|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14989873|NCT01722656|Growth Substances|growth substances|mesh-ancestor
14989874|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989875|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
14989876|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031202|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031203|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031204|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15031205|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031206|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031207|NCT01973101|Gemcitabine|gemcitabine|mesh-list
15031208|NCT01973101|Cisplatin|cisplatin|mesh-list
15031209|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801322|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
14801323|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
14801324|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
14801325|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14801326|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801327|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
14801328|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
14801329|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
14801330|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801331|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801332|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801333|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14801334|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
14801335|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
15031210|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15031211|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
14989877|NCT01722708|Metronidazole|metronidazole|mesh-list
14989878|NCT01722708|Clindamycin|clindamycin|mesh-list
14989879|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
14989880|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
14989881|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989882|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989883|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14989884|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14989885|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14989886|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989887|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989888|NCT01722799|Paclitaxel|paclitaxel|mesh-list
14989889|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14989890|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989891|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
14989892|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
14989893|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
14989894|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989895|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
14989896|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
14989897|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
14523459|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523460|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
14523461|NCT03593902|Hormones|hormones|mesh-ancestor
14523462|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523463|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14523464|NCT03593902|Protective Agents|protective agents|mesh-ancestor
14523465|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14523466|NCT03594045|Apixaban|apixaban|mesh-list
14523467|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14523468|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
14523469|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14523470|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
14523471|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523472|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523473|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
14989898|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989899|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14989900|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14989901|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
14989902|NCT01722942|Amiodarone|amiodarone|mesh-list
14989903|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14989904|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989905|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14989906|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14989907|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989908|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14989909|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14523474|NCT03595449|Lidocaine|lidocaine|mesh-list
14989910|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14801336|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801337|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801338|NCT00792012|Temozolomide|temozolomide|mesh-list
14801339|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14801340|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
14801341|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989911|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989912|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14989913|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14989914|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14989915|NCT01722968|Paclitaxel|paclitaxel|mesh-list
14989916|NCT01722968|Bevacizumab|bevacizumab|mesh-list
14989917|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14989918|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989919|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
14989920|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
14801342|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801343|NCT00792025|Sunitinib|sunitinib|mesh-list
14801344|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989921|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
14989922|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989923|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14989924|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989925|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14989926|NCT01722968|Growth Substances|growth substances|mesh-ancestor
14989927|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989928|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
14989929|NCT01723059|Amoxicillin|amoxicillin|mesh-list
14989930|NCT01723059|Metronidazole|metronidazole|mesh-list
14989931|NCT01723059|Clarithromycin|clarithromycin|mesh-list
14989932|NCT01723059|Omeprazole|omeprazole|mesh-list
14989933|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989934|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989935|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14989936|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14989937|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14989938|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14989939|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14989940|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989941|NCT01723059|Molecular Mechanisms of 